PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Darzi, Y; Jiao, YZ; Hasegawa, M; Moon, H; Nunez, G; Inohara, N; Raes, J				Darzi, Youssef; Jiao, Yizu; Hasegawa, Mizuho; Moon, Henry; Nunez, Gabriel; Inohara, Naohiro; Raes, Jeroen			The Genomic Sequence of the Oral Pathobiont Strain NI1060 Reveals Unique Strategies for Bacterial Competition and Pathogenicity	PLOS ONE			English	Article							HAEMOPHILUS-INFLUENZAE RD; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; NOD1; PEPTIDOGLYCAN; ALGORITHM; GROWTH; INDUCTION; VIRULENCE; ISLAND; GENES	Strain NI1060 is an oral bacterium responsible for periodontitis in a murine ligature-induced disease model. To better understand its pathogenicity, we have determined the complete sequence of its 2,553,982 bp genome. Although closely related to Pasteurella pneumotropica, a pneumonia-associated rodent commensal based on its 16S rRNA, the NI1060 genomic content suggests that they are different species thriving on different energy sources via alternative metabolic pathways. Genomic and phylogenetic analyses showed that strain NI1060 is distinct from the genera currently described in the family Pasteurellaceae, and is likely to represent a novel species. In addition, we found putative virulence genes involved in lipooligosaccharide synthesis, adhesins and bacteriotoxic proteins. These genes are potentially important for host adaption and for the induction of dysbiosis through bacterial competition and pathogenicity. Importantly, strain NI1060 strongly stimulates Nod1, an innate immune receptor, but is defective in two peptidoglycan recycling genes due to a frameshift mutation. The in-depth analysis of its genome thus provides critical insights for the development of NI1060 as a prime model system for infectious disease.	[Darzi, Youssef; Raes, Jeroen] Vrije Univ Brussel, Microbiol Unit, Dept Bioengn Sci, Brussels, Belgium; [Darzi, Youssef; Raes, Jeroen] VIB, Ctr Biol Dis, Leuven, Belgium; [Darzi, Youssef; Raes, Jeroen] Katholieke Univ Leuven, Rega Inst, Dept Microbiol & Immunol, Leuven, Belgium; [Jiao, Yizu; Hasegawa, Mizuho; Moon, Henry; Nunez, Gabriel; Inohara, Naohiro] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Nunez, Gabriel] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA	Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); KU Leuven; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Raes, J (corresponding author), Vrije Univ Brussel, Microbiol Unit, Dept Bioengn Sci, Brussels, Belgium.; Raes, J (corresponding author), VIB, Ctr Biol Dis, Leuven, Belgium.; Raes, J (corresponding author), Katholieke Univ Leuven, Rega Inst, Dept Microbiol & Immunol, Leuven, Belgium.; Inohara, N (corresponding author), Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA.	ino@umich.edu; jeroen.raes@med.kuleuven.be	Nuñez, Gabriel/A-7160-2014; raes, jeroen/D-7835-2018; Darzi, Youssef/I-8920-2019	raes, jeroen/0000-0002-1337-041X; Darzi, Youssef/0000-0001-7655-5764	Research Foundation Flanders (FWO); Flemish agency for Innovation by Science and Technology (IWT); KU Leuven; Rega Institute; NIH [R01DE018503]	Research Foundation Flanders (FWO)(FWO); Flemish agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); KU Leuven(KU Leuven); Rega Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the Research Foundation Flanders (FWO) (JR); The Flemish agency for Innovation by Science and Technology (IWT) (JR); KU Leuven (JR); The Rega Institute (JR) and grant R01DE018503 from NIH (NI).	Avila M, 2009, DNA CELL BIOL, V28, P405, DOI 10.1089/dna.2009.0874; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Boetzer M, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-211; Boetzer M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r56; Bonazzi M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003087; Brenner DJ, 2006, BERGEYS MANUAL SYS B, V2, P851; Bryant CE, 2010, NAT REV MICROBIOL, V8, P8, DOI 10.1038/nrmicro2266; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Christensen H, 2004, INT J SYST EVOL MICR, V54, P1601, DOI 10.1099/ijs.0.03018-0; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Di Bonaventura MP, 2010, MOL PHYLOGENET EVOL, V54, P950, DOI 10.1016/j.ympev.2009.08.010; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; English AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041444; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Frirdich E, 2014, J BIOL CHEM, V289, P8007, DOI 10.1074/jbc.M113.491829; Giltner CL, 2012, MICROBIOL MOL BIOL R, V76, P740, DOI 10.1128/MMBR.00035-12; Gwinn ML, 1998, J BACTERIOL, V180, P746, DOI 10.1128/JB.180.3.746-748.1998; Hasegawa M, 2006, J BIOL CHEM, V281, P29054, DOI 10.1074/jbc.M602638200; Henderson B, 2010, PERIODONTOL 2000, V54, P78, DOI 10.1111/j.1600-0757.2009.00331.x; HERRIOTT RM, 1970, J BACTERIOL, V101, P517, DOI 10.1128/JB.101.2.517-524.1970; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; INZANA TJ, 1987, AM J VET RES, V48, P366; Jacobsen I, 2005, INFECT IMMUN, V73, P226, DOI 10.1128/IAI.73.1.226-234.2005; Jiao YZ, 2013, CELL HOST MICROBE, V13, P595, DOI 10.1016/j.chom.2013.04.005; Kachlany SC, 2010, J DENT RES, V89, P561, DOI 10.1177/0022034510363682; Kawai T, 2007, ORAL MICROBIOL IMMUN, V22, P208, DOI 10.1111/j.1399-302X.2007.00348.x; KLEIN RD, 1979, J GEN MICROBIOL, V113, P409, DOI 10.1099/00221287-113-2-409; Lee J, 2009, J BIOL CHEM, V284, P23818, DOI 10.1074/jbc.M109.033670; Leo JC, 2012, PHILOS T R SOC B, V367, P1088, DOI 10.1098/rstb.2011.0208; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Marsh Philip D., 2000, Microbial Ecology in Health and Disease, V12, P130, DOI 10.1080/089106000750051800; Naushad HS, 2012, ANTON LEEUW INT J G, V101, P105, DOI 10.1007/s10482-011-9628-4; Nigro G, 2008, CELL MICROBIOL, V10, P682, DOI 10.1111/j.1462-5822.2007.01075.x; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rautemaa R, 1999, MICROBES INFECT, V1, P785, DOI 10.1016/S1286-4579(99)80081-1; Redfield RJ, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-82; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Roberts IS, 1996, ANNU REV MICROBIOL, V50, P285, DOI 10.1146/annurev.micro.50.1.285; Ruhe ZC, 2013, TRENDS MICROBIOL, V21, P230, DOI 10.1016/j.tim.2013.02.003; Sasaki H, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-55; Sasaki H, 2009, J BACTERIOL, V191, P3698, DOI 10.1128/JB.01527-08; Schreiner HC, 2003, P NATL ACAD SCI USA, V100, P7295, DOI 10.1073/pnas.1237223100; Segata N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3304; Silverman JM, 2012, ANNU REV MICROBIOL, V66, P453, DOI 10.1146/annurev-micro-121809-151619; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; Tang HB, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-102; Tomich M, 2007, NAT REV MICROBIOL, V5, P363, DOI 10.1038/nrmicro1636; van der Woude MW, 2008, ANNU REV MICROBIOL, V62, P153, DOI 10.1146/annurev.micro.62.081307.162938; VANHELLEMOND JJ, 1994, BIOCHEM J, V304, P321, DOI 10.1042/bj3040321; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963; Wall Dennis P., 2007, V396, P95; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Williams KP, 2010, J BACTERIOL, V192, P2305, DOI 10.1128/JB.01480-09; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zheng J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023876; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	63	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158866	10.1371/journal.pone.0158866	http://dx.doi.org/10.1371/journal.pone.0158866			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27409077	Green Published, gold, Green Submitted			2022-12-27	WOS:000379508300038
J	Lv, XY; Sun, W; Yin, JF; Ni, R; Su, R; Wang, QZ; Gao, W; Bao, JJ; Yu, JR; Wang, LH; Chen, L				Lv, Xiaoyang; Sun, Wei; Yin, Jinfeng; Ni, Rong; Su, Rui; Wang, Qingzeng; Gao, Wen; Bao, Jianjun; Yu, Jiarui; Wang, Lihong; Chen, Ling			An Integrated Analysis of MicroRNA and mRNA Expression Profiles to Identify RNA Expression Signatures in Lambskin Hair Follicles in Hu Sheep	PLOS ONE			English	Article							GROWTH; IDENTIFICATION; CELLS; MORPHOGENESIS; ACTIVATION; MECHANISM; PROTEIN; GENE; SKIN	Wave patterns in lambskin hair follicles are an important factor determining the quality of sheep's wool. Hair follicles in lambskin from Hu sheep, a breed unique to China, have 3 types of waves, designated as large, medium, and small. The quality of wool from small wave follicles is excellent, while the quality of large waves is considered poor. Because no molecular and biological studies on hair follicles of these sheep have been conducted to date, the molecular mechanisms underlying the formation of different wave patterns is currently unknown. The aim of this article was to screen the candidate microRNAs (miRNA) and genes for the development of hair follicles in Hu sheep. Two-day-old Hu lambs were selected from full-sib individuals that showed large, medium, and small waves. Integrated analysis of microRNA and mRNA expression profiles employed high-throughout sequencing technology. Approximately 13, 24, and 18 differentially expressed miRNAs were found between small and large waves, small and medium waves, and medium and large waves, respectively. A total of 54, 190, and 81 differentially expressed genes were found between small and large waves, small and medium waves, and medium and large waves, respectively, by RNA sequencing (RNA-seq) analysis. Differentially expressed genes were classified using gene ontology and pathway analyses. They were found to be mainly involved in cell differentiation, proliferation, apoptosis, growth, immune response, and ion transport, and were associated with MAPK and the Notch signaling pathway. Reverse transcriptionpolymerase chain reaction (RT-PCR) analyses of differentially-expressed miRNA and genes were consistent with sequencing results. Integrated analysis of miRNA and mRNA expression indicated that, compared to small waves, large waves included 4 downregulated miRNAs that had regulatory effects on 8 upregulated genes and 3 upregulated miRNAs, which in turn influenced 13 downregulated genes. Compared to small waves, medium waves included 13 downregulated miRNAs that had regulatory effects on 64 upregulated genes and 4 upregulated miRNAs, which in turn had regulatory effects on 22 downregulated genes. Compared to medium waves, large waves consisted of 13 upregulated miRNAs that had regulatory effects on 48 downregulated genes. These differentially expressed miRNAs and genes may play a significant role in forming different patterns, and provide evidence for the molecular mechanisms underlying the formation of hair follicles of varying patterns.	[Lv, Xiaoyang; Sun, Wei; Yin, Jinfeng; Ni, Rong; Su, Rui; Wang, Qingzeng; Gao, Wen; Bao, Jianjun; Yu, Jiarui; Wang, Lihong] Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou, Jiangsu, Peoples R China; [Chen, Ling] Anim Sci & Vet Med Bur Suzhou City, Suzhou, Peoples R China	Yangzhou University	Sun, W (corresponding author), Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou, Jiangsu, Peoples R China.	dkxmsunwei@163.com			Ministry of Science and Technology of China, Jiangsu Agricultural Science and the Technology support program of China [BE2012331]; graduate education innovation project of Jiangsu province of China [KYLX15_1375]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Project of Jiangsu Province Engineering Research Center of China [BM2012308]; key project of Jiangsu Province of the national Spark Program of China [2012GA690003]; Subei Science and Technology program of Jiangsu Province of China [BN2014003, BN2015013, BN2015014]; Project of Jiangsu Province Agricultural Science and Technology Innovation Fund [CX(14)2073]; Project of Six Peak of Talents of Jiangsu Province of China	Ministry of Science and Technology of China, Jiangsu Agricultural Science and the Technology support program of China; graduate education innovation project of Jiangsu province of China; Priority Academic Program Development of Jiangsu Higher Education Institutions; Project of Jiangsu Province Engineering Research Center of China; key project of Jiangsu Province of the national Spark Program of China; Subei Science and Technology program of Jiangsu Province of China; Project of Jiangsu Province Agricultural Science and Technology Innovation Fund; Project of Six Peak of Talents of Jiangsu Province of China	This work was supported by the projects of the domesticated animals platform of the Ministry of Science and Technology of China, Jiangsu Agricultural Science and the Technology support program of China (BE2012331), the graduate education innovation project of Jiangsu province of China (KYLX15_1375), the project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions, the Project of Jiangsu Province Engineering Research Center of China (BM2012308), the key project of Jiangsu Province of the national Spark Program of China (2012GA690003), the Subei Science and Technology program of Jiangsu Province of China (BN2014003, BN2015013, BN2015014), the Project of Jiangsu Province Agricultural Science and Technology Innovation Fund (CX(14)2073), and the Project of Six Peak of Talents of Jiangsu Province of China.; This work was supported by the projects of the domesticated animals platform of the Ministry of Science and Technology of China, Jiangsu Agricultural Science and the Technology support program of China (BE2012331), the graduate education innovation project of Jiangsu province of China (KYLX15_1375), the project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions, the Project of Jiangsu Province Engineering Research Center of China (BM2012308), the key project of Jiangsu Province of the national Spark Program of China (2012GA690003), the Subei Science and Technology program of Jiangsu Province of China (BN2014003, BN2015013, BN2015014), the Project of Jiangsu Province Agricultural Science and Technology Innovation Fund (CX(14)2073), and the Project of Six Peak of Talents of Jiangsu Province of China.	Alonso L, 2006, J CELL SCI, V119, P391, DOI 10.1242/jcs02793; Assa-Kunik E, 2007, DEVELOPMENT, V134, P1161, DOI 10.1242/dev.02800; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Blahnik KR, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1012; Boras K, 2002, J BIOL CHEM, V277, P1120, DOI 10.1074/jbc.M109912200; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cha HJ, 2010, INT J DEV BIOL, V54, P135, DOI 10.1387/ijdb.082735hc; Cheng R. H., 1980, J EC ANIMAL, P40; Cheung HH, 2011, ONCOGENE, V30, P3404, DOI 10.1038/onc.2011.60; DAVIDSON P, 1952, J ANAT, V86, P342; Foitzik K, 1999, DEV BIOL, V212, P278, DOI 10.1006/dbio.1999.9325; Frayling TM, 2007, NAT REV GENET, V8, P657, DOI 10.1038/nrg2178; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Grose R, 2005, CYTOKINE GROWTH F R, V16, P179, DOI 10.1016/j.cytogfr.2005.01.003; Guo TF, 2013, CHINA HERBIVORE SCI, V33, P68; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Harris PJ, 2010, CANCER PREV RES, V3, P1217, DOI 10.1158/1940-6207.CAPR-10-0210; He XL, 2014, SMALL RUMINANT RES, V116, P111, DOI 10.1016/j.smallrumres.2013.10.020; Headon DJ, 1999, NAT GENET, V22, P370, DOI 10.1038/11943; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li W, 2012, EXP CELL RES, V318, P1633, DOI 10.1016/j.yexcr.2012.05.003; Li XP, 2013, MOL CELLS, V36, P316, DOI 10.1007/s10059-013-0093-y; Liu GB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077801; Liu J, 2008, DEV CELL, V14, P751, DOI 10.1016/j.devcel.2008.02.015; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu B. G., 1979, CHINESE J ANIMAL SCI, P14; Lu Z, 2006, ONCOGENE, V25, P2920, DOI 10.1038/sj.onc.1209318; Lund AH, 2010, CELL DEATH DIFFER, V17, P209, DOI 10.1038/cdd.2009.58; Mardaryev AN, 2010, FASEB J, V24, P3869, DOI 10.1096/fj.10-160663; Miao Y, 2008, SHANDONG MED J, V48, P17; Millar SE, 1999, DEV BIOL, V207, P133, DOI 10.1006/dbio.1998.9140; Nakamura M, 2013, J DERMATOL SCI, V69, P6, DOI 10.1016/j.jdermsci.2012.10.001; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004; Schmidt-Ullrich R, 2005, BIOESSAYS, V27, P247, DOI 10.1002/bies.20184; Sennett R, 2012, SEMIN CELL DEV BIOL, V23, P917, DOI 10.1016/j.semcdb.2012.08.011; Standley HJ, 2006, DEV BIOL, V289, P318, DOI 10.1016/j.ydbio.2005.10.012; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; Su J, 2012, INT J ONCOL, V40, P1162, DOI 10.3892/ijo.2011.1322; Tampe D, 2014, NAT REV NEPHROL, V10, P226, DOI 10.1038/nrneph.2014.14; Trakooljul N, 2010, ANIM GENET, V41, P357, DOI 10.1111/j.1365-2052.2009.02015.x; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Yuan C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-511; Zhao JA, 2011, J NUTR BIOCHEM, V22, P227, DOI 10.1016/j.jnutbio.2010.01.008	51	17	17	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0157463	10.1371/journal.pone.0157463	http://dx.doi.org/10.1371/journal.pone.0157463			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27404636	Green Published, Green Submitted, gold			2022-12-27	WOS:000379508200003
J	Sloan, CD; Gebretsadik, T; Rosas-Salazar, C; Wu, PS; Carroll, KN; Mitchel, E; Anderson, LJ; Larkin, EK; Hartert, TV				Sloan, Chantel D.; Gebretsadik, Tebeb; Rosas-Salazar, Christian; Wu, Pingsheng; Carroll, Kecia N.; Mitchel, Edward; Anderson, Larry J.; Larkin, Emma K.; Hartert, Tina V.			Seasonal Timing of Infant Bronchiolitis, Apnea and Sudden Unexplained Infant Death	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; INFECTION	Rates of Sudden Unexplained Infant Death (SUID), bronchiolitis, and central apnea increase in winter in temperate climates. Though associations between these three conditions are suggested, more work is required to establish if there is a causal pathway linking bronchiolitis to SUID through inducing central apnea. Utilizing a large population-based cohort of infants studied over a 20-year period (n = 834,595, from birth years 1989-2009)), we analyzed ecological associations between timing of SUID cases, bronchiolitis, and apnea healthcare visits. Data were analyzed between 2013 and 2015. We used a Cox Proportional Hazards model to analyze possible interactions between maternal smoking and maternal asthma with infant bronchiolitis on time to SUID. SUID and bronchiolitis both occurred more frequently in winter. An increase in bronchiolitis clinical visits occurred within a few days prior to apnea visits. We found a temporal relationship between infant bronchiolitis and apnea. In contrast, no peak in SUID cases was seen during peaks of bronchiolitis. Among those without any bronchiolitis visits, maternal smoking was associated with an increased risk of SUID: Hazard Ratio (HR) of 2.38 (95% CI: 2.11, 2.67, p-value <0.001). Maternal asthma was associated with an increased risk of SUID among infants with at least one bronchiolitis visit: HR of 2.40 (95% CI: 1.04, 5.54, p-value = 0.04). Consistent trends between bronchiolitis, apnea, and SUID were not established due to small numbers of SUID cases. However, interaction analysis revealed potential differential associations of bronchiolitis and SUID by maternal smoking, maternal asthma status.	[Sloan, Chantel D.] Brigham Young Univ, Dept Hlth Sci, Provo, UT USA; [Gebretsadik, Tebeb; Rosas-Salazar, Christian; Wu, Pingsheng; Carroll, Kecia N.; Larkin, Emma K.; Hartert, Tina V.] Vanderbilt Univ, Sch Med, Ctr Asthma Res, Nashville, TN USA; [Gebretsadik, Tebeb; Wu, Pingsheng] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN USA; [Rosas-Salazar, Christian; Carroll, Kecia N.; Hartert, Tina V.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN USA; [Wu, Pingsheng; Larkin, Emma K.; Hartert, Tina V.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN USA; [Mitchel, Edward] Vanderbilt Univ, Sch Med, Dept Hlth Policy, Nashville, TN USA; [Anderson, Larry J.] Emory Univ, Sch Med, Dept Pediat Pediat Infect Dis, Atlanta, GA USA	Brigham Young University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Emory University	Hartert, TV (corresponding author), Vanderbilt Univ, Sch Med, Ctr Asthma Res, Nashville, TN USA.; Hartert, TV (corresponding author), Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN USA.; Hartert, TV (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN USA.	tina.hartert@vanderbilt.edu	Rosas-Salazar, Christian/AAC-8571-2021; Sloan-Aagard, Chantel/GWC-7572-2022	Rosas-Salazar, Christian/0000-0001-6644-5780; 	National Institute of Environmental Health Sciences [ES00267]; National Institute of Allergy and Infectious Diseases [K24 77930]; National Institutes of Health [ES15855, R01 HS 018454]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS018454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI077930] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267, K12ES015855] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by a National Institute of Environmental Health Sciences (http://www.niehs.nih.gov/) ES00267 to TVH and CS, National Institute of Allergy and Infectious Diseases (https://www.niaid.nih.gov) K24 77930 to TVH, National Institutes of Health (http://www.nih.gov/) ES15855 to TVH, and R01 HS 018454 to TVH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are indebted to the Tennessee Bureau of TennCare of the Department of Finance and Administration, and the Tennessee Department of Health, Office of Policy, Planning & Assessment, for providing the data. This work was supported by a National Institute of Environmental Health Sciences (http://www.niehs.nih.gov/) ES00267 to TVH and CS, National Institute of Allergy and Infectious Diseases (https://www.niaid.nih.gov) K24 77930 to TVH, National Institutes of Health (http://www.nih.gov/) ES15855 to TVH, and R01 HS 018454 to TVH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carroll KN, 2009, J ALLERGY CLIN IMMUN, V124, P1121, DOI 10.1016/j.jaci.2009.07.060; HEDNER J, 1984, J APPL PHYSIOL, V56, P849, DOI 10.1152/jappl.1984.56.4.849; Kelly D H, 1985, Pediatr Pulmonol, V1, P215, DOI 10.1002/ppul.1950010409; Limelette A, 2013, ANN BIOL CLIN-PARIS, V71, P299, DOI 10.1684/abc.2013.0825; Martin Richard J, 2004, Paediatr Respir Rev, V5 Suppl A, pS377, DOI 10.1016/S1526-0542(04)90067-X; Moon RY, 2007, LANCET, V370, P1578, DOI 10.1016/S0140-6736(07)61662-6; Ralston S, 2009, J PEDIATR-US, V155, P728, DOI 10.1016/j.jpeds.2009.04.063; Ricart S, 2014, PEDIATR INFECT DIS J, V33, P988, DOI 10.1097/INF.0000000000000365; Rothman KJ., 2012, EPIDEMIOLOGY INTRO; Sabogal C, 2005, PEDIATR RES, V57, P819, DOI 10.1203/01.PDR.0000157679.67227.11; Samuels Martin, 2003, Paediatr Respir Rev, V4, P178, DOI 10.1016/S1526-0542(03)00050-2; Schiller O, 2011, ACTA PAEDIATR, V100, P216, DOI 10.1111/j.1651-2227.2010.02004.x; Sekizawa SI, 2010, TOXICOL APPL PHARM, V242, P199, DOI 10.1016/j.taap.2009.10.009; Sloan Chantel D, 2013, Ann Am Thorac Soc, V10, P131, DOI 10.1513/AnnalsATS.201209-076BC; Thach B, 2008, EMBO REP, V9, P114, DOI 10.1038/sj.embor.7401163; Tortorolo L, 2005, AM J RESP CRIT CARE, V172, P233, DOI 10.1164/rccm.200412-1693OC; Tripp RA, 2003, J VIROL, V77, P6580, DOI 10.1128/JVI.77.11.6580-6584.2003; Urrego F, 2009, PEDIATR PULM, V44, P1075, DOI 10.1002/ppul.21099; Wu PS, 2008, AM J RESP CRIT CARE, V178, P1123, DOI 10.1164/rccm.200804-579OC; Zhao J, 2011, EUR J PEDIATR, V170, P1097, DOI 10.1007/s00431-011-1409-6	20	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0158521	10.1371/journal.pone.0158521	http://dx.doi.org/10.1371/journal.pone.0158521			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27404386	Green Submitted, Green Published, gold			2022-12-27	WOS:000379508200011
J	von Websky, MW; Kitamura, K; Ludwig-Portugall, I; Kurts, C; von Laffert, M; LeMaoult, J; Carosella, ED; Abu-Elmagd, K; Kalff, JC; Schafer, N				von Websky, Martin W.; Kitamura, Koji; Ludwig-Portugall, Isis; Kurts, Christian; von Laffert, Maximilian; LeMaoult, Joel; Carosella, Edgardo D.; Abu-Elmagd, Kareem; Kalff, Joerg C.; Schaefer, Nico			Recombinant HLA-G as Tolerogenic Immunomodulant in Experimental Small Bowel Transplantation	PLOS ONE			English	Article							T-CELL; INTESTINAL TRANSPLANTATION; G EXPRESSION; REJECTION; INFLAMMATION; DYSFUNCTION; ALLOGRAFTS; APOPTOSIS	The non-classical MHC I paralogue HLA-G is expressed by cytotrophoblast cells and implicated with fetomaternal tolerance by downregulating the maternal adaptive and innate immune response against the fetus. HLA-G expression correlates with favorable graft outcome in humans and recently promising immunosuppressive effects of therapeutic HLA-G in experimental transplantation (skin allograft acceptance) were shown. Consequently, we examined this novel therapeutic approach in solid organ transplantation. In this study, therapeutic recombinant HLA-G5 was evaluated for the first time in a solid organ model of acute rejection (ACR) after orthotopic intestinal transplantation (ITX). Allogenic ITX was performed in rats (Brown Norway to Lewis) with and without HLA-G treatment. It was found that HLA-G treatment significantly reduced histologically proven ACR at both an early and late postoperative timepoint (POD 4/7), concomitant to a functionally preserved graft contractility at POD 7. Interestingly, graft infiltration by myeloperoxidase+ cells was significantly reduced at POD7 by HLA-G treatment. Moreover, HLA-G treatment showed an effect on the allogenic T-cell immune response as assessed by flow cytometry: The influx of recipient-derived CD8(+) T-cells into the graft mesenteric lymphnodes at POD7 was significantly reduced while CD4(+) populations were not affected. As a potential mechanism of action, an induction of T-reg populations in the mesenteric lymphnodes was postulated, but flow cytometric analysis of classical CD4(+)/CD25(+)/FoxP3(+)T(reg)-cells showed no significant alteration by HLA-G treatment. The novel therapeutic approach using recombinant HLA-G5 reported herein demonstrates a significant immunosuppressive effect in this model of allogenic experimental intestinal transplantation. This effect may be mediated via inhibition of recipient-derived CD8(+) T-cell populations either directly or by induction of non-classical T-reg populations.	[von Websky, Martin W.; Kitamura, Koji; Kalff, Joerg C.; Schaefer, Nico] Univ Hosp Bonn, Dept Surg, Bonn, Germany; [Kitamura, Koji] Kyoto Univ Hosp, Dept Hepatobiliary Pancreat Surg & Transplantat, Kyoto, Japan; [Ludwig-Portugall, Isis; Kurts, Christian] Univ Bonn, Inst Expt Immunol, Bonn, Germany; [von Laffert, Maximilian] Charite, Inst Pathol, Berlin, Germany; [LeMaoult, Joel; Carosella, Edgardo D.] St Louis Hosp, CEA, iMETI, Res Div Hematol & Immunol, Paris, France; [Abu-Elmagd, Kareem] Cleveland Clin, Transplant Ctr, Cleveland, OH 44106 USA	University of Bonn; Kyoto University; University of Bonn; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; CEA; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; Cleveland Clinic Foundation	Schafer, N (corresponding author), Univ Hosp Bonn, Dept Surg, Bonn, Germany.	nico.schaefer@ukb.uni-bonn.de	Kalff, Joerg C/U-8580-2017; LeMaoult, Joel/E-9583-2011	von Laffert, Maximilian/0000-0002-8799-0427; LeMaoult, Joel/0000-0002-4513-9482	Else-Kroner Fresenius Foundation	Else-Kroner Fresenius Foundation	Martin W von Websky received a scholarship from the Else-Kroner Fresenius Foundation [http://www.ekfs.de/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Elmagd K, 1998, J AM COLL SURGEONS, V186, P512, DOI 10.1016/S1072-7515(98)00083-0; Abu-Elmagd KM, 2009, ANN SURG, V250, P567, DOI 10.1097/SLA.0b013e3181b67725; Abu-Elmagd KM, 2009, TRANSPL INT, V22, P96, DOI 10.1111/j.1432-2277.2008.00785.x; Briscoe DDM, 2002, NAT MED, V8, P220, DOI 10.1038/nm0302-220; Brugiere O, 2009, AM J TRANSPLANT, V9, P1427, DOI 10.1111/j.1600-6143.2009.02650.x; Carosella ED, 2011, BLOOD, V118, P6499, DOI 10.1182/blood-2011-07-370742; Contini P, 2003, EUR J IMMUNOL, V33, P125, DOI 10.1002/immu.200390015; Creput C, 2003, AM J TRANSPLANT, V3, P348, DOI 10.1034/j.1600-6143.2003.00050.x; Favier B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021011; Fuzzi B, 2002, EUR J IMMUNOL, V32, P311, DOI 10.1002/1521-4141(200202)32:2<311::AID-IMMU311>3.3.CO;2-#; Grant D, INTESTINAL TRANSPLAN; Horne PH, 2007, J IMMUNOL, V179, P80, DOI 10.4049/jimmunol.179.1.80; Ito T, 2005, J INVEST DERMATOL, V125, P1139, DOI 10.1111/j.0022-202X.2005.23927.x; Kalff JC, 1999, SURGERY, V126, P498, DOI 10.1016/S0039-6060(99)70091-7; Kitamura K, 2012, JOVE-J VIS EXP, DOI 10.3791/4102; KOVATS S, 1990, SCIENCE, V248, P220, DOI 10.1126/science.2326636; Krams SM, 1998, J IMMUNOL, V160, P3673; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Le Discorde M, 2003, HUM IMMUNOL, V64, P1039, DOI 10.1016/j.humimm.2003.08.346; Le Rond S, 2006, J IMMUNOL, V176, P3266, DOI 10.4049/jimmunol.176.5.3266; LeMaoult J, 2013, FASEB J, V27, P3643, DOI 10.1096/fj.13-228247; Liang SY, 2002, EUR J IMMUNOL, V32, P2418, DOI 10.1002/1521-4141(200209)32:9<2418::AID-IMMU2418>3.0.CO;2-L; Newell KA, 1997, TRANSPLANTATION, V64, P959, DOI 10.1097/00007890-199710150-00004; Pech T, 2012, AM J TRANSPLANT, V12, pS9, DOI 10.1111/j.1600-6143.2012.04262.x; Puppo Francesco, 2002, ScientificWorldJournal, V2, P421; Riteau B, 1999, J REPROD IMMUNOL, V43, P203, DOI 10.1016/S0165-0378(99)00034-0; RouasFreiss N, 1997, P NATL ACAD SCI USA, V94, P11520, DOI 10.1073/pnas.94.21.11520; Schaefer N, 2007, AM J TRANSPLANT, V7, P1062, DOI 10.1111/j.1600-6143.2007.01747.x; Schaefer N, 2008, TRANSPLANTATION, V85, P1465, DOI 10.1097/TP.0b013e31816fc189; Shin CR, 2011, J PEDIATR SURG, V46, P1732, DOI 10.1016/j.jpedsurg.2011.04.016; Starkey HDV, 2012, J MOL NEUROSCI, V48, P111, DOI 10.1007/s12031-012-9783-8; Takai T, 2005, IMMUNOLOGY, V115, P433, DOI 10.1111/j.1365-2567.2005.02177.x; Tsuruyama T, 2012, TRANSPL INT, V25, P537, DOI 10.1111/j.1432-2277.2012.01450.x; Tuler A, 2002, TRANSPLANT P, V34, P921, DOI 10.1016/S0041-1345(02)02670-2; Wu T, 2003, TRANSPLANTATION, V75, P1241, DOI 10.1097/01.TP.0000062840.49159.2F	35	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0158907	10.1371/journal.pone.0158907	http://dx.doi.org/10.1371/journal.pone.0158907			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27404095	gold, Green Published, Green Submitted			2022-12-27	WOS:000379508200020
J	Asemaninejad, A; Weerasuriya, N; Gloor, GB; Lindo, Z; Thorn, RG				Asemaninejad, Asma; Weerasuriya, Nimalka; Gloor, Gregory B.; Lindo, Zoe; Thorn, R. Greg			New Primers for Discovering Fungal Diversity Using Nuclear Large Ribosomal DNA	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; PHYLOGENETIC ANALYSIS; COMMUNITY ANALYSIS; SEQUENCE-DATA; RNA; IDENTIFICATION; BARCODE; REGION; PENICILLIUM; GENERATION	Metabarcoding has become an important tool in the discovery of biodiversity, including fungi, which are the second most speciose group of eukaryotes, with diverse and important ecological roles in terrestrial ecosystems. We have designed and tested new PCR primers that target the D1 variable region of nuclear large subunit (LSU) ribosomal DNA; one set that targets the phylum Ascomycota and another that recovers all other fungal phyla. The primers yield amplicons compatible with the Illumina MiSeq platform, which is cost-effective and has a lower error rate than other high throughput sequencing platforms. The new primer set LSU200A-F/LSU476A-R (Ascomycota) yielded 95-98% of reads of target taxa from environmental samples, and primers LSU200-F/LSU481-R (all other fungi) yielded 72-80% of target reads. Both primer sets have fairly low rates of data loss, and together they cover a wide variety of fungal taxa. We compared our results with these primers by amplifying and sequencing a subset of samples using the previously described ITS3_KYO2/ITS4_KYO3 primers, which amplify the internal transcribed spacer 2 (ITS2) of Ascomycota and Basidiomycota. With approximately equivalent read depth, our LSU primers recovered a greater number and phylogenetic diversity of sequences than the ITS2 primers. For instance, ITS3_KYO2/ITS4_KYO3 primers failed to pick up any members of Eurotiales, Mytilinidiales, Pezizales, Saccharomycetales, or Venturiales within Ascomycota, or members of Exobasidiomycetes, Microbotryomycetes, Pucciniomycetes, or Tremellomycetes within Basidiomycota, which were retrieved in good numbers from the same samples by our LSU primers. Among the OTUs recovered using the LSU primers were 127 genera and 28 species that were not obtained using the ITS2 primers, although the ITS2 primers recovered 10 unique genera and 16 species that were not obtained using either of the LSU primers These features identify the new primer sets developed in this study as useful complements to other universal primers for the study of fungal diversity and community composition.	[Asemaninejad, Asma; Weerasuriya, Nimalka; Lindo, Zoe; Thorn, R. Greg] Univ Western Ontario, Dept Biol, London, ON N6A 5B7, Canada; [Gloor, Gregory B.] Univ Western Ontario, Dept Biochem, London, ON N6A 5B7, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Thorn, RG (corresponding author), Univ Western Ontario, Dept Biol, London, ON N6A 5B7, Canada.	rgthorn@uwo.ca	Gloor, Greg B/D-1671-2013; Thorn, R Greg/I-3398-2012	Thorn, R Greg/0000-0002-7199-6226; Gloor, Gregory/0000-0001-5803-3380; Lindo, Zoe/0000-0001-9942-7204; Weerasuriya, Nimalka Manori/0000-0002-8909-3551	Natural Sciences and Engineering Research Council (Canada) [EGP 446568-13]; Entomogen, Inc. Parks Canada; Natural Sciences and Engineering Research Council of Canada (NSERC) [418241-2012]; NSERC Engage grant [EGP 446568-13]	Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Entomogen, Inc. Parks Canada; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Engage grant	This work was supported in part by Natural Sciences and Engineering Research Council (Canada) Engage Partnership Grant Program EGP 446568-13 to RGT and partner Entomogen, Inc. Parks Canada provided financial and logistical support for fieldwork by M. Bidochka and F. Hunter (Entomogen) in Torngat Mountains National Park. Funding for ZL is from the Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grants Program (#418241-2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by NSERC Engage grant EGP 446568-13 to RGT and partner Entomogen, Inc. Parks Canada provided financial and logistical support for fieldwork by M. Bidochka and F. Hunter (Entomogen) in Torngat Mountains National Park, and Michael Burzysnki (formerly with Parks Canada, Rocky Harbour, Newfoundland) identified plants from photos of the sampling areas in Torngat. Peat samples are provided as part of a larger experiment supported by Dr. James McLaughlin (Ontario Ministry of Natural Resources-Ontario Forest Research Institute), Dr. Brian Branfireun (University of Western Ontario, Biotron), and Dr. Charmaine Dean, Dean of the Faculty of Science, University of Western Ontario. Funding for ZL is from the Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grants Program (#418241-2012). The supportive comments, feedback and discussion provided by two anonymous reviewers were greatly appreciated and significantly improved the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Atkins Simon D., 2004, Journal of Applied Genetics, V45, P3; Balint M, 2014, ECOL EVOL, V4, P2642, DOI 10.1002/ece3.1107; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Brown SP, 2015, FUNGAL ECOL, V13, P221, DOI 10.1016/j.funeco.2014.08.006; Chase MW, 2009, SCIENCE, V325, P682, DOI 10.1126/science.1176906; Clemmensen KE, 2013, SCIENCE, V339, P1615, DOI 10.1126/science.1231923; Dentinger BTM, 2010, MOL ECOL RESOUR, V10, P628, DOI 10.1111/j.1755-0998.2009.02825.x; Dieleman CM, 2015, GLOBAL CHANGE BIOL, V21, P388, DOI 10.1111/gcb.12643; Dumbrell AJ, 2011, NEW PHYTOL, V190, P794, DOI 10.1111/j.1469-8137.2010.03636.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fierer N, 2013, SCIENCE, V342, P621, DOI 10.1126/science.1243768; GEORGIEV OI, 1981, NUCLEIC ACIDS RES, V9, P6953, DOI 10.1093/nar/9.24.6953; Gloor GB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015406; HASSOUNA N, 1984, NUCLEIC ACIDS RES, V12, P3563, DOI 10.1093/nar/12.8.3563; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Helgason T, 1998, NATURE, V394, P431, DOI 10.1038/28764; Hert DG, 2008, ELECTROPHORESIS, V29, P4618, DOI 10.1002/elps.200800456; Hibbett D, 2014, SYSTEMATICS EVOLUTIO, P373, DOI DOI 10.1007/978-3-642-55318-9_14; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Jang J-h, 2014, KOREAN J PUBLIC HLTH, V2, P81; Kohout P, 2014, SOIL BIOL BIOCHEM, V68, P482, DOI 10.1016/j.soilbio.2013.08.027; Koski LB, 2001, J MOL EVOL, V52, P540, DOI 10.1007/s002390010184; Kurtzman CP, 1998, ANTON LEEUW INT J G, V73, P331, DOI 10.1023/A:1001761008817; Lawley B, 2004, APPL ENVIRON MICROB, V70, P5963, DOI 10.1128/AEM.70.10.5963-5972.2004; Lee J, 2008, FEMS MICROBIOL ECOL, V65, P339, DOI 10.1111/j.1574-6941.2008.00531.x; Lindahl BD, 2013, NEW PHYTOL, V199, P288, DOI 10.1111/nph.12243; Lindner DL, 2011, MYCOLOGIA, V103, P731, DOI 10.3852/10-331; Luo CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030087; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Moncalvo JM, 2002, MOL PHYLOGENET EVOL, V23, P357, DOI 10.1016/S1055-7903(02)00027-1; O'Brien HE, 2005, APPL ENVIRON MICROB, V71, P5544, DOI 10.1128/AEM.71.9.5544-5550.2005; Parenicova L, 2001, APPL ENVIRON MICROB, V67, P521, DOI 10.1128/AEM.67.2.521-527.2001; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rosling A, 2011, SCIENCE, V333, P876, DOI 10.1126/science.1206958; Sato Kouichi, 2005, Grassland Science, V51, P179, DOI 10.1111/j.1744-697X.2005.00023.x; Schmidt PA, 2013, SOIL BIOL BIOCHEM, V65, P128, DOI 10.1016/j.soilbio.2013.05.014; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Schoch CL, 2009, SYST BIOL, V58, P224, DOI 10.1093/sysbio/syp020; Seifert KA, 2007, P NATL ACAD SCI USA, V104, P3901, DOI 10.1073/pnas.0611691104; Shenoy BD, 2007, FUNGAL DIVERS, V26, P1; SIMON L, 1992, APPL ENVIRON MICROB, V58, P291, DOI 10.1128/AEM.58.1.291-295.1992; Skouboe P, 1999, MYCOL RES, V103, P873, DOI 10.1017/S0953756298007904; Smith DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090234; Sun Xiang, 2012, Mycology - An International Journal on Fungal Biology, V3, P65; Taylor DL, 2014, ECOL MONOGR, V84, P3, DOI 10.1890/12-1693.1; Tedersoo L, 2015, SCIENCE, V349, DOI 10.1126/science.aaa5594; Tedersoo L, 2014, SCIENCE, V346, P1078, DOI 10.1126/science.1256688; Toju H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040863; Treseder KK, 2015, MICROBIOL MOL BIOL R, V79, P243, DOI 10.1128/MMBR.00001-15; Valverde JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058118; Varga J, 2000, FUNGAL GENET BIOL, V30, P71, DOI 10.1006/fgbi.2000.1204; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Wang H, 2011, J CLIN MICROBIOL, V49, P1890, DOI 10.1128/JCM.02415-10; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Watanabe M, 2011, J SCI FOOD AGR, V91, P2500, DOI 10.1002/jsfa.4507; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996	61	28	29	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159043	10.1371/journal.pone.0159043	http://dx.doi.org/10.1371/journal.pone.0159043			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391306	Green Published, gold, Green Submitted			2022-12-27	WOS:000380005400198
J	Kang, YJ; Abalajon, MJ; Jang, WS; Kwon, JK; Yoon, CY; Lee, JY; Cho, KS; Ham, WS; Choi, YD				Kang, Yong Jin; Abalajon, Mark Joseph; Jang, Won Sik; Kwon, Jong Kyou; Yoon, Cheol Yong; Lee, Joo Yong; Cho, Kang Su; Ham, Won Sik; Choi, Young Deuk			Association of Anterior and Lateral Extraprostatic Extensions with Base-Positive Resection Margins in Prostate Cancer	PLOS ONE			English	Article							RADICAL RETROPUBIC PROSTATECTOMY; ISUP CONSENSUS CONFERENCE; SURGICAL MARGINS; BLADDER NECK; PROGNOSTIC-SIGNIFICANCE; INTERNATIONAL SOCIETY; ANTIGEN RECURRENCE; CAPSULAR INCISION; FREE SURVIVAL; SPECIMENS	Introduction Positive surgical margins (PSM) detected in the radical prostatectomy specimen increase the risk of biochemical recurrence (BCR). Still, with formidable number of patients never experiencing BCR in their life, the reason for this inconsistency has been attributed to the artifacts and to the spontaneous regression of micrometastatic site. To investigate the origin of margin positive cancers, we have looked into the influence of extraprostatic extension location on the resection margin positive site and its implications on BCR risk. Materials & Methods The clinical information and follow-up data of 612 patients who had extraprostatic extension and positive surgical margin at the time of robot assisted radical prostatectomy (RARP) in the single center between 2005 and 2014 were modeled using Fine and Gray's competing risk regression analysis for BCR. Extraprostatic extensions were divided into categories according to location as apex, base, anterior, posterior, lateral, and posterolateral. Extraprostatic extensions were defined as presence of tumor beyond the borders of the gland in the posterior and posterolateral regions. Tumor admixed with periprostatic fat was additionally considered as having extraprostatic extension if capsule was vague in the anterior, apex, and base regions. Positive surgical margins were defined as the presence of tumor cells at the inked margin on the inspection under microscopy. Association of these classifications with the site of PSM was evaluated by Cohen's Kappa analysis for concordance and logistic regression for the odds of apical and base PSMs. Results Median follow-up duration was 36.5 months (interquartile range[IQR] 20.1-36.5). Apex involvement was found in 158 (25.8%) patients and base in 110 (18.0%) patients. PSMs generally were found to be associated with increased risk of BCR regardless of location, with BCR risk highest for base PSM (HR 1.94, 95% CI 1.40-2.68, p<0.001) after adjusting for age, initial prostate-specific antigen, pathologic Gleason score, and pathologic T stage in the multivariate model. Logistic regression for PSM site revealed no significant correlation of apex PSM with extraprostatic extension location, while base PSM was associated with increased odds of anterior (OR 2.513, 95% CI 1.425-4.430, p = 0.001) and lateral (OR 2.715, 95% CI 1.735-4.250, p<0.001) extraprostatic extension. Conclusion Extension into the extraprostatic tissue on some specific locations do not share the same recur risk due to the different anatomical structures surrounding the organ. Anterior and lateral EPEs are prone to leave PSM on the base of the prostate, probably because of the lack of anatomical barricades slowing down the direct invasion process. More study on the pattern of spread of the tumors found to have extraprostatic extension is suggested for optimal planning of the operation extent and of the adjuvant radiotherapy.	[Kang, Yong Jin; Abalajon, Mark Joseph; Jang, Won Sik; Kwon, Jong Kyou; Yoon, Cheol Yong; Lee, Joo Yong; Cho, Kang Su; Ham, Won Sik; Choi, Young Deuk] Yonsei Univ, Coll Med, Urol Sci Inst, Dept Urol, Seoul, South Korea	Yonsei University; Yonsei University Health System	Choi, YD (corresponding author), Yonsei Univ, Coll Med, Urol Sci Inst, Dept Urol, Seoul, South Korea.	youngd74@yuhs.ac	; Lee, Joo Yong/C-3851-2013	Choi, Young Deuk/0000-0002-8545-5797; Jang, Won Sik/0000-0002-9082-0381; kang, yongjin/0000-0002-2987-3249; Cho, Kang Su/0000-0002-3500-8833; Lee, Joo Yong/0000-0002-3470-1767; Ham, Won Sik/0000-0003-2246-8838				Aydin H, 2004, UROLOGY, V64, P551, DOI 10.1016/j.urology.2004.04.003; Barocas DA, 2001, UROLOGY, V58, P746, DOI 10.1016/S0090-4295(01)01336-X; Blute ML, 1997, UROLOGY, V50, P733, DOI 10.1016/S0090-4295(97)00450-0; Cheng L, 1999, CANCER, V86, P1775, DOI 10.1002/(SICI)1097-0142(19991101)86:9<1775::AID-CNCR20>3.0.CO;2-L; Coelho RF, 2010, EUR UROL, V57, P1022, DOI 10.1016/j.eururo.2010.01.040; Dash A, 2002, UROLOGY, V60, P276, DOI 10.1016/S0090-4295(02)01727-2; Eastham JA, 2007, UROLOGY, V70, DOI 10.1016/j.urology.2007.08.040; Egevad L, 2011, MODERN PATHOL, V24, P1, DOI 10.1038/modpathol.2010.159; EPSTEIN JI, 1990, AM J SURG PATHOL, V14, P626, DOI 10.1097/00000478-199007000-00003; Evans AJ, 2008, AM J SURG PATHOL, V32, P1503, DOI 10.1097/PAS.0b013e31817fb3a0; Fesseha T, 1997, J UROLOGY, V158, P2176, DOI 10.1016/S0022-5347(01)68189-8; Fine SW, 2007, ADV ANAT PATHOL, V14, P401, DOI 10.1097/PAP.0b013e3181597a9c; Johnson MT, 2014, WORLD J UROL, V32, P761, DOI 10.1007/s00345-013-1149-5; Kausik SJ, 2002, CANCER, V95, P1215, DOI 10.1002/cncr.10871; Kiyoshima K, 2004, JPN J CLIN ONCOL, V34, P463, DOI 10.1093/jjco/hyh078; Koppie TM, 2006, BJU INT, V98, P1167, DOI 10.1111/j.1464-410X.2006.06578.x; Magi-Galluzzi C, 2011, MODERN PATHOL, V24, P26, DOI 10.1038/modpathol.2010.158; Marks RA, 2007, HUM PATHOL, V38, P1207, DOI 10.1016/j.humpath.2007.01.006; Marry L., 2012, BIOCHEM MEDICA, V22, P276; MCLAUGHLIN AP, 1976, J UROLOGY, V115, P89, DOI 10.1016/S0022-5347(17)59078-3; Patel VR, 2011, J UROLOGY, V186, P511, DOI 10.1016/j.juro.2011.03.112; Pierorazio PM, 2010, J UROLOGY, V183, P151, DOI 10.1016/j.juro.2009.08.138; Poulos CK, 2004, CANCER-AM CANCER SOC, V101, P1563, DOI 10.1002/cncr.20551; Psutka SP, 2011, UROLOGY, V78, P121, DOI 10.1016/j.urology.2010.10.036; Secin FP, 2007, J UROLOGY, V177, P521, DOI 10.1016/j.juro.2006.09.028; Shuford MD, 2004, J UROLOGY, V172, P119, DOI 10.1097/01.ju.0000132137.02846.ec; Sofer M, 2002, J CLIN ONCOL, V20, P1853, DOI 10.1200/JCO.2002.07.069; Stephenson AJ, 2009, J UROLOGY, V182, P1357, DOI 10.1016/j.juro.2009.06.046; Walz J, 2010, EUR UROL, V57, P179, DOI 10.1016/j.eururo.2009.11.009; Weckermann D, 2007, BJU INT, V99, P1036, DOI 10.1111/j.1464-410X.2007.06791.x; Yossepowitch O, 2000, UROLOGY, V56, P448, DOI 10.1016/S0090-4295(00)00676-2	31	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158922	10.1371/journal.pone.0158922	http://dx.doi.org/10.1371/journal.pone.0158922			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391650	gold, Green Published, Green Submitted			2022-12-27	WOS:000380005400163
J	Moneim, AEA				Moneim, Ahmed E. Abdel			Indigofera oblongifolia Prevents Lead Acetate-Induced Hepatotoxicity, Oxidative Stress, Fibrosis and Apoptosis in Rats	PLOS ONE			English	Article							FLAXSEED OIL; LIVER; EXPRESSION; REVERSAL; CADMIUM; KIDNEY; TESTES; ASSAY; NRF2	The current study was aimed to evaluate the preventive effects of Indigofera oblongifolia leaf extract (IOLE) on lead acetate (PbAc)-induced hepatotoxicity in adult male Wistar rats. PbAc was intraperitoneally injected at a dose of 20 mg/kg body weight for 5 days alone or in combination with the IOLE (100 mg/kg). Liver lead concentration and oxidative stress markers such as lipid peroxidation, hydrogen peroxide, nitric oxide, and glutathione content were investigated in addition to the enzymatic antioxidant activities. PbAc injection caused a significant elevation in the liver function parameters, lead level, lipid peroxidation, hydrogen peroxide, and nitric oxide, with a concomitant decline in the glutathione content compared with the control, accompanied by a significant inhibition of antioxidant enzyme activities. The induction of oxidative stress, lead accumulation, and histological alterations in the liver were successfully minimized by pre-administration of IOLE. In addition, the PbAc group showed increase in the levels of Bax, caspase-3, and matrix metalloproteinase-9 proteins, while the expression of Bcl-2 protein was decreased. Prior administration of IOLE significantly mitigated apoptosis and fibrosis in the liver. Finally, the major components in I. oblongifolia extract were identified as polyphenols, flavonoids, and organic acids using liquid chromatography coupled mass spectroscopy. Thus, the findings of the current study revealed that I. oblongifolia had protective, anti-fibrotic, antioxidant, and anti-apoptotic activities on PbAc-induced hepatotoxicity. The beneficial effects of I. oblongifolia were in part mediated by Nrf2/HO-1 pathway.	[Moneim, Ahmed E. Abdel] Helwan Univ, Fac Sci, Dept Zool & Entomol, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Helwan University	Moneim, AEA (corresponding author), Helwan Univ, Fac Sci, Dept Zool & Entomol, Cairo, Egypt.	aest1977@hotmail.com	Moneim, Ahmed E. Abdel/C-7461-2012	Moneim, Ahmed E. Abdel/0000-0002-2654-2591				Moneim AEA, 2012, BIOL TRACE ELEM RES, V148, P363, DOI 10.1007/s12011-012-9370-4; Abdel-Moneim AE, 2011, BIOL TRACE ELEM RES, V143, P457, DOI 10.1007/s12011-010-8882-z; Abdou HM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/435857; Aggarwal BB, 2011, CURR DRUG TARGETS, V12, P1595; Al-Olayan EM, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-164; Al-Olayan E, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/381413; Aleksunes LM, 2007, TOXICOL PATHOL, V35, P459, DOI 10.1080/01926230701311344; Aykin-Burns N, 2003, ARCH ENVIRON CON TOX, V44, P417, DOI 10.1007/s00244-002-2023-4; BELFIELD A, 1971, ENZYME, V12, P561, DOI 10.1159/000459586; Berrahal AA, 2011, ENVIRON TOXICOL, V26, P68, DOI 10.1002/tox.20530; Dkhil MA, 2016, BIOL TRACE ELEM RES, V173, P354, DOI 10.1007/s12011-016-0689-0; Dkhil MA, 2016, DRUG DES DEV THER, V10, P1847, DOI 10.2147/DDDT.S105511; El-Nekeety AA, 2009, FOOD CHEM TOXICOL, V47, P2209, DOI 10.1016/j.fct.2009.06.019; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Flora Gagan, 2012, Interdiscip Toxicol, V5, P47, DOI 10.2478/v10102-012-0009-2; Flora SJS, 2008, INDIAN J MED RES, V128, P501; Flora SJS, 2007, J PHARMACOL EXP THER, V322, P108, DOI 10.1124/jpet.107.121996; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Jia QH, 2012, TOXICOL MECH METHOD, V22, P705, DOI 10.3109/15376516.2012.718811; Kumar S, 2013, SCI WORLD J, DOI 10.1155/2013/162750; Lahat N, 2002, J NEUROIMMUNOL, V132, P123, DOI 10.1016/S0165-5728(02)00323-5; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lubbad MY, 2015, PARASITOL RES, V114, P3431, DOI 10.1007/s00436-015-4568-y; Mohamed OI, 2016, PHARM BIOL, V54, P1164, DOI 10.3109/13880209.2015.1057651; Mudipalli A, 2007, INDIAN J MED RES, V126, P518; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Oyagbemi A, 2014, FASEB J, V28; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Parola M, 2001, J HEPATOL, V35, P297, DOI 10.1016/S0168-8278(01)00142-8; Ponce-Canchihuaman JC, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-35; REITMAN S, 1957, AM J CLIN PATHOL, V28, P56, DOI 10.1093/ajcp/28.1.56; Reyes JL, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/730789; Schmidt M, 1975, Fortschr Med, V93, P1461; Sethi G, 2006, J BIOL CHEM, V281, P23425, DOI 10.1074/jbc.M602627200; Shahjahan M, 2005, J MED FOOD, V8, P261, DOI 10.1089/jmf.2005.8.261; Sharif A, 2005, ARCH PHARM RES, V28, P761, DOI 10.1007/BF02977339; Sternberger LA., 1979, IMMUNOCYTOCHEMISTRY; Szkoda J, 2005, B VET I PULAWY, V49, P89; Tantawy EI- WH, 2015, J TRADIT COMPLEMENT; Wang Y, 2013, ENVIRON TOXICOL PHAR, V35, P109, DOI 10.1016/j.etap.2012.12.001; Wang Y, 2013, NEURAL REGEN RES, V8, P2021, DOI 10.3969/j.issn.1673-5374.2013.22.001; Ye F, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2075915; Yu CL, 2016, MOL NEUROBIOL, V53, P6489, DOI 10.1007/s12035-015-9555-x; Yuan GP, 2014, INT J CLIN EXP PATHO, V7, P2905	44	88	89	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158965	10.1371/journal.pone.0158965	http://dx.doi.org/10.1371/journal.pone.0158965			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391413	Green Published, gold			2022-12-27	WOS:000380005400174
J	Nasi, S; Ea, HK; Liote, F; So, A; Busso, N				Nasi, Sonia; Ea, Hang-Korng; Liote, Frederic; So, Alexander; Busso, Nathalie			Sodium Thiosulfate Prevents Chondrocyte Mineralization and Reduces the Severity of Murine Osteoarthritis	PLOS ONE			English	Article							BASIC CALCIUM-PHOSPHATE; PROTEIN-KINASE-C; CHRONIC KIDNEY-DISEASE; ANNEXIN-V; TERMINAL DIFFERENTIATION; INFLAMMATORY CYTOKINES; CRYSTALS; CALCIFICATION; EXPRESSION; CARTILAGE	Objectives Calcium-containing crystals participate in the pathogenesis of OA. Sodium thiosulfate (STS) has been shown to be an effective treatment in calcification disorders such as calciphylaxis and vascular calcification. This study investigated the effects and mechanisms of action of STS in a murine model of OA and in chondrocyte calcification. Methods Hydroxyapatite (HA) crystals-stimulated murine chondrocytes and macrophages were treated with STS. Mineralization and cellular production of IL-6, MCP-1 and reactive oxygen species (ROS) were assayed. STS's effects on genes involved in calcification, inflammation and cartilage matrix degradation were studied by RT-PCR. STS was administered in the menisectomy model of murine OA, and the effect on periarticular calcific deposits and cartilage degeneration was investigated by micro-CT-scan and histology. Results In vitro, STS prevented in a dose-dependent manner calcium crystal deposition in chondrocytes and inhibited Annexin V gene expression. In addition, there was a reduction in crystal-induced IL-6 and MCP-1 production. STS also had an antioxidant effect, diminished HA-induced ROS generation and abrogated HA-induced catabolic responses in chondrocytes. In vivo, administration of STS reduced the histological severity of OA, by limiting the size of new periarticular calcific deposits and reducing the severity of cartilage damage. Conclusions STS reduces the severity of periarticular calcification and cartilage damage in an animal model of OA via its effects on chondrocyte mineralization and its attenuation of crystalinduced inflammation as well as catabolic enzymes and ROS generation. Our study suggests that STS may be a disease-modifying drug in crystal-associated OA.	[Nasi, Sonia; So, Alexander; Busso, Nathalie] CHU Vaudois, Dept Musculoskeletal Med, Serv Rheumatol, Lausanne, Switzerland; [Nasi, Sonia; So, Alexander; Busso, Nathalie] Univ Lausanne, Lausanne, Switzerland; [Ea, Hang-Korng; Liote, Frederic] Univ Sch Med, Serv Rheumatol, Hosp Lariboisiere, Paris VII, France	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP	Nasi, S (corresponding author), CHU Vaudois, Dept Musculoskeletal Med, Serv Rheumatol, Lausanne, Switzerland.; Nasi, S (corresponding author), Univ Lausanne, Lausanne, Switzerland.	Sonia.Nasi@chuv.ch	Liote, Frederic/AAD-6926-2020; Ea, HK/P-5527-2016	Nasi, Sonia/0000-0002-6625-8309; Liote, Frederic/0000-0003-4419-0726; Ea, HK/0000-0002-2393-7475	Fonds National Suisse de la recherche scientifique [310030-130085/1]; Institute of Arthritis Research; Fondation RMR; Fondation Jean and Linette Warnery	Fonds National Suisse de la recherche scientifique; Institute of Arthritis Research; Fondation RMR; Fondation Jean and Linette Warnery	This work was supported by the Fonds National Suisse de la recherche scientifique (grant 310030-130085/1) and the Institute of Arthritis Research, the Fondation RMR, the Fondation Jean and Linette Warnery.; We thank Nathaliane Bagnoud and Veronique Chobaz for their excellent technical support. We are grateful to Dr Laurent Galibert for his suggestions, critical reading and editing of the manuscript. Hydroxyapatite (HA) and calcium pyrophosphate dihydrate (CPPD) crystals were kindly provided by Prof. Christele Combes (CIRIMAT, INPT-UPS-CNRS, Toulouse France). This work was supported by the Fonds national suisse de la recherche scientifique (grant 310030-130085/1).	Abdoon ASS, 2011, THERIOGENOLOGY, V76, P1207, DOI 10.1016/j.theriogenology.2011.05.019; Agharazii M, 2015, AM J HYPERTENS, V28, P746, DOI 10.1093/ajh/hpu225; Brogley MA, 1999, J CELL PHYSIOL, V180, P215, DOI 10.1002/(SICI)1097-4652(199908)180:2<215::AID-JCP9>3.0.CO;2-J; Cheung HS, 2006, ARTHRITIS RHEUM-US, V54, P2452, DOI 10.1002/art.22017; Cunningham CC, 2012, CLIN IMMUNOL, V144, P228, DOI 10.1016/j.clim.2012.06.007; Ding M, 2008, CALCIFIED TISSUE INT, V82, P77, DOI 10.1007/s00223-007-9093-2; Ea HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057352; Ea HK, 2005, ARTHRITIS RES THER, V7, pR915, DOI 10.1186/ar1763; Fox B, 2012, J CELL MOL MED, V16, P896, DOI 10.1111/j.1582-4934.2011.01357.x; Fuerst M, 2009, ARTHRITIS RHEUM, V60, P2694, DOI 10.1002/art.24774; GOEL R, 1989, J NATL CANCER I, V81, P1552, DOI 10.1093/jnci/81.20.1552; Goldring MB, 2006, BEST PRACT RES CL RH, V20, P1003, DOI 10.1016/j.berh.2006.06.003; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Grskovic I, 2012, J BONE MINER RES, V27, P2399, DOI 10.1002/jbmr.1682; Hayden MR, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-4; Hayden MR, 2010, SEMIN DIALYSIS, V23, P258, DOI 10.1111/j.1525-139X.2010.00738.x; Horn DA, 2004, BIOTECH HISTOCHEM, V79, P151, DOI 10.1080/10520290400004708; Ives A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7555; Ju YJ, 2013, CAN J PHYSIOL PHARM, V91, P8, DOI 10.1139/cjpp-2012-0293; Kamekura S, 2005, OSTEOARTHR CARTILAGE, V13, P632, DOI 10.1016/j.joca.2005.03.004; Karageuzyan Konstantin G., 2005, Current Drug Targets - Inflammation and Allergy, V4, P85, DOI 10.2174/1568010053622939; Kim HJ, 2008, J BIOL CHEM, V283, P10310, DOI 10.1074/jbc.M708456200; Kirsch T, 2000, OSTEOARTHR CARTILAGE, V8, P294, DOI 10.1053/joca.1999.0304; Legendre F, 2005, J RHEUMATOL, V32, P1307; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; MARKMAN M, 1985, CANCER, V56, P2364, DOI 10.1002/1097-0142(19851115)56:10<2364::AID-CNCR2820561003>3.0.CO;2-4; Marutani E, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002125; Mathy-Hartert M, 2008, OSTEOARTHR CARTILAGE, V16, P756, DOI 10.1016/j.joca.2007.10.009; Matsui S, 2009, J ENDODONT, V35, P67, DOI 10.1016/j.joen.2008.08.034; McCarthy GM, 1998, J BIOL CHEM, V273, P35161, DOI 10.1074/jbc.273.52.35161; Mollenhauer J, 1999, J HISTOCHEM CYTOCHEM, V47, P209, DOI 10.1177/002215549904700209; Morita K, 2007, J EXP MED, V204, P1613, DOI 10.1084/jem.20062525; Nadra I, 2005, CIRC RES, V96, P1248, DOI 10.1161/01.RES.0000171451.88616.c2; Nair D, 1997, J BIOL CHEM, V272, P18920, DOI 10.1074/jbc.272.30.18920; Nalbant S, 2003, OSTEOARTHR CARTILAGE, V11, P50, DOI 10.1053/joca.2002.0861; Nasi S, 2015, ANN RHEUMATIC DIS; Neuwelt EA, 1998, J PHARMACOL EXP THER, V286, P77; Pasch A, 2008, KIDNEY INT, V74, P1444, DOI 10.1038/ki.2008.455; Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014; Prudhommeaux F, 1996, ARTHRITIS RHEUM, V39, P1319, DOI 10.1002/art.1780390809; Ramjan KA, 2009, NAT CLIN PRACT ENDOC, V5, P167, DOI 10.1038/ncpendmet1067; Reuben PM, 2004, J BIOL CHEM, V279, P35719, DOI 10.1074/jbc.M403406200; Ryu JH, 2011, ARTHRITIS RHEUM-US, V63, P2732, DOI 10.1002/art.30451; Sakaguchi M, 2014, ANESTHESIOLOGY, V121, P1248, DOI 10.1097/ALN.0000000000000456; Shirozu K, 2014, ANTIOXID REDOX SIGN, V20, P204, DOI 10.1089/ars.2013.5354; Sun YB, 2002, J BIOL CHEM, V277, P1544, DOI 10.1074/jbc.M100567200; Sun YB, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/326267; Tokuda K, 2012, ANTIOXID REDOX SIGN, V17, P11, DOI 10.1089/ars.2011.4363; vonderMark K, 1997, CELL MOL LIFE SCI, V53, P539, DOI 10.1007/s000180050069; Wang W, 2005, EXP CELL RES, V305, P156, DOI 10.1016/j.yexcr.2004.12.022	51	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158196	10.1371/journal.pone.0158196	http://dx.doi.org/10.1371/journal.pone.0158196			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391970	Green Submitted, gold, Green Published			2022-12-27	WOS:000380005400036
J	Nusrat, S; Siddiqi, MK; Zaman, M; Zaidi, N; Ajmal, MR; Alam, P; Qadeer, A; Abdelhameed, AS; Khan, RH				Nusrat, Saima; Siddiqi, Mohammad Khursheed; Zaman, Masihuz; Zaidi, Nida; Ajmal, Mohammad Rehan; Alam, Parvez; Qadeer, Atiyatul; Abdelhameed, Ali Saber; Khan, Rizwan Hasan			A Comprehensive Spectroscopic and Computational Investigation to Probe the Interaction of Antineoplastic Drug Nordihydroguaiaretic Acid with Serum Albumins	PLOS ONE			English	Article							CIRCULAR-DICHROISM; BINDING-SITES; BOVINE; FLUORESCENCE; AGGREGATION; DERIVATIVES; NDGA; ABSORPTION; MECHANISMS; INHIBITORS	Exogenous drugs that are used as antidote against chemotheray, inflammation or viral infection, gets absorbed and interacts reversibly to the major serum transport protein i.e. albumins, upon entering the circulatory system. To have a structural guideline in the rational drug designing and in the synthesis of drugs with greater efficacy, the binding mechanism of an antineoplastic and anti-inflammatory drug Nordihydroguaiaretic acid (NDGA) with human and bovine serum albumins (HSA & BSA) were examined by spectroscopic and computational methods. NDGA binds to site II of HSA with binding constant (K-b) similar to 10(5) M-1 and free energy (Delta G) similar to -7.5 kcal.mol(-1). It also binds at site II of BSA but with lesser binding affinity (K-b) similar to 10(5) M-1 and Delta G similar to -6.5 kcal.mol(-1). The negative value of Delta G, Delta H and Delta S for both the albumins at three different temperatures confirmed that the complex formation process between albumins and NDGA is spontaneous and exothermic. Furthermore, hydrogen bonds and hydrophobic interactions are the main forces involved in complex formation of NDGA with both the albumins as evaluated from fluorescence and molecular docking results. Binding of NDGA to both the albumins alter the conformation and causes minor change in the secondary structure of proteins as indicated by the CD spectra.	[Nusrat, Saima; Siddiqi, Mohammad Khursheed; Zaman, Masihuz; Zaidi, Nida; Ajmal, Mohammad Rehan; Alam, Parvez; Qadeer, Atiyatul; Khan, Rizwan Hasan] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh 202002, Uttar Pradesh, India; [Abdelhameed, Ali Saber] King Saud Univ, Dept Pharmaceut Chem, Coll Pharm, POB 2457, Riyadh 11451, Saudi Arabia	Aligarh Muslim University; King Saud University	Khan, RH (corresponding author), Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh 202002, Uttar Pradesh, India.	rizwanhkhan@hotmail.com	Abdelhameed, Ali/A-1333-2012; Khan, Rizwan/GXZ-5789-2022; Khan, Rizwan Hasan/F-8276-2014; Siddiqi, Mohammad Khursheed/V-9183-2018; Khan, Rehan/AAR-4803-2020; Alam, Dr Parvez/E-9136-2013	Abdelhameed, Ali/0000-0002-5910-2832; Khan, Rizwan Hasan/0000-0002-9965-8982; Siddiqi, Mohammad Khursheed/0000-0002-6522-1643; Khan, Rehan/0000-0001-8724-5788; Zaidi, Dr Nida/0000-0003-2579-2190; Alam, Dr Parvez/0000-0002-4484-8340; khan, mohammad rehan ajmal/0000-0002-2480-9379	Department of biotechnology, Government of India [BT/PR 13194/BRP/10/742/2009]; University Grant Commission, New Delhi, MANF-SRF; University Grant Commission, New Delhi, UGC-post doctoral fellowship; University Grant Commission, New Delhi, UGC-SRF (NET) fellowship; Department of Biotechnology (DBT) DBT-JRF (NET) fellowship; University Grant Commission, New Delhi; Department of Biotechnology (DBT); DBT [BT/PR 13194/10/742/2009]; DST [SR/SO/BB-0018/2011]; Deanship of Scientific Research at King Saud University [RG-1435-025];  [0014];  [RG-1435-02]	Department of biotechnology, Government of India(Department of Biotechnology (DBT) India); University Grant Commission, New Delhi, MANF-SRF; University Grant Commission, New Delhi, UGC-post doctoral fellowship; University Grant Commission, New Delhi, UGC-SRF (NET) fellowship; Department of Biotechnology (DBT) DBT-JRF (NET) fellowship(Department of Biotechnology (DBT) India); University Grant Commission, New Delhi(University Grants Commission, India); Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); DBT(Department of Biotechnology (DBT) India); DST(Department of Science & Technology (India)); Deanship of Scientific Research at King Saud University(King Saud University); ; 	Funding was provided by the Department of biotechnology, Government of India as project BT/PR 13194/BRP/10/742/2009 and DST SR/SO/BB-0018/2011 to RHK; the University Grant Commission, New Delhi, MANF-SRF to SN and MZ; the University Grant Commission, New Delhi, UGC-post doctoral fellowship to NZ; the University Grant Commission, New Delhi, UGC-SRF (NET) fellowship to MRA; the Department of Biotechnology (DBT) DBT-JRF (NET) fellowship to MKS; and the International Scientific Partnership Program ISPP at King Saud University for funding the research work through ISPP#0014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r Facilities provided by Interdisciplinary Biotechnology Unit, AMU, Aligarh are highly acknowledged. SN and MZ are highly thankful to University Grant Commission, New Delhi, for financial assistance in the form of MANF-SRF. MKS is highly thankful to Department of Biotechnology (DBT) for financial assistance in the form of DBT-JRF (NET) fellowship. NZ is highly thankful to University Grant Commission, New Delhi, for financial assistance in the form of UGC-post doctoral fellowship. MRA is highly thankful to University Grant Commission, New Delhi, for financial assistance in the form of UGC-SRF (NET) fellowship. We are thankful to Dr. AtiyatulQadeer for the careful revision of the manuscript to fix the grammatical errors and improve the overall readability of the text. RHK is thankful to DBT and DST for project numbers BT/PR 13194/10/742/2009 and SR/SO/BB-0018/2011, respectively. The authors would like to extend their sincere appreciation to the Deanship of ScientificResearch at King Saud University for its funding this Research Group No. RG-1435-025	Ahmad B, 2006, BIOMACROMOLECULES, V7, P1350, DOI 10.1021/bm050996b; Ahmad E, 2011, CELL BIOCHEM BIOPHYS, V61, P313, DOI 10.1007/s12013-011-9214-4; Ajmal MR, 2016, J MOL STRUCT, V1117, P208, DOI 10.1016/j.molstruc.2016.03.081; Ajmal MR, 2016, SPECTROCHIM ACTA A, V159, P199, DOI 10.1016/j.saa.2016.01.049; Ajmal M, 2015, J HYDRO-ENVIRON RES, V9, P592, DOI 10.1016/j.jher.2014.11.003; Alam P, 2015, J LUMINESCENCE; Arteaga S, 2005, J ETHNOPHARMACOL, V98, P231, DOI 10.1016/j.jep.2005.02.002; CARTER DC, 1994, EUR J BIOCHEM, V226, P1049, DOI 10.1111/j.1432-1033.1994.01049.x; Chaturvedi SK, 2015, MOL BIOSYST, V11, P307, DOI 10.1039/c4mb00548a; Chi ZX, 2011, BIOMACROMOLECULES, V12, P203, DOI 10.1021/bm1011568; Feroz SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076067; Floriano-Sanchez E, 2006, FREE RADICAL RES, V40, P523, DOI 10.1080/10715760500419365; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Gentili PL, 2008, J PHYS CHEM B, V112, P16793, DOI 10.1021/jp805922g; Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075; Gong AQ, 2007, TALANTA, V73, P668, DOI 10.1016/j.talanta.2007.04.041; GOODMAN Y, 1994, BRAIN RES, V654, P171, DOI 10.1016/0006-8993(94)91586-5; He X.M, 1992, ATOMIC STRUCTURE CHE; Hu YJ, 2005, J MOL STRUCT, V750, P174, DOI 10.1016/j.molstruc.2005.04.032; Il'ichev YV, 2002, J PHYS CHEM B, V106, P452, DOI 10.1021/jp012314u; Jiang N, 2014, ORG BIOMOL CHEM, V12, P5250, DOI 10.1039/c4ob00405a; KASAI S, 1987, J PHARM SCI, V76, P387, DOI 10.1002/jps.2600760510; Khan AB, 2011, COLLOID SURFACE B, V87, P447, DOI 10.1016/j.colsurfb.2011.06.007; KRAGHHANSEN U, 1981, PHARMACOL REV, V33, P17; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, P63; Lakowicz JR, 1999, INTRO FLUORESCENCE P, P1; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; LIU L, 1995, INT J CANCER, V62, P345, DOI 10.1002/ijc.2910620319; Lu JM, 2010, MED SCI MONITOR, V16, pRA93; Matsuzaki K, 2007, BBA-BIOMEMBRANES, V1768, P122, DOI 10.1016/j.bbamem.2006.09.014; Olson RE, 1996, ANNU REP MED CHEM, V31, P327, DOI 10.1016/S0065-7743(08)60472-8; Ono K, 2002, J NEUROCHEM, V81, P434, DOI 10.1046/j.1471-4159.2002.00904.x; Paul BK, 2010, J PHYS CHEM B, V114, P6183, DOI 10.1021/jp100004t; Perry JL, 2003, J PHYS CHEM B, V107, P6644, DOI 10.1021/jp034284w; PETERS T, 1985, ADV PROTEIN CHEM, V37, P161, DOI 10.1016/S0065-3233(08)60065-0; Petitpas I, 2001, J BIOL CHEM, V276, P22804, DOI 10.1074/jbc.M100575200; Qadeer A, 2014, BIOCHEMISTRY-MOSCOW+, V79, P785, DOI 10.1134/S0006297914080069; Qadeer A, 2013, ARCH BIOCHEM BIOPHYS, V540, P101, DOI 10.1016/j.abb.2013.10.015; ROSS PD, 1981, BIOCHEMISTRY-US, V20, P3096, DOI 10.1021/bi00514a017; Shu Y, 2011, J PHYS CHEM B, V115, P12306, DOI 10.1021/jp2071925; Singh SS, 2006, CURR DRUG METAB, V7, P165, DOI 10.2174/138920006775541552; SUDLOW G, 1976, MOL PHARMACOL, V12, P1052; Sulkowska A, 2002, J MOL STRUCT, V614, P227, DOI 10.1016/S0022-2860(02)00256-9; TAKIKAWA H, 1987, BIOCHIM BIOPHYS ACTA, V926, P145, DOI 10.1016/0304-4165(87)90231-5; VANDERKOOI JM, 1987, SCIENCE, V236, P568, DOI 10.1126/science.3576185; Varlan A, 2010, MOLECULES, V15, P3905, DOI 10.3390/molecules15063905; You KM, 1999, ARCH PHARM RES, V22, P18, DOI 10.1007/BF02976430; Youngren JF, 2005, BREAST CANCER RES TR, V94, P37, DOI 10.1007/s10549-005-6939-z; Yu MR, 2011, SPECTROCHIM ACTA A, V83, P453, DOI 10.1016/j.saa.2011.08.065; Zaidi N, 2014, J PHYS CHEM B, V118, P13025, DOI 10.1021/jp501515g; Zaidi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071422; Zaidi N, 2013, J PHYS CHEM B, V117, P2595, DOI 10.1021/jp3069877; Zaman M, 2016, RSC ADV, V6, P37591, DOI 10.1039/c6ra01079b; Zaman M, 2014, INT J NANOMED, V9, P899, DOI 10.2147/IJN.S54171; Zavodovskaya M, 2008, J CELL BIOCHEM, V103, P624, DOI 10.1002/jcb.21435; Zhang HM, 2009, J MOL STRUCT, V938, P221, DOI 10.1016/j.molstruc.2009.09.032; Zsila F, 2003, BIOCHEM PHARMACOL, V65, P447, DOI 10.1016/S0006-2952(02)01521-6	57	57	57	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158833	10.1371/journal.pone.0158833	http://dx.doi.org/10.1371/journal.pone.0158833			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391941	Green Published, gold, Green Submitted			2022-12-27	WOS:000380005400139
J	Zhou, ZQ; Song, LY; Zhang, XX; Li, XH; Yan, N; Xia, RP; Zhu, H; Weng, JF; Hao, ZF; Zhang, DG; Yong, HJ; Li, MS; Zhang, SH				Zhou, Zhiqiang; Song, Liya; Zhang, Xiaoxing; Li, Xinhai; Yan, Na; Xia, Renpei; Zhu, Hui; Weng, Jianfeng; Hao, Zhuanfang; Zhang, Degui; Yong, Hongjun; Li, Mingshun; Zhang, Shihuang			Introgression of opaque2 into Waxy Maize Causes Extensive Biochemical and Proteomic Changes in Endosperm	PLOS ONE			English	Article							QUALITY PROTEIN MAIZE; ENDOPLASMIC-RETICULUM STRESS; GAMMA-ZEIN; TRANSCRIPTIONAL ACTIVATOR; BRANCHING ENZYME; AMINO-ACID; LYSINE; EXPRESSION; GENE; MUTANTS	Waxy maize is prevalently grown in China and other countries due to the excellent characters and economic value. However, its low content of lysine can't meet the nutritional requirements of humans and livestock. In the present study, we introgressed the opaque2 (o2) allele into waxy maize line Zhao OP-6/O2O2 by using marker-assisted selection (MAS) technique and successfully improved the lysine content and quality of waxy maize. Transcript abundance analysis indicated that the wx1 expression levels had no difference between Zhao OP-6/o2o2 and Zhao OP-6/O2O2. However, Zhao OP-6/o2o2 was characterized by a phenotype of hard and vitreous kernels and accumulation of protein bodies at smaller size (one third of that of parents) but in larger numbers. Biochemical analyses showed that Zhao OP-6/o2o2 had 16.7% less free amino acids than Zhao OP-6/O2O2, especially those derived from glycolytic intermediates, but its content of lysine was increased by 51.6%(0.47% vs. 0.31%). The content of amylopectin was 98.5% in Zhao OP-6/o2o2, significantly higher than that in Zhao OP-6/O2O2 (97.7%). Proteomic analyses indicated that o2 introgression not only decreased the accumulation of various zein proteins except for 27-kDa gamma-zein, but also affected other endosperm proteins related to amino acid biosynthesis, starch-protein balance, stress response and signal transduction. This study gives us an intriguing insight into the metabolism changes in endosperm of waxy maize introgressed with opaque2.	[Zhou, Zhiqiang; Zhang, Xiaoxing; Li, Xinhai; Yan, Na; Xia, Renpei; Zhu, Hui; Weng, Jianfeng; Hao, Zhuanfang; Zhang, Degui; Yong, Hongjun; Li, Mingshun; Zhang, Shihuang] Chinese Acad Agr Sci, Inst Crop Sci, Dept Crop Genet & Breeding, Beijing, Peoples R China; [Song, Liya] Beijing Technol & Business Univ, Beijing Key Lab Plant Resource Res & Dev, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Beijing Technology & Business University	Li, MS; Zhang, SH (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Dept Crop Genet & Breeding, Beijing, Peoples R China.	limingshun@caas.cn; zhangshihuang@caas.cn	yan, na/HDM-3747-2022		China Agriculture Research System [CARS-02-01]; Beijing Municipal Natural Science Foundation [31401390]	China Agriculture Research System; Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by the China Agriculture Research System (CARS-02-01) and the funding was received by MSL. The Beijing Municipal Natural Science Foundation (31401390) and the funding was received by LYS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu BK, 2015, PLANT CELL REP, V34, P37, DOI 10.1007/s00299-014-1685-5; BOYER CD, 1978, CARBOHYD RES, V61, P321, DOI 10.1016/S0008-6215(00)84492-4; BRIGGS RW, 1965, NATURE, V207, P890, DOI 10.1038/207890a0; BROCHETTOBRAGA MR, 1992, PLANT PHYSIOL, V98, P1139, DOI 10.1104/pp.98.3.1139; Chen Y, 2014, PLOS ONE, V9, pe10; Damerval C, 1998, MOL GEN GENET, V257, P354, DOI 10.1007/s004380050657; Gallusci P, 1996, PLANT MOL BIOL, V31, P45, DOI 10.1007/BF00020605; GEETHA KB, 1991, PLANT CELL, V3, P1207, DOI 10.1105/tpc.3.11.1207; Gibbon BC, 2005, TRENDS GENET, V21, P227, DOI 10.1016/j.tig.2005.02.009; Gibbon BC, 2003, P NATL ACAD SCI USA, V100, P15329, DOI 10.1073/pnas.2136854100; Guan HP, 1997, ARCH BIOCHEM BIOPHYS, V342, P92, DOI 10.1006/abbi.1997.0115; HARTINGS H, 1989, EMBO J, V8, P2795, DOI 10.1002/j.1460-2075.1989.tb08425.x; Hartings H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-41; Holding DR, 2006, MAYDICA, V51, P243; HOSPITAL F, 1992, GENETICS, V132, P1199; Huizen VR, 2003, J BIOL CHEM, V278, P15558; Hunter BG, 2002, PLANT CELL, V14, P2591, DOI 10.1105/tpc.003905; Iwata Y, 2008, PLANT CELL, V20, P3107, DOI 10.1105/tpc.108.061002; Jia H, 2007, CROP SCI, V47, pS45, DOI 10.2135/cropsci2006-00025tpg; Jia M, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-60; Kemper EL, 1999, PLANT CELL, V11, P1981, DOI 10.1105/tpc.11.10.1981; Kirst ME, 2005, PLANT PHYSIOL, V138, P218, DOI 10.1104/pp.105.060087; Klosgen RB, 1986, MOL GEN GENET, V227, P91; Klucinec JD, 2002, CEREAL CHEM, V79, P19, DOI 10.1094/CCHEM.2002.79.1.19; KULESHOV N. N., 1954, Ann. Mo. Bot. Gdn., V41, P271, DOI 10.2307/2394586; Li X. Y., 1993, Acta Agronomica Sinica, V19, P460; LOHMER S, 1991, EMBO J, V10, P617, DOI 10.1002/j.1460-2075.1991.tb07989.x; LOPES MA, 1991, CROP SCI, V31, P1655, DOI 10.2135/cropsci1991.0011183X003100060055x; Lu DL, 2012, STARCH-STARKE, V64, P874, DOI 10.1002/star.201200038; Maddaloni M, 1996, MOL GEN GENET, V250, P647, DOI 10.1007/s004380050117; Mason-Gamer RJ, 1998, MOL BIOL EVOL, V15, P1658, DOI 10.1093/oxfordjournals.molbev.a025893; Meng ZD, 2001, J MAIZE SCI, V9, P14; MERTZ ET, 1964, SCIENCE, V145, P279, DOI 10.1126/science.145.3629.279; Moro GL, 1996, CROP SCI, V36, P1651, DOI 10.2135/cropsci1996.0011183X003600060039x; NELSON OE, 1962, BIOCHEM BIOPH RES CO, V9, P297, DOI 10.1016/0006-291X(62)90043-8; PAULIS JW, 1974, J AGR FOOD CHEM, V22, P318, DOI 10.1021/jf60192a001; PAULIS JW, 1992, THEOR APPL GENET, V85, P407, DOI 10.1007/BF00222321; Pereira CA, 2014, EXP PARASITOL, V142, P43, DOI 10.1016/j.exppara.2014.04.009; Prasanna BM, 2001, CURR SCI INDIA, V81, P1308; Price J, 2004, PLANT CELL, V16, P2128, DOI 10.1105/tpc.104.022616; ROBINSON K, 1995, BIOCHEM J, V307, P267, DOI 10.1042/bj3070267; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; SCHMIDT RJ, 1990, P NATL ACAD SCI USA, V87, P46, DOI 10.1073/pnas.87.1.46; SCHMIDT RJ, 1992, PLANT CELL, V4, P689, DOI 10.1105/tpc.4.6.689; Smith AM, 1997, ANNU REV PLANT PHYS, V48, P65, DOI 10.1146/annurev.arplant.48.1.67; SODEK L, 1970, ARCH BIOCHEM BIOPHYS, V140, P29, DOI 10.1016/0003-9861(70)90006-8; SODEK L, 1971, J AGR FOOD CHEM, V19, P1144, DOI 10.1021/jf60178a011; Sprague G. F., 1943, JOUR AMER SOC AGRON, V35, P817; Tian QZ, 2004, J MAIZE SCI, V12; WALLACE JC, 1990, PLANT PHYSIOL, V92, P191, DOI 10.1104/pp.92.1.191; Wang Y, 2014, J BIOL CHEM, V289, P31361, DOI 10.1074/jbc.M114.597153; Wu YR, 2010, PLANT PHYSIOL, V153, P337, DOI 10.1104/pp.110.154690; Xia Tao, 1997, Acta Agronomica Sinica, V23, P753; Yang LQ, 2013, MOL BREEDING, V31, P767, DOI 10.1007/s11032-012-9830-8; Yang Yin-fu, 2009, ACTA BOTANICA BOREALI-OCCIDENTALIA SINICA, V29, P2213; Yao Y, 2004, PLANT PHYSIOL, V136, P3515, DOI 10.1104/pp.104.043315; Yuan LL, 2014, PLANT PHYSIOL, V164, P119, DOI 10.1104/pp.113.230961; Zeng MQ, 1987, CROP BREED RESOURCE, V3, P8; Zhang W., 2013, INT J COMPUT CONSUM, V2, P37; Zhao G, 2012, PLANTA, V235, P205, DOI 10.1007/s00425-011-1491-z; Zheng HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066606	61	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158971	10.1371/journal.pone.0158971	http://dx.doi.org/10.1371/journal.pone.0158971			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391593	gold, Green Submitted, Green Published			2022-12-27	WOS:000380005400175
J	Joshi, RK; Megha, S; Basu, U; Rahman, MH; Kav, NNV				Joshi, Raj Kumar; Megha, Swati; Basu, Urmila; Rahman, Muhammad H.; Kav, Nat N. V.			Genome Wide Identification and Functional Prediction of Long Non-Coding RNAs Responsive to Sclerotinia sclerotiorum Infection in Brassica napus	PLOS ONE			English	Article							NATURAL ANTISENSE TRANSCRIPTS; DIFFERENTIAL GENE; MESSENGER-RNA; STEM ROT; SEQ; EXPRESSION; ARABIDOPSIS; L.; REVEALS; CANOLA	Sclerotinia stem rot caused by Sclerotinia sclerotiorum affects canola production worldwide. Emerging evidence suggests that long non-coding RNAs (lncRNAs) play important roles in the regulation of gene expression in plants, in response to both abiotic and biotic stress. So far, identification of lncRNAs has been limited to a few model plant species, and their roles in mediating responses to biotic stresses are yet to be characterized in Brassica napus. The present study reports the identification of novel lncRNAs responsive to S. sclerotiorum infection in B. napus at two time points after infection (24 hpi and 48 hpi) using a stranded RNA-Sequencing technique and a detection pipeline for lncRNAs. Of the total 3,181 lncRNA candidates, 2,821 lncRNAs were intergenic, 111 were natural antisense transcripts, 76 possessed exonic overlap with the reference coding transcripts while the remaining 173 represented novel lnc-isoforms. Forty one lncRNAs were identified as the precursors for microRNAs (miRNAs) including miR156, miR169 and miR394, with significant roles in mediating plant responses to fungal phytopathogens. A total of 931 differentially expressed lncRNAs were identified in response to S. sclerotiorum infection and the expression of 12 such lncRNAs was further validated using qRT-PCR. B. napus antisense lncRNA, TCONS_00000966, having 90% overlap with a plant defensin gene, showed significant induction at both infection stages, suggesting its involvement in the transcriptional regulation of defense responsive genes under S. sclerotiorum infection. Additionally, nine lncRNAs showed overlap with cis-regulatory regions of differentially expressed genes of B. napus. Quantitative RT-PCR verification of a set of S. sclerotiorum responsive sense/anti-sense transcript pairs revealed contrasting expression patterns, supporting the hypothesis that steric clashes of transcriptional machinery may lead to inactivation of sense promoter. Our findings highlight the potential contributions of lncRNAs in regulating expression of plant genes that respond to biotic stress.	[Joshi, Raj Kumar; Megha, Swati; Basu, Urmila; Rahman, Muhammad H.; Kav, Nat N. V.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB T6G 2P5, Canada; [Joshi, Raj Kumar] Siksha O Anusandhan Univ, Ctr Biotechnol, Bhubaneswar 751003, Orissa, India	University of Alberta; Siksha 'O' Anusandhan University	Kav, NNV (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB T6G 2P5, Canada.	nat@ualberta.ca	Megha, Swati/AAV-6859-2021; JOSHI, RAJ KUMAR/S-8886-2019; JOSHI, RAJ K/N-3982-2016	JOSHI, RAJ KUMAR/0000-0003-0505-2881; JOSHI, RAJ K/0000-0003-0505-2881	Department of Biotechnology, Government of India [BT/IN/DBT-CREST Awards/32/RKJ/2012-13]; Natural Sciences and Engineering Research Council (NSERC) of Canada	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	RKJ is grateful to Department of Biotechnology, Government of India for providing DBT-CRESTaward (Sanction letter no. BT/IN/DBT-CREST Awards/32/RKJ/2012-13) to pursue research as a Visiting Scientist at the University of Alberta. Work in NNVK's laboratory was supported in part by a Discovery Grant from the Natural Sciences and Engineering Research Council (NSERC) of Canada awarded to NNVK.; RKJ is grateful to Department of Biotechnology, Government of India for providing DBT-CREST award (Sanction letter no. BT/IN/DBT-CREST Awards/32/RKJ/2012-13) to pursue research as a Visiting Scientist at the University of Alberta.	Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; Arthanari Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091353; Ben Amor B, 2009, GENOME RES, V19, P57, DOI 10.1101/gr.080275.108; Benjamini Y, 2001, ANN STAT, V29, P1165; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bolton MD, 2006, MOL PLANT PATHOL, V7, P1, DOI 10.1111/J.1364-3703.2005.00316.X; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cai XZ, 2007, RNA, V13, P313, DOI 10.1261/rna.351707; Campalans A, 2004, PLANT CELL, V16, P1047, DOI 10.1105/tpc.019406; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carrieri C, 2012, NATURE, V491, P454, DOI 10.1038/nature11508; Chen L, 2012, PLANTA, V235, P873, DOI 10.1007/s00425-011-1548-z; Chen XM, 2012, CURR OPIN GENET DEV, V22, P361, DOI 10.1016/j.gde.2012.04.004; Chitwood DH, 2010, NATURE, V467, P415, DOI 10.1038/nature09351; Cho JK, 2005, EUPHYTICA, V146, P271, DOI 10.1007/s10681-005-9023-1; Darzacq X, 2002, EMBO J, V21, P2746, DOI 10.1093/emboj/21.11.2746; del Rio LE, 2007, PLANT DIS, V91, P191, DOI 10.1094/PDIS-91-2-0191; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Geisler S, 2013, NAT REV MOL CELL BIO, V14, P699, DOI 10.1038/nrm3679; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gontan C, 2011, PROG MOL SUBCELL BIO, V51, P43, DOI 10.1007/978-3-642-16502-3_3; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Heo JB, 2011, SCIENCE, V331, P76, DOI 10.1126/science.1197349; Hobson DJ, 2012, MOL CELL, V48, P365, DOI 10.1016/j.molcel.2012.08.027; Jin WB, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0410-4; Joshi RK, 2016, GENE, V590, P57, DOI 10.1016/j.gene.2016.06.003; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim ED, 2012, TRENDS PLANT SCI, V17, P16, DOI 10.1016/j.tplants.2011.10.008; Koch S, 2007, PHYTOPATHOLOGY, V97, P1186, DOI 10.1094/PHYTO-97-9-1186; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Li L, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r40; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liang Y, 2008, J AGR FOOD CHEM, V56, P1963, DOI 10.1021/jf073012d; Liu J, 2012, PLANT CELL, V24, P4333, DOI 10.1105/tpc.112.102855; Liu SY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4930; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenzo O, 2003, PLANT CELL, V15, P165, DOI 10.1105/tpc.007468; Lu TT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-721; Ma JX, 2008, J CELL BIOCHEM, V105, P136, DOI 10.1002/jcb.21807; Malvarez G, 2007, PHYTOPATHOLOGY, V97, P470, DOI 10.1094/PHYTO-97-4-0470; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Osato N, 2007, GENETICS, V176, P1299, DOI 10.1534/genetics.106.069484; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Sanchez-Leon N, 2012, J EXP BOT, V63, P3829, DOI 10.1093/jxb/ers075; Seo JK, 2013, MOL PLANT MICROBE IN, V26, P617, DOI 10.1094/MPMI-10-12-0255-IA; Shuai P, 2014, J EXP BOT, V65, P4975, DOI 10.1093/jxb/eru256; Stotz HU, 2009, PLANT SIGNAL BEHAV, V4, P1010, DOI 10.4161/psb.4.11.9755; Sun K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S2-S7; Sun L, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-331; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Swiezewski S, 2009, NATURE, V462, P799, DOI 10.1038/nature08618; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wang H, 2015, PLANT J, V84, P404, DOI 10.1111/tpj.13018; Wang H, 2014, GENOME RES, V24, P444, DOI 10.1101/gr.165555.113; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Wu HJ, 2013, PLANT PHYSIOL, V161, P1875, DOI 10.1104/pp.113.215962; Wu YG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-107; Xie CY, 2014, NUCLEIC ACIDS RES, V42, pD98, DOI 10.1093/nar/gkt1222; Xin MM, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-61; Yang B, 2007, PLANT SCI, V173, P156, DOI 10.1016/j.plantsci.2007.04.012; Zhang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098958; Zhang YC, 2013, BIOCHEM BIOPH RES CO, V436, P111, DOI 10.1016/j.bbrc.2013.05.086; Zhao JW, 2009, MOL PLANT PATHOL, V10, P635, DOI [10.1111/J.1364-3703.2009.00558.X, 10.1111/j.1364-3703.2009.00558.x]; Zhu Q-H, 2012, GENES, V3, P15; Zhu QH, 2014, NEW PHYTOL, V201, P574, DOI 10.1111/nph.12537; Zwieb C, 1997, NUCLEIC ACIDS RES, V25, P102, DOI 10.1093/nar/25.1.102	75	86	93	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158784	10.1371/journal.pone.0158784	http://dx.doi.org/10.1371/journal.pone.0158784			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27388760	gold, Green Published, Green Submitted			2022-12-27	WOS:000379811500046
J	Chen, JF; Yang, CY; Tizioto, PC; Huang, H; Lee, MOK; Payne, HR; Lawhon, SD; Schroeder, F; Taylor, JF; Womack, JE				Chen, Junfeng; Yang, Chingyuan; Tizioto, Polyana C.; Huang, Huan; Lee, Mi O. K.; Payne, Harold R.; Lawhon, Sara D.; Schroeder, Friedhelm; Taylor, Jeremy F.; Womack, James E.			Expression of the Bovine NK-Lysin Gene Family and Activity against Respiratory Pathogens	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; VIRAL DIARRHEA VIRUS; ANTIMICROBIAL PEPTIDES; FEEDLOT CATTLE; ANTITUMOR-ACTIVITY; FEEDER CATTLE; UNITED-STATES; T-CELLS; DISEASE; GRANULYSIN	Unlike the genomes of many mammals that have a single NK-lysin gene, the cattle genome contains a family of four genes, one of which is expressed preferentially in the lung. In this study, we compared the expression of the four bovine NK-lysin genes in healthy animals to animals challenged with pathogens known to be associated with bovine respiratory disease (BRD) using transcriptome sequencing (RNA-seq). The expression of several NK-lysins, especially NK2C, was elevated in challenged relative to control animals. The effects of synthetic peptides corresponding to functional region helices 2 and 3 of each gene product were tested on both model membranes and bio-membranes. Circular dichroism spectroscopy indicated that these peptides adopted a more helical secondary structure upon binding to an anionic model membrane and liposome leakage assays suggested that these peptides disrupt membranes. Bacterial killing assays further confirmed the antimicrobial effects of these peptides on BRD-associated bacteria, including both Pasteurella multocida and Mannhemia haemolytica and an ultrastructural examination of NK-lysin-treated P. multocida cells by transmission electron microscopy revealed the lysis of target membranes. These studies demonstrate that the expanded bovine NK-lysin gene family is potentially important in host defense against pathogens involved in bovine respiratory disease.	[Chen, Junfeng; Yang, Chingyuan; Lee, Mi O. K.; Payne, Harold R.; Lawhon, Sara D.; Womack, James E.] Texas A&M Univ, Coll Vet Med, Dept Vet Pathobiol, College Stn, TX 77843 USA; [Tizioto, Polyana C.] Embrapa Southeast Livestock, Sao Carlos, SP, Brazil; [Tizioto, Polyana C.; Taylor, Jeremy F.] Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA; [Huang, Huan; Schroeder, Friedhelm] Texas A&M Univ, Coll Vet Med, Dept Physiol & Pharmacol, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); University of Missouri System; University of Missouri Columbia; Texas A&M University System; Texas A&M University College Station	Womack, JE (corresponding author), Texas A&M Univ, Coll Vet Med, Dept Vet Pathobiol, College Stn, TX 77843 USA.	JWOMACK@cvm.tamu.edu	Lawhon, Sara D./G-5147-2011	Lawhon, Sara D./0000-0001-9154-8909	Agriculture and Food Research Initiative from the United States Department of Agriculture National Institute of Food [2011-68004-30367]	Agriculture and Food Research Initiative from the United States Department of Agriculture National Institute of Food	This project was supported by Agriculture and Food Research Initiative competitive grant number 2011-68004-30367 from the United States Department of Agriculture National Institute of Food.	ANDERSSON M, 1995, EMBO J, V14, P1615, DOI 10.1002/j.1460-2075.1995.tb07150.x; Andreu D, 1999, BIOCHEM J, V344, P845, DOI 10.1042/0264-6021:3440845; Bermingham ML, 2014, HEREDITY, V112, P543, DOI 10.1038/hdy.2013.137; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Casas E, 2015, ANIM GENET, V46, P8, DOI 10.1111/age.12239; Cernicchiaro N, 2012, J ANIM SCI, V90, P1929, DOI 10.2527/jas.2011-4599; Cernicchiaro N, 2012, J ANIM SCI, V90, P1328, DOI 10.2527/jas.2011-4657; Chen J, 2015, P NATL ACAD IN PRESS; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; Chen YX, 2007, ANTIMICROB AGENTS CH, V51, P1398, DOI 10.1128/AAC.00925-06; Ellis JA, 2010, VET CLIN N AM-FOOD A, V26, P575, DOI 10.1016/j.cvfa.2010.08.002; Endsley JJ, 2004, J IMMUNOL, V173, P2607, DOI 10.4049/jimmunol.173.4.2607; Gagea MI, 2006, J VET DIAGN INVEST, V18, P18, DOI 10.1177/104063870601800104; Garcia MD, 2010, J ANIM SCI, V88, P491, DOI 10.2527/jas.2009-1874; Gershwin LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142479; Glass EJ, 2012, VET IMMUNOL IMMUNOP, V148, P90, DOI 10.1016/j.vetimm.2011.05.009; Griffin D, 1997, VET CLIN N AM-FOOD A, V13, P367, DOI 10.1016/S0749-0720(15)30302-9; Jacobs T, 2003, ANTIMICROB AGENTS CH, V47, P607, DOI 10.1128/AAC.47.2.607-613.2003; JONGSTRA J, 1987, J EXP MED, V165, P601, DOI 10.1084/jem.165.3.601; Klima CL, 2014, J CLIN MICROBIOL, V52, P438, DOI 10.1128/JCM.02485-13; Krensky AM, 2000, BIOCHEM PHARMACOL, V59, P317, DOI 10.1016/S0006-2952(99)00177-X; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee MO, 2012, P NATL ACAD SCI USA, V109, P12087, DOI 10.1073/pnas.1209161109; Linde CMA, 2005, INFECT IMMUN, V73, P6332, DOI 10.1128/IAI.73.10.6332-6339.2005; MUGGLICOCKETT NE, 1992, J ANIM SCI, V70, P2013, DOI 10.2527/1992.7072013x; Neibergs H, 2011, J ANIM SCI, V89, P907, DOI 10.2527/jas.2010-3330; Neibergs HL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1164; Norrby SR, 2005, LANCET INFECT DIS, V5, P115, DOI 10.1016/S1473-3099(05)01283-1; Pena SV, 1997, J IMMUNOL, V158, P2680; Rice J. A., 2007, Animal Health Research Reviews, V8, P117, DOI 10.1017/S1466252307001375; Shahriar FM, 2002, CAN VET J, V43, P863; Snowder GD, 2007, J ANIM SCI, V85, P1885, DOI 10.2527/jas.2007-0008; Snowder GD, 2006, J ANIM SCI, V84, P1999, DOI 10.2527/jas.2006-046; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Taylor JD, 2010, CAN VET J, V51, P1095; Tizioto PC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131459; Wang Z, 2000, J IMMUNOL, V165, P1486, DOI 10.4049/jimmunol.165.3.1486; Welsh RD, 2004, J VET DIAGN INVEST, V16, P426, DOI 10.1177/104063870401600510; Yan JX, 2012, BIOCHIMIE, V94, P184, DOI 10.1016/j.biochi.2011.10.005; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	41	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158882	10.1371/journal.pone.0158882	http://dx.doi.org/10.1371/journal.pone.0158882			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27409794	gold, Green Published, Green Submitted			2022-12-27	WOS:000379508300040
J	Gorokhova, E; Lehtiniemi, M; Postel, L; Rubene, G; Amid, C; Lesutiene, J; Uusitalo, L; Strake, S; Demereckiene, N				Gorokhova, Elena; Lehtiniemi, Maiju; Postel, Lutz; Rubene, Gunta; Amid, Callis; Lesutiene, Jurate; Uusitalo, Laura; Strake, Solvita; Demereckiene, Natalja			Indicator Properties of Baltic Zooplankton for Classification of Environmental Status within Marine Strategy Framework Directive	PLOS ONE			English	Article							SPRAT SPRATTUS-SPRATTUS; BODY-SIZE; CLUPEA-HARENGUS; COMMUNITY STRUCTURE; ECOLOGICAL ASSESSMENT; TROPHIC CASCADES; CONTROL CHARTS; SEA; LAKES; PREDATION	The European Marine Strategy Framework Directive requires the EU Member States to estimate the level of anthropogenic impacts on their marine systems using 11 Descriptors. Assessing food web response to altered habitats is addressed by Descriptor 4 and its indicators, which are being developed for regional seas. However, the development of simple foodweb indicators able to assess the health of ecologically diverse, spatially variable and complex interactions is challenging. Zooplankton is a key element in marine foodwebs and thus comprise an important part of overall ecosystem health. Here, we review work on zooplankton indicator development using long-term data sets across the Baltic Sea and report the main findings. A suite of zooplankton community metrics were evaluated as putative ecological indicators that track community state in relation to Good Environmental Status (GES) criteria with regard to eutrophication and fish feeding conditions in the Baltic Sea. On the basis of an operational definition of GES, we propose mean body mass of zooplankton in the community in combination with zooplankton stock measured as either abundance or biomass to be applicable as an integrated indicator that could be used within the Descriptor 4 in the Baltic Sea. These metrics performed best in predicting zooplankton being in-GES when considering all datasets evaluated. However, some other metrics, such as copepod biomass, the contribution of copepods to the total zooplankton biomass or biomass-based Cladocera: Copepoda ratio, were equally reliable or even superior in certain basin-specific assessments. Our evaluation suggests that in several basins of the Baltic Sea, zooplankton communities currently appear to be out-of-GES, being comprised by smaller zooplankters and having lower total abundance or biomass compared to the communities during the reference conditions; however, the changes in the taxonomic structure underlying these trends vary widely across the sea basins due to the estuarine character of the Baltic Sea.	[Gorokhova, Elena; Amid, Callis] Stockholm Univ, Dept Environm Sci & Analyt Chem, Stockholm, Sweden; [Lehtiniemi, Maiju; Uusitalo, Laura] Ctr Marine Res, Finnish Environm Inst, Helsinki, Finland; [Postel, Lutz] Leibniz Inst Balt Sea Res, Rostock, Germany; [Rubene, Gunta] Inst Food Safety Anim Hlth & Environm, Dept Fish Resources Res, Riga, Latvia; [Lesutiene, Jurate] Klaipeda Univ, Open Access Ctr Marine Res, Klaipeda, Lithuania; [Strake, Solvita] Latvian Inst Aquat Ecol, Riga, Latvia; [Demereckiene, Natalja] Lithuanian Environm Protect Agcy, Klaipeda, Lithuania	Stockholm University; Finnish Environment Institute; Leibniz Institut fur Ostseeforschung Warnemunde; Institute of Food Safety, Animal Health & Environment "BIOR"; Klaipeda University	Gorokhova, E (corresponding author), Stockholm Univ, Dept Environm Sci & Analyt Chem, Stockholm, Sweden.	elena.gorokhova@aces.su.se	Gorokhova, Elena/E-7105-2018; Lehtiniemi, Maiju/AAN-6012-2020	Gorokhova, Elena/0000-0002-4192-6956; Lesutiene, Jurate/0000-0002-9636-8218; Uusitalo, Laura/0000-0002-5143-5253	Research Council of Lithuania [SIT-10/2015]; Swedish EPA (Project ZOOIND); Helsinki Commission (HELCOM); Swedish Agency for Marine and Water Management (Havsoch Vattenmyndigheten)	Research Council of Lithuania(Research Council of Lithuania (LMTLT)); Swedish EPA (Project ZOOIND); Helsinki Commission (HELCOM); Swedish Agency for Marine and Water Management (Havsoch Vattenmyndigheten)	Helsinki Commission (HELCOM), Swedish EPA (Project ZOOIND, grant recipient EG), Swedish Agency for Marine and Water Management (Havsoch Vattenmyndigheten) and Research Council of Lithuania (project no. SIT-10/2015, grant recipient: JL) provided support for networking activities of Zooplankton Expert Network (ZEN) and facilitated joint analysis of the data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian R, 1999, INT REV HYDROBIOL, V84, P609; Andersen JH, 2017, BIOL REV, V92, P135, DOI 10.1111/brv.12221; Andersen JH, 2011, BIOGEOCHEMISTRY, V106, P137, DOI 10.1007/s10533-010-9508-4; [Anonymous], [No title captured]; Attayde JL, 1998, CAN J FISH AQUAT SCI, V55, P1789, DOI 10.1139/cjfas-55-8-1789; Berglund J, 2007, LIMNOL OCEANOGR, V52, P121, DOI 10.4319/lo.2007.52.1.0121; BERZINS B, 1989, HYDROBIOLOGIA, V185, P95, DOI 10.1007/BF00010808; BERZINS B, 1989, HYDROBIOLOGIA, V182, P171, DOI 10.1007/BF00006043; Boyce DG, 2015, MAR ECOL PROG SER, V534, P251, DOI 10.3354/meps11411; BROOKS JL, 1965, SCIENCE, V150, P28, DOI 10.1126/science.150.3692.28; Brucet S, 2010, LIMNOL OCEANOGR, V55, P1697, DOI 10.4319/lo.2010.55.4.1697; Cardinale M, 2002, AQUAT LIVING RESOUR, V15, P273, DOI 10.1016/S0990-7440(02)01188-9; Caroni R, 2010, BIOL ENVIRON, V110B, P35, DOI 10.3318/BIOE.2010.110.1.35; Casini M, 2006, OIKOS, V112, P638, DOI 10.1111/j.0030-1299.2006.13860.x; Casini M, 2009, P NATL ACAD SCI USA, V106, P197, DOI 10.1073/pnas.0806649105; Fleming-Lehtinen V, 2008, AMBIO, V37, P86, DOI 10.1579/0044-7447(2008)37[86:LDOINA]2.0.CO;2; Fleming-Lehtinen V, 2015, ECOL INDIC, V48, P380, DOI 10.1016/j.ecolind.2014.08.022; Flinkman J, 1998, MAR ECOL PROG SER, V165, P127, DOI 10.3354/meps165127; FLINKMAN J, 1992, CAN J FISH AQUAT SCI, V49, P73, DOI 10.1139/f92-008; Flinkman J, 2009, HELCOM BALT SEA EN B, P43; Fuchs HL, 2010, MAR ECOL PROG SER, V413, P1, DOI 10.3354/meps08716; GLIWICZ Z M, 1969, Ekologia Polska Seria A, V17, P663; Haberman J, 2007, HYDROBIOLOGIA, V584, P157, DOI 10.1007/s10750-007-0592-y; HANSON JM, 1984, CAN J FISH AQUAT SCI, V41, P439, DOI 10.1139/f84-052; HAWKINS DM, 1997, CUMULATIVE SUM CHART; HELCOM, 2007, BALT SEA ACT PLAN HE, P101; HELCOM, 2009, BALT SEA ENV P; Hsieh CH, 2011, BIOGEOSCIENCES, V8, P1383, DOI 10.5194/bg-8-1383-2011; Ibanez F, 2002, ECOL MODEL, V154, P9, DOI 10.1016/S0304-3800(02)00033-9; ICES, 2013, BENCHM WORKSH BALT M; ICES, 2011, REP ICES HELCOM WORK; Irigoien X, 2004, NATURE, V429, P863, DOI 10.1038/nature02593; Jeppesen E, 2000, FRESHWATER BIOL, V45, P201, DOI 10.1046/j.1365-2427.2000.00675.x; Jeppesen E, 2011, HYDROBIOLOGIA, V676, P279, DOI 10.1007/s10750-011-0831-0; Jiang XD, 2014, J PLANKTON RES, V36, P956, DOI 10.1093/plankt/fbu032; Johansson M, 2004, J PLANKTON RES, V26, P67, DOI 10.1093/plankt/fbg115; JOHANSSON S, 1993, ECOGRAPHY, V16, P167, DOI 10.1111/j.1600-0587.1993.tb00068.x; Kimmel DG, 2012, ESTUAR COAST SHELF S, V101, P76, DOI 10.1016/j.ecss.2012.02.019; Lavaniegos BE, 2007, PROG OCEANOGR, V75, P42, DOI 10.1016/j.pocean.2007.07.002; LEGENDRE P, 1985, AM NAT, V125, P257, DOI 10.1086/284340; Lehtiniemi M, 2008, HYDROBIOLOGIA, V614, P309, DOI 10.1007/s10750-008-9515-9; Ljunggren L, 2010, ICES J MAR SCI, V67, P1587, DOI 10.1093/icesjms/fsq109; Lougheed VL, 2002, ECOL APPL, V12, P474, DOI 10.1890/1051-0761(2002)012[0474:DAUOAZ]2.0.CO;2; LUCAS JM, 1982, J QUAL TECHNOL, V14, P51, DOI 10.1080/00224065.1982.11978790; Manly BFJ, 2003, ENVIRON ECOL STAT, V10, P231, DOI 10.1023/A:1023682426285; McGowan J.A., 1980, California Cooperative Oceanic Fisheries Investigations Reports, V21, P29; Mesnil B, 2009, AQUAT LIVING RESOUR, V22, P187, DOI 10.1051/alr/2008058; MILLS E L, 1987, North American Journal of Fisheries Management, V7, P369, DOI 10.1577/1548-8659(1987)7<369:UOZSTA>2.0.CO;2; Mitra A, 2014, PROG OCEANOGR, V129, P176, DOI 10.1016/j.pocean.2014.04.025; Mollmann C, 2012, ADV ECOL RES, V47, P303, DOI 10.1016/B978-0-12-398315-2.00004-1; MOORE M, 1993, TRENDS ECOL EVOL, V8, P178, DOI 10.1016/0169-5347(93)90144-E; Morrison L, 2008, NAT AREA J, V28, P66, DOI 10.3375/0885-8608(2008)28[66:TUOCCT]2.0.CO;2; Motwani NH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079230; Nowaczyk A, 2011, BIOGEOSCIENCES, V8, P2159, DOI 10.5194/bg-8-2159-2011; Osterblom H, 2006, MAR ECOL PROG SER, V323, P233, DOI 10.3354/meps323233; PACE ML, 1986, LIMNOL OCEANOGR, V31, P45, DOI 10.4319/lo.1986.31.1.0045; PACE ML, 1981, LIMNOL OCEANOGR, V26, P822, DOI 10.4319/lo.1981.26.5.0822; Park GS, 2000, J PLANKTON RES, V22, P121, DOI 10.1093/plankt/22.1.121; PATALAS K, 1972, J FISH RES BOARD CAN, V29, P1451, DOI 10.1139/f72-224; PEJLER B, 1983, HYDROBIOLOGIA, V101, P111, DOI 10.1007/BF00008662; Peltonen H, 2004, ICES J MAR SCI, V61, P966, DOI 10.1016/j.icesjms.2004.06.008; PERROW MR, 1992, HYDROBIOLOGIA, V241, P155, DOI 10.1007/BF00028638; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Poikane S, 2014, ENVIRON SCI POLICY, V44, P237, DOI 10.1016/j.envsci.2014.08.006; Rabalais NN, 2002, AMBIO, V31, P102, DOI 10.1579/0044-7447-31.2.102; Rahikainen M, 2004, ICES J MAR SCI, V61, P338, DOI 10.1016/j.icesjms.2004.02.005; Remm K., 1984, HYDROBIOLOGICAL REGI, P34; Ronkkonen S, 2004, CAN J FISH AQUAT SCI, V61, P219, DOI 10.1139/F03-167; Ruokolainen L, 2006, BOREAL ENVIRON RES, V11, P1; Scandol JP, 2003, FISH RES, V64, P19, DOI 10.1016/S0165-7836(03)00104-8; Scharf FS, 2000, MAR ECOL PROG SER, V208, P229, DOI 10.3354/meps208229; Scheinin M, 2010, BOREAL ENVIRON RES, V15, P397; SCHINDLER DW, 1987, CAN J FISH AQUAT SCI, V44, P6; SELLNER KG, 1994, HYDROBIOLOGIA, V293, P249, DOI 10.1007/BF00229948; Shurin JB, 2001, ECOLOGY, V82, P3404, DOI 10.2307/2680161; SLADECEK V, 1983, HYDROBIOLOGIA, V100, P169, DOI 10.1007/BF00027429; STEMBERGER RS, 1994, CAN J FISH AQUAT SCI, V51, P2435, DOI 10.1139/f94-243; Suikkanen S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066475; Sun XX, 2012, J PLANKTON RES, V34, P853, DOI 10.1093/plankt/fbs047; Thurow F, 1997, ICES J MAR SCI, V54, P444, DOI 10.1006/jmsc.1996.0195; Welsch R, 1980, REGRESSION DIAGNOSTI; Woodward G, 2005, TRENDS ECOL EVOL, V20, P402, DOI 10.1016/j.tree.2005.04.005; Xu FL, 2001, WATER RES, V35, P3157, DOI 10.1016/S0043-1354(01)00040-9; Yan ND, 2008, CAN J FISH AQUAT SCI, V65, P862, DOI 10.1139/F07-197	84	27	30	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158326	10.1371/journal.pone.0158326	http://dx.doi.org/10.1371/journal.pone.0158326			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410261	Green Submitted, gold, Green Published			2022-12-27	WOS:000379508300021
J	Horyniak, D; Melo, JS; Farrell, RM; Ojeda, VD; Strathdee, SA				Horyniak, Danielle; Melo, Jason S.; Farrell, Risa M.; Ojeda, Victoria D.; Strathdee, Steffanie A.			Epidemiology of Substance Use among Forced Migrants: A Global Systematic Review	PLOS ONE			English	Review							POSTTRAUMATIC-STRESS-DISORDER; INTERNALLY DISPLACED PERSONS; COMPARATIVE RISK-ASSESSMENT; INTIMATE PARTNER VIOLENCE; INJECTION-DRUG USERS; LA REFUGEE CAMP; MENTAL-HEALTH; ALCOHOL-USE; UNITED-STATES; CAMBODIAN REFUGEES	Introduction Forced migration is occurring at unprecedented levels. Forced migrants may be at risk for substance use for reasons including coping with traumatic experiences, co-morbid mental health disorders, acculturation challenges and social and economic inequality. This paper aimed to systematically review the literature examining substance use among forced migrants, and identify priority areas for intervention and future research. Methods Seven medical, allied health and social science databases were searched from inception to September 2015 in accordance with PRISMA guidelines to identify original peer-reviewed articles describing any findings relating to alcohol and/or illicit drug use among refugees, internally displaced people (IDPs), asylum seekers, people displaced by disasters and deportees. A descriptive synthesis of evidence from quantitative studies was conducted, focusing primarily on studies which used validated measures of substance use. Synthesis of evidence from qualitative studies focused on identifying prominent themes relating to the contexts and consequences of substance use. Critical Appraisal Skills Programme ( CASP) checklists were used to assess methodological quality of included studies. Results Forty-four quantitative (82% cross-sectional), 16 qualitative and three mixed-methods studies were included. Ten studies were rated as high methodological quality (16%), 39 as moderate quality (62%) and 14 as low quality (22%). The majority of research was conducted among refugees, IDPs and asylum seekers (n = 55, 87%), predominantly in high-income settings. The highest-quality prevalence estimates of hazardous/harmful alcohol use ranged from 17%-36% in camp settings and 4%-7% in community settings. Few studies collected validated measures of illicit drug use. Seven studies compared substance use among forced migrants to other migrant or native-born samples. Among eight studies which conducted multivariable analysis, male sex, trauma exposure and symptoms of mental illness were commonly identified correlates of substance use. Conclusion Our understanding of substance use among forced migrants remains limited, particularly regarding persons displaced due to disasters, development and deportation. Despite a growing body of work among refugee-background populations, few studies include refugees in low and middle-income countries, where over 80% of the global refugee population resides. Findings suggest a need to integrate substance use prevention and treatment into services offered to forced migrants, particularly in camp settings. Efforts to develop and evaluate interventions to reduce substance use and related harms are needed.	[Horyniak, Danielle; Melo, Jason S.; Farrell, Risa M.; Ojeda, Victoria D.; Strathdee, Steffanie A.] Univ Calif San Diego, Div Global Publ Hlth, La Jolla, CA 92093 USA; [Horyniak, Danielle] Burnet Inst, Ctr Populat Hlth, Melbourne, Vic 3004, Australia; [Horyniak, Danielle] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia	University of California System; University of California San Diego; Burnet Institute; Monash University	Horyniak, D (corresponding author), Univ Calif San Diego, Div Global Publ Hlth, La Jolla, CA 92093 USA.; Horyniak, D (corresponding author), Burnet Inst, Ctr Populat Hlth, Melbourne, Vic 3004, Australia.; Horyniak, D (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia.	dhoryniak@uscd.edu	Strathdee, Steffanie A/B-9042-2009	Melo, Jason/0000-0003-2116-4656; Strathdee, Steffanie/0000-0002-7724-691X	Australian National Health & Medical Research Council Early Career Fellowship [1092077]; UCSD Center for US-Mexican Studies; NIDA Merit Award [R37DA019829]; FOGARTY INTERNATIONAL CENTER [D43TW009343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA019829] Funding Source: NIH RePORTER	Australian National Health & Medical Research Council Early Career Fellowship; UCSD Center for US-Mexican Studies; NIDA Merit Award; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	DH is supported by an Australian National Health & Medical Research Council Early Career Fellowship (#1092077). VO is supported in part by a Fellowship provided by the UCSD Center for US-Mexican Studies. SS is supported by NIDA Merit Award R37DA019829. The funding bodies played no role in the study design, data analysis, decision to publish, or preparation of the manuscript.; DH is supported by an Australian National Health & Medical Research Council Early Career Fellowship (#1092077). VO is supported in part by a Fellowship provided by the UCSD Center for US-Mexican Studies. SS is supported by NIDA Merit Award R37DA019829. The funding bodies played no role in the study design, data analysis, decision to publish, or preparation of the manuscript.	Abraido-Lanza AF, 2005, SOC SCI MED, V61, P1243, DOI 10.1016/j.socscimed.2005.01.016; Ahlmark N, 2014, ETHNICITY HLTH, V20, P611; Akinyemi Oluwaseun O, 2012, BMC Res Notes, V5, P394, DOI 10.1186/1756-0500-5-394; Anikeeva O, 2010, ASIA-PAC J PUBLIC HE, V22, P159, DOI 10.1177/1010539509358193; [Anonymous], 2011, SPHERE HDB HUMANITAR; [Anonymous], 2014, GLOB EST 2014 PEOPL; Arfken CL, 2014, J IMMIGR MINOR HEALT, V16, P1303, DOI 10.1007/s10903-013-9960-z; Arfken CL, 2011, J IMMIGR MINOR HEALT, V13, P713, DOI 10.1007/s10903-011-9447-8; Beard E, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0839-2; Beckerleg S, 2005, DRUGS ALCOHOL TODAY, V5, P25, DOI 10.1108/17459265200500043; Beckwith CG, 2009, INT J INFECT DIS, V13, P186, DOI 10.1016/j.ijid.2008.06.004; Berry JW, 1997, APPL PSYCHOL-INT REV, V46, P5, DOI 10.1111/j.1464-0597.1997.tb01087.x; Bhui K, 2006, SOC PSYCH PSYCH EPID, V41, P400, DOI 10.1007/s00127-006-0043-5; Bhui K, 2010, J ETHNOPHARMACOL, V132, P549, DOI 10.1016/j.jep.2010.07.027; Blanco C, 2013, J PSYCHIATR RES, V47, P226, DOI 10.1016/j.jpsychires.2012.09.019; Blinder S, 2012, DEPORTATIONS REMOVAL; Borges G, 2012, DRUG ALCOHOL DEPEN, V125, pS4, DOI 10.1016/j.drugalcdep.2012.05.007; Brouwer KC, 2009, J IMMIGR MINOR HEALT, V11, P1, DOI 10.1007/s10903-008-9119-5; Browne J, 2010, PREVENTION ALCOHOL O; Brune M, 2003, EUR ADDICT RES, V9, P144, DOI 10.1159/000070985; Buchanan RL, 2009, SUBST USE MISUSE, V44, P740, DOI 10.1080/10826080802544216; Buljan Danijel, 2002, Alcoholism (Zagreb), V38, P35; Carter TS, 2009, J IMMIGR REFUG STUD, V7, P308, DOI 10.1080/15562940903150097; Centre for Research on the Epidemiology of Disasters, 2014, 2013 DIS NUMB; Cepeda A, 2010, DISASTERS, V34, P426, DOI 10.1111/j.1467-7717.2009.01136.x; Colic-Peisker V, 2007, INT MIGR, V45, P59, DOI 10.1111/j.1468-2435.2007.00396.x; Cooke A, 2012, QUAL HEALTH RES, V22, P1435, DOI 10.1177/1049732312452938; Critical Appraisal Skills Programme (CASP), 2014, CASP CHECKL; D'Amico EJ, 2007, J STUD ALCOHOL DRUGS, V68, P11, DOI 10.15288/jsad.2007.68.11; D'Avanzo C E, 2000, Health Care Women Int, V21, P319; DAVANZO CE, 1994, J STUD ALCOHOL, V55, P420, DOI 10.15288/jsa.1994.55.420; De La Rosa M, 2002, SUBST USE MISUSE, V37, P429, DOI 10.1081/JA-120002804; De Maio J, 2014, FAMILY MATTERS, P5; Degenhardt L, 2013, LANCET, V382, P1564, DOI 10.1016/S0140-6736(13)61530-5; Degenhardt L, 2012, LANCET, V379, P55, DOI 10.1016/S0140-6736(11)61138-0; Delavari M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-458; Dotinga A, 2004, ETHNIC HEALTH, V9, P139, DOI 10.1080/1355785042000222851; Dua T, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001122; Dunlap E, 2009, J PSYCHOACTIVE DRUGS, V41, P219, DOI 10.1080/02791072.2009.10400532; Dupont HJBHM, 2005, INT J DRUG POLICY, V16, P27, DOI 10.1016/j.drugpo.2004.06.002; Durrant R., 2003, SUBSTANCE USE ABUSE; Edge S, 2014, SOC SCI MED, V117, P34, DOI 10.1016/j.socscimed.2014.07.025; Ezard N, 2012, CONFL HEALTH, V6, P1; Ezard N, 2014, SUBST USE MISUSE, V49, P684, DOI 10.3109/10826084.2013.863343; Ezard N, 2012, DISASTERS, V36, P533, DOI 10.1111/j.1467-7717.2011.01261.x; Ezard Nadine, 2011, Confl Health, V5, P1, DOI 10.1186/1752-1505-5-1; Ezard N, 2010, INTERVENTION, V8, P223, DOI 10.1097/WTF.0b013e3283413134; Fazel M, 2005, LANCET, V365, P1309, DOI 10.1016/S0140-6736(05)61027-6; Fazel M, 2012, LANCET, V379, P266, DOI 10.1016/S0140-6736(11)60051-2; Fosados R, 2007, ADDICT BEHAV, V32, P2990, DOI 10.1016/j.addbeh.2007.06.015; Fozdar F, 2014, J REFUG STUD, V27, P126, DOI 10.1093/jrs/fet018; Frohlich KL, 2008, AM J PUBLIC HEALTH, V98, P216, DOI 10.2105/AJPH.2007.114777; Fu HY, 2010, J REFUG STUD, V23, P160, DOI 10.1093/jrs/feq012; Fulu E, 2013, LANCET GLOB HEALTH, V1, pE187, DOI 10.1016/S2214-109X(13)70074-3; Furber S, 2013, J IMMIGR MINOR HEALT, V15, P1133, DOI 10.1007/s10903-013-9881-x; Galea S, 2004, EPIDEMIOL REV, V26, P36, DOI 10.1093/epirev/mxh007; Gee GC, 2015, J HEALTH CARE POOR U, V26, P488, DOI 10.1353/hpu.2015.0045; Gibney MJ, 2013, REFUG SURV Q, V32, P116, DOI 10.1093/rsq/hdt003; Gifford SM, 2007, J REFUG STUD, V20, P414, DOI 10.1093/jrs/fem004; Gil-Gonzalez D, 2015, ETHNIC HEALTH, V20, P523, DOI 10.1080/13557858.2014.946473; GILLMORE MR, 1990, AM J DRUG ALCOHOL AB, V16, P185, DOI 10.3109/00952999009001583; Guerrero EG, 2013, DRUG ALCOHOL DEPEN, V133, P805, DOI 10.1016/j.drugalcdep.2013.07.027; Gushulak BD, 2011, CAN MED ASSOC J, V183, pE952, DOI 10.1503/cmaj.090287; Hadgkiss EJ, 2014, AUST HEALTH REV, V38, P142, DOI 10.1071/AH13113; Hahne SJM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-181; Horyniak D, 2016, ETHNIC HEALTH, V21, P284, DOI 10.1080/13557858.2015.1061105; Huhtanen P, 2012, DRUG ALCOHOL REV, V31, P841, DOI 10.1111/j.1465-3362.2012.00480.x; Inkster N, 2015, IISS ARMED CONFLICT; International Organisation for Migration, 2004, GLOSS MIGR; Isac S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007106; JENKINS CNH, 1990, WESTERN J MED, V153, P34; Jeon WT, 2008, PSYCHIAT INVEST, V5, P213, DOI 10.4306/pi.2008.5.4.213; Johnson TP, 2003, SUBST USE MISUSE, V38, P1447, DOI 10.1081/JA-120023394; Johnson TP, 1996, SUBST USE MISUSE, V31, P1853, DOI 10.3109/10826089609064003; Kane JC, TOL WA MENTAL NEUROL; Karriker-Jaffe KJ, 2011, DRUG ALCOHOL REV, V30, P84, DOI 10.1111/j.1465-3362.2010.00191.x; Kennedy S, 2015, J INT MIGR INTEGR, V16, P317, DOI 10.1007/s12134-014-0340-x; Khanani MR, 2010, J INFECTION, V61, P434, DOI 10.1016/j.jinf.2010.08.009; Kluttig T, 2009, INT FORUM PSYCHOANAL, V18, P42, DOI 10.1080/08037060802658512; Kozaric-Kovacic D, 2000, CROAT MED J, V41, P173; Kroll J, 2011, SOC PSYCH PSYCH EPID, V46, P481, DOI 10.1007/s00127-010-0216-0; Laczko F., 2009, Migration, environment and climate change: assessing the evidence; Larrance R, 2007, ANN EMERG MED, V49, P590, DOI 10.1016/j.annemergmed.2006.12.004; Laslett AM, 2011, ADDICTION, V106, P1603, DOI 10.1111/j.1360-0443.2011.03445.x; Liang WB, 2011, ADDICTION, V106, P1126, DOI 10.1111/j.1360-0443.2011.03362.x; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Livingston M, 2012, AUST NZ J PUBL HEAL, V36, P41, DOI 10.1111/j.1753-6405.2011.00776.x; Luitel NP, 2013, ALCOHOL ALCOHOLISM, V48, P349, DOI 10.1093/alcalc/agt009; Maksimovic M, 2011, INT J PUBLIC HEALTH, V56, P305, DOI 10.1007/s00038-010-0211-y; Mao TE, 2014, B WORLD HEALTH ORGAN, V92, P573, DOI 10.2471/BLT.13.131581; Marshall GN, 2005, JAMA-J AM MED ASSOC, V294, P571, DOI 10.1001/jama.294.5.571; MARTIN J, 1993, J PSYCHOACTIVE DRUGS, V25, P73, DOI 10.1080/02791072.1993.10472593; Masson-Delmotte V., 2018, GLOBAL WARMING 15 C; McCabe SE, 2015, SOCIAL PSYCHIAT PSYC, P1; McHugh, 2015, INTEGRATION OUTCOMES; McLeod Alison, 2005, N Z Med J, V118, pU1702; McMichael C, 2015, J REFUG STUD, V28, P238, DOI 10.1093/jrs/feu017; Meyer S, 2013, GLOB PUBLIC HEALTH, V8, P1027, DOI 10.1080/17441692.2013.811531; Mills KL, 2015, DRUG ALCOHOL REV, V34, P231, DOI 10.1111/dar.12273; Milner K, 2010, J PAC RIM PSYCHOL, V4, P19, DOI 10.1375/prp.4.1.19; Miremadi S, 2011, ASIA-PAC PSYCHIAT, V3, P137, DOI 10.1111/j.1758-5872.2011.00136.x; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Morris MD, 2009, J COMMUN HEALTH, V34, P529, DOI 10.1007/s10900-009-9175-3; Mukeshimana C, 2001, INT J GLOBAL HLTH, V1, P24; Mulvaney-Day N, 2012, DRUG ALCOHOL DEPEN, V125, pS44, DOI 10.1016/j.drugalcdep.2012.05.005; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nava-Aguilera E, 2009, INT J TUBERC LUNG D, V13, P17; Neumann K, 2015, HUM ECOL, V43, P309, DOI 10.1007/s10745-015-9733-5; Ojeda VD, 2011, J URBAN HEALTH, V88, P104, DOI 10.1007/s11524-010-9508-7; Palic S, 2014, J NERV MENT DIS, V202, P111, DOI 10.1097/NMD.0000000000000079; Poppitt G, 2007, AUST J GUID COUNS, V17, P160, DOI 10.1375/ajgc.17.2.160; Porter M, 2005, JAMA-J AM MED ASSOC, V294, P602, DOI 10.1001/jama.294.5.602; PORTES A, 1992, J HEALTH SOC BEHAV, V33, P283, DOI 10.2307/2137309; Posselt M, 2013, MENT HLTH SUBST USE, V7, P19, DOI DOI 10.1080/17523281.2013.772914; Posselt M, 2015, AUST PSYCHOL, V50, P130, DOI 10.1111/ap.12096; Pottie K, 2011, CAN MED ASSOC J, V183, pE824, DOI 10.1503/cmaj.090313; Power DV, 2012, INT J MIGR HEALTH SO, V8, P156, DOI 10.1108/17479891211287058; Priest N, 2013, SOC SCI MED, V95, P115, DOI 10.1016/j.socscimed.2012.11.031; Prost A, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0837-4; Puertas G, 2006, REV PANAM SALUD PUBL, V20, P324, DOI 10.1590/S1020-49892006001000005; Rachlis B, 2007, DRUG ALCOHOL DEPEN, V90, P107, DOI 10.1016/j.drugalcdep.2007.03.014; Reid G, 2001, DRUG-EDUC PREV POLIC, V8, P359; Roberts B, 2015, ADDICTION, V110, P889, DOI 10.1111/add.12869; Roberts B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098299; Roberts B, 2011, ADDICT BEHAV, V36, P870, DOI 10.1016/j.addbeh.2011.03.006; Robertson AM, 2012, QUAL HEALTH RES, V22, P499, DOI 10.1177/1049732311422238; Robertson AM, 2012, DRUG ALCOHOL DEPEN, V120, P142, DOI 10.1016/j.drugalcdep.2011.07.012; Robinson W., 2003, RISKS RIGHTS CAUSES; Rosenberg L, 2011, J BEHAV HEALTH SER R, V38, P428, DOI 10.1007/s11414-011-9256-9; Rosenblum M.R., 2014, DEPORTATION DISCRETI; Sabes-Figuera R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029603; Salas-Wright CP, 2014, DRUG ALCOHOL DEPEN, V142, P345, DOI 10.1016/j.drugalcdep.2014.06.008; Sandberg S, 2008, BRIT J CRIMINOL, V48, P602, DOI 10.1093/bjc/azn041; Schuckit MA, 2006, ADDICTION, V101, P76, DOI 10.1111/j.1360-0443.2006.01592.x; Shedlin MG, 2014, J IMMIGR MINOR HEALT, V16, P119, DOI 10.1007/s10903-013-9777-9; Shield KD, 2013, ADDICTION, V108, P912, DOI 10.1111/add.12112; Singh GK, 2006, INT J EPIDEMIOL, V35, P903, DOI 10.1093/ije/dyl089; Singh Negi N, 2011, 103 CTR MIT CIT DEV; Siriwardhana Chesmal, 2014, Confl Health, V8, P13, DOI 10.1186/1752-1505-8-13; Sleijpen M, 2016, ETHNIC HEALTH, V21, DOI 10.1080/13557858.2015.1080484; Spiegel PB, 2010, LANCET, V375, P341, DOI 10.1016/S0140-6736(09)61873-0; Stark L, 2011, TRAUMA VIOLENCE ABUS, V12, P127, DOI 10.1177/1524838011404252; Steel Z, 2005, ACTA PSYCHIAT SCAND, V111, P300, DOI 10.1111/j.1600-0447.2004.00458.x; Steel Z, 2009, JAMA-J AM MED ASSOC, V302, P537, DOI 10.1001/jama.2009.1132; Streel E, 2010, INTERVENTION, V8, P268, DOI 10.1097/WTF.0b013e328341315f; Sundquist K, 2004, ADDICTION, V99, P1298, DOI 10.1111/j.1360-0443.2004.00810.x; Swendsen J, 2010, ADDICTION, V105, P1117, DOI 10.1111/j.1360-0443.2010.02902.x; Timpson S, 2009, SUBST USE MISUSE, V44, P1695, DOI 10.3109/10826080902962094; Toole MJ, 1997, ANNU REV PUBL HEALTH, V18, P283, DOI 10.1146/annurev.publhealth.18.1.283; United Nations High Commissioner for Refugees, 2015, WORLD WAR UNHCR GLOB; vandeWijngaart GF, 1997, SUBST USE MISUSE, V32, P909, DOI 10.3109/10826089709055864; Viruell-Fuentes EA, 2012, SOC SCI MED, V75, P2099, DOI 10.1016/j.socscimed.2011.12.037; Weaver H, 2010, SUBST USE MISUSE, V45, P2340, DOI 10.3109/10826081003793920; Welbel M, 2013, DRUG-EDUC PREV POLIC, V20, P74, DOI 10.3109/09687637.2012.706757; Westermeyer J, 1996, AM J ADDICTION, V5, P231; WESTERMEYER J, 1989, BRIT J ADDICT, V84, P785; WHO, 2001, AUDIT ALCOHOL USE DI; Wilkinson R., 2006, SOCIAL DETERMINANTS, V2nd; World Health Organisation United Nations HIgh Commissioner for Refugees, 2015, MHGAP HUM INT GUID M; World Health Organization, 2010, HLTH MIGR WAY FORW R; YEE BWK, 1987, J PSYCHOACTIVE DRUGS, V19, P77, DOI 10.1080/02791072.1987.10472382; Zafar T, 2003, JAIDS-J ACQ IMM DEF, V32, P394, DOI 10.1097/00126334-200304010-00008	163	80	80	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159134	10.1371/journal.pone.0159134	http://dx.doi.org/10.1371/journal.pone.0159134			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ9CP	27411086	Green Published, gold, Green Submitted			2022-12-27	WOS:000379508300059
J	Kang, J; Ge, CY; Yu, L; Li, LL; Ma, HT				Kang, Jian; Ge, Chongyang; Yu, Lei; Li, Longlong; Ma, Haitian			Long-Term Administration of Dehydroepiandrosterone Accelerates Glucose Catabolism via Activation of PI3K/Akt-PFK-2 Signaling Pathway in Rats Fed a High-Fat Diet	PLOS ONE			English	Article							LIPID-METABOLISM PARAMETERS; ADIPOSE-TISSUE; GLUCONEOGENIC ENZYMES; ENDOCRINE FUNCTIONS; GENE-EXPRESSION; BETA-CELLS; IN-VIVO; DHEA; ANTIOBESITY; OBESITY	Dehydroepiandrosterone ( DHEA) has a fat-reducing effect, while little information is available on whether DHEA regulates glucose metabolism, which would in turn affect fat deposition. To investigate the effects of DHEA on glucose metabolism, rats were administered a high-fat diet containing either 0 (HCG), 25 (HLG), 50 (HMG), or 100 (HHG) mg.kg(-1) DHEA per day via gavage for 8 weeks. Results showed that long-term administration of DHEA inhibited body weight gain in rats on a high-fat diet. No statistical differences in serum glucose levels were observed, whereas hepatic glycogen content in HMG and HHG groups and muscle glycogen content in HLG and HMG groups were higher than those in HCG group. Glucokinase, malate dehydrogenase and phosphofructokinase-2 activities in HMG and HHG groups, pyruvate kinase and succinate dehydrogenase activities in HMG group, and pyruvate dehydrogenase activity in all DHEA treatment groups were increased compared with those in HCG group. Phosphoenolpyruvate carboxykinase and glycogen phosphorylase mRNA levels were decreased in HMG and HHG groups, whereas glycogen synthase-2 mRNA level was increased in HMG group compared with those in HCG. The abundance of Glut2 mRNA in HMG and HHG groups and Glut4 mRNA in HMG group was higher than that in HCG group. DHEA treatment increased serum leptin content in HMG and HHG groups compared with that in HCG group. Serum insulin content and insulin receptor mRNA level in HMG group and insulin receptor substrate-2 mRNA level in HMG and HHG group were increased compared with those in HCG group. Furthermore, Pi3k mRNA level in HMG and Akt mRNA level in HMG and HHG groups were significantly increased than those in HCG group. These data showed that DHEA treatment could enhance glycogen storage and accelerate glucose catabolism in rats fed a high- fat diet, and this effect may be associated with the activation of PI3K/Akt-PFK-2 signaling pathway.	[Kang, Jian; Ge, Chongyang; Yu, Lei; Li, Longlong; Ma, Haitian] Nanjing Agr Univ, Coll Vet Med, Key Lab Anim Physiol & Biochem, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Ma, HT (corresponding author), Nanjing Agr Univ, Coll Vet Med, Key Lab Anim Physiol & Biochem, Nanjing, Jiangsu, Peoples R China.	mahaitian@njau.edu.cn			National Natural Science Foundation of China [31572483]; Natural Science Foundation of Jiangsu Province [BK20151434]; A Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); A Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Natural Science Foundation of China (No. 31572483), the Natural Science Foundation of Jiangsu Province (No. BK20151434) and A Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).; This work was supported by the National Natural Science Foundation of China (No. 31572483), the Natural Science Foundation of Jiangsu Province (No. BK20151434), and A Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Adeneye AA, 2010, J ETHNOPHARMACOL, V130, P307, DOI 10.1016/j.jep.2010.05.009; Agius L, 2015, MOL ASPECTS MED, V46, P34, DOI 10.1016/j.mam.2015.09.002; Bacsi Krisztian, 2007, Orvosi Hetilap, V148, P1273, DOI 10.1556/OH.2007.28102; BURCH PT, 1985, DIABETES, V34, P1014, DOI 10.2337/diabetes.34.10.1014; Chakravarty K, 2005, CRIT REV BIOCHEM MOL, V40, P129, DOI 10.1080/10409230590935479; Chen J, 2010, COMP BIOCHEM PHYS B, V155, P380, DOI 10.1016/j.cbpb.2009.12.005; Ciszak EM, 2003, J BIOL CHEM, V278, P21240, DOI 10.1074/jbc.M300339200; CLEARY MP, 1991, P SOC EXP BIOL MED, V196, P8; CLEARY MP, 1986, INT J OBESITY, V10, P193; De Pergola G, 2000, INT J OBESITY, V24, pS59, DOI 10.1038/sj.ijo.0801280; Du GX, 2015, FOOD SCI TECHNOL RES, V21, P835, DOI 10.3136/fstr.21.835; FARKAS I, 1991, J BIOL CHEM, V266, P15602; Frojdo S, 2011, MOL CELL ENDOCRINOL, V335, P166, DOI 10.1016/j.mce.2011.01.008; GANSLER TS, 1985, P SOC EXP BIOL MED, V180, P155; Goel RM, 2011, CURR OPIN ENDOCRINOL, V18, P171, DOI 10.1097/MED.0b013e3283461818; Gui SY, 2013, J CELL BIOCHEM, V114, P1488, DOI 10.1002/jcb.24490; Hagiwara H, 2003, THROMB RES, V111, P301, DOI 10.1016/j.thromres.2003.09.023; Halimi S, 2014, DIABETES METAB, V40, P167, DOI 10.1016/j.diabet.2014.03.005; Hariri N, 2010, NUTR RES REV, V23, P270, DOI 10.1017/S0954422410000168; Jaimes R, 2015, PFLUGERS ARCH EUROPE, P1; Jessen N, 2003, J APPL PHYSIOL, V94, P1373, DOI 10.1152/japplphysiol.00250.2002; Hernandez-Morante JJ, 2011, OBES SURG, V21, P102, DOI 10.1007/s11695-009-0064-8; Karbowska J, 2005, BIOCHEM PHARMACOL, V70, P249, DOI 10.1016/j.bcp.2005.04.022; Karbowska J, 2013, HORM MOL BIOL CLIN I, V14, P65, DOI 10.1515/hmbci-2013-0009; Karbowska J, 2012, STEROIDS, V77, P1359, DOI 10.1016/j.steroids.2012.08.002; Kelly PJ, 2014, DIABETIC MED, V31, P954, DOI 10.1111/dme.12468; Kim YB, 2000, ENDOCRINOLOGY, V141, P2328, DOI 10.1210/en.141.7.2328; Kim YJ, 2008, GENES NUTR, V2, P353, DOI 10.1007/s12263-007-0070-1; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kubota N, 2008, CELL METAB, V8, P49, DOI 10.1016/j.cmet.2008.05.007; Legrain S, 2003, DRUG AGING, V20, P949, DOI 10.2165/00002512-200320130-00001; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; MARIE S, 1993, J BIOL CHEM, V268, P23881; Mauriege P, 2003, METABOLISM, V52, P264, DOI 10.1053/meta.2003.50043; Mayer D, 1996, INT J ONCOL, V8, P1069; Merrins MJ, 2013, J BIOL CHEM, V288, P33312, DOI 10.1074/jbc.M113.508127; Merrins MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034036; Minarik P, 2002, GEN PHYSIOL BIOPHYS, V21, P257; Monette MCE, 2014, CAN J DIABETES, V38, P401, DOI 10.1016/j.jcjd.2014.01.014; NAKASHIMA N, 1995, METABOLISM, V44, P543, DOI 10.1016/0026-0495(95)90065-9; Naredi Nikita, 2015, Med J Armed Forces India, V71, P274, DOI 10.1016/j.mjafi.2014.12.022; Nelson DL, 2013, LEHNINGER PRINCIPLES, V32, P947; Perrini S, 2004, DIABETES, V53, P41, DOI 10.2337/diabetes.53.1.41; Rencurel F, 1996, BIOCHEM J, V314, P903, DOI 10.1042/bj3140903; Roy S, 2003, GENE EXPRESSION, V11, P251, DOI 10.3727/000000003783992289; Rutter J, 2010, MITOCHONDRION, V10, P393, DOI 10.1016/j.mito.2010.03.001; Safiulina D, 2006, TOXICOL SCI, V93, P348, DOI 10.1093/toxsci/kfl064; Sato K, 2008, AJP ENDOCRINOLOGY ME, V294; Sato K, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-47; Shen XH, 2012, GEN COMP ENDOCR, V177, P177, DOI 10.1016/j.ygcen.2012.03.007; Song LJ, 2010, STEROIDS, V75, P213, DOI 10.1016/j.steroids.2009.11.007; Sturm R, 2007, PUBLIC HEALTH, V121, P492, DOI 10.1016/j.puhe.2007.01.006; Suge R, 2012, BRAIN RES, V1481, P97, DOI 10.1016/j.brainres.2012.08.056; Tang X, 2007, LIPIDS, V42, P1025, DOI 10.1007/s11745-007-3104-y; Tang X, 2009, BRIT J NUTR, V102, P680, DOI 10.1017/S0007114509289021; Villareal DT, 2004, JAMA-J AM MED ASSOC, V292, P2243, DOI 10.1001/jama.292.18.2243; Yamashita R, 2005, ENDOCR J, V52, P727, DOI 10.1507/endocrj.52.727; Yang NC, 2002, LIFE SCI, V70, P1979, DOI 10.1016/S0024-3205(01)01542-9; Zhang YT, 2012, J ANIM VET ADV, V11, P4332; Zhou Y, 2015, PLOS ONE, V10	60	9	9	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159077	10.1371/journal.pone.0159077	http://dx.doi.org/10.1371/journal.pone.0159077			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410429	Green Published, Green Submitted, gold			2022-12-27	WOS:000379508300055
J	Terayama, Y; Matsuura, T; Ozaki, K				Terayama, Yui; Matsuura, Tetsuro; Ozaki, Kiyokazu			Lack of Correlation between Aberrant p16, RAR-beta 2, TIMP3, ERCC1, and BRCA1 Protein Expression and Promoter Methylation in Squamous Cell Carcinoma Accompanying Candida albicans-Induced Inflammation	PLOS ONE			English	Article							RAT LUNG CARCINOGENESIS; RETINOIC ACID RECEPTOR; DNA METHYLATION; P16(INK4A) OVEREXPRESSION; PRECANCEROUS LESIONS; OVARIAN-CANCER; ORAL-CANCER; GENE; HYPERMETHYLATION; BETA	Hyperplastic candidiasis is characterized by thickening of the mucosal epithelia with Candida albicans infection with occasional progression to squamous cell carcinoma (SCC). C. albicans is a critical factor in tumor development; however, the oncogenic mechanism is unclear. We have previously produced an animal model for hyperplastic candidiasis in the rat forestomach. In the present study, we investigate whether impaired DNA methylation and associated protein expression of tumor suppressor and DNA repair genes are involved in the SCC carcinogenesis process using this hyperplastic candidiasis model. Promoter methylation and protein expression were analyzed by methylation specific PCR and immunohistochemical staining, respectively, of 5 areas in the forestomachs of alloxan-induced diabetic rats with hyperplastic candidiasis: normal squamous epithelia, squamous hyperplasia, squamous hyperplasia adjacent to SCC, squamous hyperplasia transitioning to SCC, and SCC. We observed nuclear p16 overexpression despite increases in p16 gene promoter methylation during the carcinogenic process. TIMP3 and RAR-beta 2 promoter methylation progressed until the precancerous stage but disappeared upon malignant transformation. In comparison, TIMP3 protein expression was suppressed during carcinogenesis and RAR-beta 2 expression was attenuated in the cytoplasm but enhanced in nuclei. ERCC1 and BRCA1 promoters were not methylated at any stage; however, their protein expression disappeared beginning at hyperplasia and nuclear protein re-expression in SCC was observed only for ERCC1. These results suggest that aberrant p16, RAR-beta 2, TIMP3, ERCC1, and BRCA1 expression might occur that is inconsistent with the respective gene promoter methylation status, and that this overexpression might serve to promote the inflammatory carcinogenesis caused by C. albicans infection.	[Terayama, Yui; Matsuura, Tetsuro; Ozaki, Kiyokazu] Setsunan Univ, Fac Pharmaceut Sci, Pathol Lab, Osaka, Japan	Setsunan University	Ozaki, K (corresponding author), Setsunan Univ, Fac Pharmaceut Sci, Pathol Lab, Osaka, Japan.	ozaki@pharm.setsunan.ac.jp	Ozaki, Kiyokazu/AAL-8633-2021	Ozaki, Kiyokazu/0000-0003-4275-6677				Bakri M.M., 2010, J ORAL MICROBIOL, V21; Brait M, 2012, EPIGENETICS-US, V7, P710, DOI 10.4161/epi.20524; Chang S, 2012, MOL CELLS, V34, P425, DOI 10.1007/s10059-012-0118-y; Chen HY, 2010, INT J CANCER, V126, P1944, DOI 10.1002/ijc.24772; Choi Yoon Sung, 2015, J Cancer Prev, V20, P268, DOI 10.15430/JCP.2015.20.4.268; Ciaparrone M, 2015, ONCOLOGY-BASEL, V89, P227, DOI 10.1159/000430447; Diez-Perez R, 2011, ONCOL REP, V25, P1203, DOI 10.3892/or.2011.1205; Dwivedi PP, 2009, MED MYCOL, V47, P157, DOI 10.1080/13693780802165797; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Facista Alexander, 2012, Genome Integr, V3, P3, DOI 10.1186/2041-9414-3-3; Fendrich V, 2005, PANCREAS, V30, pE40, DOI 10.1097/01.mpa.0000153325.62192.8a; Friboulet L, 2013, CELL CYCLE, V12, P3298, DOI 10.4161/cc.26309; Galle F, 2013, NEW MICROBIOL, V36, P283; Gao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052589; Ge H, 2014, PATHOL RES PRACT, V210, P656, DOI 10.1016/j.prp.2014.06.013; Guan ZY, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-110; Gump J, 2003, J BIOL CHEM, V278, P6619, DOI 10.1074/jbc.C200622200; Hoftijzer HC, 2009, EUR J ENDOCRINOL, V160, P631, DOI 10.1530/EJE-08-0812; Kang GH, 2012, KOREAN J PATHOL, V46, P1, DOI 10.4132/KoreanJPathol.2012.46.1.1; Kobayashi T, 2013, MOL CANCER RES, V11, P828, DOI 10.1158/1541-7786.MCR-13-0207; Kodama Y, 2006, CANCER SCI, V97, P1023, DOI 10.1111/j.1349-7006.2006.00279.x; Kurie JM, 2003, J NATL CANCER I, V95, P206, DOI 10.1093/jnci/95.3.206; Lai ZL, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/378358; Larque AB, 2015, VIRCHOWS ARCH, V466, P375, DOI 10.1007/s00428-015-1725-8; Li MH, 2016, CANCER RES, V76, P561, DOI 10.1158/0008-5472.CAN-14-3812; Lindsey JC, 2004, CARCINOGENESIS, V25, P661, DOI 10.1093/carcin/bgh055; Liu WB, 2011, BIOCHEM BIOPH RES CO, V408, P595, DOI 10.1016/j.bbrc.2011.04.067; Liu WB, 2011, TOXICOL APPL PHARM, V251, P70, DOI 10.1016/j.taap.2010.12.002; Liu WB, 2010, BIOCHEM BIOPH RES CO, V402, P507, DOI 10.1016/j.bbrc.2010.10.061; Liu WB, 2009, TOXICOL LETT, V189, P5, DOI 10.1016/j.toxlet.2009.04.022; LIU WZ, 2016, AM J CANCER RES, V6, P1, DOI DOI 10.1038/SREP28591; Lu DW, 2003, MODERN PATHOL, V16, P692, DOI 10.1097/01.MP.0000077417.08371.CE; Masson D, 2010, EUR J CANCER, V46, P1430, DOI 10.1016/j.ejca.2010.01.009; Mauro LV, 2008, MEDICINA-BUENOS AIRE, V68, P205; Nakamura M, 2005, LAB INVEST, V85, P165, DOI 10.1038/labinvest.3700223; Niwa T, 2010, CANCER RES, V70, P1430, DOI 10.1158/0008-5472.CAN-09-2755; Oka D, 2009, CANCER-AM CANCER SOC, V115, P3412, DOI 10.1002/cncr.24394; Perez-Sayans M, 2009, ONCOL REP, V22, P1277, DOI 10.3892/or_00000565; Ralhan R, 2006, INT J CANCER, V118, P1077, DOI 10.1002/ijc.21483; Richter F, 2002, J ANDROL, V23, P830; Rochaix P, 1998, HISTOPATHOLOGY, V33, P337, DOI 10.1046/j.1365-2559.1998.00486.x; Romagosa C, 2011, ONCOGENE, V30, P2087, DOI 10.1038/onc.2010.614; Sano T, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/509325; Sano T, 2009, TOXICOL PATHOL, V37, P790, DOI 10.1177/0192623309344204; Sitheeque MAM, 2003, CRIT REV ORAL BIOL M, V14, P253, DOI 10.1177/154411130301400403; Smith E, 2008, WORLD J GASTROENTERO, V14, P203, DOI 10.3748/wjg.14.203; Virani S, 2012, ILAR J, V53, P359, DOI 10.1093/ilar.53.3-4.359; Wang JM, 2008, CANCER EPIDEM BIOMAR, V17, P118, DOI 10.1158/1055-9965.EPI-07-0733; Wang YM, 2003, CLIN CANCER RES, V9, P5257; Welcsh PL, 2001, HUM MOL GENET, V10, P705, DOI 10.1093/hmg/10.7.705; Williams D W, 2001, Gerodontology, V18, P73, DOI 10.1111/j.1741-2358.2001.00073.x; Yang D, 2011, JAMA-J AM MED ASSOC, V306, P1557, DOI 10.1001/jama.2011.1456; Yoshida K, 2004, CANCER SCI, V95, P866, DOI 10.1111/j.1349-7006.2004.tb02195.x; Zhao P, 2006, WORLD J GASTROENTERO, V12, P6391, DOI 10.3748/wjg.v12.i39.6391	54	2	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159090	10.1371/journal.pone.0159090	http://dx.doi.org/10.1371/journal.pone.0159090			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410681	Green Published, Green Submitted, gold			2022-12-27	WOS:000379508300056
J	Wijayathilaka, N; Meegaskumbura, M				Wijayathilaka, Nayana; Meegaskumbura, Madhava			An Acoustic Analysis of the Genus Microhyla (Anura: Microhylidae) of Sri Lanka	PLOS ONE			English	Article							ADVERTISEMENT CALLS; VOCAL REPERTOIRE; WESTERN-GHATS; FROG; BEHAVIOR; TOADS	Vocalizing behavior of frogs and toads, once quantified, is useful for systematics, rapid species identification, behavioral experimentation and conservation monitoring. But yet, for many lineages vocalizations remain unknown or poorly quantified, especially in diversity rich tropical regions. Here we provide a quantitative acoustical analysis for all four Sri Lankan congeners of the genus Microhyla. Three of these species are endemic to the island, but Microhyla ornata is regionally widespread. Two of these endemics, M. karunaratnei (Critically Endangered) and M. zeylanica (Endangered), are highly threatened montane isolates; the other, M. mihintalei, is relatively common across the dry lowlands. We recorded and analyzed 100 advertisement calls from five calling males for each species, except for M. zeylanica, which only had 53 calls from three males suitable for analyses. All four species call in choruses and their vocal repertoires are simple compared to most frogs. Their calls contain multiple pulses and no frequency modulation. We quantified eight call characters. Call duration and number of pulses were higher for the two montane isolates (inhabiting cooler habitats at higher altitudes) compared to their lowland congeners. Microhyla zeylanica has the longest call duration (of 1.8 +/- 0.12 s) and the highest number of pulses (of 6192 pulses). The smallest of the species, Microhyla karunaratnei (16.2-18.3 mm), has the highest mean dominant frequency (3.3 +/- 0.14 kHz) and pulse rate (77 +/- 5.8 pulses per second). The calls separate well in the Principal Component space: PC1 axis is mostly explained by the number of pulses per call and call duration; PC2 is mostly explained by the pulse rate. A canonical means plot of a Discriminant Function analysis shows non-overlapping 95% confidence ellipses. This suggests that some call parameters can be used to distinguish these species effectively. We provide detailed descriptions for eight call properties and compare these with congeners for which data is available. This work provides a foundation for comparative bioacoustic analyses and species monitoring while facilitating the systematics of Microhyla across its range.	[Meegaskumbura, Madhava] Univ Peradeniya, Dept Mol Biol & Biotechnol, Fac Sci, Peradeniya 20400, Sri Lanka; Univ Peradeniya, Postgrad Inst Sci, Peradeniya 20400, Sri Lanka	University of Peradeniya; University of Peradeniya	Meegaskumbura, M (corresponding author), Univ Peradeniya, Dept Mol Biol & Biotechnol, Fac Sci, Peradeniya 20400, Sri Lanka.	madhavam@pdn.ac.lk	Meegaskumbura, Madhava/F-8782-2013; Wijayathilaka, Nayana/B-2652-2018	Meegaskumbura, Madhava/0000-0002-4599-6724; Wijayathilaka, Nayana/0000-0002-7376-7355	National Research Council of Sri Lanka [NRC 11-124]; University of Peradeniya Research Grant [RG/2012/45/S]	National Research Council of Sri Lanka; University of Peradeniya Research Grant	This research was supported by the National Research Council of Sri Lanka (NRC 11-124) to MM, and the University of Peradeniya Research Grant (RG/2012/45/S) to MM.	Aide TM, 2013, PEERJ, V1, DOI 10.7717/peerj.103; Angulo A, 2010, SYST BIODIVERS, V8, P357, DOI 10.1080/14772000.2010.507264; [Anonymous], 2015, IUCN RED LIST THREAT; ARAK A, 1983, ANIM BEHAV, V31, P292, DOI 10.1016/S0003-3472(83)80199-7; Bee MA, 2001, ETHOLOGY, V107, P65, DOI 10.1046/j.1439-0310.2001.00640.x; Bee MA, 2013, BIOACOUSTICS, V22, P67, DOI 10.1080/09524622.2012.712750; Bee MA, 2013, HERPETOLOGICA, V69, P22, DOI 10.1655/HERPETOLOGICA-D-11-00042; Bosch J, 2004, CAN J ZOOL, V82, P880, DOI 10.1139/Z04-060; Bossuyt F, 2004, SCIENCE, V306, P479, DOI 10.1126/science.1100167; Bridges AS, 2000, COPEIA, P587, DOI 10.1643/0045-8511(2000)000[0587:TVIACB]2.0.CO;2; COCROFT RB, 1995, ANIM BEHAV, V49, P283, DOI 10.1006/anbe.1995.0043; Dehling JM, 2010, SALAMANDRA, V46, P114; Dring JCM., 1979, B BR MUS, V34; Dutta SK, 1996, AMPHIBIAN FAUNA SRI; Fernando Prithiviraj, 1996, Journal of South Asian Natural History, V2, P135; Frost DR., 2015, AMPHIBIAN SPECIES OF; GAYOU DC, 1984, COPEIA, P733, DOI 10.2307/1445157; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; Glaw F., 2010, ZOOTAXA, V2383, P82; Grosselet Olivier, 2004, Hamadryad, V29, P131; Heyer R, 2014, MEASURING AND MONITO; HEYER W R, 1971, Fieldiana Zoology, V58, P61; Howlader MSA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119825; KANAMADI RD, 1994, CURR SCI INDIA, V66, P683; Kelley DB, 2004, CURR OPIN NEUROBIOL, V14, P751, DOI 10.1016/j.conb.2004.10.015; KURAMOTO M, 1987, ZOOL SCI, V4, P563; Kuramoto Mitsuru, 2006, Current Herpetology, V25, P15, DOI 10.3105/1345-5834(2006)25[15:MAACOM]2.0.CO;2; Marquez R, 2006, J NAT HIST, V40, P571, DOI 10.1080/00222930600712129; Meegaskumbura M, 2002, SCIENCE, V298, P379, DOI 10.1126/science.298.5592.379; Meegaskumbura M, 2015, ZOOTAXA, V3911, P245, DOI 10.11646/zootaxa.3911.2.6; Narins PM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0401; Narins PM, 2006, SPRINGER HANDBOOK OF, DOI [10.1007/978-0-387-47796-1, DOI 10.1007/978-0-387-47796-1]; Padial JM, 2009, ZOOL J LINN SOC-LOND, V155, P97, DOI 10.1111/j.1096-3642.2008.00424.x; Parker H., 1948, J NAT HIST, V1, P759, DOI [10.1080/00222934808653944, DOI 10.1080/00222934808653944]; RAND AS, 1981, Z TIERPSYCHOL, V57, P209; Seshadri KS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149727; Toledo LF, 2015, SCIENCE, V347, P484, DOI 10.1126/science.347.6221.484-b; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; WELLS KD, 1977, ANIM BEHAV, V25, P666, DOI 10.1016/0003-3472(77)90118-X; Wells KD, 2010, THE ECOLOGY AND BEHA; Wells KD, 2007, SPR HDB AUD, V28, P44; Wijayathilaka N, 2016, ZOOTAXA, V4066, P331, DOI 10.11646/zootaxa.4066.3.9; Zoological Society of London, 2015, EDGE EX PROGR	43	14	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0159003	10.1371/journal.pone.0159003	http://dx.doi.org/10.1371/journal.pone.0159003			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27403744	gold, Green Published, Green Submitted			2022-12-27	WOS:000379508200028
J	Ma, C; Monsma, E				Ma, Cecilia; Monsma, Eva			Testing Cross-Cultural Generalizability of the Task and Ego Orientation in Sport Questionnaire across American and Chinese Samples	PLOS ONE			English	Article							ACHIEVEMENT GOALS; PHYSICAL-ACTIVITY; FIT INDEXES; MOTIVATION; CONCEPTIONS; VALIDATION; EDUCATION; ABILITY; YOUTH	This paper examines the factor structure and measurement invariance of the Task and Ego Orientation in Sport Questionnaire (TEOSQ) across American and Chinese samples. Results based on the mean and covariance structure analyses supported configural invariance, metric invariance and scalar invariance across groups. Latent means analyses revealed that American sample had significantly higher mean scores on task and ego orientations than the Chinese sample. The findings suggest that the TEOSQ is a valid and reliable instrument in assessing achievement motivation across these two diverse populations.	[Ma, Cecilia] Hong Kong Polytech Univ, Dept Appl Social Sci, Hunghom, Hong Kong, Peoples R China; [Monsma, Eva] Univ South Carolina, Dept Phys Educ & Athlet Training, Columbia, SC 29208 USA	Hong Kong Polytechnic University; University of South Carolina System; University of South Carolina Columbia	Ma, C (corresponding author), Hong Kong Polytech Univ, Dept Appl Social Sci, Hunghom, Hong Kong, Peoples R China.	cecilia.ma@polyu.edu.hk	, Cecilia/E-7830-2013	, Cecilia/0000-0001-7092-7715				American College Health Association, 2002, HLTH CAMP 2010 MAK I; Anderman E. M., 2006, HDB ED PSYCHOL, V2, P369; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Brislin R.W., 1986, FIELD METHODS CROSS, P137; BROWNE MW, 1989, MULTIVAR BEHAV RES, V24, P445, DOI 10.1207/s15327906mbr2404_4; Castelli DM, 2014, MONOGR SOC RES CHILD, V79, P119, DOI 10.1111/mono.12133; CHEN CS, 1988, HUM DEV, V31, P351, DOI 10.1159/000276334; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Curran PJ, 1996, PSYCHOL METHODS, V1, P16, DOI 10.1037//1082-989X.1.1.16; Duda J. L., 1989, TASK EGO ORIEN UNPUB; Duda J.L., 2003, INT J EDUC RES, V39, P415, DOI [10.1016/j.ijer.2004.06.007, DOI 10.1016/J.IJER.2004.06.007]; DUDA JL, 1990, J SPORT EXERCISE PSY, V12, P114, DOI 10.1123/jsep.12.2.114; Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037/1082-989X.4.3.272; Finney SJ, 2006, QUANT METH EDUC BEHA, P269; GOUDAS M, 1994, PEDIATR EXERC SCI, V6, P159; Ha AS., 2003, PHYS ED, V60, P194; Harzing AW, 2012, MANAGE INT REV, V52, P341, DOI 10.1007/s11575-011-0111-2; Hayashi CT, 1996, J SPORT EXERCISE PSY, V18, P194, DOI 10.1123/jsep.18.2.194; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Huang CJ, 2012, J EDUC PSYCHOL, V104, P48, DOI 10.1037/a0026223; HUI CH, 1985, J CROSS CULT PSYCHOL, V16, P131, DOI 10.1177/0022002185016002001; Joreskog KG, 2006, LISREL VERSION 8 80; Kim BJ, 1997, J SPORT EXERCISE PSY, V19, P142, DOI 10.1123/jsep.19.2.142; Li FZ, 1996, J SPORT EXERCISE PSY, V18, P392, DOI 10.1123/jsep.18.4.392; Li J, 2001, ETHOS, V29, P111, DOI 10.1525/eth.2001.29.2.111; Lindner K. J., 2000, Psychology of Sport and Exercise, V1, P7, DOI 10.1016/S1469-0292(00)00003-0; Maehr M.L., 1980, STUDIES CROSS CULTUR, VVol. 2, P221; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Nicholls J.G., 1989, COMPETITIVE ETHOS DE; NICHOLLS JG, 1984, PSYCHOL REV, V91, P328, DOI 10.1037/0033-295X.91.3.328; Papaioannou A., 1996, J APPL SPORT PSYCHOL, V8, pS15; REJESKI WJ, 1994, PHYSICAL ACTIVITY FI, P1040; Schumacker R. E, 2004, BEGINNERS GUIDE STRU, V2nd, DOI DOI 10.4135/9781412973380.N17; Tsoi MM., 1999, CTR ASIAN STUDIES OC, V137, P13; Tudor-Locke C, 2003, INT J OBESITY, V27, P1093, DOI 10.1038/sj.ijo.0802377; Vandenberg RJ, 2000, ORGAN RES METHODS, V3, P4, DOI 10.1177/109442810031002; Watkins W., 2001, RACE ED ROLES HIST S, P100; Xiang P, 1997, J CROSS CULT PSYCHOL, V28, P645, DOI 10.1177/0022022197286001; Xiang P, 2001, CONTEMP EDUC PSYCHOL, V26, P348, DOI 10.1006/ceps.2000.1061	39	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2016	11	7							e0158953	10.1371/journal.pone.0158953	http://dx.doi.org/10.1371/journal.pone.0158953			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ9CN	27399869	Green Submitted, Green Published, gold			2022-12-27	WOS:000379508100013
J	Bishop, DVM; Snowling, MJ; Thompson, PA; Greenhalgh, T; Adams, C; Archibald, L; Baird, G; Bauer, A; Bellair, J; Boyle, C; Brownlie, E; Carter, G; Clark, B; Clegg, J; Cohen, N; Conti-Ramsden, G; Dockrell, J; Dunn, J; Ebbels, S; Gallagher, A; Gibbs, S; -Langton, EG; Grist, M; Hartshorne, M; Huneke, A; Joanisse, M; Kedge, S; Klee, T; Krishnan, S; Lascelles, L; Law, J; Leonard, L; Lynham, S; Arnold, EM; Mathura, N; McCartney, E; McKean, C; McNeill, B; Morgan, A; Murphy, CA; Norbury, C; O'Hare, A; Cardy, JO; O'Toole, C; Paul, R; Purdy, S; Redmond, S; Reilly, S; Restrepo, L; Rice, M; Slonims, V; Snow, P; Soppitt, R; Speake, J; Spencer, S; Stringer, H; Tager-Flusberg, H; Tannock, R; Taylor, C; Tomblin, B; Volden, J; Westerveld, M; Whitehouse, A				Bishop, D. V. M.; Snowling, Margaret J.; Thompson, Paul A.; Greenhalgh, Trisha; Adams, Catherine; Archibald, Lisa; Baird, Gillian; Bauer, Ann; Bellair, Jude; Boyle, Christopher; Brownlie, Elizabeth; Carter, Glenn; Clark, Becky; Clegg, Judy; Cohen, Nancy; Conti-Ramsden, Gina; Dockrell, Julie; Dunn, Janet; Ebbels, Susan; Gallagher, Aoife; Gibbs, Simon; -Langton, Emma Gore; Grist, Mandy; Hartshorne, Mary; Huneke, Alison; Joanisse, Marc; Kedge, Sally; Klee, Thomas; Krishnan, Saloni; Lascelles, Linda; Law, James; Leonard, Laurence; Lynham, Stephanie; Arnold, Elina Mainela; Mathura, Narad; McCartney, Elspeth; McKean, Cristina; McNeill, Brigid; Morgan, Angela; Murphy, Carol-Anne; Norbury, Courtenay; O'Hare, Anne; Cardy, Janis Oram; O'Toole, Ciara; Paul, Rhea; Purdy, Suzanne; Redmond, Sean; Reilly, Sheena; Restrepo, Laida; Rice, Mabel; Slonims, Vicky; Snow, Pamela; Soppitt, Richard; Speake, Jane; Spencer, Sarah; Stringer, Helen; Tager-Flusberg, Helen; Tannock, Rosemary; Taylor, Cate; Tomblin, Bruce; Volden, Joanne; Westerveld, Marleen; Whitehouse, Andrew		CATALISE Consortium	CATALISE: A Multinational and Multidisciplinary Delphi Consensus Study. Identifying Language Impairments in Children	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDER; DYNAMIC ASSESSMENT; YOUNG-CHILDREN; SPEECH; COMMUNICATION; DELAY; OUTCOMES; PREVALENCE; THERAPY; COMPREHENSION	Delayed or impaired language development is a common developmental concern, yet there is little agreement about the criteria used to identify and classify language impairments in children. Children's language difficulties are at the interface between education, medicine and the allied professions, who may all adopt different approaches to conceptualising them. Our goal in this study was to use an online Delphi technique to see whether it was possible to achieve consensus among professionals on appropriate criteria for identifying children who might benefit from specialist services. We recruited a panel of 59 experts representing ten disciplines (including education, psychology, speech-language therapy/pathology, paediatrics and child psychiatry) from English-speaking countries (Australia, Canada, Ireland, New Zealand, United Kingdom and USA). The starting point for round 1 was a set of 46 statements based on articles and commentaries in a special issue of a journal focusing on this topic. Panel members rated each statement for both relevance and validity on a seven-point scale, and added free text comments. These responses were synthesised by the first two authors, who then removed, combined or modified items with a view to improving consensus. The resulting set of statements was returned to the panel for a second evaluation (round 2). Consensus (percentage reporting 'agree' or 'strongly agree') was at least 80 percent for 24 of 27 round 2 statements, though many respondents qualified their response with written comments. These were again synthesised by the first two authors. The resulting consensus statement is reported here, with additional summary of relevant evidence, and a concluding commentary on residual disagreements and gaps in the evidence base.	[Bishop, D. V. M.; Snowling, Margaret J.; Thompson, Paul A.] Univ Oxford, Dept Expt Psychol, Oxford, Oxon, England; [Greenhalgh, Trisha] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, Oxon, England; [Adams, Catherine; Conti-Ramsden, Gina] Univ Manchester, Manchester, Lancs, England; [Archibald, Lisa; Joanisse, Marc; Cardy, Janis Oram] Univ Western Ontario, London, ON, Canada; [Baird, Gillian; Bellair, Jude; Carter, Glenn; Lynham, Stephanie; Mathura, Narad; Slonims, Vicky; Soppitt, Richard; Speake, Jane] NHS, London, England; [Bauer, Ann] Vyne Community Sch, Language Resource Provis, Basingstoke, Hants, England; [Boyle, Christopher] Univ New England, Armidale, NSW, Australia; [Brownlie, Elizabeth; Cohen, Nancy; Arnold, Elina Mainela; Tannock, Rosemary] Univ Toronto, Toronto, ON, Canada; [Clark, Becky] ClarkSLT, RALLI, Surrey, England; [Clegg, Judy; Spencer, Sarah] Univ Sheffield, Sheffield, S Yorkshire, England; [Dockrell, Julie] UCL, Inst Educ, London, England; [Dunn, Janet] Meath Sch, Surrey, England; [Ebbels, Susan] Moor House Sch & Coll, Surrey, England; [Ebbels, Susan; -Langton, Emma Gore] UCL, London, England; [Gallagher, Aoife; Murphy, Carol-Anne] Univ Limerick, Dept Clin Therapies, Limerick, Ireland; [Gibbs, Simon; Law, James; McKean, Cristina; Stringer, Helen] Newcastle Univ, Newcastle Upon Tyne, Tyne & Wear, England; [Grist, Mandy; Hartshorne, Mary] ICAN, London, England; [Huneke, Alison; Lascelles, Linda] Afasic, London, England; [Kedge, Sally; Purdy, Suzanne] Univ Auckland, Auckland, New Zealand; [Klee, Thomas; McNeill, Brigid] Univ Canterbury, Canterbury, New Zealand; [Krishnan, Saloni] Univ Oxford, Oxford, England; [Leonard, Laurence] Purdue Univ, W Lafayette, IN 47907 USA; [McCartney, Elspeth] Univ Strathclyde, Glasgow, Lanark, Scotland; [Morgan, Angela] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Norbury, Courtenay] Royal Holloway Univ London, London, England; [O'Hare, Anne] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [O'Toole, Ciara] Univ Coll Cork, Cork, Ireland; [Paul, Rhea] Sacred Heart Univ, Fairfield, CT USA; [Redmond, Sean] Univ Utah, Salt Lake City, UT 84112 USA; [Reilly, Sheena] Griffith Univ, Menzies Hlth Inst Queensland, Nathan, Qld, Australia; [Restrepo, Laida] Arizona State Univ, Tempe, AZ 85287 USA; [Rice, Mabel] Univ Kansas, Lawrence, KS 66045 USA; [Snow, Pamela] La Trobe Univ, Bundoora, Vic, Australia; [Tager-Flusberg, Helen] Boston Univ, Boston, MA 02215 USA; [Taylor, Cate] Univ Western Australia, Nedlands, WA, Australia; [Tomblin, Bruce] Univ Iowa, Iowa City, IA 52242 USA; [Volden, Joanne] Univ Alberta, Edmonton, AB, Canada; [Westerveld, Marleen] Griffith Univ, Nathan, Qld, Australia; [Whitehouse, Andrew] Univ Western Australia, Telethon Kids Inst, Nedlands, WA, Australia	University of Oxford; University of Oxford; University of Manchester; Western University (University of Western Ontario); University of New England; University of Toronto; University of Sheffield; University of London; University College London; UCL Institute of Education; University of London; University College London; University of Limerick; Newcastle University - UK; University of Auckland; University of Canterbury; University of Oxford; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Strathclyde; Murdoch Children's Research Institute; University of London; Royal Holloway University London; University of Edinburgh; University College Cork; Sacred Heart University; Utah System of Higher Education; University of Utah; Griffith University; Arizona State University; Arizona State University-Tempe; University of Kansas; La Trobe University; Boston University; University of Western Australia; University of Iowa; University of Alberta; Griffith University; Telethon Kids Institute; University of Western Australia	Bishop, DVM (corresponding author), Univ Oxford, Dept Expt Psychol, Oxford, Oxon, England.	dorothy.bishop@psy.ox.ac.uk	Gallagher, Aoife Lily/AAE-3283-2021; Krishnan, Saloni/I-2642-2019; Westerveld, Marleen/C-6638-2011; Dockrell, Julie/A-3613-2008; Ebbels, Susan/AAE-1709-2022; Cardy, Janis Oram/AAF-4147-2019; Westerveld, Marleen/ABB-3561-2021; Boyle, Chris/F-5138-2012; Whitehouse, Andrew J.O./AGJ-2519-2022; Greenhalgh, Trisha/B-1825-2015; Klee, Thomas/I-2270-2012	Gallagher, Aoife Lily/0000-0001-9291-9361; Krishnan, Saloni/0000-0002-6466-141X; Westerveld, Marleen/0000-0002-5194-2335; Dockrell, Julie/0000-0003-3595-6064; Cardy, Janis Oram/0000-0002-7170-6145; Westerveld, Marleen/0000-0002-5194-2335; Boyle, Chris/0000-0001-6196-7619; Whitehouse, Andrew J.O./0000-0001-8722-1575; Greenhalgh, Trisha/0000-0003-2369-8088; Klee, Thomas/0000-0002-1577-8689	Wellcome Trust [082498/Z/07/Z]; National Institute for Health Research [NF-SI-0512-10031] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by Wellcome Trust (http://www.wellcome.ac.uk/) grant 082498/Z/07/Z to DVMB.	Adams C, 2012, INT J LANG COMM DIS, V47, P233, DOI 10.1111/j.1460-6984.2011.00146.x; Akins RB, 2005, BMS RES METH, V5; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Archibald LMD, 2009, J SPEECH LANG HEAR R, V52, P899, DOI 10.1044/1092-4388(2009/08-0099); Armon-Lotem S., 2015, ASSESSING MULTILINGU; Baglieri S, 2004, J LEARN DISABIL-US, V37, P525, DOI 10.1177/00222194040370060701; BAIRD G., 2014, INT J LANG COMM DIS, V49, P381, DOI [10.1111/1460-6984.12101, DOI 10.1111/1460-6984.12101]; Beitchman J., 2014, LANGUAGE DISORDERS C; Bishop D, 2008, RUTTERS CHILD ADOLES, P32, DOI DOI 10.1002/9781444300895.CH3; Bishop DVM, 2014, INT J LANG COMM DIS, V49, P381, DOI 10.1111/1460-6984.12101; Bishop D.V.M., 2000, SPEECH LANGUAGE IMPA; Bishop DVM, 2012, CHILD LANG TEACH THE, V28, P259, DOI 10.1177/0265659012459467; Bishop DVM, 2011, ACTA PAEDIATR, V100, P903, DOI 10.1111/j.1651-2227.2011.02150.x; Bishop DVM, 2009, INT J LANG COMM DIS, V44, P600, DOI 10.1080/13682820802259662; Bishop DVM, 2006, INT J LANG COMM DIS, V41, P19, DOI 10.1080/13682820500144000; Bishop DVM, 2006, GENES BRAIN BEHAV, V5, P158, DOI 10.1111/j.1601-183X.2005.00148.x; Bishop DVM, 2004, CLASSIFICATION OF DEVELOPMENTAL LANGUAGE DISORDERS: THEORETICAL ISSUES AND CLINICAL IMPLICATIONS, P309; BISHOP DVM, 1987, J SPEECH HEAR DISORD, V52, P156, DOI 10.1044/jshd.5202.156; Bishop DVM, 1988, LANGUAGE DEV EXCEPTI, P203; Boulkedid R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020476; Bowyer-Crane C, 2011, LEARN DISAB, V9, P107; Boyle J, 2007, HEALTH TECHNOL ASSES, V11, P1; Briscoe J, 2001, J CHILD PSYCHOL PSYC, V42, P329, DOI 10.1111/1469-7610.00726; Camilleri B, 2014, INT J SPEECH-LANG PA, V16, P507, DOI 10.3109/17549507.2013.847497; Campbell T, 1997, J SPEECH LANG HEAR R, V40, P519, DOI 10.1044/jslhr.4003.519; Cattani A, 2014, INT J LANG COMM DIS, V49, P649, DOI 10.1111/1460-6984.12082; Christensen CA., 2018, PERSPECTIVES LEARNIN, P227, DOI [10.4324/9780429498381-10, DOI 10.4324/9780429498381-10]; COHEN NJ, 1989, J AM ACAD CHILD PSY, V28, P107, DOI 10.1097/00004583-198901000-00020; COLE KN, 1990, APPL PSYCHOLINGUIST, V11, P291, DOI 10.1017/S0142716400008900; COLE KN, 1995, APPL PSYCHOLINGUIST, V16, P103, DOI 10.1017/S0142716400006445; Conti-Ramsden G, 2001, J CHILD PSYCHOL PSYC, V42, P741, DOI 10.1111/1469-7610.00770; Dawes P, 2010, ARCH DIS CHILD, V95, P432, DOI 10.1136/adc.2009.170118; De Villiers MR, 2005, MED TEACH, V27, P639, DOI 10.1080/13611260500069947; Deevy P, 2010, LANG SPEECH HEAR SER, V41, P277, DOI 10.1044/0161-1461(2009/08-0096); Department for Education, 2014, EYFSP ATT PUP CHAR 2; Dockrell J, 2012, UNDERSTANDING SPEECH; Dockrell JE, 2006, INT J LANG COMM DIS, V41, P423, DOI 10.1080/13682820500442073; Dockrell JE, 2015, BRIT J SPEC EDUC, V42, P411, DOI 10.1111/1467-8578.12115; Dockrell JE, 2015, CHILD LANG TEACH THE, V31, P271, DOI 10.1177/0265659015572165; Dodd B, 2014, CURR DEV DISORD REP, V1; Dollaghan CA, 2011, J SPEECH LANG HEAR R, V54, P1361, DOI 10.1044/1092-4388(2011/10-0187); Dyck MJ, 2011, RES DEV DISABIL, V32, P2704, DOI 10.1016/j.ridd.2011.06.001; Eadie P, 2015, DEV MED CHILD NEUROL, V57, P578, DOI 10.1111/dmcn.12635; Ebbels S, 2014, INT J LANG COMM DIS, V49, P377, DOI 10.1111/1460-6984.12119; Fletcher JM, 2009, CHILD DEV PERSPECT, V3, P30, DOI 10.1111/j.1750-8606.2008.00072.x; Greenhalgh T, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-115; Greenspan S, 2014, CURR OPIN PSYCHIATR, V27, P110, DOI 10.1097/YCO.0000000000000037; Grigorenko EL, 2009, J LEARN DISABIL-US, V42, P111, DOI 10.1177/0022219408326207; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; Hasson N, 2013, CHILD LANG TEACH THE, V29, P57, DOI 10.1177/0265659012459526; Hawker K, 2008, EAR HEARING, V29, P467, DOI 10.1097/AUD.0b013e318167b857; Haynes C., 1991, CHILDREN SPECIFIC SP; Heilmann JJ, 2010, LANG SPEECH HEAR SER, V41, P84, DOI 10.1044/0161-1461(2009/08-0075); Hsu C.C, 2007, PRACT ASSESS RES EVA, V12, P1, DOI [DOI 10.7275/PDZ9-TH90, 10.7275/pdz9-th90]; Jeltova I., 2007, INT J SPEECH LANGUAG, V9, P273, DOI DOI 10.1080/14417040701460390; Jones RB, 2001, J MED ETHICS, V27, P377, DOI 10.1136/jme.27.6.377; Kjelgaard MM, 2001, LANG COGNITIVE PROC, V16, P287, DOI 10.1080/01690960042000058; Kohnert K, 2010, J COMMUN DISORD, V43, P456, DOI 10.1016/j.jcomdis.2010.02.002; Landeta J, 2006, TECHNOL FORECAST SOC, V73, P467, DOI 10.1016/j.techfore.2005.09.002; Law J, 2000, DEV MED CHILD NEUROL, V42, P190, DOI 10.1017/S0012162200000335; Law J, 2013, INT J LANG COMM DIS, V48, P486, DOI 10.1111/1460-6984.12027; Laws G, 2004, INT J LANG COMM DIS, V39, P423, DOI 10.1080/13682820410001681207; Leonard L., 1991, LANG SPEECH HEAR SER, V22, P66, DOI DOI 10.1044/0161-1461.2202.66; Loucas T, 2008, J CHILD PSYCHOL PSYC, V49, P1184, DOI 10.1111/j.1469-7610.2008.01951.x; McCauley RJ, 2013, ASSESSMENT LANGUAGE; Morgan A, 2013, INT J SPEECH-LANG PA, V15, P245, DOI 10.3109/17549507.2013.777786; Morgan G, 2007, INT J LANG COMM DIS, V42, P97, DOI 10.1080/13682820600783178; Nation K, 2004, J SPEECH LANG HEAR R, V47, P199, DOI 10.1044/1092-4388(2004/017); Norbury CF, 2004, INT J LANG COMM DIS, V39, P345, DOI 10.1080/13682820410001654883; Norbury CF, 2016, J CHILD PSYCHOL PSYC, V57; Norbury CF, 2016, J CHILD PSY IN PRESS; Norbury CF, 2014, J CHILD PSYCHOL PSYC, V55, P204, DOI 10.1111/jcpp.12154; O'Neill DK, 2007, J SPEECH LANG HEAR R, V50, P214, DOI 10.1044/1092-4388(2007/017); Okoli C, 2004, INFORM MANAGE-AMSTER, V42, P15, DOI 10.1016/j.im.2003.11.002; Paquier PF, 1996, ACTA NEUROL SCAND, V93, P428; Paradis J., 2011, DUAL LANGUAGE DEV DI; Paradis J, 2015, J SPEECH LA IN PRESS; Paradis J, 2010, J COMMUN DISORD, V43, P474, DOI 10.1016/j.jcomdis.2010.01.002; Paul R., 2012, LANGUAGE DISORDERS I; Paul R, 2011, LANG SPEECH HEAR SER, V42, P331, DOI 10.1044/0161-1461(2010/09-0067); Pena E. D., 2007, ADV SPEECH LANGUAGE, V9, P332, DOI [DOI 10.1080/14417040701413738, 10.1080/14417040701413738]; Pena ED, 2014, J SPEECH LANG HEAR R, V57, P2208, DOI 10.1044/2014_JSLHR-L-13-0151; Pennington BF, 2009, ANNU REV PSYCHOL, V60, P283, DOI 10.1146/annurev.psych.60.110707.163548; R Core Team, 2021, R LANGUAGE ENV STAT; Redmond SM, 2011, J SPEECH LANG HEAR R, V54, P99, DOI 10.1044/1092-4388(2010/10-0010); Reilly S, 2014, INT J LANG COMM DIS, V49, P452, DOI 10.1111/1460-6984.12111; Reilly S, 2014, INT J LANG COMM DIS, V49, P416, DOI 10.1111/1460-6984.12102; Reilly S, 2010, PEDIATRICS, V126, pE1530, DOI 10.1542/peds.2010-0254; RICE M. L, 2014, INT J LANG COMM DIS, V49, P381, DOI [10.1111/1460-6984.12101, DOI 10.1111/1460-6984.12101]; Rice ML, 2016, J SPEECH LANG HEAR R, V59, P122, DOI 10.1044/2015_JSLHR-L-15-0255; Rice ML, 1996, J SPEECH HEAR RES, V39, P1239, DOI 10.1044/jshr.3906.1239; Rice ML, 1998, J SPEECH LANG HEAR R, V41, P419, DOI 10.1044/jslhr.4102.419; Roberts JE, 2004, PEDIATRICS, V113, pE238, DOI 10.1542/peds.113.3.e238; Roy P, 2013, CURR ISS DEV PSYCHOL, P125; Royal College of Speech and Language Therapists, 2014, SLI IJLCD SPEC ISS D; SANDGREN O., 2014, INT J LANG COMM DIS, V49, P381, DOI [10.1111/1460-6984.12101, DOI 10.1111/1460-6984.12101]; Shriberg LD, 1999, J SPEECH LANG HEAR R, V42, P1461, DOI 10.1044/jslhr.4206.1461; Siu AL, 2015, PEDIATRICS, V136, pE474, DOI 10.1542/peds.2015-1711; Snowling MJ, 2016, J CHILD PSYCHOL PSYC; Spaulding TJ, 2012, LANG SPEECH HEAR SER, V43, P176, DOI 10.1044/0161-1461(2011/10-0103); Spaulding TJ, 2006, LANG SPEECH HEAR SER, V37, P61, DOI 10.1044/0161-1461(2006/007); Spencer M, 2014, LEARN DISABILITY Q, V37, P161, DOI 10.1177/0731948714530967; Spencer S, 2012, INT J LANG COMM DIS, V47, P274, DOI 10.1111/j.1460-6984.2011.00104.x; Stevenson J, 1996, LANGUAGE LEARNING BE, P78; Strand S., 2015, ENGLISH ADDITIONAL L; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Thomas-Stonell N, 2013, DEV MED CHILD NEUROL, V55, P546, DOI 10.1111/dmcn.12123; Thomas-Stonell NL, 2010, DEV MED CHILD NEUROL, V52, P47, DOI 10.1111/j.1469-8749.2009.03410.x; Tomblin J.B., 2008, UNDERSTANDING DEV LA, P93; Tomblin JB, 2004, DEVELOPMENTAL LANGUAGE DISORDERS: FROM PHENOTYPES TO ETIOLOGIES, P53; Tomblin JB, 1999, DEV COGN NEUROSCI, P361; Tomblin JB, 1996, J SPEECH HEAR RES, V39, P1284, DOI 10.1044/jshr.3906.1284; Visser-Bochane MI, 2016, INT J LANG COMMUN DI; Vu JA, 2011, EXCEPT CHILDREN, V77, P263, DOI 10.1177/001440291107700301; Washington K.N., 2007, ADV SPEECH LANGUAGE, V9, P242, DOI [10.1080/14417040701261525, DOI 10.1080/14417040701261525]; WHO, 2001, WHO INT CLASS FUNCT; Williams D, 2013, J AUTISM DEV DISORD, V43, P404, DOI 10.1007/s10803-012-1579-8; WILSON JMG, 1968, B OFIC SANIT PANAM, V65, P281; WOODS BT, 1978, ANN NEUROL, V3, P273, DOI 10.1002/ana.410030315; World Health Organization, 1992, ICD 10 CLASSIFICATIO, DOI DOI 10.1002/1520-6505(2000)9:5%3C201::AID-EVAN2%3E3.3.CO;2-P; Zambrana IM, 2014, INT J LANG COMM DIS, V49, P304, DOI 10.1111/1460-6984.12073	121	160	161	2	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158753	10.1371/journal.pone.0158753	http://dx.doi.org/10.1371/journal.pone.0158753			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27392128	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000380005400115
J	Costa, NS; Pinto, TCA; Merquior, VLC; Castro, LFS; da Rocha, FSP; Morais, JM; Peralta, JM; Teixeira, LM				Costa, Natalia S.; Pinto, Tatiana C. A.; Merquior, Vania L. C.; Castro, Luciana F. S.; da Rocha, Filomena S. P.; Morais, Jaqueline M.; Peralta, Jose M.; Teixeira, Lucia M.			MLVA Typing of Streptococcus pneumoniae Isolates with Emphasis on Serotypes 14, 9N and 9V: Comparison of Previously Described Panels and Proposal of a Novel 7 VNTR Loci-Based Simplified Scheme	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; CLONAL COMPLEX; RESISTANCE; CHILDREN; STRAINS; PNEUMOCOCCUS; PROTEIN	Streptococcus pneumoniae remains as an important cause of community-acquired bacterial infections, and the nasopharynx of asymptomatic carriers is the major reservoir of this microorganism. Pneumococcal strains of serotype 14 and serogroup 9 are among the most frequently isolated from both asymptomatic carriers and patients with invasive disease living in Brazil. Internationally disseminated clones belonging to such serotypes have been associated with the emergence and spread of antimicrobial resistance in our setting, highlighting the need for epidemiological tracking of these isolates. In this scenario, Multiple Loci VNTR Analysis (MLVA) has emerged as an alternative tool for the molecular characterization of pneumococci, in addition to more traditional techniques such as Multi-Locus Sequence Typing (MLST) and Pulsed-Field Gel Electrophoresis (PFGE). In the present study, 18 VNTR loci, as well as other previously described reduced MLVA panels (7 VNTR loci), were evaluated as tools to characterize pneumococcal strains of serotypes 14, 9N and 9V belonging to international and regional clones isolated in Brazil. The 18 VNTR loci panel was highly congruent with MLST and PFGE, being also useful for indicating the genetic relationship with international clones and for discriminating among strains with indistinguishable STs and PFGE profiles. Analysis of the results also allowed deducing a novel shorter 7 VNTR loci panel, keeping a high discriminatory power for isolates of the serotypes investigated and a high congruence level with MLST and PFGE. The newly proposed simplified panel was then evaluated for typing pneumococcal strains of other commonly isolated serotypes. The results indicate that MLVA is a faster and easier to perform, reliable approach for the molecular characterization of S. pneumoniae isolates, with potential for cost-effective application, especially in resource-limited countries.	[Costa, Natalia S.; Pinto, Tatiana C. A.; Castro, Luciana F. S.; da Rocha, Filomena S. P.; Morais, Jaqueline M.; Peralta, Jose M.; Teixeira, Lucia M.] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Rio De Janeiro, RJ, Brazil; [Costa, Natalia S.; Merquior, Vania L. C.] Univ Estado Rio de Janeiro, Fac Ciencias Med, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Universidade do Estado do Rio de Janeiro	Teixeira, LM (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Rio De Janeiro, RJ, Brazil.	lmt2@micro.ufrj.br	Pinto, Tatiana CA/O-1265-2015; Teixeira, Lucia Martins/AAO-7988-2020; Merquior, Vânia Lúcia Carreira/AAL-9502-2021	Pinto, Tatiana CA/0000-0002-7878-9377; Teixeira, Lucia Martins/0000-0002-4017-7076; Merquior, Vânia Lúcia Carreira/0000-0001-6593-5489	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported in part by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ).; This work was supported in part by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). We thank Drs. Bernard Beall and Lesley McGee (Streptococcus Laboratory, Centers for Diseases Control and Prevention, Atlanta, GA, USA) for kindly providing reference strains of the PMEN clones.	Andrade AL, 2012, VACCINE, V30, P1901, DOI 10.1016/j.vaccine.2011.12.012; Barroso DE, 2012, PEDIATR INFECT DIS J, V31, P30, DOI 10.1097/INF.0b013e31822f8a92; Blumental S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133885; Caierao J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111129; Calix JJ, 2012, J BIOL CHEM, V287, P27885, DOI 10.1074/jbc.M112.380451; Camargos P, 2006, PAEDIATR RESPIR REV, V7, P209, DOI 10.1016/j.prrv.2006.04.004; Croucher NJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-120; Dagan R, 2003, PEDIATR INFECT DIS J, V22, P532, DOI 10.1097/00006454-200306000-00009; Dias CA, 2007, J MED MICROBIOL, V56, P1185, DOI 10.1099/jmm.0.47347-0; Elberse KEM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020390; Elberse KEM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019668; Franco CM, 2010, PEDIATR INFECT DIS J, V29, P77, DOI 10.1097/INF.0b013e3181af7e90; Grundmann H, 2001, J CLIN MICROBIOL, V39, P4190, DOI 10.1128/JCM.39.11.4190-4192.2001; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Imohl M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-299; KLUGMAN KP, 1990, CLIN MICROBIOL REV, V3, P171, DOI 10.1128/CMR.3.2.171-196.1990; Koeck JL, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-66; Lambertsen L, 2010, SCAND J INFECT DIS, V42, P333, DOI 10.3109/00365540903501616; Mantese OC, 2009, J PEDIAT-BRAZIL, V85, P495, DOI [10.2223/JPED.1950, 10.1590/S0021-75572009000600005]; MARTIN B, 1992, NUCLEIC ACIDS RES, V20, P3479, DOI 10.1093/nar/20.13.3479; Melin MM, 2008, CLIN VACCINE IMMUNOL, V15, P1555, DOI 10.1128/CVI.00177-08; Mendonca-Souza CRV, 2004, MICROB DRUG RESIST, V10, P313, DOI 10.1089/mdr.2004.10.313; Ministerio da Saude, 2010, PROP INTR VAC PNEUM; Pichon B, 2010, J CLIN MICROBIOL, V48, P1926, DOI 10.1128/JCM.02054-09; Pinto TCA, 2013, J CLIN MICROBIOL, V51, P3242, DOI 10.1128/JCM.01168-13; Pinto TCA, STREPTOCOCCUS  UNPUB; Qian J, 2012, EUR J CLIN MICROBIOL, V31, P217, DOI 10.1007/s10096-011-1296-9; Rakov AV, 2011, INFECT GENET EVOL, V11, P1929, DOI 10.1016/j.meegid.2011.08.016; Rayner RE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121870; Sa-Leao R, 2011, J CLIN MICROBIOL, V49, P1369, DOI 10.1128/JCM.01763-10; Sadowy E, 2010, ANTIMICROB AGENTS CH, V54, P1720, DOI 10.1128/AAC.01340-09; Sanchez-Beato AR, 1998, FEMS MICROBIOL LETT, V164, P207, DOI 10.1016/S0378-1097(98)00206-7; Sanda AA, 2015, T ROY SOC TROP MED H, V109, P477, DOI 10.1093/trstmh/trv033; Severiano A, 2011, J CLIN MICROBIOL, V49, P3997, DOI 10.1128/JCM.00624-11; SORENSEN UBS, 1993, J CLIN MICROBIOL, V31, P2097; Spellerberg B, 2011, MANUAL CLIN MICROBIO, V2, P340; Staples M, 2015, EPIDEMIOL INFECT, V143, P325, DOI 10.1017/S0950268814000648; van Cuyck H, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-241; Weiser JN, 2010, J MOL MED, V88, P97, DOI 10.1007/s00109-009-0557-x	40	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158651	10.1371/journal.pone.0158651	http://dx.doi.org/10.1371/journal.pone.0158651			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391462	Green Published, gold, Green Submitted			2022-12-27	WOS:000380005400096
J	Li, T; Zhou, XD; Wang, Z; Zhu, J; Shen, WL; Jiang, B				Li, Tao; Zhou, Xiaodong; Wang, Zhi; Zhu, Jie; Shen, Wenli; Jiang, Bo			Assessment of Retinal and Choroidal Measurements in Chinese School-Age Children with Cirrus-HD Optical Coherence Tomography	PLOS ONE			English	Article							MACULAR THICKNESS; AXIAL LENGTH; HEALTHY-SUBJECTS; MYOPIC EYES; DEPTH; VOLUME; SEX	Purpose To evaluate retinal thickness (RT), retinal volume (RV) and choroidal thickness (ChT) in Chinese children using Cirrus-HD optical coherence tomography (OCT), and assess their associations with spherical equivalent (SE), age and gender. Methods This was a prospective study that recruited 193 healthy Chinese children (193 eyes) with no ophthalmic disease history between December 2012 and December 2013. RT and RV were acquired using OCT. Subfoveal ChT (SFCT) and ChT1-mm and 2-mm temporal, nasal, superior and inferior to the fovea were measured manually. Results RT in the inner temporal and nasal regionsdiffered significantly between refraction groups (both P < 0.05). Significant differences were also found inSFCT andChT 1- and 2-mm inferior to the fovea (all P < 0.05). RT differed significantly between males and females in the outer superior region in the emmetropia group ( P < 0.05). ChT differed significantly between males and females 2-mm temporal to the fovea in the emmetropia group (P < 0.05), and 1-mm temporal to the fovea in the mild myopia group (P < 0.05). SE correlated positively with RT in the inner temporal (r = 0.230), nasal (r = 0.252) and inferior (r = 0.149) regions (all P < 0.05). Age correlated positively with foveolar (r = 0.169), total macular (r = 0.202), inner temporal (r = 0.237), inner nasal (r = 0.248), inner superior (r = 0.378) and inner inferior (r = 0.345) region thicknesses, and with RV (r = 0.207)(all P < 0.05). SE correlated positively with SFCT (r = 0.195), and with ChT1-mm temporal (r = 0.167), 1- and 2-mm nasal (r = 0.144 and r = 0.162), 2-mm superior (r = 0.175), and 1- and 2-mm inferior (r = 0.207 and r = 0.238) to the fovea (all P< 0.05). Age had no significant association with ChT. Conclusions SE, age and gender did not influence macular RT and ChT in most regions, and correlations of RT with age and ChT with SE were weak.	[Li, Tao; Zhou, Xiaodong; Wang, Zhi; Zhu, Jie; Shen, Wenli; Jiang, Bo] Fudan Univ, Jinshan Hosp, Dept Ophthalmol, 1508 Longhang Rd, Shanghai, Peoples R China	Fudan University	Zhou, XD (corresponding author), Fudan Univ, Jinshan Hosp, Dept Ophthalmol, 1508 Longhang Rd, Shanghai, Peoples R China.	xdzhou2013@126.com			Shanghai Municipality Health Bureau Youth Project [2013-121]; Shanghai Municipality Jinshan District Health Bureau Youth Project [JSKJ-KTQN-2013-02]; Shanghai Municipality Science and Technology Commission Project [13ZR1405800]	Shanghai Municipality Health Bureau Youth Project; Shanghai Municipality Jinshan District Health Bureau Youth Project; Shanghai Municipality Science and Technology Commission Project	This work was supported in part by the Shanghai Municipality Health Bureau Youth Project (2013-121), the Shanghai Municipality Jinshan District Health Bureau Youth Project (JSKJ-KTQN-2013-02), and Shanghai Municipality Science and Technology Commission Project (13ZR1405800).	Ding XY, 2011, INVEST OPHTH VIS SCI, V52, P9555, DOI 10.1167/iovs.11-8076; Drexler W, 2003, ARCH OPHTHALMOL-CHIC, V121, P695, DOI 10.1001/archopht.121.5.695; Duan XR, 2010, OPHTHALMOLOGY, V117, P1585, DOI 10.1016/j.ophtha.2009.12.036; Faghihi Hooshang, 2010, J Ophthalmic Vis Res, V5, P110; Fujiwara A, 2012, JPN J OPHTHALMOL, V56, P230, DOI 10.1007/s10384-012-0128-5; Huynh SC, 2006, INVEST OPHTH VIS SCI, V47, P2351, DOI 10.1167/iovs.05-1396; Huynh SC, 2009, OPHTHALMOLOGY, V116, P1604, DOI 10.1016/j.ophtha.2009.03.013; Hwang YH, 2012, CLIN EXP OPTOM, V95, P492, DOI 10.1111/j.1444-0938.2012.00749.x; Ikuno Y, 2013, CLIN OPHTHALMOL, V7, P889, DOI 10.2147/OPTH.S44138; Ikuno Y, 2010, INVEST OPHTH VIS SCI, V51, P2173, DOI 10.1167/iovs.09-4383; Keane PA, 2009, BRIT J OPHTHALMOL, V93, P1461, DOI 10.1136/bjo.2008.155846; Li XQ, 2011, INVEST OPHTH VIS SCI, V52, P8438, DOI 10.1167/iovs.11-8108; Luo HD, 2006, INVEST OPHTH VIS SCI, V47, P2773, DOI 10.1167/iovs.05-1380; Margolis R, 2009, AM J OPHTHALMOL, V147, P811, DOI 10.1016/j.ajo.2008.12.008; Nickla DL, 2010, PROG RETIN EYE RES, V29, P144, DOI 10.1016/j.preteyeres.2009.12.002; Nishida Y, 2012, RETINA-J RET VIT DIS, V32, P1229, DOI 10.1097/IAE.0b013e318242b990; Osmanbasoglu OA, 2013, J OPHTHALMOL, V2013, DOI 10.1155/2013/687165; Othman SF, 2012, CLIN EXP OPTOM, V95, P484, DOI 10.1111/j.1444-0938.2012.00752.x; Pang Y, 2011, INVEST OPHTH VIS SCI, V52, P2444, DOI 10.1167/iovs.10-5550; Park KA, 2012, INVEST OPHTH VIS SCI, V53, P7201, DOI 10.1167/iovs.12-10599; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Read SA, 2013, INVEST OPHTH VIS SCI, V54, P3586, DOI 10.1167/iovs.13-11732; Ruiz-Moreno JM, 2013, INVEST OPHTH VIS SCI, V54, P353, DOI 10.1167/iovs.12-10863; Samarawickrama C, 2009, J AAPOS, V13, P142, DOI 10.1016/j.jaapos.2008.11.004; Serbecic N, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00020; Song WK, 2010, INVEST OPHTH VIS SCI, V51, P3913, DOI 10.1167/iovs.09-4189; Vincent SJ, 2013, INVEST OPHTH VIS SCI, V54, P2445, DOI 10.1167/iovs.12-11434; Wakitani Y, 2003, RETINA-J RET VIT DIS, V23, P177, DOI 10.1097/00006982-200304000-00007; Wu PC, 2008, EYE, V22, P551, DOI 10.1038/sj.eye.6702789; Yeoh J, 2010, GRAEF ARCH CLIN EXP, V248, P1719, DOI 10.1007/s00417-010-1437-3; Zhang ZW, 2011, INVEST OPHTH VIS SCI, V52, P6377, DOI 10.1167/iovs.11-7477; Zhou MW, 2013, INVEST OPHTH VIS SCI, V54, P1971, DOI 10.1167/iovs.12-11090; Zou HD, 2006, INVEST OPHTH VIS SCI, V47, P341, DOI 10.1167/iovs.05-0480	33	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158948	10.1371/journal.pone.0158948	http://dx.doi.org/10.1371/journal.pone.0158948			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391015	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400169
J	Lumbreras, B; Vilar, J; Gonzalez-Alvarez, I; Gomez-Saez, N; Domingo, ML; Lorente, MF; Pastor-Valero, M; Hernandez-Aguado, I				Lumbreras, Blanca; Vilar, Jose; Gonzalez-Alvarez, Isabel; Gomez-Saez, Noemi; Domingo, Maria L.; Lorente, Maria F.; Pastor-Valero, Maria; Hernandez-Aguado, Ildefonso			The Fate of Patients with Solitary Pulmonary Nodules: Clinical Management and Radiation Exposure Associated	PLOS ONE			English	Article							DOSE CT; RISK; PROBABILITY; MULTICENTER; MALIGNANCY; CARE	Background The appropriate management of the large number of lung nodules detected during the course of routine medical care presents a challenge. We aimed to evaluate the usual clinical practice in solitary pulmonary nodule (SPN) management and associated radiation exposure. Methods We examined 893 radiology reports of consecutive patients undergoing chest computed tomography (CT) and radiography at two public hospitals in Spain. Information on diagnostic procedures from SPN detection and lung cancer diagnosis was collected prospectively for 18 months. Results More than 20% of patients with SPN detected on either chest radiograph (19.8%) or CT (26.1%) underwent no additional interventions and none developed lung cancer (100% negative predictive value). 346 (72.0%) patients with SPN detected on chest radiograph and 254 (61.5%) patients with SPN detected on CT had additional diagnostic tests and were not diagnosed with lung cancer. In patients undergoing follow-up imaging for SPNs detected on CT median number of additional imaging tests was 3.5 and the mean cumulative effective dose was 24.4 mSv; for those detected on chest radiograph the median number of additional imaging tests was 2.8 and the mean cumulative effective dose was 10.3 mSv. Conclusions Patients who did not have additional interventions were not diagnosed of lung cancer. There was an excessive amount of interventions in a high percentage of patients presenting SPN, which was associated with an excess of radiation exposure.	[Lumbreras, Blanca; Gomez-Saez, Noemi; Pastor-Valero, Maria; Hernandez-Aguado, Ildefonso] Miguel Hernandez Univ, Dept Publ Hlth, Alicante, Spain; [Lumbreras, Blanca; Pastor-Valero, Maria; Hernandez-Aguado, Ildefonso] CIBER Epidemiol Salud Publ, Madrid, Spain; [Vilar, Jose; Domingo, Maria L.] Peset Hosp, Radiodiagnost Dept, Valencia, Spain; [Gonzalez-Alvarez, Isabel; Lorente, Maria F.] San Juan Hosp, Radiodiagnost Dept, Alicante, Spain	Universidad Miguel Hernandez de Elche; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Lumbreras, B (corresponding author), Miguel Hernandez Univ, Dept Publ Hlth, Alicante, Spain.; Lumbreras, B (corresponding author), CIBER Epidemiol Salud Publ, Madrid, Spain.	blumbreras@umh.es	Gonzalez-Alvarez, Isabel/AAD-5896-2019; Hernandez-Aguado, Ildefonso/I-2634-2015	Gonzalez-Alvarez, Isabel/0000-0002-1685-142X; Lumbreras, Blanca/0000-0003-1665-0860; Pastor-Valero, Maria/0000-0001-9282-5787; Hernandez-Aguado, Ildefonso/0000-0003-1911-5759	Instituto de Salud Carlos III (Minister of Science, Spain) [PI09/0477]; Fondo Europeo de Desarrollo Regional (FEDER)	Instituto de Salud Carlos III (Minister of Science, Spain); Fondo Europeo de Desarrollo Regional (FEDER)(European Commission)	This study has received funding by Instituto de Salud Carlos III (Minister of Science, Spain) (Ref. PI09/0477) and and co-funded by the Fondo Europeo de Desarrollo Regional (FEDER).	Aberle DR, 2013, NEW ENGL J MED, V369, P920, DOI 10.1056/NEJMoa1208962; Al-Ameri A, 2015, LUNG CANCER, V89, P27, DOI 10.1016/j.lungcan.2015.03.018; Alzahouri K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-93; Berlin L, 2003, AM J ROENTGENOL, V180, P317, DOI 10.2214/ajr.180.2.1800317; Bhargavan M, 2008, HEALTH PHYS, V95, P612, DOI 10.1097/01.HP.0000327659.42618.c1; Callister ME, 2015, THORAX, V70, P1188, DOI 10.1136/thoraxjnl-2015-207168corr1; Deyo RA, 2002, ANNU REV PUBL HEALTH, V23, P23, DOI 10.1146/annurev.publhealth.23.092101.134534; Einstein AJ, 2007, JAMA-J AM MED ASSOC, V298, P317, DOI 10.1001/jama.298.3.317; Fisher ES, 1999, JAMA-J AM MED ASSOC, V281, P446, DOI 10.1001/jama.281.5.446; Fritz A, 2000, INT CLASSIFICATION D; Gomez-Saez N, 2014, EUR RADIOL, V24, P2174, DOI 10.1007/s00330-014-3249-z; Gomez-Saez N, 2015, EUR RADIOL, V25, P3518, DOI 10.1007/s00330-015-3775-3; Gould MK, 2007, CHEST, V132, p108S, DOI 10.1378/chest.07-1353; Gould MK, 2013, CHEST, V143, pE93, DOI 10.1378/chest.12-2351; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Hein PA, 2010, J DIGIT IMAGING, V23, P8, DOI 10.1007/s10278-008-9157-5; Horeweg N, 2014, LANCET ONCOL, V15, P1332, DOI 10.1016/S1470-2045(14)70389-4; Lin EC, 2010, MAYO CLIN PROC, V85, P1142, DOI 10.4065/mcp.2010.0260; Lumbreras B, 2010, BRIT J RADIOL, V83, P276, DOI 10.1259/bjr/98067945; Lumbreras B, 2010, EUR J RADIOL, V74, P269, DOI 10.1016/j.ejrad.2009.01.029; MacMahon H, 2005, RADIOLOGY, V237, P395, DOI 10.1148/radiol.2372041887; Mettler FA, 2008, RADIOLOGY, V248, P254, DOI 10.1148/radiol.2481071451; MOLD JW, 1986, NEW ENGL J MED, V314, P512, DOI 10.1056/NEJM198602203140809; Swensen SJ, 1999, MAYO CLIN PROC, V74, P319, DOI 10.4065/74.4.319; Swensen SJ, 1997, ARCH INTERN MED, V157, P849, DOI 10.1001/archinte.157.8.849; Tanner NT, 2015, CHEST, V148, P1405, DOI 10.1378/chest.15-0630; VIGGIANO RW, 1992, CLIN CHEST MED, V13, P83; Wiener RS, 2014, JAMA INTERN MED, V174, P871, DOI 10.1001/jamainternmed.2014.561	28	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158458	10.1371/journal.pone.0158458	http://dx.doi.org/10.1371/journal.pone.0158458			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27392032	gold, Green Published, Green Submitted			2022-12-27	WOS:000380005400063
J	Singh, B; Kinne, HE; Milligan, RD; Washburn, LJ; Olsen, M; Lucci, A				Singh, Balraj; Kinne, Hannah E.; Milligan, Ryan D.; Washburn, Laura J.; Olsen, Mark; Lucci, Anthony			Important Role of FTO in the Survival of Rare Panresistant Triple-Negative Inflammatory Breast Cancer Cells Facing a Severe Metabolic Challenge	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; CLONAL EVOLUTION; OBESITY GENE; METASTASIS; RISK; ENCODES; IMPACT; TUMOR	We have previously shown that only 0.01% cells survive a metabolic challenge involving lack of glutamine in culture medium of SUM149 triple-negative Inflammatory Breast Cancer cell line. These cells, designated as SUM149-MA for metabolic adaptability, are resistant to chemotherapeutic drugs, and they efficiently metastasize to multiple organs in nude mice. We hypothesized that obesity-related molecular networks, which normally help in cellular and organismal survival under metabolic challenges, may help in the survival of MA cells. The fat mass and obesity-associated protein FTO is overexpressed in MA cells. Obesity-associated cis-acting elements in non-coding region of FTO regulate the expression of IRX3 gene, thus activating obesity networks. Here we found that IRX3 protein is significantly overexpressed in MA cells (5 to 6-fold) as compared to the parental SUM149 cell line, supporting our hypothesis. We also obtained evidence that additional key regulators of energy balance such as ARID5B, IRX5, and CUX1 P200 repressor could potentially help progenitor-like TNBC cells survive in glutamine-free medium. MO-I-500, a pharmacological inhibitor of FTO, significantly (> 90%) inhibited survival and/or colony formation of SUM149-MA cells as compared to untreated cells or those treated with a control compound MO-I-100. Curiously, MO-I-500 treatment also led to decreased levels of FTO and IRX3 proteins in the SUM149 cells initially surviving in glutamine-free medium as compared to MO-I-100 treatment. Interestingly, MO-I-500 treatment had a relatively little effect on cell growth of either the SUM149 or SUM149-MA cell line when added to a complete medium containing glutamine that does not pose a metabolic challenge. Importantly, once selected and cultured in glutamine-free medium, SUM149-MA cells were no longer affected by MO-I-500 even in Gln-free medium. We conclude that panresistant MA cells contain interconnected molecular networks that govern developmental status and energy balance, and genetic and epigenetic alterations that are selected during cancer evolution.	[Singh, Balraj; Kinne, Hannah E.; Milligan, Ryan D.; Washburn, Laura J.; Lucci, Anthony] Univ Texas MD Anderson Canc Ctr, Dept Breast Surg Oncol, Houston, TX 77030 USA; [Singh, Balraj; Kinne, Hannah E.; Milligan, Ryan D.; Washburn, Laura J.; Lucci, Anthony] Univ Texas MD Anderson Canc Ctr, Morgan Welch Inflammatory Breast Canc Res Program, Houston, TX 77030 USA; [Olsen, Mark] Midwestern Univ, Coll Pharm Glendale, Dept Pharmaceut Sci, Glendale, AZ USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Midwestern University; Midwestern University - College of Pharmacy - Glendale	Lucci, A (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Breast Surg Oncol, Houston, TX 77030 USA.; Lucci, A (corresponding author), Univ Texas MD Anderson Canc Ctr, Morgan Welch Inflammatory Breast Canc Res Program, Houston, TX 77030 USA.	alucci@mdanderson.org		Lucci, Anthony/0000-0003-4039-174X	State of Texas Rare and Aggressive Breast Cancer Research Program Grant; Breast Cancer Metastasis Research Program at MD Anderson Cancer Center; National Institutes of Health [CA16672]	State of Texas Rare and Aggressive Breast Cancer Research Program Grant; Breast Cancer Metastasis Research Program at MD Anderson Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by a State of Texas Rare and Aggressive Breast Cancer Research Program Grant, Breast Cancer Metastasis Research Program at MD Anderson Cancer Center, and CA16672 (Core) from the National Institutes of Health. Sponsors or funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnabas N, 2013, INT J BREAST CANCER, V2013, DOI 10.1155/2013/872743; Bellefroid EJ, 1998, EMBO J, V17, P191, DOI 10.1093/emboj/17.1.191; Berulava T, 2013, EUR J HUM GENET, V21, P317, DOI 10.1038/ejhg.2012.168; Chao HH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051719; Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214; Hernandez-Caballero ME, 2015, MOL BIOL REP, V42, P699, DOI 10.1007/s11033-014-3817-y; FIDLER IJ, 1977, SCIENCE, V197, P893, DOI 10.1126/science.887927; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Fredriksson R, 2008, ENDOCRINOLOGY, V149, P2062, DOI 10.1210/en.2007-1457; Garcia-Closas M, 2013, NAT GENET, V45, P392, DOI 10.1038/ng.2561; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Gulati P, 2013, P NATL ACAD SCI USA, V110, P2557, DOI 10.1073/pnas.1222796110; Jacobsson JA, 2012, OBES REV, V13, P1096, DOI 10.1111/j.1467-789X.2012.01025.x; Jain R, 2013, J MAMMARY GLAND BIOL, V18, P257, DOI 10.1007/s10911-013-9307-3; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Masuda H, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3579; McKnight SL, 2010, SCIENCE, V330, P1338, DOI 10.1126/science.1199908; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Peters U, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003171; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Singh B, 2007, ONCOGENE, V26, P3789, DOI 10.1038/sj.onc.1210154; Singh B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109487; Singh B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036510; Singh B, 2010, CLIN EXP METASTAS, V27, P233, DOI 10.1007/s10585-010-9321-4; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Stratigopoulos G, 2011, J BIOL CHEM, V286, P2155, DOI 10.1074/jbc.M110.188482; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Tiwari A, 2012, DOMEST ANIM ENDOCRIN, V42, P1, DOI 10.1016/j.domaniend.2011.08.001; Van Laere SJ, 2013, CLIN CANCER RES, V19, P4685, DOI 10.1158/1078-0432.CCR-12-2549; Wang Y, 2014, NATURE, V512, P155, DOI 10.1038/nature13600; Yamakawa T, 2010, BIOCHEM BIOPH RES CO, V391, P277, DOI 10.1016/j.bbrc.2009.11.049; Zheng GQ, 2014, ACS CHEM NEUROSCI, V5, P658, DOI 10.1021/cn500042t	32	58	58	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159072	10.1371/journal.pone.0159072	http://dx.doi.org/10.1371/journal.pone.0159072			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27390851	Green Submitted, Green Published, gold			2022-12-27	WOS:000380005400207
J	Johnson, GR; Knibbs, LD; Kidd, TJ; Wainwright, CE; Wood, ME; Ramsay, KA; Bell, SC; Morawska, L				Johnson, Graham R.; Knibbs, Luke D.; Kidd, Timothy J.; Wainwright, Claire E.; Wood, Michelle E.; Ramsay, Kay A.; Bell, Scott C.; Morawska, Lidia			A Novel Method and Its Application to Measuring Pathogen Decay in Bioaerosols from Patients with Respiratory Disease	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; HYGROSCOPIC BEHAVIOR; ROTATING DRUM; INFLUENZA-A; AEROSOLS; SIZE; TRANSMISSION; MECHANISMS; BACTERIA; OXYGEN	This work aimed to develop an in vivo approach for measuring the duration of human bioaerosol infectivity. To achieve this, techniques designed to target short-term and long-term bioaerosol aging, were combined in a tandem system and optimized for the collection of human respiratory bioaerosols, without contamination. To demonstrate the technique, cough aerosols were sampled from two persons with cystic fibrosis and chronic Pseudomonas aeruginosa infection. Measurements and cultures from aerosol ages of 10, 20, 40, 900 and 2700 seconds were used to determine the optimum droplet nucleus size for pathogen transport and the airborne bacterial biological decay. The droplet nuclei containing the greatest number of colony forming bacteria per unit volume of airborne sputum were between 1.5 and 2.6 mu m. Larger nuclei of 3.9 mu m, were more likely to produce a colony when impacted onto growth media, because the greater volume of sputum comprising the larger droplet nuclei, compensated for lower concentrations of bacteria within the sputum of larger nuclei. Although more likely to produce a colony, the larger droplet nuclei were small in number, and the greatest numbers of colonies were instead produced by nuclei from 1.5 to 5.7 mu m. Very few colonies were produced by smaller droplet nuclei, despite their very large numbers. The concentration of viable bacteria within the dried sputum comprising the droplet nuclei exhibited an orderly dual decay over time with two distinct half-lives. Nuclei exhibiting a rapid biological decay process with a 10 second half-life were quickly exhausted, leaving only a subset characterized by a half-life of greater than 10 minutes. This finding implied that a subset of bacteria present in the aerosol was resistant to rapid biological decay and remained viable in room air long enough to represent an airborne infection risk.	[Johnson, Graham R.; Morawska, Lidia] Queensland Univ Technol, ILAQH, Brisbane, Qld, Australia; [Knibbs, Luke D.] Univ Queensland, Sch Publ Hlth, Herston, Qld, Australia; [Kidd, Timothy J.] Univ Queensland, Child Hlth Res Ctr, Herston, Qld, Australia; [Kidd, Timothy J.] Queens Univ, Ctr Med Expt, Belfast, Antrim, North Ireland; [Wainwright, Claire E.; Ramsay, Kay A.; Bell, Scott C.] Univ Queensland, Sch Med, Herston, Qld, Australia; [Wainwright, Claire E.] Royal Lady Cilento Childrens Hosp, Dept Resp & Sleep Med, South Brisbane, Qld, Australia; [Wood, Michelle E.; Ramsay, Kay A.; Bell, Scott C.] QIMR Berghofer Med Res Inst, Lung Bacteria Res Grp, Herston, Qld, Australia; [Wood, Michelle E.; Bell, Scott C.] Prince Charles Hosp, Dept Thorac Med, Chermside, Qld, Australia	Queensland University of Technology (QUT); University of Queensland; University of Queensland; Queens University Belfast; University of Queensland; QIMR Berghofer Medical Research Institute; Prince Charles Hospital	Johnson, GR (corresponding author), Queensland Univ Technol, ILAQH, Brisbane, Qld, Australia.	g.johnson@qut.edu.au	Knibbs, Luke/C-7865-2012; Kidd, Timothy/F-2149-2010; Bell, Scott/AAJ-4298-2020; Wainwright, Claire E/G-4218-2013; Johnson, Graham/B-4128-2011; Bell, Scott C/A-7241-2011; Morawska, Lidia/B-4140-2011	Kidd, Timothy/0000-0002-6135-6364; Bell, Scott/0000-0001-8651-7139; Wainwright, Claire E/0000-0001-8389-3809; Johnson, Graham/0000-0001-6874-0230; Bell, Scott C/0000-0001-8651-7139; Morawska, Lidia/0000-0002-0594-9683; Knibbs, Luke/0000-0002-0399-2370	Prince Charles Hospital Foundation [MS2010-42]; Children's Health Foundation Queensland [50005]; Institute of Health and Biomedical Innovation-Queensland University of Technology (IHBI) (Collaborative Research Development Grants) [2010002239]; Institute of Health and Biomedical Innovation-Queensland University of Technology (IHBI) (Collaborative Research Development Grants) (IHBI Early Career Researcher's Grant) [2009001211]; Australian Research Council Discovery Grant [DP0558410]; Perpetual Philanthropy; Queensland Health Office of Health and Medical Research (Health Fellowships) [QCOS012808, QCOS013795]; National Health and Medical Research Council (NHMRC) Early Career (Australian Public Health) Fellowship [1036620]; ERS-EU RESPIRE2 Marie Sklodowska-Curie Postdoctoral Research Fellowship [4571-2013]	Prince Charles Hospital Foundation; Children's Health Foundation Queensland; Institute of Health and Biomedical Innovation-Queensland University of Technology (IHBI) (Collaborative Research Development Grants); Institute of Health and Biomedical Innovation-Queensland University of Technology (IHBI) (Collaborative Research Development Grants) (IHBI Early Career Researcher's Grant); Australian Research Council Discovery Grant(Australian Research Council); Perpetual Philanthropy; Queensland Health Office of Health and Medical Research (Health Fellowships); National Health and Medical Research Council (NHMRC) Early Career (Australian Public Health) Fellowship(National Health and Medical Research Council (NHMRC) of Australia); ERS-EU RESPIRE2 Marie Sklodowska-Curie Postdoctoral Research Fellowship	The study was funded by grants from The Prince Charles Hospital Foundation (#MS2010-42), Children's Health Foundation Queensland (#50005), Institute of Health and Biomedical Innovation-Queensland University of Technology (IHBI) (Collaborative Research Development Grants to LM, LDK, and GRJ (#2010002239), IHBI Early Career Researcher's Grant to GRJ (#2009001211)), Australian Research Council Discovery Grant to LM (DP0558410), Perpetual Philanthropy, Queensland Health Office of Health and Medical Research (Health Fellowships CEW (QCOS012808) and SCB (QCOS013795)), National Health and Medical Research Council (NHMRC) Early Career (Australian Public Health) Fellowship to LDK (#1036620), and a ERS-EU RESPIRE2 Marie Sklodowska-Curie Postdoctoral Research Fellowship to TJK (#4571-2013).	Agranovski V, 2003, J AEROSOL SCI, V34, P1711, DOI 10.1016/S0021-8502(03)00191-5; [American Society of Heating R Air-Conditioning Engineers], 2015, ASHRAE POS DOC FILTR; ANDERSEN AA, 1958, J BACTERIOL, V76, P471, DOI 10.1128/JB.76.5.471-484.1958; ASGHARIAN B, 1992, AEROSOL SCI TECH, V17, P263, DOI 10.1080/02786829208959575; BENBOUGH JE, 1967, J GEN MICROBIOL, V47, P325, DOI 10.1099/00221287-47-3-325; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Chao CYH, 2009, J AEROSOL SCI, V40, P122, DOI 10.1016/j.jaerosci.2008.10.003; Clifton IJ, 2010, J CYST FIBROS, V9, P64, DOI 10.1016/j.jcf.2009.11.004; Cox C. S., 1995, BIOAEROSOLS HDB; Cox CS., 1987, AEROBIOLOGICAL PATHW; DAHL TA, 1989, J BACTERIOL, V171, P2188, DOI 10.1128/jb.171.4.2188-2194.1989; Edwards DA, 2004, P NATL ACAD SCI USA, V101, P17383, DOI 10.1073/pnas.0408159101; Frostling H., 1973, J AEROSOL SCI, V4, P411, DOI [10.1016/0021-8502(73)90030-x, DOI 10.1016/0021-8502(73)90030-X]; GOLDBERG LJ, 1971, APPL MICROBIOL, V21, P244, DOI 10.1128/AEM.21.2.244-252.1971; GOLDBERG LJ, 1958, AM J HYG, V68, P85, DOI 10.1093/oxfordjournals.aje.a119954; GRUEL RL, 1987, J AEROSOL SCI, V18, P17, DOI 10.1016/0021-8502(87)90004-8; Hairston PP, 1997, J AEROSOL SCI, V28, P471, DOI 10.1016/S0021-8502(96)00448-X; HALLIWELL B, 1978, CELL BIOL INT REP, V2, P113, DOI 10.1016/0309-1651(78)90032-2; HESS GE, 1965, APPL MICROBIOL, V13, P781, DOI 10.1128/AEM.13.5.781-787.1965; Hinds W. C., 1999, AEROSOL TECHNOLOGY P; Holmgren H, 2010, J AEROSOL SCI, V41, P439, DOI 10.1016/j.jaerosci.2010.02.011; JANNING B, 1994, J APPL BACTERIOL, V77, P319, DOI 10.1111/j.1365-2672.1994.tb03080.x; Johnson G, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020126; Johnson GR, 2008, J AEROSOL SCI, V39, P850, DOI 10.1016/j.jaerosci.2008.05.005; Johnson GR, 2011, J AEROSOL SCI, V42, P839, DOI 10.1016/j.jaerosci.2011.07.009; Johnson GR, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005657; Johnson GR, 2004, J AEROSOL SCI, V35, P443, DOI 10.1016/j.jaerosci.2003.10.008; Johnson GR, 2009, J AEROSOL MED PULM D, V22, P229, DOI 10.1089/jamp.2008.0720; Kidd TJ, 2011, J CLIN MICROBIOL, V49, P263, DOI 10.1128/JCM.01421-10; Kidd TJ, 2009, J CLIN MICROBIOL, V47, P1503, DOI 10.1128/JCM.00014-09; Kim J, 2009, J ANTIMICROB CHEMOTH, V63, P129, DOI 10.1093/jac/dkn462; Knibbs LD, 2014, THORAX, V69, P740, DOI 10.1136/thoraxjnl-2014-205213; KOLTER R, 1993, ANNU REV MICROBIOL, V47, P855, DOI 10.1146/annurev.micro.47.1.855; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Kreidenweis SM, 2005, ATMOS CHEM PHYS, V5, P1357, DOI 10.5194/acp-5-1357-2005; Lindsley WG, 2012, J OCCUP ENVIRON HYG, V9, P443, DOI 10.1080/15459624.2012.684582; MACHER JM, 1989, AM IND HYG ASSOC J, V50, P561, DOI 10.1080/15298668991375164; MCMURRY PH, 1989, ATMOS ENVIRON, V23, P497, DOI 10.1016/0004-6981(89)90593-3; Morawska L, 2009, J AEROSOL SCI, V40, P256, DOI 10.1016/j.jaerosci.2008.11.002; Morawska L, 2009, ENVIRON SCI TECHNOL, V43, P1015, DOI 10.1021/es802193n; Neidhardt FC, 1992, PHYSL BACTERIAL CELL, P124; Nicas M, 2005, J OCCUP ENVIRON HYG, V2, P143, DOI 10.1080/15459620590918466; REYNOLDS HY, 1984, DM-DIS MON, V30, P1, DOI 10.1016/0011-5029(84)90008-7; SATTAR SA, 1987, CRIT REV ENV CONTR, V17, P89, DOI 10.1080/10643388709388331; Sutton TA, 2005, ANAL AEROSOL AGING R; TANG IN, 1993, ATMOS ENVIRON A-GEN, V27, P467, DOI 10.1016/0960-1686(93)90204-C; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426; Todar K, 2015, TXB BACTERIOLOGY; Verreault D, 2011, APPL ENVIRON MICROB, V77, P491, DOI 10.1128/AEM.01391-10; Wainwright CE, 2009, THORAX, V64, P926, DOI 10.1136/thx.2008.112466; Wexler A. S., 2002, J GEOPHYS RES-ATMOS, V7, DOI [10.1029/ 2001jd000451, 2002., DOI 10.1029/2001JD000451]; Yang W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021481; Yao M., 2008, REMOVAL VOLATILE ORG	53	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158763	10.1371/journal.pone.0158763	http://dx.doi.org/10.1371/journal.pone.0158763			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27388489	gold, Green Published, Green Submitted			2022-12-27	WOS:000379811500044
J	Kuntzen, T; Kuhn, S; Kuntzen, D; Seifert, B; Mullhaupt, B; Geier, A				Kuntzen, Thomas; Kuhn, Sereina; Kuntzen, Daniela; Seifert, Burkhardt; Mullhaupt, Beat; Geier, Andreas			Influence of Ribavirin Serum Levels on Outcome of Antiviral Treatment and Anemia in Hepatitis C Virus Infection	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; GENOTYPE 2/3 INFECTION; PLASMA-CONCENTRATION; PEGINTERFERON-ALPHA; HCV INFECTION; SOFOSBUVIR; THERAPY; POLYMORPHISMS; LEDIPASVIR; PREDICTOR	Background Ribavirin blood levels vary considerably between patients with standard weight-based dosing. Their impact on sustained virological response (SVR) with pegylated interferon and ribavirin is controversial, but has mostly been studied before the IL28b gene polymorphism as a possible confounder was discovered. Methods The impact of serum ribavirin trough levels at week 4, at the end of treatment and of mean levels across the entire antiviral treatment with pegylated interferon and ribavirin on relapse, SVR rates and anemia was retrospectively studied by univariate and multivariable logistic regression analyses in 214 patients with HCV genotype 1-4 infection, including 88 patients with available IL28b genotyping. Results Mean ribavirin levels varied between 0.68-5.65 mg/l and significantly differed between patients with or without SVR. By multivariable regression including age, sex, HCV viral load, HCV genotype, liver fibrosis stage, prior treatments, immunosuppression and IL28b genotype, ribavirin levels consistently displayed significant influence on SVR and relapse without indication for a specific importance of higher concentrations early or late in the treatment course. Although hemoglobin decline was on average more pronounced in patients with higher ribavirin levels, hemoglobin remained relatively stable in a significant proportion of these, indicating that ribavirin levels alone are insufficient to predict anemia. Conclusion While data are scarce to draw conclusions applicable for modern DAA therapies, these results support ribavirin treatment based on serum levels instead of purely weight-based dosing in combination with pegylated interferon.	[Kuntzen, Thomas; Kuhn, Sereina; Mullhaupt, Beat; Geier, Andreas] Univ Zurich Hosp, Dept Gastroenterol & Hepatol, Zurich, Switzerland; [Kuntzen, Daniela] Kantonsspital Baden, Dept Internal Med, Baden, Switzerland; [Seifert, Burkhardt] Univ Zurich, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland; [Geier, Andreas] Univ Hosp Wurzburg, Dept Internal Med 2, Wurzburg, Germany	University of Zurich; University Zurich Hospital; University of Zurich; University of Wurzburg	Kuntzen, T (corresponding author), Univ Zurich Hosp, Dept Gastroenterol & Hepatol, Zurich, Switzerland.	thomas.kuntzen@usz.ch	Müllhaupt, Beat/O-3744-2016	Müllhaupt, Beat/0000-0002-9020-8192; Seifert, Burkhardt/0000-0002-5829-2478				Ackefors M, 2012, J VIRAL HEPATITIS, V19, P635, DOI 10.1111/j.1365-2893.2012.01587.x; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bodeau S, 2013, THER DRUG MONIT, V35, P791, DOI 10.1097/FTD.0b013e3182966dee; Bourliere M, 2015, LANCET INFECT DIS, V15, P397, DOI 10.1016/S1473-3099(15)70050-2; Brochot E, 2015, THER DRUG MONIT, V37, P550, DOI 10.1097/FTD.0000000000000161; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Chan AHW, 2009, ANN PHARMACOTHER, V43, P2044, DOI 10.1345/aph.1M225; Craxi A, 2011, J HEPATOL, V55, P245, DOI 10.1016/j.jhep.2011.02.023; D'Avolio A, 2012, THER DRUG MONIT, V34, P165, DOI 10.1097/FTD.0b013e31824bf778; de Kanter CT, 2016, ANTIVIR THER, V21, P153, DOI 10.3851/IMP2994; de Kanter CTMM, 2015, ANTIVIR THER, V20, P515, DOI 10.3851/IMP2935; Eslam M, 2014, J HEPATOL, V61, P235, DOI 10.1016/j.jhep.2014.03.039; Ferenci P, 2014, NEW ENGL J MED, V370, P1983, DOI 10.1056/NEJMoa1402338; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Jen JF, 2000, THER DRUG MONIT, V22, P555, DOI 10.1097/00007691-200010000-00010; Jin RY, 2012, AM J GASTROENTEROL, V107, P1675, DOI 10.1038/ajg.2012.306; Kovari H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133879; Labarga P, 2012, J INFECT DIS, V206, P961, DOI 10.1093/infdis/jis449; Lindahl K, 2005, HEPATOLOGY, V41, P275, DOI 10.1002/hep.20563; Lindahl K, 2004, J VIRAL HEPATITIS, V11, P84, DOI 10.1046/j.1365-2893.2003.00475.x; Lindahl K, 2015, THER DRUG MONIT; Mangia A, 2013, WORLD J GASTROENTERO, V19, P8924, DOI 10.3748/wjg.v19.i47.8924; Maynard M, 2008, ANTIVIR THER, V13, P607; Nelson DR, 2015, HEPATOLOGY, V61, P1127, DOI 10.1002/hep.27726; Pawlotsky JM, 2015, J HEPATOL, V63, P199, DOI 10.1016/j.jhep.2015.03.025; Pedersen C, 2011, J VIRAL HEPATITIS, V18, P245, DOI 10.1111/j.1365-2893.2010.01303.x; Rau M, 2013, J HEPATOL, V58, P669, DOI 10.1016/j.jhep.2012.11.027; Reddy KR, 2015, HEPATOLOGY, V62, P79, DOI 10.1002/hep.27826; Rower JE, 2015, J ANTIMICROB CHEMOTH, V70, P2322, DOI 10.1093/jac/dkv122; Russmann S, 2006, CURR MED CHEM, V13, P3351, DOI 10.2174/092986706778773059; Sarrazin C, 2010, Z GASTROENTEROL, V48, P289, DOI 10.1055/s-0028-1110008; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P1181, DOI 10.1053/j.gastro.2010.06.016; Torres-Cornejo A, 2014, J VIRAL HEPATITIS, V21, P178, DOI 10.1111/jvh.12128; Wu LS, 2015, ANTIMICROB AGENTS CH, V59, P2179, DOI 10.1128/AAC.04618-14	34	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158512	10.1371/journal.pone.0158512	http://dx.doi.org/10.1371/journal.pone.0158512			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27388623	Green Published, gold			2022-12-27	WOS:000379811500025
J	Lecomte, X; Fedriani, JM; Caldeira, MC; Clemente, AS; Olmi, A; Bugalho, MN				Lecomte, Xavier; Fedriani, Jose M.; Caldeira, Maria C.; Clemente, Adelaide S.; Olmi, Alessandro; Bugalho, Miguel N.			Too Many Is Too Bad: Long-Term Net Negative Effects of High Density Ungulate Populations on a Dominant Mediterranean Shrub	PLOS ONE			English	Article							DEER CERVUS-ELAPHUS; SEED BANK DYNAMICS; REPRODUCTIVE-BIOLOGY; LARGE HERBIVORES; PLANT; RED; GROWTH; PRODUCTIVITY; DISPERSAL; MANAGEMENT	Plant-animal interactions imply costs and benefits with net balance depending on interacting species and ecological context. Ungulates, in particular, confer costs (e.g., plant leaf consumption, flower bud predation) and benefits (e.g., plant overcompensation, seed dispersal) to plants. Magnitude of costs and benefits may be altered by habitat management or ecological conditions favoring high density ungulate populations. Little is known however on whether plant costs or benefits predominate over the years, or the long-term outcomes of plant-animal interactions in habitat types sustaining high density ungulate populations. We investigated how high density ungulate populations alter plant costs and benefits by quantifying ungulate long-term effects on the shrub Cistus ladanifer (Cistaceae) individual size, seed weight and number, seed bank, and population density, through a 12-year ungulate exclusion experiment in a Mediterranean scrubland. We monitored plant size and flower buds in plants exposed or protected from ungulates and number of developed capsules and seeds consumed (potential seed dispersal) by ungulates during three reproductive seasons. We found that ungulates negatively affected shrub size and led to a dramatically decline of shrub reproductive structures and seed production, affecting the plant reproductive cycle. Number of buds was 27 times higher and number of developed seed 5 times higher in ungulate-excluded as compared to ungulate-exposed plots. After 9 years of ungulate exclusion, the C. ladanifer seed bank was 2.6 times higher in ungulate-excluded plots. The population density of C. ladanifer was 4 times higher in ungulate-excluded plots. Our long-term experiment showed that high density ungulate populations can alter plant-animal interactions by reducing plant benefits and increasing plant costs.	[Lecomte, Xavier; Caldeira, Maria C.] Univ Lisbon, Sch Agr, Forest Res Ctr CEF, Lisbon, Portugal; [Fedriani, Jose M.; Olmi, Alessandro; Bugalho, Miguel N.] Univ Lisbon, Sch Agr, Ctr Appl Ecol CEABN InBio, Lisbon, Portugal; [Fedriani, Jose M.] CSIC, Estn Biol Donana, Seville, Spain; [Clemente, Adelaide S.] Univ Lisbon, Fac Sci, Ctr Ecol Evolut & Environm Changes cE3c, Lisbon, Portugal; [Olmi, Alessandro] Univ Florence, Fac Agron Sci, Florence, Italy	Universidade de Lisboa; Forest Research Centre; Universidade de Lisboa; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Universidade de Lisboa; University of Florence	Lecomte, X (corresponding author), Univ Lisbon, Sch Agr, Forest Res Ctr CEF, Lisbon, Portugal.	xlecomte@isa.ulisboa.pt	Bugalho, Miguel N/J-2993-2013; Lecomte, Xavier/T-4036-2018; Fedriani, Jose/R-1328-2018; Caldeira, Maria/D-4107-2013	Bugalho, Miguel N/0000-0002-7081-657X; Lecomte, Xavier/0000-0003-3518-5490; Fedriani, Jose/0000-0002-1581-2621; Caldeira, Maria/0000-0002-3586-8526; Clemente, Adelaide/0000-0002-8961-4791; Bugalho, Miguel/0000-0001-9449-4424	Fundacao para a Ciencia e a Tecnologia [SFRH/BD/90753/2012, SFRH/BPD/87690/2012, IF/740/2014, BGCT/33418/2008, SFRH/BPD/90668/2012, IF/01171/2014, IF/00728/2013, UID/AGR/00239/2013]; Portuguese Foundation for Science and Technology (FCT)	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology)	This work was funded by the Fundacao para a Ciencia e a Tecnologia: SFRH/BD/90753/2012, SFRH/BPD/87690/2012 and IF/740/2014, BGCT/33418/2008, SFRH/BPD/90668/2012 and IF/01171/2014, IF/00728/2013, and UID/AGR/00239/2013.; We are grateful to M. Lopez Ramos for help during field work and to Fundacao da Casa de Braganca for granting access to Tapada Real de Vila Vicosa. The Portuguese Foundation for Science and Technology (FCT) funded research project and research grants.	Acevedo P, 2008, J ZOOL, V276, P37, DOI 10.1111/j.1469-7998.2008.00464.x; Albert A, 2015, ECOGRAPHY, V38, P440, DOI 10.1111/ecog.00709; ALLISON TD, 1990, OECOLOGIA, V83, P523, DOI 10.1007/BF00317204; ANDERSON JE, 1981, J RANGE MANAGE, V34, P25, DOI 10.2307/3898446; [Anonymous], 2006, SAS MIXED MODELS; Augustine DJ, 2004, J APPL ECOL, V41, P45, DOI 10.1111/j.1365-2664.2004.00864.x; Azorit C, 2012, ANIM PROD SCI, V52, P720, DOI 10.1071/AN12016; Baskin CC, 2014, SEEDS: ECOLOGY, BIOGEOGRAPHY, AND EVOLUTION OF DORMANCY AND GERMINATION, 2ND EDITION, P1, DOI 10.1016/B978-0-12-416677-6.00001-9; Bastida F, 2002, ANN BOT-LONDON, V89, P427, DOI 10.1093/aob/mcf065; Beauchamp VB, 2013, APPL VEG SCI, V16, P571, DOI 10.1111/avsc.12036; Bugalho MN, 2013, FOREST ECOL MANAG, V308, P90, DOI 10.1016/j.foreco.2013.07.036; Bugalho MN, 2011, FOREST ECOL MANAG, V261, P2133, DOI 10.1016/j.foreco.2011.03.009; Bugalho MN, 2011, FRONT ECOL ENVIRON, V9, P278, DOI 10.1890/100084; Bugalho MN, 2003, FOREST ECOL MANAG, V181, P23, DOI 10.1016/S0378-1127(03)00125-7; Bugalho MN, 2001, J ZOOL, V255, P285, DOI 10.1017/S0952836901001376; Caldeira MC, 2015, SCI REP-UK, V5, DOI 10.1038/srep15110; Chaideftou E, 2009, PLANT ECOL, V201, P255, DOI 10.1007/s11258-008-9548-1; Chamberlain SA, 2014, ECOL LETT, V17, P881, DOI 10.1111/ele.12279; Clemente AS, 2007, PLANT ECOL, V190, P175, DOI 10.1007/s11258-006-9199-z; Clemente AS, 1996, INT J WILDLAND FIRE, V6, P5, DOI 10.1071/WF9960005; Cote SD, 2004, ANNU REV ECOL EVOL S, V35, P113, DOI 10.1146/annurev.ecolsys.35.021103.105725; Delgado JA, 2001, ENVIRON EXP BOT, V46, P11, DOI 10.1016/S0098-8472(01)00076-4; Diaz-Villa MD, 2003, J VEG SCI, V14, P701, DOI 10.1111/j.1654-1103.2003.tb02202.x; DiTommaso A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091155; Fedriani JM, 2013, J ECOL, V101, P1581, DOI 10.1111/1365-2745.12146; Fedriani JM, 2012, ECOLOGY, V93, P575, DOI 10.1890/11-0429.1; Fornara DA, 2007, ECOLOGY, V88, P200, DOI 10.1890/0012-9658(2007)88[200:BLROAN]2.0.CO;2; Frerker K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115843; Goheen JR, 2007, J ECOL, V95, P129, DOI 10.1111/j.1365-2745.2006.01196.x; Gomez JM, 2005, ECOL MONOGR, V75, P231, DOI 10.1890/04-0722; Gordon IJ, 2004, J APPL ECOL, V41, P1021, DOI 10.1111/j.0021-8901.2004.00985.x; Guzman B, 2009, J BIOGEOGR, V36, P954, DOI 10.1111/j.1365-2699.2008.02040.x; Haarmeyer DH, 2010, BIOL CONSERV, V143, P588, DOI 10.1016/j.biocon.2009.11.008; Harrison RD, 2013, ECOL LETT, V16, P687, DOI 10.1111/ele.12102; HOFMANN RR, 1989, OECOLOGIA, V78, P443, DOI 10.1007/BF00378733; Holland JN, 2009, ECOL LETT, V12, P1357, DOI 10.1111/j.1461-0248.2009.01390.x; Huffman DW, 2003, J RANGE MANAGE, V56, P358, DOI 10.2307/4004039; Iravani M, 2011, BASIC APPL ECOL, V12, P505, DOI 10.1016/j.baae.2011.07.004; JANZEN DH, 1984, AM NAT, V123, P338, DOI 10.1086/284208; Kay CE, 1995, BROWS NAT UNG EFF SH; Kiers ET, 2010, ECOL LETT, V13, P1459, DOI 10.1111/j.1461-0248.2010.01538.x; MALO JE, 1995, OECOLOGIA, V104, P246, DOI 10.1007/BF00328589; Maron JL, 2014, J ECOL, V102, P1485, DOI 10.1111/1365-2745.12305; Mathisen KM, 2010, J VEG SCI, V21, P705, DOI 10.1111/j.1654-1103.2010.01180.x; Miranda M, 2011, PLANT BIOLOGY, V13, P160, DOI 10.1111/j.1438-8677.2009.00316.x; Oba G, 2000, ECOL APPL, V10, P1133, DOI 10.1890/1051-0761(2000)010[1133:CGOTAD]2.0.CO;2; OCONNOR TG, 1992, J APPL ECOL, V29, P247, DOI 10.2307/2404367; Paige KN, 1999, OECOLOGIA, V118, P316, DOI 10.1007/s004420050732; Palmer TM, 2008, SCIENCE, V319, P192, DOI 10.1126/science.1151579; Papanastasis VP, 2008, ANIM FEED SCI TECH, V140, P1, DOI 10.1016/j.anifeedsci.2007.03.012; Paton D, 1998, J ARID ENVIRON, V38, P221, DOI 10.1006/jare.1997.0328; Pringle RM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0390; Roberts H. A., 1981, Advances in Applied Biology, V6, P1; Rooney TP, 2003, FOREST ECOL MANAG, V181, P165, DOI 10.1016/S0378-1127(03)00130-0; Sankaran M, 2013, J ECOL, V101, P1389, DOI 10.1111/1365-2745.12147; Schmitz OJ, 2000, AM NAT, V155, P141, DOI 10.1086/303311; Seligman N G, 1996, ECOLOGY MANAGEMENT G, P359; Sternberg M, 2003, J VEG SCI, V14, P375, DOI 10.1658/1100-9233(2003)014[0375:EOGOSS]2.0.CO;2; Stoner KE, 2007, BIOTROPICA, V39, P385, DOI 10.1111/j.1744-7429.2007.00291.x; TALAVERA S, 1993, PLANT SYST EVOL, V186, P123, DOI 10.1007/BF00940792; Thompson J., 2013, RELENTLESS EVOLUTION, DOI DOI 10.7208/CHICAGO/9780226018898.001.0001; Thompson JD., 2005, PLANT EVOLUTION MEDI, DOI DOI 10.1093/ACPROF:OSO/9780198515340.001.0001; Traveset A, 2014, ANNU REV ECOL EVOL S, V45, P89, DOI 10.1146/annurev-ecolsys-120213-091857; VARGAS JD, 1995, AGROFOREST SYST, V29, P77, DOI 10.1007/BF00711283; Webster CR, 2008, OECOLOGIA, V157, P497, DOI 10.1007/s00442-008-1085-z; White MA, 2012, FOREST ECOL MANAG, V269, P222, DOI 10.1016/j.foreco.2011.12.043; Willan R. L., 1991, GUIDE FOREST SEED HA; Zar J. H., 1996, BIOSTATISTICAL ANAL	68	12	12	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158139	10.1371/journal.pone.0158139	http://dx.doi.org/10.1371/journal.pone.0158139			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27387134	Green Published, gold			2022-12-27	WOS:000379811500014
J	Saez-Lopez, E; Cossa, A; Benmessaoud, R; Madrid, L; Moraleda, C; Villanueva, S; Tligui, H; Moiane, B; Alami, H; Massora, S; Bezad, R; Mandomando, I; Bosch, J; Vila, J; Bassat, Q; Soto, SM				Saez-Lopez, Emma; Cossa, Anelsio; Benmessaoud, Rachid; Madrid, Lola; Moraleda, Cinta; Villanueva, Sonia; Tligui, Houssain; Moiane, Benilde; Alami, Hassan; Massora, Sergio; Bezad, Rachid; Mandomando, Inacio; Bosch, Jordi; Vila, Jordi; Bassat, Quique; Soto, Sara M.			Characterization of Vaginal Escherichia coli Isolated from Pregnant Women in Two Different African Sites	PLOS ONE			English	Article							STRAINS; COLONIZATION; PREVALENCE; COMMENSAL; RESISTANCE; SEROTYPES; DIARRHEA	The relevance of vaginal colonization of pregnant women by Escherichia coli is poorly understood, despite these strains sharing a similar virulence profile with other extraintestinal pathogenic E. coli producing severe obstetric and neonatal infections. We characterized the epidemiology, antimicrobial susceptibility and virulence profiles of 84 vaginal E. coli isolates from pregnant women from Rabat (Morocco) and Manhica (Mozambique), two very distinct epidemiological settings. Low levels of antimicrobial resistance were observed to all drugs tested, except for trimethoprim-sulfamethoxazole in Manhica, where this drug is extensively used as prophylaxis for opportunistic HIV infections. The most prevalent virulence factors were related to iron acquisition systems. Phylogroup A was the most common in Rabat, while phylogroups E and non-typeable were the most frequent in Manhica. Regardless of the apparently "low virulence" of these isolates, the frequency of infections is higher and the outcomes more devastating in constrained-resources conditions, especially among pregnant women and newborns.	[Saez-Lopez, Emma; Villanueva, Sonia; Bosch, Jordi; Vila, Jordi; Soto, Sara M.] Univ Barcelona, Hosp Clin, Dept Clin Microbiol, Barcelona, Spain; [Saez-Lopez, Emma; Benmessaoud, Rachid; Madrid, Lola; Moraleda, Cinta; Villanueva, Sonia; Bosch, Jordi; Vila, Jordi; Bassat, Quique; Soto, Sara M.] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain; [Cossa, Anelsio; Madrid, Lola; Moiane, Benilde; Massora, Sergio; Mandomando, Inacio; Bassat, Quique] CISM, Maputo, Mozambique; [Tligui, Houssain] Univ Mohammed V Souissi, Fac Med & Pharm, Equipe Rech Sante & Nutr Couple Mere Enfant, Rabat, Morocco; [Alami, Hassan; Bezad, Rachid] Univ Mohammed V Souissi, Equipe Rech Perinatol, Rabat, Morocco	University of Barcelona; Hospital Clinic de Barcelona; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Centro de Investigacao em Saude de Manhica; Mohammed First University of Oujda; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat; Mohammed V University in Rabat	Soto, SM (corresponding author), Univ Barcelona, Hosp Clin, Dept Clin Microbiol, Barcelona, Spain.; Soto, SM (corresponding author), Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain.	sara.soto@isglobal.org	Vila, Jordi/P-3613-2016; Mandomando, Inacio/ABD-8007-2020; Soto, Sara M/J-6297-2012; Bassat, Quique/P-2341-2016; Sáez-López, Emma/AAA-8170-2020	Vila, Jordi/0000-0002-8025-3926; Mandomando, Inacio/0000-0002-1078-2187; Soto, Sara M/0000-0002-9507-105X; Bassat, Quique/0000-0003-0875-7596; Moraleda, Cinta/0000-0002-8335-903X; Madrid, Lola/0000-0003-4034-6033; Bosch, Jordi/0000-0001-9263-3371; Saez-Lopez, Emma/0000-0001-8313-3017	Instituto de Salud Carlos III [CM13/00260, CP11/00269, PI10/01579, PI13/00127]; European Directorate-General for Research and Innovation [612216]; Spanish Agency of International Cooperation and Development (AECID) [07-CO1-021]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Directorate-General for Research and Innovation; Spanish Agency of International Cooperation and Development (AECID)	This study was supported by the Instituto de Salud Carlos III under the grants CM13/00260, CP11/00269, PI10/01579 and PI13/00127; the European Directorate-General for Research and Innovation Grant Agreement 612216; the Spanish Agency of International Cooperation and Development (AECID) 07-CO1-021. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barman N., 2014, CLIN MICROBIOL OPEN, P3; Bergstrom S, 2003, J NUTR, V133, p1656S, DOI 10.1093/jn/133.5.1656S; Birosova E, 2004, CLIN MICROBIOL INFEC, V10, P569, DOI 10.1111/j.1469-0691.2004.00922.x; Breman JG, 2016, MALARIA ENDEMIC AREA; Chintu C, 2004, LANCET, V364, P1865, DOI 10.1016/S0140-6736(04)17442-4; Chongsomchai C, ANTIBIOTIC REGIMENS; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; Clinical and Laboratory Standards Institute (CLSI), 2014, M100S24 CLSI S; Cook S W, 2001, Infect Dis Obstet Gynecol, V9, P203, DOI 10.1155/S1064744901000333; Duriez P, 2001, MICROBIOL-SGM, V147, P1671, DOI 10.1099/00221287-147-6-1671; Villar HE, 2013, J CHEMOTHERAPY, V25, P324, DOI 10.1179/1973947813Y.0000000081; Edwards RK, 2005, OBSTET GYN CLIN N AM, V32, P287, DOI 10.1016/j.ogc.2004.12.002; Goldenberg RL, 2010, LANCET, V375, P1482, DOI 10.1016/S0140-6736(09)61712-8; Gonzalez R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132053; Gordon DM, 2008, ENVIRON MICROBIOL, V10, P2484, DOI 10.1111/j.1462-2920.2008.01669.x; Guiral E, 2015, J CLIN MICROBIOL, V53, P1745, DOI 10.1128/JCM.00487-15; Guiral E, 2011, FEMS MICROBIOL LETT, V314, P170, DOI 10.1111/j.1574-6968.2010.02160.x; Hemati Z, 2014, ADV CLIN EXP MED, V23, P523, DOI 10.17219/acem/37217; Iranpour D, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/846219; Iregbu K. C., 2013, African Journal of Clinical and Experimental Microbiology, V14, P95; Johnson JR, 2002, J LAB CLIN MED, V139, P155, DOI 10.1067/mlc.2002.121550; KORHONEN TK, 1985, INFECT IMMUN, V48, P486, DOI 10.1128/IAI.48.2.486-491.1985; Krohn MA, 1997, J INFECT DIS, V175, P606, DOI 10.1093/infdis/175.3.606; Lescat M, 2013, ENV MICROBIOL REP, V5, P49, DOI 10.1111/j.1758-2229.2012.00374.x; Mandomando I, 2010, AM J TROP MED HYG, V83, P152, DOI 10.4269/ajtmh.2010.09-0578; Mandomando IM, 2007, AM J TROP MED HYG, V76, P522, DOI 10.4269/ajtmh.2007.76.522; Mentr F, 2014, CLIN MICROBIOL INFEC, V20, P01035; Mobley HLT, 2016, PATHOGENS, V5, DOI 10.3390/pathogens5010001; Moreno E, 2006, J ANTIMICROB CHEMOTH, V57, P204, DOI 10.1093/jac/dki468; Motayo BO, 2012, J MICROBIOL RES, V2, P141, DOI [10.5923/j.microbiology.20120205.05, DOI 10.5923/J.MICROBIOLOGY.20120205.05]; Mshana SE, 2013, ANN CLIN MICROB ANTI, V12, DOI 10.1186/1476-0711-12-28; Obata-Yasuoka M, 2002, MICROBIOL-SGM, V148, P2745, DOI 10.1099/00221287-148-9-2745; PERCIVALSMITH R, 1983, CONTRACEPTION, V27, P497, DOI 10.1016/0010-7824(83)90046-X; Pitout JDD, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00009; Pons MJ, 2015, J GLOB ANTIMICROB RE, V3, P19, DOI 10.1016/j.jgar.2015.01.004; Radouani Ma, 2014, J INFECT DIS THER, V02, P2, DOI [10.4172/2332-0877.1000167, DOI 10.4172/2332-0877.1000167]; Rani S, 2014, ASIAN J MED SCI, V5, P58, DOI [10.3126/ajms.v5i4.9889, DOI 10.3126/AJMS.V5I4.9889]; Russo TA, 2000, J INFECT DIS, V181, P1753, DOI 10.1086/315418; Sabate M, 2006, CLIN MICROBIOL INFEC, V12, P880, DOI 10.1111/j.1469-0691.2006.01461.x; Saez-Lopez E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146531; Tameliene R, 2012, MEDICINA-LITHUANIA, V48, P71, DOI 10.3390/medicina48020013; Watt S, 2003, J CLIN MICROBIOL, V41, P1929, DOI 10.1128/JCM.41.5.1929-1935.2003; World Health Organization, 2013, POCK BOOK HOSP CAR C; Yusuf L, ANTIBIOTIC REGIMENS	44	17	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158695	10.1371/journal.pone.0158695	http://dx.doi.org/10.1371/journal.pone.0158695			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27387665	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000379811500038
J	Kojima, T; Kunitake, E; Ihara, K; Kobayashi, T; Nakano, H				Kojima, Takaaki; Kunitake, Emi; Ihara, Kunio; Kobayashi, Tetsuo; Nakano, Hideo			A Robust Analytical Pipeline for Genome-Wide Identification of the Genes Regulated by a Transcription Factor: Combinatorial Analysis Performed Using gSELEX-Seq and RNA-Seq	PLOS ONE			English	Article							DNA-BINDING SPECIFICITY; ASPERGILLUS-NIDULANS; EXPONENTIAL ENRICHMENT; SYSTEMATIC EVOLUTION; AMYLASE GENES; SELEX; AMYR; NIGER; EXPRESSION; PROMOTER	For identifying the genes that are regulated by a transcription factor (TF), we have established an analytical pipeline that combines genomic systematic evolution of ligands by exponential enrichment (gSELEX)-Seq and RNA-Seq. Here, SELEX was used to select DNA fragments from an Aspergillus nidulans genomic library that bound specifically to AmyR, a TF from A. nidulans. High-throughput sequencing data were obtained for the DNAs enriched through the selection, following which various in silico analyses were performed. Mapping reads to the genome revealed the binding motifs including the canonical AmyR-binding motif, CGGN(8)CGG, as well as the candidate promoters controlled by AmyR. In parallel, differentially expressed genes related to AmyR were identified by using RNA-Seq analysis with samples from A. nidulans WT and amyR deletant. By obtaining the intersecting set of genes detected using both gSELEX-Seq and RNA-Seq, the genes directly regulated by AmyR in A. nidulans can be identified with high reliability. This analytical pipeline is a robust platform for comprehensive genome-wide identification of the genes that are regulated by a target TF.	[Kojima, Takaaki; Nakano, Hideo] Nagoya Univ, Grad Sch Bioagr Sci, Dept Bioengn Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan; [Kunitake, Emi; Kobayashi, Tetsuo] Nagoya Univ, Grad Sch Bioagr Sci, Dept Biol Mech & Funct, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan; [Ihara, Kunio] Nagoya Univ, Ctr Gene Res, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan	Nagoya University; Nagoya University; Nagoya University	Kojima, T; Nakano, H (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Dept Bioengn Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	kojimat@nuagr1.agr.nagoya-u.ac.jp; hnakano@agr.nagoya-u.ac.jp	IHARA, Kunio/D-1952-2011; Kojima, Takaaki/H-6802-2017; Kobayashi, Tetsuo/I-6901-2014	Kobayashi, Tetsuo/0000-0002-4008-454X	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) [22760605, 23360367]; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry [26011A]	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry	This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) https://www.jsps.go.jp/english/e-grants/ 22760605 to TK, 23360367 to HN and by the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry http://www.maff.go.jp/e/index.html, 26011A to TK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Norihito Nakamichi of Nagoya University for helpful advice on bioinformatics analysis. This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) [22760605 and 23360367] and the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry [26011A].	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cerqueira GC, 2014, NUCLEIC ACIDS RES, V42, pD705, DOI 10.1093/nar/gkt1029; Coutinho PM, 2009, FUNGAL GENET BIOL, V46, pS161, DOI 10.1016/j.fgb.2008.07.020; Cultrone A, 2005, MOL MICROBIOL, V57, P276, DOI 10.1111/j.1365-2958.2005.04686.x; DelSorbo G, 1997, MOL GEN GENET, V254, P417, DOI 10.1007/s004380050434; dEnfert C, 1997, MOL MICROBIOL, V24, P203, DOI 10.1046/j.1365-2958.1997.3131693.x; Dittmar KA, 2012, MOL CELL BIOL, V32, P1468, DOI 10.1128/MCB.06536-11; Dror I, 2015, GENOME RES, V25, P1268, DOI 10.1101/gr.184671.114; DYER PS, 1993, PHYSIOL MOL PLANT P, V43, P403, DOI 10.1006/pmpp.1993.1068; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Gu GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076109; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Ito T, 2004, BIOSCI BIOTECH BIOCH, V68, P1906, DOI 10.1271/bbb.68.1906; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Jolma A, 2010, GENOME RES, V20, P861, DOI 10.1101/gr.100552.109; Kojima T, 2010, J BIOSCI BIOENG, V109, P519, DOI 10.1016/j.jbiosc.2009.11.024; Levin AM, 2007, EUKARYOT CELL, V6, P2311, DOI 10.1128/EC.00244-07; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nakamura T, 2006, BIOSCI BIOTECH BIOCH, V70, P2363, DOI 10.1271/bbb.50694; Oberegger H, 2002, APPL ENVIRON MICROB, V68, P5769, DOI 10.1128/AEM.68.11.5769-5772.2002; OLIPHANT AR, 1989, MOL CELL BIOL, V9, P2944, DOI 10.1128/MCB.9.7.2944; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; PAPOULAS O, 1992, J BIOL CHEM, V267, P10470; Petersen KL, 1999, MOL GEN GENET, V262, P668, DOI 10.1007/s004380051129; Rahmatallah Y, 2016, BRIEF BIOINFORM, V17, P393, DOI 10.1093/bib/bbv069; Reiss DJ, 2011, J BIOL CHEM, V286, P44726, DOI 10.1074/jbc.M111.290684; Riley TR, 2014, METHODS MOL BIOL, V1196, P255, DOI 10.1007/978-1-4939-1242-1_16; Roulet E, 2002, NAT BIOTECHNOL, V20, P831, DOI 10.1038/nbt718; ROWLANDS RT, 1973, MOL GEN GENET, V126, P201, DOI 10.1007/BF00267531; Shimada T, 2005, GENES CELLS, V10, P907, DOI 10.1111/j.1365-2443.2005.00888.x; Singer BS, 1997, NUCLEIC ACIDS RES, V25, P781, DOI 10.1093/nar/25.4.781; Slattery M, 2011, CELL, V147, P1270, DOI 10.1016/j.cell.2011.10.053; Tani S, 2001, BIOSCI BIOTECH BIOCH, V65, P1568, DOI 10.1271/bbb.65.1568; Tani S, 2001, CURR GENET, V39, P10, DOI 10.1007/s002940000175; Todeschini AL, 2014, TRENDS GENET, V30, P211, DOI 10.1016/j.tig.2014.04.002; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; vanKuyk PA, 2012, APPL MICROBIOL BIOT, V93, P285, DOI 10.1007/s00253-011-3550-6; Wang B, 2010, NUCLEIC ACIDS RES, V38, P5075, DOI 10.1093/nar/gkq256; Wang JK, 2011, J ENDOCRINOL, V210, P15, DOI 10.1530/JOE-11-0010; Wang PH, 2012, BIOSCI BIOTECH BIOCH, V76, P1128, DOI 10.1271/bbb.110949; Wong D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r70; Yuan XL, 2008, MOL GENET GENOMICS, V279, P545, DOI 10.1007/s00438-008-0332-7; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zykovich A, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp802	45	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159011	10.1371/journal.pone.0159011	http://dx.doi.org/10.1371/journal.pone.0159011			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27411092	gold, Green Published, Green Submitted			2022-12-27	WOS:000379508300048
J	Qu, YJ; Liu, XQ; Zhuang, J; Chen, GC; Mai, JZ; Guo, XL; Ou, YQ; Chen, JM; Gong, W; Gao, XM; Wu, Y; Nie, ZQ				Qu, Yanji; Liu, Xiaoqing; Zhuang, Jian; Chen, Guanchun; Mai, Jinzhuang; Guo, Xiaoling; Ou, Yanqiu; Chen, Jimei; Gong, Wei; Gao, Xiangmin; Wu, Yong; Nie, Zhiqiang			Incidence of Congenital Heart Disease: The 9-Year Experience of the Guangdong Registry of Congenital Heart Disease, China	PLOS ONE			English	Article							BIRTH-DEFECTS SURVEILLANCE; UNITED-STATES; PREVALENCE; MORTALITY; MALFORMATIONS; EPIDEMIOLOGY; CHILDREN; ENGLAND; TRENDS	There are 16.5 million newborns in China annually. However, the incidence of congenital heart disease (CHD) has not been evaluated. In 2004, we launched an active province-wide hospital-based CHD registry in the Guangdong Province of southern China. In this study, we examined the incidence of CHD and its subtypes from 2004 to 2012 and compared our findings to the literature. Our results indicate there is an increasing trend of CHD incidence. The increase in incidence occurred mainly for single lesion and the most common subtypes (e.g., ventricular or atrial septal defect, patent ductus arteriosus). There were no increases found for multiple lesions or more complex subtypes. The proportion of CHD cases that were detected early (e.g., 1 week) increased over time. The incidence of CHD stabilized in 2010-2012 with the average cumulative incidences of 9.7, 9.9, and 11.1 per 1,000 live births at 1 week, 1 month, and 1 year, respectively. The incidences of CHD subtypes were comparable with recent international results. The data did not support previous reports that Asian children have a higher incidence of pulmonary outflow obstructions and lower incidence of transposition of the great arteries. However, there was a lower incidence of left ventricular outflow tract obstructions observed in our series. The increase in CHD incidence observed over time was due to improved detection and diagnosis. The true incidence of CHD in China was approximately 11.1 per 1,000 live births, which is higher than previously reported.	[Qu, Yanji; Liu, Xiaoqing; Mai, Jinzhuang; Ou, Yanqiu; Gao, Xiangmin; Wu, Yong; Nie, Zhiqiang] Guangdong Acad Med Sci, Guangdong Gen Hosp, Guangdong Prov Key Lab South China Struct Heart D, Dept Cardiovasc Dis Epidemiol,Guangdong Cardiovas, Guangzhou, Guangdong, Peoples R China; [Zhuang, Jian; Chen, Jimei] Guangdong Acad Med Sci, Guangdong Gen Hosp, Guangdong Prov Key Lab South China Struct Heart D, Dept Cardiac Surg,Guangdong Cardiovasc Inst, Guangzhou, Guangdong, Peoples R China; [Chen, Guanchun] Dongguan Houjie Hosp, Dept Ultrasound, Dongguan, Guangdong, Peoples R China; [Guo, Xiaoling] Boai Hosp Zhongshan, Dept Pediat Cardiol, Zhongshan, Guangdong, Peoples R China; [Gong, Wei] Hexian Mem Hosp, Dept Ultrasound, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Medical Sciences & Guangdong General Hospital; Guangdong Academy of Medical Sciences & Guangdong General Hospital	Zhuang, J (corresponding author), Guangdong Acad Med Sci, Guangdong Gen Hosp, Guangdong Prov Key Lab South China Struct Heart D, Dept Cardiac Surg,Guangdong Cardiovasc Inst, Guangzhou, Guangdong, Peoples R China.	drzhuangjian5413@163.com	Ou, Yanqiu/AAJ-6251-2021; Qu, Yanji/GSN-4453-2022	Zhiqiang, Nie/0000-0001-7642-3286	National 12th Five-Year Support Projects of China (Ministry of national science and technology, China) [2011BAI11B22, 2012BAI04B05]; National Natural Science Foundation of China (Ministry of national science and technology, China) [U1401255]; Guangdong International Cooperative Project, China (Science and Technology Department of Guangdong Province) [2014A050503048]	National 12th Five-Year Support Projects of China (Ministry of national science and technology, China); National Natural Science Foundation of China (Ministry of national science and technology, China); Guangdong International Cooperative Project, China (Science and Technology Department of Guangdong Province)	This research was funded by the National 12th Five-Year Support Projects of China (funder: Ministry of national science and technology, China, no. 2011BAI11B22, 2012BAI04B05, received by JZ), National Natural Science Foundation of China (funder: Ministry of national science and technology, China, no. U1401255, received by JZ), and Guangdong International Cooperative Project, China (funder: Science and Technology Department of Guangdong Province no. 2014A050503048, received by XL). All the funders had role in the study design, data collection and analysis, decision to publish.	[Anonymous], 1980, Pediatrics, V65, P375; Bernier Pierre-Luc, 2010, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, V13, P26, DOI 10.1053/j.pcsu.2010.02.005; Billett J, 2008, HEART, V94, P342, DOI 10.1136/hrt.2006.113787; Botto LD, 2006, AM J PUBLIC HEALTH, V96, P774, DOI 10.2105/AJPH.2004.057760; Chen XH, 2011, CHINESE J EUGENICS G, V19, P101; Dadvand P, 2009, PAEDIATR PERINAT EP, V23, P58, DOI 10.1111/j.1365-3016.2008.00987.x; Dai L, 2011, WORLD J PEDIATR, V7, P302, DOI 10.1007/s12519-011-0326-0; Dolk H, 2009, SPECIAL REPORT CONGE; Dolk H, 2011, CIRCULATION, V123, P841, DOI 10.1161/CIRCULATIONAHA.110.958405; Egbe A, 2015, CONGENIT HEART DIS, V10, P43, DOI 10.1111/chd.12176; FERENCZ C, 1985, AM J EPIDEMIOL, V121, P31, DOI 10.1093/oxfordjournals.aje.a113979; FIXLER DE, 1990, CIRCULATION, V81, P137, DOI 10.1161/01.CIR.81.1.137; Gilboa SM, 2010, CIRCULATION, V122, P2254, DOI 10.1161/CIRCULATIONAHA.110.947002; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Hoffman JI, 2013, CARDIOVASC J AFR, V24, P141, DOI 10.5830/CVJA-2013-028; Hu Z, 2014, J THORAC CARDIOV SUR, V148, P596, DOI 10.1016/j.jtcvs.2013.08.067; Ionescu-Ittu R, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1673; Jacobs EGJ, 2000, PEDIATR CARDIOL, V21, P148, DOI 10.1007/s002469910025; Khoshnood B, 2013, J PEDIATR-US, V162, P108, DOI 10.1016/j.jpeds.2012.06.035; Leirgul E, 2014, AM HEART J, V168, P956, DOI 10.1016/j.ahj.2014.07.030; Li S, 1999, CHIN J PEDIAT, V37, P375; Liu KB, 2013, CHINESE J EUGENICS G, V21, P127; Liu WT, 1995, CHIN J PEDIAT, V33, P347; Mai CT, 2015, J PUBLIC HLTH MANAG; Mai Q, 2006, MATERN CHILD HLTH J, V21, P2715; Oyen N, 2009, AM HEART J, V157, P467, DOI 10.1016/j.ahj.2008.10.017; Pradat P, 2003, PEDIATR CARDIOL, V24, P195, DOI 10.1007/s00246-002-9401-6; Reller MD, 2008, J PEDIATR-US, V153, P807, DOI 10.1016/j.jpeds.2008.05.059; Rudan I, 2010, LANCET, V375, P1083, DOI 10.1016/S0140-6736(10)60060-8; Song Y, 2002, CHINESE J EUGENICS G, V10, P96; van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025; Wren C, 2000, HEART, V83, P414, DOI 10.1136/heart.83.4.414; Wu L, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-152; Wu MH, 2010, J PEDIATR-US, V156, P782, DOI 10.1016/j.jpeds.2009.11.062; Xia JH, 2005, CHINESE J CHILD PROT, V13, P443; Yang JF, 2007, CHINESE J NEONATES, V22, P72; Yang XY, 2009, CHINESE MED J-PEKING, V122, P1128, DOI 10.3760/cma.j.issn.0366-6999.2009.10.002; Yang XY, 2009, CHINESE J EUGENICS G, V9, P416; 朱军, 2004, [四川大学学报. 医学版, Journal of West China University of Medical Sciences], V35, P875	39	59	78	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159257	10.1371/journal.pone.0159257	http://dx.doi.org/10.1371/journal.pone.0159257			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27409588	Green Published, gold, Green Submitted			2022-12-27	WOS:000379508300072
J	Forstneric, V; Ivicak-Kocjan, K; Ljubetic, A; Jerala, R; Bencina, M				Forstneric, Vida; Ivicak-Kocjan, Karolina; Ljubetic, Ajasja; Jerala, Roman; Bencina, Mojca			Ditsinctive Recognition of Flagellin by Human and Mouse Toll-Like Receptor 5	PLOS ONE			English	Article							BACTERIAL FLAGELLIN; MOLECULAR-DYNAMICS; PROTEIN STRUCTURES; STRUCTURAL BASIS; ACTIVATION; CELLS; TLR5; TOLL-LIKE-RECEPTOR-5; SEQUENCE; PROTOFILAMENT	Toll-like receptor 5 (TLR5) is a receptor of the innate immune system that recognizes flagellin from certain bacterial species and triggers an inflammatory response. The Salmonella dublin flagellin in complex with zebrafish TLR5 has been crystallized previously. In the present study, we extrapolate the structure of this complex using structure-guided mutagenesis to determine the recognition modes of human and mouse TLR5 receptors and demonstrate species-specific differences in flagellin recognition. In general, the recognition mode of the mouse receptor can be said to be more robust in comparison to that of the human receptor. All-atom molecular dynamics simulation showed differences between the two receptors within the primary binding region. Using a functional motility assay, we show that although the highly conserved area of the flagellin analyzed in this study encompasses key structural requirements for flagella formation, a direct correlation between immune recognition and structure on the level of amino acid residues is not observed.	[Forstneric, Vida; Ivicak-Kocjan, Karolina; Ljubetic, Ajasja; Jerala, Roman; Bencina, Mojca] Natl Inst Chem, Dept Synthet Biol & Immunol, Ljubljana, Slovenia; [Jerala, Roman; Bencina, Mojca] Ctr Excellence EN FIST, Ljubljana, Slovenia	National Institute of Chemistry - Slovenia	Jerala, R; Bencina, M (corresponding author), Natl Inst Chem, Dept Synthet Biol & Immunol, Ljubljana, Slovenia.; Jerala, R; Bencina, M (corresponding author), Ctr Excellence EN FIST, Ljubljana, Slovenia.	roman.jerala@ki.si; mojca.bencina@ki.si		Ljubetic, Ajasja/0000-0002-2171-1579	state budget by the Slovenian Research Agency; EN-FIST Centre of Excellence	state budget by the Slovenian Research Agency(Slovenian Research Agency - Slovenia); EN-FIST Centre of Excellence	The authors acknowledge the financial support from the state budget by the Slovenian Research Agency (VF, KIK, AL, MB, RJ), EN-FIST Centre of Excellence (RJ, MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo R, 2004, AM J RESP CELL MOL, V30, P627, DOI 10.1165/rcmb.2003-0260OC; Akashi S, 2001, INT IMMUNOL, V13, P1595, DOI 10.1093/intimm/13.12.1595; Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102; Andersen-Nissen E, 2007, J EXP MED, V204, P393, DOI 10.1084/jem.20061400; Beatson SA, 2006, TRENDS MICROBIOL, V14, P151, DOI 10.1016/j.tim.2006.02.008; Blohmke CJ, 2008, J IMMUNOL, V180, P7764, DOI 10.4049/jimmunol.180.11.7764; Buck M, 2006, BIOPHYS J, V90, pL36, DOI 10.1529/biophysj.105.078154; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Eaves-Pyles T, 2001, J IMMUNOL, V166, P1248, DOI 10.4049/jimmunol.166.2.1248; Eaves-Pyles TD, 2001, J IMMUNOL, V167, P7009, DOI 10.4049/jimmunol.167.12.7009; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Grabiec A, 2004, J BIOL CHEM, V279, P48004, DOI 10.1074/jbc.M405311200; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Ivicak-Kocjan K, 2013, BIOCHEM BIOPH RES CO, V435, P40, DOI 10.1016/j.bbrc.2013.04.030; Keestra AM, 2008, MOL IMMUNOL, V45, P1298, DOI 10.1016/j.molimm.2007.09.013; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Kulka M, 2004, J ALLERGY CLIN IMMUN, V114, P174, DOI 10.1016/j.jaci.2004.03.049; Kurt-Jones EA, 2004, J ENDOTOXIN RES, V10, P419, DOI 10.1179/096805104225006516; McGibbon RT, 2015, BIOPHYS J, V109, P1528, DOI 10.1016/j.bpj.2015.08.015; Means TK, 2003, J IMMUNOL, V170, P5165, DOI 10.4049/jimmunol.170.10.5165; Murthy KGK, 2004, J BIOL CHEM, V279, P5667, DOI 10.1074/jbc.M307759200; Ohto U, 2015, NATURE, V520, P702, DOI 10.1038/nature14138; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pohar J, 2015, J IMMUNOL, V195, P4396, DOI 10.4049/jimmunol.1500600; Pohar J, 2015, J IMMUNOL, V194, P3901, DOI 10.4049/jimmunol.1402755; Rhee SH, 2005, P NATL ACAD SCI USA, V102, P13610, DOI 10.1073/pnas.0502174102; Samatey FA, 2001, NATURE, V410, P331, DOI 10.1038/35066504; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; Taylor DN, 2012, VACCINE, V30, P5761, DOI 10.1016/j.vaccine.2012.06.086; Treanor JJ, 2010, VACCINE, V28, P8268, DOI 10.1016/j.vaccine.2010.10.009; Turley CB, 2011, VACCINE, V29, P5145, DOI 10.1016/j.vaccine.2011.05.041; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; Vergara-Jaque A, 2013, J PHYS CHEM B, V117, P6801, DOI 10.1021/jp4000363; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830; Yoon SI, 2012, SCIENCE, V335, P859, DOI 10.1126/science.1215584	41	16	20	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158894	10.1371/journal.pone.0158894	http://dx.doi.org/10.1371/journal.pone.0158894			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391968	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400153
J	Gilkey, MB; McRee, AL; Magnus, BE; Reiter, PL; Dempsey, AF; Brewer, NT				Gilkey, Melissa B.; McRee, Annie-Laurie; Magnus, Brooke E.; Reiter, Paul L.; Dempsey, Amanda F.; Brewer, Noel T.			Vaccination Confidence and Parental Refusal/Delay of Early Childhood Vaccines	PLOS ONE			English	Article							DECISION-MAKING; IMMUNIZATION; EXEMPTIONS; PERTUSSIS; HESITANCY; PROVIDER; STATE	Objective To support efforts to address parental hesitancy towards early childhood vaccination, we sought to validate the Vaccination Confidence Scale using data from a large, population-based sample of U.S. parents. Methods We used weighted data from 9,354 parents who completed the 2011 National Immunization Survey. Parents reported on the immunization history of a 19- to 35-month-old child in their households. Healthcare providers then verified children's vaccination status for vaccines including measles, mumps, and rubella (MMR), varicella, and seasonal flu. We used separate multivariable logistic regression models to assess associations between parents' mean scores on the 8-item Vaccination Confidence Scale and vaccine refusal, vaccine delay, and vaccination status. Results A substantial minority of parents reported a history of vaccine refusal (15%) or delay (27%). Vaccination confidence was negatively associated with refusal of any vaccine (odds ratio [OR] = 0.58, 95% confidence interval [CI], 0.54-0.63) as well as refusal of MMR, varicella, and flu vaccines specifically. Negative associations between vaccination confidence and measures of vaccine delay were more moderate, including delay of any vaccine (OR = 0.81, 95% CI, 0.76-0.86). Vaccination confidence was positively associated with having received vaccines, including MMR (OR = 1.53, 95% CI, 1.40-1.68), varicella (OR = 1.54, 95% CI, 1.42-1.66), and flu vaccines (OR = 1.32, 95% CI, 1.23-1.42). Conclusions Vaccination confidence was consistently associated with early childhood vaccination behavior across multiple vaccine types. Our findings support expanding the application of the Vaccination Confidence Scale to measure vaccination beliefs among parents of young children.	[Gilkey, Melissa B.] Harvard Med Sch, Dept Populat Med, Boston, MA USA; [Gilkey, Melissa B.] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [McRee, Annie-Laurie] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Magnus, Brooke E.] Univ N Carolina, Dept Psychol, Chapel Hill, NC USA; [Reiter, Paul L.] Ohio State Univ, Div Canc Prevent & Control, Columbus, OH 43210 USA; [Dempsey, Amanda F.] Univ Colorado Denver, Adult & Child Ctr Outcomes Res & Disseminat Sci A, Aurora, CO USA; [Brewer, Noel T.] Univ N Carolina, Dept Hlth Behav, Chapel Hill, NC USA; [Brewer, Noel T.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; University of Minnesota System; University of Minnesota Twin Cities; University of North Carolina; University of North Carolina Chapel Hill; University System of Ohio; Ohio State University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Gilkey, MB (corresponding author), Harvard Med Sch, Dept Populat Med, Boston, MA USA.; Gilkey, MB (corresponding author), Harvard Pilgrim Hlth Care Inst, Boston, MA USA.	gilkey@email.unc.edu	Brewer, Noel T/C-4375-2008	Brewer, Noel T/0000-0003-2241-7002; McRee, Annie-Laurie/0000-0001-6588-5995; Magnus, Brooke/0000-0001-6905-972X	Academic Pediatric Association Young Investigator Award; National Cancer Institute [R25 CA57726, K22 CA186979]; NATIONAL CANCER INSTITUTE [R25CA057726, K22CA186979, T32CA057726] Funding Source: NIH RePORTER	Academic Pediatric Association Young Investigator Award; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by: 1. An Academic Pediatric Association Young Investigator Award (no award number, to MG, https://www.academicpeds.org/research/research_YIA_APA.cfm) 2. The National Cancer Institute (R25 CA57726 to MG, K22 CA186979 to MG, http://www.cancer.gov/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benin AL, 2006, PEDIATRICS, V117, P1532, DOI 10.1542/peds.2005-1728; Centers for Disease Control and Prevention, 2015, VACC CHILDR VFC PROG; Centers for Disease Control and Prevention, 2015, NAT IMM SURV US GUID; Centers for Disease Control and Prevention, 2015, MEASL CAS OUTBR; Centers for Disease Control and Prevention, 2015, DAT REL DOC NAT IMM; Clemmon NS, 2015, MMWR-MORBID MORTAL W, V64, P373; Dempsey AF, 2011, PEDIATRICS, V128, P848, DOI 10.1542/peds.2011-0400; Dube E, 2013, HUM VACC IMMUNOTHER, V9, P1763, DOI 10.4161/hv.24657; Fredrickson DD, 2004, FAM MED, V36, P431; Gilkey MB, 2016, ACAD PEDIATR, V16, P42, DOI 10.1016/j.acap.2015.06.007; Gilkey MB, 2014, VACCINE, V32, P6259, DOI 10.1016/j.vaccine.2014.09.007; Gilkey MB, 2013, PREV MED, V56, P202, DOI 10.1016/j.ypmed.2012.12.019; Gust DA, 2004, PEDIATRICS, V114, pE16, DOI 10.1542/peds.114.1.e16; Gust DA, 2008, PEDIATRICS, V122, P718, DOI 10.1542/peds.2007-0538; Imdad A, 2013, PEDIATRICS, V132, P37, DOI 10.1542/peds.2012-3449; Kempe A, 2011, AM J PREV MED, V40, P548, DOI 10.1016/j.amepre.2010.12.025; Larson HJ, 2015, VACCINE, V33, P4165, DOI 10.1016/j.vaccine.2015.04.037; Larson HJ, 2015, PLOS CURR, V7; McRee AL, 2010, SEX TRANSM DIS, V37, P234, DOI 10.1097/OLQ.0b013e3181c37e15; Nyhan B, 2014, PEDIATRICS, V133, pE835, DOI 10.1542/peds.2013-2365; Omer SB, 2006, JAMA-J AM MED ASSOC, V296, P1757, DOI 10.1001/jama.296.14.1757; Opel DJ, 2013, PEDIATRICS, V132, P1037, DOI 10.1542/peds.2013-2037; Opel DJ, 2013, JAMA PEDIATR, V167, P1065, DOI 10.1001/jamapediatrics.2013.2483; Reiter PL, 2009, SOC SCI MED, V69, P475, DOI 10.1016/j.socscimed.2009.05.024; Robison SG, 2012, PEDIATRICS, V130, P32, DOI 10.1542/peds.2011-3154; ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P328, DOI 10.1177/109019817400200403; Senier L, 2008, SOCIOL INQ, V78, P207, DOI 10.1111/j.1475-682X.2008.00235.x; Smith PJ, 2011, PUBLIC HEALTH REP, V126, P135, DOI 10.1177/00333549111260S215; Smith PJ, 2015, PUB HLTH REP, V130, P1; Szilagyi P G, 1996, J Public Health Manag Pract, V2, P18; U.S. Department of Health and Human Services. NVAC Vaccine Confidence Working Group, 2015, NVAC VACC CONF WORK	31	54	55	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159087	10.1371/journal.pone.0159087	http://dx.doi.org/10.1371/journal.pone.0159087			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27391098	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400209
J	Guo, DD; Wu, JF; Hu, YY; Sun, W; Lv, TL; Jiang, WJ; Wu, H; Wang, XR; Jonas, JB; Bi, HS				Guo, Da-dong; Wu, Jian-feng; Hu, Yuan-yuan; Sun, Wei; Lv, Tai-liang; Jiang, Wen-jun; Wu, Hui; Wang, Xing-rong; Jonas, Jost B.; Bi, Hong-sheng			Stereoacuity and Related Factors: The Shandong Children Eye Study	PLOS ONE			English	Article							UNILATERAL VISUAL IMPAIRMENT; PRESCHOOL-CHILDREN; YOUNG-CHILDREN; AMBLYOPIA; STEREOPSIS; ANISOMETROPIA; VISION; ACUITY	Objective To assess stereoacuity in a population-based sample of children and to examine ocular and systemic parameters related to stereoacuity. Methods Using a random cluster sampling method, four-to 18-year-old children from kindergartens, elementary schools, junior high schools and senior high schools from a rural area and an urban area in the East Chinese province of Shandong were included in the school-based cross-sectional study. All participants underwent a comprehensive eye examination including assessment of cycloplegic refraction and measurement of stereoacuity using the Titmus Stereo test. Results Out of 6364 eligible children, 5780 (90.8%) children with a mean age of 10.1 +/- 3.2 years (range: 4 to 18 years) participated. Mean (+/- standard deviation) stereoacuity was 50.2 +/- 50.6 arc seconds. Stereoacuity improved significantly (P<0.01) from the age group of 4 years to the age group of 6 to 7 years, then showed a plateau, deteriorated (P = 0.001) for both sexes from the age group of 9 years to the age group of 12 years (P<0.001), after which it improved (P = 0.001) again in the age group of 16 years or older to the pre-puberty values. In multivariate analysis, larger angle of binocular disparity (i.e., lower stereoacuity) was significantly associated with lower best corrected visual acuity (logMAR; P<0.001), higher intereye difference in refractive error (spherical equivalent) (P<0.001), higher cylindrical refractive error (P<0.001), higher refractive error (spherical value; P<0.001), higher intereye difference in best corrected visual acuity (logMAR) (P = 0.001), higher intereye difference in axial length (P = 0.001), and rural region of habitation (P = 0.006). Conclusions Stereoacuity as tested with the Titmus Stereo test improved significantly from an age of 4 years to an age of 6 and 7 years, then remained constant, temporarily deteriorated for both sexes in pre-puberty and puberty, after which it improved again to pre-puberty or better values at the age of 16 years or older. Lower stereoacuity was associated with lower best corrected visual acuity and higher intereye difference in best corrected visual acuity, higher cylindrical and spherical refractive errors, higher inter-eye difference in refractive error, higher intereye difference in axial length, and rural region of habitation.	[Guo, Da-dong; Jiang, Wen-jun; Wu, Hui; Bi, Hong-sheng] Shandong Univ Tradit Chinese Med, Inst Eye, Jinan, Shandong, Peoples R China; [Wu, Jian-feng] Shandong Univ Tradit Chinese Med, Ophthalmol & Optometry Sch, Jinan, Shandong, Peoples R China; [Hu, Yuan-yuan; Sun, Wei; Lv, Tai-liang; Wang, Xing-rong] Shandong Univ Tradit Chinese Med, Affiliated Hosp 2, Jinan, Shandong, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Bergheimer Str 58, D-69115 Heidelberg, Germany	Shandong University of Traditional Chinese Medicine; Shandong University of Traditional Chinese Medicine; Shandong University of Traditional Chinese Medicine; Ruprecht Karls University Heidelberg	Bi, HS (corresponding author), Shandong Univ Tradit Chinese Med, Inst Eye, Jinan, Shandong, Peoples R China.	hongshengbi@126.com		Guo, Dadong/0000-0002-1712-0055; Jonas, Jost/0000-0003-2972-5227	Mundipharma Co. (Cambridge, UK); Alimera Co. (Alpharetta, GA, USA); Boehringer Ingelheim Co. (Ingelheim, Germany); Sanofi Co. (Paris, France); Allergan Co. (Dublin, Ireland); National Health and Family Planning Commission of China [201302015]; National Ministry of Science Technology [2015BAI04B04]; National Natural Science Foundation of China [81303081]; Science and Technology Development Plan of Shandong Province [2014GGH219004]; Medicine and Health Development Plan of Shandong Province [2015WS0141]	Mundipharma Co. (Cambridge, UK); Alimera Co. (Alpharetta, GA, USA); Boehringer Ingelheim Co. (Ingelheim, Germany)(Boehringer Ingelheim); Sanofi Co. (Paris, France); Allergan Co. (Dublin, Ireland); National Health and Family Planning Commission of China; National Ministry of Science Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Development Plan of Shandong Province; Medicine and Health Development Plan of Shandong Province	This work was funded by Jost P. Jonas, Consultant for Mundipharma Co. (Cambridge, UK), Alimera Co. (Alpharetta, GA, USA), Boehringer Ingelheim Co. (Ingelheim, Germany), Sanofi Co. (Paris, France), and Allergan Co. (Dublin, Ireland); Patent holder with Biocompatibles UK Ltd. (Franham, Surrey, UK) (Title: Treatment of eye diseases using encapsulated cells encoding and secreting neuroprotective factor and / or anti-angiogenic factor; Patent number: 20120263794), and patent application with University of Heidelberg (Heidelberg, Germany) (Title: Agents for use in the therapeutic or prophylactic treatment of myopia or hyperopia; Europaische Patentanmeldung 15 000 771.4). This study was also supported by National Health and Family Planning Commission of China (201302015), National Ministry of Science & Technology (2015BAI04B04), National Natural Science Foundation of China (81303081), Science and Technology Development Plan of Shandong Province (2014GGH219004) and Medicine and Health Development Plan of Shandong Province (2015WS0141).	Barnea-Goraly N, 2005, CEREB CORTEX, V15, P1848, DOI 10.1093/cercor/bhi062; Birch E, 2008, J AAPOS, V12, P23, DOI 10.1016/j.jaapos.2007.06.003; BURIAN H M, 1951, Doc Ophthalmol, V5-6, P169, DOI 10.1007/BF00143660; Ciner EB, 2014, OPTOMETRY VISION SCI, V91, P351, DOI 10.1097/OPX.0000000000000165; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; FOX R, 1986, INVEST OPHTH VIS SCI, V27, P598; Goddings AL, 2014, NEUROIMAGE, V88, P242, DOI 10.1016/j.neuroimage.2013.09.073; HERON G, 1985, AM J OPTOM PHYS OPT, V62, P505; Hong SW, 2008, BRIT J OPHTHALMOL, V92, P1186, DOI 10.1136/bjo.2008.138362; Hrisos S, 2006, BRIT J OPHTHALMOL, V90, P836, DOI 10.1136/bjo.2006.090910; Hu YY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117482; Jiang WJ, 2014, INVEST OPHTH VIS SCI, V55, P4128, DOI 10.1167/iovs.14-14244; Li SS, 2014, J PEDIAT OPHTH STRAB, V51, P105, DOI 10.3928/01913913-20140220-04; McKean-Cowdin R, 2013, OPHTHALMOLOGY, V120, P2117, DOI 10.1016/j.ophtha.2013.03.001; Noorden GK., 2002, BINOCULAR VISION OCU, V25, P298; Oduntan Alabi O, 1998, Clin Exp Optom, V81, P193; Oguz H, 2000, J PEDIAT OPHTH STRAB, V37, P214; Richardson SR, 2005, INVEST OPHTH VIS SCI, V46, P150, DOI 10.1167/iovs.04-0672; ROGERS BJ, 1993, NATURE, V361, P253, DOI 10.1038/361253a0; ROMANO PE, 1975, AM J OPHTHALMOL, V79, P966, DOI 10.1016/0002-9394(75)90679-0; Rubin GS, 1997, INVEST OPHTH VIS SCI, V38, P557; SIMONS K, 1981, ARCH OPHTHALMOL-CHIC, V99, P439; Thompson PM, 2000, NATURE, V404, P190, DOI 10.1038/35004593; Tomac S, 2000, Binocul Vis Strabismus Q, V15, P221; Wallace DK, 2011, J AAPOS, V15, P455, DOI 10.1016/j.jaapos.2011.06.007; Watanabe H, 2014, GRAEF ARCH CLIN EXP, V252, P1207, DOI 10.1007/s00417-014-2566-x; Wu JB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082763, 10.1371/journal.pone.0081986, 10.1371/journal.pone.0081982]; Yang JW, 2013, JPN J OPHTHALMOL, V57, P316, DOI 10.1007/s10384-013-0231-2; Ying GS, 2013, OPHTHALMOLOGY, V120, P495, DOI 10.1016/j.ophtha.2012.08.014	29	17	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0157829	10.1371/journal.pone.0157829	http://dx.doi.org/10.1371/journal.pone.0157829			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391873	Green Submitted, Green Published, gold			2022-12-27	WOS:000380005400022
J	Kumar, N; Malik, YS; Kumar, S; Sharma, K; Sircar, S; Saurabh, S; Gulati, BR; Singh, N; Singh, AK; Joshi, VG; Banyai, K; Dhama, K				Kumar, Naveen; Malik, Yashpal Singh; Kumar, Satish; Sharma, Kuldeep; Sircar, Subhankar; Saurabh, Sharad; Gulati, Baldev R.; Singh, Neeraj; Singh, Arvind Kumar; Joshi, Vinay G.; Banyai, Krisztian; Dhama, Kuldeep			Peptide-Recombinant VP6 Protein Based Enzyme Immunoassay for the Detection of Group A Rotaviruses in Multiple Host Species	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; BURSAL DISEASE VIRUS; MAJOR CAPSID PROTEIN; DIAGNOSING ROTAVIRUS; LATEX AGGLUTINATION; CIRCULAR-DICHROISM; CHEMICAL-SYNTHESIS; ESCHERICHIA-COLI; ANTIBODIES; INFECTION	We developed a novel enzyme immunoassay for the detection of group A rotavirus (RVA) antigen in fecal samples of multiple host species. The assay is based on the detection of conserved VP6 protein using anti-recombinant VP6 antibodies as capture antibodies and anti-multiple antigenic peptide (identified and constructed from highly immunodominant epitopes within VP6 protein) antibodies as detector antibodies. The clinical utility of the assay was evaluated using a panel of 914 diarrhoeic fecal samples from four different host species (bovine, porcine, poultry and human) collected from diverse geographical locations in India. Using VP6-based reverse transcription-polymerase chain reaction (RT-PCR) as the gold standard, we found that the diagnostic sensitivity (DSn) and specificity (DSp) of the new assay was high [bovine (DSn = 94.2% & DSp = 100%); porcine (DSn = 94.6% & DSp = 93.3%); poultry (DSn = 74.2%& DSp = 97.7%) and human (DSn = 82.1%& DSp = 98.7%)]. The concordance with RT-PCR was also high [weighted kappa (k) = 0.831-0.956 at 95% CI = 0.711-1.0] as compared to RNA-polyacrylamide gel electrophoresis (RNA-PAGE). The performance characteristics of the new immunoassay were comparable to those of the two commercially available ELISA kits. Our results suggest that this peptide-recombinant protein based assay may serve as a preliminary assay for epidemiological surveillance of RVA antigen and for evaluation of vaccine effectiveness especially in low and middle income settings.	[Kumar, Naveen; Malik, Yashpal Singh; Sircar, Subhankar; Saurabh, Sharad; Singh, Neeraj] Indian Vet Res Inst, Biol Standardizat Div, Izatnagar, Uttar Pradesh, India; [Kumar, Satish; Singh, Arvind Kumar; Joshi, Vinay G.] Indian Vet Res Inst, Div Anim Biotechnol, Izatnagar, Uttar Pradesh, India; [Sharma, Kuldeep] Natl Inst Res Tribal Hlth, Jabalpur, Madhya Pradesh, India; [Gulati, Baldev R.] Natl Res Ctr Equines, Hisar, Haryana, India; [Banyai, Krisztian] Hungarian Acad Sci, Vet Med Res Inst, Agr Res Ctr, Hungariakrt 21, Budapest, Hungary; [Dhama, Kuldeep] Indian Vet Res Inst, Div Vet Immunol, Izatnagar, Uttar Pradesh, India; [Kumar, Naveen] Natl Inst High Secur Anim Dis, Bhopal, Madhya Pradesh, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tribal Health (NIRTH); Indian Council of Agricultural Research (ICAR); ICAR - National Research Centre on Equines; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Hungarian Veterinary Medical Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - National Institute of High Security Animal Diseases	Malik, YS (corresponding author), Indian Vet Res Inst, Biol Standardizat Div, Izatnagar, Uttar Pradesh, India.	malikyps@ivri.res.in	Gulati, Baldev/AAF-7492-2020; sircar, Shubhankar/D-3691-2019; Dhama, Kuldeep/B-7852-2015; Kumar, Naveen/V-1009-2019; Kumar, Naveen/GZK-9881-2022; Malik, Yashpal Singh/AAI-2259-2019; Kumar, Naveen/L-1588-2019; Joshi, Vinay Ganeshrao/AAW-8156-2021	Gulati, Baldev/0000-0002-4338-7941; sircar, Shubhankar/0000-0002-1947-4463; Dhama, Kuldeep/0000-0001-7469-4752; Kumar, Naveen/0000-0003-2529-8344; Kumar, Naveen/0000-0002-3326-5465; Joshi, Vinay Ganeshrao/0000-0001-8872-1838; Banyai, Krisztian/0000-0002-6270-1772; Singh, Arvind Kumar/0000-0001-8711-9191	Education Division, Indian Council of Agricultural Research, Ministry of Agriculture & Farmer's Welfare, Govt. of India, New Delhi; Hungarian Scientific Research Fund (OTKA) [T100727]	Education Division, Indian Council of Agricultural Research, Ministry of Agriculture & Farmer's Welfare, Govt. of India, New Delhi; Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	The financial support from Education Division, Indian Council of Agricultural Research, Ministry of Agriculture & Farmer's Welfare, Govt. of India, New Delhi in the form of National Fellow project is acknowledged. Dr. Krisztian Banyai was supported by the Hungarian Scientific Research Fund (OTKA, T100727).	Bennett A, 2015, J CLIN MICROBIOL, V53, P1951, DOI 10.1128/JCM.00875-15; Choi AHC, 2004, PROTEIN EXPRES PURIF, V38, P205, DOI 10.1016/j.pep.2004.08.009; Choi AHC, 2003, VACCINE, V21, P761, DOI 10.1016/S0264-410X(02)00595-9; Choi AHC, 2000, J VIROL, V74, P11574, DOI 10.1128/JVI.74.24.11574-11580.2000; Cunliffe NA, 2010, J INFECT DIS, V202, pS168, DOI 10.1086/653577; Dechamma HJ, 2006, VET MICROBIOL, V118, P201, DOI 10.1016/j.vetmic.2006.07.023; DYSON HJ, 1988, ANNU REV BIOPHYS BIO, V17, P305; Erk I, 2003, J VIROL, V77, P3595, DOI 10.1128/JVI.77.6.3595-3601.2003; ERNST H, 1988, GENE, V68, P345, DOI 10.1016/0378-1119(88)90037-6; Espejo RT, 1977, J INFECT DIS, V139, P879; Gladstone BP, 2011, NEW ENGL J MED, V365, P337, DOI 10.1056/NEJMoa1006261; GOUVEA V, 1990, J CLIN MICROBIOL, V28, P276, DOI 10.1128/JCM.28.2.276-282.1990; Greenberg HB, 2009, GASTROENTEROLOGY, V136, P1939, DOI 10.1053/j.gastro.2009.02.076; Greenfield NJ, 1996, ANAL BIOCHEM, V235, P1, DOI 10.1006/abio.1996.0084; Iturriza-Gomara M, 2009, EPIDEMIOL INFECT, V137, P922, DOI 10.1017/S0950268808001556; Jackwood M W, 1995, Adv Exp Med Biol, V380, P213; Kawada T, 2012, CLIN RADIOL, V67, P940, DOI 10.1016/j.crad.2012.04.002; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LANG E, 1994, J IMMUNOL METHODS, V170, P103, DOI 10.1016/0022-1759(94)90250-X; LANGEVELD JPM, 1994, J VIROL, V68, P4506, DOI 10.1128/JVI.68.7.4506-4513.1994; de Goes ACMA, 2008, J VIROL METHODS, V148, P211, DOI 10.1016/j.jviromet.2007.11.013; Malik YS, 2012, J VET SCI, V13, P271, DOI 10.4142/jvs.2012.13.3.271; Matthijnssens J, 2012, ARCH VIROL, V157, P1177, DOI 10.1007/s00705-012-1273-3; Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z; McNeal MM, 2007, VIROLOGY, V363, P410, DOI 10.1016/j.virol.2007.01.041; Merrifield B, 1996, PROTEIN SCI, V5, P1947, DOI 10.1002/pro.5560050925; Merrifield B., 1963, J AM CHEM SOC, V85, P2149; Mihalov-Kovacs E, 2015, EMERG INFECT DIS, V21, P660, DOI 10.3201/eid2104.141370; Mukhopadhya I, 2010, EPIDEMIOL INFECT, V138, P442, DOI 10.1017/S0950268809990732; Nilsson BL, 2005, ANNU REV BIOPH BIOM, V34, P91, DOI 10.1146/annurev.biophys.34.040204.144700; Papp H, 2013, VET MICROBIOL, V165, P190, DOI 10.1016/j.vetmic.2013.03.020; Phillips G, 2009, J CLIN VIROL, V44, P242, DOI 10.1016/j.jcv.2008.12.001; POSNETT DN, 1988, J BIOL CHEM, V263, P1719; Sambrook J., 2001, MOL CLONING LAB MANU; SANEKATA T, 1981, J IMMUNOL METHODS, V41, P377, DOI 10.1016/0022-1759(81)90199-X; Saravanan P, 2004, ACTA VIROL, V48, P39; Saravanan P, 2004, J IMMUNOL METHODS, V293, P61, DOI 10.1016/j.jim.2004.07.001; Seo JH, 2010, KOREAN J PEDIAT GAST, V13, P134; SIMMONDS P, 1993, J CLIN MICROBIOL, V31, P1493, DOI 10.1128/JCM.31.6.1493-1503.1993; SVENSSON L, 1986, J MED VIROL, V18, P101, DOI 10.1002/jmv.1890180202; TAM JP, 1988, P NATL ACAD SCI USA, V85, P5409, DOI 10.1073/pnas.85.15.5409; Tang BZ, 1997, VIROLOGY, V237, P89, DOI 10.1006/viro.1997.8762; TANIGUCHI K, 1992, EPIDEMIOL INFECT, V109, P303, DOI 10.1017/S0950268800050263; Tate JE, 2013, EMERG INFECT DIS, V19, P1245, DOI 10.3201/eid1908.130461; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; YANG JT, 1986, METHOD ENZYMOL, V130, P208; Zamorano PI, 1998, VACCINE, V16, P558, DOI 10.1016/S0264-410X(97)00244-2; Zhu JY, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-91	51	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159027	10.1371/journal.pone.0159027	http://dx.doi.org/10.1371/journal.pone.0159027			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391106	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400196
J	Mahmoudi, R; Jabbari, N; Aghdasi, M; Khalkhali, HR				Mahmoudi, Reza; Jabbari, Nasrollah; Aghdasi, Mehdi; Khalkhali, Hamid Reza			Energy Dependence of Measured CT Numbers on Substituted Materials Used for CT Number Calibration of Radiotherapy Treatment Planning Systems	PLOS ONE			English	Article							QUALITY-ASSURANCE; HOUNSFIELD UNITS; DOSE CALCULATION; CONVERSION; TISSUE; CONVOLUTION	Introduction For accurate dose calculations, it is necessary to provide a correct relationship between the CT numbers and electron density in radiotherapy treatment planning systems (TPSs). The purpose of this study was to investigate the energy dependence of measured CT numbers on substituted materials used for CT number calibration of radiotherapy TPSs and the resulting errors in the treatment planning calculation doses. Materials and Methods In this study, we designed a cylindrical water phantom with different materials used as tissue equivalent materials for the simulation of tissues and obtaining the related CT numbers. For evaluating the effect of CT number variations of substituted materials due to energy changing of scanner (kVp) on the dose calculation of TPS, the slices of the scanned phantom at three kVp's were imported into the desired TPSs (MIRS and CorePLAN). Dose calculations were performed on two TPSs. Results The mean absolute percentage differences between the CT numbers of CT scanner and two treatment planning systems for all the samples were 3.22%+/- 2.57% for CorePLAN and 2.88%+/- 2.11% for MIRS. It was also found that the maximum absolute percentage difference between all of the calculated doses from each photon beam of linac (6 and 15 MV) at three kVp's was less than 1.2%. Discussion The present study revealed that, for the materials with effective low atomic number, the mean CT number increased with increasing energy, which was opposite for the materials with an effective high atomic number. We concluded that the tissue substitute materials had a different behavior in the energy ranges from 80 to 130 kVp. So, it is necessary to consider the energy dependence of the substitute materials used for the measurement or calibration of CT number for radiotherapy treatment planning systems.	[Mahmoudi, Reza] Urmia Univ Med Sci, Dept Med Phys & Imaging, Orumiyeh, Iran; [Jabbari, Nasrollah] Urmia Univ Med Sci, Solid Tumor Res Ctr, Orumiyeh, Iran; [Aghdasi, Mehdi] Omid Hosp, Radiotherapy Ctr, Orumiyeh, Iran; [Aghdasi, Mehdi] Radiotherapy Ctr Parto, Orumiyeh, Iran; [Khalkhali, Hamid Reza] Urmia Univ Med Sci, Dept Biostat & Epidemiol, Orumiyeh, Iran	Urmia University of Medical Sciences; Urmia University of Medical Sciences; Urmia University of Medical Sciences	Jabbari, N (corresponding author), Urmia Univ Med Sci, Solid Tumor Res Ctr, Orumiyeh, Iran.	njabbarimp@gmail.com	khalkhali, hamid reza/G-7920-2017; Jabbari, Nasrollah/D-4928-2017	khalkhali, hamid reza/0000-0003-2837-0735; Jabbari, Nasrollah/0000-0003-3044-4609	Urmia University of Medical Sciences	Urmia University of Medical Sciences	This study was only scientifically approved by Urmia University of Medical Sciences. These authors have no support or funding to report.	AHNESJO A, 1989, MED PHYS, V16, P577, DOI 10.1118/1.596360; Begg AC, 2011, NAT REV CANCER, V11, P239, DOI 10.1038/nrc3007; Bryant JA, 2012, RADIAT PHYS CHEM, V81, P358, DOI 10.1016/j.radphyschem.2011.12.026; Chow JCL, 2003, MED PHYS, V30, P2686, DOI 10.1118/1.1601331; Cropp RJ, 2013, J APPL CLIN MED PHYS, V14, P338, DOI 10.1120/jacmp.v14i6.4417; Fraass B, 1998, MED PHYS, V25, P1773, DOI 10.1118/1.598373; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kanematsu N, 2003, PHYS MED BIOL, V48, P1053, DOI 10.1088/0031-9155/48/8/307; Kilby W, 2002, PHYS MED BIOL, V47, P1485, DOI 10.1088/0031-9155/47/9/304; Lamba R, 2014, AM J ROENTGENOL, V203, P1013, DOI 10.2214/AJR.12.10037; MACKIE TR, 1985, MED PHYS, V12, P188, DOI 10.1118/1.595774; Mutic S, 2003, MED PHYS, V30, P2762, DOI 10.1118/1.1609271; Nasrollah J, 2014, J CANCER RES THER, V10, P147, DOI 10.4103/0973-1482.131465; Nobah A, 2011, J APPL CLIN MED PHYS, V12, P80, DOI 10.1120/jacmp.v12i3.3432; Okayama S, 2012, RADIOL RES PRACT, V2012, DOI 10.1155/2012/150980; Garcia LIR, 2016, PHYS MED BIOL, V61, P265, DOI 10.1088/0031-9155/61/1/265; Saberi H, 2013, RES J APPL SCI ENG T, V6, P2110, DOI 10.19026/rjaset.6.3833; Schneider U, 1996, PHYS MED BIOL, V41, P111, DOI 10.1088/0031-9155/41/1/009; Vanderstraeten B, 2007, PHYS MED BIOL, V52, P539, DOI 10.1088/0031-9155/52/3/001; Watson PF, 2010, THERIOGENOLOGY, V73, P1167, DOI 10.1016/j.theriogenology.2010.01.003; Yagi M, 2013, J APPL CLIN MED PHYS, V14, P173, DOI 10.1120/jacmp.v14i5.4335; Yohannes I, 2012, PHYS MED BIOL, V57, P1173, DOI 10.1088/0031-9155/57/5/1173; Zurl B, 2014, STRAHLENTHER ONKOL, V190, P88, DOI 10.1007/s00066-013-0464-5	23	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158828	10.1371/journal.pone.0158828	http://dx.doi.org/10.1371/journal.pone.0158828			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391672	Green Published, gold, Green Submitted			2022-12-27	WOS:000380005400137
J	Thomas, MA; Nyanhete, T; Tuero, I; Venzon, D; Robert-Guroff, M				Thomas, Michael A.; Nyanhete, Tinashe; Tuero, Iskra; Venzon, David; Robert-Guroff, Marjorie			Beyond Oncolytics: E1B55K-Deleted Adenovirus as a Vaccine Delivery Vector	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELL RESPONSES; RHESUS MACAQUES; PROTECTIVE EFFICACY; IMMUNE-RESPONSES; E1B PROTEINS; CHALLENGE; IMMUNIZATION; EXPRESSION; REPLICATION	Type 5 human adenoviruses (Ad5) deleted of genes encoding the early region 1B 55-kDa (E1B55K) protein including Onyx-015 (dl1520) and H101 are best known for their oncolytic potential. As a vaccine vector the E1B55K deletion may allow for the insertion of a transgene nearly 1,000 base pairs larger than now possible. This has the potential of extending the application for which the vectors are clinically known. However, the immune priming ability of E1B55K-deleted vectors is unknown, undermining our ability to gauge their usefulness in vaccine applications. For this reason, we created an E1B55K-deleted Ad5 vector expressing full-length single chain HIV(BaL)gp120 attached to a flexible linker and the first two domains of rhesus CD4 (rhFLSC) in exchange for the E3 region. In cell-based experiments the E1B55K-deleted vector promoted higher levels of innate immune signals including chemokines, cytokines, and the NKG2D ligands MIC A/B compared to an E1B55K wild-type vector expressing the same immunogen. Based on these results we evaluated the immune priming ability of the E1B55K-deleted vector in mice. The E1B55K-deleted vector promoted similar levels of Ad5-, HIVgp120, and rhFLSC-specific cellular and humoral immune responses as the E1B55K wild-type vector. In pre-clinical HIV-vaccine studies the wild-type vector has been employed as part of a very effective prime-boost strategy. This study demonstrates that E1B55K-deleted adenoviruses may serve as effective vaccine delivery vectors.	[Thomas, Michael A.; Nyanhete, Tinashe; Tuero, Iskra; Robert-Guroff, Marjorie] NCI, Sect Immune Biol Retroviral Infect, Vaccine Branch, NIH, Bethesda, MD USA; [Venzon, David] NCI, Biostat & Data Management Sect, NIH, Bethesda, MD USA; [Thomas, Michael A.] Howard Univ, Dept Biol, Washington, DC USA; [Nyanhete, Tinashe] Duke Univ, Durham, NC USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Howard University; Duke University	Thomas, MA; Robert-Guroff, M (corresponding author), NCI, Sect Immune Biol Retroviral Infect, Vaccine Branch, NIH, Bethesda, MD USA.; Thomas, MA (corresponding author), Howard Univ, Dept Biol, Washington, DC USA.	michael.thomas1@howard.edu; guroffm@mail.nih.gov		Tuero, Iskra/0000-0002-5788-1051	Pathway to Independence Award (K99) [1K99AI114379 - 01]; Intramural Research Program of the National Institutes of Health, National Cancer Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R00AI114379] Funding Source: NIH RePORTER	Pathway to Independence Award (K99); Intramural Research Program of the National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Pathway to Independence Award (K99) Grant Number 1K99AI114379 - 01 to MAT and by the Intramural Research Program of the National Institutes of Health, National Cancer Institute to MRG.	Alexander J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082380; Alexander J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031177; BABISS LE, 1985, MOL CELL BIOL, V5, P2552, DOI 10.1128/MCB.5.10.2552; BARKER DD, 1987, VIROLOGY, V156, P107, DOI 10.1016/0042-6822(87)90441-7; BETT AJ, 1993, J VIROL, V67, P5911, DOI 10.1128/JVI.67.10.5911-5921.1993; Bogers WMJM, 2008, VIROLOGY, V382, P217, DOI 10.1016/j.virol.2008.09.016; Champsaur M, 2010, IMMUNOL REV, V235, P267, DOI 10.1111/j.0105-2896.2010.00893.x; COUTELIER JP, 1987, J EXP MED, V165, P64, DOI 10.1084/jem.165.1.64; Crompton AM, 2007, CURR CANCER DRUG TAR, V7, P133; Demberg T, 2007, J VIROL, V81, P3414, DOI 10.1128/JVI.02453-06; Dutt S, 2011, BLOOD, V117, P3230, DOI 10.1182/blood-2010-10-312751; Fouts TR, 2000, J VIROL, V74, P11427, DOI 10.1128/JVI.74.24.11427-11436.2000; Garber K, 2006, J NATL CANCER I, V98, P298, DOI 10.1093/jnci/djj111; Goodrum FD, 1999, J VIROL, V73, P7474, DOI 10.1128/JVI.73.9.7474-7488.1999; Gurwith M, 2013, LANCET INFECT DIS, V13, P238, DOI 10.1016/S1473-3099(12)70345-6; Lubeck MD, 1997, NAT MED, V3, P651, DOI 10.1038/nm0697-651; Malkevitch NV, 2006, VIROLOGY, V353, P83, DOI 10.1016/j.virol.2006.05.012; McSharry BP, 2008, J VIROL, V82, P4585, DOI 10.1128/JVI.02251-07; Miller DL, 2009, J VIROL, V83, P3591, DOI 10.1128/JVI.02269-08; Patterson LJ, 2008, EXPERT OPIN BIOL TH, V8, P1347, DOI [10.1517/14712598.8.9.1347, 10.1517/14712598.8.9.1347 ]; Patterson LJ, 2004, J VIROL, V78, P2212, DOI 10.1128/JVI.78.5.2212-2221.2004; Qiu F, 2012, INT J MOL MED, V29, P12, DOI 10.3892/ijmm.2011.801; Robert-Guroff M, 1998, J VIROL, V72, P10275, DOI 10.1128/JVI.72.12.10275-10280.1998; Routes JM, 2005, J EXP MED, V202, P1477, DOI 10.1084/jem.20050240; Schaack J, 2004, P NATL ACAD SCI USA, V101, P3124, DOI 10.1073/pnas.0303709101; Tanghe A, 2001, INFECT IMMUN, V69, P3041, DOI 10.1128/IAI.69.5.3041-3047.2001; Thomas MA, 2014, VIROLOGY, V471, P81, DOI 10.1016/j.virol.2014.10.001; Thomas MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076344; Thomas MA, 2009, J VIROL, V83, P2406, DOI 10.1128/JVI.01972-08	29	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158505	10.1371/journal.pone.0158505	http://dx.doi.org/10.1371/journal.pone.0158505			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391605	Green Submitted, gold, Green Published			2022-12-27	WOS:000380005400072
J	Wang, XX; Long, WX; Schamp, BS; Yang, XB; Kang, Y; Xie, ZX; Xiong, MH				Wang, Xixi; Long, Wenxing; Schamp, Brandon S.; Yang, Xiaobo; Kang, Yong; Xie, Zhixu; Xiong, Menghui			Vascular Epiphyte Diversity Differs with Host Crown Zone and Diameter, but Not Orientation in a Tropical Cloud Forest	PLOS ONE			English	Article							SPATIAL-DISTRIBUTION; AIR-TEMPERATURE; RAIN-FOREST; TREE SIZE; ASSOCIATIONS; VEGETATION; PATTERNS; CANOPY	Vascular epiphytes are important components of biological diversity in tropical forests. We measured the species richness and abundance of vascular epiphytes along four vertical crown zones and five horizontal orientations on 376 trees, as well as the diameter at breast height (DBH) of host trees in tropical cloud forests in Bawangling, Hainan, China. The relationship between vascular epiphyte species richness and host tree DBH was assessed using a generalized linear model. There were 1,453 vascular individual epiphytes attributed to 9 families, 24 genera and 35 species, with orchids and pteridophytes dominating. Both the species richness and abundance of epiphytes significantly differed among the four crown zones for all collections and each host tree, suggesting that vertical microhabitats contribute to the distribution of epiphytes on host trees. Neither epiphyte abundance nor species richness differed among the eastern, southern, western, and northern orientations for all host trees; however, both richness and abundance were significantly higher for epiphytes that encircled host tree trunks. This suggests that morphological and physiological characteristics of the tree, but not microclimates probably contribute to the distribution of epiphytes on host trees. Epiphyte species richness was positively correlated with tree DBH across the six host tree species studied, with increases in DBH among smaller trees resulting in larger increases in richness, while increases in DBH among larger host trees resulting in more modest increases in ephiphyte richness. Our findings contribute support for a positive relationship between epiphyte species richness and host tree DBH and provide important guidance for future surveys of epiphyte community development.	[Wang, Xixi; Long, Wenxing; Yang, Xiaobo; Kang, Yong; Xie, Zhixu; Xiong, Menghui] Hainan Univ, Minist Educ, Coll Hort & Landscape Agr, Key Lab Protect & Dev Utilizat Trop Crop Germplas, Haikou, Peoples R China; [Schamp, Brandon S.] Algoma Univ, Dept Biol, Sault Ste Marie, ON P6A 2G4, Canada	Hainan University; Algoma University	Long, WX (corresponding author), Hainan Univ, Minist Educ, Coll Hort & Landscape Agr, Key Lab Protect & Dev Utilizat Trop Crop Germplas, Haikou, Peoples R China.	oklong@hainu.edu.cn			National Natural Science Foundation of China [31260109]; Innovative Research Team grant of the Natural Science Foundation of Hainan Province [2016CXTD003]; Natural Science Foundation of Hainan Province [312064]; Natural Science and Engineering Research Council of Canada	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovative Research Team grant of the Natural Science Foundation of Hainan Province; Natural Science Foundation of Hainan Province; Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Financial support came from National Natural Science Foundation of China (Grant 31260109), the Innovative Research Team grant of the Natural Science Foundation of Hainan Province (2016CXTD003), Natural Science Foundation of Hainan Province (312064) (to W.X.), and a Natural Science and Engineering Research Council of Canada grant (to B. Schamp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo-Fordjour P, 2009, AFR J ECOL, V47, P767, DOI 10.1111/j.1365-2028.2009.01072.x; BALFOUR DA, 1993, J ECOL, V81, P93, DOI 10.2307/2261227; BENNETT BC, 1987, B TORREY BOT CLUB, V114, P265, DOI 10.2307/2996464; Benzing D., 1990, J TROP ECOL, V8, P55, DOI [10.1017/S0266467400006088, DOI 10.1017/S0266467400006088]; BENZING D H, 1978, Selbyana, V2, P133; Benzing D. H., 1981, SELBYANA, V5, P248; Boelter CR, 2014, J VEG SCI, V25, P1090, DOI 10.1111/jvs.12154; Bubb P., 2004, CLOUD FOREST AGENDA; Burns KC, 2010, ECOLOGY, V91, P377, DOI 10.1890/08-2004.1; Burns KC, 2005, AUSTRAL ECOL, V30, P891; Chazdon R.L., 2008, INTROPICAL FORESTCOM, P384; Kersten RD, 2009, REV BIOL TROP, V57, P749; Editorial Committee of Flora of China, FLORA REIPUBLICAE PO; Eisermann K, 2005, REV BIOL TROP, V53, P577; Flores-Palacios A, 2006, J BIOGEOGR, V33, P323, DOI 10.1111/j.1365-2699.2005.01382.x; Flores-Palacios A., 2001, Selbyana, V22, P181; GUSTAFSSON L, 1995, J APPL ECOL, V32, P412, DOI 10.2307/2405107; Ingram Stephen W., 1995, P587; JOHANSSON D, 1974, Acta Phytogeographica Suecica, V59, P1; KRESS W J, 1986, Selbyana, V9, P2; Laube S, 2006, ANN BOT-LONDON, V97, P1103, DOI 10.1093/aob/mcl067; Lie MH, 2009, BIODIVERS CONSERV, V18, P3579, DOI 10.1007/s10531-009-9661-z; Long WX, 2015, BIOTROPICA, V47, P416, DOI 10.1111/btp.12235; Long WX, 2015, J VEG SCI, V26, P513, DOI 10.1111/jvs.12256; Long WX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060252; Long WenXing, 2011, Biodiversity Science, V19, P558, DOI 10.3724/SP.J.1003.2011.09309; Long WX, 2011, FLORA, V206, P896, DOI 10.1016/j.flora.2011.05.007; Long WX, 2011, OECOLOGIA, V167, P1103, DOI 10.1007/s00442-011-2050-9; Male TD, 2005, AUSTRAL ECOL, V30, P229, DOI 10.1111/j.1442-9993.2005.01442.x; Nieder J, 2001, PLANT ECOL, V153, P51, DOI 10.1023/A:1017517119305; Nieder Juergen, 1999, Selbyana, V20, P66; PERRY DR, 1978, BIOTROPICA, V10, P155, DOI 10.2307/2388019; Quaresma AC, 2014, ACTA BOT BRAS, V28, P68, DOI 10.1590/S0102-33062014000100007; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; SANFORD WW, 1968, J ECOL, V56, P697, DOI 10.2307/2258101; Song L, 2012, OECOLOGIA, V170, P847, DOI 10.1007/s00442-012-2341-9; SOUTHWOOD TRE, 1983, OIKOS, V41, P359, DOI 10.2307/3544094; Stadtmuller T, 1987, CLOUD FOREST HUMID T; Stanton DE, 2014, FUNCT ECOL, V28, P1274, DOI 10.1111/1365-2435.12249; Taylor A, 2015, J VEG SCI, V26, P902, DOI 10.1111/jvs.12289; Tremblay RL, 2009, TROP ECOL, V50, P211; Woods CL, 2015, J ECOL, V103, P421, DOI 10.1111/1365-2745.12357; Xu HaiQing, 2005, Biodiversity Science, V13, P137, DOI 10.1360/biodiv.040123; Zhao ML, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005125; Zotz G, 2003, J TROP ECOL, V19, P81, DOI 10.1017/S0266467403003092	45	12	13	6	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158548	10.1371/journal.pone.0158548	http://dx.doi.org/10.1371/journal.pone.0158548			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391217	Green Published, gold, Green Submitted			2022-12-27	WOS:000380005400080
J	Labib, RM; Abdelrahim, MEA; Elnadi, E; Hesham, RM; Yassin, D				Labib, Rania M.; Abdelrahim, Mohamed E. A.; Elnadi, Enas; Hesham, Reem M.; Yassin, Dina			CYP2B6rs2279343 Is Associated with Improved Survival of Pediatric Rhabdomyosarcoma Treated with Cyclophosphamide	PLOS ONE			English	Article							BREAST-CANCER; GENETIC POLYMORPHISMS; HUMAN CYP2B6; HUMAN LIVER; IN-VIVO; PHARMACOKINETICS; PHARMACOGENETICS; CHEMOTHERAPY; TOXICITY; 4-HYDROXYCYCLOPHOSPHAMIDE	Background Rhabdomyosarcoma (RMS) is a small round blue cell malignant tumor, representing 7% of childhood malignancies, and over 50% of all soft tissue sarcomas. Cyclophosphamide (CPA) is a prodrug and is the mainstay of RMS treatment. CYP2B6 is a highly polymorphic drug metabolizing enzyme involved in CPA bioactivation. The influence of CYP2B6 single nucleotide polymorphisms (SNPs) on the survival of RMS is still unknown. Methods We genotyped CYP2B6SNPs rs2279343, rs3745274, and rs3211371 by restriction fragment polymorphism (RFLP) after PCR amplification in a cohort of 73 pediatric RMS patients treated with CPA-based first line treatment. We then analyzed the association between those genotypes and survival outcome of RMS. Results The frequencies of CYP2B6 rs2279343, rs3745274, and rs3211371 were 63%, 45.2%, and 5.5%, respectively. There was no association between rs3745274, rs3211371 genotypes and survival outcomes of RMS. However, the carriers of at least one mutant allele CYP2B6rs2279343 had significantly longer event-free survival (p-value = 0.03). Conclusion Our results demonstrated that CYP2B6 rs2279343 may predict EFS in RMS patients and warrants future studies to clarify the pharmacogenetics of CPA in pediatrics. If validated, integration of genetic factors with clinical and molecular characteristics could be used for a composite algorithm to better stratify risk prior to treatment.	[Labib, Rania M.] Childrens Canc Hosp Egypt 57357, Res Dept, Cairo, Egypt; [Labib, Rania M.; Abdelrahim, Mohamed E. A.] Beni Suef Univ, Fac Pharm, Clin Pharm, Dept, Bani Suwayf, Egypt; [Elnadi, Enas] Beni Suef Univ, Fac Med, Dept Pediat Oncol, Bani Suwayf, Egypt; [Elnadi, Enas] Childrens Canc Hosp Egypt 57357, Dept Pediat Oncol, Cairo, Egypt; [Hesham, Reem M.] Beni Suef Univ, Dept Biochem, Fac Pharm, Bani Suwayf, Egypt; [Yassin, Dina] Childrens Canc Hosp Egypt 57357, Dept Mol Biol, Cairo, Egypt	Children's Cancer Hospital 57357; Egyptian Knowledge Bank (EKB); Beni Suef University; Egyptian Knowledge Bank (EKB); Beni Suef University; Children's Cancer Hospital 57357; Egyptian Knowledge Bank (EKB); Beni Suef University; Children's Cancer Hospital 57357	Labib, RM (corresponding author), Childrens Canc Hosp Egypt 57357, Res Dept, Cairo, Egypt.; Labib, RM (corresponding author), Beni Suef Univ, Fac Pharm, Clin Pharm, Dept, Bani Suwayf, Egypt.	raniamlabib@gmail.com	Emam, Mohamed/AAJ-7075-2020; Singab, Abdel Nasser Badawi/AAD-7134-2021; labib, Rania/AAM-8316-2021; Labib, Rania/AAO-6770-2020	Singab, Abdel Nasser Badawi/0000-0001-7445-963X; Labib, Rania/0000-0001-6774-9911; abdelrahim, mohamed/0000-0003-0227-8404				Bray J, 2010, BRIT J CANCER, V102, P1003, DOI 10.1038/sj.bjc.6605587; Breitfeld PP, 2005, ONCOLOGIST, V10, P518, DOI 10.1634/theoncologist.10-7-518; Crist WM, 2001, J CLIN ONCOL, V19, P3091, DOI 10.1200/JCO.2001.19.12.3091; Egas-Bejar D, 2014, ADOLESC HEALTH MED T, V5, P115, DOI 10.2147/AHMT.S44582; Ekhart C, 2008, PHARMACOGENET GENOM, V18, P515, DOI 10.1097/FPC.0b013e3282fc9766; Gor PP, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2570; Haroun F, 2015, CANCER CHEMOTH PHARM, V75, P207, DOI 10.1007/s00280-014-2632-4; Hayes-Jordan A, 2009, CURR OPIN PEDIATR, V21, P373, DOI 10.1097/MOP.0b013e32832b4171; Helsby NA, 2012, DRUG METAB DISPOS, V40, P635, DOI 10.1124/dmd.111.043646; Kim J, 2014, ASIA LIFE SCI, P115; Lang T, 2001, PHARMACOGENETICS, V11, P399, DOI 10.1097/00008571-200107000-00004; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Naik Adviti, 2013, Frontiers in Genetics, V4, P2, DOI 10.3389/fgene.2013.00002; Perez EA, 2011, J SURG RES, V170, pE243, DOI 10.1016/j.jss.2011.03.001; Petros WP, 2005, J CLIN ONCOL, V23, P6117, DOI 10.1200/JCO.2005.06.075; Preissner SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082562; Raccor BS, 2012, DRUG METAB DISPOS, V40, P54, DOI 10.1124/dmd.111.039347; Radzikowska J, 2015, WSPOLCZESNA ONKOL, V19, P98, DOI 10.5114/wo.2015.49158; Riccardi LN, 2015, GENET TEST MOL BIOMA, V19, P103, DOI 10.1089/gtmb.2014.0239; Roy P, 1999, DRUG METAB DISPOS, V27, P655; Takada K, 2004, ARTHRITIS RHEUM-US, V50, P2202, DOI 10.1002/art.20338; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Timm R, 2005, PHARMACOGENOMICS J, V5, P365, DOI 10.1038/sj.tpj.6500330; Turpeinen Miia, 2012, Drug Metabolism and Drug Interactions, V27, P185, DOI 10.1515/dmdi-2012-0027; Uppugunduri CRS, 2014, PHARMACOGENOMICS J, V14, P263, DOI 10.1038/tpj.2013.38; Watanabe T, 2010, PHARMACOGENET GENOM, V20, P459, DOI 10.1097/FPC.0b013e32833bba0e; Xie HJ, 2003, PHARMACOGENOMICS J, V3, P53, DOI 10.1038/sj.tpj.6500157; Xu C, 2013, DRUG METAB DISPOS, V41, P2004, DOI 10.1124/dmd.113.051755; Yao S, 2010, CLIN CANCER RES, V16, P6169, DOI 10.1158/1078-0432.CCR-10-0281; Zanger UM, 2007, PHARMACOGENOMICS, V8, P743, DOI 10.2217/14622416.8.7.743	30	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158890	10.1371/journal.pone.0158890	http://dx.doi.org/10.1371/journal.pone.0158890			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27388155	Green Submitted, Green Published, gold			2022-12-27	WOS:000379811500061
J	Al Harbi, M; Khandekar, R; Kozak, I; Schatz, P				Al Harbi, Majed; Khandekar, Rajiv; Kozak, Igor; Schatz, Patrik			Association between Sickle Cell Trait and the Prevalence and Severity of Diabetic Retinopathy	PLOS ONE			English	Article							COMPLICATIONS; PROGRESSION; RISK; CANDESARTAN; KINGDOM; DISEASE; REGION; TRIAL	Purpose To determine whether Sickle cell trait (SCT) is associated with an increased severity of diabetic retinopathy. Methods This was a single center retrospective study case control study of 100 eyes of 100 patients with diabetes mellitus (DM) with SCT (SCT group) and 100 eyes of 100 age-matched patients with DM without SCT (control group). The main outcome measure was the difference in the prevalence of sight threatening DR [here defined as diabetic macular edema (DME) and/or proliferative diabetic retinopathy (PDR)], between the SCT and control groups. Secondary outcome measures included differences in visual acuity, ocular comor-bidities, intraocular pressure, glycemic control as assessed by random blood glucose measurement, diabetes duration, nephropathy, hyperlipidemia and hypertension. Results The SCT group had statistically significantly shorter duration of DM (median [25% quartile] 15 [8.3] years versus 20 [14.7] years, respectively)(P<0.001) and presented with statistically better metabolic control (mean difference 1.6 mmol/l, (95% confidence interval [CI], 0.1-3.3; P = 0.03). The prevalence of PDR and/or DME was significantly lower in the SCT group (58%) compared to the control group, (95%)(P<0.001). The absence of SCT (adjusted odds ratio [AOR] = 24; 95% CI, 8-72; P<0.001) and longer duration of DM (AOR = 1.1 [95% CI, 1.02-1.13]; P = 0.003) were independent predictors of PDR and/or DME. Conclusions SCT seems to protect against the development and progression of DR. This may have implications for monitoring and screening. Prospective studies are required to confirm this association. If true, this association may indicate an increased blood glucose buffering capacity of abnormal hemoglobin.	[Al Harbi, Majed; Khandekar, Rajiv; Kozak, Igor; Schatz, Patrik] King Khalid Eye Specialist Hosp, Vitreoretinal Div, Riyadh, Saudi Arabia; [Schatz, Patrik] Lund Univ, Skane Cty Univ Hosp, Clin Sci, Dept Ophthalmol, Lund, Sweden	King Khaled Eye Specialist Hospital; Lund University	Schatz, P (corresponding author), King Khalid Eye Specialist Hosp, Vitreoretinal Div, Riyadh, Saudi Arabia.; Schatz, P (corresponding author), Lund Univ, Skane Cty Univ Hosp, Clin Sci, Dept Ophthalmol, Lund, Sweden.	patrik.schatz@med.lu.se	Khandekar, Rajiv/ABE-6707-2020; Schatz, Patrik/E-3739-2018; Kozak, Igor/AAC-4645-2019; Schatz, Patrik/K-9894-2019	Khandekar, Rajiv/0000-0002-3925-1005; Schatz, Patrik/0000-0002-1747-0928; Schatz, Patrik/0000-0002-1747-0928	Cronqvist Foundation of the Swedish Society of Medicine; Eye Foundation; Foundation for the visually impaired in the Skane County; Crownprincess Margareta's Board for the visually impaired; Cronqvist Foundation of the Swedish Society of Medicine; Eye Foundation; Foundation for the visually impaired in the Skane County; Crownprincess Margareta's Board for the visually impaired	Cronqvist Foundation of the Swedish Society of Medicine; Eye Foundation; Foundation for the visually impaired in the Skane County; Crownprincess Margareta's Board for the visually impaired; Cronqvist Foundation of the Swedish Society of Medicine; Eye Foundation; Foundation for the visually impaired in the Skane County; Crownprincess Margareta's Board for the visually impaired	Grants from the Cronqvist Foundation of the Swedish Society of Medicine, the Eye Foundation, the Foundation for the visually impaired in the Skane County and the Crownprincess Margareta's Board for the visually impaired. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, DIABETES, V44, P968; Bleyer AJ, 2010, CLIN J AM SOC NEPHRO, V5, P1015, DOI 10.2215/CJN.08841209; Chaturvedi N, 2008, LANCET, V372, P1394, DOI 10.1016/S0140-6736(08)61412-9; Chew EY, 2010, NEW ENGL J MED, V363, P233, DOI 10.1056/NEJMoa1001288; Diabet Control Complications Trial DCCT Res Grp, 1995, AM J CARDIOL, V75, P894; Diaw M, 2015, DIABETES CARE, V38, P2120, DOI 10.2337/dc15-0699; El-Bab MF, 2012, CLIN OPHTHALMOL, V6, P269, DOI 10.2147/OPTH.S27363; Galvez-Ruiz A, 2016, J NEURO-OPHTHALMOL, V36, P131, DOI 10.1097/WNO.0000000000000329; Gross JG, 2015, JAMA-J AM MED ASSOC, V314, P2137, DOI 10.1001/jama.2015.15217; Han SZ, 2006, INT J IMMUNOGENET, V33, P281, DOI 10.1111/j.1744-313X.2006.00614.x; JACKSON H, 1995, EYE, V9, P589, DOI 10.1038/eye.1995.145; Jastaniah W, 2011, ANN SAUDI MED, V31, P289, DOI 10.4103/0256-4947.81540; Khan AR, 2010, MIDDLE EAST AFR J OP, V17, P257, DOI 10.4103/0974-9233.65502; Kopplin LJ, 2010, GENES IMMUN, V11, P609, DOI 10.1038/gene.2010.39; Lee Bao-Shiang, 2011, J Biomol Tech, V22, P90; Lemaire C, 2013, CLIN HEMORHEOL MICRO, V55, P205, DOI 10.3233/CH-2012-1622; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sjolie AK, 2008, LANCET, V372, P1385, DOI 10.1016/S0140-6736(08)61411-7; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Turner R, 1996, ANN INTERN MED, V124, P136, DOI 10.7326/0003-4819-124-1_Part_2-199601011-00011; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Wellems TE, 2009, J CLIN INVEST, V119, P2496, DOI 10.1172/JCI38307; Zhang LY, 2001, DIABETES CARE, V24, P1275, DOI 10.2337/diacare.24.7.1275	24	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159215	10.1371/journal.pone.0159215	http://dx.doi.org/10.1371/journal.pone.0159215			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414024	Green Published, Green Submitted, gold			2022-12-27	WOS:000379579500099
J	Lee, MN; Kim, JW; Oh, SH; Jeong, BC; Hwang, YC; Koh, JT				Lee, Mi Nam; Kim, Jung-Woo; Oh, Sin-Hye; Jeong, Byung-Chul; Hwang, Yun-Chan; Koh, Jeong-Tae			FGF2 Stimulates COUP-TFII Expression via the MEK1/2 Pathway to Inhibit Osteoblast Differentiation in C3H10T1/2 Cells	PLOS ONE			English	Article							FIBROBLAST GROWTH FACTOR-2; MESENCHYMAL STEM-CELLS; TRANSCRIPTION FACTOR-II; ACTIVATED PROTEIN-KINASE; OSTEOGENIC DIFFERENTIATION; CYCLIN D1; C-FOS; PROLIFERATION; MAINTENANCE; PROGRESSION	Chicken ovalbumin upstream promoter transcription factor II (COUP-TFII) is an orphan nuclear receptor that regulates many key biological processes, including organ development and cell fate determination. Although the biological functions of COUP-TFII have been studied extensively, little is known about what regulates its gene expression, especially the role of inducible extracellular factors in triggering it. Here we report that COUP-TFII expression is regulated specifically by fibroblast growth factor 2 (FGF2), which mediates activation of the MEK1/2 pathway in mesenchymal lineage C3H10T1/2 cells. Although FGF2 treatment increased cell proliferation, the induction of COUP-TFII expression was dispensable. Instead, FGF2-primed cells in which COUP-TFII expression was induced showed a low potential for osteoblast differentiation, as evidenced by decreases in alkaline phosphatase activity and osteogenic marker gene expression. Reducing COUP-TFII by U0126 or siRNA against COUP-TFII prevented the anti-osteogenic effect of FGF2, indicating that COUP-TFII plays a key role in the FGF2-mediated determination of osteoblast differentiation capability. This report is the first to suggest that FGF2 is an extracellular inducer of COUP-TFII expression and may suppress the osteogenic potential of mesenchymal cells by inducing COUP-TFII expression prior to the onset of osteogenic differentiation.	[Lee, Mi Nam; Kim, Jung-Woo; Oh, Sin-Hye; Jeong, Byung-Chul; Koh, Jeong-Tae] Chonnam Natl Univ, Sch Dent, Res Ctr Biomineralizat Disorders, Gwangju, South Korea; [Lee, Mi Nam; Kim, Jung-Woo; Oh, Sin-Hye; Jeong, Byung-Chul; Hwang, Yun-Chan; Koh, Jeong-Tae] Chonnam Natl Univ, Sch Dent, Dept Pharmacol & Dent Therapeut, Gwangju, South Korea; [Hwang, Yun-Chan] Chonnam Natl Univ, Sch Dent, Dept Conservat Dent, Gwangju, South Korea	Chonnam National University; Chonnam National University; Chonnam National University	Koh, JT (corresponding author), Chonnam Natl Univ, Sch Dent, Res Ctr Biomineralizat Disorders, Gwangju, South Korea.; Koh, JT (corresponding author), Chonnam Natl Univ, Sch Dent, Dept Pharmacol & Dent Therapeut, Gwangju, South Korea.	jtkoh@chonnam.ac.kr			National Research Foundation of Korea (NRF) grants - Korean government [2011-0030121]; Chonnam National University Hospital Research Institute of Clinical Medicine [CRI 13905-21]	National Research Foundation of Korea (NRF) grants - Korean government; Chonnam National University Hospital Research Institute of Clinical Medicine	This study was supported by National Research Foundation of Korea (NRF) grants funded by the Korean government (2011-0030121) and Chonnam National University Hospital Research Institute of Clinical Medicine (CRI 13905-21). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by National Research Foundation of Korea (NRF) grants funded by the Korean government (2011-0030121) and Chonnam National University Hospital Research Institute of Clinical Medicine (CRI 13905-21).	Ahn HJ, 2009, FEBS LETT, V583, P2922, DOI 10.1016/j.febslet.2009.07.056; Byun MR, 2014, BONE, V58, P72, DOI 10.1016/j.bone.2013.09.024; Carreira AC, 2014, J DENT RES, V93, P335, DOI 10.1177/0022034513518561; Chen XP, 2012, MOL ENDOCRINOL, V26, P1268, DOI 10.1210/me.2011-1305; Choi SC, 2008, STEM CELLS DEV, V17, P725, DOI 10.1089/scd.2007.0230; Cuevas BD, 2007, ONCOGENE, V26, P3159, DOI 10.1038/sj.onc.1210409; Debiais F, 2004, EXP CELL RES, V297, P235, DOI 10.1016/j.yexcr.2004.03.032; Debiais F, 1998, J BONE MINER RES, V13, P645, DOI 10.1359/jbmr.1998.13.4.645; Deschaseaux F, 2009, TRENDS MOL MED, V15, P417, DOI 10.1016/j.molmed.2009.07.002; Di Maggio N, 2012, STEM CELLS, V30, P1455, DOI 10.1002/stem.1106; El Agha E, 2016, SEMIN CELL DEV BIOL, V53, P76, DOI 10.1016/j.semcdb.2015.10.009; Eom YW, 2014, BIOCHEM BIOPH RES CO, V445, P16, DOI 10.1016/j.bbrc.2014.01.084; Frederick TJ, 2007, GLIA, V55, P1011, DOI 10.1002/glia.20520; Hu SJ, 2013, STEM CELLS, V31, P259, DOI 10.1002/stem.1278; Hur SW, 2015, J DENT RES, V94, P1135, DOI 10.1177/0022034515585125; Ito T, 2007, BIOCHEM BIOPH RES CO, V359, P108, DOI 10.1016/j.bbrc.2007.05.067; Jeong BC, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.485; Kakudo N, 2007, BIOCHEM BIOPH RES CO, V359, P239, DOI 10.1016/j.bbrc.2007.05.070; Kalajzic I, 2003, J CELL BIOCHEM, V88, P1168, DOI 10.1002/jcb.10459; Kang HB, 2005, STEM CELLS DEV, V14, P395, DOI 10.1089/scd.2005.14.395; Kang IH, 2015, J CELL PHYSIOL, V230, P911, DOI 10.1002/jcp.24822; Kim S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120073; Lai WT, 2011, STEM CELLS, V29, P1102, DOI 10.1002/stem.661; Lee KN, 2012, J BIOL CHEM, V287, P18888, DOI 10.1074/jbc.M111.311878; Lim S, 2016, CELL TISSUE RES, V364, P137, DOI 10.1007/s00441-015-2311-8; Martin I, 1997, ENDOCRINOLOGY, V138, P4456, DOI 10.1210/en.138.10.4456; Montero A, 2000, J CLIN INVEST, V105, P1085, DOI 10.1172/JCI8641; Nakshatri H, 2000, BIOCHEM BIOPH RES CO, V270, P1144, DOI 10.1006/bbrc.2000.2562; Okamura M, 2009, P NATL ACAD SCI USA, V106, P5819, DOI 10.1073/pnas.0901676106; OKAZAKI R, 1992, J BONE MINER RES, V7, P1149; Pereira FA, 1999, GENE DEV, V13, P1037, DOI 10.1101/gad.13.8.1037; Qin J, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-58; Quarto N, 2008, BONE, V42, P1040, DOI 10.1016/j.bone.2008.01.026; Rosa A, 2011, EMBO J, V30, P237, DOI 10.1038/emboj.2010.319; Satija NK, 2007, STEM CELLS DEV, V16, P7, DOI 10.1089/scd.2006.9998; Solchaga LA, 2010, TISSUE ENG PT A, V16, P1009, DOI [10.1089/ten.tea.2009.0100, 10.1089/ten.TEA.2009.0100]; Song T, 2013, INT J BIOCHEM CELL B, V45, P1639, DOI 10.1016/j.biocel.2013.05.005; Standal T, 2007, BLOOD, V109, P3024, DOI 10.1182/blood-2006-07-034884; Tsai SY, 1997, ENDOCR REV, V18, P229, DOI 10.1210/er.18.2.229; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Uhlik MT, 2004, BIOCHEM CELL BIOL, V82, P658, DOI 10.1139/O04-114; van Gastel N, 2014, STEM CELLS, V32, P2407, DOI 10.1002/stem.1783; Wen Q, 2012, J CELL MOL MED, V16, P1260, DOI 10.1111/j.1582-4934.2011.01407.x; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Xie X, 2011, P NATL ACAD SCI USA, V108, P14843, DOI 10.1073/pnas.1110236108; Xu Z, 2008, P NATL ACAD SCI USA, V105, P2421, DOI 10.1073/pnas.0707082105	46	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0159234	10.1371/journal.pone.0159234	http://dx.doi.org/10.1371/journal.pone.0159234			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27404388	Green Published, Green Submitted, gold			2022-12-27	WOS:000379508200044
J	Song, J; Liu, ZX; Hong, HL; Ma, YS; Tian, L; Li, XX; Li, YH; Guan, RX; Guo, Y; Qiu, LJ				Song, Jian; Liu, Zhangxiong; Hong, Huilong; Ma, Yansong; Tian, Long; Li, Xinxiu; Li, Ying-Hui; Guan, Rongxia; Guo, Yong; Qiu, Li-Juan			Identification and Validation of Loci Governing Seed Coat Color by Combining Association Mapping and Bulk Segregation Analysis in Soybean	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; GENOME-WIDE ASSOCIATION; IRON-DEFICIENCY CHLOROSIS; GENETIC-LINKAGE MAP; NATURAL VARIATION; FLAVONOID 3'-HYDROXYLASE; MARKER DEVELOPMENT; TOLERANCE; PIGMENTATION; RESISTANCE	Soybean seed coat exists in a range of colors from yellow, green, brown, black, to bicolor. Classical genetic analysis suggested that soybean seed color was a moderately complex trait controlled by multi-loci. However, only a couple of loci could be detected using a single biparental segregating population. In this study, a combination of association mapping and bulk segregation analysis was employed to identify genes/loci governing this trait in soybean. A total of 14 loci, including nine novel and five previously reported ones, were identified using 176,065 coding SNPs selected from entire SNP dataset among 56 soybean accessions. Four of these loci were confirmed and further mapped using a biparental population developed from the cross between ZP95-5383 (yellow seed color) and NY279 (brown seed color), in which different seed coat colors were further dissected into simple trait pairs (green/yellow, green/black, green/brown, yellow/black, yellow/brown, and black/brown) by continuously developing residual heterozygous lines. By genotyping entire F-2 population using flanking markers located in fine-mapping regions, the genetic basis of seed coat color was fully dissected and these four loci could explain all variations of seed colors in this population. These findings will be useful for map-based cloning of genes as well as marker-assisted breeding in soybean. This work also provides an alternative strategy for systematically isolating genes controlling relative complex trait by association analysis followed by biparental mapping.	[Guo, Yong; Qiu, Li-Juan] Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing, Peoples R China; Chinese Acad Agr Sci, MOA Key Lab Soybean Biol Beijing, Inst Crop Sci, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Guo, Y; Qiu, LJ (corresponding author), Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing, Peoples R China.	guoyong@caas.cn; qiulijuan@caas.cn	Song, Jian/HGD-2320-2022		Agricultural Science and Technology Innovation Program (ASTIP) of Chinese Academy of Agricultural Sciences; State High-tech Research and Development Program [2013AA102602]; National Natural Science Foundation of China [31271753]; Accurate Identification and Display of Soybean Germplasm [NB2010-2130315-25-05]; National Crop Germplasm Platform [2012-004, 2014-004]	Agricultural Science and Technology Innovation Program (ASTIP) of Chinese Academy of Agricultural Sciences; State High-tech Research and Development Program(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Accurate Identification and Display of Soybean Germplasm; National Crop Germplasm Platform	This work was supported by the Agricultural Science and Technology Innovation Program (ASTIP) of Chinese Academy of Agricultural Sciences, recipient: LJQ; the State High-tech Research and Development Program, grant no. 2013AA102602, recipient: YG; National Natural Science Foundation of China, grant no. 31271753; Accurate Identification and Display of Soybean Germplasm, grant no. NB2010-2130315-25-05; and National Crop Germplasm Platform, grant no. 2012-004; 2014-004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appels R, 2013, FUNCT INTEGR GENOMIC, V13, P1, DOI 10.1007/s10142-013-0319-2; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Bastien M, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2013.10.0030; Benitez ER, 2004, CROP SCI, V44, P2038, DOI 10.2135/cropsci2004.2038; Brachi B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000940; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; BUZZELL RI, 1987, J HERED, V78, P53, DOI 10.1093/oxfordjournals.jhered.a110309; Carpenter J, 2002, COMP ENV IMPACTS BIO, P15; Cho YB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076954; Clough SJ, 2004, GENOME, V47, P819, DOI 10.1139/G04-049; Cregan PB, 1999, CROP SCI, V39, P1464, DOI 10.2135/cropsci1999.3951464x; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Dixon RA, 2003, PLANT PHYSIOL, V131, P878, DOI 10.1104/pp.102.017319; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Famoso AN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002221; Fang C, 2014, PLANT J, V77, P700, DOI 10.1111/tpj.12419; Gillman JD, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-155; Githiri SM, 2007, J HERED, V98, P360, DOI 10.1093/jhered/esm042; Gore MA, 2002, GENOME, V45, P592, DOI 10.1139/G02-009; Guan RX, 2014, PLANT J, V80, P937, DOI 10.1111/tpj.12695; Guiamet JJ, 1996, PHYSIOL PLANTARUM, V96, P655, DOI 10.1111/j.1399-3054.1996.tb00239.x; Guo Y, 2013, THEOR APPL GENET, V126, P1445, DOI 10.1007/s00122-013-2063-3; Hao DR, 2012, THEOR APPL GENET, V124, P447, DOI 10.1007/s00122-011-1719-0; Hartman GL, 2011, FOOD SECUR, V3, P5, DOI 10.1007/s12571-010-0108-x; Henry IM, 2014, PLANT CELL, V26, P181, DOI 10.1105/tpc.113.120626; HOLTON TA, 1995, PLANT CELL, V7, P1071, DOI 10.1105/tpc.7.7.1071; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Hymowitz T., 1980, Advances in legume science (Summerfield, R.J.; Bunting, A.H. [Editors])., P251; Kadam S, 2016, PLANT SCI, V242, P342, DOI 10.1016/j.plantsci.2015.08.015; Koes R, 2005, TRENDS PLANT SCI, V10, P236, DOI 10.1016/j.tplants.2005.03.002; Korir PC, 2013, THEOR APPL GENET, V126, P1659, DOI 10.1007/s00122-013-2082-0; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; LARK KG, 1993, THEOR APPL GENET, V86, P901, DOI 10.1007/BF00211039; Li H, 2013, NAT GENET, V45, P43, DOI 10.1038/ng.2484; Li YB, 2011, NAT GENET, V43, P1266, DOI 10.1038/ng.977; Li YH, 2014, NAT BIOTECHNOL, V32, P1045, DOI 10.1038/nbt.2979; Li YH, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0251-1; Li YH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-579; Li YH, 2011, CONSERV GENET, V12, P1145, DOI 10.1007/s10592-011-0216-y; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Lohnes DG, 1997, CROP SCI, V37, P254, DOI 10.2135/cropsci1997.0011183X003700010045x; Mamidi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107469; Mamidi S, 2011, PLANT GENOME-US, V4, P154, DOI 10.3835/plantgenome2011.04.0011; Mitchell-Olds T, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-113; Motte H, 2014, P NATL ACAD SCI USA, V111, P8305, DOI 10.1073/pnas.1404978111; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nakano M, 2014, PLANT CELL PHYSIOL, V55, P1763, DOI 10.1093/pcp/pcu107; Niu Y, 2013, MOL BREEDING, V31, P785, DOI 10.1007/s11032-012-9833-5; Ohnishi S, 2011, THEOR APPL GENET, V122, P633, DOI 10.1007/s00122-010-1475-6; Owen FV, 1928, GENETICS, V13, P0050; Oyoo ME, 2011, CROP SCI, V51, P464, DOI 10.2135/cropsci2010.02.0121; Palmer R, 2004, QUALITATIVE GENETICS, V3rd; REESE PF, 1989, J HERED, V80, P86, DOI 10.1093/oxfordjournals.jhered.a110803; Ren ZH, 2010, P NATL ACAD SCI USA, V107, P5669, DOI 10.1073/pnas.0910798107; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Senda M, 2004, PLANT CELL, V16, P807, DOI 10.1105/tpc.019885; Senda M, 2013, BREEDING SCI, V63, P384, DOI 10.1270/jsbbs.63.384; Senda M, 2011, BREEDING SCI, V61, P523, DOI 10.1270/jsbbs.61.523; Sonah H, 2015, PLANT BIOTECHNOL J, V13, P211, DOI 10.1111/pbi.12249; Song QJ, 2010, CROP SCI, V50, P1950, DOI 10.2135/cropsci2009.10.0607; Song QJ, 2004, THEOR APPL GENET, V109, P122, DOI 10.1007/s00122-004-1602-3; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Sterken R, 2012, P NATL ACAD SCI USA, V109, P4678, DOI 10.1073/pnas.1120811109; Takahashi R, 1996, CROP SCI, V36, P559, DOI 10.2135/cropsci1996.0011183X003600030004x; Takahashi R, 1997, CROP SCI, V37, P1755, DOI 10.2135/cropsci1997.0011183X003700060014x; Tardivel A, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2013.10.0034; Toda K, 2002, PLANT MOL BIOL, V50, P187, DOI 10.1023/A:1016087221334; TODD JJ, 1993, PLANT PHYSIOL, V102, P663, DOI 10.1104/pp.102.2.663; Todd JJ, 1996, PLANT CELL, V8, P687, DOI 10.1105/tpc.8.4.687; Turner S.D., 2018, BIORXIV, V3, P731, DOI [10.1101/005165, 10.21105/joss.00731, DOI 10.1101/005165.V1]; Tuteja JH, 2004, PLANT CELL, V16, P819, DOI 10.1105/tpc.021352; Tuteja JH, 2009, PLANT CELL, V21, P3063, DOI 10.1105/tpc.109.069856; van Berloo R, 2008, J HERED, V99, P232, DOI 10.1093/jhered/esm109; Vuong TD, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1811-y; Wang J, 2008, THEOR APPL GENET, V116, P777, DOI 10.1007/s00122-008-0710-x; Watanabe S, 2011, GENETICS, V188, P395, DOI 10.1534/genetics.110.125062; Watanabe S, 2009, GENETICS, V182, P1251, DOI 10.1534/genetics.108.098772; WEISS MG, 1970, CROP SCI, V10, P300, DOI 10.2135/cropsci1970.0011183X001000030027x; Woodworth CM, 1921, GENETICS, V6, P487; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yang K, 2010, J HERED, V101, P757, DOI 10.1093/jhered/esq078; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zabala G, 2003, GENETICS, V163, P295; Zabala G, 2007, CROP SCI, V47, pS113, DOI 10.2135/cropsci2006.12.0838tpg; Zabala G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111959; Zhang ZY, 2006, PLANT CELL, V18, P1524, DOI 10.1105/tpc.105.039602	88	26	30	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0159064	10.1371/journal.pone.0159064	http://dx.doi.org/10.1371/journal.pone.0159064			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27404272	Green Published, gold, Green Submitted			2022-12-27	WOS:000379508200032
J	Baruah, PS; Beauchemin, M; Hebert, J; Bertrand, R				Baruah, Prasamit Saurav; Beauchemin, Myriam; Hebert, Josee; Bertrand, Richard			Dynamic Bcl-xL (S49) and (S62) Phosphorylation/Dephosphorylation during Mitosis Prevents Chromosome Instability and Aneuploidy in Normal Human Diploid Fibroblasts	PLOS ONE			English	Article							INFLAMMATORY CYTOKINE SECRETION; CELL-CYCLE PROGRESSION; POLO-LIKE KINASES; FAMILY-MEMBERS; IN-VIVO; MITOCHONDRIAL APOPTOSIS; BUBR1 INSUFFICIENCY; GENE-EXPRESSION; BH3 DOMAIN; BCL-X(L)	Bcl-xL proteins undergo dynamic phosphorylation/dephosphorylation on Ser49 and Ser62 residues during mitosis. The expression of Bcl-xL(S49A), (S62A) and dual (S49/62A) phosphorylation mutants in tumor cells lead to severe mitotic defects associated with multipolar spindle, chromosome lagging and bridging, and micro-, bi- and multi-nucleated cells. Because the above observations were made in tumor cells which already display genomic instability, we now address the question: will similar effects occur in normal human diploid cells? We studied normal human diploid BJ foreskin fibroblast cells expressing Bcl-xL (wild type), (S49A), (S49D), (S62A), (S62D) and the dual-site (S49/62A) and (S49/62D) mutants. Cells expressing S49 and/or S62 phosphorylation mutants showed reduced kinetics of cell population doubling. These effects on cell population doubling kinetics correlated with early outbreak of senescence with no impact on the cell death rate. Senescent cells displayed typical senescence-associated phenotypes including high-level of senescence-associated beta-galactosidase activity, interleukin-6 (IL-6) secretion, tumor suppressor p53 and cyclin-dependent kinase inhibitor p21Waf1/Cip1 activation as well as gamma H2A.X-associated nuclear chromatin foci. Fluorescence in situ hybridization analysis and Giemsa-banded karyotypes revealed that the expression of Bcl-xL phosphorylation mutants in normal diploid BJ cells provoked chromosome instability and aneuploidy. These findings suggest that dynamic Bcl-xL(S49) and (S62) phosphorylation/dephosphorylation cycles are important in the maintenance of chromosome integrity during mitosis in normal cells. They could impact future strategies aiming to develop and identify compounds that could target not only the anti-apoptotic domain of Bcl-xL protein, but also its mitotic domain for cancer therapy.	[Baruah, Prasamit Saurav; Beauchemin, Myriam; Bertrand, Richard] Ctr Hosp Univ Montreal CRCHUM, Ctr Rech, Montreal, PQ, Canada; [Baruah, Prasamit Saurav; Beauchemin, Myriam; Bertrand, Richard] Inst Canc Montreal, Montreal, PQ, Canada; [Hebert, Josee] Hop Maisonneuve Rosemt, Ctr Rech, Quebec Leukemia Cell Bank, Montreal, PQ, Canada; [Hebert, Josee; Bertrand, Richard] Univ Montreal, Dept Med, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Bertrand, R (corresponding author), Ctr Hosp Univ Montreal CRCHUM, Ctr Rech, Montreal, PQ, Canada.; Bertrand, R (corresponding author), Inst Canc Montreal, Montreal, PQ, Canada.; Bertrand, R (corresponding author), Univ Montreal, Dept Med, Montreal, PQ, Canada.	richard.bertrand@umontreal.ca			Canadian Institutes of Health Research [MOP-97913]; Natural Sciences and Engineering Research Council of Canada [328207]; Cancer Research Network of Fonds de recherche du Quebec-Sante; Faculte des etudes superieures (Universite de Montreal, Canada); Fondation de l'Institut du cancer de Montreal (Canada)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Cancer Research Network of Fonds de recherche du Quebec-Sante; Faculte des etudes superieures (Universite de Montreal, Canada); Fondation de l'Institut du cancer de Montreal (Canada)	This work was funded by Grant MOP-97913 from the Canadian Institutes of Health Research and Grant 328207 from the Natural Sciences and Engineering Research Council of Canada to RB, and a grant from the Cancer Research Network of Fonds de recherche du Quebec-Sante to JH. PSB received scholarships from the Faculte des etudes superieures (Universite de Montreal, Canada) and the Fondation de l'Institut du cancer de Montreal (Canada).	Baker DJ, 2008, NAT CELL BIOL, V10, P825, DOI 10.1038/ncb1744; Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382; Basu A, 2003, FEBS LETT, V538, P41, DOI 10.1016/S0014-5793(03)00131-5; Berman SB, 2009, J CELL BIOL, V184, P707, DOI 10.1083/jcb.200809060; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Borner C, 1996, J BIOL CHEM, V271, P12695, DOI 10.1074/jbc.271.22.12695; Burri SH, 1999, INT J RADIAT ONCOL, V43, P423, DOI 10.1016/S0360-3016(98)00385-X; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1; Chang BS, 1997, EMBO J, V16, P968, DOI 10.1093/emboj/16.5.968; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Degterev A, 2001, NAT CELL BIOL, V3, P173, DOI 10.1038/35055085; Diaz JL, 1997, J BIOL CHEM, V272, P11350; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dumay A, 2006, ONCOGENE, V25, P3196, DOI 10.1038/sj.onc.1209344; Fan MY, 2000, J BIOL CHEM, V275, P29980, DOI 10.1074/jbc.M003776200; Fang W, 1996, IMMUNITY, V4, P291, DOI 10.1016/S1074-7613(00)80437-9; Fujise K, 2000, J BIOL CHEM, V275, P39458, DOI 10.1074/jbc.M006626200; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Helmke C, 2016, ONCOGENE, V35, P135, DOI 10.1038/onc.2015.105; Huang DCS, 1997, EMBO J, V16, P4628, DOI 10.1093/emboj/16.15.4628; Janumyan YM, 2003, EMBO J, V22, P5459, DOI 10.1093/emboj/cdg533; Juin P, 2013, NAT REV CANCER, V13, P455, DOI 10.1038/nrc3538; Karczmarek-Borowska B, 2006, LUNG CANCER, V51, P61, DOI 10.1016/j.lungcan.2005.08.010; Krajewska M, 1996, CANCER RES, V56, P2422; Kumar S, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/705745; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Li HM, 2013, NAT CELL BIOL, V15, P773, DOI 10.1038/ncb2791; Liu XQ, 2015, TRANSL ONCOL, V8, P185, DOI 10.1016/j.tranon.2015.03.010; Mallick S, 2013, HEAD NECK-J SCI SPEC, V35, P1448, DOI 10.1002/hed.23153; Morales CP, 1999, NAT GENET, V21, P115, DOI 10.1038/5063; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Poruchynsky MS, 1998, CANCER RES, V58, P3331; Qian J, 2004, ANAL BIOCHEM, V328, P131, DOI 10.1016/j.ab.2003.12.034; REED JC, 1994, J CELL BIOL, V124, P1, DOI 10.1083/jcb.124.1.1; Rodier F, 2011, J CELL SCI, V124, P68, DOI 10.1242/jcs.071340; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Saintigny Y, 2001, EMBO J, V20, P2596, DOI 10.1093/emboj/20.10.2596; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Schliekelman M, 2009, CANCER RES, V69, P45, DOI 10.1158/0008-5472.CAN-07-6330; Schmitt E, 2007, ONCOGENE, V26, P5851, DOI 10.1038/sj.onc.1210396; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; Sharma J, 2005, PANCREAS, V30, P337, DOI 10.1097/01.mpa.0000160282.64451.f1; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Talati C, 2016, CRIT REV ONCOL HEMAT, V98, P200, DOI 10.1016/j.critrevonc.2015.10.013; Tao ZF, 2014, ACS MED CHEM LETT, V5, P1088, DOI 10.1021/ml5001867; Wang JF, 2014, CELL CYCLE, V13, P1313, DOI 10.4161/cc.28293; Wang JF, 2012, CELL CYCLE, V11, P2159, DOI 10.4161/cc.20672; Wang JF, 2011, CELL SIGNAL, V23, P2030, DOI 10.1016/j.cellsig.2011.07.017; Wang QH, 2008, MOL CELL, V29, P488, DOI 10.1016/j.molcel.2007.12.029; Watanabe J, 2004, SURGERY, V135, P604, DOI 10.1016/j.surg.2003.11.015; Wiese C, 2002, CANCER RES, V62, P1279; Williams J, 2005, GYNECOL ONCOL, V96, P287, DOI 10.1016/j.ygyno.2004.10.026; Wong H, 1996, EXP GERONTOL, V31, P311, DOI 10.1016/0531-5565(95)00025-9; Yamaguchi R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024102; Yang JS, 2011, ACTA HISTOCHEM, V113, P810, DOI 10.1016/j.acthis.2011.01.002; Zitouni S, 2014, NAT REV MOL CELL BIO, V15, P433, DOI 10.1038/nrm3819	57	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2016	11	7							e0159091	10.1371/journal.pone.0159091	http://dx.doi.org/10.1371/journal.pone.0159091			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CN	27398719	gold, Green Published, Green Submitted			2022-12-27	WOS:000379508100018
J	Verburg, PE; Tucker, G; Scheil, W; Erwich, JJHM; Dekker, GA; Roberts, CT				Verburg, Petra E.; Tucker, Graeme; Scheil, Wendy; Erwich, Jan Jaap H. M.; Dekker, Gus A.; Roberts, Claire Trelford			Sexual Dimorphism in Adverse Pregnancy Outcomes - A Retrospective Australian Population Study 1981-2011	PLOS ONE			English	Article							FETAL SEX; PRETERM BIRTH; PLACENTAL DYSFUNCTION; GESTATIONAL-AGE; GENDER; PREECLAMPSIA; HYPERTENSION; EXCESS; MALES	Objectives Sexual inequality starts in utero. The contribution of biological sex to the developmental origins of health and disease is increasingly recognized. The aim of this study was to assess and interpret sexual dimorphisms for three major adverse pregnancy outcomes which affect the health of the neonate, child and potentially adult. Methods Retrospective population-based study of 574,358 South Australian singleton live births during 1981-2011. The incidence of three major adverse pregnancy outcomes [preterm birth (PTB), pregnancy induced hypertensive disorders (PIHD) and gestational diabetes mellitus (GDM)] in relation to fetal sex was compared according to traditional and fetus-at-risk (FAR) approaches. Results The traditional approach showed male predominance for PTB [20-24 weeks: Relative Risk (RR) M/F 1.351, 95%-CI 1.274-1.445], spontaneous PTB [25-29 weeks: RR M/F 1.118, 95%-CI 1.044-1.197%], GDM [RR M/F 1.042, 95%-CI 1.011-1.074], overall PIHD [RR M/F 1.053, 95%-CI 1.034-1.072] and PIHD with term birth [RR M/F 1.074, 95%-CI 1.044-1.105]. The FAR approach showed that males were at increased risk for PTB [20-24 weeks: RR M/F 1.273, 95%-CI 1.087-1.490], for spontaneous PTB [25-29 weeks: RR M/F 1.269, 95%-CI 1.143-1.410] and PIHD with term birth [RR M/F 1.074, 95%-CI 1.044-1.105%]. The traditional approach demonstrated female predominance for iatrogenic PTB [25-29 weeks: RR M/F 0.857, 95%-CI 0.780-0.941] and PIHD associated with PTB [25-29 weeks: RR M/F 0.686, 95%-CI 0.581-0.811]. The FAR approach showed that females were at increased risk for PIHD with PTB [25-29 weeks: RR M/F 0.779, 95%-CI 0.648-0.937]. Conclusions This study confirms the presence of sexual dimorphisms and presents a coherent framework based on two analytical approaches to assess and interpret the sexual dimorphisms for major adverse pregnancy outcomes. The mechanisms by which these occur remain elusive, but sex differences in placental gene expression and function are likely to play a key role. Further research on sex differences in placental function and maternal adaptation to pregnancy is required to delineate the causal molecular mechanisms in sex-specific pregnancy outcome. Identifying these mechanisms may inform fetal sex specific tailored antenatal and neonatal care.	[Verburg, Petra E.; Dekker, Gus A.; Roberts, Claire Trelford] Univ Adelaide, Sch Med, Robinson Res Inst, Adelaide, SA, Australia; [Verburg, Petra E.; Erwich, Jan Jaap H. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynaecol, Groningen, Netherlands; [Verburg, Petra E.; Tucker, Graeme; Scheil, Wendy] SA Hlth, Epidemiol Branch, Adelaide, SA, Australia; [Tucker, Graeme; Scheil, Wendy] Univ Adelaide, Sch Med, Adelaide, SA, Australia; [Dekker, Gus A.] Lyell McEwin Hosp, Dept Obstet & Gynaecol, Elizabeth Vale, SA, Australia	Robinson Research Institute; University of Adelaide; University of Groningen; University of Adelaide; Lyell McEwin Hospital	Roberts, CT (corresponding author), Univ Adelaide, Sch Med, Robinson Res Inst, Adelaide, SA, Australia.	claire.roberts@adelaide.edu.au	Tucker, Graeme R/AAP-4228-2020	Roberts, Claire/0000-0002-9250-2192				Aibar L, 2012, J PERINAT MED, V40, P271, DOI 10.1515/jpm-2011-0137; Alzaim M, 2013, NUTR REV, V71, P158, DOI 10.1111/nure.12018; Asvold BO, 2014, HUM REPROD, V29, P1153, DOI 10.1093/humrep/deu068; Blencowe H, 2013, PEDIATR RES, V74, P17, DOI 10.1038/pr.2013.204; Brettell R, 2008, EUR J OBSTET GYN R B, V141, P123, DOI 10.1016/j.ejogrb.2008.07.030; Buckberry S, 2014, MOL HUM REPROD, V20, P810, DOI 10.1093/molehr/gau035; BYRNE J, 1987, AM J MED GENET, V26, P605, DOI 10.1002/ajmg.1320260315; Clifton VL, 2010, PLACENTA, V31, pS33, DOI 10.1016/j.placenta.2009.11.010; Colagiuri S, 2014, DIABETES RES CLIN PR, V103, P364, DOI 10.1016/j.diabres.2014.02.012; Cooperstock M, 1996, OBSTET GYNECOL, V88, P189, DOI 10.1016/0029-7844(96)00106-8; Di Renzo GC, 2007, GENDER MED, V4, P19, DOI 10.1016/S1550-8579(07)80004-0; Elsmen E, 2006, ACTA OBSTET GYN SCAN, V85, P1285, DOI 10.1080/00016340600578274; Eriksson JG, 2010, AM J HUM BIOL, V22, P330, DOI 10.1002/ajhb.20995; Gardner DK, 2010, MOL HUM REPROD, V16, P539, DOI 10.1093/molehr/gaq042; Ghidini A, 2005, ACTA OBSTET GYN SCAN, V84, P547, DOI 10.1111/j.0001-6349.2005.00694.x; Ghidini A, 2005, BJOG-INT J OBSTET GY, V112, P140, DOI 10.1111/j.1471-0528.2004.00308.x; Gilbert JS, 2008, AM J PHYSIOL-REG I, V295, pR1941, DOI 10.1152/ajpregu.90724.2008; Illescas T, 2013, EUR J OBSTET GYN R B, V167, P14, DOI 10.1016/j.ejogrb.2012.10.023; Ingemarsson I, 2003, BJOG-INT J OBSTET GY, V110, P34, DOI 10.1016/S1470-0328(03)00022-3; Joseph K S, 2007, BMC Pregnancy Childbirth, V7, P4, DOI 10.1186/1471-2393-7-4; Khalil MM, 2013, LIBYAN J MED, V8, DOI 10.3402/ljm.v8i0.20008; Khong Y, 2011, BEST PRACT RES CL OB, V25, P301, DOI 10.1016/j.bpobgyn.2010.10.012; McLean A, 2001, VALIDATION 1994 S AU; Melamed N, 2010, J MATERN-FETAL NEO M, V23, P338, DOI 10.3109/14767050903300969; Muenchhoff M, 2014, J INFECT DIS, V209, pS120, DOI 10.1093/infdis/jiu232; Newbern D, 2011, CURR OPIN ENDOCRINOL, V18, P409, DOI 10.1097/MED.0b013e32834c800d; Redman CWG, 2010, AM J REPROD IMMUNOL, V63, P534, DOI 10.1111/j.1600-0897.2010.00831.x; Roberge S, 2011, J OBSTET GYNAECOL CA, V33, P216, DOI 10.1016/S1701-2163(16)34822-8; Roberts CT, 2010, PLACENTA, V31, pS47, DOI 10.1016/j.placenta.2010.01.001; Sheiner E, 2004, FETAL DIAGN THER, V19, P366, DOI 10.1159/000077967; Shiozaki A, 2011, J REPROD IMMUNOL, V89, P133, DOI 10.1016/j.jri.2010.12.011; Stark MJ, 2009, AM J PHYSIOL-REG I, V297, pR510, DOI 10.1152/ajpregu.00175.2009; Townsend EA, 2012, ENDOCR REV, V33, P1, DOI 10.1210/er.2010-0031; Tranquilli AL, 2012, PREGNANCY HYPERTENS, V2, P350, DOI [10.1016/j.preghy.2012.05.006, 10.1016/j.preghy.2012.04.146]; Vatten LJ, 2004, EARLY HUM DEV, V76, P47, DOI 10.1016/j.earlhumdev.2003.10.006; Walker MG, 2012, PLACENTA, V33, P568, DOI 10.1016/j.placenta.2012.03.011; Xiao L, 2014, DIABETIC MED, P1; YUDKIN PL, 1987, LANCET, V1, P1192; Zeitlin J, 2004, AM J OBSTET GYNECOL, V190, P1322, DOI 10.1016/j.ajog.2003.10.703; Zeitlin J, 2002, HUM REPROD, V17, P2762, DOI 10.1093/humrep/17.10.2762	40	46	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2016	11	7							e0158807	10.1371/journal.pone.0158807	http://dx.doi.org/10.1371/journal.pone.0158807			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CN	27398996	Green Published, Green Submitted, gold			2022-12-27	WOS:000379508100009
J	Jiang, D; Hao, GZ; Huang, LW; Zhang, D				Jiang, Dan; Hao, Guozhu; Huang, Liwen; Zhang, Dan			Use of Cusp Catastrophe for Risk Analysis of Navigational Environment: A Case Study of Three Gorges Reservoir Area	PLOS ONE			English	Article							SAFETY ASSESSMENT	A water traffic system is a huge, nonlinear, complex system, and its stability is affected by various factors. Water traffic accidents can be considered to be a kind of mutation of a water traffic system caused by the coupling of multiple navigational environment factors. In this study, the catastrophe theory, principal component analysis (PCA), and multivariate statistics are integrated to establish a situation recognition model for a navigational environment with the aim of performing a quantitative analysis of the situation of this environment via the extraction and classification of its key influencing factors; in this model, the natural environment and traffic environment are considered to be two control variables. The Three Gorges Reservoir area of the Yangtze River is considered as an example, and six critical factors, i.e., the visibility, wind, current velocity, route intersection, channel dimension, and traffic flow, are classified into two principal components: the natural environment and traffic environment. These two components are assumed to have the greatest influence on the navigation risk. Then, the cusp catastrophe model is employed to identify the safety situation of the regional navigational environment in the Three Gorges Reservoir area. The simulation results indicate that the situation of the navigational environment of this area is gradually worsening from downstream to upstream.	[Jiang, Dan; Hao, Guozhu; Huang, Liwen] Wuhan Univ Technol, Dept Nav, Wuhan, Hubei, Peoples R China; [Jiang, Dan; Hao, Guozhu; Huang, Liwen; Zhang, Dan] Key Lab Hubei Inland Shipping Technol, Wuhan, Hubei, Peoples R China; [Zhang, Dan] Chongqing Jiaotong Univ, Dept Nav, Chongqing, Peoples R China	Wuhan University of Technology; Chongqing Jiaotong University	Hao, GZ (corresponding author), Wuhan Univ Technol, Dept Nav, Wuhan, Hubei, Peoples R China.; Hao, GZ (corresponding author), Key Lab Hubei Inland Shipping Technol, Wuhan, Hubei, Peoples R China.	65518385@qq.com			National Natural Science Foundation of China [51379170]; Fundamental Research Funds for the Central Universities (Self-determined and innovative research funds of WUT); Fundamental Research Funds for the Central Universities [2014-JL-010]; Key Project in the National Science AMP; Technology Pillar Program [2015BAG20B05]; Fund of Hubei Inland Shipping Technology Key Laboratory [NHHY2014002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities (Self-determined and innovative research funds of WUT)(Fundamental Research Funds for the Central Universities); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Key Project in the National Science AMP; Technology Pillar Program; Fund of Hubei Inland Shipping Technology Key Laboratory	This work was financially supported by the National Natural Science Foundation of China (Grant No. 51379170) received by LWH, the Fundamental Research Funds for the Central Universities (Self-determined and innovative research funds of WUT), Fundamental Research Funds for the Central Universities (Grant No. 2014-JL-010) received by DJ, grants from the Key Project in the National Science & Technology Pillar Program (Grant No. 2015BAG20B05) received by LWH, and the Fund of Hubei Inland Shipping Technology Key Laboratory (No. NHHY2014002) received by DZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balmat JF, 2009, OCEAN ENG, V36, P1278, DOI 10.1016/j.oceaneng.2009.07.003; [陈蜀喆 Chen Shuzhe], 2014, [中国航海, Journal of Navigation of China], V37, P36; Chen YH, 2015, MAR GEORESOUR GEOTEC, V33, P222, DOI 10.1080/1064119X.2013.836259; Girtler J, 2014, POL MARIT RES, V21, P9, DOI 10.2478/pomr-2014-0002; Hetherington C, 2006, J SAFETY RES, V37, P401, DOI 10.1016/j.jsr.2006.04.007; Kujala P, 2009, RELIAB ENG SYST SAFE, V94, P1349, DOI 10.1016/j.ress.2009.02.028; Liu Q, 2014, J WUHAN U TECHNOL TR, V38, P59; [刘文远 Liu Wenyuan], 2010, [中国安全科学学报, China Safety Science Journal], V20, P113; Lu CS, 2008, ACCIDENT ANAL PREV, V40, P594, DOI 10.1016/j.aap.2007.08.015; Mao CK, 2010, TOURISM MANAGE, V31, P855, DOI 10.1016/j.tourman.2009.09.003; Paulauskas V., 2006, TRANSPORT-VILNIUS, V21, P12, DOI [10.3846/16484142.2006.9638034, DOI 10.3846/16484142.2006.9638034]; Qu XB, 2012, TRANSPORT RES REC, P106, DOI 10.3141/2273-13; Wang JS, 2014, SAFETY SCI, V62, P46, DOI 10.1016/j.ssci.2013.08.002; [文元桥 Wen Yuanqiao], 2013, [中国安全科学学报, China Safety Science Journal（CSSJ）], V23, P32; Yang K., 2010, MIN SCI TECHNOL, V20, P71, DOI [10.1016/S1674-5264(09)60163-0, DOI 10.1016/S1674-5264(09)60163-0]; Yang K, 2015, J CHINA U MIN TECHNO, V15, P129; Yingluk Saerue, 2011, Information Technology Journal, V10, P585, DOI 10.3923/itj.2011.585.590; Zhang D, 2013, RELIAB ENG SYST SAFE, V118, P93, DOI 10.1016/j.ress.2013.04.006; Zhang YP, 2004, J HARBIN I TECHNOLOG, V1, P1; Zheng XP, 2010, SAFETY SCI, V48, P1236, DOI 10.1016/j.ssci.2010.07.003	20	6	7	4	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158482	10.1371/journal.pone.0158482	http://dx.doi.org/10.1371/journal.pone.0158482			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27391057	Green Submitted, Green Published, gold			2022-12-27	WOS:000380005400066
J	Moore, MW; Perston, Y				Moore, Mark W.; Perston, Yinika			Experimental Insights into the Cognitive Significance of Early Stone Tools	PLOS ONE			English	Article							WEST TURKANA; TECHNOLOGICAL SKILLS; CORE TECHNOLOGY; HUMAN-EVOLUTION; DESIGN SPACE; PLEISTOCENE; ARCHAEOLOGY; LEVALLOIS; LANGUAGE; PLIOCENE	Stone-flaking technology is the most enduring evidence for the evolving cognitive abilities of our early ancestors. Flake-making was mastered by African hominins similar to 3.3 ma, followed by the appearance of handaxes similar to 1.75 ma and complex stone reduction strategies by similar to 1.6 ma. Handaxes are stones flaked on two opposed faces ('bifacially'), creating a robust, sharpedged tool, and complex reduction strategies are reflected in strategic prior flaking to prepare or 'predetermine' the nature of a later flake removal that served as a tool blank. These technologies are interpreted as major milestones in hominin evolution that reflect the development of higher-order cognitive abilities, and the presence and nature of these technologies are used to track movements of early hominin species or 'cultures' in the archaeological record. However, the warranting argument that certain variations in stone tool morphologies are caused by differences in cognitive abilities relies on analogy with technical replications by skilled modern stoneworkers, and this raises the possibility that researchers are projecting modern approaches to technical problems onto our non-modern hominin ancestors. Here we present the results of novel experiments that randomise flake removal and disrupt the modern stoneworker's inclination to use higher-order reasoning to guide the stone reduction process. Although our protocols prevented goal-directed replication of stone tool types, the experimental assemblage is morphologically standardised and includes handaxe-like 'protobifaces' and cores with apparently 'predetermined' flake removals. This shows that the geometrical constraints of fracture mechanics can give rise to what appear to be highly-designed stoneworking products and techniques when multiple flakes are removed randomly from a stone core.	[Moore, Mark W.; Perston, Yinika] Univ New England, Stone Tools & Cognit Hub, Archaeol, Armidale, NSW, Australia	University of New England	Moore, MW (corresponding author), Univ New England, Stone Tools & Cognit Hub, Archaeol, Armidale, NSW, Australia.	mmoore2@une.edu.au	Moore, Mark W/B-4729-2015	Moore, Mark W/0000-0003-4768-5329; Perston, Yinika/0000-0002-8043-6466	Australian Research Council [DP1096558]	Australian Research Council(Australian Research Council)	This work was funded by a grant to MWM from the Australian Research Council, "The Spandrel Hypothesis: Towards a Unified Theory of Stone Flaking", DP1096558 (arc.gov.au). The funding body had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose SH, 2001, SCIENCE, V291, P1748, DOI 10.1126/science.1059487; [Anonymous], 2005, PEOPLES FLUTE STUDY; Ashton NM, 2003, MULTIPLE APPROACHES, p109 ; Baker T., 2002, SPECIAL PUBLICATION, V4, P209; Bar-Yosef O, 1999, AM ANTHROPOL, V101, P322, DOI 10.1525/aa.1999.101.2.322; Bar-Yosef O, 2009, CURR ANTHROPOL, V50, P103, DOI 10.1086/592234; Beyene Y, 2013, P NATL ACAD SCI USA, V110, P1584, DOI 10.1073/pnas.1221285110; BINFORD LR, 1984, J ANTHROPOL RES, V40, P406, DOI 10.1086/jar.40.3.3629763; Boeda E, 2013, QUATERN INT, V295, P191, DOI 10.1016/j.quaint.2012.07.020; Boeda E., 1991, TECHNIQUES CULTURE, V17, P37; Bradley B, 1986, STONE AGE PREHISTORY, P29; Braun DR, 2008, J ARCHAEOL SCI, V35, P2153, DOI 10.1016/j.jas.2008.01.015; Braun DR, 2005, J HUM EVOL, V48, P525, DOI 10.1016/j.jhevol.2005.02.002; Bril B, 2012, PHILOS T R SOC B, V367, P59, DOI 10.1098/rstb.2011.0147; Callahan E., 1979, ARCHAEOLOGY E N AM, V7, P1; Callow P., 1986, STONE AGE PREHISTORY, P243; Coolidge F. L., 2015, HUMAN PALEONEUROLOGY, P177; Crabtree DE., 1972, TEBIWA, V15, P29; Davidson I., 2002, TRANSITION LANGUAGE, P180; De Beaune S.A., 2009, COGNITIVE ARCHAEOLOG; de la Torre I, 2004, CURR ANTHROPOL, V45, P439, DOI 10.1086/422079; de la Torre I, 2003, J HUM EVOL, V44, P203, DOI 10.1016/S0047-2484(02)00206-3; de la Torre I, 2009, CUTTING EDGE NEW APP, V3, P93; Debenath A., 1994, HDB PALEOLITHIC TYPO, V1; Delagnes A, 2005, J HUM EVOL, V48, P435, DOI 10.1016/j.jhevol.2004.12.005; Dibble E., 1995, DEFINITION INTERPRET, P41; Edwards SW, 2001, KALAMBO FALLS PREHIS, VIII, P605; Elkin AP, 1948, MAN, V48, P110, DOI 10.2307/2791788; Eren MI, 2009, LITHIC TECHNOL, V34, P119, DOI 10.1080/01977261.2009.11721077; Eren MI, 2011, J ARCHAEOL SCI, V38, P2731, DOI 10.1016/j.jas.2011.06.011; Eren MI, 2011, AM ANTIQUITY, V76, P229, DOI 10.7183/0002-7316.76.2.229; Foley R, 2003, EVOL ANTHROPOL, V12, P109, DOI 10.1002/evan.10108; Foley R, 1997, CAMB ARCHAEOL J, V7, P3, DOI 10.1017/S0959774300001451; Gibson K.R., 1990, P97, DOI 10.1017/CBO9780511665486.005; GIBSON KR, 1993, TOOLS, LANGUAGE AND COGNITION IN HUMAN EVOLUTION, P187; Gowlett J.A.J., 2011, PALEOANTHROPOLOGY, V2011, P174, DOI DOI 10.4207/PA.2011.ART51; Gowlett J.A.J., 2006, AXE AGE ACHEULIAN TO, P203; GOWLETT JAJ, 1979, NATURE, V278, P14, DOI 10.1038/278014b0; Gowlett JohnJ., 1990, ARCHAEOL REV CAMB, V9, P82; GREENFIELD PM, 1991, BEHAV BRAIN SCI, V14, P531, DOI 10.1017/S0140525X00071235; Harmand S, 2015, NATURE, V521, P310, DOI 10.1038/nature14464; Hecht EE, 2015, BRAIN STRUCT FUNCT, V220, P2315, DOI 10.1007/s00429-014-0789-6; Hiscock Peter, 2014, Biology Theory, V9, P27, DOI 10.1007/s13752-013-0158-3; Hovers E, 2012, DEV QUATER SCI, V16, P51, DOI 10.1016/B978-0-444-53821-5.00005-1; Hughes P, 2011, AUST ARCHAEOL, P45; Inizan M-L, 1999, TECHNOLOGY TERMINOLO; Isaac G.L., 1986, STONE AGE PREHISTORY, P221; Isaac GL, 1977, OLORGESAILIE ARCHAEO; Jones P.R., 1994, OLDUVAI GORGE, P254; Jones R., 1988, ARCHAEOLOGY ETHNOGRA, P51; Klein RG, 2000, EVOL ANTHROPOL, V9, P17, DOI 10.1002/(SICI)1520-6505(2000)9:1<17::AID-EVAN3>3.0.CO;2-A; Kuman K, 2001, S AFR ARCHAEOL BULL, V56, P8, DOI 10.2307/3889024; Leakey M.D., 1971, OLDUVAI GORGE; Li H, 2014, WORLD ARCHAEOL, V46, P705, DOI 10.1080/00438243.2014.953707; Lycett SJ, 2008, WORLD ARCHAEOL, V40, P295, DOI 10.1080/00438240802260970; Lycett SJ, 2008, J ARCHAEOL SCI, V35, P2640, DOI 10.1016/j.jas.2008.05.002; Lycett SJ, 2008, J ARCHAEOL SCI, V35, P553, DOI 10.1016/j.jas.2007.05.003; Lycett SJ, 2009, J HUM EVOL, V56, P175, DOI 10.1016/j.jhevol.2008.10.001; Madsen B., 2004, EURASIAN PREHISTORY, V2, P3; Marzke MW, 1998, AM J PHYS ANTHROPOL, V105, P315, DOI 10.1002/(SICI)1096-8644(199803)105:3<315::AID-AJPA3>3.3.CO;2-D; MARZKE MW, 1986, J HUM EVOL, V15, P439, DOI 10.1016/S0047-2484(86)80027-6; McCarthy F.D., 1976, AUSTR ABORIGINAL STO; McNabb J, 2004, CURR ANTHROPOL, V45, P653, DOI 10.1086/423973; Moore MW, 2009, J HUM EVOL, V57, P503, DOI 10.1016/j.jhevol.2008.10.006; Moore MW, 2015, J ARCHAEOL METHOD TH, V22, P913, DOI 10.1007/s10816-014-9212-0; Moore MW, 2011, WORLD ARCHAEOL, V43, P702, DOI 10.1080/00438243.2011.624778; Moore MW, 2010, STONE TOOLS AND THE EVOLUTION OF HUMAN COGNITION, P13; Moore MW, 2007, STUD LANG C, V92, P11; Morgan TJH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7029; NEWCOMER MH, 1971, WORLD ARCHAEOL, V3, P85, DOI 10.1080/00438243.1971.9979493; Noble W., 1996, HUMAN EVOLUTION LANG; Nonaka T, 2010, J HUM EVOL, V59, P155, DOI 10.1016/j.jhevol.2010.04.006; Nowell A, 2010, STONE TOOLS AND THE EVOLUTION OF HUMAN COGNITION, P1; Owen AWE, 1938, MAN, V38, P203; Pelegrin J, 2005, STONE KNAPPING NECES, P23; Pelegrin J., 1993, USE TOOLS HUMANS NON, P302, DOI DOI 10.1093/ACPROF:OSO/9780198522638.001.0001; Pelegrin J., 2009, COGNITIVE ARCHAEOLOG, P95; Pollarolo L, 2010, S AFR ARCHAEOL BULL, V65, P3; Pope M., 2006, LITHICS J LITHIC STU, V27, P47; Riddle ATR, 2014, WORLD ARCHAEOL, V46, P123, DOI 10.1080/00438243.2014.890915; Roche H, 1999, NATURE, V399, P57, DOI 10.1038/19959; Roche H, 2005, STONE KNAPPING NECES, P35; Roche Helene, 1995, P153; Roux V, 2005, STONE KNAPPING NECES; Schick K., 2009, CUTTING EDGE NEW APP; Schick K.D., 1993, MAKING SILENT STONE; Schlanger N, 1996, CAMB ARCHAEOL J, V6, P231, DOI DOI 10.1017/S0959774300001724; Semaw S, 2000, J ARCHAEOL SCI, V27, P1197, DOI 10.1006/jasc.1999.0592; Sharon G., 2006, AXE AGE ACHEULIAN TO, P181; Sharon G, 2009, CURR ANTHROPOL, V50, P335, DOI 10.1086/598849; Shipton C, 2010, CAMB ARCHAEOL J, V20, P197, DOI 10.1017/S0959774310000235; Spikins P, 2012, WORLD ARCHAEOL, V44, P378, DOI 10.1080/00438243.2012.725889; Stout D, 2011, EUR J NEUROSCI, V2011, P1; Stout D., 2006, OLDOWAN CASE STUDIES, P321; Stout D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121804; Stout D, 2012, PHILOS T R SOC B, V367, P75, DOI 10.1098/rstb.2011.0099; Texier P.-J., 1995, EVOLUCION HUMANA EUR, V2, P403; TEXIER PJ, 1995, CR ACAD SCI II, V320, P647; TOTH N, 1985, J HUM EVOL, V14, P607, DOI 10.1016/S0047-2484(85)80087-7; TOTH N, 1985, J ARCHAEOL SCI, V12, P101, DOI 10.1016/0305-4403(85)90056-1; TOTH N, 1987, J HUM EVOL, V16, P763, DOI 10.1016/0047-2484(87)90023-6; Tryon C. A., 2005, AFR ARCHAEOL REV, V22, P199, DOI [10.1007/s10437-006-9002-5, DOI 10.1007/S10437-006-9002-5]; Uomini NT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072693; Van Peer P., 1992, MONOGRAPHS WORLD ARC, V13; Villa P, 2009, SOURCEBOOK OF PALEOLITHIC TRANSITIONS, P265, DOI 10.1007/978-0-387-76487-0_17; Webb JA, 2008, ARCHAEOMETRY, V50, P555, DOI 10.1111/j.1475-4754.2007.00381.x; White M, 2011, DEV QUATER SCI, V14, P53; Williams EM, 2014, J HUM EVOL, V72, P52, DOI 10.1016/j.jhevol.2014.03.004; Wynn T, 2004, J HUM EVOL, V46, P467, DOI 10.1016/j.jhevol.2004.01.005; Wynn T, 2002, BEHAV BRAIN SCI, V25, P389, DOI 10.1017/S0140525X02000079; Wynn T., 1989, EVOLUTION SPATIAL CO; Wynn T, 2010, COGNITIVE ARCHAEOLOG, P117; Wynn T, 2010, CURR ANTHROPOL, V51, pS5, DOI 10.1086/650526; [No title captured]	114	40	40	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158803	10.1371/journal.pone.0158803	http://dx.doi.org/10.1371/journal.pone.0158803			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DR6IK	27392022	Green Submitted, Green Published, gold			2022-12-27	WOS:000380005400127
J	Ramkumar, G; Karthi, S; Muthusamy, R; Suganya, P; Natarajan, D; Kweka, EJ; Shivakumar, MS				Ramkumar, Govindaraju; Karthi, Sengodan; Muthusamy, Ranganathan; Suganya, Ponnusamy; Natarajan, Devarajan; Kweka, Eliningaya J.; Shivakumar, Muthugounder S.			Mosquitocidal Effect of Glycosmis pentaphylla Leaf Extracts against Three Mosquito Species (Diptera: Culicidae)	PLOS ONE			English	Article							CHEMICAL-COMPOSITION; ANOPHELES-STEPHENSI; LARVICIDAL ACTIVITY; ESSENTIAL OILS; MALARIA; PLANT; REPELLENT; RUTACEAE; AEDES	Background The resistance status of malaria vectors to different classes of insecticides used for public health has raised concern for vector control programmes. Alternative compounds to supplement the existing tools are important to be searched to overcome the existing resistance and persistence of pesticides in vectors and the environment respectively. The mosquitocidal effects of Glycosmis pentaphylla using different solvents of acetone, methanol, chloroform and ethyl acetate extracts against three medically important mosquito vectors was conducted. Methods Glycosmis pentaphylla plant leaves were collected from Kolli Hills, India. The WHO test procedures for larval and adult bioassays were used to evaluate extracts against mosquito vectors, and the chemical composition of extracts identified using GC-MS analysis. Results The larvicidal and adulticidal activity of G. pentaphylla plant extracts clearly impacted the three species of major mosquitoes vectors. Acetone extracts had the highest larvicidal effect against An. stephensi, Cx. quinquefasciatus and Ae. aegypti with the LC50 and LC90 values of 0.0004, 138.54; 0.2669, 73.7413 and 0.0585, 303.746 mg/ml, respectively. The LC50 and LC90 adulticide values of G. pentaphylla leaf extracts in acetone, methanol, chloroform and ethyl acetate, solvents were as follows for Cx. quinquefasciatus, An. stephensi and Ae. Aegypti: 2.957, 5.458, 2.708, and 4.777, 3.449, 6.676 mg/ml respectively. The chemical composition of G. pentaphylla leaf extract has been found in 20 active compounds. Conclusions The plant leaf extracts of G. pentaphylla bioactive molecules which are effective and can be developed as an eco-friendly approach for larvicides and adulticidal mosquitoes vector control. Detailed identification and characterization of mosquitocidal effect of individual bioactive molecules ingredient may result into biodegradable effective tools for the control of mosquito vectors.	[Ramkumar, Govindaraju; Karthi, Sengodan; Muthusamy, Ranganathan; Suganya, Ponnusamy; Shivakumar, Muthugounder S.] Periyar Univ, Dept Biotechnol, Mol Entomol Lab, Salem 636011, Tamil Nadu, India; [Natarajan, Devarajan] Periyar Univ, Dept Biotechnol, Nat Drug Res Lab, Salem 636011, Tamil Nadu, India; [Kweka, Eliningaya J.] Trop Pesticides Res Inst, Div Livestock & Human Dis Vector Control, Mosquito Sect, POB 3024, Arusha, Tanzania; [Kweka, Eliningaya J.] Catholica Univ Hlth & Allied Sci, Dept Med Parasitol & Entomol, POB 1464, Mwanza, Tanzania	Periyar University; Periyar University	Kweka, EJ (corresponding author), Trop Pesticides Res Inst, Div Livestock & Human Dis Vector Control, Mosquito Sect, POB 3024, Arusha, Tanzania.; Kweka, EJ (corresponding author), Catholica Univ Hlth & Allied Sci, Dept Med Parasitol & Entomol, POB 1464, Mwanza, Tanzania.	pat.kweka@gmail.com	Karthi, Sengodan/D-5371-2015; Shivakumar, Muthugounder S./AAD-6241-2019; D., Natarajan/ABB-1036-2020; Govindaraju, Ramkumar/D-5331-2015; Muthusamy, Ranganathan/GOV-6650-2022	Shivakumar, Muthugounder S./0000-0002-1910-5510; Muthusamy, Ranganathan/0000-0002-2650-9791; Ramkumar, Govindaraju/0000-0001-7262-8428				Amer A, 2006, PARASITOL RES, V99, P466, DOI 10.1007/s00436-006-0182-3; Athikomkulchai S, 2006, CHEM PHARM BULL, V54, P262, DOI 10.1248/cpb.54.262; Bharati K, 2013, INDIAN J MED RES, V137, P36; Bowers William S., 1995, Insect Science and its Application, V16, P339; Brogdon WG, 1998, J AM MOSQUITO CONTR, V14, P159; CDC, 2014, ED TRAINING; Cheng SS, 2009, BIORESOURCE TECHNOL, V100, P465, DOI 10.1016/j.biortech.2007.11.060; CHOGO JB, 1981, J NAT PROD, V44, P308, DOI 10.1021/np50015a012; Chopra N, 1969, GLOSSARY INDIAN MED; Das A, 2012, ACTA TROP, V121, P267, DOI 10.1016/j.actatropica.2011.11.008; Das N. G., 2003, Journal of Vector Borne Diseases, V40, P49; FINNEY D J, 1971, P333; Govindarajan M, 2010, ASIAN PAC J TROP MED, V3, P874, DOI 10.1016/S1995-7645(10)60210-6; Khanna VG, 2011, PARASITOL RES, V109, P1373, DOI 10.1007/s00436-011-2384-6; Kilonzo B. S., 2001, Insect Science and its Application, V21, P89; Komalamisra Narumon, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P1412; Kumar DS, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-14; Lee SE, AGR CHEM BIOTECHNOL, V44, P105; Liu SQ, 2000, SURVEY PESTICIDAL CO, P1098; Manjari MS, 2014, PARASITOL RES, V113, P2475, DOI 10.1007/s00436-014-3896-7; Mdoe F. P., 2014, Parasites and Vectors, V7; Murugan K, 2012, PARASITOL RES, V111, P1757, DOI 10.1007/s00436-012-3021-8; Nathan SS, 2005, ACTA TROP, V96, P47, DOI 10.1016/j.actatropica.2005.07.002; Okumu FO, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-63; Quader MA, 1999, FITOTERAPIA, V70, P305, DOI 10.1016/S0367-326X(99)00028-3; Rajkumar S., 2005, African Journal of Biomedical Research, V8, P31; Sarwar M, 2009, PAK J BOT, V41, P3047; Seyoum A, 2003, TROP MED INT HEALTH, V8, P1005, DOI 10.1046/j.1360-2276.2003.01125.x; Sharma SK, 2012, INDIAN J MED RES, V135, P382; Suganya G, 2014, PARASITOL RES, V113, P875, DOI [10.1007/s00436-013-3718-3, 10.1007/s00436-014-3811-2]; Uddin S.N., 2006, TRADITIONAL USES ETH; WHO, 2005, GUID LAB FIELD TEST; WHO (World Health Organization), 1981, INSTR DET SUSC RES A	33	18	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158088	10.1371/journal.pone.0158088	http://dx.doi.org/10.1371/journal.pone.0158088			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391146	Green Submitted, gold, Green Published			2022-12-27	WOS:000380005400028
J	Sun, XQ; Shen, HW; Cheng, XQ; Zhang, YQ				Sun, Xiao-Qian; Shen, Hua-Wei; Cheng, Xue-Qi; Zhang, Yuqing			Market Confidence Predicts Stock Price: Beyond Supply and Demand	PLOS ONE			English	Article							NETWORKS; FLUCTUATIONS; BEHAVIOR; VOLUME	Stock price prediction is an important and challenging problem in stock market analysis. Existing prediction methods either exploit autocorrelation of stock price and its correlation with the supply and demand of stock, or explore predictive indictors exogenous to stock market. In this paper, using transaction record of stocks with identifier of traders, we introduce an index to characterize market confidence, i.e., the ratio of the number of traders who is active in two successive trading days to the number of active traders in a certain trading day. Strong Granger causality is found between the index of market confidence and stock price. We further predict stock price by incorporating the index of market confidence into a neural network based on time series of stock price. Experimental results on 50 stocks in two Chinese Stock Exchanges demonstrate that the accuracy of stock price prediction is significantly improved by the inclusion of the market confidence index. This study sheds light on using cross-day trading behavior to characterize market confidence and to predict stock price.	[Sun, Xiao-Qian; Zhang, Yuqing] Univ Chinese Acad Sci, Beijing, Peoples R China; [Sun, Xiao-Qian; Shen, Hua-Wei; Cheng, Xue-Qi] Chinese Acad Sci, Inst Comp Technol, CAS Key Lab Network Data Sci & Technol, Beijing, Peoples R China	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Computing Technology, CAS	Shen, HW (corresponding author), Chinese Acad Sci, Inst Comp Technol, CAS Key Lab Network Data Sci & Technol, Beijing, Peoples R China.	shenhuawei@ict.ac.cn	Shen, Hua-Wei/E-8028-2010; Chanelian, Serena/ABE-4873-2021	Shen, Hua-Wei/0000-0002-1081-8119; Chanelian, Serena/0000-0001-5727-6137	National Basic Research Program of China (the 973 program) [2014CB340401, 2012CB316303]; National Natural Science Foundation of China [61232010, 61425016, 61433014]	National Basic Research Program of China (the 973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Basic Research Program of China (the 973 program) under grant numbers 2014CB340401 and 2012CB316303, and the National Natural Science Foundation of China with Nos. 61232010, 61425016, and 61433014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, SCIENCE, DOI [DOI 10.21055/0370-1069-2020-1-51-60, DOI 10.1016/j.jocs.2010.12.007]; Baesteans D. J. E., 1996, FORECASTING FINANCIA; Ball P., 2013, NATURE; BESSEMBINDER H, 1992, J FINANC, V47, P2015, DOI 10.2307/2329008; Bordino I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040014; Cootner P., 1964, THE RANDOM CHARACTER; FAMA EF, 1965, J BUS, V38, P34, DOI 10.1086/294743; FAMA EF, 1991, J FINANC, V46, P1575, DOI 10.2307/2328565; Gabaix X, 2003, NATURE, V423, P267, DOI 10.1038/nature01624; Gallagher L. A., 2002, SO ECO J, V69, P245; Jiang Z.-Q., 2013, QUANT FINANC LETT, V1, P1, DOI DOI 10.1080/21649502.2013.802877; Kavussanos M.G., 2001, APPL FINANCIAL EC, V11, P573, DOI [10.1080/09603100010013006, DOI 10.1080/09603100010013006]; Li MX, 2015, PHYSICA A, V419, P575, DOI 10.1016/j.physa.2014.10.039; Onnela JP, 2004, EUR PHYS J B, V38, P353, DOI 10.1140/epjb/e2004-00128-7; Plerou V, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046109; Plerou V, 2001, QUANT FINANC, V1, P262, DOI 10.1088/1469-7688/1/2/308; Podobnik B, 2009, P NATL ACAD SCI USA, V106, P22079, DOI 10.1073/pnas.0911983106; Podobnik B, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.084102; Preis T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01684; Qian B, 2007, APPL INTELL, V26, P25, DOI 10.1007/s10489-006-0001-7; Sun XQ, 2014, SCI REP-UK, V4, DOI 10.1038/srep03711; Sun XQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045598; Sun XQ, 2011, PHYSICA A, V390, P3427, DOI 10.1016/j.physa.2011.04.006; Walczak S, 2001, J MANAGE INFORM SYST, V17, P203; Zheludev I, 2014, SCI REP-UK, V4, DOI 10.1038/srep04213; Zhou WX, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.066211	26	5	5	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158742	10.1371/journal.pone.0158742	http://dx.doi.org/10.1371/journal.pone.0158742			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27391816	Green Submitted, Green Published, gold			2022-12-27	WOS:000380005400112
J	Want, A; Gillespie, SR; Wang, Z; Gordon, R; Iomini, C; Ritch, R; Wolosin, JM; Bernstein, AM				Want, Andrew; Gillespie, Stephanie R.; Wang, Zheng; Gordon, Ronald; Iomini, Carlo; Ritch, Robert; Wolosin, J. Mario; Bernstein, Audrey M.			Autophagy and Mitochondrial Dysfunction in Tenon Fibroblasts from Exfoliation Glaucoma Patients	PLOS ONE			English	Article							PIGMENTED EPITHELIAL-CELLS; PSEUDOEXFOLIATION SYNDROME; ALZHEIMERS-DISEASE; SYSTEMIC DISORDER; PROTEIN; LC3; MICROTUBULES; TRAFFICKING; EXPRESSION; MATURATION	Purpose To test the hypothesis that autophagy dysfunction is involved in exfoliation syndrome (XFS), a systemic disorder of extracellular elastic matrices that causes a distinct form of human glaucoma. Methods Fibroblasts derived from tenon tissue discards (TFs) from filtration surgery to relieve intraocular pressure in XFS patients were compared against age-matched TFs derived from surgery in primary open-angle glaucoma (POAG) patients or from strabismus surgery. Differential interference contrast light, and electron microscopy were used to examine structural cell features. Immunocytochemistry was used to visualize LOXL1 and Fibulin-5, lysosomes, endosomes, Golgi, and microtubules. Light scatter, Cyto-ID (TM) and JC1 flow cytometry were used to measure relative cell size, autophagic flux rate and mitochondrial membrane potential (MMPT), respectively. Enhanced autophagy was induced by serum withdrawal. Results In culture, XFS-TFs were 1.38-fold larger (by light scatter ratio, p = 0.05), proliferated 42% slower (p = 0.026), and were morphologically distinct in 2D and 3D culture compared to their POAG counterparts. In extended 3D cultures, XFS-TFs accumulated 8-10 times more Fibulin-5 than the POAG-TFs, and upon serum withdrawal, there were marked deficiencies in relocation of endosomes and lysosomes to the perinuclear area. Correspondingly, the XFS-TFs displayed significant accumulation of the autophagasome marker LC3 II (3.9 fold increase compared to POAG levels, p = 0.0001) and autophagic flux rate as measured by Cyto-ID dye was 53% lower in XFS-TFs than in POAG-TFs (p = 0.01), indicating reduced clearance of autophagasomes. Finally the percent of cells with diminished MMPT was 3-8 times larger in the XFS-TFs than in POAG-TFs (p = 0.02). Conclusions Our results provide for the first time a link between XFS pathology to autophagy dysfunction, a major contributor to multiple age related diseases systemically throughout the body, in the brain and in the retina. A diminished capacity for degradation of denatured protein and aging cellular organelles may underpin the development of extracellular protein aggregates in XFS.	[Want, Andrew; Gillespie, Stephanie R.; Wang, Zheng; Iomini, Carlo; Wolosin, J. Mario; Bernstein, Audrey M.] Icahn Sch Med Mt Sinai, Dept Ophthalmol, New York, NY 10029 USA; [Gordon, Ronald] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA; [Gillespie, Stephanie R.; Bernstein, Audrey M.] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Ritch, Robert] New York Eye & Ear Infirm Mt Sinai, Einhorn Clin Res Ctr, New York, NY 10003 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; New York Eye & Ear Infirmary of Mount Sinai	Wolosin, JM; Bernstein, AM (corresponding author), Icahn Sch Med Mt Sinai, Dept Ophthalmol, New York, NY 10029 USA.; Bernstein, AM (corresponding author), Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA.	jmario.wolosin@mssm.edu; audrey.bernstein@mssm.edu		Bernstein, Audrey/0000-0002-2537-2594; wolosin, j. mario/0000-0002-6751-2794	Research to Prevent Blindness; MYS Family U.S. Charitable Foundation, Inc.; Bright Focus Foundation; Glaucoma Foundation; NIH-NEI [R01 EY024942, R01 EY018748, EY022639]; NIH [T32 GM062754]; NATIONAL EYE INSTITUTE [R01EY024942, R01EY014878, R01EY022639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB018748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM062754] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021838] Funding Source: NIH RePORTER	Research to Prevent Blindness(Research to Prevent Blindness (RPB)); MYS Family U.S. Charitable Foundation, Inc.; Bright Focus Foundation(BrightFocus Foundation); Glaucoma Foundation; NIH-NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by The Research to Prevent Blindness (AMB, JMW, and CI), The MYS Family U.S. Charitable Foundation, Inc., The Bright Focus Foundation, and The Glaucoma Foundation (AMB and JMW), NIH-NEI R01 EY024942 (AMB), NIH-NEI R01 EY018748 (JMW), NIH training grant T32 GM062754 (SRG), NIH-NEI EY022639 (CI). Microscopy and image analysis was performed at the Microscopy CORE. The authors would like to thank Leica and Mount Sinai's Microscopy CORE for providing access to the Leica TCS SP8 STED3X. The authors gratefully acknowledge the contribution of the surgeons who supplied surgical specimens: Dr. Celso Tello, (Manhattan Eye and Ear and Throat Hospital); Dr. Sung Chul Park (Manhattan Eye and Ear and Throat Hospital); Dr. Jeffrey Liebmann (Columbia University Medical Center); Dr. Brian Campollataro (New York Eye and Ear Infirmary of Mount Sinai). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bojic L, 2005, GRAEF ARCH CLIN EXP, V243, P446, DOI 10.1007/s00417-004-1074-9; Bourdenx M, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00083; Choi J, 2009, MATRIX BIOL, V28, P211, DOI 10.1016/j.matbio.2009.03.004; Cortes CJ, 2014, DRUG DISCOV TODAY, V19, P963, DOI 10.1016/j.drudis.2014.02.014; Cuervo AM, 2008, TRENDS GENET, V24, P604, DOI 10.1016/j.tig.2008.10.002; Divi RL, 2007, ENVIRON MOL MUTAGEN, V48, P179, DOI 10.1002/em.20245; Dutta D, 2015, METHOD CELL BIOL, V130, P127, DOI 10.1016/bs.mcb.2015.04.004; Elhawy E, 2012, HUM GENOMICS, V6, DOI 10.1186/1479-7364-6-22; Esteves AR, 2014, BBA-MOL BASIS DIS, V1842, P7, DOI 10.1016/j.bbadis.2013.10.003; Friedman LG, 2015, NEUROTHERAPEUTICS, V12, P94, DOI 10.1007/s13311-014-0320-z; Funk K. E., 2012, INT J ALZHEIMERS DIS, V2012, DOI DOI 10.1155/2012/752894; Furuta K, 1999, ARCH BIOCHEM BIOPHYS, V365, P75, DOI 10.1006/abbi.1999.1147; Guha S, 2014, ADV EXP MED BIOL, V801, P105, DOI 10.1007/978-1-4614-3209-8_14; Guha S, 2012, J NEUROCHEM, V122, P823, DOI 10.1111/j.1471-4159.2012.07804.x; Guo XQ, 2007, INVEST OPHTH VIS SCI, V48, P4050, DOI 10.1167/iovs.06-1216; Gutierrez MG, 2005, CELL MICROBIOL, V7, P981, DOI 10.1111/j.1462-5822.2005.00527.x; Haynes MK, 2009, J BIOMOL SCREEN, V14, P596, DOI 10.1177/1087057109335671; Huang B, 2009, ANNU REV BIOCHEM, V78, P993, DOI 10.1146/annurev.biochem.77.061906.092014; Kaarniranta Kai, 2010, Front Biosci (Elite Ed), V2, P1374; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kiselyov K, 2007, AUTOPHAGY, V3, P259, DOI 10.4161/auto.3906; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; KREIS TE, 1990, CELL MOTIL CYTOSKEL, V15, P67, DOI 10.1002/cm.970150202; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Liu XQ, 2004, NAT GENET, V36, P178, DOI 10.1038/ng1297; Lopez-Lluch G, 2015, BIOGERONTOLOGY, V16, P599, DOI 10.1007/s10522-015-9585-9; Mackeh R, 2013, J CELL SCI, V126, P1071, DOI 10.1242/jcs.115626; Miglior S, 2015, PROG BRAIN RES, V221, P233, DOI 10.1016/bs.pbr.2015.06.007; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; Mortensen M, 2010, P NATL ACAD SCI USA, V107, P832, DOI 10.1073/pnas.0913170107; N'Diaye EN, 2009, EMBO REP, V10, P173, DOI 10.1038/embor.2008.238; O'Donovan TR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134676; Ovodenko B, 2007, INVEST OPHTH VIS SCI, V48, P1447, DOI 10.1167/iovs.06-0411; Pirkmajer S, 2011, AM J PHYSIOL-CELL PH, V301, pC272, DOI 10.1152/ajpcell.00091.2011; Ritch R, 2001, SURV OPHTHALMOL, V45, P265, DOI 10.1016/S0039-6257(00)00196-X; Ritch Robert, 2014, J Glaucoma, V23, pS1, DOI 10.1097/IJG.0000000000000119; Ritch R, 2001, CURR OPIN OPHTHALMOL, V12, P124, DOI 10.1097/00055735-200104000-00008; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Schlotzer-Schrehardt U, 2001, EXP EYE RES, V73, P765, DOI 10.1006/exer.2001.1084; SCHLOTZERSCHREHARDT U, 1994, AM J OPHTHALMOL, V118, P730, DOI 10.1016/S0002-9394(14)72552-8; SCHLOTZERSCHREHARDT UM, 1992, ARCH OPHTHALMOL-CHIC, V110, P1752, DOI 10.1001/archopht.1992.01080240092038; STREETEN BW, 1992, ARCH OPHTHALMOL-CHIC, V110, P1757, DOI 10.1001/archopht.1992.01080240097039; Sydor AM, 2015, TRENDS CELL BIOL, V25, P730, DOI 10.1016/j.tcb.2015.10.004; Tanida I, 2008, AUTOPHAGY, V4, P131, DOI 10.4161/auto.5233; Tillement JP, 2014, CNS NEUROL DISORD-DR, V13, P593, DOI 10.2174/18715273113126660197; Trantow CM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001008; Trantow CM, 2009, INVEST OPHTH VIS SCI, V50, P1205, DOI 10.1167/iovs.08-2791; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Wang X, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-31; Whigham BT, 2011, SAUDI J OPHTHALMOL, V25, P347, DOI 10.1016/j.sjopt.2011.07.001; Wohlgemuth SE, 2014, J MOL CELL CARDIOL, V71, P62, DOI 10.1016/j.yjmcc.2014.03.007; Xu W, 2016, J CLIN INVEST, V126, P1815, DOI 10.1172/JCI82409; Zhou Y, 2013, J BIOMED RES, V27, P23, DOI 10.7555/JBR.27.20110142	54	27	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0157404	10.1371/journal.pone.0157404	http://dx.doi.org/10.1371/journal.pone.0157404			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391778	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400008
J	Nagamine, K; Ishikawa, Y; Hoshizaki, S				Nagamine, Keisuke; Ishikawa, Yukio; Hoshizaki, Sugihiko			Insights into How Longicorn Beetle Larvae Determine the Timing of Metamorphosis: Starvation-Induced Mechanism Revisited	PLOS ONE			English	Article							PSACOTHEA-HILARIS PASCOE; MANDUCA-SEXTA L; TOBACCO HORNWORM; PREMATURE METAMORPHOSIS; COLEOPTERA; SIZE; DIAPAUSE; CERAMBYCIDAE; BEHAVIOR; HORMONE	Larvae of holometabolous insects must determine the timing of their metamorphosis. How they determine this timing has only been studied in detail for a few insect species. In a few species of Coleoptera, starvation is known to be a cue for metamorphosis, leading to the formation of smaller adults (starvation-induced pupation, SiP). We investigated the occurrence of SiP in the beetle Psacothea hilaris. When P. hilaris larvae were starved late in the feeding phase of the last (5th) instar, they exhibited typical SiP characterized by constancy of the time from food deprivation to pupation (TTP) irrespective of the body weight upon food deprivation or the length of prior feeding. In contrast, when larvae were starved early in the feeding phase, TTP decreased by roughly 1 day as the feeding became 1 day longer. The change in the response to starvation was estimated to occur on day 5.9 in the last instar. A series of refeeding experiments suggested that whereas SiP occurred readily in the larvae starved in the late feeding phase, activation of SiP was suspended until day 5.9 in the larvae starved early in the feeding phase. When P. hilaris larvae were fed continuously, they eventually ceased feeding spontaneously and pupated. The time length between spontaneous cessation of feeding and pupation was approximately equal to the TTP in SiP. This suggests that the same mechanism was activated by food deprivation in the late feeding phase and by spontaneous cessation of ad libitum feeding.	[Nagamine, Keisuke; Ishikawa, Yukio; Hoshizaki, Sugihiko] Univ Tokyo, Grad Sch Agr & Life Sci, Appl Entomol Lab, Dept Agr & Environm Biol, Tokyo, Japan	University of Tokyo	Nagamine, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Appl Entomol Lab, Dept Agr & Environm Biol, Tokyo, Japan.	ef10140@yahoo.co.jp	Ishikawa, Yukio/J-5676-2019	Ishikawa, Yukio/0000-0003-3067-2513				[Anonymous], 2014, R LANG ENV STAT COMP; Bocak L, 2014, SYST ENTOMOL, V39, P97, DOI 10.1111/syen.12037; DOMINICK OS, 1985, J EXP BIOL, V117, P45; Estes AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079061; Fox J, 2005, J BEHAV EDUC, V14, P1, DOI 10.1007/s10864-005-0957-0; FUJISHITA M, 1982, J INSECT PHYSIOL, V28, P961, DOI 10.1016/0022-1910(82)90113-5; Fukaya M, 2004, APPL ENTOMOL ZOOL, V39, P603, DOI 10.1303/aez.2004.603; Hatem NE, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0155-z; JONES D, 1981, J INSECT PHYSIOL, V27, P779, DOI 10.1016/0022-1910(81)90068-8; Jucker C., 2006, Bollettino di Zoologia Agraria e di Bachicoltura, V38, P187; Kemirembe K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044429; Koyama T, 2014, ELIFE, V3, DOI 10.7554/eLife.03091; Kusama T, 1984, LONGICORN BEETLES JA, P262; Lupi D., 2013, Bulletin OEPP, V43, P316, DOI 10.1111/epp.12045; Muggeo V.M., 2008, R NEWS, V8, P20; Muggeo VMR, 2003, STAT MED, V22, P3055, DOI 10.1002/sim.1545; Munyiri FN, 2005, GEN COMP ENDOCR, V144, P150, DOI 10.1016/j.ygcen.2005.05.006; Munyiri FN, 2004, J INSECT PHYSIOL, V50, P1075, DOI 10.1016/j.jinsphys.2004.09.009; Munyiri FN, 2003, APPL ENTOMOL ZOOL, V38, P509, DOI 10.1303/aez.2003.509; Nagamine K, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-539; Nijhout H.F., 1998, INSECT HORMONES, P280; Nijhout HF, 2008, DEV CELL, V15, P491, DOI 10.1016/j.devcel.2008.09.014; Nijhout HF, 2014, WIRES DEV BIOL, V3, P113, DOI 10.1002/wdev.124; NIJHOUT HF, 1974, J EXP BIOL, V61, P481; NIJHOUT HF, 1974, J EXP BIOL, V61, P493; ROUNTREE DB, 1986, J EXP BIOL, V120, P41; Sato T, 2001, APPL ENTOMOL ZOOL, V36, P189, DOI 10.1303/aez.2001.189; Sehnal F., 1985, P1; Shafiei M, 2001, PHYSIOL ENTOMOL, V26, P173, DOI 10.1046/j.1365-3032.2001.00231.x; Shintani Y, 1997, APPL ENTOMOL ZOOL, V32, P347, DOI 10.1303/aez.32.347; Shintani Y, 2003, J INSECT PHYSIOL, V49, P975, DOI 10.1016/S0022-1910(03)00167-7; Shintani Y, 1996, APPL ENTOMOL ZOOL, V31, P489; Shintani Y, 1998, ENTOMOL EXP APPL, V86, P41, DOI 10.1023/A:1003114926558; Stieper BC, 2008, DEV BIOL, V321, P18, DOI 10.1016/j.ydbio.2008.05.556; Suzuki Y, 2013, P NATL ACAD SCI USA, V110, P12518, DOI 10.1073/pnas.1311405110; Terao M, 2015, ENTOMOL SCI, V18, P85, DOI 10.1111/ens.12084; TRUMAN JW, 1974, J EXP BIOL, V60, P371; Walsh AL, 2011, J INSECT PHYSIOL, V57, P809, DOI 10.1016/j.jinsphys.2011.03.009	38	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158831	10.1371/journal.pone.0158831	http://dx.doi.org/10.1371/journal.pone.0158831			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27386861	Green Published, gold, Green Submitted			2022-12-27	WOS:000379811500053
J	Pincet, F; Adrien, V; Yang, R; Delacotte, J; Rothman, JE; Urbach, W; Tareste, D				Pincet, Frederic; Adrien, Vladimir; Yang, Rong; Delacotte, Jerome; Rothman, James E.; Urbach, Wladimir; Tareste, David			FRAP to Characterize Molecular Diffusion and Interaction in Various Membrane Environments	PLOS ONE			English	Article							SYNAPTIC VESICLE DOCKING; FLUORESCENCE RECOVERY; LIPID-BILAYERS; LATERAL MOBILITY; MODEL MEMBRANES; PROTEINS; DYNAMICS; DOMAINS; COMPLEX; FUSION	Fluorescence recovery after photobleaching (FRAP) is a standard method used to study the dynamics of lipids and proteins in artificial and cellular membrane systems. The advent of confocal microscopy two decades ago has made quantitative FRAP easily available to most laboratories. Usually, a single bleaching pattern/area is used and the corresponding recovery time is assumed to directly provide a diffusion coefficient, although this is only true in the case of unrestricted Brownian motion. Here, we propose some general guidelines to perform FRAP experiments under a confocal microscope with different bleaching patterns and area, allowing the experimentalist to establish whether the molecules undergo Brownian motion (free diffusion) or whether they have restricted or directed movements. Using in silico simulations of FRAP measurements, we further indicate the data acquisition criteria that have to be verified in order to obtain accurate values for the diffusion coefficient and to be able to distinguish between different diffusive species. Using this approach, we compare the behavior of lipids in three different membrane platforms (supported lipid bilayers, giant liposomes and sponge phases), and we demonstrate that FRAP measurements are consistent with results obtained using other techniques such as Fluorescence Correlation Spectroscopy (FCS) or Single Particle Tracking (SPT). Finally, we apply this method to show that the presence of the synaptic protein Munc 18-1 inhibits the interaction between the synaptic vesicle SNARE protein, VAMP2, and its partner from the plasma membrane, Syn1A.	[Pincet, Frederic; Adrien, Vladimir; Delacotte, Jerome; Urbach, Wladimir] Sorbonne Univ, Univ Paris 06, Ecole Normale Super, Lab Phys Stat,CNRS,UMR 8550, Paris, France; [Pincet, Frederic; Rothman, James E.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Adrien, Vladimir] Univ Paris 05, Sorbonne Paris Cite, Lab Cristallog & RMN Biol, CNRS,UMR 8015, Paris, France; [Yang, Rong] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY USA; [Urbach, Wladimir] Univ Paris 05, Sorbonne Paris Cite, UFR Biomed, Paris, France; [Tareste, David] Univ Paris Diderot, Sorbonne Paris Cite, Membrane Traff Hlth & Dis, INSERM,ERL U950, Paris, France; [Tareste, David] Univ Paris Diderot, Sorbonne Paris Cite, Inst Jacques Monod, CNRS,UMR 7592, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Universite Paris Cite; Yale University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Columbia University; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Pincet, F (corresponding author), Sorbonne Univ, Univ Paris 06, Ecole Normale Super, Lab Phys Stat,CNRS,UMR 8550, Paris, France.; Pincet, F (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA.; Tareste, D (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Membrane Traff Hlth & Dis, INSERM,ERL U950, Paris, France.; Tareste, D (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Inst Jacques Monod, CNRS,UMR 7592, Paris, France.	pincet@lps.ens.fr; david.tareste@inserm.fr	Urbach, Wladimir/AAG-9004-2019; Adrien, Vladimir/HHM-9186-2022; Tareste, David/L-2639-2017; Delacotte, Jérôme/Q-2788-2018; URBACH, Wladimir/AAA-5969-2022; Tareste, David/P-9249-2019	Urbach, Wladimir/0000-0002-1673-6923; Tareste, David/0000-0002-8744-7598; Delacotte, Jérôme/0000-0001-9681-1200; URBACH, Wladimir/0000-0002-1673-6923; Tareste, David/0000-0002-8744-7598; PINCET, FREDERIC/0000-0002-4243-2157	ANR@RATION SynBioExo; ANR Blanc [ANR-12-BSV5-0002, ANR-12-BSV8-0010-ASSEMBLY]; ANR Jeunes Chercheurs [ANR-09-JCJC-0062-01]; AFM Trampoline [16799]; PhD Program "Frontieres du Vivant (FdV) - Cursus Bettencourt"; James Rothman's lab.	ANR@RATION SynBioExo(French National Research Agency (ANR)); ANR Blanc(French National Research Agency (ANR)); ANR Jeunes Chercheurs(French National Research Agency (ANR)); AFM Trampoline; PhD Program "Frontieres du Vivant (FdV) - Cursus Bettencourt"; James Rothman's lab.	This work was supported by the ANR@RATION SynBioExo to J.E.R.; by the ANR Blanc ANR-12-BSV5-0002 to F.P.; by the ANR Blanc ANR-12-BSV8-0010-ASSEMBLY to W.U.; by the ANR Jeunes Chercheurs ANR-09-JCJC-0062-01 and the AFM Trampoline 16799 to D.T.; V.A. is supported by funds from the PhD Program "Frontieres du Vivant (FdV) - Cursus Bettencourt". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Rong Yang worked in James Rothman's lab at Columbia University as a post-doctoral research scientist from January 2005 to October 2006. Any research work performed by this author during this period was funded by James Rothman's lab. None of the work related to this manuscript was funded by Rong Yang's current employer, Adimab, LLC. This current employer did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DM, 1990, J PHYS CHEM-US, V94, P8683, DOI 10.1021/j100387a012; ANGELOVA MI, 1992, PROG COLL POL SCI S, V89, P127; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Bacia K, 2004, J BIOL CHEM, V279, P37951, DOI 10.1074/jbc.M407020200; Blumenthal D, 2015, SCI REP-UK, V5, DOI 10.1038/srep11655; Bockmann RA, 2003, BIOPHYS J, V85, P1647, DOI 10.1016/S0006-3495(03)74594-9; Braeckmans K, 2003, BIOPHYS J, V85, P2240, DOI 10.1016/S0006-3495(03)74649-9; Braga J, 2004, MOL BIOL CELL, V15, P4749, DOI 10.1091/mbc.E04-06-0496; CALAKOS N, 1994, SCIENCE, V263, P1146, DOI 10.1126/science.8108733; Chan YHM, 2007, CURR OPIN CHEM BIOL, V11, P581, DOI 10.1016/j.cbpa.2007.09.020; DAVOUST J, 1982, EMBO J, V1, P1233, DOI 10.1002/j.1460-2075.1982.tb00018.x; Domanov YA, 2011, P NATL ACAD SCI USA, V108, P12605, DOI 10.1073/pnas.1102646108; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Li F, 2007, NAT STRUCT MOL BIOL, V14, P890, DOI 10.1038/nsmb1310; Gambin Y, 2006, P NATL ACAD SCI USA, V103, P2098, DOI 10.1073/pnas.0511026103; Gambin Y, 2010, J PHYS CHEM B, V114, P3559, DOI 10.1021/jp911354y; GORDON GW, 1995, BIOPHYS J, V68, P766, DOI 10.1016/S0006-3495(95)80251-1; Guo L, 2008, CHEMPHYSCHEM, V9, P721, DOI 10.1002/cphc.200700611; Ji H, 2010, BIOPHYS J, V99, P553, DOI 10.1016/j.bpj.2010.04.060; Jonsson P, 2008, BIOPHYS J, V95, P5334, DOI 10.1529/biophysj.108.134874; Kang M, 2015, PLOS ONE, DOI [10.1371/journal.pone.0127966, DOI 10.1371/JOURNAL.PONE.0127966PMID]; Lenne PF, 2006, EMBO J, V25, P3245, DOI 10.1038/sj.emboj.7601214; Liang BY, 2014, BIOCHEMISTRY-US, V53, P1485, DOI 10.1021/bi401638u; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Loren N, 2015, Q REV BIOPHYS, V48, P323, DOI 10.1017/S0033583515000013; Maldonado A, 1996, PHYS REV E, V54, P1774, DOI 10.1103/PhysRevE.54.1774; MARRA J, 1985, J COLLOID INTERF SCI, V107, P446, DOI 10.1016/0021-9797(85)90197-3; MERKEL R, 1989, J PHYS-PARIS, V50, P1535, DOI 10.1051/jphys:0198900500120153500; Merzlyakov M, 2006, LANGMUIR, V22, P10145, DOI 10.1021/la061976d; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Ostuni MA, 2014, BIOL OPEN, V3, P1173, DOI 10.1242/bio.20149845; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; Rayan G, 2014, BIOPHYS J, V107, P1129, DOI 10.1016/j.bpj.2014.07.016; Rayan G, 2010, SENSORS-BASEL, V10, P5927, DOI 10.3390/s100605927; Reffay M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005035; Richmond DL, 2011, P NATL ACAD SCI USA, V108, P9431, DOI 10.1073/pnas.1016410108; Rickman C, 2007, J BIOL CHEM, V282, P12097, DOI 10.1074/jbc.M700227200; Salome L, 1998, EUR BIOPHYS J BIOPHY, V27, P391, DOI 10.1007/s002490050146; Samsonov AV, 2001, BIOPHYS J, V81, P1486, DOI 10.1016/S0006-3495(01)75803-1; Seiffert S, 2005, J MICROSC-OXFORD, V220, P20, DOI 10.1111/j.1365-2818.2005.01512.x; Sezgin E, 2012, MOL MEMBR BIOL, V29, P144, DOI 10.3109/09687688.2012.700490; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOUMPASIS DM, 1983, BIOPHYS J, V41, P95, DOI 10.1016/S0006-3495(83)84410-5; Sprague BL, 2005, TRENDS CELL BIOL, V15, P84, DOI 10.1016/j.tcb.2004.12.001; Staras K, 2013, J NEUROCHEM, V126, P213, DOI 10.1111/jnc.12240; Tareste D, 2008, P NATL ACAD SCI USA, V105, P2380, DOI 10.1073/pnas.0712125105; Taulier N, 2000, BIOPHYS J, V78, P857, DOI 10.1016/S0006-3495(00)76643-4; Wagner ML, 2000, BIOPHYS J, V79, P1400, DOI 10.1016/S0006-3495(00)76392-2; Wawrezinieck L, 2005, BIOPHYS J, V89, P4029, DOI 10.1529/biophysj.105.067959; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042854; YGUERABIDE J, 1982, BIOPHYS J, V40, P69, DOI 10.1016/S0006-3495(82)84459-7; Zilly FE, 2006, PLOS BIOL, V4, P1789, DOI 10.1371/journal.pbio.0040330	55	55	54	3	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158457	10.1371/journal.pone.0158457	http://dx.doi.org/10.1371/journal.pone.0158457			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27387979	Green Published, gold, Green Submitted			2022-12-27	WOS:000379811500020
J	Roberts, A; Austin, W; Evans, K; Bird, C; Schweizer, M; Darling, K				Roberts, Angela; Austin, William; Evans, Katharine; Bird, Clare; Schweizer, Magali; Darling, Kate			A New Integrated Approach to Taxonomy: The Fusion of Molecular and Morphological Systematics with Type Material in Benthic Foraminifera	PLOS ONE			English	Article							RIBOSOMAL DNA; GLOBAL DISTRIBUTION; SEQUENCES; DISTRIBUTIONS; PHYLOGENY; DIVERSITY; AMMONIA; REGION; MARSH	A robust and consistent taxonomy underpins the use of fossil material in palaeoenvironmental research and long-term assessment of biodiversity. This study presents a new integrated taxonomic protocol for benthic foraminifera by unequivocally reconciling the traditional taxonomic name to a specific genetic type. To implement this protocol, a fragment of the small subunit ribosomal RNA (SSU rRNA) gene is used in combination with 16 quantitative morphometric variables to fully characterise the benthic foraminiferal species concept of Elphidium williamsoni Haynes, 1973. A combination of live contemporary topotypic specimens, original type specimens and specimens of genetic outliers were utilised in this study. Through a series of multivariate statistical tests we illustrate that genetically characterised topotype specimens are morphologically congruent with both the holotype and paratype specimens of E. williamsoni Haynes, 1973. We present the first clear link between morphologically characterised type material and the unique SSU rRNA genetic type of E. williamsoni. This example provides a standard framework for the benthic foraminifera which bridges the current discontinuity between molecular and morphological lines of evidence, allowing integration with the traditional Linnaean roots of nomenclature to offer a new prospect for taxonomic stability.	[Roberts, Angela; Austin, William; Darling, Kate] Univ St Andrews, Sch Geog & Geosci, St Andrews KY16 9AL, Fife, Scotland; [Austin, William] Scottish Marine Inst, Scottish Assoc Marine Sci, Oban PA37 1QA, Argyll, Scotland; [Evans, Katharine; Bird, Clare; Schweizer, Magali; Darling, Kate] Univ Edinburgh, Sch Geosci, W Mains Rd, Edinburgh EH9 3JW, Midlothian, Scotland; [Schweizer, Magali] Univ Angers, LPG BIAF Recent & Fossil Bioindicators, UMR CNRS 6112, 2 Bd Lavoisier, F-49045 Angers, France	University of St Andrews; UHI Millennium Institute; University of Edinburgh; Centre National de la Recherche Scientifique (CNRS); Universite d'Angers	Roberts, A (corresponding author), Univ St Andrews, Sch Geog & Geosci, St Andrews KY16 9AL, Fife, Scotland.	adr37@st-andrews.ac.uk	Evans, Katharine/L-1709-2013; Schweizer, Magali/F-9358-2014	Evans, Katharine/0000-0002-9819-1049; Schweizer, Magali/0000-0001-5115-1616; Bird, Clare/0000-0002-7500-5573	NERC [NE4/G018502/1, NE/G020310/1]; Carnegie Trust for the Universities of Scotland; Estuarine Coastal and Shelf Science Association; Swiss National Science Foundation (SNSF) [PA00P2_126226, PA00P2_142065]; Natural Environment Research Council [dml011000, 1147226, NE/G020310/1, NE/G018502/1] Funding Source: researchfish; NERC [dml011000, NE/G018502/1] Funding Source: UKRI	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Carnegie Trust for the Universities of Scotland; Estuarine Coastal and Shelf Science Association; Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by NERC grant NE4/G018502/1 and NE/G020310/1 (Website: http://www.nerc.ac.uk). The authors also thank the following for their support: the Carnegie Trust for the Universities of Scotland (Website: http://www.carnegie-trust.org) and the Estuarine Coastal and Shelf Science Association (Website: http://www.ecsa-news.org). M.S. was also supported by the Swiss National Science Foundation (SNSF), fellowships for advanced researchers PA00P2_126226 and PA00P2_142065 (Website: http://www.snf.ch/en/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS T. D., 1965, CONTRIB CUSHMAN FOUND FORAMINIFERAL RES, V16, P55; Bortolus A, 2008, AMBIO, V37, P114, DOI 10.1579/0044-7447(2008)37[114:ECITBS]2.0.CO;2; Brodniewicz I, 1965, RECENT SOME HOLOCENE; Burrows MT, 2014, NATURE, V507, P492, DOI 10.1038/nature12976; BUZAS MA, 1985, J PALEONTOL, V59, P1075; BUZAS MARTIN A., 1966, J PALEONTOL, V40, P585; Camacho SG, 2015, PALAEONTOL ELECTRON, V18, P1; Cushman JA, 1930, NONIONIDAE CAMERINID; Cushman JA, 1939, MONOGRAPH FORAMINIFE; Cushman JA, 1949, RECENT BELGIAN FORAM; Darling KF, 2008, MAR MICROPALEONTOL, V67, P216, DOI 10.1016/j.marmicro.2008.01.009; Darling KF, MAR MICROPALEO UNPUB; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; Ebach MC, 2011, ZOOTAXA, P67, DOI 10.11646/zootaxa.2742.1.5; Ertan KT, 2004, MAR MICROPALEONTOL, V53, P367, DOI 10.1016/j.marmicro.2004.08.001; Feyling-Hanssen RW, 1964, FORAMINIFERA LATE QU; Forey PL, 2004, PHILOS T R SOC B, V359, P639, DOI 10.1098/rstb.2003.1453; Garcia-Vallve S., DENDROUPGMA DENDROGR; Geoffrey Bowker, 1999, SORTING THINGS OUT C; Gooday AJ, 2012, ANNU REV MAR SCI, V4, P237, DOI 10.1146/annurev-marine-120709-142737; Grimm GW, 2009, USING MULTIPLE ANAL; GROSS O, 2001, PATRIMOINES NATURELS, V50, P60; Haake F-W, 1962, UNTERSUCHUNGEN FORAM; Habura A, 2008, LIMNOL OCEANOGR, V53, P1339, DOI 10.4319/lo.2008.53.4.1339; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Haynes J.R., 1969, GEOL J, V6, P217, DOI DOI 10.1002/GJ.3350060207; Haynes J.R., 1973, CARDIGAN BAY RECENT; Hayward B. W, 1997, RECENT ELPHIDIIDAE F; Hayward BW, 2004, MAR MICROPALEONTOL, V50, P237, DOI 10.1016/S0377-8398(03)00074-4; Hayward BW, WORLD MODERN FORAMIN; Henderson A. S., 2002, PALAEONTOL ELECTRON, V4, P34; Hesemann, FORAMINIFERA GALLERY; Holzmann M, 2000, MICROPALEONTOLOGY, V46, P21; Holzmann Maria, 1998, Revue de Micropaleontologie, V41, P59, DOI 10.1016/S0035-1598(98)90098-8; Horton BP, 2007, MAR MICROPALEONTOL, V63, P169, DOI 10.1016/j.marmicro.2006.11.006; Horton BP, 2005, HOLOCENE, V15, P216, DOI 10.1191/0959683605hl787rp; International Commission on Zoological Nomenclature, 1999, INT CODE ZOOLOGICAL, V4th; Jacob E, 1798, ADAMS ESSAYS MICROSC, P1; Kemp AC, 2011, J FORAMIN RES, V41, P114, DOI 10.2113/gsjfr.41.2.114; Langer MR, 2001, J MICROPALAEONTOL, V20, P183, DOI 10.1144/jm.20.2.183; Lejzerowicz F, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0283; Levy A., 1969, Revue Micropaleont., V12, P92; Lutze G. F., 1965, Meyniana, V15, P75; MILLER AAL, 1982, J FORAMIN RES, V12, P116, DOI 10.2113/gsjfr.12.2.116; Murray JW, 2007, MAR MICROPALEONTOL, V64, P163, DOI 10.1016/j.marmicro.2007.04.002; Murray JW, 2006, ECOLOGY AND APPLICATIONS OF BENTHIC FORAMINIFERA, P1, DOI 10.1017/CBO9780511535529; MURRAY JW, 1965, J MAR BIOL ASSOC UK, V45, P481, DOI 10.1017/S0025315400054965; National Center for Biotechnology Information, 2015, GENBANK OV; Pawlowski J, 2010, FORAMBARCODING MOL D; Pawlowski J, 2014, J FORAMIN RES, V44, P62, DOI 10.2113/gsjfr.44.1.62; Pillet L, 2013, MAR MICROPALEONTOL, V103, P1, DOI 10.1016/j.marmicro.2013.07.001; Pillet L, 2011, PROTIST, V162, P394, DOI 10.1016/j.protis.2010.10.001; Portner H.-O., 2022, CLIMATE CHANGE 2022; Roberts A, 2016, RECONCILING MOL MORP; Schweizer M, 2005, MAR MICROPALEONTOL, V57, P51, DOI 10.1016/j.marmicro.2005.07.001; Schweizer M, 2012, J FORAMIN RES, V42, P340, DOI 10.2113/gsjfr.42.4.340; Schweizer M, 2011, CR PALEVOL, V10, P95, DOI 10.1016/j.crpv.2011.01.003; Schweizer M, 2009, J FORAMIN RES, V39, P300, DOI 10.2113/gsjfr.39.4.300; Scott GH, 2011, MAR MICROPALEONTOL, V78, P96, DOI 10.1016/j.marmicro.2010.11.001; Sejrup HP, 2004, MAR MICROPALEONTOL, V53, P197, DOI 10.1016/j.marmicro.2004.05.009; TODD RUTH, 1961, CONTR CUSHMAN FOUND FORAMINIFERAL RES, V12, P5; Tsuchiya M, 2000, MICROPALEONTOLOGY, V46, P13; Tsuchiya M, 2008, MAR MICROPALEONTOL, V69, P212, DOI 10.1016/j.marmicro.2008.07.008; Waterton C., 2013, BARCODING NATURE SHI; WILKINSON IP, 1979, J PALEONTOL, V53, P628; Williamson W.C, 1858, RECENT FORAMINIFERA	66	20	20	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158754	10.1371/journal.pone.0158754	http://dx.doi.org/10.1371/journal.pone.0158754			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27388271	Green Published, Green Submitted, gold			2022-12-27	WOS:000379811500042
J	Jakubec, D; Laskowski, RA; Vondrasek, J				Jakubec, David; Laskowski, Roman A.; Vondrasek, Jiri			Sequence-Specific Recognition of DNA by Proteins: Binding Motifs Discovered Using a Novel Statistical/Computational Analysis	PLOS ONE			English	Article							MOLECULAR ELECTROSTATIC POTENTIALS; SIDE-CHAIN INTERACTIONS; AMINO ACID INTERACTIONS; TRANSCRIPTION FACTORS; STRUCTURAL-ANALYSIS; CRYSTAL-STRUCTURE; BASE-PAIRS; DIELECTRIC MEDIUM; NUCLEIC-ACIDS; FORCE-FIELD	Decades of intensive experimental studies of the recognition of DNA sequences by proteins have provided us with a view of a diverse and complicated world in which few to no features are shared between individual DNA-binding protein families. The originally conceived direct readout of DNA residue sequences by amino acid side chains offers very limited capacity for sequence recognition, while the effects of the dynamic properties of the interacting partners remain difficult to quantify and almost impossible to generalise. In this work we investigated the energetic characteristics of all DNA residue-amino acid side chain combinations in the conformations found at the interaction interface in a very large set of protein-DNA complexes by the means of empirical potential-based calculations. General specificity-defining criteria were derived and utilised to look beyond the binding motifs considered in previous studies. Linking energetic favourability to the observed geometrical preferences, our approach reveals several additional amino acid motifs which can distinguish between individual DNA bases. Our results remained valid in environments with various dielectric properties.	[Jakubec, David; Vondrasek, Jiri] Inst Organ Chem & Biochem, Prague 6, Czech Republic; [Jakubec, David] Charles Univ Prague, Fac Sci, Dept Phys & Macromol Chem, Prague 2, Czech Republic; [Laskowski, Roman A.] EMBL EBI, Wellcome Trust Genome Campus, Cambridge, England	Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Charles University Prague; European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute	Vondrasek, J (corresponding author), Inst Organ Chem & Biochem, Prague 6, Czech Republic.	jiri.vondrasek@uochb.cas.cz	Jakubec, David/O-7570-2017	Jakubec, David/0000-0003-4288-0344; Laskowski, Roman/0000-0001-5528-0087	Ministry of Education, Youth, and Sports of the Czech Republic (KONTAKT II programme) [LH11020]; Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic [Z40550506]	Ministry of Education, Youth, and Sports of the Czech Republic (KONTAKT II programme); Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic(Czech Academy of Sciences)	This work was supported by the Ministry of Education, Youth, and Sports of the Czech Republic (KONTAKT II programme LH11020, http://www.msmt.cz/), and the Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic (research project No. Z40550506, http://www.uochb.cz/). Access to computing and storage facilities was provided by ELIXIR CZ and the National Grid Infrastructure MetaCentrum, administered under the programme "Projects of Large Infrastructure for Research, Development, and Innovations." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKINRIMISI EO, 1964, BIOCHEMISTRY-US, V3, P619, DOI 10.1021/bi00893a004; Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020; Balasubramanian S, 2009, BIOPHYS J, V96, P2245, DOI 10.1016/j.bpj.2008.11.040; Battistini F, 2012, J MOL BIOL, V420, P8, DOI 10.1016/j.jmb.2012.03.026; Benos PV, 2002, NUCLEIC ACIDS RES, V30, P4442, DOI 10.1093/nar/gkf578; BERG OG, 1987, J MOL BIOL, V193, P723, DOI 10.1016/0022-2836(87)90354-8; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Berka K, 2010, J CHEM THEORY COMPUT, V6, P2191, DOI 10.1021/ct100007y; Berka K, 2009, J CHEM THEORY COMPUT, V5, P982, DOI 10.1021/ct800508v; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BERNSTEIN FC, 1977, EUR J BIOCHEM, V80, P319, DOI 10.1111/j.1432-1033.1977.tb11885.x; BONACCORSI R, 1972, THEOR CHIM ACTA, V24, P51, DOI 10.1007/BF00528310; Chocholousova J, 2006, J PHYS CHEM B, V110, P17240, DOI 10.1021/jp0627675; Contreras-Moreira B, 2010, NUCLEIC ACIDS RES, V38, pD91, DOI 10.1093/nar/gkp781; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; de Ruiter A, 2015, NUCLEIC ACIDS RES, V43, P708, DOI 10.1093/nar/gku1344; Drablos F, 2004, DNA REPAIR, V3, P1389, DOI 10.1016/j.dnarep.2004.05.004; Dror I, 2014, NUCLEIC ACIDS RES, V42, P430, DOI 10.1093/nar/gkt862; FREEDMAN D, 1981, Z WAHRSCHEINLICHKEIT, V57, P453, DOI 10.1007/BF01025868; Gaillard T, 2011, J CHEM THEORY COMPUT, V7, P3181, DOI 10.1021/ct200384r; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Hawkins GD, 1996, J PHYS CHEM-US, V100, P19824, DOI 10.1021/jp961710n; HAWKINS GD, 1995, CHEM PHYS LETT, V246, P122, DOI 10.1016/0009-2614(95)01082-K; HEGDE RS, 1992, NATURE, V359, P505, DOI 10.1038/359505a0; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hobza P, 2002, J AM CHEM SOC, V124, P11802, DOI 10.1021/ja026759n; Hostas J, 2015, J CHEM THEORY COMPUT, V11, P4086, DOI 10.1021/acs.jctc.5b00398; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jakubec D, 2015, J CHEM THEORY COMPUT, V11, P1939, DOI 10.1021/ct501168n; Jones S, 1999, J MOL BIOL, V287, P877, DOI 10.1006/jmbi.1999.2659; Jurecka P, 2006, PHYS CHEM CHEM PHYS, V8, P1985, DOI 10.1039/b600027d; Kilic S, 2014, NUCLEIC ACIDS RES, V42, pD156, DOI 10.1093/nar/gkt1123; KIM YC, 1993, NATURE, V365, P512, DOI 10.1038/365512a0; Kleinjung J, 2014, CURR OPIN STRUC BIOL, V25, P126, DOI 10.1016/j.sbi.2014.04.003; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; LUSTIG B, 1995, NUCLEIC ACIDS RES, V23, P4707, DOI 10.1093/nar/23.22.4707; Lustig B, 1997, NUCLEIC ACIDS RES, V25, P2562, DOI 10.1093/nar/25.13.2562; Mandel-Gutfreund Y, 1998, NUCLEIC ACIDS RES, V26, P2306, DOI 10.1093/nar/26.10.2306; Mirny LA, 2002, NUCLEIC ACIDS RES, V30, P1704, DOI 10.1093/nar/30.7.1704; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; OTWINOWSKI Z, 1988, NATURE, V335, P321, DOI 10.1038/335321a0; Parker SCJ, 2009, SCIENCE, V324, P389, DOI 10.1126/science.1169050; PERAHIA D, 1978, THEOR CHIM ACTA, V48, P263, DOI 10.1007/BF00549025; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pichierri F, 1999, J AM CHEM SOC, V121, P6152, DOI 10.1021/ja984124b; Prabakaran P, 2001, BIOINFORMATICS, V17, P1027, DOI 10.1093/bioinformatics/17.11.1027; Qiu D, 1997, J PHYS CHEM A, V101, P3005, DOI 10.1021/jp961992r; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Rohs R, 2009, CURR OPIN STRUC BIOL, V19, P171, DOI 10.1016/j.sbi.2009.03.002; SCHLITTER J, 1993, CHEM PHYS LETT, V215, P617, DOI 10.1016/0009-2614(93)89366-P; SEEMAN NC, 1976, P NATL ACAD SCI USA, V73, P804, DOI 10.1073/pnas.73.3.804; SHAKKED Z, 1989, NATURE, V342, P456, DOI 10.1038/342456a0; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; SINGH J, 1990, J MOL BIOL, V211, P595, DOI 10.1016/0022-2836(90)90268-Q; Singh J, 1992, ATLAS OF PROTEIN SID, VII; Singh J, 1992, ATLAS OF PROTEIN SID, VI; SMITH ML, 1995, ONCOGENE, V10, P1053; SPONER J, 1994, J PHYS CHEM-US, V98, P3161, DOI 10.1021/j100063a019; STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038; Stojic L, 2004, DNA REPAIR, V3, P1091, DOI 10.1016/j.dnarep.2004.06.006; THOMAS PD, 1978, FEBS LETT, V96, P90, DOI 10.1016/0014-5793(78)81069-2; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Yang L, 2014, NUCLEIC ACIDS RES, V42, pD148, DOI 10.1093/nar/gkt1087; Zhu C, 2009, GENOME RES, V19, P556, DOI 10.1101/gr.090233.108	70	10	10	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158704	10.1371/journal.pone.0158704	http://dx.doi.org/10.1371/journal.pone.0158704			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384774	Green Submitted, gold, Green Published			2022-12-27	WOS:000379809400077
J	Moyer, AE; Zheng, WX; Schweitzer, MH				Moyer, Alison E.; Zheng, Wenxia; Schweitzer, Mary H.			Keratin Durability Has Implications for the Fossil Record: Results from a 10 Year Feather Degradation Experiment	PLOS ONE			English	Article							BETA BETA KERATINS; BACTERIAL-DEGRADATION; SOFT-TISSUE; EVOLUTION; BIRD; PRESERVATION; DECAY; DIVERSIFICATION; EPIDERMIS; ORIGIN	Keratinous 'soft tissue' structures (i.e. epidermally derived and originally non-biomineralized), include feathers, skin, claws, beaks, and hair. Despite their relatively common occurrence in the fossil record (second only to bone and teeth), few studies have addressed natural degradation processes that must occur in all organic material, including those keratinous structures that are incorporated into the rock record as fossils. Because feathers have high preservation potential and strong phylogenetic signal, in the current study we examine feathers subjected to different burial environments for a duration of similar to 10 years, using transmission electron microscopy (TEM) and in situ immunofluorescence (IF). We use morphology and persistence of specific immunoreactivity as indicators of preservation at the molecular and microstructural levels. We show that feather keratin is durable, demonstrates structural and microstructural integrity, and retains epitopes suitable for specific antibody recognition in even the harshest conditions. These data support the hypothesis that keratin antibody reactivity can be used to identify the nature and composition of epidermal structures in the rock record, and to address evolutionary questions by distinguishing between alpha- (widely distributed) and beta- (limited to sauropsids) keratin.	[Moyer, Alison E.; Zheng, Wenxia; Schweitzer, Mary H.] North Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA; [Schweitzer, Mary H.] North Carolina Museum Nat Sci, Raleigh, NC 27601 USA	University of North Carolina; North Carolina State University	Moyer, AE (corresponding author), North Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA.	aemoyer@ncsu.edu	schweitzer, mary h/A-6756-2010; Schweitzer, Mary/V-8143-2019	schweitzer, mary h/0000-0002-0427-3829; 	David and Lucile Packard Foundation; NSF INSPIRE program [EAR-1344198]; National Science Foundation Graduate Research Fellowship Program [DGE-1252376]; Directorate For Geosciences [1344198] Funding Source: National Science Foundation	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); NSF INSPIRE program(National Science Foundation (NSF)); National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was funded by grants to MHS from the David and Lucile Packard Foundation and the NSF INSPIRE program (EAR-1344198), and the National Science Foundation Graduate Research Fellowship Program (DGE-1252376) To AEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibardi L, 2002, J EXP ZOOL, V293, P27, DOI 10.1002/jez.10145; Alibardi L, 2015, PROTOPLASMA, V252, P1529, DOI 10.1007/s00709-015-0782-9; Allentoft ME, 2012, P ROY SOC B-BIOL SCI, V279, P4724, DOI 10.1098/rspb.2012.1745; Briggs DEG, 2003, ANNU REV EARTH PL SC, V31, P275, DOI 10.1146/annurev.earth.31.100901.144746; Briggs DEG, 1995, PALAIOS, V10, P539, DOI 10.2307/3515093; Cai CG, 2009, J IND MICROBIOL BIOT, V36, P875, DOI 10.1007/s10295-009-0565-4; Carvalho ID, 2015, BRAZ J GEOL, V45, P161, DOI 10.1590/23174889201500020001; Carvalho ID, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8141; Chen CF, 2015, ANNU REV ANIM BIOSCI, V3, P169, DOI 10.1146/annurev-animal-022513-114127; Chiappe LM, 1998, NATURE, V392, P275, DOI 10.1038/32642; Collins MJ, 1998, THE GEOCHEMICAL FATE, P74, DOI [10.1021/bk-1998-0707.ch006, DOI 10.1021/BK-1998-0707.CH006]; DAVIS PG, 1995, GEOLOGY, V23, P783, DOI 10.1130/0091-7613(1995)023<0783:FOF>2.3.CO;2; Dent BB, 2004, ENVIRON GEOL, V45, P576, DOI 10.1007/s00254-003-0913-z; EGLINTON G, 1991, PHILOS T ROY SOC B, V333, P315, DOI 10.1098/rstb.1991.0081; Eglinton G, 1991, PHILOS T R SOC LON B, V333, P327, DOI [10.1098/rstb.1991.0081, DOI 10.1098/RSTB.1991.0081]; Eliason CM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1505; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Fraser RDB, 2008, J STRUCT BIOL, V162, P1, DOI 10.1016/j.jsb.2008.01.011; Fraser RDB, 2011, J STRUCT BIOL, V173, P391, DOI 10.1016/j.jsb.2010.09.020; Fujii T, 2008, J BIOL MACROMOL, V8, P48; Goldstein G, 2004, AUK, V121, P656, DOI 10.1642/0004-8038(2004)121[0656:BDOBAW]2.0.CO;2; Greenwold MJ, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0249-1; Greenwold MJ, 2013, J EXP ZOOL PART B, V320, P393, DOI 10.1002/jez.b.22514; Gunderson AR, 2008, J AVIAN BIOL, V39, P539, DOI 10.1111/j.0908-8857.2008.04413.x; Hitchcock E., 1841, SCENOGRAPHICAL GEOLO; Hitchcock E., 1841, ELEMENTARY GEOLOGY; Hitchcock E, 1841, 4 PARTS 1 EC GEOLOGY; Hitchcock E., 1841, SCI GEOLOGY; Holthaus KB, 2016, MOL BIOL EVOL, V33, P726, DOI 10.1093/molbev/msv265; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lindgren J, 2015, SCI REP-UK, V5, DOI 10.1038/srep13520; Lucas A., 1972, AVIAN ANATOMY INTEGU; Manning PL, 2013, J ANAL ATOM SPECTROM, V28, P1024, DOI 10.1039/c3ja50077b; Moyer AE, 2014, SCI REP-UK, V4, DOI [10.1038/srep04233, 10.1038/srep06191]; Navalon G, 2015, SCI REP-UK, V5, DOI 10.1038/srep14864; Ng CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002748; NOTBOHM H, 1992, J PROTEIN CHEM, V11, P635, DOI 10.1007/BF01024964; O'Connor J, 2015, J ORNITHOL, V156, pS333, DOI 10.1007/s10336-015-1222-5; Osborn HF., 1911, AM MUSEUM J, V2, P7; Pacton M, 2007, GEOMICROBIOL J, V24, P571, DOI 10.1080/01490450701672042; Sawyer RH, 2003, J EXP ZOOL PART B, V298B, P57, DOI 10.1002/jez.b.26; Schweitzer MH, 2015, BIOESSAYS, V37, P1174, DOI 10.1002/bies.201500061; Schweitzer MH, 2011, ANNU REV EARTH PL SC, V39, P187, DOI 10.1146/annurev-earth-040610-133502; Schweitzer MH, 1999, J EXP ZOOL, V285, P146; Schweitzer MH, 1999, J VERTEBR PALEONTOL, V19, P712, DOI 10.1080/02724634.1999.10011183; Shawkey MD, 2015, J MORPHOL, V276, P378, DOI 10.1002/jmor.20347; Stettenheim PR, 2000, AM ZOOL, V40, P461, DOI 10.1668/0003-1569(2000)040[0461:TIMOMB]2.0.CO;2; Strasser B, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0360-y; Symondson WOC, 1999, INSECT BIOCHEM MOLEC, V29, P873, DOI 10.1016/S0965-1748(99)00063-6; Vinther J, 2015, BIOESSAYS, V37, P643, DOI 10.1002/bies.201500018; Westall F, 2001, PRECAMBRIAN RES, V106, P93, DOI 10.1016/S0301-9268(00)00127-3; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813; Willerslev E, 2004, TRENDS ECOL EVOL, V19, P141, DOI 10.1016/j.tree.2003.11.010	54	27	27	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0157699	10.1371/journal.pone.0157699	http://dx.doi.org/10.1371/journal.pone.0157699			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384819	Green Published, gold, Green Submitted			2022-12-27	WOS:000379809400021
J	Aguirre, M; Bussolo de Souza, C; Venema, K				Aguirre, Marisol; Bussolo de Souza, Carlota; Venema, Koen			The Gut Microbiota from Lean and Obese Subjects Contribute Differently to the Fermentation of Arabinogalactan and Inulin	PLOS ONE			English	Article							IN-VITRO FERMENTATION; CHAIN FATTY-ACIDS; OLIGOFRUCTOSE-ENRICHED INULIN; NONSTARCH POLYSACCHARIDES; FECAL MICROBIOTA; PROPIONIC-ACID; DIETARY FIBER; BACTEROIDES-THETAIOTAOMICRON; RESISTANT STARCH; LARGE-INTESTINE	Background An aberrant metabolic activity or a compositional alteration of the gut microbiota has been proposed as a factor that makes us more prone to disease. Therefore, we explored the effect of two dietary fibers (arabinogalactan and inulin) on the microbiota from lean and obese subjects during 72 h in vitro fermentation experiments using the validated TNO dynamic in vitro model of the proximal colon: TIM-2. Metabolically, arabinogalactan fermentation showed a higher production of propionate when compared to n-butyrate in the obese microbiota fermentations. In general, lean microbiota produced more n-butyrate from the fermentation of both substrates when compared to the obese microbiota. Furthermore, the obese microbiota extracted more energy from the fermentation of both fibers. Results Compositionally, bacteria belonging to Gemmiger, Dorea, Roseburia, Alistipes, Lactobacillus and Bifidobacterium genera were found to be highly abundant or stimulated by the prebiotics in the lean microbiota suggesting a potential role in leanness. Furthermore, a significant correlation between known butyrogenic strains including B. adolescentis, an unclassified Bifidobacterium and F. prausnitzii with this metabolite in the fermentation of inulin in both microbiotas was found. Conclusions Although supplementary in vivo studies are needed, the current study provides more evidence for the consumption of specific ingredients with the aim of modulating the gut microbiota in the context of obesity.	[Aguirre, Marisol; Venema, Koen] Top Inst Food & Nutr, Wageningen, Netherlands; [Aguirre, Marisol; Venema, Koen] Maastricht Univ, Sch Nutr & Translat Res Metab NUTRIM, Fac Hlth Med & Life Sci, Dept Human Biol, Maastricht, Netherlands; [Aguirre, Marisol; Bussolo de Souza, Carlota] Netherlands Org Appl Sci Res TNO, Zeist, Netherlands; [Bussolo de Souza, Carlota] CNPq, Brasilia, DF, Brazil; [Bussolo de Souza, Carlota] Univ Groningen, Groningen, Netherlands; [Venema, Koen] Beneficial Microbes Consultancy, Wageningen, Netherlands	Top Institute Food & Nutrition; Maastricht University; Netherlands Organization Applied Science Research; University of Groningen	Venema, K (corresponding author), Top Inst Food & Nutr, Wageningen, Netherlands.; Venema, K (corresponding author), Maastricht Univ, Sch Nutr & Translat Res Metab NUTRIM, Fac Hlth Med & Life Sci, Dept Human Biol, Maastricht, Netherlands.; Venema, K (corresponding author), Beneficial Microbes Consultancy, Wageningen, Netherlands.	koen.venema@outlook.com			Top Institute Food AMP; Nutrition (TIFN, Wageningen, The Netherlands) [GH004]; CNPq (National Council for Scientific and Technological Development) - Brazil - under the Program "Science without Borders" [246027/2012-6]; TIFN	Top Institute Food AMP; Nutrition (TIFN, Wageningen, The Netherlands); CNPq (National Council for Scientific and Technological Development) - Brazil - under the Program "Science without Borders"; TIFN	This study was partly funded by the Top Institute Food & Nutrition (GH004; TIFN, Wageningen, The Netherlands). Carlota Bussolo de Souza received a scholarship from CNPq (National Council for Scientific and Technological Development) - Brazil - under the Program "Science without Borders" (grant number 246027/2012-6). Koen Venema is chief executive officer of Beneficial Microbes Consultancy. TIFN provided support in the form of salaries for authors KV and MA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aguirre M, 2015, J MICROBIOL METH, V117, P78, DOI 10.1016/j.mimet.2015.07.019; Aguirre Marisol, 2015, Microorganisms, V3, P213, DOI 10.3390/microorganisms3020213; Aguirre M, 2014, J MICROBIOL METH, V107, P1, DOI 10.1016/j.mimet.2014.08.022; Aguirre M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113864; Al-Lahham S, 2012, EUR J CLIN INVEST, V42, P357, DOI 10.1111/j.1365-2362.2011.02590.x; Al-Lahham SH, 2010, BBA-MOL CELL BIOL L, V1801, P1175, DOI 10.1016/j.bbalip.2010.07.007; Anderson JW, 2009, NUTR REV, V67, P188, DOI 10.1111/j.1753-4887.2009.00189.x; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Basson MD, 1996, DIGEST DIS SCI, V41, P1986, DOI 10.1007/BF02093601; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; de Souza CB, 2014, J FUNCT FOODS, V11, P210, DOI 10.1016/j.jff.2014.09.019; Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Condezo-Hoyos L, 2014, FOOD CHEM, V161, P208, DOI 10.1016/j.foodchem.2014.03.122; CROCIANI F, 1994, INT J FOOD MICROBIOL, V24, P199, DOI 10.1016/0168-1605(94)90119-8; Cummings JH, 1996, BRIT J NUTR, V75, P733, DOI 10.1079/BJN19960177; Cummings JH, 2004, CLIN NUTR, P5, DOI [10.1016/j.clnu.2004.09.003, 10.1016/j.clru.2004.09.003]; Daguet D, 2016, J FUNCT FOODS, V20, P369, DOI 10.1016/j.jff.2015.11.005; Daniel M, 1997, J NUTR, V127, P1981, DOI 10.1093/jn/127.10.1981; Davis LMG, 2010, INT J FOOD MICROBIOL, V144, P285, DOI 10.1016/j.ijfoodmicro.2010.10.007; de Graaf' AA, 2008, ADV MICROB PHYSIOL, V53, P73, DOI 10.1016/S0065-2911(07)53002-X; de Graaf AA, 2010, NMR BIOMED, V23, P2, DOI 10.1002/nbm.1418; De Preter V, 2007, AM J PHYSIOL-GASTR L, V292, pG358, DOI 10.1152/ajpgi.00052.2006; De Preter V, 2010, MOL NUTR FOOD RES, V54, P1791, DOI 10.1002/mnfr.201000136; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; DiBaise JK, 2008, MAYO CLIN PROC, V83, P460, DOI 10.4065/83.4.460; Elli M, 2010, MED HYPOTHESES, V75, P350, DOI 10.1016/j.mehy.2010.03.022; Freeland KR, 2010, BRIT J NUTR, V103, P460, DOI 10.1017/S0007114509991863; Grootaert C, 2009, FEMS MICROBIOL ECOL, V69, P231, DOI 10.1111/j.1574-6941.2009.00712.x; HAUER J, 1993, CANCER IMMUNOL IMMUN, V36, P237, DOI 10.1007/BF01740905; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hughes SA, 2007, J AGR FOOD CHEM, V55, P4589, DOI 10.1021/jf070293g; Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132; Juskiewicz J, 2007, ARCH ANIM NUTR, V61, P201, DOI 10.1080/17450390701297735; Kim Linda S, 2002, Altern Med Rev, V7, P138; KNUDSEN KEB, 1994, BRIT J NUTR, V71, P471, DOI 10.1079/BJN19940156; Kolida S, 2007, EUR J CLIN NUTR, V61, P1189, DOI 10.1038/sj.ejcn.1602636; Korpela K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090702; Liu SM, 2003, AM J CLIN NUTR, V78, P920, DOI 10.1093/ajcn/78.5.920; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Lyon MR, 2012, CURR OBES REP, V1, P59, DOI 10.1007/s13679-012-0016-9; Maathuis A, 2009, J AM COLL NUTR, V28, P657, DOI 10.1080/07315724.2009.10719798; MacFabe DF, 2011, BEHAV BRAIN RES, V217, P47, DOI 10.1016/j.bbr.2010.10.005; MACFARLANE GT, 1995, ANAEROBE, V1, P275, DOI 10.1006/anae.1995.1027; Marino PL, 2012, ICU BOOK; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Payne AN, 2011, NUTR DIABETES, V1, DOI 10.1038/nutd.2011.8; Ramirez-Farias C, 2009, BRIT J NUTR, V101, P541, DOI 10.1017/S0007114508019880; Roberfroid MB, 2001, AM J CLIN NUTR, V73, p406S, DOI 10.1093/ajcn/73.2.406s; Robinson RR, 2001, J AM COLL NUTR, V20, P279, DOI 10.1080/07315724.2001.10719048; Roelofsen H, 2010, BENEF MICROBES, V1, P433, DOI 10.3920/BM2010.0028; ROYALL D, 1990, AM J GASTROENTEROL, V85, P1307; Russell WR, 2011, AM J CLIN NUTR, V93, P1062, DOI 10.3945/ajcn.110.002188; Sakaguchi E, 1998, BRIT J NUTR, V80, P469, DOI 10.1017/S0007114598001548; Santacruz A, 2009, OBESITY, V17, P1906, DOI 10.1038/oby.2009.112; Sarbini SR, 2014, BRIT J NUTR, V112, P1303, DOI 10.1017/S0007114514002177; Sarbini SR, 2013, BRIT J NUTR, V109, P1980, DOI 10.1017/S0007114512004205; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Spill MK, 2011, AM J CLIN NUTR, V94, P735, DOI 10.3945/ajcn.111.015206; Tarini J, 2010, APPL PHYSIOL NUTR ME, V35, P9, DOI 10.1139/H09-119; Tilg H, 2010, J CLIN GASTROENTEROL, V44, pS16, DOI 10.1097/MCG.0b013e3181dd8b64; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; van de Wiele T, 2007, J APPL MICROBIOL, V102, P452, DOI 10.1111/j.1365-2672.2006.03084.x; Van der Kamp J. W., 2010, DIETARY FIBRE NEW FR; Van Nuenen M., 2003, MICROB ECOL HEALTH D, V15, P137, DOI DOI 10.1080/08910600310018959; Velazquez OC, 1997, ADV EXP MED BIOL, V427, P123; Venema K, 2003, FEMS MICROBIOL LETT, V224, P143, DOI 10.1016/S0378-1097(03)00436-1; VINCE AJ, 1990, BRIT J NUTR, V63, P17, DOI 10.1079/BJN19900088; Wanders AJ, 2013, BRIT J NUTR, V109, P1330, DOI 10.1017/S0007114512003145; Willing B, 2009, INFLAMM BOWEL DIS, V15, P653, DOI 10.1002/ibd.20783; Wisker E, 1997, J NUTR, V127, P108, DOI 10.1093/jn/127.1.108; Yang JY, 2013, J MED FOOD, V16, P862, DOI [10.1089/jmf.2012.0292, 10.1100/jmf.2012.0292]; Zocco MA, 2007, DIGEST LIVER DIS, V39, P707, DOI 10.1016/j.dld.2007.04.003	77	56	57	4	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159236	10.1371/journal.pone.0159236	http://dx.doi.org/10.1371/journal.pone.0159236			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410967	Green Published, Green Submitted, gold			2022-12-27	WOS:000379508300068
J	Cox, AR; Barrandon, O; Cai, EP; Rios, JS; Chavez, J; Bonnyman, CW; Lam, CJ; Yi, P; Melton, DA; Kushner, JA				Cox, Aaron R.; Barrandon, Ornella; Cai, Erica P.; Rios, Jacqueline S.; Chavez, Julia; Bonnyman, Claire W.; Lam, Carol J.; Yi, Peng; Melton, Douglas A.; Kushner, Jake A.			Resolving Discrepant Findings on ANGPTL8 in beta-Cell Proliferation: A Collaborative Approach to Resolving the Betatrophin Controversy	PLOS ONE			English	Article							MALTOSE-BINDING-PROTEIN; METABOLISM; GENE; MICE	The beta-cell mitogenic effects of ANGPTL8 have been subjected to substantial debate. The original findings suggested that ANGPTL8 overexpression in mice induced a 17-fold increase in beta-cell proliferation. Subsequent studies in mice contested this claim, but a more recent report in rats supported the original observations. These conflicting results might be explained by variable ANGPTL8 expression and differing methods of beta-cell quantification. To resolve the controversy, three independent labs collaborated on a blinded study to test the effects of ANGPTL8 upon beta-cell proliferation. Recombinant human betatrophin (hBT) fused to maltose binding protein (MBP) was delivered to mice by intravenous injection. The results demonstrate that ANGPTL8 does not stimulate significant beta-cell proliferation. Each lab employed different methods for beta-cell identification, resulting in variable quantification of beta-cell proliferation and suggests a need for standardizing practices for beta-cell quantification. We also observed a new action of ANGPTL8 in stimulating CD45(+) hematopoietic-derived cell proliferation which may explain, in part, published discrepancies. Overall, the hypothesis that ANGPTL8 induces dramatic and specific beta-cell proliferation can no longer be supported. However, while ANGPTL8 does not stimulate robust beta-cell proliferation, the original experimental model using drug-induced (S961) insulin resistance was validated in subsequent studies, and thus still represents a robust system for studying signals that are either necessary or sufficient for beta-cell expansion. As an added note, we would like to commend collaborative group efforts, with repetition of results and procedures in multiple laboratories, as an effective method to resolve discrepancies in the literature.	[Cox, Aaron R.; Rios, Jacqueline S.; Chavez, Julia; Bonnyman, Claire W.; Lam, Carol J.; Kushner, Jake A.] Texas Childrens Hosp, Baylor Coll Med, McNair Med Inst, Pediat Diabet & Endocrinol, Houston, TX 77030 USA; [Barrandon, Ornella; Cai, Erica P.; Yi, Peng; Melton, Douglas A.] Harvard Univ, Harvard Stem Cell Inst, Stem Cell & Regenerat Biol, Cambridge, MA USA; [Cai, Erica P.; Yi, Peng] Harvard Med Sch, Joslin Diabet Ctr, Boston, MA USA	Baylor College of Medicine; Harvard University; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Kushner, JA (corresponding author), Texas Childrens Hosp, Baylor Coll Med, McNair Med Inst, Pediat Diabet & Endocrinol, Houston, TX 77030 USA.	kushner@bcm.edu	Cai, Erica/ABE-4408-2020; Kushner, Jake A/AAF-5049-2022; Young, Richard A/F-6495-2012; Kushner, Jake A/AFJ-8198-2022	Kushner, Jake A/0000-0002-3646-1744; Young, Richard A/0000-0001-8855-8647; Kushner, Jake A/0000-0002-3646-1744; Bonnyman, Claire/0000-0002-6570-2623; Chavez, Julia/0000-0001-7831-7989; Cai, Erica/0000-0003-2386-5747	National Institutes of Health (NIH NIA) [1R01AG04101]; Howard Hughes Medical Institute (HHMI); Harvard Stem Cell Institute; Robert and Janice McNair Foundation; Diabetes Research Center at Baylor College of Medicine; NATIONAL INSTITUTE ON AGING [R01AG040110] Funding Source: NIH RePORTER	National Institutes of Health (NIH NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); Harvard Stem Cell Institute; Robert and Janice McNair Foundation; Diabetes Research Center at Baylor College of Medicine; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health (NIH NIA - 1R01AG04101) (www.nia.nih.gov), the Howard Hughes Medical Institute (HHMI) (www.hhmi.org), the Harvard Stem Cell Institute (hsci.harvard.edu), the Robert and Janice McNair Foundation (www.mcnairfoundation.org) and the Diabetes Research Center at Baylor College of Medicine (www.bcm.edu/research/centers/diabetesresearch/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen JX, 2015, DIABETOLOGIA, V58, P1036, DOI 10.1007/s00125-015-3521-z; Gusarova V, 2014, CELL, V159, P691, DOI 10.1016/j.cell.2014.09.027; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Pryor KD, 1997, PROTEIN EXPRES PURIF, V10, P309, DOI 10.1006/prep.1997.0759; Quagliarini F, 2012, P NATL ACAD SCI USA, V109, P19751, DOI 10.1073/pnas.1217552109; Rankin MM, 2013, DIABETES, V62, P1634, DOI 10.2337/db12-0848; Ren G, 2012, AM J PHYSIOL-ENDOC M, V303, pE334, DOI 10.1152/ajpendo.00084.2012; Taylor BL, 2013, CELL REP, V4, P1262, DOI 10.1016/j.celrep.2013.08.010; Tuttle AH, 2010, J VIS EXP, V7; Van De Casteele M, 2013, DIABETOLOGIA, V56, P2647, DOI 10.1007/s00125-013-3049-z; Wang Y, 2013, P NATL ACAD SCI USA, V110, P16109, DOI 10.1073/pnas.1315292110; Yi P, 2013, CELL, V153, P747, DOI 10.1016/j.cell.2013.04.008; Zhang R, 2012, BIOCHEM BIOPH RES CO, V424, P786, DOI 10.1016/j.bbrc.2012.07.038	14	35	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159276	10.1371/journal.pone.0159276	http://dx.doi.org/10.1371/journal.pone.0159276			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410263	gold, Green Published, Green Submitted			2022-12-27	WOS:000379508300076
J	Dannenmann, M; Bimuller, C; Gschwendtner, S; Leberecht, M; Tejedor, J; Bilela, S; Gasche, R; Hanewinkel, M; Baltensweiler, A; Kogel-Knabner, I; Polle, A; Schloter, M; Simon, J; Rennenberg, H				Dannenmann, Michael; Bimueller, Carolin; Gschwendtner, Silvia; Leberecht, Martin; Tejedor, Javier; Bilela, Silvija; Gasche, Rainer; Hanewinkel, Marc; Baltensweiler, Andri; Koegel-Knabner, Ingrid; Polle, Andrea; Schloter, Michael; Simon, Judy; Rennenberg, Heinz			Climate Change Impairs Nitrogen Cycling in European Beech Forests	PLOS ONE			English	Article							PLANT-MICROBE COMPETITION; SPRUCE PICEA-ABIES; FAGUS-SYLVATICA L.; AMINO-ACIDS; SOIL-MICROORGANISMS; ANNUAL GRASSLAND; QUERCUS-PETRAEA; NET UPTAKE; TREES; ROOTS	European beech forests growing on marginal calcareous soils have been proposed to be vulnerable to decreased soil water availability. This could result in a large-scale loss of ecological services and economical value in a changing climate. In order to evaluate the potential consequences of this drought-sensitivity, we investigated potential species range shifts for European beech forests on calcareous soil in the 21st century by statistical species range distribution modelling for present day and projected future climate conditions. We found a dramatic decline by 78% until 2080. Still the physiological or biogeochemical mechanisms underlying the drought sensitivity of European beech are largely unknown. Drought sensitivity of beech is commonly attributed to plant physiological constraints. Furthermore, it has also been proposed that reduced soil water availability could promote nitrogen (N) limitation of European beech due to impaired microbial N cycling in soil, but this hypothesis has not yet been tested. Hence we investigated the influence of simulated climate change (increased temperatures, reduced soil water availability) on soil gross microbial N turnover and plant N uptake in the beech-soil interface of a typical mountainous beech forest stocking on calcareous soil in SW Germany. For this purpose, triple N-15 isotope labelling of intact beech seedling-soil-microbe systems was combined with a space-for-time climate change experiment. We found that nitrate was the dominant N source for beech natural regeneration. Reduced soil water content caused a persistent decline of ammonia oxidizing bacteria and therefore, a massive attenuation of gross nitrification rates and nitrate availability in the soil. Consequently, nitrate and total N uptake of beech seedlings were strongly reduced so that impaired growth of beech seedlings was observed already after one year of exposure to simulated climatic change. We conclude that the N cycle in this ecosystem and here specifically nitrification is vulnerable to reduced water availability, which can directly lead to nutritional limitations of beech seedlings. This tight link between reduced water availability, drought stress for nitrifiers, decreased gross nitrification rates and nitrate availability and finally nitrate uptake by beech seedlings could represent the Achilles' heel for beech under climate change stresses.	[Dannenmann, Michael; Tejedor, Javier; Gasche, Rainer] Karlsruhe Inst Technol, Inst Meteorol & Climate Res Atmospher Environm Re, Kreuzeckbahnstr 19, D-82467 Garmisch Partenkirchen, Germany; [Dannenmann, Michael; Bilela, Silvija; Simon, Judy; Rennenberg, Heinz] Univ Freiburg, Inst Forest Sci, Chair Tree Physiol, Georges Koehler Allee 53-54, D-79110 Freiburg, Germany; [Bimueller, Carolin; Koegel-Knabner, Ingrid] Tech Univ Munich, Wissenschaftszentrum Weihenstephan, Dept Okol Okosyst Management, Lehrstuhl Bodenkunde, D-85350 Freising Weihenstephan, Germany; [Gschwendtner, Silvia; Schloter, Michael] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Environm Genom, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany; [Leberecht, Martin; Polle, Andrea] Univ Gottingen, Busgen Inst, Forest Bot & Tree Physiol, Busgenweg 2, D-37077 Gottingen, Germany; [Koegel-Knabner, Ingrid] Tech Univ Munich, IAS, Lichtenbergstr 2a, D-85748 Garching, Germany; [Rennenberg, Heinz] King Saud Univ, POB 2454, Riyadh 11451, Saudi Arabia; [Hanewinkel, Marc] Univ Freiburg, Chair Forestry Econ & Forest Planning, D-79110 Freiburg, Germany; [Hanewinkel, Marc; Baltensweiler, Andri] Swiss Fed Res Inst WSL, Res Unit Forest Resources & Management, Zuercherstr 111, CH-8903 Birmensdorf, Switzerland; [Simon, Judy] Univ Konstanz, Chair Plant Physiol & Biochem, Univ Str 10, D-78457 Constance, Germany	Helmholtz Association; Karlsruhe Institute of Technology; University of Freiburg; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Gottingen; Technical University of Munich; King Saud University; University of Freiburg; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of Konstanz	Dannenmann, M (corresponding author), Karlsruhe Inst Technol, Inst Meteorol & Climate Res Atmospher Environm Re, Kreuzeckbahnstr 19, D-82467 Garmisch Partenkirchen, Germany.; Dannenmann, M (corresponding author), Univ Freiburg, Inst Forest Sci, Chair Tree Physiol, Georges Koehler Allee 53-54, D-79110 Freiburg, Germany.	michael.dannenmann@kit.edu	Dannenmann, Michael/A-7278-2013; Schloter, 1Michael/H-9151-2013; hanewinkel, marc/E-5639-2011; Tejedor, Javier/AAA-6473-2020; Kögel-Knabner, Ingrid/A-7905-2008; Baltensweiler, Andri/V-2327-2019; Simon, Judy/C-7875-2011	hanewinkel, marc/0000-0003-4081-6621; Kögel-Knabner, Ingrid/0000-0002-7216-8326; Baltensweiler, Andri/0000-0003-1933-6535; , Javier/0000-0002-5994-0131; Polle, Andrea/0000-0001-8697-6394; Dannenmann, Michael/0000-0001-5924-7612; Leberecht, Martin/0000-0002-5672-8928; Simon, Judy/0000-0002-8879-2449	German Science Foundation (DFG) [DA 1217/2-1, KO 1035/41-1, SCHL 446/11-1, RE 515/33-1, PO 362/19-1]; Ministry of Science, Research and the Arts Baden-Wurttemberg; European Social Fund	German Science Foundation (DFG)(German Research Foundation (DFG)); Ministry of Science, Research and the Arts Baden-Wurttemberg; European Social Fund(European Social Fund (ESF))	This work has been supported by the German Science Foundation (DFG) under the contract numbers DA 1217/2-1, KO 1035/41-1, SCHL 446/11-1, RE 515/33-1 and PO 362/19-1. J.S. was financially supported by the Ministry of Science, Research and the Arts Baden-Wurttemberg and the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work has been supported by the German Science Foundation (DFG) under the contract numbers DA 1217/2-1, KO 1035/41-1, SCHL 446/11-1, RE 515/33-1 and PO 362/19-1. J.S. was financially supported by the Ministry of Science, Research and the Arts Baden-Wurttemberg and the European Social Fund. We thank Rudi Meier (KIT/IMK-IFU-CSI), Jens Dyckmans (KOSI, Universitat Gottingen) and Franz Buegger (Helmholtz Zentrum Munchen) for isotope analyses, Thomas Klein for field work, Elisabeth Zumbusch for analysis of carbon and nitrogen in soil extracts and Allison Kolar for language correction.	Bimuller C, 2014, SOIL BIOL BIOCHEM, V68, P241, DOI 10.1016/j.soilbio.2013.10.003; Burger M, 2004, PLANT SOIL, V266, P289; Chapman SK, 2006, NEW PHYTOL, V169, P27, DOI 10.1111/j.1469-8137.2005.01571.x; Coumou D, 2013, CLIMATIC CHANGE, V118, P771, DOI 10.1007/s10584-012-0668-1; Dannenmann M, 2008, SOIL BIOL BIOCHEM, V40, P2317, DOI 10.1016/j.soilbio.2008.05.009; Dannenmann M, 2006, PLANT SOIL, V287, P279, DOI 10.1007/s11104-006-9077-4; Dannenmann M, 2009, SOIL BIOL BIOCHEM, V41, P1622, DOI 10.1016/j.soilbio.2009.04.024; Dell CJ, 2005, SOIL SCI SOC AM J, V69, P371, DOI 10.2136/sssaj2005.0371; Ellenberg H, 1996, VEGETATION MITTELEUR; Fernandez-Martinez M, 2014, NAT CLIM CHANGE, V4, P471, DOI [10.1038/nclimate2177, 10.1038/NCLIMATE2177]; Finzi AC, 2005, ECOLOGY, V86, P3345, DOI 10.1890/04-1460; Gessler A, 2005, EUR J FOREST RES, V124, P95, DOI 10.1007/s10342-005-0055-9; Gessler A, 2004, PLANT BIOLOGY, V6, P289, DOI 10.1055/s-2004-820878; Gessler A, 1998, NEW PHYTOL, V138, P275, DOI 10.1046/j.1469-8137.1998.00107.x; Gessler A, 2007, TREES-STRUCT FUNCT, V21, P1, DOI 10.1007/s00468-006-0107-x; Gschwendtner S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116614; Guo CJ, 2013, PLANT SOIL, V369, P657, DOI 10.1007/s11104-013-1603-6; Haas E, 2013, LANDSCAPE ECOL, V28, P615, DOI 10.1007/s10980-012-9772-x; Hanewinkel M, 2014, J ENVIRON MANAGE, V134, P153, DOI 10.1016/j.jenvman.2014.01.010; Hanewinkel M, 2013, NAT CLIM CHANGE, V3, P203, DOI [10.1038/nclimate1687, 10.1038/NCLIMATE1687]; Harrison KA, 2008, SOIL BIOL BIOCHEM, V40, P228, DOI 10.1016/j.soilbio.2007.08.004; Harrison KA, 2007, ECOLOGY, V88, P989, DOI 10.1890/06-1018; HART SC, 1991, BIOGEOCHEMISTRY, V12, P103; JACKSON LE, 1989, SOIL BIOL BIOCHEM, V21, P409, DOI 10.1016/0038-0717(89)90152-1; Jackson LE, 2008, ANNU REV PLANT BIOL, V59, P341, DOI 10.1146/annurev.arplant.59.032607.092932; Jaeger CH, 1999, ECOLOGY, V80, P1883, DOI 10.1890/0012-9658(1999)080[1883:SPONBP]2.0.CO;2; JOHNSON DW, 1992, J ENVIRON QUAL, V21, P1, DOI 10.2134/jeq1992.00472425002100010001x; Kohler M, 2010, EUR J FOREST RES, V129, P1109, DOI 10.1007/s10342-010-0397-9; Kreuzwieser J, 2010, TREE PHYSIOL, V30, P1221, DOI 10.1093/treephys/tpq055; Kuzyakov Y, 2013, NEW PHYTOL, V198, P656, DOI 10.1111/nph.12235; Leuschner C, 2001, FOREST ECOL MANAG, V149, P33, DOI 10.1016/S0378-1127(00)00543-0; Lipson DA, 1998, OECOLOGIA, V113, P406, DOI 10.1007/s004420050393; Liu XP, 2005, PLANT PHYSIOL BIOCH, V43, P147, DOI 10.1016/j.plaphy.2005.01.010; Michelot A, 2012, FOREST ECOL MANAG, V265, P161, DOI 10.1016/j.foreco.2011.10.024; Moosmayer H. U., 2002, LANGFRISTIGE REGIONA; Nadelhoffer KJ, 1999, ECOL APPL, V9, P72, DOI 10.1890/1051-0761(1999)009[0072:SFNEAT]2.0.CO;2; Nakicenovic N., 2000, SPECIAL REPORT EMISS; Nasholm T, 2009, NEW PHYTOL, V182, P31, DOI 10.1111/j.1469-8137.2008.02751.x; Norton JM, 2011, METHOD ENZYMOL, V486, P343, DOI [10.1016/S0076-6879(11)86015-5, 10.1016/B978-0-12-381294-0.00015-8]; Pachauri R.K., 2014, CLIMATE CHANGE 2014, P151; Pena R, 2010, APPL ENVIRON MICROB, V76, P1831, DOI 10.1128/AEM.01703-09; Pretzsch H, 2013, PLANT BIOLOGY, V15, P483, DOI 10.1111/j.1438-8677.2012.00670.x; Rennenberg H, 2006, PLANT BIOLOGY, V8, P556, DOI 10.1055/s-2006-924084; Rennenberg H, 2009, PLANT BIOLOGY, V11, P4, DOI 10.1111/j.1438-8677.2009.00241.x; Rennenberg H, 2001, J APPL BOT-ANGEW BOT, V75, P101; Schimel JP, 2004, ECOLOGY, V85, P591, DOI 10.1890/03-8002; SCHIMEL JP, 1989, SOIL BIOL BIOCHEM, V21, P1059, DOI 10.1016/0038-0717(89)90044-8; Simon J, 2010, PLANT BIOLOGY, V12, P453, DOI 10.1111/j.1438-8677.2009.00225.x; Simon J, 2011, FOREST ECOL MANAG, V262, P105, DOI 10.1016/j.foreco.2011.01.035; Smiatek G, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD011353; Stoelken G, 2010, TREE PHYSIOL, V30, P1118, DOI 10.1093/treephys/tpq050; Tarp P, 2000, FOREST ECOL MANAG, V130, P187, DOI 10.1016/S0378-1127(99)00190-5; Wagner S, 2013, CLIM DYNAM, V40, P415, DOI 10.1007/s00382-012-1510-1; Weber P, 2013, TREES-STRUCT FUNCT, V27, P171, DOI 10.1007/s00468-012-0786-4; WINTER H, 1992, PLANT PHYSIOL, V99, P996, DOI 10.1104/pp.99.3.996; Wu HH, 2011, PLANT SOIL, V340, P127, DOI 10.1007/s11104-010-0575-z; ZAK DR, 1990, ECOLOGY, V71, P651, DOI 10.2307/1940319; Zimmermann J, 2015, ECOSYSTEMS IN PRESS	58	34	36	7	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158823	10.1371/journal.pone.0158823	http://dx.doi.org/10.1371/journal.pone.0158823			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410969	Green Published, gold			2022-12-27	WOS:000379508300035
J	Greene, AC; Henderson, IM; Gomez, A; Paxton, WF; VanDelinder, V; Bachand, GD				Greene, Adrienne C.; Henderson, Ian M.; Gomez, Andrew; Paxton, Walter F.; VanDelinder, Virginia; Bachand, George D.			The Role of Membrane Fluidization in the Gel-Assisted Formation of Giant Polymersomes	PLOS ONE			English	Article							UNILAMELLAR VESICLES; DRUG-DELIVERY; MODEL SYSTEMS; LIPOSOMES; COPOLYMERS; NETWORKS; FILMS	Polymersomes are being widely explored as synthetic analogs of lipid vesicles based on their enhanced stability and potential uses in a wide variety of applications in (e.g., drug delivery, cell analogs, etc.). Controlled formation of giant polymersomes for use in membrane studies and cell mimetic systems, however, is currently limited by low-yield production methodologies. Here, we describe for the first time, how the size distribution of giant poly(ethylene glycol)-poly(butadiene) (PEO-PBD) polymersomes formed by gel-assisted rehydration may be controlled based on membrane fluidization. We first show that the average diameter and size distribution of PEO-PBD polymersomes may be readily increased by increasing the temperature of the rehydration solution. Further, we describe a correlative relationship between polymersome size and membrane fluidization through the addition of sucrose during rehydration, enabling the formation of PEO-PBD polymersomes with a range of diameters, including giant-sized vesicles (>100 mu m). This correlative relationship suggests that sucrose may function as a small molecule fluidizer during rehydration, enhancing polymer diffusivity during formation and increasing polymersome size. Overall the ability to easily regulate the size of PEO-PBD polymersomes based on membrane fluidity, either through temperature or fluidizers, has broadly applicability in areas including targeted therapeutic delivery and synthetic biology.	[Greene, Adrienne C.; Henderson, Ian M.; Paxton, Walter F.; VanDelinder, Virginia; Bachand, George D.] Sandia Natl Labs, Ctr Integrated Nanotechnol, POB 5800, Albuquerque, NM 87185 USA; [Gomez, Andrew] Sandia Natl Labs, Ctr Mat Sci & Engn, Albuquerque, NM USA	United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Sandia National Laboratories	Bachand, GD (corresponding author), Sandia Natl Labs, Ctr Integrated Nanotechnol, POB 5800, Albuquerque, NM 87185 USA.	gdbacha@sandia.gov	Paxton, Walter/AAP-8682-2021	Paxton, Walter/0000-0002-2438-4542; Greene, Adrienne/0000-0003-0270-3351; Bachand, George/0000-0002-3169-9980	U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering (BES-MSE); U.S. Department of Energy (DOE) Office of Science [RA2015A0004]; U.S. Department of Energy's National Nuclear Security Administration [DE-AC04-94AL85000]	U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering (BES-MSE); U.S. Department of Energy (DOE) Office of Science(United States Department of Energy (DOE)); U.S. Department of Energy's National Nuclear Security Administration(National Nuclear Security Administration)	This work was supported by the U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering (BES-MSE). The funder provided support in the form of salaries for authors [ACG, AG, WFP, GDB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. This work was performed, in part, at the Center for Integrated Nanotechnologies, an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science (user project number RA2015A0004). The funder provided support in the form of salaries for authors [IMH and VV], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. Sandia National Laboratories is a multi-program laboratory managed and operated by Sandia Corporation, a wholly owned subsidiary of Lockheed Martin Corporation, for the U.S. Department of Energy's National Nuclear Security Administration under contract DE-AC04-94AL85000.	Amos RC, 2012, SOFT MATTER, V8, P5947, DOI 10.1039/c2sm25172h; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Bermudez H, 2002, MACROMOLECULES, V35, P8203, DOI 10.1021/ma020669l; Christian DA, 2009, NAT MATER, V8, P843, DOI [10.1038/NMAT2512, 10.1038/nmat2512]; Dimova R, 2002, EUR PHYS J E, V7, P241, DOI 10.1140/epje/i200101032; Ding LP, 2010, LANGMUIR, V26, P5544, DOI 10.1021/la9038045; Discher BM, 1999, SCIENCE, V284, P1143, DOI 10.1126/science.284.5417.1143; Discher DE, 2002, SCIENCE, V297, P967, DOI 10.1126/science.1074972; Discher DE, 2006, ANNU REV BIOMED ENG, V8, P323, DOI 10.1146/annurev.bioeng.8.061505.095838; Egli S, 2011, J AM CHEM SOC, V133, P4476, DOI 10.1021/ja110275f; Ganta S, 2008, J CONTROL RELEASE, V126, P187, DOI 10.1016/j.jconrel.2007.12.017; Hansen JS, 2013, J AM CHEM SOC, V135, P17294, DOI 10.1021/ja409708e; Henderson IM, 2014, ANGEW CHEM INT EDIT, V53, P3372, DOI 10.1002/anie.201309433; Hickey RJ, 2014, ACS NANO, V8, P495, DOI 10.1021/nn405012h; Horger KS, 2009, J AM CHEM SOC, V131, P1810, DOI 10.1021/ja805625u; Howse JR, 2009, NAT MATER, V8, P507, DOI [10.1038/NMAT2446, 10.1038/nmat2446]; Jang WS, 2016, SOFT MATTER, V12, P1014, DOI 10.1039/c5sm01881a; Jonsson P, 2008, BIOPHYS J, V95, P5334, DOI 10.1529/biophysj.108.134874; Kim KT, 2009, ADV MATER, V21, P2787, DOI 10.1002/adma.200900300; Lee JCM, 2002, MACROMOLECULES, V35, P323, DOI 10.1021/ma0112063; Liu GY, 2012, SOFT MATTER, V8, P8811, DOI 10.1039/c2sm25721a; Mabrouk E, 2009, SOFT MATTER, V5, P1870, DOI 10.1039/b815817g; Marquardt D, 2015, MEMBRANES, V5, P180, DOI 10.3390/membranes5020180; Moodley K, 2012, INT J MOL SCI, V13, P18, DOI 10.3390/ijms13010018; Najer A, 2016, CHIMIA, V70, P288, DOI 10.2533/chimia.2016.288; Pata V, 2003, BIOPHYS J, V85, P2111, DOI 10.1016/S0006-3495(03)74639-6; Paxton WF, 2015, NANOSCALE, V7, P10998, DOI 10.1039/c5nr00826c; Paxton WF, 2013, SOFT MATTER, V9, P11295, DOI 10.1039/c3sm51575c; Rodriguez-Garcia R, 2011, SOFT MATTER, V7, P1532, DOI 10.1039/c0sm00823k; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmaljohann D, 2006, ADV DRUG DELIVER REV, V58, P1655, DOI 10.1016/j.addr.2006.09.020; Streicher P, 2009, BBA-BIOMEMBRANES, V1788, P2291, DOI 10.1016/j.bbamem.2009.07.025; Tsai FC, 2011, LANGMUIR, V27, P10061, DOI 10.1021/la201604z; Tsumoto K, 2009, COLLOID SURFACE B, V68, P98, DOI 10.1016/j.colsurfb.2008.09.023; Walde P, 2010, CHEMBIOCHEM, V11, P848, DOI 10.1002/cbic.201000010; Weinberger A, 2013, BIOPHYS J, V105, P154, DOI 10.1016/j.bpj.2013.05.024; Wesolowska O, 2009, ACTA BIOCHIM POL, V56, P33	37	22	22	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158729	10.1371/journal.pone.0158729	http://dx.doi.org/10.1371/journal.pone.0158729			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410487	gold, Green Published, Green Submitted			2022-12-27	WOS:000379508300033
J	Hartmann, A; Mullner, J; Meier, N; Hesekamp, H; van Meerbeeck, P; Habert, MO; Kas, A; Tanguy, ML; Mazmanian, M; Oya, H; Abuaf, N; Gaouar, H; Salhi, S; Charbonnier-Beaupel, F; Fievet, MH; Galanaud, D; Arguillere, S; Roze, E; Degos, B; Grabli, D; Lacomblez, L; Hubsch, C; Vidailhet, M; Bonnet, AM; Corvol, JC; Schupbach, M				Hartmann, Andreas; Mullner, Julia; Meier, Niklaus; Hesekamp, Helke; van Meerbeeck, Priscilla; Habert, Marie-Odile; Kas, Aurelie; Tanguy, Marie-Laure; Mazmanian, Merry; Oya, Herve; Abuaf, Nissen; Gaouar, Hafida; Salhi, Sabrina; Charbonnier-Beaupel, Fanny; Fievet, Marie-Helene; Galanaud, Damien; Arguillere, Sophie; Roze, Emmanuel; Degos, Bertrand; Grabli, David; Lacomblez, Lucette; Hubsch, Cecile; Vidailhet, Marie; Bonnet, Anne-Marie; Corvol, Jean-Christophe; Schupbach, Michael			Bee Venom for the Treatment of Parkinson Disease - A Randomized Controlled Clinical Trial	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNELS; SMALL-CONDUCTANCE; DOPAMINERGIC-NEURONS; MOUSE MODEL; ACUPUNCTURE; STIMULATION; THERAPY; PATTERN; MEMORY	In the present study, we examined the potential symptomatic and/or disease-modifying effects of monthly bee venom injections compared to placebo in moderatly affected Parkinson disease patients. We conducted a prospective, randomized double-blind study in 40 Parkinson disease patients at Hoehn & Yahr stages 1.5 to 3 who were either assigned to monthly bee venom injections or equivalent volumes of saline (treatment/placebo group: n = 20/20). The primary objective of this study was to assess a potential symptomatic effect of s.c. bee venom injections (100 mu g) compared to placebo 11 months after initiation of therapy on United Parkinson's Disease Rating Scale (UPDRS) III scores in the "off" condition pre-and post-injection at a 60 minute interval. Secondary objectives included the evolution of UPDRS III scores over the study period and [1231]-FP-CIT scans to evaluate disease progression. Finally, safety was assessed by monitoring specific IgE against bee venom and skin tests when necessary. After an 11 month period of monthly administration, bee venom did not significantly decrease UPDRS III scores in the "off" condition. Also, UPDRS III scores over the study course, and nuclear imaging, did not differ significantly between treatment groups. Four patients were excluded during the trial due to positive skin tests but no systemic allergic reaction was recorded. After an initial increase, specific IgE against bee venom decreased in all patients completing the trial. This study did not evidence any clear symptomatic or disease-modifying effects of monthly bee venom injections over an 11 month period compared to placebo using a standard bee venom allergy desensitization protocol in Parkinson disease patients. However, bee venom administration appeared safe in non-allergic subjects. Thus, we suggest that higher administration frequency and possibly higher individual doses of bee venom may reveal its potency in treating Parkinson disease.	[Hartmann, Andreas; Mullner, Julia; Meier, Niklaus; Hesekamp, Helke; van Meerbeeck, Priscilla; Arguillere, Sophie; Roze, Emmanuel; Degos, Bertrand; Grabli, David; Lacomblez, Lucette; Hubsch, Cecile; Vidailhet, Marie; Bonnet, Anne-Marie; Corvol, Jean-Christophe; Schupbach, Michael] UPMC, Hop La Pitie Salpetriere, AP HP,Dept Malad Syst Nerveux, INSERM,ICM,Ctr Invest Clin Pitie Neurosci,CIC 142, Paris, France; [Habert, Marie-Odile; Kas, Aurelie] Hop La Pitie Salpetriere, AP HP, Nucl Med Serv, Paris, France; [Tanguy, Marie-Laure; Mazmanian, Merry; Oya, Herve] Hop La Pitie Salpetriere, AP HP, Unite Rech Clin, Paris, France; [Abuaf, Nissen; Gaouar, Hafida] Hop Tenon, AP HP, Serv Dermatol & Allergie, Paris, France; [Salhi, Sabrina] AP HP, Agence Gen Equipements & Prod Sante, Paris, France; [Charbonnier-Beaupel, Fanny; Fievet, Marie-Helene] Hop La Pitie Salpetriere, AP HP, Pharm, Sect Essais Clin & Dispensat Medicaments Aux Pati, Paris, France; [Galanaud, Damien] Hop La Pitie Salpetriere, AP HP, Serv Neuroradiol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); AGEPS Agence Generale des Equipements et Produits de Sante - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Hartmann, A (corresponding author), UPMC, Hop La Pitie Salpetriere, AP HP,Dept Malad Syst Nerveux, INSERM,ICM,Ctr Invest Clin Pitie Neurosci,CIC 142, Paris, France.	andreas.hartmann@aphp.fr	corvol, jean-christophe/I-6387-2012; Habert, Marie-Odile/AAO-3763-2020; Corvol, Jean-Christophe/F-2124-2017	corvol, jean-christophe/0000-0001-7325-0199; Corvol, Jean-Christophe/0000-0001-7325-0199; Abuaf, Nisen/0000-0002-1277-0593; Muellner, Julia/0000-0002-6819-6586	DRCD (Programme 'Booster', APHP patent office); France Parkinson; program "Investissements d'Avenir" [ANR-10-IAIHU-06]; Swiss National Science Foundation [PBBSP3-133377]	DRCD (Programme 'Booster', APHP patent office); France Parkinson; program "Investissements d'Avenir"(French National Research Agency (ANR)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the DRCD (Programme 'Booster', APHP patent office), by France Parkinson (Grand Appel d'Offre 2011) and by funding from the program "Investissements d'Avenir" ANR-10-IAIHU-06. NM was supported by a grant from the Swiss National Science Foundation (PBBSP3-133377).	Alvarez-Fischer D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061700; Brown TC, 2013, CURR OPIN ALLERGY CL, V13, P365, DOI 10.1097/ACI.0b013e3283625144; CHANG LT, 1978, IEEE T NUCL SCI, V25, P638, DOI 10.1109/TNS.1978.4329385; Chen L, 2014, INT J NEUROPSYCHOPH, V17, P1295, DOI 10.1017/S1461145714000236; Cho SY, 2012, PARKINSONISM RELAT D, V18, P948, DOI 10.1016/j.parkreldis.2012.04.030; Chung ES, 2012, BRAIN BEHAV IMMUN, V26, P1322, DOI 10.1016/j.bbi.2012.08.013; Degos B, 2005, J NEUROSCI, V25, P7687, DOI 10.1523/JNEUROSCI.1056-05.2005; Doo AR, 2010, NEUROL RES, V32, pS88, DOI 10.1179/016164109X12537002794282; Fahn S., 1987, RECENT DEV PARKINSON, VVol. 2, P153; Hammond RS, 2006, J NEUROSCI, V26, P1844, DOI 10.1523/JNEUROSCI.4106-05.2006; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Kas A, 2007, J NUCL MED, V48, P1459, DOI 10.2967/jnumed.106.038646; Khalil WKB, 2015, NEUROCHEM INT, V80, P79, DOI 10.1016/j.neuint.2014.11.008; Lee G, 2016, TOXINS, V8, DOI 10.3390/toxins8020048; Maurice N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142838; Mpari B, 2008, EUR J PHARMACOL, V589, P140, DOI 10.1016/j.ejphar.2008.05.019; NIEMEIJER NR, 1993, ALLERGY, V48, P498, DOI 10.1111/j.1398-9995.1993.tb01105.x; Obeso JA, 2014, LANCET, V384, P523, DOI 10.1016/S0140-6736(13)62418-6; Pedarzani P, 2008, CELL MOL LIFE SCI, V65, P3196, DOI 10.1007/s00018-008-8216-x; Salthun-Lassalle B, 2004, J NEUROSCI, V24, P5922, DOI 10.1523/JNEUROSCI.5668-03.2004; Schupbach WMM, 2010, J NEUROL NEUROSUR PS, V81, P20, DOI 10.1136/jnnp.2008.159699; Soden ME, 2013, NEURON, V80, P997, DOI 10.1016/j.neuron.2013.07.044; Stackman RW, 2002, J NEUROSCI, V22, P10163; Stocker M, 2004, NAT REV NEUROSCI, V5, P758, DOI 10.1038/nrn1516; Waroux O, 2005, EUR J NEUROSCI, V22, P3111, DOI 10.1111/j.1460-9568.2005.04484.x; Wesselius T, 2005, NEUROLOGY, V65, P1764, DOI 10.1212/01.wnl.0000184442.02551.4b; Yang EJ, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-69	27	32	32	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0158235	10.1371/journal.pone.0158235	http://dx.doi.org/10.1371/journal.pone.0158235			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27403743	Green Published, Green Submitted, gold			2022-12-27	WOS:000379508200006
J	Lori, L; Pasquo, A; Lori, C; Petrosino, M; Chiaraluce, R; Tallant, C; Knapp, S; Consalvi, V				Lori, Laura; Pasquo, Alessandra; Lori, Clorinda; Petrosino, Maria; Chiaraluce, Roberta; Tallant, Cynthia; Knapp, Stefan; Consalvi, Valerio			Effect of BET Missense Mutations on Bromodomain Function, Inhibitor Binding and Stability	PLOS ONE			English	Article							STAPHYLOCOCCAL NUCLEASE; TARGETING BROMODOMAINS; ACETYLATED CHROMATIN; STRUCTURAL-ANALYSIS; EPIGENETIC READERS; MIDLINE CARCINOMA; PROTEIN STABILITY; BRD4; CANCER; DISEASE	Lysine acetylation is an important epigenetic mark regulating gene transcription and chromatin structure. Acetylated lysine residues are specifically recognized by bromodomains, small protein interaction modules that read these modification in a sequence and acetylation dependent way regulating the recruitment of transcriptional regulators and chromatin remodelling enzymes to acetylated sites in chromatin. Recent studies revealed that bromodomains are highly druggable protein interaction domains resulting in the development of a large number of bromodomain inhibitors. BET bromodomain inhibitors received a lot of attention in the oncology field resulting in the rapid translation of early BET bromodomain inhibitors into clinical studies. Here we investigated the effects of mutations present as polymorphism or found in cancer on BET bromodomain function and stability and the influence of these mutants on inhibitor binding. We found that most BET missense mutations localize to peripheral residues in the two terminal helices. Crystal structures showed that the three dimensional structure is not compromised by these mutations but mutations located in close proximity to the acetyl-lysine binding site modulate acetyl-lysine and inhibitor binding. Most mutations affect significantly protein stability and tertiary structure in solution, suggesting new interactions and an alternative network of protein-protein interconnection as a consequence of single amino acid substitution. To our knowledge this is the first report studying the effect of mutations on bromodomain function and inhibitor binding.	[Lori, Laura; Lori, Clorinda; Petrosino, Maria; Chiaraluce, Roberta; Consalvi, Valerio] Univ Roma La Sapienza, Dept Biochem Sci A Rossi Fanelli, Rome, Italy; [Pasquo, Alessandra] SSPT BIOAG BIOTEC ENEA Casaccia ENEA, Rome, Italy; [Tallant, Cynthia; Knapp, Stefan] Univ Oxford, Nuffield Dept Clin Med, Struct Genom Consortium & Target Discovery Inst, Oxford, England; [Tallant, Cynthia; Knapp, Stefan] Goethe Univ Frankfurt, Inst Pharmaceut Chem, Frankfurt, Germany; [Tallant, Cynthia; Knapp, Stefan] Goethe Univ Frankfurt, Buchmann Inst Life Sci BMLS, Frankfurt, Germany	Sapienza University Rome; Italian National Agency New Technical Energy & Sustainable Economics Development; University of Oxford; Goethe University Frankfurt; Goethe University Frankfurt	Chiaraluce, R (corresponding author), Univ Roma La Sapienza, Dept Biochem Sci A Rossi Fanelli, Rome, Italy.	roberta.chiaraluce@uniroma1.it	Knapp, Stefan/AAG-2347-2019; consalvi, valerio/F-1918-2011	Knapp, Stefan/0000-0001-5995-6494; Tallant, Cynthia/0000-0001-5645-435X	Regione Lazio [FILAS-RU-2014-1020]	Regione Lazio(Regione Lazio)	This work was supported by Regione Lazio (Prot. FILAS-RU-2014-1020).	Belkina AC, 2014, J LEUKOCYTE BIOL, V95, P451, DOI 10.1189/jlb.1112588; Benjwal S, 2006, PROTEIN SCI, V15, P635, DOI 10.1110/ps.051917406; Casadio R, 2011, HUM MUTAT, V32, P1161, DOI 10.1002/humu.21555; Choy N, 2003, J MOL BIOL, V334, P527, DOI 10.1016/j.jmb.2003.09.059; Dawson MA, 2012, NEW ENGL J MED, V367, P647, DOI 10.1056/NEJMra1112635; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engin HB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152929; Evans P., 2007, SCALA SCALE TOGETHER; Filippakopoulos P, 2014, NAT REV DRUG DISCOV, V13, P339, DOI 10.1038/nrd4286; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Fish PV, 2012, J MED CHEM, V55, P9831, DOI 10.1021/jm3010515; Fong CY, 2015, NATURE, V525, P538, DOI 10.1038/nature14888; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; French CA, 2004, J CLIN ONCOL, V22, P4135, DOI 10.1200/JCO.2004.02.107; French CA, 2001, AM J PATHOL, V159, P1987, DOI 10.1016/S0002-9440(10)63049-0; French CA, 2012, ANNU REV PATHOL-MECH, V7, P247, DOI 10.1146/annurev-pathol-011811-132438; Fuchs JE, 2015, J CHEM THEORY COMPUT, V11, P851, DOI 10.1021/ct500633u; Gaboriau DCA, 2015, BIOCHEM J, V466, P613, DOI 10.1042/BJ20141077; Gao M, 2015, STRUCTURE, V23, P1362, DOI 10.1016/j.str.2015.03.028; Geierhaas CD, 2007, PROTEIN SCI, V16, P125, DOI 10.1110/ps.062383807; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Hewings DS, 2012, J MED CHEM, V55, P9393, DOI 10.1021/jm300915b; HOLLIDAY R, 1987, SCIENCE, V238, P163, DOI 10.1126/science.3310230; Ishii H, 2005, DNA CELL BIOL, V24, P432, DOI 10.1089/dna.2005.24.432; Jung M, 2015, EPIGENOMICS-UK, V7, P487, DOI 10.2217/epi.14.91; Kiss RS, 2003, J BIOL CHEM, V278, P21952, DOI 10.1074/jbc.M302676200; Kucukkal TG, 2015, CURR OPIN STRUC BIOL, V32, P18, DOI 10.1016/j.sbi.2015.01.003; Kumar R, 2016, ONCOGENE, V35, P4423, DOI 10.1038/onc.2015.513; Lamonica JM, 2011, P NATL ACAD SCI USA, V108, pE159, DOI 10.1073/pnas.1102140108; Leroy G, 2008, MOL CELL, V30, P51, DOI 10.1016/j.molcel.2008.01.018; LESLIE AGW, 2007, MOSFLM; Lori C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064824; Martin LJ, 2016, J MED CHEM, V59, P4462, DOI 10.1021/acs.jmedchem.5b01865; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Muller S, 2011, EXPERT REV MOL MED, V13, P1, DOI 10.1017/S1462399411001992; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishiyama A, 2006, MOL BIOL CELL, V17, P814, DOI 10.1091/mbc.E05-08-0729; Owen DJ, 2000, EMBO J, V19, P6141, DOI 10.1093/emboj/19.22.6141; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pasquo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032555; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Picaud S, 2013, CANCER RES, V73, P3336, DOI 10.1158/0008-5472.CAN-12-3292; Pradeep L, 2004, BIOCHEMISTRY-US, V43, P11393, DOI 10.1021/bi049320b; Rathert P, 2015, NATURE, V525, P543, DOI 10.1038/nature14898; Rowling PJE, 2010, J BIOL CHEM, V285, P20080, DOI 10.1074/jbc.M109.088922; ROYER CA, 1993, PROTEIN SCI, V2, P1844, DOI 10.1002/pro.5560021106; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; SHORTLE D, 1995, ADV PROTEIN CHEM, V46, P217, DOI 10.1016/S0065-3233(08)60336-8; Sinha A, 2005, BIOCHEM J, V387, P257, DOI 10.1042/BJ20041793; Spudich G, 2000, BIOCHEMISTRY-US, V39, P11677, DOI 10.1021/bi000466u; Sutherell CL, 2016, J MED CHEM, V59, P5095, DOI 10.1021/acs.jmedchem.5b01997; Wrabl J, 1999, NAT STRUCT BIOL, V6, P876; Yang ZY, 2008, MOL CELL BIOL, V28, P967, DOI 10.1128/MCB.01020-07; Zhou Ming, 2003, Ai Zheng, V22, P123; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	59	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0159180	10.1371/journal.pone.0159180	http://dx.doi.org/10.1371/journal.pone.0159180			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27403962	Green Published, gold			2022-12-27	WOS:000379508200041
J	Shi, YH; Quan, RF; Xie, SJ; Li, Q; Cao, GP; Zhuang, W; Zhang, L; Shao, RX; Yang, DS				Shi, Yihui; Quan, Renfu; Xie, Shangju; Li, Qiang; Cao, Guoping; Zhuang, Wei; Zhang, Liang; Shao, Rongxue; Yang, Disheng			Evaluation of a Novel HA/ZrO2-Based Porous Bioceramic Artificial Vertebral Body Combined with a rhBMP-2/Chitosan Slow-Release Hydrogel	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-2; ZIRCONIA; COMPOSITE; DELIVERY; RHBMP-2; MICROSPHERES; FUSION; BMP-2	A new HA/ZrO2-based porous bioceramic artificial vertebral body (AVB), carried a recombinant human bone morphogenetic protein-2 (rhBMP-2)/chitosan slow-release hydrogel was prepared to repair vertebral bone defect in beagles. An ionic cross-linking was used to prepare the chitosan hydrogel (CS gel) as the rhBMP-2 slow-release carrier. The vertebral body defects were implanted with the rhBMP-2-loaded AVB in group A, or a non-drug-loaded AVB in group B, or autologous iliac in group C. The encapsulation rate of rhBMP-2 in rhBMP-2-loaded CS gel was 91.88 +/- 1.53%, with a drug load of 39.84 +/- 2.34 ng/mg. At 6, 12, 24 weeks postoperatively, radiography showed that the bone calluses gradually increased with time in group A, where the artificial vertebral body had completely fused with host-bone at 24 weeks after surgery. In group C, an apparent bone remodeling was occurred in the early stages, and the graft-bone and host-bone had also fused completely at 24 weeks postoperatively. In group B, fusion occurred less than in groups A and C. At 24 weeks after surgery, micro-computed tomography (Micro-CT) revealed that the volume of newly-formed bone in group A was significantly more than in group B (p<0.05). At 24 weeks after surgery, ultra-compressive strengths of the operated segments were 14.03 +/- 1.66 MPa in group A, 8.62 +/- 1.24 MPa in group B, and 13.78 +/- 1.43 MPa in group C. Groups A and C were both significantly higher than group B (p<0.05). At 24 weeks postoperatively, the hard tissue sections showed that the AVB of group A had tightly fused with host bone, and that pores of the AVB had been filled with abundant nearly mature bone, and that the new bone structured similarly to a trabecular framework, which was similar to that in group C. In contrast, implant fusion of the AVB in group B was not as apparent as group A. In conclusion, the novel HA/ZrO2-based porous bioceramic AVB carried the rhBMP-2-loaded CS gel can promote the repair of bony defect, and induce bone tissue to grow into the pores, which may replace iliac bone grafts as commonly applied in clinical practice.	[Shi, Yihui; Zhang, Liang] Zhejiang Chinese Med Univ, Hangzhou, Zhejiang, Peoples R China; [Quan, Renfu; Xie, Shangju; Li, Qiang; Cao, Guoping; Zhuang, Wei] Zhejiang Chinese Med Univ, Affiliated JiangNan Hosp, Dept Orthoped, Hangzhou, Zhejiang, Peoples R China; [Shao, Rongxue] Zhejiang Chinese Med Univ, Guangxing Hosp, Hangzhou, Zhejiang, Peoples R China; [Yang, Disheng] Zhejiang Univ, Affiliated Hosp 2, Coll Med, Dept Orthoped, Hangzhou, Zhejiang, Peoples R China	Zhejiang Chinese Medical University; Zhejiang Chinese Medical University; Zhejiang Chinese Medical University; Zhejiang University	Quan, RF (corresponding author), Zhejiang Chinese Med Univ, Affiliated JiangNan Hosp, Dept Orthoped, Hangzhou, Zhejiang, Peoples R China.	quanrenfu@126.com			Zhejiang Key Science and Technology Project [2014CO3031]; Public Welfare Technology and Social Development Project Zhejing Science and Technology Department [2012C33114]; Hanghou Key Science and Technology Project [20122513A14]	Zhejiang Key Science and Technology Project; Public Welfare Technology and Social Development Project Zhejing Science and Technology Department; Hanghou Key Science and Technology Project	The study of "Evaluation of a novel HA/ZrO<INF>2</INF>-based porous bioceramic artificial vertebral body combined with a rhBMP-2/chitosan slow-release hydrogel" was supported by Zhejiang Key Science and Technology Project (2014CO3031); Public Welfare Technology and Social Development Project (2012C33114) Zhejing Science and Technology Department and Hanghou Key Science and Technology Project (20122513A14). All funders above were belonging to government public welfare funder. There was no author and individual employed or contracted by the funders involved in this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarrategi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034117; Abarrategi A, 2009, ACTA BIOMATER, V5, P2633, DOI 10.1016/j.actbio.2009.02.031; Alt V, 2009, EUR SPINE J, V18, P800, DOI 10.1007/s00586-009-0935-7; Branemark PI, 1985, TISSUE INTEGRATED PR, P11; Chen L, 2014, J MATER SCI-MATER M, V25, P1709, DOI 10.1007/s10856-014-5194-4; Fu RW, 2013, ANN INTERN MED, V158, P890, DOI 10.7326/0003-4819-158-12-201306180-00006; Hannink G, 2013, J MATER SCI-MATER M, V24, P325, DOI 10.1007/s10856-012-4802-4; Jun SH, 2013, J MATER SCI-MATER M, V24, P773, DOI 10.1007/s10856-012-4822-0; Kim H, 2012, EUR SPINE J, V21, P1324, DOI 10.1007/s00586-011-2092-z; Kim S, 2012, ACTA BIOMATER, V8, P1768, DOI 10.1016/j.actbio.2012.01.009; Matsuno T, 2000, J MATER SCI LETT, V19, P573, DOI 10.1023/A:1006722110462; MOSEKILDE L, 1986, BONE, V7, P207, DOI 10.1016/8756-3282(86)90019-0; Muller U, 2006, EUR CELLS MATER, V11, P8, DOI 10.22203/eCM.v011a02; Nayak Y, 2008, J MATER SCI-MATER M, V19, P2437, DOI 10.1007/s10856-008-3371-z; OHGUSHI H, 1993, J BIOMED MATER RES, V27, P1401, DOI 10.1002/jbm.820271107; Patel ZS, 2008, ACTA BIOMATER, V4, P1126, DOI 10.1016/j.actbio.2008.04.002; Piva RH, 2015, SCANNING, V37, P372, DOI 10.1002/sca.21221; Quan R, 2006, JOURNAL OF BIOMATERI, V23, P123; Quan RF, 2008, J MATER SCI-MATER M, V19, P183, DOI 10.1007/s10856-006-0025-x; [全仁夫 Quan Renfu], 2012, [中华创伤杂志, Chinese Journal of Trauma], V28, P946; [全仁夫 QUAN RenJu], 2006, [中华创伤杂志, Chinese Journal of Traumatology], V22, P852; Rodgers MA, 2013, BMJ-BRIT MED J, V346, P398; Ruhe PQ, 2006, J MATER SCI-MATER M, V17, P919, DOI 10.1007/s10856-006-0181-z; Seeherman H, 2005, CYTOKINE GROWTH F R, V16, P329, DOI 10.1016/j.cytogfr.2005.05.001; Shi SS, 2009, J BIOMATER APPL, V23, P331, DOI 10.1177/0885328208090013; Shields LBE, 2006, SPINE, V31, P542, DOI 10.1097/01.brs.0000201424.27509.72; Smucker JD, 2006, SPINE, V31, P2813, DOI 10.1097/01.brs.0000245863.52371.c2; Sollazzo V, 2008, DENT MATER, V24, P357, DOI 10.1016/j.dental.2007.06.003; Vaidya R, 2008, J SPINAL DISORD TECH, V21, P557, DOI 10.1097/BSD.0b013e31815ea897; Wang AH, 2009, J MICROENCAPSUL, V26, P593, DOI 10.3109/02652040802586167; [王玮 Wang Wei], 2011, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V15, P4611; Woo EJ, 2011, SPINE, V36, P1817, DOI 10.1097/BRS.0b013e31822e6028; Xie SJ, 2015, COMPOS INTERFACE, V22, P151, DOI 10.1080/15685543.2015.997174; Yusop A. H., 2012, INT J BIOMATER, DOI DOI 10.1155/2012/641430; [张敏 Zhang Min], 2006, [复合材料学报, Acta Materiae Compositae Sinica], V23, P115; Zhou S.H., 2007, CHINESE J TISSUE ENG, V11, P9688	36	4	5	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2016	11	7							e0157698	10.1371/journal.pone.0157698	http://dx.doi.org/10.1371/journal.pone.0157698			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CN	27400197	Green Published, gold, Green Submitted			2022-12-27	WOS:000379508100003
J	Bsteh, G; Ehling, R; Lutterotti, A; Hegen, H; Di Pauli, F; Auer, M; Deisenhammer, F; Reindl, M; Berger, T				Bsteh, Gabriel; Ehling, Rainer; Lutterotti, Andreas; Hegen, Harald; Di Pauli, Franziska; Auer, Michael; Deisenhammer, Florian; Reindl, Markus; Berger, Thomas			Long Term Clinical Prognostic Factors in Relapsing-Remitting Multiple Sclerosis: Insights from a 10-Year Observational Study	PLOS ONE			English	Article							NATURAL-HISTORY; DIAGNOSTIC-CRITERIA; COGNITIVE DYSFUNCTION; DEPRESSIVE SYMPTOMS; BRAIN ATROPHY; EARLY PHASE; FOLLOW-UP; DISABILITY; PROGRESSION; IMPAIRMENT	Background Multiple sclerosis (MS) has a highly heterogenic course making prediction of long term outcome very difficult. Objective The objective was to evaluate current and identify additional clinical factors that are linked to long term outcome of relapsing-remitting MS assessed by disability status 10 years after disease onset. Methods This observational study included 793 patients with relapsing-remitting MS. Clinical factors hypothesized to influence long term outcome measured by EDSS scores 10 years after disease onset were analysed by Kaplan-Meier-estimates. Multinomial logistic regression models regarding mild (EDSS <= 2.5), moderate (EDSS 3.0-5.5) or severe (EDSS >= 6.0) disability were calculated to correct for confounders. Results Secondary progression was the strongest predictor of severe disability (Hazard ratio [HR] 503.8, 95% confidence interval [CI] 160.0-1580.1); p<0.001). Complete remission of neurological symptoms at onset reduced the risk of moderate disability (HR 0.42; CI 0.23-0.77; p = 0.005), while depression (HR 3.59; CI 1.14-11.24; p = 0.028) and cognitive dysfunction (HR 4.64; CI 1.11-19.50; p = 0.036) 10 years after disease onset were associated with severe disability. Oligoclonal bands and pregnancy were not correlated with disability. Conclusion We were able to identify clinically apparent chronic depression and cognitive dysfunction to be associated with adverse long term outcome in MS and to confirm that pregnancy has no negative impact. Additionally, we emphasize the positive predictive value of complete remission of initial symptoms.	[Bsteh, Gabriel; Ehling, Rainer; Lutterotti, Andreas; Hegen, Harald; Di Pauli, Franziska; Auer, Michael; Deisenhammer, Florian; Reindl, Markus; Berger, Thomas] Med Univ Innsbruck, Dept Clin Neurol, Innsbruck, Austria; [Lutterotti, Andreas] Univ Zurich Hosp, Dept Neurol, Zurich, Switzerland; [Lutterotti, Andreas] Univ Zurich, Zurich, Switzerland	Medical University of Innsbruck; University of Zurich; University Zurich Hospital; University of Zurich	Bsteh, G (corresponding author), Med Univ Innsbruck, Dept Clin Neurol, Innsbruck, Austria.	gabriel.bsteh@i-med.ac.at	Reindl, Markus/ABE-5880-2020	Berger, Thomas/0000-0001-5626-1144; Reindl, Markus/0000-0003-2817-1402	Austrian Federal Ministery of Science and Economy	Austrian Federal Ministery of Science and Economy	This study was supported by a research grant from the Austrian Federal Ministery of Science and Economy (grant name: BIG WIG MS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato M. P., 2000, Neurological Sciences, V21, pS831, DOI 10.1007/s100720070021; Amato MP, 2001, ARCH NEUROL-CHICAGO, V58, P1602, DOI 10.1001/archneur.58.10.1602; Arnett PA, 2005, CNS SPECTRUMS, V10, P372, DOI 10.1017/S1092852900022744; Asamer E-M, 2014, CENSUS 2011 AUSTRIA, P1; Bakshi R, 2000, NEUROREPORT, V11, P1153, DOI 10.1097/00001756-200004270-00003; Baumhackl U, 2002, NEUROEPIDEMIOLOGY, V21, P226, DOI 10.1159/000065640; Confavreux C, 1998, NEW ENGL J MED, V339, P285, DOI 10.1056/NEJM199807303390501; Confavreux C, 2003, BRAIN, V126, P770, DOI 10.1093/brain/awg081; Denney DR, 2005, ARCH CLIN NEUROPSYCH, V20, P967, DOI 10.1016/j.acn.2005.04.012; Dobson R, 2013, J NEUROL NEUROSUR PS, V84, P909, DOI 10.1136/jnnp-2012-304695; Eriksson M, 2003, MULT SCLER J, V9, P260, DOI 10.1191/1352458503ms914oa; Feinstein A, 2004, NEUROLOGY, V62, P586, DOI 10.1212/01.WNL.0000110316.12086.0C; GOOD K, 1992, J NERV MENT DIS, V180, P730, DOI 10.1097/00005053-199211000-00009; GOODKIN DE, 1991, NEUROLOGY, V41, P332, DOI 10.1212/WNL.41.2_Part_1.332; Horakova D, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-10; Kiy G, 2011, MULT SCLER J, V17, P1088, DOI 10.1177/1352458511403530; Koch M, 2008, MULT SCLER J, V14, P815, DOI 10.1177/1352458508088937; Koch MW, 2015, MULT SCLER J, V21, P76, DOI 10.1177/1352458514536086; Kremenchutzky M, 2006, BRAIN, V129, P584, DOI 10.1093/brain/awh721; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Landro NI, 2004, J NEUROL SCI, V217, P211, DOI 10.1016/j.jns.2003.10.012; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Popescu V, 2013, J NEUROL NEUROSUR PS, V84, P1082, DOI 10.1136/jnnp-2012-304094; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; RUNMARKER B, 1993, BRAIN, V116, P117, DOI 10.1093/brain/116.1.117; Scalfari A, 2013, JAMA NEUROL, V70, P214, DOI 10.1001/jamaneurol.2013.599; Scalfari A, 2010, BRAIN, V133, P1914, DOI 10.1093/brain/awq118; SCHUMACHER GA, 1965, ANN NY ACAD SCI, V122, P552; Stangel M, 2015, THER ADV NEUROL DISO, V8, P3, DOI 10.1177/1756285614560733; Tintore M, 2015, BRAIN, V138, P1863, DOI 10.1093/brain/awv105; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Tremlett H, 2009, NEUROLOGY, V73, P1616, DOI 10.1212/WNL.0b013e3181c1e44f; Vukusic S, 2004, BRAIN, V127, P1353, DOI 10.1093/brain/awh152; WEINSHENKER BG, 1989, BRAIN, V112, P1419, DOI 10.1093/brain/112.6.1419; WEINSHENKER BG, 1989, BRAIN, V112, P133, DOI 10.1093/brain/112.1.133; Zivadinov R, 2001, J NEUROL NEUROSUR PS, V70, P773, DOI 10.1136/jnnp.70.6.773	40	39	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158978	10.1371/journal.pone.0158978	http://dx.doi.org/10.1371/journal.pone.0158978			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391947	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000380005400178
J	Carlsson, E; Thwaite, JE; Jenner, DC; Spear, AM; Flick-Smith, H; Atkins, HS; Byrne, B; Ding, JL				Carlsson, Emil; Thwaite, Joanne E.; Jenner, Dominic C.; Spear, Abigail M.; Flick-Smith, Helen; Atkins, Helen S.; Byrne, Bernadette; Ding, Jeak Ling			Bacillus anthracis TIR Domain-Containing Protein Localises to Cellular Microtubule Structures and Induces Autophagy	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; INNATE IMMUNITY; BRUCELLA-MELITENSIS; RECEPTOR; SUBVERSION; MACROPHAGES; FAMILY; RECOGNITION; PROTECTION; INFECTION	Toll-like receptors (TLRs) recognise invading pathogens and mediate downstream immune signalling via Toll/IL-1 receptor (TIR) domains. TIR domain proteins (Tdps) have been identified in multiple pathogenic bacteria and have recently been implicated as negative regulators of host innate immune activation. A Tdp has been identified in Bacillus anthracis, the causative agent of anthrax. Here we present the first study of this protein, designated BaTdp. Recombinantly expressed and purified BaTdp TIR domain interacted with several human TIR domains, including that of the key TLR adaptor MyD88, although BaTdp expression in cultured HEK293 cells had no effect on TLR4- or TLR2-mediated immune activation. During expression in mammalian cells, BaTdp localised to microtubular networks and caused an increase in lipidated cytosolic microtubule-associated protein 1A/1B-light chain 3 (LC3), indicative of autophagosome formation. In vivo intra-nasal infection experiments in mice showed that a BaTdp knockout strain colonised host tissue faster with higher bacterial load within 4 days post-infection compared to the wild type B. anthracis. Taken together, these findings indicate that BaTdp does not play an immune suppressive role, but rather, its absence increases virulence. BaTdp present in wild type B. anthracis plausibly interact with the infected host cell, which undergoes autophagy in self-defence.	[Carlsson, Emil; Byrne, Bernadette] Imperial Coll London, Dept Life Sci, London, England; [Carlsson, Emil; Ding, Jeak Ling] Natl Univ Singapore, Dept Biol Sci, Fac Sci, Singapore, Singapore; [Thwaite, Joanne E.; Jenner, Dominic C.; Spear, Abigail M.; Flick-Smith, Helen; Atkins, Helen S.] Def Sci & Technol Lab, Salisbury, Wilts, England	Imperial College London; National University of Singapore; Defence Science & Technology Laboratory	Byrne, B (corresponding author), Imperial Coll London, Dept Life Sci, London, England.; Ding, JL (corresponding author), Natl Univ Singapore, Dept Biol Sci, Fac Sci, Singapore, Singapore.	b.byrne@imperial.ac.uk; dbsdjl@nus.edu.sg	Ding, Jeak/H-8057-2012	Byrne, Bernadette/0000-0001-9598-9832	Imperial College International Joint Scholarship	Imperial College International Joint Scholarship	Funded by Imperial College International Joint Scholarship awarded to BB and JLD.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alaidarous M, 2014, J BIOL CHEM, V289, P654, DOI 10.1074/jbc.M113.523274; Askarian F, 2014, J INNATE IMMUN, V6, P485, DOI 10.1159/000357618; Beedham RJ, 2001, VACCINE, V19, P4409, DOI 10.1016/S0264-410X(01)00197-9; Bergman NH, 2007, INFECT IMMUN, V75, P3434, DOI 10.1128/IAI.01345-06; Beron W, 2002, INFECT IMMUN, V70, P5816, DOI 10.1128/IAI.70.10.5816-5821.2002; Campoy E, 2009, CURR TOP MICROBIOL, V335, P227, DOI 10.1007/978-3-642-00302-8_11; Campoy E, 2009, BBA-MOL CELL RES, V1793, P1465, DOI 10.1016/j.bbamcr.2009.03.003; Carlsson E, 2016, BBA-MOL CELL RES, V1863, P244, DOI 10.1016/j.bbamcr.2015.11.021; Carty M, 2006, NAT IMMUNOL, V7, P1074, DOI 10.1038/ni1382; Chan SL, 2009, J BIOL CHEM, V284, P21386, DOI 10.1074/jbc.C109.007591; Chen CY, 2011, J CELL BIOL, V193, P769, DOI 10.1083/jcb.201008050; Cirl C, 2008, NAT MED, V14, P399, DOI 10.1038/nm1734; Deretic V, 2006, CELL MICROBIOL, V8, P719, DOI 10.1111/j.1462-5822.2006.00705.x; Felix C, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/s12964-014-0053-y; Geeraert C, 2010, J BIOL CHEM, V285, P24184, DOI 10.1074/jbc.M109.091553; Hoshino K, 1999, J IMMUNOL, V162, P3749; Hu HJ, 2006, CELL MICROBIOL, V8, P1634, DOI 10.1111/j.1462-5822.2006.00738.x; Huth JR, 1997, PROTEIN SCI, V6, P2359; Janes BK, 2006, INFECT IMMUN, V74, P1949, DOI 10.1128/IAI.74.3.1949-1953.2006; Kagan JC, 2014, NAT REV IMMUNOL, V14, P821, DOI 10.1038/nri3757; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kim YH, 2007, J EXP MED, V204, P2063, DOI 10.1084/jem.20070868; Kirkegaard K, 2004, NAT REV MICROBIOL, V2, P301, DOI 10.1038/nrmicro865; Kondo T, 2012, TRENDS IMMUNOL, V33, P449, DOI 10.1016/j.it.2012.05.002; Kraemer Thomas Daniel, 2014, Int J Microbiol, V2014, P918143, DOI 10.1155/2014/918143; Narayanan KB, 2015, APOPTOSIS, V20, P196, DOI 10.1007/s10495-014-1073-1; Newman RM, 2006, INFECT IMMUN, V74, P594, DOI 10.1128/IAI.74.1.594-601.2006; Niu H, 2008, CELL MICROBIOL, V10, P593, DOI 10.1111/j.1462-5822.2007.01068.x; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Park JM, 2004, J EXP MED, V200, P1647, DOI 10.1084/jem.20041215; Patterson Nicholas J, 2014, Front Microbiol, V5, P662, DOI 10.3389/fmicb.2014.00662; Peng J, 2010, EUR J IMMUNOL, V40, P1738, DOI 10.1002/eji.200940034; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Radhakrishnan Girish K, 2012, Biomol Concepts, V3, P571; Radhakrishnan GK, 2011, BIOCHEM J, V439, P79, DOI 10.1042/BJ20110577; Radhakrishnan GK, 2010, BIOCHEM BIOPH RES CO, V397, P59, DOI 10.1016/j.bbrc.2010.05.056; Radhakrishnan GK, 2009, J BIOL CHEM, V284, P9892, DOI 10.1074/jbc.M805458200; Rana RR, 2013, MED MICROBIOL IMMUN, V202, P1, DOI 10.1007/s00430-012-0253-2; Rana RR, 2011, MICROB PATHOGENESIS, V51, P89, DOI 10.1016/j.micpath.2011.05.004; REED L. J., 1938, AMER JOUR HYG, V27, P493; Salcedo SP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040021; Schnaith A, 2007, J BIOL CHEM, V282, P2695, DOI 10.1074/jbc.M609784200; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shannon JG, 2003, INFECT IMMUN, V71, P3183, DOI 10.1128/IAI.71.6.3183-3189.2003; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Snyder GA, 2014, J BIOL CHEM, V289, P669, DOI 10.1074/jbc.M113.523407; Spear AM, 2012, MICROBIOL-SGM, V158, P1593, DOI 10.1099/mic.0.055012-0; Spear AM, 2009, TRENDS MICROBIOL, V17, P393, DOI 10.1016/j.tim.2009.06.005; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Underhill DM, 1999, P NATL ACAD SCI USA, V96, P14459, DOI 10.1073/pnas.96.25.14459; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033	54	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158575	10.1371/journal.pone.0158575	http://dx.doi.org/10.1371/journal.pone.0158575			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391310	Green Submitted, Green Published, gold			2022-12-27	WOS:000380005400081
J	Dorling, L; Kar, S; Michailidou, K; Hiller, L; Vallier, AL; Ingle, S; Hardy, R; Bowden, SJ; Dunn, JA; Twelves, C; Poole, CJ; Caldas, C; Earl, HM; Pharoah, PDP; Abraham, JE				Dorling, Leila; Kar, Siddhartha; Michailidou, Kyriaki; Hiller, Louise; Vallier, Anne-Laure; Ingle, Susan; Hardy, Richard; Bowden, Sarah J.; Dunn, Janet A.; Twelves, Chris; Poole, Christopher J.; Caldas, Carlos; Earl, Helena M.; Pharoah, Paul D. P.; Abraham, Jean E.			The Relationship between Common Genetic Markers of Breast Cancer Risk and Chemotherapy-Induced Toxicity: A Case-Control Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SENSORY NEUROPATHY; PACLITAXEL; LOCI; CYCLOPHOSPHAMIDE; EPIRUBICIN; LISTS	Ninety-four common genetic variants are confirmed to be associated with breast cancer. This study tested the hypothesis that breast cancer susceptibility variants may also be associated with chemotherapy-induced toxicity through shared mechanistic pathways such as DNA damage response, an association that, to our knowledge, has not been previously investigated. The study included breast cancer patients who received neoadjuvant/adjuvant chemotherapy from the Pharmacogenetic SNPs (PGSNPS) study. For each patient, a breast cancer polygenic risk score was created from the 94 breast cancer risk variants, all of which were genotyped or successfully imputed in PGSNPS. Logistic regression was performed to test the association with two clinically important toxicities: taxane-related neuropathy (n = 1279) and chemotherapy-induced neutropenia (n = 1676). This study was well powered (>= 96%) to detect associations between polygenic risk score and chemotherapy toxicity. Patients with high breast cancer risk scores experienced less neutropenia compared to those with low risk scores (adjusted p-value = 0.06). Exploratory functional pathway analysis was performed and no functional pathways driving this trend were identified. Polygenic risk was not associated with taxane neuropathy (adjusted p-value = 0.48). These results suggest that breast cancer patients with high genetic risk of breast cancer, conferred by common variants, can safely receive standard chemotherapy without increased risk of taxane-related sensory neuropathy or chemotherapy-induced neutropenia and may experience less neutropenia. As neutropenia has previously been associated with improved survival and may reflect drug efficacy, these patients may be less likely to benefit from standard chemotherapy treatment.	[Dorling, Leila; Kar, Siddhartha; Michailidou, Kyriaki; Pharoah, Paul D. P.; Abraham, Jean E.] Univ Cambridge, Strangeways Res Lab, Ctr Canc Genet Epidemiol, Cambridge, England; [Vallier, Anne-Laure; Ingle, Susan; Hardy, Richard; Caldas, Carlos; Earl, Helena M.; Abraham, Jean E.] Univ Cambridge NHS Fdn Hosp, Cambridge Breast Unit, Cambridge, England; [Vallier, Anne-Laure; Ingle, Susan; Hardy, Richard; Caldas, Carlos; Earl, Helena M.; Abraham, Jean E.] Univ Cambridge NHS Fdn Hosp, NIHR Cambridge Biomed Res Ctr, Cambridge, England; [Caldas, Carlos; Earl, Helena M.; Abraham, Jean E.] Cambridge Expt Canc Med Ctr, Cambridge, England; [Caldas, Carlos] Canc Res UK Cambridge Res Inst, Li Ka Shing Ctr, Robinson Way, Cambridge, England; [Hiller, Louise; Dunn, Janet A.; Poole, Christopher J.] Univ Warwick, Warwick Clin Trials Unit, Coventry, W Midlands, England; [Bowden, Sarah J.] Univ Birmingham, Canc Res UK Clin Trials Unit CRCTU, Birmingham, W Midlands, England; [Twelves, Chris] Leeds Inst Canc & Pathol, Leeds, W Yorkshire, England; [Twelves, Chris] Leeds Expt Canc Med Ctr, Leeds, W Yorkshire, England; [Michailidou, Kyriaki] Cyprus Inst Neurol & Genet, Dept Electron Microscopy Mol Pathol, Nicosia, Cyprus	University of Cambridge; University of Cambridge; University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Warwick; Cancer Research UK; University of Birmingham	Dorling, L (corresponding author), Univ Cambridge, Strangeways Res Lab, Ctr Canc Genet Epidemiol, Cambridge, England.	ld429@medschl.cam.ac.uk	Pharoah, Paul/V-6658-2019; Caldas, Carlos/U-7250-2019; Michailidou, Kyriaki/ABD-5122-2020	Pharoah, Paul/0000-0001-8494-732X; Caldas, Carlos/0000-0003-3547-1489; Michailidou, Kyriaki/0000-0001-7065-1237; Earl, Helena/0000-0003-1549-8094; Bowden, Sarah/0000-0001-7506-1340; Kar, Siddhartha P./0000-0002-2314-1426; Abraham, Jean/0000-0003-0688-4807; Dunn, Janet/0000-0001-7313-4446	Cancer Research UK [C507/A6306, C10097/A7484, C57/A4180, NEAT/BR9601]; Eli Lilly Limited; Bristol Myers Squibb Ltd [2004-002356-34, ISRCTN 78234870, NCT00070278]; Eli Lilly (GemzarTM); Bristol Myers Squibb (TaxolTM); NIHR Cambridge Biomedical Research Centre; Addenbrookes Charitable Trust; Medical Research Council; Cancer Research UK Research Grant [C57/A4180]; Cancer Research Campaign; Cancer Research UK [16942, 16561] Funding Source: researchfish; Medical Research Council [1366822, MR/M008975/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0515-10090, NF-SI-0507-10244, NF-SI-0611-10154] Funding Source: researchfish; The Francis Crick Institute [10119] Funding Source: researchfish; MRC [MR/M008975/1] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Eli Lilly Limited; Bristol Myers Squibb Ltd(Bristol-Myers Squibb); Eli Lilly (GemzarTM)(Eli Lilly); Bristol Myers Squibb (TaxolTM); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Addenbrookes Charitable Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK Research Grant; Cancer Research Campaign(Cancer Research UK); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); The Francis Crick Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by 1) PGSNPS: project and fellowship grants received by Jean Abraham from Cancer Research UK, C507/A6306 and C10097/A7484, http://www.cancerresearchuk.org/; 2) Neo-tAnGo funding: Cancer Research UK Research Grant (C57/A4180) and an additional unrestricted educational grant from Eli Lilly Limited who also provided free Gemzar (R)/gemcitabine; Bristol Myers Squibb Ltd provided free Taxol (R)/paclitaxel from January 2005 to June 2006 [EudraCT No: 2004-002356-34, ISRCTN 78234870, ClinicalTrials.gov number: NCT00070278]; 3) tAnGo funding: Unrestricted educational grants and free drug from Eli Lilly (GemzarTM) and Bristol Myers Squibb (TaxoITM); and 4) NEAT/BR9601 funding: Project grant from Cancer Research UK (formerly Cancer Research Campaign) 1996-2003: Unrestricted educational grant Pfizer (formerly Pharmacia). HME, JEA, and CC acknowledge funding from the NIHR Cambridge Biomedical Research Centre. JEA acknowledges funding from Addenbrookes Charitable Trust. LD acknowledges funding from Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham J, BMC MED; Abraham JE, 2014, CLIN CANCER RES, V20, P2466, DOI 10.1158/1078-0432.CCR-13-3232; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Baldwin RM, 2012, CLIN CANCER RES, V18, P5099, DOI 10.1158/1078-0432.CCR-12-1590; Bergh J, 2016, ASCO ANN M P S, V34; Cameron DA, 2003, BRIT J CANCER, V89, P1837, DOI 10.1038/sj.bjc.6601366; Comen EA, 2010, CANCER J, V16, P48, DOI 10.1097/PPO.0b013e3181cf01eb; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Earl HM, 2014, LANCET ONCOL, V15, P201, DOI 10.1016/S1470-2045(13)70554-0; Fernandez-Rozadilla C, 2013, PHARMACOGENOMICS J, V13, P209, DOI 10.1038/tpj.2012.2; Han JY, 2013, PHARMACOGENOMICS J, V13, P417, DOI 10.1038/tpj.2012.24; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Leandro-Garcia LJ, 2013, J MED GENET, V50, P599, DOI 10.1136/jmedgenet-2012-101466; Mavaddat N, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv036; Michailidou K, 2015, NAT GENET, V47, P373, DOI 10.1038/ng.3242; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Milne RL, 2014, HUM MOL GENET, V23, P6096, DOI 10.1093/hmg/ddu311; Poole CJ, 2006, NEW ENGL J MED, V355, P1851, DOI 10.1056/NEJMoa052084; Poole CJ, 2008, J CLIN ONCOL, V26, P506; Schneider BP, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.1000; Schneider BP, 2015, CLIN CANC RES; Shitara K, 2011, CANCER CHEMOTH PHARM, V68, P301, DOI 10.1007/s00280-010-1487-6	24	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158984	10.1371/journal.pone.0158984	http://dx.doi.org/10.1371/journal.pone.0158984			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27392074	Green Published, gold			2022-12-27	WOS:000380005400180
J	Kupz, A; Zedler, U; Staber, M; Kaufmann, SHE				Kupz, Andreas; Zedler, Ulrike; Staeber, Manuela; Kaufmann, Stefan H. E.			A Mouse Model of Latent Tuberculosis Infection to Study Intervention Strategies to Prevent Reactivation	PLOS ONE			English	Article							CD8(+) T-CELLS; HUMAN-IMMUNODEFICIENCY-VIRUS; IN-VIVO; MYCOBACTERIUM-TUBERCULOSIS; IMMUNE RECONSTITUTION; ANTI-IL-2 MAB; CUTTING EDGE; NK CELLS; IL-2; COMPLEXES	Infection with Mycobacterium tuberculosis (Mtb) is the leading cause of death in human immunodeficiency virus (HIV)(+) individuals, particularly in Sub-Saharan Africa. Management of this deadly co-infection is a significant global health challenge that is exacerbated by the lack of efficient vaccines against both Mtb and HIV, as well as the lack of reliable and robust animal models for Mtb/HIV co-infection. Here we describe a tractable and reproducible mouse model to study the reactivation dynamics of latent Mtb infection following the loss of CD4(+) T cells as it occurs in HIV-co-infected individuals. Whereas intradermally (i.d.) infected C57BL/6 mice contained Mtb within the local draining lymph nodes, depletion of CD4(+) cells led to progressive systemic spread of the bacteria and induction of lung pathology. To interrogate whether reactivation of Mtb after CD4(+) T cell depletion can be reversed, we employed interleukin (IL)-2/anti-IL-2 complex-mediated cell boost approaches. Although populations of non-CD4 lymphocytes, such as CD8(+) memory T cells, natural killer (NK) cells and double-negative (DN) T cells significantly expanded after IL-2/anti-IL-2 complex treatment, progressive development of bacteremia and pathologic lung alterations could not be prevented. These data suggest that the failure to reverse Mtb reactivation is likely not due to anergy of the expanded cell subsets and rather indicates a limited potential for IL-2-complex-based therapies in the management of Mtb/HIV co-infection.	[Kupz, Andreas; Zedler, Ulrike; Staeber, Manuela; Kaufmann, Stefan H. E.] Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany; [Kupz, Andreas] James Cook Univ, Ctr Biosecur & Trop Infect Dis, Australian Inst Trop Hlth & Med, Cairns, Qld, Australia	Max Planck Society; James Cook University	Kupz, A; Kaufmann, SHE (corresponding author), Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany.	andreas.kupz@jcu.edu.au; kaufmann@mpiib-berlin.mpg.de	Kaufmann, Stefan HE/I-5454-2014	Kaufmann, Stefan HE/0000-0001-9866-8268; Kupz, Andreas/0000-0002-9259-7873	Max Planck Society; European Union [HEALTH-F4-2011-28087]; EU [643381]; National Health and Medical Research Council of Australia [APP1052764]	Max Planck Society(Max Planck SocietyFoundation CELLEX); European Union(European Commission); EU(European Commission); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Max Planck Society; the European Union's Seventh Framework Programme (EU FP7; http://www.aditecproject.eu/) project "ADITEC" (HEALTH-F4-2011-28087; and EU Horizon 2020 (http://www.horizont2020.de/) project "TBVAC 2020" (grant 643381) to SHEK; AK was supported by the National Health and Medical Research Council of Australia (https://www.nhmrc.gov.au/) through a CJ Martin Biomedical Early Career Fellowship (APP1052764). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams D, 2009, NEW ENGL J MED, V361, P1548, DOI 10.1056/NEJMoa0903175; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Behr MA, 2014, LANCET INFECT DIS, V14, P250, DOI 10.1016/S1473-3099(13)70253-6; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; CARSON WE, 1994, J EXP MED, V180, P1395, DOI 10.1084/jem.180.4.1395; Dubois S, 2008, J IMMUNOL, V180, P2099, DOI 10.4049/jimmunol.180.4.2099; Duque-Correa MA, 2014, P NATL ACAD SCI USA, V111, pE4024, DOI 10.1073/pnas.1408839111; Epardaud M, 2008, CANCER RES, V68, P2972, DOI 10.1158/0008-5472.CAN-08-0045; Favre D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000295; Gengenbacher M, 2012, FEMS MICROBIOL REV, V36, P514, DOI 10.1111/j.1574-6976.2012.00331.x; Hamilton SE, 2010, J IMMUNOL, V185, P6584, DOI 10.4049/jimmunol.1001215; Heyckendorf J, 2015, EMERG INFECT DIS, V21, P1685, DOI 10.3201/eid2109.150461; Huntington ND, 2009, J EXP MED, V206, P25, DOI 10.1084/jem.20082013; Kamimura D, 2006, J IMMUNOL, V177, P306, DOI 10.4049/jimmunol.177.1.306; Kasprowicz VO, 2016, J INFECT DIS, V213, P628, DOI 10.1093/infdis/jiv455; Kovacs JA, 1996, NEW ENGL J MED, V335, P1350, DOI 10.1056/NEJM199610313351803; KOVACS JA, 1995, NEW ENGL J MED, V332, P567, DOI 10.1056/NEJM199503023320904; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; Kupz A, 2016, J CLIN INVEST, V126, P2109, DOI 10.1172/JCI84978; Kupz A, 2013, P NATL ACAD SCI USA, V110, P2252, DOI 10.1073/pnas.1222047110; Kupz A, 2012, NAT IMMUNOL, V13, P162, DOI 10.1038/ni.2195; Lai RPJ, 2016, SEMIN IMMUNOPATHOL, V38, P185, DOI 10.1007/s00281-015-0532-2; Li XC, 2001, NAT MED, V7, P114, DOI 10.1038/83253; Thomas ZR, 2015, T ROY SOC TROP MED H, V109, P175, DOI 10.1093/trstmh/tru206; Molloy MJ, 2009, J IMMUNOL, V182, P4512, DOI 10.4049/jimmunol.0804175; Nishimura H, 1996, J IMMUNOL, V156, P663; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Pawlowski A, 2012, PLOS PATHOG, V8, DOI [10.1371/jou rnal.ppat.1002464, DOI 10.1371/J0U]; Potash MJ, 2005, P NATL ACAD SCI USA, V102, P3760, DOI 10.1073/pnas.0500649102; Reece ST, 2010, J CLIN INVEST, V120, P3365, DOI 10.1172/JCI42796; Schneider BE, 2010, EUR J IMMUNOL, V40, P396, DOI 10.1002/eji.200939583; Sprent J, 2001, CURR OPIN IMMUNOL, V13, P248, DOI 10.1016/S0952-7915(00)00211-9; Stoklasek TA, 2006, J IMMUNOL, V177, P6072, DOI 10.4049/jimmunol.177.9.6072; Stonier SW, 2010, IMMUNOL LETT, V127, P85, DOI 10.1016/j.imlet.2009.09.009; Tomala J, 2013, ACS CHEM BIOL, V8, P871, DOI 10.1021/cb3007242; Tomala J, 2009, J IMMUNOL, V183, P4904, DOI 10.4049/jimmunol.0900284; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Votavova P, 2014, IMMUNOL LETT, V159, P1, DOI 10.1016/j.imlet.2014.01.017; Waithman J, 2008, J IMMUNOL, V180, P5789, DOI 10.4049/jimmunol.180.9.5789; WHO, 2014, GLOB TUB REP 2014; Zwirner NW, 2010, BIOFACTORS, V36, P274, DOI 10.1002/biof.107	42	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158849	10.1371/journal.pone.0158849	http://dx.doi.org/10.1371/journal.pone.0158849			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391012	Green Published, Green Accepted, gold			2022-12-27	WOS:000380005400143
J	Mishra, P; Kaur, S; Sharma, AN; Jolly, RS				Mishra, Pradeep; Kaur, Suneet; Sharma, Amar Nath; Jolly, Ravinder S.			Characterization of an Indole-3-Acetamide Hydrolase from Alcaligenes faecalis subsp parafaecalis and Its Application in Efficient Preparation of Both Enantiomers of Chiral Building Block 2,3-Dihydro-1,4-Benzodioxin-2-Carboxylic Acid	PLOS ONE			English	Article							MOLECULAR-CLONING; PHENOXY ANALOGS; AMIDASE; POTENT; SERIES; 1,4-BENZODIOXANE; ANTAGONISTS; AFFINITY; AGONIST; MKC-242	Both the enantiomers of 2,3-dihydro-1,4-benzodioxin-2-carboxylic acid are valuable chiral synthons for enantiospecific synthesis of therapeutic agents such as (S)-doxazosin mesylate, WB 4101, MKC 242, 2,3-dihydro-2-hydroxymethyl-1,4-benzodioxin, and N-[2,4-oxo-1,3-thiazolidin-3-yl]-2,3-dihydro-1,4-benzodioxin-2-carboxamide. Pharmaceutical applications require these enantiomers in optically pure form. However, currently available methods suffer from one drawback or other, such as low efficiency, uncommon and not so easily accessible chiral resolving agent and less than optimal enantiomeric purity. Our interest in finding a biocatalyst for efficient production of enantiomerically pure 2,3-dihydro-1,4-benzodioxin-2-carboxylic acid lead us to discover an amidase activity from Alcaligenes faecalis subsp. parafaecalis, which was able to kinetically resolve 2,3-dihydro-1,4-benzodioxin-2-carboxyamide with E value of >200. Thus, at about 50% conversion, (R)-2,3-dihydro-1,4-benzodioxin-2-carboxylic acid was produced in >99% e.e. The remaining amide had (S)configuration and 99% e.e. The amide and acid were easily separated by aqueous (alkaline)-organic two phase extraction method. The same amidase was able to catalyse, albeit at much lower rate the hydrolysis of (S)-amide to (S)-acid without loss of e.e. The amidase activity was identified as indole-3-acetamide hydrolase (IaaH). IaaH is known to catalyse conversion of indole-3-acetamide (IAM) to indole-3-acetic acid (IAA), which is phytohormone of auxin class and is widespread among plants and bacteria that inhabit plant rhizosphere. IaaH exhibited high activity for 2,3-dihydro-1,4-benzodioxin-2-carboxamide, which was about 65% compared to its natural substrate, indole-3-acetamide. The natural substrate for IaaH indole-3-acetamide shared, at least in part a similar bicyclic structure with 2,3-dihydro-1,4-benzodioxin-2-carboxamide, which may account for high activity of enzyme towards this un-natural substrate. To the best of our knowledge this is the first application of IaaH in production of industrially important molecules.	[Mishra, Pradeep; Kaur, Suneet; Sharma, Amar Nath; Jolly, Ravinder S.] CSIR Inst Microbial Technol, Dept Bioorgan Chem, Sect 39, Chandigarh, India; [Kaur, Suneet] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); Duke University	Jolly, RS (corresponding author), CSIR Inst Microbial Technol, Dept Bioorgan Chem, Sect 39, Chandigarh, India.	jolly@imtech.res.in	Kaur, Suneet/ABB-4807-2020	Kaur, Suneet/0000-0001-9271-8519	Council of Scientific and Industrial Research (CSIR), New Delhi, India [BSC0211]; CSIR, New Delhi, India [BSC0211]; CSIR	Council of Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); CSIR, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Supra Institutional Project Grant BSC0211 from Council of Scientific and Industrial Research (CSIR), New Delhi, India to RSJ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Supra Institutional Project Grant BSC0211 from CSIR, New Delhi, India. PM, SK and ANS acknowledge CSIR for award of Senior Research Fellowship. We acknowledge the technical help provided by Chander Prakash and Pradeep Patel.	Baoz N., 1994, Patent No. [US 5306638, 5306638]; Benz P, 2007, J CHEM TECHNOL BIOT, V82, P1087, DOI 10.1002/jctb.1795; Bolchi C, 2004, BIOORGAN MED CHEM, V12, P4937, DOI 10.1016/j.bmc.2004.06.040; Bolchi C, 2003, TETRAHEDRON-ASYMMETR, V14, P3779, DOI 10.1016/j.tetasy.2003.09.012; Bracey MH, 2002, SCIENCE, V298, P1793, DOI 10.1126/science.1076535; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAMPBELL SF, 1987, J MED CHEM, V30, P49, DOI 10.1021/jm00384a009; Chebrou H, 1996, BBA-PROTEIN STRUCT M, V1298, P285, DOI 10.1016/S0167-4838(96)00145-8; CHEN CS, 1982, J AM CHEM SOC, V104, P7294, DOI 10.1021/ja00389a064; Egorova K, 2004, APPL MICROBIOL BIOT, V65, P38, DOI 10.1007/s00253-004-1607-5; Faber K, 2012, COMPUTER PROGRAM DET; Fang QK, 2001, TETRAHEDRON-ASYMMETR, V12, P2169, DOI 10.1016/S0957-4166(01)00368-8; Fumagalli L, 2005, BIOORGAN MED CHEM, V13, P2547, DOI 10.1016/j.bmc.2005.01.034; Fumagalli L, 2012, EUR J MED CHEM, V58, P184, DOI 10.1016/j.ejmech.2012.09.049; KATRITZKY AR, 1989, SYNTHESIS-STUTTGART, P949; Khalilullah H, 2012, B KOREAN CHEM SOC, V33, P575, DOI 10.5012/bkcs.2012.33.2.575; Kuwabe S, 2001, J AM CHEM SOC, V123, P12202, DOI 10.1021/ja012046d; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lin Y, 2013, BIOCHEMISTRY-US, V52, P690, DOI 10.1021/bi301242m; Ma S, 2006, ACTA PHARMACOL SIN, V27, P8; Masterson DS, 2009, TETRAHEDRON-ASYMMETR, V20, P1476, DOI 10.1016/j.tetasy.2009.05.037; Matsuda T, 1995, JPN J PHARMACOL, V69, P357, DOI 10.1254/jjp.69.357; Mehta Praveen Kumar B SK, 2013, EXTREMOPHILES, V17; Moon LS, 2009, THESIS; NELSON WL, 1979, J MED CHEM, V22, P1125, DOI 10.1021/jm00195a024; Neu D, 2007, FEBS J, V274, P3440, DOI 10.1111/j.1742-4658.2007.05876.x; Neumann S, 2002, ACTA CRYSTALLOGR D, V58, P333, DOI 10.1107/S0907444901020248; Pallavicini M, 2006, EUR J MED CHEM, V41, P1025, DOI 10.1016/j.ejmech.2006.04.004; Pollmann S, 2003, PHYTOCHEMISTRY, V62, P293, DOI 10.1016/S0031-9422(02)00563-0; Quaglia W, 2008, J MED CHEM, V51, P6359, DOI 10.1021/jm800461k; SCHRODER G, 1984, EUR J BIOCHEM, V138, P387, DOI 10.1111/j.1432-1033.1984.tb07927.x; SEKINE M, 1989, J BACTERIOL, V171, P1718, DOI 10.1128/jb.171.3.1718-1724.1989; Shen WL, 2012, APPL MICROBIOL BIOT, V94, P1007, DOI 10.1007/s00253-011-3704-6; Smith ME, 2012, CHEMCATCHEM, V4, P472, DOI 10.1002/cctc.201100490; Somboonthum P, 1997, NEUROPHARMACOLOGY, V36, P1733, DOI 10.1016/S0028-3908(97)00174-3; Torisu K, 2004, BIOORGAN MED CHEM, V12, P5361, DOI 10.1016/j.bmc.2004.07.048; Valoti E, 2001, J ORG CHEM, V66, P1018, DOI 10.1021/jo0008340; Verho O, 2015, J AM CHEM SOC, V137, P3996, DOI 10.1021/jacs.5b01031; Vorwerk SB, 2001, PLANTA, V212, P9; Wang YS, 2011, WORLD J MICROB BIOT, V27, P2885, DOI 10.1007/s11274-011-0769-4; 신승훈, 2002, Annals of Rehabilitation Medicine, V26, P1	41	4	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159009	10.1371/journal.pone.0159009	http://dx.doi.org/10.1371/journal.pone.0159009			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391673	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400189
J	Saunders, ME; Luck, GW				Saunders, Manu E.; Luck, Gary W.			Combining Costs and Benefits of Animal Activities to Assess Net Yield Outcomes in Apple Orchards	PLOS ONE			English	Article							CYDIA-POMONELLA L; LANDSCAPE COMPLEXITY; ECOSYSTEM SERVICES; FRUIT ABORTION; PAN TRAPS; POLLINATION; CROP; PEST; BIRDS; BIODIVERSITY	Diverse animal communities influence ecosystem function in agroecosystems through positive and negative plant-animal interactions. Yet, past research has largely failed to examine multiple interactions that can have opposing impacts on agricultural production in a given context. We collected data on arthropod communities and yield quality and quantity parameters (fruit set, yield loss and net outcomes) in three major apple-growing regions in south-eastern Australia. We quantified the net yield outcome (accounting for positive and negative interactions) of multiple animal activities (pollination, fruit damage, biological control) across the entire growing season on netted branches, which excluded vertebrate predators of arthropods, and open branches. Net outcome was calculated as the number of undamaged fruit at harvest as a proportion of the number of blossoms (i.e., potential fruit yield). Vertebrate exclusion resulted in lower levels of fruit set and higher levels of arthropod damage to apples, but did not affect net outcomes. Yield quality and quantity parameters (fruit set, yield loss, net outcomes) were not directly associated with arthropod functional groups. Model variance and significant differences between the ratio of pest to beneficial arthropods between regions indicated that complex relationships between environmental factors and multiple animal interactions have a combined effect on yield. Our results show that focusing on a single crop stage, species group or ecosystem function/service can overlook important complexity in ecological processes within the system. Accounting for this complexity and quantifying the net outcome of ecological interactions within the system, is more informative for research and management of biodiversity and ecosystem services in agricultural landscapes.	[Saunders, Manu E.; Luck, Gary W.] Charles Sturt Univ, Inst Land Water & Soc, POB 789, Albury, NSW 2640, Australia	Charles Sturt University	Saunders, ME (corresponding author), Charles Sturt Univ, Inst Land Water & Soc, POB 789, Albury, NSW 2640, Australia.	masaunders@csu.edu.au	Saunders, Manu E./H-4246-2019	Saunders, Manu E./0000-0003-0645-8277	Australian Research Council [DP140100709]	Australian Research Council(Australian Research Council)	This research was funded by Australian Research Council Discovery Grant DP140100709, awarded to G.W.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded by an Australian Research Council Discovery Grant DP140100709 awarded to G.W.L. We thank orchard managers for providing access to orchards; R. Peisley provided field assistance; D. Nimmo provided helpful comments on statistical analyses; anonymous reviewers provided helpful comments to improve the manuscript.	Adler LS, 2001, ECOLOGY, V82, P2032, DOI 10.1890/0012-9658(2001)082[2032:DAIEOA]2.0.CO;2; Aguirre-Gutierrez J, 2015, DIVERS DISTRIB, V21, P1129, DOI 10.1111/ddi.12350; Anderies JM, 2006, ECOSYSTEMS, V9, P865, DOI 10.1007/s10021-006-0017-1; Bennett Andrew F., 1997, Pacific Conservation Biology, V3, P244; Bianchi FJJA, 2006, P ROY SOC B-BIOL SCI, V273, P1715, DOI 10.1098/rspb.2006.3530; Blitzer EJ, 2016, AGR ECOSYST ENVIRON, V221, P1, DOI 10.1016/j.agee.2016.01.004; Bone NJ, 2009, CROP PROT, V28, P675, DOI 10.1016/j.cropro.2009.03.021; Boreux V, 2013, P NATL ACAD SCI USA, V110, P8387, DOI 10.1073/pnas.1210590110; Bos MM, 2007, ECOL APPL, V17, P1841, DOI 10.1890/06-1763.1; Botes C, 2009, INT J PLANT SCI, V170, P151, DOI 10.1086/595291; BOYLE RMD, 1983, J HORTIC SCI, V58, P355, DOI 10.1080/00221589.1983.11515130; BROWN MW, 1995, J ECON ENTOMOL, V88, P127, DOI 10.1093/jee/88.1.127; Brown MW, 2001, ENVIRON ENTOMOL, V30, P415, DOI 10.1603/0046-225X-30.2.415; Chaplin-Kramer R, 2011, ECOL LETT, V14, P922, DOI 10.1111/j.1461-0248.2011.01642.x; Chapman T. F., 2007, Journal of the Royal Society of Western Australia, V90, P33; CHURCHILL D M, 1970, Australian Journal of Zoology, V18, P427, DOI 10.1071/ZO9700427; Classen A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3148; de Bello F, 2010, BIODIVERS CONSERV, V19, P2873, DOI 10.1007/s10531-010-9850-9; Dennis F. G. Jr., 1979, Horticultural Reviews, V1, P395; Dodds K, 2014, ORCHARD PLANT PROTEC; Garratt M.P.D., 2014, Journal of Pollination Ecology, V12, P9; Garratt MPD, 2014, AGR ECOSYST ENVIRON, V184, P34, DOI 10.1016/j.agee.2013.10.032; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Hamilton J., 2006, FLY INTERACTIVE ATLA; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Herrera CM, 2009, ANN BOT-LONDON, V103, P1415, DOI 10.1093/aob/mcp026; Jonsson M, 2015, J APPL ECOL, V52, P1274, DOI 10.1111/1365-2664.12489; KENDALL DA, 1973, J APPL ECOL, V10, P847, DOI 10.2307/2401873; Keogh R., 2010, POLLINATION AWARE RE; Koh LP, 2008, ECOL APPL, V18, P821, DOI 10.1890/07-1650.1; Leather SR, 2005, METH ECOL, P1, DOI 10.1002/9780470750513.ch1; Letourneau DK, 2012, J APPL ECOL, V49, P1405, DOI 10.1111/1365-2664.12001; Lindborg R, 2004, ECOLOGY, V85, P1840, DOI 10.1890/04-0367; Losada JM, 2013, SCI HORTIC-AMSTERDAM, V150, P283, DOI 10.1016/j.scienta.2012.11.031; Lundin O, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2243; Maas B, 2013, ECOL LETT, V16, P1480, DOI 10.1111/ele.12194; Macfadyen S, 2015, ECOL ENTOMOL, V40, P56, DOI 10.1111/een.12213; Macfadyen S, 2009, ECOL LETT, V12, P229, DOI 10.1111/j.1461-0248.2008.01279.x; MADSEN HF, 1966, CAN ENTOMOL, V98, P903, DOI 10.4039/Ent98903-9; Martin EA, 2015, PEERJ, V3, DOI 10.7717/peerj.1095; Martins KT, 2015, AGR ECOSYST ENVIRON, V200, P12, DOI 10.1016/j.agee.2014.10.018; McCall AC, 2006, ECOL LETT, V9, P1351, DOI 10.1111/j.1461-0248.2006.00975.x; Meehan TD, 2011, P NATL ACAD SCI USA, V108, P11500, DOI 10.1073/pnas.1100751108; Michener C.D., 2007, BEES WORLD, Vsecond; MOEED A, 1979, NEW ZEAL J ZOOL, V6, P475, DOI 10.1080/03014223.1979.10428389; Mols CMM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000202; Morrison EB, 2012, ECOLOGICAL APPL, V22, P1536; Ndang'ang'a PK, 2013, INT J PEST MANAGE, V59, P211, DOI 10.1080/09670874.2013.820005; Nicholls CI, 2013, AGRON SUSTAIN DEV, V33, P257, DOI 10.1007/s13593-012-0092-y; Peisley RK, SPRINGER SC IN PRESS; Puech C, 2014, AGR ECOSYST ENVIRON, V194, P48, DOI 10.1016/j.agee.2014.05.002; R Development Core Team, 2012, R LANG ENV STAT COMP; Raudsepp-Hearne C, 2010, P NATL ACAD SCI USA, V107, P5242, DOI 10.1073/pnas.0907284107; Raymond L, 2014, AGR ECOSYST ENVIRON, V185, P99, DOI 10.1016/j.agee.2013.12.019; Rusch A, 2013, AGR ECOSYST ENVIRON, V166, P118, DOI 10.1016/j.agee.2011.05.004; Saunders ME, 2016, AMBIO, V45, P4, DOI 10.1007/s13280-015-0696-y; Saunders ME, 2013, J INSECT CONSERV, V17, P1011, DOI 10.1007/s10841-013-9584-6; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Sheffield Cory S., 2014, Journal of Pollination Ecology, V12, P120; Sheffield CS, 2005, ANN BOT-LONDON, V95, P583, DOI 10.1093/aob/mci058; SOLOMON ME, 1976, J APPL ECOL, V13, P341, DOI 10.2307/2401784; STEPHENSON AG, 1981, ANNU REV ECOL SYST, V12, P253, DOI 10.1146/annurev.es.12.110181.001345; Stevens NB, 2007, WHAT WASP THAT INTER; Suckling DM, 2010, ANNU REV ENTOMOL, V55, P285, DOI 10.1146/annurev-ento-112408-085311; Tuell JK, 2009, ENTOMOL EXP APPL, V131, P93, DOI 10.1111/j.1570-7458.2009.00826.x; Vadkertiova R, 2012, CAN J MICROBIOL, V58, P1344, DOI 10.1139/cjm-2012-0468; Vandewalle M, 2010, BIODIVERS CONSERV, V19, P2921, DOI 10.1007/s10531-010-9798-9; Veres A, 2013, AGR ECOSYST ENVIRON, V166, P110, DOI 10.1016/j.agee.2011.05.027; Vicens N, 2000, ENVIRON ENTOMOL, V29, P235, DOI 10.1603/0046-225X(2000)029[0235:PEOOCA]2.0.CO;2; Vrdoljak SM, 2012, J INSECT CONSERV, V16, P345, DOI 10.1007/s10841-011-9420-9; WEARING CH, 1992, BIOCONTROL SCI TECHN, V2, P285, DOI 10.1080/09583159209355244; Winqvist C, 2011, J APPL ECOL, V48, P570, DOI 10.1111/j.1365-2664.2010.01950.x; Witzgall P, 2012, J CHEM ECOL, V38, P949, DOI 10.1007/s10886-012-0158-y; Wright JW, 2003, ECOLOGY, V84, P2062, DOI 10.1890/02-0676	74	8	8	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158618	10.1371/journal.pone.0158618	http://dx.doi.org/10.1371/journal.pone.0158618			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391022	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400091
J	Weinheimer, I; Haikonen, T; Ala-Poikela, M; Moser, M; Streng, J; Rajamaki, ML; Valkonen, JPT				Weinheimer, Isabel; Haikonen, Tuuli; Ala-Poikela, Marjo; Moser, Mirko; Streng, Janne; Rajamaki, Minna-Liisa; Valkonen, Jari P. T.			Viral RNase3 Co-Localizes and Interacts with the Antiviral Defense Protein SGS3 in Plant Cells	PLOS ONE			English	Article							HELPER COMPONENT PROTEINASE; POTATO-VIRUS-A; SILENCING SUPPRESSOR; SIRNA BIOGENESIS; MOSAIC-VIRUS; ARABIDOPSIS; INFECTION; GENE; TRANSITIVITY; RECOGNITION	Sweet potato chlorotic stunt virus (SPCSV; family Closteroviridae) encodes a Class 1 RNase III endoribonuclease (RNase3) that suppresses post-transcriptional RNA interference (RNAi) and eliminates antiviral defense in sweetpotato plants (Ipomoea batatas). For RNAi suppression, RNase3 cleaves double-stranded small interfering RNAs (ds-siRNA) and long dsRNA to fragments that are too short to be utilized in RNAi. However, RNase3 can suppress only RNAi induced by sense RNA. Sense-mediated RNAi involves host suppressor of gene silencing 3 (SGS3) and RNA-dependent RNA polymerase 6 (RDR6). In this study, subcellular localization and host interactions of RNase3 were studied in plant cells. RNase3 was found to interact with SGS3 of sweetpotato and Arabidopsis thaliana when expressed in leaves, and it localized to SGS3/RDR6 bodies in the cytoplasm of leaf cells and protoplasts. RNase3 was also detected in the nucleus. Co-expression of RNase3 and SGS3 in leaf tissue enhanced the suppression of RNAi, as compared with expression of RNase3 alone. These results suggest additional mechanisms needed for efficient RNase3-mediated suppression of RNAi and provide new information about the subcellular context and phase of the RNAi pathway in which RNase3 realizes RNAi suppression.	[Weinheimer, Isabel; Haikonen, Tuuli; Ala-Poikela, Marjo; Streng, Janne; Rajamaki, Minna-Liisa; Valkonen, Jari P. T.] Univ Helsinki, Dept Agr Sci, Helsinki, Finland; [Moser, Mirko] Fdn Edmund Mach, San Michele, Italy; [Weinheimer, Isabel] Roche Diagnost GmbH, Penzberg, Germany; [Haikonen, Tuuli] Nat Resources Inst Finland Luke, Hort Prod Res, Piikkio, Finland; [Ala-Poikela, Marjo] Univ Idaho, Dept Plant Soil & Entomol Sci, Moscow, ID 83843 USA	University of Helsinki; Fondazione Edmund Mach; Roche Holding; Natural Resources Institute Finland (Luke); Idaho; University of Idaho	Rajamaki, ML (corresponding author), Univ Helsinki, Dept Agr Sci, Helsinki, Finland.	minna.rajamaki@helsinki.fi	Haikonen, Tuuli/AAY-6303-2020; Rajamäki, Minna-Liisa/AAY-5758-2020	Rajamäki, Minna-Liisa/0000-0002-7952-0433; Valkonen, Jari/0000-0002-3704-9911; Moser, Mirko/0000-0002-1936-984X; Haikonen, Tuuli/0000-0002-9631-9774	Academy of Finland [1134335, 1253126, 1276136]; Viikki Doctoral Program in Molecular Biosciences; Finnish Doctoral Program in Plant Sciences	Academy of Finland(Academy of Finland); Viikki Doctoral Program in Molecular Biosciences; Finnish Doctoral Program in Plant Sciences	This work was funded by the Academy of Finland (grants 1134335, 1253126 and 1276136 to JPTV), Viikki Doctoral Program in Molecular Biosciences (to IW), and the Finnish Doctoral Program in Plant Sciences (to TH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adenot X, 2006, CURR BIOL, V16, P927, DOI 10.1016/j.cub.2006.03.035; Ala-Poikela M, 2011, J VIROL, V85, P6784, DOI 10.1128/JVI.00485-11; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Axtell MJ, 2006, CELL, V127, P565, DOI 10.1016/j.cell.2006.09.032; Chen H, 2015, VIROLOGY, V476, P395, DOI 10.1016/j.virol.2014.12.034; Cuellar WJ, 2009, P NATL ACAD SCI USA, V106, P10354, DOI 10.1073/pnas.0806042106; Du ZG, 2011, MOL PLANT PATHOL, V12, P808, DOI [10.1111/J.1364-3703.2011.00716.X, 10.1111/j.1364-3703.2011.00716.x]; Fukunaga R, 2009, EMBO J, V28, P545, DOI 10.1038/emboj.2009.2; Gall JG, 2003, NAT REV MOL CELL BIO, V4, P975, DOI 10.1038/nrm1262; Garcia-Ruiz H, 2010, PLANT CELL, V22, P481, DOI 10.1105/tpc.109.073056; Glick E, 2008, P NATL ACAD SCI USA, V105, P157, DOI 10.1073/pnas.0709036105; Guo HY, 2013, MOL PLANT MICROBE IN, V26, P927, DOI 10.1094/MPMI-02-13-0040-R; Haas G, 2008, EMBO J, V27, P2102, DOI 10.1038/emboj.2008.129; Haikonen T, 2013, MOL PLANT MICROBE IN, V26, P734, DOI 10.1094/MPMI-01-13-0023-R; Himber C, 2003, EMBO J, V22, P4523, DOI 10.1093/emboj/cdg431; Hoffer P, 2011, P NATL ACAD SCI USA, V108, P409, DOI 10.1073/pnas.1009805108; Jouannet V, 2012, EMBO J, V31, P1704, DOI 10.1038/emboj.2012.20; Karyeija RF, 2000, PHYTOPATHOLOGY, V90, P1250, DOI 10.1094/PHYTO.2000.90.11.1250; Kim SH, 2007, EMBO J, V26, P2169, DOI 10.1038/sj.emboj.7601674; Kreuze JF, 2005, J VIROL, V79, P7227, DOI 10.1128/JVI.79.11.7227-7238.2005; Kumakura N, 2009, FEBS LETT, V583, P1261, DOI 10.1016/j.febslet.2009.03.055; Mann KS, 2016, VIROLOGY, V490, P27, DOI 10.1016/j.virol.2016.01.003; Moissiard G, 2007, RNA, V13, P1268, DOI 10.1261/rna.541307; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Muangsan N, 2004, PLANT J, V38, P1004, DOI 10.1111/j.1365-313X.2004.02103.x; Okano Y, 2014, PLANT CELL, V26, P2168, DOI 10.1105/tpc.113.120535; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Pumplin N, 2013, NAT REV MICROBIOL, V11, P745, DOI 10.1038/nrmicro3120; Rajamaki ML, 2014, MOL PLANT MICROBE IN, V27, P1199, DOI 10.1094/MPMI-04-14-0109-R; Rajamaki ML, 2009, PLANT CELL, V21, P2485, DOI 10.1105/tpc.108.064147; Voinnet O, 2005, NAT REV GENET, V6, P206, DOI 10.1038/nrg1555; Weinheimer I, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004711; Weinheimer I, 2014, J GEN VIROL, V95, P486, DOI 10.1099/vir.0.058693-0; Xie FL, 2012, PLANTA, V236, P101, DOI 10.1007/s00425-012-1591-4; Yoshikawa M, 2013, P NATL ACAD SCI USA, V110, P4117, DOI 10.1073/pnas.1217050110; Zamyatnin AA, 2006, PLANT J, V46, P145, DOI 10.1111/j.1365-313X.2006.02674.x; Zhang DP, 2008, CELL CYCLE, V7, P2268, DOI 10.4161/cc.7.14.6306	37	12	12	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159080	10.1371/journal.pone.0159080	http://dx.doi.org/10.1371/journal.pone.0159080			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391019	Green Published, gold, Green Submitted			2022-12-27	WOS:000380005400208
J	Jindrova, A; Tuma, J; Sladek, V				Jindrova, Alena; Tuma, Jan; Sladek, Vladimir			Impact of Non-Invasively Induced Motor Deficits on Tibial Cortical Properties in Mutant Lurcher Mice	PLOS ONE			English	Article							CROSS-SECTIONAL GEOMETRY; EARLY BRONZE-AGE; OSTEOCYTE MORPHOLOGY; BONE-STRUCTURE; BODY-SIZE; MOUSE; ADAPTATION; PURKINJE; DENSITY; SKILLS	It has been shown that Lurcher mutant mice have significantly altered motor abilities, regarding their motor coordination and muscular strength because of olivorecebellar degeneration. We assessed the response of the cross-sectional geometry and lacuno-canalicular network properties of the tibial mid-diaphyseal cortical bone to motor differences between Lurcher and wild-type (WT) male mice from the B6CBA strain. The first data set used in the cross-sectional geometry analysis consists of 16 mice of 4 months of age and 32 mice of 9 months of age. The second data set used in the lacunar-canalicular network analysis consists of 10 mice of 4 months of age. We compared two cross-sectional geometry and four lacunar-canalicular properties by I-region using the maximum and minimum second moment of area and anatomical orientation as well as H-regions using histological differences within a cross section. We identified inconsistent differences in the studied cross-sectional geometry properties between Lurcher and WT mice. The biggest significant difference between Lurcher and WT mice is found in the number of canaliculi, whereas in the other studied properties are only limited. Lurcher mice exhibit an increased number of canaliculi (p < 0.01) in all studied regions compared with the WT controls. The number of canaliculi is also negatively correlated with the distance from the centroid in the Lurcher and positively correlated in the WT mice. When the Lurcher and WT sample is pooled, the number of canaliculi and lacunar volume is increased in the posterior I-max region, and in addition, midcortical H-region exhibit lower number of canaliculi, lacuna to lacuna distance and increased lacunar volume. Our results indicate, that the importance of precise sample selection within cross sections in future studies is highlighted because of the histological heterogeneity of lacunar-canalicular network properties within the I-region and H-region in the mouse cortical bone.	[Jindrova, Alena; Sladek, Vladimir] Charles Univ Prague, Dept Anthropol & Human Genet, Fac Sci, Prague, Czech Republic; [Tuma, Jan] Charles Univ Prague, Fac Med Pilsen, Dept Pathophysiol, Plzen, Czech Republic; [Tuma, Jan] Charles Univ Prague, Fac Med Pilsen, Lab Neurodegenerat Disorders, Biomed Ctr, Plzen, Czech Republic	Charles University Prague; Charles University Prague; Charles University Prague	Jindrova, A (corresponding author), Charles Univ Prague, Dept Anthropol & Human Genet, Fac Sci, Prague, Czech Republic.	aja.jindrova@seznam.cz	Tuma, Jan/AFK-6976-2022; Tuma, Jan/AAG-5323-2022; Tuma, Jan/A-1572-2010	Tuma, Jan/0000-0002-7197-8482; Tuma, Jan/0000-0002-7197-8482; Tuma, Jan/0000-0002-7197-8482	Charles University Grant Agency [408911]	Charles University Grant Agency	This study was funded by the Charles University Grant Agency, grant number 408911 (AJ), http://www.cuni.cz/UK-33.html. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This study was funded by the Charles University Grant Agency, grant number 408911. We would like to thank Ondrej Sebesta for technical support and assistance in the high resolution confocal scanning of bone samples and the modification of the ImageJ macro for the CSG analyses of histological sections. We would also like to thank Eliska Makajevova, Jaroslav Roman and Veronika Sabolova for assistance in the preparation of bone samples and morphometric analyses. We also thank Sebastien Nogue for technical assistance.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Babuska V, 2015, CEREBELLUM, V14, P632, DOI 10.1007/s12311-015-0656-x; Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Britz HM, 2012, BONE, V51, P913, DOI 10.1016/j.bone.2012.08.112; Brodt MD, 1999, J BONE MINER RES, V14, P2159, DOI 10.1359/jbmr.1999.14.12.2159; Burger EH, 1999, FASEB J, V13, pS101, DOI 10.1096/fasebj.13.9001.s101; Burr DB, 2002, BONE, V30, P781, DOI 10.1016/S8756-3282(02)00707-X; CADDY KWT, 1976, BRAIN RES, V111, P396, DOI 10.1016/0006-8993(76)90783-6; Carter Y, 2013, BONE, V52, P126, DOI 10.1016/j.bone.2012.09.010; Cendelin J, 2014, BEHAV BRAIN RES, V271, P218, DOI 10.1016/j.bbr.2014.06.023; Cendelin J, 2010, BEHAV BRAIN RES, V210, P8, DOI 10.1016/j.bbr.2010.01.035; Ciani C, 2009, BONE, V44, P1015, DOI 10.1016/j.bone.2009.01.376; De Souza RL, 2005, BONE, V37, P810, DOI 10.1016/j.bone.2005.07.022; FORTIER PA, 1987, EXP BRAIN RES, V66, P271, DOI 10.1007/bf00243304; FROST HM, 1982, METAB BONE DIS RELAT, V4, P217, DOI 10.1016/0221-8747(82)90031-5; FROST HM, 1987, ANAT RECORD, V219, P1, DOI 10.1002/ar.1092190104; Halloran BP, 2002, J BONE MINER RES, V17, P1044, DOI 10.1359/jbmr.2002.17.6.1044; Hamrick MW, 2000, BONE, V27, P343, DOI 10.1016/S8756-3282(00)00339-2; Hartmann N, 2001, J CELL BIOCHEM, P222; Hilber P, 2004, BRAIN RES, V1003, P108, DOI 10.1016/j.brainres.2004.01.008; Hilber P, 2001, NEUROSCIENCE, V102, P615, DOI 10.1016/S0306-4522(00)00509-1; Hirose S, 2007, J BONE MINER METAB, V25, P374, DOI 10.1007/s00774-007-0764-x; Hora M, 2014, J HUM EVOL, V67, P19, DOI 10.1016/j.jhevol.2013.09.011; HUISKES R, 1982, J BIOMECH, V15, P65, DOI 10.1016/0021-9290(82)90036-7; Huiskes R, 2000, NATURE, V405, P704, DOI 10.1038/35015116; Jerome C, 2012, COMP ANATOMY HISTOLO, P53; Jindrova A, 2012, FOLIA ZOOL, V61, P340, DOI 10.25225/fozo.v61.i3.a1.2012; Kamioka H, 2001, BONE, V28, P145, DOI 10.1016/S8756-3282(00)00421-X; Klein-Nulend J, 2013, BONE, V54, P182, DOI 10.1016/j.bone.2012.10.013; Kodama Y, 1999, BONE, V25, P183, DOI 10.1016/S8756-3282(99)00155-6; Krizkova A, 2004, BEHAV BRAIN RES, V150, P65, DOI 10.1016/S0166-4328(03)00247-X; Lalonde R, 1996, BEHAV BRAIN RES, V74, P213, DOI 10.1016/0166-4328(95)00164-6; LANYON LE, 1982, J BIOMECH, V15, P141, DOI 10.1016/0021-9290(82)90246-9; LeMarec N, 1997, EXP BRAIN RES, V116, P131, DOI 10.1007/PL00005733; Leroux A, 2002, GAIT POSTURE, V15, P64, DOI 10.1016/S0966-6362(01)00181-3; Longair M, 2011, BIOINFORMATICS; Mader KS, 2013, BONE, V57, P142, DOI 10.1016/j.bone.2013.06.026; Merzin M., 2008, APPL STEREOLOGICAL M; Nicolella DP, 2006, J BIOMECH, V39, P1735, DOI 10.1016/j.jbiomech.2005.04.032; O'Neill MC, 2004, J HUM EVOL, V47, P221, DOI 10.1016/j.jhevol.2004.07.002; Pearson OM, 2004, YEARB PHYS ANTHROPOL, V47, P63, DOI 10.1002/ajpa.20155; PHILLIPS RITA J. S., 1960, JOUR GENET, V57, P35, DOI 10.1007/BF02985337; Polk JD, 2000, J HUM EVOL, V39, P297, DOI 10.1006/jhev.2000.0420; Porras-Garcia E, 2005, EUR J NEUROSCI, V21, P979, DOI 10.1111/j.1460-9568.2005.03940.x; Price C, 2005, J BONE MINER RES, V20, P1983, DOI 10.1359/JBMR.050707; Qing H, 2012, J BONE MINER RES, V27, P1018, DOI 10.1002/jbmr.1567; Robling AG, 2002, J BONE MINER RES, V17, P1545, DOI 10.1359/jbmr.2002.17.8.1545; ROUX W, 1881, KAMPF TEILE ORGANISM; RUBIN CT, 1984, J BONE JOINT SURG AM, V66A, P397, DOI 10.2106/00004623-198466030-00012; Ruff C, 2002, ANNU REV ANTHROPOL, V31, P211, DOI 10.1146/annurev.anthro.31.040402.085407; Ruff C.B., 2006, MOMENT MACRO NIH IMA; Ruff C. B, 2007, BIOL ANTHR HUMAN SKE, P183; Ruff CB, 2000, J HUM EVOL, V38, P269, DOI 10.1006/jhev.1999.0322; RUFF CB, 1993, AM J PHYS ANTHROPOL, V91, P21, DOI 10.1002/ajpa.1330910103; RUFF CB, 1983, AM J PHYS ANTHROPOL, V60, P359, DOI 10.1002/ajpa.1330600308; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sharma D, 2012, BONE, V51, P488, DOI 10.1016/j.bone.2012.05.014; SIMSKE SJ, 1992, J BIOMECH, V25, P489, DOI 10.1016/0021-9290(92)90089-J; Skedros JG, 2004, J MORPHOL, V259, P281, DOI 10.1002/jmor.10167; Skedros JG, 2003, ANAT REC PART A, V273A, P609, DOI 10.1002/ar.a.10073; Sladek V, 2007, AM J PHYS ANTHROPOL, V133, P669, DOI 10.1002/ajpa.20551; Sladek V, 2006, AM J PHYS ANTHROPOL, V130, P320, DOI 10.1002/ajpa.20372; STEINBERG ME, 1981, CLIN ORTHOP RELAT R, P52; Stout S, 2011, BONE HISTOLOGY ANTHR, P153; Styner M, 2014, BONE, V64, P39, DOI 10.1016/j.bone.2014.03.044; Sugawara Y, 2005, BONE, V36, P877, DOI 10.1016/j.bone.2004.10.008; Sugawara Y, 2013, BONE, V52, P189, DOI 10.1016/j.bone.2012.09.033; Thullier F, 1997, DEV BRAIN RES, V100, P22, DOI 10.1016/S0165-3806(97)00010-2; Trinkaus E, 1999, J HUM EVOL, V37, P1, DOI 10.1006/jhev.1999.0295; Turner CH, 1998, BONE, V23, P399, DOI 10.1016/S8756-3282(98)00118-5; van Hove RP, 2009, BONE, V45, P321, DOI 10.1016/j.bone.2009.04.238; Vatsa A, 2008, BONE, V43, P452, DOI 10.1016/j.bone.2008.01.030; Weinstein RS, 1998, J CLIN INVEST, V102, P274, DOI 10.1172/JCI2799; WETTS R, 1982, BRAIN RES, V250, P358, DOI 10.1016/0006-8993(82)90431-0; Zuo J, 1997, NATURE, V388, P769, DOI 10.1038/42009	76	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158877	10.1371/journal.pone.0158877	http://dx.doi.org/10.1371/journal.pone.0158877			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27387489	Green Published, gold, Green Submitted			2022-12-27	WOS:000379811500057
J	You, H; Gu, H; Ning, WQ; Zhou, H; Dong, HJ				You, Hua; Gu, Hai; Ning, Weiqing; Zhou, Hua; Dong, Hengjin			Comparing Maternal Services Utilization and Expense Reimbursement before and after the Adjustment of the New Rural Cooperative Medical Scheme Policy in Rural China	PLOS ONE			English	Article							HEALTH-CARE; MORTALITY	Background The New Rural Cooperative Medical Scheme (NCMS) includes a maternal care benefits package that is associated with increasing maternal health services. The local compensation policies have been frequently adjusted in recent years. This study examined the association between the NCMS maternal-services policy adjustment and expense reimbursement in Yuyao, China. Methods Two household surveys were conducted in Yuyao in 2008 and 2011 (before and after the NCMS policy adjustment, respectively). Local women (N = 154) who had delivery history in the past three years were recruited. A questionnaire was used to collect information about delivery history, maternal health services utilization (prenatal care, postnatal care, and the grade of delivery institutions), NCMS participation, and reimbursement status. Logistic regression analyses were used to predict the association between policy adjustment and maternal health utilization and the association between policy adjustment and out-of-pocket proportion. Next, t-tests and covariance analyses adjusting for household income were used to compare the out-of-pocket proportion between 2008 and 2011. Results Results revealed that compensation policy adjustment was associated with an increase in postnatal visits (adjusted OR = 3.32, p = 0.009) and the use of second level or above institutions for delivery (adjusted OR = 2.32, p = 0.03) among participants. In 2008, only 9.1% of pregnant women received reimbursement from the NCMS; however, this rate increased to 36.8% in 2011. After policy adjustment, there were no significant changes in the proportion of out-of-pocket expenses shared in delivery fee (F = 0.24, p = 0.63) and in household income (F = 0.46, p = 0.50). Conclusions Financial compensation increase improved maternal health services utilization; however, this effect was limited. Although the reimbursement rate was raised, the out-of-pocket proportion was not significant changed; therefore, the compensation design scheme must be adjusted in practice.	[You, Hua] Nanjing Med Univ, Sch Publ Hlth, Dept Social Med & Hlth Educ, Nanjing, Jiangsu, Peoples R China; [You, Hua; Gu, Hai] Nanjing Univ, Sch Govt, Ctr Hlth Management & Care Secur Policy Res, Nanjing, Jiangsu, Peoples R China; [Ning, Weiqing] Nanjing Med Univ, Affiliated Hosp 1, Dept Women Hlth Care, Nanjing, Jiangsu, Peoples R China; [Zhou, Hua] Maternal & Child Hlth Hosp Changzhou, Dept Child Hlth Care, Changzhou, Jiangsu, Peoples R China; [Dong, Hengjin] Zhejiang Univ, Sch Med, Ctr Hlth Policy Studies, Hangzhou, Zhejiang, Peoples R China	Nanjing Medical University; Nanjing University; Nanjing Medical University; Zhejiang University	Dong, HJ (corresponding author), Zhejiang Univ, Sch Med, Ctr Hlth Policy Studies, Hangzhou, Zhejiang, Peoples R China.	donghj@zju.edu.cn			Enlarging the risk pool of NCMS [09-989]; National Natural Science Foundation of China [71373102]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Enlarging the risk pool of NCMS; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This study was supported by Enlarging the risk pool of NCMS to improve sustainability of rural health insurance in Zhejiang province 09-989, National Natural Science Foundation of China 71373102, and Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Celik Y, 2000, SOC SCI MED, V50, P1797, DOI 10.1016/S0277-9536(99)00418-9; Chen Y, 2006, MED PHILOS HUMANISTI, V27, P4; Cheng B, 2008, MATERN CHILD HLTH J, V23, P1323; Chinese Ministry of Health, CHIN HLTH SERV DEV S; Criel B, 1999, SOC SCI MED, V48, P897, DOI 10.1016/S0277-9536(98)00391-8; Cui Y, 2007, RES SITUATION PRENAT; Dong LJ, 2007, CHINESE RURAL HLTH S, V27, P550; Fatmi Z, 2002, J Pak Med Assoc, V52, P138; Goodburn E, 2001, BRIT MED J, V322, P917, DOI 10.1136/bmj.322.7291.917; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hu Y, 2009, SUSTAINABILITY CHINA; Lei XL, 2002, ZHEJIANG J PREVENTIV, V14, P32; Li CR, 2006, ELEMENTARY STUDY SOC; Li WJ, 2009, MATERN CHILD HLTH J, V24, P4645; Li WJ, 2009, IMPACT NEW COOPERATI; Long QA, 2011, B WORLD HEALTH ORGAN, V89, P144, DOI 10.2471/BLT.10.079434; Long QA, 2010, TROP MED INT HEALTH, V15, P1210, DOI 10.1111/j.1365-3156.2010.02602.x; Luo GH, 2007, RES INFLUENCE RURAL; Saga S, 2008, SOC SCI MED, V66, P2460, DOI DOI 10.1016/J; Shi QL, 2008, MATERN CHILD HLTH J, V23, P2491; Shuval J., 1992, SOCIAL DIMENSIONS HL; Song AH, 2008, MATERN CHILD HLTH J, V23, P299; Sun XY, 2007, CHINESE HLTH EC, V26, P14	24	5	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158473	10.1371/journal.pone.0158473	http://dx.doi.org/10.1371/journal.pone.0158473			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR3OC	27388439	gold, Green Published			2022-12-27	WOS:000379811500023
J	Keren-Rotem, T; Levy, N; Wolf, L; Bouskila, A; Geffen, E				Keren-Rotem, Tammy; Levy, Noga; Wolf, Lior; Bouskila, Amos; Geffen, Eli			Alternative Mating Tactics in Male Chameleons (Chamaeleo chamaeleon) Are Evident in Both Long-Term Body Color and Short-Term Courtship Pattern	PLOS ONE			English	Article							MALE COMMON CHAMELEONS; MALE REPRODUCTIVE STRATEGIES; FEMALE MATE CHOICE; MALE TREE LIZARDS; SELECTION; EVOLUTION; BEHAVIOR; ADJUST; SIZE; COMMUNICATION	Alternative mating tactics in males of various taxa are associated with body color, body size, and social status. Chameleons are known for their ability to change body color following immediate environmental or social stimuli. In this study, we examined whether the differential appearance of male common chameleon during the breeding season is indeed an expression of alternative mating tactics. We documented body color of males and used computer vision techniques to classify images of individuals into discrete color patterns associated with seasons, individual characteristics, and social contexts. Our findings revealed no differences in body color and color patterns among males during the non-breeding season. However, during the breeding season males appeared in several color displays, which reflected body size, social status, and behavioral patterns. Furthermore, smaller and younger males resembled the appearance of small females. Consequently, we suggest that long-term color change in males during the breeding season reflects male alternative mating tactics. Upon encounter with a receptive female, males rapidly alter their appearance to that of a specific brief courtship display, which reflects their social status. The females, however, copulated indiscriminately in respect to male color patterns. Thus, we suggest that the differential color patterns displayed by males during the breeding season are largely aimed at inter-male signaling.	[Keren-Rotem, Tammy; Geffen, Eli] Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel; [Levy, Noga; Wolf, Lior] Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel; [Bouskila, Amos] Ben Gurion Univ Negev, Blaustein Inst Desert Res, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Bouskila, Amos] Ben Gurion Univ Negev, Blaustein Inst Desert Res, Mitrani Dept Desert Ecol, IL-84105 Beer Sheva, Israel	Tel Aviv University; Tel Aviv University; Ben Gurion University; Ben Gurion University	Geffen, E (corresponding author), Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel.	geffene@post.tau.ac.il	Bouskila, Amos/B-4847-2010	Bouskila, Amos/0000-0002-6995-5070				Ancona S, 2010, ANIM BEHAV, V79, P75, DOI 10.1016/j.anbehav.2009.10.005; Andersson Malte, 1994; Bajer K, 2010, BEHAV ECOL SOCIOBIOL, V64, P2007, DOI 10.1007/s00265-010-1012-2; Bergman TJ, 2008, BIOL J LINN SOC, V94, P231, DOI 10.1111/j.1095-8312.2008.00981.x; Bouskila A., 2001, HDB REPTILES AMPHIBI; Bowmaker JK, 2005, J COMP PHYSIOL A, V191, P925, DOI 10.1007/s00359-005-0014-4; Brumm H, 2006, BEHAV ECOL SOCIOBIOL, V60, P475, DOI 10.1007/s00265-006-0188-y; Bustard HR, 1965, COPEIA, V1965, P401; Calsbeek R, 2002, P NATL ACAD SCI USA, V99, P14897, DOI 10.1073/pnas.242645199; Censky EJ, 1997, BEHAV ECOL SOCIOBIOL, V40, P221, DOI 10.1007/s002650050336; Chih-Chung C, 2011, ACM T INTEL SYST TEC, V2; Cooper W.E. Jr, 1992, P298; COOPER WE, 1993, ANIM BEHAV, V45, P683, DOI 10.1006/anbe.1993.1083; COOPER WE, 1987, OECOLOGIA, V72, P321, DOI 10.1007/BF00377558; Corl A, 2010, EVOLUTION, V64, P79, DOI 10.1111/j.1558-5646.2009.00791.x; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cuadrado M, 2000, HERPETOLOGICA, V56, P387; Cuadrado M, 2001, BIOL J LINN SOC, V72, P547, DOI 10.1111/j.1095-8312.2001.tb01337.x; Cuadrado M, 1998, J ZOOL, V246, P351, DOI 10.1111/j.1469-7998.1998.tb00165.x; Cuadrado M, 1998, J ETHOL, V16, P73, DOI 10.1007/BF02769285; Cuadrado M, 2000, ETHOLOGY, V106, P79, DOI 10.1046/j.1439-0310.2000.00493.x; Cuadrado M, 2001, J ZOOL, V255, P425; Greenberg N, 2003, PHYSIOL BEHAV, V79, P429, DOI 10.1016/S0031-9384(03)00162-8; Greenberg N, 2002, INTEGR COMP BIOL, V42, P526, DOI 10.1093/icb/42.3.526; GREENBERG N, 1990, GEN COMP ENDOCR, V77, P246, DOI 10.1016/0016-6480(90)90309-A; GROSS MR, 1980, P NATL ACAD SCI-BIOL, V77, P6937, DOI 10.1073/pnas.77.11.6937; Gross MR, 1996, TRENDS ECOL EVOL, V11, P92, DOI 10.1016/0169-5347(96)81050-0; GROSS MR, 1982, Z TIERPSYCHOL, V60, P1; Hews DK, 1996, PHYSIOL BEHAV, V60, P425, DOI 10.1016/S0031-9384(96)80014-X; Hodar JA, 2000, BIOL CONSERV, V94, P63, DOI 10.1016/S0006-3207(99)00163-9; How TL, 2002, J ZOOL, V257, P333, DOI 10.1017/S0952836902000936; Jenssen TA, 2005, ANIM BEHAV, V69, P1325, DOI 10.1016/j.anbehav.2004.07.023; Kano Y, 2006, J ETHOL, V24, P1, DOI 10.1007/s10164-005-0153-7; Kelso EC, 2002, ETHOLOGY, V108, P495, DOI 10.1046/j.1439-0310.2002.00789.x; Keren T., 2001, THESIS; Keren-Rotem T, 2006, BEHAV ECOL SOCIOBIOL, V59, P723, DOI 10.1007/s00265-005-0102-z; Knapp R, 2003, HORM BEHAV, V43, P83, DOI 10.1016/S0018-506X(02)00018-1; Lebas NR, 2001, BEHAVIOUR, V138, P965, DOI 10.1163/156853901753286515; Lengagne T, P ROYAL SOC B, V266, P1623; Ligon RA, 2014, BEHAV ECOL SOCIOBIOL, V68, P1007, DOI 10.1007/s00265-014-1713-z; Ligon RA, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0892; LUCAS JR, 1995, AM NAT, V146, P365, DOI 10.1086/285805; Martin J, 1999, BEHAV ECOL, V10, P396, DOI 10.1093/beheco/10.4.396; Martin J., 1992, CHAMELEONS NATURES M; Maynard Smith J., 1982, pi; Moczek AP, 2000, ANIM BEHAV, V59, P459, DOI 10.1006/anbe.1999.1342; MOORE MC, 1991, HORM BEHAV, V25, P154, DOI 10.1016/0018-506X(91)90048-M; Norman MD, 1999, P ROY SOC B-BIOL SCI, V266, P1347, DOI 10.1098/rspb.1999.0786; OLSSON M, 1995, BEHAV ECOL SOCIOBIOL, V36, P179, DOI 10.1007/BF00177794; Ord TJ, 2002, BIOL J LINN SOC, V77, P127, DOI 10.1046/j.1095-8312.2002.00100.x; de Lanuza GPI, 2013, BEHAV ECOL, V24, P273, DOI 10.1093/beheco/ars164; Pike TW, 2011, BEHAV ECOL SOCIOBIOL, V65, P849, DOI 10.1007/s00265-010-1097-7; Price JJ, 2013, BEHAVIOUR, V150, P995, DOI 10.1163/1568539X-00003051; RADWAN J, 1993, BEHAV ECOL SOCIOBIOL, V33, P201, DOI 10.1007/BF00216601; RAND MS, 1992, GEN COMP ENDOCR, V88, P461, DOI 10.1016/0016-6480(92)90241-B; REYNOLDS JD, 1993, ANIM BEHAV, V45, P145, DOI 10.1006/anbe.1993.1013; Serre T, 2007, IEEE T PATTERN ANAL, V29, P411, DOI 10.1109/TPAMI.2007.56; Shine R, 2003, BEHAVIOUR, V140, P1509, DOI 10.1163/156853903771980693; SHUSTER SM, 1991, NATURE, V350, P608, DOI 10.1038/350608a0; Sinervo B, 2000, HORM BEHAV, V38, P222, DOI 10.1006/hbeh.2000.1622; Smith JM, 1997, J HERPETOL, V31, P179, DOI 10.2307/1565385; Stamps J.A., 1977, P265; Stevens M, 2007, BIOL J LINN SOC, V90, P211, DOI 10.1111/j.1095-8312.2007.00725.x; Stuart-Fox D, 2008, PLOS BIOL, V6, P22, DOI 10.1371/journal.pbio.0060025; Stuart-Fox D, 2007, AM NAT, V170, P916, DOI 10.1086/522835; Stuart-Fox D, 2009, PHILOS T R SOC B, V364, P463, DOI 10.1098/rstb.2008.0254; Stuart-Fox DM, 2005, BIOL LETTERS, V1, P231, DOI 10.1098/rsbl.2005.0299; Sullivan BK, 2007, FUNCT ECOL, V21, P666, DOI 10.1111/j.1365-2435.2007.01244.x; TABORSKY M, 1994, ADV STUD BEHAV, V23, P1, DOI 10.1016/S0065-3454(08)60351-4; THOMPSON CW, 1991, ANIM BEHAV, V42, P745, DOI 10.1016/S0003-3472(05)80120-4; THURMAN CL, 1988, COMP BIOCHEM PHYS C, V91, P171, DOI 10.1016/0742-8413(88)90184-3; TOKARZ RR, 1995, HERPETOLOGICAL MONOGRAPHS, NO 9, 1995, P17, DOI 10.2307/1466994; Tolley KA, 2014, AFR J HERPETOL, V63, P47, DOI 10.1080/21564574.2013.872701; Vercken E, 2007, J EVOLUTION BIOL, V20, P221, DOI 10.1111/j.1420-9101.2006.01208.x; Whiting MJ, 2009, P ROY SOC B-BIOL SCI, V276, P1585, DOI 10.1098/rspb.2008.1822; Wikelski M, 1996, ANIM BEHAV, V52, P581, DOI 10.1006/anbe.1996.0199; Zhang J, 2012, ECCV 2012	77	8	8	3	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159032	10.1371/journal.pone.0159032	http://dx.doi.org/10.1371/journal.pone.0159032			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27409771	gold, Green Published, Green Submitted			2022-12-27	WOS:000379508300051
J	Yu, C; Wang, J				Yu, Chong; Wang, Jin			A Physical Mechanism and Global Quantification of Breast Cancer	PLOS ONE			English	Article							GENE-EXPRESSION; P53; LANDSCAPE; PATHWAY; BRCA1; ROBUSTNESS; CELLS; HER2	Initiation and progression of cancer depend on many factors. Those on the genetic level are often considered crucial. To gain insight into the physical mechanisms of breast cancer, we construct a gene regulatory network (GRN) which reflects both genetic and environmental aspects of breast cancer. The construction of the GRN is based on available experimental data. Three basins of attraction, representing the normal, premalignant and cancer states respectively, were found on the phenotypic landscape. The progression of breast cancer can be seen as switching transitions between different state basins. We quantified the stabilities and kinetic paths of the three state basins to uncover the biological process of breast cancer formation. The gene expression levels at each state were obtained, which can be tested directly in experiments. Furthermore, by performing global sensitivity analysis on the landscape topography, six key genes (HER2, MDM2, TP53, BRCA1, ATM, CDK2) and four regulations (HER2aTP53, CDK2aBRCA1, ATM -> MDM2, TP53 -> ATM) were identified as being critical for breast cancer. Interestingly, HER2 and MDM2 are the most popular targets for treating breast cancer. BRCA1 and TP53 are the most important oncogene of breast cancer and tumor suppressor gene, respectively. This further validates the feasibility of our model and the reliability of our prediction results. The regulation ATM -> MDM2 has been extensive studied on DNA damage but not on breast cancer. We notice the importance of ATM -> MDM2 on breast cancer. Previous studies of breast cancer have often focused on individual genes and the anti-cancer drugs are mainly used to target the individual genes. Our results show that the network-based strategy is more effective on treating breast cancer. The landscape approach serves as a new strategy for analyzing breast cancer on both the genetic and epigenetic levels and can help on designing network based medicine for breast cancer.	[Yu, Chong; Wang, Jin] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun 130022, Jilin, Peoples R China; [Wang, Jin] Jilin Univ, Coll Phys, Changchun 130012, Jilin, Peoples R China; [Wang, Jin] SUNY Stony Brook, Dept Chem Phys & Appl Math, Stony Brook, NY 11794 USA	Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; Jilin University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Wang, J (corresponding author), Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun 130022, Jilin, Peoples R China.; Wang, J (corresponding author), Jilin Univ, Coll Phys, Changchun 130012, Jilin, Peoples R China.; Wang, J (corresponding author), SUNY Stony Brook, Dept Chem Phys & Appl Math, Stony Brook, NY 11794 USA.	jin.wang.1@stonybrook.edu		Yu, Chong/0000-0003-1289-8578	Natural Science Foundation of China (NSFC) [91430217]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work is supported by Natural Science Foundation of China (NSFC Grant No. 91430217).	Al-Mulla F, 2005, J HISTOCHEM CYTOCHEM, V53, P621, DOI 10.1369/jhc.4A6544.2005; Amar D, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002955; [Anonymous], 2012, MORTALITY STAT; [Anonymous], 2010, INTRO CANC BIOL; Ao P, 2008, MED HYPOTHESES, V70, P678, DOI 10.1016/j.mehy.2007.03.043; Blagosklonny MV, 2000, J CLIN INVEST, V105, P533, DOI 10.1172/JCI8625; Brekman A, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3130; Burga LN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2850; Chen GC, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003666; Chou WW, 2009, J CELL BIOCHEM, V107, P408, DOI 10.1002/jcb.22137; Dang CV, 2012, GENE DEV, V26, P877, DOI 10.1101/gad.189365.112; Das KC, 2004, AM J PHYSIOL-LUNG C, V286, pL87, DOI 10.1152/ajplung.00203.2002; Deisenroth Chad, 2011, Genes Cancer, V2, P392, DOI 10.1177/1947601911409737; Flobak A, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004426; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; Garner E, 2007, CANCER RES, V67, P7631, DOI 10.1158/0008-5472.CAN-07-0334; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Huang S, 2009, SEMIN CELL DEV BIOL, V20, P869, DOI 10.1016/j.semcdb.2009.07.003; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Khosravi R, 1999, P NATL ACAD SCI USA, V96, P14973, DOI 10.1073/pnas.96.26.14973; Li CH, 2015, CANCER RES, V75, P2607, DOI 10.1158/0008-5472.CAN-15-0079; Li CH, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0774; Li CH, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003165; Lin WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068578; Loboda A, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-26; Loeb KR, 2000, CARCINOGENESIS, V21, P379, DOI 10.1093/carcin/21.3.379; Molina MA, 2001, CANCER RES, V61, P4744; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Papanikolaou V, 2009, INT J ONCOL, V35, P1141, DOI 10.3892/ijo_00000430; Parikh AP, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003713; PIERCE GB, 1971, CANCER RES, V31, P127; Reznik E, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004176; Sasai M, 2003, P NATL ACAD SCI USA, V100, P2374, DOI 10.1073/pnas.2627987100; Scata KA, 2007, ADV EXP MED BIOL, V608, P70; Smith J, 2010, ADV CANCER RES, V108, P73, DOI 10.1016/S0065.230X(10)08002.4; Storey KB, 2004, BIOL REV, V79, P207, DOI 10.1017/S1464793103006195; Walerych D, 2012, CARCINOGENESIS, V33, P2007, DOI 10.1093/carcin/bgs232; Wang H, 2001, CLIN CANCER RES, V7, P3613; Wang J, 2008, P NATL ACAD SCI USA, V105, P12271, DOI 10.1073/pnas.0800579105; Wang J, 2011, P NATL ACAD SCI USA, V108, P8257, DOI 10.1073/pnas.1017017108; Wang J, 2010, P NATL ACAD SCI USA, V107, P8195, DOI 10.1073/pnas.0910331107; Welcsh PL, 2001, HUM MOL GENET, V10, P705, DOI 10.1093/hmg/10.7.705; Xia WY, 2004, CLIN CANCER RES, V10, P3815, DOI 10.1158/1078-0432.CCR-03-0527	44	12	13	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0157422	10.1371/journal.pone.0157422	http://dx.doi.org/10.1371/journal.pone.0157422			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410227	Green Submitted, Green Published, gold			2022-12-27	WOS:000379508300009
J	Wesolowski, CA; Wesolowski, MJ; Babyn, PS; Wanasundara, SN				Wesolowski, Carl A.; Wesolowski, Michal J.; Babyn, Paul S.; Wanasundara, Surajith N.			Time Varying Apparent Volume of Distribution and Drug Half-Lives Following Intravenous Bolus Injections	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; PLASMA-CLEARANCE	We present a model that generalizes the apparent volume of distribution and half-life as functions of time following intravenous bolus injection. This generalized model defines a time varying apparent volume of drug distribution. The half-lives of drug remaining in the body vary in time and become longer as time elapses, eventually converging to the terminal half-life. Two example fit models were substituted into the general model: biexponential models from the least relative concentration error, and gamma variate models using adaptive regularization for least relative error of clearance. Using adult population parameters from 41 studies of the renal glomerular filtration marker Yb-169-DTPA, simulations of extracellular fluid volumes of 5, 10, 15 and 20 litres and plasma clearances of 40 and 100 ml/min were obtained. Of these models, the adaptively obtained gamma variate models had longer times to 95% of terminal volume and longer half-lives.	[Wesolowski, Carl A.; Wesolowski, Michal J.; Babyn, Paul S.; Wanasundara, Surajith N.] Univ Saskatchewan, Coll Med, Dept Med Imaging, Saskatoon, SK, Canada; [Wesolowski, Carl A.] Mem Univ Newfoundland, Dept Radiol, St John, NF, Canada	University of Saskatchewan; Memorial University Newfoundland	Wesolowski, CA (corresponding author), Univ Saskatchewan, Coll Med, Dept Med Imaging, Saskatoon, SK, Canada.; Wesolowski, CA (corresponding author), Mem Univ Newfoundland, Dept Radiol, St John, NF, Canada.	carl.wesolowski@usask.ca	Wesolowski, Carl A/C-1317-2010	Wesolowski, Carl A/0000-0003-0134-9346; Wanasundara, Surajith/0000-0003-0939-1039	Sylvia Fedoruk Canadian Centre for Nuclear Innovation [J2012-114]; College of Medicine of the University of Saskatchewan	Sylvia Fedoruk Canadian Centre for Nuclear Innovation; College of Medicine of the University of Saskatchewan	This work was supported by the Sylvia Fedoruk Canadian Centre for Nuclear Innovation (grant no. J2012-114), http://www.fedorukcentre.ca/, and the College of Medicine of the University of Saskatchewan, https://www.usask.ca/. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to express their gratitude to Dr. Charles D. Russell for making the patient data available. The authors express their gratitude especially to Dr. Richard C. Puetter and to Dr. Jane Alcorn for their contributions to previous submissions of this work. This work was supported by the Sylvia Fedoruk Canadian Centre for Nuclear Innovation (grant no. J2012-114) and the College of Medicine of the University of Saskatchewan. There was no additional external funding received for this study.	Becker R, 1991, Eur J Drug Metab Pharmacokinet, VSpec No 3, P15; BENET LZ, 1979, J PHARM SCI, V68, P1071, DOI 10.1002/jps.2600680845; Berezhkovskiy LM, 2007, J PHARM SCI-US, V96, P1638, DOI 10.1002/jps.20804; BROCHNERMORTENSEN J, 1981, SCAND J CLIN LAB INV, V41, P91, DOI 10.3109/00365518109092020; COLBURN WA, 1983, J PHARMACOKINET BIOP, V11, P389, DOI 10.1007/BF01058957; FLORIJN KW, 1994, KIDNEY INT, V46, P252, DOI 10.1038/ki.1994.267; Heiene RD, 1998, J VET INTERN MED, V12, P401, DOI 10.1111/j.1939-1676.1998.tb02143.x; NIAZI S, 1976, J PHARM SCI, V65, P452, DOI 10.1002/jps.2600650339; Orlando R, 1998, BRIT J CLIN PHARMACO, V46, P605; Perkinson AS, 2010, PHYSIOL MEAS, V31, P183, DOI 10.1088/0967-3334/31/2/005; RUSSELL CD, 1985, J NUCL MED, V26, P1243; Smith DA, 2015, J MED CHEM, V58, P5691, DOI 10.1021/acs.jmedchem.5b00201; Toutain PL, 2004, J VET PHARMACOL THER, V27, P441, DOI 10.1111/j.1365-2885.2004.00602.x; Toutain PL, 2004, J VET PHARMACOL THER, V27, P415, DOI 10.1111/j.1365-2885.2004.00605.x; Wada DR, 1998, CLIN PHARMACOKINET, V35, P1, DOI 10.2165/00003088-199835010-00001; Wanasundara SN, 2016, NUCL MED COMMUN, V37, P79, DOI 10.1097/MNM.0000000000000405; Wanasundara SN, 2015, NUCL MED COMMUN, V36, P392, DOI 10.1097/MNM.0000000000000255; Wesolowski CA, 2010, J NUCL MED S2, V51; Wesolowski CA, 2010, J PHARMACOKINET PHAR, V37, P435, DOI 10.1007/s10928-010-9167-z; Wesolowski CA, 2011, EUR J NUCL MED MOL I, V38, P2247, DOI 10.1007/s00259-011-1887-9; ZIERLER K, 1981, ANNU REV BIOPHYS BIO, V10, P531, DOI 10.1146/annurev.bb.10.060181.002531	21	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0158798	10.1371/journal.pone.0158798	http://dx.doi.org/10.1371/journal.pone.0158798			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27403663	gold, Green Published, Green Submitted			2022-12-27	WOS:000379508200016
J	Szirovicza, L; Lopez, P; Kopena, R; Benko, M; Martin, J; Penzes, JJ				Szirovicza, Leonora; Lopez, Pilar; Kopena, Renata; Benko, Maria; Martin, Jose; Penzes, Judit J.			Random Sampling of Squamate Reptiles in Spanish Natural Reserves Reveals the Presence of Novel Adenoviruses in Lacertids (Family Lacertidae) and Worm Lizards (Amphisbaenia)	PLOS ONE			English	Article							DRAGONS POGONA-VITTICEPS; ADENO-LIKE VIRUS; INFECTION; EVOLUTION; ANTIBODIES; HEPATITIS; SEQUENCE; GENUS; PCR; DNA	Here, we report the results of a large-scale PCR survey on the prevalence and diversity of adenoviruses (AdVs) in samples collected randomly from free-living reptiles. On the territories of the Guadarrama Mountains National Park in Central Spain and of the Chafarinas Islands in North Africa, cloacal swabs were taken from 318 specimens of eight native species representing five squamate reptilian families. The healthy-looking animals had been captured temporarily for physiological and ethological examinations, after which they were released. We found 22 AdV-positive samples in representatives of three species, all from Central Spain. Sequence analysis of the PCR products revealed the existence of three hitherto unknown AdVs in 11 Carpetane rock lizards (Iberolacerta cyreni), nine Iberian worm lizards (Blanus cinereus), and two Iberian green lizards (Lacerta schreiberi), respectively. Phylogeny inference showed every novel putative virus to be a member of the genus Atadenovirus. This is the very first description of the occurrence of AdVs in amphisbaenian and lacertid hosts. Unlike all squamate atadenoviruses examined previously, two of the novel putative AdVs had A+T rich DNA, a feature generally deemed to mirror previous host switch events. Our results shed new light on the diversity and evolution of atadenoviruses.	[Szirovicza, Leonora; Benko, Maria; Penzes, Judit J.] Hungarian Acad Sci, Agr Res Ctr, Vet Med Res Inst, 21 Hungaria Krt, H-1143 Budapest, Hungary; [Lopez, Pilar; Kopena, Renata; Martin, Jose] CSIC, Museo Nacl Ciencias Nat, Dept Ecol Evolut, Jose Gutierrez Abascal 2, E-28006 Madrid, Spain	Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Hungarian Veterinary Medical Research Institute; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Penzes, JJ (corresponding author), Hungarian Acad Sci, Agr Res Ctr, Vet Med Res Inst, 21 Hungaria Krt, H-1143 Budapest, Hungary.	Judit.Penzes@iaf.inrs.ca	Lopez, Pilar/K-6221-2014; BENKO, Maria/A-4135-2008; Kopena, Renata/AAG-4392-2020; Martin, Jose/B-1073-2014	Lopez, Pilar/0000-0001-6577-1509; Martin, Jose/0000-0001-6648-3998; Kopena, Renata/0000-0001-7850-6472; Szirovicza, Leonora/0000-0003-1528-044X	Hungarian Scientific Research Fund (OTKA) [K100163];  [MICIIN-CGL2011-24150/BOS];  [MINECO-CGL2014-53523-P]	Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); ; 	The authors gratefully acknowledge the financial support provided by the Hungarian Scientific Research Fund (OTKA grant K100163) and by the projects MICIIN-CGL2011-24150/BOS and MINECO CGL2014-53523-P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Abbas MD, 2011, VET MICROBIOL, V150, P70, DOI 10.1016/j.vetmic.2011.01.010; Aderem A, 2000, CELL, V103, P993, DOI 10.1016/S0092-8674(00)00201-4; Ambinder RF, 1999, SEMIN CANCER BIOL, V9, P369, DOI 10.1006/scbi.1999.0137; Amo L, 2004, PARASITOL RES, V94, P290, DOI 10.1007/s00436-004-1212-7; Ascher JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060977; Ball I, 2014, VET J, V202, P176, DOI 10.1016/j.tvjl.2014.07.027; Ball I, 2014, J ZOO WILDLIFE MED, V45, P287, DOI 10.1638/2013-0143.1; Ball Inna, 2012, Journal of Herpetological Medicine and Surgery, V22, P12, DOI 10.5818/1529-9651-22.1-2.12; Behncke H, 2013, VET REC, V173, P248, DOI 10.1136/vr.101545; Benko M, 2003, CURR TOP MICROBIOL, V272, P3; Benko M, 2002, J VIROL, V76, P10056, DOI 10.1128/JVI.76.19.10056-10059.2002; Benko M, 1998, ARCH VIROL, V143, P829, DOI 10.1007/s007050050335; Benko M., 2011, SPRINGER INDEX VIRUS, P29; Dan A, 2003, ACTA VET HUNG, V51, P551, DOI 10.1556/AVet.51.2003.4.13; Davison AJ, 2003, J GEN VIROL, V84, P2895, DOI 10.1099/vir.0.19497-0; Davison AJ, 2000, J GEN VIROL, V81, P2431, DOI 10.1099/0022-1317-81-10-2431; Doszpoly A, 2013, INFECT GENET EVOL, V17, P106, DOI 10.1016/j.meegid.2013.03.049; Farkas SL, 2008, MAGYAR ALLATORVOSOK, V130, P775; Farkas SL, 2008, VIRUS RES, V132, P132, DOI 10.1016/j.virusres.2007.11.009; Flajnik MF, 2000, CURR TOP MICROBIOL, V252, P233; FRYE FL, 1994, J ZOO WILDLIFE MED, V25, P167; Harrach B, 2000, ACTA VET HUNG, V48, P485, DOI 10.1556/004.48.2000.4.11; Harrach B., 2012, VIRUS TAXONOMY, P125, DOI DOI 10.1016/8978-0-12-384684-6.00009-4; HELDSTAB A, 1984, J ZOO ANIM MED, V15, P118, DOI 10.2307/20094703; Hess M, 1997, VIROLOGY, V238, P145, DOI 10.1006/viro.1997.8815; Hyndman T, 2011, AUST VET J, V89, P232, DOI 10.1111/j.1751-0813.2011.00712.x; JACOBSON ER, 1985, J AM VET MED ASSOC, V187, P1226; JACOBSON ER, 1986, J ZOO WILDLIFE MED, V17, P149, DOI 10.2307/20094810; JACOBSON ER, 1990, VET PATHOL, V27, P210, DOI 10.1177/030098589002700313; Judit P, 2011, MAGY ALLATORVOSOK, V133, P432; JUHASZ A, 1993, ARCH VIROL, V130, P429, DOI 10.1007/BF01309671; JULIAN AF, 1982, NEW ZEAL VET J, V30, P59, DOI 10.1080/00480169.1982.34880; Kinsel MJ, 1997, J ZOO WILDLIFE MED, V28, P498; Kovacs ER, 2010, J VIROL METHODS, V163, P262, DOI 10.1016/j.jviromet.2009.10.007; Krieg AM, 2003, SCAND J INFECT DIS, V35, P653, DOI 10.1080/00365540310015999; Kubiak M, 2013, VET REC, V172, P475, DOI 10.1136/vr.101087; Kubber-Heiss A, 2006, WIEN TIERARZTL MONAT, V93, P68; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Madsen T, 2007, EVOL ECOL, V21, P271, DOI 10.1007/s10682-006-9004-4; Mahapatra D, 2013, J ZOO WILDLIFE MED, V44, P220, DOI 10.1638/1042-7260-44.1.220; Marschang RE, 2011, VIRUSES-BASEL, V3, P2087, DOI 10.3390/v3112087; Marschang RE, 2003, P 6 INT C VET VIR VI, P152; OGAWA M, 1992, J VET MED B, V39, P732, DOI 10.1111/j.1439-0450.1992.tb01228.x; Papp T, 2009, VET MICROBIOL, V134, P233, DOI 10.1016/j.vetmic.2008.08.003; Parkin DB, 2009, INFECT GENET EVOL, V9, P501, DOI 10.1016/j.meegid.2009.01.010; Penzes JJ, 2015, J GEN VIROL, V96, P2769, DOI 10.1099/vir.0.000215; Penzes JJ, 2014, J VIROL, V88, P11304, DOI 10.1128/JVI.00306-14; Penzes JJ, 2014, ACTA VET HUNG, V62, P284, DOI 10.1556/AVet.2014.010; Perkins LEL, 2001, J VET DIAGN INVEST, V13, P365, DOI 10.1177/104063870101300418; Poss M, 2006, J VIROL, V80, P2728, DOI 10.1128/JVI.80.6.2728-2737.2006; Ramis A, 2000, J VET DIAGN INVEST, V12, P573, DOI 10.1177/104063870001200616; Raymond JT, 2003, J WILDLIFE DIS, V39, P431, DOI 10.7589/0090-3558-39.2.431; Rivera S, 2009, J VET DIAGN INVEST, V21, P415, DOI 10.1177/104063870902100402; SCHUMACHER J, 1994, J ZOO WILDLIFE MED, V25, P461; Shackelton LA, 2005, P NATL ACAD SCI USA, V102, P379, DOI 10.1073/pnas.0406765102; Staden R, 2000, Methods Mol Biol, V132, P115; Wellehan JFX, 2004, J VIROL, V78, P13366, DOI 10.1128/JVI.78.23.13366-13369.2004; Wozniak E. J., 2000, Journal of Herpetological Medicine and Surgery, V10, P4	59	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2016	11	7							e0159016	10.1371/journal.pone.0159016	http://dx.doi.org/10.1371/journal.pone.0159016			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CN	27399970	gold, Green Submitted, Green Published			2022-12-27	WOS:000379508100014
J	Larson, BA; Rockers, PC; Bonawitz, R; Sriruttan, C; Glencross, DK; Cassim, N; Coetzee, LM; Greene, GS; Chiller, TM; Vallabhaneni, S; Long, L; van Rensburg, C; Govender, NP				Larson, Bruce A.; Rockers, Peter C.; Bonawitz, Rachael; Sriruttan, Charlotte; Glencross, Deborah K.; Cassim, Naseem; Coetzee, Lindi M.; Greene, Gregory S.; Chiller, Tom M.; Vallabhaneni, Snigdha; Long, Lawrence; van Rensburg, Craig; Govender, Nelesh P.			Screening HIV-Infected Patients with Low CD4 Counts for Cryptococcal Antigenemia prior to Initiation of Antiretroviral Therapy: Cost Effectiveness of Alternative Screening Strategies in South Africa	PLOS ONE			English	Article							MORTALITY; CARE	Background In 2015 South Africa established a national cryptococcal antigenemia (CrAg) screening policy targeted at HIV-infected patients with CD4+ T-lymphocyte (CD4) counts <100 cells/mu l who are not yet on antiretroviral treatment (ART). Two screening strategies are included in national guidelines: reflex screening, where a CrAg test is performed on remnant blood samples from CD4 testing; and provider-initiated screening, where providers order a CrAg test after a patient returns for CD4 test results. The objective of this study was to compare costs and effectiveness of these two screening strategies. Methods We developed a decision analytic model to compare reflex and provider-initiated screening in terms of programmatic and health outcomes (number screened, number identified for preemptive treatment, lives saved, and discounted years of life saved) and screening and treatment costs (2015 USD). We estimated a base case with prevalence and other parameters based on data collected during CrAg screening pilot projects integrated into routine HIV care in Gauteng, Free State, and Western Cape Provinces. We conducted sensitivity analyses to explore how results change with underlying parameter assumptions. Results In the base case, for each 100,000 CD4 tests, the reflex strategy compared to the provider-initiated strategy has higher screening costs ($37,536 higher) but lower treatment costs ($55,165 lower), so overall costs of screening and treatment are $17,629 less with the reflex strategy. The reflex strategy saves more lives (30 lives, 647 additional years of life saved). Sensitivity analyses suggest that reflex screening dominates provider-initiated screening ( lower total costs and more lives saved) or saves additional lives for small additional costs (<$125 per life year) across a wide range of conditions (CrAg prevalence, patient and provider behavior, patient survival without treatment, and effectiveness of preemptive fluconazole treatment). Conclusions In countries with substantial numbers of people with untreated, advanced HIV disease such as South Africa, CrAg screening before initiation of ART has the potential to reduce cryptococcal meningitis and save lives. Reflex screening compared to provider-initiated screening saves more lives and is likely to be cost saving or have low additional costs per additional year of life saved.	[Larson, Bruce A.; Rockers, Peter C.; Bonawitz, Rachael] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA USA; [Sriruttan, Charlotte; Govender, Nelesh P.] Natl Inst Communicable Dis, Ctr Opportunist Trop & Hosp Infect, Johannesburg, South Africa; [Glencross, Deborah K.; Cassim, Naseem; Coetzee, Lindi M.] Natl Hlth Lab Serv, Johannesburg, South Africa; [Glencross, Deborah K.; Cassim, Naseem; Coetzee, Lindi M.; Long, Lawrence; van Rensburg, Craig; Govender, Nelesh P.] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa; [Long, Lawrence; van Rensburg, Craig] Wits Hlth Consortium, Hlth Econ & Epidemiol Off, Johannesburg, South Africa; [Greene, Gregory S.; Chiller, Tom M.; Vallabhaneni, Snigdha] Ctr Dis Control & Prevent, Mycot Dis Branch, Atlanta, GA USA; [Bonawitz, Rachael] Boston Univ, Sch Med, Dept Pediat, Boston, MA 02118 USA	Boston University; National Institute for Communicable Diseases (NICD); National Health Laboratory Service; University of Witwatersrand; University of Witwatersrand; Centers for Disease Control & Prevention - USA; Boston University	Larson, BA (corresponding author), Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA USA.	blarson@bu.edu	Govender, Nelesh/ABI-6429-2020; Cassim, Naseem/GLR-4911-2022; Cassim, Naseem/AFU-5522-2022	Cassim, Naseem/0000-0003-4389-2849; Cassim, Naseem/0000-0003-4389-2849; Larson, Bruce/0000-0002-9322-2387; Govender, Nelesh/0000-0001-7869-9462; Glencross, Deborah/0000-0001-7106-769X; Long, Lawrence/0000-0003-4986-4988	CDC Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118511] Funding Source: NIH RePORTER	CDC Foundation(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Boston University School of Public received a grant from the CDC Foundation, which provided support to BU and HE2RO related authors for completing this analysis. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binnicker MJ, 2012, CLIN VACCINE IMMUNOL, V19, P1988, DOI 10.1128/CVI.00446-12; Castelnuovo B, 2009, CLIN INFECT DIS, V49, P965, DOI 10.1086/605500; Fox MP, 2012, TROP MED INT HEALTH, V17, P1235, DOI 10.1111/j.1365-3156.2012.03055.x; French N, 2002, AIDS, V16, P1031, DOI 10.1097/00002030-200205030-00009; Glencross DK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114727; Govender NP, 2015, HIV MED, V16, P468, DOI 10.1111/hiv.12245; Govender NP, 2014, SAMJ S AFR MED J, V104, P896, DOI 10.7196/SAMJ.9070; Govender NP, PHASED IMPLEMENTATIO; Jarvis JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069288; Jarvis JN, 2009, CLIN INFECT DIS, V48, P856, DOI 10.1086/597262; Kaplan JE, 2015, JAIDS-J ACQ IMM DEF, V68, pS331, DOI 10.1097/QAI.0000000000000484; Kapoor SW, 2015, AIDS, V29, P2473, DOI 10.1097/QAD.0000000000000872; Larson BA, 2013, AIDS RES TREAT, V2013, DOI 10.1155/2013/941493; Larson Bruce A, 2013, Cost Eff Resour Alloc, V11, P18, DOI 10.1186/1478-7547-11-18; Larson BA, 2010, B WORLD HEALTH ORGAN, V88, P675, DOI 10.2471/BLT.09.068981; Larson BA, 2010, TROP MED INT HEALTH, V15, P43, DOI 10.1111/j.1365-3156.2010.02511.x; Liechty CA, 2007, TROP MED INT HEALTH, V12, P929, DOI 10.1111/j.1365-3156.2007.01874.x; Mathers CD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P45; Meiring ST, 2012, AIDS, V26, P2307, DOI 10.1097/QAD.0b013e3283570567; Meya David, 2015, Curr Trop Med Rep, V2, P81; Meya DB, 2010, CLIN INFECT DIS, V51, P448, DOI 10.1086/655143; Micol R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013856; National Institute of Communicable Diseases, 2015, MONTHL SURV REP 1 JA; National Institute of Communicable Diseases National Health Laboratory Service, 2014, GERMS SA ANN REP 201; Rajasingham R, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001316; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Smith RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062213; South African National Department of Health, 2018, GUIDELINES IMPLEMENT; Vallabhaneni S, 2016, N LONGL SESS TITL CR; Wake RM, 2016, AIDS, V30, P339, DOI 10.1097/QAD.0000000000000967	30	25	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158986	10.1371/journal.pone.0158986	http://dx.doi.org/10.1371/journal.pone.0158986			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27390864	Green Submitted, Green Published, gold			2022-12-27	WOS:000380005400181
J	Lim, I; Jung, Y; Kim, DY; Kim, KT				Lim, Ilgye; Jung, Youngseob; Kim, Do-Yeon; Kim, Kyong-Tai			HnRNP Q Has a Suppressive Role in the Translation of Mouse Cryptochrome1	PLOS ONE			English	Article							MAMMALIAN CIRCADIAN CLOCK; RNA-BINDING PROTEINS; MESSENGER-RNA; SUPRACHIASMATIC NUCLEUS; DEPENDENT TRANSLATION; FEEDBACK LOOPS; DEGRADATION; CRY; OSCILLATION; RHYTHMS	Precise regulation of gene expression is especially important for circadian timekeeping which is maintained by the proper oscillation of the mRNA and protein of clock genes and clock-controlled genes. As a main component of the core negative arm feedback loops in the circadian clock, the Cry1 gene contributes to the maintenance of behavioral and molecular rhythmicity. Despite the central role of Cry1, the molecular mechanisms regulating expression levels of Cry1 mRNA and protein are not well defined. In particular, the post-transcriptional regulation of Cry1 mRNA fate decisions is unclear. Here, we demonstrate that hnRNP Q binds to mCry1 mRNA via the 5'UTR. Furthermore, hnRNP Q inhibits the translation of mCry1 mRNA, leading to altered rhythmicity in the mCRY1 protein profile.	[Lim, Ilgye; Kim, Kyong-Tai] Pohang Univ Sci & Technol POSTECH, Dept Life Sci, Pohang, Gyeongbuk, South Korea; [Lim, Ilgye] CHA Univ, Sch Med, Seongnam, South Korea; [Jung, Youngseob; Kim, Kyong-Tai] Pohang Univ Sci & Technol POSTECH, Div Integrat Biosci & Biotechnol, Pohang, Gyeongbuk, South Korea; [Kim, Do-Yeon] Kyungpook Natl Univ, Brain Sci & Engn Inst, Sch Dent, Dept Pharmacol, Daegu, South Korea	Pohang University of Science & Technology (POSTECH); Pochon Cha University; Pohang University of Science & Technology (POSTECH); Kyungpook National University	Kim, KT (corresponding author), Pohang Univ Sci & Technol POSTECH, Dept Life Sci, Pohang, Gyeongbuk, South Korea.; Kim, KT (corresponding author), Pohang Univ Sci & Technol POSTECH, Div Integrat Biosci & Biotechnol, Pohang, Gyeongbuk, South Korea.; Kim, DY (corresponding author), Kyungpook Natl Univ, Brain Sci & Engn Inst, Sch Dent, Dept Pharmacol, Daegu, South Korea.	dykim82@knu.ac.kr; ktk@postech.ac.kr		KIM, KYONG-TAI/0000-0001-7292-2627	"Cooperative Research Program for Agriculture Science & Technology Development" from Rural Development Administration [PJ01121602]; BK21 Plus - Ministry of Education [10Z20130012243]; POSCO (AP-TP, Green science), Korea	"Cooperative Research Program for Agriculture Science & Technology Development" from Rural Development Administration; BK21 Plus - Ministry of Education; POSCO (AP-TP, Green science), Korea	This work was carried out with the support of the "Cooperative Research Program for Agriculture Science & Technology Development (Project No. PJ01121602)" from Rural Development Administration, BK21 Plus funded by the Ministry of Education [10Z20130012243], and POSCO (AP-TP, Green science), Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand SN, 2013, J NEUROSCI, V33, P7145, DOI 10.1523/JNEUROSCI.4950-12.2013; Barinaga M, 2000, SCIENCE, V288, P943; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Doi M, 2010, NAT MED, V16, P67, DOI 10.1038/nm.2061; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Gerstberger S, 2014, NAT REV GENET, V15, P829, DOI 10.1038/nrg3813; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Guo HW, 1998, SCIENCE, V279, P1360, DOI 10.1126/science.279.5355.1360; Hashiramoto A, 2010, J IMMUNOL, V184, P1560, DOI 10.4049/jimmunol.0903284; Hirano A, 2013, CELL, V152, P1106, DOI 10.1016/j.cell.2013.01.054; Hirota T, 2012, SCIENCE, V337, P1094, DOI 10.1126/science.1223710; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Kim DY, 2011, NUCLEIC ACIDS RES, V39, P8901, DOI 10.1093/nar/gkr605; Kim DY, 2010, NUCLEIC ACIDS RES, V38, P7068, DOI 10.1093/nar/gkq569; Kim JH, 2003, MOL CELL BIOL, V23, P708, DOI 10.1128/MCB.23.2.708-720.2003; Kim TD, 2007, GENE DEV, V21, P797, DOI 10.1101/gad.1519507; Kim TD, 2005, MOL CELL BIOL, V25, P3232, DOI 10.1128/MCB.25.8.3232-3246.2005; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Lee KH, 2014, NUCLEIC ACIDS RES, V42, P3590, DOI 10.1093/nar/gkt1379; Lee KH, 2012, MOL CELL BIOL, V32, P717, DOI 10.1128/MCB.06177-11; Miyamoto Y, 1998, P NATL ACAD SCI USA, V95, P6097, DOI 10.1073/pnas.95.11.6097; Narasimamurthy R, 2012, P NATL ACAD SCI USA, V109, P12662, DOI 10.1073/pnas.1209965109; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; Ono D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2670; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Paz I, 2014, NUCLEIC ACIDS RES, V42, pW361, DOI 10.1093/nar/gku406; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Schmalen I, 2014, CELL, V157, P1203, DOI 10.1016/j.cell.2014.03.057; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Shi GS, 2013, P NATL ACAD SCI USA, V110, P4750, DOI 10.1073/pnas.1302560110; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Thresher RJ, 1998, SCIENCE, V282, P1490, DOI 10.1126/science.282.5393.1490; Woo KC, 2010, MOL CELL BIOL, V30, P197, DOI 10.1128/MCB.01154-09; Xing WM, 2013, NATURE, V496, P64, DOI 10.1038/nature11964; Xu H., 2015, BIOMED RES INT, V2015, P1, DOI DOI 10.1016/J.CECA.2015.02.006; Yoo SH, 2013, CELL, V152, P1091, DOI 10.1016/j.cell.2013.01.055; Zhang EE, 2010, NAT MED, V16, P1152, DOI 10.1038/nm.2214	41	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159018	10.1371/journal.pone.0159018	http://dx.doi.org/10.1371/journal.pone.0159018			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27392095	Green Published, gold, Green Submitted			2022-12-27	WOS:000380005400193
J	Rebelo, F; Franco-Sena, AB; Struchiner, CJ; Kac, G				Rebelo, Fernanda; Franco-Sena, Ana Beatriz; Struchiner, Claudio Jose; Kac, Gilberto			Changes in Maternal Plasma Adiponectin from Late Pregnancy to the Postpartum Period According to the Mode of Delivery: Results from a Prospective Cohort in Rio de Janeiro, Brazil	PLOS ONE			English	Article							C-REACTIVE PROTEIN; TYPE-2 DIABETIC-PATIENTS; HUMAN-MILK ADIPONECTIN; SERUM ADIPONECTIN; WOMEN; WEIGHT; INSULIN; ASSOCIATIONS; POPULATION; ADIPOCYTES	Introduction Maternal plasma adiponectin is inversely related to insulin resistance, atherosclerosis and child health. However, little is known about its concentrations in the perinatal period, especially according to mode of delivery. Our aim is to evaluate the association between mode of delivery and changes in maternal plasma adiponectin from 3rd trimester of pregnancy to 30-45 days postpartum. Methods A cohort was recruited in Rio de Janeiro, Brazil, with four waves of follow-up: 5-13th, 22-26th, 30-36th gestational weeks and 30-45 days postpartum. Eligible subjects should be between 20-40 years of age, be free of chronic and infectious diseases and presenting with a singleton pregnancy. The mode of delivery was classified as vaginal (VD) or cesarean (CS). Plasma adiponectin concentration (mu g/mL) was measured using commercial ELISA kits. Statistical analyses included the Wilcoxon rank-sum test and the multiple linear mixed effects model. Results A total of 159 participated in the study. Median adiponectin concentrations were higher for the VD group (n = 99; 8.25, IQR: 5.85-11.90) than for the CS group (n = 60; 7.34, IQR: 4.36-9.76; p = 0.040) in the postpartum samples but were not different between the two groups in the 3rd trimester. Women who underwent CS had a lower rate of increase in adiponectin concentration from the 3rd trimester to 30-45 days postpartum compared to those who underwent VD (beta = -.15, 95% CI: -.28-.02, p = 0.030). Conclusion The CS procedure was associated with lower maternal circulating concentrations of adiponectin at 30-45 days postpartum, compared to the VD.	[Rebelo, Fernanda; Struchiner, Claudio Jose] Fundacao Oswaldo Cruz, Natl Sch Publ Hlth, Rio De Janeiro, RJ, Brazil; [Rebelo, Fernanda; Franco-Sena, Ana Beatriz; Kac, Gilberto] Univ Fed Rio de Janeiro, Inst Nutr Josue de Castro, Dept Social & Appl Nutr, Nutr Epidemiol Observ, Rio De Janeiro, RJ, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro	Kac, G (corresponding author), Univ Fed Rio de Janeiro, Inst Nutr Josue de Castro, Dept Social & Appl Nutr, Nutr Epidemiol Observ, Rio De Janeiro, RJ, Brazil.	gilberto.kac@gmail.com	Rebelo, Fernanda/AAN-5125-2020; Struchiner, Claudio Jose/HGB-9492-2022; Kac, Gilberto/H-6862-2012; Struchiner, Claudio J/M-9360-2013	Kac, Gilberto/0000-0001-8603-9077; Struchiner, Claudio J/0000-0003-2114-847X; Rebelo, Fernanda/0000-0001-6207-5161	National Council for Scientific and Technological Development (CNPq) [471196/2010-0, 304182/2013-3]; Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State (FAPERJ) [E-26/111.400/2010, E-26/110.681/2012, E-26/112.181/2012, E-26/111.698/2013]; National School of Public Health; Brazilian Coordination for the Training of University Level Personnel (CAPES in the Portuguese acronym); CAPES; CNPq	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); National School of Public Health; Brazilian Coordination for the Training of University Level Personnel (CAPES in the Portuguese acronym)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding for this study was provided by the National Council for Scientific and Technological Development (CNPq, grant numbers: 471196/2010-0, 304182/2013-3) and the Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State (FAPERJ, grant numbers: E-26/111.400/2010, E-26/110.681/2012, E-26/112.181/2012, E-26/111.698/2013). These agencies had no roles in the study design; collection, analysis and interpretation of the data; writing of the paper; or the decision to submit the paper for publication. FR received scholarships from the National School of Public Health and Brazilian Coordination for the Training of University Level Personnel (CAPES in the Portuguese acronym). ABFS received a scholarship from the CAPES. GK and CJS received scholarships from CNPq.; We would like to thank the funding agencies that have made possible the realization of this study. FR received scholarships from the National School of Public Health and Brazilian Coordination for the Training of University Level Personnel (CAPES in the Portuguese acronym). ABFS received a scholarship from the CAPES. GK and CJS received scholarships from CNPq. The authors have no conflicts of interest to report. We also thank Professor Michelle A. Williams and the Global Research and Training in Non-Communicable Diseases and Perinatal Epidemiology Group (Harvard T. H. Chan School of Public Health, Boston/MA) for the ideas and contributions that they provided for the improvement of the article.	Andreasson AN, 2012, AM J HUM BIOL, V24, P595, DOI 10.1002/ajhb.22279; Asai-Sato M, 2006, ENDOCR J, V53, P555, DOI 10.1507/endocrj.K06-026; Asayama K, 2003, OBES RES, V11, P1072, DOI 10.1038/oby.2003.147; Aso Y, 2006, DIABETES, V55, P1954, DOI 10.2337/db05-1525; Bowen JM, 2002, PLACENTA, V23, P257, DOI 10.1053/plac.2001.0782; Brown S, 1998, BRIT J OBSTET GYNAEC, V105, P156, DOI 10.1111/j.1471-0528.1998.tb10045.x; Catalano PM, 2006, DIABETOLOGIA, V49, P1677, DOI 10.1007/s00125-006-0264-x; Childbirth Connection, 2012, VAG CES BIRTH WHAT I; Cicarelli LM, 2005, MEDIAT INFLAMM, P96, DOI 10.1155/MI.2005.96; Eriksson B, 2010, BRIT J NUTR, V103, P50, DOI 10.1017/S0007114509991371; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; KAAPA P, 1993, ACTA OBSTET GYN SCAN, V72, P543, DOI 10.3109/00016349309058160; Kew S, 2014, DIABETES CARE, V37, P1998, DOI 10.2337/dc14-0087; Kishida K, 2014, BEST PRACT RES CL EN, V28, P119, DOI 10.1016/j.beem.2013.08.006; Ley SH, 2012, AM J CLIN NUTR, V95, P867, DOI 10.3945/ajcn.111.028431; Matyjaszek-Matuszek B, 2014, ANN AGR ENV MED, V21, P850, DOI 10.5604/12321966.1129945; Mazaki-Tovi S, 2011, GYNECOL ENDOCRINOL, V27, P725, DOI 10.3109/09513590.2010.500426; Merl V, 2005, INT J OBESITY, V29, P998, DOI 10.1038/sj.ijo.0802971; Mutlu B, 2011, J MATERN-FETAL NEO M, V24, P1367, DOI 10.3109/14767058.2010.548883; Newburg DS, 2010, J PEDIATR-US, V156, pS41, DOI 10.1016/j.jpeds.2009.11.020; *NIH, 2006, NIH STAT OF THE SCI, P1; Ouchi N, 2003, CIRCULATION, V107, P671, DOI 10.1161/01.CIR.0000055188.83694.B3; Ozarda Y, 2012, CLIN CHEM LAB MED, V50, P911, DOI 10.1515/cclm-2011-0724; Retnakaran R, 2007, DIABETIC MED, V24, P245, DOI 10.1111/j.1464-5491.2007.02077.x; Retnakaran R, 2010, DIABETOLOGIA, V53, P268, DOI 10.1007/s00125-009-1600-8; Savino F, 2012, ACTA PAEDIATR, V101, P1058, DOI 10.1111/j.1651-2227.2012.02744.x; Shand B, 2006, CLIN CHEM LAB MED, V44, P1264, DOI 10.1515/CCLM.2006.227; Domingues RMSM, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00105113; Stefan N, 2002, J CLIN ENDOCR METAB, V87, P4652, DOI 10.1210/jc.2002-020694; Textor J, 2011, EPIDEMIOLOGY, V22, P745, DOI 10.1097/EDE.0b013e318225c2be; Vitoratos N, 2008, GYNECOL ENDOCRINOL, V24, P614, DOI 10.1080/09513590802342866; Woo JG, 2009, BREASTFEED MED, V4, P101, DOI 10.1089/bfm.2008.0137; Yuan GY, 2007, J ENDOCRINOL, V194, P275, DOI 10.1677/JOE-07-0133	34	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158886	10.1371/journal.pone.0158886	http://dx.doi.org/10.1371/journal.pone.0158886			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391647	gold, Green Published, Green Submitted			2022-12-27	WOS:000380005400150
J	Chakrabarti, M; Klionsky, DJ; Ray, SK				Chakrabarti, Mrinmay; Klionsky, Daniel J.; Ray, Swapan K.			miR-30e Blocks Autophagy and Acts Synergistically with Proanthocyanidin for Inhibition of AVEN and BIRC6 to Increase Apoptosis in Glioblastoma Stem Cells and Glioblastoma SNB19 Cells	PLOS ONE			English	Article							OLIGOMER PROCYANIDINS; GRAPE SEEDS; IN-VITRO; EXPRESSION; DIFFERENTIATION; PROLIFERATION; INVASION; INDUCE; DEATH	Glioblastoma is the most common and malignant brain tumor in humans. It is a heterogeneous tumor harboring glioblastoma stem cells (GSC) and other glioblastoma cells that survive and sustain tumor growth in a hypoxic environment via induction of autophagy and resistance to apoptosis. So, a therapeutic strategy to inhibit autophagy and promote apoptosis could greatly help control growth of glioblastoma. We created hypoxia using sodium sulfite (SS) for induction of substantiated autophagy in human GSC and glioblastoma SNB19 cells. Induction of autophagy was confirmed by acridine orange (AO) staining and significant increase in Beclin-1 in autophagic cells. microRNA database (miRDB) search suggested that miR-30e could suppress the autophagy marker Beclin-1 and also inhibit the caspase activation inhibitors (AVEN and BIRC6). Pro-apoptotic effect of proanthocyanidin (PAC) has not yet been explored in glioblastoma cells. Combination of 50 nM miR-30e and 150 mu M PAC acted synergistically for inhibition of viability in both cells. This combination therapy most effectively altered expression of molecules for inhibition of autophagy and induced extrinsic and intrinsic pathways of apoptosis through suppression of AVEN and BIRC6. Collectively, combination of miR-30e and PAC is a promising therapeutic strategy to inhibit autophagy and increase apoptosis in GSC and SNB19 cells.	[Chakrabarti, Mrinmay; Ray, Swapan K.] Univ South Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA; [Klionsky, Daniel J.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA	University of South Carolina System; University of South Carolina Columbia; University of Michigan System; University of Michigan	Ray, SK (corresponding author), Univ South Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA.	swapan.ray@uscmed.sc.edu	CHAKRABARTI, MRINMAY/M-5652-2019		University of South Carolina School of Medicine Research Development Fund (USC SOM RDF, Columbia, SC, USA); South Carolina Spinal Cord Injury Research Fund (Columbia, SC, USA) [SC SCIRF-2015-I-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053396] Funding Source: NIH RePORTER	University of South Carolina School of Medicine Research Development Fund (USC SOM RDF, Columbia, SC, USA); South Carolina Spinal Cord Injury Research Fund (Columbia, SC, USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The present study was supported in part by the grants from University of South Carolina School of Medicine Research Development Fund (USC SOM RDF, Columbia, SC, USA) and South Carolina Spinal Cord Injury Research Fund (SC SCIRF-2015-I-01, Columbia, SC, USA) to SKR.	Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Bhutia SK, 2010, CANCER RES, V70, P3667, DOI 10.1158/0008-5472.CAN-09-3647; BLOCK G, 1992, NUTR CANCER, V18, P1, DOI 10.1080/01635589209514201; Chakrabarti M, 2013, EXP CELL RES, V319, P1575, DOI 10.1016/j.yexcr.2013.02.025; Chakrabarti M, 2013, NEUROCHEM RES, V38, P420, DOI 10.1007/s11064-012-0936-5; Chakrabarti M, 2012, BRAIN RES, V1454, P1, DOI 10.1016/j.brainres.2012.03.017; Chen LH, 2011, BIOCHEM PHARMACOL, V81, P594, DOI 10.1016/j.bcp.2010.12.011; Chifenti Barbara, 2013, Clin Exp Reprod Med, V40, P33, DOI 10.5653/cerm.2013.40.1.33; DEMESQUITA HBB, 1991, INT J CANCER, V48, P540, DOI 10.1002/ijc.2910480411; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gallo S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.155; Hershkovitz-Rokah O, 2015, CANCER LETT, V356, P597, DOI 10.1016/j.canlet.2014.10.006; Jiang B, 2011, J BIOL INORG CHEM, V16, P267, DOI 10.1007/s00775-010-0723-1; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Meeran SM, 2009, CARCINOGENESIS, V30, P520, DOI 10.1093/carcin/bgp019; Mohan N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078958; Nandakumar V, 2008, CANC LETT, V375, P162; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; Pintha K, 2015, BIOL PHARM BULL, V38, P571, DOI 10.1248/bpb.b14-00719; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Singh T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027444; Sun Q, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-134; Tanabe F, 2011, AUTOPHAGY, V7, P1462, DOI 10.4161/auto.7.12.17892; Turcotte S, 2010, CURR OPIN CELL BIOL, V22, P246, DOI 10.1016/j.ceb.2009.12.007; Vaid M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021539; Viry E, 2014, BIOCHEM PHARMACOL, V92, P31, DOI 10.1016/j.bcp.2014.07.006; Yamanaka-Tatematsu M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076605; Zarzynska JM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/710345; Zhang FJ, 2010, PHARM BIOL, V48, P883, DOI 10.3109/13880200903311102; Zhang FJ, 2009, CHEM-BIOL INTERACT, V179, P419, DOI 10.1016/j.cbi.2008.12.017; Zhang Y, 2014, BIOCHEM PHARMACOL, V87, P562, DOI 10.1016/j.bcp.2013.12.004; Zheng HL, 2015, INT J ONCOL, V46, P708, DOI 10.3892/ijo.2014.2744; Zou ZY, 2012, J BIOL CHEM, V287, P4148, DOI 10.1074/jbc.M111.307405	38	22	22	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158537	10.1371/journal.pone.0158537	http://dx.doi.org/10.1371/journal.pone.0158537			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27388765	Green Published, Green Submitted, gold			2022-12-27	WOS:000379811500026
J	Jung, CE; Strother, L; Feil-Seifer, DJ; Hutsler, JJ				Jung, Corinne E.; Strother, Lars; Feil-Seifer, David J.; Hutsler, Jeffrey J.			Atypical Asymmetry for Processing Human and Robot Faces in Autism Revealed by fNIRS	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; SPECTRUM DISORDER; HEMODYNAMIC-RESPONSE; YOUNG-CHILDREN; LANGUAGE LATERALIZATION; FACIAL EXPRESSIONS; CORPUS-CALLOSUM; FAMILIAR FACES; VISUAL-CORTEX; BRAIN	Deficits in the visual processing of faces in autism spectrum disorder (ASD) individuals may be due to atypical brain organization and function. Studies assessing asymmetric brain function in ASD individuals have suggested that facial processing, which is known to be lateralized in neurotypical (NT) individuals, may be less lateralized in ASD. Here we used functional near-infrared spectroscopy (fNIRS) to first test this theory by comparing patterns of lateralized brain activity in homologous temporal-occipital facial processing regions during observation of faces in an ASD group and an NT group. As expected, the ASD participants showed reduced right hemisphere asymmetry for human faces, compared to the NT participants. Based on recent behavioral reports suggesting that robots can facilitate increased verbal interaction over human counterparts in ASD, we also measured responses to faces of robots to determine if these patterns of activation were lateralized in each group. In this exploratory test, both groups showed similar asymmetry patterns for the robot faces. Our findings confirm existing literature suggesting reduced asymmetry for human faces in ASD and provide a preliminary foundation for future testing of how the use of categorically different social stimuli in the clinical setting may be beneficial in this population.	[Jung, Corinne E.; Strother, Lars; Hutsler, Jeffrey J.] Univ Nevada, Program Neurosci, Dept Psychol, Reno, NV 89557 USA; [Feil-Seifer, David J.] Univ Nevada, Dept Comp Sci & Engn, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno	Jung, CE (corresponding author), Univ Nevada, Program Neurosci, Dept Psychol, Reno, NV 89557 USA.	corinnejung@gmail.com		Feil-Seifer, David/0000-0002-5502-7513	Integrative Neuroscience Center of Biomedical Research Excellence award - National Institute of General Medical Sciences of the National Institutes of Health [P20 GM103650]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103650] Funding Source: NIH RePORTER	Integrative Neuroscience Center of Biomedical Research Excellence award - National Institute of General Medical Sciences of the National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by The Integrative Neuroscience Center of Biomedical Research Excellence award, funded by National Institute of General Medical Sciences of the National Institutes of Health (P20 GM103650). CJ was awarded the support for participant compensation.	Allen G, 2003, AM J PSYCHIAT, V160, P262, DOI 10.1176/appi.ajp.160.2.262; ALLEN MH, 1991, J AUTISM DEV DISORD, V21, P483, DOI 10.1007/BF02206872; Anderson JS, 2010, AM J NEURORADIOL, V31, P131, DOI 10.3174/ajnr.A1789; [Anonymous], 1999, PSYCHOL SOFTWARE TOO; BARONCOHEN S, 1993, COGNITION EMOTION, V7, P507, DOI 10.1080/02699939308409202; Behrmann M, 2006, NEUROPSYCHOLOGIA, V44, P110, DOI 10.1016/j.neuropsychologia.2005.04.002; Behrmann M, 2014, CEREB CORTEX, V24, P1102, DOI 10.1093/cercor/bhs390; Behrmann M, 2013, TRENDS COGN SCI, V17, P210, DOI 10.1016/j.tics.2013.03.007; Bergerbest D, 2009, NEUROIMAGE, V45, P237, DOI 10.1016/j.neuroimage.2008.10.019; Cantlon JF, 2011, CEREB CORTEX, V21, P191, DOI 10.1093/cercor/bhq078; Chance B, 1998, OPT EXPRESS, V2, P411, DOI 10.1364/OE.2.000411; Chung MK, 2004, NEUROIMAGE, V23, P242, DOI 10.1016/j.neuroimage.2004.04.037; Dawson G, 2005, DEV NEUROPSYCHOL, V27, P403, DOI 10.1207/s15326942dn2703_6; De Winter FL, 2015, NEUROIMAGE, V106, P340, DOI 10.1016/j.neuroimage.2014.11.020; Dehaene S, 2010, SCIENCE, V330, P1359, DOI 10.1126/science.1194140; del Carmen Bravo M, 2011, NEAR INFRARED SPECTR, P42; Dundas EM, 2013, J EXP PSYCHOL GEN, V142, P348, DOI 10.1037/a0029503; Flagg EJ, 2005, NEUROSCI LETT, V386, P82, DOI 10.1016/j.neulet.2005.05.037; Frazier TW, 2009, BIOL PSYCHIAT, V66, P935, DOI 10.1016/j.biopsych.2009.07.022; Gilliam J.E., 2006, GILLIAM AUTISM RATIN, DOI DOI 10.1016/j.heares.2016.06.001; Grelotti DJ, 2005, NEUROPSYCHOLOGIA, V43, P373, DOI 10.1016/j.neuropsychologia.2004.06.015; Groen MA, 2012, BRAIN BEHAV, V2, P256, DOI 10.1002/brb3.56; Hadjikhani N, 2004, NEUROREPORT, V15, P267, DOI 10.1097/00001756-200402090-00011; Hadjikhani N, 2009, SOC COGN AFFECT NEUR, V4, P70, DOI 10.1093/scan/nsn038; Hauck M, 1998, CHILD NEUROPSYCHOL, V4, P187, DOI 10.1076/chin.4.3.187.3174; Hoshi Y, 2001, J APPL PHYSIOL, V90, P1657, DOI 10.1152/jappl.2001.90.5.1657; Hsiao JHW, 2008, PSYCHOL SCI, V19, P998, DOI 10.1111/j.1467-9280.2008.02191.x; Humphreys K, 2007, NEUROPSYCHOLOGIA, V45, P685, DOI 10.1016/j.neuropsychologia.2006.08.003; Huppert TJ, 2009, APPL OPTICS, V48, pD280, DOI 10.1364/AO.48.00D280; Ichikawa H, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00480; Ichikawa H, 2010, NEUROSCI LETT, V482, P90, DOI 10.1016/j.neulet.2010.06.086; Jancke L, 1997, NEUROPSYCHOLOGIA, V35, P1389, DOI 10.1016/S0028-3932(97)00068-7; Kaiser V, 2014, NEUROIMAGE, V85, P432, DOI 10.1016/j.neuroimage.2013.04.097; Kim ES, 2013, J AUTISM DEV DISORD, V43, P1038, DOI 10.1007/s10803-012-1645-2; Kleinhans NM, 2008, BRAIN RES, V1221, P115, DOI 10.1016/j.brainres.2008.04.080; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Knaus TA, 2012, COGN BEHAV NEUROL, V25, P186, DOI 10.1097/WNN.0b013e318280e154; Leff D, 2006, LECT NOTES COMPUT SC, V4091, P140; LINCOLN AJ, 1988, J AUTISM DEV DISORD, V18, P505, DOI 10.1007/BF02211870; Lo YC, 2011, PSYCHIAT RES-NEUROIM, V192, P60, DOI 10.1016/j.pscychresns.2010.09.008; Lohmann H, 2005, NEUROIMAGE, V24, P780, DOI 10.1016/j.neuroimage.2004.08.053; Maestro S, 2005, CHILD PSYCHIAT HUM D, V35, P383, DOI 10.1007/s10578-005-2695-x; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; Nakato E, 2011, NEUROIMAGE, V54, P1600, DOI 10.1016/j.neuroimage.2010.09.021; Narita N, 2012, J PEDIATR NEUROL, V10, P87, DOI 10.3233/JPN-2012-0541; Narita T, 1987, NEUROPSYCHOLOGICAL A; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ozonoff S, 2008, AUTISM, V12, P457, DOI 10.1177/1362361308096402; Pierce K, 2004, BRAIN, V127, P2703, DOI 10.1093/brain/awh289; Plaut DC, 2011, COGN NEUROPSYCHOL, V28, P251, DOI 10.1080/02643294.2011.609812; Plichta MM, 2007, NEUROIMAGE, V35, P625, DOI 10.1016/j.neuroimage.2006.11.028; Renteria ME, 2012, TWIN RES HUM GENET, V15, P401, DOI 10.1017/thg.2012.13; Rossion B, 2003, NEUROIMAGE, V20, P1609, DOI 10.1016/j.neuroimage.2003.07.010; Rossion B, 2003, NEUROIMAGE, V19, P877, DOI 10.1016/S1053-8119(03)00105-8; RUMSEY JM, 1988, J CLIN EXP NEUROPSYC, V10, P201, DOI 10.1080/01688638808408236; Scassellati B, 2012, ANNU REV BIOMED ENG, V14, P275, DOI 10.1146/annurev-bioeng-071811-150036; Schroeter ML, 2003, NEUROIMAGE, V19, P555, DOI 10.1016/S1053-8119(03)00155-1; Shimada S, 2006, NEUROIMAGE, V32, P930, DOI 10.1016/j.neuroimage.2006.03.044; Smith FW, 2009, PSYCHOL SCI, V20, P1202, DOI 10.1111/j.1467-9280.2009.02427.x; Swettenham J, 1998, J CHILD PSYCHOL PSYC, V39, P747, DOI 10.1111/1469-7610.00373; Tong F, 2000, COGNITIVE NEUROPSYCH, V17, P257, DOI 10.1080/026432900380607; VENTER A, 1992, J CHILD PSYCHOL PSYC, V33, P489, DOI 10.1111/j.1469-7610.1992.tb00887.x; Vidal CN, 2006, BIOL PSYCHIAT, V60, P218, DOI 10.1016/j.biopsych.2005.11.011; Wang AT, 2004, J AM ACAD CHILD PSY, V43, P481, DOI 10.1097/00004583-200404000-00015; Wang XJ, 2011, NEUROIMAGE, V55, P1346, DOI 10.1016/j.neuroimage.2010.12.062; Webb SJ, 2006, J AUTISM DEV DISORD, V36, P881, DOI 10.1007/s10803-006-0126-x; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Weigelt S, 2012, NEUROSCI BIOBEHAV R, V36, P1060, DOI 10.1016/j.neubiorev.2011.12.008; Whyte EM, 2015, DEV SCI; Zhang L, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.5.057012; Zhu HL, 2014, BIOMED OPT EXPRESS, V5, P1262, DOI 10.1364/BOE.5.001262	72	20	20	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158804	10.1371/journal.pone.0158804	http://dx.doi.org/10.1371/journal.pone.0158804			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR3OC	27389017	gold, Green Submitted, Green Published			2022-12-27	WOS:000379811500048
J	Luo, LN; He, LJ; Gao, XY; Huang, XX; Shan, HB; Luo, GY; Li, Y; Lin, SY; Wang, GB; Zhang, R; Xu, GL; Li, JJ				Luo, Lin-na; He, Long-jun; Gao, Xiao-yan; Huang, Xin-xin; Shan, Hong-bo; Luo, Guang-yu; Li, Yin; Lin, Shi-yong; Wang, Guo-bao; Zhang, Rong; Xu, Guo-liang; Li, Jian-jun			Endoscopic Ultrasound for Preoperative Esophageal Squamous Cell Carcinoma: a Meta-Analysis	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; FINE-NEEDLE ASPIRATION; COMPUTED-TOMOGRAPHY; MAGNIFYING ENDOSCOPY; DIAGNOSTIC-ACCURACY; CANCER; ULTRASONOGRAPHY; ENDOSONOGRAPHY; CT; INVASION	Background Treatment options and prognosis of esophageal squamous cell carcinoma (ESCC) depend on the primary tumor depth (T-staging) and regional lymph node status (N-staging). Endoscopic ultrasound (EUS) has emerged as a useful staging tool, but studies regarding its benefits have been variable. The objective of this study was to evaluate the diagnostic accuracy of EUS for detecting preoperative ESCC. Methods We included in our meta-analysis studies involving EUS-based staging of preoperative ESCC compared with pathological staging. Using a random-effects model, we performed a meta-analysis of the accuracy of EUS by calculating pooled estimates of sensitivity, specificity and the diagnostic odds ratio. In addition, we created a summary receiver operating characteristic (SROC) curve. Results Forty-four studies (n = 2880) met the inclusion criteria. The pooled sensitivity and specificity of T1 were 77% (95% CI: 73 to 80) and 95% (95% CI: 94 to 96). Among the T1 patients, EUS had a pooled sensitivity in differentiating T1a and T1b of 84% (95% CI: 80 to 88) and 83% (95% CI: 80 to 86), and a specificity of 91% (95% CI: 88 to 94) and 89% (95% CI: 86 to 92). To stage T4, EUS had a pooled sensitivity of 84% (95% CI: 79 to 89) and a specificity of 96% (95% CI: 95 to 97). The overall accuracy of EUS for T-staging was 79% (95% CI: 77 to 80), and for N-staging, 71% (95% CI: 69 to 73). Conclusions EUS has good diagnostic accuracy for staging ESCC, which has better performance in T1 sub-staging (T1a and T1b) and advanced disease (T4).	[Luo, Lin-na; He, Long-jun; Gao, Xiao-yan; Huang, Xin-xin; Shan, Hong-bo; Luo, Guang-yu; Li, Yin; Lin, Shi-yong; Wang, Guo-bao; Zhang, Rong; Xu, Guo-liang; Li, Jian-jun] Sun Yat Sen Univ, Ctr Canc, Dept Endoscopy, Guangzhou, Guangdong, Peoples R China; [Luo, Lin-na; He, Long-jun; Gao, Xiao-yan; Huang, Xin-xin; Shan, Hong-bo; Luo, Guang-yu; Li, Yin; Lin, Shi-yong; Wang, Guo-bao; Zhang, Rong; Xu, Guo-liang; Li, Jian-jun] State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Luo, Lin-na; He, Long-jun; Gao, Xiao-yan; Huang, Xin-xin; Shan, Hong-bo; Luo, Guang-yu; Li, Yin; Lin, Shi-yong; Wang, Guo-bao; Zhang, Rong; Xu, Guo-liang; Li, Jian-jun] Guangdong Esophageal Canc Inst, Guangzhou, Guangdong, Peoples R China; [Luo, Lin-na; He, Long-jun; Gao, Xiao-yan; Huang, Xin-xin; Shan, Hong-bo; Luo, Guang-yu; Li, Yin; Lin, Shi-yong; Wang, Guo-bao; Zhang, Rong; Xu, Guo-liang; Li, Jian-jun] Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China	Xu, GL; Li, JJ (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Endoscopy, Guangzhou, Guangdong, Peoples R China.; Xu, GL; Li, JJ (corresponding author), State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China.; Xu, GL; Li, JJ (corresponding author), Guangdong Esophageal Canc Inst, Guangzhou, Guangdong, Peoples R China.; Xu, GL; Li, JJ (corresponding author), Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China.	xugl@sysucc.org.cn; lijj@sysucc.org.cn			Science and Technology Plan Projects of Guangdong Province, P.R.China [2012B061700076, 2014A020212146]; Sun Yat-Sen University Cancer Center Clinical Research 308 Program; Plan Project of Guangdong Esophageal Cancer Research Institute	Science and Technology Plan Projects of Guangdong Province, P.R.China; Sun Yat-Sen University Cancer Center Clinical Research 308 Program; Plan Project of Guangdong Esophageal Cancer Research Institute	This work was supported by the Science and Technology Plan Projects of Guangdong Province, P.R.China (No: 2012B061700076 and 2014A020212146); and Sun Yat-Sen University Cancer Center Clinical Research 308 Program and Plan Project of Guangdong Esophageal Cancer Research Institute.	BINMOELLER KF, 1995, GASTROINTEST ENDOSC, V41, P547, DOI 10.1016/S0016-5107(95)70188-5; Catalano MF, 1999, GASTROINTEST ENDOSC, V50, P352, DOI 10.1053/ge.1999.v50.98154; CATALANO MF, 1994, GASTROINTEST ENDOSC, V40, P442, DOI 10.1016/S0016-5107(94)70206-3; Choi J, 2010, SURG ENDOSC, V24, P1380, DOI 10.1007/s00464-009-0783-x; Cox DR., 1970, ANAL BINARY DATA; Curvers WL, 2008, BEST PRACT RES CL GA, V22, P687, DOI 10.1016/j.bpg.2008.01.001; Eloubeidi MA, 2001, GASTROINTEST ENDOSC, V54, P714, DOI 10.1067/mge.2001.119873; Gheorghe Cristian, 2006, J Gastrointestin Liver Dis, V15, P137; Goda K, 2009, DIS ESOPHAGUS, V22, P453, DOI 10.1111/j.1442-2050.2009.00942.x; GRIMM H, 1993, ENDOSCOPY, V25, P224, DOI 10.1055/s-2007-1010297; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hasegawa N, 1996, GASTROINTEST ENDOSC, V44, P388, DOI 10.1016/S0016-5107(96)70086-X; He LJ, 2014, WORLD J GASTROENTERO, V20, P1340, DOI 10.3748/wjg.v20.i5.1340; HEINTZ A, 1991, SURG ENDOSC-ULTRAS, V5, P75, DOI 10.1007/BF00316841; Hunerbein M, 2003, SURG ENDOSC, V17, P615, DOI 10.1007/s00464-002-8622-3; Hunerbein M, 1996, SURG ENDOSC-ULTRAS, V10, P1205, DOI 10.1007/s004649900280; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kantarci M, 2004, DIS ESOPHAGUS, V17, P32, DOI 10.1111/j.1442-2050.2004.00354.x; Kawano T, 2003, ABDOM IMAGING, V28, P477, DOI 10.1007/s00261-002-0076-5; Kienle P, 2002, DIGESTION, V66, P230, DOI 10.1159/000068360; Knabe M, 2015, J DIGEST DIS, V16, P363, DOI 10.1111/1751-2980.12264; Kutup A, 2007, ENDOSCOPY, V39, P715, DOI 10.1055/s-2007-966655; Lee G, 2014, J NUCL MED, V55, P1242, DOI 10.2967/jnumed.114.138974; Li JJ, 2013, ENDOSCOPY, V45, P667, DOI 10.1055/s-0033-1344024; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lok KH, 2008, J DIGEST DIS, V9, P41, DOI 10.1111/j.1443-9573.2007.00318.x; Massari M, 1997, SURG LAPAROSC ENDOSC, V7, P162, DOI 10.1097/00019509-199704000-00021; May A, 2004, GUT, V53, P634, DOI 10.1136/gut.2003.029421; MOSES LE, 1993, STAT MED, V12, P1293, DOI 10.1002/sim.4780121203; Murata Y, 1988, Surg Endosc, V2, P180, DOI 10.1007/BF02498796; Murata Y., 1996, SMALL ULTRASONIC PRO; Natsugoe S, 1996, ENDOSCOPY, V28, P674, DOI 10.1055/s-2007-1005575; Nesje LB, 2000, SCAND J GASTROENTERO, V35, P997; Nishimaki T, 1999, ANN THORAC SURG, V68, P2059, DOI 10.1016/S0003-4975(99)01171-6; Pennathur A, 2009, ANN THORAC SURG, V87, P1048, DOI 10.1016/j.athoracsur.2008.12.060; Pham T, 1998, AUST NZ J SURG, V68, P209, DOI 10.1111/j.1445-2197.1998.tb04748.x; Pongpornsup Sopa, 2012, Journal of the Medical Association of Thailand, V95, P704; Puli SR, 2008, WORLD J GASTROENTERO, V14, P1479, DOI 10.3748/wjg.14.1479; Rice Thomas W, 2015, Korean J Thorac Cardiovasc Surg, V48, P157, DOI 10.5090/kjtcs.2015.48.3.157; Rosch T, 1995, Gastrointest Endosc Clin N Am, V5, P537; Sandha GS, 2008, GASTROINTEST ENDOSC, V67, P402, DOI 10.1016/j.gie.2007.09.006; Shin S, 2014, EUR J CARDIO-THORAC, V46, P274, DOI 10.1093/ejcts/ezt607; Shinkai M, 2000, GUT, V47, P120, DOI 10.1136/gut.47.1.120; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; TAKASHIMA S, 1991, AM J ROENTGENOL, V156, P297, DOI 10.2214/ajr.156.2.1898802; TAKEMOTO T, 1986, ENDOSCOPY, V18, P22, DOI 10.1055/s-2007-1018437; Takizawa K, 2009, J GASTROEN HEPATOL, V24, P1687, DOI 10.1111/j.1440-1746.2009.05927.x; Tekola Bezawit D, 2014, J Gastrointest Cancer, V45, P342, DOI 10.1007/s12029-014-9616-9; Thosani N, 2012, GASTROINTEST ENDOSC, V75, P242, DOI 10.1016/j.gie.2011.09.016; TIO TL, 1990, GASTROINTEST ENDOSC, V36, pS2, DOI 10.1016/S0016-5107(90)71008-5; TIO TL, 1989, RADIOLOGY, V173, P411, DOI 10.1148/radiology.173.2.2678255; TIO TL, 1989, GASTROENTEROLOGY, V96, P1478, DOI 10.1016/0016-5085(89)90515-5; TOH Y, 1993, HEPATO-GASTROENTEROL, V40, P212; van Vliet EPM, 2006, AM J GASTROENTEROL, V101, P234, DOI 10.1111/j.1572-0241.2006.00413.x; Vazquez-Sequeiros E, 2001, GASTROINTEST ENDOSC, V53, P751, DOI 10.1067/mge.2001.112741; Vickers J, 1998, BRIT J SURG, V85, P999; Vickers J, 1998, Ann R Coll Surg Engl, V80, P233; Wakelin SJ, 2002, EUR J RADIOL, V41, P161, DOI 10.1016/S0720-048X(01)00418-1; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Wu LF, 2003, WORLD J GASTROENTERO, V9, P219, DOI 10.3748/wjg.v9.i2.219; Yanai H., 1996, ENDOSCOPIC ULTRASONO; Yen TJ, 2012, DIS ESOPHAGUS, V25, P40, DOI 10.1111/j.1442-2050.2011.01204.x; Yoshida T, 2004, GASTROINTEST ENDOSC, V59, P288, DOI 10.1016/S0016-5107(03)02532-X; YOSHIKANE H, 1994, AM J GASTROENTEROL, V89, P702; ZIEGLER K, 1991, GUT, V32, P16, DOI 10.1136/gut.32.1.16	65	37	40	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158373	10.1371/journal.pone.0158373	http://dx.doi.org/10.1371/journal.pone.0158373			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27387830	Green Published, gold, Green Submitted			2022-12-27	WOS:000379811500019
J	Rajora, OP; Eckert, AJ; Zinck, JWR				Rajora, Om P.; Eckert, Andrew J.; Zinck, John W. R.			Single-Locus versus Multilocus Patterns of Local Adaptation to Climate in Eastern White Pine (Pinus strobus, Pinaceae)	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; ADAPTIVE POPULATION DIFFERENTIATION; GENETIC DIVERSITY; LINKAGE DISEQUILIBRIUM; CANDIDATE GENES; NUCLEOTIDE POLYMORPHISMS; PHENOTYPIC ASSOCIATIONS; POPULUS-TREMULA; NEUTRAL MARKERS; COLD-HARDINESS	Natural plant populations are often adapted to their local climate and environmental conditions, and populations of forest trees offer some of the best examples of this pattern. However, little empirical work has focused on the relative contribution of single-locus versus multilocus effects to the genetic architecture of local adaptation in plants/forest trees. Here, we employ eastern white pine (Pinus strobus) to test the hypothesis that it is the inter-genic effects that primarily drive climate-induced local adaptation. The genetic structure of 29 range-wide natural populations of eastern white pine was determined in relation to local climatic factors using both a reference set of SSR markers, and SNPs located in candidate genes putatively involved in adaptive response to climate. Comparisons were made between marker sets using standard single-locus outlier analysis, single-locus and multilocus environment association analyses and a novel implementation of Population Graphs. Magnitudes of population structure were similar between the two marker sets. Outlier loci consistent with diversifying selection were rare for both SNPs and SSRs. However, genetic distances based on the multilocus among population covariances (cGD) were significantly more correlated to climate, even after correcting for spatial effects, for SNPs as compared to SSRs. Coalescent simulations confirmed that the differences in mutation rates between SSRs and SNPs did not affect the topologies of the Population Graphs, and hence values of cGD and their correlations with associated climate variables. We conclude that the multilocus covariances among populations primarily reflect adaptation to local climate and environment in eastern white pine. This result highlights the complexity of the genetic architecture of adaptive traits, as well as the need to consider multilocus effects in studies of local adaptation.	[Rajora, Om P.; Zinck, John W. R.] Univ New Brunswick, Fac Forestry & Environm Management, Fredericton, NB, Canada; [Eckert, Andrew J.] Virginia Commonwealth Univ, Dept Biol, Richmond, VA USA	University of New Brunswick; Virginia Commonwealth University	Rajora, OP (corresponding author), Univ New Brunswick, Fac Forestry & Environm Management, Fredericton, NB, Canada.	Om.Rajora@unb.ca		Zinck, John/0000-0002-6116-3976	Natural Sciences and Engineering Research Council of Canada Discovery Grant [RGPIN 170651]; Canada Research Chair Program [CRC950-201869]	Natural Sciences and Engineering Research Council of Canada Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair Program(Canada Research Chairs)	The research was funded and John W.R. Zinck was financially supported by the Natural Sciences and Engineering Research Council of Canada Discovery Grant RGPIN 170651, and Canada Research Chair Program (CRC950-201869) funds to the Principal Investigator Om P. Rajora. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. John W.R. Zinck is currently affiliated with Athletigen Technologies Inc., which had no role whatsoever in the study or manuscript preparation.	Aitken SN, 2008, EVOL APPL, V1, P95, DOI 10.1111/j.1752-4571.2007.00013.x; Albert EM, 2013, ECOL LETT, V16, P86, DOI 10.1111/ele.12061; Alberto FJ, 2013, GLOBAL CHANGE BIOL, V19, P1645, DOI 10.1111/gcb.12181; BARTON NH, 1995, GENET RES, V65, P123, DOI 10.1017/S0016672300033140; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Bourret V, 2014, MOL ECOL, V23, P4444, DOI 10.1111/mec.12798; Bradburd GS, 2013, EVOLUTION, V67, P3258, DOI 10.1111/evo.12193; Buchert GP, 1997, CONSERV BIOL, V11, P747, DOI 10.1046/j.1523-1739.1997.96074.x; Burger R, 1999, GENETICS, V152, P807; Chhatre VE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097291; Coop G, 2014, ARXIV13077759; Coop G, 2010, GENETICS, V185, P1411, DOI 10.1534/genetics.110.114819; Csillery K, 2014, MOL ECOL, V23, P4696, DOI 10.1111/mec.12902; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Doyle J. J., 1987, PHYTOCHEM B, P11; Dyer RJ, 2004, MOL ECOL, V13, P1713, DOI 10.1111/j.1365-294X.2004.02177.x; Dyer RJ, 2007, THEOR POPUL BIOL, V71, P71, DOI 10.1016/j.tpb.2006.07.001; Dyer Rodney J., 2015, Annual Review of Ecology Evolution and Systematics, V46, P327; Dyer RJ, 2010, MOL ECOL, V19, P3746, DOI 10.1111/j.1365-294X.2010.04748.x; Eckert AJ, 2013, GENETICS, V195, P1353, DOI 10.1534/genetics.113.157198; Eckert AJ, 2010, GENETICS, V185, P969, DOI 10.1534/genetics.110.115543; Endler J.A., 1986, Monographs in Population Biology, pviii; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; EXCOFFIER L, 1992, GENETICS, V131, P479; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; FOWLER D P, 1969, Silvae Genetica, V18, P123; GENYS JB, 1987, CAN J FOREST RES, V17, P228, DOI 10.1139/x87-039; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; GRATTAPAGLIA D, 2011, TREE GENET GENOMES, V7, P241, DOI DOI 10.1007/S11295-010-0328-4; Gugger PF, 2013, MOL ECOL, V22, P3598, DOI 10.1111/mec.12317; Hall D, 2007, EVOLUTION, V61, P2849, DOI 10.1111/j.1558-5646.2007.00230.x; Hamblin MT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001367; Hancock AM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001375; Hancock AM, 2010, P NATL ACAD SCI USA, V107, P8924, DOI 10.1073/pnas.0914625107; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoffmann AA, 2008, NAT REV GENET, V9, P421, DOI 10.1038/nrg2339; Holliday JA, 2012, G3-GENES GENOM GENET, V2, P1085, DOI 10.1534/g3.112.002733; Holsinger KE, 2009, NAT REV GENET, V10, P639, DOI 10.1038/nrg2611; Howe GT, 2003, CAN J BOT, V81, P1247, DOI [10.1139/b03-141, 10.1139/B03-141]; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Joyce DG, 2013, FOREST ECOL MANAG, V295, P173, DOI 10.1016/j.foreco.2012.12.024; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Keller SR, 2012, MOL BIOL EVOL, V29, P3143, DOI 10.1093/molbev/mss121; Klutsch CFC, 2012, CONSERV GENET, V13, P21, DOI 10.1007/s10592-011-0259-0; Kremer A, 2012, HEREDITY, V108, P375, DOI 10.1038/hdy.2011.81; Kremer A, 1997, GENETICS, V145, P1229; Kremer A, 2012, ECOL LETT, V15, P378, DOI 10.1111/j.1461-0248.2012.01746.x; Krutovsky KV, 2005, GENETICS, V171, P2029, DOI 10.1534/genetics.105.044420; Latta RG, 2004, NEW PHYTOL, V161, P51, DOI 10.1046/j.1469-8137.2003.00920.x; Latta RG, 1998, AM NAT, V151, P283, DOI 10.1086/286119; Le Corre V, 2003, GENETICS, V164, P1205; Le Corre V, 2012, MOL ECOL, V21, P1548, DOI 10.1111/j.1365-294X.2012.05479.x; LEGENDRE P, 1994, EVOLUTION, V48, P1487, DOI 10.1111/j.1558-5646.1994.tb02191.x; Leips J, 2000, GENETICS, V155, P1773; LEWONTIN RC, 1973, GENETICS, V74, P175; Li P, 1997, CAN J FOREST RES, V27, P199, DOI 10.1139/cjfr-27-2-199; Ma XF, 2010, GENETICS, V186, P1033, DOI 10.1534/genetics.110.120873; Mackay TFC, 2014, NAT REV GENET, V15, P22, DOI 10.1038/nrg3627; MARONEK DM, 1974, FOREST SCI, V20, P135; Marquardt PE, 2007, CAN J FOREST RES, V37, P2652, DOI 10.1139/X07-114; Marquardt PE, 2004, MOL ECOL, V13, P3305, DOI 10.1111/j.1365-294X.2004.02341.x; Martinoia E, 2002, PLANTA, V214, P345, DOI 10.1007/s004250100661; McCallum CM, 2000, NAT BIOTECHNOL, V18, P455, DOI 10.1038/74542; Mehes M, 2009, J PLANT ECOL-UK, V2, P143, DOI 10.1093/jpe/rtp016; Morgenstern EK, 1996, GEOGRAPHIC VARIATION; Nadeau S, 2015, AM J BOT, V102, P1342, DOI 10.3732/ajb.1500160; Namroud MC, 2008, MOL ECOL, V17, P3599, DOI 10.1111/j.1365-294X.2008.03840.x; Neale DB, 2011, NAT REV GENET, V12, P111, DOI 10.1038/nrg2931; Neale DB, 2004, TRENDS PLANT SCI, V9, P325, DOI 10.1016/j.tplants.2004.05.006; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; OHTA T, 1982, GENETICS, V101, P139; Pannell JR, 2014, NEW PHYTOL, V201, P417, DOI 10.1111/nph.12495; Pidugu SR, 2006, MOL ECOL NOTES, V6, P580, DOI 10.1111/j.1471-8286.2006.01286.x; Prunier J, 2012, MOL ECOL, V21, P4270, DOI 10.1111/j.1365-294X.2012.05691.x; R Core Team, 2021, R LANGUAGE ENV STAT; Rajora OP, 2000, MOL ECOL, V9, P339, DOI 10.1046/j.1365-294x.2000.00886.x; Rajora OP, 1998, CAN J BOT, V76, P500, DOI 10.1139/cjb-76-3-500; Savolainen O, 2007, ANNU REV ECOL EVOL S, V38, P595, DOI 10.1146/annurev.ecolsys.38.091206.095646; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Sork VL, 2013, TREE GENET GENOMES, V9, P901, DOI 10.1007/s11295-013-0596-x; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Storz JF, 2008, GENETICS, V180, P367, DOI 10.1534/genetics.108.088732; Walsh B, 1999, GENETICS ANAL QUANTI; Wang TL, 2010, ECOL APPL, V20, P153, DOI 10.1890/08-2257.1; Watling JI, 2012, ECOL MODEL, V246, P79, DOI 10.1016/j.ecolmodel.2012.07.018; Wegrzyn Jill L, 2008, Int J Plant Genomics, V2008, P412875, DOI 10.1155/2008/412875; Wendel G. W., 1990, USDA FOREST SERVICE, V654, P476; Wheeler NC, 2005, MOL BREEDING, V15, P145, DOI 10.1007/s11032-004-3978-9; Whitlock MC, 2011, MOL ECOL, V20, P1083, DOI 10.1111/j.1365-294X.2010.04996.x; Willyard A, 2008, MOL BIOL EVOL, V24, P90; Zinck JWR, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0624-1	94	15	15	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158691	10.1371/journal.pone.0158691	http://dx.doi.org/10.1371/journal.pone.0158691			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27387485	gold, Green Submitted, Green Published			2022-12-27	WOS:000379811500037
J	Cardenas-Garcia, S; Dunwoody, RP; Marcano, V; Diel, DG; Williams, RJ; Gogal, RM; Brown, CC; Miller, PJ; Afonso, CL				Cardenas-Garcia, Stivalis; Dunwoody, Robert P.; Marcano, Valerie; Diel, Diego G.; Williams, Robert J.; Gogal, Robert M., Jr.; Brown, Corrie C.; Miller, Patti J.; Afonso, Claudio L.			Effects of Chicken Interferon Gamma on Newcastle Disease Virus Vaccine Immunogenicity	PLOS ONE			English	Article							RECOMBINANT SUBUNIT VACCINE; IFN-GAMMA; DNA VACCINE; IMMUNE-RESPONSE; EXPRESSION; ADJUVANT; CLONING; INFECTION; EFFICACY	More effective vaccines are needed to control avian diseases. The use of chicken interferon gamma (chIFN gamma) during vaccination is a potentially important but controversial approach that may improve the immune response to antigens. In the present study, three different systems to co-deliver chIFN gamma with Newcastle disease virus (NDV) antigens were evaluated for their ability to enhance the avian immune response and their protective capacity upon challenge with virulent NDV. These systems consisted of: 1) a DNA vaccine expressing the Newcastle disease virus fusion (F) protein co-administered with a vector expressing the chIFN gamma gene for in ovo and booster vaccination, 2) a recombinant Newcastle disease virus expressing the chIFN gamma gene (rZJ1*L/IFN gamma) used as a live vaccine delivered in ovo and into juvenile chickens, and 3) the same rZJ1*L/IFN gamma virus used as an inactivated vaccine for juvenile chickens. Co-administration of chIFN gamma with a DNA vaccine expressing the F protein resulted in higher levels of morbidity and mortality, and higher amounts of virulent virus shed after challenge when compared to the group that did not receive chIFN gamma. The live vaccine system co-delivering chIFN gamma did not enhanced post-vaccination antibody response, nor improved survival after hatch, when administered in ovo, and did not affect survival after challenge when administered to juvenile chickens. The low dose of the inactivated vaccine co-delivering active chIFN gamma induced lower antibody titers than the groups that did not receive the cytokine. The high dose of this vaccine did not increase the antibody titers or antigen-specific memory response, and did not reduce the amount of challenge virus shed or mortality after challenge. In summary, regardless of the delivery system, chIFN gamma, when administered simultaneously with the vaccine antigen, did not enhance Newcastle disease virus vaccine immunogenicity.	[Cardenas-Garcia, Stivalis; Marcano, Valerie; Miller, Patti J.; Afonso, Claudio L.] USDA SEA, Southeast Poultry Res Lab, Athens, GA 30613 USA; [Cardenas-Garcia, Stivalis; Marcano, Valerie; Brown, Corrie C.] Univ Georgia, Coll Vet Med, Dept Vet Pathol, Athens, GA USA; [Dunwoody, Robert P.] Mercer Univ, Mem Univ Med Ctr, Sch Med, Savannah, GA USA; [Diel, Diego G.] South Dakota State Univ, Dept Vet & Biomed Sci, Brookings, SD 57007 USA; [Williams, Robert J.; Gogal, Robert M., Jr.] Univ Georgia, Coll Vet Med, Dept Biosci & Diagnost Imaging, Athens, GA USA	United States Department of Agriculture (USDA); University System of Georgia; University of Georgia; Mercer University; South Dakota State University; University System of Georgia; University of Georgia	Afonso, CL (corresponding author), USDA SEA, Southeast Poultry Res Lab, Athens, GA 30613 USA.	claudio.afonso@ars.usda.gov	Diel, Diego G./ABC-6242-2021; Miller, Patti/T-3933-2019	Diel, Diego G./0000-0003-3237-8940; Marcano, Valerie/0000-0003-2218-7577; Cardenas Garcia, Stivalis/0000-0002-7613-8642	United States Department of Agriculture, Agricultural Research Service [CRIS 6612-32000-064-00D]	United States Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was funded by the United States Department of Agriculture, Agricultural Research Service, CRIS 6612-32000-064-00D.	Abbas AK aL, 2012, CELLULAR MOL IMMUNOL; Alexander D.J., 2008, LAB MANUAL ISOLATION, V4th, P135; Asif M, 2004, IMMUNOL CELL BIOL, V82, P638, DOI 10.1111/j.1440-1711.2004.01295.x; Cardenas-Garcia S, 2015, BIOLOGICALS, V43, P136, DOI 10.1016/j.biologicals.2014.11.003; Choi KS, 2014, TROP ANIM HEALTH PRO, V46, P271, DOI 10.1007/s11250-013-0475-3; Choi KS, 2013, VIRUS GENES, V47, P244, DOI 10.1007/s11262-013-0930-2; DIGBY MR, 1995, J INTERF CYTOK RES, V15, P939, DOI 10.1089/jir.1995.15.939; Ding XC, 2004, INFECT IMMUN, V72, P6939, DOI 10.1128/IAI.72.12.6939-6944.2004; Fringuelli E, 2010, RES VET SCI, V89, P367, DOI 10.1016/j.rvsc.2010.03.021; Gallili GE, 1998, BIOTECHNOL ADV, V16, P343, DOI 10.1016/S0734-9750(97)00081-5; Ganar K, 2014, VIRUS RES, V184, P71, DOI 10.1016/j.virusres.2014.02.016; Goossens KE, 2013, DEV COMP IMMUNOL, V41, P370, DOI 10.1016/j.dci.2013.05.020; Haq K, 2011, ANTIVIR RES, V90, P218, DOI 10.1016/j.antiviral.2011.04.001; He HQ, 2011, CYTOKINE, V53, P363, DOI 10.1016/j.cyto.2010.12.009; HEATH AW, 1989, IMMUNOLOGY, V67, P520; Jaganathan S, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0537-z; Jansen T, 2005, VACCINE, V23, P1053, DOI 10.1016/j.vaccine.2004.08.023; Kaiser P, 1998, J INTERF CYTOK RES, V18, P711, DOI 10.1089/jir.1998.18.711; Kaiser P, 2010, AVIAN PATHOL, V39, P309, DOI 10.1080/03079457.2010.508777; Kammon A, 2015, AVIAN DIS, V59, P422, DOI 10.1637/11068-032215-ResNote.1; Kim SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074022; Li HT, 2007, VET IMMUNOL IMMUNOP, V117, P67, DOI 10.1016/j.vetimm.2007.01.009; Liu YL, 2007, ARCH VIROL, V152, P1241, DOI 10.1007/s00705-007-0961-x; LOWENTHAL JW, 1995, J INTERF CYTOK RES, V15, P933, DOI 10.1089/jir.1995.15.933; Lowenthal JW, 1998, J INTERF CYTOK RES, V18, P617, DOI 10.1089/jir.1998.18.617; Miller PJ, 2009, AVIAN DIS, V53, P39, DOI 10.1637/8407-071208-Reg.1; Min WG, 2001, VACCINE, V20, P267, DOI 10.1016/S0264-410X(01)00270-5; Nath B, 2015, MICROB PATHOG; Nimal S, 2005, VACCINE, V23, P3984, DOI 10.1016/j.vaccine.2005.01.160; OIE (World Organisation for Animal Health), 2012, MANUAL DIAGNOSTIC TE; Park JH, 2009, J VET SCI, V10, P131, DOI 10.4142/jvs.2009.10.2.131; QUIROGA JA, 1990, HEPATOLOGY, V12, P661, DOI 10.1002/hep.1840120407; Rautenschlein S, 1999, VACCINE, V18, P426, DOI 10.1016/S0264-410X(99)00254-6; Sawant PM, 2011, VET IMMUNOL IMMUNOP, V144, P36, DOI 10.1016/j.vetimm.2011.07.006; Schat K. A., 2013, AVIAN IMMUNOLOGY, V2nd; Schijns VECJ, 2000, VACCINE, V18, P2147, DOI 10.1016/S0264-410X(99)00537-X; Schultz UA, 1999, J VIROL, V73, P3162, DOI 10.1128/JVI.73.4.3162-3168.1999; Shabbir MZ, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-170; Shen SY, 2015, VET IMMUNOL IMMUNOP, V167, P200, DOI 10.1016/j.vetimm.2015.08.002; Song KD, 1997, VET IMMUNOL IMMUNOP, V58, P321, DOI 10.1016/S0165-2427(97)00034-2; Sreekumar E, 2009, INT J POULTRY SCI, V8, P122; Sun M., 2013, GENOME ANNOUNC, V1; Susta L, 2013, MICROB PATHOGENESIS, V61-62, P73, DOI 10.1016/j.micpath.2013.05.009; Weining KC, 1996, EUR J IMMUNOL, V26, P2440, DOI 10.1002/eji.1830261026; Xu JJ, 2012, J ANIM VET ADV, V11, P4394; Yeh HY, 1999, J INTERF CYTOK RES, V19, P687, DOI 10.1089/107999099313848; Yin JM, 2007, VIRAL IMMUNOL, V20, P288, DOI 10.1089/vim.2006.0108	48	17	19	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159153	10.1371/journal.pone.0159153	http://dx.doi.org/10.1371/journal.pone.0159153			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27409587	gold, Green Published, Green Submitted			2022-12-27	WOS:000379508300061
J	Lassale, C; Gunter, MJ; Romaguera, D; Peelen, LM; Van der Schouw, YT; Beulens, JWJ; Freisling, H; Muller, DC; Ferrari, P; Huybrechts, I; Fagherazzi, G; Boutron-Ruault, MC; Affret, A; Overvad, K; Dahm, CC; Olsen, A; Roswall, N; Tsilidis, KK; Katzke, VA; Kuhn, T; Buijsse, B; Quiros, JR; Sanchez-Cantalejo, E; Etxezarreta, N; Huerta, JM; Barricarte, A; Bonet, C; Khaw, KT; Key, TJ; Trichopoulou, A; Bamia, C; Lagiou, P; Palli, D; Agnoli, C; Tumino, R; Fasanelli, F; Panico, S; Bueno-De-Mesquita, HB; Boer, JMA; Sonestedt, E; Nilsson, LM; Renstrom, F; Weiderpass, E; Skeie, G; Lund, E; Moons, KGM; Riboli, E; Tzoulaki, I				Lassale, Camille; Gunter, Marc J.; Romaguera, Dora; Peelen, Linda M.; Van der Schouw, Yvonne T.; Beulens, Joline W. J.; Freisling, Heinz; Muller, David C.; Ferrari, Pietro; Huybrechts, Inge; Fagherazzi, Guy; Boutron-Ruault, Marie-Christine; Affret, Aurelie; Overvad, Kim; Dahm, Christina C.; Olsen, Anja; Roswall, Nina; Tsilidis, Konstantinos K.; Katzke, Verena A.; Kuehn, Tilman; Buijsse, Brian; Quiros, Jose-Ramon; Sanchez-Cantalejo, Emilio; Etxezarreta, Nerea; Maria Huerta, Jose; Barricarte, Aurelio; Bonet, Catalina; Khaw, Kay-Tee; Key, Timothy J.; Trichopoulou, Antonia; Bamia, Christina; Lagiou, Pagona; Palli, Domenico; Agnoli, Claudia; Tumino, Rosario; Fasanelli, Francesca; Panico, Salvatore; Bueno-de-Mesquita, H. Bas; Boer, Jolanda M. A.; Sonestedt, Emily; Nilsson, Lena Maria; Renstrom, Frida; Weiderpass, Elisabete; Skeie, Guri; Lund, Eiliv; Moons, Karel G. M.; Riboli, Elio; Tzoulaki, Ioanna			Diet Quality Scores and Prediction of All-Cause, Cardiovascular and Cancer Mortality in a Pan-European Cohort Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; HEALTHY EATING INDEX; POSTMENOPAUSAL WOMEN; MULTIETHNIC COHORT; MEDITERRANEAN DIET; EPIC PROJECT; LIFE-STYLE; RISK; ADHERENCE; NUTRITION	Scores of overall diet quality have received increasing attention in relation to disease aetiology; however, their value in risk prediction has been little examined. The objective was to assess and compare the association and predictive performance of 10 diet quality scores on 10-year risk of all-cause, CVD and cancer mortality in 451,256 healthy participants to the European Prospective Investigation into Cancer and Nutrition, followed-up for a median of 12.8y. All dietary scores studied showed significant inverse associations with all outcomes. The range of HRs (95% CI) in the top vs. lowest quartile of dietary scores in a composite model including non-invasive factors (age, sex, smoking, body mass index, education, physical activity and study centre) was 0.75 (0.72-0.79) to 0.88 (0.84-0.92) for all-cause, 0.76 (0.69-0.83) to 0.84 (0.76-0.92) for CVD and 0.78 (0.73-0.83) to 0.91 (0.85-0.97) for cancer mortality. Models with dietary scores alone showed low discrimination, but composite models also including age, sex and other non-invasive factors showed good discrimination and calibration, which varied little between different diet scores examined. Mean C-statistic of full models was 0.73, 0.80 and 0.71 for all-cause, CVD and cancer mortality. Dietary scores have poor predictive performance for 10-year mortality risk when used in isolation but display good predictive ability in combination with other non-invasive common risk factors.	[Lassale, Camille; Gunter, Marc J.; Romaguera, Dora; Tsilidis, Konstantinos K.; Riboli, Elio; Tzoulaki, Ioanna] Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Romaguera, Dora] Inst Invest Sanit Palma IdISPa, Palma De Mallorca, Spain; [Romaguera, Dora; Sanchez-Cantalejo, Emilio; Etxezarreta, Nerea; Maria Huerta, Jose; Barricarte, Aurelio; Bonet, Catalina] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Madrid, Spain; [Peelen, Linda M.; Van der Schouw, Yvonne T.; Beulens, Joline W. J.; Moons, Karel G. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Epidemiol, Utrecht, Netherlands; [Freisling, Heinz; Muller, David C.; Ferrari, Pietro; Huybrechts, Inge] Int Agcy Res Canc, Lyon, France; [Fagherazzi, Guy; Boutron-Ruault, Marie-Christine; Affret, Aurelie] Inst Natl Sante & Rech Med, Ctr Res Epidemiol & Populat, U1018, Hlth,Team 9, Villejuif, France; [Fagherazzi, Guy; Boutron-Ruault, Marie-Christine; Affret, Aurelie] Inst Gustave Roussy, Villejuif, France; [Fagherazzi, Guy; Boutron-Ruault, Marie-Christine; Affret, Aurelie] Paris South Univ, Unite Mixte Rech 1018, Villejuif, France; [Overvad, Kim; Dahm, Christina C.] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark; [Olsen, Anja; Roswall, Nina] Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark; [Tsilidis, Konstantinos K.] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Katzke, Verena A.; Kuehn, Tilman] Deutsch Inst Ernahrungsforsch Potsdam Rehbrucke, German Inst Human Nutr, Potsdam, Germany; [Buijsse, Brian] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Ioannina, Greece; [Quiros, Jose-Ramon] Publ Hlth Directorate, Oviedo, Spain; [Sanchez-Cantalejo, Emilio] Andalusian Sch Publ Hlth, Granada, Spain; [Etxezarreta, Nerea] Publ Hlth Direct, San Sebastian, Spain; [Etxezarreta, Nerea] Biodonostia Basque Reg Hlth Dept, San Sebastian, Spain; [Maria Huerta, Jose] Murcia Reg Hlth Council, Dept Epidemiol, Murcia, Spain; [Barricarte, Aurelio] Navarre Publ Hlth Inst, Pamplona, Spain; [Bonet, Catalina] Catalan Inst Oncol, Unit Nutr Environm & Canc, Barcelona, Spain; [Khaw, Kay-Tee] Univ Cambridge, Sch Clin Med, Clin Gerontol Unit, Cambridge, England; [Key, Timothy J.] Univ Oxford, Nuffield Dept Clin Med, Canc Epidemiol Unit, Oxford OX1 2JD, England; [Trichopoulou, Antonia; Bamia, Christina; Lagiou, Pagona] Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, Athens, Greece; [Trichopoulou, Antonia; Bamia, Christina; Lagiou, Pagona] Hellen Hlth Fdn, Athens, Greece; [Palli, Domenico] Canc Res & Prevent Inst ISPO, Mol & Nutr Epidemiol Unit, Florence, Italy; [Agnoli, Claudia] Fdn Carlo Besta Neurol Inst, Epidemiol & Prevent Unit, Dept Prevent & Predict Med, Milan, Italy; [Tumino, Rosario] Civic MP Arezzo Hosp, Canc Registry & Histopathol Unit, Ragusa, Italy; [Fasanelli, Francesca] Human Genet Fdn, Turin, Italy; [Panico, Salvatore] Univ Naples Federico II, Dept Clin & Expt Med, Naples, Italy; [Bueno-de-Mesquita, H. Bas; Boer, Jolanda M. A.] Natl Inst Publ Hlth & Environm, Ctr Nutr Prevent & Hlth Serv, Bilthoven, Netherlands; [Sonestedt, Emily] Lund Univ, Dept Clin Sci Malmo, Lund, Sweden; [Nilsson, Lena Maria; Renstrom, Frida] Umea Univ, Dept Publ Hlth & Clin Med, Nutr Res, Umea, Sweden; [Weiderpass, Elisabete; Skeie, Guri; Lund, Eiliv] Univ Tromso, Arctic Univ Norway, Dept Community Med, Fac Hlth Sci, Tromso, Norway; [Weiderpass, Elisabete] Canc Registry Norway, Dept Res, Oslo, Norway; [Weiderpass, Elisabete] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Weiderpass, Elisabete] Folkhalsan Res Ctr, Genet Epidemiol Grp, Helsinki, Finland	Imperial College London; Institut Investigacio Sanitaria Illes Balears (IdISBa); CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Utrecht University; Utrecht University Medical Center; World Health Organization; International Agency for Research on Cancer (IARC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Aarhus University; Danish Cancer Society; Helmholtz Association; German Cancer Research Center (DKFZ); Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); University of Ioannina; Escuela Andaluza de Salud Publica; Murcia Regional Health Council; Public Health Institute of Navarra; Catalan Institute of Oncology; University of Cambridge; University of Oxford; Athens Medical School; National & Kapodistrian University of Athens; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; IRCCS Istituto Neurologico Besta; Civile M.P. Arezzo Hospital; University of Naples Federico II; Netherlands National Institute for Public Health & the Environment; Lund University; Umea University; UiT The Arctic University of Tromso; University of Oslo; Karolinska Institutet; Folkhalsan Research Center	Tzoulaki, I (corresponding author), Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England.	i.tzoulaki@imperial.ac.uk	Dahm, Christina C/G-9787-2014; Boutron-Ruault, Marie-Christine/H-3936-2014; Affret, Aurélie/T-1297-2019; Weiderpass, Elisabete/M-4029-2016; Romaguera, Dora/AAB-2852-2020; Tzoulaki, Ioanna/ABE-6269-2020; Fagherazzi, Guy/P-3534-2017; Weiderpass, Elisabete/AAP-2747-2021; Muller, David C/V-8207-2017; Huerta, José María/N-8654-2015; Fagherazzi, Guy/ABB-2555-2020; Romaguera, Dora/ABE-7004-2020; Bonet, Catalina/AFR-7176-2022; TRICHOPOULOU, ANTONIA/ABF-8727-2021; van der Schouw, Yvonne T./F-8327-2014; Khaw, Kay-Tee/AAZ-3209-2021; Lassale, Camille/ABE-7813-2020; Gunter, Marc/AAP-8621-2020; Roswall, Nina/AAJ-6700-2020; Agnoli, Claudia/K-5916-2016	Dahm, Christina C/0000-0003-0481-2893; Boutron-Ruault, Marie-Christine/0000-0002-5956-5693; Affret, Aurélie/0000-0002-6070-1197; Weiderpass, Elisabete/0000-0003-2237-0128; Tzoulaki, Ioanna/0000-0002-4275-9328; Fagherazzi, Guy/0000-0001-5033-5966; Weiderpass, Elisabete/0000-0003-2237-0128; Muller, David C/0000-0002-2350-0417; Huerta, José María/0000-0002-9637-3869; Fagherazzi, Guy/0000-0001-5033-5966; Romaguera, Dora/0000-0002-5762-8558; TRICHOPOULOU, ANTONIA/0000-0002-7204-6396; van der Schouw, Yvonne T./0000-0002-4605-435X; Lassale, Camille/0000-0002-9340-2708; Roswall, Nina/0000-0003-3071-1658; Agnoli, Claudia/0000-0003-4472-1179; Lund, Eiliv/0000-0002-8071-8711; Gunter, Marc/0000-0001-5472-6761; Bonet, Catalina/0000-0003-0259-2591; Riboli, Elio/0000-0001-6795-6080; Nilsson, Lena Maria/0000-0002-2354-7258; Olsen, Anja/0000-0003-4788-503X; Skeie, Guri/0000-0003-2476-4251; Freisling, Heinz/0000-0001-8648-4998; Tsilidis, Konstantinos/0000-0002-8452-8472; Beulens, Joline/0000-0002-4181-0937; Rasul, holem/0000-0003-0579-9029; Overvad, Kim/0000-0001-6429-7921; tumino, rosario/0000-0003-2666-414X	European Commission (D-GSANCO); International Agency for Research on Cancer; Danish Cancer Society (Denmark); Ligue Contre le Cancer (France); Institut Gustave Roussy (France); Mutuelle Generale de l'Education Nationale (France); Institut National de la Sante et de la Recherche Medicale (INSERM) (France); German Cancer Aid, German Cancer Research Center (DKFZ) (Germany); Federal Ministry of Education and Research (BMBF) (Germany); Deutsche Krebshilfe (Germany); Deutsches Krebsforschungszentrum (Germany); Federal Ministry of Education and Research (Germany); Hellenic Health Foundation (Greece); Associazione Italiana per la Ricerca sul Cancro-AIRC- Italy (Italy); National Research Council (Italy); Dutch Ministry of Public Health, Welfare and Sports (VWS); Netherlands Cancer Registry (NKR); LK Research Funds; Dutch Prevention Funds; Dutch ZON (Zorg Onderzoek Nederland); World Cancer Research Fund (WCRF); Statistics Netherlands (The Netherlands); Health Research Fund (FIS) [PI13/00061]; Regional Governments of Andalucia, Asturias, Basque Country, Murcia [6236]; Navarra, ISCIII RETIC [RD06/0020]; Swedish Cancer Society, Swedish Research Council and County Councils of Skane and Vasterbotten (Sweden); Cancer Research UK [14136, C570/A16491, C8221/A19170]; Medical Research Council (United Kingdom) [1000143, MR/M012190/1]; MRC [MR/N003284/1] Funding Source: UKRI; Cancer Research UK [16491] Funding Source: researchfish; Medical Research Council [G1000143, MR/N003284/1, G0401527] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10114] Funding Source: researchfish	European Commission (D-GSANCO)(European CommissionEuropean Commission Joint Research Centre); International Agency for Research on Cancer; Danish Cancer Society (Denmark)(Danish Cancer Society); Ligue Contre le Cancer (France); Institut Gustave Roussy (France); Mutuelle Generale de l'Education Nationale (France); Institut National de la Sante et de la Recherche Medicale (INSERM) (France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); German Cancer Aid, German Cancer Research Center (DKFZ) (Germany); Federal Ministry of Education and Research (BMBF) (Germany)(Federal Ministry of Education & Research (BMBF)); Deutsche Krebshilfe (Germany)(Deutsche Krebshilfe); Deutsches Krebsforschungszentrum (Germany); Federal Ministry of Education and Research (Germany)(Federal Ministry of Education & Research (BMBF)); Hellenic Health Foundation (Greece); Associazione Italiana per la Ricerca sul Cancro-AIRC- Italy (Italy)(Fondazione AIRC per la ricerca sul cancro); National Research Council (Italy)(Consiglio Nazionale delle Ricerche (CNR)); Dutch Ministry of Public Health, Welfare and Sports (VWS); Netherlands Cancer Registry (NKR); LK Research Funds; Dutch Prevention Funds; Dutch ZON (Zorg Onderzoek Nederland)(Netherlands Organization for Scientific Research (NWO)); World Cancer Research Fund (WCRF)(World Cancer Research Fund International (WCRF)); Statistics Netherlands (The Netherlands)(Netherlands Government); Health Research Fund (FIS)(Instituto de Salud Carlos III); Regional Governments of Andalucia, Asturias, Basque Country, Murcia; Navarra, ISCIII RETIC; Swedish Cancer Society, Swedish Research Council and County Councils of Skane and Vasterbotten (Sweden); Cancer Research UK(Cancer Research UK); Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The coordination of EPIC is financially supported by the European Commission (D-GSANCO) and the International Agency for Research on Cancer. The national cohorts are supported by Danish Cancer Society (Denmark); Ligue Contre le Cancer, Institut Gustave Roussy, Mutuelle Generale de l'Education Nationale, Institut National de la Sante et de la Recherche Medicale (INSERM) (France); German Cancer Aid, German Cancer Research Center (DKFZ), Federal Ministry of Education and Research (BMBF), Deutsche Krebshilfe, Deutsches Krebsforschungszentrum and Federal Ministry of Education and Research (Germany); the Hellenic Health Foundation (Greece); Associazione Italiana per la Ricerca sul Cancro-AIRC- Italy and National Research Council (Italy); Dutch Ministry of Public Health, Welfare and Sports (VWS), Netherlands Cancer Registry (NKR), LK Research Funds, Dutch Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland), World Cancer Research Fund (WCRF), Statistics Netherlands (The Netherlands); Health Research Fund (FIS), PI13/00061 to Granada, Regional Governments of Andalucia, Asturias, Basque Country, Murcia (no. 6236) and Navarra, ISCIII RETIC (RD06/0020) (Spain); Swedish Cancer Society, Swedish Research Council and County Councils of Skane and Vasterbotten (Sweden); Cancer Research UK (14136 to EPIC-Norfolk; C570/A16491 and C8221/A19170 to EPIC-Oxford), Medical Research Council (1000143 to EPIC-Norfolk, MR/M012190/1 to EPIC-Oxford) (United Kingdom).	Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; Berentzen NE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070535; Buckland G, 2009, AM J EPIDEMIOL, V170, P1518, DOI 10.1093/aje/kwp282; Chiuve SE, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000954; Chiuve SE, 2012, J NUTR, V142, P1009, DOI 10.3945/jn.111.157222; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Fransen HP, 2008, CURR OPIN CLIN NUTR, V11, P559, DOI 10.1097/MCO.0b013e32830a49db; Fung TT, 2008, ARCH INTERN MED, V168, P713, DOI 10.1001/archinte.168.7.713; George SM, 2014, AM J EPIDEMIOL, V180, P616, DOI 10.1093/aje/kwu173; Guenther PM, 2013, J ACAD NUTR DIET, V113, P569, DOI 10.1016/j.jand.2012.12.016; Harmon BE, 2015, AM J CLIN NUTR, V101, P587, DOI 10.3945/ajcn.114.090688; Hippisley-Cox J, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007825; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Ireland J, 2002, EUR J CLIN NUTR, V56, pS33, DOI 10.1038/sj.ejcn.1601427; Jankovic N, 2014, AM J EPIDEMIOL, V180, P978, DOI 10.1093/aje/kwu229; Kaaks R, 1997, INT J EPIDEMIOL, V26, pS15, DOI 10.1093/ije/26.suppl_1.S15; Kim S, 2003, J NUTR, V133, P3476, DOI 10.1093/jn/133.11.3476; Kipnis V, 2002, PUBLIC HEALTH NUTR, V5, P915, DOI 10.1079/PHN2002383; McKenzie F, 2015, INT J CANCER, V136, P2640, DOI 10.1002/ijc.29315; Mendis S., 2011, GLOBAL ATLAS CARDIOV; Olsen A, 2011, J NUTR, V141, P639, DOI 10.3945/jn.110.131375; Paynter NP, 2014, CIRCULATION, V130, P1466, DOI 10.1161/CIRCULATIONAHA.114.012069; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Price HC, 2011, DIABETIC MED, V28, P363, DOI 10.1111/j.1464-5491.2010.03212.x; Reedy J, 2014, J NUTR, V144, P881, DOI 10.3945/jn.113.189407; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Riboli E, 1997, INT J EPIDEMIOL, V26, pS6, DOI 10.1093/ije/26.suppl_1.S6; Roswall N, 2015, EUR J EPIDEMIOL, V30, P509, DOI 10.1007/s10654-015-0021-x; Roswall N, 2014, PUBLIC HEALTH NUTR, V17, P2650, DOI 10.1017/S1368980014000159; Rumawas ME, 2009, J NUTR, V139, P1150, DOI 10.3945/jn.108.103424; Schwingshackl L, 2015, J ACAD NUTR DIET, V115, P780, DOI 10.1016/j.jand.2014.12.009; Siontis GCM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3318; Siontis GCM, 2011, ARCH INTERN MED, V171, P1721, DOI 10.1001/archinternmed.2011.334; Slimani N, 2007, EUR J CLIN NUTR, V61, P1037, DOI 10.1038/sj.ejcn.1602679; Sofi F, 2014, PUBLIC HEALTH NUTR, V17, P2769, DOI 10.1017/S1368980013003169; Steyerberg E., 2009, CLIN PREDICTION MODE; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; Vergnaud AC, 2013, AM J CLIN NUTR, V97, P1107, DOI 10.3945/ajcn.112.049569; Waijers PMCM, 2007, BRIT J NUTR, V97, P219, DOI 10.1017/S0007114507250421; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; WCRF/AICR, 2015, CANC LINK GREAT BOD; WCRF/AICR, 2007, FOOD NUTR PHYS ACT P; WHO, 2011, ICD 10 INT STAT CLAS, V2; Yourman LC, 2012, JAMA-J AM MED ASSOC, V307, P182, DOI 10.1001/jama.2011.1966	46	60	61	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159025	10.1371/journal.pone.0159025	http://dx.doi.org/10.1371/journal.pone.0159025			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27409582	Green Submitted, Green Published, gold			2022-12-27	WOS:000379508300050
J	Tian, YJ; Ma, ZM; Chen, ZH; Li, MG; Wu, ZP; Hong, M; Wang, HZ; Svatek, R; Rodriguez, R; Wang, ZP				Tian, Yuejun; Ma, Zhiming; Chen, Zhaohui; Li, Mingguo; Wu, Zhiping; Hong, Mei; Wang, Hanzhang; Svatek, Robert; Rodriguez, Ronald; Wang, Zhiping			Clinicopathological and Prognostic Value of Ki-67 Expression in Bladder Cancer: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							TRANSITIONAL-CELL CARCINOMA; TRANSURETHRAL RESECTION SPECIMENS; CYCLE REGULATORY PROTEINS; PREDICTIVE-VALUE; UROTHELIAL CARCINOMA; URINARY-BLADDER; LABELING INDEX; E-CADHERIN; PROGRESSION; SURVIVAL	Background Ki-67 is an established marker of cell proliferation, and the Ki-67 index correlates with the clinical course of several cancer types, including bladder cancer (BC). However, the clinicopathological and prognostic significance of Ki-67 in bladder cancer remains unclear. Therefore, we performed a systematic review and meta-analysis to clarify this relationship. Methods A comprehensive literature search for relevant studies published up to February 1, 2016, was performed using PubMed, Cochrane Library, Embase and ISI Web of Knowledge. The effects of Ki-67 expression on survival outcome in patients with BC and BC subtypes were evaluated. Furthermore, the relationship between Ki-67 expression and the clinicopathological features of BC were assessed. Results Thirty-one studies with 5147 bladder cancer patients were selected for evaluation. Ki- 67 expression was significantly associated with shorter recurrence-free (HR 1.69, 95% CI: 1.33-2.14), progression- free (HR 1.89, 95% CI: 1.43-2.51), overall (HR 2.03, 95% CI: 1.31-3.16), and cancer-specific (HR 1.69, 95% CI: 1.47-1.95) survival. Moreover, whereas high expression was more common in high tumor stage, recurrence status, tumor size, there was no correlation between high Ki-67 expression and age, gender, smoking habits, and tumor number. Importantly, analysis of the different subgroups of BC suggested that significant correlations between high Ki-67 expression and survival outcome (recurrencefree/progression-free/overall/cancer-specificsurvival) are present only in European-American patients. Conclusion The present results indicate that over-expression of Ki-67 is distinctly correlated with poor patient survival. Ki-67 may serve as a valuable biomarker for prognosis in BC patients, particularly in non-Asian BC patients. The results suggest no significant association between Ki-67 expression and BC prognosis in Asian patients. Further efforts are needed to fully clarify this relationship.	[Tian, Yuejun; Ma, Zhiming; Chen, Zhaohui; Li, Mingguo; Hong, Mei; Wang, Zhiping] Lanzhou Univ, Hosp 2, Clin Ctr Gansu Prov Nephrourol, Key Lab Gansu Prov Urol Dis,Inst Urol, Lanzhou, Peoples R China; [Wu, Zhiping] Lanzhou Univ, Hosp 2, Dept Gastroenterol, Lanzhou, Peoples R China; [Wang, Hanzhang; Svatek, Robert; Rodriguez, Ronald] Univ Texas Hlth Sci Ctr San Antonio, Dept Urol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA	Lanzhou University; Lanzhou University; University of Texas System; University of Texas Health San Antonio	Wang, ZP (corresponding author), Lanzhou Univ, Hosp 2, Clin Ctr Gansu Prov Nephrourol, Key Lab Gansu Prov Urol Dis,Inst Urol, Lanzhou, Peoples R China.	erywzp@lzu.edu.com		Tian, Yuejun/0000-0001-5798-8142	National Natural Science Foundation of China [81372733/H1619]; Fundamental Scientific Research Fund for Colleges and Universities Directly Under the Ministry of Education [lzujbky-2014-165]; Twelfth Five-Year National Science and Technology Support Program projects [2012BAI10B01]; National Science Foundation of China [81302240]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Scientific Research Fund for Colleges and Universities Directly Under the Ministry of Education; Twelfth Five-Year National Science and Technology Support Program projects; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (grant no. 81372733/H1619), the National Science Foundation of China (no. 81302240), the Fundamental Scientific Research Fund for Colleges and Universities Directly Under the Ministry of Education (no. lzujbky-2014-165), and the Twelfth Five-Year National Science and Technology Support Program projects (2012BAI10B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Natural Science Foundation of China (Grant No. 81372733/H1619), the National Science Foundation of China (No. 81302240), the Fundamental Scientific Research Fund for Colleges and Universities Directly Under the Ministry of Education (No. lzujbky-2014-165), and the Twelfth Five-Year National Science and Technology Support Program projects (2012BAI10B01).	Acikalin D, 2012, TUMORI, V98, P344, DOI 10.1700/1125.12403; Avritscher EBC, 2006, UROLOGY, V68, P549, DOI 10.1016/j.urology.2006.03.062; Behnsawy HM, 2011, UROL ONCOL-SEMIN ORI, V29, P495, DOI 10.1016/j.urolonc.2009.08.002; Bertz S, 2014, EUR UROL, V65, P218, DOI 10.1016/j.eururo.2012.05.033; Bi JB, 2012, UROL ONCOL-SEMIN ORI, V30, P688, DOI 10.1016/j.urolonc.2010.08.001; Bryan RT, 2010, BJU INT, V105, P608, DOI 10.1111/j.1464-410X.2009.08880.x; Chen JY, 2012, GUILTY OF INDIGENCE: THE URBAN POOR IN CHINA, 1900-1953, P13; da Silva SD, 2015, CLIN EXP METASTAS, V32, P55, DOI 10.1007/s10585-014-9690-1; Ding WH, 2014, UROL ONCOL-SEMIN ORI, V32, DOI 10.1016/j.urolonc.2013.05.004; Freedman ND, 2011, JAMA-J AM MED ASSOC, V306, P737, DOI 10.1001/jama.2011.1142; Gakiopoulou-Givalou H, 2003, HISTOPATHOLOGY, V43, P272, DOI 10.1046/j.1365-2559.2003.01690.x; Galmozzi F, 2006, J CANCER RES CLIN, V132, P757, DOI 10.1007/s00432-006-0123-7; Gayed BA, 2014, BJU INT, V113, P668, DOI 10.1111/bju.12263; Gontero P, 2014, UROL INT, V92, P136, DOI 10.1159/000351961; Hilmy M, 2006, BRIT J CANCER, V95, P1234, DOI 10.1038/sj.bjc.6603415; Islam SS, 2016, MOL CARCINOGEN, V55, P537, DOI 10.1002/mc.22300; Kamai T, 2001, BRIT J CANCER, V84, P1242, DOI 10.1054/bjoc.2000.1736; Krabbe LM, 2015, J UROLOGY, V193, P1486, DOI 10.1016/j.juro.2014.11.007; Kruger S, 2003, EUR UROL, V43, P138, DOI 10.1016/S0302-2838(02)00580-8; Lan YJ, 2014, PATHOL ONCOL RES, V20, P263, DOI 10.1007/s12253-013-9690-5; Lopez-Beltran A, 2004, AM J CLIN PATHOL, V122, P444, DOI 10.1309/LTFU3UUMBY095HUM; Lotan Y, 2006, CANCER-AM CANCER SOC, V107, P982, DOI 10.1002/cncr.22084; Maeng YH, 2010, KOREAN J UROL, V51, P94, DOI 10.4111/kju.2010.51.2.94; Mahnken A, 2005, ONCOL REP, V14, P1065; Makboul R, 2015, KOREAN J UROL, V56, P31, DOI 10.4111/kju.2015.56.1.31; Margulis V, 2009, JNCI-J NATL CANCER I, V101, P114, DOI 10.1093/jnci/djn451; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Mylona E, 2006, ANTICANCER RES, V26, P3567; Oderda M, 2013, UROL INT, V90, P184, DOI 10.1159/000343431; Otto W, 2013, CLIN GENITOURIN CANC, V11, P537, DOI 10.1016/j.clgc.2013.05.001; Park J, 2013, UROL ONCOL-SEMIN ORI, V31, P849, DOI 10.1016/j.urolonc.2011.06.004; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Pichu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048567; Poyet C, 2015, J CLIN PATHOL, V68, P819, DOI 10.1136/jclinpath-2015-202898; Quintero A, 2006, J CLIN PATHOL, V59, P83, DOI 10.1136/jcp.2004.022939; Ruan J, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0445-z; Santos LL, 2003, EUR J SURG ONCOL, V29, P74, DOI 10.1053/ejso.2002.1371; Schepeler T, 2013, ONCOGENE, V32, P3577, DOI 10.1038/onc.2012.381; SCHLUTER C, 1993, J CELL BIOL, V123, P513, DOI 10.1083/jcb.123.3.513; Seo HK, 2010, UROLOGY, V76, DOI 10.1016/j.urology.2010.04.040; Shan GY, 2012, TUMOR BIOL, V33, P847, DOI 10.1007/s13277-011-0311-1; Shariat SF, 2009, J UROLOGY, V182, P78, DOI 10.1016/j.juro.2009.02.125; Shui RH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125131; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Tanabe K, 2015, CLIN GENITOURIN CANC, V13, pE243, DOI 10.1016/j.clgc.2015.03.002; Theodoropoulos VE, 2005, BJU INT, V95, P425, DOI 10.1111/j.1464-410X.2005.05314.x; Wang LC, 2014, UROL ONCOL-SEMIN ORI, V32, P433, DOI 10.1016/j.urolonc.2013.10.015; Wang LJ, 2016, INT UROL NEPHROL, V48, P495, DOI 10.1007/s11255-015-1197-4; Wang LJ, 2014, TUMOR BIOL, V35, P2989, DOI 10.1007/s13277-013-1384-9; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Weiss C, 2005, STRAHLENTHER ONKOL, V181, P213, DOI 10.1007/s00066-005-1417-4; Wen S, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1524-2; Wosnitzer MS, 2011, J UROLOGY, V186, P2094, DOI 10.1016/j.juro.2011.06.051; Youssef RF, 2011, HUM PATHOL, V42, P347, DOI 10.1016/j.humpath.2010.07.012; Yu Jian-Qin, 2015, Asian Pac J Cancer Prev, V16, P4271; Yurakh AO, 2006, EUR UROL, V50, P506, DOI 10.1016/j.eururo.2006.03.027; Zintzaras E, 2005, BIOINFORMATICS, V21, P3672, DOI 10.1093/bioinformatics/bti536	58	35	39	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158891	10.1371/journal.pone.0158891	http://dx.doi.org/10.1371/journal.pone.0158891			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410033	Green Published, gold, Green Submitted			2022-12-27	WOS:000379508300041
J	Fu, Q; Zhou, XY; Dong, Y; Huang, YH; Yang, JH; Oh, KW; Hu, ZZ				Fu, Qiang; Zhou, Xiaoyan; Dong, Yun; Huang, Yonghong; Yang, Jianhua; Oh, Ki-Wan; Hu, Zhenzhen			Decreased Caffeine-Induced Locomotor Activity via Microinjection of CART Peptide into the Nucleus Accumbens Is Linked to Inhibition of the pCaMKIIa-D3R Interaction	PLOS ONE			English	Article							AMPHETAMINE-REGULATED TRANSCRIPT; CONDITIONED PLACE PREFERENCE; D3 DOPAMINE-RECEPTORS; MESSENGER-RNA; GENE-EXPRESSION; PROTEIN-KINASE; CAMKII-ALPHA; RAT-BRAIN; COCAINE; CREB	The purpose of this study was to characterize the inhibitory modulation of cocaine-and amphetamine-regulated transcript (CART) peptides, particularly with respect to the function of the D-3 dopamine receptor (D3R), which is activated by its interaction with phosphorylated CaMKII alpha (pCaMKII alpha) in the nucleus accumbens (NAc). After repeated oral administration of caffeine (30 mg/kg) for five days, microinjection of CART peptide (0.08 mu M/0.5 mu l/hemisphere) into the NAc affected locomotor behavior. The pCaMKII alpha-D3R interaction, D3R phosphorylation and cAMP/PKA/phosphorylated CREB (pCREB) signaling pathway activity were measured in NAc tissues, and Ca2+ influx and pCaMKIIa levels were measured in cultured NAc neurons. We found that CART attenuated the caffeine-mediated enhancement of depolarization-induced Ca2+ influx and CaMKII alpha phosphorylation in cultured NAc neurons. Repeated microinjection of CART peptides into the NAc decreased the caffeine-induced enhancement of Ca2+ channels activity, pCaMKII alpha levels, the pCaMKII alpha-D3R interaction, D3R phosphorylation, cAMP levels, PKA activity and pCREB levels in the NAc. Furthermore, behavioral sensitization was observed in rats that received five-day administration of caffeine following microinjection of saline but not in rats that were treated with caffeine following microinjection of CART peptide. These results suggest that caffeine-induced CREB phosphorylation in the NAc was ameliorated by CART peptide due to its inhibition of D3R phosphorylation. These effects of CART peptides may play a compensatory role by inhibiting locomotor behavior in rats.	[Fu, Qiang] Nanchang Univ, Affiliated Hosp 4, Dept Respirat, Nanchang, Jiangxi, Peoples R China; [Fu, Qiang] Jiangxi Prov Peoples Hosp, Dept 2, Dept Respirat, Nanchang, Jiangxi, Peoples R China; [Zhou, Xiaoyan; Huang, Yonghong; Hu, Zhenzhen] Nanchang Univ, Coll Med, Dept Pathophysiol, Nanchang, Jiangxi, Peoples R China; [Dong, Yun] Jiangxi Tumor Hosp, Dept Breast Surg, Nanchang, Jiangxi, Peoples R China; [Yang, Jianhua] Nanchang Univ, Coll Med, Dept Physiol, Nanchang, Jiangxi, Peoples R China; [Oh, Ki-Wan] Chungbuk Natl Univ, Coll Pharm, Cheongju, South Korea	Nanchang University; Nanchang University; Nanchang University; Chungbuk National University	Hu, ZZ (corresponding author), Nanchang Univ, Coll Med, Dept Pathophysiol, Nanchang, Jiangxi, Peoples R China.	huzhenzhen@ncu.edu.cn			National Foundation of China [81201035]; Health and Family Planning Commission of Jiangxi province [2015A041]	National Foundation of China; Health and Family Planning Commission of Jiangxi province	This work was supported by the National Foundation of China (Grant no. 81201035, http://www.nsfc.gov.cn/, ZH) and the Health and Family Planning Commission of Jiangxi province (Grant no. 2015A041, http://www.jxwst.gov.cn/, ZH).	Ahlgren-Beekendorf JA, 2004, J RECEPT SIG TRANSD, V24, P117, DOI 10.1081/LRST-200029953; Avalos-Fuentes A, 2013, NEUROPHARMACOLOGY, V71, P273, DOI 10.1016/j.neuropharm.2013.04.010; Beaudry G, 2004, SYNAPSE, V51, P233, DOI 10.1002/syn.10302; Biala G, 2003, POL J PHARMACOL, V55, P327; Brunzell DH, 2009, NEUROPSYCHOPHARMACOL, V34, P1993, DOI 10.1038/npp.2009.11; Cai ZY, 2014, BRAIN RES, V1557, P101, DOI 10.1016/j.brainres.2014.02.024; Cappelletti S, 2015, CURR NEUROPHARMACOL, V13, P71, DOI 10.2174/1570159X13666141210215655; Carelli RM, 2002, PHYSIOL BEHAV, V76, P379, DOI 10.1016/S0031-9384(02)00760-6; Cho JH, 2015, NEUROPEPTIDES, V50, P1, DOI 10.1016/j.npep.2015.03.004; Connolly S, 2010, BIOCHEM BIOPH RES CO, V397, P152, DOI 10.1016/j.bbrc.2010.05.054; Couceyro PR, 2005, J PHARMACOL EXP THER, V315, P1091, DOI 10.1124/jpet.105.091678; Cruz-Trujillo R, 2013, NEUROPHARMACOLOGY, V67, P370, DOI 10.1016/j.neuropharm.2012.11.032; Dallvechia-Adams S, 2002, J COMP NEUROL, V448, P360, DOI 10.1002/cne.10268; de Lartigue G, 2007, J NEUROSCI, V27, P2876, DOI 10.1523/JNEUROSCI.5508-06.2007; DiRocco DP, 2009, J NEUROSCI, V29, P2393, DOI 10.1523/JNEUROSCI.4356-08.2009; Dominguez G, 2004, MOL BRAIN RES, V126, P22, DOI 10.1016/j.molbrainres.2004.02.027; DOUGLASS J, 1995, J NEUROSCI, V15, P2471; Ferre S, 2010, J ALZHEIMERS DIS, V20, pS35, DOI 10.3233/JAD-2010-1400; Hollander JA, 2010, NATURE, V466, P197, DOI 10.1038/nature09202; Hu ZZ, 2015, KOREAN J PHYSIOL PHA, V19, P89, DOI 10.4196/kjpp.2015.19.2.89; Hu ZZ, 2014, BEHAV PHARMACOL, V25, P32, DOI 10.1097/FBP.0000000000000016; Hubert GW, 2010, NEUROSCIENCE, V165, P179, DOI 10.1016/j.neuroscience.2009.10.013; Hunter RG, 2006, NEUROPHARMACOLOGY, V50, P858, DOI 10.1016/j.neuropharm.2005.12.007; Jaworski JN, 2007, NEUROPEPTIDES, V41, P65, DOI 10.1016/j.npep.2006.12.003; Jaworski JN, 2006, PEPTIDES, V27, P1993, DOI 10.1016/j.peptides.2006.03.034; Jaworski JN, 2003, J PHARMACOL EXP THER, V307, P1038, DOI 10.1124/jpet.103.052332; Jones DC, 2009, NEUROSCIENCE, V160, P339, DOI 10.1016/j.neuroscience.2009.02.051; Jones DC, 2006, J PHARMACOL EXP THER, V317, P454, DOI 10.1124/jpet.105.096123; Kaya E, 2016, SYNAPSE, V70, P283, DOI 10.1002/syn.21903; KIM HS, 1995, GEN PHARMACOL, V26, P1071, DOI 10.1016/0306-3623(94)00267-Q; Kimmel HL, 2000, J PHARMACOL EXP THER, V294, P784; Kurokawa K, 2011, NEUROSCIENCE, V176, P328, DOI 10.1016/j.neuroscience.2010.11.062; Lakatos A, 2002, MOL BRAIN RES, V104, P81, DOI 10.1016/S0169-328X(02)00321-2; Larson EB, 2015, J NEUROSCI, V35, P3537, DOI 10.1523/JNEUROSCI.1524-14.2015; Larson EB, 2011, J NEUROSCI, V31, P16447, DOI 10.1523/JNEUROSCI.3070-11.2011; Liu XY, 2009, NEURON, V61, P425, DOI 10.1016/j.neuron.2008.12.015; Loweth JA, 2008, NEUROSCI LETT, V444, P157, DOI 10.1016/j.neulet.2008.08.004; Loweth JA, 2013, J NEUROSCI, V33, P1411, DOI 10.1523/JNEUROSCI.4386-13.2013; Loweth JA, 2010, J NEUROSCI, V30, P939, DOI 10.1523/JNEUROSCI.4383-09.2010; Ma H, 2014, CELL, V159, P281, DOI 10.1016/j.cell.2014.09.019; Moffett MC, 2011, SYNAPSE, V65, P1, DOI 10.1002/syn.20815; Newman AH, 2005, J MED CHEM, V48, P3663, DOI 10.1021/jm040190e; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Peng QH, 2014, NEUROCHEM INT, V75, P105, DOI 10.1016/j.neuint.2014.06.005; Salinas A, 2006, J NEUROCHEM, V97, P408, DOI 10.1111/j.1471-4159.2006.03745.x; Self DW, 1998, J NEUROSCI, V18, P1848; SHI WX, 1994, J NEUROSCI, V14, P4548	47	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0159104	10.1371/journal.pone.0159104	http://dx.doi.org/10.1371/journal.pone.0159104			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27404570	Green Published, gold, Green Submitted			2022-12-27	WOS:000379508200035
J	Yarnoff, BO; Hoerger, TJ; Simpson, SA; Pavkov, ME; Burrows, NR; Shrestha, SS; Williams, DE; Zhuo, XH				Yarnoff, Benjamin O.; Hoerger, Thomas J.; Simpson, Siobhan A.; Pavkov, Meda E.; Burrows, Nilka R.; Shrestha, Sundar S.; Williams, Desmond E.; Zhuo, Xiaohui			The Cost-Effectiveness of Anemia Treatment for Persons with Chronic Kidney Disease	PLOS ONE			English	Article							ERYTHROPOIESIS-STIMULATING AGENTS; QUALITY-OF-LIFE; DARBEPOETIN ALPHA; HEMODIALYSIS; CKD; MORTALITY; THERAPY; STROKE; TRIAL; LEVEL	Background Although major guidelines uniformly recommend iron supplementation and erythropoietin stimulating agents (ESAs) for managing chronic anemia in persons with chronic kidney disease (CKD), there are differences in the recommended hemoglobin (Hb) treatment target and no guidelines consider the costs or cost-effectiveness of treatment. In this study, we explored the most cost-effective Hb target for anemia treatment in persons with CKD stages 3-4. Methods and Findings The CKD Health Policy Model was populated with a synthetic cohort of persons over age 30 with prevalent CKD stages 3-4 (i.e., not on dialysis) and anemia created from the 19992010 National Health and Nutrition Examination Survey. Incremental cost-effectiveness ratios (ICERs), computed as incremental cost divided by incremental quality adjusted life years (QALYs), were assessed for Hb targets of 10 g/dl to 13 g/dl at 0.5 g/dl increments. Targeting a Hb of 10 g/dl resulted in an ICER of $32,111 compared with no treatment and targeting a Hb of 10.5 g/dI resulted in an ICER of $32,475 compared with a Hb target of 10 g/dl. QALYs increased to 4.63 for a Hb target of 10 g/dl and to 4.75 for a target of 10.5 g/dl or 11 g/dl. Any treatment target above 11 g/dl increased medical costs and decreased QALYs. Conclusions In persons over age 30 with CKD stages 3-4, anemia treatment is most cost-effective when targeting a Hb level of 10.5 g/dl. This study provides important information for framing guidelines related to treatment of anemia in persons with CKD.	[Yarnoff, Benjamin O.; Hoerger, Thomas J.; Simpson, Siobhan A.] RTI Int, Res Triangle Pk, NC 27709 USA; [Pavkov, Meda E.; Burrows, Nilka R.; Shrestha, Sundar S.; Williams, Desmond E.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Zhuo, Xiaohui] Merck Res Labs, N Wales, PA USA	Research Triangle Institute; Centers for Disease Control & Prevention - USA; Merck & Company	Yarnoff, BO (corresponding author), RTI Int, Res Triangle Pk, NC 27709 USA.	byarnoff@rti.org		Yarnoff, Benjamin/0000-0002-5147-1588; Hoerger, Thomas/0000-0003-4154-7806	Centers for Disease Control and Prevention (CDC) [200-2008-27958]	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research was supported by funding (Contract #200-2008-27958) from the Centers for Disease Control and Prevention (CDC). The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of CDC. Xiaohui Zhuo is now employed by Merck Laboratories, but was employed by the Centers for Disease Control and Prevention while working on this project. The funder provided support in the form of salaries for authors BOY, TJH, SAS, MEP, NRB, SSS, DEW, and XZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ara R, 2008, VALUE HEALTH, V11, P1131, DOI 10.1111/j.1524-4733.2008.00352.x; Astor BC, 2002, ARCH INTERN MED, V162, P1401, DOI 10.1001/archinte.162.12.1401; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; Blumberg N, 1996, AM J SURG, V171, P324, DOI 10.1016/S0002-9610(97)89635-3; Boulware LE, 2003, JAMA-J AM MED ASSOC, V290, P3101, DOI 10.1001/jama.290.23.3101; Centers for Medicare and Medicaid Services, 2012, MED PART B DRUG AV S; Clement FM, 2010, AM J KIDNEY DIS, V56, P1050, DOI 10.1053/j.ajkd.2010.07.015; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; Finkelstein FO, 2009, CLIN J AM SOC NEPHRO, V4, P33, DOI 10.2215/CJN.00630208; Grosse Scott D, 2008, Expert Rev Pharmacoecon Outcomes Res, V8, P165, DOI 10.1586/14737167.8.2.165; Group KAW, 2012, KIDNEY INT, V2, P279, DOI DOI 10.1038/kisup.2012.37; Hoerger TJ, 2015, AM J KIDNEY DIS, V65, P403, DOI 10.1053/j.ajkd.2014.09.023; Hoerger TJ, 2012, J AM SOC NEPHROL, V23, P2035, DOI 10.1681/ASN.2012040347; Hoerger TJ, 2010, AM J KIDNEY DIS, V55, P452, DOI 10.1053/j.ajkd.2009.11.016; Hoerger TJ, 2010, AM J KIDNEY DIS, V55, P463, DOI 10.1053/j.ajkd.2009.11.017; Kopple JD, 2001, AM J KIDNEY DIS, V37, pS66, DOI 10.1053/ajkd.2001.20748; Koulouridis I, 2013, AM J KIDNEY DIS, V61, P44, DOI 10.1053/j.ajkd.2012.07.014; Lawer EV, 2010, CLIN J AM SOC NEPHRO, V5, P667, DOI 10.2215/CJN.06020809; Leaf DE, 2009, KIDNEY INT, V75, P15, DOI 10.1038/ki.2008.414; Locatelli F, 2009, NEPHROL DIAL TRANSPL, V24, P348, DOI 10.1093/ndt/gfn653; Lu M, 2010, AM J HEMATOL, V85, P315, DOI 10.1002/ajh.21656; Meenan RT, 2007, MED DECIS MAKING, V27, P161, DOI 10.1177/0272989X06297388; National Institute for Health and Clinical Excellence, 2011, AN MAN PEOPL CHRON K; Nishio A, 2013, BLOOD PURIFICAT, V36, P29, DOI 10.1159/000350583; Palmer SC, 2010, ANN INTERN MED, V153, P23, DOI 10.7326/0003-4819-153-1-201007060-00252; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Quon P, 2012, HLTH OUTCOMES RES ME, V3, pe79, DOI DOI 10.1016/J.EHRM.2012.03.004; Singh AK, 2010, CURR OPIN NEPHROL HY, V19, P420, DOI 10.1097/MNH.0b013e32833cf1d6; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Skali H, 2011, CIRCULATION, V124, P2903, DOI 10.1161/CIRCULATIONAHA.111.030411; Tonelli M, 2003, KIDNEY INT, V64, P295, DOI 10.1046/j.1523-1755.2003.00079.x; TSEVAT J, 1993, MED DECIS MAKING, V13, P161, DOI 10.1177/0272989X9301300210; Vlagopoulos PT, 2005, J AM SOC NEPHROL, V16, P3403, DOI 10.1681/ASN.2005030226; Weinstein MC, 1996, COST EFFECTIVENESS H	34	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0157323	10.1371/journal.pone.0157323	http://dx.doi.org/10.1371/journal.pone.0157323			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27404556	gold, Green Published, Green Submitted			2022-12-27	WOS:000379508200002
J	Tanaka, S; Fujita, S; Kizawa, S; Morita, H; Ishizaka, N				Tanaka, Suguru; Fujita, Shu-ichi; Kizawa, Shun; Morita, Hideaki; Ishizaka, Nobukazu			Association between FGF23, alpha-Klotho, and Cardiac Abnormalities among Patients with Various Chronic Kidney Disease Stages	PLOS ONE			English	Article							GROWTH-FACTOR 23; LEFT-VENTRICULAR HYPERTROPHY; CARDIOVASCULAR-DISEASE; SOLUBLE KLOTHO; HEART; PHOSPHATE; RECEPTOR; DEATH; POPULATION; FACTOR-23	Background Several experimental studies have demonstrated that fibroblast growth factor 23 (FGF23) may induce myocardial hypertrophy via pathways independent of a-Klotho, its co-factor in the induction of phosphaturia. On the other hand, few studies have clearly demonstrated the relationship between FGF23 level and left ventricular hypertrophy among subjects without chronic kidney disease (CKD; i.e., CKD stage G1 or G2). Purpose To investigate the data from 903 patients admitted to the cardiology department with various degrees of renal function, including 234 patients with CKD stage G1/G2. Methods and Results Serum levels of full-length FGF23 and a-Klotho were determined by enzyme immunoassay. After adjustment for sex, age, and estimated glomerular filtration rate (eGFR), the highest FGF23 tertile was significantly associated with left ventricular hypertrophy among patients with CKD stage G1/G2 and those with CKD stage G3a/G3b/G4 as compared with the lowest FGF23 tertile, and the association retained significance after further adjustment for serum levels of corrected calcium, inorganic phosphate, and C-reactive protein, as well as diuretic use, history of hypertension, and systolic blood pressure. FGF23 was also associated with low left ventricular ejection fraction among patients with CKD stage G1/G2 and those with CKD stage G3a/G3b/G4 after adjusting for age, sex, eGFR, corrected calcium, and inorganic phosphate. On the other hand, compared with the highest a-Klotho tertile, the lowest a-Klotho tertile was associated with left ventricular hypertrophy and systolic dysfunction only among patients with CKD stage G3b and stage G3a, respectively. Conclusions An association between FGF23 and cardiac hypertrophy and systolic dysfunction was observed among patients without CKD as well as those with CKD after multivariate adjustment. However, the association between alpha-Klotho and cardiac hypertrophy and systolic dysfunction was significant only among patients with CKD G3b and G3a, respectively.	[Tanaka, Suguru; Fujita, Shu-ichi; Kizawa, Shun; Morita, Hideaki; Ishizaka, Nobukazu] Osaka Med Coll, Dept Cardiol, Osaka, Japan	Osaka Medical College	Ishizaka, N (corresponding author), Osaka Med Coll, Dept Cardiol, Osaka, Japan.	ishizaka@osaka-med.ac.jp			Ministry of Education, Science, and Culture of Japan [15K09106]	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants in Aid for Scientific Research from the Ministry of Education, Science, and Culture of Japan (No. 15K09106) but there are no relationships with the company relating to employment, consultancy, patents, products in development or marketed products, and other categories that may potently the authors' adherence to all the PLOS ONE policies.; This work was supported in part by Grants in Aid for Scientific Research from the Ministry of Education, Science, and Culture of Japan (No. 15K09106) but there are no relationships with the company relating to employment, consultancy, patents, products in development or marketed products, and other categories that may potently our adherence to all the PLOS ONE policies. We are highly appreciative of Chieko Ohta, Yumiko Ohgami, and Megumi Hashimoto for their excellent technical assistance.	Andersen IA, 2016, NEPHROL DIAL TRANSPL, V31, P767, DOI 10.1093/ndt/gfv398; Bhattacharyya N, 2012, J BONE MINER RES, V27, P1132, DOI 10.1002/jbmr.1546; Brandenburg VM, 2014, ATHEROSCLEROSIS, V237, P53, DOI 10.1016/j.atherosclerosis.2014.08.037; Buiten MS, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-197; Chudek J, 2014, NEPHROL DIAL TRANSPL, V29, P1757, DOI 10.1093/ndt/gfu063; DEVEREUX RB, 1977, CIRCULATION, V55, P613, DOI 10.1161/01.CIR.55.4.613; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Grabner A, 2015, CELL METAB, V22, P1020, DOI 10.1016/j.cmet.2015.09.002; Gruson D, 2012, PEPTIDES, V37, P258, DOI 10.1016/j.peptides.2012.08.003; Gutierrez OM, 2009, CIRCULATION, V119, P2545, DOI 10.1161/CIRCULATIONAHA.108.844506; Hu MC, 2015, J AM SOC NEPHROL, V26, P1290, DOI 10.1681/ASN.2014050465; Imazu M, 2014, AM J PHYSIOL-HEART C, V307, pH1504, DOI 10.1152/ajpheart.00331.2014; Isakova T, 2013, PEDIATR NEPHROL, V28, P2035, DOI 10.1007/s00467-013-2515-7; Isakova T, 2011, KIDNEY INT, V79, P1370, DOI 10.1038/ki.2011.47; Ix JH, 2012, J AM COLL CARDIOL, V60, P200, DOI 10.1016/j.jacc.2012.03.040; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Leaf DE, 2016, KIDNEY INT, V89, P939, DOI 10.1016/j.kint.2015.12.035; Leifheit-Nestler M, 2016, NEPHROL DIAL TRANSPL, V31, P1088, DOI 10.1093/ndt/gfv421; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Mirza MAI, 2009, ATHEROSCLEROSIS, V207, P546, DOI 10.1016/j.atherosclerosis.2009.05.013; Navarro-Gonzalez JF, 2014, HEART, V100, P34, DOI 10.1136/heartjnl-2013-304746; Negishi K, 2010, CIRC J, V74, P2734, DOI 10.1253/circj.CJ-10-0355; Ozeki M, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-147; Roman MJ, 1996, J AM COLL CARDIOL, V28, P751, DOI 10.1016/0735-1097(96)00225-2; Rowell J, 2010, J CARDIOVASC TRANSL, V3, P516, DOI 10.1007/s12265-010-9208-4; Scialla JJ, 2014, NAT REV NEPHROL, V10, P268, DOI 10.1038/nrneph.2014.49; Seiler C, 2011, EUR HEART J, V32, P261, DOI [10.1093/eurheartj/ehq314, 10.1093/eurheartj/ehr215]; Seiler S, 2013, KIDNEY INT, V83, P121, DOI 10.1038/ki.2012.288; Semba RD, 2011, J AM GERIATR SOC, V59, P1596, DOI 10.1111/j.1532-5415.2011.03558.x; Sharma S, 2013, CLIN NEPHROL, V80, P313, DOI 10.5414/CN107991; Shibata K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073184; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; van Breda F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128994; Wachtell K, 2000, HYPERTENSION, V35, P6, DOI 10.1161/01.HYP.35.1.6; Wolf M, 2014, CURR OPIN NEPHROL HY, V23, P411, DOI 10.1097/01.mnh.0000447020.74593.6f; Xie J, 2015, J AM SOC NEPHROL, V26, P1150, DOI 10.1681/ASN.2014040325; Xie J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2240; Yamazaki Y, 2010, BIOCHEM BIOPH RES CO, V398, P513, DOI 10.1016/j.bbrc.2010.06.110; Yang K, 2015, J AM SOC NEPHROL, V26, P2434, DOI 10.1681/ASN.2014060543; 2000, NAT GENET, V26, P345, DOI DOI 10.1038/81664	42	32	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2016	11	7							e0156860	10.1371/journal.pone.0156860	http://dx.doi.org/10.1371/journal.pone.0156860			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CN	27400031	Green Submitted, Green Published, gold			2022-12-27	WOS:000379508100002
J	Calisto, KL; Carvalho, BD; Ropelle, ER; Mittestainer, FC; Camacho, ACA; Guadagnini, D; Carvalheira, JBC; Saad, MJA				Calisto, Kelly Lima; Carvalho, Bruno de Melo; Ropelle, Eduardo Rochete; Mittestainer, Francine Cappa; Aranha Camacho, Angelica Costa; Guadagnini, Dioze; Campelo Carvalheira, Jose Barreto; Abdalla Saad, Mario Jose			RETRACTION: Atorvastatin Improves Survival in Septic Rats: Effect on Tissue Inflammatory Pathway and on Insulin Signaling (Retraction of vol 5, e14232, 2010)	PLOS ONE			English	Retraction													Saad, Mario/ABD-8262-2020					Calisto KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014232; PLOS ONE Staff, 2015, PLoS One, V10, pe0118383, DOI 10.1371/journal.pone.0118383	2	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159283	10.1371/journal.pone.0159283	http://dx.doi.org/10.1371/journal.pone.0159283			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391461	gold, Green Published, Green Submitted			2022-12-27	WOS:000380005400226
J	Cesqui, B; Russo, M; Lacquaniti, F; d'Avella, A				Cesqui, Benedetta; Russo, Marta; Lacquaniti, Francesco; d'Avella, Andrea			Grasping in One-Handed Catching in Relation to Performance	PLOS ONE			English	Article							VISUAL CONTROL; MOVING TARGET; EYE-MOVEMENTS; COORDINATION; INFORMATION; PERCEPTION; ONLINE; MOTION; MODEL; PERTURBATION	Catching a flying ball involves bringing the hand to the aimed interception point at the right time, adjusting the hand posture to receive the incoming ball and to absorb the ball momentum, and closing the hand to ensure a stable grip. A small error in any of these actions can lead to a failure in catching the ball. Here we sought to gather new insights on what aspects of the catching movements affect the interceptive performance most. In particular, we wondered whether the errors occurred in bringing the hand to the interception point or in closing the fingers on the ball, and whether these two phases of interception differed between individuals. To this end, we characterized grasping and wrist movement kinematics of eleven participants attempting to catch a ball projected in space with different ball arrival heights and flight durations. The spatial position of the ball and of several markers placed on the participant's arm were recorded by a motion capture system, the hand joint angles were recorded with an instrumented glove, and several movement features were extracted. All participants were able to intercept the ball trajectory (i.e. to touch the ball) in over 90% of cases, but they differed in the ability to grasp the ball (success rate varied between 2% and 85%). Similar temporal features were observed across individuals when they caught the ball. In particular, all participants adapted their wrist movements under varying temporal and arrival height constraints, they aligned the time of peak hand closing velocity to the time of hand-ball contact, and they maintained the same hand closing duration in the different experimental conditions. These movement features characterized successful trials, and hence allowed to evaluate the possible sources of errors underlying unsuccessful trials. Thus, inter-individual and inter-trial variability in the modulation of each kinematic feature were related to catching performance. We observed that different participants used different solutions to bring the hand to the interception point. In particular the value of the wrist velocity at impact distinguished good from poor catchers. However, each individual showed similar wrist kinematics in grasped and touched trials. We also found that specific grasping features predicted the catching outcome, both on a trial-by-trial basis and across individuals of different performance level. A higher speed of hand closing distinguished touched from grasped trials. A proper triggering of the enclosing phase of the grasping movement and an accurate alignment of the peak of the hand closing speed to the impact event predicted the catching performance of different participants. These results indicate that the control of the grasping movement was the main source of errors affecting catching performance in our experiments. Moreover, these results suggest that distinct temporal and spatial features in the coordination of the grasping movement are related to individual catching abilities.	[Cesqui, Benedetta; Russo, Marta; Lacquaniti, Francesco] Univ Roma Tor Vergata, Ctr Space Biomed, I-00133 Rome, Italy; [Cesqui, Benedetta; Lacquaniti, Francesco; d'Avella, Andrea] IRCCS Santa Lucia Fdn, Lab Neuromotor Physiol, I-00179 Rome, Italy; [Lacquaniti, Francesco] Univ Rome, Dept Syst Med, I-00133 Rome, Italy; [d'Avella, Andrea] Univ Messina, Dept Biomed & Dent Sci & Morphofunct Imaging, Messina, Italy	University of Rome Tor Vergata; IRCCS Santa Lucia; Sapienza University Rome; University of Messina	Cesqui, B (corresponding author), Univ Roma Tor Vergata, Ctr Space Biomed, I-00133 Rome, Italy.; Cesqui, B (corresponding author), IRCCS Santa Lucia Fdn, Lab Neuromotor Physiol, I-00179 Rome, Italy.	b.cesqui@hsantalucia.it	Russo, Marta/K-3674-2018; d'Avella, Andrea/K-6856-2018	Russo, Marta/0000-0003-1020-7542; d'Avella, Andrea/0000-0002-3393-4956	European Union [248311, ICT-23-2014 618, 644727 - CogIMon]; Italian Space Agency (CRUSOE grant); Italian Space Agency (COREA grant); Italian University Ministry (PRIN project) [2010MEFNF7_002]	European Union(European Commission); Italian Space Agency (CRUSOE grant)(Agenzia Spaziale Italiana (ASI)); Italian Space Agency (COREA grant)(Agenzia Spaziale Italiana (ASI)); Italian University Ministry (PRIN project)	Research was supported by grants from the European Union FP7-ICT program (Adaptive Modular Architectures for Rich Motor skills, AMARSI, Grant 248311), and Horizon 2020 robotics program (ICT-23-2014 618 under grant agreement 644727 - CogIMon), the Italian Space Agency (CRUSOE and COREA grants), and the Italian University Ministry (PRIN project, grant 2010MEFNF7_002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERNETHY B, 1987, J SPORT EXERCISE PSY, V9, P326, DOI 10.1123/jsp.9.4.326; Agresti A, 2002, CATEGORICAL DATA ANA; ALDERSON GJ, 1974, J MOTOR BEHAV, V6, P217, DOI 10.1080/00222895.1974.10734998; Amazeen EL, 2001, ECOL PSYCHOL, V13, P71, DOI 10.1207/S15326969ECO1302_1; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; BAHILL AT, 1984, AM SCI, V72, P249; Barr DJ, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00328; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BOOTSMA RJ, 1990, J EXP PSYCHOL HUMAN, V16, P21, DOI 10.1037/0096-1523.16.1.21; Bosco G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049381; Brenner E, 2015, J VIS, P15; Button C, 2000, ACTA PSYCHOL, V105, P9, DOI 10.1016/S0001-6918(00)00044-5; Button C, 2002, ACTA PSYCHOL, V109, P75, DOI 10.1016/S0001-6918(01)00052-X; Carnahan H, 1996, ACTA PSYCHOL, V92, P17, DOI 10.1016/0001-6918(95)00006-2; Cesqui B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119445; Cesqui B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031770; Croft JL, 2010, HUM MOVEMENT SCI, V29, P751, DOI 10.1016/j.humov.2009.10.004; D'Andola M, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00107; d'Avella A, 2011, J NEUROSCI METH, V196, P264, DOI 10.1016/j.jneumeth.2011.01.013; de la Malla C, 2015, EXP BRAIN RES, V233, P2507, DOI 10.1007/s00221-015-4321-x; de Leva P, 1996, J BIOMECH, V29, P1223, DOI 10.1016/0021-9290(95)00178-6; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Faisal AA, 2009, J NEUROPHYSIOL, V101, P1901, DOI 10.1152/jn.90974.2008; Golenia L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112806; Hoffman L, 2007, BEHAV RES METHODS, V39, P101, DOI 10.3758/BF03192848; La Scaleia B, 2015, J NEUROPHYSIOL, V114, P1577, DOI 10.1152/jn.00475.2015; La Scaleia B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099837; LACQUANITI F, 1989, J NEUROSCI, V9, P134, DOI 10.1523/JNEUROSCI.09-01-00134.1989; Land MF, 2000, NAT NEUROSCI, V3, P1340, DOI 10.1038/81887; LAURENT M, 1994, EXP BRAIN RES, V101, P314, DOI 10.1007/BF00228752; LEE DN, 1976, PERCEPTION, V5, P437, DOI 10.1068/p050437; Mann DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058289; Mazyn LIN, 2007, J MOTOR BEHAV, V39, P491, DOI 10.3200/JMBR.39.6.491-502; Mazyn LIN, 2007, ACTA PSYCHOL, V126, P59, DOI 10.1016/j.actpsy.2006.10.001; Mazyn LIN, 2006, MOTOR CONTROL, V10, P143, DOI 10.1123/mcj.10.2.143; Merchant H, 2009, ADV EXP MED BIOL, V629, P201, DOI 10.1007/978-0-387-77064-2_10; Montagne G, 2000, J MOTOR BEHAV, V32, P37, DOI 10.1080/00222890009601358; Moscatelli A, 2012, J VISION, V12, DOI 10.1167/12.11.26; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; REGAN D, 1979, VISION RES, V19, P1331, DOI 10.1016/0042-6989(79)90205-0; Ryu D, 2013, RES Q EXERCISE SPORT, V84, P252, DOI 10.1080/02701367.2013.784843; SAVELSBERGH GJP, 1992, J MOTOR BEHAV, V24, P320, DOI 10.1080/00222895.1992.9941628; SAVELSBERGH GJP, 1992, EXP BRAIN RES, V89, P223; SAVELSBERGH GJP, 1991, J EXP PSYCHOL HUMAN, V17, P315, DOI 10.1037/0096-1523.17.2.315; SCHMIDT RA, 1982, J EXP PSYCHOL HUMAN, V8, P158, DOI 10.1037/0096-1523.8.1.158; Tijtgat P, 2011, EXP BRAIN RES, V214, P483, DOI 10.1007/s00221-011-2846-1; Tijtgat P, 2010, EXP BRAIN RES, V201, P875, DOI 10.1007/s00221-009-2102-0; Tresilian JR, 2005, PERCEPT PSYCHOPHYS, V67, P129, DOI 10.3758/BF03195017; Tresilian JR, 2002, EXP BRAIN RES, V142, P193, DOI 10.1007/s00221-001-0920-9; van Beers RJ, 2004, J NEUROPHYSIOL, V91, P1050, DOI 10.1152/jn.00652.2003; van de Kamp C, 2012, HUM MOVEMENT SCI, V31, P529, DOI 10.1016/j.humov.2011.06.007; van de Kamp C, 2010, HUM MOVEMENT SCI, V29, P518, DOI 10.1016/j.humov.2010.02.010; Zago M, 2005, J NEUROPHYSIOL, V93, P1055, DOI 10.1152/jn.00833.2004; Zago M, 2004, J NEUROPHYSIOL, V91, P1620, DOI 10.1152/jn.00862.2003; Zago M, 2009, EXP BRAIN RES, V192, P571, DOI 10.1007/s00221-008-1691-3; Zhao HY, 2015, VISION RES, V110, P190, DOI 10.1016/j.visres.2014.10.008	56	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158606	10.1371/journal.pone.0158606	http://dx.doi.org/10.1371/journal.pone.0158606			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27392041	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400088
J	Chi, PC; Chang, SC; Yun, CH; Kuo, JY; Hung, CL; Hou, CJY; Liu, CY; Yang, FS; Wu, TH; Bezerra, HG; Yeh, HI				Chi, Po-Ching; Chang, Shun-Chuan; Yun, Chun-Ho; Kuo, Jen-Yuan; Hung, Chung-Lieh; Hou, Charles Jia-Yin; Liu, Chia-Yuan; Yang, Fei-Shih; Wu, Tung-Hsin; Bezerra, Hiram G.; Yeh, Hung-I			The Associations between Various Ectopic Visceral Adiposity and Body Surface Electrocardiographic Alterations: Potential Differences between Local and Remote Systemic Effects	PLOS ONE			English	Article							ATRIAL-FIBRILLATION; PERICARDIAL FAT; CARDIOVASCULAR-DISEASE; ABDOMINAL FAT; RISK SCORE; TISSUE; HEART; OBESITY; ATHEROSCLEROSIS; EXPRESSION	Background The associations between pericardial adiposity and altered atrial conduction had been demonstrated. However, data comparing differential effects of various body sites visceral adiposity on atrial and ventricular electrocardiographic alterations remains largely unknown. Methods and Results We assessed both peri-cardial fat (PCF) and peri-aortic visceral adiposity (TAT) using dedicated computed tomography (CT) software (Aquarius 3D Workstation, TeraRecon, San Mateo, CA, USA), with anthropometrics including body mass index (BMI) and biochemical data obtained. We further related PCF and TAT data to standardized 12-leads electrocardiogram (ECG), including P and QRS wave morphologies. Among 3,087 study subjects (mean age, 49.6 years; 28% women), we observed a linear association among greater visceral adiposity burden, leftward deviation of P and QRS axes, longer PR interval and widened QRS duration (all p< 0.001). These associations became attenuated after accounting for BMI and baseline clinical co-variates, with greater PCF remained independently associated with prolonged QRS duration (beta = 0.91 [ 95% CI: 0.52, 1.31] per 1-SD increase in PCF, p< 0.001). Finally, both PCF and TAT showed incremental value in identifying abnormally high PR interval (> 200ms, likelihood-ratio: 33.17 to 41.4 & 39.03 for PCF and TAT) and widened QRS duration (> 100ms, likelihood- ratio: 55.67 to 65.4 & 61.94 for PCF and TAT, all X-2 p< 0.05) when superimposed on age and BMI. Conclusion We show in our data greater visceral fat burden may have differential associations on several body surface electrocardiographic parameters. Compared to remote adiposity, those surrounding the heart tissue demonstrated greater influences on altered cardiac activation or conduction, indicating a possible local biological effect.	[Chi, Po-Ching; Kuo, Jen-Yuan; Hung, Chung-Lieh; Hou, Charles Jia-Yin; Yeh, Hung-I] Mackay Mem Hosp, Div Cardiol, Dept Internal Med, Taipei, Taiwan; [Chi, Po-Ching; Kuo, Jen-Yuan; Hung, Chung-Lieh; Hou, Charles Jia-Yin; Yeh, Hung-I] Mackay Mem Hosp, Med Res, Taipei, Taiwan; [Chi, Po-Ching; Chang, Shun-Chuan; Kuo, Jen-Yuan; Hung, Chung-Lieh; Hou, Charles Jia-Yin; Yeh, Hung-I] Mackay Med Coll, Dept Med, New Taipei, Taiwan; [Chi, Po-Ching; Yun, Chun-Ho; Hung, Chung-Lieh; Hou, Charles Jia-Yin] Nursing & Management Coll, Mackay Med, New Taipei, Taiwan; [Yun, Chun-Ho; Hung, Chung-Lieh; Hou, Charles Jia-Yin; Yang, Fei-Shih] Mackay Mem Hosp, Dept Radiol, Taipei, Taiwan; [Liu, Chia-Yuan] Mackay Mem Hosp, Dept Gastroenterol, Taipei, Taiwan; [Wu, Tung-Hsin] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei, Taiwan; [Bezerra, Hiram G.] Baptist Cardiac Vasc Inst, Cardiovasc MRI & CT Program, Miami, FL USA	Mackay Memorial Hospital; Mackay Memorial Hospital; Mackay Medical College; Mackay Junior College of Medicine, Nursing & Management; Mackay Memorial Hospital; Mackay Memorial Hospital; National Yang Ming Chiao Tung University; Baptist Cardiac & Vascular Institute	Hung, CL; Yeh, HI (corresponding author), Mackay Mem Hosp, Div Cardiol, Dept Internal Med, Taipei, Taiwan.; Hung, CL; Yeh, HI (corresponding author), Mackay Mem Hosp, Med Res, Taipei, Taiwan.; Hung, CL; Yeh, HI (corresponding author), Mackay Med Coll, Dept Med, New Taipei, Taiwan.; Hung, CL (corresponding author), Nursing & Management Coll, Mackay Med, New Taipei, Taiwan.; Hung, CL (corresponding author), Mackay Mem Hosp, Dept Radiol, Taipei, Taiwan.	jotaro3791@gmail.com; yehmmc@mmc.edu.tw	Kuo, Jen-Yuan/AAX-5448-2021		National Science Council [NSC-101-2314-B-195-020, NSC103-2314-B-010-005-MY3, 103-2314-B-195-001-MY3, 101-2314-B-195 -020 -MY1, MOST 103-2314-B-195-006-MY3]; Mackay Memorial Hospital [10271, 10248, 10220, 10253, 10375, 10358, E-102003]; Taiwan Foundation for geriatric emergency and critical care	National Science Council(Ministry of Science and Technology, Taiwan); Mackay Memorial Hospital; Taiwan Foundation for geriatric emergency and critical care	This work was partly supported by grants of the National Science Council: NSC-101-2314-B-195-020, NSC103-2314-B-010-005-MY3, 103-2314-B-195-001-MY3, 101-2314-B-195 -020 -MY1, MOST 103-2314-B-195-006-MY3; Mackay Memorial Hospital: 10271, 10248, 10220, 10253, 10375, 10358, E-102003; Taiwan Foundation for geriatric emergency and critical care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed HS, 2013, HEART RHYTHM, V10, P90, DOI 10.1016/j.hrthm.2012.08.043; Al Chekakie MO, 2010, J AM COLL CARDIOL, V56, P784, DOI 10.1016/j.jacc.2010.03.071; Babcock MJ, 2011, OBESITY, V19, P179, DOI 10.1038/oby.2010.121; Bagi Z, 2014, CURR VASC PHARMACOL, V12, P453, DOI 10.2174/1570161112666140423221843; Baker AR, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-1; Biernacka A, 2011, AGING DIS, V2, P158; Britton KA, 2013, OBESITY, V21, P1496, DOI 10.1002/oby.20166; Chamberlain AM, 2011, AM J CARDIOL, V107, P85, DOI 10.1016/j.amjcard.2010.08.049; Chao TF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097472; Chiou CW, 1997, CIRCULATION, V95, P2573, DOI 10.1161/01.CIR.95.11.2573; Crendal E, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-95; Fitzgibbons TP, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000582; FLEG JL, 1990, J GERONTOL, V45, pM95, DOI 10.1093/geronj/45.3.M95; Friedman DJ, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000477; Graner M, 2014, NUTR METAB CARDIOVAS, V24, P315, DOI 10.1016/j.numecd.2013.09.013; Guzzardi Maria A, 2011, Rev Diabet Stud, V8, P403, DOI 10.1900/RDS.2011.8.403; Hamdy O, 2006, CURR DIABETES REV, V2, P367, DOI 10.2174/1573399810602040367; Hense HW, 1998, J AM COLL CARDIOL, V32, P451, DOI 10.1016/S0735-1097(98)00240-X; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; Iacobellis G, 2005, NAT CLIN PRACT CARD, V2, P536, DOI 10.1038/ncpcardio0319; Iacobellis G, 2005, CYTOKINE, V29, P251, DOI 10.1016/j.cyto.2004.11.002; Iacobellis G, 2007, INT J CARDIOL, V115, P272, DOI 10.1016/j.ijcard.2006.04.016; James TN, 2001, PROG CARDIOVASC DIS, V43, P495, DOI 10.1053/pcad.2001.24598; Kaya Z, 2015, WIEN KLIN WOCHENSCHR, V127, P191, DOI 10.1007/s00508-015-0722-x; Lehman SJ, 2010, ATHEROSCLEROSIS, V210, P656, DOI 10.1016/j.atherosclerosis.2010.01.007; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Magnani JW, 2013, CIRC-ARRHYTHMIA ELEC, V6, P84, DOI 10.1161/CIRCEP.112.975342; Mahabadi AA, 2009, EUR HEART J, V30, P850, DOI 10.1093/eurheartj/ehn573; Mazurek T, 2003, CIRCULATION, V108, P2460, DOI 10.1161/01.CIR.0000099542.57313.C5; MESSERLI FH, 1986, NEW ENGL J MED, V314, P378, DOI 10.1056/NEJM198602063140608; Narayanan K, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001654; Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016; Rodriguez A, 2007, CURR PHARM DESIGN, V13, P2169; Rosito GA, 2008, CIRCULATION, V117, P605, DOI 10.1161/CIRCULATIONAHA.107.743062; Sacks HS, 2007, AM HEART J, V153, P907, DOI 10.1016/j.ahj.2007.03.019; Schnabel RB, 2009, LANCET, V373, P739, DOI 10.1016/S0140-6736(09)60443-8; Shin SY, 2011, J CARDIOVASC ELECTR, V22, P647, DOI 10.1111/j.1540-8167.2010.01993.x; Spiroglou SG, 2010, J ATHEROSCLER THROMB, V17, P115; Thanassoulis G, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.000885; Thanassoulis G, 2010, CIRC-ARRHYTHMIA ELEC, V3, P345, DOI 10.1161/CIRCEP.109.912055; Yang FS, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-98; Yun CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061997; Yun CH, 2012, EUR J RADIOL, V81, P749, DOI 10.1016/j.ejrad.2011.01.035	43	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158300	10.1371/journal.pone.0158300	http://dx.doi.org/10.1371/journal.pone.0158300			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391045	gold, Green Published, Green Submitted			2022-12-27	WOS:000380005400040
J	Holcomb, N; Goswami, M; Han, SG; Clark, S; Orren, DK; Gairola, CG; Mellon, I				Holcomb, Nathaniel; Goswami, Mamta; Han, Sung Gu; Clark, Samuel; Orren, David K.; Gairola, C. Gary; Mellon, Isabel			Exposure of Human Lung Cells to Tobacco Smoke Condensate Inhibits the Nucleotide Excision Repair Pathway	PLOS ONE			English	Article							INDUCED DNA-DAMAGE; GROUP-C PROTEIN; CIGARETTE-SMOKE; MUTATIONAL HOTSPOTS; UBIQUITIN LIGASE; P53 MUTATION; DIOL EPOXIDE; XPA PROTEIN; CANCER; GENE	Exposure to tobacco smoke is the number one risk factor for lung cancer. Although the DNA damaging properties of tobacco smoke have been well documented, relatively few studies have examined its effect on DNA repair pathways. This is especially true for the nucleotide excision repair (NER) pathway which recognizes and removes many structurally diverse DNA lesions, including those introduced by chemical carcinogens present in tobacco smoke. The aim of the present study was to investigate the effect of tobacco smoke on NER in human lung cells. We studied the effect of cigarette smoke condensate (CSC), a surrogate for tobacco smoke, on the NER pathway in two different human lung cell lines; IMR-90 lung fibroblasts and BEAS-2B bronchial epithelial cells. To measure NER, we employed a slot-blot assay to quantify the introduction and removal of UV light-induced 6-4 photoproducts and cyclobutane pyrimidine dimers. We find a dose-dependent inhibition of 6-4 photoproduct repair in both cell lines treated with CSC. Additionally, the impact of CSC on the abundance of various NER proteins and their respective RNAs was investigated. The abundance of XPC protein, which is required for functional NER, is significantly reduced by treatment with CSC while the abundance of XPA protein, also required for NER, is unaffected. Both XPC and XPA RNA levels are modestly reduced by CSC treatment. Finally, treatment of cells with MG-132 abrogates the reduction in the abundance of XPC protein produced by treatment with CSC, suggesting that CSC enhances proteasome-dependent turnover of the protein that is mediated by ubiquitination. Together, these findings indicate that tobacco smoke can inhibit the same DNA repair pathway that is also essential for the removal of some of the carcinogenic DNA damage introduced by smoke itself, increasing the DNA damage burden of cells exposed to tobacco smoke.	[Holcomb, Nathaniel; Goswami, Mamta; Clark, Samuel; Orren, David K.; Gairola, C. Gary; Mellon, Isabel] Univ Kentucky, Dept Toxicol & Canc Biol, Markey Canc Ctr, Lexington, KY USA; [Han, Sung Gu] Konkuk Univ, Toxicol Lab, Dept Food Sci & Biotechnol Anim Resources, Coll Anim Biosci & Technol, Seoul, South Korea	University of Kentucky; Konkuk University	Mellon, I (corresponding author), Univ Kentucky, Dept Toxicol & Canc Biol, Markey Canc Ctr, Lexington, KY USA.	mellon@uky.edu		Holcomb, Nathaniel/0000-0002-8214-2613; Han, Sung Gu/0000-0002-1485-861X	Kentucky Lung Cancer Research Program; Lexington Cancer Foundation; NIH [T32ES007266]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007266] Funding Source: NIH RePORTER	Kentucky Lung Cancer Research Program; Lexington Cancer Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Support was provided by Kentucky Lung Cancer Research Program [http://kentuckylungcancer.org/] to IM and The Lexington Cancer Foundation [http://lexingtoncancerfoundation.org/] to IM and NIH Training Grant T32ES007266 to NH.	Adimoolam S, 2002, P NATL ACAD SCI USA, V99, P12985, DOI 10.1073/pnas.202485699; AUTRUP JL, 1992, CHEM-BIOL INTERACT, V85, P141, DOI 10.1016/0009-2797(92)90058-S; Balansky R, 2010, INT J CANCER, V126, P1047, DOI 10.1002/ijc.24942; Barckhausen C, 2014, ONCOGENE, V33, P1964, DOI 10.1038/onc.2013.141; Bunick CG, 2006, BIOCHEMISTRY-US, V45, P14965, DOI 10.1021/bi061370o; Chen GS, 2010, ENVIRON MOL MUTAGEN, V51, P330, DOI 10.1002/em.20540; Coggins CRE, 2010, INHAL TOXICOL, V22, P974, DOI 10.3109/08958378.2010.501831; Curtin GM, 2004, TOXICOL SCI, V81, P14, DOI 10.1093/toxsci/kfh172; DeMarini DM, 2008, MUTAT RES-GEN TOX EN, V650, P15, DOI 10.1016/j.mrgentox.2007.09.006; DeMarini DM, 2004, MUTAT RES-REV MUTAT, V567, P447, DOI 10.1016/j.mrrev.2004.02.001; Denissenko MF, 1996, SCIENCE, V274, P430, DOI 10.1126/science.274.5286.430; EISENSTADT E, 1982, P NATL ACAD SCI-BIOL, V79, P1945, DOI 10.1073/pnas.79.6.1945; Feng ZH, 2006, P NATL ACAD SCI USA, V103, P15404, DOI 10.1073/pnas.0607031103; Ford JM, 1997, J BIOL CHEM, V272, P28073, DOI 10.1074/jbc.272.44.28073; Foresta M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087984; Friedberg EC, 2000, MUTAT RES-DNA REPAIR, V459, P99, DOI 10.1016/S0921-8777(99)00068-3; GAIROLA C, 1982, MUTAT RES, V102, P123, DOI 10.1016/0165-1218(82)90113-6; Gibbons DL, 2014, MOL CANCER RES, V12, P3, DOI 10.1158/1541-7786.MCR-13-0539; GREENBLATT MS, 1994, CANCER RES, V54, P4855; Gunz D, 1996, J BIOL CHEM, V271, P25089, DOI 10.1074/jbc.271.41.25089; Guo XQ, 2011, MUTAGENESIS, V26, P273, DOI 10.1093/mutage/geq083; Hainaut P, 2001, CARCINOGENESIS, V22, P367, DOI 10.1093/carcin/22.3.367; Han SG, 2016, ENVIRON MOL MUTAGEN, V57, P220, DOI 10.1002/em.22000; Hang B, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/709521; He JS, 2014, J BIOL CHEM, V289, P27278, DOI 10.1074/jbc.M114.589812; Hecht SS, 2005, CARCINOGENESIS, V26, P1488, DOI 10.1093/carcin/bgi148; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; Hecht SS, 2008, CHEM RES TOXICOL, V21, P160, DOI 10.1021/tx7002068; Hecht SS, 2012, INT J CANCER, V131, P2724, DOI 10.1002/ijc.27816; Hess MT, 1997, MOL CELL BIOL, V17, P7069, DOI 10.1128/MCB.17.12.7069; Hollander MC, 2005, P NATL ACAD SCI USA, V102, P13200, DOI 10.1073/pnas.0503133102; HSU TC, 1991, MUTAT RES, V259, P67, DOI 10.1016/0165-1218(91)90110-8; Hutt JA, 2005, CARCINOGENESIS, V26, P1999, DOI 10.1093/carcin/bgi150; Hwang BJ, 1999, P NATL ACAD SCI USA, V96, P424, DOI 10.1073/pnas.96.2.424; Ide F, 2000, CARCINOGENESIS, V21, P1263, DOI 10.1093/carcin/21.6.1263; Ishikawa T, 2001, MUTAT RES-FUND MOL M, V477, P41, DOI 10.1016/S0027-5107(01)00094-X; Islami F, 2015, TRANSL LUNG CANCER R, V4, P327, DOI 10.3978/j.issn.2218-6751.2015.08.04; Islami F, 2015, CANCER CAUSE CONTROL, V26, P409, DOI 10.1007/s10552-014-0517-9; Jaiswal AS, 2013, NEOPLASIA, V15, P454, DOI 10.1593/neo.13176; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kang TH, 2011, NUCLEIC ACIDS RES, V39, P3176, DOI 10.1093/nar/gkq1318; Kim SY, 2011, J BIOL CHEM, V286, P31932, DOI 10.1074/jbc.M111.267633; Koberle B, 2006, DNA REPAIR, V5, P641, DOI 10.1016/j.dnarep.2005.12.001; Kundu CN, 2007, ONCOGENE, V26, P1428, DOI 10.1038/sj.onc.1209925; Kwon MC, 2013, MOL ONCOL, V7, P165, DOI 10.1016/j.molonc.2013.02.010; Larsen JE, 2011, CLIN CHEST MED, V32, P703, DOI 10.1016/j.ccm.2011.08.003; Luijsterburg MS, 2010, J CELL BIOL, V189, P445, DOI 10.1083/jcb.200909175; Luo LZ, 2004, MUTAT RES-FUND MOL M, V554, P375, DOI 10.1016/j.mrfmmm.2004.06.031; Matsumoto S, 2015, NUCLEIC ACIDS RES, V43, P1700, DOI 10.1093/nar/gkv038; MELLON I, 1986, P NATL ACAD SCI USA, V83, P8878, DOI 10.1073/pnas.83.23.8878; Mellon I, 2002, DNA REPAIR, V1, P531, DOI 10.1016/S1568-7864(02)00053-8; Meschini R, 2008, MUTAT RES-FUND MOL M, V637, P93, DOI 10.1016/j.mrfmmm.2007.07.005; Moktar A, 2011, INT J ONCOL, V39, P941, DOI 10.3892/ijo.2011.1106; Moktar A, 2009, INT J ONCOL, V35, P1297, DOI 10.3892/ijo_00000447; Moser J, 2005, DNA REPAIR, V4, P571, DOI 10.1016/j.dnarep.2005.01.001; Muotri AR, 2002, CARCINOGENESIS, V23, P1039, DOI 10.1093/carcin/23.6.1039; Narayan S, 2004, ONCOGENE, V23, P5880, DOI 10.1038/sj.onc.1207792; Ng JMY, 2003, GENE DEV, V17, P1630, DOI 10.1101/gad.260003; Nik-Zainal S, 2015, MUTAGENESIS, V30, P763, DOI 10.1093/mutage/gev073; Nishi R, 2009, DNA REPAIR, V8, P767, DOI 10.1016/j.dnarep.2009.02.004; Nollen M, 2009, MOL NUTR FOOD RES, V53, P572, DOI 10.1002/mnfr.200800480; PILLSBURY HC, 1972, J ASSOC OFF ANA CHEM, V55, P636; Porter PC, 2005, DNA REPAIR, V4, P341, DOI 10.1016/j.dnarep.2004.10.007; Poulsen SL, 2013, J CELL BIOL, V201, P797, DOI 10.1083/jcb.201212075; Povlsen LK, 2012, NAT CELL BIOL, V14, P1089, DOI 10.1038/ncb2579; Puumalainen MR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4695; Qiu JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115224; Quan TH, 1996, MOL CARCINOGEN, V16, P32, DOI 10.1002/(SICI)1098-2744(199605)16:1<32::AID-MC5>3.0.CO;2-Q; QUAN TH, 1995, MOL CARCINOGEN, V12, P91, DOI 10.1002/mc.2940120206; Renaud E, 2011, DNA REPAIR, V10, P835, DOI 10.1016/j.dnarep.2011.05.003; RUGGERI B, 1993, P NATL ACAD SCI USA, V90, P1013, DOI 10.1073/pnas.90.3.1013; Scharer Orlando D, 2013, Cold Spring Harb Perspect Biol, V5, pa012609, DOI 10.1101/cshperspect.a012609; Smith ML, 2002, MUTAGENESIS, V17, P149, DOI 10.1093/mutage/17.2.149; Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Talikka M, 2012, CRIT REV TOXICOL, V42, P877, DOI 10.3109/10408444.2012.725244; Tang MS, 2011, MOL NUTR FOOD RES, V55, P1291, DOI 10.1002/mnfr.201100148; Torre LA, 2016, CANCER EPIDEM BIOMAR, V25, P16, DOI 10.1158/1055-9965.EPI-15-0578; USDHSS, 2014, HLTH CONSMOK 50 YE; van Cuijk L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8499; Vermeulen W, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012625; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Walaszek Z, 2007, INT J TOXICOL, V26, P345, DOI 10.1080/10915810701490422; Wang HT, 2012, J BIOL CHEM, V287, P12379, DOI 10.1074/jbc.M111.329623; Wang QE, 2005, NUCLEIC ACIDS RES, V33, P4023, DOI 10.1093/nar/gki684; Wang QE, 2007, NUCLEIC ACIDS RES, V35, P5338, DOI 10.1093/nar/gkm550; WANG YC, 1993, MOL CELL BIOL, V13, P4276, DOI 10.1128/MCB.13.7.4276; Witschi H, 2007, INT J TOXICOL, V26, P339, DOI 10.1080/10915810701490380; Yang MH, 2005, ENVIRON MOL MUTAGEN, V45, P374, DOI 10.1002/em.20097; Yeo JE, 2012, CHEM RES TOXICOL, V25, P2462, DOI 10.1021/tx3003033; Yoon JH, 2001, CANCER RES, V61, P7110; Youlden DR, 2008, J THORAC ONCOL, V3, P819, DOI 10.1097/JTO.0b013e31818020eb; Zhao B, 2006, NUCLEIC ACIDS RES, V34, P417, DOI 10.1093/nar/gkj446	94	11	12	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158858	10.1371/journal.pone.0158858	http://dx.doi.org/10.1371/journal.pone.0158858			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391141	gold, Green Published, Green Submitted			2022-12-27	WOS:000380005400145
J	Ni, LH; Zhao, ZL; Dorje, G; Ma, M				Ni, Lianghong; Zhao, Zhili; Dorje, Gaawe; Ma, Mi			The Complete Chloroplast Genome of Ye-Xing-Ba (Scrophularia dentata; Scrophulariaceae), an Alpine Tibetan Herb	PLOS ONE			English	Article							SEQUENCE; GLYCOSIDES	Scrophularia dentata is an important Tibetan medicinal plant and traditionally used for the treatment of exanthema and fever in Traditional Tibetan Medicine (TTM). However, there is little sequence and genomic information available for S. dentata. In this paper, we report the complete chloroplast genome sequence of S. dentata and it is the first sequenced member of the Sect. Tomiophyllum within Scrophularia (Scrophulariaceae). The gene order and organization of the chloroplast genome of S. dentata are similar to other Lamiales chloroplast genomes. The plastome is 152,553 bp in length and includes a pair of inverted repeats (IRs) of 25,523 bp that separate a large single copy (LSC) region of 84,058 bp and a small single copy (SSC) region of 17,449 bp. It has 38.0% GC content and includes 114 unique genes, of which 80 are protein-coding, 30 are transfer RNA, and 4 are ribosomal RNA. Also, it contains 21 forward repeats, 19 palindrome repeats and 41 simple sequence repeats (SSRs). The repeats and SSRs within S. dentata were compared with those of S. takesimensis and present certain discrepancies. The chloroplast genome of S. dentata was compared with other five publicly available Lamiales genomes from different families. All the coding regions and non-coding regions (introns and intergenic spacers) within the six chloroplast genomes have been extracted and analysed. Furthermore, the genome divergent hotspot regions were identified. Our studies could provide basic data for the alpine medicinal species conservation and molecular phylogenetic researches of Scrophulariaceae and Lamiales.	[Ni, Lianghong; Zhao, Zhili] Shanghai Univ Tradit Chinese Med, Sch Pharm, Shanghai, Peoples R China; [Dorje, Gaawe; Ma, Mi] Tibetan Tradit Med Coll, Lhasa, Peoples R China	Shanghai University of Traditional Chinese Medicine; University of Tibetan Medicine	Zhao, ZL (corresponding author), Shanghai Univ Tradit Chinese Med, Sch Pharm, Shanghai, Peoples R China.	zhilzhao@163.com		zhao, zhili/0000-0003-2127-4134	National Natural Science Foundation of China [81173654]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No. 81173654). Professor Zhili Zhao received the funding in 2012 (https://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cavalier-Smith T, 2002, CURR BIOL, V12, pR62, DOI 10.1016/S0960-9822(01)00675-3; Chen JH, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00447; Choi KS, 2014, MITOCHONDR DNA, P1; Choi KS, 2015, GENE, V572, P214, DOI 10.1016/j.gene.2015.07.020; Chumley TW, 2006, MOL BIOL EVOL, V23, P2175, DOI 10.1093/molbev/msl089; Conant GC, 2008, BIOINFORMATICS, V24, P861, DOI 10.1093/bioinformatics/btm598; Curci PL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120589; De las Rivas J, 2002, GENOME RES, V12, P567, DOI 10.1101/gr.209402; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Gogniashvili M, 2015, GENET RESOUR CROP EV, V62, P1269, DOI 10.1007/s10722-015-0230-x; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; HONG DY, 1983, ANN MO BOT GARD, V70, P701; Kong WW, 2015, COMM COM INF SC, V546, P1, DOI 10.1007/978-3-662-48558-3_1; Ku C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062548; Kurtz S, 1999, BIOINFORMATICS, V15, P426, DOI 10.1093/bioinformatics/15.5.426; Li Xi-wen, 2012, Yaoxue Xuebao, V47, P124; Liu Yang, 2013, Biomed Res Int, V2013, P839683, DOI 10.1155/2013/839683; Nazareno AG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129930; Ni LH, 2016, GENE, V577, P281, DOI 10.1016/j.gene.2015.12.005; OLMSTEAD RG, 1994, AM J BOT, V81, P1205, DOI 10.2307/2445483; Oxelman B, 2005, TAXON, V54, P411, DOI 10.2307/25065369; Qian J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057607; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Vieira LD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090618; Wang WY, 1991, TIBETAN MED, P333; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; Williams AV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125768; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yang JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073053; Yang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110656; Yao XH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129347; Yap JYS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128126; Yi DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035872; Zedane L, 2016, BIOL J LINN SOC, V117, P44, DOI 10.1111/bij.12509; Zhang LQ, 2015, FITOTERAPIA, V106, P72, DOI 10.1016/j.fitote.2015.08.005; Zhang LQ, 2014, FITOTERAPIA, V98, P84, DOI 10.1016/j.fitote.2014.07.005; Zhang LQ, 2013, J MOL STRUCT, V1049, P299, DOI 10.1016/j.molstruc.2013.05.039; Zhang TW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030531; Zhang Y, 2014, GENE, V549, P58, DOI 10.1016/j.gene.2014.07.041; Zhao ZL, 2010, J ETHNOPHARMACOL, V132, P122, DOI 10.1016/j.jep.2010.07.051; Zhao Z.-L., 1992, CHIN PHARM J, V27, P269; Zhong BQ, 1979, FLORA REIPUBLICAE PO, V67, P46	43	21	21	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158488	10.1371/journal.pone.0158488	http://dx.doi.org/10.1371/journal.pone.0158488			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391235	Green Submitted, gold, Green Published			2022-12-27	WOS:000380005400068
J	Opiyo, MA; Hamer, GL; Lwetoijera, DW; Auckland, LD; Majambere, S; Okumu, FO				Opiyo, Mercy A.; Hamer, Gabriel L.; Lwetoijera, Dickson W.; Auckland, Lisa D.; Majambere, Silas; Okumu, Fredros O.			Using Stable Isotopes of Carbon and Nitrogen to Mark Wild Populations of Anopheles and Aedes Mosquitoes in South-Eastern Tanzania	PLOS ONE			English	Article							CULEX MOSQUITOS; DISPERSAL	Background Marking wild mosquitoes is important for understanding their ecology, behaviours and role in disease transmission. Traditional insect marking techniques include using fluorescent dyes, protein labels, radioactive labels and tags, but such techniques have various limitations; notably low marker retention and inability to mark wild mosquitoes at source. Stable isotopes are gaining wide spread use for non-invasive marking of arthropods, permitting greater understanding of mosquito dispersal and responses to interventions. We describe here a simple technique for marking naturally-breeding malaria and dengue vectors using stable isotopes of nitrogen (N-15) and carbon (C-13), and describe potential field applications. Methods We created man-made aquatic mosquito habitats and added either N-15-labelled potassium nitrate or C-13-labelled glucose, leaving non-adulterated habitats as controls. We then allowed wild mosquitoes to lay eggs in these habitats and monitored their development in situ. Pupae were collected promptly as they appeared and kept in netting cages. Emergent adults (in pools of similar to 4 mosquitoes/pool) and individually stored pupae were desiccated and analysed using Isotope Ratio Mass Spectrometry (IRMS). Findings Anopheles gambiae s.l and Aedes spp. from enriched C-13 and enriched N-15 larval habitats had significantly higher isotopic levels than controls (P = 0.005), and both isotopes produced sufficient distinction between marked and unmarked mosquitoes. Mean delta N-15 for enriched females and males were 275.6 +/- 65.1 and 248.0 +/- 54.6, while mean delta N-15 in controls were 2.1 +/- 0.1 and 3.9 +/- 1.7 respectively. Similarly, mean delta C-13 for enriched females and males were 36.08 +/- 5.28 and 38.5 +/- 6.86, compared to - 4.3 +/- 0.2 and - 7.9 +/- 3.6 in controls respectively. Mean delta N-15 and delta C-13 was significantly higher in any pool containing at least one enriched mosquito compared to pools with all unenriched mosquitoes, P<0.001. In all cases, there were variations in standardized isotopic ratios between mosquito species. Conclusion Enrichment of semi-natural mosquito larval habitats with stable isotopes of nitrogen and carbon resulted in effective marking of Anopheles and Aedes mosquitoes colonizing these habitats. This approach can significantly enhance studies on mosquito eco-physiology, dispersal, pathogen transmission and responses to control measures.	[Opiyo, Mercy A.; Lwetoijera, Dickson W.; Majambere, Silas; Okumu, Fredros O.] Ifakara Hlth Inst, Environm Hlth & Ecol Sci Themat Grp, Ifakara, Tanzania; [Opiyo, Mercy A.; Majambere, Silas] Univ Liverpool Liverpool Sch Trop Med, Vector Biol Dept, Liverpool, Merseyside, England; [Hamer, Gabriel L.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Auckland, Lisa D.] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX 77843 USA; [Majambere, Silas] Innovat Vector Control Consortium, Liverpool, Merseyside, England; [Okumu, Fredros O.] Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, Parktown, South Africa	Ifakara Health Institute; Liverpool School of Tropical Medicine; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; University of Witwatersrand	Opiyo, MA (corresponding author), Ifakara Hlth Inst, Environm Hlth & Ecol Sci Themat Grp, Ifakara, Tanzania.; Opiyo, MA (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Vector Biol Dept, Liverpool, Merseyside, England.	mopiyo@ihi.or.tz			Bill & Melinda Gates Foundation [OPP52644]; Wellcome Trust Intermediate Fellowship in Public Health and Tropical Medicine [WT102350/Z/13/Z]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Wellcome Trust Intermediate Fellowship in Public Health and Tropical Medicine(Wellcome Trust)	This work was funded by Bill & Melinda Gates Foundation (Grant Numbers: OPP52644). Fredros Okumu was also supported by Wellcome Trust Intermediate Fellowship in Public Health and Tropical Medicine (Grant number: WT102350/Z/13/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge Nuru Nchimbi, Zuhura Kondo, Monica Mpingwa, and Andrew Kafwenji for assisting in field data collections. We also thank Japhet Kihonda for assisting in mosquito species identifications, Emmanuel Kaindoa for going over this manuscript and providing initial reviews on figures and results, and Brendan Roark and the Stable Isotope Geosciences Facility at Texas A&M University for sample analysis. This work was funded by Bill & Melinda Gates Foundation (Grant Numbers: OPP52644). Fredros Okumu was also supported by Wellcome Trust Intermediate Fellowship in Public Health and Tropical Medicine (Grant number: WT102350/Z/13/Z).	Chiu C, 2008, P NATL ACAD SCI USA, V105, P13116, DOI 10.1073/pnas.0804408105; Ciota AT, 2012, J MED ENTOMOL, V49, P35, DOI 10.1603/ME11077; Corp. I., 2012, IBM SPSS STAT WIND V; Devine GJ, 2009, P NATL ACAD SCI USA, V106, P11530, DOI 10.1073/pnas.0901369106; Dickens BL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-65; Gilbreath TM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-353; Gillies M, 1987, ANOPHELINAE AFRICA S; Guerra CA, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-276; Hagler JR, 2001, ANNU REV ENTOMOL, V46, P511, DOI 10.1146/annurev.ento.46.1.511; Hamer GL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002768; Hamer GL, 2012, J MED ENTOMOL, V49, P61, DOI 10.1603/ME11076; Hamer SA, 2015, J MED ENTOMOL, V52, P1043, DOI 10.1093/jme/tjv063; Head G, 2010, J APPL ECOL, V47, P583, DOI 10.1111/j.1365-2664.2010.01796.x; Helinski MEH, 2007, J EXP BIOL, V210, P1266, DOI 10.1242/jeb.002642; Hood-Nowotny R, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-6; Hood-Nowotny R, 2007, ENTOMOL EXP APPL, V124, P3, DOI 10.1111/j.1570-7458.2007.00572.x; Hood-Nowotny R, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.7901; IAEA, 2009, INT AT EN AG MAN US, P69; METZGER R, 1979, Angewandte Parasitologie, V20, P77; R Development Core Team, 2011, LANG ENV STAT COMP, DOI 10.1007/978-3-540-74686-7; Verhulst NO, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-200; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024767; Winters AE, 2012, ECOL ENTOMOL, V37, P56, DOI 10.1111/j.1365-2311.2011.01337.x	23	17	17	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159067	10.1371/journal.pone.0159067	http://dx.doi.org/10.1371/journal.pone.0159067			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27392083	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000380005400206
J	Zahonova, K; Fussy, Z; Obornik, M; Elias, M; Yurchenko, V				Zahonova, Kristina; Fussy, Zoltan; Obornik, Miroslav; Elias, Marek; Yurchenko, Vyacheslav			RuBisCO in Non-Photosynthetic Alga Euglena longa: Divergent Features, Transcriptomic Analysis and Regulation of Complex Formation	PLOS ONE			English	Article							A/B-BINDING-PROTEIN; CARBOXYLASE OXYGENASE; SMALL-SUBUNIT; RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; POLYPROTEIN PRECURSOR; MECHANISTIC DIVERSITY; GENE REPLACEMENT; MESSENGER-RNA; LIGHT; EXPRESSION	Euglena longa, a close relative of the photosynthetic model alga Euglena gracilis, possesses an enigmatic non-photosynthetic plastid. Its genome has retained a gene for the large subunit of the enzyme RuBisCO (rbcL). Here we provide new data illuminating the putative role of RuBisCO in E. longa. We demonstrated that the E. longa RBCL protein sequence is extremely divergent compared to its homologs from the photosynthetic relatives, suggesting a possible functional shift upon the loss of photosynthesis. Similarly to E. gracilis, E. longa harbors a nuclear gene encoding the small subunit of RuBisCO (RBCS) as a precursor polyprotein comprising multiple RBCS repeats, but one of them is highly divergent. Both RBCL and the RBCS proteins are synthesized in E. longa, but their abundance is very low compared to E. gracilis. No RBCS monomers could be detected in E. longa, suggesting that processing of the precursor polyprotein is inefficient in this species. The abundance of RBCS is regulated post-transcriptionally. Indeed, blocking the cytoplasmic translation by cycloheximide has no immediate effect on the RBCS stability in photosynthetically grown E. gracilis, but in E. longa, the protein is rapidly degraded. Altogether, our results revealed signatures of evolutionary degradation (becoming defunct) of RuBisCO in E. longa and suggest that its biological role in this species may be rather unorthodox, if any.	[Zahonova, Kristina; Elias, Marek; Yurchenko, Vyacheslav] Univ Ostrava, Dept Biol & Ecol, Life Sci Res Ctr, Ostrava 70100, Czech Republic; [Zahonova, Kristina; Elias, Marek; Yurchenko, Vyacheslav] Univ Ostrava, Fac Sci, Inst Environm Technol, Ostrava 70100, Czech Republic; [Fussy, Zoltan; Obornik, Miroslav; Yurchenko, Vyacheslav] Biol Ctr ASCR, Inst Parasitol, Ceske Budejovice 37005, Czech Republic; [Obornik, Miroslav] Univ South Bohemia, Fac Sci, Ceske Budejovice 37005, Czech Republic; [Obornik, Miroslav] Ctr Agaltech, Inst Microbiol ASCR, Trebon 37901, Czech Republic	University of Ostrava; University of Ostrava; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Yurchenko, V (corresponding author), Univ Ostrava, Dept Biol & Ecol, Life Sci Res Ctr, Ostrava 70100, Czech Republic.; Yurchenko, V (corresponding author), Univ Ostrava, Fac Sci, Inst Environm Technol, Ostrava 70100, Czech Republic.; Yurchenko, V (corresponding author), Biol Ctr ASCR, Inst Parasitol, Ceske Budejovice 37005, Czech Republic.	vyacheslav.yurchenko@osu.cz	Elias, Marek/D-6851-2014; Füssy, Zoltán/A-6025-2013; Obornik, Miroslav/G-9350-2014; Záhonová, Kristína/AAT-9188-2020; Yurchenko, Vyacheslav/E-4532-2013	Elias, Marek/0000-0003-0066-6542; Füssy, Zoltán/0000-0002-0820-6359; Záhonová, Kristína/0000-0002-5766-0267; Yurchenko, Vyacheslav/0000-0003-4765-3263	Czech Science Foundation [13-24983S, 13-33039S]; National Feasibility Programme I of the Czech Republic [TEWEP LO1208]; Czech Academy of Sciences; European Regional Development Fund [CZ.1.05/1.1.00/02.0068]	Czech Science Foundation(Grant Agency of the Czech Republic); National Feasibility Programme I of the Czech Republic; Czech Academy of Sciences(Czech Academy of Sciences); European Regional Development Fund(European Commission)	This study was supported by the Czech Science Foundation grants 13-24983S (to ME) and 13-33039S (to MO), the project TEWEP LO1208 of the National Feasibility Programme I of the Czech Republic, and by Czech Academy of Sciences fellowship (to ZF). The MS analysis was carried out at the Proteomics Core Facility of CEITEC - Central European Institute of Technology, ID number CZ.1.05/1.1.00/02.0068, financed by the European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Prof. Juraj Krajcovic (Comenius University in Bratislava, Slovakia) for providing cultures of both Euglena species and permission to use unpublished transcriptomic data generated in frame of a collaborative project. This study was supported by the Czech Science Foundation grants 13-24983S (to ME) and 13-33039S (to MO), the project TEWEP LO1208 of the National Feasibility Programme I of the Czech Republic (to KZ, ME, and VY), and by the Czech Academy of Sciences fellowship (to ZF). The MS analysis was carried out at the Proteomics Core Facility of CEITEC-Central European Institute of Technology, ID number CZ.1.05/1.1.00/02.0068, financed by the European Regional Development Fund.	Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDREWS TJ, 1988, J BIOL CHEM, V263, P12213; BASSHAM JA, 1950, J BIOL CHEM, V185, P781; Bennett MS, 2015, J EUKARYOT MICROBIOL, V62, P773, DOI 10.1111/jeu.12235; Busse I, 2003, INT J SYST EVOL MICR, V53, P617, DOI 10.1099/ijs.0.02295-0; CHAN RL, 1990, EMBO J, V9, P333, DOI 10.1002/j.1460-2075.1990.tb08115.x; CRAMER M, 1952, ARCH MIKROBIOL, V17, P384, DOI 10.1007/BF00410835; Dey S, 2015, J BIOL CHEM, V290, P30658, DOI 10.1074/jbc.M115.691295; Doyle CM, 2013, ARCH BIOCHEM BIOPHYS, V531, P44, DOI 10.1016/j.abb.2012.12.005; Durnford DG, 2006, EUKARYOT CELL, V5, P2079, DOI 10.1128/EC.00222-06; Enomoto T, 1997, PLANT CELL PHYSIOL, V38, P743, DOI 10.1093/oxfordjournals.pcp.a029229; Feiz L, 2014, PLANT J, V80, P862, DOI 10.1111/tpj.12686; Genkov T, 2010, J BIOL CHEM, V285, P19833, DOI 10.1074/jbc.M110.124230; Genkov T, 2009, J BIOL CHEM, V284, P30105, DOI 10.1074/jbc.M109.044081; Gockel G, 2000, PROTIST, V151, P347, DOI 10.1078/S1434-4610(04)70033-4; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HALLICK RB, 1993, NUCLEIC ACIDS RES, V21, P3537, DOI 10.1093/nar/21.15.3537; Hauser T, 2015, NAT STRUCT MOL BIOL, V22, P720, DOI 10.1038/nsmb.3062; Hauser T, 2015, NAT PLANTS, V1, P1, DOI [10.1038/NPLANTS.2015.65, 10.1038/nplants.2015.65]; Imker HJ, 2008, BIOCHEMISTRY-US, V47, P11171, DOI 10.1021/bi801685f; Imker HJ, 2007, BIOCHEMISTRY-US, V46, P4077, DOI 10.1021/bi7000483; Janouskovec J, 2010, P NATL ACAD SCI USA, V107, P10949, DOI 10.1073/pnas.1003335107; Kanevski I, 1999, PLANT PHYSIOL, V119, P133, DOI 10.1104/pp.119.1.133; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Keeling PJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001889; KELLER M, 1991, PLANT MOL BIOL, V17, P73, DOI 10.1007/BF00036807; Knight JRP, 2013, NUCLEIC ACIDS RES, V41, P4185, DOI 10.1093/nar/gkt129; Koziol AG, 2008, MOL BIOL EVOL, V25, P92, DOI 10.1093/molbev/msm232; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Leander BS, 2004, TRENDS MICROBIOL, V12, P251, DOI 10.1016/j.tim.2004.04.001; Lin MT, 2014, NATURE, V513, P547, DOI 10.1038/nature13776; MACHADO MA, 1990, PLANTA, V181, P91, DOI 10.1007/BF00202329; Manen JF, 2004, MOL PHYLOGENET EVOL, V33, P482, DOI 10.1016/j.ympev.2004.06.010; Marin B, 2003, PROTIST, V154, P99, DOI 10.1078/143446103764928521; Markunas CM, 2016, J EUKARYOT MICROBIOL, V63, P326, DOI 10.1111/jeu.12282; MUCHHAL US, 1992, PLANT MOL BIOL, V18, P287, DOI 10.1007/BF00034956; Nowitzki U, 2004, EUR J BIOCHEM, V271, P4123, DOI 10.1111/j.1432-1033.2004.04350.x; PRICE GD, 1993, J BACTERIOL, V175, P2871, DOI 10.1128/JB.175.10.2871-2879.1993; Randle CP, 2005, AM J BOT, V92, P1575, DOI 10.3732/ajb.92.9.1575; Rice DW, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-31; RIKIN A, 1988, P NATL ACAD SCI USA, V85, P5117, DOI 10.1073/pnas.85.14.5117; SAILLAND A, 1986, PLANT MOL BIOL, V7, P213, DOI 10.1007/BF00021333; SIEMEISTER G, 1990, PLANT MOL BIOL, V14, P825, DOI 10.1007/BF00016515; Song JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050300; Spreitzer RJ, 2002, ANNU REV PLANT BIOL, V53, P449, DOI 10.1146/annurev.arplant.53.100301.135233; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stotz M, 2011, NAT STRUCT MOL BIOL, V18, P1366, DOI 10.1038/nsmb.2171; Tabita FR, 2007, MICROBIOL MOL BIOL R, V71, P576, DOI 10.1128/MMBR.00015-07; van Lun M, 2014, J AM CHEM SOC, V136, P3165, DOI 10.1021/ja411579b; Vesteg M, 2009, J EUKARYOT MICROBIOL, V56, P159, DOI 10.1111/j.1550-7408.2008.00383.x; Watson GMF, 1997, FEMS MICROBIOL LETT, V146, P13, DOI 10.1016/S0378-1097(96)00417-X; Wheatley NM, 2014, J BIOL CHEM, V289, P7973, DOI 10.1074/jbc.M113.531236; Wolfe AD, 1998, MOL BIOL EVOL, V15, P1243, DOI 10.1093/oxfordjournals.molbev.a025853; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Yamaguchi A, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-29; YOKOTA A, 1989, J BIOCHEM, V105, P400, DOI 10.1093/oxfordjournals.jbchem.a122676; Yurchenko V, 2006, MOL CELL BIOL, V26, P1786, DOI 10.1128/MCB.26.5.1786-1794.2006; Yurchenko V, 2008, BIOCHEM BIOPH RES CO, V366, P263, DOI 10.1016/j.bbrc.2007.11.136; Zahonova K, 2014, FEBS LETT, V588, P783, DOI 10.1016/j.febslet.2014.01.034; Zhang H, 2003, J PHYCOL, V39, P1160, DOI 10.1111/j.0022-3646.2003.03-055.x	61	19	19	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158790	10.1371/journal.pone.0158790	http://dx.doi.org/10.1371/journal.pone.0158790			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391690	Green Submitted, Green Published, gold			2022-12-27	WOS:000380005400124
J	Yan, XY; Meng, WB; Wu, FF; Xu, AL; Chen, SW; Huang, SF				Yan, Xinyu; Meng, Wenbin; Wu, Fenfang; Xu, Anlong; Chen, Shangwu; Huang, Shengfeng			The Nuclear DNA Content and Genetic Diversity of Lampetra morii	PLOS ONE			English	Article							COMPLETE MITOCHONDRIAL GENOME; VERTEBRATE GENOME; LAMPREY; EVOLUTION; PETROMYZONTIFORMES; INSIGHTS; HAGFISH; PETROMYZONIDAE; CHROMOSOMES; CYCLOSTOMES	We investigated the nuclear DNA content and genetic diversity of a river lamprey, the Korean lamprey Lampetra morii, which is distributed in the northeast of China. L. morii spends its whole life cycle in fresh water, and its adult size is relatively small (similar to 160 mm long) compared with that of other lampreys. The haploid nuclear DNA content of L. morii is 1.618 pg (approximately 1.582 Gb) in germline cells, and there is similar to 15% germline DNA loss in somatic cells. These values are significantly smaller than those of Petromyzon marinus, a lamprey with a published draft genome. The chromosomes of L. morii are small and acrocentric, with a diploid modal number of 2n = 132, lower than some other lampreys. Sequence and AFLP analyses suggest that the allelic polymorphism rate (similar to 0.14% based on examined nuclear and mitochondrial DNA sequences) of L. morii is much lower than that (similar to 2%) of P. marinus. Phylogenetic analysis based on a mitochondrial DNA fragment confirms that L. morii belongs to the genus Lampetra, which, together with the genus Lethenteron, forms a sister group to P. marinus. These genetic background data are valuable for subsequent genetic and genomic research on L. morii.	[Yan, Xinyu; Meng, Wenbin; Wu, Fenfang; Xu, Anlong; Chen, Shangwu; Huang, Shengfeng] Sun Yat Sen Univ, State Key Lab Biocontrol, Guangdong Key Lab Pharmaceut Funct Genes, Sch Life Sci, Guangzhou, Guangdong, Peoples R China; [Xu, Anlong] Beijing Univ Chinese Med, Beijing, Peoples R China	Sun Yat Sen University; Beijing University of Chinese Medicine	Huang, SF (corresponding author), Sun Yat Sen Univ, State Key Lab Biocontrol, Guangdong Key Lab Pharmaceut Funct Genes, Sch Life Sci, Guangzhou, Guangdong, Peoples R China.	hshengf2@mail.sysu.edu.cn		Huang, Shengfeng/0000-0002-0968-1370	National Basic Research Program of China (973 Program) [2013CB835305]; National Natural Science Foundation of China [31171193]; National Supercomputer Center in Guangzhou; Special Program for Applied Research on Super Computation of the NSFC-Guangdong Joint Fund	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Supercomputer Center in Guangzhou; Special Program for Applied Research on Super Computation of the NSFC-Guangdong Joint Fund	This work was supported by the project of the National Basic Research Program of China (973 Program; No. 2013CB835305 to SH), the National Natural Science Foundation of China (No. 31171193 to SH), and National Supercomputer Center in Guangzhou and the Special Program for Applied Research on Super Computation of the NSFC-Guangdong Joint Fund (to SH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajmone-Marsan P, 1997, ANIM GENET, V28, P418, DOI 10.1111/j.1365-2052.1997.00204.x; Barucchi VC, 2013, CYTOGENET GENOME RES, V141, P80, DOI 10.1159/000354098; Boehm T, 2012, ANNU REV IMMUNOL, V30, P203, DOI 10.1146/annurev-immunol-020711-075038; Caputo V, 2011, CHROMOSOME RES, V19, P481, DOI 10.1007/s10577-011-9197-4; Delarbre C, 2000, MOL BIOL EVOL, V17, P519, DOI 10.1093/oxfordjournals.molbev.a026332; Filcek KB, 2005, N AM J FISH MANAGE, V25, P502, DOI 10.1577/M03-206.1; HOWELL WM, 1971, EXPERIENTIA, V27, P222, DOI 10.1007/BF02145908; Huang SF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6896; Hwang DS, 2013, MITOCHONDR DNA, V24, P678, DOI 10.3109/19401736.2013.773989; Hwang DS, 2013, MITOCHONDR DNA, V24, P406, DOI 10.3109/19401736.2013.763246; Kasamatsu J, 2013, MICROBIOL IMMUNOL, V57, P1, DOI 10.1111/j.1348-0421.2012.00500.x; Kuraku S, 2006, ZOOL SCI, V23, P1053, DOI 10.2108/zsj.23.1053; Kuraku S, 2008, ZOOL SCI, V25, P960, DOI 10.2108/zsj.25.960; LEE WJ, 1995, GENETICS, V139, P873; Mehta TK, 2013, P NATL ACAD SCI USA, V110, P16044, DOI 10.1073/pnas.1315760110; Mejia O, 2004, GENETICA, V122, P325, DOI 10.1007/s10709-004-3127-8; NAKAI Y, 1991, CYTOGENET CELL GENET, V56, P196, DOI 10.1159/000133087; POTTER IC, 1981, GENETICA, V56, P149, DOI 10.1007/BF00055414; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; RASCH EM, 1971, CHROMOSOMA, V33, P1, DOI 10.1007/BF00326379; ROBINSON ES, 1975, EXPERIENTIA, V31, P912, DOI 10.1007/BF02358846; ROBINSON ES, 1981, EXPERIENTIA, V37, P239, DOI 10.1007/BF01991630; Semon M, 2012, CURR BIOL, V22, pR641, DOI 10.1016/j.cub.2012.06.022; Shimeld SM, 2012, DEVELOPMENT, V139, P2091, DOI 10.1242/dev.074716; Smith JJ, 2013, NAT GENET, V45, P415, DOI 10.1038/ng.2568; Smith JJ, 2012, CURR BIOL, V22, P1524, DOI 10.1016/j.cub.2012.06.028; Smith JJ, 2010, CHROMOSOMA, V119, P381, DOI 10.1007/s00412-010-0263-z; Smith JJ, 2009, P NATL ACAD SCI USA, V106, P11212, DOI 10.1073/pnas.0902358106; Suzuki A, 1999, CHROMOSOME SCI, P3; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; White MM, 2009, J MOL EVOL, V68, P715, DOI 10.1007/s00239-009-9246-1	31	5	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0157494	10.1371/journal.pone.0157494	http://dx.doi.org/10.1371/journal.pone.0157494			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27388621	Green Submitted, Green Published, gold			2022-12-27	WOS:000379811500005
J	Aalsalem, MY; Khan, WZ; Saad, NM; Hossain, MS; Atiquzzaman, M; Khan, MK				Aalsalem, Mohammed Y.; Khan, Wazir Zada; Saad, N. M.; Hossain, Md. Shohrab; Atiquzzaman, Mohammed; Khan, Muhammad Khurram			A New Random Walk for Replica Detection in WSNs	PLOS ONE			English	Article							WIRELESS SENSOR NETWORKS; DISTRIBUTED DETECTION; CLONE ATTACKS; SECURITY; PROTOCOL	Wireless Sensor Networks (WSNs) are vulnerable to Node Replication attacks or Clone attacks. Among all the existing clone detection protocols in WSNs, RAWL shows the most promising results by employing Simple Random Walk (SRW). More recently, RAND outperforms RAWL by incorporating Network Division with SRW. Both RAND and RAWL have used SRW for random selection of witness nodes which is problematic because of frequently revisiting the previously passed nodes that leads to longer delays, high expenditures of energy with lower probability that witness nodes intersect. To circumvent this problem, we propose to employ a new kind of constrained random walk, namely Single Stage Memory Random Walk and present a distributed technique called SSRWND (Single Stage Memory Random Walk with Network Division). In SSRWND, single stage memory random walk is combined with network division aiming to decrease the communication and memory costs while keeping the detection probability higher. Through intensive simulations it is verified that SSRWND guarantees higher witness node security with moderate communication and memory overheads. SSRWND is expedient for security oriented application fields of WSNs like military and medical.	[Aalsalem, Mohammed Y.; Khan, Wazir Zada] Jazan Univ, Farasan Networking Res Lab, Fac CS & IS, Jazan, Saudi Arabia; [Saad, N. M.] Univ Teknol PETRONAS, Elect & Elect Engn Dept, Tronoh, Perak, Malaysia; [Hossain, Md. Shohrab] Bangladesh Univ Engn & Technol, Dept Comp Sci & Engn, Dhaka, Bangladesh; [Atiquzzaman, Mohammed] Univ Oklahoma, Sch Comp Sci, Norman, OK USA; [Khan, Muhammad Khurram] King Saud Univ, Ctr Excellence Informat Assurance, Riyadh, Saudi Arabia	Jazan University; Universiti Teknologi Petronas; Bangladesh University of Engineering & Technology (BUET); University of Oklahoma System; University of Oklahoma - Norman; King Saud University	Khan, WZ (corresponding author), Jazan Univ, Farasan Networking Res Lab, Fac CS & IS, Jazan, Saudi Arabia.	wazirzadakhan@jazanu.edu.sa	Atiquzzaman, Mohammed/G-4059-2017; Khan, Wazir Zada/G-8580-2015; KHAN, MUHAMMAD KHURRAM/E-4836-2014	Atiquzzaman, Mohammed/0000-0001-9440-7669; Khan, Wazir Zada/0000-0003-0819-4236; KHAN, MUHAMMAD KHURRAM/0000-0001-6636-0533; Hossain, Md Shohrab/0000-0002-4612-6771	Deanship of Scientific Research at Jazan University; Deanship of Scientific Research at King Saud University through Prolific Research Group [PRG-1436-16]	Deanship of Scientific Research at Jazan University; Deanship of Scientific Research at King Saud University through Prolific Research Group	This work was supported by the Deanship of Scientific Research at Jazan University and The Deanship of Scientific Research at King Saud University through the Prolific Research Group (PRG-1436-16). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thanks the anonymous reviewers for their valuable comments for the improvement of this manuscript. The authors wish to acknowledge the support and help of Deanship of Scientific Research at Jazan University and the authors also extend their sincere appreciations to Deanship of Scientific Research at King Saud University for its funding this Prolific Research Group (PRG-1436-16).	Aalsalem M. Y., 2010, COMP SYST APPL AICCS, P1; Akyildiz IF, 2002, COMPUT NETW, V38, P393, DOI 10.1016/S1389-1286(01)00302-4; Angelopoulos CM, 2011, ACM INT SYM MOB MAN, P53; Avin C, 2008, COMPUT NETW, V52, P44, DOI 10.1016/j.comnet.2007.09.012; Brooks R, 2007, IEEE T SYST MAN CY C, V37, P1246, DOI 10.1109/TSMCC.2007.905824; Choi H, 2007, 2007 THIRD INTERNATIONAL CONFERENCE ON SECURITY AND PRIVACY IN COMMUNICATION NETWORKS AND WORKSHOPS, P341, DOI 10.1109/SECCOM.2007.4550353; Conti M, 2014, J COMPUT SYST SCI, V80, P654, DOI 10.1016/j.jcss.2013.06.017; Conti M, 2011, IEEE T DEPEND SECURE, V8, P685, DOI 10.1109/TDSC.2010.25; Conti M, 2007, MOBIHOC'07: PROCEEDINGS OF THE EIGHTH ACM INTERNATIONAL SYMPOSIUM ON MOBILE AD HOC NETWORKING AND COMPUTING, P80; Estrin D., 1999, MobiCom'99. Proceedings of Fifth Annual ACM/IEEE International Conference on Mobile Computing and Networking, P263, DOI 10.1145/313451.313556; Gao Y, 2014, 2014 TENTH INTERNATIONAL CONFERENCE ON COMPUTATIONAL INTELLIGENCE AND SECURITY (CIS), P633, DOI 10.1109/CIS.2014.147; Ge MM, 2016, J NETW COMPUT APPL, V63, P24, DOI 10.1016/j.jnca.2016.01.012; Ge MM, 2014, LECT NOTES COMPUT SC, V8792, P462, DOI 10.1007/978-3-319-11698-3_35; Jiang Q, 2015, PEER PEER NETW APPL, V8, P1070, DOI 10.1007/s12083-014-0285-z; Jiang Q, 2014, WIRELESS PERS COMMUN, V77, P1489, DOI 10.1007/s11277-013-1594-x; Karlof C., 2003, AD HOC NETW, V1, P293, DOI DOI 10.1016/S1570-8705(03)00008-8; Karp B., 2000, MobiCom 2000. Proceedings of the Sixth Annual International Conference on Mobile Computing and Networking, P243, DOI 10.1145/345910.345953; Kenaza T, 2015, SECUR COMMUN NETW, V8, P220, DOI 10.1002/sec.975; Khan WZ, 2016, J NETW COMPUT APPL, V63, P68, DOI 10.1016/j.jnca.2016.01.014; Khan WZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123069; Khan WZ, 2014, 2014 IEEE ASIA PACIFIC CONFERENCE ON CIRCUITS AND SYSTEMS (APCCAS), P559, DOI 10.1109/APCCAS.2014.7032843; Khan WZ, 2014, IEEE WCNC, P2623, DOI 10.1109/WCNC.2014.6952822; Khan WZ, 2013, INT J GRID UTIL COMP, V4, P119; Khan WZ, 2013, INT J DISTRIB SENS N, DOI 10.1155/2013/149023; Khan WZ, 2013, IEEE COMMUN SURV TUT, V15, P402, DOI 10.1109/SURV.2012.031412.00077; Liu A, 2008, 2008 INTERNATIONAL CONFERENCE ON INFORMATION PROCESSING IN SENSOR NETWORKS, PROCEEDINGS, P245, DOI 10.1109/IPSN.2008.47; Nam J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116709; Parno B, 2005, P IEEE S SECUR PRIV, P49, DOI 10.1109/SP.2005.8; Ratnasamy S., 2002, P 1 ACM INT WORKSH W, P78, DOI DOI 10.1145/570738.570750; Seo W. J., 2015, P 11 INT C SEC PRIV, P649, DOI DOI 10.1007/978-3-319-28865-9_43; Seshadri A, 2004, P IEEE S SECUR PRIV, P272; Shah R.C., 2003, AD HOC NETW, V1, P215, DOI [DOI 10.1016/S1570-8705(03)00003-9, 10.1016/S1570-8705(03)00003-9]; Shen J, 2015, J COMMUN NETW-S KOR, V17, P453, DOI 10.1109/JCN.2015.000083; Spitzer F., 2013, PRINCIPLES RANDOM WA, V34; Vanstone S., 1996, HDB APPL CRYPTOGRAPH; Wood AD, 2002, COMPUTER, V35, P54, DOI 10.1109/MC.2002.1039518; Zeng P, 2010, IEEE T CONSUM ELECTR, V56, P566, DOI 10.1109/TCE.2010.5505971; Zeng P, 2009, IEEE COMMUN LETT, V13, P426, DOI 10.1109/LCOMM.2009.082215; Zeng YP, 2010, IEEE J SEL AREA COMM, V28, P677, DOI 10.1109/JSAC.2010.100606; Zhou YP, 2014, EURASIP J WIREL COMM, DOI 10.1186/1687-1499-2014-163; Zhu B, 2007, TWENTY-THIRD ANNUAL COMPUTER SECURITY APPLICATIONS CONFERENCE, PROCEEDINGS, P257, DOI 10.1109/ACSAC.2007.26; Zhu B, 2010, IEEE T MOBILE COMPUT, V9, P913, DOI 10.1109/TMC.2010.40; Zhu WT, 2012, J NETW COMPUT APPL, V35, P1022, DOI 10.1016/j.jnca.2012.01.002; Zuniga M, 2010, LECT NOTES COMPUT SC, V5970, P49, DOI 10.1007/978-3-642-11917-0_4	44	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158072	10.1371/journal.pone.0158072	http://dx.doi.org/10.1371/journal.pone.0158072			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27409082	gold, Green Submitted, Green Published			2022-12-27	WOS:000379508300016
J	Chizzali, C; Swiddan, AK; Abdelaziz, S; Gaid, M; Richter, K; Fischer, TC; Liu, B; Beerhues, L				Chizzali, Cornelia; Swiddan, Asya K.; Abdelaziz, Sahar; Gaid, Mariam; Richter, Klaus; Fischer, Thilo C.; Liu, Benye; Beerhues, Ludger			Expression of Biphenyl Synthase Genes and Formation of Phytoalexin Compounds in Three Fire Blight-Infected Pyrus communis Cultivars	PLOS ONE			English	Article							AUCUPARIA CELL-CULTURES; SORBUS-AUCUPARIA; VENTURIA-INAEQUALIS; PHENOL COUPLINGS; HOLSTEINER COX; CV CONFERENCE; BIOSYNTHESIS; APPLE; DIBENZOFURANS; PROTEINS	Pear (Pyrus communis) is an economically important fruit crop. Drops in yield and even losses of whole plantations are caused by diseases, most importantly fire blight which is triggered by the bacterial pathogen Erwinia amylovora. In response to the infection, biphenyls and dibenzofurans are formed as phytoalexins, biosynthesis of which is initiated by biphenyl synthase (BIS). Two PcBIS transcripts were cloned from fire blight-infected leaves and the encoded enzymes were characterized regarding substrate specificities and kinetic parameters. Expression of PcBIS1 and PcBIS2 was studied in three pear cultivars after inoculation with E. amylovora. Both PcBIS1 and PcBIS2 were expressed in 'Harrow Sweet', while only PcBIS2 transcripts were detected in 'Alexander Lucas' and 'Conference'. Expression of the PcBIS genes was observed in both leaves and the transition zone of the stem; however, biphenyls and dibenzofurans were only detected in stems. The maximum phytoalexin level (similar to 110 mu g/g dry weight) was observed in the transition zone of 'Harrow Sweet', whereas the concentrations were ten times lower in 'Conference' and not even detectable in 'Alexander Lucas'. In 'Harrow Sweet', the accumulation of the maximum phytoalexin level correlated with the halt of migration of the transition zone, whereby the residual part of the shoot survived. In contrast, the transition zones of 'Alexander Lucas' and 'Conference' advanced down to the rootstock, resulting in necrosis of the entire shoots.	[Chizzali, Cornelia; Swiddan, Asya K.; Abdelaziz, Sahar; Gaid, Mariam; Liu, Benye; Beerhues, Ludger] Tech Univ Carolo Wilhelmina Braunschweig, Inst Pharmaceut Biol, Mendelssohnstr 1, D-38106 Braunschweig, Germany; [Richter, Klaus] Inst Resistance Res & Stress Tolerance, Julius Kuhn Inst, Fed Res Ctr Cultivated Plants, Erwin Baur Str 27, D-06484 Quedlinburg, Germany; [Fischer, Thilo C.] Tech Univ Munich, Life Sci Ctr Weihenstephan, Biotechnol Nat Prod, Liesel Beckmann Str 1, D-85354 Freising Weihenstephan, Germany; [Abdelaziz, Sahar] Zagazig Univ, Fac Pharm, Dept Pharmacognosy, Zagazig 44519, Egypt	Braunschweig University of Technology; Julius Kuhn-Institut; Technical University of Munich; Egyptian Knowledge Bank (EKB); Zagazig University	Beerhues, L (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Pharmaceut Biol, Mendelssohnstr 1, D-38106 Braunschweig, Germany.	l.beerhues@tu-bs.de	Abdelaziz, Sahar/HHZ-9560-2022; Gaid, Mariam/AAF-9512-2019; Liu, Benye/AAF-4840-2020	Gaid, Mariam/0000-0002-7290-0628; Abdelaziz, Sahar/0000-0001-9475-6121; Liu, Benye/0000-0001-8527-565X; Beerhues, Ludger/0000-0002-2147-2731	Deutsche Forschungsgemeinschaft [BE 1174]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by BE 1174 (LB); www.dfg.de; Deutsche Forschungsgemeinschaft.	Chagne D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092644; Chizzali C, 2012, BEILSTEIN J ORG CHEM, V8, P613, DOI 10.3762/bjoc.8.68; Chizzali C, 2012, PHYTOCHEMISTRY, V77, P179, DOI 10.1016/j.phytochem.2012.01.023; Chizzali C, 2012, PLANT PHYSIOL, V158, P864, DOI 10.1104/pp.111.190918; Coyne S, 2013, ANGEW CHEM INT EDIT, V52, P10564, DOI 10.1002/anie.201305595; Deckers T, 2008, ACTA HORTIC, P95, DOI 10.17660/ActaHortic.2008.800.8; El-Awaad I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11472; Fischer TC, 2007, TREES-STRUCT FUNCT, V21, P521, DOI 10.1007/s00468-007-0145-z; Hrazdina G, 1997, PHYTOPATHOLOGY, V87, P868, DOI 10.1094/PHYTO.1997.87.8.868; Huttner C, 2010, J AGR FOOD CHEM, V58, P11977, DOI 10.1021/jf1026857; Khalil MNA, 2015, PLANT J, V83, P263, DOI 10.1111/tpj.12885; Khalil MNA, 2013, PHYTOCHEMISTRY, V96, P101, DOI 10.1016/j.phytochem.2013.09.003; KOKUBUN T, 1995, PHYTOCHEMISTRY, V40, P1649, DOI 10.1016/0031-9422(95)00443-B; Konarska A, 2013, SCI WORLD J, DOI 10.1155/2013/846796; Liu B, 2007, PLANTA, V225, P1495, DOI 10.1007/s00425-006-0435-5; Liu BY, 2010, PLANT MOL BIOL, V72, P17, DOI 10.1007/s11103-009-9548-0; Liu BY, 2004, PLANTA, V218, P492, DOI 10.1007/s00425-003-1144-y; MIYAKODO M, 1985, J PESTIC SCI, V10, P101; Paris R, 2009, TREE GENET GENOMES, V5, P81, DOI 10.1007/s11295-008-0177-6; Peters S, 1998, PLANTA, V204, P64, DOI 10.1007/s004250050230; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reiland Holly, 2015, Nutr Today, V50, P301, DOI 10.1097/NT.0000000000000112; Sircar D, 2015, PLANT PHYSIOL, V168, P428, DOI 10.1104/pp.15.00074; Teotia D, 2016, J CHROMATOGR SCI, V54, P918, DOI 10.1093/chromsci/bmw019; Vrancken K, 2013, PLANT PHYSIOL BIOCH, V72, P134, DOI 10.1016/j.plaphy.2013.03.010; Yakovin NA, 2011, RUSS J GENET+, V47, P564, DOI 10.1134/S1022795411040156	26	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158713	10.1371/journal.pone.0158713	http://dx.doi.org/10.1371/journal.pone.0158713			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410389	Green Published, gold, Green Submitted			2022-12-27	WOS:000379508300032
J	Attane, C; Peyot, ML; Lussier, R; Zhang, DW; Joly, E; Madiraju, SRM; Prentki, M				Attane, Camille; Peyot, Marie-Line; Lussier, Roxane; Zhang, Dongwei; Joly, Erik; Madiraju, S. R. Murthy; Prentki, Marc			Differential Insulin Secretion of High-Fat Diet-Fed C57BL/6NN and C57BL/6NJ Mice: Implications of Mixed Genetic Background in Metabolic Studies	PLOS ONE			English	Article							NICOTINAMIDE NUCLEOTIDE TRANSHYDROGENASE; ADIPOSE TRIGLYCERIDE LIPASE; INBRED MOUSE STRAINS; INDUCED OBESITY; GLUCOSE-TOLERANCE; GENOMIC ANALYSIS; SUBSTRAINS; SUSCEPTIBILITY; TRAIT	Many metabolic studies employ tissue-specific gene knockout mice, which requires breeding of floxed gene mice, available mostly on C57BL/6N (NN) genetic background, with cre or Flp recombinase-expressing mice, available on C57BL/6J (JJ) background, resulting in the generation of mixed C57BL/6NJ (NJ) genetic background mice. Recent awareness of many genetic differences between NN and JJ strains including the deletion of nicotinamide nucleotide transhydrogenase (nnt), necessitates examination of the consequence of mixed NJ background on glucose tolerance, beta cell function and other metabolic parameters. Male mice with NN and NJ genetic background were fed with normal or high fat diets (HFD) for 12 weeks and glucose and insulin homeostasis were studied. Genotype had no effect on body weight and food intake in mice fed normal or high fat diets. Insulinemia in the fed and fasted states and after a glucose challenge was lower in HFD-fed NJ mice, even though their glycemia and insulin sensitivity were similar to NN mice. NJ mice showed mild glucose intolerance. Moreover, glucose-but not KCl-stimulated insulin secretion in isolated islets was decreased in HFD-fed NJ vs NN mice without changes in insulin content and beta cell mass. Under normal diet, besides reduced fed insulinemia, NN and NJ mice presented similar metabolic parameters. However, HFD-fed NJ mice displayed lower fed and fasted insulinemia and glucose-induced insulin secretion in vivo and ex vivo, as compared to NN mice. These results strongly caution against using unmatched mixed genetic background C57BL/6 mice for comparisons, particularly under HFD conditions.	[Prentki, Marc] CRCHUM, Montreal Diabet Res Ctr, Dept Biochem & Nutr, Montreal, PQ, Canada; Univ Montreal, Montreal, PQ, Canada; [Zhang, Dongwei] Beijing Univ Chinese Med, Diabet Res Ctr, Beijing, Peoples R China	Universite de Montreal; Universite de Montreal; Beijing University of Chinese Medicine	Prentki, M (corresponding author), CRCHUM, Montreal Diabet Res Ctr, Dept Biochem & Nutr, Montreal, PQ, Canada.	marc.prentki@umontreal.ca	Zhang, Dongwei/AAS-8384-2020	Zhang, Dongwei/0000-0002-7793-1482	Canadian Institutes of Health Research; Canadian Diabetes Association	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association	This study was supported by grants from the Canadian Institutes of Health Research to MP and SRMM. M.P. holds the Canada Research Chair in Diabetes and Metabolism. CA was supported by a fellowship from the Canadian Diabetes Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso LC, 2012, OBESITY, V20, P1403, DOI 10.1038/oby.2012.36; Andrikopoulos S, 2005, J ENDOCRINOL, V187, P45, DOI 10.1677/joe.1.06333; Aston-Mourney K, 2007, DIABETOLOGIA, V50, P2476, DOI 10.1007/s00125-007-0814-x; Berglund ED, 2008, DIABETES, V57, P1790, DOI 10.2337/db07-1615; Bourdi M, 2011, CHEM RES TOXICOL, V24, P794, DOI 10.1021/tx200143x; DIWAN BA, 1980, CANCER LETT, V9, P111, DOI 10.1016/0304-3835(80)90114-7; Fergusson G, 2014, MOL METAB, V3, P848, DOI 10.1016/j.molmet.2014.09.006; Fex M, 2007, J ENDOCRINOL, V194, P551, DOI 10.1677/JOE-07-0161; Fisher-Wellman KH, 2015, BIOCHEM J, V467, P271, DOI 10.1042/BJ20141447; Fontaine DA, 2016, DIABETES, V65, P25, DOI 10.2337/db15-0982; Freeman HC, 2006, DIABETES, V55, P2153, DOI 10.2337/db06-0358; Grottick AJ, 2005, MOL BRAIN RES, V139, P153, DOI 10.1016/j.molbrainres.2005.05.020; Heiker JT, 2014, PHYSIOL GENOMICS, V46, P377, DOI 10.1152/physiolgenomics.00014.2014; Huang TT, 2006, HUM MOL GENET, V15, P1187, DOI 10.1093/hmg/ddl034; Kahle M, 2013, MOL METAB, V2, P435, DOI 10.1016/j.molmet.2013.07.009; KAKU K, 1988, DIABETES, V37, P707, DOI 10.2337/diabetes.37.6.707; Kern M, 2012, BIOCHEM BIOPH RES CO, V417, P717, DOI 10.1016/j.bbrc.2011.12.008; Kooptiwut S, 2002, ENDOCRINOLOGY, V143, P2085, DOI 10.1210/en.143.6.2085; Lee JY, 2006, J BIOL CHEM, V281, P2649, DOI 10.1074/jbc.M512373200; Magnuson MA, 2013, CELL METAB, V18, P9, DOI 10.1016/j.cmet.2013.06.011; Mulligan MK, 2008, GENES BRAIN BEHAV, V7, P677, DOI 10.1111/j.1601-183X.2008.00405.x; Nicholson A, 2010, OBESITY, V18, P1902, DOI 10.1038/oby.2009.477; Peyot ML, 2009, J BIOL CHEM, V284, P16848, DOI 10.1074/jbc.M109.006650; Prentki M, 2013, CELL METAB, V18, P162, DOI 10.1016/j.cmet.2013.05.018; Rossmeisl M, 2003, DIABETES, V52, P1958, DOI 10.2337/diabetes.52.8.1958; Rydstrom J, 2006, TRENDS BIOCHEM SCI, V31, P355, DOI 10.1016/j.tibs.2006.05.003; Simon MM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r82; Sluyter F, 1999, BEHAV BRAIN RES, V98, P39; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Tamarina NA, 2014, ISLETS, V6, DOI 10.4161/isl.27685; Toye AA, 2005, DIABETOLOGIA, V48, P675, DOI 10.1007/s00125-005-1680-z; Watkins-Chow DE, 2008, GENOME RES, V18, P60, DOI 10.1101/gr.6927808; Wong N, 2010, ENDOCRINOLOGY, V151, P96, DOI 10.1210/en.2009-0887; Wu JW, 2011, HEPATOLOGY, V54, P122, DOI 10.1002/hep.24338	34	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0159165	10.1371/journal.pone.0159165	http://dx.doi.org/10.1371/journal.pone.0159165			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27403868	Green Published, gold, Green Submitted			2022-12-27	WOS:000379508200040
J	Gerencser, AA; Mookerjee, SA; Jastroch, M; Brand, MD				Gerencser, Akos A.; Mookerjee, Shona A.; Jastroch, Martin; Brand, Martin D.			Measurement of the Absolute Magnitude and Time Courses of Mitochondrial Membrane Potential in Primary and Clonal Pancreatic Beta-Cells	PLOS ONE			English	Article							STIMULATED INSULIN-SECRETION; OXIDATIVE-PHOSPHORYLATION; GLUCOSE SENSITIVITY; CA2+ CONCENTRATION; MOUSE ISLETS; B-CELLS; CALCIUM; ATP; METABOLISM; PLASMA	The aim of this study was to simplify, improve and validate quantitative measurement of the mitochondrial membrane potential (Delta psi M) in pancreatic beta-cells. This built on our previously introduced calculation of the absolute magnitude of Delta psi M in intact cells, using time-lapse imaging of the non-quench mode fluorescence of tetramethylrhodamine methyl ester and a bis-oxonol plasma membrane potential (Delta psi P) indicator Delta psi M is a central mediator of glucose-stimulated insulin secretion in pancreatic beta-cells Delta psi M is at the crossroads of cellular energy production and demand, therefore precise assay of its magnitude is a valuable tool to study how these processes interplay in insulin secretion. Dispersed islet cell cultures allowed cell type-specific, single-cell observations of cell-to-cell heterogeneity of Delta psi M and Delta psi P. Glucose addition caused hyperpolarization of Delta psi M and depolarization of Delta psi P. The hyperpolarization was a monophasic step increase, even in cells where the Delta psi P depolarization was biphasic. The biphasic response of Delta psi P was associated with a larger hyperpolarization of Delta psi M than the monophasic response. Analysis of the relationships between Delta psi P and Delta psi M revealed that primary dispersed beta-cells responded to glucose heterogeneously, driven by variable activation of energy metabolism. Sensitivity analysis of the calibration was consistent with beta-cells having substantial cell-to-cell variations in amounts of mitochondria, and this was predicted not to impair the accuracy of determinations of relative changes in Delta psi M and Delta psi P. Finally, we demonstrate a significant problem with using an alternative Delta psi M probe, rhodamine 123. In glucose-stimulated and oligomycin-inhibited beta-cells the principles of the rhodamine 123 assay were breached, resulting in misleading conclusions.	[Gerencser, Akos A.; Mookerjee, Shona A.; Jastroch, Martin; Brand, Martin D.] Buck Inst Res Aging, Novato, CA 94945 USA; [Gerencser, Akos A.] Image Analyst Software, Novato, CA 94945 USA; [Mookerjee, Shona A.] Touro Univ Calif, Coll Pharm, Vallejo, CA USA; [Jastroch, Martin] Helmholtz Zentrum Munchen, Helmholtz Diabet Ctr, Neuherberg, Germany; [Jastroch, Martin] Helmholtz Zentrum Munchen, German Diabet Ctr DZD, Neuherberg, Germany	Buck Institute for Research on Aging; Touro University California; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Gerencser, AA (corresponding author), Buck Inst Res Aging, Novato, CA 94945 USA.; Gerencser, AA (corresponding author), Image Analyst Software, Novato, CA 94945 USA.	agerencser@buckinstitute.org	Jastroch, Martin/I-7494-2017; Brand, Martin D/A-9423-2012	Brand, Martin D/0000-0003-4418-6153	Buck Institute for Research on Aging	Buck Institute for Research on Aging	The study including salaries was funded by Buck Institute for Research on Aging internal funds to MDB. Image Analyst Software contributed to the study by computer software. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Akhmedov D, 2010, FASEB J, V24, P4613, DOI 10.1096/fj.10-162222; Anello M, 2005, DIABETOLOGIA, V48, P282, DOI 10.1007/s00125-004-1627-9; Antinozzi PA, 2002, J BIOL CHEM, V277, P11746, DOI 10.1074/jbc.M108462200; Birket MJ, 2011, J CELL SCI, V124, P348, DOI 10.1242/jcs.072272; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Brand MD, 1997, J EXP BIOL, V200, P193; Casimir M, 2009, BIOCHEM J, V424, P459, DOI 10.1042/BJ20090729; CHACON E, 1994, BIOPHYS J, V66, P942, DOI 10.1016/S0006-3495(94)80904-X; Detimary P, 1996, J BIOL CHEM, V271, P20559, DOI 10.1074/jbc.271.34.20559; DETIMARY P, 1995, J CLIN INVEST, V96, P1738, DOI 10.1172/JCI118219; Doliba NM, 2012, AM J PHYSIOL-ENDOC M, V302, pE87, DOI 10.1152/ajpendo.00218.2011; DUCHEN MR, 1993, BIOCHEM J, V294, P35, DOI 10.1042/bj2940035; Gerencser AA, 2001, CELL CALCIUM, V30, P311, DOI 10.1054/ceca.2001.0238; Gerencser AA, 2015, BIOCH J; Gerencser AA, 2016, MOL CELL, V61, P642, DOI 10.1016/j.molcel.2016.02.026; Gerencser AA, 2015, ENDOCRINOLOGY, V156, P3496, DOI 10.1210/en.2015-1552; Gerencser AA, 2012, J PHYSIOL-LONDON, V590, P2845, DOI 10.1113/jphysiol.2012.228387; GHOSH A, 1991, J BIOL CHEM, V266, P22887; Goehring I, 2012, J BIOL CHEM, V287, P15706, DOI 10.1074/jbc.M111.314567; Gray JP, 2012, AM J PHYSIOL-ENDOC M, V303, pE191, DOI 10.1152/ajpendo.00465.2011; GRODSKY GM, 1972, J CLIN INVEST, V51, P2047, DOI 10.1172/JCI107011; HACKENBROCK CR, 1971, J CELL BIOL, V51, P123, DOI 10.1083/jcb.51.1.123; Heart E, 2006, AM J PHYSIOL-ENDOC M, V290, pE143, DOI 10.1152/ajpendo.00216.2005; Heart E, 2009, AM J PHYSIOL-ENDOC M, V296, pE1354, DOI 10.1152/ajpendo.90836.2008; HEIMBERG H, 1993, EMBO J, V12, P2873, DOI 10.1002/j.1460-2075.1993.tb05949.x; Henquin JC, 2006, DIABETES, V55, P3470, DOI 10.2337/db06-0868; HOEK JB, 1980, J BIOL CHEM, V255, P1458; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Huber HJ, 2009, J NEUROSCI METH, V176, P270, DOI 10.1016/j.jneumeth.2008.09.003; Huypens P, 2011, DIABETOLOGIA, V54, P135, DOI 10.1007/s00125-010-1923-5; Johnson D, 2007, DIABETES, V56, P1694, DOI 10.2337/db07-0026; Joseph JW, 2006, J BIOL CHEM, V281, P35624, DOI 10.1074/jbc.M602606200; Joseph JW, 2004, J BIOL CHEM, V279, P51049, DOI 10.1074/jbc.M409189200; Kennedy HJ, 1999, J BIOL CHEM, V274, P13281, DOI 10.1074/jbc.274.19.13281; Kibbey RG, 2007, CELL METAB, V5, P253, DOI 10.1016/j.cmet.2007.02.008; Kindmark H, 2001, J BIOL CHEM, V276, P34530, DOI 10.1074/jbc.M102492200; Krippeit-Drews P, 2000, BIOCHEM BIOPH RES CO, V267, P179, DOI 10.1006/bbrc.1999.1921; Lu HF, 2010, DIABETES, V59, P448, DOI 10.2337/db09-0129; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Metelkin E, 2009, FEBS J, V276, P6942, DOI 10.1111/j.1742-4658.2009.07394.x; Nicholls DG, 2006, J BIOL CHEM, V281, P14864, DOI 10.1074/jbc.M510916200; Nicholls DG, 2012, METHODS MOL BIOL, V810, P119, DOI 10.1007/978-1-61779-382-0_8; Nicholls DG, 2000, TRENDS NEUROSCI, V23, P166, DOI 10.1016/S0166-2236(99)01534-9; NICHOLLS DG, 2013, BIOENERGETICS; Nita II, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046649; Ohara-Imaizumi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015553; Panten U, 2013, METABOLISM, P1; PIPELEERS D, 1994, DIABETOLOGIA, V37, pS57, DOI 10.1007/BF00400827; Prentki M, 2013, CELL METAB, V18, P162, DOI 10.1016/j.cmet.2013.05.018; Rorsman P, 2011, PROG BIOPHYS MOL BIO, V107, P224, DOI 10.1016/j.pbiomolbio.2011.06.009; Schulz N, 2013, INT J MOL SCI, V14, P18989, DOI 10.3390/ijms140918989; SLATE DL, 1995, ANTICANCER RES, V15, P811; SMOLEN P, 1993, BIOPHYS J, V64, P1668, DOI 10.1016/S0006-3495(93)81539-X; Sweet IR, 2008, AM J TRANSPLANT, V8, P183, DOI 10.1111/j.1600-6143.2007.02041.x; Szot Gregory L, 2007, J Vis Exp, P255, DOI 10.3791/255; Wikstrom JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033023	56	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0159199	10.1371/journal.pone.0159199	http://dx.doi.org/10.1371/journal.pone.0159199			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27404273	Green Published, Green Submitted, gold			2022-12-27	WOS:000379508200043
J	Kurachi, M; Mikuni, M; Ishizaki, Y				Kurachi, Masashi; Mikuni, Masahiko; Ishizaki, Yasuki			Extracellular Vesicles from Vascular Endothelial Cells Promote Survival, Proliferation and Motility of Oligodendrocyte Precursor Cells	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; EXOSOMES; BRAIN; DIFFERENTIATION; MIGRATION; MICROVESICLES; EXPRESSION; PERICYTES; MIR-219; ROLES	We previously examined the effect of brain microvascular endothelial cell (MVEC) transplantation on rat white matter infarction, and found that MVEC transplantation promoted remyelination of demyelinated axons in the infarct region and reduced apoptotic death of oligodendrocyte precursor cells (OPCs). We also found that the conditioned medium (CM) from cultured MVECs inhibited apoptosis of cultured OPCs. In this study, we examined contribution of extracellular vesicles (EVs) contained in the CM to its inhibitory effect on OPC apoptosis. Removal of EVs from the CM by ultracentrifugation reduced its inhibitory effect on OPC apoptosis. To confirm whether EVs derived from MVECs are taken up by cultured OPCs, we labeled EVs with PKH67, a fluorescent dye, and added them to OPC cultures. Many vesicular structures labeled with PKH67 were found within OPCs immediately after their addition. Next we examined the effect of MVEC-derived EVs on OPC behaviors. After 2 days in culture with EVs, there was significantly less pyknotic and more BrdU-positive OPCs when compared to control. We also examined the effect of EVs on motility of OPCs. OPCs migrated longer in the presence of EVs when compared to control. To examine whether these effects on cultured OPCs are shared by EVs from endothelial cells, we prepared EVs from conditioned media of several types of endothelial cells, and tested their effects on cultured OPCs. EVs from all types of endothelial cells we examined reduced apoptosis of OPCs and promoted their motility. Identification of the molecules contained in EVs from endothelial cells may prove helpful for establishment of effective therapies for demyelinating diseases.	[Kurachi, Masashi; Ishizaki, Yasuki] Gunma Univ, Grad Sch Med, Dept Mol & Cellular Neurobiol, Maebashi, Gunma, Japan; [Mikuni, Masahiko] Gunma Univ, Grad Sch Med, Dept Psychiat & Neurosci, Maebashi, Gunma, Japan	Gunma University; Gunma University	Ishizaki, Y (corresponding author), Gunma Univ, Grad Sch Med, Dept Mol & Cellular Neurobiol, Maebashi, Gunma, Japan.	yasukiishizaki@gunma-u.ac.jp	Ishizaki, Yasuki/AAB-1209-2020		Japan Society for the Promotion of Science [25122704, 15K15448]; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); Japan Agency for Medical Research and Development (AMED)	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	No. 25122704 from the Japan Society for the Promotion of Science (https://www.jsps.go.jp) to Y.I. No. 15K15448 from the Japan Society for the Promotion of Science (https://www.jsps.go.jp) to M.K. 'Integrated Research on Neuropsychiatric Disorders' carried out under the Strategic Research program for Brain Sciences (SRPBS) by the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT, http://www.mext.go.jp) and Japan Agency for Medical Research and Development (AMED, http://www.amed.go.jp) to Y.I. and M.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Ms. Kao Abe (Department of Molecular and Cellular Neurobiology, Gunma University Graduate School of Medicine), and Ms. Yu Miyazaki (Department of Pharmacy, Takasaki University of Health and Welfare, Takasaki, Japan) for excellent technical assistance (cell culture and data analysis). We also thank for Bioresource Center at Gunma University Graduate School of Medicine. This work was partly supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science to Y. Ishizaki (No. 25122704) and to M. Kurachi (No. 15K15448). A part of this study is the result of 'Integrated Research on Neuropsychiatric Disorders' carried out under the Strategic Research program for Brain Sciences (SRPBS) by the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) and Japan Agency for Medical Research and Development (AMED).	Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Atay SDC, EXOSOMES AND MICROVE, V1, DOI [10.5772/56180, DOI 10.5772/56180, 10. 5772/56180]; Barca-Mayo O, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00013; BARRES BA, 1993, DEVELOPMENT, V118, P283; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; BOGLER O, 1990, P NATL ACAD SCI USA, V87, P6368, DOI 10.1073/pnas.87.16.6368; Budde H, 2010, DEVELOPMENT, V137, P2127, DOI 10.1242/dev.050633; Chan JR, 2004, NEURON, V43, P183, DOI 10.1016/j.neuron.2004.06.024; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064; de Faria Omar Jr., 2012, Frontiers in Genetics, V3, P46, DOI 10.3389/fgene.2012.00046; de Jong OG, 2012, J EXTRACELL VESICLES, V1, DOI 10.3402/jev.v1i0.18396; Desmond DW, 2002, CEREBROVASC DIS, V13, P53, DOI 10.1159/000049151; Dugas JC, 2007, J NEUROSCI, V27, P6185, DOI 10.1523/JNEUROSCI.0628-07.2007; Dugas JC, 2010, NEURON, V65, P597, DOI 10.1016/j.neuron.2010.01.027; Fitzpatrick JMK, 2015, INT J BIOCHEM CELL B, V65, P134, DOI 10.1016/j.biocel.2015.05.021; Fruhbeis C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00182; Fruhbeis C, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00119; Haqqani AS, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-4; Hayakawa K, 2011, J NEUROSCI, V31, P10666, DOI 10.1523/JNEUROSCI.1944-11.2011; Hu JG, 2009, J NEUROSCI RES, V87, P2854, DOI 10.1002/jnr.22111; Iijima K, 2015, J NEUROCHEM, V135, P539, DOI 10.1111/jnc.13262; Issa Razao, 2005, Angiogenesis, V8, P53, DOI 10.1007/s10456-005-5613-8; Kawikova I, 2015, BRAIN RES, V1617, P63, DOI 10.1016/j.brainres.2014.09.070; Liu XJ, 2012, J MOL CELL CARDIOL, V52, P245, DOI 10.1016/j.yjmcc.2011.11.008; MCKINNON RD, 1990, NEURON, V5, P603, DOI 10.1016/0896-6273(90)90215-2; Milner R, 1996, J NEUROSCI, V16, P7240; Miyamoto Y, 2008, J NEUROSCI, V28, P8326, DOI 10.1523/JNEUROSCI.1482-08.2008; Mogilyansky E, 2013, CELL DEATH DIFFER, V20, P1603, DOI 10.1038/cdd.2013.125; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; Perriere N, 2005, J NEUROCHEM, V93, P279, DOI 10.1111/j.1471-4159.2004.03020.x; Puentes S, 2012, BRAIN RES, V1469, P43, DOI 10.1016/j.brainres.2012.06.042; Pusic AD, 2014, J NEUROIMMUNOL, V266, P12, DOI 10.1016/j.jneuroim.2013.10.014; Pusic AD, 2014, GLIA, V62, P284, DOI 10.1002/glia.22606; RAFF MC, 1988, NATURE, V333, P562, DOI 10.1038/333562a0; RAFF MC, 1993, SCIENCE, V262, P695, DOI 10.1126/science.8235590; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; RICHARDSON WD, 1988, CELL, V53, P309, DOI 10.1016/0092-8674(88)90392-3; SCHWEIGERER L, 1987, NATURE, V325, P257, DOI 10.1038/325257a0; Shi H, 2015, EXP NEUROL, V272, P17, DOI 10.1016/j.expneurol.2015.03.017; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; SOMMER I, 1981, DEV BIOL, V83, P311, DOI 10.1016/0012-1606(81)90477-2; Szabo C A, 1997, Neurobiology (Bp), V5, P1; Tilling T, 2002, CELL TISSUE RES, V310, P19, DOI 10.1007/s00441-002-0604-1; van Balkom BWM, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.26760; VLODAVSKY I, 1987, J CELL PHYSIOL, V131, P402, DOI 10.1002/jcp.1041310312; Wang SS, 2009, CURR OPIN GENET DEV, V19, P205, DOI 10.1016/j.gde.2009.04.002; Xin HQ, 2013, J CEREBR BLOOD F MET, V33, P1711, DOI 10.1038/jcbfm.2013.152; Yanez-Mo M, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27066	50	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0159158	10.1371/journal.pone.0159158	http://dx.doi.org/10.1371/journal.pone.0159158			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27403742	Green Submitted, Green Published, gold			2022-12-27	WOS:000379508200039
J	Bian, J; Yoshigoe, K; Hicks, A; Yuan, JW; He, Z; Xie, MJ; Guo, Y; Prosperi, M; Salloum, R; Modave, F				Bian, Jiang; Yoshigoe, Kenji; Hicks, Amanda; Yuan, Jiawei; He, Zhe; Xie, Mengjun; Guo, Yi; Prosperi, Mattia; Salloum, Ramzi; Modave, Francois			Mining Twitter to Assess the Public Perception of the "Internet of Things"	PLOS ONE			English	Article								Social media analysis has shown tremendous potential to understand public's opinion on a wide variety of topics. In this paper, we have mined Twitter to understand the public's perception of the Internet of Things (IoT). We first generated the discussion trends of the IoT from multiple Twitter data sources and validated these trends with Google Trends. We then performed sentiment analysis to gain insights of the public's attitude towards the IoT. As anticipated, our analysis indicates that the public's perception of the IoT is predominantly positive. Further, through topic modeling, we learned that public tweets discussing the IoT were often focused on business and technology. However, the public has great concerns about privacy and security issues toward the IoT based on the frequent appearance of related terms. Nevertheless, no unexpected perceptions were identified through our analysis. Our analysis was challenged by the limited fraction of tweets relevant to our study. Also, the user demographics of Twitter users may not be strongly representative of the population of the general public.	[Bian, Jiang; Hicks, Amanda; Guo, Yi; Salloum, Ramzi; Modave, Francois] Univ Florida, Hlth Outcomes & Policy, Gainesville, FL 32611 USA; [Yoshigoe, Kenji; Xie, Mengjun] Univ Arkansas, Dept Comp Sci, Little Rock, AR 72204 USA; [Yuan, Jiawei] Embry Riddle Aeronaut Univ, Dept Elect Comp Software & Syst Engn, Daytona Beach, FL USA; [He, Zhe] Florida State Univ, Sch Informat, Tallahassee, FL 32306 USA; [Prosperi, Mattia] Univ Florida, Dept Epidemiol, Gainesville, FL USA	State University System of Florida; University of Florida; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock; Embry-Riddle Aeronautical University; State University System of Florida; Florida State University; State University System of Florida; University of Florida	Bian, J (corresponding author), Univ Florida, Hlth Outcomes & Policy, Gainesville, FL 32611 USA.	bianjiang@ufl.edu	he, zhe/GSJ-2307-2022; He, Zhe/M-2593-2018; He, Zhe/E-1549-2017	He, Zhe/0000-0003-3608-0244; He, Zhe/0000-0003-3608-0244; Xie, Mengjun/0000-0001-5089-9614; Bian, Jiang/0000-0002-2238-5429	National Center for Advancing Translational Sciences [UL1 TR000064]; NIH/NCATS Clinical and Translational Science Awards [UL1TR001427]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001427] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH/NCATS Clinical and Translational Science Awards(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The work described in this manuscript is supported by award UL1 TR000064 through National Center for Advancing Translational Sciences.; This work was supported in part by the NIH/NCATS Clinical and Translational Science Awards to the University of Florida UL1TR001427. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies.	Agarwal A., 2011, P WORKSHOP LANGUAGES, P30; Aramaki E., 2011, P C EMPIRICAL METHOD, P1568, DOI DOI 10.1016/J.DEUGALCDEP.2015.07.1199; Bian J, 2012, PROCEEDINGS OF THE 2012 INTERNATIONAL WORKSHOP ON SMART HEALTH AND WELLBEING, P25, DOI 10.1145/2389707.2389713; Blei DM, 2012, COMMUN ACM, V55, P77, DOI 10.1145/2133806.2133826; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Blei DM, 2003, NEURAL INFORM PROCES; Bo Pang, 2008, Foundations and Trends in Information Retrieval, V2, P1, DOI 10.1561/1500000001; Broniatowski DA, 2014, SCIENCE, V345, P148, DOI 10.1126/science.345.6193.148-a; Business Wire, 2010, INT CONN DEV PAS 5 B; Chang J., 2009, NIPS; Cobb NK, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1911; Culotta A., 2010, P 1 WORKSHOP SOCIAL, P115, DOI [10.1145/1964858.1964874, DOI 10.1145/1964858.1964874]; Duggan M., 2014, DEMOGRAPHICS KEY SOC; Esuli A., 2006, LREC, P417, DOI DOI 10.1155/2015/715730; Evans D., 2011, INTERNET THINGS NEXT, V1, P1; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Go A., 2009, CS224N PROJECT REPOR, V1; Golder SA, 2011, SCIENCE, V333, P1878, DOI 10.1126/science.1202775; Hicks A, 2016, P 8 GLOB WORDNET C G, V2016, P122; Hicks Amanda, 2015, AMIA Annu Symp Proc, V2015, P611; Hoffman M., 2010, ADV NEURAL INFORM PR, P856; Hu M., 2004, P 10 ACM SIGKDD INT, P168, DOI DOI 10.1145/1014052.1014073; Huang J., 2005, MAXIMUM LIKELIHOOD E; Kouloumpis E., 2011, P 5 INT AAAI C WEBL, P538; Lazer D, 2014, SCIENCE, V345, P148, DOI 10.1126/science.345.6193.148-b; Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506; Liu B, 2005, WWW, P342, DOI DOI 10.1145/1060745.1060797; OConnor B., 2010, ICWSM, P122; Pak A, 2010, LREC, V10, P1320, DOI DOI 10.17148/IJARCCE.2016.51274; Paul M.J., 2011, P 5 INT AAAI C WEBL, P265; Sakamura K., 1984, OPERATING SYSTEM SUT, V1984, P24; Solis B., CONVERSATION PRISM; Stone PJ, 1963, P MAY 21 23 1963 SPR, P241, DOI DOI 10.1145/1461551.1461583; Tausczik YR, 2010, J LANG SOC PSYCHOL, V29, P24, DOI 10.1177/0261927X09351676; Tumasjan A., 2010, P 4 INT AAAI C WEBLO, V4, P178, DOI DOI 10.1074/JBC.M501708200; WEISER M, 1991, SCI AM, V265, P94, DOI 10.1038/scientificamerican0991-94	38	37	37	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158450	10.1371/journal.pone.0158450	http://dx.doi.org/10.1371/journal.pone.0158450			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391760	Green Submitted, Green Published, gold			2022-12-27	WOS:000380005400060
J	Cellier, M; James, AL; Orenga, S; Perry, JD; Turnbull, G; Stanforth, SP				Cellier, Marie; James, Arthur L.; Orenga, Sylvain; Perry, John D.; Turnbull, Graeme; Stanforth, Stephen P.			The Synthesis of L-Alanyl and beta-Alanyl Derivatives of 2-Aminoacridone and Their Application in the Detection of Clinically-Important Microorganisms	PLOS ONE			English	Article							AMINOPEPTIDASE; 2-ARYLBENZOTHIAZOLE; NITROREDUCTASE; BENZOXAZOLE; BACTERIA	In clinical microbiology the speed with which pathogenic microorganisms may be detected has a direct impact on patient health. One important strategy used in the laboratory is the growth of cultures in the presence of an enzymatic substrate which, once transformed by the appropriate microbial enzyme, generates a detectable colour or fluorescence output. Such substrates have previously been prepared by our group and others and are available as commercial diagnostic kits, however they all suffer from some degree of diffusion when used in a solid growth medium. This diffusion complicates the detection and differentiation of species in polymicrobial cultures and so we sought to improve on our previous work. In this work we have prepared and evaluated a series of novel fluorogenic enzyme substrates based on N-substituted-2-aminoacridones. All of the prepared substrates were found to be suitable for the detection and differentiation of certain microorganisms, however those based on the 2-amino-10-benzylacridone core in particular showed no apparent diffusion when incorporated into solid growth media. On transformation these substrates generated brightly fluorescent colonies that are clearly contrasted with the background medium due to the difference in emission wavelength (lambda(em) 445-450 nm for the substrate, lambda(em) 550 nm for the product). Here we have shown that our L-alanyl aminopeptidase substrate, 2-(N-L-alanylamino)-10-benzylacridone, is particularly suited to the detection of Gram-negative bacteria, and our beta-alanyl aminopeptidase substrate, 2-(N-beta-alanylamino)-10-benzylacridone, to the detection of Pseudomonas aeruginosa and Serratia marcescens when grown on solid media incorporating these substrates. The resulting fluorophore shows no apparent diffusion from the colonies of interest, and the enhanced sensitivity offered by fluorescent emission may allow for the detection of these organisms as microcolonies using automated fluorescence microscopy.	[Cellier, Marie; Orenga, Sylvain] bioMerieux SA, Res & Dev Microbiol, La Balme Les Grottes, France; [James, Arthur L.; Turnbull, Graeme; Stanforth, Stephen P.] Northumbria Univ, Dept Appl Sci, Newcastle Upon Tyne, Tyne & Wear, England; [Perry, John D.] Freeman Rd Hosp, Dept Microbiol, Newcastle Upon Tyne, Tyne & Wear, England	Northumbria University; Newcastle Freeman Hospital; Newcastle University - UK	Turnbull, G (corresponding author), Northumbria Univ, Dept Appl Sci, Newcastle Upon Tyne, Tyne & Wear, England.	g.turnbull@northumbria.ac.uk	Orenga, Sylvain/AAE-5471-2020; Turnbull, Graeme/H-8457-2014	Turnbull, Graeme/0000-0003-2606-3387	bioMerieux, SA, France; Northumbria University, Faculty of Health and Life Sciences, UK; bioMerieux	bioMerieux, SA, France; Northumbria University, Faculty of Health and Life Sciences, UK; bioMerieux	Work reported in this paper was conducted as part of a co-funded PhD studentship between bioMerieux, SA, France and Northumbria University, Faculty of Health and Life Sciences, UK with assistance from the Freeman Hospital, Department of Microbiology, UK. bioMerieux staff (MC and SO) received funding in the form of salaries. JDP is employed by the Freeman Hospital, and receives funding from bioMerieux. The specific roles of these authors are articulated in the 'author contributions' section. bioMerieux staff also provided direction on study design and performed some analysis using the synthetic substrates described in this manuscript. Northumbria University provided facilities for synthesis and analysis (performed by GT under the direction of SPS and ALJ). Freeman Hospital staff (JDP) contributed to the study design and evaluation of the substrates.	Anderson RJ, 2008, BIOORG MED CHEM LETT, V18, P832, DOI 10.1016/j.bmcl.2007.11.018; BLANCHARD C, 1981, J HETEROCYCLIC CHEM, V18, P841, DOI 10.1002/jhet.5570180447; CARLONE GM, 1982, J CLIN MICROBIOL, V16, P1157, DOI 10.1128/JCM.16.6.1157-1159.1982; Cellier M, 2015, BIOORG MED CHEM LETT, V25, P5694, DOI 10.1016/j.bmcl.2015.10.099; Cellier M, 2014, BIOORGAN MED CHEM, V22, P1250, DOI 10.1016/j.bmc.2014.01.013; Cellier M, 2011, BIOORGAN MED CHEM, V19, P2903, DOI 10.1016/j.bmc.2011.03.043; Haughland R, 2002, HDB FLUORESCENT PROB; Laine L, 2009, J CYST FIBROS, V8, P143, DOI 10.1016/j.jcf.2008.11.003; London R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008609; Orenga S, 2009, J MICROBIOL METH, V79, P139, DOI 10.1016/j.mimet.2009.08.001; Perry JD, 2007, J APPL MICROBIOL, V103, P2046, DOI 10.1111/j.1365-2672.2007.03442.x; Reymond JL, 2009, CHEM COMMUN, P34, DOI 10.1039/b813732c; Steen AD, 2015, AQUAT MICROB ECOL, V75, P271, DOI 10.3354/ame01755; Vaiyapuri S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000796; Zaytsev AV, 2008, ORG BIOMOL CHEM, V6, P682, DOI 10.1039/b716978g	15	3	4	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158378	10.1371/journal.pone.0158378	http://dx.doi.org/10.1371/journal.pone.0158378			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391894	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000380005400048
J	Dysli, M; Abegg, M				Dysli, Muriel; Abegg, Mathias			Nystagmus Does Not Limit Reading Ability in Albinism	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; RETINAL-IMAGE MOTION; INFANTILE NYSTAGMUS; CONGENITAL NYSTAGMUS; EYE-MOVEMENTS; VISUAL-ACUITY; PERFORMANCE; STRATEGIES; FREQUENCY; TEXTS	Purpose Subjects with albinism usually suffer from nystagmus and reduced visual acuity, which may impair reading performance. The contribution of nystagmus to decreased reading ability is not known. Low vision and nystagmus may have an additive effect. We aimed to address this question by motion compensation of the nystagmus in affected subjects and by simulating nystagmus in healthy controls. Methods Reading speed and eye movements were assessed in 9 subjects with nystagmus associated with albinism and in 12 healthy controls. We compared the reading ability with steady word presentation and with words presented on a gaze contingent display where words move in parallel to the nystagmus and thus correct for the nystagmus. As the control, healthy subjects were asked to read words and texts in steady reading conditions as well as text passages that moved in a pattern similar to nystagmus. Results Correcting nystagmus with a gaze contingent display neither improved nor reduced the reading speed for single words. Subjects with nystagmus and healthy participants achieved comparable reading speed when reading steady texts. However, movement of text in healthy controls caused a significantly reduced reading speed and more regressive saccades. Conclusions Our results argue against nystagmus as the rate limiting factor for reading speed when words were presented in high enough magnification and support the notion that other sensory visual impairments associated with albinism (for example reduced visual acuity) might be the primary causes for reading impairment.	[Dysli, Muriel; Abegg, Mathias] Univ Bern, Univ Hosp Bern, Dept Ophthalmol, Inselspital, Bern, Switzerland	University of Bern; University Hospital of Bern	Dysli, M (corresponding author), Univ Bern, Univ Hosp Bern, Dept Ophthalmol, Inselspital, Bern, Switzerland.	muriel.dysli@insel.ch			Swiss National Science Foundation [320030 147023]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation, Grant-Nr 320030 147023, http://www.snf.ch/de/Seiten/default.aspx MA.	Abadi RV, 2000, INVEST OPHTH VIS SCI, V41, P3805; ABADI RV, 1993, INVEST OPHTH VIS SCI, V34, P1683; ABADI RV, 1989, OPTOMETRY VISION SCI, V66, P276, DOI 10.1097/00006324-198905000-00004; Abadi RV, 2002, BRIT J OPHTHALMOL, V86, P1152, DOI 10.1136/bjo.86.10.1152; ABADI RV, 1994, INVEST OPHTH VIS SCI, V35, P4080; ABADI RV, 1990, OPHTHALMIC PAED GEN, V11, P171, DOI 10.3109/13816819009020976; Barot N, 2014, OPHTHALMOLOGY, V121, P804, DOI 10.1016/j.ophtha.2013.10.026; Barot N, 2013, OPHTHALMOLOGY, V120, P1232, DOI 10.1016/j.ophtha.2012.11.032; Booth RW, 2013, MEM COGNITION, V41, P82, DOI 10.3758/s13421-012-0244-y; Chung STL, 2011, OPTOMETRY VISION SCI, V88, P200, DOI 10.1097/OPX.0b013e31820846dd; Dysli M, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00431; FULCHER T, 1995, J PEDIATR OPHTHALMOL, V32, P368; Gronskov K, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-43; Hahn GA, 2006, BRIT J OPHTHALMOL, V90, P480, DOI 10.1136/bjo.2005.087379; Hertle Richard W, 2013, Middle East Afr J Ophthalmol, V20, P248, DOI 10.4103/0974-9233.114804; Kanonidou E, 2010, INVEST OPHTH VIS SCI, V51, P3502, DOI 10.1167/iovs.09-4236; Kanski JJ, 2011, CLIN OPHTHALMOLOGY S; Kirkwood Bradley J, 2009, Insight, V34, P13; Kumar A, 2011, INVEST OPHTH VIS SCI, V52, P2306, DOI 10.1167/iovs.10-5685; MacDonald JT, 2012, J PEDIAT OPHTH STRAB, V49, P184, DOI 10.3928/01913913-20111101-03; Merrill K, 2011, J AAPOS, V15, P29, DOI 10.1016/j.jaapos.2010.12.005; Mohammad S, 2011, OPHTHALMOLOGY, V118, P1645, DOI 10.1016/j.ophtha.2011.01.037; Montoliu L, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12167; Oetting W S, 1994, Metab Pediatr Syst Ophthalmol (1985), V17, P5; Rayner K., 1989, PSYCHOL READING; Rayner K., 1983, EYE MOVEMENTS READIN; Sheldon CA, 2012, NEUROPSYCHOLOGIA, V50, P841, DOI 10.1016/j.neuropsychologia.2012.01.020; Smith ND, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/120528; Thomas MG, 2011, INVEST OPHTH VIS SCI, V52, P8156, DOI 10.1167/iovs.10-6645; Thomas MG, 2011, OPHTHALMOLOGY, V118, P1653, DOI 10.1016/j.ophtha.2011.01.028; Trauzettel-Klosinski S, 2012, INVEST OPHTH VIS SCI, V53, P5452, DOI 10.1167/iovs.11-8284; Ukwade MT, 1999, VISION RES, V39, P2963, DOI 10.1016/S0042-6989(99)00050-4; Wang ZI, 2007, VISION RES, V47, P1550, DOI 10.1016/j.visres.2007.01.008; WESTHEIMER G, 1975, J OPT SOC AM, V65, P847, DOI 10.1364/JOSA.65.000847; Whang SJ, 2002, J AAPOS, V6, P393, DOI 10.1067/mpa.2002.129047; WILSON HR, 1988, VISION RES, V28, P991, DOI 10.1016/0042-6989(88)90076-4; WILSON HR, 1988, VISION RES, V28, P979, DOI 10.1016/0042-6989(88)90075-2; Woo S, 2006, OPTOMETRY VISION SCI, V83, P559, DOI 10.1097/01.opx.0000230272.10471.03; Yang SN, 2009, VISION RES, V49, P2843, DOI 10.1016/j.visres.2009.08.023	39	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158815	10.1371/journal.pone.0158815	http://dx.doi.org/10.1371/journal.pone.0158815			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391149	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000380005400132
J	Li, LP; Zhang, BG; Xiao, PG; Qi, YD; Zhang, Z; Liu, HT; Li, XJ; Wang, GP; Terwei, A				Li, Liping; Zhang, Bengang; Xiao, Peigen; Qi, Yaodong; Zhang, Zhao; Liu, Haitao; Li, Xiaojin; Wang, Guoping; Terwei, Andre			Patterns and Environmental Determinants of Medicinal Plant : Vascular Plant Ratios in Xinjiang, Northwest China	PLOS ONE			English	Article							GLOBAL PATTERNS; CONSERVATION; DIVERSITY; KNOWLEDGE; DISTRICT	With both a full collection of native vascular plant distributions and a full checklist of source plants of the Chinese Materia Medica (CMM), the Uygur Medicine (UM), and the Kazak Medicine (KM) for the Xinjiang region, we defined medicinal plant: vascular plant ratios (simplified as medicinal plant ratios hereafter) as the value of medicinal plant richness divided by vascular plant richness. We aimed to find whether the ratios are constant or change in different environments, which environmental variables determine medicinal plant ratios, and whether the ratios are more influenced by human or by natural environments. Finally, suggestions for medicinal plant conservation were addressed. We found that (1) medicinal plant ratios were not constant, and they were high in the Tarim Basin which was largely covered by desert, while they were relatively low in mountainous areas, especially in the Tianshan Mountains where the general species richness was high; (2) medicinal plant ratios were not significantly influenced by human activities, indicated by human population density distributions, but they were highly correlated with plant species richness and climate, i.e. ratios decreased with plant species richness and MAP, and were related quadratically with MAT; (3) CMM ratio and UM ratio were more influenced by plant richness than by climate, while KM ratio was more influenced by climate. We concluded that the percentages of plants used as medicines were not influenced by distances from human settlements, but were determined by species richness or climate. We suggest that (1), in general, the medicinal plant ratio could be a complementary indicator for medicinal plant conservation planning and (2), for the region of Xinjiang, not only high diversity areas, but also some extreme environments should be considered as compensation for a better protection of medicinal plants.	[Li, Liping] Chinese Acad Sci, Inst Remote Sensing & Digital Earth, Beijing, Peoples R China; [Li, Liping; Zhang, Bengang; Xiao, Peigen; Qi, Yaodong; Zhang, Zhao; Liu, Haitao] Chinese Acad Med Sci, Peking Union Med Coll, Inst Med Plant Dev, Minist Educ,Key Lab Bioact Subst & Resources Util, Beijing, Peoples R China; [Zhang, Bengang; Liu, Haitao; Li, Xiaojin; Wang, Guoping] Xinjiang Inst Chinese & Ethn Med, Urumqi, Peoples R China; [Terwei, Andre] German Fed Inst Hydrol, Dept Ecol Interact, Koblenz, Germany	Chinese Academy of Sciences; The Institute of Remote Sensing & Digital Earth, CAS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Peking Union Medical College	Zhang, BG (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Inst Med Plant Dev, Minist Educ,Key Lab Bioact Subst & Resources Util, Beijing, Peoples R China.; Zhang, BG (corresponding author), Xinjiang Inst Chinese & Ethn Med, Urumqi, Peoples R China.	bgzhang@implad.ac.cn	Li, Liping/C-2574-2011	Li, Liping/0000-0002-5550-1932	National Natural Science Foundation of China [81503183, 81560660]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by National Natural Science Foundation of China (81503183, 81560660). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya KP, 2010, J MED PLANTS RES, V4, P235; Adnan M, 2012, ECON BOT, V66, P344, DOI 10.1007/s12231-012-9213-4; Akhtar N, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-25; Bhuwendra Singh, 2012, Journal of Forestry Research, V23, P145, DOI 10.1007/s11676-012-0245-5; Caniago I, 1998, ECON BOT, V52, P229, DOI 10.1007/BF02862141; China National Corporation of Traditional & Herbal Medicine, 1994, REC CHIN MED RES; Commissione Redactorum Florae Xinjiangensis, 1992, FLOR XINJ; Dhyani PP, 2005, CURR SCI INDIA, V88, P335; Editorial Committee of Chinese Physical Geography of the Chinese Academy of Sciences, 1984, CHIN PHYS GEOGR CLIM; Gaston KJ, 2008, ANNU REV ECOL EVOL S, V39, P93, DOI 10.1146/annurev.ecolsys.39.110707.173529; Ghimire SK, 2008, J APPL ECOL, V45, P41, DOI 10.1111/j.1365-2664.2007.01375.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoareau L., 1999, ELECTRON J BIOTECHN, V2, P3; Huang Lin-fang, 2013, Yaoxue Xuebao, V48, P580; Huang LQ, 2005, RES INFORM TRADITION, V7; Kala CP, 2004, BIODIVERS CONSERV, V13, P453, DOI 10.1023/B:BIOC.0000006511.67354.7f; Kandari L. S., 2011, Journal of Forestry Research (Harbin), V22, P403, DOI 10.1007/s11676-011-0110-y; Kreft H, 2007, P NATL ACAD SCI USA, V104, P5925, DOI 10.1073/pnas.0608361104; Law W, 2007, BIODIVERS CONSERV, V16, P1747, DOI 10.1007/s10531-006-9057-2; Li JZ, 1995, RESOURCES TRADITIONA, V1, P11; Li LP, 2015, CHIN HERB MED, V7, P45, DOI 10.1016/S1674-6384(15)60019-3; Li LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066450; Li LiPing, 2011, Ganhanqu Yanjiu (Arid Zone Research), V28, P1, DOI 10.3724/SP.J.1148.2011.00001; Lopez-Pujol J, 2006, BIODIVERS CONSERV, V15, P3983, DOI 10.1007/s10531-005-3015-2; MANANDHAR NP, 1995, J ETHNOPHARMACOL, V48, P1, DOI 10.1016/0378-8741(95)01269-J; Manish Mishra, 2013, International Research Journal of Biological Sciences, V2, P1; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Pei SJ, 2010, BIODIVERS CONSERV, V19, P2619, DOI 10.1007/s10531-010-9862-5; R Core Team, 2021, R LANGUAGE ENV STAT; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; Rokaya MB, 2012, J MT SCI-ENGL, V9, P201, DOI 10.1007/s11629-012-2144-9; Sang WG, 2011, BIOSCIENCE, V61, P720, DOI 10.1525/bio.2011.61.9.11; Shaheen H, 2012, PAK J BOT, V44, P739; Shinwari ZK, 2011, PAK J BOT, V43, P5; Shrestha PM, 2003, J ETHNOPHARMACOL, V86, P81, DOI 10.1016/S0378-8741(03)00051-5; Sivasankari Balayogan, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P975, DOI 10.1016/S2221-1691(13)60188-4; Stangeland T, 2008, J ETHNOPHARMACOL, V117, P290, DOI 10.1016/j.jep.2008.02.008; State Administration of Traditional Chinese Medicine-Chinese Materia Medica Editorial Board, 2005, CHIN MAT MED UIGH CA; Tang JL, 2008, LANCET, V372, P1938, DOI 10.1016/S0140-6736(08)61354-9; The State Key Laboratory of Resources and Environment Information System Institute of Geographic Sciences and Natural Resources Research Chinese Academy of Sciences, 1996, CHIN POP 1 4000000; Verpoorte R, 2014, J ETHNOPHARMACOL, V158, P447, DOI 10.1016/j.jep.2014.10.038; Wang R., 2008, MATERIA MED KAZAK NA; Wang XJ, 2012, WORLD SCI TECHNOLOGY, V14, P1904; Zhang HX, 2014, BIOL CONSERV, V177, P165, DOI 10.1016/j.biocon.2014.07.005; Zhao ZZ, 2012, J ETHNOPHARMACOL, V140, P476, DOI 10.1016/j.jep.2012.01.048; Zheng XL, 2013, J ETHNOPHARMACOL, V148, P964, DOI 10.1016/j.jep.2013.05.051; Zhu GQ, 2014, CHECKLIST MED PLANTS	47	6	6	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158405	10.1371/journal.pone.0158405	http://dx.doi.org/10.1371/journal.pone.0158405			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391239	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400055
J	Pacheco, AG; Grinsztejn, B; da Fonseca, MDM; Griep, RH; Lotufo, P; Bensenor, I; Mill, JG; Moreira, RD; Moreira, RI; Friedman, RK; Santini-Oliveira, M; Cardoso, SW; Veloso, VG; Chor, D				Pacheco, Antonio G.; Grinsztejn, Beatriz; da Fonseca, Maria de Jesus M.; Griep, Rosane Harter; Lotufo, Paulo; Bensenor, Isabela; Mill, Jose G.; Moreira, Rodrigo de C.; Moreira, Ronaldo I.; Friedman, Ruth K.; Santini-Oliveira, Marilia; Cardoso, Sandra W.; Veloso, Valdilea G.; Chor, Dora			HIV Infection Is Not Associated with Carotid Intima-Media Thickness in Brazil: A Cross-Sectional Analysis from the INI/ELSA-Brasil Study	PLOS ONE			English	Article							RIO-DE-JANEIRO; ANTIRETROVIRAL THERAPY; CARDIOVASCULAR-DISEASE; RISK-FACTORS; ELSA-BRAZIL; HAART ERA; ATHEROSCLEROSIS; DEATH; INDIVIDUALS; PROGRESSION	Background Carotid intima-media thickness (cIMT) has been used as an early marker of atherosclerotic disease in the general population. Recently its role among HIV-infected patients has been questioned. To date, no Brazilian study has compared cIMT in respect to HIV status. Methods We compared data from 535 patients actively followed in a prospective cohort in Rio de Janeiro (HIV group); 88 HIV-negative individuals who were nominated by patients (friend controls-FCs); and 10,943 participants of the ELSA-Brasil study. Linear regression models were used to study associations of the 3 groups and several covariables with cIMT. Propensity scores weighting (PSW) were also employed to balance data. Results Median thickness in mm (IQR) were 0.54 (0.49,0.62); 0.58 (0.52,0.68); and 0.57 (0.49,0.70), HIV, FCs and ELSA-Brasil groups, respectively (p-value<0.001). The best linear model chosen did not include the group variables, after adjusting for all the variables chosen, showing no difference of cIMT across groups. Similar results were obtained with PSW. Several traditional CVD risk factors were also significantly associated with cIMT: female gender, higher education and higher HDL were negatively associated while risk factors were older age, current/former smoker, AMI/stroke family history, CVD history, hypertension, DM, higher BMI and total cholesterol. Conclusions We show for the first time in a middle-income setting that cIMT, is not different in HIV-infected patients in Rio de Janeiro compared with 2 different groups of non-HIV-infected individuals. Traditional CVD risk factors are associated with this outcome. Our results point out that high standards of care and prevention for CVD risk factors should always be sought both in the HIV-infected and non-infected populations to prevent CVD-related events.	[Pacheco, Antonio G.; Moreira, Rodrigo de C.] Fiocruz MS, Programa Comp Cient, Rio De Janeiro, Brazil; [Grinsztejn, Beatriz; Moreira, Rodrigo de C.; Moreira, Ronaldo I.; Friedman, Ruth K.; Santini-Oliveira, Marilia; Cardoso, Sandra W.; Veloso, Valdilea G.] Fiocruz MS, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil; [da Fonseca, Maria de Jesus M.; Chor, Dora] Fiocruz MS, Dept Epidemiol & Metodos Quantitat Saude, Rio De Janeiro, Brazil; [Griep, Rosane Harter] Fiocruz MS, Lab Hlth & Environm Educ, Rio De Janeiro, Brazil; [Lotufo, Paulo; Bensenor, Isabela] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil; [Mill, Jose G.] Univ Fed Espirito Santo, Dept Ciencias Fisiol, Vitoria, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade de Sao Paulo; Universidade Federal do Espirito Santo	Pacheco, AG (corresponding author), Fiocruz MS, Programa Comp Cient, Rio De Janeiro, Brazil.	antgui@gmail.com	Pacheco, Antonio Guilherme/E-6378-2013; Lotufo, Paulo/A-9843-2008; Griep, Rosane Härter/ABB-4509-2020; Bensenor, Isabela Judith Martins/L-3306-2017; Griep, Rosane Harter/E-3763-2013	Pacheco, Antonio Guilherme/0000-0003-3095-1774; Lotufo, Paulo/0000-0002-4856-8450; Griep, Rosane Harter/0000-0002-6250-2036	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro [E-26/102398/2009, E-26/201.471/2014]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [01 06 0010.00 RS, 01 06 0212.00 BA, 01 06 0300.00 ES, 01 06 0278.00 MG, 01 06 0115.00 SP, 01 06 0071.00 RJ, 407446/2012-5, 304614/2012-2]; Programa Estrategico de Apoio a Pesquisa em Saude-Fundacao Oswaldo Cruz [407446/2012-5]; Brazilian Ministry of Science and Technology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069476] Funding Source: NIH RePORTER	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Programa Estrategico de Apoio a Pesquisa em Saude-Fundacao Oswaldo Cruz; Brazilian Ministry of Science and Technology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work has been supported by the Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro [E-26/102398/2009 to DC and E-26/201.471/2014 to AGP]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [grant numbers 01 06 0010.00 RS, 01 06 0212.00 BA, 01 06 0300.00 ES, 01 06 0278.00 MG, 01 06 0115.00 SP, 01 06 0071.00 RJ, 407446/2012-5 to AGP and 304614/2012-2 to AGP]; Programa Estrategico de Apoio a Pesquisa em Saude-Fundacao Oswaldo Cruz [407446/2012-5 to AGP] and the Brazilian Ministry of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff KN, 2013, HIV MED, V14, P191, DOI 10.1111/hiv.12007; Ann B., 2015, TWANG TOOLKIT WEIGHT; Bavinger C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059551; Falcao MDBD, 2012, ARQ BRAS CARDIOL, V99, P971; Calcagno V, 2010, J STAT SOFTW, V34, P1; Calza L, 2008, J INFECTION, V57, P16, DOI 10.1016/j.jinf.2008.02.006; Crum NF, 2006, JAIDS-J ACQ IMM DEF, V41, P194, DOI 10.1097/01.qai.0000179459.31562.16; Duprez DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044454; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; Gill J, 2010, CLIN INFECT DIS, V50, P1387, DOI 10.1086/652283; Albuquerque VMG, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-274; Grinsztejn B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059768; Grunfeld C, 2009, AIDS, V23, P1841, DOI 10.1097/QAD.0b013e32832d3b85; Hanna DB, 2015, CLIN INFECT DIS, V61, P640, DOI 10.1093/cid/civ325; Hsue PY, 2012, J INFECT DIS, V205, pS375, DOI 10.1093/infdis/jis200; Hsue PY, 2004, CIRCULATION, V109, P1603, DOI 10.1161/01.CIR.0000124480.32233.8A; Hulten E, 2009, HEART, V95, P1826, DOI 10.1136/hrt.2009.177774; Islam FM, 2012, HIV MED, V13, P453, DOI 10.1111/j.1468-1293.2012.00996.x; Kaplan RC, 2008, AIDS, V22, P1615, DOI 10.1097/QAD.0b013e328300581d; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; McCaffrey DF, 2004, PSYCHOL METHODS, V9, P403, DOI 10.1037/1082-989X.9.4.403; Ministerio da Saude-Secretaria de Vigilancia em Saude-Programa Nacional de DST; Aids e Hepatites Virais, 2014, B EP HIV AIDS; Mugavero MJ, 2011, CLIN INFECT DIS, V53, P927, DOI 10.1093/cid/cir526; Pacheco AG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001531; Pacheco AG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117461; Pacheco AG, 2009, JAIDS-J ACQ IMM DEF, V51, P624, DOI 10.1097/QAI.0b013e3181a4ecf5; Pan W, 2015, PROPENSITY SCORE ANA, Vxiv; Paula AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094636; Paula AA, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-32; Polak JF, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000087; R Development Core Team, 2014, R LANG ENV STAT COMP; Santos IS, 2015, ARTERIOSCL THROM VAS, V35, P2054, DOI 10.1161/ATVBAHA.115.305765; Santos IS, 2014, ATHEROSCLEROSIS, V237, P227, DOI 10.1016/j.atherosclerosis.2014.09.004; Schmidt MI, 2015, INT J EPIDEMIOL, V44, P68, DOI 10.1093/ije/dyu027; Schoffelen AF, 2015, CLIN INFECT DIS, V61, P1606, DOI 10.1093/cid/civ586; Spence JD, 2015, ARTERIOSCL THROM VAS, V35, P1910, DOI 10.1161/ATVBAHA.115.306209; Ssinabulya I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089537; Stein JH, 2014, JACC-CARDIOVASC IMAG, V7, P515, DOI 10.1016/j.jcmg.2013.08.019; Stein JH, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.001396; Torres TS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115900; Torres TS, 2013, BRAZ J INFECT DIS, V17, P324, DOI 10.1016/j.bjid.2012.10.024; Touboul PJ, 2012, CEREBROVASC DIS, V34, P290, DOI 10.1159/000343145	42	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158999	10.1371/journal.pone.0158999	http://dx.doi.org/10.1371/journal.pone.0158999			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391355	Green Submitted, Green Published, gold			2022-12-27	WOS:000380005400186
J	Chen, C; Zeger, S; Breysse, P; Katz, J; Checkley, W; Curriero, FC; Tielsch, JM				Chen, Chen; Zeger, Scott; Breysse, Patrick; Katz, Joanne; Checkley, William; Curriero, Frank C.; Tielsch, James M.			Estimating Indoor PM2.5 and CO Concentrations in Households in Southern Nepal: The Nepal Cookstove Intervention Trials	PLOS ONE			English	Article							PARTICULATE MATTER; AIR-POLLUTION; HEALTH; EXPOSURES; CHILDREN; QUALITY	High concentrations of household air pollution (HAP) due to biomass fuel usage with unvented, insufficient combustion devices are thought to be an important health risk factor in South Asia population. To better characterize the indoor concentrations of particulate matter (PM2.5) and carbon monoxide (CO), and to understand their impact on health in rural southern Nepal, this study analyzed daily monitoring data collected with DataRAM pDR-1000 and LASCAR CO data logger in 2980 households using traditional biomass cookstove indoor through the Nepal Cookstove Intervention Trial-Phase I between March 2010 and October 2011. Daily average PM2.5 and CO concentrations collected in area near stove were 1,376 (95% CI, 1,331-1,423) mu g/m(3) and 10.9 (10.5-11.3) parts per million (ppm) among households with traditional cookstoves. The 95th percentile, hours above 100 mu g/m(3) for PM2.5 or 6ppm for CO, and hours above 1000 mu g/m(3) for PM2.5 or 9ppm for CO were also reported. An algorithm was developed to differentiate stove-influenced (SI) periods from non-stove-influenced (non-SI) periods in monitoring data. Average stove-influenced concentrations were 3,469 (3,350-3,588) mu g/m(3) for PM2.5 and 21.8 (21.1-22.6) ppm for CO. Dry season significantly increased PM2.5 concentration in all metrics; wood was the cleanest fuel for PM2.5 and CO, while adding dung into the fuel increased concentrations of both pollutants. For studies in rural southern Nepal, CO concentration is not a viable surrogate for PM2.5 concentrations based on the low correlation between these measures. In sum, this study filled a gap in knowledge on HAP in rural Nepal using traditional cookstoves and revealed very high concentrations in these households.	[Chen, Chen; Breysse, Patrick] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA; [Zeger, Scott] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Katz, Joanne; Checkley, William] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Checkley, William] Johns Hopkins Sch Med, Dept Med, Div Pulm & Crit Care, Baltimore, MD USA; [Curriero, Frank C.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Tielsch, James M.] George Washington Univ, Sch Publ Hlth, Milken Inst, Dept Global Hlth, Washington, DC 20052 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; George Washington University	Tielsch, JM (corresponding author), George Washington Univ, Sch Publ Hlth, Milken Inst, Dept Global Hlth, Washington, DC 20052 USA.	jtielsch@gwu.edu	Chen, Chen/X-1025-2019	Chen, Chen/0000-0002-0632-946X; Zeger, Scott/0000-0001-8907-1603; Checkley, William/0000-0003-1106-8812; Katz, Joanne/0000-0002-5997-7823	National Institute of Environmental Health Sciences, United States National Institutes of Health [ES015558]; Thrasher Research Fund [02830-4]; Global Alliance for Clean Cookstoves of the United Nations Foundation [UNF-12-380]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015558] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences, United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Thrasher Research Fund; Global Alliance for Clean Cookstoves of the United Nations Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	National Institute of Environmental Health Sciences, United States National Institutes of Health (ES015558) (JT), the Thrasher Research Fund (02830-4) (JT), and the Global Alliance for Clean Cookstoves of the United Nations Foundation (UNF-12-380) (JT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was performed with financial support from the National Institute of Environmental Health Sciences, United States National Institutes of Health (ES015558), the Thrasher Research Fund (02830-4), and the Global Alliance for Clean Cookstoves of the United Nations Foundation (UNF-12-380).	Clark ML, 2013, ENVIRON HEALTH PERSP, V121, P1120, DOI 10.1289/ehp.1206429; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Dutta K, 2007, ENERGY SUSTAIN DEV, V11, P19, DOI DOI 10.1016/S0973-0826(08)60397-X; Edwards RD, 2007, INDOOR AIR, V17, P189, DOI 10.1111/j.1600-0668.2007.00465.x; Gordon SB, 2014, LANCET RESP MED, V2, P823, DOI 10.1016/S2213-2600(14)70168-7; Gurley ES, 2013, INDOOR AIR, V23, P379, DOI 10.1111/ina.12038; Gurung A, 2013, ENVIRON RES, V124, P54, DOI 10.1016/j.envres.2013.03.007; Intensive Study and Research Center Pvt. Ltd, 2014, DISTR VDC PROF NEP 2; Johansson TB, 2012, GLOB EN ASS GEA; Kurmi OP, 2011, THORAX, V66, P724, DOI 10.1136/thx.2010.144717; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; McCracken JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055670; Mukhopadhyay R, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI [10.3402/gha.v5i0.19016, 10.3402/gha.v510.19016]; Naeher LP, 2001, ENVIRON SCI TECHNOL, V35, P575, DOI 10.1021/es991225g; Northcross A, 2010, J ENVIRON MONITOR, V12, P873, DOI 10.1039/b916068j; Shrestha IL, 2005, INT J OCCUP ENV HEAL, V11, P150, DOI 10.1179/oeh.2005.11.2.150; Soneja S, 2014, INT J ENV RES PUB HE, V11, P6400, DOI 10.3390/ijerph110606400; Thermo Electron Corporation, 2003, MODEL PDR 1000AN 120; Tielsch JM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1271; Wallace L, 2006, ATMOS ENVIRON, V40, P399, DOI 10.1016/j.atmosenv.2005.08.042; Wallace LA, 2011, J EXPO SCI ENV EPID, V21, P49, DOI 10.1038/jes.2010.15; WHO, 2014, WHO GUID IND AIR QUA; Wolrd Health Organization, 2010, WHO GUID IND AIR QUA; World Health Organization, 2006, AIR QUAL GUID GLOB U; Wu CF, 2005, J EXPO ANAL ENV EPID, V15, P99, DOI 10.1038/sj.jea.7500351	25	29	29	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0157984	10.1371/journal.pone.0157984	http://dx.doi.org/10.1371/journal.pone.0157984			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27389398	gold, Green Published, Green Submitted			2022-12-27	WOS:000379811500010
J	Dong, MX; Hu, QC; Shen, P; Pan, JX; Wei, YD; Liu, YY; Ren, YF; Liang, ZH; Wang, HY; Zhao, LB; Xie, P				Dong, Mei-Xue; Hu, Qing-Chuan; Shen, Peng; Pan, Jun-Xi; Wei, You-Dong; Liu, Yi-Yun; Ren, Yi-Fei; Liang, Zi-Hong; Wang, Hai-Yang; Zhao, Li-Bo; Xie, Peng			Recombinant Tissue Plasminogen Activator Induces Neurological Side Effects Independent on Thrombolysis in Mechanical Animal Models of Focal Cerebral Infarction: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; BRAIN-BARRIER PERMEABILITY; THERAPEUTIC TIME WINDOW; TPA-DEFICIENT MICE; HEMORRHAGIC TRANSFORMATION; INTRACEREBRAL HEMORRHAGE; RT-PA; POLY(ADP-RIBOSE)POLYMERASE INHIBITOR; DELAYED TREATMENT; ARTERY OCCLUSION	Background and Purpose Recombinant tissue plasminogen activator (rtPA) is the only effective drug approved by US FDA to treat ischemic stroke, and it contains pleiotropic effects besides thrombolysis. We performed a meta-analysis to clarify effect of tissue plasminogen activator (tPA) on cerebral infarction besides its thrombolysis property in mechanical animal stroke. Methods Relevant studies were identified by two reviewers after searching online databases, including Pubmed, Embase, and ScienceDirect, from 1979 to 2016. We identified 6, 65, 17, 12, 16, 12 and 13 comparisons reporting effect of endogenous tPA on infarction volume and effects of rtPA on infarction volume, blood-brain barrier, brain edema, intracerebral hemorrhage, neurological function and mortality rate in all 47 included studies. Standardized mean differences for continuous measures and risk ratio for dichotomous measures were calculated to assess the effects of endogenous tPA and rtPA on cerebral infarction in animals. The quality of included studies was assessed using the Stroke Therapy Academic Industry Roundtable score. Subgroup analysis, meta-regression and sensitivity analysis were performed to explore sources of heterogeneity. Funnel plot, Trim and Fill method and Egger's test were obtained to detect publication bias. Results We found that both endogenous tPA and rtPA had not enlarged infarction volume, or deteriorated neurological function. However, rtPA would disrupt blood-brain barrier, aggravate brain edema, induce intracerebral hemorrhage and increase mortality rate. Conclusions This meta-analysis reveals rtPA can lead to neurological side effects besides thrombolysis in mechanical animal stroke, which may account for clinical exacerbation for stroke patients that do not achieve vascular recanalization with rtPA.	[Dong, Mei-Xue; Shen, Peng; Wei, You-Dong; Liu, Yi-Yun; Ren, Yi-Fei; Liang, Zi-Hong; Xie, Peng] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China; [Dong, Mei-Xue; Xie, Peng] Chongqing Med Univ, Inst Neurosci, Chongqing, Peoples R China; [Dong, Mei-Xue; Xie, Peng] Chongqing Med Univ, Collaborat Innovat Ctr Brain Sci, Chongqing, Peoples R China; [Dong, Mei-Xue; Hu, Qing-Chuan; Pan, Jun-Xi; Wang, Hai-Yang; Xie, Peng] Chongqing Key Lab Neurobiol, Chongqing, Peoples R China; [Zhao, Li-Bo] Chongqing Med Univ, Dept Neurol, Yongchuan Hosp, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Xie, P (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China.; Xie, P (corresponding author), Chongqing Med Univ, Inst Neurosci, Chongqing, Peoples R China.; Xie, P (corresponding author), Chongqing Med Univ, Collaborat Innovat Ctr Brain Sci, Chongqing, Peoples R China.; Xie, P (corresponding author), Chongqing Key Lab Neurobiol, Chongqing, Peoples R China.	xiepeng@cqmu.edu.cn		Liang, Zihong/0000-0002-7466-0832; dong, meixue/0000-0001-5853-7861	National Key Clinical Specialties Construction Program of China; National Basic Research Program of China (973 Program) [2009CB918300]	National Key Clinical Specialties Construction Program of China; National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the National Key Clinical Specialties Construction Program of China and National Basic Research Program of China (973 Program, grant no. 2009CB918300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Fanne R, 2010, NEUROPHARMACOLOGY, V58, P972, DOI 10.1016/j.neuropharm.2009.12.017; Allahtavakoli M, 2015, BASIC CLIN PHARMACOL, V117, P335, DOI 10.1111/bcpt.12413; Armstead WM, 2006, NAT NEUROSCI, V9, P1150, DOI 10.1038/nn1757; Armstead WM, 2012, J NEUROTRAUM, V29, P1794, DOI 10.1089/neu.2012.2328; Armugam A, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-120; Balami JS, 2013, CNS NEUROL DISORD-DR, V12, P155; Benchenane K, 2007, J CELL SCI, V120, P578, DOI 10.1242/jcs.03354; Berny-Lang MA, 2011, STROKE, V42, P1736, DOI 10.1161/STROKEAHA.110.603811; Bertrand T, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.296; Burggraf D, 2007, BRAIN RES, V1164, P55, DOI 10.1016/j.brainres.2007.05.066; Burggraf D, 2010, THROMB HAEMOSTASIS, V103, P891, DOI 10.1160/TH09-07-0500; Cechmanek BK, 2015, THER HYPOTHERMIA TEM, V5, P203, DOI 10.1089/ther.2015.0010; Cheng PF, 2015, MENOPAUSE, V22, P198, DOI [10.1097/GME.0000000000000290, 10.1097/gme.0000000000000290]; Cheng PF, 2015, CELL MOL NEUROBIOL, V35, P1149, DOI 10.1007/s10571-015-0208-4; Cheng PF, 2015, SCI REP-UK, V5, DOI 10.1038/srep14161; Chevilley A, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00415; Copin JC, 2011, EUR J NEUROSCI, V34, P1085, DOI 10.1111/j.1460-9568.2011.07843.x; Crawley JTB, 2013, J THROMB HAEMOST, V11, P64; Crumrine RC, 2012, EXPERIMENTAL AND TRA, V4; Crumrine RC, 2011, EXPERIMENTAL AND TRA, V3; Deguchi K, 2012, BRAIN RES, V1436, P168, DOI 10.1016/j.brainres.2011.12.016; Dhillon S, 2012, CNS DRUGS, V26, P899, DOI 10.2165/11209940-000000000-00000; ElAli A, 2016, NEUROPSYCHOPHARMACOL, V41, P1297, DOI 10.1038/npp.2015.279; Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; Fraser PA, 2011, FREE RADICAL BIO MED, V51, P967, DOI 10.1016/j.freeradbiomed.2011.06.003; Gautier S, 2003, STROKE, V34, P2975, DOI 10.1161/01.STR.0000101914.62066.7B; Grobholz K, 2005, NEUROL RES, V27, P212, DOI 10.1179/016164105X35576; Haddad M, 2013, FUND CLIN PHARMACOL, V27, P393, DOI 10.1111/j.1472-8206.2012.01036.x; Haile WB, 2012, J CEREBR BLOOD F MET, V32, P57, DOI 10.1038/jcbfm.2011.106; Harston GWJ, 2010, J CEREBR BLOOD F MET, V30, P1804, DOI 10.1038/jcbfm.2010.149; Hu L, 2016, EUR J NEUROL, V23, P1195, DOI 10.1111/ene.13013; Ishiguro M, 2012, NEUROSCIENCE, V220, P302, DOI 10.1016/j.neuroscience.2012.06.015; Ishiguro M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015178; Jin R, 2010, NEUROBIOL DIS, V38, P376, DOI 10.1016/j.nbd.2010.03.008; Kikuchi K, 2014, CNS DRUGS, V28, P929, DOI 10.1007/s40263-014-0199-6; Kilic E, 1999, NEUROREPORT, V10, P107, DOI 10.1097/00001756-199901180-00021; Kilic E, 2005, STROKE, V36, P332, DOI 10.1161/01.STR.0000152273.24063.f7; Kilic E, 2001, STROKE, V32, P2641, DOI 10.1161/hs1101.097381; Kilic E, 2005, NEURODEGENER DIS, V2, P49, DOI 10.1159/000089283; Klein GM, 1999, NEUROLOGY, V52, P1381, DOI 10.1212/WNL.52.7.1381; Kocic I, 2015, N-S ARCH PHARMACOL, V388, P79, DOI 10.1007/s00210-014-1061-6; Kumar G, 2015, CNS DRUGS, V29, P659, DOI 10.1007/s40263-015-0265-8; Lee SR, 2007, NEUROSCIENCE, V150, P50, DOI 10.1016/j.neuroscience.2007.06.029; Lee SH, 2014, MOL NEUROBIOL, V49, P199, DOI 10.1007/s12035-013-8511-x; Lemarchand E, 2016, CELL DEATH DIFFER, V23, P123, DOI 10.1038/cdd.2015.76; Lenglet S, 2014, J CEREBR BLOOD F MET, V34, P802, DOI 10.1038/jcbfm.2014.9; Li Q, 2015, STROKE, V46, P2119, DOI 10.1161/STROKEAHA.115.009185; Li Q, 2015, SCI REP-UK, V5, DOI 10.1038/srep11357; Liang J, 2015, STROKE, V46, P1344, DOI 10.1161/STROKEAHA.114.008599; Liu B., 2015, J UNCERTAIN ANAL APP, V3, P10, DOI [DOI 10.1186/S40467-015-0036-6, 10.1186/s40467-015-0036-6]; Liu B, 2015, SCI REP-UK, V5, DOI 10.1038/srep15771; Lu AG, 2009, NEUROL RES, V31, P209, DOI 10.1179/174313209X393933; Lyden P, 2015, EXPERT REV NEUROTHER, V15, P571, DOI 10.1586/14737175.2015.1041510; Machado LS, 2009, STROKE, V40, P3028, DOI 10.1161/STROKEAHA.109.556852; Macleod MR, 2009, STROKE, V40, pE50, DOI 10.1161/STROKEAHA.108.525386; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Mendis S, 2015, STROKE, V46, pE121, DOI 10.1161/STROKEAHA.115.008097; Meng W, 1999, J CEREBR BLOOD F MET, V19, P1316, DOI 10.1097/00004647-199912000-00004; Meyer G, 2014, NEW ENGL J MED, V370, P1402, DOI 10.1056/NEJMoa1302097; Nakano T, 2015, BRAIN RES, V1624, P330, DOI 10.1016/j.brainres.2015.07.027; Niego B, 2012, BLOOD, V119, P4752, DOI 10.1182/blood-2011-07-369512; Oka F, 2009, J NEUROTRAUM, V26, P1577, DOI [10.1089/neu.2008.0768, 10.1089/neu.2008-0768]; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Parcq J, 2012, CELL DEATH DIFFER, V19, P1983, DOI 10.1038/cdd.2012.86; Roussel BD, 2009, BRAIN, V132, P2219, DOI 10.1093/brain/awp162; Sena ES, 2010, J CEREBR BLOOD F MET, V30, P1905, DOI 10.1038/jcbfm.2010.116; Shen LH, 2011, STROKE, V42, P459, DOI 10.1161/STROKEAHA.110.593863; Siao CJ, 2003, J NEUROSCI, V23, P3234; Sumii T, 2002, STROKE, V33, P831, DOI 10.1161/hs0302.104542; Sutherland Brad A, 2013, J Cereb Blood Flow Metab, V33, pe1, DOI 10.1038/jcbfm.2013.148; Tabrizi P, 1999, ARTERIOSCL THROM VAS, V19, P2801, DOI 10.1161/01.ATV.19.11.2801; Tang J, 2010, NEUROL RES, V32, P541, DOI 10.1179/174313209X414560; Tang J, 2009, NEUROL RES, V31, P189, DOI 10.1179/174313209X393898; Tang XN, 2013, THER HYPOTHERMIA TEM, V3, P74, DOI 10.1089/ther.2013.0010; Teng F, 2013, EXP NEUROL, V248, P416, DOI 10.1016/j.expneurol.2013.07.007; TSIRKA SE, 1995, NATURE, V377, P340, DOI 10.1038/377340a0; Tsuji K, 2005, STROKE, V36, P1954, DOI 10.1161/01.STR.0000177517.01203.eb; Tucker HM, 2000, J NEUROSCI, V20, P3937; Turner RJ, 2012, NEUROSCIENCE, V220, P1, DOI 10.1016/j.neuroscience.2012.06.047; Wang YMF, 1998, NAT MED, V4, P228, DOI 10.1038/nm0298-228; Wardlaw J M, 2003, Cochrane Database Syst Rev, pCD000213; Wardlaw JM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000213.pub3; Won S, 2014, J CEREBR BLOOD F MET, V34, P72, DOI 10.1038/jcbfm.2013.163; Wu F, 2013, J CEREBR BLOOD F MET, V33, P1761, DOI 10.1038/jcbfm.2013.124; Wu F, 2012, J NEUROSCI, V32, P9848, DOI 10.1523/JNEUROSCI.1241-12.2012; Wu JL, 2010, AM J PATHOL, V177, P2576, DOI 10.2353/ajpath.2010.100466; Yagi K, 2009, STROKE, V40, P626, DOI 10.1161/STROKEAHA.108.520262; Yepes M, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3339/fncel.2015.00304, 10.3389/fncel.2015.00304]; Yepes M, 2013, ANN NEUROL, V74, pS7; Yepes M, 2009, TRENDS NEUROSCI, V32, P48, DOI 10.1016/j.tins.2008.09.006; Zechariah A, 2010, J NEUROL, V257, pS193; Zhang WR, 2004, NEUROL RES, V26, P342, DOI 10.1179/016164104225014058; Zhou XY, 2015, WORLD PSYCHIATRY, V14, P207, DOI 10.1002/wps.20217; Zhou XY, 2015, ADDICTION, V110, P38, DOI 10.1111/add.12698; Zhou XY, 2012, STROKE, V43, P2923, DOI 10.1161/STROKEAHA.112.667535; Zhu WB, 2014, TRANSL STROKE RES, V5, P612, DOI 10.1007/s12975-014-0348-8; Zuo W, 2014, EUR J NEUROSCI, V39, P2107, DOI 10.1111/ejn.12551	97	33	34	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158848	10.1371/journal.pone.0158848	http://dx.doi.org/10.1371/journal.pone.0158848			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27387385	Green Submitted, gold, Green Published			2022-12-27	WOS:000379811500056
J	Han, K; Hwang, E; Park, JB				Han, Kyungdo; Hwang, Eunkyung; Park, Jun-Beom			Association between Consumption of Coffee and the Prevalence of Periodontitis: The 2008-2010 Korea National Health and Nutrition Examination Survey	PLOS ONE			English	Article							GREEN TEA CONSUMPTION; BONE-MINERAL DENSITY; INSULIN-RESISTANCE; METABOLIC SYNDROME; TOOTH LOSS; ADULTS; WOMEN; CAFFEINE; DISEASE; RISK	Background This study was performed to assess the relationship between the consumption of coffee and periodontitis using nationally representative data. Methods The data from the Korea National Health and Nutrition Examination Survey were used; the analysis in this study was confined to a total of 16,730 respondents over 19 years old who had no missing values for the consumption of coffee or outcome variables. A community periodontal index greater than or equal to code 3 was defined as periodontal disease. Results Consumption of coffee was significantly higher in the individuals with periodontitis in males. The odds ratios of the percentage of individuals with periodontitis tended to increase with the consumption of coffee. Adjusted odds ratios and their 95% confidence intervals of the male participants were 1, 1.131(0.792-1.617), 1.161(0.857-1.573), 1.053(0.805-1.379), 1.299(1.007-1.676), and 1.458(1.141-1.862) for once per month or less, once per month<x <= 3 times per week, three times per week<x <= 6 times per week, once per day, twice per day, and three or more per day, respectively. Conclusions Consumption of coffee may be considered an independent risk indicator of periodontal disease in Korean male adults, and we suggest that the periodontal health of male may benefit from reduction of coffee consumption.	[Han, Kyungdo] Catholic Univ Korea, Coll Med, Dept Biostat, Seoul, South Korea; [Hwang, Eunkyung] Myongji Univ, Bangmok Coll Gen Educ, Seoul, South Korea; [Park, Jun-Beom] Catholic Univ Korea, Coll Med, Dept Periodont, Seoul, South Korea	Catholic University of Korea; Myongji University; Catholic University of Korea	Park, JB (corresponding author), Catholic Univ Korea, Coll Med, Dept Periodont, Seoul, South Korea.	jbassoonis@yahoo.co.kr	Park, Jun-Beom/I-8201-2019	Park, Jun-Beom/0000-0002-8915-1555	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, Information Communication Technology (ICT) & Future Planning (Seoul, Republic of Korea) [NRF-2014R1A1A1003106]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, Information Communication Technology (ICT) & Future Planning (Seoul, Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, Information Communication Technology (ICT) & Future Planning (NRF-2014R1A1A1003106) (Seoul, Republic of Korea).; This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, Information and Communication Technology & Future Planning (NRF-2014R1A1A1003106). The authors have stated explicitly that there are no conflicts of interest in connection with this article.	Bae J, 2015, RHEUMATOL INT, V35, P327, DOI 10.1007/s00296-014-3061-8; Bernabe E, 2014, J DENT, V42, P952, DOI 10.1016/j.jdent.2014.04.011; Bezerra JP, 2008, J PERIODONTOL, V79, P2356, DOI [10.1902/jop.2008.080204, 10.1902/jop.2008.080204 ]; Broderick Pamela, 2004, J Okla State Med Assoc, V97, P538; Budhathoki S, 2015, INT J CANCER, V137, P463, DOI 10.1002/ijc.29390; Choi EJ, 2014, KOREAN J FAM MED, V35, P11, DOI 10.4082/kjfm.2014.35.1.11; Choi HM, 2015, J PERIODONTOL, V86, P866, DOI 10.1902/jop.2015.150025; Chun YH, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-84; Chung JH, 2016, J PERIODONTOL, P1; de Mejia EG, 2014, TRENDS ENDOCRIN MET, V25, P489, DOI 10.1016/j.tem.2014.07.003; Duarte PM, 2015, J EVID-BASED DENT PR, V15, P77, DOI 10.1016/j.jebdp.2015.03.010; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; Han K, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002791; Han K, 2016, MATURITAS, V85, P73, DOI 10.1016/j.maturitas.2015.12.010; Han K, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001839; Hong JW, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002864; Ikeda M, 2010, SCAND J CLIN LAB INV, V70, P171, DOI 10.3109/00365511003650165; Islam SKMA, 2015, ENDOCR J, V62, P981, DOI 10.1507/endocrj.EJ15-0350; Je Y, 2014, ASIA PAC J CLIN NUTR, V23, P691, DOI 10.6133/apjcn.2014.23.4.11; Jeon JY, 2013, DIABETES METAB J, V37, P349, DOI 10.4093/dmj.2013.37.5.349; Kamagata-Kiyoura Y, 1999, J PERIODONTOL, V70, P283, DOI 10.1902/jop.1999.70.3.283; Kim HJ, 2014, DIABETES RES CLIN PR, V106, P145, DOI 10.1016/j.diabres.2014.07.007; Kim J, 2012, J ACAD NUTR DIET, V112, P246, DOI 10.1016/j.jada.2011.10.005; Kim SY, 2014, KOREAN J FAM MED, V35, P1, DOI 10.4082/kjfm.2014.35.1.1; Kim Y. H., 2013, CLIN ORAL INVEST; Kim YH, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0142-3; Koyama Y, 2010, PREV MED, V50, P173, DOI 10.1016/j.ypmed.2010.01.010; Lee JK, 2015, EUR J ENDOCRINOL, V172, P595, DOI 10.1530/EJE-14-0805; Lee JH, 2016, KOREAN J FAM MED, V37, P7, DOI 10.4082/kjfm.2016.37.1.7; Lim HS, 2015, FOOD ADDIT CONTAM A, V32, P1786, DOI 10.1080/19440049.2015.1077396; Lin WY, 2011, EUR J CLIN INVEST, V41, P659, DOI 10.1111/j.1365-2362.2010.02455.x; Macedo Rander Moreira, 2015, Braz. Dent. J., V26, P175, DOI 10.1590/0103-6440201300219; Machida T, 2014, NUTRIENTS, V6, P4476, DOI 10.3390/nu6104476; MARKKANEN H, 1978, COMMUNITY DENT ORAL, V6, P240, DOI 10.1111/j.1600-0528.1978.tb01158.x; Ng N, 2014, J PERIODONTOL, V85, P1042, DOI 10.1902/jop.2013.130179; Pham NM, 2014, METABOLISM, V63, P400, DOI 10.1016/j.metabol.2013.11.008; Oh JY, 2007, KOREAN J FAM MED, V28, P532; Park JB, 2014, J PERIODONTOL, V85, P1521, DOI 10.1902/jop.2014.130782; Sakamoto W, 2001, BONE, V28, P332, DOI 10.1016/S8756-3282(00)00444-0; Setiawan VW, 2015, GASTROENTEROLOGY, V148, P118, DOI 10.1053/j.gastro.2014.10.005; Tan EK, 2003, J NEUROL SCI, V216, P163, DOI 10.1016/j.jns.2003.07.006; Tanaka Keiko, 2008, Fukuoka Acta Medica, V99, P80; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Yi JR, 2016, ARCH ORAL BIOL, V64, P51, DOI 10.1016/j.archoralbio.2015.12.009; Zuccarello D, 2014, GENE, V535, P286, DOI 10.1016/j.gene.2013.11.016	45	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158845	10.1371/journal.pone.0158845	http://dx.doi.org/10.1371/journal.pone.0158845			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27387296	gold, Green Published, Green Submitted			2022-12-27	WOS:000379811500055
J	Puig, J; Sanchez-Gonzalez, J; Blasco, G; Daunis-i-Estadella, P; Federau, C; Alberich-Bayarri, A; Biarnes, C; Nael, K; Essig, M; Jain, R; Wintermark, M; Pedraza, S				Puig, Josep; Sanchez-Gonzalez, Javier; Blasco, Gerard; Daunis-i-Estadella, Pepus; Federau, Christian; Alberich-Bayarri, Angel; Biarnes, Carles; Nael, Kambiz; Essig, Marco; Jain, Rajan; Wintermark, Max; Pedraza, Salvador			Intravoxel Incoherent Motion Metrics as Potential Biomarkers for Survival in Glioblastoma	PLOS ONE			English	Article							CEREBRAL BLOOD-VOLUME; DIFFUSION-WEIGHTED MRI; PERFUSION-RELATED PARAMETERS; INITIAL CLINICAL-EXPERIENCE; BRAIN PERFUSION; BOLUS TRACKING; TUMOR GRADE; GLIOMAS; CONTRAST; MODEL	Objective Intravoxel incoherent motion (IVIM) is an MRI technique with potential applications in measuring brain tumor perfusion, but its clinical impact remains to be determined. We assessed the usefulness of IVIM-metrics in predicting survival in newly diagnosed glioblastoma. Methods Fifteen patients with glioblastoma underwent MRI including spin-echo echo-planar DWI using 13 b-values ranging from 0 to 1000 s/mm(2). Parametric maps for diffusion coefficient (D), pseudodiffusion coefficient (D*), and perfusion fraction (f) were generated for contrast-enhancing regions (CER) and non-enhancing regions (NCER). Regions of interest were manually drawn in regions of maximum f and on the corresponding dynamic susceptibility contrast images. Prognostic factors were evaluated by Kaplan-Meier survival and Cox proportional hazards analyses. Results We found that f(CER) and D*(CER) correlated with rCBF(CER). The best cutoffs for 6-month survival were f(CER)>9.86% and D*(CER)>21.712 x 10(-3)mm(2)/s (100% sensitivity, 71.4% specificity, 100% and 80% positive predictive values, and 80% and 100% negative predictive values; AUC: 0.893 and 0.857, respectively). Treatment yielded the highest hazard ratio (5.484; 95% CI: 1.162-25.88; AUC: 0.723; P = 0.031); f(CER) combined with treatment predicted survival with 100% accuracy. Conclusions The IVIM-metrics f(CER) and D*(CER) are promising biomarkers of 6-month survival in newly diagnosed glioblastoma.	[Puig, Josep; Blasco, Gerard; Biarnes, Carles; Pedraza, Salvador] Hosp Univ Dr Josep Trueta, Imaging Res Unit, IDI, Girona Biomed Res Inst IDIBGI, Girona, Spain; [Sanchez-Gonzalez, Javier] Philips Healthcare Iber, Madrid, Spain; [Daunis-i-Estadella, Pepus] Univ Girona, Dept Comp Sci Appl Math & Stat, Girona, Spain; [Federau, Christian] CHU Vaudois, Dept Diagnost & Intervent Radiol, Lausanne, Switzerland; [Federau, Christian; Wintermark, Max] Univ Lausanne, Lausanne, Switzerland; [Federau, Christian; Wintermark, Max] Stanford Univ, Dept Radiol, Neuroradiol Div, Palo Alto, CA 94304 USA; [Alberich-Bayarri, Angel] La Fe Polytech & Univ Hosp, Biomed Imaging Res Grp GIBI230, La Fe Hlth Res Inst, Valencia, Spain; [Nael, Kambiz] Icahn Sch Med Mt Sinai, Dept Radiol, New York, NY 10029 USA; [Essig, Marco] Univ Manitoba, Dept Radiol, Winnipeg, MB, Canada; [Jain, Rajan] NYU, Div Neuroradiol, Dept Radiol, Langone Med Ctr, New York, NY USA	Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Philips; Philips Healthcare; Universitat de Girona; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Stanford University; Icahn School of Medicine at Mount Sinai; University of Manitoba; New York University; NYU Langone Medical Center	Puig, J (corresponding author), Hosp Univ Dr Josep Trueta, Imaging Res Unit, IDI, Girona Biomed Res Inst IDIBGI, Girona, Spain.	jpuigalcantara@idibgi.org	Daunis-i-Estadella, Pepus/B-9082-2011; pedraza, salvador/AAC-1728-2019; Alberich-Bayarri, Angel/E-3822-2010	Daunis-i-Estadella, Pepus/0000-0001-6134-9255; pedraza, salvador/0000-0003-2517-4413; Alberich-Bayarri, Angel/0000-0002-5932-2392; essig, marco/0000-0002-7964-2297; Jain, Rajan/0000-0002-4879-0457; Sanchez-Gonzalez, Javier/0000-0003-1427-3870; Blasco, Gerard/0000-0002-5302-0625	Philips Healthcare Iberica	Philips Healthcare Iberica	The authors received no specific funding for this work. Javier Sanchez-Gonzalez is employed by Philips Healthcare Iberica. Philips Healthcare Iberica provided support in the form of salary for author Javier Sanchez-Gonzalez, but this company did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Andreou A, 2013, EUR RADIOL, V23, P428, DOI 10.1007/s00330-012-2604-1; ARONEN HJ, 1994, RADIOLOGY, V191, P41, DOI 10.1148/radiology.191.1.8134596; Bisdas S, 2014, NMR BIOMED, V27, P1184, DOI 10.1002/nbm.3172; Bisdas S, 2013, NEURORADIOLOGY, V55, P1189, DOI 10.1007/s00234-013-1229-7; Boxerman JL, 2006, AM J NEURORADIOL, V27, P859; Calamante F, 2002, STROKE, V33, P1146, DOI 10.1161/01.STR.0000014208.05597.33; Carroll TJ, 2003, RADIOLOGY, V227, P593, DOI 10.1148/radiol.2272020092; Cha S, 2002, RADIOLOGY, V223, P11, DOI 10.1148/radiol.2231010594; Chandarana H, 2012, INVEST RADIOL, V47, P688, DOI 10.1097/RLI.0b013e31826a0a49; Federau C, 2014, AM J NEURORADIOL, V35, P256, DOI 10.3174/ajnr.A3686; Federau C, 2015, NMR BIOMED, V28, P9, DOI 10.1002/nbm.3223; Federau C, 2014, J MAGN RESON IMAGING, V39, P624, DOI 10.1002/jmri.24195; Federau C, 2012, RADIOLOGY, V265, P874, DOI 10.1148/radiol.12120584; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Goldbrunner RH, 2000, J NEURO-ONCOL, V50, P53, DOI 10.1023/A:1006462504447; Grech-Sollars M, 2015, NMR BIOMED, V28, P468, DOI 10.1002/nbm.3269; Hakyemez B, 2010, CLIN RADIOL, V65, P15, DOI 10.1016/j.crad.2009.09.005; Hu YC, 2014, SCI REP-UK, V4, DOI 10.1038/srep07208; Iima M, 2014, INVEST RADIOL, V49, P485, DOI 10.1097/RLI.0000000000000040; Jain R, 2011, AM J NEURORADIOL, V32, P388, DOI 10.3174/ajnr.A2280; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Kim HS, 2014, AM J NEURORADIOL, V35, P490, DOI 10.3174/ajnr.A3719; Knutsson L, 2010, MAGN RESON MATER PHY, V23, P1, DOI 10.1007/s10334-009-0190-2; Koh DM, 2011, AM J ROENTGENOL, V196, P1351, DOI 10.2214/AJR.10.5515; Kono K, 2001, AM J NEURORADIOL, V22, P1081; LATOUR LL, 1994, P NATL ACAD SCI USA, V91, P1229, DOI 10.1073/pnas.91.4.1229; Law M, 2003, AM J NEURORADIOL, V24, P1989; Law M, 2008, RADIOLOGY, V247, P490, DOI 10.1148/radiol.2472070898; Le Bihan D, 2013, RADIOLOGY, V268, P318, DOI 10.1148/radiol.13130420; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; Liu CL, 2013, EUR J RADIOL, V82, pE782, DOI 10.1016/j.ejrad.2013.08.006; More J. J., 1980, ANL8074, VIII; Myles PS, 2007, BRIT J ANAESTH, V99, P309, DOI 10.1093/bja/aem214; Niendorf T, 1996, MAGN RESON MED, V36, P847, DOI 10.1002/mrm.1910360607; Olson JJ, 2009, J NEURO-ONCOL, V93, P1, DOI 10.1007/s11060-009-9838-z; Ostergaard L, 1998, J CEREBR BLOOD F MET, V18, P935, DOI 10.1097/00004647-199809000-00002; Pang YX, 2013, MAGN RESON MED, V69, P553, DOI 10.1002/mrm.24277; Paulson ES, 2008, RADIOLOGY, V249, P601, DOI 10.1148/radiol.2492071659; Pope WB, 2005, AM J NEURORADIOL, V26, P2466; Prince MR, 2009, J MAGN RESON IMAGING, V30, P1298, DOI 10.1002/jmri.21973; Rock K, 2012, BRIT J RADIOL, V85, pE729, DOI 10.1259/bjr/83796755; Ronning PA, 2012, NEURO-ONCOLOGY, V14, P1178, DOI 10.1093/neuonc/nos153; Sasaki M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112866; Shin JH, 2002, AM J ROENTGENOL, V179, DOI 10.2214/ajr.179.3.1790783; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sugahara T, 1999, JMRI-J MAGN RESON IM, V9, P53, DOI 10.1002/(SICI)1522-2586(199901)9:1<53::AID-JMRI7>3.0.CO;2-2; Sumi M, 2013, AM J NEURORADIOL, V34, P410, DOI 10.3174/ajnr.A3227; Sumi M, 2012, RADIOLOGY, V263, P770, DOI 10.1148/radiol.12111248; Wang LL, 2014, EUR RADIOL, V24, P1914, DOI 10.1007/s00330-014-3176-z; Weber MA, 2010, INVEST RADIOL, V45, P755, DOI 10.1097/RLI.0b013e3181ec9db0; Wirestam R, 2001, ACTA RADIOL, V42, P123, DOI 10.1080/028418501127346459; Yuan J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087024	52	22	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158887	10.1371/journal.pone.0158887	http://dx.doi.org/10.1371/journal.pone.0158887			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27387822	Green Published, gold, Green Submitted			2022-12-27	WOS:000379811500059
J	Wang, L; Liu, GH; Fu, SJ; Xu, LZ; Zhao, K; Zhang, CM				Wang, Lu; Liu, Guohua; Fu, Shujun; Xu, Lingzhong; Zhao, Kun; Zhang, Caiming			Retinal Image Enhancement Using Robust Inverse Diffusion Equation and Self-Similarity Filtering	PLOS ONE			English	Article							DIABETIC-RETINOPATHY; FUNDUS IMAGES; VISUAL IMPAIRMENT; SHOCK FILTERS; RISK-FACTORS; DIAGNOSIS; RESTORATION; PREVALENCE; ALGORITHMS; FEATURES	As a common ocular complication for diabetic patients, diabetic retinopathy has become an important public health problem in the world. Early diagnosis and early treatment with the help of fundus imaging technology is an effective control method. In this paper, a robust inverse diffusion equation combining a self-similarity filtering is presented to detect and evaluate diabetic retinopathy using retinal image enhancement. A flux corrected transport technique is used to control diffusion flux adaptively, which eliminates overshoots inherent in the Laplacian operation. Feature preserving denoising by the self-similarity filtering ensures a robust enhancement of noisy and blurry retinal images. Experimental results demonstrate that this algorithm can enhance important details of retinal image data effectively, affording an opportunity for better medical interpretation and subsequent processing.	[Wang, Lu; Xu, Lingzhong] Shandong Univ, Sch Publ Hlth, Jinan 250012, Peoples R China; [Liu, Guohua] Shandong Univ, Qilu Childrens Hosp, Dept Ophthalmol, Jinan 250022, Peoples R China; [Fu, Shujun] Shandong Univ, Sch Math, Jinan 250100, Peoples R China; [Zhao, Kun] Shandong Univ, Hosp 2, Dept Med Imaging, Jinan 250033, Peoples R China; [Zhang, Caiming] Shandong Univ Finance & Econ, Sch Comp Sci & Technol, Jinan 250061, Peoples R China; [Zhang, Caiming] Shandong Univ, Sch Comp Sci & Technol, Jinan 250101, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University; Shandong University of Finance & Economics; Shandong University	Fu, SJ (corresponding author), Shandong Univ, Sch Math, Jinan 250100, Peoples R China.	shujunfu@163.com			National Natural Science Foundation of China [61272239, 61070094, 61020106001]; NSFC Joint Fund with Guangdong [U1201258]; Science and Technology Development Project of Shandong Province of China [2014GGX101024]; Fundamental Research Funds of Shandong University [2014JC012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSFC Joint Fund with Guangdong(National Natural Science Foundation of Guangdong Province); Science and Technology Development Project of Shandong Province of China; Fundamental Research Funds of Shandong University	The research has been supported in part by the National Natural Science Foundation of China (61272239, 61070094, 61020106001); the NSFC Joint Fund with Guangdong (U1201258); the Science and Technology Development Project of Shandong Province of China (2014GGX101024); and the Fundamental Research Funds of Shandong University (2014JC012).	Abbas Q, 2013, INT J INNOV COMPUT I, V9, P3731; Abramoff Michael D, 2010, IEEE Rev Biomed Eng, V3, P169, DOI 10.1109/RBME.2010.2084567; ALVAREZ L, 1994, SIAM J NUMER ANAL, V31, P590, DOI 10.1137/0731032; Aubert G., 2006, MATH PROBLEMS IMAGE, DOI 10.1007/978-0-387-44588-5; Azzopardi G, 2015, MED IMAGE ANAL, V19, P46, DOI 10.1016/j.media.2014.08.002; Bernardes R, 2011, OPHTHALMOLOGICA, V226, P161, DOI 10.1159/000329597; Buades A, 2005, MULTISCALE MODEL SIM, V4, P490, DOI 10.1137/040616024; Chang HB, 2015, OPT ENG, V54, DOI 10.1117/1.OE.54.1.013107; Dabov K, 2007, IEEE T IMAGE PROCESS, V16, P2080, DOI 10.1109/TIP.2007.901238; Foracchia M, 2005, MED IMAGE ANAL, V9, P179, DOI 10.1016/j.media.2004.07.001; Fu S, 2010, ELECTRON LETT, V46, P907, DOI 10.1049/el.2010.0027; Fu SJ, 2007, NEUROCOMPUTING, V70, P883, DOI 10.1016/j.neucom.2006.10.035; Fu SJ, 2011, SCI CHINA INFORM SCI, V54, P1184, DOI 10.1007/s11432-011-4239-2; Giancardo L, 2012, MED IMAGE ANAL, V16, P216, DOI 10.1016/j.media.2011.07.004; Gonzalez R.C, 2007, DIGITAL IMAGE PROCES, V3rd; Gordois A, 2012, GLOB PUBLIC HEALTH, V7, P465, DOI 10.1080/17441692.2011.634815; Kyari F, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1299; Mookiah MRK, 2013, COMPUT BIOL MED, V43, P2136, DOI 10.1016/j.compbiomed.2013.10.007; Noronha K, 2013, J MED IMAG HEALTH IN, V3, P280, DOI 10.1166/jmihi.2013.1169; OSHER S, 1988, J COMPUT PHYS, V79, P12, DOI 10.1016/0021-9991(88)90002-2; OSHER S, 1990, SIAM J NUMER ANAL, V27, P919, DOI 10.1137/0727053; Patton N, 2006, PROG RETIN EYE RES, V25, P99, DOI 10.1016/j.preteyeres.2005.07.001; Patwari MB, 2013, INT J ENG, V2, P395; Quellec G, 2011, IEEE T MED IMAGING, V30, P523, DOI 10.1109/TMI.2010.2089383; Rampal H., 2013, P WORLD C MED PHYS B, P900; Ravishankar S, 2009, PROC CVPR IEEE, P210, DOI 10.1109/CVPRW.2009.5206763; Reza AM, 2004, J VLSI SIG PROC SYST, V38, P35, DOI 10.1023/B:VLSI.0000028532.53893.82; Rodrigues P, 2010, THESIS; Sepasian M, 2008, P WORLD C ENG COMP S, P22; Setiawan A. W., 2013, ICT SMART SOC ICISS, P1, DOI [10.1109/ICTSS.2013.6588092, DOI 10.1109/ICTSS.2013.6588092]; Shujun Fu, 2008, 2008 9th International Conference on Signal Processing (ICSP 2008), P1231, DOI 10.1109/ICOSP.2008.4697353; Tariq A., 2010, 2010 IEEE Symposium on Industrial Electronics and Applications (ISIEA 2010), P423, DOI 10.1109/ISIEA.2010.5679430; Walter T, 2002, IEEE T MED IMAGING, V21, P1236, DOI 10.1109/TMI.2002.806290; Xue WF, 2014, IEEE T IMAGE PROCESS, V23, P4850, DOI 10.1109/TIP.2014.2355716; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909; Yu H, 2012, IEEE T INF TECHNOL B, V16, P644, DOI 10.1109/TITB.2012.2198668; Zheng YJ, 2014, MED IMAGE ANAL, V18, P903, DOI 10.1016/j.media.2013.09.009	37	2	2	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158480	10.1371/journal.pone.0158480	http://dx.doi.org/10.1371/journal.pone.0158480			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27388503	Green Published, Green Submitted, gold			2022-12-27	WOS:000379811500024
J	Gutierrez, AH; Loving, C; Moise, L; Terry, FE; Brockmeier, SL; Hughes, HR; Martin, WD; De Groot, AS				Gutierrez, Andres H.; Loving, Crystal; Moise, Leonard; Terry, Frances E.; Brockmeier, Susan L.; Hughes, Holly R.; Martin, William D.; De Groot, Anne S.			In Vivo Validation of Predicted and Conserved T Cell Epitopes in a Swine Influenza Model	PLOS ONE			English	Article							A VIRUS; MOLECULAR CHARACTERIZATION; RESPIRATORY-DISEASE; VACCINE DEVELOPMENT; IMMUNE-RESPONSES; HELPER EPITOPES; IDENTIFICATION; CLADE; IMMUNOGENICITY; HEMAGGLUTININ	Swine influenza is a highly contagious respiratory viral infection in pigs that is responsible for significant financial losses to pig farmers annually. Current measures to protect herds from infection include: inactivated whole-virus vaccines, subunit vaccines, and alpha replicon-based vaccines. As is true for influenza vaccines for humans, these strategies do not provide broad protection against the diverse strains of influenza A virus (IAV) currently circulating in U.S. swine. Improved approaches to developing swine influenza vaccines are needed. Here, we used immunoinformatics tools to identify class I and II T cell epitopes highly conserved in seven representative strains of IAV in U.S. swine and predicted to bind to Swine Leukocyte Antigen (SLA) alleles prevalent in commercial swine. Epitope-specific interferon-gamma (IFN gamma) recall responses to pooled peptides and whole virus were detected in pigs immunized with multi-epitope plasmid DNA vaccines encoding strings of class I and II putative epitopes. In a retrospective analysis of the IFN. responses to individual peptides compared to predictions specific to the SLA alleles of cohort pigs, we evaluated the predictive performance of PigMatrix and demonstrated its ability to distinguish non-immunogenic from immunogenic peptides and to identify promiscuous class II epitopes. Overall, this study confirms the capacity of PigMatrix to predict immunogenic T cell epitopes and demonstrate its potential for use in the design of epitope-driven vaccines for swine. Additional studies that match the SLA haplotype of animals with the study epitopes will be required to evaluate the degree of immune protection conferred by epitope-driven DNA vaccines in pigs.	[Gutierrez, Andres H.; Moise, Leonard; De Groot, Anne S.] Univ Rhode Isl, Inst Immunol & Informat, Dept Cell & Mol Biol, 825 Chalkstone Ave, Providence, RI 02908 USA; [Loving, Crystal; Brockmeier, Susan L.; Hughes, Holly R.] ARS, Virus & Prion Dis Res Unit, NADC, USDA, Ames, IA USA; [Moise, Leonard; Terry, Frances E.; Martin, William D.; De Groot, Anne S.] EpiVax Inc, Providence, RI USA	University of Rhode Island; United States Department of Agriculture (USDA)	De Groot, AS (corresponding author), Univ Rhode Isl, Inst Immunol & Informat, Dept Cell & Mol Biol, 825 Chalkstone Ave, Providence, RI 02908 USA.; De Groot, AS (corresponding author), EpiVax Inc, Providence, RI USA.	dr.annie.degroot@gmail.com	Moise, Lenny/AAE-7448-2019; De Groot, Annie/B-6221-2013	Moise, Lenny/0000-0002-4410-865X; De Groot, Annie/0000-0001-5911-1459; Gutierrez, Andres/0000-0002-6127-8327	National Pork Board [12-121]	National Pork Board	This study was supported by the National Pork Board (www.pork.org; project #12-121) to ADG. The funder provided support in the form of salary for author AHG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section. EpiVax Inc. did not play the role of funder in this work. WDM and FET performed the work as EpiVax employees. ADG and LM performed the work as URI employees, but because ADG and LM are both EpiVax employees, they affiliate on papers.	Adar Y, 2009, VACCINE, V27, P2099, DOI 10.1016/j.vaccine.2009.02.011; Anderson TK, 2015, VIRUS RES, V201, P24, DOI 10.1016/j.virusres.2015.02.009; Anderson TK, 2013, INFLUENZA OTHER RESP, V7, P42, DOI 10.1111/irv.12193; Assarsson E, 2008, J VIROL, V82, P12241, DOI 10.1128/JVI.01563-08; Babon JAB, 2009, HUM IMMUNOL, V70, P711, DOI 10.1016/j.humimm.2009.06.004; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Belz GT, 2002, J VIROL, V76, P12388, DOI 10.1128/JVI.76.23.12388-12393.2002; Braucher DR, 2012, CLIN VACCINE IMMUNOL, V19, P1722, DOI 10.1128/CVI.00315-12; Chen Qi, 2012, Anim Health Res Rev, V13, P181, DOI 10.1017/S1466252312000175; De Groot AS, 2013, EXPERT REV CLIN PHAR, V6, P651, DOI 10.1586/17512433.2013.835698; De Groot AS, 2004, METHODS, V34, P476, DOI 10.1016/j.ymeth.2004.06.003; De Groot AS, 2005, VACCINE, V23, P2136, DOI 10.1016/j.vaccine.2005.01.097; De Groot AS, 2003, VACCINE, V21, P4486, DOI 10.1016/S0264-410X(03)00390-6; Gauger PC, 2012, VET PATHOL, V49, P900, DOI 10.1177/0300985812439724; Goodman AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025938; Gorres JP, 2011, CLIN VACCINE IMMUNOL, V18, P1987, DOI 10.1128/CVI.05171-11; Gottlieb T, 2014, J AUTOIMMUN, V54, P15, DOI 10.1016/j.jaut.2014.07.005; Gutierrez AH, 2015, BMC BIOINFO IN PRESS; Gutierrez AH, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0724-8; Ho CS, 2010, ANIM GENET, V41, P428, DOI 10.1111/j.1365-2052.2010.02019.x; Ho CS, 2009, ANIM GENET, V40, P468, DOI 10.1111/j.1365-2052.2009.01860.x; Kamperschroer C, 2006, J IMMUNOL, V177, P5317, DOI 10.4049/jimmunol.177.8.5317; Kitikoon P, 2013, J GEN VIROL, V94, P1236, DOI [10.1099/vir.0.51839-0, 10.1099/vir.0.051839-0]; Kothalawala H, 2006, VET QUART, V28, P45, DOI 10.1080/01652176.2006.9695207; Lee LYH, 2008, J CLIN INVEST, V118, P3478, DOI 10.1172/JCI32460; LIN YL, 1981, J EXP MED, V154, P225, DOI 10.1084/jem.154.2.225; Livingston B, 2002, J IMMUNOL, V168, P5499, DOI 10.4049/jimmunol.168.11.5499; Lorusso A, 2013, CURR TOP MICROBIOL, V370, P113, DOI 10.1007/82_2011_196; Lorusso A, 2011, J GEN VIROL, V92, P919, DOI 10.1099/vir.0.027557-0; Loving CL, 2014, VIRAL IMMUNOL, V27, P334, DOI 10.1089/vim.2014.0034; Loving CL, 2012, VACCINE, V30, P5830, DOI 10.1016/j.vaccine.2012.07.033; Marshall D, 1999, J IMMUNOL, V163, P4673; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; Moise L, 2013, HUM VACC IMMUNOTHER, V9, P2060, DOI 10.4161/hv.26511; Moise L, 2013, HUM VACC IMMUNOTHER, V9, P1598, DOI 10.4161/hv.25598; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Moss SF, 2011, VACCINE, V29, P2085, DOI 10.1016/j.vaccine.2010.12.130; Nelson MI, 2015, TRENDS MICROBIOL, V23, P142, DOI 10.1016/j.tim.2014.12.002; Opriessnig T., 2011, Animal Health Research Reviews, V12, P133, DOI 10.1017/S1466252311000120; Pedersen LE, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-163; Price GE, 2009, VACCINE, V27, P6512, DOI 10.1016/j.vaccine.2009.08.053; Rasmussen IB, 2001, P NATL ACAD SCI USA, V98, P10296, DOI 10.1073/pnas.181336898; SCHNEIDER C, 1992, ARCH VIROL, V125, P103, DOI 10.1007/BF01309631; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; Southwood S, 1998, J IMMUNOL, V160, P3363; Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555, DOI 10.1038/9858; Sun YP, 2010, J GEN VIROL, V91, P919, DOI 10.1099/vir.0.016766-0; Terry FE, 2015, EXPERT REV VACCINES, V14, P21, DOI 10.1586/14760584.2015.955478; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Ulmer JB, 2012, VACCINE, V30, P4414, DOI 10.1016/j.vaccine.2012.04.060; Velders MP, 2001, J IMMUNOL, V166, P5366, DOI 10.4049/jimmunol.166.9.5366; Vincent A, 2014, ZOONOSES PUBLIC HLTH, V61, P4, DOI 10.1111/zph.12049; Vincent AL, 2008, ADV VIRUS RES, V72, P127, DOI 10.1016/S0065-3527(08)00403-X; Wideman G., 2013, 13th London Swine Conference Proceedings. Managing for production, London, Ontario, Canada, 27-28 March 2013, P191; YAP KL, 1978, NATURE, V273, P238, DOI 10.1038/273238a0; Zhang NZ, 2011, J VIROL, V85, P11709, DOI 10.1128/JVI.05040-11	56	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159237	10.1371/journal.pone.0159237	http://dx.doi.org/10.1371/journal.pone.0159237			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27411061	Green Submitted, Green Published, gold			2022-12-27	WOS:000379508300069
J	Haffner-Luntzer, M; Kemmler, J; Heidler, V; Prystaz, K; Schinke, T; Amling, M; Kovtun, A; Rapp, AE; Ignatius, A; Liedert, A				Haffner-Luntzer, Melanie; Kemmler, Julia; Heidler, Verena; Prystaz, Katja; Schinke, Thorsten; Amling, Michael; Kovtun, Anna; Rapp, Anna E.; Ignatius, Anita; Liedert, Astrid			Inhibition of Midkine Augments Osteoporotic Fracture Healing	PLOS ONE			English	Article							TRABECULAR BONE-FORMATION; RETINOIC ACID; MICE LACKING; ESTROGEN; GROWTH; PROTEIN; REPAIR; PERIOD; MODEL; AGE	The heparin-binding growth and differentiation factor midkine (Mdk) is proposed to negatively regulate osteoblast activity and bone formation in the adult skeleton. As Mdk-deficient mice were protected from ovariectomy (OVX)-induced bone loss, this factor may also play a role in the pathogenesis of postmenopausal osteoporosis. We have previously demonstrated that Mdk negatively influences bone regeneration during fracture healing. Here, we investigated whether the inhibition of Mdk using an Mdk-antibody (Mdk-Ab) improves compromised bone healing in osteoporotic OVX-mice. Using a standardized femur osteotomy model, we demonstrated that Mdk serum levels were significantly enhanced after fracture in both non-OVX and OVX-mice, however, the increase was considerably greater in osteoporotic mice. Systemic treatment with the Mdk-Ab significantly improved bone healing in osteoporotic mice by increasing bone formation in the fracture callus. On the molecular level, we demonstrated that the OVX-induced reduction of the osteoanabolic beta-catenin signaling in the bony callus was abolished by Mdk-Ab treatment. Furthermore, the injection of the Mdk-Ab increased trabecular bone mass in the skeleton of the osteoporotic mice. These results implicate that antagonizing Mdk may be useful for the therapy of osteoporosis and osteoporotic fracture-healing complications.	[Haffner-Luntzer, Melanie; Kemmler, Julia; Heidler, Verena; Prystaz, Katja; Kovtun, Anna; Rapp, Anna E.; Ignatius, Anita; Liedert, Astrid] Univ Med Ctr Ulm, Inst Orthoped Res & Biomech, Ulm, Germany; [Schinke, Thorsten; Amling, Michael] Univ Med Ctr Hamburg Eppendorf, Inst Osteol & Biomech, Hamburg, Germany	Ulm University; University of Hamburg; University Medical Center Hamburg-Eppendorf	Liedert, A (corresponding author), Univ Med Ctr Ulm, Inst Orthoped Res & Biomech, Ulm, Germany.	astrid.liedert@uni-ulm.de	Fischer, Verena/GVU-3636-2022; Haffner-Luntzer, Melanie/L-3562-2019; Vikman, Anna/F-1115-2017; Ignatius, Anita/M-6012-2013; Rapp, Anna/L-8807-2016	Haffner-Luntzer, Melanie/0000-0002-3333-2613; Ignatius, Anita/0000-0002-4782-1979; Rapp, Anna/0000-0001-5122-765X; Fischer, Verena/0000-0001-7039-8008; Vikman, Anna/0000-0001-8531-9712	German Research Foundation [IG 18-3/3, AM103/10-3]; Elsbeth Bonhoff Foundation	German Research Foundation(German Research Foundation (DFG)); Elsbeth Bonhoff Foundation	This work was supported by grants from the German Research Foundation (IG 18-3/3 and AM103/10-3) and from the Elsbeth Bonhoff Foundation. http://www.dfg.de http://www.elsbeth-bonhoff-stiftung.de.	Beil FT, 2010, J TRAUMA, V69, P1259, DOI 10.1097/TA.0b013e3181c4544d; Bindl R, 2013, J ORTHOP RES, V31, P1851, DOI 10.1002/jor.22416; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Chen Y, 2007, PLOS MED, V4, P1216, DOI 10.1371/journal.pmed.0040249; Davey DA, 1998, S AFR MED J, V88, P1419; Diamond-Stanic MK, 2011, AM J PHYSIOL-RENAL, V300, pF139, DOI 10.1152/ajprenal.00249.2010; DIDDLE AW, 1984, SOUTH MED J, V77, P868, DOI 10.1097/00007611-198407000-00020; Haffner-Luntzer M, 2016, BRIT J PHARMACOL, V173, P2237, DOI 10.1111/bph.13503; Haffner-Luntzer M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116282; Histing T, 2013, J INVEST SURG, V26, P30, DOI 10.3109/08941939.2012.687435; Histing T, 2012, J SURG RES, V175, P271, DOI 10.1016/j.jss.2011.03.052; JAWORSKI ZF, 1971, ISRAEL J MED SCI, V7, P491; Kanis JA, 2007, TECHNICAL REPORT, V2007, P6; Kondoh S, 2014, BONE, V60, P68, DOI 10.1016/j.bone.2013.12.005; Kubo T, 1999, J STEROID BIOCHEM, V68, P197, DOI 10.1016/S0960-0760(99)00032-1; Li CY, 2011, BONE, V49, P1178, DOI 10.1016/j.bone.2011.08.012; Liedert A, 2011, BONE, V48, P945, DOI 10.1016/j.bone.2010.12.019; Lu CY, 2008, J ORTHOP RES, V26, P1384, DOI 10.1002/jor.20667; Lu CY, 2005, J ORTHOP RES, V23, P1300, DOI 10.1016/j.orthres.2005.04.003; McCann RM, 2008, J ORTHOP RES, V26, P384, DOI 10.1002/jor.20505; MELTON LJ, 1992, J BONE MINER RES, V7, P1005, DOI 10.1002/jbmr.5650070902; MITSIADIS TA, 1995, J CELL BIOL, V129, P267, DOI 10.1083/jcb.129.1.267; MURAMATSU T, 1993, INT J DEV BIOL, V37, P183; Namkung-Matthai H, 2001, BONE, V28, P80, DOI 10.1016/S8756-3282(00)00414-2; Narisawa S, 2007, J BONE MINER RES, V22, P1700, DOI 10.1359/JBMR.070714; Neunaber C, 2010, J BONE MINER RES, V25, P1724, DOI 10.1002/jbmr.75; Nikolaou VS, 2009, INJURY, V40, P663, DOI 10.1016/j.injury.2008.10.035; Ohta S, 1999, J BONE MINER RES, V14, P1132, DOI 10.1359/jbmr.1999.14.7.1132; Ominsky MS, 2011, J BONE MINER RES, V26, P1012, DOI 10.1002/jbmr.307; Pang J, 2014, REJUVENATION RES; Rontgen V, 2010, J ORTHOP RES, V28, P1456, DOI 10.1002/jor.21148; Wehrle E, 2015, DIS MODEL MECH, V8, P93, DOI 10.1242/dmm.018622; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Yukata K, 2014, BONE, V62, P79, DOI 10.1016/j.bone.2014.02.002	34	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159278	10.1371/journal.pone.0159278	http://dx.doi.org/10.1371/journal.pone.0159278			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410432	gold, Green Published, Green Submitted			2022-12-27	WOS:000379508300077
J	Ondracka, A; Robbins, JA; Cross, FR				Ondracka, Andrej; Robbins, Jonathan A.; Cross, Frederick R.			An APC/C-Cdh1 Biosensor Reveals the Dynamics of Cdh1 Inactivation at the G1/S Transition	PLOS ONE			English	Article							ANAPHASE-PROMOTING COMPLEX/CYCLOSOME; YEAST-CELL CYCLE; SACCHAROMYCES-CEREVISIAE; MULTISITE PHOSPHORYLATION; DEPENDENT DEGRADATION; MITOTIC CYCLIN; BUDDING YEAST; POLO KINASE; S-PHASE; DESTRUCTION	B-type cyclin-dependent kinase activity must be turned off for mitotic exit and G1 stabilization. B-type cyclin degradation is mediated by the anaphase-promoting complex/cyclosome (APC/C); during and after mitotic exit, APC/C is dependent on Cdh1. Cdh1 is in turn phosphorylated and inactivated by cyclin-CDK at the Start transition of the new cell cycle. We developed a biosensor to assess the cell cycle dynamics of APC/C-Cdh1. Nuclear exit of the G1 transcriptional repressor Whi5 is a known marker of Start; APC/C-Cdh1 is inactivated 12 min after Whi5 nuclear exit with little measurable cell-to-cell timing variability. Multiple phosphorylation sites on Cdh1 act in a redundant manner to repress its activity. Reducing the number of phosphorylation sites on Cdh1 can to some extent be tolerated for cell viability, but it increases variability in timing of APC/C-Cdh1 inactivation. Mutants with minimal subsets of phosphorylation sites required for viability exhibit striking stochasticity in multiple responses including budding, nuclear division, and APC/C-Cdh1 activity itself. Multiple cyclin-CDK complexes, as well as the stoichiometric inhibitor Acm1, contribute to APC/C-Cdh1 inactivation; this redundant control is likely to promote rapid and reliable APC/CCdh1 inactivation immediately following the Start transition.	[Ondracka, Andrej; Robbins, Jonathan A.; Cross, Frederick R.] Rockefeller Univ, Lab Cell Cycle Genet, New York, NY 10065 USA	Rockefeller University	Cross, FR (corresponding author), Rockefeller Univ, Lab Cell Cycle Genet, New York, NY 10065 USA.	fred.r.cross@gmail.com		Ondracka, Andrej/0000-0003-4193-6027; Robbins, Jonathan/0000-0001-9690-4976	PHS [5RO1-GM078153]; Boehringer Ingelheim Fonds predoctoral fellowship; National Institutes of Health Medical Scientist Training Program [T32GM007739]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007061] Funding Source: NIH RePORTER	PHS(United States Department of Health & Human ServicesUnited States Public Health Service); Boehringer Ingelheim Fonds predoctoral fellowship(Boehringer Ingelheim); National Institutes of Health Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by PHS 5RO1-GM078153 to F.C., and Boehringer Ingelheim Fonds predoctoral fellowship to A.O. J.A.R. was supported by National Institutes of Health Medical Scientist Training Program grant T32GM007739.	Amon A, 1997, EMBO J, V16, P2693, DOI 10.1093/emboj/16.10.2693; AMON A, 1993, CELL, V74, P993, DOI 10.1016/0092-8674(93)90722-3; Bean JM, 2006, MOL CELL, V21, P3, DOI 10.1016/j.molcel.2005.10.035; Chang LF, 2015, NATURE, V522, P450, DOI 10.1038/nature14471; Charles JF, 1998, CURR BIOL, V8, P497, DOI 10.1016/S0960-9822(98)70201-5; Charvin G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001468; Charvin G, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000284; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Costanzo M, 2004, CELL, V117, P899, DOI 10.1016/j.cell.2004.05.024; Crasta K, 2008, NAT CELL BIOL, V10, P665, DOI 10.1038/ncb1729; Di Talia S, 2007, NATURE, V448, P947, DOI 10.1038/nature06072; Enquist-Newman M, 2008, MOL CELL, V30, P437, DOI 10.1016/j.molcel.2008.04.004; EPSTEIN CB, 1992, GENE DEV, V6, P1695, DOI 10.1101/gad.6.9.1695; Eser U, 2011, MOL CELL, V43, P515, DOI 10.1016/j.molcel.2011.06.024; Ferrezuelo F, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r67; Hall MC, 2004, CELL CYCLE, V3, P1278, DOI 10.4161/cc.3.10.1153; Hildebrandt ER, 2001, MOL BIOL CELL, V12, P3402, DOI 10.1091/mbc.12.11.3402; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Huang JN, 2001, J CELL BIOL, V154, P85, DOI 10.1083/jcb.200102007; Jaquenoud M, 2002, EMBO J, V21, P6515, DOI 10.1093/emboj/cdf634; JOHNSTON GC, 1977, EXP CELL RES, V105, P79, DOI 10.1016/0014-4827(77)90154-9; Juang YL, 1997, SCIENCE, V275, P1311, DOI 10.1126/science.275.5304.1311; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; Koivomagi M, 2011, NATURE, V480, P128, DOI 10.1038/nature10560; Kraft C, 2005, MOL CELL, V18, P543, DOI 10.1016/j.molcel.2005.04.023; LEW DJ, 1993, J CELL BIOL, V120, P1305, DOI 10.1083/jcb.120.6.1305; LEW DJ, 1995, J CELL BIOL, V129, P739, DOI 10.1083/jcb.129.3.739; Lu D, 2014, J CELL BIOL, V207, P23, DOI 10.1083/jcb.201402041; Lu Y, 2010, CELL, V141, P268, DOI 10.1016/j.cell.2010.03.021; Martinez JS, 2006, MOL CELL BIOL, V26, P9162, DOI 10.1128/MCB.00603-06; Melesse M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103517; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Prinz S, 1998, CURR BIOL, V8, P750, DOI 10.1016/S0960-9822(98)70298-2; Robbins JA, 2010, MOL BIOL CELL, V21, P914, DOI 10.1091/mbc.E09-10-0901; Sajman J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8075; Schreiber A, 2011, NATURE, V470, P227, DOI 10.1038/nature09756; Schwab M, 1997, CELL, V90, P683, DOI 10.1016/S0092-8674(00)80529-2; SCHWOB E, 1993, GENE DEV, V7, P1160, DOI 10.1101/gad.7.7a.1160; Shirayama M, 1999, NATURE, V402, P203, DOI 10.1038/46080; Skotheim JM, 2008, NATURE, V454, P291, DOI 10.1038/nature07118; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Strickfaden SC, 2007, CELL, V128, P519, DOI 10.1016/j.cell.2006.12.032; SUDAKIN V, 1995, MOL BIOL CELL, V6, P185, DOI 10.1091/mbc.6.2.185; Visintin C, 2008, GENE DEV, V22, P79, DOI 10.1101/gad.1601308; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Wasch R, 2002, NATURE, V418, P556, DOI 10.1038/nature00856; Yeong FM, 2001, MOL CELL BIOL, V21, P5071, DOI 10.1128/MCB.21.15.5071-5081.2001; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721	50	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159166	10.1371/journal.pone.0159166	http://dx.doi.org/10.1371/journal.pone.0159166			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410035	gold, Green Submitted, Green Published			2022-12-27	WOS:000379508300063
J	Ferguson, R; Subramanian, V				Ferguson, Ross; Subramanian, Vasanta			PA6 Stromal Cell Co-Culture Enhances SH-SY5Y and VSC4.1 Neuroblastoma Differentiation to Mature Phenotypes	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; NEURO-BLASTOMA CELLS; EMBRYONIC STEM-CELLS; DOPAMINERGIC-NEURONS; HUMAN ANGIOGENIN; RETINOIC ACID; LINE; GROWTH; IMMUNOGLOBULINS; VARIANTS	Neuroblastoma cell lines such as SH-SY5Y have been used for modelling neurodegenerative diseases and for studying basic mechanisms in neuroscience. Since neuroblastoma cells proliferate and generally do not express markers of mature or functional neurons, we exploited a co-culture system with the stromal cell line PA6 to better induce differentiation to a more physiologically relevant status. We found that co-culture of the neuroblastoma cell lines in the presence of neural inducers such retinoic acid was able to generate a high proportion of quiescent neurons with very long neurites expressing differentiation markers. The co-culture system additionally cuts short the time taken to produce a more mature phenotype. We also show the application of this system to study proteins implicated in motor neuron disease.	[Ferguson, Ross; Subramanian, Vasanta] Univ Bath, Dept Biol & Biochem, Bath, Avon, England	University of Bath	Subramanian, V (corresponding author), Univ Bath, Dept Biol & Biochem, Bath, Avon, England.	V.Subramanian@bath.ac.uk			NC3Rs-National Centre for the Replacement, Refinement and Reduction of Animals in Research [G0900786]; NC3R'S, UK; National Centre for the Replacement [G0900786/1] Funding Source: researchfish	NC3Rs-National Centre for the Replacement, Refinement and Reduction of Animals in Research; NC3R'S, UK; National Centre for the Replacement	This work was funded by a NC3Rs-National Centre for the Replacement, Refinement and Reduction of Animals in Research, grant to VS, grant number G0900786, http://www.nc3rs.org.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to gratefully acknowledge the Developmental Studies Hybridoma Bank, Iowa, USA, for the 2H3 and rat 401 monoclonal antibodies and the NC3R'S, UK, for funding.	ADEM A, 1987, DEV BRAIN RES, V33, P235, DOI 10.1016/0165-3806(87)90156-8; ALEXIANU ME, 1994, J NEUROCHEM, V63, P2365; BIEDLER JL, 1973, CANCER RES, V33, P2643; Cheung YT, 2009, NEUROTOXICOLOGY, V30, P127, DOI 10.1016/j.neuro.2008.11.001; CICCARONE V, 1989, CANCER RES, V49, P219; Constantinescu R, 2007, J NEURAL TRANSM-SUPP, P17; Encinas M, 2000, J NEUROCHEM, V75, P991, DOI 10.1046/j.1471-4159.2000.0750991.x; Greenway MJ, 2004, NEUROLOGY, V63, P1936, DOI 10.1212/01.WNL.0000144344.39103.F6; Guloglu MO, 2014, J NEUROSCI RES, V92, P564, DOI 10.1002/jnr.23355; Inoka S, 2007, FASEB J, V21, P912; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Knaryan VH, 2014, J NEUROCHEM, V130, P280, DOI 10.1111/jnc.12629; KODAMA HA, 1982, J CELL PHYSIOL, V112, P83, DOI 10.1002/jcp.1041120113; Korecka JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063862; Kwon YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085736; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Lyuh E, 2007, GROWTH HORM IGF RES, V17, P315, DOI 10.1016/j.ghir.2007.03.002; PAHLMAN S, 1983, CELL DIFFER DEV, V12, P165, DOI 10.1016/0045-6039(83)90006-4; PAHLMAN S, 1984, CELL DIFFER DEV, V14, P135, DOI 10.1016/0045-6039(84)90038-1; Presgraves SP, 2004, NEUROTOX RES, V5, P579, DOI 10.1007/bf03033178; Razavi S, 2013, BIOCHEM BIOPH RES CO, V440, P381, DOI 10.1016/j.bbrc.2013.09.069; ROSS RA, 1983, J NATL CANCER I, V71, P741; SMITH RG, 1994, P NATL ACAD SCI USA, V91, P3393, DOI 10.1073/pnas.91.8.3393; Storch A, 2000, J NEUROCHEM, V75, P2259, DOI 10.1046/j.1471-4159.2000.0752259.x; Subramanian V, 2008, HUM MOL GENET, V17, P130, DOI 10.1093/hmg/ddm290; Subramanian V, 2007, HUM MOL GENET, V16, P1445, DOI 10.1093/hmg/ddm095; Thiyagarajan N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2126; Vazin T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006606; Xie HR, 2010, CHINESE MED J-PEKING, V123, P1086, DOI 10.3760/cma.j.issn.0366-6999.2010.08.021; Zeng XM, 2004, STEM CELLS, V22, P925, DOI 10.1634/stemcells.22-6-925	30	11	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159051	10.1371/journal.pone.0159051	http://dx.doi.org/10.1371/journal.pone.0159051			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391595	Green Submitted, Green Published, gold			2022-12-27	WOS:000380005400201
J	Heed, T; Backhaus, J; Roder, B; Badde, S				Heed, Tobias; Backhaus, Jenny; Roeder, Brigitte; Badde, Stephanie			Disentangling the External Reference Frames Relevant to Tactile Localization	PLOS ONE			English	Article							SPATIAL REFERENCE FRAMES; EYE-HAND COORDINATION; TEMPORAL-ORDER; OSCILLATORY ACTIVITY; TOUCH LOCATION; INFORMATION; INTEGRATION; GAZE; MOVEMENT; BODY	Different reference frames appear to be relevant for tactile spatial coding. When participants give temporal order judgments (TOJ) of two tactile stimuli, one on each hand, performance declines when the hands are crossed. This effect is attributed to a conflict between anatomical and external location codes: hand crossing places the anatomically right hand into the left side of external space. However, hand crossing alone does not specify the anchor of the external reference frame, such as gaze, trunk, or the stimulated limb. Experiments that used explicit localization responses, such as pointing to tactile stimuli rather than crossing manipulations, have consistently implicated gaze-centered coding for touch. To test whether crossing effects can be explained by gaze-centered coding alone, participants made TOJ while the position of the hands was manipulated relative to gaze and trunk. The two hands either lay on different sides of space relative to gaze or trunk, or they both lay on one side of the respective space. In the latter posture, one hand was on its "regular side of space" despite hand crossing, thus reducing overall conflict between anatomical and external codes. TOJ crossing effects were significantly reduced when the hands were both located on the same side of space relative to gaze, indicating gaze-centered coding. Evidence for trunk-centered coding was tentative, with an effect in reaction time but not in accuracy. These results link paradigms that use explicit localization and TOJ, and corroborate the relevance of gaze-related coding for touch. Yet, gaze and trunk-centered coding did not account for the total size of crossing effects, suggesting that tactile localization relies on additional, possibly limb-centered, reference frames. Thus, tactile location appears to be estimated by integrating multiple anatomical and external reference frames.	[Heed, Tobias; Backhaus, Jenny; Roeder, Brigitte; Badde, Stephanie] Univ Hamburg, Biol Psychol & Neuropsychol, Fac Psychol & Human Movement Sci, Hamburg, Germany; [Backhaus, Jenny] UKSH, Dept Internal Med 1, Campus Lubeck, Lubeck, Germany; [Badde, Stephanie] NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA	University of Hamburg; University of Kiel; Schleswig Holstein University Hospital; New York University	Heed, T (corresponding author), Univ Hamburg, Biol Psychol & Neuropsychol, Fac Psychol & Human Movement Sci, Hamburg, Germany.	tobias.heed@uni-hamburg.de	Heed, Tobias/C-5330-2008	Heed, Tobias/0000-0001-5632-6091	DFG Emmy Noether grant [He 6368/1-1]; DFG [SFB936]; University of Hamburg	DFG Emmy Noether grant(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); University of Hamburg	This research was supported by grants to TH (DFG Emmy Noether grant He 6368/1-1; DFG grant SFB936, project B1; [www.dfg.de]). SB was supported by a post-doc transition grant of the University of Hamburg [www.uni-hamburg.de]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aglioti S, 1999, J COGNITIVE NEUROSCI, V11, P67, DOI 10.1162/089892999563256; Azanon E, 2008, CURR BIOL, V18, P1044, DOI 10.1016/j.cub.2008.06.045; Azanon E, 2015, CURR BIOL, V25, P512, DOI 10.1016/j.cub.2014.12.038; Azanon E, 2010, EUR J NEUROSCI, V31, P1858, DOI 10.1111/j.1460-9568.2010.07233.x; Badde S, 2016, COGN NEUROPSYCHOL, V33, P26, DOI 10.1080/02643294.2016.1168791; Badde S, 2016, PSYCHON B REV, V23, P387, DOI 10.3758/s13423-015-0918-0; Badde S, 2015, NEUROPSYCHOLOGIA, V70, P367, DOI 10.1016/j.neuropsychologia.2014.10.001; Badde S, 2014, ATTEN PERCEPT PSYCHO, V76, P1136, DOI 10.3758/s13414-013-0590-2; Badde S, 2014, J EXP PSYCHOL HUMAN, V40, P784, DOI 10.1037/a0034690; Barr DJ, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00328; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Batista AP, 1999, SCIENCE, V285, P257, DOI 10.1126/science.285.5425.257; Buchholz VN, 2013, J NEUROSCI, V33, P3492, DOI 10.1523/JNEUROSCI.3208-12.2013; Buchholz VN, 2011, J NEUROSCI, V31, P16864, DOI 10.1523/JNEUROSCI.3404-11.2011; Cadieux ML, 2010, EXP BRAIN RES, V204, P431, DOI 10.1007/s00221-010-2268-5; Chen XD, 2013, NEURON, V80, P1310, DOI 10.1016/j.neuron.2013.09.006; Dean HL, 2011, J NEUROSCI, V31, P2399, DOI 10.1523/JNEUROSCI.4591-10.2011; Gallace A, 2005, NEUROSCI LETT, V379, P63, DOI 10.1016/j.neulet.2004.12.052; Graziano MSA, 1997, SCIENCE, V277, P239, DOI 10.1126/science.277.5323.239; Graziano MSA, 1997, J NEUROPHYSIOL, V77, P2268, DOI 10.1152/jn.1997.77.5.2268; Harrar V, 2010, EXP BRAIN RES, V203, P615, DOI 10.1007/s00221-010-2252-0; Harrar V, 2009, EXP BRAIN RES, V198, P403, DOI 10.1007/s00221-009-1884-4; Harris LR, 2008, EXP BRAIN RES, V187, P429, DOI 10.1007/s00221-008-1313-0; Heed T, 2015, TRENDS COGN SCI, V19, P251, DOI 10.1016/j.tics.2015.03.001; Heed T, 2015, MULTISENS RES, V28, P173, DOI 10.1163/22134808-00002485; Heed T, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00076; Heed T, 2012, J EXP PSYCHOL HUMAN, V38, P386, DOI 10.1037/a0024059; Heed T, 2010, J COGNITIVE NEUROSCI, V22, P184, DOI 10.1162/jocn.2008.21168; Ho C, 2007, BRAIN RES, V1144, P136, DOI 10.1016/j.brainres.2007.01.091; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; KARNATH HO, 1991, BRAIN, V114, P1997, DOI 10.1093/brain/114.4.1997; Kuang SB, 2016, CEREB CORTEX, V26, P731, DOI 10.1093/cercor/bhu312; LACQUANITI F, 1995, CEREB CORTEX, V5, P391, DOI 10.1093/cercor/5.5.391; Lawson R, 2014, ATTEN PERCEPT PSYCHO, V76, P559, DOI 10.3758/s13414-013-0579-x; Lewald J, 1996, EXP BRAIN RES, V108, P473; Medendorp WP, 2005, J NEUROPHYSIOL, V93, P954, DOI 10.1152/jn.00725.2004; MOSCOVITCH M, 1994, J COGNITIVE NEUROSCI, V6, P151, DOI 10.1162/jocn.1994.6.2.151; Mueller S, 2014, NEUROPSYCHOLOGIA, V62, P184, DOI 10.1016/j.neuropsychologia.2014.07.025; Mueller S, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00066; Pouget A, 2002, COGNITION, V83, pB1, DOI 10.1016/S0010-0277(01)00163-9; Pritchett LM, 2012, EXP BRAIN RES, V222, P437, DOI 10.1007/s00221-012-3231-4; Pritchett LM, 2011, EXP BRAIN RES, V213, P229, DOI 10.1007/s00221-011-2713-0; R Core Team, 2021, R LANGUAGE ENV STAT; Reuschel J, 2012, J NEUROSCI, V32, P2422, DOI 10.1523/JNEUROSCI.2714-11.2012; Roberts RD, 2003, EUROHAPTICS, P300; Roder B, 2004, CURR BIOL, V14, P121, DOI 10.1016/j.cub.2003.12.054; Roder B, 2008, EUR J NEUROSCI, V28, P475, DOI 10.1111/j.1460-9568.2008.06352.x; Roder B, 2013, COGNITION, V126, P301, DOI 10.1016/j.cognition.2012.09.009; Schicke T, 2002, NEUROREPORT, V13, P1627, DOI 10.1097/00001756-200209160-00011; Schicke T, 2006, P NATL ACAD SCI USA, V103, P11808, DOI 10.1073/pnas.0601486103; Schubert JTW, 2015, NEUROIMAGE, V117, P417, DOI 10.1016/j.neuroimage.2015.05.068; Shore DI, 2005, PERCEPTION, V34, P1251, DOI 10.1068/p3313; Shore DI, 2002, COGNITIVE BRAIN RES, V14, P153, DOI 10.1016/S0926-6410(02)00070-8; SMANIA N, 1995, NEUROLOGY, V45, P1725, DOI 10.1212/WNL.45.9.1725; Snyder LH, 1998, NATURE, V394, P887, DOI 10.1038/29777; Snyder LH, 2002, J NEUROPHYSIOL, V87, P2279, DOI 10.1152/jn.00854.2001; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yamamoto S, 2001, NAT NEUROSCI, V4, P759, DOI 10.1038/89559; Zampini M, 2003, INT J PSYCHOPHYSIOL, V50, P165, DOI 10.1016/S0167-8760(03)00132-6	59	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158829	10.1371/journal.pone.0158829	http://dx.doi.org/10.1371/journal.pone.0158829			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27391805	gold, Green Published, Green Submitted			2022-12-27	WOS:000380005400138
J	Nogusa, S; Slifker, MJ; Ingram, JP; Thapa, RJ; Balachandran, S				Nogusa, Shoko; Slifker, Michael J.; Ingram, Justin P.; Thapa, Roshan J.; Balachandran, Siddharth			RIPK3 Is Largely Dispensable for RIG-I-Like Receptor- and Type I Interferon-Driven Transcriptional Responses to Influenza A Virus in Murine Fibroblasts	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; PROGRAMMED NECROSIS; NLRP3 INFLAMMASOME; RECOGNITION; ACTIVATION; PROTEIN; SIGNAL; IRF-7; CELL	The kinase RIPK3 is a key regulator of cell death responses to a growing number of viral and microbial agents. We have found that influenza A virus (IAV)-mediated cell death is largely reliant on RIPK3 and that RIPK3-deficient mice are notably more susceptible to lethal infection by IAV than their wild-type counterparts. Recent studies demonstrate that RIPK3 also participates in regulating gene transcription programs during host pro-inflammatory and innate-immune responses, indicating that this kinase is not solely an inducer of cell death and that RIPK3-driven transcriptional responses may collaborate with cell death in promoting clearance of IAV. Here, we carried out DNA microarray analyses to determine the contribution of RIPK3 to the IAV-elicited host transcriptional response. We report that RIPK3 does not contribute significantly to the RLR-activated transcriptome or to the induction of type I IFN genes, although, interestingly, IFN-beta production at a post-transcriptional step was modestly attenuated in IAV-infected ripk3(-/-) fibroblasts. Overall, RIPK3 regulated the expression of <5% of the IAV-induced transcriptome, and no genes were found to be obligate RIPK3 targets. IFN-beta signaling was also found to be largely normal in the absence of RIPK3. Together, these results indicate that RIPK3 is not essential for the host antiviral transcriptional response to IAV in murine fibroblasts.	[Nogusa, Shoko; Ingram, Justin P.; Thapa, Roshan J.; Balachandran, Siddharth] Fox Chase Canc Ctr, Blood Cell Dev & Funct Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Slifker, Michael J.] Fox Chase Canc Ctr, Dept Bioinformat & Biostat, 7701 Burholme Ave, Philadelphia, PA 19111 USA	Fox Chase Cancer Center; Fox Chase Cancer Center	Balachandran, S (corresponding author), Fox Chase Canc Ctr, Blood Cell Dev & Funct Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	siddharth.balachandran@fccc.edu			National Institutes of Health [CA168621, AI113469]; National Institutes of Health Cancer Center Support Grant [P30CA006927]; Commonwealth of Pennsylvania; NATIONAL CANCER INSTITUTE [P30CA006927, R01CA168621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI113469] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth of Pennsylvania; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants CA168621 and AI113469 to SB. Additional funds were provided by National Institutes of Health Cancer Center Support Grant P30CA006927 and an appropriation from the Commonwealth of Pennsylvania (SB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Vishva Dixit for providing ripk3<SUP>-/-</SUP> mice, and to Luis Sigal for supplying mavs<SUP>-/-</SUP> and ifnar1<SUP>-/-</SUP> mice. We also thank John Bertin and Peter Gough for RIPK3 inhibitor GSK'872 and Paul Thomas for PR8-Delta NS1 virus. We gratefully acknowledge Yuesheng Li and Suraj Peri for processing microarray samples, and for bioinformatic support, respectively. This work was supported by National Institutes of Health grants CA168621 and AI113469 to SB. Additional funds were provided by National Institutes of Health Cancer Center Support Grant P30CA006927 and an appropriation from the Commonwealth of Pennsylvania (SB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Balachandran S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002165; Basagoudanavar SH, 2011, J VIROL, V85, P2599, DOI 10.1128/JVI.02213-10; Chen P., 2013, J APPL CHEM, V2013, P1, DOI DOI 10.1155/2013/424253; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Kang TB, 2014, METHOD ENZYMOL, V545, P67, DOI 10.1016/B978-0-12-801430-1.00003-2; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Krug RM, 2015, CURR OPIN VIROL, V12, P1, DOI 10.1016/j.coviro.2015.01.007; Kumagai Y, 2007, IMMUNITY, V27, P240, DOI 10.1016/j.immuni.2007.07.013; Mandal P, 2014, MOL CELL, V56, P481, DOI 10.1016/j.molcel.2014.10.021; Moriwaki K, 2013, GENE DEV, V27, P1640, DOI 10.1101/gad.223321.113; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Nogusa S, 2016, CELL HOST M IN PRESS; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sridharan H, 2014, TRENDS MICROBIOL, V22, P199, DOI 10.1016/j.tim.2014.01.005; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Wang XQ, 2014, NAT IMMUNOL, V15, P1126, DOI 10.1038/ni.3015; Weinlich R, 2014, MOL CELL, V56, P469, DOI 10.1016/j.molcel.2014.11.001; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x	29	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158774	10.1371/journal.pone.0158774	http://dx.doi.org/10.1371/journal.pone.0158774			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391363	gold, Green Published, Green Submitted			2022-12-27	WOS:000380005400121
J	Rymarczyk, K; Zurawski, L; Jankowiak-Siuda, K; Szatkowska, I				Rymarczyk, Krystyna; Zurawski, Lukasz; Jankowiak-Siuda, Kamila; Szatkowska, Iwona			Do Dynamic Compared to Static Facial Expressions of Happiness and Anger Reveal Enhanced Facial Mimicry?	PLOS ONE			English	Article							MIRROR NEURON SYSTEM; SEX-DIFFERENCES; ELECTROMYOGRAPHIC ACTIVITY; GENDER-DIFFERENCES; EMOTIONAL MIMICRY; SOCIAL-CONTEXT; MECHANISMS; EXPERIENCE; RESPONSES; EMPATHY	Facial mimicry is the spontaneous response to others' facial expressions by mirroring or matching the interaction partner. Recent evidence suggested that mimicry may not be only an automatic reaction but could be dependent on many factors, including social context, type of task in which the participant is engaged, or stimulus properties (dynamic vs static presentation). In the present study, we investigated the impact of dynamic facial expression and sex differences on facial mimicry and judgment of emotional intensity. Electromyography recordings were recorded from the corrugator supercilii, zygomaticus major, and orbicularis oculi muscles during passive observation of static and dynamic images of happiness and anger. The ratings of the emotional intensity of facial expressions were also analysed. As predicted, dynamic expressions were rated as more intense than static ones. Compared to static images, dynamic displays of happiness also evoked stronger activity in the zygomaticus major and orbicularis oculi, suggesting that subjects experienced positive emotion. No muscles showed mimicry activity in response to angry faces. Moreover, we found that women exhibited greater zygomaticus major muscle activity in response to dynamic happiness stimuli than static stimuli. Our data support the hypothesis that people mimic positive emotions and confirm the importance of dynamic stimuli in some emotional processing.	[Rymarczyk, Krystyna; Zurawski, Lukasz; Szatkowska, Iwona] Polish Acad Sci, Dept Neurophysiol, Nencki Inst Expt Biol, Psychophysiol Lab, Warsaw, Poland; [Rymarczyk, Krystyna; Jankowiak-Siuda, Kamila] Univ Social Sci & Humanities, Inst Cognit & Behav Neurosci, Dept Expt Psychol, Warsaw, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; SWPS University of Social Sciences & Humanities	Rymarczyk, K; Zurawski, L (corresponding author), Polish Acad Sci, Dept Neurophysiol, Nencki Inst Expt Biol, Psychophysiol Lab, Warsaw, Poland.; Rymarczyk, K (corresponding author), Univ Social Sci & Humanities, Inst Cognit & Behav Neurosci, Dept Expt Psychol, Warsaw, Poland.	k.rymarczyk@nencki.gov.pl; l.zurawski@nencki.gov.pl	Szatkowska, Iwona/R-4152-2016; Jankowiak-Siuda, Kamila/I-6352-2017	Jankowiak-Siuda, Kamila/0000-0002-0210-2487; Rymarczyk, Krystyna/0000-0002-4085-9480; Szatkowska, Iwona/0000-0002-3185-7336	Polish National Science Centre [2011/03/B/HS6/05161]	Polish National Science Centre	This study was supported by grant no. 2011/03/B/HS6/05161 from the Polish National Science Centre provided to the first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves Nelson Torro, 2013, Estud. psicol. (Natal), V18, P125, DOI 10.1590/S1413-294X2013000100020; Ambadar Z, 2005, PSYCHOL SCI, V16, P403, DOI 10.1111/j.0956-7976.2005.01548.x; Arsalidou M, 2011, BRAIN TOPOGR, V24, P149, DOI 10.1007/s10548-011-0171-4; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Biele C, 2006, EXP BRAIN RES, V171, P1, DOI 10.1007/s00221-005-0254-0; Bourgeois P, 2008, BIOL PSYCHOL, V77, P343, DOI 10.1016/j.biopsycho.2007.11.008; CACIOPPO JT, 1986, J PERS SOC PSYCHOL, V50, P260, DOI 10.1037/0022-3514.50.2.260; Carr EW, 2014, J EXP PSYCHOL GEN, V143, P997, DOI 10.1037/a0034972; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Cunningham D.W., 2009, P 6 S APPL PERC GRAP, P41, DOI [10.1145/1620993.1621002, DOI 10.1145/1620993.1621002]; Davis MH, 1996, EMPATHY A SOCIAL PSY; Dimberg U, 2000, PSYCHOL SCI, V11, P86, DOI 10.1111/1467-9280.00221; Dimberg U, 2000, PSYCHOPHYSIOLOGY, V37, P693, DOI 10.1111/1469-8986.3750693; Dimberg U, 1998, SCAND J PSYCHOL, V39, P39, DOI 10.1111/1467-9450.00054; DIMBERG U, 1990, BIOL PSYCHOL, V30, P151, DOI 10.1016/0301-0511(90)90024-Q; DIMBERG U, 1982, PSYCHOPHYSIOLOGY, V19, P643, DOI 10.1111/j.1469-8986.1982.tb02516.x; EKMAN P, 1988, J PERS SOC PSYCHOL, V54, P414, DOI 10.1037/0022-3514.54.3.414; EKMAN P, 1982, J NONVERBAL BEHAV, V6, P238, DOI 10.1007/BF00987191; Ferrari PF, 2003, EUR J NEUROSCI, V17, P1703, DOI 10.1046/j.1460-9568.2003.02601.x; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Greenwald M. K., 1989, J PSYCHOPHYSIOL, V3, P51; Gunnery SD, 2016, COGNITION EMOTION, V30, P501, DOI 10.1080/02699931.2015.1018817; Hatfield E., 2014, INTERPERSONA INT J P, V8, P159, DOI DOI 10.5964/IJPR.V8I2.162; Heerey EA, 2013, PSYCHOL SCI, V24, P1446, DOI 10.1177/0956797612472203; Hess U, 1998, COGNITION EMOTION, V12, P509, DOI 10.1080/026999398379547; Hess U, 2001, INT J PSYCHOPHYSIOL, V40, P129, DOI 10.1016/S0167-8760(00)00161-6; Hess U, 2014, SOC PERSONAL PSYCHOL, V8, P45, DOI 10.1111/spc3.12083; Hess U, 2013, PERS SOC PSYCHOL REV, V17, P142, DOI 10.1177/1088868312472607; Hess U, 2010, BIOL PSYCHOL, V84, P514, DOI 10.1016/j.biopsycho.2009.11.001; Horgan, 2000, GENDER EMOTION SOCIA, P97, DOI DOI 10.1017/CBO9780511628191.006; Horstmann G, 2003, EMOTION, V3, P150, DOI 10.1037/1528-3542.3.2.150; Huhnel I, 2014, J EXP SOC PSYCHOL, V50, P136, DOI 10.1016/j.jesp.2013.09.011; Jackson PL, 2006, NEUROPSYCHOLOGIA, V44, P752, DOI 10.1016/j.neuropsychologia.2005.07.015; Kessler Henrik, 2011, Psychosoc Med, V8, pDoc03, DOI 10.3205/psm000072; Kilts CD, 2003, NEUROIMAGE, V18, P156, DOI 10.1006/nimg.2002.1323; Korb S, 2010, BIOL PSYCHOL, V85, P347, DOI 10.1016/j.biopsycho.2010.07.012; Koriat A, 2009, J EXP PSYCHOL LEARN, V35, P1338, DOI 10.1037/a0016374; Kring AM, 1998, J PERS SOC PSYCHOL, V74, P686, DOI 10.1037/0022-3514.74.3.686; Krumhuber EG, 2014, J NONVERBAL BEHAV, V38, P1, DOI 10.1007/s10919-013-0167-8; LaFrance M, 2003, PSYCHOL BULL, V129, P305, DOI 10.1037/0033-2909.129.2.305; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; Larsen JT, 2003, PSYCHOPHYSIOLOGY, V40, P776, DOI 10.1111/1469-8986.00078; Light SN, 2015, BIOL PSYCHOL, V104, P116, DOI 10.1016/j.biopsycho.2014.11.015; Likowski KU, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00214; McClure EB, 2000, PSYCHOL BULL, V126, P424, DOI 10.1037/0033-2909.126.3.424; Messinger DS, 2012, EMOTION, V12, P430, DOI 10.1037/a0026498; Messinger DS, 2001, DEV PSYCHOL, V37, P642, DOI 10.1037/0012-1649.37.5.642; O'Doherty J, 2003, NEUROPSYCHOLOGIA, V41, P147, DOI 10.1016/S0028-3932(02)00145-8; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rymarczyk K, 2011, INT J PSYCHOPHYSIOL, V79, P330, DOI 10.1016/j.ijpsycho.2010.11.001; Sato W, 2015, NAT PUBL GR, P1, DOI [10.1038/srep12432, DOI 10.1038/SREP12432]; Sato W, 2008, INT J PSYCHOPHYSIOL, V70, P70, DOI 10.1016/j.ijpsycho.2008.06.001; Sato W, 2007, COGNITION, V104, P1, DOI 10.1016/j.cognition.2006.05.001; Sato W, 2007, J NONVERBAL BEHAV, V31, P119, DOI 10.1007/s10919-007-0025-7; Sato W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057889; Schmidt K.L., 2001, AM J PHYS ANTHROPOL, V116, P3, DOI DOI 10.1002/AJPA.20001; Schulte-Ruther M, 2008, NEUROIMAGE, V42, P393, DOI 10.1016/j.neuroimage.2008.04.180; SCHWARTZ GE, 1980, PSYCHOPHYSIOLOGY, V17, P75, DOI 10.1111/j.1469-8986.1980.tb02463.x; Seibt B, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01122; Sims TB, 2012, PSYCHOPHYSIOLOGY, V49, P998, DOI 10.1111/j.1469-8986.2012.01377.x; Trautmann SA, 2009, BRAIN RES, V1284, P100, DOI 10.1016/j.brainres.2009.05.075; van der Gaag C, 2007, SOC NEUROSCI-UK, V2, P179, DOI 10.1080/17470910701376878; van der Schalk J, 2011, EMOTION, V11, P286, DOI 10.1037/a0022582; Vrana SR, 2004, BIOL PSYCHOL, V66, P63, DOI 10.1016/j.biopsycho.2003.07.004; Weyers P, 2006, PSYCHOPHYSIOLOGY, V43, P450, DOI 10.1111/j.1469-8986.2006.00451.x	68	39	39	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158534	10.1371/journal.pone.0158534	http://dx.doi.org/10.1371/journal.pone.0158534			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27390867	Green Submitted, Green Published, gold			2022-12-27	WOS:000380005400077
J	Shin, SY; Kim, T; Seo, DW; Sohn, CH; Kim, SH; Ryoo, SM; Lee, YS; Lee, JH; Kim, WY; Lim, KS				Shin, Soo-Yong; Kim, Taerim; Seo, Dong-Woo; Sohn, Chang Hwan; Kim, Sung-Hoon; Ryoo, Seung Mok; Lee, Yoon-Seon; Lee, Jae Ho; Kim, Won Young; Lim, Kyoung Soo			Correlation between National Influenza Surveillance Data and Search Queries from Mobile Devices and Desktops in South Korea	PLOS ONE			English	Article							TWITTER	Background Digital surveillance using internet search queries can improve both the sensitivity and timeliness of the detection of a health event, such as an influenza outbreak. While it has recently been estimated that the mobile search volume surpasses the desktop search volume and mobile search patterns differ from desktop search patterns, the previous digital surveillance systems did not distinguish mobile and desktop search queries. The purpose of this study was to compare the performance of mobile and desktop search queries in terms of digital influenza surveillance. Methods and Results The study period was from September 6, 2010 through August 30, 2014, which consisted of four epidemiological years. Influenza-like illness (ILI) and virologic surveillance data from the Korea Centers for Disease Control and Prevention were used. A total of 210 combined queries from our previous survey work were used for this study. Mobile and desktop weekly search data were extracted from Naver, which is the largest search engine in Korea. Spearman's correlation analysis was used to examine the correlation of the mobile and desktop data with ILI and virologic data in Korea. We also performed lag correlation analysis. We observed that the influenza surveillance performance of mobile search queries matched or exceeded that of desktop search queries over time. The mean correlation coefficients of mobile search queries and the number of queries with an r-value of >= 0.7 equaled or became greater than those of desktop searches over the four epidemiological years. A lag correlation analysis of up to two weeks showed similar trends. Conclusion Our study shows that mobile search queries for influenza surveillance have equaled or even become greater than desktop search queries over time. In the future development of influenza surveillance using search queries, the recognition of changing trend of mobile search data could be necessary.	[Shin, Soo-Yong; Lee, Jae Ho] Asan Med Ctr, Dept Biomed Informat, Seoul 138736, South Korea; [Kim, Taerim; Seo, Dong-Woo; Sohn, Chang Hwan; Ryoo, Seung Mok; Lee, Yoon-Seon; Lee, Jae Ho; Kim, Won Young; Lim, Kyoung Soo] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Emergency Med, Seoul 138736, South Korea; [Kim, Sung-Hoon] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Anesthesiol & Pain Med, Seoul 138736, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Seo, DW (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Emergency Med, Seoul 138736, South Korea.	leiseo@gmail.com		Ryoo, Seung Mok/0000-0002-2436-3311				Althouse BM, 2015, EPJ DATA SCI, V4, DOI 10.1140/epjds/s13688-015-0054-0; Baeza-Yates R, 2007, STUDY MOBILE SEARCH, DOI DOI 10.1109/IZS.2008.4497268; Bernardo TM, 2013, J MED INTERNET RES, V15, P239, DOI 10.2196/jmir.2740; Broniatowski DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083672; Brownstein J.S., 2010, NEW ENGL J MED, V362, P1731, DOI DOI 10.1056/NEJMSR1002707; Cho S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081422; Church K, 2008, P 10; Church K., 2011, P INT C HUMAN COMPUT, P67, DOI [DOI 10.1145/2037373.2037385, 10.1145/2037373.2037385]; Eysenbach Gunther, 2006, AMIA Annu Symp Proc, P244; Generous N, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003892; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Henning Kelly J, 2004, MMWR Suppl, V53, P5; Hulth A, 2011, EURO SURVEILL, V16; Hulth A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-252; Irvin CB, 2003, ANN EMERG MED, V41, P447, DOI 10.1067/mem.2003.104; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kamvar M, 2009, COMPUTERS IPHONES MO; Kamvar M, 2006, LARGE SCALE STUDY WI; Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506; Li J, 2009, GOOD ABANDONMENT MOB; McIver DJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003581; Milinovich GJ, 2014, LANCET INFECT DIS, V14, P160, DOI 10.1016/S1473-3099(13)70244-5; Morse SS, 2012, BIOSECUR BIOTERROR, V10, P6, DOI 10.1089/bsp.2011.0088; Nagar R, 2014, J MED INTERNET RES, V16, P260, DOI 10.2196/jmir.3416; Olson DR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003256; Santillana M, 2014, AM J PREV MED, V47, P341, DOI 10.1016/j.amepre.2014.05.020; Santos JC, 2014, THEOR BIOL MED MODEL, V11, DOI 10.1186/1742-4682-11-S1-S6; Seo Dong-Woo, 2014, J Med Internet Res, V16, pe289, DOI 10.2196/jmir.3680; Soler MS, 2011, LANCET, V378, P1833, DOI 10.1016/S0140-6736(11)60834-9; Valdivia A, 2010, EURO SURVEILL, V15	30	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158539	10.1371/journal.pone.0158539	http://dx.doi.org/10.1371/journal.pone.0158539			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391028	Green Published, gold, Green Submitted			2022-12-27	WOS:000380005400078
J	Wilson, D; Moehlis, J				Wilson, Dan; Moehlis, Jeff			Toward a More Efficient Implementation of Antifibrillation Pacing	PLOS ONE			English	Article							IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS; CARDIAC TISSUE; VENTRICULAR-TACHYCARDIA; ATRIAL-FIBRILLATION; EXCITABLE MEDIA; SPIRAL WAVES; TRANSTHORACIC DEFIBRILLATION; BIDOMAIN EQUATIONS; MONOPHASIC SHOCKS; HEART	We devise a methodology to determine an optimal pattern of inputs to synchronize firing patterns of cardiac cells which only requires the ability to measure action potential durations in individual cells. In numerical bidomain simulations, the resulting synchronizing inputs are shown to terminate spiral waves with a higher probability than comparable inputs that do not synchronize the cells as strongly. These results suggest that designing stimuli which promote synchronization in cardiac tissue could improve the success rate of defibrillation, and point towards novel strategies for optimizing antifibrillation pacing.	[Wilson, Dan; Moehlis, Jeff] Univ Calif Santa Barbara, Dept Mech Engn, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Wilson, D (corresponding author), Univ Calif Santa Barbara, Dept Mech Engn, Santa Barbara, CA 93106 USA.	dan.d.wilson8@gmail.com			National Science Foundation [NSF-1363243]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation, NSF-1363243 (http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Support for this work by National Science Foundation Grant NSF-1363243 is gratefully acknowledged.	Ambrosi CM, 2011, HEART RHYTHM, V8, P101, DOI 10.1016/j.hrthm.2010.10.018; [Anonymous], 2008, INTRO PROBABILITY TH; Bell N, 2013, CUSP GENERIC PARALLE; Bilge AK, 2006, PACE, V29, P619, DOI 10.1111/j.1540-8159.2006.00409.x; Bittihn P, 2010, PHILOS T R SOC A, V368, P2221, DOI 10.1098/rsta.2010.0038; Cherry EM, 2008, J THEOR BIOL, V254, P674, DOI 10.1016/j.jtbi.2008.06.030; Cherry EM, 2004, AM J PHYSIOL-HEART C, V286, pH2332, DOI 10.1152/ajpheart.00747.2003; Cysyk J, 2008, BIOPHYS J, V94, P1533, DOI 10.1529/biophysj.107.116244; Dillon SM, 1998, J CARDIOVASC ELECTR, V9, P529, DOI 10.1111/j.1540-8167.1998.tb01847.x; DiMarco JP, 2003, NEW ENGL J MED, V349, P1836, DOI 10.1056/NEJMra035432; Dosdall DJ, 2010, ANNU REV BIOMED ENG, V12, P233, DOI [10.1146/annurev-bioeng-070909-105305, 10.1146/armurev-bioeng-070909-105305]; Dreyfus S. E., 1962, APPL DYNAMIC PROGRAM; Duncan OD, 1955, AM J SOCIOL, V60, P493, DOI 10.1086/221609; Efimov IR, 2004, CIRC RES, V95, P21, DOI 10.1161/01.RES.0000130529.18016.35; Epstein AE, 1998, CIRCULATION, V98, P1517, DOI 10.1161/01.CIR.98.15.1517; ERMENTROUT GB, 1991, J MATH BIOL, V29, P195, DOI 10.1007/BF00160535; Faddy SC, 2003, RESUSCITATION, V58, P9, DOI 10.1016/S0300-9572(03)00077-7; Fast VG, 1998, CIRC RES, V82, P375, DOI 10.1161/01.RES.82.3.375; Fenton FH, 2009, CIRCULATION, V120, P467, DOI 10.1161/CIRCULATIONAHA.108.825091; Fishler MG, 2000, IEEE T BIO-MED ENG, V47, P59, DOI 10.1109/10.817620; Gray RA, 2005, P NATL ACAD SCI USA, V102, P4672, DOI 10.1073/pnas.0407860102; Hooks DA, 2002, CIRC RES, V91, P331, DOI 10.1161/01.RES.0000031957.70034.89; HOPPENSTEADT F, 1997, WEAKLY CONNECTED NEU; Ichinose N, 1998, INT J BIFURCAT CHAOS, V8, P2375, DOI 10.1142/S021812749800190X; IDEKER RE, 1995, PACE, V18, P512, DOI 10.1111/j.1540-8159.1995.tb02562.x; Jacq F, 2009, GEN HOSP PSYCHIAT, V31, P266, DOI 10.1016/j.genhosppsych.2009.01.003; Karma A, 1994, CHAOS, V4, P461, DOI 10.1063/1.166024; Keener JP, 1998, CHAOS, V8, P234, DOI 10.1063/1.166300; Kirk DE., 1998, OPTIMAL CONTROL THEO; Kroll MW, 2007, J INTERV CARD ELECTR, V18, P247, DOI 10.1007/s10840-007-9095-z; KROLL MW, 1994, PACE, V17, P1782, DOI 10.1111/j.1540-8159.1994.tb03746.x; Kuck KH, 2000, CIRCULATION, V102, P748, DOI 10.1161/01.CIR.102.7.748; Laughner JI, 2012, AM J PHYSIOL-HEART C, V303, pH753, DOI 10.1152/ajpheart.00404.2012; Li DS, 1999, CIRCULATION, V100, P87, DOI 10.1161/01.CIR.100.1.87; Li WW, 2009, HEART RHYTHM, V6, P1020, DOI 10.1016/j.hrthm.2009.03.015; Luther S, 2011, NATURE, V475, P235, DOI 10.1038/nature10216; PLONSEY R, 1986, MED BIOL ENG COMPUT, V24, P130, DOI 10.1007/BF02443925; PLONSEY R, 1982, BIOPHYS J, V39, P309, DOI 10.1016/S0006-3495(82)84521-9; Rabinovitch A, 1999, CHAOS, V9, P880, DOI 10.1063/1.166460; Ripplinger CM, 2006, AM J PHYSIOL-HEART C, V291, pH184, DOI 10.1152/ajpheart.01300.2005; ROTH BJ, 1994, IEEE T BIO-MED ENG, V41, P232, DOI 10.1109/10.284941; Roth BJ, 1997, IEEE T BIO-MED ENG, V44, P326, DOI 10.1109/10.563303; Rush S, 1978, BIOMEDICAL ENG IEEE, P389, DOI [10.1109/TBME.1978.326270, DOI 10.1109/TBME.1978.326270]; Schneider T, 2000, CIRCULATION, V102, P1780; Spach MS, 2007, CIRC RES, V101, P743, DOI 10.1161/CIRCRESAHA.107.163956; SPACH MS, 1986, CIRC RES, V58, P356, DOI 10.1161/01.RES.58.3.356; Suzuki T, 2010, PACE, V33, P1455, DOI 10.1111/j.1540-8159.2010.02887.x; Sweeney MO, 2004, PACE, V27, P1292, DOI 10.1111/j.1540-8159.2004.00622.x; Swerdlow CD, 1996, CIRCULATION, V94, P2278, DOI 10.1161/01.CIR.94.9.2278; ten Tusscher KHWJ, 2006, AM J PHYSIOL-HEART C, V291, pH1088, DOI 10.1152/ajpheart.00109.2006; Thomas SA, 2006, AM J CRIT CARE, V15, P389; Trayanova N, 1998, J ELECTROCARDIOL, V31, P23, DOI 10.1016/S0022-0736(98)90274-6; Trayanova N, 2001, PHILOS T ROY SOC A, V359, P1327, DOI 10.1098/rsta.2001.0834; Trayanova N., 2009, CARDIAC BIOELECTRIC, P85; Vigmond EJ, 2008, PROG BIOPHYS MOL BIO, V96, P3, DOI 10.1016/j.pbiomolbio.2007.07.012; Walcott GP, 2003, RESUSCITATION, V59, P59, DOI 10.1016/S0300-9572(03)00161-8; Wathen MS, 2004, CIRCULATION, V110, P2591, DOI 10.1161/01.CIR.0000145610.64014.E4; Wilson D, 2015, SIAM REV, V57, P201, DOI 10.1137/140952478; Wilson D, 2014, SIAM J APPL DYN SYST, V13, P944, DOI 10.1137/130942851; Wilson D, 2014, SIAM J APPL DYN SYST, V13, P276, DOI 10.1137/120901702; Winfree AT., 1980, GEOMETRY BIOL TIME; Winter J, 2000, AM J CARDIOL, V86, p71K, DOI 10.1016/S0002-9149(00)01294-7	62	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158239	10.1371/journal.pone.0158239	http://dx.doi.org/10.1371/journal.pone.0158239			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391010	Green Published, gold, Green Submitted			2022-12-27	WOS:000380005400039
J	Zhuang, L; Ma, Y; Wang, Q; Zhang, J; Zhu, C; Zhang, L; Xu, XP				Zhuang, Lin; Ma, Yan; Wang, Qian; Zhang, Jing; Zhu, Chen; Zhang, Lu; Xu, Xiaoping			Atg3 Overexpression Enhances Bortezomib-Induced Cell Death in SKM-1 Cell	PLOS ONE			English	Article							RISK MYELODYSPLASTIC SYNDROME; UBIQUITIN-PROTEASOME SYSTEM; DOUBLE-EDGED-SWORD; SELECTIVE AUTOPHAGY; PROTECTIVE AUTOPHAGY; POOR-PROGNOSIS; CANCER CELLS; PROTEIN; RESISTANCE; APOPTOSIS	Background Myelodysplastic syndrome (MDS) is a group of heterogeneous hematopoietic stem cell malignancies with a high risk of transformation into acute myeloid leukemia (AML). Clonal evolutions are significantly associated with transformation to AML. According to a gene expression microarray, atg3 is downregulated in MDS patients progressing to leukemia, but less is known about the function of Atg3 in the survival and death of MSD/AML cells. Moreover, the role of autophagy as a result of bortezomib treatment is controversial. The current study was designed to investigate the function of Atg3 in SKM-1 cells and to study the effect of Atg3 on cell viability and cell death following bortezomib treatment. Methods Four leukemia cell lines (SKM-1, THP-1, NB4 and K562) and two healthy patients' bone marrow cells were analyzed for Atg3 expression via qRT-PCR and Western blotting analysis. The role of Atg3 in SKM-1 cell survival and cell death was analyzed by CCK-8 assay, trypan blue exclusion assay, DAPI staining and Annexin V/PI dual staining with or without bortezomib treatment. Western blotting analysis was used to detect proteins in autophagic and caspase signaling pathways. Electron microscopy was used to observe ultrastructural changes after Atg3 overexpression. Results Downregulation of Atg3 expression was detected in four leukemia cell lines compared with healthy bone marrow cells. Atg3 mRNA was significantly decreased in MDS patients' bone marrow cells. Overexpression of Atg3 in SKM-1 cells resulted in AKT-mTOR-dependent autophagy, a significant reduction in cell proliferation and increased cell death, which could be overcome by the autophagy inhibitor 3-MA. SKM-1 cells overexpressing Atg3 were hypersensitive to bortezomib treatment at different concentrations via autophagic cell death and enhanced sensitivity to apoptosis in the SKM-1 cell line. Following treatment with 3-MA, the sensitivity of Atg3-overexpressing cells to bortezomib treatment was reduced. Atg3 knockdown blocked cell growth inhibition and cell death induced by bortezomib. Conclusion Our preliminary study of Atg3 in the high-risk MDS cell line suggests that Atg3 might be possibly a critical regulator of autophagic cell death and a gene target for therapeutic interventions in MDS.	[Zhuang, Lin; Ma, Yan; Wang, Qian; Zhang, Jing; Zhu, Chen; Zhang, Lu; Xu, Xiaoping] Fudan Univ, Huashan Hosp, Shanghai Med Coll, Dept Hematol, Shanghai, Peoples R China	Fudan University	Xu, XP (corresponding author), Fudan Univ, Huashan Hosp, Shanghai Med Coll, Dept Hematol, Shanghai, Peoples R China.	xpxu1111@163.com			Natural Science Foundation of China [81070404, 81100340]; Shanghai Municipal Commission of Health and Family Planning [15GWZK0801]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Commission of Health and Family Planning	The project was financially supported by a grant from the Natural Science Foundation of China (Grant No.81070404 and 81100340) and Shanghai Municipal Commission of Health and Family Planning (Grant No. 15GWZK0801). The funders had a role in study design, data collection and analysis, decision to publish.	Alimena G, 2011, LEUKEMIA RES, V35, P504, DOI 10.1016/j.leukres.2010.08.021; Chang L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.415; Chen S, 2014, BLOOD, V124, P2687, DOI 10.1182/blood-2014-03-564534; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Dayyani F, 2010, CANCER-AM CANCER SOC, V116, P2174, DOI 10.1002/cncr.24984; Fang J, 2012, BLOOD, V120, P858, DOI 10.1182/blood-2012-02-407999; Fulda S, 2015, ONCOGENE, V34, P5105, DOI 10.1038/onc.2014.458; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Gao ZH, 2010, AUTOPHAGY, V6, P126, DOI 10.4161/auto.6.1.10928; Heras-Sandoval D, 2014, CELL SIGNAL, V26, P2694, DOI 10.1016/j.cellsig.2014.08.019; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Jabbour E, 2013, AM J HEMATOL, V88, P831, DOI 10.1002/ajh.23513; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405; Liu L, 2011, LEUKEMIA, V25, P23, DOI 10.1038/leu.2010.225; Liu ZZ, 2014, CANCER CELL, V26, P106, DOI 10.1016/j.ccr.2014.05.015; Ma Y, 2013, MOL BIOL REP, V40, P469, DOI 10.1007/s11033-012-2082-1; Min H, 2014, CANCER CHEMOTH PHARM, V74, P167, DOI 10.1007/s00280-014-2451-7; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Mortensen M, 2011, AUTOPHAGY, V7, P1069, DOI 10.4161/auto.7.9.15886; Natarajan-Ame S, 2012, BRIT J HAEMATOL, V158, P232, DOI 10.1111/j.1365-2141.2012.09153.x; Oral O, 2012, APOPTOSIS, V17, P810, DOI 10.1007/s10495-012-0735-0; Pyo JO, 2005, J BIOL CHEM, V280, P20722, DOI 10.1074/jbc.M413934200; Radoshevich L, 2010, CELL, V142, P590, DOI 10.1016/j.cell.2010.07.018; Raza A, 2012, NAT REV CANCER, V12, P849, DOI 10.1038/nrc3321; Sahasrabuddhe AA, 2015, IMMUNOL REV, V263, P224, DOI 10.1111/imr.12236; Schreiber A, 2014, BBA-MOL CELL RES, V1843, P163, DOI 10.1016/j.bbamcr.2013.03.019; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Terpos E, 2007, LEUKEMIA RES, V31, P559, DOI 10.1016/j.leukres.2006.05.018; Wang H, 2010, CANCER GENET CYTOGEN, V196, P159, DOI 10.1016/j.cancergencyto.2009.09.015; Wang L, 2014, MOL BIOL REP, V41, P2093, DOI 10.1007/s11033-014-3058-0; Wertz IE, 2014, CURR OPIN CHEM BIOL, V23, P71, DOI 10.1016/j.cbpa.2014.10.011; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Yamaguchi M, 2010, J BIOL CHEM, V285, P29599, DOI 10.1074/jbc.M110.113670; Yoo BH, 2015, AUTOPHAGY, V11, P1230, DOI 10.1080/15548627.2015.1056968; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Zhang MJ, 2015, ONCOTARGET, V6, P8567, DOI 10.18632/oncotarget.3251; Zhao Z, 2015, CANCER LETT, V358, P17, DOI 10.1016/j.canlet.2014.11.046	39	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158761	10.1371/journal.pone.0158761	http://dx.doi.org/10.1371/journal.pone.0158761			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391105	Green Submitted, gold, Green Published			2022-12-27	WOS:000380005400118
J	Espinosa-Montero, J; Monterrubio-Flores, EA; Sanchez-Estrada, M; Buendia-Jimenez, I; Lieberman, HR; Allaert, FA; Barquera, S				Espinosa-Montero, Juan; Monterrubio-Flores, Eric A.; Sanchez-Estrada, Marcela; Buendia-Jimenez, Inmaculada; Lieberman, Harris R.; Allaert, Francois-Andre; Barquera, Simon			Development and Validation of an Instrument to Evaluate Perceived Wellbeing Associated with the Ingestion of Water: The Water Ingestion-Related Wellbeing Instrument (WIRWI)	PLOS ONE			English	Article							SUGAR-SWEETENED BEVERAGES; METABOLIC SYNDROME; MILD DEHYDRATION; COGNITIVE PERFORMANCE; CONTROLLED-TRIAL; KIDNEY-DISEASE; MEXICO; MOOD; HEALTH; ADULTS	Background Ingestion of water has been associated with general wellbeing. When water intake is insufficient, symptoms such as thirst, fatigue and impaired memory result. Currently there are no instruments to assess water consumption associated with wellbeing. The objective of our study was to develop and validate such an instrument in urban, low socioeconomic, adult Mexican population. Methods To construct the Water Ingestion-Related Wellbeing Instrument (WIRWI), a qualitative study in which wellbeing related to everyday practices and experiences in water consumption were investigated. To validate the WIRWI a formal, five-process procedure was used. Face and content validation were addressed, consistency was assessed by exploratory and confirmatory psychometric factor analyses, repeatability, reproducibility and concurrent validity were assessed by conducting correlation tests with other measures of wellbeing such as a quality of life instrument, the SF-36, and objective parameters such as urine osmolality, 24-hour urine total volume and others. Results The final WIRWI is composed of 17 items assessing physical and mental dimensions. Items were selected based on their content and face validity. Exploratory and confirmatory factor analyses yielded Cronbach's alpha of 0.87 and 0.86, respectively. The final confirmatory factor analysis demonstrated that the model estimates were satisfactory for the constructs. Statistically significant correlations with the SF-36, total liquid consumption and simple water consumption were observed. Conclusion The resulting WIRWI is a reliable tool for assessing wellbeing associated with consumption of plain water in Mexican adults and could be useful for similar groups.	[Espinosa-Montero, Juan; Monterrubio-Flores, Eric A.; Barquera, Simon] Mexican Natl Inst Publ Hlth, Nutr & Hlth Res Ctr, Nutr Epidemiol, Cuernavaca, Morelos, Mexico; [Sanchez-Estrada, Marcela] Mexican Natl Inst Publ Hlth, Acad Secretary, Acad Operat, Cuernavaca, Morelos, Mexico; [Buendia-Jimenez, Inmaculada] Danone Res, Kidney Hlth, Palaiseau, France; [Allaert, Francois-Andre] ESC Dijon Bourgogne, Med Evaluat, Dijon, France	Instituto Nacional de Salud Publica; Instituto Nacional de Salud Publica; Danone Nutricia	Barquera, S (corresponding author), Mexican Natl Inst Publ Hlth, Nutr & Hlth Res Ctr, Nutr Epidemiol, Cuernavaca, Morelos, Mexico.	sbarquera@insp.mx	; Espinosa, Juan/E-7192-2010	Monterrubio, Eric/0000-0003-1417-9243; Espinosa, Juan/0000-0001-5408-5044; Allaert, Francois/0000-0002-7667-5528	National Institute of Public Health, Mexico [EUA-4729-GD, CINYS917]; Danone Research Daniel Carasso Center (France); Danone Waters through the National Institute of Public Health, Mexico [EUA-4729-GD, CINYS917]	National Institute of Public Health, Mexico; Danone Research Daniel Carasso Center (France); Danone Waters through the National Institute of Public Health, Mexico	Research grant EUA-4729-GD through the National Institute of Public Health, Mexico (CINYS917), Funding Institution: Danone Research Daniel Carasso Center (France). Recipient SB.; This study was supported by Danone Waters (research grant EUA-4729-GD) through the National Institute of Public Health, Mexico (CINYS917). IB is an employee and HRL a consultant of the funding center (Danone Research Daniel Carasso Center, France). The specific roles of these authors are articulated in the 'author contributions' section. The authors thank the exceptional support and valuable comments by Liliana Jimenez, PhD, Gloria Cervantes, MS, Sabine Boesen, PhD and Erika Fricke, MS.	Aaronson N K, 1992, Qual Life Res, V1, P349, DOI 10.1007/BF00434949; Adan A, 2012, J AM COLL NUTR, V31, P71, DOI 10.1080/07315724.2012.10720011; [Anonymous], 2010, ACTIVIDAD FISICA BIE, V12, P1; Armstrong LE, 2012, CLIN OBES, V2, P115, DOI 10.1111/cob.12006; Armstrong LE, 2012, J NUTR, V142, P382, DOI 10.3945/jn.111.142000; Arnaud MJ, 2003, EUR J CLIN NUTR, V57, pS88, DOI 10.1038/sj.ejcn.1601907; Barquera S, 2013, OBES REV, V14, P69, DOI 10.1111/obr.12096; Barquera S, 2008, J NUTR, V138, P2454, DOI 10.3945/jn.108.092163; Barquera S, 2015, ARCH MED RES, V46, P328, DOI 10.1016/j.arcmed.2015.06.006; Beaman P., 2004, SALUD ADULTO MAYOR, P117; Bech P, 2003, INT J METH PSYCH RES, V12, P85, DOI 10.1002/mpr.145; Bentler PM, 2006, EQS 6 1; Blazquez FP, 2002, THESIS; Boomsma A, 2000, STRUCT EQU MODELING, V7, P461, DOI 10.1207/S15328007SEM0703_6; Casado A, 2011, GUIA BUENA PRACTICA, P1; Cheungpasitporn W, 2014, NEPHROLOGY, V19, P791, DOI 10.1111/nep.12343; Cohen S, 2006, CURR DIR PSYCHOL SCI, V15, P122, DOI 10.1111/j.0963-7214.2006.00420.x; Comite de expertos de OMS, 1995, OMS SER INF TECN; [Constitution of the World Health Organization OMS], 1946, AM J PUBLIC HEALTH, V36, P1315; Corral Y., 2010, REV CIENCIAS EDCACIO, V20; Diener E, 2000, AM PSYCHOL, V55, P34, DOI 10.1037/0003-066X.55.1.34; Diener E., 1994, PSYCHOSOC INTERV, V3, P1; Embretson S, 2000, MULTIVARIATE APPL BO; Espinosa-Montero J, 2014, AGUA SALUD BIENESTAR, P127; Espinosa-Montero J, 2013, SALUD PUBLICA MEXICO, V55, pS423; Ferder L, 2010, CURR HYPERTENS REP, V12, P105, DOI 10.1007/s11906-010-0097-3; Ganio MS, 2011, BRIT J NUTR, V106, P1535, DOI 10.1017/S0007114511002005; Ganong WF, 2010, REV MED PHYSL; Gibbs G.R., 2007, ANAL QUALITATIVE DAT; Goldstein EB, 2005, SENSACION PERCEPCION, P1; Grandjean AC, 2007, J AM COLL NUTR, V26, p549S, DOI 10.1080/07315724.2007.10719657; Hadley C, 2009, HUM ORGAN, V68, P451, DOI 10.17730/humo.68.4.932w421317680w5x; Hernandez-Cordero S, 2014, J NUTR, V144, P1742, DOI 10.3945/jn.114.193490; Illescas D, 2015, BMC PUBLIC HEALTH, V15, P115; Institute of Medicine (U.S.), 2004, PAN DIET REF INT EL, P73; Jepson W, 2014, GEOFORUM, V51, P107, DOI 10.1016/j.geoforum.2013.10.002; Jequier E, 2010, EUR J CLIN NUTR, V64, P115, DOI 10.1038/ejcn.2009.111; Johnson RJ, 2007, AM J CLIN NUTR, V86, P899; Kieta-Fyda A, 1974, Przegl Lek, V31, P483; Lee PH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-115; Long SJ, 2013, PSYCHOSOM MED, V75, P144, DOI 10.1097/PSY.0b013e31827d5fbd; Lopez C., 1995, PAPERS REV SOCIOLOGI, P055; Lopez H., 2009, NIVEL SOCIOECONOMICO; Maisto AA, 2005, INTRO PSICOLOGIA, P1; Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079; Mattes RD, 2009, AM J CLIN NUTR, V89, P1, DOI 10.3945/ajcn.2008.26792; Mayo Clinic, 2014, DEHYDRATION SYMPTOMS; McDonald RP, 2002, PSYCHOL METHODS, V7, P64, DOI 10.1037//1082-989X.7.1.64; Moriyama IM, 1968, INDICATORS SOCIAL CH, P573; Moyano Díaz Emilio, 2007, Universum, V22, P177; Muhr T., 1997, ATLAS TI; [OPS Pan American Health Organization], 2008, ALC PRIM HLTH CAR BA, P1; Pipingas A, 2013, APPETITE, V69, P123, DOI 10.1016/j.appet.2013.05.016; Popkin BM, 2006, AM J CLIN NUTR, V83, P529, DOI 10.1093/ajcn.83.3.529; Rhee H, 2011, J PEDIATR HEALTH CAR, V25, P105, DOI 10.1016/j.pedhc.2009.10.003; Ritz P, 2005, NUTR REV, V63, pS6, DOI [10.1301/nr.2005.jun.S6-S13, 10.1111/j.1753-4887.2005.tb00155.x]; Rivera JA, 2008, SALUD PUBLICA MEXICO, P50; Ryff CD, 2006, PSYCHOTHER PSYCHOSOM, V75, P85, DOI 10.1159/000090892; Shamah-Levy T, 2006, MANUAL PROCEDIMENTOS; Stern D, 2014, J NUTR, V144, P949, DOI 10.3945/jn.114.190652; Stevenson E, SOC SCI MED, V75, P392, DOI [10.1016/j.socscimed.2012.03.022, DOI 10.1016/J.S0CSCIMED.2012.03.022]; Tsai AC, 2016, J WATER HEALTH, V14, P280, DOI 10.2166/wh.2015.165; WARE JE, 1995, INT J TECHNOL ASSESS, V11, P525, DOI 10.1017/S0266462300008710; White DJ, 2015, NUTRIENTS, V7, P9005, DOI 10.3390/nu7115451; Wutich A, 2008, SOC SCI MED, V67, P2116, DOI 10.1016/j.socscimed.2008.09.042; Zuniga MA, 1999, SALUD PUBLICA MEXICO, V41, P110	66	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158567	10.1371/journal.pone.0158567	http://dx.doi.org/10.1371/journal.pone.0158567			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR3OC	27388902	Green Published, gold, Green Submitted			2022-12-27	WOS:000379811500027
J	Shin, D; Yoon, D; Lim, SG; Hong, JM; Park, RW; Lee, JS				Shin, Dahye; Yoon, Dukyong; Lim, Sun Gyo; Hong, Ji Man; Park, Rae Woong; Lee, Jin Soo			Comparison of the Risk of Gastrointestinal Bleeding among Different Statin Exposures with Concomitant Administration of Warfarin: Electronic Health Record-Based Retrospective Cohort Study	PLOS ONE			English	Article							ORAL ANTICOAGULANT-THERAPY; ATRIAL-FIBRILLATION; CAROTID ATHEROSCLEROSIS; AMERICAN-COLLEGE; CHOLESTEROL; STROKE; ROSUVASTATIN; PREVENTION; MANAGEMENT; COMPLICATIONS	Background and Objective Patients who should be treated with both warfarin and a statin are frequently seen in vascular clinics. The risk for bleeding and potential drug interactions should be considered when prescribing both medications together. This study aimed to compare the risk for gastrointestinal bleeding among different statin exposures with concomitant administration of warfarin. Materials and Methods This is a single-hospital retrospective cohort study. We included patients who were concomitantly exposed to one of four statins (pravastatin, simvastatin, atorvastatin, and rosuvastatin) and warfarin for up to 2 years (730 days). The observation period ended when a gastrointestinal bleeding event occurred or the observation was censored. Within-class comparisons were used, and 1: 1 matching using a propensity score was performed for comparisons between each statin and all of the other statins. Kaplan-Meier analyses with log-rank tests and Cox proportional hazard regression analyses were conducted to determine associations with the risk of gastrointestinal bleeding. Results Data were analyzed for 1,686 patients who were concomitantly administered a statin and warfarin. Log-rank tests for the gastrointestinal bleeding-free survival rate showed that the risk for gastrointestinal bleeding was significantly lower in the pravastatin group (p = 0.0499) and higher in the rosuvastatin group (p = 0.009). In the Cox proportional hazard regression analysis, the hazard ratio of 5.394 for gastrointestinal bleeding based on statin exposure in the rosuvastatin group was significant (95% confidence interval, 1.168-24.916). Conclusions There was a relatively high risk of gastrointestinal bleeding with rosuvastatin when administered concomitantly with warfarin.	[Shin, Dahye; Yoon, Dukyong; Park, Rae Woong] Ajou Univ, Sch Med, Dept Biomed Informat, Suwon, Gyeonggi Do, South Korea; [Lim, Sun Gyo] Ajou Univ, Sch Med, Dept Gastroenterol, Suwon, Gyeonggi Do, South Korea; [Hong, Ji Man; Lee, Jin Soo] Ajou Univ, Sch Med, Dept Neurol, Suwon, Gyeonggi Do, South Korea; [Park, Rae Woong] Ajou Univ, Grad Sch Med, Dept Biomed Sci, Suwon, Gyeonggi Do, South Korea	Ajou University; Ajou University; Ajou University; Ajou University	Park, RW (corresponding author), Ajou Univ, Sch Med, Dept Biomed Informat, Suwon, Gyeonggi Do, South Korea.; Lee, JS (corresponding author), Ajou Univ, Sch Med, Dept Neurol, Suwon, Gyeonggi Do, South Korea.; Park, RW (corresponding author), Ajou Univ, Grad Sch Med, Dept Biomed Sci, Suwon, Gyeonggi Do, South Korea.	veritas@ajou.ac.kr; jinsoo22@gmail.com	Hong, Ji Man/AAE-2686-2022; Lim, Sun Gyo/GZL-8052-2022	Hong, Ji Man/0000-0001-6803-1207; Lim, Sun Gyo/0000-0003-2045-5099	Daiichi-Sankyo Korea; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2014R1A1A1008249]; Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI13C0723]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI16C0992]	Daiichi-Sankyo Korea; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning(National Research Foundation of Korea); Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant from Daiichi-Sankyo Korea (JSL) and by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2014R1A1A1008249, JSL). The study was also supported by a grant of the Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI13C0723, RWP) and a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number : HI16C0992, RWP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo-Salem E, 2014, J THROMB THROMBOLYS, V37, P372, DOI 10.1007/s11239-014-1060-y; Amarenco P, 2004, STROKE, V35, P2902, DOI 10.1161/01.STR.0000147965.52712.fa; Amarenco P, 2009, LANCET NEUROL, V8, P453, DOI 10.1016/S1474-4422(09)70058-4; Barry M, 2004, LANCET, V363, P328, DOI 10.1016/S0140-6736(03)15396-2; Beyth RJ, 1998, AM J MED, V105, P91, DOI 10.1016/S0002-9343(98)00198-3; CANNEGIETER SC, 1995, NEW ENGL J MED, V333, P11, DOI 10.1056/NEJM199507063330103; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Chaturvedi S, 2007, NEUROLOGY, V69, P2063, DOI 10.1212/01.wnl.0000279338.18776.26; CHIMOWITZ MI, 1995, NEUROLOGY, V45, P1488, DOI 10.1212/WNL.45.8.1488; Douketis JD, 2007, AM J MED, V120, DOI 10.1016/j.amjmed.2006.06.008; Douketis JD, 2006, ARCH INTERN MED, V166, P853, DOI 10.1001/archinte.166.8.853; Guyatt GH, 2012, CHEST, V141, p7S, DOI 10.1378/chest.1412S3; Hatanaka T, 2000, CLIN PHARMACOKINET, V39, P397, DOI 10.2165/00003088-200039060-00002; Hong KS, 2015, J STROKE, V17, P282, DOI 10.5853/jos.2015.17.3.282; Hubner U, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-8; JACOBS D, 1992, CIRCULATION, V86, P1046, DOI 10.1161/01.CIR.86.3.1046; January CT, 2014, CIRCULATION, V130, P2071, DOI 10.1161/CIR.0000000000000040; Jha AK, 2009, NEW ENGL J MED, V360, P1628, DOI 10.1056/NEJMsa0900592; Jindal D, 2005, EUR J CLIN PHARMACOL, V61, P621, DOI 10.1007/s00228-005-0986-6; Jones M, 2005, HEART, V91, P472, DOI 10.1136/hrt.2004.042465; Kang S, 2004, ATHEROSCLEROSIS, V177, P433, DOI 10.1016/j.atherosclerosis.2004.08.005; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Kizer JR, 2010, AM J CARDIOL, V105, P1289, DOI 10.1016/j.amjcard.2009.12.051; LANDEFELD CS, 1989, AM J MED, V87, P144; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; Massie BM, 2009, CIRCULATION, V119, P1616, DOI 10.1161/CIRCULATIONAHA.108.801753; McDermott MM, 2003, CIRCULATION, V107, P757, DOI 10.1161/01.CIR.0000050380.64025.07; McKenney JM, 2005, AM J HEALTH-SYST PH, V62, P1033, DOI 10.1093/ajhp/62.10.1033; Nicholls SJ, 2007, JAMA-J AM MED ASSOC, V297, P499, DOI 10.1001/jama.297.5.499; Nishimura RA, 2014, CIRCULATION, V129, P2440, DOI 10.1161/CIR.0000000000000029; Nissen SE, 2005, NEW ENGL J MED, V352, P29, DOI 10.1056/NEJMoa042000; Oden A, 2006, THROMB RES, V117, P493, DOI 10.1016/j.thromres.2004.11.025; Ohvo-Rekila H, 2002, PROG LIPID RES, V41, P66, DOI 10.1016/S0163-7827(01)00020-0; Olsson G, 2004, LANCET, V363, P897, DOI 10.1016/S0140-6736(04)15747-4; Park MY, 2011, PHARMACOEPIDEM DR S, V20, P598, DOI 10.1002/pds.2139; Park YK, 2015, J STROKE, V17, P192, DOI 10.5853/jos.2015.17.2.192; RETTIE AE, 1992, CHEM RES TOXICOL, V5, P54, DOI 10.1021/tx00025a009; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Sadowitz B, 2010, VASC ENDOVASC SURG, V44, P241, DOI 10.1177/1538574410362922; Schelleman H, 2010, AM J MED, V123, P151, DOI 10.1016/j.amjmed.2009.07.020; VANDERMEER FJM, 1993, ARCH INTERN MED, V153, P1557, DOI 10.1001/archinte.153.13.1557; WELLS PS, 1994, ANN INTERN MED, V121, P676, DOI 10.7326/0003-4819-121-9-199411010-00009; Whayne TF, 2012, INT J ANGIOL, V21, P187, DOI 10.1055/s-0032-1330232; White RH, 1996, ARCH INTERN MED, V156, P1197, DOI 10.1001/archinte.156.11.1197; Wysowski DK, 2007, ARCH INTERN MED, V167, P1414, DOI 10.1001/archinte.167.13.1414; YANO K, 1989, STROKE, V20, P1460, DOI 10.1161/01.STR.20.11.1460; Yoon D, 2012, CLIN PHARMACOL THER, V91, P467, DOI 10.1038/clpt.2011.248	47	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158130	10.1371/journal.pone.0158130	http://dx.doi.org/10.1371/journal.pone.0158130			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27386858	Green Published, gold, Green Submitted			2022-12-27	WOS:000379811500013
J	Vallerand, D; Massonnet, G; Kebir, F; Gentien, D; Maciorowski, Z; De la Grange, P; Sigal-Zafrani, B; Richardson, M; Humbert, S; Thuleau, A; Assayag, F; de Plater, L; Nicolas, A; Scholl, S; Marangoni, E; Weigand, S; Roman-Roman, S; Savina, A; Decaudin, D				Vallerand, David; Massonnet, Gerald; Kebir, Fatima; Gentien, David; Maciorowski, Zofia; De la Grange, Pierre; Sigal-Zafrani, Brigitte; Richardson, Marion; Humbert, Sandrine; Thuleau, Aurelie; Assayag, Franck; de Plater, Ludmilla; Nicolas, Andre; Scholl, Suzy; Marangoni, Elisabetta; Weigand, Stefan; Roman-Roman, Sergio; Savina, Ariel; Decaudin, Didier			Characterization of Breast Cancer Preclinical Models Reveals a Specific Pattern of Macrophage Polarization	PLOS ONE			English	Article							SUPPRESSES GROWTH; TUMOR XENOGRAFTS; MOUSE MODELS; EXPRESSION; STROMA; MICROENVIRONMENT; ESTABLISHMENT; PROGRESSION; METASTASIS; IMPACT	Drug discovery efforts have focused on the tumor microenvironment in recent years. However, few studies have characterized the stroma component in patient-derived xenografts (PDXs) and genetically engineered mouse models (GEMs). In this study, we characterized the stroma in various models of breast cancer tumors in mice. We performed transcriptomic and flow cytometry analyses on murine populations for a series of 25 PDXs and the two most commonly used GEMs (MMTV-PyMT and MMTV-erBb2). We sorted macrophages from five models. We then profiled gene expression in these cells, which were also subjected to flow cytometry for phenotypic characterization. Hematopoietic cell composition, mostly macrophages and granulocytes, differed between tumors. Macrophages had a specific polarization phenotype related to their M1/M2 classification and associated with the expression of genes involved in the recruitment, invasion and metastasis processes. The heterogeneity of the stroma component of the models studied suggests that tumor cells modify their microenvironment to satisfy their needs. Our observations suggest that such models are of relevance for preclinical studies.	[Vallerand, David; Massonnet, Gerald; Thuleau, Aurelie; Assayag, Franck; de Plater, Ludmilla; Marangoni, Elisabetta; Decaudin, Didier] PSL Univ, Inst Curie, Lab Preclin Invest, Translat Res Dept, Paris, France; [Vallerand, David; Savina, Ariel] Inst Roche, Boulogne, France; [Kebir, Fatima; Sigal-Zafrani, Brigitte; Richardson, Marion; Nicolas, Andre] Inst Curie, Dept Pathol, Boulogne, France; [Gentien, David] PSL Univ, Inst Curie, Platform Mol Biol Facil, Paris, France; [Maciorowski, Zofia] PSL Univ, Inst Curie, Flow Cytometry Core Facil, Paris, France; [De la Grange, Pierre] Inst Univ Hematol, GenoSplice Technol, Paris, France; [Sigal-Zafrani, Brigitte] PSL Univ, Inst Curie, INSERM, U830, Paris, France; [Humbert, Sandrine] PSL Univ, Inst Curie, INSERM, CNRS UMR3306,U1005, Orsay, France; [Scholl, Suzy; Decaudin, Didier] Inst Curie, Dept Med Oncol, Orsay, France; [Weigand, Stefan] Roche Diagnost GmbH, Penzberg, Germany; [Roman-Roman, Sergio; Decaudin, Didier] PSL Univ, Inst Curie, Translat Res Dept, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Roche Holding; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Decaudin, D (corresponding author), PSL Univ, Inst Curie, Lab Preclin Invest, Translat Res Dept, Paris, France.; Decaudin, D (corresponding author), Inst Curie, Dept Med Oncol, Orsay, France.; Decaudin, D (corresponding author), PSL Univ, Inst Curie, Translat Res Dept, Paris, France.	didier.decaudin@curie.net	Gentien, David/O-9356-2019; Humbert, Sandrine/S-2981-2016; Gentien, David/L-7757-2017; Roman-Roman, Sergio/K-9993-2014; Marangoni, Elisabetta/GSO-3945-2022	Gentien, David/0000-0001-8317-5188; Roman-Roman, Sergio/0000-0001-6459-2613; Marangoni, Elisabetta/0000-0002-3337-6448; Humbert, Sandrine/0000-0002-9501-2658	ROCHE laboratories; ROCHE laboratories (CIFRE PhD grant) [2010/0553]; CIFRE PhD grant from Roche [2010/0553]	ROCHE laboratories; ROCHE laboratories (CIFRE PhD grant); CIFRE PhD grant from Roche	David Vallerand was paid by ROCHE laboratories and a part of experiments was supported by ROCHE laboratories (CIFRE PhD grant 2010/0553). Stefan Weigand and Ariel Savina were employed by Roche Diagnostics GmbH. Pierre De La Grange was employed by GenoSplice Technology. The specific roles of these authors are articulated in the "author contributions" section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We would like to thank the staff of our laboratory for their contribution to this study. We also thank the Department of Pathology of the Institut Curie for assistance with pathology studies. We thank Sophie Grondin, Annick Viguier, Benoit Albaud, and Frederic Lemoine for their advice and technical support. We also thank the staff of the Institut Curie animal facility. We thank Prof. Dominique Bellet for his generosity in sharing his laboratory facilities at the Faculty of Pharmacy of Paris Descartes University with us. Finally, we thank Dr Nathalie Varoqueaux, Dr Emilie Vinolo and Dr Sebastian Amigorena for their careful review of the manuscript. This work was supported by CIFRE PhD grant 2010/0553 from Roche.	Aharinejad S, 2004, CANCER RES, V64, P5378, DOI 10.1158/0008-5472.CAN-04-0961; Bergamaschi A, 2009, MOL ONCOL, V3, P469, DOI 10.1016/j.molonc.2009.07.003; Chaudary Naz, 2012, Cancers (Basel), V4, P821, DOI 10.3390/cancers4030821; Coffelt SB, 2009, BBA-REV CANCER, V1796, P11, DOI 10.1016/j.bbcan.2009.02.004; Cottu P, 2011, BREAST CANC RES TREA; Davies E, 2010, J LEUKOCYTE BIOL, V88, P529, DOI 10.1189/jlb.0909648; de la Grange P, 2005, NUCLEIC ACIDS RES, V33, P4276, DOI 10.1093/nar/gki738; de la Grange P, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-180; de la Grange P, 2010, NUCLEIC ACIDS RES, V38, P2825, DOI 10.1093/nar/gkq008; de Plater L, 2010, BRIT J CANCER, V103, P1192, DOI 10.1038/sj.bjc.6605900; Decaudin D, 2011, ANTI-CANCER DRUG, V22, P827, DOI 10.1097/CAD.0b013e3283475f70; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Doedens AL, 2010, CANCER RES, V70, P7465, DOI 10.1158/0008-5472.CAN-10-1439; Engels B, 2012, SEMIN CANCER BIOL, V22, P41, DOI 10.1016/j.semcancer.2011.12.008; Garber K, 2009, J NATL CANCER I, V101, P6, DOI 10.1093/jnci/djn481; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hao NB, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/948098; Houghton AM, 2006, CANCER RES, V66, P6149, DOI 10.1158/0008-5472.CAN-04-0297; Howell A, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2435; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Julien S, 2012, CLIN CANCER RES, V18, P5314, DOI 10.1158/1078-0432.CCR-12-0372; Kaler P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011700; Kim IS, 2010, BIOCHEM BIOPH RES CO, V394, P443, DOI 10.1016/j.bbrc.2010.03.070; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kraman M, 2010, SCIENCE, V330, P827, DOI 10.1126/science.1195300; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li XQ, 2012, CURR PHARM DESIGN, V18, P2404, DOI 10.2174/13816128112092404; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; LUCCHINI F, 1992, CANCER LETT, V64, P203, DOI 10.1016/0304-3835(92)90044-V; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Marangoni E, 2007, CLIN CANCER RES, V13, P3989, DOI 10.1158/1078-0432.CCR-07-0078; Nakasone ES, 2012, CANCER CELL, V21, P488, DOI 10.1016/j.ccr.2012.02.017; Nemati F, 2010, CLIN CANCER RES, V16, P2352, DOI 10.1158/1078-0432.CCR-09-3066; Petit V, 2013, LAB INVEST, V93, P611, DOI 10.1038/labinvest.2013.44; Petrillo LA, 2012, BREAST CANCER RES TR, V135, P913, DOI 10.1007/s10549-012-2226-y; Place AE, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2912; Reinheckel T, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00133; Reyal F, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3095; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Takaoka A, 2006, CELL MICROBIOL, V8, P907, DOI 10.1111/j.1462-5822.2006.00716.x; Tovey MG, 1996, J LEUKOCYTE BIOL, V59, P512, DOI 10.1002/jlb.59.4.512; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642	45	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0157670	10.1371/journal.pone.0157670	http://dx.doi.org/10.1371/journal.pone.0157670			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27388901	Green Submitted, Green Published, gold			2022-12-27	WOS:000379811500007
J	Wang, J; Zhao, L; Yan, H; Che, JJ; Li, HH; Jun, W; Liu, B; Cao, BW				Wang, Jing; Zhao, Lei; Yan, Han; Che, Juanjuan; Li Huihui; Jun, Wu; Liu, Bing; Cao, Bangwei			A Meta-Analysis and Systematic Review on the Association between Human Papillomavirus (Types 16 and 18) Infection and Esophageal Cancer Worldwide	PLOS ONE			English	Review							SQUAMOUS-CELL CARCINOMA; CHINESE POPULATION; BARRETTS-ESOPHAGUS; P53 POLYMORPHISM; RISK; DNA; CARCINOGENESIS; ADENOCARCINOMA; PREVALENCE; ALCOHOL	Background Esophageal cancer is a common and aggressive malignant tumor. This study aimed to investigate the association between human papillomavirus (HPV) Types 16 and 18 and esophageal carcinoma (EC) in the world population by conducting a meta-analysis. Materials and Methods Computerized bibliographic and manual searches were performed to identify all eligible literatures between 1982 and 2014. PUBMED (http://www.ncbi.nlm.nih.gov/pubmed/) and CNKI (http://www.cnki.net/) were the primary sources of case-control studies, and key words used include human papillomavirus, HPV, esophageal, esophagus, cancer, carcinoma, and tumor. All searches were performed by reviewing articles and abstracts cited in the published systematic reviews and case-control studies. Prospective studies that reported relative risk (RR) estimates with 95% CIs for the association between HPV and EC were included. Results Thirty-three randomized studies were identified, and the main features of these trials were included in this systematic review. HPV infection rate in the EC group was 46.5%, while HPV infection rate in the control group was 26.2% (OR = 1.62; 95% CI, 1.33-1.98). In China, the merger OR value was 1.62 (95% CI: 1.26-2.07); while in the Asian region, the merger OR value was 1.63 (95% CI: 1.29-2.04). There were statistical differences in HPV testing due to different detection methods such as PCR, IHC and ISH. In the PCR detection group, the merger OR value was 1.61 (95% CI: 1.33-1.95). Conclusions These results indicate that HPV infection and the incidence of EC are closely associated.	[Wang, Jing; Zhao, Lei; Yan, Han; Che, Juanjuan; Li Huihui; Jun, Wu; Cao, Bangwei] Capital Med Univ, Beijing Friendship Hosp, Dept Oncol, Beijing, Peoples R China; [Liu, Bing] Capital Med Univ, Beijing Friendship Hosp, Dept Emergency, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Cao, BW (corresponding author), Capital Med Univ, Beijing Friendship Hosp, Dept Oncol, Beijing, Peoples R China.; Liu, B (corresponding author), Capital Med Univ, Beijing Friendship Hosp, Dept Emergency, Beijing, Peoples R China.	liubing20160101@163.com; oncologychina@163.com		Zhao, Lei/0000-0001-5027-2379	Administration of Hospitals' Youth Programme [QML20150107]; traditional Chinese medicine science and technology development fund project of Beijing [QN2015-10]; Research Foundation of Beijing Friendship Hospital [yyqdkt2014-10]; Capital Medical and Health Development Fund	Administration of Hospitals' Youth Programme; traditional Chinese medicine science and technology development fund project of Beijing; Research Foundation of Beijing Friendship Hospital; Capital Medical and Health Development Fund	This study was supported by the Administration of Hospitals' Youth Programme, code: QML20150107 (to Jing Wang); The traditional Chinese medicine science and technology development fund project of Beijing (QN2015-10) (to Jing Wang); The Research Foundation of Beijing Friendship Hospital (yyqdkt2014-10) (to Jing Wang); The Capital Medical and Health Development Fund (2016) (to Jing Wang).	Acevedo-Nuno E, 2004, ANTICANCER RES, V24, P1319; Agarwal A, 2012, INT J CLIN EXP PATHO, V5, P382; Astori G, 2001, DIGESTION, V64, P9, DOI 10.1159/000048834; Bahnassy AA, 2005, PATHOL INT, V55, P53, DOI 10.1111/j.1440-1827.2005.01804.x; BENAMOUZIG R, 1992, INT J CANCER, V50, P549, DOI 10.1002/ijc.2910500409; Brewster DH, 2015, CANCER EPIDEMIOL, V39, P313, DOI 10.1016/j.canep.2015.02.009; Brown LM, 2001, AM J EPIDEMIOL, V153, P114, DOI 10.1093/aje/153.2.114; Cao Bangwei, 2010, JOURNAL OF CAPITAL M, V3, P258; Chang F, 2000, SCAND J GASTROENTERO, V35, P123, DOI 10.1080/003655200750024272; Chen J, 2004, CHINESE J LAB DIAGNO, V8, P182; Dabrowski A, 2012, WORLD J GASTROENTERO, V18, P5739, DOI 10.3748/wjg.v18.i40.5739; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fan YH, 2008, NUTR CANCER, V60, P354, DOI 10.1080/01635580701883011; Farhadi M, 2005, WORLD J GASTROENTERO, V11, P1200, DOI 10.3748/wjg.v11.i8.1200; Georgantis G, 2015, WORLD J GASTROENTERO, V21, P2352, DOI 10.3748/wjg.v21.i8.2352; Han CL, 1996, JNCI-J NATL CANCER I, V88, P1467, DOI 10.1093/jnci/88.20.1467; Jiang HY, 2005, JOURNAL OF CLINICAL, V22, P1061; Kamangar F, 2006, INT J CANCER, V119, P579, DOI 10.1002/ijc.21871; Kawaguchi H, 2000, CANCER RES, V60, P2753; Khurshid A, 1998, J Pak Med Assoc, V48, P138; Kuang ZS, 2000, GUANGDONG MEDICINE, V4, P305; Lagergren J, 1999, J NATL CANCER I, V91, P156, DOI 10.1093/jnci/91.2.156; Lagergren J, J NATL CANC I, V91, P156; Li Y, 1991, Hua Xi Yi Ke Da Xue Xue Bao, V22, P157; Liao Pei-hua, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P951; Liu J, 2000, WORLD CHIN J DIGESTO, V8, P494; Lu LC, 1999, CHINESE JOURNAL OF C, V2, P162; Lu XM, 2004, WORLD J GASTROENTERO, V10, P2775; Lyronis ID, 2008, PATHOL ONCOL RES, V14, P267, DOI 10.1007/s12253-008-9032-1; Mosavi-Jarrahi Alireza, 2006, Asian Pac J Cancer Prev, V7, P375; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Parkin DM, 2008, INT J CLIN ONCOL, V13, P102, DOI 10.1007/s10147-008-0762-6; Ren ZHP, 1996, CHINESE JOURNAL OF C, V12, P203; Rubenstein JH, 2015, GASTROENTEROLOGY, V149, P302, DOI 10.1053/j.gastro.2015.04.053; Shen ZY, 2004, ONCOL REP, V11, P647; Shengli H, 2004, JOURNAL OF NINGXIA M, V26, P85; Sun LB, 2001, GASTROENTEROLOGY, V6, P5; Syrjanen K, 2013, SCAND J INFECT DIS, V45, P1, DOI 10.3109/00365548.2012.702281; Syrjanen KJ, 2002, J CLIN PATHOL, V55, P721, DOI 10.1136/jcp.55.10.721; Tornesello ML, 2009, J CLIN VIROL, V45, P28, DOI 10.1016/j.jcv.2009.02.004; Wang XJ, 1996, CHINESE JOURNAL OF C, V23, P761; Xu Chun-Lei, 2004, Ai Zheng, V23, P165; Xu Wei-guo, 2003, Zhonghua Yi Xue Za Zhi, V83, P1910; Yu DongHong, 2000, Chinese Journal of Zoonoses, V16, P48; Zhang SK, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1096-1; Zhang SK, 2014, ASIAN PAC J CANCER P, V15, P10143, DOI 10.7314/APJCP.2014.15.23.10143; Zhou SM, 2009, WORLD CHIN J DIGESTO, V17, P3214; Zhou XB, 2003, WORLD J GASTROENTERO, V9, P1170, DOI 10.3748/wjg.v9.i6.1170; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	50	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159140	10.1371/journal.pone.0159140	http://dx.doi.org/10.1371/journal.pone.0159140			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27409078	Green Published, gold, Green Submitted			2022-12-27	WOS:000379508300060
J	Hayase, T				Hayase, Tamaki			Putative Epigenetic Involvement of the Endocannabinoid System in Anxiety- and Depression-Related Behaviors Caused by Nicotine as a Stressor	PLOS ONE			English	Article							CANNABINOID CB1 RECEPTOR; ELEVATED PLUS-MAZE; INHIBITOR SODIUM-BUTYRATE; MOUSE FORCED SWIM; WORKING-MEMORY; ACETYLCHOLINE-RECEPTORS; INDUCED ACTIVATION; ANXIOLYTIC-LIKE; IMMOBILIZATION STRESS; ANTAGONIST RIMONABANT	Like various stressors, the addictive use of nicotine (NC) is associated with emotional symptoms such as anxiety and depression, although the underlying mechanisms have not yet been fully elucidated due to the complicated involvement of target neurotransmitter systems. In the elicitation of these emotional symptoms, the fundamental involvement of epigenetic mechanisms such as histone acetylation has recently been suggested. Furthermore, among the interacting neurotransmitter systems implicated in the effects of NC and stressors, the endocannabinoid (ECB) system is considered to contribute indispensably to anxiety and depression. In the present study, the epigenetic involvement of histone acetylation induced by histone deacetylase (HDAC) inhibitors was investigated in anxiety-and depression- related behavioral alterations caused by NC and/or immobilization stress (IM). Moreover, based on the contributing roles of the ECB system, the interacting influence of ECB ligands on the effects of HDAC inhibitors was evaluated in order to examine epigenetic therapeutic interventions. Anxiety-like (elevated plus-maze test) and depression-like (forced swimming test) behaviors, which were observed in mice treated with repeated (4 days) NC (subcutaneous 0.8 mg/kg) and/or IM (10 min), were blocked by the HDAC inhibitors sodium butyrate (SB) and valproic acid (VA). The cannabinoid type 1 (CB1) agonist ACPA (arachidonylcyclopropylamide; AC) also antagonized these behaviors. Conversely, the CB1 antagonist SR 141716A (SR), which counteracted the effects of AC, attenuated the anxiolytic-like effects of the HDAC inhibitors commonly in the NC and/or IM groups. SR also attenuated the antidepressant-like effects of the HDAC inhibitors, most notably in the IM group. From these results, the combined involvement of histone acetylation and ECB system was shown in anxiety-and depression-related behaviors. In the NC treatment groups, the limited influence of SR against the HDAC inhibitor-induced antidepressant-like effects may reflect the characteristic involvement of histone acetylation within the NC-related neurotransmitter systems other than the ECB system.	[Hayase, Tamaki] Kyoto Univ, Dept Legal Med, Kyoto 6068501, Japan	Kyoto University	Hayase, T (corresponding author), Kyoto Univ, Dept Legal Med, Kyoto 6068501, Japan.	thayase@mri.biglobe.ne.jp						Alves SH, 2004, BEHAV PHARMACOL, V15, P37, DOI 10.1097/00008877-200402000-00005; Anderson SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048665; Andreasen JT, 2011, J PSYCHOPHARMACOL, V25, P1134, DOI 10.1177/0269881110391831; Andreasen JT, 2009, BEHAV PHARMACOL, V20, P286, DOI 10.1097/FBP.0b013e32832c713e; ARMARIO A, 1991, PHARMACOL BIOCHEM BE, V39, P373, DOI 10.1016/0091-3057(91)90194-7; Aronson KR, 2008, ANN BEHAV MED, V36, P259, DOI 10.1007/s12160-008-9068-1; Balerio GN, 2006, PSYCHOPHARMACOLOGY, V184, P504, DOI 10.1007/s00213-005-0251-9; Bambico FR, 2012, PROG NEURO-PSYCHOPH, V38, P88, DOI 10.1016/j.pnpbp.2012.02.006; Benekareddy M, 2011, BIOL PSYCHIAT, V70, P1024, DOI 10.1016/j.biopsych.2011.08.005; Biala G, 2009, J PHYSIOL PHARMACOL, V60, P113; Biala G, 2006, LIFE SCI, V79, P81, DOI 10.1016/j.lfs.2005.12.043; Braida D, 2007, EUR J PHARMACOL, V555, P156, DOI 10.1016/j.ejphar.2006.10.038; Bruijnzeel AW, 2012, NEUROSCI BIOBEHAV R, V36, P1418, DOI 10.1016/j.neubiorev.2012.02.015; Castino MR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124796; Chegini HR, 2014, BEHAV BRAIN RES, V261, P114, DOI 10.1016/j.bbr.2013.12.007; Chen YW, 2012, NEUROSCIENCE, V206, P155, DOI 10.1016/j.neuroscience.2011.12.009; Childs E, 2009, PSYCHOPHARMACOLOGY, V203, P1, DOI 10.1007/s00213-008-1359-5; Choi D, 2015, INT J PSYCHOPHYSIOL, V98, P470, DOI 10.1016/j.ijpsycho.2015.10.005; Cippitelli A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028142; CLARKE PBS, 1990, CIBA F SYMP, V152, P153; Cohen A, 2009, PSYCHOPHARMACOLOGY, V204, P541, DOI 10.1007/s00213-009-1486-7; D'Addario C, 2013, FEBS J, V280, P1905, DOI 10.1111/febs.12125; DEANGELIS L, 1995, PHARMACOL BIOCHEM BE, V52, P329, DOI 10.1016/0091-3057(95)00100-B; Dunlop BW, 2007, ARCH GEN PSYCHIAT, V64, P327, DOI 10.1001/archpsyc.64.3.327; Dyrvig M, 2012, BRAIN RES BULL, V88, P507, DOI 10.1016/j.brainresbull.2012.05.004; Edwards AC, 2011, NICOTINE TOB RES, V13, P677, DOI 10.1093/ntr/ntr058; Egashira N, 2008, EUR J PHARMACOL, V589, P117, DOI 10.1016/j.ejphar.2008.03.046; Faraday MM, 1999, PHARMACOL BIOCHEM BE, V62, P273, DOI 10.1016/S0091-3057(98)00159-2; Faraday MM, 2003, PHARMACOL BIOCHEM BE, V74, P325, DOI 10.1016/S0091-3057(02)00999-1; Faravelli C, 2012, CURR PHARM DESIGN, V18, P5663, DOI 10.2174/138161212803530907; Ferland CL, 2014, ENDOCRINOLOGY, V155, P2942, DOI 10.1210/en.2013-1918; File SE, 1996, PHARMACOL BIOCHEM BE, V54, P3, DOI 10.1016/0091-3057(95)02175-2; FILE SE, 1988, NEUROPSYCHOBIOLOGY, V20, P82, DOI 10.1159/000118478; File SE, 2000, PHARMACOL BIOCHEM BE, V66, P65, DOI 10.1016/S0091-3057(00)00198-2; Fisher DJ, 2012, BRAIN RES, V1429, P72, DOI 10.1016/j.brainres.2011.10.029; Fokos S, 2010, J PSYCHOPHARMACOL, V24, P767, DOI 10.1177/0269881109104904; Gagliano H, 2014, NEUROPHARMACOLOGY, V79, P75, DOI 10.1016/j.neuropharm.2013.10.031; Gangarossa G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019415; Gilbert DG, 1997, PSYCHOPHARMACOLOGY, V130, P197, DOI 10.1007/s002130050229; Gold PW, 2015, MOL PSYCHIATR, V20, P32, DOI 10.1038/mp.2014.163; Gonzalez-Aparicio R, 2014, NEUROBIOL DIS, V62, P416, DOI 10.1016/j.nbd.2013.10.008; Gozen O, 2013, SYNAPSE, V67, P545, DOI 10.1002/syn.21659; Griebel G, 2005, BIOL PSYCHIAT, V57, P261, DOI 10.1016/j.biopsych.2004.10.032; Grundey J, 2015, PSYCHOPHARMACOLOGY, V232, P2491, DOI 10.1007/s00213-015-3880-7; Grundey J, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00186; Gundersen BB, 2009, NEUROPHARMACOLOGY, V57, P67, DOI 10.1016/j.neuropharm.2009.04.008; Haring M, 2007, NEUROSCIENCE, V146, P1212, DOI 10.1016/j.neuroscience.2007.02.021; Haring M, 2013, NEUROPHARMACOLOGY, V65, P83, DOI 10.1016/j.neuropharm.2012.09.002; Haring M, 2012, NEUROSCIENCE, V204, P145, DOI 10.1016/j.neuroscience.2011.12.035; Hale MW, 2012, CELL MOL NEUROBIOL, V32, P695, DOI 10.1007/s10571-012-9827-1; Haller J, 2007, EUR J NEUROSCI, V25, P2445, DOI 10.1111/j.1460-9568.2007.05476.x; Han A, 2014, NEUROPHARMACOLOGY, V81, P292, DOI 10.1016/j.neuropharm.2014.02.017; Harrist A, 2004, SYNAPSE, V54, P200, DOI 10.1002/syn.20081; Hayase T, 2000, Nihon Arukoru Yakubutsu Igakkai Zasshi, V35, P402; Hayase T, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-76; Hayase T, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-20; Hayase Tamaki, 2011, BMC Pharmacology, V11, P6, DOI 10.1186/1471-2210-11-6; Hayase T, 2011, J TOXICOL SCI, V36, P31, DOI 10.2131/jts.36.31; Hermann H, 2002, NEUROSCIENCE, V109, P451, DOI 10.1016/S0306-4522(01)00509-7; Hill MN, 2006, NEUROPSYCHOPHARMACOL, V31, P2591, DOI 10.1038/sj.npp.1301092; Hill MN, 2004, EUR J PHARMACOL, V499, P291, DOI 10.1016/j.ejphar.2004.06.069; Hsu HR, 2007, EUR J PHARMACOL, V566, P124, DOI 10.1016/j.ejphar.2007.03.040; Hughes JR, 2007, NICOTINE TOB RES, V9, P315, DOI 10.1080/14622200701188919; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Ji SJ, 2014, BRAIN RES, V1577, P77, DOI 10.1016/j.brainres.2014.06.035; Jiang W, 2005, J CLIN INVEST, V115, P3104, DOI 10.1172/JCI25509; Kaplan GB, 2011, PHARMACOL BIOCHEM BE, V99, P217, DOI 10.1016/j.pbb.2011.01.009; Kelsey JE, 2009, BEHAV BRAIN RES, V203, P304, DOI 10.1016/j.bbr.2009.04.035; Kinlein SA, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00031; Kobayashi H, 2012, NEUROSCI RES, V72, P355, DOI 10.1016/j.neures.2011.12.009; Kotlyar M, 2011, NICOTINE TOB RES, V13, P492, DOI 10.1093/ntr/ntr011; Lanfumey L, 2008, NEUROSCI BIOBEHAV R, V32, P1174, DOI 10.1016/j.neubiorev.2008.04.006; Leventhal AM, 2013, DRUG ALCOHOL DEPEN, V133, P324, DOI 10.1016/j.drugalcdep.2013.06.015; Li S, 2006, PHARMACOL BIOCHEM BE, V85, P324, DOI 10.1016/j.pbb.2006.08.015; Liu D, 2014, EXP BIOL MED, V239, P330, DOI 10.1177/1535370213513987; Loughlin SE, 2006, J COMP NEUROL, V497, P575, DOI 10.1002/cne.20999; Lutfy K, 2006, J NEUROCHEM, V99, P1321, DOI 10.1111/j.1471-4159.2006.04217.x; Maldonado R, 2006, TRENDS NEUROSCI, V29, P225, DOI 10.1016/j.tins.2006.01.008; Mannucci C, 2011, NICOTINE TOB RES, V13, P239, DOI 10.1093/ntr/ntq242; Marco EM, 2004, BEHAV PHARMACOL, V15, P21, DOI 10.1097/00008877-200402000-00003; McEwen BS, 2012, NEUROPHARMACOLOGY, V62, P3, DOI 10.1016/j.neuropharm.2011.07.014; McLaughlin RJ, 2012, NEUROSCIENCE, V204, P134, DOI 10.1016/j.neuroscience.2011.07.052; McMahon LR, 2007, EUR J PHARMACOL, V569, P70, DOI 10.1016/j.ejphar.2007.04.054; Melis M, 2008, J NEUROSCI, V28, P13985, DOI 10.1523/JNEUROSCI.3221-08.2008; Mineur YS, 2016, NEUROPSYCHOPHARMACOL, V41, P1579, DOI 10.1038/npp.2015.316; Mineur YS, 2013, P NATL ACAD SCI USA, V110, P3573, DOI 10.1073/pnas.1219731110; Molteni R, 2010, J PSYCHOPHARMACOL, V24, P595, DOI 10.1177/0269881108099815; Moonat S, 2013, BIOL PSYCHIAT, V73, P763, DOI 10.1016/j.biopsych.2013.01.012; Morilak DA, 2005, PROG NEURO-PSYCHOPH, V29, P1214, DOI 10.1016/j.pnpbp.2005.08.007; MORSE DE, 1989, PSYCHOPHARMACOLOGY, V98, P539, DOI 10.1007/BF00441956; Nestler EJ, 2014, NEUROPHARMACOLOGY, V76, P259, DOI 10.1016/j.neuropharm.2013.04.004; Newman MB, 2001, PROG NEURO-PSYCHOPH, V25, P609, DOI 10.1016/S0278-5846(00)00178-0; Nikolaus S, 2010, REV NEUROSCIENCE, V21, P119; Nikolaus S, 2009, BEHAV BRAIN RES, V204, P32, DOI 10.1016/j.bbr.2009.06.009; Ookubo M, 2013, J PSYCHIATR RES, V47, P1204, DOI 10.1016/j.jpsychires.2013.05.028; Papadopoulos A, 2011, EUR NEUROPSYCHOPHARM, V21, P316, DOI 10.1016/j.euroneuro.2010.05.005; Parrott AC, 2004, PSYCHOL REP, V94, P33; Pastor V, 2011, J NEUROCHEM, V116, P636, DOI 10.1111/j.1471-4159.2010.07149.x; Patel S, 2004, ENDOCRINOLOGY, V145, P5431, DOI 10.1210/en.2004-0638; Pathak G, 2015, NEUROPHARMACOLOGY, V95, P434, DOI 10.1016/j.neuropharm.2015.04.026; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; PETRAGLIA F, 1986, NEUROENDOCRINOLOGY, V44, P320, DOI 10.1159/000124663; Philip NS, 2010, PSYCHOPHARMACOLOGY, V212, P1, DOI 10.1007/s00213-010-1932-6; Picciotto MR, 2008, PROG NEUROBIOL, V84, P329, DOI 10.1016/j.pneurobio.2007.12.005; Picciotto MR, 2000, NEUROPSYCHOPHARMACOL, V22, P451, DOI 10.1016/S0893-133X(99)00146-3; Picciotto MR, 2002, NEUROREPORT, V13, P1097, DOI 10.1097/00001756-200207020-00006; Popik P, 2005, EUR J PHARMACOL, V515, P128, DOI 10.1016/j.ejphar.2005.04.009; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Prini P, 2013, 36 C NAZ SOC IT FARM; Prior H, 2004, HIPPOCAMPUS, V14, P135, DOI 10.1002/hipo.10166; Rey AA, 2012, NEUROPSYCHOPHARMACOL, V37, P2624, DOI 10.1038/npp.2012.123; Richards JM, 2011, BIOL PSYCHOL, V88, P1, DOI 10.1016/j.biopsycho.2011.06.009; Riebe CJ, 2011, STRESS, V14, P384, DOI 10.3109/10253890.2011.586753; Rubino T, 2007, NEUROPSYCHOPHARMACOL, V32, P2036, DOI 10.1038/sj.npp.1301330; Sadri-Vakili G, 2007, HUM MOL GENET, V16, P1293, DOI 10.1093/hmg/ddm078; Sailaja BS, 2012, P NATL ACAD SCI USA, V109, pE3687, DOI 10.1073/pnas.1209990110; Scherma M, 2008, CNS NEUROL DISORD-DR, V7, P468, DOI 10.2174/187152708786927859; Schiltz CA, 2007, BIOL PSYCHIAT, V61, P127, DOI 10.1016/j.biopsych.2006.03.002; Schmidt HD, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a012047; Schmuckermair C, 2013, NEUROPSYCHOPHARMACOL, V38, P1234, DOI 10.1038/npp.2013.21; Shingo AS, 2005, J NEURAL TRANSM, V112, P1475, DOI 10.1007/s00702-005-0370-2; Spencer SJ, 2004, EUR J NEUROSCI, V20, P1008, DOI 10.1111/j.1460-9568.2004.03569.x; Steiner MA, 2008, PSYCHONEUROENDOCRINO, V33, P54, DOI 10.1016/j.psyneuen.2007.09.008; STOLERMAN IP, 1991, TRENDS PHARMACOL SCI, V12, P467, DOI 10.1016/0165-6147(91)90638-9; Stone EA, 2007, PROG NEURO-PSYCHOPH, V31, P1196, DOI 10.1016/j.pnpbp.2007.04.010; Subbanna S, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu028; Suemaru K, 2006, PHYSIOL BEHAV, V88, P545, DOI 10.1016/j.physbeh.2006.05.007; Suri D, 2014, INT J NEUROPSYCHOPH, V17, P289, DOI 10.1017/S1461145713001004; Takahashi E, 2008, EUR J PHARMACOL, V589, P149, DOI 10.1016/j.ejphar.2008.05.020; Takahashi RN, 2005, NEUROSCI LETT, V380, P270, DOI 10.1016/j.neulet.2005.01.049; Takamura N, 2014, PROG NEURO-PSYCHOPH, V50, P116, DOI 10.1016/j.pnpbp.2013.12.011; Taylor G, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1151; Terzian AL, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00049; Turner JR, 2011, NICOTINE TOB RES, V13, P48, DOI 10.1093/ntr/ntq206; Umka J, 2010, NEUROSCIENCE, V166, P15, DOI 10.1016/j.neuroscience.2009.11.073; Vialou V, 2013, ANNU REV PHARMACOL, V53, P59, DOI 10.1146/annurev-pharmtox-010611-134540; Viveros MP, 2007, BEHAV PHARMACOL, V18, P375, DOI 10.1097/FBP.0b013e3282d28fb4; Waddington CH, 2012, INT J EPIDEMIOL, V41, P10, DOI 10.1093/ije/dyr184; West R, 1997, AM J PSYCHIAT, V154, P1589, DOI 10.1176/ajp.154.11.1589; Wong CCY, 2011, ADDICTION, V106, P480, DOI 10.1111/j.1360-0443.2010.03321.x; World Health Organization, 2019, WHO REPORT GLOBAL TO; World Health Organization-WHO, 2013, WHO REP GLOB TOB EP; Xing B, 2013, BEHAV BRAIN RES, V243, P261, DOI 10.1016/j.bbr.2013.01.019; YOSHIDA T, 1994, PHYSIOL BEHAV, V55, P53, DOI 10.1016/0031-9384(94)90009-4	144	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0158950	10.1371/journal.pone.0158950	http://dx.doi.org/10.1371/journal.pone.0158950			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ9CO	27404492	gold, Green Published, Green Submitted			2022-12-27	WOS:000379508200023
J	Korbut, R; Mehrdana, F; Kania, PW; Larsen, MH; Frees, D; Dalsgaard, I; Jorgensen, LV				Korbut, Rozalia; Mehrdana, Foojan; Kania, Per Walter; Larsen, Marianne Halberg; Frees, Dorte; Dalsgaard, Inger; Jorgensen, Louise von Gersdorff			Antigen Uptake during Different Life Stages of Zebrafish (Danio rerio) Using a GFP-Tagged Yersinia ruckeri	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; INNATE IMMUNE-RESPONSE; RAINBOW-TROUT; AEROMONAS-SALMONICIDA; MODEL ORGANISM; GILL CELLS; IN-VITRO; SYSTEM; PROTEIN; TRANSPARENT	Immersion-vaccines (bacterins) are routinely used for aquacultured rainbow trout to protect against Yersinia ruckeri (Yr). During immersion vaccination, rainbow trout take up and process the antigens, which induce protection. The zebrafish was used as a model organism to study uptake mechanisms and subsequent antigen transport in fish. A genetically modified Yr was developed to constitutively express green fluorescent protein (GFP) and was used for bacterin production. Larval, juvenile and adult transparent zebrafish (tra:nac mutant) received a bath in the bacterin for up to 30 minutes. Samples were taken after 1 min, 15 min, 30 min, 2 h, 12 h and 24 h. At each sampling point fish were used for live imaging of the uptake using a fluorescence stereomicroscope and for immunohistochemistry (IHC). In adult fish, the bacterin could be traced within 30 min in scale pockets, skin, oesophagus, intestine and fins. Within two hours post bath (pb) Yr-antigens were visible in the spleen and at 24 h in liver and kidney. Bacteria were associated with the gills, but uptake at this location was limited. Antigens were rarely detected in the blood and never in the nares. In juvenile fish uptake of the bacterin was seen in the intestine 30 min pb and in the nares 2 hpb but never in scale pockets. Antigens were detected in the spleen 12 hpb. Zebrafish larvae exhibited major Yr uptake only in the mid-intestine enterocytes 24 hpb. The different life stages of zebrafish varied with regard to uptake locations, however the gut was consistently a major uptake site. Zebrafish and rainbow trout tend to have similar uptake mechanisms following immersion or bath vaccination, which points towards zebrafish as a suitable model organism for this aquacultured species.	[Korbut, Rozalia; Mehrdana, Foojan; Kania, Per Walter; Jorgensen, Louise von Gersdorff] Univ Copenhagen, Dept Vet Dis Biol, Lab Aquat Pathobiol, Frederiksberg, Denmark; [Larsen, Marianne Halberg; Frees, Dorte] Univ Copenhagen, Dept Vet Dis Biol, Food Safety & Zoonoses, Frederiksberg, Denmark; [Dalsgaard, Inger] Tech Univ Denmark, Natl Vet Inst, Sect Bacteriol & Pathol, Frederiksberg, Denmark	University of Copenhagen; University of Copenhagen; Technical University of Denmark	Jorgensen, LV (corresponding author), Univ Copenhagen, Dept Vet Dis Biol, Lab Aquat Pathobiol, Frederiksberg, Denmark.	lvgj@sund.ku.dk		Larsen, Marianne Halberg/0000-0001-6242-6937; Dalsgaard, Inger/0000-0003-2066-1060; Jorgensen, Louise von Gersdorff/0000-0002-6005-3249; Frees, Dorte/0000-0003-4946-2890	Danish Council for Independent Research, Technology and Production Sciences, LVGJ; Villum Foundation, Denmark [VKR022858]; Villum Fonden [00007220] Funding Source: researchfish	Danish Council for Independent Research, Technology and Production Sciences, LVGJ; Villum Foundation, Denmark; Villum Fonden(Villum Fonden)	This work was supported by the Danish Council for Independent Research, Technology and Production Sciences, (http://ufm.dk/en/research-and-innovation/councils-and-commissions/the-danish-council-for-independent-research) LVGJ. Grant no. VKR022858 to Kurt Buchmann from the Villum Foundation, Denmark. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel B, 2000, DEV DYNAM, V219, P155, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1052>3.3.CO;2-B; Berghmans S, 2005, BIOTECHNIQUES, V39, P227, DOI 10.2144/05392RV02; Cantas L, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-37; Chettri JK, 2012, DEV COMP IMMUNOL, V36, P463, DOI 10.1016/j.dci.2011.08.014; Chettri JK, 2013, VET IMMUNOL IMMUNOP, V154, P42, DOI 10.1016/j.vetimm.2013.04.001; Davidson AJ, 2004, ONCOGENE, V23, P7233, DOI 10.1038/sj.onc.1207943; Ellis A.E, 1988, FISH VACCINATION; Encinas P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-518; FERGUSON HW, 1976, J COMP PATHOL, V86, P377, DOI 10.1016/0021-9975(76)90005-0; Fishman MC, 2001, SCIENCE, V294, P1290, DOI 10.1126/science.1066652; Fortineau N, 2000, RES MICROBIOL, V151, P353, DOI 10.1016/S0923-2508(00)00158-3; Fuiman LA, 1998, COPEIA, P602, DOI 10.2307/1447790; Gomez-Requeni P, 2011, COMP BIOCHEM PHYS D, V6, P178, DOI 10.1016/j.cbd.2011.02.002; Handy RD, 2011, J FISH BIOL, V79, P821, DOI 10.1111/j.1095-8649.2011.03080.x; Harmache A, 2006, J VIROL, V80, P3655, DOI 10.1128/JVI.80.7.3655-3659.2006; Harvie EA, 2013, INFECT IMMUN, V81, P110, DOI 10.1128/IAI.00642-12; Herbomel P, 2001, DEV BIOL, V238, P274, DOI 10.1006/dbio.2001.0393; JOHNSON KA, 1982, J FISH DIS, V5, P207, DOI 10.1111/j.1365-2761.1982.tb00475.x; Jorgensen LV, 2011, J FISH DIS, V34, P749, DOI 10.1111/j.1365-2761.2011.01291.x; Khimmakthong U, 2013, MICROB PATHOGENESIS, V59-60, P33, DOI 10.1016/j.micpath.2013.03.001; Krauss J, 2013, BIOL OPEN, V2, P703, DOI 10.1242/bio.20135132; Kwok KWH, 2012, AQUAT TOXICOL, V120, P59, DOI 10.1016/j.aquatox.2012.04.012; Lam SH, 2004, DEV COMP IMMUNOL, V28, P9, DOI 10.1016/S0145-305X(03)00103-4; LaPatra S, 2015, VACCINE, V33, P771, DOI 10.1016/j.vaccine.2014.12.055; Ledent V, 2002, DEVELOPMENT, V129, P597; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Lin B, 2007, MOL IMMUNOL, V44, P295, DOI 10.1016/j.molimm.2006.03.001; Lister JA, 1999, DEVELOPMENT, V126, P3757; Lu AJ, 2014, FISH SHELLFISH IMMUN, V36, P229, DOI 10.1016/j.fsi.2013.11.007; Ludwig M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001269; McCollum CW, 2011, BIRTH DEFECTS RES C, V93, P67, DOI 10.1002/bdrc.20210; Meeker ND, 2008, DEV COMP IMMUNOL, V32, P745, DOI 10.1016/j.dci.2007.11.011; Ng ANY, 2005, DEV BIOL, V286, P114, DOI 10.1016/j.ydbio.2005.07.013; Novoa B, 2006, VACCINE, V24, P5806, DOI 10.1016/j.vaccine.2006.05.015; Novoa B, 2012, ADV EXP MED BIOL, V946, P253, DOI 10.1007/978-1-4614-0106-3_15; Ohtani M, 2014, PLOS ONE, V9; Press CM, 1999, FISH SHELLFISH IMMUN, V9, P309, DOI 10.1006/fsim.1998.0181; Rendueles O, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002815; Ribas L, 2014, REV AQUACULT, V6, P209, DOI 10.1111/raq.12041; ROBOHM RA, 1995, FISH SHELLFISH IMMUN, V5, P137, DOI 10.1016/S1050-4648(05)80023-3; Rodriguez I, 2008, FISH SHELLFISH IMMUN, V25, P239, DOI 10.1016/j.fsi.2008.05.002; Ruyra A, 2014, VACCINE, V32, P3955, DOI 10.1016/j.vaccine.2014.05.010; Sullivan C, 2008, FISH SHELLFISH IMMUN, V25, P341, DOI 10.1016/j.fsi.2008.05.005; TATNER MF, 1984, J FISH BIOL, V25, P95, DOI 10.1111/j.1095-8649.1984.tb04854.x; TORROBA M, 1993, HISTOL HISTOPATHOL, V8, P363; Traver D, 2003, ADV IMMUNOL, V81, P253; Ulloa PE, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00313; Ulloa PE, 2011, REV FISH BIOL FISHER, V21, P649, DOI 10.1007/s11160-011-9203-0; Uribe C, 2011, VET MED-CZECH, V56, P486, DOI 10.17221/3294-VETMED; Volff JN, 2005, HEREDITY, V94, P280, DOI 10.1038/sj.hdy.6800635; WALKER C, 1983, GENETICS, V103, P125; Wallace KN, 2005, MECH DEVELOP, V122, P157, DOI 10.1016/j.mod.2004.10.009; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002; Yoder JA, 2002, MICROBES INFECT, V4, P1469, DOI 10.1016/S1286-4579(02)00029-1; Zapata A, 2006, FISH SHELLFISH IMMUN, V20, P126, DOI 10.1016/j.fsi.2004.09.005; ZAPATA AG, 1987, J FISH BIOL, V31, P209, DOI 10.1111/j.1095-8649.1987.tb05315.x; Zhang ZH, 2012, FISH SHELLFISH IMMUN, V33, P36, DOI 10.1016/j.fsi.2012.03.031; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	58	12	12	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0158968	10.1371/journal.pone.0158968	http://dx.doi.org/10.1371/journal.pone.0158968			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27404564	Green Published, gold, Green Submitted			2022-12-27	WOS:000379508200024
J	Priller, JPR; Reid, S; Konein, P; Dietrich, P; Sonnewald, S				Priller, Johannes Peter Roman; Reid, Stephen; Konein, Patrick; Dietrich, Petra; Sonnewald, Sophia			The Xanthomonas campestris pv. vesicatoria Type-3 Effector XopB Inhibits Plant Defence Responses by Interfering with ROS Production	PLOS ONE			English	Article							PSEUDOMONAS-SYRINGAE EFFECTOR; APOPLASTIC OXIDATIVE BURST; NADPH OXIDASE RBOHD; ARABIDOPSIS INNATE IMMUNITY; SALICYLIC-ACID; III EFFECTORS; MOLECULAR CHARACTERIZATION; PATHOGEN INTERACTIONS; MICROBE INTERACTIONS; BACTERIAL PATHOGENS	The bacterial pathogen Xanthomonas campestris pv. vesicatoria 85-10 (Xcv) translocates about 30 type-3 effector proteins (T3Es) into pepper plants (Capsicum annuum) to suppress plant immune responses. Among them is XopB which interferes with PTI, ETI and sugar-mediated defence responses, but the underlying molecular mechanisms and direct targets are unknown so far. Here, we examined the XopB-mediated suppression of plant defence responses in more detail. Infection of susceptible pepper plants with Xcv lacking xopB resulted in delayed symptom development compared to Xcv wild type infection concomitant with an increased formation of salicylic acid (SA) and expression of pathogenesis-related (PR) genes. Expression of xopB in Arabidopsis thaliana promoted the growth of the virulent Pseudomonas syringae pv. tomato (Pst) DC3000 strain. This was paralleled by a decreased SA-pool and a lower induction of SA-dependent PR gene expression. The expression pattern of early flg22-responsive marker genes indicated that MAPK signalling was not altered in the presence of XopB. However, XopB inhibited the flg22-triggered burst of reactive oxygen species (ROS). Consequently, the transcript accumulation of AtOXI1, a ROS-dependent marker gene, was reduced in xopB-expressing Arabidopsis plants as well as callose deposition. The lower ROS production correlated with a low level of basal and flg22-triggered expression of apoplastic peroxidases and the NADPH oxidase RBOHD. Conversely, deletion of xopB in Xcv caused a higher production of ROS in leaves of susceptible pepper plants. Together our results demonstrate that XopB modulates ROS responses and might thereby compromise plant defence.	[Priller, Johannes Peter Roman; Reid, Stephen; Konein, Patrick; Sonnewald, Sophia] Univ Erlangen Nurnberg, Div Biochem, Dept Biol, Erlangen, Germany; [Dietrich, Petra] Univ Erlangen Nurnberg, Div Mol Plant Physiol, Dept Biol, Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Sonnewald, S (corresponding author), Univ Erlangen Nurnberg, Div Biochem, Dept Biol, Erlangen, Germany.	sophia.sonnewald@fau.de		Priller, Josef/0000-0001-7596-0979	Deutsche Forschungsgemeinschaft [SFB796]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported by a grant from the Deutsche Forschungsgemeinschaft to SS in the frame of collaborative research centre "reprogramming of host cells by microbial effectors" (SFB796; http://www.dfg.de/en/research_funding/programmes/list/projectdetails/index.jsp?id=52732026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Torres MA, 2010, PHYSIOL PLANTARUM, V138, P414, DOI 10.1111/j.1399-3054.2009.01326.x; Arnold DL, 2001, PHYSIOL MOL PLANT P, V58, P55, DOI 10.1006/pmpp.2000.0315; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Biemelt S, 2006, J PLANT PHYSIOL, V163, P307, DOI 10.1016/j.jplph.2005.10.011; Bindschedler LV, 2006, PLANT J, V47, P851, DOI 10.1111/j.1365-313X.2006.02837.x; Block A, 2005, PLANT PHYSIOL, V138, P1481, DOI 10.1104/pp.105.059246; Block A, 2008, CURR OPIN PLANT BIOL, V11, P396, DOI 10.1016/j.pbi.2008.06.007; Block A, 2014, NEW PHYTOL, V201, P1358, DOI 10.1111/nph.12626; Blume B, 2000, PLANT CELL, V12, P1425, DOI 10.1105/tpc.12.8.1425; Boldt R, 2001, J PLANT PHYSIOL, V158, P1591, DOI 10.1078/0176-1617-00571; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Bolouri Moghaddam MR, 2012, J EXP BOT, V63, P3989, DOI 10.1093/jxb/ers129; Boudsocq M, 2010, NATURE, V464, P418, DOI 10.1038/nature08794; Buttner D, 2010, FEMS MICROBIOL REV, V34, P107, DOI 10.1111/j.1574-6976.2009.00192.x; Caddick MX, 1998, NAT BIOTECHNOL, V16, P177, DOI 10.1038/nbt0298-177; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Choi HW, 2007, PLANT PHYSIOL, V145, P890, DOI 10.1104/pp.107.103325; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Collmer A, 2009, PLANT PHYSIOL, V150, P1623, DOI 10.1104/pp.109.140327; Daudi A, 2012, PLANT CELL, V24, P275, DOI 10.1105/tpc.111.093039; Deslandes L, 2012, TRENDS PLANT SCI, V17, P644, DOI 10.1016/j.tplants.2012.06.011; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Dubiella U, 2013, P NATL ACAD SCI USA, V110, P8744, DOI 10.1073/pnas.1221294110; Engelsdorf T, 2013, PLANT PHYSIOL, V162, P225, DOI 10.1104/pp.112.209676; Feng F, 2012, CURR OPIN PLANT BIOL, V15, P469, DOI 10.1016/j.pbi.2012.03.004; Feng F, 2012, NATURE, V485, P114, DOI 10.1038/nature10962; Ferreira SJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-93; Gao XQ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003127; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Guo M, 2009, MOL PLANT MICROBE IN, V22, P1069, DOI 10.1094/MPMI-22-9-1069; Hao HQ, 2014, PLANT CELL, V26, P1729, DOI 10.1105/tpc.113.122358; Hauck P, 2003, P NATL ACAD SCI USA, V100, P8577, DOI 10.1073/pnas.1431173100; He P, 2006, CELL, V125, P563, DOI 10.1016/j.cell.2006.02.047; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Herbers K, 1996, PLANT CELL, V8, P793, DOI 10.1105/tpc.8.5.793; Herbers K, 1996, FEBS LETT, V397, P239, DOI 10.1016/S0014-5793(96)01183-0; HOFGEN R, 1990, PLANT SCI, V66, P221, DOI 10.1016/0168-9452(90)90207-5; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kadota Y, 2015, PLANT CELL PHYSIOL, V56, P1472, DOI 10.1093/pcp/pcv063; Kadota Y, 2014, MOL CELL, V54, P43, DOI 10.1016/j.molcel.2014.02.021; Kocal N, 2008, PLANT PHYSIOL, V148, P1523, DOI 10.1104/pp.108.127977; Li L, 2014, CELL HOST MICROBE, V15, P329, DOI 10.1016/j.chom.2014.02.009; Lindeberg M, 2012, TRENDS MICROBIOL, V20, P199, DOI 10.1016/j.tim.2012.01.003; Liu YK, 2016, PLANT CELL REP, V35, P995, DOI 10.1007/s00299-016-1950-x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOGEMANN J, 1987, ANAL BIOCHEM, V163, P16, DOI 10.1016/0003-2697(87)90086-8; Macho AP, 2014, MOL CELL, V54, P263, DOI 10.1016/j.molcel.2014.03.028; Mammarella ND, 2015, PHYTOCHEMISTRY, V112, P110, DOI 10.1016/j.phytochem.2014.07.010; Munkvold KR, 2009, MOL PLANT PATHOL, V10, P777, DOI 10.1111/j.1364-3703.2009.00586.x; Navarro L, 2004, PLANT PHYSIOL, V135, P1113, DOI 10.1104/pp.103.036749; Noel L, 2001, MOL MICROBIOL, V41, P1271, DOI 10.1046/j.1365-2958.2001.02567.x; Nuhse TS, 2007, PLANT J, V51, P931, DOI 10.1111/j.1365-313X.2007.03192.x; O'Brien JA, 2012, PLANTA, V236, P765, DOI 10.1007/s00425-012-1696-9; O'Brien JA, 2012, PLANT PHYSIOL, V158, P2013, DOI 10.1104/pp.111.190140; Ogasawara Y, 2008, J BIOL CHEM, V283, P8885, DOI 10.1074/jbc.M708106200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Proels RK, 2014, MOL PLANT PATHOL, V15, P858, DOI 10.1111/mpp.12139; Ranf S, 2008, PLANT J, V53, P287, DOI 10.1111/j.1365-313X.2007.03342.x; Ranf S, 2011, PLANT J, V68, P100, DOI 10.1111/j.1365-313X.2011.04671.x; Rentel MC, 2004, NATURE, V427, P858, DOI 10.1038/nature02353; Rodriguez-Herva JJ, 2012, CELL MICROBIOL, V14, P669, DOI 10.1111/j.1462-5822.2012.01749.x; Roitsch T, 2004, TRENDS PLANT SCI, V9, P606, DOI 10.1016/j.tplants.2004.10.009; Salomon D, 2011, MOL PLANT MICROBE IN, V24, P305, DOI 10.1094/MPMI-09-10-0196; Schulze S, 2012, NEW PHYTOL, V195, P894, DOI 10.1111/j.1469-8137.2012.04210.x; Segonzac C, 2011, PLANT PHYSIOL, V156, P687, DOI 10.1104/pp.110.171249; Silhavy D, 2002, EMBO J, V21, P3070, DOI 10.1093/emboj/cdf312; Sinha AK, 2002, PLANT PHYSIOL, V128, P1480, DOI 10.1104/pp.010771; Smith JM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004578; Smith JM, 2014, PLANT PHYSIOL, V164, P440, DOI 10.1104/pp.113.229179; Sonnewald S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051763; Sun Y, 2009, SCIENCE, V342, P403; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Torres MA, 2005, NAT GENET, V37, P1130, DOI 10.1038/ng1639; Tsuda K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000772; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Voll LM, 2012, NEW PHYTOL, V195, P189, DOI 10.1111/j.1469-8137.2012.04129.x; White FF, 2009, MOL PLANT PATHOL, V10, P749, DOI 10.1111/j.1364-3703.2009.00590.x; Xiang TT, 2008, CURR BIOL, V18, P74, DOI 10.1016/j.cub.2007.12.020; Xin XF, 2013, ANNU REV PHYTOPATHOL, V51, P473, DOI 10.1146/annurev-phyto-082712-102321; Xu J, 2014, PLANT J, V77, P222, DOI 10.1111/tpj.12382; Zhang J, 2007, CELL HOST MICROBE, V1, P175, DOI 10.1016/j.chom.2007.03.006; Zhang J, 2010, MOL PLANT, V3, P783, DOI 10.1093/mp/ssq035; Zhang J, 2010, CELL HOST MICROBE, V7, P290, DOI 10.1016/j.chom.2010.03.007	84	17	17	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2016	11	7							e0159107	10.1371/journal.pone.0159107	http://dx.doi.org/10.1371/journal.pone.0159107			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CN	27398933	Green Published, Green Submitted, gold			2022-12-27	WOS:000379508100020
J	Anzai, J; Nagayasu-Tanaka, T; Terashima, A; Asano, T; Yamada, S; Nozaki, T; Kitamura, M; Murakami, S				Anzai, Jun; Nagayasu-Tanaka, Toshie; Terashima, Akio; Asano, Taiji; Yamada, Satoru; Nozaki, Takenori; Kitamura, Masahiro; Murakami, Shinya			Long-term Observation of Regenerated Periodontium Induced by FGF-2 in the Beagle Dog 2-Wall Periodontal Defect Model	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; GUIDED TISSUE REGENERATION; INTRA-BONY DEFECTS; IMPLANTATION; STIMULATION; MATURATION; THERAPY; CELLS; BFGF	The long-term stability and qualitative characteristics of periodontium regenerated by FGF-2 treatment were compared with normal physiological healing tissue controls in a Beagle dog 2-wall periodontal defect model 13 months after treatment by assessing tissue histology and three-dimensional microstructure using micro-computed tomography (mu CT). After FGF-2 (0.3%) or vehicle treatment at the defect sites, serial changes in the bone mineral content (BMC) were observed using periodic X-ray imaging. Tissues were harvested at 13 months, evaluated histomorphometrically, and the cortical bone volume and trabecular bone structure of the newly formed bone were analyzed using mu CT. FGF-2 significantly increased the BMC of the defect area at 2 months compared with that of the control group, and this difference was unchanged through 13 months. The cortical bone volume was significantly increased by FGF-2, but there was no difference between the groups in trabecular bone structure. Bone maturation was occurring in both groups because of the lower cortical volume and denser trabecular bone than what is found in intact bone. FGF-2 also increased the area of newly formed bone as assessed histomorphometrically, but the ratios of trabecular bone in the defect area were similar between the control and FGF-2 groups. These results suggest that FGF-2 stimulates neogenesis of alveolar bone that is of similar quality to that of the control group. The lengths of the regenerated periodontal ligament and cementum, measured as the distance from the defect bottom to the apical end of the gingival epithelium, and height and area of the newly formed bone in the FGF-2 group were larger than those in the control group. The present study demonstrated that, within the limitation of artificial periodontal defect model, the periodontal tissue regenerated by FGF-2 was maintained for 13 months after treatment and was qualitatively equivalent to that generated through the physiological healing process.	[Anzai, Jun; Nagayasu-Tanaka, Toshie; Terashima, Akio; Asano, Taiji] Kaken Pharmaceut Co LTD, Drug Res Ctr, Dept Pharmacol, Yamashina Ku, Kyoto, Japan; [Nagayasu-Tanaka, Toshie; Yamada, Satoru; Nozaki, Takenori; Kitamura, Masahiro; Murakami, Shinya] Osaka Univ, Grad Sch Dent, Dept Periodontol, Suita, Osaka, Japan	Kaken Pharmaceutical Co Ltd; Osaka University	Murakami, S (corresponding author), Osaka Univ, Grad Sch Dent, Dept Periodontol, Suita, Osaka, Japan.	ipshinya@dent.osaka-u.ac.jp		Murakami, Shinya/0000-0002-5230-452X	Kaken Pharmaceutical Co., LTD.	Kaken Pharmaceutical Co., LTD.(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Kaken Pharmaceutical Co., LTD. The funder provided support in the form of salaries for authors [JA, TNT, ST, AT, and TA], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Anzai J, 2010, BIOCHEM BIOPH RES CO, V403, P345, DOI 10.1016/j.bbrc.2010.11.032; Bartold PM, 2000, PERIODONTOL 2000, V24, P253, DOI 10.1034/j.1600-0757.2000.2240113.x; BERGLUNDH T, 1991, J CLIN PERIODONTOL, V18, P616, DOI 10.1111/j.1600-051X.1991.tb00099.x; Bouxsein ML, 2003, OSTEOPOROSIS INT, V14, pS118, DOI 10.1007/s00198-003-1489-x; Eickholz P, 2007, J PERIODONTOL, V78, P37, DOI 10.1902/jop.2007.060097; GOTTLOW J, 1993, J PERIODONTOL, V64, P1157, DOI 10.1902/jop.1993.64.11s.1157; Graziani F, 2005, J CLIN PERIODONTOL, V32, P905, DOI 10.1111/j.1600-051X.2005.00789.x; Hidaka T, 2012, ARCH ORAL BIOL, V57, P830, DOI 10.1016/j.archoralbio.2011.12.003; Huja SS, 2008, J MORPHOL, V269, P138, DOI 10.1002/jmor.10582; Kallai I, 2011, NAT PROTOC, V6, P105, DOI 10.1038/nprot.2010.180; Kim TG, 2009, J CLIN PERIODONTOL, V36, P589, DOI 10.1111/j.1600-051X.2009.01420.x; Kinoshita A, 1997, J PERIODONTOL, V68, P103, DOI 10.1902/jop.1997.68.2.103; Kitamura M, 2016, J BONE MINER RES, V31, P806, DOI 10.1002/jbmr.2738; Kitamura M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002611; Laurell L, 2006, J CLIN PERIODONTOL, V33, P596, DOI 10.1111/j.1600-051X.2006.00951.x; Lee JS, 2012, J CLIN PERIODONTOL, V39, P466, DOI 10.1111/j.1600-051X.2012.01862.x; Muller R, 2009, NAT REV RHEUMATOL, V5, P373, DOI 10.1038/nrrheum.2009.107; Murakami S, 2003, J PERIODONTAL RES, V38, P97, DOI 10.1034/j.1600-0765.2003.00640.x; Murakami S, 1999, J PERIODONTAL RES, V34, P425, DOI 10.1111/j.1600-0765.1999.tb02277.x; Nagayasu-Tanaka T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131870; Nakamura K, 1997, J ORTHOPAED RES, V15, P307, DOI 10.1002/jor.1100150222; NAKAMURA T, 1995, ENDOCRINOLOGY, V136, P1276, DOI 10.1210/en.136.3.1276; Nevins M, 2005, J PERIODONTOL, V76, P2205, DOI 10.1902/jop.2005.76.12.2205; NYMAN S, 1982, J CLIN PERIODONTOL, V9, P290, DOI 10.1111/j.1600-051X.1982.tb02095.x; Park JC, 2012, J CLIN PERIODONTOL, V39, P565, DOI 10.1111/j.1600-051X.2012.01868.x; Pun S, 2000, BONE, V27, P197, DOI 10.1016/S8756-3282(00)00312-4; Sculean A, 2015, PERIODONTOL 2000, V68, P7, DOI 10.1111/prd.12091; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; Shirakata Y, 2010, J CLIN PERIODONTOL, V37, P374, DOI 10.1111/j.1600-051X.2010.01539.x; Slotte C, 2007, J CLIN PERIODONTOL, V34, P977, DOI 10.1111/j.1600-051X.2007.01138.x; Stavropoulos A, 2004, J CLIN PERIODONTOL, V31, P939, DOI 10.1111/j.1600-051X.2004.00586.x; Takayama S, 2001, J DENT RES, V80, P2075, DOI 10.1177/00220345010800121001; Takeda K, 2005, TISSUE ENG, V11, P1618, DOI 10.1089/ten.2005.11.1618	33	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158485	10.1371/journal.pone.0158485	http://dx.doi.org/10.1371/journal.pone.0158485			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391131	Green Submitted, Green Published, gold			2022-12-27	WOS:000380005400067
J	Bhushan, C; Chong, MQ; Choi, S; Joshi, AA; Haldar, JP; Damasio, H; Leahy, RM				Bhushan, Chitresh; Chong, Minqi; Choi, Soyoung; Joshi, Anand A.; Haldar, Justin P.; Damasio, Hanna; Leahy, Richard M.			Temporal Non-Local Means Filtering Reveals Real-Time Whole-Brain Cortical Interactions in Resting fMRI	PLOS ONE			English	Article							HUMAN CONNECTOME PROJECT; FUNCTIONAL CONNECTIVITY; ARTIFACT REMOVAL; STATE FMRI; NETWORK; MRI; PARCELLATIONS; RESOLUTION; STRATEGY; IMAGES	Intensity variations over time in resting BOLD fMRI exhibit spatial correlation patterns consistent with a set of large scale cortical networks. However, visualizations of this data on the brain surface, even after extensive preprocessing, are dominated by local intensity fluctuations that obscure larger scale behavior. Our novel adaptation of non-local means (NLM) filtering, which we refer to as temporal NLM or tNLM, reduces these local fluctuations without the spatial blurring that occurs when using standard linear filtering methods. We show examples of tNLM filtering that allow direct visualization of spatio-temporal behavior on the cortical surface. These results reveal patterns of activity consistent with known networks as well as more complex dynamic changes within and between these networks. This ability to directly visualize brain activity may facilitate new insights into spontaneous brain dynamics. Further, temporal NLM can also be used as a preprocessor for resting fMRI for exploration of dynamic brain networks. We demonstrate its utility through application to graph-based functional cortical parcellation. Simulations with known ground truth functional regions demonstrate that tNLM filtering prior to parcellation avoids the formation of false parcels that can arise when using linear filtering. Application to resting fMRI data from the Human Connectome Project shows significant improvement, in comparison to linear filtering, in quantitative agreement with functional regions identified independently using task-based experiments as well as in test-retest reliability.	[Bhushan, Chitresh; Chong, Minqi; Choi, Soyoung; Joshi, Anand A.; Haldar, Justin P.; Leahy, Richard M.] Univ So Calif, Signal & Image Proc Inst, Los Angeles, CA USA; [Choi, Soyoung] Univ So Calif, Neurosci Grad Program, Los Angeles, CA USA; [Damasio, Hanna] Univ So Calif, Brain & Creat Inst Dornsife Coll Letters Arts & S, Los Angeles, CA USA	University of Southern California; University of Southern California; University of Southern California	Leahy, RM (corresponding author), Univ So Calif, Signal & Image Proc Inst, Los Angeles, CA USA.	leahy@sipi.usc.edu	Joshi, Anand/AAA-8378-2020; Bhushan, Chitresh/AAG-3305-2020; Haldar, Justin P/B-4983-2008	Joshi, Anand/0000-0002-9582-3848; Bhushan, Chitresh/0000-0002-2935-2515; Haldar, Justin P/0000-0002-1838-0211; Choi, So Young/0000-0001-7165-4691	National Institutes of Health [R01 NS089212, R01 NS074980, R01 EB009048]; 16 NIH Institutes and Centers [1U54MH091657]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH091657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089212, R01NS074980] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 16 NIH Institutes and Centers(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Clinical Center (CC)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by National Institutes of Health grants R01 NS089212, R01 NS074980 and R01 EB009048.; Data were provided [in part] by the Human Connectome Project, WU-Minn Consortium (Principal Investigators: David Van Essen and Kamil Ugurbil; 1U54MH091657) funded by the 16 NIH Institutes and Centers that support the NIH Blueprint for Neuroscience Research; and by the McDonnell Center for Systems Neuroscience at Washington University. This research was supported by NIH grants R01 NS089212, R01 NS074980 and R01 EB009048.	Angenent S, 1999, IEEE T MED IMAGING, V18, P700, DOI 10.1109/42.796283; [Anonymous], 2014, WU MINN HCP 500 SUBJ; ANTROBUS JS, 1970, T NEW YORK ACAD SCI, V32, P242, DOI 10.1111/j.2164-0947.1970.tb02056.x; Barch DM, 2013, NEUROIMAGE, V80, P169, DOI 10.1016/j.neuroimage.2013.05.033; Bernier M, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00715; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Blumensath T, 2013, NEUROIMAGE, V76, P313, DOI 10.1016/j.neuroimage.2013.03.024; Buades A, 2005, PROC CVPR IEEE, P60, DOI 10.1109/cvpr.2005.38; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2007, NEUROIMAGE, V37, P1091, DOI 10.1016/j.neuroimage.2007.01.010; Chambers MC, 2015, I S BIOMED IMAGING, P1364, DOI 10.1109/ISBI.2015.7164129; Coupe P, 2008, IEEE T MED IMAGING, V27, P425, DOI 10.1109/TMI.2007.906087; Craddock RC, 2012, HUM BRAIN MAPP, V33, P1914, DOI 10.1002/hbm.21333; Duna J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081390; Faro S. H., 2006, FUNCTIONAL MRI BASIC; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Fransson P, 2002, NEUROIMAGE, V16, P977, DOI 10.1006/nimg.2002.1079; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; GALE D, 1962, AM MATH MON, V69, P9, DOI 10.2307/2312726; Gibbons J.D., 2003, NONPARAMETRIC STAT I, V4th; Glasser MF, 2013, NEUROIMAGE, V80, P105, DOI 10.1016/j.neuroimage.2013.04.127; Joshi AA, 2009, IEEE T IMAGE PROCESS, V18, P1358, DOI 10.1109/TIP.2009.2016163; Kelly RE, 2010, J NEUROSCI METH, V189, P233, DOI 10.1016/j.jneumeth.2010.03.028; Khullar S, 2011, NEUROIMAGE, V54, P2867, DOI 10.1016/j.neuroimage.2010.10.063; Kruggel F, 1999, NEUROIMAGE, V10, P530, DOI 10.1006/nimg.1999.0490; Kundu P, 2013, P NATL ACAD SCI USA, V110, P16187, DOI 10.1073/pnas.1301725110; Li BJ, 2011, NEUROIMAGE, V58, P442, DOI 10.1016/j.neuroimage.2011.01.085; Manjon JV, 2008, MED IMAGE ANAL, V12, P514, DOI 10.1016/j.media.2008.02.004; Manjon JV, 2009, INT J BIOMED IMAGING, V2009, DOI 10.1155/2009/756897; Mikl M, 2008, MAGN RESON IMAGING, V26, P490, DOI 10.1016/j.mri.2007.08.006; Pruim RHR, 2015, NEUROIMAGE, V112, P267, DOI 10.1016/j.neuroimage.2015.02.064; Raichle ME, 2011, BRAIN CONNECT, V1, P3, DOI 10.1089/brain.2011.0019; Rydell J, 2008, IEEE J-STSP, V2, P891, DOI 10.1109/JSTSP.2008.2007826; Seo S, 2011, I S BIOMED IMAGING, P372, DOI 10.1109/ISBI.2011.5872426; Seo S, 2010, LECT NOTES COMPUT SC, V6363, P505; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; Smith SM, 2013, TRENDS COGN SCI, V17, P666, DOI 10.1016/j.tics.2013.09.016; Smith SM, 2013, NEUROIMAGE, V80, P144, DOI 10.1016/j.neuroimage.2013.05.039; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Song X, 2006, IEEE IMAGE PROC, P2857, DOI 10.1109/ICIP.2006.313025; St-Jean S, 2014, JOINT ANN M ISMRM ES, P758; Thirion B, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00167; Tohka J, 2008, NEUROIMAGE, V39, P1227, DOI 10.1016/j.neuroimage.2007.10.013; Triantafyllou C, 2006, NEUROIMAGE, V32, P551, DOI 10.1016/j.neuroimage.2006.04.182; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; Van Essen DC, 2012, CEREB CORTEX, V22, P2241, DOI 10.1093/cercor/bhr291; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Wiest-Daessle N, 2008, LECT NOTES COMPUT SC, V5242, P171, DOI 10.1007/978-3-540-85990-1_21; Wig GS, 2014, NEUROIMAGE, V93, P276, DOI 10.1016/j.neuroimage.2013.07.035; Wink AM, 2004, IEEE T MED IMAGING, V23, P374, DOI 10.1109/TMI.2004.824234; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Xing XX, 2013, 19 ANN M ORG HUM BRA, P2030; Yu SX, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P313, DOI 10.1109/iccv.2003.1238361; Zalesky A, 2014, P NATL ACAD SCI USA, V111, P10341, DOI 10.1073/pnas.1400181111; Zuo XN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026703	57	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158504	10.1371/journal.pone.0158504	http://dx.doi.org/10.1371/journal.pone.0158504			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391481	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400071
J	Kwiatek, M; Majka, M; Majka, J; Belter, J; Suchowilska, E; Wachowska, U; Wiwart, M; Wisniewska, H				Kwiatek, Michal; Majka, Maciej; Majka, Joanna; Belter, Jolanta; Suchowilska, Elzbieta; Wachowska, Urszula; Wiwart, Marian; Wisniewska, Halina			Intraspecific Polymorphisms of Cytogenetic Markers Mapped on Chromosomes of Triticum polonicum L.	PLOS ONE			English	Article							FUSARIUM HEAD BLIGHT; IN-SITU HYBRIDIZATION; RIBOSOMAL-RNA GENES; GENOME DIFFERENTIATION; TETRAPLOID WHEAT; B-GENOME; POLYPLOID WHEATS; BREAD WHEAT; EVOLUTION; AEGILOPS	Triticum genus encloses several tetraploid species that are used as genetic stocks for expanding the genetic variability of wheat (Triticum aestivum L.). Although the T. aestivum (2n = 6x = 42, AABBDD) and T. durum (2n = 4x = 28, AABB) karyotypes were well examined by chromosome staining, Giemsa C-banding and FISH markers, other tetraploids are still poorly characterized. Here, we established and compared the fluorescence in situ hybridization (FISH) patterns on chromosomes of 20 accessions of T. polonicum species using different repetitive sequences from BAC library of wheat 'Chinese Spring'. The chromosome patterns of Polish wheat were compared to tetraploid (2n = 4x = 28, AABB) Triticum species: T. durum, T. diccocon and T. turanicum, as well. A combination of pTa-86, pTa-535 and pTa-713 probes was the most informative among 6 DNA probes tested. Probe pTa-k374, which is similar to 28S rDNA sequence enabled to distinguish signal size and location differences, as well as rDNA loci elimination. Furthermore, pTa-465 and pTa-k566 probes are helpful for the detection of similar organized chromosomes. The polymorphisms of signals distribution were observed in 2A, 2B, 3B, 5B, 6A and 7B chromosomes. Telomeric region of the short arm of 6B chromosome was the most polymorphic. Our work is novel and contributes to the understanding of T. polonicum genome organization which is essential to develop successful advanced breeding strategies for wheat. Collection and characterization of this germplasm can contribute to the wheat biodiversity safeguard.	[Kwiatek, Michal; Majka, Maciej; Majka, Joanna; Belter, Jolanta; Wisniewska, Halina] Polish Acad Sci, Inst Plant Genet, Strzeszynska 34, PL-60479 Poznan, Poland; [Suchowilska, Elzbieta; Wiwart, Marian] Univ Warmia & Mazury, Dept Plant Breeding & Seed Prod, Pl Lodzki 3, PL-10727 Olsztyn, Poland; [Wachowska, Urszula] Univ Warmia & Mazury, Dept Entomol Phytopathol & Mol Diagnost, Pl Lodzki 3, PL-10727 Olsztyn, Poland	Polish Academy of Sciences; Institute of Plant Genetics of the Polish Academy of Sciences; University of Warmia & Mazury; University of Warmia & Mazury	Kwiatek, M (corresponding author), Polish Acad Sci, Inst Plant Genet, Strzeszynska 34, PL-60479 Poznan, Poland.	mkwi@igr.poznan.pl	Wiwart, Marian/ABC-4518-2020; Majka, Maciej/ABG-2805-2020; Wiwart, Marian/AAC-6367-2021; Kwiatek, Michał T./ABG-5673-2020	Wiwart, Marian/0000-0003-2693-7021; Majka, Maciej/0000-0002-5039-9465; Kwiatek, Michał T./0000-0001-9442-3124; Suchowilska, Elzbieta/0000-0002-8999-6742; Majka, Joanna/0000-0001-9918-2980; Wachowska, Urszula/0000-0002-9043-6128	National Science Centre [SONATA6-2013/11/D/NZ9/02719]	National Science Centre(National Science Centre, Poland)	This work was supported by grant from the National Science Centre (SONATA6-2013/11/D/NZ9/02719).	Akhunov ED, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-702; Badaeva ED, 2010, RUSS J GENET+, V46, P769, DOI 10.1134/S102279541007001X; Badaeva ED, 2004, PLANT SYST EVOL, V246, P45, DOI 10.1007/s00606-003-0072-4; Badaeva ED, 1996, GENOME, V39, P1150, DOI 10.1139/g96-145; Badaeva ED, 2002, PLANT SYST EVOL, V231, P163, DOI 10.1007/s006060200018; Badaeva ED, 2015, CYTOGENET GENOME RES, V146, P71, DOI 10.1159/000433458; Buerstmayr H, 2003, EUPHYTICA, V130, P17, DOI 10.1023/A:1022324727780; Cuadrado A, 2000, THEOR APPL GENET, V101, P711, DOI 10.1007/s001220051535; Cuadrado A, 2008, GENOME, V51, P809, DOI 10.1139/G08-065; Dean M, 2007, J CEREAL SCI, V46, P188, DOI 10.1016/j.jcs.2007.06.007; DUBCOVSKY J, 1995, GENETICS, V140, P1367; Dvorak J, LINNEAN, P127; Dvorak J, 2006, MOL BIOL EVOL, V23, P1386, DOI 10.1093/molbev/msl004; Endo TR, 1996, J HERED, V87, P295, DOI 10.1093/oxfordjournals.jhered.a023003; FLAVELL RB, 1974, BIOCHEM GENET, V12, P257, DOI 10.1007/BF00485947; GERLACH WL, 1980, NUCLEIC ACIDS RES, V8, P4851, DOI 10.1093/nar/8.21.4851; GERLACH WL, 1979, NUCLEIC ACIDS RES, V7, P1869, DOI 10.1093/nar/7.7.1869; GILL BS, 1974, P NATL ACAD SCI USA, V71, P4086, DOI 10.1073/pnas.71.10.4086; Goral T, 2015, PLANT PATHOLOGY J, V31, P226, DOI 10.5423/PPJ.OA.03.2015.0038; Grausgruber H, 2005, FIELD CROP RES, V91, P319, DOI 10.1016/j.fcr.2004.08.001; Guo X, 2014, PLANT CELL, V26, P4311, DOI 10.1105/tpc.114.129841; Heckmann S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5979; Heslop-Harrison JS, 2000, PLANT CELL, V12, P617, DOI 10.1105/tpc.12.5.617; JIANG JM, 1994, CHROMOSOMA, V103, P179, DOI 10.1007/BF00368010; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Komuro S, 2013, GENOME, V56, P131, DOI 10.1139/gen-2013-0003; Ksiazczyk T, 2011, J APPL GENET, V52, P305, DOI 10.1007/s13353-011-0048-y; Kubalakova M, 2005, GENETICS, V170, P823, DOI 10.1534/genetics.104.039180; Kwiatek M, 2016, PROTOPLASMA, V253, P329, DOI 10.1007/s00709-015-0813-6; Kwiatek M, 2015, J APPL GENET, V56, P163, DOI 10.1007/s13353-014-0264-3; Levy AA, 2002, PLANT PHYSIOL, V130, P1587, DOI 10.1104/pp.015727; LUKASZEWSKI AJ, 1995, CEREAL RES COMMUN, V23, P9; Matsuoka Y, 2004, THEOR APPL GENET, V109, P1710, DOI 10.1007/s00122-004-1806-6; Miller JD, 1998, CAN J PLANT PATHOL, V20, P95; MUKAI Y, 1993, CHROMOSOMA, V102, P88, DOI 10.1007/BF00356025; Oliver RE, 2008, CROP SCI, V48, P213, DOI 10.2135/cropsci2007.03.0129; Pedersen C, 1997, GENOME, V40, P589, DOI 10.1139/g97-077; Qi LL, 2007, CHROMOSOME RES, V15, P3, DOI 10.1007/s10577-006-1108-8; Rozen S, 2000, Methods Mol Biol, V132, P365; Salina EA, 2006, GENOME, V49, P1023, DOI 10.1139/G06-050; Salina EA, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-99; Salina EA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-414; Sears E.R., 1954, MISSOURI AGR EXPT ST, V572, P1; Stack RW, 2002, CROP SCI, V42, P637, DOI 10.2135/cropsci2002.0637; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384; Wisniewska H, 2013, J APPL GENET, V54, P435, DOI 10.1007/s13353-013-0171-z; Wisniewska Halina, 2005, Journal of Applied Genetics, V46, P35; Wiwart M, 2013, GENET RESOUR CROP EV, V60, P2359, DOI 10.1007/s10722-013-0004-2; Zaharieva MZ, 2010, GENET RESOUR CROP EV, V57, P937, DOI 10.1007/s10722-010-9572-6; Zhang P, 2004, CHROMOSOMA, V112, P288, DOI 10.1007/s00412-004-0273-9; Zohary D, 2000, DOMESTICATION PLANTS, V3, P316	51	13	13	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158883	10.1371/journal.pone.0158883	http://dx.doi.org/10.1371/journal.pone.0158883			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391447	Green Submitted, gold, Green Published			2022-12-27	WOS:000380005400148
J	Mather, AE; Reeve, R; Mellor, DJ; Matthews, L; Reid-Smith, RJ; Dutil, L; Haydon, DT; Reid, SWJ				Mather, Alison E.; Reeve, Richard; Mellor, Dominic J.; Matthews, Louise; Reid-Smith, Richard J.; Dutil, Lucie; Haydon, Daniel T.; Reid, Stuart W. J.			Detection of Rare Antimicrobial Resistance Profiles by Active and Passive Surveillance Approaches	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; FOOD ANIMALS; SALMONELLA; TYPHIMURIUM; ENVIRONMENT; DISEASE	Antimicrobial resistance (AMR) surveillance systems are generally not specifically designed to detect emerging resistances and usually focus primarily on resistance to individual drugs. Evaluating the diversity of resistance, using ecological metrics, allows the assessment of sampling protocols with regard to the detection of rare phenotypes, comprising combinations of resistances. Surveillance data of phenotypic AMR of Canadian poultry Salmonella Heidelberg and swine Salmonella Typhimurium var. 5- were used to contrast active (representative isolates derived from healthy animals) and passive (diagnostic isolates) surveillance and assess their suitability for detecting emerging resistance patterns. Although in both datasets the prevalences of resistance to individual antimicrobials were not significantly different between the two surveillance systems, analysis of the diversity of entire resistance phenotypes demonstrated that passive surveillance of diagnostic isolates detected more unique phenotypes. Whilst the most appropriate surveillance method will depend on the relevant objectives, under the conditions of this study, passive surveillance of diagnostic isolates was more effective for the detection of rare and therefore potentially emerging resistance phenotypes.	[Mather, Alison E.; Reeve, Richard; Mellor, Dominic J.; Matthews, Louise; Haydon, Daniel T.; Reid, Stuart W. J.] Univ Glasgow, Boyd Orr Ctr Populat & Ecosyst Hlth, Glasgow, Lanark, Scotland; [Mather, Alison E.; Mellor, Dominic J.; Reid, Stuart W. J.] Univ Glasgow, Sch Vet Med, Glasgow, Lanark, Scotland; [Reeve, Richard; Matthews, Louise; Haydon, Daniel T.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland; [Reid-Smith, Richard J.] Publ Hlth Agcy Canada, Guelph, ON, Canada; [Reid-Smith, Richard J.] Univ Guelph, Dept Populat Med, Guelph, ON, Canada; [Dutil, Lucie] Publ Hlth Agcy Canada, St Hyacinthe, PQ, Canada; [Mather, Alison E.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Reid, Stuart W. J.] Univ London, Royal Vet Coll, Hatfield, Herts, England	University of Glasgow; University of Glasgow; University of Glasgow; Public Health Agency of Canada; University of Guelph; Public Health Agency of Canada; University of Cambridge; University of London; University of London Royal Veterinary College	Mather, AE (corresponding author), Univ Glasgow, Boyd Orr Ctr Populat & Ecosyst Hlth, Glasgow, Lanark, Scotland.; Mather, AE (corresponding author), Univ Glasgow, Sch Vet Med, Glasgow, Lanark, Scotland.	am2382@cam.ac.uk	Reeve, Richard/K-9918-2015; Matthews, Louise/E-2913-2013	Reeve, Richard/0000-0003-2589-8091; Matthews, Louise/0000-0003-4420-8367	William Stewart Fellowship whilst at the University of Glasgow; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/M014088/1, BB/E010326/1, BB/L004070/1]; National Science Foundation [BB/L004070/1, BB/K01126X/1, BB/F015313/1, DEB1216040]; EU [264639]; BBSRC [BB/K01126X/1, BB/F015313/1, BB/M014088/1, BB/J020567/1, BB/L004070/1, BB/E010326/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K01126X/1, BB/F015313/1, BB/L004070/1, BB/E010326/1, BB/M014088/1, BB/J020567/1] Funding Source: researchfish	William Stewart Fellowship whilst at the University of Glasgow; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Science Foundation(National Science Foundation (NSF)); EU(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	AEM was supported by the William Stewart Fellowship whilst at the University of Glasgow, and is currently supported by Biotechnology and Biological Sciences Research Council (BBSRC) grant BB/M014088/1; RR is supported by BBSRC grant BB/E010326/1 and BB/L004070/1; LM is supported by BB/K01126X/1, BB/L004070/1, BB/F015313/1, National Science Foundation DEB1216040 and an EUfunded Marie Curie Initial Training Network (MCITN) program (NEMATODE SYSTEM HEALTH project (FP7-PEOPLE-2010-ITN-ID: 264639)). The funders played no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aarestrup FM, 2004, J VET MED B, V51, P380, DOI 10.1111/j.1439-0450.2004.00775.x; Afema JA, 2015, ZOONOSES PUBLIC HLTH, V62, P506, DOI 10.1111/zph.12172; Anderson RM, 1999, NAT MED, V5, P147, DOI 10.1038/5507; [Anonymous], CLSI PERF STAND ANT; Auguie B, 2017, GRIDEXTRA MISCELLANE; Bax R, 2001, CLIN MICROBIOL INFEC, V7, P316, DOI 10.1046/j.1198-743x.2001.00239.x; Beal RK, 2004, VET IMMUNOL IMMUNOP, V100, P151, DOI 10.1016/j.vetimm.2004.04.005; Brant R, 2010, CONFIDENCE INTERVALS; Canton R, 2005, CLIN MICROBIOL INFEC, V11, P3, DOI 10.1111/j.1469-0691.2005.01081.x; Caprioli A, 2000, MONITORING ANTIBIOTI, P295; Critchley IA, 2004, CLIN MICROBIOL INFEC, V10, P502, DOI 10.1111/j.1469-0691.2004.00911.x; Doherr MG, 2001, PHILOS T R SOC B, V356, P1097, DOI 10.1098/rstb.2001.0898; Fluit AC, 2006, CLIN MICROBIOL INFEC, V12, P410, DOI 10.1111/j.1469-0691.2006.01406.x; Gill J, 2000, EMERG INFECT DIS, V6, P30; Hadorn DC, 2008, VET RES, V39, DOI 10.1051/vetres:2008033; Hall BG, 2004, DRUG RESIST UPDATE, V7, P111, DOI 10.1016/j.drup.2004.02.003; Harrell, 2010, HMISC HARRELL MISCEL; Hawkey PM, 2008, J ANTIMICROB CHEMOTH, V62, pI1, DOI 10.1093/jac/dkn241; Johnson AP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0080; Johnson JM, 2005, CAN VET J, V46, P141; Laupland KB, 2007, CLIN INVEST MED, V30, pE159, DOI 10.25011/cim.v30i4.1777; Lewis D, 2002, J ANTIMICROB CHEMOTH, V49, P3, DOI 10.1093/jac/49.1.3; Livermore DM, 1998, BRIT MED J, V317, P614, DOI 10.1136/bmj.317.7159.614; Masterton RG, 2000, J ANTIMICROB CHEMOTH, V46, P53, DOI 10.1093/jac/46.suppl_2.53; Mather AE, 2012, P ROY SOC B-BIOL SCI, V279, P1630, DOI 10.1098/rspb.2011.1975; McEwan S. A., 2006, ANTIMICROBIAL RESIST, P397; Perencevich EN, 2004, CLIN INFECT DIS, V38, P1108, DOI 10.1086/382886; Perron GG, 2007, INFECT GENET EVOL, V7, P223, DOI 10.1016/j.meegid.2006.09.003; Poppe C, 2001, MICROB DRUG RESIST, V7, P197, DOI 10.1089/10766290152045084; Rempel OR, 2009, EPIDEMIOL INFECT, V137, P1665, DOI 10.1017/S0950268809990100; Renyi A., 1961, P 4 BERK S MATH STAT, P547; Sahm DF, 1997, INFECT DIS CLIN N AM, V11, P767, DOI 10.1016/S0891-5520(05)70389-5; Shannon KP, 2002, J ANTIMICROB CHEMOTH, V49, P201, DOI 10.1093/jac/49.1.201; Tapsall John W, 2003, Commun Dis Intell Q Rep, V27 Suppl, pS70; Vergison A, 2006, PEDIATRICS, V118, pE801, DOI 10.1542/peds.2005-3195; Wales AD, 2009, VET REC, V165, P648, DOI 10.1136/vr.165.22.648; WHO-AGISAR, 2010, WHO ADV GROUP INT SU	37	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158515	10.1371/journal.pone.0158515	http://dx.doi.org/10.1371/journal.pone.0158515			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391966	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000380005400075
J	Rosinach, M; Fernandez-Banares, F; Carrasco, A; Ibarra, M; Temino, R; Salas, A; Esteve, M				Rosinach, Merce; Fernandez-Banares, Fernando; Carrasco, Anna; Ibarra, Montserrat; Temino, Rocio; Salas, Antonio; Esteve, Maria			Double-Blind Randomized Clinical Trial: Gluten versus Placebo Rechallenge in Patients with Lymphocytic Enteritis and Suspected Celiac Disease	PLOS ONE			English	Article							INTRAEPITHELIAL LYMPHOCYTOSIS; SENSITIVITY; DUODENOSIS; DISORDERS; DIAGNOSIS; ETIOLOGY; SPECTRUM	Background The role of gluten as a trigger of symptoms in non-coeliac gluten sensitivity has been questioned. Aim To demonstrate that gluten is the trigger of symptoms in a subgroup of patients fulfilling the diagnostic criteria for non-coeliac gluten sensitivity (NCGS), which presented with lymphocytic enteritis, positive celiac genetics and negative celiac serology. Methods Double-blind randomized clinical trial of gluten vs placebo rechallenge. Inclusion criteria: >18 years of age, HLA-DQ2/8+, negative coeliac serology and gluten-dependent lymphocytic enteritis, and GI symptoms, with clinical and histological remission at inclusion. Eighteen patients were randomised: 11 gluten (20 g/day) and 7 placebo. Clinical symptoms, quality of life (GIQLI), and presence of gamma/delta+ cells and transglutaminase deposits were evaluated. Results 91% of patients had clinical relapse during gluten challenge versus 28.5% after placebo (p = 0.01). Clinical scores and GIQLI worsened after gluten but not after placebo (p<0.01). The presence of coeliac tissue markers at baseline biopsy on a gluten-free diet allowed classifying 9 out of the 18 (50%) patients as having probable 'coeliac lite' disease. Conclusion This proof-of-concept study indicates that gluten is the trigger of symptoms in a subgroup of patients fulfilling the diagnostic criteria for NCGS. They were characterized by positive celiac genetics, lymphocytic enteritis, and clinical and histological remission after a gluten-free diet.	[Rosinach, Merce; Fernandez-Banares, Fernando; Carrasco, Anna; Ibarra, Montserrat; Temino, Rocio; Esteve, Maria] Hosp Univ Mutua Terrassa, Dept Gastroenterol, Barcelona, Spain; [Rosinach, Merce; Fernandez-Banares, Fernando; Carrasco, Anna; Salas, Antonio; Esteve, Maria] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain; [Salas, Antonio] Hosp Univ Mutua Terrassa, Dept Pathol, Barcelona, Spain	Hospital Universitario Mutua Terrassa; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Hospital Universitario Mutua Terrassa	Fernandez-Banares, F (corresponding author), Hosp Univ Mutua Terrassa, Dept Gastroenterol, Barcelona, Spain.; Fernandez-Banares, F (corresponding author), Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain.	ffbanares@mutuaterrassa.es		Carrasco, Anna/0000-0001-8810-1583; ESTEVE, MARIA/0000-0002-3178-7008; ESTEVE, MARIA/0000-0001-7716-0027; Fernandez-Banares, Fernando/0000-0002-1489-504X	'Fundacion Mutua Madrilena' (Madrid, Spain)	'Fundacion Mutua Madrilena' (Madrid, Spain)	This study was funded by a grant from the 'Fundacion Mutua Madrilena' (Madrid, Spain). This sponsor had no role in the study design, acquisition, analysis or interpretation of the data, or the report writing.	Aziz I, 2010, ALIMENT PHARM THER, V32, P1392, DOI 10.1111/j.1365-2036.2010.04477.x; Aziz I, 2015, J CLIN GASTROENTEROL, V49, P477, DOI 10.1097/MCG.0000000000000184; Biesiekierski JR, 2013, GASTROENTEROLOGY, V145, P320, DOI 10.1053/j.gastro.2013.04.051; Biesiekierski JR, 2011, AM J GASTROENTEROL, V106, P508, DOI 10.1038/ajg.2010.487; Brown I, 2006, ARCH PATHOL LAB MED, V130, P1020; Camarero C, 2000, ACTA PAEDIATR, V89, P285, DOI 10.1080/080352500750028410; Catassi C, 2010, AM J MED, V123, P691, DOI 10.1016/j.amjmed.2010.02.019; Di Sabatino A, 2015, CLIN GASTROENTEROL H, V13, P1604, DOI 10.1016/j.cgh.2015.01.029; Ferch Courtney C, 2012, Gastroenterology, V142, P664, DOI 10.1053/j.gastro.2012.01.020; Fernandez-Banares F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101249; Hayat M, 2002, J CLIN PATHOL, V55, P393, DOI 10.1136/jcp.55.5.393; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; Husby S, 2014, J PEDIATR-US, V164, P436, DOI 10.1016/j.jpeds.2013.11.024; JAESCHKE R, 1990, CONTROL CLIN TRIALS, V11, P43, DOI 10.1016/0197-2456(90)90031-V; Kaukinen K, 2000, SCAND J GASTROENTERO, V35, P942, DOI 10.1080/003655200750022995; Koskinen O, 2010, J CLIN GASTROENTEROL, V44, P483, DOI 10.1097/MCG.0b013e3181b64557; Kurppa K, 2009, GASTROENTEROLOGY, V136, P816, DOI 10.1053/j.gastro.2008.11.040; Maglio M, 2011, DIGEST LIVER DIS, V43, P604, DOI 10.1016/j.dld.2011.01.015; Mahadeva S, 2002, J CLIN PATHOL, V55, P424, DOI 10.1136/jcp.55.6.424; Molina-Infante J, 2015, ALIMENT PHARM THER, V41, P807, DOI 10.1111/apt.13155; Polvi A, 1998, HUM IMMUNOL, V59, P169, DOI 10.1016/S0198-8859(98)00008-1; Quintana JM, 2001, REV ESP ENFERM DIG, V93, P700; Rosinach M, 2012, DIGEST LIVER DIS, V44, P643, DOI 10.1016/j.dld.2012.03.006; Rostami K, 2015, WORLD J GASTROENTERO, V21, P2593, DOI 10.3748/wjg.v21.i9.2593; Santolaria S, 2013, GASTROENT HEPAT-BARC, V36, P565, DOI 10.1016/j.gastrohep.2013.06.003; Sapone A, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-13; Sapone A, 2010, INT ARCH ALLERGY IMM, V152, P75, DOI 10.1159/000260087; Shahbazkhani B, 2015, NUTRIENTS, V7, P4542, DOI 10.3390/nu7064542; Volta U, 2015, BEST PRACT RES CL GA, V29, P477, DOI 10.1016/j.bpg.2015.04.006; Volta U, 2013, CELL MOL IMMUNOL, V10, P383, DOI 10.1038/cmi.2013.28; Zanini B, 2015, ALIMENT PHARM THER, V42, P968, DOI 10.1111/apt.13372	31	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0157879	10.1371/journal.pone.0157879	http://dx.doi.org/10.1371/journal.pone.0157879			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27392045	Green Submitted, Green Published, gold			2022-12-27	WOS:000380005400024
J	Sun, RS; Yang, YQ; Ran, XZ; Yang, T				Sun, Renshan; Yang, Yongqiang; Ran, Xinze; Yang, Tao			Calcium Influx of Mast Cells Is Inhibited by Aptamers Targeting the First Extracellular Domain of Orai1	PLOS ONE			English	Article							ACTIVATED CA2+ CHANNELS; CRAC CHANNEL; IL-2 PRODUCTION; T-LYMPHOCYTES; ION CHANNELS; RELEASE	Using the systematic evolution of ligands by exponential enrichment (SELEX) method, we identified oligonucleotides that bind to the first extracellular domain of the Orai1 protein with high affinities and high specificities. These ligands were isolated from a random singlestrand DNA (ssDNA) library with 40 randomized sequence positions, using synthesized peptides with amino acid sequences identical to the first extracellular domain of the Orai1 protein as the targets for SELEX selection. Seven aptamers were obtained after 12 rounds of SELEX. An enzyme-linked oligonucleotide assay (ELONA) was performed to determine the affinities of the aptamers. Aptamer Y1 had the highest affinity (Kd = 1.72x10(-8) mol/L) and was selected for functional experiments in mast cells. Using LAD2 cells with the human high-affinity IgE receptor and Ca2+ release activation channel (CRAC), we demonstrated that Aptamer Y1 blocked IgE-mediated beta-hexosaminidase release from cells triggered by biotin-IgE and streptavidin. A specific binding assay showed that Aptamer Y1 not only bound the Orai1 peptide specifically but also that the Orai1 peptide did not bind significantly to other random oligonucleotide molecules. Furthermore, Aptamer Y1 regulation of intracellular Ca2+ mobilization was investigated by probing intracellular Ca2+ with a Fluo-4-AM fluorescent probe. We found that Aptamer Y1 inhibits Ca2+ influx into antigen-activated mast cells. These results indicate that the target of Aptamer Y1 in the degranulation pathway is upstream of Ca2+ influx. Therefore, these oligonucleotide agents represent a novel class of CRAC inhibitors that may be useful in the fight against allergic diseases.	[Sun, Renshan; Yang, Yongqiang; Yang, Tao] Third Mil Med Univ, Daping Hosp, Inst Battle Surg, Dept Dermatol, Chongqing 400042, Peoples R China; [Ran, Xinze] Third Mil Med Univ, Coll Mil Prevent Med, Inst Combined Injury, Chongqing 400038, Peoples R China	Army Medical University; Army Medical University	Sun, RS (corresponding author), Third Mil Med Univ, Daping Hosp, Inst Battle Surg, Dept Dermatol, Chongqing 400042, Peoples R China.	pharma3061@163.com			National Natural Science Foundation of China [81571569]; National Natural Science Foundation of P.R. China [81571569]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of P.R. China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 81571569).; We thank Dr. Wei Sun for experimental assistance with laser confocal microscopy and providing helpful advice that contributed to this work, in the Third Military Medical University, China. This work was supported by the National Natural Science Foundation of P.R. China (Grants No. 81571569).	CHUNG SC, 1994, BRIT J PHARMACOL, V113, P861, DOI 10.1111/j.1476-5381.1994.tb17072.x; Derler I, 2012, FRONT BIOSCI-LANDMRK, V17, P1304, DOI 10.2741/3988; Di Capite JL, 2011, CURR OPIN ALLERGY CL, V11, P33, DOI 10.1097/ACI.0b013e32834232b0; Di Sabatino A, 2009, J IMMUNOL, V183, P3454, DOI 10.4049/jimmunol.0802887; Fahrner M, 2013, CHANNELS, V7, P330, DOI 10.4161/chan.26742; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2015, ANNU REV IMMUNOL, V33, P291, DOI 10.1146/annurev-immunol-032414-112212; Ishikawa J, 2003, J IMMUNOL, V170, P4441, DOI 10.4049/jimmunol.170.9.4441; Muik M, 2012, CELL MOL LIFE SCI, V69, P4163, DOI 10.1007/s00018-012-1072-8; Ni J, 2012, CANCER METAST REV, V31, P779, DOI 10.1007/s10555-012-9389-1; Ni X, 2011, CURR MED CHEM, V18, P4206, DOI 10.2174/092986711797189600; Nonaka Y, 2013, ANAL CHEM, V85, P1132, DOI 10.1021/ac303023d; Pan Q, 2014, MOL THER, V22, P940, DOI 10.1038/mt.2014.31; Prakriya M, 2001, J PHYSIOL-LONDON, V536, P3, DOI 10.1111/j.1469-7793.2001.t01-1-00003.x; Prakriya M, 2015, PHYSIOL REV, V95, P1383, DOI 10.1152/physrev.00020.2014; Rice LV, 2013, EUR J PHARMACOL, V704, P49, DOI 10.1016/j.ejphar.2013.02.022; Rysavy Noel M, 2014, Bioarchitecture, V4, P127, DOI 10.1080/19490992.2014.995516; Sutovska M, 2013, ADV EXP MED BIOL, V756, P39, DOI 10.1007/978-94-007-4549-0_6; Tabarzad M, 2016, PROTEIN J, V35, P81, DOI 10.1007/s10930-016-9653-2; Tang XL, 2014, J INFECTION, V69, P569, DOI 10.1016/j.jinf.2014.05.015; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zhang BD, 2012, INT ARCH ALLERGY IMM, V159, P23, DOI 10.1159/000335178; Zhang BD, 2011, J ALLERGY CLIN IMMUN, V127, P1522, DOI 10.1016/j.jaci.2011.02.005; Zhu J, 2014, IET NANOBIOTECHNOL, V8, P2, DOI 10.1049/iet-nbt.2013.0028	27	15	15	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158223	10.1371/journal.pone.0158223	http://dx.doi.org/10.1371/journal.pone.0158223			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27390850	gold, Green Published, Green Submitted			2022-12-27	WOS:000380005400038
J	Yaish, MW; Al-Lawati, A; Jana, GA; Patankar, HV; Glick, BR				Yaish, Mahmoud W.; Al-Lawati, Abbas; Jana, Gerry Aplang; Patankar, Himanshu Vishwas; Glick, Bernard R.			Impact of Soil Salinity on the Structure of the Bacterial Endophytic Community Identified from the Roots of Caliph Medic (Medicago truncatula)	PLOS ONE			English	Article							GROWTH-PROMOTING BACTERIA; PHOENIX-DACTYLIFERA L.; PSEUDOMONAS-PUTIDA UW4; 16S RIBOSOMAL-RNA; PLANT-GROWTH; SP-NOV.; 1-AMINOCYCLOPROPANE-1-CARBOXYLATE DEAMINASE; BONFERRONI PROCEDURE; MULTIPLE TESTS; SALT TOLERANCE	In addition to being a forage crop, Caliph medic (Medicago truncatula) is also a model legume plant and is used for research focusing on the molecular characterization of the interaction between rhizobia and plants. However, the endophytic microbiome in this plant is poorly defined. Endophytic bacteria play a role in supplying plants with the basic requirements necessary for growth and development. Moreover, these bacteria also play a role in the mechanism of salinity stress adaptation in plants. As a prelude to the isolation and utilization of these bacteria in Caliph medic farming, 41 bacterial OTUs were identified in this project from within the interior of the roots of this plant by pyrosequencing of the small ribosomal subunit gene (16S rDNA) using a cultivation-independent approach. In addition, the differential abundance of these bacteria was studied following exposure of the plants to salinity stress. About 29,064 high-quality reads were obtained from the sequencing of six libraries prepared from control and salinity-treated tissues. Statistical analysis revealed that the abundance of similar to 70% of the OTUs was significantly (p <= 0.05) altered in roots that were exposed to salinity stress. Sequence analysis showed a similarity between some of the identified species and other, known, growth-promoting bacteria, marine and salt-stressed soil-borne bacteria, and nitrogen-fixing bacterial isolates. Determination of the amendments to the bacterial community due to salinity stress in Caliph medic provides a crucial step toward developing an understanding of the association of these endophytes, under salt stress conditions, in this model plant. To provide direct evidence regarding their growth promoting activity, a group of endophytic bacteria were isolated from inside of plant roots using a cultivation-dependent approach. Several of these isolates were able to produce ACC-deaminase, ammonia and IAA; and to solubilize Zn+2 and PO4-3. This data is consistent with the predicted occurrence (based on cultivation-independent techniques) of these bacteria and provides some insight into the importance of the endophytic bacteria in Caliph medic when grown under normal and saline conditions.	[Yaish, Mahmoud W.; Al-Lawati, Abbas; Jana, Gerry Aplang; Patankar, Himanshu Vishwas] Sultan Qaboos Univ, Dept Biol, Coll Sci, Muscat, Oman; [Glick, Bernard R.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada	Sultan Qaboos University; University of Waterloo	Yaish, MW (corresponding author), Sultan Qaboos Univ, Dept Biol, Coll Sci, Muscat, Oman.	myaish@squ.edu.om	Yaish, Mahmoud W/F-7168-2014; Patankar, Himanshu/L-9643-2019	Yaish, Mahmoud W/0000-0002-5171-3014; Patankar, Himanshu/0000-0001-6739-2895; Jana, Gerry Aplang/0000-0002-0314-2392	Ministry of Agriculture and Fisheries; College of Science, Sultan Qaboos University, Oman	Ministry of Agriculture and Fisheries; College of Science, Sultan Qaboos University, Oman	This work was supported by the Ministry of Agriculture and Fisheries and the College of Science, Sultan Qaboos University, Oman. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Ministry of Agriculture and Fisheries and the College of Science, Sultan Qaboos University, Oman for funding this research project. Authors would like to thank Dr. Aliya Al-Ansari for the help in the bioinformatics analysis.	Ahn SJ, 1996, NUCLEIC ACIDS RES, V24, P2623, DOI 10.1093/nar/24.13.2623; Al-Lawati A, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15018299; Ali S, 2014, PLANT PHYSIOL BIOCH, V80, P160, DOI 10.1016/j.plaphy.2014.04.003; Barker D. G., 1990, Plant Molecular Biology Reporter, V8, P40, DOI 10.1007/BF02668879; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Chapman H.D., 1962, SOIL SCI SOC AM J, V93, P68, DOI [DOI 10.1097/00010694-196201000-00015, 10.12691/wjar-4-2-4, DOI 10.2136/SSSAJ1963.03615995002700010004X]; Cheng ZY, 2007, CAN J MICROBIOL, V53, P912, DOI 10.1139/W07-050; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Compant S, 2005, APPL ENVIRON MICROB, V71, P4951, DOI 10.1128/AEM.71.9.4951-4959.2005; Dong YM, 2003, APPL ENVIRON MICROB, V69, P1783, DOI 10.1128/AEM.69.3.1783-1790.2003; FURUKAWA K, 1989, J BACTERIOL, V171, P5467, DOI 10.1128/jb.171.10.5467-5472.1989; Gamalero E, 2010, J APPL MICROBIOL, V108, P236, DOI 10.1111/j.1365-2672.2009.04414.x; Gao W, 2013, ANTON LEEUW INT J G, V103, P485, DOI 10.1007/s10482-012-9830-z; Glick BR, 2004, ADV APPL MICROBIOL, V56, P291, DOI 10.1016/S0065-2164(04)56009-4; GLICK BR, 1995, CAN J MICROBIOL, V41, P109, DOI 10.1139/m95-015; Glick BR, 2012, PLANT GROWTH PROMOTI; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.1093/biomet/53.3-4.325; Gower JC, 1985, ENCY STAT SC, V5, P3; Gu J, 2007, INT J SYST EVOL MICR, V57, P250, DOI 10.1099/ijs.0.64522-0; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Han YL, 2015, J MICROBIOL BIOTECHN, V25, P1119, DOI 10.4014/jmb.1412.12053; HATTORI M, 1986, ANAL BIOCHEM, V152, P232, DOI 10.1016/0003-2697(86)90403-3; Ramirez-Bahena MH, 2013, INT J SYST EVOL MICR, V63, P1760, DOI 10.1099/ijs.0.041368-0; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Howieson J, 2004, SOIL BIOL BIOCHEM, V36, P1261, DOI 10.1016/j.soilbio.2004.04.008; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Jha B, 2012, PLANT SOIL, V356, P265, DOI 10.1007/s11104-011-0877-9; Jiang SM, 2008, MAR BIOL, V153, P945, DOI 10.1007/s00227-007-0866-y; Johnston-Monje D, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0233-3; Kem MP, 2015, BIOCHEMISTRY-US, V54, P744, DOI 10.1021/bi5013673; Khalifa AYZ, 2016, SAUDI J BIOL SCI, V23, P79, DOI 10.1016/j.sjbs.2015.06.008; Kloepper JW, 1996, BIOSCIENCE, V46, P406, DOI 10.2307/1312874; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lane D.J., 1991, NUCL ACID TECHNIQUES, P125; LIM HS, 1991, APPL ENVIRON MICROB, V57, P510, DOI 10.1128/AEM.57.2.510-516.1991; Lipson DA, 2004, APPL ENVIRON MICROB, V70, P2867, DOI 10.1128/AEM.70.5.2867-2879.2004; Magurran AE, 2013, MEASURING BIOL DIVER; Marques APGC, 2010, SOIL BIOL BIOCHEM, V42, P1229, DOI 10.1016/j.soilbio.2010.04.014; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; Metternicht G., 2008, REMOTE SENSING SOIL; Moradi A, 2011, AFR J MICROBIOL RES, V5, P144; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Nogi Y, 2014, INT J SYST EVOL MICR, V64, P1149, DOI 10.1099/ijs.0.058321-0; Oggerin M, 2011, INT J SYST EVOL MICR, V61, P1757, DOI 10.1099/ijs.0.032805-0; Pan E, 2012, ORG LETT, V14, P2390, DOI 10.1021/ol300806e; Peel MD, 2004, CROP SCI, V44, P2049, DOI 10.2135/cropsci2004.2049; Pei AY, 2010, APPL ENVIRON MICROB, V76, P3886, DOI 10.1128/AEM.02953-09; Penrose DM, 2003, PHYSIOL PLANTARUM, V118, P10, DOI 10.1034/j.1399-3054.2003.00086.x; Pikovskaya R.I., 1948, MIKROBIOLOGIYA, V17, pe370; Pini F, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-78; Postnikova OA, 2013, PLANT CELL PHYSIOL, V54, P1041, DOI 10.1093/pcp/pct056; Rashid S, 2012, APPL SOIL ECOL, V61, P217, DOI 10.1016/j.apsoil.2011.09.011; Ryan RP, 2008, FEMS MICROBIOL LETT, V278, P1, DOI 10.1111/j.1574-6968.2007.00918.x; SARGENT MG, 1980, J GEN MICROBIOL, V116, P511; Sauvetre A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00083; Setia R, 2013, SCI TOTAL ENVIRON, V465, P267, DOI 10.1016/j.scitotenv.2012.08.028; Siddikee MA, 2011, PLANT PHYSIOL BIOCH, V49, P427, DOI 10.1016/j.plaphy.2011.01.015; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Spain AM, 2009, ISME J, V3, P992, DOI 10.1038/ismej.2009.43; Stajkovic O., 2009, Botanica Serbica, V33, P107; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Suarez C, 2014, INT J SYST EVOL MICR, V64, P481, DOI 10.1099/ijs.0.054817-0; Suarez R, 2008, MOL PLANT MICROBE IN, V21, P958, DOI 10.1094/MPMI-21-7-0958; Szilagyi-Zecchin VJ, 2014, AMB EXPRESS, V4, DOI 10.1186/s13568-014-0026-y; Szymanska Sonia, 2013, Ecological Questions, V18, P9, DOI 10.2478/ecoq-2013-0001; Tewari S, 2014, CURR MICROBIOL, V69, P484, DOI 10.1007/s00284-014-0612-x; Timmusk S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096086; Trujillo ME, 2010, ISME J, V4, P1265, DOI 10.1038/ismej.2010.55; Vurukonda SSKP, 2016, MICROBIOL RES, V184, P13, DOI 10.1016/j.micres.2015.12.003; Wang Y, 2008, INT J SYST EVOL MICR, V58, P2065, DOI 10.1099/ijs.0.65436-0; Widada J, 2002, CHEMOSPHERE, V49, P485, DOI 10.1016/S0045-6535(02)00334-X; Xu J, 2014, ISOLATION ASSESSMENT; Yaish MW, 2015, GENET MOL RES, V14, P9943, DOI 10.4238/2015.August.19.30; Yaish MW, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00348; Yaish MW, 2015, ANTON LEEUW INT J G, V107, P1519, DOI 10.1007/s10482-015-0445-z; Yan YL, 2008, P NATL ACAD SCI USA, V105, P7564, DOI 10.1073/pnas.0801093105; Zhang H, 2008, MOL PLANT MICROBE IN, V21, P737, DOI 10.1094/MPMI-21-6-0737; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zhao BS, 2010, INT J SYST EVOL MICR, V60, P1125, DOI 10.1099/ijs.0.013201-0	81	58	60	3	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159007	10.1371/journal.pone.0159007	http://dx.doi.org/10.1371/journal.pone.0159007			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391592	gold, Green Published, Green Submitted			2022-12-27	WOS:000380005400188
J	Zhang, GF; Lovei, GL; Wu, X; Wan, FH				Zhang, Gui Fen; Lovei, Gabor L.; Wu, Xia; Wan, Fang Hao			Presence of Native Prey Does Not Divert Predation on Exotic Pests by Harmonia axyridis in Its Indigenous Range	PLOS ONE			English	Article							FRANKLINIELLA-OCCIDENTALIS PERGANDE; CLASSICAL BIOLOGICAL-CONTROL; BEMISIA-TABACI; ALTERNATIVE PREY; NATURAL ENEMIES; INVERTEBRATE PREDATORS; HEMIPTERA ALEYRODIDAE; APPARENT COMPETITION; PALLAS COLEOPTERA; MOLECULAR MARKERS	In China, two invasive pests, Bemisia tabaci MEAM1 (Gennadius) and Frankliniella occidentalis (Pergande), often co-occur with the native pest, Aphis gossypii (Glover), on plants of Malvaceae and Cucurbitaceae. All three are preyed on by the native ladybird, Harmonia axyridis (Pallas); however, the native predator might be expected to prefer native prey to the exotic ones due to a shared evolutionary past. In order to clarify whether the presence of native prey affected the consumption of these two invasive species by the native predator, field-cage experiments were conducted. A duplex qPCR was used to simultaneously detect both non-native pests within the gut of the predator. H. axyridis readily accepted both invasive prey species, but preferred B. tabaci. With all three prey species available, H. axyridis consumption of B. tabaci was 39.3 +/- 2.2% greater than consumption of F. occidentalis. The presence of A. gossypii reduced (by 59.9% on B. tabaci, and by 60.6% on F. occidentalis), but did not stop predation on the two exotic prey when all three were present. The consumption of B. tabaci was similar whether it was alone or together with A. gossypii. However, the presence of aphids reduced predation on the invasive thrips. Thus, some invasive prey may be incorporated into the prey range of a native generalist predator even in the presence of preferred native prey.	[Zhang, Gui Fen; Lovei, Gabor L.; Wu, Xia; Wan, Fang Hao] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China; [Lovei, Gabor L.] Aarhus Univ, Dept Agroecol, Flakkebjerg Res Ctr, Slagelse, Denmark; [Wan, Fang Hao] Qingdao Agr Univ, Coll Agron & Plant Protect, Qingdao, Shandong, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Aarhus University; Qingdao Agricultural University	Zhang, GF; Wan, FH (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China.; Wan, FH (corresponding author), Qingdao Agr Univ, Coll Agron & Plant Protect, Qingdao, Shandong, Peoples R China.	zhangguifen@caas.cn; wanfanghao@caas.cn	Lövei, Gabor L./B-7763-2008	Lövei, Gabor L./0000-0002-6467-9812	National Natural Science Foundation of China [30971967, 31572067]; National Basic Research Program of China [2009CB119200]; Commonwealth Special Fund for the Agricultural Industry [201103026, 201303019, 201409061]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Commonwealth Special Fund for the Agricultural Industry	This study was supported by the National Natural Science Foundation of China (30971967, 31572067) to GFZ; the National Basic Research Program of China (2009CB119200) to FHW; and the Commonwealth Special Fund for the Agricultural Industry (201103026, 201303019, 201409061) to GFZ and FHW. GFZ and FHW prepared the manuscript.	Agusti N, 2003, MOL ECOL, V12, P3467, DOI 10.1046/j.1365-294X.2003.02014.x; Asplen MK, 2015, J PEST SCI, V88, P469, DOI 10.1007/s10340-015-0681-z; Bailey SF, 1940, J ECON ENTOMOL, V33, P133, DOI 10.1093/jee/33.1.133; Berkvens N, 2008, BIOCONTROL, V53, P211, DOI 10.1007/s10526-007-9130-0; Bompard A, 2013, POPUL ECOL, V55, P433, DOI 10.1007/s10144-013-0371-8; Caraguel CGB, 2011, J VET DIAGN INVEST, V23, P2, DOI 10.1177/104063871102300102; Carlsson NOL, 2009, FRONT ECOL ENVIRON, V7, P525, DOI 10.1890/080093; Chailleux A, 2014, PEST MANAG SCI, V70, P1769, DOI 10.1002/ps.3916; Colares F, 2015, J ECON ENTOMOL, V108, P2546, DOI 10.1093/jee/tov235; Colares F, 2015, BIOL CONTROL, V90, P16, DOI 10.1016/j.biocontrol.2015.05.009; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; DeBach P, 1964, BIOL CONTROL INSECT; deRivera CE, 2005, ECOLOGY, V86, P3364, DOI 10.1890/05-0479; Desneux N, 2008, B ENTOMOL RES, V98, P631, DOI 10.1017/S0007485308006238; Desneux N, 2010, J PEST SCI, V83, P197, DOI 10.1007/s10340-010-0321-6; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Elton C. S., 1958, ECOLOGY INVASIONS AN; Enkegaard A, 2001, ENTOMOL EXP APPL, V101, P81, DOI 10.1023/A:1019230603364; Gariepy TD, 2007, J APPL ENTOMOL, V131, P225, DOI 10.1111/j.1439-0418.2007.01145.x; Gomez-Polo P, 2014, J PEST SCI, V87, P371, DOI 10.1007/s10340-013-0550-6; HAN Y, 1997, EC INSECT FAUNA CHIN, P263; Harper GL, 2005, MOL ECOL, V14, P819, DOI [10.1111/j.1365-294X.2005.02442.x, 10.1111/j.1365-294x.2005.02442.x]; Harwood JD, 2007, MOL ECOL, V16, P4390, DOI 10.1111/j.1365-294X.2007.03482.x; Hoddle MS, 2004, CONSERV BIOL, V18, P38, DOI 10.1111/j.1523-1739.2004.00249.x; Hodek I., 1996, ECOLOGY COCCINELLIDA; Hodek Ivo, 2012, P141; HOLLINGSWORTH RG, 1994, J ECON ENTOMOL, V87, P293, DOI 10.1093/jee/87.2.293; HOLT RD, 1977, THEOR POPUL BIOL, V12, P197, DOI 10.1016/0040-5809(77)90042-9; HOLT RD, 1994, ANNU REV ECOL SYST, V25, P495, DOI 10.1146/annurev.es.25.110194.002431; Horowitz AR, 2005, ARCH INSECT BIOCHEM, V58, P216, DOI 10.1002/arch.20044; HOWARTH FG, 1991, ANNU REV ENTOMOL, V36, P485, DOI 10.1146/annurev.en.36.010191.002413; Jaworski CC, 2015, J PEST SCI, V88, P793, DOI 10.1007/s10340-015-0698-3; Jaworski CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082231; Jensen K, 2012, P ROY SOC B-BIOL SCI, V279, P2212, DOI 10.1098/rspb.2011.2410; Jensen Sten E., 2000, Integrated Pest Management Reviews, V5, P131, DOI 10.1023/A:1009600426262; Jiao XG, 2014, J PEST SCI, V87, P629, DOI 10.1007/s10340-014-0594-2; Kenis M., 2008, HARMONIA AXYRIDIS IN; Kirk WDJ, 2003, AGR FOREST ENTOMOL, V5, P301, DOI 10.1046/j.1461-9563.2003.00192.x; Koch R L, 2003, J Insect Sci, V3, P32; Levine JM, 2004, ECOL LETT, V7, P975, DOI 10.1111/j.1461-0248.2004.00657.x; Liu HC, 1989, CHINESE J BIOL CONT, V2, P92; Lockwood JL, 2007, INVASION ECOLOGY; Lovei GL, 2012, TRENDS ECOL EVOL, V27, P2, DOI 10.1016/j.tree.2011.10.009; Luo Chen, 2002, Acta Entomologica Sinica, V45, P759; Mayntz D, 2005, SCIENCE, V307, P111, DOI 10.1126/science.1105493; Michaud JP, 2008, ENTOMOL EXP APPL, V126, P40, DOI 10.1111/j.1570-7458.2007.00636.x; Michaud JP, 2002, ENVIRON ENTOMOL, V31, P827, DOI 10.1603/0046-225X-31.5.827; Michaud JP, 2005, EUR J ENTOMOL, V102, P385, DOI 10.14411/eje.2005.055; Michaud JP, 2002, ANN ENTOMOL SOC AM, V95, P531, DOI 10.1603/0013-8746(2002)095[0531:CBCACR]2.0.CO;2; Moreno-Ripoll R, 2014, J PEST SCI, V87, P133, DOI 10.1007/s10340-013-0522-x; MURDOCH WW, 1985, AM NAT, V125, P344, DOI 10.1086/284347; MURDOCH WW, 1969, ECOL MONOGR, V39, P335, DOI 10.2307/1942352; Nedved O, 2008, EUR J ENTOMOL, V105, P431, DOI 10.14411/eje.2008.055; O'Gorman EJ, 2009, P NATL ACAD SCI USA, V106, P13393, DOI 10.1073/pnas.0903682106; Oliveira MRV, 2001, CROP PROT, V20, P709, DOI 10.1016/S0261-2194(01)00108-9; Pettersson Jan, 2012, P444; Pimentel D, 2001, AGR ECOSYST ENVIRON, V84, P1, DOI 10.1016/S0167-8809(00)00178-X; Pysek P, 2010, P NATL ACAD SCI USA, V107, P12157, DOI 10.1073/pnas.1002314107; Rao Q, 2012, J INTEGR AGR, V11, P321, DOI 10.1016/S2095-3119(12)60016-1; SAS Institute Inc, 2006, P US MAN VERS 8; Schmidt JM, 2014, MOL ECOL, V23, P3777, DOI 10.1111/mec.12734; Seo Mi Ja, 2000, Korean Journal of Applied Entomology, V39, P59; SILVER ARJ, 1995, PESTIC SCI, V43, P21, DOI 10.1002/ps.2780430104; Simberloff D, 1996, ECOLOGY, V77, P1965, DOI 10.2307/2265693; Sint D, 2012, METHODS ECOL EVOL, V3, P898, DOI 10.1111/j.2041-210X.2012.00215.x; Symondson WOC, 2002, ANNU REV ENTOMOL, V47, P561, DOI 10.1146/annurev.ento.47.091201.145240; van Steenis M., 1995, THESIS; Wang Na, 2007, Acta Agriculturae Zhejiangensis, V19, P346; Wang Su, 2007, Yingyong Shengtai Xuebao, V18, P2117; XU RM, 1984, Z ANGEW ENTOMOL, V97, P305; Yang R., 2009, RES BIOL INVASIONS C, P10; Zappala L, 2013, J PEST SCI, V86, P635, DOI 10.1007/s10340-013-0531-9; Zhang GF, 2012, J APPL ENTOMOL, V136, P410, DOI 10.1111/j.1439-0418.2011.01661.x; Zhang GF, 2007, ENTOMOL EXP APPL, V123, P81, DOI 10.1111/j.1570-7458.2007.00528.x; Zhang GF, 2007, MOL ECOL NOTES, V7, P947, DOI 10.1111/j.1471-8286.2007.01819.x; Zhang GF, 2014, ENTOMOL EXP APPL, V150, P66, DOI 10.1111/eea.12134; Zhang GF, 2011, ENVIRON ENTOMOL, V40, P140, DOI 10.1603/EN10135; [张友军 Zhang Youjun], 2011, [植物保护, Plant Protection], V37, P1; 张友军, 2003, [植物保护, Plant Protection], V29, P58	79	2	4	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159048	10.1371/journal.pone.0159048	http://dx.doi.org/10.1371/journal.pone.0159048			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391468	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400200
J	Jones, K; Ballesteros, A; Mentink-Kane, M; Warren, J; Rattila, S; Malech, H; Kang, E; Dveksler, G				Jones, Karlie; Ballesteros, Angela; Mentink-Kane, Margaret; Warren, James; Rattila, Shemona; Malech, Harry; Kang, Elizabeth; Dveksler, Gabriela			PSG9 Stimulates Increase in FoxP3(+) Regulatory T-Cells through the TGF-beta 1 Pathway	PLOS ONE			English	Article							LATENT TGF-BETA; PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN; GROWTH-FACTOR-BETA; TRANSCRIPTION FACTOR FOXP3; GLYCOPROTEIN 1 PSG1; CUTTING EDGE; EXPRESSION; ACTIVATION; RECEPTOR; SURFACE	The pregnancy-specific glycoproteins (PSGs) are a family of proteins secreted by the syncytiotrophoblast of the placenta and are the most abundant trophoblastic proteins in maternal blood during the third trimester. The human PSG family consists of 10 protein-coding genes, some of which have a possible role in maintaining maternal immune tolerance to the fetus. PSG9 was reported as a potential predictive biomarker of pre-eclampsia, a serious complication of pregnancy that has been related to immunological dysfunction at the fetal-maternal interface. Therefore, we hypothesized that PSG9 may have an immunoregulatory role during pregnancy. We found that PSG9 binds to LAP and activates the latent form of TGF-beta 1. In addition, PSG9 induces the secretion of TGF-beta 1 from macrophages but not from CD4(+) T-cells. TGF-beta 1 is required for the ex vivo differentiation of regulatory T-cells and, consistent with the ability of PSG9 to activate this cytokine, we observed that PSG9 induces the differentiation of FoxP3(+) regulatory T-cells from naive murine and human T-cells. Cytokines that are associated with inflammatory responses were also reduced in the supernatants of T-cells treated with PSG9, suggesting that PSG9, through its activation of TGF beta-1, could be a potent inducer of immune tolerance.	[Jones, Karlie; Malech, Harry; Kang, Elizabeth] NIAID, NIH, Bethesda, MD USA; [Ballesteros, Angela] NIDCD, NIH, Bethesda, MD USA; [Mentink-Kane, Margaret; Warren, James; Rattila, Shemona; Dveksler, Gabriela] USUHS, Dept Pathol, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Dveksler, G (corresponding author), USUHS, Dept Pathol, Bethesda, MD USA.	gabriela.dveksler@usuhs.edu		Malech, Harry/0000-0001-5874-5775; Ballesteros Morcillo, Angela/0000-0001-5796-6875	USUHS [R0742495]; Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH) [Z-A1-00-0989]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000988, ZIAAI000644, ZIAAI000989] Funding Source: NIH RePORTER	USUHS; Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the USUHS intramural award R0742495 to GD and the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH) under intramural project number Z-A1-00-0989 supported the research reported in this publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; Annes JP, 2004, J CELL BIOL, V165, P723, DOI 10.1083/jcb.200312172; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Bailly S, 1997, J BIOL CHEM, V272, P16329, DOI 10.1074/jbc.272.26.16329; Ballesteros A, 2015, J BIOL CHEM, V290, P4422, DOI 10.1074/jbc.M114.597518; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Blankley RT, 2013, MOL CELL PROTEOMICS; Blois SM, 2014, MUCOSAL IMMUNOL, V7, P348, DOI 10.1038/mi.2013.53; Camolotto S, 2010, PLACENTA, V31, P312, DOI 10.1016/j.placenta.2010.01.004; Chang CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061701; Chatterjee P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00253; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chen ZB, 2005, J EXP MED, V202, P1387, DOI 10.1084/jem.20051409; Coghill JM, 2011, BLOOD, V117, P3268, DOI 10.1182/blood-2010-12-290403; Duan W, 2011, J IMMUNOL, V187, P6499, DOI 10.4049/jimmunol.1101398; Dumont BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075949; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gandhi R, 2010, J IMMUNOL, V184, P4620, DOI 10.4049/jimmunol.0903329; Han KL, 2013, J IMMUNOL, V190, P458, DOI 10.4049/jimmunol.1201325; HORNE CHW, 1976, EXPERIENTIA, V32, P1197, DOI 10.1007/BF01927624; Jurisicova A, 1999, HUM REPROD, V14, P1852, DOI 10.1093/humrep/14.7.1852; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Lisboa FA, 2011, J BIOL CHEM, V286, P7577, DOI 10.1074/jbc.M110.161810; Lu LF, 2006, NATURE, V442, P997, DOI 10.1038/nature05010; Lu L, 2010, J IMMUNOL, V184, P4295, DOI 10.4049/jimmunol.0903418; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Martinez FF, 2013, AM J REPROD IMMUNOL, V69, P383, DOI 10.1111/aji.12089; Murphy-Ullrich JE, 2000, CYTOKINE GROWTH F R, V11, P59, DOI 10.1016/S1359-6101(99)00029-5; OLSEN A, 1994, GENOMICS, V23, P659, DOI 10.1006/geno.1994.1555; Pihl K, 2009, PRENATAL DIAG, V29, P1256, DOI 10.1002/pd.2408; Radaev S, 2010, J BIOL CHEM, V285, P14806, DOI 10.1074/jbc.M109.079921; Falcon CR, 2014, AM J REPROD IMMUNOL, V72, P527, DOI 10.1111/aji.12307; SALEM HT, 1981, BRIT J OBSTET GYNAEC, V88, P371, DOI 10.1111/j.1471-0528.1981.tb00999.x; Shanley DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057491; Snyder SK, 2001, AM J REPROD IMMUNOL, V45, P205, DOI 10.1111/j.8755-8920.2001.450403.x; Stockis J, 2009, EUR J IMMUNOL, V39, P3315, DOI 10.1002/eji.200939684; Sudmant PH, 2015, NATURE, V526, P75, DOI 10.1038/nature15394; Sweetwyne MT, 2012, MATRIX BIOL, V31, P178, DOI 10.1016/j.matbio.2012.01.006; TEGLUND S, 1995, BIOCHEM BIOPH RES CO, V211, P656, DOI 10.1006/bbrc.1995.1862; Todorovic V, 2005, INT J BIOCHEM CELL B, V37, P38, DOI 10.1016/j.biocel.2004.03.011; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; TOWLER CM, 1976, BRIT J OBSTET GYNAEC, V83, P775, DOI 10.1111/j.1471-0528.1976.tb00743.x; Tran DQ, 2012, J MOL CELL BIOL, V4, P29, DOI 10.1093/jmcb/mjr033; Tran DQ, 2009, P NATL ACAD SCI USA, V106, P13445, DOI 10.1073/pnas.0901944106; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wakabayashi Y, 2011, J BIOL CHEM, V286, P35456, DOI 10.1074/jbc.M111.236794; Wakefield LM, 1989, GROWTH FACTORS, V1, P203, DOI 10.3109/08977198908997997; WURZ H, 1981, J PERINAT MED, V9, P67, DOI 10.1515/jpme.1981.9.2.67; Xu LL, 2007, J IMMUNOL, V178, P6725, DOI 10.4049/jimmunol.178.11.6725; Young GD, 2004, J BIOL CHEM, V279, P38032, DOI 10.1074/jbc.M405658200	52	23	24	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158050	10.1371/journal.pone.0158050	http://dx.doi.org/10.1371/journal.pone.0158050			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27389696	Green Published, gold			2022-12-27	WOS:000379811500012
J	Papp-Kadar, V; Szabo, JE; Nyiri, K; Vertessy, BG				Papp-Kadar, Veronika; Szabo, Judit Eszter; Nyiri, Kinga; Vertessy, Beata G.			In Vitro Analysis of Predicted DNA-Binding Sites for the Stl Repressor of the Staphylococcus aureus SaPIBov1 Pathogenicity Island	PLOS ONE			English	Article							ESCHERICHIA-COLI; HORIZONTAL TRANSFER; HELPER PHAGE; DUTPASE; PROTEIN; EXPRESSION; MECHANISM; URACIL; INHIBITION; MUTATIONS	The regulation model of the Staphylococcus aureus pathogenicity island SaPIbov1 transfer was recently reported. The repressor protein Stl obstructs the expression of SaPI proteins Str and Xis, latter which is responsible for mobilization initiation. Upon Phi 11 phage infection of S. aureus. phage dUTPase activates the SaPI transfer via Stl-dUTPase complex formation. Our aim was to predict the binding sites for the Stl repressor within the S. aureus pathogenicity island DNA sequence. We found that Stl was capable to bind to three 23-mer oligonucleotides, two of those constituting sequence segments in the stl-str, while the other corresponding to sequence segment within the str-xis intergenic region. Within these oligonucleotides, mutational analysis revealed that the predicted binding site for the Stl protein exists as a palindromic segment in both intergenic locations. The palindromes are built as 6-mer repeat sequences involved in Stl binding. The 6-mer repeats are separated by a 5 oligonucleotides long, nonspecific sequence. Future examination of the interaction between Stl and its binding sites in vivo will provide a molecular explanation for the mechanisms of gene repression and gene activation exerted simultaneously by the Stl protein in regulating transfer of the SaPIbov1 pathogenicity island in S. aureus.	[Papp-Kadar, Veronika; Szabo, Judit Eszter; Nyiri, Kinga; Vertessy, Beata G.] Budapest Univ Technol & Econ, Dept Appl Biotechnol & Food Sci, H-1111 Budapest, Hungary; [Papp-Kadar, Veronika; Szabo, Judit Eszter; Nyiri, Kinga; Vertessy, Beata G.] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Lab Genome Metab & Repair, H-1117 Budapest, Hungary	Budapest University of Technology & Economics; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Vertessy, BG (corresponding author), Budapest Univ Technol & Econ, Dept Appl Biotechnol & Food Sci, H-1111 Budapest, Hungary.; Vertessy, BG (corresponding author), Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Lab Genome Metab & Repair, H-1117 Budapest, Hungary.	vertessy@mail.bme.hu	Vertessy, Beata G/H-6202-2012	Vertessy, Beata G./0000-0002-1288-2982	National Institute for Research and Innovation (NKFIH) [OTKA NK 84008, OTKA K109486]; Baross program of the New Hungary Development Plan [OMFB-00266/2010 REG-KM-09-1- 2009-0050, 3DSTRUCT]; Hungarian Academy of Sciences [TTK IF-28/ 2012]; MedinProt program of the Hungarian Academy of Sciences; European Commission FP7 BioStruct-X project [283570]; ICGEB Research Grant [CRP/HUN14-01]	National Institute for Research and Innovation (NKFIH); Baross program of the New Hungary Development Plan; Hungarian Academy of Sciences(Hungarian Academy of Sciences); MedinProt program of the Hungarian Academy of Sciences; European Commission FP7 BioStruct-X project; ICGEB Research Grant	This work was supported by grants from the National Institute for Research and Innovation (NKFIH) (OTKA NK 84008, OTKA K109486), the Baross program of the New Hungary Development Plan (3DSTRUCT, OMFB-00266/2010 REG-KM-09-1- 2009-0050), the Hungarian Academy of Sciences (TTK IF-28/ 2012), the MedinProt program of the Hungarian Academy of Sciences, the European Commission FP7 BioStruct-X project (contract No. 283570), and CRP/HUN14-01 ICGEB Research Grant to BGV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Tormo-Mas MA, 2010, NATURE, V465, P779, DOI 10.1038/nature09065; Atalla Heba, 2011, Animal Health Research Reviews, V12, P33, DOI 10.1017/S1466252311000065; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 2015, NUCLEIC ACIDS RES, V43, pW39, DOI 10.1093/nar/gkv416; Baldo AM, 1999, J VIROL, V73, P7710, DOI 10.1128/JVI.73.9.7710-7721.1999; Brown NL, 2003, FEMS MICROBIOL REV, V27, P145, DOI 10.1016/S0168-6445(03)00051-2; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; Carr JF, 2015, J BACTERIOL, V197, P2981, DOI 10.1128/JB.00219-15; Chen CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063210; Dearborn Altaira D, 2012, Bacteriophage, V2, P70; Fraunholz M, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00775-13; Godovikova V, 2015, APPL ENVIRON MICROB, V81, P6496, DOI 10.1128/AEM.01541-15; Golding GR, 2012, J BACTERIOL, V194, P6627, DOI 10.1128/JB.01680-12; HARRISON SC, 1991, NATURE, V353, P715, DOI 10.1038/353715a0; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Hirmondo R, 2015, DNA REPAIR, V30, P21, DOI 10.1016/j.dnarep.2015.03.005; Hochschild A, 2009, CURR OPIN STRUC BIOL, V19, P79, DOI 10.1016/j.sbi.2008.12.008; Ladner RD, 2001, CURR PROTEIN PEPT SC, V2, P361, DOI 10.2174/1389203013380991; Lari SU, 2006, DNA REPAIR, V5, P1407, DOI 10.1016/j.dnarep.2006.06.009; Larsson G, 1996, J BIOL CHEM, V271, P24010, DOI 10.1074/jbc.271.39.24010; Leveles I, 2013, ACTA CRYSTALLOGR D, V69, P2298, DOI 10.1107/S0907444913021136; Lewis M, 2005, CR BIOL, V328, P521, DOI 10.1016/j.crvi.2005.04.004; Liu YF, 2001, P NATL ACAD SCI USA, V98, P6877, DOI 10.1073/pnas.121013398; MAAS WK, 1994, MICROBIOL REV, V58, P631, DOI 10.1128/MMBR.58.4.631-640.1994; Mahdi LK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-769; MANIATIS T, 1975, CELL, V5, P109, DOI 10.1016/0092-8674(75)90018-5; McClure MA, 2001, CURR PROTEIN PEPT SC, V2, P313, DOI 10.2174/1389203013381062; Mir-Sanchis I, 2012, MOL MICROBIOL, V85, P833, DOI 10.1111/j.1365-2958.2012.08145.x; Muha V, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002738; Nagy GN, 2014, FEBS J, V281, P4207, DOI 10.1111/febs.12941; Nemeth-Pongracz V, 2007, NUCLEIC ACIDS RES, V35, P495, DOI 10.1093/nar/gkl1074; Nguyen M, 2015, INFECT IMMUN, V83, P130, DOI 10.1128/IAI.02467-14; Nickels BE, 2002, J MOL BIOL, V324, P17, DOI 10.1016/S0022-2836(02)01043-4; Novick RP, 2010, NAT REV MICROBIOL, V8, P541, DOI 10.1038/nrmicro2393; Nyri K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139086; Pecsi I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037461; Santillan M, 2001, P NATL ACAD SCI USA, V98, P1364, DOI 10.1073/pnas.98.4.1364; Solovjev V, 2011, METAGENOMICITAPP, P61; Szabo JE, 2014, NUCLEIC ACIDS RES, V42, P11912, DOI 10.1093/nar/gku882; Tallent SM, 2007, J BACTERIOL, V189, P7520, DOI 10.1128/JB.00738-07; THUKRAL SK, 1991, MOL CELL BIOL, V11, P1566, DOI 10.1128/MCB.11.3.1566; Toth J, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706230200; Ubeda C, 2008, MOL MICROBIOL, V67, P493, DOI 10.1111/j.1365-2958.2007.06027.x; Vertessy BG, 2009, ACCOUNTS CHEM RES, V42, P97, DOI 10.1021/ar800114w; Wang YJ, 2010, MOL BIOL REP, V37, P3991, DOI 10.1007/s11033-010-0058-6	45	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158793	10.1371/journal.pone.0158793	http://dx.doi.org/10.1371/journal.pone.0158793			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27388898	Green Accepted, Green Published, gold			2022-12-27	WOS:000379811500047
J	Tamarit, I; Sanchez, A				Tamarit, Ignacio; Sanchez, Angel			Emotions and Strategic Behaviour: The Case of the Ultimatum Game	PLOS ONE			English	Article							DECISION-MAKING; PERSPECTIVE; FAIRNESS; MODEL	Human behaviour in economic interactions has attracted an increasing amount of attention over the last decades. The economic assumption that people would behave focusing on their own material self-interest was proved incomplete, once the empirical evidence consistently showed that many other motives may influence such behaviour. Therefore, models that can incorporate rational decision process as well as other intervening factors are a key issue to both understand the observations from economic experiments and to apply the lessons learned from them. In this paper, we incorporate the influence of emotions to the utility function in an explicit manner, using the Ultimatum Game as a case study. Our model is amenable to analytical study, and is connected with the Circumplex model of emotions and with Kahneman's two-system theory. The simplicity of the model allows to obtain predictions for the offers and acceptance thresholds. We study two specific examples, when the model parameters are distributed uniformly or normally, and show that in the latter case the results are already qualitatively correct. Although this work can be considered as a first approach, it includes what we believe are the main stylized facts, is able to qualitatively reproduce experimental results in a very simple manner, and can be straightforwardly extended to other games.	[Tamarit, Ignacio; Sanchez, Angel] Univ Carlos III Madrid, Grp Interdisciplinar Sistemas Complejos, Dept Matemat, Madrid 28911, Spain; [Sanchez, Angel] Univ Carlos III Madrid, Inst UC3M BS Financial Big Data, Madrid 28911, Spain; [Sanchez, Angel] Univ Zaragoza, Inst Biocomp & Fis Sistemas Complejos BIFI, Zaragoza 50018, Spain	Universidad Carlos III de Madrid; Universidad Carlos III de Madrid; University of Zaragoza	Tamarit, I (corresponding author), Univ Carlos III Madrid, Grp Interdisciplinar Sistemas Complejos, Dept Matemat, Madrid 28911, Spain.	ignacio.tamarit@uc3m.es	Sanchez, Angel/A-9229-2008	Sanchez, Angel/0000-0003-1874-2881; Tamarit, Ignacio/0000-0002-5467-4284	Ministerio de Economia y Competitividad, grant VARIANCE; European Commission through FET Open IBSEN [RIA 662725]; European Commission through (FET Proactive Global Systems Science), Distributed Global Financial Systems for Society (DOLFINS) [RIA 640772]	Ministerio de Economia y Competitividad, grant VARIANCE; European Commission through FET Open IBSEN; European Commission through (FET Proactive Global Systems Science), Distributed Global Financial Systems for Society (DOLFINS)	This work was supported by Ministerio de Economia y Competitividad, grant VARIANCE (http://www.mineco.gob.es/portal/site/mineco?lang_choosen = en) (author receiving the funding: AS); European Commission through FET Open RIA 662725 IBSEN (http://ec.europa.eu/programmes/horizon2020/en/h2020-section/fet-open) (author receiving the funding: AS); and European Commission through (FET Proactive Global Systems Science), RIA 640772 Distributed Global Financial Systems for Society (DOLFINS) (https://ec.europa.eu/programmes/horizon2020/en/news/first-future-and-emerging-technologies-fet-proactive-projects-under-horizon-2020-framework). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Jose A. Cuesta for discussions on this work. This work has been supported in part by Ministerio de Economia y Competitividad (Spain) through grant VARIANCE and by the European Commission through FET Open RIA 662725 IBSEN and FET Proactive Global Systems Science RIA 640772 DOLFINS.	Bearden J. N, 2001, ULTIMATUM BARGAINING; Blanco M, 2011, GAME ECON BEHAV, V72, P321, DOI 10.1016/j.geb.2010.09.008; Bosman R, 2001, EMOTIONS REJEC UNPUB; Branas-Garza P, 2014, SCI REP-UK, V4, DOI 10.1038/srep06025; Camerer C, 1999, ECONOMETRICA, V67, P827, DOI 10.1111/1468-0262.00054; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Charness G, 2002, Q J ECON, V117, P817, DOI 10.1162/003355302760193904; Cox JC, 2007, GAME ECON BEHAV, V59, P17, DOI 10.1016/j.geb.2006.05.001; Dunn BD, 2012, COGN AFFECT BEHAV NE, V12, P419, DOI 10.3758/s13415-012-0092-z; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Gintis H, 2009, GAME THEORY EVOLVING: A PROBLEM-CENTERED INTRODUCTION TO MODELING STRATEGIC INTERACTION, SECOND EDITION, P1; Glimcher PW, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P1; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; GUTH W, 1990, J ECON PSYCHOL, V11, P417, DOI 10.1016/0167-4870(90)90021-Z; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Jonker CS, 2013, SA J IND PSYCHOL, V39, DOI 10.4102/sajip.v39i1.1006; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; Kahneman D., 2002, NOBEL PRIZE LECT, V8, P351; KIRMAN AP, 1992, J ECON PERSPECT, V6, P117, DOI 10.1257/jep.6.2.117; Phelps EA, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P233, DOI 10.1016/B978-0-12-374176-9.00016-6; RABIN M, 1993, AM ECON REV, V83, P1281; ROTH AE, 1995, GAME ECON BEHAV, V8, P164, DOI 10.1016/S0899-8256(05)80020-X; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Schweitzer F, 2010, EUR PHYS J B, V77, P533, DOI 10.1140/epjb/e2010-00292-1; SMITH VL, 1982, AM ECON REV, V72, P923; Stacchetti, 1989, GAME ECON BEHAV, V1, P60, DOI [10.1016/0899-8256(89)90005-5, DOI 10.1016/0899-8256(89)90005-5]; THALER RH, 1988, J ECON PERSPECT, V2, P195, DOI 10.1257/jep.2.4.195; van't Wout M, 2006, EXP BRAIN RES, V169, P564, DOI 10.1007/s00221-006-0346-5; VanKampen N. G., 1992, STOCHASTIC PROCESSES, V1; Vega-Redondo F., 2003, EC THEORY GAMES, P1, DOI [10.1017/CBO9780511753954, DOI 10.1017/CBO9780511753954]	31	1	1	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158733	10.1371/journal.pone.0158733	http://dx.doi.org/10.1371/journal.pone.0158733			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR3NH	27385254	gold, Green Submitted, Green Published			2022-12-27	WOS:000379809400081
J	Kripke, K; Perales, N; Lija, J; Fimbo, B; Mlanga, E; Mahler, H; Juma, JM; Baingana, E; Plotkin, M; Kakiziba, D; Semini, I; Castor, D; Njeuhmeli, E				Kripke, Katharine; Perales, Nicole; Lija, Jackson; Fimbo, Bennet; Mlanga, Eric; Mahler, Hally; Juma, James McOllogi; Baingana, Emmanuel; Plotkin, Marya; Kakiziba, Deogratias; Semini, Iris; Castor, Delivette; Njeuhmeli, Emmanuel			The Economic and Epidemiological Impact of Focusing Voluntary Medical Male Circumcision for HIV Prevention on Specific Age Groups and Regions in Tanzania	PLOS ONE			English	Article							YOUNG MEN; RISK; TRIAL	Background Since its launch in 2010, the Tanzania National Voluntary Medical Male Circumcision (VMMC) Program has focused efforts on males ages 10-34 in 11 priority regions. Implementers have noted that over 70% of VMMC clients are between the ages of 10 and 19, raising questions about whether additional efforts would be required to recruit men age 20 and above. This analysis uses mathematical modeling to examine the economic and epidemiological consequences of scaling up VMMC among specific age groups and priority regions in Tanzania. Methods and Findings Analyses were conducted using the Decision Makers' Program Planning Tool Version 2.0 (DMPPT 2.0), a compartmental model implemented in Microsoft Excel 2010. The model was populated with population, mortality, and HIV incidence and prevalence projections from external sources, including outputs from Spectrum/AIDS Impact Module (AIM). A separate DMPPT 2.0 model was created for each of the 11 priority regions. Tanzania can achieve the most immediate impact on HIV incidence by circumcising males ages 20-34. This strategy would also require the fewest VMMCs for each HIV infection averted. Circumcising men ages 10-24 will have the greatest impact on HIV incidence over a 15-year period. The most cost-effective approach (lowest cost per HIV infection averted) targets men ages 15-34. The model shows the VMMC program is cost saving in all 11 priority regions. VMMC program cost-effectiveness varies across regions due to differences in projected HIV incidence, with the most cost-effective programs in Njombe and Iringa. Conclusions The DMPPT 2.0 results reinforce Tanzania's current VMMC strategy, providing newfound confidence in investing in circumcising adolescents. Tanzanian policy makers and program implementers will continue to focus scale-up of VMMC on men ages 10-34 years, seeking to maximize program impact and cost-effectiveness while acknowledging trends in demand among the younger and older age groups.	[Kripke, Katharine] Avenir Hlth, Hlth Policy Project, Glastonbury, CT USA; [Perales, Nicole] Futures Grp Inc, Hlth Policy Project, Washington, DC USA; [Lija, Jackson; Juma, James McOllogi] Tanzania Natl AIDS Control Program, Dar Es Salaam, Tanzania; [Fimbo, Bennet] Independent Consultant, Dar Es Salaam, Tanzania; [Mlanga, Eric; Plotkin, Marya] US Agcy Int Dev, Dar Es Salaam, Tanzania; [Mahler, Hally] Jhpiego, Dar Es Salaam, Tanzania; [Baingana, Emmanuel; Semini, Iris] Joint United Nations Programme HIV AIDS, Dar Es Salaam, Tanzania; [Kakiziba, Deogratias] US Dept Def, Dar Es Salaam, Tanzania; [Castor, Delivette] Off US Global AIDS Coordinator, Washington, DC USA; [Njeuhmeli, Emmanuel] US Agcy Int Dev, Washington, DC USA	United States Agency for International Development (USAID); Jhpiego; United States Agency for International Development (USAID)	Kripke, K (corresponding author), Avenir Hlth, Hlth Policy Project, Glastonbury, CT USA.	kkripke@avenirhealth.org	Kripke, Katharine/J-2146-2019	Kripke, Katharine/0000-0001-8228-4577	President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development (USAID) \ Health Policy Project [AID-OAA-A-10-00067]	President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development (USAID) \ Health Policy Project(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was funded by the President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development (USAID) vertical bar Health Policy Project, Agreement No. AID-OAA-A-10-00067, beginning September 30, 2010. The Health Policy Project is implemented by Futures Group, in collaboration with Plan International USA, Avenir Health (formerly Futures Institute), Partners in Population and Development, Africa Regional Office (PPD ARO), Population Reference Bureau (PRB), RTI International, and the White Ribbon Alliance for Safe Motherhood (WRA). The funder was involved in study design, analysis of data, decision to publish, and preparation of the manuscript. The findings and conclusions in this paper do not necessarily represent the views or positions of USAID or the U.S. Government.	Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2009, J INFECT DIS, V199, P14, DOI 10.1086/595566; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; CAMERON DW, 1989, LANCET, V2, P403; FRUS, 1975, COMMUNICATION 1114, V28; Ghys PD, 2007, AIDS, V21, pS1, DOI 10.1097/01.aids.0000299404.99033.bf; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Gray RH, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.07.069; Hankins C, 2015, CUTTING IT COU UNPUB; Kanagat N, 2013, AIDSTAR ONE CASE STU; Kripke K, 2015, ASSESSING PROG UNPUB; Kripke K., 2015, AGE TARGETING UNPUB; Larke Natasha, 2010, Br J Nurs, V19, P629; Liu CM, 2013, MBIO, V4, DOI 10.1128/mBio.00076-13; Mahler HR, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001131; MBOERA LEG, 2009, CHALLENGES OPPORTUNI; Menon V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083925; Menzies NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048726; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; Plotkin M, 2011, EMBE HALIJAMENYWA UN; Plotkin M, 2013, GLOB HLTH SCI PRACT, V1; Stover J, 2014, AIDS, V28, pS427, DOI 10.1097/QAD.0000000000000483; Tanzania Commission for AIDS (TACAIDS) ZACZ National Bureau of Statistics (NBS) Office of Chief Government Statistician (OCGS) and ICF International, 2013, TANZ HIV AIDS MAL IN; The United Republic Of Tanzania MOHASW The National AIDS Control Programme, 2014, VOL MED MAL CIRC COU; Tobian AAR, 2009, NEW ENGL J MED, V360, P1298, DOI 10.1056/NEJMoa0802556; [UNAIDS WHO], 2007, NEW DAT MAL CIRC HIV; UNAIDS, 2011, JOINT STRAT ACT FRAM; United Republic of Tanzania MoHaSW National AIDS Control Programme, 2010, NAT STRAT SCAL MAL C; Wambura M, 2009, SITUATION ANAL MALE; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E	30	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0153363	10.1371/journal.pone.0153363	http://dx.doi.org/10.1371/journal.pone.0153363			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410384	Green Published, Green Submitted, gold			2022-12-27	WOS:000379508300001
J	Nogueira, SSC; Caselli, CB; Costa, TSO; Moura, LN; Nogueira, SLG				Nogueira, Selene S. C.; Caselli, Christini B.; Costa, Thaise S. O.; Moura, Leiliany N.; Nogueira-Filho, Sergio L. G.			The Role of Grunt Calls in the Social Dominance Hierarchy of the White-Lipped Peccary (Mammalia, Tayassuidae)	PLOS ONE			English	Article							ACOUSTIC FEATURES; VOCAL RECOGNITION; FEMALE BABOONS; HOME-RANGE; PATTERNS; BEHAVIOR; SEX; CONTEXT; INDIVIDUALITY; COMMUNICATION	Grunt-like calls are present in the vocal repertoire of many group-living mammals and seem to facilitate social interactions between lower and higher-ranking members. The white-lipped peccary (Tayassu pecari) lives in stable hierarchical mixed-sex groups and like non-human primates, usually emits grunt-like calls following aggressive interactions, mainly during feeding contexts. We investigated the possible functions of peccaries' grunt-like calls and their relationship to the individuals' social rank, identity, and sexual dimorphism. We observed that low-ranking individuals emitted grunt-like calls more often than high-ranking ones, and that the alpha male never emitted this vocalization. Moreover, the mean minimum frequency of grunt-like calls decreased as the peccary's rank increased. The findings revealed differences among individual grunts, but the low accuracy of cross-validation (16%) suggests that individual recognition in peccaries may be less important than an honest signal of individual social status. In addition, the absence of differences in the acoustic parameters of grunt-like calls between males and females points to the lack of sexual dimorphism in this species. We verified that after hearing grunt calls, dominant opponents were more likely to cease attacking a victim, or at least delay the continuation of conflict, probably decreasing the severity of agonistic interactions. Our findings are particularly important to improve the current understanding of the role of grunt-like calls in herd-living mammals with linear dominant hierarchies, and strongly suggest that they are involved in the maintenance of herd social stability and cohesion.	[Nogueira, Selene S. C.; Caselli, Christini B.; Moura, Leiliany N.] Univ Estadual Santa Cruz, Dept Ciencias Biol, Rod Jorge Amado,Km 16, BR-45662900 Ilheus, BA, Brazil; [Costa, Thaise S. O.; Nogueira-Filho, Sergio L. G.] Univ Estadual Santa Cruz, Dept Ciencias Agr & Ambientais, Rod Jorge Amado,Km 16, BR-45662900 Ilheus, BA, Brazil	Universidade Estadual de Santa Cruz; Universidade Estadual de Santa Cruz	Nogueira, SSC (corresponding author), Univ Estadual Santa Cruz, Dept Ciencias Biol, Rod Jorge Amado,Km 16, BR-45662900 Ilheus, BA, Brazil.	selene.nogueira@pq.cnpq.br	Nogueira, Selene/W-5237-2019; Caselli, Christini Barbosa/F-5737-2017; Nogueira, Selene/I-1843-2013; Nogueira-Filho, Sérgio L.G./F-6264-2014	Nogueira, Selene/0000-0001-8078-4172; Caselli, Christini Barbosa/0000-0002-3058-7872; Nogueira, Selene/0000-0001-8078-4172; Nogueira-Filho, Sergio/0000-0001-5392-0773	Coordination for the Improvement of Higher Education Personnel (CAPES); UESC; National Council for Scientific and Technological Development (CNPq) [300587/2009-0, 306154/2010-2]	Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); UESC; National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Coordination for the Improvement of Higher Education Personnel (CAPES), UESC and the National Council for Scientific and Technological Development (CNPq) under process no. 300587/2009-0 and 306154/2010-2.; We are grateful to Plos One's Editor (Elisabetta Palagi) and anonymous reviewers for all contributions to the manuscript. We thank Roger Mundry for kindly providing his pDFA R script and instructions to conduct this analysis. We thank Michele D. Singh (University of West Indies), Dr Fatima Felisberti (Kingston University) and Dr. Michael Mendl (University of Bristol) for their kind review of the English manuscript. We would also like to thank Dr. Tokumaru, R.S. from the Department of Developmental Psychology of the Federal University of Espirito Santo for suggestions concerning the manuscript. We also thank all the staff of the Laboratory of Applied Ethology at the State University of Santa Cruz. This work was supported by the Coordination for the Improvement of Higher Education Personnel (CAPES), UESC and the National Council for Scientific and Technological Development (CNPq) under process no. 300587/2009-0 and 306154/2010-2, respectively.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Arnold K, 2001, BEHAVIOUR, V138, P649, DOI 10.1163/156853901316924520; Aubin T, 2002, ADV STUD BEHAV, V31, P243, DOI 10.1016/S0065-3454(02)80010-9; Aubin T, 2007, POLAR BIOL, V30, P1027, DOI 10.1007/s00300-007-0262-6; Bergman TJ, 2010, P ROY SOC B-BIOL SCI, V277, P3045, DOI 10.1098/rspb.2010.0580; Blumstein DT, 2005, ANIM BEHAV, V69, P353, DOI 10.1016/j.anbehav.2004.10.001; Bohn KM, 2008, J ACOUST SOC AM, V124, P1838, DOI 10.1121/1.2953314; Briefer EF, 2012, J ZOOL, V288, P1, DOI 10.1111/j.1469-7998.2012.00920.x; Caselli CB, 2014, AM J PRIMATOL, V76, P788, DOI 10.1002/ajp.22270; Charrier I, 2002, J EXP BIOL, V205, P603; Chaverri G, 2013, BEHAV ECOL, V24, P481, DOI 10.1093/beheco/ars188; Cheney DL, 1997, ANIM BEHAV, V54, P409, DOI 10.1006/anbe.1996.0438; CHENEY DL, 1980, ANIM BEHAV, V28, P362, DOI 10.1016/S0003-3472(80)80044-3; CHENEY DL, 1995, ANIM BEHAV, V50, P249, DOI 10.1006/anbe.1995.0237; Cinkova I, 2016, ANIM COGN, V19, P375, DOI 10.1007/s10071-015-0940-7; Cinkova I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098475; Jacomo ATD, 2013, J MAMMAL, V94, P137, DOI 10.1644/11-MAMM-A-411.1; De Vries H, 2000, ANIM BEHAV, V59, P239, DOI 10.1006/anbe.1999.1299; De Vries H, 1998, ANIM BEHAV, V55, P827, DOI 10.1006/anbe.1997.0708; DEVRIES H, 1995, ANIM BEHAV, V50, P1375, DOI 10.1016/0003-3472(95)80053-0; DEWAAL F, 1982, CHIMPANZEE POLITICS; Dubost G, 2001, MAMM BIOL, V66, P65; Ey E, 2007, PRIMATES, V48, P253, DOI 10.1007/s10329-006-0033-y; Filzmoser P, MULTIVARIATE OUTLIER; Fitch WT, 2002, ANIM BEHAV, V63, P407, DOI 10.1006/anbe.2001.1912; Fragoso JMV, 1998, BIOTROPICA, V30, P458, DOI 10.1111/j.1744-7429.1998.tb00080.x; Gamba M., 2005, J ANTHROPOL SCI, V83, P61; HERNANDEZ OE, 1995, MAMMALIA, V59, P146; Janik VM, 1998, ANIM BEHAV, V56, P829, DOI 10.1006/anbe.1998.0881; KOJIMA H, 1980, ACTA OTO-LARYNGOL, V89, P547, DOI 10.3109/00016488009127173; Kuhn M, PACKAGE CARET VERSIO; Laporte MNC, 2011, DEVELOPMENTAL SCI, V14, P1220, DOI 10.1111/j.1467-7687.2011.01069.x; Laporte MNC, 2010, ANIM BEHAV, V80, P467, DOI 10.1016/j.anbehav.2010.06.005; Lehner PN, 1996, HDB ETHOLOGICAL METH; Mathevon Nicolas, 2010, BMC Ecology, V10, P9, DOI 10.1186/1472-6785-10-9; McComb K, 2005, BIOL LETTERS, V1, P381, DOI 10.1098/rsbl.2005.0366; MORTON ES, 1977, AM NAT, V111, P855, DOI 10.1086/283219; Mundry R, 2007, ANIM BEHAV, V74, P965, DOI 10.1016/j.anbehav.2006.12.028; Naimi B., UNCERTAINTY ANAL SPE; Newton-Fisher NE, 2004, PRIMATES, V45, P81, DOI 10.1007/s10329-003-0064-6; NOE R, 1980, FOLIA PRIMATOL, V34, P90, DOI 10.1159/000155949; Nogueira SSC, 2011, ANIM WELFARE, V20, P505; Nogueira SSC, 2012, ETHOLOGY, V118, P1001, DOI 10.1111/eth.12001; Nogueira-Filho S. L. G., 1999, REV ETOL, V1, P89; Owen-Smith N., 1973, THESIS; Owren MJ, 1997, J ACOUST SOC AM, V101, P2951, DOI 10.1121/1.418523; Palagi E, 2006, CHEM SENSES, V31, P437, DOI 10.1093/chemse/bjj048; Phillips AV, 2000, MAR MAMMAL SCI, V16, P592, DOI 10.1111/j.1748-7692.2000.tb00954.x; Policht R, 2008, BIOACOUSTICS, V18, P69, DOI 10.1080/09524622.2008.9753591; Rendall D, 2009, J ACOUST SOC AM, V125, P1792, DOI 10.1121/1.3068453; Riede T, 2001, J ACOUST SOC AM, V110, P2191, DOI 10.1121/1.1398052; Sakamaki Tetsuya, 2011, African Study Monographs, V32, P25; Schehka S, 2009, BEHAV BRAIN RES, V203, P223, DOI 10.1016/j.bbr.2009.05.007; Setchell JM, 2010, CHEM SENSES, V35, P205, DOI 10.1093/chemse/bjp105; Silk JB, 2004, ANIM BEHAV, V67, P573, DOI 10.1016/j.anbehav.2003.07.001; Silk JB, 1996, ANIM BEHAV, V52, P259, DOI 10.1006/anbe.1996.0171; Silk JB, 2001, EVOLUTION CAPACITY C, P138; Sowls LK., 1997, JAVELINAS OTHER PECC; Tabachnick B. G., 2001, USING MULTIVARIATE S; Titze IR, 2008, J ACOUST SOC AM, V123, P2733, DOI 10.1121/1.2832337; van Hoof J.A.R.A.M., 1987, Perspectives in Vertebrate Science, V4, P219; Vannoni E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003113; Venables WN., 2002, MODERN APPL STAT S 4; Vignal C, 2008, BEHAV PROCESS, V77, P191, DOI 10.1016/j.beproc.2007.09.003; Whitehead H, 2009, BEHAV ECOL SOCIOBIOL, V63, P765, DOI 10.1007/s00265-008-0697-y; Wittig RM, 2007, BEHAV ECOL SOCIOBIOL, V61, P899, DOI 10.1007/s00265-006-0319-5; Yeo IK, 2000, BIOMETRIKA, V87, P954, DOI 10.1093/biomet/87.4.954; Yin S, 2004, ANIM BEHAV, V68, P343, DOI 10.1016/j.anbehav.2003.07.016; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	69	5	5	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158665	10.1371/journal.pone.0158665	http://dx.doi.org/10.1371/journal.pone.0158665			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27409797	Green Published, gold, Green Submitted			2022-12-27	WOS:000379508300029
J	Ortega, Z; Martin-Vallejo, J; Mencia, A; Galindo-Villardon, MP; Perez-Mellado, V				Ortega, Zaida; Martin-Vallejo, Javier; Mencia, Abraham; Purificacion Galindo-Villardon, Maria; Perez-Mellado, Valentin			Introducing Meta-Partition, a Useful Methodology to Explore Factors That Influence Ecological Effect Sizes	PLOS ONE			English	Article							RANDOM-EFFECTS MODELS; REGRESSION TREES; METAANALYSIS; HETEROGENEITY; TRIALS	The study of the heterogeneity of effect sizes is a key aspect of ecological meta-analyses. Here we propose a meta-analytic methodology to study the influence of moderators in effect sizes by splitting heterogeneity: meta-partition. To introduce this methodology, we performed a meta-partition of published data about the traits that influence species sensitivity to habitat loss, that have been previously analyzed through meta-regression. Thus, here we aim to introduce meta-partition and to make an initial comparison with meta-regression. Meta-partition algorithm consists of three steps. Step 1 is to study the heterogeneity of effect sizes under the assumption of fixed effect model. If heterogeneity is found, we perform step 2, that is, to partition the heterogeneity by the moderator that minimizes heterogeneity within a subset while maximizing heterogeneity between subsets. Then, if effect sizes of the subset are still heterogeneous, we repeat step 1 and 2 until we reach final subsets. Finally, step 3 is to integrate effect sizes of final subsets, with fixed effect model if there is homogeneity, and with random effects model if there is heterogeneity. Results show that meta-partition is valuable to assess the importance of moderators in explaining heterogeneity of effect sizes, as well as to assess the directions of these relations and to detect possible interactions between moderators. With meta-partition we have been able to evaluate the importance of moderators in a more objective way than with meta-regression, and to visualize the complex relations that may exist between them. As ecological issues are often influenced by several factors interacting in complex ways, ranking the importance of possible moderators and detecting possible interactions would make meta-partition a useful exploration tool for ecological meta-analyses.	[Ortega, Zaida; Mencia, Abraham; Perez-Mellado, Valentin] Univ Salamanca, Dept Anim Biol, Salamanca, Spain; [Ortega, Zaida; Martin-Vallejo, Javier; Purificacion Galindo-Villardon, Maria] Univ Salamanca, Dept Stat, Salamanca, Spain	University of Salamanca; University of Salamanca	Ortega, Z (corresponding author), Univ Salamanca, Dept Anim Biol, Salamanca, Spain.; Ortega, Z (corresponding author), Univ Salamanca, Dept Stat, Salamanca, Spain.	zaidaortega@usal.es	Vallejo, Francisco Javier F J Martin/B-4029-2012; Ortega, Zaida/T-1466-2017; Galindo-Villardón, Purificación/E-3594-2013	Vallejo, Francisco Javier F J Martin/0000-0003-3962-7356; Ortega, Zaida/0000-0002-8167-1652; Galindo-Villardón, Purificación/0000-0001-6977-7545	University of Salamanca (FPI program); Spanish Ministry of Science and Innovation [CGL2012-39850-CO2-02]	University of Salamanca (FPI program); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Financial support was provided to ZO and AM by predoctoral grants of the University of Salamanca (FPI program). This work was also supported by the research project CGL2012-39850-CO2-02 from the Spanish Ministry of Science and Innovation.; We thank Pauline Quesnelle, Kathryn Lindsay and Lenore Fahrig because we used their study to test meta-partition and compare it with meta-regression, and all authors of primary studies used in the present work. We also thank Robert B. O'Hara and two anonymous reviewers for useful suggestions that helped to improve the study, and Mary Trini Mencia and Joe McIntyre for linguistic revision. Financial support was provided to ZO and AM by predoctoral grants of the University of Salamanca (FPI program). This work was also supported by the research project CGL2012-39850-CO2-02 from the Spanish Ministry of Science and Innovation.	Adams DC, 2008, EVOLUTION, V62, P567, DOI 10.1111/j.1558-5646.2007.00314.x; ARNQVIST G, 1995, TRENDS ECOL EVOL, V10, P236, DOI 10.1016/S0169-5347(00)89073-4; Berlin JA, 1994, ONLINE J CURR CLIN T, P134; Borenstein M, 2010, RES SYNTH METHODS, V1, P97, DOI 10.1002/jrsm.12; Breiman L., 1984, CLASSIFICATION REGRE; Chalmers T C, 1993, Stat Methods Med Res, V2, P161; Davey J, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-160; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; De'ath G, 2007, ECOLOGY, V88, P243, DOI 10.1890/0012-9658(2007)88[243:BTFEMA]2.0.CO;2; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; EYSENCK HJ, 1978, AM PSYCHOL, V33, P517, DOI 10.1037/0003-066X.33.5.517.a; Freedman D.A., 1999, INT ENCY SOCIAL BEHA, V6, P4027; Gurevitch J, 2013, HDB METAANALYSIS ECO, P426; Hardy RJ, 1998, STAT MED, V17, P841, DOI 10.1002/(SICI)1097-0258(19980430)17:8<841::AID-SIM781>3.0.CO;2-D; Hedges LV, 1998, PSYCHOL METHODS, V3, P486, DOI 10.1037/1082-989X.3.4.486; Hedges LV, 2014, STAT METHODS META AN; Higgins JPT, 2004, STAT MED, V23, P1663, DOI 10.1002/sim.1752; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hillebrand H, 2013, ECOL LETT, V16, P1419, DOI 10.1111/ele.12190; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Humphrey SE, 2011, ORGAN PSYCHOL REV, V1, P99, DOI 10.1177/2041386611401273; Hunter J.E., 2004, METHODS META ANAL CO; Ioannidis JPA, 2008, BMJ-BRIT MED J, V336, P1413, DOI 10.1136/bmj.a117; Jeng GT, 1995, JAMA-J AM MED ASSOC, V247, P831; Jennions MD, 2013, HDB METAANALYSIS ECO, P381; JONES DR, 1992, J ROY SOC MED, V85, P165; Krist M, 2011, BIOL REV, V86, P692, DOI 10.1111/j.1469-185X.2010.00166.x; Lajeunesse MJ, 2009, AM NAT, V174, P369, DOI 10.1086/603628; Lortie CJ, 2015, RES SYNTH METHODS, V6, P124, DOI 10.1002/jrsm.1109; Martin-Vallejo J, 1995, THESIS; Mengersen K., 2013, HDB META ANAL ECOLOG, P89, DOI DOI 10.1515/9781400846184-010; Mezei P, 2014, FOREST ECOL MANAG, V331, P196, DOI 10.1016/j.foreco.2014.07.031; Moller AP, 2002, OECOLOGIA, V132, P492, DOI 10.1007/s00442-002-0952-2; Nakagawa S, 2012, EVOL ECOL, V26, P1253, DOI 10.1007/s10682-012-9555-5; Nakagawa S, 2012, EVOL ECOL, V26, P1085, DOI 10.1007/s10682-012-9593-z; Oakes M, 1993, Stat Methods Med Res, V2, P147; PETO R, 1987, STAT MED, V6, P233, DOI 10.1002/sim.4780060306; Quesnelle PE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090926; Rosenberg MS, 2000, METAWIN STAT SOFTWAR; Sall J., 2002, MONTE CARLO CALIBRAT; Schwenk K, 2009, INTEGR COMP BIOL, V49, P7, DOI 10.1093/icb/icp034; Stewart G, 2010, BIOL LETTERS, V6, P78, DOI 10.1098/rsbl.2009.0546; Sutton AJ, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P175; Thompson S G, 1993, Stat Methods Med Res, V2, P173, DOI 10.1177/096228029300200205; THOMPSON SG, 1991, LANCET, V338, P1127, DOI 10.1016/0140-6736(91)91975-Z; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Zhang Y, 2012, J ECOL, V100, P742, DOI 10.1111/j.1365-2745.2011.01944.x	50	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158624	10.1371/journal.pone.0158624	http://dx.doi.org/10.1371/journal.pone.0158624			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27409084	Green Published, gold, Green Submitted			2022-12-27	WOS:000379508300027
J	Mizukami, K; Raj, K; Osborne, C; Giger, U				Mizukami, Keijiro; Raj, Karthik; Osborne, Carl; Giger, Urs			Cystinuria Associated with Different SLC7A9 Gene Variants in the Cat	PLOS ONE			English	Article							ACUTE INTERMITTENT PORPHYRIA; CANINE CYSTINURIA; UROLITH-CENTER; MUTATIONS; SLC3A1; IDENTIFICATION; DIAGNOSIS; PATTERNS; DOMINANT; BREEDS	Cystinuria is a classical inborn error of metabolism characterized by a selective proximal renal tubular defect affecting cystine, ornithine, lysine, and arginine (COLA) reabsorption, which can lead to uroliths and urinary obstruction. In humans, dogs and mice, cystinuria is caused by variants in one of two genes, SLC3A1 and SLC7A9, which encode the rBAT and b(o,+) AT subunits of the b(o,+) basic amino acid transporter system, respectively. In this study, exons and flanking regions of the SLC3A1 and SLC7A9 genes were sequenced from genomic DNA of cats (Felis catus) with COLAuria and cystine calculi. Relative to the Felis catus-6.2 reference genome sequence, DNA sequences from these affected cats revealed 3 unique homozygous SLC7A9 missense variants: one in exon 5 (p.Asp236Asn) from a non-purpose-bred medium-haired cat, one in exon 7 (p. Val294Glu) in a Maine Coon and a Sphinx cat, and one in exon 10 (p.Thr392Met) from a non-purpose-bred long-haired cat. A genotyping assay subsequently identified another cystinuric domestic medium-haired cat that was homozygous for the variant originally identified in the purebred cats. These missense variants result in deleterious amino acid substitutions of highly conserved residues in the b(o,+) AT protein. A limited population survey supported that the variants found were likely causative. The remaining 2 sequenced domestic short-haired cats had a heterozygous variant at a splice donor site in intron 10 and a homozygous single nucleotide variant at a branchpoint in intron 11 of SLC7A9, respectively. This study identifies the first SLC7A9 variants causing feline cystinuria and reveals that, as in humans and dogs, this disease is genetically heterogeneous in cats.	[Mizukami, Keijiro; Raj, Karthik; Giger, Urs] Univ Penn, Sch Vet Med, Med Genet Sect, Philadelphia, PA 19104 USA; [Osborne, Carl] Univ Minnesota, Coll Vet Med, Vet Clin Sci, St Paul, MN 55108 USA	University of Pennsylvania; University of Minnesota System; University of Minnesota Twin Cities	Giger, U (corresponding author), Univ Penn, Sch Vet Med, Med Genet Sect, Philadelphia, PA 19104 USA.	giger@vet.upenn.edu		Raj, Karthik/0000-0001-7736-1101	National Institutes of Health [OD 010939]; Japan Society for the Promotion of Science	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was in part supported by a grant from the National Institutes of Health (https://www.nih.gov/) OD 010939 and a Postdoctoral Fellowship for Research Abroad from Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/e-ab/) to KM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albasan H, 2012, JAVMA-J AM VET MED A, V240, P842, DOI 10.2460/javma.240.7.842; Brons AK, 2013, J VET INTERN MED, V27, P1400, DOI 10.1111/jvim.12176; BUSH M, 1978, J AM VET MED ASSOC, V173, P1159; Chatzikyriakidou A, 2005, GENET TEST, V9, P175, DOI 10.1089/gte.2005.9.175; Clavero S, 2013, VET J, V198, P720, DOI 10.1016/j.tvjl.2013.10.008; Clavero S, 2010, HUM MOL GENET, V19, P584, DOI 10.1093/hmg/ddp525; den Dunnen J, 2016, NOMENCLATURE DESCRIP; Di Perna M, 2008, GENET TEST, V12, P351, DOI 10.1089/gte.2007.0113; DIBARTOLA SP, 1991, J AM VET MED ASSOC, V198, P102; Dong CL, 2015, HUM MOL GENET, V24, P2125, DOI 10.1093/hmg/ddu733; Duran M., 2008, LAB GUIDE METHODS BI, DOI DOI 10.1007/978-3-540-76698-8_5; Eggermann T, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-19; Espino M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137277; Feliubadalo L, 2003, HUM MOL GENET, V12, P2097, DOI 10.1093/hmg/ddg228; Fernandez E, 2002, AM J PHYSIOL-RENAL, V283, pF540, DOI 10.1152/ajprenal.00071.2002; Font-Llitjos M, 2005, J MED GENET, V42, P58, DOI 10.1136/jmg.2004.022244; Frousios K, 2013, GENOMICS, V102, P223, DOI 10.1016/j.ygeno.2013.06.005; Giger U, 2014, P 2014 AM COLL VET I; Henthorn PS, 2006, COLD SPRING HARB MON, V44, P349; Henthorn PS, 2000, HUM GENET, V107, P295; Houston DM, 2009, CAN VET J, V50, P1263; JACKSON OF, 1979, J COMP PATHOL, V89, P39, DOI 10.1016/0021-9975(79)90006-9; Kurushima JD, 2013, ANIM GENET, V44, P311, DOI 10.1111/age.12008; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee MH, 2015, CURR RHEUMATOL REP, V17, DOI 10.1007/s11926-015-0510-7; Li G, 2016, G3-GENES GENOM GENET, V6, P1607, DOI 10.1534/g3.116.028746; Li Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104452; Lim LP, 2001, P NATL ACAD SCI USA, V98, P11193, DOI 10.1073/pnas.201407298; Lipinski MJ, 2008, GENOMICS, V91, P12, DOI 10.1016/j.ygeno.2007.10.009; Livrozet M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102700; Lulich JP, 2013, VET REC, V172, P363, DOI 10.1136/vr.101056; Menotti-Raymond M, 2008, GENOMICS, V91, P1, DOI 10.1016/j.ygeno.2007.08.008; Mizukami K, 2015, J VET INTERN MED, V29, P120, DOI 10.1111/jvim.12501; MORRIS JG, 1985, J NUTR, V115, P524, DOI 10.1093/jn/115.4.524; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Nwaokorie EE, 2013, JAVMA-J AM VET MED A, V242, P1099, DOI 10.2460/javma.242.8.1099; Osborne C, 2001, P 19 FOR AM COLL VET, P794; Osborne CA, 1999, FELINE PRACT, V27, pS31; Osborne CA, 2009, VET CLIN N AM-SMALL, V39, P65, DOI 10.1016/j.cvsm.2008.09.005; Osborne CA, 2009, VET CLIN N AM-SMALL, V39, P183, DOI 10.1016/j.cvsm.2008.09.011; Palacin M, 2013, THE ONLINE METABOLIC; Peters T, 2003, HUM MOL GENET, V12, P2109, DOI 10.1093/hmg/ddg189; Sahota A, 2014, UROLOGY, V84, DOI 10.1016/j.urology.2014.07.043; SMITH A, 1977, MED J AUSTRALIA, V2, P153, DOI 10.5694/j.1326-5377.1977.tb99112.x; Tordiffe ASW, 2012, J ZOO WILDLIFE MED, V43, P649, DOI 10.1638/2011-0236R1.1; Ulrich LK, 1996, VET CLIN N AM-SMALL, V26, P393, DOI 10.1016/S0195-5616(96)50218-4; Wong KA, 2015, BJU INT, V116, P109, DOI 10.1111/bju.12894	47	10	10	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0159247	10.1371/journal.pone.0159247	http://dx.doi.org/10.1371/journal.pone.0159247			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27404572	Green Published, Green Submitted, gold			2022-12-27	WOS:000379508200046
J	Bautista, CA; Park, HJ; Mazur, CM; Aaron, RK; Bilgen, B				Bautista, Catherine A.; Park, Hee Jun; Mazur, Courtney M.; Aaron, Roy K.; Bilgen, Bahar			Effects of Chondroitinase ABC-Mediated Proteoglycan Digestion on Decellularization and Recellularization of Articular Cartilage	PLOS ONE			English	Article							ADULT STEM-CELLS; EXTRACELLULAR-MATRIX; BIOLOGIC SCAFFOLDS; CHONDROGENIC DIFFERENTIATION; ENGINEERED CARTILAGE; GROWTH-FACTORS; TISSUE; BONE; DEFECTS; KNEE	Articular cartilage has a limited capacity to heal itself and thus focal defects often result in the development of osteoarthritis. Current cartilage tissue engineering strategies seek to regenerate injured tissue by creating scaffolds that aim to mimic the unique structure and composition of native articular cartilage. Decellularization is a novel strategy that aims to preserve the bioactive factors and 3D biophysical environment of the native extracellular matrix while removing potentially immunogenic factors. The purpose of this study was to develop a procedure that can enable decellularization and recellularization of intact articular cartilage matrix. Full-thickness porcine articular cartilage plugs were decellularized with a series of freeze-thaw cycles and 0.1% (w/v) sodium dodecyl sulfate detergent cycles. Chondroitinase ABC (ChABC) was applied before the detergent cycles to digest glycosaminoglycans in order to enhance donor chondrocyte removal and seeded cell migration. Porcine synovium-derived mesenchymal stem cells were seeded onto the decellularized cartilage scaffolds and cultured for up to 28 days. The optimized decellularization protocol removed 94% of native DNA per sample wet weight, while collagen content and alignment were preserved. Glycosaminoglycan depletion prior to the detergent cycles increased removal of nuclear material. Seeded cells infiltrated up to 100 mu m into the cartilage deep zone after 28 days in culture. ChABC treatment enhances decellularization of the relatively dense, impermeable articular cartilage by reducing glycosaminoglycan content. ChABC treatment did not appear to affect cell migration during recellularization under static, in vitro culture, highlighting the need for more dynamic seeding methods.	[Bautista, Catherine A.; Mazur, Courtney M.] Brown Univ, Ctr Biomed Engn, Providence, RI 02912 USA; [Park, Hee Jun] Brown Univ, Div Biol & Med, Providence, RI 02912 USA; [Aaron, Roy K.; Bilgen, Bahar] Brown Univ, Rhode Isl Hosp, Dept Orthopaed, Warren Alpert Brown Med Sch, Providence, RI 02903 USA; [Bilgen, Bahar] Providence VA Med Ctr, Providence, RI USA	Brown University; Brown University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center	Bilgen, B (corresponding author), Brown Univ, Rhode Isl Hosp, Dept Orthopaed, Warren Alpert Brown Med Sch, Providence, RI 02903 USA.; Bilgen, B (corresponding author), Providence VA Med Ctr, Providence, RI USA.	bahar_bilgen@brown.edu	Bilgen, Bahar/B-3096-2009	Bilgen, Bahar/0000-0002-7395-2315; Bautista, Catherine/0000-0002-4923-3249	Department of Veterans Affairs, Rehabilitation RD Service [IK2 RX000760]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008155] Funding Source: NIH RePORTER; Veterans Affairs [IK2RX000760] Funding Source: NIH RePORTER	Department of Veterans Affairs, Rehabilitation RD Service(US Department of Veterans Affairs); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	BB was funded by the Department of Veterans Affairs, Rehabilitation R&D Service, Grant No. IK2 RX000760 (http://www.research.va.gov/services/rrd.cfm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JL, 2012, MOL BIOL CELL, V23, P3731, DOI 10.1091/mbc.E12-03-0172; [Anonymous], 2014, ONE WAY ANOVA POSTHO; Asanbaeva A, 2007, ARTHRITIS RHEUM, V56, P188, DOI 10.1002/art.22298; ATHANASIOU KA, 1991, J ORTHOP RES, V9, P330, DOI 10.1002/jor.1100090304; Bautista C, 2015, 61 ANN M ORTH RES SO; Benders KEM, 2013, TRENDS BIOTECHNOL, V31, P169, DOI 10.1016/j.tibtech.2012.12.004; Bian LM, 2009, TISSUE ENG PT A, V15, P2065, DOI 10.1089/ten.tea.2008.0495; Bilgen B, 2009, TISSUE ENG PT A, V15, P3261, DOI [10.1089/ten.tea.2008.0273, 10.1089/ten.TEA.2008.0273]; Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040; Carey James L, 2012, J Bone Joint Surg Am, V94, pe80, DOI 10.2106/JBJS.L.00319; Cheng CW, 2014, BIOTECHNOL ADV, V32, P462, DOI 10.1016/j.biotechadv.2013.12.012; Cheng NC, 2009, TISSUE ENG PT A, V15, P231, DOI 10.1089/ten.tea.2008.0253; Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057; Davies-Tuck ML, 2008, OSTEOARTHR CARTILAGE, V16, P337, DOI 10.1016/j.joca.2007.07.005; Demange M, 2012, CURR REV MUSCULOSKE, V5, P229, DOI 10.1007/s12178-012-9132-0; Diekman BO, 2010, TISSUE ENG PT A, V16, P523, DOI 10.1089/ten.TEA.2009.0398; Elder BD, 2010, NEUROSURGERY, V66, P722, DOI 10.1227/01.NEU.0000367616.49291.9F; Erickson IE, 2012, ACTA BIOMATER, V8, P3027, DOI 10.1016/j.actbio.2012.04.033; Farr J, 2011, CLIN ORTHOP RELAT R, V469, P2696, DOI 10.1007/s11999-010-1764-z; Fermor HL, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5517-0; Frisbie DD, 1999, VET SURG, V28, P242, DOI 10.1053/jvet.1999.0242; Gao Y, 2014, BIOMED RES INT; Ghanavi P, 2012, CELL TISSUE RES, V347, P643, DOI 10.1007/s00441-012-1323-x; Gong YY, 2011, BIOMATERIALS, V32, P2265, DOI 10.1016/j.biomaterials.2010.11.078; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; HOLLANDER AP, 1994, J CLIN INVEST, V93, P1722, DOI 10.1172/JCI117156; Juran CM, 2015, TISSUE ENG PT A, V21, P829, DOI [10.1089/ten.tea.2014.0250, 10.1089/ten.TEA.2014.0250]; Katta J, 2008, P I MECH ENG H, V222, P1, DOI 10.1243/09544119JEIM325; Keane TJ, 2015, METHODS, V84, P25, DOI 10.1016/j.ymeth.2015.03.005; Keane TJ, 2012, BIOMATERIALS, V33, P1771, DOI 10.1016/j.biomaterials.2011.10.054; Kheir E, 2011, J BIOMED MATER RES A, V99A, P283, DOI 10.1002/jbm.a.33171; Krych AJ, 2012, J BONE JOINT SURG AM, V94A, P971, DOI 10.2106/JBJS.K.00815; Kuo J, 2010, J BIOMECH, V43, P1316, DOI 10.1016/j.jbiomech.2010.01.020; Kwon JS, 2013, INT J PHARMACEUT, V454, P183, DOI 10.1016/j.ijpharm.2013.06.023; Laasanen MS, 2003, BIORHEOLOGY, V40, P133; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Lee YHD, 2014, CARTILAGE, V5, P145, DOI 10.1177/1947603514529445; Luo L, 2016, ADV MATER SCI ENG, V2016, DOI 10.1155/2016/1596047; Luo L, 2016, J MECH BEHAV BIOMED, V55, P21, DOI 10.1016/j.jmbbm.2015.10.002; Mauck RL, 2006, OSTEOARTHR CARTILAGE, V14, P179, DOI 10.1016/j.joca.2005.09.002; Mazur C, 2014, 60 ANN M ORTH RES SO; Mollon B, 2013, OSTEOARTHR CARTILAGE, V21, P1824, DOI 10.1016/j.joca.2013.08.024; Murphy MK, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4409; Natoli RM, 2009, TISSUE ENG PT A, V15, P3119, DOI 10.1089/ten.TEA.2008.0478; Ng KW, 2011, ANN BIOMED ENG, V39, P2491, DOI 10.1007/s10439-011-0356-8; Pallante AL, 2012, J BONE JOINT SURG AM, V94A, P1984, DOI 10.2106/JBJS.K.00439; Pearle AD, 2005, CLIN SPORT MED, V24, P1, DOI 10.1016/j.csm.2004.08.007; Peretti GM, 2000, TISSUE ENG, V6, P567, DOI 10.1089/107632700750022206; Schlie-Wolter S, 2013, EXP CELL RES, V319, P1553, DOI 10.1016/j.yexcr.2013.03.016; SCHMIDT MB, 1990, J ORTHOPAED RES, V8, P353, DOI 10.1002/jor.1100080307; Schwarz S, 2015, J TISSUE ENG REGEN M, V9, pE239, DOI 10.1002/term.1650; Sutherland AJ, 2015, ADV HEALTHC MATER, V4, DOI 10.1002/adhm.201400165; Tan LJ, 2012, J BIOMATER APPL, V26, P877, DOI 10.1177/0885328210389504; Utomo L, 2015, BIOMED MATER, V10, DOI 10.1088/1748-6041/10/1/015010; Vinardell T, 2009, ANN BIOMED ENG, V37, P2556, DOI 10.1007/s10439-009-9791-1; Wang ZJ, 2014, GENET MOL RES, V13, P4599, DOI 10.4238/2014.June.18.2; Yang Q, 2008, BIOMATERIALS, V29, P2378, DOI 10.1016/j.biomaterials.2008.01.037; Yang Q, 2014, SCI WORLD J, DOI 10.1155/2014/127084; Yang ZQ, 2010, TISSUE ENG PART C-ME, V16, P865, DOI [10.1089/ten.tec.2009.0444, 10.1089/ten.TEC.2009.0444]; Zhang ZZ, 2015, ACS APPL MATER INTER, V7, P15294, DOI 10.1021/acsami.5b03129; Zhao YH, 2013, CHINESE MED J-PEKING, V126, P3130, DOI 10.3760/cma.j.issn.0366-6999.20130212; Zheng XF, 2011, J MATER SCI-MATER M, V22, P693, DOI 10.1007/s10856-011-4248-0	62	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158976	10.1371/journal.pone.0158976	http://dx.doi.org/10.1371/journal.pone.0158976			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391810	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400177
J	Dimitrov, DT; Boily, MC; Hallett, TB; Albert, J; Boucher, C; Mellors, JW; Pillay, D; van de Vijver, DAMC				Dimitrov, Dobromir T.; Boily, Marie-Claude; Hallett, Timothy B.; Albert, Jan; Boucher, Charles; Mellors, John W.; Pillay, Deenan; van de Vijver, David A. M. C.			How Much Do We Know about Drug Resistance Due to PrEP Use? Analysis of Experts' Opinion and Its Influence on the Projected Public Health Impact	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; PREEXPOSURE PROPHYLAXIS; ANTIRETROVIRAL THERAPY; VAGINAL MICROBICIDES; MATHEMATICAL-MODELS; VIROLOGICAL FAILURE; COST-EFFECTIVENESS; POTENTIAL IMPACT; UNITED-STATES; SOUTH-AFRICA	Background Randomized controlled trials reported that pre-exposure prophylaxis (PrEP) with tenofovir and emtricitabine rarely selects for drug resistance. However, drug resistance due to PrEP is not completely understood. In daily practice, PrEP will not be used under the well-controlled conditions available in the trials, suggesting that widespread use of PrEP can result in increased drug resistance. Methods We surveyed expert virologists with questions about biological assumptions regarding drug resistance due to PrEP use. The influence of these assumptions on the prevalence of drug resistance and the fraction of HIV transmitted resistance was studied with a mathematical model. For comparability, 50% PrEP-coverage of and 90% per-act efficacy of PrEP in preventing HIV acquisition are assumed in all simulations. Results Virologists disagreed on the following: the time until resistance emergence (range: 20-180 days) in infected PrEP users with breakthrough HIV infections; the efficacy of PrEP against drug-resistant HIV (25%-90%); and the likelihood of resistance acquisition upon transmission (10%-75%). These differences translate into projections of 0.6%-1% and 3.5%-6% infected individuals with detectable resistance 10 years after introducing PrEP, assuming 100% and 50% adherence, respectively. The rate of resistance emergence following breakthrough HIV infection and the rate of resistance reversion after PrEP use is discontinued, were the factors identified as most influential on the expected resistance associated with PrEP. Importantly, 17-23% infected individuals could virologically fail treatment as a result of past PrEP use or transmitted resistance to PrEP with moderate adherence. Conclusions There is no broad consensus on quantification of key biological processes that underpin the emergence of PrEP-associated drug resistance. Despite this, the contribution of PrEP use to the prevalence of the detectable drug resistance is expected to be small. However, individuals who become infected despite the use of PrEP should be closely monitored due to higher risk of virological failure when initiating antiretroviral treatment in the future.	[Dimitrov, Dobromir T.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Dimitrov, Dobromir T.] Univ Washington, Dept Appl Math, Seattle, WA 98195 USA; [Boily, Marie-Claude; Hallett, Timothy B.] Imperial Coll London, Dept Infect Dis Epidemiol, London, England; [Albert, Jan] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Albert, Jan] Karolinska Univ Hosp, Dept Clin Microbiol, Stockholm, Sweden; [Boucher, Charles; van de Vijver, David A. M. C.] Univ Med Ctr Rotterdam, Erasmus Med Ctr, Dept Virol, Rotterdam, Netherlands; [Mellors, John W.] Univ Pittsburgh, Sch Med, Div Infect Dis, Pittsburgh, PA USA; [Pillay, Deenan] UCL, Sch Med, Res Dept Infect, London, England	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Imperial College London; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Erasmus University Rotterdam; Erasmus MC; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of London; University College London; UCL Medical School	Dimitrov, DT (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.; Dimitrov, DT (corresponding author), Univ Washington, Dept Appl Math, Seattle, WA 98195 USA.	ddimitro@fredhutch.org		Boily, Marie-Claude/0000-0003-3919-006X; van de Vijver, David/0000-0001-5877-8526; Hallett, Timothy/0000-0002-9681-0424	HIV Modeling Consortium - Bill and Melinda Gates Foundation [WPIA_P33638]; NIH grant [UM1AI068617]; Bill and Melinda Gates Foundation [OPP1019228]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068617] Funding Source: NIH RePORTER; Medical Research Council [MR/K010174/1B, MR/K010174/1] Funding Source: researchfish; MRC [MR/K010174/1] Funding Source: UKRI	HIV Modeling Consortium - Bill and Melinda Gates Foundation; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This project was funded by the HIV Modeling Consortium (award WPIA_P33638), which was supported by a grant from the Bill and Melinda Gates Foundation. DTD was also supported by NIH grant (UM1AI068617). JWM was supported in part by a grant from the Bill and Melinda Gates Foundation (OPP1019228). There was no additional external funding received for this study.	Abbas UL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000875; Abbas UL, 2013, J INFECT DIS, V208, P224, DOI 10.1093/infdis/jit150; Abbas UL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018165; ABDOOL KQ, 2010, SCIENCE, V329, P1168, DOI DOI 10.1126/SCIENCE.1193748; Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Bershteyn A, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-11; Boily MC, 2011, SEX TRANSM INFECT, V87, P646, DOI 10.1136/sextrans-2011-050184; Breban R, 2006, MATH BIOSCI ENG, V3, P459; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Clavel F, 2004, NEW ENGL J MED, V350, P1023, DOI 10.1056/NEJM2ra025195; Cox AP, 2011, SEX TRANSM INFECT, V87, P635, DOI 10.1136/sti.2010.046227; Deeks SG, 2001, NEW ENGL J MED, V344, P472, DOI 10.1056/NEJM200102153440702; Desai K, 2008, AIDS, V22, P1829, DOI 10.1097/QAD.0b013e32830e00f5; Dimitrov D, 2012, J AIDS CLIN RES, VS5; Dimitrov D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080927; Dimitrov D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073770; Dimitrov DT, 2013, JAIDS-J ACQ IMM DEF, V62, P95, DOI 10.1097/QAI.0b013e3182785638; Dimitrov Dobromir T, 2010, Stat Commun Infect Dis, V2, P1012; Dimitrov DT, 2011, J THEOR BIOL, V288, P9, DOI 10.1016/j.jtbi.2011.08.001; Dolling D, 2012, HIV MED, V13, P309, DOI 10.1111/j.1468-1293.2011.00968.x; Frentz D, 2012, AIDS REV, V14, P17; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Gomez GB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001323; Grant RM, 2015, J INFECT DIS; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hallett TB, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001123; Hurt CB, 2011, CLIN INFECT DIS, V53, P1265, DOI 10.1093/cid/cir684; Jain V, 2011, J INFECT DIS, V203, P1174, DOI 10.1093/infdis/jiq167; Juusola JL, 2012, ANN INTERN MED, V156, P541, DOI [10.7326/0003-4819-156-8-201204170-00004, 10.7326/0003-4819-156-8-201204170-00001]; Lehman DA, 2015, J INFECT DIS; Li JZ, 2011, JAMA-J AM MED ASSOC, V305, P1327, DOI 10.1001/jama.2011.375; Liegler T, 2014, J INFECT DIS, V210, P1217, DOI 10.1093/infdis/jiu233; Little SJ, 2008, J VIROL, V82, P5510, DOI 10.1128/JVI.02579-07; Margot NA, 2009, JAIDS-J ACQ IMM DEF, V52, P209, DOI 10.1097/QAI.0b013e3181b05f7c; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; Maserati R, 2010, AIDS, V24, P1013, DOI 10.1097/QAD.0b013e328336e962; McCormack S, 2015, CROI 2015; Metzner KJ, 2009, CLIN INFECT DIS, V48, P239, DOI 10.1086/595703; Metzner KJ, 2005, AIDS, V19, P1819, DOI 10.1097/01.aids.0000189878.97480.ed; Nichols BE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059549; Okano JT, 2014, J INFECT DIS, V209, P163, DOI 10.1093/infdis/jit544; Pao D, 2004, JAIDS-J ACQ IMM DEF, V37, P1570, DOI 10.1097/00126334-200412150-00006; Paredes R, 2010, J INFECT DIS, V201, P662, DOI 10.1086/650543; Parienti JJ, 2004, CLIN INFECT DIS, V38, P1311, DOI 10.1086/383572; Pretorius C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013646; Sethi AK, 2003, CLIN INFECT DIS, V37, P1112, DOI 10.1086/378301; Supervie V, 2011, SCI REP-UK, V1, DOI 10.1038/srep00185; Supervie V, 2010, P NATL ACAD SCI USA, V107, P12381, DOI 10.1073/pnas.1006061107; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; van de Vijver DA, 2006, JAIDS-J ACQ IMM DEF, V41, P352, DOI 10.1097/01.qai.0000209899.05126.e4; van de Vijver DAMC, 2013, AIDS, V27, P2943, DOI 10.1097/01.aids.0000433237.63560.20; van de Vijver DAMC, 2010, CURR OPIN INFECT DIS, V23, P621, DOI 10.1097/QCO.0b013e32833ff1e6; Vickerman P, 2008, JAIDS-J ACQ IMM DEF, V48, P460, DOI 10.1097/QAI.0b013e31817aebd6; Vickerman P, 2006, SEX TRANSM DIS, V33, P397, DOI 10.1097/01.olq.0000218974.77208.cc; Vissers DCJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002077; Williams BG, 2011, JAIDS-J ACQ IMM DEF, V58, P207, DOI 10.1097/QAI.0b013e3182253c19; Wilson DP, 2008, P NATL ACAD SCI USA, V105, P9835, DOI 10.1073/pnas.0711813105	58	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158620	10.1371/journal.pone.0158620	http://dx.doi.org/10.1371/journal.pone.0158620			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391094	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400092
J	Lee, KH; Nam, H; Jeong, DE; Kim, SS; Song, HJ; Pyeon, HJ; Kang, K; Hong, SC; Nam, DH; Joo, KM				Lee, Kee Hang; Nam, Hyun; Jeong, Da Eun; Kim, Sung Soo; Song, Hye Jin; Pyeon, Hee Jang; Kang, Kyeongjin; Hong, Seung-Cheol; Nam, Do-Hyun; Joo, Kyeung Min			Sensitive Tumorigenic Potential Evaluation of Adult Human Multipotent Neural Cells Immortalized by hTERT Gene Transduction	PLOS ONE			English	Article							STEM-CELL; STRUCTURAL VARIATION; MODELS; TRANSLATION; PROTEIN; BONE	Stem cells and therapeutic genes are emerging as a new therapeutic approach to treat various neurodegenerative diseases with few effective treatment options. However, potential formation of tumors by stem cells has hampered their clinical application. Moreover, adequate preclinical platforms to precisely test tumorigenic potential of stem cells are controversial. In this study, we compared the sensitivity of various animal models for in vivo stem cell tumorigenicity testing to identify the most sensitive platform. Then, tumorigenic potential of adult human multipotent neural cells (ahMNCs) immortalized by the human telomerase reverse transcriptase (hTERT) gene was examined as a stem cell model with therapeutic genes. When human glioblastoma (GBM) cells were injected into adult (4-6-week-old) Balb/c-nu, adult NOD/SCID, adult NOG, or neonate (1-2-week-old) NOG mice, the neonate NOG mice showed significantly faster tumorigenesis than that of the other groups regardless of intracranial or subcutaneous injection route. Two kinds of ahMNCs (682TL and 779TL) were primary cultured from surgical samples of patients with temporal lobe epilepsy. Although the ahMNCs were immortalized by lentiviral hTERT gene delivery (hTERT-682TL and hTERT-779TL), they did not form any detectable masses, even in the most sensitive neonate NOG mouse platform. Moreover, the hTERT-ahMNCs had no gross chromosomal abnormalities on a karyotype analysis. Taken together, our data suggest that neonate NOG mice could be a sensitive animal platform to test tumorigenic potential of stem cell therapeutics and that ahMNCs could be a genetically stable stem cell source with little tumorigenic activity to develop regenerative treatments for neurodegenerative diseases.	[Lee, Kee Hang; Jeong, Da Eun; Kim, Sung Soo; Hong, Seung-Cheol; Nam, Do-Hyun; Joo, Kyeung Min] Sungkyunkwan Univ, SAIHST, Dept Hlth Sci & Technol, Seoul, South Korea; [Nam, Hyun; Nam, Do-Hyun] Sungkyunkwan Univ, Dept Neurosurg, Samsung Med Ctr, Seoul, South Korea; [Song, Hye Jin; Pyeon, Hee Jang; Kang, Kyeongjin; Joo, Kyeung Min] Sungkyunkwan Univ, Sch Med, Dept Anat & Cell Biol, Seoul, South Korea; [Lee, Kee Hang; Nam, Hyun; Jeong, Da Eun; Kim, Sung Soo; Song, Hye Jin; Pyeon, Hee Jang; Hong, Seung-Cheol; Nam, Do-Hyun; Joo, Kyeung Min] Samsung Med Ctr, Res Inst Future Med, Stem Cell & Regenerat Med Ctr, Seoul 06351, South Korea	Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung Medical Center	Joo, KM (corresponding author), Sungkyunkwan Univ, SAIHST, Dept Hlth Sci & Technol, Seoul, South Korea.; Joo, KM (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Anat & Cell Biol, Seoul, South Korea.; Joo, KM (corresponding author), Samsung Med Ctr, Res Inst Future Med, Stem Cell & Regenerat Med Ctr, Seoul 06351, South Korea.	kmjoo@skku.edu			Ministry of Food and Drug Safety [14172MFDS974]; National Research Foundation [NRF-2013R1A1A2058169]	Ministry of Food and Drug Safety(Ministry of Food & Drug Safety (MFDS), Republic of Korea); National Research Foundation	This research was supported by grants from Ministry of Food and Drug Safety in 2014 (14172MFDS974) and National Research Foundation (NRF-2013R1A1A2058169). KMJ received grants, which supported salary, materials and fees for equipment. The URL of Ministry of Food and Drug Safety is (http://www.mfds.go.kr/index.do). The URL of National Research Foundation is (http://www.nrf.re.kr/nrf_tot_cms/index.jsp?pmi-sso-return2=none).; This research was supported by grants from Ministry of Food and Drug Safety in 2014 (14172MFDS974) and National Research Foundation (NRF-2013R1A1A2058169).	Baraniak PR, 2010, REGEN MED, V5, P121, DOI 10.2217/RME.09.74; Beck B, 2013, NAT REV CANCER, V13, P727, DOI 10.1038/nrc3597; Bocker W, 2008, J CELL MOL MED, V12, P1347, DOI [10.1111/j.1582-4934.2008.00299.x, 10.1111/j.1582-4934.2008.0299.x]; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; Bullwinkel J, 2006, J CELL PHYSIOL, V206, P624, DOI 10.1002/jcp.20494; Chen B, 2009, BRAIN RES, V1284, P1, DOI 10.1016/j.brainres.2009.05.100; Clark MJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000832; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Denton PW, 2011, AIDS REV, V13, P135; Drost J, 2015, NATURE, V521, P43, DOI 10.1038/nature14415; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Flammang TJ, 1997, REGUL TOXICOL PHARM, V26, P230, DOI 10.1006/rtph.1997.1125; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; Frey-Vasconcells J, 2012, STEM CELL TRANSL MED, V1, P353, DOI 10.5966/sctm.2012-0018; Fuentealba LC, 2015, CELL, V161, P1644, DOI 10.1016/j.cell.2015.05.041; GANICK DJ, 1980, INT ARCH ALLER A IMM, V62, P330, DOI 10.1159/000232530; Goldring CEP, 2011, CELL STEM CELL, V8, P618, DOI 10.1016/j.stem.2011.05.012; Gupta B, 2007, CANCER IMMUNOL IMMUN, V56, P1215, DOI 10.1007/s00262-006-0273-0; Hahn WC, 2001, ANN MED, V33, P123, DOI 10.3109/07853890109002067; Harding J, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt171; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Johnson DR, 2012, J NEURO-ONCOL, V107, P359, DOI 10.1007/s11060-011-0749-4; Joo KM, 2013, CELL REP, V3, P260, DOI 10.1016/j.celrep.2012.12.013; Joo KM, 2013, EXP NEUROL, V240, P168, DOI 10.1016/j.expneurol.2012.11.021; Kanemura H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085336; Kawamata S, 2015, J CLIN MED, V4, P159, DOI 10.3390/jcm4010159; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Lee HJ, 2010, J NEUROSCI RES, V88, P3282, DOI 10.1002/jnr.22474; Lindvall O, 2010, J CLIN INVEST, V120, P29, DOI 10.1172/JCI40543; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; Lunn JS, 2011, ANN NEUROL, V70, P353, DOI 10.1002/ana.22487; Marei HES, 2015, J CELL PHYSIOL, V230, P116, DOI 10.1002/jcp.24688; Martino G, 2011, PHYSIOL REV, V91, P1281, DOI 10.1152/physrev.00032.2010; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; McClain RM, 2001, TOXICOL PATHOL, V29, P128, DOI 10.1080/019262301753178537; Nam H, 2015, WORLD J STEM CELLS, V7, P126, DOI 10.4252/wjsc.v7.i1.126; Nombela-Arrieta C, 2011, NAT REV MOL CELL BIO, V12, P126, DOI 10.1038/nrm3049; Oh JE, 2011, J BIOL CHEM, V286, P38757, DOI 10.1074/jbc.M111.244939; PIETRA G, 1959, NATURE, V183, P1689, DOI 10.1038/1831689a0; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Reddel RR, 2000, CARCINOGENESIS, V21, P477, DOI 10.1093/carcin/21.3.477; Roy NS, 2007, NAT PROTOC, V2, P2815, DOI 10.1038/nprot.2007.402; Sakaguchi Y, 2005, ARTHRITIS RHEUM-US, V52, P2521, DOI 10.1002/art.21212; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Urraca N, 2015, STEM CELL RES, V15, P722, DOI 10.1016/j.scr.2015.11.004; Wilson R, 2015, STEM CELL TRANSL MED, V4, P905, DOI 10.5966/sctm.2014-0196; Worthley DL, 2015, CELL, V160, P269, DOI 10.1016/j.cell.2014.11.042	51	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158639	10.1371/journal.pone.0158639	http://dx.doi.org/10.1371/journal.pone.0158639			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391353	Green Published, gold, Green Submitted			2022-12-27	WOS:000380005400095
J	Marczok, S; Bortz, B; Wang, C; Pospisil, H				Marczok, Stefanie; Bortz, Birgit; Wang, Chong; Pospisil, Heike			Comprehensive Analysis of Genome Rearrangements in Eight Human Malignant Tumor Tissues	PLOS ONE			English	Article							CHROMOSOMAL FRAGILE SITES; COPY-NUMBER ALTERATIONS; LI-FRAUMENI-SYNDROME; COLORECTAL-CANCER; DNA-REPLICATION; INSTABILITY; ADAMS; P53	Carcinogenesis is a complex multifactorial, multistage process, but the precise mechanisms are not well understood. In this study, we performed a genome-wide analysis of the copy number variation (CNV), breakpoint region (BPR) and fragile sites in 2,737 tumor samples from eight tumor entities and in 432 normal samples. CNV detection and BPR identification revealed that BPRs tended to accumulate in specific genomic regions in tumor samples whereas being dispersed genome-wide in the normal samples. Hotspots were observed, at which segments with similar alteration in copy number were overlapped along with BPRs adjacently clustered. Evaluation of BPR occurrence frequency showed that at least one was detected in about and more than 15% of samples for each tumor entity while BPRs were maximal in 12% of the normal samples. 127 of 2,716 tumor-relevant BPRs (termed 'common BPRs') exhibited also a noticeable occurrence frequency in the normal samples. Colocalization assessment identified 20,077 CNV-affecting genes and 169 of these being known tumor-related genes. The most noteworthy genes are KIAA0513 important for immunologic, synaptic and apoptotic signal pathways, intergenic non-coding RNA RP11-115C21.2 possibly acting as oncogene or tumor suppressor by changing the structure of chromatin, and ADAM32 likely importance in cancer cell proliferation and progression by ectodomain-shedding of diverse growth factors, and the well-known tumor suppressor gene p53. The BPR distributions indicate that CNV mutations are likely non-random in tumor genomes. The marked recurrence of BPRs at specific regions supports common progression mechanisms in tumors. The presence of hotspots together with common BPRs, despite its small group size, imply a relation between fragile sites and cancer-gene alteration. Our data further suggest that both protein-coding and non-coding genes possessing a range of biological functions might play a causative or functional role in tumor biology. This research enhances our understanding of the mechanisms for tumorigenesis and progression.	[Marczok, Stefanie; Bortz, Birgit; Wang, Chong; Pospisil, Heike] Univ Appl Sci Wildau, High Performance Comp Life Sci, Inst Appl Biosci, Wildau, Germany	University of Applied Sciences Wildau	Pospisil, H (corresponding author), Univ Appl Sci Wildau, High Performance Comp Life Sci, Inst Appl Biosci, Wildau, Germany.	pospisil@th-wildau.de			Europaischer Fonds fur regionale Entwicklung, State Brandenburg [EFRE 1416689]; Bundesministerium fur Bildung und Forschung in the project "Prediction and modeling of hybrid performance and yield gain in oilseed rape by systems biology" [PROGReSs - 031A297G]	Europaischer Fonds fur regionale Entwicklung, State Brandenburg; Bundesministerium fur Bildung und Forschung in the project "Prediction and modeling of hybrid performance and yield gain in oilseed rape by systems biology"(Federal Ministry of Education & Research (BMBF))	Funding for S. Marczok and B. Bortz was provided by a grant of the Europaischer Fonds fur regionale Entwicklung, EFRE 1416689, State Brandenburg (www.esf.brandenburg.de); and by the Bundesministerium fur Bildung und Forschung in the project "Prediction and modeling of hybrid performance and yield gain in oilseed rape by systems biology" (PROGReSs - 031A297G) (www.bmbf.de).	Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; [Anonymous], 2009, AFFYMETRIX, V2, P1; [Anonymous], RAW DAT DOWNL AFFYME; Bernstein C., 2013, NEW RES DIRECTIONS D; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bose P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101607; Bougeard G, 2008, J MED GENET, V45, P535, DOI 10.1136/jmg.2008.057570; Brocker Chad N., 2009, Human Genomics, V4, P43; de Andrade M, 2011, HUM HERED, V71, P221, DOI 10.1159/000328843; Dillon LW, 2010, CURR GENOMICS, V11, P326, DOI 10.2174/138920210791616699; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Frohlich C, 2013, BIOCHEM J, V452, P97, DOI 10.1042/BJ20121558; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Gratias S, 2007, CANCER RES, V67, P408, DOI 10.1158/0008-5472.CAN-06-1317; Gutschner T, 2013, CANCER RES, V73, P1180, DOI 10.1158/0008-5472.CAN-12-2850; Gutschner T, 2012, RNA BIOL, V9, P703, DOI 10.4161/rna.20481; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Idriss HT, 2000, MICROSC RES TECHNIQ, V50, P184, DOI 10.1002/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H; Karimpour-Fard Anis, 2010, Hum Genomics, V4, P421; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Lauriat TL, 2006, BRAIN RES, V1121, P1, DOI 10.1016/j.brainres.2006.08.099; Le Scouarnec S, 2012, HEREDITY, V108, P75, DOI 10.1038/hdy.2011.100; Li WL, 2013, PHYSIOL GENOMICS, V45, P1, DOI 10.1152/physiolgenomics.00082.2012; Li YD, 2012, HUM MOL GENET, V21, P4957, DOI 10.1093/hmg/dds340; Mahfouz EM, 2014, CENT EUR J PUBL HEAL, V22, P215, DOI 10.21101/cejph.a3919; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; McAllister HA, 1978, ATLAS TUMOR PATHOL, P46; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Mochizuki S, 2007, CANCER SCI, V98, P621, DOI 10.1111/j.1349-7006.2007.00434.x; Neuvial P, 2011, SPR HBK COMPU STAT, P225, DOI 10.1007/978-3-642-16345-6_11; Nordman J, 2012, DEVELOPMENT, V139, P455, DOI 10.1242/dev.061838; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Ruijs MWG, 2010, J MED GENET, V47, P421, DOI 10.1136/jmg.2009.073429; Shlien A, 2008, P NATL ACAD SCI USA, V105, P11264, DOI 10.1073/pnas.0802970105; Silva AG, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-63; Standfuss C, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-380; Stewart B, 2014, WORLD CANC REPORT 20; Thys RG, 2015, CURR GENOMICS, V16, P60, DOI 10.2174/1389202916666150114223205; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Weber S, 2012, DEVELOPMENT, V139, P3693, DOI 10.1242/dev.076398; Yan XH, 2015, CANCER CELL, V28, P529, DOI 10.1016/j.ccell.2015.09.006; Yang RX, 2014, CARCINOGENESIS, V35, P315, DOI 10.1093/carcin/bgt344; Zarrei M, 2015, NAT REV GENET, V16, P172, DOI 10.1038/nrg3871; Zhang F, 2009, NAT GENET, V41, P849, DOI 10.1038/ng.399; Zhao XJ, 2004, CANCER RES, V64, P3060, DOI 10.1158/0008-5472.CAN-03-3308	51	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158995	10.1371/journal.pone.0158995	http://dx.doi.org/10.1371/journal.pone.0158995			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391163	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400184
J	Park, EY; Kim, EH; Kim, CY; Kim, MH; Choung, JS; Oh, YS; Moon, HS; Jun, HS				Park, Eun-Young; Kim, Eung-Hwi; Kim, Chul-Young; Kim, Mi-Hwi; Choung, Jin-Seung; Oh, Yoon-Sin; Moon, Hong-Sub; Jun, Hee-Sook			Angelica dahurica Extracts Improve Glucose Tolerance through the Activation of GPR119	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; GLYCEMIC CONTROL; TYPE-2; AGONISTS; FURANOCOUMARINS; PATHOGENESIS; ROOTS	G protein-coupled receptor (GPR) 119 is expressed in pancreatic beta-cells and intestinal L cells, and is involved in glucose-stimulated insulin secretion and glucagon-like peptide-1 (GLP-1) release, respectively. Therefore, the development of GPR119 agonists is a potential treatment for type 2 diabetes. We screened 1500 natural plant extracts for GPR119 agonistic actions and investigated the most promising extract, that from Angelica dahurica (AD), for hypoglycemic actions in vitro and in vivo. Human GPR119 activation was measured in GeneBLAzer T-Rex GPR119-CRE-bla CHO-K1 cells; intracellular cAMP levels and insulin secretion were measured in INS-1 cells; and GLP-1 release was measured in GLUTag cells. Glucose tolerance tests and serum plasma insulin levels were measured in normal C57BL6 mice and diabetic db/db mice. AD extract-treated cells showed significant increases in GPR119 activation, intracellular cAMP levels, GLP-1 levels and glucose-stimulated insulin secretion as compared with controls. In normal mice, a single treatment with AD extract improved glucose tolerance and increased insulin secretion. Treatment with multiple doses of AD extract or n-hexane fraction improved glucose tolerance in diabetic db/db mice. Imperatorin, phellopterin and isoimperatorin were identified in the active fraction of AD extract. Among these, phellopterin activated GPR119 and increased active GLP-1 and insulin secretion in vitro and enhanced glucose tolerance in normal and db/db mice. We suggest that phellopterin might have a therapeutic potential for the treatment of type 2 diabetes.	[Park, Eun-Young; Moon, Hong-Sub] Mokpo Natl Univ, Coll Pharm, Muan Gun 534729, Jeonnam, South Korea; [Kim, Eung-Hwi; Kim, Mi-Hwi; Choung, Jin-Seung; Oh, Yoon-Sin; Jun, Hee-Sook] Gachon Univ, Lee Gil Ya Canc & Diabet Inst, 7-45 Songdo Dong, Inchon 406840, South Korea; [Kim, Chul-Young] Hanyang Univ, Coll Pharm, Ansan 426791, Kyeonggi, South Korea; [Oh, Yoon-Sin; Jun, Hee-Sook] Gil Hosp, Gachon Med Res Inst, Inchon, South Korea; [Jun, Hee-Sook] Gachon Univ, Coll Pharm, 7-45 Songdo Dong, Inchon 406840, South Korea; [Jun, Hee-Sook] Gachon Univ, Gachon Inst Pharmaceut Sci, 7-45 Songdo Dong, Inchon 406840, South Korea	Mokpo National University; Gachon University; Hanyang University; Gachon University; Gachon University; Gachon University	Jun, HS (corresponding author), Gachon Univ, Lee Gil Ya Canc & Diabet Inst, 7-45 Songdo Dong, Inchon 406840, South Korea.; Jun, HS (corresponding author), Gil Hosp, Gachon Med Res Inst, Inchon, South Korea.; Jun, HS (corresponding author), Gachon Univ, Coll Pharm, 7-45 Songdo Dong, Inchon 406840, South Korea.; Jun, HS (corresponding author), Gachon Univ, Gachon Inst Pharmaceut Sci, 7-45 Songdo Dong, Inchon 406840, South Korea.	hsjun@gachon.ac.kr	오, 윤신/AAS-2225-2020	Jun, Hee-Sook/0000-0002-1166-4932; Oh, Yoon Sin/0000-0003-3995-4429	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI12C1564]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI12C1564).	Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS13, DOI 10.2337/dc09-S013; Ban HS, 2003, PLANTA MED, V69, P408, DOI 10.1055/s-2003-39702; Chu ZL, 2008, ENDOCRINOLOGY, V149, P2038, DOI 10.1210/en.2007-0966; Chu ZL, 2007, ENDOCRINOLOGY, V148, P2601, DOI 10.1210/en.2006-1608; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; Fyfe MCT, 2008, EXPERT OPIN DRUG DIS, V3, P403, DOI 10.1517/17460441.3.4.403; Jones RM, 2009, EXPERT OPIN THER PAT, V19, P1339, DOI 10.1517/13543770903153878; KIM C M, 1991, Archives of Pharmacal Research (Seoul), V14, P87, DOI 10.1007/BF02857821; Kim YK, 2007, PHYTOTHER RES, V21, P288, DOI 10.1002/ptr.2043; Lechner D, 2004, PHYTOCHEMISTRY, V65, P331, DOI 10.1016/j.phytochem.2003.11.010; Liu DP, 2011, MOLECULES, V16, P6339, DOI 10.3390/molecules16086339; Ohishi T, 2012, EXPERT OPIN INV DRUG, V21, P321, DOI 10.1517/13543784.2012.657797; Overton HA, 2008, BRIT J PHARMACOL, V153, pS76, DOI 10.1038/sj.bjp.0707529; Overton HA, 2006, CELL METAB, V3, P167, DOI 10.1016/j.cmet.2006.02.004; Prokopenko I, 2008, TRENDS GENET, V24, P613, DOI 10.1016/j.tig.2008.09.004; Russell-Jones D, 2012, CLIN ENDOCRINOL, V77, P489, DOI 10.1111/j.1365-2265.2012.04483.x; Seo WD, 2013, J FUNCT FOODS, V5, P1421, DOI 10.1016/j.jff.2013.05.011; Shalaby NMM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/480545; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; TAYLOR SI, 1994, DIABETES, V43, P735, DOI 10.2337/diab.43.6.735; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Wajchenberg BL, 2007, ENDOCR REV, V28, P187, DOI 10.1210/er.2006-0038; Zhang M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063861	23	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158796	10.1371/journal.pone.0158796	http://dx.doi.org/10.1371/journal.pone.0158796			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391814	Green Published, gold, Green Submitted			2022-12-27	WOS:000380005400125
J	Singh, AK; Paritosh, K; Kant, U; Burma, PK; Pental, D				Singh, Amarjeet Kumar; Paritosh, Kumar; Kant, Uma; Burma, Pradeep Kumar; Pental, Deepak			High Expression of Cry1Ac Protein in Cotton (Gossypium hirsutum) by Combining Independent Transgenic Events that Target the Protein to Cytoplasm and Plastids	PLOS ONE			English	Article							HELICOVERPA-ARMIGERA LEPIDOPTERA; BACILLUS-THURINGIENSIS TOXINS; FIELD-EVOLVED RESISTANCE; IN-VITRO REGENERATION; BT-COTTON; INSECT RESISTANCE; CRYSTAL-PROTEIN; PYRAMIDING BT; FULL-LENGTH; GENE	Transgenic cotton was developed using two constructs containing a truncated and codon-modified cry1Ac gene (1,848 bp), which was originally characterized from Bacillus thuringiensis subspecies kurstaki strain HD73 that encodes a toxin highly effective against many lepidopteran pests. In Construct I, the cry1Ac gene was cloned under FMVde, a strong constitutively expressing promoter, to express the encoded protein in the cytoplasm. In Construct II, the encoded protein was directed to the plastids using a transit peptide taken from the cotton rbcSIb gene. Genetic transformation experiments with Construct I resulted in a single copy insertion event in which the Cry1Ac protein expression level was 2-2.5 times greater than in the Bacillus thuringiensis cotton event Mon 531, which is currently used in varieties and hybrids grown extensively in India and elsewhere. Another high expression event was selected from transgenics developed with Construct II. The Cry protein expression resulting from this event was observed only in the green plant parts. No transgenic protein expression was observed in the non-green parts, including roots, seeds and non-green floral tissues. Thus, leucoplasts may lack the mechanism to allow entry of a protein tagged with the transit peptide from a protein that is only synthesized in tissues containing mature plastids. Combining the two events through sexual crossing led to near additive levels of the toxin at 4-5 times the level currently used in the field. The two high expression events and their combination will allow for effective resistance management against lepidopteran insect pests, particularly Helicoverpa armigera, using a high dosage strategy.	[Singh, Amarjeet Kumar; Paritosh, Kumar; Kant, Uma; Pental, Deepak] Univ Delhi, Ctr Genet Manipulat Crop Plants, South Campus,Benito Juarez Rd, New Delhi 110021, India; [Burma, Pradeep Kumar] Univ Delhi, Dept Genet, South Campus,Benito Juarez Rd, New Delhi 110021, India	University of Delhi; University of Delhi	Pental, D (corresponding author), Univ Delhi, Ctr Genet Manipulat Crop Plants, South Campus,Benito Juarez Rd, New Delhi 110021, India.	depental@gmail.com		paritosh, kumar/0000-0001-6250-7112	Department of Biotechnology, Government of India [BT/AB/NP/07/98, BA/AB/NP/07/Cotton/2005]; Indian Council of Agricultural Research, Government of India [ICAR-NPTC/EFC/XII Plan]; J. C. Bose Fellowship (Department of Science and Technology, Government of India)	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Indian Council of Agricultural Research, Government of India(Indian Council of Agricultural Research (ICAR)); J. C. Bose Fellowship (Department of Science and Technology, Government of India)(Department of Science & Technology (India))	Research work was supported by grants from the Department of Biotechnology, Government of India (1999-2009, from grant number "BT/AB/NP/07/98" and "BA/AB/NP/07/Cotton/2005") and the Indian Council of Agricultural Research, Government of India (2015-onwards, from grant number "ICAR-NPTC/EFC/XII Plan"). DP acknowledges award of a J. C. Bose Fellowship (Department of Science and Technology, Government of India). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; DP acknowledges award of a J. C. Bose Fellowship (Department of Science and Technology, Government of India). We thank Dr. Paresh Verma, (Shriram Bioseed Genetics, India) for providing seeds of the BioCot lines.	Acharjee S, 2010, PLANT SCI, V178, P333, DOI 10.1016/j.plantsci.2010.02.001; Adamczyk JJ, 2009, TRANSGENIC RES, V18, P143, DOI 10.1007/s11248-008-9198-z; ADANG MJ, 1985, GENE, V36, P289, DOI 10.1016/0378-1119(85)90184-2; Akin DS, 2010, MIDSOUTH ENTOMOL, V4, P1; Bates SL, 2005, NAT BIOTECHNOL, V23, P57, DOI 10.1038/nbt1056; BENFEY PN, 1989, EMBO J, V8, P2195, DOI 10.1002/j.1460-2075.1989.tb08342.x; Carriere Y, 2015, NAT BIOTECHNOL, V33, P161, DOI 10.1038/nbt.3099; Carriere Y, 2010, EVOL APPL, V3, P561, DOI 10.1111/j.1752-4571.2010.00129.x; Cattaneo MG, 2006, P NATL ACAD SCI USA, V103, P7571, DOI 10.1073/pnas.0508312103; Chakrabarti SK, 1998, J INVERTEBR PATHOL, V72, P336, DOI 10.1006/jipa.1998.4786; Chaudhary B, 2003, PLANT CELL REP, V21, P955, DOI 10.1007/s00299-003-0613-x; Choudhary B., 2015, ISAAA SERIES BIOTECH; Crickmore N., 2016, BACILLUS THURINGIENS; Cui JJ, 2011, J ECON ENTOMOL, V104, P673, DOI 10.1603/EC09228; DALE EC, 1991, P NATL ACAD SCI USA, V88, P10558, DOI 10.1073/pnas.88.23.10558; Dhurua S, 2011, PEST MANAG SCI, V67, P898, DOI 10.1002/ps.2127; Dong HZ, 2007, J AGRON CROP SCI, V193, P21, DOI 10.1111/j.1439-037X.2006.00240.x; Edge J. M., 2001, Journal of Cotton Science, V5, P121; Falck-Zepeda J. B., 2000, Agribusiness (New York), V16, P21, DOI 10.1002/(SICI)1520-6297(200024)16:1&lt;21::AID-AGR3&gt;3.0.CO;2-F; GALLIE DR, 1987, NUCLEIC ACIDS RES, V15, P8693, DOI 10.1093/nar/15.21.8693; Gatehouse JA, 2008, PLANT PHYSIOL, V146, P881, DOI 10.1104/pp.107.111096; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; Greenplate JT, 1999, J ECON ENTOMOL, V92, P1377, DOI 10.1093/jee/92.6.1377; Gryspeirt A, 2012, TOXINS, V4, P810, DOI 10.3390/toxins4100810; Gupta GP, 2004, INDIAN J AGR SCI, V74, P548; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Halpin C, 2005, PLANT BIOTECHNOL J, V3, P141, DOI 10.1111/j.1467-7652.2004.00113.x; HOFTE H, 1989, MICROBIOL REV, V53, P242; James C., 2014, ISAAA BRIEF; Kanoria S, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-85; Kathage J, 2012, P NATL ACAD SCI USA, V109, P11652, DOI 10.1073/pnas.1203647109; KAY R, 1987, SCIENCE, V236, P1299, DOI 10.1126/science.236.4806.1299; Kiani S, 2013, J BIOTECHNOL, V166, P88, DOI 10.1016/j.jbiotec.2013.04.011; Klumper W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111629; Kranthi KR, 2005, CURR SCI INDIA, V89, P291; Kumar M, 2009, J BIOTECHNOL, V140, P143, DOI 10.1016/j.jbiotec.2009.01.005; Kumar S, 2005, J INVERTEBR PATHOL, V88, P83, DOI 10.1016/j.jip.2004.09.002; Kumar S, 1998, PLANT CELL REP, V18, P59, DOI 10.1007/s002990050532; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Li HM, 2013, TRENDS PLANT SCI, V18, P360, DOI 10.1016/j.tplants.2013.04.003; Li LB, 2014, ACTA PHYSIOL PLANT, V36, P2717, DOI 10.1007/s11738-014-1642-5; Liao CY, 2002, J INVERTEBR PATHOL, V80, P55, DOI 10.1016/S0022-2011(02)00035-6; Liu FY, 2010, PEST MANAG SCI, V66, P155, DOI 10.1002/ps.1849; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Maiti IB, 1997, TRANSGENIC RES, V6, P143, DOI 10.1023/A:1018477705019; Moar WJ, 2007, SCIENCE, V318, P1561, DOI 10.1126/science.1151313; Olsen KM, 2005, J ECON ENTOMOL, V98, P1007, DOI 10.1603/0022-0493-98.3.1007; OMIRULLEH S, 1993, PLANT MOL BIOL, V21, P415, DOI 10.1007/BF00028800; Palma L, 2014, TOXINS, V6, P3296, DOI 10.3390/toxins6123296; Paritosh K, 2013, PLANT MOL BIOL REP, V31, P1176, DOI 10.1007/s11105-013-0576-1; PERLAK FJ, 1990, BIO-TECHNOL, V8, P939, DOI 10.1038/nbt1090-939; Perlak FJ, 2001, PLANT J, V27, P489, DOI 10.1046/j.1365-313X.2001.01120.x; Rawat P, 2011, J BIOSCIENCES, V36, P363, DOI 10.1007/s12038-011-9074-5; Romeis J, 2006, NAT BIOTECHNOL, V24, P63, DOI 10.1038/nbt1180; Soberon M, 2015, BT RESISTANCE CHARAC; Strizhov N, 1996, P NATL ACAD SCI USA, V93, P15012, DOI 10.1073/pnas.93.26.15012; TABASHNIK BE, 1982, ENVIRON ENTOMOL, V11, P1137, DOI 10.1093/ee/11.6.1137; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; Teng YS, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001416; Wan P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029975; Wang Q, 2016, SCI CHINA LIFE SCI, V59, P172, DOI 10.1007/s11427-015-4920-6; Wu JH, 2011, TRANSGENIC RES, V20, P963, DOI 10.1007/s11248-011-9483-0; Yan XX, 2006, FEBS LETT, V580, P6509, DOI 10.1016/j.febslet.2006.10.057; Yu J, 2014, NUCLEIC ACIDS RES, V42, pD1229, DOI 10.1093/nar/gkt1064; Zhang HN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022874; Zhang TZ, 2015, NAT BIOTECHNOL, V33, P531, DOI 10.1038/nbt.3207	67	5	5	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158603	10.1371/journal.pone.0158603	http://dx.doi.org/10.1371/journal.pone.0158603			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391960	Green Published, gold, Green Submitted			2022-12-27	WOS:000380005400087
J	Urso, K; Charles, JF; Shull, GE; Aliprantis, AO; Balestrieri, B				Urso, Katia; Charles, Julia F.; Shull, Gary E.; Aliprantis, Antonios O.; Balestrieri, Barbara			Anion Exchanger 2 Regulates Dectin-1-Dependent Phagocytosis and Killing of Candida albicans	PLOS ONE			English	Article							NF-KAPPA-B; AE2 CL-/HCO3-EXCHANGER; C-TYPE LECTIN; INNATE IMMUNITY; HOST-DEFENSE; RECOGNITION; ACTIVATION; DECTIN-2; RECEPTOR; MACROPHAGES	Anion exchanger 2 (Ae2; gene symbol, Slc4a2) is a plasma membrane Cl-/HCO3- exchanger expressed in the gastrointestinal tract, kidney and bone. We have previously shown that Ae2 is required for the function of osteoclasts, bone resorbing cells of the macrophage lineage, to maintain homeostatic cytoplasmic pH and electroneutrality during acid secretion. Macrophages require endosomal acidification for pathogen killing during the process known as phagocytosis. Chloride is thought to be the principal ion responsible for maintaining electroneutrality during organelle acidification, but whether Cl-/HCO3- exchangers such as Ae2 contribute to macrophage function is not known. In this study we investigated the role of Ae2 in primary macrophages during phagocytosis. We find that Ae2 is expressed in macrophages where it regulates intracellular pH and the binding of Zymosan, a fungal cell wall derivative. Surprisingly, the transcription and surface expression of Dectin- 1, the major phagocytic receptor for Candida albicans (C. albicans) and Zymosan, is reduced in the absence of Ae2. As a consequence, Zymosan-induced Tnfa expression is also impaired in Ae2-deficient macrophages. Similar to Ae2 deficiency, pharmacological alkalinization of lysosomal pH with bafilomycin A decreases both Dectin-1 mRNA and cell surface expression. Finally, Ae2-deficient macrophages demonstrate defective phagocytosis and killing of the human pathogenic fungus C. albicans. Our results strongly suggest that Ae2 is a critical factor in the innate response to C. albicans. This study represents an important contribution to a better understanding of how Dectin-1 expression and fungal clearance is regulated.	[Urso, Katia; Charles, Julia F.; Aliprantis, Antonios O.; Balestrieri, Barbara] Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA; [Urso, Katia; Charles, Julia F.; Aliprantis, Antonios O.; Balestrieri, Barbara] Harvard Med Sch, Boston, MA 02115 USA; [Shull, Gary E.] Univ Cincinnati, Coll Med, Dept Mol Genet, Cincinnati, OH USA; [Balestrieri, Barbara] Harvard Med Sch, Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Jeff & Penny Vinik Ctr Allerg Dis Res, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University System of Ohio; University of Cincinnati; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Balestrieri, B (corresponding author), Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA.; Balestrieri, B (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Balestrieri, B (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Jeff & Penny Vinik Ctr Allerg Dis Res, Boston, MA 02115 USA.	bbalestrieri@partners.org	Balestrieri, Barbara/Y-2547-2018	Balestrieri, Barbara/0000-0002-0323-3278; Charles, Julia/0000-0002-5875-314X	National Institute of Health [R01HL113071, R01AR060363, K08AR062590]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR062590, R01AR060363] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institute of Health grants R01HL113071, R01AR060363, K08AR062590. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama TE, 2002, MOL CELL BIOL, V22, P2607, DOI 10.1128/MCB.22.8.2607-2619.2002; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Aliprantis AO, 2008, J CLIN INVEST, V118, P3775, DOI 10.1172/JCI35711; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Alper SL, 2009, J EXP BIOL, V212, P1672, DOI 10.1242/jeb.029454; Balestrieri B, 2006, J BIOL CHEM, V281, P6691, DOI 10.1074/jbc.M508314200; Balestrieri B, 2009, J IMMUNOL, V182, P4891, DOI 10.4049/jimmunol.0803776; Bi LK, 2010, J BIOL CHEM, V285, P25969, DOI 10.1074/jbc.M110.131300; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Concepcion AR, 2014, EUR J IMMUNOL, V44, P1341, DOI 10.1002/eji.201344218; Coury F, 2013, P NATL ACAD SCI USA, V110, P2163, DOI 10.1073/pnas.1206392110; Davis JT, 2010, CHEM SOC REV, V39, P3843, DOI 10.1039/b926164h; Davis JT, 2009, NAT CHEM, V1, P138, DOI [10.1038/NCHEM.178, 10.1038/nchem.178]; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; Flannagan RS, 2012, ANNU REV PATHOL-MECH, V7, P61, DOI 10.1146/annurev-pathol-011811-132445; Frische S, 2004, AM J PHYSIOL-RENAL, V286, pF1163, DOI 10.1152/ajprenal.00409.2003; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Gawenis LR, 2010, AM J PHYSIOL-GASTR L, V298, pG493, DOI 10.1152/ajpgi.00178.2009; Gawenis LR, 2004, J BIOL CHEM, V279, P30531, DOI 10.1074/jbc.M403779200; Gilbert AS, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a019661; Girotti M, 2004, J BIOL CHEM, V279, P19113, DOI 10.1074/jbc.M313867200; Goodridge HS, 2009, IMMUNOL REV, V230, P38, DOI 10.1111/j.1600-065X.2009.00793.x; GORDON AH, 1980, NATURE, V286, P79, DOI 10.1038/286079a0; Greenblatt MB, 2010, J EXP MED, V207, P923, DOI 10.1084/jem.20092531; Hise AG, 2009, CELL HOST MICROBE, V5, P487, DOI 10.1016/j.chom.2009.05.002; HISHIKAWA T, 1991, J CELL BIOL, V115, P59, DOI 10.1083/jcb.115.1.59; Kerscher B, 2013, INT IMMUNOL, V25, P271, DOI 10.1093/intimm/dxt006; Khan NS, 2016, J IMMUNOL, V196, P2249, DOI 10.4049/jimmunol.1401545; KIMURA M, 1994, AM J PHYSIOL-REG I, V267, pR1596, DOI 10.1152/ajpregu.1994.267.6.R1596; Kullberg BJ, 2015, NEW ENGL J MED, V373, P1445, DOI 10.1056/NEJMra1315399; Lecanda J, 2000, BIOCHEM BIOPH RES CO, V276, P117, DOI 10.1006/bbrc.2000.3439; Mansour MK, 2013, J BIOL CHEM, V288, P16043, DOI 10.1074/jbc.M113.473223; McGreal EP, 2006, GLYCOBIOLOGY, V16, P422, DOI 10.1093/glycob/cwj077; Means TK, 2009, J EXP MED, V206, P637, DOI 10.1084/jem.20082109; Medina JF, 2000, BIOCHEM BIOPH RES CO, V267, P228, DOI 10.1006/bbrc.1999.1951; Naumann K, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/283649; Netea MG, 2006, J CLIN INVEST, V116, P1642, DOI 10.1172/JCI27114; Netea MG, 2015, NAT REV IMMUNOL, V15, P630, DOI 10.1038/nri3897; Nilius B, 2003, ACTA PHYSIOL SCAND, V177, P119, DOI 10.1046/j.1365-201X.2003.01060.x; Recalde S, 2006, AM J PATHOL, V169, P165, DOI 10.2353/ajpath.2006.051096; Saijo S, 2011, INT IMMUNOL, V23, P467, DOI 10.1093/intimm/dxr046; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Sato K, 2006, J BIOL CHEM, V281, P38854, DOI 10.1074/jbc.M606542200; Sato M, 2003, J IMMUNOL, V171, P417, DOI 10.4049/jimmunol.171.1.417; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; Underhill DM, 2012, NAT REV IMMUNOL, V12, P492, DOI 10.1038/nri3244; van Vugt MJ, 1999, BLOOD, V94, P808, DOI 10.1182/blood.V94.2.808.414k31_808_817; Wongchana W, 2015, J IMMUNOL, V195, P5337, DOI 10.4049/jimmunol.1401770; Wu J, 2008, P NATL ACAD SCI USA, V105, P16934, DOI 10.1073/pnas.0808763105	49	4	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158893	10.1371/journal.pone.0158893	http://dx.doi.org/10.1371/journal.pone.0158893			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391897	Green Published, gold, Green Submitted			2022-12-27	WOS:000380005400152
J	Zhang, XQ; Wang, J; Wang, B; Chen, S; Fu, QH; Sun, K				Zhang, Xiaoqing; Wang, Jian; Wang, Bo; Chen, Sun; Fu, Qihua; Sun, Kun			A Novel Missense Mutation of GATA4 in a Chinese Family with Congenital Heart Disease	PLOS ONE			English	Article							VENTRICULAR SEPTAL-DEFECT; TETRALOGY; FALLOT; REGULATOR; GENE	Background Congenital heart disease (CHD) is the most prevalent type of birth defect in human, with high morbidity in infant. Several genes essential for heart development have been identified. GATA4 is a pivotal transcription factor that can regulate the cardiac development. Many GATA4 mutations have been identified in patients with different types of CHD. Aims In this study, the NKX2-5, HAND1 and GATA4 coding regions were sequenced in a family spanning three generations in which seven patients had CHD. Disease-causing potential variation in this family was evaluated by bioinformatics programs and the transcriptional activity of mutant protein was analyzed by the dual luciferase reporter assay. Results A novel GATA4 mutation, c.C931T (p.R311W), was identified and co-segregated with the affected patients in this family. The bioinformatics programs predicted this heterozygous mutation to be deleterious and the cross-species alignment of GATA4 sequences showed that the mutation occurred within a highly conserved amino acid. Even though it resided in the nuclear localization signal domain, the mutant protein didn't alter its intracellular distribution. Nevertheless, further luciferase reporter assay demonstrated that the p.R311W mutation reduced the ability of GATA4 to activate its downstream target gene. Conclusions Our study identified a novel mutation in GATA4 that likely contributed to the CHD in this family. This finding expanded the spectrum of GATA4 mutations and underscored the pathogenic correlation between GATA4 mutations and CHD.	[Zhang, Xiaoqing; Wang, Jian; Wang, Bo; Fu, Qihua] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Lab Med, Shanghai, Peoples R China; [Chen, Sun; Sun, Kun] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Pediat Cardiol, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Fu, QH (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Lab Med, Shanghai, Peoples R China.; Sun, K (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Pediat Cardiol, Shanghai, Peoples R China.	qfu@shsmu.edu.cn; drsunkun@xinhuamed.com.cn	Fu, Qihua/AAW-9989-2020		National Natural Science Foundation of China [81371893]; Innovation Program of Shanghai Municipal Education Commission [13ZZ086]; Shanghai Municipality Health Bureau [20114y072]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); Shanghai Municipality Health Bureau	This work was supported by the National Natural Science Foundation of China (No. 81371893 to QF), the Innovation Program of Shanghai Municipal Education Commission (No. 13ZZ086 to QF), the research fund of Shanghai Municipality Health Bureau (No. 20114y072 to JW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburawi EH, 2015, TRENDS CARDIOVAS MED, V25, P291, DOI 10.1016/j.tcm.2014.11.007; Agnihotri S, 2011, J EXP MED, V208, P689, DOI 10.1084/jem.20102099; Bruneau BG, 2008, NATURE, V451, P943, DOI 10.1038/nature06801; Chen MW, 2010, PEDIATR CARDIOL, V31, P85, DOI 10.1007/s00246-009-9576-1; Epstein JA, 2005, CIRCULATION, V112, P592, DOI 10.1161/CIRCULATIONAHA.104.479857; Fuhrmann J, 2015, CHEM REV, V115, P5413, DOI 10.1021/acs.chemrev.5b00003; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Goldmuntz E, 2001, CIRCULATION, V104, P2565, DOI 10.1161/hc4601.098427; Heineke J, 2007, J CLIN INVEST, V117, P3198, DOI 10.1172/JCI32573; Latinkic BV, 2003, DEVELOPMENT, V130, P3865, DOI 10.1242/dev.00599; Liu XY, 2011, INT J MOL MED, V28, P17, DOI 10.3892/ijmm.2011.638; Lu CX, 2016, INT J MOL MED, V37, P445, DOI 10.3892/ijmm.2015.2436; MOLKENTIN JD, 1994, MOL CELL BIOL, V14, P4947, DOI 10.1128/MCB.14.7.4947; NORA JJ, 1968, CIRCULATION, V38, P604, DOI 10.1161/01.CIR.38.3.604; Philips AS, 2007, J BIOL CHEM, V282, P24915, DOI 10.1074/jbc.M701789200; Pikkarainen S, 2004, CARDIOVASC RES, V63, P196, DOI 10.1016/j.cardiores.2004.03.025; Pu WT, 2004, DEV BIOL, V275, P235, DOI 10.1016/j.ydbio.2004.08.008; Shah G S, 2008, Kathmandu Univ Med J (KUMJ), V6, P33; Takaya T, 2008, J BIOL CHEM, V283, P9828, DOI 10.1074/jbc.M707391200; van der Bom T, 2011, NAT REV CARDIOL, V8, P50, DOI 10.1038/nrcardio.2010.166; van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025; Wang E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062138; Wang J, 2011, PATHOLOGY, V43, P322, DOI 10.1097/PAT.0b013e32834635a9; Wang J, 2012, DNA CELL BIOL, V31, P1610, DOI 10.1089/dna.2012.1814; Wang XK, 2014, MOL MED REP, V9, P695, DOI 10.3892/mmr.2013.1847; Wang XK, 2013, CARDIOL YOUNG, V23, P394, DOI 10.1017/S1047951112001035; Wu GH, 2012, TRANSL RES, V159, P376, DOI 10.1016/j.trsl.2011.10.012; Yang YQ, 2013, HUM MUTAT, V34, P1662, DOI 10.1002/humu.22434; Yang YQ, 2012, PEDIATR CARDIOL, V33, P539, DOI 10.1007/s00246-011-0146-y	29	14	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158904	10.1371/journal.pone.0158904	http://dx.doi.org/10.1371/journal.pone.0158904			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391137	Green Submitted, Green Published, gold			2022-12-27	WOS:000380005400158
J	Wang, N; Guo, XY; Yan, Z; Wang, W; Chen, B; Ge, F; Ye, BP				Wang, Na; Guo, Xinyan; Yan, Zheng; Wang, Wei; Chen, Biao; Ge, Feng; Ye, Boping			A Comprehensive Analysis on Spread and Distribution Characteristic of Antibiotic Resistance Genes in Livestock Farms of Southeastern China	PLOS ONE			English	Article							MANURE APPLICATION; SOILS ADJACENT; WASTE-WATER; ABUNDANCE; SULFONAMIDE; BACTERIA; LAGOONS; COSELECTION; PREVALENCE; TOLERANCE	The pollution of antibiotic resistance genes (ARGs) in livestock farms is a problem which need to be paid more attention to, due to the severe resistance dissemination and the further human health risk. In this study, all the relevant exposure matrices (manure, soil and water) of sixteen animal farms in Southeastern China were sampled to determine twenty-two ARGs conferring resistance to five major classes of antibiotics including tetracyclines, sulfonamides, quinolones, aminoglycosides, and macrolides. The results showed that the spread property of sul genes was most extensive and strong, followed by tet and erm genes. The abundance of tet genes expressing ribosomal protection proteins (tetM, tetO, tetQ, tetT and tetW) was higher than that expressing efflux pump proteins (tetA, tetC, tetE and tetG) in each type of samples. The high abundance and frequency of ermB gene in the matrices should be paid more attention, because macrolides is a major medicine for human use. For manures, it was found that the similar ARGs distribution rules were existing in poultry manure or porcine manure samples, despite of the different origins of these two types of livestock farms. Meanwhile, it was interesting that the distribution rule of tet genes in animal manure was nearly the same as all the ARGs. For soils, the result of nonmetric multi-dimensional scaling (NMDS) analysis showed that the pollution of ARGs in the soils fertilized by poultry and cattle manures were more substantial in northern Jiangsu, but no significant ARGs diversity was observed among porcine manured soils of five different regions. Furthermore, most ARGs showed significant positive relationships with environmental variables such as concentration of sulfonamides, tetracyclines, Cu, Zn and total organic carbon (TOC). The pollution profile and characteristics of so many ARGs in livestock farms can provide significative foundation for the regulation and legislation of antibiotics in China.	[Wang, Na; Guo, Xinyan; Wang, Wei; Ge, Feng] Minist Environm Protect China, Nanjing Inst Environm Sci, Nanjing 210042, Jiangsu, Peoples R China; [Wang, Na; Guo, Xinyan] Minist Environm Protect China, Key Lab Pesticide Environm Assessment & Pollut Co, Nanjing 210042, Jiangsu, Peoples R China; [Chen, Biao; Ye, Boping] China Pharmaceut Univ, Sch Life Sci & Technol, Nanjing 210009, Jiangsu, Peoples R China; [Yan, Zheng] Chinese Soc Environm Sci, Beijing 100082, Peoples R China	China Pharmaceutical University	Ge, F (corresponding author), Minist Environm Protect China, Nanjing Inst Environm Sci, Nanjing 210042, Jiangsu, Peoples R China.; Ye, BP (corresponding author), China Pharmaceut Univ, Sch Life Sci & Technol, Nanjing 210009, Jiangsu, Peoples R China.	gefeng@nies.org; yebp@cpu.edu.cn			Commonwealth and Environmental Protection Project - MEP [201309031]; Natural Science Foundation of China [21507037]; Fundamental Research Funds for NIES "Source apportionment research of antibiotics pollution in typical drinking water resource"	Commonwealth and Environmental Protection Project - MEP; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for NIES "Source apportionment research of antibiotics pollution in typical drinking water resource"	The authors would like to acknowledge the financial support from 2013 Commonwealth and Environmental Protection Project granted by the MEP (201309031), the Natural Science Foundation of China (no. 21507037), and the Fundamental Research Funds for NIES in 2016 "Source apportionment research of antibiotics pollution in typical drinking water resource".	Berg J, 2010, ENVIRON SCI TECHNOL, V44, P8724, DOI 10.1021/es101798r; Boxall ABA, 2010, HANDB EXP PHARMACOL, V199, P291, DOI 10.1007/978-3-642-10324-7_12; Brooks JP, 2014, WATER RES, V57, P96, DOI 10.1016/j.watres.2014.03.017; Byrne-Bailey KG, 2009, ANTIMICROB AGENTS CH, V53, P696, DOI 10.1128/AAC.00652-07; Chen BA, 2015, ENVIRON SCI POLLUT R, V22, P13950, DOI 10.1007/s11356-015-4636-y; Chen F, 2011, ENVIRON POLLUT, V159, P1490, DOI 10.1016/j.envpol.2011.03.016; Cheng WX, 2013, ENVIRON INT, V61, P1, DOI 10.1016/j.envint.2013.08.023; Durso LM, 2014, CURR OPIN MICROBIOL, V19, P37, DOI 10.1016/j.mib.2014.05.019; Fahrenfeld N, 2014, ENVIRON SCI TECHNOL, V48, P2643, DOI 10.1021/es404988k; Fernandez-Calvino D, 2013, SOIL BIOL BIOCHEM, V57, P953, DOI 10.1016/j.soilbio.2012.08.017; Gao PP, 2012, WATER RES, V46, P2355, DOI 10.1016/j.watres.2012.02.004; Guo XY, 2016, J ENVIRON SCI HEAL B, V51, P383, DOI 10.1080/03601234.2016.1142743; Heuer H, 2011, CURR OPIN MICROBIOL, V14, P236, DOI 10.1016/j.mib.2011.04.009; Hsu JT, 2014, J HAZARD MATER, V277, P34, DOI 10.1016/j.jhazmat.2014.02.016; Huerta B, 2013, SCI TOTAL ENVIRON, V456, P161, DOI 10.1016/j.scitotenv.2013.03.071; Icgen B, 2014, B ENVIRON CONTAM TOX, V93, P735, DOI 10.1007/s00128-014-1383-6; Jensen LB, 2002, ENVIRON INT, V28, P487, DOI 10.1016/S0160-4120(02)00076-4; Joy SR, 2014, SCI TOTAL ENVIRON, V481, P69, DOI 10.1016/j.scitotenv.2014.02.027; Knapp CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027300; Kristiansson E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017038; Ling ZH, 2013, J ENVIRON SCI, V25, P1656, DOI 10.1016/S1001-0742(12)60223-X; McIntosh D, 2008, J ANTIMICROB CHEMOTH, V61, P1221, DOI 10.1093/jac/dkn123; McKinney CW, 2010, ENVIRON SCI TECHNOL, V44, P6102, DOI 10.1021/es9038165; Peak N, 2007, ENVIRON MICROBIOL, V9, P143, DOI 10.1111/j.1462-2920.2006.01123.x; Pei RT, 2006, WATER RES, V40, P2427, DOI 10.1016/j.watres.2006.04.017; Pruden A, 2013, ENVIRON HEALTH PERSP, V121, P878, DOI 10.1289/ehp.1206446; Scientific Committee on Emerging and Newly Identified Health Risks, 2009, ASS ANT RES EFF BIOC; Shi Y, 2012, B ENVIRON CONTAM TOX, V9, P857; Smith MS, 2004, APPL ENVIRON MICROB, V70, P7372, DOI 10.1128/AEM.70.12.7372-7377.2004; Storteboom H, 2010, ENVIRON SCI TECHNOL, V44, P7397, DOI 10.1021/es101657s; Su HC, 2014, SCI TOTAL ENVIRON, V490, P708, DOI 10.1016/j.scitotenv.2014.05.060; Wang N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112626; Wardwell LH, 2009, GEOMICROBIOL J, V26, P238, DOI [10.1080/01490450902891854, 10.1080/01490450902889072]; Wu N, 2010, ENVIRON SCI TECHNOL, V44, P6933, DOI 10.1021/es1007802; Yuan CG, 2004, ENVIRON INT, V30, P769, DOI 10.1016/j.envint.2004.01.001; Zhang QQ, 2015, ENVIRON SCI TECHNOL, V49, P6772, DOI 10.1021/acs.est.5b00729	36	79	88	11	139	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0156889	10.1371/journal.pone.0156889	http://dx.doi.org/10.1371/journal.pone.0156889			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27388166	Green Published, gold			2022-12-27	WOS:000379811500001
J	Chase, ID; Lindquist, WB				Chase, Ivan D.; Lindquist, W. Brent			The Fragility of Individual-Based Explanations of Social Hierarchies: A Test Using Animal Pecking Orders	PLOS ONE			English	Article							DOMINANCE HIERARCHIES; HERMIT-CRABS; VACANCY CHAINS; NETWORK MOTIFS; FISH; SOCIETIES; DYNAMICS; MODELS; COMPLEXITY; MECHANISM	The standard approach in accounting for hierarchical differentiation in biology and the social sciences considers a hierarchy as a static distribution of individuals possessing differing amounts of some valued commodity, assumes that the hierarchy is generated by microlevel processes involving individuals, and attempts to reverse engineer the processes that produced the hierarchy. However, sufficient experimental and analytical results are available to evaluate this standard approach in the case of animal dominance hierarchies (pecking orders). Our evaluation using evidence from hierarchy formation in small groups of both hens and cichlid fish reveals significant deficiencies in the three tenets of the standard approach in accounting for the organization of dominance hierarchies. In consequence, we suggest that a new approach is needed to explain the organization of pecking orders and, very possibly, by implication, for other kinds of social hierarchies. We develop an example of such an approach that considers dominance hierarchies to be dynamic networks, uses dynamic sequences of interaction (dynamic network motifs) to explain the organization of dominance hierarchies, and derives these dynamic sequences directly from observation of hierarchy formation. We test this dynamical explanation using computer simulation and find a good fit with actual dynamics of hierarchy formation in small groups of hens. We hypothesize that the same dynamic sequences are used in small groups of many other animal species forming pecking orders, and we discuss the data required to evaluate our hypothesis. Finally, we briefly consider how our dynamic approach may be generalized to other kinds of social hierarchies using the example of the distribution of empty gastropod ( snail) shells occupied in populations of hermit crabs.	[Chase, Ivan D.] SUNY Stony Brook, Dept Sociol, Stony Brook, NY 11794 USA; [Chase, Ivan D.] SUNY Stony Brook, Grad Program Ecol & Evolut, Stony Brook, NY 11794 USA; [Lindquist, W. Brent] Texas Tech Univ, Dept Math & Stat, Lubbock, TX 79409 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Texas Tech University System; Texas Tech University	Chase, ID (corresponding author), SUNY Stony Brook, Dept Sociol, Stony Brook, NY 11794 USA.; Chase, ID (corresponding author), SUNY Stony Brook, Grad Program Ecol & Evolut, Stony Brook, NY 11794 USA.	ivan.chase@stonybrook.edu						Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; ANDERSON PW, 1972, SCIENCE, V177, P393, DOI 10.1126/science.177.4047.393; Ang TZ, 2010, BEHAV ECOL, V21, P819, DOI 10.1093/beheco/arq062; [Anonymous], 2013, SOCIAL FAIRNESS EC E; Becker G.S., 2002, HUMAN CAPITAL, V2, P1; Bonabeau E, 1999, B MATH BIOL, V61, P727, DOI 10.1006/bulm.1999.0108; Bonabeau E, 1996, B MATH BIOL, V58, P661, DOI 10.1007/BF02459478; Bradbury JW, 2014, BEHAV ECOL, V25, P435, DOI 10.1093/beheco/aru014; Briffa M, 2013, ETHOLOGY, V119, P1014, DOI 10.1111/eth.12148; Broom M, 2002, J THEOR BIOL, V219, P397, DOI 10.1006/jtbi.2002.3137; Chakravarty S. R., 2013, ECONOPHYSICS INCOME; Chartrand G., 1984, INTRO GRAPH THEORY; Chase I., 2009, OXFORD HDB ANAL SOCI, P566, DOI [10.1093/oxfordhb/9780199215362.013.24, DOI 10.1093/OXFORDHB/9780199215362.013.24]; CHASE ID, 1982, BEHAVIOUR, V80, P218, DOI 10.1163/156853982X00364; CHASE ID, 1985, ANIM BEHAV, V33, P86, DOI 10.1016/S0003-3472(85)80122-6; Chase ID, 2003, BEHAVIOUR, V140, P1193, DOI 10.1163/156853903771980558; CHASE ID, 1987, ANIM BEHAV, V35, P1113, DOI 10.1016/S0003-3472(87)80168-9; CHASE ID, 1988, ANIM BEHAV, V36, P1265, DOI 10.1016/S0003-3472(88)80195-7; CHASE ID, 1974, BEHAV SCI, V19, P374, DOI 10.1002/bs.3830190604; Chase ID, 2002, P NATL ACAD SCI USA, V99, P5744, DOI 10.1073/pnas.082104199; CHASE ID, 1982, SCIENCE, V216, P439, DOI 10.1126/science.216.4544.439; CHASE ID, 1991, ANNU REV SOCIOL, V17, P133; Chase Ivan D, 2006, Front Zool, V3, P18, DOI 10.1186/1742-9994-3-18; Dugatkin LA, 1997, BEHAV ECOL, V8, P583, DOI 10.1093/beheco/8.6.583; Frank Laurence, 1995, SERENGETI, P364; Goldenfeld N, 1999, SCIENCE, V284, P87, DOI 10.1126/science.284.5411.87; Gould RV, 2002, AM J SOCIOL, V107, P1143, DOI 10.1086/341744; Grosenick L, 2007, NATURE, V445, P429, DOI 10.1038/nature05511; Hemelrijk CK, 1999, P ROY SOC B-BIOL SCI, V266, P361, DOI 10.1098/rspb.1999.0646; Hemelrijk CK, 2000, ANIM BEHAV, V59, P1035, DOI 10.1006/anbe.2000.1400; JOHNSEN EC, 1989, IMA V MATH, V17, P169; Johnsson JI, 1997, ETHOLOGY, V103, P267; LANDAU H. G., 1951, BULL MATH BIOPHYS, V13, P1, DOI 10.1007/BF02478336; Lewis SM, 2009, ETHOLOGY, V115, P356, DOI 10.1111/j.1439-0310.2009.01626.x; Lindquist WB, 2009, B MATH BIOL, V71, P556, DOI 10.1007/s11538-008-9371-9; Martin JL, 2009, SOCIAL STRUCTURES, P1; McDonald DB, 2013, BEHAV ECOL, V24, P511, DOI 10.1093/beheco/ars192; Miklosi A, 1997, BEHAV PROCESS, V40, P97; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; MINCER J, 1958, J POLIT ECON, V66, P281, DOI 10.1086/258055; NELISSEN MHJ, 1985, BEHAVIOUR, V94, P85, DOI 10.1163/156853985X00280; Oliveira RF, 1998, P ROY SOC B-BIOL SCI, V265, P1045, DOI 10.1098/rspb.1998.0397; Oliveira RF, 1996, AGGRESSIVE BEHAV, V22, P37, DOI 10.1002/(SICI)1098-2337(1996)22:1<37::AID-AB4>3.0.CO;2-R; Paz-y-Mino G, 2004, NATURE, V430, P778, DOI 10.1038/nature02723; Pinter-Wollman N, 2014, BEHAV ECOL, V25, P242, DOI 10.1093/beheco/art047; Shizuka D, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0080; Skvoretz J, 1996, J MATH SOCIOL, V21, P57, DOI 10.1080/0022250X.1996.9990174; So NN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134509; Tilly C, 1998, DURABLE INEQUALITY; Ulanowicz RE, 2009, A 3 WINDOW; VANCE RR, 1972, ECOLOGY, V53, P1062, DOI 10.2307/1935418; Wilson E.O., 1975, P1; Wiszniewski J, 2012, J MAMMAL, V93, P239, DOI 10.1644/10-MAMM-A-366.1; Wittemyer G, 2007, BEHAV ECOL SOCIOBIOL, V61, P1919, DOI 10.1007/s00265-007-0432-0	54	22	22	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158900	10.1371/journal.pone.0158900	http://dx.doi.org/10.1371/journal.pone.0158900			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ9CP	27410230	Green Published, Green Submitted, gold			2022-12-27	WOS:000379508300042
J	Milano, N; Nolfi, S				Milano, Nicola; Nolfi, Stefano			Robustness to Faults Promotes Evolvability: Insights from Evolving Digital Circuits	PLOS ONE			English	Article							EVOLUTION; REDUNDANCY; TOLERANT	We demonstrate how the need to cope with operational faults enables evolving circuits to find more fit solutions. The analysis of the results obtained in different experimental conditions indicates that, in absence of faults, evolution tends to select circuits that are small and have low phenotypic variability and evolvability. The need to face operation faults, instead, drives evolution toward the selection of larger circuits that are truly robust with respect to genetic variations and that have a greater level of phenotypic variability and evolvability. Overall our results indicate that the need to cope with operation faults leads to the selection of circuits that have a greater probability to generate better circuits as a result of genetic variation with respect to a control condition in which circuits are not subjected to faults.	[Milano, Nicola; Nolfi, Stefano] CNR, Inst Cognit Sci & Technol, Rome, Italy; [Milano, Nicola] Univ Plymouth, Ctr Robot & Neural Syst, Plymouth, Devon, England	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR); University of Plymouth	Milano, N; Nolfi, S (corresponding author), CNR, Inst Cognit Sci & Technol, Rome, Italy.; Milano, N (corresponding author), Univ Plymouth, Ctr Robot & Neural Syst, Plymouth, Devon, England.	nicola.milano@istc.cnr.it; stefano.nolfi@istc.cnr.it		Milano, Nicola/0000-0002-1604-5161				Ancel LW, 2000, J EXP ZOOL, V288, P242, DOI 10.1002/1097-010X(20001015)288:3<242::AID-JEZ5>3.0.CO;2-O; Back T., 1994, Proceedings of the First IEEE Conference on Evolutionary Computation. IEEE World Congress on Computational Intelligence (Cat. No.94TH0650-2), P40, DOI 10.1109/ICEC.1994.350045; Balch M., 2003, COMPLETE DIGITAL DES, V1st; Edelman GM, 2001, P NATL ACAD SCI USA, V98, P13763, DOI 10.1073/pnas.231499798; Hartmann M, 2004, IEE P-COMPUT DIG T, V151, P287, DOI 10.1049/ip-cdt:20040014; Hu T, 2012, GENET PROGRAM EVOL M, V13, P305, DOI 10.1007/s10710-012-9159-4; Hu T, 2011, LECT NOTES COMPUT SC, V6621, P13, DOI 10.1007/978-3-642-20407-4_2; Jin Y, 2005, IEEE T EVOLUT COMPUT, V9, P303, DOI 10.1109/TEVC.2005.846356; Keymeulen D, 2000, IEEE T RELIAB, V49, P305, DOI 10.1109/24.914547; Koza JR, 1992, GENETIC PROGRAMMING; Krischner M.W., 2005, PLAUSIBILITY LIFE RE; Levitan B, 1995, MOL DIVERS, V1, P53, DOI 10.1007/BF01715809; Macia J, 2009, J R SOC INTERFACE, V6, P393, DOI 10.1098/rsif.2008.0236; Miller J.F., 2000, LECT NOTES COMPUTER, V1801; Miller JF, 2001, THIRD NASA/DOD WORKSHOP ON EVOLVABLE HARDWARE, PROCEEDINGS, P116, DOI 10.1109/EH.2001.937953; Miller JF, 2000, LECT NOTES COMPUT SC, V1802, P121; Newman M.E.J., 2010, NETWORKS INTRO; Nolfi S., 2000, EVOLUTIONARY ROBOTIC; Raman K, 2011, J R SOC INTERFACE, V8, P269, DOI 10.1098/rsif.2010.0212; Rana S., 1996, Parallel Problem Solving from Nature - PPSN IV. International Conference on Evolutionary Computation - The 4th International Conference on Parallel Problem Solving from Nature. Proceedings, P198, DOI 10.1007/3-540-61723-X_984; SCHUSTER P, 1994, P ROY SOC B-BIOL SCI, V255, P279, DOI 10.1098/rspb.1994.0040; Sniegowsky P.D., 2006, CURR BIOL, V19, P831; Thompson A, 1999, IEEE T EVOLUT COMPUT, V3, P167, DOI 10.1109/4235.788489; Tononi G, 1999, P NATL ACAD SCI USA, V96, P3257, DOI 10.1073/pnas.96.6.3257; van Nimwegen E, 1999, P NATL ACAD SCI USA, V96, P9716, DOI 10.1073/pnas.96.17.9716; Wagner A, 2011, ORIGINS OF EVOLUTIONARY INNOVATIONS: A THEORY OF TRANSFORMATIVE CHANGE IN LIVING SYSTEMS, P1, DOI 10.1093/acprof:oso/9780199692590.001.0001; Wagner A, 2008, NAT REV GENET, V9, P965, DOI 10.1038/nrg2473; Wagner A, 2008, P ROY SOC B-BIOL SCI, V275, P91, DOI 10.1098/rspb.2007.1137; Wagner GP, 1996, EVOLUTION, V50, P967, DOI [10.2307/2410639, 10.1111/j.1558-5646.1996.tb02339.x]; West-Eberhard Mary Jane, 2003, pi; Wilke CO, 2001, B MATH BIOL, V63, P715, DOI 10.1006/bulm.2001.0244	32	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158627	10.1371/journal.pone.0158627	http://dx.doi.org/10.1371/journal.pone.0158627			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27409589	gold, Green Published, Green Submitted			2022-12-27	WOS:000379508300028
J	Lofruthe, N; Gallitz, I; Traeger, L; Baumer, N; Schulze, I; Kuhlmann, T; Muller-Tidow, C; Steinbicker, AU				Lofruthe, Niklas; Gallitz, Inka; Traeger, Lisa; Baeumer, Nicole; Schulze, Isabell; Kuhlmann, Tanja; Mueller-Tidow, Carsten; Steinbicker, Andrea U.			Intravenous Iron Carboxymaltose as a Potential Therapeutic in Anemia of Inflammation	PLOS ONE			English	Article							MOUSE MODEL; PEPTIDE HEPCIDIN; INTERLEUKIN-6; TRANSFUSION; FERROPORTIN; EXPRESSION; EFFICACY; GENE; MICE	Intravenous iron supplementation is an effective therapy in iron deficiency anemia (IDA), but controversial in anemia of inflammation (AI). Unbound iron can be used by bacteria and viruses for their replication and enhance the inflammatory response. Nowadays available high molecular weight iron complexes for intravenous iron substitution, such as ferric carboxymaltose, might be useful in AI, as these pharmaceuticals deliver low doses of free iron over a prolonged period of time. We tested the effects of intravenous iron carboxymaltose in murine AI: Wild-type mice were exposed to the heat-killed Brucella abortus (BA) model and treated with or without high molecular weight intravenous iron. 4h after BA injection followed by 2h after intravenous iron treatment, inflammatory cytokines were upregulated by BA, but not enhanced by iron treatment. In long term experiments, mice were fed a regular or an iron deficient diet and then treated with intravenous iron or saline 14 days after BA injection. Iron treatment in mice with BA-induced AI was effective 24h after iron administration. In contrast, mice with IDA (on iron deficiency diet) prior to BA-IA required 7d to recover from AI. In these experiments, inflammatory markers were not further induced in iron-treated compared to vehicle-treated BA-injected mice. These results demonstrate that intravenous iron supplementation effectively treated the murine BA-induced AI without further enhancement of the inflammatory response. Studies in humans have to reveal treatment options for AI in patients.	[Lofruthe, Niklas; Gallitz, Inka; Traeger, Lisa; Steinbicker, Andrea U.] Univ Munster, Univ Hosp Muenster, Dept Anesthesiol Intens Care & Pain Med, Munster, Germany; [Baeumer, Nicole; Schulze, Isabell; Mueller-Tidow, Carsten] Univ Hosp Muenster, Dept Med Hematol Oncol & Pneumol A, Munster, Germany; [Kuhlmann, Tanja] Univ Munster, Univ Hosp Muenster, Inst Neuropathol, Munster, Germany; [Mueller-Tidow, Carsten] Univ Hosp Halle, Dept Med Hematol & Oncol 4, Halle, Germany	University of Munster; University of Munster; University of Munster; Martin Luther University Halle Wittenberg	Steinbicker, AU (corresponding author), Univ Munster, Univ Hosp Muenster, Dept Anesthesiol Intens Care & Pain Med, Munster, Germany.	andrea.steinbicker@ukmuenster.de	Müller-Tidow, Carsten/O-7207-2018	Müller-Tidow, Carsten/0000-0002-7166-5232; Steinbicker, Andrea U./0000-0002-5237-961X	"Innovative Medical Research" Muenster Medical School, Muenster University [IMF ST 111206]; German Research Foundation (Deutsche Forschungsgemeinschaft) [STE 1894/4-1]	"Innovative Medical Research" Muenster Medical School, Muenster University; German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This work was supported by grants from "Innovative Medical Research" Muenster Medical School, Muenster University (IMF ST 111206) and from the German Research Foundation (Deutsche Forschungsgemeinschaft) STE 1894/4-1 (AUS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from "Innovative Medical Research" Muenster Medical School, Muenster University (IMF ST 111206) and from the German Research Foundation (Deutsche Forschungsgemeinschaft) STE 1894/4-1 (AUS).	Baumer N, 2011, J BIOL CHEM, V286, P28210, DOI 10.1074/jbc.M110.203471; Bothwell, 1980, METHODS HEMATOLOGY, V1, P90; Brown CO, 2012, BIOCHEM J, V444, P515, DOI 10.1042/BJ20112019; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Gardenghi S, 2014, BLOOD, V123, P1137, DOI 10.1182/blood-2013-08-521625; Geisser P, 2010, PHARMACEUTICS, V3, P12; Heming N, 2012, CRIT CARE MED, V40, P2141, DOI 10.1097/CCM.0b013e31824e6713; Kim A, 2014, BLOOD, V123, P1129, DOI 10.1182/blood-2013-08-521419; Lin L, 2007, BLOOD, V110, P2182, DOI 10.1182/blood-2007-04-087593; Litton E, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4822; McCranor BJ, 2014, BLOOD CELL MOL DIS, V52, P126, DOI 10.1016/j.bcmd.2013.09.004; Michels K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004998; Nairz M, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00152; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nemeth E, 2014, HEMATOL ONCOL CLIN N, V28, P671, DOI 10.1016/j.hoc.2014.04.005; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Prince OD, 2012, HAEMATOL-HEMATOL J, V97, P1648, DOI 10.3324/haematol.2011.053397; Ramos E, 2011, HEPATOLOGY, V53, P1333, DOI 10.1002/hep.24178; Rohde JM, 2014, JAMA-J AM MED ASSOC, V311, P1317, DOI 10.1001/jama.2014.2726; Sasu BJ, 2010, BLOOD, V115, P3616, DOI 10.1182/blood-2009-09-245977; Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2; Song SNJ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4323; Steinbicker AU, 2013, NUTRIENTS, V5, P3034, DOI 10.3390/nu5083034; Steinbicker AU, 2011, BLOOD, V118, P4224, DOI 10.1182/blood-2011-03-339952; Steinbicker AU, 2011, BLOOD, V117, P4915, DOI 10.1182/blood-2010-10-313064; Valenti L, 2011, ARTERIOSCL THROM VAS, V31, P683, DOI 10.1161/ATVBAHA.110.214858; Ward DM, 2012, BBA-MOL CELL RES, V1823, P1426, DOI 10.1016/j.bbamcr.2012.03.004	29	8	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0158599	10.1371/journal.pone.0158599	http://dx.doi.org/10.1371/journal.pone.0158599			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27404499	Green Published, gold, Green Submitted			2022-12-27	WOS:000379508200012
J	Furlan, M; Smith, AT; Walker, R				Furlan, Michele; Smith, Andrew T.; Walker, Robin			An fMRI Investigation of Preparatory Set in the Human Cerebral Cortex and Superior Colliculus for Pro- and Anti-Saccades	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; FRONTAL EYE FIELD; VOLUNTARY CONTROL; MOVEMENTS; TASK; ACTIVATION; SIGNALS; LOBE; EXECUTION; PATTERNS	Previous studies have identified several cortical regions that show larger BOLD responses during preparation and execution of anti-saccades than pro-saccades. We confirmed this finding with a greater BOLD response for anti-saccades than pro-saccades during the preparation phase in the FEF, IPS and DLPFC and in the FEF and IPS in the execution phase. We then applied multi-voxel pattern analysis (MVPA) to establish whether different neural populations are involved in the two types of saccade. Pro-saccades and anti-saccades were reliably decoded during saccade execution in all three cortical regions (FEF, DLPFC and IPS) and in IPS during saccade preparation. This indicates neural specialization, for programming the desired response depending on the task rule, in these regions. In a further study tailored for imaging the superior colliculus in the midbrain a similar magnitude BOLD response was observed for pro-saccades and anti-saccades and the two saccade types could not be decoded with MVPA. This was the case both for activity related to the preparation phase and also for that elicited during the execution phase. We conclude that separate cortical neural populations are involved in the task-specific programming of a saccade while in contrast, the SC has a role in response preparation but may be less involved in high-level, task-specific aspects of the control of saccades.	[Furlan, Michele; Smith, Andrew T.; Walker, Robin] Royal Holloway Univ London, Egham Hill, Egham TW20 0EX, Surrey, England	University of London; Royal Holloway University London	Walker, R (corresponding author), Royal Holloway Univ London, Egham Hill, Egham TW20 0EX, Surrey, England.	Robin.Walker@rhul.ac.uk		Walker, Robin/0000-0002-5277-1195	Leverhulme Trust [RPG-2012-586]	Leverhulme Trust(Leverhulme Trust)	Our research was funded by Leverhulme Trust Grant number RPG-2012-586 awarded to Prof. Andrew T. Smith and Prof. Robin Walker (https://www.leverhulme.ac.uk/).	Bender J, 2013, BRAIN COGNITION, V83, P1, DOI [10.1016/j.bandc.2013:06.005, 10.1016/j.bandc.2013.06.005]; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brouwer GJ, 2009, J NEUROSCI, V29, P13992, DOI 10.1523/JNEUROSCI.3577-09.2009; Carpenter RHS, 1988, MOVEMENTS EYES; Chan JL, 2015, J COGNITIVE NEUROSCI, V27, P1789, DOI 10.1162/jocn_a_00819; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Connolly JD, 2000, J NEUROPHYSIOL, V84, P1645, DOI 10.1152/jn.2000.84.3.1645; Connolly JD, 2002, NAT NEUROSCI, V5, P1345, DOI 10.1038/nn969; Cox DD, 2003, NEUROIMAGE, V19, P261, DOI 10.1016/S1053-8119(03)00049-1; Curtis CE, 2008, J NEUROPHYSIOL, V99, P133, DOI 10.1152/jn.00899.2007; DeSouza JFX, 2003, J NEUROPHYSIOL, V89, P1016, DOI 10.1152/jn.00562.2002; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Everling S, 2000, J NEUROSCI, V20, P387, DOI 10.1523/JNEUROSCI.20-01-00387.2000; Everling S, 1999, J NEUROSCI, V19, P2740; Everling S, 1998, J NEUROPHYSIOL, V80, P1584, DOI 10.1152/jn.1998.80.3.1584; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; FUKUSHIMA J, 1988, BIOL PSYCHIAT, V23, P670, DOI 10.1016/0006-3223(88)90050-9; Furlan M, 2015, J NEUROPHYSIOL; Furlan M, 2014, CEREB CORTEX, V24, P2848, DOI 10.1093/cercor/bht132; GUITTON D, 1985, EXP BRAIN RES, V58, P455; Hagberg GE, 2001, NEUROIMAGE, V14, P1193, DOI 10.1006/nimg.2001.0880; HALLETT PE, 1978, VISION RES, V18, P1279, DOI 10.1016/0042-6989(78)90218-3; HALLETT PE, 1980, VISION RES, V20, P329, DOI 10.1016/0042-6989(80)90019-X; Hutton SB, 2006, PSYCHOPHYSIOLOGY, V43, P302, DOI 10.1111/j.1469-8986.2006.00403.x; Johnston K, 2006, J NEUROSCI, V26, P12471, DOI 10.1523/JNEUROSCI.4101-06.2006; Johnston K, 2014, CEREB CORTEX, V24, P1373, DOI 10.1093/cercor/bhs424; Krebs RM, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00193; Krebs RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008691; Liversedge SP, 2000, TRENDS COGN SCI, V4, P6, DOI 10.1016/S1364-6613(99)01418-7; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Munoz DP, 2000, CAN J PHYSIOL PHARM, V78, P934, DOI 10.1139/cjpp-78-11-934; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Munoz DP, 2002, PROG BRAIN RES, V140, P89; Muri RM, 1998, J NEUROL NEUROSUR PS, V65, P374, DOI 10.1136/jnnp.65.3.374; ODRISCOLL GA, 1995, P NATL ACAD SCI USA, V92, P925, DOI 10.1073/pnas.92.3.925; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PIERROTDESEILLIGNY C, 1991, BRAIN, V114, P1473, DOI 10.1093/brain/114.3.1473; RIVAUD S, 1994, EXP BRAIN RES, V102, P110; ROBINSON DA, 1972, VISION RES, V12, P1795, DOI 10.1016/0042-6989(72)90070-3; Schwarzbach J, 2011, BEHAV RES METHODS; Sparks D L, 1989, Rev Oculomot Res, V3, P213; Sparks DL, 1999, CURR OPIN NEUROBIOL, V9, P698, DOI 10.1016/S0959-4388(99)00039-2; Walker R, 1998, NEUROPSYCHOLOGIA, V36, P1141, DOI 10.1016/S0028-3932(98)00004-9; Wurtz RH, 2000, COGNITIVE NEUROSCIEN, P341	46	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158337	10.1371/journal.pone.0158337	http://dx.doi.org/10.1371/journal.pone.0158337			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391390	gold, Green Published, Green Submitted			2022-12-27	WOS:000380005400044
J	Idelevich, EA; Becker, K; Schmitz, J; Knaack, D; Peters, G; Kock, R				Idelevich, Evgeny A.; Becker, Karsten; Schmitz, Janne; Knaack, Dennis; Peters, Georg; Koeck, Robin			Evaluation of an Automated System for Reading and Interpreting Disk Diffusion Antimicrobial Susceptibility Testing of Fastidious Bacteria	PLOS ONE			English	Article							VIDEO READER SYSTEM; ZONE READER; OSIRIS	Results of disk diffusion antimicrobial susceptibility testing depend on individual visual reading of inhibition zone diameters. Therefore, automated reading using camera systems might represent a useful tool for standardization. In this study, the ADAGIO automated system (Bio-Rad) was evaluated for reading disk diffusion tests of fastidious bacteria. 144 clinical isolates (68 beta-haemolytic streptococci, 28 Streptococcus pneumoniae, 18 viridans group streptococci, 13 Haemophilus influenzae, 7 Moraxella catarrhalis, and 10 Campylobacter jejuni) were tested on Mueller-Hinton agar supplemented with 5% defibrinated horse blood and 20 mg/L beta-NAD (MH-F, Oxoid) according to EUCAST. Plates were read manually with a ruler and automatically using the ADAGIO system. Inhibition zone diameters, indicated by the automated system, were visually controlled and adjusted, if necessary. Among 1548 isolate-antibiotic combinations, comparison of automated vs. manual reading yielded categorical agreement (CA) without visual adjustment of the automatically determined zone diameters in 81.4%. In 20% (309 of 1548) of tests it was deemed necessary to adjust the automatically determined zone diameter after visual control. After adjustment, CA was 94.8%; very major errors (false susceptible interpretation), major errors (false resistant interpretation) and minor errors (false categorization involving intermediate result), calculated according to the ISO 20776-2 guideline, accounted to 13.7% (13 of 95 resistant results), 3.3% (47 of 1424 susceptible results) and 1.4% (21 of 1548 total results), respectively, compared to manual reading. The ADAGIO system allowed for automated reading of disk diffusion testing in fastidious bacteria and, after visual validation of the automated results, yielded good categorical agreement with manual reading.	[Idelevich, Evgeny A.; Becker, Karsten; Knaack, Dennis; Peters, Georg; Koeck, Robin] Univ Hosp Munster, Inst Med Microbiol, Munster, Germany; [Schmitz, Janne] Univ Hosp Munster, Inst Hyg, Munster, Germany	University of Munster; University of Munster	Idelevich, EA (corresponding author), Univ Hosp Munster, Inst Med Microbiol, Munster, Germany.	evgeny.idelevich@ukmuenster.de	Becker, Karsten/O-2302-2018; Köck, Robin/AAC-1552-2019	Becker, Karsten/0000-0002-6391-1341; 				Andrews JM, 2000, J ANTIMICROB CHEMOTH, V46, P535, DOI 10.1093/jac/46.4.535; [Anonymous], 2007, ISOFDIS 20776 22007; Croxatto A, 2016, CLIN MICROBIOL INFEC, V22, P217, DOI 10.1016/j.cmi.2015.09.030; European Committee on Antimicrobial Susceptibility Testing, 2014, BREAKP TABL INT MICS; Geiss HK, 2000, DIAGN MICR INFEC DIS, V37, P151, DOI 10.1016/S0732-8893(00)00132-2; Hombach M, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-225; Jorgensen JH, 2009, CLIN INFECT DIS, V49, P1749, DOI 10.1086/647952; Kolbert M, 2004, CLIN MICROBIOL INFEC, V10, P416, DOI 10.1111/j.1469-0691.2004.00885.x; Korgenski EK, 1998, J CLIN MICROBIOL, V36, P302, DOI 10.1128/JCM.36.1.302-304.1998; Lestari ES, 2008, J MICROBIOL METH, V75, P177, DOI 10.1016/j.mimet.2008.05.020; Medeiros AA, 2000, J CLIN MICROBIOL, V38, P1688, DOI 10.1128/JCM.38.4.1688-1693.2000; Nijs A, 2003, J CLIN MICROBIOL, V41, P3627, DOI 10.1128/JCM.41.8.3627-3630.2003; Sanchez MA, 2001, CLIN MICROBIOL INFEC, V7, P352, DOI 10.1046/j.1198-743x.2001.00274.x; The European Committee on Antimicrobial Susceptibility Testing, 2014, EUCAST DISK DIFF MET; van Belkum A, 2013, J CLIN MICROBIOL, V51, P2018, DOI 10.1128/JCM.00313-13	15	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159183	10.1371/journal.pone.0159183	http://dx.doi.org/10.1371/journal.pone.0159183			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391898	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400217
J	Tiwari, A; Lemke, J; Altmueller, J; Thiele, H; Glaus, E; Fleischhauer, J; Nurnberg, P; Neidhardt, J; Berger, W				Tiwari, Amit; Lemke, Johannes; Altmueller, Janine; Thiele, Holger; Glaus, Esther; Fleischhauer, Johannes; Nuernberg, Peter; Neidhardt, John; Berger, Wolfgang			Identification of Novel and Recurrent Disease-Causing Mutations in Retinal Dystrophies Using Whole Exome Sequencing (WES): Benefits and Limitations	PLOS ONE			English	Article							AUTOSOMAL RECESSIVE BESTROPHINOPATHY; DOMINANT RETINITIS-PIGMENTOSA; SPLICING FACTOR PRP8; MISSENSE SUBSTITUTIONS; MACULAR DEGENERATION; PROTEIN FUNCTION; DOMAIN; VARIANTS; GENES; BRR2	Inherited retinal dystrophies (IRDs) are Mendelian diseases with tremendous genetic and phenotypic heterogeneity. Identification of the underlying genetic basis of these dystrophies is therefore challenging. In this study we employed whole exome sequencing (WES) in 11 families with IRDs and identified disease-causing variants in 8 of them. Sequence analysis of about 250 IRD-associated genes revealed 3 previously reported disease-associated variants in RHO, BEST1 and RP1. We further identified 5 novel pathogenic variants in RPGRIP1 (p.Ser964Profs*37), PRPF8 (p.Tyr2334Leufs*51), CDHR1 (p.Pro133Arg and c.439-17G>A) and PRPF31 (p.Glu183_Met193dup). In addition to confirming the power of WES in genetic diagnosis of IRDs, we document challenges in data analysis and show cases where the underlying genetic causes of IRDs were missed by WES and required additional techniques. For example, the mutation c.439-17G>A in CDHR1 would be rated unlikely applying the standardWES analysis. Only transcript analysis in patient fibroblasts confirmed the pathogenic nature of this variant that affected splicing of CDHR1 by activating a cryptic splice-acceptor site. In another example, a 33-base pair duplication in PRPF31 missed by WES could be identified only via targeted analysis by Sanger sequencing. We discuss the advantages and challenges of using WES to identify mutations in heterogeneous diseases like IRDs.	[Tiwari, Amit; Lemke, Johannes; Glaus, Esther; Neidhardt, John; Berger, Wolfgang] Univ Zurich, Inst Med Mol Genet, Wagistr 12, CH-8952 Schlieren, Switzerland; [Altmueller, Janine; Thiele, Holger; Nuernberg, Peter] Univ Cologne, CCG, Weyertal 115b, D-50931 Cologne, Germany; [Fleischhauer, Johannes] Univ Zurich Hosp, Dept Ophthalmol, Frauenklin Str 24, CH-8091 Zurich, Switzerland; [Nuernberg, Peter] Univ Cologne, CMMC, Robert Koch Str 21, D-50931 Cologne, Germany; [Nuernberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Joseph Stelzmann Str 26, D-50931 Cologne, Germany; [Berger, Wolfgang] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Berger, Wolfgang] Univ Zurich, Neurosci Ctr Zurich ZNZ, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Berger, Wolfgang] Swiss Fed Inst Technol, Neurosci Ctr Zurich ZNZ, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Lemke, Johannes] Univ Clin Leipzig, Inst Human Genet, Leipzig AoR, Philipp Rosenthal Str 55, D-04103 Leipzig, Germany; [Neidhardt, John] Carl von Ossietzky Univ Oldenburg, Fac Med & Hlth Sci, Human Genet, D-26129 Oldenburg, Germany; [Berger, Wolfgang] Carl von Ossietzky Univ Oldenburg, Res Ctr Neurosensory Sci, D-26111 Oldenburg, Germany	University of Cologne; University of Zurich; University Zurich Hospital; University of Cologne; University of Cologne; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Leipzig University; Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg	Tiwari, A (corresponding author), Univ Zurich, Inst Med Mol Genet, Wagistr 12, CH-8952 Schlieren, Switzerland.	tiwari@medmolgen.uzh.ch	Neidhardt, John/J-4310-2017; Thiele, Holger/ABE-6792-2020	Thiele, Holger/0000-0002-0169-998X; Neidhardt, John/0000-0002-9205-8394	Swiss National Science Foundation [320030_138507]; Velux Stiftung, Switzerland	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Velux Stiftung, Switzerland	This study was funded by a grant from the Swiss National Science Foundation (Grant Number: 320030_138507) to WB and JN and from Velux Stiftung, Switzerland to WB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Safieh L, 2013, GENOME RES, V23, P236, DOI 10.1101/gr.144105.112; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aldahmesh MA, 2009, MOL VIS, V15, P2464; Audo I, 2012, HUM MUTAT, V33, P73, DOI 10.1002/humu.21640; Berger W, 2010, PROG RETIN EYE RES, V29, P335, DOI 10.1016/j.preteyeres.2010.03.004; Beryozkin A, 2015, SCI REP-UK, V5, DOI 10.1038/srep13187; Boon CJF, 2009, PROG RETIN EYE RES, V28, P187, DOI 10.1016/j.preteyeres.2009.04.002; Consugar MB, 2015, GENET MED, V17, P253, DOI 10.1038/gim.2014.172; Corton M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065574; Davidson AE, 2011, INVEST OPHTH VIS SCI, V52, P3730, DOI 10.1167/iovs.10-6707; Dietrich K, 2002, BRIT J OPHTHALMOL, V86, P328, DOI 10.1136/bjo.86.3.328; Ellingford JM, 2016, J MED GENET, V53, P761, DOI 10.1136/jmedgenet-2016-103837; Glaus E, 2011, MOL THER, V19, P936, DOI 10.1038/mt.2011.7; Glockle N, 2014, EUR J HUM GENET, V22, P99, DOI 10.1038/ejhg.2013.72; Huang L, 2016, EXP EYE RES, V146, P252, DOI 10.1016/j.exer.2016.03.015; Johnson AA, 2015, INVEST OPHTH VIS SCI, V56, P4619, DOI 10.1167/iovs.15-16910; Kramer F, 2000, EUR J HUM GENET, V8, P286, DOI 10.1038/sj.ejhg.5200447; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu S, 2007, SCIENCE, V316, P115, DOI 10.1126/science.1137924; MacDonald IM, 2012, OPHTHALMIC GENET, V33, P123, DOI 10.3109/13816810.2011.592172; Maeder C, 2009, NAT STRUCT MOL BIOL, V16, P42, DOI 10.1038/nsmb.1535; Mathe E, 2006, NUCLEIC ACIDS RES, V34, P1317, DOI 10.1093/nar/gkj518; Mozaffari-Jovin S, 2013, SCIENCE, V341, P80, DOI 10.1126/science.1237515; Mozaffari-Jovin S, 2012, GENE DEV, V26, P2422, DOI 10.1101/gad.200949.112; Nikopoulos K, 2015, SCI REP-UK, V5, DOI 10.1038/srep13902; Payne A, 2000, INVEST OPHTH VIS SCI, V41, P4069; Pena V, 2007, MOL CELL, V25, P615, DOI 10.1016/j.molcel.2007.01.023; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Stone EA, 2005, GENOME RES, V15, P978, DOI 10.1101/gr.3804205; Sullivan LS, 2006, INVEST OPHTH VIS SCI, V47, P3052, DOI 10.1167/iovs.05-1443; Tavtigian SV, 2006, J MED GENET, V43, P295, DOI 10.1136/jmg.2005.033878; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Villegas Jacob, 2005, Curr Protoc Mol Biol, VChapter 28, DOI 10.1002/0471142727.mb2803s71; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Xu Y, 2014, HUM GENET, V133, P1255, DOI 10.1007/s00439-014-1460-2; Yang ZL, 2008, J CLIN INVEST, V118, P2908, DOI 10.1172/JCI35891; Zhang LD, 2007, PROTEIN SCI, V16, P1024, DOI 10.1110/ps.072872007; Zhao L, 2015, HUM GENET, V134, P217, DOI 10.1007/s00439-014-1512-7	41	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158692	10.1371/journal.pone.0158692	http://dx.doi.org/10.1371/journal.pone.0158692			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391102	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000380005400105
J	Tschinkel, WR; Seal, JN				Tschinkel, Walter R.; Seal, Jon N.			Bioturbation by the Fungus-Gardening Ant, Trachymyrmex septentrionalis	PLOS ONE			English	Article							GRASS-CUTTING ANT; ACROMYRMEX-HEYERI; NEST ARCHITECTURE; SOIL PROPERTIES; HYMENOPTERA; FORMICIDAE; PHYLOGEOGRAPHY; PREFERENCE; AUSTRALIA; EVOLUTION	Soil invertebrates such as ants are thought to be important manipulators of soils in temperate and tropical ecosystems. The fungus gardening ant, Trachymyrmex septentrionalis, is an important agent of biomantling, that is, of depositing soil excavated from below onto the surface, and has been suggested as an agent of bioturbation (moving soil below ground) as well. The amount of bioturbation by this ant was quantified by planting queenright colonies in sand columns consisting of 5 layers of different colored sand. The amount of each color of sand deposited on the surface was determined from April to November 2015. In November, colonies were excavated and the color and amount of sand deposited below ground (mostly as backfill in chambers) was determined. Extrapolated to one ha, T. septentrionalis deposited 800 kg of sand per annum on the surface, and an additional 200 kg (17% of the total excavated) below ground. On average, this mixes 1.3% of the sand from other layers within the top meter of soil per millennium, but this mixing is unlikely to be homogeneous, and probably occurs as "hotspots" in both horizontal and vertical space. Such mixing is discussed as a challenge to sediment dating by optically stimulated luminescence (OSL).	[Tschinkel, Walter R.] Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA; [Seal, Jon N.] Univ Texas Tyler, Ctr Environm Biodivers & Conservat, Dept Biol, Tyler, TX 75799 USA	State University System of Florida; Florida State University; University of Texas System; University of Texas at Tyler	Tschinkel, WR (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	tschinkel@bio.fsu.edu	Seal, Jon/M-7396-2018	Seal, Jon/0000-0001-8013-1438	National Science Foundation [IOS 1021632, DEB 1354629]; Division Of Integrative Organismal Systems [1552822] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by National Science Foundation grant No. IOS 1021632 and DEB 1354629. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful for the competent and cheerful technical help of Tyler Murdock, Nicholas Hanley and Daniel Dominguez. This work was supported in part by National Science Foundation grant No. IOS 1021632 and DEB 1354629. We thank the US Forest Service, Apalachicola National Forest for permits to carry out this research project in the national forest.	Bateman MD, 2003, QUATERNARY SCI REV, V22, P1169, DOI 10.1016/S0277-3791(03)00019-2; Bollazzi M, 2002, INSECT SOC, V49, P153, DOI 10.1007/s00040-002-8295-x; Bollazzi M, 2008, OECOLOGIA, V158, P165, DOI 10.1007/s00442-008-1113-z; Bollazzi M, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.13701; Bucher EH, 2004, BIOTROPICA, V36, P327, DOI 10.1646/04005; Cerda A, 2008, J APPL ENTOMOL, V132, P306, DOI 10.1111/j.1439-0418.2008.01267.x; Darwin C, 1881, FORMATION VEGETABLE, DOI DOI 10.1017/CBO9780511703850; DEBRUYN LAL, 1994, AUST J SOIL RES, V32, P555, DOI 10.1071/SR9940555; Dorn RI, 2014, GEOLOGY, V42, P771, DOI 10.1130/G35825.1; ELDRIDGE DJ, 1994, AUST J SOIL RES, V32, P323, DOI 10.1071/SR9940323; Farji Brener AG, 2004, J VEG SCI, V15, P823; Folgarait PJ, 1998, BIODIVERS CONSERV, V7, P1221, DOI 10.1023/A:1008891901953; Forrest B, 2003, QUATERNARY SCI REV, V22, P1279, DOI 10.1016/S0277-3791(03)00028-3; Gabet EJ, 2003, ANNU REV EARTH PL SC, V31, P249, DOI 10.1146/annurev.earth.31.100901.141314; Galbraith RF, 1999, ARCHAEOMETRY, V41, P339, DOI 10.1111/j.1475-4754.1999.tb00987.x; HAINES B, 1983, Tropical Ecology, V24, P85; Halfen AF, 2010, 19 WORLD C SOIL SCI; Humphreys G.S., 1998, 16 WORLD C SOIL SCI; HUNTLEY DJ, 1985, NATURE, V313, P105, DOI 10.1038/313105a0; JOHNSON DL, 1990, SOIL SCI, V149, P84, DOI 10.1097/00010694-199002000-00004; Johnson DL, 2010, 19 WORLD C SOIL SCI; King JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075843; Licht HHD, 2010, EVOLUTION, V64, P2055, DOI 10.1111/j.1558-5646.2010.00948.x; McGlynn TP, 2012, ANNU REV ENTOMOL, V57, P291, DOI 10.1146/annurev-ento-120710-100708; Meysman FJR, 2006, TRENDS ECOL EVOL, V21, P688, DOI 10.1016/j.tree.2006.08.002; Mikheyev AS, 2008, MOL ECOL, V17, P4480, DOI 10.1111/j.1365-294X.2008.03940.x; Moser JC, 2006, ANN ENTOMOL SOC AM, V99, P891, DOI 10.1603/0013-8746(2006)99[891:CEAMOA]2.0.CO;2; Moutinho P, 2003, ECOLOGY, V84, P1265, DOI 10.1890/0012-9658(2003)084[1265:IOLANO]2.0.CO;2; Mueller UG, 2011, P NATL ACAD SCI USA, V108, P4053, DOI 10.1073/pnas.1015806108; Myers R.L., 1990, P150; Nkem JN, 2000, PEDOBIOLOGIA, V44, P609, DOI 10.1078/S0031-4056(04)70075-X; Phillips JD, 2007, CATENA, V70, P92, DOI 10.1016/j.catena.2006.08.002; Pielstrom S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057040; Richards PJ, 2011, EARTH SURF PROC LAND, V36, P1240, DOI 10.1002/esp.2149; Richards PJ, 2009, EARTH-SCI REV, V96, P92, DOI 10.1016/j.earscirev.2009.06.004; Rink WJ, 2013, J ARCHAEOL SCI, V40, P2217, DOI 10.1016/j.jas.2012.11.006; Robins R, 2011, ENVIRON ARCHAEOL, V16, P151, DOI 10.1179/174963111X13110803261010; Roces F, 2000, INSECT SOC, V47, P348, DOI 10.1007/PL00001728; Rodrigues K. F., 2013, THESIS; Scott JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009922; Seal JN, 2007, PHYSIOL ENTOMOL, V32, P8, DOI 10.1111/j.1365-3032.2006.00534.x; Seal JN, 2006, ANN ENTOMOL SOC AM, V99, P673, DOI 10.1603/0013-8746(2006)99[673:CPOTFA]2.0.CO;2; Seal JN, 2015, BIOL J LINN SOC, V114, P689, DOI 10.1111/bij.12426; Seal JN, 2010, INSECT CONSERV DIVER, V3, P134, DOI 10.1111/j.1752-4598.2010.00085.x; Tschinkel WR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139922; Tschinkel WR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120407; Tschinkel WR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112981; TSCHINKEL WR, 1974, ENVIRON ENTOMOL, V3, P667, DOI 10.1093/ee/3.4.667; Tschinkel WR, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.21; Tschinkel WR, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.9; Tschinkel WR, 2003, PALAEOGEOGR PALAEOCL, V192, P321, DOI 10.1016/S0031-0182(02)00690-9; Tschinkel WR, 2011, J INSECT SCI; Whitford WG, 2000, INVERTEBRATES AS WEB-MASTERS IN ECOSYSTEMS, P25, DOI 10.1079/9780851993942.0025; Wilkinson MT, 2009, EARTH-SCI REV, V97, P257, DOI 10.1016/j.earscirev.2009.09.005	54	15	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158920	10.1371/journal.pone.0158920	http://dx.doi.org/10.1371/journal.pone.0158920			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391485	Green Published, gold			2022-12-27	WOS:000380005400162
J	van Lummel, RC; Walgaard, S; Maier, AB; Ainsworth, E; Beek, PJ; van Dieen, JH				van Lummel, Rob C.; Walgaard, Stefan; Maier, Andrea B.; Ainsworth, Erik; Beek, Peter J.; van Dieen, Jaap H.			The Instrumented Sit-to-Stand Test (iSTS) Has Greater Clinical Relevance than the Manually Recorded Sit-to-Stand Test in Older Adults	PLOS ONE			English	Article							PHYSICAL PERFORMANCE-MEASURES; BODY FIXED SENSOR; FUNCTIONAL STATUS; CHAIR; ACCELEROMETERS; PREDICTOR; MOVEMENTS; ACCURACY; STRENGTH; BREAKING	Background The ability to rise from sitting to standing is critical to an individual's quality of life, as it is a prerequisite for functional independence. The purpose of the current study was to examine the hypothesis that test durations as assessed with the instrumented repeated Sit-To-Stand (STS) show stronger associations with health status, functional status and daily physical activity of older adults than manually recorded test durations. Methods In 63 older participants (mean age 83 +/- 6.9 years, 51 female), health status was assessed using the European Quality of Life questionnaire and functional status was assessed using the physical function index of the of the RAND-36. Physical performance was measured using a wearable sensor-based STS test. From this test, durations, sub-durations and kinematics of the STS movements were estimated and analysed. In addition, physical activity was measured for one week using an activity monitor and episodes of lying, sitting, standing and locomotion were identified. Associations between STS parameters with health status, functional status and daily physical activity were assessed. Results The manually recorded STS times were not significantly associated with health status (p = 0.457) and functional status (p = 0.055), whereas the instrumented STS times were (both p = 0.009). The manually recorded STS durations showed a significant association to daily physical activity for mean sitting durations (p = 0.042), but not for mean standing durations (p = 0.230) and mean number of locomotion periods (p = 0.218). Furthermore, durations of the dynamic sit-to-stand phase of the instrumented STS showed more significant associations with health status, functional status and daily physical activity (all p = 0.001) than the static phases standing and sitting (p = 0.043-0.422). Conclusions As hypothesized, instrumented STS durations were more strongly associated with participant health status, functional status and physical activity than manually recorded STS durations in older adults. Furthermore, instrumented STS allowed assessment of the dynamic phases of the test, which were likely more informative than the static sitting and standing phases.	[van Lummel, Rob C.; Walgaard, Stefan; Ainsworth, Erik] McRoberts BV, Raamweg 43, NL-2596 HN The Hague, Netherlands; [van Lummel, Rob C.; Maier, Andrea B.; Beek, Peter J.; van Dieen, Jaap H.] Vrije Univ Amsterdam, Dept Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands; [Maier, Andrea B.] Univ Melbourne, Royal Melbourne Hosp, Dept Med & Aged Care, Melbourne, Vic 3010, Australia	Vrije Universiteit Amsterdam; Royal Melbourne Hospital; University of Melbourne	van Lummel, RC (corresponding author), McRoberts BV, Raamweg 43, NL-2596 HN The Hague, Netherlands.; van Lummel, RC (corresponding author), Vrije Univ Amsterdam, Dept Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands.	r.vanlummel@mcroberts.nl	van Dieen, Jaap/B-3937-2013; Maier, Andrea/W-7060-2019; Maier, Andrea B./Q-5548-2019	van Dieen, Jaap/0000-0002-7719-5585; Maier, Andrea/0000-0001-7206-1724; Beek, Peter/0000-0002-0917-8548	Netherlands Organization for Scientific Research (NWO TOP NIG grant) [91209021]; Innovation Fund of Agis/Achmea (Innovatiefonds grant) [499256]; Dutch health insurance company	Netherlands Organization for Scientific Research (NWO TOP NIG grant)(Netherlands Organization for Scientific Research (NWO)); Innovation Fund of Agis/Achmea (Innovatiefonds grant); Dutch health insurance company	This work was supported by a grant from the Netherlands Organization for Scientific Research (NWO TOP NIG grant 91209021) for the development of a novel instrument to support fall prevention in extramural care, as well as a grant from the Innovation Fund of Agis/Achmea (Innovatiefonds grant 499256), a Dutch health insurance company. The aim was to develop a fall prevention program for inhabitants of a care home and the community. These funding organizations had no involvement with the contents of the study.	Benatti FB, 2015, MED SCI SPORT EXER, V47, P2053, DOI 10.1249/MSS.0000000000000654; BOHANNON RW, 1995, PERCEPT MOTOR SKILL, V80, P163, DOI 10.2466/pms.1995.80.1.163; Boonstra MC, 2006, J BIOMECH, V39, P354, DOI 10.1016/j.jbiomech.2004.11.021; Buford TW, 2010, AGEING RES REV, V9, P369, DOI 10.1016/j.arr.2010.04.004; Chauhan JS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067008, 10.1371/journal.pone.0080000]; Dijkstra B, 2008, AGE AGEING, V37, P436, DOI 10.1093/ageing/afn097; Dunstan DW, 2012, DIABETES CARE, V35, P976, DOI 10.2337/dc11-1931; Foldvari M, 2000, J GERONTOL A-BIOL, V55, pM192, DOI 10.1093/gerona/55.4.M192; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fryback DG, 2007, MED CARE, V45, P1162, DOI 10.1097/MLR.0b013e31814848f1; Giansanti D, 2006, PHYSIOL MEAS, V27, P713, DOI 10.1088/0967-3334/27/8/006; Glenn JM, 2015, J GERIATR PHYS THER, V71270, P1; Gray M, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-145; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; GURALNIK JM, 1989, J GERONTOL, V44, pM141, DOI 10.1093/geronj/44.5.M141; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Hamilton MT, 2008, CURR CARDIOVASC RISK, V2, P292, DOI 10.1007/s12170-008-0054-8; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; HODGE WA, 1986, P NATL ACAD SCI USA, V83, P2879, DOI 10.1073/pnas.83.9.2879; Hortobagyi T, 2003, J GERONTOL A-BIOL, V58, P453; Hughes MA, 1996, J BIOMECH, V29, P1509, DOI 10.1016/0021-9290(96)00083-8; Ito K, 2009, CHEST, V135, P173, DOI 10.1378/chest.08-1419; Jones CJ, 1999, RES Q EXERCISE SPORT, V70, P113, DOI 10.1080/02701367.1999.10608028; Jones SE, 2013, THORAX, V68, P1015, DOI 10.1136/thoraxjnl-2013-203576; Millor N, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-86; Najafi B, 2002, IEEE T BIO-MED ENG, V49, P843, DOI 10.1109/TBME.2002.800763; Narici MV, 2010, BRIT MED BULL, V95, P139, DOI 10.1093/bmb/ldq008; Pai Y, 1990, MED SCI SPORTS EXERC; Penninx BWJH, 2000, J GERONTOL A-BIOL, V55, pM691, DOI 10.1093/gerona/55.11.M691; Rabinovich RA, 2013, EUR RESPIR J, V42, P1205, DOI 10.1183/09031936.00134312; Regterschot GRH, 2015, GAIT POSTURE, V41, P935, DOI 10.1016/j.gaitpost.2015.03.350; RILEY PO, 1991, J BIOMECH, V24, P77, DOI 10.1016/0021-9290(91)90328-K; Rolland Y, 2006, EUR J EPIDEMIOL, V21, P113, DOI 10.1007/s10654-005-5458-x; Rosenberg IH, 1997, J NUTR, V127, P990; SCHENKMAN M, 1990, PHYS THER, V70, P638, DOI 10.1093/ptj/70.10.638; Schwenk M, 2012, PHYSIOL MEAS, V33, P1931, DOI 10.1088/0967-3334/33/11/1931; SKELTON DA, 1994, AGE AGEING, V23, P371, DOI 10.1093/ageing/23.5.371; Studenski S, 2003, J AM GERIATR SOC, V51, P314, DOI 10.1046/j.1532-5415.2003.51104.x; Van Hees VT, 2009, MED SCI SPORT EXER, V41, P810, DOI 10.1249/MSS.0b013e31818ff636; Van Lummel RC, 2013, GAIT POSTURE, V38, P153, DOI 10.1016/j.gaitpost.2012.10.008; van Lummel RC, 2012, PHYSIOL MEAS, V33, P1855, DOI 10.1088/0967-3334/33/11/1855; van Lummel RC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151881; van Lummel RC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144048; Van Remoortel H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039198; van Schooten KS, 2015, J AGING PHYS ACTIV, V23, P9, DOI [10.1123/japa.2013-0103, 10.1123/JAPA.2013-0103]; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Williamson R, 2001, MED BIOL ENG COMPUT, V39, P294, DOI 10.1007/BF02345283; Zijlstra A., 2012, J NEUROENG REHABIL, V9, P1, DOI DOI 10.HTT0S://D0I.0RG/10.1186/1743-0003-9-75	49	47	47	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0157968	10.1371/journal.pone.0157968	http://dx.doi.org/10.1371/journal.pone.0157968			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27391082	Green Published, gold			2022-12-27	WOS:000380005400027
J	Huang, PP; Brusman, LE; Iyer, AK; Webster, NJG; Mellon, PL				Huang, Polly P.; Brusman, Liza E.; Iyer, Anita K.; Webster, Nicholas J. G.; Mellon, Pamela L.			A Novel Gonadotropin-Releasing Hormone 1 (Gnrh1) Enhancer-Derived Noncoding RNA Regulates Gnrh1 Gene Expression in GnRH Neuronal Cell Models	PLOS ONE			English	Article							INTEGRATIVE GENOMICS VIEWER; HOMEODOMAIN PROTEINS; GT1-7 CELLS; TRANSCRIPTION; CHROMATIN; INFERTILITY; PROMOTER; ELEMENTS; REVEALS; OCT-1	Gonadotropin-releasing hormone (GnRH), a neuropeptide released from a small population of neurons in the hypothalamus, is the central mediator of the hypothalamic-pituitarygonadal axis, and is required for normal reproductive development and function. Evolutionarily conserved regulatory elements in the mouse, rat, and human Gnrh1 gene include three enhancers and the proximal promoter, which confer Gnrh1 gene expression specifically in GnRH neurons. In immortalized mouse hypothalamic GnRH (GT1-7) neurons, which show pulsatile GnRH release in culture, RNA sequencing and RT-qPCR revealed that expression of a novel long noncoding RNA at Gnrh1 enhancer 1 correlates with high levels of GnRH mRNA expression. In GT1-7 neurons, which contain a transgene carrying 3 kb of the rat Gnrh1 regulatory region, both the mouse and rat Gnrh1 enhancer-derived noncoding RNAs (GnRH-E1 RNAs) are expressed. We investigated the characteristics and function of the endogenous mouse GnRH-E1 RNA. Strand-specific RT-PCR analysis of GnRH-E1 RNA in GT1-7 cells revealed GnRH-E1 RNAs that are transcribed in the sense and antisense directions from distinct 5' start sites, are 3' polyadenylated, and are over 2 kb in length. These RNAs are localized in the nucleus and have a half-life of over 8 hours. In GT1-7 neurons, siRNA knockdown of mouse GnRH-E1 RNA resulted in a significant decrease in the expression of the Gnrh1 primary transcript and Gnrh1 mRNA. Over-expression of either the sense or antisense mouse GnRH-E1 RNA in immature, migratory GnRH (GN11) neurons, which do not express either GnRH-E1 RNA or GnRH mRNA, induced the transcriptional activity of co-transfected rat Gnrh1 gene regulatory elements, where the induction requires the presence of the rat Gnrh1 promoter. Together, these data indicate that GnRH-E1 RNA is an inducer of Gnrh1 gene expression. GnRH-E1 RNA may play an important role in the development and maturation of GnRH neurons.	[Huang, Polly P.; Brusman, Liza E.; Iyer, Anita K.; Mellon, Pamela L.] Univ Calif San Diego, Dept Reprod Med, La Jolla, CA 92093 USA; [Webster, Nicholas J. G.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Huang, Polly P.; Brusman, Liza E.; Iyer, Anita K.; Webster, Nicholas J. G.; Mellon, Pamela L.] Univ Calif San Diego, Ctr Reprod Sci & Med, La Jolla, CA 92093 USA; [Iyer, Anita K.] Illumina Inc, 5200 Illumina Way, San Diego, CA 92122 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Illumina	Mellon, PL (corresponding author), Univ Calif San Diego, Dept Reprod Med, La Jolla, CA 92093 USA.; Mellon, PL (corresponding author), Univ Calif San Diego, Ctr Reprod Sci & Med, La Jolla, CA 92093 USA.	pmellon@ucsd.edu	Webster, Nick/AAI-8410-2021	Mellon, Pamela/0000-0002-8856-0410	National Institutes of Health [R01 HD082567, R01 HD072754, R01 HD020377, R01 CA196853, U54 CA155435, P30 DK063491, P42 ES101337]; National Institutes of Health, Specialized Cooperative Centers Program in Reproduction and Infertility Research [U54 HD012303]; Veterans Affairs [101BX002709]; Endocrine Society;  [P30 CA023100];  [T32 DK007541];  [F32 HD058427];  [T32 DK007494]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007203, P50HD012303, R01HD082567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, Specialized Cooperative Centers Program in Reproduction and Infertility Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs); Endocrine Society; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health grants R01 HD082567, R01 HD072754, and R01 HD020377 (to P.L.M.) and by the National Institutes of Health through a cooperative agreement (U54 HD012303) as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research (P.L.M. and N.J. G.W.). This work was also supported by National Institutes of Health grants R01 CA196853 and U54 CA155435 and Veterans Affairs grant 101BX002709 (N.J.G.W.). P.L.M. and N.J.G.W. were partially supported by P30 DK063491 and P30 CA023100, and P.L.M. was partially supported by P42 ES101337. P.P.H. was partially supported by T32 DK007541. L.E.B. was partially supported by the Endocrine Society. A.K.I. was partially supported by F32 HD058427 and T32 DK007494. Additional grants: National Institutes of Health R01 HD020377 to Pamela L. Mellon, National Institutes of Health P30 DK063491 to Pamela L. Mellon and Nicholas J. G. Webster, and National Institutes of Health P42 ES101337 to Pamela L. Mellon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281; Caley DP, 2010, THESCIENTIFICWORLDJO, V10, P90, DOI 10.1100/tsw.2010.7; Chappell PE, 2003, J NEUROSCI, V23, P11202; CLARK ME, 1995, MOL CELL BIOL, V15, P6169; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Eraly SA, 1998, MOL ENDOCRINOL, V12, P469, DOI 10.1210/me.12.4.469; Feng JC, 2006, GENE DEV, V20, P1470, DOI 10.1101/gad.1416106; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Givens ML, 2005, J BIOL CHEM, V280, P19156, DOI 10.1074/jbc.M502004200; Givens ML, 2004, MOL ENDOCRINOL, V18, P2950, DOI 10.1210/me.2003-0437; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hoffmann HM, 2016, J NEUROSCI, V36, P3506, DOI 10.1523/JNEUROSCI.2723-15.2016; Iyer AK, 2011, MOL ENDOCRINOL, V25, P460, DOI 10.1210/me.2010-0403; Iyer AK, 2010, MOL ENDOCRINOL, V24, P1949, DOI 10.1210/me.2010-0156; Kaiser UB, 2005, ENDOCRINE, V26, P277, DOI 10.1385/ENDO:26:3:277; Kelley CG, 2002, MOL ENDOCRINOL, V16, P2413, DOI 10.1210/me.2002-0189; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kinsey-Jones JS, 2005, J NEUROENDOCRINOL, V17, P541, DOI 10.1111/j.1365-2826.2005.01341.x; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Lai F, 2014, CURR OPIN GENET DEV, V25, P38, DOI 10.1016/j.gde.2013.11.017; Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884; Larder R, 2011, J NEUROSCI, V31, P426, DOI 10.1523/JNEUROSCI.1688-10.2011; Lawson MA, 1998, MOL CELL ENDOCRINOL, V140, P157, DOI 10.1016/S0303-7207(98)00044-6; Lawson MA, 1996, MOL CELL BIOL, V16, P3596; Lawson MA, 1998, MOL ENDOCRINOL, V12, P364, DOI 10.1210/me.12.3.364; Lawson MA, 2002, ENDOCRINOLOGY, V143, P1404, DOI 10.1210/en.143.4.1404; Layman LC, 2003, ENDOCRIN METAB CLIN, V32, P549, DOI 10.1016/S0889-8529(03)00040-9; Maamar H, 2013, GENE DEV, V27, P1260, DOI 10.1101/gad.217018.113; Maggi R, 2000, ENDOCRINOLOGY, V141, P2105, DOI 10.1210/en.141.6.2105; Melgar MF, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r113; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Mercer TR, 2013, NAT STRUCT MOL BIOL, V20, P300, DOI 10.1038/nsmb.2480; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Nelson SB, 2000, MOL ENDOCRINOL, V14, P1509, DOI 10.1210/me.14.9.1509; Novaira HJ, 2011, J NEUROSCI, V31, P3336, DOI 10.1523/JNEUROSCI.5419-10.2011; Orom UA, 2011, CURR OPIN GENET DEV, V21, P194, DOI 10.1016/j.gde.2011.01.020; Pnueli L, 2015, P NATL ACAD SCI USA, V112, P4369, DOI 10.1073/pnas.1414841112; RADOVICK S, 1991, P NATL ACAD SCI USA, V88, P3402, DOI 10.1073/pnas.88.8.3402; Rave-Harel N, 2004, J BIOL CHEM, V279, P30287, DOI 10.1074/jbc.M402960200; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sun M, 2015, ENDOCR REV, V36, P25, DOI 10.1210/er.2014-1034; Swaab DF, 1997, ACTA PAEDIATR, V86, P50; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tobet SA, 2006, ENDOCRINOLOGY, V147, P1159, DOI 10.1210/en.2005-1275; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tsai PS, 2006, NAT CLIN PRACT ENDOC, V2, P160, DOI 10.1038/ncpendmet0119; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; WEINER RI, 1993, HUM REPROD, V8, P13, DOI 10.1093/humrep/8.suppl_2.13; WETSEL WC, 1991, ENDOCRINOLOGY, V129, P1584, DOI 10.1210/endo-129-3-1584; WETSEL WC, 1992, P NATL ACAD SCI USA, V89, P4149, DOI 10.1073/pnas.89.9.4149; WHYTE DB, 1995, MOL ENDOCRINOL, V9, P467, DOI 10.1210/me.9.4.467; Zhen SJ, 1997, J BIOL CHEM, V272, P12620, DOI 10.1074/jbc.272.19.12620	56	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158597	10.1371/journal.pone.0158597	http://dx.doi.org/10.1371/journal.pone.0158597			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27389022	Green Published, gold, Green Submitted			2022-12-27	WOS:000379811500028
J	Niu, SY; Wang, YL; Zhao, ZL; Deng, MJ; Cao, L; Yang, L; Fan, GQ				Niu, Suyan; Wang, Yuanlong; Zhao, Zhenli; Deng, Minjie; Cao, Lin; Yang, Lu; Fan, Guoqiang			Transcriptome and Degradome of microRNAs and Their Targets in Response to Drought Stress in the Plants of a Diploid and Its Autotetraploid Paulownia australis	PLOS ONE			English	Article							GENOME-WIDE IDENTIFICATION; ABSCISIC-ACID; REGULATED MICRORNAS; ARABIDOPSIS; TOLERANCE; SALT; EXPRESSION; GENE; MIRNAS; OVEREXPRESSION	MicroRNAs (miRNAs) are small, non-coding RNAs that play vital roles in plant growth, development, and stress response. Increasing numbers of studies aimed at discovering miRNAs and analyzing their functions in plants are being reported. In this study, we investigated the effect of drought stress on the expression of miRNAs and their targets in plants of a diploid and derived autotetraploid Paulownia australis. Four small RNA (sRNA) libraries and four degradome libraries were constructed from diploid and autotetraploid P. australis plants treated with either 75% or 25% relative soil water content. A total of 33 conserved and 104 novel miRNAs (processing precision value > 0.1) were identified, and 125 target genes were identified for 36 of the miRNAs by using the degradome sequencing. Among the identified miRNAs, 54 and 68 were differentially expressed in diploid and autotetraploid plants under drought stress (25% relative soil water content), respectively. The expressions of miRNAs and target genes were also validated by quantitative real-time PCR. The results showed that the relative expression trends of the randomly selected miRNAs were similar to the trends predicted by Illumina sequencing. And the correlations between miRNAs and their target genes were also analyzed. Furthermore, the functional analysis showed that most of these miRNAs and target genes were associated with plant development and environmental stress response. This study provided molecular evidence for the possible involvement of certain miRNAs in the drought response and/or tolerance in P. australis, and certain level of differential expression between diploid and autotetraploid plants.	[Niu, Suyan; Wang, Yuanlong; Zhao, Zhenli; Deng, Minjie; Cao, Lin; Yang, Lu; Fan, Guoqiang] Henan Agr Univ, Inst Paulownia, 95 Wenhua Rd, Zhengzhou 450002, Henan, Peoples R China; [Niu, Suyan; Wang, Yuanlong; Zhao, Zhenli; Deng, Minjie; Cao, Lin; Yang, Lu; Fan, Guoqiang] Henan Agr Univ, Coll Forestry, 95 Wenhua Rd, Zhengzhou 450002, Henan, Peoples R China	Henan Agricultural University; Henan Agricultural University	Fan, GQ (corresponding author), Henan Agr Univ, Inst Paulownia, 95 Wenhua Rd, Zhengzhou 450002, Henan, Peoples R China.; Fan, GQ (corresponding author), Henan Agr Univ, Coll Forestry, 95 Wenhua Rd, Zhengzhou 450002, Henan, Peoples R China.	zlxx64@126.com	Zhou, Man/S-4256-2016		National Natural Science Foundation of China [30271082, 30571496, U1204309]; Outstanding Talents Project 347 of Henan Province [122101110700]; Transformation Project of the National Agricultural Scientific and Technological Achievement of China [2012GB2D000271]; Science and Technology Innovation Team Project of Zhengzhou City, China [121PCXTD515]; Outstanding Talents Project of Henan Province [122101110700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Outstanding Talents Project 347 of Henan Province; Transformation Project of the National Agricultural Scientific and Technological Achievement of China; Science and Technology Innovation Team Project of Zhengzhou City, China; Outstanding Talents Project of Henan Province	This study was funded by the National Natural Science Foundation of China (grant number 30271082, 30571496, U1204309), by the Outstanding Talents Project 347 of Henan Province (grant number 122101110700), by the Transformation Project of the National Agricultural Scientific and Technological Achievement of China (grant number 2012GB2D000271), and by the Science and Technology Innovation Team Project of Zhengzhou City, China (grant number 121PCXTD515). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We sincerely thank the editor and reviewers for their thoughtful comments for improving our manuscript. We also thank Dr. Xiu-Qing Li of Agriculture and Agri-Food Canada for internal review of the revised manuscript. This study was funded by the National Natural Science Foundation of China (Grant number 30271082, 30571496, U1204309), by the Outstanding Talents Project of Henan Province (Grant number 122101110700), by the Transformation Project of the National Agricultural Scientific and Technological Achievement of China (Grant number 2012GB2D000271), and by the Science and Technology Innovation Team Project of Zhengzhou City, China (Grant number 121PCXTD515).	Adams KL, 2005, CURR OPIN PLANT BIOL, V8, P135, DOI 10.1016/j.pbi.2005.01.001; Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Anssour S, 2009, ANN BOT-LONDON, V103, P1207, DOI 10.1093/aob/mcp058; Ates S, 2008, AFR J BIOTECHNOL, V7, P4153; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Cartolano M, 2007, NAT GENET, V39, P901, DOI 10.1038/ng2056; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dai XY, 2007, PLANT PHYSIOL, V143, P1739, DOI 10.1104/pp.106.094532; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Dong YP, 2014, INT J MOL SCI, V15, P4583, DOI 10.3390/ijms15034583; Fan GQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140590; Fan GQ, 2014, BIOCHIMIE, V102, P68, DOI 10.1016/j.biochi.2014.02.008; Fan GuoQiang, 2009, Journal of Northwest A & F University - Natural Science Edition, V37, P83; Geddy R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-130; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; GIRAUDAT J, 1994, PLANT MOL BIOL, V26, P1557, DOI 10.1007/BF00016490; Goettel W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086153; GOFFEAU A, 2004, CHEMISTRY, V1, P1; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Hao DC, 2012, PHYSIOL PLANTARUM, V146, P388, DOI 10.1111/j.1399-3054.2012.01668.x; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kuang HH, 2005, PLANT J, V44, P37, DOI 10.1111/j.1365-313X.2005.02506.x; Kulcheski FR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-307; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Kwak PB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-457; Leitch IJ, 1997, TRENDS PLANT SCI, V2, P470, DOI 10.1016/S1360-1385(97)01154-0; Li BS, 2011, J EXP BOT, V62, P3765, DOI 10.1093/jxb/err051; Li JJ, 2001, PLANT CELL, V13, P2269, DOI 10.1105/tpc.13.10.2269; Li W, 2012, PLANT PHYSIOL, V158, P1279, DOI 10.1104/pp.111.188789; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Li XQ, 2016, CURR ISSUES MOL BIOL, V20, P29; Liao Y, 2008, PLANTA, V228, P225, DOI 10.1007/s00425-008-0731-3; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu SF, 2008, PLANT J, V55, P131, DOI 10.1111/j.1365-313X.2008.03497.x; Mallory AC, 2004, CURR BIOL, V14, P1035, DOI 10.1016/j.cub.2004.06.022; Man MZ, 2000, BIOINFORMATICS, V16, P953, DOI 10.1093/bioinformatics/16.11.953; Marechal A, 2010, NEW PHYTOL, V186, P299, DOI 10.1111/j.1469-8137.2010.03195.x; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Nagpal P, 2005, DEVELOPMENT, V132, P4107, DOI 10.1242/dev.01955; Newman SM, 1997, AGROFOREST SYST, V39, P23, DOI 10.1023/A:1005938310106; Ni ZY, 2012, BIOCHEM BIOPH RES CO, V427, P330, DOI 10.1016/j.bbrc.2012.09.055; Niu SY, 2016, MOL GENET GENOMICS, V291, P181, DOI 10.1007/s00438-015-1102-y; Niu SY, 2014, PLANT CELL TISS ORG, V119, P457, DOI 10.1007/s11240-014-0546-9; Niu SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106736; Niu SuYan, 2013, Scientia Silvae Sinicae, V49, P77; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Pang MX, 2011, J PLANT PHYSIOL, V168, P824, DOI 10.1016/j.jplph.2010.10.006; Peng XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032997, 10.1371/journal.pone.0040120]; Rao KVM, 2006, PHYSIOLOGY AND MOLECULAR BIOLOGY OF STRESS TOLERANCE IN PLANTS, P1; Ren YY, 2012, FUNCT INTEGR GENOMIC, V12, P327, DOI 10.1007/s10142-012-0271-6; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Ruan MB, 2009, GENOMICS, V94, P263, DOI 10.1016/j.ygeno.2009.07.002; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Song J.B., 2016, PLANT GENE, V5, P56, DOI [10.1016/j.plgene.2015.12.001, DOI 10.1016/J.PLGENE.2015.12.001]; Song JB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125427; Song JB, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-210; Song JB, 2012, PLANT CELL PHYSIOL, V53, P1283, DOI 10.1093/pcp/pcs080; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; TANG R C, 1980, Southern Journal of Applied Forestry, V4, P19; Valliyodan B, 2006, CURR OPIN PLANT BIOL, V9, P189, DOI 10.1016/j.pbi.2006.01.019; Wang D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-44; Wang M, 2013, GENE, V530, P26, DOI 10.1016/j.gene.2013.08.009; Wu L, 2010, MOL CELL, V38, P465, DOI 10.1016/j.molcel.2010.03.008; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhang X.S., 2013, J HENAN AGR U, V46, P646; Zhao BT, 2007, BIOCHEM BIOPH RES CO, V354, P585, DOI 10.1016/j.bbrc.2007.01.022; Zhou LG, 2010, J EXP BOT, V61, P4157, DOI 10.1093/jxb/erq237; Zhou M, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.28700; Zhou M, 2013, PLANT PHYSIOL, V161, P1375, DOI 10.1104/pp.112.208702; Zhou X, 2007, BIOTECHNOLOGY AND SUSTAINABLE AGRICULTURE 2006 AND BEYOND, P471, DOI 10.1007/978-1-4020-6635-1_78; Zhou XF, 2008, BBA-GENE REGUL MECH, V1779, P780, DOI 10.1016/j.bbagrm.2008.04.005; Zhou ZS, 2012, J EXP BOT, V63, P4597, DOI 10.1093/jxb/ers136	83	2	2	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158750	10.1371/journal.pone.0158750	http://dx.doi.org/10.1371/journal.pone.0158750			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27388154	gold, Green Submitted, Green Published			2022-12-27	WOS:000379811500041
J	Conway, TM; Hoffmann, LJ; Breitbarth, E; Strzepek, RF; Wolff, EW				Conway, Tim M.; Hoffmann, Linn J.; Breitbarth, Eike; Strzepek, Robert F.; Wolff, Eric W.			The Growth Response of Two Diatom Species to Atmospheric Dust from the Last Glacial Maximum	PLOS ONE			English	Article							SOUTHERN-OCEAN PHYTOPLANKTON; NATURAL IRON FERTILIZATION; EAST ANTARCTICA ICE; LIGHT INTERACTIONS; FLOW-INJECTION; TRACE-ELEMENTS; SILICIC-ACID; CO2 CHANGE; CARBON; CLIMATE	Relief of iron (Fe) limitation in the surface Southern Ocean has been suggested as one driver of the regular glacial-interglacial cycles in atmospheric carbon dioxide (CO2). The proposed cause is enhanced deposition of Fe-bearing atmospheric dust to the oceans during glacial intervals, with consequent effects on export production and the carbon cycle. However, understanding the role of enhanced atmospheric Fe supply in biogeochemical cycles is limited by knowledge of the fluxes and 'bioavailability' of atmospheric Fe during glacial intervals. Here, we assess the effect of Fe fertilization by dust, dry-extracted from the Last Glacial Maximum portion of the EPICA Dome C Antarctic ice core, on the Antarctic diatom species Eucampia antarctica and Proboscia inermis. Both species showed strong but differing reactions to dust addition. E. antarctica increased cell number (3880 vs. 786 cells mL(-1)), chlorophyll a (51 vs. 3.9 mu g mL(-1)) and particulate organic carbon (POC; 1.68 vs. 0.28 mu g mL(-1)) production in response to dust compared to controls. P. inermis did not increase cell number in response to dust, but chlorophyll a and POC per cell both strongly increased compared to controls (39 vs. 15 and 2.13 vs. 0.95 ng cell(-1) respectively). The net result of both responses was a greater production of POC and chlorophyll a, as well as decreased Si:C and Si:N incorporation ratios within cells. However, E, antarctica decreased silicate uptake for the same nitrate and carbon uptake, while P. inermis increased carbon and nitrate uptake for the same silicate uptake. This suggests that nutrient utilization changes in response to Fe addition could be driven by different underlying mechanisms between different diatom species. Enhanced supply of atmospheric dust to the surface ocean during glacial intervals could therefore have driven nutrient-utilization changes which could permit greater carbon fixation for lower silica utilization. Additionally, both species responded more strongly to lower amounts of direct Fe chloride addition than they did to dust, suggesting that not all the Fe released from dust was in a bioavailable form available for uptake by diatoms.	[Conway, Tim M.; Wolff, Eric W.] British Antarct Survey, Cambridge, England; [Conway, Tim M.; Wolff, Eric W.] Univ Cambridge, Dept Earth Sci, Cambridge, England; [Conway, Tim M.] Swiss Fed Inst Technol, Dept Earth Sci, Zurich, Switzerland; [Hoffmann, Linn J.; Breitbarth, Eike; Strzepek, Robert F.] Univ Otago, Dept Chem, Dunedin, New Zealand; [Conway, Tim M.] Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA; [Hoffmann, Linn J.] Univ Otago, Dept Bot, Dunedin, New Zealand; [Breitbarth, Eike] REZO Water Energy, Dunedin, New Zealand; [Strzepek, Robert F.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of Cambridge; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Otago; State University System of Florida; University of South Florida; University of Otago; Australian National University	Conway, TM (corresponding author), Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA.	conway.tm@gmail.com	Wolff, Eric W/D-7925-2014; Wolff, Eric/AAB-1097-2021; Strzepek, Robert Francis/A-1216-2011; Hoffmann, Linn/J-3761-2019; Strzepek, Robert/GQH-8703-2022	Wolff, Eric W/0000-0002-5914-8531; Wolff, Eric/0000-0002-5914-8531; Strzepek, Robert Francis/0000-0002-6442-7121; Hoffmann, Linn/0000-0003-0242-4686; Conway, Tim/0000-0002-3069-9786	Natural Environment Research Council studentship; Royal Society Research Professorship [RP120096]; German Research Foundation [HO-4217, BR-3794]; NERC [bas0100034] Funding Source: UKRI; Natural Environment Research Council [bas0100034] Funding Source: researchfish	Natural Environment Research Council studentship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Royal Society Research Professorship; German Research Foundation(German Research Foundation (DFG)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the Natural Environment Research Council studentship to TMC (http://www.nerc.ac.uk/), Royal Society Research Professorship to EWW (https://royalsociety.org/) RP120096, LJH and EB were funded by German Research Foundation grants HO-4217 and BR-3794 (http://www.dfg.de/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achterberg EP, 2001, ANAL CHIM ACTA, V442, P1, DOI 10.1016/S0003-2670(01)01091-1; Achterberg EP, 2013, GEOPHYS RES LETT, V40, P921, DOI 10.1002/grl.50221; Adkins JF, 2013, PALEOCEANOGRAPHY, V28, P539, DOI 10.1002/palo.20046; Allen CS, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001055; Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; Behrenfeld MJ, 2013, ANNU REV MAR SCI, V5, P217, DOI 10.1146/annurev-marine-121211-172356; Boutron C. F., 1985, ANN GLACIOL, V7, P7; Bowie AR, 1998, ANAL CHIM ACTA, V361, P189, DOI 10.1016/S0003-2670(98)00015-4; Boyd P.W., 2000, CHANGING OCEAN CARBO, p[61, 107]; Boyle E, 1998, NATURE, V393, P733, DOI 10.1038/31585; Breitbarth E, 2010, BIOGEOSCIENCES, V7, P1075, DOI 10.5194/bg-7-1075-2010; Browning TJ, 2014, GEOPHYS RES LETT, V41, P2851, DOI 10.1002/2014GL059364; Browning TJ, 2014, BIOGEOSCIENCES, V11, P463, DOI 10.5194/bg-11-463-2014; Brzezinski MA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014349; BURCKLE LH, 1983, MICROPALEONTOLOGY, V29, P6, DOI 10.2307/1485648; Cavender-Bares KK, 1999, LIMNOL OCEANOGR, V44, P237, DOI 10.4319/lo.1999.44.2.0237; Chever F, 2010, BIOGEOSCIENCES, V7, P455, DOI 10.5194/bg-7-455-2010; Coale KH, 2004, SCIENCE, V304, P408, DOI 10.1126/science.1089778; Conway T, 2010, THESIS; Conway TM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8850; Croot PL, 2000, ELECTROANAL, V12, P565, DOI 10.1002/(SICI)1521-4109(200005)12:8<565::AID-ELAN565>3.0.CO;2-L; Croot PL, 2002, ANAL CHIM ACTA, V466, P261, DOI 10.1016/S0003-2670(02)00596-2; Currie KI, 2011, BIOGEOCHEMISTRY, V104, P23, DOI 10.1007/s10533-009-9355-3; Cutter GA, 2012, LIMNOL OCEANOGR-METH, V10, P425, DOI 10.4319/lom.2012.10.425; de Baar HJW, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002601; DEANGELIS M, 1987, NATURE, V325, P318, DOI 10.1038/325318a0; Duggen S, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL027522; Eldridge ML, 2004, AQUAT MICROB ECOL, V35, P79, DOI 10.3354/ame035079; Falkowski P.G., 1992, OCEANOGRAPHY, V5, P84, DOI [DOI 10.5670/OCEANOG.1992.14, 10.5670/oceanog.1992.14]; Fischer AC, 2007, MAR CHEM, V107, P533, DOI 10.1016/j.marchem.2007.08.004; Franck VM, 2005, LIMNOL OCEANOGR, V50, P825, DOI 10.4319/lo.2005.50.3.0825; Franck VM, 2003, MAR ECOL PROG SER, V252, P15, DOI 10.3354/meps252015; Franck VM, 2000, DEEP-SEA RES PT II, V47, P3315; Gabrielli P, 2005, ATMOS ENVIRON, V39, P6420, DOI 10.1016/j.atmosenv.2005.07.025; Gaspari V, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024352; Gervais F, 2002, LIMNOL OCEANOGR, V47, P1324, DOI 10.4319/lo.2002.47.5.1324; Grasshoff K., 1983, METHODS SEAWATER ANA, P125; Green SE, 2006, DEEP-SEA RES PT II, V53, P620, DOI 10.1016/j.dsr2.2006.01.022; GREENE RM, 1994, LIMNOL OCEANOGR, V39, P1061, DOI 10.4319/lo.1994.39.5.1061; Hendry KR, 2014, QUATERNARY SCI REV, V89, P13, DOI 10.1016/j.quascirev.2014.01.019; Hillebrand H, 1999, J PHYCOL, V35, P403, DOI 10.1046/j.1529-8817.1999.3520403.x; Hoffmann LJ, 2007, BIOGEOSCIENCES, V4, P569, DOI 10.5194/bg-4-569-2007; Hoffmann LJ, 2012, MAR CHEM, V132, P28, DOI 10.1016/j.marchem.2012.02.003; Hoffmann LJ, 2006, LIMNOL OCEANOGR, V51, P1217, DOI 10.4319/lo.2006.51.3.1217; Hutchins DA, 1998, NATURE, V393, P561, DOI 10.1038/31203; Jaccard SL, 2013, SCIENCE, V339, P1419, DOI 10.1126/science.1227545; Jouzel J, 2007, SCIENCE, V317, P793, DOI 10.1126/science.1141038; Knap A., 1996, 19 JGOFS UNESCO; Kohfeld KE, 2005, SCIENCE, V308, P74, DOI 10.1126/science.11053 75; Kohfeld KE, 2009, GLACIAL INTERGLACIAL; Kolbowski J, 1995, PHOTOSYNTHESIS: FROM LIGHT TO BIOSPHERE, VOL 5, P825; Lambert F, 2008, NATURE, V452, P616, DOI 10.1038/nature06763; Landschutzer P, 2015, SCIENCE, V349, P1221, DOI 10.1126/science.aab2620; Luthi D, 2008, NATURE, V453, P379, DOI 10.1038/nature06949; Mahowald NM, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002402; Marteel A, 2008, EARTH PLANET SC LETT, V272, P579, DOI 10.1016/j.epsl.2008.05.021; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; Martinez-Garcia A, 2014, SCIENCE, V343, P1347, DOI 10.1126/science.1246848; Martinez-Garcia A, 2011, NATURE, V476, P312, DOI 10.1038/nature10310; Mawji E, 2015, MAR CHEM, V177, P1, DOI 10.1016/j.marchem.2015.04.005; MILLERO FJ, 1987, GEOCHIM COSMOCHIM AC, V51, P793, DOI 10.1016/0016-7037(87)90093-7; Millero FJ, 1998, EARTH PLANET SC LETT, V154, P323, DOI 10.1016/S0012-821X(97)00179-9; Moore CM, 2007, DEEP-SEA RES PT II, V54, P2045, DOI 10.1016/j.dsr2.2007.06.011; Morel FMM, 2003, SCIENCE, V300, P944, DOI 10.1126/science.1083545; Parrenin F, 2007, CLIM PAST, V3, P485, DOI 10.5194/cp-3-485-2007; Parsons T.R., 1984, MANUAL BIOL CHEM MET; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Pollard RT, 2009, NATURE, V457, P577, DOI 10.1038/nature07716; Rothlisberger R, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020338; Sarthou G, 2008, DEEP-SEA RES PT II, V55, P734, DOI 10.1016/j.dsr2.2007.12.033; Schlosser C, 2011, MAR CHEM, V127, P48, DOI 10.1016/j.marchem.2011.07.008; Sedwick PN, 2000, J GEOPHYS RES-OCEANS, V105, P11321, DOI 10.1029/2000JC000256; Shatova O, 2016, J EXP MAR BIO ECOL I; Siegenthaler U, 2005, SCIENCE, V310, P1313, DOI 10.1126/science.1120130; Sigman DM, 2010, NATURE, V466, P47, DOI 10.1038/nature09149; Sigman DM, 2000, NATURE, V407, P859, DOI 10.1038/35038000; STAUBER JL, 1987, MAR BIOL, V94, P511, DOI 10.1007/BF00431397; Strzepek RF, 2012, LIMNOL OCEANOGR, V57, P1182, DOI 10.4319/lo.2012.57.4.1182; Strzepek RF, 2011, LIMNOL OCEANOGR, V56, P1983, DOI 10.4319/lo.2011.56.6.1983; SUNDA WG, 1995, MAR CHEM, V50, P189, DOI 10.1016/0304-4203(95)00035-P; Tagliabue A, 2012, BIOGEOSCIENCES, V9, P2333, DOI 10.5194/bg-9-2333-2012; Takeda S, 1998, NATURE, V393, P774, DOI 10.1038/31674; Throndsen J., 1978, PHYTOPLANKTON MANUAL, P69; Timmermans KR, 2004, LIMNOL OCEANOGR, V49, P2141, DOI 10.4319/lo.2004.49.6.2141; Timmermans KR, 2001, LIMNOL OCEANOGR, V46, P260, DOI 10.4319/lo.2001.46.2.0260; Visser F, 2003, J PHYCOL, V39, P1085, DOI 10.1111/j.0022-3646.2003.03-023.x; Watson AJ, 2000, NATURE, V407, P730, DOI 10.1038/35037561; Willmott V, 2010, ANTARCT SCI, V22, P3, DOI 10.1017/S095410200999037X; Wolff EW, 2006, NATURE, V440, P491, DOI 10.1038/nature04614; Zhang HN, 1996, MAR CHEM, V52, P17, DOI 10.1016/0304-4203(95)00076-3; Ziegler M, 2013, NAT GEOSCI, V6, P457, DOI [10.1038/NGEO1782, 10.1038/ngeo1782]	91	3	3	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158553	10.1371/journal.pone.0158553	http://dx.doi.org/10.1371/journal.pone.0158553			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384948	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000379809400059
J	Deakin, A; Browne, WJ; Hodge, JJL; Paul, ES; Mendl, M				Deakin, Amanda; Browne, William J.; Hodge, James J. L.; Paul, Elizabeth S.; Mendl, Michael			A Screen-Peck Task for Investigating Cognitive Bias in Laying Hens	PLOS ONE			English	Article							ANXIETY-DEPRESSION MODEL; JUDGMENT BIAS; DOMESTIC CHICKS; ANIMAL EMOTION; COLOR-VISION; GROUP-SIZE; WELFARE; PREFERENCES; STARLINGS; BEHAVIOR	Affect-induced cognitive judgement biases occur in both humans and animals. Animals in a more negative affective state tend to interpret ambiguous cues more negatively than animals in a more positive state and vice versa. Investigating animals' responses to ambiguous cues can therefore be used as a proxy measure of affective state. We investigated laying hens' responses to ambiguous stimuli using a novel cognitive bias task. In the 'screen-peck' task, hens were trained to peck a high/low saturation orange circle presented on a computer screen (positive cue-P) to obtain a mealworm reward, and to not peck when the oppositely saturated orange circle was presented (negative cue-N) to avoid a one second air puff. Ambiguous cues were orange circles of intermediate saturation between the P and N cue (near-positive-NP; middle-M; near-negative-NN), and were unrewarded. Cue pecking showed a clear generalisation curve from P through NP, M, NN to N suggesting that hens were able to associate colour saturation with reward or punishment, and could discriminate between stimuli that were more or less similar to learnt cues. Across six test sessions, there was no evidence for extinction of pecking responses to ambiguous cues. We manipulated affective state by changing temperature during testing to either similar to 20 degrees C or similar to 29 degrees C in a repeated measures cross-over design. Hens have been shown to prefer temperatures in the higher range and hence we assumed that exposure to the higher temperature would induce a relatively positive affective state. Hens tested under warmer conditions were significantly more likely to peck the M probe than those tested at cooler temperatures suggesting that increased temperature in the ranges tested here may have some positive effect on hens, inducing a positive cognitive bias.	[Deakin, Amanda; Paul, Elizabeth S.; Mendl, Michael] Univ Bristol, Sch Vet Sci, Langford, England; [Browne, William J.] Univ Bristol, Ctr Multilevel Modelling, Bristol, Avon, England; [Hodge, James J. L.] Univ Bristol, Sch Physiol Pharmacol & Neurosci, Bristol, Avon, England	University of Bristol; University of Bristol; University of Bristol	Deakin, A (corresponding author), Univ Bristol, Sch Vet Sci, Langford, England.	amanda.deakin@bristol.ac.uk	Browne, William J/A-8686-2010; Mendl, Michael/D-7220-2016	Browne, William J/0000-0002-6659-6885; Deakin, Amanda/0000-0001-7934-6984; Mendl, Michael/0000-0002-5302-1871; Hodge, James/0000-0003-4741-2363	Biotechnology and Biological Sciences Research Council [1363964]; BBSRC; BBSRC [BB/J017221/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J017221/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Biotechnology and Biological Sciences Research Council (Grant number 1363964 awarded to AD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the BBSRC for funding this work, Dr. Jo Edgar for running preliminary studies and the Animal Services Unit at the University of Bristol for caring for the hens for the duration of the study.	Abeyesinghe SM, 2001, APPL ANIM BEHAV SCI, V73, P199, DOI 10.1016/S0168-1591(01)00142-3; Baciadonna L, 2015, ANIM WELFARE, V24, P81, DOI 10.7120/09627286.24.1.081; Bateson L., 2007, ANIM WELFARE, P16; Bethell EJ, 2015, J APPL ANIM WELF SCI, V18, pS18, DOI 10.1080/10888705.2015.1075833; Boissy A, 2007, PHYSIOL BEHAV, V92, P375, DOI 10.1016/j.physbeh.2007.02.003; Brilot BO, 2010, ANIM COGN, V13, P721, DOI 10.1007/s10071-010-0323-z; DAWKINS MS, 1982, APPL ANIM ETHOL, V8, P365, DOI 10.1016/0304-3762(82)90069-4; Doyle RE, 2010, BEHAV PROCESS, V83, P349, DOI 10.1016/j.beproc.2010.01.019; FISCHER GJ, 1975, J COMP PHYSIOL PSYCH, V89, P802, DOI 10.1037/h0078149; Gygax L, 2014, ANIM BEHAV, V95, P59, DOI 10.1016/j.anbehav.2014.06.013; Hales CA, 2014, BRIT J PHARMACOL, V171, P4524, DOI 10.1111/bph.12603; Ham AD, 2007, P ROY SOC B-BIOL SCI, V274, P1941, DOI 10.1098/rspb.2007.0538; Harding EJ, 2004, NATURE, V427, P312, DOI 10.1038/427312a; Hernandez CE, 2015, APPL ANIM BEHAV SCI, V163, P135, DOI 10.1016/j.applanim.2014.12.002; HESS EH, 1956, PSYCHOL REP, V2, P477; HUGHES BO, 1977, BRIT POULTRY SCI, V18, P9, DOI 10.1080/00071667708416325; Hymel KA, 2012, NEUROPHARMACOLOGY, V62, P161, DOI 10.1016/j.neuropharm.2011.06.009; Kampen MV, 1979, J AGR SCI, V92, P219; Kleitman N, 1937, AM J PHYSIOL, V83, P134; Matheson SM, 2008, APPL ANIM BEHAV SCI, V109, P374, DOI 10.1016/j.applanim.2007.03.007; Mendl M, 2010, P ROY SOC B-BIOL SCI, V277, P2895, DOI 10.1098/rspb.2010.0303; Mendl M, 2009, APPL ANIM BEHAV SCI, V118, P161, DOI 10.1016/j.applanim.2009.02.023; Miklosi A, 2002, J COMP PHYSIOL A, V188, P135, DOI 10.1007/s00359-002-0284-z; Nicol CJ, 2009, ANIM BEHAV, V78, P413, DOI 10.1016/j.anbehav.2009.05.016; Osorio D, 1999, J EXP BIOL, V202, P2951; Paul ES, 2005, NEUROSCI BIOBEHAV R, V29, P469, DOI 10.1016/j.neubiorev.2005.01.002; Rolls E. T., 2005, EMOTION EXPLAINED; Salmeto AL, 2011, BRAIN RES, V1373, P124, DOI 10.1016/j.brainres.2010.12.007; Seehuus B, 2013, APPL ANIM BEHAV SCI, V148, P85, DOI 10.1016/j.applanim.2013.07.008; Wichman A, 2012, APPL ANIM BEHAV SCI, V140, P62, DOI 10.1016/j.applanim.2012.05.006; Wright KP, 2002, AM J PHYSIOL-REG I, V283, pR1370, DOI 10.1152/ajpregu.00205.2002; Yeates JW, 2008, VET J, V175, P293, DOI 10.1016/j.tvjl.2007.05.009	32	20	20	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158222	10.1371/journal.pone.0158222	http://dx.doi.org/10.1371/journal.pone.0158222			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410229	Green Submitted, Green Published, gold			2022-12-27	WOS:000379508300020
J	Vaughan, MM; Huffaker, A; Schmelz, EA; Dafoe, NJ; Christensen, SA; McAuslane, HJ; Alborn, HT; Allen, LH; Teal, PEA				Vaughan, Martha M.; Huffaker, Alisa; Schmelz, Eric A.; Dafoe, Nicole J.; Christensen, Shawn A.; McAuslane, Heather J.; Alborn, Hans T.; Allen, Leon Hartwell; Teal, Peter E. A.			Interactive Effects of Elevated [CO2] and Drought on the Maize Phytochemical Defense Response against Mycotoxigenic Fusarium verticillioides	PLOS ONE			English	Article							ATMOSPHERIC CARBON-DIOXIDE; CLIMATE-CHANGE; PLANT-PATHOGENS; ABSCISIC-ACID; JASMONIC ACID; HDMBOA-GLC; RESISTANCE; INDUCTION; CORN; PHOTOSYNTHESIS	Changes in climate due to rising atmospheric carbon dioxide concentration ([CO2]) are predicted to intensify episodes of drought, but our understanding of how these combined conditions will influence crop-pathogen interactions is limited. We recently demonstrated that elevated [CO2] alone enhances maize susceptibility to the mycotoxigenic pathogen, Fusarium verticillioides (Fv) but fumonisin levels remain unaffected. In this study we show that maize simultaneously exposed to elevated [CO2] and drought are even more susceptible to Fv proliferation and also prone to higher levels of fumonisin contamination. Despite the increase in fumonisin levels, the amount of fumonisin produced in relation to pathogen biomass remained lower than corresponding plants grown at ambient [CO2]. Therefore, the increase in fumonisin contamination was likely due to even greater pathogen biomass rather than an increase in host-derived stimulants. Drought did not negate the compromising effects of elevated [CO2] on the accumulation of maize phytohormones and metabolites. However, since elevated [CO2] does not influence the drought-induced accumulation of abscisic acid (ABA) or root terpenoid phytoalexins, the effects elevated [CO2] are negated belowground, but the stifled defense response aboveground may be a consequence of resource redirection to the roots.	[Vaughan, Martha M.] ARS, Mycotoxin Prevent & Appl Microbiol Res Unit, Natl Ctr Agr Utilizat Res, USDA, 1815 N Univ St, Peoria, IL 61604 USA; [Huffaker, Alisa; Schmelz, Eric A.; Dafoe, Nicole J.; Christensen, Shawn A.; Alborn, Hans T.; Allen, Leon Hartwell; Teal, Peter E. A.] ARS, Chem Res Unit, Ctr Med Agr & Vet Entomol, USDA, 1600 SW 23rd Dr, Gainesville, FL 32608 USA; [McAuslane, Heather J.] Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32610 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); State University System of Florida; University of Florida	Vaughan, MM (corresponding author), ARS, Mycotoxin Prevent & Appl Microbiol Res Unit, Natl Ctr Agr Utilizat Res, USDA, 1815 N Univ St, Peoria, IL 61604 USA.	Martha.vaughan@ars.usda.gov		Schmelz, Eric/0000-0002-2837-734X	United States Department of Agriculture, Agricultural Research Service	United States Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Research was funded by the United States Department of Agriculture, Agricultural Research Service. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adie BAT, 2007, PLANT CELL, V19, P1665, DOI 10.1105/tpc.106.048041; Allen LH, 2011, J PLANT PHYSIOL, V168, P1909, DOI 10.1016/j.jplph.2011.05.005; Atkinson NJ, 2012, J EXP BOT, V63, P3523, DOI 10.1093/jxb/ers100; Bird CB, 2002, J AOAC INT, V85, P404; Boyer JS, 2004, J EXP BOT, V55, P2385, DOI 10.1093/jxb/erh219; Burow GB, 1997, MOL PLANT MICROBE IN, V10, P380, DOI 10.1094/MPMI.1997.10.3.380; Calvo AM, 1999, APPL ENVIRON MICROB, V65, P3668; Cao FY, 2011, J PLANT RES, V124, P489, DOI 10.1007/s10265-011-0409-y; Casteel C, 2012, AGR NORDESTE BRASILE, V6, P1; Casteel C. L, 2010, THESIS; Chakraborty S, 2011, PLANT PATHOL, V60, P2, DOI 10.1111/j.1365-3059.2010.02411.x; Chakraborty S, 2013, GLOBAL CHANGE BIOL, V19, P1985, DOI 10.1111/gcb.12205; Christensen SA, 2013, PLANT J, V74, P59, DOI 10.1111/tpj.12101; Christensen SA, 2011, FUNGAL GENET BIOL, V48, P4, DOI 10.1016/j.fgb.2010.05.005; DeLucia EH, 2012, PLANT PHYSIOL, V160, P1677, DOI 10.1104/pp.112.204750; Driscoll SP, 2006, J EXP BOT, V57, P381, DOI 10.1093/jxb/erj030; Edenhofer O., 2014, CONTRIBUTION WORKING; Elad Y, 2014, J CROP IMPROV, V28, P99, DOI 10.1080/15427528.2014.865412; Erb M, 2011, NEW PHYTOL, V189, P308, DOI 10.1111/j.1469-8137.2010.03450.x; Erb M, 2009, PLANT SIGNAL BEHAV, V4, P636, DOI 10.1111/j.1365-313X.2009.03868.x; Erb M, 2009, PLANT J, V59, P292, DOI 10.1111/j.1365-313X.2009.03868.x; Fan J, 2009, PLANT PHYSIOL, V150, P1750, DOI 10.1104/pp.109.137943; Gao XQ, 2007, MOL PLANT MICROBE IN, V20, P922, DOI 10.1094/MPMI-20-8-0922; Gao XQ, 2009, TOXIN REV, V28, P79, DOI 10.1080/15569540802420584; Ghannoum O, 2000, PLANT CELL ENVIRON, V23, P931, DOI 10.1046/j.1365-3040.2000.00609.x; Glenn AE, 2002, MOL PLANT MICROBE IN, V15, P91, DOI 10.1094/MPMI.2002.15.2.91; Glenn AE, 2001, APPL ENVIRON MICROB, V67, P2973, DOI 10.1128/AEM.67.7.2973-2981.2001; Hey SJ, 2010, ANN BOT-LONDON, V105, P197, DOI 10.1093/aob/mcp285; Howe GA, 2004, J PLANT GROWTH REGUL, V23, P223, DOI 10.1007/s00344-004-0030-6; Howe GA, 2002, CURR OPIN PLANT BIOL, V5, P230, DOI 10.1016/S1369-5266(02)00250-9; Huang J, 2002, J ECON ENTOMOL, V95, P849, DOI 10.1603/0022-0493-95.4.849; Huffaker A, 2011, PLANT PHYSIOL, V156, P2082, DOI 10.1104/pp.111.179457; Huffaker A, 2011, PLANT PHYSIOL, V155, P1325, DOI 10.1104/pp.110.166710; Kallenbach M, 2010, PLANT PHYSIOL, V152, P96, DOI 10.1104/pp.109.149013; Leakey ADB, 2009, J EXP BOT, V60, P2859, DOI 10.1093/jxb/erp096; Leakey ADB, 2009, P ROY SOC B-BIOL SCI, V276, P2333, DOI 10.1098/rspb.2008.1517; Leakey Andrew D. B., 2006, Plant Biology (Rockville), V2006, P106; Long SP, 2004, ANNU REV PLANT BIOL, V55, P591, DOI 10.1146/annurev.arplant.55.031903.141610; Marin P, 2010, FEMS MICROBIOL ECOL, V73, P303, DOI 10.1111/j.1574-6941.2010.00894.x; Medina A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00348; Miller JD, 2001, ENVIRON HEALTH PERSP, V109, P321, DOI 10.2307/3435025; Murillo-Williams A, 2008, PLANT DIS, V92, P1695, DOI 10.1094/PDIS-92-12-1695; Nicolaisen M, 2009, J MICROBIOL METH, V76, P234, DOI 10.1016/j.mimet.2008.10.016; Oikawa A, 2004, PHYTOCHEMISTRY, V65, P2995, DOI 10.1016/j.phytochem.2004.09.006; Oikawa A, 2002, PHYTOCHEMISTRY, V61, P331, DOI 10.1016/S0031-9422(02)00225-X; Parsons MW, 2010, FOOD ADDIT CONTAM A, V27, P591, DOI 10.1080/19440040903456337; Pautasso M, 2012, EUR J PLANT PATHOL, V133, P295, DOI 10.1007/s10658-012-9936-1; RICHARDSON MD, 1993, J CHEM ECOL, V19, P1613, DOI 10.1007/BF00982296; Riemann M, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01077; Samapundo S, 2007, INT J FOOD MICROBIOL, V113, P339, DOI 10.1016/j.ijfoodmicro.2006.09.006; Schmelz EA, 2004, PLANT J, V39, P790, DOI 10.1111/j.1365-313X.2004.02168.x; SHELBY RA, 1994, PLANT DIS, V78, P582, DOI 10.1094/PD-78-0582; Sun YC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019751, 10.1371/journal.pone.0028156]; Ton J, 2009, TRENDS PLANT SCI, V14, P310, DOI 10.1016/j.tplants.2009.03.006; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892, DOI 10.2136/sssaj1980.03615995004400050002x; Vaughan MM, 2014, PLANT CELL ENVIRON, V37, P2691, DOI 10.1111/pce.12337; Vaughan MM, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-5; Vaughan MM, 2015, PLANT CELL ENV; Yates IE, 2003, CAN J BOT, V81, P422, DOI [10.1139/B03-034, 10.1139/b03-034]; Zavala JA, 2013, ANNU REV ENTOMOL, V58, P79, DOI 10.1146/annurev-ento-120811-153544	60	31	31	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159270	10.1371/journal.pone.0159270	http://dx.doi.org/10.1371/journal.pone.0159270			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410032	gold, Green Published			2022-12-27	WOS:000379508300074
J	Kim, MO; Ryu, HW; Choi, JH; Son, TH; Oh, SR; Lee, HS; Yuk, HJ; Cho, S; Kang, JS; Lee, CW; Lee, J; Lee, CK; Hong, ST; Lee, SU				Kim, Mun Ock; Ryu, Hyung Won; Choi, Ji-Hee; Son, Tae Hyun; Oh, Sei-Ryang; Lee, Hyun-Sun; Yuk, Heung Joo; Cho, Sungchan; Kang, Jong Soon; Lee, Chang Woo; Lee, Jinhyuk; Lee, Chong-Kil; Hong, Sung-Tae; Lee, Su Ui			Anti-Obesity Effects of Spiramycin In Vitro and In Vivo	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; PPAR-GAMMA; ADIPOCYTE DIFFERENTIATION; 3T3-L1 ADIPOCYTES; ADIPOSE-TISSUE; AMPK; OBESITY; ADIPOGENESIS; ENERGY; METABOLISM	The effects of spiramycin on adipogenesis and high fat diet (HFD)-induced obesity were investigated. Potential mechanisms contributing to these effects were elucidated. The inhibitory effect of spiramycin on adipocyte differentiation was assessed using 3T3-L1 preadipocyte cells, in which several parameters involved in AMPK signal pathways and lipid metabolism were examined. To further investigate the pharmacological effects of spiramycin in vivo, we examined several obesity-related parameters in HFD-induced obese mice. Spiramycin significantly inhibited preadipocyte differentiation by attenuating intracellular lipid accumulation. Spiramycin also reduced the expression of adipogenic master regulators (PPAR gamma, C/EBP alpha, and SREBP1c) and their downstream target genes (FAS, aP2, and GLUT4) in 3T3-L1 cells. In addition, AMPK phosphorylation was increased by spiramycin treatment in 3T3-L1 cells during early differentiation. Notably, HFD-induced obese mice administered spiramycin showed substantial decreases in body weight gain, serum leptin levels, adipose tissue mass, and hepatic lipid accumulation. Moreover, the decreased levels of GPT and GOT in the serum indicated that spiramycin attenuated hepatic injury caused by HFD. Taken together, these results demonstrate for the first time that spiramycin effectively attenuates HFD-induced obesity and hepatic steatosis by inhibiting adipogenesis.	[Kim, Mun Ock; Ryu, Hyung Won; Choi, Ji-Hee; Son, Tae Hyun; Oh, Sei-Ryang; Lee, Hyun-Sun; Yuk, Heung Joo; Lee, Su Ui] Korea Res Inst Biosci & Biotechnol, Nat Med Res Ctr, 30 Yeongudanji Ro, Cheongju 28116, Chungbuk, South Korea; [Cho, Sungchan] Korea Res Inst Biosci & Biotechnol, Anticanc Agent Res Ctr, 30 Yeongudanji Ro, Cheongju 28116, Chungbuk, South Korea; [Kang, Jong Soon; Lee, Chang Woo] Korea Res Inst Biosci & Biotechnol, Bioevaluat Ctr, 30 Yeongudanji Ro, Cheongju 28116, Chungbuk, South Korea; [Lee, Jinhyuk] Korea Res Inst Biosci & Biotechnol, Korean Bioinformat Ctr KOBIC, 125 Gwahak Ro, Yuseong 34141, Daejeon, South Korea; [Son, Tae Hyun; Lee, Chong-Kil] Chungbuk Natl Univ, Coll Pharm, Cheongju 28644, South Korea; [Hong, Sung-Tae] Korea Adv Inst Sci & Technol, Dept Biol Sci, 291 Daehak Ro, Daejeon 34141, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chungbuk National University; Korea Advanced Institute of Science & Technology (KAIST)	Lee, SU (corresponding author), Korea Res Inst Biosci & Biotechnol, Nat Med Res Ctr, 30 Yeongudanji Ro, Cheongju 28116, Chungbuk, South Korea.; Hong, ST (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, 291 Daehak Ro, Daejeon 34141, South Korea.	mogwai@kaist.ac.kr; iamsuui@kribb.re.kr	Yuk, Heung Joo/T-5882-2019	Kang, Jong Soon/0000-0001-7698-0162; Hong, Sung-Tae/0000-0001-5981-4859	Korea Research Institute of Bioscience and Biotechnology Research Initiative Program [KGM1221622]; Basic Science Research Program of the National Research Foundation (NRF) - Ministry of Science, ICT and Future Planning [NRF-2013R1A1A3008189, 2013R1A1A3009382]; NRF of Korea Grant - Korean Government [35B-2011-1-C00033]	Korea Research Institute of Bioscience and Biotechnology Research Initiative Program; Basic Science Research Program of the National Research Foundation (NRF) - Ministry of Science, ICT and Future Planning; NRF of Korea Grant - Korean Government	This work was supported by grants from the Korea Research Institute of Bioscience and Biotechnology Research Initiative Program (KGM1221622) and the Basic Science Research Program of the National Research Foundation (NRF) funded by the Ministry of Science, ICT and Future Planning (NRF-2013R1A1A3008189 and 2013R1A1A3009382). This research was also supported by an NRF of Korea Grant funded by the Korean Government (35B-2011-1-C00033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Martinez JA, 2014, ADV NUTR, V5, P71, DOI 10.3945/an.113.004705; Ballinger A, 2002, EUR J PHARMACOL, V440, P109, DOI 10.1016/S0014-2999(02)01422-X; Benoit SC, 2004, RECENT PROG HORM RES, V59, P267, DOI 10.1210/rp.59.1.267; Chen SF, 2011, CAN J PHYSIOL PHARM, V89, P793, DOI 10.1139/Y11-077; Choi KM, 2014, J NUTR BIOCHEM, V25, P201, DOI 10.1016/j.jnutbio.2013.10.007; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Daval M, 2006, J PHYSIOL-LONDON, V574, P55, DOI 10.1113/jphysiol.2006.111484; Fernandez-Veledo S, 2013, IUBMB LIFE, V65, P572, DOI 10.1002/iub.1170; Giri S, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-31; Ha SK, 2011, J COMP PATHOL, V145, P88, DOI 10.1016/j.jcpa.2010.11.011; He Y, 2013, INT J DISTRIB SENS N, DOI 10.1155/2013/481580; Henriksen BS, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-29; Hwang JT, 2009, NEW BIOTECHNOL, V26, P17, DOI 10.1016/j.nbt.2009.03.005; Hwang JT, 2005, BIOCHEM BIOPH RES CO, V338, P694, DOI 10.1016/j.bbrc.2005.09.195; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kim WS, 2009, AM J PHYSIOL-ENDOC M, V296, pE812, DOI 10.1152/ajpendo.90710.2008; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Lafontan M, 2014, DIABETES METAB, V40, P16, DOI 10.1016/j.diabet.2013.08.002; Lee H, 2011, INT J MOL MED, V28, P65, DOI 10.3892/ijmm.2011.674; Lee YK, 2009, J AGR FOOD CHEM, V57, P305, DOI 10.1021/jf802737z; Lefterova MI, 2014, TRENDS ENDOCRIN MET, V25, P293, DOI 10.1016/j.tem.2014.04.001; Luo ZJ, 2010, FUTURE ONCOL, V6, P457, DOI 10.2217/FON.09.174; Matejkova O, 2004, FEBS LETT, V569, P245, DOI 10.1016/j.febslet.2004.06.002; Misra P, 2008, EXPERT OPIN THER TAR, V12, P91, DOI 10.1517/14728222.12.1.91; Poulsen SM, 2000, J MOL BIOL, V304, P471, DOI 10.1006/jmbi.2000.4229; Ragab SMM, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0087-1; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Scioli MG, 2014, INT J MOL SCI, V15, P6517, DOI 10.3390/ijms15046517; Shan TZ, 2013, FASEB J, V27, P277, DOI 10.1096/fj.12-211516; Vivarelli F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150913	32	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2016	11	7							e0158632	10.1371/journal.pone.0158632	http://dx.doi.org/10.1371/journal.pone.0158632			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CN	27398599	Green Submitted, Green Published, gold			2022-12-27	WOS:000379508100005
J	Kunert, R; Willems, RM; Hagoort, P				Kunert, Richard; Willems, Roel M.; Hagoort, Peter			An Independent Psychometric Evaluation of the PROMS Measure of Music Perception Skills	PLOS ONE			English	Article							ABILITY	The Profile of Music Perception Skills (PROMS) is a recently developed measure of perceptual music skills which has been shown to have promising psychometric properties. In this paper we extend the evaluation of its brief version to three kinds of validity using an individual difference approach. The brief PROMS displays good discriminant validity with working memory, given that it does not correlate with backward digit span (r = .04). Moreover, it shows promising criterion validity (association with musical training (r = .45), musicianship status (r = .48), and self-rated musical talent (r = .51)). Finally, its convergent validity, i.e. relation to an unrelated measure of music perception skills, was assessed by correlating the brief PROMS to harmonic closure judgment accuracy. Two independent samples point to good convergent validity of the brief PROMS (r = .36; r = .40). The same association is still significant in one of the samples when including self-reported music skill in a partial correlation (r(partial) = .30; r(partial) = .17). Overall, the results show that the brief version of the PROMS displays a very good pattern of construct validity. Especially its tuning subtest stands out as a valuable part for music skill evaluations in Western samples. We conclude by briefly discussing the choice faced by music cognition researchers between different musical aptitude measures of which the brief PROMS is a well evaluated example.	[Kunert, Richard; Hagoort, Peter] Max Planck Inst Psycholinguist, Nijmegen, Netherlands; [Kunert, Richard; Willems, Roel M.; Hagoort, Peter] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Willems, Roel M.] Radboud Univ Nijmegen, Ctr Language Studies, Nijmegen, Netherlands	Max Planck Society; Radboud University Nijmegen; Radboud University Nijmegen	Kunert, R (corresponding author), Max Planck Inst Psycholinguist, Nijmegen, Netherlands.; Kunert, R (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands.	RiKunert@gmail.com	Hagoort, Peter/B-7417-2012	Willems, Roel/0000-0002-4963-5387; Kunert, Richard/0000-0002-0203-2108	Dutch science organization; Max Planck Society	Dutch science organization; Max Planck Society(Max Planck Society)	This study was financially supported by a Dutch science organization (Nederlandse Organisatie voor Wetenschappelijk Onderzoek: www.nwo.nl/) Spinoza Prize awarded to PH and a PhD grant from the Max Planck Society (www.mpg.de) to RK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anvari SH, 2002, J EXP CHILD PSYCHOL, V83, P111, DOI 10.1016/S0022-0965(02)00124-8; Brown S, 2013, PSYCHOL MUSIC, V41, P229, DOI 10.1177/0305735611425896; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; ERICSSON KA, 1993, PSYCHOL REV, V100, P363, DOI 10.1037/0033-295X.100.3.363; Gingras B, 2015, PHILOS T R SOC B, V370, P76, DOI 10.1098/rstb.2014.0092; Gordon Edwin, 1989, ADV MEASURES MUSIC A; Groth-Marnat G, 2001, CA CH AD PS, P29; Hansen M, 2013, PSYCHOL MUSIC, V41, P779, DOI 10.1177/0305735612452186; Kunert R, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150685; Law LNC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052508; Macnamara BN, 2014, PSYCHOL SCI, V25, P1608, DOI 10.1177/0956797614535810; Mullensiefan D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089642; Pasinski AC, 2016, PSYCHON B REV, V23, P1553, DOI 10.3758/s13423-015-0998-x; Peretz I, 2003, ANN NY ACAD SCI, V999, P58, DOI 10.1196/annals.1284.006; Peretz I, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00030; Schaal NK, 2014, MUSIC SCI, V18, P423, DOI 10.1177/1029864914541851; Seashore C. E., 1960, MEASURES MUSICAL TAL; Slevc LR, 2006, PSYCHOL SCI, V17, P675, DOI 10.1111/j.1467-9280.2006.01765.x; Ullen F, 2014, PERS INDIV DIFFER, V63, P87, DOI 10.1016/j.paid.2014.01.057; Wallentin M, 2010, LEARN INDIVID DIFFER, V20, P188, DOI 10.1016/j.lindif.2010.02.004; Westen D, 2003, J PERS SOC PSYCHOL, V84, P608, DOI 10.1037/0022-3514.84.3.608	21	9	9	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2016	11	7							e0159103	10.1371/journal.pone.0159103	http://dx.doi.org/10.1371/journal.pone.0159103			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DQ9CN	27398805	Green Submitted, Green Published, gold			2022-12-27	WOS:000379508100019
J	Barker, JC; Guerra, C; Gonzalez-Vargas, MJ; Hoeft, KS				Barker, Judith C.; Guerra, Claudia; Gonzalez-Vargas, M. Judy; Hoeft, Kristin S.			Acceptability of Salt Fluoridation in a Rural Latino Community in the United States: An Ethnographic Study	PLOS ONE			English	Article							ORAL-HEALTH; LOW-INCOME; WATER-USE; PREFERENCES; SERVICES; BELIEFS; MIGRANT; FOOD	Compared to other population groups in the United States, caries (tooth decay) is a disproportionately prevalent disease among Latino populations, especially among low-income and rural sub-groups and children under five years of age. Fluoride is a primary preventive for caries. While water fluoridation is a major and effective public health means for delivering fluoride on a mass scale, it does not reach many rural areas or population groups such as Latinos who eschew drinking water from municipal sources. This study examines the acceptability to such groups of salt fluoridation, an alternate means of delivering fluoride long used on a global scale. An ethnographic study in California's rural Central Valley was performed. Thirty individual interviews and 5 focus groups (N = 61) were conducted in Spanish to investigate low-income Latino migrant caregivers' experiences, views and understandings of domestic salt, oral health, caries prevention and fluoride. Audio data were transcribed, translated, coded and thematically analyzed. Table salt was readily available and frequently consumed. Both adult and child daily sodium consumption was high. Despite a general feeling that it was good, and present in dentifrices or dietary supplements, most participants had little knowledge about fluoride. Concerns were raised about cardio-vascular and other possibly deleterious effects if an increase in salt consumption occurred because fluoridated salt was viewed as having 'extra' benefits. Once informed about fluoride's safety and role in caries prevention, most participants expressed willingness to use fluoridated salt, especially if it benefitted children. Reassurance about its safety and benefits, and demonstration of its taste, were important aspects of acceptance. Taste was paramount. Participants would not consume more fluoridated salt than their current salt as that would result in unpleasant changes in food flavor and taste. While salt fluoridation is acceptable, the feasibility of producing and distributing fluoridated salt in the United States is, however, complex and challenging.	[Barker, Judith C.; Guerra, Claudia; Hoeft, Kristin S.] Univ Calif San Francisco, Dept Anthropol Hist & Social Med, San Francisco, CA 94143 USA; [Hoeft, Kristin S.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Hoeft, Kristin S.] Univ Calif San Francisco, Dept Prevent & Restorat Dent Sci, San Francisco, CA 94143 USA; [Guerra, Claudia] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Community Educ & Outreach Pasick Res Grp, San Francisco, CA 94143 USA; [Gonzalez-Vargas, M. Judy] Univ Calif San Francisco, Inst Hlth Policy Studies, San Francisco, CA 94143 USA; [Barker, Judith C.; Guerra, Claudia; Hoeft, Kristin S.] Univ Calif San Francisco, Ctr Address Childrens Oral Hlth Dispar, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Barker, JC (corresponding author), Univ Calif San Francisco, Dept Anthropol Hist & Social Med, San Francisco, CA 94143 USA.; Barker, JC (corresponding author), Univ Calif San Francisco, Ctr Address Childrens Oral Hlth Dispar, San Francisco, CA 94143 USA.	Judith.Barker@ucsf.edu			National Institute of Dental and Craniofacial Research (NIDCR) [U54 DE019285]	National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	All authors received funding from the National Institute of Dental and Craniofacial Research (NIDCR; www.nidcr.nih.gov) through grant number U54 DE019285. The authors also acknowledge assistance with publication costs from the University of California San Francisco (UCSF) Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADA, 2005, FLUOR FACTS; ADA Division of Communication, 2003, J Am Dent Assoc, V134, P1287; Adams SH, 2009, J PUBLIC HEALTH DENT, V69, P217, DOI 10.1111/j.1752-7325.2009.00125.x; Allen Lindsay, 2006, GUIDELINES FOOD FORT; American Academy of Pediatric Dentistry (AAPD), POL EARL CHILDH CAR; American Dental Association (ADA), 2015, ADA NEWS; [Anonymous], 2007, NAT I HLTH APPL RES; Banoczy J, 2009, MILK FLUORIDATION FOR THE PREVENTION OF DENTAL CARIES, P19; Barker JC., 2008, BMC ORAL HEALTH, V8, P8, DOI DOI 10.1186/1472-6831-8-8; Beltran-Aguilar Eugenio D., 2005, Morbidity and Mortality Weekly Report, V54, P1; Bernard R.H., 2005, RES METHODS ANTHR QU; Cagetti MG, 2013, ACTA ODONTOL SCAND, V71, P381, DOI 10.3109/00016357.2012.690447; Hernandez-Guerrero JC, 2008, J PUBLIC HEALTH DENT, V68, P242, DOI 10.1111/j.1752-7325.2008.00084.x; Casamassimo PS, 2009, J AM DENT ASSOC, V140, P650, DOI 10.14219/jada.archive.2009.0250; Centers for Disease Control and Prevention, 1999, MMWR, V48, P933; Centers for Disease Control and Prevention (CDC), 2012 COMM WAT FLUOR; Charmaz K., 2003, STRATEGIES QUALITATI, V2nd ed., P249; Cortes DE, 2013, AM J PREV MED, V44, pS267, DOI 10.1016/j.amepre.2012.11.012; Espelid I, 2009, EUR ARCH PAEDIATR DE, V10, P149, DOI 10.1007/BF03262676; Estupinan-Day S, 2005, SCI PUBLICATION, V615; Finlayson Tracy L, 2014, J Dent Oral Craniofac Epidemiol, V2, P15; Finlayson TL, 2010, J PUBLIC HEALTH DENT, V70, P292, DOI 10.1111/j.1752-7325.2010.00184.x; Flores G, 2008, PEDIATRICS, V121, pE286, DOI 10.1542/peds.2007-1243; Food US and Drug Administration, 2010, CONS UPD LOW SALT YO; Food US and Drug Administration (FDA), 2010, BOTTL WAT EV KEEP IT; Gooch B, 2015, PUBLIC HEALTH REP, V130, P318, DOI 10.1177/003335491513000408; Hansen E, 2003, J HEALTH CARE POOR U, V14, P153, DOI 10.1177/1049208903014002001; Henney JE, 2010, STRATEGIES TO REDUCE SODIUM INTAKE IN THE UNITED STATES, P1; Hobson WL, 2007, ARCH PEDIAT ADOL MED, V161, P457, DOI 10.1001/archpedi.161.5.457; Hoeft KS, 2015, APPETITE, V87, P1, DOI 10.1016/j.appet.2014.11.031; Holmes Seth, 2013, FRESH FRUIT BROKEN B; Horton S, 2009, COMMUNITY DENT HLTH, V26, P216, DOI 10.1922/CDH_2320Horton06; Horton S, 2008, J PUBLIC HEALTH DENT, V68, P22, DOI 10.1111/j.1752-7325.2007.00078.x; Horton SB, 2010, ANN ANTHROPL PRACT, V34, P68, DOI 10.1111/j.1556-4797.2010.01052.x; International Food Information Council Foundation, 2014, FOOS INS IS FOOD FOR; International Food Information Council Foundation, 2014, FOOD INS FOOD PORT T; Isong IA, 2012, PEDIATRICS, V130, P306, DOI 10.1542/peds.2011-0838; Koreishi S, 2012, PUBLIC HLTH SOCIAL J, P85; Leung AM, 2012, NUTRIENTS, V4, P1740, DOI 10.3390/nu4111740; del Valle LML, 2005, J DENT CHILD, V72, P61; Lukes S, 2006, DENT SERVICES MIGRAN, V22; Mapes LV, 2000, SEATTLE TIMES; Marin G, 1991, RES HISPANIC POPULAT; Marino R, 2012, COMMUNITY DENT HLTH, V29, P302, DOI 10.1922/CDH_2893Marino07; Marthaler Thomas M, 2005, Schweiz Monatsschr Zahnmed, V115, P785; Marthaler TM, 2005, INT DENT J, V55, P351; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Milgrom P, 2013, BMC ORAL HEALTH, V13, DOI 10.1186/1472-6831-13-38; MOBED K, 1992, WESTERN J MED, V157, P367; Morgan DL, 1999, FOCUS GROUPS QUALITA; Moss M, 2013, SUGAR SALT FAT; National Center for Chronic Disease Prevention and Health Promotion, 2009, COMM WAT FLUOR OTH F; National Center for Chronic Disease Prevention and Health Promotion, 2009, NAT OR HLTH SURV SYS; National Center for Farmworker Health, 2013, FARMW OCC HLTH SAF; Pan American Health Organization, 1986, SCI PUBLICATION, V501; Penn State Extension, 2012, FOOD HLTH HOM FOOD P; Penn State Extension, FOOD HLTH HOM FOOD P; Peretz Benjamin, 2003, Pediatr Dent, V25, P114; Perez-Escamilla R, 2009, J AM DIET ASSOC, V109, P988, DOI 10.1016/j.jada.2009.03.014; Pollick HF, 2013, J CALIF DENT ASSOC, P400; Pollick HF, 2013, J CALIF DENT ASSOC, V41, P471; Pollick Howard F, 2013, J Calif Dent Assoc, V41, P395; Quandt S, 2007, J IMMIG MIN HLTH, V9; Sampaio FC, 2011, MONOGR ORAL SCI, V22, P133, DOI 10.1159/000325161; Scherzer T, 2011, J PUBLIC HEALTH DENT, V71, P79, DOI 10.1111/j.1752-7325.2011.00242.x; Scherzer T, 2010, J PUBLIC HEALTH DENT, V70, P337, DOI 10.1111/j.1752-7325.2010.00193.x; Semba RD, 2012, J NUTR, V142, p143S, DOI 10.3945/jn.110.137745; Sriraman NK, 2009, PEDIATR DENT, V31, P310; Stewart DCL, 2002, J PUBLIC HEALTH DENT, V62, P84, DOI 10.1111/j.1752-7325.2002.tb03427.x; Stoecklin-Marois MT, 2011, J AGRIC SAF HEALTH, V17, P291, DOI 10.13031/2013.39803; Strauss A., 1990, BASICS QUALITATIVE R; Surgeon General. U.S. Department of Health and Human Services. National Institute of Dental and Craniofacial Research (U.S.), 2000, OR HLTH AM REP SURG; Swan MA, 2010, PEDIATR DENT, V32, P400; Telleen S, 2012, J PUBLIC HEALTH DENT, V72, P8, DOI 10.1111/j.1752-7325.2011.00275.x; The Hispanic Institute (THI), 2013, OB HISP AM BIGG CHAL; US Census Bureau data, POV THRESH POV THRES; Vallejos-Sanchez AA, 2006, ACTA ODONTOL SCAND, V64, P209, DOI 10.1080/00016350600555537; VanDerslice J, 2011, AM J PUBLIC HEALTH, V101, pS109, DOI 10.2105/AJPH.2011.300189; Villarejo D, 2003, ANNU REV PUBL HEALTH, V24, P175, DOI 10.1146/annurev.publhealth.24.100901.140901; Weintraub JA, 2013, J PUBLIC HEALTH DENT, V73, P311, DOI 10.1111/jphd.12029; Weissman AM, 1997, AM J PUBLIC HEALTH, V87, P1379, DOI 10.2105/AJPH.87.8.1379-a; Wespi HJ, 1986, SCI PUBLICATION, V501; Williams BL, 2001, J EXPO ANAL ENV EPID, V11, P510, DOI 10.1038/sj.jea.7500192; Yengopal V, 2010, SADJ, V65, P60; Yeung C Albert, 2011, Evid Based Dent, V12, P17, DOI 10.1038/sj.ebd.6400776; Yeung C Albert, 2008, Evid Based Dent, V9, P39, DOI 10.1038/sj.ebd.6400578	86	2	2	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158540	10.1371/journal.pone.0158540	http://dx.doi.org/10.1371/journal.pone.0158540			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27391112	gold, Green Published, Green Submitted			2022-12-27	WOS:000380005400079
J	Bauer, J; Groneberg, DA				Bauer, Jan; Groneberg, David A.			Measuring Spatial Accessibility of Health Care Providers - Introduction of a Variable Distance Decay Function within the Floating Catchment Area (FCA) Method	PLOS ONE			English	Article							ACCESS; SERVICES; DISPARITIES	We integrated recent improvements within the floating catchment area (FCA) method family into an integrated 'iFCA' method. Within this method we focused on the distance decay function and its parameter. So far only distance decay functions with constant parameters have been applied. Therefore, we developed a variable distance decay function to be used within the FCA method. We were able to replace the impedance coefficient beta by readily available distribution parameter (i.e. median and standard deviation (SD)) within a logistic based distance decay function. Hence, the function is shaped individually for every single population location by the median and SD of all population-to-provider distances within a global catchment size. Theoretical application of the variable distance decay function showed conceptually sound results. Furthermore, the existence of effective variable catchment sizes defined by the asymptotic approach to zero of the distance decay function was revealed, satisfying the need for variable catchment sizes. The application of the iFCA method within an urban case study in Berlin (Germany) confirmed the theoretical fit of the suggested method. In summary, we introduced for the first time, a variable distance decay function within an integrated FCA method. This function accounts for individual travel behaviors determined by the distribution of providers. Additionally, the function inherits effective variable catchment sizes and therefore obviates the need for determining variable catchment sizes separately.	[Bauer, Jan; Groneberg, David A.] Goethe Univ Frankfurt, Inst Occupat Social & Environm Med, Frankfurt, Hessen, Germany	Goethe University Frankfurt	Bauer, J (corresponding author), Goethe Univ Frankfurt, Inst Occupat Social & Environm Med, Frankfurt, Hessen, Germany.	j.bauer@med.uni-frankfurt.de	Groneberg, David/A-5132-2018; Bauer, Jan/Q-2197-2015	Groneberg, David/0000-0001-8551-6556; Bauer, Jan/0000-0001-6267-9731				Association of Statutory Health Insurance Berlin, 2015, PHYS SEARCH; Dai DJ, 2011, ENVIRON PLANN B, V38, P659, DOI 10.1068/b36149; Dai DJ, 2010, HEALTH PLACE, V16, P1038, DOI 10.1016/j.healthplace.2010.06.012; de Vries JJ, 2009, ENVIRON PLANN A, V41, P461, DOI 10.1068/a39369; Delamater PL, 2013, HEALTH PLACE, V24, P30, DOI 10.1016/j.healthplace.2013.07.012; Delamater PL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054900; Donohoe J, 2015, MED CARE, V53, P980, DOI 10.1097/MLR.0000000000000432; Federal Bureau of Statistics of Berlin-Brandenburg, 2015, RES BERL LOR; Fransen K, 2015, HEALTH PLACE, V32, P65, DOI 10.1016/j.healthplace.2015.01.002; Guagliardo Mark F, 2004, Int J Health Geogr, V3, P3; Hu RS, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-35; HUFF DL, 1964, J MARKETING, V28, P34, DOI 10.1177/002224296402800307; JOSEPH AE, 1982, SOC SCI MED, V16, P85, DOI 10.1016/0277-9536(82)90428-2; Kwan MP, 1998, GEOGR ANAL, V30, P191, DOI 10.1111/j.1538-4632.1998.tb00396.x; Lagu T, 2014, NEW ENGL J MED, V370, P1847, DOI 10.1056/NEJMsb1315940; Langford M, 2012, INT J GEOGR INF SCI, V26, P193, DOI 10.1080/13658816.2011.574140; Langford M, 2016, HEALTH PLACE, V38, P70, DOI 10.1016/j.healthplace.2015.11.007; Luo J, 2014, T GIS, V18, P436, DOI 10.1111/tgis.12096; Luo W, 2003, ENVIRON PLANN B, V30, P865, DOI 10.1068/b29120; Luo W, 2012, HEALTH PLACE, V18, P789, DOI 10.1016/j.healthplace.2012.04.002; Luo W, 2009, HEALTH PLACE, V15, P1100, DOI 10.1016/j.healthplace.2009.06.002; McGrail MR, 2014, APPL GEOGR, V54, P182, DOI 10.1016/j.apgeog.2014.08.005; McGrail MR, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-50; McGrail MR, 2009, APPL GEOGR, V29, P533, DOI 10.1016/j.apgeog.2008.12.003; McGrail MR, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0880-6; Ni JH, 2015, INT J ENV RES PUB HE, V12, P14490, DOI 10.3390/ijerph121114490; PENCHANSKY R, 1981, MED CARE, V19, P127, DOI 10.1097/00005650-198102000-00001; Peters E., 2011, OSM BERLIN GERMANY S; Polo G, 2013, PREV VET MED, V111, P10, DOI 10.1016/j.prevetmed.2013.03.010; Radke J., 2000, GEOGRAPHIC INFORM SC, V6, P105, DOI [10.1080/10824000009480538, DOI 10.1080/10824000009480538]; Senate Administration for City Development and Environment, 2015, GEOD SERV; Wan N, 2012, INT J GEOGR INF SCI, V26, P1073, DOI 10.1080/13658816.2011.624987; Wan N, 2012, HEALTH PLACE, V18, P321, DOI 10.1016/j.healthplace.2011.10.007; Wan N, 2012, APPL GEOGR, V32, P291, DOI 10.1016/j.apgeog.2011.05.001; Wang FH, 2012, ANN ASSOC AM GEOGR, V102, P1104, DOI 10.1080/00045608.2012.657146; Wang L, 2007, HEALTH PLACE, V13, P656, DOI 10.1016/j.healthplace.2006.10.001; WHO, 2010, WOR HEALT REP, P1; Zwiefelhofer D., 2015, FIND LATITUDE LONGIT	38	50	52	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159148	10.1371/journal.pone.0159148	http://dx.doi.org/10.1371/journal.pone.0159148			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27391649	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400215
J	Daughton, AR; Velappan, N; Abeyta, E; Priedhorsky, R; Deshpande, A				Daughton, Ashlynn R.; Velappan, Nileena; Abeyta, Esteban; Priedhorsky, Reid; Deshpande, Alina			Novel Use of Flu Surveillance Data: Evaluating Potential of Sentinel Populations for Early Detection of Influenza Outbreaks	PLOS ONE			English	Article							ADENOVIRUSES; ILLNESS	Influenza causes significant morbidity and mortality each year, with 2-8% of weekly outpatient visits around the United States for influenza-like-illness (ILI) during the peak of the season. Effective use of existing flu surveillance data allows officials to understand and predict current flu outbreaks and can contribute to reductions in influenza morbidity and mortality. Previous work used the 2009-2010 influenza season to investigate the possibility of using existing military and civilian surveillance systems to improve early detection of flu outbreaks. Results suggested that civilian surveillance could help predict outbreak trajectory in local military installations. To further test that hypothesis, we compare pairs of civilian and military outbreaks in seven locations between 2000 and 2013. We find no predictive relationship between outbreak peaks or time series of paired outbreaks. This larger study does not find evidence to support the hypothesis that civilian data can be used as sentinel surveillance for military installations. We additionally investigate the effect of modifying the ILI case definition between the standard Department of Defense definition, a more specific definition proposed in literature, and confirmed Influenza A. We find that case definition heavily impacts results. This study thus highlights the importance of careful selection of case definition, and appropriate consideration of case definition in the interpretation of results.	[Daughton, Ashlynn R.; Abeyta, Esteban; Deshpande, Alina] Los Alamos Natl Lab, Analyt Intelligence & Technol Div, Los Alamos, NM USA; [Velappan, Nileena] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM USA; [Priedhorsky, Reid] Los Alamos Natl Lab, High Performance Comp Div, Los Alamos, NM USA	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory	Daughton, AR; Deshpande, A (corresponding author), Los Alamos Natl Lab, Analyt Intelligence & Technol Div, Los Alamos, NM USA.	adaughton@lanl.gov; deshpande_a@lanl.gov		Abeyta, Esteban/0000-0001-5574-4822; Deshpande, Alina/0000-0003-4541-4410; Velappan, Nileena/0000-0002-4488-9126	Defense Threat Reduction Agency - Joint Science and Technology Office [CB10092, DTRA10027-19082]; DTRA	Defense Threat Reduction Agency - Joint Science and Technology Office(United States Department of DefenseDefense Threat Reduction Agency); DTRA(United States Department of DefenseDefense Threat Reduction Agency)	This project was funded by the Defense Threat Reduction Agency - Joint Science and Technology Office (Grant # CB10092, DTRA10027-19082) (http://www.dtra.mil/).; AFHSC provided data and technical assistance in interpreting it. We would like to specifically acknowledge Aaron Kite-Powell, Jean Chretien, Vivek Khatri and Angela Eick-Cost for assistance understanding data, and ideas about effective ways to analyze in R. We also would like to thank DTRA for funding this work.	American Medical Association, 2015, 2015 ICD 9 CM HOSP, V2; American Medical Association, 2015, 2015 ICD 9 CM HOSP, V1; American Medical Association, 2015, 2015 ICD 9 CM HOSP, V3; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P1586; Appiah GD, 2015, MMWR-MORBID MORTAL W, V64, P583; Armed Forces Health Surveillance Branch, 2016, DEF MED SURV SYST; Armed Forces Health Surveillance Branch, 2016, ARM FORC HLTH SURV B; Balish A., 2009, Morbidity and Mortality Weekly Report, V58, P826; Buckeridge David L, 2008, AMIA Annu Symp Proc, P76; California Department of Public Health, 2016, CPDH INFL SURV PROGR; Centers for Disease Control and Prevention, 2016, OV INFL SURV US; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467; Defense Health Agency, 2015, DEF MED INF SYST DMI; Demian PN, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-50; Department of Health and Human Services CDC, 2016, OV INFL SURV US; Department of Public Health and Social Services, 2016, GUAM EP NEWSL; Eick-Cost Angelia A, 2015, MSMR, V22, P2; Hersey S, 2015, MMWR-MORBID MORTAL W, V64, P981, DOI 10.15585/mmwr.mm6435a6; Hobbs J., 2016, SAS BDAT VERS 2 0 7; Huo X, 2012, J MED VIROL, V84, P1980, DOI 10.1002/jmv.23401; International Organization for Standardization, 2016, 3166 ISO; Kool JL, 2012, GLOB PUBLIC HEALTH, V7, P670, DOI 10.1080/17441692.2012.699536; Korean Influenza Surveillance Scheme, 2016, INFL WEEKL REP CDC; National Institute of Infectious Disease, 2016, WEEKS END LOG 2015; National Institute of Infectious Diseases, 2016, IASR REP; North Carolina Department of Health and Human Services, 2016, NC DHHS INFL FLU INF; North Carolina Division of Public Health, 2010, N CAR WEEKL INFL SUR; Omori R, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-2; R boxplot, 2016, R MAN; Riley P, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003064; Rohatgi A., 2015, WEBPLOTDIGITIZER VER; Texas Department of State Health Services, 2016, INFL LIK ILLN; Texas Department of State Health Services, 2016, TEX INFL SURV ACT RE; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Tohma K, 2012, JPN J INFECT DIS, V65, P289, DOI 10.7883/yoken.65.289; Tourbin A, 2010, SQLITE3 PCRE; Yang TU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084873	37	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158330	10.1371/journal.pone.0158330	http://dx.doi.org/10.1371/journal.pone.0158330			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391232	gold, Green Published, Green Submitted			2022-12-27	WOS:000380005400042
J	Hidalgo, J; Latorre, P; Carrodeguas, JA; Velazquez-Campoy, A; Sancho, J; Lopez-Buesa, P				Hidalgo, Jorge; Latorre, Pedro; Alberto Carrodeguas, Jose; Velazquez-Campoy, Adrian; Sancho, Javier; Lopez-Buesa, Pascual			Inhibition of Pig Phosphoenolpyruvate Carboxykinase Isoenzymes by 3-Mercaptopicolinic Acid and Novel Inhibitors	PLOS ONE			English	Article							DIABETES-MELLITUS; GTP; GLUCONEOGENESIS; PCK1	There exist two isoforms of cytosolic phosphoenolpyruvate carboxykinase (PEPCK-C) in pig populations that differ in a single amino acid (Met139Leu). The isoenzymes have different kinetic properties, affecting more strongly the K-m and V-max of nucleotides. They are associated to different phenotypes modifying traits of considerable economic interest. In this work we use inhibitors of phosphoenolpyruvate carboxykinase activity to search for further differences between these isoenzymes. On the one hand we have used the well-known inhibitor 3-mercaptopicolinic acid. Its inhibition patterns were the same for both isoenzymes: a three-fold decrease of the K-i values for GTP in 139Met and 139Leu (273 and 873 mu M, respectively). On the other hand, through screening of a chemical library we have found two novel compounds with inhibitory effects of a similar magnitude to that of 3-mercaptopicolinic acid but with less solubility and specificity. One of these novel compounds, (N'1-({5-[1-methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl]-2-thienyl}methylidene)-2,4-dichlorobenzene-1-carbohydrazide), exhibited significantly different inhibitory effects on either isoenzyme: it enhanced threefold the apparent K-m value for GTP in 139Met, whereas in 139Leu, it reduced it from 99 to 69 mu M. The finding of those significant differences in the binding of GTP reinforces the hypothesis that the Met139Leu substitution affects strongly the nucleotide binding site of PEPCK-C.	[Hidalgo, Jorge; Latorre, Pedro; Lopez-Buesa, Pascual] Univ Zaragoza, Fac Vet, Dept Prod Anim & Ciencia Alimentos, Zaragoza, Spain; [Hidalgo, Jorge; Latorre, Pedro; Alberto Carrodeguas, Jose; Velazquez-Campoy, Adrian; Sancho, Javier; Lopez-Buesa, Pascual] Univ Zaragoza, Inst Biocomputac & Fis Sistemas Complejos BIFI, BIFI IQFR CSIC Joint Unit, Zaragoza, Spain; [Alberto Carrodeguas, Jose; Velazquez-Campoy, Adrian; Sancho, Javier] Univ Zaragoza, Fac Ciencias, Dept Bioquim & Biol Mol, Zaragoza, Spain; [Alberto Carrodeguas, Jose; Velazquez-Campoy, Adrian; Sancho, Javier] Univ Zaragoza, Fac Ciencias, Celular, Zaragoza, Spain; [Alberto Carrodeguas, Jose; Velazquez-Campoy, Adrian; Sancho, Javier] IIS Aragon, Zaragoza, Spain; [Velazquez-Campoy, Adrian] Govt Aragon, Fdn ARAID, Zaragoza, Spain	University of Zaragoza; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of Zaragoza; University of Zaragoza; University of Zaragoza	Lopez-Buesa, P (corresponding author), Univ Zaragoza, Fac Vet, Dept Prod Anim & Ciencia Alimentos, Zaragoza, Spain.; Lopez-Buesa, P (corresponding author), Univ Zaragoza, Inst Biocomputac & Fis Sistemas Complejos BIFI, BIFI IQFR CSIC Joint Unit, Zaragoza, Spain.	plopezbu@unizar.es	Román, Pedro Ángel Latorre/K-1052-2019; Velazquez-Campoy, Adrian/E-7946-2012; Sancho, javier/AAA-1225-2019	Velazquez-Campoy, Adrian/0000-0001-5702-4538; Sancho, javier/0000-0002-2879-9200; Latorre Muro, Pedro/0000-0002-6794-3535; Hidalgo, Jorge/0000-0002-6041-0963	Fundacion La Caixa;  [AGL2008-01487ALI];  [DGA-IAF FITE2012/2013];  [UZ2014-CIE-03];  [AGL2015-66177];  [BFU2013-47064-P];  [BIO2014-57314-REDT];  [PI078/08]	Fundacion La Caixa(La Caixa Foundation); ; ; ; ; ; ; 	This study was supported by research grants AGL2008-01487ALI (www.mineco.gob.es), DGA-IAF FITE2012/2013 (www.aragob.es), and UZ2014-CIE-03 (www.unizar.es) to P.L.B., AGL2015-66177 to P.L.B. and J.A.C., and grants BFU2013-47064-P (www.micinn.es), BIO2014-57314-REDT (www.mineco.gob.es) and PI078/08 to J.S. P.L. was supported by a predoctoral fellowship of Fundacion La Caixa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balan MD, 2015, BIOCHEMISTRY-US, V54, P5878, DOI 10.1021/acs.biochem.5b00822; Beale EG, 2007, CELL BIOCHEM BIOPHYS, V48, P89, DOI 10.1007/s12013-007-0025-6; Bergman RN, 2000, TRENDS ENDOCRIN MET, V11, P351, DOI 10.1016/S1043-2760(00)00323-4; Case CL, 2007, BBA-GEN SUBJECTS, V1770, P1576, DOI 10.1016/j.bbagen.2007.07.012; Copeland R. A., 2004, ENZYMES PRACTICAL IN; Cremades N, 2009, ACS CHEM BIOL, V4, P928, DOI 10.1021/cb900166q; Foley LH, 2003, BIOORG MED CHEM LETT, V13, P3607, DOI 10.1016/S0960-894X(03)00722-4; Hakimi P, 2007, J BIOL CHEM, V282, P32844, DOI 10.1074/jbc.M706127200; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Jiang WQ, 2011, MOL CELL, V43, P33, DOI 10.1016/j.molcel.2011.04.028; LAGUNAS R, 1983, EUR J BIOCHEM, V137, P479, DOI 10.1111/j.1432-1033.1983.tb07851.x; Latorre P, 2016, SCI REP-UK, V6, DOI 10.1038/srep19617; Leithner K, 2015, ONCOGENE, V34, P1044, DOI 10.1038/onc.2014.47; Lyne PD, 2002, DRUG DISCOV TODAY, V7, P1047, DOI 10.1016/S1359-6446(02)02483-2; Pey AL, 2008, J CLIN INVEST, V118, P2858, DOI 10.1172/JCI34355; ROBINSON BH, 1975, FEBS LETT, V58, P12, DOI 10.1016/0014-5793(75)80214-6; Shoichet BK, 2004, NATURE, V432, P862, DOI 10.1038/nature03197; Stiffin RM, 2008, BIOCHEMISTRY-US, V47, P2099, DOI 10.1021/bi7020662; VALERA A, 1994, P NATL ACAD SCI USA, V91, P9151, DOI 10.1073/pnas.91.19.9151; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; VUILLEUMIER S, 1993, BIOCHEMISTRY-US, V32, P10303, DOI 10.1021/bi00090a005; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yang JQ, 2009, J BIOL CHEM, V284, P27031, DOI 10.1074/jbc.R109.040535; Yang JQ, 2009, J BIOL CHEM, V284, P27025, DOI 10.1074/jbc.R109.040543; Zhang P, 2014, P NATL ACAD SCI USA, V111, P10684, DOI 10.1073/pnas.1411026111	25	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159002	10.1371/journal.pone.0159002	http://dx.doi.org/10.1371/journal.pone.0159002			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391465	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400187
J	Huang, Q; Wei, HF; Wu, ZP; Li, L; Yao, LF; Sun, ZW; Li, L; Lin, ZJ; Xu, W; Han, S; Cao, WJ; Xu, YF; Song, DW; Yang, XH; Xiao, JR				Huang, Quan; Wei, Haifeng; Wu, Zhipeng; Li, Lin; Yao, Liangfang; Sun, Zhengwang; Li, Lei; Lin, Zaijun; Xu, Wei; Han, Shuai; Cao, Wenjiao; Xu, Yunfei; Song, Dianwen; Yang, Xinghai; Xiao, Jianru			Preferentially Expressed Antigen of Melanoma Prevents Lung Cancer Metastasis	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; E-CADHERIN; PRAME EXPRESSION; TUMOR-GROWTH; INHIBITION; MIGRATION; INVASION; MODEL	Lung cancer is the most common cause of cancer death worldwide. The poor survival rate is largely due to the extensive local invasion and metastasis. However, the mechanisms underlying the invasion and metastasis of lung cancer cells remain largely elusive. In this study, we examined the role of preferentially expressed antigen of melanoma (PRAME) in lung cancer metastasis. Our results show that PRAME is downregulated in lung adenocarcinoma and lung bone metastasis compared with normal human lung. Knockdown of PRAME decreases the expression of E-Cadherin and promotes the proliferation, invasion, and metastasis of lung cancer cells by regulating multiple critical genes, most of which are related to cell migration, including MMP1, CCL2, CTGF, and PLAU. Clinical data analysis reveals that the expression of MMP1 correlates with the clinical features and outcome of lung adenocarcinoma. Taken together, our data demonstrate that PRAME plays a role in preventing the invasion and metastasis of lung adenocarcinoma and novel diagnostic or therapeutic strategies can be developed by targeting PRAME.	[Huang, Quan; Yao, Liangfang; Li, Lei] East China Normal Univ, Sch Life Sci, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, 500 Dongchuan Rd, Shanghai 200241, Peoples R China; [Huang, Quan; Wei, Haifeng; Wu, Zhipeng; Li, Lin; Sun, Zhengwang; Li, Lei; Lin, Zaijun; Xu, Wei; Han, Shuai; Song, Dianwen; Yang, Xinghai; Xiao, Jianru] Second Mil Med Univ, Changzheng Hosp, Dept Orthoped Oncol, 415 Fengyang Rd, Shanghai 200003, Peoples R China; [Cao, Wenjiao] China Welf Inst IPMCH, Int Peace Matern & Child Hlth Hosp, Shanghai, Peoples R China; [Xu, Yunfei] Tongji Univ, Peoples Hosp 10, Dept Urol, Shanghai, Peoples R China	East China Normal University; Naval Medical University; Tongji University	Wei, HF; Song, DW; Yang, XH; Xiao, JR (corresponding author), Second Mil Med Univ, Changzheng Hosp, Dept Orthoped Oncol, 415 Fengyang Rd, Shanghai 200003, Peoples R China.; Xu, YF (corresponding author), Tongji Univ, Peoples Hosp 10, Dept Urol, Shanghai, Peoples R China.	weihaifeng_sh@sina.com; yunfei_sh@sina.com; dianwen_sh@sina.com; xinghai_cz@sohu.com; xiaojianru_sh@163.com	Xiao, Jian/GYU-4351-2022					Aikawa T, 2006, MOL CANCER THER, V5, P1108, DOI 10.1158/1535-7163.MCT-05-0516; Bankovic J, 2010, LUNG CANCER, V67, P151, DOI 10.1016/j.lungcan.2009.04.010; Banyard J, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-387; Bonapace L, 2014, NATURE, V515, DOI 10.1038/nature13862; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Dornhofer N, 2006, CANCER RES, V66, P5816, DOI 10.1158/0008-5472.CAN-06-0081; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Epping MT, 2008, BRIT J CANCER, V99, P398, DOI 10.1038/sj.bjc.6604494; Finger EC, 2014, ONCOGENE, V33, P1093, DOI 10.1038/onc.2013.47; Ikeda H, 1997, IMMUNITY, V6, P199, DOI 10.1016/S1074-7613(00)80426-4; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Lau LF, 1999, EXP CELL RES, V248, P44, DOI 10.1006/excr.1999.4456; Lin TS, 2004, ONCOL REP, V12, P717; Liu H, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-583; Liu KC, 2011, ONCOL REP, V26, P177, DOI 10.3892/or.2011.1264; Liu YN, 2005, ONCOGENE, V24, P8277, DOI 10.1038/sj.onc.1208991; McDowall MD, 2009, NUCLEIC ACIDS RES, V37, pD651, DOI 10.1093/nar/gkn870; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Rosol TJ, 2003, CANCER-AM CANCER SOC, V97, P748, DOI 10.1002/cncr.11150; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Simmons J. K., 2014, Veterinary Sciences, V1, P16; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Sunami E, 2000, Oncologist, V5, P108, DOI 10.1634/theoncologist.5-2-108; Szczepanski MJ, 2013, BIOMARK MED, V7, P575, DOI 10.2217/bmm.13.68; Tan PX, 2012, BIOCHEM BIOPH RES CO, V419, P801, DOI 10.1016/j.bbrc.2012.02.110; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Wenger C, 1999, ONCOGENE, V18, P1073, DOI 10.1038/sj.onc.1202395; Xie D, 2001, CANCER RES, V61, P8917	34	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0149640	10.1371/journal.pone.0149640	http://dx.doi.org/10.1371/journal.pone.0149640			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391090	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400001
J	Roy, S; Ramiah, H; Reza, AW; Lim, CC; Ferrer, EM				Roy, Sukanta; Ramiah, Harikrishnan; Reza, Ahmed Wasif; Lim, Chee Cheow; Ferrer, Eloi Marigo			Design of a MEMS-Based Oscillator Using 180nm CMOS Technology	PLOS ONE			English	Article							PHASE NOISE; RESONATOR; MODE	Micro-electro mechanical system (MEMS) based oscillators are revolutionizing the timing industry as a cost effective solution, enhanced with more features, superior performance and better reliability. The design of a sustaining amplifier was triggered primarily to replenish MEMS resonator's high motion losses due to the possibility of their 'system-on-chip' integrated circuit solution. The design of a sustaining amplifier observing high gain and adequate phase shift for an electrostatic clamp-clamp (C-C) beam MEMS resonator, involves the use of an 180nm CMOS process with an unloaded Q of 1000 in realizing a fixed frequency oscillator. A net 122dB Omega transimpedance gain with adequate phase shift has ensured 17.22MHz resonant frequency oscillation with a layout area consumption of 0.121 mm(2) in the integrated chip solution, the sustaining amplifier draws 6.3mW with a respective phase noise of -84dBc/Hz at 1kHz offset is achieved within a noise floor of -103dB(C)/Hz. In this work, a comparison is drawn among similar design studies on the basis of a defined figure of merit (FOM). A low phase noise of 1kHz, high figure of merit and the smaller size of the chip has accredited to the design's applicability towards in the implementation of a clock generative integrated circuit. In addition to that, this complete silicon based MEMS oscillator in a monolithic solution has offered a cost effective solution for industrial or biomedical electronic applications.	[Roy, Sukanta; Ramiah, Harikrishnan; Reza, Ahmed Wasif; Lim, Chee Cheow] Univ Malaya, Dept Elect Engn, Kuala Lumpur 50603, Fed Territory O, Malaysia; [Ferrer, Eloi Marigo] Univ Malaya, Dept Elect Engn, Kuala Lumpur 50603, Fed Territory O, Malaysia; Silterra Malaysia Sdn Bhd 368948 D, Petaling Jaya 47800, Selangor, Malaysia	Universiti Malaya; Universiti Malaya		wasif@um.edu.my	RAMIAH, HARIKRISHNAN/B-8594-2010; Reza, Ahmed Wasif/ABE-5779-2020; Roy, Sukanta/AHD-0713-2022	Roy, Sukanta/0000-0001-6775-7727	University of Malaya High Impact Research (HIR) - Ministry of Higher Education (MOHE), Malaysia [UM.C/HIR/MOHE/ENG/51]; Silterra; UM High Impact Research Grant from the Ministry of Higher Education Malaysia [UM.C/HIR/MOHE/ENG/51]	University of Malaya High Impact Research (HIR) - Ministry of Higher Education (MOHE), Malaysia; Silterra; UM High Impact Research Grant from the Ministry of Higher Education Malaysia	This research work is supported by the University of Malaya High Impact Research (HIR) Grant (UM.C/HIR/MOHE/ENG/51) sponsored by the Ministry of Higher Education (MOHE), Malaysia. The authors acknowledge members of Silterra (M) Sdn. Bhd, a commercial company, in the support of research materials towards the completion of this work. Co-author Eloi Marigo Ferrer receives salary from Silterra. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions' section.; This research is supported by the UM High Impact Research Grant UM.C/HIR/MOHE/ENG/51 from the Ministry of Higher Education Malaysia.	Arefin MS, MEMS INTERFACE IC LO; Asl SZ, 2014, SOL STAT CIRC C ISSC; Bhugra H, 2014, MICR SYST MEMS 2014; Gong CSA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106055; Gronicz J, 2014, CIRC SYST ISCAS 2014; He L, 2010, IEEE T CIRCUITS-I, V57, P189, DOI 10.1109/TCSI.2009.2018932; Hui Y, 2015, J MICROELECTROMECH S, V24, P134, DOI 10.1109/JMEMS.2014.2322012; Langfelder G, 2014, IEEE T IND ELECTRON, V61, P567, DOI 10.1109/TIE.2013.2247233; Lavasani HM, 2015, ULTRASONICS FERROELE, V62, P802; Lavasani HM, 2011, IEEE J SOLID-ST CIRC, V46, P224, DOI 10.1109/JSSC.2010.2085890; Li M-H, 2014, FREQ CONTR S FCS 201; Li MH, 2015, J MICROELECTROMECH S, V24, P360, DOI 10.1109/JMEMS.2014.2331497; Nabki F, 2009, IEEE J SOLID-ST CIRC, V44, P2154, DOI 10.1109/JSSC.2009.2022914; Pachkawade V, 2013, IEEE SENS J, V13, P2882, DOI 10.1109/JSEN.2013.2259809; Pardo M, 2012, IEEE T CIRCUITS-I, V59, P979, DOI 10.1109/TCSI.2012.2195129; Phang K., 2001, CMOS OPTICAL PREAMPL; Poddar AK, 2012, IEEE MICROW MAG, V13, P120, DOI 10.1109/MMM.2012.2206952; Ramiah H, 2012, IETE J RES, V58, P425, DOI 10.4103/0377-2063.104161; Razavi B, 1996, IEEE J SOLID-ST CIRC, V31, P331, DOI 10.1109/4.494195; Razavi B, 2012, DESIGN INTEGRATED CI; Ruffieux D, 2014, IEEE J SOLID-ST CIRC, V49, P212, DOI 10.1109/JSSC.2013.2282111; Ruffieux D, 2010, IEEE J SOLID-ST CIRC, V45, P224, DOI 10.1109/JSSC.2009.2034434; Sedra A. S., 1998, MICROELECTRONIC CIRC; Seth S, 2012, ESSCIRC ESSCIRC 2012; Sobreviela G, 2014, MICR EL PRIME 2014 1; Sobreviela G, 2014, SENSORS; Tabatabaei S, 2010, IEEE MICRO, V30, P80, DOI 10.1109/MM.2010.39; Thakar VA, 2013, J MICROELECTROMECH S, V22, P815, DOI 10.1109/JMEMS.2013.2245403; Verd J, 2008, IEEE ELECTR DEVICE L, V29, P146, DOI 10.1109/LED.2007.914085; Zaliasl S, 2015, SOLID STATE CIRCUITS, V50, P291; Zuo C, 2009, POWER HANDLING RELAT; Zuo CJ, 2010, IEEE T ULTRASON FERR, V57, P82, DOI [10.1109/TUFFC.1382, 10.1109/TUFFC.2010.1382]	32	4	4	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158954	10.1371/journal.pone.0158954	http://dx.doi.org/10.1371/journal.pone.0158954			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391136	Green Submitted, Green Published, gold			2022-12-27	WOS:000380005400171
J	Swetnam, TL; O'Connor, CD; Lynch, AM				Swetnam, Tyson L.; O'Connor, Christopher D.; Lynch, Ann M.			Tree Morphologic Plasticity Explains Deviation from Metabolic Scaling Theory in Semi-Arid Conifer Forests, Southwestern USA	PLOS ONE			English	Article							SANTA-CATALINA MOUNTAINS; SIZE DISTRIBUTIONS; ALLOMETRIC EQUATIONS; PINALENO MOUNTAINS; CARBON STOCKS; MODEL; TEMPERATURE; COMPETITION; MORTALITY; ARIZONA	A significant concern about Metabolic Scaling Theory (MST) in real forests relates to consistent differences between the values of power law scaling exponents of tree primary size measures used to estimate mass and those predicted by MST. Here we consider why observed scaling exponents for diameter and height relationships deviate from MST predictions across three semi-arid conifer forests in relation to: (1) tree condition and physical form, (2) the level of inter-tree competition (e.g. open vs closed stand structure), (3) increasing tree age, and (4) differences in site productivity. Scaling exponent values derived from non-linear least-squares regression for trees in excellent condition (n = 381) were above the MST prediction at the 95% confidence level, while the exponent for trees in good condition were no different than MST (n = 926). Trees that were in fair or poor condition, characterized as diseased, leaning, or sparsely crowned had exponent values below MST predictions (n = 2,058), as did recently dead standing trees (n = 375). Exponent value of the mean-tree model that disregarded tree condition (n = 3,740) was consistent with other studies that reject MST scaling. Ostensibly, as stand density and competition increase trees exhibited greater morphological plasticity whereby the majority had characteristically fair or poor growth forms. Fitting by least-squares regression biases the mean-tree model scaling exponent toward values that are below MST idealized predictions. For 368 trees from Arizona with known establishment dates, increasing age had no significant impact on expected scaling. We further suggest height to diameter ratios below MST relate to vertical truncation caused by limitation in plant water availability. Even with environmentally imposed height limitation, proportionality between height and diameter scaling exponents were consistent with the predictions of MST.	[Swetnam, Tyson L.] Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ USA; [O'Connor, Christopher D.; Lynch, Ann M.] US Forest Serv, Rocky Mt Res Stn, Missoula, MT USA; [Lynch, Ann M.] Univ Arizona, Tree Ring Res Lab, Tucson, AZ 85721 USA	University of Arizona; United States Department of Agriculture (USDA); United States Forest Service; University of Arizona	Swetnam, TL (corresponding author), Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ USA.	tswetnam@email.arizona.edu	Swetnam, Tyson/Q-4216-2018	Swetnam, Tyson/0000-0002-6639-7181	USFS Region 3 Office; Coronado National Forest; Rocky Mountain Research Station, U.S. Forest Service through Research Joint Venture Agreement [07-JV-11221615-317]; University of Arizona; Nature Conservancy; Critical Zone Observatory (NSF Award) [0724958]; USDA Forest Service, Rocky Mountain Research Station [07-JV-11221615-317]; U.S. Forest Service; United States National Park Service, Valles Caldera National Preserve	USFS Region 3 Office; Coronado National Forest; Rocky Mountain Research Station, U.S. Forest Service through Research Joint Venture Agreement; University of Arizona; Nature Conservancy; Critical Zone Observatory (NSF Award); USDA Forest Service, Rocky Mountain Research Station(United States Department of Agriculture (USDA)United States Forest Service); U.S. Forest Service(United States Department of Agriculture (USDA)United States Forest Service); United States National Park Service, Valles Caldera National Preserve	The Santa Catalina field work and TL Swetnam were funded by the USFS Region 3 Office and the Coronado National Forest. The Pinaleno Demography Project, AM Lynch, and CD O'Connor were funded by the Rocky Mountain Research Station, U.S. Forest Service through Research Joint Venture Agreement 07-JV-11221615-317, the Coronado National Forest, University of Arizona, and the Nature Conservancy. The Valles Caldera field work and TL Swetnam were funded by the Critical Zone Observatory (NSF Award #0724958).; The research, analysis and other work documented in this publication was partially funded by the USDA Forest Service, Rocky Mountain Research Station, through Agreement # 07-JV-11221615-317 in cooperation with the U.S. Forest Service, Coronado National Forest, and the United States National Park Service, Valles Caldera National Preserve; however the findings, conclusions, and views expressed are those of the authors and do not necessarily represent the views of the U.S. Forest Service or National Park Service. Additional funding and support was provided by the USFS Region 3 Office, the Coronado National Forest, and the Critical Zone Observatory (NSF Award #0724958). Pinaleno lidar data were analyzed by the USFS Remote Sensing and Application Center (RSAC): Tom Mellin, Denise Laes, and Brent Mitchell. Pinaleno plot data were collected by USFS Personnel: Craig Wilcox, and Matt Littrell; University of Arizona personnel: Don Falk, Jesse Minor, Rebecca Minor, Laura Marshall, Alex Arizpe, Josh Farella, Jacquie Dewar, Ben Schippers, Anastasia Rabin, Kyle Miller, Alicia Durnin and Andrew McIntyre. Valles Caldera plot data were collected by Scott Compton of the Valles Caldera Preserve; Jon Pelletier, Shirley Papuga, Joshua Conver, and Kristine Nelson of the University of Arizona CZO. The Santa Catalina plot data were collected by Alicia Durnham, Anastasia Rabin, Benjamin Schippers, Jacquie Dewar, Jesse Minor, Joshua Conver, Kyle Miller, and Shane Cook.	[Anonymous], 2013, MATLAB R2013A; APPLEQUIST M. B., 1958, JOUR FOREST, V56, P141; Bentley LP, 2013, ECOL LETT, V16, P1069, DOI 10.1111/ele.12127; Brohman R, 2014, WO67 USDA FOR SERV E; Brown PM, 2008, INT J WILDLAND FIRE, V17, P28, DOI 10.1071/WF07023; Brown PM, 2008, ECOL APPL, V18, P1984, DOI 10.1890/07-1337.1; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Chojnacky DC, 2014, FORESTRY, V87, P129, DOI 10.1093/forestry/cpt053; Clarke A, 2006, FUNCT ECOL, V20, P405, DOI 10.1111/j.1365-2435.2006.01109.x; Coomes DA, 2003, ECOL LETT, V6, P980, DOI 10.1046/j.1461-0248.2003.00520.x; Coomes DA, 2007, J ECOL, V95, P1084, DOI 10.1111/j.1365-2745.2007.01280.x; Coomes DA, 2007, J ECOL, V95, P27, DOI 10.1111/j.1365-2745.2006.01179.x; Coomes DA, 2011, J ECOL, V99, P748, DOI 10.1111/j.1365-2745.2011.01811.x; Coomes DA, 2009, J ECOL, V97, P1369, DOI 10.1111/j.1365-2745.2009.01571.x; Duncanson L, 2015, SCI REP-UK, V5, DOI 10.1038/srep17153; Duncanson LI, 2015, GLOBAL ECOL BIOGEOGR, V24, P1465, DOI 10.1111/geb.12371; Duursma RA, 2003, FOREST ECOL MANAG, V186, P373, DOI 10.1016/S0378-1127(03)00307-4; Enquist BJ, 1998, NATURE, V395, P163, DOI 10.1038/25977; Enquist BJ, 1999, NATURE, V401, P907, DOI 10.1038/44819; Ernest SKM, 2003, ECOL LETT, V6, P990, DOI 10.1046/j.1461-0248.2003.00526.x; ESRI, 2011, ARCGIS DESKT REL 10; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Grissino-Mayer, 2001, TREE-RING RES, V57, P205, DOI DOI 10.1016/J.DENDRO.2010.12.002; GrissinoMayer HD, 1995, USDA ROCKY, V264, P399; Heyerdahl EK, 2011, GTRRMRS261 USDA FOR; HOLMES R L, 1983, Tree-Ring Bulletin, V43, P69; Jenkins J. C., 2004, NE319 USDA FOR SERV, DOI [10.2737/NE-GTR-319, DOI 10.2737/NE-GTR-319]; Jenkins JC, 2003, FOREST SCI, V49, P12; Kempes CP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020551; Kerkhoff AJ, 2007, BIOSCIENCE, V57, P489, DOI 10.1641/B570606; Koch GW, 2004, NATURE, V428, P851, DOI 10.1038/nature02417; Lines ER, 2012, GLOBAL ECOL BIOGEOGR, V21, P1017, DOI 10.1111/j.1466-8238.2011.00746.x; Liu FJ, 2008, ECOHYDROLOGY, V1, P239, DOI 10.1002/eco.22; Lutz JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036131; Mascaro J, 2011, REMOTE SENS ENVIRON, V115, P3770, DOI 10.1016/j.rse.2011.07.019; McDowell N, 2002, OECOLOGIA, V132, P12, DOI 10.1007/s00442-002-0904-x; McDowell NG, 2015, NAT CLIM CHANGE, V5, P669, DOI [10.1038/nclimate2641, 10.1038/NCLIMATE2641]; McDowell NG, 2002, TREE PHYSIOL, V22, P763, DOI 10.1093/treephys/22.11.763; Miles PD, 2009, NRS38, V38, P39; Muldavin E, 2006, VEGETATION MAP VALLE; Muller-Landau HC, 2006, ECOL LETT, V9, P589, DOI 10.1111/j.1461-0248.2006.00915.x; Muller-Landau HC, 2006, ECOL LETT, V9, P575, DOI 10.1111/j.1461-0248.2006.00904.x; Navar J, 2009, FOREST ECOL MANAG, V257, P427, DOI 10.1016/j.foreco.2008.09.028; Navar-Chaidez J. de J., 2010, Tropical and Subtropical Agroecosystems, V12, P507; NIERING WA, 1984, VEGETATIO, V58, P3; O'Connor C.D., ECOLOGICAL IN PRESS; O'Connor CD, 2015, FOREST ECOL MANAG, V336, P148, DOI 10.1016/j.foreco.2014.10.021; O'Connor CD, 2014, FOREST ECOL MANAG, V329, P264, DOI 10.1016/j.foreco.2014.06.032; Pelletier JD, 2013, J GEOPHYS RES-EARTH, V118, P741, DOI 10.1002/jgrf.20046; Price CA, 2007, ECOLOGY, V88, P1132, DOI 10.1890/06-1158; Price CA, 2007, P NATL ACAD SCI USA, V104, P13204, DOI 10.1073/pnas.0702242104; Purves DW, 2008, P NATL ACAD SCI USA, V105, P17018, DOI 10.1073/pnas.0807754105; Purves DW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000870; Rasmussen C, 2012, HYDROL EARTH SYST SC, V16, P725, DOI 10.5194/hess-16-725-2012; Rasmussen C, 2015, VADOSE ZONE J, V14, DOI 10.2136/vzj2014.07.0102; Rasmussen C, 2011, BIOGEOCHEMISTRY, V102, P15, DOI 10.1007/s10533-010-9476-8; Ryan MG, 1997, BIOSCIENCE, V47, P235, DOI 10.2307/1313077; Savage VM, 2010, P NATL ACAD SCI USA, V107, P22722, DOI 10.1073/pnas.1012194108; Savage VM, 2004, AM NAT, V163, P429, DOI 10.1086/381872; Shea K, 2004, ECOL LETT, V7, P491, DOI 10.1111/j.1461-0248.2004.00600.x; Shinozaki K, 1964, JPN J ECOL, V14, P97, DOI DOI 10.18960/SEITAI.14.3_97; Shinozaki K, 1964, JAPANESE J ECOL, V14, P133, DOI DOI 10.18960/SEITAI.14.4_133; Shreve, 1915, VEGETATION DESERT MO; Sillett SC, 2010, FOREST ECOL MANAG, V259, P976, DOI 10.1016/j.foreco.2009.12.003; Smith DD, 2014, NEW PHYTOL, V201, P217, DOI 10.1111/nph.12487; Smith T. M., 1993, P272; Speer JH, 2010, FUNDAMENTALS TREE RI; Sperry JS, 2012, FUNCT ECOL, V26, P1054, DOI 10.1111/j.1365-2435.2012.02022.x; Stephenson NL, 2014, NATURE, V507, P90, DOI 10.1038/nature12914; Stokes M.A., 1968, INTRO TREE RING DATI; Suding KN, 2001, ECOLOGY, V82, P2133, DOI 10.2307/2680221; Swetnam TL, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00384.1; Swetnam T. L., 2013, THESIS; Swetnam TL, 2014, FOREST ECOL MANAG, V330, P271, DOI 10.1016/j.foreco.2014.07.011; Swetnam TL, 2014, FOREST ECOL MANAG, V323, P158, DOI 10.1016/j.foreco.2014.03.016; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; West GB, 2009, P NATL ACAD SCI USA, V106, P7040, DOI 10.1073/pnas.0812294106; WHITTAKER RH, 1975, ECOLOGY, V56, P771, DOI 10.2307/1936291; YAMAGUCHI DK, 1991, CAN J FOREST RES, V21, P414, DOI 10.1139/x91-053	79	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0157582	10.1371/journal.pone.0157582	http://dx.doi.org/10.1371/journal.pone.0157582			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391084	gold, Green Submitted, Green Published			2022-12-27	WOS:000380005400014
J	Triplett, LR; Shidore, T; Long, J; Miao, JM; Wu, SC; Han, Q; Zhou, CH; Ishihara, H; Li, JY; Zhao, BY; Leach, JE				Triplett, Lindsay R.; Shidore, Teja; Long, John; Miao, Jiamin; Wu, Shuchi; Han, Qian; Zhou, Changhe; Ishihara, Hiromichi; Li, Jianyong; Zhao, Bingyu; Leach, Jan E.			AvrRxo1 Is a Bifunctional Type III Secreted Effector and Toxin-Antitoxin System Component with Homologs in Diverse Environmental Contexts	PLOS ONE			English	Article							RESISTANCE; BACTERIA; REVEALS; GENE; DIVERGENCE; SEQUENCE; MAIZE	Toxin-antitoxin (TA) systems are ubiquitous bacterial systems that may function in genome maintenance and metabolic stress management, but are also thought to play a role in virulence by helping pathogens survive stress. We previously demonstrated that the Xanthomonas oryzae pv. oryzicola protein AvrRxo1 is a type III-secreted virulence factor that has structural similarities to the zeta family of TA toxins, and is toxic to plants and bacteria in the absence of its predicted chaperone Arc1. In this work, we confirm that AvrRxo1 and its binding partner Arc1 function as a TA system when expressed in Escherichia coli. Sequences of avrRxo1 homologs were culled from published and newly generated phytopathogen genomes, revealing that avrRxo1:arc1 modules are rare or frequently inactivated in some species and highly conserved in others. Cloning and functional analysis of avrRxo1 from Acidovorax avenae, A. citrulli, Burkholderia andropogonis, Xanthomonas translucens, and Xanthomonas euvesicatoria showed that some AvrRxo1 homologs share the bacteriostatic and Rxo1-mediated cell death triggering activities of AvrRxo1 from X. oryzae. Additional distant putative homologs of avrRxo1 and arc1 were identified in genomic or metagenomic sequence of environmental bacteria with no known pathogenic role. One of these distant homologs was cloned from the filamentous soil bacterium Cystobacter fuscus. avrRxo1 from C. fuscus caused watersoaking and triggered Rxo1-dependent cell collapse in Nicotiana benthamiana, but no growth suppression in E. coli was observed. This work confirms that a type III effector can function as a TA system toxin, and illustrates the potential of microbiome data to reveal new environmental origins or reservoirs of pathogen virulence factors.	[Triplett, Lindsay R.; Shidore, Teja] Connecticut Agr Expt Stn, Dept Plant Pathol & Ecol, New Haven, CT 06504 USA; [Long, John; Ishihara, Hiromichi; Leach, Jan E.] Colorado State Univ, Dept Bioagr Sci & Pest Management, Ft Collins, CO 80523 USA; [Long, John; Ishihara, Hiromichi; Leach, Jan E.] Colorado State Univ, Program Plant Mol Biol, Ft Collins, CO 80523 USA; [Miao, Jiamin; Wu, Shuchi; Zhou, Changhe; Zhao, Bingyu] Virginia Polytech Inst & State Univ, Dept Hort, Blacksburg, VA 24061 USA; [Han, Qian; Li, Jianyong] Virginia Polytech Inst & State Univ, Dept Biochem, Blacksburg, VA 24061 USA; [Han, Qian] Hainan Univ, Lab Trop Vet Med & Vector Biol, Coll Agr, Haikou 570228, Hainan, Peoples R China	Connecticut Agricultural Experiment Station; Colorado State University; Colorado State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Hainan University	Triplett, LR (corresponding author), Connecticut Agr Expt Stn, Dept Plant Pathol & Ecol, New Haven, CT 06504 USA.	lindsay.triplett@ct.gov	Han, Qian/J-8696-2014; LI, JIAN/GRY-2197-2022; li, jian/GSE-0245-2022; Han, Qian/AAS-2134-2020	Han, Qian/0000-0001-6245-5252; Wu, Shuchi/0000-0001-9578-4626	Agriculture and Food Research Initiative Competitive grant of the USDA National Institute of Food and Agriculture [2014-67013-21564]; National Science Foundation [IOS-0845283]	Agriculture and Food Research Initiative Competitive grant of the USDA National Institute of Food and Agriculture; National Science Foundation(National Science Foundation (NSF))	This project was supported by the Agriculture and Food Research Initiative Competitive grant no. 2014-67013-21564 of the USDA National Institute of Food and Agriculture (nifa.usda.gov) to LRT and JEL and National Science Foundation (nsf.gov) grant no. IOS-0845283 to BZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was supported by the Agriculture and Food Research Initiative Competitive Grant no. 2014-67013-21564 of the USDA National Institute of Food and Agriculture to L.R.T., and J.E.L. and National Science Foundation grant no. IOS-0845283 to B.Z.	Arbing MA, 2010, STRUCTURE, V18, P996, DOI 10.1016/j.str.2010.04.018; Audoly G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026528; Brown BL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000706; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; De la Cruz MA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003827; de Lange O, 2015, NUCLEIC ACIDS RES, V43, P10065, DOI 10.1093/nar/gkv1053; Eckshtain-Levi N, 2014, PHYTOPATHOLOGY, V104, P1152, DOI 10.1094/PHYTO-12-13-0350-R; Han Q, 2015, STRUCTURE, V23, P1900, DOI 10.1016/j.str.2015.06.030; He XS, 2015, P NATL ACAD SCI USA, V112, P244, DOI 10.1073/pnas.1419038112; Leplae R, 2011, NUCLEIC ACIDS RES, V39, P5513, DOI 10.1093/nar/gkr131; Liu HF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113875; Maisonneuve E, 2014, CELL, V157, P539, DOI 10.1016/j.cell.2014.02.050; Makarova KS, 2006, BIOINFORMATICS, V22, P2581, DOI 10.1093/bioinformatics/btl418; McCann HC, 2008, NEW PHYTOL, V177, P33, DOI 10.1111/j.1469-8137.2007.02293.x; Mutschler H, 2011, J MOL MED, V89, P1183, DOI 10.1007/s00109-011-0797-4; Mutschler H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001033; Nelson WC, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00713; Norton JP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002954; Page R, 2016, NAT CHEM BIOL, V12, P208, DOI [10.1038/NCHEMBIO.2044, 10.1038/nchembio.2044]; REIMERS PJ, 1991, PHYSIOL MOL PLANT P, V38, P39, DOI 10.1016/S0885-5765(05)80141-9; Salomon D, 2011, MOL PLANT MICROBE IN, V24, P305, DOI 10.1094/MPMI-09-10-0196; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Sberro H, 2013, MOL CELL, V50, P136, DOI 10.1016/j.molcel.2013.02.002; Schuster CF, 2013, FEMS MICROBIOL LETT, V340, P73, DOI 10.1111/1574-6968.12074; Singletary LA, 2009, J BACTERIOL, V191, P7456, DOI 10.1128/JB.00963-09; Sletvold H, 2008, PLASMID, V60, P75, DOI 10.1016/j.plasmid.2008.04.002; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Triplett LR, 2011, APPL ENVIRON MICROB, V77, P3930, DOI 10.1128/AEM.00028-11; Van Melderen L, 2010, CURR OPIN MICROBIOL, V13, P781, DOI 10.1016/j.mib.2010.10.006; Van Melderen L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000437; Wang XX, 2011, APPL ENVIRON MICROB, V77, P5577, DOI 10.1128/AEM.05068-11; Wilson K., 2001, CURR PROTOC MOL BIOL, V71, P27, DOI [10.1002/0471142727.mb0204s56, DOI 10.1002/0471142727.MB0204S56]; Wonni I, 2014, PHYTOPATHOLOGY, V104, P520, DOI 10.1094/PHYTO-07-13-0213-R; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412; Zhao BY, 2005, P NATL ACAD SCI USA, V102, P15383, DOI 10.1073/pnas.0503023102; Zhao BY, 2004, MOL PLANT MICROBE IN, V17, P771, DOI 10.1094/MPMI.2004.17.7.771; Zielenkiewicz U, 2005, J BACTERIOL, V187, P6094, DOI 10.1128/JB.187.17.6094-6105.2005	37	27	27	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158856	10.1371/journal.pone.0158856	http://dx.doi.org/10.1371/journal.pone.0158856			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391081	gold, Green Published, Green Submitted			2022-12-27	WOS:000380005400144
J	Virostko, J; Hilmes, M; Eitel, K; Moore, DJ; Powers, AC				Virostko, John; Hilmes, Melissa; Eitel, Kelsey; Moore, Daniel J.; Powers, Alvin C.			Use of the Electronic Medical Record to Assess Pancreas Size in Type 1 Diabetes	PLOS ONE			English	Article							MELLITUS; VOLUME; PATHOGENESIS; WEIGHT; ORGAN; AGE	Aims This study harnessed the electronic medical record to assess pancreas volume in patients with type 1 diabetes (T1D) and matched controls to determine whether pancreas volume is altered in T1D and identify covariates that influence pancreas volume. Methods This study included 25 patients with T1D and 25 age-, sex-, and weight-matched controls from the Vanderbilt University Medical Center enterprise data warehouse. Measurements of pancreas volume were made from medical imaging studies using magnetic resonance imaging (MRI) or computed tomography (CT). Results Patients with T1D had a pancreas volume 47% smaller than matched controls (41.16 ml vs. 77.77 ml, P < 0.0001) as well as pancreas volume normalized by subject body weight, body mass index, or body surface area (all P < 0.0001). Pancreatic volume was smaller with a longer duration of T1D across the patient population (N = 25, P = 0.04). Additionally, four individual patients receiving multiple imaging scans displayed progressive declines in pancreas volume over time (similar to 6% of volume/year), whereas five controls scanned a year apart did not exhibit a decline in pancreas size (P = 0.03). The pancreas was uniformly smaller on the right and left side of the abdomen. Conclusions Pancreas volume declines with disease duration in patients with T1D, suggesting a protracted pathological process that may include the exocrine pancreas.	[Virostko, John] Vanderbilt Univ, Inst Imaging Sci, 221 Kirkland Hall, Nashville, TN 37235 USA; [Virostko, John; Hilmes, Melissa] Vanderbilt Univ, Dept Radiol & Radiol Sci, Nashville, TN 37235 USA; [Hilmes, Melissa; Moore, Daniel J.] Vanderbilt Univ, Dept Pediat, Nashville, TN USA; [Eitel, Kelsey] Loyola Univ Chicago, Stritch Sch Med, Maywood, IL 60153 USA; [Moore, Daniel J.] Vanderbilt Univ, Dept Pathol Immunol & Microbiol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Powers, Alvin C.] Vanderbilt Univ, Dept Med, Div Diabet Endocrinol & Metab, Nashville, TN USA; [Powers, Alvin C.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Powers, Alvin C.] VA Tennessee Valley Healthcare Syst, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Loyola University Chicago; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Virostko, J (corresponding author), Vanderbilt Univ, Inst Imaging Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.; Virostko, J (corresponding author), Vanderbilt Univ, Dept Radiol & Radiol Sci, Nashville, TN 37235 USA.	jack.virostko@Vanderbilt.edu	Moore, Daniel/V-6145-2019; Virostko, Jack/AAR-5947-2021; Moore, Daniel J/A-4924-2008	Moore, Daniel/0000-0002-6889-9345; Virostko, Jack/0000-0003-3413-8801; Moore, Daniel J/0000-0002-6889-9345; Eitel, Kelsey/0000-0001-5310-1057	Vanderbilt Office of Clinical and Translational Scientist Development; CTSA award from the National Center for Advancing Translational Sciences [UL1TR000445]; Juvenile Diabetes Research Foundation [3-SRA-2015-102-M-B]; National Institute of Diabetes and Digestive and Kidney Diseases [DK094199]; Vanderbilt Diabetes Research and Training Center [DK20593]; Veterans Administration; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094199, P30DK020593, P60DK020593] Funding Source: NIH RePORTER	Vanderbilt Office of Clinical and Translational Scientist Development; CTSA award from the National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Vanderbilt Diabetes Research and Training Center; Veterans Administration(US Department of Veterans Affairs); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was supported by the Vanderbilt Office of Clinical and Translational Scientist Development and CTSA award No. UL1TR000445 from the National Center for Advancing Translational Sciences, Juvenile Diabetes Research Foundation Grant 3-SRA-2015-102-M-B, National Institute of Diabetes and Digestive and Kidney Diseases Grant DK094199, and Vanderbilt Diabetes Research and Training Center Grant DK20593. AI Powers is supported by grants from the Juvenile Diabetes Research Foundation and a Merit Review Award from the Veterans Administration.; The authors would like to thank Jana Shirey-Rice and the resources of the Vanderbilt Research Derivative for help with subject identification. This project was supported by the Vanderbilt Office of Clinical and Translational Scientist Development and CTSA award No. UL1TR000445 from the National Center for Advancing Translational Sciences, Juvenile Diabetes Research Foundation Grant 3-SRA-2015-102-M-B, National Institute of Diabetes and Digestive and Kidney Diseases Grant DK094199, and Vanderbilt Diabetes Research and Training Center Grant DK20593. Al Powers is supported by grants from the Juvenile Diabetes Research Foundation and a Merit Review Award from the Veterans Administration. The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent official views of Vanderbilt University, the National Center for Advancing Translational Sciences, or the National Institutes of Health. Data stripped of PHI will be made available to all interested researchers upon request, as per the Vanderbilt IRB approval governing this work and PLOS ONE guidelines.	Altobelli E, 1998, J CLIN ULTRASOUND, V26, P391, DOI 10.1002/(SICI)1097-0096(199810)26:8<391::AID-JCU3>3.0.CO;2-D; Burute N, 2014, PANCREATOLOGY, V14, P268, DOI 10.1016/j.pan.2014.04.031; Campbell-Thompson M, 2012, JAMA-J AM MED ASSOC, V308, P2337, DOI 10.1001/jama.2012.15008; Campbell-Thompson ML, 2016, DIABETOLOGIA, V59, P217, DOI 10.1007/s00125-015-3752-z; CHIARELLI F, 1995, DIABETES CARE, V18, P1504, DOI 10.2337/diacare.18.11.1504; Dale BM, 2010, INVEST RADIOL, V45, P104, DOI 10.1097/RLI.0b013e3181c8ceac; Danciu I, 2014, J BIOMED INFORM, V52, P28, DOI 10.1016/j.jbi.2014.02.003; Du Bois D, 1916, ARCH INTERN MED, V17, P863, DOI 10.1001/archinte.1916.00080130010002; FONSECA V, 1985, BRIT MED J, V291, P1240, DOI 10.1136/bmj.291.6504.1240; FOULIS AK, 1984, DIABETOLOGIA, V26, P456; Gaglia JL, 2011, J CLIN INVEST, V121, P442, DOI 10.1172/JCI44339; GEPTS W, 1965, DIABETES, V14, P619, DOI 10.2337/diab.14.10.619; Goda K, 2001, ACTA DIABETOL, V38, P145, DOI 10.1007/s005920170012; HENDERSON JR, 1981, GUT, V22, P158, DOI 10.1136/gut.22.2.158; Imperatore G, 2012, DIABETES CARE, V35, P2515, DOI 10.2337/dc12-0669; KLOPPEL G, 1985, SURV SYN PATHOL RES, V4, P110; LOHR M, 1987, DIABETOLOGIA, V30, P757; Macauley M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126825; RAHIER J, 1983, J CLIN ENDOCR METAB, V56, P441, DOI 10.1210/jcem-56-3-441; Rodriguez-Calvo T, 2014, DIABETES, V63, P3880, DOI 10.2337/db14-0549; Saisho Y, 2007, CLIN ANAT, V20, P933, DOI 10.1002/ca.20543; Syed AB, 2012, PANCREAS, V41, P589, DOI 10.1097/MPA.0b013e318237457f; Szczepaniak EW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055991; Vesterhus M, 2008, J CLIN ENDOCR METAB, V93, P3505, DOI 10.1210/jc.2008-0340; Williams AJK, 2007, DIABETIC MED, V24, P35, DOI 10.1111/j.1464-5491.2007.02027.x; Williams AJK, 2012, J CLIN ENDOCR METAB, V97, pE2109, DOI 10.1210/jc.2012-1815; Yao XZ, 2014, DIAGNOSTIC INTERVENT; Ziegler AG, 2010, IMMUNITY, V32, P468, DOI 10.1016/j.immuni.2010.03.018	28	21	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158825	10.1371/journal.pone.0158825	http://dx.doi.org/10.1371/journal.pone.0158825			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391588	gold, Green Published, Green Submitted			2022-12-27	WOS:000380005400136
J	Wang, JJ; Lv, Y; Zhang, Y; Zheng, DX; Zhao, YL; Castellan, D; Liu, HL; Wang, ZL				Wang, Jingjing; Lv, Yan; Zhang, Yi; Zheng, Dongxia; Zhao, Yunling; Castellan, David; Liu, Hualei; Wang, Zhiliang			Genomic Characterizations of a Newcastle Disease Virus Isolated from Ducks in Live Bird Markets in China	PLOS ONE			English	Article							NORTHEASTERN UNITED-STATES; AVIAN INFLUENZA; HEMAGGLUTININ-NEURAMINIDASE; PHYLOGENETIC ANALYSIS; GENETIC DIVERSITY; EASTERN CHINA; WATERFOWL; SURVEILLANCE; GENOTYPE; SEQUENCE	One class I Newcastle disease virus (NDV), designated as duck/Guangxi/1261/2015 (GX1261), was isolated from asymptomatic ducks in live bird markets (LBM) from southern China during the national active surveillance for NDVs in 2015. The complete genome length of GX1261 isolate was 15,198 nucleotides with the gene order of 3'-NP-P-M-F-HN-L5'. The motif at the cleavage site of F protein was (112)ERQER/L-117, which was typical of low virulence NDV. Several mutations were identified in the functional domains of F and HN proteins, including fusion peptide, heptad repeat region, transmembrane domains and neutralizing epitopes. Phylogenetic analysis based on the complete F gene revealed that the isolate was clustered into sub-genotype 1c in class I, and showed a high level of similarity with the strains isolated from waterfowl in the United States of America. This is the first report of this kind of virus in the mainland of China. These results demonstrated that GX1261-like viruses might exist in asymptomatic waterfowl, and remain undetected or unidentified. Thus, more investigation needs to be done in order to identify the source of the virus. This study revealed the genetic and phylogenetic characteristics of GX1261 isolate and could help us to better understand the epidemiological context of class I NDV in China.	[Wang, Jingjing; Lv, Yan; Zheng, Dongxia; Zhao, Yunling; Liu, Hualei; Wang, Zhiliang] China Anim Hlth & Epidemiol Ctr, OIE Reference Lab Newcastle Dis, Qingdao 266032, Peoples R China; [Zhang, Yi] China Anim Hlth & Epidemiol Ctr, OIE Collaborating Ctr Vet Epidemiol & Publ Hlth, Qingdao 266032, Peoples R China; [Castellan, David] DM Castellan Int Vet Consulting, Niagara Falls, ON, Canada	China Animal Health & Epidemiology Center; China Animal Health & Epidemiology Center	Liu, HL; Wang, ZL (corresponding author), China Anim Hlth & Epidemiol Ctr, OIE Reference Lab Newcastle Dis, Qingdao 266032, Peoples R China.	hualeiliuwy@163.com; zlwang111@163.com			Chinese Special Fund for Agro-scientific Research in the Public Interest [201303033]; DM Castellan International Veterinary Consulting	Chinese Special Fund for Agro-scientific Research in the Public Interest; DM Castellan International Veterinary Consulting	This work was supported by the Chinese Special Fund for Agro-scientific Research in the Public Interest (201303033). DM Castellan International Veterinary Consulting provided support in the form of salaries for author David Castellan, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Aldous EW, 2010, AVIAN PATHOL, V39, P519, DOI 10.1080/03079457.2010.530938; Alexander DJ, 2009, NEWCASTLE DIS OIE TE; Bulaga LL, 2003, AVIAN DIS, V47, P996, DOI 10.1637/0005-2086-47.s3.996; CHAMBERS P, 1986, J GEN VIROL, V67, P475, DOI 10.1099/0022-1317-67-3-475; Cho SH, 2008, J CLIN MICROBIOL, V46, P1541, DOI 10.1128/JCM.00187-08; Cho SH, 2007, VIRUS GENES, V35, P293, DOI 10.1007/s11262-007-0078-z; Czegledi A, 2006, VIRUS RES, V120, P36, DOI 10.1016/j.virusres.2005.11.009; Diel DG, 2012, INFECT GENET EVOL, V12, P1770, DOI 10.1016/j.meegid.2012.07.012; Dimitrov KM, 2016, INFECT GENET EVOL, V39, P22, DOI 10.1016/j.meegid.2016.01.008; Guo HB, 2013, ARCH VIROL, V158, P1121, DOI 10.1007/s00705-012-1572-8; Hu SL, 2010, VET MICROBIOL, V140, P92, DOI 10.1016/j.vetmic.2009.07.029; Jindal N, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-191; Kim LM, 2007, J VIROL, V81, P12641, DOI 10.1128/JVI.00843-07; King DJ, 1997, AVIAN DIS, V41, P683, DOI 10.2307/1592161; Liu XW, 2009, AVIAN PATHOL, V38, P377, DOI 10.1080/03079450903183637; MCGINNES LW, 1995, VIROLOGY, V212, P398, DOI 10.1006/viro.1995.1497; Meng CC, 2012, ARCH VIROL, V157, P869, DOI 10.1007/s00705-012-1248-4; Pfitzer S, 2000, AVIAN DIS, V44, P655, DOI 10.2307/1593107; Romer-Oberdorfer A, 2006, AVIAN DIS, V50, P259, DOI 10.1637/7471-111505R.1; Seal BS, 2005, VET MICROBIOL, V106, P7, DOI 10.1016/j.vetmic.2004.11.013; Senne DA, 2003, AVIAN DIS, V47, P898, DOI 10.1637/0005-2086-47.s3.898; Shengqing Y, 2002, VIROLOGY, V301, P206, DOI 10.1006/viro.2002.1539; Snoeck CJ, 2013, J CLIN MICROBIOL, V51, P2250, DOI 10.1128/JCM.00684-13; Takakuwa H, 1998, JPN J VET RES, V45, P207; TOYODA T, 1989, VIROLOGY, V169, P273, DOI 10.1016/0042-6822(89)90152-9; Umali DV, 2014, VIRUS GENES, V49, P89, DOI 10.1007/s11262-014-1075-7; Wang J. Q., 2015, SCI WORLD J, V2015, P1, DOI [DOI 10.1371/J0URNAL.P0NE.0124261, DOI 10.2118/174392-MS]; Zhu J, 2014, VIROL J, V11, DOI 10.1186/s12985-014-0211-2	28	14	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158771	10.1371/journal.pone.0158771	http://dx.doi.org/10.1371/journal.pone.0158771			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391305	gold, Green Published, Green Submitted			2022-12-27	WOS:000380005400120
J	Oner, C; Cosan, DT; Colak, E				Oner, Cagri; Cosan, Didem Turgut; Colak, Ertugrul			Estrogen and Androgen Hormone Levels Modulate the Expression of PIWI Interacting RNA in Prostate and Breast Cancer	PLOS ONE			English	Article							NOVO DNA METHYLATION; HUMAN GASTRIC-CANCER; CELL-LINE MCF-7; NONCODING RNAS; MESSENGER-RNA; IN-VITRO; RECEPTOR; CARCINOMA; PROLIFERATION; PIRNAS	PIWI interacting RNAs (piRNAs), a member of non-coding RNA, originate from intergenic repetitive regions of the genome. piRNA expressions increase in various cancers and it is thought that this increase could be caused by hormones. We aimed to determine the effects of hormones on piRNA expression in breast and prostate cancer. High viability and a decrease in adhesion were observed at the concentrations of the highest proliferation. Furthermore, an increase in adhesion was also observed in MDA-MB-231 cells. After hormone treatment, while piR-651 expression had increased both breast and prostate cancer cell lines, piR-823 expressions increased in prostate cancer cell lines and only in the breast cancer cell line which was malignant. Thus, it was determined that piR-823 might show different expressions in different type of cancers.	[Oner, Cagri; Cosan, Didem Turgut] Eskisehir Osmangazi Univ, Fac Med, Dept Med Biol, TR-26480 Eskisehir, Turkey; [Colak, Ertugrul] Eskisehir Osmangazi Univ, Fac Med, Dept Biostat & Med Informat, TR-26480 Eskisehir, Turkey	Eskisehir Osmangazi University; Eskisehir Osmangazi University	Oner, C (corresponding author), Eskisehir Osmangazi Univ, Fac Med, Dept Med Biol, TR-26480 Eskisehir, Turkey.	coner86@gmail.com	Coşan, Didem Turgut/ABC-1466-2020; ÖNER, ÇAĞRI/O-4220-2015; ÖNER, Çağrı/AAP-1421-2020; Çolak, Ertuğrul/AAG-2140-2020	Coşan, Didem Turgut/0000-0002-8488-6405; Çolak, Ertuğrul/0000-0003-3251-1043; ONER, Cagri/0000-0003-3771-3277	Eskisehir Osmangazi University Scientific Research Project Commission [2014-576]	Eskisehir Osmangazi University Scientific Research Project Commission(Eskisehir Osmangazi University)	This study was supported by Eskisehir Osmangazi University Scientific Research Project Commission (Project Number: 2014-576).	Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Aravin AA, 2008, GENE DEV, V22, P970, DOI 10.1101/gad.1669408; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Burow ME, 1999, CARCINOGENESIS, V20, P2057, DOI 10.1093/carcin/20.11.2057; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Chen Y, 2007, CURR BIOL, V17, P637, DOI 10.1016/j.cub.2007.02.027; Cheng J, 2012, CANCER LETT, V315, P12, DOI 10.1016/j.canlet.2011.10.004; Cheng J, 2011, CLIN CHIM ACTA, V412, P1621, DOI 10.1016/j.cca.2011.05.015; Chu H, 2015, CANCER, V0, P2044; Chu HY, 2015, CANCER LETT, V356, P561, DOI 10.1016/j.canlet.2014.10.004; Cook HA, 2004, CELL, V116, P817, DOI 10.1016/S0092-8674(04)00250-8; Cui L, 2011, CLIN BIOCHEM, V44, P1050, DOI 10.1016/j.clinbiochem.2011.06.004; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Evangelou A, 2002, ENDOCRINOLOGY, V143, P3897, DOI 10.1210/en.2002-220156; Falany JL, 1996, CANCER RES, V56, P1551; Fan SJ, 2000, CANCER RES, V60, P5635; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; FURUYA Y, 1989, CANCER RES, V49, P6670; GIERTHY JF, 1987, CANCER RES, V47, P6198; Ginsburg ES, 1999, J STEROID BIOCHEM, V69, P299, DOI 10.1016/S0960-0760(99)00047-3; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Grochola LF, 2008, BRIT J CANCER, V99, P1083, DOI 10.1038/sj.bjc.6604653; Harrington WR, 2006, MOL ENDOCRINOL, V20, P491, DOI 10.1210/me.2005-0186; Hashim A, 2014, ONCOTARGET, V5, P9901, DOI 10.18632/oncotarget.2476; He W, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-426; Heneweer M, 2005, TOXICOL SCI, V83, P257, DOI 10.1093/toxsci/kfi025; HENTTU P, 1992, ENDOCRINOLOGY, V130, P766, DOI 10.1210/en.130.2.766; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Ipsaro JJ, 2012, NATURE, V491, P279, DOI 10.1038/nature11502; Ishizu H, 2012, GENE DEV, V26, P2361, DOI 10.1101/gad.203786.112; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kang HJ, 2014, MOL BIOL REP, V41, P6729, DOI 10.1007/s11033-014-3558-y; KAREY KP, 1988, CANCER RES, V48, P4083; KIERSZENBAUM A. L., 2006, HISTOLOGY CELL BIOL; Kuramochi-Miyagawa S, 2008, GENE DEV, V22, P908, DOI 10.1101/gad.1640708; Law PTY, 2013, J HEPATOL, V58, P1165, DOI 10.1016/j.jhep.2013.01.032; Le Bail JC, 1998, CANCER LETT, V130, P209, DOI 10.1016/S0304-3835(98)00141-4; LEE C, 1995, ENDOCRINOLOGY, V136, P796, DOI 10.1210/en.136.2.796; Litvinov IV, 2003, J CLIN ENDOCR METAB, V88, P2972, DOI 10.1210/jc.2002-022038; Martinez VD, 2015, SCI REP-UK, V5, DOI 10.1038/srep10423; Mei YP, 2013, CANCER LETT, V336, P46, DOI 10.1016/j.canlet.2013.04.008; Momma T, 1997, INT J CANCER, V72, P1062; Ni M, 2011, CANCER CELL, V20, P119, DOI 10.1016/j.ccr.2011.05.026; Palmer CP, 2008, EUR BIOPHYS J BIOPHY, V37, P359, DOI 10.1007/s00249-007-0219-2; Pandya G. M., 2014, Current Trends in Biotechnology and Pharmacy, V8, P303; Przylipiak A, 1996, ARCH GYNECOL OBSTET, V258, P137, DOI 10.1007/s004040050114; Rajah TT, 2012, ANTICANCER RES, V32, P1181; SAPINO A, 1986, CANCER RES, V46, P2526; Siddiqi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033711; SIMANOWSKI UA, 1986, GUT, V27, P278, DOI 10.1136/gut.27.3.278; Singletary KW, 2001, CANCER LETT, V165, P131, DOI 10.1016/S0304-3835(01)00419-0; Tai S, 2011, PROSTATE, V71, P1668, DOI 10.1002/pros.21383; Teixeira C, 1995, CANC RES, V55; THOMPSON EW, 1989, CANCER RES, V49, P6929; Trapman J, 1996, PATHOL RES PRACT, V192, P752, DOI 10.1016/S0344-0338(96)80097-5; Tsai EM, 2001, CANCER RES, V61, P8390; WANG TTY, 1995, CANCER RES, V55, P2487; Wang Y, 2012, INT J CLIN EXP PATHO, V5, P315; Watanabe T, 2011, SCIENCE, V332, P848, DOI 10.1126/science.1203919; WIESE TE, 1992, IN VITRO CELL DEV-AN, V28A, P595; WOLF DA, 1993, MOL ENDOCRINOL, V7, P924, DOI 10.1210/me.7.7.924; Wu QL, 2010, BIOCHEM BIOPH RES CO, V396, P915, DOI 10.1016/j.bbrc.2010.05.022; Yamaguchi Y, 2014, CANCER MICROENVIRON, V7, P23, DOI 10.1007/s12307-013-0139-x; Yan H, 2015, LEUKEMIA, V29, P196, DOI 10.1038/leu.2014.135; Yang QL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066809; Zhao XY, 2000, ENDOCRINOLOGY, V141, P2548, DOI 10.1210/en.141.7.2548; Zhou HH, 2010, BIOL CELL, V102, P645, DOI 10.1042/BC20100029; Zhu ML, 2010, FASEB J, V24, P769, DOI 10.1096/fj.09-136994	71	31	33	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159044	10.1371/journal.pone.0159044	http://dx.doi.org/10.1371/journal.pone.0159044			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414029	Green Published, Green Submitted, gold			2022-12-27	WOS:000379579500063
J	Kimura, H; Tomatsu, K; Saiki, H; Arimitsu, K; Ono, M; Kawashima, H; Iwata, R; Nakanishi, H; Ozeki, E; Kuge, Y; Saji, H				Kimura, Hiroyuki; Tomatsu, Kenji; Saiki, Hidekazu; Arimitsu, Kenji; Ono, Masahiro; Kawashima, Hidekazu; Iwata, Ren; Nakanishi, Hiroaki; Ozeki, Eiichi; Kuge, Yuji; Saji, Hideo			Continuous-Flow Synthesis of N-Succinimidyl 4-[F-18]fluorobenzoate Using a Single Microfluidic Chip	PLOS ONE			English	Article							LABELING PROTEINS; PET; RADIOSYNTHESIS; REACTOR; F-18; RADIOPHARMACEUTICALS; RADIOCHEMISTRY; RADIOTRACER; CONJUGATION; TECHNOLOGY	In the field of positron emission tomography ( PET) radiochemistry, compact microreactors provide reliable and reproducible synthesis methods that reduce the use of expensive precursors for radiolabeling and make effective use of the limited space in a hot cell. To develop more compact microreactors for radiosynthesis of F-18-labeled compounds required for the multistep procedure, we attempted radiosynthesis of N-succinimidyl 4-[F-18]fluorobenzoate ([F-18]SFB) via a three-step procedure using a microreactor. We examined individual steps for [F-18]SFB using a batch reactor and microreactor and developed a new continuous-flow synthetic method with a single microfluidic chip to achieve rapid and efficient radiosynthesis of [F-18]SFB. In the synthesis of [F-18]SFB using this continuous-flow method, the three-step reaction was successfully completed within 6.5 min and the radiochemical yield was 64 +/- 2% (n = 5). In addition, it was shown that the quality of [F-18]SFB synthesized on this method was equal to that synthesized by conventional methods using a batch reactor in the radiolabeling of bovine serum albumin with [F-18]SFB.	[Kimura, Hiroyuki; Tomatsu, Kenji; Arimitsu, Kenji; Ono, Masahiro; Kawashima, Hidekazu; Kuge, Yuji; Saji, Hideo] Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto, Kyoto, Japan; [Kimura, Hiroyuki] Kyoto Pharmaceut Univ, Dept Analyt & Bioinorgan Chem, Kyoto, Kyoto, Japan; [Saiki, Hidekazu; Nakanishi, Hiroaki; Ozeki, Eiichi] Shimadzu Co Ltd, Technol Res Lab, Kyoto, Japan; [Arimitsu, Kenji] Mukogawa Womens Univ, Sch Pharm & Pharmaceut Sci, Nishinomiya, Hyogo, Japan; [Kawashima, Hidekazu] Kyoto Pharmaceut Univ, Radioisotope Res Ctr, Kyoto, Kyoto, Japan; [Iwata, Ren] Tohoku Univ, CYRIC, Sendai, Miyagi, Japan; [Kuge, Yuji] Hokkaido Univ, Cent Inst Isotope Sci, Sapporo, Hokkaido, Japan	Kyoto University; Kyoto Pharmaceutical University; Shimadzu Corporation; Mukogawa Women's University; Kyoto Pharmaceutical University; Tohoku University; Hokkaido University	Kimura, H; Saji, H (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto, Kyoto, Japan.; Kimura, H (corresponding author), Kyoto Pharmaceut Univ, Dept Analyt & Bioinorgan Chem, Kyoto, Kyoto, Japan.	hkimura@mb.kyoto-phu.ac.jp; hsaji@pharm.kyoto-u.ac.jp		Arimitsu, Kenji/0000-0003-2844-1652	New Energy and Industrial Technology Development Organization [P08029]; Shimadzu Corporation; Grants-in-Aid for Scientific Research [15K15444] Funding Source: KAKEN	New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Shimadzu Corporation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the New Energy and Industrial Technology Development Organization (P08029, H. Saji, http://www.nedo.go.jp/activities/ZZ_00259.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Shimadzu Corporation provided support in the form of the salaries for authors, H. Saiki, H. Nakanishi and E. Ozeki, but did not have any additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Arima V, 2013, LAB CHIP, V13, P2328, DOI 10.1039/c3lc00055a; Audrain H, 2007, ANGEW CHEM INT EDIT, V46, P1772, DOI 10.1002/anie.200603509; BANNWARTH W, 1991, TETRAHEDRON LETT, V32, P1157, DOI 10.1016/S0040-4039(00)92032-X; Bouvet V, 2012, BIOORG MED CHEM LETT, V22, P2291, DOI 10.1016/j.bmcl.2012.01.083; Bouvet VR, 2011, NUCL MED BIOL, V38, P235, DOI 10.1016/j.nucmedbio.2010.09.002; Chun JH, 2010, J ORG CHEM, V75, P3332, DOI 10.1021/jo100361d; Dahl K, 2012, J LABELLED COMPD RAD, V55, P455, DOI 10.1002/jlcr.2970; Elizarov AM, 2010, J NUCL MED, V51, P282, DOI 10.2967/jnumed.109.065946; Elizarov AM, 2009, LAB CHIP, V9, P1326, DOI 10.1039/b820299k; Fletcher PDI, 2002, TETRAHEDRON, V58, P4735, DOI 10.1016/S0040-4020(02)00432-5; Gillies JM, 2006, APPL RADIAT ISOTOPES, V64, P333, DOI 10.1016/j.apradiso.2005.08.009; Gillies JM, 2006, APPL RADIAT ISOTOPES, V64, P325, DOI 10.1016/j.apradiso.2005.08.007; Guenther KJ, 2006, J MED CHEM, V49, P1466, DOI 10.1021/jm0509344; Haroun S, 2013, CAN J CHEM, V91, P326, DOI 10.1139/cjc-2012-0331; Kealey S, 2011, ORG BIOMOL CHEM, V9, P3313, DOI 10.1039/c0ob00631a; Kimura H, 2014, J LABELLED COMPD RAD, V57, P680, DOI 10.1002/jlcr.3232; Lee CC, 2005, SCIENCE, V310, P1793, DOI 10.1126/science.1118919; Liang SH, 2014, MEDCHEMCOMM, V5, P432, DOI 10.1039/c3md00335c; Lin WY, 2009, NANO TODAY, V4, P470, DOI 10.1016/j.nantod.2009.10.007; Lu SY, 2004, LAB CHIP, V4, P523, DOI 10.1039/b407938h; Mading P, 2005, APPL RADIAT ISOTOPES, V63, P329, DOI 10.1016/j.apradiso.2005.03.005; Marik J, 2007, APPL RADIAT ISOTOPES, V65, P199, DOI 10.1016/j.apradiso.2006.06.007; Miller PW, 2007, ANGEW CHEM INT EDIT, V46, P2875, DOI 10.1002/anie.200604541; Miller PW, 2011, CHEM-EUR J, V17, P460, DOI 10.1002/chem.201002644; Miller PW, 2009, J CHEM TECHNOL BIOT, V84, P309, DOI 10.1002/jctb.2061; Mitchell P, 2001, NAT BIOTECHNOL, V19, P717, DOI 10.1038/90754; Phelps ME, 2000, P NATL ACAD SCI USA, V97, P9226, DOI 10.1073/pnas.97.16.9226; Ramsey JM, 1999, NAT BIOTECHNOL, V17, P1061, DOI 10.1038/15044; REGENFUSS P, 1985, REV SCI INSTRUM, V56, P283, DOI 10.1063/1.1138345; Steel CJ, 2007, J LABELLED COMPD RAD, V50, P308, DOI 10.1002/jlcr.1259; Tang G, 2008, J LABELLED COMPD RAD, V51, P68, DOI 10.1002/jlcr.1481; Ungersboeck J, 2012, NUCL MED BIOL, V39, P1087, DOI 10.1016/j.nucmedbio.2012.04.004; VAIDYANATHAN G, 1992, NUCL MED BIOL, V19, P275; Vaidyanathan G, 2006, NAT PROTOC, V1, P1655, DOI 10.1038/nprot.2006.264; Watts P, 2012, J FLOW CHEM, V2, P37, DOI 10.1556/JFC-D-12-00010; Wester HJ, 1996, NUCL MED BIOL, V23, P365, DOI 10.1016/0969-8051(96)00017-0; Wong R, 2012, APPL RADIAT ISOTOPES, V70, P193, DOI 10.1016/j.apradiso.2011.09.022; Wust F, 2003, APPL RADIAT ISOTOPES, V59, P43, DOI 10.1016/S0969-8043(03)00161-1	38	14	14	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159303	10.1371/journal.pone.0159303	http://dx.doi.org/10.1371/journal.pone.0159303			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410684	Green Published, gold, Green Submitted			2022-12-27	WOS:000379508300078
J	Marvibaigi, M; Amini, N; Supriyanto, E; Majid, FAA; Jaganathan, SK; Jamil, S; Almaki, JH; Nasiri, R				Marvibaigi, Mohsen; Amini, Neda; Supriyanto, Eko; Majid, Fadzilah Adibah Abdul; Jaganathan, Saravana Kumar; Jamil, Shajarahtunnur; Almaki, Javad Hamzehalipour; Nasiri, Rozita			Antioxidant Activity and ROS-Dependent Apoptotic Effect of Scurrula ferruginea (Jack) Danser Methanol Extract in Human Breast Cancer Cell MDA-MB-231	PLOS ONE			English	Article							MISTLETOE VISCUM-ALBUM; TUMOR-GROWTH STIMULATION; IN-VITRO; BIOACTIVE COMPOUNDS; CYTOTOXIC ACTIVITY; DEATH; MITOCHONDRIA; MECHANISMS; ASSAY; METASTASIS	Scurrula ferruginea (Jack) Danser is one of the mistletoe species belonging to Loranthaceae family, which grows on the branches of many deciduous trees in tropical countries. This study evaluated the antioxidant activities of S. ferruginea extracts. The cytotoxic activity of the selected extracts, which showed potent antioxidant activities, and high phenolic and flavonoid contents, were investigated in human breast cancer cell line (MDA-MB-231) and non-cancer human skin fibroblast cells (HSF-1184). The activities and characteristics varied depending on the different parts of S. ferruginea, solvent polarity, and concentrations of extracts. The stem methanol extract showed the highest amount of both phenolic (273.51 +/- 4.84 mg gallic acid/g extract) and flavonoid contents (163.41 +/- 4.62 mg catechin/g extract) and strong DPPH center dot radical scavenging (IC50 = 27.81 mu g/mL) and metal chelation activity (IC50 = 80.20 mu g/mL). The stem aqueous extract showed the highest ABTS(center dot+) scavenging ability. The stem methanol and aqueous extracts exhibited dose-dependent cytotoxic activity against MDA-MB-231 cells with IC50 of 19.27 and 50.35 mu g/mL, respectively. Furthermore, the extracts inhibited the migration and colony formation of MDA-MB-231 cells in a concentration-dependent manner. Morphological observations revealed hallmark properties of apoptosis in treated cells. The methanol extract induced an increase in ROS generation and mitochondrial depolarization in MDA-MB-231 cells, suggesting its potent apoptotic activity. The present study demonstrated that the S. ferruginea methanol extract mediated MDA-MB-231 cell growth inhibition via induction of apoptosis which was confirmed by Western blot analysis. It may be a potential anticancer agent; however, its in vivo anticancer activity needs to be investigated.	[Marvibaigi, Mohsen; Amini, Neda; Supriyanto, Eko; Jaganathan, Saravana Kumar] Univ Teknol Malaysia, Fac Biosci & Med Engn, IJN UTM Cardiovasc Engn Ctr, Skudai, Johor, Malaysia; [Majid, Fadzilah Adibah Abdul; Almaki, Javad Hamzehalipour; Nasiri, Rozita] Univ Teknol Malaysia, Fac Chem Engn, Bioproc Engn Dept, Skudai, Johor, Malaysia; [Jamil, Shajarahtunnur] Univ Teknol Malaysia, UTM Johor Bahru, Fac Sci, Dept Chem, Skudai, Johor, Malaysia; [Majid, Fadzilah Adibah Abdul] Univ Malaysia Terengganu, Inst Marine Biotechnol, Kuala Terengganu, Malaysia	Universiti Teknologi Malaysia; Universiti Teknologi Malaysia; Universiti Teknologi Malaysia; Universiti Malaysia Terengganu	Marvibaigi, M; Supriyanto, E (corresponding author), Univ Teknol Malaysia, Fac Biosci & Med Engn, IJN UTM Cardiovasc Engn Ctr, Skudai, Johor, Malaysia.	mohsen_marvi@yahoo.com; eko.sup1950@gmail.com	Nasiri, Rozita/AAG-9484-2020; abdul majid, fadzilah adibah/AAA-1134-2022; Nasiri, Rozita/ABI-3475-2020; Jamil, Shajarahtunnur/GXG-9807-2022; Jaganathan, Saravana Kumar/N-2385-2017; Supriyanto, Eko/AAZ-1135-2021	Nasiri, Rozita/0000-0002-3897-8034; abdul majid, fadzilah adibah/0000-0001-8122-9605; Nasiri, Rozita/0000-0002-3897-8034; Jaganathan, Saravana Kumar/0000-0002-2785-137X; Amini, Neda/0000-0001-5084-1279; Marvibaigi, Mohsen/0000-0002-0640-2268; SUPRIYANTO, EKO/0000-0002-2142-8351				Abhyankar G, 2010, INNOV FOOD SCI EMERG, V11, P526, DOI 10.1016/j.ifset.2010.02.005; Ameer OZ, 2009, INT J PHARMACOL, V5, P44, DOI 10.3923/ijp.2009.44.50; Anders GT, 2002, FITOTERAPIA, V73, P400; Ashraf MF, 2013, SCI WORLD J, DOI 10.1155/2013/216894; Astley SB, 2003, TRENDS FOOD SCI TECH, V14, P93, DOI 10.1016/S0924-2244(02)00281-9; Barlow B. A., 1991, Flora Malesiana Bulletin, V10, P335; BECKER H, 1986, ONCOLOGY, V43, P2, DOI 10.1159/000226413; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Bras M, 2005, BIOCHEMISTRY-MOSCOW+, V70, P231, DOI 10.1007/s10541-005-0105-4; Bussing A, 2006, ARZNEIMITTEL-FORSCH, V56, P508; Bussing A., 2000, MISTLETOE GENUS VISC, P123; Cotter TG, 2009, NAT REV CANCER, V9, P501, DOI 10.1038/nrc2663; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; DARZYNKIEWICZ Z, 1992, CYTOMETRY, V13, P795, DOI 10.1002/cyto.990130802; Dashora N, 2011, PHARM CROPS, V2, P24, DOI [10.2174/2210290601102010024, DOI 10.2174/2210290601102010024]; DECKER EA, 1990, J AGR FOOD CHEM, V38, P674, DOI 10.1021/jf00093a019; Delanty N, 2000, ARCH NEUROL-CHICAGO, V57, P1265, DOI 10.1001/archneur.57.9.1265; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Ganie SA, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/792574; Gardner PT, 2000, FOOD CHEM, V68, P471, DOI 10.1016/S0308-8146(99)00225-3; Gomes A, 2005, J BIOCHEM BIOPH METH, V65, P45, DOI 10.1016/j.jbbm.2005.10.003; Grieve M., 1994, MODERN HERBAL, P547; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harmsma M, 2006, ARZNEIMITTEL-FORSCH, V56, P474; Heinzerling L, 2006, J CLIN IMMUNOL, V26, P347, DOI 10.1007/s10875-006-9023-5; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hsu YL, 2012, J AGR FOOD CHEM, V60, P852, DOI 10.1021/jf2052515; Hu W, 2003, LANCET ONCOL, V4, P721, DOI 10.1016/S1470-2045(03)01277-4; Isa NM, 2013, J FUNCT FOODS, V5, P87, DOI 10.1016/j.jff.2012.08.008; Johansson S, 2003, CELL MOL LIFE SCI, V60, P165, DOI 10.1007/s000180300011; Kahkonen MP, 1999, J AGR FOOD CHEM, V47, P3954, DOI 10.1021/jf990146l; Katsarou A, 2012, REC NAT PROD, V6, P394; Kelter G, 2007, ANTICANCER RES, V27, P223; Koizumi T, 1996, TOXICOLOGY, V114, P125, DOI 10.1016/S0300-483X(96)03477-4; Kris-Etherton PM, 2002, AM J MED, V113, P71, DOI 10.1016/S0002-9343(01)00995-0; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kuete V, 2012, PLANTA MED, V78, P193, DOI 10.1055/s-0031-1280319; Kumar J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098696; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lin KL, 2011, CHEM-BIOL INTERACT, V194, P148, DOI 10.1016/j.cbi.2011.10.002; Lohezic-Le Devehat F, 2002, Z NATURFORSCH C, V57, P1092; Maier G, 2002, ANTI-CANCER DRUG, V13, P373, DOI 10.1097/00001813-200204000-00006; Martin EJ, 2004, J PHARMACOL EXP THER, V310, P33, DOI 10.1124/jpet.104.066019; Marvibaigi M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/785479; Massaoka MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038698; Mathew S, 2006, FOOD CHEM TOXICOL, V44, P198, DOI 10.1016/j.fct.2005.06.013; Miliauskas G, 2004, FOOD CHEM, V85, P231, DOI 10.1016/j.foodchem.2003.05.007; Oluwaseun AA, 2008, AFR J BIOTECHNOL, V7, P3138; Onay-Ucar E, 2006, FITOTERAPIA, V77, P556, DOI 10.1016/j.fitote.2006.08.001; Osadebe PO, 2004, J ETHNOPHARMACOL, V95, P133, DOI 10.1016/j.jep.2004.06.029; Perry L, 1978, MED PLANTS E SE ASIA, P2138; Phang CW, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-243; Pieme CA, 2012, TOXICOL ENVIRON CHEM, V94, P987, DOI 10.1080/02772248.2012.674135; Ramaekers FCS, 2007, MEDICINA-BUENOS AIRE, V67, P79; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Sahreen S, 2010, FOOD CHEM, V122, P1205, DOI 10.1016/j.foodchem.2010.03.120; SCUDIERO DA, 1988, CANCER RES, V48, P4827; Shall S, 2000, MUTAT RES-DNA REPAIR, V460, P1, DOI 10.1016/S0921-8777(00)00016-1; Shim HY, 2007, MOL CELLS, V24, P95; Singh R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079242; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Steiner R, 1961, VORTRAG VOM 2 4, p[312, 242]; Stevigny C., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P173, DOI 10.2174/1568011053174864; STEWART BW, 1994, JNCI-J NATL CANCER I, V86, P1286, DOI 10.1093/jnci/86.17.1286; Tian LQ, 2012, MOL MED REP, V5, P126, DOI 10.3892/mmr.2011.624; Tong WM, 2001, BBA-REV CANCER, V1552, P27, DOI 10.1016/S0304-419X(01)00035-X; Van Cruchten S, 2002, ANAT HISTOL EMBRYOL, V31, P214, DOI 10.1046/j.1439-0264.2002.00398.x; van Zijl F, 2011, MUTAT RES-REV MUTAT, V728, P23, DOI 10.1016/j.mrrev.2011.05.002; Velioglu YS, 1998, J AGR FOOD CHEM, V46, P4113, DOI 10.1021/jf9801973; Vicas S., 2008, Bulletin of University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca. Agriculture, V65, P327; Vicas S, 2009, NOT BOT HORTI AGROBO, V37, P112; Vicas SI, 2011, J MED PLANTS RES, V5, P2237; Vicas SI, 2011, NOT BOT HORTI AGROBO, V39, P48; Yoo KM, 2008, FOOD CHEM, V106, P929, DOI 10.1016/j.foodchem.2007.07.006; Zhao YL, 2012, Z NATURFORSCH C, V67, P129, DOI 10.5560/ZNC.2012.67c0129; Zorov DB, 2006, BBA-BIOENERGETICS, V1757, P509, DOI 10.1016/j.bbabio.2006.04.029	79	31	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158942	10.1371/journal.pone.0158942	http://dx.doi.org/10.1371/journal.pone.0158942			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410459	Green Submitted, Green Published, gold			2022-12-27	WOS:000379508300044
J	Murai, Y; Yotsumoto, Y				Murai, Yuki; Yotsumoto, Yuko			Timescale- and Sensory Modality-Dependency of the Central Tendency of Time Perception	PLOS ONE			English	Article							TEMPORAL BISECTION; INTERVAL; DURATION; MEMORY; CLOCK; RANGE; DISCRIMINATION; MECHANISMS; ATTENTION; STIMULI	When individuals are asked to reproduce intervals of stimuli that are intermixedly presented at various times, longer intervals are often underestimated and shorter intervals overestimated. This phenomenon may be attributed to the central tendency of time perception, and suggests that our brain optimally encodes a stimulus interval based on current stimulus input and prior knowledge of the distribution of stimulus intervals. Two distinct systems are thought to be recruited in the perception of sub-and supra-second intervals. Sub-second timing is subject to local sensory processing, whereas supra-second timing depends on more centralized mechanisms. To clarify the factors that influence time perception, the present study investigated how both sensory modality and timescale affect the central tendency. In Experiment 1, participants were asked to reproduce sub-or supra-second intervals, defined by visual or auditory stimuli. In the sub-second range, the magnitude of the central tendency was significantly larger for visual intervals compared to auditory intervals, while visual and auditory intervals exhibited a correlated and comparable central tendency in the supra-second range. In Experiment 2, the ability to discriminate sub-second intervals in the reproduction task was controlled across modalities by using an interval discrimination task. Even when the ability to discriminate intervals was controlled, visual intervals exhibited a larger central tendency than auditory intervals in the sub-second range. In addition, the magnitude of the central tendency for visual and auditory sub-second intervals was significantly correlated. These results suggest that a common modality-independent mechanism is responsible for the supra-second central tendency, and that both the modality-dependent and modality-independent components of the timing system contribute to the central tendency in the sub-second range.	[Murai, Yuki; Yotsumoto, Yuko] Univ Tokyo, Dept Life Sci, Tokyo, Japan; [Murai, Yuki] Japan Soc Promot Sci, Tokyo, Japan	University of Tokyo; Japan Society for the Promotion of Science	Yotsumoto, Y (corresponding author), Univ Tokyo, Dept Life Sci, Tokyo, Japan.	cyuko@mail.ecc.u-tokyo.ac.jp			Japan Society for the Promotion of Science [25119003, 16H03749, 14J03550]; Grants-in-Aid for Scientific Research [16H03749] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/index.html) Grant-in-Aid for Scientific Research on Innovative Areas (25119003) for YY, Grant-in-Aid for Scientific Research(B) (16H03749) for YY, and Grant-in-Aid for JSPS Fellows (14J03550) for YM.	Acerbi L, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002771; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Buonomano DV, 2009, NAT REV NEUROSCI, V10, P113, DOI 10.1038/nrn2558; Burr D, 2009, EXP BRAIN RES, V198, P49, DOI 10.1007/s00221-009-1933-z; Cheng RK, 2008, BRAIN RES, V1237, P167, DOI 10.1016/j.brainres.2008.08.062; Cicchini GM, 2012, J NEUROSCI, V32, P1056, DOI 10.1523/JNEUROSCI.3411-11.2012; Filippopoulos PC, 2013, PSYCHOL RES-PSYCH FO, V77, P708, DOI 10.1007/s00426-012-0464-6; Gibbon J, 1997, CURR OPIN NEUROBIOL, V7, P170, DOI 10.1016/S0959-4388(97)80005-0; GIBBON J, 1977, PSYCHOL REV, V84, P279, DOI 10.1037/0033-295X.84.3.279; Grondin S, 2014, ADV EXP MED BIOL, V829, P17, DOI 10.1007/978-1-4939-1782-2_2; Grondin S, 2010, ATTEN PERCEPT PSYCHO, V72, P561, DOI 10.3758/APP.72.3.561; Gu BM, 2011, LECT NOTES ARTIF INT, V6789, P67, DOI 10.1007/978-3-642-21478-3_6; Hayashi MJ, 2014, J COGNITIVE NEUROSCI, V26, P1685, DOI 10.1162/jocn_a_00580; Heron J, 2012, P ROY SOC B-BIOL SCI, V279, P690, DOI 10.1098/rspb.2011.1131; Hollingworth H. L., 1910, J PHILOS PSYCHOL SCI, V7, P461, DOI [10.2307/2012819, DOI 10.2307/2012819]; Jazayeri M, 2010, NAT NEUROSCI, V13, P1020, DOI 10.1038/nn.2590; Johnston A, 2006, CURR BIOL, V16, P472, DOI 10.1016/j.cub.2006.01.032; Kanai R, 2011, EXP BRAIN RES, V209, P465, DOI 10.1007/s00221-011-2577-3; Karmarkar UR, 2007, NEURON, V53, P427, DOI 10.1016/j.neuron.2007.01.006; KEELE SW, 1985, ACTA PSYCHOL, V60, P173, DOI 10.1016/0001-6918(85)90054-X; Kuroda T, 2014, ACTA PSYCHOL, V149, P134, DOI 10.1016/j.actpsy.2013.11.013; Lejeune H, 2009, EUR J COGN PSYCHOL, V21, P941, DOI 10.1080/09541440802453006; Levy JM, 2015, FRONT INTEGR NEUROSC, V9, DOI 10.3389/fnint.2015.00044; Lewis PA, 2009, PHILOS T R SOC B, V364, P1897, DOI 10.1098/rstb.2009.0020; Lewis PA, 2006, TRENDS COGN SCI, V10, P401, DOI 10.1016/j.tics.2006.07.006; Malapani C, 1998, J COGNITIVE NEUROSCI, V10, P316, DOI 10.1162/089892998562762; MECK WH, 1985, J EXP PSYCHOL ANIM B, V11, P52, DOI 10.1037/0097-7403.11.1.52; Merchant H, 2008, J NEUROPHYSIOL, V99, P939, DOI 10.1152/jn.01225.2007; Merchant H, 2013, ANNU REV NEUROSCI, V36, P313, DOI 10.1146/annurev-neuro-062012-170349; Murai Yuki, 2016, Front Integr Neurosci, V10, P12, DOI 10.3389/fnint.2016.00012; Noulhiane M, 2009, EUR J COGN PSYCHOL, V21, P18, DOI 10.1080/09541440701825981; Ortega L, 2014, ATTEN PERCEPT PSYCHO, V76, P1485, DOI 10.3758/s13414-014-0663-x; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Penney TB, 2000, J EXP PSYCHOL HUMAN, V26, P1770, DOI 10.1037//0096-1523.26.6.1770; Petzschner FH, 2015, TRENDS COGN SCI, V19, P285, DOI 10.1016/j.tics.2015.03.002; Petzschner FH, 2011, J NEUROSCI, V31, P17220, DOI 10.1523/JNEUROSCI.2028-11.2011; Rammsayer TH, 2014, ACTA PSYCHOL, V147, P68, DOI 10.1016/j.actpsy.2013.05.004; Rattat AC, 2012, BEHAV RES METHODS, V44, P67, DOI 10.3758/s13428-011-0135-3; Ryan LJ, 2011, J COGN PSYCHOL, V23, P157, DOI 10.1080/20445911.2011.477812; Shi ZH, 2016, CURR OPIN BEHAV SCI, V8, P200, DOI [10.1016/j.cobeha.2016.02.014, 10.1163/9789004307339_002]; Shi ZH, 2013, TRENDS COGN SCI, V17, P556, DOI 10.1016/j.tics.2013.09.009; Stauffer CC, 2012, PSYCHOL RES-PSYCH FO, V76, P20, DOI 10.1007/s00426-011-0333-8; TREISMAN M, 1963, PSYCHOL MONOGR, V77, P1, DOI 10.1037/h0093864; Tse PU, 2004, PERCEPT PSYCHOPHYS, V66, P1171, DOI 10.3758/BF03196844; WEARDEN JH, 1995, Q J EXP PSYCHOL-B, V48, P289; Wearden JH, 2003, TIME AND MIND II: INFORMATION PROCESSING PERSPECTIVES, P21; Wiener M, 2015, NEUROIMAGE, V113, P268, DOI 10.1016/j.neuroimage.2015.03.054; Wiener M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100803; Wiener M, 2010, NEUROIMAGE, V49, P1728, DOI 10.1016/j.neuroimage.2009.09.064	50	16	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0158921	10.1371/journal.pone.0158921	http://dx.doi.org/10.1371/journal.pone.0158921			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ9CO	27404269	gold, Green Published, Green Submitted			2022-12-27	WOS:000379508200021
J	Selton-Suty, C; Delahaye, F; Tattevin, P; Federspiel, C; Le Moing, V; Chirouze, C; Nazeyrollas, P; Vernet-Garnier, V; Bernard, Y; Chocron, S; Obadia, JF; Alla, F; Hoen, B; Duval, X				Selton-Suty, Christine; Delahaye, Francois; Tattevin, Pierre; Federspiel, Claire; Le Moing, Vincent; Chirouze, Catherine; Nazeyrollas, Pierre; Vernet-Garnier, Veronique; Bernard, Yvette; Chocron, Sidney; Obadia, Jean-Francois; Alla, Francois; Hoen, Bruno; Duval, Xavier		AEPEI	Symptomatic and Asymptomatic Neurological Complications of Infective Endocarditis: Impact on Surgical Management and Prognosis	PLOS ONE			English	Article							CEREBROVASCULAR COMPLICATIONS; CARDIAC-SURGERY; DIAGNOSIS; EMBOLISM	Objectives Symptomatic neurological complications (NC) are a major cause of mortality in infective endocarditis (IE) but the impact of asymptomatic complications is unknown. We aimed to assess the impact of asymptomatic NC (AsNC) on the management and prognosis of IE. Methods From the database of cases collected for a population-based study on IE, we selected 283 patients with definite left-sided IE who had undergone at least one neuroimaging procedure (cerebral CT scan and/or MRI) performed as part of initial evaluation. Results Among those 283 patients, 100 had symptomatic neurological complications (SNC) prior to the investigation, 35 had an asymptomatic neurological complications (AsNC), and 148 had a normal cerebral imaging (NoNC). The rate of valve surgery was 43% in the 100 patients with SNC, 77% in the 35 with AsNC, and 54% in the 148 with NoNC (p<0.001). In-hospital mortality was 42% in patients with SNC, 8.6% in patients with AsNC, and 16.9% in patients with NoNC (p<0.001). Among the 135 patients with NC, 95 had an indication for valve surgery (71%), which was performed in 70 of them (mortality 20%) and not performed in 25 (mortality 68%). In a multivariate adjusted analysis of the 135 patients with NC, age, renal failure, septic shock, and IE caused by S. aureus were independently associated with in-hospital and 1-year mortality. In addition SNC was an independent predictor of 1-year mortality. Conclusions The presence of NC was associated with a poorer prognosis when symptomatic. Patients with AsNC had the highest rate of valve surgery and the lowest mortality rate, which suggests a protective role of surgery guided by systematic neuroimaging results.	[Selton-Suty, Christine] CHU Nancy Brabois, Cardiol, F-54511 Nancy, France; [Delahaye, Francois] Univ Lyon 1, Hospices Civils Lyon, Hop Cardiol Louis Pradel, Lyon, France; [Tattevin, Pierre] Ctr Hosp Univ, Malad Infectieuses & Reanim Med, Rennes, France; [Federspiel, Claire] Ctr Hosp Dept Vendee, Cardiol, La Roche Sur Yon, France; [Le Moing, Vincent] Univ Montpellier, Inst Rech Dev, Ctr Hosp Reg Univ, Malad Infectieuses & Trop,UMI 233, Montpellier, France; [Chirouze, Catherine] Univ Franche Comte, Ctr Hosp Univ, Malad Infectieuses & Trop, Lab Chronoenvironm UMR 6249, Besancon, France; [Nazeyrollas, Pierre] Ctr Hosp Univ, Cardiol, Reims, France; [Vernet-Garnier, Veronique] Ctr Hosp Univ, Microbiol, Reims, France; [Bernard, Yvette] Ctr Hosp Univ, Cardiol, Besancon, France; [Chocron, Sidney] Ctr Hosp Univ, Chirurg Card, Besancon, France; [Obadia, Jean-Francois] Hop Louis Pradel Chirurg Cardiothorac & Transplan, UCBL1, Lab Physiol Lyon Nord, Uninte INSERM Cardioprotect 886, Lyon, France; [Alla, Francois] Univ Paris 05, Apemac, EA4360, Univ Lorraine,INSERM,CIC EC,CIE6, Nancy, France; [Hoen, Bruno] Ctr Hosp Univ, Malad Infectieuses & Trop, Point A Pitre, France; [Duval, Xavier] Univ Paris Diderot Paris 7, Hop Univ Bichat, AP HP, Inserm IAME U1137,UFR Med Bichat,Inserm CIC 1425, Paris, France	CHU de Nancy; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Rennes; CHD Vendee; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; CHU de Montpellier; Universite de Franche-Comte; CHU Besancon; CHU de Reims; Universite de Reims Champagne-Ardenne; CHU de Reims; Universite de Franche-Comte; CHU Besancon; Universite de Franche-Comte; CHU Besancon; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Lorraine; CHU Guadeloupe; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Selton-Suty, C (corresponding author), CHU Nancy Brabois, Cardiol, F-54511 Nancy, France.	c.suty-selton@chu-nancy.fr	Vernet-Garnier, Véronique/P-5729-2016; Carmen, Team3/Y-7384-2019; alla, francois/D-2295-2014	Carmen, Team3/0000-0002-3614-0924; Le Moing, Vincent/0000-0002-9529-2792; alla, francois/0000-0002-5793-7190; Selton-Suty, Christine/0000-0003-4129-5784; Lab, Carmen/0000-0002-5935-3236	Ministere de la Sante (FR); Programme Hospitalier de Recherche Clinique; Association pour l'Enseignement de la Therapeutique; Societe de Pathologie Infectieuse de Langue Francaise; Societe Francaise de Microbiologie; Societe Nationale Francaise de Medecine Interne; Societe de Reanimation de Langue Francaise; Societe Francaise de Gerontologie; Societe Francaise de Cardiologie; Societe Francaise de Chirurgie Thoracique et Cardiovasculaire; Societe Francaise d'Anesthesie-Reanimation; Federation Francaise de Cardiologie	Ministere de la Sante (FR); Programme Hospitalier de Recherche Clinique; Association pour l'Enseignement de la Therapeutique; Societe de Pathologie Infectieuse de Langue Francaise; Societe Francaise de Microbiologie; Societe Nationale Francaise de Medecine Interne; Societe de Reanimation de Langue Francaise; Societe Francaise de Gerontologie; Societe Francaise de Cardiologie; Societe Francaise de Chirurgie Thoracique et Cardiovasculaire; Societe Francaise d'Anesthesie-Reanimation; Federation Francaise de Cardiologie	This work was supported by Ministere de la Sante (FR), and Programme Hospitalier de Recherche Clinique 2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was scientifically supported by the following French professional organizations: Association pour l'Enseignement de la Therapeutique, Societe de Pathologie Infectieuse de Langue Francaise, Societe Francaise de Microbiologie, Societe Nationale Francaise de Medecine Interne, Societe de Reanimation de Langue Francaise, Societe Francaise de Gerontologie, Societe Francaise de Cardiologie, Societe Francaise de Chirurgie Thoracique et Cardiovasculaire, Societe Francaise d'Anesthesie-Reanimation, and Federation Francaise de Cardiologie.	Barsic B, 2013, CLIN INFECT DIS, V56, P209, DOI 10.1093/cid/cis878; Cooper HA, 2009, CIRCULATION, V120, P585, DOI 10.1161/CIRCULATIONAHA.108.834432; Duval X, 2010, ANN INTERN MED, V152, P497, DOI 10.7326/0003-4819-152-8-201004200-00006; Garcia-Cabrera E, 2013, CIRCULATION, V127, P2272, DOI 10.1161/CIRCULATIONAHA.112.000813; Goulenok T, 2013, CEREBROVASC DIS, V35, P327, DOI 10.1159/000348317; Habib G, 2015, EUR HEART J, V36, P3075, DOI [10.1093/eurheartj/ehv319, 10.5603/KP.2015.0227]; Habib G, 2009, EUR HEART J, V30, P2369, DOI 10.1093/eurheartj/ehp285; Kang DH, 2012, NEW ENGL J MED, V366, P2466, DOI 10.1056/NEJMoa1112843; Lee SJ, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-30; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Meshaal MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118616; Misfeld M, 2014, J THORAC CARDIOV SUR, V147, P1837, DOI 10.1016/j.jtcvs.2013.10.076; Pruitt AA, 2013, CURR TREAT OPTION NE, V15, P465, DOI 10.1007/s11940-013-0235-8; Selton-Suty C, 2012, CLIN INFECT DIS, V54, P1230, DOI 10.1093/cid/cis199; Snygg-Martin U, 2008, CLIN INFECT DIS, V47, P23, DOI 10.1086/588663; Thuny F, 2007, EUR HEART J, V28, P1155, DOI 10.1093/eurheartj/ehm005; Thuny F, 2012, LANCET, V379, P965, DOI 10.1016/S0140-6736(11)60755-1	17	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2016	11	7							e0158522	10.1371/journal.pone.0158522	http://dx.doi.org/10.1371/journal.pone.0158522			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CN	27400273	Green Published, Green Submitted, gold			2022-12-27	WOS:000379508100004
J	Groendahl, S; Fink, P				Groendahl, Sophie; Fink, Patrick			The Effect of Diet Mixing on a Nonselective Herbivore	PLOS ONE			English	Article							COMPLEMENTARY RESOURCES; GENERALIST HERBIVORES; INSECT HERBIVORE; FOOD; GROWTH; FITNESS; SELECTION; QUALITY; CYANOBACTERIUM; INFOCHEMICALS	The balanced-diet hypothesis states that a diverse prey community is beneficial to consumers due to resource complementarity among the prey species. Nonselective consumer species cannot differentiate between prey items and are therefore not able to actively regulate their diet intake. We thus wanted to test whether the balanced-diet hypothesis is applicable to nonselective consumers. We conducted a laboratory experiment in which a nonselective model grazer, the freshwater gastropod Lymnaea stagnalis, was fed benthic green algae as single species or as a multi-species mixture and quantified the snails' somatic growth rates and shell lengths over a seven-week period. Gastropods fed the mixed diet were found to exhibit a higher somatic growth rate than the average of the snails fed single prey species. However, growth on the multi-species mixture did not exceed the growth rate obtained on the best single prey species. Similar results were obtained regarding the animals' shell height increase over time. The mixed diet did not provide the highest growth rate, which confirms our hypothesis. We thus suggest that the balanced-diet hypothesis is less relevant for non-selective generalist consumers, which needs to be considered in estimates of secondary production.	[Groendahl, Sophie; Fink, Patrick] Univ Cologne, Inst Zool, Workgrp Aquat Chem Ecol, Cologne, Nrw, Germany; [Fink, Patrick] Univ Dusseldorf, Inst Zoomorphol & Cell Biol, Dusseldorf, Nrw, Germany	University of Cologne; Heinrich Heine University Dusseldorf	Groendahl, S (corresponding author), Univ Cologne, Inst Zool, Workgrp Aquat Chem Ecol, Cologne, Nrw, Germany.	sgroenda@uni-koeln.de	Fink, Patrick/A-5901-2009	Fink, Patrick/0000-0002-5927-8977	Deutsche Forschungsgemeinschaft (DFG) [FI 1548/5-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The work was supported by Deutsche Forschungsgemeinschaft (DFG), Grant FI 1548/5-1, http://www.dfg.de/, PF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle N, 2005, FRESHWATER BIOL, V50, P369, DOI 10.1111/j.1365-2427.2004.01325.x; Alva-Martinez AF, 2007, AQUAT ECOL, V41, P579, DOI 10.1007/s10452-007-9115-1; Araya RG, 2012, AQUACULTURE, V364, P272, DOI 10.1016/j.aquaculture.2012.08.036; Armitage P. D., 2012, CHIRONOMIDAE BIOL EC; Behmer ST, 2009, ANNU REV ENTOMOL, V54, P165, DOI 10.1146/annurev.ento.54.110807.090537; BERGMAN E, 1994, ECOLOGY, V75, P1233, DOI 10.2307/1937449; Bernays EA, 1997, ECOLOGY, V78, P1157, DOI 10.1890/0012-9658(1997)078[1157:IHDRFB]2.0.CO;2; BERNAYS EA, 1994, ECOLOGY, V75, P1997, DOI 10.2307/1941604; Boenigk J, 2002, AQUAT MICROB ECOL, V27, P195, DOI 10.3354/ame027195; Camacho FA, 2006, LIMNOL OCEANOGR, V51, P1870, DOI 10.4319/lo.2006.51.4.1870; CARMICHAEL WW, 1986, ADV BOT RES, V12, P47, DOI 10.1016/S0065-2296(08)60193-7; CHUNG TK, 1991, J NUTR, V121, P979, DOI 10.1093/jn/121.7.979; COLLINS M, 1978, MICROBIOL REV, V42, P725, DOI 10.1128/MMBR.42.4.725-746.1978; Coogan SCP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105719; Cruz-Rivera E, 2000, ECOLOGY, V81, P201; Dame R.F., 2011, ECOLOGY MARINE BIVAL; Dawes C J, 1966, LIGHT ELECT MICROSCO; DEARING MD, 1992, ECOLOGY, V73, P845, DOI 10.2307/1940162; DeMott WR, 2010, ECOLOGY, V91, P540, DOI 10.1890/08-2103.1; DeMott WR, 1998, ECOLOGY, V79, P2463, DOI 10.2307/176836; Dillon R. T., 2000, ECOLOGY FRESHWATER M, DOI 10.1017/CBO9780511542008; FENCHEL T, 1975, MAR BIOL, V30, P119, DOI 10.1007/BF00391586; Fink P, 2006, OIKOS, V115, P484, DOI 10.1111/j.2006.0030-1299.14951.x; Foster GG, 1999, MAR BIOL, V134, P307, DOI 10.1007/s002270050548; Franzke A, 2010, ECOL ENTOMOL, V35, P126, DOI 10.1111/j.1365-2311.2009.01168.x; FREELAND WJ, 1974, AM NAT, V108, P269, DOI 10.1086/282907; Gamfeldt L, 2005, ECOL LETT, V8, P696, DOI 10.1111/j.1461-0248.2005.00765.x; HABDIJA I, 1995, INT REV GES HYDROBIO, V80, P103, DOI 10.1002/iroh.19950800113; Hagele BF, 1999, OECOLOGIA, V119, P521, DOI 10.1007/s004420050815; Hillebrand H, 1999, LIMNOL OCEANOGR, V44, P440, DOI 10.4319/lo.1999.44.2.0440; Kennish R, 1996, OECOLOGIA, V105, P22, DOI 10.1007/BF00328787; Khait R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082391; Lampert W, 2011, DAPHNIA DEV MODEL OR; Lampert W, 1996, FUNCTIONAL ECOLOGY, P631; Lefcheck JS, 2013, ECOLOGY, V94, P565, DOI 10.1890/12-0192.1; LIMA SL, 1986, ANIM BEHAV, V34, P536, DOI 10.1016/S0003-3472(86)80122-1; LOBEL PS, 1981, MAR BIOL, V64, P173, DOI 10.1007/BF00397106; LOPEZ GR, 1978, OECOLOGIA, V32, P263, DOI 10.1007/BF00345106; Moelzner J, 2015, OIKOS, V124, P1603, DOI 10.1111/oik.02069; Moelzner J, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00246.1; Moelzner J, 2014, J ANIM ECOL, V83, P1007, DOI 10.1111/1365-2656.12220; PENNINGS SC, 1993, ECOLOGY, V74, P879, DOI 10.2307/1940813; Raubenheimer D, 2006, ANIM BEHAV, V71, P1253, DOI 10.1016/j.anbehav.2005.07.024; RAUBENHEIMER D, 1992, ECOLOGY, V73, P1012, DOI 10.2307/1940176; RAUBENHEIMER D, 1993, ANIM BEHAV, V45, P953, DOI 10.1006/anbe.1993.1114; Senior AM, 2015, AM NAT, V186, P649, DOI 10.1086/683182; Senior AM, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004111; Simpson SJ, 2015, ANNU REV ENTOMOL, V60, P293, DOI 10.1146/annurev-ento-010814-020917; Unsicker SB, 2008, OECOLOGIA, V156, P313, DOI 10.1007/s00442-008-0973-6; Valiela I, 1995, MARINE ECOLOGICAL PR; VanDonk E, 1997, LIMNOL OCEANOGR, V42, P357; von Elert E, 1997, LIMNOL OCEANOGR, V42, P1796, DOI 10.4319/lo.1997.42.8.1796; WATANABE JM, 1984, OECOLOGIA, V62, P47, DOI 10.1007/BF00377371; WEST L, 1986, ECOLOGY, V67, P798, DOI 10.2307/1937702; WESTOBY M, 1978, AM NAT, V112, P627, DOI 10.1086/283303; WESTOBY M, 1974, AM NAT, V108, P290, DOI 10.1086/282908; Zotin AA, 2009, BIOL BULL+, V36, P455, DOI 10.1134/S1062359009050057	57	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158924	10.1371/journal.pone.0158924	http://dx.doi.org/10.1371/journal.pone.0158924			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391787	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400164
J	Guo, DD; Liu, F; Tu, YH; He, BX; Gao, Y; Guo, ML				Guo, Dan-Dan; Liu, Fei; Tu, Yan-Hua; He, Bei-Xuan; Gao, Yue; Guo, Mei-Li			Expression Patterns of Three UGT Genes in Different Chemotype Safflower Lines and under MeJA Stimulus Revealed Their Potential Role in Flavonoid Biosynthesis	PLOS ONE			English	Article							NOMENCLATURE UPDATE; MOLECULAR-CLONING; GLYCOSYLTRANSFERASES; GLUCOSYLTRANSFERASE; QUINOCHALCONES; GLYCOSYLATION; NICOTIFLORIN; FLORETS	Safflower (Carthamus tinctorius L.) has received a significant amount of attention as a medicinal plant in China. Flavonoids are the dominant active medical compounds. UDP-glycosyltransferase plays an essential role in the biosynthesis and storage of flavonoids in safflower. In this study, 45 UGT unigenes were screened from our transcriptomic database of safflower. Among them, 27 UGT unigenes were predicted to own a complete open reading frame with various pI and Mw. The phylogenetic tree showed that CtUGT3 and CtUGT16 were classified under the UGT71 subfamily involved in metabolite process, whereas CtUGT25 has high identities with PoUGT both catalyzing the glycosylation of flavonoids and belonging to the UGT90 subfamily. cDNA microarray exhibited that the three UGT genes displayed temporal difference in two chemotype safflower lines. To functionally characterize UGT in safflower, CtUGT3, CtUGT16 and CtUGT25 were cloned and analyzed. Subcellular localization suggested that the three UGTs might be located in the cell cytoplasm and chloroplast. The expression pattern showed that the three UGTs were all suppressed in two lines responsive to methyl jasmonate induction. The co-expression relation of expression pattern and metabolite accumulation demonstrated that CtUGT3 and CtUGT25 were positively related to kaempferol-3-O-beta-D-glucoside and CtUGT16 was positively related to quercetin-3-O-beta-D-glucoside in yellow line, whereas CtUGT3 and CtUGT25 were positively related to quercetin-3-O-beta-D-glucoside in white line. This study indicates that the three CtUGTs play a significant and multiple role in flavonoids biosynthesis with presenting different functional characterization in two safflower lines.	[Guo, Dan-Dan; Liu, Fei; Tu, Yan-Hua; He, Bei-Xuan; Gao, Yue; Guo, Mei-Li] Second Mil Med Univ, Coll Pharm, Dept Pharmacognosy, Shanghai 200433, Peoples R China	Naval Medical University	Gao, Y; Guo, ML (corresponding author), Second Mil Med Univ, Coll Pharm, Dept Pharmacognosy, Shanghai 200433, Peoples R China.	gaoyue2000@hotmail.com; mlguo@126.com			Natural Science Foundation of China [81173484, 81473300]; Shanghai Natural Science Foundation [13ZR1448200]; "863" High Technology Project [2008AA02Z137]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai); "863" High Technology Project(National High Technology Research and Development Program of China)	This work was supported by a grant from Natural Science Foundation of China (81173484 and 81473300), Shanghai Natural Science Foundation (13ZR1448200) and "863" High Technology Project (2008AA02Z137).	Ahmed A, 2006, J AM CHEM SOC, V128, P14224, DOI 10.1021/ja064686s; Bock KW, 2015, BIOCHEM PHARMACOL, V8; Bowles D, 2005, CURR OPIN PLANT BIOL, V8, P254, DOI 10.1016/j.pbi.2005.03.007; Brazier-Hicks M, 2007, P NATL ACAD SCI USA, V104, P20238, DOI 10.1073/pnas.0706421104; Brazier-Hicks M, 2009, J BIOL CHEM, V284, P17926, DOI 10.1074/jbc.M109.009258; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen QY, 2015, PLANT CELL REP, V34, P1761, DOI 10.1007/s00299-015-1822-9; Chen S, 2011, PLANT CELL REP, V30, P1593, DOI 10.1007/s00299-011-1070-6; Dixon RA, 1999, TRENDS PLANT SCI, V4, P394, DOI 10.1016/S1360-1385(99)01471-5; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gandia-Herrero F, 2008, PLANT J, V56, P963, DOI 10.1111/j.1365-313X.2008.03653.x; Gecgel U, 2007, J AM OIL CHEM SOC, V84, P47, DOI 10.1007/s11746-006-1007-3; He L-S, 2013, PLOS ONE, V8; Hu L, 2015, PLOS ONE, V10; Jiang JS, 2010, ORG LETT, V12, P1196, DOI 10.1021/ol902971w; Jones P, 2003, J BIOL CHEM, V278, P43910, DOI 10.1074/jbc.M303523200; Kazuma K, 2000, BIOSCI BIOTECH BIOCH, V64, P1588, DOI 10.1271/bbb.64.1588; Kim JH, 2006, PLANT SCI, V170, P897, DOI 10.1016/j.plantsci.2005.12.013; Ko JH, 2006, PLANT CELL REP, V25, P741, DOI 10.1007/s00299-006-0119-4; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li RP, 2006, BIOL PHARM BULL, V29, P1868, DOI 10.1248/bpb.29.1868; Li RP, 2006, J ETHNOPHARMACOL, V107, P143, DOI 10.1016/j.jep.2006.04.024; Li X, 2015, SHOCK VIB, V2015, DOI 10.1155/2015/431476; Lim EK, 2003, GLYCOBIOLOGY, V13, P139, DOI 10.1093/glycob/cwg017; Liu Z, 2015, BMC PLANT BIOL, V15; Mackenzie PI, 2005, PHARMACOGENET GENOM, V15, P677, DOI 10.1097/01.fpc.0000173483.13689.56; Mackenzie PI, 1997, PHARMACOGENETICS, V7, P255, DOI 10.1097/00008571-199708000-00001; Masada S, 2009, PLANT CELL PHYSIOL, V50, P1401, DOI 10.1093/pcp/pcp088; Modolo LV, 2007, PLANT MOL BIOL, V64, P499, DOI 10.1007/s11103-007-9167-6; Naoumkina M, 2007, P NATL ACAD SCI USA, V104, P17909, DOI 10.1073/pnas.0708697104; Ono E, 2010, PLANT CELL, V22, P2856, DOI 10.1105/tpc.110.074625; Reddy NRR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129422; Shahin A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-640; Suzuki H, 2005, PLANTA, V220, P696, DOI 10.1007/s00425-004-1387-2; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Trapero A, 2012, PLANT PHYSIOL, V159, P1335, DOI 10.1104/pp.112.198069; Vogt T, 2000, TRENDS PLANT SCI, V5, P380, DOI 10.1016/S1360-1385(00)01720-9; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; WeymouthWilson AC, 1997, NAT PROD REP, V14, P99, DOI 10.1039/np9971400099; Williams C, 1994, FLAVONOIDS ADV RES 1; Xie KB, 2014, ORG LETT, V16, P4874, DOI 10.1021/ol502380p; Zhou XD, 2014, J ETHNOPHARMACOL, V151, P27, DOI 10.1016/j.jep.2013.10.050	43	10	17	6	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158159	10.1371/journal.pone.0158159	http://dx.doi.org/10.1371/journal.pone.0158159			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391785	gold, Green Published, Green Submitted			2022-12-27	WOS:000380005400034
J	Hall, LH; Johnson, J; Watt, I; Tsipa, A; O'Connor, DB				Hall, Louise H.; Johnson, Judith; Watt, Ian; Tsipa, Anastasia; O'Connor, Daryl B.			Healthcare Staff Wellbeing, Burnout, and Patient Safety: A Systematic Review	PLOS ONE			English	Review							QUALITY-OF-CARE; MEDICAL ERRORS; HOSPITAL NURSES; PRACTICE ENVIRONMENT; WORKING-CONDITIONS; OUTCOMES; SLEEP; SATISFACTION; ASSOCIATION; DEPRESSION	Objective To determine whether there is an association between healthcare professionals' wellbeing and burnout, with patient safety. Design Systematic research review. Data Sources PsychInfo (1806 to July 2015), Medline (1946 to July 2015), Embase (1947 to July 2015) and Scopus (1823 to July 2015) were searched, along with reference lists of eligible articles. Eligibility Criteria for Selecting Studies Quantitative, empirical studies that included i) either a measure of wellbeing or burnout, and ii) patient safety, in healthcare staff populations. Results Forty-six studies were identified. Sixteen out of the 27 studies that measured wellbeing found a significant correlation between poor wellbeing and worse patient safety, with six additional studies finding an association with some but not all scales used, and one study finding a significant association but in the opposite direction to the majority of studies. Twenty-one out of the 30 studies that measured burnout found a significant association between burnout and patient safety, whilst a further four studies found an association between one or more (but not all) subscales of the burnout measures employed, and patient safety. Conclusions Poor wellbeing and moderate to high levels of burnout are associated, in the majority of studies reviewed, with poor patient safety outcomes such as medical errors, however the lack of prospective studies reduces the ability to determine causality. Further prospective studies, research in primary care, conducted within the UK, and a clearer definition of healthcare staff wellbeing are needed.	[Hall, Louise H.; Johnson, Judith; Tsipa, Anastasia; O'Connor, Daryl B.] Univ Leeds, Sch Psychol, Leeds, W Yorkshire, England; [Hall, Louise H.; Johnson, Judith] Bradford Inst Hlth Res, Yorkshire Qual & Safety Res Grp, Bradford, W Yorkshire, England; [Watt, Ian] Univ York, Dept Hlth Sci, York, N Yorkshire, England; [Tsipa, Anastasia] Leeds City Council, Leeds, W Yorkshire, England	University of Leeds; University of York - UK	Hall, LH (corresponding author), Univ Leeds, Sch Psychol, Leeds, W Yorkshire, England.; Hall, LH (corresponding author), Bradford Inst Hlth Res, Yorkshire Qual & Safety Res Grp, Bradford, W Yorkshire, England.	L.H.Hall13@leeds.ac.uk	Johnson, Judith/E-7668-2011	Johnson, Judith/0000-0003-0431-013X; O'Connor, Daryl/0000-0003-4117-4093; Hall, Louise/0000-0001-9032-4540	University of Leeds, UK; National Institute for Health Research (NIHR) Collaborations for Leadership in Applied Health Research and Care (CLAHRCs) under the Evidence Based Transformation Theme	University of Leeds, UK; National Institute for Health Research (NIHR) Collaborations for Leadership in Applied Health Research and Care (CLAHRCs) under the Evidence Based Transformation Theme	This research was undertaken as part of a PhD funded by the University of Leeds, UK (www.leeds.ac.uk), and National Institute for Health Research (NIHR) Collaborations for Leadership in Applied Health Research and Care (CLAHRCs) under the Evidence Based Transformation Theme (www.clahrcpp.co.uk).	Arakawa C, 2011, IND HEALTH, V49, P381, DOI 10.2486/indhealth.MS968; Arimura M, 2010, IND HEALTH, V48, P811, DOI 10.2486/indhealth.MS1093; Association BM, 2015, BMA Q TRACK SURV CUR; Avery T, 2012, INVESTIGATING PREVAL; Baldwin PJ, 1997, SOC SCI MED, V45, P35, DOI 10.1016/S0277-9536(96)00306-1; Bao YJ, 2013, J ADV NURS, V69, P631, DOI 10.1111/j.1365-2648.2012.06045.x; Block L, 2013, POSTGRAD MED J, V89, P495, DOI 10.1136/postgradmedj-2012-131743; Chen KY, 2013, INT J MED SCI, V10, P1471, DOI 10.7150/ijms.6743; Cimiotti JP, 2012, AM J INFECT CONTROL, V40, P486, DOI 10.1016/j.ajic.2012.02.029; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; de Oliveira GS, 2013, ANESTH ANALG, V117, P182, DOI 10.1213/ANE.0b013e3182917da9; Dollarhide AW, 2014, J HEALTHC QUAL, V36, P5, DOI 10.1111/jhq.12012; Dorrian J, 2008, APPL ERGON, V39, P605, DOI 10.1016/j.apergo.2008.01.012; Dorrian J, 2006, CHRONOBIOL INT, V23, P1149, DOI 10.1080/07420520601059615; DUGAN J, 1996, J NURS CARE QUAL, V10, P46; Dyrbye LN, 2013, J GEN INTERN MED, V28, P421, DOI 10.1007/s11606-012-2252-9; Fahrenkopf AM, 2008, BRIT MED J, V336, P488, DOI 10.1136/bmj.39469.763218.BE; Fogarty GJ, 2006, ERGONOMICS, V49, P444, DOI 10.1080/00140130600568410; Garrouste-Orgeas M, 2015, INTENS CARE MED, V41, P273, DOI 10.1007/s00134-014-3601-4; Gibson J, 2015, 8 NATL GP WORKLIFE S; GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644; Halbesleben JRB, 2008, WESTERN J NURS RES, V30, P560, DOI 10.1177/0193945907311322; HAMMER JS, 1986, ANN EMERG MED, V15, P536, DOI 10.1016/S0196-0644(86)80988-X; Hayashino Y, 2012, HOPE MODIFIED ASS DI; Health Do, 2000, ORG MEM REP EXP GROU; Holden RJ, 2011, BMJ QUAL SAF, V20, P15, DOI 10.1136/bmjqs.2008.028381; Holden RJ, 2010, RES SOC ADMIN PHARM, V6, P293, DOI 10.1016/j.sapharm.2009.10.001; Houston DM, 1997, BRIT J HEALTH PSYCH, V2, P141, DOI 10.1111/j.2044-8287.1997.tb00530.x; Johnson J, 2016, COGNITIVE THERAPY RE, P1, DOI DOI 10.1016/J.CPR.2010.01.002; Kirwan M, 2013, INT J NURS STUD, V50, P253, DOI 10.1016/j.ijnurstu.2012.08.020; Klein J, 2010, INT J QUAL HEALTH C, V22, P525, DOI 10.1093/intqhc/mzq056; Laschinger HKS, 2006, J NURS ADMIN, V36, P259; LINDEN DVD, 2005, WORK STRESS, V19, P23, DOI DOI 10.1080/02678370500065275; Linzer M, 2009, ANN INTERN MED, V151, P28, DOI 10.7326/0003-4819-151-1-200907070-00006; MASLACH C, 1981, J OCCUP BEHAV, V2, P99, DOI 10.1002/job.4030020205; Maslach C, 1996, MASLACH BURNOUT INVE; Moher D, 2015, CULT MED PSYCHIAT, V4, DOI DOI 10.1023/B:MEDI.0000005484.26741.79; Niven K, 2015, INT J STRESS MANAGE, V22, P207, DOI 10.1037/a0039131; Park YM, 2013, SAF HEALTH WORK-KR, V4, P210, DOI 10.1016/j.shaw.2013.10.003; Prins JT, 2009, PSYCHOL HEALTH MED, V14, P654, DOI 10.1080/13548500903311554; Profit J, 2014, BMJ QUAL SAF, V23, P806, DOI 10.1136/bmjqs-2014-002831; Ramanujam R, 2008, NURS HEALTH SCI, V10, P144, DOI 10.1111/j.1442-2018.2008.00382.x; Raymond J., 2014, BMA Q TRACKER SURVEY; Saleh AM, 2014, EGYPT J CHEST DIS TU, V63, P145, DOI 10.1016/j.ejcdt.2013.10.001; Schaufeli W., 1998, BURNOUT COMPANION ST; Shanafelt TD, 2010, ANN SURG, V251, P995, DOI 10.1097/SLA.0b013e3181bfdab3; Shanafelt TD, 2002, ANN INTERN MED, V136, P358, DOI 10.7326/0003-4819-136-5-200203050-00008; Pelliciotti JD, 2010, REV LAT-AM ENFERM, V18, P1062, DOI 10.1590/S0104-11692010000600004; Squires M, 2010, J NURS MANAGE, V18, P914, DOI 10.1111/j.1365-2834.2010.01181.x; Suzuki K, 2004, J OCCUP HEALTH, V46, P448, DOI 10.1539/joh.46.448; Tanaka M, 2012, BMJ QUAL SAF, V21, P784, DOI 10.1136/bmjqs-2010-048330; Teng CI, 2010, INT J NURS STUD, V47, P1442, DOI 10.1016/j.ijnurstu.2010.04.005; Van Bogaert P, 2014, INT J NURS STUD, V51, P1123, DOI 10.1016/j.ijnurstu.2013.12.009; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Welp A, 2015, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01573; West CP, 2006, JAMA-J AM MED ASSOC, V296, P1071, DOI 10.1001/jama.296.9.1071; West CP, 2009, JAMA-J AM MED ASSOC, V302, P1294, DOI 10.1001/jama.2009.1389; Wilkins Kathryn, 2008, Health Rep, V19, P7; Williams ES, 2007, HEALTH CARE MANAGE R, V32, P203, DOI 10.1097/01.HMR.0000281626.28363.59; World Health Organization, 2004, INT STAT CLASS DIS H; Zander B, 2013, INT J NURS STUD, V50, P219, DOI 10.1016/j.ijnurstu.2012.07.008; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	62	632	641	9	137	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159015	10.1371/journal.pone.0159015	http://dx.doi.org/10.1371/journal.pone.0159015			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27391946	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000380005400191
J	Kirby, KR; Gray, RD; Greenhill, SJ; Jordan, FM; Gomes-Ng, S; Bibiko, HJ; Blasi, DE; Botero, CA; Bowern, C; Ember, CR; Leehr, D; Low, BS; McCarter, J; Divale, W; Gavin, MC				Kirby, Kathryn R.; Gray, Russell D.; Greenhill, Simon J.; Jordan, Fiona M.; Gomes-Ng, Stephanie; Bibiko, Hans-Joeg; Blasi, Damian E.; Botero, Carlos A.; Bowern, Claire; Ember, Carol R.; Leehr, Dan; Low, Bobbi S.; McCarter, Joe; Divale, William; Gavin, Michael C.			D-PLACE: A Global Database of Cultural, Linguistic and Environmental Diversity	PLOS ONE			English	Article							BAYESIAN PHYLOGENETIC ANALYSIS; EVOLUTION; EXPANSION; LANGUAGES; MODELS; ORIGIN	From the foods we eat and the houses we construct, to our religious practices and political organization, to who we can marry and the types of games we teach our children, the diversity of cultural practices in the world is astounding. Yet, our ability to visualize and understand this diversity is limited by the ways it has been documented and shared: on a culture-by-culture basis, in locally-told stories or difficult-to-access repositories. In this paper we introduce D-PLACE, the Database of Places, Language, Culture, and Environment. This expandable and open-access database (accessible at https://d-place.org) brings together a dispersed corpus of information on the geography, language, culture, and environment of over 1400 human societies. We aim to enable researchers to investigate the extent to which patterns in cultural diversity are shaped by different forces, including shared history, demographics, migration/diffusion, cultural innovations, and environmental and ecological conditions. We detail how D-PLACE helps to overcome four common barriers to understanding these forces: i) location of relevant cultural data, (ii) linking data from distinct sources using diverse ethnonyms, (iii) variable time and place foci for data, and (iv) spatial and historical dependencies among cultural groups that present challenges for analysis. D-PLACE facilitates the visualisation of relationships among cultural groups and between people and their environments, with results downloadable as tables, on a map, or on a linguistic tree. We also describe how D-PLACE can be used for exploratory, predictive, and evolutionary analyses of cultural diversity by a range of users, from members of the worldwide public interested in contrasting their own cultural practices with those of other societies, to researchers using large-scale computational phylogenetic analyses to study cultural evolution. In summary, we hope that D-PLACE will enable new lines of investigation into the major drivers of cultural change and global patterns of cultural diversity.	[Kirby, Kathryn R.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada; [Kirby, Kathryn R.] Univ Toronto, Dept Geog & Planning, Toronto, ON, Canada; [Gray, Russell D.; Greenhill, Simon J.; Jordan, Fiona M.; Bibiko, Hans-Joeg; Blasi, Damian E.; Gavin, Michael C.] Max Planck Inst Sci Human Hist, Jena, Germany; [Gray, Russell D.; Gomes-Ng, Stephanie] Univ Auckland, Sch Psychol, Auckland, New Zealand; [Gray, Russell D.; Greenhill, Simon J.; Bowern, Claire] Australian Natl Univ, ARC Ctr Excellence Dynam Language, ANU Coll Asia & Pacific, Canberra, ACT, Australia; [Jordan, Fiona M.] Univ Bristol, Dept Archaeol & Anthropol, Bristol, Avon, England; [Blasi, Damian E.] Univ Zurich, Dept Comparat Linguist, Zurich, Switzerland; [Blasi, Damian E.] Univ Zurich, Psycholinguist Lab, Zurich, Switzerland; [Botero, Carlos A.] Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA; [Bowern, Claire] Yale Univ, Dept Linguist, New Haven, CT USA; [Ember, Carol R.] Yale Univ, Human Relat Area Files, New Haven, CT USA; [Leehr, Dan] Duke Univ, Ctr Genom & Computat Biol, Durham, NC 27706 USA; [Low, Bobbi S.] Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA; [Low, Bobbi S.] Univ Michigan, Inst Social Res, Ann Arbor, MI USA; [McCarter, Joe] Amer Museum Nat Hist, Ctr Biodivers & Conservat, New York, NY 10024 USA; [Divale, William] CUNY York Coll, New York, NY USA; [Gavin, Michael C.] Colorado State Univ, Dept Human Dimens Nat Resources, Ft Collins, CO 80523 USA	University of Toronto; University of Toronto; University of Auckland; Australian National University; University of Bristol; University of Zurich; University of Zurich; Washington University (WUSTL); Yale University; Yale University; Duke University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; American Museum of Natural History (AMNH); City University of New York (CUNY) System; Colorado State University	Kirby, KR (corresponding author), Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada.; Kirby, KR (corresponding author), Univ Toronto, Dept Geog & Planning, Toronto, ON, Canada.	kate.kirby@utoronto.ca	Greenhill, Simon/I-3554-2019; Blasi, Damián Ezequiel/AAD-6049-2019	Greenhill, Simon/0000-0001-7832-6156; Blasi, Damián Ezequiel/0000-0002-9885-1414; Leehr, Dan/0000-0003-3221-9579; Gavin, Michael/0000-0002-2169-4668; Gomes-Ng, Stephanie/0000-0001-7699-5903	National Evolutionary Synthesis Center; Max Planck Institute for the Science of Human History; National Science Foundation [1519987, BCS-1423711, EF-0905606]; SBE Off Of Multidisciplinary Activities [1519987] Funding Source: National Science Foundation	National Evolutionary Synthesis Center; Max Planck Institute for the Science of Human History; National Science Foundation(National Science Foundation (NSF)); SBE Off Of Multidisciplinary Activities(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	D-PLACE was developed with generous support from the National Evolutionary Synthesis Center (www.nescent.org), the Max Planck Institute for the Science of Human History (http://www.shh.mpg.de/en), and the National Science Foundation (award numbers 1519987, BCS-1423711, and EF-0905606). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahuchet S, 2012, HUM BIOL, V84, P11, DOI 10.3378/027.084.0101; Barker D, 2007, BIOINFORMATICS, V23, P14, DOI 10.1093/bioinformatics/btl558; Barnett DW, 2011, BIOINFORMATICS, V27, P1691, DOI 10.1093/bioinformatics/btr174; BARRY H, 1980, ETHNOLOGY, V19, P245; Binford L. R., 2006, DOCUMENTATION PROGRA; Binford L.R., 2001, CONSTRUCTING FRAMES; Bondarenko D, 2005, ETHNOLOGY, V44, P261, DOI 10.2307/3774059; Botero CA, 2014, P NATL ACAD SCI USA, V111, P16784, DOI 10.1073/pnas.1408701111; Bouckaert R, 2012, SCIENCE, V337, P957, DOI 10.1126/science.1219669; Bowern C, 2016, LANG DOC CONSERV, V10, P1; Bowern C, 2012, LANGUAGE, V88, P817, DOI 10.1353/lan.2012.0081; Chacon T, 2015, J LANGUAGE RELATIONS, V13, P177; Currie TE, 2010, NATURE, V467, P801, DOI 10.1038/nature09461; Dunn M, 2011, NATURE, V473, P79, DOI 10.1038/nature09923; Ember C. R., 2009, CROSS CULTURAL RES M; Ember CR, 2007, CROSS-CULT RES, V41, P396, DOI 10.1177/1069397107306593; Ember CR, 1992, COMPUTERIZED CONCORD; Ember M, 2007, CROSS-CULT RES, V41, P428, DOI 10.1177/1069397107307672; FitzJohn RG, 2012, METHODS ECOL EVOL, V3, P1084, DOI 10.1111/j.2041-210X.2012.00234.x; Gavin MC, 2013, BIOSCIENCE, V63, P524, DOI 10.1525/bio.2013.63.7.6; Gavin MC, 2012, GLOBAL ECOL BIOGEOGR, V21, P958, DOI 10.1111/j.1466-8238.2011.00744.x; GMI (Global Mapping International), 2005, WORLD LANG MAPP SYST; Gragson TL, 1989, THESIS; Gray J., 1999, WORLD CULTURES J, V10, P24; Gray RD, 2009, SCIENCE, V323, P479, DOI 10.1126/science.1166858; Gray RD, 2007, BIOL THEORY IN PRESS, V2, P4; Greaves RD, 2007, EXPEDITION, V49; Grollemund R, 2015, P NATL ACAD SCI USA, V112, P13296, DOI 10.1073/pnas.1503793112; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hammarstrom Harald, 2015, GLOTTOLOG 2 6; Holden C, 1999, AM J PHYS ANTHROPOL, V110, P27, DOI 10.1002/(SICI)1096-8644(199909)110:1<27::AID-AJPA3>3.0.CO;2-G; Holden CJ, 2003, P ROY SOC B-BIOL SCI, V270, P2425, DOI 10.1098/rspb.2003.2535; Hollis S, 1992, PLANT TAXONOMIC DATA; Jordan FM, 2009, P ROY SOC B-BIOL SCI, V276, P1957, DOI 10.1098/rspb.2009.0088; Jorgensen JG, W INDIANS COMP ENV L; Kitchen A, 2009, P ROY SOC B-BIOL SCI, V276, P2703, DOI 10.1098/rspb.2009.0408; Korotayev A, 2004, ETHNOLOGY, V43, P83, DOI 10.2307/3773857; Kushnick G, 2014, EVOL HUM BEHAV, V35, P309, DOI 10.1016/j.evolhumbehav.2014.03.001; Lee S, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0128448, 10.1371/journal.pone.0136385]; Lee S, 2011, P ROY SOC B-BIOL SCI, V278, P3662, DOI 10.1098/rspb.2011.0518; Leeds A, 1960, ANTROPOLOGICA, V9, P1; Lewis M. Paul, 2013, ETHNOLOGUE LANGUAGES; LinguistList, 2009, DIG LIB LANG REL; Mace R, 2005, TRENDS ECOL EVOL, V20, P116, DOI 10.1016/j.tree.2004.12.002; Mace R, 2011, PHILOS T R SOC B, V366, P402, DOI 10.1098/rstb.2010.0238; Mesoudi A., 2011, CULTURAL EVOLUTION D; Miller HJ, 2004, ANN ASSOC AM GEOGR, V94, P284, DOI 10.1111/j.1467-8306.2004.09402005.x; Murdock G. P., 1983, OUTLINE WORLD CULTUR, V6th; MURDOCK GP, 1969, ETHNOLOGY, V8, P329, DOI 10.2307/3772907; Murdock GP, ETHNOGRAPHIC ATLAS I, P1; Nunn C. L., 2011, COMP APPROACH EVOLUT; Opie C, 2014, P NATL ACAD SCI USA, V111, P17414, DOI 10.1073/pnas.1415744111; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Richerson P. J., 2008, EXPLAINING CULTURE S, P75; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Sicoli MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091722; SIL International, 2015, ISO 639 3 REG AUTH; Watts J, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2556	59	99	104	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158391	10.1371/journal.pone.0158391	http://dx.doi.org/10.1371/journal.pone.0158391			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27391016	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400052
J	Marin, V; Rosso, N; Dal Ben, M; Raseni, A; Boschelle, M; Degrassi, C; Nemeckova, I; Nachtigal, P; Avellini, C; Tiribelli, C; Gazzin, S				Marin, Veronica; Rosso, Natalia; Dal Ben, Matteo; Raseni, Alan; Boschelle, Manuela; Degrassi, Cristina; Nemeckova, Ivana; Nachtigal, Petr; Avellini, Claudio; Tiribelli, Claudio; Gazzin, Silvia			An Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis	PLOS ONE			English	Article							HEPATIC STEATOSIS; HIGH-FRUCTOSE; BODY-WEIGHT; DIET; CHILDREN; ADOLESCENTS; METABOLISM; OBESITY; GENDER; MOUSE	Non Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) are the hepatic manifestations of the metabolic syndrome; worrisome is the booming increase in pediatric age. To recreate the full spectrum of juvenile liver pathology and investigate the gender impact, male and female C57Bl/6 mice were fed with high fat diet plus fructose in the drinking water (HFHC) immediately after weaning (equal to 3-years old human), and disease progression followed for 16 weeks, until adults (equal to 30-years old human). 100% of subjects of both genders on HFHC diet developed steatosis in 4weeks, and some degree of fibrosis in 8weeks, with the 86% of males and 15% of females presenting a stage 2 fibrosis at 16weeks. Despite a similar final liver damage both groups, a sex difference in the pathology progression was observed. Alterations in glucose homeostasis, dyslipidemia, hepatomegaly and obese phenotype were evident from the very beginning in males with an increased hepatic inflammatory activity. Conversely, such alterations were present in females only at the end of the HFHC diet (with the exception of insulin resistance and the hepatic inflammatory state). Interestingly, only females showed an altered hepatic redox state. This juvenile model appears a good platform to unravel the underlying gender dependent mechanisms in the progression from NAFLD to NASH, and to characterize novel therapeutic approaches.	[Marin, Veronica; Rosso, Natalia; Dal Ben, Matteo; Tiribelli, Claudio; Gazzin, Silvia] Fdn Italiana Fegato, AREA Sci Pk, Trieste, Italy; [Raseni, Alan; Boschelle, Manuela] IRCCS Osped Burlo Garofolo Pediat Hosp, Clin Chem Lab, Trieste, Italy; [Degrassi, Cristina] Med Res Inst, AREA Sci Pk, Trieste, Italy; [Nemeckova, Ivana; Nachtigal, Petr] Charles Univ Prague, Dept Biol & Med Sci, Fac Pharm Hradec Kralove, Heyrovskeho 1203, Hradec Kralove 50005, Czech Republic; [Avellini, Claudio] Azienda Osped Univ Santa Maria Misericordia, Dip Anat & Patol, Udine, Italy; [Tiribelli, Claudio] Univ Trieste, Dept Med Sci, Trieste, Italy	IRCCS Burlo Garofolo; Charles University Prague; Hospital Santa Maria della Misericordia; University of Trieste	Gazzin, S (corresponding author), Fdn Italiana Fegato, AREA Sci Pk, Trieste, Italy.	silvia.gazzin@csf.units.it	Nachtigal, Petr/S-8022-2017; Nemeckova, Ivana/T-6610-2017; Rosso, Natalia/K-9035-2016; Dal Ben, Matteo/N-6658-2015; Tiribelli, Claudio/A-4716-2014	Nachtigal, Petr/0000-0001-9568-7295; Nemeckova, Ivana/0000-0002-9795-8471; Rosso, Natalia/0000-0002-4251-3547; Dal Ben, Matteo/0000-0001-9294-2107; Tiribelli, Claudio/0000-0001-6596-7595	Italian National Grant MIUR [Art.13 D.LGS 297/99]; Fondazione Italiana Fegato, ONLUS	Italian National Grant MIUR(Ministry of Education, Universities and Research (MIUR)); Fondazione Italiana Fegato, ONLUS	The present work was funded by Italian National Grant MIUR - Art.13 D.LGS 297/99 - Progetto Nutrizione e Salute (NR, VM, SG); and in part by an in-house grant from Fondazione Italiana Fegato, ONLUS (MDB, CT).	Akagiri S, 2008, J CLIN BIOCHEM NUTR, V42, P150, DOI 10.3164/jcbn.2008022; Alini Schultz, 2014, J DIABETES METAB DIS, V1; Altunkaynak BZ, 2007, SAUDI MED J, V28, P891; Anstee QM, 2011, LIVER INT, V31, P440, DOI 10.1111/j.1478-3231.2011.02463.x; Bellentani S, 2010, DIGEST DIS, V28, P155, DOI 10.1159/000282080; Blachier M, 2013, J HEPATOL, V58, P593, DOI 10.1016/j.jhep.2012.12.005; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Brunt EM, 2011, HEPATOLOGY, V53, P810, DOI 10.1002/hep.24127; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Escola-Gil JC, 2011, ARTERIOSCL THROM VAS, V31, P2493, DOI 10.1161/ATVBAHA.111.236075; Della Corte C, 2012, J ADOLESCENT HEALTH, V51, P305, DOI 10.1016/j.jadohealth.2012.01.010; DIETZ WH, 1994, AM J CLIN NUTR, V59, P955, DOI 10.1093/ajcn/59.5.955; Feldstein AE, 2009, GUT, V58, P1538, DOI 10.1136/gut.2008.171280; Fu JF, 2009, WORLD J GASTROENTERO, V15, P912, DOI 10.3748/wjg.15.912; Ganz M, 2014, WORLD J GASTROENTERO, V20, P8525, DOI 10.3748/wjg.v20.i26.8525; Getz GS, 2006, ARTERIOSCL THROM VAS, V26, P242, DOI 10.1161/01.ATV.0000201071.49029.17; Giorgio V, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-40; Hewitt KN, 2004, ENDOCRINOLOGY, V145, P1842, DOI 10.1210/en.2003-1369; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Ito M, 2007, HEPATOL RES, V37, P50, DOI 10.1111/j.1872-034X.2007.00008.x; Kamada Y, 2011, AM J PHYSIOL-GASTR L, V301, pG1031, DOI 10.1152/ajpgi.00211.2011; Keyamura Y, 2015, BIOL PHARM BULL, V38, P785, DOI 10.1248/bpb.b14-00775; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Ko JS, 2009, DIGEST DIS SCI, V54, P2225, DOI 10.1007/s10620-009-0949-3; Kohli R, 2010, HEPATOLOGY, V52, P934, DOI 10.1002/hep.23797; Larter CZ, 2008, J GASTROEN HEPATOL, V23, P1635, DOI 10.1111/j.1440-1746.2008.05543.x; LEY CJ, 1992, AM J CLIN NUTR, V55, P950, DOI 10.1093/ajcn/55.5.950; Lichtenstein AH, 2000, ATHEROSCLEROSIS, V150, P227, DOI 10.1016/S0021-9150(99)00504-3; Loomba R, 2009, HEPATOLOGY, V50, P1282, DOI 10.1002/hep.23119; LOPEZDELEON A, 1985, J HISTOCHEM CYTOCHEM, V33, P737, DOI 10.1177/33.8.2410480; Louet Jean-Francois, 2004, Curr Atheroscler Rep, V6, P180, DOI 10.1007/s11883-004-0030-9; Lustig RH, 2012, NATURE, V482, P27, DOI 10.1038/482027a; Machado MV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127991; de Castro UGM, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-136; Nobili V, 2006, HEPATOLOGY, V44, P458, DOI 10.1002/hep.21262; Patton HM, 2006, J PEDIATR GASTR NUTR, V43, P413, DOI 10.1097/01.mpg.0000239995.58388.56; Pettersson US, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046057; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Roberts EA, 2007, J HEPATOL, V46, P1133, DOI 10.1016/j.jhep.2007.03.003; Rosso N, 2014, WORLD J GASTROENTERO, V20, P9038, DOI 10.3748/wjg.v20.i27.9038; Sanches SCL, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/574832; Schwimmer JB, 2005, PEDIATRICS, V115, pE561, DOI 10.1542/peds.2004-1832; Schwinnner JB, 2005, HEPATOLOGY, V42, P641, DOI 10.1002/hep.20842; Shi H, 2009, PHYSIOL BEHAV, V97, P199, DOI 10.1016/j.physbeh.2009.02.017; Suzuki D, 2005, J GASTROEN HEPATOL, V20, P327, DOI 10.1111/j.1440-1746.2005.03724.x; Takahashi Y, 2012, WORLD J GASTROENTERO, V18, P2300, DOI 10.3748/wjg.v18.i19.2300; Takahashi Y, 2011, HEPATOL RES, V41, P1066, DOI 10.1111/j.1872-034X.2011.00855.x	47	31	32	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158817	10.1371/journal.pone.0158817	http://dx.doi.org/10.1371/journal.pone.0158817			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391242	Green Published, gold, Green Submitted			2022-12-27	WOS:000380005400133
J	Nahidiazar, L; Agronskaia, AV; Broertjes, J; van den Broek, B; Jalink, K				Nahidiazar, Leila; Agronskaia, Alexandra V.; Broertjes, Jorrit; van den Broek, Bram; Jalink, Kees			Optimizing Imaging Conditions for Demanding Multi-Color Super Resolution Localization Microscopy	PLOS ONE			English	Article							SINGLE-MOLECULE FLUORESCENCE; OXYGEN SCAVENGING SYSTEM; SUPERRESOLUTION MICROSCOPY; PROBES; DYES	Single Molecule Localization super-resolution Microscopy (SMLM) has become a powerful tool to study cellular architecture at the nanometer scale. In SMLM, single fluorophore labels are made to repeatedly switch on and off ("blink"), and their exact locations are determined by mathematically finding the centers of individual blinks. The image quality obtainable by SMLM critically depends on efficacy of blinking (brightness, fraction of molecules in the on-state) and on preparation longevity and labeling density. Recent work has identified several combinations of bright dyes and imaging buffers that work well together. Unfortunately, different dyes blink optimally in different imaging buffers, and acquisition of good quality 2- and 3-color images has therefore remained challenging. In this study we describe a new imaging buffer, OxEA, that supports 3-color imaging of the popular Alexa dyes. We also describe incremental improvements in preparation technique that significantly decrease lateral-and axial drift, as well as increase preparation longevity. We show that these improvements allow us to collect very large series of images from the same cell, enabling image stitching, extended 3D imaging as well as multi-color recording.	[Nahidiazar, Leila; van den Broek, Bram; Jalink, Kees] Netherlands Canc Inst, Dept Cell Biol, Cell Biophys Grp, Amsterdam, Netherlands; [Agronskaia, Alexandra V.] Univ Utrecht, Mol Biophys Grp, Utrecht, Netherlands; [Broertjes, Jorrit; Jalink, Kees] Univ Amsterdam, Fac Sci, Amsterdam, Netherlands; [Jalink, Kees] Univ Amsterdam, Swammerdam Inst Life Sci, Mol Cytol, Van Leeuwenhoek Ctr Adv Microscopy, Amsterdam, Netherlands	Netherlands Cancer Institute; Utrecht University; University of Amsterdam; University of Amsterdam	Jalink, K (corresponding author), Netherlands Canc Inst, Dept Cell Biol, Cell Biophys Grp, Amsterdam, Netherlands.; Jalink, K (corresponding author), Univ Amsterdam, Fac Sci, Amsterdam, Netherlands.; Jalink, K (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Mol Cytol, Van Leeuwenhoek Ctr Adv Microscopy, Amsterdam, Netherlands.	k.jalink@nki.nl		Jalink, Kees/0000-0001-7019-3440	Stichting Technische Wetenschappen [STW12150]	Stichting Technische Wetenschappen	Support was provided by grant# STW12150 from the Stichting Technische Wetenschappen [http://www.stw.nl/en/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken CE, 2008, BIOPHYS J, V94, P1826, DOI 10.1529/biophysj.107.117689; Altman RB, 2012, NAT METHODS, V9, P68, DOI [10.1038/nmeth.1774, 10.1038/NMETH.1774]; Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/NMETH.1768, 10.1038/nmeth.1768]; Enderlein J, 2012, RECENT DEV GSDIM MIC, V8228, DOI [10.1117/12.912748, DOI 10.1117/12.912748]; Engelhardt J, 2011, NANO LETT, V11, P209, DOI 10.1021/nl103472b; FONTIJN R, 1995, EXP CELL RES, V216, P199, DOI 10.1006/excr.1995.1025; Geerts D, 1999, J CELL BIOL, V147, P417, DOI 10.1083/jcb.147.2.417; Groussard C, 2000, J APPL PHYSIOL, V89, P169, DOI 10.1152/jappl.2000.89.1.169; Ha T, 2012, ANNU REV PHYS CHEM, V63, P595, DOI 10.1146/annurev-physchem-032210-103340; Ho Kwei-Chi, 2003, Am J Clin Oncol, V26, pe86, DOI 10.1097/00000421-200308000-00029; Hoogendoorn E, 2014, SCI REP-UK, V4, DOI 10.1038/srep03854; Liu B, 2015, SCI REP-UK, V5, DOI 10.1038/srep13017; Nahidiazar L, 2015, J CELL SCI, V128, P3714, DOI 10.1242/jcs.171892; Olivier N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069004; Olivier N, 2013, BIOMED OPT EXPRESS, V4, P885, DOI 10.1364/BOE.4.000885; Ovesny M, 2014, BIOINFORMATICS, V30, P2389, DOI 10.1093/bioinformatics/btu202; Pereira PM, 2015, METHOD CELL BIOL, V125, P95, DOI 10.1016/bs.mcb.2014.10.004; Prakash K, 2015, P NATL ACAD SCI USA, V112, P14635, DOI 10.1073/pnas.1516928112; Shi XH, 2010, ANAL CHEM, V82, P6132, DOI 10.1021/ac1008749; van de Linde S, 2010, J BIOTECHNOL, V149, P260, DOI 10.1016/j.jbiotec.2010.02.010; Vogelsang J, 2008, ANGEW CHEM INT EDIT, V47, P5465, DOI 10.1002/anie.200801518; Vogelsang J, 2010, CHEMPHYSCHEM, V11, P2475, DOI 10.1002/cphc.201000189; Vogelsang J, 2009, P NATL ACAD SCI USA, V106, P8107, DOI 10.1073/pnas.0811875106; Widengren J, 2007, J PHYS CHEM A, V111, P429, DOI 10.1021/jp0646325	24	91	91	4	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158884	10.1371/journal.pone.0158884	http://dx.doi.org/10.1371/journal.pone.0158884			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391487	Green Submitted, Green Published, gold			2022-12-27	WOS:000380005400149
J	Rodriguez-Viera, L; Perera, E; Martos-Sitcha, JA; Perdomo-Morales, R; Casuso, A; Montero-Alejo, V; Garcia-Galano, T; Martinez-Rodriguez, G; Mancera, JM				Rodriguez-Viera, Leandro; Perera, Erick; Antonio Martos-Sitcha, Juan; Perdomo-Morales, Rolando; Casuso, Antonio; Montero-Alejo, Vivian; Garcia-Galano, Tsai; Martinez-Rodriguez, Gonzalo; Miguel Mancera, Juan			Molecular, Biochemical, and Dietary Regulation Features of alpha-Amylase in a Carnivorous Crustacean, the Spiny Lobster Panulirus argus	PLOS ONE			English	Article							PROTEIN-STRUCTURE PREDICTION; DIGESTIVE ENZYME-ACTIVITIES; PHENOLOXIDASE ACTIVITY; CARBOHYDRATE SOURCES; GENE POLYMORPHISM; FORMULATED DIETS; EVOLUTION; EXPRESSION; TRYPSIN; GROWTH	Alpha-amylases are ubiquitously distributed throughout microbials, plants and animals. It is widely accepted that omnivorous crustaceans have higher alpha-amylase activity and number of isoforms than carnivorous, but contradictory results have been obtained in some species, and carnivorous crustaceans have been less studied. In addition, the physiological meaning of alpha-amylase polymorphism in crustaceans is not well understood. In this work we studied alpha-amylase in a carnivorous lobster at the gene, transcript, and protein levels. It was showed that alpha-amylase isoenzyme composition (i.e., phenotype) in lobster determines carbohydrate digestion efficiency. Most frequent alpha-amylase phenotype has the lowest digestion efficiency, suggesting this is a favoured trait. We revealed that gene and intron loss have occurred in lobster alpha-amylase, thus lobsters express a single 1830 bp cDNA encoding a highly conserved protein with 513 amino acids. This protein gives rise to two isoenzymes in some individuals by glycosylation but not by limited proteolysis. Only the glycosylated isoenzyme could be purified by chromatography, with biochemical features similar to other animal amylases. High carbohydrate content in diet down-regulates a-amylase gene expression in lobster. However, high alpha-amylase activity occurs in lobster gastric juice irrespective of diet and was proposed to function as an early sensor of the carbohydrate content of diet to regulate further gene expression. We concluded that gene/isoenzyme simplicity, post-translational modifications and low Km, coupled with a tight regulation of gene expression, have arose during evolution of alpha-amylase in the carnivorous lobster to control excessive carbohydrate digestion in the presence of an active alpha-amylase.	[Rodriguez-Viera, Leandro; Casuso, Antonio; Garcia-Galano, Tsai] Univ Havana, Ctr Marine Res, Havana, Cuba; [Perera, Erick; Antonio Martos-Sitcha, Juan; Martinez-Rodriguez, Gonzalo] CSIC, Inst Ciencias Marinas Andalucia, ICMAN, Cadiz, Spain; [Perdomo-Morales, Rolando; Montero-Alejo, Vivian] Ctr Pharmaceut Res & Dev, Dept Biochem, Havana, Cuba; [Rodriguez-Viera, Leandro; Miguel Mancera, Juan] Univ Cadiz, Dept Biol, Cadiz, Spain; [Perera, Erick] CSIC, IATS, Dept Fish Physiol & Biotechnol, Control Food Intake Grp, Castellon de La Plana, Spain; [Antonio Martos-Sitcha, Juan] CSIC, IATS, Nutrigen & Fish Growth Endocrinol Grp, Castellon de La Plana, Spain	Universidad de la Habana; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias Marinas de Andalucia (ICMAN); Universidad de Cadiz; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Acuicultura de Torre de la Sal (IATS); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Acuicultura de Torre de la Sal (IATS)	Rodriguez-Viera, L (corresponding author), Univ Havana, Ctr Marine Res, Havana, Cuba.; Perera, E (corresponding author), CSIC, Inst Ciencias Marinas Andalucia, ICMAN, Cadiz, Spain.; Rodriguez-Viera, L (corresponding author), Univ Cadiz, Dept Biol, Cadiz, Spain.; Perera, E (corresponding author), CSIC, IATS, Dept Fish Physiol & Biotechnol, Control Food Intake Grp, Castellon de La Plana, Spain.	leandro@cim.uh.cu; erick.perera@icman.csic.es	Rodriguez-Viera, Leandro/AAA-8942-2020; Martos-Sitcha, Juan Antonio/L-6140-2014; MARTINEZ-RODRIGUEZ, GONZALO/A-2564-2009; Perdomo-Morales, Rolando/AAC-8280-2020; Rodriguez-Viera, Leandro/AAD-3149-2020; Perera, Erick/E-9908-2018; Montero-Alejo, Vivian/AAY-1316-2020	Rodriguez-Viera, Leandro/0000-0002-2392-0075; Martos-Sitcha, Juan Antonio/0000-0002-0151-7250; MARTINEZ-RODRIGUEZ, GONZALO/0000-0003-3379-580X; Perdomo-Morales, Rolando/0000-0001-5598-6864; Rodriguez-Viera, Leandro/0000-0002-2392-0075; Perera, Erick/0000-0001-6108-1340; Montero-Alejo, Vivian/0000-0002-0089-7925	International Foundation for Science [A/4306-2]; Escuela Internacional de Doctorado en Agroalimentacion	International Foundation for Science(International Foundation for Science); Escuela Internacional de Doctorado en Agroalimentacion	This work was partially supported by International Foundation for Science (http://www.ifs.se/) through project no. A/4306-2 granted to EP, and Escuela Internacional de Doctorado en Agroalimentacion (http://www.ceia3.es/eida3) fellowship granted to LRV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelsson E, 2013, NATURE, V495, P360, DOI 10.1038/nature11837; BENKEL BF, 1987, P NATL ACAD SCI USA, V84, P1337, DOI 10.1073/pnas.84.5.1337; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Castro PF, 2012, J CRUSTACEAN BIOL, V32, P607, DOI 10.1163/193724012X634206; Celis-Guerrero LE, 2004, MAR BIOTECHNOL, V6, P262, DOI 10.1007/s10126-003-0032-6; Chow S, 2011, MAR BIOTECHNOL, V13, P305, DOI 10.1007/s10126-010-9301-3; Cox C, 1997, MAR FRESHWATER RES, V48, P671, DOI 10.1071/MF97198; Da Lage JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019673; DaLage JL, 1996, J MOL EVOL, V43, P334, DOI 10.1007/PL00006093; Darnis S, 1999, BBA-PROTEIN STRUCT M, V1430, P281, DOI 10.1016/S0167-4838(99)00011-4; Del Toro MDAN, 2006, J EXP ZOOL PART A, V305A, P645, DOI 10.1002/jez.a.318; Dojnov B, 2008, COMP BIOCHEM PHYS B, V149, P153, DOI 10.1016/j.cbpb.2007.09.009; Douglas SE, 2000, AQUACULTURE, V190, P247, DOI 10.1016/S0044-8486(00)00398-7; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FRIED M, 1987, DIGEST DIS SCI, V32, P1097, DOI 10.1007/BF01300195; Froystad MK, 2006, COMP BIOCHEM PHYS A, V145, P479, DOI 10.1016/j.cbpa.2006.08.003; GAUTHIER SF, 1982, J NUTR, V112, P1718, DOI 10.1093/jn/112.9.1718; Gella FJ, 1997, CLIN CHIM ACTA, V259, P147, DOI 10.1016/S0009-8981(96)06481-9; German DP, 2010, PHYSIOL BIOCHEM ZOOL, V83, P1, DOI 10.1086/648510; Grossman G.L., 1993, Insect Molecular Biology, V1, P223, DOI 10.1111/j.1365-2583.1993.tb00095.x; Guarna MM, 1995, COMP BIOCHEM PHYS B, V112, P619, DOI 10.1016/0305-0491(95)00099-2; Hasan K, 2008, BIOLOGIA, V63, P1044, DOI 10.2478/s11756-008-0167-z; HICKEY DA, 1981, BIOCHEM GENET, V19, P783, DOI 10.1007/BF00484009; Hirtz C, 2005, PROTEOMICS, V5, P4597, DOI 10.1002/pmic.200401316; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; HUGHES BL, 1994, POULTRY SCI, V73, P953, DOI 10.3382/ps.0730953; Huvet A, 2008, ANIM GENET, V39, P662, DOI 10.1111/j.1365-2052.2008.01776.x; Huvet A, 2012, COMP BIOCHEM PHYS B, V163, P96, DOI 10.1016/j.cbpb.2012.05.003; Inomata N, 1997, MOL BIOL EVOL, V14, P942, DOI 10.1093/oxfordjournals.molbev.a025837; Inomata N, 1995, J MOL EVOL, V41, P1076, DOI 10.1007/BF00173189; Inomata N, 2008, GENE, V412, P102, DOI 10.1016/j.gene.2008.01.023; Janecek S, 2002, BIOLOGIA, V57, P29; JANECEK S, 1995, PROTEIN ENG, V8, P809, DOI 10.1093/protein/8.8.809; Johnston D, 2005, BIOL BULL-US, V208, P36, DOI 10.2307/3593099; Johnston DJ, 2003, MAR BIOL, V143, P1071, DOI 10.1007/s00227-003-1154-0; Karasov WH, 2011, ANNU REV PHYSIOL, V73, P69, DOI 10.1146/annurev-physiol-012110-142152; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Krylov DM, 2003, GENOME RES, V13, P2229, DOI 10.1101/gr.1589103; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LeMoullac G, 1997, J EXP MAR BIOL ECOL, V208, P107, DOI 10.1016/S0022-0981(96)02671-8; LIPCIUS RN, 1982, MAR BIOL, V68, P241, DOI 10.1007/BF00409591; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lombrana M, 2005, COMP BIOCHEM PHYS B, V142, P56, DOI 10.1016/j.cbpc.2005.05.017; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LYLE WG, 1983, J CRUSTACEAN BIOL, V3, P208, DOI 10.2307/1548257; Martinez G, 1998, BIOTECHNIQUES, V24, P238, DOI 10.2144/98242bm14; MARX JM, 1985, B MAR SCI, V36, P423; MCCOMMAS S, 1990, BIOCHEM GENET, V28, P585, DOI 10.1007/BF00553951; Moreau Y, 2001, COMP BIOCHEM PHYS B, V128, P543, DOI 10.1016/S1096-4959(00)00358-4; O'Rorke R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042757; Perdomo-Morales R, 2007, FISH SHELLFISH IMMUN, V23, P1187, DOI 10.1016/j.fsi.2007.04.001; Perera E, 2008, COMP BIOCHEM PHYS B, V151, P250, DOI 10.1016/j.cbpb.2008.07.005; Perera E, 2008, COMP BIOCHEM PHYS B, V150, P247, DOI 10.1016/j.cbpb.2008.03.009; Perera E, 2015, REV AQUACULT, V7, P243, DOI 10.1111/raq.12066; Perera E, 2012, BIOL BULL-US, V222, P158, DOI 10.1086/BBLv222n2p158; Perera E, 2010, AQUACULTURE, V310, P178, DOI 10.1016/j.aquaculture.2010.10.009; Perera E, 2010, FEBS J, V277, P3489, DOI 10.1111/j.1742-4658.2010.07751.x; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Prudence M, 2006, ANIM GENET, V37, P348, DOI 10.1111/j.1365-2052.2006.01481.x; Quinn G.P., 2002, EXPT DESIGN DATA ANA; Rodriguez-Viera L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108875; Saunders MI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036580; SAVOIE L, 1986, J FOOD SCI, V51, P494, DOI 10.1111/j.1365-2621.1986.tb11164.x; Simon CJ, 2011, AQUACULT NUTR, V17, P613, DOI 10.1111/j.1365-2095.2011.00861.x; Simon CJ, 2009, AQUACULTURE, V294, P271, DOI 10.1016/j.aquaculture.2009.06.023; Simon CJ, 2009, AQUACULTURE, V290, P275, DOI 10.1016/j.aquaculture.2009.02.026; SMITH VJ, 1991, DEV COMP IMMUNOL, V15, P251, DOI 10.1016/0145-305X(91)90018-T; SVENSSON B, 1994, PLANT MOL BIOL, V25, P141, DOI 10.1007/BF00023233; Takashima S, 2012, ADV BIOL CHEM, V2, P10; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsuji A, 2014, FEBS OPEN BIO, V4, P560, DOI 10.1016/j.fob.2014.06.002; VANWORMHOUDT A, 1995, BIOCHEM SYST ECOL, V23, P139, DOI 10.1016/0305-1978(94)00090-4; VanWormhoudt A, 1996, J MOL EVOL, V42, P543, DOI 10.1007/BF02352284; Wang M, 2014, MAR FRESHWATER RES, V65, P337, DOI 10.1071/MF13048; Williams KC, 2007, AQUACULTURE, V263, P1, DOI 10.1016/j.aquaculture.2006.10.019; WOJTOWICZ MB, 1972, COMP BIOCHEM PHYSIOL, V42, P295, DOI 10.1016/0305-0491(72)90274-X; ZACHARIUS RM, 1969, ANAL BIOCHEM, V30, P148, DOI 10.1016/0003-2697(69)90383-2; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588; Zhang Z, 2003, J MOL EVOL, V56, P121, DOI 10.1007/s00239-002-2384-3; Zoltowska K, 2001, ACTA BIOCHIM POL, V48, P763	82	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158919	10.1371/journal.pone.0158919	http://dx.doi.org/10.1371/journal.pone.0158919			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391425	Green Published, gold, Green Submitted			2022-12-27	WOS:000380005400161
J	Vallet, A; Locatelli, B; Levrel, H; Perez, CB; Imbach, P; Carmona, NE; Manlay, R; Oszwald, J				Vallet, Ameline; Locatelli, Bruno; Levrel, Harold; Brenes Perez, Christian; Imbach, Pablo; Carmona, Natalia Estrada; Manlay, Raphael; Oszwald, Johan			Dynamics of Ecosystem Services during Forest Transitions in Reventazon, Costa Rica	PLOS ONE			English	Article							LAND-USE CHANGE; BIODIVERSITY CONSERVATION; CLIMATE-CHANGE; TRADE-OFFS; COVER; SYNERGIES; IMPLEMENTATION; HETEROGENEITY; ADAPTATION; FRAMEWORK	The forest transition framework describes the temporal changes of forest areas with economic development. A first phase of forest contraction is followed by a second phase of expansion once a turning point is reached. This framework does not differentiate forest types or ecosystem services, and describes forests regardless of their contribution to human well-being. For several decades, deforestation in many tropical regions has degraded ecosystem services, such as watershed regulation, while increasing provisioning services from agriculture, for example, food. Forest transitions and expansion have been observed in some countries, but their consequences for ecosystem services are often unclear. We analyzed the implications of forest cover change on ecosystem services in Costa Rica, where a forest transition has been suggested. A review of literature and secondary data on forest and ecosystem services in Costa Rica indicated that forest transition might have led to an ecosystem services transition. We modeled and mapped the changes of selected ecosystem services in the upper part of the Reventazon watershed and analyzed how supply changed over time in order to identify possible transitions in ecosystem services. The modeled changes of ecosystem services is similar to the second phase of a forest transition but no turning point was identified, probably because of the limited temporal scope of the analysis. Trends of provisioning and regulating services and their tradeoffs were opposite in different spatial subunits of our study area, which highlights the importance of scale in the analysis of ecosystem services and forest transitions. The ecosystem services transition framework proposed in this study is useful for analyzing the temporal changes of ecosystem services and linking socio-economic drivers to ecosystem services demand at different scales.	[Vallet, Ameline; Levrel, Harold] Univ Paris Saclay, Ecole Ponts ParisTech, EHESS, CIRED,AgroParisTech,Cirad,CNRS, Nogent Sur Marne, France; [Vallet, Ameline; Locatelli, Bruno] CIRAD, Res Unit Forests & Soc, Montpellier, France; [Vallet, Ameline; Locatelli, Bruno] CIFOR, Lima, Peru; [Brenes Perez, Christian; Imbach, Pablo] CATIE, Turrialba, Costa Rica; [Carmona, Natalia Estrada] Biovers Int, Montpellier, France; [Manlay, Raphael] AgroParisTech, Unite Mixte Rech Eco&Sols, Montpellier, France; [Oszwald, Johan] Univ Rennes 2, Unite Mixte Rech CNRS 6554, LETG Rennes COSTEL, Rennes, France	AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CIRAD; Ecole des Ponts ParisTech; UDICE-French Research Universities; Universite Paris Saclay; CIRAD; CGIAR; Center for International Forestry Research (CIFOR); Alliance; Bioversity International; AgroParisTech; Universite Rennes 2	Vallet, A (corresponding author), Univ Paris Saclay, Ecole Ponts ParisTech, EHESS, CIRED,AgroParisTech,Cirad,CNRS, Nogent Sur Marne, France.; Vallet, A (corresponding author), CIRAD, Res Unit Forests & Soc, Montpellier, France.; Vallet, A (corresponding author), CIFOR, Lima, Peru.	A.Vallet@cgiar.org	Locatelli, Bruno/C-9957-2009; Manlay, Raphaël J./C-8986-2011; CARMONA, NATALIA ESTRADA/AAN-7794-2020; Vallet, Améline/F-4037-2018	Locatelli, Bruno/0000-0003-2983-1644; Manlay, Raphaël J./0000-0003-0482-8457; CARMONA, NATALIA ESTRADA/0000-0003-4329-5470; Vallet, Améline/0000-0002-2731-0098; Levrel, Harold/0000-0002-4611-3639; Imbach, Pablo/0000-0003-4078-6063	International Climate Initiative IKI of the German Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety; Norwegian Agency for Development Cooperation; CGIAR Research Program on Forests, Trees and Agroforestry CRP-FTA; CGIAR Fund	International Climate Initiative IKI of the German Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety; Norwegian Agency for Development Cooperation; CGIAR Research Program on Forests, Trees and Agroforestry CRP-FTA(CGIAR); CGIAR Fund(CGIAR)	The International Climate Initiative IKI of the German Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety (http://www.international-climate-initiative.com/en/) [AV and BL], the Norwegian Agency for Development Cooperation (https://www.norad.no/en/front/) [BL], and the CGIAR Research Program on Forests, Trees and Agroforestry CRP-FTA (http://foreststreesagroforestry.org/) with financial support from the CGIAR Fund [AV and BL]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BJ, 2009, J APPL ECOL, V46, P888, DOI 10.1111/j.1365-2664.2009.01666.x; [Anonymous], 2010, EV REC FOR MUND INF; [Anonymous], 2014, R LANG ENV STAT COMP; Arriagada R, 2009, 200907 LAT AM CAR EN; Arroyo-Mora JP, 2005, AGR ECOSYST ENVIRON, V106, P27, DOI 10.1016/j.agee.2004.07.002; Bagstad KJ, 2013, ECOSYST SERV, V5, pE40, DOI 10.1016/j.ecoser.2013.07.007; Bagstad KJ, 2013, ECOSYST SERV, V5, pE27, DOI 10.1016/j.ecoser.2013.07.004; Balthazar V, 2015, ECOL INDIC, V48, P63, DOI 10.1016/j.ecolind.2014.07.043; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Bank World, 2000, COST RIC FOR POL LAN; Bennett EM, 2009, ECOL LETT, V12, P1394, DOI 10.1111/j.1461-0248.2009.01387.x; Bienabe E, 2006, FOREST POLICY ECON, V9, P335, DOI 10.1016/j.forpol.2005.10.002; Bray DB, 2010, LANDSC SER, V10, P85, DOI 10.1007/978-1-4020-9656-3_5; Bremer LL, 2010, BIODIVERS CONSERV, V19, P3893, DOI 10.1007/s10531-010-9936-4; Brenes Perez C, 2009, ANALISIS MULTITEMPOR; Brockett CD, 2002, LAT AM RES REV, V37, P7; Calvo-Alvarado J, 2009, FOREST ECOL MANAG, V258, P931, DOI 10.1016/j.foreco.2008.10.035; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; Carreno L, 2012, AGR ECOSYST ENVIRON, V154, P68, DOI 10.1016/j.agee.2011.05.019; Castro R, 2000, ENVIRON MONIT ASSESS, V61, P75, DOI 10.1023/A:1006366118268; Chadzon R L, 2016, AMBIO, V45, P538, DOI DOI 10.1007/913280-016-0772-Y; Daniels AE, 2009, REFORESTING LANDSCAP, P227; de Groot D, 2014, LINK BIODIVERSITY EC; Dearing JA, 2012, P NATL ACAD SCI USA, V109, pE1111, DOI 10.1073/pnas.1118263109; DeFries R, 2010, LAND USE POLICY, V27, P130, DOI 10.1016/j.landusepol.2009.07.003; ESRI, 2013, ARCGIS; Estrada Carmona N., 2009, IDENTIFICACION AREAS; FAO, 1989, 2 FAO; Farley KA, 2007, ANN ASSOC AM GEOGR, V97, P755, DOI 10.1111/j.1467-8306.2007.00581.x; Florian EM, 2008, ZONA CAFETALERA CORR; Geneletti D, 2013, ENVIRON IMPACT ASSES, V40, P25, DOI 10.1016/j.eiar.2012.12.003; Goldstein JH, 2012, P NATL ACAD SCI USA, V109, P7565, DOI 10.1073/pnas.1201040109; Grainger A, 2010, LANDSC SER, V10, P15, DOI 10.1007/978-1-4020-9656-3_2; Haase D, 2012, ECOL SOC, V17, DOI 10.5751/ES-04853-170322; Hall JM, 2012, LANDSCAPE ECOL, V27, P1135, DOI 10.1007/s10980-012-9755-y; HARRIS S A, 1973, Arctic and Alpine Research, V5, pA187; Harrison PA, 2014, ECOSYST SERV, V9, P191, DOI 10.1016/j.ecoser.2014.05.006; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HIJMANS RJ, 2015, GEOGRAPHIC DATA ANAL; Holland RA, 2011, BIODIVERS CONSERV, V20, P3285, DOI 10.1007/s10531-011-0113-1; IMN MINAET, 2011, EST CUENC HIDR COST; INEC, 2012, 10 CENS NAC POBL 6 V; ITCR, 2004, DIG ATL COST RIC CD; Kleinn C, 2002, ENVIRON MONIT ASSESS, V73, P17, DOI 10.1023/A:1012659129083; Kull CA, 2007, SOC NATUR RESOUR, V20, P723, DOI 10.1080/08941920701329702; Lambin EF, 2010, LAND USE POLICY, V27, P108, DOI 10.1016/j.landusepol.2009.09.003; Leh MDK, 2013, AGR ECOSYST ENVIRON, V165, P6, DOI 10.1016/j.agee.2012.12.001; Locatelli B, 2014, ENVIRON CONSERV, V41, P27, DOI 10.1017/S0376892913000234; Locatelli B, 2011, REG ENVIRON CHANGE, V11, P393, DOI 10.1007/s10113-010-0149-x; Locatelli B, 2011, FORESTS, V2, P431, DOI 10.3390/f2010431; Locatelli B, 2009, FOREST ECOL MANAG, V258, P1864, DOI 10.1016/j.foreco.2009.01.015; Martinez ML, 2009, FOREST ECOL MANAG, V258, P1856, DOI 10.1016/j.foreco.2009.02.023; Mace GM, 2012, TRENDS ECOL EVOL, V27, P19, DOI 10.1016/j.tree.2011.08.006; Maes J, 2012, BIOL CONSERV, V155, P1, DOI 10.1016/j.biocon.2012.06.016; Maitre D. C. L., 2009, ECOSYSTEM SERVICES L, P14; Marchamalo M, 2007, ECOL ECON, V63, P740, DOI 10.1016/j.ecolecon.2007.01.006; MATHER AS, 1992, AREA, V24, P367; Mather AS, 1998, AREA, V30, P117, DOI 10.1111/j.1475-4762.1998.tb00055.x; Mendoza-Gonzalez G, 2012, ECOL ECON, V82, P23, DOI 10.1016/j.ecolecon.2012.07.018; Meyfroidt P., 2009, REFORESTING LANDSCAP, P315; Moran-Ordonez A, 2013, ECOSYSTEMS, V16, P765, DOI 10.1007/s10021-013-9649-0; Murrieta Arevalo E., 2006, CARACTERIZACION COBE; NASA LP DAAC, 2011, ASTER GLOB DIG EL MO; Nelson E, 2009, FRONT ECOL ENVIRON, V7, P4, DOI 10.1890/080023; Nelson E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014327; Nemec KT, 2013, BIODIVERS CONSERV, V22, P1, DOI 10.1007/s10531-012-0406-z; Pagella TF, 2014, LANDSCAPE ECOL, V29, P383, DOI 10.1007/s10980-013-9983-9; Pagiola S., 2006, PAYMENTS ENV SERVICE; Perz SG, 2007, PROF GEOGR, V59, P105, DOI 10.1111/j.1467-9272.2007.00594.x; Polasky S, 2011, ENVIRON RESOUR ECON, V48, P219, DOI 10.1007/s10640-010-9407-0; Pramova E, 2012, CLIM POLICY, V12, P393, DOI 10.1080/14693062.2011.647848; PREVDA, 2008, PLAN CUENC REV PAR 2; Putz FE, 2010, BIOTROPICA, V42, P10, DOI 10.1111/j.1744-7429.2009.00567.x; Raudsepp-Hearne C, 2010, P NATL ACAD SCI USA, V107, P5242, DOI 10.1073/pnas.0907284107; Redo DJ, 2012, P NATL ACAD SCI USA, V109, P8839, DOI 10.1073/pnas.1201664109; Renard D, 2015, P NATL ACAD SCI USA, V112, P13411, DOI 10.1073/pnas.1502565112; Rounsevell MDA, 2010, BIODIVERS CONSERV, V19, P2823, DOI 10.1007/s10531-010-9838-5; Rudel TK, 2005, GLOBAL ENVIRON CHANG, V15, P23, DOI 10.1016/j.gloenvcha.2004.11.001; Rudel TK, 2009, REFORESTING LANDSCAP; SADER SA, 1988, BIOTROPICA, V20, P11, DOI 10.2307/2388421; Safriel U., 2005, ECOSYSTEMS HUMAN WEL, P623; Sanchez-Azofeifa GA, 2007, CONSERV BIOL, V21, P1165, DOI 10.1111/j.1523-1739.2007.00751.x; Sharp R, 2014, INVEST 3 1 0 USERS G; Stem CJ, 2003, SOC NATUR RESOUR, V16, P387, DOI 10.1080/08941920309177; Swallow BM, 2009, ENVIRON SCI POLICY, V12, P504, DOI 10.1016/j.envsci.2008.11.003; Turner MG, 2013, LANDSCAPE ECOL, V28, P1081, DOI 10.1007/s10980-012-9741-4; Vignola R, 2010, DECISION MAKING FARM, P1132, DOI [10.1016/j.landusepol.2010.03.003, DOI 10.1016/J.LANDUSEP0L.2010.03.003]; Wang WJ, 2014, ENVIRON SCI POLICY, V44, P62, DOI 10.1016/j.envsci.2014.07.004; Willemen L, 2012, J ENVIRON MANAGE, V100, P86, DOI 10.1016/j.jenvman.2012.01.022; Wischmeier W. H., 1978, AGR HDB, V537, DOI DOI 10.1016/j.geomorph.2007.03.001; Wolff S, 2015, ECOL INDIC, V55, P159, DOI 10.1016/j.ecolind.2015.03.016; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Yackulic CB, 2011, ECOL SOC, V16, DOI 10.5751/ES-04275-160315; Zhang W, 2011, ENVIRON CONSERV, V38, P406, DOI 10.1017/S0376892911000555; Zomer R., 2006, CARBON LAND WATER GL	95	11	11	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158615	10.1371/journal.pone.0158615	http://dx.doi.org/10.1371/journal.pone.0158615			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27390869	Green Submitted, Green Published, gold			2022-12-27	WOS:000380005400090
J	Thakur, JS; Jeet, G; Pal, A; Singh, S; Singh, A; Deepti, SS; Lal, M; Gupta, S; Prasad, R; Jain, S; Saran, R				Thakur, J. S.; Jeet, Gursimer; Pal, Arnab; Singh, Shavinder; Singh, Amarjit; Deepti, S. S.; Lal, Mohan; Gupta, Sanjay; Prasad, Rajender; Jain, Sanjay; Saran, Rajiv			Profile of Risk Factors for Non-Communicable Diseases in Punjab, Northern India: Results of a State-Wide STEPS Survey	PLOS ONE			English	Article							SERUM TOTAL CHOLESTEROL; REFERENCE INTERVALS; PHYSICAL-ACTIVITY; LDL-CHOLESTEROL; HDL-CHOLESTEROL; SOUTH-ASIA; TRIGLYCERIDES; PREVALENCE; PATTERNS; OBESITY	Background Efforts to assess the burden of non-communicable diseases risk factors has improved in low and middle-income countries after political declaration of UN High Level Meeting on NCDs. However, lack of reliable estimates of risk factors distribution are leading to delay in implementation of evidence based interventions in states of India. Methods A STEPS Survey, comprising all the three steps for assessment of risk factors of NCDs, was conducted in Punjab state during 2014-15. A statewide multistage sample of 5,127 residents, aged 18-69 years, was taken. STEPS questionnaire version 3.1 was used to collect information on behavioral risk factors, followed by physical measurements and blood and urine sampling for biochemical profile. Results Tobacco and alcohol consumption were observed in 11.3% (20% men and 0.9% women) and 15% (27% men and 0.3% women) of the population, respectively. Low levels of physical activity were recorded among 31% (95% CI: 26.7-35.5) of the participants. The prevalence of overweight and obesity was 28.6% (95% CI: 26.3-30.9) and 12.8% (95% CI: 11.2-14.4) respectively. Central obesity was higher among women (69.3%, 95% CI: 66.5-72.0) than men (49.5%, 95% CI: 45.3-53.7). Prevalence of hypertension in population was 40.1% (95% CI: 37.3-43.0). The mean sodium intake in grams per day for the population was 7.4 gms (95% CI: 7.2-7.7). The prevalence of diabetes (hyperglycemia), hypertriglyceridemia and hypercholesterolemia was 14.3% (95% CI: 11.7-16.8), 21.6% (95% CI: 18.5-25.1) and 16.1% (95% CI: 13.1-19.2), respectively. In addition, 7% of the population aged 40-69 years had a cardiovascular risk of >= 30% over a period of next 10 years. Conclusion We report high prevalence of risk factors of chronic non-communicable diseases among adults in Punjab. There is an urgent need to implement population, individual and programme wide prevention and control interventions to lower the serious consequences of NCDs.	[Thakur, J. S.; Jeet, Gursimer] Post Grad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh, India; [Pal, Arnab; Prasad, Rajender] Post Grad Inst Med Educ & Res, Dept Biochem, Chandigarh, India; [Singh, Shavinder] Christian Med Coll & Hosp, Dept Community Med, Ludhiana, Punjab, India; [Singh, Amarjit] Govt Med Coll, Dept Community Med, Patiala, Punjab, India; [Deepti, S. S.; Lal, Mohan] Govt Med Coll, Dept Community Med, Amritsar, Punjab, India; [Gupta, Sanjay] Guru Gobind Singh Med Coll, Dept Community Med, Faridkot, India; [Jain, Sanjay] Post Grad Inst Med Educ & Res, Dept Internal Med, Chandigarh, India; [Saran, Rajiv] Univ Michigan, Dept Internal Med & Epidemiol, Ann Arbor, MI 48109 USA	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; University of Michigan System; University of Michigan	Thakur, JS (corresponding author), Post Grad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh, India.	jsthakur64@gmail.com	Pal, Arnab/B-6024-2012; Pal, Arnab/AAK-7311-2021	Pal, Arnab/0000-0002-0850-3118; Pal, Arnab/0000-0002-0850-3118; Jain, Sanjay K/0000-0002-9241-3114; /0000-0003-3727-9941	National Health Mission, Punjab, India; National Health Mission (Punjab), Ministry of Health and Family Welfare, Government of India	National Health Mission, Punjab, India; National Health Mission (Punjab), Ministry of Health and Family Welfare, Government of India	National Health Mission, Punjab, India, JST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We appreciate the support from Department of Health and Family welfare, Punjab especially Professor. KK Talwar, Advisor (Health), Government of Punjab, Ms. Vini Mahajan, IAS, Principal Secretary, Department of Health and Family Welfare and Mr. Hussan Lal, IAS, Secretary, Medical Education and Mission Director, National Health Mission, Punjab for their guidance and support for the project in conducting the study. Contributions by Biosense Pvt. Limited are acknowledged. We would like to thanks the members of Technical Advisory Committee and chairperson Prof. SK Jindal who provided technical oversight for the designing and implementation of survey. In addition inputs from advisors from University of Michigan were valuable. We sincerely acknowledge the financial support by National Health Mission (Punjab), Ministry of Health and Family Welfare, Government of India and technical support of WHO with special thanks to Dr. Dhirendra N Sinha, Regional Advisor (NCD and Tobacco Surveillance), WHO-SEARO and Dr. Lubna Bhatti, Epidemiologist, Prevention of Non-communicable Diseases (PND), World Health Organization, Geneva.	Anjana RM, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-26; Aryal KK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134834; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bhagyalaxmi A, 2013, J HEALTH POPUL NUTR, V31, P78; Devi BN, 2014, INDIAN J BASIC APPL, V4, P487; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Government of India, 2013, DISTR LEV HOUS FAC S; Institute for Health Metrics and Evaluation, 2010, GLOB BURD DIS STUD P; Jalali MT, 2013, INDIAN J CLIN BIOCHE, V28, P277, DOI 10.1007/s12291-012-0268-x; Jayawardena R, 2013, OBESITY FACTS, V6, P405, DOI 10.1159/000355598; Jayawardena R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-380; Kar SS, 2010, NATL MED J INDIA, V23, P206; Kaur V, 2012, INDIAN J CLIN BIOCHE, V27, P290, DOI 10.1007/s12291-012-0208-9; KISH L, 1949, J AM STAT ASSOC, V44, P380, DOI 10.2307/2280236; Kumar Rajesh, 2006, Indian Heart J, V58, P126; Kumaresan Kuppusamy, 2015, International Journal of Medicine and Public Health, V5, P253; Malati T, 2009, INDIAN J CLIN BIOCHE, V24, P343, DOI 10.1007/s12291-009-0063-5; [Ministry of Health and Family Welfare National Centre for Disease Control Government of India], 2015, INT DIS SURV PROGR; [Ministry of Health and Family Welfare Government of India International Institute for Population Sciences], 2009, GLOB AD TOB SURV GAT; Misra A, 2009, J Assoc Physicians India, V57, P163; Msyamboza KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020316; National Institute of Medical Statistics Indian Council of Medical Research (ICMR), 2009, IDSP NONC DIS RISK F; Nongkynrih Baridalyne, 2008, J Assoc Physicians India, V56, P165; PGIMER, 2014, BURD NCD RISK FACT P; Prinja S, 2012, INDIAN J MED RES, V136, P722; Registrar General of India, 2013, REP MED CERT CAUS DE; SGPC, 2006, SIKH REH MAR; Shah B, 2010, INDIAN J MED RES, V132, P634; Suryanarayana M.H., 2011, INEQUALITY ADJUSTED, P31; Thakur J, 2014, BURDEN NCD RISK FACT; Thakur J S, 2008, Int J Environ Res Public Health, V5, P399; Thakur Js, 2016, Asian Pac J Cancer Prev, V17, P791; Thomas MB, 2014, GLOBAL HEALTH ACTION, V7, P98, DOI 10.3402/gha.v7.22938; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Wilsnack RW, 2009, ADDICTION, V104, P1487, DOI 10.1111/j.1360-0443.2009.02696.x; World Health Organaisation, 2014, TIM LEST STEPS NONC, P2; World Health Organisation, 2014, BHUT NONC DIS RISK F, P2; World Health Organization, 2005, WHO STEPS SURV MAN W; Zaman MM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1938-4; Zendejas B, 2013, SURGERY, V153, P160, DOI 10.1016/j.surg.2012.06.025	40	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0157705	10.1371/journal.pone.0157705	http://dx.doi.org/10.1371/journal.pone.0157705			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27389020	gold, Green Published, Green Submitted			2022-12-27	WOS:000379811500008
J	Fujio, K; Obata, H; Kawashima, N; Nakazawa, K				Fujio, Kimiya; Obata, Hiroki; Kawashima, Noritaka; Nakazawa, Kimitaka			The Effects of Temporal and Spatial Predictions on Stretch Reflexes of Ankle Flexor and Extensor Muscles While Standing	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; TIBIALIS ANTERIOR MUSCLE; AUTOMATIC POSTURAL RESPONSES; SUPPORT-SURFACE; LEG MUSCLES; ELECTROMYOGRAPHIC RESPONSES; CORTICOSPINAL PATHWAYS; STANCE PERTURBATION; HUMAN WALKING; LOWER-LIMB	The purpose of the present study was to investigate how stretch reflex (SR) responses in the ankle extensor (soleus: SOL) and flexor (tibialis anterior: TA) muscles would be modulated with temporal and/or spatial predictions of external perturbations and whether their effects are specific to the standing posture. SR responses in the SOL/TA were elicited by imposing quick ankle toes-up/toes-down rotations while standing upright and in the supine position. We designed four experimental conditions based on pre-information about perturbations: no information (No Cue), the timing of the perturbation onset (TIM), the direction of the perturbation (DIR), and both the timing and direction of the perturbation (TIM/DIR). Each condition was separated and its order was counterbalanced. In the SR of TA evoked by toes-down rotation, integrated electromyography activities of the late component were significantly reduced in the TIM and TIM/DIR conditions as compared with those in the No Cue and DIR conditions. The occurrence rate of late SR components that reflects how often the reflex response was observed was also lower in the TIM and TIM/DIR conditions as compared with that in the No Cue and DIR conditions. On the other hand, no significant changes were seen among the four conditions in the early SR component in the TA and both SR components in the SOL. The same results in the occurrence rate were found in the supine position. The present results suggest (1) only temporal predictions have a remarkable effect on the SR excitability of the TA, and (2) this effect is independent of posture.	[Fujio, Kimiya; Obata, Hiroki; Nakazawa, Kimitaka] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Sports Sci Lab, Tokyo, Japan; [Kawashima, Noritaka] Res Inst Natl Rehabil Ctr Persons Disabil, Dept Rehabil Movement Funct, Tokorozawa, Saitama, Japan	University of Tokyo	Fujio, K (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Sports Sci Lab, Tokyo, Japan.	fujiokimiya@yahoo.co.jp						ACKERMANN H, 1991, NEUROSCI LETT, V127, P242, DOI 10.1016/0304-3940(91)90803-2; ARMSTRONG DM, 1988, J PHYSIOL-LONDON, V405, P1, DOI 10.1113/jphysiol.1988.sp017319; BECKLEY DJ, 1991, ELECTROEN CLIN NEURO, V81, P353, DOI 10.1016/0168-5597(91)90024-R; BROUWER B, 1995, ELECTROMYOGR MOTOR C, V97, P49, DOI 10.1016/0924-980X(94)00265-9; Burleigh A, 1996, J NEUROPHYSIOL, V75, P1619, DOI 10.1152/jn.1996.75.4.1619; Carpenter MG, 2004, J NEUROPHYSIOL, V92, P3255, DOI 10.1152/jn.01139.2003; Carpenter MG, 1999, EXP BRAIN RES, V129, P93, DOI 10.1007/s002210050940; Chong RKY, 1999, EXP BRAIN RES, V124, P513, DOI 10.1007/s002210050647; Christensen LOD, 2001, J PHYSIOL-LONDON, V531, P545, DOI 10.1111/j.1469-7793.2001.0545i.x; CORNA S, 1995, J PHYSIOL-LONDON, V484, P803, DOI 10.1113/jphysiol.1995.sp020705; DIENER HC, 1991, EXP BRAIN RES, V84, P219; DIETZ V, 1992, PHYSIOL REV, V72, P33, DOI 10.1152/physrev.1992.72.1.33; Geertsen SS, 2010, J PHYSIOL-LONDON, V588, P2391, DOI 10.1113/jphysiol.2010.190678; Gilles M, 1999, EXP BRAIN RES, V124, P137, DOI 10.1007/s002210050607; Gruneberg C, 2005, J NEUROPHYSIOL, V94, P3143, DOI 10.1152/jn.00538.2004; HAMMOND PH, 1956, BRIT MED BULL, V12, P214, DOI 10.1093/oxfordjournals.bmb.a069553; HANSEN PD, 1988, EXP BRAIN RES, V73, P627, DOI 10.1007/BF00406622; Haridas C, 2005, BRAIN RES, V1062, P48, DOI 10.1016/j.brainres.2005.09.003; Honeycutt CF, 2009, J NEUROPHYSIOL, V101, P2751, DOI 10.1152/jn.91040.2008; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369, DOI 10.1152/jn.1986.55.6.1369; HORAK FB, 1989, J NEUROPHYSIOL, V62, P841, DOI 10.1152/jn.1989.62.4.841; Hudson HM, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00033; Jackson ND, 2009, J ELECTROMYOGR KINES, V19, P75, DOI 10.1016/j.jelekin.2007.06.016; Kimura T, 2003, NEUROSCI LETT, V347, P25, DOI 10.1016/S0304-3940(03)00612-8; McChesney JW, 1996, EXP BRAIN RES, V108, P315; MOORE SP, 1988, EXP BRAIN RES, V73, P648, DOI 10.1007/BF00406624; Musienko P, 2012, J NEUROPHYSIOL, V107, P2072, DOI 10.1152/jn.00730.2011; Nakazawa K, 2003, NEUROSCI LETT, V338, P53, DOI 10.1016/S0304-3940(02)01353-8; Nakazawa K, 2009, J ELECTROMYOGR KINES, V19, P782, DOI 10.1016/j.jelekin.2008.01.002; NARDONE A, 1990, EXP BRAIN RES, V80, P323; NASHNER LM, 1976, EXP BRAIN RES, V26, P59; Petersen N, 1998, J PHYSIOL-LONDON, V512, P267, DOI 10.1111/j.1469-7793.1998.267bf.x; ROTHWELL JC, 1986, EXP BRAIN RES, V63, P197; ROTHWELL JC, 1980, NATURE, V286, P496, DOI 10.1038/286496a0; Schieppati M, 1997, J PHYSIOL-LONDON, V503, P691, DOI 10.1111/j.1469-7793.1997.691bg.x; SCHIEPPATI M, 1995, J PHYSIOL-LONDON, V487, P787, DOI 10.1113/jphysiol.1995.sp020918; Taube W, 2006, J APPL PHYSIOL, V101, P420, DOI 10.1152/japplphysiol.01447.2005; TOFT E, 1989, EXP BRAIN RES, V74, P213; van Doornik J, 2004, EXP BRAIN RES, V157, P403, DOI 10.1007/s00221-004-1966-2; WOOLLACOTT MH, 1984, EXP BRAIN RES, V55, P263; YAMAMOTO C, 1989, EXP BRAIN RES, V77, P12; Zuur AT, 2009, J PHYSIOL-LONDON, V587, P1669, DOI 10.1113/jphysiol.2009.169367	42	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158721	10.1371/journal.pone.0158721	http://dx.doi.org/10.1371/journal.pone.0158721			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27385043	Green Published, gold, Green Submitted			2022-12-27	WOS:000379809400079
J	Lowe, LC; Gaser, C; Franke, K				Loewe, Luise Christine; Gaser, Christian; Franke, Katja		Alzheimer's Dis Neuroimaging	The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease	PLOS ONE			English	Article							APOLIPOPROTEIN-E GENOTYPE; EPSILON 4 ALLELE; E TYPE-4 ALLELE; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; HIPPOCAMPAL ATROPHY; NATIONAL INSTITUTE; DECLINE; ONSET; MRI	In our aging society, diseases in the elderly come more and more into focus. An important issue in research is Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD) with their causes, diagnosis, treatment, and disease prediction. We applied the Brain Age Gap Estimation (BrainAGE) method to examine the impact of the Apolipoprotein E (APOE) genotype on structural brain aging, utilizing longitudinal magnetic resonance image (MRI) data of 405 subjects from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database. We tested for differences in neuroanatomical aging between carrier and non-carrier of APOE epsilon 4 within the diagnostic groups and for longitudinal changes in individual brain aging during about three years follow-up. We further examined whether a combination of BrainAGE and APOE status could improve prediction accuracy of conversion to AD in MCI patients. The influence of the APOE status on conversion from MCI to AD was analyzed within all allelic subgroups as well as for e4 carriers and non-carriers. The BrainAGE scores differed significantly between normal controls, stable MCI (sMCI) and progressive MCI (pMCI) as well as AD patients. Differences in BrainAGE changing rates over time were observed for APOE e4 carrier status as well as in the pMCI and AD groups. At baseline and during follow-up, BrainAGE scores correlated significantly with neuropsychological test scores in APOE e4 carriers and non-carriers, especially in pMCI and AD patients. Prediction of conversion was most accurate using the BrainAGE score as compared to neuropsychological test scores, even when the patient's APOE status was unknown. For assessing the individual risk of coming down with AD as well as predicting conversion from MCI to AD, the BrainAGE method proves to be a useful and accurate tool even if the information of the patient's APOE status is missing.	[Loewe, Luise Christine] Univ Jena, Fac Med, Jena, Germany; [Gaser, Christian; Franke, Katja] Univ Hosp Jena, Dept Neurol, Struct Brain Mapping Grp, Jena, Germany; [Gaser, Christian] Univ Hosp Jena, Dept Psychiat, Jena, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Franke, K (corresponding author), Univ Hosp Jena, Dept Neurol, Struct Brain Mapping Grp, Jena, Germany.	katja.franke@uni-jena.de	Gaser, Christian/F-5103-2010; Franke, Katja/S-7577-2017	Gaser, Christian/0000-0002-9940-099X; Franke, Katja/0000-0003-1859-5738	European Community [FB7 HEALTH Project (Brain Age)] [279281]; NATIONAL INSTITUTE ON AGING [U01AG024904] Funding Source: NIH RePORTER	European Community [FB7 HEALTH Project (Brain Age)]; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the European Community [FB7 HEALTH Project 279281 (Brain Age) to K.F.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar Carlos, 2014, Front Aging Neurosci, V6, P145, DOI 10.3389/fnagi.2014.00145; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Anderson VM, 2012, NEUROBIOL AGING, V33, P1194, DOI 10.1016/j.neurobiolaging.2010.11.001; [Anonymous], 1996, Lancet, V347, P1091; Apostolova LG, 2014, NEUROIMAGE-CLIN, V4, P461, DOI 10.1016/j.nicl.2013.12.012; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Basso M, 2006, NEUROBIOL AGING, V27, P1416, DOI 10.1016/j.neurobiolaging.2005.08.002; Berlau DJ, 2009, NEUROLOGY, V72, P829, DOI 10.1212/01.wnl.0000343853.00346.a4; Bertram L, 2004, PHARMACOL RES, V50, P385, DOI 10.1016/j.phrs.2003.11.018; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Bigler ED, 2000, AM J NEURORADIOL, V21, P1857; Boissonneault GA, 2010, JAAPA-J AM ACAD PHYS, V23, P21; Boissonneault Gilbert A, 2010, JAAPA, V23, P21; Brouwers N, 2008, ANN MED, V40, P562, DOI 10.1080/07853890802186905; COCKRELL JR, 1988, PSYCHOPHARMACOL BULL, V24, P689; CORDER EH, 1995, NEUROLOGY, V45, P1323, DOI 10.1212/WNL.45.7.1323; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cosentino S, 2008, NEUROLOGY, V70, P1842, DOI 10.1212/01.wnl.0000304038.37421.cc; Cuadra MB, 2005, IEEE T MED IMAGING, V24, P1548, DOI 10.1109/TMI.2005.857652; Davatzikos C, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.023; Davatzikos C, 2009, BRAIN, V132, P2026, DOI 10.1093/brain/awp091; Desikan RS, 2008, NEUROLOGY, V71, P819, DOI 10.1212/01.wnl.0000320055.57329.34; Driscoll I, 2009, NEUROLOGY, V72, P1906, DOI 10.1212/WNL.0b013e3181a82634; Dukart J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022193; Fotenos AF, 2005, NEUROLOGY, V64, P1032, DOI 10.1212/01.WNL.0000154530.72969.11; Franke K, 2012, GEROPSYCH, V25, P235, DOI 10.1024/1662-9647/a000074; Franke K, 2010, NEUROIMAGE, V50, P883, DOI 10.1016/j.neuroimage.2010.01.005; Franko E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071354; Gaser C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067346; Genin E, 2011, MOL PSYCHIATR, V16, P903, DOI 10.1038/mp.2011.52; Growdon JH, 1996, NEUROLOGY, V47, P444, DOI 10.1212/WNL.47.2.444; Hinrichs C, 2009, NEUROIMAGE, V48, P138, DOI 10.1016/j.neuroimage.2009.05.056; Hirono N, 2003, J NEUROPSYCH CLIN N, V15, P354, DOI 10.1176/appi.neuropsych.15.3.354; Holmes C, 1996, J NEUROL NEUROSUR PS, V61, P580, DOI 10.1136/jnnp.61.6.580; Honea RA, 2009, J ALZHEIMERS DIS, V18, P553, DOI 10.3233/JAD-2009-1163; Hoyt BD, 2005, ARCH NEUROL-CHICAGO, V62, P454, DOI 10.1001/archneur.62.3.454; Hua X, 2009, NEUROIMAGE, V48, P668, DOI 10.1016/j.neuroimage.2009.07.011; Jack CR, 2008, NEUROLOGY, V70, P1740, DOI 10.1212/01.wnl.0000281688.77598.35; Jack CR, 2010, BRAIN, V133, P3336, DOI 10.1093/brain/awq277; Jack CR, 1998, ANN NEUROL, V43, P303, DOI 10.1002/ana.410430307; Jack CR, 2004, NEUROLOGY, V62, P591, DOI 10.1212/01.WNL.0000110315.26026.EF; Jicha GA, 2006, ARCH NEUROL-CHICAGO, V63, P674, DOI 10.1001/archneur.63.5.674; Jones DT, 2011, NEUROLOGY, V77, P1524, DOI 10.1212/WNL.0b013e318233b33d; Karas GB, 2004, NEUROIMAGE, V23, P708, DOI 10.1016/j.neuroimage.2004.07.006; Kester Maartje I, 2009, Pract Neurol, V9, P241, DOI 10.1136/jnnp.2009.182477; Kurz A, 1996, J NEUROL, V243, P452, DOI 10.1007/BF00900498; Lehtovirta M, 1996, J NEUROL NEUROSUR PS, V60, P644, DOI 10.1136/jnnp.60.6.644; Liddell MB, 2001, BRIT J PSYCHIAT, V178, P7, DOI 10.1192/bjp.178.1.7; Manning E, 2014, TECHNOL LIVED ABSTR, P1; Martins CAR, 2005, NEUROLOGY, V65, P1888, DOI 10.1212/01.wnl.0000188871.74093.12; Mayeux R, 1998, NEW ENGL J MED, V338, P506, DOI 10.1056/NEJM199802193380804; Meyer MR, 1998, NAT GENET, V19, P321, DOI 10.1038/1206; MOHS RC, 1988, PSYCHOPHARMACOL BULL, V24, P627; Mori E, 2002, ANN NEUROL, V51, P209, DOI 10.1002/ana.10093; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Mortimer JA, 2009, ALZ DIS ASSOC DIS, V23, P152, DOI 10.1097/WAD.0b013e318190a855; NALBANTOGLU J, 1994, ANN NEUROL, V36, P889, DOI 10.1002/ana.410360614; Olichney JM, 1996, NEUROLOGY, V47, P190, DOI 10.1212/WNL.47.1.190; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Querbes O, 2009, BRAIN, V132, P2036, DOI 10.1093/brain/awp105; Rajapakse JC, 1997, IEEE T MED IMAGING, V16, P176, DOI 10.1109/42.563663; ROSES AD, 1994, LANCET, V343, P1564, DOI 10.1016/S0140-6736(94)92960-2; Saunders AM, 2000, J NEUROPATH EXP NEUR, V59, P751, DOI 10.1093/jnen/59.9.751; Sluimer JD, 2009, EUR RADIOL, V19, P2826, DOI 10.1007/s00330-009-1512-5; SOBEL E, 1995, NEUROLOGY, V45, P903, DOI 10.1212/WNL.45.5.903; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Spulber G, 2010, NEUROBIOL AGING, V31, P1601, DOI 10.1016/j.neurobiolaging.2008.08.018; Stern Y, 2003, J CLIN EXP NEUROPSYC, V25, P691, DOI 10.1076/jcen.25.5.691.14573; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stern Y, 1997, ANN NEUROL, V41, P615, DOI 10.1002/ana.410410510; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Susanto TAK, 2015, J ALZHEIMERS DIS, V45, P253, DOI 10.3233/JAD-142451; Thakkinstian A, 2006, AM J EPIDEMIOL, V164, P813, DOI 10.1093/aje/kwj279; Tipping ME, 2000, ADV NEUR IN, V12, P652; Tohka J, 2004, NEUROIMAGE, V23, P84, DOI 10.1016/j.neuroimage.2004.05.007; Tsuang D, 1999, ARCH NEUROL-CHICAGO, V56, P1489, DOI 10.1001/archneur.56.12.1489; UTERMANN G, 1980, AM J HUM GENET, V32, P339; Walhovd KB, 2010, AM J NEURORADIOL, V31, P347, DOI 10.3174/ajnr.A1809; Wilson RS, 2011, ARCH NEUROL-CHICAGO, V68, P351, DOI 10.1001/archneurol.2011.31; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Yu L, 2013, PSYCHOL AGING, V28, P1015, DOI 10.1037/a0031642; ZANNIS VI, 1981, AM J HUM GENET, V33, P11	84	62	63	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0157514	10.1371/journal.pone.0157514	http://dx.doi.org/10.1371/journal.pone.0157514			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410431	Green Published, gold, Green Submitted			2022-12-27	WOS:000379508300011
J	Pandey, S; Patel, MK; Mishra, A; Jha, B				Pandey, Sonika; Patel, Manish Kumar; Mishra, Avinash; Jha, Bhavanath			In planta Transformed Cumin (Cuminum cyminum L.) Plants, Overexpressing the SbNHX1 Gene Showed Enhanced Salt Endurance	PLOS ONE			English	Article							VACUOLAR NA+/H+ ANTIPORTER; SALICORNIA-BRACHIATA; ARABIDOPSIS-THALIANA; EXTINCTION COEFFICIENTS; SEED TRANSFORMATION; TISSUE-CULTURE; CHLOROPHYLL-A; REGENERATION; STRESS; EXPRESSION	Cumin is an annual, herbaceous, medicinal, aromatic, spice glycophyte that contains diverse applications as a food and flavoring additive, and therapeutic agents. An efficient, less time consuming, Agrobacterium-mediated, a tissue culture-independent in planta genetic transformation method was established for the first time using cumin seeds. The SbNHX1 gene, cloned from an extreme halophyte Salicornia brachiata was transformed in cumin using optimized in planta transformation method. The SbNHX1 gene encodes a vacuolar Na+/H+ antiporter and is involved in the compartmentalization of excess Na+ ions into the vacuole and maintenance of ion homeostasis Transgenic cumin plants were confirmed by PCR using gene (SbNHX1, uidA and hptII) specific primers. The single gene integration event and overexpression of the gene were confirmed by Southern hybridization and competitive RT-PCR, respectively. Transgenic lines L3 and L13 showed high expression of the SbNHX1 gene compared to L6 whereas moderate expression was detected in L5 and L10 transgenic lines. Transgenic lines (L3, L5, L10 and L13), overexpressing the SbNHX1 gene, showed higher photosynthetic pigments (chlorophyll a, b and carotenoid), and lower electrolytic leakage, lipid peroxidation (MDA content) and proline content as compared to wild type plants under salinity stress. Though transgenic lines were also affected by salinity stress but performed better compared to WT plants. The ectopic expression of the SbNHX1 gene confirmed enhanced salinity stress tolerance in cumin as compared to wild type plants under stress condition. The present study is the first report of engineering salt tolerance in cumin, so far and the plant may be utilized for the cultivation in saline areas.	[Pandey, Sonika; Patel, Manish Kumar; Mishra, Avinash; Jha, Bhavanath] CSIR Cent Salt & Marine Chem Res Inst, Marine Biotechnol & Ecol Div, GB Marg, Bhavnagar 364002, Gujarat, India; [Pandey, Sonika; Mishra, Avinash; Jha, Bhavanath] Acad Sci & Innovat Res, CSIR, New Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Salt & Marine Chemical Research Institute (CSMCRI); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India	Mishra, A; Jha, B (corresponding author), CSIR Cent Salt & Marine Chem Res Inst, Marine Biotechnol & Ecol Div, GB Marg, Bhavnagar 364002, Gujarat, India.; Mishra, A; Jha, B (corresponding author), Acad Sci & Innovat Res, CSIR, New Delhi, India.	avinash@csmcri.org; bjha@csmcri.org	Mishra, Avinash/C-3210-2009; Patel, Manish Kumar/I-6335-2017; Mishra, Avinash/AAG-2961-2019	Mishra, Avinash/0000-0003-0342-010X; Patel, Manish Kumar/0000-0001-5250-1008; Mishra, Avinash/0000-0003-0342-010X	Council of Scientific and Industrial Research (CSIR); Government of India, New Delhi [BSC0107-PlaGen]	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Government of India, New Delhi	This study was supported by the Council of Scientific and Industrial Research (CSIR; www.csir.res.in), Government of India, New Delhi [BSC0107-PlaGen]. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	ADAMS P, 1992, PLANT CELL PHYSIOL, V33, P1215; Ahmad P., 2016, PLANT ENV INTERACTIO; Alireza Bahraminejad, 2012, Australian Journal of Crop Science, V6, P194; Bai JJ, 2013, PROTOC EXCH, DOI [10.1038/protex.2013.067, DOI 10.1038/PROTEX.2013.067]; Bairu MW, 2011, PLANT GROWTH REGUL, V63, P147, DOI 10.1007/s10725-010-9554-x; Bairwa RK., 2015, INT J SEED SPICES, V5, P68; Barampuram S, 2011, METHODS MOL BIOL, V701, P1, DOI 10.1007/978-1-61737-957-4_1; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; BRAUN AC, 1952, GROWTH, V16, P65; Chaturvedi AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111379; Demidchik V, 2014, J EXP BOT, V65, P1259, DOI 10.1093/jxb/eru004; Ebrahimie E, 2006, IN VITRO CELL DEV-PL, V42, P455, DOI 10.1079/IVP2006789; EVANS DA, 1986, BIO-TECHNOL, V4, P528, DOI 10.1038/nbt0686-528; FELDMANN KA, 1987, MOL GEN GENET, V208, P1, DOI 10.1007/BF00330414; Gordon-Kamm W, 2002, P NATL ACAD SCI USA, V99, P11975, DOI 10.1073/pnas.142409899; Hassanzadehdelouei M., 2013, Cercetari Agronomice in Moldova, V46, P89; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Hunault H, 1989, BIOTECHNOLOGY AGR FO, P185; INSKEEP WP, 1985, PLANT PHYSIOL, V77, P483, DOI 10.1104/pp.77.2.483; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jha B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071136; Jha B, 2012, J AGR FOOD CHEM, V60, P4320, DOI 10.1021/jf203632v; Jha B, 2011, MOL BIOL REP, V38, P4823, DOI 10.1007/s11033-010-0625-x; Johri R K, 2011, Pharmacogn Rev, V5, P63, DOI 10.4103/0973-7847.79101; Joshi M, 2012, IND CROP PROD, V35, P313, DOI 10.1016/j.indcrop.2011.06.024; Joshi M, 2011, IND CROP PROD, V33, P67, DOI 10.1016/j.indcrop.2010.09.002; Kabak B, 2017, CRIT REV FOOD SCI, V57, P18, DOI 10.1080/10408398.2013.772891; Kaefer CM, 2008, J NUTR BIOCHEM, V19, P347, DOI 10.1016/j.jnutbio.2007.11.003; Koocheki A., 2008, Journal of Herbs, Spices & Medicinal Plants, V14, P37, DOI 10.1080/10496470802341201; Lal R, 2011, WORLD SOIL RESOURCES; LARKIN PJ, 1981, THEOR APPL GENET, V60, P197, DOI 10.1007/BF02342540; Lin JZ, 2009, PLANT CELL REP, V28, P1065, DOI 10.1007/s00299-009-0706-2; Lutts S, 1996, ANN BOT-LONDON, V78, P389, DOI 10.1006/anbo.1996.0134; Mayavan S, 2013, PLANT CELL REP, V32, P1557, DOI 10.1007/s00299-013-1467-5; Meena RS, 2015, INT J SEED SPICES, V5, P99; Mishra A, 2008, MOL BIOL REP, V35, P81, DOI 10.1007/s11033-007-9056-8; Mishra A, 2015, J FUNCT FOODS, V13, P21, DOI 10.1016/j.jff.2014.12.027; Mishra A, 2013, CARBOHYD POLYM, V92, P1942, DOI 10.1016/j.carbpol.2012.11.055; Moore K, 1998, FREE RADICAL RES, V28, P659, DOI 10.3109/10715769809065821; Morshedi D, 2015, J FOOD SCI, V80, pH2336, DOI 10.1111/1750-3841.13016; PADAN E, 1994, J EXP BIOL, V196, P443; Pandey S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144469; Pandey S, 2013, APPL BIOCHEM BIOTECH, V171, P1, DOI 10.1007/s12010-013-0349-1; Park BJ, 2005, PLANT CELL REP, V24, P494, DOI 10.1007/s00299-005-0973-5; Patel MK, 2015, PLANT CELL TISS ORG, V122, P477, DOI 10.1007/s11240-015-0785-4; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Qadir M, 2014, NAT RESOUR FORUM, V38, P282, DOI 10.1111/1477-8947.12054; Rebey IB, 2012, J FOOD SCI, V77, pC734, DOI 10.1111/j.1750-3841.2012.02731.x; Rengasamy P, 2002, AUST J EXP AGR, V42, P351, DOI 10.1071/EA01111; SANGWAN RS, 1992, PLANTA, V188, P439, DOI 10.1007/BF00192812; Sankara Rao K, 2008, Physiol Mol Biol Plants, V14, P321, DOI 10.1007/s12298-008-0030-2; Shao HB, 2008, CR BIOL, V331, P215, DOI 10.1016/j.crvi.2008.01.002; Shoor M, 2014, RES J AGR ENV MANAGE, V3, P340; Singh N, 2014, GENE, V547, P119, DOI 10.1016/j.gene.2014.06.037; Singh N, 2014, MAR BIOTECHNOL, V16, P321, DOI 10.1007/s10126-013-9548-6; Singh N, 2010, PLANT CELL TISS ORG, V103, P1, DOI 10.1007/s11240-010-9746-0; Sottosanto JB, 2004, PLANT J, V40, P752, DOI 10.1111/j.1365-313X.2004.02253.x; Sottosanto JB, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-18; Sowbhagya HB, 2013, CRIT REV FOOD SCI, V53, P1, DOI 10.1080/10408398.2010.500223; Subramanyam K, 2013, APPL BIOCHEM BIOTECH, V171, P450, DOI 10.1007/s12010-013-0359-z; TIWARI V, 2015, PLOS ONE, V10, DOI DOI 10.1371/JOURNAL.PONE.0131567; Tiwari V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148494; Tiwari V, 2015, APPL BIOCHEM BIOTECH, V175, P436, DOI 10.1007/s12010-014-1286-3; Tiwari V, 2014, PLANT CELL PHYSIOL, V55, P201, DOI 10.1093/pcp/pct172; Udawat P, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00518; Verma D, 2007, J BIOSCIENCES, V32, P621, DOI 10.1007/s12038-007-0061-9; Wei J, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/474509	68	13	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159349	10.1371/journal.pone.0159349	http://dx.doi.org/10.1371/journal.pone.0159349			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27411057	Green Published, gold, Green Submitted			2022-12-27	WOS:000379508300080
J	Dejene, SW; Heitkonig, IMA; Prins, HHT; Lemma, FA; Mekonnen, DA; Alemu, ZE; Kelkay, TZ; de Boer, WF				Dejene, Sintayehu W.; Heitkonig, Ignas M. A.; Prins, Herbert H. T.; Lemma, Fitsum A.; Mekonnen, Daniel A.; Alemu, Zelalem E.; Kelkay, Tessema Z.; de Boer, Willem F.			Risk Factors for Bovine Tuberculosis (bTB) in Cattle in Ethiopia	PLOS ONE			English	Article							LIVESTOCK/WILDLIFE INTERFACE AREAS; MYCOBACTERIUM-BOVIS; INDIGENOUS CATTLE; PREVALENCE; MANAGEMENT; INFECTION; EPIDEMIOLOGY; TRANSHUMANT; INSPECTION; HUSBANDRY	Bovine tuberculosis (bTB) infection is generally correlated with individual cattle's age, sex, body condition, and with husbandry practices such as herd composition, cattle movement, herd size, production system and proximity to wildlife-including bTB maintenance hosts. We tested the correlation between those factors and the prevalence of bTB, which is endemic in Ethiopia's highland cattle, in the Afar Region and Awash National Park between November 2013 and April 2015. A total of 2550 cattle from 102 herds were tested for bTB presence using the comparative intradermal tuberculin test (CITT). Data on herd structure, herd movement, management and production system, livestock transfer, and contact with wildlife were collected using semi-structured interviews with cattle herders and herd owners. The individual overall prevalence of cattle bTB was 5.5%, with a herd prevalence of 46%. Generalized Linear Mixed Models with a random herd-effect were used to analyse risk factors of cattle reactors within each herd. The older the age of the cattle and the lower the body condition the higher the chance of a positive bTB test result, but sex, lactation status and reproductive status were not correlated with bTB status. At herd level, General Linear Models showed that pastoral production systems with transhumant herds had a higher bTB prevalence than sedentary herds. A model averaging analysis identified herd size, contact with wildlife, and the interaction of herd size and contact with wildlife as significant risk factors for bTB prevalence in cattle. A subsequent Structural Equation Model showed that the probability of contact with wildlife was influenced by herd size, through herd movement. Larger herds moved more and grazed in larger areas, hence the probability of grazing in an area with wildlife and contact with either infected cattle or infected wildlife hosts increased, enhancing the chances for bTB infection. Therefore, future bTB control strategies in cattle in pastoral areas should consider herd size and movement as important risk factors.	[Dejene, Sintayehu W.; Heitkonig, Ignas M. A.; Prins, Herbert H. T.; de Boer, Willem F.] Wageningen Univ, Resource Ecol Grp, Wageningen, Netherlands; [Dejene, Sintayehu W.; Alemu, Zelalem E.; Kelkay, Tessema Z.] Haramaya Univ, Coll Agr & Environm Sci, Dire Dawa, Ethiopia; [Lemma, Fitsum A.; Mekonnen, Daniel A.] Haramaya Univ, Coll Vet Med, Dire Dawa, Ethiopia	Wageningen University & Research; Haramaya University; Haramaya University	Dejene, SW (corresponding author), Wageningen Univ, Resource Ecol Grp, Wageningen, Netherlands.; Dejene, SW (corresponding author), Haramaya Univ, Coll Agr & Environm Sci, Dire Dawa, Ethiopia.	sintekal@gmail.com		Prins, Herbert/0000-0003-1131-5107; Heitkonig, Ignas/0000-0001-7771-3111	NUFFIC through Wageningen University	NUFFIC through Wageningen University	The authors are grateful to NUFFIC for the financial support of the PhD scholarship through Wageningen University for the first author. The authors thank Haramaya University for the logistical support.	Afar National Regional State, 2009, AF NAT REG STAT PROG; Ameni G., 2003, International Journal of Applied Research in Veterinary Medicine, V1, P17; Ameni G, 2007, CLIN VACCINE IMMUNOL, V14, P1356, DOI 10.1128/CVI.00205-07; Anderson DR, 2000, J WILDLIFE MANAGE, V64, P912, DOI 10.2307/3803199; [Anonymous], [No title captured]; Asseged B, 2004, TROP ANIM HEALTH PRO, V36, P537, DOI 10.1023/B:TROP.0000040934.32330.44; Ayele WY, 2004, INT J TUBERC LUNG D, V8, P924; Bernard F, 2005, PREV VET MED, V67, P267, DOI 10.1016/j.prevetmed.2004.11.002; Boland F, 2010, PREV VET MED, V93, P153, DOI 10.1016/j.prevetmed.2009.09.021; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [10.1007/b97636, DOI 10.1007/B97636]; Caron A, 2003, ECOL APPL, V13, P1338, DOI 10.1890/02-5266; Central Statistical Agency, 2008, STAT B, V388; Chalmers RP, 2012, J STAT SOFTW, V48, P1; Cleaveland S, 2001, PHILOS T R SOC B, V356, P991, DOI 10.1098/rstb.2001.0889; Cleaveland S, 2007, TUBERCULOSIS, V87, P30, DOI 10.1016/j.tube.2006.03.001; Cook AJC, 1996, BRIT VET J, V152, P37, DOI 10.1016/S0007-1935(96)80084-4; Corner LAL, 2006, VET MICROBIOL, V112, P303, DOI 10.1016/j.vetmic.2005.11.015; Cosivi O, 1998, EMERG INFECT DIS, V4, P59, DOI 10.3201/eid0401.980108; Davies J, 2007, J DEV STUD, V43, P490, DOI 10.1080/00220380701204422; De Garine-Wichatitsky M, 2013, EPIDEMIOL INFECT, V141, P1342, DOI 10.1017/S0950268813000708; de Lisle GW, 2002, REV SCI TECH OIE, V21, P317, DOI 10.20506/rst.21.2.1339; De Vos V, 2001, ONDERSTEPOORT J VET, V68, P119; Ethiopian Meteorological Agency, 2013, MEAN MONTHL RAINF 19; Faye B., 2005, PREV VET MED, V67, p267 , DOI DOI 10.1016/J.PREVETMED.2004.11.002; Fetene T, 2009, TROP ANIM HEALTH PRO, V41, P273, DOI 10.1007/s11250-008-9186-6; Franks P, 2003, AWASH CONSERVATION D, P1; Gopal R, 2006, VET REC, V159, P265, DOI 10.1136/vr.159.9.265; Gumi B, 2011, TROP ANIM HEALTH PRO, V43, P1081, DOI 10.1007/s11250-010-9777-x; Hermandez J, J AM VET MED ASS, V213, P851; Huang ZYX, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0624; Humblet MF, 2009, VET RES, V40, DOI 10.1051/vetres/2009033; Inangolet FO, 2008, TROP ANIM HEALTH PRO, V40, P501, DOI 10.1007/s11250-007-9126-x; Johnston WT, 2011, INT J INFECT DIS, V15, pE833, DOI 10.1016/j.ijid.2011.08.004; Kaneene JB, 2002, J AM VET MED ASSOC, V221, P837, DOI 10.2460/javma.2002.221.837; Kassa B., 2005, J RURAL DEVELOP, V28, p[2, 185]; Katale BZ, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-267; Kazwala RR, 2001, VET RES COMMUN, V25, P609, DOI 10.1023/A:1012757011524; Keet DF, 2001, ONDERSTEPOORT J VET, V68, P225; Mamo G, 2013, J VET MED ANIM HLTH, V5, P171; Marangon S, 1998, PREV VET MED, V34, P87, DOI 10.1016/S0167-5877(97)00087-1; Menzies FD, 2000, VET J, V160, P92, DOI 10.1053/tvjl.2000.0482; Mfinanga S G M, 2004, East Afr Med J, V81, P171; Moritz M, 2013, HUM ECOL, V41, P205, DOI 10.1007/s10745-012-9546-8; Munyeme M, 2009, TROP ANIM HEALTH PRO, V41, P345, DOI 10.1007/s11250-008-9195-5; Munyeme M, 2008, PREV VET MED, V85, P317, DOI 10.1016/j.prevetmed.2008.03.006; Munyeme M, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-21; Nieminen P.L., 2013, EPIDEMIOLOGY BIOSTAT, V10, P1, DOI DOI 10.2427/8854; NOLAN A, 1994, VET MICROBIOL, V40, P179, DOI 10.1016/0378-1135(94)90054-X; O'Brien DJ, 2011, VET MICROBIOL, V151, P23, DOI 10.1016/j.vetmic.2011.02.022; Office International des Epizooties, 2009, TERR MAN BOV TUB; Oloya J, 2007, PREV VET MED, V80, P318, DOI 10.1016/j.prevetmed.2007.03.004; Preston DL, 2012, ECOLOGY, V93, P1254, DOI 10.1890/11-1821.1; Prins Herbert H.T., 2000, Conservation Biology Series (Dordrecht), V12, P51; Rahman M. A., 2008, Bangladesh Journal of Veterinary Medicine, V6, P175; Regassa A, 2008, VET J, V178, P119, DOI 10.1016/j.tvjl.2007.06.019; Reilly LA, 2007, PREV VET MED, V80, P129, DOI 10.1016/j.prevetmed.2007.02.002; Renwick AR, 2007, EPIDEMIOL INFECT, V135, P529, DOI 10.1017/S0950268806007205; Sitters J, 2009, BIOL CONSERV, V142, P738, DOI 10.1016/j.biocon.2008.12.001; Skuce Robin A, 2012, Vet Med Int, V2012, P621210, DOI 10.1155/2012/621210; Teklu A, 2004, REV SCI TECH OIE, V23, P957, DOI 10.20506/rst.23.3.1534; Thrusfield M., 2005, VET EPIDEMIOLOGY; Tschopp R, 2010, J WILDLIFE DIS, V46, P753, DOI 10.7589/0090-3558-46.3.753; Tschopp R, 2009, PREV VET MED, V89, P205, DOI 10.1016/j.prevetmed.2009.02.006	63	31	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0159083	10.1371/journal.pone.0159083	http://dx.doi.org/10.1371/journal.pone.0159083			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27404387	Green Submitted, gold, Green Published			2022-12-27	WOS:000379508200033
J	Jia, P; Anderson, JD; Leitner, M; Rheingans, R				Jia, Peng; Anderson, John D.; Leitner, Michael; Rheingans, Richard			High-Resolution Spatial Distribution and Estimation of Access to Improved Sanitation in Kenya	PLOS ONE			English	Article							DIARRHEA; IMPACT; INFECTION	Background Access to sanitation facilities is imperative in reducing the risk of multiple adverse health outcomes. A distinct disparity in sanitation exists among different wealth levels in many lowincome countries, which may hinder the progress across each of the Millennium Development Goals. Methods The surveyed households in 397 clusters from 2008-2009 Kenya Demographic and Health Surveys were divided into five wealth quintiles based on their national asset scores. A series of spatial analysis methods including excess risk, local spatial autocorrelation, and spatial interpolation were applied to observe disparities in coverage of improved sanitation among different wealth categories. The total number of the population with improved sanitation was estimated by interpolating, time-adjusting, and multiplying the surveyed coverage rates by high-resolution population grids. A comparison was then made with the annual estimates from United Nations Population Division and World Health Organization /United Nations Children's Fund Joint Monitoring Program for Water Supply and Sanitation. Results The Empirical Bayesian Kriging interpolation produced minimal root mean squared error for all clusters and five quintiles while predicting the raw and spatial coverage rates of improved sanitation. The coverage in southern regions was generally higher than in the north and east, and the coverage in the south decreased from Nairobi in all directions, while Nyanza and North Eastern Province had relatively poor coverage. The general clustering trend of high and low sanitation improvement among surveyed clusters was confirmed after spatial smoothing. Conclusions There exists an apparent disparity in sanitation among different wealth categories across Kenya and spatially smoothed coverage rates resulted in a closer estimation of the available statistics than raw coverage rates. Future intervention activities need to be tailored for both different wealth categories and nationally where there are areas of greater needs when resources are limited.	[Jia, Peng] Univ Twente, Fac Geoinformat Sci & Earth Observat ITC, NL-7500 Enschede, Netherlands; [Anderson, John D.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Anderson, John D.] Univ Florida, Dept Environm & Global Hlth, Gainesville, FL USA; [Leitner, Michael] Louisiana State Univ, Dept Geog & Anthropol, Baton Rouge, LA 70803 USA; [Leitner, Michael] Salzburg Univ, Dept Geoinformat Z GIS, Salzburg, Austria; [Rheingans, Richard] Appalachian State Univ, Goodnight Sustainable Dev Dept, Boone, NC 28608 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Louisiana State University System; Louisiana State University; Salzburg University; University of North Carolina; Appalachian State University	Jia, P (corresponding author), Univ Twente, Fac Geoinformat Sci & Earth Observat ITC, NL-7500 Enschede, Netherlands.; Rheingans, R (corresponding author), Appalachian State Univ, Goodnight Sustainable Dev Dept, Boone, NC 28608 USA.	jiapengff@hotmail.com; rheingansrd@appstate.edu	Jia, Peng/K-1446-2017; Rheingans, Richard D/P-1638-2017	Jia, Peng/0000-0003-0110-3637; Anderson, John/0000-0003-0840-9890	UK aid from the Department for International Development (DfID), SHARE research programme; Austrian Science Fund (FWF) through the Doctoral College GIScience [DK W 1237-N23]	UK aid from the Department for International Development (DfID), SHARE research programme; Austrian Science Fund (FWF) through the Doctoral College GIScience(Austrian Science Fund (FWF))	The research was funded by UK aid from the Department for International Development (DfID), as part of the SHARE (www.SHAREreseamh.org) research programme and the Austrian Science Fund (FWF) through the Doctoral College GIScience (DK W 1237-N23).	Andersson Neil, 2006, Int J Health Geogr, V5, P1, DOI 10.1186/1476-072X-5-1; Andrade IG, 2009, T ROY SOC TROP MED H, V103, P506, DOI 10.1016/j.trstmh.2008.12.017; Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x; Barreto ML, 2010, ENVIRON HEALTH PERSP, V118, P1637, DOI 10.1289/ehp.1002058; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Bohra Alpana, 2001, Dengue Bulletin, V25, P92; Carvajal L., 2006, HUMAN DEV REPORT 200; Clasen T, 2007, BMJ-BRIT MED J, V334, P782, DOI 10.1136/bmj.39118.489931.BE; DANIELS DL, 1990, B WORLD HEALTH ORGAN, V68, P455; DeBarros RP, 2009, MEASURING INEQUALITY OF OPPORTUNITIES IN LATIN AMERICA AND THE CARIBBEAN, P1, DOI 10.1596/978-0-8213-7745-1; Dreibelbis R, 2013, INT J EDUC DEV, V33, P457, DOI 10.1016/j.ijedudev.2012.07.002; English PB, 2003, SOC SCI MED, V56, P2073, DOI 10.1016/S0277-9536(02)00202-2; ESREY SA, 1991, B WORLD HEALTH ORGAN, V69, P609; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Freeman M. C., 2012, Waterlines, V31, P226, DOI 10.3362/1756-3488.2012.023; Gent DH, 2004, PLANT DIS, V88, P446, DOI 10.1094/PDIS.2004.88.5.446; Greene LE, 2012, AM J TROP MED HYG, V87, P385, DOI 10.4269/ajtmh.2012.11-0633; Humphrey JH, 2009, LANCET, V374, P1032, DOI 10.1016/S0140-6736(09)60950-8; ICF International, 2012, DEM HLTH SURV SAMPL; Jackson B., 2004, SANITATION HYGIENE K; Kenya national Bureau of statistics (KNBS) and ICF macro, 2010, KEN DEM HLTH SURV 20; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Krivoruchko Konstantin, 2012, EMPIRICAL BAYESIAN K; Lee L, 1997, J ECONOMETRICS; Mara D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000363; Norman G, 2010, LANCET INFECT DIS, V10, P536, DOI 10.1016/S1473-3099(10)70123-7; Rheingans R., 2012, ESTIMATING INEQUITIE; Rutstein S.O., 2004, DHS COMP REPORTS; StataCorp, 2011, STAT STAT SOFTW REL; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Tatem AJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001298; TOBLER WR, 1970, ECON GEOGR, V46, P234, DOI 10.2307/143141; UNICEF, 2010, 9789280645378 UNICEF; UNICEF, 2010, PROGR SAN DRINK WAT; UNICEF and WHO, 2014, PROGR DRINK WAT SAN; UNICEF WHO, 2010, EST US IMPR SAN FAC; WHO UNICEF, 2013, 9789241505390 WHO UN; World Health Organization, 2012, PROGR DRINK WAT SAN; Ziegelbauer K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001162	39	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0158490	10.1371/journal.pone.0158490	http://dx.doi.org/10.1371/journal.pone.0158490			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ9CO	27404271	Green Published, gold			2022-12-27	WOS:000379508200010
J	Barongo, MB; Bishop, RP; Fevre, EM; Knobel, DL; Ssematimba, A				Barongo, Mike B.; Bishop, Richard P.; Fevre, Eric M.; Knobel, Darryn L.; Ssematimba, Amos			A Mathematical Model that Simulates Control Options for African Swine Fever Virus (ASFV)	PLOS ONE			English	Article							DOMESTIC PIGS; IMMUNIZATION; CHALLENGE; OUTBREAKS; GENOTYPES; DISEASE; SPREAD	A stochastic model designed to simulate transmission dynamics of African swine fever virus (ASFV) in a free-ranging pig population under various intervention scenarios is presented. The model was used to assess the relative impact of the timing of the implementation of different control strategies on disease-related mortality. The implementation of biosecurity measures was simulated through incorporation of a decay function on the transmission rate. The model predicts that biosecurity measures implemented within 14 days of the onset of an epidemic can avert up to 74% of pig deaths due to ASF while hypothetical vaccines that confer 70% immunity when deployed prior to day 14 of the epidemic could avert 65% of pig deaths. When the two control measures are combined, the model predicts that 91% of the pigs that would have otherwise succumbed to the disease if no intervention was implemented would be saved. However, if the combined interventions are delayed (defined as implementation from >60 days) only 30% of ASF-related deaths would be averted. In the absence of vaccines against ASF, we recommend early implementation of enhanced biosecurity measures. Active surveillance and use of pen-side diagnostic assays, preferably linked to rapid dissemination of this data to veterinary authorities through mobile phone technology platforms are essential for rapid detection and confirmation of ASF outbreaks. This prediction, although it may seem intuitive, rationally confirms the importance of early intervention in managing ASF epidemics. The modelling approach is particularly valuable in that it determines an optimal timing for implementation of interventions in controlling ASF outbreaks.	[Barongo, Mike B.; Bishop, Richard P.; Fevre, Eric M.; Ssematimba, Amos] Int Livestock Res Inst, POB 30709, Nairobi 00100, Kenya; [Fevre, Eric M.] Univ Liverpool, Inst Infect & Global Hlth, Leahurst Campus, Neston CH64 7TE, England; [Knobel, Darryn L.] Univ Pretoria, Fac Vet Sci, Dept Vet Trop Dis, Pretoria, South Africa; [Ssematimba, Amos] Gulu Univ, Fac Sci, Dept Math, POB 166, Gulu, Uganda; [Barongo, Mike B.] Makerere Univ, Dept Acad Registrar, POB 7062, Kampala, Uganda; [Knobel, Darryn L.] Ross Univ, Sch Vet Med, Ctr Conservat Med & Ecosyst Hlth, POB 334, Basseterre, St Kitts & Nevi	CGIAR; International Livestock Research Institute (ILRI); University of Liverpool; University of Pretoria; Makerere University	Barongo, MB (corresponding author), Int Livestock Res Inst, POB 30709, Nairobi 00100, Kenya.; Barongo, MB (corresponding author), Makerere Univ, Dept Acad Registrar, POB 7062, Kampala, Uganda.	mbarongo@acadreg.mak.ac.ug	Ssematimba, Amos/S-3217-2019; Knobel, Darryn/O-7057-2014	Ssematimba, Amos/0000-0002-5407-2478; Knobel, Darryn/0000-0002-0425-3799; Fevre, Eric/0000-0001-8931-4986	CISA-INIA [TF069018]; Commonwealth Scientific and Industrial Research Organisation; University of Pretoria; Wellcome Trust [085308]; CGIAR research program on 'Livestock and Fish'; Biotechnology and Biological Sciences Research Council [BB/L019019/1] Funding Source: researchfish; BBSRC [BB/L019019/1] Funding Source: UKRI	CISA-INIA; Commonwealth Scientific and Industrial Research Organisation(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); University of Pretoria; Wellcome Trust(Wellcome TrustEuropean Commission); CGIAR research program on 'Livestock and Fish'(CGIAR); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was funded by CISA-INIA (TF069018), Commonwealth Scientific and Industrial Research Organisation, University of Pretoria, Wellcome Trust (085308), and CGIAR research program on 'Livestock and Fish.' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Argilaguet JM, 2013, ANTIVIR RES, V98, P61, DOI 10.1016/j.antiviral.2013.02.005; Argilaguet JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040942; Arias M, 2002, TRENDS IN EMERGING VIRAL INFECTIONS OF SWINE, P119; Atuhaire D, 2015, AFRICAN J BIOTECHNOL; Beltran-Alcrudo D., 2008, AFRICAN SWINE FEVER, P1; Chowell G, 2004, J THEOR BIOL, V229, P119, DOI 10.1016/j.jtbi.2004.03.006; Chowell G, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0196-0; Costard S, 2009, PHILOS T R SOC B, V364, P2683, DOI 10.1098/rstb.2009.0098; Dixon L.K., 2000, VIRUS TAXONOMY; Ferreira HCD, 2013, VET MICROBIOL, V165, P296, DOI 10.1016/j.vetmic.2013.03.026; Ferreira HCDC, 2012, VET MICROBIOL, V160, P327, DOI 10.1016/j.vetmic.2012.06.025; Food and Agriculture Organization, 2008, EMPRES WATCH AFR SWI; Gallardo C, 2013, VET MICROBIOL, V162, P32, DOI 10.1016/j.vetmic.2012.08.011; Gallardo C, 2011, AFR J BIOTECHNOL, V10, P3488; Gallardo C, 2011, J GEN VIROL, V92, P432, DOI 10.1099/vir.0.025874-0; Garner MG, 2005, AUST VET J, V83, P758, DOI 10.1111/j.1751-0813.2005.tb11589.x; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Giraldo JO, 2008, EPIDEMIOL INFECT, V136, P679, DOI 10.1017/S0950268807009260; Grenfell BT, 1994, PARASITIC INFECT DIS, P219; Gulenkin VM, 2011, PREV VET MED, V102, P167, DOI 10.1016/j.prevetmed.2011.07.004; Kalenzi Atuhaire David, 2013, J Vet Med, V2013, P949638, DOI 10.1155/2013/949638; Keeling MJ, 2009, BRIT MED BULL, V92, P33, DOI 10.1093/bmb/ldp038; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; Lacasta A, 2014, J VIROL, V88, P13322, DOI 10.1128/JVI.01893-14; Nantima N, 2015, TROP ANIM HLTH PROD, V47; OIE, 2008, AFR SWIN FEV; OIE, 2010, AQ AN HLTH COD 2010, V1-4; Penrith M.L., 2005, INFECT DIS LIVESTOCK, P1087, DOI [10.4102/jsava.v76i4.435, DOI 10.4102/JSAVA.V76I4.435]; Penrith M.L, 2009, PREPARATION AFRICAN; Ravaomanana J, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-115; Sanchez-Vizcaino JM, 2015, J COMP PATHOL, V152, P9, DOI 10.1016/j.jcpa.2014.09.003; Thomas LF, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-46; WILKINSON PJ, 1984, PREV VET MED, V2, P71, DOI 10.1016/0167-5877(84)90050-3	34	32	32	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158658	10.1371/journal.pone.0158658	http://dx.doi.org/10.1371/journal.pone.0158658			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391689	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400098
J	Brousseau, L; Postolache, D; Lascoux, M; Drouzas, AD; Kallman, T; Leonarduzzi, C; Liepelt, S; Piotti, A; Popescu, F; Roschanski, AM; Zhelev, P; Fady, B; Vendramin, GG				Brousseau, Louise; Postolache, Dragos; Lascoux, Martin; Drouzas, Andreas D.; Kallman, Thomas; Leonarduzzi, Cristina; Liepelt, Sascha; Piotti, Andrea; Popescu, Flaviu; Roschanski, Anna M.; Zhelev, Peter; Fady, Bruno; Vendramin, Giovanni Giuseppe			Local Adaptation in European Firs Assessed through Extensive Sampling across Altitudinal Gradients in Southern Europe	PLOS ONE			English	Article							ABIES-ALBA MILL.; PINUS-PINASTER AIT.; POPULATION-STRUCTURE; GENE-FREQUENCY; CLIMATE-CHANGE; GENOMIC SCANS; LINKAGE DISEQUILIBRIUM; CONTRASTING PATTERNS; NUCLEOTIDE DIVERSITY; QUANTITATIVE TRAITS	Background Local adaptation is a key driver of phenotypic and genetic divergence at loci responsible for adaptive traits variations in forest tree populations. Its experimental assessment requires rigorous sampling strategies such as those involving population pairs replicated across broad spatial scales. Methods A hierarchical Bayesian model of selection (HBM) that explicitly considers both the replication of the environmental contrast and the hierarchical genetic structure among replicated study sites is introduced. Its power was assessed through simulations and compared to classical 'within-site' approaches (FDIST, BAYESCAN) and a simplified, within-site, version of the model introduced here (SBM). Results HBM demonstrates that hierarchical approaches are very powerful to detect replicated patterns of adaptive divergence with low false-discovery (FDR) and false-non-discovery (FNR) rates compared to the analysis of different sites separately through within-site approaches. The hypothesis of local adaptation to altitude was further addressed by analyzing replicated Abies alba population pairs (low and high elevations) across the species' southern distribution range, where the effects of climatic selection are expected to be the strongest. For comparison, a single population pair from the closely related species A. cephalonica was also analyzed. The hierarchical model did not detect any pattern of adaptive divergence to altitude replicated in the different study sites. Instead, idiosyncratic patterns of local adaptation among sites were detected by within-site approaches. Conclusion Hierarchical approaches may miss idiosyncratic patterns of adaptation among sites, and we strongly recommend the use of both hierarchical (multi-site) and classical (within-site) approaches when addressing the question of adaptation across broad spatial scales.	[Brousseau, Louise; Fady, Bruno] INRA, Domaine St Paul, URFM Ecol Forets Mediterraneennes UR629, Site Agroparc CS,Site Agroparc CS 40509, F-84914 Avignon 9, France; [Brousseau, Louise; Postolache, Dragos; Leonarduzzi, Cristina; Piotti, Andrea; Vendramin, Giovanni Giuseppe] Natl Res Council IBBR CNR, Div Florence, Inst Biosci & BioResources, Via Madonna Piano 10, I-50019 Sesto Fiorentino, FI, Italy; [Postolache, Dragos] Scuola Super Sant Anna, Piazza Martiri Liberta 33, I-56127 Pisa, Italy; [Postolache, Dragos; Popescu, Flaviu] Natl Inst Forest Res & Dev INCDS, Res Stn Simeria, Str Biscaria 1, Simeria 335900, Romania; [Lascoux, Martin; Kallman, Thomas] Uppsala Univ, Dept Ecol & Genet, Evolutionary Biol Ctr, S-75236 Uppsala, Sweden; [Lascoux, Martin; Kallman, Thomas] Uppsala Univ, Sci Life Lab, S-75236 Uppsala, Sweden; [Drouzas, Andreas D.] Aristotle Univ Thessaloniki, Sch Biol, GR-54124 Thessaloniki, Greece; [Leonarduzzi, Cristina] Natl 3 Res Council Corso Calatafimi, Div Palermo, Inst Biosci & BioResources, Natl Res Council IBBR CNR, I-90129 Palermo, PA, Italy; [Liepelt, Sascha; Roschanski, Anna M.] Univ Marburg, Fac Biol, Conservat Biol, Karl von Frisch Str, D-35032 Marburg, Germany; [Roschanski, Anna M.] Leibniz Inst Plant Genet & Crop Plant Res IPK, Genebank Collect North, Inselstr 9, D-23999 Malchow Poel, Germany; [Zhelev, Peter] Univ Forestry, 10 Kl Ohridsky Blvd, Sofia 1797, Bulgaria	INRAE; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR); Scuola Superiore Sant'Anna; National Research & Development Institute in Forestry "Marin Dracea"; Uppsala University; Uppsala University; Aristotle University of Thessaloniki; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR); Philipps University Marburg; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; University of Forestry - Bulgaria	Brousseau, L (corresponding author), INRA, Domaine St Paul, URFM Ecol Forets Mediterraneennes UR629, Site Agroparc CS,Site Agroparc CS 40509, F-84914 Avignon 9, France.; Brousseau, L (corresponding author), Natl Res Council IBBR CNR, Div Florence, Inst Biosci & BioResources, Via Madonna Piano 10, I-50019 Sesto Fiorentino, FI, Italy.	louise.brousseau.ecogenomix@gmail.com	Brousseau, Louise/E-5346-2015; Zhelev, Petar/ABG-4248-2020; Piotti, Andrea/C-1304-2009; Liepelt, Sascha/H-1047-2011; Postolache, Dragos/P-4587-2014	Brousseau, Louise/0000-0003-2769-2767; Zhelev, Petar/0000-0002-4273-3400; Piotti, Andrea/0000-0002-3324-5325; Liepelt, Sascha/0000-0001-6529-2882; Postolache, Dragos/0000-0001-5250-8752; Drouzas, Andreas/0000-0001-5234-3572	ERAnet BiodivERsA project 'LinkTree' [ANR-08-Biodiversa-006-06]; ERAnet BiodivERsA project 'TipTree' [ANR-12-EBID-0003]; COST Action [FP 1202]; Italian MIUR project 'Biodiversitalia' [RBAP10A2T4]; 'Young Scientist Contract' (INRA, CJS)	ERAnet BiodivERsA project 'LinkTree'; ERAnet BiodivERsA project 'TipTree'; COST Action(European Cooperation in Science and Technology (COST)); Italian MIUR project 'Biodiversitalia'; 'Young Scientist Contract' (INRA, CJS)	Funding was provided by the ERAnet BiodivERsA project 'LinkTree' (ANR-08-Biodiversa-006-06), the ERAnet BiodivERsA project 'TipTree' (ANR-12-EBID-0003) and COST Action FP 1202. GGV was also supported by a grant by the Italian MIUR project 'Biodiversitalia' (RBAP10A2T4). LB was funded by a 'Young Scientist Contract' (INRA, CJS).r Funding was provided by the ERAnet BiodivERsA project 'LinkTree' (ANR-08-Biodiversa-006-06), the ERAnet BiodivERsA project 'TipTree' (ANR-12-EBID-0003) and COST Action FP 1202. GGV was also supported by a grant by the Italian MIUR project 'Biodiversitalia' (RBAP10A2T4). LB was funded by a 'Young Scientist Contract' (INRA, CJS). We thank Frederic Jean, Norbert Turion, Olivier Gilg (UEFM, INRA Avignon), Carlo Urbinati, Valeria Gallucci, Alma Piermattei and Emidia Santini (Universita Politecnica delle Marche) for their help with fieldwork. The Ente Parco Nazionale del Gran Sasso e Monti della Laga kindly granted permission for sampling and logistic support. We also thank Etienne Klein (BioSP, INRA Avignon) for its critical review of the hierarchical Bayesian model. Last, we thank EuroGeo-graphics for the administrative boundaries of the European basemap used in Fig 1.	Aitken SN, 2008, EVOL APPL, V1, P95, DOI 10.1111/j.1752-4571.2007.00013.x; Alberto FJ, 2013, GENETICS, V195, P495, DOI 10.1534/genetics.113.153783; Alberto FJ, 2013, GLOBAL CHANGE BIOL, V19, P1645, DOI 10.1111/gcb.12181; Alizoti PG, 2003, EUFORGENT TECHNICAL; Angert AL, 2005, EVOLUTION, V59, P1671, DOI 10.1111/j.0014-3820.2005.tb01817.x; Bazin E, 2010, GENETICS, V185, P587, DOI 10.1534/genetics.109.112391; Beaumont MA, 2005, TRENDS ECOL EVOL, V20, P435, DOI 10.1016/j.tree.2005.05.017; Beaumont MA, 2004, NAT REV GENET, V5, P251, DOI 10.1038/nrg1318; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Bella E, 2015, PLANT SYST EVOL, V301, P749, DOI 10.1007/s00606-014-1113-x; Brousseau L, 2013, ANN BOT-LONDON, V112, P1169, DOI 10.1093/aob/mct176; Byars SG, 2007, EVOLUTION, V61, P2925, DOI 10.1111/j.1558-5646.2007.00248.x; Callister AN, 2008, TREE GENET GENOMES, V4, P237, DOI 10.1007/s11295-007-0104-2; Carlson JE, 2011, EVOLUTION, V65, P108, DOI 10.1111/j.1558-5646.2010.01131.x; Carnegie AJ, 2004, CAN J FOREST RES, V34, P2314, DOI [10.1139/x04-114, 10.1139/X04-114]; Chambel MR, 2007, ANN FOREST SCI, V64, P87, DOI 10.1051/forest:2006092; Chen J, 2012, GENETICS, V191, P865, DOI 10.1534/genetics.112.140749; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Corander J, 2003, GENETICS, V163, P367; Cordell S, 1998, OECOLOGIA, V113, P188, DOI 10.1007/s004420050367; Cruickshank TE, 2014, MOL ECOL, V23, P3133, DOI 10.1111/mec.12796; Csillery K, 2014, MOL ECOL, V23, P4696, DOI 10.1111/mec.12902; De Mita S, 2013, MOL ECOL, V22, P1383, DOI 10.1111/mec.12182; de Villemereuil P, 2014, MOL ECOL, V23, P2006, DOI 10.1111/mec.12705; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eckert AJ, 2010, GENETICS, V185, P969, DOI 10.1534/genetics.110.115543; Eckert AJ, 2010, MOL ECOL, V19, P3789, DOI 10.1111/j.1365-294X.2010.04698.x; Ekberg I., 1979, HOLARCTIC ECOL, V2, P255, DOI [10.1111/j.1600-0587.1979.tb01297.x, DOI 10.1111/J.1600-0587.1979.TB01297.X]; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Eveno E, 2008, MOL BIOL EVOL, V25, P417, DOI 10.1093/molbev/msm272; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fahrmeir L, 2001, J ROY STAT SOC C-APP, V50, P201, DOI 10.1111/1467-9876.00229; Falush D, 2003, GENETICS, V164, P1567; Foll M, 2014, BIORXIV; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Gaggiotti OE, 2010, MOL ECOL RESOUR, V10, P821, DOI 10.1111/j.1755-0998.2010.02873.x; Genovese C, 2002, J ROY STAT SOC B, V64, P499, DOI 10.1111/1467-9868.00347; Gompert Z, 2011, GENETICS, V187, P903, DOI 10.1534/genetics.110.124693; Gonzalez-Martinez SC, 2002, HEREDITY, V89, P199, DOI 10.1038/sj.hdy.6800114; Gonzalo-Turpin H, 2009, J ECOL, V97, P742, DOI 10.1111/j.1365-2745.2009.01509.x; Hancock AM, 2011, SCIENCE, V334, P83, DOI 10.1126/science.1209244; Hermisson J, 2009, HEREDITY, V103, P283, DOI 10.1038/hdy.2009.101; Heschel MS, 2005, AM J BOT, V92, P37, DOI 10.3732/ajb.92.1.37; Heuertz M, 2006, GENETICS, V174, P2095, DOI 10.1534/genetics.106.065102; HODGE GR, 1992, SILVAE GENET, V41, P252; Huber CD, 2014, MOL BIOL EVOL, V31, P3026, DOI 10.1093/molbev/msu247; Jensen JD, 2016, MOL ECOL, V25, P1, DOI 10.1111/mec.13493; Jump AS, 2006, MOL ECOL, V15, P3469, DOI 10.1111/j.1365-294X.2006.03027.x; Kallman T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095306; Kovmutak A., 1985, STUDY SPECIES HYDRID; Kremer A, 2012, HEREDITY, V108, P375, DOI 10.1038/hdy.2011.81; Kremer A, 2014, FUNCT ECOL, V28, P22, DOI 10.1111/1365-2435.12169; Kremer A, 2012, ECOL LETT, V15, P378, DOI 10.1111/j.1461-0248.2012.01746.x; Kumar N, 2006, PHOTOSYNTH RES, V88, P63, DOI 10.1007/s11120-005-9028-6; LEWONTIN RC, 1973, GENETICS, V74, P175; Li JR, 2012, MOL ECOL, V21, P28, DOI 10.1111/j.1365-294X.2011.05308.x; Liepelt S, 2009, REV PALAEOBOT PALYNO, V153, P139, DOI 10.1016/j.revpalbo.2008.07.007; Lotterhos KE, 2014, MOL ECOL, V23, P2178, DOI 10.1111/mec.12725; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Manel S, 2010, MOL ECOL, V19, P3824, DOI 10.1111/j.1365-294X.2010.04716.x; Mimura M, 2010, J EVOLUTION BIOL, V23, P249, DOI 10.1111/j.1420-9101.2009.01910.x; Montesinos-Navarro A, 2011, NEW PHYTOL, V189, P282, DOI 10.1111/j.1469-8137.2010.03479.x; Mosca E, 2012, MOL ECOL, V21, P5530, DOI 10.1111/mec.12043; Mosca E, 2014, NEW PHYTOL, V201, P180, DOI 10.1111/nph.12476; Mosca E, 2012, EVOL APPL, V5, P762, DOI 10.1111/j.1752-4571.2012.00256.x; Namroud MC, 2010, J MOL EVOL, V70, P371, DOI 10.1007/s00239-010-9335-1; Narum SR, 2011, MOL ECOL RESOUR, V11, P184, DOI 10.1111/j.1755-0998.2011.02987.x; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Oleksyn J, 1998, FUNCT ECOL, V12, P573, DOI 10.1046/j.1365-2435.1998.00236.x; Parent C, 2011, PLANT CELL ENVIRON, V34, P14; Parry ML, 2007, CLIMATE CHANGE 2007; Pavy N, 2012, HEREDITY, V108, P273, DOI 10.1038/hdy.2011.72; Peng B, 2005, BIOINFORMATICS, V21, P3686, DOI 10.1093/bioinformatics/bti584; Pineda-Garcia F, 2011, PLANT CELL ENVIRON, V34, P1536, DOI 10.1111/j.1365-3040.2011.02351.x; Pluess AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033636; Poncet BN, 2010, MOL ECOL, V19, P2896, DOI 10.1111/j.1365-294X.2010.04696.x; Pritchard JK, 2000, GENETICS, V155, P945; Prunier J, 2011, MOL ECOL, V20, P1702, DOI 10.1111/j.1365-294X.2011.05045.x; Rehfeldt GE, 2014, FOREST ECOL MANAG, V324, P147, DOI 10.1016/j.foreco.2014.02.040; Richardson BA, 2009, INT J PLANT SCI, V170, P1120, DOI 10.1086/605870; ROBERTSON A, 1975, GENETICS, V81, P775; Roschanski AM, 2016, MOL ECOL, V25, P776, DOI 10.1111/mec.13516; Roschanski AM, 2013, APPL PLANT SCI, V1, DOI 10.3732/apps.1200179; Saenz-Romero C, 2006, FOREST ECOL MANAG, V229, P340, DOI 10.1016/j.foreco.2006.04.014; Sagnard F, 2002, FOREST ECOL MANAG, V157, P175, DOI 10.1016/S0378-1127(00)00664-2; Sarkar SK, 2006, ANN STAT, V34, P394, DOI 10.1214/009053605000000778; Savolainen O, 2007, ANNU REV ECOL EVOL S, V38, P595, DOI 10.1146/annurev.ecolsys.38.091206.095646; Silva JCE, 2001, CAN J FOREST RES, V31, P1887, DOI 10.1139/cjfr-31-11-1887; Siol M, 2010, NEW PHYTOL, V188, P313, DOI 10.1111/j.1469-8137.2010.03401.x; SLATKIN M, 1991, GENETICS, V127, P627; Sork VL, 2013, TREE GENET GENOMES, V9, P901, DOI 10.1007/s11295-013-0596-x; Stephens M, 2009, NAT REV GENET, V10, P681, DOI 10.1038/nrg2615; Storz JF, 2005, MOL ECOL, V14, P671, DOI 10.1111/j.1365-294X.2005.02437.x; Teshima KM, 2006, GENOME RES, V16, P702, DOI 10.1101/gr.5105206; Vilas A, 2012, J EVOLUTION BIOL, V25, P1364, DOI 10.1111/j.1420-9101.2012.02526.x; Voltas J, 2008, TREES-STRUCT FUNCT, V22, P759, DOI 10.1007/s00468-008-0236-5; Wolf H., 2003, EUFORGEN TECHNICAL G	102	23	23	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158216	10.1371/journal.pone.0158216	http://dx.doi.org/10.1371/journal.pone.0158216			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27392065	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400037
J	Emmons, S; Kobourov, S; Gallant, M; Borner, K				Emmons, Scott; Kobourov, Stephen; Gallant, Mike; Borner, Katy			Analysis of Network Clustering Algorithms and Cluster Quality Metrics at Scale	PLOS ONE			English	Article								Overview Notions of community quality underlie the clustering of networks. While studies surrounding network clustering are increasingly common, a precise understanding of the realtionship between different cluster quality metrics is unknown. In this paper, we examine the relationship between stand-alone cluster quality metrics and information recovery metrics through a rigorous analysis of four widely-used network clustering algorithms-Louvain, Infomap, label propagation, and smart local moving. We consider the stand-alone quality metrics of modularity, conductance, and coverage, and we consider the information recovery metrics of adjusted Rand score, normalized mutual information, and a variant of normalized mutual information used in previous work. Our study includes both synthetic graphs and empirical data sets of sizes varying from 1,000 to 1,000,000 nodes. Cluster Quality Metrics We find significant differences among the results of the different cluster quality metrics. For example, clustering algorithms can return a value of 0.4 out of 1 onmodularity but score 0 out of 1 on information recovery. We find conductance, though imperfect, to be the stand-alone quality metric that best indicates performance on the information recovery metrics. Additionally, our study shows that the variant of normalized mutual information used in previous work cannot be assumed to differ only slightly from traditional normalized mutual information. Network Clustering Algorithms Smart local moving is the overall best performing algorithm in our study, but discrepancies between cluster evaluation metrics prevent us from declaring it an absolutely superior algorithm. Interestingly, Louvain performed better than Infomap in nearly all the tests in our study, contradicting the results of previous work in which Infomap was superior to Louvain. We find that although label propagation performs poorly when clusters are less clearly defined, it scales efficiently and accurately to large graphs with well-defined clusters.	[Emmons, Scott; Gallant, Mike; Borner, Katy] Indiana Univ, Sch Informat & Comp, Bloomington, IN 47405 USA; [Kobourov, Stephen] Univ Arizona, Dept Comp Sci, Tucson, AZ 85721 USA; [Borner, Katy] Indiana Univ, Indiana Univ Network Sci Inst, Bloomington, IN USA	Indiana University System; Indiana University Bloomington; University of Arizona; Indiana University System; Indiana University Bloomington	Emmons, S (corresponding author), Indiana Univ, Sch Informat & Comp, Bloomington, IN 47405 USA.	sremmons@indiana.edu	Kobourov, Stephen G/A-3016-2008	Kobourov, Stephen G/0000-0002-0477-2724	National Institutes of Health; Lilly Endowment, Inc.; Indiana METACyt Initiative	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lilly Endowment, Inc.; Indiana METACyt Initiative	This research was partially funded by the National Institutes of Health. This research was supported in part by Lilly Endowment, Inc., through its support for the Indiana University Pervasive Technology Institute, and in part by the Indiana METACyt Initiative. The Indiana METACyt Initiative at IU is also supported in part by Lilly Endowment, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported in part by Lilly Endowment, Inc., through its support for the Indiana University Pervasive Technology Institute, and in part by the Indiana METACyt Initiative. The Indiana METACyt Initiative at IU is also supported in part by Lilly Endowment, Inc.	Almeida H, 2011, LECT NOTES ARTIF INT, V6911, P44, DOI 10.1007/978-3-642-23780-5_13; [Anonymous], EUROVIS SHORT PAPERS; [Anonymous], P 19 ACM INT C INF K; Barabasi AL, 2001, PHYSICA A, V299, P559, DOI 10.1016/S0378-4371(01)00369-7; Bastian M., 2009, 3 INT AAAI C WEBL SO; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Brandes U, 2003, LECT NOTES COMPUT SC, V2832, P568; Correll M, 2014, IEEE T VIS COMPUT GR, V20, P2142, DOI 10.1109/TVCG.2014.2346298; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Franke R, 2016, PHYSICA A, V461, P384, DOI 10.1016/j.physa.2016.05.063; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Grnwald P.D., 2005, ADV MINIMUM DESCRIPT; Hintze JL, 1998, AM STAT, V52, P181, DOI 10.2307/2685478; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Kheirkhahzadeh M, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.032309; Lancichinetti A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056117; Lancichinetti A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046110; Lancichinetti A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033015; Leskovec J, 2005, LECT NOTES ARTIF INT, V3721, P133; McAuley J, 2012, LECT NOTES COMPUT SC, V7575, P828, DOI 10.1007/978-3-642-33765-9_59; Meila M, 2007, J MULTIVARIATE ANAL, V98, P873, DOI 10.1016/j.jmva.2006.11.013; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Raghavan UN, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036106; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; RISSANEN J, 1978, AUTOMATICA, V14, P465, DOI 10.1016/0005-1098(78)90005-5; Ronhovde P, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046114; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Rotta R., 2011, J EXP ALGORITHMICS, V16, p2.1, DOI DOI 10.1145/1963190.1970376; Schaeffer SE, 2007, COMPUT SCI REV, V1, P27, DOI 10.1016/j.cosrev.2007.05.001; Schaub MT, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.026112; Schaub MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032210; SCOTT DW, 1979, BIOMETRIKA, V66, P605, DOI 10.1093/biomet/66.3.605; Tibely G, 2008, PHYSICA A, V387, P4982, DOI 10.1016/j.physa.2008.04.024; Vinh NX, 2010, J MACH LEARN RES, V11, P2837; Waltman L, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-40829-0; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yang J, 2015, KNOWL INF SYST, V42, P181, DOI 10.1007/s10115-013-0693-z	39	95	95	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159161	10.1371/journal.pone.0159161	http://dx.doi.org/10.1371/journal.pone.0159161			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391786	Green Submitted, gold, Green Published			2022-12-27	WOS:000380005400216
J	Klein, N; Sander, PM; Krahl, A; Scheyer, TM; Houssaye, A				Klein, Nicole; Sander, P. Martin; Krahl, Anna; Scheyer, Torsten M.; Houssaye, Alexandra			Diverse Aquatic Adaptations in Nothosaurus spp. (Sauropterygia)-Inferences from Humeral Histology and Microanatomy	PLOS ONE			English	Article							LONG-BONE HISTOLOGY; LOWER MUSCHELKALK; LIFE-STYLE; WINTERSWIJK; SKELETOCHRONOLOGY; EOSAUROPTERYGIA; NETHERLANDS; EVOLUTION; REPTILIA; AMNIOTES	Mid-diaphyseal cortical bone tissue in humeri of Nothosaurus spp. consists of coarse parallel-fibered bone, finer and higher organized parallel-fibered bone, and lamellar bone. Vascular canals are mainly arranged longitudinally and radially in a dominantly radial system. Blood vessels are represented by simple vascular canals, incompletely lined primary osteons, and fully developed primary osteons. Nothosaurus spp. shows a variety of diaphyseal microanatomical patterns, ranging from thick to very thin-walled cortices. In the early Anisian (Lower Muschelkalk), small- and large-bodied Nothosaurus spp. generally exhibit bone mass increase (BMI). In the middle to late Anisian (Middle Muschelkalk) small-bodied nothosaurs retain BMI whereas larger-bodied forms tend to show a decrease in bone mass (BMD). During the latest Anisian to early Ladinian (Upper Muschelkalk), small-and few large-bodied nothosaurs retain BMI, whereas the majority of large-bodied forms exhibit BMD. The stratigraphically youngest nothosaurs document five microanatomical categories, two of which are unique among marine amniotes: One consists of a very heterogeneously distributed spongy periosteal organization, the other of very thin-walled cortices. The functional significance of the two unique microanatomical specializations seen in large-bodied nothosaurs is the reduction of bone mass, which minimizes inertia of the limbs, and thus saves energy during locomotion. Transitions between the various microanatomical categories are rather gradual. Our results suggest that small-bodied Nothosaurus marchicus and other, not further assignable small-bodied nothosaurs seem to have been bound to near-shore, shallow marine environments throughout their evolution. Some large-bodied Nothosaurus spp. followed the same trend but others became more active swimmers and possibly inhabited open marine environments. The variety of microanatomical patterns may be related to taxonomic differences, developmental plasticity, and possibly sexual dimorphism. Humeral microanatomy documents the diversification of nothosaur species into different environments to avoid intraclade competition as well as competition with other marine reptiles. Nothosaur microanatomy indicates that knowledge of processes involved in secondary aquatic adaptation and their interaction are more complex than previously believed.	[Klein, Nicole] Staatliches Museum Nat Kunde Stuttgart, Rosenstein 1, D-70191 Stuttgart, Germany; [Sander, P. Martin] Univ Bonn, Div Paleontol, Steinmann Inst, Nussallee 8, D-53115 Bonn, Germany; [Krahl, Anna] Ruhr Univ Bochum, Fac Mech Engn, Biomech Res Grp, Univ Str 150, D-44801 Bochum, Germany; [Scheyer, Torsten M.] Univ Zurich, Palaeontol Inst & Museum, Karl Schmid Str 4, CH-8006 Zurich, Switzerland; [Houssaye, Alexandra] Museum Natl Hist Nat, UMR CNRS 7179, Dept Ecol & Gest Biodiversite, 57 Rue Cuvier CP-55, F-75000 Paris, France	University of Bonn; Ruhr University Bochum; University of Zurich; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN)	Klein, N (corresponding author), Staatliches Museum Nat Kunde Stuttgart, Rosenstein 1, D-70191 Stuttgart, Germany.	nicole.klein@smns-bw.de		Scheyer, Torsten M./0000-0002-6301-8983; Krahl, Anna/0000-0003-1806-2907	French National Research agency [ANR-13-PDOC-0011]; Swiss National Science Foundation (SNSF) [31003A_149506]; Deutsche Forschungsgemeinsschaft [WI1398/8-1]; SNSF [31003A_149506]; DFG [WI1389/8-1]	French National Research agency(French National Research Agency (ANR)); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Deutsche Forschungsgemeinsschaft(German Research Foundation (DFG)); SNSF(Swiss National Science Foundation (SNSF)); DFG(German Research Foundation (DFG))	The French National Research agency (ANR-13-PDOC-0011; http://www.agence-nationalerecherche.fr/?Project=ANR-13-PDOC-0011); Swiss National Science Foundation (SNSF grant no. 31003A_149506; http://www.snf.ch/en/funding/careers/snsf-professorships/Pages/default.aspx); Deutsche Forschungsgemeinsschaft (WI1398/8-1, http://gepris.dfg.de/gepris/projekt/270835314). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge O. Dulfer (StIPB), Ch. Wimmer-Pfeil (SMNS), and J. Hugi (formerly PIMUZ) for the production of the thin sections. C. Klug (PIMUZ), H. Furrer (formerly PIMUZ), H. Hagdorn (MHI), N. Hauschke (IGWH), P. Havlik (GPIT), R. Schoch (SMNS), and D. Schwarz-Wings (MfN) kindly gave permission for the histological sampling of nothosaur bones. H. Hagdorn (MHI), R. Bottcher (SMNS), and D. Seegis helped with Upper Muschelkalk stratigraphy. M. Laurin (CNRS) is acknowledged for discussion on Bone Profiler. M. Rasser and R. Baumann (both SMNS) provided technical support. A. H. acknowledges financial support from the ANR-13-PDOC-0011. T.M.S. acknowledges support of SNSF grant no. 31003A_149506. AK acknowledges financial support from the DFG (WI1389/8-1). We are grateful to the helpful comments of M. Laurin, one anonymous reviewer, and of the academic editor A. Farke.	Albers PCH, 2011, NETH J GEOSCI, V90, P15, DOI 10.1017/S0016774600000639; [Anonymous], 2000, HDB PALEOHERPETOLOGY; Bickelmann C, 2008, J VERTEBR PALEONTOL, V28, P326, DOI 10.1671/0272-4634(2008)28[326:APSAIH]2.0.CO;2; Braun J., 1985, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V169, P307; BUFFRENIL VD, 1980, B SOC ZOOL FR, V105, P355; Canoville A, 2010, BIOL J LINN SOC, V100, P384, DOI 10.1111/j.1095-8312.2010.01431.x; CARROLL RL, 1985, PHILOS T ROY SOC B, V309, P343, DOI 10.1098/rstb.1985.0091; De Buffrenil V, 2000, J HERPETOL, V34, P414, DOI 10.2307/1565365; de Buffrenil V, 2008, J MORPHOL, V269, P533, DOI 10.1002/jmor.10604; de Buffrenil Vivian, 1992, Revue de Paleobiologie, V11, P397; de Buffrenil V, 2010, J MAMM EVOL, V17, P101, DOI 10.1007/s10914-010-9130-1; de Ricqles Armand, 2001, P289; Digby KH, 1916, J ANAT PHYSIOL, V50, P187; FELDKAMP SD, 1987, J ZOOL, V212, P43, DOI 10.1111/j.1469-7998.1987.tb05113.x; Francillon-Vieillot H., 1990, P471; Girondot M, 2003, J VERTEBR PALEONTOL, V23, P458, DOI 10.1671/0272-4634(2003)023[0458:BPATTQ]2.0.CO;2; GRAY DJ, 1969, AM J ANAT, V124, P431, DOI 10.1002/aja.1001240403; Gray NM, 2007, ANAT REC, V290, P638, DOI 10.1002/ar.20533; Hanni K, 2004, GATTUNG CERESIOSAURU; Hayashi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059146; Houssaye A, 2016, BIOL J LINN SOC, V117, P350, DOI 10.1111/bij.12660; Houssaye A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095637; Houssaye A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076741; Houssaye A, 2013, BIOL J LINN SOC, V108, P3, DOI 10.1111/j.1095-8312.2012.02002.x; Houssaye A, 2013, BIOL REV, V88, P117, DOI 10.1111/j.1469-185X.2012.00243.x; Houssaye A, 2009, INTEGR ZOOL, V4, P325, DOI 10.1111/j.1749-4877.2009.00146.x; Huene F.von., 1944, Neues Jahrbuch fuer Mineralogie Geologie und Palaeontologie Stuttgart, VB 7-9, P223; Hugi J, 2012, J HERPETOL, V46, P312, DOI 10.1670/11-071; Hugi Jasmina, 2011, Swiss Journal of Palaeontology, V130, P297, DOI 10.1007/s13358-011-0023-6; Hugi J, 2011, CR PALEVOL, V10, P413, DOI 10.1016/j.crpv.2011.03.009; KLEIN N, 2016, Patent No. 201615; Klein N, 2008, PALEOBIOLOGY, V34, P247, DOI 10.1666/0094-8373(2008)034[0247:OSITLB]2.0.CO;2; Klein N, 2007, SP PALAEONT, P169; Klein N, 2016, J VERTEBR PALEONTOL, V36, DOI 10.1080/02724634.2016.1163712; Klein N, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140440; Klein N, 2015, PALAEONTOL Z, V89, P961, DOI 10.1007/s12542-015-0273-5; Klein N, 2015, CONTRIB ZOOL, V84, P59, DOI 10.1163/18759866-08401005; Klein N, 2012, PALAEONTOL Z, V86, P389, DOI 10.1007/s12542-012-0137-1; Klein N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011613; Klein N, 2009, ACTA PALAEONTOL POL, V54, P589, DOI 10.4202/app.2008.0083; Klein N, 2009, FOSS REC, V12, P121, DOI 10.1002/mmng.200900002; Konietzko-Meier D, 2013, NETH J GEOSCI, V92, P97, DOI 10.1017/S0016774600000020; Krahl A, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-123; Laurin M, 2016, CR PALEVOL, V15, P115, DOI 10.1016/j.crpv.2015.01.001; Laurin M, 2011, CR PALEVOL, V10, P381, DOI 10.1016/j.crpv.2011.02.003; Meyer Hvon, 1847, SAURIER MUSCHELKALKS; Meyer Hvon, 1842, NEUES JB MINERALOGIE, V1842, P184; Motani Ryosuke., 2009, Evolution Education and Outreach, V2, P224; Peyer B., 1939, ABHANDLUNGEN SCHWEIZ, V62:, P1; Rieppel, 1994, FIELDIANA GEOL, V28, P1, DOI DOI 10.5962/BHL.TITLE.3399; Rieppel O, 2002, ZOOL J LINN SOC-LOND, V135, P33, DOI 10.1046/j.1096-3642.2002.00019.x; Rieppel O., 1996, FIELDIANA GEOLOGY, V34, P1; Rieppel Olivier, 2001, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V263, P137; SANDER PM, 1990, ANN SCI NAT ZOOL, V11, P213; Sander PM., 1999, GEOWISSENSCHAFTLICHE, V2, P103; Shelton CD, 2013, T EARTH SCI, V103, P217, DOI DOI 10.1017/S175569101300025X]; SUES HD, 1987, ZOOL J LINN SOC-LOND, V90, P109, DOI 10.1111/j.1096-3642.1987.tb01351.x; TSCHANZ K, 1989, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V208, P153; Voeten DFAE, 2015, PALAEONTOL Z, V89, P943, DOI 10.1007/s12542-014-0250-4; Watson DMS, 1924, P ZOOL SOC LOND, V1924, P885; Wiffen J, 1995, GEOBIOS-LYON, V28, P625, DOI 10.1016/S0016-6995(95)80216-9; Zhang QY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4973	62	28	28	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158448	10.1371/journal.pone.0158448	http://dx.doi.org/10.1371/journal.pone.0158448			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391607	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000380005400059
J	Ma, YF; Liu, L; Jin, J; Lou, YJ				Ma, Yafang; Liu, Lu; Jin, Jie; Lou, Yinjun			All-Trans Retinoic Acid plus Arsenic Trioxide versus All-Trans Retinoic Acid plus Chemotherapy for Newly Diagnosed Acute Promyelocytic Leukemia: A Meta-Analysis	PLOS ONE			English	Article							RAR-ALPHA; RISK; CONSOLIDATION; REMISSION; SURVIVAL; EFFICACY; TRANSLOCATION; INDUCTION; T(15-17); THERAPY	Background Recently, the all-trans retinoic acid (ATRA) plus arsenic trioxide (ATO) protocol has become a promising first-line therapeutic approach in patients with newly diagnosed acute promyelocytic leukemia (APL), but its benefits compared with standard ATRA plus chemotherapy regimen needs to be proven. Herein, we conducted a meta-analysis comparing the efficacy of ATRA plus ATO with ATRA plus chemotherapy for adult patients with newly diagnosed APL. Methods We systematically searched biomedical electronic databases and conference proceedings through February 2016. Two reviewers independently assessed all studies for relevance and validity. Results Overall, three studies were eligible for inclusion in this meta-analysis, which included a total of 585 patients, with 317 in ATRA plus ATO group and 268 in ATRA plus chemotherapy group. Compared with patients who received ATRA and chemotherapy, patients who received ATRA plus ATO had a significantly better event-free survival (hazard ratio [HR] = 0.38, 95% confidence interval [CI]: 0.22-0.67, p = 0.009), overall survival (HR = 0.44, 95% CI: 0.24-0.82, p = 0.009), complete remission rate (relative risk [RR] = 1.05; 95% CI: 1.01-1.10; p = 0.03). There were no significant differences in earlymortality (RR = 0.48; 95% CI: 0.22-1.05; p = 0.07). Conclusion Thus, this analysis indicated that ATRA plus ATO protocol may be preferred to standard ATRA plus chemotherapy protocol, particularly in low-to-intermediate risk APL patients. Further larger trials were needed to provide more evidence in high-risk APL patients.	[Ma, Yafang; Liu, Lu; Jin, Jie; Lou, Yinjun] Zhejiang Univ, Affiliated Hosp 1, Dept Hematol, Inst Hematol, Hangzhou, Zhejiang, Peoples R China; [Jin, Jie; Lou, Yinjun] Key Lab Hematopoiet Malignancies Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Lou, YJ (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Dept Hematol, Inst Hematol, Hangzhou, Zhejiang, Peoples R China.; Lou, YJ (corresponding author), Key Lab Hematopoiet Malignancies Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China.	yinjunlou2@163.com		Lou, Yinjun/0000-0003-4495-2460				BERNARD J, 1973, BLOOD, V41, P489, DOI 10.1182/blood.V41.4.489.489; Burnett AK, 2015, LANCET ONCOL, V16, P1295, DOI 10.1016/S1470-2045(15)00193-X; Chen L, 2014, HEMATOLOGY, V19, P202, DOI 10.1179/1607845413Y.0000000118; Coombs CC, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.25; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; DIDISHEIM P, 1964, BLOOD, V23, P717, DOI 10.1182/blood.V23.6.717.717; Efficace F, 2014, J CLIN ONCOL, V32, P3406, DOI 10.1200/JCO.2014.55.3453; Estey E, 2006, BLOOD, V107, P3469, DOI 10.1182/blood-2005-10-4006; Gianni M, 1998, BLOOD, V91, P4300, DOI 10.1182/blood.V91.11.4300.411k41_4300_4310; GODDARD AD, 1991, SCIENCE, V254, P1371, DOI 10.1126/science.1720570; Hu J, 2009, P NATL ACAD SCI USA, V106, P3342, DOI 10.1073/pnas.0813280106; HUANG ME, 1988, BLOOD, V72, P567, DOI 10.1182/blood.V72.2.567.567; Iland HJ, 2015, LANCET HAEMATOL, V2, pE357, DOI 10.1016/S2352-3026(15)00115-5; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; Lo-Coco F, 2013, NEW ENGL J MED, V369, P111, DOI 10.1056/NEJMoa1300874; Lo-Coco F, 2010, BLOOD, V116, P3171, DOI 10.1182/blood-2010-03-276196; Lou YJ, 2015, LEUKEMIA RES, V39, P938, DOI 10.1016/j.leukres.2015.05.016; Niu C, 1999, BLOOD, V94, P3315, DOI 10.1182/blood.V94.10.3315.422k16_3315_3324; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Powell BL, 2010, BLOOD, V116, P3751, DOI 10.1182/blood-2010-02-269621; Sanz MA, 2000, BLOOD, V96, P1247; Sanz MA, 2010, BLOOD, V115, P5137, DOI 10.1182/blood-2010-01-266007; Shen ZX, 2004, P NATL ACAD SCI USA, V101, P5328, DOI 10.1073/pnas.0400053101; Shen ZX, 1997, BLOOD, V89, P3354, DOI 10.1182/blood.V89.9.3354; Soignet SL, 1998, NEW ENGL J MED, V339, P1341, DOI 10.1056/NEJM199811053391901; Takahashi H, 2016, BRIT J HAEMATOL, V174, P437, DOI 10.1111/bjh.14068; Tallman MS, 2009, BLOOD, V114, P5126, DOI 10.1182/blood-2009-07-216457; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Wang H, 2011, LEUKEMIA RES, V35, P1170, DOI 10.1016/j.leukres.2011.06.002; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798	31	22	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158760	10.1371/journal.pone.0158760	http://dx.doi.org/10.1371/journal.pone.0158760			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391027	Green Submitted, Green Published, gold			2022-12-27	WOS:000380005400117
J	Tedeschi, GJ; Cummins, SE; Anderson, CM; Anthenelli, RM; Zhuang, YL; Zhu, SH				Tedeschi, Gary J.; Cummins, Sharon E.; Anderson, Christopher M.; Anthenelli, Robert M.; Zhuang, Yue-Lin; Zhu, Shu-Hong			Smokers with Self-Reported Mental Health Conditions: A Case for Screening in the Context of Tobacco Cessation Services	PLOS ONE			English	Article							SMOKING-CESSATION; PRIMARY-CARE; PSYCHIATRIC-DISORDERS; UNITED-STATES; DRUG-USE; DEPRESSION; ILLNESS; QUITLINE; ALCOHOL; PEOPLE	Background People with mental health conditions (MHC) smoke at high rates and many die prematurely from smoking-related illnesses. Smoking cessation programs, however, generally do not screen for MHC. This study examined the utility of MHC screening in a large tobacco quitline to determine whether self-reported MHC predicts service utilization and quitting behaviors. Methods & Findings A brief set of question on MHC was embedded in the routine intake of a state quitline, and 125,261 smokers calling from June 2012 to September 2015 were asked the questions. Quit attempt rate and 6-month success rate were analyzed for a random subset of participants. Overall, 52.2% of smokers reported at least one MHC. Demographic patterns like gender or ethnic difference in self-reported MHC were similar to that in the general population. Depression disorder was reported most often (38.6%), followed by anxiety disorder (33.8%), bipolar disorder (17.0%), drug/alcohol abuse (11.9%), and schizophrenia (7.9%). Among those reporting any MHC, about two-thirds reported more than 1 MHC. Smokers with MHC received more counseling than smokers with no MHC. Quit attempt rates were high for all three groups (>70%). The probability of relapse was greater for those with more than one MHC than for those with one MHC (p<0.005), which in turn was greater than those with no MHC (p<.01). The six-month prolonged abstinence rates for the three conditions were, 21.8%, 28.6%, and 33.7%, respectively. The main limitation of this study is the use of a non-validated self-report question to assess MHC, even though it appears to be useful for predicting quitting behavior. Conclusions Smokers with MHC actively seek treatment to quit. Smoking cessation services can use a brief set of questions to screen for MHC to help identify smokers in need of more intensive treatment to quit smoking.	[Tedeschi, Gary J.; Cummins, Sharon E.; Anderson, Christopher M.; Zhuang, Yue-Lin; Zhu, Shu-Hong] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Cummins, Sharon E.; Zhu, Shu-Hong] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Anthenelli, Robert M.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Zhu, SH (corresponding author), Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA.; Zhu, SH (corresponding author), Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA.	szhu@ucsd.edu	Zhu, Shu-Hong/AAF-5164-2019	Tedeschi, Gary/0000-0001-5121-7064; Cummins, Sharon/0000-0003-3481-8436	California Department of Public Health (CDPH) [CDPH-09-13058, CDPH-14-10611]; First 5 California Children and Family Commission [CCFC-7235, CCFC-7318]; National Institutes of Health (NIAAA) [U01 AA013641]	California Department of Public Health (CDPH); First 5 California Children and Family Commission; National Institutes of Health (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Moores Cancer Center and Department of Family Medicine & Public Health staff contributions to the manuscript supported by the California Department of Public Health (CDPH), www.cdph.ca.gov, Contract #CDPH-09-13058 and CDPH-14-10611, and First 5 California Children and Family Commission, www.ccfc.ca.gov, Contract #CCFC-7235 and CCFC-7318. Dr. Anthenelli's contributions supported in part by the National Institutes of Health (NIAAA), www.niaaa.nih.gov, Grant # U01 AA013641 (INIA Stress Consortium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CM, 2007, TOB CONTROL, V16, pI81, DOI 10.1136/tc.2007.020701; Aubin HJ, 2012, NEUROSCI BIOBEHAV R, V36, P271, DOI 10.1016/j.neubiorev.2011.06.007; Bahorik AL, 2014, PSYCHOL MED, V44, P61, DOI 10.1017/S0033291713000548; Bowden CL, 2001, PSYCHIAT SERV, V52, P51, DOI 10.1176/appi.ps.52.1.51; Campion J., 2008, ADV PSYCHIAT TREAT, V14, P217, DOI [DOI 10.1192/APT.BP.108.005710, 10.1192/apt.bp.108.005710]; Cerimele JM, 2014, J AM BOARD FAM MED, V27, P399, DOI 10.3122/jabfm.2014.03.130252; Chu J.P., 2011, ONLINE READINGS PSYC, V3, P2307, DOI [10.9707/2307-0919.1026, DOI 10.9707/2307-0919.1026]; Druss BG, 2011, MED CARE, V49, P599, DOI 10.1097/MLR.0b013e31820bf86e; Gfroerer J, 2013, MMWR-MORBID MORTAL W, V62, P81; Grant BF, 2004, ARCH GEN PSYCHIAT, V61, P1107, DOI 10.1001/archpsyc.61.11.1107; Hebert KK, 2011, AM J PREV MED, V40, P47, DOI 10.1016/j.amepre.2010.09.030; Himelhoch S, 2003, AM J PSYCHIAT, V160, P2228, DOI 10.1176/appi.ajp.160.12.2228; Hormes JM, 2012, AIDS CARE, V24, P420, DOI 10.1080/09540121.2011.608795; Kerkvliet JL, 2015, NICOTINE TOB RES, V17, P735, DOI 10.1093/ntr/ntu239; Lasser K, 2000, JAMA-J AM MED ASSOC, V284, P2606, DOI 10.1001/jama.284.20.2606; Lawrence D, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-285; Le Cook B, 2014, JAMA-J AM MED ASSOC, V311, P172, DOI 10.1001/jama.2013.284985; Lembke A, 2016, TOB CONTROL, V25, P261, DOI 10.1136/tobaccocontrol-2014-052215; Lukowski AV, 2015, NICOTINE TOB RES, V17, P924, DOI 10.1093/ntr/ntu252; Meyer F, 2009, J AFFECT DISORDERS, V112, P174, DOI 10.1016/j.jad.2008.04.022; Mitchell AJ, 2007, BRIT J GEN PRACT, V57, P144; Morral AR, 2000, DRUG ALCOHOL DEPEN, V57, P193, DOI 10.1016/S0376-8716(99)00048-4; Morris Chad D, 2009, J Am Psychiatr Nurses Assoc, V15, P32, DOI 10.1177/1078390308330050; North American Quitline Consortium, 2011, MDS STAND OPT QUEST; Olfson M, 2015, JAMA PSYCHIAT, V72, P1172, DOI 10.1001/jamapsychiatry.2015.1737; Parks J., 2006, MORBIDITY MORTALITY; Phillips KM, 2004, PROF PSYCHOL-RES PR, V35, P281, DOI 10.1037/0735-7028.35.3.281; Pinto-Meza A, 2005, J GEN INTERN MED, V20, P738, DOI 10.1111/j.1525-1497.2005.0144.x; Rogers E, 2014, AM J PUBLIC HEALTH, V104, P90, DOI 10.2105/AJPH.2013.301584; SAS Institute Inc, 2014, SAS 9 4 LANG REF; Saul J, 2013, RESULTS 2012 NAQC AN; Schroeder SA, 2010, ANNU REV PUBL HEALTH, V31, P297, DOI 10.1146/annurev.publhealth.012809.103701; Siru R, 2009, ADDICTION, V104, P719, DOI 10.1111/j.1360-0443.2009.02545.x; Stockwell T, 2004, ADDICTION, V99, P1024, DOI 10.1111/j.1360-0443.2004.00815.x; Substance Abuse and Mental Health Services Administration, 2013, RES 2012 NAT SURV DR; Thorndike A N, 2001, Nicotine Tob Res, V3, P85, DOI 10.1080/14622200020032132; Tidey JW, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4065; Trosclair A, 2010, ADDICT BEHAV, V35, P438, DOI 10.1016/j.addbeh.2009.12.011; Vickerman KA, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/817298; Williams JM, 2013, AM J PUBLIC HEALTH, V103, P1549, DOI 10.2105/AJPH.2013.301232; Zhu SH, 2002, NEW ENGL J MED, V347, P1087, DOI 10.1056/NEJMsa020660; ZHU SH, 1995, PROF PSYCHOL-RES PR, V26, P624, DOI 10.1037/0735-7028.26.6.624; Zhu SH, 1996, J COUNS DEV, V75, P93, DOI 10.1002/j.1556-6676.1996.tb02319.x; Zhu SH, 1996, J CONSULT CLIN PSYCH, V64, P202, DOI 10.1037/0022-006X.64.1.202; Ziedonis DM, 2003, CURR OPIN PSYCHIATR, V16, P305, DOI 10.1097/01.yco.0000069086.26384.5f; Ziedonis D, 2008, NICOTINE TOB RES, V10, P1691, DOI 10.1080/14622200802443569	46	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159127	10.1371/journal.pone.0159127	http://dx.doi.org/10.1371/journal.pone.0159127			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27391334	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400212
J	Toro, R; Perez-Serra, A; Campuzano, O; Moncayo-Arlandi, J; Allegue, C; Iglesias, A; Mangas, A; Brugada, R				Toro, Rocio; Perez-Serra, Alexandra; Campuzano, Oscar; Moncayo-Arlandi, Javier; Allegue, Catarina; Iglesias, Anna; Mangas, Alipio; Brugada, Ramon			Familial Dilated Cardiomyopathy Caused by a Novel Frameshift in the BAG3 Gene	PLOS ONE			English	Article							HEART-FAILURE; MUTATION; PROTEIN; LOCI	Background Dilated cardiomyopathy, a major cause of chronic heart failure and cardiac transplantation, is characterized by left ventricular or biventricular heart dilatation. In nearly 50% of cases the pathology is inherited, and more than 60 genes have been reported as disease-causing. However, in 30% of familial cases the mutation remains unidentified even after comprehensive genetic analysis. This study clinically and genetically assessed a large Spanish family affected by dilated cardiomyopathy to search for novel variations. Methods and Results Our study included a total of 100 family members. Clinical assessment was performed in alive, and genetic analysis was also performed in alive and 1 deceased relative. Genetic screening included resequencing of 55 genes associated with sudden cardiac death, and Sanger sequencing of main disease-associated genes. Genetic analysis identified a frame-shift variation in BAG3 (p.H243Tfr*64) in 32 patients. Genotype-phenotype correlation identified substantial heterogeneity in disease expression. Of 32 genetic carriers (one deceased), 21 relatives were clinically affected, and 10 were asymptomatic. Seventeen of the symptomatic genetic carriers exhibited proto-diastolic septal knock by echocardiographic assessment. Conclusions We report p.H243Tfr*64_BAG3 as a novel pathogenic variation responsible for familial dilated cardiomyopathy. This variation correlates with a more severe phenotype of the disease, mainly in younger individuals. Genetic analysis in families, even asymptomatic individuals, enables early identification of individuals at risk and allows implementation of preventive measures.	[Toro, Rocio; Mangas, Alipio] Sch Med, Dept Med, Cadiz, Spain; [Perez-Serra, Alexandra; Campuzano, Oscar; Moncayo-Arlandi, Javier; Allegue, Catarina; Iglesias, Anna; Brugada, Ramon] Univ Girona, IDIBGI, Cardiovasc Genet Ctr, Girona, Spain; [Campuzano, Oscar; Brugada, Ramon] Univ Girona, Sch Med, Dept Med Sci, Girona, Spain; [Brugada, Ramon] Univ Girona, Hosp Josep Trueta, Cardiac Genet Unit, Girona, Spain	Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Universitat de Girona; Universitat de Girona; Girona University Hospital Dr. Josep Trueta	Brugada, R (corresponding author), Univ Girona, IDIBGI, Cardiovasc Genet Ctr, Girona, Spain.; Brugada, R (corresponding author), Univ Girona, Sch Med, Dept Med Sci, Girona, Spain.; Brugada, R (corresponding author), Univ Girona, Hosp Josep Trueta, Cardiac Genet Unit, Girona, Spain.	ramon@brugada.org	campuzano, oscar/J-1968-2014; Toro, Rocio/AEU-8689-2022; Mangas, Alipio/AAN-2722-2020	campuzano, oscar/0000-0001-5298-5276; Toro, Rocio/0000-0003-3136-1776; Mangas, Alipio/0000-0002-5402-6674; ALLEGUE TOSCANO, CATARINA/0000-0002-5121-3159; Moncayo-Arlandi, Javier/0000-0002-3564-4063	Obra Social "la Caixa"	Obra Social "la Caixa"(La Caixa Foundation)	This work was supported by Obra Social "la Caixa". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinrinade O, 2015, EUR HEART J, V36, P2327, DOI 10.1093/eurheartj/ehv253; Arimura T, 2011, HUM MUTAT, V32, P1481, DOI 10.1002/humu.21603; Bruch C, 2003, J AM SOC ECHOCARDIOG, V16, P1031, DOI 10.1016/S0894-7317(03)00634-5; Cuenca S, 2016, THE JOURNAL OF HEART; De Backer J, 2005, Eur J Echocardiogr, V6, P243, DOI 10.1016/j.euje.2004.09.010; De Marco M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.8; De Marco M, 2014, JACC-HEART FAIL, V2, P673, DOI 10.1016/j.jchf.2014.05.012; Fatkin D, 2011, CIRC-CARDIOVASC GENE, V4, P342, DOI 10.1161/CIRCGENETICS.110.958918; Feldman AM, 2014, J CELLULAR PHYSL; Flachskampf FA, 2007, HERZ, V32, P89, DOI 10.1007/s00059-007-2960-9; Franaszczyk M, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-192; Garnier S, 2015, INT J CARDIOL, V189, P105, DOI 10.1016/j.ijcard.2015.04.003; Gupta P, 2010, BASIC RES CARDIOL, V105, P365, DOI 10.1007/s00395-010-0085-4; Haas J, 2015, EUR HEART J, V36, P1123, DOI 10.1093/eurheartj/ehu301; Hershberger RE, 2011, J AM COLL CARDIOL, V57, P1641, DOI 10.1016/j.jacc.2011.01.015; Hershberger RE, 2010, GENET MED, V12, P655, DOI 10.1097/GIM.0b013e3181f2481f; Hishiya A, 2010, CIRC RES, V107, P1220, DOI 10.1161/CIRCRESAHA.110.225649; Homma S, 2006, AM J PATHOL, V169, P761, DOI 10.2353/ajpath.2006.060250; Jefferies JL, 2010, LANCET, V375, P752, DOI 10.1016/S0140-6736(09)62023-7; Knezevic T, 2015, HEART FAIL REV, V20, P423, DOI 10.1007/s10741-015-9487-6; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Marco-Sola S, 2012, NAT METHODS, V9, P1185, DOI [10.1038/NMETH.2221, 10.1038/nmeth.2221]; Morales A, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-013-0375-1; Norton N, 2011, AM J HUM GENET, V88, P273, DOI 10.1016/j.ajhg.2011.01.016; Odgerel Z, 2010, NEUROMUSCULAR DISORD, V20, P438, DOI 10.1016/j.nmd.2010.05.004; Perez-Serra A, 2015, J CARD FAIL, V21, P217, DOI 10.1016/j.cardfail.2014.12.003; Selcen D, 2009, ANN NEUROL, V65, P83, DOI 10.1002/ana.21553; Takayama S, 1999, J BIOL CHEM, V274, P781, DOI 10.1074/jbc.274.2.781; van Rijsingen IAW, 2012, J AM COLL CARDIOL, V59, P493, DOI 10.1016/j.jacc.2011.08.078; Villard E, 2011, EUR HEART J, V32, P1065, DOI 10.1093/eurheartj/ehr105	31	26	27	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158730	10.1371/journal.pone.0158730	http://dx.doi.org/10.1371/journal.pone.0158730			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391596	gold, Green Published, Green Submitted			2022-12-27	WOS:000380005400110
J	Dziewit, L; Radlinska, M				Dziewit, Lukasz; Radlinska, Monika			Two Inducible Prophages of an Antarctic Pseudomonas sp ANT_H14 Use the Same Capsid for Packaging Their Genomes - Characterization of a Novel Phage Helper-Satellite System	PLOS ONE			English	Article							ESCHERICHIA-COLI DEFICIENT; PATHOGENICITY ISLAND; CHROMOSOMAL ISLANDS; LAMBDOID PHAGE; HIM MUTANTS; BACTERIOPHAGE; DNA; TEMPERATE; GENES; INTEGRATION	Two novel prophages phi AH14a and phi AH14b of a psychrotolerant Antarctic bacterium Pseudomonas sp. ANT_H14 have been characterized. They were simultaneously induced with mitomycin C and packed into capsids of the same size and protein composition. The genome sequences of phi AH14a and phi AH14b have been determined. phi AH14b, the phage with a smaller genome (16,812 bp) seems to parasitize phi AH14a (55,060 bp) and utilizes its capsids, as only the latter encodes a complete set of structural proteins. Both viruses probably constitute a phage helper-satellite system, analogous to the P2-P4 duo. This study describes the architecture and function of the phi AH14a and phi AH14b genomes. Moreover, a functional analysis of a phi AH14a-encoded lytic enzyme and a DNA methyltransferase was performed. In silico analysis revealed the presence of the homologs of phi AH14a and phi AH14b in other Pseudomonas genomes, which may suggest that helper-satellite systems related to the one described in this work are common in pseudomonads.	[Dziewit, Lukasz] Univ Warsaw, Inst Microbiol, Dept Bacterial Genet, Fac Biol, Warsaw, Poland; [Radlinska, Monika] Univ Warsaw, Inst Microbiol, Dept Virol, Fac Biol, Warsaw, Poland	University of Warsaw; University of Warsaw	Radlinska, M (corresponding author), Univ Warsaw, Inst Microbiol, Dept Virol, Fac Biol, Warsaw, Poland.	m.radlinska@biol.uw.edu.pl	Dziewit, Lukasz/L-1131-2016	Dziewit, Lukasz/0000-0002-5057-2811; Radlinska, Monika/0000-0001-6818-8685	National Science Centre, Poland [DEC-2013/09/D/NZ8/03046]; European Union-the European Regional Development Fund [POIG.02.02.00-14-024/08-00]	National Science Centre, Poland(National Science Centre, Poland); European Union-the European Regional Development Fund	This work was supported by the National Science Centre, Poland (grant number DEC-2013/09/D/NZ8/03046). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Krzysztof Skowronek for useful comments and critical reading of the manuscript. This work was supported by the National Science Centre, Poland (grant no. DEC-2013/09/D/NZ8/03046). Library construction and phage genomes assembly was carried out at the DNA Sequencing and Oligonucleotide Synthesis Laboratory IBB PAS using the CePT infrastructure financed by the European Union-the European Regional Development Fund [Innovative economy 2007-13, Agreement POIG.02.02.00-14-024/08-00].	Al-Hasani K, 2001, MICROB PATHOGENESIS, V30, P1, DOI 10.1006/mpat.2000.0404; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Tormo MA, 2008, J BACTERIOL, V190, P2434, DOI 10.1128/JB.01349-07; Asadulghani M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000408; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bandyopadhyay K, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-34; Belcaid M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S9-S10; Bishop AL, 2005, J BACTERIOL, V187, P2469, DOI 10.1128/JB.187.7.2469-2482.2005; Bobay LM, 2014, P NATL ACAD SCI USA, V111, P12127, DOI 10.1073/pnas.1405336111; BUTKUS V, 1987, NUCLEIC ACIDS RES, V15, P7091, DOI 10.1093/nar/15.17.7091; Byrne M, 2005, GENE, V346, P187, DOI 10.1016/j.gene.2004.11.001; CALENDAR R, 1981, VIROLOGY, V113, P20, DOI 10.1016/0042-6822(81)90133-1; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; Casjens Sherwood R., 2009, V502, P91, DOI 10.1007/978-1-60327-565-1_7; Catalano CE, 2000, CELL MOL LIFE SCI, V57, P128, DOI 10.1007/s000180050503; Ceyssens PJ, 2010, FUTURE MICROBIOL, V5, P1041, DOI 10.2217/FMB.10.66; Christie GE, 2012, VIROLOGY, V434, P210, DOI 10.1016/j.virol.2012.10.028; Di Lallo G, 2014, J BASIC MICROB, V54, P1210, DOI 10.1002/jobm.201300951; Domka J, 2007, ENVIRON MICROBIOL, V9, P332, DOI 10.1111/j.1462-2920.2006.01143.x; Drozdz M, 2012, NUCLEIC ACIDS RES, V40, P2119, DOI 10.1093/nar/gkr1039; Dziewit L, 2014, J VIROL, V88, P13111, DOI 10.1128/JVI.01875-14; Frigols B, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005609; Garcia P, 2008, APPL ENVIRON MICROB, V74, P7552, DOI 10.1128/AEM.01709-08; HAYASHI S, 1990, J BIOENERG BIOMEMBR, V22, P451, DOI 10.1007/BF00763177; HENTHORN KS, 1995, J BACTERIOL, V177, P3185, DOI 10.1128/jb.177.11.3185-3190.1995; Hernandez-Sanchez J, 2008, ARCH VIROL, V153, P1271, DOI 10.1007/s00705-008-0111-0; Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499; Hulo N, 2004, NUCLEIC ACIDS RES, V32, pD134, DOI 10.1093/nar/gkh044; INOUYE S, 1991, SCIENCE, V252, P969, DOI 10.1126/science.1709758; Santamaria RI, 2014, APPL ENVIRON MICROB, V80, P446, DOI 10.1128/AEM.02256-13; Iyer LM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r60; Jung K, 2012, CURR OPIN MICROBIOL, V15, P118, DOI 10.1016/j.mib.2011.11.009; Keen Eric C, 2014, Bacteriophage, V4, pe28365; KIRBY JE, 1994, J BACTERIOL, V176, P2068, DOI 10.1128/jb.176.7.2068-2081.1994; Kropinski AM, 2000, J BACTERIOL, V182, P6066, DOI 10.1128/JB.182.21.6066-6074.2000; Kropinski AM, 2009, ENVIRON MICROBIOL, V11, P2775, DOI 10.1111/j.1462-2920.2009.01970.x; Kumar Ritesh, 2013, Subcell Biochem, V61, P81, DOI 10.1007/978-94-007-4525-4_4; Kung VL, 2010, MICROBIOL MOL BIOL R, V74, P621, DOI 10.1128/MMBR.00027-10; Laanto E, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00829; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Latino L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093777; Leplae R, 2004, NUCLEIC ACIDS RES, V32, pD45, DOI 10.1093/nar/gkh084; LINDQVIST BH, 1993, MICROBIOL REV, V57, P683, DOI 10.1128/MMBR.57.3.683-702.1993; Lindsay JA, 1998, MOL MICROBIOL, V29, P527, DOI 10.1046/j.1365-2958.1998.00947.x; Lopes A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1027; Lynch KH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-599; MARVIK OJ, 1994, VIROLOGY, V205, P51, DOI 10.1006/viro.1994.1619; MOZOLA MA, 1985, VIROLOGY, V140, P313, DOI 10.1016/0042-6822(85)90368-X; MOZOLA MA, 1985, VIROLOGY, V140, P328, DOI 10.1016/0042-6822(85)90369-1; Nilssen O, 1996, VIROLOGY, V219, P432, DOI 10.1006/viro.1996.0269; Niu YD, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0494-5; Novick RP, 2010, NAT REV MICROBIOL, V8, P541, DOI 10.1038/nrmicro2393; Penades JR, 2015, ANNU REV VIROL, V2, P181, DOI 10.1146/annurev-virology-031413-085446; PIERSON LS, 1987, J MOL BIOL, V196, P487, DOI 10.1016/0022-2836(87)90026-X; Ram G, 2012, P NATL ACAD SCI USA, V109, P16300, DOI 10.1073/pnas.1204615109; Refardt D, 2011, ISME J, V5, P1451, DOI 10.1038/ismej.2011.30; Rice SA, 2009, ISME J, V3, P271, DOI 10.1038/ismej.2008.109; Roberts RJ, 2015, NUCLEIC ACIDS RES, V43, pD298, DOI 10.1093/nar/gku1046; Sambrook J., 2001, MOL CLONING LAB MANU; Samson JE, 2013, NAT REV MICROBIOL, V11, P675, DOI 10.1038/nrmicro3096; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Schubert RA, 2007, GENE DEV, V21, P2461, DOI 10.1101/gad.1584907; Sepulveda-Robles O, 2012, APPL ENVIRON MICROB, V78, P4510, DOI 10.1128/AEM.00065-12; SHORE D, 1978, P NATL ACAD SCI USA, V75, P400, DOI 10.1073/pnas.75.1.400; Silby MW, 2011, FEMS MICROBIOL REV, V35, P652, DOI 10.1111/j.1574-6976.2011.00269.x; SIX EW, 1991, VIROLOGY, V182, P34, DOI 10.1016/0042-6822(91)90645-R; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Summer EJ, 2004, J MOL BIOL, V340, P49, DOI 10.1016/j.jmb.2004.04.053; Svenningsen SL, 2005, P NATL ACAD SCI USA, V102, P4465, DOI 10.1073/pnas.0409839102; Tokuda H, 2004, BBA-MOL CELL RES, V1693, P5, DOI 10.1016/j.bbamcr.2004.02.005; Uc-Mass A, 2004, VIROLOGY, V329, P425, DOI 10.1016/j.virol.2004.09.005; Vostrov AA, 1996, J BACTERIOL, V178, P1484, DOI 10.1128/jb.178.5.1484-1486.1996; Wang IN, 2000, ANNU REV MICROBIOL, V54, P799, DOI 10.1146/annurev.micro.54.1.799; Wang XX, 2009, ISME J, V3, P1164, DOI 10.1038/ismej.2009.59; Webb JS, 2004, J BACTERIOL, V186, P8066, DOI 10.1128/JB.186.23.8066-8073.2004; Weinbauer MG, 2004, FEMS MICROBIOL REV, V28, P127, DOI 10.1016/j.femsre.2003.08.001; Wietzorrek A, 2006, J BACTERIOL, V188, P1419, DOI 10.1128/JB.188.4.1419-1436.2006; Yeo CC, 1998, PLASMID, V40, P203, DOI 10.1006/plas.1998.1365; Young R, 2002, J MOL MICROB BIOTECH, V4, P21; Zhang N, 1999, MOL GEN GENET, V262, P659, DOI 10.1007/s004380051128; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	84	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158889	10.1371/journal.pone.0158889	http://dx.doi.org/10.1371/journal.pone.0158889			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27387973	gold, Green Published, Green Submitted			2022-12-27	WOS:000379811500060
J	Zador, Z; Sperrin, M; King, AT				Zador, Zsolt; Sperrin, Matthew; King, Andrew T.			Predictors of Outcome in Traumatic Brain Injury: New Insight Using Receiver Operating Curve Indices and Bayesian Network Analysis	PLOS ONE			English	Article							HEAD-INJURY; VALIDATION; MORTALITY; DESIGN; MODELS; CRASH; COMA	Background Traumatic brain injury remains a global health problem. Understanding the relative importance of outcome predictors helps optimize our treatment strategies by informing assessment protocols, clinical decisions and trial designs. In this study we establish importance ranking for outcome predictors based on receiver operating indices to identify key predictors of outcome and create simple predictive models. We then explore the associations between key outcome predictors using Bayesian networks to gain further insight into predictor importance. Methods We analyzed the corticosteroid randomization after significant head injury (CRASH) trial database of 10008 patients and included patients for whom demographics, injury characteristics, computer tomography (CT) findings and Glasgow Outcome Scale (GCS) were recorded (total of 13 predictors, which would be available to clinicians within a few hours following the injury in 6945 patients). Predictions of clinical outcome (death or severe disability at 6 months) were performed using logistic regression models with 5-fold cross validation. Predictive performance was measured using standardized partial area (pAUC) under the receiver operating curve (ROC) and we used Delong test for comparisons. Variable importance ranking was based on pAUC targeted at specificity (pAUC(SP)) and sensitivity (pAUC(SE)) intervals of 90-100%. Probabilistic associations were depicted using Bayesian networks. Results Complete AUC analysis showed very good predictive power (AUC = 0.8237, 95% CI: 0.8138-0.8336) for the complete model. Specificity focused importance ranking highlighted age, pupillary, motor responses, obliteration of basal cisterns/3rd ventricle and midline shift. Interestingly when targeting model sensitivity, the highest-ranking variables were age, severe extracranial injury, verbal response, hematoma on CT and motor response. Simplified models, which included only these key predictors, had similar performance (pAUC(SP) = 0.6523, 95% CI: 0.6402-0.6641 and pAUC(SE) = 0.6332, 95% CI: 0.62-0.6477) compared to the complete models (pAUC(SP) = 0.6664, 95% CI: 0.6543-0.679, pAUC(SE) = 0.6436, 95% CI: 0.6289-0.6585, de Long p value 0.1165 and 0.3448 respectively). Bayesian networks showed the predictors that did not feature in the simplified models were associated with those that did. Conclusion We demonstrate that importance based variable selection allows simplified predictive models to be created while maintaining prediction accuracy. Variable selection targeting specificity confirmed key components of clinical assessment in TBI whereas sensitivity based ranking suggested extracranial injury as one of the important predictors. These results help refine our approach to head injury assessment, decision-making and outcome prediction targeted at model sensitivity and specificity. Bayesian networks proved to be a comprehensive tool for depicting probabilistic associations for key predictors giving insight into why the simplified model has maintained accuracy.	[Zador, Zsolt; King, Andrew T.] Salford Royal Fdn Trust, Dept Neurosurg, Salford, Greater Manches, England; [Zador, Zsolt] Univ Manchester, Ctr Vasc & Stroke Res, Inst Cardiovasc Sci, Manchester, Lancs, England; [Sperrin, Matthew] Univ Manchester, Manchester Acad Hlth Sci Ctr, Hlth eRes Ctr, Farr Inst, Manchester, Lancs, England	Salford Royal NHS Foundation Trust; University of Manchester; University of Manchester	Zador, Z (corresponding author), Salford Royal Fdn Trust, Dept Neurosurg, Salford, Greater Manches, England.; Zador, Z (corresponding author), Univ Manchester, Ctr Vasc & Stroke Res, Inst Cardiovasc Sci, Manchester, Lancs, England.	zadzso@gmail.com	King, Andrew/AAR-1656-2020	Sperrin, Matthew/0000-0002-5351-9960; Zador, Zsolt/0000-0001-9767-3372; King, Andrew/0000-0002-6546-7248	National Institute for Health and Research; University of Manchester's Health eResearch Centre (HeRC) - Medical Research Council Grant [MR/K006665/1]; Medical Research Council [MC_PC_13042, MR/K006665/1] Funding Source: researchfish; National Institute for Health Research [CL-2014-06-004] Funding Source: researchfish; MRC [MR/K006665/1] Funding Source: UKRI	National Institute for Health and Research; University of Manchester's Health eResearch Centre (HeRC) - Medical Research Council Grant; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	ZZ is an Academic Clinical Lecturer Funded by the National Institute for Health and Research. MS is supported by the University of Manchester's Health eResearch Centre (HeRC) funded by the Medical Research Council Grant MR/K006665/1.	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; [Anonymous], 2021, LANG ENV STAT COMP; Bateman DE, 2001, J NEUROL NEUROSUR PS, V71, P13; Cai ZQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120805; Chen Jeff W, 2011, Surg Neurol Int, V2, P82, DOI 10.4103/2152-7806.82248; Chiu WT, 2000, AM J PUBLIC HEALTH, V90, P793, DOI 10.2105/AJPH.90.5.793; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Edwards P, 2005, LANCET, V365, P1957; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; FOULKES MA, 1991, J NEUROSURG, V75, pS8, DOI 10.3171/sup.1991.75.1s.00s8; Heinzelmann M, 1996, INJURY, V27, P345, DOI 10.1016/0020-1383(95)00223-5; Kehoe A, 2016, EMERG MED J, V33, P381, DOI 10.1136/emermed-2015-205180; Korb K.B., 2004, COM SCI DAT; Lecky F, 2015, EMERG MED J, V32, P906, DOI 10.1136/emermed-2015-205460; Lingsma H, 2013, J TRAUMA ACUTE CARE, V74, P639, DOI 10.1097/TA.0b013e31827d602e; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Marion DW, 2006, NEUROSURGERY, V58, P655; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; MCCLISH DK, 1989, MED DECIS MAKING, V9, P190, DOI 10.1177/0272989X8900900307; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Nagarajan R, 2013, BAYESIAN NETWORKS R; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Patel HC, 2010, ACTA NEUROCHIR, V152, P1353, DOI 10.1007/s00701-010-0666-x; Perdue PW, 1998, J TRAUMA, V45, P805, DOI 10.1097/00005373-199810000-00034; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sesen MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082349; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; TEASDALE G, 1974, LANCET, V2, P81; The CRASH trial management group, 2001, BMC Emerg Med, V1, P1; Turck N, 2010, INTENS CARE MED, V36, P107, DOI 10.1007/s00134-009-1641-y; van Leeuwen N, 2012, NEUROSURGERY, V70, P811, DOI 10.1227/NEU.0b013e318235d640; Wong George K C, 2011, J Emerg Trauma Shock, V4, P346, DOI 10.4103/0974-2700.83861; Wong GKC, 2013, J CLIN NEUROSCI, V20, P1693, DOI 10.1016/j.jocn.2012.12.032	39	27	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158762	10.1371/journal.pone.0158762	http://dx.doi.org/10.1371/journal.pone.0158762			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27388421	Green Published, gold, Green Submitted			2022-12-27	WOS:000379811500043
J	Chai, YJ; Yi, JW; Jee, HG; Kim, YA; Kim, JH; Xing, MZ; Lee, KE				Chai, Young Jun; Yi, Jin Wook; Jee, Hyeon-Gun; Kim, Young A.; Kim, Ju Han; Xing, Mingzhao; Lee, Kyu Eun			Significance of the BRAF mRNA Expression Level in Papillary Thyroid Carcinoma: An Analysis of The Cancer Genome Atlas Data	PLOS ONE			English	Article							BRAF(V600E) MUTATION; V600E MUTATION; IMMUNOHISTOCHEMICAL DETECTION; PROTEIN EXPRESSION; SIGNALING PATHWAY; ACTIVATION; PREDICTS; RET/PTC; RISK; MICROCARCINOMA	Background BRAF(V600E) is the most common mutation in papillary thyroid carcinoma (PTC), and it is associated with high-risk prognostic factors. However, the significance of the BRAF mRNA level in PTC remains unknown. We evaluated the significance of BRAF mRNA expression level by analyzing PTC data from The Cancer Genome Atlas (TCGA) database. Methods Data from 499 patients were downloaded from the TCGA database. After excluding other PTC variants, we selected 353 cases of classic PTC, including 193 cases with BRAF(V600E) and 160 cases with the wild-type BRAF. mRNA abundances were measured using RNA-Seq with the Expectation Maximization algorithm. Results The mean BRAF mRNA level was significantly higher in BRAF(V600E) patients than in patients with wild-type BRAF (197.6 vs. 179.3, p = 0.031). In wild-type BRAF patients, the mean BRAF mRNA level was higher in cases with a tumor > 2 cm than those with a tumor <= 2.0 cm (189.4 vs. 163.8, p = 0.046), and was also higher in cases with lymph node metastasis than in those without lymph node metastasis (188.5 vs. 157.9, p = 0.040). Within BRAF(V600E) patients, higher BRAF mRNA expression was associated with extrathyroidal extension (186.4 vs. 216.4, p = 0.001) and higher T stage (188.1 vs. 210.2, p = 0.016). Conclusions A higher BRAF mRNA expression level was associated with tumor aggressiveness in classic PTC regardless of BRAF mutational status. Evaluation of BRAF mRNA level may be helpful in prognostic risk stratification of PTC.	[Chai, Young Jun] Seoul Natl Univ, Boramae Med Ctr, Dept Surg, 20 Boramae Ro 5 Gil, Seoul 15670, South Korea; [Chai, Young Jun; Yi, Jin Wook; Lee, Kyu Eun] Seoul Natl Univ, Coll Med, Canc Res Inst, 101 Daehak Ro, Seoul 110744, South Korea; [Yi, Jin Wook; Lee, Kyu Eun] Seoul Natl Univ Hosp, Dept Surg, 101 Daehak Ro, Seoul 110744, South Korea; [Yi, Jin Wook; Lee, Kyu Eun] Coll Med, 101 Daehak Ro, Seoul 110744, South Korea; [Jee, Hyeon-Gun] Natl Med Ctr, Ctr Chron Dis, Res Inst, Seoul, South Korea; [Kim, Young A.] Seoul Natl Univ, Boramae Med Ctr, Dept Pathol, 20 Boramae Ro 5 Gil, Seoul 15670, South Korea; [Kim, Ju Han] Seoul Natl Univ, Coll Med, Syst Biomed Informat Res Ctr, Div Biomed Informat, 101 Daehak Ro, Seoul, South Korea; [Xing, Mingzhao] Johns Hopkins Univ, Sch Med, Div Endocrinol & Metab, 1830E Monument St,Ste 333, Baltimore, MD 21287 USA	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; National Medical Center - Korea; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Johns Hopkins University	Lee, KE (corresponding author), Seoul Natl Univ, Coll Med, Canc Res Inst, 101 Daehak Ro, Seoul 110744, South Korea.; Lee, KE (corresponding author), Seoul Natl Univ Hosp, Dept Surg, 101 Daehak Ro, Seoul 110744, South Korea.; Lee, KE (corresponding author), Coll Med, 101 Daehak Ro, Seoul 110744, South Korea.	kyu.eun.lee.md@snu.ac.kr	Chai, Young/AAW-6684-2021	Chai, Young Jun/0000-0001-8830-3433; Yi, Jin Wook/0000-0002-9296-8443	Korean Foundation for Cancer Research [CB-2011-03-01]; Korean Health Technology R&D Project, Ministry of Health and Welfare [HI13C2164]	Korean Foundation for Cancer Research; Korean Health Technology R&D Project, Ministry of Health and Welfare	This study was conducted with research grants from the Korean Foundation for Cancer Research (Grant Number: CB-2011-03-01) and the Korean Health Technology R&D Project, Ministry of Health and Welfare (HI13C2164). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubaker J, 2008, J CLIN ENDOCR METAB, V93, P611, DOI 10.1210/jc.2007-1717; Agrawal N, 2014, CELL, V159, P676, DOI 10.1016/j.cell.2014.09.050; Ahn D, 2012, AURIS NASUS LARYNX, V39, P198, DOI 10.1016/j.anl.2011.07.011; Ardekani GS, 2013, BRIT J DERMATOL, V169, P320, DOI 10.1111/bjd.12351; Chai YJ, 2014, SURGERY, V156, P1559, DOI 10.1016/j.surg.2014.08.050; Cheng SP, 2014, ANN SURG ONCOL, V21, pS619, DOI 10.1245/s10434-014-3723-5; Araujo PPC, 2012, PATHOL RES PRACT, V208, P489, DOI 10.1016/j.prp.2012.05.013; Crescenzi A, 2014, HORM METAB RES, V46, P370, DOI 10.1055/s-0034-1368700; Csardi G, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005206; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; de Biase D, 2014, J CLIN ENDOCR METAB, V99, pE1530, DOI 10.1210/jc.2013-4389; Finkel A, 2016, J CLIN ENDOCR METAB, V101, P1407, DOI 10.1210/jc.2015-4031; Ghossein RA, 2013, J CLIN ENDOCR METAB, V98, pE1414, DOI 10.1210/jc.2013-1408; Guerra A, 2012, J CLIN ENDOCR METAB, V97, P2333, DOI 10.1210/jc.2011-3106; Guerra A, 2012, J CLIN ENDOCR METAB, V97, P517, DOI 10.1210/jc.2011-0618; Ilie MI, 2014, THYROID, V24, P858, DOI 10.1089/thy.2013.0302; Ito Y, 2009, ENDOCR J, V56, P89, DOI 10.1507/endocrj.K08E-208; Kim MH, 2014, ENDOCR-RELAT CANCER, V21, P891, DOI 10.1530/ERC-14-0147; Kim TH, 2012, CANCER-AM CANCER SOC, V118, P1764, DOI 10.1002/cncr.26500; Kimura ET, 2003, CANCER RES, V63, P1454; Kondo T, 2007, HUM PATHOL, V38, P1810, DOI 10.1016/j.humpath.2007.04.014; Koperek O, 2012, AM J SURG PATHOL, V36, P844, DOI 10.1097/PAS.0b013e318246b527; Koussounadis A, 2015, SCI REP-UK, V5, DOI 10.1038/srep10775; Lang BHH, 2014, ENDOCR-RELAT CANCER, V21, P285, DOI 10.1530/ERC-13-0291; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li F, 2015, ENDOCR-RELAT CANCER, V22, P159, DOI 10.1530/ERC-14-0531; Mitsutake N, 2006, ENDOCRINOLOGY, V147, P1014, DOI 10.1210/en.2005-0280; Nam JK, 2012, AM J SURG, V203, P436, DOI 10.1016/j.amjsurg.2011.02.013; Nixon IJ, 2016, THYROID, V26, P373, DOI 10.1089/thy.2015.0315; Ouyang B, 2006, CLIN CANCER RES, V12, P1785, DOI 10.1158/1078-0432.CCR-05-1729; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Shi HB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1727; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Steelman LS, 2010, CELL CYCLE, V9, P1629, DOI 10.4161/cc.9.8.11487; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Walczyk A, 2014, CLIN ENDOCRINOL, V80, P899, DOI 10.1111/cen.12386; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Xing M, 2005, ENDOCR-RELAT CANCER, V12, P245, DOI 10.1677/erc.1.0978; Xing MZ, 2007, ENDOCR REV, V28, P742, DOI 10.1210/er.2007-0007; Xing MZ, 2015, J CLIN ONCOL, V33, P42, DOI 10.1200/JCO.2014.56.8253; Xing MZ, 2013, JAMA-J AM MED ASSOC, V309, P1493, DOI 10.1001/jama.2013.3190; Xing MZ, 2012, J CLIN ENDOCR METAB, V97, P2295, DOI 10.1210/jc.2012-2201; Xing MZ, 2010, MOL CELL ENDOCRINOL, V321, P86, DOI 10.1016/j.mce.2009.10.012; Xing MZ, 2005, J CLIN ENDOCR METAB, V90, P6373, DOI 10.1210/jc.2005-0987; Zagzag J, 2013, SURGERY, V154, P1199, DOI 10.1016/j.surg.2013.06.020; Zimmermann AK, 2014, CANCER CYTOPATHOL, V122, P48, DOI 10.1002/cncy.21352	47	9	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159235	10.1371/journal.pone.0159235	http://dx.doi.org/10.1371/journal.pone.0159235			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410688	gold, Green Published, Green Submitted			2022-12-27	WOS:000379508300067
J	Kripke, K; Chen, PA; Vazzano, A; Thambinayagam, A; Pillay, Y; Loykissoonlal, D; Bonnecwe, C; Barron, P; Kiwango, E; Castor, D; Njeuhmeli, E				Kripke, Katharine; Chen, Ping-An; Vazzano, Andrea; Thambinayagam, Ananthy; Pillay, Yogan; Loykissoonlal, Dayanund; Bonnecwe, Collen; Barron, Peter; Kiwango, Eva; Castor, Delivette; Njeuhmeli, Emmanuel			Cost and Impact of Voluntary Medical Male Circumcision in South Africa: Focusing the Program on Specific Age Groups and Provinces	PLOS ONE			English	Article							HIV PREVENTION; TRIAL; MEN	Background In 2012, South Africa set a goal of circumcising 4.3 million men ages 15-49 by 2016. By the end of March 2014, 1.9 million men had received voluntary medical male circumcision (VMMC). In an effort to accelerate progress, South Africa undertook a modeling exercise to determine whether circumcising specific client age groups or geographic locations would be particularly impactful or cost-effective. Results will inform South Africa's efforts to develop a national strategy and operational plan for VMMC. Methods and Findings The study team populated the Decision Makers' Program Planning Tool, Version 2.0 (DMPPT 2.0) with HIV incidence projections from the Spectrum/AIDS Impact Module (AIM), as well as national and provincial population and HIV prevalence estimates. We derived baseline circumcision rates from the 2012 South African National HIV Prevalence, Incidence and Behaviour Survey. The model showed that circumcising men ages 20-34 offers the most immediate impact on HIV incidence and requires the fewest circumcisions per HIV infection averted. The greatest impact over a 15-year period is achieved by circumcising men ages 15-24. When the model assumes a unit cost increase with client age, men ages 15-29 emerge as the most cost-effective group. When we assume a constant cost for all ages, the most cost-effective age range is 15-34 years. Geographically, the program is cost saving in all provinces; differences in the VMMC program's cost-effectiveness across provinces were obscured by uncertainty in HIV incidence projections. Conclusion The VMMC program's impact and cost-effectiveness vary by age-targeting strategy. A strategy focusing on men ages 15-34 will maximize program benefits. However, because clients older than 25 access VMMC services at low rates, South Africa could consider promoting demand among men ages 25-34, without denying services to those in other age groups. Uncertainty in the provincial estimates makes them insufficient to support geographic targeting.	[Kripke, Katharine] Avenir Hlth, Hlth Policy Project, Washington, DC USA; [Chen, Ping-An; Vazzano, Andrea] Futures Grp Inc, Hlth Policy Project, Washington, DC USA; [Thambinayagam, Ananthy] US Agcy Int Dev, Pretoria, South Africa; [Pillay, Yogan; Loykissoonlal, Dayanund; Bonnecwe, Collen] Natl Dept Hlth, Pretoria, South Africa; [Barron, Peter] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Kiwango, Eva] Joint United Nations Programme HIV AIDS, Pretoria, South Africa; [Castor, Delivette] US Off Global AIDS Coordinator, Washington, DC USA; [Njeuhmeli, Emmanuel] US Agcy Int Dev, Washington, DC USA	United States Agency for International Development (USAID); University of Witwatersrand; United States Agency for International Development (USAID)	Kripke, K (corresponding author), Avenir Hlth, Hlth Policy Project, Washington, DC USA.	kkripke@avenirhealth.org	Kripke, Katharine/J-2146-2019	Kripke, Katharine/0000-0001-8228-4577; Vazzano, Andrea/0000-0001-9653-4151	American people through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR); U.S. Agency for International Development (USAID) [AID-OAA-A-10-00067, AID-OAA-14-00026]; USAID; PEPFAR	American people through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR); U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID)); USAID(United States Agency for International Development (USAID)); PEPFAR	This manuscript is made possible by the generous support of the American people through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) with the U.S. Agency for International Development (USAID) under the Cooperative Agreement Health Policy Project, Agreement No. AID-OAA-A-10-00067, beginning September 30, 2010, and Cooperative Agreement Project SOAR (Supporting Operational AIDS Research), number AID-OAA-14-00026. The Health Policy Project is implemented by Futures Group, in collaboration with Plan International USA, Avenir Health (formerly Futures Institute), Partners in Population and Development, Africa Regional Office (PPD ARO), Population Reference Bureau (PRB), RTI International, and the White Ribbon Alliance for Safe Motherhood (WRA). The funder was involved in study design, decision to publish, and preparation of the manuscript. The findings and conclusions in this paper do not necessarily represent the views or positions of PEPFAR, USAID, or the U.S. Government.; John Stover of Avenir Health developed the DMPPT 2.0 model at the request of USAID, under the USAID- and PEPFAR-funded Health Policy Project. The authors gratefully acknowledge the South Africa National Department of Health for providing data and critical feedback and James Ndirangu and Jorge Quevedo of the Clinton Health Access Initiative for providing some of the compiled and cleaned historical program data. We thank Carlos Toledo and Alfred Bere of the U.S. Centers for Disease Control and Prevention in the United States and South Africa, respectively, for their thorough review of and input into the manuscript in its development stages. We thank the PEPFAR VMMC Technical Working Group, colleagues from the U.S. Centers for Disease Control and Prevention in Pretoria, Jason Reed, and Sema Sgaier for their feedback, helpful discussion, and information sharing. We also thank Carel Pretorius of Avenir Health for assisting with the provincial analyses in this manuscript. We are also grateful to Melissa Schnure for assistance with some of the analyses, figure preparation, and overall management of the manuscript preparation process. Finally, the authors would like to thank the publications staff at the Health Policy Project for their help with copy editing and formatting.	Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; AVAC, 2014, VOL MED MAL CIRC MOD; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hankins C, 2016, PLOS ONE IN PRESS; Khumalo-Sakutukwa G, 2013, CULT HEALTH SEX, V15, P1085, DOI 10.1080/13691058.2013.807519; Kripke K, 2016, PLOS ONE IN PRESS; Kripke K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156909; National Department of Health SA, 2012, GUID PHARM SUBM; National Department of Health SA, 2012, STRAT PLAN SCAL MED; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; Peltzer K, 2009, CULT HEALTH SEX, V11, P83, DOI 10.1080/13691050802389777; Shisana O, 2014, S AFRICAN NATL HIV P; Stover J, 2014, AIDS, V28, pS427, DOI 10.1097/QAD.0000000000000483; Tchuenche T, 2016, PLOS ONE IN PRESS; UNAIDS/WHO, 2007, NEW DAT MAL CIRC HIV	16	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0157071	10.1371/journal.pone.0157071	http://dx.doi.org/10.1371/journal.pone.0157071			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27409079	Green Published, gold			2022-12-27	WOS:000379508300005
J	Njeuhmeli, E; Stegman, P; Kripke, K; Mugurungi, O; Ncube, G; Xaba, S; Hatzold, K; Christensen, A; Stover, J				Njeuhmeli, Emmanuel; Stegman, Peter; Kripke, Katharine; Mugurungi, Owen; Ncube, Gertrude; Xaba, Sinokuthemba; Hatzold, Karin; Christensen, Alice; Stover, John			Modeling Costs and Impacts of Introducing Early Infant Male Circumcision for Long-Term Sustainability of the Voluntary Medical Male Circumcision Program	PLOS ONE			English	Article							HIV PREVENTION; TRIAL; MEN	Voluntary medical male circumcision (VMMC) has been shown to be an effective prevention strategy against HIV infection in males [1-3]. Since 2007, the President's Emergency Plan for AIDS Relief (PEPFAR) has supported VMMC programs in 14 priority countries in Africa. Today several of these countries are preparing to transition their VMMC programs from a scale-up and expansion phase to a maintenance phase. As they do so, they must consider the best approaches to sustain high levels of male circumcision in the population. The two alternatives under consideration are circumcising adolescents 10-14 years old over the long term or integrating early infant male circumcision (EIMC) into maternal and child health programs. The paper presents an analysis, using the Decision Makers Program Planning Tool, Version 2.0 (DMPPT 2.0), of the estimated cost and impact of introducing EIMC into existing VMMC programs in several countries in eastern and southern Africa. Limited cost data exist for the implementation of EIMC, but preliminary studies, such as the one detailed in Mangenah, et al. [4-5], suggest that the cost of EIMC may be less than that of adolescent and adult male circumcision. If this is the case, then adding EIMC to the VMMC program will increase the number of circumcisions that need to be performed but will not increase the total cost of the program over the long term. In addition, we found that a delayed or slow start-up of EIMC would not substantially reduce the impact of adding it to the program or increase cumulative long-term costs, which should make introduction of EIMC more feasible and attractive to countries contemplating such a program innovation.	[Njeuhmeli, Emmanuel] US Agcy Int Dev, Washington, DC 20523 USA; [Stegman, Peter; Kripke, Katharine; Stover, John] Avenir Hlth, Hlth Policy Project, Glastonbury, CT USA; [Mugurungi, Owen; Ncube, Gertrude; Xaba, Sinokuthemba] Minist Hlth & Child Care, Harare, Zimbabwe; [Hatzold, Karin] Populat Serv Int, Harare, Zimbabwe; [Christensen, Alice] AIDSFree Project, Dar Es Salaam, Tanzania	United States Agency for International Development (USAID)	Njeuhmeli, E (corresponding author), US Agcy Int Dev, Washington, DC 20523 USA.	enjeuhmeli@usaid.gov	Kripke, Katharine/J-2146-2019	Kripke, Katharine/0000-0001-8228-4577	American people through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR); U.S. Agency for International Development (USAID) [AID-OAA-A-10-00067, AID-OAA-14-00026]; USAID	American people through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR); U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID)); USAID(United States Agency for International Development (USAID))	This manuscript is made possible by the generous support of the American people through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) with the U.S. Agency for International Development (USAID) under the Cooperative Agreement Health Policy Project, Agreement No. AID-OAA-A-10-00067, beginning September 30, 2010, and Cooperative Agreement Project SOAR (Supporting Operational AIDS Research), number AID-OAA-14-00026. The Health Policy Project is implemented by Futures Group, in collaboration with Plan International USA, Avenir Health (formerly Futures Institute), Partners in Population and Development, Africa Regional Office (PPD ARO), Population Reference Bureau (PRB), RTI International, and the White Ribbon Alliance for Safe Motherhood (WRA). The funder was involved in study design, decision to publish, and preparation of the manuscript. The findings and conclusions in this paper do not necessarily represent the views or positions of PEPFAR, USAID, or the U.S. Government.; John Stover of Avenir Health developed the DMPPT 2.0 model at the request of USAID, under the USAID-funded Health Policy Project. The authors gratefully acknowledge the Zimbabwe Ministry of Health and Child Care for providing data for this analysis. We also thank the United Nations Children's Fund and the PEPFAR VMMC Technical Working Group for their feedback, helpful discussion, and information sharing. We thank Melissa Schnure for assistance with some of the analyses, figure preparation, and overall management of the manuscript preparation process. The authors are also grateful to the publications staff at AIDSFree for their assistance with copy editing and formatting.	Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hankins C, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000109; Kripke K, 2016, PLOS ONE; Mangenah C, 2016, GLOB HLTH SCI PRA S1, V4; Mangenah C, 2015, JAIDS-J ACQ IMM DEF, V69, P560, DOI 10.1097/QAI.0000000000000699; Ministry of Health and Child Care, ACC STRAT OP PLAN 20; WHO/UNAIDS (Word Health Organization-United Nations Programme on HIV/AIDS, 2010, NEON CHILD MAL CIRC; World Health Organization (WHO)/Joint United Nations Programme on HIV/AIDS (UNAIDS), 2010, JOINT STRAT ACT FRAM; ZimStat ICF International, 2012, ZIMB DEM HLTH SURV 2	11	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159167	10.1371/journal.pone.0159167	http://dx.doi.org/10.1371/journal.pone.0159167			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410233	gold, Green Published			2022-12-27	WOS:000379508300064
J	Joseph, TT; Mincer, JS				Joseph, Thomas T.; Mincer, Joshua S.			Common Internal Allosteric Network Links Anesthetic Binding Sites in a Pentameric Ligand-Gated Ion Channel	PLOS ONE			English	Article							GENERAL-ANESTHETICS; TRANSMEMBRANE DOMAIN; DYNAMICS; ACETYLCHOLINE; PROPOFOL; KETAMINE; RECEPTOR; MODULATION; MECHANISMS; SIMULATION	General anesthetics bind reversibly to ion channels, modifying their global conformational distributions, but the underlying atomic mechanisms are not completely known. We examine this issue by way of the model protein Gloeobacter violaceous ligand-gated ion channel (GLIC) using computational molecular dynamics, with a coarse-grained model to enhance sampling. We find that in flooding simulations, both propofol and a generic particle localize to the crystallographic transmembrane anesthetic binding region, and that propofol also localizes to an extracellular region shared with the crystallographic ketamine binding site. Subsequent simulations to probe these binding modes in greater detail demonstrate that ligand binding induces structural asymmetry in GLIC. Consequently, we employ residue interaction correlation analysis to describe the internal allosteric network underlying the coupling of ligand and distant effector sites necessary for conformational change. Overall, the results suggest that the same allosteric network may underlie the actions of various anesthetics, regardless of binding site.	[Joseph, Thomas T.; Mincer, Joshua S.] Icahn Sch Med Mt Sinai, Dept Anesthesiol, New York, NY 10029 USA; [Mincer, Joshua S.] James J Peters Vet Affairs Med Ctr, Bronx, NY USA	Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center	Mincer, JS (corresponding author), Icahn Sch Med Mt Sinai, Dept Anesthesiol, New York, NY 10029 USA.; Mincer, JS (corresponding author), James J Peters Vet Affairs Med Ctr, Bronx, NY USA.	joshua.mincer@mountsinai.org	Mincer, Joshua/B-4785-2008	Mincer, Joshua/0000-0002-2482-3154	Eliasberg Clinical Scientist Training Program of the Department of Anesthesiology at Icahn School of Medicine at Mount Sinai; National Science Foundation's XSEDE program [TG-MCB140093]; Department of Scientific Computing at the Icahn School of Medicine at Mount Sinai	Eliasberg Clinical Scientist Training Program of the Department of Anesthesiology at Icahn School of Medicine at Mount Sinai; National Science Foundation's XSEDE program; Department of Scientific Computing at the Icahn School of Medicine at Mount Sinai	Support to T.T.J. is acknowledged from the Eliasberg Clinical Scientist Training Program of the Department of Anesthesiology at Icahn School of Medicine at Mount Sinai. Computational resources on the Stampede computer cluster at the Texas Advanced Computing Center, University of Texas, were supplied through the National Science Foundation's XSEDE program (allocation TG-MCB140093). This work was supported in part through the computational resources and staff expertise provided by the Department of Scientific Computing at the Icahn School of Medicine at Mount Sinai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraini JH, 2014, ANESTHESIOLOGY, V121, P1018, DOI 10.1097/ALN.0000000000000435; Ahmad S, 2010, J R SOC INTERFACE, V7, pS423, DOI 10.1098/rsif.2010.0190.focus; Bojak I, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00022; Brannigan G, 2010, P NATL ACAD SCI USA, V107, P14122, DOI 10.1073/pnas.1008534107; Brown EN, 2010, NEW ENGL J MED, V363, P2638, DOI 10.1056/NEJMra0808281; Calimet N, 2013, P NATL ACAD SCI USA, V110, pE3987, DOI 10.1073/pnas.1313785110; Carswell CL, 2015, STRUCTURE, V23, P1655, DOI 10.1016/j.str.2015.06.020; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Chen QA, 2010, BIOPHYS J, V99, P1801, DOI 10.1016/j.bpj.2010.07.023; Chen YH, 2006, J BIOL CHEM, V281, P18184, DOI 10.1074/jbc.M600349200; Demerdash ONA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000531; Fourati Z, 2015, ACTA CRYSTALLOGR D, V71, P454, DOI 10.1107/S1399004714026698; Ghosh B, 2013, J BIOL CHEM, V288, P17420, DOI 10.1074/jbc.M113.464040; Hendrickx JFA, 2008, ANESTH ANALG, V107, P494, DOI 10.1213/ane.0b013e31817b859e; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilser VJ, 2007, P NATL ACAD SCI USA, V104, P8311, DOI 10.1073/pnas.0700329104; Howard RJ, 2014, PHARMACOL REV, V66, P396, DOI 10.1124/pr.113.007468; Joseph TT, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002693; Kong YF, 2007, STRUCTURE, V15, P611, DOI 10.1016/j.str.2007.04.002; Kong YF, 2009, PROTEINS, V74, P145, DOI 10.1002/prot.22139; Krasowski MD, 1999, CELL MOL LIFE SCI, V55, P1278, DOI 10.1007/s000180050371; LeBard DN, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002532; Lee U, 2013, ANESTHESIOLOGY, V118, P1264, DOI 10.1097/ALN.0b013e31829103f5; Li XY, 2014, EUR BIOPHYS J BIOPHY, V43, P623, DOI 10.1007/s00249-014-0992-7; Liu RY, 2012, ANESTH ANALG, V114, P947, DOI 10.1213/ANE.0b013e31824c4def; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Mowrey D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064326; Mowrey D, 2013, J AM CHEM SOC, V135, P2172, DOI 10.1021/ja307275v; Negami T, 2014, J COMPUT CHEM, V35, P1835, DOI 10.1002/jcc.23693; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Nury H, 2010, P NATL ACAD SCI USA, V107, P6275, DOI 10.1073/pnas.1001832107; Pan JJ, 2012, STRUCTURE, V20, P1463, DOI 10.1016/j.str.2012.08.009; Pan JJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1703; Periole Xavier, 2013, Methods Mol Biol, V924, P533, DOI 10.1007/978-1-62703-017-5_20; Prevost MS, 2013, J MED CHEM, V56, P4619, DOI 10.1021/jm400374q; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Tieleman DP, 2001, PROTEINS, V44, P63, DOI 10.1002/prot.1073; Towns J, 2014, COMPUT SCI ENG, V16, P62, DOI 10.1109/MCSE.2014.80; Velisetty P, 2014, J BIOL CHEM, V289, P3013, DOI 10.1074/jbc.M113.523050; Weng Y, 2010, ANESTH ANALG, V110, P59, DOI 10.1213/ANE.0b013e3181c4bc69; Willenbring D, 2011, BIOPHYS J, V101, P1905, DOI 10.1016/j.bpj.2011.09.026; Yesylevskyy SO, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000810	43	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0158795	10.1371/journal.pone.0158795	http://dx.doi.org/10.1371/journal.pone.0158795			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27403526	Green Published, gold, Green Submitted			2022-12-27	WOS:000379508200015
J	Kolbeneva, MG; Alexandrov, YI				Kolbeneva, Marina G.; Alexandrov, Yuri I.			Mental Reactivation and Pleasantness Judgment of Experience Related to Vision, Hearing, Skin Sensations, Taste and Olfaction	PLOS ONE			English	Article							NERVOUS-SYSTEM RESPONSES; VISUAL WORD RECOGNITION; AGE-OF-ACQUISITION; MODALITY-EXCLUSIVITY; LEXICAL DECISION; CATEGORY SIZE; FREQUENCY; EMOTIONS; LANGUAGE; IMAGERY	Language acquisition is based on our knowledge about the world and forms through multiple sensory-motor interactions with the environment. We link the properties of individual experience formed at different stages of ontogeny with the phased development of sensory modalities and with the acquisition of words describing the appropriate forms of sensitivity. To test whether early-formed experience related to skin sensations, olfaction and taste differs from later-formed experience related to vision and hearing, we asked Russian-speaking participants to categorize or to assess the pleasantness of experience mentally reactivated by sense-related adjectives found in common dictionaries. It was found that categorizing adjectives in relation to vision, hearing and skin sensations took longer than categorizing adjectives in relation to olfaction and taste. In addition, experience described by adjectives predominantly related to vision, hearing and skin sensations took more time for the pleasantness judgment and generated less intense emotions than that described by adjectives predominantly related to olfaction and taste. Interestingly the dynamics of skin resistance corresponded to the intensity and pleasantness of reported emotions. We also found that sense-related experience described by early-acquired adjectives took less time for the pleasantness judgment and generated more intense and more positive emotions than that described by later-acquired adjectives. Correlations were found between the time of the pleasantness judgment of experience, intensity and pleasantness of reported emotions, age of acquisition, frequency, imageability and length of sense-related adjectives. All in all these findings support the hypothesis that early-formed experience is less differentiated than later-formed experience.	[Kolbeneva, Marina G.; Alexandrov, Yuri I.] Russian Acad Sci, Inst Psychol, VB Shvyrkov Lab Neuronal Bases Mind, Moscow, Russia; [Alexandrov, Yuri I.] Natl Res Univ, Higher Sch Econ, Dept Psychol, Moscow, Russia	Institute of Psychology of Russian Academy of Sciences; Russian Academy of Sciences; HSE University (National Research University Higher School of Economics)	Kolbeneva, MG (corresponding author), Russian Acad Sci, Inst Psychol, VB Shvyrkov Lab Neuronal Bases Mind, Moscow, Russia.	kolbenevamarina@mail.ru	Alexandrov, Yuri/O-6826-2015; Kolbeneva, Marina G./AAD-2163-2022	Alexandrov, Yuri/0000-0002-2644-3016; Kolbeneva, Marina/0000-0002-6171-2162	Russian Science Foundation [14-28-00229]	Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by the Russian Science Foundation grant # 14-28-00229. URL: http://xn-m1afn.xn-p1ai/node/8. MK and YA received this grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDROV LI, 1993, ALCOHOL, V10, P213, DOI 10.1016/0741-8329(93)90038-P; Alexandrov Y.I., 2009, DEV THEORY DIFFERENT, P17; Alexandrov Y.I., 1999, NEURONAL BASES PSYCH, V8, P201, DOI [10.1142/9789814313254_0017, DOI 10.1142/9789814313254_0017]; Alexandrov YI, 2005, COGNITIVE BRAIN RES, V25, P387, DOI 10.1016/j.cogbrainres.2005.08.006; Alexandrov YI, 2001, ACTA PHYSIOL SCAND, V171, P87, DOI 10.1046/j.1365-201x.2001.171001087.x; Alexandrov YI, 1989, PHYSL SIGNIFICANCE A; Alexandrov YI, 1995, 3 INT C, P5; Alexandrov YI, 2008, SOC SCI INFORM, V47, P419, DOI 10.1177/0539018408092580; Alexandrov YI, 2007, INT J PSYCHOPHYSIOL, V65, P261, DOI 10.1016/j.ijpsycho.2007.05.004; Alexopoulos T, 2007, J EXP SOC PSYCHOL, V43, P1010, DOI 10.1016/j.jesp.2006.10.017; ANOKHIN KV, 1991, BRAIN RES, V544, P101, DOI 10.1016/0006-8993(91)90890-8; ANOKHIN KV, 2000, CONC ADV BRAIN RES, V2, P53; Anokhin P K, 1978, PHILOS ASPECTS THEOR; Anokhin P. K., 1973, BIOL NEUROPHYSIOLOGY; [Anonymous], 2000, CONC ADV BRAIN RES; Baars BJ, 2003, J CONSCIOUSNESS STUD, V10, P100; BALABAN PM, 1993, EUR J NEUROSCI, V5, P768, DOI 10.1111/j.1460-9568.1993.tb00541.x; Barsalou LW, 2003, TRENDS COGN SCI, V7, P84, DOI 10.1016/S1364-6613(02)00029-3; Baumeister R.F., 2001, REV GEN PSYCHOL, V5, P323, DOI [10.1037//1089-2680.5.4.323, DOI 10.1037//1089-2680.5.4.323, https://doi.org/10.1037/1089-2680.5.4.323, DOI 10.1037/1089-2680.5.4.323]; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Bensafi M, 2003, NAT NEUROSCI, V6, P1142, DOI 10.1038/nn1145; Bensafi M, 2002, CHEM SENSES, V27, P703, DOI 10.1093/chemse/27.8.703; BERNTSON GG, 1993, ANN NY ACAD SCI, V702, P75, DOI 10.1111/j.1749-6632.1993.tb17243.x; Bird H, 2001, BEHAV RES METH INS C, V33, P73, DOI 10.3758/BF03195349; Blass EM, 1980, NEURAL MECHANISMS GO, P461; Bloom P, 1997, TRENDS COGN SCI, V1, P9, DOI 10.1016/S1364-6613(97)01006-1; BOCK M, 1986, PSYCHOL RES-PSYCH FO, V48, P107, DOI 10.1007/BF00309324; BOUCHER J, 1969, J VERB LEARN VERB BE, V8, P1, DOI 10.1016/S0022-5371(69)80002-2; Boucsein W., 1992, ELECTRODERMAL ACTIVI; Bradley MM, 2000, PSYCHOPHYSIOLOGY, V37, P204, DOI 10.1111/1469-8986.3720204; Briesemeister BB, 2012, SAGE OPEN, V2, DOI 10.1177/2158244012466558; Brysbaert M, 2000, EUR J COGN PSYCHOL, V12, P65, DOI 10.1080/095414400382208; Cacioppo JT, 1999, ANNU REV PSYCHOL, V50, P191, DOI 10.1146/annurev.psych.50.1.191; Catmur C, 2013, NEUROSCI LETT, V540, P21, DOI 10.1016/j.neulet.2012.10.001; Chernigovskaya TV, 2003, SPEAKING COLORS ODOR, P227; Chiarello C, 1999, BEHAV RES METH INS C, V31, P603, DOI 10.3758/BF03200739; Chuprikova NI, 1997, PSYCHOL MENTAL DEV P; COLLINS AM, 1970, J VERB LEARN VERB BE, V9, P432, DOI 10.1016/S0022-5371(70)80084-6; Connell L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033321; Connell L, 2010, COGNITION, V115, P1, DOI 10.1016/j.cognition.2009.10.005; Cuccio V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115381; D'Hondt F, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00033; DAVIDSON RJ, 1992, PSYCHOL SCI, V3, P21, DOI 10.1111/j.1467-9280.1992.tb00250.x; DAVIDSON RJ, 1990, J PERS SOC PSYCHOL, V58, P330, DOI 10.1037/0022-3514.58.2.330; Dawson ME, 2000, HDB PSYCHOPHYSIOLOGY; de Gelder B, 2000, TRENDS COGN SCI, V4, P126, DOI 10.1016/S1364-6613(00)01470-4; Dementienko VV., 2000, HUMAN PHYSL, V26, P232, DOI DOI 10.1007/BF02760098; Dennett D.C., 1996, UNDERSTANDING CONSCI; Distel H, 1999, CHEM SENSES, V24, P191, DOI 10.1093/chemse/24.2.191; Dodds PS, 2015, P NATL ACAD SCI USA, V112, P2389, DOI 10.1073/pnas.1411678112; Edelman GM, 2003, P NATL ACAD SCI USA, V100, P5520, DOI 10.1073/pnas.0931349100; Eilola TM, 2011, INT J BILINGUAL, V15, P353, DOI 10.1177/1367006910379263; Estes Z, 2008, COGNITION, V108, P557, DOI 10.1016/j.cognition.2008.03.003; Estes Z, 2008, EMOTION, V8, P441, DOI 10.1037/1528-3542.8.4.441; EVGENYEVA A.P., 1999, DICT RUSSIAN LANGUAG; Farrow TFD, 2013, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00349; Gentilucci M, 2006, NEUROSCI BIOBEHAV R, V30, P949, DOI 10.1016/j.neubiorev.2006.02.004; Gerhand S, 1999, MEM COGNITION, V27, P592, DOI 10.3758/BF03211553; Ghyselinck M, 2004, ACTA PSYCHOL, V115, P43, DOI 10.1016/j.actpsy.2003.11.002; Glenberg AM, 2002, PSYCHON B REV, V9, P558, DOI 10.3758/BF03196313; Goldberg RF, 2006, J NEUROSCI, V26, P4917, DOI 10.1523/JNEUROSCI.5389-05.2006; Goldfield E.C., 1995, EMERGENT FORMS ORIGI; Gostev AA., 1992, HUMAN IMAGINATIVE SP; Gottlieb G., 1971, BIOPSYCHOLOGY DEV, P67; Hajcak G, 2004, BRAIN COGNITION, V56, P189, DOI 10.1016/j.bandc.2003.11.001; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; HERZ RS, 1992, CHEM SENSES, V17, P519, DOI 10.1093/chemse/17.5.519; Heyes C, 2010, NEUROSCI BIOBEHAV R, V34, P575, DOI 10.1016/j.neubiorev.2009.11.007; Hoffman P, 2013, NEUROPSYCHOLOGIA, V51, P14, DOI 10.1016/j.neuropsychologia.2012.11.009; HYMAN R, 1953, J EXP PSYCHOL, V45, P188, DOI 10.1037/h0056940; Izura C., 2002, PSICOLOGICA, V23, P245; Jeannerod M, 1995, CURR OPIN NEUROBIOL, V5, P727, DOI 10.1016/0959-4388(95)80099-9; Karpov LP, 1986, NEURONS BEHAV SYSTEM, P206; Khalfa S, 2002, NEUROSCI LETT, V328, P145, DOI 10.1016/S0304-3940(02)00462-7; Khayutin SN, 1997, PHYSL GEN BIOL REV, V12, P1; Kosslyn SM, 2005, COGN NEUROPSYCHOL, V22, P333, DOI 10.1080/02643290442000130; Kousta ST, 2011, J EXP PSYCHOL GEN, V140, P14, DOI 10.1037/a0021446; Kousta ST, 2009, COGNITION, V112, P473, DOI 10.1016/j.cognition.2009.06.007; Laeng B, 2002, COGNITIVE SCI, V26, P207, DOI 10.1016/S0364-0213(01)00065-9; Lakoff George, 2003, METAPHOR WE LIVE BY; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; LEVENSON RW, 1990, PSYCHOPHYSIOLOGY, V27, P363, DOI 10.1111/j.1469-8986.1990.tb02330.x; Levinson SC, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0302; LIBET B, 1993, NEUROPHYSIOLOGY CONS; Lickliter R, 2000, PSYCHOL BULL, V126, P260, DOI 10.1037/0033-2909.126.2.260; Liu YY, 2007, BEHAV RES METHODS, V39, P192, DOI 10.3758/BF03193147; Lynott D, 2009, BEHAV RES METHODS, V41, P558, DOI 10.3758/BRM.41.2.558; Mahon BZ, 2009, ANNU REV PSYCHOL, V60, P27, DOI 10.1146/annurev.psych.60.110707.163532; Mahon BZ, 2005, COGN NEUROPSYCHOL, V22, P480, DOI 10.1080/02643290442000446; Marchenko OP, 2009, THESIS; Marchenko OP, 2008, 3 INT C COGN SCI JUN, V1, P103; Maturana H., 1978, BIOL COGNITION; MERZLYAKOVA A.K., 2003, TYPES SEMANTIC VARIA; Meschyan G, 2002, MEM COGNITION, V30, P262, DOI 10.3758/BF03195287; Meteyard L, 2012, CORTEX, V48, P788, DOI 10.1016/j.cortex.2010.11.002; Mirabella G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035403; New B, 2006, PSYCHON B REV, V13, P45, DOI 10.3758/BF03193811; Niedenthal PM, 2007, SCIENCE, V316, P1002, DOI 10.1126/science.1136930; Nummenmaa L, 2014, P NATL ACAD SCI USA, V111, P646, DOI 10.1073/pnas.1321664111; Osgood C, 1975, MEASUREMENT MEANING; Panksepp J., 2000, EVOLUTION COGNITION, V6, P108, DOI DOI 10.1146/ANNUREV.AN.18.100189.0; Panksepp J., 2000, CONSCIOUSNESS EMOTIO, V1, P15, DOI [10.1075/ce.1.1.04pan, DOI 10.1075/CE.1.1.04PAN]; Pavlenko A, 2012, INT J PSYCHOL, V47, P405, DOI 10.1080/00207594.2012.743665; Peeters G., 1990, EUROPEAN REV SOCIAL, V1, P33, DOI [10.1080/14792779108401856, DOI 10.1080/14792779108401856]; Pieron H., 1967, FEELINGS EMOTIONS, P117; PRATTO F, 1991, J PERS SOC PSYCHOL, V61, P380, DOI 10.1037/0022-3514.61.3.380; Pulvermuller F, 2005, NAT REV NEUROSCI, V6, P576, DOI 10.1038/nrn1706; Robin O, 1999, CHEM SENSES, V24, P327, DOI 10.1093/chemse/24.3.327; Rousmans S, 2000, CHEM SENSES, V25, P709, DOI 10.1093/chemse/25.6.709; Rozin P, 2001, PERS SOC PSYCHOL REV, V5, P296, DOI 10.1207/S15327957PSPR0504_2; SCHMALHAUSEN II, 1960, EVOLUTION, V14, P509, DOI 10.2307/2405999; SCHNEIRLA TC, 1959, NEBR SYM MOTIV, V7, P1; Schrauf R.W., 2004, J MULTILING MULTICUL, V25, P266, DOI [DOI 10.1080/01434630408666532, 10.1080/01434630408666532]; SHVYRKOV VB, 1990, MACHINERY OF THE MIND, P337; Shvyrkov VB, 1995, INTRO OBJECTIVE PSYC; Silvert L, 2004, INT J PSYCHOPHYSIOL, V53, P135, DOI 10.1016/j.ijpsycho.2004.03.005; Slobin D. I., 1979, PSYCHOLINGUISTICS; Spadacenta S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104349; Spivey MJ, 2001, PSYCHOL RES-PSYCH FO, V65, P235, DOI 10.1007/s004260100059; Stadthagen-Gonzalez H, 2006, BEHAV RES METHODS, V38, P598, DOI 10.3758/BF03193891; Sternberg S, 1969, ACTA PSYCHOL, V30, P276, DOI 10.1016/0001-6918(69)90055-9; Tomasello M, 2008, JEAN NICOD LECT, P1; Tononi G, 1998, SCIENCE, V282, P1846, DOI 10.1126/science.282.5395.1846; Tugade MM, 2004, J PERS, V72, P1161, DOI 10.1111/j.1467-6494.2004.00294.x; Turner JE, 1998, MEM COGNITION, V26, P1282, DOI 10.3758/BF03201200; UEXKULL JAKOB VON, 1957, INSTINCTIVE BEHAV DE, P5, DOI DOI 10.1515/SEMI.1992.89.4.319; Usher M, 2002, J MATH PSYCHOL, V46, P704, DOI 10.1006/jmps.2002.1420; van Dantzig S, 2011, BEHAV RES METHODS, V43, P145, DOI 10.3758/s13428-010-0038-8; Viinikainen M, 2010, HUM BRAIN MAPP, V31, P1030, DOI 10.1002/hbm.20915; Vygotsky L.S., 1987, COLLECTED WORKS LS V, P43; WALLEY AC, 1992, MEM COGNITION, V20, P171, DOI 10.3758/BF03197166; Waxman SR, 2001, COGNITIVE PSYCHOL, V43, P217, DOI 10.1006/cogp.2001.0764; WERNER H, 1956, AM ANTHROPOL, V58, P866, DOI 10.1525/aa.1956.58.5.02a00070; WIERZBICKA A, 1986, STUD LANG, V10, P353, DOI 10.1075/sl.10.2.05wie; WILKINS AJ, 1971, J VERB LEARN VERB BE, V10, P382, DOI 10.1016/S0022-5371(71)80036-1; Wilson E. O., 1998, CONSILIENCE UNITY KN; WINTON WM, 1984, J EXP SOC PSYCHOL, V20, P195, DOI 10.1016/0022-1031(84)90047-7; Wismeijer DA, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00105; Yeshurun Y, 2010, ANNU REV PSYCHOL, V61, P219, DOI 10.1146/annurev.psych.60.110707.163639; Zajonc R., 2004, FEELINGS EMOTIONS AM, P194; ZAJONC RB, 1980, AM PSYCHOL, V35, P151, DOI 10.1037/0003-066X.35.2.151; Zevin JD, 2002, J MEM LANG, V47, P1, DOI 10.1006/jmla.2001.2834; Zwaan RA, 2006, J EXP PSYCHOL GEN, V135, P1, DOI 10.1037/0096-3445.135.1.1	143	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2016	11	7							e0159036	10.1371/journal.pone.0159036	http://dx.doi.org/10.1371/journal.pone.0159036			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ9CN	27400090	Green Published, Green Submitted, gold			2022-12-27	WOS:000379508100015
J	Barbar, SD; Pauchard, LA; Bruyere, R; Bruillard, C; Hayez, D; Croisier, D; Pugin, J; Charles, PE				Barbar, Saber-Davide; Pauchard, Laure-Anne; Bruyere, Remi; Bruillard, Caroline; Hayez, Davy; Croisier, Delphine; Pugin, Jerome; Charles, Pierre-Emmanuel			Mechanical Ventilation Alters the Development of Staphylococcus aureus Pneumonia in Rabbit	PLOS ONE			English	Article							TIDAL-VOLUME VENTILATION; TOLL-LIKE RECEPTOR-2; LUNG INJURY; NOSOCOMIAL PNEUMONIA; GENE-EXPRESSION; PRESSURE; BACTEREMIA; ACTIVATION; CYTOKINES; IMPACT	Ventilator-associated pneumonia (VAP) is common during mechanical ventilation (MV). Beside obvious deleterious effects on muco-ciliary clearance, MV could adversely shift the host immune response towards a pro-inflammatory pattern through toll-like receptor (TLRs) up-regulation. We tested this hypothesis in a rabbit model of Staphylococcus aureus VAP. Pneumonia was caused by airway challenge with S. aureus, in either spontaneously breathing (SB) or MV rabbits (n = 13 and 17, respectively). Pneumonia assessment regarding pulmonary and systemic bacterial burden, as well as inflammatory response was done 8 and 24 hours after S. aureus challenge. In addition, ex vivo stimulations of whole blood taken from SB or MV rabbits (n = 7 and 5, respectively) with TLR2 agonist or heat-killed S. aureus were performed. Data were expressed as mean +/- standard deviation. After 8 hours of infection, lung injury was more severe in MV animals (1.40 +/- 0.33 versus [vs] 2.40 +/- 0.55, p = 0.007), along with greater bacterial concentrations (6.13 +/- 0.63 vs. 4.96 +/- 1.31 colony forming units/gram, p = 0.002). Interleukin (IL)-8 and tumor necrosis factor (TNF)-alpha serum concentrations reached higher levels in MV animals (p = 0.010). Whole blood obtained from MV animals released larger amounts of cytokines if stimulated with TLR2 agonist or heat-killed S. aureus (e.g., TNF-alpha: 1656 +/- 166 vs. 1005 +/- 89; p = 0.014). Moreover, MV induced TLR2 overexpression in both lung and spleen tissue. MV hastened tissue injury, impaired lung bacterial clearance, and promoted a systemic inflammatory response, maybe through TLR2 overexpression.	[Barbar, Saber-Davide; Pauchard, Laure-Anne; Bruyere, Remi; Bruillard, Caroline; Charles, Pierre-Emmanuel] Univ Bourgogne, INRA, UMR 1347, Lab Ventilat Immunite Poumon,Pole Microbiol Envir, Dijon, France; [Hayez, Davy; Croisier, Delphine] Vivexia SARL, Gemeaux, France; [Pugin, Jerome] Univ Hosp Geneva, Intens Care Lab, CH-1211 Geneva 14, Switzerland; [Pugin, Jerome] Fac Med, Dept Microbiol & Mol Med, CH-1211 Geneva 14, Switzerland	INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; University of Geneva; University of Geneva	Charles, PE (corresponding author), Univ Bourgogne, INRA, UMR 1347, Lab Ventilat Immunite Poumon,Pole Microbiol Envir, Dijon, France.	pierre-emmanuel.charles@chu-dijon.fr		Barbar, Saber Davide/0000-0002-5089-8088; Charles, Pierre-Emmanuel/0000-0002-0201-9544; Croisier, Delphine/0000-0002-8744-5832	Pfizer; "Vivexia" company	Pfizer(Pfizer); "Vivexia" company	PEC received a grant from Pfizer, namely the ASPIRE competitive grant in 2011.DCB and DH received support from the "Vivexia" company in the form of salaries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Altemeier WA, 2004, AM J PHYSIOL-LUNG C, V287, pL533, DOI 10.1152/ajplung.00004.2004; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Bouadma L, 2004, CRIT CARE MED, V32, P1563, DOI 10.1097/01.CCM.0000129674.25259.D4; Bouadma L, 2010, CRIT CARE MED, V38, P789, DOI 10.1097/CCM.0b013e3181ce21af; Bregeon F, 2005, ANESTHESIOLOGY, V102, P331; Broccard A, PRONE POSITIONING AT; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Charles PE, 2005, CRIT CARE MED, V33, P1029, DOI 10.1097/01.CCM.0000163404.35338.72; Charles PE, 2004, INTENS CARE MED, V30, P2263, DOI 10.1007/s00134-004-2442-y; Charles PE, 2002, CRIT CARE MED, V30, P2278, DOI 10.1097/00003246-200210000-00016; Charles PE, 2011, CRIT CARE, V15, DOI 10.1186/cc10330; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; Christaki E, 2014, VIRULENCE, V5, P57, DOI 10.4161/viru.26514; Croisier-Bertin D, 2014, ANTIMICROB AGENTS CH, V58, P1855, DOI 10.1128/AAC.01707-13; Dhanireddy S, 2006, LAB INVEST, V86, P790, DOI 10.1038/labinvest.3700440; Droemann D, 2003, HISTOCHEM CELL BIOL, V119, P103, DOI 10.1007/s00418-003-0497-4; Dunzendorfer S, 2004, CIRC RES, V95, P684, DOI 10.1161/01.RES.0000143900.19798.47; Elson G, 2007, BLOOD, V109, P1574, DOI 10.1182/blood-2006-06-032961; Futier E, 2013, NEW ENGL J MED, V369, P428, DOI 10.1056/NEJMoa1301082; Hess DR, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.11.014; Hillman NH, 2007, AM J RESP CRIT CARE, V176, P575, DOI 10.1164/rccm.200701-051OC; Hilmi D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096416; Kajikawa O, 2005, GENE, V344, P193, DOI 10.1016/j.gene.2004.09.032; Kuipers MT, 2011, CRIT CARE, V15, DOI 10.1186/cc10437; Ladoire S, 2013, ANESTHESIOLOGY; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luna CM, 1999, CHEST, V116, P1075, DOI 10.1378/chest.116.4.1075; Magret M, 2011, CRIT CARE, V15, DOI 10.1186/cc10036; Mourgeon E, 2000, AM J PHYSIOL-LUNG C, V279, pL699, DOI 10.1152/ajplung.2000.279.4.L699; Murphy DB, 2000, AM J RESP CRIT CARE, V162, P27, DOI 10.1164/ajrccm.162.1.9908110; Neto AS, 2012, JAMA-J AM MED ASSOC, V308, P1651, DOI 10.1001/jama.2012.13730; Oudin S, 2002, AM J RESP CELL MOL, V27, P107, DOI 10.1165/ajrcmb.27.1.4766; Ricard JD, 2001, AM J RESP CRIT CARE, V163, P1176, DOI 10.1164/ajrccm.163.5.2006053; Rubinstein E, 2008, CLIN INFECT DIS, V46, pS378, DOI 10.1086/533594; Neto AS, 2014, INTENS CARE MED, V40, P950, DOI 10.1007/s00134-014-3318-4; Neto AS, 2014, CURR OPIN CRIT CARE, V20, P25, DOI 10.1097/MCC.0000000000000044; Slutsky AS, 1998, AM J RESP CRIT CARE, V157, P1721, DOI 10.1164/ajrccm.157.6.9709092; Summers C, 2014, THORAX, V69, P623, DOI 10.1136/thoraxjnl-2013-204742; Terragni PP, 2007, AM J RESP CRIT CARE, V175, P160, DOI 10.1164/rccm.200607-915OC; Torres A, 2009, INTENS CARE MED, V35, P9, DOI 10.1007/s00134-008-1336-9; Tremblay L, 1997, J CLIN INVEST, V99, P944, DOI 10.1172/JCI119259; Valenza F, 2003, CRIT CARE MED, V31, P1993, DOI 10.1097/01.CCM.0000070401.65534.F9; Vaneker M, 2008, ANESTHESIOLOGY, V109, P465, DOI 10.1097/ALN.0b013e318182aef1; Villar J, 2010, INTENS CARE MED, V36, P1049, DOI 10.1007/s00134-010-1799-3; WEBB HH, 1974, AM REV RESPIR DIS, V110, P556; Wunderink RG, 2012, CLIN INFECT DIS, V54, P621, DOI 10.1093/cid/cir895; Xiang M, 2010, MOL MED, V16, P69, DOI 10.2119/molmed.2009.00097	48	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158799	10.1371/journal.pone.0158799	http://dx.doi.org/10.1371/journal.pone.0158799			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391952	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400126
J	Burke, GR				Burke, Gaelen R.			Analysis of Genetic Variation across the Encapsidated Genome of Microplitis demolitor Bracovirus in Parasitoid Wasps	PLOS ONE			English	Article							PSEUDOPLUSIA-INCLUDENS; PHYLOGENETIC ANALYSIS; HOST SPECIALIZATION; CHELONUS-INANITUS; MANDUCA-SEXTA; TRADE-OFFS; S2 CELLS; DNA; POLYDNAVIRUS; REPLICATION	Insect parasitoids must complete part of their life cycle within or on another insect, ultimately resulting in the death of the host insect. One group of parasitoid wasps, the 'microgastroid complex' (Hymenoptera: Braconidae), engage in an association with beneficial symbiotic viruses that are essential for successful parasitism of hosts. These viruses, known as Bracoviruses, persist in an integrated form in the wasp genome, and activate to replicate in wasp ovaries during development to ultimately be delivered into host insects during parasitism. The lethal nature of host-parasitoid interactions, combined with the involvement of viruses in mediating these interactions, has led to the hypothesis that Bracoviruses are engaged in an arms race with hosts, resulting in recurrent adaptation in viral (and host) genes. Deep sequencing was employed to characterize sequence variation across the encapsidated Bracovirus genome within laboratory and field populations of the parasitoid wasp species Microplitis demolitor. Contrary to expectations, there was a paucity of evidence for positive directional selection among virulence genes, which generally exhibited signatures of purifying selection. These data suggest that the dynamics of host-parasite interactions may not result in recurrent rounds of adaptation, and that adaptation may be more variable in time than previously expected.	[Burke, Gaelen R.] Univ Georgia, Dept Entomol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Burke, GR (corresponding author), Univ Georgia, Dept Entomol, Athens, GA 30602 USA.	grburke@uga.edu			National Institutes of Health [F32 AI096552]; University of Georgia Research Foundation; Georgia Agricultural Experiment Station	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Georgia Research Foundation; Georgia Agricultural Experiment Station	This work was supported by the National Institutes of Health (F32 AI096552), the University of Georgia Research Foundation, and the Georgia Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguileta G, 2010, MOL ECOL, V19, P292, DOI 10.1111/j.1365-294X.2009.04454.x; ALBRECHT U, 1994, J GEN VIROL, V75, P3353, DOI 10.1099/0022-1317-75-12-3353; Andolfatto P, 2008, GENETICS, V180, P1767, DOI 10.1534/genetics.108.091850; Beck M, 2003, VIROLOGY, V314, P521, DOI 10.1016/S0042-6822(03)00463-X; Beck M, 2005, J VIROL, V79, P1861, DOI 10.1128/JVI.79.3.1861-1870.2005; Beck MH, 2007, P NATL ACAD SCI USA, V104, P19267, DOI 10.1073/pnas.0708056104; Beck MH, 2007, VIROLOGY, V359, P179, DOI 10.1016/j.virol.2006.09.002; Beckage NE, 2012, PARASITOID VIRUSES: SYMBIONTS AND PATHOGENS, P163, DOI 10.1016/B978-0-12-384858-1.00013-8; Bezier A, 2009, SCIENCE, V323, P926, DOI 10.1126/science.1166788; Bezier A, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0047; Bitra K, 2016, VIROLOGY, V492, P259, DOI 10.1016/j.virol.2016.02.023; Bitra K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002722; Burke GR, 2015, J VIROL, V89, P9511, DOI 10.1128/JVI.01388-15; Burke GR, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004660; Burke GR, 2014, MOL ECOL, V23, P890, DOI 10.1111/mec.12648; Burke Gaelen R., 2012, Insects, V3, P91, DOI 10.3390/insects3010091; Burke GR, 2012, J VIROL, V86, P3293, DOI 10.1128/JVI.06434-11; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Daugherty MD, 2012, ANNU REV GENET, V46, P677, DOI 10.1146/annurev-genet-110711-155522; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Desjardins CA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r183; Drezen JM, 2003, J INSECT PHYSIOL, V49, P407, DOI 10.1016/S0022-1910(03)00058-1; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fry JD, 1996, AM NAT, V148, pS84, DOI 10.1086/285904; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Henry LM, 2008, EVOLUTION, V62, P689, DOI 10.1111/j.1558-5646.2007.00316.x; Herniou EA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0051; Holt C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-491; Ikeda M, 2013, VIROLOGY, V435, P1, DOI 10.1016/j.virol.2012.10.016; Jancek S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064432; Kofler R, 2011, BIOINFORMATICS, V27, P3435, DOI 10.1093/bioinformatics/btr589; Kofler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015925; Kraaijeveld AR, 1998, PARASITOLOGY, V116, pS29, DOI 10.1017/S0031182000084924; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lawrence PO, 2005, J INSECT PHYSIOL, V51, P99, DOI 10.1016/j.jinsphys.2004.12.012; Lee DF, 2000, J VIROL, V74, P11873, DOI 10.1128/JVI.74.24.11873-11880.2000; Lewis S.E., 2002, GENOME BIOL, V3, pRESEARCH0082, DOI [10.1186/gb-2002-3-12-research0082, DOI 10.1186/GB-2002-3-12-RESEARCH0082]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lu Z, 2008, J BIOL CHEM, V283, P21325, DOI 10.1074/jbc.M801593200; Lu ZQ, 2010, INSECT BIOCHEM MOLEC, V40, P497, DOI 10.1016/j.ibmb.2010.04.009; Marti D, 2003, J GEN VIROL, V84, P1141, DOI 10.1099/vir.0.18832-0; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Miller LK, 1997, BACULOVIRUSES, P217, DOI DOI 10.1007/978; Murphy N, 2008, MOL PHYLOGENET EVOL, V47, P378, DOI 10.1016/j.ympev.2008.01.022; Narasimhan V, 2016, BIOINFORMATICS; Pasquier-Barre F, 2002, J GEN VIROL, V83, P2035, DOI 10.1099/0022-1317-83-8-2035; Pichon A, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1501150; Quicke D. L. J., 1997, PARASITIC WASPS; Rodriguez JJ, 2013, INSECT CONSERV DIVER, V6, P530, DOI 10.1111/icad.12003; Serbielle C, 2009, BIOL CHEM, V390, P493, DOI 10.1515/BC.2009.061; SHENEFELT RD, 1973, HYMENOPTERORUM CATAL, P669; SHEPARD M, 1983, ENVIRON ENTOMOL, V12, P641, DOI 10.1093/ee/12.3.641; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Strand MR, 2012, PARASITOID VIRUSES: SYMBIONTS AND PATHOGENS, P149, DOI 10.1016/B978-0-12-384858-1.00012-6; STRAND MR, 1991, J INSECT PHYSIOL, V37, P839, DOI 10.1016/0022-1910(91)90080-J; STRAND MR, 1991, ARCH INSECT BIOCHEM, V18, P131, DOI 10.1002/arch.940180302; TAJIMA F, 1989, GENETICS, V123, P585; Teakle R.E., 1991, HELIOTHIS RES METHOD, P22; Thiem Suzanne M., 2009, Virologica Sinica, V24, P436, DOI 10.1007/s12250-009-3058-8; Thoetkiattikul H, 2005, P NATL ACAD SCI USA, V102, P11426, DOI 10.1073/pnas.0505240102; Webb BA, 2005, COMPREHENSIVE MOL IN, V6, P323, DOI DOI 10.1016/B0-44-451924-6/00086-7; Whitfield JB, 1998, ANNU REV ENTOMOL, V43, P129, DOI 10.1146/annurev.ento.43.1.129; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	64	3	4	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158846	10.1371/journal.pone.0158846	http://dx.doi.org/10.1371/journal.pone.0158846			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27390861	Green Submitted, gold, Green Published			2022-12-27	WOS:000380005400142
J	Czerniawski, R; Slugocki, L; Kowalska-Goralska, M				Czerniawski, Robert; Slugocki, Lukasz; Kowalska-Goralska, Monika			Diurnal Changes of Zooplankton Community Reduction Rate at Lake Outlets and Related Environmental Factors	PLOS ONE			English	Article							ST-LAWRENCE-RIVER; FISH PREDATION; VERTICAL-DISTRIBUTION; BIOTIC FACTORS; STREAM; PLANKTON; ROTIFERS; WATER; DRIFT; DIEL	The reduced zooplankton abundance at the outlet sections of lakes depends on the occurrence of preying fry. Therefore, light conditions can play a major role in the drift of zooplankton along river outlets. The aim of this study was to determine the influence of diurnal light conditions on the decline of zooplankton densities at lake outlets. Photosynthetically active radiation (PAR) levels were measured to determine their effect on the rate of reduced zooplankton abundance. Cladocerans and copepods showed a significantly greater reduction in abundance than rotifers and nauplii. A significant positive relationship was observed between the PAR levels and the reduced abundance of Asplanchna sp., small cladocerans, large cladocerans and Copepoda at the lake outlets. Among the rotifers, small pelagic rotifers drifted the farthest at all hours of the day. Large crustaceans, especially the large cladocerans and copepodites and adult copepods, had the lowest chance of dispersing over a wide area. Our results indicate that light conditions play an important role in the reduction of zooplankton abundance at lake outlets and have an indirect influence on the downstream food web.	[Czerniawski, Robert; Slugocki, Lukasz] Univ Szczecin, Dept Gen Zool, Szczecin, Poland; [Czerniawski, Robert; Slugocki, Lukasz] Univ Szczecin, Ctr Mol Biol & Biotechnol, Szczecin, Poland; [Kowalska-Goralska, Monika] Wroclaw Univ Environm & Life Sci, Dept Hydrobiol & Aquaculture, Wroclaw, Poland	University of Szczecin; University of Szczecin; Wroclaw University of Environmental & Life Sciences	Czerniawski, R (corresponding author), Univ Szczecin, Dept Gen Zool, Szczecin, Poland.; Czerniawski, R (corresponding author), Univ Szczecin, Ctr Mol Biol & Biotechnol, Szczecin, Poland.	czerniawski@univ.szczecin.pl	Kowalska-Góralska, Monika/A-1312-2017; Sługocki, Łukasz/T-2320-2019	Kowalska-Góralska, Monika/0000-0001-9614-2000; Sługocki, Łukasz/0000-0003-0064-006X; czerniawski, robert/0000-0001-7785-087X	Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW)	Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW)	This publication was supported by Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW) for years 2014-2018.; Publication supported by Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW) for years 2014-2018.	Akopian M, 1999, J PLANKTON RES, V21, P285, DOI 10.1093/plankt/21.2.285; Allan J D, 2007, STREAM ECOLOGY STRUC, V2nd; Basu BK, 1997, J PLANKTON RES, V19, P237, DOI 10.1093/plankt/19.2.237; Campbell CE, 2002, CAN J ZOOL, V80, P997, DOI 10.1139/Z02-077; Casper AF, 2007, RIVER RES APPL, V23, P73, DOI 10.1002/rra.966; Chang KH, 2008, LIMNOLOGY, V9, P125, DOI 10.1007/s10201-008-0244-6; CHRISTOFFERSEN K, 1993, LIMNOL OCEANOGR, V38, P561, DOI 10.4319/lo.1993.38.3.0561; Cobbaert D, 2010, HYDROBIOLOGIA, V644, P103, DOI 10.1007/s10750-010-0100-7; Czerniawski R, 2011, J APPL ICHTHYOL, V27, P984, DOI 10.1111/j.1439-0426.2011.01761.x; Czerniawski R, 2014, INT REV HYDROBIOL, V99, P300, DOI 10.1002/iroh.201301674; Czerniawski R, 2013, OCEANOL HYDROBIOL ST, V42, P123, DOI 10.2478/s13545-013-0065-z; Czerniawski R, 2013, BIOLOGIA, V68, P448, DOI 10.2478/s11756-013-0170-x; Czerniawski R, 2012, POL J ECOL, V60, P323; Czerniawski R, 2012, OCEANOL HYDROBIOL ST, V41, P46, DOI 10.2478/s13545-012-0006-2; Czerniawski R, 2011, CENT EUR J BIOL, V6, P659, DOI 10.2478/s11535-011-0024-x; Czerniawski R, 2010, CENT EUR J BIOL, V5, P240, DOI 10.2478/s11535-009-0062-9; Czerniawski R, 2010, HYDROBIOLOGIA, V638, P137, DOI 10.1007/s10750-009-0036-y; DEPAGGI SJ, 1995, HYDROBIOLOGIA, V310, P87, DOI 10.1007/BF00015526; Fontaneto D, 2005, HYDROBIOLOGIA, V542, P131, DOI 10.1007/s10750-004-5495-6; GLIWICZ ZM, 1986, ECOLOGY, V67, P883, DOI 10.2307/1939811; Hieber M, 2003, FRESHWATER BIOL, V48, P1078, DOI 10.1046/j.1365-2427.2003.01073.x; Hoffman JC, 2001, FRESHWATER BIOL, V46, P759, DOI 10.1046/j.1365-2427.2001.00716.x; HUTCHINSON BP, 1971, T AM FISH SOC, V100, P325, DOI 10.1577/1548-8659(1971)100<325:TEOFPO>2.0.CO;2; Jack JD, 2002, J PLANKTON RES, V24, P119, DOI 10.1093/plankt/24.2.119; Karabin A, 2005, HYDROBIOLOGIA, V546, P381, DOI 10.1007/s10750-005-4280-5; Lair N, 2006, RIVER RES APPL, V22, P567, DOI 10.1002/rra.923; Maier G, 2011, J LIMNOL, V70, P145, DOI 10.4081/jlimnol.2011.145; Mehner T, 2000, FRESHWATER BIOL, V45, P253, DOI 10.1046/j.1365-2427.2000.00551.x; Nielsen D, 2005, HYDROBIOLOGIA, V543, P101, DOI 10.1007/s10750-004-6946-9; Pourriot R, 1997, HYDROBIOLOGIA, V345, P143, DOI 10.1023/A:1002935807795; Radwan S., 2004, FRESHWATER FAUNA POL; Richardson WB, 1997, HYDROBIOLOGIA, V354, P141, DOI 10.1023/A:1003048431234; Romare P, 1999, LIMNOL OCEANOGR, V44, P1655, DOI 10.4319/lo.1999.44.7.1655; Rybak J. I., 2010, PLANKTONIC CRUSTACEA; Schram MD, 1998, J FRESHWATER ECOL, V13, P47, DOI 10.1080/02705060.1998.9663590; Sluss TD, 2008, FRESHWATER BIOL, V53, P1999, DOI 10.1111/j.1365-2427.2008.02023.x; TAYLOR BE, 1980, AM SOC LIMNOL OCEANO, V3, P377; Thorp JH, 2002, FRESHWATER BIOL, V47, P107, DOI 10.1046/j.1365-2427.2002.00787.x; Walks DJ, 2004, FRESHWATER BIOL, V49, P745, DOI 10.1111/j.1365-2427.2004.01220.x; Wissel B, 2003, LIMNOL OCEANOGR, V48, P1965, DOI 10.4319/lo.2003.48.5.1965; ZARET TM, 1976, LIMNOL OCEANOGR, V21, P804, DOI 10.4319/lo.1976.21.6.0804; Zhou SC, 2008, INT REV HYDROBIOL, V93, P297, DOI 10.1002/iroh.200711038	42	15	15	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158837	10.1371/journal.pone.0158837	http://dx.doi.org/10.1371/journal.pone.0158837			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27392017	Green Published, gold, Green Submitted			2022-12-27	WOS:000380005400140
J	Kivlin, SN; Hawkes, CV				Kivlin, Stephanie N.; Hawkes, Christine V.			Temporal and Spatial Variation of Soil Bacteria Richness, Composition, and Function in a Neotropical Rainforest	PLOS ONE			English	Article							MICROBIAL COMMUNITY STRUCTURE; MULTIPLE SEQUENCE ALIGNMENT; FUNGAL COMMUNITIES; ENZYME-ACTIVITIES; PLANT DIVERSITY; CLIMATE-CHANGE; DECOMPOSITION; RESPONSES; MOISTURE; DYNAMICS	The high diversity of tree species has traditionally been considered an important controller of belowground processes in tropical rainforests. However, soil water availability and resources are also primary regulators of soil bacteria in many ecosystems. Separating the effects of these biotic and abiotic factors in the tropics is challenging because of their high spatial and temporal heterogeneity. To determine the drivers of tropical soil bacteria, we examined tree species effects using experimental tree monocultures and secondary forests at La Selva Biological Station in Costa Rica. A randomized block design captured spatial variation and we sampled at four dates across two years to assess temporal variation. We measured bacteria richness, phylogenetic diversity, community composition, biomass, and functional potential. All bacteria parameters varied significantly across dates. In addition, bacteria richness and phylogenetic diversity were affected by the interaction of vegetation type and date, whereas bacteria community composition was affected by the interaction of vegetation type and block. Shifts in bacteria community richness and composition were unrelated to shifts in enzyme function, suggesting physiological overlap among taxa. Based on the observed temporal and spatial heterogeneity, our understanding of tropical soil bacteria will benefit from additional work to determine the optimal temporal and spatial scales for sampling. Understanding spatial and temporal variation will facilitate prediction of how tropical soil microbes will respond to future environmental change.	[Kivlin, Stephanie N.; Hawkes, Christine V.] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Hawkes, CV (corresponding author), Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA.	chawkes@austin.utexas.edu		Hawkes, Christine/0000-0002-1043-9469	National Science Foundation [DEB-1119169]; Division Of Environmental Biology [1119169] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The material is based upon work supported by the National Science Foundation under Grant No. DEB-1119169 to CVH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank R. Bedoya, F. Cascante, M. Hernandez, E. Paniagua, and M. Sanchez for assistance with fieldwork. Previous versions of this manuscript were improved by comments from K. DeAngelis, C. Looby, T. Miki, and two anonymous reviewers. The material is based upon work supported by the National Science Foundation under Grant No. DEB-1119169 to CVH. Soils were collected under Conagebio permit No. R-005-2012.	Acosta-Martinez V, 2007, APPL SOIL ECOL, V35, P35, DOI 10.1016/j.apsoil.2006.05.012; Allison SD, 2005, SOIL BIOL BIOCHEM, V37, P937, DOI 10.1016/j.soilbio.2004.09.014; Allison SD, 2011, SOIL BIOL, V22, P229, DOI 10.1007/978-3-642-14225-3_12; Allison SD, 2009, SOIL BIOL BIOCHEM, V41, P293, DOI 10.1016/j.soilbio.2008.10.032; ALVARADO G, 1990, TECNOLOGIA MARCHA, V10, P11; Anderson MJ, 2013, ECOL MONOGR, V83, P557, DOI 10.1890/12-2010.1; [Anonymous], 1996, SOIL MICROBIOLOGY BI; Barberan A, 2015, ECOL LETT, V18, P1397, DOI 10.1111/ele.12536; Bedoya R., 2009, PLANTACIONES FORESTA; Berlemont R, 2013, APPL ENVIRON MICROB, V79, P1545, DOI 10.1128/AEM.03305-12; Bonferroni C. E., 1936, PUBBL R I SUPER SCI, V8, P1; Bouskill N, 2016, FRONTIERS MICROBIOLO, P7; Bouskill N.J., 2016, FRONTIERS MICROBIOLO, V7; Bouskill NJ, 2013, ISME J, V7, P384, DOI 10.1038/ismej.2012.113; Brabcova V, 2016, NEW PHYTOL, V210, P1369, DOI 10.1111/nph.13849; Brockett BFT, 2012, SOIL BIOL BIOCHEM, V44, P9, DOI 10.1016/j.soilbio.2011.09.003; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carney KM, 2006, MICROB ECOL, V52, P226, DOI 10.1007/s00248-006-9115-z; Carney KM, 2005, ECOSYSTEMS, V8, P928, DOI 10.1007/s10021-005-0047-0; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; Cleveland CC, 2010, ECOLOGY, V91, P2313, DOI 10.1890/09-1582.1; Dickie IA, 2010, NEW PHYTOL, V188, P916, DOI 10.1111/j.1469-8137.2010.03473.x; Eaton WD, 2012, TROP ECOL, V53, P207; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Espeleta JF, 2007, ECOL MONOGR, V77, P377, DOI 10.1890/06-1257.1; Evans SE, 2014, ECOL LETT, V17, P155, DOI 10.1111/ele.12206; Feng X, 2013, NAT CLIM CHANGE, V3, P811, DOI [10.1038/nclimate1907, 10.1038/NCLIMATE1907]; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; FRIESE CF, 1991, AGR ECOSYST ENVIRON, V34, P87, DOI 10.1016/0167-8809(91)90096-G; GONZALEZ JE, 1994, FOREST ECOL MANAG, V70, P159, DOI 10.1016/0378-1127(94)90083-3; Hall SJ, 2013, GLOBAL CHANGE BIOL, V19, P2804, DOI 10.1111/gcb.12229; Hall SJ, 2013, ECOSYSTEMS, V16, P576, DOI 10.1007/s10021-012-9631-2; Jones SE, 2010, P NATL ACAD SCI USA, V107, P5881, DOI 10.1073/pnas.0912765107; Kaiser C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9960; Karmalkar AV, 2011, CLIM DYNAM, V37, P605, DOI 10.1007/s00382-011-1099-9; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kivlin SN, 2016, ENVIRON MICROBIOL, V18, P4662, DOI 10.1111/1462-2920.13342; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Locey KJ, 2016, P NATL ACAD SCI USA, V113, P5970, DOI 10.1073/pnas.1521291113; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; Mirarab S, 2015, J COMPUT BIOL, V22, P377, DOI 10.1089/cmb.2014.0156; Mueller RC, 2014, ISME J, V8, P1548, DOI 10.1038/ismej.2013.253; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; NEWSTROM LE, 1994, BIOTROPICA, V26, P141, DOI 10.2307/2388804; Nusslein K, 1999, APPL ENVIRON MICROB, V65, P3622; Oksanen J, 2022, COMMUNITY ECOLOGY PA; Placella SA, 2012, P NATL ACAD SCI USA, V109, P10931, DOI 10.1073/pnas.1204306109; Powers JS, 1997, FOREST ECOL MANAG, V99, P43, DOI 10.1016/S0378-1127(97)00193-X; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; R Core Team, 2020, R LANG ENV STAT COMP; Raich JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100275; Ramirez KS, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1988; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Russell AE, 2007, SOIL SCI SOC AM J, V71, P1389, DOI 10.2136/sssaj2006.0069; Russell AE, 2010, ECOL APPL, V20, P1087, DOI 10.1890/09-0635.1; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Scott-Denton LE, 2006, GLOBAL CHANGE BIOL, V12, P205, DOI 10.1111/j.1365-2486.2005.01064.x; Sinsabaugh RL, 2008, ECOL LETT, V11, P1252, DOI 10.1111/j.1461-0248.2008.01245.x; Slik JWF, 2013, GLOBAL ECOL BIOGEOGR, V22, P1261, DOI 10.1111/geb.12092; Smith AP, 2015, GLOBAL CHANGE BIOL, V21, P3532, DOI 10.1111/gcb.12947; Stocker T F, 2013, CLIM CHANG 2013 PHYS; Stone MM, 2014, SOIL BIOL BIOCHEM, V75, P237, DOI 10.1016/j.soilbio.2014.04.017; Treseder KK, 2007, GLOBAL CHANGE BIOL, V13, P78, DOI 10.1111/j.1365-2486.2006.01279.x; Tripathi BM, 2012, MICROB ECOL, V64, P474, DOI 10.1007/s00248-012-0028-8; Tucker CM, 2017, BIOL REV, V92, P698, DOI 10.1111/brv.12252; Urbanova M, 2015, SOIL BIOL BIOCHEM, V84, P53, DOI 10.1016/j.soilbio.2015.02.011; Vandecar KL, 2011, SOIL SCI SOC AM J, V75, P1520, DOI 10.2136/sssaj2010.0390; VITOUSEK PM, 1986, ANNU REV ECOL SYST, V17, P137, DOI 10.1146/annurev.es.17.110186.001033; Wallenstein MD, 2009, GLOBAL CHANGE BIOL, V15, P1631, DOI 10.1111/j.1365-2486.2008.01819.x; Waring BG, 2016, NEW PHYTOL, V209, P845, DOI 10.1111/nph.13654; Waring BG, 2015, P ROY SOC B-BIOL SCI, V282, P91, DOI 10.1098/rspb.2015.1001; Waring BG, 2015, MICROB ECOL, V69, P843, DOI 10.1007/s00248-014-0436-z; Wheeler TJ, 2007, BIOINFORMATICS, V23, pI559, DOI 10.1093/bioinformatics/btm226; Zak DR, 2003, ECOLOGY, V84, P2042, DOI 10.1890/02-0433; Zimmerman AE, 2013, ISME J, V7, P1187, DOI 10.1038/ismej.2012.176	80	22	22	5	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159131	10.1371/journal.pone.0159131	http://dx.doi.org/10.1371/journal.pone.0159131			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391450	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400213
J	Liu, GQ; Qiu, XH; Cao, L; Zhang, Y; Zhan, ZB; Han, RC				Liu, Guiqing; Qiu, Xuehong; Cao, Li; Zhang, Yi; Zhan, Zubing; Han, Richou			Evaluation of Reference Genes for Reverse Transcription Quantitative PCR Studies of Physiological Responses in the Ghost Moth, Thitarodes armoricanus (Lepidoptera, Hepialidae)	PLOS ONE			English	Article							TIME RT-PCR; INTERNAL CONTROL GENES; CORDYCEPS-SINENSIS; EXPRESSION ANALYSIS; SACCHAROMYCES-CEREVISIAE; ENTOMOPATHOGENIC FUNGUS; OPHIOCORDYCEPS-SINENSIS; HOUSEKEEPING GENES; BEAUVERIA-BASSIANA; PUI LEPIDOPTERA	Reverse transcription quantitative real-time polymerase chain reaction (RT-qPCR) is the sensitive method to quantify the expression levels of target genes on the basis of endogenous control. An appropriate reference gene set for normalization is essential for reliable results. The ghost moth, Thitarodes armoricanus, a host species of a medicinal fungus, Ophiocordyceps sinensis, is an economically important member of the Lepidoptera. Recent studies have focused on the mechanism of adaptation of this species to its high-altitude environment and host immune response to O. sinensis infection and RT-qPCR is commonly used in these studies to decipher the genetic basis of physiological functions. However, a thorough assessment of candidate reference genes in the genus Thitarodes is lacking. Here, the expression levels of eight candidate reference genes (ACT, EF, EIF4A, GAPDH, G6PDH, RPL13A, TUB and 18S) in T. armoricanus at different developmental stages and in different body parts of the seventh instar larvae were analyzed, along with larvae kept under low temperatures, larvae exposed to two fungal infections and larvae fed different diets. Three established software programs-Bestkeeper, geNorm and NormFinder-were employed to calculate variation among the treatments. The results revealed that the best-suited reference genes differed across the treatments, with EF, EIF4A and GAPDH found to be the best suited for the different developmental stages and larvae body parts; EF, EIF4A and RPL13A found to be the best suited for low-temperature challenge; and EF, EIF4A and TUB found to be the best suited for the fungal infections and dietary treatments. This study thus further contributes to the establishment of an accurate method for normalizing RT-qPCR results for T. armoricanus and serves as a reference for gene expression studies of related insect species.	[Han, Richou] Guangdong Inst Appl Biol Resources, Guangdong Key Lab IPM Agr, Guangzhou, Guangdong, Peoples R China; Guangdong Inst Appl Biol Resources, Publ Lab Wild Anim Conservat & Utilizat, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Sciences; Institute of Zoology, Guangdong Academy of Sciences; Guangdong Academy of Sciences; Institute of Zoology, Guangdong Academy of Sciences	Han, RC (corresponding author), Guangdong Inst Appl Biol Resources, Guangdong Key Lab IPM Agr, Guangzhou, Guangdong, Peoples R China.	hanrc@gdei.gd.cn			Guangdong Provincial Science and Technology Project [2015B070701019]; Environment Construction and Capacity Building of GDAS' Research Platform [2016GDASPT-0107]; Guangzhou science and technology plan projects [201604020030]	Guangdong Provincial Science and Technology Project; Environment Construction and Capacity Building of GDAS' Research Platform; Guangzhou science and technology plan projects	This work was supported by Guangdong Provincial Science and Technology Project (No. 2015B070701019) http://pro.gdstc.gov.cn/egrantweb/RCH preparation of the manuscript, Environment Construction and Capacity Building of GDAS' Research Platform (No. 2016GDASPT-0107) http://www.gdas.gd.cn/RCH preparation of the manuscript, and Guangzhou science and technology plan projects (201604020030) http://www.gzsi.gov.cn/LC preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Buenz EJ, 2005, J ETHNOPHARMACOL, V96, P19, DOI 10.1016/j.jep.2004.09.029; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Concha C, 2012, INSECT MOL BIOL, V21, P169, DOI 10.1111/j.1365-2583.2011.01123.x; Coulson DTR, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-46; Dowling CM, 2016, F1000 RES, V156, P9; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; FENG MG, 1994, BIOCONTROL SCI TECHN, V4, P3, DOI 10.1080/09583159409355309; Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995; Hodkinson ID, 2005, BIOL REV, V80, P489, DOI 10.1017/S1464793105006767; Hornakova D, 2010, ANAL BIOCHEM, V397, P118, DOI 10.1016/j.ab.2009.09.019; Ji DB, 2009, PHYTOTHER RES, V23, P116, DOI 10.1002/ptr.2576; Kirsch R, 2011, P ROY SOC B, P1; Koh JH, 2003, BIOL PHARM BULL, V26, P84, DOI 10.1248/bpb.26.84; Koppelkamm A, 2010, INT J LEGAL MED, V124, P371, DOI 10.1007/s00414-010-0433-9; Kylee J, 2011, PLOS ONE, V6; Ling DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017762; Meng Q, 2015, INSECT BIOCHEM MOLEC, V64, P1, DOI 10.1016/j.ibmb.2015.06.014; Nadai C, 2015, INT J FOOD MICROBIOL, V215, P49, DOI 10.1016/j.ijfoodmicro.2015.08.012; Nijhof AM, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-112; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Perez R, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-79; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Ponton F, 2011, J INSECT PHYSIOL, V57, P840, DOI 10.1016/j.jinsphys.2011.03.014; Rangel DEN, 2008, MYCOL RES, V112, P1355, DOI 10.1016/j.mycres.2008.04.011; Scharlaken B, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3301; Selvey S, 2001, MOL CELL PROBE, V15, P307, DOI 10.1006/mcpr.2001.0376; Shen GM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-76; Simmons J, 2013, INSECT MOL BIOL, V22, P62, DOI 10.1111/imb.12003; Sun ZX, 2012, ARCH INSECT BIOCHEM, V80, P1, DOI 10.1002/arch.20456; Sun ZX, 2011, J INSECT PHYSIOL, V57, P1660, DOI 10.1016/j.jinsphys.2011.08.019; Sung GH, 2007, STUD MYCOL, P5, DOI 10.3114/sim.2007.57.01; Svitkin YV, 2001, RNA, V7, P1743; Szabo A, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-r59; Tao Z, 2015, J ECON ENTOMOL, P1; Teng XL, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.6001; Teste MA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-99; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang XL, 2011, ZOOKEYS, P43, DOI 10.3897/zookeys.127.802; Wu S, 2010, DEV COMP IMMUNOL, V34, P1191, DOI 10.1016/j.dci.2010.06.013; Wu WJ, 2015, GENE, V574, P95, DOI 10.1016/j.gene.2015.07.084; Wu YL, 2006, PHYTOTHER RES, V20, P646, DOI 10.1002/ptr.1921; Wu YL, 2005, PLANTA MED, V71, P381, DOI 10.1055/s-2005-864111; Yuan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086503; Zeng XQ, 2015, P NATL ACAD SCI USA, V112, P1095, DOI 10.1073/pnas.1423628112; Zhang GQ, 2006, APPL MICROBIOL BIOT, V72, P1152, DOI 10.1007/s00253-006-0411-9; Zhang SD, 2015, GENE, V555, P393, DOI 10.1016/j.gene.2014.11.038; Zhao DJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-631; Zhou XW, 2014, CRIT REV BIOTECHNOL, V34, P233, DOI 10.3109/07388551.2013.791245; Zhu J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-172; Zhu W, 2016, J INSECT PHYSIOL, V85, P76, DOI 10.1016/j.jinsphys.2015.11.008; Zou ZW, 2011, CRYOLETTERS, V32, P225	54	24	28	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159060	10.1371/journal.pone.0159060	http://dx.doi.org/10.1371/journal.pone.0159060			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27392023	Green Submitted, Green Published, gold			2022-12-27	WOS:000380005400205
J	Qu, YY; Hui, J; Wang, LM; Tang, N; Zhong, H; Liu, YM; Li, Z; Feng, Q; He, F				Qu, Yuan-yuan; Hui, Jing; Wang, La-mei; Tang, Na; Zhong, Hua; Liu, Yong-min; Li, Zhen; Feng, Qian; He, Fang			Reduced Expression of the Extracellular Calcium-Sensing Receptor (CaSR) Is Associated with Activation of the Renin-Angiotensin System (RAS) to Promote Vascular Remodeling in the Pathogenesis of Essential Hypertension	PLOS ONE			English	Article							BLOOD-PRESSURE; ENDOTHELIAL-CELLS; CALCIMIMETICS; ALDOSTERONE; MODULATION; RATS	The proliferation of vascular smooth muscle cells (VSMCs), remodeling of the vasculature, and the renin-angiotensin system (RAS) play important roles in the development of essential hypertension (EH), which is defined as high blood pressure (BP) in which secondary causes, such as renovascular disease, are absent. The calcium-sensing receptor (CaSR) is involved in the regulation of BP. However, the underlying mechanisms by which the CaSR regulates BP are poorly understood. In the present study, the role of the CaSR in EH was investigated using male spontaneously hypertensive rats (SHRs) and rat and human plasma samples. The percentages of medial wall thickness to external diameter (WT%), total vessel wall cross-sectional area to the total area (WA%) of thoracic arteries, as well as the percentage of wall area occupied by collagen to total vessel wall area (CA%) were determined. Tissue protein expression and plasma concentrations of the CaSR, cyclic adenosine monophosphate (cAMP), renin, and angiotensin II (Ang II) were additionally assessed. WT%, WA%, and CA% were found to increase with increasing BP, whereas the plasma concentration of CaSR was found to decrease. With increasing BP, the levels of smooth muscle actin and calponin decreased, whereas those of osteopontin and proliferating cell nuclear antigen increased. The CaSR level negatively correlated with the levels of cAMP and Ang II, but positively correlated with those of renin. Our data suggest that reduced expression of the CaSR is correlated with activation of the RAS, which induces increased vascular remodeling and VSMC proliferation, and thereby associated with EH in the SHR model and in the Han Chinese population. Our findings provide new insights into the pathogenesis of EH.	[Qu, Yuan-yuan; Hui, Jing; Tang, Na; Zhong, Hua; Liu, Yong-min; Li, Zhen; Feng, Qian; He, Fang] Shihezi Univ, Dept Pathophysiol, Key Lab Educ, Minist Xinjiang Endem & Ethn Dis,Coll Med, Shihezi, Peoples R China; [Qu, Yuan-yuan] Shihezi Univ, Dept Emergency & Crit Care Med, Affiliated Hosp 1, Coll Med, Shihezi 832008, Peoples R China; [Wang, La-mei] Shihezi Univ, Coll Med, Ctr Med Funct Expt, Shihezi, Peoples R China	Shihezi University; Shihezi University; Shihezi University	He, F (corresponding author), Shihezi Univ, Dept Pathophysiol, Key Lab Educ, Minist Xinjiang Endem & Ethn Dis,Coll Med, Shihezi, Peoples R China.	fangf2002shz@126.com	Liu, Yong/GWQ-6163-2022		National Natural Science Foundation of China [31560287]; Science & Technology Research and Development Program of Shihezi University [2014ZRKXYQ22]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science & Technology Research and Development Program of Shihezi University	This project was supported by grants from National Natural Science Foundation of China (No. 31560287) and the Science & Technology Research and Development Program of Shihezi University (2014ZRKXYQ22).	Atchison DK, 2010, AM J PHYSIOL-REG I, V299, pR1020, DOI 10.1152/ajpregu.00238.2010; AYACHI S, 1979, METABOLISM, V28, P1234, DOI 10.1016/0026-0495(79)90136-7; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; CHURCHILL PC, 1985, AM J PHYSIOL, V249, pF175, DOI 10.1152/ajprenal.1985.249.2.F175; Cow D, 1911, J PHYSIOL-LONDON, V42, P125; Davies E, 1999, HYPERTENSION, V33, P703, DOI 10.1161/01.HYP.33.2.703; GENEST J, 1975, CAN MED ASSOC J, V113, P421; Intengan HD, 2001, HYPERTENSION, V38, P581, DOI 10.1161/hy09t1.096249; Kang G, 2015, KOREAN J PHYSIOL PHA, V19, P467, DOI 10.4196/kjpp.2015.19.5.467; Laragh John H., 1995, P1813; Liang Xiao, 2012, Shengli Xuebao, V64, P289; Molostvov G, 2007, AM J PHYSIOL-RENAL, V293, pF946, DOI 10.1152/ajprenal.00474.2006; Nijenhuis T, 2005, J CLIN INVEST, V115, P1651, DOI 10.1172/JCI24134; Ogata H, 2003, J AM SOC NEPHROL, V14, P959, DOI 10.1097/01.ASN.0000056188.23717.E5; Ortiz-Capisano MC, 2013, AM J PHYSIOL-RENAL, V304, pF248, DOI 10.1152/ajprenal.00451.2012; Rybczynska A, 2010, J PHYSIOL PHARMACOL, V61, P163; Rybczynska A, 2006, J ENDOCRINOL, V191, P189, DOI 10.1677/joe.1.06924; Saito M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03822; Smajilovic S, 2006, BIOCHEM BIOPH RES CO, V348, P1215, DOI 10.1016/j.bbrc.2006.07.192; Smajilovic S, 2011, BRIT J PHARMACOL, V164, P884, DOI 10.1111/j.1476-5381.2011.01317.x; Strom A, 2004, J VASC RES, V41, P314, DOI 10.1159/000079205; Svetkey LP, 2011, AM J HYPERTENS, V24, P209, DOI 10.1038/ajh.2010.223; Tang N, 2014, MED SCI MONITOR, V20, P2508, DOI 10.12659/MSM.892861; Wang R, 2003, EUR J BIOCHEM, V270, P2680, DOI 10.1046/j.1432-1033.2003.03645.x; Weston AH, 2011, ACTA PHYSIOL, V203, P127, DOI 10.1111/j.1748-1716.2010.02249.x; Weston AH, 2005, CIRC RES, V97, P391, DOI 10.1161/01.RES.0000178787.59594.a0; Yang Y-L, 2015, J RENIN-ANGIO-ALDO S; Yi B, 2012, GENE, V492, P354, DOI 10.1016/j.gene.2011.11.010	28	14	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0157456	10.1371/journal.pone.0157456	http://dx.doi.org/10.1371/journal.pone.0157456			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391973	Green Submitted, Green Published, gold			2022-12-27	WOS:000380005400010
J	Sanchez-Iglesias, S; Unruh-Pinheiro, A; Guillin-Amarelle, C; Gonzalez-Mendez, B; Ruiz-Riquelme, A; Rodriguez-Canete, BL; Rodriguez-Garcia, S; Guillen-Navarro, E; Domingo-Jimenez, R; Araujo-Vilar, D				Sanchez-Iglesias, Sofia; Unruh-Pinheiro, Alexander; Guillin-Amarelle, Cristina; Gonzalez-Mendez, Blanca; Ruiz-Riquelme, Alejandro; Leticia Rodriguez-Canete, Blanca; Rodriguez-Garcia, Silvia; Guillen-Navarro, Encarnacion; Domingo-Jimenez, Rosario; Araujo-Vilar, David			Skipped BSCL2 Transcript in Celia's Encephalopathy (PELD): New Insights on Fatty Acids Involvement, Senescence and Adipogenesis	PLOS ONE			English	Article							SEIP CONGENITAL LIPODYSTROPHY; ENDOPLASMIC-RETICULUM STRESS; DOCOSAHEXAENOIC ACID; DROPLET MORPHOLOGY; ARACHIDONIC-ACID; GENE-EXPRESSION; ER STRESS; CELLS; PROTEIN; YEAST	Objective PELD (Progressive Encephalopathy with or without Lipodystrophy or Celia's Encephalopathy) is a fatal and rare neurodegenerative syndrome associated with the BSCL2 mutation c.985C>T, that results in an aberrant transcript without the exon 7 (Celia seipin). The aim of this study was to evaluate both the process of cellular senescence and the effect of unsaturated fatty acids on preadipocytes from a homozygous c.985C>T patient. Also, the role of aberrant seipin isoform on adipogenesis was studied in adipose-derived human mesenchymal stem cells. Material and methods Cellular senescence was evaluated using beta-galactosidase staining of preadipocytes obtained from a homozygous c.985C>T patient. Moreover, these cells were cultured during 24 hours with Intralipid, a soybean oil-based commercial lipid emulsion. The expression of the different BSCL2 transcripts was measured by qPCR. Adipose-derived human mesenchymal stem cells were differentiated to a fat lineage using StemPRO adipogenesis kit, and the expression of BSCL2 transcripts and several adipogenesis-related genes was measured by qPCR. Results the treatment of preadipocytes with unsaturated fatty acids significantly reduced the expression of the BSCL2 transcript without exon 7 by 34 to 63%. On the other hand, at least in preadipocytes, this mutation does not disturb cellular senescence rate. Finally, during adipocyte differentiation of adipose-derived human mesenchymal stem cells, the expression of adipogenic genes (PPARG, LPIN1, and LPL) increased significantly over 14 days, and noteworthy is that the BSCL2 transcript without exon 7 was differentially expressed by 332 to 723% when compared to day 0, suggesting an underlying role in adipogenesis. Conclusions our results suggest that Celia seipin is probably playing an underestimated role in adipocyte maturation, but not in senescence, and its expression can be modified by exogenous factors as fatty acids.	[Sanchez-Iglesias, Sofia; Unruh-Pinheiro, Alexander; Guillin-Amarelle, Cristina; Gonzalez-Mendez, Blanca; Ruiz-Riquelme, Alejandro; Leticia Rodriguez-Canete, Blanca; Rodriguez-Garcia, Silvia; Araujo-Vilar, David] Univ Santiago de Compostela, Thyroid & Metab Dis Unit UETeM, Dept Med, Ctr Res Mol Med & Chron Dis CIMUS IDIS, Santiago De Compostela, Spain; [Guillen-Navarro, Encarnacion] Hosp Clin Univ Virgen de la Arrixaca, Div Pediat, Unit Med Genet & Dysmorphol, Murcia, Spain; [Domingo-Jimenez, Rosario] Hosp Clin Univ Virgen de la Arrixaca, Div Pediat, Sect Neuropediat, Murcia, Spain	Universidade de Santiago de Compostela; Hospital Clinico Universitario Virgen de la Arrixaca; Hospital Clinico Universitario Virgen de la Arrixaca	Araujo-Vilar, D (corresponding author), Univ Santiago de Compostela, Thyroid & Metab Dis Unit UETeM, Dept Med, Ctr Res Mol Med & Chron Dis CIMUS IDIS, Santiago De Compostela, Spain.	david.araujo@usc.es	Sánchez-Iglesias, Sofía/L-2644-2014; Riquelme, Alejandro Ruiz/AAG-7010-2019; araujo-vilar, david/L-1267-2014; Guillén Navarro, Encarna/AFU-6717-2022; Rodriguez-Garcia, Silvia/L-7893-2015	Sánchez-Iglesias, Sofía/0000-0003-3887-0573; Riquelme, Alejandro Ruiz/0000-0001-6581-7132; Guillén Navarro, Encarna/0000-0002-2915-7381; Rodriguez-Garcia, Silvia/0000-0001-5479-0237; Domingo-Jimenez, Rosario/0000-0001-5115-194X	Instituto de Salud Carlos III; European Regional Development Fund; Conselleria de Industria, Xunta de Galicia [10PXIB208013PR]; Asociacion Espanola de Familiares y Afectados de Lipodistrofias (AELIP); FEDER [PI10/02873, PI13/00314];  [ISCIII/PI13/00314/Cofinanciado FEDER]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Regional Development Fund(European Commission); Conselleria de Industria, Xunta de Galicia(Xunta de Galicia); Asociacion Espanola de Familiares y Afectados de Lipodistrofias (AELIP); FEDER(European Commission); 	This work was supported by the Instituto de Salud Carlos III and the European Regional Development Fund, FEDER (grants number PI10/02873 and PI13/00314, http://www.isciii.es/), ISCIII/PI13/00314/Cofinanciado FEDER and by the Conselleria de Industria, Xunta de Galicia (grant number 10PXIB208013PR, http://www.xunta.es/). SRG was awarded a Research Fellowship, granted by the Asociacion Espanola de Familiares y Afectados de Lipodistrofias (AELIP, http://www.aelip.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOURRE JM, 1989, J NUTR, V119, P1880, DOI 10.1093/jn/119.12.1880; Boutet E, 2009, BIOCHIMIE, V91, P796, DOI 10.1016/j.biochi.2009.01.011; Cartwright BR, 2015, MOL BIOL CELL, V26, P726, DOI 10.1091/mbc.E14-08-1303; Cartwright BR, 2012, J LIPID RES, V53, P1042, DOI 10.1194/jlr.R023754; Casanas-Sanchez V, 2014, J NEUROCHEM, V131, P470, DOI 10.1111/jnc.12833; Chalfant CE, 2002, J BIOL CHEM, V277, P12587, DOI 10.1074/jbc.M112010200; Chen WQ, 2009, ENDOCRINOLOGY, V150, P4552, DOI 10.1210/en.2009-0236; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Fei WH, 2008, J CELL BIOL, V180, P473, DOI 10.1083/jcb.200711136; Fei WH, 2011, J LIPID RES, V52, P2136, DOI 10.1194/jlr.M017566; Ghosh N, 2007, ENDOCRINOLOGY, V148, P1359, DOI 10.1210/en.2006-0750; Gluckman PD, 2009, PRINCIPLES EVOLUTION; GORDON N, 1987, BRAIN DEV-JPN, V9, P571, DOI 10.1016/S0387-7604(87)80087-6; Gordon N, 1997, BRAIN DEV-JPN, V19, P165, DOI 10.1016/S0387-7604(96)00560-8; Guillen-Navarro E, 2013, J MED GENET, V50, P401, DOI 10.1136/jmedgenet-2013-101525; Hamosh M, 1998, BIOL NEONATE, V74, P106, DOI 10.1159/000014017; Harvey KA, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0005-6; Holtta-Vuori M, 2013, HUM MOL GENET, V22, P1157, DOI 10.1093/hmg/dds523; Innis SM, 2007, J NUTR, V137, P855, DOI 10.1093/jn/137.4.855; Innis SM, 2008, BRAIN RES, V1237, P35, DOI 10.1016/j.brainres.2008.08.078; Ito D, 2007, ANN NEUROL, V61, P237, DOI 10.1002/ana.21070; Ito D, 2009, BRAIN, V132, P8, DOI 10.1093/brain/awn216; Kurat CF, 2009, MOL CELL, V33, P53, DOI 10.1016/j.molcel.2008.12.019; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lundin C, 2006, FEBS LETT, V580, P2281, DOI 10.1016/j.febslet.2006.03.040; Magre J, 2001, NAT GENET, V28, P365, DOI 10.1038/ng585; Panganiban RAM, 2013, INT J RADIAT BIOL, V89, P656, DOI 10.3109/09553002.2012.711502; Patwardhan GA, 2014, BBA-MOL CELL BIOL L, V1841, P1571, DOI 10.1016/j.bbalip.2014.08.017; Payne VA, 2008, DIABETES, V57, P2055, DOI 10.2337/db08-0184; Perez MA, 2013, BEHAV BRAIN FUNCT, V9, DOI 10.1186/1744-9081-9-25; Reardon HT, 2013, PROSTAG LEUKOTR ESS, V88, P15, DOI 10.1016/j.plefa.2012.02.003; Ruiz-Riquelme A, 2015, NEUROBIOLOGY DIS; Szymanski KM, 2007, P NATL ACAD SCI USA, V104, P20890, DOI 10.1073/pnas.0704154104; Tian Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001364; Van Maldergem L, 2002, J MED GENET, V39, P722, DOI 10.1136/jmg.39.10.722; Victoria B, 2010, DIABETIC MED, V27, P1178, DOI 10.1111/j.1464-5491.2010.03052.x; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wei SH, 2014, J NEUROCHEM, V129, P328, DOI 10.1111/jnc.12638; Wei SH, 2013, J NEUROCHEM, V124, P478, DOI 10.1111/jnc.12099; Wijendran V, 2013, PROSTAG LEUKOTR ESS, V89, P345, DOI 10.1016/j.plefa.2013.08.004; Wolinski H, 2011, J CELL SCI, V124, P3894, DOI 10.1242/jcs.091454; Yagi T, 2011, HUM MOL GENET, V20, P3831, DOI 10.1093/hmg/ddr304; Yang WL, 2013, BIOCHEM J, V452, P37, DOI 10.1042/BJ20121870	43	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158874	10.1371/journal.pone.0158874	http://dx.doi.org/10.1371/journal.pone.0158874			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391332	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400147
J	Sanders, JG; Jenkins, R				Sanders, Jet G.; Jenkins, Rob			Weekly Fluctuations in Risk Tolerance and Voting Behaviour	PLOS ONE			English	Article							DECISION-MAKING; TASK BART; POLITICAL CONSERVATISM; TAKING PROPENSITY; DISCRETE EMOTIONS; PLANNED BEHAVIOR; ATTITUDES; METAANALYSIS; PERSUASION; LIBERALS	Risk tolerance is fundamental to decision-making and behaviour. Here we show that individuals' tolerance of risk follows a weekly cycle. We observed this cycle directly in a behavioural experiment using the Balloon Analogue Risk Task (Lejuez et al., 2002; Study 1). We also observed it indirectly via voting intentions, gathered from 81,564 responses across 70 opinion polls ahead of the Scottish Independence Referendum of 2014 (Study 2) and 149,064 responses across 77 opinion polls ahead of the United Kingdom European Union membership referendum of 2016 (Study 3). In all three studies, risk-tolerance decreased from Monday to Thursday before returning to a higher level on Friday. This pattern is politically significant because UK elections and referendums are traditionally held on a Thursday -the lowest point for risk tolerance. In particular, it raises the possibility that voting outcomes in the UK could be systematically risk-averse. In line with our analysis, the actual proportion of Yes votes in the Scottish Independence Referendum was 4% lower than forecast. Taken together, our findings reveal that the seven-day weekly cycle may have unexpected consequences for human decision-making. They also suggest that the day on which a vote is held could determine its outcome.	[Sanders, Jet G.; Jenkins, Rob] Univ York, York YO10 5DD, N Yorkshire, England	University of York - UK	Jenkins, R (corresponding author), Univ York, York YO10 5DD, N Yorkshire, England.	rob.jenkins@york.ac.uk			Economic and Social Research Council [ES/J500215/1]; Prins Bernhard Cultuurfonds [E/30/30.13.0630/HVH/IE]	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Prins Bernhard Cultuurfonds	This work was supported by the Economic and Social Research Council, Studentship ES/J500215/1, http://www.esrc.ac.uk/funding/ and Prins Bernhard Cultuurfonds, grant E/30/30.13.0630/HVH/IE, http://www.cultuurfonds.nl/aanvragen/cultuurfondsbeurzen.	Ainslie G, 2005, BEHAV BRAIN SCI, V28, P635, DOI 10.1017/S0140525X05000117; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Angie AD, 2011, COGNITION EMOTION, V25, P1393, DOI 10.1080/02699931.2010.550751; Areni CS, 2011, PSYCHOL REP, V109, P723, DOI 10.2466/13.20.PR0.109.6.723-733; Armitage CJ, 2001, BRIT J SOC PSYCHOL, V40, P471, DOI 10.1348/014466601164939; Attanasi G, 2010, VOTING AS A LOTTERY; Attanasi G, 2014, PAC ECON REV, V19, P355, DOI 10.1111/1468-0106.12070; Blake M. J. F., 1967, PSYCHON SCI, V9, DOI [10.3758/BF03327842, DOI 10.3758/BF03327842]; Bornovalova MA, 2005, EXP CLIN PSYCHOPHARM, V13, P311, DOI 10.1037/1064-1297.13.4.311; Bradvik L, 2003, SUICIDE LIFE-THREAT, V33, P186, DOI 10.1521/suli.33.2.186.22773; Carney DR, 2008, POLIT PSYCHOL, V29, P807, DOI 10.1111/j.1467-9221.2008.00668.x; Choma BL, 2014, SOCIAL PSYCHOL PERSO; Cross F., 1973, FINANCIAL ANALYSTS J, V29, P67, DOI 10.2469/faj.v29.n6.67; Curtice J., 2015, BRIT SOCIAL ATTITUDE; Curtice J., 2014, WHAT SCOTLAND THINKS; DeSteno D, 2004, J PERS SOC PSYCHOL, V86, P43, DOI 10.1037/0022-3514.86.1.43; Ellis DA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134555; Ellis DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051365; Friese M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044130; GIBBONS MR, 1981, J BUS, V54, P579, DOI 10.1086/296147; Glasman LR, 2006, PSYCHOL BULL, V132, P778, DOI 10.1037/0033-2909.132.5.778; Hirsh JB, 2010, PERS SOC PSYCHOL B, V36, P655, DOI 10.1177/0146167210366854; Jost JT, 2007, PERS SOC PSYCHOL B, V33, P989, DOI 10.1177/0146167207301028; Jost JT, 2003, PSYCHOL BULL, V129, P339, DOI 10.1037/0033-2909.129.3.339; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Keller PA, 2003, J MARKETING RES, V40, P54, DOI 10.1509/jmkr.40.1.54.19133; KRAUS SJ, 1995, PERS SOC PSYCHOL B, V21, P58, DOI 10.1177/0146167295211007; Lee K, 2010, J RES PERS, V44, P115, DOI 10.1016/j.jrp.2009.08.007; Lejuez C, 2003, J ADOLESCENCE, V26, P475, DOI 10.1016/S0140-1971(03)00036-8; Lejuez CW, 2004, ADDICT BEHAV, V29, P1643, DOI 10.1016/j.addbeh.2004.02.035; Lejuez CW, 2003, EXP CLIN PSYCHOPHARM, V11, P26, DOI 10.1037/1064-1297.11.1.26; Lejuez CW, 2002, J EXP PSYCHOL-APPL, V8, P75, DOI 10.1037//1076-898X.8.2.75; Lo J, 2014, POLIT ANAL, V22, P205, DOI 10.1093/pan/mpt028; Lundberg KB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085680; MASSING W, 1985, SOC SCI MED, V21, P433, DOI 10.1016/0277-9536(85)90223-0; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; Proudfoot J, 2014, PSYCHIAT RES, V218, P290, DOI 10.1016/j.psychres.2014.04.047; Raghunathan R, 1999, ORGAN BEHAV HUM DEC, V79, P56, DOI 10.1006/obhd.1999.2838; Refaeilzadeh P., ENCY DATABASE SYSTEM, P532; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; Upton DJ, 2011, PERS INDIV DIFFER, V50, P492, DOI 10.1016/j.paid.2010.11.013; Wallace DS, 2005, REV GEN PSYCHOL, V9, P214, DOI 10.1037/1089-2680.9.3.214; Wheatley J, 2014, PARTY POLIT, V20, P864, DOI 10.1177/1354068812458614; WILLICH SN, 1994, CIRCULATION, V90, P87, DOI 10.1161/01.CIR.90.1.87; Zerubavel E, 1985, 7 DAY CIRCLE HIST ME	46	2	2	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159017	10.1371/journal.pone.0159017	http://dx.doi.org/10.1371/journal.pone.0159017			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27392020	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000380005400192
J	Albanna, W; Conzen, C; Weiss, M; Clusmann, H; Fuest, M; Mueller, M; Brockmann, MA; Vilser, W; Schmidt-Trucksass, A; Hoellig, A; Seiz, M; Thome, C; Kotliar, K; Schubert, GA				Albanna, Walid; Conzen, Catharina; Weiss, Miriam; Clusmann, Hans; Fuest, Matthias; Mueller, Marguerite; Brockmann, Marc Alexander; Vilser, Walthard; Schmidt-Trucksass, Arno; Hoellig, Anke; Seiz, Marcel; Thome, Claudius; Kotliar, Konstantin; Schubert, Gerrit Alexander			Retinal Vessel Analysis (RVA) in the Context of Subarachnoid Hemorrhage - A Proof of Concept Study	PLOS ONE			English	Article							ATHEROSCLEROSIS RISK; MICROVASCULAR ABNORMALITIES; CEREBRAL AUTOREGULATION; COMMUNITIES; STATEMENT; ISCHEMIA; ANALYZER; EYE	Background Timely detection of impending delayed cerebral ischemia after subarachnoid hemorrhage (SAH) is essential to improve outcome, but poses a diagnostic challenge. Retinal vessels as an embryological part of the intracranial vasculature are easily accessible for analysis and may hold the key to a new and non-invasive monitoring technique. This investigation aims to determine the feasibility of standardized retinal vessel analysis (RVA) in the context of SAH. Methods In a prospective pilot study, we performed RVA in six patients awake and cooperative with SAH in the acute phase (day 2-14) and eight patients at the time of follow-up (mean 4.6 +/- 1.7months after SAH), and included 33 age-matched healthy controls. Data was acquired using a manoeuvrable Dynamic Vessel Analyzer (Imedos Systems UG, Jena) for examination of retinal vessel dimension and neurovascular coupling. Results Image quality was satisfactory in the majority of cases (93.3%). In the acute phase after SAH, retinal arteries were significantly dilated when compared to the control group (124.2 +/- 4.3MU vs 110.9 +/- 11.4MU, p<0.01), a difference that persisted to a lesser extent in the later stage of the disease (122.7 +/- 17.2MU, p<0.05). Testing for neurovascular coupling showed a trend towards impaired primary vasodilation and secondary vasoconstriction (p = 0.08, p = 0.09 resp.) initially and partial recovery at the time of follow-up, indicating a relative improvement in a time-dependent fashion. Conclusion RVA is technically feasible in patients with SAH and can detect fluctuations in vessel diameter and autoregulation even in less severely affected patients. Preliminary data suggests potential for RVA as a new and non-invasive tool for advanced SAH monitoring, but clinical relevance and prognostic value will have to be determined in a larger cohort.	[Albanna, Walid; Conzen, Catharina; Weiss, Miriam; Clusmann, Hans; Hoellig, Anke; Schubert, Gerrit Alexander] Rhein Westfal TH Aachen, Dept Neurosurg, Aachen, Germany; [Fuest, Matthias] Rhein Westfal TH Aachen, Dept Ophthalmol, Aachen, Germany; [Mueller, Marguerite; Brockmann, Marc Alexander] Rhein Westfal TH Aachen, Dept Diagnost & Intervent Neuroradiol, Aachen, Germany; [Vilser, Walthard] IMEDOS Syst UG, Jena, Germany; [Schmidt-Trucksass, Arno] Univ Basel, Dept Exercise & Hlth Sci, Basel, Switzerland; [Seiz, Marcel] Heidelberg Univ, Univ Med Mannheim, Dept Neurosurg, Mannheim, Germany; [Thome, Claudius] Med Univ Innsbruck, Dept Neurosurg, Innsbruck, Austria; [Kotliar, Konstantin] FH Aachen Univ Appl Sci, Dept Med Engn & Technomath, Aachen, Germany	RWTH Aachen University; RWTH Aachen University; RWTH Aachen University; University of Basel; Ruprecht Karls University Heidelberg; Medical University of Innsbruck	Schubert, GA (corresponding author), Rhein Westfal TH Aachen, Dept Neurosurg, Aachen, Germany.	gerrit.schubert@me.com	Fuest, Matthias/AAC-8858-2020; Schubert, Gerrit Alexander/Q-9192-2017; Weiss, Miriam/AAJ-8845-2020; Schmidt-Trucksäss, Arno/I-7673-2015	Schubert, Gerrit Alexander/0000-0001-9135-6042; Weiss, Miriam/0000-0001-8820-0805; Schmidt-Trucksäss, Arno/0000-0002-4662-3911; Albanna, Walid/0000-0001-9986-8739; Kotliar, Konstantin/0000-0003-2087-957X	START-Program of the Faculty of Medicine, RWTH Aachen University	START-Program of the Faculty of Medicine, RWTH Aachen University	This research program is supported by the START-Program of the Faculty of Medicine, RWTH Aachen University. One of the authors [WV], is affiliated to IMEDOS Systems, employed as CEO of the company. IMEDOS Systems provided the utilized imaging device for research purposes only. IMEDOS Systems gave technical instruction and support for the imaging device. The funder provided support in the form of research material, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Particularly in view of the constructional setup of the imaging device, the authors would like to express our gratitude for the invaluable practical support that was generously provided by Mrs Jasmin Dell'Anna and Professor Klaus Radermacher (Faculty of Medical Engineering, Helmholtz-Institute for Biomedical Engineering, RWTH Aachen University).	Balbi M, 2017, J CEREBR BLOOD F MET, V37, P178, DOI 10.1177/0271678X15621253; Budohoski KP, 2013, NAT REV NEUROL, V9, P152, DOI 10.1038/nrneurol.2013.11; Budohoski KP, 2013, J CEREBR BLOOD F MET, V33, P449, DOI 10.1038/jcbfm.2012.189; Chen HI, 2011, NEUROSURGERY, V69, P53, DOI 10.1227/NEU.0b013e3182191451; Cooper LS, 2006, STROKE, V37, P82, DOI 10.1161/01.STR.0000195134.04355.e5; Couper DJ, 2002, AM J OPHTHALMOL, V133, P78, DOI 10.1016/S0002-9394(01)01315-0; Dengler J, 2011, INTENS CARE MED, V37, P1809, DOI 10.1007/s00134-011-2316-z; Derdeyn CP, 2002, BRAIN, V125, P595, DOI 10.1093/brain/awf047; Friedrich B, 2014, J CEREBR BLOOD F MET, V34, P1422, DOI 10.1038/jcbfm.2014.96; Garhofer G., 2012, OCULAR BLOOD FLOW, P101; Garhofer G, 2010, ACTA OPHTHALMOL, V88, P717, DOI 10.1111/j.1755-3768.2009.01587.x; Heitmar R, 2011, INVEST OPHTH VIS SCI, V52, P6199, DOI 10.1167/iovs.10-6628; Horn P, 2001, CEREBROVASC DIS, V12, P197, DOI 10.1159/000047704; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Jaeger M, 2012, STROKE, V43, P2097, DOI 10.1161/STROKEAHA.112.659888; Koide M, 2013, ACTA NEUROCHIR SUPPL, V115, P167, DOI 10.1007/978-3-7091-1192-5_32; Koide M, 2012, P NATL ACAD SCI USA, V109, pE1387, DOI 10.1073/pnas.1121359109; Kotliar KE, 2004, GRAEF ARCH CLIN EXP, V242, P377, DOI 10.1007/s00417-003-0847-x; Kotliar KE, 2011, MICROVASC RES, V81, P123, DOI 10.1016/j.mvr.2010.11.007; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; Polak K, 2000, BRIT J OPHTHALMOL, V84, P1285, DOI 10.1136/bjo.84.11.1285; Vajkoczy P, 2003, J NEUROSURG, V98, P1227, DOI 10.3171/jns.2003.98.6.1227; Vergouwen MDI, 2010, STROKE, V41, P2391, DOI 10.1161/STROKEAHA.110.589275; Vilser W, 2002, Biomed Tech (Berl), V47 Suppl 1 Pt 2, P682, DOI 10.1515/bmte.2002.47.s1b.682; White H, 2006, INTENS CARE MED, V32, P981, DOI 10.1007/s00134-006-0173-y; Wong T, 2007, LANCET, V369, P425, DOI 10.1016/S0140-6736(07)60198-6; Wong TY, 2001, LANCET, V358, P1134, DOI 10.1016/S0140-6736(01)06253-5	27	11	11	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158781	10.1371/journal.pone.0158781	http://dx.doi.org/10.1371/journal.pone.0158781			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27388619	Green Published, Green Submitted, gold			2022-12-27	WOS:000379811500045
J	David, MM; Enard, D; Ozturk, A; Daniels, J; Jung, JY; Diaz-Beltran, L; Wall, DP				David, Maude M.; Enard, David; Ozturk, Alp; Daniels, Jena; Jung, Jae-Yoon; Diaz-Beltran, Leticia; Wall, Dennis. P.			Comorbid Analysis of Genes Associated with Autism Spectrum Disorders Reveals Differential Evolutionary Constraints	PLOS ONE			English	Article							POSITIVE SELECTION; CHILDREN; BRAIN; BETA; TOOL	The burden of comorbidity in Autism Spectrum Disorder (ASD) is substantial. The symptoms of autism overlap with many other human conditions, reflecting common molecular pathologies suggesting that cross-disorder analysis will help prioritize autism gene candidates. Genes in the intersection between autism and related conditions may represent nonspecific indicators of dysregulation while genes unique to autism may play a more causal role. Thorough literature review allowed us to extract 125 ICD-9 codes comorbid to ASD that we mapped to 30 specific human disorders. In the present work, we performed an automated extraction of genes associated with ASD and its comorbid disorders, and found 1031 genes involved in ASD, among which 262 are involved in ASD only, with the remaining 779 involved in ASD and at least one comorbid disorder. A pathway analysis revealed 13 pathways not involved in any other comorbid disorders and therefore unique to ASD, all associated with basal cellular functions. These pathways differ from the pathways associated with both ASD and its comorbid conditions, with the latter being more specific to neural function. To determine whether the sequence of these genes have been subjected to differential evolutionary constraints, we studied long term constraints by looking into Genomic Evolutionary Rate Profiling, and showed that genes involved in several comorbid disorders seem to have undergone more purifying selection than the genes involved in ASD only. This result was corroborated by a higher dN/dS ratio for genes unique to ASD as compare to those that are shared between ASD and its comorbid disorders. Short-term evolutionary constraints showed the same trend as the pN/pS ratio indicates that genes unique to ASD were under significantly less evolutionary constraint than the genes associated with all other disorders.	[David, Maude M.; Ozturk, Alp; Daniels, Jena; Jung, Jae-Yoon; Diaz-Beltran, Leticia; Wall, Dennis. P.] Stanford Univ, Dept Pediat, Div Syst Med, Stanford, CA 94305 USA; [Enard, David] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University; Stanford University	Wall, DP (corresponding author), Stanford Univ, Dept Pediat, Div Syst Med, Stanford, CA 94305 USA.	dpwall@stanford.edu		David, Maude/0000-0003-1561-418X; Enard, David/0000-0003-2634-8016	National Institutes of Mental Health [1R01MH090611-01A1]; Hartwell Foundation's Autism Technology and Research Initiative (iHART); NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090611] Funding Source: NIH RePORTER	National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Hartwell Foundation's Autism Technology and Research Initiative (iHART); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The work was supported by funds to DPW under grant 1R01MH090611-01A1 from the National Institutes of Mental Health (http://www.nimh.nih.gov) and under the Hartwell Foundation's Autism Technology and Research Initiative (iHART). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-36; Aldred S, 2003, J AUTISM DEV DISORD, V33, P93, DOI 10.1023/A:1022238706604; Autism and Developmental Disabilities Monitoring Network, 2012, PREV AUT SPECTR DIS, P1; Barone R, 2016, AUTISM RES, V9, P423, DOI 10.1002/aur.1541; Becker R, 1988, COMPUTER SCI SERIES; Borg I, 2010, MODERN MULTIDIMENSIO; Bukauskas FF, 2004, BBA-BIOMEMBRANES, V1662, P42, DOI 10.1016/j.bbamem.2004.01.008; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Crider A, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-46; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Fletcher W, 2010, MOL BIOL EVOL, V27, P2257, DOI 10.1093/molbev/msq115; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Gargus JJ, 2009, ANN NY ACAD SCI, V1151, P133, DOI 10.1111/j.1749-6632.2008.03572.x; Gong XH, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-7; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Jiang YH, 2013, AM J HUM GENET, V93, P249, DOI 10.1016/j.ajhg.2013.06.012; Jordan G, 2012, MOL BIOL EVOL, V29, P1125, DOI 10.1093/molbev/msr272; Jung JY, 2014, J AM MED INFORM ASSN, V21, P399, DOI 10.1136/amiajnl-2012-001563; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Keller MC, 2006, BEHAV BRAIN SCI, V29, P385, DOI 10.1017/S0140525X06009095; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kohane IS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033224; Matson JL, 2007, RES DEV DISABIL, V28, P341, DOI 10.1016/j.ridd.2005.12.004; Maussion G, 2008, HUM MOL GENET, V17, P2541, DOI 10.1093/hmg/ddn154; Nadkarni Prakash M, 2012, J Clin Bioinforma, V2, P9, DOI 10.1186/2043-9113-2-9; Nelson TH, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-56; Pearson BL, 2013, BEHAV BRAIN RES, V243, P138, DOI 10.1016/j.bbr.2012.12.062; Philippi A, 2005, MOL PSYCHIATR, V10, P950, DOI 10.1038/sj.mp.4001704; Reissner C, 2014, J BIOL CHEM, V289, P27585, DOI 10.1074/jbc.M114.595413; Ruta L, 2011, PSYCHONEUROENDOCRINO, V36, P1154, DOI 10.1016/j.psyneuen.2011.02.007; Rzhetsky A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003518; Schengrund CL, 2012, NEUROCHEM RES, V37, P1201, DOI 10.1007/s11064-011-0697-6; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Shimodaira H, 2004, APPROXIMATELY UNBIAS; Shu XD, 2002, MOL CELL BIOL, V22, P7758, DOI 10.1128/MCB.22.22.7758-7768.2002; Simonoff E, 2008, J AM ACAD CHILD PSY, V47, P921, DOI 10.1097/CHI.0b013e318179964f; Wang HY, 2007, PLOS BIOL, V5, P335, DOI 10.1371/journal.pbio.0050013; Wingate M, 2014, MMWR SURVEILL SUMM, V63; Yu W, 2010, BIOINFORMATICS, V26, P145, DOI 10.1093/bioinformatics/btp618; Yuen RKC, 2015, NAT MED, V21, P185, DOI 10.1038/nm.3792	40	12	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0157937	10.1371/journal.pone.0157937	http://dx.doi.org/10.1371/journal.pone.0157937			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414027	Green Submitted, gold, Green Published			2022-12-27	WOS:000379579500015
J	Amano, T; Tamari, K; Tanaka, S; Uchida, S; Ito, H; Morikawa, S; Kawamura, K				Amano, Tetsuya; Tamari, Kotaro; Tanaka, Shigeharu; Uchida, Shigehiro; Ito, Hideyuki; Morikawa, Shinya; Kawamura, Kenji			Factors for Assessing the Effectiveness of Early Rehabilitation after Minimally Invasive Total Knee Arthroplasty: A Prospective Cohort Study	PLOS ONE			English	Article							RANDOMIZED CLINICAL-TRIAL; QUALITY-OF-LIFE; HIP; OSTEOARTHRITIS; RECOVERY; OUTCOMES; PATHWAY; GO	The effectiveness of current rehabilitation programs is supported by high-level evidence from the results of randomized controlled trials, but an increasing number of patients are not discharged from the hospital because of the schedule of the critical path (CP). The present study aimed to determine which factors can be used to assess the effectiveness of early rehabilitation. We enrolled 123 patients with medial knee osteoarthritis (OA) who had undergone unilateral minimally invasive total knee arthroplasty for the first time. The following factors were assessed preoperatively: the maximum isometric muscle strength of the knee extensors and flexors, maximum knee and hip joint angle, pain, 5-m maximum walking speed, sex, age, body mass index, exercise habits, Kellgren-Lawrence grade, femorotibial angle, failure side (bilateral or unilateral knee OA), and functional independence measure. We re-evaluated physical function (i.e., muscle strength, joint angle, and pain) and motor function (5-m maximum walking speed) 14 days postoperatively. Changes in physical function, motor function (5-m maximum walking speed), and number of days to independent walking were used as explanatory variables. The postoperative duration of hospitalization (in days) was used as the dependent variable in multivariate analyses. These analyses were adjusted for sex, age, body mass index, exercise habits, Kellgren-Lawrence grade, femorotibial angle, failure side, and functional independence measure. The duration of hospitalization was significantly affected by the number of days to independent walking (p < 0.001, beta = 0.507) and a change in the 5-m maximum walking speed (p = 0.016, beta = -0.262). Multiple regression analysis showed that the radiographic knee grade (p = 0.029, beta = 0.239) was a significant confounding factor. Independent walking and walking speed recovery were considered to reduce the duration of hospitalization. Therefore, these indices can be used to assess the effectiveness of early rehabilitation.	[Amano, Tetsuya] Tokoha Univ, Fac Hlth & Med Sci, Dept Phys Therapy, Hamamatsu, Shizuoka, Japan; [Amano, Tetsuya; Kawamura, Kenji] KIBI Int Univ, Grad Sch Hlth Sci, Takahashi, Okayama, Japan; [Tamari, Kotaro] JICA Guatemala Off, Zona, Calle, Guatemala; [Tanaka, Shigeharu] Kawasaki Jr Coll Rehabil, Dept Phys Therapy, Kurashiki, Okayama, Japan; [Uchida, Shigehiro] Hiroshima Int Univ, Fac Rehabil, Dept Rehabil, Higashihiroshima, Hiroshima, Japan; [Ito, Hideyuki] Yamaguchi Allied Hlth Coll, Dept Phys Therapy, Yamaguchi, Yamaguchi, Japan; [Morikawa, Shinya] Hohsyasen Daiichi Hosp, Dept Rehabil, Imabari, Ehime, Japan		Amano, T (corresponding author), Tokoha Univ, Fac Hlth & Med Sci, Dept Phys Therapy, Hamamatsu, Shizuoka, Japan.	tamano@hm.tokoha-u.ac.jp			JSPS KAKENHI [25750245]; Grants-in-Aid for Scientific Research [25750245] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI (grant number: 25750245). URL: http://www.jsps.go.jp/english/e-grants/index.html. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cho KY, 2014, KNEE SURG SPORT TR A, V22, P1759, DOI 10.1007/s00167-013-2556-2; Chotanaphuti Thanainit, 2008, Journal of the Medical Association of Thailand, V91, P1382; Duncan CM, 2013, REGION ANESTH PAIN M, V38, P533, DOI 10.1097/AAP.0000000000000014; Katoh M, 2009, J PHYS THER SCI, V21, P37, DOI 10.1589/jpts.21.37; Kennedy DM, 2006, J ARTHROPLASTY, V21, P559, DOI 10.1016/j.arth.2005.07.010; Kim TK, 2009, KNEE SURG SPORT TR A, V17, P1152, DOI 10.1007/s00167-009-0731-2; Loftus T, 2014, J KNEE SURG, V27, P221, DOI 10.1055/s-0033-1360657; Moffet H, 2004, ARCH PHYS MED REHAB, V85, P546, DOI 10.1016/j.apmr.2003.08.080; Munin MC, 1998, JAMA-J AM MED ASSOC, V279, P847, DOI 10.1001/jama.279.11.847; Petterson SC, 2009, ARTHRIT RHEUM-ARTHR, V61, P174, DOI 10.1002/art.24167; Piva SR, 2010, PHYS THER, V90, P880, DOI 10.2522/ptj.20090150; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Sajima Y, 2001, RIGAKU RYOHOGAKU, V28, P14; Labraca NS, 2011, CLIN REHABIL, V25, P557, DOI 10.1177/0269215510393759; Shumway-Cook A, 2000, PHYS THER, V80, P896, DOI 10.1093/ptj/80.9.896; Tamari K, 2009, AUST J PHYSIOTHER, V55, P201, DOI 10.1016/S0004-9514(09)70082-0; Tria AJ, 2003, CLIN ORTHOP RELAT R, P185, DOI 10.1097/01.blo.0000093030.56370.d9; Weigl M, 2006, OSTEOARTHR CARTILAGE, V14, P641, DOI 10.1016/j.joca.2006.01.001; Yoo Ju-Hyung, 2014, Knee Surg Relat Res, V26, P149, DOI 10.5792/ksrr.2014.26.3.149; Zhang W, 2010, OSTEOARTHR CARTILAGE, V18, P476, DOI 10.1016/j.joca.2010.01.013	20	8	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159172	10.1371/journal.pone.0159172	http://dx.doi.org/10.1371/journal.pone.0159172			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410385	Green Published, Green Submitted, gold			2022-12-27	WOS:000379508300065
J	Daryabor, F; Ooi, SH; Abu Samah, A; Akbari, A				Daryabor, Farshid; Ooi, See Hai; Abu Samah, Azizan; Akbari, Abolghasem			Dynamics of the Water Circulations in the Southern South China Sea and Its Seasonal Transports	PLOS ONE			English	Article							INTEROCEAN CIRCULATION; INDONESIAN THROUGHFLOW; PENINSULAR MALAYSIA; FRESH-WATER; EAST-COAST; MODEL; OCEAN; SIMULATION; SURFACE; HEAT	A three-dimensional Regional Ocean Modeling System is used to study the seasonal water circulations and transports of the Southern South China Sea. The simulated seasonal water circulations and estimated transports show consistency with observations, e.g., satellite altimeter data set and re-analysis data of the Simple Ocean Data Assimilation. It is found that the seasonal water circulations are mainly driven by the monsoonal wind stress and influenced by the water outflow/inflow and associated currents of the entire South China Sea. The intrusion of the strong current along the East Coast of Peninsular Malaysia and the eddies at different depths in all seasons are due to the conservation of the potential vorticity as the depth increases. Results show that the water circulation patterns in the northern part of the East Coast of Peninsular Malaysia are generally dominated by the geostrophic currents while those in the southern areas are due solely to the wind stress because of negligible Coriolis force there. This study clearly shows that individual surface freshwater flux ( evaporation minus precipitation) controls the sea salinity balance in the Southern South China Sea thermohaline circulations. Analysis of climatological data from a high resolution Regional Ocean Modeling System reveals that the complex bathymetry is important not only for water exchange through the Southern South China Sea but also in regulating various transports across the main passages in the Southern South China Sea, namely the Sunda Shelf and the Strait of Malacca. Apart from the above, in comparision with the dynamics of the Sunda Shelf, the Strait of Malacca reflects an equally significant role in the annual transports into the Andaman Sea.	[Daryabor, Farshid; Ooi, See Hai; Abu Samah, Azizan] Univ Malaya, Inst Postgrad Studies, Natl Antarctic Res Ctr, Kuala Lumpur 50603, Malaysia; [Daryabor, Farshid; Abu Samah, Azizan] Univ Malaya, Inst Postgrad Studies, Inst Ocean & Earth Sci, Kuala Lumpur 50603, Malaysia; [Akbari, Abolghasem] Univ Malaysia Pahang, Fac Civil Engn & Earth Resources, Lebuhraya Tun Razak, Kuantan 26300, Pahang, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaysia Pahang	Daryabor, F (corresponding author), Univ Malaya, Inst Postgrad Studies, Natl Antarctic Res Ctr, Kuala Lumpur 50603, Malaysia.; Daryabor, F (corresponding author), Univ Malaya, Inst Postgrad Studies, Inst Ocean & Earth Sci, Kuala Lumpur 50603, Malaysia.	fdaryabor@um.edu.my	Daryabor, Farshid/A-9345-2019; ABU SAMAH, AZIZAN HJ/B-8295-2010; Akbari, Abolghasem/L-5971-2019; Daryabor, Farshid/K-6084-2015; Akbari, Abolghasem/N-1341-2014	Daryabor, Farshid/0000-0001-8217-8504; Akbari, Abolghasem/0000-0003-4394-1970; Daryabor, Farshid/0000-0001-8217-8504; Akbari, Abolghasem/0000-0003-4394-1970	Higher Institution Centre of Excellence (HICoE) Grant under the Institute of Ocean and Earth Sciences (IOES)	Higher Institution Centre of Excellence (HICoE) Grant under the Institute of Ocean and Earth Sciences (IOES)	This research study is funded by the Higher Institution Centre of Excellence (HICoE) Grant under the Institute of Ocean and Earth Sciences (IOES-2014a, Air-Ocean-Land Interaction).; This research study is funded by the Higher Institution Centre of Excellence (HICoE) Grant under the Institute of Ocean and Earth Sciences (IOES-2014a, Air-Ocean-Land Interaction). It is also strongly supported by the Vice-Chancellor of the University of Malaya. Above all, the authors greatly appreciate the invaluable and constructive comments and suggestions by the reviewers on this manuscript.	Akhir M.F., 2015, OPEN J MAR SCI, V5, P273, DOI [10.4236/ojms.2015.53022, DOI 10.4236/OJMS.2015.53022]; Antonov J. I., 2006, WORLD OCEAN ATLAS 20; Cai SQ, 2005, ACTA OCEANOL SIN, V24, P10; Cai SQ, 2005, ACTA OCEANOL SIN, V24, P31; Carton JA, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002817; Carton JA, 2008, MON WEATHER REV, V136, P2999, DOI 10.1175/2007MWR1978.1; Chen GX, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007724; Daryabor F., 2015, OCEAN SCI DISCUSS, V12, P275, DOI [10.5194/osd-12-275-2015, DOI 10.5194/OSD-12-275-2015]; Daryabor F, 2010, GEOPH RES ABSTR, V12; Daryabor F, 2015, OCEAN DYNAM, V65, P93, DOI 10.1007/s10236-014-0787-5; Daryabor F, 2014, SAINS MALAYS, V43, P389; Ezer T, 2002, OCEAN MODEL, V4, P249, DOI 10.1016/S1463-5003(02)00003-3; Fang GH, 2005, ADV ATMOS SCI, V22, P946; Fang GH, 2003, SCI CHINA SER D, V46, P149, DOI 10.1360/03yd9014; Fang GH, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2010JC006225; Fang GH, 2009, DYNAM ATMOS OCEANS, V47, P55, DOI 10.1016/j.dynatmoce.2008.09.003; He ZG, 2015, CONT SHELF RES, V92, P16, DOI 10.1016/j.csr.2014.10.007; LARGE WG, 1994, REV GEOPHYS, V32, P363, DOI 10.1029/94RG01872; Li JX, 2011, OCEAN SCI, V7, P661, DOI 10.5194/os-7-661-2011; Locarnini R., 2006, NOAA ATLAS NESDIS, V1; Lonin SA, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2008JC005100; Marchesiello P, 2009, OCEAN MODEL, V26, P156, DOI 10.1016/j.ocemod.2008.09.004; MILLERO FJ, 1973, J GEOPHYS RES, V78, P4499, DOI 10.1029/JC078i021p04499; Qu TD, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL028350; Reynolds RW, 2007, J CLIMATE, V20, P5473, DOI 10.1175/2007JCLI1824.1; Schiller A, 1998, J PHYS OCEANOGR, V28, P2288, DOI 10.1175/1520-0485(1998)028<2288:SNSDAT>2.0.CO;2; Shchepetkin AF, 1998, MON WEATHER REV, V126, P1541, DOI 10.1175/1520-0493(1998)126<1541:QMASBO>2.0.CO;2; Shchepetkin AF, 2005, OCEAN MODEL, V9, P347, DOI 10.1016/j.ocemod.2004.08.002; Shchepetkin AF, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001047; Silva AM Da, 2006, TECHNICAL REPORT; Smith WHF, 1997, SCIENCE, V277, P1956, DOI 10.1126/science.277.5334.1956; Song YT, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003189; Tangang FT, 2011, OCEAN DYNAM, V61, P1317, DOI 10.1007/s10236-011-0432-5; Thyng KM, 2013, OCEAN MODEL, V72, P104, DOI 10.1016/j.ocemod.2013.08.008; Wyrtki K., 1961, TECHNICAL REPORT; Yanagi T., 2001, J OCEANOGR, V57, P461, DOI [10.1023/A:1021237721368, DOI 10.1023/A:1021237721368]; Ye J, 1998, J HYDRAUL ENG, V124, P687, DOI 10.1061/(ASCE)0733-9429(1998)124:7(687)	37	22	23	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158415	10.1371/journal.pone.0158415	http://dx.doi.org/10.1371/journal.pone.0158415			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410682	gold, Green Published, Green Submitted			2022-12-27	WOS:000379508300023
J	Hamrick, KS; Andrews, M				Hamrick, Karen S.; Andrews, Margaret			SNAP Participants' Eating Patterns over the Benefit Month: A Time Use Perspective	PLOS ONE			English	Article							FOOD-STAMP PARTICIPATION; WEIGHT; CYCLE; 1ST	Individuals receiving monthly benefits through the U.S. Supplemental Nutrition Assistance Program (SNAP) often fall short of food at the end of the month and some report feelings of hunger. To investigate this situation, we used time diaries from the 2006-08 American Time Use Survey and Eating & Health Module to identify the timing of days where respondents reported no eating occurrences. Analysis includes descriptive statistics, a logit model, and a simulated benefit month. We found that SNAP participants were increasingly more likely than nonparticipants to report a day with no eating occurrences over the benefit issuance cycle. This supports the view that there is a monthly cycle in food consumption associated with the SNAP monthly benefit issuance policy.	[Hamrick, Karen S.; Andrews, Margaret] USDA, Econ Res Serv, Washington, DC 20024 USA	United States Department of Agriculture (USDA)	Hamrick, KS (corresponding author), USDA, Econ Res Serv, Washington, DC 20024 USA.	khamrick@ers.usda.gov						Almada L, 2015, 21596 NAT BUR EC RES; Beatty T, 2013, SUPPLEMENTAL NUTR AS; Bickel G., 2000, J COOK GUIDE MEASURI; Bollinger CR, 2001, J BUS ECON STAT, V19, P129, DOI 10.1198/073500101316970368; Bustillo M., 2010, WALL STREET J; Calloway EE., 2015, J APPL RES CHILDREN, V6, P5; Castellari E., 2015, ONE MORE SATURDAY NI; Castner Laura, 2011, BENEFIT REDEMPTION P; Chen Z, 2005, AM J AGR ECON, V87, P1167, DOI 10.1111/j.1467-8276.2005.00803.x; Coleman-Jensen A, 2014, ERR173 USDA EC RES S; Coleman-Jensen Alisha, 2013, EC INFORM B, V113; D'Innocenzio A, 2010, WASH POST, pA8; Damon AL, 2013, FOOD POLICY, V41, P18, DOI 10.1016/j.foodpol.2013.04.005; Falk G, 2014, 75700 C RES SERV; Farzad Roben, 2011, BLOOMBERG BUSINESSWE; Hamrick KS, 2011, EC INFORM B; Hastings J, 2010, AM ECON J-ECON POLIC, V2, P142, DOI 10.1257/pol.2.2.142; Hopper J, 2011, WAITING MIDNIGHT HUN; Johnson EJ, 2012, MARKET LETT, V23, P487, DOI 10.1007/s11002-012-9186-1; Kalilani L, 2006, EPIDEMIOLOGIC PERSPE, V3, P5; Karaca-Mandic P, 2012, HEALTH SERV RES, V47, P255, DOI 10.1111/j.1475-6773.2011.01314.x; KING G, 2001, POLITICAL ANAL, V0009; Lesser D., 2013, TASK FORCE CONSIDER; Li C., 2013, BIAS FOOD STAMPS PAR; Ponza M, 1999, 53319840025 USDA FOO; Robinson JP, 2011, MON LABOR REV, V134, P43; Robinson JP, 1997, SURPRISING WAYS AM U; Seligman HK, 2014, HEALTH AFFAIR, V33, P116, DOI 10.1377/hlthaff.2013.0096; Shapiro JM, 2005, J PUBLIC ECON, V89, P303, DOI 10.1016/j.jpubeco.2004.05.003; Tarabay J, 2010, MIDNIGHT SHOPPING BR; Tarasuk V, 2007, J NUTR, V137, P1980, DOI 10.1093/jn/137.8.1980; THOMPSON FE, 1988, AM J PUBLIC HEALTH, V78, P1298, DOI 10.2105/AJPH.78.10.1298; Todd JE, 2015, APPL ECON PERSPECT P, V37, P437, DOI 10.1093/aepp/ppu039; U.S. Census Bureau, 2004, DIFF EST FOOD STAMP; U.S. Department of Labor Bureau of Labor Statistics, 2013, AM TIM US SURV US GU; U.S. Department of Labor Bureau of Labor Statistics U.S. Department of Commerce Census Bureau, 2006, 66 US DEP LAB BUR LA; USDA Economic Research Service, 2020, RUR ED; Weinstein JL, 2009, J HUNGER ENVIRON NUT, V4, P48, DOI 10.1080/19320240802706833; Wilde P., 2006, CHANGING MONTHLY FOO; Wilde PE, 2000, AM J AGR ECON, V82, P200, DOI 10.1111/0002-9092.00016; Zagorsky JL, 2009, ECON HUM BIOL, V7, P246, DOI 10.1016/j.ehb.2009.05.003	42	56	56	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158422	10.1371/journal.pone.0158422	http://dx.doi.org/10.1371/journal.pone.0158422			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ9CP	27410962	Green Published, Green Submitted, gold			2022-12-27	WOS:000379508300024
J	Hicar, MD; Chen, XM; Sulli, C; Barnes, T; Goodman, J; Sojar, H; Briney, B; Willis, J; Chukwuma, VU; Kalams, SA; Doranz, BJ; Spearman, P; Crowe, JE				Hicar, Mark D.; Chen, Xuemin; Sulli, Chidananda; Barnes, Trevor; Goodman, Jason; Sojar, Hakimuddin; Briney, Bryan; Willis, Jordan; Chukwuma, Valentine U.; Kalams, Spyros A.; Doranz, Benjamin J.; Spearman, Paul; Crowe, James E., Jr.			Human Antibodies that Recognize Novel Immunodominant Quaternary Epitopes on the HIV-1 Env Protein	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODIES; B-CELL RESPONSES; ENVELOPE GLYCOPROTEIN; NONNEUTRALIZING ANTIBODIES; NEUTRALIZING ANTIBODIES; COMPARATIVE IMMUNOGENICITY; CONFORMATIONAL EPITOPE; BROAD NEUTRALIZATION; ANTI-GP41 ANTIBODIES	Numerous broadly neutralizing antibodies (Abs) target epitopes that are formed or enhanced during mature HIV envelope formation (i.e. quaternary epitopes). Generally, it is thought that Env epitopes that induce broadly neutralizing Abs are difficult to access and poorly immunogenic because of the characteristic oligomerization, conformational flexibility, sequence diversity and extensive glycosylation of Env protein. To enhance for isolation of quaternary epitope-targeting Abs (QtAbs), we previously used HIV virus-like particles (VLPs) to bind B cells from long-term non-progressor subjects to identify a panel of monoclonal Abs. When expressed as recombinant full-length Abs, a subset of these novel Abs exhibited the binding profiles of QtAbs, as they either failed to bind to monomeric Env protein or showed much higher affinity for Env trimers and VLPs. These QtAbs represented a significant proportion of the B-cell response identified with VLPs. The Ab genes of these clones were highly mutated, but they did not neutralize common HIV strains. We sought to further define the epitopes targeted by these QtAbs. Competition-binding and mapping studies revealed these Abs targeted four separate epitopes; they also failed to compete for binding by Abs to known major neutralizing epitopes. Detailed epitope mapping studies revealed that two of the four epitopes were located in the gp41 subunit of Env. These QtAbs bound pre-fusion forms of antigen and showed differential binding kinetics depending on whether oligomers were produced as recombinant gp140 trimers or as full-length Env incorporated into VLPs. Antigenic regions within gp41 present unexpectedly diverse structural epitopes, including these QtAb epitopes, which may be targeted by the naturally occurring Ab response to HIV infection.	[Hicar, Mark D.; Sojar, Hakimuddin] Univ Buffalo, Dept Pediat, Buffalo, NY USA; [Hicar, Mark D.] Univ Buffalo, Dept Microbiol, New York, NY USA; [Hicar, Mark D.] Univ Buffalo, Dept Immunol, New York, NY USA; [Chen, Xuemin; Spearman, Paul] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Chen, Xuemin; Spearman, Paul] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA USA; [Sulli, Chidananda; Barnes, Trevor; Goodman, Jason; Doranz, Benjamin J.] Integral Mol Inc, Philadelphia, PA USA; [Briney, Bryan; Chukwuma, Valentine U.; Kalams, Spyros A.; Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Dept Pathol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Briney, Bryan; Chukwuma, Valentine U.; Kalams, Spyros A.; Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Dept Microbiol & Immunol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Willis, Jordan] Vanderbilt Univ, Med Ctr, Program Chem Biol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Kalams, Spyros A.] Vanderbilt Univ, Med Ctr, Dept Med, 221 Kirkland Hall, Nashville, TN 37235 USA; [Spearman, Paul] Childrens Healthcare Atlanta, Atlanta, GA USA; [Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Vanderbilt Vaccine Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Emory University; Emory University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Children's Healthcare of Atlanta (CHOA); Vanderbilt University	Crowe, JE (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol, 221 Kirkland Hall, Nashville, TN 37235 USA.; Crowe, JE (corresponding author), Vanderbilt Univ, Med Ctr, Dept Microbiol & Immunol, 221 Kirkland Hall, Nashville, TN 37235 USA.; Crowe, JE (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Vaccine Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA.	james.crowe@vanderbilt.edu	Crowe, James/B-5549-2009	Crowe, James/0000-0002-0049-1079	NIAID NIH HHS [K08 AI083078, P30 AI110527, R01 AI125119] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125119, P30AI110527] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Beddows S, 2007, VIROLOGY, V360, P329, DOI 10.1016/j.virol.2006.10.032; Blattner C, 2014, IMMUNITY, V40, P669, DOI 10.1016/j.immuni.2014.04.008; BRIGGS WE, 1983, BIOPHYS CHEM, V18, P67, DOI 10.1016/0301-4622(83)80028-3; Burton DR, 2005, P NATL ACAD SCI USA, V102, P14943, DOI 10.1073/pnas.0505126102; Caffrey M, 1998, EMBO J, V17, P4572, DOI 10.1093/emboj/17.16.4572; Crooks ET, 2007, VIROLOGY, V366, P245, DOI 10.1016/j.virol.2007.04.033; Dennison SM, 2011, J VIROL, V85, P1340, DOI 10.1128/JVI.01680-10; Do Kwon Y, 2015, NAT STRUCT MOL BIOL, V22, P522, DOI 10.1038/nsmb.3051; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Fouts TR, 1997, J VIROL, V71, P2779, DOI 10.1128/JVI.71.4.2779-2785.1997; Frey G, 2010, NAT STRUCT MOL BIOL, V17, P1486, DOI 10.1038/nsmb.1950; Gorny MK, 2000, J VIROL, V74, P6186, DOI 10.1128/JVI.74.13.6186-6192.2000; Gorny MK, 2005, J VIROL, V79, P5232, DOI 10.1128/JVI.79.8.5232-5237.2005; Gustchina E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078187; Hammonds J, 2007, VACCINE, V25, P8036, DOI 10.1016/j.vaccine.2007.09.016; Hicar MD, 2016, MOL IMMUNOL, V70, P94, DOI 10.1016/j.molimm.2015.12.002; Hicar MD, 2010, JAIDS-J ACQ IMM DEF, V54, P223, DOI 10.1097/QAI.0b013e3181dc98a3; Hicar MD, 2010, VACCINE, V28, pB18, DOI 10.1016/j.vaccine.2010.02.002; Hoffenberg S, 2013, J VIROL, V87, P5372, DOI 10.1128/JVI.02827-12; Holl V, 2006, J VIROL, V80, P6177, DOI 10.1128/JVI.02625-05; Jacobs A, 2005, J BIOL CHEM, V280, P27284, DOI 10.1074/jbc.M414411200; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Klein F, 2012, J EXP MED, V209, P1469, DOI 10.1084/jem.20120423; Kunert R, 1998, AIDS RES HUM RETROV, V14, P1115, DOI 10.1089/aid.1998.14.1115; Kuwata T, 2013, J VIROL, V87, P5424, DOI 10.1128/JVI.00201-13; Liao HX, 2011, J EXP MED, V208, P2237, DOI 10.1084/jem.20110363; Lin G, 2007, CURR HIV RES, V5, P514, DOI 10.2174/157016207782418489; Louis JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104683; Mayr LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070859; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; MOORE JP, 1993, J VIROL, V67, P863, DOI 10.1128/JVI.67.2.863-875.1993; Moore PL, 2006, J VIROL, V80, P2515, DOI 10.1128/JVI.80.5.2515-2528.2006; Paes C, 2009, J AM CHEM SOC, V131, P6952, DOI 10.1021/ja900186n; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Parren PWHI, 1998, J VIROL, V72, P3512, DOI 10.1128/JVI.72.5.3512-3519.1998; Peressin M, 2011, J VIROL, V85, P1077, DOI 10.1128/JVI.01619-10; Pietzsch J, 2010, J VIROL, V84, P5032, DOI 10.1128/JVI.00154-10; Poignard P, 2003, J VIROL, V77, P353, DOI 10.1128/JVI.77.1.353-365.2003; Ringe RP, 2013, P NATL ACAD SCI USA, V110, P18256, DOI 10.1073/pnas.1314351110; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; SATTENTAU QJ, 1995, J EXP MED, V182, P185, DOI 10.1084/jem.182.1.185; Scharf L, 2014, CELL REP, V7, P785, DOI 10.1016/j.celrep.2014.04.001; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Schief WR, 2009, CURR OPIN HIV AIDS, V4, P431, DOI 10.1097/COH.0b013e32832e6184; Sellhorn G, 2009, VACCINE, V28, P430, DOI 10.1016/j.vaccine.2009.10.028; Sok D, 2014, P NATL ACAD SCI USA, V111, P17624, DOI 10.1073/pnas.1415789111; Stamatatos L, 2000, AIDS RES HUM RETROV, V16, P981, DOI 10.1089/08892220050058407; Steimer K S, 1991, Biotechnol Ther, V2, P63; STIGLER RD, 1995, PROTEIN ENG, V8, P471, DOI 10.1093/protein/8.5.471; Sundling C, 2010, J EXP MED, V207, P2003, DOI 10.1084/jem.20100025; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; Tran EEH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002797; TYLER DS, 1990, J IMMUNOL, V145, P3276; VANCOTT TC, 1995, J IMMUNOL, V155, P4100; Vincent N, 2012, IMMUNOBIOLOGY, V217, P943, DOI 10.1016/j.imbio.2012.01.007; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; XU JY, 1991, J VIROL, V65, P4832, DOI 10.1128/JVI.65.9.4832-4838.1991; Yang XZ, 2000, J VIROL, V74, P5716, DOI 10.1128/JVI.74.12.5716-5725.2000; Yuan W, 2009, AIDS RES HUM RETROV, V25, P319, DOI 10.1089/aid.2008.0213	59	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158861	10.1371/journal.pone.0158861	http://dx.doi.org/10.1371/journal.pone.0158861			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27411063	Green Published, Green Submitted, gold			2022-12-27	WOS:000379508300036
J	Kripke, K; Chimbwandira, F; Mwandi, Z; Matchere, F; Schnure, M; Reed, J; Castor, D; Sgaier, S; Njeuhmeli, E				Kripke, Katharine; Chimbwandira, Frank; Mwandi, Zebedee; Matchere, Faustin; Schnure, Melissa; Reed, Jason; Castor, Delivette; Sgaier, Sema; Njeuhmeli, Emmanuel			Voluntary Medical Male Circumcision for HIV Prevention in Malawi: Modeling the Impact and Cost of Focusing the Program by Client Age and Geography	PLOS ONE			English	Article							TRIAL; HIV/AIDS; MEN	Background In 2007, the World Health Organization (WHO) recommended scaling up voluntary medical male circumcision (VMMC) in priority countries with high HIV prevalence and low male circumcision (MC) prevalence. According to the Joint United Nations Programme on HIV/AIDS (UNAIDS), an estimated 5.8 million males had undergone VMMC by the end of 2013. Implementation experience has raised questions about the need to refocus VMMC programs on specific subpopulations for the greatest epidemiological impact and programmatic effectiveness. As Malawi prepared its national operational plan for VMMC, it sought to examine the impacts of focusing on specific subpopulations by age and region. Methods We used the Decision Makers' Program Planning Toolkit, Version 2.0, to study the impact of scaling up VMMC to different target populations of Malawi. National MC prevalence by age group from the 2010 Demographic and Health Survey was scaled according to the MC prevalence for each district and then halved, to adjust for over-reporting of circumcision. In-country stakeholders advised a VMMC unit cost of $100, based on implementation experience. We derived a cost of $451 per patient-year for antiretroviral therapy from costs collected as part of a strategic planning exercise previously conducted in-country by UNAIDS. Results Over a fifteen-year period, circumcising males ages 10-29 would avert 75% of HIV infections, and circumcising males ages 10-34 would avert 88% of infections, compared to the current strategy of circumcising males ages 15-49. The Ministry of Health's South West and South East health zones had the lowest cost per HIV infection averted. Moreover, VMMC met WHO's definition of cost-effectiveness (that is, the cost per disability-adjusted life-year [DALY] saved was less than three times the per capita gross domestic product) in all health zones except Central East. Comparing urban versus rural areas in the country, we found that circumcising men in urban areas would be both cost-effective and cost-saving, with a VMMC cost per DALY saved of $120 USD and with 15 years of VMMC implementation resulting in lifetime HIV treatment costs savings of $331 million USD. Conclusions Based on the age analyses and programmatic experience, Malawi's VMMC operational plan focuses on males ages 10-34 in all districts in the South East and South West zones, as well as Lilongwe (an urban district in the Central zone). This plan covers 14 of the 28 districts in the country.	[Kripke, Katharine] Avenir Hlth, Hlth Policy Project, Washington, DC USA; [Chimbwandira, Frank] Minist Hlth, Lilongwe, Malawi; [Mwandi, Zebedee] US Agcy Int Dev, Lilongwe, Malawi; [Matchere, Faustin] US Dept Def, Lilongwe, Malawi; [Schnure, Melissa] Futures Grp Inc, Hlth Policy Project, Washington, DC USA; [Reed, Jason; Castor, Delivette; Njeuhmeli, Emmanuel] USAID, Washington, DC USA; [Sgaier, Sema] Bill & Melinda Gates Fdn, Seattle, WA USA; [Sgaier, Sema] Univ Washington, Seattle, WA USA	United States Agency for International Development (USAID); United States Agency for International Development (USAID); Bill & Melinda Gates Foundation; University of Washington; University of Washington Seattle	Kripke, K (corresponding author), Avenir Hlth, Hlth Policy Project, Washington, DC USA.	kkripke@avenirhealth.org	Kripke, Katharine/J-2146-2019	Kripke, Katharine/0000-0001-8228-4577	American people through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR); U.S. Agency for International Development (USAID) [AID-OAA-A-10-00067, AID-OAA-14-00026]	American people through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR); U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID))	This manuscript is made possible by the generous support of the American people through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) with the U.S. Agency for International Development (USAID) under the Cooperative Agreement Health Policy Project, Agreement No. AID-OAA-A-10-00067, beginning September 30, 2010, and Cooperative Agreement Project SOAR (Supporting Operational AIDS Research), number AID-OAA-14-00026. The Health Policy Project is implemented by Futures Group, in collaboration with Plan International USA, Avenir Health (formerly Futures Institute), Partners in Population and Development, Africa Regional Office (PPD ARO), Population Reference Bureau (PRB), RTI International, and the White Ribbon Alliance for Safe Motherhood (WRA). The funder was involved in study design, decision to publish, and preparation of the manuscript. The findings and conclusions in this paper do not necessarily represent the views or positions of PEPFAR, USAID, or the U.S. Government.	Anderson SJ, 2014, LANCET, V384, P249, DOI 10.1016/S0140-6736(14)61053-9; [Anonymous], COST EFF STRAT PLANN; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Awad S, 2015, INVESTIGATING UNPUB; Awad S, 2015, REEVALUATION V UNPUB; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bautista-Arredondo S, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327625.69974.08; Bautista-Arredondo S, 2010, CURR OPIN HIV AIDS, V5, P232, DOI 10.1097/COH.0b013e32833860d3; BENGO JM, 2010, SITUATION ANAL MALE; Bertozzi SM, 2008, LANCET, V372, P831, DOI 10.1016/S0140-6736(08)60889-2; Bollinger LA, 2012, RETHINKHIV: SMARTER WAYS TO INVEST IN ENDING HIV IN SUB-SAHARAN AFRICA, P74; Futures Institute, 2011, GOALS MAN MOD EST EF; Government of Malawi National AIDS Commission., 2014, NAT HIV PREV STRAT 2; Government of Malawi National AIDS Commission, 2014, VOL MED MAL CIRC STR; Government of Malawi National AIDS Commission, 2014, NAT STRAT PLAN HIV A; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Haacker M, 2016, PLOS MED IN PRESS; Kripke K., 2015, AGE TARGETING UNPUB; Malawi National Statistical Office and MEASURE DHS, 2010, MAL DEM HLTH SURV 20; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Stover J, 2014, AIDS, V28, pS427, DOI 10.1097/QAD.0000000000000483; Thomas AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027561; UNAIDS, 2014, LOC EP ISS BRIEF; UNAIDS/WHO, 2007, NEW DAT MAL CIRC HIV; WHO & UNAIDS, 2011, JOINT STRAT ACT FRAM; World Bank, 2012, GDP PER CAP CURR USD	27	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0156521	10.1371/journal.pone.0156521	http://dx.doi.org/10.1371/journal.pone.0156521			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410474	Green Submitted, gold, Green Published			2022-12-27	WOS:000379508300002
J	Luszczynska, A; Hagger, MS; Banik, A; Horodyska, K; Knoll, N; Scholz, U				Luszczynska, Aleksandra; Hagger, Martin S.; Banik, Anna; Horodyska, Karolina; Knoll, Nina; Scholz, Urte			Self-Efficacy, Planning, or a Combination of Both? A Longitudinal Experimental Study Comparing Effects of Three Interventions on Adolescents' Body Fat	PLOS ONE			English	Article							INTENTIONS-BASED INTERVENTIONS; BEHAVIOR-CHANGE TECHNIQUES; PHYSICAL-ACTIVITY; IMPLEMENTATION INTENTIONS; BUILT-ENVIRONMENT; VEGETABLE INTAKE; OLDER-ADULTS; METAANALYSIS; CHILDREN; OBESITY	Background The superiority of an intervention combining two sets of theory-based behavior change techniques targeting planning and self-efficacy over an intervention targeting planning only or self-efficacy only has rarely been investigated. Purpose We compared the influence of self-efficacy, planning, and self-efficacy+ planning interventions with an education-based control condition on adolescents' body fat, assuming mediating effects of respective social cognitive variables and moderate-to-vigorous physical activity (MVPA). The moderating role of the built environment was examined. Methods Participants (N = 1217, aged 14-18 years) were randomly assigned to four conditions: planning (n = 270), self-efficacy (n = 311), self-efficacy+ planning (n = 351), and control (n = 285). The measurement was conducted at baseline (T1), two-month follow-up (T2), and fourteen-month follow-up (T3). Interventions/control group procedures were delivered at T1 and T2. Percent of body fat tissue (measured at T1 and T3) was the main outcome. Social cognitive mediators (self-efficacy and planning) were assessed at T1 and T2. The behavioral mediator (MVPA) and the presence of built MVPA facilities (the moderator) were evaluated at T1 and T3. Results Similar small increases of body fat were found across the three intervention groups, but the increment of body fat was significantly larger in the control group. On average, differences between control and intervention groups translated to approximately 1% of body fat. Effects of the interventions on body fat were mediated by relevant social cognitive variables and MVPA. A lower increase of body fat was found among intervention group participants who had access to newly-built MVPA facilities. Conclusions We found no superiority of an intervention targeting two social cognitive variables over the intervention targeting one cognition only.	[Luszczynska, Aleksandra; Banik, Anna; Horodyska, Karolina] SWPS Univ Social Sci & Humanities, Dept Psychol, Wroclaw, Poland; [Luszczynska, Aleksandra] Univ Colorado, Trauma Hlth & Hazards Ctr, Colorado Springs, CO 80907 USA; [Hagger, Martin S.] Curtin Univ, Sch Psychol & Speech Pathol, Hlth Psychol & Behav Med Res Grp, Perth, WA, Australia; [Hagger, Martin S.] Univ Jyvaskyla, Fac Sport & Hlth Sci, Jyvaskyla, Finland; [Knoll, Nina] Free Univ Berlin, Dept Educ & Psychol, Berlin, Germany; [Scholz, Urte] Univ Zurich, Dept Psychol, Zurich, Switzerland	SWPS University of Social Sciences & Humanities; University of Colorado System; University of Colorado at Colorado Springs; Curtin University; University of Jyvaskyla; Free University of Berlin; University of Zurich	Luszczynska, A (corresponding author), SWPS Univ Social Sci & Humanities, Dept Psychol, Wroclaw, Poland.; Luszczynska, A (corresponding author), Univ Colorado, Trauma Hlth & Hazards Ctr, Colorado Springs, CO 80907 USA.	aluszczy@uccs.edu	Horodyska, Karolina/AAI-3851-2021; Hagger, Martin S./G-5211-2012; Banik, Anna/AAH-9896-2021; Luszczynska, Aleksandra/F-3692-2014	Horodyska, Karolina/0000-0002-6969-0017; Hagger, Martin S./0000-0002-2685-1546; Banik, Anna/0000-0002-8674-9981; Luszczynska, Aleksandra/0000-0002-4704-9544; Scholz, Urte/0000-0003-0184-5921	National Science Centre, Poland [NN 106 012240]; Finnish Distinguished Professor Award from the Finnish Academy of Science; TEKES, Finland	National Science Centre, Poland(National Science Centre, Poland); Finnish Distinguished Professor Award from the Finnish Academy of Science; TEKES, Finland(Finnish Funding Agency for Technology & Innovation (TEKES))	Funding received during this study includes grant no. NN 106 012240 from the National Science Centre, Poland (https://www.ncn.gov.pl/?language=en). In addition, Martin Hagger's contribution was supported by a Finnish Distinguished Professor Award from the Finnish Academy of Science (http://www.acadsci.fi/frontpage.htm) and TEKES, Finland (http://www.tekes.fi/en/funding/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM C, 2014, JAIDS-J ACQ IMM D S3, V66, pS293; Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; Belanger-Gravel A, 2013, HEALTH PSYCHOL REV, V7, P23, DOI 10.1080/17437199.2011.560095; Carraro N, 2013, PSYCHOL SPORT EXERC, V14, P228, DOI 10.1016/j.psychsport.2012.10.004; Cerin E, 2008, HEALTH PSYCHOL, V27, pS126, DOI 10.1037/0278-6133.27.2(Suppl.).S126; Cleary J, 2008, J AM DIET ASSOC, V108, P136, DOI 10.1016/j.jada.2007.10.004; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Conner M, 2010, HEALTH PSYCHOL, V29, P529, DOI 10.1037/a0020317; Craggs C, 2011, AM J PREV MED, V40, P645, DOI 10.1016/j.amepre.2011.02.025; French DP, 2014, ANN BEHAV MED, V48, P225, DOI 10.1007/s12160-014-9593-z; GODIN G, 1985, Canadian Journal of Applied Sport Sciences, V10, P141; Gollwitzer PM, 2006, ADV EXP SOC PSYCHOL, V38, P69, DOI 10.1016/S0065-2601(06)38002-1; Guillaumie L, 2013, GLOB HEALTH PROMOT, V20, P83, DOI 10.1177/1757975913483336; Guillaumie L, 2012, PSYCHOL HEALTH, V27, P30, DOI 10.1080/08870446.2010.541910; Hagger MS, 2014, APPL PSYCHOL-HLTH WE, V6, P1, DOI 10.1111/aphw.12017; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Horodyska K, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1354-9; Kyle UG, 2004, CLIN NUTR, V23, P1430, DOI 10.1016/j.clnu.2004.09.012; Luszczynska A, 2016, PSYCHOL HEALTH, V31, P40, DOI 10.1080/08870446.2015.1070156; Luszczynska A, 2011, PSYCHOL HEALTH, V26, P151, DOI 10.1080/08870446.2011.531571; McGrath LJ, 2015, SPORTS MED, V45, P841, DOI 10.1007/s40279-015-0301-3; Michie S, 2011, PSYCHOL HEALTH, V26, P1479, DOI 10.1080/08870446.2010.540664; Moliner-Urdiales D, 2009, INT J OBESITY, V33, P1126, DOI 10.1038/ijo.2009.139; Olson EA, 2015, J BEHAV MED, V38, P886, DOI 10.1007/s10865-015-9660-3; Oreskovic NM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1596-6; Ramires VV, 2015, J PHYS ACT HEALTH, V12, P1344, DOI 10.1123/jpah.2014-0222; Rothman KJ, 2008, INT J OBESITY, V32, pS56, DOI 10.1038/ijo.2008.87; Safron M, 2011, INT J ENVIRON HEAL R, V21, P317, DOI 10.1080/09603123.2011.552713; Safron M, 2011, BEHAV MED, V37, P15, DOI 10.1080/08964289.2010.543194; Schwarzer R, 2008, HEALTH PSYCHOL, V27, pS54, DOI 10.1037/0278-6133.27.1(Suppl.).S54; Schwarzer R, 2008, APPL PSYCHOL-INT REV, V57, P1, DOI 10.1111/j.1464-0597.2007.00325.x; Sniehotta FF, 2005, EUR J SOC PSYCHOL, V35, P565, DOI 10.1002/ejsp.258; Teixeira PJ, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0323-6; Warner LM, 2014, HEALTH PSYCHOL, V33, P1298, DOI 10.1037/hea0000085; WORLD HEALTH ORGANIZATION (WHO), GLOB STRAT DIET PHYS	35	19	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159125	10.1371/journal.pone.0159125	http://dx.doi.org/10.1371/journal.pone.0159125			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ9CP	27410961	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000379508300057
J	Manning, SW; Griggs, CB; Lorentzen, B; Barjamovic, G; Ramsey, CB; Kromer, B; Wild, EM				Manning, Sturt W.; Griggs, Carol B.; Lorentzen, Brita; Barjamovic, Gojko; Ramsey, Christopher Bronk; Kromer, Bernd; Wild, Eva Maria			Integrated Tree-Ring-Radiocarbon High-Resolution Timeframe to Resolve Earlier Second Millennium BCE Mesopotamian Chronology	PLOS ONE			English	Article							AGE MINOAN ERUPTION; VOLCANIC-ERUPTIONS; SANTORINI; BRONZE; CALIBRATION; OFFSETS; BABYLON; EPONYMS; FALL; AMS	500 years of ancient Near Eastern history from the earlier second millennium BCE, including such pivotal figures as Hammurabi of Babylon, Samsi-Adad I (who conquered Assur) and Zimrilim of Mari, has long floated in calendar time subject to rival chronological schemes up to 150+ years apart. Texts preserved on clay tablets provide much information, including some astronomical references, but despite 100+ years of scholarly effort, chronological resolution has proved impossible. Documents linked with specific Assyrian officials and rulers have been found and associated with archaeological wood samples at Kultepe and Acemhoyuk in Turkey, and offer the potential to resolve this long-running problem. Here we show that previous work using tree-ring dating to place these timbers in absolute time has fundamental problems with key dendrochronological crossdates due to small sample numbers in overlapping years and insufficient critical assessment. To address, we have integrated secure dendrochronological sequences directly with radiocarbon (C-14) measurements to achieve tightly resolved absolute (calendar) chronological associations and identify the secure links of this tree-ring chronology with the archaeological-historical evidence. The revised tree-ring-sequenced C-14 time-series for Kultepe and Acemhoyuk is compatible only with the so-called Middle Chronology and not with the rival High, Low or New Chronologies. This finding provides a robust resolution to a century of uncertainty in Mesopotamian chronology and scholarship, and a secure basis for construction of a coherent timeframe and history across the Near East and East Mediterranean in the earlier second millennium BCE. Our re-dating also affects an unusual tree-ring growth anomaly in wood from Porsuk, Turkey, previously tentatively associated with the Minoan eruption of the Santorini volcano. This tree-ring growth anomaly is now directly dated similar to 1681-1673 BCE (68.2% highest posterior density range), similar to 20 years earlier than previous assessments, indicating that it likely has no association with the subsequent Santorini volcanic eruption.	[Manning, Sturt W.; Griggs, Carol B.; Lorentzen, Brita] Cornell Univ, Dept Class, Cornell Tree Ring Lab, B48 Goldwin Smith Hall, Ithaca, NY 14853 USA; [Barjamovic, Gojko] Harvard Univ, Dept Near Eastern Languages & Civilizat, 6 Divin Ave, Cambridge, MA 02138 USA; [Ramsey, Christopher Bronk] Univ Oxford, Res Lab Archaeol & Hist Art, Oxford Radiocarbon Accelerator Unit, Oxford OX1 3QY, England; [Kromer, Bernd] Heidelberg Univ, Inst Environm Phys, D-69120 Heidelberg, Germany; [Wild, Eva Maria] Univ Vienna, VERA Lab, Fac Phys Isotope Res & Nucl Phys, Wahringer Str 17, A-1090 Vienna, Austria	Cornell University; Harvard University; University of Oxford; Ruprecht Karls University Heidelberg; University of Vienna	Manning, SW (corresponding author), Cornell Univ, Dept Class, Cornell Tree Ring Lab, B48 Goldwin Smith Hall, Ithaca, NY 14853 USA.	sm456@cornell.edu	Ramsey, Christopher Bronk/AAQ-2227-2021; Ramsey, Christopher Bronk/A-3277-2012	Ramsey, Christopher Bronk/0000-0002-8641-9309; Ramsey, Christopher Bronk/0000-0002-8641-9309; Manning, Sturt/0000-0002-6917-0927; Lorentzen, Brita/0000-0001-5379-288X	National Science Foundation [BCS 1219315]; Social Science and Humanities Research Council, Canada via CRANE project; Malcolm H. Wiener Foundation; NERC [NRCF010002] Funding Source: UKRI; Natural Environment Research Council [NRCF010002] Funding Source: researchfish; Division Of Behavioral and Cognitive Sci [1219315] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Social Science and Humanities Research Council, Canada via CRANE project; Malcolm H. Wiener Foundation; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This work was supported by the National Science Foundation, BCS 1219315, http://www.nsf.gov/(SWM); Social Science and Humanities Research Council, Canada, http://www.sshrc-crsh.gc.ca/home-accueil-eng.aspx, via CRANE project, https://www.crane.utoronto.ca/index.html (SWM); and Malcolm H. Wiener Foundation (SWM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkemik ?., 2012, WOOD ANATOMY E MEDIT; Badertscher S, 2014, EARTH PLANET SC LETT, V392, P58, DOI 10.1016/j.epsl.2014.01.041; BAILLIE MGL, 1988, NATURE, V332, P344, DOI 10.1038/332344a0; Balkan K., 1955, OBSERVATIONS CHRONOL; Barjamovic G, 2011, HIST GEOGRAPHY ANATO; Barjamovic G, 2012, KANESH OBSERVATIONS; Bayliss A, 2004, RADIOCARBON; Ben-Tor Amnon, 2004, A L, V14, P45; Bietak M, 2013, RADIOCARBON CHRONOLO, P76; Bloch Y, 2014, J NEAR EASTERN STUD, V73, P191, DOI 10.1086/677250; Brock F, 2010, RADIOCARBON, V52, P103, DOI 10.1017/S0033822200045069; Broodbank Cyprian, 2013, MAKING MIDDLE SEA HI; Charpin D, 2004, MESOPOTAMIEN ALTBABY; Charpin D, 2012, HAMMURABI OF BABYLON; Cook E.R., 2013, METHODS DENDROCHRONO; Crivellaro A, 2013, ATLAS WOOD BARK PITH; DE JONG T., 2010, JAARBERICHT VOORAZIA, V42, P143; de Jong Teije, 2013, JEOL, V44, P147; Dee M, 2000, NUCL INSTRUM METH B, V172, P449, DOI 10.1016/S0168-583X(00)00337-2; Friedrich WL, 2006, SCIENCE, V312, P548, DOI 10.1126/science.1125087; Galimberti M, 2004, RADIOCARBON, V46, P917, DOI 10.1017/S0033822200035967; Gasche H., 1998, DATING FALL BABYLON; Grissino-Mayer, 2001, TREE-RING RES, V57, P205, DOI DOI 10.1016/J.DENDRO.2010.12.002; Grudd H, 2000, GEOPHYS RES LETT, V27, P2957, DOI 10.1029/1999GL010852; HAMMER CU, 1987, NATURE, V328, P517, DOI 10.1038/328517a0; Harris K., CORINA 1 1 2007 VERS; Hoflmayer F, 2015, THERE AND BACK AGAIN - THE CROSSROADS II, P265; Hoeflmayer F, 2012, RADIOCARBON, V54, P435, DOI 10.1017/S0033822200047196; HOLMES R L, 1983, Tree-Ring Bulletin, V43, P69; Huber PJ, 1982, ASTRONOMICAL DATING; Huber PJ, 1999, ARCH ORIENTFORSCHUNG, V46, P50; HUGHES MK, 1988, NATURE, V335, P211, DOI 10.1038/335211b0; HUNGER H., 2009, MONOGRAPHS DANISH I, V10, P145; Johnston EN, 2014, J GEOL SOC LONDON, V171, P583, DOI 10.1144/jgs2013-113; Klinger Jorg, 2006, ANCIENT EGYPTIAN CHR, VI/83, P304; KROMER B, 1992, RADIOCARBON AFTER FOUR DECADES, P184; Kromer B, 2001, SCIENCE, V294, P2529, DOI 10.1126/science.1066114; Kromer B, 1993, RADIOCARBON; Kuniholm P.I., 1989, ANATOLIA ANCIENT NEA, P279; Kuniholm P. I., 1992, SYRIA, V69, P379; Kuniholm P.I., 1993, STUDIES HONOR N OZGU, P371; Kuniholm PI, 2011, GORDION SPEC STUD, V6, P79; Kuniholm PI, 1996, NATURE, V381, P780, DOI 10.1038/381780a0; KUNIHOLM PI, 1987, J FIELD ARCHAEOL, V14, P385, DOI 10.1179/jfa.1987.14.4.385; Kutschera W, 2012, RADIOCARBON, V54, P407, DOI 10.1017/S0033822200047172; LAMARCHE VC, 1984, NATURE, V307, P121, DOI 10.1038/307121a0; Larsen M.T, 2015, ANCIENT KANESH MERCH; Manning S., 2014, SIMA, V143, P23; Manning S. W., 2014, TEST TIME TEST TIME; Manning S. W., 2010, OXFORD HDB BRONZE AG, P457; Manning SW, 2014, ANTIQUITY, V88, P1164, DOI 10.1017/S0003598X00115388; Manning SW, 2010, RADIOCARBON, V52, P1571, DOI 10.1017/S0033822200056320; Manning SW, 2006, SCIENCE, V312, P565, DOI 10.1126/science.1125682; Manning SW, 2001, SCIENCE, V294, P2532, DOI 10.1126/science.1066112; Manning SW., 2013, RADIOCARBON CHRONOLO, P121, DOI 10.2307/j.ctvh1dmh2.14; Mebert J., 2010, VENUSTAFELN AMMI SAD; MEIGGS R., 1982, TREES TIMBER ANCIENT; MICHEL C., 1997, JEOL, V35-36, P111; Moeller N., 2011, AGYPTEN LEVANTE, V21, P87; Moorey PRS., 1999, ANCIENT MESOPOTAMIA; Muscheler R, 2009, TIMES DATING MINOAN, P275; Nahm Werner, 2013, AF, V40, P350; Newton M.W., 2004, TURKIYE BILIMLER AKA, V7, P165; Otto A., 2000, ENTSTEHUNG ENTWICKLU; ozguc N., 1980, ANCIENT ART SEALS, P61; Ozguc N., 2015, CYLINDER SEALS BULLA; Ozguc T., 1999, PALACES TEMPLES KULT; Pearson CL, 2009, J ARCHAEOL SCI, V36, P1206, DOI 10.1016/j.jas.2009.01.009; Pruzsinszky R, 2009, DENKSCHR GESAMTAKAD, V56, P1; Ramsey CB, 2008, ARCHAEOMETRY, V50, P249, DOI [10.1111/J.1475-4754.2008.00394.X, 10.1111/j.1475-4754.2008.00394.x]; Ramsey CB, 2004, RADIOCARBON, V46, P17, DOI 10.1017/S0033822200039308; Ramsey CB, 2001, RADIOCARBON, V43, P381; Ramsey CB, 2010, SCIENCE, V328, P1554, DOI 10.1126/science.1189395; Ramsey CB, 2009, RADIOCARBON, V51, P1023, DOI 10.1017/S0033822200034093; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Reimer PJ, 2004, RADIOCARBON, V46, P1029, DOI 10.1017/S0033822200032999; Rinn F., 1996, TSAP TIME SERIES ANA; Roaf M, 2012, AKKADICA, V133, P147; Sallaberger Walther, 2015, ASS REGIONAL CHRONOL, V3; Salzer MW, 2007, QUATERNARY RES, V67, P57, DOI 10.1016/j.yqres.2006.07.004; Sass-Klaassen U, 2008, INT BIODETER BIODEGR, V61, P96, DOI 10.1016/j.ibiod.2007.07.013; Schweingruber F. H., 1988, TREE RINGS BASICS AP; Sigl M, 2015, NATURE, V523, P543, DOI 10.1038/nature14565; Smith Sidney, 1940, ALALAKH CHRONOLOGY; Southon J, 2004, RADIOCARBON, V46, P1239, DOI 10.1017/S0033822200033129; Speer JH, 2010, FUNDAMENTALS TREE RI; Steier P, 2004, RADIOCARBON, V46, P5, DOI 10.1017/S0033822200039291; Stratford E, 2015, J NEAR EASTERN STUD, V74, P301, DOI 10.1086/682062; Veenhof Klaas R., 2003, OLD ASSYRIAN LIST YE; Veenhof Klaas R., 2008, MESOPOTAMIA OLD ASSY, P15; Veenhof KR, P 2 KULT IN IN PRESS; Vinther BM, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009083; Warburton DA, 2009, MIN ERUPT CHRON WORK; Warburton DA, 2011, AKKADICA, V132, P1; WARD GK, 1978, ARCHAEOMETRY, V20, P19, DOI 10.1111/j.1475-4754.1978.tb00208.x; Wild EM, 2008, RADIOCARBON, V50, P1, DOI 10.1017/S0033822200043332; Wild EM, 2013, RADIOCARBON, V55, P599, DOI 10.1017/S003382220005774X	98	26	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0157144	10.1371/journal.pone.0157144	http://dx.doi.org/10.1371/journal.pone.0157144			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DQ9CP	27409585	Green Published, gold, Green Submitted			2022-12-27	WOS:000379508300006
J	Nolan, SJ; Hambleton, I; Dwan, K				Nolan, Sarah Jane; Hambleton, Ian; Dwan, Kerry			The Use and Reporting of the Cross-Over Study Design in Clinical Trials and Systematic Reviews: A Systematic Assessment	PLOS ONE			English	Review							METAANALYSIS COMBINING PARALLEL	Background Systematic reviews of treatment interventions in stable or chronic conditions often require the synthesis of clinical trials with a cross-over design. Previous work has indicated that methodology for analysing cross-over data is inadequate in trial reports and in systematic reviews assessing trials with this design. Objective We assessed systematic review methodology for synthesising cross-over trials among Cochrane Cystic Fibrosis and Genetic Disorders Group reviews published to July 2015, and assessed the quality of reporting among the cross-over trials included in these reviews. Methodology We performed data extraction of methodology and reporting in reviews, trials identified and trials included within reviews. Principal Findings We reviewed a total of 142 Cochrane systematic reviews including 53 reviews which synthesised evidence from 218 cross-over trials. Thirty-three (63%) Cochrane reviews described a clear and appropriate method for the inclusion of cross-over data, and of these 19 (56%) used the same method to analyse results. 145 cross-over trials were described narratively or treated as parallel trials in reviews but in 30 (21%) of these trials data existed in the trial reports to account for the cross-over design. At the trial level, the analysis and presentation of results were often inappropriate or unclear, with only 69 (32%) trials presenting results that could be included in meta-analysis. Conclusions Despite development of accessible, technical guidance and training for Cochrane systematic reviewers, statistical analysis and reporting of cross-over data is inadequate at both thesystematic review and the trial level. Plain language and practical guidance for the inclusion of cross-over data in meta-analysis would benefit systematic reviewers, who come from a wide range of health specialties. Minimum reporting standards for cross-over trials are needed.	[Nolan, Sarah Jane] Univ Liverpool, Dept Biostat, Liverpool, Merseyside, England; [Nolan, Sarah Jane; Hambleton, Ian] Cochrane Cyst Fibrosis & Genet Disorders Grp, Liverpool, Merseyside, England; [Hambleton, Ian] Univ West Indies, Chron Dis Res Ctr, Wanstead, Barbados; [Dwan, Kerry] Cochrane Editorial Unit, London, England	University of Liverpool; University West Indies Mona Jamaica; University West Indies Cave Hill Campus	Nolan, SJ (corresponding author), Univ Liverpool, Dept Biostat, Liverpool, Merseyside, England.; Nolan, SJ (corresponding author), Cochrane Cyst Fibrosis & Genet Disorders Grp, Liverpool, Merseyside, England.	sjn16@liverpool.ac.uk	Dwan, Kerry/AAG-4726-2022; Hambleton, Ian/AAP-3519-2020; Nevitt, Sarah/E-3470-2018; Dwan, Kerry/AFK-6469-2022	Dwan, Kerry/0000-0001-6918-1215; Hambleton, Ian/0000-0002-5638-9794; Nevitt, Sarah/0000-0001-9988-2709; Dwan, Kerry/0000-0001-6918-1215	National Institute for Health Research via Cochrane Infrastructure	National Institute for Health Research via Cochrane Infrastructure	The time of SJN and KD was partly supported by the National Institute for Health Research, via Cochrane Infrastructure funding to the Cochrane Cystic Fibrosis and Genetic Disorders Group [http://www.nihr.ac.uk/research/systematic-reviews.htm],[http://cfgd.cochrane.org/funding-and-support]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. IH received no specific funding for this work.	Altman DG, 1996, BRIT MED J, V313, P570; BECKER MP, 1993, BIOMETRICS, V49, P997, DOI 10.2307/2532242; BROWN BW, 1980, BIOMETRICS, V36, P69, DOI 10.2307/2530496; Curtin F, 2002, STAT MED, V21, P2161, DOI 10.1002/sim.1207; Curtin F, 2002, STAT MED, V21, P2145, DOI 10.1002/sim.1206; Curtin F, 2002, STAT MED, V21, P2131, DOI 10.1002/sim.1205; Elbourne DR, 2002, INT J EPIDEMIOL, V31, P140, DOI 10.1093/ije/31.1.140; Friedman M, 1937, J AM STAT ASSOC, V32, P675, DOI 10.2307/2279372; HILLS M, 1979, BRIT J CLIN PHARMACO, V8, P7, DOI 10.1111/j.1365-2125.1979.tb05903.x; Lathyris DN, 2007, INT J EPIDEMIOL, V36, P422, DOI 10.1093/ije/dym001; LEHMACHER W, 1991, STAT MED, V10, P891, DOI 10.1002/sim.4780100610; LOUIS TA, 1984, NEW ENGL J MED, V310, P24, DOI 10.1056/NEJM198401053100106; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Mills EJ, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-27; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Senn S, 2002, CROSS OVER TRIALS CL	17	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159014	10.1371/journal.pone.0159014	http://dx.doi.org/10.1371/journal.pone.0159014			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27409076	gold, Green Published, Green Submitted			2022-12-27	WOS:000379508300049
J	Salice, S; Esposito, R; Ciavardelli, D; Delli Pizzi, S; di Bastiano, R; Tartaro, A				Salice, Simone; Esposito, Roberto; Ciavardelli, Domenico; Delli Pizzi, Stefano; di Bastiano, Rossella; Tartaro, Armando			Combined 3 Tesla MRI Biomarkers Improve the Differentiation between Benign vs Malignant Single Ring Enhancing Brain Masses	PLOS ONE			English	Article							DIFFUSION-WEIGHTED MR; CEREBRAL ABSCESSES; ORIGINAL REPORT; TUMORS; DIAGNOSIS; DISCRIMINATION; GLIOMAS; LESIONS; DISTINCTION; METASTASES	Purpose To evaluate whether the combination of imaging biomarkers obtained by means of different 3 Tesla (3T) Magnetic Resonance Imaging (MRI) advanced techniques can improve the diagnostic accuracy in the differentiation between benign and malignant single ring-enhancing brain masses. Materials and Methods 14 patients presenting at conventional 3T MRI single brain mass with similar appearance as regard ring enhancement, presence of peri-lesional edema and absence of hemorrhage signs were included in the study. All lesions were histologically proven: 5 pyogenic abscesses, 6 glioblastomas, and 3 metastases. MRI was performed at 3 Tesla and included Diffusion Weighted Imaging (DWI), Dynamic Susceptibility Contrast -Perfusion Weighted Imaging (DSC-PWI), Magnetic Resonance Spectroscopy (MRS), and Diffusion Tensor Imaging (DTI). Imaging biomarkers derived by those advanced techniques [Cerebral Blood Flow (CBF), relative Cerebral Blood Volume (rCBV), relative Main Transit Time (rMTT), Choline (Cho), Creatine (Cr), Succinate, N-Acetyl Aspartate (NAA), Lactate (Lac), Lipids, relative Apparent Diffusion Coefficient (rADC), and Fractional Anisotropy (FA)] were detected by two experienced neuroradiologists in joint session in 4 areas: Internal Cavity (IC), Ring Enhancement (RE), Peri-Lesional edema (PL), and Contralateral Normal Appearing White Matter (CNAWM). Significant differences between benign (n=5) and malignant (n=9) ring enhancing lesions were tested with Mann-Withney U test. The diagnostic accuracy of MRI biomarkers taken alone and MRI biomarkers ratios were tested with Receiver Operating Characteristic (ROC) analysis with an Area Under the Curve (AUC) >= 0.9 indicating a very good diagnostic accuracy of the variable. Results Five MRI biomarker ratios achieved excellent accuracy: IC-rADC/PL-NAA (AUC = 1), ICrADC/IC-FA (AUC = 0.978), RE-rCBV/RE-FA (AUC = 0.933), IC-rADC/RE-FA (AUC = 0.911), and IC-rADC/PL-FA (AUC = 0.911). Only IC-rADC achieved a very good diagnostic accuracy (AUC = 0.909) among MRI biomarkers taken alone. Conclusion Although the major limitation of the study was the small sample size, preliminary results seem to suggest that combination of multiple 3T MRI biomarkers is a feasible approach to MRI biomarkers in order to improve diagnostic accuracy in the differentiation between benign and malignant single ring enhancing brain masses. Further studies in larger cohorts are needed to reach definitive conclusions.	[Salice, Simone; Esposito, Roberto; Delli Pizzi, Stefano; di Bastiano, Rossella; Tartaro, Armando] Univ G dAnnunzio, Dept Neurosci Imaging & Clin Sci, Chieti, Italy; [Esposito, Roberto] AO Osped Riuniti Marche Nord, Pesaro, Italy; [Ciavardelli, Domenico] Kore Univ Enna, Sch Human & Social Sci, Enna, Italy; [Ciavardelli, Domenico] Univ G dAnnunzio, Ctr Excellence Aging & Translat Med CeSI MeT, Mol Neurol Unit, Chieti, Italy	G d'Annunzio University of Chieti-Pescara; Universita Kore di ENNA; G d'Annunzio University of Chieti-Pescara	Tartaro, A (corresponding author), Univ G dAnnunzio, Dept Neurosci Imaging & Clin Sci, Chieti, Italy.	tartaro@unich.it	Pizzi, Stefano Delli/J-3935-2016	Pizzi, Stefano Delli/0000-0003-4075-0132; Esposito, Roberto/0000-0003-4708-6860				Altmaier E, 2008, ENDOCRINOLOGY, V149, P3478, DOI 10.1210/en.2007-1747; Andrews DW, 2004, LANCET, V363, P1665, DOI 10.1016/S0140-6736(04)16250-8; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Bang Casper N, 2011, Ugeskr Laeger, V173, P1364; Bankier AA, 2010, RADIOLOGY, V257, P14, DOI 10.1148/radiol.10100252; Brouwer MC, 2014, NEW ENGL J MED, V371, P447, DOI 10.1056/NEJMra1301635; Brouwer MC, 2014, NEUROLOGY, V82, P806, DOI 10.1212/WNL.0000000000000172; Bukte Y, 2005, CLIN RADIOL, V60, P375, DOI 10.1016/j.crad.2004.05.019; Cartes-Zumelzu FW, 2004, AM J NEURORADIOL, V25, P1310; Caulo M, 2014, RADIOLOGY, V272, P494, DOI 10.1148/radiol.14132040; Chang SC, 2002, CLIN IMAG, V26, P227, DOI 10.1016/S0899-7071(02)00436-9; Chiang IC, 2009, BRIT J RADIOL, V82, P813, DOI 10.1259/bjr/90100265; DEAN BL, 1990, RADIOLOGY, V174, P411, DOI 10.1148/radiology.174.2.2153310; DELATTRE JY, 1988, ARCH NEUROL-CHICAGO, V45, P741, DOI 10.1001/archneur.1988.00520310047016; Desbarats LN, 2003, MAGN RESON IMAGING, V21, P645, DOI 10.1016/S0730-725X(03)00084-5; Desprechins B, 1999, AM J NEURORADIOL, V20, P1252; Ebisu T, 1996, MAGN RESON IMAGING, V14, P1113, DOI 10.1016/S0730-725X(96)00237-8; Eichler AF, 2007, ONCOLOGIST, V12, P884, DOI 10.1634/theoncologist.12-7-884; Eng J, 2003, RADIOLOGY, V227, P309, DOI 10.1148/radiol.2272012051; Erdogan C, 2005, J COMPUT ASSIST TOMO, V29, P663, DOI 10.1097/01.rct.0000168868.50256.55; Espeland A, 2013, BMC MED IMAGING, V13, DOI 10.1186/1471-2342-13-4; Gomar JJ, 2011, ARCH GEN PSYCHIAT, V68, P961, DOI 10.1001/archgenpsychiatry.2011.96; Gupta RK, 2005, AM J NEURORADIOL, V26, P1107; Guzman R, 2002, J NEUROSURG, V97, P1101, DOI 10.3171/jns.2002.97.5.1101; HAIMES AB, 1989, AM J ROENTGENOL, V152, P1073, DOI 10.2214/ajr.152.5.1073; Hakyemez B, 2006, J MAGN RESON IMAGING, V24, P817, DOI 10.1002/jmri.20707; Hartmann M, 2001, AM J NEURORADIOL, V22, P1738; Holmes TM, 2004, AM J ROENTGENOL, V183, P1247, DOI 10.2214/ajr.183.5.1831247; HSIA DY, 1958, J MENT DEFIC RES, V2, P8, DOI 10.1111/j.1365-2788.1958.tb00380.x; Jensen Todd, 2010, MAGN RESON MED, V64, P907, DOI [10.1002/mrm.22445, DOI 10.1002/MRM.22445]; Kim YJ, 1998, AM J ROENTGENOL, V171, P1487, DOI 10.2214/ajr.171.6.9843275; Krabbe K, 1997, NEURORADIOLOGY, V39, P483, DOI 10.1007/s002340050450; Krug S, 2012, FASEB J, V26, P2607, DOI 10.1096/fj.11-198093; Lai Ping-Hong, 2004, Acta Neurol Taiwan, V13, P107; Liu DP, 2014, BIOSTATISTICS, V15, P706, DOI 10.1093/biostatistics/kxu020; Maier EM, 2005, HUM MUTAT, V25, P443, DOI 10.1002/humu.20163; Muccio CF, 2008, RADIOL MED, V113, P747, DOI 10.1007/s11547-008-0254-9; Nath K, 2009, MAGN RESON IMAGING, V27, P198, DOI 10.1016/j.mri.2008.06.006; Nathoo N, 2011, WORLD NEUROSURG, V75, P716, DOI 10.1016/j.wneu.2010.11.043; Noguchi K, 1999, NEURORADIOLOGY, V41, P171, DOI 10.1007/s002340050726; Omuro A, 2013, JAMA-J AM MED ASSOC, V310, P1842, DOI 10.1001/jama.2013.280319; Park SH, 2000, NEURORADIOLOGY, V42, P716, DOI 10.1007/s002340000394; Patchell RA, 1998, JAMA-J AM MED ASSOC, V280, P1485, DOI 10.1001/jama.280.17.1485; Paul Tofts, 2004, QUANTITATIVE MRI BRA; Paulson ES, 2008, RADIOLOGY, V249, P601, DOI 10.1148/radiol.2492071659; Petersen AK, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-120; Price SJ, 2016, J MAGN RESON IMAGING, V43, P487, DOI 10.1002/jmri.24996; Reddy JS, 2006, SURG NEUROL, V66, P246, DOI 10.1016/j.surneu.2006.03.032; Reiche W, 2010, CLIN NEUROL NEUROSUR, V112, P218, DOI 10.1016/j.clineuro.2009.11.016; Smith E.T.S., 2011, BRIT J RADIOL, V84, pS196, DOI [10.1259/bjr/16586938, DOI 10.1259/BJR/16586938]; Toh CH, 2011, AM J NEURORADIOL, V32, P1646, DOI 10.3174/ajnr.A2581; Tung GA, 2001, AM J ROENTGENOL, V177, P709, DOI 10.2214/ajr.177.3.1770709; Wardlaw JM, 2012, EUR RADIOL, V22, P2295, DOI 10.1007/s00330-012-2500-8; Williams FMK, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2839; *WORLD MED ASS DEC, 1997, JAMA-J AM MED ASSOC, V277, P925, DOI DOI 10.1001/JAMA.1997.03540350075038; Xu XX, 2014, CLIN RADIOL, V69, P909, DOI 10.1016/j.crad.2014.04.012; Yuan Z, 2008, BIOMETRICS, V64, P431, DOI 10.1111/j.1541-0420.2007.00904.x	57	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159047	10.1371/journal.pone.0159047	http://dx.doi.org/10.1371/journal.pone.0159047			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410226	Green Submitted, Green Published, gold			2022-12-27	WOS:000379508300053
J	Moretti, A; Ghidini, M; De Angelis, C; Lambertini, M; Cremolini, C; Imbimbo, M; Berardi, R; Di Maio, M; Cascinu, S; La Verde, N				Moretti, Anna; Ghidini, Michele; De Angelis, Carmine; Lambertini, Matteo; Cremolini, Chiara; Imbimbo, Martina; Berardi, Rossana; Di Maio, Massimo; Cascinu, Stefano; La Verde, Nicla			What Medical Oncologist Residents Think about the Italian Speciality Schools: A Survey of the Italian Association of Medical Oncology (AIOM) on Educational, Clinical and Research Activities	PLOS ONE			English	Article							RADIATION ONCOLOGY; EUROPEAN-SOCIETY; POSITION PAPER; FELLOWS; CARE; ESMO	Background and objectives Relevant heterogeneity exists among Postgraduate Schools in Medical Oncology, also within the same country. In order to provide a comprehensive overview of the landscape of Italian Postgraduate Schools in Medical Oncology, the Italian Association of Medical Oncology (AIOM) undertook an online survey, inviting all the residents to describe their daily activities and to express their overall satisfaction about their programs. Methods A team composed of five residents and three consultants in medical oncology prepared a 38 items questionnaire that was published online in a reserved section, accessible through a link sent by e-mail. Residents were invited to anonymously fill in the questionnaire that included the following sub-sections: quality of teaching, clinical and research activity, overall satisfaction. Results Three-hundred and eleven (57%) out of 547 invited residents filled in the questionnaire. Two-hundred and twenty-three (72%) participants declared that attending lessons was frequently difficult and 153 (49%) declared they did not gain substantial improvement in their knowledge from them. Fifty-five percent stated that they did not receive lessons on palliative care. Their overall judgment about didactic activity was low in 63% of the interviewed. The satisfaction for clinical activity was in 86% of cases good: 84% recognized that, during the training period, they acquired a progressive independence on patients' management. About research activity, the majority (79%) of participants in the survey was actively engaged in managing patients included in clinical trials but the satisfaction level for the involvement in research activities was quite low (54%). Overall, 246 residents (79%) gave a positive global judgment of their Medical Oncology Schools. Conclusions The landscape of Italian Postgraduate Schools in Medical Oncology is quite heterogeneous across the country. Some improvements in the organization of teaching and in the access to research opportunity are needed; the perception about clinical activity and the overall judgment of the programs are quite satisfactory.	[Moretti, Anna; La Verde, Nicla] Presidio Osped Fatebenefratelli, Dept Med Oncol, Azienda Socio Sanit Terr Fatebenefrat, Milan, Italy; [Ghidini, Michele] Presidio Osped Cremona, Azienda Socio Sanit Terr Cremona, Div Oncol, Dept Med, Cremona, Italy; [De Angelis, Carmine] Univ Naples Federico II, Div Oncol, Dept Clin Med & Surg, Naples, Italy; [Lambertini, Matteo] IRCCS AOU San Martino IST, UO Oncol Med 2, Dept Med Oncol, Genoa, Italy; [Cremolini, Chiara] Univ Pisa, Azienda Osped, Polo Oncol, Univ Pisana, Pisa, Italy; [Imbimbo, Martina] Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol, Milan, Italy; [Berardi, Rossana] Univ Politecn Marche, Med Oncol, Osped Riuniti Ancona, Ancona, Italy; [Di Maio, Massimo] Univ Turin, Dept Med Oncol, SCDU Oncol Med, AOU San Luigi Gonzaga, Turin, Italy; [Cascinu, Stefano] Univ Modena, Dept Med Oncol, Modena, Italy	University of Naples Federico II; University of Genoa; IRCCS AOU San Martino IST; University of Pisa; Azienda Ospedaliero Universitaria Pisana; Fondazione IRCCS Istituto Nazionale Tumori Milan; Marche Polytechnic University; University of Turin; Universita di Modena e Reggio Emilia	Ghidini, M (corresponding author), Presidio Osped Cremona, Azienda Socio Sanit Terr Cremona, Div Oncol, Dept Med, Cremona, Italy.	micheleghidini@outlook.com	la verde, nicla/AAW-9398-2020; Imbimbo, Martina/K-4510-2016; Berardi, Rossana/AAC-5758-2022; Cascinu, Stefano/G-2399-2017; Cascinu, Stefano/AAN-1923-2020; Cremolini, Chiara/AAC-1889-2019; Berardi, Rossana/AAC-5216-2022; DE ANGELIS, CARMINE/L-2788-2015; Lambertini, Matteo/T-2563-2017; Ghidini, Michele/I-7362-2018	la verde, nicla/0000-0002-2884-1632; Imbimbo, Martina/0000-0003-2521-7540; Cascinu, Stefano/0000-0003-2215-0731; Berardi, Rossana/0000-0002-9529-2960; DE ANGELIS, CARMINE/0000-0003-1158-4630; Lambertini, Matteo/0000-0003-1797-5296; Ghidini, Michele/0000-0001-5435-1218; CREMOLINI, CHIARA/0000-0002-0520-4841	Italian Association of Medical Oncology (AIOM)	Italian Association of Medical Oncology (AIOM)	This work was supported by the Italian Association of Medical Oncology (AIOM) supported publication costs. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee S, 2014, COMMUNICATION; Ciardiello F, 2014, ANN ONCOL, V25, P1673, DOI 10.1093/annonc/mdu217; Debenham B, 2012, INT J RADIAT ONCOL, V82, P1326, DOI 10.1016/j.ijrobp.2011.04.030; Fromson JA, WOMEN PHYS SPECIALIT; Hansen HH, 2004, J CLIN ONCOL, V22, P4616, DOI 10.1200/JCO.2004.08.134; Mougalian Sarah Schellhorn, 2013, J Support Oncol, V11, P95; Patel S, 2006, INT J RADIAT ONCOL, V66, P1199, DOI 10.1016/j.ijrobp.2006.06.024; Popescu RA, 2014, ANN ONCOL, V25, P9, DOI 10.1093/annonc/mdt522; Schrijvers D, 2003, ANN ONCOL, V14, P1455, DOI 10.1093/annonc/mdg421; Semrau R, 2008, STRAHLENTHER ONKOL, V184, P239, DOI 10.1007/s00066-008-1821-7; Shanafelt TD, 2014, J CLIN ONCOL, V32, P2991, DOI 10.1200/JCO.2014.56.2827; The ESMO MOSES Task Force, 2008, MED ONC STAT EUR SUR; Thomas RA, 2015, J PALLIAT MED, V18, P747, DOI 10.1089/jpm.2015.0035; Zumberg MS, 2015, J CANCER EDUC, V30, P711, DOI 10.1007/s13187-014-0778-8	14	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0159146	10.1371/journal.pone.0159146	http://dx.doi.org/10.1371/journal.pone.0159146			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27403529	Green Published, gold			2022-12-27	WOS:000379508200037
J	Kloten, V; Schlensog, M; Eschenbruch, J; Gasthaus, J; Tiedemann, J; Mijnes, J; Heide, T; Braunschweig, T; Knuchel, R; Dahl, E				Kloten, Vera; Schlensog, Martin; Eschenbruch, Julian; Gasthaus, Janina; Tiedemann, Janina; Mijnes, Jolein; Heide, Timon; Braunschweig, Till; Knuechel, Ruth; Dahl, Edgar			Abundant NDRG2 Expression Is Associated with Aggressiveness and Unfavorable Patients' Outcome in Basal-Like Breast Cancer	PLOS ONE			English	Article							REGULATED GENE 2; CELL-LINES; PROMOTER METHYLATION; MOLECULAR PORTRAITS; PROGNOSTIC MARKER; TGF-BETA; RECEPTOR; TUMOR; CD24; RECURRENCE	NDRG2, a member of the N-myc downstream-regulated gene family, is thought to be a putative tumor suppressor gene with promising clinical impact in breast cancer. Since breast cancer comprises heterogeneous intrinsic subtypes with distinct clinical outcomes we investigated the pivotal role of NDRG2 in basal-type breast cancers. Based on subtype classified tumor (n = 45) and adjacent normal tissues (n = 17) we examined NDRG2 mRNA expression and CpG-hypermethylation, whose significance was further validated by independent data sets from The Cancer Genome Atlas (TCGA). In addition, NDRG2 protein expression was evaluated immunohistochemically using a tissue micro array (TMA, n = 211). In vitro, we investigated phenotypic effects caused by NDRG2 silencing in the basal A-like HCC1806 as well as NDRG2 over-expression in basal A-like BT20 compared to luminal-type MCF7 breast cancer cells. Our tissue collections demonstrated an overall low NDRG2 mRNA expression in breast cancer subtypes compared to normal breast tissue in line with an increased CpG-hypermethylation in breast cancer tissue. Independent TCGA data sets verified a significant (P<0.001) expression loss of NDRG2 in breast tumors. Of interest, basal-like tumors more frequently retained abundant NDRG2 expression concordant with a lower CpG-hypermethylation. Unexpectedly, basal-like breast cancer revealed an association of NDRG2 expression with unfavorable patients' outcome. In line with this observation, in vitro experiments demonstrated reduced proliferation and migration rates (similar to 20%) in HCC1806 cells following NDRG2 silencing. In contrast, NDRG2 over-expressing luminal-type MCF7 cells demonstrated a 26% decreased proliferation rate. Until now, this is the first study investigating the putative role of NDRG2 in depth in basal-type breast cancer. Our data indicate that the described putative tumor suppressive function of NDRG2 may be confined to luminal-and basal B-type breast cancers.	[Kloten, Vera; Schlensog, Martin; Eschenbruch, Julian; Gasthaus, Janina; Tiedemann, Janina; Mijnes, Jolein; Heide, Timon; Braunschweig, Till; Knuechel, Ruth; Dahl, Edgar] Rhein Westfal TH Aachen, Fac Med, Inst Pathol, Mol Oncol Grp, Aachen, Germany	RWTH Aachen University	Kloten, V (corresponding author), Rhein Westfal TH Aachen, Fac Med, Inst Pathol, Mol Oncol Grp, Aachen, Germany.	vkloten@ukaachen.de	Braunschweig, Till/AAO-5725-2020	Braunschweig, Till/0000-0001-9166-2912; Eschenbruch, Julian/0000-0002-3430-3590; Gasthaus, Janina/0000-0003-0890-6141				Bertucci F, 2008, INT J CANCER, V123, P236, DOI 10.1002/ijc.23518; Boulkroun S, 2005, PFLUG ARCH EUR J PHY, V451, P388, DOI 10.1007/s00424-005-1410-x; Boulkroun S, 2002, J BIOL CHEM, V277, P31506, DOI 10.1074/jbc.M200272200; Charafe-Jauffret E, 2006, ONCOGENE, V25, P2273, DOI 10.1038/sj.onc.1209254; Dahl E, 2006, CLIN CANCER RES, V12, P3950, DOI 10.1158/1078-0432.CCR-05-2090; Foletta VC, 2009, J PHYSIOL-LONDON, V587, P1619, DOI 10.1113/jphysiol.2008.167882; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jeschke J, 2012, EPIGENETICS-US, V7, P701, DOI 10.4161/epi.20445; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Kim MJ, 2014, MOL CELLS, V37, P759, DOI 10.14348/molcells.2014.0232; Kim MJ, 2014, CANCER LETT, V354, P33, DOI 10.1016/j.canlet.2014.06.023; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kristiansen G, 2011, J BIOL CHEM; Lee DC, 2008, CANCER RES, V68, P4210, DOI 10.1158/0008-5472.CAN-07-5040; Li Y, 2011, J BIOL CHEM, V286, P32289, DOI 10.1074/jbc.M111.247825; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Liu N, 2008, NUCLEIC ACIDS RES, V36, P5335, DOI 10.1093/nar/gkn504; Liu N, 2007, BIOCHEM BIOPH RES CO, V358, P164, DOI 10.1016/j.bbrc.2007.04.089; Ma J, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3628; Ma J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032368; Ma YL, 2014, BRAIN RES, V1569, P1, DOI 10.1016/j.brainres.2014.04.036; Malaterre J, 2007, FRONT BIOSCI-LANDMRK, V12, P492, DOI 10.2741/2077; Nakahata S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4393; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nielsen TO, 2010, CLIN CANCER RES, V16, P5222, DOI 10.1158/1078-0432.CCR-10-1282; Noetzel E, 2012, ONCOGENE, V31, P2101, DOI 10.1038/onc.2011.403; Noetzel E, 2010, ONCOGENE, V29, P4814, DOI 10.1038/onc.2010.229; Oh SS, 2012, CARCINOGENESIS, V33, P1882, DOI 10.1093/carcin/bgs211; Okuda T, 2008, J HISTOCHEM CYTOCHEM, V56, P175, DOI 10.1369/jhc.7A7323.2007; PAGET S, 1989, CANCER METAST REV, V8, P98; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rakha EA, 2009, CLIN CANCER RES, V15, P2302, DOI 10.1158/1078-0432.CCR-08-2132; Reed AEM, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0519-x; Shen L, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2013.48; Shon SK, 2009, BIOCHEM BIOPH RES CO, V385, P198, DOI 10.1016/j.bbrc.2009.05.038; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Song SP, 2012, MED ONCOL, V29, P1879, DOI 10.1007/s12032-011-0110-y; Takeichi T, 2011, NEUROCHEM INT, V59, P21, DOI 10.1016/j.neuint.2011.03.019; Tuominen VJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2615; Veeck J, 2008, ONCOGENE, V27, P865, DOI 10.1038/sj.onc.1210669; Volk-Draper LD, 2012, NEOPLASIA, V14, P926, DOI 10.1593/neo.12956; Yamamura A, 2013, BIOCHEM BIOPH RES CO, V441, P102, DOI 10.1016/j.bbrc.2013.10.010; Yau C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2753; Zheng J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-251; Zheng J, 2010, ASIAN PAC J CANCER P, V11, P1817	48	9	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2016	11	7							e0159073	10.1371/journal.pone.0159073	http://dx.doi.org/10.1371/journal.pone.0159073			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CN	27400234	Green Submitted, gold, Green Published			2022-12-27	WOS:000379508100016
J	Page, MJ; Higgins, JPT; Clayton, G; Sterne, JAC; Hrobjartsson, A; Savovic, J				Page, Matthew J.; Higgins, Julian P. T.; Clayton, Gemma; Sterne, Jonathan A. C.; Hrobjartsson, Asbjorn; Savovic, Jelena			Empirical Evidence of Study Design Biases in Randomized Trials: Systematic Review of Meta-Epidemiological Studies	PLOS ONE			English	Review							CLINICAL-TRIALS; OBSERVER BIAS; METHODOLOGICAL QUALITY; ALLOCATION CONCEALMENT; MULTICENTER TRIALS; OUTCOMES; RISK; INTERVENTIONS; METAANALYSES; IMPACT	Objective To synthesise evidence on the average bias and heterogeneity associated with reported methodological features of randomized trials. Design Systematic review of meta-epidemiological studies. Methods We retrieved eligible studies included in a recent AHRQ-EPC review on this topic (latest search September 2012), and searched Ovid MEDLINE and Ovid EMBASE for studies indexed from Jan 2012-May 2015. Data were extracted by one author and verified by another. We combined estimates of average bias (e.g. ratio of odds ratios (ROR) or difference in standardised mean differences (dSMD)) in meta-analyses using the random-effects model. Analyses were stratified by type of outcome ("mortality" versus "other objective" versus "subjective"). Direction of effect was standardised so that ROR < 1 and dSMD < 0 denotes a larger intervention effect estimate in trials with an inadequate or unclear (versus adequate) characteristic. Results We included 24 studies. The available evidence suggests that intervention effect estimates may be exaggerated in trials with inadequate/unclear (versus adequate) sequence generation (ROR 0.93, 95% CI 0.86 to 0.99; 7 studies) and allocation concealment (ROR 0.90, 95% CI 0.84 to 0.97; 7 studies). For these characteristics, the average bias appeared to be larger in trials of subjective outcomes compared with other objective outcomes. Also, intervention effects for subjective outcomes appear to be exaggerated in trials with lack of/unclear blinding of participants (versus blinding) (dSMD -0.37, 95% CI -0.77 to 0.04; 2 studies), lack of/unclear blinding of outcome assessors (ROR 0.64, 95% CI 0.43 to 0.96; 1 study) and lack of/unclear double blinding (ROR 0.77, 95% CI 0.61 to 0.93; 1 study). The influence of other characteristics (e.g. unblinded trial personnel, attrition) is unclear. Conclusions Certain characteristics of randomized trials may exaggerate intervention effect estimates. The average bias appears to be greatest in trials of subjective outcomes. More research on several characteristics, particularly attrition and selective reporting, is needed.	[Page, Matthew J.; Higgins, Julian P. T.; Clayton, Gemma; Sterne, Jonathan A. C.; Savovic, Jelena] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Page, Matthew J.] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Hrobjartsson, Asbjorn] Univ Southern Denmark, Ctr Evidence Based Med, Odense, Denmark; [Hrobjartsson, Asbjorn] Odense Univ Hosp, Odense, Denmark; [Savovic, Jelena] Univ Hosp Bristol NHS Fdn Trust, Natl Inst Hlth Res Collaborat Leadership Appl Hlt, Bristol, Avon, England	University of Bristol; Monash University; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Bristol	Page, MJ (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol, Avon, England.; Page, MJ (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia.	matthew.page@monash.edu	Higgins, Julian PT/H-4008-2011; Sterne, Jonathan/Z-3106-2019; Savović, Jelena/O-4107-2019	Higgins, Julian PT/0000-0002-8323-2514; Sterne, Jonathan/0000-0001-8496-6053; Savović, Jelena/0000-0002-2861-0578; Page, Matthew/0000-0002-4242-7526; Clayton, Gemma/0000-0002-9525-2758	MRC Network of Hubs for Trials Methodology Research [MR/L004933/1- N61]; Australian National Health and Medical Research Council (NHMRC) Early Career Fellowship [1088535]; National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care West (NIHR CLAHRC West); Medical Research Council [MR/L004933/1, MR/L004933/2, MR/K025643/1, MR/M025209/1, G0701659] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10168, NF-SI-0514-10114] Funding Source: researchfish; MRC [MR/M025209/1, MR/L004933/2, MR/L004933/1, G0701659, MR/K025643/1] Funding Source: UKRI	MRC Network of Hubs for Trials Methodology Research(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Australian National Health and Medical Research Council (NHMRC) Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia); National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care West (NIHR CLAHRC West); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the MRC Network of Hubs for Trials Methodology Research (MR/L004933/1- N61). MJP is supported by an Australian National Health and Medical Research Council (NHMRC) Early Career Fellowship (1088535). JS is supported by a National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care West (NIHR CLAHRC West). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.	Abraha I, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2445; Als-Nielsen B, 2004, 12 INT COCHR COLL OT, P102; Armijo-Olivo S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008562; Armijo-Olivo S, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-88; Bafeta A, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e813; Balk EM, 2002, JAMA-J AM MED ASSOC, V287, P2973, DOI 10.1001/jama.287.22.2973; Bassler D, 2010, JAMA-J AM MED ASSOC, V303, P1180, DOI 10.1001/jama.2010.310; Berkman ND, 2014, AHRQ METHODS EFFECTI; Bialy Liza, 2014, Evid Based Child Health, V9, P1052, DOI 10.1002/ebch.1985; Chaimani A, 2013, INT J EPIDEMIOL, V42, P1120, DOI 10.1093/ije/dyt074; Chinn S, 2000, STAT MED, V19, P3127, DOI 10.1002/1097-0258(20001130)19:22<3127::AID-SIM784>3.0.CO;2-M; Contopoulos-Ioannidis DG, 2005, AM J PSYCHIAT, V162, P578, DOI 10.1176/appi.ajp.162.3.578; Dechartres A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2304; Dechartres A, 2011, ANN INTERN MED, V155, P39, DOI 10.7326/0003-4819-155-1-201107050-00006; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Devereaux PJ, 2004, J CLIN EPIDEMIOL, V57, P1232, DOI 10.1016/j.jclinepi.2004.03.017; Dossing Anna, 2014, BMJ Open, V4, pe005297, DOI 10.1136/bmjopen-2014-005297; Egger M, 2003, Health Technol Assess, V7, P1; Feys F, 2012, SYST REV, V1, DOI 10.1186/2046-4053-1-54; Giraudeau B, 2016, STAT MED, V35, P239, DOI 10.1002/sim.6627; GUYATT G, 1992, JAMA-J AM MED ASSOC, V268, P2420, DOI 10.1001/jama.1992.03490170092032; Hansen JB, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005491; Hartling L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088008; Herbison P, 2011, J CLIN EPIDEMIOL, V64, P1070, DOI 10.1016/j.jclinepi.2010.12.018; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hrobjartsson A, 2014, INT J EPIDEMIOL, V43, P1272, DOI 10.1093/ije/dyu115; Hrobjartsson A, 2014, INT J EPIDEMIOL, V43, P937, DOI 10.1093/ije/dyt270; Hrobjartsson A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000058; Hrobjartsson A, 2013, CAN MED ASSOC J, V185, pE201, DOI 10.1503/cmaj.120744; Hrobjartsson A, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1119; Jacobs WCH, 2013, J CLIN EPIDEMIOL, V66, P1347, DOI 10.1016/j.jclinepi.2013.06.007; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kjaergard LL, 2008, ANN INTERN MED, V149, P219, DOI 10.7326/0003-4819-149-3-200808050-00023; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; Lundh A, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000033.pub3, 10.1002/14651858.MR000033.pub2]; Mhaskar R, 2012, J CLIN EPIDEMIOL, V65, P602, DOI 10.1016/j.jclinepi.2011.10.016; Mills EJ, 2015, CONTEMP CLIN TRIALS, V45, P2, DOI 10.1016/j.cct.2015.07.019; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moher D., 1999, HEALTH TECHNOL ASSES, V3, pi, DOI [DOI 10.3310/HTA3120, 10.3310/hta3120]; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; NHMRC, 2000, US EV ASS APPL SCI E; Nuesch E, 2009, ARTHRIT RHEUM-ARTHR, V61, P1633, DOI 10.1002/art.24894; Nuesch E, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3244; OCEBM Levels of Evidence Working Group, OXFORD 2011 LEVELS E; Panagiotou OA, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f707; Papageorgiou SN, 2015, J CLIN EPIDEMIOL, V68, P1512, DOI 10.1016/j.jclinepi.2015.03.008; Pildal J, 2007, INT J EPIDEMIOL, V36, P847, DOI 10.1093/ije/dym087; Saltaji H, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004527; Savovic J, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16350; Savovic J, 2012, ANN INTERN MED, V157, P429, DOI 10.7326/0003-4819-157-6-201209180-00537; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Siersma V, 2007, STAT MED, V26, P2745, DOI 10.1002/SIM.2752; Sterne JAC, 2002, STAT MED, V21, P1513, DOI 10.1002/sim.1184; Unverzagt S, 2013, J CLIN EPIDEMIOL, V66, P1271, DOI 10.1016/j.jclinepi.2013.05.016; Vale CL, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1798; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD	58	135	136	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2016	11	7							e0159267	10.1371/journal.pone.0159267	http://dx.doi.org/10.1371/journal.pone.0159267			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CN	27398997	Green Submitted, Green Published, gold			2022-12-27	WOS:000379508100021
J	Yang, L; Xia, LP; Wang, Y; Hong, SD; Chen, HY; Liang, SB; Peng, PJ; Chen, Y				Yang, Lin; Xia, Liangping; Wang, Yan; Hong, Shaodong; Chen, Haiyang; Liang, Shaobo; Peng, Peijian; Chen, Yong			Low Prognostic Nutritional Index (PNI) Predicts Unfavorable Distant Metastasis-Free Survival in Nasopharyngeal Carcinoma: A Propensity Score-Matched Analysis	PLOS ONE			English	Article							INTENSITY-MODULATED RADIOTHERAPY; EPSTEIN-BARR-VIRUS; NEOADJUVANT CHEMOTHERAPY; SERUM-ALBUMIN; CANCER; OUTCOMES; INFLAMMATION; CYTOKINES	Background Poor nutritional status is associated with progression and advanced disease in patients with cancer. The prognostic nutritional index (PNI) may represent a simple method of assessing host immunonutritional status. This study was designed to investigate the prognostic value of the PNI for distant metastasis-free survival (DMFS) in patients with nasopharyngeal carcinoma (NPC). Methods A training cohort of 1,168 patients with non-metastatic NPC from two institutions was retrospectively analyzed. The optimal PNI cutoff value for DMFS was identified using the online tool "Cutoff Finder". DMFS was analyzed using stratified and adjusted analysis. Propensity score-matched analysis was performed to balance baseline characteristics between the high and low PNI groups. Subsequently, the prognostic value of the PNI for DMFS was validated in an external validation cohort of 756 patients with NPC. The area under the receiver operating characteristics curve (AUC) was calculated to compare the discriminatory ability of different prognostic scores. Results The optimal PNI cutoff value was determined to be 51. Low PNI was significantly associated with poorer DMFS than high PNI in univariate analysis (P<0.001) as well as multivariate analysis (P<0.001) before propensity score matching. In subgroup analyses, PNI could also stratify different risks of distant metastases. Propensity score-matched analyses confirmed the prognostic value of PNI, excluding other interpretations and selection bias. In the external validation cohort, patients with high PNI also had significantly lower risk of distant metastases than those with low PNI (Hazards Ratios, 0.487; P<0.001). The PNI consistently showed a higher AUC value at 1-year (0.780), 3-year (0.793) and 5-year (0.812) in comparison with other prognostic scores. Conclusion PNI, an inexpensive and easily assessable inflammatory index, could aid clinicians in developing individualized treatment and follow-up strategies for patients with non-metastatic NPC.	[Yang, Lin; Xia, Liangping; Wang, Yan; Hong, Shaodong; Chen, Yong] Sun Yat Sen Univ, Ctr Canc, Guangzhou, Guangdong, Peoples R China; [Yang, Lin; Xia, Liangping; Wang, Yan; Hong, Shaodong; Chen, Yong] State Key Lab Oncol Southern China, Guangzhou, Guangdong, Peoples R China; [Yang, Lin; Xia, Liangping; Wang, Yan; Hong, Shaodong; Chen, Yong] Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China; [Chen, Haiyang] Sun Yat Sen Univ, Affiliated Hosp 6, Guangzhou, Guangdong, Peoples R China; [Liang, Shaobo] First Hosp Foshan, Foshan, Peoples R China; [Peng, Peijian] Sun Yat Sen Univ, Affiliated Hosp 5, Zhuhai, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University	Chen, Y (corresponding author), Sun Yat Sen Univ, Ctr Canc, Guangzhou, Guangdong, Peoples R China.; Chen, Y (corresponding author), State Key Lab Oncol Southern China, Guangzhou, Guangdong, Peoples R China.; Chen, Y (corresponding author), Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China.	chenyong@sysucc.org.cn	Chen, Yongming/E-3656-2015	Chen, Yongming/0000-0003-2843-5543				Budczies J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051862; Ceze N, 2011, CANCER CHEMOTH PHARM, V68, P1305, DOI 10.1007/s00280-011-1610-3; Chan AT, 2007, NEW ENGL J MED, V356, P2131, DOI 10.1056/NEJMoa067208; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; Chang JTC, 2005, INT J RADIAT ONCOL, V62, P501, DOI 10.1016/j.ijrobp.2004.09.057; Chaves MR, 2010, ONCOLOGIST, V15, P523, DOI 10.1634/theoncologist.2009-0283; Chen C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112581; Chen YP, 2015, CHIN J CANCER, V34, DOI 10.1186/s40880-015-0006-x; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Guigay J, 2006, ANN ONCOL, V17, pX304, DOI 10.1093/annonc/mdl278; Gupta D, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-69; Hong SD, 2015, TUMOR BIOL, V36, P3389, DOI 10.1007/s13277-014-2973-y; Ikeya T, 2015, J CANCER RES CLIN, V141, P307, DOI 10.1007/s00432-014-1799-8; Koehne CH, 2004, SEMIN ONCOL, V31, P12, DOI 10.1053/j.seminoncol.2004.03.041; Lai SZ, 2011, INT J RADIAT ONCOL, V80, P661, DOI 10.1016/j.ijrobp.2010.03.024; Landskron G, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/149185; Lee AWM, 2012, RADIOTHER ONCOL, V104, P272, DOI 10.1016/j.radonc.2012.08.001; Lee AWM, 2005, INT J RADIAT ONCOL, V61, P1107, DOI 10.1016/j.ijrobp.2004.07.702; LIEBOWITZ D, 1994, SEMIN ONCOL, V21, P376; Lien YC, 2004, J GASTROINTEST SURG, V8, P1041, DOI 10.1016/j.gassur.2004.09.033; Lorusso G, 2008, HISTOCHEM CELL BIOL, V130, P1091, DOI 10.1007/s00418-008-0530-8; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Migita K, 2013, ANN SURG ONCOL, V20, P2647, DOI 10.1245/s10434-013-2926-5; Okabayashi T, 2008, J GASTROEN HEPATOL, V23, P1869, DOI 10.1111/j.1440-1746.2008.05504.x; Onodera T, 1984, Nihon Geka Gakkai Zasshi, V85, P1001; Peerawong T, 2012, ASIAN PAC J CANCER P, V13, P5805, DOI 10.7314/APJCP.2012.13.11.5805; Qiu WZ, 2016, CHIN J CANCER, V35, DOI 10.1186/s40880-015-0076-9; ROTHSCHILD MA, 1988, HEPATOLOGY, V8, P385, DOI 10.1002/hep.1840080234; Sarmiento MPCB, 2014, CHIN J CANCER, V33, P159, DOI 10.5732/cjc.013.10010; Tang LQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122965; Thompson MP, 2004, CLIN CANCER RES, V10, P803, DOI 10.1158/1078-0432.CCR-0670-3; Tsujimoto H, 2010, GASTRIC CANCER, V13, P212, DOI 10.1007/s10120-010-0568-x; Wei KR, 2014, CHIN J CANCER, V33, P381, DOI 10.5732/cjc.014.10086; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Xu LY, 2010, RADIOTHER ONCOL, V96, P94, DOI 10.1016/j.radonc.2010.04.006; Yao ZH, 2013, J CANCER RES CLIN, V139, P2117, DOI 10.1007/s00432-013-1523-0; ZHENG X, 1994, ACTA OTO-LARYNGOL, V114, P98, DOI 10.3109/00016489409126024	38	41	44	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2016	11	7							e0158853	10.1371/journal.pone.0158853	http://dx.doi.org/10.1371/journal.pone.0158853			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CN	27399281	gold, Green Submitted, Green Published			2022-12-27	WOS:000379508100011
J	Augusto, JF; Langs, V; Demiselle, J; Lavigne, C; Brilland, B; Duveau, A; Poli, C; Chevailler, A; Croue, A; Tollis, F; Sayegh, J; Subra, JF				Augusto, Jean-Francois; Langs, Virginie; Demiselle, Julien; Lavigne, Christian; Brilland, Benoit; Duveau, Agnes; Poli, Caroline; Chevailler, Alain; Croue, Anne; Tollis, Frederic; Sayegh, Johnny; Subra, Jean-Francois			Low Serum Complement C3 Levels at Diagnosis of Renal ANCA-Associated Vasculitis Is Associated with Poor Prognosis	PLOS ONE			English	Article							ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES; SMALL-VESSEL VASCULITIS; CRESCENTIC GLOMERULONEPHRITIS; ACTIVATION; PATHOGENESIS; PROTECTS; PATHWAY; MICE; GN	Background Recent studies have demonstrated the key role of the complement alternative pathway (cAP) in the pathophysiology of experimental ANCA-associated vasculitis (AAV). However, in human AAV the role of cAP has not been extensively explored. In the present work, we analysed circulating serum C3 levels measured at AAV onset and their relation to outcomes. Methods We conducted a retrospective observational cohort study including 45 consecutive patients with AAV diagnosed between 2000 and 2014 with serum C3 measurement at diagnosis, before immunosuppressive treatment initiation. Two groups were defined according to the median serum C3 level value: the low C3 group (C3<120 mg/dL) and the high C3 level group (C3 >= 120 mg/dL). Patient and renal survivals, association between C3 level and renal pathology were analysed. Results Serum complement C3 concentration remained in the normal range [78-184 mg/dL]. Compared with the high C3 level, the patients in the low C3 level group had lower complement C4 concentrations (P = 0.008) and lower eGFR (P = 0.002) at diagnosis. The low C3 level group had poorer patient and death-censored renal survivals, compared with the high C3 level group (P = 0.047 and P = 0.001, respectively). We observed a significant negative correlation between C3 levels and the percentage of glomeruli affected by cellular crescent (P = 0.017, r = -0.407). According to the Berden et al renal histologic classification, patients in the crescentic/mixed category had low C3 levels more frequently (P<0.01). Interestingly, we observed that when patients with the crescentic/mixed histologic form were analysed according to C3 level, long term renal survival was significantly greater in the high C3 level group than in the low C3 level group (100% vs 40.7% at 6 years, p = 0.046). No relationship between serum C4 and renal outcome was observed. Conclusion A Low C3 serum level in AAV patients at diagnosis is associated with worse long-term patient and renal survival.	[Augusto, Jean-Francois; Poli, Caroline; Chevailler, Alain; Subra, Jean-Francois] LUNAM Univ, Angers, France; [Augusto, Jean-Francois; Langs, Virginie; Demiselle, Julien; Brilland, Benoit; Duveau, Agnes; Sayegh, Johnny; Subra, Jean-Francois] Univ Angers, CHU Angers, Serv Nephrol Dialyse Transplantat, Angers, France; [Lavigne, Christian] Univ Angers, CHU Angers, Serv Med Interne, Angers, France; [Poli, Caroline; Chevailler, Alain] Univ Angers, CHU Angers, Immunol Lab, Angers, France; [Croue, Anne] Univ Angers, CHU Angers, Dept Pathol Cellulaire & Tissulaire, Angers, France; [Tollis, Frederic] Diaverum Dialysis Ctr, Angers, France	Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Diaverum	Augusto, JF (corresponding author), LUNAM Univ, Angers, France.; Augusto, JF (corresponding author), Univ Angers, CHU Angers, Serv Nephrol Dialyse Transplantat, Angers, France.	jfaugusto@chu-angers.fr	Brilland, Benoît/AAP-3193-2021; Jean-François, Augusto/L-2887-2015	Brilland, Benoît/0000-0001-9622-4014; Jean-François, Augusto/0000-0003-1498-2132; DEMISELLE, JULIEN/0000-0002-7255-1114; POLI, Caroline/0000-0002-4145-5373				Beauvillain C, 2008, CLIN REV ALLERG IMMU, V35, P47, DOI 10.1007/s12016-007-8071-9; Berden AE, 2010, J AM SOC NEPHROL, V21, P1628, DOI 10.1681/ASN.2010050477; Chen M, 2009, NEPHROL DIAL TRANSPL, V24, P1247, DOI 10.1093/ndt/gfn586; Gou SJ, 2013, CLIN J AM SOC NEPHRO, V8, P1884, DOI 10.2215/CJN.02790313; Gou SJ, 2013, KIDNEY INT, V83, P129, DOI 10.1038/ki.2012.313; Haas M, 2004, KIDNEY INT, V65, P2145, DOI 10.1111/j.1523-1755.2004.00632.x; Henique C, 2014, SEMIN IMMUNOPATHOL, V36, P479, DOI 10.1007/s00281-014-0435-7; Hilhorst M, 2017, NEPHROL DIAL TRANSPL, V32, P1302, DOI 10.1093/ndt/gfv288; Huugen D, 2007, KIDNEY INT, V71, P646, DOI 10.1038/sj.ki.5002103; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Jennette JC, 2013, ANNU REV PATHOL-MECH, V8, P139, DOI 10.1146/annurev-pathol-011811-132453; Jennette JC, 2011, CONTRIB NEPHROL, V169, P211, DOI 10.1159/000314776; Jennette JC, 1997, NEW ENGL J MED, V337, P1512, DOI 10.1056/NEJM199711203372106; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; LUQMANI RA, 1994, Q J MED, V87, P671; Manenti L, 2015, CLIN J AM SOC NEPHRO, V10, P2143, DOI 10.2215/CJN.00120115; Mathern DR, 2015, CLIN J AM SOC NEPHRO, V10, P1636, DOI 10.2215/CJN.06230614; Mihlan M, 2009, CELL DEATH DIFFER, V16, P1630, DOI 10.1038/cdd.2009.103; Molad Y, 2014, NEPHRON CLIN PRACT, V126, P67, DOI 10.1159/000357154; Schreiber A, 2009, J AM SOC NEPHROL, V20, P289, DOI 10.1681/ASN.2008050497; Sinico RA, 2013, AUTOIMMUN REV, V12, P477, DOI 10.1016/j.autrev.2012.08.006; Watts R, 2007, ANN RHEUM DIS, V66, P222, DOI 10.1136/ard.2006.054593; Xiao H, 2002, J CLIN INVEST, V110, P955, DOI 10.1172/JCI200215918; Xiao H, 2007, AM J PATHOL, V170, P52, DOI 10.2353/ajpath.2007.060573; Xiao H, 2014, J AM SOC NEPHROL, V25, P225, DOI 10.1681/ASN.2013020143; Xing GQ, 2009, J CLIN IMMUNOL, V29, P282, DOI 10.1007/s10875-008-9268-2	26	47	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158871	10.1371/journal.pone.0158871	http://dx.doi.org/10.1371/journal.pone.0158871			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391243	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400146
J	Boudellioua, I; Saidi, R; Hoehndorf, R; Martin, MJ; Solovyev, V				Boudellioua, Imane; Saidi, Rabie; Hoehndorf, Robert; Martin, Maria J.; Solovyev, Victor			Prediction of Metabolic Pathway Involvement in Prokaryotic UniProtKB Data by Association Rule Mining	PLOS ONE			English	Article							ANNOTATION; ALGORITHM	The widening gap between known proteins and their functions has encouraged the development of methods to automatically infer annotations. Automatic functional annotation of proteins is expected to meet the conflicting requirements of maximizing annotation coverage, while minimizing erroneous functional assignments. This trade-off imposes a great challenge in designing intelligent systems to tackle the problem of automatic protein annotation. In this work, we present a system that utilizes rule mining techniques to predict metabolic pathways in prokaryotes. The resulting knowledge represents predictive models that assign pathway involvement to UniProtKB entries. We carried out an evaluation study of our system performance using cross-validation technique. We found that it achieved very promising results in pathway identification with an F-1-measure of 0.982 and an AUC of 0.987. Our prediction models were then successfully applied to 6.2 million UniProtKB/TrEMBL reference proteome entries of prokaryotes. As a result, 663,724 entries were covered, where 436,510 of them lacked any previous pathway annotations.	[Boudellioua, Imane; Hoehndorf, Robert] KAUST, Comp Elect & Math Sci & Engn Div CEMSE, CBRC, Thuwal, Saudi Arabia; [Saidi, Rabie; Martin, Maria J.] European Bioinformat Inst EMBL EBI, European Mol Biol Lab, Cambridge, England; [Solovyev, Victor] Softberry Inc, 116 Radio Circle,Suite 400, Mt Kisco, NY 10549 USA	King Abdullah University of Science & Technology; European Molecular Biology Laboratory (EMBL)	Saidi, R (corresponding author), European Bioinformat Inst EMBL EBI, European Mol Biol Lab, Cambridge, England.	rsaidi@ebi.ac.uk	Boudellioua, Imane/AAG-1041-2019; Hoehndorf, Robert/H-6127-2019; Martín, María/HDL-9512-2022; Hoehndorf, Robert/A-9943-2011; Solovyev, Victor/C-4614-2013	Hoehndorf, Robert/0000-0001-8149-5890; Hoehndorf, Robert/0000-0001-8149-5890; Martin, Maria-Jesus/0000-0001-5454-2815; Solovyev, Victor/0000-0001-8885-493X; Saidi, Rabie/0000-0002-0449-5253	King Abdullah University of Science and Technology; BBSRC [BB/N004876/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/N004876/1] Funding Source: researchfish	King Abdullah University of Science and Technology(King Abdullah University of Science & Technology); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	IB, RH and VS were supported by funding provided by the King Abdullah University of Science and Technology.	Agrawal R., 1994, VLDB, P487, DOI DOI 10.1007/BF02948845; Agrawal R., 1994, P 20 INT C VER LARG, P487; Artamonova II, 2005, BIOINFORMATICS, V21, P49, DOI 10.1093/bioinformatics/bti1206; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bebek G, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-335; Biswas Margaret, 2002, Brief Bioinform, V3, P285, DOI 10.1093/bib/3.3.285; Bodenreider O, 2005, P PAC S BIOC, P104; Borgelt C, 2002, COMPSTAT 2002: PROCEEDINGS IN COMPUTATIONAL STATISTICS, P395; Borgelt C., 2004, CEUR WORKSHOP P, V126; Borgelt C., 2003, P FIMI IEEE ICDM WOR; BOUKER S, 2012, IEEE 24 INT C TOOLS, P658, DOI DOI 10.1109/ICTAI.2012.94; Bouker S, 2014, INT J ARTIF INTELL T, V23, DOI 10.1142/S0218213014600112; Brin S., 1997, SIGMOD REC, P265, DOI [DOI 10.1145/253262.253327, 10.1145/253260.253327]; Button WG, 2003, J CHEM INF COMP SCI, V43, P1371, DOI 10.1021/ci0202739; Campbell NA, 2002, BIOLOGY, V1; Chen XJ, 2011, BIOINFORMATICS, V27, P649, DOI 10.1093/bioinformatics/btq714; Chen Y, 2009, AM J PATHOL, V175, P2676, DOI 10.2353/ajpath.2009.080945; Chibucos MC, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau075; Chiu SH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-304; Creighton C, 2003, BIOINFORMATICS, V19, P79, DOI 10.1093/bioinformatics/19.1.79; Dale JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-15; Hou BK, 2004, J IND MICROBIOL BIOT, V31, P261, DOI 10.1007/s10295-004-0144-7; Jaworska J, 2002, SAR QSAR ENVIRON RES, V13, P307, DOI 10.1080/10629360290002794; Karp PD, 2011, STAND GENOMIC SCI, V5, P424, DOI 10.4056/sigs.1794338; Kirsch A, 2009, PODS'09: PROCEEDINGS OF THE TWENTY-EIGHTH ACM SIGMOD-SIGACT-SIGART SYMPOSIUM ON PRINCIPLES OF DATABASE SYSTEMS, P117, DOI 10.1145/1559795.1559814; Klopman G, 1997, J CHEM INF COMP SCI, V37, P329, DOI 10.1021/ci9601123; Kretschmann E, 2001, BIOINFORMATICS, V17, P920, DOI 10.1093/bioinformatics/17.10.920; Moller S, 1999, BIOINFORMATICS, V15, P219, DOI 10.1093/bioinformatics/15.3.219; Mulder Nicola J, 2002, Brief Bioinform, V3, P225; National Human Genome Research Institute, BIOL PATHW; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Pedruzzi I, 2013, NUCLEIC ACIDS RES, V41, pD584, DOI 10.1093/nar/gks1157; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; Silberberg Y, 2012, J COMPUT BIOL, V19, P163, DOI 10.1089/cmb.2011.0264; Wu CH, 2002, NUCLEIC ACIDS RES, V30, P35, DOI 10.1093/nar/30.1.35	35	10	10	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158896	10.1371/journal.pone.0158896	http://dx.doi.org/10.1371/journal.pone.0158896			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27390860	Green Published, gold, Green Submitted			2022-12-27	WOS:000380005400155
J	Brittnacher, MJ; Heltshe, SL; Hayden, HS; Radey, MC; Weiss, EJ; Damman, CJ; Zisman, TL; Suskind, DL; Miller, SI				Brittnacher, Mitchell J.; Heltshe, Sonya L.; Hayden, Hillary S.; Radey, Matthew C.; Weiss, Eli J.; Damman, Christopher J.; Zisman, Timothy L.; Suskind, David L.; Miller, Samuel I.			GUTSS: An Alignment-Free Sequence Comparison Method for Use in Human Intestinal Microbiome and Fecal Microbiota Transplantation Analysis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ABUNDANCE ESTIMATION; ULCERATIVE-COLITIS; SIMILARITY; ACCURATE; REMISSION; ALGORITHM; DYSBIOSIS; PROFILES; DYNAMICS	Background Comparative analysis of gut microbiomes in clinical studies of human diseases typically rely on identification and quantification of species or genes. In addition to exploring specific functional characteristics of the microbiome and potential significance of species diversity or expansion, microbiome similarity is also calculated to study change in response to therapies directed at altering the microbiome. Established ecological measures of similarity can be constructed from species abundances, however methods for calculating these commonly used ecological measures of similarity directly from whole genome shotgun (WGS) metagenomic sequence are lacking. Results We present an alignment-free method for calculating similarity of WGS metagenomic sequences that is analogous to the Bray-Curtis index for species, implemented by the General Utility for Testing Sequence Similarity (GUTSS) software application. This method was applied to intestinal microbiomes of healthy young children to measure developmental changes toward an adult microbiome during the first 3 years of life. We also calculate similarity of donor and recipient microbiomes to measure establishment, or engraftment, of donor microbiota in fecal microbiota transplantation (FMT) studies focused on mild to moderate Crohn's disease. We show how a relative index of similarity to donor can be calculated as a measure of change in a patient's microbiome toward that of the donor in response to FMT. Conclusion Because clinical efficacy of the transplant procedure cannot be fully evaluated without analysis methods to quantify actual FMT engraftment, we developed a method for detecting change in the gut microbiome that is independent of species identification and database bias, sensitive to changes in relative abundance of the microbial constituents, and can be formulated as an index for correlating engraftment success with clinical measures of disease. More generally, this method may be applied to clinical evaluation of human microbiomes and provide potential diagnostic determination of individuals who may be candidates for specific therapies directed at alteration of the microbiome.	[Brittnacher, Mitchell J.; Hayden, Hillary S.; Radey, Matthew C.; Weiss, Eli J.; Miller, Samuel I.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Heltshe, Sonya L.; Suskind, David L.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Heltshe, Sonya L.] Seattle Childrens Res Inst, Seattle, WA USA; [Damman, Christopher J.; Zisman, Timothy L.] Univ Washington, Div Gastroenterol, Seattle, WA 98195 USA; [Suskind, David L.] Seattle Childrens Hosp, Seattle, WA USA; [Miller, Samuel I.] Univ Washington, Dept Med, Seattle, WA USA; [Miller, Samuel I.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Miller, Samuel I.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Brittnacher, MJ (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	mbrittna@uw.edu			Kenneth Rainin Foundation [13H7]; Broad Foundation [BMRP 66-4945]; National Institutes of Health, NIDDK grant [P30DK089507-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089507] Funding Source: NIH RePORTER	Kenneth Rainin Foundation; Broad Foundation; National Institutes of Health, NIDDK grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Kenneth Rainin Foundation, grant 13H7, The Broad Foundation, grant BMRP 66-4945 and the National Institutes of Health, NIDDK grant P30DK089507-01 to S.I.M.; The authors thank Lucas Hoffman MD, PhD, Pediatrics Department, University of Washington, for use of fecal microbiome data from young children serving as controls in his pediatric cystic fibrosis study. This work was supported by Kenneth Rainin Foundation, grant 13H7, The Broad Foundation, grant BMRP 66-4945 and the National Institutes of Health, NIDDK grant P30DK089507-01 to S.I.M.	Albertsen M, 2013, NAT BIOTECHNOL, V31, P533, DOI 10.1038/nbt.2579; Angelberger S, 2013, AM J GASTROENTEROL, V108, P1620, DOI 10.1038/ajg.2013.257; Backhed F, 2015, CELL HOST MICROBE, V17, P690, DOI [10.1016/j.chom.2015.04.004, 10.1016/j.chom.2015.05.012]; Baran Y, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002373; Borody TJ, 2012, NAT REV GASTRO HEPAT, V9, P88, DOI 10.1038/nrgastro.2011.244; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Carr R, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003292; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Clarridge JE, 2004, CLIN MICROBIOL REV, V17, P840, DOI 10.1128/CMR.17.4.840-862.2004; Damman CJ, 2012, AM J GASTROENTEROL, V107, P1452, DOI 10.1038/ajg.2012.93; Di Bella JM, 2013, J MICROBIOL METH, V95, P401, DOI 10.1016/j.mimet.2013.08.011; Freitas TAK, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv180; Gao SP D-T, 2015, BMC BIOINFORMATI S15, V16; Gori F, 2011, BIOINFORMATICS, V27, P196, DOI 10.1093/bioinformatics/btq649; Hoffman LR, 2014, CLIN INFECT DIS, V58, P396, DOI 10.1093/cid/cit715; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Jari Oksanen FGB, 2015, R PACKAGE VERSION; Jiang HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046450; Jiang XP, 2012, J MATH BIOL, V64, P697, DOI 10.1007/s00285-011-0428-2; Kump PK, 2013, INFLAMM BOWEL DIS, V19, P2155, DOI 10.1097/MIB.0b013e31829ea325; Landy J, 2015, SCI REP-UK, V5, DOI 10.1038/srep12955; Lawley TD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002995; Legendre P., 2012, NUMERICAL ECOLOGY, V16; Lindner MS, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks803; Liu B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S2-S4; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2013, GENOME RES, V23, P1704, DOI 10.1101/gr.151803.112; Maillet Nicolas, 2014, 2014 IEEE International Conference on Bioinformatics and Biomedicine (BIBM), P94, DOI 10.1109/BIBM.2014.6999135; Maillet N, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S19-S10; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; Martin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036427; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Moayyedi P, 2015, GASTROENTEROLOGY, V149, P102, DOI 10.1053/j.gastro.2015.04.001; Morgan XC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002808; Petrof EO, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-3; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Schloissnig S, 2013, NATURE, V493, P45, DOI 10.1038/nature11711; Seekatz AM, 2014, MBIO, V5, DOI 10.1128/mBio.00893-14; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Sharon I, 2013, GENOME RES, V23, P111, DOI 10.1101/gr.142315.112; Sohn MB, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-242; Song K, 2014, BRIEF BIOINFORM, V15, P343, DOI 10.1093/bib/bbt067; Song Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0081330, 10.1371/journal.pone.0075729]; Suskind DL, 2015, INFLAMM BOWEL DIS, V21, P556, DOI 10.1097/MIB.0000000000000307; Treangen TJ, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r2; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Vermeire S, 2016, J CROHNS COLITIS, V10, P387, DOI 10.1093/ecco-jcc/jjv203; Vinga S, 2003, BIOINFORMATICS, V19, P513, DOI 10.1093/bioinformatics/btg005; Wan L, 2010, J COMPUT BIOL, V17, P1467, DOI 10.1089/cmb.2010.0056; Wang Y, 2012, BIOINFORMATICS, V28, pI356, DOI 10.1093/bioinformatics/bts397; Wang Y, 2012, J COMPUT BIOL, V19, P241, DOI 10.1089/cmb.2011.0276; Weingarden A, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0070-0; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Wu YW, 2011, J COMPUT BIOL, V18, P523, DOI 10.1089/cmb.2010.0245; Yang F, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-136; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yoshioka PM, 2008, MAR ECOL PROG SER, V368, P309, DOI 10.3354/meps07728; Youngster I, 2014, CLIN INFECT DIS, V58, P1515, DOI 10.1093/cid/ciu135; Yue JC, 2005, COMMUN STAT-THEOR M, V34, P2123, DOI 10.1080/STA-200066418	60	8	8	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158897	10.1371/journal.pone.0158897	http://dx.doi.org/10.1371/journal.pone.0158897			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391011	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400156
J	Delaney, JR; Stupack, DG				Delaney, Joe Ryan; Stupack, Dwayne G.			Whole Genome Pathway Analysis Identifies an Association of Cadmium Response Gene Loss with Copy Number Variation in Mutant p53 Bearing Uterine Endometrial Carcinomas	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; MUTATIONAL LANDSCAPE; CARBONIC-ANHYDRASE; METALLOTHIONEIN 1A; CANCER GENOMICS; AUTOPHAGY GENE; MESSENGER-RNA; STRAND BREAKS; COMPLEX; CELLS	Background Massive chromosomal aberrations are a signature of advanced cancer, although the factors promoting the pervasive incidence of these copy number alterations (CNAs) are poorly understood. Gatekeeper mutations, such as p53, contribute to aneuploidy, yet p53 mutant tumors do not always display CNAs. Uterine Corpus Endometrial Carcinoma (UCEC) offers a unique system to begin to evaluate why some cancers acquire high CNAs while others evolve another route to oncogenesis, since about half of p53 mutant UCEC tumors have a relatively flat CNA landscape and half have 20-90% of their genome altered in copy number. Methods We extracted copy number information from 68 UCEC genomes mutant in p53 by the GIS-TIC2 algorithm. GO term pathway analysis, via GOrilla, was used to identify suppressed pathways. Genes within these pathways were mapped for focal or wide distribution. Deletion hotspots were evaluated for temporal incidence. Results Multiple pathways contributed to the development of pervasive CNAs, including developmental, metabolic, immunological, cell adhesion and cadmium response pathways. Surprisingly, cadmium response pathway genes are predicted as the earliest loss events within these tumors: in particular, the metallothionein genes involved in heavy metal sequestration. Loss of cadmium response genes were associated with copy number changes and poorer prognosis, contrasting with 'copy number flat' tumors which instead exhibited substantive mutation. Conclusion Metallothioneins are lost early in the development of high CNA endometrial cancer, providing a potential mechanism and biological rationale for increased incidence of endometrial cancer with cadmium exposure. Developmental and metabolic pathways are altered later in tumor progression.	[Delaney, Joe Ryan; Stupack, Dwayne G.] Rebecca & John UCSD Moores Canc Ctr, Div Gynecol Oncol, Dept Reprod Med, La Jolla, CA USA		Stupack, DG (corresponding author), Rebecca & John UCSD Moores Canc Ctr, Div Gynecol Oncol, Dept Reprod Med, La Jolla, CA USA.	dstupack@ucsd.edu			NCI grants [CA107263, T32CA121938]	NCI grants	This work was supported by NCI grants CA107263 (DGS) and T32CA121938 (JD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JU, 2015, NATURE, V527, pS108, DOI 10.1038/527S108a; Adams SV, 2014, ENVIRON HEALTH PERSP, V122, P594, DOI 10.1289/ehp.1307054; Akesson A, 2008, CANCER RES, V68, P6435, DOI 10.1158/0008-5472.CAN-08-0329; Apostolova MD, 2006, TOXICOL SCI, V89, P465, DOI 10.1093/toxsci/kfj035; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Berger AH, 2011, J PATHOL, V223, P137, DOI 10.1002/path.2800; Burke WM, 2014, GYNECOL ONCOL, V134, P393, DOI 10.1016/j.ygyno.2014.06.003; Cho YA, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075087, 10.1371/journal.pone.0081560]; Choe H, 2002, J MOL BIOL, V324, P691, DOI 10.1016/S0022-2836(02)01131-2; Cline MS, 2013, SCI REP-UK, V3, DOI 10.1038/srep02652; Coddou C, 2005, TOXICOL APPL PHARM, V202, P121, DOI 10.1016/j.taap.2004.06.015; Davoli T, 2013, CELL, V155, P948, DOI 10.1016/j.cell.2013.10.011; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Eriksen KT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100815; Fogal V, 2010, MOL CELL BIOL, V30, P1303, DOI 10.1128/MCB.01101-09; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; GOERING PL, 1984, TOXICOL APPL PHARM, V74, P321, DOI 10.1016/0041-008X(84)90285-0; Guyot E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142590; Haldsrud R, 2009, J TOXICOL ENV HEAL A, V72, P155, DOI 10.1080/15287390802538964; Hartwig A, 2013, METAL IONS LIFE SCI, V11, P491, DOI 10.1007/978-94-007-5179-8_15; Jin YH, 2003, NAT GENET, V34, P326, DOI 10.1038/ng1172; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kawano Y, 2011, GYNECOL OBSTET INVES, V71, P240, DOI 10.1159/000319615; Klaassen CD, 2009, TOXICOL APPL PHARM, V238, P215, DOI 10.1016/j.taap.2009.03.026; Kladney RD, 2010, CANCER RES, V70, P8937, DOI 10.1158/0008-5472.CAN-10-1646; Kracun S, 2010, J BIOL CHEM, V285, P10110, DOI 10.1074/jbc.M109.089185; Larson J, 2010, TOXICOL LETT, V199, P166, DOI 10.1016/j.toxlet.2010.08.020; LEE MJ, 1995, ARCH TOXICOL, V69, P590, DOI 10.1007/s002040050218; Li M, 2010, P NATL ACAD SCI USA, V107, P14188, DOI 10.1073/pnas.1005960107; LITTEFIELD NA, 1994, CELL BIOL TOXICOL, V10, P127, DOI 10.1007/BF00756493; Liu XQ, 2009, CANCER LETT, V286, P217, DOI 10.1016/j.canlet.2009.05.030; Liu Y, 2013, J CELL PHYSIOL, V228, P78, DOI 10.1002/jcp.24108; Liu Y, 2016, NATURE, V531, P471, DOI 10.1038/nature17157; Lohr JG, 2014, CANCER CELL, V25, P91, DOI 10.1016/j.ccr.2013.12.015; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Mudunuri U, 2009, BIOINFORMATICS, V25, P555, DOI 10.1093/bioinformatics/btn654; NATARAJAN AT, 1993, MUTAT RES, V287, P113, DOI 10.1016/0027-5107(93)90150-E; Nordberg M, 2000, CELL MOL BIOL, V46, P451; Pinter TBJ, 2015, BIOCHEM J, V471, P347, DOI 10.1042/BJ20150676; Pinter TBJ, 2014, BIOCHEMISTRY-US, V53, P6276, DOI 10.1021/bi5008673; Prickett TD, 2014, J INVEST DERMATOL, V134, P2390, DOI 10.1038/jid.2014.190; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Quintas-Cardama A, 2009, BLOOD, V113, P1619, DOI 10.1182/blood-2008-03-144790; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Rampias T, 2014, NAT MED, V20, P1199, DOI 10.1038/nm.3678; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sadik NAH, 2008, J BIOCHEM MOL TOXIC, V22, P345, DOI 10.1002/jbt.20247; SHIMADA T, 1976, MUTAT RES, V40, P389, DOI 10.1016/0165-1218(76)90038-0; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Strehl B, 2005, IMMUNOL REV, V207, P19, DOI 10.1111/j.0105-2896.2005.00308.x; Thompson SL, 2010, J CELL BIOL, V188, P369, DOI 10.1083/jcb.200905057; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Wang Z, 1996, TOXICOL APPL PHARM, V139, P115, DOI 10.1006/taap.1996.0149; White E, 2015, J CLIN INVEST, V125, P42, DOI 10.1172/JCI73941; Xue W, 2012, P NATL ACAD SCI USA, V109, P8212, DOI 10.1073/pnas.1206062109; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhang XF, 2013, MOL CELL PROTEOMICS, V12, P3199, DOI 10.1074/mcp.M113.029413; Zhu J, 2007, CANCER CELL, V12, P23, DOI 10.1016/j.ccr.2007.06.004	62	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159114	10.1371/journal.pone.0159114	http://dx.doi.org/10.1371/journal.pone.0159114			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391266	gold, Green Published, Green Submitted			2022-12-27	WOS:000380005400211
J	Ding, XL; Hu, J; Zhang, HY; Xu, YX				Ding, Xiaolin; Hu, Jin; Zhang, Hanying; Xu, Yinxue			Genetic Variants in the STMN1 Transcriptional Regulatory Region Affect Promoter Activity and Fear Behavior in English Springer Spaniels	PLOS ONE			English	Article							SCG10 MESSENGER-RNA; PHYLOGENETIC CONSERVATION; STARTLING STIMULI; STATHMIN FAMILY; BINDING LECTIN; ADULT-RAT; PROTEIN; EXPRESSION; AMYGDALA; ANXIETY	Stathmin 1 (STMN1) is a neuronal growth-associated protein that is involved in microtubule dynamics and plays an important role in synaptic outgrowth and plasticity. Given that STMN1 affects fear behavior, we hypothesized that genetic variations in the STMN1 transcriptional regulatory region affect gene transcription activity and control fear behavior. In this study, two single nucleotide polymorphisms (SNPs), g.-327A > Gand g.-125C > T, were identified in 317 English Springer Spaniels. A bioinformatics analysis revealed that both were loci located in the canine STMN1 putative promoter region and affected transcription factor binding. A statistical analysis revealed that the TT genotype at g.-125C > T produced a significantly greater fear level than that of the CC genotype (P < 0.05). Furthermore, the H4H4 (GTGT) haplotype combination was significantly associated with canine fear behavior (P < 0.01). Using serially truncated constructs of the STMN1 promoters and the luciferase reporter, we found that a 395 bp (-312 nt to + 83 nt) fragment constituted the core promoter region. The luciferase assay also revealed that the H4 (GT) haplotype promoter had higher activity than that of other haplotypes. Overall, our results suggest that the two SNPs in the canine STMN1 promoter region could affect canine fear behavior by altering STMN1 transcriptional activity.	[Ding, Xiaolin; Hu, Jin; Xu, Yinxue] Nanjing Agr Univ, Coll Anim Sci & Technol, Dept Anim Genet Breeding & Reprod, Nanjing, Jiangsu, Peoples R China; [Zhang, Hanying] Nanjing Sanhome Pharmaceut Co LTD, Dept Pharmacol, R&D Ctr, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Xu, YX (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Dept Anim Genet Breeding & Reprod, Nanjing, Jiangsu, Peoples R China.	xuyinxue@njau.edu.cn						Alanentalo T, 2006, GENE EXPR PATTERNS, V6, P162, DOI 10.1016/j.modgep.2005.06.012; Alcaidinho J, 2014, NORD C HUM COMP INT; Araujo JA, 2013, J VET BEHAV, V8, P204, DOI 10.1016/j.jveb.2012.10.008; Banham AH, 2001, CANCER RES, V61, P8820; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; Brauer AU, 2001, NEUROSCIENCE, V102, P515, DOI 10.1016/S0306-4522(00)00471-1; Brocke B, 2010, AM J MED GENET B, V153B, P243, DOI 10.1002/ajmg.b.30989; Capparelli R, 2008, IMMUNOGENETICS, V60, P157, DOI 10.1007/s00251-008-0284-4; Chorley BN, 2008, MUTAT RES-REV MUTAT, V659, P147, DOI 10.1016/j.mrrev.2008.05.001; Conley MJ, 2014, APPL ANIM BEHAV SCI, V156, P62, DOI 10.1016/j.applanim.2014.03.008; Ehlis AC, 2011, AM J MED GENET B, V156B, P291, DOI 10.1002/ajmg.b.31161; Fallin D, 2001, GENOME RES, V11, P143, DOI 10.1101/gr.148401; Ferland RJ, 2003, J COMP NEUROL, V460, P266, DOI 10.1002/cne.10654; Fu Y, 2014, ANIM GENET, V45, P373, DOI 10.1111/age.12148; GODDARD ME, 1985, BEHAV GENET, V15, P69, DOI 10.1007/BF01071933; Gray J.A., 1987, PSYCHOL FEAR STRESS, V2nd, P422; Hafler BP, 2008, BRAIN RES, V1222, P42, DOI 10.1016/j.brainres.2008.04.072; Hayashi K, 2006, J NEUROCHEM, V99, P237, DOI 10.1111/j.1471-4159.2006.04113.x; HOSHINO S, 1992, HUM IMMUNOL, V33, P98, DOI 10.1016/0198-8859(92)90059-V; Hu J, 2015, GENE, V574, P204, DOI 10.1016/j.gene.2015.08.008; Hydbring-Sandberg E, 2004, J ENDOCRINOL, V180, P439, DOI 10.1677/joe.0.1800439; Jones AC, 2005, APPL ANIM BEHAV SCI, V95, P1, DOI 10.1016/j.applanim.2005.04.008; JONES RB, 1992, ANIM BEHAV, V43, P1021, DOI 10.1016/0003-3472(92)90015-2; King T, 2003, APPL ANIM BEHAV SCI, V82, P45, DOI 10.1016/S0168-1591(03)00040-6; KOPPEL J, 1990, J BIOL CHEM, V265, P3703; Ley J, 2007, APPL ANIM BEHAV SCI, V104, P71, DOI 10.1016/j.applanim.2006.03.021; Li SR, 2004, MOL CELL BIOL, V24, P809, DOI 10.1128/MCB.24.2.809-822.2004; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Madsen HO, 1998, J IMMUNOL, V161, P3169; Martel G, 2008, P NATL ACAD SCI USA, V105, P14620, DOI 10.1073/pnas.0807507105; Martel G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030942; MAUCUER A, 1993, J BIOL CHEM, V268, P16420; Morrow M, 2015, J VET BEHAV, V10, P286, DOI 10.1016/j.jveb.2015.03.002; Muhr J, 2001, CELL, V104, P861, DOI 10.1016/S0092-8674(01)00283-5; Ozon S, 1998, J NEUROCHEM, V70, P2386; Ozon S, 1997, EUR J BIOCHEM, V248, P794, DOI 10.1111/j.1432-1033.1997.t01-2-00794.x; Pan Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058795; PESCHANSKI M, 1993, J COMP NEUROL, V337, P655, DOI 10.1002/cne.903370410; Radosta-Huntley L, 2007, APPL ANIM BEHAV SCI, V105, P330, DOI 10.1016/j.applanim.2006.11.005; Ruefenacht S, 2002, APPL ANIM BEHAV SCI, V79, P113, DOI 10.1016/S0168-1591(02)00134-X; Shumyatsky GP, 2005, CELL, V123, P697, DOI 10.1016/j.cell.2005.08.038; Shumyatsky GP, 2002, CELL, V111, P905, DOI 10.1016/S0092-8674(02)01116-9; STEIN R, 1988, NEURON, V1, P463, DOI 10.1016/0896-6273(88)90177-8; Stephenson AH, 2006, LIFE SCI, V79, P1221, DOI 10.1016/j.lfs.2006.03.042; Svartberg K, 2002, APPL ANIM BEHAV SCI, V79, P133, DOI 10.1016/S0168-1591(02)00121-1; Teramitsu I, 2004, J NEUROSCI, V24, P3152, DOI 10.1523/JNEUROSCI.5589-03.2004; Tiira K, 2014, APPL ANIM BEHAV SCI, V155, P82, DOI 10.1016/j.applanim.2014.03.007; van den Berg L, 2004, GENE, V326, P131, DOI 10.1016/j.gene.2003.10.028; Walczak M, 2014, J VET BEHAV, V6, pe13; Wang Xuting, 2005, Toxicol Appl Pharmacol, V207, P84, DOI 10.1016/j.taap.2004.09.024; Wang YL, 1999, J BIOL CHEM, V274, P22095, DOI 10.1074/jbc.274.31.22095; Wang YL, 2001, BIOCHEM J, V355, P45, DOI 10.1042/0264-6021:3550045; Wilsson E, 1998, APPL ANIM BEHAV SCI, V58, P151, DOI 10.1016/S0168-1591(97)00093-2; Wilsson E, 2012, APPL ANIM BEHAV SCI, V141, P158, DOI 10.1016/j.applanim.2012.08.012; Yu SG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131572; Zhang LN, 2015, BIOMED REP, V3, P28, DOI 10.3892/br.2014.386; Zovkic IB, 2013, NEUROPSYCHOPHARMACOL, V38, P77, DOI 10.1038/npp.2012.79	57	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158756	10.1371/journal.pone.0158756	http://dx.doi.org/10.1371/journal.pone.0158756			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27390866	Green Published, gold, Green Submitted			2022-12-27	WOS:000380005400116
J	Gabarre, S; Herrera, A; Ibarz, E; Mateo, J; Gil-Albarova, J; Gracia, L				Gabarre, Sergio; Herrera, Antonio; Ibarz, Elena; Mateo, Jesus; Gil-Albarova, Jorge; Gracia, Luis			Comparative Analysis of the Biomechanical Behaviour of Two Cementless Short Stems for Hip Replacement: Linea Anatomic and Minihip	PLOS ONE			English	Article							PRIMARY STABILITY; FOLLOW-UP; IN-VITRO; MECHANICAL-PROPERTIES; CANCELLOUS BONE; CLINICAL-TRIAL; EBRA-FCA; ARTHROPLASTY; IMPLANTS; PROSTHESIS	A comparative study between two stems (Linea Anatomic and Minihip) has been performed in order to analyse the differences in their biomechanical behaviour, concerning stem micromotions and load transmission between stem and bone. From the corresponding finite element models, a parametric study was carried out to quantify ranges of micromotions taking into account: friction coefficient in the stem-bone interface, press-fit and two types of gait cycle. Micromotions were evaluated for each stem at six different levels along repeated gait cycles. An initial and marked stem subsidence at the beginning of the simulation was observed, followed by an asymptotic decrease due to friction forces. Once migration occurs, a repeated reversible cyclic micromotion is developed and stabilized as gait cycle times are simulated. The general motion pattern exhibited higher amplitude of micromotion for Minihip compared to Linea stem. The load transmission mechanism was analyzed, identifying the main internal forces. The results show higher local forces for Minihip stem up to 80% greater than for Linea stem. The differences of design between Minihip and Linea conditioned different distributions of load, influencing the posterior stress-shielding. Consequently, short stems require high bone stock and quality should, being indicated for young patients with high bone quality.	[Gabarre, Sergio; Ibarz, Elena; Gracia, Luis] Univ Zaragoza, Dept Mech Engn, Zaragoza, Spain; [Gabarre, Sergio; Ibarz, Elena; Gracia, Luis] Aragon Inst Engn Res, Zaragoza, Spain; [Herrera, Antonio; Mateo, Jesus; Gil-Albarova, Jorge] Univ Zaragoza, Dept Surg, Zaragoza, Spain; [Herrera, Antonio; Mateo, Jesus; Gil-Albarova, Jorge] Aragon Hlth Sci Inst, Zaragoza, Spain; [Mateo, Jesus; Gil-Albarova, Jorge] Miguel Servet Univ Hosp, Dept Orthopaed Surg & Traumatol, Zaragoza, Spain	University of Zaragoza; University of Zaragoza; Miguel Servet University Hospital	Herrera, A (corresponding author), Univ Zaragoza, Dept Surg, Zaragoza, Spain.; Herrera, A (corresponding author), Aragon Hlth Sci Inst, Zaragoza, Spain.	antonio.herrera@unizar.es	Ibarz, Elena/ABF-7630-2020; Gil-Albarova, Jorge/AAA-9146-2019; Herrera, Antonio/E-5532-2011; Mateo, Jesús J./AAA-9385-2019	Herrera, Antonio/0000-0001-7877-4733; Mateo, Jesús J./0000-0002-8289-791X; Gabarre, Sergio/0000-0002-2934-1525				Abdul-Kadir MR, 2008, J BIOMECH, V41, P587, DOI 10.1016/j.jbiomech.2007.10.009; Acklin YP, 2016, ARCH ORTHOP TRAUM SU, V136, P277, DOI 10.1007/s00402-015-2401-9; Albers A, 2015, J ARTHROPLASTY; Baharuddin MY, 2014, BMC MUSCULOSKEL DIS; Bergmann gEa, 2013, ORTH DAT BAS LOAD OR; Bieger R, 2013, J ORTHOP RES, V31, P1180, DOI 10.1002/jor.22349; Bieger R, 2012, CLIN BIOMECH, V27, P158, DOI 10.1016/j.clinbiomech.2011.08.004; Carter dr hw, 1977, J BONE JOINT SURG, V59, P954; CHARNLEY J, 1961, LANCET, V1, P1129; Ettinger M, 2011, HIP INT, V21, P583, DOI 10.5301/HIP.2011.8658; Floerkemeier T, 2015, ARCH ORTHOP TRAUM SU, V135, P715, DOI 10.1007/s00402-015-2195-9; Floerkemeier T, 2013, INT ORTHOP, V37, P369, DOI 10.1007/s00264-012-1725-0; Fottner A, 2009, CLIN BIOMECH, V24, P429, DOI 10.1016/j.clinbiomech.2009.02.007; Freitag T KT, 2014, ARCH ORTHOP TRAUMA S, V84, P32; Freitag T, 2016, ARCH ORTHOP TRAUM SU, V136, P125, DOI 10.1007/s00402-015-2370-z; Gustke K, 2012, J BONE JOINT SURG BR, V94B, P47, DOI 10.1302/0301-620X.94B11.30677; Harris WH, 2009, CLIN ORTHOP RELAT R, V467, P28, DOI 10.1007/s11999-008-0467-1; Jasty M, 1997, J BONE JOINT SURG AM, V79A, P707, DOI 10.2106/00004623-199705000-00010; Kadir MRA, 2008, IFMBE PROC, V21, P428; Kim YH, 2014, CLIN ORTHOP RELAT R, V472, P943, DOI 10.1007/s11999-013-3354-3; Kim YH, 2013, INT ORTHOP, V37, P2323, DOI 10.1007/s00264-013-2044-9; Kim YH, 2011, J ARTHROPLASTY, V26, P931, DOI 10.1016/j.arth.2010.10.001; Kobayashi A, 1997, J BONE JOINT SURG BR, V79B, P583, DOI 10.1302/0301-620X.79B4.7210; Kress AM, 2012, ARCH ORTHOP TRAUM SU, V132, P1111, DOI 10.1007/s00402-012-1537-0; Krismer M, 1999, J BONE JOINT SURG BR, V81B, P273, DOI 10.1302/0301-620X.81B2.8840; Lazarinis S, 2013, ACTA ORTHOP, V84, P32, DOI 10.3109/17453674.2013.765623; Lerch M, 2013, TECHNOL HEALTH CARE, V21, P493, DOI 10.3233/THC-130743; Lerch M, 2012, J ORTHOP RES, V30, P1822, DOI 10.1002/jor.22120; Logroscino G, 2011, INT J IMMUNOPATH PH, V24, P113, DOI 10.1177/03946320110241S221; LOTZ JC, 1991, J BIOMECH, V24, P317, DOI 10.1016/0021-9290(91)90350-V; Maier MW, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0830-9; McElroy MJ, 2011, BULL HOSP JT DIS, V69, pS68; Molli RG, 2012, CLIN ORTHOP RELAT R, V470, P450, DOI 10.1007/s11999-011-2068-7; Monea AG, 2014, COMPUT METHOD BIOMEC, V17, P263, DOI 10.1080/10255842.2012.681644; Nho SJ, 2013, J AM ACAD ORTHOP SUR, V21, pS1, DOI 10.5435/JAAOS-21-07-S1; Ostbyhaug PO, 2013, P I MECH ENG H, V227, P481, DOI 10.1177/0954411912471779; Patel RM, 2012, CLIN ORTHOP RELAT R, V470, P442, DOI 10.1007/s11999-011-2063-z; RANCOURT D, 1990, J BIOMED MATER RES, V24, P1503, DOI 10.1002/jbm.820241107; Renkawitz T, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-147; RHO JY, 1995, MED ENG PHYS, V17, P347, DOI 10.1016/1350-4533(95)97314-F; Ruben RB, 2006, VIRTUAL PHYS PROTOTY, V1, P147, DOI 10.1080/17452750600942285; Salemyr M, 2015, ACTA ORTHOP, V86, P659, DOI 10.3109/17453674.2015.1067087; Schmidutz F, 2012, ACTA ORTHOP, V83, P360, DOI 10.3109/17453674.2012.712891; Schmidutz F, 2012, INT ORTHOP, V36, P1767, DOI 10.1007/s00264-012-1532-7; Schmidutz F, 2012, INT ORTHOP, V36, P1341, DOI 10.1007/s00264-011-1477-2; Schmidutz F, 2012, AM J SPORT MED, V40, P425, DOI 10.1177/0363546511424386; SHIRAZIADL A, 1993, J BIOMED MATER RES, V27, P167, DOI 10.1002/jbm.820270205; Spears IR, 1999, J BIOMECH, V32, P1183, DOI 10.1016/S0021-9290(99)00121-9; Thorey F, 2013, ORTHOP REV, V5, P147, DOI 10.4081/or.2013.e34; van Oldenrijk J, 2014, ACTA ORTHOP, V85, P250, DOI 10.3109/17453674.2014.908343; Viceconti M, 2000, J BIOMECH, V33, P1611, DOI 10.1016/S0021-9290(00)00140-8; Viceconti M, 2006, J BIOMECH, V39, P1169, DOI 10.1016/j.jbiomech.2005.03.024; von Lewinski G, 2015, ORTHOPEDICS, V38, pS51, DOI 10.3928/01477447-20150215-57; Westphal FM, 2006, CLIN BIOMECH, V21, P834, DOI 10.1016/j.clinbiomech.2006.04.004; Wittenberg RH, 2013, ORTHOP REV, V5, P16, DOI 10.4081/or.2013.e4	55	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158411	10.1371/journal.pone.0158411	http://dx.doi.org/10.1371/journal.pone.0158411			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391328	Green Published, gold, Green Submitted			2022-12-27	WOS:000380005400056
J	Hu, KM; Lou, LX; Tian, W; Pan, T; Ye, J; Zhang, SZ				Hu, Kaimin; Lou, Lixia; Tian, Wei; Pan, Tao; Ye, Juan; Zhang, Suzhan			The Outcome of Breast Cancer Is Associated with National Human Development Index and Health System Attainment	PLOS ONE			English	Article							MORTALITY-RATES; PATTERNS	Breast cancer is a worldwide threat to female health with patient outcomes varying widely. The exact correlation between global outcomes of breast cancer and the national socioeconomic status is still undetermined. Mortality-to-incidence ratio (MIR) of breast cancer was calculated with the contemporary age standardized incidence and mortality rates for countries with data available at GLOBOCAN 2012 database. The MIR matched national human development indexes (HDIs) and health system attainments were respectively obtained from Human Development Report and World Health Report. Correlation analysis, regression analysis, and Tukey-Kramer post hoc test were used to explore the effects of HDI and health system attainment on breast cancer MIR. Our results demonstrated that breast cancer MIR was inversely correlated with national HDI (r = -.950; P < .001) and health system attainment (r = -.898; P < .001). Countries with very high HDI had significantly lower MIRs than those with high, medium and low HDI (P < .001). Liner regression model by ordinary least squares also indicated negative effects of both HDI (adjusted R-2 = .903, standardize beta = -.699, P < .001) and health system attainment (adjusted R-2 = .805, standardized beta = -.009; P < .001), with greater effects in developing countries identified by quantile regression analysis. It is noteworthy that significant health care disparities exist among countries in accordance with the discrepancy of HDI. Policies should be made in less developed countries, which are more likely to obtain worse outcomes in female breast cancer, that in order to improve their comprehensive economic strength and optimize their health system performance.	[Hu, Kaimin; Tian, Wei; Pan, Tao; Zhang, Suzhan] Zhejiang Univ, Coll Med, Affiliated Hosp 2, Inst Canc, Hangzhou, Zhejiang, Peoples R China; [Lou, Lixia; Ye, Juan] Zhejiang Univ, Coll Med, Affiliated Hosp 2, Dept Ophthalmol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Zhang, SZ (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 2, Inst Canc, Hangzhou, Zhejiang, Peoples R China.	zhangscy@tom.com			Zhejiang Provincial Natural Science Foundation of China [LQ13H160015, LQ14H160010]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	The work was supported by Zhejiang Provincial Natural Science Foundation of China (LQ13H160015 and LQ14H160010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althuis MD, 2005, INT J EPIDEMIOL, V34, P405, DOI 10.1093/ije/dyh414; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Corbex M, 2014, EUR J CANCER, V50, P1808, DOI 10.1016/j.ejca.2014.03.016; Coughlin SS, 2009, CANCER EPIDEMIOL, V33, P315, DOI 10.1016/j.canep.2009.10.003; de Kruijf EM, 2014, MOL ONCOL, V8, P1014, DOI 10.1016/j.molonc.2014.03.022; DeSantis C, 2014, CA-CANCER J CLIN, V64, P52, DOI 10.3322/caac.21203; DeSantis CE, 2015, CANCER EPIDEM BIOMAR, V24, P1495, DOI 10.1158/1055-9965.EPI-15-0535; El Mistiri M, 2015, ANN EPIDEMIOLOGY; GLOBOCAN, 2012, EST CANC INC MORT PR; Gonzaga CMR, 2014, BREAST, V23, P180, DOI 10.1016/j.breast.2014.01.006; Institute NC, 1975, SEER CANC STAT REV; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Kantelhardt EJ, 2015, CURR OPIN OBSTET GYN, V27, P108, DOI 10.1097/GCO.0000000000000139; Katzke VA, 2015, CANCER J, V21, P104, DOI 10.1097/PPO.0000000000000101; KOENKER R, 1978, ECONOMETRICA, V46, P33, DOI 10.2307/1913643; Lauby-Secretan B, 2015, NEW ENGL J MED, V372, P2353, DOI 10.1056/NEJMsr1504363; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; Pace LE, 2014, JAMA-J AM MED ASSOC, V311, P1327, DOI 10.1001/jama.2014.1398; Patel AR, 2012, J UROLOGY, V187, P1978, DOI 10.1016/j.juro.2012.01.121; PINNEAU SR, 1966, PERCEPT MOTOR SKILL, V23, P1209, DOI 10.2466/pms.1966.23.3f.1209; Programme UND, HUM DEV REP 2013 RIS; ROSENTHAL R, 1968, PSYCHOL REP, V22, P570, DOI 10.2466/pr0.1968.22.2.570; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Swan J, 2003, CANCER, V97, P1528, DOI 10.1002/cncr.11208; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; TUKEY JW, 1949, BIOMETRICS, V5, P99, DOI 10.2307/3001913; Vostakolaei FA, 2011, EUR J PUBLIC HEALTH, V21, P573, DOI 10.1093/eurpub/ckq120; World Health Organization, 2000, WORLD HLTH REP 2000	30	12	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158951	10.1371/journal.pone.0158951	http://dx.doi.org/10.1371/journal.pone.0158951			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27391077	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400170
J	Lee, JE; Yang, HK; Hwang, JM				Lee, Ji Eun; Yang, Hee Kyung; Hwang, Jeong-Min			Surgical Outcomes of Inferior Oblique Myectomy in Unilateral Congenital Superior Oblique Palsy with or without Trochlear Nerve	PLOS ONE			English	Article							MUSCLE MYECTOMY; RECESSION; SURGERY	Objectives To compare the surgical outcomes of inferior oblique (IO) myectomy in congenital superior oblique palsy (SOP) according to the presence of the trochlear nerve identified with high-resolution MRI. Data Extraction Forty-one congenital SOP patients without a trochlear nerve (absent group) and 23 patients with a trochlear nerve (present group) who underwent IO myectomy as the primary surgical treatment were retrospectively reviewed. "Motor success" was defined as postoperative ipsilateral hypertropia <= 4 prism diopter (PD). "Head tilt improvement" was regarded as postoperative angle of head tilt < 5 degrees (degrees). Success rates for motor alignment and head tilt improvement, cumulative probabilities of success, and factors influencing surgical responses were evaluated. Results The cumulative probabilities of motor success at 2 years after IO myectomy were 92% in patients with a trochlear nerve and 86% in patients without a trochlear nerve (P = 0.138). The cumulative probabilities of undercorrection and recurrence of hypertropia after 2 years were 0% in the present group versus 21% in the absent group (P = 0.014). The cumulative probabilities of persistent head tilt after 2 years were 14% in the present group and 20% in the absent group (P = 0.486). A younger age at operation was associated with reduced probabilities of motor success and head tilt improvement (P = 0.009, P = 0.022 respectively). A greater preoperative angle of head tilt was associated with persistent head tilt after surgery (P = 0.038). Conclusions Congenital SOP without a trochlear nerve had a higher risk of hypertropia undercorrection after IO myectomy compared to patients with a trochlear nerve. A younger age at operation and larger preoperative head tilt was related to poor outcomes.	[Lee, Ji Eun; Yang, Hee Kyung; Hwang, Jeong-Min] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Ophthalmol, Seongnam, South Korea	Seoul National University (SNU)	Hwang, JM (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Ophthalmol, Seongnam, South Korea.	hjm@snu.ac.kr						Ashishi M, 1999, CLIN STRABISMUS MANA, P19; Bahl RS, 2013, BRIT J OPHTHALMOL, V97, P184, DOI 10.1136/bjophthalmol-2012-301485; Caca I, 2012, J PEDIAT OPHTH STRAB, V49, P103, DOI 10.3928/01913913-20110628-01; Choi BS, 2010, AM J NEURORADIOL, V31, P1076, DOI 10.3174/ajnr.A1992; De Angelis D, 1999, AM J OPHTHALMOL, V128, P485, DOI 10.1016/S0002-9394(99)00225-1; ELLIS F D, 1976, International Ophthalmology Clinics, V16, P127, DOI 10.1097/00004397-197601630-00012; Ellis FJ, 1998, OPHTHALMOLOGY, V105, P544, DOI 10.1016/S0161-6420(98)93041-X; Ghazawy S, 2007, J AAPOS, V11, P601, DOI 10.1016/j.jaapos.2007.06.011; GUYTON DL, 1981, OPHTHALMOLOGY, V88, P1035; Helveston E M, 1996, Trans Am Ophthalmol Soc, V94, P315; Isenberg SJ, 1999, CLIN STRABISMUS MANA, P453; Khawam E, 2000, Binocul Vis Strabismus Q, V15, P331; Kim JH, 2012, GRAEF ARCH CLIN EXP, V250, P151, DOI 10.1007/s00417-010-1580-x; Kim JH, 2010, OPHTHALMOLOGY, V117, P2208, DOI 10.1016/j.ophtha.2010.02.017; Kim JH, 2010, BRIT J OPHTHALMOL, V94, P346, DOI 10.1136/bjo.2009.161398; Knapp P, 1971, Am Orthopt J, V21, P29; KNAPP P, 1976, International Ophthalmology Clinics, V16, P137, DOI 10.1097/00004397-197601630-00013; Kushner BJ, 2009, J AAPOS, V13, P132, DOI 10.1016/j.jaapos.2008.10.012; Lau FHS, 2009, BRIT J OPHTHALMOL, V93, P1616, DOI 10.1136/bjo.2008.156687; Lee DS, 2014, INVEST OPHTH VIS SCI, V55, P8571, DOI 10.1167/iovs.14-15323; Maruo T, 1996, JPN J OPHTHALMOL, V40, P235; Molinari A, 2009, J AAPOS, V13, P571, DOI 10.1016/j.jaapos.2009.08.015; Muchnick R S, 1998, J AAPOS, V2, P340, DOI 10.1016/S1091-8531(98)90031-3; REYNOLDS JD, 1984, ARCH OPHTHALMOL-CHIC, V102, P1503; Scott W E, 1986, Trans New Orleans Acad Ophthalmol, V34, P15; Shipman T, 2003, EYE, V17, P1013, DOI 10.1038/sj.eye.6700488; Simons B D, 1998, Binocul Vis Strabismus Q, V13, P273; TOOSI SH, 1979, AM J OPHTHALMOL, V88, P602, DOI 10.1016/0002-9394(79)90522-1; Yang HK, 2012, OPHTHALMOLOGY, V119, P170, DOI 10.1016/j.ophtha.2011.06.038; Yanyali A, 2001, Strabismus, V9, P83, DOI 10.1076/stra.9.2.83.702; 안재환, 2010, [Journal of The Korean Ophthalmological Society, 대한안과학회지], V51, P76	31	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0156872	10.1371/journal.pone.0156872	http://dx.doi.org/10.1371/journal.pone.0156872			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391445	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400005
J	Li, JL; Zhou, P; Li, L; Zhang, Y; Shao, Y; Tang, L; Tian, SM				Li, Jiale; Zhou, Ping; Li, Lan; Zhang, Yan; Shao, Yang; Tang, Li; Tian, Shuangming			Effects of Cationic Microbubble Carrying CD/TK Double Suicide Gene and alpha(V)beta(3) Integrin Antibody in Human Hepatocellular Carcinoma HepG2 Cells	PLOS ONE			English	Article							IN-VIVO; ULTRASOUND DESTRUCTION; NEUTRAL MICROBUBBLES; CANCER-THERAPY; DELIVERY; ANGIOGENESIS; TRANSFECTION; LIVER; APOPTOSIS; DISEASES	Objective Hepatocellular carcinoma (HCC), mostly derived from hepatitis or cirrhosisis, is one of the most common types of liver cancer. T-cell mediated immune response elicited by CD/TK double suicide gene has shown a substantial antitumor effect in HCC. Integrin alpha(V)beta(3) over expresssion has been suggested to regulate the biology behavior of HCC. In this study, we investigated the strategy of incorporating CD/TK double suicide gene and anti-alpha(V)beta(3) integrin monoclonal antibodies into cationic microbubbles (CMBs(alpha v beta 3)), and evaluated its killing effect in HCC cells. Methods To improve the transfection efficiency of targeted CD/TK double suicide gene, we adopted cationic microbubbles (CMBs), a cationic delivery agent with enhanced DNA-carrying capacity. The ultrasound and high speed shearing method was used to prepare the non-targeting cationic microbubbles (CMBs). Using the biotin-avidin bridge method, alpha(V)beta(3) integrin antibody was conjugated to CMBs, and CMBs(av beta 3) was generated to specifically target to HepG2 cells. The morphology and physicochemical properties of the CMBs(alpha v beta 3) was detected by optical microscope and zeta detector. The conjugation of plasmid and the antibody in CMBs(alpha v beta 3) were examined by immunofluorescent microscopy and flow cytometry. The binding capacities of CMBs(alpha v beta 3) and CMBs to HCC HepG2 and normal L-02 cells were compared using rosette formation assay. To detect EGFP fluorescence and examine the transfection efficiencies of CMBs(alpha v beta 3) and CMBs in HCC cells, fluorescence microscope and contrast-enhanced sonography were adopted. mRNA and protein level of CD/TK gene were detected by RT-PCR and Western blot, respectively. To evaluate the anti-tumor effect of CMBs(alpha v beta 3), HCC cells with CMBs(alpha v beta 3) were exposed to 5-flurocytosine / ganciclovir (5-FC/GCV). Then, cell cycle distribution after treatment were detected by PI staining and flow cytometry. Apoptotic cells death were detected by optical microscope and assessed by MTT assay and TUNEL-staining assay. Results CMBs(alpha v beta 3) had a regular shape and good dispersion. Compared to CMBs, CMBs(alpha v beta 3) had more stable concentrations of alpha(V)beta(3) ligand and pEGFP-KDRP-CD/TK, and CMBs(alpha v beta 3) was much sticker to HepG2 HCC cells than normal liver L-02cells. Moreover, after exposed to anti-alpha(V)beta(3) monoclonal antibody, the adhesion of CMBs(alpha v beta 3) to HepG2 cells and L-02 cells were significantly reduced. Also, CMBs(alpha v beta 3) demonstrated a substantially higher efficiency in pEGFP-KDRP-CD/TK plasmid transfection in HepG2 cells than CMBs. In addition, CMBs(alpha v beta 3) could significantly facilitate 5-FC/GCV-induced cell cycle arrest in S phase. Moreover, treatment of 5-FC/GCV combined with CMBs(alpha v beta 3) resulted in a marked apoptotic cell death in HepG2 and SK-Herp-1 HCC cells. In vitro, treatment of 5-FC/GCV combined with CMBs(alpha v beta 3) suppresed cell proliferation. In nude mice model, 5-FU + GCV combined with plasmid + CMBs(alpha v beta 3) were able to significantly suppress tumor volumes. Conclusion Through biotin-avidinmediation system, CMBs(alpha v beta 3) were successfully generated to specifically target HCC HepG2 cells. More importantly, CMBs(alpha v beta 3) could significantly facilitate 5-FC/GCV-induced cell cycle arrest and apoptotic cell death in HepG2 cells. Our study demonstrated a potential strategy that could be translated clinically to improve liver tumor gene delivery.	[Li, Jiale; Zhou, Ping; Li, Lan; Zhang, Yan; Shao, Yang; Tian, Shuangming] Cent S Univ, Xiangya Hosp 3, Dept Ultrasound, Changsha, Hunan, Peoples R China; [Tang, Li] Corp Pk Doral, MDFLOW Syst, Doral, FL USA	Central South University	Zhou, P (corresponding author), Cent S Univ, Xiangya Hosp 3, Dept Ultrasound, Changsha, Hunan, Peoples R China.	zhouping1000@hotmail.com	li, jia/GVT-7587-2022		National Natural Science Foundation of China [81271680]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from National Natural Science Foundation of China (81271680) and PZ received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Our work was funded by a grant from National Natural Science Foundation of China (81271680) and PingZhou received the funding.And PingZhou was the person making decisions to publish.	Barry MA, 2009, CURR OPIN MOL THER, V11, P411; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chang SF, 2013, ULTRASON SONOCHEM, V20, P171, DOI 10.1016/j.ultsonch.2012.06.015; Christiansen JP, 2003, ULTRASOUND MED BIOL, V29, P1759, DOI 10.1016/S0301-5629(03)00976-1; Cui K, 2014, DNA CELL BIOL, V33, P301, DOI 10.1089/dna.2013.2229; Fujii H, 2011, EUR HEART J, V32, P2075, DOI 10.1093/eurheartj/ehq475; Gao Feng, 2009, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V34, P1255; Gao Y, 2011, INT J NANOMED, V6, P1017, DOI 10.2147/IJN.S17040; Hu ZY, 2008, INT J CANCER, V123, P2418, DOI 10.1002/ijc.23752; Kluza E, 2010, NANO LETT, V10, P52, DOI 10.1021/nl902659g; Kojima Y, 2009, J SURG RES, V157, pE63, DOI 10.1016/j.jss.2008.12.016; Li QM, 2002, WORLD J GASTROENTERO, V8, P994; Li XH, 2012, ULTRASONICS, V52, P186, DOI 10.1016/j.ultras.2011.08.002; Lindner JR, 2000, CIRCULATION, V102, P2745, DOI 10.1161/01.CIR.102.22.2745; Panje CM, 2012, THERANOSTICS, V2, P1078, DOI 10.7150/thno.4240; Phillips LC, 2010, J VASC RES, V47, P270, DOI 10.1159/000258905; Pralhad T, 2003, J PHARM PHARMACOL, V55, P1045, DOI 10.1211/0022357021819; Sheldrake HM, 2009, CURR CANCER DRUG TAR, V9, P519, DOI 10.2174/156800909788486713; Song S, 2011, GENE THER, V18, P1006, DOI 10.1038/gt.2011.34; Sun L, 2013, BIOMATERIALS, V34, P2107, DOI 10.1016/j.biomaterials.2012.11.041; Suzuki J, 2010, J AM COLL CARDIOL, V55, P904, DOI 10.1016/j.jacc.2009.09.054; Touraine RL, 1998, HUM GENE THER, V9, P2385, DOI 10.1089/hum.1998.9.16-2385; Vassaux G, 2004, EXPERT OPIN BIOL TH, V4, P519; Villanueva FS, 1998, CIRCULATION, V98, P1, DOI 10.1161/01.CIR.98.1.1; Vongchan P, 2011, ANTICANCER RES, V31, P4067; Wang DS, 2012, RADIOLOGY, V264, P721, DOI 10.1148/radiol.12112368; Wei KR, 2014, CHIN J CANCER, V33, P388, DOI 10.5732/cjc.014.10088; Willmann JK, 2008, RADIOLOGY, V248, P936, DOI 10.1148/radiol.2483072231; Xu G, 2001, CLIN CANCER RES, V7, P3314	30	12	17	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158592	10.1371/journal.pone.0158592	http://dx.doi.org/10.1371/journal.pone.0158592			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391603	Green Submitted, gold, Green Published			2022-12-27	WOS:000380005400084
J	Petrushanko, IY; Lobachev, VM; Kononikhin, AS; Makarov, AA; Devred, F; Kovacic, H; Kubatiev, AA; Tsvetkov, PO				Petrushanko, Irina Yu; Lobachev, Vladimir M.; Kononikhin, Alexey S.; Makarov, Alexander A.; Devred, Francois; Kovacic, Herve; Kubatiev, Aslan A.; Tsvetkov, Philipp O.			Oxidation of Ca2+-Binding Domain of NADPH Oxidase 5 (NOX5): Toward Understanding the Mechanism of Inactivation of NOX5 by ROS	PLOS ONE			English	Article							METHIONINE RESIDUES; TARGET-SITE; CALMODULIN; BINDING; CALCIUM; PROTEIN; ANTIOXIDANTS; CALORIMETRY; PEPTIDE; DISEASE	NOX5 protein, one of the most active generators of reactive oxygen species (ROS), plays an important role in many processes, including regulation of cell growth, death and differentiation. Because of its central role in ROS generation, it needs to be tightly regulated to guarantee cellular homeostasis. Contrary to other members of NADPH-oxidases family, NOX5 has its own regulatory calcium-binding domain and thus could be activated directly by calcium ions. While several mechanisms of activation have been described, very little is known about the mechanisms that could prevent the overproduction of ROS by NOX5. In the present study using calorimetric methods and circular dichroism we found that oxidation of cysteine and methionine residues of NOX5 decreases binding of Ca2+ ions and perturbs both secondary and tertiary structure of protein. Our data strongly suggest that oxidation of calcium-binding domain of NOX5 could be implicated in its inactivation, serving as a possible defense mechanism against oxidative stress.	[Petrushanko, Irina Yu; Lobachev, Vladimir M.; Makarov, Alexander A.] Russian Acad Sci, Engelhardt Inst Mol Biol, Vavilov St 32, Moscow 119991, Russia; [Kononikhin, Alexey S.] Moscow Inst Phys & Technol, Dolgoprudnyi 141700, Moscow Region, Russia; [Devred, Francois; Kovacic, Herve; Tsvetkov, Philipp O.] Aix Marseille Univ, INSERM, UMR S CRO2 911, Fac Pharm, F-13385 Marseille, France; [Kubatiev, Aslan A.; Tsvetkov, Philipp O.] RAMS, Inst Gen Pathol & Pathophysiol, Moscow 125315, Russia	Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Moscow Institute of Physics & Technology; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Russian Academy of Medical Sciences; Institute of General Pathology & Pathophysiology, RAMS	Tsvetkov, PO (corresponding author), Aix Marseille Univ, INSERM, UMR S CRO2 911, Fac Pharm, F-13385 Marseille, France.; Tsvetkov, PO (corresponding author), RAMS, Inst Gen Pathol & Pathophysiol, Moscow 125315, Russia.	philipp.tsvetkov@univ-amu.fr	Kubatiev, Aslan/AAF-8186-2021; kovacic, hervé/ABF-2451-2020; Makarov, Alexander/P-5279-2016; Kononikhin, Alexey/L-3171-2013; Devred, Francois/AAO-6337-2020	Devred, Francois/0000-0001-5990-8898	Russian Science Foundation [14-14-01152]; European Union [627524]	Russian Science Foundation(Russian Science Foundation (RSF)); European Union(European Commission)	The analysis of alpha-helical content and thermal denaturation of NOX5-EF as well as analysis of NOX5-EF oxidation level were supported by the Russian Science Foundation (grant #14-14-01152). Funding was also provided by European Union Seventh Framework Programme [FP7/2007-2013] Marie Curie Actions FP7-PEOPLE-2013-IIF#627524 (http://ec.europa.eu/research/participants/portal/desktop/en/opportunities/fp7/calls/fp7-people-2013-iif.html) for data analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research leading to these results has received funding from the European Union Seventh Framework Programme [FP7/2007-2013] under Grant Agreement FIT no627524. The analysis of alpha-helical content and thermal denaturation of NOX5-EF as well as analysis of NOX5-EF oxidation level were supported by the Russian Science Foundation (grant #14-14-01152). We would like to thank Dr. Svetlana Gorokhova for helpful discussions and Dr. Jos Cox for providing plasmid for protein purification. Microcalorimetry experiments were performed in Timone Microcalorimetry Platform, Marseille.	Audran E, 2013, BBA-MOL CELL RES, V1833, P1720, DOI 10.1016/j.bbamcr.2013.01.008; Baladi S, 2001, PROTEIN SCI, V10, P771, DOI 10.1110/ps.40601; Banfi B, 2004, J BIOL CHEM, V279, P18583, DOI 10.1074/jbc.M310268200; Banfi B, 2001, J BIOL CHEM, V276, P37594, DOI 10.1074/jbc.M103034200; Bedard K, 2012, FREE RADICAL BIO MED, V52, P725, DOI 10.1016/j.freeradbiomed.2011.11.023; Brar SS, 2003, AM J PHYSIOL-CELL PH, V285, pC353, DOI 10.1152/ajpcell.00525.2002; Chen F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088405; Doroshow JH, 2014, NAT REV CLIN ONCOL, V11, P649, DOI 10.1038/nrclinonc.2014.158; El Jamali A, 2008, FREE RADICAL BIO MED, V44, P868, DOI 10.1016/j.freeradbiomed.2007.11.020; Fulton DJR, 2009, ANTIOXID REDOX SIGN, V11, P2443, DOI [10.1089/ars.2009.2587, 10.1089/ARS.2009.2587]; Garnier C, 1998, BIOCHEM BIOPH RES CO, V249, P197, DOI 10.1006/bbrc.1998.9108; Hill TJ, 2000, BIOCHEMISTRY-US, V39, P7284, DOI 10.1021/bi000139m; Indeykina MI, 2011, ANAL CHEM, V83, P3205, DOI 10.1021/ac103213j; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Kalyanaraman B, 2013, REDOX BIOL, V1, P244, DOI 10.1016/j.redox.2013.01.014; Kawahara T, 2011, BIOCHEMISTRY-US, V50, P2013, DOI 10.1021/bi1020088; Krause KH, 2004, JPN J INFECT DIS, V57, pS28; Lafitte D, 2002, BBA-PROTEINS PROTEOM, V1600, P105, DOI 10.1016/S1570-9639(02)00450-8; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Liang XW, 2012, BMC BIOCHEM, V13, DOI 10.1186/1471-2091-13-21; Roman AY, 2016, CAN J MICROBIOL, V62, P123, DOI 10.1139/cjm-2015-0580; Schulz E, 2008, J AM COLL CARDIOL, V52, P1810, DOI 10.1016/j.jacc.2008.08.040; Thomson J.A., 2004, BIOCALORIMETRY, P35; Tirone F, 2007, FEBS LETT, V581, P1202, DOI 10.1016/j.febslet.2007.02.047; Tirone F, 2010, BIOCHEMISTRY-US, V49, P761, DOI 10.1021/bi901846y; Tsvetkov F O, 2010, Mol Biol (Mosk), V44, P938; Tsvetkov PO, 1999, J BIOL CHEM, V274, P18161, DOI 10.1074/jbc.274.26.18161; Tsvetkov PO, 2005, BIOCHIMIE, V87, P473, DOI 10.1016/j.biochi.2004.11.020; Tsvetkov PO, PROTEIN SEQUENCE ANA; Van Patten SM, 1999, J BIOL CHEM, V274, P10268, DOI 10.1074/jbc.274.15.10268; Weyemi U, 2015, RADIAT RES, V183, P262, DOI 10.1667/RR13799.1; Ziyarat FP, 2014, J BIOMOL STRUCT DYN, V32, P613, DOI 10.1080/07391102.2013.785919	32	22	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158726	10.1371/journal.pone.0158726	http://dx.doi.org/10.1371/journal.pone.0158726			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391469	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400109
J	Wang, SS; Lei, T; Zhang, M				Wang, Shanshan; Lei, Ting; Zhang, Man			The Reversal Effect and Its Mechanisms of Tetramethylpyrazine on Multidrug Resistance in Human Bladder Cancer	PLOS ONE			English	Article							P-GLYCOPROTEIN; EPIGALLOCATECHIN GALLATE; CISPLATIN RESISTANCE; DRUG-RESISTANCE; MOLECULAR-MECHANISMS; GINSENOSIDE RH-2; PROTEIN MRP; EXPRESSION; CELLS; INHIBITION	Chemotherapy is an important strategy for the treatment of bladder cancer. However, the main problem limiting the success of chemotherapy is the development of multidrug resistance (MDR). To improve the management of bladder cancer, it is an urgent matter to search for strategies to reverse MDR. We chose three kinds of herbal medicines including ginsenoside Rh2, (-)-Epigallocatechin gallate (EGCG) and Tetramethylpyrazine (TMP) to detect their effects on bladder cancer. Reversal effects of these three herbal medicines for drug resistance in adriamycin (ADM)-resistant Pumc-91 cells (Pumc-91/ADM) were assessed by Cell Counting Kit-8 (CCK-8) cell proliferation assay system. The mechanisms of reversal effect for TMP were explored in Pumc-91/ADM and T24/DDP cells. After Pumc91/ADM and T24/DDP cells were treated with TMP, cell cycle distribution analysis was performed by flow cytometry. The expression of MRP1, GST, BCL-2, LRP and TOPO-II was evaluated using quantitative real-time polymerase chain reaction (qRT-PCR), immunefluorescence assay and western blot. It was observed that TMP was capable of enhancing the cytotoxicity of anticancer agents on Pumc-91/ADM cells in response to ADM, however Rh2 and EGCG were unable to. The reversal effect of TMP was also demonstrated in T24/DDP cells. Moreover, the treatment with TMP in Pumc-91/ADM and T24/DDP cells led to an increased of G1 phase accompanied with a concomitant decrease of cell numbers in S phase. Compared to the control group, an obvious decrease of MRP1, GST, BCL-2 and an increase of TOPO-II were shown in TMP groups with a dose-dependency in mRNA and protein levels. However, there was no difference on LRP expression between TMP groups and the control group. TMP could effectively reverse MDR of Pumc-91/ADM and T24/DDP cells and its mechanisms might be correlated with the alteration of MRP1, GST, BCL-2 and TOPO-II. TMP might be a potential candidate for reversing drug resistance in bladder cancer chemotherapy.	[Wang, Shanshan; Lei, Ting; Zhang, Man] Capital Med Univ, Beijing Shijitan Hosp, Clin Lab Med, Beijing, Peoples R China; [Wang, Shanshan; Lei, Ting; Zhang, Man] Beijing Key Lab Urinary Cellular Mol Diagnost, Beijing, Peoples R China	Capital Medical University	Zhang, M (corresponding author), Capital Med Univ, Beijing Shijitan Hosp, Clin Lab Med, Beijing, Peoples R China.; Zhang, M (corresponding author), Beijing Key Lab Urinary Cellular Mol Diagnost, Beijing, Peoples R China.	mzhang99@aliyun.com			Beijing Administration of traditional Chinese medical [2014-ZYJ04]; Beijing Key Laboratory of Urinary Cellular Molecular Diagnostics [Z151100001615060]	Beijing Administration of traditional Chinese medical; Beijing Key Laboratory of Urinary Cellular Molecular Diagnostics	This study was funded by Beijing Administration of traditional Chinese medical (2014-ZYJ04) and Beijing Key Laboratory of Urinary Cellular Molecular Diagnostics (Z151100001615060). Man Zhang received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by Beijing Administration of traditional Chinese medical (2014-ZYJ04) and Beijing Key Laboratory of Urinary Cellular Molecular Diagnostics (Z151100001615060).	Arantes-Rodrigues R, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/791406; Atkins CD, 2012, NEW ENGL J MED, V367, P380, DOI 10.1056/NEJMc1206002; Bode AM, 2004, MUTAT RES-FUND MOL M, V555, P33, DOI 10.1016/j.mrfmmm.2004.05.018; Cervello M, 2006, WORLD J GASTROENTERO, V12, P5113; Chen L, 2009, BIOCHEM BIOPH RES CO, V386, P374, DOI 10.1016/j.bbrc.2009.06.042; Chen ZS, 1999, MOL PHARMACOL, V55, P921; Chisholm K, 2004, ANTI-CANCER DRUG, V15, P889, DOI 10.1097/00001813-200410000-00010; Cullen KJ, 2003, CANCER RES, V63, P8097; Diestra JE, 2003, J UROLOGY, V170, P1383, DOI 10.1097/01.ju.0000074710.96154.c9; Fei XF, 2002, ACTA PHARMACOL SIN, V23, P315; Fu YS, 2008, NEURO-ONCOLOGY, V10, P139, DOI 10.1215/15228517-2007-051; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Gruber BM, 2010, MED SCI MONITOR, V16, pBR45; Hapke G, 2001, CANCER METAST REV, V20, P109, DOI 10.1023/A:1013116826788; HASEGAWA S, 1995, BRIT J CANCER, V71, P907, DOI 10.1038/bjc.1995.177; Hoffmann AC, 2010, NEOPLASIA, V12, P628, DOI 10.1593/neo.10402; Hong L, 2005, MOL CANCER THER, V4, P1936, DOI 10.1158/1535-7163.MCT-05-0182; Huang F, 2014, EXP THER MED, V7, P1611, DOI 10.3892/etm.2014.1662; Ishikawa Y, 2010, BIOL PHARM BULL, V33, P504, DOI 10.1248/bpb.33.504; Jacobs BL, 2010, CA-CANCER J CLIN, V60, P244, DOI 10.3322/caac.20077; Jia WWG, 2004, CAN J PHYSIOL PHARM, V82, P431, DOI 10.1139/Y04-049; Kaufman DS, 2009, LANCET, V374, P239, DOI 10.1016/S0140-6736(09)60491-8; Kellner U, 2002, LANCET ONCOL, V3, P235, DOI 10.1016/S1470-2045(02)00715-5; Khodadadian M, 2009, LUNG CANCER, V66, P48, DOI 10.1016/j.lungcan.2009.01.006; Khoshyomn S, 2000, PEDIATR NEUROSURG, V33, P123, DOI 10.1159/000028993; KIKUCHI Y, 1991, ANTI-CANCER DRUG, V2, P63, DOI 10.1097/00001813-199102000-00009; Kim HS, 2004, ARCH PHARM RES, V27, P429, DOI 10.1007/BF02980085; Kim KC, 2014, KOREAN J PHYSIOL PHA, V18, P61, DOI 10.4196/kjpp.2014.18.1.61; Koberle B, 2010, BBA-REV CANCER, V1806, P172, DOI 10.1016/j.bbcan.2010.07.004; Krishna R, 2000, EUR J PHARM SCI, V11, P265, DOI 10.1016/S0928-0987(00)00114-7; Lee KY, 1996, CANCER LETT, V110, P193, DOI 10.1016/S0304-3835(96)04502-8; Li WM, 2010, BASIC CLIN PHARMACOL, V106, P45, DOI 10.1111/j.1742-7843.2009.00470.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; Nakata H, 1998, JPN J CANCER RES, V89, P733, DOI 10.1111/j.1349-7006.1998.tb03278.x; Palaniyandi Kanagaraj, 2011, Int J Biochem Mol Biol, V2, P155; Park OJ, 2004, TOXICOL LETT, V150, P43, DOI 10.1016/j.toxlet.2003.06.001; Patel J, 2001, Pharmacogenomics, V2, P401, DOI 10.1517/14622416.2.4.401; Qian F, 2005, BIOMED PHARMACOTHER, V59, P64, DOI 10.1016/j.biopha.2005.01.002; Rioja J, 2011, BJU INT, V107, P1833, DOI 10.1111/j.1464-410X.2010.09653.x; Sakamoto M, 2001, Hum Cell, V14, P305; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Scheffer GL, 2000, CURR OPIN ONCOL, V12, P550, DOI 10.1097/00001622-200011000-00007; Serretta V, 2003, J CANCER RES CLIN, V129, P472, DOI 10.1007/s00432-003-0455-5; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Tada Y, 2002, INT J CANCER, V98, P630, DOI 10.1002/ijc.10246; Wang XB, 2010, ONCOL REP, V23, P211, DOI 10.3892/or_00000625; Xiao Z, 2003, J BIOL CHEM, V278, P21767, DOI 10.1074/jbc.M300229200; Xiong L, 2007, AM J CHINESE MED, V35, P1011, DOI 10.1142/S0192415X07005478; Xu HW, 2010, J INT MED RES, V38, P34, DOI 10.1177/147323001003800104; Xu N, 2012, BIOCHEM BIOPH RES CO, V425, P468, DOI 10.1016/j.bbrc.2012.07.127; Zhang Min, 2009, J MED RES, V38, P70; Zhao HX, 2014, RADIOTHER ONCOL, V110, P132, DOI 10.1016/j.radonc.2013.10.014; Zhao M, 2015, IMMUNOASSAYS CLIN ME, V22, P338	55	24	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0157759	10.1371/journal.pone.0157759	http://dx.doi.org/10.1371/journal.pone.0157759			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391608	Green Published, gold, Green Submitted			2022-12-27	WOS:000380005400020
J	Yuan, H; Xia, Q; Ling, K; Wang, XT; Wang, XM; Du, XP				Yuan, Hai; Xia, Qing; Ling, Kang; Wang, Xiaotong; Wang, Xiumin; Du, Xunping			Association of Choline Acetyltransferase Gene Polymorphisms (SNPs rs868750G/A, rs1880676G/A, rs2177369G/A and rs3810950G/A) with Alzheimer's Disease Risk: A Meta-Analysis	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; SINGLE NUCLEOTIDE POLYMORPHISM; MILD COGNITIVE IMPAIRMENT; CHAT; LOCUS; 2384G-GREATER-THAN-A; IDENTIFICATION; EXPRESSION; EPSILON-4; NEURONS	Background Epidemiological studies have investigated the role of choline acetyltransferase (ChAT) in Alzheimer's disease (AD). ChAT gene polymorphisms (SNPs rs868750G/A, rs1880676G/ A, rs2177369G/A, and rs3810950G/A) may be associated with the risk of AD. In this meta-analysis, we determined the relationship between the four polymorphisms and the risk of AD. Methods We searched MEDLINE, EMBASE, and HuGEnet databases for studies linking the four polymorphisms with AD risk. We included 16 articles in our meta-analysis to assess the association between the four polymorphisms and susceptibility to AD by calculating the pooled odds ratios (ORs) and 95% confidence intervals (CIs). Results The combined results showed no significant association with rs1880676G/A and rs2177369G/A polymorphisms. The risk of AD (GG+GA versus AA: OR = 0.01, 95%CI = 0.01-0.02, P < 0.05; GG versus GA+AA: OR = 0.85, 95% CI = 0.72-1.00, P = 0.05; GA versus AA: OR = 0.60, 95% CI = 0.37-0.98, P = 0.04) with rs868750G/A polymorphism, or the association of rs3810950G/A polymorphism with AD risk in the overall population (GA versus AA: OR = 0.64, 95% CI = 0.44-0.93, P = 0.02; GG+GA versus AA: OR = 0.62, 95% CI = 0.39-0.97, P = 0.04) or Asian group (GA versus AA: OR = 0.50, 95% CI = 0.32-0.76, P = 0.001, and GG+GA versus AA: OR = 0.46, 95% CI = 0.30-0.09, P = 0.0002) was demonstrated. Conclusions Our meta-analysis suggested that rs1880670G/A, and rs2177369 G/A polymorphisms were not risk factors for AD. However, rs3810950G/A, or rs868750G/A genetic polymorphism was a genetic risk factor for the development of AD. The rs3810950G/A polymorphism had a negative effect on the risk of AD for GA or GG+GA genotypes compared with AA in the overall population or Asians.	[Yuan, Hai; Xia, Qing; Ling, Kang; Wang, Xiumin] Second Peoples Hosp Hefei City, Dept Rehabil Med, Hefei 230011, Anhui, Peoples R China; [Wang, Xiaotong] Wenzhou Med Univ, Affiliated Hosp 2, Dept Neurol, Wenzhou 325027, Zhejiang, Peoples R China; [Du, Xunping] Second Peoples Hosp Hefei City, Dept Neurol, Hefei 230011, Anhui, Peoples R China	Wenzhou Medical University	Yuan, H (corresponding author), Second Peoples Hosp Hefei City, Dept Rehabil Med, Hefei 230011, Anhui, Peoples R China.	haiyuan103@163.com						American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Beach TG, 2000, J NEUROPATH EXP NEUR, V59, P308, DOI 10.1093/jnen/59.4.308; Boissiere F, 1997, NEUROSCI LETT, V225, P169, DOI 10.1016/S0304-3940(97)00210-3; CHIREUX MA, 1995, J NEUROSCI RES, V40, P427, DOI 10.1002/jnr.490400402; Cook LJ, 2005, AM J MED GENET B, V132B, P5, DOI 10.1002/ajmg.b.30068; DAVIES P, 1976, LANCET, V2, P1403; DeKosky ST, 2002, ANN NEUROL, V51, P145, DOI 10.1002/ana.10069; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Doumoud P, 1995, NEUROBIOL AGING, V16, P817; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; ERICKSON JD, 1994, J BIOL CHEM, V269, P21929; Giedraitis V, 2009, DEMENT GERIATR COGN, V27, P59, DOI 10.1159/000191203; Grunblatt E, 2008, J PSYCHIATR RES, V43, P298, DOI 10.1016/j.jpsychires.2008.05.008; Hahm SH, 1997, J MOL NEUROSCI, V9, P223, DOI 10.1007/BF02800504; Harold D, 2003, HUM GENET, V113, P258, DOI 10.1007/s00439-003-0960-2; Haroutunian V, 1997, MOL BRAIN RES, V46, P161, DOI 10.1016/S0169-328X(96)00297-5; Jo SA, 2006, CLIN CHIM ACTA, V368, P179, DOI 10.1016/j.cca.2005.12.037; Kim KW, 2004, NEUROSCI LETT, V366, P182, DOI 10.1016/j.neulet.2004.05.041; LAU J, 1992, NEW ENGL J MED, V327, P248, DOI 10.1056/NEJM199207233270406; Lee JJ, 2012, ALZ DIS ASSOC DIS, V26, P81, DOI 10.1097/WAD.0b013e31821cbcaf; Li H, 2008, ARCH NEUROL-CHICAGO, V65, P45, DOI 10.1001/archneurol.2007.3; Lin L, 1999, P NATL ACAD SCI USA, V96, P12108, DOI 10.1073/pnas.96.21.12108; MANTEL N, 1959, J NATL CANCER I, V22, P719; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mengel-From J, 2011, GENES BRAIN BEHAV, V10, P876, DOI 10.1111/j.1601-183X.2011.00728.x; Meziane H, 1998, P NATL ACAD SCI USA, V95, P12683, DOI 10.1073/pnas.95.21.12683; Mubumbila V, 2002, NEUROSCI LETT, V333, P9, DOI 10.1016/S0304-3940(02)00955-2; Ohno K, 2001, P NATL ACAD SCI USA, V98, P2017, DOI 10.1073/pnas.98.4.2017; Ozturk A, 2006, NEUROBIOL AGING, V27, P1440, DOI 10.1016/j.neurobiolaging.2005.08.024; Piccardi M, 2007, AM J MED GENET B, V144B, P895, DOI 10.1002/ajmg.b.30548; Reiman EM, 2007, NEURON, V54, P713, DOI 10.1016/j.neuron.2007.05.022; Scacchi R, 2009, AM J MED GENET B, V150B, P502, DOI 10.1002/ajmg.b.30846; Schwarz S, 2003, NEUROSCI LETT, V343, P167, DOI 10.1016/S0304-3940(03)000380-X; Tang M, 2008, DEMENT GERIATR COGN, V26, P9, DOI 10.1159/000140612; WELSH KA, 1994, NEUROLOGY, V44, P609, DOI 10.1212/WNL.44.4.609; WILCOCK GK, 1982, J NEUROL SCI, V57, P407, DOI 10.1016/0022-510X(82)90045-4	36	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159022	10.1371/journal.pone.0159022	http://dx.doi.org/10.1371/journal.pone.0159022			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27390868	gold, Green Published, Green Submitted			2022-12-27	WOS:000380005400194
J	Zakrzewska, M; Fendler, W; Zakrzewski, K; Sikorska, B; Grajkowska, W; Dembowska-Baginska, B; Filipek, I; Stefanczyk, L; Liberski, PP				Zakrzewska, Magdalena; Fendler, Wojciech; Zakrzewski, Krzysztof; Sikorska, Beata; Grajkowska, Wieslawa; Dembowska-Baginska, Bozenna; Filipek, Iwona; Stefanczyk, Lukasz; Liberski, Pawel P.			Altered MicroRNA Expression Is Associated with Tumor Grade, Molecular Background and Outcome in Childhood Infratentorial Ependymoma	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; INTRACRANIAL EPENDYMOMA; DRUG-RESISTANCE; CLUSTER; CANCER; CLASSIFICATION; METASTASIS; MIR-17-5P; GENES; ROLES	Background Ependymal tumors are the third most common group of brain tumors in children, accounting for about 10% of all primary brain neoplasms. According to the current WHO classification, they comprise four entities with the most frequent ependymoma and anaplastic ependymoma. The most of pediatric tumors are located within the posterior fossa, with a tendency to infiltrate the vital brain structures. This limits surgical resection and poses a considerable clinical problem. Moreover, there are no appropriate outcome prognostic factors besides the extent of surgical resection. Despite definition of molecular subgroups, the majority of childhood ependymomas present a balanced genome, which makes it difficult to establish molecular prognostic factors. Methods The purpose of our study was to explore whether miRNA expression could be used as prognostic markers in pediatric infratentorial ependymomas. We also performed a mRNA expression pattern analysis of NELL2 and LAMA2 genes, with immunohistochemical illustrations of representative cases. The miRNA and mRNA expression was measured in 53 pediatric infratentorial ependymomas using a real-time quantitative PCR. Results Three miRNAs were shown to efficiently differentiate between grade II and III ependymomas: miR-17-5p, miR-19a-3p, and miR-106b-5p. Survival analysis showed that the probabilities of overall (p = 0.036) and event-free survival (p = 0.002) were reduced with higher than median miRNA expression levels of miR-17-5p. Using multivariate analysis adjusted for patient's age, sex, tumor grade and localization, we showed statistically significant associations with event-free survival (p = 0004) and borderline statistical significance with overall survival (p = 0.057) for miR-17-5p. Correlation analysis of miR-19a, miR-17-5p, miR-106b revealed that their expression levels were significantly correlated with EZH2 expression, suggested marker of PFA ependymomas. Furthermore, lower expression level of LAMA2 mRNA was shown to be associated with an increased risk of death in covariate-adjusted analyses. Conclusions Our data provide a better understanding of pediatric ependymoma and suggests the presence of plausible molecular biomarkers connected with the outcome.	[Zakrzewska, Magdalena; Sikorska, Beata; Liberski, Pawel P.] Med Univ Lodz, Dept Mol Pathol & Neuropathol, Lodz, Poland; [Fendler, Wojciech] Med Univ Lodz, Dept Biostat & Translat Med, Lodz, Poland; [Zakrzewski, Krzysztof] Polish Mother Mem Hosp Res Inst, Dept Neurosurg, Lodz, Poland; [Grajkowska, Wieslawa] Childrens Mem Hlth Inst, Dept Pathol, Warsaw, Poland; [Grajkowska, Wieslawa] Polish Acad Sci, Dept Expt & Clin Neuropathol, M Mossakowski Med Res Ctr, Warsaw, Poland; [Dembowska-Baginska, Bozenna; Filipek, Iwona] Childrens Mem Hlth Inst, Dept Pediat Oncol, Warsaw, Poland; [Stefanczyk, Lukasz] Third Municipal Hosp Lodz, Lodz, Poland	Medical University Lodz; Medical University Lodz; Polish Mother's Memorial Hospital - Research Institute; Children's Memorial Health Institute; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Children's Memorial Health Institute	Zakrzewska, M (corresponding author), Med Univ Lodz, Dept Mol Pathol & Neuropathol, Lodz, Poland.	magdalena.zakrzewska@umed.lodz.pl	Fendler, Wojciech Maksymilian/S-9592-2016; Zakrzewska, Magdalena/S-9308-2016; Fendler, Wojciech/AAG-7020-2019; Sikorska, Beata/H-7138-2016	Fendler, Wojciech Maksymilian/0000-0002-5083-9168; Zakrzewska, Magdalena/0000-0001-5826-7726; Fendler, Wojciech/0000-0002-5083-9168; Sikorska, Beata/0000-0002-6166-0729; Grajkowska, Wieslawa/0000-0001-8318-5781; Liberski, Pawel P./0000-0001-6507-4682; Dembowska-Baginska, Bozenna/0000-0002-3845-5380; Zakrzewski, Krzysztof/0000-0001-5454-1783; Filipek, Iwona/0000-0003-2867-2696	Polish NCN grant [2011/01/B/NZ4/03573]	Polish NCN grant	Work was supported by the Polish NCN grant No. 2011/01/B/NZ4/03573.	Akhavan A, 2012, CANCER RES, V72, P2578, DOI 10.1158/0008-5472.CAN-11-3732; Araki A, 2014, NEURO-ONCOLOGY, V16, P23; Birks DK, 2011, PEDIATR BLOOD CANCER, V56, P211, DOI 10.1002/pbc.22723; Chen L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118003; Chou CH, 2016, NUCLEIC ACIDS RES, V44, pD239, DOI 10.1093/nar/gkv1258; Chua JH, 2009, CURR OPIN MOL THER, V11, P189; Cloonan N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-234; Costa FF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025114; Ellison DW, 2011, J NEGAT RESULTS BIOM, V10, DOI 10.1186/1477-5751-10-7; Ellison DW, 2016, WHO CLASSIFICATION T, V4; Fan MY, 2014, BREAST CANCER RES TR, V146, P487, DOI 10.1007/s10549-014-3040-5; Fang LK, 2014, ONCOTARGET, V5, P2974, DOI 10.18632/oncotarget.1614; Fang Y, 2015, J BIOL RES-THESSALON, V22, DOI 10.1186/s40709-015-0035-2; Godfraind C, 2009, CHILD NERV SYST, V25, P1185, DOI 10.1007/s00381-008-0804-4; Gyongyosi B, 2014, J HISTOCHEM CYTOCHEM, V62, P547, DOI 10.1369/0022155414537277; Kleinman CL, 2014, NAT GENET, V46, P39, DOI 10.1038/ng.2849; Li AM, 2015, CANCER-AM CANCER SOC, V121, P1499, DOI 10.1002/cncr.29198; Lourdusamy A, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0206-2; Mack SC, 2014, NATURE, V506, P445, DOI 10.1038/nature13108; Mao SS, 2014, FEBS J, V281, P1144, DOI 10.1111/febs.12680; Mathis SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105710; Mc Lendon RE, 2007, WHO CLASSIFICATION T, P74; Mogilyansky E, 2013, CELL DEATH DIFFER, V20, P1603, DOI 10.1038/cdd.2013.125; Niibori-Nambu A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059558; Pajtler Kristian W, 2015, Oncoscience, V2, P827; Pajtler KW, 2015, CANCER CELL, V27, P728, DOI 10.1016/j.ccell.2015.04.002; Ridley L, 2008, NEURO-ONCOLOGY, V10, P675, DOI 10.1215/15228517-2008-036; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Spencer Peter, 2012, Frontiers in Genetics, V3, P192, DOI 10.3389/fgene.2012.00192; Srinivasan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017438; Tan WQ, 2014, WORLD J GASTROENTERO, V20, P5962, DOI 10.3748/wjg.v20.i20.5962; Tena-Suck ML., 2015, J HISTOL HISTOPATHOL, V2, P17, DOI [10.7243/2055-091X-2-17, DOI 10.7243/2055-091X-2-17]; Tihan T, 2008, MODERN PATHOL, V21, P165, DOI 10.1038/modpathol.3800999; Wani K, 2012, ACTA NEUROPATHOL, V123, P727, DOI 10.1007/s00401-012-0941-4; Witt H, 2011, CANCER CELL, V20, P143, DOI 10.1016/j.ccr.2011.07.007; Yeh TS, 2014, ANN SURG, V259, P346, DOI 10.1097/SLA.0000000000000223; Zheng JJ, 2013, HEPATO-GASTROENTEROL, V60, P549, DOI 10.5754/hge12754	37	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158464	10.1371/journal.pone.0158464	http://dx.doi.org/10.1371/journal.pone.0158464			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27390862	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400064
J	Zhou, Y; Wu, Y; Qin, Y; Liu, L; Wan, J; Zou, LY; Zhang, QY; Zhu, JD; Mi, MT				Zhou, Yong; Wu, Ying; Qin, Yu; Liu, Lei; Wan, Jing; Zou, Lingyun; Zhang, Qianyong; Zhu, Jundong; Mi, Mantian			Ampelopsin Improves Insulin Resistance by Activating PPAR. and Subsequently Up-Regulating FGF21-AMPK Signaling Pathway	PLOS ONE			English	Article							SKELETAL-MUSCLE CELLS; BREAST-CANCER CELLS; GROWTH-FACTOR 21; RECEPTOR-GAMMA; ANTIDIABETIC ACTIONS; ENERGY-METABOLISM; PARTIAL AGONIST; GLUCOSE-UPTAKE; AMPK; AKT	Ampelopsin (APL), a major bioactive constituent of Ampelopsis grossedentata, exerts a number of biological effects. Here, we explored the anti-diabetic activity of APL and elucidate the underlying mechanism of this action. In palmitate-induced insulin resistance of L6 myotubes, APL treatment markedly up-regulated phosphorylated insulin receptor substrate-1 and protein kinase B, along with a corresponding increase of glucose uptake capacity. APL treatment also increased expressions of fibroblast growth factor (FGF21) and phosphorylated adenosine 5'-monophosphate -activated protein kinase (p-AMPK), however inhibiting AMPK by Compound C or AMPK siRNA, or blockage of FGF21 by FGF21 siRNA, obviously weakened APL -induced increases of FGF21 and p-AMPK as well as glucose uptake capacity in palmitate -pretreated L6 myotubes. Furthermore, APL could activate PPAR. resulting in increases of glucose uptake capacity and expressions of FGF21 and p-AMPK in palmitate -pretreated L6 myotubes, whereas all those effects were obviously abolished by addition of GW9662, a specific inhibitor of peroxisome proliferator-activated receptor -gamma (PPAR.), and PPAR gamma siRNA. Using molecular modeling and the luciferase reporter assays, we observed that APL could dock with the catalytic domain of PPAR. and dose-dependently up-regulate PPAR. activity. In summary, APL maybe a potential agonist of PPAR. and promotes insulin sensitization by activating PPAR. and subsequently regulating FGF21-AMPK signaling pathway. These results provide new insights into the protective health effects of APL, especially for the treatment of Type 2 diabetesmellitus.	[Zhou, Yong; Wu, Ying; Qin, Yu; Liu, Lei; Wan, Jing; Zhang, Qianyong; Zhu, Jundong; Mi, Mantian] Third Mil Med Univ, Res Ctr Nutr & Food Safety, Inst Mil Prevent Med, Chongqing Key Lab Nutr & Food Safety,Res Ctr Med, Chongqing 400038, Peoples R China; [Zou, Lingyun] Third Mil Med Univ, Coll Basic Med Sci, Chongqing 400038, Peoples R China	Army Medical University; Army Medical University	Mi, MT (corresponding author), Third Mil Med Univ, Res Ctr Nutr & Food Safety, Inst Mil Prevent Med, Chongqing Key Lab Nutr & Food Safety,Res Ctr Med, Chongqing 400038, Peoples R China.	mantian_mi@163.com			"12th Five year plan" for National Key Technology Research and Development Program of China [2012BAI35B02]	"12th Five year plan" for National Key Technology Research and Development Program of China	This work was supported by the "12th Five year plan" for National Key Technology Research and Development Program of China (grant number: 2012BAI35B02). Prof. Mantian MI received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Angelin B, 2012, CELL METAB, V16, P693, DOI 10.1016/j.cmet.2012.11.001; ARCHINTERNMED, 2010, ARCH INTERN MED, V170, P1191, DOI DOI 10.1001/ARCHINTERNMED.2010.207; Atanasov AG, 2013, BBA-GEN SUBJECTS, V1830, P4813, DOI 10.1016/j.bbagen.2013.06.021; Avior Y, 2013, FOOD FUNCT, V4, P831, DOI 10.1039/c3fo60063g; Babu PVA, 2013, J NUTR BIOCHEM, V24, P1777, DOI 10.1016/j.jnutbio.2013.06.003; Badeau RM, 2014, ANN MED, V46, P18, DOI 10.3109/07853890.2013.853369; Chau MDL, 2010, P NATL ACAD SCI USA, V107, P12553, DOI 10.1073/pnas.1006962107; Dostalova I, 2009, PHYSIOL RES, V58, P1, DOI 10.33549/physiolres.931610; Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062; Goto T, 2013, MOL NUTR FOOD RES, V57, P20, DOI 10.1002/mnfr.201200522; Huang WW, 2013, INT J ONCOL, V42, P2069, DOI 10.3892/ijo.2013.1909; Izumiya Y, 2008, FEBS LETT, V582, P3805, DOI 10.1016/j.febslet.2008.10.021; Kim B, 2015, J BIOL CHEM, V290, P19146, DOI 10.1074/jbc.M115.636852; Kim JH, 2015, ARCH PHARM RES, V38, P302, DOI 10.1007/s12272-015-0559-x; Liu HJ, 2015, J PHARMACOL EXP THER, V353, P573, DOI 10.1124/jpet.115.223107; Mashili F, 2013, DIABETES, V62, P457, DOI 10.2337/db12-0337; Meshkani R, 2014, CELL BIOCHEM FUNCT, V32, P683, DOI 10.1002/cbf.3072; Muise ES, 2008, MOL PHARMACOL, V74, P403, DOI 10.1124/mol.108.044826; Ohashi M, 2015, BIOORG MED CHEM LETT, V25, P2639, DOI 10.1016/j.bmcl.2015.04.076; Park SY, 2014, KOREAN J PHYSIOL PHA, V18, P255, DOI 10.4196/kjpp.2014.18.3.255; Piemontese L, 2015, EUR J MED CHEM, V90, P583, DOI 10.1016/j.ejmech.2014.11.044; Puhl AC, 2012, MOL PHARMACOL, V81, P788, DOI 10.1124/mol.111.076216; Qiang L, 2012, CELL, V148, P397, DOI 10.1016/j.cell.2012.01.020; Rathmann W, 2004, DIABETES CARE, V27, P2568, DOI 10.2337/diacare.27.10.2568; Ribas F, 2014, BIOCHEM J, V463, P191, DOI 10.1042/BJ20140403; Shen Y, 2012, J NEUROSCI, V32, P390, DOI 10.1523/JNEUROSCI.4639-11.2012; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wang H, 2008, MOL CELL BIOL, V28, P188, DOI 10.1128/MCB.00992-07; Xie Q, 2014, GENE CHROMOSOME CANC, V53, P422, DOI 10.1002/gcc.22154; Xie XN, 2015, BBA-GEN SUBJECTS, V1850, P62, DOI 10.1016/j.bbagen.2014.09.027; Yu LF, 2010, CURR TOP MED CHEM, V10, P397, DOI 10.2174/156802610790980611; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhang HT, 2013, EUR J PHARMACOL, V718, P235, DOI 10.1016/j.ejphar.2013.08.026; Zhou Y, 2014, CANCER SCI, V105, P1279, DOI 10.1111/cas.12494; Zhou Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089021; Zou D, 2014, MED SCI SPORT EXER, V46, P2077, DOI 10.1249/MSS.0000000000000336	37	17	22	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159191	10.1371/journal.pone.0159191	http://dx.doi.org/10.1371/journal.pone.0159191			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391974	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400218
J	Guglielmi, V; Maresca, L; Lanzillo, C; Marinoni, GM; D'Adamo, M; Di Roma, M; Preziosi, P; Bellia, A; Calo, L; Sbraccia, P				Guglielmi, Valeria; Maresca, Luciano; Lanzillo, Chiara; Marinoni, Giorgia Michela; D'Adamo, Monica; Di Roma, Mauro; Preziosi, Paolo; Bellia, Alfonso; Calo, Leonardo; Sbraccia, Paolo			Relationship between Regional Fat Distribution and Hypertrophic Cardiomyopathy Phenotype	PLOS ONE			English	Article							EPICARDIAL ADIPOSE-TISSUE; CARDIOVASCULAR MAGNETIC-RESONANCE; LEFT-VENTRICULAR MASS; CLINICAL PRESENTATION; HEART-ASSOCIATION; TASK-FORCE; OBESITY; DISEASE; DIAGNOSIS; RISK	Background Hypertrophic cardiomyopathy (HCM), the most common genetic heart disease, is characterized by heterogeneous phenotypic expression. Body mass index has been associated with LV mass and heart failure symptoms in HCM. The aim of our study was to investigate whether regional (trunk, appendicular, epicardial) fat distribution and extent could be related to hypertrophy severity and pattern in HCM. Methods Cardiovascular magnetic resonance was performed in 32 subjects with echocardiography-based diagnosis of HCM (22M/10F, 57.2 +/- 12.6 years) characterized by predominant hypertrophy at the interventricular septum (IVS). Regional fat distribution was assessed by dual-energy X-ray absorptiometry. Results Gender differences were detected in maximum IVS thickness (M: 18.3 +/- 3.8 mm vs. F: 14.3 +/- 4 mm, p = 0.012), right ventricle (RV) systolic function (M: 61.3 +/- 6.7%; F: 67.5 +/- 6.3%, p = 0.048), indexed RV end-diastolic (M: 64.8 +/- 16.3 ml/m(2); F: 50.7 +/- 15.5 ml/m(2), p = 0.04) and end-systolic volumes (M: 24.3 +/- 8.3 ml/m(2); F: 16.7 +/- 7.4 ml/m(2), p = 0.04). After adjusting for age and gender, maximum IVS thickness was associated with truncal fat (Tr-FAT) (beta = 0.43, p = 0.02), but not with either appendicular or epicardial fat. Epicardial fat resulted independently associated with NT-proBNP levels (beta = 0.63, p = 0.04). Late Gadolinium Enhancement-positive subjects displayed greater maximum IVS thickness (p = 0.02), LV mass index (p = 0.015) and NT-proBNP levels (p = 0.04), but no associations with fat amount or distribution were observed. Conclusion Truncal, but not appendicular or epicardial fat amount, seems to be related with maximum IVS thickness, the hallmark feature in our cohort of HCM patients. Further prospective researches are needed to assess a potential causative effect of central adiposity on HCM phenotype.	[Guglielmi, Valeria; Marinoni, Giorgia Michela; D'Adamo, Monica; Bellia, Alfonso; Sbraccia, Paolo] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy; [Maresca, Luciano; Di Roma, Mauro; Preziosi, Paolo] Policlin Casilino, Dept Diagnost Imaging, Rome, Italy; [Lanzillo, Chiara; Calo, Leonardo] Policlin Casilino, Dept Cardiol, Rome, Italy	University of Rome Tor Vergata	Sbraccia, P (corresponding author), Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy.	sbraccia@med.uniroma2.it	D'Adamo, Monica/AAL-4676-2020; bellia, alfonso/AIA-9860-2022; Calo, Leonardo/R-1892-2016	D'Adamo, Monica/0000-0002-1673-1591; Calo, Leonardo/0000-0002-6062-5286; Guglielmi, Valeria/0000-0002-6912-7814	Ministero dell'Istruzione, dell'Universita e della Ricerca [2010329EKE_003]	Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR))	This work was supported by a grant from the Ministero dell'Istruzione, dell'Universita e della Ricerca (prot. 2010329EKE_003) to PS.; We gratefully acknowledge Amleto Alberico, Stefano Bonetti, Gianluca Campo e Giorgio Sebastiano for technical assistance in MRI scan execution. We are also grateful to Stefano Coppa and Luca Colangeli, students in Medicine, for their help in collecting clinical data. This work was supported by a grant from the Ministero dell'Istruzione, dell'Universita e della Ricerca (prot. 2010329EKE_003).	Abel ED, 2008, PHYSIOL REV, V88, P389, DOI 10.1152/physrev.00017.2007; Adabag AS, 2008, J AM COLL CARDIOL, V51, P1369, DOI 10.1016/j.jacc.2007.11.071; Arad M, 2005, CIRCULATION, V112, P2805, DOI 10.1161/CIRCULATIONAHA.105.547448; Canepa M, 2013, AM J CARDIOL, V112, P1182, DOI 10.1016/j.amjcard.2013.05.070; Choudhury L, 2002, J AM COLL CARDIOL, V40, P2156, DOI 10.1016/S0735-1097(02)02602-5; CIRO E, 1983, CIRCULATION, V67, P1227, DOI 10.1161/01.CIR.67.6.1227; [Criteria Committee New York Heart Association], 1979, NOM CRIT DIAGN DIS H, pxiii; Danias PG, 2003, J CARDIOV MAGN RESON, V5, P431, DOI 10.1081/JCMR-120022259; Doesch C, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-40; Elliott P, 2004, LANCET, V363, P1881, DOI 10.1016/S0140-6736(04)16358-7; Elliott PM, 2014, EUR HEART J, V35, P2733, DOI 10.1093/eurheartj/ehu284; Fluchter S, 2007, OBESITY, V15, P870, DOI 10.1038/oby.2007.591; Fox CS, 2009, CIRCULATION, V119, P1586, DOI 10.1161/CIRCULATIONAHA.108.828970; Gaborit B, 2012, OBESITY, V20, P1200, DOI 10.1038/oby.2011.283; Gersh BJ, 2011, J AM COLL CARDIOL, V58, P2703, DOI 10.1016/j.jacc.2011.10.825; Green JJ, 2012, JACC-CARDIOVASC IMAG, V5, P370, DOI 10.1016/j.jcmg.2011.11.021; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Guglielmi V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103381; Heckbert SR, 2006, J AM COLL CARDIOL, V48, P2285, DOI 10.1016/j.jacc.2006.03.072; Iacobellis G, 2004, AM J CARDIOL, V94, P1084, DOI 10.1016/j.amjcard.2004.06.075; Kankaanpaa M, 2006, J CLIN ENDOCR METAB, V91, P4689, DOI 10.1210/jc.2006-0584; Karelis AD, 2004, J CLIN ENDOCR METAB, V89, P2569, DOI 10.1210/jc.2004-0165; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Lamounier-Zepter V, 2009, CIRC RES, V105, P326, DOI 10.1161/CIRCRESAHA.109.200501; Leonardi S, 2009, EUR HEART J, V30, P2003, DOI 10.1093/eurheartj/ehp152; Maron BJ, 2013, LANCET, V381, P242, DOI 10.1016/S0140-6736(12)60397-3; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; Maron BJ, 2004, AM J MED, V116, P63, DOI 10.1016/j.amjmed.2003.10.012; Maron MS, 2011, CIRCULATION, V124, P40, DOI 10.1161/CIRCULATIONAHA.110.985812; Maron MS, 2006, CIRCULATION, V114, P2232, DOI 10.1161/CIRCULATIONAHA.106.644682; Maron MS, 2003, NEW ENGL J MED, V348, P295, DOI 10.1056/NEJMoa021332; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McKenna WJ, 1997, HEART, V77, P130, DOI 10.1136/hrt.77.2.130; Muhib S, 2013, INT HEART J, V54, P297, DOI 10.1536/ihj.54.297; Neeland IJ, 2013, CIRC-CARDIOVASC IMAG, V6, P800, DOI 10.1161/CIRCIMAGING.113.000532; Olivotto I, 2005, J AM COLL CARDIOL, V46, P480, DOI 10.1016/j.jacc.2005.04.043; Olivotto I, 2008, J AM COLL CARDIOL, V52, P559, DOI 10.1016/j.jacc.2008.04.047; Olivotto I, 2013, J AM COLL CARDIOL, V62, P449, DOI 10.1016/j.jacc.2013.03.062; Olivotto I, 2012, CIRC-HEART FAIL, V5, P535, DOI 10.1161/CIRCHEARTFAILURE.112.967026; Olivotto I, 2009, J CARDIOVASC TRANSL, V2, P349, DOI 10.1007/s12265-009-9137-2; Ouwens DM, 2010, J CELL MOL MED, V14, P2223, DOI 10.1111/j.1582-4934.2010.01141.x; Piran S, 2012, J AM COLL CARDIOL, V60, P283, DOI 10.1016/j.jacc.2012.05.005; Rider OJ, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-9; Seferovic PM, 2015, EUR HEART J, V36, P1718, DOI 10.1093/eurheartj/ehv134; Smith SC, 2011, J AM COLL CARDIOL, V58, P2432, DOI 10.1016/j.jacc.2011.10.824; Tsybouleva N, 2004, CIRCULATION, V109, P1284, DOI 10.1161/01.CIR.0000121426.43044.2B; Venteclef N, 2015, EUR HEART J, V36, P795, DOI 10.1093/eurheartj/eht099; Wang LB, 2010, ANN INTERN MED, V152, P513, DOI 10.7326/0003-4819-152-8-201004200-00008; Watkins H, 2008, HEART, V94, P1264, DOI 10.1136/hrt.2008.154104; Watkins H, 2011, NEW ENGL J MED, V364, P1643, DOI 10.1056/NEJMra0902923; Yndestad A, 2004, CIRCULATION, V109, P1379, DOI 10.1161/01.CIR.0000120704.97934.41	51	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158892	10.1371/journal.pone.0158892	http://dx.doi.org/10.1371/journal.pone.0158892			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27388274	Green Submitted, Green Published, gold			2022-12-27	WOS:000379811500062
J	Kinny-Koster, B; Bartels, M; Becker, S; Scholz, M; Thiery, J; Ceglarek, U; Kaiser, T				Kinny-Koester, Benedict; Bartels, Michael; Becker, Susen; Scholz, Markus; Thiery, Joachim; Ceglarek, Uta; Kaiser, Thorsten			Plasma Amino Acid Concentrations Predict Mortality in Patients with End-Stage Liver Disease	PLOS ONE			English	Article							HEPATIC-ENCEPHALOPATHY; CIRRHOTIC-PATIENTS; SKELETAL-MUSCLE; MODEL; SURVIVAL; HYPONATREMIA; VALIDATION; METABOLISM; MATURATION; AMMONIA	Background The liver plays a key role in amino acid metabolism. In former studies, a ratio between branched-chain and aromatic amino acids (Fischer's ratio) revealed associations with hepatic encephalopathy. Furthermore, low concentrations of branched-chain amino acids were linked to sarcopenia in literature. Encephalopathy and sarcopenia are known to dramatically worsen the prognosis. Aim of this study was to investigate a complex panel of plasma amino acids in the context of mortality in patients with end-stage liver disease. Methods 166 patients evaluated for orthotopic liver transplantation were included. 19 amino acids were measured from citrated plasma samples using mass spectrometry. We performed survival analysis for plasma amino acid constellations and examined the relationship to established mortality predictors. Results 33/166 (19.9%) patients died during follow-up. Lower values of valine (p<0.001), Fischer's ratio (p<0.001) and valine to phenylalanine ratio (p<0.001) and higher values of phenylalanine (p<0.05) and tyrosine (p<0.05) were significantly associated with mortality. When divided in three groups, the tertiles discriminated cumulative survival for valine (p =0.016), phenylalanine (p = 0.024) and in particular for valine to phenylalanine ratio (p = 0.003) and Fischer's ratio (p = 0.005). Parameters were also significantly correlated with MELD and MELD-Na score. Conclusions Amino acids in plasma are valuable biomarkers to determine increased risk of mortality in patients with end-stage liver disease. In particular, valine concentrations and constellations composed of branched-chain and aromatic amino acids were strongly associated with prognosis. Due to their pathophysiological importance, the identified amino acids could be used to examine individual dietary recommendations to serve as potential therapeutic targets.	[Kinny-Koester, Benedict; Becker, Susen; Thiery, Joachim; Ceglarek, Uta; Kaiser, Thorsten] Univ Hosp Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, Leipzig, Germany; [Bartels, Michael] Univ Hosp Leipzig, Dept Visceral Vasc Thorac & Transplant Surg, Leipzig, Germany; [Becker, Susen; Scholz, Markus; Thiery, Joachim; Ceglarek, Uta] Univ Hosp Leipzig, LIFE Leipzig Res Ctr Civilizat Dis, Leipzig, Germany; [Scholz, Markus] Univ Leipzig, Inst Med Informat Stat & Epidemiol, Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University; Leipzig University	Kaiser, T (corresponding author), Univ Hosp Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, Leipzig, Germany.	thorsten.kaiser@medizin.uni-leipzig.de	Ceglarek, Uta/GOE-5561-2022		LIFE - Leipzig Research Center for Civilization Diseases, Universitat Leipzig; European Union; European Regional Development Fund (ERDF); Free State of Saxony within excellence initiative	LIFE - Leipzig Research Center for Civilization Diseases, Universitat Leipzig; European Union(European Commission); European Regional Development Fund (ERDF)(European Commission); Free State of Saxony within excellence initiative	This publication is supported by LIFE - Leipzig Research Center for Civilization Diseases, Universitat Leipzig. LIFE is funded by means of the European Union, by the European Regional Development Fund (ERDF) and by means of the Free State of Saxony within the framework of the excellence initiative.; We thank Dr. rer. nat. Sonja C. Stadler and Lars Schinkel for their substantial impact in discussions and support in measurements. This publication is supported by LIFE-Leipzig Research Center for Civilization Diseases, Universitat Leipzig. LIFE is funded by means of the European Union, by the European Regional Development Fund (ERDF) and by means of the Free State of Saxony within the framework of the excellence initiative.	Amer Assoc Study Liver Dis, 2014, J HEPATOL, V61, P642, DOI 10.1016/j.jhep.2014.05.042; Asrani SK, 2011, CLIN LIVER DIS, V15, P685, DOI 10.1016/j.cld.2011.08.009; Bobbert M, 2013, CLIN TRANSPLANT, V27, P34, DOI 10.1111/ctr.12154; Brauer R, 2011, METABOLOMICS, V7, P344, DOI 10.1007/s11306-010-0256-1; Ceglarek U, 2002, CLIN CHEM LAB MED, V40, P693, DOI 10.1515/CCLM.2002.119; Cholongitas E, 2010, NAT REV GASTRO HEPAT, V7, P659, DOI 10.1038/nrgastro.2010.169; Damink SWMO, 2007, HEPATOLOGY, V45, P560, DOI 10.1002/hep.21463; Dejong CHC, 2007, J NUTR, V137, p1579S, DOI 10.1093/jn/137.6.1579S; Englesbe MJ, 2010, J AM COLL SURGEONS, V211, P271, DOI 10.1016/j.jamcollsurg.2010.03.039; FISCHER JE, 1971, LANCET, V2, P75, DOI 10.1016/s0140-6736(71)92048-4; FISCHER JE, 1974, AM J SURG, V127, P40, DOI 10.1016/0002-9610(74)90009-9; Gines P, 2008, HEPATOLOGY, V48, P1002, DOI 10.1002/hep.22418; Gluud LL, 2013, J NUTR, V143, P1263, DOI 10.3945/jn.113.174375; Hamaguchi Y, 2014, LIVER TRANSPLANT, V20, P1413, DOI 10.1002/lt.23970; Holecek M, 2015, NUTRITION, V31, P14, DOI 10.1016/j.nut.2014.03.016; Holecek M, 2013, NUTRITION, V29, P1186, DOI 10.1016/j.nut.2013.01.022; Kachaamy T, 2012, CLIN GASTROENTEROL H, V10, P100, DOI 10.1016/j.cgh.2011.11.002; Kakazu E, 2007, J IMMUNOL, V179, P7137, DOI 10.4049/jimmunol.179.10.7137; Kakazu E, 2013, SCI REP-UK, V3, DOI 10.1038/srep03459; Kakazu E, 2009, HEPATOLOGY, V50, P1936, DOI 10.1002/hep.23248; Kamath PS, 2007, HEPATOLOGY, V45, P797, DOI 10.1002/hep.21563; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Kawaguchi T, 2014, CLIN GASTROENTEROL H, V12, P1012, DOI 10.1016/j.cgh.2013.08.050; Kawaguchi T, 2011, HEPATOLOGY, V54, P1063, DOI 10.1002/hep.24412; Kawamura E, 2009, LIVER TRANSPLANT, V15, P790, DOI 10.1002/lt.21758; Kim TY, 2014, J KOREAN MED SCI, V29, P1253, DOI 10.3346/jkms.2014.29.9.1253; Kim WR, 2008, NEW ENGL J MED, V359, P1018, DOI 10.1056/NEJMoa0801209; Malinchoc M, 2000, HEPATOLOGY, V31, P864, DOI 10.1053/he.2000.5852; Montano-Loza AJ, 2014, CURR OPIN CLIN NUTR, V17, P219, DOI 10.1097/MCO.0000000000000046; Montano-Loza AJ, 2012, CLIN GASTROENTEROL H, V10, P166, DOI 10.1016/j.cgh.2011.08.028; Ney M, 2015, NUTR CLIN PRACT, V30, P530, DOI 10.1177/0884533614567716; Plauth M, 2011, CURR OPIN CLIN NUTR, V14, P61, DOI 10.1097/MCO.0b013e3283413726; Schwabl P, 2015, LIVER INT, V35, P2121, DOI 10.1111/liv.12795; Tsien C, 2015, HEPATOLOGY, V61, P2018, DOI 10.1002/hep.27717; Wedd J, 2014, LIVER TRANSPLANT, V20, P1193, DOI 10.1002/lt.23929; Weismuller TJ, 2009, TRANSPL INT, V22, P970, DOI 10.1111/j.1432-2277.2009.00915.x; Wong RJ, 2015, LIVER TRANSPLANT, V21, P873, DOI 10.1002/lt.24153; Yoo HY, 2003, AM J GASTROENTEROL, V98, P1395, DOI 10.1016/S0002-9270(03)00240-5	38	28	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159205	10.1371/journal.pone.0159205	http://dx.doi.org/10.1371/journal.pone.0159205			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410482	gold, Green Published, Green Submitted			2022-12-27	WOS:000379508300066
J	Veluchamy, A; Jegu, T; Ariel, F; Latrasse, D; Mariappan, KG; Kim, SK; Crespi, M; Hirt, H; Bergounioux, C; Raynaud, C; Benhamed, M				Veluchamy, Alaguraj; Jegu, Teddy; Ariel, Federico; Latrasse, David; Mariappan, Kiruthiga Gayathri; Kim, Soon-Kap; Crespi, Martin; Hirt, Heribert; Bergounioux, Catherine; Raynaud, Cecile; Benhamed, Moussa			LHP1 Regulates H3K27me3 Spreading and Shapes the Three-Dimensional Conformation of the Arabidopsis Genome	PLOS ONE			English	Article							POLYCOMB REPRESSIVE COMPLEX; FLOWERING-LOCUS-C; DNA-POLYMERASE-ALPHA; EMBRYONIC STEM-CELLS; GROUP PROTEINS; HISTONE H3; CATALYTIC SUBUNIT; NONCODING RNA; GROUP GENE; TRANSCRIPTIONAL REGULATION	Precise expression patterns of genes in time and space are essential for proper development of multicellular organisms. Dynamic chromatin conformation and spatial organization of the genome constitute a major step in this regulation to modulate developmental outputs. Polycomb repressive complexes (PRCs) mediate stable or flexible gene repression in response to internal and environmental cues. In Arabidopsis thaliana, LHP1 co-localizes with H3K27me3 epigenetic marks throughout the genome and interacts with PRC1 and PRC2 members as well as with a long noncoding RNA. Here, we show that LHP1 is responsible for the spreading of H3K27me3 towards the 3' end of the gene body. We also identified a subset of LHP1-activated genes and demonstrated that LHP1 shapes local chromatin topology in order to control transcriptional co-regulation. Our work reveals a general role of LHP1 from local to higher conformation levels of chromatin configuration to determine its accessibility to define gene expression patterns.	[Veluchamy, Alaguraj; Mariappan, Kiruthiga Gayathri; Kim, Soon-Kap; Hirt, Heribert] King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Thuwal 239556900, Saudi Arabia; [Jegu, Teddy; Ariel, Federico; Latrasse, David; Crespi, Martin; Bergounioux, Catherine; Raynaud, Cecile; Benhamed, Moussa] Univ Paris Saclay, Univ Paris Diderot, Univ Evry,Inst Plant Sci Paris Saclay IPS2, Univ Paris 11,Sorbonne Paris Cite,CNRS,INRA, Batiment 630, F-91405 Orsay, France	King Abdullah University of Science & Technology; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay	Benhamed, M (corresponding author), Univ Paris Saclay, Univ Paris Diderot, Univ Evry,Inst Plant Sci Paris Saclay IPS2, Univ Paris 11,Sorbonne Paris Cite,CNRS,INRA, Batiment 630, F-91405 Orsay, France.	moussa.benhamed@u-psud.fr	Ariel, Federico/AAU-6726-2020; Raynaud, Cécile/H-9711-2012; Crespi, Martin/AAB-1424-2020; Veluchamy, Alaguraj/AAW-1680-2020	Ariel, Federico/0000-0001-8478-8808; Raynaud, Cécile/0000-0002-5231-8120; Crespi, Martin/0000-0002-5698-9482; Veluchamy, Alaguraj/0000-0002-5349-5794; MARIAPPAN, Kiruthiga Gayathri/0000-0002-0831-8756; Benhamed, Moussa/0000-0002-4181-1702; Hirt, Heribert/0000-0003-3119-9633	LabExSaclay Plant Sciences-SPS [ANR-10-LABX-0040-SPS]	LabExSaclay Plant Sciences-SPS	TJ was Paris-Sud University PhD fellow. The IPS2 benefits from the support of the LabExSaclay Plant Sciences-SPS (ANR-10-LABX-0040-SPS).r TJ was Paris-Sud University PhD fellow. The IPS2 benefits from the support of the LabExSaclay Plant Sciences-SPS (ANR-10-LABX-0040-SPS).	Aguilo F, 2011, CANCER RES, V71, P5365, DOI 10.1158/0008-5472.CAN-10-4379; Ariel F, 2015, TRENDS PLANT SCI, V20, P362, DOI 10.1016/j.tplants.2015.03.003; Ariel F, 2014, MOL CELL, V55, P383, DOI 10.1016/j.molcel.2014.06.011; Bantignies F, 2011, CELL, V144, P214, DOI 10.1016/j.cell.2010.12.026; Barrero JM, 2007, PLANT CELL, V19, P2822, DOI 10.1105/tpc.107.054130; Berger N, 2011, PLANT CELL, V23, P4065, DOI 10.1105/tpc.111.087866; Bouyer D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002014; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Bratzel F, 2012, MOL PLANT, V5, P260, DOI 10.1093/mp/ssr078; Bratzel F, 2010, CURR BIOL, V20, P1853, DOI 10.1016/j.cub.2010.09.046; Calonje M, 2008, PLANT CELL, V20, P277, DOI 10.1105/tpc.106.049957; Chanvivattana Y, 2004, DEVELOPMENT, V131, P5263, DOI 10.1242/dev.01400; Chen DH, 2010, CELL RES, V20, P1332, DOI 10.1038/cr.2010.151; De Lucia F, 2008, P NATL ACAD SCI USA, V105, P16831, DOI 10.1073/pnas.0808687105; del Olmo I, 2010, PLANT J, V61, P623, DOI 10.1111/j.1365-313X.2009.04093.x; Deleris A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003062; Delest A, 2012, CURR OPIN CELL BIOL, V24, P405, DOI 10.1016/j.ceb.2012.01.008; Deng WW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-593; Denholtz M, 2013, CELL STEM CELL, V13, P602, DOI 10.1016/j.stem.2013.08.013; Derkacheva M, 2014, J EXP BOT, V65, P2769, DOI 10.1093/jxb/ert410; Derkacheva M, 2013, EMBO J, V32, P2073, DOI 10.1038/emboj.2013.145; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; Exner V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005335; Feng SH, 2014, MOL CELL, V55, P694, DOI 10.1016/j.molcel.2014.07.008; Gaudin V, 2001, DEVELOPMENT, V128, P4847; Gendall AR, 2001, CELL, V107, P525, DOI 10.1016/S0092-8674(01)00573-6; Gendrel AV, 2005, NAT METHODS, V2, P213, DOI 10.1038/nmeth0305-213; Gil J, 2004, NAT CELL BIOL, V6, P67, DOI 10.1038/ncb1077; Goodrich J, 1997, NATURE, V386, P44, DOI 10.1038/386044a0; Grob S, 2014, MOL CELL, V55, P678, DOI 10.1016/j.molcel.2014.07.009; Grossniklaus U, 1998, SCIENCE, V280, P446, DOI 10.1126/science.280.5362.446; He GM, 2010, PLANT CELL, V22, P17, DOI 10.1105/tpc.109.072041; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Helliwell CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021513; Heo JB, 2011, SCIENCE, V331, P76, DOI 10.1126/science.1197349; Hyun Y, 2013, DEVELOPMENT, V140, P156, DOI 10.1242/dev.084624; Isono K, 2013, DEV CELL, V26, P565, DOI 10.1016/j.devcel.2013.08.016; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jegu T, 2014, PLANT CELL, V26, P538, DOI 10.1105/tpc.113.114454; Jiang DH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003404; Kim SY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002512; Kim SY, 2010, PLANT PHYSIOL, V152, P516, DOI 10.1104/pp.109.143495; Kohler C, 2003, GENE DEV, V17, P1540, DOI 10.1101/gad.257403; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lafos M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002040; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Latrasse D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016592; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Li H, 2011, MOL PLANT, V4, P748, DOI 10.1093/mp/ssr036; Libault M, 2005, PLANTA, V222, P910, DOI 10.1007/s00425-005-0129-4; Liu C, 2009, DEV CELL, V16, P711, DOI 10.1016/j.devcel.2009.03.011; Liu T, 2011, GENOME RES, V21, P227, DOI 10.1101/gr.115519.110; Lodha M, 2013, GENE DEV, V27, P596, DOI 10.1101/gad.211425.112; Makarevich G, 2006, EMBO REP, V7, P947, DOI 10.1038/sj.embor.7400760; Makarevitch I, 2013, PLANT CELL, V25, P780, DOI 10.1105/tpc.112.106427; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Mozgova I, 2015, ANNU REV PLANT BIOL, V66, P269, DOI 10.1146/annurev-arplant-043014-115627; Nakahigashi K, 2005, PLANT CELL PHYSIOL, V46, P1747, DOI 10.1093/pcp/pci195; Oh SY, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000077; Piacentini L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000670; Rajasekhar VK, 2007, STEM CELLS, V25, P2498, DOI 10.1634/stemcells.2006-0608; Rizzardi K, 2011, PLANT J, V65, P897, DOI 10.1111/j.1365-313X.2010.04470.x; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; Schoenfelder S, 2015, NAT GENET, V47, P1179, DOI 10.1038/ng.3393; Schubert D, 2006, EMBO J, V25, P4638, DOI 10.1038/sj.emboj.7601311; Schwartz YB, 2014, CELL REP, V8, P321, DOI 10.1016/j.celrep.2014.07.001; Schwartz YB, 2013, NAT REV GENET, V14, P853, DOI 10.1038/nrg3603; Sequeira-Mendes J, 2014, PLANT CELL, V26, P2351, DOI 10.1105/tpc.114.124578; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Sheldon CC, 2009, PLANT J, V59, P488, DOI 10.1111/j.1365-313X.2009.03883.x; Sheldon CC, 2002, PLANT CELL, V14, P2527, DOI 10.1105/tpc.004564; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Shen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065598; Shen LS, 2014, DEVELOPMENT, V141, P1303, DOI 10.1242/dev.104513; Sieburth LE, 1997, PLANT CELL, V9, P355, DOI 10.1105/tpc.9.3.355; Terranova R, 2008, DEV CELL, V15, P668, DOI 10.1016/j.devcel.2008.08.015; Tolhuis B, 2006, NAT GENET, V38, P694, DOI 10.1038/ng1792; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Turck F, 2007, PLOS GENET, V3, P855, DOI 10.1371/journal.pgen.0030086; Wang XF, 2009, PLANT CELL, V21, P1053, DOI 10.1105/tpc.109.065714; Wang YZ, 2014, DEV CELL, V28, P727, DOI 10.1016/j.devcel.2014.01.029; Weinhofer I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001152; Wingett Steven, 2015, F1000Res, V4, P1310, DOI 10.12688/f1000research.7334.1; Wolff P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002126; Wutz A, 2011, NAT REV GENET, V12, P542, DOI 10.1038/nrg3035; Xu L, 2008, CURR BIOL, V18, P1966, DOI 10.1016/j.cub.2008.11.019; Yang C, 2013, CURR BIOL, V23, P1324, DOI 10.1016/j.cub.2013.05.050; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Yoshida N, 2001, PLANT CELL, V13, P2471, DOI 10.1105/tpc.13.11.2471; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang X, 2007, NAT STRUCT MOL BIOL, V14, P869, DOI 10.1038/nsmb1283; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	94	74	76	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158936	10.1371/journal.pone.0158936	http://dx.doi.org/10.1371/journal.pone.0158936			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410265	Green Published, gold, Green Submitted			2022-12-27	WOS:000379508300043
J	Ionut, V; Woolcott, OO; Mkrtchyan, HJ; Stefanovski, D; Kabir, M; Iyer, MS; Liu, HW; Castro, AVB; Wu, Q; Broussard, JL; Kolka, CM; Asare-Bediako, I; Bergman, RN				Ionut, Viorica; Woolcott, Orison O.; Mkrtchyan, Hasmik J.; Stefanovski, Darko; Kabir, Morvarid; Iyer, Malini S.; Liu, Huiwen; Castro, Ana V. B.; Wu, Qiang; Broussard, Josiane L.; Kolka, Cathryn M.; Asare-Bediako, Isaac; Bergman, Richard N.			Exenatide Treatment Alone Improves beta-Cell Function in a Canine Model of Pre-Diabetes	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; INSULIN SENSITIVITY; FASTING GLUCOSE; HUMAN ISLETS; EXENDIN-4; RESISTANCE; METFORMIN; RECEPTOR; HOMEOSTASIS; MECHANISM	Background Exenatide's effects on glucose metabolism have been studied extensively in diabetes but not in pre-diabetes. Objective We examined the chronic effects of exenatide alone on glucose metabolism in pre-diabetic canines. Design and Methods After 10 weeks of high-fat diet (HFD), adult dogs received one injection of streptozotocin (STZ, 18.5 mg/kg). After induction of pre-diabetes, while maintained on HFD, animals were randomized to receive either exenatide (n = 7) or placebo (n = 7) for 12 weeks. beta-Cell function was calculated from the intravenous glucose tolerance test (IVGTT, expressed as the acute insulin response, AIR(G)), the oral glucose tolerance test (OGTT, insulinogenic index) and the graded-hyperglycemic clamp (clamp insulinogenic index). Whole-body insulin sensitivity was assessed by the IVGTT. At the end of the study, pancreatic islets were isolated to assess beta-cell function in vitro. Results OGTT: STZ caused an increase in glycemia at 120 min by 22.0% (interquartile range, IQR, 31.5%) (P = 0.011). IVGTT: This protocol also showed a reduction in glucose tolerance by 48.8% (IQR, 36.9%) (P = 0.002). AIRG decreased by 54.0% (IQR, 40.7%) (P = 0.010), leading to mild fasting hyperglycemia (P = 0.039). Exenatide, compared with placebo, decreased body weight (P<0.001) without altering food intake, fasting glycemia, insulinemia, glycated hemoglobin A1c, or glucose tolerance. Exenatide, compared with placebo, increased both OGTT- (P = 0.040) and clamp-based insulinogenic indexes (P = 0.016), improved insulin secretion in vitro (P = 0.041), but had no noticeable effect on insulin sensitivity (P = 0.405). Conclusions In pre-diabetic canines, 12-week exenatide treatment improved beta-cell function but not glucose tolerance or insulin sensitivity. These findings demonstrate partial beneficial metabolic effects of exenatide alone on an animal model of pre-diabetes.	[Ionut, Viorica; Woolcott, Orison O.; Mkrtchyan, Hasmik J.; Stefanovski, Darko; Kabir, Morvarid; Iyer, Malini S.; Castro, Ana V. B.; Wu, Qiang; Broussard, Josiane L.; Kolka, Cathryn M.; Asare-Bediako, Isaac; Bergman, Richard N.] Cedars Sinai Med Ctr, Diabet & Obes Res Inst, Los Angeles, CA 90048 USA; [Liu, Huiwen] Univ Southern Calif, Dept Physiol & Biophys, Los Angeles, CA USA	Cedars Sinai Medical Center; University of Southern California	Bergman, RN (corresponding author), Cedars Sinai Med Ctr, Diabet & Obes Res Inst, Los Angeles, CA 90048 USA.	Richard.Bergman@cshs.org	Woolcott, Orison O./AAQ-3440-2020; Kolka, Cathryn/B-1526-2015; Kabir, Morvarid/P-8154-2018	Woolcott, Orison O./0000-0003-2905-972X; Kolka, Cathryn/0000-0002-6636-7062; Kabir, Morvarid/0000-0003-0880-3767; Bergman, Richard/0000-0003-1539-4471; Iyer, Malini S./0000-0001-7776-7216	National Institutes of Health [DK29867, DK27619]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (DK29867 and DK27619 to RNB) (https://report.nih.gov/award/index.cfm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani MA, 2009, CURR DIABETES REP, V9, P193, DOI 10.1007/s11892-009-0032-7; Ader M, 2014, OBESITY, V22, P1238, DOI 10.1002/oby.20625; [Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005; Armato J, 2012, ENDOCR PRACT, V18, P342, DOI 10.4158/EP11194.OR; Bentsi-Barnes K, 2011, ISLETS, V3, P284, DOI 10.4161/isl.3.5.15938; Bergman RN, 2007, DIABETES, V56, P1489, DOI 10.2337/db07-9903; BERGMAN RN, 1981, J CLIN INVEST, V68, P1456, DOI 10.1172/JCI110398; Bradley DP, 2012, APPL PHYSIOL NUTR ME, V37, P893, DOI [10.1139/H2012-068, 10.1139/h2012-068]; Castro AVB, 2015, OBESITY, V23, P105, DOI 10.1002/oby.20906; Cechin SR, 2012, CELL TRANSPLANT, V21, P633, DOI 10.3727/096368911X576027; Colagiuri S, 2011, MED CLIN N AM, V95, P299, DOI 10.1016/j.mcna.2010.11.003; Deeds MC, 2011, LAB ANIM-UK, V45, P131, DOI 10.1258/la.2010.010090; DeFronzo RA, 2010, DIABETES CARE, V33, P951, DOI [10.2337/dc09-1521, 10.2337/dc10-0646]; Drucker DJ, 2013, DIABETES, V62, P3316, DOI 10.2337/db13-0822; Gallwitz B, 2012, LANCET, V379, P2270, DOI 10.1016/S0140-6736(12)60479-6; Garber AJ, 2011, DIABETES CARE, V34, pS258, DOI 10.2337/dc11-s230; Gastaldelli A, 2014, CLIN ENDOCRINOL, V80, P545, DOI 10.1111/cen.12199; Gedulin BR, 2005, ENDOCRINOLOGY, V146, P2069, DOI 10.1210/en.2004-1349; GOKE R, 1993, J BIOL CHEM, V268, P19650; Hamilton LC., 2008, STAT STATA UPDATED V, P387; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Idris I, 2002, BIOCHEM PHARMACOL, V63, P993, DOI 10.1016/S0006-2952(01)00924-8; Ionut V, 2014, AM J PHYSIOL-ENDOC M, V307, pE644, DOI 10.1152/ajpendo.00244.2014; Ionut V, 2010, AM J PHYSIOL-ENDOC M, V298, pE38, DOI 10.1152/ajpendo.00466.2009; Karve A, 2010, DIABETES CARE, V33, P2355, DOI 10.2337/dc09-1957; Kelly AS, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-64; Kendall DM, 2005, DIABETES CARE, V28, P1083, DOI 10.2337/diacare.28.5.1083; Kim W, 2008, PHARMACOL REV, V60, P470, DOI 10.1124/pr.108.000604; Lotfy M, 2014, J ENDOCRINOL, V220, P291, DOI 10.1530/JOE-13-0426; Lupi R, 2008, DIABETES OBES METAB, V10, P515, DOI 10.1111/j.1463-1326.2007.00838.x; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; Park YJ, 2013, DIABETOLOGIA, V56, P508, DOI 10.1007/s00125-012-2802-z; Parkes DG, 2001, METABOLISM, V50, P583, DOI 10.1053/meta.2001.22519; Richey JM, 2009, AM J PHYSIOL-ENDOC M, V296, pE1311, DOI 10.1152/ajpendo.90972.2008; Rosenstock J, 2010, DIABETES CARE, V33, P1173, DOI 10.2337/dc09-1203; Selph S, 2015, ANN INTERN MED, V162, P765, DOI 10.7326/M14-2221; Stefanovski D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018134; Tella H, 2015, THER ADV ENDOCRINOL, V6, P109, DOI 10.1177/2042018815580257; Vella A, 2002, DIABETOLOGIA, V45, P1410, DOI 10.1007/s00125-002-0924-4; Wang LN, 2011, PEPTIDES, V32, P1313, DOI 10.1016/j.peptides.2011.03.018; Waugh J, 2006, DRUGS, V66, P85, DOI 10.2165/00003495-200666010-00005; Weyer C, 2001, DIABETES CARE, V24, P89, DOI 10.2337/diacare.24.1.89; Woolcott OO, 2006, CELL CALCIUM, V39, P529, DOI 10.1016/j.ceca.2006.02.003; Woolcott OO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123558; Woolcott OO, 2012, PANCREAS, V41, P31, DOI 10.1097/MPA.0b013e318221fd0e; Zheng D, 2009, DIABETES, V58, P352, DOI 10.2337/db08-0875	46	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2016	11	7							e0158703	10.1371/journal.pone.0158703	http://dx.doi.org/10.1371/journal.pone.0158703			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CN	27398720	Green Submitted, gold, Green Published			2022-12-27	WOS:000379508100006
J	Alford, JE; Marongiu, M; Watkins, GL; Anderson, EC				Alford, Justine E.; Marongiu, Michela; Watkins, Gemma L.; Anderson, Emma C.			Human Immunodeficiency Virus Type 2 (HIV-2) Gag Is Trafficked in an AP-3 and AP-5 Dependent Manner	PLOS ONE			English	Article							INTRACELLULAR TRAFFICKING; PLASMA-MEMBRANE; SPASTIC PARAPLEGIA; HUMAN MACROPHAGES; PROTEIN; CELLS; ENDOSOMES; PARTICLES; ASSEMBLES; INFECTION	Although human immunodeficiency virus (HIV) types 1 and 2 are closely related lentiviruses with similar replication cycles, HIV-2 infection is associated with slower progression to AIDS, a higher proportion of long term non-progressors, and lower rates of transmission than HIV-1, likely as a consequence of a lower viral load during HIV-2 infection. A mechanistic explanation for the differential viral load remains unclear but knowledge of differences in particle production between HIV-1 and HIV-2 may help to shed light on this issue. In contrast to HIV-1, little is known about the assembly of HIV-2 particles, and the trafficking of HIV-2 Gag, the structural component of the virus, within cells. We have established that HIV-2 Gag accumulates in intracellular CD63 positive compartments, from which it may be delivered or recycled to the cell surface, or degraded. HIV-2 particle release was dependent on the adaptor protein complex AP-3 and the newly identified AP-5 complex, but much less so on AP-1. In contrast, HIV-1 particle release required AP-1 and AP-3, but not AP-5. AP-2, an essential component of clathrin-mediated endocytosis, which was previously shown to be inhibitory to HIV-1 particle release, had no effect on HIV-2. The differential requirement for adaptor protein complexes confirmed that HIV-1 and HIV-2 Gag have distinct cellular trafficking pathways, and that HIV-2 particles may be more susceptible to degradation prior to release.	[Alford, Justine E.; Marongiu, Michela; Watkins, Gemma L.; Anderson, Emma C.] Univ Warwick, Sch Life Sci, Coventry, W Midlands, England	University of Warwick	Anderson, EC (corresponding author), Univ Warwick, Sch Life Sci, Coventry, W Midlands, England.	e.c.anderson@warwick.ac.uk			UK Medical Research Council [G0701220]; Medical Research Council; MRC [G0701220] Funding Source: UKRI; Medical Research Council [G0701220] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the UK Medical Research Council (grant number G0701220 to ECA). JEA and GLW were recipients of Medical Research Council PhD studentships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091429; Azevedo C, 2009, P NATL ACAD SCI USA, V106, P21161, DOI 10.1073/pnas.0909176106; Batonick M, 2005, VIROLOGY, V342, P190, DOI 10.1016/j.virol.2005.08.001; Camus G, 2007, MOL BIOL CELL, V18, P3193, DOI 10.1091/mbc.E06-12-1147; de Silva TI, 2008, TRENDS MICROBIOL, V16, P588, DOI 10.1016/j.tim.2008.09.003; Denek M, 2007, J CELL BIOL, V177, P329, DOI 10.1083/jcb.200609050; Dong XH, 2005, CELL, V120, P663, DOI 10.1016/j.cell.2004.12.023; Gaudin R, 2012, J CELL BIOL, V199, P467, DOI 10.1083/jcb.201201144; Gousset K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000015; Griffin SDC, 2001, J VIROL, V75, P12058, DOI 10.1128/JVI.75.24.12058-12069.2001; Hirst J, 2013, MOL BIOL CELL, V24, P2558, DOI 10.1091/mbc.E13-03-0170; Hirst J, 2013, TRAFFIC, V14, P153, DOI 10.1111/tra.12028; Hirst J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001170; Hogue IB, 2011, J VIROL, V85, P9749, DOI 10.1128/JVI.00743-11; Hunt SD, 2011, BIOCHEM SOC T, V39, P1179, DOI 10.1042/BST0391179; Jouve M, 2007, CELL HOST MICROBE, V2, P85, DOI 10.1016/j.chom.2007.06.011; Jouvenet N, 2006, PLOS BIOL, V4, P2296, DOI 10.1371/journal.pbio.0040435; KANKI PJ, 1994, LANCET, V343, P943, DOI 10.1016/S0140-6736(94)90065-5; Lee SK, 2012, J BIOL CHEM, V287, P40867, DOI 10.1074/jbc.R112.399444; Liu L, 2012, J VIROL, V86, P11242, DOI 10.1128/JVI.00544-12; LUO LZ, 1990, VIROLOGY, V179, P874, DOI 10.1016/0042-6822(90)90159-O; MacNeil A, 2007, J VIROL, V81, P5325, DOI 10.1128/JVI.02625-06; MARLINK R, 1994, SCIENCE, V265, P1587, DOI 10.1126/science.7915856; Martinez NW, 2008, J VIROL, V82, P9937, DOI 10.1128/JVI.00819-08; Morikawa Y, 2007, J VIROL, V81, P9911, DOI 10.1128/JVI.00027-07; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Ono A, 2004, J VIROL, V78, P1552, DOI 10.1128/JVI.78.3.1552-1563.2004; Pachulska-Wieczorek K, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0245-1; Pelchen-Matthews A, 2003, J CELL BIOL, V162, P443, DOI 10.1083/jcb.200304008; Perlman M, 2006, TRAFFIC, V7, P731, DOI 10.1111/j.1398-9219.2006.00428.x; Popov S, 2011, J VIROL, V85, P3792, DOI 10.1128/JVI.02329-10; Popper SJ, 1999, J INFECT DIS, V180, P1116, DOI 10.1086/315010; Raposo G, 2002, TRAFFIC, V3, P718, DOI 10.1034/j.1600-0854.2002.31004.x; Robinson MS, 2001, CURR OPIN CELL BIOL, V13, P444, DOI 10.1016/S0955-0674(00)00235-0; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Saad JS, 2008, J MOL BIOL, V382, P434, DOI 10.1016/j.jmb.2008.07.027; Sundquist WI, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006924; Zhang FW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002119	39	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158941	10.1371/journal.pone.0158941	http://dx.doi.org/10.1371/journal.pone.0158941			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27392064	Green Published, gold, Green Submitted			2022-12-27	WOS:000380005400167
J	Gan, Q; Wang, D; Ye, J; Zhang, ZS; Wang, XR; Hu, CZ; Shao, PF; Xu, RX				Gan, Qi; Wang, Dong; Ye, Jian; Zhang, Zeshu; Wang, Xinrui; Hu, Chuanzhen; Shao, Pengfei; Xu, Ronald X.			Benchtop and Animal Validation of a Projective Imaging System for Potential Use in Intraoperative Surgical Guidance	PLOS ONE			English	Article							NEAR-INFRARED FLUORESCENCE; BREAST-CONSERVING SURGERY; INDOCYANINE GREEN; CANCER; LYMPHOGRAPHY; PREDICTORS; HANDS; NODE; ICG	We propose a projective navigation system for fluorescence imaging and image display in a natural mode of visual perception. The system consists of an excitation light source, a monochromatic charge coupled device (CCD) camera, a host computer, a projector, a proximity sensor and a Complementary metal-oxide-semiconductor (CMOS) camera. With perspective transformation and calibration, our surgical navigation system is able to achieve an overall imaging speed higher than 60 frames per second, with a latency of 330 ms, a spatial sensitivity better than 0.5 mm in both vertical and horizontal directions, and a projection bias less than 1 mm. The technical feasibility of image-guided surgery is demonstrated in both agar-agar gel phantoms and an ex vivo chicken breast model embedding Indocyanine Green (ICG). The biological utility of the system is demonstrated in vivo in a classic model of ICG hepatic metabolism. Our benchtop, ex vivo and in vivo experiments demonstrate the clinical potential for intraoperative delineation of disease margin and image-guided resection surgery.	[Gan, Qi; Wang, Dong; Ye, Jian; Zhang, Zeshu; Wang, Xinrui; Hu, Chuanzhen; Shao, Pengfei; Xu, Ronald X.] Univ Sci & Technol China, Dept Precis Machinery & Precis Instrumentat, Hefei, Anhui, Peoples R China; [Wang, Dong; Xu, Ronald X.] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; University System of Ohio; Ohio State University	Shao, PF; Xu, RX (corresponding author), Univ Sci & Technol China, Dept Precis Machinery & Precis Instrumentat, Hefei, Anhui, Peoples R China.; Xu, RX (corresponding author), Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA.	spf@ustc.edu.cn; xu.202@osu.edu			Natural Science Foundation of China [81271527, 81327803]; Fundamental Research Funds for the Central Universities [WK2090090013]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This project was funded by Natural Science Foundation of China (Nos. 81271527 and 81327803) and the Fundamental Research Funds for the Central Universities (WK2090090013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apantaku LM, 2002, AM FAM PHYSICIAN, V66, P2271; CHERRICK GR, 1960, J CLIN INVEST, V39, P592, DOI 10.1172/JCI104072; Corlu A, 2007, OPT EXPRESS, V15, P6696, DOI 10.1364/OE.15.006696; Crane LMA, 2011, GYNECOL ONCOL, V120, P291, DOI 10.1016/j.ygyno.2010.10.009; Desmettre T, 2000, SURV OPHTHALMOL, V45, P15, DOI 10.1016/S0039-6257(00)00123-5; El-Desoky A, 1999, BRIT J SURG, V86, P1005, DOI 10.1046/j.1365-2168.1999.01186.x; Fujiwara M, 2009, J PLAST RECONSTR AES, V62, pE373, DOI 10.1016/j.bjps.2007.12.074; Gioux S, 2010, MOL IMAGING, V9, P237, DOI 10.2310/7290.2010.00034; Gurfinkel M, 2000, PHOTOCHEM PHOTOBIOL, V72, P94, DOI 10.1562/0031-8655(2000)072<0094:POIAHC>2.0.CO;2; Hillman EMC, 2007, NAT PHOTONICS, V1, P526, DOI 10.1038/nphoton.2007.146; Hillman EMC, 2011, PHILOS T R SOC A, V369, P4620, DOI 10.1098/rsta.2011.0264; Horst Kathleen C, 2005, Clin Breast Cancer, V5, P425, DOI 10.3816/CBC.2005.n.001; Hutteman M, 2011, EJSO-EUR J SURG ONC, V37, P252, DOI 10.1016/j.ejso.2010.12.014; Kaneko H, 2012, RESP CARE, V57, P1442, DOI 10.4187/respcare.01655; Kang Y, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0004651, 10.1371/journal.pone.0004275]; Kitai Toshiyuki, 2005, Breast Cancer, V12, P211, DOI 10.2325/jbcs.12.211; Lee BT, 2010, PLAST RECONSTR SURG, V126, P1472, DOI 10.1097/PRS.0b013e3181f059c7; Liu Y, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.10.101303; Liu Y, 2011, SURGERY, V149, P689, DOI 10.1016/j.surg.2011.02.007; Meier R, 2012, ARTHRITIS RHEUM-US, V64, P2489, DOI 10.1002/art.34467; Mery E, 2011, GYNECOL ONCOL, V122, P155, DOI 10.1016/j.ygyno.2011.02.035; Michalet X, 2006, P NATL ACAD SCI USA, V103, P4797, DOI 10.1073/pnas.0600808103; Mieog JSD, 2010, MOL IMAGING, V9, P223, DOI 10.2310/7290.2010.00014; Miyashiro I, 2008, ANN SURG ONCOL, V15, P1640, DOI 10.1245/s10434-008-9872-7; Morita Y, 2013, INT J CLIN ONCOL, V18, P232, DOI 10.1007/s10147-011-0367-3; Park CC, 2000, J CLIN ONCOL, V18, P1668, DOI 10.1200/JCO.2000.18.8.1668; Saxena V, 2006, INT J PHARMACEUT, V308, P200, DOI 10.1016/j.ijpharm.2005.11.003; Schaafsma BE, 2011, J SURG ONCOL, V104, P323, DOI 10.1002/jso.21943; Shao PF, 2014, ANN BIOMED ENG, V42, P2228, DOI 10.1007/s10439-014-1062-0; Smitt MC, 2003, INT J RADIAT ONCOL, V57, P979, DOI 10.1016/S0360-3016(03)00740-5; Tagaya N, 2008, AM J SURG, V195, P850, DOI 10.1016/j.amjsurg.2007.02.032; Tan IC, 2011, ARCH PHYS MED REHAB, V92, P756, DOI 10.1016/j.apmr.2010.12.027; Tanaka E, 2008, SURGERY, V144, P39, DOI 10.1016/j.surg.2008.03.017; Themelis G, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3259362; Troyan SL, 2009, ANN SURG ONCOL, V16, P2943, DOI 10.1245/s10434-009-0594-2; van der Poel HG, 2011, EUR UROL, V60, P826, DOI 10.1016/j.eururo.2011.03.024; Vogt PR, 2003, THORAC CARDIOV SURG, V51, P49, DOI 10.1055/s-2003-37276; Waljee JF, 2008, ANN SURG ONCOL, V15, P1297, DOI 10.1245/s10434-007-9777-x; Weber WP, 2008, WORLD J SURG, V32, P2599, DOI 10.1007/s00268-008-9757-8; Wu JR, 2014, COMPUT METH PROG BIO, V113, P869, DOI 10.1016/j.cmpb.2013.12.021; Yamamoto T, 2011, PLAST RECONSTR SURG, V128, P941, DOI 10.1097/PRS.0b013e3182268cd9; Yaseen MA, 2009, MOL PHARMACEUT, V6, P1321, DOI 10.1021/mp800270t; Yuasa Y, 2012, ANN SURG ONCOL, V19, P486, DOI 10.1245/s10434-011-1922-x	43	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0157794	10.1371/journal.pone.0157794	http://dx.doi.org/10.1371/journal.pone.0157794			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391764	Green Submitted, Green Published, gold			2022-12-27	WOS:000380005400021
J	Monaghan, KA				Monaghan, Kieran A.			Four Reasons to Question the Accuracy of a Biotic Index; the Risk of Metric Bias and the Scope to Improve Accuracy	PLOS ONE			English	Article							WATER-QUALITY; INDICATOR VALUES; ABUNDANCE; TOOL; REAPPRAISAL; ORGANISMS; MODEL	Natural ecological variability and analytical design can bias the derived value of a biotic index through the variable influence of indicator body-size, abundance, richness, and ascribed tolerance scores. Descriptive statistics highlight this risk for 26 aquatic indicator systems; detailed analysis is provided for contrasting weighted-average indices applying the example of the BMWP, which has the best supporting data. Differences in body size between taxa from respective tolerance classes is a common feature of indicator systems; in some it represents a trend ranging from comparatively small pollution tolerant to larger intolerant organisms. Under this scenario, the propensity to collect a greater proportion of smaller organisms is associated with negative bias however, positive bias may occur when equipment (e.g. mesh-size) selectively samples larger organisms. Biotic indices are often derived from systems where indicator taxa are unevenly distributed along the gradient of tolerance classes. Such skews in indicator richness can distort index values in the direction of taxonomically rich indicator classes with the subsequent degree of bias related to the treatment of abundance data. The misclassification of indicator taxa causes bias that varies with the magnitude of the misclassification, the relative abundance of misclassified taxa and the treatment of abundance data. These artifacts of assessment design can compromise the ability to monitor biological quality. The statistical treatment of abundance data and the manipulation of indicator assignment and class richness can be used to improve index accuracy. While advances in methods of data collection (i.e. DNA barcoding) may facilitate improvement, the scope to reduce systematic bias is ultimately limited to a strategy of optimal compromise. The shortfall in accuracy must be addressed by statistical pragmatism. At any particular site, the net bias is a probabilistic function of the sample data, resulting in an error variance around an average deviation. Following standardized protocols and assigning precise reference conditions, the error variance of their comparative ratio (test-site: reference) can be measured and used to estimate the accuracy of the resultant assessment.	[Monaghan, Kieran A.] Univ Aveiro, CESAM Ctr Environm & Marine Studies, Campus Univ Santiago, P-3810193 Aveiro, Portugal; [Monaghan, Kieran A.] Univ Aveiro, Dept Biol, Campus Univ Santiago, P-3810193 Aveiro, Portugal	Universidade de Aveiro; Universidade de Aveiro	Monaghan, KA (corresponding author), Univ Aveiro, CESAM Ctr Environm & Marine Studies, Campus Univ Santiago, P-3810193 Aveiro, Portugal.; Monaghan, KA (corresponding author), Univ Aveiro, Dept Biol, Campus Univ Santiago, P-3810193 Aveiro, Portugal.	kamonaghan@ua.pt		monaghan, kieran/0000-0002-3063-7817	CESAM [UID/AMB/50017]; FCT/MEC through national funds; FEDER, within the PT Partnership Agreement and Compete; FCT fellowship [SFRH/BPD98533/2013]	CESAM; FCT/MEC through national funds(Portuguese Foundation for Science and Technology); FEDER, within the PT Partnership Agreement and Compete; FCT fellowship(Portuguese Foundation for Science and Technology)	Thanks are due, for the financial support to CESAM (UID/AMB/50017), to FCT/MEC through national funds, and the co-funding by the FEDER, within the PT2020 Partnership Agreement and Compete 2020. KAM is recipient of FCT fellowship (SFRH/BPD98533/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN MM, 1984, WATER RES, V18, P145, DOI 10.1016/0043-1354(84)90062-9; Andersen T., 2013, INSECT SYST EVOL SUP, V66, P1; [Anonymous], 2000, OFFICIAL J EUROPEAN, V327; Armitage P. D., 1995, CHIRONOMIDAE BIOL EC; ARMITAGE PD, 1983, WATER RES, V17, P333, DOI 10.1016/0043-1354(83)90188-4; Baird DJ, 2012, MOL ECOL, V21, P2039, DOI 10.1111/j.1365-294X.2012.05519.x; Bennett C, 2011, HYDROBIOLOGIA, V667, P31, DOI 10.1007/s10750-011-0635-2; Besse-Lototskaya A, 2011, ECOL INDIC, V11, P456, DOI 10.1016/j.ecolind.2010.06.017; Birk S, 2012, ECOL INDIC, V18, P31, DOI 10.1016/j.ecolind.2011.10.009; Borja A, 2000, MAR POLLUT BULL, V40, P1100, DOI 10.1016/S0025-326X(00)00061-8; Brinkhurst R. O., 1971, AQUATIC OLIGOCHAETA; Cao Y, 2002, ECOL MONOGR, V72, P41, DOI 10.1890/0012-9615(2002)072[0041:COECTP]2.0.CO;2; Carlisle DM, 2007, ECOL INDIC, V7, P22, DOI 10.1016/j.ecolind.2005.09.005; Chilundo M, 2008, PHYS CHEM EARTH, V33, P655, DOI 10.1016/j.pce.2008.06.055; Clarke RT, 2013, HYDROBIOLOGIA, V704, P39, DOI 10.1007/s10750-012-1245-3; Council of the European Communities, 1992, OFFICIAL J EUROPEAN, V35, P7, DOI DOI 10.1017/CB09780511610851.039; DAMUTH J, 1981, NATURE, V290, P699, DOI 10.1038/290699a0; Deiner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088786; Demars BOL, 2012, FRESHWATER BIOL, V57, P1745, DOI 10.1111/j.1365-2427.2012.02834.x; Diaz RJ, 2004, J ENVIRON MANAGE, V73, P165, DOI 10.1016/j.jenvman.2004.06.004; Diekmann M, 2003, BASIC APPL ECOL, V4, P493, DOI 10.1078/1439-1791-00185; Dornelas M, 2014, SCIENCE, V344, P296, DOI 10.1126/science.1248484; ELLENBERG H., 1948, Berichte uber Landtechnik, V4, P130; Feio MJ, 2006, INT REV HYDROBIOL, V91, P509, DOI 10.1002/iroh.200610877; Gray BR, 2005, ECOL MODEL, V185, P1, DOI 10.1016/j.ecolmodel.2004.11.006; Hawkes HA, 1998, WATER RES, V32, P964, DOI 10.1016/S0043-1354(97)00275-3; Hayek LC, 1997, SURVEYING NATURAL PO; Hildrew Alan G., 2007, P326; HILSENHOFF W L, 1988, Journal of the North American Benthological Society, V7, P65, DOI 10.2307/1467832; HILSENHOFF WL, 1987, GREAT LAKES ENTOMOL, V20, P31; Hudson PL, 1998, J KANSAS ENTOMOL SOC, V71, P456; Jaynes ET, 2003, PROBABILITY THEORY L, P753; Kelly M, 2011, ECOL INDIC, V11, P1492, DOI 10.1016/j.ecolind.2011.02.014; Kelly MG, 1998, WATER RES, V32, P236, DOI 10.1016/S0043-1354(97)00157-7; KLERKS PL, 1987, ENVIRON POLLUT, V45, P173, DOI 10.1016/0269-7491(87)90057-1; Kolkwitz R., 1902, MITT PRUFUNGSANST WA, V1, P33; LENAT DR, 1993, J N AM BENTHOL SOC, V12, P279, DOI 10.2307/1467463; Lenoir A, 1996, P INT S INNSBR AUSTR; Magurran A.E, 2004, MEASURING BIOL DIVER; Magurran AE, 2003, NATURE, V422, P714, DOI 10.1038/nature01547; McGill BJ, 2007, ECOL LETT, V10, P995, DOI 10.1111/j.1461-0248.2007.01094.x; Monaghan KA, 2015, HYDROBIOLOGIA, V760, P91, DOI 10.1007/s10750-015-2307-0; Niyogi S, 2004, ENVIRON SCI TECHNOL, V38, P6177, DOI 10.1021/es0496524; Norris RH, 1993, FRESHWATER BIOMONITO; PFRENDER ME, 2010, Q REV BIOL, V85, P319, DOI DOI 10.1086/655118; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; R Core Team, 2021, R LANGUAGE ENV STAT; Ranasinghe JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040875; Rimet F, 2012, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2012018; Round FE, 2007, DIATOMS BIOL MORPHOL; Schmidt-Kloiber A, 2015, ECOL INDIC, V53, P271, DOI 10.1016/j.ecolind.2015.02.007; Silveira MP, 2005, ENVIRON MONIT ASSESS, V101, P117; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Tachet H., 2000, INVERTEBRES EAU DOUC; TAYLOR LR, 1961, NATURE, V189, P732, DOI 10.1038/189732a0; TAYLOR LR, 1978, J ANIM ECOL, V47, P383, DOI 10.2307/3790; Ter Braak C. J. F., 1995, P91; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Tokeshi M, 2002, POPUL ECOL, V44, P189, DOI 10.1007/s101440200022; UK National Biodiversity Network, SEPA MACR DAT SCOTT; Valentini A, 2016, MOL ECOL, V25, P929, DOI 10.1111/mec.13428; Walley WJ, 2001, WATER RES, V35, P4285, DOI 10.1016/S0043-1354(01)00162-2; Walley WJ, 1996, WATER RES, V30, P2086, DOI 10.1016/0043-1354(96)00013-9; Warwick RM, 2010, MAR POLLUT BULL, V60, P554, DOI 10.1016/j.marpolbul.2009.11.009; WARWICK RM, 1986, MAR BIOL, V92, P557, DOI 10.1007/BF00392515; Whitfield J, 2001, NATURE, V411, P989, DOI 10.1038/35082694; Wright John F., 2000, P1	68	9	9	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158383	10.1371/journal.pone.0158383	http://dx.doi.org/10.1371/journal.pone.0158383			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27392036	Green Submitted, gold, Green Published			2022-12-27	WOS:000380005400050
J	Mozar, A; Lin, H; Williams, K; Chin, C; Li, R; Kondegowda, NG; Stewart, AF; Garcia-Ocana, A; Vasavada, RC				Mozar, Anais; Lin, Hugo; Williams, Katoura; Chin, Connie; Li, Rosemary; Kondegowda, Nagesha Guthalu; Stewart, Andrew F.; Garcia-Ocana, Adolfo; Vasavada, Rupangi Chhaya			Parathyroid Hormone-Related Peptide (1-36) Enhances Beta Cell Regeneration and Increases Beta Cell Mass in a Mouse Model of Partial Pancreatectomy	PLOS ONE			English	Article							ISLET HYPERPLASIA; IN-VIVO; PROTEIN; PROLIFERATION; ACTIVATION; KINASE; GROWTH; OVEREXPRESSION; MECHANISMS; INDUCTION	Aims/Hypothesis Finding ways to stimulate the regeneration of endogenous pancreatic beta cells is an important goal in the treatment of diabetes. Parathyroid hormone-related protein (PTHrP), the full-length (1-139) and amino-terminal (1-36) peptides, enhance beta cell function, proliferation, and survival. Therefore, we hypothesize that PTHrP(1-36) has the potential to regenerate endogenous beta cells. Methods The partial pancreatectomy (PPx) mouse model of beta cell injury was used to test this hypothesis. Male Balb/c mice underwent either sham-operation or PPx, and were subsequently injected with PTHrP(1-36) (160 mu g/kg) or vehicle (veh), for 7, 30, or 90 days. The four groups of mice, sham-veh, sham-PTHrP, PPx-veh, and PPx-PTHrP were assessed for PTHrP and receptor expression, and glucose and beta cell homeostasis. Results PTHrP-receptor, but not the ligand, was significantly up-regulated in islets from mice that underwent PPx compared to sham-operated mice. This suggests that exogenous PTHrP could further enhance beta cell regeneration after PPx. PTHrP did not significantly affect body weight, blood glucose, plasma insulin, or insulin sensitivity, in either sham or PPx mice. Glucose tolerance improved in the PPx-PTHrP versus PPx-veh mice only in the early stages of treatment. As hypothesized, there was a significant increase in beta cell proliferation in PPx-PTHrP mice at days 7 and 30; however, this was normalized by day 90, compared to PPx-veh mice. Enhanced beta cell proliferation translated to a marked increase in beta cell mass at day 90, in PPx-PTHrP versus PPx-veh mice. Conclusions PTHrP(1-36) significantly enhances beta cell regeneration through increased beta cell proliferation and beta cell mass after PPx. Future studies will determine the potential of PTHrP to enhance functional beta cell mass in the setting of diabetes.	[Mozar, Anais; Li, Rosemary; Kondegowda, Nagesha Guthalu; Stewart, Andrew F.; Garcia-Ocana, Adolfo; Vasavada, Rupangi Chhaya] Icahn Sch Med Mt Sinai, Diabet Obes & Metab Inst, New York, NY 10029 USA; [Lin, Hugo; Williams, Katoura; Chin, Connie] Univ Pittsburgh, Div Endocrinol, Pittsburgh, PA USA; [Mozar, Anais] Univ Antilles Guyane, CHU Pointe A Pitre, UMR Inserm U1134, Pointe A Pitre, Guadeloupe, France; [Williams, Katoura] Univ Tennessee, Grad Sch Med, Knoxville, TN USA; [Chin, Connie] Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA	Icahn School of Medicine at Mount Sinai; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; CHU Guadeloupe; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite des Antilles; University of Tennessee System; University of Tennessee Health Science Center; Case Western Reserve University	Vasavada, RC (corresponding author), Icahn Sch Med Mt Sinai, Diabet Obes & Metab Inst, New York, NY 10029 USA.	rupangi.vasavada@mssm.edu		Li, Rosemary/0000-0002-2605-634X	National Institutes of Health [DK078060]; Juvenile Diabetes Research Foundation [17-2012-46]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105015, P30DK020541, R01DK102893] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health (DK078060) and the Juvenile Diabetes Research Foundation (17-2012-46) to RCV.	Alvarez-Perez JC, 2014, DIABETES, V63, P216, DOI 10.2337/db13-0333; ASA SL, 1990, J CLIN ENDOCR METAB, V71, P1112, DOI 10.1210/jcem-71-5-1112; Augustine M, 2013, CURR OSTEOPOROS REP, V11, P400, DOI 10.1007/s11914-013-0171-2; Bellido T, 2003, J BIOL CHEM, V278, P50259, DOI 10.1074/jbc.M307444200; Boggi U, 2013, CURR OPIN ORGAN TRAN, V18, P102, DOI 10.1097/MOT.0b013e32835c28c5; Bonner-Weir S, 2010, DIABETES, V59, P2340, DOI 10.2337/db10-0084; Cebrian A, 2002, DIABETES, V51, P3003, DOI 10.2337/diabetes.51.10.3003; De Leon DD, 2003, DIABETES, V52, P365, DOI 10.2337/diabetes.52.2.365; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; DRUCKER DJ, 1989, MOL ENDOCRINOL, V3, P1589, DOI 10.1210/mend-3-10-1589; Faucheux C, 2004, DEV DYNAM, V231, P88, DOI 10.1002/dvdy.20117; de Castro LF, 2010, TISSUE ENG PT A, V16, P1157, DOI 10.1089/ten.TEA.2009.0355; Frolik CA, 2003, BONE, V33, P372, DOI 10.1016/S8756-3282(03)00202-3; Fujinaka Y, 2004, DIABETES, V53, P3120, DOI 10.2337/diabetes.53.12.3120; Gremizzi C, 2010, CURR OPIN ORGAN TRAN, V15, P119, DOI 10.1097/MOT.0b013e32833552bc; Guo J, 1997, AM J PHYSIOL-ENDOC M, V273, pE383, DOI 10.1152/ajpendo.1997.273.2.E383; Horwitz MJ, 2003, J CLIN ENDOCR METAB, V88, P569, DOI 10.1210/jc.2002-021122; Kondegowda NG, 2010, DIABETES, V59, P3131, DOI 10.2337/db09-1796; Kudo S, 2011, OSTEOARTHR CARTILAGE, V19, P886, DOI 10.1016/j.joca.2011.04.007; Lee JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008653; Macica CM, 2006, GLIA, V53, P637, DOI 10.1002/glia.20319; McCall M, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007823; Misfeldt AA, 2008, DIABETES, V57, P3069, DOI 10.2337/db08-0878; Perl S, 2010, J CLIN ENDOCR METAB, V95, pE234, DOI 10.1210/jc.2010-0932; Philbrick WM, 1996, PHYSIOL REV, V76, P127, DOI 10.1152/physrev.1996.76.1.127; PLAWNER LL, 1995, J BIOL CHEM, V270, P14078, DOI 10.1074/jbc.270.23.14078; Porter SE, 1998, ENDOCRINOLOGY, V139, P3743, DOI 10.1210/en.139.9.3743; Rieck S, 2010, TRENDS ENDOCRIN MET, V21, P151, DOI 10.1016/j.tem.2009.11.001; Sachdeva MM, 2009, MOL ENDOCRINOL, V23, P747, DOI 10.1210/me.2008-0400; Sawada Y, 2001, MOL CELL ENDOCRINOL, V182, P265, DOI 10.1016/S0303-7207(01)00482-8; Sawada Y, 2000, ENDOCR PATHOL, V11, P31, DOI 10.1385/EP:11:1:31; Teta M, 2005, DIABETES, V54, P2557, DOI 10.2337/diabetes.54.9.2557; Tschen SI, 2009, DIABETES, V58, P1312, DOI 10.2337/db08-1651; Vasavada RC, 1996, J BIOL CHEM, V271, P1200, DOI 10.1074/jbc.271.2.1200; Vasavada RC, 2007, DIABETES, V56, P2732, DOI 10.2337/db07-0461; Vilardaga JP, 2011, CELL MOL LIFE SCI, V68, P1, DOI 10.1007/s00018-010-0465-9; Villanueva-Penacarrillo ML, 1999, J ENDOCRINOL, V163, P403, DOI 10.1677/joe.0.1630403; Williams K, 2011, DIABETOLOGIA, V54, P2867, DOI 10.1007/s00125-011-2260-z; Wysolmerski JJ, 2012, J CLIN ENDOCR METAB, V97, P2947, DOI 10.1210/jc.2012-2142; Zhang B, 2003, DIABETES, V52, P2720, DOI 10.2337/diabetes.52.11.2720	40	12	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158414	10.1371/journal.pone.0158414	http://dx.doi.org/10.1371/journal.pone.0158414			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391423	Green Submitted, Green Published, gold			2022-12-27	WOS:000380005400057
J	Mutyambai, DM; Bruce, TJA; van den Berg, J; Midega, CAO; Pickett, JA; Khan, ZR				Mutyambai, Daniel M.; Bruce, Toby J. A.; van den Berg, Johnnie; Midega, Charles A. O.; Pickett, John A.; Khan, Zeyaur R.			An Indirect Defence Trait Mediated through Egg-Induced Maize Volatiles from Neighbouring Plants	PLOS ONE			English	Article							HERBIVORE-INDUCED VOLATILES; INDUCED RESISTANCE; CHILO-PARTELLUS; SPIDER-MITES; STEM BORERS; CIS-JASMONE; OVIPOSITION; RESPONSES; SIGNALS; APHID	Attack of plants by herbivorous arthropods may result in considerable changes to the plant's chemical phenotype with respect to emission of herbivore-induced plant volatiles (HIPVs). These HIPVs have been shown to act as repellents to the attacking insects as well as attractants for the insects antagonistic to these herbivores. Plants can also respond to HIPV signals from other plants that warn them of impending attack. Recent investigations have shown that certain maize varieties are able to emit volatiles following stemborer egg deposition. These volatiles attract the herbivore's parasitoids and directly deter further oviposition. However, it was not known whether these oviposition-induced maize (Zea mays, L.) volatiles can mediate chemical phenotypic changes in neighbouring unattacked maize plants. Therefore, this study sought to investigate the effect of oviposition-induced maize volatiles on intact neighbouring maize plants in 'Nyamula', a landrace known to respond to oviposition, and a standard commercial hybrid, HB515, that did not. Headspace volatile samples were collected from maize plants exposed to Chilo partellus (Swinhoe) (Lepidoptera: Crambidae) egg deposition and unoviposited neighbouring plants as well as from control plants kept away from the volatile emitting ones. Behavioural bioassays were carried out in a four-arm olfactometer using egg (Trichogramma bournieri Pintureau & Babault (Hymenoptera: Trichogrammatidae)) and larval (Cotesia sesamiae Cameron (Hymenoptera: Braconidae)) parasitoids. Coupled Gas Chromatography-Mass Spectrometry (GC-MS) was used for volatile analysis. For the ` Nyamula' landrace, GC-MS analysis revealed HIPV production not only in the oviposited plants but also in neighbouring plants not exposed to insect eggs. Higher amounts of EAG-active biogenic volatiles such as (E)-4,8-dimethyl-1,3,7-nonatriene were emitted from these plants compared to control plants. Subsequent behavioural assays with female T. bournieri and C. sesamiae parasitic wasps indicated that these parasitoids preferred volatiles from oviposited and neighbouring landrace plants compared to those from the control plants. This effect was absent in the standard commercial hybrid we tested. There was no HIPV induction and no difference in parasitoid attraction in neighbouring and control hybrid maize plants. These results show plant-plant signalling: 'Nyamula' maize plants emitting oviposition-induced volatiles attractive to the herbivore's natural enemies can induce this indirect defence trait in conspecific neighbouring undamaged maize plants. Maize plants growing in a field may thus benefit from this indirect defence through airborne signalling which may enhance the fitness of the volatile-emitting plant by increasing predation pressure on herbivores.	[Mutyambai, Daniel M.; Midega, Charles A. O.; Khan, Zeyaur R.] Int Ctr Insect Physiol & Ecol, Habitat Management Programme, POB 30-40305, Mbita, Kenya; [van den Berg, Johnnie; Khan, Zeyaur R.] North West Univ, Sch Biol Sci, ZA-2520 Potchefstroom, South Africa; [Mutyambai, Daniel M.] South Eastern Kenya Univ, Dept Biol, POB 170-90200, Kitui, Kenya; [Bruce, Toby J. A.; Pickett, John A.] Rothamsted Res, Dept Biol Chem, Harpenden AL5 2JQ, Herts, England	International Centre of Insect Physiology & Ecology (ICIPE); North West University - South Africa; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Mutyambai, DM (corresponding author), Int Ctr Insect Physiol & Ecol, Habitat Management Programme, POB 30-40305, Mbita, Kenya.; Mutyambai, DM (corresponding author), South Eastern Kenya Univ, Dept Biol, POB 170-90200, Kitui, Kenya.	dmutyambai@icipe.org	Van den Berg, Johnnie/M-7256-2013; Bruce, Toby JA/H-3131-2011	Van den Berg, Johnnie/0000-0002-6831-3180; Bruce, Toby JA/0000-0002-9912-0605	German Academic Exchange [A/11/94849]; European Union [DCI-FOOD.2010/230224]; German Academic Exchange (DAAD) fellowship; Biotechnology and Biological Sciences Research Council (BBSRC); Biotechnology and Biological Sciences Research Council [BBS/E/C/00004945, BBS/E/C/00004944, BB/J011371/1, BBS/E/C/00005194, BB/J020281/1] Funding Source: researchfish; BBSRC [BBS/E/C/00005194, BB/J020281/1, BBS/E/C/00004945, BB/J011371/1, BBS/E/C/00004944] Funding Source: UKRI	German Academic Exchange(Deutscher Akademischer Austausch Dienst (DAAD)); European Union(European Commission); German Academic Exchange (DAAD) fellowship(Deutscher Akademischer Austausch Dienst (DAAD)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by German Academic Exchange, A/11/94849 (https://www.daad.de/en/) and European Union DCI-FOOD.2010/230224 (http://europa.eu/index_en.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to local farmers in Homabay County, Kenya, for providing landrace maize seeds. We thank Amos Gadi, Isaac Odera, Silas Ouko, Kennedy Omendo and Daniel Simiyu for insect rearing, technical assistance and screen house operations. Financial support was from German Academic Exchange (DAAD) fellowship to Daniel Mutyambai and European Union funded ADOPT Project DCI-FOOD.2010/230224. Rothamsted Research receives grant-aided support from Biotechnology and Biological Sciences Research Council (BBSRC).	Agelopoulos NG, 1999, J CHEM ECOL, V25, P1411, DOI 10.1023/A:1020939112234; [Anonymous], 2005, NIST MASS SPECTR SEA; [Anonymous], 2013, R3 0 R FDN STAT COMP; Arimura G, 2000, NATURE, V406, P512, DOI 10.1038/35020072; Arimura G, 2002, PLANT J, V29, P87, DOI 10.1046/j.1365-313x.2002.01198.x; Arimura G, 2001, BIOCHEM SYST ECOL, V29, P1049, DOI 10.1016/S0305-1978(01)00049-7; Arimura G, 2009, PLANT CELL PHYSIOL, V50, P911, DOI 10.1093/pcp/pcp030; BALDWIN IT, 1983, SCIENCE, V221, P277, DOI 10.1126/science.221.4607.277; Bate NJ, 1998, PLANT J, V16, P561, DOI 10.1046/j.1365-313x.1998.00324.x; Birkett MA, 2000, P NATL ACAD SCI USA, V97, P9329, DOI 10.1073/pnas.160241697; Bruce TJA, 2003, PEST MANAG SCI, V59, P1031, DOI 10.1002/ps.730; Bruce TJA, 2010, BIOL LETTERS, V6, P314, DOI 10.1098/rsbl.2009.0953; BRUIN J, 1992, EXPERIENTIA, V48, P525, DOI 10.1007/BF01928181; Chamberlain K, 2001, BIOCHEM SYST ECOL, V29, P1063, DOI 10.1016/S0305-1978(01)00050-3; Chamberlain K, 2014, SKVORTSOVIA, V1, P112; Chamberlain K, 2000, MOL PLANT PATHOL, V1, P67, DOI 10.1046/j.1364-3703.2000.00009.x; Dicke M, 2009, NAT CHEM BIOL, V5, P317, DOI 10.1038/nchembio.169; Engelberth J, 2004, P NATL ACAD SCI USA, V101, P1781, DOI 10.1073/pnas.0308037100; Penaflor MFGV, 2011, PLANTA, V234, P207, DOI 10.1007/s00425-011-1409-9; FOWLER SV, 1985, AM NAT, V126, P181, DOI 10.1086/284408; Gomi K, 2003, J PLANT PHYSIOL, V160, P1219, DOI 10.1078/0176-1617-01177; Gouinguene S, 2001, CHEMOECOLOGY, V11, P9, DOI 10.1007/PL00001832; Heil M, 2008, TRENDS PLANT SCI, V13, P264, DOI 10.1016/j.tplants.2008.03.005; Heil M, 2008, NEW PHYTOL, V178, P41, DOI 10.1111/j.1469-8137.2007.02330.x; Hilker M, 2002, ENTOMOL EXP APPL, V104, P181, DOI 10.1023/A:1021232319226; Hilker M, 2006, J CHEM ECOL, V32, P1379, DOI 10.1007/s10886-006-9057-4; Hoballah ME, 2004, OIKOS, V105, P168, DOI 10.1111/j.0030-1299.2004.12831.x; Hoballah MEF, 2002, J CHEM ECOL, V28, P951, DOI 10.1023/A:1015253600083; Karban R, 2000, OECOLOGIA, V125, P66, DOI 10.1007/PL00008892; Karban R, 2002, ECOLOGY, V83, P1209, DOI 10.1890/0012-9658(2002)083[1209:TFCOIE]2.0.CO;2; Karban R., 1997, INDUCED RESPONSES HE, DOI [DOI 10.7208/CHICAG0/9780226424972.001.0001, 10.7208/chicago/9780226424972.001.0001]; Karban R, 2011, FUNCT ECOL, V25, P339, DOI 10.1111/j.1365-2435.2010.01789.x; Kessler A, 2002, ANNU REV PLANT BIOL, V53, P299, DOI 10.1146/annurev.arplant.53.100301.135207; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Kfir R, 2002, ANNU REV ENTOMOL, V47, P701, DOI 10.1146/annurev.ento.47.091201.145254; Khan ZR, 2010, J EXP BOT, V61, P4185, DOI 10.1093/jxb/erq229; Khan ZR, 1997, NATURE, V388, P631, DOI 10.1038/41681; Kost C, 2006, J ECOL, V94, P619, DOI 10.1111/j.1365-2745.2006.01120.x; Mutyambai DM, 2015, J CHEM ECOL, V41, P323, DOI 10.1007/s10886-015-0570-1; Mutyambai DM, 2014, ENTOMOL EXP APPL, V153, P170, DOI 10.1111/eea.12237; Mutyambai DM, 2015, THESIS; Ninkovic V, 2002, ENTOMOL EXP APPL, V102, P177, DOI 10.1023/A:1015851430481; OCHIENG RS, 1985, INSECT SCI APPL, V6, P425, DOI 10.1017/S1742758400004744; Overholt WA, 1994, INSECT SCI APPL, V15, P253, DOI 10.1017/S1742758400017549; Paschold A, 2006, PLANT J, V45, P275, DOI 10.1111/j.1365-313X.2005.02623.x; Pettersson J, 1999, ACTA AGR SCAND B-S P, V49, P152, DOI 10.1080/09064719909362511; PETTERSSON J, 1970, Entomologica Scandinavica, V1, P63; Pickett JA, 2001, TRENDS PLANT SCI, V6, P137, DOI 10.1016/S1360-1385(01)01899-4; Pickett JA, 2014, CURR OPIN BIOTECH, V26, P125, DOI 10.1016/j.copbio.2013.12.006; Pieterse CMJ, 2007, TRENDS PLANT SCI, V12, P564, DOI 10.1016/j.tplants.2007.09.004; Roda AL, 2003, BASIC APPL ECOL, V4, P15, DOI 10.1078/1439-1791-00130; Rodriguez-Saona CR, 2009, J CHEM ECOL, V35, P163, DOI 10.1007/s10886-008-9579-z; Ruther J, 2005, J CHEM ECOL, V31, P2217, DOI 10.1007/s10886-005-6413-8; Giron-Calva PS, 2012, J CHEM ECOL, V38, P226, DOI 10.1007/s10886-012-0072-3; Schaller A., 2008, INDUCED PLANT RESIST; SHONLE I, 1995, ECOLOGY, V76, P2660, DOI 10.2307/2265837; Shulaev V, 1997, NATURE, V385, P718, DOI 10.1038/385718a0; Takabayashi J., 1991, Chemoecology, VNo. 2, P1, DOI 10.1007/BF01240659; Tamiru A, 2015, CURR OPIN INSECT SCI, V9, P51, DOI 10.1016/j.cois.2015.02.011; Tamiru A, 2012, J CHEM ECOL, V38, P231, DOI 10.1007/s10886-012-0082-1; Tamiru A, 2011, ECOL LETT, V14, P1075, DOI 10.1111/j.1461-0248.2011.01674.x; Tscharntke T, 2001, BIOCHEM SYST ECOL, V29, P1025, DOI 10.1016/S0305-1978(01)00048-5; Turlings TCJ, 1998, BIOL CONTROL, V11, P122, DOI 10.1006/bcon.1997.0591; van den Berg J., 1998, P333; Van den Berg J., 1998, AFRICAN CEREAL STEMB; War AR, 2011, PLANT SIGNAL BEHAV, V6, P1973, DOI 10.4161/psb.6.12.18053	66	12	13	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158744	10.1371/journal.pone.0158744	http://dx.doi.org/10.1371/journal.pone.0158744			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27392034	Green Published, gold, Green Accepted			2022-12-27	WOS:000380005400114
J	Natusch, DJD; Lyons, JA; Mumpuni; Riyanto, A; Shine, R				Natusch, Daniel J. D.; Lyons, Jessica A.; Mumpuni; Riyanto, Awal; Shine, Richard			Jungle Giants: Assessing Sustainable Harvesting in a Difficult-to-Survey Species (Python reticulatus)	PLOS ONE			English	Article							STATISTICAL POWER ANALYSIS; INVASIVE BURMESE PYTHONS; INTERNATIONAL-TRADE; MORELIA-SPILOTA; SNAKE; SIZE; CONSEQUENCES; INDICATORS; SERPENTES; DECLINES	Sustainability of wildlife harvests is critical but difficult to assess. Evaluations of sustainability typically combine modelling with the measurement of underlying abundances. For many taxa harvested in developing countries, however, abundances are near-impossible to survey and a lack of detailed ecological information impedes the reliability of models. In such cases, repeated surveys of the attributes of harvested individuals may provide more robust information on sustainability. If the numbers, sizes and other demographic attributes of animals taken for the commercial trade do not change over biologically significant time intervals (decades), there is a prima facie case that the harvest is indeed sustainable. Here, we report the results of examinations of > 4,200 reticulated pythons (Python reticulatus) taken for the commercial leather industry in northern and southern Sumatra, Indonesia. The numbers, mean body sizes, clutch sizes, sizes at maturity and proportion of giant specimens have not decreased between our first surveys (1995) and repeat surveys (2015). Thus, despite assumptions to the contrary, the harvest appears to be sustainable. We use our data to inform the design of future monitoring programs for this species. Our study underpins the need for robust science to inform wildlife trade policy and decision-making, and urges wildlife managers to assess sustainability of difficult-to-survey terrestrial wildlife by drawing inferences directly from the harvest itself.	[Natusch, Daniel J. D.; Shine, Richard] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia; [Lyons, Jessica A.] Resource Evaluat & Dev, Bamaga, Qld, Australia; [Mumpuni; Riyanto, Awal] Indonesian Inst Sci, Museum Zool Bogoriense, Biol Res Ctr, Bogor, Indonesia	University of Sydney; Bogor Zoology Museum; Indonesian Institute of Sciences	Natusch, DJD (corresponding author), Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia.	d_natusch_14@hotmail.com	Riyanto, Awal/AAE-2791-2020	Lyons, Jessica A./0000-0002-7579-447X; RIYANTO, AWAL/0000-0002-6887-9352	Python Conservation Partnership	Python Conservation Partnership	This study was carried out with funding from the Python Conservation Partnership: http://www.iucn.org/?uNewsID=14068. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abensperg-Traun M, 2011, CITES CBNRM P INT S; Ashley D, 2013, TARCEABILITY SYSTEMS; Balmford A, 2006, CONSERV BIOL, V20, P692, DOI 10.1111/j.1523-1739.2006.00434.x; Caughley GJ, 1994, WILDLIFE ECOLOGY MAN; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cooney R., 2004, IUCN POLICY GLOBAL C, V2; Dorcas ME, 2012, P NATL ACAD SCI USA, V109, P2418, DOI 10.1073/pnas.1115226109; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fearn S, 2001, WILDLIFE RES, V28, P573, DOI 10.1071/WR00106; Fitzgerald LA, 2000, WILDLIFE SOC B, V28, P235; FITZGERALD LA, 1993, J HERPETOL, V27, P70, DOI 10.2307/1564908; GERRODETTE T, 1987, ECOLOGY, V68, P1364, DOI 10.2307/1939220; Groombridge B, 1991, PYTHONS S E ASIA REV; Gunarso P., 2013, OIL PALM LAND USE CH; Harvey RG, 2016, J ENVIRON PLANN MAN, V59, P789, DOI 10.1080/09640568.2015.1040489; Hunter Jr M. L., 2009, FUNDAMENTALS CONSERV; Ingram DJ, 2015, ECOL SOC, V20, DOI 10.5751/ES-07823-200340; Jenkins M., 1994, INT TRADE REPTILE SK; Kasterine A, 2012, TRADE S E ASIAN PYTH; Lyons JA, 2011, BIOL CONSERV, V144, P3073, DOI 10.1016/j.biocon.2011.10.002; Madsen T, 1999, ECOLOGY, V80, P989, DOI 10.1890/0012-9658(1999)080[0989:LHCONS]2.0.CO;2; Margono BA, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/034010; Natusch DJD, 2015, DEV CITES NONDETRIME; PETERMAN RM, 1990, CAN J FISH AQUAT SCI, V47, P2, DOI 10.1139/f90-001; PHKA, 2015, KUOT PENG TUMB AL PE; Reed RN, 2002, CONSERV BIOL, V16, P451, DOI 10.1046/j.1523-1739.2002.02283.x; Reed RN, 2011, WILDLIFE RES, V38, P114, DOI 10.1071/WR10202; Saputra G, 1998, MERTENSIELLA, V9, P23; Shin YJ, 2005, ICES J MAR SCI, V62, P384, DOI 10.1016/j.icesjms.2005.01.004; SHINE R, 1990, HERPETOLOGICA, V46, P283; Shine R, 1998, J ZOOL, V244, P405, DOI 10.1111/j.1469-7998.1998.tb00045.x; Shine R, 1999, BIOL CONSERV, V87, P349, DOI 10.1016/S0006-3207(98)00068-8; Shine R, 1998, FUNCT ECOL, V12, P248, DOI 10.1046/j.1365-2435.1998.00179.x; Siregar J., 2012, UPAYA PELESTARIAN PE; SLIP DJ, 1988, AUST WILDLIFE RES, V15, P515; Smith MJ, 2011, BIOL CONSERV, V144, P82, DOI 10.1016/j.biocon.2010.10.018; Stahlschmidt ZR, 2012, FUNCT ECOL, V26, P812, DOI 10.1111/j.1365-2435.2012.02003.x; Swiss Federal Veterinary Office, 2013, AN HUM KILL METH REP; TRIPPEL EA, 1995, BIOSCIENCE, V45, P759, DOI 10.2307/1312628; Waller Tomas, 2007, P340; Webb JK, 2002, ORYX, V36, P170, DOI 10.1017/S0030605302000248; Weinbaum KZ, 2013, ECOL LETT, V16, P99, DOI 10.1111/ele.12008; World Bank, 2020, WORLD DEV IND; Zhou ZH, 2004, CONSERV BIOL, V18, P1386, DOI 10.1111/j.1523-1739.2004.00251.x	44	20	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158397	10.1371/journal.pone.0158397	http://dx.doi.org/10.1371/journal.pone.0158397			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391138	gold, Green Published, Green Submitted			2022-12-27	WOS:000380005400054
J	Reichenau, TG; Korres, W; Montzka, C; Fiener, P; Wilken, F; Stadler, A; Waldhoff, G; Schneider, K				Reichenau, Tim G.; Korres, Wolfgang; Montzka, Carsten; Fiener, Peter; Wilken, Florian; Stadler, Anja; Waldhoff, Guido; Schneider, Karl			Spatial Heterogeneity of Leaf Area Index (LAI) and Its Temporal Course on Arable Land: Combining Field Measurements, Remote Sensing and Simulation in a Comprehensive Data Analysis Approach (CDAA)	PLOS ONE			English	Article							FRACTIONAL VEGETATION COVER; SOIL-MOISTURE; CROP GROWTH; CARBON FLUXES; WINTER-WHEAT; PATTERNS; VARIABILITY; SYSTEM; FOREST; ENERGY	The ratio of leaf area to ground area (leaf area index, LAI) is an important state variable in ecosystem studies since it influences fluxes of matter and energy between the land surface and the atmosphere. As a basis for generating temporally continuous and spatially distributed datasets of LAI, the current study contributes an analysis of its spatial variability and spatial structure. Soil-vegetation-atmosphere fluxes of water, carbon and energy are nonlinearly related to LAI. Therefore, its spatial heterogeneity, i.e., the combination of spatial variability and structure, has an effect on simulations of these fluxes. To assess LAI spatial heterogeneity, we apply a Comprehensive Data Analysis Approach that combines data from remote sensing (5 m resolution) and simulation (150 m resolution) with field measurements and a detailed land use map. Test area is the arable land in the fertile loess plain of the Rur catchment on the Germany-Belgium-Netherlands border. LAI from remote sensing and simulation compares well with field measurements. Based on the simulation results, we describe characteristic crop-specific temporal patterns of LAI spatial variability. By means of these patterns, we explain the complex multimodal frequency distributions of LAI in the remote sensing data. In the test area, variability between agricultural fields is higher than within fields. Therefore, spatial resolutions less than the 5 m of the remote sensing scenes are sufficient to infer LAI spatial variability. Frequency distributions from the simulation agree better with the multimodal distributions from remote sensing than normal distributions do. The spatial structure of LAI in the test area is dominated by a short distance referring to field sizes. Longer distances that refer to soil and weather can only be derived from remote sensing data. Therefore, simulations alone are not sufficient to characterize LAI spatial structure. It can be concluded that a comprehensive picture of LAI spatial heterogeneity and its temporal course can contribute to the development of an approach to create spatially distributed and temporally continuous datasets of LAI.	[Reichenau, Tim G.; Korres, Wolfgang; Waldhoff, Guido; Schneider, Karl] Univ Cologne, Inst Geog, Cologne, Germany; [Montzka, Carsten] Res Ctr Julich, Inst Bio & Geosphere Agrosphere IBG 3, Julich, Germany; [Fiener, Peter; Wilken, Florian] Univ Augsburg, Inst Geog, Augsburg, Germany; [Wilken, Florian] Brandenburg Univ Technol Cottbus Senftenberg, Geopedol & Landscape Dev, Cottbus, Germany; [Wilken, Florian] Leibniz Ctr Agr Landscape Res ZALF eV, Inst Soil Landscape Res, Muncheberg, Germany; [Stadler, Anja] Univ Bonn, Inst Crop Sci & Resource Conservat, Bonn, Germany	University of Cologne; Helmholtz Association; Research Center Julich; University of Augsburg; Brandenburg University of Technology Cottbus; Leibniz Zentrum fur Agrarlandschaftsforschung (ZALF); University of Bonn	Reichenau, TG; Schneider, K (corresponding author), Univ Cologne, Inst Geog, Cologne, Germany.	tim.reichenau@uni-koeln.de; karl.schneider@uni-koeln.de	Schneider, Karl/B-6303-2016	Schneider, Karl/0000-0002-4381-2151; Fiener, Peter/0000-0001-6244-4705; Reichenau, Tim/0000-0002-5062-6218; Wilken, Florian/0000-0003-0860-4557; Montzka, Carsten/0000-0003-0812-8570	"Patterns in Soil-Vegetation-Atmosphere Systems: Monitoring, Modelling, and Data Assimilation" - German Science Foundation (DFG) [CRC/TR 32, TRR 32/3]; TERENO "Terrestrial Environmental Observatories" - Helmholtz Association; Federal Ministry of Education and Research (BMBF); "Patterns in soil-vegetation-atmosphere-systems" [TR32]	"Patterns in Soil-Vegetation-Atmosphere Systems: Monitoring, Modelling, and Data Assimilation" - German Science Foundation (DFG); TERENO "Terrestrial Environmental Observatories" - Helmholtz Association; Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); "Patterns in soil-vegetation-atmosphere-systems"	Financial support for the study was given by the CRC/TR 32 "Patterns in Soil-Vegetation-Atmosphere Systems: Monitoring, Modelling, and Data Assimilation" funded by the German Science Foundation (DFG, TRR 32/3) and by TERENO "Terrestrial Environmental Observatories" funded by the Helmholtz Association and the Federal Ministry of Education and Research (BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors gratefully acknowledge the farmers who allowed the comprehensive scientific observation of their fields. Special thanks go to Ulrike Schwedler for cartography and figure layout of Fig 1, to Karen Schneider for proofreading and to our students for their assistance during fieldwork. RapidEye data were provided by the RapidEye Science Archive (RESA). We also thank all colleagues from the project TR32 "Patterns in soil-vegetation-atmosphere-systems" for lively discussions.	Ali M, 2015, REMOTE SENS-BASEL, V7, P2808, DOI 10.3390/rs70302808; ASRAR G, 1984, AGRON J, V76, P300, DOI 10.2134/agronj1984.00021962007600020029x; Aubin I, 2000, CAN J FOREST RES, V30, P168, DOI 10.1139/cjfr-30-1-168; Bareth, INT ARCH PHOTOGRAMME, VXXXVII, P1059; Barth M, 2004, CYBERNET SYST, V35, P639, DOI 10.1080/01969720490499425; Barthel R, 2012, WATER RESOUR MANAG, V26, P1929, DOI 10.1007/s11269-012-0001-9; Bergamaschi H, 2010, PESQUI AGROPECU BRAS, V45, P1331, DOI 10.1590/S0100-204X2010001200001; Beringer J, 2011, AGR FOREST METEOROL, V151, P1409, DOI 10.1016/j.agrformet.2011.05.003; Boegh E, 2002, REMOTE SENS ENVIRON, V81, P179, DOI 10.1016/S0034-4257(01)00342-X; BONAN GB, 1995, REMOTE SENS ENVIRON, V51, P57, DOI 10.1016/0034-4257(94)00065-U; Breda NJJ, 2003, J EXP BOT, V54, P2403, DOI 10.1093/jxb/erg263; Bsaibes A, 2009, REMOTE SENS ENVIRON, V113, P716, DOI 10.1016/j.rse.2008.11.014; Campbell G.S., 1998, INTRO ENV BIOPHYSICS, Vsecond, DOI [10.1007/978-1-4612-1626-1, DOI 10.1007/978-1-4612-1626-1]; Carlson TN, 1997, REMOTE SENS ENVIRON, V62, P241, DOI 10.1016/S0034-4257(97)00104-1; CARLSON TN, 1990, AGR FOREST METEOROL, V52, P45, DOI 10.1016/0168-1923(90)90100-K; Chen M, 2015, J HYDROL, V522, P274, DOI 10.1016/j.jhydrol.2014.12.027; Colombo R, 2003, REMOTE SENS ENVIRON, V86, P120, DOI 10.1016/S0034-4257(03)00094-4; Duan SB, 2014, INT J APPL EARTH OBS, V26, P12, DOI 10.1016/j.jag.2013.05.007; Ehammer A, 2010, REMOTE SENSING SPIE; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Garrigues S, 2006, REMOTE SENS ENVIRON, V103, P81, DOI 10.1016/j.rse.2006.03.013; Garriques S, 2008, AGR FOREST METEOROL, V148, P1193, DOI 10.1016/j.agrformet.2008.02.014; Gates D. M., 1980, BIOPHYSICAL ECOLOGY; Geologischer Dienst Nordrhein-Westfalen, 2009, INF BOD 50 1 50000; Guo X., 2008, INT ARCH PHOTOGRA B7, V37, P31; Haboudane D, 2004, REMOTE SENS ENVIRON, V90, P337, DOI 10.1016/j.rse.2003.12.013; Hasan S, 2014, ISPRS J PHOTOGRAMM, V91, P59, DOI 10.1016/j.isprsjprs.2014.02.005; Hatfield JL, 2007, AGRON J, V99, P285, DOI 10.2134/agronj2005.0116S; Hoffmeister D, 2009, 6 INT S DIG EARTH SP; Jonckheere I, 2004, AGR FOREST METEOROL, V121, P19, DOI 10.1016/j.agrformet.2003.08.027; Jones C., 1986, SIMULATION MODEL MAI; Klar CW, 2008, ECOL MODEL, V217, P181, DOI 10.1016/j.ecolmodel.2008.06.019; Korres W, 2015, J HYDROL, V520, P326, DOI 10.1016/j.jhydrol.2014.11.042; Korres W, 2013, J HYDROL, V498, P89, DOI 10.1016/j.jhydrol.2013.05.050; Kutsch WL, 2005, GLOBAL CHANGE BIOL, V11, P70, DOI 10.1111/j.1365-2486.2004.00884.x; Landsberg JJ., 1986, APPL BOT CROP SCI, V4; Lefsky MA, 2002, BIOSCIENCE, V52, P19, DOI 10.1641/0006-3568(2002)052[0019:LRSFES]2.0.CO;2; Lenz-Wiedemann VIS, 2010, ECOL MODEL, V221, P314, DOI 10.1016/j.ecolmodel.2009.10.014; Lussem U., 2013, ENHANCED LAND USE CL; Mauser W, 2009, J HYDROL, V376, P362, DOI 10.1016/j.jhydrol.2009.07.046; Muerth M, 2012, ENVIRON MODELL SOFTW, V35, P149, DOI 10.1016/j.envsoft.2012.02.017; Nguy-Robertson A, 2012, AGRON J, V104, P1336, DOI 10.2134/agronj2012.0065; NORMAN JM, 1995, AGR FOREST METEOROL, V77, P263, DOI 10.1016/0168-1923(95)02265-Y; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Potithep S, 2013, AGR FOREST METEOROL, V169, P148, DOI 10.1016/j.agrformet.2012.09.003; Propastin P, 2010, INT J APPL EARTH OBS, V12, P47, DOI 10.1016/j.jag.2009.09.013; Rascher U, 2015, GLOBAL CHANGE BIOL; Richter D., 1995, BERICHTE DTSCH WETTE, V194; Rudolph S, 2015, GEODERMA, V241, P262, DOI 10.1016/j.geoderma.2014.11.015; scilands GmbH, 2010, DIG EL MOD 10 ANTHR; Sellers PJ, 1996, J CLIMATE, V9, P706, DOI 10.1175/1520-0442(1996)009<0706:ARLSPF>2.0.CO;2; Simmer C, 2015, B AM METEOROL SOC, V96, P1765, DOI 10.1175/BAMS-D-13-00134.1; Stadler A, 2015, EUR J AGRON, V64, P8, DOI 10.1016/j.eja.2014.12.004; Streck NA, 2003, AGR FOREST METEOROL, V115, P139, DOI 10.1016/S0168-1923(02)00228-9; Streck NA, 2003, AGRON J, V95, P155, DOI 10.2134/agronj2003.0155; Sun YY, 2014, FIELD CROP RES, V167, P1, DOI 10.1016/j.fcr.2014.07.002; Tsialtas JT, 2007, PHOTOSYNTHETICA, V45, P527, DOI 10.1007/s11099-007-0090-5; Vereecken H, 2010, VADOSE ZONE J, V9, P821, DOI 10.2136/vzj2010.0122; Waldhoff G., 2014, THESIS; Waldhoff G., 2012, ISPRS ANN PHOTOGRAMM, V1, DOI [10.5194/isprsannalsI-7-177-2012, DOI 10.5194/ISPRSANNALSI-7-177-2012]; Weiss M, 2004, AGR FOREST METEOROL, V121, P37, DOI 10.1016/j.agrformet.2003.08.001; Woodgate W, 2015, AGR FOREST METEOROL, V205, P83, DOI 10.1016/j.agrformet.2015.02.012; Wulder MA, 2004, BIOSCIENCE, V54, P511, DOI 10.1641/0006-3568(2004)054[0511:HSRRSD]2.0.CO;2; Yin X, 2005, CROP SYSTEMS DYNAMIC; Yin XY, 2000, ANN BOT-LONDON, V85, P579, DOI 10.1006/anbo.1999.1104; Yin XY, 2003, ANN BOT-LONDON, V91, P893, DOI 10.1093/aob/mcg096; Zacharias S, 2011, VADOSE ZONE J, V10, P955, DOI 10.2136/vzj2010.0139; Zeng XB, 2000, J APPL METEOROL, V39, P826, DOI 10.1175/1520-0450(2000)039<0826:DAEOGK>2.0.CO;2; Zeng XB, 2003, J APPL METEOROL, V42, P1525, DOI 10.1175/1520-0450(2003)042<1525:IVADTO>2.0.CO;2; Zhang Y, 2002, ECOL MODEL, V151, P75, DOI 10.1016/S0304-3800(01)00527-0; Zhao B, 2014, AGRON J, V106, P379, DOI 10.2134/agronj2013.0213; Zheng G, 2009, SENSORS-BASEL, V9, P2719, DOI 10.3390/s90402719	72	27	27	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158451	10.1371/journal.pone.0158451	http://dx.doi.org/10.1371/journal.pone.0158451			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391858	Green Published, gold, Green Submitted			2022-12-27	WOS:000380005400061
J	Taglieri, N; Reggiani, MLB; Ghetti, G; Saia, F; Dall'Ara, G; Gallo, P; Moretti, C; Palmerini, T; Marrozzini, C; Marzocchi, A; Rapezzi, C				Taglieri, Nevio; Reggiani, Maria Letizia Bacchi; Ghetti, Gabriele; Saia, Francesco; Dall'Ara, Gianni; Gallo, Pamela; Moretti, Carolina; Palmerini, Tullio; Marrozzini, Cinzia; Marzocchi, Antonio; Rapezzi, Claudio			Risk of Stroke in Patients with Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention versus Optimal Medical Therapy: Systematic Review and Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Review							CONTROLLED CLINICAL-TRIAL; MASS-II; ANGIOPLASTY; SURGERY; STRATEGIES; OUTCOMES; PCI	Background Stroke is a rare but serious adverse event associated with percutaneous coronary intervention (PCI). However, the relative risk of stroke between stable patients undergoing a direct PCI strategy and those undergoing an initial optimal medical therapy (OMT) strategy has not been established yet. This study sought to investigate if, in patients with stable coronary artery disease (SCAD), an initial strategy PCI is associated with a higher risk of stroke than a strategy based on OMT alone. Methods We performed a meta-analysis of 6 contemporary randomized control trials in which 5673 patients with SCAD were randomized to initial PCI or OMT. Only trials with stent utilization more than 50% were included. Study endpoint was the rate of stroke during follow up. Results Mean age of patients ranged from 60 to 65 years and stent utilization ranged from 72% to 100%. Rate of stroke was 2.0% at a weighted mean follow up of 55.3 months. On pooled analysis, the risk of stroke was similar between patients undergoing a PCI plus OMT and those receiving only OMT (2.2% vs. 1.8%, OR on fixed effect = 1.24 95% CI: 0.85-1.79). There was no heterogeneity among the studies (I-2 = 0.0%, P = 0.15). On sensitivity analysis after removing each individual study the pooled effect estimate remains unchanged. Conclusions In patients with SCAD an initial strategy based on a direct PCI is not associated with an increased risk of stroke during long-term follow up compared to an initial strategy based on OMT alone.	[Taglieri, Nevio; Reggiani, Maria Letizia Bacchi; Ghetti, Gabriele; Saia, Francesco; Dall'Ara, Gianni; Gallo, Pamela; Moretti, Carolina; Palmerini, Tullio; Marrozzini, Cinzia; Marzocchi, Antonio; Rapezzi, Claudio] Univ Bologna, Alma Mater Studiorum, Dipartimento Med Specialist Diagnost & Sperimenta, Ist Cardiol, Bologna, Italy	University of Bologna	Taglieri, N (corresponding author), Univ Bologna, Alma Mater Studiorum, Dipartimento Med Specialist Diagnost & Sperimenta, Ist Cardiol, Bologna, Italy.	nevio.taglieri@unibo.it	Palmerini, Tullio/K-4543-2016; Dall'Ara, Gianni/AAK-9691-2020; Bacchi Reggiani, Maria Letizia/O-2311-2014	Dall'Ara, Gianni/0000-0003-1394-402X; Bacchi Reggiani, Maria Letizia/0000-0003-3985-1542; Saia, Francesco/0000-0001-9969-2649				Aggarwal A, 2009, AM J CARDIOL, V104, P349, DOI 10.1016/j.amjcard.2009.03.046; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Borden WB, 2011, JAMA-J AM MED ASSOC, V305, P1882, DOI 10.1001/jama.2011.601; DEBRUYNE B, 2012, NEW ENGL J MED, V367, P991, DOI [DOI 10.1056/NEJM0A1205361, 10.1056/NEJMoa1205361]; Frye RL, 2009, NEW ENGL J MED, V360, P2503, DOI [DOI 10.1056/NEJMOA0805796, 10.1056/NEJMoa0805796]; Gouya G, 2014, STROKE, V45, P492, DOI 10.1161/STROKEAHA.113.002590; Guptill JT, 2013, CIRC-CARDIOVASC INTE, V6, P176, DOI 10.1161/CIRCINTERVENTIONS.112.000159; Hambrecht R, 2004, CIRCULATION, V109, P1371, DOI 10.1161/01.CIR.0000121360.31954.1F; Helton TJ, 2007, AM J CARDIOVASC DRUG, V7, P289, DOI 10.2165/00129784-200707040-00006; Hoffman SJ, 2012, JACC-CARDIOVASC INTE, V5, P200, DOI 10.1016/j.jcin.2011.10.014; Hueb W, 2004, J AM COLL CARDIOL, V43, P1743, DOI 10.1016/j.jacc.2003.08.065; Hueb W, 2007, CIRCULATION, V115, P1082, DOI 10.1161/CIRCULATIONAHA.106.625475; Kwok CS, 2015, EUR HEART J; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Nishigaki K, 2008, JACC-CARDIOVASC INTE, V1, P469, DOI 10.1016/j.jcin.2008.08.002; Palmerini T, 2012, J AM COLL CARDIOL, V60, P798, DOI 10.1016/j.jacc.2011.10.912; Pursnani S, 2012, CIRC-CARDIOVASC INTE, V5, P476, DOI 10.1161/CIRCINTERVENTIONS.112.970954; Stergiopoulos K, 2014, JAMA INTERN MED, V174, P232, DOI 10.1001/jamainternmed.2013.12855; Stergiopoulos K, 2012, ARCH INTERN MED, V172, P312, DOI 10.1001/archinternmed.2011.1484; Trikalinos TA, 2009, LANCET, V373, P911, DOI 10.1016/S0140-6736(09)60319-6; Werner N, 2013, CIRC-CARDIOVASC INTE, V6, P362, DOI 10.1161/CIRCINTERVENTIONS.112.000170	21	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158769	10.1371/journal.pone.0158769	http://dx.doi.org/10.1371/journal.pone.0158769			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391212	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400119
J	Cristobal-Narvaez, P; Sheinbaum, T; Rosa, A; Ballespi, S; de Castro-Catala, M; Pena, E; Kwapil, TR; Barrantes-Vidal, N				Cristobal-Narvaez, Paula; Sheinbaum, Tamara; Rosa, Araceli; Ballespi, Sergi; de Castro-Catala, Marta; Pena, Elionora; Kwapil, Thomas R.; Barrantes-Vidal, Neus			The Interaction between Childhood Bullying and the FKBP5 Gene on Psychotic-Like Experiences and Stress Reactivity in Real Life	PLOS ONE			English	Article							SOCIAL DEFEAT; ENVIRONMENT INTERACTION; HIGH-RISK; TRAUMA; SCHIZOTYPY; SCHIZOPHRENIA; METAANALYSIS; ASSOCIATION; SYMPTOMS; DISORDER	Aim The present study employed Experience Sampling Methodology to examine whether the interaction between childhood bullying and FKBP5 variability (i) is associated with the expression of psychotic-like experiences, paranoia, and negative affect, and (ii) moderates psychotic-like, paranoid, and affective reactivity to different forms of momentary stress (situational and social) in daily life. Methods A total of 206 nonclinical young adults were interviewed for bullying with the Childhood Experience of Care and Abuse and were prompted randomly eight times daily for one week to complete assessments of their current experiences, affect, and stress appraisals. Participants were genotyped for three FKBP5 single nucleotide polymorphisms (SNPs) (rs3800373, rs9296158, and rs1360780) that have been linked to hypothalamus-pituitary-adrenal axis reactivity. Multilevel analyses were conducted to examine the effect of the interaction between childhood bullying and the FKBP5 haplotype derived from these three SNPs. Results The interaction between bullying and the FKBP5 haplotype was associated with positive, but not negative, psychotic-like experiences, paranoia, and negative affect. The bullying x FKBP5 interaction also moderated the association of a social stress appraisal (specifically, being alone because people do not want to be with you) with psychotic-like experiences and negative affect in daily life. Simple slopes analyses indicated that, in all cases, the associations were significantly increased by exposure to bullying in participants with the risk haplotype, but not for those with the non-risk haplotype. D iscussion The present study provides the first evidence of the interplay between childhood bullying and FKBP5 variability in the real-world expression of psychosis proneness and social stress reactivity. The findings underscore the importance of investigating how gene-environment interactions are involved in mechanistic pathways to the extended psychosis phenotype and lend further support to the increasing relevance given to socially defeating appraisals in the experience of reality distortion.	[Cristobal-Narvaez, Paula; Sheinbaum, Tamara; Ballespi, Sergi; Barrantes-Vidal, Neus] Univ Autonoma Barcelona, Dept Psicol Clin & Salut, Barcelona, Spain; [Rosa, Araceli; de Castro-Catala, Marta; Pena, Elionora] Univ Barcelona, Fac Biol, Dept Biol Evolut Ecol & Ciencies Ambientals, Seccio Zool & Antropol, Barcelona, Spain; [Rosa, Araceli; Barrantes-Vidal, Neus] Inst Salud Carlos III, Ctr Biomed Res Network Mental Hlth CIBERSAM, Madrid, Spain; [Rosa, Araceli; de Castro-Catala, Marta; Pena, Elionora] IBUB, Barcelona, Spain; [Kwapil, Thomas R.; Barrantes-Vidal, Neus] UNCG, Dept Psychol, Greensboro, NC USA; [Barrantes-Vidal, Neus] St Pere Claver Fundacio Sanit, Barcelona, Spain	Autonomous University of Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Instituto de Salud Carlos III; University of Barcelona; University of North Carolina; University of North Carolina Greensboro	Barrantes-Vidal, N (corresponding author), Univ Autonoma Barcelona, Dept Psicol Clin & Salut, Barcelona, Spain.; Barrantes-Vidal, N (corresponding author), Inst Salud Carlos III, Ctr Biomed Res Network Mental Hlth CIBERSAM, Madrid, Spain.; Barrantes-Vidal, N (corresponding author), UNCG, Dept Psychol, Greensboro, NC USA.; Barrantes-Vidal, N (corresponding author), St Pere Claver Fundacio Sanit, Barcelona, Spain.	neus.barrantes@uab.cat	Kwapil, Thomas R./L-1127-2014; de Castro-Catala, Marta/E-2246-2019; Cristóbal-Narváez, Paula/AFU-7048-2022; Cristóbal-Narváez, Paula/K-3265-2017; Ballespí, Sergi/L-6492-2014; Rosa, Araceli/Q-2099-2016; Sheinbaum, Tamara/A-8008-2016; Kwapil, Thomas/I-3163-2019; Peña, Elionora/ABH-7588-2020; Barrantes-Vidal, Neus/A-9578-2013	Kwapil, Thomas R./0000-0003-1116-5954; de Castro-Catala, Marta/0000-0002-5550-4885; Cristóbal-Narváez, Paula/0000-0001-8184-6347; Cristóbal-Narváez, Paula/0000-0001-8184-6347; Ballespí, Sergi/0000-0002-6584-4138; Rosa, Araceli/0000-0001-6935-3785; Sheinbaum, Tamara/0000-0002-2268-7697; Peña, Elionora/0000-0001-5003-5453; Barrantes-Vidal, Neus/0000-0002-8671-1238	Spanish Ministerio de Economia y Competitividad (Plan Nacional de I+D) [PSI2014-54009-R, PSI2011-30321-C02-01, PSI2011-30321-C02-02]; Spanish Ministerio de Economia y Competitividad (Red de Excelencia PROMOSAM) [PSI2014-56303-REDT]; Fundacio La Marato de TV3 [091110]; Generalitat de Catalunya (Suport als Grups de Recerca) [2014SGR1070, 2014SGR1636]; Institucio Catalana de Recerca i Estudis Avancats (ICREA), ICREA Academia Award	Spanish Ministerio de Economia y Competitividad (Plan Nacional de I+D); Spanish Ministerio de Economia y Competitividad (Red de Excelencia PROMOSAM); Fundacio La Marato de TV3; Generalitat de Catalunya (Suport als Grups de Recerca)(Generalitat de Catalunya); Institucio Catalana de Recerca i Estudis Avancats (ICREA), ICREA Academia Award(ICREA)	This work was supported by the Spanish Ministerio de Economia y Competitividad (Plan Nacional de I+D PSI2014-54009-R, PSI2011-30321-C02-01 and C02-02, and Red de Excelencia PROMOSAM PSI2014-56303-REDT), Fundacio La Marato de TV3 (091110), and Generalitat de Catalunya (Suport als Grups de Recerca 2014SGR1070 and 2014SGR1636). NBV is supported by the Institucio Catalana de Recerca i Estudis Avancats (ICREA), ICREA Academia Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajnakina O, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00084; Alemany S, 2016, PSYCHOL MED, V46, P221, DOI 10.1017/S0033291715001695; [Anonymous], 2013, HLM 7 01 FOR WINDOWS; Arseneault L, 2011, AM J PSYCHIAT, V168, P65, DOI 10.1176/appi.ajp.2010.10040567; Barrantes-Vidal N, 2015, SCHIZOPHRENIA BULL, V41, pS408, DOI 10.1093/schbul/sbu191; Barrantes-Vidal N, 2013, J ABNORM PSYCHOL, V122, P1077, DOI 10.1037/a0034793; Barrantes-Vidal N, 2013, SCHIZOPHR RES, V145, P50, DOI 10.1016/j.schres.2013.01.007; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BIFULCO A, 1994, J CHILD PSYCHOL PSYC, V35, P1419, DOI 10.1111/j.1469-7610.1994.tb01284.x; Bifulco AT, 2013, UNDERSTANDING ADULT; Binder EB, 2009, PSYCHONEUROENDOCRINO, V34, P99, DOI 10.1016/j.psyneuen.2009.05.021; Binder EB, 2004, NAT GENET, V36, P1319, DOI 10.1038/ng1479; Bjorkqvist K, 2001, PHYSIOL BEHAV, V73, P435, DOI 10.1016/S0031-9384(01)00490-5; Bolger N, 2013, INTENSIVE LONGITUDIN; Chun CA, 2017, PERSONAL DISORD, V8, P64, DOI 10.1037/per0000141; Collip D, 2013, BRIT J PSYCHIAT, V202, P261, DOI 10.1192/bjp.bp.112.115972; Conner TS, 2009, SOC PERSONAL PSYCHOL, V3, P292, DOI 10.1111/j.1751-9004.2009.00170.x; Crawford DC, 2005, ANNU REV MED, V56, P303, DOI 10.1146/annurev.med.56.082103.104540; Cristobal-Narvaez P, IMPACT OF ADVERSE CH; Daskalakis NP, 2015, SCHIZOPHRENIA BULL, V41, P323, DOI 10.1093/schbul/sbu189; Ellsworth KA, 2013, PHARMACOGENET GENOM, V23, P156, DOI 10.1097/FPC.0b013e32835dc133; Gawlik M, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-52; Hammels C, 2015, NEUROSCI BIOBEHAV R, V59, P111, DOI 10.1016/j.neubiorev.2015.10.006; Hartmann J, 2012, PSYCHONEUROENDOCRINO, V37, P2009, DOI 10.1016/j.psyneuen.2012.04.017; Hektner JM, 2007, EXPERIENCE SAMPLING; Hernaus D, 2015, J ABNORM PSYCHOL, V124, P27, DOI 10.1037/abn0000010; Kelleher I, 2013, AM J PSYCHIAT, V170, P734, DOI 10.1176/appi.ajp.2012.12091169; Keller MC, 2014, BIOL PSYCHIAT, V75, P18, DOI 10.1016/j.biopsych.2013.09.006; Klengel T, 2013, NAT NEUROSCI, V16, P33, DOI 10.1038/nn.3275; Kwapil TR, 2012, PSYCHOL MED, V42, P2555, DOI 10.1017/S0033291712000827; Kwapil TR, 2015, SCHIZOPHRENIA BULL, V41, pS366, DOI 10.1093/schbul/sbu186; Matheson SL, 2013, PSYCHOL MED, V43, P225, DOI 10.1017/S0033291712000785; Moffitt TE, 2005, ARCH GEN PSYCHIAT, V62, P473, DOI 10.1001/archpsyc.62.5.473; Muthen B., 2010, MPLUS USERS GUIDE; Myin-Germeys I, 2003, CURR OPIN PSYCHIATR, V16, pS33, DOI 10.1097/00001504-200304002-00006; Myin-Germeys I, 2009, PSYCHOL MED, V39, P1533, DOI 10.1017/S0033291708004947; Nezlek J. B., 2011, MULTILEVEL MODELING; OLWEUS D, 1994, J CHILD PSYCHOL PSYC, V35, P1171, DOI 10.1111/j.1469-7610.1994.tb01229.x; Oorschot M, 2009, PSYCHOL ASSESSMENT, V21, P498, DOI 10.1037/a0017077; Ostrov JM, 2015, J CLIN CHILD ADOLESC, V44, P509, DOI 10.1080/15374416.2015.1012723; Palmier-Claus JE, 2012, PSYCHOL MED, V42, P1003, DOI 10.1017/S0033291711001929; Parker JG, 2006, DEV PSYCHOPATHOL, P419, DOI DOI 10.1002/9780470939383.CH12; Reininghaus U, SCHIZOPHR BULL IN PR; Selten JP, 2013, SCHIZOPHRENIA BULL, V39, P1180, DOI 10.1093/schbul/sbt134; Sheinbaum T, 2015, ADV MENT HEALTH RES, P116; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Valmaggia LR, 2015, SCHIZOPHR RES, V168, P16, DOI 10.1016/j.schres.2015.07.050; van Dam DS, 2012, PSYCHOL MED, V42, P2463, DOI 10.1017/S0033291712000360; van Nierop M, 2014, ACTA PSYCHIAT SCAND, V129, P467, DOI 10.1111/acps.12212; van Os J, 2009, PSYCHOL MED, V39, P179, DOI 10.1017/S0033291708003814; van Winkel M, 2014, EUR NEUROPSYCHOPHARM, V24, P930, DOI 10.1016/j.euroneuro.2014.02.005; van Winkel R, 2008, SCHIZOPHRENIA BULL, V34, P1095, DOI 10.1093/schbul/sbn101; van Winkel R, 2013, CAN J PSYCHIAT, V58, P44, DOI 10.1177/070674371305800109; Varese F, 2012, SCHIZOPHRENIA BULL, V38, P661, DOI 10.1093/schbul/sbs050; Velikonja T, 2015, PSYCHOL MED, V45, P947, DOI 10.1017/S0033291714002086; Wichers M, 2014, PSYCHOL MED, V44, P1349, DOI 10.1017/S0033291713001979; WOLKE D, 2014, PSYCHOL MED, V44, P2199, DOI DOI 10.1017/S0033291713002912; Wolke D, 2015, ARCH DIS CHILD, V100, P879, DOI 10.1136/archdischild-2014-306667; Zannas AS, 2014, GENES BRAIN BEHAV, V13, P25, DOI 10.1111/gbb.12104; Zannas AS, 2016, NEUROPSYCHOPHARMACOL, V41, P261, DOI 10.1038/npp.2015.235	60	19	19	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158809	10.1371/journal.pone.0158809	http://dx.doi.org/10.1371/journal.pone.0158809			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27389186	Green Published, gold			2022-12-27	WOS:000379811500049
J	Masel, EK; Kitta, A; Huber, P; Rumpold, T; Unseld, M; Schur, S; Porpaczy, E; Watzke, HH				Masel, Eva K.; Kitta, Anna; Huber, Patrick; Rumpold, Tamara; Unseld, Matthias; Schur, Sophie; Porpaczy, Edit; Watzke, Herbert H.			What Makes a Good Palliative Care Physician? A Qualitative Study about the Patient's Expectations and Needs when Being Admitted to a Palliative Care Unit	PLOS ONE			English	Article							OF-LIFE CARE; END; COMMUNICATION; PROGNOSIS; ONCOLOGY; PERSPECTIVES; ISSUES; INFORMATION; DISCUSSIONS; EXPERIENCES	Objective The aims of the study were to examine a) patients' knowledge of palliative care, b) patients' expectations and needs when being admitted to a palliative care unit, and c) patient's concept of a good palliative care physician. Methods The study was based on a qualitative methodology, comprising 32 semistructured interviews with advanced cancer patients admitted to the palliative care unit of the Medical University of Vienna. Interviews were conducted with 20 patients during the first three days after admission to the unit and after one week, recorded digitally, and transcribed verbatim. Data were analyzed using NVivo 10 software, based on thematic analysis enhanced with grounded theory techniques. Results The results revealed four themes: (1) information about palliative care, (2) supportive care needs, (3) being treated in a palliative care unit, and (4) qualities required of palliative care physicians. The data showed that patients lack information about palliative care, that help in social concerns plays a central role in palliative care, and attentiveness as well as symptom management are important to patients. Patients desire a personal patient-physician relationship. The qualities of a good palliative care physician were honesty, the ability to listen, taking time, being experienced in their field, speaking the patient's language, being human, and being gentle. Patients experienced relief when being treated in a palliative care unit, perceived their care as an interdisciplinary activity, and felt that their burdensome symptoms were being attended to with emotional care. Negative perceptions included the overtly intense treatment. Conclusions The results of the present study offer an insight into what patients expect from palliative care teams. Being aware of patient's needs will enable medical teams to improve professional and individualized care.	[Masel, Eva K.; Kitta, Anna; Huber, Patrick; Rumpold, Tamara; Unseld, Matthias; Schur, Sophie; Watzke, Herbert H.] Med Univ Vienna, Div Palliat Care, Dept Internal Med 1, Vienna, Austria; [Porpaczy, Edit] Med Univ Vienna, Div Hematol & Hemostaseol, Dept Internal Med 1, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Masel, EK (corresponding author), Med Univ Vienna, Div Palliat Care, Dept Internal Med 1, Vienna, Austria.	eva.masel@meduniwien.ac.at	Masel, Eva Katharina/AAU-7439-2020; Masel, Eva Katharina/ABH-1594-2020	Masel, Eva Katharina/0000-0001-6415-4488; Kitta, Anna/0000-0001-9102-593X; Unseld, Matthias/0000-0002-1699-9846				Abdul-Razzak A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005653; Aldridge MD, 2015, PALLIATIVE MED, V24; Almack K, 2012, BMC PALLIAT CARE, V11, DOI 10.1186/1472-684X-11-15; Back AL, 2006, J CLIN ONCOL, V24, P4209, DOI 10.1200/JCO.2006.06.007; Back AL, 2014, J PALLIAT MED, V17, P1019, DOI 10.1089/jpm.2013.0651; Bakitas MA, 2015, J CLIN ONCOL, V33, P1438, DOI 10.1200/JCO.2014.58.6362; Beernaert K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137251; Bleidorn J, 2012, DEUT MED WOCHENSCHR, V137, P1343, DOI 10.1055/s-0032-1305045; Bosma H, 2010, PALLIATIVE MED, V24, P510, DOI 10.1177/0269216309351380; Braun V, 2014, INT J QUAL STUD HEAL, V9, DOI 10.3402/qhw.v9.26152; Centeno C, 2015, PALLIATIVE MED, V31; Ciemins EL, 2015, J PALLIAT MED, V18, P282, DOI 10.1089/jpm.2014.0155; Clayton JA, 2005, J PAIN SYMPTOM MANAG, V30, P132, DOI 10.1016/j.jpainsymman.2005.02.014; Dugdale DC, 1999, J GEN INTERN MED, V14, pS34, DOI 10.1046/j.1525-1497.1999.00263.x; Enzinger AC, 2015, J CLIN ONCOL, V33, P3809, DOI 10.1200/JCO.2015.61.9239; Farber Stuart J, 2003, J Palliat Med, V6, P19, DOI 10.1089/10966210360510082; Ferrell B, 2008, J CLIN ONCOL, V26, P3824, DOI 10.1200/JCO.2007.15.7552; Gomes B, 2015, J CLIN ONCOL, V33, P1420, DOI 10.1200/JCO.2014.60.5386; Grande GE, 2000, PALLIATIVE MED, V14, P69, DOI 10.1191/026921600677940614; Gysels M, 2008, BMC MED ETHICS, V9, P1472; Gysels M, 2008, J PAIN SYMPTOM MANAG, V35, P347, DOI 10.1016/j.jpainsymman.2007.05.012; Hoare S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142723; Innes S, 2009, PALLIATIVE MED, V23, P29, DOI 10.1177/0269216308098799; Kapo J, 2007, J PALLIAT MED, V10, P185, DOI 10.1089/jpm.2006.9989; Kogan AC, 2015, J PALLIAT MED, V18, P1019, DOI 10.1089/jpm.2015.0038; Kon AA, 2010, JAMA-J AM MED ASSOC, V304, P903, DOI 10.1001/jama.2010.1208; Mann K, 2015, MED TEACH, V21, P1; Martinsson L, 2016, BMJ SUPPORT PALLIAT, V6, P452, DOI 10.1136/bmjspcare-2014-000688; Masel EK, 2015, SUPPORT CARE CANCER, V23, P2335, DOI 10.1007/s00520-015-2601-4; McAteer R, 2013, AM FAM PHYSICIAN, V88, P807; McIlfatrick S, 2014, PALLIATIVE MED, V28, P273, DOI 10.1177/0269216313502372; Monroe B., 1994, Annals Academy of Medicine Singapore, V23, P252; MOR V, 1984, CANCER-AM CANCER SOC, V53, P2002, DOI 10.1002/1097-0142(19840501)53:9<2002::AID-CNCR2820530933>3.0.CO;2-W; Murray CD, 2015, PALLIAT SUPPORT CARE, V13, P369, DOI 10.1017/S1478951514000455; Parikh RB, 2013, NEW ENGL J MED, V369, P2347, DOI 10.1056/NEJMsb1305469; Parry R, 2014, BMJ SUPPORT PALLIAT, V4, P331, DOI 10.1136/bmjspcare-2014-000649; Quill TE, 2000, JAMA-J AM MED ASSOC, V284, P2502, DOI 10.1001/jama.284.19.2502; Ranganathan A, 2014, ANN PALLIAT MED, V3, P144, DOI 10.3978/j.issn.2224-5820.2014.07.04; Robinson J, 2015, PALLIATIVE MED, V13; Sampson C, 2014, BMJ SUPPORT PALLIAT, V16; Sandsdalen T, 2015, PALLIATIVE MED, V29, P399, DOI 10.1177/0269216314557882; Sapir R, 2000, SUPPORT CARE CANCER, V8, P458, DOI 10.1007/s005200000163; Seccareccia D, 2015, J PALLIAT MED, V18, P758, DOI 10.1089/jpm.2014.0408; Stephen N, 2013, J PALLIAT MED, V16, P555, DOI 10.1089/jpm.2012.0442; Stiel S, 2010, J PALLIAT MED, V13, P997, DOI 10.1089/jpm.2010.0050; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; van der Plas AGM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133197; Virdun C, 2015, PALLIATIVE MED, V29, P774, DOI 10.1177/0269216315583032; Walczak A, 2013, PATIENT EDUC COUNS, V90, P307, DOI 10.1016/j.pec.2011.08.009; Wheatley VJ, 2007, POSTGRAD MED J, V83, P643, DOI 10.1136/pgmj.2007.058487	50	16	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158830	10.1371/journal.pone.0158830	http://dx.doi.org/10.1371/journal.pone.0158830			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27389693	Green Published, Green Submitted, gold			2022-12-27	WOS:000379811500052
J	Suzuki, M; Segawa, T; Mori, H; Akiyoshi, A; Ootsuki, R; Kurihara, A; Sakayama, H; Kitayama, T; Abe, T; Kogame, K; Kawai, H; Nozaki, H				Suzuki, Masahiro; Segawa, Takahiro; Mori, Hiroshi; Akiyoshi, Ayumi; Ootsuki, Ryo; Kurihara, Akira; Sakayama, Hidetoshi; Kitayama, Taiju; Abe, Tsuyoshi; Kogame, Kazuhiro; Kawai, Hiroshi; Nozaki, Hisayoshi			Next-Generation Sequencing of an 88-Year-Old Specimen of the Poorly Known Species Liagora japonica (Nemaliales, Rhodophyta) Supports the Recognition of Otohimella gen. nov.	PLOS ONE			English	Article							SENSU-LATO NEMALIALES; CARPOSPOROPHYTE DEVELOPMENT; GANONEMA LIAGORACEAE; SYSTEMATICS; MORPHOLOGY; ALIGNMENT; DATABASE	Liagora japonica is a red algal species distributed in temperate regions of Japan. This species has not been collected from its type locality on the Pacific coast of Japan since 1927 and seems to have become extinct in this area. For molecular characterization of L. japonica, we extracted DNA from the topotype material of L. japonica collected in 1927, analyzed seven genes using Illumina next-generation sequencing, and compared these data with sequences from modern samples of similar red algae collected from the Japan Sea coast of Japan. Both morphological and molecular data from modern samples and historical specimens (including the lectotype and topotype) suggest that the specimens from the Pacific and Japan Sea coasts of Japan should be treated as a single species, and that L. japonica is phylogenetically separated from the genus Liagora. Based on the phylogenetic results and examination of reproductive structures, we propose Otohimella japonica gen. et comb. nov., characterized morphologically by diffuse carposporophytes, undivided carposporangia, and involucral filaments initiated only from the cortical cell on the supporting cell.	[Suzuki, Masahiro; Kawai, Hiroshi] Kobe Univ, Res Ctr Inland Sea, Awaji, Hyogo, Japan; [Segawa, Takahiro] Univ Yamanashi, Ctr Life Sci Res, Yamanashi, Japan; [Segawa, Takahiro; Akiyoshi, Ayumi] Natl Inst Polar Res, Midori Cho, Tachikawa, Tokyo, Japan; [Segawa, Takahiro; Akiyoshi, Ayumi] Transdisciplinary Res Integrat Ctr, Minato Ku, Tokyo, Japan; [Mori, Hiroshi] Tokyo Inst Technol, Dept Biol Informat, Grad Sch Biosci & Biotechnol, Meguro Ku, Tokyo, Japan; [Ootsuki, Ryo] Komazawa Univ, Dept Nat Sci, Fac Arts & Sci, Setagaya Ku, Tokyo, Japan; [Ootsuki, Ryo] Japan Womens Univ, Fac Chem & Biol Sci, Tokyo, Japan; [Kurihara, Akira] Kyushu Univ, Bioresource Sci, Fac Agr, Higashi Ku, Fukuoka, Japan; [Sakayama, Hidetoshi] Kobe Univ, Grad Sch Sci, Dept Biol, Nada Ku, Kobe, Hyogo, Japan; [Kitayama, Taiju] Natl Museum Nat & Sci, Dept Bot, Tsukuba, Ibaraki, Japan; [Abe, Tsuyoshi] Hokkaido Univ, Hokkaido Univ Museum, Sapporo, Hokkaido, Japan; [Kogame, Kazuhiro] Hokkaido Univ, Dept Biol Sci, Fac Sci, Sapporo, Hokkaido, Japan; [Nozaki, Hisayoshi] Univ Tokyo, Dept Biol Sci, Grad Sch Sci, Bunkyo Ku, Tokyo, Japan	Kobe University; University of Yamanashi; Research Organization of Information & Systems (ROIS); National Institute of Polar Research (NIPR) - Japan; Tokyo Institute of Technology; Japan Womens University; Kyushu University; Kobe University; National Museum of Nature and Science; Hokkaido University; Hokkaido University; University of Tokyo	Suzuki, M (corresponding author), Kobe Univ, Res Ctr Inland Sea, Awaji, Hyogo, Japan.	dtk-shark2625@goo.jp		Mori, Hiroshi/0000-0003-0806-7704; Nozaki, Hisayoshi/0000-0002-9308-4498; Segawa, Takahiro/0000-0002-3111-708X	Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI [26840125, 24247042]; Center for the Promotion of Integrated Science (CPIS) of Sokendai	Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI; Center for the Promotion of Integrated Science (CPIS) of Sokendai	MS and HN were supported by Grants-in-Aid for Scientific Research (grant numbers 26840125 and 24247042) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI (https://www.jsps.go.jp/english/e-grants/).; We are grateful to the late Dr Makoto Yoshizaki (Toho University) for his many suggestions regarding the description of Liagora japonica. We thank Dr Dorothee Huchon, Dr John Huisman, and an anonymous reviewer for their helpful and valuable suggestions. This work was supported by the Center for the Promotion of Integrated Science (CPIS) of Sokendai (to Jun Adachi).	Abbott Isabella A., 1995, Chinese Journal of Oceanology and Limnology, V13, P343, DOI 10.1007/BF02889469; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Boo GH, 2013, TAXON, V62, P1105, DOI 10.12705/626.7; Carlile AL, 2010, PHYCOLOGIA, V49, P336, DOI 10.2216/09-19.1; CHIHARA M, 1972, Bulletin of the National Science Museum (Tokyo), V15, P395; Dabney J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012567; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Guiry GM, 2015, WORLD WIDE ELECT PUB, V10, P28; Hind KR, 2014, J PHYCOL, V50, P760, DOI 10.1111/jpy.12205; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hughey JR, 2014, SCI REP-UK, V4, DOI 10.1038/srep05113; Huisman JM, 2004, EUR J PHYCOL, V39, P257, DOI 10.1080/09670260410001710123; Huisman JM, 2002, AUST SYST BOT, V15, P773, DOI 10.1071/SB01027; Huisman JM, 1999, BOT MAR, V42, P219, DOI 10.1515/BOT.1999.025; Huisman JM, 2006, ALGAE AUSTR NEMALIAL, P116; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le Gall L, 2010, CRYPTOGAMIE ALGOL, V31, P403; Lin SM, 2015, J PHYCOL, V51, P546, DOI 10.1111/jpy.12301; Lin SM, 2014, PHYCOLOGIA, V53, P37, DOI 10.2216/13-201.1; Lin SM, 2013, EUR J PHYCOL, V48, P173, DOI 10.1080/09670262.2013.786791; Lin SM, 2013, PHYCOLOGIA, V52, P161, DOI 10.2216/12-101.1; Lin SM, 2011, EUR J PHYCOL, V46, P249, DOI 10.1080/09670262.2011.592221; Lin SM, 2011, J PHYCOL, V47, P352, DOI 10.1111/j.1529-8817.2011.00965.x; Omori Y, 1988, NAT HIST REP KANAGAW, V19, P105; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Popolizio TR, 2015, J PHYCOL, V51, P637, DOI 10.1111/jpy.12306; Rambaut A., 2007, TRACER V1 4; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Suzuki M, 2012, PHYCOLOGIA, V51, P479, DOI 10.2216/11-78.1; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Thalmann O, 2013, SCIENCE, V342, P871, DOI 10.1126/science.1243650; Wuyts J, 2002, NUCLEIC ACIDS RES, V30, P183, DOI 10.1093/nar/30.1.183; YAMADA Y., 1938, SCI PAPERS INST ALGOL RES HOKKAIDO IMP UNIV, V2, P1; Yokosawa T, 2008, JPN J PHYCOL, V56, P213; YOSHIZAKI M, 1987, PHYCOLOGIA, V26, P47, DOI 10.2216/i0031-8884-26-1-47.1; Yosihda A., 2012, B HOT SPRINGS RES I, V44, P17	38	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158944	10.1371/journal.pone.0158944	http://dx.doi.org/10.1371/journal.pone.0158944			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27388436	Green Submitted, Green Published, gold			2022-12-27	WOS:000379811500063
J	Tian, XF; Ji, FJ; Zang, HL; Cao, H				Tian, Xiao-Feng; Ji, Fu-Jian; Zang, Hong-Liang; Cao, Hong			Activation of the miR-34a/SIRT1/p53 Signaling Pathway Contributes to the Progress of Liver Fibrosis via Inducing Apoptosis in Hepatocytes but Not in HSCs	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; TUMOR-SUPPRESSOR; HEPATOCELLULAR-CARCINOMA; CANCER; MICRORNAS; EXPRESSION; RATS; IDENTIFICATION; RESVERATROL; METASTASIS	Liver fibrosis results from a sustained wound healing response to chronic liver injury, and the activation of nonparenchymal hepatic stellate cells (HSCs) is the pivotal process. Micro-RNA-34a (miR-34a) is the direct target gene of p53 and activates p53 through sirtuin 1 (SIRT1) simultaneously. The miR-34a/SIRT1/p53 signaling pathway thus forms a positive feedback loop wherein p53 induces miR-34a and miR-34a activates p53 by inhibiting SIRT1, playing an important role in cell proliferation and apoptosis. miR-34a expression has been found to be increased in animal models or in human patients with different liver diseases, including liver fibrosis. However, the exact role of this classical miR-34a/SIRT1/p53 signaling pathway in liver fibrosis remains unclear. In the present study, using a CCl4-induced rat liver fibrosis model, we found that the miR-34a/SIRT1/p53 signaling pathway was activated and could be inhibited by SIRT1 activator SRT1720. Further studies showed that the miR-34a/SIRT1/p53 signaling pathway was activated in hepatocytes but not in HSCs. The activation of this pathway in hepatocytes resulted in the apoptosis of hepatocytes and thus activated HSCs. Our data indicate that the miR-34a/SIRT1/p53 signaling pathway might be a promising therapeutic target for liver fibrosis.	[Tian, Xiao-Feng; Ji, Fu-Jian; Zang, Hong-Liang; Cao, Hong] Jilin Univ, China Japan Union Hosp, Dept Gen Surg, Changchun 130021, Peoples R China	Jilin University	Cao, H (corresponding author), Jilin Univ, China Japan Union Hosp, Dept Gen Surg, Changchun 130021, Peoples R China.	caohong010829@163.com						Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Castro RE, 2013, J HEPATOL, V58, P119, DOI 10.1016/j.jhep.2012.08.008; Chavez E, 2008, J APPL TOXICOL, V28, P35, DOI 10.1002/jat.1249; Chen F, 2012, J BIOCHEM MOL TOXIC, V26, P79, DOI 10.1002/jbt.20412; Duval F, 2014, ADV PHARMACOL SCI, V2014, DOI 10.1155/2014/373295; Friedman SL, 2003, J HEPATOL, V38, pS38, DOI 10.1016/S0168-8278(02)00429-4; Gori M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/741465; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hong SW, 2010, ARCH PHARM RES, V33, P601, DOI 10.1007/s12272-010-0415-y; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Janiszewska J, 2013, CRIT REV ONCOL HEMAT, V88, P716, DOI 10.1016/j.critrevonc.2013.07.012; Ju JF, 2013, FUTURE MED CHEM, V5, P983, DOI 10.4155/fmc.13.74; Katayama Y, 2012, ONCOL LETT, V4, P817, DOI 10.3892/ol.2012.810; Kemper JK, 2013, VITAM HORM, V91, P385, DOI 10.1016/B978-0-12-407766-9.00016-X; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Li WQ, 2011, FEBS J, V278, P1522, DOI 10.1111/j.1742-4658.2011.08075.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mallat A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/869390; Meng FY, 2012, AM J PATHOL, V181, P804, DOI 10.1016/j.ajpath.2012.06.010; Moreira RK, 2007, ARCH PATHOL LAB MED, V131, P1728; Murakami Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016081; Noetel A, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00049; Pang RTK, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-25; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Raisch J, 2013, WORLD J GASTROENTERO, V19, P2985, DOI 10.3748/wjg.v19.i20.2985; Schug TT, 2011, ANN MED, V43, P198, DOI 10.3109/07853890.2010.547211; Takehara T, 2004, GASTROENTEROLOGY, V127, P1189, DOI 10.1053/j.gastro.2004.07.019; Vettori Serena, 2012, Open Rheumatol J, V6, P130, DOI 10.2174/1874312901206010130; Wiggins JF, 2010, CANCER RES, V70, P5923, DOI 10.1158/0008-5472.CAN-10-0655; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yamakuchi M, 2009, CELL CYCLE, V8, P712, DOI 10.4161/cc.8.5.7753; Yan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033778; Yang S, 2013, ONCOGENE, V32, P4294, DOI 10.1038/onc.2012.432; Zhan SS, 2006, HEPATOLOGY, V43, P435, DOI 10.1002/hep.21093	36	61	69	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158657	10.1371/journal.pone.0158657	http://dx.doi.org/10.1371/journal.pone.0158657			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27387128	Green Submitted, gold, Green Published			2022-12-27	WOS:000379811500034
J	Wang, SC; Huang, CC; Shen, CH; Lin, LC; Zhao, PW; Chen, SY; Deng, YC; Liu, YW				Wang, Shou-Chieh; Huang, Chin-Chin; Shen, Cheng-Huang; Lin, Lei-Chen; Zhao, Pei-Wen; Chen, Shih-Ying; Deng, Yu-Chiao; Liu, Yi-Wen			Gene Expression and DNA Methylation Status of Glutathione S-Transferase Mu1 and Mu5 in Urothelial Carcinoma	PLOS ONE			English	Article							BLADDER-CANCER; URINARY-BLADDER; POOLED ANALYSIS; P21; SMOKING; NRF2; P53; N-BUTYL-N-(4-HYDROXYBUTYL)NITROSAMINE; DEGRADATION; PROTEIN	Bladder cancer is highly recurrent after therapy, which has an enormous impact on the health and financial condition of the patient. It is worth developing diagnostic tools for bladder cancer. In our previous study, we found that the bladder carcinogen BBN increased urothelial global DNA CpG methylation and decreased GSTM1 protein expression in mice. Here, the correlation of BBN-decreased GSTM1 and GSTM gene CpG methylation status was analyzed in mice bladders. BBN treatment decreased the protein and mRNA expression of GSTM1, and the CpG methylation ratio of GSTM1 gene promoter was slightly increased in mice bladders. Unlike mouse GSTM1, the human GSTM1 gene tends to be deleted in bladder cancers. Among 7 human bladder cancer cell lines, GSTM1 gene is really null in 6 cell lines except one, T24 cells. The CpG methylation level of GSTM1 was 9.9% and 5-aza-dC did not significantly increase GSTM1 protein and mRNA expression in T24 cells; however, the GSTM5 gene was CpG hypermethylated (65.4%) and 5-aza-dC also did not affect the methylation ratio and mRNA expression. However, in other cell lines without GSTM1, 5-aza-dC increased GSTM5 expression and decreased its CpG DNA methylation ratio from 84.6% to 61.5% in 5637, and from 97.4% to 75% in J82 cells. In summary, two biomarkers of bladder tumor were provided. One is the GSTM1 gene which is down-regulated in mice bladder carcinogenesis and is usually deleted in human urothelial carcinoma, while the other is the GSTM5 gene, which is inactivated by DNA CpG methylation.	[Wang, Shou-Chieh] Kuang Tien Gen Hosp, Dept Internal Med, Div Nephrol, Taichung 437, Taiwan; [Huang, Chin-Chin; Zhao, Pei-Wen; Chen, Shih-Ying; Deng, Yu-Chiao; Liu, Yi-Wen] Natl Chiayi Univ, Coll Life Sci, Dept Microbiol Immunol & Biopharmaceut, Chiayi, Taiwan; [Shen, Cheng-Huang] Chiayi Christian Hosp, Dept Urol, Chiayi, Taiwan; [Lin, Lei-Chen] Natl Chiayi Univ, Coll Agr, Dept Forestry & Nat Resources, Chiayi, Taiwan	National Chiayi University; Chia-Yi Christian Hospital; National Chiayi University	Liu, YW (corresponding author), Natl Chiayi Univ, Coll Life Sci, Dept Microbiol Immunol & Biopharmaceut, Chiayi, Taiwan.	ywlss@mail.ncyu.edu.tw			Ministry of Science and Technology of Republic of China, Taiwan [MOST104-2320-B-415-001-MY3]	Ministry of Science and Technology of Republic of China, Taiwan	This work is supported by grants from the Ministry of Science and Technology MOST104-2320-B-415-001-MY3 of the Republic of China, Taiwan.	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Brennan P, 2000, INT J CANCER, V86, P289, DOI 10.1002/(SICI)1097-0215(20000415)86:2<289::AID-IJC21>3.0.CO;2-M; BROCKMOLLER J, 1992, BIOCHEM PHARMACOL, V43, P647, DOI 10.1016/0006-2952(92)90591-6; Chatterjee SJ, 2004, J CLIN ONCOL, V22, P1007, DOI 10.1200/JCO.2004.05.174; Chuang JJ, 2014, TOXICOL APPL PHARM, V279, P322, DOI 10.1016/j.taap.2014.06.018; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Engel LS, 2002, AM J EPIDEMIOL, V156, P95, DOI 10.1093/aje/kwf018; Esteve-Puig R, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004721; Ha YS, 2011, J KOREAN MED SCI, V26, P231, DOI 10.3346/jkms.2011.26.2.231; He ZM, 2012, MUTAT RES-GEN TOX EN, V742, P92, DOI 10.1016/j.mrgentox.2011.11.015; Ibragimova I, 2014, EPIGENETICS-US, V9, P760, DOI 10.4161/epi.28078; Iida K, 2004, CANCER RES, V64, P6424, DOI 10.1158/0008-5472.CAN-04-1906; JANZOWSKI C, 1989, TOXICOLOGY, V59, P195, DOI 10.1016/0300-483X(89)90057-7; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jeong WS, 2006, ANTIOXID REDOX SIGN, V8, P99, DOI 10.1089/ars.2006.8.99; Kim SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026131; Kunze E, 1990, IARC Sci Publ, P345; KUNZE E, 1976, Z KREBSFORSCH KLIN O, V87, P139; Lee JY, 2007, MOL CELL BIOL, V27, P3187, DOI 10.1128/MCB.01461-06; Lin PY, 2012, TOXICOL APPL PHARM, V259, P27, DOI 10.1016/j.taap.2011.11.016; Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212; Matic M, 2013, UROL ONCOL-SEMIN ORI, V31, P1184, DOI 10.1016/j.urolonc.2011.08.005; Michaud DS, 2006, AM J CLIN NUTR, V84, P1177, DOI 10.1093/ajcn/84.5.1177; Mohsen MAA, 1999, INT J CANCER, V82, P789, DOI 10.1002/(SICI)1097-0215(19990909)82:6&lt;789::AID-IJC3&gt;3.0.CO;2-C; Nair J, 1996, CRIT REV TOXICOL, V26, P149, DOI 10.3109/10408449609017928; Nakanishi Y, 2000, AM J RESP CELL MOL, V22, P747, DOI 10.1165/ajrcmb.22.6.3877; OKAJIMA E, 1981, CANCER RES, V41, P1958; Oliveira P. A., 2006, Experimental Oncology, V28, P2; Oliveira PA, 2005, J EXP CLIN CANC RES, V24, P609; Peng DF, 2009, GUT, V58, P5, DOI 10.1136/gut.2007.146290; Poole AJ, 2004, ONCOGENE, V23, P8128, DOI 10.1038/sj.onc.1207994; Riedel K, 2006, J ANAL TOXICOL, V30, P187, DOI 10.1093/jat/30.3.187; Samanic C, 2006, CANCER EPIDEM BIOMAR, V15, P1348, DOI 10.1158/1055-9965.EPI-06-0021; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; STICKLER DJ, 1992, PARAPLEGIA, V30, P855, DOI 10.1038/sc.1992.162; Straif K, 2009, LANCET ONCOL, V10, P453, DOI 10.1016/S1470-2045(09)70134-2; Strange RC, 2001, MUTAT RES-FUND MOL M, V482, P21, DOI 10.1016/S0027-5107(01)00206-8; Tang SC, 2011, CANCER-AM CANCER SOC, V117, P3209, DOI 10.1002/cncr.25875; Williams PD, 2008, NEOPLASIA, V10, P838, DOI 10.1593/neo.08432; Yu MC, 2002, MUTAT RES-FUND MOL M, V506, P21, DOI 10.1016/S0027-5107(02)00148-3	40	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0159102	10.1371/journal.pone.0159102	http://dx.doi.org/10.1371/journal.pone.0159102			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27404495	gold, Green Published, Green Submitted			2022-12-27	WOS:000379508200034
J	Foley, KR; Taffe, J; Bourke, J; Einfeld, SL; Tonge, BJ; Trollor, J; Leonard, H				Foley, Kitty-Rose; Taffe, John; Bourke, Jenny; Einfeld, Stewart L.; Tonge, Bruce J.; Trollor, Julian; Leonard, Helen			Young People with Intellectual Disability Transitioning to Adulthood: Do Behaviour Trajectories Differ in Those with and without Down Syndrome?	PLOS ONE			English	Article							MENTAL ILL-HEALTH; PSYCHIATRIC-DISORDERS; MALADAPTIVE BEHAVIOR; EMOTIONAL-PROBLEMS; CHILDREN; PSYCHOPATHOLOGY; ADOLESCENTS; DEPRESSION; DEMENTIA; ASSOCIATION	Background Young people with intellectual disability exhibit substantial and persistent problem behaviours compared with their non-disabled peers. The aim of this study was to compare changes in emotional and behavioural problems for young people with intellectual disability with and without Down syndrome as they transition into adulthood in two different Australian cohorts. Methods Emotional and behavioural problems were measured over three time points using the Developmental Behaviour Checklist (DBC) for those with Down syndrome (n = 323 at wave one) and compared to those with intellectual disability of another cause (n = 466 at wave one). Outcome scores were modelled using random effects regression as linear functions of age, Down syndrome status, ability to speak and gender. Results DBC scores of those with Down syndrome were lower than those of people without Down syndrome indicating fewer behavioural problems on all scales except communication disturbance. For both groups disruptive, communication disturbance, anxiety and self-absorbed DBC subscales all declined on average over time. There were two important differences between changes in behaviours for these two cohorts. Depressive symptoms did not significantly decline for those with Down syndrome compared to those without Down syndrome. The trajectory of the social relating behaviours subscale differed between these two cohorts, where those with Down syndrome remained relatively steady and, for those with intellectual disability from another cause, the behaviours increased over time. Conclusions These results have implications for needed supports and opportunities for engagement in society to buffer against these emotional and behavioural challenges.	[Foley, Kitty-Rose; Trollor, Julian] UNSW Australia, Sch Psychiat, Dept Dev Disabil, Neuropsychiat, Sydney, NSW, Australia; [Taffe, John; Tonge, Bruce J.] Monash Univ, Sch Psychol Psychiat & Psychol Med, Ctr Dev Psychiat & Psychol, Melbourne, Vic, Australia; [Bourke, Jenny; Leonard, Helen] Univ Western Australia, Telethon Kids Inst, Perth, WA, Australia; [Einfeld, Stewart L.] Univ Sydney, Fac Hlth Sci, Sydney, NSW, Australia; [Einfeld, Stewart L.] Univ Sydney, Brain & Mind Res Inst, Sydney, NSW, Australia	University of New South Wales Sydney; Monash University; Telethon Kids Institute; University of Western Australia; University of Sydney; University of Sydney	Bourke, J (corresponding author), Univ Western Australia, Telethon Kids Inst, Perth, WA, Australia.	Jenny.Bourke@telethonkids.org	Tonge, Bruce J/T-8036-2018; Foley, Kitty-Rose/C-8800-2018; Leonard, Helen/A-1010-2013	Tonge, Bruce J/0000-0002-4236-9688; Foley, Kitty-Rose/0000-0002-1956-4995; Leonard, Helen/0000-0001-6405-5834	Australian Research Council [LP0989847]	Australian Research Council(Australian Research Council)	The study was funded by the Australian Research Council (Linkage Grant #LP0989847). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen D, 2008, J INTELLECT DISABILI, V12, P267, DOI 10.1177/1744629508100494; Baumer N, 2014, CURR OPIN PEDIATR, V26, P428, DOI 10.1097/MOP.0000000000000122; Berkovits LD, 2014, J INTELL DISABIL RES, V58, P765, DOI 10.1111/jir.12088; Blacher J, 2006, J INTELL DISABIL RES, V50, P184, DOI 10.1111/j.1365-2788.2005.00768.x; Blacher J, 2003, CURR OPIN PSYCHIATR, V16, P495, DOI 10.1097/00001504-200309000-00001; Bourke J, 2008, J PEDIATR-US, V153, P320, DOI 10.1016/j.jpeds.2008.02.047; Bower C, 2012, REPORT W AUSTR REGIS; BURT DB, 1995, AM J MENT RETARD, V100, P262; Clarke AR, 2003, J INTELL DISABIL RES, V47, P210, DOI 10.1046/j.1365-2788.2003.00470.x; COLLACOTT RA, 1992, BRIT J PSYCHIAT, V161, P671, DOI 10.1192/bjp.161.5.671; COOPER SA, 1994, BRIT J PSYCHIAT, V165, P399, DOI 10.1192/bjp.165.3.399; Coppus A, 2006, J INTELL DISABIL RES, V50, P768, DOI 10.1111/j.1365-2788.2006.00842.x; de la Torre R, 2012, PROG BRAIN RES, V197, P1, DOI 10.1016/B978-0-444-54299-1.00001-7; Douma JCH, 2006, J AM ACAD CHILD PSY, V45, P1224, DOI 10.1097/01.chi.0000233158.21925.95; Dyke P., 2007, SYNDROME NEEDS OPINI; Dykens EM, 2007, MENT RETARD DEV D R, V13, P272, DOI 10.1002/mrdd.20159; Dykens EM, 2015, J NEURODEV DISORD, V7, DOI 10.1186/s11689-015-9101-1; Dykens EM, 1997, AM J MENT RETARD, V102, P228, DOI 10.1352/0895-8017(1997)102<0228:MBICWP>2.0.CO;2; Dykens EM, 2002, J INTELL DISABIL RES, V46, P484, DOI 10.1046/j.1365-2788.2002.00431.x; EINFELD SL, 1995, J AUTISM DEV DISORD, V25, P81, DOI 10.1007/BF02178498; Einfeld SL, 1996, J INTELL DISABIL RES, V40, P99, DOI 10.1111/j.1365-2788.1996.tb00611.x; Einfeld SL, 2001, AM J MENT RETARD, V106, P73, DOI 10.1352/0895-8017(2001)106<0073:LCOBAE>2.0.CO;2; Einfeld SL, 2006, JAMA-J AM MED ASSOC, V296, P1981, DOI 10.1001/jama.296.16.1981; Einfeld SL, 2006, INT REV RES MENT RET, V33, P247, DOI 10.1016/S0074-7750(06)33010-8; Esbensen AJ, 2008, AM J MENT RETARD, V113, P263, DOI 10.1352/0895-8017(2008)113[263:SACIHF]2.0.CO;2; Fitzgerald P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070401; Foley KR, 2013, CHILD CARE HLTH DEV, V39, P789, DOI 10.1111/cch.12019; Foley K-R, 2014, SOCIAL PSYCHIAT PSYC; Foley KR, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0266-z; Fonseca LM, 2014, NEUROPSYCH DIS TREAT, V10, P2209, DOI 10.2147/NDT.S68831; Glass TA, 2006, J AGING HEALTH, V18, P604, DOI 10.1177/0898264306291017; Glidden LM, 2014, AJIDD-AM J INTELLECT, V119, P389, DOI 10.1352/1944-7558-119.5.389; Gray KM, 2011, RES DEV DISABIL, V32, P1194, DOI 10.1016/j.ridd.2010.12.044; Griffith GM, 2010, J AUTISM DEV DISORD, V40, P610, DOI 10.1007/s10803-009-0906-1; Guralnick MJ, 2007, CHILD DEV, V78, P459, DOI 10.1111/j.1467-8624.2007.01009.x; Haynes A, 2013, RES DEV DISABIL, V34, P847, DOI 10.1016/j.ridd.2012.11.008; Hughes EK, 2010, J CLIN PSYCHOL, V66, P978, DOI 10.1002/jclp.20695; KHAN S, 2002, MENTAL HLTH ASPECTS, V5, P46; Leonard H, 2005, SOCIAL SCI MED, V60; Leonard H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017875; Makary AT, 2014, RES DEV DISABIL, V35, P1868, DOI 10.1016/j.ridd.2014.04.010; Mantry D, 2008, J INTELL DISABIL RES, V52, P141, DOI 10.1111/j.1365-2788.2007.00985.x; McGillivray JA, 2007, RES DEV DISABIL, V28, P59, DOI 10.1016/j.ridd.2005.11.001; Mohr C, 2005, J INTELL DISABIL RES, V49, P469, DOI 10.1111/j.1365-2788.2005.00701.x; Mohr C, 2011, DEV BEHAV CHECKLIST; MYERS BA, 1991, J NERV MENT DIS, V179, P609, DOI 10.1097/00005053-199110000-00004; Partington M, 2000, AM J MED GENET, V92, P57, DOI 10.1002/(SICI)1096-8628(20000501)92:1<57::AID-AJMG10>3.0.CO;2-0; Patti P. J., 2006, INT J DISABIL HUM DE, V5, DOI [DOI 10.155/UDHD.2006.5.4.357, 10.1515/IJDHD.2006.5.4.357]; Pruijssers AC, 2014, J INTELLECTUAL DISAB, V58; Taffe J, 2008, INT J METHODS PSYCHI, V17; Thomas K, 2010, INT REV RES MENTAL R; Thomas K, 2011, J PEDIATR-US, V158, P194, DOI 10.1016/j.jpeds.2010.08.045; Tonge BJ, 2003, INT REV RES MENT RET, V26, P61, DOI 10.1016/S0074-7750(03)01002-4; Walker JC, 2011, RES DEV DISABIL, V32, P1432, DOI 10.1016/j.ridd.2011.02.010; Wark S, 2014, J INTELLECT DISABILI, V18, P305, DOI 10.1177/1744629514552152	55	12	12	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0157667	10.1371/journal.pone.0157667	http://dx.doi.org/10.1371/journal.pone.0157667			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27391326	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400017
J	Fritze, T; Teipel, S; Ovari, A; Kilimann, I; Witt, G; Doblhammer, G				Fritze, Thomas; Teipel, Stefan; Ovari, Attila; Kilimann, Ingo; Witt, Gabriele; Doblhammer, Gabriele			Hearing Impairment Affects Dementia Incidence. An Analysis Based on Longitudinal Health Claims Data in Germany	PLOS ONE			English	Article							VASCULAR RISK-FACTORS; ALZHEIMERS-DISEASE; COGNITIVE DECLINE; FOLLOW-UP; PHYSICAL-ACTIVITY; PREVALENCE; ADULTS; AIDS; EPIDEMIOLOGY; LONELINESS	Recent research has revealed an association between hearing impairment and dementia. The objective of this study is to determine the effect of hearing impairment on dementia incidence in a longitudinal study, and whether ear, nose, and throat (ENT) specialist care, care level, institutionalization, or depression mediates or moderates this pathway. The present study used a longitudinal sample of 154,783 persons aged 65 and older from claims data of the largest German health insurer; containing 14,602 incident dementia diagnoses between 2006 and 2010. Dementia and hearing impairment diagnoses were defined according to International Classification of Diseases, Tenth Revision, codes. We used a Kaplan Meier estimator and performed Cox proportional hazard models to explore the effect of hearing impairment on dementia incidence, controlling for ENT specialist care, care level, institutionalization, and depression. Gender, age, and comorbidities were controlled for as potential confounders. Patients with bilateral (HR = 1.43, p<0.001) and side-unspecified (HR = 1.20, p<0.001) hearing impairment had higher risks of dementia incidence than patients without hearing impairment. We found no significant effect for unilateral hearing impairment and other diseases of the ear. The effect of hearing impairment was only partly mediated through ENT specialist utilization. Significant interaction between hearing impairment and specialist care, care level, and institutionalization, respectively, indicated moderating effects. We discuss possible explanations for these effects. This study underlines the importance of the association between hearing impairment and dementia. Preserving hearing ability may maintain social participation and may reduce the burden associated with dementia. The particular impact of hearing aid use should be the subject of further investigations, as it offers potential intervention on the pathway to dementia.	[Fritze, Thomas; Teipel, Stefan; Kilimann, Ingo] German Ctr Neurodegenerat Dis DZNE, Rostock, Germany; [Fritze, Thomas] Rostock Ctr, Study Demog Change, Rostock, Germany; [Teipel, Stefan; Kilimann, Ingo] Univ Med, Dept Psychosomat Med, Rostock, Germany; [Ovari, Attila; Witt, Gabriele] Univ Med Rostock, Dept Otorhinolaryngol Head & Neck Surg, Rostock, Germany; [Doblhammer, Gabriele] Univ Rostock, Inst Sociol & Demog, Rostock, Germany; [Doblhammer, Gabriele] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Doblhammer, Gabriele] Max Planck Inst Demog Res, Rostock, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Rostock; University of Rostock; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Max Planck Society	Fritze, T (corresponding author), German Ctr Neurodegenerat Dis DZNE, Rostock, Germany.; Fritze, T (corresponding author), Rostock Ctr, Study Demog Change, Rostock, Germany.	thomas.fritze@dzne.de		Fritze, Thomas/0000-0001-7649-6936; Ovari, Attila/0000-0003-4610-6890				Aarsland D, 2010, AGING MENT HEALTH, V14, P386, DOI 10.1080/13607860903586136; Abdollahpour I, 2015, PSYCHOGERIATRICS, V15, P51, DOI 10.1111/psyg.12094; Acar B, 2011, ARCH GERONTOL GERIAT, V52, P250, DOI 10.1016/j.archger.2010.04.013; Aguero-Torres H, 1998, AM J PUBLIC HEALTH, V88, P1452, DOI 10.2105/AJPH.88.10.1452; Aguero-Torres H, 2001, J CLIN EPIDEMIOL, V54, P795, DOI 10.1016/S0895-4356(00)00371-1; Albers Kristi, 2012, Minn Med, V95, P52; Alpar A, 2009, J NEUROSCI RES, V87, P1813, DOI 10.1002/jnr.22008; Amieva H, 2015, J AM GERIATR SOC, V63, P2099, DOI 10.1111/jgs.13649; Bakhos D, 2015, GERIATR PSYCHOL NEUR, V13, P195, DOI 10.1684/pnv.2015.0539; Bennion A, 2013, INT J OLDER PEOPLE N, V8, P270, DOI 10.1111/j.1748-3743.2012.00318.x; Bickel H, 2000, GESUNDHEITSWESEN, V62, P211, DOI 10.1055/s-2000-10858; Bickel H., 2005, DEMENZEN, P1, DOI [10.1055/b-0034-22394, DOI 10.1055/B-0034-22394]; BRAAK H, 1993, EUR NEUROL, V33, P403, DOI 10.1159/000116984; Breteler MMB, 2000, NEUROBIOL AGING, V21, P153, DOI 10.1016/S0197-4580(99)00110-4; Brodaty Henry, 2009, Dialogues Clin Neurosci, V11, P217; Buchman AS, 2007, PSYCHOSOM MED, V69, P483, DOI 10.1097/psy.0b013e318068de1d; Bundesausschuss Gemeinsamer (G-BA), 2004, RICHTL VER HILFSM VE; Cherubini A, 2005, NEUROBIOL AGING, V26, P987, DOI 10.1016/j.neurobiolaging.2004.09.002; Chia EM, 2006, ARCH OPHTHALMOL-CHIC, V124, P1465, DOI 10.1001/archopht.124.10.1465; Ciorba A, 2012, CLIN INTERV AGING, V7, P159, DOI 10.2147/CIA.S26059; Cook G, 2006, INT J OLDER PEOPLE N, V1, P216, DOI 10.1111/j.1748-3743.2006.00034.x; Craft S, 2009, ARCH NEUROL-CHICAGO, V66, P300, DOI 10.1001/archneurol.2009.27; Dalton DS, 2003, GERONTOLOGIST, V43, P661, DOI 10.1093/geront/43.5.661; DAVIS AC, 1989, INT J EPIDEMIOL, V18, P911, DOI 10.1093/ije/18.4.911; Dawes P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119616; Desmond DW, 2002, STROKE, V33, P2254, DOI 10.1161/01.STR.0000028235.91778.95; Dewey ME, 2001, INT J GERIATR PSYCH, V16, P751, DOI 10.1002/gps.397.abs; Doblhammer G., 2012, DEMOGRAFIE DEMENZ; Doblhammer G, 2013, GERIATRIC MENTAL HLT, V1, P29, DOI DOI 10.1016/J.GMHC.2013.04.002; Doblhammer G, 2015, ALZHEIMERS DEMENT, V11, P291, DOI 10.1016/j.jalz.2014.02.006; Duijvestijn JA, 1999, ACTA OTO-LARYNGOL, V119, P420; Dupuis K, 2015, AGING NEUROPSYCHOL C, V22, P413, DOI 10.1080/13825585.2014.968084; Enache D, 2011, CURR OPIN PSYCHIATR, V24, P461, DOI 10.1097/YCO.0b013e32834bb9d4; Fasano A, 2012, NEUROL SCI, V33, P1215, DOI 10.1007/s10072-012-1126-6; Gorelick PB, 2004, STROKE, V35, P2620, DOI 10.1161/01.STR.0000143318.70292.47; Gray SL, 2013, J GERONTOL A-BIOL, V68, P1083, DOI 10.1093/gerona/glt013; Gruber-Baldini AL, 2003, J AM GERIATR SOC, V51, P1227, DOI 10.1046/j.1532-5415.2003.51406.x; Gurgel RK, 2012, OTOLARYNG HEAD NECK, V147, P803, DOI 10.1177/0194599812458401; Gurgel RK, 2014, OTOL NEUROTOL, V35, P775, DOI 10.1097/MAO.0000000000000313; Hamer M, 2009, PSYCHOL MED, V39, P3, DOI 10.1017/S0033291708003681; Hebert LE, 2013, NEUROLOGY, V80, P1778, DOI 10.1212/WNL.0b013e31828726f5; Holmen K, 2000, ARCH GERONTOL GERIAT, V31, P177, DOI 10.1016/S0167-4943(00)00070-4; Hung SC, 2015, J EPIDEMIOL, V25, P517, DOI 10.2188/jea.JE20140147; Ivan CS, 2004, STROKE, V35, P1264, DOI 10.1161/01.STR.0000127810.92616.78; Jakob A, 2002, Z GERONTOL GERIATR, V35, P474, DOI 10.1007/s00391-002-0066-9; Kiely KM, 2012, J GERONTOL A-BIOL, V67, P997, DOI 10.1093/gerona/gls066; Kilimann I, 2014, Z GERONTOL GERIATR; Kopf D, 2009, J ALZHEIMERS DIS, V16, P677, DOI 10.3233/JAD-2009-1011; Larrieu S, 2004, J Nutr Health Aging, V8, P150; Launer LJ, 1999, NEUROLOGY, V52, P78, DOI 10.1212/WNL.52.1.78; Lin FR, 2013, JAMA INTERN MED, V173, P293, DOI 10.1001/jamainternmed.2013.1868; Lin FR, 2011, NEUROPSYCHOLOGY, V25, P763, DOI 10.1037/a0024238; Lin FR, 2011, ARCH NEUROL-CHICAGO, V68, P214, DOI 10.1001/archneurol.2010.362; Lindsay J, 1997, STROKE, V28, P526, DOI 10.1161/01.STR.28.3.526; Lupsakko TA, 2005, EUR ARCH OTO-RHINO-L, V262, P165, DOI 10.1007/s00405-004-0789-x; McCormack A, 2013, INT J AUDIOL, V52, P360, DOI 10.3109/14992027.2013.769066; MORITZ DJ, 1995, AM J EPIDEMIOL, V141, P41, DOI 10.1093/oxfordjournals.aje.a117344; Morris MC, 2003, ARCH NEUROL-CHICAGO, V60, P194, DOI 10.1001/archneur.60.2.194; Nondahl DM, 1998, AUDIOLOGY, V37, P295; Nyatsanza S, 2003, J NEUROL NEUROSUR PS, V74, P1398, DOI 10.1136/jnnp.74.10.1398; Okamoto M, 2004, INT J AUDIOL, V43, P54, DOI 10.1080/14992020400050008; Panza F, 2015, NAT REV NEUROL, V11; Perry RJ, 1999, BRAIN, V122, P383, DOI 10.1093/brain/122.3.383; PICHORAFULLER MK, 1995, J ACOUST SOC AM, V97, P593, DOI 10.1121/1.412282; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Quaranta A, 1996, SCAND AUDIOL, V25, P9; Ravaglia G, 2005, NEUROLOGY, V64, P1525, DOI 10.1212/01.WNL.0000160107.02316.BF; Reuben DB, 1999, J AM GERIATR SOC, V47, P930, DOI 10.1111/j.1532-5415.1999.tb01286.x; Richards M, 2004, BMJ-BRIT MED J, V328, P552, DOI 10.1136/bmj.37972.513819.EE; Ries P W, 1994, Vital Health Stat 10, P1; Ronnberg J, 2011, J SPEECH LANG HEAR R, V54, P705, DOI 10.1044/1092-4388(2010/09-0088); Rousseaux M, 2010, NEUROPSYCHOLOGIA, V48, P3884, DOI 10.1016/j.neuropsychologia.2010.09.026; Sauvaget C, 2002, GERONTOLOGY, V48, P226, DOI 10.1159/000058355; SCHOW RL, 1980, J SPEECH HEAR DISORD, V45, P124, DOI 10.1044/jshd.4501.124; Schulz A, 2012, AKTUELLER ZUKUNFTIGE AKTUELLER ZUKUNFTIGE, P161; Sindhusake D, 2001, INT J EPIDEMIOL, V30, P1371, DOI 10.1093/ije/30.6.1371; SINHA UK, 1993, NEUROLOGY, V43, P779, DOI 10.1212/WNL.43.4.779; Solfrizzi V, 2004, NEUROLOGY, V63, P1882, DOI 10.1212/01.WNL.0000144281.38555.E3; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Strawbridge WJ, 2000, GERONTOLOGIST, V40, P320, DOI 10.1093/geront/40.3.320; Teipel S, 2015, J AM GERIATR SOC, V63, P1527, DOI 10.1111/jgs.13561; UHLMANN RF, 1989, JAMA-J AM MED ASSOC, V261, P1916, DOI 10.1001/jama.261.13.1916; Valentijn SAM, 2005, J AM GERIATR SOC, V53, P374, DOI 10.1111/j.1532-5415.2005.53152.x; van der Flier WM, 2005, J NEUROL NEUROSUR PS, V76, pV2, DOI 10.1136/jnnp.2005.082867; Van Eyken E, 2007, AUDIOL NEURO-OTOL, V12, P345, DOI 10.1159/000106478; VandenLangenberg GM, 1998, AM J EPIDEMIOL, V148, P204, DOI 10.1093/oxfordjournals.aje.a009625; von Gablenz P, 2015, HNO, V63, P195, DOI 10.1007/s00106-014-2949-7; Weyerer S., 2005, GESUNDHEITSBERICHTER; Wilson RS, 2007, ARCH GEN PSYCHIAT, V64, P234, DOI 10.1001/archpsyc.64.2.234; Wimo A, 2003, ALZ DIS ASSOC DIS, V17, P63, DOI 10.1097/00002093-200304000-00002; World Health Organization, 2015, GRADES OF HEARING IM	91	45	48	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0156876	10.1371/journal.pone.0156876	http://dx.doi.org/10.1371/journal.pone.0156876			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27391486	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400006
J	Munck, C; Helby, J; Westergaard, CG; Porsbjerg, C; Backer, V; Hansen, LH				Munck, Christian; Helby, Jens; Westergaard, Christian G.; Porsbjerg, Celeste; Backer, Vibeke; Hansen, Lars H.			Smoking Cessation and the Microbiome in Induced Sputum Samples from Cigarette Smoking Asthma Patients	PLOS ONE			English	Article							AIRWAY INFLAMMATION; SMOKERS; SEQUENCES	Asthma is a common disease causing cough, wheezing and shortness of breath. It has been shown that the lung microbiota in asthma patients is different from the lung microbiota in healthy controls suggesting that a connection between asthma and the lung microbiome exists. Individuals with asthma who are also tobacco smokers experience more severe asthma symptoms and smoking cessation is associated with improved asthma control. In the present study we investigated if smoking cessation in asthma patients is associated with a change in the bacterial community in the lungs, examined using induced sputum. We found that while tobacco smokers with asthma have a greater bacterial diversity in the induced sputum compared to non-smoking healthy controls, smoking cessation does not lead to a change in the microbial diversity.	[Munck, Christian] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Horsholm, Denmark; [Helby, Jens] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Clin Biochem, Herlev, Denmark; [Westergaard, Christian G.; Porsbjerg, Celeste; Backer, Vibeke] Bispebjerg Hosp, Resp Res Unit, Copenhagen, Denmark; [Hansen, Lars H.] Aarhus Univ, Dept Environm Sci, Roskilde, Denmark	Technical University of Denmark; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; Aarhus University	Munck, C (corresponding author), Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Horsholm, Denmark.; Hansen, LH (corresponding author), Aarhus Univ, Dept Environm Sci, Roskilde, Denmark.	chrmu@biosustain.dtu.dk; lhha@envs.au.dk	Backer, Vibeke/AAQ-9379-2021	Helby, Jens/0000-0002-1876-8187; Porsbjerg, Celeste/0000-0003-4825-9436	Danish Lung Association	Danish Lung Association	This research was funded by the Danish Lung Association, www.lunge.dk. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; JH and CM thank Karin Vestberg for technical assistance. The research was supported by grants from The Danish Lung Association.	Bassis CM, 2015, MBIO, V6, DOI 10.1128/mBio.00037-15; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Charlson ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015216; Colak Y, 2015, AM J RESP CRIT CARE, V192, P172, DOI 10.1164/rccm.201502-0302OC; Dickson RP, 2013, EXPERT REV RESP MED, V7, P245, DOI [10.1586/ers.13.24, 10.1586/ERS.13.24]; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Hansen CHF, 2012, DIABETOLOGIA, V55, P2285, DOI 10.1007/s00125-012-2564-7; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Huang YJ, 2011, J ALLERGY CLIN IMMUN, V127, P372, DOI 10.1016/j.jaci.2010.10.048; Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07; Lozupone CA, 2008, FEMS MICROBIOL REV, V32, P557, DOI 10.1111/j.1574-6976.2008.00111.x; Marri PR, 2013, J ALLERGY CLIN IMMUN, V131, P346, DOI 10.1016/j.jaci.2012.11.013; Mcleish AC, 2010, J ASTHMA, V47, P345, DOI 10.3109/02770900903556413; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Morris A, 2013, AM J RESP CRIT CARE, V187, P1067, DOI 10.1164/rccm.201210-1913OC; Park H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109710; Thomson NC, 2009, CURR OPIN PULM MED, V15, P39, DOI 10.1097/MCP.0b013e32831da894; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Westergaard CG, 2014, CLIN EXP ALLERGY, V44, P353, DOI 10.1111/cea.12243; Westergaard CG, 2015, RESP MED, V109, P1416, DOI 10.1016/j.rmed.2015.07.017; Westergaard CG, 2014, J ASTHMA, V51, P341, DOI 10.3109/02770903.2014.880718	23	19	19	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158622	10.1371/journal.pone.0158622	http://dx.doi.org/10.1371/journal.pone.0158622			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391160	Green Published, gold, Green Submitted			2022-12-27	WOS:000380005400093
J	Murphy, TF; Brauer, AL; Johnson, A; Kirkham, C				Murphy, Timothy F.; Brauer, Aimee L.; Johnson, Antoinette; Kirkham, Charmaine			ATP-Binding Cassette (ABC) Transporters of the Human Respiratory Tract Pathogen, Moraxella catarrhalis: Role in Virulence	PLOS ONE			English	Article							MEMBRANE PROTEIN CD; PULMONARY CLEARANCE; NASOPHARYNGEAL COLONIZATION; STREPTOCOCCUS-PNEUMONIAE; M. CATARRHALIS; PERMEASE; GENOME; OPPA; IDENTIFICATION; ACQUISITION	Moraxella catarrhalis is a human respiratory tract pathogen that causes otitis media (middle ear infections) in children and respiratory tract infections in adults with chronic obstructive pulmonary disease. In view of the huge global burden of disease caused by M. catarrhalis, the development of vaccines to prevent these infections and better approaches to treatment have become priorities. In previous work, we used a genome mining approach that identified three substrate binding proteins (SBPs) of ATP-binding cassette (ABC) transporters as promising candidate vaccine antigens. In the present study, we performed a comprehensive assessment of 19 SBPs of 15 ABC transporter systems in the M. catarrhalis genome by engineering knockout mutants and studying their role in assays that assess mechanisms of infection. The capacity of M. catarrhalis to survive and grow in the nutrient-limited and hostile environment of the human respiratory tract, including intracellular growth, account in part for its virulence. The results show that ABC transporters that mediate uptake of peptides, amino acids, cations and anions play important roles in pathogenesis by enabling M. catarrhalis to 1) grow in nutrient-limited conditions, 2) invade and survive in human respiratory epithelial cells and 3) persist in the lungs in a murine pulmonary clearance model. The knockout mutants of SBPs and ABC transporters showed different patterns of activity in the assay systems, supporting the conclusion that different SBPs and ABC transporters function at different stages in the pathogenesis of infection. These results indicate that ABC transporters are nutritional virulence factors, functioning to enable the survival of M catarrhalis in the diverse microenvironments of the respiratory tract. Based on the role of ABC transporters as virulence factors of M. catarrhalis, these molecules represent potential drug targets to eradicate the organism from the human respiratory tract.	[Murphy, Timothy F.; Brauer, Aimee L.; Johnson, Antoinette; Kirkham, Charmaine] SUNY Buffalo, Clin & Translat Res Ctr, Buffalo, NY 14260 USA; [Murphy, Timothy F.; Brauer, Aimee L.; Johnson, Antoinette; Kirkham, Charmaine] SUNY Buffalo, Dept Med, Div Infect Dis, Buffalo, NY 14260 USA; [Murphy, Timothy F.] SUNY Buffalo, Dept Microbiol, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Murphy, TF (corresponding author), SUNY Buffalo, Clin & Translat Res Ctr, Buffalo, NY 14260 USA.; Murphy, TF (corresponding author), SUNY Buffalo, Dept Med, Div Infect Dis, Buffalo, NY 14260 USA.; Murphy, TF (corresponding author), SUNY Buffalo, Dept Microbiol, Buffalo, NY 14260 USA.	murphyt@buffalo.edu		Murphy, Timothy/0000-0002-3496-2641	National Institute on Deafness and Other Communication Disorders [R01 DC012200]; National Center for Advancing Translational Sciences [UL1TR001412]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012200] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institute on Deafness and Other Communication Disorders grant R01 DC012200 (TFM) and by the National Center for Advancing Translational Sciences award UL1TR001412 to the University at Buffalo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimana C, 2007, FEMS MICROBIOL LETT, V271, P12, DOI 10.1111/j.1574-6968.2007.00693.x; Balder R, 2009, INFECT IMMUN, V77, P4597, DOI 10.1128/IAI.00212-09; Becker PD, 2007, INFECT IMMUN, V75, P1778, DOI 10.1128/IAI.01081-06; Borezee E, 2000, INFECT IMMUN, V68, P7069, DOI 10.1128/IAI.68.12.7069-7077.2000; CUNDELL DR, 1995, INFECT IMMUN, V63, P2493, DOI 10.1128/IAI.63.7.2493-2498.1995; de Vries SPW, 2010, J BACTERIOL, V192, P3574, DOI 10.1128/JB.00121-10; Faden H, 1997, J INFECT DIS, V175, P1440, DOI 10.1086/516477; FADEN H, 1991, ANN OTO RHINOL LARYN, V100, P612, DOI 10.1177/000348949110000802; FADEN H, 1994, J INFECT DIS, V169, P1312, DOI 10.1093/infdis/169.6.1312; Forsgren A, 2004, J INFECT DIS, V190, P352, DOI 10.1086/422155; Garmory HS, 2004, INFECT IMMUN, V72, P6757, DOI 10.1128/IAI.72.12.6757-6763.2004; Heiniger N, 2007, J INFECT DIS, V196, P1080, DOI 10.1086/521194; HIGGINS CF, 1985, EMBO J, V4, P1033, DOI 10.1002/j.1460-2075.1985.tb03735.x; Hu EG, 2000, INFECT IMMUN, V68, P4980, DOI 10.1128/IAI.68.9.4980-4985.2000; Hu WG, 1999, VACCINE, V18, P799, DOI 10.1016/S0264-410X(99)00335-7; Hung MC, 2015, VACCINE, V33, P4486, DOI 10.1016/j.vaccine.2015.07.032; Jones MM, 2014, INFECT IMMUN, V82, P4758, DOI 10.1128/IAI.02185-14; JUNI E, 1986, APPL ENVIRON MICROB, V52, P546, DOI 10.1128/AEM.52.3.546-551.1986; Kerr AR, 2004, INFECT IMMUN, V72, P3902, DOI 10.1128/IAI.72.7.3902-3906.2004; Lee EM, 2004, FEMS MICROBIOL LETT, V240, P21, DOI 10.1016/j.femsle.2004.09.007; Lewis M, 1996, SCIENCE, V271, P1247, DOI 10.1126/science.271.5253.1247; Linton KJ, 1998, MOL MICROBIOL, V28, P5, DOI 10.1046/j.1365-2958.1998.00764.x; Liu DF, 2007, INFECT IMMUN, V75, P2818, DOI 10.1128/IAI.00074-07; MAO B, 1982, J BIOL CHEM, V257, P1131; Maqbool A, 2015, BIOCHEM SOC T, V43, P1011, DOI 10.1042/BST20150135; MENARD R, 1993, J BACTERIOL, V175, P5899; Murphy TF, 2005, AM J RESP CRIT CARE, V172, P195, DOI 10.1164/rccm.200412-1747OC; Murphy TF, 2016, VACCINE, V34, P3855, DOI 10.1016/j.vaccine.2016.05.045; Murphy TF, 2013, INFECT IMMUN, V81, P3406, DOI 10.1128/IAI.00589-13; Murphy TF, 2009, CLIN INFECT DIS, V49, P124, DOI 10.1086/599375; Otsuka T, 2016, INFECT IMMUN, V84, P432, DOI 10.1128/IAI.00799-15; Otsuka T, 2014, INFECT IMMUN, V82, P3503, DOI 10.1128/IAI.01832-14; Pletzer D, 2015, J BACTERIOL, V197, P2217, DOI 10.1128/JB.00234-15; Reddy MS, 1997, OTOLARYNG HEAD NECK, V116, P175, DOI 10.1016/S0194-5998(97)70321-8; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Rhodes ER, 2005, INFECT IMMUN, V73, P3758, DOI 10.1128/IAI.73.6.3758-3763.2005; Ruckdeschel EA, 2008, INFECT IMMUN, V76, P1599, DOI 10.1128/IAI.01253-07; Shevchuk NA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh014; Su YC, 2012, FUTURE MICROBIOL, V7, P1073, DOI [10.2217/fmb.12.80, 10.2217/FMB.12.80]; TAM R, 1993, MICROBIOL REV, V57, P320, DOI 10.1128/MMBR.57.2.320-346.1993; Tanabe M, 2006, INFECT IMMUN, V74, P3687, DOI 10.1128/IAI.01837-05; UNHANAND M, 1992, J INFECT DIS, V165, P644, DOI 10.1093/infdis/165.4.644; Vidakovics MLP, 2009, CURR OPIN INFECT DIS, V22, P279, DOI 10.1097/QCO.0b013e3283298e4e; Watson K, 2006, PEDIATR INFECT DIS J, V25, P782, DOI 10.1097/01.inf.0000232705.49634.68; Wilkens Stephan, 2015, F1000Prime Rep, V7, P14, DOI 10.12703/P7-14; Yang M, 2011, INFECT IMMUN, V79, P846, DOI 10.1128/IAI.00314-10; Zomer A, 2012, J BACTERIOL, V194, P6969, DOI 10.1128/JB.01833-12; Zuckert WR, 2014, BBA-MOL CELL RES, V1843, P1509, DOI 10.1016/j.bbamcr.2014.04.022	48	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158689	10.1371/journal.pone.0158689	http://dx.doi.org/10.1371/journal.pone.0158689			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391026	Green Published, gold, Green Submitted			2022-12-27	WOS:000380005400104
J	Nunes, BC; Pavan, MG; Jaeger, LH; Monteiro, KJL; Xavier, SCC; Monteiro, FA; Boia, MN; Carvalho-Costa, FA				Nunes, Beatriz Coronato; Pavan, Marcio G.; Jaeger, Lauren H.; Monteiro, Kerla J. L.; Xavier, Samanta C. C.; Monteiro, Fernando A.; Boia, Marcio N.; Carvalho-Costa, Filipe A.			Spatial and Molecular Epidemiology of Giardia intestinalis Deep in the Amazon, Brazil	PLOS ONE			English	Article							SOIL-TRANSMITTED HELMINTHS; PARASITIC INFECTIONS; CHILDREN; PROTOZOA; DUODENALIS; HEALTH; SCHOOLCHILDREN; PREVALENCE; LAMBLIA; SAMPLES	Background Current control policies for intestinal parasitosis focuses on soil-transmitted helminths, being ineffective against Giardia intestinalis, a highly prevalent protozoon that impacts children's nutritional status in developing countries. The objective of this study was to explore spatial and molecular epidemiology of Giardia intestinalis in children of Amerindian descent in the Brazilian Amazon. Methodology/Principal Findings A cross sectional survey was performed in the Brazilian Amazon with 433 children aged 1 to 14 years. Fecal samples were processed through parasitological techniques and molecular characterization. Prevalence of G. intestinalis infection was 16.9%(73/433), reaching 22.2% (35/158) among children aged 2-5 years, and a wide distribution throughout the city with some hot spots. Positivity-rate was similar among children living in distinct socio-economic strata (48/280 [17.1%] and 19/116 [16.4%] below and above the poverty line, respectively). Sequencing of the beta-giardin gene revealed 52.2% (n = 12) of assemblage A and 47.8% (n = 11) of assemblage B with high haplotype diversity for the latter. The isolates clustered into two well-supported G. intestinalis clades. A total of 38 haplotypes were obtained, with the following subassemblages distribution: 5.3% (n = 2) AII, 26.3% (n = 10) AIII, 7.9% (n = 3) BIII, and 60.5%(n = 23) new B genotypes not previously described. Conclusions/Significance Giardia intestinalis infection presents a high prevalence rate among Amerindian descended children living in Santa Isabel do Rio Negro/Amazon. The wide distribution observed in a small city suggests the presence of multiple sources of infection, which could be related to environmental contamination with feces, possibly of human and animal origin, highlighting the need of improving sanitation, safe water supply and access to diagnosis and adequate treatment of infections.	[Nunes, Beatriz Coronato; Pavan, Marcio G.; Jaeger, Lauren H.; Monteiro, Kerla J. L.; Xavier, Samanta C. C.; Monteiro, Fernando A.; Boia, Marcio N.; Carvalho-Costa, Filipe A.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, Brazil; [Carvalho-Costa, Filipe A.] Fundacao Oswaldo Cruz, Teresina, Piaui, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Carvalho-Costa, FA (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.; Carvalho-Costa, FA (corresponding author), Fundacao Oswaldo Cruz, Teresina, Piaui, Brazil.	guaratiba@ioc.fiocruz.br	Jaeger, Lauren Hubert/GVU-0797-2022; Pavan, Marcio G/F-3270-2015	Pavan, Marcio G/0000-0002-5699-242X; Xavier, Samanta Cristina/0000-0002-3475-0075	Oswaldo Cruz Foundation (Fiocruz); Brazilian Federal Agency for Support and Evaluation of Graduate Education (CAPES)/Brazilian Ministry of Education; Ministry of Social Development, in the context of the CAPES-Fiocruz-Brazil	Oswaldo Cruz Foundation (Fiocruz); Brazilian Federal Agency for Support and Evaluation of Graduate Education (CAPES)/Brazilian Ministry of Education; Ministry of Social Development, in the context of the CAPES-Fiocruz-Brazil	This work was supported by the Oswaldo Cruz Foundation (Fiocruz) and the Brazilian Federal Agency for Support and Evaluation of Graduate Education (CAPES)/Brazilian Ministry of Education and Ministry of Social Development, in the context of the CAPES-Fiocruz-Brazil without Poverty Plan.	Adam RD, 2013, GENOME BIOL EVOL, V5, P2498, DOI 10.1093/gbe/evt197; Barry MA, 2013, PEDIATR CLIN N AM, V60, P471, DOI 10.1016/j.pcl.2012.12.011; Caccio SA, 2002, INT J PARASITOL, V32, P1023, DOI 10.1016/S0020-7519(02)00068-1; Caccio SM, 2010, EXP PARASITOL, V124, P107, DOI 10.1016/j.exppara.2009.02.007; Carvalho-Costa Filipe Anibal, 2007, Rev. Inst. Med. trop. S. Paulo, V49, P147, DOI 10.1590/S0036-46652007000300003; David EB, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0714-8; Durigan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115489; Ehsan AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118239; Feng YY, 2011, CLIN MICROBIOL REV, V24, P110, DOI 10.1128/CMR.00033-10; Ferreira FS, 2015, J TROP PEDIATRICS, V61, P106, DOI 10.1093/tropej/fmu078; Fletcher SM, 2012, CLIN MICROBIOL REV, V25, P420, DOI 10.1128/CMR.05038-11; Garbossa G, 2013, PATHOG GLOB HEALTH, V107, P141, DOI 10.1179/2047773213Y.0000000087; Ignatius R, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001677; Jenkins EJ, 2013, ADV PARASIT, V82, P33, DOI 10.1016/B978-0-12-407706-5.00002-2; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Luther A, 2015, F1000PRIME REP, V7, P62, DOI 10.12703/P7-62; Macchioni F, 2015, AM J TROP MED HYG, V92, P794, DOI 10.4269/ajtmh.14-0039; Messing J, 1993, Methods Mol Biol, V23, P9; Monis PT, 2009, TRENDS PARASITOL, V25, P93, DOI 10.1016/j.pt.2008.11.006; Nematian J, 2008, ANN TROP MED PARASIT, V102, P209, DOI 10.1179/136485908X267876; Nygard K, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-141; Quihui L, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-85; RITCHIE LAWRENCE S., 1948, BULL U S ARMY MED DEPT, V8, P326; Robertson LJ, 2011, GIARDIA: A MODEL ORGANISM, P29; Trivino-Valencia J, 2016, PARASITOL RES, V115, P1789, DOI 10.1007/s00436-016-4917-5; Turkeltaub JA, 2015, CURR OPIN GASTROEN, V31, P38, DOI 10.1097/MOG.0000000000000135; Verhagen LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077581	27	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158805	10.1371/journal.pone.0158805	http://dx.doi.org/10.1371/journal.pone.0158805			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27392098	gold, Green Published, Green Submitted			2022-12-27	WOS:000380005400128
J	Sahoo, BR; Fujiwara, T				Sahoo, Bikash Ranjan; Fujiwara, Toshimichi			Membrane Mediated Antimicrobial and Antitumor Activity of Cathelicidin 6: Structural Insights from Molecular Dynamics Simulation on Multi-Microsecond Scale	PLOS ONE			English	Article							SOLID-STATE NMR; LIPID-BILAYERS; INNATE IMMUNITY; FORCE-FIELD; OLIGOMERIC STRUCTURE; PORE FORMATION; PEPTIDE LL-37; MECHANISM; INSERTION; MELITTIN	The cathelicidin derived bovine antimicrobial peptide BMAP27 exhibits an effective microbicidal activity and moderate cytotoxicity towards erythrocytes. Irrespective of its therapeutic and multidimensional potentiality, the structural studies are still elusive. Moreover, the mechanism of BMAP27 mediated pore formation in heterogeneous lipid membrane systems is poorly explored. Here, we studied the effect of BMAP27 in model cell-membrane systems such as zwitterionic, anionic, thymocytes-like (TLM) and leukemia-like membranes (LLM) by performing molecular dynamics (MD) simulation longer than 100 mu s. All-atom MD studies revealed a stable helical conformation in the presence of anionic lipids, however, significant loss of helicity was identified in TLM and zwitterionic systems. A peptide tilt (similar to 45 degrees) and central kink (at residue F10) was found in anionic and LLM models, respectively, with an average membrane penetration of < 0.5 nm. Coarse-grained (CG) MD analysis on a multi-mu s scale shed light on the membrane-dependent peptide and lipid organization. Stable micelle and end-to-end like oligomers were formed in zwitterionic and TLM models, respectively. In contrast, unstable oligomer formation and monomeric BMAP27 penetration were observed in anionic and LLM systems with selective anionic lipid aggregation (in LLM). Peptide penetration up to similar to 1.5 nm was observed in CG-MD systems with the BMAP27 C-terminal oriented towards the bilayer core. Structural inspection suggested membrane penetration by micelle/end-to-end like peptide oligomers (carpet-model like) in the zwitterionic/TLM systems, and transmembrane-mode (toroidal-pore like) in the anionic/LLM systems, respectively. Structural insights and energetic interpretation in BMAP27 mutant highlighted the role of F10 and hydrophobic residues in mediating a membrane-specific peptide interaction. Free energy profiling showed a favorable (-4.58 kcal mol(-1) for LLM) and unfavorable (+0.17 kcal mol(-1) for TLM) peptide insertion in anionic and neutral systems, respectively. This determination can be exploited to regulate cell-specific BMAP27 cytotoxicity for the development of potential drugs and antibiotics.	[Sahoo, Bikash Ranjan; Fujiwara, Toshimichi] Osaka Univ, Inst Prot Res, Lab Mol Biophys, Suita, Osaka, Japan	Osaka University	Fujiwara, T (corresponding author), Osaka Univ, Inst Prot Res, Lab Mol Biophys, Suita, Osaka, Japan.	tfjwr@protein.osaka-u.ac.jp	Sahoo, Bikash Ranjan/H-7399-2012	Sahoo, Bikash Ranjan/0000-0002-3683-1178	Japan Society for the Promotion of Science (JSPS) [26291029]; Grants-in-Aid for Scientific Research [26291029] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science (JSPS), Grant-in-Aid for Scientific Research (https://www.jsps.go.jp/english/e-grants/), Grant Number 26291029. TF has received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2009, BIOCHEMISTRY-US, V48, P10905, DOI 10.1021/bi9009874; Allen WJ, 2009, J COMPUT CHEM, V30, P1952, DOI 10.1002/jcc.21172; Andoh Y, 2013, BBA-BIOMEMBRANES, V1828, P1259, DOI 10.1016/j.bbamem.2013.01.005; Arnusch CJ, 2007, BIOCHEMISTRY-US, V46, P13437, DOI 10.1021/bi7015553; Berglund NA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004180; Boman HG, 2000, IMMUNOL REV, V173, P5, DOI 10.1034/j.1600-065X.2000.917301.x; Bond PJ, 2008, BIOCHEMISTRY-US, V47, P11321, DOI 10.1021/bi800642m; Bond PJ, 2008, BIOPHYS J, V95, P3802, DOI 10.1529/biophysj.108.128686; Bonucci A, 2015, BIOCHEMISTRY-US, V54, P6760, DOI 10.1021/acs.biochem.5b00813; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Chen W, 2015, J PHYS CHEM B, V119, P7902, DOI 10.1021/acs.jpcb.5b02290; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Dennison SR, 2008, CHEM PHYS LIPIDS, V151, P92, DOI 10.1016/j.chemphyslip.2007.10.007; Ding B, 2013, SCI REP-UK, V3, DOI 10.1038/srep01854; Gaspar D, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00294; Ghahremanpour MM, 2014, BIOINFORMATICS, V30, P439, DOI 10.1093/bioinformatics/btt680; Gkeka P, 2010, J PHYS CHEM B, V114, P826, DOI 10.1021/jp908320b; He Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066440; Hong M, 2011, PROTEIN SCI, V20, P641, DOI 10.1002/pro.600; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Johansson J, 1998, J BIOL CHEM, V273, P3718, DOI 10.1074/jbc.273.6.3718; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Krauson AJ, 2012, J AM CHEM SOC, V134, P12732, DOI 10.1021/ja3042004; Kreder R, 2015, ACS CHEM BIOL, V10, P1435, DOI 10.1021/cb500922m; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Ladokhin AS, 2001, BBA-BIOMEMBRANES, V1514, P253, DOI 10.1016/S0005-2736(01)00382-0; Langham A, 2010, METHODS MOL BIOL, V618, P267, DOI 10.1007/978-1-60761-594-1_17; Li YL, 2005, J VIROL, V79, P12065, DOI 10.1128/JVI.79.18.12065-12076.2005; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Mani R, 2006, P NATL ACAD SCI USA, V103, P16242, DOI 10.1073/pnas.0605079103; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Nawae W, 2014, SCI REP-UK, V4, DOI 10.1038/srep03933; Nielsen SL, 2007, PROTEIN SCI, V16, P1969, DOI 10.1110/ps.072966007; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; Oren Z, 1998, BIOPOLYMERS, V47, P451; Orioni B, 2009, BBA-BIOMEMBRANES, V1788, P1523, DOI 10.1016/j.bbamem.2009.04.013; Park TJ, 2011, BIOPHYS J, V101, P1193, DOI 10.1016/j.bpj.2011.06.067; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Ramamoorthy A, 2013, J PHYS CHEM B, V117, P6693, DOI 10.1021/jp4034003; Risso A, 2002, MOL CELL BIOL, V22, P1926, DOI 10.1128/MCB.22.6.1926-1935.2002; Risso A, 1998, CELL IMMUNOL, V189, P107, DOI 10.1006/cimm.1998.1358; Santo KP, 2013, J PHYS CHEM B, V117, P5031, DOI 10.1021/jp312328n; Saravanan R, 2011, BBA-BIOMEMBRANES, V1808, P369, DOI 10.1016/j.bbamem.2010.10.001; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Simons K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004697; Skerlavaj B, 1996, J BIOL CHEM, V271, P28375, DOI 10.1074/jbc.271.45.28375; Splith K, 2011, EUR BIOPHYS J BIOPHY, V40, P387, DOI 10.1007/s00249-011-0682-7; Stafford JH, NEOPLASIA, V13, P299; Suh JY, 1996, FEBS LETT, V392, P309, DOI 10.1016/0014-5793(96)00840-X; Tieleman DP, 2001, INT J QUANTUM CHEM, V83, P166, DOI 10.1002/qua.1208; Ulmschneider JP, 2012, BIOPHYS J, V103, P472, DOI 10.1016/j.bpj.2012.06.040; Upadhyay SK, 2015, J MEMBRANE BIOL, V248, P497, DOI 10.1007/s00232-015-9807-8; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VANBLITTERSWIJK WJ, 1982, BIOCHIM BIOPHYS ACTA, V688, P495, DOI 10.1016/0005-2736(82)90361-3; Wang Y, 2012, BBA-BIOMEMBRANES, V1818, P1402, DOI 10.1016/j.bbamem.2012.02.017; Wang YK, 2014, BBA-BIOMEMBRANES, V1838, P2280, DOI 10.1016/j.bbamem.2014.04.009; Wolf MG, 2010, J COMPUT CHEM, V31, P2169, DOI 10.1002/jcc.21507; Wu EL, 2014, J COMPUT CHEM, V35, P1997, DOI 10.1002/jcc.23702; Yu LL, 2009, BBA-BIOMEMBRANES, V1788, P333, DOI 10.1016/j.bbamem.2008.10.005; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	61	7	9	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158702	10.1371/journal.pone.0158702	http://dx.doi.org/10.1371/journal.pone.0158702			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391304	Green Submitted, Green Published, gold			2022-12-27	WOS:000380005400107
J	Valm, AM; Oldenbourg, R; Borisy, GG				Valm, Alex M.; Oldenbourg, Rudolf; Borisy, Gary G.			Multiplexed Spectral Imaging of 120 Different Fluorescent Labels	PLOS ONE			English	Article							ARCHITECTURE; MICROSCOPY; PROTEINS	The number of fluorescent labels that can unambiguously be distinguished in a single image when acquired through band pass filters is severely limited by the spectral overlap of available fluorophores. The recent development of spectral microscopy and the application of linear unmixing algorithms to spectrally recorded image data have allowed simultaneous imaging of fluorophores with highly overlapping spectra. However, the number of distinguishable fluorophores is still limited by the unavoidable decrease in signal to noise ratio when fluorescence signals are fractionated over multiple wavelength bins. Here we present a spectral image analysis algorithm to greatly expand the number of distinguishable objects labeled with binary combinations of fluorophores. Our algorithm utilizes a priori knowledge about labeled specimens and imposes a binary label constraint on the unmixing solution. We have applied our labeling and analysis strategy to identify microbes labeled by fluorescence in situ hybridization and here demonstrate the ability to distinguish 120 differently labeled microbes in a single image.	[Valm, Alex M.; Oldenbourg, Rudolf] Marine Biol Lab, Woods Hole, MA 02543 USA; [Valm, Alex M.; Oldenbourg, Rudolf] Brown Univ, Providence, RI 02912 USA; [Borisy, Gary G.] Forsyth Inst, Cambridge, MA USA; [Valm, Alex M.] NICHHD, NIH, NIH NICHD, Bethesda, MD 20892 USA	Marine Biological Laboratory - Woods Hole; Brown University; Harvard University; Forsyth Institute; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Valm, AM (corresponding author), Marine Biol Lab, Woods Hole, MA 02543 USA.; Valm, AM (corresponding author), Brown Univ, Providence, RI 02912 USA.; Valm, AM (corresponding author), NICHHD, NIH, NIH NICHD, Bethesda, MD 20892 USA.	Alex.Valm@nih.gov			Alfred P. Sloan Foundation [2007-3-13]; National Institutes of Health from the National Institute of Dental and Craniofacial Research (NIDCR) [1RC1-DE020630]; National Institutes of Health from NIDCR [1F31-DE019576]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114274] Funding Source: NIH RePORTER	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); National Institutes of Health from the National Institute of Dental and Craniofacial Research (NIDCR); National Institutes of Health from NIDCR; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grant 2007-3-13 from the Alfred P. Sloan Foundation (to GGB), National Institutes of Health Grant 1RC1-DE020630 from the National Institute of Dental and Craniofacial Research (NIDCR) (to GGB) and by National Institutes of Health Fellowship 1F31-DE019576 from NIDCR (to AMV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Collman F, 2015, J NEUROSCI, V35, P5792, DOI 10.1523/JNEUROSCI.4274-14.2015; Faust K, 2012, NAT REV MICROBIOL, V10, P538, DOI 10.1038/nrmicro2832; Garini Y, 2006, CYTOM PART A, V69A, P735, DOI 10.1002/cyto.a.20311; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lubeck E, 2012, NAT METHODS, V9, P743, DOI [10.1038/NMETH.2069, 10.1038/nmeth.2069]; Mansfield James R, 2008, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1419s84; Neher R, 2004, J MICROSC-OXFORD, V213, P46, DOI 10.1111/j.1365-2818.2004.01262.x; Subach FV, 2011, NAT METHODS, V8, P1019, DOI [10.1038/nmeth.1776, 10.1038/NMETH.1776]; Tsuriel S, 2015, NAT METHODS, V12, P547, DOI 10.1038/nmeth.3367; Valm AM, 2011, P NATL ACAD SCI USA, V108, P4152, DOI 10.1073/pnas.1101134108; Wan XH, 2009, CELL, V137, P672, DOI 10.1016/j.cell.2009.03.035; Waters JC, 2009, J CELL BIOL, V185, P1135, DOI 10.1083/jcb.200903097; Zimmermann T, 2014, METHODS MOL BIOL, V1075, P129, DOI 10.1007/978-1-60761-847-8_5	17	44	46	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158495	10.1371/journal.pone.0158495	http://dx.doi.org/10.1371/journal.pone.0158495			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391327	Green Published, gold, Green Submitted			2022-12-27	WOS:000380005400069
J	Zakharchenko, M; Los, F; Brodska, H; Balik, M				Zakharchenko, Mychajlo; Los, Ferdinand; Brodska, Helena; Balik, Martin			The Effects of High Level Magnesium Dialysis/Substitution Fluid on Magnesium Homeostasis under Regional Citrate Anticoagulation in Critically Ill	PLOS ONE			English	Article							CONTINUOUS VENOVENOUS HEMODIAFILTRATION; RENAL-REPLACEMENT THERAPY; ACID-BASE; SERUM MAGNESIUM; HEPARIN; HEMODIALYSIS; RISK; HEMOFILTRATION; HYPOMAGNESEMIA; METABOLISM	Background The requirements for magnesium (Mg) supplementation increase under regional citrate anticoagulation (RCA) because citrate acts by chelation of bivalent cations within the blood circuit. The level of magnesium in commercially available fluids for continuous renal replacement therapy (CRRT) may not be sufficient to prevent hypomagnesemia. Methods Patients (n = 45) on CRRT (2,000 ml/h, blood flow (Qb) 100 ml/min) with RCA modality (4% trisodium citrate) using calcium free fluid with 0.75 mmol/l of Mg with additional magnesium substitution were observed after switch to the calcium-free fluid with magnesium concentration of 1.50 mmol/l (n = 42) and no extra magnesium replenishment. All patients had renal indications for CRRT, were treated with the same devices, filters and the same postfilter ionized calcium endpoint (< 0.4 mmol/l) of prefilter citrate dosage. Under the high level Mg fluid the Qb, dosages of citrate and CRRT were consequently escalated in 9h steps to test various settings. Results Median balance of Mg was -0.91 (-1.18 to -0.53) mmol/h with Mg 0.75 mmol/l and 0.2 (0.06-0.35) mmol/h when fluid with Mg 1.50 mmol/l was used. It was close to zero (0.02 (-0.12-0.18) mmol/h) with higher blood flow and dosage of citrate, increased again to 0.15 (-0.11-0.25) mmol/h with 3,000 ml/h of high magnesium containing fluid (p< 0.001). The arterial levels of Mg were mildly increased after the change for high level magnesium containing fluid (p< 0.01). Conclusions Compared to ordinary dialysis fluid the mildly hypermagnesemic fluid provided even balances and adequate levels within ordinary configurations of CRRT with RCA and without a need for extra magnesium replenishment.	[Zakharchenko, Mychajlo; Balik, Martin] Charles Univ Prague, Fac Med 1, Dept Anesthesiol & Intens Care, Prague, Czech Republic; [Zakharchenko, Mychajlo; Los, Ferdinand; Brodska, Helena; Balik, Martin] Gen Univ Hosp Prague, Prague, Czech Republic; [Los, Ferdinand; Brodska, Helena] Charles Univ Prague, Fac Med 1, Dept Clin Biochem, Prague, Czech Republic	Charles University Prague; General University Hospital Prague; Charles University Prague	Balik, M (corresponding author), Charles Univ Prague, Fac Med 1, Dept Anesthesiol & Intens Care, Prague, Czech Republic.; Balik, M (corresponding author), Gen Univ Hosp Prague, Prague, Czech Republic.	martin.balik@vfn.cz	Lahoda Brodska, Helena/I-6694-2017	Lahoda Brodska, Helena/0000-0001-7962-8287	ESICM Stoutenbeek Award	ESICM Stoutenbeek Award	The study (ClinicalTrials.gov Identifier: NCT01361581) was supported in part from ESICM Stoutenbeek Award 2012.	Alves SC, 2013, NEPHROL DIAL TRANSPL, V28, P910, DOI 10.1093/ndt/gfs268; Balik M, 2005, BLOOD PURIFICAT, V23, P325, DOI 10.1159/000087770; Balik M, 2014, BLOOD PURIFICAT, V38, P263, DOI 10.1159/000369956; Balik M, 2013, J CRIT CARE, V28, P87, DOI 10.1016/j.jcrc.2012.06.003; Balik M, 2012, BLOOD PURIFICAT, V33, P80, DOI 10.1159/000334641; Bellomo R, 2009, NEW ENGL J MED, V361, P1627, DOI 10.1056/NEJMoa0902413; Bollmann MD, 2004, INTENS CARE MED, V30, P1103, DOI 10.1007/s00134-004-2251-3; Brain M, 2012, CRIT CARE RESUSC, V14, P274; Brain M, 2011, CRIT CARE RESUSC, V13, P72; Cole L, 2003, INTENS CARE MED, V29, P1113, DOI 10.1007/s00134-003-1812-1; Dorval M, 2003, INTENS CARE MED, V29, P1186, DOI 10.1007/s00134-003-1801-4; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Escuela MP, 2005, INTENS CARE MED, V31, P151, DOI 10.1007/s00134-004-2508-x; Fairley J, 2015, J CRIT CARE, V30, P1349, DOI 10.1016/j.jcrc.2015.07.029; Hebert P, 1997, CRIT CARE MED, V25, P749, DOI 10.1097/00003246-199705000-00007; Hetzel GR, 2011, NEPHROL DIAL TRANSPL, V26, P232, DOI 10.1093/ndt/gfq575; Huijgen HJ, 2000, AM J CLIN PATHOL, V114, P688, DOI 10.1309/JR9Y-PPTX-AJTC-QDRD; Karvellas CJ, 2011, CRIT CARE, V15, DOI 10.1186/cc10061; Matias PJ, 2014, BLOOD PURIFICAT, V38, P244, DOI 10.1159/000366124; Morgera S, 2005, NEPHRON CLIN PRACT, V101, pC211, DOI 10.1159/000088177; Morgera S, 2004, NEPHRON CLIN PRACT, V97, pC131, DOI 10.1159/000079171; Morgera S, 2009, CRIT CARE MED, V37, P2018, DOI 10.1097/CCM.0b013e3181a00a92; Oudemans-van Straaten HM, 2009, CRIT CARE MED, V37, P545, DOI 10.1097/CCM.0b013e3181953c5e; Palevsky PM, 2008, NEW ENGL J MED, V359, P7, DOI 10.1056/NEJMoa0802639; Relton S, 1992, ASAIO J, V38, pM691, DOI 10.1097/00002480-199207000-00127; Seabra VF BE, 2008, AM J KIDNEY DIS, V52; Soliman HM, 2003, CRIT CARE MED, V31, P1082, DOI 10.1097/01.CCM.0000060867.17556.A0; Tong Garrison M, 2005, J Intensive Care Med, V20, P3, DOI 10.1177/0885066604271539; Uchino S, 2003, INTENS CARE MED, V29, P575, DOI 10.1007/s00134-003-1672-8; Wu MY, 2012, AM J KIDNEY DIS, V59, P810, DOI 10.1053/j.ajkd.2011.11.030; Zakharchenko M, 2016, BLOOD PURIFICAT, V41, P41, DOI 10.1159/000440972; Zhang ZH, 2012, INTENS CARE MED, V38, P20, DOI 10.1007/s00134-011-2438-3	32	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158179	10.1371/journal.pone.0158179	http://dx.doi.org/10.1371/journal.pone.0158179			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391902	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400035
J	Guang-Han, O; Leang-Chung, C; Vellasamy, KM; Mariappan, V; Li-Yen, C; Vadivelu, J				Guang-Han, Ong; Leang-Chung, Choh; Vellasamy, Kumutha Malar; Mariappan, Vanitha; Li-Yen, Chang; Vadivelu, Jamuna			Experimental Phage Therapy for Burkholderia pseudomallei Infection	PLOS ONE			English	Article							MYCOBACTERIUM-AVIUM; IN-VIVO; BACTERIOPHAGE; MELIOIDOSIS; RESISTANCE; SUSCEPTIBILITY; EFFICACY; MODEL; MICE	Burkholderia pseudomallei is an intracellular Gram-negative bacterial pathogen intrinsically resistant to a variety of antibiotics. Phages have been developed for use as an alternative treatment therapy, particularly for bacterial infections that do not respond to conventional antibiotics. In this study, we investigated the use of phages to treat cells infected with B. pseudomallei. Phage C34 isolated from seawater was purified and characterised on the basis of its host range and morphology using transmission electron microscopy (TEM). Phage C34 was able to lyse 39.5% of B. pseudomallei clinical strains. Due to the presence of contractile tail, phage C34 is classified as a member of the family Myoviridae, a tailed double-stranded DNA virus. When 2 x 10(5) A549 cells were exposed to 2 x 10(7) PFU of phage C34, 24 hours prior to infection with 2 x 10(6) CFU of B. pseudomallei, it was found that the survivability of the cells increased to 41.6 +/- 6.8% as compared to 22.8 +/- 6.0% in untreated control. Additionally, application of phage successfully rescued 33.3% of mice infected with B. pseudomallei and significantly reduced the bacterial load in the spleen of the phage-treated mice. These findings indicate that phage can be a potential antimicrobial agent for B. pseudomallei infections.	[Guang-Han, Ong; Leang-Chung, Choh; Vellasamy, Kumutha Malar; Mariappan, Vanitha; Li-Yen, Chang; Vadivelu, Jamuna] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Li-Yen, Chang] Univ Malaya, TIDREC, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Vadivelu, J (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia.	jamuna@ummc.edu.my	Mariappan, Vanitha/ABD-4066-2020; Mariappan, Vanitha/I-4769-2013; Vellasamy, Kumutha Malar/CAF-0007-2022; VADIVELU, JAMUNARANI S/B-8696-2010; Vellasamy, Kumutha Malar/A-6592-2017; CHANG, LI-YEN/B-8353-2010	Mariappan, Vanitha/0000-0002-2351-1597; Mariappan, Vanitha/0000-0002-2351-1597; Vellasamy, Kumutha Malar/0000-0001-7661-3928; VADIVELU, JAMUNARANI S/0000-0001-7322-3676; Vellasamy, Kumutha Malar/0000-0001-7661-3928; Ong, Guang Han/0000-0003-3286-3823; Chang, Li-Yen/0000-0001-6850-2435	Ministry of Education (MOE), Malaysia under the High Impact Research (HIR)-MOE [UM.C/625/1/HIR/MoE/CHAN/02 H-50001-A000013, UM.C/625/1/HIR/MoE/CHAN/13/5 (H-50001-00-A000033)]; Postgraduate Research Fund under University of Malaya [PV066/2011A]; University of Malaya Research Grant (UMRG) [RP013C-13HTM]; University of Malaya Postgraduate Research Fund [PV066/2011A]	Ministry of Education (MOE), Malaysia under the High Impact Research (HIR)-MOE; Postgraduate Research Fund under University of Malaya; University of Malaya Research Grant (UMRG); University of Malaya Postgraduate Research Fund(Universiti Malaya)	Research in the authors' laboratory was supported by Ministry of Education (MOE), Malaysia under the High Impact Research (HIR)-MOE, project UM.C/625/1/HIR/MoE/CHAN/13/5 (H-50001-00-A000033), University of Malaya Research Grant (UMRG) (RP013C-13HTM) and University of Malaya Postgraduate Research Fund (PV066/2011A). Funding was awarded to JV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Research in the authors' laboratory was supported by Ministry of Education (MOE), Malaysia under the High Impact Research (HIR)-MOE, project UM.C/625/1/HIR/MoE/CHAN/02 H-50001-A000013 and the Postgraduate Research Fund (PV066/2011A) under University of Malaya.	Ackermann Hans-W., 2009, V501, P127, DOI 10.1007/978-1-60327-164-6_13; Alegado RA, 2011, CELL MICROBIOL, V13, P1618, DOI 10.1111/j.1462-5822.2011.01645.x; Brockhurst MA, 2007, INFECT GENET EVOL, V7, P547, DOI 10.1016/j.meegid.2007.01.005; Broxmeyer L, 2002, J INFECT DIS, V186, P1155, DOI 10.1086/343812; Brussow H, 2005, MICROBIOL-SGM, V151, P2133, DOI 10.1099/mic.0.27849-0; Bruynoghe R, 1921, C R SOC BIOL, V85, P1; Capparelli R, 2007, ANTIMICROB AGENTS CH, V51, P2765, DOI 10.1128/AAC.01513-06; Capra ML, 2004, LETT APPL MICROBIOL, V38, P499, DOI 10.1111/j.1472-765X.2004.01525.x; Carmody LA, 2010, J INFECT DIS, V201, P264, DOI 10.1086/649227; Chan BK, 2013, FUTURE MICROBIOL, V8, P769, DOI [10.2217/FMB.13.47, 10.2217/fmb.13.47]; CHAOWAGUL W, 1993, J INFECT DIS, V168, P1181, DOI 10.1093/infdis/168.5.1181; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Choh LC, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00005; Conejero L, 2011, AM J PATHOL, V179, P270, DOI 10.1016/j.ajpath.2011.03.031; D'Herelle F., 1926, BACTERIOPHAGE SON CO; d'Herelle F., 1917, ACAD SCI PARIS, V165, P3; DANCE DAB, 1989, J ANTIMICROB CHEMOTH, V24, P295, DOI 10.1093/jac/24.3.295; Danelishvili L, 2006, MICROB DRUG RESIST, V12, P1, DOI 10.1089/mdr.2006.12.1; Dubos RJ, 1943, J EXP MED, V78, P161, DOI 10.1084/jem.78.3.161; Filippov AA, 2012, ADV EXP MED BIOL, V954, P337, DOI 10.1007/978-1-4614-3561-7_41; Gatedee J, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-366; Hall AR, 2012, APPL ENVIRON MICROB, V78, P5646, DOI 10.1128/AEM.00757-12; Hanlon GW, 2007, INT J ANTIMICROB AG, V30, P118, DOI 10.1016/j.ijantimicag.2007.04.006; Hyman Paul, 2009, V501, P175, DOI 10.1007/978-1-60327-164-6_18; Jenney AWJ, 2001, INT J ANTIMICROB AG, V17, P109, DOI 10.1016/S0924-8579(00)00334-4; Kvitko BH, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-289; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Limmathurotsakul D, 2006, CLIN INFECT DIS, V43, P979, DOI 10.1086/507632; Lipsitz Rebecca, 2012, Emerg Infect Dis, V18, pe2, DOI 10.3201/eid1812.120638; Markoishvili K, 2002, INT J DERMATOL, V41, P453, DOI 10.1046/j.1365-4362.2002.01451.x; Merril CR, 1996, P NATL ACAD SCI USA, V93, P3188, DOI 10.1073/pnas.93.8.3188; Nasner-Posso KM, 2015, INT J INFECT DIS, V35, P103, DOI 10.1016/j.ijid.2015.05.009; Nobrega FL, 2015, TRENDS MICROBIOL, V23, P185, DOI 10.1016/j.tim.2015.01.006; O'Flynn G, 2004, APPL ENVIRON MICROB, V70, P3417, DOI 10.1128/AEM.70.6.3417-3424.2004; OHSHIMA Y, 1988, MED MICROBIOL IMMUN, V177, P229; Puthucheary S D, 2009, Med J Malaysia, V64, P266; Sambrook J., 2001, MOL CLONING LAB MANU; Sariya L, 2006, SCI ASIA, V32, P9; Scanlan PD, 2011, MOL ECOL, V20, P981, DOI 10.1111/j.1365-294X.2010.04903.x; Semler DD, 2014, ANTIMICROB AGENTS CH, V58, P4005, DOI 10.1128/AAC.02388-13; SMITH HW, 1982, J GEN MICROBIOL, V128, P307; SMITH HW, 1987, J GEN MICROBIOL, V133, P1111; SOOKPRANEE M, 1992, ANTIMICROB AGENTS CH, V36, P158, DOI 10.1128/AAC.36.1.158; Sulakvelidze A, 2001, ANTIMICROB AGENTS CH, V45, P649, DOI 10.1128/AAC.45.3.649-659.2001; Suppiah J, 2010, FEMS MICROBIOL LETT, V306, P9, DOI 10.1111/j.1574-6968.2010.01923.x; Takemura-Uchiyama I, 2014, MICROBES INFECT, V16, P512, DOI 10.1016/j.micinf.2014.02.011; Van Twest Rohan, 2009, V501, P15, DOI 10.1007/978-1-60327-164-6_2; Wiersinga WJ, 2012, NEW ENGL J MED, V367, P1035, DOI 10.1056/NEJMra1204699; YAMAMOTO KR, 1970, VIROLOGY, V40, P734, DOI 10.1016/0042-6822(70)90218-7; Yordpratum U, 2011, FEMS MICROBIOL LETT, V314, P81, DOI 10.1111/j.1574-6968.2010.02150.x	51	24	25	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158213	10.1371/journal.pone.0158213	http://dx.doi.org/10.1371/journal.pone.0158213			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27387381	Green Published, gold, Green Submitted			2022-12-27	WOS:000379811500016
J	Zea, AH; Stewart, T; Ascani, J; Tate, DJ; Finkel-Jimenez, B; Wilk, A; Reiss, K; Smoyer, WE; Aviles, DH				Zea, Arnold H.; Stewart, Tyrus; Ascani, Jeannine; Tate, David J.; Finkel-Jimenez, Beatriz; Wilk, Anna; Reiss, Krzysztof; Smoyer, William E.; Aviles, Diego H.			Activation of the IL-2 Receptor in Podocytes: A Potential Mechanism for Podocyte Injury in Idiopathic Nephrotic Syndrome?	PLOS ONE			English	Article							SOLUBLE UROKINASE RECEPTOR; FOCAL SEGMENTAL GLOMERULOSCLEROSIS; VASCULAR LEAK SYNDROME; GROWTH-FACTOR-BETA; DIABETIC-NEPHROPATHY; GLOMERULAR PROTEIN; LIPOID NEPHROSIS; STAT5 REGULATION; EXPRESSION; DISEASE	The renal podocyte plays an important role in maintaining the structural integrity of the glomerular basement membrane. We have previously reported that patients with idiopathic nephrotic syndrome (INS) have increased IL-2 production. We hypothesized that podocytes express an IL-2 receptor (IL-2R) and signaling through this receptor can result in podocyte injury. To confirm the presence of the IL-2R, we tested a conditionally immortalized murine podocyte cell line by flow cytometry, qPCR, and Western blot. To test for the presence of the IL-2R in vivo, immunohistochemical staining was performed on human renal biopsies in children with FSGS and control. Podocytes were stimulated with IL-2 in vitro, to study signaling events via the JAK/STAT pathway. The results showed that stimulation with IL-2 resulted in increased mRNA and protein expression of STAT 5a, phosphorylated STAT 5, JAK 3, and phosphorylated JAK 3. We then investigated for signs of cellular injury and the data showed that pro-apoptotic markers Bax and cFLIP were significantly increased following IL-2 exposure, whereas LC3 II was decreased. Furthermore, mitochondrial depolarization and apoptosis were both significantly increased following activation of the IL-2R. We used a paracellular permeability assay to monitor the structural integrity of a podocyte monolayer following IL-2 exposure. The results showed that podocytes exposed to IL-2 have increased albumin leakage across the monolayer. We conclude that murine podocytes express the IL-2R, and that activation through the IL-2R results in podocyte injury.	[Zea, Arnold H.] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA USA; [Stewart, Tyrus; Aviles, Diego H.] Louisiana State Univ, Hlth Sci Ctr, Dept Pediat Nephrol, New Orleans, LA 70112 USA; [Ascani, Jeannine] Ochsner Hlth Syst, Dept Res Ochsner Biobank, New Orleans, LA USA; [Tate, David J.] Eurofins Cent Analyt Labs, New Orleans, LA USA; [Finkel-Jimenez, Beatriz] Amer Univ, Caribbean Sch Med, Dept Med Microbiol & Immunol, Coral Gables, FL USA; [Wilk, Anna; Reiss, Krzysztof] Louisiana State Univ, Hlth Sci Ctr, Dept Genet, New Orleans, LA USA; [Smoyer, William E.] Nationwide Childrens Hosp, Dept Nephrol, Columbus, OH USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Ochsner Health System; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University System of Ohio; Ohio State University; Nationwide Childrens Hospital	Aviles, DH (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Pediat Nephrol, New Orleans, LA 70112 USA.	davile@lsuhsc.edu						Aviles DH, 2004, KIDNEY INT, V66, P60, DOI 10.1111/j.1523-1755.2004.00706.x; Baqi N, 1997, J NEPHROL, V10, P85; Bianchi M, 2000, P NATL ACAD SCI USA, V97, P9573, DOI 10.1073/pnas.160099797; Bitzer M, 1998, KIDNEY BLOOD PRESS R, V21, P1, DOI 10.1159/000025837; Bock ME, 2013, CLIN J AM SOC NEPHRO, V8, P1304, DOI 10.2215/CJN.07680712; Bonilla-Felix M, 1999, KIDNEY INT, V55, P1885, DOI 10.1046/j.1523-1755.1999.00408.x; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Buckler JL, 2006, J IMMUNOL, V177, P4262, DOI 10.4049/jimmunol.177.7.4262; Cho BS, 1999, PEDIATR NEPHROL, V13, P199, DOI 10.1007/s004670050592; Fang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060546; Hicks C, 1991, Growth Factors, V5, P201, DOI 10.3109/08977199109000284; HISANAGA S, 1990, NEPHRON, V54, P277, DOI 10.1159/000185875; Huber TB, 2002, J IMMUNOL, V168, P6244, DOI 10.4049/jimmunol.168.12.6244; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; KOYAMA A, 1991, KIDNEY INT, V40, P453, DOI 10.1038/ki.1991.232; KRAMS SM, 1992, TRANSPLANTATION, V53, P151, DOI 10.1097/00007890-199201000-00031; Kumar PA, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00151; Laflam PF, 2002, NEPHRON, V91, P620, DOI 10.1159/000065022; LAGRUE G, 1975, BIOMED EXPRESS, V23, P37; Lennon R, 2008, J AM SOC NEPHROL, V19, P2140, DOI 10.1681/ASN.2007080940; Leonard W.J., 1999, FUNDAMENTAL IMMUNOLO, Vfourth, P741; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; LIN WC, 1995, J IMMUNOL, V155, P4805; Maas RJH, 2012, KIDNEY INT, V81, P1043, DOI 10.1038/ki.2012.32; Marrero MB, 2006, AM J PHYSIOL-RENAL, V290, pF762, DOI 10.1152/ajprenal.00181.2005; Meijers B, 2014, KIDNEY INT, V85, P636, DOI 10.1038/ki.2013.505; MINAMI Y, 1993, ANNU REV IMMUNOL, V11, P245, DOI 10.1146/annurev.immunol.11.1.245; Nagy ZS, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-67; PLAISANCE S, 1992, INT IMMUNOL, V4, P739, DOI 10.1093/intimm/4.7.739; Pollak MR, 2008, CURR OPIN NEPHROL HY, V17, P138, DOI 10.1097/MNH.0b013e3282f5dbe4; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; Rafi-Janajreh AQ, 1999, J IMMUNOL, V163, P1619; Ransom RF, 2005, KIDNEY INT, V68, P2473, DOI 10.1111/j.1523-1755.2005.00723.x; Rico M, 2005, AM J PHYSIOL-RENAL, V289, pF431, DOI 10.1152/ajprenal.00389.2004; ROSENSTEIN M, 1986, J IMMUNOL, V137, P1735; SAVIN M, 1993, RENAL FAILURE, V15, P551, DOI 10.3109/08860229309054973; Schiffer M, 2001, J CLIN INVEST, V108, P807, DOI 10.1172/JCI12367; Schonenberger E, 2011, NEPHROL DIAL TRANSPL, V26, P18, DOI 10.1093/ndt/gfq617; SHALHOUB RJ, 1974, LANCET, V2, P556; Shimoyama H, 2004, PEDIATR NEPHROL, V19, P1115, DOI 10.1007/s00467-004-1569-y; Sinha A, 2014, KIDNEY INT, V85, P649, DOI 10.1038/ki.2013.546; Sivakumar PV, 2013, COMPARATIVE MED, V63, P13; Spangler JB, 2015, ANNU REV IMMUNOL, V33, P139, DOI 10.1146/annurev-immunol-032713-120211; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.01.06.db05-0894; TANIGUCHI T, 1993, CELL, V73, P5, DOI 10.1016/0092-8674(93)90152-G; Wada T, 2014, KIDNEY INT, V85, P641, DOI 10.1038/ki.2013.544; Waldman M, 2007, CLIN J AM SOC NEPHRO, V2, P445, DOI 10.2215/CJN.03531006; Wei C, 2008, J AM SOC NEPHROL, V19, p103A; Wei C, 2008, NAT MED, V14, P55, DOI 10.1038/nm1696; WHITE RHR, 1970, LANCET, V1, P1353; WHITESIDE TL, 1995, CURR OPIN IMMUNOL, V7, P704, DOI 10.1016/0952-7915(95)80080-8; YOSHIMURA N, 1985, TRANSPLANTATION, V40, P661, DOI 10.1097/00007890-198512000-00018; Yu CL, 2000, J BIOL CHEM, V275, P599, DOI 10.1074/jbc.275.1.599; Zeng CH, 2014, J PATHOL, V234, P203, DOI 10.1002/path.4382	56	12	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0157907	10.1371/journal.pone.0157907	http://dx.doi.org/10.1371/journal.pone.0157907			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27389192	Green Published, gold, Green Submitted			2022-12-27	WOS:000379811500009
J	Karlson, AML; Niemand, C; Savage, C; Pilditch, CA				Karlson, Agnes M. L.; Niemand, Clarisse; Savage, Candida; Pilditch, Conrad A.			Density of Key-Species Determines Efficiency of Macroalgae Detritus Uptake by Intertidal Benthic Communities	PLOS ONE			English	Article							ECOSYSTEM FUNCTION; SPATIAL-DISTRIBUTION; FEEDING BIVALVE; STABLE-ISOTOPES; FRESH-WATER; BIODIVERSITY; DIVERSITY; MACROFAUNA; PRESERVATION; ASSEMBLAGES	Accumulating evidence shows that increased biodiversity has a positive effect on ecosystem functioning, but the mechanisms that underpin this positive relationship are contentious. Complete extinctions of regional species pools are comparatively rare whereas compositional changes and reductions in abundance and biomass are common, although seldom the focus of biodiversity-ecosystem functioning studies. We use natural, small-scale patchiness in the density of two species of large bivalves with contrasting feeding modes (the suspension-feeding Austrovenus stutchburyi and deposit-feeding Macomona liliana) to examine their influence on the uptake of nitrogen from macroalgae detritus (i.e. measure of ecosystem function and food web efficiency) by other infauna in a 10-d laboratory isotope-tracer experiment. We predicted that densities of these key bivalve species and functional group diversity (calculated as Shannons H, a density-independent measure of community composition) of the intact infaunal community will be critical factors explaining variance in macroalgal per capita uptake rates by the community members and hence determine total uptake by the community. Results show that only two species, M. liliana and a large orbiniid polychaete (Scoloplos cylindrifer) dominated macroalgal nitrogen taken up by the whole community due to their large biomass. However, their densities were mostly not important or negatively influenced per capita uptake by other species. Instead, the density of a head-down deposit-feeder (the capitellid Heteromastus filiformis), scavengers (mainly nemertines and nereids) and species and functional group diversity, best explained per capita uptake rates in community members. Our results demonstrate the importance of species identity, density and large body size for ecosystem functioning and highlight the complex interactions underlying loss of ecological functions with declining biodiversity and compositional changes.	[Karlson, Agnes M. L.] Stockholm Univ, Dept Environm Sci & Analyt Chem, Stockholm, Sweden; [Niemand, Clarisse; Pilditch, Conrad A.] Univ Waikato, Sch Sci, Hamilton, New Zealand; [Savage, Candida] Univ Otago, Dept Marine Sci, Dunedin, New Zealand; [Savage, Candida] Univ Cape Town, Dept Biol Sci, Cape Town, South Africa	Stockholm University; University of Waikato; University of Otago; University of Cape Town	Karlson, AML (corresponding author), Stockholm Univ, Dept Environm Sci & Analyt Chem, Stockholm, Sweden.	agnes.karlson@aces.su.se	Karlson, Agnes/N-9230-2017; Karlson, Agnes/ABG-3861-2020	Karlson, Agnes/0000-0001-6493-9533; Karlson, Agnes/0000-0001-6493-9533	Swedish Research Council (VR) [623-2010-600]; Bay of Plenty Regional Council	Swedish Research Council (VR)(Swedish Research Council); Bay of Plenty Regional Council	This study was funded by a postdoctoral scholarship by the Swedish Research Council (VR) to AMLK (contract 623-2010-600). Performance Based Research Funds to CS for stable isotope costs and a Bay of Plenty Regional Council PhD Scholarship supported CN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2008, GUID SOFTW STAT METH; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Bolam SG, 2002, ECOL MONOGR, V72, P599, DOI 10.1890/0012-9615(2002)072[0599:DBAEPI]2.0.CO;2; Byren L, 2006, MAR ECOL PROG SER, V313, P135, DOI 10.3354/meps313135; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; CARLTON JT, 1993, AM ZOOL, V33, P499; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Covich AP, 2004, BIOSCIENCE, V54, P767, DOI 10.1641/0006-3568(2004)054[0767:TROBIT]2.0.CO;2; Dangles O, 2004, ECOL LETT, V7, P395, DOI 10.1111/j.1461-0248.2004.00591.x; Elahi R, 2015, CURR BIOL, V25, P1938, DOI 10.1016/j.cub.2015.05.030; Emmerson MC, 2000, OIKOS, V91, P195; Emmerson MC, 2001, NATURE, V411, P73, DOI 10.1038/35075055; Goedkoop W, 2006, FRESHWATER BIOL, V51, P878, DOI 10.1111/j.1365-2427.2006.01539.x; Greenfield BL, 2014, THESIS; Hewitt JE, 2008, J EXP MAR BIOL ECOL, V366, P116, DOI 10.1016/j.jembe.2008.07.016; Hiddink JG, 2009, OIKOS, V118, P1892, DOI 10.1111/j.1600-0706.2009.17556.x; Jones HFE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027065; Kaehler S, 2001, MAR ECOL PROG SER, V219, P299, DOI 10.3354/meps219299; Karlson AML, 2015, SCI REP-UK, V5, DOI 10.1038/srep09715; Karlson AML, 2011, OECOLOGIA, V166, P1055, DOI 10.1007/s00442-011-1936-x; Karlson AML, 2010, ECOLOGY, V91, P1414, DOI 10.1890/09-0660.1; Larsen TH, 2005, ECOL LETT, V8, P538, DOI 10.1111/j.1461-0248.2005.00749.x; Lau DCP, 2012, LIMNOL OCEANOGR-METH, V10, P75, DOI 10.4319/lom.2012.10.75; LAWTON JH, 1994, OIKOS, V71, P367, DOI 10.2307/3545824; Leduc D, 2006, NEW ZEAL J MAR FRESH, V40, P615, DOI 10.1080/00288330.2006.9517450; Lohrer AM, 2010, J EXP MAR BIOL ECOL, V390, P6, DOI 10.1016/j.jembe.2010.04.035; Lohrer AM, 2004, NATURE, V431, P1092, DOI 10.1038/nature03042; McKie BG, 2008, J ANIM ECOL, V77, P495, DOI 10.1111/j.1365-2656.2008.01357.x; Naeem S, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P3; NAEEM S, 1995, PHILOS T R SOC B, V347, P249, DOI 10.1098/rstb.1995.0025; Naeem S, 2012, SCIENCE, V336, P1401, DOI 10.1126/science.1215855; Nascimento FJA, 2011, OECOLOGIA, V166, P337, DOI 10.1007/s00442-010-1865-0; Nielsen UN, 2011, EUR J SOIL SCI, V62, P105, DOI 10.1111/j.1365-2389.2010.01314.x; Nordstrom MC, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00515.1; Norkko A, 2001, LIMNOL OCEANOGR, V46, P2067, DOI 10.4319/lo.2001.46.8.2067; Norkko A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02646; Olafsson E, 2005, MAR ECOL PROG SER, V298, P179, DOI 10.3354/meps298179; Paavo B, 2008, NEW ZEAL J MAR FRESH, V42, P85, DOI 10.1080/00288330809509938; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Raffaelli D, 2003, J SEA RES, V49, P133, DOI 10.1016/S1385-1101(02)00200-9; Raikow DF, 2001, LIMNOL OCEANOGR, V46, P514, DOI 10.4319/lo.2001.46.3.0514; Rodil IF, 2011004 AUCKL COUNC; Rossi F, 2006, J EXP MAR BIOL ECOL, V332, P84, DOI 10.1016/j.jembe.2005.11.003; Rossi F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066650; RUDNICK DT, 1989, MAR ECOL PROG SER, V50, P231, DOI 10.3354/meps050231; Sandwell DR, 2009, J EXP MAR BIOL ECOL, V373, P16, DOI 10.1016/j.jembe.2009.02.015; SEGERSTRALE S G, 1973, Commentationes Biologicae Societas Scientiarum Fennica, V67, P1; Snelgrove P, 1997, AMBIO, V26, P578; Snelgrove PVR, 2014, TRENDS ECOL EVOL, V29, P398, DOI 10.1016/j.tree.2014.05.002; Solan M, 2004, SCIENCE, V306, P1177, DOI 10.1126/science.1103960; Stachowicz JJ, 2008, ECOLOGY, V89, P3008, DOI 10.1890/07-1873.1; Teichberg M, 2010, GLOBAL CHANGE BIOL, V16, P2624, DOI 10.1111/j.1365-2486.2009.02108.x; Thrush SF, 2006, ECOSYSTEMS, V9, P1029, DOI 10.1007/s10021-005-0068-8; Thrush SF, 2014, ECOLOGY, V95, P1451, DOI 10.1890/13-1879.1; Thrush SF, 2012, MARINE BIODIVERSITY AND ECOSYSTEM FUNCTIONING: FRAMEWORKS, METHODOLOGIES, AND INTEGRATION, P200; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; van Nugteren P, 2009, LIMNOL OCEANOGR, V54, P1413, DOI 10.4319/lo.2009.54.5.1413; Volkenborn N, 2012, J MAR RES, V70, P794, DOI 10.1357/002224012806770955; WALKER BH, 1992, CONSERV BIOL, V6, P18, DOI 10.1046/j.1523-1739.1992.610018.x; WEINBERG JR, 1983, J MAR RES, V41, P557, DOI 10.1357/002224083788519696; Whitlatch RB, 1997, J EXP MAR BIOL ECOL, V216, P171, DOI 10.1016/S0022-0981(97)00095-6; Widdicombe S, 1998, J EXP MAR BIOL ECOL, V228, P241, DOI 10.1016/S0022-0981(98)00032-X; Widdicombe S, 1999, MAR ECOL PROG SER, V189, P181, DOI 10.3354/meps189181; Wolf N, 2009, FUNCT ECOL, V23, P17, DOI 10.1111/j.1365-2435.2009.01529.x	65	14	14	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158785	10.1371/journal.pone.0158785	http://dx.doi.org/10.1371/journal.pone.0158785			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414032	Green Published, Green Submitted, gold			2022-12-27	WOS:000379579500039
J	Ellis, J; Fosdick, BK; Rasmussen, C				Ellis, Jessica; Fosdick, Bailey K.; Rasmussen, Chris			Women 1.5 Times More Likely to Leave STEM Pipeline after Calculus Compared to Men: Lack of Mathematical Confidence a Potential Culprit	PLOS ONE			English	Article							PERSISTENCE; STUDENTS; ASSOCIATION; UNIVERSITY; EDUCATION; PEDAGOGY; FACULTY; MAJORS; GENDER; FIELD	The substantial gender gap in the science, technology, engineering, and mathematics (STEM) workforce can be traced back to the underrepresentation of women at various milestones in the career pathway. Calculus is a necessary step in this pathway and has been shown to often dissuade people from pursuing STEM fields. We examine the characteristics of students who begin college interested in STEM and either persist or switch out of the calculus sequence after taking Calculus I, and hence either continue to pursue a STEM major or are dissuaded from STEM disciplines. The data come from a unique, national survey focused on mainstream college calculus. Our analyses show that, while controlling for academic preparedness, career intentions, and instruction, the odds of a woman being dissuaded from continuing in calculus is 1.5 times greater than that for a man. Furthermore, women report they do not understand the course material well enough to continue significantly more often than men. When comparing women and men with above-average mathematical abilities and preparedness, we find women start and end the term with significantly lower mathematical confidence than men. This suggests a lack of mathematical confidence, rather than a lack of mathematically ability, may be responsible for the high departure rate of women. While it would be ideal to increase interest and participation of women in STEM at all stages of their careers, our findings indicate that if women persisted in STEM at the same rate as men starting in Calculus I, the number of women entering the STEM workforce would increase by 75%.	[Ellis, Jessica] Colorado State Univ, Dept Math, Ft Collins, CO 80523 USA; [Fosdick, Bailey K.] Colorado State Univ, Dept Stat, Ft Collins, CO 80523 USA; [Rasmussen, Chris] San Diego State Univ, Dept Math & Stat, San Diego, CA 92182 USA	Colorado State University; Colorado State University; California State University System; San Diego State University	Ellis, J (corresponding author), Colorado State Univ, Dept Math, Ft Collins, CO 80523 USA.	ellis@math.colostate.edu		Fosdick, Bailey/0000-0003-3736-2219	National Science Foundation [0910240]; Characteristics of Successful Programs in College Calculus (CSPCC) project, National Science Foundation Directorate for Education & Human Resources, Research on Learning in Formal and Informal Settings [0910240]; Direct For Education and Human Resources [0910240] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Characteristics of Successful Programs in College Calculus (CSPCC) project, National Science Foundation Directorate for Education & Human Resources, Research on Learning in Formal and Informal Settings; Direct For Education and Human Resources(National Science Foundation (NSF)NSF - Directorate for STEM Education (EDU))	This work is part of the Characteristics of Successful Programs in College Calculus (CSPCC) project, National Science Foundation Directorate for Education & Human Resources, Research on Learning in Formal and Informal Settings #0910240 (http://www.nsf.gov/div/index.jsp?div=DRL). CR was part of the research team that received this funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is part of the Characteristics of Successful Programs in College Calculus project and would not have been possible without the many contributors to this work, especially David Bressoud. The authors are grateful to feedback from Sandra Laursen, Jennifer Hoeting, Tyler McCormick, and Rachel Heath, as well as the anonymous reviewers and the editor for their extremely helpful comments. Support for this work was funded by the National Science Foundation under grant No. 0910240. The opinions expressed do not necessarily reflect the views of the Foundation.	Blickenstaff JC, 2005, GENDER EDUC, V17, P369, DOI 10.1080/09540250500145072; Bressoud D., 2015, MAA NOTES; Canizares CR., 2009, MEMORIAM, P35; Chen X., 2013, 2014001 NCES US DEP; Cross LH, 1999, APPL MEAS EDUC, V12, P53, DOI 10.1207/s15324818ame1201_4; Cunningham Brittany C., 2015, 2015075 NCES US DEP; Dweck C., 2008, MINDSETS MATH SCI AC; Eagan K, 2009, AM FRESHMAN NATL NOR; Ehrenberg RG, 2010, ECON EDUC REV, V29, P888, DOI 10.1016/j.econedurev.2010.06.012; Ellis J, 2014, ZDM-MATH EDUC, V46, P661, DOI 10.1007/s11858-014-0577-z; Fennema E., 1978, J RES MATH EDUC, V9, P189, DOI DOI 10.2307/748997; Forsman J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103261; Gago JM, 2004, INCREASING HUMAN RES; Good C, 2012, J PERS SOC PSYCHOL, V102, P700, DOI 10.1037/a0026659; Graham MJ, 2013, SCIENCE, V341, P1455, DOI 10.1126/science.1240487; Griffith AL, 2010, ECON EDUC REV, V29, P911, DOI 10.1016/j.econedurev.2010.06.010; Hill C., 2010, WHY SO FEW WOMEN SCI; Holmegaard HT, 2014, INT J SCI EDUC, V36, P186, DOI 10.1080/09500693.2012.749362; Islam MM, 2015, INT J HIGHER ED, V4, P67, DOI [10.5430/ijhe.v4n2p67, DOI 10.5430/IJHE.V4N2P67]; Landivar L.C., 2013, EDUC REV, V29, P911; Lindberg SM, 2010, PSYCHOL BULL, V136, P1123, DOI 10.1037/a0021276; Lodico M.G., 2010, METHODS ED RES THEOR, VVolume 28; Maltese AV, 2011, SCI EDUC, V95, P877, DOI 10.1002/sce.20441; National Center for Education Statistics (NCES), 2014, TOT UND FALL ENR DEG; National Center for Education Statistics (NCES), 2014, BACH MAST DOCT DEGR; Nugent G, 2015, INT J SCI EDUC, V37, P1067, DOI 10.1080/09500693.2015.1017863; Nugent KL, 2013, NAT BIOTECHNOL, V31, P853, DOI 10.1038/nbt.2694; Olson S., 2012, REP PRES; Pampaka M, 2012, BRIT EDUC RES J, V38, P473, DOI [10.1080/01411926.2011.555518, 10.1080/01411926.2011.613453]; Seymour E., THESIS; Seymour E., 1997, TALKING LEAVING WHY; Sheltzer JM, 2014, P NATL ACAD SCI USA, V111, P10107, DOI 10.1073/pnas.1403334111; Steen Lynn Arthur, 1987, C WASH DC OCT 28 29; TINTO V, 1975, REV EDUC RES, V45, P89, DOI 10.2307/1170024; U.S. Census Bureau, 2008, SINGL GRAD ENR HIGH; U.S. Census Bureau, 2007, SIGNL GRAD ENR HIGH; U.S. Census Bureau, 1999, SINGL GRAD ENR HIGH; Wake G, 2011, RES MATH EDUCAT, V13, P109, DOI 10.1080/14794802.2011.585822; Williams WM, 2015, P NATL ACAD SCI USA, V112, P5360, DOI 10.1073/pnas.1418878112; Wolniak GC, 2012, J HIGH EDUC-UK, V83, P795, DOI 10.1353/jhe.2012.0041	40	120	121	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0157447	10.1371/journal.pone.0157447	http://dx.doi.org/10.1371/journal.pone.0157447			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ9CP	27410262	Green Published, Green Submitted, gold			2022-12-27	WOS:000379508300010
J	Fischer, M; Renevey, N; Thur, B; Hoffmann, D; Beer, M; Hoffmann, B				Fischer, Melina; Renevey, Nathalie; Thur, Barbara; Hoffmann, Donata; Beer, Martin; Hoffmann, Bernd			Efficacy Assessment of Nucleic Acid Decontamination Reagents Used in Molecular Diagnostic Laboratories	PLOS ONE			English	Article							PCR; CONTAMINATION	The occurrence of nucleic acid cross contamination in the laboratory resulting in false positive results of diagnostic samples is seriously problematic. Despite precautions to minimize or even avoid nucleic acid cross contaminations, it may appear anyway. Until now, no standardized strategy is available to evaluate the efficacy of commercially offered decontamination reagents. Therefore, a protocol for the reliable determination of nucleic acid decontamination efficacy using highly standardized solution and surface tests was established and validated. All tested sodium hypochlorite-based reagents proved to be highly efficient in nucleic acid decontamination even after short reaction times. For DNA Away, a sodium hydroxide-based decontamination product, dose- and time-dependent effectiveness was ascertained. For two other commercial decontamination reagents, the phosphoric acid-based DNA Remover and the non-enzymatic reagent DNA-ExitusPlus (TM) IF, no reduction of amplifiable DNA/RNA was observed. In conclusion, a simple test procedure for evaluation of the elimination efficacy of decontamination reagents against amplifiable nucleic acid is presented.	[Fischer, Melina; Hoffmann, Donata; Beer, Martin; Hoffmann, Bernd] Friedrich Loeffler Inst, Inst Diagnost Virol, Sudufer 10, D-17493 Greifswald, Germany; [Renevey, Nathalie; Thur, Barbara] Inst Immunol & Virol, Sensemattstr 293, D-3147 Mittelhausern, Germany; [Fischer, Melina] Genolytic GmbH, Deutsch Pl 5, D-04103 Leipzig, Germany	Friedrich Loeffler Institute	Hoffmann, B (corresponding author), Friedrich Loeffler Inst, Inst Diagnost Virol, Sudufer 10, D-17493 Greifswald, Germany.	Bernd.Hoffmann@fli.bund.de		Hoffmann, Donata/0000-0003-4552-031X				[Anonymous], 2009, 1656 DIN EN; [Anonymous], 2014, 14349 DIN EN; Arena A., 2010, INVESTIG SCI J, V2, P20; BELAK S, 1993, MOL CELL PROBE, V7, P241, DOI 10.1006/mcpr.1993.1035; Cantalupo PG, 2015, J VIROL, V89, P4051, DOI 10.1128/JVI.03365-14; Champlot S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013042; Deutsche Veterinarmedizinische Gesellschaft e.V, 2000, RICHTL PRUF CHEM DES; Esser KH, 2006, BIOTECHNIQUES, V40, P238, DOI 10.2144/06402AF01; Haerinck S., 2011, J FORENSIC RES, VS2; Hoffmann B, 2006, J VIROL METHODS, V136, P200, DOI 10.1016/j.jviromet.2006.05.020; Hoffmann B, 2005, J VIROL METHODS, V130, P36, DOI 10.1016/j.jviromet.2005.05.030; KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0; Niederhauser C, 1994, PCR Methods Appl, V4, P117; PRINCE AM, 1992, BIOTECHNIQUES, V12, P358; Reybrouck G, 1998, INT BIODETER BIODEGR, V41, P269, DOI 10.1016/S0964-8305(98)00024-9; Tetzner Reimo, 2009, V507, P357, DOI 10.1007/978-1-59745-522-0_26; van Klingeren B, 1998, INT BIODETER BIODEGR, V41, P289, DOI 10.1016/S0964-8305(98)00020-1	17	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159274	10.1371/journal.pone.0159274	http://dx.doi.org/10.1371/journal.pone.0159274			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410228	gold, Green Published, Green Submitted			2022-12-27	WOS:000379508300075
J	Kripke, K; Vazzano, A; Kirungi, W; Musinguzi, J; Opio, A; Ssempebwa, R; Nakawunde, S; Kyobutungi, S; Akao, JN; Magala, F; Mwidu, G; Castor, D; Njeuhmeli, E				Kripke, Katharine; Vazzano, Andrea; Kirungi, William; Musinguzi, Joshua; Opio, Alex; Ssempebwa, Rhobbinah; Nakawunde, Susan; Kyobutungi, Sheila; Akao, Juliet N.; Magala, Fred; Mwidu, George; Castor, Delivette; Njeuhmeli, Emmanuel			Modeling the Impact of Uganda's Safe Male Circumcision Program: Implications for Age and Regional Targeting	PLOS ONE			English	Article							HIV PREVENTION; IMPROVEMENTS; RAKAI; MEN	Background Uganda aims to provide safe male circumcision (SMC) to 80% of men ages 15-49 by 2016. To date, only 2 million men have received SMC of the 4.2 million men required. In response to age and regional trends in SMC uptake, the country sought to re-examine its targets with respect to age and subnational region, to assess the program's progress, and to refine the implementation approach. Methods and Findings The Decision Makers' Program Planning Tool, Version 2.0 (DMPPT 2.0), was used in conjunction with incidence projections from the Spectrum/AIDS Impact Module (AIM) to conduct this analysis. Population, births, deaths, and HIV incidence and prevalence were used to populate the model. Baseline male circumcision prevalence was derived from the 2011 AIDS Indicator Survey. Uganda can achieve the most immediate impact on HIV incidence by circumcising men ages 20-34. This group will also require the fewest circumcisions for each HIV infection averted. Focusing on men ages 10-19 will offer the greatest impact over a 15-year period, while focusing on men ages 15-34 offers the most cost-effective strategy over the same period. A regional analysis showed little variation in cost-effectiveness of scaling up SMC across eight regions. Scale-up is cost-saving in all regions. There is geographic variability in program progress, highlighting two regions with low baseline rates of circumcision where additional efforts will be needed. Conclusion Focusing SMC efforts on specific age groups and regions may help to accelerate Uganda's SMC program progress. Policy makers in Uganda have already used model outputs in planning efforts, proposing males ages 10-34 as a priority group for SMC in the 2014 application to the Global Fund's new funding model. As scale-up continues, the country should also consider a greater effort to expand SMC in regions with low MC prevalence.	[Kripke, Katharine] Avenir Hlth, Hlth Policy Project, Washington, DC USA; [Vazzano, Andrea] Futures Grp Inc, Hlth Policy Project, Washington, DC USA; [Kirungi, William; Musinguzi, Joshua; Opio, Alex] Minist Hlth, Kampala, Uganda; [Ssempebwa, Rhobbinah; Nakawunde, Susan; Kyobutungi, Sheila] US Agcy Int Dev, Kampala, Uganda; [Akao, Juliet N.] US Dept Def, Kampala, Uganda; [Magala, Fred; Mwidu, George] Makerere Univ, Walter Reed Project, Kampala, Uganda; [Castor, Delivette; Njeuhmeli, Emmanuel] USAID, Washington, DC USA	United States Agency for International Development (USAID); Makerere University; United States Agency for International Development (USAID)	Kripke, K (corresponding author), Avenir Hlth, Hlth Policy Project, Washington, DC USA.	kkripke@avenirhealth.org	Kripke, Katharine/J-2146-2019	Kripke, Katharine/0000-0001-8228-4577; Vazzano, Andrea/0000-0001-9653-4151	American people through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR); U.S. Agency for International Development (USAID) [AID-OAA-A-10-00067, AID-OAA-14-00026]; USAID	American people through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR); U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID)); USAID(United States Agency for International Development (USAID))	This manuscript is made possible by the generous support of the American people through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) with the U.S. Agency for International Development (USAID) under the Cooperative Agreement Health Policy Project, Agreement No. AID-OAA-A-10-00067, and Cooperative Agreement Project SOAR (Supporting Operational AIDS Research), number AID-OAA-14-00026. The Health Policy Project is implemented by Futures Group, in collaboration with Plan International USA, Avenir Health (formerly Futures Institute), Partners in Population and Development, Africa Regional Office (PPD ARO), Population Reference Bureau (PRB), RTI International, and the White Ribbon Alliance for Safe Motherhood (WRA). The funder was involved in study design, decision to publish, and preparation of the manuscript. The findings and conclusions in this paper do not necessarily represent the views or positions of PEPFAR, USAID, or the U.S. Government.; John Stover of Avenir Health developed the DMPPT 2.0 model at the request of USAID, under the USAID-funded Health Policy Project. The authors gratefully acknowledge the Ugandan Ministry of Health for providing the data for this analysis. We thank the PEPFAR VMMC Technical Working Group and colleagues from the U.S. Centers for Disease Control and Prevention in Kampala for their feedback, helpful discussion, and information sharing. We thank Melissa Schnure for assistance with some of the analyses, figure preparation, and overall management of the manuscript preparation process. The authors are also grateful to the publications staff at the Health Policy Project for their assistance with copy editing and formatting.	Anderson SJ, 2014, LANCET, V384, P249, DOI 10.1016/S0140-6736(14)61053-9; [Anonymous], 2012, UG DEM HLTH SURV 201; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Baine SO, 2009, SITUATION ANAL DETER; Brown T, 2014, AIDS, V28, pS415, DOI 10.1097/QAD.0000000000000454; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hankins C, 2016, PLOS ONE IN PRESS; Hankins C, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000109; Hasunira R, 2012, TOO LITTLE TOO SLOW; Jones A, 2014, LANCET, V384, P272, DOI 10.1016/S0140-6736(13)62230-8; Kong XR, 2014, AIDS BEHAV, V18, P880, DOI 10.1007/s10461-014-0740-0; Kripke K, PLOS ONE; Kripke K, 2016, PLOS ONE IN PRESS; MOH ICF, 2012, UG AIDS IND SURV 201; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Stover J, 2010, SEX TRANSM INFECT, V86, pII16, DOI 10.1136/sti.2010.044222; Stover J, 2014, AIDS, V28, pS427, DOI 10.1097/QAD.0000000000000483; The Joint United Nation Programme on HIV/AIDS, 2014, 90 90 90 AMB TREATM; Uganda Ministry of Health (MOH) ICF International, 2012, 2011 UG AIDS IND SUR; UNAIDS, 2013, REP GLOB AIDS EP; UNAIDS/WHO, 2007, NEW DAT MAL CIRC HIV; WHO Regional Office for Africa, 2013, PROGR SCAL VOL MED M; Williams BG, 2006, PLOS MED, V3, P1032, DOI 10.1371/journal.pmed.0030262	25	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158693	10.1371/journal.pone.0158693	http://dx.doi.org/10.1371/journal.pone.0158693			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410234	Green Submitted, Green Published, gold			2022-12-27	WOS:000379508300031
J	Khoa, LTP; Azami, T; Tsukiyama, T; Matsushita, J; Tsukiyama-Fujii, S; Takahashi, S; Ema, M				Le Tran Phuc Khoa; Azami, Takuya; Tsukiyama, Tomoyuki; Matsushita, Jun; Tsukiyama-Fujii, Setsuko; Takahashi, Satoru; Ema, Masatsugu			Visualization of the Epiblast and Visceral Endodermal Cells Using Fgf5-P2A-Venus BAC Transgenic Mice and Epiblast Stem Cells	PLOS ONE			English	Article							MOUSE EMBRYOS; GROUND-STATE; IN-VIVO; PLURIPOTENT CELLS; PRIMITIVE STREAK; CHIMERIC EMBRYO; SELF-RENEWAL; NANOG; GENE; GASTRULATION	Fibroblast growth factor 5 (Fgf5) has been widely used as a marker for the epiblast in the postimplantation embryo and epiblast stem cells (mEpiSCs) in the mouse, making it valuable for study of differentiation of various tissues and epiblast cells in vivo and in vitro. Here, we report for the first time the generation of Fgf5-P2A-Venus BAC transgenic (Tg) mice and show that the BAC Tg can recapitulate endogenous Fgf5 expression in epiblast and visceral endodermal cells of E6.5 and 7.5 embryos. We also show that Fgf5-P2A-Venus BAC Tg mEpiSCs in the undifferentiated state expressed abundant Venus, and upon reprogramming into naive state, Venus was suppressed. Furthermore, while most Tg mEpiSCs expressed Venus abundantly, surprisingly the Tg mEpiSCs contained a minor subpopulation of Venus-negative cells that were capable of conversion to Venus-positive cells, indicating that even Fgf5 expression shows dynamic heterogeneity in mEpiSCs. Taken together, Fgf5-P2A-Venus BAC Tg mice and mEpiSCs generated in this study will be useful for developmental biology as well as stem cell biology research.	[Le Tran Phuc Khoa] Univ Tsukuba, Sch Integrat & Global Majors, PhD Program Human Biol, Dept Anat & Embryol, Tsukuba, Ibaraki, Japan; [Azami, Takuya; Takahashi, Satoru] Univ Tsukuba, Fac Med, Dept Anat & Embryol, Tsukuba, Ibaraki, Japan; [Azami, Takuya; Tsukiyama, Tomoyuki; Matsushita, Jun; Tsukiyama-Fujii, Setsuko; Ema, Masatsugu] Shiga Univ Med Sci, Res Ctr Anim Life Sci, Dept Stem Cells & Human Dis Models, Otsu, Shiga, Japan; [Takahashi, Satoru] Univ Tsukuba, Life Sci Ctr, Int Inst Integrat Sleep Med, Tsukuba, Ibaraki, Japan; [Takahashi, Satoru] Univ Tsukuba, Anim Resource Ctr, Tsukuba, Ibaraki, Japan; [Ema, Masatsugu] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan	University of Tsukuba; University of Tsukuba; Shiga University of Medical Science; University of Tsukuba; University of Tsukuba; Japan Science & Technology Agency (JST)	Azami, T (corresponding author), Univ Tsukuba, Fac Med, Dept Anat & Embryol, Tsukuba, Ibaraki, Japan.; Azami, T; Ema, M (corresponding author), Shiga Univ Med Sci, Res Ctr Anim Life Sci, Dept Stem Cells & Human Dis Models, Otsu, Shiga, Japan.; Ema, M (corresponding author), Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan.	tazami@belle.shiga-med.ac.jp; mema@belle.shiga-med.ac.jp	TSUKIYAMA, Tomoyuki/AAI-3082-2020; Le, Khoa/AAL-2599-2020	TSUKIYAMA, Tomoyuki/0000-0002-2657-7719; Ema, Masatsugu/0000-0003-0645-6183; Tran Phuc Le, Khoa/0000-0002-6076-3857; Azami, Takuya/0000-0002-3759-9710	PRESTO, Japan Science and Technology Agency (JST)	PRESTO, Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This work was supported in part by a grant from PRESTO, Japan Science and Technology Agency (JST) (to M.E.) and a Grant-in-Aid for JSPS Fellows (to T.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Ms. Keiko Amagai for preparation of BAC Tg DNA. This work was supported in part by a grant from PRESTO, Japan Science and Technology Agency (JST) (to M. E.) and a Grant-in-Aid for JSPS Fellows (to T. A.)	Bernemann C, 2011, STEM CELLS, V29, P1496, DOI 10.1002/stem.709; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Di-Gregorio A, 2007, DEVELOPMENT, V134, P3359, DOI 10.1242/dev.005967; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; Ema M, 2008, CELL STEM CELL, V3, P555, DOI 10.1016/j.stem.2008.09.003; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Festuccia N, 2012, CELL STEM CELL, V11, P477, DOI 10.1016/j.stem.2012.08.002; Furusawa T, 2004, BIOL REPROD, V70, P1452, DOI 10.1095/biolreprod.103.024190; Gasnier M, 2013, NAT PROTOC, V8, P2538, DOI 10.1038/nprot.2013.160; Gillich A, 2012, CELL STEM CELL, V10, P425, DOI 10.1016/j.stem.2012.01.020; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Guzman-Ayala M, 2015, DEVELOPMENT, V142, P118, DOI 10.1242/dev.114843; Han DW, 2010, CELL, V143, P617, DOI 10.1016/j.cell.2010.10.015; Hanaka H, 2014, EXP ANIM TOKYO, V63, P85, DOI 10.1538/expanim.63.85; HAUB O, 1991, DEVELOPMENT, V112, P397; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; HEBERT JM, 1994, CELL, V78, P1017, DOI 10.1016/0092-8674(94)90276-3; HEBERT JM, 1990, DEV BIOL, V138, P454, DOI 10.1016/0012-1606(90)90211-Z; HEBERT JM, 1991, DEVELOPMENT, V112, P407; Huang YL, 2012, CELL REP, V2, P1571, DOI 10.1016/j.celrep.2012.10.022; Jeon H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150715; Kojima Y, 2014, CELL STEM CELL, V14, P107, DOI 10.1016/j.stem.2013.09.014; Lanner F, 2010, DEVELOPMENT, V137, P3351, DOI 10.1242/dev.050146; Lawson KA, 1999, INT J DEV BIOL, V43, P773; Li LY, 2013, DEVELOPMENT, V140, P4533, DOI 10.1242/dev.092866; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Mason J., 1994, CELL, V79, P547; Mesnard D, 2011, GENE DEV, V25, P1871, DOI 10.1101/gad.16738711; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Ornitz DM, 2015, WIRES DEV BIOL, V4, P215, DOI 10.1002/wdev.176; Pelton TA, 2002, J CELL SCI, V115, P329; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Straub L, 2015, MOL METAB, V4, P605, DOI 10.1016/j.molmet.2015.06.008; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Tam PPL, 1997, MECH DEVELOP, V68, P3, DOI 10.1016/S0925-4773(97)00123-8; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Trott J, 2013, BIOL OPEN, V2, P1049, DOI 10.1242/bio.20135934; Tsakiridis A, 2014, DEVELOPMENT, V141, P1209, DOI 10.1242/dev.101014; YEOM YI, 1991, MECH DEVELOP, V35, P171; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	46	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159246	10.1371/journal.pone.0159246	http://dx.doi.org/10.1371/journal.pone.0159246			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27409080	Green Published, gold, Green Submitted			2022-12-27	WOS:000379508300071
J	Randremanana, RV; Razafindratsimandresy, R; Andriatahina, T; Randriamanantena, A; Ravelomanana, L; Randrianirina, F; Richard, V				Randremanana, Rindra Vatosoa; Razafindratsimandresy, Richter; Andriatahina, Todisoa; Randriamanantena, Arthur; Ravelomanana, Lovaniaina; Randrianirina, Frederique; Richard, Vincent			Etiologies, Risk Factors and Impact of Severe Diarrhea in the Under-Fives in Moramanga and Antananarivo, Madagascar	PLOS ONE			English	Article							ROTAVIRUS VACCINE; CHILDREN; BURDEN; GASTROENTERITIS; UNDERNUTRITION; INFECTIONS; NOROVIRUS; STRAINS; DISEASE; TRENDS	Background Diarrheal disease remains a leading cause of death in children in low-income countries. We investigated the etiology, risk factors and effects on nutritional status of severe diarrhea in children from two districts in Madagascar. Methods We performed a matched case-control study in 2011 to 2014, on children under the age of five years from Moramanga and Antananarivo. The cases were children hospitalized for severe diarrhea and the controls were children without diarrhea selected at random from the community. Stool samples were collected from both groups. Anthropometric measurements were made during follow-up visits about one and two months after enrolment. Results We enrolled 199 cases and 199 controls. Rotavirus infection was the most frequently detected cause of diarrhea. It was strongly associated with severe diarrhea (OR: 58.3; 95% CI: 7.7-439.9), accounting for 42.4%(95% CI: 37.6-43.1) of severe diarrhea cases. At the household level, possession of cattle (OR = 0.3; 95% CI: 0.1-0.6) and living in a house with electricity (OR = 0.4; 95% CI: 0.2-0.8) were protective factors. The presence of garbage around the house was a risk factor for severe diarrhea (OR = 3.2; 95% CI: 1.9-5.4). We found no significant association between severe diarrhea and the nutritional status of the children at follow-up visits, but evident wasting at enrolment was associated with a higher risk of severe diarrhea (OR = 9; 95% CI: 4.5-17.9). Conclusions Severe childhood diarrhea is mostly caused by rotavirus infection. An anti-rotavirus vaccine has already been introduced in Madagascar and should be promoted more widely. However, post-licensing surveillance is required. Interventions to improve the nutritional status of children, preventive measures focused on household and personal hygiene and nutritional rehabilitation during severe diarrheal disease should be reinforced.	[Randremanana, Rindra Vatosoa; Randriamanantena, Arthur] Inst Pasteur Madagascar, Epidemiol Unit, Antananarivo, Madagascar; [Razafindratsimandresy, Richter] Inst Pasteur Madagascar, Virol Unit, Antananarivo, Madagascar; [Andriatahina, Todisoa] Ctr Hospitalier Dist Niveau 2, Serv Pediat, Moramanga, Madagascar; [Ravelomanana, Lovaniaina] Ctr Hosp Univ Mere Enfant Ambohimiandra, Antananarivo, Madagascar; [Randrianirina, Frederique] Inst Pasteur Madagascar, Clin Biol Ctr, Antananarivo, Madagascar; [Richard, Vincent] Inst Pasteur, Epidemiol Unit, Dakar, Senegal	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar	Randremanana, RV (corresponding author), Inst Pasteur Madagascar, Epidemiol Unit, Antananarivo, Madagascar.	rrandrem@pasteur.mg		Vincent, RICHARD/0000-0002-6961-1753	TOTAL Foundation; Cellule Realisatrice de Projet of the epidemiology unit of the Institut Pasteur de Madagascar	TOTAL Foundation(Total SA); Cellule Realisatrice de Projet of the epidemiology unit of the Institut Pasteur de Madagascar	Funded by TOTAL Foundation. The funding was given to the Institut Pasteur de Madagascar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all study participants and all workers from the pediatrics departments of CHD2 Moramanga and the Centre Hospitalier Mere Enfant d'Ambohimiandra. We also thank Prof. Philippe Sansonetti from Institut Pasteur de Paris, Prof. Christophe Rogier, Marie Gousseff, Hugues Cordel, Perlinot Herindrainy, Jean Marius Rakotondramanga, Dr Patrice Piola and the Cellule Realisatrice de Projet of the epidemiology unit of the Institut Pasteur de Madagascar for their support.	Ahmed SM, 2014, LANCET INFECT DIS, V14, P725, DOI 10.1016/S1473-3099(14)70767-4; Al-Mazrou Y Y, 1995, J Family Community Med, V2, P27; Alam DS, 2000, INT J EPIDEMIOL, V29, P916, DOI 10.1093/ije/29.5.916; Banyai K, 2009, J CLIN VIROL, V46, P391, DOI 10.1016/j.jcv.2009.08.005; Boadi KO, 2005, WORLD HLTH POPULATIO; Candy DCA, 2007, PLOS MED, V4, P614, DOI 10.1371/journal.pmed.0040117; Cattaneo MD, 2007, HOUSING HLTH HAPPINE; Correia JB, 2010, J INFECT DIS, V201, P363, DOI 10.1086/649843; de Onis M, 2009, ARCH PEDIATRIE, V16, P47, DOI 10.1016/j.arcped.2008.10.010; Groome MJ, 2014, LANCET INFECT DIS, V14, P1096, DOI 10.1016/S1473-3099(14)70940-5; Justino MCA, 2011, PEDIATR INFECT DIS J, V30, P396, DOI 10.1097/INF.0b013e3182055cc2; Kosek M, 2003, B WORLD HEALTH ORGAN, V81, P197; Kossmann J, 2000, EUR J CLIN NUTR, V54, P463, DOI 10.1038/sj.ejcn.1600998; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Krumkamp Ralf, 2015, PLoS Negl Trop Dis, V9, pe0003728, DOI 10.1371/journal.pntd.0003728; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Luchs A, 2014, J CLIN VIROL, V59, P74, DOI 10.1016/j.jcv.2013.11.001; Martella V, 2010, VET MICROBIOL, V140, P246, DOI 10.1016/j.vetmic.2009.08.028; Masibo PK, 2012, PUBLIC HEALTH NUTR, V15, P1715, DOI 10.1017/S1368980012002856; Muller D, 2007, APPL ENVIRON MICROB, V73, P3380, DOI 10.1128/AEM.02855-06; Mwangome MK, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-92; Nhampossa T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119824; Nitiema LW, 2011, INT J INFECT DIS, V15, pE646, DOI 10.1016/j.ijid.2011.05.009; Nyaga MM, 2015, INFECT GENET EVOL, V31, P321, DOI 10.1016/j.meegid.2015.02.011; Papaventsis DC, 2007, EMERG INFECT DIS, V13, P908, DOI 10.3201/eid1306.070215; Randremanana R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044533; Randremanana RV, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-372; Razafindratsimandresy R, 2013, J MED VIROL, V85, P1652, DOI 10.1002/jmv.23631; Team RDC, 2019, R LANG ENV STAT COMP; Vasco G, 2014, AM J TROP MED HYG, V91, P563, DOI 10.4269/ajtmh.13-0744; World Health Organization (WHO), 2009, WHO ANTHROPLUS PERS	32	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158862	10.1371/journal.pone.0158862	http://dx.doi.org/10.1371/journal.pone.0158862			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27411101	Green Published, Green Submitted, gold			2022-12-27	WOS:000379508300037
J	Richardson, VA; Peres, CA				Richardson, Vanessa A.; Peres, Carlos A.			Temporal Decay in Timber Species Composition and Value in Amazonian Logging Concessions	PLOS ONE			English	Article							FOREST MANAGEMENT; NATURAL-RESOURCE; SUSTAINABILITY; DEFORESTATION; EXTINCTION; ATLANTIC; FRONTIER; VULNERABILITY; EXPLOITATION; CONSERVATION	Throughout human history, slow-renewal biological resource populations have been predictably overexploited, often to the point of economic extinction. We assess whether and how this has occurred with timber resources in the Brazilian Amazon. The asynchronous advance of industrial-scale logging frontiers has left regional-scale forest landscapes with varying histories of logging. Initial harvests in unlogged forests can be highly selective, targeting slow-growing, high-grade, shade-tolerant hardwood species, while later harvests tend to focus on fast-growing, light-wooded, long-lived pioneer trees. Brazil accounts for 85% of all native neotropical forest roundlog production, and the State of Para for almost half of all timber production in Brazilian Amazonia, the largest old-growth tropical timber reserve controlled by any country. Yet the degree to which timber harvests beyond the first-cut can be financially profitable or demographically sustainable remains poorly understood. Here, we use data on legally planned logging of similar to 17.3 million cubic meters of timber across 314 species extracted from 824 authorized harvest areas in private and community-owned forests, 446 of which reported volumetric composition data by timber species. We document patterns of timber extraction by volume, species composition, and monetary value along aging eastern Amazonian logging frontiers, which are then explained on the basis of historical and environmental variables. Generalized linear models indicate that relatively recent logging operations farthest from heavy-traffic roads are the most selective, concentrating gross revenues on few high-value species. We find no evidence that the post-logging timber species composition and total value of forest stands recovers beyond the first-cut, suggesting that the commercially most valuable timber species become predictably rare or economically extinct in old logging frontiers. In avoiding even more destructive land-use patterns, managing yields of selectively-logged forests is crucial for the long-term integrity of forest biodiversity and financial viability of local industries. The logging history of eastern Amazonian old-growth forests likely mirrors unsustainable patterns of timber depletion over time in Brazil and other tropical countries.	[Richardson, Vanessa A.; Peres, Carlos A.] Univ East Anglia, Sch Environm Sci, Ctr Ecol Evolut & Conservat, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Richardson, VA (corresponding author), Univ East Anglia, Sch Environm Sci, Ctr Ecol Evolut & Conservat, Norwich NR4 7TJ, Norfolk, England.	vanessa-anne.richardson@uea.ac.uk; C.Peres@uea.ac.uk	Peres, Carlos A./B-1276-2013; Peres, Carlos Augusto/N-8275-2019; Peres, Carlos A./ABE-8361-2020	Peres, Carlos A./0000-0002-1588-8765; Peres, Carlos A./0000-0002-1588-8765	NERC PhD studentship at UEA [1092538]; NERC doctoral studentship at the University of East Anglia; CAPES [PVE 004/2012]; Natural Environment Research Council [1092538] Funding Source: researchfish; The British Council [GII111] Funding Source: researchfish	NERC PhD studentship at UEA; NERC doctoral studentship at the University of East Anglia(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); The British Council	We thank the Secretaria Especial do Meio Ambiente do Estado do Para (SEMA) for making raw data on forest management plans available and IMAZON (Instituto do Homem e Ambiente da Amazonia) for discussing these data with us. VAR was funded by a NERC PhD studentship (1092538) at UEA. We thank P Amaral for insightful discussions about selective logging in the eastern Amazon.; VAR is supported by an NERC doctoral studentship (http://www.nerc.ac.uk/) at the University of East Anglia. CAP co-wrote this paper during a CAPES-funded visiting fellowship (http://www.capes.gov.br/) to Museu Goeldi, Brazil (PVE 004/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asner GP, 2006, P NATL ACAD SCI USA, V103, P12947, DOI 10.1073/pnas.0604093103; Asner GP, 2009, CONSERV BIOL, V23, P1386, DOI 10.1111/j.1523-1739.2009.01333.x; Barlow J, 2003, J TROP ECOL, V19, P291, DOI 10.1017/S0266467403003328; Barreto P, 1998, FOREST ECOL MANAG, V108, P9, DOI 10.1016/S0378-1127(97)00251-X; Brandt JS, 2016, LAND USE POLICY, V52, P15, DOI 10.1016/j.landusepol.2015.11.028; Burivalova Z, 2014, CURR BIOL, V24, P1893, DOI 10.1016/j.cub.2014.06.065; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Busa JHM, 2013, CONSERV LETT, V6, P192, DOI 10.1111/j.1755-263X.2012.00304.x; Bacha CJC, 2007, ECOL ECON, V63, P70, DOI 10.1016/j.ecolecon.2006.09.024; Cardoso MA, 1998, MOL ECOL, V7, P601, DOI 10.1046/j.1365-294x.1998.00363.x; CLARK CW, 1973, J POLIT ECON, V81, P950, DOI 10.1086/260090; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; Cordell D, 2009, GLOBAL ENVIRON CHANG, V19, P292, DOI 10.1016/j.gloenvcha.2008.10.009; Crawley M. J, 2002, STAT COMPUTING INTRO; de Avila AL, 2015, BIOL CONSERV, V191, P577, DOI 10.1016/j.biocon.2015.08.004; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Dulvy NK, 2003, FISH FISH, V4, P25, DOI 10.1046/j.1467-2979.2003.00105.x; Edwards DP, 2014, TRENDS ECOL EVOL, V29, P511, DOI 10.1016/j.tree.2014.07.003; Edwards DP, 2013, SCIENCE, V339, P646, DOI 10.1126/science.339.6120.646-b; Fa JE, 2005, BIOL CONSERV, V121, P167, DOI 10.1016/j.biocon.2004.04.016; FAO, 2012, STAT WORLDS FOR; Field A., 2012, DISCOVERING STAT USI; Finer M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04719; Freitas da Silva M., 1977, NOMES VULGARES PLANT; Galetti M, 1998, J APPL ECOL, V35, P294, DOI 10.1046/j.1365-2664.1998.00295.x; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Greenpeace, 2014, AM SIL CRIS; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; He F, 2014, ECOLOGY, V83, P1185; Higgins MA, 2004, CONSERV BIOL, V18, P799, DOI 10.1111/j.1523-1739.2004.00235.x; Holmes T, 2002, FOR ECOL, V5583, P1; Homma A. K. O., 1992, Advances in Economic Botany, V9, P23; Howard AF, 1996, FOREST ECOL MANAG, V89, P43, DOI 10.1016/S0378-1127(96)03867-4; Hutchings JA, 2004, BIOSCIENCE, V54, P297, DOI 10.1641/0006-3568(2004)054[0297:MFPCCF]2.0.CO;2; IBAMA, 2008, LIST ESP AM EXT; ITTO, 2012, ANN REV ASS WORLD TR; Jerozolimski A, 2003, BIOL CONSERV, V111, P415, DOI 10.1016/S0006-3207(02)00310-5; Kammesheidt L, 2001, J APPL ECOL, V38, P756, DOI 10.1046/j.1365-2664.2001.00629.x; Kastner T, 2011, GLOBAL ENVIRON CHANG, V21, P947, DOI 10.1016/j.gloenvcha.2011.05.003; Kirby KR, 2006, FUTURES, V38, P432, DOI 10.1016/j.futures.2005.07.011; Laporte NT, 2007, SCIENCE, V316, P1451, DOI 10.1126/science.1141057; Laufer J, 2013, TROP CONSERV SCI, V6, P16, DOI 10.1177/194008291300600106; Laurance WF, 2002, J BIOGEOGR, V29, P737, DOI 10.1046/j.1365-2699.2002.00721.x; Leao TCC, 2014, CONSERV BIOL, V28, P1349, DOI 10.1111/cobi.12286; Levi T, 2013, BIOL CONSERV, V163, P99, DOI 10.1016/j.biocon.2013.03.016; Lorenzi H, 2002, ARVORES BRASILEIRAS, V2; LORENZI H., 2016, ARVORES BRASILEIRAS, V1; LORENZI H, 1998, ARVORES BRASILEIRAS, V2; LUDWIG D, 1993, SCIENCE, V260, P17, DOI 10.1126/science.260.5104.17; Mace GM, 1999, CONSERV BIOL, V13, P242, DOI 10.1046/j.1523-1739.1999.013002242.x; MacKenzie BR, 2009, CONSERV LETT, V2, P25, DOI 10.1111/j.1755-263X.2008.00039.x; Macpherson AJ, 2012, LAND USE POLICY, V29, P339, DOI 10.1016/j.landusepol.2011.07.004; MARTINI AMZ, 1994, ENVIRON CONSERV, V21, P152, DOI 10.1017/S0376892900024589; May PH, 2004, ECON BOT, V58, P257, DOI 10.1663/0013-0001(2004)058[0257:REITBA]2.0.CO;2; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; McGill BJ, 2007, ECOL LETT, V10, P995, DOI 10.1111/j.1461-0248.2007.01094.x; Menard S.W., 1995, APPL LOGISTIC REGRES, V2nd ed.; Merry F, 2009, ENVIRON MANAGE, V44, P395, DOI 10.1007/s00267-009-9337-1; Monteiro A, 2008, ESTADO RESUMO ESTADO; Monteiro A, 2011, 15 S, P5615; Monteiro A, 2012, TRANSPARENCY FOREST, P14; Monteiro A, 2011, B TRANSPARENCIA MANE; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Myers RA, 1997, ECOL APPL, V7, P91, DOI 10.1890/1051-0761(1997)007[0091:WDFSCT]2.0.CO;2; Nellemann C., 2012, RAPID RESPONSE ASSES; Ostrom E, 1999, SCIENCE, V284, P278, DOI 10.1126/science.284.5412.278; PARROTTA JA, 1995, TREES TAPAJOS PHOTOG; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Pearce D, 2003, FOREST ECOL MANAG, V172, P229, DOI 10.1016/S0378-1127(01)00798-8; Pena-Claros M, 2008, FOREST ECOL MANAG, V256, P1458, DOI 10.1016/j.foreco.2007.11.013; PEREIRA D., 2010, FATOS FLORESTAIS AMA, V1; Peres CA, 2003, SCIENCE, V302, P2112, DOI 10.1126/science.1091698; Peres CA, 2012, BIOL CONSERV, V151, P65, DOI 10.1016/j.biocon.2011.11.011; Peres CA, 2010, CONSERVATION BIOLOGY FOR ALL, P107; Perez MR, 2005, FOREST ECOL MANAG, V214, P221, DOI 10.1016/j.foreco.2005.04.020; Phillips PD, 2004, ECOL MODEL, V173, P335, DOI 10.1016/j.ecolmodel.2003.09.023; Pielou E. C., 1975, ECOLOGICAL DIVERSITY; Plumptre AJ, 1996, FOREST ECOL MANAG, V89, P101, DOI 10.1016/S0378-1127(96)03854-6; Potapov P, 2008, ECOL SOC, V13, DOI 10.5751/es-02670-130251; Putz FE, 2008, FOREST ECOL MANAG, V256, P1427, DOI 10.1016/j.foreco.2008.03.036; REPETTO R, 1988, PUBLIC POLICIES MISU; Ribeiro J.E.L. da S., 1999, FLORA RESERVA DUCKE, V1; Rice RE, 1997, SCI AM, V276, P44, DOI 10.1038/scientificamerican0497-44; RODAN BD, 1992, ENVIRON CONSERV, V19, P331, DOI 10.1017/S0376892900031453; Rodrigues ASL, 2009, SCIENCE, V324, P1435, DOI 10.1126/science.1174002; Romero C., 2015, CONTEXT NATURAL FORE; Schulze M, 2008, FOREST ECOL MANAG, V256, P1443, DOI 10.1016/j.foreco.2008.02.051; Servitho Florestal Brasileiro, 2013, FLOR BRAS RES 2013 D; SFB, 2013, PLAN AN OUT FLOR 201; Shearman P, 2012, BIOL CONSERV, DOI [10.1016/j.biocon.2011.10.036, DOI 10.1016/J.BIOCON.2011.10.]; Sist P, 2007, FOREST ECOL MANAG, V243, P199, DOI 10.1016/j.foreco.2007.02.014; Smith J, 2006, FOREST POLICY ECON, V8, P458, DOI 10.1016/j.forpol.2005.08.001; SMITH VL, 1968, AM ECON REV, V58, P409; Sorrell S, 2010, ENERG POLICY, V38, P5290, DOI 10.1016/j.enpol.2010.04.046; Southworth J, 2011, REMOTE SENS-BASEL, V3, P1047, DOI 10.3390/rs3051047; Souza CM, 2005, REMOTE SENS ENVIRON, V98, P329, DOI 10.1016/j.rse.2005.07.013; Souza Jr C, 1997, SERIE AMAZONIA, V8; Stone SW, 1998, WORLD DEV, V26, P433, DOI 10.1016/S0305-750X(97)10056-0; Tabarelli M, 2012, BIOL CONSERV, V155, P136, DOI 10.1016/j.biocon.2012.06.020; ter Steege H, 2013, SCIENCE, V342, P325, DOI 10.1126/science.1243092; UHL C, 1991, FOREST ECOL MANAG, V46, P243, DOI 10.1016/0378-1127(91)90235-N; Uhl C, 1997, BIOSCIENCE, V47, P160, DOI 10.2307/1313035; Verissimo A, 1998, CONSERV BIOL, V12, P128, DOI 10.1046/j.1523-1739.1998.96234.x; VERISSIMO A, 1995, FOREST ECOL MANAG, V72, P39, DOI 10.1016/0378-1127(94)03432-V; Wadsworth FH, 2006, FOREST ECOL MANAG, V233, P45, DOI 10.1016/j.foreco.2006.05.072; Weinhold D, 2015, GLOBAL ENVIRON CHANG, V35, P391, DOI 10.1016/j.gloenvcha.2015.09.013; Wilcove DS, 2013, TRENDS ECOL EVOL, V28, P531, DOI 10.1016/j.tree.2013.04.005; Winterhalder B, 2000, EVOL ANTHROPOL, V9, P51; Zarin DJ, 2007, CONSERV BIOL, V21, P916, DOI 10.1111/j.1523-1739.2007.00670.x; Zimmerman BL, 2012, BIOSCIENCE, V62, P479, DOI 10.1525/bio.2012.62.5.9; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	111	38	38	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159035	10.1371/journal.pone.0159035	http://dx.doi.org/10.1371/journal.pone.0159035			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ9CP	27410029	Green Published, Green Submitted, gold			2022-12-27	WOS:000379508300052
J	Siegling, AB; Petrides, KV				Siegling, Alex B.; Petrides, K. V.			Drive: Theory and Construct Validation	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; THEORETICAL FRAMEWORK; INTRINSIC MOTIVATION; PERSONALITY-TRAITS; SCALE; VALIDITY; MODEL; ISSUES; ALPHA; STEPS	This article explicates the theory of drive and describes the development and validation of two measures. A representative set of drive facets was derived from an extensive corpus of human attributes (Study 1). Operationalised using an International Personality Item Pool version (the Drive: IPIP), a three-factor model was extracted from the facets in two samples and confirmed on a third sample (Study 2). The multi-item IPIP measure showed congruence with a short form, based on single-item ratings of the facets, and both demonstrated cross-informant reliability. Evidence also supported the measures' convergent, discriminant, concurrent, and incremental validity (Study 3). Based on very promising findings, the authors hope to initiate a stream of research in what is argued to be a rather neglected niche of individual differences and non-cognitive assessment.	[Siegling, Alex B.; Petrides, K. V.] UCL, London Psychometr Lab, London, England	University of London; University College London	Petrides, KV (corresponding author), UCL, London Psychometr Lab, London, England.	k.petrides@ucl.ac.uk	Siegling, Alex/O-2327-2019	Siegling, Alex/0000-0003-2411-9826				Alexandrov Aliosha, 2010, Electronic Journal of Business Research Methods, V8, P1; American Psychiatric Association, 2013, DIAGNOSTIC AND STATI; Bernard LC, 2008, ASSESSMENT, V15, P16, DOI 10.1177/1073191107306131; Bernard LC, 2009, MOTIV EMOTION, V33, P303, DOI 10.1007/s11031-009-9131-7; BURISCH M, 1984, AM PSYCHOL, V39, P214, DOI 10.1037/0003-066X.39.3.214; Byrne B.M., 2010, STRUCTURAL EQUATION, DOI DOI 10.4324/9781410600219; Cattell RB, 1977, THE SCIENTIFIC ANALY; Chamorro-Premuzic T., 2007, PERSONALITY AND INDI; Clark LA, 1995, PSYCHOL ASSESSMENT, V7, P309, DOI 10.1037/1040-3590.7.3.309; Corr PJ, 2013, SOC PERSONAL PSYCHOL, V7, P158, DOI 10.1111/spc3.12016; CORTINA JM, 1993, J APPL PSYCHOL, V78, P98, DOI 10.1037/0021-9010.78.1.98; Costa PT, 2007, REVISED NEO PERSONAL; Denissen JJA, 2008, J RES PERS, V42, P1285, DOI 10.1016/j.jrp.2008.04.002; DISHMAN RK, 1980, J APPL SOC PSYCHOL, V10, P115, DOI 10.1111/j.1559-1816.1980.tb00697.x; DOLAN LJ, 1983, EDUC PSYCHOL MEAS, V43, P295, DOI 10.1177/001316448304300140; Duckworth AL, 2007, J PERS SOC PSYCHOL, V92, P1087, DOI 10.1037/0022-3514.92.6.1087; Duckworth AL, 2009, J PERS ASSESS, V91, P166, DOI 10.1080/00223890802634290; Elliot AJ, 1997, J PERS SOC PSYCHOL, V72, P218, DOI 10.1037/0022-3514.72.1.218; Fehnel SE, 2004, QUAL LIFE RES, V13, P1321, DOI 10.1023/B:QURE.0000037502.64077.4d; Field A., 2005, DISCOVERING STATISTI, DOI [10.1016/j.landurbplan.2008.06.008, DOI 10.1016/J.LANDURBPLAN.2008.06.008]; Gardner DG, 1998, EDUC PSYCHOL MEAS, V58, P898, DOI 10.1177/0013164498058006003; GILL DL, 1988, J SPORT EXERCISE PSY, V10, P139, DOI 10.1123/jsep.10.2.139; Goldberg LR, 2006, J RES PERS, V40, P84, DOI 10.1016/j.jrp.2005.08.007; Goldberg LR, 2002, PERS INDIV DIFFER, V32, P49, DOI 10.1016/S0191-8869(01)00005-8; Goldberg LR, 2008, THE EUGENE SPRINGFIE; Hogan J, 1996, MOTIVES VALUES PREFE; Hogan R., 2007, HOGAN PERSONALITY IN; Hooper D., 2008, EJBRM, V6, P53, DOI DOI 10.21427/D7CF7R; Hopwood CJ, 2010, PERS SOC PSYCHOL REV, V14, P332, DOI 10.1177/1088868310361240; Iacobucci D, 2010, J CONSUM PSYCHOL, V20, P90, DOI 10.1016/j.jcps.2009.09.003; Jackson DN, 1984, PERSONALITY RESEARCH; Johnson RE, 2011, J BUS PSYCHOL, V26, P241, DOI 10.1007/s10869-011-9238-1; Judge TA, 2002, J APPL PSYCHOL, V87, P797, DOI 10.1037//0021-9010.87.4.797; Kanfer R, 2000, APPL PSYCHOL-INT REV, V49, P470, DOI 10.1111/1464-0597.00026; Liem GAD, 2012, AUST PSYCHOL, V47, P3, DOI 10.1111/j.1742-9544.2011.00049.x; Loehlin JC, 1976, HEREDITY ENVIRONMENT; LOEVINGER J, 1957, PSYCHOL REP, V3, P635, DOI 10.2466/PR0.3.7.635-694; Loo R., 2002, J MANAGERIAL PSYCHOL, V17, P68, DOI [10.1108/02683940210415933, DOI 10.1108/02683940210415933]; Massey EK, 2008, DEV REV, V28, P421, DOI 10.1016/j.dr.2008.03.002; Mayer JD, 2007, MOTIV EMOTION, V31, P83, DOI 10.1007/s11031-007-9060-2; Murray H. A., 1943, THEMATIC APPERCEPTIO; Mussel P, 2013, J PERS SOC PSYCHOL, V104, P885, DOI 10.1037/a0031918; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Nygard R., 1973, SCAND J EDUC RES, V17, P39, DOI [10.1080/0031383730170104, DOI 10.1080/0031383730170104]; Paunonen SV, 2001, J PERS SOC PSYCHOL, V81, P524, DOI 10.1037/0022-3514.81.3.524; Pelletier LG, 1998, J APPL SOC PSYCHOL, V28, P437, DOI 10.1111/j.1559-1816.1998.tb01714.x; Petrides KV, 2007, BRIT J PSYCHOL, V98, P273, DOI 10.1348/000712606X120618; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reiss S, 1998, PSYCHOL ASSESSMENT, V10, P97, DOI 10.1037/1040-3590.10.2.97; Reiss S, 2004, REV GEN PSYCHOL, V8, P179, DOI 10.1037/1089-2680.8.3.179; Revelle W., 2011, WILEY BLACKWELL HDB, P1, DOI [10.1002/9781444343120.ch1, DOI 10.1002/9781444343120.CH1]; Revelle W, 2009, PSYCHOMETRIKA, V74, P145, DOI 10.1007/s11336-008-9102-z; Saucier G, 1998, J PERS, V66, P495, DOI 10.1111/1467-6494.00022; Schmidt F.L., 1992, CURRENT DIRECTIONS P, V1, P89, DOI [DOI 10.1111/1467-8721.EP10768758, 10.1111/1467-8721.ep10768758]; Schonbrodt FD, 2012, J RES PERS, V46, P725, DOI 10.1016/j.jrp.2012.08.010; Schweizer K, 2010, EUR J PSYCHOL ASSESS, V26, P1, DOI 10.1027/1015-5759/a000001; SEIFRIZ JJ, 1992, J SPORT EXERCISE PSY, V14, P375, DOI 10.1123/jsep.14.4.375; Simms L.J., 2007, HDB RES METHODS PERS, P240; Smith GT, 2005, PSYCHOL ASSESSMENT, V17, P396, DOI 10.1037/1040-3590.17.4.396; Stone LL, 2013, EUR J PSYCHOL ASSESS, V29, P44, DOI 10.1027/1015-5759/a000119; Tett RP, 2003, J APPL PSYCHOL, V88, P500, DOI 10.1037/0021-9010.88.3.500; VALLERAND RJ, 1992, EDUC PSYCHOL MEAS, V52, P1003, DOI 10.1177/0013164492052004025; Velicer WF, 1998, PSYCHOL METHODS, V3, P231, DOI 10.1037/1082-989X.3.2.231; Worthington RL, 2006, COUNS PSYCHOL, V34, P806, DOI 10.1177/0011000006288127; Ziegler M, 2014, EUR J PSYCHOL ASSESS, V30, P239, DOI 10.1027/1015-5759/a000228; Zuckerman M, 1999, PERS INDIV DIFFER, V26, P487, DOI 10.1016/S0191-8869(98)00161-5; ZUCKERMAN M, 1976, J PERS ASSESS, V40, P422, DOI 10.1207/s15327752jpa4004_12a	67	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0157295	10.1371/journal.pone.0157295	http://dx.doi.org/10.1371/journal.pone.0157295			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ9CP	27409773	Green Published, gold, Green Submitted			2022-12-27	WOS:000379508300007
J	Schrem, H; Schneider, V; Kurok, M; Goldis, A; Dreier, M; Kaltenborn, A; Gwinner, W; Barthold, M; Liebeneiner, J; Winny, M; Klempnauer, J; Kleine, M				Schrem, Harald; Schneider, Valentin; Kurok, Marlene; Goldis, Alon; Dreier, Maren; Kaltenborn, Alexander; Gwinner, Wilfried; Barthold, Marc; Liebeneiner, Jan; Winny, Markus; Klempnauer, Juergen; Kleine, Moritz			Independent Pre-Transplant Recipient Cancer Risk Factors after Kidney Transplantation and the Utility of G-Chart Analysis for Clinical Process Control	PLOS ONE			English	Article							DE-NOVO MALIGNANCIES; RENAL-TRANSPLANTATION; CENTER EXPERIENCE; ORGAN; TUMORS; PAPILLOMAVIRUS; SPECTRUM; DISEASE; COHORT	Background The aim of this study is to identify independent pre-transplant cancer risk factors after kidney transplantation and to assess the utility of G-chart analysis for clinical process control. This may contribute to the improvement of cancer surveillance processes in individual transplant centers. Patients and Methods 1655 patients after kidney transplantation at our institution with a total of 9,425 person-years of follow-up were compared retrospectively to the general German population using site-specific standardized-incidence-ratios (SIRs) of observed malignancies. Risk-adjusted multivariable Cox regression was used to identify independent pre-transplant cancer risk factors. G-chart analysis was applied to determine relevant differences in the frequency of cancer occurrences. Results Cancer incidence rates were almost three times higher as compared to the matched general population (SIR = 2.75; 95%-CI: 2.33-3.21). Significantly increased SIRs were observed for renal cell carcinoma (SIR = 22.46), post-transplant lymphoproliferative disorder (SIR = 8.36), prostate cancer (SIR = 2.22), bladder cancer (SIR = 3.24), thyroid cancer (SIR = 10.13) and melanoma (SIR = 3.08). Independent pre-transplant risk factors for cancer-free survival were age <52.3 years (p = 0.007, Hazard ratio (HR): 0.82), age >62.6 years (p = 0.001, HR: 1.29), polycystic kidney disease other than autosomal dominant polycystic kidney disease (ADPKD) (p = 0.001, HR: 0.68), high body mass index in kg/m(2) (p<0.001, HR: 1.04), ADPKD (p = 0.008, HR: 1.26) and diabetic nephropathy (p = 0.004, HR = 1.51). G-chart analysis identified relevant changes in the detection rates of cancer during aftercare with no significant relation to identified risk factors for cancer-free survival (p<0.05). Conclusions Risk-adapted cancer surveillance combined with prospective G-chart analysis likely improves cancer surveillance schemes by adapting processes to identified risk factors and by using G-chart alarm signals to trigger Kaizen events and audits for root-cause analysis of relevant detection rate changes. Further, comparative G-chart analysis would enable benchmarking of cancer surveillance processes between centers.	[Schrem, Harald; Winny, Markus; Klempnauer, Juergen; Kleine, Moritz] Hannover Med Sch, Gen Visceral & Transplant Surg, Hannover, Germany; [Schrem, Harald; Schneider, Valentin; Kurok, Marlene; Goldis, Alon; Kaltenborn, Alexander; Barthold, Marc; Liebeneiner, Jan; Kleine, Moritz] Hannover Med Sch, Integrated Res & Treatment Ctr Transplantat IFB T, Core Facil Qual Management & Hlth Technol Assessm, Hannover, Germany; [Kurok, Marlene] KRH Klinikum Nordstadt, Gynecol & Obstet, Hannover, Germany; [Goldis, Alon] Lean Six Sigma Black Belt, Amstelveen, Netherlands; [Dreier, Maren] Hannover Med Sch, Inst Epidemiol Social Med & Hlth Syst Res, Hannover, Germany; [Kaltenborn, Alexander] Fed Armed Forces Hosp Westerstede, Med Serv Fed Armed Forces, Trauma & Orthoped Surg, Westerstede, Germany; [Gwinner, Wilfried] Hannover Med Sch, Nephrol, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School	Schrem, H (corresponding author), Hannover Med Sch, Gen Visceral & Transplant Surg, Hannover, Germany.; Schrem, H (corresponding author), Hannover Med Sch, Integrated Res & Treatment Ctr Transplantat IFB T, Core Facil Qual Management & Hlth Technol Assessm, Hannover, Germany.	schrem.harald@mh-hannover.de			German Federal Ministry of Education and Research [01EO1302]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by a grant from the German Federal Ministry of Education and Research (reference number: 01EO1302) to authors HS and MB. The contributions provided by author AG who is also professionally affiliated with a commercial company have been funded within the framework of the same grant agreement with the German Federal Ministry of Education and Research in the context of a consultancy agreement on quality management methodology. The commercial affiliation of author AG and the funder of the grant support for this study did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.	Altaee IK, 2006, SAUDI J KIDNEY DIS T, V17, P408; Apel H, 2013, CLIN TRANSPLANT, V27, pE30, DOI 10.1111/ctr.12050; Baccarani U, 2006, TRANSPLANT P, V38, P1135, DOI 10.1016/j.transproceed.2006.02.016; Benneyan J C, 2001, Health Care Manag Sci, V4, P305, DOI 10.1023/A:1011846412909; Benneyan J C, 2001, Health Care Manag Sci, V4, P319, DOI 10.1023/A:1011806727354; Berger NA, 2014, ANN NY ACAD SCI, V1311, P57, DOI 10.1111/nyas.12416; Bichari W, 2009, TRANSPL P, V41, P672, DOI 10.1016/j.transproceed.2008.12.013; Birkeland S A, 1997, Ann Transplant, V2, P22; BIRKELAND SA, 1983, CANCER, V51, P1571, DOI 10.1002/1097-0142(19830501)51:9<1571::AID-CNCR2820510903>3.0.CO;2-S; Bosmans JL, 2007, KIDNEY INT, V71, P1197, DOI 10.1038/sj.ki.5002306; Brady PW, 2014, BMJ QUAL SAF, V23, P499, DOI 10.1136/bmjqs-2013-002179; Bretagnol A, 2010, TRANSPL INT, V23, P878, DOI 10.1111/j.1432-2277.2010.01070.x; Buysschaert M, 2013, DIABETES METAB SYND, V7, P247, DOI 10.1016/j.dsx.2013.08.001; Chiang YJ, 2004, TRANSPL P, V36, P2150, DOI 10.1016/j.transproceed.2004.08.013; Collett D, 2010, AM J TRANSPLANT, V10, P1889, DOI 10.1111/j.1600-6143.2010.03181.x; Debray D, 2009, TRANSPL P, V41, P674, DOI 10.1016/j.transproceed.2008.12.020; Engels EA, 2011, JAMA-J AM MED ASSOC, V306, P1891, DOI 10.1001/jama.2011.1592; GAYA SBM, 1995, TRANSPLANTATION, V59, P1705, DOI 10.1097/00007890-199506270-00011; Haberal AN, 2007, TRANSPL P, V39, P1057, DOI 10.1016/j.transproceed.2007.02.036; HARRISON J H, 1956, Surg Forum, V6, P432; Hosmer DW, 2008, APPL SURVIVAL ANAL R, P154; Hung YM, 2007, UROLOGY, V69, P1041, DOI 10.1016/j.urology.2007.02.046; Imao T, 2007, CANCER-AM CANCER SOC, V109, P2109, DOI 10.1002/cncr.22636; Knechtges P, 2014, J AM COLL RADIOL, V11, P1126, DOI 10.1016/j.jacr.2014.08.027; Langer RM, 2003, TRANSPL P, V35, P1396, DOI 10.1016/S0041-1345(03)00472-X; Lanza LL, 2009, CLIN TRANSPLANT, V23, P582, DOI 10.1111/j.1399-0012.2009.01061.x; Maglennon GA, 2014, J VIROL, V88, P710, DOI 10.1128/JVI.02589-13; Montagnino G, 1996, CLIN TRANSPLANT, V10, P461; Nocera A, 2000, EUR J CANCER, V36, P80, DOI 10.1016/S0959-8049(99)00234-8; Piselli P, 2013, EUR J CANCER, V49, P336, DOI 10.1016/j.ejca.2012.09.013; Popov Z, 2007, TRANSPL P, V39, P2589, DOI 10.1016/j.transproceed.2007.08.022; Rodriguez RM, 2010, FUTURE ONCOL, V6, P905, DOI [10.2217/fon.10.57, 10.2217/FON.10.57]; Rubin P, 2010, SEMIN RADIAT ONCOL, V20, P3, DOI 10.1016/j.semradonc.2009.08.001; Sampaio MS, 2012, TRANSPLANTATION, V94, P990, DOI 10.1097/TP.0b013e318270bc7b; Schrem H, 2013, LIVER TRANSPLANT, V19, P1252, DOI 10.1002/lt.23722; Shaaban A A, 1998, Saudi J Kidney Dis Transpl, V9, P116; Stallone G, 2003, G Ital Nefrol, V20, P611; SUZUKI S, 1994, TRANSPLANT P, V26, P938; Talbot D, 1999, INT SURG, V84, P291; Tillou X, 2012, AM J TRANSPLANT, V12, P3308, DOI 10.1111/j.1600-6143.2012.04248.x; Tjon ASW, 2010, LIVER TRANSPLANT, V16, P837, DOI 10.1002/lt.22064; Vajdic CM, 2006, JAMA-J AM MED ASSOC, V296, P2823, DOI 10.1001/jama.296.23.2823; Veroux M, 2004, TRANSPL P, V36, P718, DOI 10.1016/j.transproceed.2004.03.021; Viart L, 2013, AM J NEPHROL, V37, P91, DOI 10.1159/000346624; Wetmore JB, 2014, J AM SOC NEPHROL, V25, P2335, DOI 10.1681/ASN.2013101122; Wieland U, 2014, CURR PROBL DERMATOL, V45, P154, DOI 10.1159/000357907; Winkelhorst JT, 2001, EUR J SURG ONCOL, V27, P409, DOI 10.1053/ejso.2001.1119; Xie M, 2002, RELIAB ENG SYST SAFE, V77, P143, DOI 10.1016/S0951-8320(02)00041-8; Zavos G, 2003, TRANSPLANT P, V35, P1399, DOI 10.1016/S0041-1345(03)00518-9; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	50	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2016	11	7							e0158732	10.1371/journal.pone.0158732	http://dx.doi.org/10.1371/journal.pone.0158732			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CN	27398803	Green Published, gold, Green Submitted			2022-12-27	WOS:000379508100007
J	Ziegler, AS; Mcllroy, SJ; Larsen, P; Albertsen, M; Hansen, AA; Heinen, N; Nielsen, PH				Ziegler, Anja S.; Mcllroy, Simon J.; Larsen, Poul; Albertsen, Mads; Hansen, Aviaja A.; Heinen, Nicolas; Nielsen, Per Halkjaer			Dynamics of the Fouling Layer Microbial Community in a Membrane Bioreactor	PLOS ONE			English	Article							BIOLOGICAL PHOSPHORUS REMOVAL; MUNICIPAL WASTE-WATER; ACTIVATED-SLUDGE; FILAMENTOUS BACTERIA; NITRIFYING BACTERIA; CHLOROFLEXI; SEQUENCES; PLANTS; MBRS	Membrane fouling presents the greatest challenge to the application of membrane bioreactor (MBR) technology. Formation of biofilms on the membrane surface is the suggested cause, yet little is known of the composition or dynamics of the microbial community responsible. To gain an insight into this important question, we applied 16S rRNA gene amplicon sequencing with a curated taxonomy and fluorescent in situ hybridization to monitor the community of a pilot-scale MBR carrying out enhanced biological nitrogen and phosphorus removal with municipal wastewater. In order to track the dynamics of the fouling process, we concurrently investigated the communities of the biofilm, MBR bulk sludge, and the conventional activated sludge system used to seed the MBR system over several weeks from start-up. As the biofilm matured the initially abundant betaproteobacterial genera Limnohabitans, Hydrogenophaga and Malikia were succeeded by filamentous Chloroflexi and Gordonia as the abundant species. This study indicates that, although putative pioneer species appear, the biofilm became increasingly similar to the bulk community with time. This suggests that the microbial population in bulk water will largely determine the community structure of the mature biofilm.	[Ziegler, Anja S.; Mcllroy, Simon J.; Larsen, Poul; Albertsen, Mads; Hansen, Aviaja A.; Nielsen, Per Halkjaer] Aalborg Univ, Dept Chem & Biosci, Ctr Microbial Communities, Aalborg, Denmark; [Heinen, Nicolas] Alfa Laval Nakskov AS, Nakskov, Denmark	Aalborg University	Nielsen, PH (corresponding author), Aalborg Univ, Dept Chem & Biosci, Ctr Microbial Communities, Aalborg, Denmark.	phn@bio.aau.dk	Nielsen, Per Halkjær/T-6796-2018; McIlroy, Simon/P-4785-2017; Albertsen, Mads/T-7358-2018	Nielsen, Per Halkjær/0000-0002-6402-1877; McIlroy, Simon/0000-0003-3749-8730; Albertsen, Mads/0000-0002-6151-190X	Danish Research Council for Strategic Research	Danish Research Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	Alfa Laval Nakskov A/S provided the MBR system but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by Danish Research Council for Strategic Research (Receiver: PHN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2007, APPL ENVIRON MICROB, V73, P2257, DOI 10.1128/AEM.02080-06; Albertsen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132783; Bjornsson L, 2002, MICROBIOL-SGM, V148, P2309, DOI 10.1099/00221287-148-8-2309; Bugge TV, 2013, WATER RES, V47, P6719, DOI 10.1016/j.watres.2013.09.009; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Eikelboom D.H., 2000, PROCESS CONTROL ACTI; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Gao DW, 2013, WATER RES, V47, P6680, DOI 10.1016/j.watres.2013.09.007; Gao WJ, 2011, J MEMBRANE SCI, V374, P110, DOI 10.1016/j.memsci.2011.03.019; Gich F, 2001, ARCH MICROBIOL, V177, P1, DOI 10.1007/s00203-001-0354-6; Guo F, 2012, WATER RES, V46, P2772, DOI 10.1016/j.watres.2012.02.039; Jinhua P, 2006, SEP SCI TECHNOL, V41, P1527, DOI 10.1080/01496390600683571; Judd S, 2011, MBR BOOK: PRINCIPLES AND APPLICATIONS OF MEMBRANE BIOREACTORS FOR WATER AND WASTEWATER TREATMENT, 2ND EDITION, P1; Kindaichi T, 2004, APPL ENVIRON MICROB, V70, P1641, DOI 10.1128/AEM.70.3.1641-1650.2004; Kong YH, 2007, MICROBIOL-SGM, V153, P4061, DOI 10.1099/mic.0.2007/007245-0; Kragelund C, 2007, FEMS MICROBIOL ECOL, V59, P671, DOI 10.1111/j.1574-6941.2006.00251.x; Kragelund C, 2011, FEMS MICROBIOL ECOL, V76, P451, DOI 10.1111/j.1574-6941.2011.01065.x; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Larsen P, 2008, WATER RES, V42, P2814, DOI 10.1016/j.watres.2008.02.015; Le-Clech P, 2010, APPL MICROBIOL BIOT, V88, P1253, DOI 10.1007/s00253-010-2885-8; Ma JX, 2013, PROCESS BIOCHEM, V48, P510, DOI 10.1016/j.procbio.2013.02.003; McIlroy SJ, 2009, ANTON LEEUW INT J G, V96, P593, DOI 10.1007/s10482-009-9374-z; McIlroy SJ, 2016, ISME J, V10, P2223, DOI 10.1038/ismej.2016.14; McIlroy SJ, 2016, ENVIRON MICROBIOL, V18, P50, DOI 10.1111/1462-2920.12614; McIlroy SJ, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav062; Meng FG, 2006, J MEMBRANE SCI, V272, P161, DOI 10.1016/j.memsci.2005.07.041; Mielczarek AT, 2013, WATER RES, V47, P1529, DOI 10.1016/j.watres.2012.12.003; Miura Y, 2007, ENVIRON SCI TECHNOL, V41, P7787, DOI 10.1021/es071263x; Miura Y, 2007, ENVIRON SCI TECHNOL, V41, P632, DOI 10.1021/es0615371; Nielsen P.H., 2009, FISH HDB BIOL WASTEW; Nielsen PH, 2010, WATER RES, V44, P5070, DOI 10.1016/j.watres.2010.07.036; Okasanen J., 2013, VEGAN COMMUNITY ECOL; Poorasgari E, 2014, CHEMOSPHERE, V117, P144, DOI 10.1016/j.chemosphere.2014.06.006; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; R Core Team, 2013, R LANG ENV STAT COMP; Sanguin H, 2006, ENVIRON MICROBIOL, V8, P289, DOI 10.1111/j.1462-2920.2005.00895.x; Saunders AM, 2013, WATER SCI TECHNOL, V68, P366, DOI 10.2166/wst.2013.183; Saunders AM, 2016, ISME J, V10, P11, DOI 10.1038/ismej.2015.117; Speirs L, 2009, APPL ENVIRON MICROB, V75, P2446, DOI 10.1128/AEM.02310-08; Stoddard SF, 2015, NUCLEIC ACIDS RES, V43, pD593, DOI 10.1093/nar/gku1201; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang ZW, 2010, CHEM ENG J, V158, P608, DOI 10.1016/j.cej.2010.02.019; Wilen BM, 2008, WATER RES, V42, P2300, DOI 10.1016/j.watres.2007.12.013; Zhang K, 2006, ENVIRON MICROBIOL, V8, P433, DOI 10.1111/j.1462-2920.2005.00909.x	47	33	34	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2016	11	7							e0158811	10.1371/journal.pone.0158811	http://dx.doi.org/10.1371/journal.pone.0158811			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CN	27399199	Green Submitted, gold, Green Published			2022-12-27	WOS:000379508100010
J	Ayenew, HY				Ayenew, Habtamu Yesigat			Production Efficiency and Market Orientation in Food Crops in North West Ethiopia: Application of Matching Technique for Impact Assessment	PLOS ONE			English	Article							AGRICULTURAL EXTENSION	Introduction Agricultural technologies developed by national and international research institutions were not benefiting the rural population of Ethiopia to the extent desired. As a response, integrated agricultural extension approaches are proposed as a key strategy to transform the smallholder farming sector. Improving Productivity and Market Success (IPMS) of Ethiopian Farmers project is one of the development projects initiated by integrating productivity enhancement technological schemes with market development model. This paper explores the impact of the project intervention in the smallholder farmers' wellbeing. Methods To test the research hypothesis of whether the project brought a significant change in the input use, marketed surplus, efficiency and income of farm households, we use a cross-section data from 200 smallholder farmers in Northwest Ethiopia, collected through multi-stage sampling procedure. To control for self-selection from observable characteristics of the farm households, we employ Propensity Score Matching (PSM). We finally use Data Envelopment Analysis (DEA) techniques to estimate technical efficiency of farm households. Results The outcome of the research is in line with the premises that the participation of the household in the IPMS project improves purchased input use, marketed surplus, efficiency of farms and the overall gain from farming. The participant households on average employ more purchased agricultural inputs and gain higher gross margin from the production activities as compared to the non-participant households. The non-participant households on average supply less output (measured both in monetary terms and proportion of total produce) to the market as compared to their participant counterparts. Except for the technical efficiency of production in potato, project participant households are better-off in production efficiency compared with the non-participant counterparts. Conclusion We verified the idea that Improving Productivity and Market Success (IPMS) of Ethiopian farmers' project has contributed for the input and out market integration and/or market oriented agricultural production. Overall, we argue that these can be seen as an experimental model with a promising potential to improve the livelihood of the poor. Furthermore, we suggest that it is worthwhile to employ integrated agricultural extension programs with further targeting in the developing world.	[Ayenew, Habtamu Yesigat] Tech Univ Munich, Prod & Resource Econ, Freising Weihenstephan, Germany	Technical University of Munich	Ayenew, HY (corresponding author), Tech Univ Munich, Prod & Resource Econ, Freising Weihenstephan, Germany.	zebabilon@gmail.com			Improving Productivity and Market Success Project (IPMS_ILRI Ethiopia); Improving Productivity and Market Success (IPMS)-ILRI-Ethiopia project	Improving Productivity and Market Success Project (IPMS_ILRI Ethiopia); Improving Productivity and Market Success (IPMS)-ILRI-Ethiopia project	The study was funded by the Improving Productivity and Market Success Project (IPMS_ILRI Ethiopia).; The author acknowledges the financial support from Improving Productivity and Market Success (IPMS)-ILRI-Ethiopia project for the financial support for the study. The paper benefits from the critical comments and suggestions of the anonymous reviewers and editor of this journal.	Abebaw D, 2013, FOOD POLICY, V38, P82, DOI 10.1016/j.foodpol.2012.10.003; [Anonymous], 2000, MOFED ACC SUST DEV E, P15; Aynsau A, 2007, ECOL ECON, V61, P294, DOI 10.1016/j.ecolecon.2006.01.014; Benin S., 2003, 25 INT C AGR EC DURB; Berhanu G., 2006, COMMERCIALIZATION ET, P36; Botes L., 2000, Community Development Journal, V35, P41, DOI 10.1093/cdj/35.1.41; Bryson A., 2002, LSE RES ONLINE DOCUM; Caeyers B, 2012, ECON DEV CULT CHANGE, V60, P639, DOI 10.1086/665602; Caliendo M, 2008, J ECON SURV, V22, P31, DOI 10.1111/j.1467-6419.2007.00527.x; CHARNES A, 1978, EUR J OPER RES, V2, P429, DOI 10.1016/0377-2217(78)90138-8; Coelli T., 2002, DEAP V 2 1 DATA ENVE, V2; Coelli T. J., 2005, MEDICINE; Dehejia RH, 2002, REV ECON STAT, V84, P151, DOI 10.1162/003465302317331982; Demese C., 2006, 8 ANN C AGR EC SOC E, P9; Dercon S, 2009, AM J AGR ECON, V91, P1007, DOI 10.1111/j.1467-8276.2009.01325.x; EPRDF, 2001, RUR DEV STRAT ETH, P15; Faltermeier L, 2009, AGR ECON-BLACKWELL, V40, P365, DOI 10.1111/j.1574-0862.2009.00383.x; Gezahegn A., 2006, PRODUCTIVITY EFFICIE; Gibson MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048708; Haji J, 2007, J AFR ECON, V16, P1, DOI 10.1093/jae/ejl044; Hasan M.F., 2013, IMPACTS AGR EXTENSIO, P33; IPMS Bure Woreda Diagnosis and Design Program, 2007, IPMS IMPR PROD MARK; IPMS IPMS-Ethiopia Information Resources Portal, 2006, ETH INF RES PORT; Jalan J., 1999, POLICY RES WORKING P; Jennifer L., 2007, FUTURE AGR PRINTING; Kebede Y., 1990, Agricultural Economics, V4, P27, DOI 10.1016/0169-5150(90)90018-V; Kidanemariam G., 2013, BIOECONOMICS WORKING, P33; King G, 2016, WHY PROPENSITY SCORE; Kydd J., 2003, DEV STUD ASS ANN C S; Lokshin M, 2004, STATA J, V4, P282, DOI 10.1177/1536867X0400400306; Mengistu H, 2000, FOOD CHAIN SUBSAHARA; Moti J., 2009, SMALLHOLDER COMMERCI, P55; Nannicini T., 2006, SENSATT SIMULATION B; Owens T, 2003, ECON DEV CULT CHANGE, V51, P337, DOI 10.1086/346113; Pedro C., 2008, IMPACT AGR EXTENSION, P54; ROSENBAUM PR, 1983, J ROY STAT SOC B MET, V45, P212; Smith HL, 1997, SOCIOL METHODOL, V27, P325, DOI 10.1111/1467-9531.271030; Smith JA, 2005, J ECONOMETRICS, V125, P305, DOI 10.1016/j.jeconom.2004.04.011; Takemura K., 2014, PLOS ONE, V9; Teklewold H, 2013, J AGR ECON, V64, P597, DOI 10.1111/1477-9552.12011	40	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158454	10.1371/journal.pone.0158454	http://dx.doi.org/10.1371/journal.pone.0158454			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27391961	Green Submitted, Green Published, gold			2022-12-27	WOS:000380005400062
J	De Silva, JR; Lau, YL; Fong, MY				De Silva, Jeremy Ryan; Lau, Yee-Ling; Fong, Mun-Yik			Expression and Evaluation of Recombinant Plasmodium knowlesi Merozoite Surface Protein-3 (MSP-3) for Detection of Human Malaria	PLOS ONE			English	Article							VIVAX; FALCIPARUM; IMMUNOGENICITY; INFECTIONS; REACTIVITY; FEATURES; PEPTIDE; VACCINE; SAFETY; ELISA	Malaria remains a major health threat in many parts of the globe and causes high mortality and morbidity with 214 million cases of malaria occurring globally in 2015. Recent studies have outlined potential diagnostic markers and vaccine candidates one of which is the merozoite surface protein (MSP)-3. In this study, novel recombinant Plasmodium knowlesi MSP-3 was cloned, expressed and purified in an Escherichia coli system. Subsequently, the recombinant protein was evaluated for its sensitivity and specificity. The recombinant pkMSP-3 protein reacted with sera from patients with P. knowlesi infection in both Western blot (61%) and ELISA (100%). Specificity-wise, pkMSP-3 did not react with healthy donor sera in either assay and only reacted with a few non-malarial parasitic patient sera in the ELISA assay (3 of 49). In conclusion, sensitivity and specificity of pkMSP-3 was found to be high in the ELISA and Western Blot assay and thus utilising both assays in tandem would provide the best sero-diagnostic result for P. knowlesi infection.	[De Silva, Jeremy Ryan; Lau, Yee-Ling; Fong, Mun-Yik] Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur 50603, Malaysia; [Lau, Yee-Ling; Fong, Mun-Yik] Univ Malaya, Fac Med, Trop Dis Res & Educ Ctr, Kuala Lumpur 50603, Malaysia	Universiti Malaya; Universiti Malaya	Lau, YL (corresponding author), Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur 50603, Malaysia.; Lau, YL (corresponding author), Univ Malaya, Fac Med, Trop Dis Res & Educ Ctr, Kuala Lumpur 50603, Malaysia.	lauyeeling@um.edu.my	FONG, MUN YIK/B-5443-2010; de Silva, Jeremy Ryan/P-5565-2017; Lau, Yee Ling/C-6996-2009; Singh, Balbir/A-3610-2009	de Silva, Jeremy Ryan/0000-0001-9378-3830; Lau, Yee Ling/0000-0002-2037-2165; 	University of Malaya High Impact Research Fund, UMMOHE [E000050: UM.C/HIR/MOHE/MED/16]	University of Malaya High Impact Research Fund, UMMOHE	This study was funded by the University of Malaya High Impact Research Fund, UMMOHE (E000050: UM.C/HIR/MOHE/MED/16). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz C, 1990, J Vet Diagn Invest, V2, P191; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Chao CC, 2008, CLIN VACCINE IMMUNOL, V15, P684, DOI 10.1128/CVI.00281-07; Cheong FW, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-454; Cheong FW, 2013, AM J TROP MED HYG, V88, P835, DOI 10.4269/ajtmh.12-0250; Cox-Singh J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-269; Daneshvar C, 2009, CLIN INFECT DIS, V49, P852, DOI 10.1086/605439; DIGGS CL, 1965, EXP PARASITOL, V16, P217, DOI 10.1016/0014-4894(65)90046-9; Galinski MR, 1999, MOL BIOCHEM PARASIT, V101, P131, DOI 10.1016/S0166-6851(99)00063-8; GONNET GH, 1994, BIOCHEM BIOPH RES CO, V199, P489, DOI 10.1006/bbrc.1994.1255; Imwong M, 2009, J CLIN MICROBIOL, V47, P4173, DOI 10.1128/JCM.00811-09; Jiang N, 2010, EMERG INFECT DIS, V16, P1476, DOI 10.3201/eid1609.100339; Jimenez MCS, 2008, BBA-GEN SUBJECTS, V1780, P983, DOI 10.1016/j.bbagen.2008.03.016; Jongwutiwes S, 2004, EMERG INFECT DIS, V10, P2211, DOI 10.3201/eid1012.040293; KAMBOJ KK, 1988, J PARASITOL, V74, P403, DOI 10.2307/3282046; Lajmi AR, 2000, PROTEIN EXPRES PURIF, V18, P394, DOI 10.1006/prep.2000.1209; Lau YL, 2014, TROP BIOMED, V31, P749; Lee KS, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-73; Lee WC, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-88; LOPEZLONGO FJ, 1994, J RHEUMATOL, V21, P1450; Luchavez J, 2008, EMERG INFECT DIS, V14, P811, DOI 10.3201/eid1405.071407; Marchand RP, 2011, EMERG INFECT DIS, V17, P1232, DOI 10.3201/eid1707.101551; MCCOLL DJ, 1994, MOL BIOCHEM PARASIT, V68, P53, DOI 10.1016/0166-6851(94)00149-9; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Ng OT, 2008, EMERG INFECT DIS, V14, P814, DOI 10.3201/eid1405.070863; OEUVRAY C, 1994, MEM I OSWALDO CRUZ, V89, P77, DOI 10.1590/S0074-02761994000600018; Palaeya V, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-182; Parodi A, 1998, BRIT J DERMATOL, V138, P114; Rayner JC, 2004, INFECT GENET EVOL, V4, P309, DOI 10.1016/j.meegid.2004.03.003; Rice BL, 2014, MOL PHYLOGENET EVOL, V78, P172, DOI 10.1016/j.ympev.2014.05.013; Rogl H, 1998, FEBS LETT, V432, P21, DOI 10.1016/S0014-5793(98)00825-4; Singh B, 2004, LANCET, V363, P1017, DOI 10.1016/S0140-6736(04)15836-4; Sirima SB, 2007, VACCINE, V25, P2723, DOI 10.1016/j.vaccine.2006.05.090; Sirima SB, 2011, NEW ENGL J MED, V365, P1062, DOI 10.1056/NEJMc1100670; Sirima SB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007549; Son Eui-Sun, 2001, Korean Journal of Parasitology, V39, P171, DOI 10.3347/kjp.2001.39.2.171; Sonaimuthu P, 2015, EXP PARASITOL, V153, P118, DOI 10.1016/j.exppara.2015.03.010; SUCHANKOVA A, 1991, J GEN VIROL, V72, P2577, DOI 10.1099/0022-1317-72-10-2577; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wipasa J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000770; YANG CF, 1994, AM J TROP MED HYG, V51, P365, DOI 10.4269/ajtmh.1994.51.365	41	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158998	10.1371/journal.pone.0158998	http://dx.doi.org/10.1371/journal.pone.0158998			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391270	Green Submitted, gold, Green Published			2022-12-27	WOS:000380005400185
J	Fonagy, P; Luyten, P; Moulton-Perkins, A; Lee, YW; Warren, F; Howard, S; Ghinai, R; Fearon, P; Lowyck, B				Fonagy, Peter; Luyten, Patrick; Moulton-Perkins, Alesia; Lee, Ya-Wen; Warren, Fiona; Howard, Susan; Ghinai, Rosanna; Fearon, Pasco; Lowyck, Benedicte			Development and Validation of a Self-Report Measure of Mentalizing: The Reflective Functioning Questionnaire	PLOS ONE			English	Article							BORDERLINE PERSONALITY-DISORDER; GENERAL PSYCHOPATHOLOGY FACTOR; CONFIRMATORY FACTOR-ANALYSIS; RANDOMIZED CONTROLLED-TRIAL; ANOREXIA-NERVOSA; ATTACHMENT SECURITY; INFANT ATTACHMENT; EATING-DISORDERS; MIND-MINDEDNESS; INVENTORY	Reflective functioning or mentalizing is the capacity to interpret both the self and others in terms of internal mental states such as feelings, wishes, goals, desires, and attitudes. This paper is part of a series of papers outlining the development and psychometric features of a new self-report measure, the Reflective Functioning Questionnaire (RFQ), designed to provide an easy to administer self-report measure of mentalizing. We describe the development and initial validation of the RFQ in three studies. Study 1 focuses on the development of the RFQ, its factor structure and construct validity in a sample of patients with Borderline Personality Disorder (BPD) and Eating Disorder (ED) (n = 108) and normal controls (n = 295). Study 2 aims to replicate these findings in a fresh sample of 129 patients with personality disorder and 281 normal controls. Study 3 addresses the relationship between the RFQ, parental reflective functioning and infant attachment status as assessed with the Strange Situation Procedure (SSP) in a sample of 136 community mothers and their infants. In both Study 1 and 2, confirmatory factor analyses yielded two factors assessing Certainty (RFQ_C) and Uncertainty (RFQ_U) about the mental states of self and others. These two factors were relatively distinct, invariant across clinical and non-clinical samples, had satisfactory internal consistency and test-retest stability, and were largely unrelated to demographic features. The scales discriminated between patients and controls, and were significantly and in theoretically predicted ways correlated with measures of empathy, mindfulness and perspective-taking, and with both self-reported and clinician-reported measures of borderline personality features and other indices of maladaptive personality functioning. Furthermore, the RFQ scales were associated with levels of parental reflective functioning, which in turn predicted infant attachment status in the SSP. Overall, this study lends preliminary support for the RFQ as a screening measure of reflective functioning. Further research is needed, however, to investigate in more detail the psychometric qualities of the RFQ.	[Fonagy, Peter; Luyten, Patrick; Lee, Ya-Wen; Ghinai, Rosanna; Fearon, Pasco] UCL, Res Dept Clin Educ & Hlth Psychol, London, England; [Luyten, Patrick] Katholieke Univ Leuven, Fac Psychol & Educ Sci, Leuven, Belgium; [Moulton-Perkins, Alesia] Sussex Partnership NHS Fdn Trust, Educ & Training Dept, Worthing, England; [Howard, Susan] Univ Surrey, Dept Psychol, Guildford, Surrey, England; [Lowyck, Benedicte] Katholieke Univ Leuven, Fac Med, Leuven, Belgium	University of London; University College London; KU Leuven; University of Surrey; KU Leuven	Fonagy, P (corresponding author), UCL, Res Dept Clin Educ & Hlth Psychol, London, England.	p.fonagy@ucl.ac.uk		Fearon, Richard/0000-0003-1847-8443; Fonagy, Peter/0000-0003-0229-0091	National Institute for Health Research [NF-SI-0514-10157] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Ainsworth M.D.S., 1978, PATTERNS ATTACHMENT, DOI DOI 10.4324/9780203758045; ALDEN LE, 1990, J PERS ASSESS, V55, P521, DOI 10.1207/s15327752jpa5503&4_10; Allen J.G., 2008, MENTALIZING CLIN PRA; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; [Anonymous], 2006, HDB MENTALIZATION BA, DOI DOI 10.1002/9780470712986.CH10; Arbuckle MH., 1999, AMOS STRUCTURAL EQUA; Arnott B, 2007, B MENNINGER CLIN, V71, P132, DOI 10.1521/bumc.2007.71.2.132; Badoud D, 2016, ATTACHMENT REF UNPUB; Badoud D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145892; Bateman A, 2004, PSYCHOTHERAPY BORDER, DOI 10.1093/med:psych/9780198527664.001.0001; Bateman A, 2008, J CLIN PSYCHOL, V64, P181, DOI 10.1002/jclp.20451; Bateman A, 2009, AM J PSYCHIAT, V166, P1355, DOI 10.1176/appi.ajp.2009.09040539; Beck AT., 1996, MANUAL BECK DEPRESSI; Bernier A, 2010, CHILD DEV, V81, P326, DOI 10.1111/j.1467-8624.2009.01397.x; Bers SA, 2013, PSYCHOANAL PSYCHOL, V30, P188, DOI 10.1037/a0032512; Bollen KA, 1989, STRUCTURAL EQUATIONS; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; Brown T.A., 2015, CONFIRMATORY FACTOR, DOI DOI 10.19030/AJBE.V6I3.7818; Byrne B.M., 2010, STRUCTURAL EQUATION, DOI DOI 10.4324/9781410600219; Caligor E., 2010, PSYCHODYNAMIC PSYCHO, P3; Caspi A, 2014, CLIN PSYCHOL SCI, V2, P119, DOI 10.1177/2167702613497473; Choi-Kain LW, 2008, AM J PSYCHIAT, V165, P1127, DOI 10.1176/appi.ajp.2008.07081360; Claes L, 2005, ADV PSY RES, V36, P183; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; der Ploeg H Van, 1982, MANUAL SELF REPORT A; Ensink K, 2015, BRIT J DEV PSYCHOL, V33, P203, DOI 10.1111/bjdp.12074; Ensink K, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01471; Ensink K, 2010, PSYCHOANAL INQ, V30, P301, DOI 10.1080/07351690903206504; Evans CDH, 1998, EUR EAT DISORD REV, V6, P48, DOI 10.1002/(SICI)1099-0968(199803)6:1<48::AID-ERV230>3.0.CO;2-9; Fearon RMP, 2006, DEV PSYCHOL, V42, P1026, DOI 10.1037/0012-1649.42.6.1026; First M.B., 1996, STRUCTURED CLIN INTE, DOI DOI 10.1037/T07827-000; First M. B., 1997, STRUCTURED CLIN INTE; Flora DB, 2004, PSYCHOL METHODS, V9, P466, DOI 10.1037/1082-989X.9.4.466; FONAGY P, 1991, INT J PSYCHOANAL, V72, P639; FONAGY P, 1991, CHILD DEV, V62, P891, DOI 10.1111/j.1467-8624.1991.tb01578.x; FONAGY P, 1991, INFANT MENT HEALTH J, V12, P201, DOI 10.1002/1097-0355(199123)12:3<201::AID-IMHJ2280120307>3.0.CO;2-7; Fonagy P., 2016, DEV PSYCHOPATHOL, P1, DOI [10.1002/9781119125556.devpsy317, DOI 10.1002/9781119125556.DEVPSY317]; Fonagy P., 1998, REFLECTIVE FUNCTIONI; Fonagy P., 1989, B A FREUD CTR, V12, P91; Fonagy P., 2002, AFFECT REGULATION ME; Fonagy P., 2010, PSYCHODYNAMIC PSYCHO, P37; Fonagy P, 2008, J PERS DISORD, V22, P4, DOI 10.1521/pedi.2008.22.1.4; Fonagy P, 2007, J CHILD PSYCHOL PSYC, V48, P288, DOI 10.1111/j.1469-7610.2007.01727.x; Fonagy P, 2009, DEV PSYCHOPATHOL, V21, P1355, DOI 10.1017/S0954579409990198; Fonagy P, 2009, J CHILD PSYCHOL PSYC, V50, P607, DOI 10.1111/j.1469-7610.2008.02025.x; GARNER DM, 1982, PSYCHOL MED, V12, P871, DOI 10.1017/S0033291700049163; Goodkind M, 2015, JAMA PSYCHIAT, V72, P305, DOI 10.1001/jamapsychiatry.2014.2206; Grienenberger J, 2005, ATTACH HUM DEV, V7, P299, DOI 10.1080/14616730500245963; Gunderson JG, 2008, J PERS DISORD, V22, P22, DOI 10.1521/pedi.2008.22.1.22; Ha C, 2013, J ADOLESCENCE, V36, P1215, DOI 10.1016/j.adolescence.2013.09.008; Ha C, 2011, EUR CHILD ADOLES PSY, V20, P291, DOI 10.1007/s00787-011-0174-4; Hermida R., 2015, COMPUT METHODS SOC S, V3, P5; Heyes CM, 2014, SCIENCE, V344, P1356, DOI 10.1126/science.1243091; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jolliffe D, 2006, J ADOLESCENCE, V29, P589, DOI 10.1016/j.adolescence.2005.08.010; Kalpakci A., 2015, J PERSONALITY DISORD, V29, P192, DOI DOI 10.1521/PEDI_; Kernberg O., 1984, SEVERE PERSONALITY D; Kline R.B., 2005, PRINCIPLES PRACTICE, V2, DOI DOI 10.1038/156278A0; Kuipers GS, 2012, CURR PSYCHIATRY REV, V8, P326, DOI 10.2174/157340012803520478; Lahey BB, 2012, J ABNORM PSYCHOL, V121, P971, DOI 10.1037/a0028355; Lahey BB, 2011, ARCH GEN PSYCHIAT, V68, P181, DOI 10.1001/archgenpsychiatry.2010.192; Lange A, 2007, MANUAL BRIEF SYMPTOM; Leckman JF, 2007, DEV SCI PSYCHOANALYS, P89; Leichsenring F, 1999, J PERS ASSESS, V73, P45, DOI 10.1207/S15327752JPA730104; Lemma A., 2011, BRIEF DYNAMIC INTERP; Lemma A, 2011, PSYCHIATRY, V74, P41, DOI 10.1521/psyc.2011.74.1.41; Lenzenweger MF, 2001, PSYCHOL ASSESSMENT, V13, P577, DOI 10.1037//1040-3590.13.4.577; Levy KN, 2011, CURR PSYCHIAT REP, V13, P50, DOI 10.1007/s11920-010-0169-8; Li CH, 2016, BEHAV RES METHODS, V48, P936, DOI 10.3758/s13428-015-0619-7; Lieberman MD, 2007, ANNU REV PSYCHOL, V58, P259, DOI 10.1146/annurev.psych.58.110405.085654; Linehan M. M., 1993, COGNITIVE BEHAV TREA; Luyten P., 2012, HDB MENTALIZING MENT, P385; Luyten P, 2012, HDB MENTALIZING MENT, P43; Luyten P, 2014, BORDERLINE PERSONALI, P223; Luyten P, 2016, PARENTAL REFLECT UNP; Main M, 1994, ADULT ATTACHMENT RAT; Meins E, 2002, CHILD DEV, V73, P1715, DOI 10.1111/1467-8624.00501; Meins E, 2001, J CHILD PSYCHOL PSYC, V42, P637, DOI 10.1111/1469-7610.00759; Meins E, 2012, INFANCY, V17, P393, DOI 10.1111/j.1532-7078.2011.00087.x; Nosek BA, 2011, TRENDS COGN SCI, V15, P152, DOI 10.1016/j.tics.2011.01.005; Holgado-Tello FP, 2010, QUAL QUANT, V44, P153, DOI 10.1007/s11135-008-9190-y; Patalay P, 2015, BRIT J PSYCHIAT, V207, P15, DOI 10.1192/bjp.bp.114.149591; Pedersen SH, 2012, EUR EAT DISORD REV, V20, P303, DOI 10.1002/erv.2158; Preissler S, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00182; Ritter K, 2011, PSYCHIAT RES, V187, P241, DOI 10.1016/j.psychres.2010.09.013; Robinson P, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-51; Roefs A, 2011, PSYCHOL BULL, V137, P149, DOI 10.1037/a0021729; Rutherford HJV, 2015, INFANT BEHAV DEV, V40, P54, DOI 10.1016/j.infbeh.2015.04.005; RYFF CD, 1989, J PERS SOC PSYCHOL, V57, P1069, DOI 10.1037/0022-3514.57.6.1069; Sadler L. S., 2006, HDB MENTALIZATION BA, P271, DOI DOI 10.1002/9780470712986.CH14; Sansone RA, 1998, J CLIN PSYCHOL, V54, P973, DOI 10.1002/(SICI)1097-4679(199811)54:7<973::AID-JCLP11>3.0.CO;2-H; Sharp C, 2008, SOC DEV, V17, P737, DOI 10.1111/j.1467-9507.2007.00457.x; Sharp C, 2013, J PERS DISORD, V27, P3, DOI 10.1521/pedi.2013.27.1.3; Sharp C, 2011, J AM ACAD CHILD PSY, V50, P563, DOI 10.1016/j.jaac.2011.01.017; Skarderud F, 2007, EUR EAT DISORD REV, V15, P323, DOI 10.1002/erv.817; Skarderud F, 2007, EUR EAT DISORD REV, V15, P243, DOI 10.1002/erv.778; Skarderud F, 2007, EUR EAT DISORD REV, V15, P163, DOI 10.1002/erv.777; Skodol AE, 2005, PSYCHOL MED, V35, P443, DOI 10.1017/S003329170400354X; Skodol AE, 2002, AM J PSYCHIAT, V159, P276, DOI 10.1176/appi.ajp.159.2.276; SkuDrderud F., 2012, HDB MENTALIZING MENT, V26, P347; Slade A, 2005, ATTACH HUM DEV, V7, P269, DOI 10.1080/14616730500245906; Slade A, 2007, ADDENDUM REFLECTIVE; Slade A., 2004, THESIS CITY U NEW YO; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Steele M, 2008, MIND MIND INFANT RES, P115, DOI DOI 10.1080/14616734.2010.501988; Suchman NE, 2011, INFANT MENT HEALTH J, V32, P427, DOI 10.1002/imhj.20303; Taubner S, 2013, PSYCHOL ASSESSMENT, V25, P127, DOI 10.1037/a0029138; Twemlow SW, 2001, AM J PSYCHIAT, V158, P808, DOI 10.1176/appi.ajp.158.5.808; van Dierendonck D, 2004, PERS INDIV DIFFER, V36, P629, DOI 10.1016/S0191-8869(03)00122-3; WESTEN D, 1992, J PERS DISORD, V6, P382, DOI 10.1521/pedi.1992.6.4.382; Zanarini MC, 2003, J PERS DISORD, V17, P233, DOI 10.1521/pedi.17.3.233.22147; Zimmerman M, 2004, J CLIN PSYCHOL, V60, P87, DOI 10.1002/jclp.10207	112	240	244	8	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158678	10.1371/journal.pone.0158678	http://dx.doi.org/10.1371/journal.pone.0158678			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27392018	gold, Green Submitted, Green Published			2022-12-27	WOS:000380005400101
J	Fuchs, A; Zimmermann, L; Graz, MB; Cherpillod, J; Tolsa, JF; Buclin, T; Giannoni, E				Fuchs, Aline; Zimmermann, Lara; Graz, Myriam Bickle; Cherpillod, Jacques; Tolsa, Jean-Francois; Buclin, Thierry; Giannoni, Eric			Gentamicin Exposure and Sensorineural Hearing Loss in Preterm Infants	PLOS ONE			English	Article							PERINATAL RISK-FACTORS; SWISS NATIONAL COHORT; BIRTH-WEIGHT INFANTS; OTOTOXICITY; IMPAIRMENT; PREVALENCE; AGE; AMINOGLYCOSIDES; MUTATIONS; PREMATURE	Objective To evaluate the impact of gentamicin exposure on sensorineural hearing loss (SNHL) in very low birth weight (VLBW) infants. Methods Exposure to gentamicin was determined in infants born between 1993 and 2010 at a gestational age < 32 weeks and/or with a birthweight < 1500 g, who presented with SNHL during the first 5 years of life. For each case, we selected two controls matched for gender, gestational age, birthweight, and year of birth. Results We identified 25 infants affected by SNHL, leading to an incidence of SNHL of 1.58% in our population of VLBW infants. The proportion of infants treated with gentamicin was 76% in the study group and 70% in controls (p = 0.78). The total cumulated dose of gentamicin administered did not differ between the study group (median 10.2 mg/kg, Q1-Q3 1.6-13.2) and the control group (median 7.9 mg/kg, Q1-Q3 0-12.8, p = 0.47). The median duration of gentamicin treatment was 3 days both in the study group and the control group (p = 0.58). Maximum predicted trough serum levels of gentamicin, cumulative area under the curve and gentamicin clearance were not different between cases and controls. Conclusion The impact of gentamicin on SNHL can be minimized with treatments of short duration, monitoring of blood levels and dose adjustment.	[Fuchs, Aline; Buclin, Thierry] Univ Lausanne Hosp, Dept Labs, Serv Biomed, Div Clin Pharmacol, Lausanne, Switzerland; [Zimmermann, Lara; Graz, Myriam Bickle; Tolsa, Jean-Francois; Giannoni, Eric] Univ Lausanne Hosp, Clin Neonatol, Lausanne, Switzerland; [Cherpillod, Jacques] Univ Lausanne Hosp, Clin Otorhinolaryngol & Head & Neck Surg, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Giannoni, E (corresponding author), Univ Lausanne Hosp, Clin Neonatol, Lausanne, Switzerland.	Eric.Giannoni@chuv.ch	Graz, Myriam Bickle/AAI-8796-2020; Buclin, Thierry/P-1640-2014	Graz, Myriam Bickle/0000-0003-2733-3588; Buclin, Thierry/0000-0003-0639-5536; Giannoni, Eric/0000-0003-0897-6529				Aust G, 2001, Int Tinnitus J, V7, P27; BERNARD PA, 1981, LARYNGOSCOPE, V91, P1985; Bitner-Glindzicz M, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-66; Boghossian NS, 2013, J PEDIATR-US, V162, P1120, DOI 10.1016/j.jpeds.2012.11.089; Borradori C, 1997, BIOL NEONATE, V71, P1; BROWN DR, 1991, DEV MED CHILD NEUROL, V33, P816; Busa J, 2007, PEDIATRICS, V120, P898, DOI 10.1542/peds.2007-2333; Carlo WA, 2011, JAMA-J AM MED ASSOC, V306, P2348, DOI 10.1001/jama.2011.1752; Cristobal R, 2008, ARCH DIS CHILD-FETAL, V93, P1462, DOI 10.1136/adc.2007.124214; Davis NM, 2001, DEV MED CHILD NEUROL, V43, P191, DOI 10.1017/S0012162201000366; DEVRIES LS, 1985, PEDIATRICS, V76, P351; Ealy M, 2011, LARYNGOSCOPE, V121, P1184, DOI 10.1002/lary.21778; El-barbary MN, 2015, INT J PEDIATR OTORHI, V79, P1294, DOI 10.1016/j.ijporl.2015.05.036; Ertl T, 2001, BIOL NEONATE, V79, P109, DOI 10.1159/000047076; Fjalstad JW, 2014, EUR J PEDIATR, V173, P489, DOI 10.1007/s00431-013-2194-1; Fligor BJ, 2005, PEDIATRICS, V115, P1519, DOI 10.1542/peds.2004-0247; Fuchs A, 2014, BRIT J CLIN PHARMACO, V78, P1090, DOI 10.1111/bcp.12444; Gopel W, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-210; HALPERN J, 1987, EAR HEARING, V8, P21, DOI 10.1097/00003446-198702000-00004; Hess M, 1998, INT J PEDIATR OTORHI, V46, P81, DOI 10.1016/S0165-5876(98)00151-7; Hille ETM, 2007, ACTA PAEDIATR, V96, P1155, DOI 10.1111/j.1651-2227.2007.00398.x; Huth M E, 2011, Int J Otolaryngol, V2011, P937861, DOI 10.1155/2011/937861; Levine M, 2001, PHARMACOTHERAPY, V21, P405, DOI 10.1592/phco.21.5.405.34503; Loughnan PM, 2006, ARCH DIS CHILD-FETAL, V91, pF156, DOI 10.1136/adc.2005.084699; Marlow ES, 2000, ARCH DIS CHILD-FETAL, V82, pF141, DOI 10.1136/fn.82.2.F141; Martin S, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13873; Metzger D, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13905; Morley CJ, 2008, NEW ENGL J MED, V358, P700, DOI 10.1056/NEJMoa072788; Musiime GM, 2015, TROP MED INT HEALTH, V20, P1593, DOI 10.1111/tmi.12608; Norton SJ, 2000, EAR HEARING, V21, P529, DOI 10.1097/00003446-200010000-00014; PETTIGREW AG, 1988, MED J AUSTRALIA, V148, P174; Pirozzo S, 2003, BRIT MED J, V327, P967, DOI 10.1136/bmj.327.7421.967; Polin RA, 2012, PEDIATRICS, V129, P1006, DOI 10.1542/peds.2012-0541; Rao SC, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005091.pub3; Robertson CMT, 2009, PEDIATRICS, V123, pE797, DOI 10.1542/peds.2008-2531; Robertson CMT, 2006, ACTA PAEDIATR, V95, P214, DOI 10.1080/08035250500294098; Roth DAE, 2006, ARCH DIS CHILD-FETAL, V91, pF257, DOI 10.1136/adc.2005.074476; SAWCHUK RJ, 1977, CLIN PHARMACOL THER, V21, P362; Schlapbach LJ, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-198; Schlapbach LJ, 2011, PEDIATRICS, V128, pE348, DOI 10.1542/peds.2010-3338; Schmidt B, 2012, JAMA-J AM MED ASSOC, V307, P275, DOI 10.1001/jama.2011.2024; Serenius F, 2013, JAMA-J AM MED ASSOC, V309, P1810, DOI 10.1001/jama.2013.3786; Setiabudy R, 2013, INT J CLIN PHARM TH, V51, P401, DOI 10.5414/CP201833; THIRINGER K, 1984, DEV MED CHILD NEUROL, V26, P799; Usami SI, 1998, J COMMUN DISORD, V31, P423, DOI 10.1016/S0021-9924(98)00014-8; Vella-Brincat JWA, 2011, NEONATOLOGY, V100, P186, DOI 10.1159/000324857; Vellanki H, 2012, PEDIATRICS, V130, pE1352, DOI 10.1542/peds.2011-2611; WALTON JP, 1991, J SPEECH HEAR RES, V34, P1362, DOI 10.1044/jshr.3406.1362; Williams AL, 2007, J ACOUST SOC AM, V121, P2681, DOI 10.1121/1.2717500; Wu J, 2015, J MED GENET, V52, P95, DOI 10.1136/jmedgenet-2014-102753	50	20	21	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158806	10.1371/journal.pone.0158806	http://dx.doi.org/10.1371/journal.pone.0158806			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27390846	Green Published, gold, Green Submitted			2022-12-27	WOS:000380005400129
J	Gibbs, J; Elle, E; Bobiwash, K; Haapalainen, T; Isaacs, R				Gibbs, Jason; Elle, Elizabeth; Bobiwash, Kyle; Haapalainen, Tiia; Isaacs, Rufus			Contrasting Pollinators and Pollination in Native and Non-Native Regions of Highbush Blueberry Production	PLOS ONE			English	Article							BOMBUS-IMPATIENS HYMENOPTERA; APIS-MELLIFERA HYMENOPTERA; LOWBUSH BLUEBERRY; BEES HYMENOPTERA; BUMBLE BEES; HONEY-BEES; NORTH-AMERICA; WILD; VACCINIUM; APIDAE	Highbush blueberry yields are dependent on pollination by bees, and introduction of managed honey bees is the primary strategy used for pollination of this crop. Complementary pollination services are also provided by wild bees, yet highbush blueberry is increasingly grown in regions outside its native range where wild bee communities may be less adapted to the crop and growers may still be testing appropriate honey bee stocking densities. To contrast crop pollination in native and non-native production regions, we sampled commercial 'Bluecrop' blueberry fields in British Columbia and Michigan with grower-selected honey bee stocking rates (0-39.5 hives per ha) to compare bee visitors to blueberry flowers, pollination and yield deficits, and how those vary with local-and landscape-scale factors. Observed and Chao-1 estimated species richness, as well as Shannon diversity of wild bees visiting blueberries were significantly higher in Michigan where the crop is within its native range. The regional bee communities were also significantly different, with Michigan farms having greater dissimilarity than British Columbia. Blueberry fields in British Columbia had fewer visits by honey bees than those in Michigan, irrespective of stocking rate, and they also had lower berry weights and a significant pollination deficit. In British Columbia, pollination service increased with abundance of wild bumble bees, whereas in Michigan the abundance of honey bees was the primary predictor of pollination. The proportion of seminatural habitat at local and landscape scales was positively correlated with wild bee abundance in both regions. Wild bee abundance declined significantly with distance from natural borders in Michigan, but not in British Columbia where large-bodied bumble bees dominated the wild bee community. Our results highlight the varying dependence of crop production on different types of bees and reveal that strategies for pollination improvement in the same crop can vary greatly across production regions.	[Gibbs, Jason; Isaacs, Rufus] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA; [Elle, Elizabeth; Bobiwash, Kyle; Haapalainen, Tiia] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC, Canada	Michigan State University; Simon Fraser University	Gibbs, J (corresponding author), Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA.	jgibbs@msu.edu	Isaacs, Rufus/AAF-4646-2019; Gibbs, Jason/H-6963-2012	Isaacs, Rufus/0000-0001-7523-4643; Gibbs, Jason/0000-0002-4945-5423	United States Department of Agriculture -National Institute for Food and Agriculture Specialty Crop Research Initiative [2012-01534]	United States Department of Agriculture -National Institute for Food and Agriculture Specialty Crop Research Initiative	The authors acknowledge funding provided by the United States Department of Agriculture -National Institute for Food and Agriculture Specialty Crop Research Initiative (http://nifa.usda.gov), from project 2012-01534: Developing Sustainable Pollination Strategies for U.S Specialty Crops awarded to RI (principal investigator) and EE (co-prinicipal investigator). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allsopp MH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003128; Artz DR, 2011, J ECON ENTOMOL, V104, P1153, DOI 10.1603/EC10431; Barton K, 2014, MUMIN MULTIMODEL INF; BC Ministry of Agriculture, 2012, BERR PROD GUID BEN M; Benjamin FE, 2014, ENVIRON ENTOMOL, V43, P1574, DOI 10.1603/EN13314; Benjamin FE, 2014, J APPL ECOL, V51, P440, DOI 10.1111/1365-2664.12198; Blaauw BR, 2015, BIOL CONTROL, V91, P94, DOI 10.1016/j.biocontrol.2015.08.003; Blaauw BR, 2014, J APPL ECOL, V51, P890, DOI 10.1111/1365-2664.12257; Bouseman J. K., 1979, Transactions of the American Entomological Society, V104, P275; BREWER JW, 1969, J ECON ENTOMOL, V62, P815, DOI 10.1093/jee/62.4.815; Buchmann S.L., 1983, P73; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Button L, 2014, AGR ECOSYST ENVIRON, V197, P255, DOI 10.1016/j.agee.2014.08.004; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; CANE JH, 1985, AM J BOT, V72, P135, DOI 10.2307/2443575; CHAO A, 1984, SCAND J STAT, V11, P265; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Courcelles DMM, 2013, J APPL ENTOMOL, V137, P693, DOI 10.1111/jen.12059; Delaplane K. S., 2000, Crop pollination by bees., DOI 10.1079/9780851994482.0000; Desjardins EC, 2006, J ECON ENTOMOL, V99, P443, DOI 10.1603/0022-0493-99.2.443; Dogterom MH, 2000, AM J BOT, V87, P1584, DOI 10.2307/2656734; Dogterom MH, 1999, CAN ENTOMOL, V131, P757, DOI 10.4039/Ent131757-6; Furst MA, 2014, NATURE, V506, P364, DOI 10.1038/nature12977; Garibaldi LA, 2014, FRONT ECOL ENVIRON, V12, P439, DOI 10.1890/130330; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Gibbs J, 2011, ZOOTAXA, P1; Gibbs J, 2010, ZOOTAXA, P1; Gibbs J, 2013, ZOOTAXA, V3672, P1, DOI 10.11646/zootaxa.3672.1.1; Girard M, 2012, BOTANY, V90, P545, DOI [10.1139/B2012-049, 10.1139/b2012-049]; Gotelli Nicholas J., 2011, P39; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; Greenleaf SS, 2006, P NATL ACAD SCI USA, V103, P13890, DOI 10.1073/pnas.0600929103; Hurd P. D. Jr., 1979, Catalog of Hymenoptera in America north of Mexico. Volume 2. Apocrita (Aculeata)., P1741; Isaacs R, 2010, J APPL ECOL, V47, P841, DOI 10.1111/j.1365-2664.2010.01823.x; Javorek SK, 2002, ANN ENTOMOL SOC AM, V95, P345, DOI 10.1603/0013-8746(2002)095[0345:CPEABH]2.0.CO;2; Kearns C. A., 1993, TECHNIQUES POLLINATI; Kennedy CM, 2013, ECOL LETT, V16, P584, DOI 10.1111/ele.12082; Kephart S., 2005, PRACTICAL POLLINATIO, P364; Kevan Peter G., 2001, P7; Kleijn D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8414; La Berge W.E., 1973, Transactions American Ent Soc, V99, P235; LABERGE W E, 1980, Transactions of the American Entomological Society (Philadelphia), V106, P395; LABERGE W E, 1970, Transactions of the American Entomological Society (Philadelphia), V96, P543; LABERGE W E, 1971, Transactions of the American Entomological Society (Philadelphia), V97, P441; LABERGE W E, 1986, Transactions of the American Entomological Society (Philadelphia), V112, P191; LAVERTY TM, 1988, CAN ENTOMOL, V120, P965, DOI 10.4039/Ent120965-11; MacKenzie KE, 1996, J KANSAS ENTOMOL SOC, V69, P185; MacKenzie KE, 1997, J AM SOC HORTIC SCI, V122, P891, DOI 10.21273/JASHS.122.6.891; Maurer Brian A., 2011, P55; MCGINLEY RJ, 1986, SMITHSONIAN CONTRIBU, V429, P1, DOI DOI 10.5479/SI.00810282.429; Miranda G.F.G., 2013, Canadian Journal of Arthropod Identification, V23, P1; Mitchell T. B., 1962, Technical Bulletin North Carolina Agricultural Experiment Station, Vno. 152, P1; MITCHELL THEODORE B., 1960, N CAROLINA AGRIC EXPT STA TECH BULL, V141, P1; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Otterstatter MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002771; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Pritts MP, 1992, HIGHBUSH BLUEBERRY P, P156; Pritts MP, 1992, HIGHBUSH BLUEBERRY P, P37; R Core Team, 2016, R FDN STAT COMP; Ratti CM, 2008, CAN ENTOMOL, V140, P348, DOI 10.4039/N07-065; Rehan SM, 2011, ZOOTAXA, P35; RIBBLE D. W., 1967, BULL UNIV NEBR STATE MUS, V6, P27; Richards Kenneth W., 1996, Linnean Society Symposium Series, V18, P81; Richards KW, 2003, J APICULT RES, V42, P21, DOI 10.1080/00218839.2003.11101082; Rightmyer MG, 2010, ZOOKEYS, P37, DOI 10.3897/zookeys.60.484; Skaug H, 2014, GLMMADMB GEN LINEAR; Strange JP, 2015, J ECON ENTOMOL, V108, P873, DOI 10.1093/jee/tov078; Strik BC, 2005, HORTTECHNOLOGY, V15, P391, DOI 10.21273/HORTTECH.15.2.0391; Stubbs CS, 2001, J ECON ENTOMOL, V94, P609, DOI 10.1603/0022-0493-94.3.609; Stubbs CS, 1997, ACTA HORTIC, P341, DOI 10.17660/ActaHortic.1997.437.42; TORCHIO PF, 1985, J KANSAS ENTOMOL SOC, V58, P448; Tuell JK, 2010, J ECON ENTOMOL, V103, P557, DOI 10.1603/EC09387; Tuell JK, 2009, ANN ENTOMOL SOC AM, V102, P275, DOI 10.1603/008.102.0209; Vander Kloet S.P., 1988, GENUS VACCINIUM N AM; Velthuis HHW, 2006, APIDOLOGIE, V37, P421, DOI 10.1051/apido:2006019; Vicens N, 2000, ENVIRON ENTOMOL, V29, P235, DOI 10.1603/0046-225X(2000)029[0235:PEOOCA]2.0.CO;2; Vockeroth JR, 1992, FLOWER FLIES SUBFAMI; Whidden TL, 1996, CAN ENTOMOL, V128, P957, DOI 10.4039/Ent128957-5; Williams NM, 2010, BIOL CONSERV, V143, P2280, DOI 10.1016/j.biocon.2010.03.024; Williams PH, 2009, APIDOLOGIE, V40, P367, DOI 10.1051/apido/2009025; Winfree R, 2015, ECOL LETT, V18, P626, DOI 10.1111/ele.12424; Winfree R, 2010, ANN NY ACAD SCI, V1195, P169, DOI 10.1111/j.1749-6632.2010.05449.x; Winfree R, 2009, ECOLOGY, V90, P2068, DOI 10.1890/08-1245.1; Zhang H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121143; Zurbuchen A, 2010, BIOL CONSERV, V143, P669, DOI 10.1016/j.biocon.2009.12.003	85	33	34	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158937	10.1371/journal.pone.0158937	http://dx.doi.org/10.1371/journal.pone.0158937			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391969	gold, Green Published, Green Submitted			2022-12-27	WOS:000380005400166
J	Jansen, RJ; van Egmond, R; de Ridder, H				Jansen, Reinier J.; van Egmond, Rene; de Ridder, Huib			Task Prioritization in Dual-Tasking: Instructions versus Preferences	PLOS ONE			English	Article							DRIVER PERFORMANCE; MENTAL WORKLOAD; MODEL; MULTITASKING; DEMANDS; STRESS; OPPORTUNITY; RESOURCES; STRATEGY; MEMORY	The role of task prioritization in performance tradeoffs during multi-tasking has received widespread attention. However, little is known on whether people have preferences regarding tasks, and if so, whether these preferences conflict with priority instructions. Three experiments were conducted with a high-speed driving game and an auditory memory task. In Experiment 1, participants did not receive priority instructions. Participants performed different sequences of single-task and dual-task conditions. Task performance was evaluated according to participants' retrospective accounts on preferences. These preferences were reformulated as priority instructions in Experiments 2 and 3. The results showed that people differ in their preferences regarding task prioritization in an experimental setting, which can be overruled by priority instructions, but only after increased dual-task exposure. Additional measures of mental effort showed that performance tradeoffs had an impact on mental effort. The interpretation of these findings was used to explore an extension of Threaded Cognition Theory with Hockey's Compensatory Control Model.	[Jansen, Reinier J.; van Egmond, Rene; de Ridder, Huib] Delft Univ Technol, Fac Ind Design Engn, Delft, Netherlands	Delft University of Technology	Jansen, RJ (corresponding author), Delft Univ Technol, Fac Ind Design Engn, Delft, Netherlands.	R.J.Jansen@tudelft.nl		de ridder, huib/0000-0002-7723-1785; Van Egmond, Rene/0000-0001-5015-0670	Nationale Politie Nederland	Nationale Politie Nederland	This research was partially funded by Staf Korpsleiding / Directie Facility Management, Nationale Politie Nederland. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann EM, 2002, COGNITIVE SCI, V26, P39, DOI 10.1207/s15516709cog2601_2; Aretz A.J., 1992, HUM PERFORM, V5, P303, DOI DOI 10.1207/S15327043HUP0504_3; Boksem MAS, 2008, BRAIN RES REV, V59, P125, DOI 10.1016/j.brainresrev.2008.07.001; Bootes K, 2010, WORK, V36, P207, DOI [10.3233/WOR-2010-01021, 10.3233/WOR-2010-1021]; Caird JK, 2008, ACCIDENT ANAL PREV, V40, P1282, DOI 10.1016/j.aap.2008.01.009; Cao S, 2011, P HUM FACT ERG SOC A, V55, P2083, DOI DOI 10.1177/1071181311551434; Cnossen F, 2004, ERGONOMICS, V47, P218, DOI 10.1080/00140130310001629757; Dressel J, 2008, TRANSPORT RES F-TRAF, V11, P347, DOI 10.1016/j.trf.2008.02.003; GOPHER D, 1989, ACTA PSYCHOL, V71, P147, DOI 10.1016/0001-6918(89)90007-3; GOPHER D, 1980, ACTA PSYCHOL, V46, P161, DOI 10.1016/0001-6918(80)90008-6; HANCOCK PA, 1989, HUM FACTORS, V31, P519; Hembrooke H., 2003, Journal of Computing in Higher Education, V15, P46, DOI 10.1007/BF02940852; Hockey G. R. J., 2011, COGNITIVE FATIGUE MU, P167, DOI [10.1037/12343-008, DOI 10.1037/12343-008]; Hockey GRJ, 1997, BIOL PSYCHOL, V45, P73; Jansen RJ, 2014, P HUM FACT ERG SOC E; Janssen CP, 2012, J COGN ENG DECIS MAK, V6, P5, DOI 10.1177/1555343411432339; Kahneman D., 2011, THINKING FAST SLOW; Killu K., 1999, J BEHAV EDUC, V9, P239, DOI DOI 10.1023/A:1022143716509; Kurzban R, 2013, BEHAV BRAIN SCI, V36, P661, DOI 10.1017/S0140525X12003196; Langner R, 2013, PSYCHOL BULL, V139, P870, DOI 10.1037/a0030694; Lansdown T, 2004, ERGONOMICS, V47, P91, DOI 10.1080/00140130310001629775; Levy J, 2008, APPL COGNITIVE PSYCH, V22, P507, DOI 10.1002/acp.1378; Liepelt R, 2011, Q J EXP PSYCHOL, V64, P1251, DOI 10.1080/17470218.2010.543284; Miller J, 2014, ATTEN PERCEPT PSYCHO, V76, P2560, DOI 10.3758/s13414-014-0730-3; Nijboer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079583; NORMAN DA, 1975, COGNITIVE PSYCHOL, V7, P44, DOI 10.1016/0010-0285(75)90004-3; O'DONNELL R. D., 1986, COGNITIVE PROCESSES; Park S., 2013, P HUM FACT ERG SOC A, V57, P773; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; Salvucci DD, 2008, PSYCHOL REV, V115, P101, DOI 10.1037/0033-295X.115.1.101; Salvucci DD, 2008, HUM FACTORS, V50, P834, DOI 10.1518/001872008X354200; Salvucci DD, 2009, CHI2009: PROCEEDINGS OF THE 27TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P1819; SANDERS AF, 1983, ACTA PSYCHOL, V53, P61, DOI 10.1016/0001-6918(83)90016-1; Schultz M, 2012, RC MINIRACERS; Siu KC, 2007, GAIT POSTURE, V25, P121, DOI 10.1016/j.gaitpost.2006.02.002; Sorensen C., 2005, Information and Organization, V15, P125, DOI 10.1016/j.infoandorg.2005.02.007; Unal AB, 2013, ACCIDENT ANAL PREV, V50, P934, DOI 10.1016/j.aap.2012.07.020; Wickens CD, 2008, HUM FACTORS, V50, P449, DOI 10.1518/001872008X288394; Wickens Christopher D., 1984, PROCESSING RESOURCES, P63; Zar J. H., 1996, BIOSTATISTICAL ANAL; Zijlstra F. R. H., 1993, EFFICIENCY WORK BEHA	41	13	13	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158511	10.1371/journal.pone.0158511	http://dx.doi.org/10.1371/journal.pone.0158511			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27391779	Green Published, gold			2022-12-27	WOS:000380005400073
J	Lahmer, T; Brandl, A; Rasch, S; Schmid, RM; Huber, W				Lahmer, Tobias; Brandl, Andreas; Rasch, Sebastian; Schmid, Roland M.; Huber, Wolfgang			Fungal Peritonitis: Underestimated Disease in Critically Ill Patients with Liver Cirrhosis and Spontaneous Peritonitis	PLOS ONE			English	Article							SPONTANEOUS BACTERIAL PERITONITIS; INTESTINAL PERMEABILITY; ADULT PATIENTS; MANAGEMENT; DIAGNOSIS; ASCITES; CANDIDIASIS; CULTURE; UPDATE	Introduction Spontaneous peritonitis, especially spontaneous fungal peritonitis (SFP), is an important and potentially fatal complication in patients with endstage liver disaese. We evaluated potential risk factors, microbiological findings, and outcome of patients with SFP compared to spontaneous bacterial peritonitis (SBP) in critically ill patients. Methods Retrospective analyses of critically ill patients with suspected spontaneous peritonitis. Results Out of 205 patients, 20 (10%) had SFP, 28 (14%) had SBP, 48 (24%) had peritonitis without microbiological findings (SP) and 109 (52%) had no-peritonitis (NP). APACHE II and SOFA score were significantly higher in patients with SFP (26; 22-28; p<0.004 and 16; 14-18; p<0.002), SBP (26; 22-28; p<0.004 and 16; 14-18; p<0.002) and SP (24; 18-30; p<0.045 and 14; 10-18; p<0.044) as compared to NP (22; 16-24 and 12; 10-14). CHILD Pugh classification was mainly CHILD C and MELD Score was in patients with SFP (34; 18-40; p<0.001), SBP (32; 12-40 p<0.002) and SP (29; 14-40 p<0.003) significantly higher as compared to NP (25; 8-40). Nosocomial peritonitis could be significantly more often found in patients with SFP (65%; p<0.023) and SBP (62%, p<0.030) as compared to SP (51 p = 0.243) and NP (45%). Antibiotic pretreatment last 3 month prior peritonitis was significantly more often in patients with SFP (85%; p<0.002), SBP (71%, p<0.033), and SP (56; p<0.040) as compared to NP (33%). Candida albicans (60%; 12/20) was the most common isolated fungus, followed by Candida glabrata (13%) and Candida krusei (13%). Mortality rate was significantly higher in patients with SFP (90%, p<0.001), followed by SBP (75%; p<0.001) and SP (69%; p<0.001) as compared to NP (45%). Conclusion SFP is not a rare complication in end stage liver disease which is associated with increased mortality. Physicians should be aware of SFP in patients with CHILD C liver cirrhosis, elevated MELD score, antibiotic pretreatment and nosocomial peritonitis.	[Lahmer, Tobias; Rasch, Sebastian; Schmid, Roland M.; Huber, Wolfgang] Tech Univ Munich, Klinikum Rechts Isar, Med Klin & Poliklin 2, Munich, Germany; [Brandl, Andreas] Charite, Campus Virchow & Mitte, Dept Gen Visceral & Transplantat Surg, Berlin, Germany; [Brandl, Andreas] Charite, Campus Virchow & Mitte, Dept Gen Visceral Vasc & Thorac Surg, Berlin, Germany	Technical University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Lahmer, T (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Med Klin & Poliklin 2, Munich, Germany.	TobiasLahmer@me.com	Brandl, Andreas/ABE-9972-2020; Lahmer, Tobias/AAD-3838-2021	Brandl, Andreas/0000-0003-1990-2584; Rasch, Sebastian/0000-0002-7917-8017				ANDREU M, 1993, GASTROENTEROLOGY, V104, P1133, DOI 10.1016/0016-5085(93)90284-J; BOBADILLA M, 1989, J CLIN MICROBIOL, V27, P2145, DOI 10.1128/JCM.27.10.2145-2147.1989; CALY WR, 1993, J HEPATOL, V18, P353, DOI 10.1016/S0168-8278(05)80280-6; Campillo B, 1999, EUR J GASTROEN HEPAT, V11, P755, DOI 10.1097/00042737-199907000-00013; CASTELLOTE J, 1990, AM J GASTROENTEROL, V85, P1605; Chakravarty-Vartak Urmi S, 2008, Saudi J Gastroenterol, V14, P147, DOI 10.4103/1319-3767.41736; Choi SH, 2004, SCAND J INFECT DIS, V36, P649, DOI 10.1080/00365540410020866; Cornely OA, 2012, CLIN MICROBIOL INFEC, V18, P19, DOI 10.1111/1469-0691.12039; Ersoz G, 1999, EUR J GASTROEN HEPAT, V11, P409, DOI 10.1097/00042737-199904000-00009; Hassan EA, 2014, INT J INFECT DIS, V23, P69, DOI 10.1016/j.ijid.2013.12.014; Hwang SY, 2014, EUR J CLIN MICROBIOL, V33, P259, DOI 10.1007/s10096-013-1953-2; Kuiper JJ, 2007, J HEPATOL, V46, pS96, DOI 10.1016/S0168-8278(07)61833-9; LLOVET JM, 1994, GUT, V35, P1648, DOI 10.1136/gut.35.11.1648; Nguyen MH, 2012, CLIN INFECT DIS, V54, P1240, DOI 10.1093/cid/cis200; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; Runyon BA, 2009, HEPATOLOGY, V49, P2087, DOI 10.1002/hep.22853; Such J, 1998, CLIN INFECT DIS, V27, P669, DOI 10.1086/514940	17	24	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158389	10.1371/journal.pone.0158389	http://dx.doi.org/10.1371/journal.pone.0158389			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27390856	gold, Green Published, Green Submitted			2022-12-27	WOS:000380005400051
J	Mogalle, K; Perez-Rovira, A; Ciet, P; Wens, SCA; van Doorn, PA; Tiddens, HAWM; van der Ploeg, AT; de Bruijne, M				Mogalle, Katja; Perez-Rovira, Adria; Ciet, Pierluigi; Wens, Stephan C. A.; van Doorn, Pieter A.; Tiddens, Harm A. W. M.; van der Ploeg, Ans T.; de Bruijne, Marleen			Quantification of Diaphragm Mechanics in Pompe Disease Using Dynamic 3D MRI	PLOS ONE			English	Article							PULMONARY-FUNCTION; MOTION ESTIMATION; HEALTHY-SUBJECTS; LUNG-VOLUMES; CHEST-WALL; ADULTS; REGISTRATION; SEGMENTATION; INVOLVEMENT; PROGRESSION	Background Diaphragm weakness is the main reason for respiratory dysfunction in patients with Pompe disease, a progressive metabolic myopathy affecting respiratory and limb-girdle muscles. Since respiratory failure is the major cause of death among adult patients, early identification of respiratory muscle involvement is necessary to initiate treatment in time and possibly prevent irreversible damage. In this paper we investigate the suitability of dynamic MR imaging in combination with state-of-the-art image analysis methods to assess respiratory muscle weakness. Methods The proposed methodology relies on image registration and lung surface extraction to quantify lung kinematics during breathing. This allows for the extraction of geometry and motion features of the lung that characterize the independent contribution of the diaphragm and the thoracic muscles to the respiratory cycle. Results Results in 16 3D+t MRI scans (10 Pompe patients and 6 controls) of a slow expiratory maneuver show that kinematic analysis from dynamic 3D images reveals important additional information about diaphragm mechanics and respiratory muscle involvement when compared to conventional pulmonary function tests. Pompe patients with severely reduced pulmonary function showed severe diaphragm weakness presented by minimal motion of the diaphragm. In patients with moderately reduced pulmonary function, cranial displacement of posterior diaphragm parts was reduced and the diaphragm dome was oriented more horizontally at full inspiration compared to healthy controls. Conclusion Dynamic 3D MRI provides data for analyzing the contribution of both diaphragm and thoracic muscles independently. The proposed image analysis method has the potential to detect less severe diaphragm weakness and could thus be used to determine the optimal start of treatment in adult patients with Pompe disease in prospect of increased treatment response.	[Mogalle, Katja; Perez-Rovira, Adria; de Bruijne, Marleen] Erasmus MC, Biomed Imaging Grp Rotterdam, Dept Med Informat, Rotterdam, Netherlands; [Mogalle, Katja; Perez-Rovira, Adria; de Bruijne, Marleen] Erasmus MC, Biomed Imaging Grp Rotterdam, Dept Radiol, Rotterdam, Netherlands; [Perez-Rovira, Adria] Sophia Childrens Univ Hosp, Erasmus MC, Dept Pediat Pulmonol, Rotterdam, Netherlands; [Ciet, Pierluigi; Tiddens, Harm A. W. M.] Erasmus MC, Dept Radiol, Rotterdam, Netherlands; [Ciet, Pierluigi; Tiddens, Harm A. W. M.] Erasmus MC Sophia, Dept Pediat Resp Med & Allergol, Rotterdam, Netherlands; [Wens, Stephan C. A.; van Doorn, Pieter A.] Erasmus MC, Dept Neurol, Rotterdam, Netherlands; [Wens, Stephan C. A.; van Doorn, Pieter A.; van der Ploeg, Ans T.] Erasmus MC Sophia, Ctr Lysosomal & Metab Dis, Rotterdam, Netherlands; [van der Ploeg, Ans T.] Erasmus MC Sophia, Div Metab Dis & Genet, Dept Pediat, Rotterdam, Netherlands; [de Bruijne, Marleen] Univ Copenhagen, Dept Comp Sci, Copenhagen, Denmark	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Copenhagen	Mogalle, K; de Bruijne, M (corresponding author), Erasmus MC, Biomed Imaging Grp Rotterdam, Dept Med Informat, Rotterdam, Netherlands.; Mogalle, K; de Bruijne, M (corresponding author), Erasmus MC, Biomed Imaging Grp Rotterdam, Dept Radiol, Rotterdam, Netherlands.; de Bruijne, M (corresponding author), Univ Copenhagen, Dept Comp Sci, Copenhagen, Denmark.	katja.mogalle@gmail.com; marleen.debruijne@erasmusmc.nl	Ciet, Pierluigi/F-8509-2017; de Bruijne, Marleen/G-2662-2010	Ciet, Pierluigi/0000-0003-4017-8957; de Bruijne, Marleen/0000-0002-6328-902X	Netherlands Organization for Scientific Research (NWO) [639.022.010]; Sophia Scientific Foundation (Sporten voor Sophia)	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Sophia Scientific Foundation (Sporten voor Sophia)	This research project was financed by The Netherlands Organization for Scientific Research (NWO, www.nwo.nl) grant no. 639.022.010 (KM, MDB) and the Sophia Scientific Foundation (Sporten voor Sophia, www.sportenvoorsophia.nl) (HAWMT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alejaldre A, 2012, NEUROMUSCULAR DISORD, V22, pS148, DOI 10.1016/j.nmd.2012.05.011; Angelini C, 2012, J NEUROL, V259, P952, DOI 10.1007/s00415-011-6293-5; Beucher S., 1979, REAL TIM EDG MOT DET, P12, DOI citeulike-article-id:4083187.; Boldea V, 2008, MED PHYS, V35, P1008, DOI 10.1118/1.2839103; Boon AJ, 2013, MUSCLE NERVE, V47, P884, DOI 10.1002/mus.23702; Buerger C, 2011, MED IMAGE ANAL, V15, P551, DOI 10.1016/j.media.2011.02.009; Carlier RY, 2011, NEUROMUSCULAR DISORD, V21, P791, DOI 10.1016/j.nmd.2011.06.748; Chu WCW, 2006, SPINE, V31, P2243, DOI 10.1097/01.brs.0000232822.74349.32; Cluzel P, 2000, RADIOLOGY, V215, P574, DOI 10.1148/radiology.215.2.r00ma28574; de Vries JM, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-73; Fang QQ, 2009, I S BIOMED IMAGING, P1142, DOI 10.1109/ISBI.2009.5193259; Fromageot C, 2001, ARCH PHYS MED REHAB, V82, P123, DOI 10.1053/apmr.2001.18053; Gaeta M, 2015, NEUROMUSCULAR DISORD, V25, P852, DOI 10.1016/j.nmd.2015.09.003; Gaeta M, 2013, MOL GENET METAB, V110, P290, DOI 10.1016/j.ymgme.2013.06.023; GAUTHIER AP, 1994, J APPL PHYSIOL, V76, P495, DOI 10.1152/jappl.1994.76.2.495; Gerscovich EO, 2001, J ULTRAS MED, V20, P597; GIERADA DS, 1995, RADIOLOGY, V194, P879, DOI 10.1148/radiology.194.3.7862995; Grady L, 2006, IEEE T PATTERN ANAL, V28, P1768, DOI 10.1109/TPAMI.2006.233; Gungor D, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-34; Hagemans MLC, 2005, BRAIN, V128, P671, DOI 10.1093/brain/awh384; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; HARRIS RS, 1983, RADIOLOGY, V146, P141, DOI 10.1148/radiology.146.1.6849035; Heimann T, 2007, LECT NOTES COMPUT SC, V4584, P1; Kiryu S, 2006, MAGN RESON IMAGING, V24, P1325, DOI 10.1016/j.mri.2006.08.009; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Kohlmann P, 2014, AUTOMATIC LUNG SEGME; Kolar P, 2009, PHYSIOL RES, V58, P383, DOI 10.33549/physiolres.931376; Kondo T, 2000, Respirology, V5, P19, DOI 10.1046/j.1440-1843.2000.00221.x; Korosec FR, 1996, MAGNET RESON MED, V36, P345, DOI 10.1002/mrm.1910360304; Mellies U, 2001, NEUROLOGY, V57, P1290, DOI 10.1212/WNL.57.7.1290; Metz CT, 2011, MED IMAGE ANAL, V15, P238, DOI 10.1016/j.media.2010.10.003; Nason LK, 2012, RADIOGRAPHICS, V32, pE51, DOI 10.1148/rg.322115127; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pellegrini N, 2005, EUR RESPIR J, V26, P1024, DOI 10.1183/09031936.05.00020005; Plathow C, 2004, INVEST RADIOL, V39, P202, DOI 10.1097/01.rli.0000113795.93565.c3; Plathow C, 2005, INVEST RADIOL, V40, P173, DOI 10.1097/00004424-200503000-00007; Plathow C, 2009, KOREAN J RADIOL, V10, P559, DOI 10.3348/kjr.2009.10.6.559; Rangayyan RM, 2008, J DIGIT IMAGING, V21, pS134, DOI 10.1007/s10278-007-9091-y; Ravaglia S, 2010, J INHERIT METAB DIS, V33, P737, DOI 10.1007/s10545-010-9204-5; Remiche G, 2013, RESP PHYSIOL NEUROBI, V186, P308, DOI 10.1016/j.resp.2013.03.004; Sarwal A, 2013, MUSCLE NERVE, V47, P319, DOI 10.1002/mus.23671; Suga K, 1999, JMRI-J MAGN RESON IM, V10, P510, DOI 10.1002/(SICI)1522-2586(199910)10:4<510::AID-JMRI3>3.0.CO;2-G; Suwatanapongched T, 2003, CHEST, V123, P2019, DOI 10.1378/chest.123.6.2019; Takazakura R, 2004, J MAGN RESON IMAGING, V19, P605, DOI 10.1002/jmri.20051; Tokuda J, 2009, ACAD RADIOL, V16, P22, DOI 10.1016/j.acra.2008.07.021; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; van der Beek NAME, 2011, MOL GENET METAB, V104, P129, DOI 10.1016/j.ymgme.2011.06.012; van der Beek NAME, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-88; van der Ploeg AT, 2008, LANCET, V372, P1342, DOI 10.1016/S0140-6736(08)61555-X; van der Ploeg AT, 2010, NEW ENGL J MED, V362, P1396, DOI 10.1056/NEJMoa0909859; VERSCHAKELEN JA, 1989, J APPL PHYSIOL, V67, P694, DOI 10.1152/jappl.1989.67.2.694; Vostatek P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056724; Wens SCA, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0058-3; Yalamanchili R, 2010, I S BIOMED IMAGING, P900, DOI 10.1109/ISBI.2010.5490132; Yang DS, 2008, MED PHYS, V35, P4577, DOI 10.1118/1.2977828; Yang Y, 2014, IEEE J BIOMED HEALTH, V18, P969, DOI 10.1109/JBHI.2013.2282183; Zhang C, 2001, 2001 INTERNATIONAL CONFERENCE ON IMAGE PROCESSING, VOL III, PROCEEDINGS, P935, DOI 10.1109/ICIP.2001.958278; Zhang JY, 2011, IEEE T VIS COMPUT GR, V17, P357, DOI 10.1109/TVCG.2010.57; Zhou X, 2008, IEEE T BIO-MED ENG, V55, P351, DOI 10.1109/TBME.2007.899337	59	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158912	10.1371/journal.pone.0158912	http://dx.doi.org/10.1371/journal.pone.0158912			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391236	Green Published, gold			2022-12-27	WOS:000380005400159
J	Mohee, AR; Gascoyne-Binzi, D; West, R; Bhattarai, S; Eardley, I; Sandoe, JAT				Mohee, Amar Raj; Gascoyne-Binzi, Deborah; West, Robert; Bhattarai, Selina; Eardley, Ian; Sandoe, Jonathan A. T.			Bacteraemia during Transurethral Resection of the Prostate: What Are the Risk Factors and Is It More Common than We Think?	PLOS ONE			English	Article							ANTIBIOTIC-PROPHYLAXIS; COMPLICATIONS; SURGERY; TURP	The aim of this work was to investigate the microbial causes, incidence, duration, risk factors and clinical implications of bacteraemia occurring during transurethral resection of the prostate (TURP) surgery to better inform prophylaxis strategies. An ethically approved, prospective, cohort study of patients undergoing TURP was conducted. Clinical information and follow-up details were collected using standardized data collection sheets. Blood was obtained for culture at 6 different time points peri-procedure. Standard of care antibiotic prophylaxis was given prior to surgery. Bacteriuria was assessed in a pre-procedure urine sample. Histopathology from all prostate chips was assessed for inflammation and malignancy. 73 patients were consented and 276 blood samples obtained. No patients developed symptomatic bacteraemia during the procedure, 17 patients developed asymptomatic bacteraemia (23.2%). Enterococcus faecalis and Pseudomonas aeruginosa were the most common organisms cultured. 10 minutes after the start of the TURP, the odds ratio (OR) of developing bacteraemia was 5.38 (CI 0.97-29.87 p = 0.05), and 20 minutes after the start of the procedure, the OR was 6.46 (CI 1.12-37.24, p = 0.03), compared to before the procedure. We also found an association between the development of intra-operative bacteraemia and recent antibiotic use (OR 4.34, CI 1.14-16.62, p = 0.032), the presence of a urinary catheter (OR 4.92, CI 1.13-21.51, p = 0.034) and a malignant histology (OR 4.90, CI 1.30-18.46, p = 0.019). There was no statistical relationship between pre-operative urine culture results and blood culture results. This study shows that asymptomatic bacteraemia is commonly caused by TURP and occurs in spite of antibiotic prophylaxis. Our findings challenge the commonly held view that urine is the primary source of bacteraemia in TURP-associated sepsis and raise the possibility of occult prostatic infection as a cause of bacteraemia. More work will be needed to determine the significance of transient bacteraemia in relation to more serious complications like infective endocarditis and malignancy.	[Mohee, Amar Raj] Christie NHS Fdn Trust, Dept Urol, 550 Wilmslow Rd, Manchester, Lancs, England; [Gascoyne-Binzi, Deborah] Leeds Teaching Hosp NHS Trust, Dept Microbiol, Beckett St, Leeds, W Yorkshire, England; [West, Robert] Univ Leeds, Dept Biostat, Woodhouse Lane, Leeds, W Yorkshire, England; [Bhattarai, Selina] Leeds Teaching Hosp NHS Trust, Dept Pathol, Beckett St, Leeds, W Yorkshire, England; [Eardley, Ian] Leeds Teaching Hosp NHS Trust, Dept Urol, Beckett St, Leeds, W Yorkshire, England; [Sandoe, Jonathan A. T.] Univ Leeds, Beckett St, Leeds, W Yorkshire, England; [Sandoe, Jonathan A. T.] Leeds Teaching Hosp NHS Trust, Beckett St, Leeds, W Yorkshire, England	Christie NHS Foundation Trust; University of Leeds; University of Leeds; University of Leeds; University of Leeds; University of Leeds; University of Leeds	Mohee, AR (corresponding author), Christie NHS Fdn Trust, Dept Urol, 550 Wilmslow Rd, Manchester, Lancs, England.	amar.mohee@gmail.com	Sandoe, Jonathan/AAL-2117-2020	Sandoe, Jonathan/0000-0003-0193-8677; Mohee, Amar/0000-0002-2672-618X	Leeds Charitable Trust, at Leeds Teaching Hospitals NHS Trust; Economic and Social Research Council [ES/G007489/1] Funding Source: researchfish; Medical Research Council [MR/K023195/1] Funding Source: researchfish	Leeds Charitable Trust, at Leeds Teaching Hospitals NHS Trust; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was supported by the Leeds Charitable Trust, a charity supporting medical research at the Leeds Teaching Hospitals NHS Trust. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Epstein JI, 2014, AM J SURG PATHOL, V38, pE6, DOI 10.1097/PAS.0000000000000238; GRABE M, 1987, EUR J CLIN MICROBIOL, V6, P11, DOI 10.1007/BF02097183; Grabe M, 2015, EUROPEAN ASS UROLOGY; Hall JC, 1996, UROLOGY, V47, P852, DOI 10.1016/S0090-4295(96)00066-0; Harris KA, 2003, J MED MICROBIOL, V52, P685, DOI 10.1099/jmm.0.05213-0; Ibrahim AIA, 2002, EUR UROL, V41, P250, DOI 10.1016/S0302-2838(02)00013-1; Mohee A, 2013, BJU INT, V114, P118; National Institute for Health and Care Excellence (NICE), 2008, SURG SIT INF PREV TR; National Institute for Health and Clinical Excellence, 2008, PROPH INF END; NIELSEN PB, 1987, INFECTION, V15, P245, DOI 10.1007/BF01644123; OHKAWA M, 1993, CHEMOTHERAPY, V39, P140, DOI 10.1159/000239117; Omabe M, 2011, INFECT GENET EVOL, V11, P1195, DOI 10.1016/j.meegid.2011.03.002; PRESCOTT S, 1990, BRIT J UROL, V66, P509, DOI 10.1111/j.1464-410X.1990.tb14999.x; Qiang W, 2005, J UROLOGY, V173, P1175, DOI 10.1097/01.ju.0000149676.15561.cb; Rassweiler J, 2006, EUR UROL, V50, P969, DOI 10.1016/j.eururo.2005.12.042; Richter SS, 2002, J CLIN MICROBIOL, V40, P2437, DOI 10.1128/JCM.40.7.2437-2444.2002; ROBINSON MRG, 1982, BRIT J UROL, V54, P542, DOI 10.1111/j.1464-410X.1982.tb13586.x; Rodrigues Paulo, 2004, Sao Paulo Med. J., V122, P4, DOI 10.1590/S1516-31802004000100002; SHEARMAN CP, 1988, BRIT J UROL, V62, P434, DOI 10.1111/j.1464-410X.1988.tb04391.x; SPRAYCAR M, 1995, STEDMANS MED DICT; SULLIVAN NM, 1972, APPL MICROBIOL, V23, P1101, DOI 10.1128/AEM.23.6.1101-1106.1972; TAYLOR EW, 1988, J HOSP INFECT, V12, P75, DOI 10.1016/0195-6701(88)90129-6; Turk S, 2014, MICROB ECOL HEALTH D, V25, DOI 10.3402/mehd.v25.22701; Wagenlehner FME, 2005, EUR UROL, V47, P549, DOI 10.1016/j.eururo.2005.01.004; Yamamoto Hiroki, 2002, J Anesth, V16, P242, DOI 10.1007/s005400200032	25	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0157864	10.1371/journal.pone.0157864	http://dx.doi.org/10.1371/journal.pone.0157864			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391962	gold, Green Published			2022-12-27	WOS:000380005400023
J	Paolicelli, D; Iannazzo, S; Santoni, L; Iaffaldano, A; Di Lecce, V; Manni, A; Lavolpe, V; Tortorella, C; D'Onghia, M; Direnzo, V; Puma, E; Trojano, M				Paolicelli, Damiano; Iannazzo, Sergio; Santoni, Laura; Iaffaldano, Antonio; Di Lecce, Valentina; Manni, Alessia; Lavolpe, Vito; Tortorella, Carla; D'Onghia, Mariangela; Direnzo, Vita; Puma, Elisa; Trojano, Maria			The Cost of Relapsing-Remitting Multiple Sclerosis Patients Who Develop Neutralizing Antibodies during Interferon Beta Therapy	PLOS ONE			English	Article							IFN-BETA; IMPACT	Background Relapsing Remitting Multiple Sclerosis (RRMS) patients treated with interferon beta (IFN beta) can develop neutralizing antibodies (NAbs) that reduce treatment efficacy. Several clinical studies explored the association of NAb+ status with increased disease activity. Objective The aim of this study was to estimate the cost of RRMS patients who develop NAbs while treated with IFN beta by the Italian National Healthcare Service (NHS) and the Italian Society perspectives. Methods The clinical data derived from a published observational study on 567 RRMS Italian patients treated with IFN beta. The management cost data derived from the published literature. Cost data were inflated to Euro 2014. Results The annual direct cost to treat a patient was estimated in (sic)15,428 in the NAb+ cohort and (sic)14,317 in the NAb-cohort. The annual societal cost was estimated in (sic)33,890 and (sic)30,790 in NAb+ and NAb-patients, respectively. The cost increase related to the NAb+ status was (sic)3,100 in the Italian societal perspective and (sic)1,111 in the Italian NHS perspective. Conclusion The results of this economic evaluation suggest the presence of an association between NAb+ status and increased costs for the management of RRMS in Italy. Further pharmacoeconomic research will be needed to confirm this first result.	[Paolicelli, Damiano; Iaffaldano, Antonio; Di Lecce, Valentina; Manni, Alessia; Lavolpe, Vito; Tortorella, Carla; D'Onghia, Mariangela; Direnzo, Vita; Trojano, Maria] Univ Bari Aldo Moro, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italy; [Iannazzo, Sergio] SIHS Hlth Econ Consulting, Turin, Italy; [Santoni, Laura; Puma, Elisa] Biogen Italia, Milan, Italy	Universita degli Studi di Bari Aldo Moro	Paolicelli, D (corresponding author), Univ Bari Aldo Moro, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italy.	damiano.paolicelli@uniba.it	Manni, Alessia/AHE-8058-2022; tortorella, carla/J-2557-2012	Manni, Alessia/0000-0001-6740-5844; tortorella, carla/0000-0001-9037-7300; Trojano, Maria/0000-0002-6329-8946	Biogen, Milan, Italy	Biogen, Milan, Italy(Biogen)	S. Iannazzo is owner and General Manager of SIHS Health Economics Consulting. Biogen, Milan, Italy, supported the development of the study through a service contract with SIHS. L. Santoni and E. Puma are Biogen's employees. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie A, 2004, STATA J, V4, P290, DOI 10.1177/1536867X0400400307; Abadie A, 2011, J BUS ECON STAT, V29, P1, DOI 10.1198/jbes.2009.07333; Agenzia Italiana del Farmaco (AIFA) (The Italian Drug Agency), REG RIMB PREZZ VEND; Amato MP, 2002, J NEUROL, V249, P152, DOI 10.1007/PL00007858; Associazione Italiana Sclerosi Multipla (AISM) (The Italian Association of Multiple Sclerosis), BIL SOC AISM 2013; Berto P, 2011, NEUROL SCI, V32, P1035, DOI 10.1007/s10072-011-0578-4; Bertolotto A, 2014, NEUROL SCI, V35, P307, DOI 10.1007/s10072-013-1616-1; Chiao E, 2009, CURR MED RES OPIN, V25, P1445, DOI 10.1185/03007990902876040; Istituto Italiano di Statistica (ISTAT) (The Italian Institute of Statistics), CONS PRIC IND; Karampampa K, 2012, MULT SCLER J, V18, P29, DOI 10.1177/1352458512441566c; Kobelt Gisela, 2006, Eur J Health Econ, V7 Suppl 2, pS45; Paolicelli D, 2013, J NEUROL, V260, P1562, DOI 10.1007/s00415-012-6829-3; Patti F, 2011, NEUROL SCI, V32, P787, DOI 10.1007/s10072-011-0499-2; Petkau AJ, 2004, MULT SCLER J, V10, P126, DOI 10.1191/1352458504ms1004oa; Ponzio M, 2015, NEUROL SCI, V36, P227, DOI 10.1007/s10072-014-1925-z; Rudick RA, 1998, NEUROLOGY, V50, P1266, DOI 10.1212/WNL.50.5.1266; Runkel L, 2001, J INTERF CYTOK RES, V21, P931, DOI 10.1089/107999001753289541; Russo P, 2004, CLIN DRUG INVEST, V24, P409, DOI 10.2165/00044011-200424070-00004; Sorensen PS, 2005, NEUROLOGY, V65, P33, DOI 10.1212/01.WNL.0000166049.51502.6A; Trojano M, 2011, NEUROL CLIN, V29, P309, DOI 10.1016/j.ncl.2010.12.008; Walter E, 2014, MULT SCLER RELAT DIS, V3, P670, DOI 10.1016/j.msard.2014.09.003	21	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159214	10.1371/journal.pone.0159214	http://dx.doi.org/10.1371/journal.pone.0159214			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27390865	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400220
J	Sperling, E; Gorecki, K; Drakenberg, T; Hagerhall, C				Sperling, Eva; Gorecki, Kamil; Drakenberg, Torbjorn; Hagerhall, Cecilia			Functional Differentiation of Antiporter-Like Polypeptides in Complex I; a Site-Directed Mutagenesis Study of Residues Conserved in MrpA and NuoL but Not in MrpD, NuoM, and NuoN	PLOS ONE			English	Article							NADH-QUINONE OXIDOREDUCTASE; ESCHERICHIA-COLI; BACILLUS-SUBTILIS; NA+/H+ ANTIPORTER; PROTON TRANSLOCATION; STRUCTURAL BASIS; ACIDIC RESIDUES; SUBUNIT; MECHANISM; DOMAIN	It has long been known that the three largest subunits in the membrane domain (NuoL, NuoM and NuoN) of complex I are homologous to each other, as well as to two subunits (MrpA and MrpD) from a Na+/H+ antiporter, Mrp. MrpA and NuoL are more similar to each other and the same is true for MrpD and NuoN. This suggests a functional differentiation which was proven experimentally in a deletion strain model system, where NuoL could restore the loss of MrpA, but not that of MrpD and vice versa. The simplest explanation for these observations was that the MrpA and MrpD proteins are not antiporters, but rather single subunit ion channels that together form an antiporter. In this work our focus was on a set of amino acid residues in helix VIII, which are only conserved in NuoL and MrpA (but not in any of the other antiporter-like subunits.) and to compare their effect on the function of these two proteins. By combining complementation studies in B. subtilis and Na-23-NMR, response of mutants to high sodium levels were tested. All of the mutants were able to cope with high salt levels; however, all but one mutation (M258I/M225I) showed differences in the efficiency of cell growth and sodium efflux. Our findings showed that, although very similar in sequence, NuoL and MrpA seem to differ on the functional level. Nonetheless the studied mutations gave rise to interesting phenotypes which are of interest in complex I research.	[Sperling, Eva; Gorecki, Kamil; Hagerhall, Cecilia] Lund Univ, Dept Biochem & Struct Biol, Ctr Mol Prot Sci, Lund, Sweden; [Drakenberg, Torbjorn] Lund Univ, Dept Biophys Chem, Ctr Mol Prot Sci, Lund, Sweden	Lund University; Lund University	Sperling, E (corresponding author), Lund Univ, Dept Biochem & Struct Biol, Ctr Mol Prot Sci, Lund, Sweden.	eva.sperling@biochemistry.lu.se		Gorecki, Kamil/0000-0002-9672-2408	Swedish Research Council [2010-5058]; Crafoord Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Crafoord Foundation	This work was supported by the Swedish Research Council, www.vr.se,2010-5058 to CH and the Crafoord Foundation, www.crafoord.se to CH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarneh B, 2003, BIOCHEMISTRY-US, V42, P4800, DOI 10.1021/bi0340346; ARWERT F, 1973, MOL GEN GENET, V123, P185, DOI 10.1007/BF00267334; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Efremov RG, 2011, NATURE, V476, P414, DOI 10.1038/nature10330; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Euro L, 2008, BBA-BIOENERGETICS, V1777, P1166, DOI 10.1016/j.bbabio.2008.06.001; FEARNLEY IM, 1992, BIOCHIM BIOPHYS ACTA, V1140, P105, DOI 10.1016/0005-2728(92)90001-I; Forrest LR, 2011, BBA-BIOENERGETICS, V1807, P167, DOI 10.1016/j.bbabio.2010.10.014; FORTNAGEL P, 1968, J BACTERIOL, V95, P1431, DOI 10.1128/JB.95.4.1431-1438.1968; Friedrich T, 1998, BBA-BIOENERGETICS, V1364, P134, DOI 10.1016/S0005-2728(98)00024-3; Galkin AS, 1999, FEBS LETT, V451, P157, DOI 10.1016/S0014-5793(99)00575-X; Gorecki K, 2014, ANAL BIOCHEM, V445, P80, DOI 10.1016/j.ab.2013.10.003; Gustavsson T, 2010, PROTEIN SCI, V19, P1445, DOI 10.1002/pro.424; HAMAMOTO T, 1994, MOL MICROBIOL, V14, P939, DOI 10.1111/j.1365-2958.1994.tb01329.x; Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046; Kajiyama Y, 2009, MICROBIOL-SGM, V155, P2137, DOI 10.1099/mic.0.025205-0; Kosono S, 2006, BBA-BIOMEMBRANES, V1758, P627, DOI 10.1016/j.bbamem.2006.04.012; Mathiesen C, 2002, BBA-BIOENERGETICS, V1556, P121, DOI 10.1016/S0005-2728(02)00343-2; Michel J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017420; Moparthi VK, 2014, BBA-BIOENERGETICS, V1837, P178, DOI 10.1016/j.bbabio.2013.09.012; Moparthi VK, 2011, BBA-BIOENERGETICS, V1807, P427, DOI 10.1016/j.bbabio.2011.01.005; Moparthi VK, 2011, STRUCTURAL PERSPECTI; Morino M, 2010, J BIOL CHEM, V285, P30942, DOI 10.1074/jbc.M110.118661; Nakamaru-Ogiso E, 2010, J BIOL CHEM, V285, P39070, DOI 10.1074/jbc.M110.157826; Ripple MO, 2013, J BIOL CHEM, V288, P5374, DOI 10.1074/jbc.M112.438945; Sambrook S, 1989, MOL CLONING LAB MANU; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Sazanov LA, 2014, J BIOENERG BIOMEMBR, V46, P247, DOI 10.1007/s10863-014-9554-z; Swartz TH, 2005, EXTREMOPHILES, V9, P345, DOI 10.1007/s00792-005-0451-6; Torres-Bacete J, 2007, J BIOL CHEM, V282, P36914, DOI 10.1074/jbc.M707855200; Torres-Bacete J, 2009, J BIOL CHEM, V284, P33062, DOI 10.1074/jbc.M109.059154; Tseng WC, 2008, ANAL BIOCHEM, V375, P376, DOI 10.1016/j.ab.2007.12.013; Verkhovskaya M, 2013, INT J BIOCHEM CELL B, V45, P491, DOI 10.1016/j.biocel.2012.08.024; Wikstrom M, 2012, P NATL ACAD SCI USA, V109, P4431, DOI 10.1073/pnas.1120949109; Yagi T, 1998, BBA-BIOENERGETICS, V1364, P125, DOI 10.1016/S0005-2728(98)00023-1	38	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158972	10.1371/journal.pone.0158972	http://dx.doi.org/10.1371/journal.pone.0158972			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391676	gold, Green Published, Green Submitted			2022-12-27	WOS:000380005400176
J	Venturas, MD; MacKinnon, ED; Dario, HL; Jacobsen, AL; Pratt, RB; Davis, SD				Venturas, Martin D.; MacKinnon, Evan D.; Dario, Hannah L.; Jacobsen, Anna L.; Pratt, R. Brandon; Davis, Stephen D.			Chaparral Shrub Hydraulic Traits, Size, and Life History Types Relate to Species Mortality during California's Historic Drought of 2014	PLOS ONE			English	Article							WATER-STRESS TOLERANCE; INDUCED TREE MORTALITY; CAVITATION RESISTANCE; VULNERABILITY CURVES; CHLOROPHYLL FLUORESCENCE; PHYSIOLOGICAL-MECHANISMS; CEANOTHUS-MEGACARPUS; CLIMATE-CHANGE; DIE-OFF; SEEDLINGS	Chaparral is the most abundant vegetation type in California and current climate change models predict more frequent and severe droughts that could impact plant community structure. Understanding the factors related to species-specific drought mortality is essential to predict such changes. We predicted that life history type, hydraulic traits, and plant size would be related to the ability of species to survive drought. We evaluated the impact of these factors in a mature chaparral stand during the drought of 2014, which has been reported as the most severe in California in the last 1,200 years. We measured tissue water potential, native xylem specific conductivity, leaf specific conductivity, percentage loss in conductivity, and chlorophyll fluorescence for 11 species in February 2014, which was exceptionally dry following protracted drought. Mortality among the 11 dominant species ranged from 0 to 93%. Total stand density was reduced 63.4% and relative dominance of species shifted after the drought. Mortality was negatively correlated with water potential, native xylem specific conductivity, and chlorophyll fluorescence, but not with percent loss in hydraulic conductivity and leaf specific conductivity. The model that best explained mortality included species and plant size as main factors and indicated that larger plants had greater survival for 2 of the species. In general, species with greater resistance to water-stress induced cavitation showed greater mortality levels. Despite adult resprouters typically being more vulnerable to cavitation, results suggest that their more extensive root systems enable them to better access soil moisture and avoid harmful levels of dehydration. These results are consistent with the hypothesis that short-term high intensity droughts have the strongest effect on mature plants of shallow-rooted dehydration tolerant species, whereas deep-rooted dehydration avoiding species fare better in the short-term. Severe droughts can drive changes in chaparral structure as a result of the differential mortality among species.	[Venturas, Martin D.; MacKinnon, Evan D.; Jacobsen, Anna L.; Pratt, R. Brandon] Calif State Univ, Dept Biol, 9001 Stockdale Hwy, Bakersfield, CA 93311 USA; [Venturas, Martin D.] Univ Politecn Madrid, Grp Invest Genet Fisiol & Hist Forestal, Avda Moreras S-N, E-28040 Madrid, Spain; [Dario, Hannah L.; Davis, Stephen D.] Pepperdine Univ, Div Nat Sci, 24255 Pacific Coast Highway, Malibu, CA 90263 USA	California State University System; California State University Bakersfield; Universidad Politecnica de Madrid; Pepperdine University	Venturas, MD (corresponding author), Calif State Univ, Dept Biol, 9001 Stockdale Hwy, Bakersfield, CA 93311 USA.; Venturas, MD (corresponding author), Univ Politecn Madrid, Grp Invest Genet Fisiol & Hist Forestal, Avda Moreras S-N, E-28040 Madrid, Spain.	martin.venturas@gmail.com	Venturas, Martin D./J-2423-2014	Venturas, Martin D./0000-0001-5972-9064; Jacobsen, Anna/0000-0001-7830-5590	Technical University of Madrid (Legado Gonzalez Esparcia Grant); National Science Foundation [IOS-0845125, IOS-1252232]; William M. Keck Foundation; Natural Science Division of Pepperdine University; National Parks Service	Technical University of Madrid (Legado Gonzalez Esparcia Grant); National Science Foundation(National Science Foundation (NSF)); William M. Keck Foundation(W.M. Keck Foundation); Natural Science Division of Pepperdine University; National Parks Service	MDV acknowledges support from the Technical University of Madrid (Legado Gonzalez Esparcia Grant; www.upm.es). MDV, EDM, and RBP were supported by National Science Foundation (IOS-0845125; www.nsf.gov). ALJ was supported by National Science Foundation (IOS-1252232; www.nsf.gov). SDD and HLD were supported by the William M. Keck Foundation (www.wmkeck.org) and the Natural Science Division of Pepperdine University (www.pepperdine.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Jo Kitz and Debbie Sharpton of the Mountains Restoration Trust for access to the study site from 1993 to present, and Marti Witter from the National Parks Service for her support. Authors would like to thank Kevin B. Doak, Allison L. Hubbard, and Alawna R. Jamison for their assistance in collecting PQS data.	Ackerly D, 2004, ECOL MONOGR, V74, P25, DOI 10.1890/03-4022; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Anderegg WRL, 2013, GLOBAL CHANGE BIOL, V19, P1188, DOI 10.1111/gcb.12100; Anderegg WRL, 2012, P NATL ACAD SCI USA, V109, P233, DOI 10.1073/pnas.1107891109; Barton K., 1995, THESIS; BJORKMAN O, 1987, PLANTA, V170, P489, DOI 10.1007/BF00402983; Board M.E.A., 2005, EC HUM WELL BEING SY; Bond WJ, 2001, TRENDS ECOL EVOL, V16, P45, DOI 10.1016/S0169-5347(00)02033-4; Breshears DD, 2005, P NATL ACAD SCI USA, V102, P15144, DOI 10.1073/pnas.0505734102; Coates AR, 2015, REMOTE SENS-BASEL, V7, P14276, DOI 10.3390/rs71114276; Cook BI, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400082; COTTAM G, 1953, ECOLOGY, V34, P741, DOI 10.2307/1931337; Cox G. W., 1985, LAB MANUAL GEN ECOLO; DAMESIN C, 1995, NEW PHYTOL, V131, P159, DOI 10.1111/j.1469-8137.1995.tb05717.x; Davis SD, 1999, ECOSCIENCE, V6, P180, DOI 10.1080/11956860.1999.11682519; Davis SD, 2002, AM J BOT, V89, P820, DOI 10.3732/ajb.89.5.820; Miranda JD, 2010, FUNCT PLANT BIOL, V37, P828, DOI 10.1071/FP09296; EPRON D, 1992, PLANT CELL ENVIRON, V15, P809, DOI 10.1111/j.1365-3040.1992.tb02148.x; Franco G, 2012, OUR CHANGING CLIMATE; FRAZER JM, 1988, OECOLOGIA, V76, P215, DOI 10.1007/BF00379955; Griffin D, 2014, GEOPHYS RES LETT, V41, P9017, DOI 10.1002/2014GL062433; Guanter L, 2014, P NATL ACAD SCI USA, V111, pE1327, DOI 10.1073/pnas.1320008111; Hacke UG, 2009, PLANT CELL ENVIRON, V32, P1324, DOI 10.1111/j.1365-3040.2009.02000.x; Hacke UG, 2000, BASIC APPL ECOL, V1, P31, DOI 10.1078/1439-1791-00006; Hacke UG, 2015, NEW PHYTOL, V205, P116, DOI 10.1111/nph.13017; HELLMERS H, 1955, ECOLOGY, V36, P667, DOI 10.2307/1931305; HORTON JS, 1955, ECOLOGY, V36, P244, DOI 10.2307/1933230; Jacobsen AL, 2007, PLANT CELL ENVIRON, V30, P1599, DOI 10.1111/j.1365-3040.2007.01729.x; Jacobsen AL, 2007, ECOL MONOGR, V77, P99, DOI 10.1890/05-1879; Jacobsen AL, 2012, NEW PHYTOL, V194, P982, DOI 10.1111/j.1469-8137.2012.04118.x; Keeley JE, 2001, CONSERV BIOL, V15, P1536, DOI 10.1046/j.1523-1739.2001.00097.x; Korner C, 2015, CURR OPIN PLANT BIOL, V25, P107, DOI 10.1016/j.pbi.2015.05.003; Mann ME, 2015, P NATL ACAD SCI USA, V112, P3858, DOI 10.1073/pnas.1503667112; Maseda PH, 2006, J EXP BOT, V57, P3963, DOI 10.1093/jxb/erl127; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; McDowell NG, 2016, NAT CLIM CHANGE, V6, P295, DOI [10.1038/nclimate2873, 10.1038/NCLIMATE2873]; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; McDowell NG, 2011, TRENDS ECOL EVOL, V26, P523, DOI 10.1016/j.tree.2011.06.003; Meddens AJH, 2015, NEW PHYTOL, V206, P91, DOI 10.1111/nph.13193; Meentemeyer RK, 2001, PLANT ECOL, V156, P19, DOI 10.1023/A:1011944805738; Mencuccini M, 2015, NEW PHYTOL, V208, P396, DOI 10.1111/nph.13461; Mueller RC, 2005, J ECOL, V93, P1085, DOI 10.1111/j.1365-2745.2005.01042.x; Nepstad DC, 2007, ECOLOGY, V88, P2259, DOI 10.1890/06-1046.1; Oliva J, 2014, NEW PHYTOL, V203, P1028, DOI 10.1111/nph.12857; Ovalle JF, 2015, FORESTS, V6, P3733, DOI 10.3390/f6103733; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Paddock William A. S. III, 2013, Aliso, V31, P49; Padilla FM, 2007, FUNCT ECOL, V21, P489, DOI 10.1111/j.1365-2435.2007.01267.x; Parker VT, 2016, ECOSYSTEMS OF CALIFORNIA, P479; Pausas JG, 2016, NEW PHYTOL, V209, P945, DOI 10.1111/nph.13644; Plaut JA, 2012, PLANT CELL ENVIRON, V35, P1601, DOI 10.1111/j.1365-3040.2012.02512.x; Porcar-Castell A, 2014, J EXP BOT, V65, P4065, DOI 10.1093/jxb/eru191; Pratt RB, 2008, J ECOL, V96, P1252, DOI 10.1111/j.1365-2745.2008.01428.x; Pratt RB, 2007, ECOL MONOGR, V77, P239, DOI 10.1890/06-0780; Pratt RB, 2014, GLOBAL CHANGE BIOL, V20, P893, DOI 10.1111/gcb.12477; Pratt RB, 2012, AM J BOT, V99, P1464, DOI 10.3732/ajb.1200193; R Core Team, 2021, R LANGUAGE ENV STAT; Redtfeldt RA, 1996, ECOSCIENCE, V3, P290, DOI 10.1080/11956860.1996.11682345; Rice KJ, 2004, OECOLOGIA, V139, P190, DOI 10.1007/s00442-004-1503-9; Rodriguez-Calcerrada J, 2007, NEW FOREST, V33, P67, DOI 10.1007/s11056-006-9014-7; Rowland L, 2015, NATURE, V528, P119, DOI 10.1038/nature15539; Sala A, 2010, NEW PHYTOL, V186, P274, DOI 10.1111/j.1469-8137.2009.03167.x; Salmon Y, 2015, PLANT CELL ENVIRON, V38, P2575, DOI 10.1111/pce.12572; SCHLESINGER WH, 1982, BOT REV, V48, P71, DOI 10.1007/BF02860536; SCHLESINGER WH, 1980, ECOLOGY, V61, P781, DOI 10.2307/1936748; Sevanto S, 2014, PLANT CELL ENVIRON, V37, P153, DOI 10.1111/pce.12141; Skelton RP, 2015, P NATL ACAD SCI USA, V112, P5744, DOI 10.1073/pnas.1503376112; Sperry JS, 2012, PLANT CELL ENVIRON, V35, P601, DOI 10.1111/j.1365-3040.2011.02439.x; SPERRY JS, 1988, PLANT CELL ENVIRON, V11, P35, DOI 10.1111/j.1365-3040.1988.tb01774.x; Swain DL, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501344; THOMAS CM, 1989, OECOLOGIA, V80, P309, DOI 10.1007/BF00379032; Urli M, 2013, TREE PHYSIOL, V33, P672, DOI 10.1093/treephys/tpt030; Valladares F, 2006, PLANT BIOLOGY, V8, P688, DOI 10.1055/s-2006-924107; van Mantgem PJ, 2007, ECOL LETT, V10, P909, DOI 10.1111/j.1461-0248.2007.01080.x; Venturas MD, 2015, PLANT CELL ENVIRON, V38, P1060, DOI 10.1111/pce.12461; Vilagrosa A, 2010, ENVIRON EXP BOT, V69, P233, DOI 10.1016/j.envexpbot.2010.04.013; Wiens D, 2012, BIOL J LINN SOC, V105, P269, DOI 10.1111/j.1095-8312.2011.01820.x; Witter M, 2007, FLORA ECOLOGY SANTA, P173	79	70	72	3	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159145	10.1371/journal.pone.0159145	http://dx.doi.org/10.1371/journal.pone.0159145			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391489	Green Published, gold, Green Submitted			2022-12-27	WOS:000380005400214
J	Vieira, WF; Kenzo-Kagawa, B; Cogo, JC; Baranauskas, V; da Cruz-Hofling, MA				Vieira, Willians Fernando; Kenzo-Kagawa, Bruno; Cogo, Jose Carlos; Baranauskas, Vitor; da Cruz-Hofling, Maria Alice			Low-Level Laser Therapy (904 nm) Counteracts Motor Deficit of Mice Hind Limb following Skeletal Muscle Injury Caused by Snakebite-Mimicking Intramuscular Venom Injection	PLOS ONE			English	Article							RAT SCIATIC-NERVE; CELL-PROLIFERATION; BOTHROPS-JARARACA; CATWALK METHOD; GAIT ANALYSIS; SAO-PAULO; IRRADIATION; PAIN; REGENERATION; LOCOMOTION	Myotoxins present in Bothrops venom disrupt the sarcolemma of muscle fibers leading to the release of sarcoplasmic proteins and loss of muscle homeostasis. Myonecrosis and tissue anoxia induced by vascularization impairment can lead to amputation or motor functional deficit. The objective of this study was to investigate the dynamic behavior of motor function in mice subjected to injection of Bothrops jararacussu venom (Bjssu) and exposed to low-level laser therapy (LLLT). Male Swiss mice received Bjssu injection (830 mu g/kg) into the medial portion of the right gastrocnemius muscle. Three hours later the injected region was irradiated with diode semiconductor Gallium Arsenide (GaAs-904 nm, 4 J/cm(2)) laser following by irradiation at 24, 48 and 72 hours. Saline injection (0.9% NaCl) was used as control. Gait analysis was performed 24 hours before Bjssu injection and at every period post-Bjssu using CatWalk method. Data from spatiotemporal parameters Stand, Maximum Intensity, Swing, Swing Speed, Stride Length and Step Cycle were considered. The period of 3 hours post venom-induced injury was considered critical for all parameters evaluated in the right hindlimb. Differences (p<0.05) were concentrated in venom and venom + placebo laser groups during the 3 hours post-injury period, in which the values of stand of most animals were null. After this period, the gait characteristics were re-established for all parameters. The venom + laser group kept the values at 3 hours post-Bjssu equal to that at 24 hours before Bjssu injection indicating that the GaAs laser therapy improved spatially and temporally gait parameters at the critical injury period caused by Bjssu. This is the first study to analyze with cutting edge technology the gait functional deficits caused by snake envenoming and gait gains produced by GaAs laser irradiation. In this sense, the study fills a gap on the field of motor function after laser treatment following snake envenoming.	[Vieira, Willians Fernando; Baranauskas, Vitor] Univ Estadual Campinas, UNICAMP, Fac Elect Engn & Computat, Dept Semicond Instruments & Photon DSIF, Campinas, SP, Brazil; [Cogo, Jose Carlos] Univ Vale Paraiba UNIVAP, Inst Res & Dev IP&D, Sao Jose Dos Campos, SP, Brazil; [Vieira, Willians Fernando; Kenzo-Kagawa, Bruno; da Cruz-Hofling, Maria Alice] Univ Estadual Campinas, UNICAMP, Inst Biol, Dept Biochem & Tissue Biol DBBT, Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade do Vale do Paraiba; Universidade de Sao Paulo; Universidade Estadual de Campinas	da Cruz-Hofling, MA (corresponding author), Univ Estadual Campinas, UNICAMP, Inst Biol, Dept Biochem & Tissue Biol DBBT, Campinas, SP, Brazil.	hofling@unicamp.br	Vieira, Willians F/A-8235-2018	Vieira, Willians F/0000-0003-3022-7997	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [05/53625-1]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [488792/2011, 486142/2012-4]; CNPq [305099/2011-6]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) at the Departamento de Semicondutores, Instrumentos e Fotonica (FEEC-UNICAMP); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) at Departamento de Bioquimica e Biologia Tecidual (IB-UNICAMP)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) at the Departamento de Semicondutores, Instrumentos e Fotonica (FEEC-UNICAMP)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) at Departamento de Bioquimica e Biologia Tecidual (IB-UNICAMP)	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (Proc. 05/53625-1) (http://www.fapesp.br/) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, grants #488792/2011 and #486142/2012-4) (http://www.cnpq.br/). MACH is a IA research fellow from CNPq (grant #305099/2011-6); WFV was a Master Sci. student granted with a scholarship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (http://www.capes.gov.br/) at the Departamento de Semicondutores, Instrumentos e Fotonica (FEEC-UNICAMP) and Departamento de Bioquimica e Biologia Tecidual (IB-UNICAMP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves AN, 2014, AM J PHYS MED REHAB, V93, P1073, DOI 10.1097/PHM.0000000000000158; Amaral AC, 2001, LASER MED SCI, V16, P44, DOI 10.1007/PL00011336; BAIN JR, 1989, PLAST RECONSTR SURG, V83, P129, DOI 10.1097/00006534-198901000-00024; Barbosa AM, 2008, TOXICON, V51, P1236, DOI 10.1016/j.toxicon.2008.02.007; Ben-Dov N, 1999, BBA-MOL CELL RES, V1448, P372, DOI 10.1016/S0167-4889(98)00147-5; Bervar M, 2000, J NEUROSCI METH, V102, P109, DOI 10.1016/S0165-0270(00)00281-8; Borato E, 2008, REV BRAS MED ESPORTE, V14, P446, DOI 10.1590/S1517-86922008000500009; Bozkurt A, 2011, BEHAV BRAIN RES, V219, P55, DOI 10.1016/j.bbr.2010.12.018; Bozkurt A, 2008, J NEUROSCI METH, V170, P117, DOI 10.1016/j.jneumeth.2008.01.006; Brazilian Health Ministry, 1999, MAN DIAGN TREATM ENV, P131; CARDOSO JLC, 1993, Q J MED, V86, P315; Andraus RAC, 2010, ACTA ORTOP BRAS, V18, P152, DOI 10.1590/S1413-78522010000300007; Conlan MJ, 1996, J CLIN PERIODONTOL, V23, P492, DOI 10.1111/j.1600-051X.1996.tb00580.x; CRISCO JJ, 1994, AM J SPORT MED, V22, P702, DOI 10.1177/036354659402200521; DEMEDINACELI L, 1982, EXP NEUROL, V77, P634, DOI 10.1016/0014-4886(82)90234-5; Desmet KD, 2006, PHOTOMED LASER SURG, V24, P121, DOI 10.1089/pho.2006.24.121; Deumens R, 2007, J NEUROSCI METH, V164, P120, DOI 10.1016/j.jneumeth.2007.04.009; Doin-Silva R, 2009, PHOTOCHEM PHOTOBIOL, V85, P63, DOI 10.1111/j.1751-1097.2008.00397.x; Dourado DM, 2003, LASER SURG MED, V33, P352, DOI 10.1002/lsm.10237; Dourado DM, 2011, PHOTOCHEM PHOTOBIOL, V87, P418, DOI 10.1111/j.1751-1097.2010.00878.x; Ferreira-Gomes J, 2008, J PAIN, V9, P945, DOI 10.1016/j.jpain.2008.05.012; Filipe VM, 2006, J NEUROSCI METH, V153, P55, DOI 10.1016/j.jneumeth.2005.10.006; Gabriel AF, 2007, J NEUROSCI METH, V163, P9, DOI 10.1016/j.jneumeth.2007.02.003; Gabriel AF, 2009, BEHAV BRAIN RES, V198, P477, DOI 10.1016/j.bbr.2008.12.018; Gao XJ, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-4; GRILLNER S, 1975, PHYSIOL REV, V55, P247, DOI 10.1104/pp.55.2.247; GUTIERREZ J M, 1989, Memorias do Instituto Butantan (Sao Paulo), V51, P211; Gutierrez Jose Maria, 1995, P645; Gutierrez JM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002162; Hui Wen Fan, 1995, P667; Iwata A, 2010, MUSCLE NERVE, V41, P694, DOI 10.1002/mus.21567; Milani R, 1997, QJM-MON J ASSOC PHYS, V90, P323, DOI 10.1093/qjmed/90.5.323; Moller KA, 2008, J NEUROSCI METH, V174, P1, DOI 10.1016/j.jneumeth.2008.06.017; Picolo G, 2002, BRAZ J MED BIOL RES, V35, P1221, DOI 10.1590/S0100-879X2002001000016; Posten W, 2005, DERMATOL SURG, V31, P334, DOI 10.1097/00042728-200503000-00016; PUBLICOVER SJ, 1978, J NEUROPATH EXP NEUR, V37, P544, DOI 10.1097/00005072-197809000-00009; Pugliese Livia Souza, 2003, Pesqui Odontol Bras, V17, P307; Queiroz LD, 2002, TOXICON, V40, P1483, DOI 10.1016/S0041-0101(02)00166-6; QUEIROZ LS, 1984, TOXICON, V22, P339, DOI 10.1016/0041-0101(84)90077-1; SANTOS PM, 1995, J NEUROSCI METH, V61, P79, DOI 10.1016/0165-0270(95)00026-Q; Shefer G, 2002, J CELL SCI, V115, P1461; Shefer G, 2003, BBA-MOL CELL RES, V1593, P131, DOI 10.1016/S0167-4889(02)00350-6; Smith KC, 2005, PHOTOMED LASER SURG, V23, P78, DOI 10.1089/pho.2005.23.78; Song H, 2004, AM J SPORT MED, V32, P1263, DOI 10.1177/0363546503262199; TONUSSI CR, 1992, PAIN, V48, P421, DOI 10.1016/0304-3959(92)90095-S; Varejao ASP, 2003, EXP NEUROL, V183, P695, DOI 10.1016/S0014-4886(03)00208-5; Varejao ASP, 2002, MUSCLE NERVE, V26, P630, DOI 10.1002/mus.10242; Vladimirov YA, 2004, BIOCHEMISTRY-MOSCOW+, V69, P81, DOI 10.1023/B:BIRY.0000016356.93968.7e; WALKER JL, 1994, J NEUROSCI METH, V52, P47, DOI 10.1016/0165-0270(94)90054-X; WALT. World Association for Laser Therapy, 1994, DOS REC; WROGEMANN K, 1976, LANCET, V1, P672; Yu W, 1997, PHOTOCHEM PHOTOBIOL, V66, P866, DOI 10.1111/j.1751-1097.1997.tb03239.x	52	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158980	10.1371/journal.pone.0158980	http://dx.doi.org/10.1371/journal.pone.0158980			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27392016	Green Submitted, Green Published, gold			2022-12-27	WOS:000380005400179
J	Zheng, Z; Zhu, TT; Qu, Y; Mu, DZ				Zheng, Zhen; Zhu, Tingting; Qu, Yi; Mu, Dezhi			Blood Glutamate Levels in Autism Spectrum Disorder: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							AMINO-ACIDS PROFILES; CHILDREN; SERUM; RISK	Objective Glutamate plays an important role in brain development, neuronal migration, differentiation, survival and synaptogenesis. Recent studies have explored the relationship between blood glutamate levels and autism spectrum disorder (ASD). However, the findings are inconsistent. We undertook the first systematic review with a meta-analysis of studies examining blood glutamate levels in ASD compared with controls. Methods A literature search was conducted using PubMed, Embase, and the Cochrane Library for studies published before March 2016. A random-effects model was used to calculate the pooled standardized mean difference (SMD) of the outcomes. Subgroup analyses were used to explore the potential sources of heterogeneity, and the publication bias was estimated using Egger's tests. Results Twelve studies involving 880 participants and 446 incident cases were included in this meta-analysis. The meta-analysis provided evidence for higher blood glutamate levels in ASD [SMD = 0.99, 95% confidence interval (95% CI) = 0.58-1.40; P < 0.001] with high heterogeneity (I-2 = 86%, P < 0.001) across studies. The subgroup analyses revealed higher glutamate levels in ASD compared with controls in plasma [SMD = 1.04, 95% CI = 0.58-1.50; P < 0.001] but not true in serum [SMD = 0.79, 95% CI = -0.41-1.99; P = 0.20]. Studies employing high performance liquid chromatography (HPLC) or liquid chromatography-tandem mass spectrometry (LC-MS) assays also revealed higher blood glutamate levels in ASD. A sensitivity analysis found that the results were stable, and there was no evidence of publication bias. Conclusions Blood glutamate levels might be a potential biomarker of ASD.	[Zheng, Zhen; Zhu, Tingting; Qu, Yi; Mu, Dezhi] Sichuan Univ, West China Univ Hosp 2, Dept Pediat, Chengdu 610041, Peoples R China; [Zheng, Zhen; Zhu, Tingting; Qu, Yi; Mu, Dezhi] Sichuan Univ, Minist Educ, Key Lab Obstet & Gynecol & Pediat Dis & Birth Def, Chengdu 610041, Peoples R China; [Mu, Dezhi] Univ Calif San Francisco, Dept Pediat & Neurol, San Francisco, CA 94143 USA	Sichuan University; Sichuan University; University of California System; University of California San Francisco	Mu, DZ (corresponding author), Sichuan Univ, West China Univ Hosp 2, Dept Pediat, Chengdu 610041, Peoples R China.; Mu, DZ (corresponding author), Sichuan Univ, Minist Educ, Key Lab Obstet & Gynecol & Pediat Dis & Birth Def, Chengdu 610041, Peoples R China.; Mu, DZ (corresponding author), Univ Calif San Francisco, Dept Pediat & Neurol, San Francisco, CA 94143 USA.	dezhi.mu@ucsf.edu		Mu, Dezhi/0000-0002-2599-7041; Qu, Yi/0000-0002-9993-8810	National Science Foundation of China [81330016, 81270724]; Major State Basic Research Development Program [2013CB967404]; Ministry of Education of China [313037, IRT0935]; State Commission of Science Technology of China [2012BAI04B04]; Science and Technology Bureau of Sichuan province [2014SZ0149]; Grant of clinical discipline program (neonatology) from the Ministry of Health of China [1311200003303]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program(National Basic Research Program of China); Ministry of Education of China(Ministry of Education, China); State Commission of Science Technology of China; Science and Technology Bureau of Sichuan province; Grant of clinical discipline program (neonatology) from the Ministry of Health of China	This work was supported by the National Science Foundation of China (No. 81330016 to Dezhi Mu and No. 81270724 to Yi Qu), the Grant from the Major State Basic Research Development Program (2013CB967404), the Grants from Ministry of Education of China (313037, IRT0935), the Grant from State Commission of Science Technology of China (2012BAI04B04), the Grant from Science and Technology Bureau of Sichuan province (2014SZ0149), and the Grant of clinical discipline program (neonatology) from the Ministry of Health of China (1311200003303).	Abu Shmais GA, 2012, J NEURODEV DISORD, V4, DOI 10.1186/1866-1955-4-4; Adams JB, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-34; Adams JB, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-22; ALFREDSSON G, 1988, BIOL PSYCHIAT, V23, P689, DOI 10.1016/0006-3223(88)90052-2; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; [Anonymous], 2014, EGYPT J MED HUM GENE, DOI DOI 10.1016/J.EJMHG.2014.02.002; Arnold GL, 2003, J AUTISM DEV DISORD, V33, P449, DOI 10.1023/A:1025071014191; Baio Jon, 2012, Morbidity and Mortality Weekly Report, V61, P1; Cai J, 2016, NEUROREPORT, V27, P272, DOI 10.1097/WNR.0000000000000532; Canitano R, 2014, RES AUTISM SPECT DIS, V8, P255, DOI 10.1016/j.rasd.2013.12.009; DEUFEMIA P, 1995, BIOMED PHARMACOTHER, V49, P288, DOI 10.1016/0753-3322(96)82645-X; Diolordi L, 2014, EAT WEIGHT DISORD-ST, V19, P295, DOI 10.1007/s40519-014-0137-0; Frye RE, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-37; Gatto Cheryl L, 2010, Front Synaptic Neurosci, V2, P4, DOI 10.3389/fnsyn.2010.00004; Hassan TH, 2013, RES AUTISM SPECT DIS, V7, P541, DOI 10.1016/j.rasd.2012.12.005; Higgins JPT, 2008, STAT MED, V27, P6072, DOI 10.1002/sim.3427; Joshi G, 2013, EUR ARCH PSY CLIN N, V263, P379, DOI 10.1007/s00406-012-0369-9; Lodge D, 2009, NEUROPHARMACOLOGY, V56, P6, DOI 10.1016/j.neuropharm.2008.08.006; Manent JB, 2007, NEUROSCIENTIST, V13, P268, DOI 10.1177/1073858406298918; Matelski L, 2016, J AUTOIMMUN, V67, P1, DOI 10.1016/j.jaut.2015.11.003; Mitchell S, 2011, DEV DISABIL RES REV, V17, P130, DOI 10.1002/ddrr.1107; Naushad SM, 2013, INDIAN J BIOCHEM BIO, V50, P474; Nicoletti E, 2011, NEUROPHARMACOLOGY, V60, P1017, DOI 10.1016/j.neuropharm.2010.10.022; Ortinski PI, 2010, NAT NEUROSCI, V13, P584, DOI 10.1038/nn.2535; Sheldon AL, 2007, NEUROCHEM INT, V51, P333, DOI 10.1016/j.neuint.2007.03.012; Shimmura C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025340; Shinohe A, 2006, PROG NEURO-PSYCHOPH, V30, P1472, DOI 10.1016/j.pnpbp.2006.06.013; Small DM, 2015, CURR BIOL, V25, pR674, DOI 10.1016/j.cub.2015.06.050; Tirouvanziam R, 2012, J AUTISM DEV DISORD, V42, P827, DOI 10.1007/s10803-011-1314-x; Tu WJ, 2012, J CLIN BIOCHEM NUTR, V51, P248, DOI 10.3164/jcbn.12-45; Walsh P, 2011, NAT REV NEUROSCI, V12, P603, DOI 10.1038/nrn3113; Wan MW, 2013, J CHILD PSYCHOL PSYC, V54, P763, DOI 10.1111/jcpp.12032; Won H, 2012, NATURE, V486, P261, DOI 10.1038/nature11208; Yang PC, 2014, CURR PHARM DESIGN, V20, P5186, DOI 10.2174/1381612819666140110120725; Yip J, 2009, AUTISM RES, V2, P50, DOI 10.1002/aur.62	35	35	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158688	10.1371/journal.pone.0158688	http://dx.doi.org/10.1371/journal.pone.0158688			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27390857	Green Published, gold, Green Submitted			2022-12-27	WOS:000380005400103
J	Kondo, T; Kondo, Y; Orita, Y; Mitarai, F; Ishitsuka, Y; Irikura, M; Shimodozono, Y; Douchi, T; Takeda, Y; Irie, T				Kondo, Tomoko; Kondo, Yuki; Orita, Yuji; Mitarai, Fumi; Ishitsuka, Yoichi; Irikura, Mitsuru; Shimodozono, Yoshihiro; Douchi, Tsutomu; Takeda, Yasuo; Irie, Tetsumi			Predictive Factors for Efficacy and Safety of Prophylactic Theophylline for Extubation in Infants with Apnea of Prematurity	PLOS ONE			English	Article							CONTROLLED-TRIAL; WEIGHING LESS; MANAGEMENT; CAFFEINE; GRAMS	Purpose This study aimed to evaluate predictive factors involved in efficacy and safety in Japanese infants who received theophylline therapy to prevent apnea of prematurity (AOP) after weaning from mechanical ventilation. Methods We retrospectively reviewed the medical records of infants who were administered intravenous aminophylline (theophylline ethylenediamine) for AOP at the neonatal intensive care unit, Kagoshima University Hospital, Japan, between January 2009 and June 2013. Results A total of 100 infants were evaluated as two separate groups in terms of efficacy and safety of theophylline. Sixty-seven (67.0%) infants had effective theophylline therapy. Multivariate logistic regression analysis showed that gestational age at birth was significant, with an odds ratio of 0.59 (p < 0.001). Receiver operating characteristic analysis showed that the cut-off value was 31.1 weeks old for predicting the efficacy of theophylline (specificity, 66.7%; sensitivity, 86.6%; p < 0.001; area under the curve, 0.750; 95% confidence interval, 0.45-0.74). Adverse reactions were identified in 21 (21.0%) infants. Multivariate logistic regression analysis showed that the number of days of theophylline administration from birth was associated with an increased risk of adverse reactions after theophylline administration (p = 0.01). Conclusions Physicians need to be aware of the possibility that theophylline fails to produce therapeutic effects for extubation in infants aged less than 31.1 weeks old, and adverse reactions can easily develop when theophylline is administered soon after birth.	[Kondo, Tomoko; Kondo, Yuki; Mitarai, Fumi; Ishitsuka, Yoichi; Irie, Tetsumi] Kumamoto Univ, Dept Clin Chem & Informat, Grad Sch Pharmaceut Sci, Kumamoto, Japan; [Kondo, Tomoko; Takeda, Yasuo] Kagoshima Univ Hosp, Dept Clin Pharm & Pharmacol, Kagoshima, Japan; [Orita, Yuji; Douchi, Tsutomu] Kagoshima Univ, Dept Obstet & Gynecol, Fac Med, Kagoshima, Japan; [Irikura, Mitsuru] Daiichi Univ, Lab Evidence Based Pharmacotherapy, Coll Pharmaceut Sci, Fukuoka, Japan; [Shimodozono, Yoshihiro] Kyusyu Univ Hlth & Welf, Lab Drug Informat, Dept Pharmaceut Sci, Nobeoka, Japan; [Irie, Tetsumi] Kumamoto Univ, Ctr Clin Pharmaceut Sci, Fac Pharmaceut Sci, Kumamoto, Japan	Kumamoto University; Kagoshima University; Kagoshima University; Kyushu University; Kumamoto University	Kondo, Y (corresponding author), Kumamoto Univ, Dept Clin Chem & Informat, Grad Sch Pharmaceut Sci, Kumamoto, Japan.	ykondo@kumamoto-u.ac.jp	KONDO, Yuki/ABB-9085-2020; Ishitsuka, Yoichi/H-5743-2019	KONDO, Yuki/0000-0003-1456-7721; Irie, Tetsumi/0000-0001-8664-7048; Ishitsuka, Yoichi/0000-0001-9442-4469				ALDEN ER, 1972, PEDIATRICS, V50, P40; ARANDA JV, 1979, CLIN PERINATOL, V6, P87, DOI 10.1016/S0095-5108(18)31165-5; BANAGALE RC, 1984, RESUSCITATION, V11, P9, DOI 10.1016/0300-9572(84)90030-3; Bhatia J, 2000, CLIN PEDIATR, V39, P327, DOI 10.1177/000992280003900602; Bhatt-Mehta Varsha, 2003, Paediatr Drugs, V5, P195, DOI 10.2165/00128072-200305030-00006; Blackmon LR, 2003, PEDIATRICS, V111, P914; BOUTROY MJ, 1979, J PEDIATR-US, V94, P996, DOI 10.1016/S0022-3476(79)80248-6; DURAND DJ, 1987, PEDIATRICS, V80, P684; Eichenwald EC, 1997, PEDIATRICS, V100, P354, DOI 10.1542/peds.100.3.354; Fukuda T, 2005, J CLIN PHARM THER, V30, P591, DOI 10.1111/j.1365-2710.2005.00689.x; HARGREAVES DB, 1983, J CLIN HOSP PHARM, V8, P133, DOI 10.1111/j.1365-2710.1983.tb01042.x; Henderson-Smart DJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000432.pub2; Henderson-Smart DJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000273.pub2; HENDERSONSMART DJ, 1981, AUST PAEDIATR J, V17, P273; KATTWINKEL J, 1977, J PEDIATR-US, V90, P342, DOI 10.1016/S0022-3476(77)80691-4; KAUFFMAN RE, 1992, PEDIATRICS, V89, P781; REESE J, 1994, ARCH DIS CHILD-FETAL, V71, pF51, DOI 10.1136/fn.71.1.F51; Rigatto H, 1984, PEDIATR CLIN N AM, V29, P1105; Skouroliakou M, 2009, J PAEDIATR CHILD H, V45, P587, DOI 10.1111/j.1440-1754.2009.01570.x	19	2	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0157198	10.1371/journal.pone.0157198	http://dx.doi.org/10.1371/journal.pone.0157198			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27388444	Green Submitted, gold, Green Published			2022-12-27	WOS:000379811500003
J	Nguyen, DG; Funk, J; Robbins, JB; Crogan-Grundy, C; Presnell, SC; Singer, T; Roth, AB				Nguyen, Deborah G.; Funk, Juergen; Robbins, Justin B.; Crogan-Grundy, Candace; Presnell, Sharon C.; Singer, Thomas; Roth, Adrian B.			Bioprinted 3D Primary Liver Tissues Allow Assessment of Organ-Level Response to Clinical Drug Induced Toxicity In Vitro	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; TROVAFLOXACIN HEPATOTOXICITY; INJURY; HEPATOCYTES; CULTURE; LIPOPOLYSACCHARIDE; IDIOSYNCRASY; RELEVANT; SYSTEM	Modeling clinically relevant tissue responses using cell models poses a significant challenge for drug development, in particular for drug induced liver injury (DILI). This is mainly because existing liver models lack longevity and tissue-level complexity which limits their utility in predictive toxicology. In this study, we established and characterized novel bioprinted human liver tissue mimetics comprised of patient-derived hepatocytes and non-parenchymal cells in a defined architecture. Scaffold-free assembly of different cell types in an in vivo-relevant architecture allowed for histologic analysis that revealed distinct intercellular hepatocyte junctions, CD31+ endothelial networks, and desmin positive, smooth muscle actin negative quiescent stellates. Unlike what was seen in 2D hepatocyte cultures, the tissues maintained levels of ATP, Albumin as well as expression and drug-induced enzyme activity of Cytochrome P450s over 4 weeks in culture. To assess the ability of the 3D liver cultures to model tissue-level DILI, dose responses of Trovafloxacin, a drug whose hepatotoxic potential could not be assessed by standard pre-clinical models, were compared to the structurally related non-toxic drug Levofloxacin. Trovafloxacin induced significant, dose-dependent toxicity at clinically relevant doses (<= 4uM). Interestingly, Trovafloxacin toxicity was observed without lipopolysaccharide stimulation and in the absence of resident macrophages in contrast to earlier reports. Together, these results demonstrate that 3D bioprinted liver tissues can both effectively model DILI and distinguish between highly related compounds with differential profile. Thus, the combination of patient-derived primary cells with bioprinting technology here for the first time demonstrates superior performance in terms of mimicking human drug response in a known target organ at the tissue level.	[Nguyen, Deborah G.; Robbins, Justin B.; Crogan-Grundy, Candace; Presnell, Sharon C.] Organovo Holdings Inc, San Diego, CA USA; [Funk, Juergen; Singer, Thomas; Roth, Adrian B.] Roche Innovat Ctr, Roche Pharmaceut Res & Early Dev, Basel, Switzerland	Roche Holding	Nguyen, DG (corresponding author), Organovo Holdings Inc, San Diego, CA USA.	dnguyen@organovo.com	Funk, Juergen/AGD-6896-2022	Nguyen, Deborah/0000-0002-1694-0617	Roche Pharmaceuticals; Organovo Holdings Inc.	Roche Pharmaceuticals(Roche Holding); Organovo Holdings Inc.	All studies were funded internally by Roche Pharmaceuticals and Organovo Holdings Inc. No specific awards or grants funded this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoine DJ, 2013, BIOMARK MED, V7, P383, DOI [10.2217/BMM.13.42, 10.2217/bmm.13.42]; Bhatia SN, 1997, J BIOMED MATER RES, V34, P189, DOI 10.1002/(SICI)1097-4636(199702)34:2<189::AID-JBM8>3.0.CO;2-M; Boelsterli UA, 2007, TOXICOL APPL PHARM, V220, P92, DOI 10.1016/j.taap.2006.12.013; Cho CH, 2010, BIOTECHNIQUES, V48, P47, DOI 10.2144/000113317; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; De Minicis S, 2007, GASTROENTEROLOGY, V132, P1937, DOI 10.1053/j.gastro.2007.02.033; Forgacs G., 2012, US patent, Patent No. [US 8,241,905 B2, 8241905]; Forgacs G., 2014, US Pat, Patent No. [US 8,852,932 B2, 8852932]; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Godoy P, 2013, ARCH TOXICOL, V87, P1315, DOI 10.1007/s00204-013-1078-5; Jakab K, 2008, TISSUE ENG PT A, V14, P413, DOI 10.1089/tea.2007.0173; KAPLOWITZ N, 1986, ANN INTERN MED, V104, P826, DOI 10.7326/0003-4819-104-6-826; Kegel V, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/640631; Kostadinova R, 2013, TOXICOL APPL PHARM, V268, P1, DOI 10.1016/j.taap.2013.01.012; Lazarczyk DA, 2001, DIGEST DIS SCI, V46, P925, DOI 10.1023/A:1010741510046; Messner S, 2013, ARCH TOXICOL, V87, P209, DOI 10.1007/s00204-012-0968-2; Murphy K, 2015, United States of America patent, Patent No. [US 9,149,952 B2, 9149952]; Murphy SV, 2014, NAT BIOTECHNOL, V32, P773, DOI 10.1038/nbt.2958; Naisbitt DJ, 2000, DRUG SAFETY, V23, P483, DOI 10.2165/00002018-200023060-00002; Nguyen DG, 2016, ENG RENAL TISSUES AR; Nicholson SC, 2002, PHARMACOTHERAPY, V22, P794, DOI 10.1592/phco.22.9.794.34066; Oh MK, 2008, ALIMENT PHARM THER, V28, P503, DOI 10.1111/j.1365-2036.2008.03752.x; Olsen AL, 2011, AM J PHYSIOL-GASTR L, V301, pG110, DOI 10.1152/ajpgi.00412.2010; Olson H, 2000, REGUL TOXICOL PHARM, V32, P56, DOI 10.1006/rtph.2000.1399; Olson MJ, 1989, CELL INTERCOMMUNICAT; Otu HH, 2007, J BIOL CHEM, V282, P11197, DOI 10.1074/jbc.M608441200; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Robbins J. B., 2013, BIOPRINTED 3 DIMENSI; Robbins JB, 2013, STEM CELL M MES JOLL; Roth RA, 2003, J PHARMACOL EXP THER, V307, P1, DOI 10.1124/jpet.102.041624; Shaw PJ, 2007, TOXICOL SCI, V100, P259, DOI 10.1093/toxsci/kfm218; Shaw PJ, 2010, TOXICOL SCI, V118, P7, DOI 10.1093/toxsci/kfq168; Shepherd B. R., 2015, US Patent, Patent No. [US9222932, 9222932]; Soldatow VY, 2013, TOXICOL RES-UK, V2, P23, DOI 10.1039/c2tx20051a; Tostoes RM, 2012, HEPATOLOGY, V55, P1227, DOI 10.1002/hep.24760; Uetrecht J, 2003, DRUG DISCOV TODAY, V8, P832, DOI 10.1016/S1359-6446(03)02816-2; Uetrecht JP, 1999, CHEM RES TOXICOL, V12, P387, DOI 10.1021/tx980249i; Waring JF, 2006, J PHARMACOL EXP THER, V316, P1080, DOI 10.1124/jpet.105.096347; Watkins PB, 2005, HEPATOLOGY, V41, P229, DOI 10.1002/hep.20598; Watkins PB, 2005, TOXICOL PATHOL, V33, P1, DOI 10.1080/01926230590888306; Williams DP, 2003, DRUG DISCOV TODAY, V8, P1044, DOI 10.1016/S1359-6446(03)02888-5; Williamson B, 2013, ANTIMICROB AGENTS CH, V57, P6366, DOI 10.1128/AAC.01124-13; Zimmerman HJ., 1999, HEPATOTOXICITY ADVER, V2nd ed	43	214	228	6	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158674	10.1371/journal.pone.0158674	http://dx.doi.org/10.1371/journal.pone.0158674			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27387377	gold, Green Published, Green Submitted			2022-12-27	WOS:000379811500036
J	Noar, RD; Daub, ME				Noar, Roslyn D.; Daub, Margaret E.			Bioinformatics Prediction of Polyketide Synthase Gene Clusters from Mycosphaerella fijiensis	PLOS ONE			English	Article							COLLO-CYGNI SUTTON; BLACK SIGATOKA; FUMONISIN B-1; PENTAKETIDE METABOLITES; MELANIN BIOSYNTHESIS; VERTICILLIUM-DAHLIAE; ASCOCHYTA-RABIEI; CAUSATIVE AGENT; CARRIER PROTEIN; DIELS-ALDERASE	Mycosphaerella fijiensis, causal agent of black Sigatoka disease of banana, is a Dothideo-mycete fungus closely related to fungi that produce polyketides important for plant pathogenicity. We utilized the M. fijiensis genome sequence to predict PKS genes and their gene clusters and make bioinformatics predictions about the types of compounds produced by these clusters. Eight PKS gene clusters were identified in the M. fijiensis genome, placing M. fijiensis into the 23rd percentile for the number of PKS genes compared to other Dothi-deomycetes. Analysis of the PKS domains identified three of the PKS enzymes as non-reducing and two as highly reducing. Gene clusters contained types of genes frequently found in PKS clusters including genes encoding transporters, oxidoreductases, methyl-transferases, and non-ribosomal peptide synthases. Phylogenetic analysis identified a putative PKS cluster encoding melanin biosynthesis. None of the other clusters were closely aligned with genes encoding known polyketides, however three of the PKS genes fell into clades with clusters encoding alternapyrone, fumonisin, and solanapyrone produced by Alternaria and Fusarium species. A search for homologs among available genomic sequences from 103 Dothideomycetes identified close homologs (>80% similarity) for six of the PKS sequences. One of the PKS sequences was not similar (<60% similarity) to sequences in any of the 103 genomes, suggesting that it encodes a unique compound. Comparison of the M. fijiensis PKS sequences with those of two other banana pathogens, M. musicola and M. eumusae, showed that these two species have close homologs to five of the M. fijiensis PKS sequences, but three others were not found in either species. RTPCR and RNA-Seq analysis showed that the melanin PKS cluster was down-regulated in infected banana as compared to growth in culture. Three other clusters, however were strongly upregulated during disease development in banana, suggesting that they may encode polyketides important in pathogenicity.	[Noar, Roslyn D.] North Carolina State Univ, Dept Plant Pathol, Raleigh, NC 27695 USA; [Daub, Margaret E.] North Carolina State Univ, Dept Plant & Microbial Biol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Daub, ME (corresponding author), North Carolina State Univ, Dept Plant & Microbial Biol, Raleigh, NC 27695 USA.	margaret_daub@ncsu.edu		Noar, Roslyn/0000-0003-1645-7147	Dole Food Company; National Science Foundation; National Institutes of Health	Dole Food Company; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by a gift from Dole Food Company to MED and by graduate fellowships from the National Science Foundation and National Institutes of Health to RDN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie C, 2009, ACTA HORTIC, V828, P171; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bachmann BO, 2009, METHOD ENZYMOL, V458, P181, DOI 10.1016/S0076-6879(09)04808-3; Balint-Kurti P, 2004, BANANA IMPROVEMENT: CELLULAR, MOLECULAR BIOLOGY, AND INDUCED MUTATIONS, P147; BELL AA, 1976, TETRAHEDRON, V32, P1353, DOI 10.1016/0040-4020(76)85009-0; BELL AA, 1976, CAN J MICROBIOL, V22, P787, DOI 10.1139/m76-115; Beltran-Garcia MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091616; Blackwell BA, 1996, ADV EXP MED BIOL, V392, P75; Bradshaw RE, 2013, NEW PHYTOL, V198, P525, DOI 10.1111/nph.12161; BRANHAM BE, 1993, MYCOPATHOLOGIA, V124, P99, DOI 10.1007/BF01103109; Brush L, 1999, FUNGAL GENET BIOL, V28, P190, DOI 10.1006/fgbi.1999.1176; Caldas ED, 1998, J AGR FOOD CHEM, V46, P4734, DOI 10.1021/jf980210j; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chen HQ, 2007, MOL MICROBIOL, V64, P755, DOI 10.1111/j.1365-2958.2007.05689.x; Chen M, 2009, ADV PHOTOSYNTH RESP, V30, P77; Cho Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002974; Choquer M, 2005, MOL PLANT MICROBE IN, V18, P468, DOI 10.1094/MPMI-18-0468; CHUMLEY FG, 1990, MOL PLANT MICROBE IN, V3, P135, DOI 10.1094/MPMI-3-135; Churchill ACL, 2011, MOL PLANT PATHOL, V12, P307, DOI 10.1111/j.1364-3703.2010.00672.x; Cox RJ, 2007, ORG BIOMOL CHEM, V5, P2010, DOI 10.1039/b704420h; D.O.E. Joint Genome Institute, 2016, MYC FIJ V2 0; Droc G, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat035; Du L, 2008, J IND MICROBIOL BIOT, V35, P455, DOI 10.1007/s10295-008-0316-y; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Finking R, 2004, BIOCHEMISTRY-US, V43, P8946, DOI 10.1021/bi0496891; Fujii I, 2005, CHEM BIOL, V12, P1301, DOI 10.1016/j.chembiol.2005.09.015; Gerber R, 2009, J AM CHEM SOC, V131, P3148, DOI 10.1021/ja8091054; Gilchrist DG, 1997, CELL DEATH DIFFER, V4, P689, DOI 10.1038/sj.cdd.4400312; Glenn AE, 2008, MOL PLANT MICROBE IN, V21, P87, DOI 10.1094/MPMI-21-1-0087; Goodwin S.B., 2014, GENOMICS PLANT ASS F, P123; Grigoriev I. V., 2011, Mycology - An International Journal on Fungal Biology, V2, P192; Grigoriev IV, 2014, NUCLEIC ACIDS RES, V42, pD699, DOI 10.1093/nar/gkt1183; Heiser I, 2004, PHYSIOL MOL PLANT P, V64, P135, DOI 10.1016/j.pmpp.2004.08.002; Heiser I, 2003, PHYSIOL MOL PLANT P, V62, P29, DOI 10.1016/S0885-5765(03)00007-9; Holler U, 2002, J NAT PROD, V65, P876, DOI 10.1021/np020097y; HOWARD RJ, 1989, EXP MYCOL, V13, P403, DOI 10.1016/0147-5975(89)90036-4; Huang WJ, 1998, EMBO J, V17, P1183, DOI 10.1093/emboj/17.5.1183; Jacobson ES, 2005, MED MYCOL, V43, P327, DOI 10.1080/13693780412331271081; Jenke-Kodama H, 2005, MOL BIOL EVOL, V22, P2027, DOI 10.1093/molbev/msi193; Kabir MS, 2015, PLANT PATHOL, V64, P225, DOI 10.1111/ppa.12229; Kasahara K, 2010, CHEMBIOCHEM, V11, P1245, DOI 10.1002/cbic.201000173; KAUR S, 1995, PLANT SCI, V109, P23, DOI 10.1016/0168-9452(95)04144-J; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Keatinge-Clay AT, 2006, STRUCTURE, V14, P737, DOI 10.1016/j.str.2006.01.009; Keller NP, 2005, NAT REV MICROBIOL, V3, P937, DOI 10.1038/nrmicro1286; Keller NP, 1997, FUNGAL GENET BIOL, V21, P17, DOI 10.1006/fgbi.1997.0970; Khaldi N, 2010, FUNGAL GENET BIOL, V47, P736, DOI 10.1016/j.fgb.2010.06.003; Kim W, 2015, MOL PLANT MICROBE IN, V28, P482, DOI 10.1094/MPMI-08-14-0234-R; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maddison WP., 2021, MESQUITE MODULAR SYS; Marasas WFO, 2004, J NUTR, V134, P711, DOI 10.1093/jn/134.4.711; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Marin DH, 2003, PLANT DIS, V87, P208, DOI 10.1094/PDIS.2003.87.3.208; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mizushina Y, 2002, J BIOL CHEM, V277, P630, DOI 10.1074/jbc.M105144200; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nicoletti R, 2009, INT J MOL SCI, V10, P1430, DOI 10.3390/ijms10041430; Pata MO, 2010, NEW PHYTOL, V185, P611, DOI 10.1111/j.1469-8137.2009.03123.x; Peraza-Echeverria L, 2008, AUSTRALAS PLANT PATH, V37, P460, DOI 10.1071/AP08042; Perpetua NS, 1996, MOL PLANT MICROBE IN, V9, P323, DOI 10.1094/MPMI-9-0323; Ploetz R. C., 2001, PLANT HLTH INSTR, DOI [10.1094/PHI-I-2001-0126-02, DOI 10.1094/PHI-I-2001-0126-02]; Proctor RH, 2003, FUNGAL GENET BIOL, V38, P237, DOI 10.1016/S1087-1845(02)00525-X; Sanchez-Rangel D, 2010, TOXIN REV, V29, P73, DOI 10.3109/15569543.2010.515370; Saparrat MCN, 2009, MYCOPATHOLOGIA, V168, P41, DOI 10.1007/s11046-009-9194-8; Seo JA, 2001, FUNGAL GENET BIOL, V34, P155, DOI 10.1006/fgbi.2001.1299; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Steiner U, 2007, PHYTOPATHOLOGY, V97, P1222, DOI 10.1094/PHYTO-97-10-1222; STIERLE AA, 1991, EXPERIENTIA, V47, P853, DOI 10.1007/BF01922472; STIPANOVIC RD, 1977, MYCOLOGIA, V69, P164, DOI 10.2307/3758627; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; UPADHYAY RK, 1990, EXPERIENTIA, V46, P982, DOI 10.1007/BF01939396; WANG YL, 1994, INFECT IMMUN, V62, P3004, DOI 10.1128/IAI.62.7.3004-3007.1994; Weissman KJ, 2015, NAT CHEM BIOL, V11, P660, DOI [10.1038/NCHEMBIO.1883, 10.1038/nchembio.1883]; WHEELER MH, 1985, ARCH MICROBIOL, V142, P234, DOI 10.1007/BF00693396; Wiemann P, 2009, MOL MICROBIOL, V72, P931, DOI 10.1111/j.1365-2958.2009.06695.x; Wight WD, 2009, MOL PLANT MICROBE IN, V22, P1258, DOI 10.1094/MPMI-22-10-1258; Yadav G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000351; Yoder OC, 1998, DEV PLANT PATHOL, V13, P3; Yu JJ, 2004, FEBS LETT, V564, P126, DOI 10.1016/S0014-5793(04)00327-8; Zhang Y, 2005, HDB IND MYCOLOGY, P410	81	17	28	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158471	10.1371/journal.pone.0158471	http://dx.doi.org/10.1371/journal.pone.0158471			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27388157	gold, Green Published, Green Submitted			2022-12-27	WOS:000379811500021
J	John, G; Bardini, C; Combescure, C; Dallenbach, P				John, Gregor; Bardini, Claire; Combescure, Christophe; Dallenbach, Patrick			Urinary Incontinence as a Predictor of Death: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							NURSING-HOME ADMISSION; FOLLOW-UP; RESIDENTIAL CARE; ELDERLY-PEOPLE; TRACT SYMPTOMS; HOSPITAL-CARE; OLDER-PEOPLE; RISK-FACTORS; MORTALITY; POPULATION	Background The association between urinary incontinence (UI) and increased mortality remains controversial. The objective of our study was to evaluate if this association exists. Methods We performed a systematic review and meta-analysis of observational studies comparing death rates among patients suffering from UI to those without incontinence. We searched in Medline, Embase and the Cochrane library using specific keywords. Studies exploring the post-stroke period were excluded. Hazard ratios (HR) were pooled using models with random effects. We stratified UI by gender and by UI severity and pooled all models with adjustment for confounding variables. Results Thirty-eight studies were retrieved. When compared to non-urinary incontinent participants, UI was associated with an increase in mortality with pooled non adjusted HR of 2.22 (95% CI 1.77-2.78). The risk increased with UI severity: 1.24 (95% CI: 0.79-1.97) for light, 1.71 (95% CI: 1.26-2.31) for moderate, and 2.72 (95% CI: 1.90-3.87) for severe UI respectively. When pooling adjusted measures of association, the resulting HR was 1.27 (95% CI: 1.13-1.42) and increased progressively for light, moderate and severe UI: 1.07 (95% CI: 0.79-1.44), 1.25 (95% CI: 0.99-1.58), and 1.47 (95% CI: 1.03-2.10) respectively. There was no difference between genders. Conclusion UI is a predictor of higher mortality in the general and particularly in the geriatric population. The association increases with the severity of UI and persists when pooling models adjusted for confounders. It is unclear if this association is causative or just reflects animpaired general health condition. As in most meta-analyses of observational studies, methodological issues should be considered when interpreting results.	[John, Gregor] Hop Neuchatelois, Dept Internal Med, Chasseral 20, CH-2300 La Chaux De Fonds, Switzerland; [John, Gregor] Univ Hosp Geneva HUG, Dept Internal Med Rehabil & Geriatr, Gabrielle Perret Gentil 4, CH-1205 Geneva, Switzerland; [Bardini, Claire] Univ Geneva, Fac Med, Geneva, Switzerland; [Combescure, Christophe] Univ Geneva, CRC, Dept Hlth & Community Med, Geneva, Switzerland; [Combescure, Christophe] Univ Geneva, Div Clin Epidemiol, CRC, Dept Hlth & Community Med, Geneva, Switzerland; [Combescure, Christophe] Geneva Univ Hosp HUG, Geneva, Switzerland; [Dallenbach, Patrick] Geneva Univ Hosp HUG, Perineol Unit, Dept Gynecol & Obstet, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Geneva	John, G (corresponding author), Hop Neuchatelois, Dept Internal Med, Chasseral 20, CH-2300 La Chaux De Fonds, Switzerland.; John, G (corresponding author), Univ Hosp Geneva HUG, Dept Internal Med Rehabil & Geriatr, Gabrielle Perret Gentil 4, CH-1205 Geneva, Switzerland.	gregor.john@h-ne.ch	John, Gregor/AAJ-6424-2021; Dällenbach, Patrick/W-7241-2019	John, Gregor/0000-0002-1548-7339; Dällenbach, Patrick/0000-0002-1469-3552				ABRAHAMIK A, 1993, ANN MED INTERNE, V144, P92; Abrams P, 2002, AM J OBSTET GYNECOL, V187, P116, DOI 10.1067/mob.2002.125704; Adams D, 2000, BRAIN, V123, P1495, DOI 10.1093/brain/123.7.1495; Anpalahan M, 2008, INTERN MED J, V38, P16, DOI 10.1111/j.1445-5994.2007.01398.x; Asemi Z, 2015, NUTR METAB CARDIOVAS, V25, P623, DOI 10.1016/j.numecd.2015.03.008; Baztan JJ, 2005, AGE AGEING, V34, P172, DOI 10.1093/ageing/afi001; Bedretdinova D, 2015, EUR UROL; Beeckman D, 2014, RES NURS HEALTH, V37, P204, DOI 10.1002/nur.21593; Berardelli M, 2013, REJUV RES, V16, P206, DOI 10.1089/rej.2013.1417; BERRIOS GE, 1986, GERONTOLOGY, V32, P119, DOI 10.1159/000212775; Bjelakovic G, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007470.pub3; Bootsma AM, J AM MED DIR ASS, V14; Borenstein M, 2009, INTRO META ANAL; BRAUER E, 1978, SCAND J SOC MED, V6, P17, DOI 10.1177/140349487800600104; Brogan E, 2015, J CLIN NEUROSCI, V22, P92, DOI 10.1016/j.jocn.2014.05.035; Brown JS, 2000, J AM GERIATR SOC, V48, P721, DOI 10.1111/j.1532-5415.2000.tb04744.x; Brubaker L, 2015, AM J OBSTET GYNECOL, V213, P644, DOI 10.1016/j.ajog.2015.05.032; CAMPBELL AJ, 1985, AGE AGEING, V14, P65, DOI 10.1093/ageing/14.2.65; CAMPBELL AJ, 1985, J EPIDEMIOL COMMUN H, V39, P337, DOI 10.1136/jech.39.4.337; Cartwright R, 2014, EUR UROL, V66, P752, DOI 10.1016/j.eururo.2014.01.007; Chen LK, 2010, J AM MED DIR ASSOC, V11, P567, DOI 10.1016/j.jamda.2009.11.012; Coyne KS, 2013, INT J CLIN PRACT, V67, P1015, DOI 10.1111/ijcp.12164; Dallosso H, 2004, EUR J CLIN NUTR, V58, P920, DOI 10.1038/sj.ejcn.1601913; Deeks J J, 2003, Health Technol Assess, V7, piii; DONALDSON LJ, 1980, J EPIDEMIOL COMMUN H, V34, P96, DOI 10.1136/jech.34.2.96; DONALDSON LJ, 1983, J EPIDEMIOL COMMUN H, V37, P176, DOI 10.1136/jech.37.3.176; Duralde ER, 2015, AM J OBSTET GYNECOL; EKELUND P, 1987, ARCH GERONTOL GERIAT, V6, P11, DOI 10.1016/0167-4943(87)90034-3; Espallargues M, 2008, QJM-INT J MED, V101, P99, DOI 10.1093/qjmed/hcm136; Faltin DL, 2009, J GYNECOL OBST BIO R, V38, pS146, DOI 10.1016/S0368-2315(09)73574-4; Farage MA, 2008, ARCH GYNECOL OBSTET, V277, P285, DOI 10.1007/s00404-007-0505-3; Gambassi G, 1999, J NEUROL NEUROSUR PS, V67, P59, DOI 10.1136/jnnp.67.1.59; Gavira Iglesias F, 2005, Aten Primaria, V35, P67, DOI 10.1157/13072183; GOLDFARB AI, 1969, ARCH GEN PSYCHIAT, V21, P172; HERZOG AR, 1994, J AM GERIATR SOC, V42, P264, DOI 10.1111/j.1532-5415.1994.tb01749.x; Hollins S, 1998, DEV MED CHILD NEUROL, V40, P50; Holroyd-Leduc JM, 2004, J AM GERIATR SOC, V52, P712, DOI 10.1111/j.1532-5415.2004.52207.x; Hunter KF, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-46; Irwin DE, 2011, BJU INT, V108, P1132, DOI 10.1111/j.1464-410X.2010.09993.x; Jerez-Roig J, 2014, NEUROUROL URODYNAM; John G, 2014, BJU INT, V113, P113, DOI 10.1111/bju.12359; Johnson TM, 2000, J AGING HEALTH, V12, P25, DOI 10.1177/089826430001200102; Kohn D, 1991, Aging (Milano), V3, P279; KOYANO W, 1986, ARCH GERONTOL GERIAT, V5, P197, DOI 10.1016/0167-4943(86)90022-1; Krumholz HM, 2001, J AM COLL CARDIOL, V38, P453, DOI 10.1016/S0735-1097(01)01395-X; Landi F, J NUTR HLTH AGING, V16, P79; Luk JKH, 2013, HONG KONG MED J, V19, P518, DOI 10.12809/hkmj133951; Markland AD, 2011, J UROLOGY, V186, P589, DOI 10.1016/j.juro.2011.03.114; Maserejian NN, 2011, EUR UROL, V59, P1039, DOI 10.1016/j.eururo.2011.03.008; Maserejian NN, 2010, AM J EPIDEMIOL, V171, P1116, DOI 10.1093/aje/kwq065; Min L, 2009, J AM GERIATR SOC, V57, P2070, DOI 10.1111/j.1532-5415.2009.02497.x; Mody L, 2014, JAMA-J AM MED ASSOC, V311, P844, DOI 10.1001/jama.2014.303; Nakanishi N, 1999, AGE AGEING, V28, P301, DOI 10.1093/ageing/28.3.301; Nuotio M, 2002, AGING CLIN EXP RES, V14, P412; Nuotio Maria, 2009, Arch Gerontol Geriatr, V49, pe85, DOI 10.1016/j.archger.2008.08.009; Oliver D, 2004, AGE AGEING, V33, P122, DOI 10.1093/ageing/afh017; Pagliacci MC, 2007, SPINAL CORD, V45, P404, DOI 10.1038/sj.sc.3101991; Pearce MM, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.07.009; Pearce MM, 2014, MBIO, V5, DOI 10.1128/mBio.01283-14; Perneger TV, 2008, CONTEMP CLIN TRIALS, V29, P762, DOI 10.1016/j.cct.2008.06.002; Sorbye LW, 2013, SCAND J CARING SCI, V27, P632, DOI 10.1111/j.1471-6712.2012.01075.x; Subak LL, 2015, JAMA INTERN MED, V175, P1378, DOI 10.1001/jamainternmed.2015.2609; Subak LL, 2009, NEW ENGL J MED, V360, P481, DOI 10.1056/NEJMoa0806375; Thom DH, 1997, AGE AGEING, V26, P367, DOI 10.1093/ageing/26.5.367; TILVIS RS, 1995, ARCH GERONTOL GERIAT, V21, P307, DOI 10.1016/0167-4943(95)00670-G; VENKATESAN P, 1990, THORAX, V45, P254, DOI 10.1136/thx.45.4.254; Zittermann Armin, 2014, Adv Exp Med Biol, V810, P106; Zivin K, 2015, J PSYCHOSOM RES, V78, P324, DOI 10.1016/j.jpsychores.2015.01.014; ZWEIG S, 1990, J FAM PRACTICE, V30, P153	69	39	40	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158992	10.1371/journal.pone.0158992	http://dx.doi.org/10.1371/journal.pone.0158992			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ9CP	27410965	Green Published, Green Submitted, gold			2022-12-27	WOS:000379508300046
J	Adu-Gyamfi, R; Wetten, A; Lopez, CMR				Adu-Gyamfi, Raphael; Wetten, Andy; Lopez, Carlos Marcelino Rodriguez			Effect of Cryopreservation and Post-Cryopreservation Somatic Embryogenesis on the Epigenetic Fidelity of Cocoa (Theobroma cacao L.)	PLOS ONE			English	Article							ELAEIS-GUINEENSIS JACQ.; DNA METHYLATION CHANGES; IN-VITRO; SOMACLONAL VARIATION; TISSUE-CULTURE; GENETIC FIDELITY; EMBRYOS; QUANTIFICATION; STABILITY; SEQUENCE	While cocoa plants regenerated from cryopreserved somatic embryos can demonstrate high levels of phenotypic variability, little is known about the sources of the observed variability. Previous studies have shown that the encapsulation-dehydration cryopreservation methodology imposes no significant extra mutational load since embryos carrying high levels of genetic variability are selected against during protracted culture. Also, the use of secondary rather than primary somatic embryos has been shown to further reduce the incidence of genetic somaclonal variation. Here, the effect of in vitro conservation, cryopreservation and post-cryopreservation generation of somatic embryos on the appearance of epigenetic somaclonal variation were comparatively assessed. To achieve this we compared the epigenetic profiles, generated using Methylation Sensitive Amplified Polymorphisms, of leaves collected from the ortet tree and from cocoa somatic embryos derived from three in vitro conditions: somatic embryos, somatic embryos cryopreserved in liquid nitrogen and somatic embryos generated from cryoproserved somatic embryos. Somatic embryos accumulated epigenetic changes but these were less extensive than in those regenerated after storage in LN. Furthermore, the passage of cryopreserved embryos through another embryogenic stage led to further increase in variation. Interestingly, this detected variability appears to be in some measure reversible. The outcome of this study indicates that the cryopreservation induced phenotypic variability could be, at least partially, due to DNA methylation changes. Key message: Phenotypic variability observed in cryostored cocoa somatic-embryos is epigenetic in nature. This variability is partially reversible, not stochastic in nature but a directed response to the in-vitro culture and cryopreservation.	[Adu-Gyamfi, Raphael] Univ Dev Studies, Fac Agr, POB TL 1882, Tamale, Ghana; [Wetten, Andy] Univ Reading, Sch Agr Policy & Dev, Reading RG6 6AS, Berks, England; [Lopez, Carlos Marcelino Rodriguez] Univ Adelaide, Fac Sci, Sch Agr Food & Wine, Environm Epigenet & Genet Grp,Plant Res Ctr, Waite Campus,PMB1, Glen Osmond, SA 5064, Australia	University for Development Studies; University of Reading; University of Adelaide	Lopez, CMR (corresponding author), Univ Adelaide, Fac Sci, Sch Agr Food & Wine, Environm Epigenet & Genet Grp,Plant Res Ctr, Waite Campus,PMB1, Glen Osmond, SA 5064, Australia.	carlos.rodriguezlopez@adelaide.edu.au		Rodriguez Lopez, Carlos Marcelino/0000-0002-9704-9788	Ghana government through Ghana Education Trust Fund (GETFund)	Ghana government through Ghana Education Trust Fund (GETFund)	This project was funded by Ghana government through Ghana Education Trust Fund (GETFund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adu-Gyamfi R, 2012, CRYOLETTERS, V33, P494; Alemanno L, 1997, IN VITRO CELL DEV-PL, V33, P163, DOI 10.1007/s11627-997-0016-8; Alemanno L, 1996, PLANT CELL TISS ORG, V46, P187, DOI 10.1007/BF02307094; Alonso C, 2016, MOL ECOL RESOUR, V16, P80, DOI 10.1111/1755-0998.12426; Amoah S, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-193; Aronen TS, 1999, PLANT SCI, V142, P163, DOI 10.1016/S0168-9452(98)00244-1; Baranek M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126638; Bardini M, 2003, PLANT CELL TISS ORG, V72, P157, DOI 10.1023/A:1022208302819; Bednarek PT, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-10; Burg K, 2007, J EXP BOT, V58, P687, DOI 10.1093/jxb/erl241; Chakrabarty D, 2003, PLANT SCI, V165, P61, DOI 10.1016/S0168-9452(03)00127-4; Cote FX, 2001, IN VITRO CELL DEV-PL, V37, P539; Dann AL, 2011, PLANT CELL REP, V30, P631, DOI 10.1007/s00299-010-0983-9; Davey C, 1997, J MOL BIOL, V267, P276, DOI 10.1006/jmbi.1997.0899; Gimenez MD, 2016, PLANT CELL REP, V35, P129, DOI 10.1007/s00299-015-1874-x; Fang JY, 2009, AGR FOOD SCI, V18, P152, DOI 10.2137/145960609789267579; Fang JY, 2004, PLANT SCI, V166, P669, DOI 10.1016/j.plantsci.2003.11.002; Guiltinan M. J., 2007, Transgenic Crops V, P497; HARDING K, 1994, PLANT CELL TISS ORG, V37, P31, DOI 10.1007/BF00048114; INAMDAR NM, 1991, PLANT MOL BIOL, V17, P111, DOI 10.1007/BF00036811; Jaligot E, 2000, PLANT CELL REP, V19, P684, DOI 10.1007/s002999900177; Joyce SM, 2002, PLANT CELL TISS ORG, V70, P125, DOI 10.1023/A:1016312303320; Kaity A, 2008, PLANT CELL REP, V27, P1529, DOI 10.1007/s00299-008-0558-1; Kass SU, 1997, TRENDS GENET, V13, P444, DOI 10.1016/S0168-9525(97)01268-7; Kitimu SR, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00590; Li ZJ, 1998, IN VITRO CELL DEV-PL, V34, P293, DOI 10.1007/BF02822737; Lopez CMR, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00397; Lopez CMR, 2010, NEW PHYTOL, V186, P856, DOI 10.1111/j.1469-8137.2010.03242.x; Lopez CMR, 2010, MOL BREEDING, V25, P501, DOI 10.1007/s11032-009-9348-x; Lopez CMR, 2004, THEOR APPL GENET, V110, P157, DOI 10.1007/s00122-004-1823-5; Martin C, 2011, J PLANT PHYSIOL, V168, P158, DOI 10.1016/j.jplph.2010.06.025; Matthes M, 2001, THEOR APPL GENET, V102, P971, DOI 10.1007/s001220000491; Maximova SN, 2002, IN VITRO CELL DEV-PL, V38, P252, DOI 10.1079/IVP2001257; Miguel C, 2011, J EXP BOT, V62, P3713, DOI 10.1093/jxb/err155; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Peredo EL, 2009, J PLANT PHYSIOL, V166, P1101, DOI 10.1016/j.jplph.2008.12.015; PHILLIPS RL, 1994, P NATL ACAD SCI USA, V91, P5222, DOI 10.1073/pnas.91.12.5222; ReynaLopez GE, 1997, MOL GEN GENET, V253, P703, DOI 10.1007/s004380050374; Lopez CMR, 2012, FOOD CHEM, V131, P1493, DOI 10.1016/j.foodchem.2011.09.120; Schmitt F, 1997, J BIOL CHEM, V272, P1534, DOI 10.1074/jbc.272.3.1534; Smykal P, 2007, PLANT CELL REP, V26, P1985, DOI 10.1007/s00299-007-0413-9; Soen Y, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0097-y; Tan CL, 2003, PLANT SCI, V164, P407, DOI 10.1016/S0168-9452(02)00428-4; Tuttle JR, 2008, PLANT PHYSIOL, V148, P41, DOI 10.1104/pp.108.123869; Vogt G, 2015, J BIOSCIENCES, V40, P159, DOI 10.1007/s12038-015-9506-8; Wetten A, 2009, CRYOLETTERS, V30, P84; Wilkinson T, 2003, ANN BOT-LONDON, V91, P65, DOI 10.1093/aob/mcg009; Xiong LZ, 1999, MOL GEN GENET, V261, P439, DOI 10.1007/s004380050986	48	16	16	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0158857	10.1371/journal.pone.0158857	http://dx.doi.org/10.1371/journal.pone.0158857			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27403857	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000379508200018
J	Bonazza, C; Andrade, SS; Sumikawa, JT; Batista, FP; Paredes-Gamero, EJ; Girao, MJBC; Oliva, MLV; Castro, RA				Bonazza, Camila; Andrade, Sheila Siqueira; Sumikawa, Joana Tomomi; Batista, Fabricio Pereira; Paredes-Gamero, Edgar J.; Girao, Manoel J. B. C.; Oliva, Maria Luiza V.; Castro, Rodrigo Aquino			Primary Human Uterine Leiomyoma Cell Culture Quality Control: Some Properties of Myometrial Cells Cultured under Serum Deprivation Conditions in the Presence of Ovarian Steroids	PLOS ONE			English	Article							SMOOTH-MUSCLE; STEM-CELLS; EXPRESSION; GROWTH; CYCLE; PREGNANCY; PROTEINS; ACTIVATE; ESTROGEN; UTERUS	Cell culture is considered the standard media used in research to emulate the in vivo cell environment. Crucial in vivo experiments cannot be conducted in humans and depend on in vitro methodologies such as cell culture systems. However, some procedures involving the quality control of cells in culture have been gradually neglected by failing to acknowledge that primary cells and cell lines change over time in culture. Thus, we report methods based on our experience for monitoring primary cell culture of human myometrial cells derived from uterine leiomyoma. We standardized the best procedure of tissue dissociation required for the study of multiple genetic marker systems that include species-specific antigens, expression of myofibroblast or myoblast markers, growth curve, serum deprivation, starvation by cell cycle synchronization, culture on collagen coated plates, and 17 beta-estradiol (E-2) and progesterone (P-4) effects. The results showed that primary myometrial cells from patients with uterine leiomyoma displayed myoblast phenotypes before and after in vitro cultivation, and leiomyoma cells differentiated into mature myocyte cells under the appropriate differentiation-inducing conditions (serum deprivation). These cells grew well on collagen coated plates and responded to E2 and P4, which may drive myometrial and leiomyoma cells to proliferate and adhere into a focal adhesion complex involvement in a paracrine manner. The establishment of these techniques as routine procedures will improve the understanding of the myometrial physiology and pathogenesis of myometrium-derived diseases such as leiomyoma. Mimicking the in vivo environment of fibrotic conditions can prevent false results and enhance results that are based on cell culture integrity.	[Bonazza, Camila; Andrade, Sheila Siqueira; Sumikawa, Joana Tomomi; Girao, Manoel J. B. C.; Castro, Rodrigo Aquino] Univ Fed Sao Paulo, Dept Gynecol, Sao Paulo, SP, Brazil; [Batista, Fabricio Pereira; Paredes-Gamero, Edgar J.; Oliva, Maria Luiza V.] Univ Fed Sao Paulo, Dept Biochem, Sao Paulo, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Castro, RA (corresponding author), Univ Fed Sao Paulo, Dept Gynecol, Sao Paulo, SP, Brazil.	rodrigo.castro@uol.com.br	Oliva, Maria Luiza V/B-9537-2012; Girao, Manoel Batista Castello/ABA-6558-2021; Bonazza, Camila/ABG-1495-2020; Castro, Rodrigo A/F-3195-2012; Paredes-Gamero, Edgar J/C-4791-2012; Vilela Oliva, Maria Luiza/AGI-6283-2022; Pereira Batista, Fabricio/H-6089-2016; Andrade, Sheila/E-1215-2012	Castro, Rodrigo A/0000-0002-0959-7363; Paredes-Gamero, Edgar J/0000-0003-3686-8402; Pereira Batista, Fabricio/0000-0001-5386-9584; Bonazza, Camila/0000-0002-7346-2746; Oliva, Maria Luiza/0000-0002-5822-0060; Andrade, Sheila/0000-0001-5524-1360	Associacao Beneficente de Coleta de Sangue (Colsan); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/19780-3, 2012/19851-8, 2009/53766-5]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Associacao Beneficente de Coleta de Sangue (Colsan); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by the Associacao Beneficente de Coleta de Sangue (Colsan), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - Process 2012/19780-3, 2012/19851-8 and 2009/53766-5), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq).; This study was supported by the Associacao Beneficente de Coleta de Sangue (Colsan), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP-Process 2012/19780-3, 2012/19851-8 and 2009/53766-5), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). We are thankful to Magda Theodoro for the technical assistance. The authors have no conflicts of interests to disclose.	de Paula CAA, 2012, J BIOL CHEM, V287, P170, DOI 10.1074/jbc.M111.263996; Basu A, 1998, MOL HUM REPROD, V4, P1099, DOI 10.1093/molehr/4.12.1099; Belt AR, 1999, AM J OBSTET GYNECOL, V181, P359, DOI 10.1016/S0002-9378(99)70562-4; BORNSTEIN MB, 1958, LAB INVEST, V7, P134; Bulun SE, 2013, NEW ENGL J MED, V369, P1344, DOI 10.1056/NEJMra1209993; Capes-Davis A, 2010, INT J CANCER, V127, P1, DOI 10.1002/ijc.25242; Chen MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028203; Condon J, 2002, BIOL REPROD, V67, P506, DOI 10.1095/biolreprod67.2.506; Davis PK, 2001, BIOTECHNIQUES, V30, P1322, DOI 10.2144/01306rv01; De Wever O, 2008, INT J CANCER, V123, P2229, DOI 10.1002/ijc.23925; Dimco G, 2010, CELL CYCLE, V9, P4638, DOI 10.4161/cc.9.23.13955; Eyden B, 2008, J CELL MOL MED, V12, P22, DOI 10.1111/j.1582-4934.2007.00213.x; Fitzgibbon J, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-2; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hoekstra AV, 2009, J CLIN ENDOCR METAB, V94, P1768, DOI 10.1210/jc.2008-2093; Holdsworth-Carson SJ, 2014, MOL HUM REPROD, V20, P250, DOI 10.1093/molehr/gat083; Karginov AV, 2014, NAT CHEM BIOL, V10, P286, DOI [10.1038/NCHEMBIO.1477, 10.1038/nchembio.1477]; KIRKLAND JL, 1979, BIOL REPROD, V21, P269, DOI 10.1095/biolreprod21.2.269; Moore AB, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-10; Moravek MB, 2015, HUM REPROD UPDATE, V21, P1, DOI 10.1093/humupd/dmu048; Mosher AA, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-S1-S7; Ono M, 2007, P NATL ACAD SCI USA, V104, P18700, DOI 10.1073/pnas.0704472104; Riley M, 2005, J CELL MOL MED, V9, P122, DOI 10.1111/j.1582-4934.2005.tb00342.x; Rohr S, 2011, J CARDIOVASC PHARM, V57, P389, DOI 10.1097/FJC.0b013e3182137e17; Ruiz-Cortes Z.T., 2012, STEROIDS PHYSL CLIN, P3, DOI [10.5772/52994, DOI 10.5772/52994]; Sakaguchi H, 2003, STEROIDS, V68, P11, DOI 10.1016/S0039-128X(02)00111-3; Shaw JE, 1998, IN VITRO CELL DEV-AN, V34, P604, DOI 10.1007/s11626-996-0002-1; Simoncini T, 2004, STEROIDS, V69, P537, DOI 10.1016/j.steroids.2004.05.009; Sparey C, 1999, J CLIN ENDOCR METAB, V84, P1705, DOI 10.1210/jc.84.5.1705; Tanaka A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061540; Weinberg RA, 2014, BIOLOGY OF CANCER, SECOND EDITION, P1; WORD RA, 1993, J CLIN INVEST, V92, P29, DOI 10.1172/JCI116564; Wu XX, 2002, J STEROID BIOCHEM, V80, P77, DOI 10.1016/S0960-0760(01)00177-7; YANG NS, 1981, CANCER RES, V41, P4093; Yin P, 2007, J CLIN ENDOCR METAB, V92, P4459, DOI 10.1210/jc.2007-0725; Young L, 2010, NAT PROTOC, V5, P929, DOI 10.1038/nprot.2010.43; Zaitseva M, 2008, HUM REPROD, V23, P1076, DOI 10.1093/humrep/den083; Zhao D, 2013, REPROD BIOMED ONLINE, V27, P64, DOI 10.1016/j.rbmo.2013.04.001	38	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158578	10.1371/journal.pone.0158578	http://dx.doi.org/10.1371/journal.pone.0158578			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391384	Green Published, gold, Green Submitted			2022-12-27	WOS:000380005400082
J	Brzuzan, P; Florczyk, M; Lakomiak, A; Wozny, M				Brzuzan, Pawel; Florczyk, Maciej; Lakomiak, Alicja; Wozny, Maciej			Illumina Sequencing Reveals Aberrant Expression of MicroRNAs and Their Variants in Whitefish (Coregonus lavaretus) Liver after Exposure to Microcystin-LR	PLOS ONE			English	Article							GENE-EXPRESSION; RAINBOW-TROUT; MATURE MICRORNAS; DRINKING-WATER; 3' ADENYLATION; IN-VIVO; C-MYC; CANCER; INSIGHTS; PATHWAYS	Molecular analyses show that challenging fish with microcystin-LR (MC-LR) causes perturbations of microRNA (miRNA) signaling. However, the significance and scope of these alterations is currently unknown. To address this issue, we studied miRNA gene expression in the liver of juvenile whitefish, C. lavaretus, during 28 days of exposure to a subacute dose of MC-LR (100 mu g.kg(-1) body mass). Using genomic resources of Atlantic salmon (AGKD03), the mature miRNA library of Atlantic salmon (miRBase-21) and bioinformatics tools (sRNAbench), we discovered and annotated a total of 377 distinct mature miRNAs belonging to 93 families of evolutionary conserved miRNAs, as well as 24 novel mature miRNA candidates that were mapped to 14 distinct S. salar miRNA precursors. miRNA-Seq transcriptome profiling of liver tissues revealed differential miRNA expression in control and treated fish at 14 days (73 miRNAs were modulated) and at 28 days (83 miRNAs) of the treatment, subsequently validated by qPCR for nine selected differentially expressed miRNAs. Additional qPCR study confirmed the miRNA-Seq data and revealed consistent, aberrant miRNAs expression profile in the later phase of MC-LR hepatotoxicity (7-28 d). Functional annotation analysis revealed that the aberrantly expressed miRNAs have target genes involved in cytoskeletal remodeling, cell metabolism, cell cycle regulation and apoptosis; dysregulation of these processes in liver cells leads to cirrhosis and hepatocellular carcinoma in humans. To enable deeper insight into the molecular responses of liver cells in fish exposed to MC-LR, we expanded the miRNAome analysis by inclusion of miRNA variants (isomiRs) profiles, and we showed that the isomiR profiles of liver specific MiR122, and a few other miRNAs, correlated with MC-LR treatment. Given the importance of isomiRs for disease biology in mammals, we believe that further research focused on the miRNA isoforms will bring us closer to better understanding the molecular mechanisms of MC-LR hepatotoxicity.	[Brzuzan, Pawel; Florczyk, Maciej; Lakomiak, Alicja; Wozny, Maciej] Univ Warmia & Mazury, Fac Environm Sci, Dept Environm Biotechnol, Olsztyn, Poland	University of Warmia & Mazury	Brzuzan, P (corresponding author), Univ Warmia & Mazury, Fac Environm Sci, Dept Environm Biotechnol, Olsztyn, Poland.	brzuzan@uwm.edu.pl	Brzuzan, Pawel/AAI-9291-2021	Brzuzan, Pawel/0000-0001-9701-5716; Wozny, Maciej/0000-0001-5201-2925; Florczyk, Maciej/0000-0003-2277-312X	National Science Centre, Poland [DEC-2012/07/B/NZ9/01320]	National Science Centre, Poland(National Science Centre, Poland)	The study was supported by research grant from National Science Centre, Poland (https://www.ncn.gov.pl/) No. DEC-2012/07/B/NZ9/01320. Grant recipient: PB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamovsky O, 2015, ENVIRON SCI TECHNOL, V49, P12457, DOI 10.1021/acs.est.5b02049; Agostini M, 2014, ONCOTARGET, V5, P872, DOI 10.18632/oncotarget.1825; Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Andreassen R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-482; Asensio PE, 2016, CURR DRUG TARGETS, V17, P1083, DOI 10.2174/1389450116666150213114103; Bailey KA, 2014, MICRORNAS TOXICOLOGY, P5; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Barturen G., 2014, METHODS NEXT GENERAT, V1, P21, DOI [DOI 10.2478/MNGS-2014-0001, 10.2478/mngs-2014-0001]; Berthelot C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4657; Biggar KK, 2014, ANAL BIOCHEM, V462, P32, DOI 10.1016/j.ab.2014.05.032; Bizuayehu TT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-11; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Brzuzan P, 2015, FISH PHYSIOL BIOCHEM, V41, P1155, DOI 10.1007/s10695-015-0077-2; Brzuzan P, 2012, AQUAT TOXICOL, V122, P188, DOI 10.1016/j.aquatox.2012.07.001; Brzuzan P, 2009, TOXICON, V54, P170, DOI 10.1016/j.toxicon.2009.03.032; Burroughs AM, 2010, GENOME RES, V20, P1398, DOI 10.1101/gr.106054.110; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chao A, 2012, ONCOGENE, V31, P764, DOI 10.1038/onc.2011.269; Chen Y, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-43; Clark SP, 2008, TOXICOL PATHOL, V36, P190, DOI 10.1177/0192623307311406; Davidson WS, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-403; Davis MPA, 2013, METHODS, V63, P41, DOI 10.1016/j.ymeth.2013.06.027; de Hoon MJL, 2010, GENOME RES, V20, P257, DOI 10.1101/gr.095273.109; Desvignes T, 2015, TRENDS GENET, V31, P613, DOI 10.1016/j.tig.2015.09.002; Dillies MA, 2013, BRIEF BIOINFORM, V14, P671, DOI 10.1093/bib/bbs046; Djediat C, 2010, TOXICON, V55, P531, DOI 10.1016/j.toxicon.2009.10.005; Dobosz Stefan, 1997, Polskie Archiwum Hydrobiologii, V44, P287; Erhard F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r79; Ernst B, 2001, ENVIRON TOXICOL, V16, P483, DOI 10.1002/tox.10006.abs; Ernst B, 2007, AQUAT TOXICOL, V82, P15, DOI 10.1016/j.aquatox.2007.01.007; Florczyk M, 2016, J FISH DIS, V39, P741, DOI 10.1111/jfd.12406; Girard M, 2008, J HEPATOL, V48, P648, DOI 10.1016/j.jhep.2008.01.019; Guo L, 2014, GENE, V544, P1, DOI 10.1016/j.gene.2014.04.039; Hata A, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005825; Heimberg AM, 2008, P NATL ACAD SCI USA, V105, P2946, DOI 10.1073/pnas.0712259105; Hudder A, 2008, TOXICOL SCI, V103, P228, DOI 10.1093/toxsci/kfn033; Juanchich A, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2505-9; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Kazun K., 2012, Archives of Polish Fisheries, V20, P173; Kazun Krzysztof, 2001, Archiwum Rybactwa Polskiego, V9, P183; Komatsu M, 2007, TOXICOL SCI, V97, P407, DOI 10.1093/toxsci/kfm054; Koop Ben F., 2008, P77; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Lakomiak A, 2016, COMP BIOCHEM PHYS B, V193, P47, DOI 10.1016/j.cbpb.2015.12.005; Landsberg JH, 2002, REV FISH SCI, V10, P113, DOI 10.1080/20026491051695; Lee LW, 2010, RNA, V16, P2170, DOI 10.1261/rna.2225110; Li HY, 2009, TOXICON, V53, P169, DOI 10.1016/j.toxicon.2008.10.027; Lillycrop KA, 2012, BEST PRACT RES CL EN, V26, P667, DOI 10.1016/j.beem.2012.03.009; Liu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055532; Llorens F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-104; Loher P, 2014, ONCOTARGET, V5, P8790, DOI 10.18632/oncotarget.2405; Malbrouck C, 2006, ENVIRON TOXICOL CHEM, V25, P72, DOI 10.1897/05-029R.1; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Maza Elie, 2013, Commun Integr Biol, V6, pe25849, DOI 10.4161/cib.25849; Meng FX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034394; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Mennigen JA, 2014, COMP BIOCHEM PHYS B, V169, P16, DOI 10.1016/j.cbpb.2013.12.002; Miller MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012576; Nakano H, 2013, INT J ONCOL, V42, P1875, DOI 10.3892/ijo.2013.1896; NISHIWAKIMATSUSHIMA R, 1992, J CANCER RES CLIN, V118, P420, DOI 10.1007/BF01629424; Paskerova H, 2012, ENVIRON SCI POLLUT R, V19, P2024, DOI 10.1007/s11356-012-0960-7; Peckova L, 2009, NEUROENDOCRINOL LETT, V30, P199; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rueda A, 2015, NUCLEIC ACIDS RES, V43, pW467, DOI 10.1093/nar/gkv555; Rusca Nicole, 2011, Mol Biol Int, V2011, P437301, DOI 10.4061/2011/437301; Shin C, 2010, MOL CELL, V38, P789, DOI 10.1016/j.molcel.2010.06.005; Soneson C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-91; Takumi S, 2010, ENVIRON HEALTH PERSP, V118, P1292, DOI 10.1289/ehp.1001899; Telonis AG, 2015, NUCLEIC ACIDS RES, V43, P9158, DOI 10.1093/nar/gkv922; Thakral S, 2015, CURR GENE THER, V15, P142, DOI 10.2174/1566523214666141224095610; Tsai WC, 2012, J CLIN INVEST, V122, P2884, DOI 10.1172/JCI63455; U.S. EPA, 2015, EPA820R15100; Ueno Y, 1996, CARCINOGENESIS, V17, P1317, DOI 10.1093/carcin/17.6.1317; van Apeldoorn ME, 2007, MOL NUTR FOOD RES, V51, P7, DOI 10.1002/mnfr.200600185; Wang MH, 2010, TOXICOL SCI, V113, P60, DOI 10.1093/toxsci/kfp248; Wang R, 2013, CURR DRUG TARGETS, V14, P1185, DOI 10.2174/13894501113149990191; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wojcicka A, 2014, INT J BIOCHEM CELL B, V53, P208, DOI 10.1016/j.biocel.2014.05.020; Wozny M, 2015, TOXICOL LETT, V238, pS259, DOI 10.1016/j.toxlet.2015.08.750; Xu LZ, 2012, MUTAT RES-GEN TOX EN, V743, P75, DOI 10.1016/j.mrgentox.2011.12.024; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Yoo BK, 2011, HEPATOLOGY, V53, P1538, DOI 10.1002/hep.24216; Yuan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035331; Zhang DW, 2009, CHEMOSPHERE, V76, P974, DOI 10.1016/j.chemosphere.2009.04.034; Zhao YY, 2012, ENVIRON SCI TECHNOL, V46, P34, DOI 10.1021/es201514h; Zhou L, 2002, BIOMED ENVIRON SCI, V15, P166	86	15	16	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158899	10.1371/journal.pone.0158899	http://dx.doi.org/10.1371/journal.pone.0158899			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391076	gold, Green Submitted, Green Published			2022-12-27	WOS:000380005400157
J	Fernandes, SA; Ruiz, FS; Antonietti, LS; Tufik, S; de Mello, MT				Fernandes-Junior, Silvio Araujo; Ruiz, Francieli Silva; Antonietti, Leandro Stetner; Tufik, Sergio; de Mello, Marco Tulio			Sleep, Fatigue and Quality of Life: A Comparative Analysis among Night Shift Workers with and without Children	PLOS ONE			English	Article							VALIDATION; DURATION; HEALTH	Introduction The reversal of the natural cycle of wakefulness and sleep may cause damage to the health of workers. However, there are few studies evaluating sleep, fatigue and quality of life of night shift workers considering the influence of small children on these variables. Aims Evaluate the sleep time, fatigue and quality of life of night shift workers and verify the relationship between these variables with the presence or absence of children in different age groups. Methods Were evaluated 78 mens shiftworkers, with or without children. Group 1, workers without children (G1-NC), group 2, workers with children pre-school age (G2-PS) and group 3, workers with children school age (G3-S). The sleep time (ST), sleep efficiency (SE), sleep latency (SL) and maximum time awake (MTA) were recorded by actigraphy. The risk of being fatigued at work was estimated by risk index for fatigue (RIF). Results The G1-NC showed a longer ST on working days and when evaluated only the first nights shift, after day off (p<0,005). This sample, the age of the children did not influence the sleep time these workers. The MTA on day off was lower in the workers from G2-PS. The RIF was lower on G1-NC in the first nights shift compared to the other groups. Conclusion In this research, workers without children had higher sleep time during the working days. These workers also were less likely to feel fatigued during night work than workers with children, regardless of age these children.	[Fernandes-Junior, Silvio Araujo; Ruiz, Francieli Silva; Tufik, Sergio; de Mello, Marco Tulio] Univ Fed Sao Paulo, Dept Psychobiol, Sao Paulo, Brazil; [Antonietti, Leandro Stetner; de Mello, Marco Tulio] Ctr Multidisciplinary Studies Sleepiness & Accide, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP)	Fernandes, SA (corresponding author), Univ Fed Sao Paulo, Dept Psychobiol, Sao Paulo, Brazil.	silviocelula@gmail.com	RUIZ, Francieli Silva/L-3160-2015; fernandes-junior, silvio f/C-8395-2019; de Mello, Marco Tulio/G-3237-2010	RUIZ, Francieli Silva/0000-0001-9975-0298; fernandes-junior, silvio f/0000-0001-7231-623X; Ruiz, Francieli S/0000-0002-9675-4063; de Mello, Marco Tulio/0000-0003-3896-2208	Universidade Federal de Sao Paulo; Associacao Fundo de Incentivo a Pesquisa; Fundacao de Amparo a pesquisa do Estado de Sao Paulo- FAPESP (CEPID) [98/14303-3]; Centro Multidisciplinar em Sonolencia e Acidentes (CEMSA); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [133659/2013-5]	Universidade Federal de Sao Paulo; Associacao Fundo de Incentivo a Pesquisa; Fundacao de Amparo a pesquisa do Estado de Sao Paulo- FAPESP (CEPID)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Centro Multidisciplinar em Sonolencia e Acidentes (CEMSA); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from the Universidade Federal de Sao Paulo, the Associacao Fundo de Incentivo a Pesquisa, Fundacao de Amparo a pesquisa do Estado de Sao Paulo- FAPESP (CEPID No. 98/14303-3 to ST), the Centro Multidisciplinar em Sonolencia e Acidentes (CEMSA), and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), number 133659/2013-5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERSTEDT T, 1995, SLEEP, V18, P1; Akerstedt T, 2009, SLEEP MED CLIN, V4, P257, DOI 10.1016/j.jsmc.2009.03.001; Alvarenga TA, 2013, FERTIL STERIL, V100, P1752, DOI 10.1016/j.fertnstert.2013.08.014; Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; ANDERSON RM, 1987, HUM FACTORS, V29, P477, DOI 10.1177/001872088702900411; BENEDITOSILVA AA, 1990, PROG CLIN BIOL RES, V341, P89; Bertolazi AN, 2009, J BRAS PNEUMOL, V35, P877, DOI 10.1590/S1806-37132009000900009; Boksem MAS, 2008, BRAIN RES REV, V59, P125, DOI 10.1016/j.brainresrev.2008.07.001; Borbely A A, 1982, Hum Neurobiol, V1, P195; Brown D, 1982, J Hum Ergol (Tokyo), V11 Suppl, P475; Crispim CA, 2011, METABOLISM, V60, P1726, DOI 10.1016/j.metabol.2011.04.014; CZEISLER CA, 1981, PHOTOCHEM PHOTOBIOL, V34, P239; Dawson D, 1997, FATIGUE ALCOHOL PERF, V388; Dawson D, 2012, SLEEP MED REV, V16, P167, DOI 10.1016/j.smrv.2011.05.004; Falcao DD, 2003, J RHEUMATOL, V30, P379; Folkard S, 2003, OCCUP MED-OXFORD, V53, P95, DOI 10.1093/occmed/kqg047; Gander P., 2008, TRANSPORT RES, P49; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Iber C., 2007, AASM MANUAL SCORING; ICAO, 2011, UN VERS FRMS FAT RIS; Jansen NWH, 2003, OCCUP ENVIRON MED, V60, P47; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Knutsson A, 2003, OCCUP MED-OXFORD, V53, P103, DOI 10.1093/occmed/kqg048; Kryger M, 2012, J CLIN SLEEP MED, V8, P117, DOI 10.5664/jcsm.1754; Mongrain V, 2006, J SLEEP RES, V15, P162, DOI 10.1111/j.1365-2869.2006.00532.x; Pandi-Perumal SR, 2002, AGEING RES REV, V1, P559, DOI 10.1016/S1568-1637(02)00014-4; Rajaratnam SM, 2001, LANCET, V358, P999, DOI 10.1016/S0140-6736(01)06108-6; Rotenberg L, 2000, BIOL RHYTHM RES, V31, P515, DOI 10.1076/0929-1016(200010)31:4;1-2;FT515; Ruiz FS, 2012, INNATE IMMUN-LONDON, V18, P44, DOI 10.1177/1753425910385962; Santos EHR, 2004, CHRONOBIOL INT, V21, P881, DOI 10.1081/CBI-200035952; Smith PM, 2013, J OCCUP ENVIRON MED, V55, P932, DOI 10.1097/JOM.0b013e31829178e1; SORENSEN G, 1987, ANNU REV PUBL HEALTH, V8, P235, DOI 10.1146/annurev.publhealth.8.1.235; Taillard J, 2001, J BIOL RHYTHM, V16, P183, DOI 10.1177/074873001129001764; Taillard J, 1999, J SLEEP RES, V8, P291, DOI 10.1046/j.1365-2869.1999.00176.x; Tuchsen F, 2008, OCCUP MED-OXFORD, V58, P302, DOI 10.1093/occmed/kqn019; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Yeung J, 2011, SCAND J WORK ENV HEA, V37, P62, DOI 10.5271/sjweh.3122; Zimberg IZ, 2012, WORK, V41, P4376, DOI 10.3233/WOR-2012-0733-4376	38	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158580	10.1371/journal.pone.0158580	http://dx.doi.org/10.1371/journal.pone.0158580			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391478	Green Published, gold, Green Submitted			2022-12-27	WOS:000380005400083
J	Guedeney, A; Forhan, A; Larroque, B; de Agostini, M; Pingault, JB; Heude, B				Guedeney, Antoine; Forhan, Anne; Larroque, Beatrice; de Agostini, Maria; Pingault, Jean-Baptiste; Heude, Barbara		EDEN Mother-child Cohort Study Grp	Social Withdrawal Behaviour at One Year of Age Is Associated with Delays in Reaching Language Milestones in the EDEN Mother-Child Cohort Study	PLOS ONE			English	Article							POSTNATAL DEPRESSION SCALE; TEMPERAMENT; SYMPTOMS; INFANTS	Objective The aim of the study was to examine the relationship between social withdrawal behaviour at one year and motor and language milestones. Materials and Methods One-year old children from the EDEN French population-based birth cohort study (Study on the pre- and postnatal determinants of the child's development and prospective health Birth Cohort Study) were included. Social withdrawal at one year was assessed by trained midwives using the Alarm Distress BaBy (ADBB) scale. Midwives concurrently examined infants' motor and language milestones. Parents reported on child's psychomotor and language milestones, during the interview with the midwife. Results After adjusting for potential confounding factors, social withdrawal behaviour was significantly associated with concurrent delays in motor and language milestones assessed by the midwife or the parents. Discussion Higher scores on social withdrawal behaviour as assessed with the ADBB were associated with delays in reaching language milestones, and to a lesser extent with lower motor ability scores. Taking the contribution of social withdrawal behaviour into account may help understand the unfolding of developmental difficulties in children.	[Guedeney, Antoine] Univ Denis Diderot Paris Cite, F-94807 Villejuif, France; [Guedeney, Antoine] INSERM, UMRS 1178, F-94807 Villejuif, France; [Forhan, Anne; de Agostini, Maria; Heude, Barbara] Paris Descartes Univ, Early ORigin Childs Hlth & Dev Team ORCHAD, INSERM, Epidemiol & Biostat UMR1153,Sorbonne Paris Cite C, F-75014 Paris, France; [Larroque, Beatrice] Beaujon Hosp, Epidemiol & Clin Res Unit, F-92110 Clichy, France; [Larroque, Beatrice; Pingault, Jean-Baptiste] UCL, Div Psychol & Language Sci, London WC1E 6BT, England; [Pingault, Jean-Baptiste] Kings Coll London, MRC Social Genet & Dev Psychiat Ctr, Inst Psychiat, London WC1E 6BT, England	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; University of London; University College London; University of London; King's College London	Guedeney, A (corresponding author), Univ Denis Diderot Paris Cite, F-94807 Villejuif, France.; Guedeney, A (corresponding author), INSERM, UMRS 1178, F-94807 Villejuif, France.	antoine.guedeney@aphp.fr	Heude, Barbara/G-3095-2016; de Lauzon-Guillain, Blandine/P-4659-2016; Bernard, Jonathan/T-7064-2017; Heude, Barbara/GLU-9626-2022; Charles, Marie Aline/F-8567-2017	Heude, Barbara/0000-0002-1565-1629; de Lauzon-Guillain, Blandine/0000-0001-5887-8842; Bernard, Jonathan/0000-0002-6418-983X; Heude, Barbara/0000-0002-1565-1629; Charles, Marie Aline/0000-0003-4025-4390; Guedeney, Antoine/0000-0002-2346-4495; Pingault, Jean-Baptiste/0000-0003-2557-4716				Bayley N., 2019, BAYLEY SCALES INFANT; Bernard JY, 2013, J PEDIATR-US, V163, P36, DOI 10.1016/j.jpeds.2012.11.090; Blondel B, 2006, J Gynecol Obstet Biol Reprod (Paris), V35, P373; Braarud HC, 2013, INFANT MENT HEALTH J, V34, P532, DOI 10.1002/imhj.21414; Brazelton TB, MOTHERINFANT INTERAC, P57; Costa R, 2011, INFANT BEHAV DEV, V34, P270, DOI 10.1016/j.infbeh.2011.01.002; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Feldman R, 2007, J CHILD PSYCHOL PSYC, V48, P329, DOI 10.1111/j.1469-7610.2006.01701.x; Foulon S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125996; Fox NA, 2004, ANN NY ACAD SCI, V1038, P171, DOI 10.1196/annals.1315.025; GARDOSI J, 1992, LANCET, V339, P283, DOI 10.1016/0140-6736(92)91342-6; Gibson J, 2009, ACTA PSYCHIAT SCAND, V119, P350, DOI 10.1111/j.1600-0447.2009.01363.x; Guedeney A, 2001, INFANT MENT HEALTH J, V22, P559, DOI 10.1002/imhj.1018; Guedeney A, 2014, EUR CHILD ADOLES PSY, V23, P1181, DOI 10.1007/s00787-013-0513-8; Guedeney A, 2013, INFANT MENT HEALTH J, V34, P516, DOI 10.1002/imhj.21412; Guedeney A, 2012, EUR CHILD ADOLES PSY, V21, P185, DOI 10.1007/s00787-012-0250-4; Guedeney N, 1998, EUR PSYCHIAT, V13, P83, DOI 10.1016/S0924-9338(98)80023-0; Heude B, 2016, INT J EPIDEMIOL, V45, P353, DOI 10.1093/ije/dyv151; Josse D., 1997, REVISED BRUNET LEZIN; Milne L, 2009, INFANT BEHAV DEV, V32, P159, DOI 10.1016/j.infbeh.2008.12.006; Molteno CD, 2014, ALCOHOL CLIN EXP RES, V38, P479, DOI 10.1111/acer.12240; Peyre H, 2014, PEERJ, V2, DOI 10.7717/peerj.335; Puura K, 2013, INFANT MENT HEALTH J, V34, P586, DOI 10.1002/imhj.21417; Tronick E, 2011, AM PSYCHOL, V66, P107, DOI 10.1037/a0021631; TRONICK EZ, 1989, CHILD DEV, V60, P85, DOI 10.2307/1131074; Yan N, 2014, J CHILD PSYCHOL PSYC, V55, P495, DOI 10.1111/jcpp.12189; Zarra-Nezhad M, 2014, J CHILD PSYCHOL PSYC, V55, P1260, DOI 10.1111/jcpp.12251	27	14	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158426	10.1371/journal.pone.0158426	http://dx.doi.org/10.1371/journal.pone.0158426			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27391482	Green Published, gold, Green Submitted			2022-12-27	WOS:000380005400058
J	Jonker, NC; Glashouwer, KA; Ostafin, BD; van Hemel-Ruiter, ME; Smink, FRE; Hoek, HW; de Jong, PJ				Jonker, Nienke C.; Glashouwer, Klaske A.; Ostafin, Brian D.; van Hemel-Ruiter, Madelon E.; Smink, Frederique R. E.; Hoek, Hans W.; de Jong, Peter J.			Attentional Bias for Reward and Punishment in Overweight and Obesity: The TRAILS Study	PLOS ONE			English	Article							INDIVIDUAL-LIVES SURVEY; EATING-DISORDERS; SUBSTANCE USE; ALCOHOL-USE; SENSITIVITY; ADOLESCENTS; FOOD; CHILDREN; PERSONALITY; PREDICTORS	More than 80% of obese adolescents will become obese adults, and it is therefore important to enhance insight into characteristics that underlie the development and maintenance of overweight and obesity at a young age. The current study is the first to focus on attentional biases towards rewarding and punishing cues as potentially important factors. Participants were young adolescents (N = 607) who were followed from the age of 13 until the age of 19, and completed a motivational game indexing the attentional bias to general cues of reward and punishment. Additionally, self-reported reward and punishment sensitivity was measured. This study showed that attentional biases to cues that signal reward or punishment and self-reported reward and punishment sensitivity were not related to body mass index or the change in body mass index over six years in adolescents. Thus, attentional bias to cues of reward and cues of punishment, and self-reported reward and punishment sensitivity, do not seem to be crucial factors in the development and maintenance of overweight and obesity in adolescents. Exploratory analyses of the current study suggest that the amount of effort to gain reward and to avoid punishment may play a role in the development and maintenance of overweight and obesity. However, since the effort measure was a construct based on face validity and has not been properly validated, more studies are necessary before firm conclusions can be drawn.	[Jonker, Nienke C.; Glashouwer, Klaske A.; Ostafin, Brian D.; de Jong, Peter J.] Univ Groningen, Dept Clin Psychol & Expt Psychopathol, Groningen, Netherlands; [Glashouwer, Klaske A.] Accare, Child & Adolescent Psychiat, Ctr Eating Disorders, Accare, Netherlands; [van Hemel-Ruiter, Madelon E.] Verslavingszorg Noord Nederland, Groningen, Netherlands; [Smink, Frederique R. E.; Hoek, Hans W.] Parnassia Psychiat Inst, The Hague, Netherlands; [Hoek, Hans W.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands; [Hoek, Hans W.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA	University of Groningen; Parnassia Psychiatric Institute; University of Groningen; Columbia University	Jonker, NC (corresponding author), Univ Groningen, Dept Clin Psychol & Expt Psychopathol, Groningen, Netherlands.	n.c.jonker@rug.nl	de Jong, Peter/E-9095-2014; Jonker, Nienke/AAE-7512-2020; de Jong, Peter/ABB-1750-2020	de Jong, Peter/0000-0002-3512-3663; Jonker, Nienke/0000-0002-2567-3776; de Jong, Peter/0000-0002-3512-3663; Hoek, Hans/0000-0001-6353-5465	NWO research talent grant [406-14-091]; Netherlands Organization for Scientific Research NWO (Medical Research Council program) [GB-MW 940-38-011]; Netherlands Organization for Scientific Research NWO (ZonMW Brainpower Grant) [100-001-004]; Netherlands Organization for Scientific Research NWO (ZonMw Risk Behavior and Dependence Grant) [60 - 60600- 98-018, 60 - 60600-97-118, 60 - 60600-97-202]; Netherlands Organization for Scientific Research NWO (ZonMw Culture and Health Grant) [261-98-710]; Netherlands Organization for Scientific Research NWO (Social Sciences Council medium-sized investment Grant) [GB-MaGW 480-01-006, GB-MaGW 480-07-001]; Netherlands Organization for Scientific Research NWO (Social Sciences Council project) [GB-MaGW 457-03-018, GB-MaGW 452-04-314, GB-MaGW 452-06-004]; Netherlands Organization for Scientific Research NWO (NWO large-sized investment Grant) [175.010.2003.005]; SophiaFoundation for Medical Research [301, 393]; Dutch Ministry of Justice (WODC); European Science Foundation (EuroSTRESS project) [FP-006]; University Medical Center, the Netherlands; University of Groningen, the Netherlands; Erasmus University Medical Center Rotterdam, the Netherlands; University of Utrecht, the Netherlands; Radboud Medical Center Nijmegen, the Netherlands; Parnassia Psychiatric Institute, the Netherlands	NWO research talent grant; Netherlands Organization for Scientific Research NWO (Medical Research Council program)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research NWO (ZonMW Brainpower Grant); Netherlands Organization for Scientific Research NWO (ZonMw Risk Behavior and Dependence Grant); Netherlands Organization for Scientific Research NWO (ZonMw Culture and Health Grant); Netherlands Organization for Scientific Research NWO (Social Sciences Council medium-sized investment Grant); Netherlands Organization for Scientific Research NWO (Social Sciences Council project); Netherlands Organization for Scientific Research NWO (NWO large-sized investment Grant); SophiaFoundation for Medical Research; Dutch Ministry of Justice (WODC); European Science Foundation (EuroSTRESS project); University Medical Center, the Netherlands; University of Groningen, the Netherlands(Netherlands Government); Erasmus University Medical Center Rotterdam, the Netherlands(Netherlands Government); University of Utrecht, the Netherlands(Netherlands Government); Radboud Medical Center Nijmegen, the Netherlands; Parnassia Psychiatric Institute, the Netherlands	The first author was supported by a NWO research talent grant [406-14-091]. This research is part of the Tracking Adolescents' Individual Lives Survey (TRAILS). Participating centers of TRAILS include various departments of the University Medical Center and University of Groningen, the Erasmus University Medical Center Rotterdam, the University of Utrecht, the Radboud Medical Center Nijmegen, and the Parnassia Psychiatric Institute, all in the Netherlands. TRAILS has been financially supported by various grants from the Netherlands Organization for Scientific Research NWO (Medical Research Council program Grant GB-MW 940-38-011; ZonMW Brainpower Grant 100-001-004; ZonMw Risk Behavior and Dependence Grants 60 - 60600- 98-018, 60 - 60600-97-118 and 60 - 60600-97-202; ZonMw Culture and Health Grant 261-98-710; Social Sciences Council medium-sized investment Grants GB-MaGW 480-01-006 and GB-MaGW 480-07-001; Social Sciences Council project Grants GB-MaGW 457-03-018, GB-MaGW 452-04-314, and GB-MaGW 452-06-004; NWO large-sized investment Grant 175.010.2003.005); the SophiaFoundation for Medical Research (projects 301 and 393), the Dutch Ministry of Justice (WODC), the European Science Foundation (EuroSTRESS project FP-006), and the participating universities.	Berridge KC, 2009, PHYSIOL BEHAV, V97, P537, DOI 10.1016/j.physbeh.2009.02.044; Bijttebier P, 2009, CLIN PSYCHOL REV, V29, P421, DOI 10.1016/j.cpr.2009.04.002; BOUCHARD C, 1990, NEW ENGL J MED, V322, P1477, DOI 10.1056/NEJM199005243222101; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Colder CR, 2002, PSYCHOL ADDICT BEHAV, V16, P325, DOI 10.1037//0893-164X.16.325; Cole T. J., 2000, OBESITY WORLDWIDE IN, P1; Corr PJ, 2001, PERS INDIV DIFFER, V30, P333, DOI 10.1016/S0191-8869(00)00028-3; Danner UN, 2012, EUR EAT DISORD REV, V20, pe56, DOI 10.1002/erv.1098; Davis C, 2004, APPETITE, V42, P131, DOI 10.1016/j.appet.2003.07.004; Davis C, 2008, APPETITE, V50, P43, DOI 10.1016/j.appet.2007.05.007; Davis C, 2007, APPETITE, V48, P12, DOI 10.1016/j.appet.2006.05.016; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Derryberry D, 2002, J ABNORM PSYCHOL, V111, P225, DOI 10.1037//0021-843X.111.2.225; Franken IHA, 2003, PROG NEURO-PSYCHOPH, V27, P563, DOI 10.1016/S0278-5846(03)00081-2; Goossens L, 2009, EAT BEHAV, V10, P71, DOI 10.1016/j.eatbeh.2008.10.008; GRAY JA, 1970, BEHAV RES THER, V8, P249, DOI 10.1016/0005-7967(70)90069-0; Gray JA, 2000, NEUROPSYCHOLOGY ANXI; Guerrieri R, 2008, INT J OBESITY, V32, P708, DOI 10.1038/sj.ijo.0803770; Harrison A, 2010, PSYCHIAT RES, V177, P1, DOI 10.1016/j.psychres.2009.06.010; Huisman M, 2008, INT J EPIDEMIOL, V37, P1227, DOI 10.1093/ije/dym273; Jonker NC, 2014, ADDICT BEHAV, V39, P945, DOI 10.1016/j.addbeh.2013.12.011; Matton A, 2013, EUR EAT DISORD REV, V21, P184, DOI 10.1002/erv.2226; Nederkoorn Chantal, 2006, Eat Behav, V7, P315, DOI 10.1016/j.eatbeh.2005.11.005; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Oldehinkel AJ, 2015, INT J EPIDEMIOL, V44, P76, DOI 10.1093/ije/dyu225; Ormel J, 2012, J AM ACAD CHILD PSY, V51, P1020, DOI 10.1016/j.jaac.2012.08.004; POSNER MI, 1987, PSYCHOBIOLOGY, V15, P107; Poston WSC, 1999, INT J EAT DISORDER, V25, P301, DOI 10.1002/(SICI)1098-108X(199904)25:3&lt;301::AID-EAT8&gt;3.0.CO;2-P; Reilly JJ, 2003, ARCH DIS CHILD, V88, P748, DOI 10.1136/adc.88.9.748; Roberts RE, 2013, EAT BEHAV, V14, P128, DOI 10.1016/j.eatbeh.2013.01.008; Robinson TE, 2001, ADDICTION, V96, P103, DOI 10.1046/j.1360-0443.2001.9611038.x; Schienle A, 2009, BIOL PSYCHIAT, V65, P654, DOI 10.1016/j.biopsych.2008.09.028; Stice E, 2013, BIOL PSYCHIAT, V73, P869, DOI 10.1016/j.biopsych.2012.11.019; TNO, 2010, TNO GROWTH CHARTS; van Hemel-Ruiter MLE, 2013, PSYCHOL ADDICT BEHAV, V27, P142, DOI 10.1037/a0028271; van Hemel-Ruiter ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121058; Van Winckel M., 2001, BEHANDELINGSSTRATEGI, P11; Verbeken S, 2012, APPETITE, V58, P478, DOI 10.1016/j.appet.2011.11.018; Wang YC, 2006, PEDIATRICS, V118, pE1721, DOI 10.1542/peds.2006-0682; Wilson PH, 1996, CLIN PSYCHOL PSYCHOT, V3, P231, DOI 10.1002/(SICI)1099-0879(199612)3:4<231::AID-CPP107>3.0.CO;2-D; World Health Organization, 2010, GLOB HLTH OBS GHO	41	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0157573	10.1371/journal.pone.0157573	http://dx.doi.org/10.1371/journal.pone.0157573			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27391017	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400013
J	Kakehashi, A; Ishii, N; Fujioka, M; Doi, K; Gi, M; Wanibuchi, H				Kakehashi, Anna; Ishii, Naomi; Fujioka, Masaki; Doi, Kenichiro; Gi, Min; Wanibuchi, Hideki			Ethanol-Extracted Brazilian Propolis Exerts Protective Effects on Tumorigenesis in Wistar Hannover Rats	PLOS ONE			English	Article							ACID PHENETHYL ESTER; PROSTATE-CANCER CELLS; ABERRANT CRYPT FOCI; CAFFEIC ACID; RED PROPOLIS; BREAST-CANCER; ARTEPILLIN-C; IN-VIVO; GROWTH; CARCINOGENESIS	The present study was conducted over a course of 104 weeks to estimate the carcinogenicity of ethanol-extracted Brazilian green propolis (EEP). Groups of 50 male and 50 female Wistar Hannover rats, 6-week-old at commencement were exposed to EEP at doses of 0, 0.5 or 2.5% in the diet. Survival rates of 0.5% and 2.5% EEP-treated male and female rats, respectively, were significantly higher than those of respective control groups. Overall histopathological evaluation of neoplasms in rat tissues after 2 years showed no significant increase of tumors or preneoplastic lesions in any organ of animals administered EEP. Significantly lower incidences of pituitary tumors in 0.5% EEP male and 2.5% EEP female groups, malignant lymphoma/ leukemia in both 2.5% EEP-treated males and females and total thyroid tumors in 0.5% EEP male group were found. Administration of EEP caused significant decreases of lymphoid hyperplasia of the thymus and lymph nodes in 2.5% EEP-treated rats, tubular cell hyperplasia of kidneys in all EEP groups, and cortical hyperplasia of adrenals in EEP-treated females. In the blood, significant reduction of neutrophils in all EEP-treated males and band neutrophils in 2.5% EEP-treated females was found indicating lower levels of inflammation. Total cholesterol and triglicerides levels were significantly lower in the blood of 2.5% EEP-treated female rats. In conclusion, under the conditions of the 2-year feeding experiment, EEP was not carcinogenic, did not induce significant histopathological changes in any organ, and further exerted anti-inflammatory and antitumorigenic effects resulting in increase of survival of Wistar Hannover rats.	[Kakehashi, Anna; Ishii, Naomi; Fujioka, Masaki; Doi, Kenichiro; Gi, Min; Wanibuchi, Hideki] Osaka City Univ, Grad Sch Med, Dept Mol Pathol, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan	Osaka Metropolitan University	Wanibuchi, H (corresponding author), Osaka City Univ, Grad Sch Med, Dept Mol Pathol, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.	wani@med.osaka-cu.ac.jp	Kakehashi, Anna/ABF-2986-2020; Fujioka, Masaki/C-7817-2019	Kakehashi, Anna/0000-0003-1149-1450; Fujioka, Masaki/0000-0003-0048-2874	Ministry of Health, Labor and Welfare of Japan	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This research was supported by a grant from the Ministry of Health, Labor and Welfare of Japan (grant title: Research on genotoxicity and carcinogenicity of food additives and health foods). No number existed.	Ahn MR, 2007, CANCER LETT, V252, P235, DOI 10.1016/j.canlet.2006.12.039; Alizadeh AM, 2015, ARCH IRAN MED, V18, P18, DOI 0151801/AIM.006; Almeida E. C. de, 2002, J. Venom. Anim. Toxins, V8, P191, DOI 10.1590/S0104-79302002000200002; Basini G, 2012, INVEST NEW DRUG, V30, P186, DOI 10.1007/s10637-010-9550-z; Baykara M, 2015, DIAGN INTERV RADIOL, V21, P317, DOI 10.5152/dir.2015.14075; Borrelli F, 2002, FITOTERAPIA, V73, pS38, DOI 10.1016/S0367-326X(02)00189-2; Bufalo MC, 2015, J PHARM PHARMACOL, V67, P740, DOI 10.1111/jphp.12364; Campos JF, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/296186; Cavendish RL, 2015, J ETHNOPHARMACOL, V173, P127, DOI 10.1016/j.jep.2015.07.022; CHIAO C, 1995, CANCER RES, V55, P3576; Chirumbolo S, 2015, J CLIN BIOCHEM NUTR, V56, P163, DOI 10.3164/jcbn.14-110; Conti BJ, 2015, J PHARM PHARMACOL, V67, P1431, DOI 10.1111/jphp.12431; da Silva RO, 2015, J ETHNOPHARMACOL, V170, P66, DOI 10.1016/j.jep.2015.05.009; Fu JY, 2004, BIOMED ENVIRON SCI, V17, P469; GHISALBERTI EL, 1979, BEE WORLD, V60, P59, DOI 10.1080/0005772X.1979.11097738; Jung BI, 2010, PHYTOTHER RES, V24, P295, DOI 10.1002/ptr.2966; Khalil Mahmoud Lotfy, 2006, Asian Pac J Cancer Prev, V7, P22; Kimoto N, 1999, CANCER LETT, V147, P221, DOI 10.1016/S0304-3835(99)00305-5; Kimoto T, 1996, Gan To Kagaku Ryoho, V23, P1855; Kimoto T, 2001, VIRCHOWS ARCH, V438, P259, DOI 10.1007/s004280000350; Kubina R, 2015, ADV CLIN EXP MED, V24, P203, DOI 10.17219/acem/31792; Li HZ, 2007, INT J ONCOL, V31, P601; Li X, 2011, TOXICOL IN VITRO, V25, P630, DOI 10.1016/j.tiv.2010.12.013; Lopez BG, 2015, J APPL MICROBIOL, DOI 10.11110m.12874; Luo JQ, 2001, ANTICANCER RES, V21, P1665; Mani F, 2006, J ETHNOPHARMACOL, V105, P95, DOI 10.1016/j.jep.2005.10.011; Mishima S, 2005, BIOL PHARM BULL, V28, P1025, DOI 10.1248/bpb.28.1025; Missima F, 2010, PHYTOTHER RES, V24, P1501, DOI 10.1002/ptr.3142; Moreno MIN, 2005, J AGR FOOD CHEM, V53, P8957, DOI 10.1021/jf0513359; Nouhi A., 2008, ARAK MED U J, V11, P102; OECD, 2009, TEST 451 CARC STUD; OECD, 2009, GOOD LAB PRACT; Okamoto Y, 2015, J TOXICOL SCI, V40, P235, DOI 10.2131/jts.40.235; Orsolic N, 2005, BIOMED PHARMACOTHER, V59, P561, DOI 10.1016/j.biopha.2005.03.013; Padmavathi R, 2006, COMP BIOCHEM PHYS C, V143, P349, DOI 10.1016/j.cbpc.2006.03.009; Patel Seema, 2016, Journal of Dietary Supplements, V13, P245, DOI 10.3109/19390211.2015.1008614; Ribeiro DR, 2015, BASIC CLIN PHARMACOL, V117, P85, DOI 10.1111/bcpt.12374; Schmidt JO, 1992, OTHER PRODUCTS HIVE, P927; Selamoglu ZS, 2015, ADV CLIN EXP MED, V24, P227, DOI 10.17219/acem/40461; Senedese JM, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nen049; Shimizu K, 2004, ARCH BIOCHEM BIOPHYS, V424, P181, DOI 10.1016/j.abb.2004.02.021; Szliszka E, 2009, MOLECULES, V14, P738, DOI [10.3390/molecules14020738, 10.3390/molecules]; Szliszka E, 2011, INT J ONCOL, V38, P941, DOI 10.3892/ijo.2011.930; Valente MJ, 2011, FOOD CHEM TOXICOL, V49, P86, DOI 10.1016/j.fct.2010.10.001; Wagh VD, 2013, ADV PHARMACOL SCI, V2013, DOI 10.1155/2013/308249; Xie XL, 2015, FOOD CHEM TOXICOL, V83, P193, DOI 10.1016/j.fct.2015.06.007; Yasui Y, 2008, ONCOL REP, V20, P493, DOI 10.3892/or_00000033; Zhang JL, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/307594; Zhao JQ, 2009, INDIAN J EXP BIOL, V47, P264	49	13	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158654	10.1371/journal.pone.0158654	http://dx.doi.org/10.1371/journal.pone.0158654			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391589	Green Published, gold, Green Submitted			2022-12-27	WOS:000380005400097
J	Koo, HY; Seo, YG; Cho, MH; Kim, MJ; Choi, HC				Koo, Hye-Yeon; Seo, Young-Gyun; Cho, Mi-Hee; Kim, Min-Jung; Choi, Ho-Chun			Weight Change and Associated Factors in Long-Term Breast Cancer Survivors	PLOS ONE			English	Article							BODY-MASS INDEX; ADJUVANT CHEMOTHERAPY; LIFE-STYLE; KOREAN WOMEN; GAIN; DIAGNOSIS; PREMENOPAUSAL; POPULATION; PROGNOSIS; MENOPAUSE	Purpose Weight gain often occurs after breast cancer diagnosis and significantly impacts the general health of cancer survivors. While the number of breast cancer survivors is increasing, few studies have reported data on weight change beyond 5 years post-diagnosis. We investigated weight change and associated factors in long-term survivors of breast cancer. Patients and Methods Medical records were reviewed on 1363 breast cancer patients and a total of 822 women who had survived beyond 5 years since diagnosis were included in the final analysis. The association between demographic, anthropometric, lifestyle, cancer related factors (including time since diagnosis, treatment modality, pathologic stage, and hormone receptor status), and weight-change over 5 years were examined. Results During an average 8.2 years of follow-up time, mean weight gain was 0.32kg (p = 0.017). 175 (21.3%) patients had gained more than 5% of their weight at diagnosis and their average gain was 5.55kg. Body mass index (BMI) at diagnosis, age at diagnosis, aromatase inhibitor (AI) use, heavy drinking, and type of surgery were associated with relative weight gain (>= 5%) in univariate analysis (all p-values< 0.05). Patients who were non-obese at diagnosis showed weight gain, while those who were obese at diagnosis lost weight (0.78kg, -1.11kg, respectively, p< 0.001). In multivariate analysis, the non-obese group showed odds ratio of 2.7 (p = 0.001) relative to the obese group. Younger age group (age 18-54 years) showed odds ratio of 1.9 (p = 0.021) relative to the older age group (age 55-75 years), and patients who did not use AI showed odds ratio of 2.2 (p = 0.006) relative to women who did. Conclusion Long-term breast cancer survivors who were non-obese at diagnosis are more likely to gain weight than obese survivors. Younger survivors and survivors who have never used AI are also likely to gain weight.	[Koo, Hye-Yeon; Seo, Young-Gyun; Cho, Mi-Hee; Kim, Min-Jung] Seoul Natl Univ Hosp, Dept Family Med, Seoul, South Korea; [Choi, Ho-Chun] Seoul Natl Univ Hosp, Dept Family Med, Healthcare Syst Gangnam Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Choi, HC (corresponding author), Seoul Natl Univ Hosp, Dept Family Med, Healthcare Syst Gangnam Ctr, Seoul, South Korea.	skyho331@gmail.com	Seo, Young-Gyun/AAV-3487-2020	Koo, Hye Yeon/0000-0002-0387-4278; Seo, Young-Gyun/0000-0001-8294-1741				Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; BROWN BW, 1993, J NATL CANCER I, V85, P979, DOI 10.1093/jnci/85.12.979; Caan BJ, 2008, CANCER CAUSE CONTROL, V19, P1319, DOI 10.1007/s10552-008-9203-0; Caan BJ, 2006, BREAST CANCER RES TR, V99, P47, DOI 10.1007/s10549-006-9179-y; CAMORIANO JK, 1990, J CLIN ONCOL, V8, P1327, DOI 10.1200/JCO.1990.8.8.1327; CHLEBOWSKI RT, 1986, BREAST CANCER RES TR, V7, P23, DOI 10.1007/BF01886732; Chlebowski RT, 2002, J CLIN ONCOL, V20, P1128, DOI 10.1200/JCO.20.4.1128; Demark-Wahnefried W, 2001, J CLIN ONCOL, V19, P2381, DOI 10.1200/JCO.2001.19.9.2381; Demark-Wahnefried W, 2012, CANCER-AM CANCER SOC, V118, P2277, DOI 10.1002/cncr.27466; DemarkWahnefried W, 1997, J AM DIET ASSOC, V97, P519, DOI 10.1016/S0002-8223(97)00133-8; Erickson KD, 2012, CANCER RES, V72, DOI 10.1158/0008-5472.SABCS12-P2-11-09; Freedman RJ, 2004, J CLIN ENDOCR METAB, V89, P2248, DOI 10.1210/jc.2003-031874; Goodwin PJ, 1999, J CLIN ONCOL, V17, P120, DOI 10.1200/JCO.1999.17.1.120; Goodwin PJ, 2001, J CLIN ONCOL, V19, P2367, DOI 10.1200/JCO.2001.19.9.2367; Han HS, 2009, BREAST CANCER RES TR, V114, P147, DOI 10.1007/s10549-008-9984-6; HEASMAN KZ, 1985, BREAST CANCER RES TR, V5, P195, DOI 10.1007/BF01805994; Heideman WH, 2009, EUR J CANCER, V45, P119, DOI 10.1016/j.ejca.2008.09.003; Herman DR, 2005, BREAST CANCER RES TR, V93, P13, DOI 10.1007/s10549-005-2418-9; Irwin ML, 2005, J CLIN ONCOL, V23, P774, DOI 10.1200/JCO.2005.04.036; Jeon YW, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0849-z; Jung KW, 2015, CANCER RES TREAT, V47, P127, DOI 10.4143/crt.2015.060; Kawachi I, 1999, J CLIN PSYCHIAT, V60, P5; Kim SH, 2013, ASIAN NURS RES, V7, P161, DOI 10.1016/j.anr.2013.09.002; Korean Statistical Information Service, 2014, KOR STAT INF SERV 5; Kroenke CH, 2005, J CLIN ONCOL, V23, P1370, DOI 10.1200/JCO.2005.01.079; Lewis CE, 1997, AM J PUBLIC HEALTH, V87, P635, DOI 10.2105/AJPH.87.4.635; Loi S, 2005, CANCER EPIDEM BIOMAR, V14, P1686, DOI 10.1158/1055-9965.EPI-05-0042; Makari-Judson G, 2007, BREAST J, V13, P258, DOI 10.1111/j.1524-4741.2007.00419.x; Makari-Judson G, 2014, WORLD J CLIN ONCOL, V5, P272, DOI 10.5306/wjco.v5.i3.272; Morrow M, 2010, DIS BREAST, P823; Nichols HB, 2009, CANCER EPIDEM BIOMAR, V18, P1403, DOI 10.1158/1055-9965.EPI-08-1094; Nissen MJ, 2011, CLIN BREAST CANCER, V11, P52, DOI 10.3816/CBC.2011.n.009; Rock CL, 2002, J NUTR, V132, p3504S, DOI 10.1093/jn/132.11.3504S; Rock CL, 1999, J AM DIET ASSOC, V99, P1212, DOI 10.1016/S0002-8223(99)00298-9; Saquib N, 2007, BREAST CANCER RES TR, V105, P177, DOI 10.1007/s10549-006-9442-2; SHAH M, 1991, INT J OBESITY, V15, P499; Vagenas D, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1026-2; Vance V, 2011, OBES REV, V12, P282, DOI 10.1111/j.1467-789X.2010.00805.x; Wang JS, 2014, MOL CLIN ONCOL, V2, P105, DOI 10.3892/mco.2013.209; WILLETT WC, 1995, JAMA-J AM MED ASSOC, V273, P461, DOI 10.1001/jama.273.6.461; WILLIAMSON DF, 1990, ARCH INTERN MED, V150, P665, DOI 10.1001/archinte.150.3.665; WILLIAMSON DF, 1993, ANN INTERN MED, V119, P646, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00004; World Health Organization Pacific Region International Association for the Study of Obesity International Obesity Task Force, 2000, AS PAC PERSP RED OB	43	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159098	10.1371/journal.pone.0159098	http://dx.doi.org/10.1371/journal.pone.0159098			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391162	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400210
J	Kouyoumdzian, NM; Mikusic, NLR; Kravetz, MC; Lee, BM; Carranza, A; Del Mauro, JS; Pandolfo, M; Gironacci, MM; Gorzalczany, S; Toblli, JE; Fernandez, BE; Choi, MR				Kouyoumdzian, Nicolas M.; Rukavina Mikusic, Natalia L.; Kravetz, Maria C.; Lee, Brenda M.; Carranza, Andrea; Del Mauro, Julieta S.; Pandolfo, Marcela; Gironacci, Mariela M.; Gorzalczany, Susana; Toblli, Jorge E.; Fernandez, Belisario E.; Choi, Marcelo R.			Atrial Natriuretic Peptide Stimulates Dopamine Tubular Transport by Organic Cation Transporters: A Novel Mechanism to Enhance Renal Sodium Excretion	PLOS ONE			English	Article							LOW-DOSE DOPAMINE; INTRARENAL DOPAMINE; DYSFUNCTION; FAILURE; SYSTEM; ROCT1	The aim of this study was to demonstrate the effects of atrial natriuretic peptide (ANP) on organic cation transporters (OCTs) expression and activity, and its consequences on dopamine urinary levels, Na+, K+-ATPase activity and renal function. Male Sprague Dawley rats were infused with isotonic saline solution during 120 minutes and randomized in nine different groups: control, pargyline plus tolcapone (P+T), ANP, dopamine (DA), D-22, DA+D-22, ANP+D-22, ANP+DA and ANP+DA+D-22. Renal functional parameters were determined and urinary dopamine concentration was quantified by HPLC. Expression of OCTs and D1-receptor in membrane preparations from renal cortex tissues were determined by western blot and Na+, K+-ATPase activity was determined using in vitro enzyme assay. H-3-DA renal uptake was determined in vitro. Compared to P+T group, ANP and dopamine infusion increased diuresis, urinary sodium and dopamine excretion significantly. These effects were more pronounced in ANP+DA group and reversed by OCTs blockade by D-22, demonstrating that OCTs are implied in ANP stimulated-DA uptake and transport in renal tissues. The activity of Na+, K+-ATPase exhibited a similar fashion when it was measured in the same experimental groups. Although OCTs and D1-receptor protein expression were not modified by ANP, OCTs-dependent-dopamine tubular uptake was increased by ANP through activation of NPR-A receptor and protein kinase G as signaling pathway. This effect was reflected by an increase in urinary dopamine excretion, natriuresis, diuresis and decreased Na+, K+-ATPase activity. OCTs represent a novel target that links the activity of ANP and dopamine together in a common mechanism to enhance their natriuretic and diuretic effects.	[Kouyoumdzian, Nicolas M.; Rukavina Mikusic, Natalia L.; Toblli, Jorge E.; Fernandez, Belisario E.; Choi, Marcelo R.] Natl Sci & Tech Res Council, Cardiol Res Inst, Buenos Aires, DF, Argentina; [Kouyoumdzian, Nicolas M.; Rukavina Mikusic, Natalia L.; Pandolfo, Marcela; Fernandez, Belisario E.; Choi, Marcelo R.] Pathophysiol & Clin Biochem Inst, Buenos Aires, DF, Argentina; [Kravetz, Maria C.; Carranza, Andrea; Del Mauro, Julieta S.; Gorzalczany, Susana] Univ Buenos Aires, Sch Pharm & Biochem, Dept Pharmacol, Buenos Aires, DF, Argentina; [Lee, Brenda M.] Johns Hopkins Univ Hosp, Dept Gen Surg, Baltimore, MD 21287 USA; [Gironacci, Mariela M.] Univ Buenos Aires, Sch Pharm & Biochem, Dept Biol Chem, Buenos Aires, DF, Argentina; [Toblli, Jorge E.] Deutsch Hosp, Buenos Aires, DF, Argentina; [Choi, Marcelo R.] Univ Buenos Aires, Sch Pharm & Biochem, Dept Anat & Histol, Buenos Aires, DF, Argentina; [Choi, Marcelo R.] Univ Buenos Aires, Sch Pharm & Biochem, Dept Pathophysiol, Buenos Aires, DF, Argentina	University of Buenos Aires; Johns Hopkins University; Johns Hopkins Medicine; University of Buenos Aires; University of Buenos Aires; University of Buenos Aires	Choi, MR (corresponding author), Natl Sci & Tech Res Council, Cardiol Res Inst, Buenos Aires, DF, Argentina.; Choi, MR (corresponding author), Pathophysiol & Clin Biochem Inst, Buenos Aires, DF, Argentina.; Choi, MR (corresponding author), Univ Buenos Aires, Sch Pharm & Biochem, Dept Anat & Histol, Buenos Aires, DF, Argentina.; Choi, MR (corresponding author), Univ Buenos Aires, Sch Pharm & Biochem, Dept Pathophysiol, Buenos Aires, DF, Argentina.	marcelinkchoi@yahoo.com.ar	Choi, Marcelo Roberto/I-4082-2019	Gironacci, Mariela/0000-0002-8189-0388; Carranza, Andrea/0000-0001-8352-5504	PICT (Proyectos de Investigacion Cientifica y Tecnologica) [2012-01775]; UBACyT (Universidad de Buenos Aires Ciencia y Tecnica) [20020130200105BA]; SAHA; Hansang Latinoamerica (Confederacion Latinoamericana de Empresarios Coreanos)	PICT (Proyectos de Investigacion Cientifica y Tecnologica)(ANPCyT); UBACyT (Universidad de Buenos Aires Ciencia y Tecnica); SAHA; Hansang Latinoamerica (Confederacion Latinoamericana de Empresarios Coreanos)	The work was supported by the following: PICT (Proyectos de Investigacion Cientifica y Tecnologica), 2012-01775 MRC; UBACyT (Universidad de Buenos Aires Ciencia y Tecnica), 20020130200105BA MRC; SAHA 2014-2015 MRC; Hansang Latinoamerica (Confederacion Latinoamericana de Empresarios Coreanos). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aperia AC, 2000, ANNU REV PHYSIOL, V62, P621, DOI 10.1146/annurev.physiol.62.1.621; Bellomo R, 2000, LANCET, V356, P2139; Breidert T, 1998, BRIT J PHARMACOL, V125, P218, DOI 10.1038/sj.bjp.0702065; BRENNER BM, 1990, PHYSIOL REV, V70, P665, DOI 10.1152/physrev.1990.70.3.665; Carey RM, 2001, HYPERTENSION, V38, P297, DOI 10.1161/hy0901.096422; Carranza A, 2004, PFLUG ARCH EUR J PHY, V448, P85, DOI 10.1007/s00424-003-1220-y; Carranza A, 2001, HORM RES, V55, P282, DOI 10.1159/000050014; Carranza A, 2008, AM J PHYSIOL-CELL PH, V295, pC1602, DOI 10.1152/ajpcell.00090.2008; Chamorro C, 2001, LANCET, V357, P1707, DOI 10.1016/S0140-6736(00)04838-8; Chen HH, 2013, JAMA-J AM MED ASSOC, V310, P2533, DOI 10.1001/jama.2013.282190; Choi MR, 2006, NEPHRON PHYSIOL, V104, P136, DOI 10.1159/000095856; Ciarimboli G, 2005, J AM SOC NEPHROL, V16, P1562, DOI 10.1681/ASN.2004040256; Ciarimboli G, 2005, PFLUG ARCH EUR J PHY, V449, P423, DOI 10.1007/s00424-004-1355-5; Citarella MR, 2009, REGUL PEPTIDES, V153, P19, DOI 10.1016/j.regpep.2008.11.009; Correa AH, 2007, REGUL PEPTIDES, V138, P26, DOI 10.1016/j.regpep.2006.08.001; Costa MD, 2004, REGUL PEPTIDES, V118, P151, DOI 10.1016/j.regpep.2003.12.009; Cuevas S, 2013, INT J MOL SCI, V14, P17553, DOI 10.3390/ijms140917553; DEBOLD AJ, 1985, SCIENCE, V230, P767, DOI 10.1126/science.2932797; del Amo EM, 2008, EUR J PHARM SCI, V35, P161, DOI 10.1016/j.ejps.2008.06.015; Eisenhofer G, 2001, PHARMACOL THERAPEUT, V91, P35, DOI 10.1016/S0163-7258(01)00144-9; Eklof AC, 2001, CLIN EXP HYPERTENS, V23, P449, DOI 10.1081/CEH-100104236; Fernandes-Cerqueira C, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/397391; Fernandez BE, 2005, REGUL PEPTIDES, V124, P137, DOI 10.1016/j.regpep.2004.07.006; Graefe KH, 1997, N-S ARCH PHARMACOL, V356, P115, DOI 10.1007/PL00005018; Grundemann D, 1998, J BIOL CHEM, V273, P30915, DOI 10.1074/jbc.273.47.30915; Holtback U, 1999, P NATL ACAD SCI USA, V96, P7271, DOI 10.1073/pnas.96.13.7271; Ibarra FR, 2006, MEDICINA-BUENOS AIRE, V66, P81; Jonker JW, 2004, J PHARMACOL EXP THER, V308, P2, DOI 10.1124/jpet.103.053298; Jose PA, 2003, NEPHRON PHYSIOL, V95, P19, DOI DOI 10.1159/000073676; Kellum JA, 2001, CRIT CARE MED, V29, P1526, DOI 10.1097/00003246-200108000-00005; Koepsell H, 2007, PHARM RES-DORDR, V24, P1227, DOI 10.1007/s11095-007-9254-z; LOWRY OH, 1946, J BIOL CHEM, V162, P421; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marik PE, 2002, INTENS CARE MED, V28, P877, DOI 10.1007/s00134-002-1346-y; Marinosci GZ, 2012, TRANSL MED UNISA, V4, P90; Mehrens T, 2000, J AM SOC NEPHROL, V11, P1216, DOI 10.1681/ASN.V1171216; Schlatter E, 2002, J MEMBRANE BIOL, V189, P237, DOI 10.1007/s00232-002-1023-7; Thomas MC, 2003, KIDNEY INT, V63, P2152, DOI 10.1046/j.1523-1755.2003.00006.x; VandeStolpe A, 1988, AM J PHYSIOL, V54, P477; Wright SH, 2004, PHYSIOL REV, V84, P987, DOI 10.1152/physrev.00040.2003; Zhang MZ, 2011, J CLIN INVEST, V121, P2845, DOI 10.1172/JCI57324	41	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0157487	10.1371/journal.pone.0157487	http://dx.doi.org/10.1371/journal.pone.0157487			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27392042	Green Published, gold, Green Submitted			2022-12-27	WOS:000380005400011
J	Qian, JH; Liu, SX; Lei, Q				Qian, Jiehui; Liu, Shengxi; Lei, Quan			Illusory Distance Modulates Perceived Size of Afterimage despite the Disappearance of Depth Cues	PLOS ONE			English	Article							PONZO ILLUSION; PERCEPTION; INVARIANCE; ATTENTION; REPRESENTATION; CONSCIOUSNESS; CONSTANCY; AREA; LAW	It is known that the perceived size of an afterimage is modulated by the perceived distance between the observer and the depth plane on which the afterimage is projected (Emmert's law). Illusions like Ponzo demonstrate that illusory distance induced by depth cues can also affect the perceived size of an object. In this study, we report that the illusory distance not only modulates the perceived size of object's afterimage during the presence of the depth cues, but the modulation persists after the disappearance of the depth cues. We used an adapted version of the classic Ponzo illusion. Illusory depth perception was induced by linear perspective cues with two tilted lines converging at the upper boundary of the display. Two horizontal bars were placed between the two lines, resulting in a percept of the upper bar to be farther away than the lower bar. Observers were instructed to make judgment about the relative size of the afterimage of the lower and the upper bars after adaptation. When the perspective cues and the bars were static, the illusory effect of the Ponzo afterimage is consistent with that of the traditional size-distance illusion. When the perspective cues were flickering and the bars were static, only the afterimage of the latter was perceived, yet still a considerable amount of the illusory effect was perceived. The results could not be explained by memory of a prejudgment of the bar length during the adaptation phase. The findings suggest that cooccurrences of depth cues and object may link a depth marker for the object, so that the perceived size of the object or its afterimage is modulated by feedback of depth information from higher-level visual cortex even when there is no depth cues directly available on the retinal level.	[Qian, Jiehui; Liu, Shengxi] Sun Yat Sen Univ, Dept Psychol, Guangzhou, Guangdong, Peoples R China; [Lei, Quan] Univ Minnesota Twin Cities, Dept Psychol, Minneapolis, MN USA	Sun Yat Sen University; University of Minnesota System; University of Minnesota Twin Cities	Qian, JH (corresponding author), Sun Yat Sen Univ, Dept Psychol, Guangzhou, Guangdong, Peoples R China.	qianjh3@mail.sysu.edu.cn		Lei, Quan/0000-0001-8277-9473	National Natural Science Foundation of China [31500919]; Fundamental Research Funds for the Central Universities [14wkpy20]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work has been supported by the National Natural Science Foundation of China, No. 31500919 (http://www.nsfc.gov.cn) and Fundamental Research Funds for the Central Universities, No. 14wkpy20. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work has been supported in part by the National Natural Science Foundation of China (31500919) and Fundamental Research Funds for the Central Universities (14wkpy20).	Boring EG, 1941, AM J PSYCHOL, V53, P293; BOWER T, 1964, PERCEPT MOTOR SKILL, V19, P510, DOI 10.2466/pms.1964.19.2.510; BRINDLEY GS, 1962, J PHYSIOL-LONDON, V164, P168, DOI 10.1113/jphysiol.1962.sp007011; BROERSE J, 1992, PERCEPTION, V21, P261, DOI 10.1068/p210261; Bross M, 2000, PERCEPTION, V29, P1385, DOI 10.1068/p3038; BURBECK CA, 1986, J OPT SOC AM A, V3, P1159, DOI 10.1364/JOSAA.3.001159; Campbell F. W., 1957, OPT ACTA, V4, P157, DOI DOI 10.1080/713826091; Chan D, 2001, J NEUROL NEUROSUR PS, V71, P515, DOI 10.1136/jnnp.71.4.515; Conway BR, 2002, CEREB CORTEX, V12, P915, DOI 10.1093/cercor/12.9.915; CORMACK RH, 1984, PERCEPT PSYCHOPHYS, V35, P423, DOI 10.3758/BF03203918; DEES JW, 1966, PERCEPT MOTOR SKILL, V23, P629, DOI 10.2466/pms.1966.23.2.629; Dobbins AC, 1998, SCIENCE, V281, P552, DOI 10.1126/science.281.5376.552; DWYER J, 1990, PERCEPTION, V19, P35, DOI 10.1068/p190035; Emmert E., 1881, KLIN MONATSBL AUGENH, P443; EPSTEIN W, 1963, J EXP PSYCHOL, V66, P78, DOI 10.1037/h0047819; EPSTEIN W, 1961, PSYCHOL BULL, V58, P491, DOI 10.1037/h0042260; Ernst M. O., 2006, HUMAN BODY PERCEPTIO, P105; Fang F, 2008, CURR BIOL, V18, P1707, DOI 10.1016/j.cub.2008.09.025; Fujita K, 1997, PERCEPT PSYCHOPHYS, V59, P284, DOI 10.3758/BF03211896; GNADT JW, 1995, J NEUROPHYSIOL, V73, P280, DOI 10.1152/jn.1995.73.1.280; Gregory RichardL., 2009, SEEING ILLUSIONS; GREGORY RL, 1963, NATURE, V199, P678, DOI 10.1038/199678a0; ITO M, 1995, J NEUROPHYSIOL, V73, P218, DOI 10.1152/jn.1995.73.1.218; Kim J, 2011, J VISION, V11, DOI 10.1167/11.3.23; Kirschfeld K, 1999, CONSCIOUS COGN, V8, P462, DOI 10.1006/ccog.1999.0388; Koch C, 2007, TRENDS COGN SCI, V11, P16, DOI 10.1016/j.tics.2006.10.012; LEIBOWIT.H, 1966, J OPT SOC AM, V56, P1120, DOI 10.1364/JOSA.56.001120; MACLEOD DIA, 1974, SCIENCE, V185, P1171, DOI 10.1126/science.185.4157.1171; Murray SO, 2006, NAT NEUROSCI, V9, P429, DOI 10.1038/nn1641; Nakamizo Sachio, 2004, J Physiol Anthropol Appl Human Sci, V23, P325, DOI 10.2114/jpa.23.325; OGLE KN, 1962, VISION RES, V2, P439, DOI 10.1016/0042-6989(62)90008-1; PRESSEY AW, 1992, PERCEPT PSYCHOPHYS, V52, P211, DOI 10.3758/BF03206774; Prinzmetal W, 2001, PERCEPT PSYCHOPHYS, V63, P99, DOI 10.3758/BF03200506; Qian JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129377; Qian JH, 2013, J VISION, V13, DOI 10.1167/13.11.7; Qian JH, 2012, J VISION, V12, DOI 10.1167/12.2.15; Ross HE, 2000, PERCEPTION, V29, P863, DOI 10.1068/p2937; ROSS HE, 1967, BRIT J PSYCHOL, V58, P301, DOI 10.1111/j.2044-8295.1967.tb01087.x; Schwarzkopf DS, 2011, NAT NEUROSCI, V14, P28, DOI 10.1038/nn.2706; Shen MW, 2015, COGNITION, V141, P26, DOI 10.1016/j.cognition.2015.04.010; Sperandio I, 2012, NAT NEUROSCI, V15, P540, DOI 10.1038/nn.3069; Sperandio I, 2012, J VISION, V12, DOI 10.1167/12.2.18; van Boxtel JJA, 2010, P NATL ACAD SCI USA, V107, P8883, DOI 10.1073/pnas.0913292107; van Lier R, 2009, CURR BIOL, V19, pR323, DOI 10.1016/j.cub.2009.03.010; WALLACH H, 1963, AM J PSYCHOL, V76, P404, DOI 10.2307/1419781; Wheatstone C, 1853, PHILOS TR R SOC, V142, P1; WILLIAMS DR, 1979, VISION RES, V19, P867, DOI 10.1016/0042-6989(79)90020-8	47	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159228	10.1371/journal.pone.0159228	http://dx.doi.org/10.1371/journal.pone.0159228			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27391335	Green Published, gold, Green Submitted			2022-12-27	WOS:000380005400225
J	van der Meulen, M; van IJzendoorn, MH; Crone, EA				van der Meulen, Mara; van IJzendoorn, Marinus H.; Crone, Eveline A.			Neural Correlates of Prosocial Behavior: Compensating Social Exclusion in a Four-Player Cyberball Game	PLOS ONE			English	Article							WITNESSING PEER REJECTION; RESPONSES; EMPATHY; NEUROSCIENCE; PUNISHMENT; CORTEX; FMRI	Prior studies demonstrated contributions of the insula and dorsal anterior cingulate cortex (dACC) for both experiencing and observing social exclusion, but it is not yet well understood how the brain processes the compensation of exclusion, as is observed in prosocial helping. Here, we tested if social brain regions, specifically the medial prefrontal cortex (mPFC) and temporal parietal junction (TPJ) are involved when individuals show prosocial behavior towards excluded others. For this purpose, 23 female participants played a four-player Cyberball Game in which participants could toss balls to each other. During the exclusion game, two players excluded one of the other players. When participants observed exclusion by others, they showed elevated activity in the insula, consistent with prior studies. However, when they tossed the ball to the excluded player, they showed increased activation in the TPJ, consistent with the hypothesis that prosocial behavior is associated with social reasoning. In addition, tossing to the excluded player was associated with increased activity in the nucleus accumbens (NAcc). Given that prior studies reported that the NAcc is involved in experiencing rewards, this may suggest a warm glow for showing prosocial compensation behavior when helping excluded others.	[van der Meulen, Mara; van IJzendoorn, Marinus H.; Crone, Eveline A.] Leiden Univ, Inst Psychol, Leiden, Netherlands; [van IJzendoorn, Marinus H.] Leiden Univ, Ctr Child & Family Studies, Leiden, Netherlands; [van der Meulen, Mara; Crone, Eveline A.] Leiden Univ, Leiden Consortium Individual Dev, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC	van der Meulen, M (corresponding author), Leiden Univ, Inst Psychol, Leiden, Netherlands.; van der Meulen, M (corresponding author), Leiden Univ, Leiden Consortium Individual Dev, Leiden, Netherlands.	m.van.der.meulen@fsw.leidenuniv.nl	van IJzendoorn, Marinus/P-4907-2019	van IJzendoorn, Marinus/0000-0003-1144-454X; Crone, Eveline/0000-0002-7508-6078	Dutch Ministry of Education, Culture, and Science; Netherlands Organization for Scientific Research (NWO grant) [024.001.003]	Dutch Ministry of Education, Culture, and Science; Netherlands Organization for Scientific Research (NWO grant)(Netherlands Organization for Scientific Research (NWO))	The Consortium on Individual Development is funded through the Gravitation programme of the Dutch Ministry of Education, Culture, and Science and the Netherlands Organization for Scientific Research (NWO grant number 024.001.003). The and analysis, decision to publish, or preparation of the manuscript.	Bartz JA, 2010, PSYCHOL SCI, V21, P1426, DOI 10.1177/0956797610383439; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Brett M., 2002, NEUROIMAGE, V16, P497; Burnett S, 2009, EUR J NEUROSCI, V29, P1294, DOI 10.1111/j.1460-9568.2009.06674.x; Cacioppo S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02027; Carter RM, 2013, TRENDS COGN SCI, V17, P328, DOI 10.1016/j.tics.2013.05.007; Cocosco S., 1997, NEUROIMAGE, V5, pS452; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; De Corte K, 2007, PSYCHOL BELG, V47, P235, DOI 10.5334/pb-47-4-235; Delgado MR, 2007, ANN NY ACAD SCI, V1104, P70, DOI 10.1196/annals.1390.002; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Guroglu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107996; Hall OF, 2012, SOC COGN AFFECT NEUR, V7, P743, DOI 10.1093/scan/nss069; Harbaugh WT, 2007, SCIENCE, V316, P1622, DOI 10.1126/science.1140738; HOFSTEE WKB, 1994, EUR J PERSONALITY, V8, P149, DOI 10.1002/per.2410080302; Konijn EA, 2007, DEV PSYCHOL, V43, P1038, DOI 10.1037/0012-1649.43.4.1038; Lieberman MD, 2015, P NATL ACAD SCI USA, V112, P15250, DOI 10.1073/pnas.1515083112; Lieberman MD, 2009, SCIENCE, V323, P890, DOI 10.1126/science.1170008; Masten CL, 2013, CHILD DEV, V84, P1338, DOI 10.1111/cdev.12056; Masten CL, 2011, NEUROIMAGE, V55, P381, DOI 10.1016/j.neuroimage.2010.11.060; Masten CL, 2010, SOC NEUROSCI-UK, V5, P496, DOI 10.1080/17470919.2010.490673; Masten CL, 2009, SOC COGN AFFECT NEUR, V4, P143, DOI 10.1093/scan/nsp007; Meyer ML, 2013, SOC COGN AFFECT NEUR, V8, P446, DOI 10.1093/scan/nss019; Moor BG, 2012, NEUROIMAGE, V59, P708, DOI 10.1016/j.neuroimage.2011.07.028; Novembre G, 2015, SOC COGN AFFECT NEUR, V10, P153, DOI 10.1093/scan/nsu038; Riem MME, 2013, PSYCHONEUROENDOCRINO, V38, P1418, DOI 10.1016/j.psyneuen.2012.12.023; Rotge JY, 2015, SOC COGN AFFECT NEUR, V10, P19, DOI 10.1093/scan/nsu110; Roth-Hanania R, 2011, INFANT BEHAV DEV, V34, P447, DOI 10.1016/j.infbeh.2011.04.007; Sebastian CL, 2011, NEUROIMAGE, V57, P686, DOI 10.1016/j.neuroimage.2010.09.063; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Stalnaker TA, 2015, NAT NEUROSCI, V18, P620, DOI 10.1038/nn.3982; Telzer EH, 2016, DEV COGN NEUROS-NETH, V17, P57, DOI 10.1016/j.dcn.2015.10.010; Waytz A, 2012, J NEUROSCI, V32, P7646, DOI 10.1523/JNEUROSCI.6193-11.2012; Wesselmann ED, 2009, J EXP SOC PSYCHOL, V45, P1308, DOI 10.1016/j.jesp.2009.08.003; Will GJ, 2015, SOC COGN AFFECT NEUR, V10, P209, DOI 10.1093/scan/nsu045; Will GJ, 2013, DEV PSYCHOL, V49, P2236, DOI 10.1037/a0032299; Williams KD, 2000, J PERS SOC PSYCHOL, V79, P748, DOI 10.1037/0022-3514.79.5.748; Woo CW, 2014, NEUROIMAGE, V91, P412, DOI 10.1016/j.neuroimage.2013.12.058; Zadro L, 2004, J EXP SOC PSYCHOL, V40, P560, DOI 10.1016/j.jesp.2003.11.006	39	30	30	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159045	10.1371/journal.pone.0159045	http://dx.doi.org/10.1371/journal.pone.0159045			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27391364	Green Submitted, gold, Green Published			2022-12-27	WOS:000380005400199
J	Wu, WS; Hsieh, YC; Lai, FJ				Wu, Wei-Sheng; Hsieh, Yen-Chen; Lai, Fu-Jou			YCRD: Yeast Combinatorial Regulation Database	PLOS ONE			English	Article							COOPERATIVE TRANSCRIPTION FACTORS; CELL-CYCLE; SYSTEMATIC IDENTIFICATION; STATISTICAL-METHODS; FACTOR PAIRS; FACTORS GLN3; GENE; EXPRESSION; PREDICTION; NETWORK	In eukaryotes, the precise transcriptional control of gene expression is typically achieved through combinatorial regulation using cooperative transcription factors (TFs). Therefore, a database which provides regulatory associations between cooperative TFs and their target genes is helpful for biologists to study the molecular mechanisms of transcriptional regulation of gene expression. Because there is no such kind of databases in the public domain, this prompts us to construct a database, called Yeast Combinatorial Regulation Database (YCRD), which deposits 434,197 regulatory associations between 2535 cooperative TF pairs and 6243 genes. The comprehensive collection of more than 2500 cooperative TF pairs was retrieved from 17 existing algorithms in the literature. The target genes of a cooperative TF pair (e.g. TF1-TF2) are defined as the common target genes of TF1 and TF2, where a TF's experimentally validated target genes were downloaded from YEASTRACT database. In YCRD, users can (i) search the target genes of a cooperative TF pair of interest, (ii) search the cooperative TF pairs which regulate a gene of interest and (iii) identify important cooperative TF pairs which regulate a given set of genes. We believe that YCRD will be a valuable resource for yeast biologists to study combinatorial regulation of gene expression. YCRD is available at http://cosbi.ee.ncku.edu.tw/YCRD/ or http://cosbi2.ee.ncku.edu.tw/YCRD/.	[Wu, Wei-Sheng; Hsieh, Yen-Chen; Lai, Fu-Jou] Natl Cheng Kung Univ, Dept Elect Engn, Tainan, Taiwan	National Cheng Kung University	Wu, WS (corresponding author), Natl Cheng Kung Univ, Dept Elect Engn, Tainan, Taiwan.	wessonwu@gmail.com	Wu, Wei-Sheng/P-5367-2019		National Cheng Kung University; Ministry of Science and Technology of Taiwan [MOST-103-2221-E-006-174-MY2]	National Cheng Kung University; Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by National Cheng Kung University and Ministry of Science and Technology of Taiwan [MOST-103-2221-E-006-174-MY2]. Funding for open access charge: National Cheng Kung University and Ministry of Science and Technology of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The physical/genetic interaction data and a TF's experimentally validated target genes were retrieved from BioGRID and YEASTRACT in March 2016, respectively. We greatly appreciate the effort of both research teams in collecting and curating such valuable data from the literature. This work was supported by National Cheng Kung University and Ministry of Science and Technology of Taiwan [MOST-103-2221-E-006-174-MY2]. Funding for open access charge: National Cheng Kung University and Ministry of Science and Technology of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaji S, 2006, J MOL BIOL, V360, P213, DOI 10.1016/j.jmb.2006.04.029; Banerjee N, 2003, NUCLEIC ACIDS RES, V31, P7024, DOI 10.1093/nar/gkg894; Chang YH, 2006, BIOINFORMATICS, V22, P2276, DOI 10.1093/bioinformatics/btl380; Chatr-aryamontri A, 2015, NUCLEIC ACIDS RES, V43, pD470, DOI 10.1093/nar/gku1204; Chen MJM, 2012, BIOINFORMATICS, V28, P701, DOI 10.1093/bioinformatics/bts002; Cheng C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-116; Chuang CL, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-400; Costanzo MC, 2014, NUCLEIC ACIDS RES, V42, pD717, DOI 10.1093/nar/gkt1158; Crespo JL, 2001, J BIOL CHEM, V276, P34441, DOI 10.1074/jbc.M103601200; Dabas N, 2007, EUKARYOT CELL, V6, P875, DOI 10.1128/EC.00307-06; Datta D, 2008, BIOINFORMATICS, V24, P545, DOI 10.1093/bioinformatics/btm523; Elati M, 2007, BIOINFORMATICS, V23, P2407, DOI 10.1093/bioinformatics/btm352; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; He D, 2006, GCC 2006: FIFTH INTERNATIONAL CONFERENCE ON GRID AND COOPERATIVE COMPUTING WORKSHOPS, PROCEEDINGS, P357; Hernandez H, 2011, BIOCHEM BIOPH RES CO, V404, P859, DOI 10.1016/j.bbrc.2010.12.075; Hofman-Bang J, 1999, MOL BIOTECHNOL, V12, P35, DOI 10.1385/MB:12:1:35; Lai FJ, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/1471-2105-16-S18-S2; Lai FJ, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S5-S2; Lai FJ, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S4-S9; Lelli KM, 2012, ANNU REV GENET, V46, P43, DOI 10.1146/annurev-genet-110711-155437; Nagamine N, 2005, NUCLEIC ACIDS RES, V33, P4828, DOI 10.1093/nar/gki793; Nemer G, 2001, ANN MED, V33, P604, DOI 10.3109/07853890109002106; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Tanguay RM., 1998, BIOCH CELL BIOL, V66, P584; Teixeira MC, 2014, NUCLEIC ACIDS RES, V42, pD161, DOI 10.1093/nar/gkt1015; Tsai HK, 2005, P NATL ACAD SCI USA, V102, P13532, DOI 10.1073/pnas.0505874102; Wang JB, 2007, J BIOMED INFORM, V40, P707, DOI 10.1016/j.jbi.2007.02.003; Wang Y, 2009, NUCLEIC ACIDS RES, V37, P5943, DOI 10.1093/nar/gkp625; Wu WS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-421; Wu WS, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S12-S10; Wu WS, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-522; Wu WS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-439; Yang Y, 2010, CELL RES, V20, P1276, DOI 10.1038/cr.2010.146; Yu XP, 2006, NUCLEIC ACIDS RES, V34, P917, DOI 10.1093/nar/gkj487	35	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159213	10.1371/journal.pone.0159213	http://dx.doi.org/10.1371/journal.pone.0159213			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27392072	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400219
J	Yu, L; Gong, XJ; Sun, L; Zhou, QY; Lu, BL; Zhu, LY				Yu, Lei; Gong, Xuejun; Sun, Lei; Zhou, Qiying; Lu, Baoling; Zhu, Liying			The Circular RNA Cdr1as Act as an Oncogene in Hepatocellular Carcinoma through Targeting miR-7 Expression	PLOS ONE			English	Article							DOWN-REGULATION; IDENTIFICATION; PROLIFERATION; TRANSCRIPTION; BIOGENESIS; INSIGHTS	CircRNAs are a class of endogenous RNA that regulates gene expression at the post-transcriptional or transcriptionallevel through interacting with other molecules or microRNAs. Increasing studies have demonstrated that circRNAs play a crucial role in biology processes. CircRNAs are proved as potentialbiomarkers in many diseases including cancers. However, the role of Cdr1as in Hepatocellular carcinoma (HCC) remains to be elucidated. We demonstrated that Cdr1as expression was upregulated in HCC tissues compared with the adjacent non-tumor tissues. In addtion, miR-7 expression was downregulated in HCC tissues compared with the adjacent non-tumor tissues. Moreover, the expression level of miR-7 was inversely correlated with that in HCC tissues. Knockdown of Cdr1as suppressed the HCC cell proliferation and invasion. Overexpression of miR-7 inhibited the HCC cell proliferation and invasion. Overexpression of miR-7 could suppress the direct target gene CCNE1 and PIK3CD expression. Knockdown of Cdr1as suppressed the expression of miR-7 and also inhibited the CCNE1 and PIK3CD expression. Furthermore, knockdown of Cdr1as suppressed the HCC cell proliferation and invasion through targeting miR-7. These data suggested that Cdr1as acted as an oncogene partly through targeting miR-7 in HCC.	[Yu, Lei; Lu, Baoling; Zhu, Liying] Harbin Med Univ, Hosp 4, Dept Infect Dis, Harbin 150001, Heilongjiang, Peoples R China; [Gong, Xuejun] Cent S Univ, Xiangya Hosp, Dept Biliary & Pancreat Surg, Changsha 410008, Hunan, Peoples R China; [Sun, Lei] Harbin Med Univ, Hosp 4, Dept Ophthalmol, Harbin 150001, Heilongjiang, Peoples R China; [Zhou, Qiying] Jilin Univ, Coll Comp Sci & Technol Network & Informat Securi, Changchun 130001, Jilin, Peoples R China	Harbin Medical University; Central South University; Harbin Medical University; Jilin University	Yu, L; Zhu, LY (corresponding author), Harbin Med Univ, Hosp 4, Dept Infect Dis, Harbin 150001, Heilongjiang, Peoples R China.	widedoor@sina.com; zlyhmu@126.com		YU, LEI/0000-0002-8837-2022	Postdoctoral scientific research developmental fund of Heilongjiang Province [LBH-Q14115]; National Science and Technology Major Project [2014ZX10002002]; Natural Science Foundation of Heilongjiang Province [ZD2015019]	Postdoctoral scientific research developmental fund of Heilongjiang Province; National Science and Technology Major Project; Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province)	This work was supported by the Postdoctoral scientific research developmental fund of Heilongjiang Province (No. LBH-Q14115), and sponsored by National Science and Technology Major Project (2014ZX10002002) and Natural Science Foundation of Heilongjiang Province (ZD2015019), URL: http://jj.hljkj.cn/zr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae HJ, 2014, ONCOGENE, V33, P2557, DOI 10.1038/onc.2013.216; Boeckel JN, 2015, CIRC RES, V117, P884, DOI 10.1161/CIRCRESAHA.115.306319; Chen I, 2015, WIRES RNA, V6, P563, DOI 10.1002/wrna.1294; Chen YJ, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/682380; Ebbesen KK, 2016, BBA-GENE REGUL MECH, V1859, P163, DOI 10.1016/j.bbagrm.2015.07.007; Fang YX, 2012, HEPATOLOGY, V55, P1852, DOI 10.1002/hep.25576; Furuta M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060155; Giray BG, 2014, MOL BIOL REP, V41, P4513, DOI 10.1007/s11033-014-3322-3; Guo JU, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0409-z; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Huang C, 2015, TRANSCR-AUSTIN, V6, P61, DOI 10.1080/21541264.2015.1071301; Lasda E, 2014, RNA, V20, P1829, DOI 10.1261/rna.047126.114; Li JQ, 2015, AM J CANCER RES, V5, P472; Li PF, 2015, CLIN CHIM ACTA, V444, P132, DOI 10.1016/j.cca.2015.02.018; Li QJ, 2012, TUMOR BIOL, V33, P1455, DOI 10.1007/s13277-012-0396-1; Liao CG, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0234-x; Liu JB, 2015, TUMOR BIOL, V36, P219, DOI 10.1007/s13277-014-2622-5; Lu TT, 2015, RNA, V21, P2076, DOI 10.1261/rna.052282.115; Lukiw Walter J., 2013, Frontiers in Genetics, V4, P307, DOI [10.3389/fgene.2013.00307, 10.3389/fgene.2013.00077]; Ma CQ, 2013, IUBMB LIFE, V65, P1026, DOI 10.1002/iub.1231; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Qu SB, 2015, CANCER LETT, V365, P141, DOI 10.1016/j.canlet.2015.06.003; Veno MT, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0801-3; Xu HY, 2015, SCI REP-UK, V5, DOI 10.1038/srep12453; Xu LB, 2014, J HEPATOL, V60, P590, DOI 10.1016/j.jhep.2013.10.028; Yang XY, 2012, PHARMAZIE, V67, P645, DOI 10.1691/ph.2012.1704; Yu L, 2015, ONCOTARGET, V6, P39225, DOI 10.18632/oncotarget.4407; Yu L, 2014, AM J CANCER RES, V4, P897; Yu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091661; Zhang HY, 2014, INT J ONCOL, V45, P2143, DOI 10.3892/ijo.2014.2596; Zhang X, 2014, BIOCHEM BIOPH RES CO, V443, P1078, DOI 10.1016/j.bbrc.2013.12.095; Zhao ZJ, 2017, RNA BIOL, V14, P514, DOI 10.1080/15476286.2015.1122162; Zheng QL, 2014, MOL CELL BIOCHEM, V389, P187, DOI 10.1007/s11010-013-1940-z; Zhou X, 2014, EURASIP J WIREL COMM, DOI 10.1186/1687-1499-2014-19	34	242	259	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158347	10.1371/journal.pone.0158347	http://dx.doi.org/10.1371/journal.pone.0158347			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391479	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400045
J	van Schooten, KS; Pijnappels, M; Rispens, SM; Elders, PJM; Lips, P; Daffertshofer, A; Beek, PJ; van Dieen, JH				van Schooten, Kimberley S.; Pijnappels, Mirjam; Rispens, Sietse M.; Elders, Petra J. M.; Lips, Paul; Daffertshofer, Andreas; Beek, Peter J.; van Dieen, Jaap H.			Daily-Life Gait Quality as Predictor of Falls in Older People: A 1-Year Prospective Cohort Study	PLOS ONE			English	Article							DYNAMIC STABILITY; RISK; COMMUNITY; VALIDATION; ACCURACY; PROVIDE; SCALE	Falls can have devastating consequences for older people. We determined the relationship between the likelihood of fall incidents and daily-life behavior. We used wearable sensors to assess habitual physical activity and daily-life gait quality (in terms of e.g. stability, variability, smoothness and symmetry), and determined their predictive ability for time-to-first-and-second-falls. 319 older people wore a trunk accelerometer (Dynaport MoveMonitor, McRoberts) during one week. Participants further completed questionnaires and performed grip strength and trail making tests to identify risk factors for falls. Their prospective fall incidence was followed up for six to twelve months. We determined interrelations between commonly used gait characteristics to gain insight in their interpretation and determined their association with time-to-falls. For all data-including questionnaires and tests-we determined the corresponding principal components and studied their predictive ability for falls. We showed that gait characteristics of walking speed, stride length, stride frequency, intensity, variability, smoothness, symmetry and complexity were often moderately to highly correlated (r > 0.4). We further showed that these characteristics were predictive of falls. Principal components dominated by history of falls, alcohol consumption, gait quality and muscle strength proved predictive for time-to-fall. The cross-validated prediction models had adequate to high accuracy (time dependent AUC of 0.66-0.72 for time-to-first-fall and 0.69-0.76 for -second-fall). Daily-life gait quality obtained from a single accelerometer on the trunk is predictive for falls. These findings confirm that ambulant measurements of daily behavior contribute substantially to the identification of elderly at (high) risk of falling.	[van Schooten, Kimberley S.; Pijnappels, Mirjam; Rispens, Sietse M.; Daffertshofer, Andreas; Beek, Peter J.; van Dieen, Jaap H.] Vrije Univ Amsterdam, Dept Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands; [Elders, Petra J. M.] Vrije Univ Amsterdam Med Ctr, Dept Gen Practice & Elderly Care, EMGO Inst, Amsterdam, Netherlands; [Lips, Paul] Vrije Univ Amsterdam Med Ctr, Dept Internal Med, MOVE Res Inst Amsterdam, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	van Dieen, JH (corresponding author), Vrije Univ Amsterdam, Dept Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands.	j.van.dieen@vu.nl	van Schooten, Kim/ABE-3702-2020; van Dieen, Jaap/B-3937-2013; van Schooten, Kimberley/A-5844-2012	van Dieen, Jaap/0000-0002-7719-5585; Rispens, Sietse/0000-0002-9400-6125; Daffertshofer, Andreas/0000-0001-9107-3552; Elders, Petra/0000-0002-5907-7219; Pijnappels, Mirjam/0000-0001-8416-2602; Beek, Peter/0000-0002-0917-8548; van Schooten, Kimberley/0000-0003-0902-8440	Netherlands Organisation for Scientific Research (NWO TOP NIG grant) [91209021]; NWO grant [400-08-127]; commercial grant of McRoberts (the Hague, the Netherlands)	Netherlands Organisation for Scientific Research (NWO TOP NIG grant)(Netherlands Organization for Scientific Research (NWO)); NWO grant; commercial grant of McRoberts (the Hague, the Netherlands)	This work was supported by the Netherlands Organisation for Scientific Research (NWO TOP NIG grant 91209021 to MP (http://www.zonmw.nl/nl/projecten/project-detail/a-novel-instrument-to-support-fall-prevention-in-extramural-care/samenvatting/) and NWO grant 400-08-127 to AD (http://www.nwo.nl/onderzoek-en-resultaten/onderzoeksprojecten/i/80/4780.html)). KS was partially supported by a commercial grant of McRoberts (the Hague, the Netherlands; http://www.mcroberts.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellanca JL, 2013, J BIOMECH, V46, P828, DOI 10.1016/j.jbiomech.2012.12.008; Brodie MA, 2015, MED HYPOTHESES, V84, P356, DOI 10.1016/j.mehy.2015.01.017; Bruijn SM, 2009, J NEUROSCI METH, V178, P327, DOI 10.1016/j.jneumeth.2008.12.015; Cameron ID, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005465.pub2; Dijkstra B, 2010, AGE AGEING, V39, P259, DOI 10.1093/ageing/afp249; Doi T, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-7; Dumith SC, 2011, PREV MED, V53, P24, DOI 10.1016/j.ypmed.2011.02.017; England SA, 2007, GAIT POSTURE, V25, P172, DOI 10.1016/j.gaitpost.2006.03.003; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gates S, 2008, J REHABIL RES DEV, V45, P1105, DOI 10.1682/JRRD.2008.04.0057; Gillespie Lesley D, 2012, Cochrane Database Syst Rev, pCD007146, DOI 10.1002/14651858.CD007146.pub3; Graafmans WC, 1996, AM J EPIDEMIOL, V143, P1129; Holtzer R, 2007, NEUROPSYCHOLOGY, V21, P540, DOI 10.1037/0894-4105.21.5.540; Klenk J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129098; Lamoth CJC, 2002, GAIT POSTURE, V16, P101, DOI 10.1016/S0966-6362(01)00146-1; Lee J, 2013, PM&R, V5, P609, DOI 10.1016/j.pmrj.2013.04.001; Marschollek M, 2011, METHOD INFORM MED, V50, P420, DOI 10.3414/ME10-01-0040; Milat Andrew J, 2011, N S W Public Health Bull, V22, P43, DOI 10.1071/NB10065; Moe-Nilssen R, 2004, J BIOMECH, V37, P121, DOI 10.1016/S0021-9290(03)00233-1; Moe-Nilssen R, 1998, CLIN BIOMECH, V13, P320, DOI 10.1016/S0268-0033(98)00089-8; Pluijm SMF, 2006, OSTEOPOROSIS INT, V17, P417, DOI 10.1007/s00198-005-0002-0; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Rispens SM, 2015, JMIR RES PROTOC, V4, DOI 10.2196/resprot.3931; Rispens SM, 2015, NEUROREHAB NEURAL RE, V29, P54, DOI 10.1177/1545968314532031; Rispens SM, 2014, GAIT POSTURE, V40, P187, DOI 10.1016/j.gaitpost.2014.03.182; Salva A, 2004, MED CLIN-BARCELONA, V122, P172, DOI 10.1157/13057813; Schwenk M, 2014, GERONTOL; Scott V, 2007, AGE AGEING, V36, P130, DOI 10.1093/ageing/afl165; Shany T, 2015, HEALTHC TECHNOL LETT, V2, P79, DOI 10.1049/htl.2015.0019; Tromp AM, 2001, J CLIN EPIDEMIOL, V54, P837, DOI 10.1016/S0895-4356(01)00349-3; van Schooten KS, 2015, J GERONTOL A-BIOL, V70, P608, DOI 10.1093/gerona/glu225; van Schooten KS, 2014, GAIT POSTURE, V39, P695, DOI 10.1016/j.gaitpost.2013.09.020; van Schooten KS, 2014, JAPA; Weiss A, 2013, NEUROREHAB NEURAL RE, V27, P742, DOI 10.1177/1545968313491004; WOLF A, 1985, PHYSICA D, V16, P285, DOI 10.1016/0167-2789(85)90011-9; YACK HJ, 1993, J GERONTOL, V48, pM225, DOI 10.1093/geronj/48.5.M225; Yardley L, 2005, AGE AGEING, V34, P614, DOI 10.1093/ageing/afi196; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Zijlstra W, 2003, GAIT POSTURE, V18, P1, DOI 10.1016/S0966-6362(02)00190-X	39	83	83	5	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158623	10.1371/journal.pone.0158623	http://dx.doi.org/10.1371/journal.pone.0158623			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27389583	Green Published, Green Submitted, gold			2022-12-27	WOS:000379811500031
J	Iwasaki, Y; Sugita, S; Mandai, M; Yonemura, S; Onishi, A; Ito, S; Mochizuki, M; Ohno-Matsui, K; Takahashi, M				Iwasaki, Yuko; Sugita, Sunao; Mandai, Michiko; Yonemura, Shigenobu; Onishi, Akishi; Ito, Shin-ichiro; Mochizuki, Manabu; Ohno-Matsui, Kyoko; Takahashi, Masayo			Differentiation/Purification Protocol for Retinal Pigment Epithelium from Mouse Induced Pluripotent Stem Cells as a Research Tool	PLOS ONE			English	Article							VISUAL CYCLE; IN-VITRO; CADHERIN EXPRESSION; EYE DEVELOPMENT; DOWN-REGULATION; 1B PROTEIN; RPE CELLS; ACTIVATION; CULTURE; PROMOTER	Purpose To establish a novel protocol for differentiation of retinal pigment epithelium (RPE) with high purity from mouse induced pluripotent stem cells (iPSC). Methods Retinal progenitor cells were differentiated from mouse iPSC, and RPE differentiation was then enhanced by activation of the Wnt signaling pathway, inhibition of the fibroblast growth factor signaling pathway, and inhibition of the Rho-associated, coiled-coil containing protein kinase signaling pathway. Expanded pigmented cells were purified by plate adhesion after Accutase (R) treatment. Enriched cells were cultured until they developed a cobblestone appearance with cuboidal shape. The characteristics of iPS-RPE were confirmed by gene expression, immunocytochemistry, and electron microscopy. Functions and immunologic features of the iPS-RPE were also evaluated. Results We obtained iPS-RPE at high purity (approximately 98%). The iPS-RPE showed apicalbasal polarity and cellular structure characteristic of RPE. Expression levels of several RPE markers were lower than those of freshly isolated mouse RPE but comparable to those of primary cultured RPE. The iPS-RPE could form tight junctions, phagocytose photoreceptor outer segments, express immune antigens, and suppress lymphocyte proliferation. Conclusion We successfully developed a differentiation/purification protocol to obtain mouse iPS-RPE. The mouse iPS-RPE can serve as an attractive tool for functional and morphological studies of RPE.	[Iwasaki, Yuko; Sugita, Sunao; Mandai, Michiko; Onishi, Akishi; Ito, Shin-ichiro; Takahashi, Masayo] RIKEN Ctr Dev Biol, Lab Retinal Regenerat, Kobe, Hyogo, Japan; [Iwasaki, Yuko; Mochizuki, Manabu; Ohno-Matsui, Kyoko] Tokyo Med & Dent Univ, Dept Ophthalmol & Visual Sci, Grad Sch Med & Dent Sci, Bunkyo Ku, Tokyo, Japan; [Yonemura, Shigenobu] RIKEN Ctr Life Sci Technol, Ultrastruct Res Team, Kobe, Hyogo, Japan; [Yonemura, Shigenobu] Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Cell Biol, Tokushima, Japan	RIKEN; Tokyo Medical & Dental University (TMDU); RIKEN; Tokushima University	Takahashi, M (corresponding author), RIKEN Ctr Dev Biol, Lab Retinal Regenerat, Kobe, Hyogo, Japan.	retinalab@cdb.riken.jp		Shida, Yuko/0000-0003-0584-0407	Junior Research Associate Program of RIKEN; Ministry of Education, Culture, Sports, Science and Technology of Japan [25293357]	Junior Research Associate Program of RIKEN; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	YI was supported by Junior Research Associate Program of RIKEN (http://www.riken.jp/en/careers/programs/jra/). SS was supported by Scientific Research Grant (B, 25293357) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aisenbrey S, 2006, INVEST OPHTH VIS SCI, V47, P5537, DOI 10.1167/iovs.05-1590; Akimoto M, 2006, P NATL ACAD SCI USA, V103, P3890, DOI 10.1073/pnas.0508214103; Aoki H, 2006, EXP EYE RES, V82, P265, DOI 10.1016/j.exer.2005.06.021; Assawachananont J, 2014, STEM CELL REP, V2, P662, DOI 10.1016/j.stemcr.2014.03.011; Baas D, 2000, MOL BRAIN RES, V78, P26, DOI 10.1016/S0169-328X(00)00060-7; Benny O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012515; Bharti K, 2008, DEVELOPMENT, V135, P1169, DOI 10.1242/dev.014142; Bora N, 1998, DEV DYNAM, V213, P283, DOI 10.1002/(SICI)1097-0177(199811)213:3<283::AID-AJA5>3.0.CO;2-H; Chen Y, 2003, MOL VIS, V9, P345; Chucair-Elliott AJ, 2012, J BIOL CHEM, V287, P24092, DOI 10.1074/jbc.M112.378240; Croze RH, 2014, STEM CELL TRANSL MED, V3, P1066, DOI 10.5966/sctm.2014-0079; Delling M, 2013, NATURE, V504, P311, DOI 10.1038/nature12833; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Ekblom P, 2003, MATRIX BIOL, V22, P35, DOI 10.1016/S0945-053X(03)00015-5; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Furukawa T, 1997, P NATL ACAD SCI USA, V94, P3088, DOI 10.1073/pnas.94.7.3088; Geisen P, 2006, CURR EYE RES, V31, P739, DOI 10.1080/02713680600837408; Gibbs D, 2003, P NATL ACAD SCI USA, V100, P6481, DOI 10.1073/pnas.1130432100; Gong J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143272; Gonzalez-Cordero A, 2013, NAT BIOTECHNOL, V31, P741, DOI 10.1038/nbt.2643; GRINDLEY JC, 1995, DEVELOPMENT, V121, P1433; HAMEL CP, 1993, J BIOL CHEM, V268, P15751; Homma K, 2013, STEM CELLS, V31, P1149, DOI 10.1002/stem.1372; Jo YJ, 2011, INVEST OPHTH VIS SCI, V52, P6089, DOI 10.1167/iovs.10-5189; Kamao H, 2014, STEM CELL REP, V2, P205, DOI 10.1016/j.stemcr.2013.12.007; Kanemura H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085336; KINTNER C, 1992, CELL, V69, P225, DOI 10.1016/0092-8674(92)90404-Z; Kiyonari H, 2010, GENESIS, V48, P317, DOI 10.1002/dvg.20614; Kuwahara A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7286; Leung T, 1996, MOL CELL BIOL, V16, P5313; Li SH, 2003, DEV CELL, V4, P613, DOI 10.1016/S1534-5807(03)00128-X; Liu W, 2010, J CLIN INVEST, V120, P3568, DOI 10.1172/JCI43219; Lopes VS, 2011, HUM MOL GENET, V20, P2560, DOI 10.1093/hmg/ddr155; Maeda T, 2013, J BIOL CHEM, V288, P34484, DOI 10.1074/jbc.M113.518571; Maekawa Y., 2015, CURR EYE RES, V41, P558, DOI [10.3109/02713683.2015.1038359, DOI 10.3109/02713683.2015.1038359]; Manes G, 1998, FEBS LETT, V423, P133, DOI 10.1016/S0014-5793(98)00081-7; Maruotti J, 2015, P NATL ACAD SCI USA, V112, P10950, DOI 10.1073/pnas.1422818112; Masuda T, 2014, J BIOL CHEM, V289, P12908, DOI 10.1074/jbc.M114.556738; Mazzoni F, 2014, EXP EYE RES, V126, P51, DOI 10.1016/j.exer.2014.01.010; Muniz A, 2014, INVEST OPHTH VIS SCI, V55, P198, DOI 10.1167/iovs.13-11740; Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009; NOSE A, 1986, J CELL BIOL, V103, P2649, DOI 10.1083/jcb.103.6.2649; Okada T, 2003, IUL BIOTECH, P253; Poche RA, 2008, J COMP NEUROL, V510, P237, DOI 10.1002/cne.21746; Schwartz SD, 2015, LANCET, V385, P509, DOI 10.1016/S0140-6736(14)61376-3; Sonoda S, 2009, NAT PROTOC, V4, P662, DOI 10.1038/nprot.2009.33; STEINBERG MS, 1994, P NATL ACAD SCI USA, V91, P206, DOI 10.1073/pnas.91.1.206; Street CA, 2011, ANTICANCER RES, V31, P3645; Sugita S, 2003, J EXP MED, V198, P161, DOI 10.1084/jem.20030097; Sugita S, 2006, EXP EYE RES, V83, P1459, DOI 10.1016/j.exer.2006.08.005; Sugita S, 2015, INVEST OPHTH VIS SCI, V56, P1051, DOI 10.1167/iovs.14-15619; Sugita S, 2009, INVEST OPHTH VIS SCI, V50, P2862, DOI 10.1167/iovs.08-2846; Toyofuku T, 2012, GENE DEV, V26, P816, DOI 10.1101/gad.184481.111; Usui Y, 2008, EXP EYE RES, V86, P52, DOI 10.1016/j.exer.2007.09.007; Wang CXZ, 2012, EXP EYE RES, V102, P1, DOI 10.1016/j.exer.2012.06.003; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Xu L, 2002, EXP EYE RES, V74, P753, DOI 10.1006/exer.2002.1175	57	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158282	10.1371/journal.pone.0158282	http://dx.doi.org/10.1371/journal.pone.0158282			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27385038	Green Published, gold			2022-12-27	WOS:000379809400041
J	Zhou, P; Huang, S; Zeng, WJ; Zhang, X; Wang, LF; Fu, XL; Li, SJ				Zhou, Pei; Huang, San; Zeng, Weijie; Zhang, Xin; Wang, Lifang; Fu, Xinliang; Li, Shoujun			Seroepidemiological Evidence of Subtype H3N8 Influenza Virus Infection among Pet Dogs in China	PLOS ONE			English	Article							LIVE POULTRY MARKETS; GENETIC-CHARACTERIZATION; GUANGDONG PROVINCE; CANINE H3N2; FERAL DOGS; A-VIRUS; EQUINE; TRANSMISSION; IDENTIFICATION	The H3N8 virus and the H3N2 virus are the main subtypes of canine influenza virus (CIV). H3N8 CIV mainly circulates in America, and H3N2 CIV mainly circulates in Asia. However, there was an outbreak of the Asian H3N2 virus in the United States (US) in 2015. Thus, it is important to evaluate the presence of subtype H3N8 virus in dogs in China. From May 2015 to November 2015, 600 sera from pet dogs were collected from Guangzhou, Shanghai, Beijing and Shenzhen for hemagglutination inhibition (HI) assays and microneutralization (MN) assays. Fifty-two (8.66%) of the 600 sera were positive for the subtype H3N2 virus, which matched the previous reports. Five (0.83%) of 600 sera were positive for the subtype H3N8 virus (H3N8 EIV or H3N8 AIV or H3N8 CIV), which is the first report of subtype H3N8 virus infection among dogs in China and remind us to play more attention to this subtype virus. Therefore, further serological and virological surveillance of influenza virus infection among dogs in China is imperative.	[Zhou, Pei; Huang, San; Zeng, Weijie; Zhang, Xin; Wang, Lifang; Fu, Xinliang; Li, Shoujun] South China Agr Univ, Coll Vet Med, Guangzhou, Guangdong, Peoples R China; [Zhou, Pei; Huang, San; Zeng, Weijie; Zhang, Xin; Wang, Lifang; Li, Shoujun] Key Lab Comprehens Prevent & Control Severe Clin, Guangzhou, Guangdong, Peoples R China; [Zhou, Pei; Huang, San; Zeng, Weijie; Zhang, Xin; Wang, Lifang; Li, Shoujun] Guangdong Engn & Technol Res Ctr Pets, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Li, SJ (corresponding author), South China Agr Univ, Coll Vet Med, Guangzhou, Guangdong, Peoples R China.; Li, SJ (corresponding author), Key Lab Comprehens Prevent & Control Severe Clin, Guangzhou, Guangdong, Peoples R China.; Li, SJ (corresponding author), Guangdong Engn & Technol Res Ctr Pets, Guangzhou, Guangdong, Peoples R China.	shoujunli@scau.edu.cn			National Natural Science Foundation of China [31372448]; Special Fund for Agro-scientific Research in the Public Interest [201303042]; Natural Science Foundation of Guangdong Province [S2013020013858]; Promote Scientific and Technological Development Program [2013B040200032]; Science and Technology Planning Project of Guangdong Province [20140224, 2013B020202001]; Guangdong Provincial Key Laboratory of Prevention and Control for Severe Clinical Animal Diseases [2013A061401013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Promote Scientific and Technological Development Program; Science and Technology Planning Project of Guangdong Province; Guangdong Provincial Key Laboratory of Prevention and Control for Severe Clinical Animal Diseases	This project was supported in part by the National Natural Science Foundation of China (31372448), the Special Fund for Agro-scientific Research in the Public Interest (201303042), the Natural Science Foundation of Guangdong Province (S2013020013858), the Promote Scientific and Technological Development Program (2013B040200032), the Science and Technology Planning Project of Guangdong Province (20140224, 2013B020202001), and the Guangdong Provincial Key Laboratory of Prevention and Control for Severe Clinical Animal Diseases (2013A061401013).	Anthony SJ, 2012, MBIO, V3, DOI 10.1128/mBio.00166-12; Centers for Disease Control and Prevention(CDC), 2015, UPD H3N2 CAN INFL DO; Crawford PC, 2005, SCIENCE, V310, P482, DOI 10.1126/science.1117950; Crispe E, 2011, AUST VET J, V89, P27, DOI 10.1111/j.1751-0813.2011.00734.x; Feng HX, 2014, VET MICROBIOL, V170, P414, DOI 10.1016/j.vetmic.2014.02.040; Gonzalez G, 2014, J VIROL, V88, P9208, DOI 10.1128/JVI.00887-14; GUO YJ, 1995, J GEN VIROL, V76, P2009, DOI 10.1099/0022-1317-76-8-2009; Henaux V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031471; Kirkland PD, 2010, EMERG INFECT DIS, V16, P699, DOI 10.3201/eid1604.091489; Kuiken T, 2006, SCIENCE, V312, P394, DOI 10.1126/science.1122818; Li SJ, 2010, INFECT GENET EVOL, V10, P1286, DOI 10.1016/j.meegid.2010.08.010; Lin DG, 2012, J GEN VIROL, V93, P119, DOI 10.1099/vir.0.037358-0; Paul E., 2010, Animal Health Research Reviews, V11, P43, DOI 10.1017/S1466252310000046; Payungporn S, 2008, EMERG INFECT DIS, V14, P902, DOI 10.3201/eid1406.071270; Qi T, 2010, VET MICROBIOL, V144, P455, DOI 10.1016/j.vetmic.2010.01.006; Song D, 2008, EMERG INFECT DIS, V14, P741, DOI 10.3201/eid1405.071471; Song D, 2012, J GEN VIROL, V93, P551, DOI 10.1099/vir.0.037739-0; Songserm T, 2006, EMERG INFECT DIS, V12, P1744, DOI 10.3201/eid1211.060542; Su S, 2014, CLIN INFECT DIS, V59, DOI 10.1093/cid/ciu345; Su S, 2014, CLIN INFECT DIS, V58, P1644, DOI 10.1093/cid/ciu154; Su S, 2014, J CLIN MICROBIOL, V52, P1762, DOI 10.1128/JCM.03522-13; Su S, 2013, INFECT GENET EVOL, V14, P444, DOI 10.1016/j.meegid.2012.11.018; Sun XX, 2013, INFECT GENET EVOL, V20, P471, DOI 10.1016/j.meegid.2013.10.012; Sun YP, 2014, VET MICROBIOL, V168, P193, DOI 10.1016/j.vetmic.2013.10.012; Sun YP, 2013, VIROLOGY, V435, P301, DOI 10.1016/j.virol.2012.09.037; Teng QY, 2013, VET MICROBIOL, V162, P345, DOI 10.1016/j.vetmic.2012.10.006; Tu JG, 2009, ARCH VIROL, V154, P887, DOI 10.1007/s00705-009-0381-1; World Health Organization, 2011, MAN LAB DIAGN VIR SU; Yang XY, 2014, VIRUS GENES, V49, P342, DOI 10.1007/s11262-014-1092-6; Yoon SW, 2014, CURR TOP MICROBIOL, V385, P359, DOI 10.1007/82_2014_396; Zhang YB, 2013, J VET MED SCI, V75, P1061, DOI 10.1292/jvms.13-0022	31	10	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159106	10.1371/journal.pone.0159106	http://dx.doi.org/10.1371/journal.pone.0159106			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414031	Green Published, gold, Green Submitted			2022-12-27	WOS:000379579500075
J	Ernstsson, O; Gyllensten, H; Alexanderson, K; Tinghog, P; Friberg, E; Norlund, A				Ernstsson, Olivia; Gyllensten, Hanna; Alexanderson, Kristina; Tinghog, Petter; Friberg, Emilie; Norlund, Anders			Cost of Illness of Multiple Sclerosis - A Systematic Review	PLOS ONE			English	Review							UNMET NEEDS TRIBUNE; QUALITY-OF-LIFE; TREATMENT EXPERIENCE; ECONOMIC BURDEN; INTANGIBLE COSTS; MS PATIENTS; DISABILITY; CONSEQUENCES; CARE; UTILITIES	Background Cost-of-illness (COI) studies of Multiple Sclerosis (MS) are vital components for describing the economic burden of MS, and are frequently used in model studies of interventions of MS. We conducted a systematic review of studies estimating the COI of MS, to compare costs between studies and examine cost drivers, emphasizing generalizability and methodological choices. Material and method A literature search on studies published in English on COI of MS was performed in PubMed for the period January 1969 to January 2014, resulting in 1,326 publications. A mapping of studies using a bottom-up approach or top-down approach, respectively, was conducted for the 48 studies assessed as relevant. In a second analysis, the cost estimates were compared between the 29 studies that used a societal perspective on costs, human capital approach for indirect costs, presenting number of patients included, time-period studied, and year of price level used. Results The mapping showed that bottom-up studies and prevalence approaches were most common. The cost ratios between different severity levels within studies were relatively stable, to the ratio of 1 to 2 to 3 for disability level categories. Drugs were the main cost drivers for MS-patients with low disease severity, representing 29% to 82% of all costs in this patient group, while the main cost components for groups with more advanced MS symptoms were production losses due to MS and informal care, together representing 17% to 67% of costs in those groups. Conclusion The bottom-up method and prevalence approach dominated in studies of COI of MS. Our findings show that there are difficulties in comparing absolute costs across studies, nevertheless, the relative costs expressed as cost ratios, comparing different severity levels, showed higher resemblance. Costs of drugs were main cost drivers for less severe MS and informal care and production losses for the most severe MS.	[Ernstsson, Olivia] Karolinska Inst, Dept Learning Informat Management & Eth, SE-17177 Stockholm, Sweden; [Ernstsson, Olivia; Gyllensten, Hanna; Alexanderson, Kristina; Tinghog, Petter; Friberg, Emilie; Norlund, Anders] Karolinska Inst, Dept Clin Neurosci, SE-17177 Stockholm, Sweden; [Tinghog, Petter] Swedish Red Cross Univ Coll, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Ernstsson, O (corresponding author), Karolinska Inst, Dept Learning Informat Management & Eth, SE-17177 Stockholm, Sweden.; Ernstsson, O (corresponding author), Karolinska Inst, Dept Clin Neurosci, SE-17177 Stockholm, Sweden.	olivia.ernstsson@ki.se	Gyllensten, Hanna/H-7378-2016	Gyllensten, Hanna/0000-0001-6890-5162; Ernstsson, Olivia/0000-0002-8920-1372; Friberg, Emilie/0000-0001-7874-4243	Biogen; Swedish Research Council for Health, Working Life and Welfare [2007-1762]	Biogen(Biogen); Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	This work was supported by Biogen and the Swedish Research Council for Health, Working Life and Welfare, Grant number 2007-1762, to Kristina Alexanderson, http://www.forte.se/en/,http://www.biogen.com/. KA received the funding, which in both cases was unrestricted The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Adelman Gabriel, 2013, J Med Econ, V16, P639, DOI 10.3111/13696998.2013.778268; Alexanderson K, 1998, SCAND J SOC MED, V26, P241, DOI 10.1177/14034948980260040301; Alexanderson Kristina, 2004, Scand J Public Health Suppl, V63, P256; Amato MP, 2002, J NEUROL, V249, P152, DOI 10.1007/PL00007858; Asche CV, 2010, J MANAGE CARE PHARM, V16, P703, DOI 10.18553/jmcp.2010.16.9.703; Asche CV, 1997, ACTA NEUROL SCAND, V95, P268, DOI 10.1111/j.1600-0404.1997.tb00208.x; Berg Jenny, 2006, Eur J Health Econ, V7 Suppl 2, pS75; Berto P, 2011, NEUROL SCI, V32, P1035, DOI 10.1007/s10072-011-0578-4; Blumhardt L., 1996, BR J MED EC, V10, P99; BOURDETTE DN, 1993, ARCH PHYS MED REHAB, V74, P26; Carton H, 1998, J NEUROL NEUROSUR PS, V64, P444, DOI 10.1136/jnnp.64.4.444; Casado V, 2007, MULT SCLER J, V13, P800, DOI 10.1177/1352458506073480; Casado V, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-143; Coleman CI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054756; Drummond MF, 2015, METHODS EC EVALUATIO; Dusankova JB, 2012, MULT SCLER J, V18, P662, DOI 10.1177/1352458511424422; Gilden DM, 2011, VALUE HEALTH, V14, P61, DOI 10.1016/j.jval.2010.10.022; Grima DT, 2000, MULT SCLER J, V6, P91, DOI 10.1177/135245850000600207; Grudzinski AN, 1999, PHARMACOECONOMICS, V15, P229, DOI 10.2165/00019053-199915030-00003; Henriksson F, 2000, J INTERN MED, V248, P387, DOI 10.1046/j.1365-2796.2000.00749.x; Henriksson F, 2001, EUR J NEUROL, V8, P27, DOI 10.1046/j.1468-1331.2001.00169.x; Henriksson F, 1998, PHARMACOECONOMICS, V13, P597, DOI 10.2165/00019053-199813050-00012; HODGSON TA, 1982, MILBANK FUND Q, V60, P429, DOI 10.2307/3349801; Holmes J., 1995, BR J MED EC, V8, P181; Jennum P, 2012, EUR NEUROPSYCHOPHARM, V22, P36, DOI 10.1016/j.euroneuro.2011.05.001; Johansson E, 2012, MULT SCLER J, V18, P17, DOI 10.1177/1352458512441566a; Karampampa Korinna, 2013, J Med Econ, V16, P939, DOI 10.3111/13696998.2013.807267; Karampampa K, 2012, MULT SCLER J, V18, P35, DOI 10.1177/1352458512441566d; Karampampa K, 2012, MULT SCLER J, V18, P7, DOI 10.1177/1352458512441566; Karampampa K, 2012, MULT SCLER J, V18, P41, DOI 10.1177/1352458512441566e; Karampampa K, 2012, MULT SCLER J, V18, P23, DOI 10.1177/1352458512441566b; Karampampa K, 2012, MULT SCLER J, V18, P29, DOI 10.1177/1352458512441566c; Karampampa K, 2012, J POPUL THER CLIN PH, V19, pE11; Kobelt G, 2006, J NEUROL NEUROSUR PS, V77, P918, DOI 10.1136/jnnp.2006.090365; Kobelt G, 2009, MULT SCLER J, V15, P741, DOI 10.1177/1352458509102771; Kobelt Gisela, 2006, Eur J Health Econ, V7 Suppl 2, pS96; Kobelt Gisela, 2006, Eur J Health Econ, V7 Suppl 2, pS55; Kobelt Gisela, 2006, Eur J Health Econ, V7 Suppl 2, pS34; Kobelt G, 2006, NEUROLOGY, V66, P1696, DOI 10.1212/01.wnl.0000218309.01322.5c; Kobelt Gisela, 2004, Eur J Health Econ, V5 Suppl 1, pS54, DOI 10.1007/s10198-005-0289-y; Kobelt Gisela, 2006, Eur J Health Econ, V7 Suppl 2, pS24; Kobelt Gisela, 2006, Eur J Health Econ, V7 Suppl 2, pS65; Kobelt Gisela, 2006, Eur J Health Econ, V7 Suppl 2, pS14; Kobelt Gisela, 2006, Eur J Health Econ, V7 Suppl 2, pS45; Kobelt Gisela, 2006, Eur J Health Econ, V7 Suppl 2, pS86; Kolasa K, 2013, PRZEGL EPIDEMIOL, V67, P157; Kolasa Katarzyna, 2013, Przegl Epidemiol, V67, P75; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; McCrone P, 2008, PHARMACOECONOMICS, V26, P847, DOI 10.2165/00019053-200826100-00005; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Murphy N, 1998, PHARMACOECONOMICS, V13, P607, DOI 10.2165/00019053-199813050-00013; Naci H, 2010, PHARMACOECONOMICS, V28, P363, DOI 10.2165/11532230-000000000-00000; Norlund A, 2001, J INTERN MED, V250, P57, DOI 10.1046/j.1365-2796.2001.00852.x; OECD, STATEXTRACTS PPPS EX; Oleen-Burkey M, 2012, PATIENT, V5, P57, DOI 10.2165/11592160-000000000-00000; Orlewska E, 2005, EUR J NEUROL, V12, P31, DOI 10.1111/j.1468-1331.2004.00950.x; Orlewska Ewa, 2006, Expert Rev Pharmacoecon Outcomes Res, V6, P145, DOI 10.1586/14737167.6.2.145; Palmer AJ, 2013, MULT SCLER J, V19, P1640, DOI 10.1177/1352458513488230; Parise H, 2013, J NEUROL SCI, V330, P71, DOI 10.1016/j.jns.2013.04.007; Patti F, 2011, NEUROL SCI, V32, P787, DOI 10.1007/s10072-011-0499-2; Patwardhan MB, 2005, MULT SCLER J, V11, P232, DOI 10.1191/1352458505ms1137oa; Phillips CJ, 2004, CNS DRUGS, V18, P561, DOI 10.2165/00023210-200418090-00002; Pugliatti M, 2008, NEUROL SCI, V29, P99, DOI 10.1007/s10072-008-0868-7; Reese JP, 2011, EUR NEUROL, V66, P311, DOI 10.1159/000331043; Romano M, 2013, ARQ NEURO-PSIQUIAT, V71, P549, DOI 10.1590/0004-282X20130082; Sharac J, 2010, DRUGS, V70, P1677, DOI 10.2165/11538000-000000000-00000; Sobocki P, 2007, MULT SCLER J, V13, P1054, DOI 10.1177/1352458507077941; Svendsen B, 2012, EUR J HEALTH ECON, V13, P81, DOI 10.1007/s10198-010-0286-7; Svensson J, 2014, ACTA NEUROL SCAND, V129, P13, DOI 10.1111/ane.12139; Tarricone R, 2006, HEALTH POLICY, V77, P51, DOI 10.1016/j.healthpol.2005.07.016; Taylor B, 2007, J CLIN NEUROSCI, V14, P532, DOI 10.1016/j.jocn.2006.08.007; Thompson JP, 2013, PHARMACOECONOMICS, V31, P455, DOI 10.1007/s40273-013-0063-4; Trisolini M, 2010, MULT SCLER INT FED, P1, DOI [10.18632/oncotarget.21284, DOI 10.18632/ONCOTARGET.21284]; World Health Organization, 2009, WHO GUID ID EC CONS; Wundes Annette, 2010, J Med Econ, V13, P626, DOI 10.3111/13696998.2010.525989; Zettl UK, 2013, EUROPEAN J HLTH EC H; 1998, CANADIAN J NEUROLOGI, V25, P23	77	102	102	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159129	10.1371/journal.pone.0159129	http://dx.doi.org/10.1371/journal.pone.0159129			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27411042	Green Published, Green Submitted, gold			2022-12-27	WOS:000379508300058
J	Guannel, G; Arkema, K; Ruggiero, P; Verutes, G				Guannel, Greg; Arkema, Katie; Ruggiero, Peter; Verutes, Gregory			The Power of Three: Coral Reefs, Seagrasses and Mangroves Protect Coastal Regions and Increase Their Resilience	PLOS ONE			English	Article							WAVE ATTENUATION; ECOSYSTEM SERVICES; WIDE DECLINES; DISSIPATION; DYNAMICS; WETLANDS; EROSION; MODEL; STATE	Natural habitats have the ability to protect coastal communities against the impacts of waves and storms, yet it is unclear how different habitats complement each other to reduce those impacts. Here, we investigate the individual and combined coastal protection services supplied by live corals on reefs, seagrass meadows, and mangrove forests during both non-storm and storm conditions, and under present and future sea-level conditions. Using idealized profiles of fringing and barrier reefs, we quantify the services supplied by these habitats using various metrics of inundation and erosion. We find that, together, live corals, seagrasses, and mangroves supply more protection services than any individual habitat or any combination of two habitats. Specifically, we find that, while mangroves are the most effective at protecting the coast under non-storm and storm conditions, live corals and seagrasses also moderate the impact of waves and storms, thereby further reducing the vulnerability of coastal regions. Also, in addition to structural differences, the amount of service supplied by habitats in our analysis is highly dependent on the geomorphic setting, habitat location and forcing conditions: live corals in the fringing reef profile supply more protection services than seagrasses; seagrasses in the barrier reef profile supply more protection services than live corals; and seagrasses, in our simulations, can even compensate for the long-term degradation of the barrier reef. Results of this study demonstrate the importance of taking integrated and place-based approaches when quantifying and managing for the coastal protection services supplied by ecosystems.	[Guannel, Greg; Verutes, Gregory] Stanford Univ, Nat Capital Project, Stanford, CA 94305 USA; [Arkema, Katie] Univ Washington, Nat Capital Project, Stanford Univ, Sch Environm & Forest Sci, Seattle, WA 98195 USA; [Ruggiero, Peter] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA	Stanford University; Stanford University; University of Washington; University of Washington Seattle; Oregon State University	Guannel, G (corresponding author), Stanford Univ, Nat Capital Project, Stanford, CA 94305 USA.	greg.guannel@gmail.com		Verutes, Gregory/0000-0002-7667-7902	Moore Foundation; Summit Foundation; Google via Tides Foundation; National Oceanic and Atmospheric Administration [NA11OAR4310136, NA14OAR4310195]	Moore Foundation(Gordon and Betty Moore Foundation); Summit Foundation; Google via Tides Foundation(Google Incorporated); National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA)	Greg Guannel, Katie Arkema and Gregory Verutes's research was funded in part by the Moore Foundation, the Summit Foundation and Google via the Tides Foundation. Greg Guannel was also supported by the National Oceanic and Atmospheric Administration through their grant NA11OAR4310136. Peter Ruggiero was supported by the National Oceanic and Atmospheric Administration through their grant NA14OAR4310195. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alongi DM, 2009, ENERGETICS MANGROVE; Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; [Anonymous], LOUIS COMPR MAST PLA; Anthony EJ, 2012, ECOL ENG, V47, P268, DOI 10.1016/j.ecoleng.2012.07.005; Arkema KK, 2015, P NATL ACAD SCI USA, V112, P7390, DOI 10.1073/pnas.1406483112; Arkema KK, 2013, NAT CLIM CHANGE, V3, P913, DOI 10.1038/NCLIMATE1944; BAGNOLD R.A., 1963, SEA, V3, P507; Barbier EB, 2013, INT REV ENVIRON RESO, V7, P35, DOI 10.1561/101.00000056; Barbier EB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058715; Battjes J.A., 1978, P 16 INT C COAST ENG P 16 INT C COAST ENG, P68; Becker JM, 2014, J GEOPHYS RES-OCEANS, V119, P914, DOI 10.1002/2013JC009373; Booij N, 1999, J GEOPHYS RES-OCEANS, V104, P7649, DOI 10.1029/98JC02622; Bowler Diana E, 2010, BMC Public Health, V10, P456, DOI 10.1186/1471-2458-10-456; Bradley K, 2009, J GEOPHYS RES-EARTH, V114, DOI 10.1029/2007JF000951; Bridges T., 2013, COASTAL RISK REDUCTI; Burger B., 2005, WAVE ATTENUATION MAN; BURKE R B, 1982, Smithsonian Contributions to the Marine Sciences, P509; Carlson PR, 1985, 12TH P ANN C WETL RE, P64; Chen SN, 2007, ESTUAR COAST, V30, P296, DOI 10.1007/BF02700172; Cheong SM, 2013, NAT CLIM CHANGE, V3, P787, DOI 10.1038/NCLIMATE1854; Cherrington EA, 2010, TECHNICAL REPORT IDE; Christianen MJA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062413; Cialone MA, 2008, INT WORKSH WAV HINDC; Cooper E., 2009, COASTAL CAPITAL BELI; Costanza R, 2008, AMBIO, V37, P241, DOI 10.1579/0044-7447(2008)37[241:TVOCWF]2.0.CO;2; DALRYMPLE RA, 1984, J WATERW PORT C-ASCE, V110, P67, DOI 10.1061/(ASCE)0733-950X(1984)110:1(67); De Vos W.J, 2004, WAVE ATTENUATION MAN; Dean R.G., 1984, ADV SER OCEAN ENG, V2, P353; Dean R.G., 2002, COASTAL PROCESSES EN; Demirbilek Z., 2009, WAVE TRANSFORMATION; Dongeren V, 2010, MODELLING INFRAGRAVI; Duncan MJ, 2014, INT J ENV RES PUB HE, V11, P3678, DOI 10.3390/ijerph110403678; FEMA, 1988, WAV HEIGHT AN FLOOD; Ferrario F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4794; Filipot JF, 2012, COAST ENG, V67, P67, DOI 10.1016/j.coastaleng.2012.04.005; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Gelfenbaum G, 2011, EARTH-SCI REV, V107, P12, DOI 10.1016/j.earscirev.2010.12.005; Guannel G, 2014, PHYS FLUIDS, V26, DOI 10.1063/1.4872160; Guannel G., 2014, CHANGES DELIVERY ECO; Guannel G, 2015, J GEOPHYS RES-OCEANS, V120, P324, DOI 10.1002/2014JC009821; Halide H, 2004, INDIAN J MAR SCI, V33, P220; HOLLAND GJ, 1980, MON WEATHER REV, V108, P1212, DOI 10.1175/1520-0493(1980)108<1212:AAMOTW>2.0.CO;2; Holthuijsen L. H., 2010, WAVES OCEANIC COASTA; Horstman EM, 2014, COAST ENG, V94, P47, DOI 10.1016/j.coastaleng.2014.08.005; Hsu SA, 1998, J COASTAL RES, V14, P667; Koch EW, 2009, FRONT ECOL ENVIRON, V7, P29, DOI 10.1890/080126; Kroeger T, 2014, VALUING ECOSYSTEM SE, P464; Lowe RJ, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002789; Lowe RJ, 2009, J PHYS OCEANOGR, V39, P873, DOI 10.1175/2008JPO3958.1; Lowe RJ, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005753; McIvor A, 2012, NATURAL COASTAL PROT; McIvor A, 2012, NATURAL COASTAL PROT; Merrifield MA, 2014, GEOPHYS RES LETT, V41, P7245, DOI 10.1002/2014GL061005; Monismith SG, 2007, ANNU REV FLUID MECH, V39, P37, DOI 10.1146/annurev.fluid.38.050304.092125; Mumby PJ, 2006, BIOL CONSERV, V128, P215, DOI 10.1016/j.biocon.2005.09.042; Nielsen P., 1992, COASTAL BOTTOM BOUND, DOI 10.1142/1269; NOAA Hurricane Research Division (HRD), 2014, FREQ ASK QUEST; Perry CT, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2409; Piazza BP, 2005, RESTOR ECOL, V13, P499, DOI 10.1111/j.1526-100X.2005.00062.x; Pinsky ML, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00080.1; Quataert E, 2015, GEOPHYS RES LETT, V42, P6407, DOI 10.1002/2015GL064861; Reniers AJHM, 1997, COAST ENG, V30, P1, DOI 10.1016/S0378-3839(96)00033-6; Ruckelshaus MH, 2016, COAST MANAG; de Alegria-Arzaburu AR, 2013, GEOMORPHOLOGY, V198, P69, DOI 10.1016/j.geomorph.2013.05.013; Sheaves M, 2009, MAR ECOL PROG SER, V391, P107, DOI 10.3354/meps08121; Shepard CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027374; Sheppard C, 2005, ESTUAR COAST SHELF S, V64, P223, DOI 10.1016/j.ecss.2005.02.016; Sheppard CRC, 2002, AMBIO, V31, P40, DOI 10.1639/0044-7447(2002)031[0040:EVROCR]2.0.CO;2; Silliman BR, 2012, P NATL ACAD SCI USA, V109, P11234, DOI 10.1073/pnas.1204922109; Simpson M.C., 2010, QUANTIFICATION MAGNI; South Atlantic Coastal Study Main Report Final Draft, 2021, S ATL COAST STUD MAI; Spalding MD, 2014, CONSERV LETT, V7, P293, DOI 10.1111/conl.12074; Stockdon HF, 2012, 20121084 USGS; Suzuki T, 2012, COAST ENG, V59, P64, DOI 10.1016/j.coastaleng.2011.07.006; Svendsen I.A., 2006, INTRO NEARSHORE HYDR; Temmerman S, 2013, NATURE, V504, P79, DOI 10.1038/nature12859; Thampanya U, 2006, ESTUAR COAST SHELF S, V68, P75, DOI 10.1016/j.ecss.2006.01.011; The White House, 2015, M1601 WHIT HOUS; THORNTON EB, 1983, J GEOPHYS RES-OCEANS, V88, P5925, DOI 10.1029/JC088iC10p05925; Tolman H.L., 2009, MMAB CONTRIBUTION, V276; TOMASKO DA, 1991, MAR ECOL PROG SER, V75, P9, DOI 10.3354/meps075009; Tomlinson P.B., 1995, BOT MANGROVES; URASAKI M, 1986, Plant Species Biology, V1, P19, DOI 10.1111/j.1442-1984.1986.tb00011.x; VANTUSSENBROEK BI, 1995, MAR BIOL, V122, P33, DOI 10.1007/BF00349275; Vetter O, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2010JC006455; Wamsley TV, 2010, OCEAN ENG, V37, P59, DOI 10.1016/j.oceaneng.2009.07.018; Watson C, 1999, ATLAS PROBABLE STORM; Young IR, 2003, MAR STRUCT, V16, P201, DOI 10.1016/S0951-8339(02)00054-0; Zeller RB, 2014, LIMNOL OCEANOGR, V59, P251, DOI 10.4319/lo.2014.59.1.0251; Zhang KQ, 2012, ESTUAR COAST SHELF S, V102, P11, DOI 10.1016/j.ecss.2012.02.021; ZIEMAN JC, 1984, MAR ECOL PROG SER, V15, P151, DOI 10.3354/meps015151	91	131	134	2	155	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158094	10.1371/journal.pone.0158094	http://dx.doi.org/10.1371/journal.pone.0158094			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27409584	Green Published, gold, Green Submitted			2022-12-27	WOS:000379508300017
J	Li, TT; Zhang, Q; Zhang, W; Wang, GC; Lu, YY; Yu, LJ; Zhang, R				Li, Tingting; Zhang, Qing; Zhang, Wen; Wang, Guocheng; Lu, Yanyu; Yu, Lijun; Zhang, Ran			Prediction CH4 Emissions from the Wetlands in the Sanjiang Plain of Northeastern China in the 21st Century	PLOS ONE			English	Article							FRESH-WATER MARSH; METHANE EMISSIONS; CLIMATE-CHANGE; NATURAL WETLANDS; CARBON STORAGE; SPATIAL-PATTERNS; MODEL; SOIL; TEMPERATURE; DYNAMICS	The Sanjiang Plain has been experienced significant wetland loss due to expanded agricultural activities, and will be potentially restored by the China National Wetland Conservation Action Plan (NWCP) in future. The objective of this study is to evaluate the impact of future climate warming and wetland restoration on wetland CH4 emissions in northeast China. We used an atmosphere-vegetation interaction model (AVIM2) to drive a modified biogeophysical model (CH4MODwetland), and projected CH4 flux variations from the Sanjiang Plain wetlands under different Representative Concentration Pathway scenarios throughout the 21st century. Model validation showed that the regressions between the observed and simulated CH4 fluxes by the modified model produced an R-2 of 0.49 with a slope of 0.87 (p < 0.001, n = 237). According to the AVIM2 simulation, the net primary productivity of the Sanjiang Plain wetlands will increase by 38.2 g m(-2) yr(-1), 116.6 g m(-2) yr(-1) and 250.4 g m(-2) yr(-1) under RCP 2.6, RCP 4.5 and RCP 8.5, respectively, by the end of this century. For RCP 2.6, 4.5 and 8.5 scenarios, the CH4 fluxes will increase by 5.7 g m(-2) yr(-1), 57.5 g m(-2) yr(-1) and 112.2 gm(-2) yr(-1). Combined with the wetland restoration, the regional emissions will increase by 0.18-1.52 Tg. The CH4 emissions will be stimulated by climate change and wetland restoration. Regional wetland restoration planning should be directed against different climate scenarios in order to suppress methane emissions.	[Li, Tingting; Zhang, Qing; Zhang, Wen; Wang, Guocheng; Yu, Lijun] Chinese Acad Sci, Inst Atmospher Phys, LAPC, Beijing 100029, Peoples R China; [Lu, Yanyu] Anhui Climate Ctr, Hefei 230031, Peoples R China; [Zhang, Ran] Chinese Acad Sci, Inst Atmospher Phys, CCRC, Beijing 100029, Peoples R China	Chinese Academy of Sciences; Institute of Atmospheric Physics, CAS; Chinese Academy of Sciences; Institute of Atmospheric Physics, CAS	Zhang, W (corresponding author), Chinese Acad Sci, Inst Atmospher Phys, LAPC, Beijing 100029, Peoples R China.	zhw@mail.iap.ac.cn	LAPC, IAP/AAI-6991-2020; WANG, YUE/GWQ-9256-2022; Zhang, Qing/AAJ-7307-2020; Wang, Yuesi/AAF-3186-2019; Li, Tingting/AAJ-7797-2020; IAP, LAPC/AAI-6390-2020; Zhang, Wen/AAH-6060-2020; Yu, Lijun/AAJ-6691-2020; Wang, Guocheng/AAJ-6674-2020	LAPC, IAP/0000-0002-0025-3484; IAP, LAPC/0000-0002-6195-7362; Zhang, Wen/0000-0001-6670-3057; Wang, Guocheng/0000-0002-4141-4395	National Natural Science Foundation of China [31000234, 41321064, 41175132]; Chinese Academy of Sciences (CAS) [XDA05050507, XDA05020204]; Climate Change Special Foundation of China Meterological Administration [CCSF201604]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences); Climate Change Special Foundation of China Meterological Administration	Funded by 31000234, http://www.nsfc.gov.cn/, the National Natural Science Foundation of China (LTT), 41321064, http://www.nsfc.gov.cn/, the National Natural Science Foundation of China (ZW), 41175132, http://www.nsfc.gov.cn/, the National Natural Science Foundation of China (ZW), XDA05050507, http://english.cas.cn/, the Chinese Academy of Sciences (CAS) strategic pilot technology special funds (ZW, study design), XDA05020204, http://english.cas.cn/, the Chinese Academy of Sciences (CAS) strategic pilot technology special funds, (LTT, Data collection), CCSF201604, http://www.cma.gov.cn/en2014/, the Climate Change Special Foundation of China Meterological Administration, (LTT, Data collection). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen R. G., 1998, FAO Irrigation and Drainage Paper; Arnold JG, 2012, T ASABE, V55, P1491; Basiliko N, 2007, ECOSYSTEMS, V10, P1148, DOI 10.1007/s10021-007-9083-2; Bernie D, 2014, FUTURE TEMPERATURE R; Beven KJ., 1979, HYDROL SCI J, V24, P43, DOI [10.1080/ 02626667909491834, 10.1080/02626667909491834, DOI 10.1080/02626667909491834]; Bhullar GS, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-32; Bloom AA, 2010, SCIENCE, V327, P322, DOI 10.1126/science.1175176; Boon PI, 1997, HYDROBIOLOGIA, V357, P73, DOI 10.1023/A:1003126601466; Booth BBB, 2013, EARTH SYST DYNAM, V4, P95, DOI 10.5194/esd-4-95-2013; Bortoluzzi E, 2006, NEW PHYTOL, V172, P708, DOI 10.1111/j.1469-8137.2006.01859.x; Bridgham SD, 2013, GLOBAL CHANGE BIOL, V19, P1325, DOI 10.1111/gcb.12131; Cai ZC, 2012, SCI CHINA EARTH SCI, V55, P173, DOI 10.1007/s11430-011-4309-8; Cao MK, 1996, J GEOPHYS RES-ATMOS, V101, P14399, DOI 10.1029/96JD00219; Cao MK, 1998, ATMOS ENVIRON, V32, P3293, DOI 10.1016/S1352-2310(98)00105-8; Chen Y, 1995, STUDIES WETLANDS CHI; CHRISTENSEN TR, 1995, TELLUS B, V47, P301, DOI 10.1034/j.1600-0889.47.issue3.2.x; Christensen TR, 2003, BIOGEOCHEMISTRY, V64, P337, DOI 10.1023/A:1024913730848; Christensen TR, 1996, TELLUS B, V48, P652, DOI 10.1034/j.1600-0889.1996.t01-4-00004.x; Cui B, 1997, SCI GEOGR SIN, V17, P93; Ding WX, 2007, PEDOSPHERE, V17, P475, DOI 10.1016/S1002-0160(07)60057-5; Ding WX, 2004, ATMOS ENVIRON, V38, P751, DOI 10.1016/j.atmosenv.2003.10.016; Ding WX, 2002, ATMOS ENVIRON, V36, P5149, DOI 10.1016/S1352-2310(02)00647-7; Fan Y, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004345; Field C.B., 2014, CLIMATE CHANGE 2014, DOI [10.1016/j.renene.2009.11.012, DOI 10.1016/J.RENENE.2009.11.012]; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; FROLKING S, 1994, GLOBAL BIOGEOCHEM CY, V8, P385, DOI 10.1029/94GB01839; Grabs T, 2009, J HYDROL, V373, P15, DOI 10.1016/j.jhydrol.2009.03.031; [郭雪莲 Guo Xuelian], 2008, [生态环境, Ecology and Environment], V17, P1739; Hao Q., 2006, THESIS; He B, 2014, FLEXIBLE GLOBAL OCEA, P225; He CQ, 2001, GRASSLAND CHINA, V4; Huang Y, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004401; Huang Y, 1998, GLOBAL CHANGE BIOL, V4, P247, DOI 10.1046/j.1365-2486.1998.00129.x; Huang Y, 2010, GLOBAL CHANGE BIOL, V16, P680, DOI 10.1111/j.1365-2486.2009.01976.x; IPCC, 2007, PHYS SCI BAS SUMM PO; Jauhiainen J, 2008, ECOLOGY, V89, P3503, DOI 10.1890/07-2038.1; Ji JJ, 2008, SCI CHINA SER D, V51, P885, DOI 10.1007/s11430-008-0039-y; Ji JJ, 1999, SCI GEOGRAPHICA SIN, V4; Jin ZN, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/8/085007; Ju WM, 2007, J ENVIRON MANAGE, V85, P538, DOI 10.1016/j.jenvman.2006.04.028; King JY, 2002, SOIL BIOL BIOCHEM, V34, P173, DOI 10.1016/S0038-0717(01)00164-X; Kleinen T, 2012, BIOGEOSCIENCES, V9, P235, DOI 10.5194/bg-9-235-2012; Li T, 2015, BIOGEOSCIENCES, V12, P6853, DOI [10.5194/bg-12-6853-2015, 10.]; Li T, 2012, BIOGEOSCIENCES, V9, P5199, DOI 10.5194/bg-9-5199-2012; Li TT, 2010, ECOL MODEL, V221, P666, DOI 10.1016/j.ecolmodel.2009.05.017; Liu H., 2004, ACTA GEOGR SINICA CH, V59, P400; Lu XL, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001843; MELILLO JM, 1993, NATURE, V363, P234, DOI 10.1038/363234a0; Mitsch W.J., 2007, WETLANDS, V4th ed., DOI DOI 10.1017/CBO9781107415324.004; MOORE TR, 1993, GEOPHYS RES LETT, V20, P587, DOI 10.1029/93GL00208; Moss R.H., 2008, IPCC EXPERT M REPORT; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Ni H, 1995, B BOT RES, V16, P356; Niu ZG, 2012, CHINESE SCI BULL, V57, P2813, DOI 10.1007/s11434-012-5093-3; PRIESTLEY CHB, 1972, MON WEATHER REV, V100, P81, DOI 10.1175/1520-0493(1972)100<0081:OTAOSH>2.3.CO;2; Rogelj J, 2012, NAT CLIM CHANGE, V2, P248, DOI [10.1038/NCLIMATE1385, 10.1038/nclimate1385]; Roulet NT, 2000, WETLANDS, V20, P605, DOI 10.1672/0277-5212(2000)020[0605:PCSGGA]2.0.CO;2; Shindell D. T., 2004, GEOPHYS RES LETT, V31; Shindell DT, 2009, SCIENCE, V326, P716, DOI 10.1126/science.1174760; Shuttleworth WJ, HDB HYDROLOGY; Song CC, 2006, ATMOS ENVIRON, V40, P6879, DOI 10.1016/j.atmosenv.2005.08.028; [宋开山 SONG Kaishan], 2008, [地理学报, Acta Geographica Sinica], V63, P93; State Forestry Administration of China, 2005, WILDL WETL RES INF; State Forestry Administration of China, 2000, CHIN NAT WETL CONS A; Stocker T. F., 2013, CLIMATE CHANGE 2013; Su FG, 2013, J CLIMATE, V26, P3187, DOI 10.1175/JCLI-D-12-00321.1; Sun G, 1998, J AM WATER RESOUR AS, V34, P843, DOI 10.1111/j.1752-1688.1998.tb01520.x; Sun L, 2008, J HYDROL, V352, P202, DOI 10.1016/j.jhydrol.2008.01.010; Thomas CR, 2009, WETLANDS, V29, P1133, DOI 10.1672/08-234.1; Todd-Brown KEO, 2014, BIOGEOSCIENCES, V11, P2341, DOI 10.5194/bg-11-2341-2014; Uvo CB, 2001, HYDROL EARTH SYST SC, V5, P259; Waddington JM, 2009, AMBIO, V38, P194, DOI 10.1579/0044-7447-38.4.194; Wang D, 2003, WETL SCI, V1, P63, DOI DOI 10.13248/J.CNKI.WETLANDSCI.2003.01.011; [王德宣 Wang Dexuan], 2002, [地理科学, Scientia Geographica Sinica], V22, P500; Wang L, 2014, INT J CLIMATOL, V34, P2059, DOI 10.1002/joc.3822; Wang Y, 1993, NAT RESOUR STUD, V2, P73; Wang YS, 2003, ADV ATMOS SCI, V20, P842, DOI 10.1007/BF02915410; Wang ZM, 2006, ENVIRON MONIT ASSESS, V112, P69, DOI 10.1007/s10661-006-0312-5; Whalen SC, 2005, ENVIRON ENG SCI, V22, P73, DOI 10.1089/ees.2005.22.73; White A, 1999, GLOBAL ENVIRON CHANG, V9, pS21, DOI 10.1016/S0959-3780(99)00016-3; WHITING GJ, 1993, NATURE, V364, P794, DOI 10.1038/364794a0; Wieder WR, 2015, NAT GEOSCI, V8, P441, DOI 10.1038/NGEO2413; Woodward FI, 2004, BIOL REV, V79, P643, DOI 10.1017/S1464793103006419; Wu SH, 2010, INT J CLIMATOL, V30, P866, DOI 10.1002/joc.1938; Xu CH, 2012, ATMOS OCEAN SCI LETT, V5, P527, DOI 10.1080/16742834.2012.11447042; Xu XF, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2010GB003946; Xu Y, 2012, ATMOS OCEAN SCI LETT, V5, P489, DOI 10.1080/16742834.2012.11447041; Yang WY, 2006, SCI TOTAL ENVIRON, V371, P286, DOI 10.1016/j.scitotenv.2006.08.034; Yang YongXing, 2002, Grassland of China, V24, P1; Yu Y. Q., 2014, FLEXIBLE GLOBAL OCEA, P61, DOI [DOI 10.1007/978-3-642-41801-3_9, 10.1007/978-3-642-41801-3_9]; Zhang S. W., 2006, ANAL SPATIAL TEMPORA; Zhang Y, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001838; Zhao DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060849; [赵魁义 ZHAO Kui-yi], 2008, [自然资源学报, Journal of Natural Resources], V23, P790; Zheng YM, 2012, CHINESE SCI BULL, V57, P1116, DOI 10.1007/s11434-011-4942-9; Zhou TJ, 2013, ADV ATMOS SCI, V30, P638, DOI 10.1007/s00376-013-2205-1; Zhu XD, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/4/045003; Zhuang QL, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026972	98	4	4	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158872	10.1371/journal.pone.0158872	http://dx.doi.org/10.1371/journal.pone.0158872			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27409586	gold, Green Published, Green Submitted			2022-12-27	WOS:000379508300039
J	Watters, SA; Mlcochova, P; Maldarelli, F; Goonetilleke, N; Pillay, D; Gupta, RK				Watters, Sarah A.; Mlcochova, Petra; Maldarelli, Frank; Goonetilleke, Nilu; Pillay, Deenan; Gupta, Ravindra K.			Sequential CCR5-Tropic HIV-1 Reactivation from Distinct Cellular Reservoirs following Perturbation of Elite Control	PLOS ONE			English	Article							T-CELLS; DISCONTINUATION; IDENTIFICATION; MACROPHAGES; PREDICTION	Background HIV Elite Controllers may reveal insights into virus persistence given they harbour small reservoir sizes, akin to HIV non-controllers treated early with combination antiretroviral therapy. Both groups of patients represent the most promising candidates for interventions aimed at sustained remission or 'cure'. Analytic treatment interruption (ATI) in the latter group leads to stochastic rebound of virus, though it is unclear whether loss of elite control is also associated with similar rebound characteristics. Methods We studied three discrete periods of virus rebound during myeloma related immune disruption over 2.5 years in an elite controller who previously underwent autologous stem cell transplantation (ASCT) in the absence of any antiretroviral therapy. Single genome sequencing of the V1-V4 region of env in PBMC and plasma was performed and phylogenies reconstructed. Average pairwise distance (APD) was calculated and non-parametric methods used to assess compartmentalisation. Coreceptor usage was predicted based on genotypic algorithms. Results 122 single genome sequences were obtained (median 26 sequences per rebound). The initial rebounding plasma env sequences following ASCT represented two distinct lineages, and clustered with proviral DNA sequences isolated prior to ASCT. One of the lineages was monophyletic, possibly indicating reactivation from clonally expanded cells. The second rebound occurred 470 days after spontaneous control of the first rebound and was phylogenetically distinct from the first, confirmed by compartmentalisation analysis, with a different cellular origin rather than ongoing replication. By contrast, third rebound viruses clustered with second rebound viruses, with evidence for ongoing evolution that was associated with lymphopenia and myeloma progression. Following ASCT a shift in tropism from CXCR4-tropic viruses to a CCR5-tropic population was observed to persist through to the third rebound. Conclusions Our data highlight similarities in the viral reservoir between elite and non-controllers undergoing ATI following allogeneic transplantation. The lack of propagation of CXCR4 using viruses following transplantation warrants further study.	[Watters, Sarah A.; Mlcochova, Petra; Pillay, Deenan; Gupta, Ravindra K.] UCL, Div Infect & Immun, London, England; [Watters, Sarah A.; Maldarelli, Frank] NCI, HIV Dynam & Replicat Program, Frederick, MD USA; [Goonetilleke, Nilu] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Pillay, Deenan] Africa Ctr Hlth & Populat Studies, Durban, Kwazulu Natal, South Africa	University of London; University College London; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of North Carolina; University of North Carolina Chapel Hill	Gupta, RK (corresponding author), UCL, Div Infect & Immun, London, England.	Ravindra.gupta@ucl.ac.uk	Maldarelli, Frank/O-2428-2016; Gupta, Ravindra/G-5529-2015	Gupta, Ravindra/0000-0001-9751-1808; Watters, Sarah A./0000-0001-6628-1261	Wellcome Trust [WT098251AIA]; National Institutes for Health Research University College London Hospitals Biomedical Research Centre; NATIONAL CANCER INSTITUTE [ZIABC011464] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes for Health Research University College London Hospitals Biomedical Research Centre; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Wellcome Trust (SAW) WT098251AIA; National Institutes for Health Research University College London Hospitals Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achaz G, 2004, MOL BIOL EVOL, V21, P1902, DOI 10.1093/molbev/msh196; Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591; Apolonia L, 2007, MOL THER, V15, P1947, DOI 10.1038/sj.mt.6300281; Cashin K, 2015, SCI REP-UK, V5, DOI 10.1038/srep08543; Cashin K, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-24; Chun TW, 2000, NAT MED, V6, P757, DOI 10.1038/77481; De Keersmaecker B, 2012, J VIROL, V86, P9351, DOI 10.1128/JVI.00472-12; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Gandhi AK, 2014, BRIT J HAEMATOL, V164, P811, DOI 10.1111/bjh.12708; Graf EH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001300; Haaland RE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000274; Haslett PAJ, 1998, J EXP MED, V187, P1885, DOI 10.1084/jem.187.11.1885; Henrich TJ, 2014, ANN INTERN MED, V161, P319, DOI 10.7326/M14-1027; Imamichi H, 2001, J INFECT DIS, V183, P36, DOI 10.1086/317641; Joos B, 2008, P NATL ACAD SCI USA, V105, P16725, DOI 10.1073/pnas.0804192105; Jordan MR, 2010, J VIROL METHODS, V168, P114, DOI 10.1016/j.jviromet.2010.04.030; Kearney MF, 2016, J VIROL, V90, P1369, DOI 10.1128/JVI.02139-15; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Lengauer T, 2007, NAT BIOTECHNOL, V25, P1407, DOI 10.1038/nbt1371; Ndung'u T, 2001, J VIROL, V75, P4964, DOI 10.1128/JVI.75.11.4964-4972.2001; Olson AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086719; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Rambaut A, 2007, PHYLOGENETICS AND EP; Rose PP, 2000, BIOINFORMATICS, V16, P400, DOI 10.1093/bioinformatics/16.4.400; Saez-Cirion A, 2011, BLOOD, V118, P955, DOI 10.1182/blood-2010-12-327106; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; SLATKIN M, 1989, GENETICS, V123, P603; Smith NMG, 2015, CLIN INFECT DIS, V61, P120, DOI 10.1093/cid/civ219; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wang TH, 2001, J VIROL, V75, P11686, DOI 10.1128/JVI.75.23.11686-11699.2001	31	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0158854	10.1371/journal.pone.0158854	http://dx.doi.org/10.1371/journal.pone.0158854			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27403738	Green Published, Green Submitted, gold			2022-12-27	WOS:000379508200017
J	Wong, NS; Wong, KH; Lee, MP; Tsang, OTY; Chan, DPC; Lee, SS				Wong, Ngai Sze; Wong, Ka Hing; Lee, Man Po; Tsang, Owen T. Y.; Chan, Denise P. C.; Lee, Shui Shan			Estimation of the Undiagnosed Intervals of HIV-Infected Individuals by a Modified Back-Calculation Method for Reconstructing the Epidemic Curves	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS HIV; LYMPHOCYTE SUBSETS; REFERENCE RANGES; HONG-KONG; POPULATION; ADULTS; PREVENTION; DIAGNOSIS; SEX; MEN	Background Undiagnosed infections accounted for the hidden proportion of HIV cases that have escaped from public health surveillance. To assess the population risk of HIV transmission, we estimated the undiagnosed interval of each known infection for constructing the HIV incidence curves. Methods We used modified back-calculation methods to estimate the seroconversion year for each diagnosed patient attending any one of the 3 HIV specialist clinics in Hong Kong. Three approaches were used, depending on the adequacy of CD4 data: (A) estimating one's pretreatment CD4 depletion rate in multilevel model;(B) projecting one's seroconversion year by referencing seroconverters' CD4 depletion rate; or (C) projecting from the distribution of estimated undiagnosed intervals in (B). Factors associated with long undiagnosed interval (>2 years) were examined in univariate analyses. Epidemic curves constructed from estimated seroconversion data were evaluated by modes of transmission. Results Between 1991 and 2010, a total of 3695 adult HIV patients were diagnosed. The undiagnosed intervals were derived from method (A) (28%), (B) (61%) and (C) (11%) respectively. The intervals ranged from 0 to 10 years, and were shortened from 2001. Heterosexual infection, female, Chinese and age >64 at diagnosis were associated with long undiagnosed interval. Overall, the peaks of the new incidence curves were reached 4-6 years ahead of reported diagnoses, while their contours varied by mode of transmission. Characteristically, the epidemic growth of heterosexual male and female declined after 1998 with slight rebound in 2004-2006, but that of MSM continued to rise after 1998. Conclusions By determining the time of seroconversion, HIV epidemic curves could be reconstructed from clinical data to better illustrate the trends of new infections. With the increasing coverage of antiretroviral therapy, the undiagnosed interval can add to the measures for assessing HIV transmission risk in the population.	[Wong, Ngai Sze; Chan, Denise P. C.; Lee, Shui Shan] Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China; [Wong, Ngai Sze] Univ North Carolina Chapel Hill, Inst Global Hlth & Infect Dis, Chapel Hill, NC USA; [Wong, Ngai Sze] Univ North Carolina Project China, Guangzhou, Guangdong, Peoples R China; [Wong, Ka Hing] Hong Kong Special Adm Reg Govt, Dept Hlth, Special Prevent Programme, Hong Kong, Hong Kong, Peoples R China; [Lee, Man Po] Queen Elizabeth Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Tsang, Owen T. Y.] Princess Margaret Hosp, Dept Med & Geriatr, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Lee, SS (corresponding author), Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China.	sslee@cuhk.edu.hk	Lee, Shui Shan/B-9374-2008; Wong, Ngai Sze/A-3145-2012	Lee, Shui Shan/0000-0003-1448-765X; Wong, Ngai Sze/0000-0003-3788-8114	Council for the AIDS Trust Fund, Hong Kong Special Administrative Region Government [MSS229R]; Guangdong Provincial Centers for Skin Diseases and STI Control; UNC-South China STD Research Training Center [FIC1D43TW009532-01, FIC1D43TW009532]; Fogarty International Center; NIH Fogarty International Center; FOGARTY INTERNATIONAL CENTER [D43TW009532] Funding Source: NIH RePORTER	Council for the AIDS Trust Fund, Hong Kong Special Administrative Region Government; Guangdong Provincial Centers for Skin Diseases and STI Control; UNC-South China STD Research Training Center; Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIH Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported by a grant approved by the Council for the AIDS Trust Fund, Hong Kong Special Administrative Region Government (project code: MSS229R). First author NSW is supported by Guangdong Provincial Centers for Skin Diseases and STI Control, the UNC-South China STD Research Training Center (FIC1D43TW009532-01) and the Fogarty International Center.; The authors thank all patients and staff of the Integrated Treatment Centre, Queen Elizabeth Hospital and Princess Margaret Hospital for their assistance in the maintenance of clinical data used in this study. Li Ka Shing Institute of Health Sciences and Stanley Ho Centre for Emerging Infectious Diseases of The Chinese University of Hong Kong are acknowledged for providing technical support in conducting the research. NSW is supported by Guangdong Provincial Center for Skin Diseases and STI Control and the UNC-South China STD Research Training Center (FIC1D43TW009532) and NIH Fogarty International Center.	Adolescents. PoAGfAa, GUIDELINES FOR THE U; Armstrong G, 2015, AIDS CARE, V27, P288, DOI 10.1080/09540121.2014.972322; BROOKMEYER R, 1986, LANCET, V2, P1320; Chang H, 2013, SHU TE ONLINE STUDIE, V9; Chau PH, 2003, J ROY STAT SOC C-APP, V52, P237, DOI 10.1111/1467-9876.00401; Chen JHK, 2009, JAIDS-J ACQ IMM DEF, V51, P530, DOI 10.1097/QAI.0b013e3181aac516; Cleveland R, J OFFICIAL STATISTIC, V6, P3; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cohen M, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.5.20482; Department of Health HKSAR, 2010, REPORT; Department of Health HKSAR, 2015, HIV SURVEILLANCE REP; Department of Health HKSAR, 2007, REPORT; Ellman TM, 2014, AIDS PATIENT CARE ST, V28, P530, DOI 10.1089/apc.2014.0152; Ferrer L, 2015, EUR J PUBLIC HEALTH, V25, P494, DOI 10.1093/eurpub/cku139; Forbi JC, 2010, J INFECT DEV COUNTR, V4, P662, DOI 10.3855/jidc.1015; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Infections HPACf, LONGITUDINAL ANALYSI; Jentsch-Ullrich K, 2005, CLIN IMMUNOL, V116, P192, DOI 10.1016/j.clim.2005.03.020; Jia ZW, 2015, SCI REP-UK, V5, DOI 10.1038/srep11205; Kassu A, 2001, CLIN DIAGN LAB IMMUN, V8, P1171, DOI 10.1128/CDLI.8.6.1171-1176.2001; Lee SS, 2007, PUBLIC HEALTH, V121, P884, DOI 10.1016/j.puhe.2007.02.017; Maartens G, 2014, LANCET, V384, P258, DOI 10.1016/S0140-6736(14)60164-1; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Mastro Timothy D, 2010, J HIV AIDS Surveill Epidemiol, V2, P1; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P729, DOI 10.1136/jech.2004.023929; Ndawinz JDA, 2011, AIDS, V25, P1905, DOI 10.1097/QAD.0b013e32834af619; Rana Y, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0120580, 10.1371/journal.pone.0125187, 10.1371/journal.pone.0121992]; Rice BD, 2012, AIDS, V26, P1961, DOI 10.1097/QAD.0b013e3283578b80; Taffe P, 2008, STAT MED, V27, P4837, DOI 10.1002/sim.3294; Vanhems P, 1999, J INFECT DIS, V180, P1803, DOI 10.1086/315110; Wolbers M, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000239; Wong H., 2013, J SEXUALLY TRANSMITT, DOI [10.1155/2013/958967, DOI 10.1155/2013/958967]; Wong NS, 2015, ASIA-PAC J PUBLIC HE, V27, P756, DOI 10.1177/1010539515589340; Wong NS, 2015, J INFECTION, V70, P676, DOI 10.1016/j.jinf.2014.10.012; Wong WS, 2013, CLIN VACCINE IMMUNOL, V20, P602, DOI 10.1128/CVI.00476-12; World Health Organization, 2015, GUIDELINE ON WHEN TO	36	6	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0159021	10.1371/journal.pone.0159021	http://dx.doi.org/10.1371/journal.pone.0159021			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ9CO	27403882	Green Submitted, Green Published, gold			2022-12-27	WOS:000379508200029
J	Chen, HY; Chiu, YL; Hsu, SP; Pai, MF; Yang, JY; Peng, YS				Chen, Hung Yuan; Chiu, Yen Ling; Hsu, Shih Ping; Pai, Mei Fen; Yang, Ju Yeh; Peng, Yu Sen			Relationship between Fetuin A, Vascular Calcification and Fracture Risk in Dialysis Patients	PLOS ONE			English	Article							BONE-MINERAL DENSITY; CHRONIC KIDNEY-DISEASE; HEMODIALYSIS-PATIENTS; SERUM FETUIN; MAINTENANCE HEMODIALYSIS; CARDIOVASCULAR-DISEASE; RANCHO BERNARDO; ASSOCIATION; MORTALITY; HIP	Background Fractures are a common morbidity that lead to worse outcomes in dialysis patients. Fetuin A inhibits vascular calcification (VC), potentially promotes bone mineralization and its level positively correlates with bone mineral density in the general population. On the other hand, the presence of VC is associated with low bone volume in dialysis patients. Whether the fetuin A level and VC can predict the occurrence of fractures in dialysis patients remains unknown. Methods We performed this prospective, observational cohort study including 685 dialysis patients (629 hemodialysis and 56 peritoneal dialysis) from a single center in Taiwan for a median follow-up period of 3.4 years. The baseline fetuin A level and status of presence of aortic arch calcification (VC) and incidence of major fractures (hip, pelvis, humerus, proximal forearm, lower leg or vertebrae) were assessed using adjusted Cox proportional hazards models, recursive partitioning analysis and competing risk models. Results Overall, 177 of the patients had major fractures. The incidence rate of major fractures was 3.29 per 100 person-years. In adjusted analyses, the patients with higher baseline fetuin A levels had a lower incidence of fractures (adjusted hazard ratio (HR), 0.3; 95% CI, 0.18-0.5, fetuin A tertile 3 vs. tertile 1 and HR, 0.52; 95% CI, 0.34-0.78, tertile 2 vs. tertile 1). The presence of aortic arch calcification (VC) independently predicted the occurrence of fractures (adjusted HR, 1.95; 95% CI, 1.34-2.84) as well. When accounting for death as an event in competing risk models, the patients with higher baseline fetuin A levels remained to have a lower incidence of fractures (SHR, 0.31; 95% CI, 0.17-0.56, fetuin A tertile 3 vs. tertile 1 and 0.51; 95% CI, 0.32-0.81, tertile 2 vs. tertile 1). Interpretations Lower baseline fetuin A levels and the presence of VC were independently linked to higher risk of incident fractures in prevalent dialysis patients.	[Chen, Hung Yuan; Chiu, Yen Ling; Hsu, Shih Ping; Pai, Mei Fen; Yang, Ju Yeh; Peng, Yu Sen] Far Eastern Mem Hosp, Dept Internal Med, Div Nephrol, New Taipei, Taiwan; [Chen, Hung Yuan; Chiu, Yen Ling; Hsu, Shih Ping; Pai, Mei Fen; Yang, Ju Yeh; Peng, Yu Sen] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Div Nephrol,Dept Internal Med, Taipei, Taiwan	Far Eastern Memorial Hospital; National Taiwan University; National Taiwan University Hospital	Peng, YS (corresponding author), Far Eastern Mem Hosp, Dept Internal Med, Div Nephrol, New Taipei, Taiwan.; Peng, YS (corresponding author), Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Div Nephrol,Dept Internal Med, Taipei, Taiwan.	taan70@yahoo.com.tw	peng, yu/GXW-2071-2022; Chiu, Yen-Ling/AAV-3431-2021	Chiu, Yen-Ling/0000-0003-4504-5571; Yang, Ju-Yeh/0000-0003-3034-021X	Far Eastern Memorial Hospital (FEMH), Taiwan [FEMH-95-C-025, FEMH-2011-C-006, FEMH-2012-D-032, FEMH-2014-D-021, FEMH-2015-D-034]	Far Eastern Memorial Hospital (FEMH), Taiwan	This study was supported by grants from Far Eastern Memorial Hospital (FEMH) (FEMH-95-C-025, FEMH-2011-C-006, FEMH-2012-D-032, FEMH-2014-D-021, FEMH-2015-D-034), Taiwan.	Adragao T, 2009, CLIN J AM SOC NEPHRO, V4, P450, DOI 10.2215/CJN.01870408; Ball AM, 2002, JAMA-J AM MED ASSOC, V288, P3014, DOI 10.1001/jama.288.23.3014; Beaubrun AC, 2013, J AM SOC NEPHROL, V24, P1461, DOI 10.1681/ASN.2012090916; Braithwaite RS, 2003, J AM GERIATR SOC, V51, P364, DOI 10.1046/j.1532-5415.2003.51110.x; Carballido-Gamio J, 2013, BONE, V57, P290, DOI 10.1016/j.bone.2013.08.017; Cejka D, 2011, CLIN J AM SOC NEPHRO, V6, P2264, DOI 10.2215/CJN.09711010; Chen HY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000619; Chen HY, 2010, AM J KIDNEY DIS, V56, P720, DOI 10.1053/j.ajkd.2010.06.015; Chen HY, 2009, EUR J ENDOCRINOL, V160, P777, DOI 10.1530/EJE-08-0813; Chiu YL, 2008, NEPHROL DIAL TRANSPL, V23, P3685, DOI 10.1093/ndt/gfn303; Danese MD, 2006, AM J KIDNEY DIS, V47, P149, DOI 10.1053/j.ajkd.2005.09.024; Drueke TB, 2011, CLIN J AM SOC NEPHRO, V6, P700, DOI 10.2215/CJN.01370211; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fink HA, 2015, J BONE MINER RES, V30, P1394, DOI 10.1002/jbmr.2475; GORDON L, 1985, CANCER TREAT REP, V69, P1065; Hermans MMH, 2007, KIDNEY INT, V72, P202, DOI 10.1038/sj.ki.5002178; Ix JH, 2006, CIRCULATION, V113, P1760, DOI 10.1161/CIRCULATIONAHA.105.588723; Ix JH, 2011, J AM COLL CARDIOL, V58, P2372, DOI 10.1016/j.jacc.2011.08.035; Ix JH, 2009, J BONE MINER RES, V24, P514, DOI 10.1359/JBMR.081017; Jadoul M, 2006, KIDNEY INT, V70, P1358, DOI 10.1038/sj.ki.5001754; Jahnen-Dechent W, 2008, J MOL MED, V86, P379, DOI 10.1007/s00109-007-0294-y; Jahnen-Dechent W, 2011, CIRC RES, V108, P1494, DOI 10.1161/CIRCRESAHA.110.234260; Jamal SA, 2006, J BONE MINER RES, V21, P543, DOI 10.1359/JBMR.060105; Jamal SA, 2007, J BONE MINER RES, V22, P503, DOI 10.1359/JBMR.070112; Jamal SA, 2007, AM J KIDNEY DIS, V49, P674, DOI 10.1053/j.ajkd.2007.02.264; Kapustin AN, 2015, CIRC RES, V116, P1312, DOI 10.1161/CIRCRESAHA.116.305012; Ketteler M, 2003, LANCET, V361, P827, DOI 10.1016/S0140-6736(03)12710-9; Laughlin GA, 2012, J AM COLL CARDIOL, V59, P1688, DOI 10.1016/j.jacc.2012.01.038; London GM, 2004, J AM SOC NEPHROL, V15, P1943, DOI 10.1097/01.asn.0000129337.50739.48; McClung MR, 2014, NEW ENGL J MED, V370, P412, DOI 10.1056/NEJMoa1305224; Moe SM, 2005, KIDNEY INT, V67, P2295, DOI 10.1111/j.1523-1755.2005.00333.x; Modder UI, 2011, J BONE MINER RES, V26, P373, DOI 10.1002/jbmr.217; Ott SM, 2013, NAT REV NEPHROL, V9, P681, DOI 10.1038/nrneph.2013.182; Price PA, 2004, J BIOL CHEM, V279, P19169, DOI 10.1074/jbc.M307880200; Rabier B, 2010, BONE, V46, P176, DOI 10.1016/j.bone.2009.06.032; Roman-Garcia P, 2010, BONE, V46, P121, DOI 10.1016/j.bone.2009.09.006; Rossier A, 2012, NEPHROL DIAL TRANSPL, V27, P352, DOI 10.1093/ndt/gfr326; Rudang R, 2013, J BONE MINER RES, V28, P2305, DOI 10.1002/jbmr.1974; Schafer C, 2003, J CLIN INVEST, V112, P357, DOI 10.1172/JCI17202; Scialla JJ, 2014, CLIN J AM SOC NEPHRO, V9, P745, DOI 10.2215/CJN.05450513; Seto J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047338; Tentori F, 2014, KIDNEY INT, V85, P166, DOI 10.1038/ki.2013.279; Tomiyama C, 2010, J BONE MINER RES, V25, P499, DOI 10.1359/jbmr.090735; Toroian D, 2008, CALCIFIED TISSUE INT, V82, P116, DOI 10.1007/s00223-007-9085-2; Toussaint ND, 2009, CLIN J AM SOC NEPHRO, V4, P221, DOI 10.2215/CJN.02550508; van Meurs JBJ, 2004, NEW ENGL J MED, V350, P2033, DOI 10.1056/NEJMoa032546; Wang AYM, 2005, NEPHROL DIAL TRANSPL, V20, P1676, DOI 10.1093/ndt/gfh891; Yamada K, 2008, AM J CLIN NUTR, V87, P106, DOI 10.1093/ajcn/87.1.106	48	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2016	11	7							e0158789	10.1371/journal.pone.0158789	http://dx.doi.org/10.1371/journal.pone.0158789			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CN	27398932	Green Published, gold, Green Submitted			2022-12-27	WOS:000379508100008
J	Burgi, J; Xue, B; Uversky, VN; van der Goot, FG				Burgi, Jerome; Xue, Bin; Uversky, Vladimir N.; van der Goot, F. Gisou			Intrinsic Disorder in Transmembrane Proteins: Roles in Signaling and Topology Prediction	PLOS ONE			English	Article							FUNCTIONAL-ANALYSIS; BINDING; SEQUENCE; REGIONS; PHOSPHORYLATION; RECOGNITION; MECHANISM; DOMAIN; ORDER; TOOL	Intrinsically disordered regions (IDRs) are peculiar stretches of amino acids that lack stable conformations in solution. Intrinsic Disorder containing Proteins (IDP) are defined by the presence of at least one large IDR and have been linked to multiple cellular processes including cell signaling, DNA binding and cancer. Here we used computational analyses and publicly available databases to deepen insight into the prevalence and function of IDRs specifically in transmembrane proteins, which are somewhat neglected in most studies. We found that 50% of transmembrane proteins have at least one IDR of 30 amino acids or more. Interestingly, these domains preferentially localize to the cytoplasmic side especially of multi-pass transmembrane proteins, suggesting that disorder prediction could increase the confidence of topology prediction algorithms. This was supported by the successful prediction of the topology of the uncharacterized multi-pass transmembrane protein TMEM117, as confirmed experimentally. Pathway analysis indicated that IDPs are enriched in cell projection and axons and appear to play an important role in cell adhesion, signaling and ion binding. In addition, we found that IDP are enriched in phosphorylation sites, a crucial post translational modification in signal transduction, when compared to fully ordered proteins and to be implicated in more protein-protein interaction events. Accordingly, IDPs were highly enriched in short protein binding regions called Molecular Recognition Features (MoRFs). Altogether our analyses strongly support the notion that the transmembrane IDPs act as hubs in cellular signal events.	[Burgi, Jerome; van der Goot, F. Gisou] Ecole Polytech Fed Lausanne, Global Hlth Inst, Fac Life Sci, Lausanne, Switzerland; [Xue, Bin] Univ S Florida, Coll Arts & Sci, Sch Nat Sci & Math, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA; [Uversky, Vladimir N.] Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL 33647 USA; [Uversky, Vladimir N.] Univ S Florida, Morsani Coll Med, USF Hlth Byrd Alzheimers Res Inst, Tampa, FL 33647 USA; [Uversky, Vladimir N.] Russian Acad Sci, Inst Biol Instrumentat, Pushchino, Moscow Region, Russia; [Uversky, Vladimir N.] King Abdulaziz Univ, Fac Sci, Dept Biol, POB 80203, Jeddah 21589, Saudi Arabia	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Russian Academy of Sciences; King Abdulaziz University	van der Goot, FG (corresponding author), Ecole Polytech Fed Lausanne, Global Hlth Inst, Fac Life Sci, Lausanne, Switzerland.	gisou.vandergoot@epfl.ch	Uversky, Vladimir N./F-4515-2011; van der Goot, Gisou/B-2279-2012	Uversky, Vladimir N./0000-0002-4037-5857; van der Goot, Gisou/0000-0002-8522-274X; Burgi, Jerome/0000-0003-1171-3455	Swiss National Science Foundation; EPFL	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EPFL	This work was funded by the Swiss National Science Foundation and core funding of the EPFL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoutzias GD, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.009555; Bah A, 2015, NATURE, V519, P106, DOI 10.1038/nature13999; Blaskovic S, 2014, CHEM PHYS LIPIDS, V180, P44, DOI 10.1016/j.chemphyslip.2014.02.001; Bozoky Z, 2013, P NATL ACAD SCI USA, V110, pE4427, DOI 10.1073/pnas.1315104110; Campen A, 2008, PROTEIN PEPTIDE LETT, V15, P956, DOI 10.2174/092986608785849164; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Disfani FM, 2012, BIOINFORMATICS, V28, pI75, DOI 10.1093/bioinformatics/bts209; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Dosztanyi Z, 2006, J PROTEOME RES, V5, P2985, DOI 10.1021/pr060171o; Ferreon ACM, 2013, NATURE, V498, P390, DOI 10.1038/nature12294; Fischer E, 1895, BERICHTE DTSCH CHEM, V28, P1429, DOI [10.1002/CBER.18950280243, DOI 10.1002/CBER.18950280243]; Gianni S, 2014, BIOPHYS CHEM, V189, P33, DOI 10.1016/j.bpc.2014.03.003; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; Hegedus T, 2008, J MOL BIOL, V378, P1052, DOI 10.1016/j.jmb.2008.03.033; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Hsu WL, 2013, PROTEIN SCI, V22, P258, DOI 10.1002/pro.2207; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Huber AH, 2001, J BIOL CHEM, V276, P12301, DOI 10.1074/jbc.M010377200; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Kotta-Loizou I, 2013, BBA-PROTEINS PROTEOM, V1834, P798, DOI 10.1016/j.bbapap.2013.01.006; Landry CR, 2009, TRENDS GENET, V25, P193, DOI 10.1016/j.tig.2009.03.003; Minezaki Y, 2007, J MOL BIOL, V368, P902, DOI 10.1016/j.jmb.2007.02.033; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Noutsou M, 2011, J MOL BIOL, V405, P773, DOI 10.1016/j.jmb.2010.11.013; Orchard S, 2012, NAT METHODS, V9, P345, DOI [10.1038/NMETH.1931, 10.1038/nmeth.1931]; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Pryor EE, 2014, BIOPHYS J, V106, P1638, DOI 10.1016/j.bpj.2014.02.025; Reichmann D, 2012, CELL, V148, P947, DOI 10.1016/j.cell.2012.01.045; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Schaefer MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031826; Shammas SL, 2016, J BIOL CHEM, V291, P6689, DOI 10.1074/jbc.R115.692715; Singh GP, 2015, PEERJ, V3, DOI 10.7717/peerj.724; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Tompa P, 2004, FASEB J, V18, P1169, DOI 10.1096/fj.04-1584rev; Tompa P, 2012, TRENDS BIOCHEM SCI, V37, P509, DOI 10.1016/j.tibs.2012.08.004; Tusnady GE, 2015, BBA-BIOMEMBRANES, V1848, P2839, DOI 10.1016/j.bbamem.2015.08.002; Uversky VN, 2013, PROTEIN SCI, V22, P693, DOI 10.1002/pro.2261; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; Vuzman D, 2010, P NATL ACAD SCI USA, V107, P21004, DOI 10.1073/pnas.1011775107; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Xue B, 2009, MOL BIOSYST, V5, P1688, DOI [10.1039/b905913j, 10.1039/B905913J]; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0	51	34	35	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158594	10.1371/journal.pone.0158594	http://dx.doi.org/10.1371/journal.pone.0158594			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391701	Green Published, gold, Green Submitted			2022-12-27	WOS:000380005400085
J	Fernando, DR; Marshall, AT; Lynch, JP				Fernando, Denise R.; Marshall, Alan T.; Lynch, Jonathan P.			Foliar Nutrient Distribution Patterns in Sympatric Maple Species Reflect Contrasting Sensitivity to Excess Manganese	PLOS ONE			English	Article							X-RAY-MICROANALYSIS; UNGUICULATA L WALP; COMMON BEAN GENOTYPES; SUGAR MAPLE; FREEZE-SUBSTITUTION; ACIDIC DEPOSITION; OXIDATIVE STRESS; CALCIUM-OXALATE; TOXICITY; SOILS	Sugar maple and red maple are closely-related co-occurring tree species significant to the North American forest biome. Plant abiotic stress effects including nutritional imbalance and manganese (Mn) toxicity are well documented within this system, and are implicated in enhanced susceptibility to biotic stresses such as insect attack. Both tree species are known to overaccumulate foliar manganese (Mn) when growing on unbuffered acidified soils, however, sugar maple is Mn-sensitive, while red maple is not. Currently there is no knowledge about the cellular sequestration of Mn and other nutrients in these two species. Here, electron-probe x-ray microanalysis was employed to examine cellular and sub-cellular deposition of excessively accumulated foliar Mn and other mineral nutrients in vivo. For both species, excess foliar Mn was deposited in symplastic cellular compartments. There were striking between-species differences in Mn, magnesium (Mg), sulphur (S) and calcium (Ca) distribution patterns. Unusually, Mn was highly co-localised with Mg in mesophyll cells of red maple only. The known sensitivity of sugar maple to excess Mn is likely linked to Mg deficiency in the leaf mesophyll. There was strong evidence that Mn toxicity in sugar maple is primarily a symplastic process. For each species, leaf-surface damage due to biotic stress including insect herbivory was compared between sites with acidified and non-acidified soils. Although it was greatest overall in red maple, there was no difference in biotic stress damage to red maple leaves between acidified and non-acidified soils. Sugar maple trees on buffered non-acidified soil were less damaged by biotic stress compared to those on unbuffered acidified soil, where they are also affected by Mn toxicity abiotic stress. This study concluded that foliar nutrient distribution in symplastic compartments is a determinant of Mn sensitivity, and that Mn stress hinders plant resistance to biotic stress.	[Fernando, Denise R.] La Trobe Univ, Dept Ecol Environm & Evolut, Bundoora, Vic, Australia; [Marshall, Alan T.] La Trobe Univ, Analyt Electron Microscopy Lab, Bundoora, Vic, Australia; [Lynch, Jonathan P.] Penn State Univ, Dept Plant Sci, University Pk, PA 16802 USA	La Trobe University; La Trobe University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Fernando, DR (corresponding author), La Trobe Univ, Dept Ecol Environm & Evolut, Bundoora, Vic, Australia.	d.fernando@latrobe.edu.au			Australian Research Council (ARC); Australian Research Council	Australian Research Council (ARC)(Australian Research Council); Australian Research Council(Australian Research Council)	This research was funded by an Australian Research Council (ARC) 'Discovery Early Career Research Award' to DRF [http://www.arc.gov.au/]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank R. Snyder (PSU), J. Gomola and E. Wiltsie (US Forest Service), and A. Fernando for fieldwork support; A. Traverse for herbarium expertise; G. Ning, M. Hazens and J. Cantolina (PSU microscopy laboratory) for sample preparation and microscopy support. DF acknowledges funding from the Australian Research Council.	Asemaneh T, 2006, PLANTA, V225, P193, DOI 10.1007/s00425-006-0340-y; Baker AJM, 2000, PHYTOREMEDIATION OF CONTAMINATED SOIL AND WATER, P85; BERNIER B, 1988, CAN J FOREST RES, V18, P1265, DOI 10.1139/x88-195; Bidwell SD, 2002, FUNCT PLANT BIOL, V29, P899, DOI 10.1071/PP01192; Bidwell SD, 2004, PLANT CELL ENVIRON, V27, P705, DOI 10.1111/j.0016-8025.2003.01170.x; Boyd R. S., 1992, P279; Brooks R. R., 1998, PLANTS HYPERACCUMULA; CHRISTELLER JT, 1979, BIOCHEM J, V183, P747, DOI 10.1042/bj1830747; Clode PL, 2004, TISSUE CELL, V36, P379, DOI 10.1016/j.tice.2004.06.005; Dean JM, 2007, CHEM ECOLOGY PLANT M; Driscoll CT, 2001, BIOSCIENCE, V51, P180, DOI 10.1641/0006-3568(2001)051[0180:ADITNU]2.0.CO;2; Drohan JR, 1997, WATER AIR SOIL POLL, V95, P299, DOI 10.1023/A:1026469814427; Edenhofer O., 2014, IPCC 2014 SUMM POL; Fecht-Christoffers MM, 2006, PLANT PHYSIOL, V140, P1451, DOI 10.1104/pp.105.070474; Fernando DR, 2008, NEW PHYTOL, V177, P178, DOI 10.1111/j.1469-8137.2007.02253.x; Fernando DR, 2006, NEW PHYTOL, V171, P751, DOI 10.1111/j.1469-8137.2006.01783.x; Fernando DR, 2010, NEW PHYTOL, V188, P1014, DOI 10.1111/j.1469-8137.2010.03431.x; Fernando DR, 2009, AUST J BOT, V57, P406, DOI 10.1071/BT09077; Fernando DR, 2008, FUNCT PLANT BIOL, V35, P193, DOI 10.1071/FP07272; Fernando DR, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00319; Fernando DR, 2013, AM J BOT, V100, P690, DOI 10.3732/ajb.1200545; Fernando DR, 2012, PLANTA, V236, P1459, DOI 10.1007/s00425-012-1699-6; Fernando DR, 2006, PLANT CELL ENVIRON, V29, P1012, DOI 10.1111/j.1365-3040.2006.01498.x; Franceschi VR, 2005, ANNU REV PLANT BIOL, V56, P41, DOI 10.1146/annurev.arplant.56.032604.144106; FRANCESCHI VR, 1989, PROTOPLASMA, V148, P130, DOI 10.1007/BF02079332; Gonzalez A, 1997, PHYSIOL PLANTARUM, V101, P872, DOI 10.1111/j.1399-3054.1997.tb01076.x; Gonzalez A, 1999, J PLANT NUTR, V22, P511, DOI 10.1080/01904169909365648; Gonzalez A, 1998, PLANT PHYSIOL, V118, P493, DOI 10.1104/pp.118.2.493; Gonzalez A, 1999, AUST J PLANT PHYSIOL, V26, P811, DOI 10.1071/PP99030; Graham R. D., 1988, INT S MANG SOILS PLA; Harvey DMR, 1980, SCANNING ELECTRON MI, VII, P409; Hayes RC, 2012, CROP PASTURE SCI, V63, P875, DOI 10.1071/CP12138; HEENAN DP, 1990, AUST J AGR RES, V41, P835, DOI 10.1071/AR9900835; HEENAN DP, 1977, PLANT SOIL, V47, P219, DOI 10.1007/BF00010381; HEISEY RM, 1995, WATER AIR SOIL POLL, V82, P675, DOI 10.1007/BF00479419; Horsley SB, 2000, CAN J FOREST RES, V30, P1365, DOI 10.1139/cjfr-30-9-1365; Horsley SB, 1998, SUG MAPL EC HLTH P I; HORST WJ, 1978, Z PFLANZ BODENKUNDE, V141, P129, DOI 10.1002/jpln.19781410202; KOLB TE, 1993, CAN J FOREST RES, V23, P2395, DOI 10.1139/x93-296; Lynch JP, 2004, FIELD CROP RES, V90, P101, DOI 10.1016/j.fcr.2004.07.008; Marshall A T, 1980, Scan Electron Microsc, P395; Marshall AT, 2007, J EXP BIOL, V210, P2453, DOI 10.1242/jeb.003343; MCCAIN DC, 1989, PLANT PHYSIOL, V90, P1417, DOI 10.1104/pp.90.4.1417; MORAGHAN JT, 1985, SOIL SCI SOC AM J, V49, P1584, DOI 10.2136/sssaj1985.03615995004900060051x; ORLOVICH DA, 1995, J MICROSC-OXFORD, V180, P117, DOI 10.1111/j.1365-2818.1995.tb03666.x; PALLAGHY CK, 1973, AUST J BIOL SCI, V26, P1015, DOI 10.1071/BI9731015; PALSGARD E, 1994, MICROSC RES TECHNIQ, V28, P254; POUCHOU JL, 1991, ELECTRON PROBE QUANTITATION, P31; Pouchou JL, 1992, ADV QUANTITATIVE PRO; RUFTY TW, 1979, AGRON J, V71, P638, DOI 10.2134/agronj1979.00021962007100040029x; Scott B. J., 1987, GENETIC ASPECTS PLAN; SIMAN A, 1974, PLANT SOIL, V41, P129, DOI 10.1007/BF00017950; SPARROW LA, 1987, AUST J EXP AGR, V27, P303, DOI 10.1071/EA9870303; St Clair SB, 2008, CAN J FOREST RES, V38, P401, DOI 10.1139/X07-161; St Clair SB, 2010, PLANT SOIL, V335, P101, DOI 10.1007/s11104-010-0328-z; St Clair SB, 2005, OECOLOGIA, V145, P258, DOI 10.1007/s00442-005-0121-5; St Clair SB, 2005, PLANT CELL ENVIRON, V28, P874, DOI 10.1111/j.1365-3040.2005.01337.x; St Clair SB, 2005, NEW PHYTOL, V165, P581, DOI 10.1111/j.1469-8137.2004.01249.x; St Clair SB, 2005, TREE PHYSIOL, V25, P85, DOI 10.1093/treephys/25.1.85; St Clair SB, 2004, FUNCT PLANT BIOL, V31, P1005, DOI 10.1071/FP04049; Tomlinson GH, 2003, BIOGEOCHEMISTRY, V65, P51, DOI 10.1023/A:1026069927380; WISSEMEIER AH, 1987, PLANT SOIL, V102, P283, DOI 10.1007/BF02370718; WISSEMEIER AH, 1990, J PLANT PHYSIOL, V136, P103, DOI 10.1016/S0176-1617(11)81622-6; WISSEMEIER AH, 1992, PLANT SOIL, V143, P299, DOI 10.1007/BF00007886	64	8	8	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0157702	10.1371/journal.pone.0157702	http://dx.doi.org/10.1371/journal.pone.0157702			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391424	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400018
J	Heffernan, A; Barber, E; Thomas, R; Fraser, C; Pickles, M; Cori, A				Heffernan, Alastair; Barber, Ella; Thomas, Ranjeeta; Fraser, Christophe; Pickles, Michael; Cori, Anne			Impact and Cost-Effectiveness of Point-Of-Care CD4 Testing on the HIV Epidemic in South Africa	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; LINKAGE; ART; INITIATION; DIAGNOSIS; PROGRAM; SITES	Rapid diagnostic tools have been shown to improve linkage of patients to care. In the context of infectious diseases, assessing the impact and cost-effectiveness of such tools at the population level, accounting for both direct and indirect effects, is key to informing adoption of these tools. Point-of-care (POC) CD4 testing has been shown to be highly effective in increasing the proportion of HIV positive patients who initiate ART. We assess the impact and cost-effectiveness of introducing POC CD4 testing at the population level in South Africa in a range of care contexts, using a dynamic compartmental model of HIV transmission, calibrated to the South African HIV epidemic. We performed a meta-analysis to quantify the differences between POC and laboratory CD4 testing on the proportion linking to care following CD4 testing. Cumulative infections averted and incremental cost-effectiveness ratios (ICERs) were estimated over one and three years. We estimated that POC CD4 testing introduced in the current South African care context can prevent 1.7% (95% CI: 0.4% - 4.3%) of new HIV infections over 1 year. In that context, POC CD4 testing was cost-effective 99.8% of the time after 1 year with a median estimated ICER of US$4,468/DALY averted. In healthcare contexts with expanded HIV testing and improved retention in care, POC CD4 testing only became cost-effective after 3 years. The results were similar when, in addition, ART was offered irrespective of CD4 count, and CD4 testing was used for clinical assessment. Our findings suggest that even if ART is expanded to all HIV positive individuals and HIV testing efforts are increased in the near future, POC CD4 testing is a cost-effective tool, even within a short time horizon. Our study also illustrates the importance of evaluating the potential impact of such diagnostic technologies at the population level, so that indirect benefits and costs can be incorporated into estimations of cost-effectiveness.	[Heffernan, Alastair; Barber, Ella; Thomas, Ranjeeta; Fraser, Christophe; Pickles, Michael; Cori, Anne] Imperial Coll London, Dept Infect Dis Epidemiol, London, England	Imperial College London	Pickles, M (corresponding author), Imperial Coll London, Dept Infect Dis Epidemiol, London, England.	m.pickles@imperial.ac.uk	Fraser, Christophe/A-8109-2008; Cori, Anne/AFL-1641-2022	Fraser, Christophe/0000-0003-2399-9657; Cori, Anne/0000-0002-8443-9162; Thomas, Ranjeeta/0000-0002-0947-4574; Pickles, Michael/0000-0002-6754-3945	International Decision Support Initiative (iDSI); Bill & Melinda Gates Foundation; UK's Department for International Development; Rockefeller Foundation; Wellcome Trust [105268/Z/14/Z]; Grundy Educational Trust; HIV Prevention Trials Network 071 Study (HPTN 071); U.S. National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Mental Health (NIMH); National Institute on Drug Abuse (NIDA); Office of the United States Global AIDS Coordinator (OGAC); Bill & Melinda Gates Foundation (BMGF); Imperial College; MRC [MR/K010174/1] Funding Source: UKRI; Medical Research Council [MR/K010174/1B, MR/K010174/1] Funding Source: researchfish	International Decision Support Initiative (iDSI); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); UK's Department for International Development; Rockefeller Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); Grundy Educational Trust; HIV Prevention Trials Network 071 Study (HPTN 071); U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Office of the United States Global AIDS Coordinator (OGAC); Bill & Melinda Gates Foundation (BMGF)(Bill & Melinda Gates Foundation); Imperial College; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was completed with support from the International Decision Support Initiative (iDSI). iDSI is funded by the Bill & Melinda Gates Foundation, the UK's Department for International Development, and the Rockefeller Foundation. The findings, interpretations and conclusions expressed in this article do not necessarily reflect the views of the above funding agencies. AH is supported by the Wellcome Trust (105268/Z/14/Z). EB is supported by the Grundy Educational Trust and Imperial College. RT, CF, MP and AC are supported by funding from the HIV Prevention Trials Network 071 Study (HPTN 071). HPTN 071 is funded by the U.S. National Institutes of Health (NIH), including the National Institute of Allergy and Infectious Diseases (NIAID), the National Institute of Mental Health (NIMH), the National Institute on Drug Abuse (NIDA), as well as the Office of the United States Global AIDS Coordinator (OGAC) and the Bill & Melinda Gates Foundation (BMGF). However, the views expressed in this paper are those of the authors, and do not necessarily reflect those of the funders or the HPTN 071 team. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cassim N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115420; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cori A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084511; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Eaton JW, 2014, LANCET GLOB HEALTH, V2, pE23, DOI 10.1016/S2214-109X(13)70172-4; Eaton JW, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001245; Edejer T, 2003, WHO GUIDE COST EFFEC; Faal M, 2011, JAIDS-J ACQ IMM DEF, V58, pE54, DOI 10.1097/QAI.0b013e3182303921; Glencross DK, 2014, PLOS ONE, V9, DOI [10.1371/Iournatponm0114727, DOI 10.1371/I0URNATP0NM0114727]; Helton JC, 2002, RISK ANAL, V22, P591, DOI 10.1111/0272-4332.00041; Hyle EP, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001725; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; Johnson LFD, 2021, THEMBISA VERSION 4 4; Larson BA, 2013, AIDS RES TREAT, V2013, DOI 10.1155/2013/941493; Larson BA, 2012, JAIDS-J ACQ IMM DEF, V61, pE13, DOI 10.1097/QAI.0b013e31825eec60; Losina E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009538; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Maskew M, 2007, SAMJ S AFR MED J, V97, P853; Matambo T, 2012, 19 INT AIDS C 22 27; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Mudaly V, 2020, W CAPE CONSOLIDATED; Patten GEM, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18518; UNAIDS, 2013, GLOBAL REPORT UNAIDS; UNAIDS, 2014, PREV DAT S AFR; UNAIDS, 2014, UND FAST TRACK ACC A; van Rooyen H, 2013, JAIDS-J ACQ IMM DEF, V64, pE1, DOI 10.1097/QAI.0b013e31829b567d; WHO, 2010, ANT THER HIV INF AD; WHO, 2002, SCAL ANT THER RES LI; WHO, 2013, GLOB UPD HIV TREATM; World Bank, 2015, EC DAT COUNTR; World Health Organization, 2015, GUID START ANT THER	32	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158303	10.1371/journal.pone.0158303	http://dx.doi.org/10.1371/journal.pone.0158303			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391129	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400041
J	Remis, RS; Liu, J; Loutfy, MR; Tharao, W; Rebbapragada, A; Huibner, S; Kesler, M; Halpenny, R; Grennan, T; Brunetta, J; Smith, G; Reko, T; Kaul, R				Remis, Robert S.; Liu, Juan; Loutfy, Mona R.; Tharao, Wangari; Rebbapragada, Anuradha; Huibner, Sanja; Kesler, Maya; Halpenny, Roberta; Grennan, Troy; Brunetta, Jason; Smith, Graham; Reko, Tatjana; Kaul, Rupert			Prevalence of Sexually Transmitted Viral and Bacterial Infections in HIV-Positive and HIV-Negative Men Who Have Sex with Men in Toronto	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HUMAN-PAPILLOMAVIRUS INFECTION; RISK-FACTORS; B-VIRUS; ANTIRETROVIRAL THERAPY; COHORT; MORTALITY; WOMEN; SEMEN; EPIDEMIOLOGY	Background Hepatitis B (HBV), hepatitis C (HCV) and other sexually transmitted infections (STIs) have been associated with HIV transmission risk and disease progression among gay men and other men who have sex with men (MSM), but the frequency and distribution of STIs in this community in Canada has not been extensively studied. Methods We recruited MSM living with and without HIV from a large primary care clinic in Toronto. Participants completed a detailed socio-behavioural questionnaire using ACASI and provided blood for syphilis, HIV, HBV and HCV, herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2), and human cytomegalovirus (CMV) serology, urine for chlamydia and gonorrhea, and a self-collected anal swab for human papillomavirus (HPV) molecular diagnostics. Prevalences were expressed as a proportion and compared using chi-square. Results 442 MSM were recruited, 294 living with HIV and 148 without. Active syphilis (11.0% vs. 3.4%), ever HBV (49.4% vs. 19.1%), HCV (10.4% vs. 3.4%), HSV-2 (55.9% vs. 38.2%), CMV (98.3% vs. 80.3%) and high-risk (HR) anal HPV (67.6% vs. 51.7%) infections were significantly more common in men living with HIV. Chlamydia and gonorrhea were infrequent in both groups. Regardless of HIV infection status, age and number of lifetime male sexual partners were associated with HBV infection and lifetime injection drug use with HCV infection. Conclusions Syphilis and viral infections, including HBV, HCV, HSV-2, CMV, and HR-HPV, were common in this clinic-based population of MSM in Toronto and more frequent among MSM living with HIV. This argues for the implementation of routine screening, vaccine-based prevention, and education programs in this high-risk population.	[Remis, Robert S.; Liu, Juan; Loutfy, Mona R.; Kesler, Maya] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Loutfy, Mona R.] Univ Toronto, Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada; [Loutfy, Mona R.; Halpenny, Roberta; Grennan, Troy; Brunetta, Jason; Smith, Graham; Reko, Tatjana] Maple Leaf Med Clin, Toronto, ON, Canada; [Tharao, Wangari] Womens Hlth Womens Hands Community Hlth Ctr, Toronto, ON, Canada; [Rebbapragada, Anuradha] Toronto Publ Hlth Ontario, Publ Hlth Lab, Toronto, ON, Canada; [Rebbapragada, Anuradha] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Huibner, Sanja; Kaul, Rupert] Univ Toronto, Univ Hlth Network, Dept Med, Toronto, ON, Canada; [Grennan, Troy] McMaster Univ, Dept Med, Hamilton, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; McMaster University	Kaul, R (corresponding author), Univ Toronto, Univ Hlth Network, Dept Med, Toronto, ON, Canada.	rupert.kaul@utoronto.ca	Grennan, Troy/AAH-5588-2020	Kaul, Rupert/0000-0002-1586-4093	Canadian Institutes of Health Research [HET-85518]; Emerging Team Grant from the Canadian Institutes of Health Research, Canada [HET-85518]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Emerging Team Grant from the Canadian Institutes of Health Research, Canada(Canadian Institutes of Health Research (CIHR))	This study was funded by the Canadian Institutes of Health Research (HET-85518). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the study participants, Jennifer Robinette and physicians at Maple Leaf Medical Clinic, staff at laboratories for diagnostic testing (Rupert Kaul laboratory; Department of Pathology, UHN; Toronto Medical Laboratories, Mt. Sinai Hospital; Toronto Public Health Laboratory; and Public Health Ontario). The study was funded by an Emerging Team Grant from the Canadian Institutes of Health Research, Canada (Grant number HET-85518). Dr. Robert Remis passed away before the submission of the final version of this manuscript; Dr. Rupert Kaul accepts responsibility for the integrity and validity of the data collected and analyzed.	Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; Andonov A, 2013, PRIMARY CARE MANAGEM; [Anonymous], 2011, ESTIMATES HIV PREVAL; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Bohl DD, 2011, SEX TRANSM DIS, V38, P617, DOI 10.1097/OLQ.0b013e31820a8c10; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Briat A, 2005, AIDS, V19, P1827, DOI 10.1097/01.aids.0000189847.98569.2d; Burchell AN, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-246; Butler DA, 2008, AIDS, V22, P1667, DOI 10.1097/QAD.0b013e32830bfed8; Centers for Disease C Prevention, 2011, MMWR-MORBID MORTAL W, V60, P945; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P966; Chesson HW, 2013, SEX TRANSM DIS, V40, P366, DOI 10.1097/OLQ.0b013e318284e544; Chin-Hong PV, 2009, AIDS, V23, P1135, DOI 10.1097/QAD.0b013e32832b4449; Chun Helen M, 2013, J Sex Transm Dis, V2013, P176459, DOI 10.1155/2013/176459; Danta M, 2007, AIDS, V21, P983, DOI 10.1097/QAD.0b013e3281053a0c; DREW WL, 1981, J INFECT DIS, V143, P188, DOI 10.1093/infdis/143.2.188; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Geibel S, 2010, PUBLIC HEALTH REP, V125, P316, DOI 10.1177/003335491012500222; Gilbert M, 2011, SEX TRANSM DIS, V38, P964, DOI 10.1097/OLQ.0b013e318222899d; Giraudon I, 2008, SEX TRANSM INFECT, V84, P111, DOI 10.1136/sti.2007.027334; Greub G, 2000, LANCET, V356, P1800, DOI 10.1016/S0140-6736(00)03232-3; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hill C, 2009, EUROSURVEILLANCE; Houlihan CF, 2012, AIDS, V26, P2211, DOI 10.1097/QAD.0b013e328358d908; Howard M, 2003, J CLIN MICROBIOL, V41, P84, DOI 10.1128/JCM.41.1.84-89.2003; Hunt PW, 2012, CURR HIV-AIDS REP, V9, P139, DOI 10.1007/s11904-012-0118-8; Jin FY, 2010, SEX TRANSM INFECT, V86, P25, DOI 10.1136/sti.2009.038182; Leruez-Ville M, 2000, LANCET, V356, P42, DOI 10.1016/S0140-6736(00)02435-1; Marcus JL, 2011, SEX TRANSM DIS, V38, P922, DOI 10.1097/OLQ.0b013e31822a2b2e; McKinnon LR, 2015, AIDS BEHAV; Nikolopoulos GK, 2009, CLIN INFECT DIS, V48, P1763, DOI 10.1086/599110; Nyitray AG, 2011, J INFECT DIS, V203, P49, DOI 10.1093/infdis/jiq021; Pathela P, 2011, JAIDS-J ACQ IMM DEF, V58, P408, DOI 10.1097/QAI.0b013e318230e1ca; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Rauch A, 2005, CLIN INFECT DIS, V41, P395, DOI 10.1086/431486; Rebbapragada A., 2007, DRUG DISCOV TODAY DI, V4, P237, DOI [10.1016/j.ddmec.2007.12.003, DOI 10.1016/J.DDMEC.2007.12.003]; Remis RS, 2012, REPORT HIV AIDS ONTA; Rockstroh JK, 2006, J HEPATOL, V44, pS25, DOI 10.1016/j.jhep.2005.11.007; Schmidt AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017781; Singh AE, 2005, SEX TRANSM DIS, V32, P95, DOI 10.1097/01.olq.0000151415.78210.85; Thio CL, 2002, LANCET, V360, P1921, DOI 10.1016/S0140-6736(02)11913-1; Urbanus AT, 2009, AIDS, V23, pF1, DOI 10.1097/QAD.0b013e32832e5631; van de Laar TJW, 2007, J INFECT DIS, V196, P230, DOI 10.1086/518796; van de Laar TJW, 2010, AIDS, V24, P1799, DOI 10.1097/QAD.0b013e32833c11a5; van der Helm J, 2013, GASTROENTEROLOGY, V144, P751, DOI 10.1053/j.gastro.2012.12.026; Wang HL, 2012, AIDS, V26, P1755, DOI 10.1097/QAD.0b013e328355ced2; Wiley DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079492; Witt MD, 2013, CLIN INFECT DIS, V57, P77, DOI 10.1093/cid/cit197; Wolitski RJ, 2011, AIDS BEHAV, V15, pS9, DOI 10.1007/s10461-011-9901-6; Xu FJ, 2010, SEX TRANSM DIS, V37, P399, DOI 10.1097/OLQ.0b013e3181ce122b; Zubach V, 2012, J CLIN MICROBIOL, V50, P460, DOI 10.1128/JCM.06090-11	52	41	42	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158090	10.1371/journal.pone.0158090	http://dx.doi.org/10.1371/journal.pone.0158090			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391265	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400029
J	Schroder, S; Leydolt, C; Menapace, R; Eppig, T; Langenbucher, A				Schroeder, Simon; Leydolt, Christina; Menapace, Rupert; Eppig, Timo; Langenbucher, Achim			Determination of Personalized IOL-Constants for the Haigis Formula under Consideration of Measurement Precision	PLOS ONE			English	Article							INTRAOCULAR-LENS POWER; PARTIAL COHERENCE INTERFEROMETRY; HOFFER-Q; REPEATABILITY; BIOMETRY; SRK/T; ERROR	The capabilities of a weighted least squares approach for the optimization of the intraocular lens (IOL) constants for the Haigis formula are studied in comparison to an ordinary least squares approach. The weights are set to the inverse variances of the effective optical anterior chamber depth. The effect of random measurement noise is simulated 100000 times using data from N = 69 cataract patients and the measurement uncertainty of two different biometers. A second, independent data set (N = 33) is used to show the differences that can be expected between both methods. The weighted least squares formalism reduces the effect of measurement error on the final constants. In more than 64% it will result in a better approximation, if the measurement errors are estimated correctly. The IOL constants can be calculated with higher precision using the weighted least squares method.	[Schroeder, Simon; Eppig, Timo; Langenbucher, Achim] Univ Saarland, Inst Expt Ophthalmol, Homburg, Germany; [Leydolt, Christina; Menapace, Rupert] Univ Eye Clin, Vienna, Austria	Saarland University	Schroder, S (corresponding author), Univ Saarland, Inst Expt Ophthalmol, Homburg, Germany.	Simon.Schroeder@uks.eu	Eppig, Timo/H-7413-2019	Eppig, Timo/0000-0003-0661-6239				Drexler W, 1998, AM J OPHTHALMOL, V126, P524, DOI 10.1016/S0002-9394(98)00113-5; Haigis W, 2004, INTRAOCULAR LENS POW, P41; Haigis W, 2007, Z MED PHYS, V17, P45, DOI 10.1016/j.zemedi.2006.11.001; HOFFER KJ, 1993, J CATARACT REFR SURG, V19, P700, DOI 10.1016/S0886-3350(13)80338-0; HOLLADAY JT, 1988, J CATARACT REFR SURG, V14, P17, DOI 10.1016/S0886-3350(88)80059-2; Huang JH, 2015, J CATARACT REFR SURG, V41, P2233, DOI 10.1016/j.jcrs.2015.10.062; International Organization for Standardization, 2000, OPHTH IMPL INTR LE 2, P11979; Kunert KS, 2016, J CATARACT REFR SURG, V42, P76, DOI 10.1016/j.jcrs.2015.07.039; Langenbucher A, 2012, OPHTHALMOLOGE, V109, P468, DOI 10.1007/s00347-012-2535-x; Leinonen J, 2006, ACTA OPHTHALMOL SCAN, V84, P532, DOI 10.1111/j.1600-0420.2006.00695.x; Liou HL, 1997, J OPT SOC AM A, V14, P1684, DOI 10.1364/JOSAA.14.001684; Norrby NES, 1996, J CATARACT REFR SURG, V22, P983; Norrby S, 2003, J CATARACT REFR SURG, V29, P100, DOI 10.1016/S0886-3350(02)01817-5; Norrby S, 2008, J CATARACT REFR SURG, V34, P368, DOI 10.1016/j.jcrs.2007.10.031; Olsen T, 2007, ACTA OPHTHALMOL SCAN, V85, P472, DOI 10.1111/j.1600-0420.2007.00879.x; Olsen T, 2014, J CATARACT REFR SURG, V40, P764, DOI 10.1016/j.jcrs.2013.10.037; Pascolini D, 2010, BR J OPHTHALMOL, V96, P614, DOI DOI 10.1136/BJ0PHTHALM0L-2011-300539; RETZLAFF JA, 1990, J CATARACT REFR SURG, V16, P333, DOI 10.1016/S0886-3350(13)80705-5; Schmidt I, 2015, OPHTHALMOLOGE, V112, P261, DOI 10.1007/s00347-014-3121-1; Srivannaboon S, 2015, J CATARACT REFR SURG, V41, P2224, DOI 10.1016/j.jcrs.2015.03.019	20	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158988	10.1371/journal.pone.0158988	http://dx.doi.org/10.1371/journal.pone.0158988			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391100	Green Published, gold, Green Submitted			2022-12-27	WOS:000380005400183
J	Ventrella, D; Laghi, L; Barone, F; Elmi, A; Romagnoli, N; Bacci, ML				Ventrella, Domenico; Laghi, Luca; Barone, Francesca; Elmi, Alberto; Romagnoli, Noemi; Bacci, Maria Laura			Age-Related H-1 NMR Characterization of Cerebrospinal Fluid in Newborn and Young Healthy Piglets	PLOS ONE			English	Article							PIG; METABOLOME; GLUTAMINE; MODEL; MICROBIOTA; DIAGNOSIS; PATHWAYS; LACTATE; BARRIER; PLASMA	When it comes to neuroscience, pigs represent an important animal model due to their resemblance with humans' brains for several patterns including anatomy and developmental stages. Cerebrospinal fluid (CSF) is a relatively easy-to-collect specimen that can provide important information about neurological health and function, proving its importance as both a diagnostic and biomedical monitoring tool. Consequently, it would be of high scientific interest and value to obtain more standard physiological information regarding its composition and dynamics for both swine pathology and the refinement of experimental protocols. Recently, proton nuclear magnetic resonance (H-1 NMR) spectroscopy has been applied in order to analyze the metabolomic profile of this biological fluid, and results showed the technique to be highly reproducible and reliable. The aim of the present study was to investigate in both qualitative and quantitative manner the composition of Cerebrospinal Fluid harvested form healthy newborn (5 days old-P5) and young (30-P30 and 50-P50 days old) piglets using H-1 NMR Spectroscopy, and to analyze any possible difference in metabolites concentration between age groups, related to age and Blood-Brain-Barrier maturation. On each of the analyzed samples, 30 molecules could be observed above their limit of quantification, accounting for 95-98% of the total area of the spectra. The concentrations of adenine, tyrosine, leucine, valine, 3-hydroxyvalerate, 3-methyl-2-oxovalerate were found to decrease between P05 and P50, while the concentrations of glutamine, creatinine, methanol, trimethylamine and myo-inositol were found to increase. The P05-P30 comparison was also significant for glutamine, creatinine, adenine, tyrosine, leucine, valine, 3-hydroxyisovalerate, 3-methyl-2-oxovalerate, while for the P30-P50 comparison we found significant differences for glutamine, myo-inositol, leucine and trimethylamine. None of these molecules showed at P30 concentrations outside the P05 -P50 range.	[Ventrella, Domenico; Barone, Francesca; Elmi, Alberto; Romagnoli, Noemi; Bacci, Maria Laura] Univ Bologna, Dept Vet Med Sci, Bologna, Italy; [Laghi, Luca] Univ Bologna, Dept Agrofood Sci & Technol, Ctr Food, Bologna, Italy	University of Bologna; University of Bologna	Ventrella, D (corresponding author), Univ Bologna, Dept Vet Med Sci, Bologna, Italy.	domenico.ventrella2@unibo.it	Laghi, Luca/R-5278-2016; Elmi, Alberto/U-2252-2019	Laghi, Luca/0000-0003-1593-7376; Elmi, Alberto/0000-0002-7827-5034; Bacci, Maria Laura/0000-0001-6702-5868; Ventrella, Domenico/0000-0002-9330-979X	RFO 60%, Ateneo di Bologna	RFO 60%, Ateneo di Bologna	This study was supported by RFO 60%, Ateneo di Bologna.	Aasly J, 1997, ACTA NEUROL SCAND, V95, P9, DOI 10.1111/j.1600-0404.1997.tb00060.x; Alvarez JI, 2013, GLIA, V61, P1939, DOI 10.1002/glia.22575; Amaral AI, 2016, GLIA, V64, P21, DOI 10.1002/glia.22900; Andrews FM, 1998, COMP CONT EDUC PRACT, V20, P376; BAILEY CS, 1985, AM J VET RES, V46, P1162; Bandeira F, 2009, P NATL ACAD SCI USA, V106, P14108, DOI 10.1073/pnas.0804650106; Bassols A, 2014, PROTEOM CLIN APPL, V8, P715, DOI 10.1002/prca.201300099; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Bourgoin-Voillard S, 2016, PROTEOMICS, V16, P831, DOI 10.1002/pmic.201500347; Brekke E, 2015, NEUROCHEM INT, V82, P33, DOI 10.1016/j.neuint.2015.02.002; Cao KAL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-253; Cobas JC, 2006, J MAGN RESON, V183, P145, DOI 10.1016/j.jmr.2006.07.013; Carnevali A, 2014, FOOD RES INT, V63, P218, DOI 10.1016/j.foodres.2014.01.065; Chen KF, 2007, INT J BIOL SCI, V3, P153; Crews B, 2009, ANAL CHEM, V81, P8538, DOI 10.1021/ac9014947; De Filippis F., 2015, GUT; Desnoyers M, 2008, DIAGNOSTIC CYTOLOGY, P215; Di Cagno R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-219; Di Terlizzi R, 2006, VET J, V172, P422, DOI 10.1016/j.tvjl.2005.07.021; Di Terlizzi R, 2009, VET J, V180, P15, DOI 10.1016/j.tvjl.2007.11.024; Dickens Alex M, 2015, AIDS, V29, P559, DOI 10.1097/QAD.0000000000000580; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; Dorokhov YL, 2015, PHYSIOL REV, V95, P603, DOI 10.1152/physrev.00034.2014; Eid T, 2013, NEUROCHEM INT, V63, P670, DOI 10.1016/j.neuint.2013.06.008; Eriksson L., 2001, MULTI MEGAVARIATE DA; Francavilla R, 2012, PEDIAT ALLERG IMM-UK, V23, P420, DOI 10.1111/j.1399-3038.2012.01286.x; Giulieri S, 2015, EUR J CLIN MICROBIOL, V34, P2049, DOI 10.1007/s10096-015-2450-6; Jeon JP, 2014, NEUROSURGERY, V75, pN12, DOI 10.1227/NEU.0000000000000517; Jones CM, 2006, ANN CLIN BIOCHEM, V43, P63, DOI 10.1258/000456306775141759; Laghi L, 2014, ANTIMICROB AGENTS CH, V58, P3411, DOI 10.1128/AAC.02469-14; Lambertini C, 2015, J NEUROSCI METH, V255, P17, DOI 10.1016/j.jneumeth.2015.07.021; Le Cao KA, 2009, BIOINFORMATICS, V25, P2855, DOI 10.1093/bioinformatics/btp515; Levine J, 2000, BIOL PSYCHIAT, V47, P586, DOI 10.1016/S0006-3223(99)00284-X; Lohren H, 2015, METALLOMICS, V7, P1420, DOI 10.1039/c5mt00171d; Merrifield CA, 2011, MOL BIOSYST, V7, P2577, DOI 10.1039/c1mb05023k; Musteata M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081192; Nakamizo S, 2013, J NEURO-ONCOL, V113, P65, DOI 10.1007/s11060-013-1090-x; Niblock MM, 2005, BRAIN RES REV, V50, P169, DOI 10.1016/j.brainresrev.2005.05.006; Noga MJ, 2012, METABOLOMICS, V8, P253, DOI 10.1007/s11306-011-0306-3; Ohman A, 2015, NEUROSCI LETT, V594, P36, DOI 10.1016/j.neulet.2015.03.051; OuYang D, 2011, APPL BIOCHEM BIOTECH, V165, P148, DOI 10.1007/s12010-011-9240-0; Romagnoli N, 2014, LAB ANIM-UK, V48, P345, DOI 10.1177/0023677214540881; Rubtsov DV, 2007, METABOLOMICS, V3, P223, DOI 10.1007/s11306-006-0040-4; Saunders NR, 2016, F1000RES, V5; Schicho R, 2012, J PROTEOME RES, V11, P3344, DOI 10.1021/pr300139q; Simmler C, 2014, CURR OPIN BIOTECH, V25, P51, DOI 10.1016/j.copbio.2013.08.004; Sorrentino NC, 2016, MOL THER, V24, P276, DOI 10.1038/mt.2015.212; Trimigno A, 2015, CURR OPIN FOOD SCI, V4, P99, DOI 10.1016/j.cofs.2015.06.008; van der Sar SA, 2015, ANAL BIOANAL CHEM, V407, P4835, DOI 10.1007/s00216-015-8663-9; Wernersson R, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-70; Wiczkowski W, 2015, MOL NUTR FOOD RES, V59, P1088, DOI 10.1002/mnfr.201400567; Wishart DS, 2008, J CHROMATOGR B, V871, P164, DOI 10.1016/j.jchromb.2008.05.001; Zheng XJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep24125	53	24	25	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0157623	10.1371/journal.pone.0157623	http://dx.doi.org/10.1371/journal.pone.0157623			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391145	Green Published, gold			2022-12-27	WOS:000380005400015
J	Wang, H; Zhao, BJ; Liu, CK; Wang, C; Tan, XY; Hu, M				Wang, Hong; Zhao, Bingjing; Liu, Changkui; Wang, Chao; Tan, Xinying; Hu, Min			A Comparison of Biocompatibility of a Titanium Alloy Fabricated by Electron Beam Melting and Selective Laser Melting	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; BONE; TI-6AL-4V; IMPLANTS; EXPRESSION; CELLS; DIFFERENTIATION; MICROSTRUCTURES; RECONSTRUCTION; PHENOTYPE	Electron beam melting (EBM) and selective laser melting (SLM) are two advanced rapid prototyping manufacturing technologies capable of fabricating complex structures and geometric shapes from metallic materials using computer tomography (CT) and Computeraided Design (CAD) data. Compared to traditional technologies used for metallic products, EBM and SLM alter the mechanical, physical and chemical properties, which are closely related to the biocompatibility of metallic products. In this study, we evaluate and compare the biocompatibility, including cytocompatibility, haemocompatibility, skin irritation and skin sensitivity of Ti6Al4V fabricated by EBM and SLM. The results were analysed using one-way ANOVA and Tukey's multiple comparison test. Both the EBM and SLM Ti6Al4V exhibited good cytobiocompatibility. The haemolytic ratios of the SLM and EBM were 2.24% and 2.46%, respectively, which demonstrated good haemocompatibility. The EBM and SLM Ti6Al4V samples showed no dermal irritation when exposed to rabbits. In a delayed hyper-sensitivity test, no skin allergic reaction from the EBM or the SLM Ti6Al4V was observed in guinea pigs. Based on these results, Ti6Al4V fabricated by EBM and SLM were good cyto-biocompatible, haemocompatible, non-irritant and non-sensitizing materials. Although the data for cell adhesion, proliferation, ALP activity and the haemolytic ratio was higher for the SLM group, there were no significant differences between the different manufacturing methods.	[Wang, Hong; Zhao, Bingjing; Hu, Min] Gen Hosp Peoples Librat Army, Dept Stomatol, Beijing, Peoples R China; [Wang, Hong; Zhao, Bingjing] Liaoning Med Univ, Affiliated Stomatol Hosp 2, Dept Stomatol, Jinzhou, Peoples R China; [Liu, Changkui] 451th Hosp Peoples Librat Army, Dept Stomatol, Xian, Peoples R China; [Wang, Chao] Nankai Univ, Sch Med, Tianjin, Peoples R China; [Tan, Xinying] 304th Hosp Peoples Librat Army, Dept Stomatol, Beijing, Peoples R China	Jinzhou Medical University; Nankai University	Hu, M (corresponding author), Gen Hosp Peoples Librat Army, Dept Stomatol, Beijing, Peoples R China.	humin48@vip.163.com						[Anonymous], 1099342002 ISO; [Anonymous], 10993122002 ISO; [Anonymous], 2002, 10993102002 ISO; Bertollo N, 2012, J ARTHROPLASTY, V27, P1429, DOI 10.1016/j.arth.2012.02.025; Cadosch D, 2009, J BIOMED MATER RES A, V91A, P29, DOI 10.1002/jbm.a.32183; Carbonare LD, 2012, STEM CELL REV REP, V8, P891, DOI 10.1007/s12015-011-9337-4; Ciocca L, 2011, MED BIOL ENG COMPUT, V49, P1347, DOI 10.1007/s11517-011-0813-4; de Peppo GM, 2012, SCI WORLD J, DOI 10.1100/2012/646417; de Wild M, 2013, TISSUE ENG PT A, V19, P2645, DOI [10.1089/ten.TEA.2012.0753, 10.1089/ten.tea.2012.0753]; FANTI P, 1992, AM J PHYSIOL, V263, pE1113; Ferrigno N, 2002, CLIN ORAL IMPLAN RES, V13, P260, DOI 10.1034/j.1600-0501.2002.130305.x; GERSTENFELD LC, 1987, DEV BIOL, V122, P49, DOI 10.1016/0012-1606(87)90331-9; Haslauer CM, 2010, MED ENG PHYS, V32, P645, DOI 10.1016/j.medengphy.2010.04.003; Hosoki M, 2009, BIO-MED MATER ENG, V19, P53, DOI 10.3233/BME-2009-0563; Hrabe NW, 2013, CONNECT TISSUE RES, V54, P351, DOI 10.3109/03008207.2013.822864; Hsieh JY, 2010, STEM CELLS DEV, V19, P1895, DOI 10.1089/scd.2009.0485; Kawase M., 2014, MAT SCI APPL, V05, P475, DOI DOI 10.4236/MSA.2014.57051; Khan SN, 2000, ORTHOP CLIN N AM, V31, P389, DOI 10.1016/S0030-5898(05)70158-9; Koike M, 2011, MATERIALS, V4, P1776, DOI 10.3390/ma4101776; LALOR PA, 1991, J BONE JOINT SURG BR, V73, P25, DOI 10.1302/0301-620X.73B1.1991768; Larsson C, 1996, BIOMATERIALS, V17, P605, DOI 10.1016/0142-9612(96)88711-4; Leopold SS, 2000, J ARTHROPLASTY, V15, P938, DOI 10.1054/arth.2000.6632; Li SJ, 2014, ACTA BIOMATER, V10, P4537, DOI 10.1016/j.actbio.2014.06.010; Li WZ, 2009, INT J MED ROBOT COMP, V5, P158, DOI 10.1002/rcs.242; Li X, 2009, P I MECH ENG H, V223, P173, DOI 10.1243/09544119JEIM466; Lian J. B., 2003, Current Pharmaceutical Design, V9, P2677, DOI 10.2174/1381612033453659; Liu CK, 2014, J MED HYPOTHESES IDE, V8, P69, DOI 10.1016/j.jmhi.2013.11.003; LUNDSTROM IMC, 1984, INT J ORAL MAXILLOF, V13, P16, DOI 10.1016/S0300-9785(84)80051-4; Merritt K, 1996, CLIN ORTHOP RELAT R, P71; Moin DA, 2013, CLIN ORAL IMPLAN RES, V24, P25, DOI 10.1111/j.1600-0501.2011.02359.x; Murdoch B, 2014, INT J ORAL MAX SURG, V43, P595, DOI 10.1016/j.ijom.2013.11.004; Murr LE, 2009, MATER CHARACT, V60, P96, DOI 10.1016/j.matchar.2008.07.006; Murr LE, 2009, J MECH BEHAV BIOMED, V2, P20, DOI 10.1016/j.jmbbm.2008.05.004; Mustafa SF, 2011, INT J ORAL MAX SURG, V40, P1357, DOI 10.1016/j.ijom.2011.04.020; Otto F, 2003, J CELL BIOCHEM, V89, P9, DOI 10.1002/jcb.10491; OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304; Peng Q, 2015, ANN MED, V47, P186, DOI 10.3109/07853890.2015.1007520; Ponader S, 2008, J BIOMED MATER RES A, V84A, P1111, DOI 10.1002/jbm.a.31540; Rafi HK, 2013, J MATER ENG PERFORM, V22, P3872, DOI 10.1007/s11665-013-0658-0; Rogers SD, 1997, J BONE JOINT SURG BR, V79B, P311, DOI 10.1302/0301-620X.79B2.7192; Ryan GE, 2008, BIOMATERIALS, V29, P3625, DOI 10.1016/j.biomaterials.2008.05.032; Sallica-Leva E, 2013, J MECH BEHAV BIOMED, V26, P98, DOI 10.1016/j.jmbbm.2013.05.011; Sicilia A, 2008, CLIN ORAL IMPLAN RES, V19, P823, DOI 10.1111/j.1600-0501.2008.01544.x; SOLOMON E, 1980, NATURE, V286, P656, DOI 10.1038/286656a0; Stejskal V, 2013, NEUROENDOCRINOL LETT, V34, P559; Takahashi Tomihisa, 2005, J Oral Sci, V47, P199, DOI 10.2334/josnusd.47.199; Thijs L, 2010, ACTA MATER, V58, P3303, DOI 10.1016/j.actamat.2010.02.004; Thomas P, 2006, CONTACT DERMATITIS, V55, P199, DOI 10.1111/j.1600-0536.2006.00931.x; Vaithilingam J, 2015, MAT SCI ENG C-MATER, V46, P52, DOI 10.1016/j.msec.2014.10.015; Wang GS, 2012, OR SURG OR MED OR PA, V113, P356, DOI 10.1016/j.tripleo.2011.03.034; Warnke PH, 2009, TISSUE ENG PART C-ME, V15, P115, DOI 10.1089/ten.tec.2008.0288; ZHOU H, 1994, J BONE MINER RES, V9, P1489	52	45	48	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158513	10.1371/journal.pone.0158513	http://dx.doi.org/10.1371/journal.pone.0158513			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391895	Green Submitted, Green Published, gold			2022-12-27	WOS:000380005400074
J	Halluin, C; Madelaine, R; Naye, F; Peers, B; Roussigne, M; Blader, P				Halluin, Caroline; Madelaine, Romain; Naye, Francois; Peers, Bernard; Roussigne, Myriam; Blader, Patrick			Habenular Neurogenesis in Zebrafish Is Regulated by a Hedgehog, Pax6 Proneural Gene Cascade	PLOS ONE			English	Article							LEFT-RIGHT ASYMMETRY; SONIC-HEDGEHOG; FOREBRAIN DEVELOPMENT; LATERAL HABENULA; SIGNAL-TRANSDUCTION; MIDBRAIN TARGET; DIENCEPHALON; EXPRESSION; IDENTITY; NEURONS	The habenulae are highly conserved nuclei in the dorsal diencephalon that connect the forebrain to the midbrain and hindbrain. These nuclei have been implicated in a broad variety of behaviours in humans, primates, rodents and zebrafish. Despite this, the molecular mechanisms that control the genesis and differentiation of neural progenitors in the habenulae remain relatively unknown. We have previously shown that, in zebrafish, the timing of habenular neurogenesis is left-right asymmetric and that in the absence of Nodal signalling this asymmetry is lost. Here, we show that habenular neurogenesis requires the homeobox transcription factor Pax6a and the redundant action of two proneural bHLH factors, Neurog1 and Neurod4. We present evidence that Hedgehog signalling is required for the expression of pax6a, which is in turn necessary for the expression of neurog1 and neurod4. Finally, we demonstrate by pharmacological inhibition that Hedgehog signalling is required continuously during habenular neurogenesis and by cell transplantation experiments that pathway activation is required cell autonomously. Our data sheds light on the mechanism underlying habenular development that may provide insights into how Nodal signalling imposes asymmetry on the timing of habenular neurogenesis.	[Halluin, Caroline; Madelaine, Romain; Roussigne, Myriam; Blader, Patrick] Univ Toulouse 3, CBD, CBI, 118 Route Narbonne, F-31062 Toulouse, France; [Halluin, Caroline; Madelaine, Romain; Roussigne, Myriam; Blader, Patrick] CNRS, CBD UMR 5547, F-31062 Toulouse, France; [Halluin, Caroline; Madelaine, Romain] Stanford Univ, Sch Med, 269-279 Campus Dr, Stanford, CA 94305 USA; [Naye, Francois; Peers, Bernard] Univ Liege, GIGA R, Unit Mol Biol & Genet Engn, B34,Ave Hop 1, B-4000 Liege, Belgium	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Stanford University; University of Liege	Roussigne, M; Blader, P (corresponding author), Univ Toulouse 3, CBD, CBI, 118 Route Narbonne, F-31062 Toulouse, France.; Roussigne, M; Blader, P (corresponding author), CNRS, CBD UMR 5547, F-31062 Toulouse, France.	myriam.roussigne@univ-tlse3.fr; patrick.blader@univ-tlse3.fr		Blader, Patrick/0000-0003-3299-6108; Roussigne, Myriam/0000-0002-4240-4105	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (INSERM); Universite de Toulouse III (UPS); Ministere de la Recherche; ARC; CNRS; INSERM; FEBS; FRM; Fondation pour la Recherche Medicale (FRM) [DEQ20131029166]; Federation pour la Recherche sur le Cerveau (FRC); Association pour la Recherche sur le Cancer (ARC) [SFI20101201699, PJA 20131200173]; Federation of European Biochemical Societies (FEBS)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite de Toulouse III (UPS); Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France); ARC(Australian Research Council); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); FEBS; FRM(Fondation pour la Recherche Medicale); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Federation pour la Recherche sur le Cerveau (FRC); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Federation of European Biochemical Societies (FEBS)	The present work was supported (Staff Salary, Equipment or functioning expenses) by the following agencies or associations: The Centre National de la Recherche Scientifique (CNRS); The Institut National de la Sante et de la Recherche Medicale (INSERM); The Universite de Toulouse III (UPS); The Ministere de la Recherche. The Fondation pour la Recherche Medicale (FRM; DEQ20131029166; http://www.frm.org); The Federation pour la Recherche sur le Cerveau (FRC; http://www.frc.asso.fr); The Association pour la Recherche sur le Cancer (ARC; http://www.fondation-arc.org) [SFI20101201699 and PJA 20131200173 to P.B.]; The Federation of European Biochemical Societies (FEBS; //www.febs.org). R.M. was financed by the Ministere de la Recherche and ARC, C.H. by the CNRS, P.B. by INSERM and M.R. by FEBS, FRM and CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agetsuma M, 2010, NAT NEUROSCI, V13, P1354, DOI 10.1038/nn.2654; Aizawa H, 2005, CURR BIOL, V15, P238, DOI 10.1016/j.cub.2005.01.014; Aizawa H, 2007, DEV CELL, V12, P87, DOI 10.1016/j.devcel.2006.10.004; Amo R, 2010, J NEUROSCI, V30, P1566, DOI 10.1523/JNEUROSCI.3690-09.2010; Barresi MJF, 2000, DEVELOPMENT, V127, P2189; Beretta CA, 2013, NEURAL DEV, V8, DOI 10.1186/1749-8104-8-19; Beretta CA, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00051; Bianco IH, 2009, PHILOS T R SOC B, V364, P1005, DOI 10.1098/rstb.2008.0213; Bianco IH, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-9; Blader P, 2004, DEVELOPMENT, V131, P5627, DOI 10.1242/dev.01455; Blader P, 2003, MECH DEVELOP, V120, P211, DOI 10.1016/S0925-4773(02)00413-6; Blader P, 1997, DEVELOPMENT, V124, P4557; Caballero IM, 2014, CELL REP, V8, P1405, DOI 10.1016/j.celrep.2014.07.051; Carl M, 2007, NEURON, V55, P393, DOI 10.1016/j.neuron.2007.07.007; Cau E, 2008, DEVELOPMENT, V135, P2391, DOI 10.1242/dev.013482; Chatterjee M, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-13; Chatterjee M, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00066; Cohen M, 2013, CURR OPIN GENET DEV, V23, P423, DOI 10.1016/j.gde.2013.04.003; Concha ML, 2012, NAT REV NEUROSCI, V13, P832, DOI 10.1038/nrn3371; Concha ML, 2003, NEURON, V39, P423, DOI 10.1016/S0896-6273(03)00437-9; Concha ML, 2001, J ANAT, V199, P63, DOI 10.1046/j.1469-7580.2001.19910063.x; Concha ML, 2000, NEURON, V28, P399, DOI 10.1016/S0896-6273(00)00120-3; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; David NB, 2002, P NATL ACAD SCI USA, V99, P16297, DOI 10.1073/pnas.252339399; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Gamse JT, 2005, DEVELOPMENT, V132, P4869, DOI 10.1242/dev.02046; Gamse JT, 2003, DEVELOPMENT, V130, P1059, DOI 10.1242/dev.00270; Georgala PA, 2011, DEV NEUROBIOL, V71, P690, DOI 10.1002/dneu.20895; Golling G, 2002, NAT GENET, V31, P135, DOI 10.1038/ng896; Grindley JC, 1997, MECH DEVELOP, V64, P111, DOI 10.1016/S0925-4773(97)00055-5; Hagemann AIH, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00076; Halpern ME, 2003, TRENDS NEUROSCI, V26, P308, DOI 10.1016/S0166-2236(03)00129-2; Heisenberg CP, 1996, DEVELOPMENT, V123, P191; Hikosaka O, 2010, NAT REV NEUROSCI, V11, P503, DOI 10.1038/nrn2866; Huang P, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002762; Husken U, 2014, CURR BIOL, V24, P2217, DOI 10.1016/j.cub.2014.08.006; Incardona JP, 1998, DEVELOPMENT, V125, P3553; Kiecker C, 2004, NAT NEUROSCI, V7, P1242, DOI 10.1038/nn1338; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kleinjan DA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040029; Kong JH, 2015, DEV CELL, V33, P373, DOI 10.1016/j.devcel.2015.03.005; Kuan YS, 2015, DEV BIOL, V406, P117, DOI 10.1016/j.ydbio.2015.06.006; Lagadec R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7686; Lawson RP, 2014, P NATL ACAD SCI USA, V111, P11858, DOI 10.1073/pnas.1323586111; Lecourtier L, 2007, NEUROSCI BIOBEHAV R, V31, P658, DOI 10.1016/j.neubiorev.2007.01.004; Lee A, 2010, CURR BIOL, V20, P2211, DOI 10.1016/j.cub.2010.11.025; Li B, 2011, NATURE, V470, P535, DOI 10.1038/nature09742; Liang JO, 2000, DEVELOPMENT, V127, P5101; MACDONALD R, 1994, NEURON, V13, P1039, DOI 10.1016/0896-6273(94)90044-2; Madelaine R, 2011, DEVELOPMENT, V138, P4753, DOI 10.1242/dev.066563; Martinez-Ferre A, 2009, J NEUROSCI, V29, P13389, DOI 10.1523/JNEUROSCI.2625-09.2009; Masai I, 1997, NEURON, V18, P43, DOI 10.1016/S0896-6273(01)80045-3; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; Mueller T, 2003, DEV BRAIN RES, V140, P137, DOI 10.1016/S0165-3806(02)00583-7; Nornes S, 1998, MECH DEVELOP, V77, P185, DOI 10.1016/S0925-4773(98)00156-7; OXTOBY E, 1993, NUCLEIC ACIDS RES, V21, P1087, DOI 10.1093/nar/21.5.1087; Park HC, 2000, DEV BIOL, V227, P279, DOI 10.1006/dbio.2000.9898; Park SH, 2003, BIOCHEM BIOPH RES CO, V308, P184, DOI 10.1016/S0006-291X(03)01353-6; PUELLES L, 1993, TRENDS NEUROSCI, V16, P472, DOI 10.1016/0166-2236(93)90080-6; Regan JC, 2009, NEURON, V61, P27, DOI 10.1016/j.neuron.2008.11.030; Roussigne M, 2012, DEV NEUROBIOL, V72, P269, DOI 10.1002/dneu.20885; Roussigne M, 2009, DEVELOPMENT, V136, P1549, DOI 10.1242/dev.034793; Sartorius A, 2007, MED HYPOTHESES, V69, P1305, DOI 10.1016/j.mehy.2007.03.021; Scardigli R, 2003, DEVELOPMENT, V130, P3269, DOI 10.1242/dev.00539; Scardigli R, 2001, NEURON, V31, P203, DOI 10.1016/S0896-6273(01)00358-0; Schauerte HE, 1998, DEVELOPMENT, V125, P2983; Scholpp S, 2006, DEVELOPMENT, V133, P855, DOI 10.1242/dev.02248; Storm EE, 2006, DEVELOPMENT, V133, P1831, DOI 10.1242/dev.02324; Stoykova A, 2000, J NEUROSCI, V20, P8042; Szabo NE, 2009, J NEUROSCI, V29, P2453, DOI 10.1523/JNEUROSCI.4524-08.2009; Varga ZM, 2001, DEVELOPMENT, V128, P3497; Vue TY, 2009, J NEUROSCI, V29, P4484, DOI 10.1523/JNEUROSCI.0656-09.2009; Walshe J, 2003, DEVELOPMENT, V130, P4337, DOI 10.1242/dev.00660; Warren N, 1997, DEVELOPMENT, V124, P1573; Yamaguchi T, 2013, NEURON, V78, P537, DOI 10.1016/j.neuron.2013.02.035	75	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158210	10.1371/journal.pone.0158210	http://dx.doi.org/10.1371/journal.pone.0158210			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27387288	Green Published, Green Submitted, gold			2022-12-27	WOS:000379811500015
J	Laramee, ME; Smolders, K; Hu, TT; Bronchti, G; Boire, D; Arckens, L				Laramee, Marie-Eve; Smolders, Katrien; Hu, Tjing-Tjing; Bronchti, Gilles; Boire, Denis; Arckens, Lutgarde			Congenital Anophthalmia and Binocular Neonatal Enucleation Differently Affect the Proteome of Primary and Secondary Visual Cortices in Mice	PLOS ONE			English	Article							VESICULAR GLUTAMATE TRANSPORTERS; CROSS-MODAL PLASTICITY; HEREDITARY HYPOTROPHIC AXONOPATHY; ETHYLMALEIMIDE-SENSITIVE FACTOR; GEL-ELECTROPHORESIS; CALLOSAL CONNECTIONS; MASS-SPECTROMETRY; OCULAR DOMINANCE; STRIATE CORTEX; CORTICOCORTICAL CONNECTIONS	In blind individuals, visually deprived occipital areas are activated by non-visual stimuli. The extent of this cross-modal activation depends on the age at onset of blindness. Cross-modal inputs have access to several anatomical pathways to reactivate deprived visual areas. Ectopic cross-modal subcortical connections have been shown in anophthalmic animals but not in animals deprived of sight at a later age. Direct and indirect cross-modal cortical connections toward visual areas could also be involved, yet the number of neurons implicated is similar between blind mice and sighted controls. Changes at the axon terminal, dendritic spine or synaptic level are therefore expected upon loss of visual inputs. Here, the proteome of V1, V2M and V2L from P0-enucleated, anophthalmic and sighted mice, sharing a common genetic background (C57BL/6J x ZRDCT/An), was investigated by 2-D DIGE and Western analyses to identify molecular adaptations to enucleation and/or anophthalmia. Few proteins were differentially expressed in enucleated or anophthalmic mice in comparison to sighted mice. The loss of sight affected three pathways: metabolism, synaptic transmission and morphogenesis. Most changes were detected in V1, followed by V2M. Overall, cross-modal adaptations could be promoted in both models of early blindness but not through the exact same molecular strategy. A lower metabolic activity observed in visual areas of blind mice suggests that even if cross-modal inputs reactivate visual areas, they could remain suboptimally processed.	[Laramee, Marie-Eve; Smolders, Katrien; Hu, Tjing-Tjing; Arckens, Lutgarde] Katholieke Univ Leuven, Lab Neuroplast & Neuroprote, B-3000 Leuven, Belgium; [Bronchti, Gilles; Boire, Denis] Univ Quebec Trois Rivieres, Dept Anat, Quebec City, PQ, Canada; [Boire, Denis] Univ Montreal, Ecole Optometrie, Quebec City, PQ, Canada	KU Leuven; University of Quebec; University of Quebec Trois Rivieres; Universite de Montreal	Arckens, L (corresponding author), Katholieke Univ Leuven, Lab Neuroplast & Neuroprote, B-3000 Leuven, Belgium.	Lut.Arckens@bio.kuleuven.be	Boire, Denis/I-4530-2019; Arckens, Lutgarde/C-3822-2016	Boire, Denis/0000-0001-5614-4976; Arckens, Lutgarde/0000-0002-2909-8449; Laramee, Marie-Eve/0000-0003-0896-6224	Alexander Graham Bell (BESC) [D3 - 378965 - 2009]; Michael Smith Foreign Study Supplements Program [2010-403534]; KU Leuven F+ postdoctoral fellowship [F+/12/006]; Fonds de Recherche du Quebec en Sante postdoctoral fellowship [FF6-14P-27498]; Agency for Innovation through Science and Technology Flanders [101421]; KU Leuven Research Council grant; National Science and Engineering Research Council of Canada (NSERC) grants; Canadian Foundation for Innovation grant	Alexander Graham Bell (BESC); Michael Smith Foreign Study Supplements Program; KU Leuven F+ postdoctoral fellowship; Fonds de Recherche du Quebec en Sante postdoctoral fellowship; Agency for Innovation through Science and Technology Flanders; KU Leuven Research Council grant; National Science and Engineering Research Council of Canada (NSERC) grants; Canadian Foundation for Innovation grant	This work was funded by an Alexander Graham Bell (BESC D3 - 378965 - 2009, http://www.nserc-crsng.gc.ca) doctoral scholarship to MEL; Michael Smith Foreign Study Supplements Program (2010-403534, http://www.nserc-crsng.gc.ca) to MEL; KU Leuven F+ postdoctoral fellowship (F+/12/006, http://www.kuleuven.be) to MEL; Fonds de Recherche du Quebec en Sante (FF6-14P-27498, http://www.frqs.gouv.qc.ca) postdoctoral fellowship to MEL; doctoral scholarship from the Agency for Innovation through Science and Technology Flanders (101421, http://www.iwt.be) to KS; KU Leuven Research Council (https://admin.kuleuven.be/raden/en/research-council) grant to LA; National Science and Engineering Research Council of Canada (NSERC) grants (http://www.nserc-crsng.gc.ca) to DB and GB; Institutional support from UQTR (www.uqtr.ca) to DB and GB; and Canadian Foundation for Innovation grant (CFI Leader, http://www.innovation.ca/en) to DB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel PL, 1996, NEUROSCI LETT, V204, P169, DOI 10.1016/0304-3940(96)12359-4; Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; Allman BL, 2008, CEREB CORTEX, V18, P2066, DOI 10.1093/cercor/bhm230; Allman BL, 2007, J NEUROPHYSIOL, V98, P545, DOI 10.1152/jn.00173.2007; Allman BL, 2009, BRAIN TOPOGR, V21, P157, DOI 10.1007/s10548-009-0088-3; Araki Y, 2010, P NATL ACAD SCI USA, V107, P11080, DOI 10.1073/pnas.1006584107; Asada H, 1997, P NATL ACAD SCI USA, V94, P6496, DOI 10.1073/pnas.94.12.6496; Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; Beston Brett R, 2010, Front Synaptic Neurosci, V2, P138, DOI 10.3389/fnsyn.2010.00138; Bravo Hermes, 1994, Biological Research, V27, P73; Bridge H, 2009, BRAIN, V132, P3467, DOI 10.1093/brain/awp279; Bronchti G, 2002, EUR J NEUROSCI, V16, P311, DOI 10.1046/j.1460-9568.2002.02063.x; Budinger E, 2006, NEUROSCIENCE, V143, P1065, DOI 10.1016/j.neuroscience.2006.08.035; Budinger E, 2000, EUR J NEUROSCI, V12, P2425, DOI 10.1046/j.1460-9568.2000.00142.x; Budinger E, 2008, BRAIN RES, V1220, P2, DOI 10.1016/j.brainres.2007.07.084; Burton H, 2002, J NEUROPHYSIOL, V88, P3359, DOI 10.1152/jn.00129.2002; Burton H, 2002, J NEUROPHYSIOL, V87, P589, DOI 10.1152/jn.00285.2001; Butts DA, 2001, J NEUROSCI, V21, P961, DOI 10.1523/JNEUROSCI.21-03-00961.2001; Butts DA, 2007, PLOS BIOL, V5, P651, DOI 10.1371/journal.pbio.0050061; Campi KL, 2010, CEREB CORTEX, V20, P89, DOI 10.1093/cercor/bhp082; CAVINESS VS, 1975, J COMP NEUROL, V164, P247, DOI 10.1002/cne.901640207; Chabot N, 2008, NEUROSCI LETT, V433, P129, DOI 10.1016/j.neulet.2008.01.003; Chabot N, 2007, EUR J NEUROSCI, V26, P2334, DOI 10.1111/j.1460-9568.2007.05854.x; Charbonneau V, 2012, EUR J NEUROSCI, V36, P2949, DOI 10.1111/j.1460-9568.2012.08215.x; Chase HB, 1941, J MORPHOL, V68, P279, DOI 10.1002/jmor.1050680205; Chow AM, 2011, INT J DEV NEUROSCI, V29, P25, DOI 10.1016/j.ijdevneu.2010.10.002; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; Clavagnier S, 2004, COGN AFFECT BEHAV NE, V4, P117, DOI 10.3758/CABN.4.2.117; Cnops L, 2006, BRAIN RES, V1088, P109, DOI 10.1016/j.brainres.2006.03.028; Cohen LG, 1999, ANN NEUROL, V45, P451, DOI 10.1002/1531-8249(199904)45:4<451::AID-ANA6>3.0.CO;2-B; Dahlhaus M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005413; DORON N, 1994, NEUROREPORT, V5, P2697, DOI 10.1097/00001756-199412000-00072; ESCLAPEZ M, 1994, J NEUROSCI, V14, P1834, DOI 10.1523/JNEUROSCI.14-03-01834.1994; Falchier A, 2002, J NEUROSCI, V22, P5749; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Frost DO, 2000, P NATL ACAD SCI USA, V97, P11068, DOI 10.1073/pnas.190179997; Fujiyama F, 2001, J COMP NEUROL, V435, P379, DOI 10.1002/cne.1037; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Gitler D, 2008, J NEUROSCI, V28, P10835, DOI 10.1523/JNEUROSCI.0924-08.2008; Goel A, 2006, NAT NEUROSCI, V9, P1001, DOI 10.1038/nn1725; Goshima Y, 2000, JPN J PHARMACOL, V82, P273, DOI 10.1254/jjp.82.273; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; Gu YJ, 2000, J BIOL CHEM, V275, P17917, DOI 10.1074/jbc.C000179200; He KW, 2012, J NEUROSCI, V32, P8469, DOI 10.1523/JNEUROSCI.1424-12.2012; HEIL P, 1991, NEUROREPORT, V2, P735, DOI 10.1097/00001756-199112000-00001; Heimel JA, 2008, GENES BRAIN BEHAV, V7, P915, DOI 10.1111/j.1601-183X.2008.00431.x; Henschke JU, 2014, BRAIN STRUCT FUNCT; Hirokawa J, 2008, NEUROSCIENCE, V153, P1402, DOI 10.1016/j.neuroscience.2008.01.011; HOFFMAN PN, 1984, J CELL BIOL, V99, P705, DOI 10.1083/jcb.99.2.705; HOFFMAN PN, 1987, P NATL ACAD SCI USA, V84, P3472, DOI 10.1073/pnas.84.10.3472; Hu TT, 2011, CEREB CORTEX, V21, P2883, DOI 10.1093/cercor/bhr079; Huang Y, 2005, NEURON, V46, P533, DOI 10.1016/j.neuron.2005.03.028; Izraeli R, 2002, EUR J NEUROSCI, V15, P693, DOI 10.1046/j.1460-9568.2002.01902.x; JOHNSON JL, 1972, BRAIN RES, V45, P205; Kahn DM, 2000, J COMP NEUROL, V428, P337; Kahn DM, 2002, P NATL ACAD SCI USA, V99, P11429, DOI 10.1073/pnas.162342799; Kaneko T, 2002, NEUROSCI RES, V42, P243, DOI 10.1016/S0168-0102(02)00009-3; Kaneko T, 2002, J COMP NEUROL, V444, P39, DOI 10.1002/cne.10129; Kanold PO, 2010, ANNU REV NEUROSCI, V33, P23, DOI 10.1146/annurev-neuro-060909-153244; Karlen SJ, 2006, NEUROSCIENCE, V142, P843, DOI 10.1016/j.neuroscience.2006.06.055; Kimura T, 2005, J NEUROCHEM, V93, P1371, DOI 10.1111/j.1471-4159.2005.03063.x; Klinge C, 2010, J NEUROSCI, V30, P12798, DOI 10.1523/JNEUROSCI.2384-10.2010; Laeremans A, 2013, J EXP NEUROSCI, V7, P60, DOI 10.4137/JEN.S12453; Laing RJ, 2012, J COMP NEUROL; Laramee ME, 2013, CEREB CORTEX, V23, P714, DOI 10.1093/cercor/bhs060; Laramee ME, 2011, EUR J NEUROSCI, V34, P65, DOI 10.1111/j.1460-9568.2011.07732.x; Laramee ME, 2014, BRAIN STRUCT FUNCT, V219, P2051, DOI 10.1007/s00429-013-0623-6; Larsen DD, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.030.2009; Laskowska-Macios K, 2014, CEREB CORTEX; Laskowska-Macios K, 2015, DEV NEUROBIOL UNPUB; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Lequeux L, 2008, CLIN GENET, V74, P392, DOI 10.1111/j.1399-0004.2008.01078.x; Linden ML, 2009, NAT NEUROSCI, V12, P390, DOI 10.1038/nn.2284; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Macaluso E, 2006, NEUROSCIENTIST, V12, P327, DOI 10.1177/1073858406287908; Masse IO, 2014, BRAIN RES, V1588, P113, DOI 10.1016/j.brainres.2014.09.025; MIZUTANI M, 1992, J HERED, V83, P234, DOI 10.1093/oxfordjournals.jhered.a111201; Moffett John R, 2013, Front Neuroenergetics, V5, P11, DOI 10.3389/fnene.2013.00011; Nakamura F, 2000, J NEUROBIOL, V44, P219, DOI 10.1002/1097-4695(200008)44:2<219::AID-NEU11>3.0.CO;2-W; Nakamura K, 2005, J COMP NEUROL, V492, P263, DOI 10.1002/cne.20705; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; Nys J, 2015, J NEUROSCI IN PRESS; Nys J, 2014, J COMP NEUROL, V522, P950, DOI 10.1002/cne.23455; OLAVARRIA J, 1988, ANAT EMBRYOL, V178, P155, DOI 10.1007/BF02463649; OLAVARRIA J, 1987, J COMP NEUROL, V260, P321, DOI 10.1002/cne.902600302; OLAVARRIA J, 1988, J COMP NEUROL, V270, P575, DOI 10.1002/cne.902700411; OLAVARRIA JF, 1995, J COMP NEUROL, V361, P138, DOI 10.1002/cne.903610111; OLAVARRIA JF, 1995, J COMP NEUROL, V363, P161, DOI 10.1002/cne.903630202; PALAIOLOGOS G, 1988, J NEUROCHEM, V51, P317, DOI 10.1111/j.1471-4159.1988.tb04872.x; PALAIOLOGOS G, 1989, NEUROCHEM RES, V14, P359, DOI 10.1007/BF01000039; PALLAS SL, 1993, J COMP NEUROL, V337, P317, DOI 10.1002/cne.903370212; PAPERNA T, 1991, J COMP NEUROL, V308, P432, DOI 10.1002/cne.903080310; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; Paxinos G, 2012, MOUSE BRAIN STEREOTA; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Piche M, 2007, NEUROSCIENCE, V145, P1144, DOI 10.1016/j.neuroscience.2006.12.050; Piche M, 2004, EUR J NEUROSCI, V20, P3463, DOI 10.1111/j.1460-9568.2004.03823.x; RHOADES RW, 1984, EXP BRAIN RES, V56, P92; Rittenhouse CD, 2006, J NEUROPHYSIOL, V95, P2947, DOI 10.1152/jn.01328.2005; Rockland KS, 2003, INT J PSYCHOPHYSIOL, V50, P19, DOI 10.1016/S0167-8760(03)00121-1; ROE AW, 1990, SCIENCE, V250, P818, DOI 10.1126/science.2237432; ROE AW, 1992, J NEUROSCI, V12, P3651; Rossi FM, 2001, P NATL ACAD SCI USA, V98, P6453, DOI 10.1073/pnas.101120998; Sadato N, 2002, NEUROIMAGE, V16, P389, DOI 10.1006/nimg.2002.1111; Santoni V, 2000, ELECTROPHORESIS, V21, P1054, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1054::AID-ELPS1054>3.3.CO;2-#; Schousboe A, 2014, ADV NEUROBIOL, V11, P13, DOI 10.1007/978-3-319-08894-5_2; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; Sheykholeslami K, 2001, HEARING RES, V159, P117, DOI 10.1016/S0378-5955(01)00326-4; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; STRYKER MP, 1986, J NEUROSCI, V6, P2117; SUR M, 1988, SCIENCE, V242, P1437, DOI 10.1126/science.2462279; Tan S, 2008, PROTEOMICS, V8, P3924, DOI 10.1002/pmic.200800597; Tannu NS, 2006, NAT PROTOC, V1, P1732, DOI 10.1038/nprot.2006.256; TOLDI J, 1994, NEUROSCIENCE, V62, P105, DOI 10.1016/0306-4522(94)90318-2; TOLDI J, 1988, NEUROSCIENCE, V24, P59, DOI 10.1016/0306-4522(88)90311-9; Tucker P, 2001, GENESIS, V31, P43, DOI 10.1002/gene.10003; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; Van Brussel L, 2011, CEREB CORTEX, V21, P2133, DOI 10.1093/cercor/bhq286; Van den Bergh G, 2003, ELECTROPHORESIS, V24, P1471, DOI 10.1002/elps.200390189; Van den Bergh G, 2003, J NEUROCHEM, V85, P193, DOI 10.1046/j.1471-4159.2003.01668.x; Van den Bergh G, 2006, PROTEOMICS, V6, P3821, DOI 10.1002/pmic.200500570; Van Hove I, 2015, DEV NEUROBIOL; Verma AS, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-47; Wallace MT, 2004, P NATL ACAD SCI USA, V101, P2167, DOI 10.1073/pnas.0305697101; Wang QX, 2007, J COMP NEUROL, V502, P339, DOI 10.1002/cne.21286; Wang WF, 2005, JPN J OPHTHALMOL, V49, P6, DOI 10.1007/s10384-004-0146-z; Warland DK, 2006, J NEUROSCI, V26, P5190, DOI 10.1523/JNEUROSCI.0328-06.2006; Watkins KE, 2012, BRAIN, V135, P1566, DOI 10.1093/brain/aws067; Whitt JL, 2014, NEUROPHARMACOLOGY, V78, P45, DOI 10.1016/j.neuropharm.2013.02.016; Willems E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094902; Wu CC, 2003, NAT BIOTECHNOL, V21, P262, DOI 10.1038/nbt0303-262; Wu LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080073; Yaka R, 2000, EXP BRAIN RES, V131, P144, DOI 10.1007/s002219900295; Yaka R, 1999, EUR J NEUROSCI, V11, P1301, DOI 10.1046/j.1460-9568.1999.00536.x; YAMASAKI H, 1991, ACTA NEUROPATHOL, V82, P427, DOI 10.1007/BF00293376; YAMASAKI H, 1992, LAB INVEST, V66, P734	137	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159320	10.1371/journal.pone.0159320	http://dx.doi.org/10.1371/journal.pone.0159320			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410964	gold, Green Published, Green Submitted			2022-12-27	WOS:000379508300079
J	Martin, JL				Martin, Jack L.			Validation of Reference Genes for Oral Cancer Detection Panels in a Prospective Blinded Cohort	PLOS ONE			English	Article							BIOMARKERS; SALIVA	Background Reference genes are needed as internal controls to determine relative expression for clinical application of gene expression panels. Candidate constitutively expressed genes must be validated as suitable reference genes in each body fluid and disease entity. Prior studies have predominantly validated oral squamous cell carcinoma associated messenger RNAs (mRNAs) based on quantitative polymerase chain reaction (qPCR) quantification cycle (Cq) values without adjustment for housekeeping genes. Methods One hundred sixty eight patients had saliva collected before clinically driven biopsy of oral lesions suspicious for cancer. Seven potential housekeeping mRNAs and six pre-specified oral cancer associated mRNAs were measured with qPCR by personnel blinded to tissue diagnosis. Housekeeping gene stability was determined with the NormFinder program in a training set of 12 randomly selected cancer and 24 control patients. Genes with stability indices <0.02 were then tested in the validation set consisting of the remaining cancer and control patients and were further validated by the geNorm program. Cancer gene delta Cqs were compared in case and control patients after subtracting the geometric mean of the reference gene raw Cqs. Results B2M and UBC had stability indices >0.02 in the training set and were not further tested. MT-ATP6, RPL30, RPL37A, RPLP0 and RPS17 all had stability indices <0.02 in the training set and in the verification set. The geNorm M values were all <= 1.10. All six pre-specified cancer genes (IL8, IL1, SAT, OAZ1, DUSP1 and S100P) were up-regulated in cancer versus control patients with from nearly twofold to over threefold higher levels (p<0.01 for all based on delta Cq values). Conclusions Five reference genes are validated for use in oral cancer salivary gene expression panels. Six pre-specified oral carcinoma associated genes are demonstrated to be highly significantly up-regulated in cancer patients based on delta Cq values. These cancer and reference genes are suitable for inclusion in gene expression panels for research and clinical applications.	[Martin, Jack L.] Sharpe Strumia Res Fdn, 130 South Bryn Mawr Ave, Bryn Mawr, PA 19010 USA; [Martin, Jack L.] PeriRx LLC, 370 Reed Rd,Suite 200, Broomall, PA 19008 USA		Martin, JL (corresponding author), Sharpe Strumia Res Fdn, 130 South Bryn Mawr Ave, Bryn Mawr, PA 19010 USA.; Martin, JL (corresponding author), PeriRx LLC, 370 Reed Rd,Suite 200, Broomall, PA 19008 USA.	Martinj@mlhs.org			PeriRx, LLC, Broomall, Pennsylvania; Delta Dental of Michigan Research and Data Institute, Okemos, MI	PeriRx, LLC, Broomall, Pennsylvania; Delta Dental of Michigan Research and Data Institute, Okemos, MI	This work was supported by PeriRx, LLC, 370 Reed Road, suite 200, Broomall, Pennsylvania 19008; and Delta Dental of Michigan Research and Data Institute, 4100 Okemos Rd., Okemos, MI 48864. The funder provided support in the form of salary for author JLM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Brinkmann O, 2011, ORAL ONCOL, V47, P51, DOI 10.1016/j.oraloncology.2010.10.009; Cameron RC, 2013, APIDOLOGIE, V44, P357, DOI 10.1007/s13592-012-0187-0; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Elashoff D, 2012, CANCER EPIDEM BIOMAR, V21, P664, DOI 10.1158/1055-9965.EPI-11-1093; Gao K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005875; Hu S, 2007, ARTHRITIS RHEUM-US, V56, P3588, DOI 10.1002/art.22954; Hu S, 2010, ARTHRIT CARE RES, V62, P1633, DOI 10.1002/acr.20289; Lee YH, 2011, CLIN CHEM, V57, P1295, DOI 10.1373/clinchem.2010.159210; Li Y, 2004, CLIN CANCER RES, V10, P8442, DOI 10.1158/1078-0432.CCR-04-1167; Martin JL, 2015, COMPEND CONTIN ED DE, V36; McCulloch RS, 2012, J ANIM SCI BIOTECHNO, V3, DOI 10.1186/2049-1891-3-36; Pepe MS, 2008, J NATL CANCER I, V100, P1432, DOI 10.1093/jnci/djn326; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wei F, 2009, CLIN CANCER RES, V15, P4446, DOI 10.1158/1078-0432.CCR-09-0050; Wong DT, 2008, AM SCI, V96, P37, DOI 10.1511/2008.69.3669; Zhang L, 2012, CELL MOL LIFE SCI, V69, P3341, DOI 10.1007/s00018-012-1027-0; Zhang L, 2010, GASTROENTEROLOGY, V138, P949, DOI 10.1053/j.gastro.2009.11.010	18	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158462	10.1371/journal.pone.0158462	http://dx.doi.org/10.1371/journal.pone.0158462			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27411053	gold, Green Published, Green Submitted			2022-12-27	WOS:000379508300025
J	Suzuki, K; Arumugam, S; Yokoyama, J; Kawauchi, Y; Honda, Y; Sato, H; Aoyagi, Y; Terai, S; Okazaki, K; Suzuki, Y; Mizumoto, S; Sugahara, K; Atreya, R; Neurath, MF; Watanabe, K; Hashiguchi, T; Yoneyama, H; Asakura, H				Suzuki, Kenji; Arumugam, Somasundaram; Yokoyama, Junji; Kawauchi, Yusuke; Honda, Yutaka; Sato, Hiroki; Aoyagi, Yutaka; Terai, Shuji; Okazaki, Kazuichi; Suzuki, Yasuo; Mizumoto, Shuji; Sugahara, Kazuyuki; Atreya, Raja; Neurath, Markus F.; Watanabe, Kenichi; Hashiguchi, Taishi; Yoneyama, Hiroyuki; Asakura, Hitoshi			Pivotal Role of Carbohydrate Sulfotransferase 15 in Fibrosis and Mucosal Healing in Mouse Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CHONDROITIN-SULFATE-E; CROHNS-DISEASE; THERAPY; LIVER; IBD	Induction of mucosal healing (MH) is an important treatment goal in inflammatory bowel disease (IBD). Although the molecular mechanisms underlying MH in IBD is not fully explored, local fibrosis would contribute to interfere mucosal repair. Carbohydrate sulfotransferase 15 (CHST15), which catalyzes sulfation of chondroitin sulfate to produce rare E-disaccharide units, is a novel mediator to create local fibrosis. Here we have used siRNA-based approach of silencing CHST15 in dextran sulfate sodium (DSS) induced colitis in mice, human colon fibroblasts and cancer cell lines. In a DSS-induced acute colitis model, CHST15 siRNA reduced CHST15 mRNA in the colon, serum IL-6, disease activity index (DAI) and accumulation of F4/80(+) macrophages and ER-TR7(+) fibroblasts, while increased Ki-67(+) epithelial cells. In DSS-induced chronic colitis models, CHST15 siRNA reduced CHST15 mRNA in the colon, DAI, alpha-smooth muscle actin(+) fibroblasts and collagen deposition, while enhanced MH as evidenced by reduced histological and endoscopic scores. We also found that endoscopic submucosal injection achieved effective pancolonic delivery of CHST15 siRNA in mice. In human CCD-18 Co cells, CHST15 siRNA inhibited the expression of CHST15 mRNA and selectively reduced E-units, a specific product biosynthesized by CHST15, in the culture supernatant. CHST15 siRNA significantly suppressed vimentin in both TGF-beta-stimulated CCD18-Co cells and HCT116 cells while up-regulated BMP7 and Ecadherin in HCT116 cells. The present study demonstrated that blockade CHST15 represses colonic fibrosis and enhances MH partly though reversing EMT pathway, illustrating a novel therapeutic opportunity to refractory and fibrotic lesions in IBD.	[Suzuki, Kenji; Yokoyama, Junji; Kawauchi, Yusuke; Honda, Yutaka; Sato, Hiroki; Aoyagi, Yutaka; Terai, Shuji; Asakura, Hitoshi] Niigata Univ, Med & Dent Hosp, Dept Gastroenterol, Niigata, Niigata, Japan; [Arumugam, Somasundaram; Watanabe, Kenichi] Niigata Univ Pharm & Appl Life Sci, Dept Clin Pharmacol, Niigata, Niigata, Japan; [Okazaki, Kazuichi] Kansai Med Univ, Dept Internal Med 3, Div Gastroenterol & Hepatol, Moriguchi, Osaka, Japan; [Suzuki, Yasuo] Toho Univ, Sakura Med Ctr, Internal Med, Sakura, Chiba, Japan; [Mizumoto, Shuji; Sugahara, Kazuyuki] Meijo Univ, Fac Pharm, Dept Pathobiochem, Nagoya, Aichi, Japan; [Sugahara, Kazuyuki] Hokkaido Univ, Grad Sch Life Sci, Lab Proteoglycan Signaling & Therapeut, Sapporo, Hokkaido, Japan; [Atreya, Raja; Neurath, Markus F.] Univ Erlangen Nurnberg, Dept Med 1, Erlangen, Bavaria, Germany; [Hashiguchi, Taishi; Yoneyama, Hiroyuki] Stelic Inst & Co Inc, Minato City, Tokyo, Japan	Niigata University; Niigata University; Kansai Medical University; Toho University; Meijo University; Hokkaido University; University of Erlangen Nuremberg	Suzuki, K (corresponding author), Niigata Univ, Med & Dent Hosp, Dept Gastroenterol, Niigata, Niigata, Japan.	kjsuzuki@med.niigata-u.ac.jp	Mizumoto, Shuji/F-8313-2018; Arumugam, S./AAT-7570-2020	Mizumoto, Shuji/0000-0002-4641-1505; Arumugam, Somasundaram/0000-0002-2096-2552	Japan Science and Technology Agency (JST) [AS117901G]	Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This work was supported by Japan Science and Technology Agency (JST - AS117901G). For additional experiments for revision, the authors received no specific funding.	Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X; Colombel JF, 2010, NEW ENGL J MED, V362, P1383, DOI 10.1056/NEJMoa0904492; D'Angelo F, 2013, CLIN EXP IMMUNOL, V174, P60, DOI 10.1111/cei.12157; Daperno M, 2004, GASTROINTEST ENDOSC, V60, P505, DOI 10.1016/S0016-5107(04)01878-4; de Bruyn JR, 2015, J CROHNS COLITIS, V9, P966, DOI 10.1093/ecco-jcc/jjv133; de Chambrun GP, 2010, NAT REV GASTRO HEPAT, V7, P15, DOI 10.1038/nrgastro.2009.203; Flier SN, 2010, J BIOL CHEM, V285, P20202, DOI 10.1074/jbc.M110.102012; Friedman SL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004700; Fujii M, 2013, MED MOL MORPHOL, V46, P141, DOI 10.1007/s00795-013-0016-1; Habuchi O, 2002, ANAL BIOCHEM, V310, P129, DOI 10.1016/S0003-2697(02)00277-4; Hanawa T, 2006, J GENE MED, V8, P623, DOI 10.1002/jgm.880; Iacucci Marietta, 2011, Therap Adv Gastroenterol, V4, P129, DOI 10.1177/1756283X11398930; Kai Y, 2007, MED MOL MORPHOL, V40, P128, DOI 10.1007/s00795-007-0370-y; Kakushima N, 2006, ENDOSCOPY, V38, P412, DOI 10.1055/s-2006-925166; Kiryu H, 2011, BIOINFORMATICS, V27, P1788, DOI 10.1093/bioinformatics/btr276; Levesque BG, 2015, GASTROENTEROLOGY, V148, P37, DOI 10.1053/j.gastro.2014.08.003; Mizumoto S, 2015, CURR OPIN STRUC BIOL, V34, P35, DOI 10.1016/j.sbi.2015.06.004; Mizumoto S, 2012, METHODS MOL BIOL, V836, P99, DOI 10.1007/978-1-61779-498-8_7; Neurath MF, 2012, GUT, V61, P1619, DOI 10.1136/gutjnl-2012-302830; Ohtake S, 2008, BBA-GEN SUBJECTS, V1780, P687, DOI 10.1016/j.bbagen.2008.01.004; Pariente B, 2011, INFLAMM BOWEL DIS, V17, P1415, DOI 10.1002/ibd.21506; Ren SY, 2013, P NATL ACAD SCI USA, V110, P1440, DOI 10.1073/pnas.1211179110; Rieder F, 2009, NAT REV GASTRO HEPAT, V6, P228, DOI 10.1038/nrgastro.2009.31; Sasaki S, 2002, EUR J IMMUNOL, V32, P3197, DOI 10.1002/1521-4141(200211)32:11<3197::AID-IMMU3197>3.0.CO;2-1; Suzuki K, 2011, PATHOL INT, V61, P228, DOI 10.1111/j.1440-1827.2011.02647.x; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Watanabe K, 2015, CELL SIGNAL, V27, P1517, DOI 10.1016/j.cellsig.2015.03.004; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Yamada Shuhei, 2008, Curr Drug Discov Technol, V5, P289; Yoneyama H, 2001, J EXP MED, V193, P35, DOI 10.1084/jem.193.1.35; Yu RZ, 2002, ANAL BIOCHEM, V304, P19, DOI 10.1006/abio.2002.5576	31	25	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158967	10.1371/journal.pone.0158967	http://dx.doi.org/10.1371/journal.pone.0158967			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410685	Green Published, gold, Green Submitted			2022-12-27	WOS:000379508300045
J	Huang, LJ; Minematsu, T; Kitamura, A; Quinetti, PC; Nakagami, G; Mugita, Y; Oe, M; Noguchi, H; Mori, T; Sanada, H				Huang, Lijuan; Minematsu, Takeo; Kitamura, Aya; Quinetti, Paes C.; Nakagami, Gojiro; Mugita, Yuko; Oe, Makoto; Noguchi, Hiroshi; Mori, Taketoshi; Sanada, Hiromi			Topical Administration of Acylated Homoserine Lactone Improves Epithelialization of Cutaneous Wounds in Hyperglycaemic Rats	PLOS ONE			English	Article							KERATINOCYTE MIGRATION; GENE-EXPRESSION; IV COLLAGEN; MATRIX; LAMININ-5; ULCERS; DIFFERENTIATION; FIBRONECTIN; RESPONSES; RECEPTOR	Clinicians often experience delayed epithelialization in diabetic patients, for which a high glucose condition is one of the causes. However, the mechanisms underlying delayed wound closure have not been fully elucidated, and effective treatments to enhance epithelialization in patients with hyperglycaemia have not been established. Here we propose a new reagent, acylated homoserine lactone (AHL), to improve the delayed epithelialization due to the disordered formation of a basement membrane of epidermis in hyperglycaemic rats. Acute hyperglycaemia was induced by streptozotocin injection in this experiment. Full thickness wounds were created on the flanks of hyperglycaemic or control rats. Histochemical and immunohistochemical analyses were performed to identify hyperglycaemia-specific abnormalities in epidermal regeneration by comparison between groups. We then examined the effects of AHL on delayed epithelialization in hyperglycaemic rats. Histological analysis showed the significantly shorter epithelializing tissue (P < 0.05), abnormal structure of basement membrane (fragmentation and immaturity), and hypo-and hyperproliferation of basal keratinocytes in hyperglycaemic rats. Treating the wound with AHL resulted in the decreased abnormalities of basement membrane, normal distribution of proliferating epidermal keratinocytes, and significantly promoted epithelialization (P < 0.05) in hyperglycemic rats, suggesting the improving effects of AHL on abnormal epithelialization due to hyperglycemia.	[Huang, Lijuan; Minematsu, Takeo; Kitamura, Aya; Quinetti, Paes C.; Nakagami, Gojiro; Mugita, Yuko; Sanada, Hiromi] Univ Tokyo, Grad Sch Med, Dept Gerontol Nursing Wound Care Management, Hongo, Tokyo, Japan; [Oe, Makoto] Univ Tokyo, Grad Sch Med, Dept Adv Nursing Technol, Hongo, Tokyo, Japan; [Noguchi, Hiroshi; Mori, Taketoshi] Univ Tokyo, Grad Sch Med, Dept Life Support Technol Molten, Hongo, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Minematsu, T; Sanada, H (corresponding author), Univ Tokyo, Grad Sch Med, Dept Gerontol Nursing Wound Care Management, Hongo, Tokyo, Japan.	tminematsu-tky@umin.ac.jp; hsanada-tky@umin.ac.jp	Noguchi, Hiroshi/GQI-0676-2022; Minematsu, Takeo/AAH-7406-2020; Nakagami, Gojiro/V-9093-2019; Mori, Taketoshi/E-3849-2016	Noguchi, Hiroshi/0000-0002-5303-5210; Minematsu, Takeo/0000-0001-5859-7290; Nakagami, Gojiro/0000-0002-9650-2464; Mori, Taketoshi/0000-0002-7208-6435; Mugita, Yuko/0000-0003-4964-7107				Antunes LCM, 2010, MICROBIOL-SGM, V156, P2271, DOI 10.1099/mic.0.038794-0; Berlowitz DR, 2007, J AM MED DIR ASSOC, V8, pS37, DOI 10.1016/j.jamda.2006.12.029; CARTER WG, 1991, CELL, V65, P599, DOI 10.1016/0092-8674(91)90092-D; Cooley MA, 2010, MICROBES INFECT, V12, P231, DOI 10.1016/j.micinf.2009.12.009; Demerjian M, 2006, EXP DERMATOL, V15, P154, DOI 10.1111/j.1600-0625.2006.00402.x; Gorecki C, 2009, J AM GERIATR SOC, V57, P1175, DOI 10.1111/j.1532-5415.2009.02307.x; Hamill KJ, 2005, CLIN EXP DERMATOL, V30, P398, DOI 10.1111/j.1365-2230.2005.01842.x; Han H, 2002, PLAST RECONSTR SURG, V110, P118, DOI 10.1097/00006534-200207000-00021; Hughes DT, 2008, NAT REV MICROBIOL, V6, P111, DOI 10.1038/nrmicro1836; Ibuki A, 2012, EXP DERMATOL, V21, P178, DOI 10.1111/j.1600-0625.2011.01409.x; Jahoor A, 2008, J BACTERIOL, V190, P4408, DOI 10.1128/JB.01444-07; Kessler L, 2003, DIABETES CARE, V26, P2378, DOI 10.2337/diacare.26.8.2378; KIM JP, 1994, LAB INVEST, V71, P401; KOLBE M, 1990, CONNECT TISSUE RES, V25, P77, DOI 10.3109/03008209009009814; Lan CCE, 2008, BRIT J DERMATOL, V159, P1103, DOI 10.1111/j.1365-2133.2008.08789.x; Lerman OZ, 2003, AM J PATHOL, V162, P303, DOI 10.1016/S0002-9440(10)63821-7; Loots MAM, 1998, J INVEST DERMATOL, V111, P850, DOI 10.1046/j.1523-1747.1998.00381.x; Maruyama K, 2007, AM J PATHOL, V170, P1178, DOI 10.2353/ajpath.2007.060018; Minematsu T, 2012, BIOL RES NURS, V14, P242, DOI 10.1177/1099800411410870; Motzkau M, 2011, EXP CLIN ENDOCR DIAB, V119, P286, DOI 10.1055/s-0030-1267235; Nakagami G, 2011, FEMS IMMUNOL MED MIC, V62, P157, DOI 10.1111/j.1574-695X.2011.00796.x; Natarajan E, 2006, AM J PATHOL, V168, P1821, DOI 10.2353/ajpath.2006.051027; Orgill DP, 2011, PLAST RECONSTR SURG, V127, p105S, DOI 10.1097/PRS.0b013e318200a427; Paes C, 2012, BIOCHEM BIOPH RES CO, V427, P273, DOI 10.1016/j.bbrc.2012.09.037; Paolisso Giuseppe, 2010, Acta Biomed, V81 Suppl 1, P47; Qiu ZY, 2007, J SURG RES, V138, P64, DOI 10.1016/j.jss.2006.06.034; ROUSSELLE P, 1991, J CELL BIOL, V114, P567, DOI 10.1083/jcb.114.3.567; Sakaguchi K., 1996, J KYUSHU DENT SOC, V50, P332; Santoro MM, 2005, EXP CELL RES, V304, P274, DOI 10.1016/j.yexcr.2004.10.033; Schenk S, 2003, J CELL BIOL, V161, P197, DOI 10.1083/jcb.200208145; Sullivan SR, 2007, J DERMATOL SCI, V48, P177, DOI 10.1016/j.jdermsci.2007.07.002; TINOIS E, 1987, ARCH DERMATOL RES, V279, P241, DOI 10.1007/BF00417322; Ueda K, 2010, J WOUND CARE, V19, P295; Usui ML, 2008, J HISTOCHEM CYTOCHEM, V56, P687, DOI 10.1369/jhc.2008.951194; van Westerloo DJ, 2005, AM J PATHOL, V166, P721, DOI 10.1016/S0002-9440(10)62293-6; Yasuoka R., 1990, J OSAKA ODONTOL SOC, V53, P361; Zboralski D, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-215; Zins SR, 2010, ANGIOGENESIS, V13, P293, DOI 10.1007/s10456-010-9186-9	38	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0158647	10.1371/journal.pone.0158647	http://dx.doi.org/10.1371/journal.pone.0158647			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27404587	gold, Green Submitted, Green Published			2022-12-27	WOS:000379508200013
J	Wheeler, GM; Sweeting, MJ; Mander, AP				Wheeler, Graham M.; Sweeting, Michael J.; Mander, Adrian P.			AplusB: A Web Application for Investigating A plus B Designs for Phase I Cancer Clinical Trials	PLOS ONE			English	Article							CONTINUAL REASSESSMENT METHOD; ONCOLOGY	In phase I cancer clinical trials, the maximum tolerated dose of a new drug is often found by a dose-escalation method known as the A + B design. We have developed an interactive web application, AplusB, which computes and returns exact operating characteristics of A + B trial designs. The application has a graphical user interface (GUI), requires no programming knowledge and is free to access and use on any device that can open an internet browser. A customised report is available for download for each design that contains tabulated operating characteristics and informative plots, which can then be compared with other dose-escalation methods. We present a step-by-step guide on how to use this application and provide several illustrative examples of its capabilities.	[Wheeler, Graham M.; Mander, Adrian P.] Cambridge Inst Publ Hlth, MRC Biostat Unit Hub Trials Methodol Res, Cambridge, England; [Wheeler, Graham M.] UCL, Canc Res UK & UCL Canc Trials Ctr, London, England; [Sweeting, Michael J.] Univ Cambridge, Strangeways Res Lab, Cardiovasc Epidemiol Unit, Cambridge, England	MRC Biostatistics Unit; University of Cambridge; Cancer Research UK; University of London; University College London; University of Cambridge	Wheeler, GM (corresponding author), Cambridge Inst Publ Hlth, MRC Biostat Unit Hub Trials Methodol Res, Cambridge, England.; Wheeler, GM (corresponding author), UCL, Canc Res UK & UCL Canc Trials Ctr, London, England.	graham.wheeler@ucl.ac.uk	Sweeting, Michael John/U-3917-2019	Sweeting, Michael John/0000-0003-0980-8965	UK Medical Research Council [G0800860, MR/L003120/1]; European Research Council Advanced Investigator Award: EPIC-Heart [268834]; British Heart Foundation; Cambridge National Institute for Health Research Biomedical Research Centre; MRC [MC_UP_1302/2, MR/L003120/1, MC_UU_00002/3] Funding Source: UKRI; Medical Research Council [MR/L003120/1, MC_UU_00002/3, MC_UP_1302/2] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council Advanced Investigator Award: EPIC-Heart; British Heart Foundation(British Heart Foundation); Cambridge National Institute for Health Research Biomedical Research Centre(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	GMW and APM are supported by the UK Medical Research Council (www.mrc.ac.uk; grant number G0800860). MJS is supported by a European Research Council Advanced Investigator Award: EPIC-Heart (https://erc.europa.eu; grant number 268834), the UK Medical Research Council (grant number MR/L003120/1), the British Heart Foundation (www.bhf.org.uk), and the Cambridge National Institute for Health Research Biomedical Research Centre (http://www.cambridge-brc.org.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Babb JS, 2004, ADV CLIN TRIAL BIOST, P1; Carter SK, 1973, DESIGN CLIN TRIALS C, P242; Chang W, 2015, WEB APPLICATION FRAM; Chen ZJ, 2009, CONTEMP CLIN TRIALS, V30, P123, DOI 10.1016/j.cct.2008.10.006; Chiuzan C, 2015, CLIN TRIALS, V12, P24, DOI 10.1177/1740774514555585; Dignam J, 2006, ONCOLOGY EVIDENCE BA, P112; Gonen M, 2009, CLIN TRIALS, V6, P203, DOI 10.1177/1740774509105374; He W, 2014, METHODS AND APPLICAT, V1, P40; Iasonos A, 2008, CLIN TRIALS, V5, P465, DOI 10.1177/1740774508096474; Iasonos A, 2012, CLIN CANCER RES, V18, P5179, DOI 10.1158/1078-0432.CCR-12-0726; Jaki T, 2013, CLIN TRIALS, V10, P344, DOI 10.1177/1740774512474375; Ji Y, 2013, J CLIN ONCOL, V31, P1785, DOI 10.1200/JCO.2012.45.7903; Kang SH, 2001, DRUG INF J, V35, P1189, DOI 10.1177/009286150103500416; Le Tourneau C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051039; Le Tourneau C, 2009, JNCI-J NATL CANCER I, V101, P708, DOI 10.1093/jnci/djp079; Lin Y, 2001, Biostatistics, V2, P203, DOI 10.1093/biostatistics/2.2.203; National Cancer Institute, 2016, DICTIONARY OF CANCER; NCI, 2009, COMMON TOXICITY CRIT; O'Quigley J, 2006, BRIT J CANCER, V94, P609, DOI 10.1038/sj.bjc.6602969; Onar A, 2009, J BIOPHARM STAT, V19, P437, DOI 10.1080/10543400902800486; Onar-Thomas A, 2010, CONTEMP CLIN TRIALS, V31, P259, DOI 10.1016/j.cct.2010.03.006; Penel Nicolas, 2009, Invest New Drugs, V27, P552, DOI 10.1007/s10637-008-9213-5; Reiner E, 1999, COMPUT STAT DATA AN, V30, P303, DOI 10.1016/S0167-9473(98)00095-4; Rogatko A, 2007, J CLIN ONCOL, V25, P4982, DOI 10.1200/JCO.2007.12.1012; Skolnik JM, 2008, J CLIN ONCOL, V26, P190, DOI 10.1200/JCO.2007.12.7712; STORER BE, 1989, BIOMETRICS, V45, P925, DOI 10.2307/2531693; Sweeting M, 2013, J STAT SOFTW, V54, DOI 10.18637/jss.v054.i13; Yuan Y, 2011, STAT MED, V30, P2098, DOI 10.1002/sim.4164	29	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0159026	10.1371/journal.pone.0159026	http://dx.doi.org/10.1371/journal.pone.0159026			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27403961	Green Published, gold, Green Submitted			2022-12-27	WOS:000379508200030
J	Giallongo, C; Romano, A; Parrinello, NL; La Cava, P; Brundo, MV; Bramanti, V; Stagno, F; Vigneri, P; Chiarenza, A; Palumbo, GA; Tibullo, D; Di Raimondo, F				Giallongo, Cesarina; Romano, Alessandra; Parrinello, Nunziatina Laura; La Cava, Piera; Brundo, Maria Violetta; Bramanti, Vincenzo; Stagno, Fabio; Vigneri, Paolo; Chiarenza, Annalisa; Palumbo, Giuseppe Alberto; Tibullo, Daniele; Di Raimondo, Francesco			Mesenchymal Stem Cells (MSC) Regulate Activation of Granulocyte-Like Myeloid Derived Suppressor Cells (G-MDSC) in Chronic Myeloid Leukemia Patients	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; PERIPHERAL-BLOOD; IMMUNE-SYSTEM; T-CELLS; TUMOR-GROWTH; EXPRESSION; IMATINIB; INDUCE; CML; MICROENVIRONMENT	It is well known that mesenchymal stem cells (MSC) have a role in promotion of tumor growth, survival and drug-resistance in chronic myeloid leukemia (CML). Recent reports indicated that a subpopulation of myeloid cells, defined as granulocyte-like myeloid-derived suppressor cells (G-MDSC) is increased in these patients. So far, the role of MSC in MDSC expansion and activation into the BM microenvironment remains unexplored. To address this question, here we use a specific experimental model in vitro, co-culturing MSC with peripheral blood mononucleated cells (PBMC) from normal individuals, in order to generate MSC-educated G-MDSC. Although MSC of healthy donors (HD) and CML patients were able to generate the same amount of MDSC, only CML-MSC-educated G-MDSC exhibited suppressive ability on autologous T lymphocytes. In addition, compared with HD-MSC, CML-MSC over-expressed some immunomodulatory factors including TGF beta, IL6 and IL10, that could be involved in MDSC activation. CML-MSC-educated G-MDSC expressed higher levels of ARG1, TNF alpha, IL1 beta, COX2 and IL6 than G-MDSC isolated from co-culture with HD-MSC. Our data provide evidence that CML-MSC may play a critical role in tumor microenvironment by orchestrating G-MDSC activation and regulating T lymphocytes-mediated leukemia surveillance, thus contributing to CML immune escape.	[Giallongo, Cesarina; Romano, Alessandra; Parrinello, Nunziatina Laura; La Cava, Piera; Stagno, Fabio; Chiarenza, Annalisa; Palumbo, Giuseppe Alberto; Tibullo, Daniele; Di Raimondo, Francesco] Univ Catania, AOU Policlin OVE, Div Hematol, Catania, Italy; [Giallongo, Cesarina; Bramanti, Vincenzo] Univ Catania, Dept Biomed & Biotechnol Sci, Catania, Italy; [Brundo, Maria Violetta; Tibullo, Daniele] Univ Catania, Dept Biol Geol & Environm Sci, Catania, Italy; [Vigneri, Paolo] Univ Catania, Dept Clin & Expt Med, Oncol, Catania, Italy	University of Catania; University of Catania; University of Catania; University of Catania	Tibullo, D (corresponding author), Univ Catania, AOU Policlin OVE, Div Hematol, Catania, Italy.; Tibullo, D (corresponding author), Univ Catania, Dept Biol Geol & Environm Sci, Catania, Italy.	d.tibullo@unict.it	Giallongo, Cesarina/J-7225-2016; Romano, Alessandra/I-9201-2012; Stagno, Fabio/AAH-2033-2020; Palumbo, Giuseppe/W-7072-2019; Chiarenza, Annalisa/AAC-2013-2019; TIBULLO, Daniele/AAC-1276-2019; Bramanti, Vincenzo/L-8828-2019; Di Raimondo, Francesco/K-7965-2016; Brundo, Maria Violetta/Q-4354-2016; VIGNERI, Paolo/K-8504-2016	Giallongo, Cesarina/0000-0002-7667-6088; Romano, Alessandra/0000-0002-6333-4433; Stagno, Fabio/0000-0002-7947-158X; Palumbo, Giuseppe/0000-0003-1859-6319; Chiarenza, Annalisa/0000-0002-8759-4854; TIBULLO, Daniele/0000-0002-4416-8556; Di Raimondo, Francesco/0000-0002-7749-0293; Brundo, Maria Violetta/0000-0001-5146-3564; Bramanti, Vincenzo/0000-0002-9380-8062; VIGNERI, Paolo/0000-0002-5943-6066	A.I.L. (Associazione Italiana contro le Leucemie) sezione di Catania; FON.CA.NE.SA. (Fondazione Catanese per lo Studio delle Malattie Neoplastiche del Sangue)	A.I.L. (Associazione Italiana contro le Leucemie) sezione di Catania; FON.CA.NE.SA. (Fondazione Catanese per lo Studio delle Malattie Neoplastiche del Sangue)	This study has been supported in part by A.I.L. (Associazione Italiana contro le Leucemie) sezione di Catania and by FON.CA.NE.SA. (Fondazione Catanese per lo Studio delle Malattie Neoplastiche del Sangue). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study has been supported in part by A.I.L. (Associazione Italiana contro le Leucemie) sezione di Catania and by FON.CA.NE.SA. (Fondazione Catanese per lo Studio delle Malattie Neoplastiche del Sangue).	Botta C, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00348; Brandau S, 2011, J LEUKOCYTE BIOL, V89, P311, DOI 10.1189/jlb.0310162; Carrara RCV, 2007, BRAZ J MED BIOL RES, V40, P57, DOI 10.1590/S0100-879X2006005000055; Chen MF, 2014, ONCOTARGET, V5, P8716, DOI 10.18632/oncotarget.2368; Christiansson L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055818; Copland M, 2006, BLOOD, V107, P4532, DOI 10.1182/blood-2005-07-2947; Filipazzi P, 2007, J CLIN ONCOL, V25, P2546, DOI 10.1200/JCO.2006.08.5829; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gallina G, 2006, J CLIN INVEST, V116, P2777, DOI 10.1172/JCI28828; Gallucci S, 2001, CURR OPIN IMMUNOL, V13, P114, DOI 10.1016/S0952-7915(00)00191-6; Giallongo C, 2011, ACTA HAEMATOL-BASEL, V126, P205, DOI 10.1159/000329911; Giallongo C., 2016, ONCOTARGET; Giallongo C, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00107; Giallongo C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101848; Giallongo C, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-60; Giallongo C, 2011, EUR J HAEMATOL, V86, P216, DOI 10.1111/j.1600-0609.2010.01570.x; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; Han ZP, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-8; Hass R, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-26; Jorgensen HG, 2007, BLOOD, V109, P4016, DOI 10.1182/blood-2006-11-057521; Lechner MG, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-90; Lechner MG, 2010, J IMMUNOL, V185, P2273, DOI 10.4049/jimmunol.1000901; Li HQ, 2009, J IMMUNOL, V182, P240, DOI 10.4049/jimmunol.182.1.240; Mougiakakos D, 2011, BLOOD, V117, P4826, DOI 10.1182/blood-2010-12-324038; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Nagaraj S, 2012, SEMIN CANCER BIOL, V22, P282, DOI 10.1016/j.semcancer.2012.01.010; Nagaraj S, 2010, J IMMUNOL, V184, P3106, DOI 10.4049/jimmunol.0902661; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Poggi A, 2014, IMMUNOL LETT, V159, P55, DOI 10.1016/j.imlet.2014.03.001; Rodriguez PC, 2005, J EXP MED, V202, P931, DOI 10.1084/jem.20050715; Sade-Feldman M, 2013, IMMUNITY, V38, P541, DOI 10.1016/j.immuni.2013.02.007; Sanchez N, 2014, CELL IMMUNOL, V289, P174, DOI 10.1016/j.cellimm.2014.04.007; Serafini P, 2008, CANCER RES, V68, P5439, DOI 10.1158/0008-5472.CAN-07-6621; Soleymaninejadian E, 2012, AM J REPROD IMMUNOL, V67, P1, DOI 10.1111/j.1600-0897.2011.01069.x; Tibullo D, 2012, HEMATOL ONCOL, V30, P27, DOI 10.1002/hon.988; Vanella L, 2011, PROSTAG OTH LIPID M, V96, P54, DOI 10.1016/j.prostaglandins.2011.07.005; Wang GY, 2013, CELL BIOL INT, V37, P137, DOI 10.1002/cbin.10024; Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271; Yamazaki S, 2009, BLOOD, V113, P1250, DOI 10.1182/blood-2008-04-146480; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Yu JP, 2014, J IMMUNOL, V193, P2574, DOI 10.4049/jimmunol.1400833; Zhang B, 2012, CANCER CELL, V21, P577, DOI 10.1016/j.ccr.2012.02.018; Zhu XS, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-47	44	20	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158392	10.1371/journal.pone.0158392	http://dx.doi.org/10.1371/journal.pone.0158392			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391078	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400053
J	Hamavid, H; Birger, M; Bulchis, AG; Lomsadze, L; Joseph, J; Baral, R; Bui, AL; Horst, C; Johnson, E; Dieleman, JL				Hamavid, Hannah; Birger, Maxwell; Bulchis, Anne G.; Lomsadze, Liya; Joseph, Jonathan; Baral, Ranju; Bui, Anthony L.; Horst, Cody; Johnson, Elizabeth; Dieleman, Joseph L.			Assessing the Complex and Evolving Relationship between Charges and Payments in US Hospitals: 1996-2012	PLOS ONE			English	Article							HEALTH; DEATH	Background In 2013 the United States spent $2.9 trillion on health care, more than in any previous year. Much of the debate around slowing health care spending growth focuses on the complicated pricing system for services. Our investigation contributes to knowledge of health care spending by assessing the relationship between charges and payments in the inpatient hospital setting. In the US, charges and payments differ because of a complex set of incentives that connect health care providers and funders. Our methodology can also be applied to adjust charge data to reflect actual spending. Methods We extracted cause of health care encounter (cause), primary payer (payer), charge, and payment information for 50,172 inpatient hospital stays from 1996 through 2012. We used linear regression to assess the relationship between charges and payments, stratified by payer, year, and cause. We applied our estimates to a large, nationally representative hospital charge sample to estimate payments. Results The average amount paid per $1 charged varies significantly across three dimensions: payer, year, and cause. Among the 10 largest causes of health care spending, average payments range from 23 to 55 cents per dollar charged. Over time, the amount paid per dollar charged is decreasing for those with private or public insurance, signifying that inpatient charges are increasing faster than the amount insurers pay. Conversely, the amount paid by out-of-pocket payers per dollar charged is increasing over time for several causes. Applying our estimates to a nationally representative hospital charge sample generates payment estimates which align with the official US estimates of inpatient spending. Conclusions The amount paid per $1 charged fluctuates significantly depending on the cause of a health care encounter and the primary payer. In addition, the amount paid per charge is changing over time. Transparent accounting of hospital spending requires a detailed assessment of the substantial and growing gap between charges and payments. Understanding what is driving this divergence and generating accurate spending estimates can inform efforts to contain health care spending.	[Hamavid, Hannah; Birger, Maxwell; Joseph, Jonathan; Horst, Cody; Johnson, Elizabeth; Dieleman, Joseph L.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Bulchis, Anne G.; Baral, Ranju] Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA; [Lomsadze, Liya] Northwell Hlth, Great Neck, NY USA; [Bui, Anthony L.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; Northwell Health; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Dieleman, JL (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA.	dieleman@uw.edu			National Institute on Aging of the National Institutes of Health [P30AG047845]; NATIONAL INSTITUTE ON AGING [P30AG047845] Funding Source: NIH RePORTER	National Institute on Aging of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research reported in this publication was supported by the National Institute on Aging of the National Institutes of Health under Award Number P30AG047845. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abe Dunn, 2015, SURV CURR BUS; [Anonymous], 2007, OV METH IMP MISS EXP; [Anonymous], 2006, RISING OUT OF POCKET; [Anonymous], 2013, NATIONAL HEALTH EXPE; Bernard Didem, 2012, Medicare Medicaid Res Rev, V2, DOI 10.5600/mmrr.002.04.a09; CARTER GM, 1994, HEALTH CARE FINANC R, V16, P127; Centers for Medicare and Medicaid Services, QUICK DEF NAT HLTH E; Clemens J, 2013, SHADOW GIANT MEDICAR; Cohen JW, 1996, INQUIRY-J HEALTH CAR, V33, P373; Design of the Nationwide Inpatient Sample (NIS), 2005, DES NAT INP SAMPL NI; Epstein AJ, 2012, MED CARE, V50, P1, DOI 10.1097/MLR.0b013e31822d5de9; Hartman M, 2015, HEALTH AFFAIR, V34, P150, DOI 10.1377/hlthaff.2014.1107; Hsia RY, 2008, ANN EMERG MED, V51, P265, DOI 10.1016/j.annemergmed.2007.08.009; Islam Ifrad, 2015, TROUBL AH HIGH DED H; John Sommers, EXAMINATION STATE ES; Meara E, 2004, HEALTH AFFAIR, V23, P176, DOI 10.1377/hlthaff.23.4.176; Melnlck GA, 2008, HEALTH AFFAIR, V27, pW116, DOI 10.1377/hlthaff.27.2.w116; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Naghavi M, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-9; R Core Team, 2021, R LANGUAGE ENV STAT; Reinhardt UE, 2006, HEALTH AFFAIR, V25, P57, DOI 10.1377/hlthaff.25.1.57; Roehrig C, 2009, HEALTH AFFAIR, V28, pW358, DOI 10.1377/hlthaff.28.2.w358; StataCorp, 2013, STATA STAT SOFTW REL; Tompkins CP, 2006, HEALTH AFFAIR, V25, P45, DOI 10.1377/hlthaff.25.1.45; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Waters HR, 2004, HEALTH POLICY, V69, P339, DOI 10.1016/j.healthpol.2004.01.003; White C, 2013, HEALTH AFFAIR, V32, P935, DOI 10.1377/hlthaff.2012.0332; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	28	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0157912	10.1371/journal.pone.0157912	http://dx.doi.org/10.1371/journal.pone.0157912			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27390858	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400025
J	Wang, WY; Viswanathan, S; Lee, T; Grafton, ST				Wang, Wuyi; Viswanathan, Shivakumar; Lee, Taraz; Grafton, Scott T.			Coupling between Theta Oscillations and Cognitive Control Network during Cross-Modal Visual and Auditory Attention: Supramodal vs Modality-Specific Mechanisms	PLOS ONE			English	Article							CORTICAL NETWORKS; BRAIN NETWORKS; HUMAN CORTEX; EEG; DYNAMICS; HUMANS; ALPHA; SENSORIMOTOR; FACILITATION; COMPETITION	Cortical theta band oscillations (4-8 Hz) in EEG signals have been shown to be important for a variety of different cognitive control operations in visual attention paradigms. However the synchronization source of these signals as defined by fMRI BOLD activity and the extent to which theta oscillations play a role in multimodal attention remains unknown. Here we investigated the extent to which cross-modal visual and auditory attention impacts theta oscillations. Using a simultaneous EEG-fMRI paradigm, healthy human participants performed an attentional vigilance task with six cross-modal conditions using naturalistic stimuli. To assess supramodal mechanisms, modulation of theta oscillation amplitude for attention to either visual or auditory stimuli was correlated with BOLD activity by conjunction analysis. Negative correlation was localized to cortical regions associated with the default mode network and positively with ventral premotor areas. Modality-associated attention to visual stimuli was marked by a positive correlation of theta and BOLD activity in fronto-parietal area that was not observed in the auditory condition. A positive correlation of theta and BOLD activity was observed in auditory cortex, while a negative correlation of theta and BOLD activity was observed in visual cortex during auditory attention. The data support a supramodal interaction of theta activity with of DMN function, and modality-associated processes within fronto-parietal networks related to top-down theta related cognitive control in cross-modal visual attention. On the other hand, in sensory cortices there are opposing effects of theta activity during cross-modal auditory attention.	[Wang, Wuyi; Lee, Taraz; Grafton, Scott T.] Univ Calif Santa Barbara, Inst Collaborat Biotechnol, Santa Barbara, CA 93106 USA; [Wang, Wuyi; Lee, Taraz; Grafton, Scott T.] Univ Calif Santa Barbara, Dept Psychol & Brain Sci, Santa Barbara, CA 93106 USA; [Viswanathan, Shivakumar] Univ Hosp Cologne, Dept Neurol, Cologne, Germany	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of Cologne	Wang, WY; Grafton, ST (corresponding author), Univ Calif Santa Barbara, Inst Collaborat Biotechnol, Santa Barbara, CA 93106 USA.; Wang, WY; Grafton, ST (corresponding author), Univ Calif Santa Barbara, Dept Psychol & Brain Sci, Santa Barbara, CA 93106 USA.	wuywang@gmail.com; grafton@psych.ucsb.edu	Viswanathan, Shivakumar/AAB-9426-2020; Wang, Wuyi/Q-4596-2016	Viswanathan, Shivakumar/0000-0002-7513-3778; Lee, Taraz/0000-0002-3186-8625	Institute for Collaborative Biotechnologies through the U.S. Army Research Office [W911NF-09-D-0001]	Institute for Collaborative Biotechnologies through the U.S. Army Research Office	This work was supported by the Institute for Collaborative Biotechnologies through contract no. W911NF-09-D-0001 from the U.S. Army Research Office. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank M. Mendoza, M. Schubert, P. Beach, M. Verket, D. Barany, J. Elliot, E. Caddigan, A. Shapiro and C. Mangi for their assistance in conducting the experiment. This work was supported by the Institute for Collaborative Biotechnologies through grant W911NF-09-0001 from the U.S. Army Research Office. The content of the information does not necessarily reflect the position or the policy of the Government, and no official endorsement should be inferred."	Allen PJ, 2000, NEUROIMAGE; Barany DA, 2014, J NEUROSCI, V34, P6860, DOI 10.1523/JNEUROSCI.5173-13.2014; Ben-Simon E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003984; Brass M, 2002, CEREB CORTEX, V12, P908, DOI 10.1093/cercor/12.9.908; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Cavanagh JF, 2014, TRENDS COGN SCI, V18, P414, DOI 10.1016/j.tics.2014.04.012; Cohen MX, 2013, J NEUROPHYSIOL, V110, P2752, DOI 10.1152/jn.00479.2013; Corbetta M, 2011, ANNU REV NEUROSCI, V34, P569, DOI 10.1146/annurev-neuro-061010-113731; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Debener S, 2006, TRENDS COGN SCI, V10, P558, DOI 10.1016/j.tics.2006.09.010; Desimone R, 1998, PHILOS T R SOC B, V353, P1245, DOI 10.1098/rstb.1998.0280; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Driver J, 1998, CURR OPIN NEUROBIOL, V8, P245, DOI 10.1016/S0959-4388(98)80147-5; Eimer M, 2002, J COGNITIVE NEUROSCI, V14, P254, DOI 10.1162/089892902317236885; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hanslmayr S, 2011, J NEUROSCI, V31, P15674, DOI 10.1523/JNEUROSCI.3140-11.2011; Hikosaka O, 2010, TRENDS COGN SCI, V14, P154, DOI 10.1016/j.tics.2010.01.006; Hipp JF, 2015, CURR BIOL, V25, P1368, DOI 10.1016/j.cub.2015.03.049; Huang S, 2015, J NEUROSCI, V35, P9064, DOI 10.1523/JNEUROSCI.3760-14.2015; Iordanescu L, 2011, ACTA PSYCHOL, V137, P252, DOI 10.1016/j.actpsy.2010.07.017; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Mayhew SD, 2010, NEUROIMAGE, V49, P849, DOI 10.1016/j.neuroimage.2009.06.080; MEREDITH MA, 1983, SCIENCE, V221, P389, DOI 10.1126/science.6867718; Min BK, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-79; Mo J, 2013, NEUROIMAGE, V68, P112, DOI 10.1016/j.neuroimage.2012.11.058; Molholm S, 2004, CEREB CORTEX, V14, P452, DOI 10.1093/cercor/bhh007; Murray MM, 2012, CROSS MODAL SPATIAL; Naue N, 2011, J NEUROSCI, V31, P7729, DOI 10.1523/JNEUROSCI.1076-11.2011; Niazy RK, 2005, NEUROIMAGE, V28, P720, DOI 10.1016/j.neuroimage.2005.06.067; PENFIELD W, 1963, BRAIN, V86, P595, DOI 10.1093/brain/86.4.595; Pessoa L, 2003, J NEUROSCI, V23, P3990; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Phillips JM, 2014, CEREB CORTEX, V24, P1996, DOI 10.1093/cercor/bht050; Scheeringa R, 2009, NEUROIMAGE, V44, P1224, DOI 10.1016/j.neuroimage.2008.08.041; Senkowski D, 2008, TRENDS NEUROSCI, V31, P401, DOI 10.1016/j.tins.2008.05.002; Shomstein S, 2004, J NEUROSCI, V24, P10702, DOI 10.1523/JNEUROSCI.2939-04.2004; Singer W, 2013, TRENDS COGN SCI, V17, P616, DOI 10.1016/j.tics.2013.09.006; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Stein BE, 2008, NAT REV NEUROSCI, V9, P255, DOI 10.1038/nrn2331; Uhlhaas PJ, 2010, TRENDS COGN SCI, V14, P72, DOI 10.1016/j.tics.2009.12.002; Uno T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122580; Wang WY, 2012, COGN NEURODYNAMICS, V6, P409, DOI 10.1007/s11571-012-9197-x; Wang WY, 2013, NEUROSCI BULL, V29, P715, DOI 10.1007/s12264-013-1386-z	47	16	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158465	10.1371/journal.pone.0158465	http://dx.doi.org/10.1371/journal.pone.0158465			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27391013	gold, Green Published, Green Submitted			2022-12-27	WOS:000380005400065
J	Ryzak, M; Bieganowski, A; Korbiel, T				Ryzak, Magdalena; Bieganowski, Andrzej; Korbiel, Tomasz			Sound Wave Energy Resulting from the Impact of Water Drops on the Soil Surface	PLOS ONE			English	Article							RAINDROP IMPACT; SIZE DISTRIBUTIONS; LASER DIFFRACTION; SINGLE WATERDROP; SPLASH EROSION; KINETIC-ENERGY; DETACHMENT; EROSIVITY; QUANTIFICATION; MOMENTUM	The splashing of water drops on a soil surface is the first step of water erosion. There have been many investigations into splashing-most are based on recording and analysing images taken with high-speed cameras, or measuring the mass of the soil moved by splashing. Here, we present a new aspect of the splash phenomenon's characterization the measurement of the sound pressure level and the sound energy of the wave that propagates in the air. The measurements were carried out for 10 consecutive water drop impacts on the soil surface. Three soils were tested (Endogleyic Umbrisol, Fluvic Endogleyic Cambisol and Haplic Chernozem) with four initial moisture levels (pressure heads: 0.1 kPa, 1 kPa, 3.16 kPa and 16 kPa). We found that the values of the sound pressure and sound wave energy were dependent on the particle size distribution of the soil, less dependent on the initial pressure head, and practically the same for subsequent water drops (from the first to the tenth drop). The highest sound pressure level (and the greatest variability) was for Endogleyic Umbrisol, which had the highest sand fraction content. The sound pressure for this soil increased from 29 dB to 42 dB with the next incidence of drops falling on the sample The smallest (and the lowest variability) was for Fluvic Endogleyic Cambisol which had the highest clay fraction. For all experiments the sound pressure level ranged from similar to 27 to similar to 42 dB and the energy emitted in the form of sound waves was within the range of 0.14 mu J to 5.26 mu J. This was from 0.03 to 1.07% of the energy of the incident drops.	[Ryzak, Magdalena; Bieganowski, Andrzej] Polish Acad Sci, Inst Agrophys, Doswiadczalna 4, PL-20290 Lublin, Poland; [Korbiel, Tomasz] AGH Univ Sci & Technol, Dept Mech & Vibroacoust, Krakow, Poland	Polish Academy of Sciences; Bohdan Dobrzanski Institute of Agrophysics of the Polish Academy of Sciences; AGH University of Science & Technology	Bieganowski, A (corresponding author), Polish Acad Sci, Inst Agrophys, Doswiadczalna 4, PL-20290 Lublin, Poland.	a.bieganowski@ipan.lublin.pl		Bieganowski, Andrzej/0000-0002-3571-3241; Korbiel, Tomasz/0000-0003-0783-6348; Ryzak, Magdalena/0000-0002-6400-5375	National Science Centre, Poland in the frame of project [2014/14/E/ST10/00851]; Statutory Research of Institute of Agrophysics Polish Academy of Sciences; Statutory Research of Department of Mechanics and Vibroacoustics University of Science and Technology Krakow [11.11.130.955]	National Science Centre, Poland in the frame of project; Statutory Research of Institute of Agrophysics Polish Academy of Sciences; Statutory Research of Department of Mechanics and Vibroacoustics University of Science and Technology Krakow	This work was partly financed from: 1) National Science Centre, Poland in the frame of project no. 2014/14/E/ST10/00851; 2) Statutory Research of Institute of Agrophysics Polish Academy of Sciences; and 3) Statutory Research of Department of Mechanics and Vibroacoustics University of Science and Technology Krakow No. 11.11.130.955. The authors declare that all the funding or sources of support (whether external or internal) were listed and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2013, EARTH SURF PROC LAND, V38, P1225, DOI 10.1002/esp.3364; ALDURRAH M, 1981, SOIL SCI SOC AM J, V45, P949, DOI 10.2136/sssaj1981.03615995004500050026x; ALDURRAH MM, 1982, SOIL SCI SOC AM J, V46, P1086, DOI 10.2136/sssaj1982.03615995004600050040x; Angulo-Martinez M, 2012, GEOMORPHOLOGY, V175, P38, DOI 10.1016/j.geomorph.2012.06.016; [Anonymous], 1972, J APPL METEOROL; Assouline S, 1997, COLLOID SURFACE A, V127, P201, DOI 10.1016/S0927-7757(97)00144-1; Bieganowski A, 2013, INT AGROPHYS, V27, P335, DOI 10.2478/intag-2013-0003; Bochet E, 2002, Z GEOMORPHOL, V46, P223; BRADFORD JM, 1986, SOIL SCI SOC AM J, V50, P1547, DOI 10.2136/sssaj1986.03615995005000060033x; EPEMA GF, 1983, CATENA, P1; Furbish DJ, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000498; Ghadiri H, 2004, EARTH SURF PROC LAND, V29, P77, DOI 10.1002/esp.1014; GHADIRI H, 1988, J SOIL SCI, V39, P563, DOI 10.1111/j.1365-2389.1988.tb01240.x; Glab T, 2009, GEODERMA, V149, P298, DOI 10.1016/j.geoderma.2008.12.007; Goebes P, 2014, J HYDROL, V517, P310, DOI 10.1016/j.jhydrol.2014.05.031; Jager H, 2015, CATENA, V128, P63, DOI 10.1016/j.catena.2015.01.018; Legout C, 2005, GEODERMA, V124, P279, DOI 10.1016/j.geoderma.2004.05.006; Lipiec J, 2003, GEODERMA, V116, P107, DOI 10.1016/S0016-7061(03)00097-1; Long EJ, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.032201; Mouzai L, 2011, EARTH SURF PROC LAND, V36, P87, DOI 10.1002/esp.2021; Mouzai L, 2003, J HYDRAUL RES, V41, P61, DOI 10.1080/00221680309499929; NEARING MA, 1985, SOIL SCI SOC AM J, V49, P547, DOI 10.2136/sssaj1985.03615995004900030003x; Poesen J., 1988, Catena Supplement, P113; Polakowski C, 2015, SOIL SCI SOC AM J, V79, P30, DOI 10.2136/sssaj2013.07.0286n; Polakowski C, 2014, INT AGROPHYS, V28, P195, DOI 10.2478/intag-20014-0008; PROSPERETTI A, 1993, ANNU REV FLUID MECH, V25, P577, DOI 10.1146/annurev.fl.25.010193.003045; Pumphrey H. C., 1988, European Journal of Physics, V9, P225, DOI 10.1088/0143-0807/9/3/011; Rejman J, 2014, SOIL TILL RES, V143, P77, DOI 10.1016/j.still.2014.05.011; Ryzak M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119269; Ryzak M, 2012, SENSORS-BASEL, V12, P11527, DOI 10.3390/s120911527; Salles C, 2000, WATER RESOUR RES, V36, P2721, DOI 10.1029/2000WR900024; SHARMA PP, 1989, SOIL SCI SOC AM J, V53, P1005, DOI 10.2136/sssaj1989.03615995005300040003x; Torri D., 1988, CATENA, V12, P127; Wysocka-Czubaszek Agnieszka, 2014, Polish Journal of Soil Science, V47, P1	34	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158472	10.1371/journal.pone.0158472	http://dx.doi.org/10.1371/journal.pone.0158472			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27388276	gold, Green Published, Green Submitted			2022-12-27	WOS:000379811500022
J	Choi, AYJ; Nivison-Smith, L; Khuu, SK; Kalloniatis, M				Choi, Agnes Yiu Jeung; Nivison-Smith, Lisa; Khuu, Sieu K.; Kalloniatis, Michael			Determining Spatial Summation and Its Effect on Contrast Sensitivity across the Central 20 Degrees of Visual Field	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; PROBABILITY SUMMATION; MACULAR DEGENERATION; PROJECTION PERIMETRY; LAYER THICKNESS; HUMAN-VISION; TEST OBJECT; LUMINANCE; DAMAGE; AREA	Purpose Recent studies propose that the use of target stimuli within or close to complete spatial summation reveal larger threshold elevation in ocular disease. The Humphrey Visual Field Analyzer (HFA) is used to assess visual function yet the spatial summation characteristics are unexplored for the central macular region. We therefore wanted to establish the relationship between contrast sensitivity and stimulus size (spatial summation) within the central 20 degrees visual field using the high sampling density of the 10-2 test grid. Methods Thresholds were measured for one eye from 37 normal subjects using the HFA 10-2 test grid with all five Goldmann (G) targets (GI to GV). Subject data were converted to 50-year-old equivalent using published and calculated location-specific decade correction factors. Spatial summation curves were fitted for all data at all locations. The size of Ricco's critical area (Ac) within which complete spatial summation operates (k = 1), and the slope of partial summation (k < 1: to characterize partial summation), was established. Results The 50-year-old age normative data were determined for all Goldmann stimulus sizes for the 10-2 HFA test grid and showed a marked change in contrast sensitivity for small test stimuli (e.g. GI) and little change in larger test stimuli (e.g. GV). Both the Ac and k values did not vary with age allowing for the application of the age correction factors. Ac and k values increased with eccentricity with GI remaining within complete spatial summation and GII was close or within complete spatial summation. GIII or larger test sizes were always outside complete spatial summation operating within various levels of partial summation. Conclusions The developed normative data now allows comparisons of data sets with high sampling density using the 10-2 grid irrespective of subject age. Test size is important when assessing ocular disease yet only GI or GII stimuli operate close to or within complete spatial summation in the macula. Current visual field testing protocols employ GIII which is always outside complete spatial summation and operates under various values of partial summation: GIII may not be the most suitable test size to assess ocular disease affecting the macula.	[Choi, Agnes Yiu Jeung; Nivison-Smith, Lisa; Kalloniatis, Michael] Univ New South Wales, Ctr Eye Hlth, Kensington, NSW, Australia; [Choi, Agnes Yiu Jeung; Nivison-Smith, Lisa; Khuu, Sieu K.; Kalloniatis, Michael] Univ New South Wales, Sch Optometry & Vis Sci, Kensington, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Kalloniatis, M (corresponding author), Univ New South Wales, Ctr Eye Hlth, Kensington, NSW, Australia.; Kalloniatis, M (corresponding author), Univ New South Wales, Sch Optometry & Vis Sci, Kensington, NSW, Australia.	m.kalloniatis@unsw.edu.au	Choi, Agnes Yiu Jeung/AAZ-3484-2020; Khuu, Sieu/N-7957-2019; Nivison-Smith, Lisa/H-3297-2019	Khuu, Sieu/0000-0003-1850-0225; Nivison-Smith, Lisa/0000-0001-6677-1949; Kalloniatis, Michael/0000-0002-5264-4639	University of New South Wales (Early Career Research Grant) [P535430]; University of New South Wales (Australian Postgraduate Award); National Health and Medical Research Council (NHMRC) [1033224]	University of New South Wales (Early Career Research Grant); University of New South Wales (Australian Postgraduate Award); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported, in part, by grants and awards from the University of New South Wales (Early Career Research Grant 2015 #P535430, an Australian Postgraduate Award) and a National Health and Medical Research Council (NHMRC) grant (#1033224). The Centre for Eye Health is an initiative between UNSW Australia and Guide Dogs NSW/ACT. Guide Dogs NSW/ACT is also a partner on the NHMRC grant and provides a supplementary PhD scholarship for AC and support for LN-S. The funding organizations had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton JH, 2012, INVEST OPHTH VIS SCI, V53, P7618, DOI 10.1167/iovs.12-10361; Acton JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039944; Anderson RS, 2006, PROG RETIN EYE RES, V25, P79, DOI 10.1016/j.preteyeres.2005.06.001; BARLOW HB, 1958, J PHYSIOL-LONDON, V141, P337, DOI 10.1113/jphysiol.1958.sp005978; Bosworth C F, 2000, Semin Ophthalmol, V15, P172, DOI 10.3109/08820530009037869; Centofanti M, 2005, OPHTHALMOLOGY, V112, P366, DOI 10.1016/j.ophtha.2004.11.030; Cubbidge RP, 2005, VISUAL FIELDS; Cukras C, 2015, OPHTHALMOLOGY, V122, P356, DOI 10.1016/j.ophtha.2014.07.056; Davson H., 1990, PHYSL EYE; Garway-Heath DF, 2000, INVEST OPHTH VIS SCI, V41, P1774; GLEZER V. D., 1965, VISION RES, V5, P497, DOI 10.1016/0042-6989(65)90084-2; GOLDMANN H, 1945, OPHTHALMOLOGICA, V109, P57, DOI 10.1159/000300224; HEIJL A, 1987, ARCH OPHTHALMOL-CHIC, V105, P1544; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Heijl A, 2012, FIELD ANAL PRIMER EF; Hood DC, 2014, INVEST OPHTH VIS SCI, V55, P632, DOI 10.1167/iovs.13-13130; Hood DC, 2013, PROG RETIN EYE RES, V32, P1, DOI 10.1016/j.preteyeres.2012.08.003; JAFFE GJ, 1986, ARCH OPHTHALMOL-CHIC, V104, P1021; Jampel HD, 2011, OPHTHALMOLOGY, V118, P986, DOI 10.1016/j.ophtha.2011.03.019; Jivrajka RV, 2013, EYE, V27, P1044, DOI 10.1038/eye.2013.112; Kalloniatis M, 2016, ASS RES VISION OPHTH; Kalloniatis M, 2016, OPHTHAL PHYSL OPT, V36, P439, DOI 10.1111/opo.12295; Kaplan E., 1990, Progress in Retinal Research, V9, P273, DOI 10.1016/0278-4327(90)90009-7; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Khuu SK, 2015, INVEST OPHTH VIS SCI, V56, P3565, DOI 10.1167/iovs.14-15606; Khuu SK, 2015, J VISION, V15, DOI 10.1167/15.1.6; LEGGE GE, 1978, VISION RES, V18, P959, DOI 10.1016/0042-6989(78)90024-X; Malik R, 2012, CLIN EXP OPHTHALMOL, V40, P369, DOI 10.1111/j.1442-9071.2012.02770.x; Meese TS, 2000, VISION RES, V40, P2101, DOI 10.1016/S0042-6989(00)00074-2; Ohkubo S, 2014, INVEST OPHTHALMOL, V55, P5269; Omodaka K, 2013, JPN J OPHTHALMOL, V57, P457, DOI 10.1007/s10384-013-0258-4; Pan F, 2006, J VISION, V6, P1159, DOI 10.1167/6.11.2; Park SC, 2013, OPHTHALMOLOGY, V120, P1546, DOI 10.1016/j.ophtha.2013.01.045; PERRY VH, 1984, NEUROSCIENCE, V12, P1125, DOI 10.1016/0306-4522(84)90007-1; Rao HL, 2015, INVEST OPHTH VIS SCI, V56, P3883, DOI 10.1167/iovs.15-16943; Raza AS, 2015, INVEST OPHTH VIS SCI, V56, P2254, DOI 10.1167/iovs.14-15952; Redmond T., 2011, OPTOM PRACT, V12, P11; Redmond T, 2013, OPTOMETRY VISION SCI, V90, P66, DOI 10.1097/OPX.0b013e318278fc2b; Redmond T, 2010, INVEST OPHTH VIS SCI, V51, P6540, DOI 10.1167/iovs.10-5718; Ricco A., 1877, ANNALI OTTALMOLOGIA, V6, P373; ROBSON JG, 1981, VISION RES, V21, P409, DOI 10.1016/0042-6989(81)90169-3; Schiefer U, 2010, INVEST OPHTH VIS SCI, V51, P5685, DOI 10.1167/iovs.09-5067; SLOAN LL, 1961, VISION RES, V1, P121, DOI 10.1016/0042-6989(61)90024-4; SLOAN LL, 1962, VISION RES, V2, P527, DOI 10.1016/0042-6989(62)90053-6; Swanson WH, 2004, INVEST OPHTH VIS SCI, V45, P466, DOI 10.1167/iovs.03-0374; Swanson WH, 2013, INVESTIGATIVE OPHTHA, V54; TOLENTINO MJ, 1994, VISION RES, V34, P409, DOI 10.1016/0042-6989(94)90099-X; Traynis I, 2014, JAMA OPHTHALMOL, V132, P291, DOI 10.1001/jamaophthalmol.2013.7656; Wall M, 1997, INVEST OPHTH VIS SCI, V38, P426; Weinreb RN, 2009, INVEST OPHTH VIS SCI, V50, P1497, DOI 10.1167/iovs.08-2843; WILSON ME, 1970, J PHYSIOL-LONDON, V207, P611, DOI 10.1113/jphysiol.1970.sp009083	51	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158263	10.1371/journal.pone.0158263	http://dx.doi.org/10.1371/journal.pone.0158263			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384954	Green Published, gold			2022-12-27	WOS:000379809400040
J	Horne, Z; Powell, D				Horne, Zachary; Powell, Derek			How Large Is the Role of Emotion in Judgments of Moral Dilemmas?	PLOS ONE			English	Article							VENTROMEDIAL PREFRONTAL CORTEX; ANTICIPATED EMOTIONS; DECISION-MAKING; DAMAGE; INTENTION; FEEDBACK; BEHAVIOR; REGRET; GUILT; HARM	Moral dilemmas often pose dramatic and gut-wrenching emotional choices. It is now widely accepted that emotions are not simply experienced alongside people's judgments about moral dilemmas, but that our affective processes play a central role in determining those judgments. However, much of the evidence purporting to demonstrate the connection between people's emotional responses and their judgments about moral dilemmas has recently been called into question. In the present studies, we reexamined the role of emotion in people's judgments about moral dilemmas using a validated self-report measure of emotion. We measured participants' specific emotional responses to moral dilemmas and, although we found that moral dilemmas evoked strong emotional responses, we found that these responses were only weakly correlated with participants' moral judgments. We argue that the purportedly strong connection between emotion and judgments of moral dilemmas may have been overestimated.	[Horne, Zachary] Univ Illinois, Urbana, IL 61801 USA; [Powell, Derek] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA USA	University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California Los Angeles	Horne, Z (corresponding author), Univ Illinois, Urbana, IL 61801 USA.	horne2@illinois.edu						[Anonymous], 2002, GROUNDWORK METAPHYSI; BAUMEISTER RF, 1994, PSYCHOL BULL, V115, P243, DOI 10.1037/0033-2909.115.2.243; Baumeister RF, 2007, PERS SOC PSYCHOL REV, V11, P167, DOI 10.1177/1088868307301033; Borg JS, 2006, J COGNITIVE NEUROSCI, V18, P803, DOI 10.1162/jocn.2006.18.5.803; Cannon PR, 2011, SOC PSYCHOL PERS SCI, V2, P325, DOI 10.1177/1948550610390525; Ciaramelli E, 2007, SOC COGN AFFECT NEUR, V2, P84, DOI 10.1093/scan/nsm001; Crockett MJ, 2013, TRENDS COGN SCI, V17, P363, DOI 10.1016/j.tics.2013.06.005; Cushman F, 2006, PSYCHOL SCI, V17, P1082, DOI 10.1111/j.1467-9280.2006.01834.x; Duke AA, 2015, COGNITION, V134, P121, DOI 10.1016/j.cognition.2014.09.006; Ekman P., 1976, FACIAL ACTION CODING; Eskine KJ, 2011, PSYCHOL SCI, V22, P295, DOI 10.1177/0956797611398497; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Giner-Sorolla R, 2008, J EXP SOC PSYCHOL, V44, P519, DOI 10.1016/j.jesp.2007.08.003; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Greene JD, 2008, COGNITION, V107, P1144, DOI 10.1016/j.cognition.2007.11.004; Greene JD, 2014, ETHICS, V124, P695, DOI 10.1086/675875; Greene JD, 2009, COGNITION, V111, P364, DOI 10.1016/j.cognition.2009.02.001; Greer J.M., 2008, SECRET JOKE KANTS SO, P35; Haidt J, 2001, PSYCHOL REV, V108, P814, DOI 10.1037//0033-295X.108.4.814; Hareli S, 2006, MOTIV EMOTION, V30, P189, DOI 10.1007/s11031-006-9025-x; Hayes A. F., 2012, PROCESS VERSATILE CO; Horne Z, 2013, P 35 ANN M COGN SCI; Hume David, 2012, TREATISE HUMAN NATUR; Hume David, 2011, ENQUIRY HUMAN UNDERS; Inbar Y, 2009, EMOTION, V9, P435, DOI 10.1037/a0015960; JOHNSON DJ, 2008, SOCIAL PSYCHOL, V45, P209, DOI DOI 10.1027/1864-9335/A000186; Kahane G, 2015, COGNITION, V134, P193, DOI 10.1016/j.cognition.2014.10.005; Kahane G, 2010, MIND LANG, V25, P561, DOI 10.1111/j.1468-0017.2010.01401.x; Kant I., 2006, ANTHROPOLOGY FROM A; Klein C, 2011, NEUROETHICS-NETH, V4, P143, DOI 10.1007/s12152-010-9077-1; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631; Kohlberg L., 1976, MORAL DEV BEHAV THEO, P31; Koop GJ, 2013, JUDGM DECIS MAK, V8, P527; Landy JF, 2015, PERSPECT PSYCHOL SCI, V10, P518, DOI 10.1177/1745691615583128; McGuire J, 2009, J EXP SOC PSYCHOL, V45, P577, DOI 10.1016/j.jesp.2009.01.002; Mellers BA, 1997, PSYCHOL SCI, V8, P423, DOI 10.1111/j.1467-9280.1997.tb00455.x; Mellers BA, 2001, CURR DIR PSYCHOL SCI, V10, P210, DOI 10.1111/1467-8721.00151; Mikhail J, 2007, TRENDS COGN SCI, V11, P143, DOI 10.1016/j.tics.2006.12.007; Miller R, 2013, SOC PERSONAL PSYCHOL, V7, P707, DOI 10.1111/spc3.12066; Moore AB, 2008, PSYCHOL SCI, V19, P549, DOI 10.1111/j.1467-9280.2008.02122.x; Moretto G, 2010, J COGNITIVE NEUROSCI, V22, P1888, DOI 10.1162/jocn.2009.21367; Nakamura K, 2013, THINK REASONING, V19, P178, DOI 10.1080/13546783.2013.768551; Patil I, 2015, J COGN PSYCHOL, V27, P349, DOI 10.1080/20445911.2015.1004334; Patil I, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00501; Perkins AM, 2013, J EXP PSYCHOL GEN, V142, P612, DOI 10.1037/a0030256; Perugini M, 2001, BRIT J SOC PSYCHOL, V40, P79, DOI 10.1348/014466601164704; Prinz Jesse, 2007, EMOTIONAL CONSTRUCTI; Rottman J, 2014, COGNITION, V130, P217, DOI 10.1016/j.cognition.2013.11.007; Rottman J, 2012, COGNITION, V124, P356, DOI 10.1016/j.cognition.2012.06.001; Royzman E.B., 2002, SOCIAL JUSTICE RES, V15, P165, DOI [10.1023/a:1019923923537, DOI 10.1023/A:1019923923537]; Salovey P., 1995, EMOTION DISCLOSURE H, P125, DOI [10.1037/10182-006, DOI 10.1037/10182-006]; Schnall S, 2008, PSYCHOL SCI, V19, P1219, DOI 10.1111/j.1467-9280.2008.02227.x; Schwarz N, 2000, COGNITION EMOTION, V14, P433, DOI 10.1080/026999300402745; Seidel A, 2013, COGNITION, V127, P1, DOI 10.1016/j.cognition.2012.11.004; Shenhav A, 2014, J NEUROSCI, V34, P4741, DOI 10.1523/JNEUROSCI.3390-13.2014; Singer, 2005, J ETHICS, V9, P331, DOI DOI 10.1007/S10892-005-3508-Y; Suter RS, 2011, COGNITION, V119, P454, DOI 10.1016/j.cognition.2011.01.018; Tremoliere B, 2014, PERS SOC PSYCHOL B, V40, P923, DOI 10.1177/0146167214530436; Valdesolo P, 2006, PSYCHOL SCI, V17, P476, DOI 10.1111/j.1467-9280.2006.01731.x; Waldmann MR, 2007, PSYCHOL SCI, V18, P247, DOI 10.1111/j.1467-9280.2007.01884.x; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Watson D., 1994, PANAS X MANUAL POSIT, DOI [10.17077/48vtm4t2, DOI 10.17077/48VTM4T2, DOI 10.13072/MIDSS.438]; Winkielman P, 2004, CURR DIR PSYCHOL SCI, V13, P120, DOI 10.1111/j.0963-7214.2004.00288.x; Zeelenberg M, 1999, J BEHAV DECIS MAKING, V12, P93, DOI 10.1002/(SICI)1099-0771(199906)12:2<93::AID-BDM311>3.0.CO;2-S; Zeelenberg M, 2008, EMOTION, V8, P589, DOI 10.1037/a0012894	66	15	15	5	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0154780	10.1371/journal.pone.0154780	http://dx.doi.org/10.1371/journal.pone.0154780			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR3NH	27385365	Green Published, gold, Green Submitted			2022-12-27	WOS:000379809400001
J	Huang, LL; Liu, CX; Deng, Y; Liu, YQ; Zhao, JY; Huang, XL; Tang, WJ; Sun, YF; Qin, X; Li, S				Huang, Liling; Liu, Cunxu; Deng, Yan; Liu, Yanqiong; Zhao, Jiangyang; Huang, Xiuli; Tang, Wenjun; Sun, Yifan; Qin, Xue; Li, Shan			Association of Hypoxia-Inducible Factor-2 Alpha Gene Polymorphisms with the Risk of Hepatitis B Virus-Related Liver Disease in Guangxi Chinese: A Case-Control Study	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; HEPATOCELLULAR-CARCINOMA; FACTOR 1-ALPHA; HUMAN CANCER; POPULATION; FACTOR-1-ALPHA; HIF-1-ALPHA; ACTIVATION; EXPRESSION; GROWTH	Objective Hypoxia-inducible factor-2 alpha (HIF-2a) plays a major role in the progression of disease, although the role of HIF-2a gene polymorphisms in hepatitis B virus (HBV)-related diseases remains elusive. The aim of this study is to determine whether HIF-2a rs13419896 and rs6715787 single-nucleotide polymorphisms (SNPs) are associated with susceptibility to chronic hepatitis B (CHB), liver cirrhosis (LC), or hepatocellular carcinoma (HCC). Method A case-control study of 107 patients with CHB, 83 patients with LC, 234 patients with HCC, and 224 healthy control subjects was carried out, and the HIF-2a rs13419896 and rs6715787 SNPs were genotyped by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Results No significant differences were observed in the genotype or allele frequency of two HIF-2a SNPs between the cases and controls (all p>0.05). However, in subgroup analysis by gender, the HIF-2a rs13419896 GA and AA genotypes were significantly associated with a risk of CHB (odds ratio [OR] = 3.565, 95% confidence interval [CI] = 1.123-11.314, p = 0.031 and OR = 12.506, 95% CI = 1.329-117.716, p = 0.027) in females, and the A allele of rs13419896 was associated with a risk of CHB (OR = 2.624, 95% CI = 1.244-5.537, p = 0.011) and LC (OR = 2.351, 95% CI = 1.002-5.518, p = 0.050) in females. The rs6715787 CG genotype polymorphism may contribute to a reduced risk of LC in the Guangxi Zhuang Chinese population (OR = 0.152, 95% CI = 0.028-0.807, p = 0.027), as determined via subgroup analysis by ethnicity. Moreover, binary logistic regression analyses that were adjusted by drinking status indicated that the AA genotype of rs13419896 may contribute to an increased risk of LC in the non-alcohol-drinking population (OR = 3.124, 95% CI = 1.091-8.947, p = 0.034). In haplotype analysis, GG haplotype was significantly associated with a reduced risk of LC (OR = 0.601, 95% CI = 0.419-0.862, p = 0.005). Conclusions The HIF-2a rs13419896 polymorphism is associated with an increased risk of CHB and LC in the Guangxi Chinese population, especially in females and in the non-alcohol-drinking population, while the HIF-2a gene rs6715787 polymorphism is associated with a decreased risk of LC in the Guangxi Zhuang population.	[Huang, Liling; Deng, Yan; Liu, Yanqiong; Zhao, Jiangyang; Huang, Xiuli; Tang, Wenjun; Qin, Xue; Li, Shan] Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi, Peoples R China; [Huang, Liling] Longtan Hosp Guangxi Zhuang Autonomous Reg, Dept Clin Lab, Liuzhou, Guangxi, Peoples R China; [Liu, Cunxu] Longtan Hosp Guangxi Zhuang Autonomous Reg, Dept Infect Dis, Liuzhou, Guangxi, Peoples R China; [Sun, Yifan] Guangxi Univ Chinese Med, Affiliated Hosp 3, Dept Clin Lab, Liuzhou, Guangxi, Peoples R China	Guangxi Medical University; Guangxi University of Chinese Medicine	Qin, X; Li, S (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi, Peoples R China.	qinxue919@126.com; lis8858@126.com			Natural Science Foundation of Guangxi [2012GXNSFAA053088]	Natural Science Foundation of Guangxi(National Natural Science Foundation of Guangxi Province)	This study was supported by grants from the Natural Science Foundation of Guangxi (NO. 2012GXNSFAA053088). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonacopoulou AG, 2011, CELL ONCOL, V34, P381, DOI 10.1007/s13402-011-0038-4; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Bhandari T, 2014, INFECT DIS THER, V3, P159, DOI 10.1007/s40121-014-0030-1; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Chen ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080337; Ciampa J, 2011, CANCER RES, V71, P3287, DOI 10.1158/0008-5472.CAN-10-2646; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Frede S, 2006, BIOCHEM J, V396, P517, DOI 10.1042/BJ20051839; Giatromanolaki A, 2001, BRIT J CANCER, V85, P881, DOI 10.1054/bjoc.2001.2018; Gong J, 2012, HUM MUTAT, V33, P254, DOI 10.1002/humu.21641; Gong L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075094; Guo L, 2015, EXP THER MED, V10, P907, DOI 10.3892/etm.2015.2611; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Harkisoen S, 2012, ANN HEPATOL, V11, P164, DOI 10.1016/S1665-2681(19)31020-8; Henderson J, 2005, HUM GENET, V118, P416, DOI 10.1007/s00439-005-0066-0; Holmquist L, 2006, ADV EXP MED BIOL, V587, P179; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Hu JL, 2016, ONCOL REP, V35, P1443, DOI 10.3892/or.2015.4480; Huang XM, 2015, GENE, V569, P218, DOI 10.1016/j.gene.2015.05.054; Imtiyaz HZ, 2010, CURR TOP MICROBIOL, V345, P105, DOI 10.1007/82_2010_74; Imtiyaz HZ, 2010, J CLIN INVEST, V120, P2699, DOI 10.1172/JCI39506; Iwamoto S, 2014, J THORAC ONCOL, V9, P1709, DOI 10.1097/JTO.0000000000000309; Jia Zhong-zhi, 2011, Chinese Medical Sciences Journal, V26, P158; Karapetsas A, 2011, INT J BIOCHEM CELL B, V43, P1582, DOI 10.1016/j.biocel.2011.07.007; Kondo K, 2001, EXP CELL RES, V264, P117, DOI 10.1006/excr.2000.5139; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Li SS, 2011, HEPAT MON, V11, P821, DOI 10.5812/kowsar.1735143X.771; Liu YQ, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0200-8; Loboda A, 2010, MOL CELLS, V29, P435, DOI 10.1007/s10059-010-0067-2; Lofstedt T, 2007, CELL CYCLE, V6, P919, DOI 10.4161/cc.6.8.4133; Lu Y, 2015, GENE, V564, P96, DOI 10.1016/j.gene.2015.03.053; Lu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110061; Maxwell PH, 1997, P NATL ACAD SCI USA, V94, P8104, DOI 10.1073/pnas.94.15.8104; Mittal S, 2013, J CLIN GASTROENTEROL, V47, pS2, DOI 10.1097/MCG.0b013e3182872f29; Mo CJ, 2014, ASIAN PAC J CANCER P, V15, P4697, DOI 10.7314/APJCP.2014.15.11.4697; Morgan TR, 2004, GASTROENTEROLOGY, V127, pS87, DOI 10.1053/j.gastro.2004.09.020; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; O'Rourke JF, 1999, J BIOL CHEM, V274, P2060, DOI 10.1074/jbc.274.4.2060; Peng QL, 2013, MOL MED REP, V8, P613, DOI 10.3892/mmr.2013.1558; Purdue MP, 2011, NAT GENET, V43, P60, DOI 10.1038/ng.723; Putra AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134496; Qing GL, 2009, CURR OPIN GENET DEV, V19, P60, DOI 10.1016/j.gde.2008.12.001; Rannala B, 2001, Am J Pharmacogenomics, V1, P203, DOI 10.2165/00129785-200101030-00005; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Reddy KR, 2011, PROSTATE, V71, P1796, DOI 10.1002/pros.21397; Rohwer N, 2011, DRUG RESIST UPDATE, V14, P191, DOI 10.1016/j.drup.2011.03.001; Sang NL, 2003, J BIOL CHEM, V278, P14013, DOI 10.1074/jbc.M209702200; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 2002, INTERNAL MED, V41, P79, DOI 10.2169/internalmedicine.41.79; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Sumbayev VV, 2008, IMMUNOL LETT, V115, P126, DOI 10.1016/j.imlet.2007.10.013; Sun YF, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0184-2; Te Helen S, 2010, Clin Liver Dis, V14, P1, DOI 10.1016/j.cld.2009.11.009; Te HS, 2010, CLIN LIVER DIS, V14, pvii, DOI DOI 10.1016/J.CLD.2009.11.009]; Arias-Loste MT, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/319745; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Xi XE, 2015, MED ONCOL, V32, DOI 10.1007/s12032-014-0355-3; Zhong H, 1999, CANCER RES, V59, P5830	61	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158241	10.1371/journal.pone.0158241	http://dx.doi.org/10.1371/journal.pone.0158241			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384772	Green Submitted, Green Published, gold			2022-12-27	WOS:000379809400039
J	Kripke, K; Opuni, M; Schnure, M; Sgaier, S; Castor, D; Reed, J; Njeuhmeli, E; Stover, J				Kripke, Katharine; Opuni, Marjorie; Schnure, Melissa; Sgaier, Sema; Castor, Delivette; Reed, Jason; Njeuhmeli, Emmanuel; Stover, John			Age Targeting of Voluntary Medical Male Circumcision Programs Using the Decision Makers' Program Planning Toolkit (DMPPT) 2.0	PLOS ONE			English	Article							HIV PREVENTION; PEOPLE; MEN	Background Despite considerable efforts to scale up voluntary medical male circumcision (VMMC) for HIV prevention in priority countries over the last five years, implementation has faced important challenges. Seeking to enhance the effect of VMMC programs for greatest and most immediate impact, the U. S. President's Plan for AIDS Relief (PEPFAR) supported the development and application of a model to inform national planning in five countries from 2013-2014. Methods and Findings The Decision Makers' Program Planning Toolkit (DMPPT) 2.0 is a simple compartmental model designed to analyze the effects of client age and geography on program impact and cost. The DMPPT 2.0 model was applied in Malawi, South Africa, Swaziland, Tanzania, and Uganda to assess the impact and cost of scaling up age-targeted VMMC coverage. The lowest number of VMMCs per HIV infection averted would be produced by circumcising males ages 20-34 in Malawi, South Africa, Tanzania, and Uganda and males ages 15-34 in Swaziland. The most immediate impact on HIV incidence would be generated by circumcising males ages 20-34 in Malawi, South Africa, Tanzania, and Uganda and males ages 20-29 in Swaziland. The greatest reductions in HIV incidence over a 15-year period would be achieved by strategies focused on males ages 10-19 in Uganda, 15-24 in Malawi and South Africa, 10-24 in Tanzania, and 15-29 in Swaziland. In all countries, the lowest cost per HIV infection averted would be achieved by circumcising males ages 15-34, although in Uganda this cost is the same as that attained by circumcising 15- to 49-year-olds. Conclusions The efficiency, immediacy of impact, magnitude of impact, and cost-effectiveness of VMMC scale-up are not uniform; there is important variation by age group of the males circumcised and countries should plan accordingly.	[Kripke, Katharine] Avenir Hlth, Hlth Policy Project, Washington, DC USA; [Opuni, Marjorie] United Nations Joint Programme HIV AIDS UNAIDS, Geneva, Switzerland; [Schnure, Melissa] Futures Grp Inc, Hlth Policy Project, Washington, DC USA; [Sgaier, Sema] Bill & Melinda Gates Fdn, Seattle, WA USA; [Sgaier, Sema] Univ Washington, Dept Global Hlth, Seattle, WA USA; [Castor, Delivette; Reed, Jason] Off US Global AIDS Coordinator & Hlth Diplomacy, Washington, DC USA; [Njeuhmeli, Emmanuel] USAID, Washington, DC USA; [Stover, John] Avenir Hlth, Hlth Policy Project, Glastonbury, CT USA	UNAIDS; Bill & Melinda Gates Foundation; University of Washington; University of Washington Seattle; United States Agency for International Development (USAID)	Kripke, K (corresponding author), Avenir Hlth, Hlth Policy Project, Washington, DC USA.	kkripke@avenirhealth.org	Kripke, Katharine/J-2146-2019	Kripke, Katharine/0000-0001-8228-4577; Opuni, Marjorie/0000-0002-0939-7695	President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development (USAID) \ Health Policy Project [AID-OAA-A-10-00067]; USAID	President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development (USAID) \ Health Policy Project(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); USAID(United States Agency for International Development (USAID))	This work was funded by the President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development (USAID) vertical bar Health Policy Project, Agreement No. AID-OAA-A-10-00067, beginning September 30, 2010. The Health Policy Project is implemented by Futures Group, in collaboration with Plan International USA, Avenir Health (formerly Futures Institute), Partners in Population and Development, Africa Regional Office (PPD ARO), Population Reference Bureau (PRB), RTI International, and the White Ribbon Alliance for Safe Motherhood (WRA). The funder was involved in study design, decision to publish, and preparation of the manuscript. The findings and conclusions in this paper do not necessarily represent the views or positions of USAID or the U.S. Government.; We would like acknowledge Laith J. Abu-Raddad and Susanne F. Awad of the Weill Cornell Medical College in Qatar for helpful discussions and for contributing to the analytical framework and model validation. Carel Pretorius, Xan Paxton, and Bernice Kuang from the USAID-funded Health Policy Project provided helpful consultation and assistance with the analyses. The PEPFAR VMMC Technical Working Group-including Naomi Bock, Carlos Toledo, Stephanie Marie Davis, and Dan Rutz from CDC; Anne Thomas from DoD; Jim Shelton, Adolfus Muyoti, Ramona Godbole, and Kim Ahanda from USAID; and Jason Reed from OGAC-contributed to the model framework and provided guidance regarding country model applications. Patrick Odawo and Maaya Sundaram from BMGF; Marelize Gorgens and Nicole Fraser-Hurt from the World Bank; Tin Tin Sint and Rene Ekpini from UNICEF; Julia Samuelson and Rachel Baggely from WHO; Karl Dehne and Celeste Sandoval from UNAIDS; Ade Fakoya from the Global Fund to Fight AIDS, Tuberculosis and Malaria; Mitchell Warren from AVAC; and Steven Forsythe from Avenir Health also contributed to the model framework. Timothy Hallett from Imperial College London reviewed and commented on the model in its early phases. We are also grateful to the publications staff of the Health Policy Project for their assistance with copyediting and formatting.	Anderson SJ, 2014, LANCET, V384, P249, DOI 10.1016/S0140-6736(14)61053-9; Appleby J, 2000, BRIT MED J, V320, P1464, DOI 10.1136/bmj.320.7247.1464; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Awad S, 2016, PLOS ONE IN PRESS; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Brown T, 2006, SEX TRANSM INFECT, V82, pIII34, DOI 10.1136/sti.2006.020230; Forsythe S, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-S1-S4; Ghys PD, 2007, AIDS, V21, pS1, DOI 10.1097/01.aids.0000299404.99033.bf; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Joint United Nations Programme on HIV/AIDS, 2014, FAST TRACK ENDING AI; Jones A, 2014, LANCET, V384, P272, DOI 10.1016/S0140-6736(13)62230-8; Justman J, 2013, JAIDS-J ACQ IMM DEF, V63, pS140, DOI 10.1097/QAI.0b013e31829875cc; Kripke K, 2016, PLOS ONE IN PRESS; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Malawi National Statistical Office ICF Macro, 2011, MAL DEM HLTH SURV 20; Ministry of Health, 2012, SWAZ INC MEAS SURV S; Njeuhmeli E, 2014, JAIDS-J ACQ IMM DEF, V66, pS193, DOI 10.1097/QAI.0000000000000179; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; Ortblad KF, 2013, AIDS, V27, P2003, DOI 10.1097/QAD.0b013e328362ba67; PEPFAR, 2014, PEPFAR 3 0 CONTR EP; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Sgaier SK, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001641; Simbayi L, 2014, S AFRICAN NATL HIV P; Stover J, 2014, AIDS, V28, pS427, DOI 10.1097/QAD.0000000000000483; Swaziland Central Statistical Office Macro International Inc, 2008, SWAZ DEM HLTH SURV 2; Tanzania Commission for AIDS (TACAIDS) Zanzibar AIDS Commission (ZAC) National Bureau of Statistics (NBS) Office of the Chief Government Statistician (OCGS) ICF International, 2013, TANZ HIV AIDS MAL IN, DOI Dares Salaam, Tanzania, and Calverton, Maryland, USA; U.S. President's Emergency Plan for AIDS Relief (PEFPAR), 2012, PEPFAR BLUEPR CREAT; Uganda Bureau of Statistics, 2012, UG DEM HLTH SURV 201; UNAIDS, 2015, AIDS CHANG EV MDG6 1; UNAIDS, 2014, LOC EP ISS BRIEF; UNAIDS/WHO, 2007, NEW DAT MAL CIRC HIV; WHO & UNAIDS, 2011, JOINT STRAT ACT FRAM	32	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0156909	10.1371/journal.pone.0156909	http://dx.doi.org/10.1371/journal.pone.0156909			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410966	Green Published, gold			2022-12-27	WOS:000379508300004
J	Zhao, CH; Zeng, HW; Wu, RTY; Cheng, WH				Zhao, Changhui; Zeng, Huawei; Wu, Ryan T. Y.; Cheng, Wen-Hsing			Loss of Selenium-Binding Protein 1 Decreases Sensitivity to Clastogens and Intracellular Selenium Content in HeLa Cells	PLOS ONE			English	Article							CELLULAR GLUTATHIONE-PEROXIDASE; COLORECTAL-CANCER; DNA-DAMAGE; OVARIAN-CANCER; IN-VITRO; EXPRESSION; MICE; SURVIVAL; OVEREXPRESSION; CARCINOGENESIS	Selenium-binding protein 1 (SBP1) is not a selenoprotein but structurally binds selenium. Loss of SBP1 during carcinogenesis usually predicts poor prognosis. Because genome instability is a hallmark of cancer, we hypothesize that SBP1 sequesters cellular selenium and sensitizes cancer cells to DNA-damaging agents. To test this hypothesis, we knocked down SBP1 expression in HeLa cervical cancer cells by employing a short hairpin RNA (shRNA) approach. Reduced sensitivity to hydrogen peroxide, paraquat and camptothecin, reactive oxygen species content, and intracellular retention of selenium after selenomethionine treatment were observed in SBP1 shRNA HeLa cells. Results from Western analyses showed that treatment of HeLa cells with selenomethionine resulted in increased SBP1 protein expression in a dose-dependent manner. Knockdown of SBP1 rendered HeLa cells increased expression of glutathione peroxidase-1 but not glutathione peroxidase-4 protein levels and accelerated migration from a wound. Altogether, SBP1 retains supplemental selenium and sensitizes HeLa cancer cells to clastogens, suggesting a new cancer treatment strategy by sequestering selenium through SBP1.	[Zhao, Changhui] Jilin Univ, Coll Food Sci & Engn, Dept Food Qual & Safety, Changchun 130062, Jilin Province, Peoples R China; [Zhao, Changhui; Wu, Ryan T. Y.] Univ Maryland, Dept Nutr & Food Sci, College Pk, MD 20742 USA; [Zeng, Huawei] USDA ARS, Grand Forks Human Nutr Res Ctr, Grand Forks, ND 58202 USA; [Cheng, Wen-Hsing] Mississippi State Univ, Dept Food Sci Nutr & Hlth Promot, Mississippi State, MS 39762 USA	Jilin University; University System of Maryland; University of Maryland College Park; United States Department of Agriculture (USDA); Mississippi State University	Zhao, CH (corresponding author), Jilin Univ, Coll Food Sci & Engn, Dept Food Qual & Safety, Changchun 130062, Jilin Province, Peoples R China.; Zhao, CH (corresponding author), Univ Maryland, Dept Nutr & Food Sci, College Pk, MD 20742 USA.; Cheng, WH (corresponding author), Mississippi State Univ, Dept Food Sci Nutr & Hlth Promot, Mississippi State, MS 39762 USA.	czhao@jlu.edu.cn; wc523@msstate.edu	Zhao, Changhui/N-2378-2019	Zhao, Changhui/0000-0002-1882-7490	USDA intramural program; Chinese Top University Graduate Student Studying Abroad Program; China Scholarship Council; ARS [ARS-0426336] Funding Source: Federal RePORTER	USDA intramural program; Chinese Top University Graduate Student Studying Abroad Program; China Scholarship Council(China Scholarship Council); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	H.W. Zeng is supported by the USDA intramural program. C.Z. was partially supported by the Chinese Top University Graduate Student Studying Abroad Program, China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baliga MS, 2007, BIOL TRACE ELEM RES, V115, P227, DOI 10.1007/BF02685998; BANSAL MP, 1989, CARCINOGENESIS, V10, P541, DOI 10.1093/carcin/10.3.541; Chen GA, 2004, J PATHOL, V202, P321, DOI 10.1002/path.1524; Cheng WH, 1997, J NUTR, V127, P675, DOI 10.1093/jn/127.5.675; Cheung-Ong K, 2013, CHEM BIOL, V20, P648, DOI 10.1016/j.chembiol.2013.04.007; Fang WF, 2010, CARCINOGENESIS, V31, P1360, DOI 10.1093/carcin/bgq114; Fukushima Tetsuhito, 2002, Environ Health Prev Med, V7, P89, DOI 10.1265/ehpm.2002.89; Glatt SJ, 2005, P NATL ACAD SCI USA, V102, P15533, DOI 10.1073/pnas.0507666102; He QY, 2004, PROTEOMICS, V4, P3276, DOI 10.1002/pmic.200300916; Huang C, 2012, CLIN CANCER RES, V18, P3042, DOI 10.1158/1078-0432.CCR-12-0183; Huang KC, 2006, INT J CANCER, V118, P2433, DOI 10.1002/ijc.21671; Jeong JY, 2009, BIOCHEM BIOPH RES CO, V379, P583, DOI 10.1016/j.bbrc.2008.12.110; Jerome-Morais A, 2012, PROSTATE, V72, P1006, DOI 10.1002/pros.21506; Kalivendi SV, 2005, BIOCHEM J, V389, P527, DOI 10.1042/BJ20050285; Kim H, 2006, PROTEOMICS, V6, P3466, DOI 10.1002/pmic.200500629; Lei XG, 2007, ANNU REV NUTR, V27, P41, DOI 10.1146/annurev.nutr.27.061406.093716; Li TH, 2008, MOL NUTR FOOD RES, V52, P1289, DOI 10.1002/mnfr.200700331; LI YB, 1994, CARCINOGENESIS, V15, P1421, DOI 10.1093/carcin/15.7.1421; Liou GY, 2010, FREE RADICAL RES, V44, P479, DOI 10.3109/10715761003667554; Lu YP, 1997, CANCER RES, V57, P1468; McClung JP, 2004, P NATL ACAD SCI USA, V101, P8852, DOI 10.1073/pnas.0308096101; Pass HI, 2004, CLIN CANCER RES, V10, P849, DOI 10.1158/1078-0432.CCR-0607-3; Pohl NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007774; PUMFORD NR, 1992, BIOCHEM BIOPH RES CO, V182, P1348, DOI 10.1016/0006-291X(92)91881-P; Qi YM, 2010, J BIOL CHEM, V285, P33010, DOI 10.1074/jbc.M110.137406; Raucci R, 2011, BBA-PROTEINS PROTEOM, V1814, P513, DOI 10.1016/j.bbapap.2011.02.006; Roman M, 2014, METALLOMICS, V6, P25, DOI 10.1039/c3mt00185g; Safaralizadeh R, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-32; Sawiris GP, 2002, CANCER RES, V62, P2923; Silvers AL, 2010, CLIN CANCER RES, V16, P2009, DOI 10.1158/1078-0432.CCR-09-2801; Singh K, 2015, HUM EXP TOXICOL, V34, P380, DOI 10.1177/0960327114533577; Slimen IB, 2014, INT J HYPERTHER, V30, P513, DOI 10.3109/02656736.2014.971446; Stewart MS, 1999, FREE RADICAL BIO MED, V26, P42, DOI 10.1016/S0891-5849(98)00147-6; Stone JR, 2004, ARCH BIOCHEM BIOPHYS, V422, P119, DOI 10.1016/j.abb.2003.12.029; Thiry C, 2013, BRIT J NUTR, V109, P2126, DOI 10.1017/S0007114512004412; Torrealba JR, 2005, AM J TRANSPLANT, V5, P58, DOI 10.1111/j.1600-6143.2004.00651.x; Van Cauwenbergh R, 2010, TRACE ELEM ELECTROLY, V27, P47; Wu RTY, 2014, J BIOL CHEM, V289, P34378, DOI 10.1074/jbc.M114.611970; Yang MH, 1998, CANCER RES, V58, P3150; Yang Y, 2009, ONCOL RES, V18, P1; Zeng HW, 2008, J NUTR BIOCHEM, V19, P1, DOI 10.1016/j.jnutbio.2007.02.005; Zeng HW, 2011, BIOL TRACE ELEM RES, V143, P1209, DOI 10.1007/s12011-010-8935-3	42	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0158650	10.1371/journal.pone.0158650	http://dx.doi.org/10.1371/journal.pone.0158650			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27404728	Green Published, gold, Green Submitted			2022-12-27	WOS:000379508200014
J	Darzi, S; Tiong, SK; Islam, MT; Soleymanpour, HR; Kibria, S				Darzi, Soodabeh; Tiong, Sieh Kiong; Islam, Mohammad Tariqul; Soleymanpour, Hassan Rezai; Kibria, Salehin			An Experience Oriented-Convergence Improved Gravitational Search Algorithm for Minimum Variance Distortionless Response Beamforming Optimum	PLOS ONE			English	Article							LINEAR ANTENNA-ARRAYS; BEAM PATTERN SYNTHESIS; PARAMETERS IDENTIFICATION; DIFFERENTIAL EVOLUTION; OPTIMIZATION; AMPLITUDE; DESIGN; SYSTEM	An experience oriented-convergence improved gravitational search algorithm (ECGSA) based on two new modifications, searching through the best experiments and using of a dynamic gravitational damping coefficient (a), is introduced in this paper. ECGSA saves its best fitness function evaluations and uses those as the agents' positions in searching process. In this way, the optimal found trajectories are retained and the search starts from these trajectories, which allow the algorithm to avoid the local optimums. Also, the agents can move faster in search space to obtain better exploration during the first stage of the searching process and they can converge rapidly to the optimal solution at the final stage of the search process by means of the proposed dynamic gravitational damping coefficient. The performance of ECGSA has been evaluated by applying it to eight standard benchmark functions along with six complicated composite test functions. It is also applied to adaptive beamforming problem as a practical issue to improve the weight vectors computed by minimum variance distortionless response (MVDR) beamforming technique. The results of implementation of the proposed algorithm are compared with some well-known heuristic methods and verified the proposed method in both reaching to optimal solutions and robustness.	[Darzi, Soodabeh] Univ Tenaga Nas, Coll Engn, Ctr Syst & Machine Intelligence, Selangor, Malaysia; [Tiong, Sieh Kiong] Univ Tenaga Nas, Power Engn Ctr, Selangor, Malaysia; [Islam, Mohammad Tariqul; Kibria, Salehin] Univ Kebangsaan Malaysia, Dept Elect Elect & Syst Engn, Bangi, Malaysia; [Soleymanpour, Hassan Rezai] Semnan Univ, Dept Elect Engn, Semnan, Iran	Universiti Tenaga Nasional; Universiti Tenaga Nasional; Universiti Kebangsaan Malaysia; Semnan University	Darzi, S (corresponding author), Univ Tenaga Nas, Coll Engn, Ctr Syst & Machine Intelligence, Selangor, Malaysia.	sdtutn@yahoo.com	Islam, Mohammad Tariqul/M-7377-2016; Tiong, Sieh Kiong/GLR-1734-2022	Islam, Mohammad Tariqul/0000-0002-4929-3209; 	Universiti Tenaga Nasional	Universiti Tenaga Nasional	This study is supported by Universiti Tenaga Nasional. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdagli A, 2003, MICROW OPT TECHN LET, V36, P16, DOI 10.1002/mop.10657; Akdagli A, 2006, ELECTROMAGNETICS, V26, P615, DOI 10.1080/02726340600978349; Ashouri M, 2013, J ADV COMPUT RES Q, V4, P41; Babayigit B, 2006, J ELECTROMAGNET WAVE, V20, P1007, DOI 10.1163/156939306776930222; BARRETT M, 1994, ELECTRON COMMUN ENG, V6, P203, DOI 10.1049/ecej:19940404; CAPON J, 1969, P IEEE, V57, P1408, DOI 10.1109/PROC.1969.7278; Dahrouj H, 2010, IEEE T WIREL COMMUN, V9, P1748, DOI 10.1109/TWC.2010.05.090936; Darzi S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140526; Darzi S, 2014, SCI WORLD J, DOI 10.1155/2014/724639; Derrac J, 2011, SWARM EVOL COMPUT, V1, P3, DOI 10.1016/j.swevo.2011.02.002; Gu BJ, 2013, INT J INNOV COMPUT I, V9, P4531; Guney K, 2007, PROG ELECTROMAGN RES, V70, P21, DOI 10.2528/PIER07011204; Guney K., 2001, PROGR ELECTROMAGNETI, V33, P167; Guney K, 2006, NEURAL NETW WORLD, V16, P489; Han XH, 2012, INFORM SCIENCES, V208, P14, DOI 10.1016/j.ins.2012.04.039; Holland J. H., 1973, SIAM Journal on Computing, V2, P88, DOI 10.1137/0202009; Karaboga D, 2004, INT J ELECTRON, V91, P241, DOI 10.1080/00207210410001690638; Karaboga N, 2002, INT J RF MICROW C E, V12, P375, DOI 10.1002/mmce.10034; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; Khajehzadeh M, 2013, STRUCT ENG MECH, V45, P111, DOI 10.12989/sem.2013.45.1.111; Khajehzadeh M, 2012, ENG APPL ARTIF INTEL, V25, P1589, DOI 10.1016/j.engappai.2012.01.011; Khatibinia M, 2014, APPL SOFT COMPUT, V16, P223, DOI 10.1016/j.asoc.2013.12.008; Khodier MM, 2005, IEEE T ANTENN PROPAG, V53, P2674, DOI 10.1109/TAP.2005.851762; Kiong TS, 2006, J APPL SCI, V6, P1766; Li CS, 2012, CHAOS SOLITON FRACT, V45, P539, DOI 10.1016/j.chaos.2012.02.005; Li CS, 2011, ENERG CONVERS MANAGE, V52, P374, DOI 10.1016/j.enconman.2010.07.012; Liang JJ, 2005, 2005 IEEE SWARM INTELLIGENCE SYMPOSIUM, P68; Liu F. L., 2011, Progress In Electromagnetics Research C, V20, P239; Lorenz RG, 2005, IEEE T SIGNAL PROCES, V53, P1684, DOI 10.1109/TSP.2005.845436; Mirjalili S, 2012, APPL MATH COMPUT, V218, P11125, DOI 10.1016/j.amc.2012.04.069; Nourani Y, 1998, J PHYS A-MATH GEN, V31, P8373, DOI 10.1088/0305-4470/31/41/011; Omar O. Kaid, 2012, Progress In Electromagnetics Research C, V32, P65; Rashedi E, 2009, INFORM SCIENCES, V179, P2232, DOI 10.1016/j.ins.2009.03.004; Shi YH, 1998, IEEE C EVOL COMPUTAT, P69, DOI 10.1109/ICEC.1998.699146; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Tiong S. K., 2014, SCI WORLD J; van den Bergh F, 2001, ANAL PARTICLE SWARM, P315; Xu Z, 2008, PROG ELECTROMAGN RES, V79, P75, DOI 10.2528/PIER07091901; Xue B, 2013, IEEE T CYBERNETICS, V43, P1656, DOI 10.1109/TSMCB.2012.2227469; Yang SW, 2004, INT J RF MICROW C E, V14, P57, DOI 10.1002/mmce.10118; Zaharis ZD, 2011, PROG ELECTROMAGN RES, V117, P165, DOI 10.2528/PIER11041904	42	7	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2016	11	7							e0156749	10.1371/journal.pone.0156749	http://dx.doi.org/10.1371/journal.pone.0156749			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CN	27399904	gold, Green Published, Green Submitted			2022-12-27	WOS:000379508100001
J	Hayashi, H; Wu, Q; Horie, M				Hayashi, Hideki; Wu, Qi; Horie, Minoru			Association between Progressive Intraventricular Conduction Disturbance and Cardiovascular Events	PLOS ONE			English	Article							BUNDLE-BRANCH-BLOCK; CARDIAC-RESYNCHRONIZATION THERAPY; CONGESTIVE-HEART-FAILURE; QRS DURATION; GENERAL-POPULATION; MORTALITY; DEATH; PREVENTION; PREDICTOR; RISK	Background Prolonged QRS duration on electrocardiogram (ECG) has been known as a poor prognostic marker. However, little is known about association between progressive intraventricular conduction disturbance and cardiovascular prognosis. Methods From among a database containing 359,737 12-lead ECG recordings, patients whose QRS duration progressively increased from <120 msec to >= 120 msec were selected using software. The prognosis of patients was searched by medical record. The primary endpoint was defined as heart failure hospitalization. The secondary endpoint was heart failure hospitalization, device implantation, or cardiovascular death. Results A total of 143 patients (100 males; age, 58.9 +/- 11.1 years) were enrolled in this study. QRS duration increased by 46.4 +/- 13.8 msec, manifesting right bundle branch block (RBBB) in 99 (69.2%) patients and non-RBBB (i.e., left bundle branch block, RBBB with left anterior hemiblock, or nonspecific intraventricular conduction disturbance) in 44 (30.8%). During the follow-up (mean, 16.6 +/- 5.3 years), 44 (30.3%), 15 (10.3%), and 6 (4.1%) patients resulted in heart failure hospitalization, device implantation, and cardiovascular death, respectively. Multivariate Cox proportional hazards models revealed that 1) the temporal increase in QRS duration was associated with the primary endpoint (hazard ratio [HR] 1.98; 95% confidence interval [CI] 1.05-3.80; p = 0.04) and the secondary endpoint (HR 2.79; 95% CI 1.55-5.00; p = 0.0001) and 2) the development of non-RBBB was associated with the primary endpoint (HR 3.02; 95% CI 1.59-5.73; p = 0.0001) and the secondary endpoint (HR 2.82; 95% CI 1.57-5.09; p = 0.001). Conclusion The temporal increase in QRS duration and the development of non-RBBB patterns were independently associated with adverse cardiovascular prognosis.	[Hayashi, Hideki; Wu, Qi; Horie, Minoru] Shiga Univ Med Sci, Dept Cardiovasc & Resp Med, Otsu, Shiga, Japan	Shiga University of Medical Science	Hayashi, H (corresponding author), Shiga Univ Med Sci, Dept Cardiovasc & Resp Med, Otsu, Shiga, Japan.	hayashih@belle.shiga-med.ac.jp	Horie, Minoru/ABG-7128-2020					Adesanya CO, 2008, ANN NONINVAS ELECTRO, V13, P165, DOI 10.1111/j.1542-474X.2008.00216.x; Aro AL, 2011, CIRC-ARRHYTHMIA ELEC, V4, P704, DOI 10.1161/CIRCEP.111.963561; Auricchio A, 2004, CIRCULATION, V109, P1133, DOI 10.1161/01.CIR.0000118502.91105.F6; Bleeker GB, 2004, J CARDIOVASC ELECTR, V15, P544, DOI 10.1046/j.1540-8167.2004.03604.x; Bongioanni S, 2007, AM J CARDIOL, V100, P503, DOI 10.1016/j.amjcard.2007.03.049; Desai AD, 2006, AM J MED, V119, P600, DOI 10.1016/j.amjmed.2005.08.028; Eriksson P, 2005, EUR HEART J, V26, P2300, DOI 10.1093/eurheartj/ehi580; Fahy GJ, 1996, AM J CARDIOL, V77, P1185, DOI 10.1016/S0002-9149(96)00160-9; Grigioni F, 2002, J HEART LUNG TRANSPL, V21, P899, DOI 10.1016/S1053-2498(02)00431-X; Haataja P, 2015, ANN MED, V47, P74, DOI 10.3109/07853890.2014.985704; Kashani A, 2005, J AM COLL CARDIOL, V46, P2183, DOI 10.1016/j.jacc.2005.01.071; Kawaguchi T, 2013, CIRC J, V77, P60, DOI 10.1253/circj.CJ-12-0849; Moss AJ, 2009, NEW ENGL J MED, V361, P1329, DOI 10.1056/NEJMoa0906431; SCHNEIDER JF, 1980, ANN INTERN MED, V92, P37, DOI 10.7326/0003-4819-92-1-37; SCHNEIDER JF, 1985, AM J CARDIOL, V55, P1332, DOI 10.1016/0002-9149(85)90499-0; Shamim W, 2002, HEART, V88, P47, DOI 10.1136/heart.88.1.47; Shenkman HJ, 2002, CHEST, V122, P528, DOI 10.1378/chest.122.2.528; Tang ASL, 2010, NEW ENGL J MED, V363, P2385, DOI 10.1056/NEJMoa1009540; Wang NC, 2008, JAMA-J AM MED ASSOC, V299, P2656, DOI 10.1001/jama.299.22.2656; Zareba W, 2011, CIRCULATION, V123, P1061, DOI 10.1161/CIRCULATIONAHA.110.960898; Zimetbaum PJ, 2004, CIRCULATION, V110, P766, DOI 10.1161/01.CIR.0000139311.32278.32	21	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0157412	10.1371/journal.pone.0157412	http://dx.doi.org/10.1371/journal.pone.0157412			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391877	Green Submitted, Green Published, gold			2022-12-27	WOS:000380005400009
J	Hollander, MR; de Waard, GA; Konijnenberg, LSF; Meijer-van Putten, RME; van den Brom, CE; Paauw, N; de Vries, HE; van de Ven, PM; Aman, J; Van Nieuw-Amerongen, GP; Hordijk, PL; Niessen, HWM; Horrevoets, AJG; Van Royen, N				Hollander, Maurits R.; de Waard, Guus A.; Konijnenberg, Lara S. F.; Meijer-van Putten, Rosalie M. E.; van den Brom, Charissa E.; Paauw, Nanne; de Vries, Helga E.; van de Ven, Peter M.; Aman, Jurjan; Van Nieuw-Amerongen, Geerten P.; Hordijk, Peter L.; Niessen, Hans W. M.; Horrevoets, Anton J. G.; Van Royen, Niels			Dissecting the Effects of Ischemia and Reperfusion on the Coronary Microcirculation in a Rat Model of Acute Myocardial Infarction	PLOS ONE			English	Article							NO-REFLOW PHENOMENON; MICROVASCULAR OBSTRUCTION; ISCHEMIA/REPERFUSION INJURY; INTRAMYOCARDIAL HEMORRHAGE; VASCULAR-PERMEABILITY; THROMBUS ASPIRATION; ARTERY OCCLUSION; RANDOMIZED-TRIAL; CELL INJURY; BLOOD-FLOW	Background Microvascular injury (MVI) after coronary ischemia-reperfusion is associated with high morbidity and mortality. Both ischemia and reperfusion are involved in MVI, but to what degree these phases contribute is unknown. Understanding the etiology is essential for the development of new potential therapies. Methods and Findings Rats were divided into 3 groups receiving either 30 minutes ischemia, 90 minutes ischemia or 30 minutes ischemia followed by 60 minutes reperfusion. Subsequently hearts were ex-vivo perfused in a Langendorff-model. Fluorescence and electron microscopy was used for analysis of capillary density, vascular permeability and ultrastructure. Most MVI was observed after 30 minutes ischemia followed by 60 minutes reperfusion. In comparison to the 30' and 90' ischemia group, wall thickness decreased (207.0 +/- 74 vs 407.8 +/- 75 and 407.5 +/- 71, p = 0.02). Endothelial nuclei in the 30'-60' group showed irreversible damage and decreased chromatin density variation (50.5 +/- 9.4, 35.4 +/- 7.1 and 23.7 +/- 3.8, p = 0.03). Cell junction density was lowest in the 30'-60' group (0.15 +/- 0.02 vs 2.5 +/- 0.6 and 1.8 +/- 0.7, p<0.01). Microsphere extravasation was increased in both the 90' ischemia and 30'-60' group. Conclusions Ischemia alone for 90 minutes induces mild morphological changes to the coronary micro-circulation, with increased vascular permeability. Ischemia for 30 minutes, followed by 60 minutes of reperfusion, induces massive MVI. This shows the direct consequences of reperfusion on the coronary microcirculation. These data imply that a therapeutic window exists to protect the microcirculation directly upon coronary revascularization.	[Hollander, Maurits R.; de Waard, Guus A.; Konijnenberg, Lara S. F.; Meijer-van Putten, Rosalie M. E.; Van Royen, Niels] Vrije Univ Amsterdam Med Ctr, Dept Cardiol, Amsterdam, Netherlands; [Hollander, Maurits R.; de Waard, Guus A.; Konijnenberg, Lara S. F.; Meijer-van Putten, Rosalie M. E.; van den Brom, Charissa E.; Aman, Jurjan; Van Nieuw-Amerongen, Geerten P.; Hordijk, Peter L.; Niessen, Hans W. M.; Horrevoets, Anton J. G.; Van Royen, Niels] Vrije Univ Amsterdam Med Ctr, Inst Cardiovasc Res, Amsterdam, Netherlands; [van den Brom, Charissa E.] Vrije Univ Amsterdam Med Ctr, Dept Anesthesiol, Amsterdam, Netherlands; [Paauw, Nanne; de Vries, Helga E.; Horrevoets, Anton J. G.] Vrije Univ Amsterdam Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands; [van de Ven, Peter M.] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Aman, Jurjan; Van Nieuw-Amerongen, Geerten P.; Hordijk, Peter L.] Vrije Univ Amsterdam Med Ctr, Dept Physiol, Amsterdam, Netherlands; [Niessen, Hans W. M.] Vrije Univ Amsterdam Med Ctr, Dept Pathol & Cardiac Surg, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Van Royen, N (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Cardiol, Amsterdam, Netherlands.; Van Royen, N (corresponding author), Vrije Univ Amsterdam Med Ctr, Inst Cardiovasc Res, Amsterdam, Netherlands.	n.vanroyen@vumc.nl	van den Brom, Charissa/AAG-7246-2019; Konijnenberg, Lara S.F./Q-4002-2018; van Royen, Niels/Q-1097-2017; de+Waard, Guus/K-5639-2019	Konijnenberg, Lara S.F./0000-0002-2634-2864; Hordijk, Peter/0000-0002-3348-078X; de Vries, Helga/0000-0001-7904-7124; van den Brom, Charissa/0000-0002-0886-1388; Niessen, Hans/0000-0001-9404-9822	Institute for Cardiovascular Research of the VU University of Amsterdam (ICaR-VU); Netherlands Heart Foundation (NHF) (The Hague) [2011T072]	Institute for Cardiovascular Research of the VU University of Amsterdam (ICaR-VU); Netherlands Heart Foundation (NHF) (The Hague)	This study was supported by the Institute for Cardiovascular Research of the VU University of Amsterdam (ICaR-VU). GPvNA was supported by the Netherlands Heart Foundation (NHF) (The Hague, grant 2011T072). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal V, 2014, ONCOTARGET, V5, P2761, DOI 10.18632/oncotarget.1942; Amado LC, 2004, J AM COLL CARDIOL, V43, P1291, DOI 10.1016/j.jacc.2003.11.034; Aman J, 2012, CIRCULATION, V126, P2728, DOI 10.1161/CIRCULATIONAHA.112.134304; AMBROSIO G, 1989, CIRCULATION, V80, P1846, DOI 10.1161/01.CIR.80.6.1846; BACHE RJ, 1974, J CLIN INVEST, V54, P1462, DOI 10.1172/JCI107894; Betgem RP, 2015, NAT REV CARDIOL, V12, P156, DOI 10.1038/nrcardio.2014.188; Bolton SJ, 1998, NEUROSCIENCE, V86, P1245, DOI 10.1016/S0306-4522(98)00058-X; Bruder O, 2008, HERZ, V33, P136, DOI 10.1007/s00059-008-3102-8; CAMILLERI JP, 1983, EXP MOL PATHOL, V39, P89, DOI 10.1016/0014-4800(83)90043-6; Carrick D, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.115.004148; Carrick D, 2014, J AM COLL CARDIOL, V63, P2088, DOI 10.1016/j.jacc.2014.02.530; Chen M, 2013, J CARDIOVASC PHARM, V62, P320, DOI 10.1097/FJC.0b013e31829be05b; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Clarke M, 2007, HEART, V93, P659, DOI 10.1136/hrt.2006.088203; Das M, 2012, ANN MED, V44, P530, DOI 10.3109/07853890.2011.577445; Devarajan P, 2006, J AM SOC NEPHROL, V17, P1503, DOI 10.1681/ASN.2006010017; Fernandez-Jimenez R, 2015, J AM COLL CARDIOL, V66, P816, DOI 10.1016/j.jacc.2015.06.023; Ge L, 2015, AM J PHYSIOL-HEART C, V308, pH500, DOI 10.1152/ajpheart.00381.2014; Gerber BL, 2000, CIRCULATION, V101, P2734, DOI 10.1161/01.CIR.101.23.2734; Hamirani YS, 2014, JACC-CARDIOVASC IMAG, V7, P940, DOI 10.1016/j.jcmg.2014.06.012; Handoko ML, 2009, AM J PHYSIOL-HEART C, V297, pH1752, DOI 10.1152/ajpheart.00555.2009; Harrison RW, 2013, AM J CARDIOL, V111, P178, DOI 10.1016/j.amjcard.2012.09.015; Huang XJ, 2016, CIRCULATION, V133, P1093, DOI 10.1161/CIRCULATIONAHA.115.020918; Jiang FY, 2014, CLIN CARDIOL, V37, P530, DOI 10.1002/clc.22292; Johnson HL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-678; KLONER RA, 1974, AM J PATHOL, V74, P399; KLONER RA, 1984, CIRCULATION, V70, P513, DOI 10.1161/01.CIR.70.3.513; KLONER RA, 1980, CIRCULATION, V62, P945, DOI 10.1161/01.CIR.62.5.945; KLONER RA, 1979, EXP MOL PATHOL, V30, P129, DOI 10.1016/0014-4800(79)90050-9; Limalanathan S, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000679; Liu DX, 2005, BLOOD, V105, P2350, DOI 10.1182/blood-2004-05-1963; Lleres D, 2009, J CELL BIOL, V187, P481, DOI 10.1083/jcb.200907029; Marzilli M, 2000, J AM COLL CARDIOL, V35, P327, DOI 10.1016/S0735-1097(99)00554-9; Milovanova T, 2008, BBA-MOL CELL RES, V1783, P1866, DOI 10.1016/j.bbamcr.2008.05.010; Morishima I, 2000, J AM COLL CARDIOL, V36, P1202, DOI 10.1016/S0735-1097(00)00865-2; Naaijkens BA, 2015, CELL TISSUE RES, V362, P623, DOI 10.1007/s00441-015-2239-z; Nagy JA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006544; Nanobasvili J, 2003, EUR SURG RES, V35, P417, DOI 10.1159/000072226; Ndrepepa G, 2010, J AM COLL CARDIOL, V55, P2383, DOI 10.1016/j.jacc.2009.12.054; Neil DAH, 2002, AM J TRANSPLANT, V2, P400, DOI 10.1034/j.1600-6143.2002.20502.x; Nilsen DWT, 2013, CATHETER CARDIO INTE, V82, P594, DOI 10.1002/ccd.24705; Panneerselvam M, 2012, ADV EXP MED BIOL, V729, P145, DOI 10.1007/978-1-4614-1222-9_10; Phinikaridou A, 2012, CIRCULATION, V126, P707, DOI 10.1161/CIRCULATIONAHA.112.092098; Pomfy M, 1992, Funct Dev Morphol, V2, P253; Reffelmann T, 2002, AM J PHYSIOL-HEART C, V282, pH766, DOI 10.1152/ajpheart.00767.2001; Regenfus M, 2015, AM J CARDIOL, V116, P1022, DOI 10.1016/j.amjcard.2015.06.034; Robbers LFHJ, 2013, EUR HEART J, V34, P2346, DOI 10.1093/eurheartj/eht100; Sardella G, 2009, J AM COLL CARDIOL, V53, P309, DOI 10.1016/j.jacc.2008.10.017; Scarabelli T, 2001, CIRCULATION, V104, P253, DOI 10.1161/01.CIR.104.3.253; Skovsted GF, 2014, BRIT J PHARMACOL, V171, P2726, DOI 10.1111/bph.12606; Teunissen PFA, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.114.001786; Tramontano AF, 2003, BIOCHEM BIOPH RES CO, V308, P990, DOI 10.1016/S0006-291X(03)01503-1; Waldow T, 2009, J SURG RES, V157, P30, DOI 10.1016/j.jss.2008.07.042; Wallez Y, 2008, BBA-BIOMEMBRANES, V1778, P794, DOI 10.1016/j.bbamem.2007.09.003; Yang ZQ, 2008, AM J PHYSIOL-HEART C, V295, pH2328, DOI 10.1152/ajpheart.00091.2008	55	35	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0157233	10.1371/journal.pone.0157233	http://dx.doi.org/10.1371/journal.pone.0157233			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391645	Green Published, gold, Green Submitted			2022-12-27	WOS:000380005400007
J	Mun, JH; Ohn, J; Kim, WI; Park, SM; Kim, MB				Mun, Je-Ho; Ohn, Jungyoon; Kim, Woo-Il; Park, Sung-Min; Kim, Moon-Bum			Dermoscopy of Melanomas on the Trunk and Extremities in Asians	PLOS ONE			English	Article							MELANOCYTIC SKIN-LESIONS; DIAGNOSTIC-ACCURACY; 7-POINT CHECKLIST; KEY POINTS; ABCD RULE; FEATURES; DERMATOSCOPY; PATTERNS; INTERNET	The incidence of melanoma among the Asian population is lower compared to that among the Western European population. These populations differed in their most common histopathologic subtypes, acral lentiginous melanoma being the most common in the Asian population. Although the dermoscopic features of the melanomas on the acral skin have been thoroughly investigated in the Asian population, studies concerning the dermoscopic patterns of melanomas on the non-acral skin have been scarce. The aim of this study was to investigate the dermoscopic patterns of melanomas on the trunk and extremities in the Asian population. To achieve this, we evaluated the dermoscopic patterns of 22 primary melanomas diagnosed at two university hospitals in Korea. In addition, 100 benign melanocytic lesions were included as the control group for comparative analysis. A P value less than 0.05 was regarded as statistically significant. Melanoma-associated dermoscopic features such as asymmetry (odds ratio [OR], 30.00), multicolor pattern (OR, 30.12), blotches (OR, 13.50), blue white veils (OR, 15.75), atypical pigment networks (OR, 9.71), irregular peripheral streaks (OR, 6.30), atypical vascular patterns (OR, 11.50), ulcers (OR, 15.83), atypical dots/globules (OR, 3.15), shiny white lines (OR, 5.88), and regression structures (OR, 7.06) were more commonly observed in patients with melanomas than in patients of the control group. The mean dermoscopic scores obtained on the 7-point checklist, revised 7-point checklist, 3-point checklist, ABCD rule, and CASH algorithm were 5.36, 3.41, 2.05, 6.89, and 9.68, respectively, in the primary melanomas, and 1.33, 0.93, 0.46, 2.45, and 3.60, respectively, in the control group (all, P < 0.001). The present study showed that melanoma-related dermoscopic patterns were common in Asian patients. Dermoscopy is a reliable diagnostic tool for the melanomas of the trunk and extremities in the Asian populations.	[Mun, Je-Ho; Ohn, Jungyoon] Seoul Natl Univ, Sch Med, Dept Dermatol, Seoul, South Korea; [Mun, Je-Ho] Seoul Natl Univ, Inst Human Environm Interface Biol, Seoul, South Korea; [Kim, Woo-Il; Park, Sung-Min; Kim, Moon-Bum] Pusan Natl Univ, Coll Med, Dept Dermatol, Busan, South Korea; [Kim, Moon-Bum] Pusan Natl Univ Hosp, Med Res Inst, Busan, South Korea	Seoul National University (SNU); Seoul National University (SNU); Pusan National University; Pusan National University; Pusan National University Hospital	Kim, MB (corresponding author), Pusan Natl Univ, Coll Med, Dept Dermatol, Busan, South Korea.; Kim, MB (corresponding author), Pusan Natl Univ Hosp, Med Res Inst, Busan, South Korea.	drkmp@hanmail.net		Mun, Je-Ho/0000-0002-0734-2850				Annessi G, 2007, J AM ACAD DERMATOL, V56, P759, DOI 10.1016/j.jaad.2007.01.014; Argenziano G, 2011, BRIT J DERMATOL, V164, P785, DOI 10.1111/j.1365-2133.2010.10194.x; Argenziano G, 1998, ARCH DERMATOL, V134, P1563, DOI 10.1001/archderm.134.12.1563; Argenziano G, 2003, J AM ACAD DERMATOL, V48, P679, DOI 10.1067/mjd.2003.281; Balagula Y, 2012, J AM ACAD DERMATOL, V67, DOI 10.1016/j.jaad.2011.04.039; Bradford PT, 2009, ARCH DERMATOL, V145, P427, DOI 10.1001/archdermatol.2008.609; Cormier JN, 2006, ARCH INTERN MED, V166, P1907, DOI 10.1001/archinte.166.17.1907; Emiroglu N, 2014, POSTEP DERM ALERGOL, V31, P362, DOI 10.5114/pdia.2014.47119; Haliasos EC, 2013, PEDIATR DERMATOL, V30, P281, DOI 10.1111/pde.12041; Haliasos HC, 2010, SEMIN CUTAN MED SURG, V29, P218, DOI 10.1016/j.sder.2010.10.003; Henning JS, 2007, J AM ACAD DERMATOL, V56, P45, DOI 10.1016/j.jaad.2006.09.003; Jang HS, 2014, ANN DERMATOL, V26, P485, DOI 10.5021/ad.2014.26.4.485; Kittler H, 2002, LANCET ONCOL, V3, P159, DOI 10.1016/S1470-2045(02)00679-4; Lee HY, 2012, ANN ACAD MED SINGAP, V41, P17; Lo JA, 2014, SCIENCE, V346, P945, DOI 10.1126/science.1253735; da Silva VPM, 2013, AN BRAS DERMATOL, V88, P712, DOI 10.1590/abd1806-4841.20132017; Mun JH, 2013, BRIT J DERMATOL, V168, P1224, DOI 10.1111/bjd.12209; Mun JH, 2014, J AM ACAD DERMATOL, V71, pE138, DOI 10.1016/j.jaad.2014.04.054; NACHBAR F, 1994, J AM ACAD DERMATOL, V30, P551, DOI 10.1016/S0190-9622(94)70061-3; Neila J, 2011, J DERMATOL, V38, P3, DOI 10.1111/j.1346-8138.2010.01131.x; Rigel DS, 2010, CA-CANCER J CLIN, V60, P301, DOI 10.3322/caac.20074; Rigel DS, 2010, ARCH DERMATOL, V146, P318, DOI 10.1001/archdermatol.2009.379; Saida T, 2004, ARCH DERMATOL, V140, P1233, DOI 10.1001/archderm.140.10.1233; Saida T, 2011, J DERMATOL, V38, P25, DOI 10.1111/j.1346-8138.2010.01174.x; Shitara D, 2014, ACTA DERM-VENEREOL, V94, P132, DOI 10.2340/00015555-1683; Sng J, 2009, J AM ACAD DERMATOL, V61, P426, DOI 10.1016/j.jaad.2009.03.031; Vestergaard ME, 2008, BRIT J DERMATOL, V159, P669, DOI 10.1111/j.1365-2133.2008.08713.x; Zalaudek I, 2006, BRIT J DERMATOL, V154, P431, DOI 10.1111/j.1365-2133.2005.06983.x	28	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158374	10.1371/journal.pone.0158374	http://dx.doi.org/10.1371/journal.pone.0158374			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391775	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400047
J	Fontan, MP; Rodriguez, CR; Naveira, MD; Sans, MB; Suarez, CR; Ganga, PQ; Alvarez, ES; Rodriguez-Carmona, A				Perez Fontan, Miguel; Remon Rodriguez, Cesar; da Cunha Naveira, Marta; Borras Sans, Merce; Rodriguez Suarez, Carmen; Quiros Ganga, Pedro; Sanchez Alvarez, Emilio; Rodriguez-Carmona, Ana			Baseline Residual Kidney Function and Its Ensuing Rate of Decline Interact to Predict Mortality of Peritoneal Dialysis Patients	PLOS ONE			English	Article							RENAL-FUNCTION; RISK-FACTORS; ADEQUACY; CLEARANCE; SURVIVAL; TRIAL; DEATH	Background Baseline residual kidney function (RKF) and its rate of decline during follow-up are purported to be reliable outcome predictors of patients undergoing Peritoneal Dialysis (PD). The independent contribution of each of these factors has not been elucidated. Method We report a multicenter, longitudinal study of 493 patients incident on PD and satisfying two conditions: a glomerular filtration rate (GFR) >= 1 mL/minute and a daily diuresis >= 300 mL. The main variables were the GFR (mean of urea and creatinine clearances) at PD inception and the GFR rate of decline during follow-up. The main outcome variable was patient mortality. The secondary outcome variables were: PD technique failure and risk of peritoneal infection. The statistical analysis was based on a multivariate approach, placing an emphasis on the interactions between the two main study variables. Main Results Baseline GFR and its rate of decline performed well as independent predictors of both patient mortality and risk of peritoneal infection. These two main study variables maintained a moderate correlation with each other (r(2) = 0.12, p<0.0005), and interacted clearly, as predictors of patient mortality. A low baseline GFR followed by a fast decline portended the worst survival outcome (adjusted HR 3.84, 95% CI 1.81-8.14, p<0.0005)(Ref. baseline GFR above median plus rate of decline below median). In general, the rate of decline of RKF had a greater effect on mortality than baseline GFR, which had no detectable effect on survival when the decline of RKF was slow (HR 1.17, 95% CI 0.81-2.22, p = 0.22). Conversely, a relatively high GFR at the start of PD still carried a significant risk of mortality, when RKF declined rapidly (HR 1.89, 95% CI 1.05-3.72, p = 0.028). Conclusion The risk-benefit balance of an early versus late start of PD cannot be evaluated without taking into consideration the rate of decline of RKF. This circumstance may contribute to explain the controversial results observed at the time of evaluating the potential benefits of an early initiation of PD.	[Perez Fontan, Miguel; da Cunha Naveira, Marta; Rodriguez-Carmona, Ana] Univ Hosp A Coruna, Div Nephrol, La Coruna, Spain; [Remon Rodriguez, Cesar; Quiros Ganga, Pedro] Univ Hosp Puerta Real, Div Nephrol, Cadiz, Spain; [Borras Sans, Merce] Univ Hosp Arnau de Vilanova, Div Nephrol, Lleida, Spain; [Rodriguez Suarez, Carmen; Sanchez Alvarez, Emilio] Univ Hosp Asturias, Div Nephrol, Oviedo, Spain	Complejo Hospitalario Universitario A Coruna; Central University Hospital Asturias	Fontan, MP (corresponding author), Univ Hosp A Coruna, Div Nephrol, La Coruna, Spain.	Miguel.Perez.Fontan@sergas.es	Perez-Fontán, Miguel/ABG-4064-2020	Perez-Fontán, Miguel/0000-0001-7027-2296; Remon-Rodriguez, Cesar/0000-0001-8232-6060				Ates K, 2001, KIDNEY INT, V60, P767, DOI 10.1046/j.1523-1755.2001.060002767.x; Bargman JM, 2001, J AM SOC NEPHROL, V12, P2158, DOI 10.1681/ASN.V12102158; Cooper BA, 2010, NEW ENGL J MED, V363, P609, DOI 10.1056/NEJMoa1000552; Diaz-Buxo JA, 1999, AM J KIDNEY DIS, V33, P523, DOI 10.1016/S0272-6386(99)70190-3; Grootendorst DC, 2011, NEPHROL DIAL TRANSPL, V26, P1932, DOI 10.1093/ndt/gfq667; Ha IS, 2015, KIDNEY INT, V88, P605, DOI 10.1038/ki.2015.108; Han SH, 2007, NEPHROL DIAL TRANSPL, V22, P2653, DOI 10.1093/ndt/gfm242; Johnson DW, 2012, PERITON DIALYSIS INT, V32, P595, DOI 10.3747/pdi.2012.00046; Johnson DW, 2003, PERITON DIALYSIS INT, V23, P276; Liao CT, 2009, NEPHROL DIAL TRANSPL, V24, P2909, DOI 10.1093/ndt/gfp056; Maiorca R, 1995, NEPHROL DIAL TRANSPL, V10, P2295, DOI 10.1093/ndt/10.12.2295; Marron B, 2008, KIDNEY INT, V73, pS42, DOI 10.1038/sj.ki.5002600; Michels WM, 2011, CLIN J AM SOC NEPHRO, V6, P537, DOI 10.2215/CJN.00470110; Moist LM, 2000, J AM SOC NEPHROL, V11, P556, DOI 10.1681/ASN.V113556; Paniagua R, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1351307; Perl J, 2009, AM J KIDNEY DIS, V53, P1068, DOI 10.1053/j.ajkd.2009.02.012; Rocco M, 2000, KIDNEY INT, V58, P446, DOI 10.1046/j.1523-1755.2000.00184.x; Rosansky S, 2011, CLIN J AM SOC NEPHRO, V6, P1222, DOI 10.2215/CJN.09301010; Shemin D, 2000, PERITON DIALYSIS INT, V20, P439; Shin SK, 1999, PERITON DIALYSIS INT, V19, P138; Singhal MK, 2000, PERITON DIALYSIS INT, V20, P429; Szeto CC, 2004, PERITON DIALYSIS INT, V24, P58; Szeto CC, 2003, NEPHROL DIAL TRANSPL, V18, P977, DOI 10.1093/ndt/gfg027; Szeto CC, 2015, PERITON DIALYSIS INT, V35, P180, DOI 10.3747/pdi.2013.00075; Termorshuizen F, 2003, AM J KIDNEY DIS, V41, P1293, DOI 10.1016/S0272-6386(03)00362-7; Wang AYM, 2006, KIDNEY INT, V69, P1726, DOI 10.1038/sj.ki.5000382	26	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158696	10.1371/journal.pone.0158696	http://dx.doi.org/10.1371/journal.pone.0158696			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391209	Green Published, gold, Green Submitted			2022-12-27	WOS:000380005400106
J	Pulford, J; Smith, I; Mueller, I; Siba, PM; Hetzel, MW				Pulford, Justin; Smith, Iso; Mueller, Ivo; Siba, Peter M.; Hetzel, Manuel W.			Health Worker Compliance with a 'Test And Treat' Malaria Case Management Protocol in Papua New Guinea	PLOS ONE			English	Article							RAPID DIAGNOSTIC-TESTS; TREATMENT GUIDELINES; COMBINATION THERAPY; FEBRILE CHILDREN; FACILITIES; ADHERENCE; IMPLEMENTATION; INTERVENTIONS; PERFORMANCE; EXPERIENCES	The Papua New Guinea (PNG) Department of Health introduced a 'test and treat' malaria case management protocol in 2011. This study assesses health worker compliance with the test and treat protocol on a wide range of measures, examines self-reported barriers to health worker compliance as well as health worker attitudes towards the test and treat protocol. Data were collected by cross-sectional survey conducted in randomly selected primary health care facilities in 2012 and repeated in 2014. The combined survey data included passive observation of current or recently febrile patients (N = 771) and interviewer administered questionnaires completed with health workers (N = 265). Across the two surveys, 77.6% of patients were tested for malaria infection by rapid diagnostic test (RDT) or microscopy, 65.6% of confirmed malaria cases were prescribed the correct antimalarials and 15.3% of febrile patients who tested negative for malaria infection were incorrectly prescribed an antimalarial. Overall compliance with a strictly defined test and treat protocol was 62.8%. A reluctance to test current/recently febrile patients for malaria infection by RDT or microscopy in the absence of acute malaria symptoms, reserving recommended antimalarials for confirmed malaria cases only and choosing to clinically diagnose a malaria infection, despite a negative RDT result were the most frequently reported barriers to protocol compliance. Attitudinal support for the test and treat protocol, as assessed by a nine-item measure, improved across time. In conclusion, health worker compliance with the full test and treat malaria protocol requires improvement in PNG and additional health worker support will likely be required to achieve this. The broader evidence base would suggest any such support should be delivered over a longer period of time, be multi-dimensional and multi-modal.	[Pulford, Justin; Smith, Iso; Siba, Peter M.] Papua New Guinea Inst Med Res, Goroka, Papua N Guinea; [Pulford, Justin] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England; [Mueller, Ivo] Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia; [Mueller, Ivo] Barcelona Ctr Int Hlth Res, Barcelona, Spain; [Hetzel, Manuel W.] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Hetzel, Manuel W.] Univ Basel, Basel, Switzerland	PNG Institute Of Medical Research; Liverpool School of Tropical Medicine; Walter & Eliza Hall Institute; ISGlobal; CRESIB; University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Pulford, J (corresponding author), Papua New Guinea Inst Med Res, Goroka, Papua N Guinea.; Pulford, J (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England.	justin.pulford@lstmed.ac.uk		Pulford, Justin/0000-0003-4756-8480; Hetzel, Manuel W./0000-0002-5285-3254	Global Fund to Fight AIDS, Tuberculosis and Malaria Round 8 Malaria grant; PNG National Department of Health	Global Fund to Fight AIDS, Tuberculosis and Malaria Round 8 Malaria grant; PNG National Department of Health	This study was funded by a Global Fund to Fight AIDS, Tuberculosis and Malaria Round 8 Malaria grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors gratefully acknowledge the many health workers and patients involved in this study. The generous support of the respective provincial and district health authorities and the PNG National Department of Health are also acknowledged as are all of the staff members from the PNG Institute of Medical Research who assisted with data collection and processing.	Abdelgader TM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-11; [Anonymous], 2011, STANDARD TREATMENT C; [Anonymous], STAND TREATM GUID CO; [Anonymous], BMC HLTH SE IN PRESS; [Anonymous], WORLD MAL REP 2014; [Anonymous], MAL DIAGN NEW TREATM; [Anonymous], PAPUA NEW GUINEA MED; Asiimwe C, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-5; Batwala V, 2011, MALARIA J, V10, DOI [10.1186/1475-2875-10-377, 10.1186/1475-2875-10-373]; Bilal JA, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0575-9; Chanda-Kapata Pascalina, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, P498, DOI 10.12980/APJTB.4.2014C153; Chandler CIR, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-83; Chappuis F, 2013, CLIN MICROBIOL INFEC, V19, P422, DOI 10.1111/1469-0691.12154; Cundill B, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0346-z; D'Acremont V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-107; Diggle E, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-502; Ezenduka Charles C, 2014, J Pharm Policy Pract, V7, P15, DOI 10.1186/2052-3211-7-15; Ezeoke OP, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-368; Galactionova K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127818; Hensen B, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-218; Hetzel Manuel W, 2014, P N G Med J, V57, P7; Juma E, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-1; Littrell M, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-371; Lourenco C, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-508; Manyando C, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-166; Martins JS, 2012, HEALTH POLICY PLANN, V27, P677, DOI 10.1093/heapol/czs019; Mbacham WF, 2014, LANCET GLOB HEALTH, V2, pE346, DOI 10.1016/S2214-109X(14)70201-3; Mbonye MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084945; Millar KR, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-447; Mubi M, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-293; Namagembe A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-44; Papua New Guinea National Department of Health, 2009, NAT MAL TREATM PROT; Pulford J, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0628-8; Pulford J, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-433; Rao VB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069654; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; Selemani M, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-334; Senn N, 2012, CLIN INFECT DIS, V54, P644, DOI 10.1093/cid/cir901; Steinhardt LC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089050; Steinhardt LC, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-64; TANNER M, 1993, T ROY SOC TROP MED H, V87, P518, DOI 10.1016/0035-9203(93)90070-7; Wasunna B, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-261; Webster J, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-261; WHO, 2010, GUID TREATM MAL, V2nd; WHO, 2015, WORLD MAL REP 2015; World Health Organisation, 2012, WORLD MALARIA REPORT; Zurovac D, 2011, LANCET, V378, P795, DOI 10.1016/S0140-6736(11)60783-6	47	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158780	10.1371/journal.pone.0158780	http://dx.doi.org/10.1371/journal.pone.0158780			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391594	Green Published, gold, Green Accepted			2022-12-27	WOS:000380005400123
J	Saikia, N; Moradhvaj; Bora, JK				Saikia, Nandita; Moradhvaj; Bora, Jayanta Kumar			Gender Difference in Health-Care Expenditure: Evidence from India Human Development Survey	PLOS ONE			English	Article							SEEKING BEHAVIOR; IMMUNIZATION; DISADVANTAGE; SERVICES; CHILDREN; CHINA; LIFE	Background While the gender disparity in health and mortality in various stages of life in India is well documented, there is limited evidence on female disadvantage in health-care expenditure (HCE). Aims Examine the gender difference in HCE in short-term and major morbidity in India, and understand the role of factors underlying the difference. Data and Methods Using two rounds of nationally representative panel data-the India Human Development Survey (IHDS) 2004-2005 and 2011-2012 (IHDS I & II)-we calculate morbidity prevalence rate and mean HCE by gender, and examine the adjusted effect of gender on major morbidity-related HCE by using a two-part regression model. Further, we performed Oaxaca-Blinder decomposition of the gender gap in HCE in major morbidity to understand the contribution of demographic and socio-economic factors. Results Health-care expenditure on females was systematically lower than on males across all demographic and socio-economic groups. Multivariate analysis confirms that female HCE is significantly lower than male HCE even after controlling demographic and socio-economic factors (beta = -0.148, p = 0.000, CI:-0.206-0.091). For both short-term and major morbidity, a female disadvantage on HCE increased from IHDS I to IHDS II. For instance, the male-female gap in major morbidity related expenditure increased from INR 1298 to INR 4172. A decomposition analysis of gender gap in HCE demonstrates that about 48% of the gap is attributable to differences in demographic and socio-economic factors (endowment effect), whereas 50% of the gap is due to the differential effect of the determinants (coefficient effect). Interpretation Indians spend less on female health care than on male health care. Most of the gender gap in HCE is not due to differential distribution of factors affecting HCE.	[Saikia, Nandita; Moradhvaj] Jawaharlal Nehru Univ, Ctr Study Reg Dev, New Delhi, India; [Bora, Jayanta Kumar] Publ Hlth Fdn India, Gurgaon, India	Jawaharlal Nehru University, New Delhi; Public Health Foundation of India	Saikia, N (corresponding author), Jawaharlal Nehru Univ, Ctr Study Reg Dev, New Delhi, India.	nanditasts@gmail.com	Bora, Jayanta/AAK-9419-2020	Bora, Jayanta/0000-0002-9735-3042; , Moradhvaj/0000-0002-8798-385X				Agarwal B, 1997, FEM EC, V3, P1, DOI [https://doi.org/10.1080/135457097338799, DOI 10.1080/135457097338799]; Ahmed SM, 2000, SOC SCI MED, V51, P361, DOI 10.1016/S0277-9536(99)00461-X; Alemayehu B, 2004, HEALTH SERV RES, V39, P627, DOI 10.1111/j.1475-6773.2004.00248.x; Anderson S., 2012, ECON POLIT WEEKLY, P87; [Anonymous], 1997, ENDANGERED SEX NEGLE; [Anonymous], 2008, ANAL HLTH EQUITY USI; Asfaw A, 2007, INTRAHOSEHOLD GENDED; Asfaw A, 2010, HEALTH ECON, V19, P265, DOI 10.1002/hec.1468; Batra A., 2014, 1403 IND STAT I; BEHRMAN JR, 1988, OXFORD ECON PAP, V40, P32, DOI 10.1093/oxfordjournals.oep.a041845; Bertakis KD, 2000, J FAM PRACTICE, V49, P147; BLINDER AS, 1973, J HUM RESOUR, V8, P436, DOI 10.2307/144855; Bora JK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141953; Borooah VK, 2004, SOC SCI MED, V58, P1719, DOI 10.1016/S0277-9536(03)00342-3; Cameron C., 2005, MICROECONOMETRICS US, P1056; Canudas-Romo V., 2015, ASIA PACIFIC POPULAT, V30; EPWRF India time series, 2016, EPWRF INDIA TIMES SE; Fikree FF, 2004, BMJ-BRIT MED J, V328, P823, DOI 10.1136/bmj.328.7443.823; Galdas PM, 2005, J ADV NURS, V49, P616, DOI 10.1111/j.1365-2648.2004.03331.x; Gao MT, 2006, ECON DEV CULT CHANGE, V55, P87, DOI 10.1086/505720; Guilmoto Christophe Z., 2015, POPUL DEV REV, V41, P241, DOI DOI 10.1111/J.1728-4457.2015.00046.X; Gupta M. D., 1987, POPUL DEV REV, V1, P77; HILL K, 1995, POPUL DEV REV, V21, P127, DOI 10.2307/2137416; Humphreys B R, 2010, DEALING ZEROS EC DAT; Iyer A, 2008, Glob Public Health, V3 Suppl 1, P13, DOI 10.1080/17441690801892174; Jayachandran S, 2015, Q J ECON, V126, P1485, DOI [10.2307/23015706, DOI 10.2307/23015706]; Kurz K M, 1997, GEBDER DIFFERENCES; Maharana B, 2014, GENDER DISPARITY HLT; Mckinsey Global Institute, 2015, POW PART ADV WOM EQ; Mishra V, 2004, POPUL DEV REV, V30, P269, DOI 10.1111/j.1728-4457.2004.013_1.x; NATHANSON CA, 1975, SOC SCI MED, V9, P57, DOI 10.1016/0037-7856(75)90094-3; NSSO, 2013, NSSO 68 ROUND JUL 20; Oaxaca R., 1973, INT ECON REV, V14, P693, DOI DOI 10.2307/2525981; Owens GM, 2008, J MANAGE CARE PHARM, V14, pS2; Pande RP, 2003, DEMOGRAPHY, V40, P395, DOI 10.1353/dem.2003.0029; Pandey A, 2002, J HEALTH POPUL NUTR, V20, P306; Roy K, 2008, SOC SCI MED, V66, P1951, DOI 10.1016/j.socscimed.2008.01.015; Saikia N, 2011, POP STUD-J DEMOG, V65, P73, DOI 10.1080/00324728.2010.534642; SANTOW G, 1995, SOC SCI MED, V40, P147, DOI 10.1016/0277-9536(94)E0069-5; Sen G, 2002, ENGENDER INT HLTH CH, V4, P281; Shugarman LR, 2008, WOMEN HEALTH ISS, V18, P199, DOI 10.1016/j.whi.2008.02.008; Song Y, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/1475-9276-13-8; Sudha S, 1999, DEV CHANGE, V30, P585, DOI 10.1111/1467-7660.00130; Sustainable development knowledge platform, 2015, SUST DEV GOAL; Vaidya V, 2012, J WOMENS HEALTH, V21, P140, DOI 10.1089/jwh.2011.2876; Willis JR, 2009, J HEALTH POPUL NUTR, V27, P62	46	44	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158332	10.1371/journal.pone.0158332	http://dx.doi.org/10.1371/journal.pone.0158332			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27391322	Green Submitted, gold, Green Published			2022-12-27	WOS:000380005400043
J	Zhang, WZ; Xiong, XM; Zhang, XJ; Wan, SM; Guan, NN; Nie, CH; Zhao, BW; Hsiao, CD; Wang, WM; Gao, ZX				Zhang, Wei-Zhuo; Xiong, Xue-Mei; Zhang, Xiu-Jie; Wan, Shi-Ming; Guan, Ning-Nan; Nie, Chun-Hong; Zhao, Bo-Wen; Hsiao, Chung-Der; Wang, Wei-Min; Gao, Ze-Xia			Mitochondrial Genome Variation after Hybridization and Differences in the First and Second Generation Hybrids of Bream Fishes	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; DNA CONTROL REGION; GENE ORGANIZATION; DARWINS COROLLARY; EVOLUTION; POLYMORPHISMS; PERCIFORMES; TELEOSTEI; TRAITS	Hybridization plays an important role in fish breeding. Bream fishes contribute a lot to aquaculture in China due to their economically valuable characteristics and the present study included five bream species, Megalobrama amblycephala, Megalobrama skolkovii, Megalobrama pellegrini, Megalobrama terminalis and Parabramis pekinensis. As maternal inheritance of mitochondrial genome (mitogenome) involves species specific regulation, we aimed to investigate in which way the inheritance of mitogenome is affected by hybridization in these fish species. With complete mitogenomes of 7 hybrid groups of bream species being firstly reported in the present study, a comparative analysis of 17 mitogenomes was conducted, including representatives of these 5 bream species, 6 first generation hybrids and 6 second generation hybrids. The results showed that these 17 mitogenomes shared the same gene arrangement, and had similar gene size and base composition. According to the phylogenetic analyses, all mitogenomes of the hybrids were consistent with a maternal inheritance. However, a certain number of variable sites were detected in all F-1 hybrid groups compared to their female parents, especially in the group of M. terminalis (female) xM. amblycephala (male) (MTxMA), with a total of 86 variable sites between MTxMA and its female parent. Among the mitogenomes genes, the protein-coding gene nd5 displayed the highest variability. The number of variation sites was found to be related to phylogenetic relationship of the parents: the closer they are, the lower amount of variation sites their hybrids have. The second generation hybrids showed less mitogenome variation than that of first generation hybrids. The non-synonymous and synonymous substitution rates (dN/dS) were calculated between all the hybrids with their own female parents and the results indicated that most PCGs were under negative selection.	[Zhang, Wei-Zhuo; Xiong, Xue-Mei; Zhang, Xiu-Jie; Wan, Shi-Ming; Guan, Ning-Nan; Nie, Chun-Hong; Zhao, Bo-Wen; Wang, Wei-Min; Gao, Ze-Xia] Huazhong Agr Univ, Minist Agr, Key Lab Freshwater Anim Breeding, Coll Fisheries, Wuhan, Hubei, Peoples R China; [Zhang, Wei-Zhuo; Xiong, Xue-Mei; Zhang, Xiu-Jie; Wan, Shi-Ming; Guan, Ning-Nan; Nie, Chun-Hong; Zhao, Bo-Wen; Gao, Ze-Xia] Freshwater Aquaculture Collaborat Innovat Ctr Hub, Wuhan, Peoples R China; [Hsiao, Chung-Der] Chung Yuan Christian Univ, Dept Biosci Technol, Chungli, Taiwan	Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs; Chung Yuan Christian University	Gao, ZX (corresponding author), Huazhong Agr Univ, Minist Agr, Key Lab Freshwater Anim Breeding, Coll Fisheries, Wuhan, Hubei, Peoples R China.; Gao, ZX (corresponding author), Freshwater Aquaculture Collaborat Innovat Ctr Hub, Wuhan, Peoples R China.	gaozexia@hotmail.com	Hsiao, Chung-Der/W-4535-2019	Hsiao, Chung-Der/0000-0002-6398-8672	National Natural Science Foundation of China [31472271]; Modern Agriculture Industry Technology System Construction Projects of China titled as-Staple Freshwater Fishes Industry Technology System [CARS-46-05]; Fundamental Research Funds for the Central Universities [2662015PY088]; Fundamental Research Funds for Innovation Center of Hubei Province [2016ZXPY04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Modern Agriculture Industry Technology System Construction Projects of China titled as-Staple Freshwater Fishes Industry Technology System; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Fundamental Research Funds for Innovation Center of Hubei Province	This work was financially supported by National Natural Science Foundation of China (No. 31472271), Modern Agriculture Industry Technology System Construction Projects of China titled as-Staple Freshwater Fishes Industry Technology System (No. CARS-46-05), Fundamental Research Funds for the Central Universities (2662015PY088) and Fundamental Research Funds for Innovation Center of Hubei Province (2016ZXPY04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquatic Products Bureau of Foushan in Guangdong Province, 1975, FISHERIES SCI TECHNO, V8, P18; AVISE JC, 1984, GENETICS, V108, P237; Bai YD, 2000, MOL CELL BIOL, V20, P805, DOI 10.1128/MCB.20.3.805-815.2000; Biase FH, 2007, GENET MOL BIOL, V30, P1058, DOI 10.1590/S1415-47572007000600005; BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7; Bolnick DI, 2008, GENETICS, V178, P1037, DOI 10.1534/genetics.107.081364; Bolnick DI, 2005, EVOLUTION, V59, P1754, DOI 10.1111/j.0014-3820.2005.tb01824.x; Broughton RE, 2001, GENOME RES, V11, P1958, DOI 10.1101/gr.156801; CHANG YS, 1994, J MOL EVOL, V38, P138, DOI 10.1007/BF00166161; Chen DX, 2012, MITOCHONDR DNA, V23, P70, DOI 10.3109/19401736.2011.653799; Chen Jie, 2014, Journal of Shanghai Ocean University, V23, P388; Chomyn A, 2001, J BIOENERG BIOMEMBR, V33, P251, DOI 10.1023/A:1010791204961; Fernandez AI, 2008, J ANIM SCI, V86, P1283, DOI 10.2527/jas.2007-0568; Guo XH, 2006, GENETICS, V172, P1745, DOI 10.1534/genetics.105.049841; Guo XH, 2003, AQUACULTURE, V224, P25, DOI 10.1016/S0044-8486(03)00168-6; Guo XH, 2004, ACTA ZOOL SINICA, V50, P408; Guo Xin-hong, 2004, Acta Genetica Sinica, V31, P983; GYLLENSTEN U, 1991, NATURE, V352, P255, DOI 10.1038/352255a0; Henderson-Arzapalo Anne, 1994, Journal of the World Aquaculture Society, V25, P289, DOI 10.1111/j.1749-7345.1994.tb00193.x; HIXSON JE, 1986, J BIOL CHEM, V261, P2384; KANEDA H, 1995, P NATL ACAD SCI USA, V92, P4542, DOI 10.1073/pnas.92.10.4542; Ke H W, 1965, ACTA HYDROBIOL SIN, V5, P282; Kim KK, 1996, FISHERIES SCI, V62, P490, DOI 10.2331/fishsci.62.490; Lai RuiFang, 2014, Journal of Fisheries of China, V38, P1; LEE WJ, 1995, J MOL EVOL, V41, P54; Li P, 2009, J GUANGDONG OCEAN U, V29, P12; Li Si-Fa, 2002, Acta Zoologica Sinica, V48, P339; Li T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055381; Li X, 2016, MITOCHONDRIAL DNA B; Liu Y, 2009, MAR GENOM, V2, P133, DOI 10.1016/j.margen.2009.07.003; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Nei M., 2000, MOL EVOLUTION PHYLOG; Nicholls JA, 2000, J AVIAN BIOL, V31, P165, DOI 10.1034/j.1600-048X.2000.310208.x; Oh DJ, 2007, GENE, V392, P174, DOI 10.1016/j.gene.2006.12.007; Qin YH, 2012, ANIM BIOTECHNOL, V23, P204, DOI 10.1080/10495398.2012.686468; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; Shirai K, 2014, GENE, V552, P239, DOI 10.1016/j.gene.2014.09.039; SPRINZL M, 1991, NUCLEIC ACIDS RES, V19, P2127, DOI 10.1093/nar/19.suppl.2127; SUOMALAINEN A, 1995, NAT GENET, V9, P146, DOI 10.1038/ng0295-146; Sutarno, 2002, THERIOGENOLOGY, V57, P1603, DOI 10.1016/S0093-691X(02)00664-7; Sutovsky P, 1999, NATURE, V402, P371, DOI 10.1038/46466; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Turelli M, 2007, GENETICS, V176, P1059, DOI 10.1534/genetics.106.065979; Wang CH, 2008, GENE, V424, P96, DOI 10.1016/j.gene.2008.07.011; Wang CH, 2012, MOL BIOL REP, V39, P6337, DOI 10.1007/s11033-012-1455-9; Wang XY, 2013, MITOCHONDR DNA, V24, P1, DOI 10.3109/19401736.2012.710222; Xie G, 2002, J HUBEI AGR COLL, V22, P330; Xu Hui, 2007, JOURNAL OF TROPICAL OCEANOGRAPHY, V26, P60; Xu W, 2008, J HYDROECOL, V1, P7; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zardoya R, 1995, J MOL EVOL, V41, P942, DOI 10.1007/BF00173174; Zhang B, 2008, BIOCHEM GENET, V46, P362, DOI 10.1007/s10528-008-9152-z; Zhang DaLong, 2014, Journal of Dalian Ocean University, V29, P121; Zhao Jin-Liang, 2006, Acta Genetica Sinica, V33, P793, DOI 10.1016/S0379-4172(06)60112-1; Zheng LeYun, 2014, Journal of Shanghai Ocean University, V23, P351; Zhou HL, 2012, J TROPICAL ORGANISMS, V3, P2; Zhou XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092033; Zhu F, 2015, MITOCHONDRIAL DNA; 刘焕章, 2002, [自然科学进展, Progress in Natural Science], V12, P266	60	6	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158915	10.1371/journal.pone.0158915	http://dx.doi.org/10.1371/journal.pone.0158915			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391325	gold, Green Published, Green Submitted			2022-12-27	WOS:000380005400160
J	Haanshuus, CG; Chandy, S; Manoharan, A; Vivek, R; Mathai, D; Xena, D; Singh, A; Langeland, N; Blomberg, B; Vasanthan, G; Sitaram, U; Appasamy, J; Nesaraj, J; Henry, A; Patil, S; Alvarez-Uria, G; Armstrong, L; Morch, K				Haanshuus, Christel Gill; Chandy, Sara; Manoharan, Anand; Vivek, Rosario; Mathai, Dilip; Xena, Deepika; Singh, Ashita; Langeland, Nina; Blomberg, Bjorn; Vasanthan, George; Sitaram, Usha; Appasamy, Jonathan; Nesaraj, Joel; Henry, Anil; Patil, Suvarna; Alvarez-Uria, Gerardo; Armstrong, Lois; Morch, Kristine			A High Malaria Prevalence Identified by PCR among Patients with Acute Undifferentiated Fever in India	PLOS ONE			English	Article							REAL-TIME-PCR; ASYMPTOMATIC PLASMODIUM-FALCIPARUM; POLYMERASE-CHAIN-REACTION; TRIBAL POPULATION; LOW TRANSMISSION; PARAHIT-F; INFECTIONS; AMPLIFICATION; DIAGNOSTICS; AREA	Background Approximately one million malaria cases were reported in India in 2015, based on microscopy. This study aims to assess the malaria prevalence among hospitalised fever patients in India identified by PCR, and to evaluate the performance of routine diagnostic methods. Methods During June 2011-December 2012, patients admitted with acute undifferentiated fever to seven secondary level community hospitals in Assam (Tezpur), Bihar (Raxaul), Chhattisgarh (Mungeli), Maharashtra (Ratnagiri), Andhra Pradesh (Anantapur) and Tamil Nadu (Oddanchatram and Ambur) were included. The malaria prevalence was assessed by polymerase chain reaction (PCR), routine microscopy, and a rapid diagnostic test (RDT) with PCR as a reference method. Results The malaria prevalence by PCR was 19% (268/1412) ranging from 6% (Oddanchatram, South India) to 35% (Ratnagiri, West India). Among malaria positive patients P. falciparum single infection was detected in 46%, while 38% had P. vivax, 11% mixed infections with P. falciparum and P. vivax, and 5% P. malariae. Compared to PCR, microscopy had sensitivity of 29% and specificity of 98%, while the RDT had sensitivity of 24% and specificity of 99%. Conclusions High malaria prevalence was identified by PCR in this cohort. Routine diagnostic methods had low sensitivity compared to PCR. The results suggest that malaria is underdiagnosed in rural India. However, low parasitaemia controlled by immunity may constitute a proportion of PCR positive cases, which calls for awareness of the fact that other pathogens could be responsible for the febrile disease in submicroscopic malaria.	[Haanshuus, Christel Gill; Langeland, Nina; Blomberg, Bjorn; Morch, Kristine] Haukeland Hosp, Dept Med, Natl Ctr Trop Infect Dis, Bergen, Norway; [Chandy, Sara; Manoharan, Anand; Vivek, Rosario; Mathai, Dilip; Xena, Deepika; Vasanthan, George; Sitaram, Usha] Christian Med Coll & Hosp, Infect Dis Training & Res Ctr, Dept Med, Dept Med,Unit 1, Vellore, Tamil Nadu, India; [Chandy, Sara; Manoharan, Anand; Vivek, Rosario; Mathai, Dilip; Xena, Deepika; Vasanthan, George; Sitaram, Usha] Christian Med Coll & Hosp, Infect Dis, Vellore, Tamil Nadu, India; [Singh, Ashita] Baptist Christian Hosp, Tezpur, Assam, India; [Langeland, Nina; Blomberg, Bjorn] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Appasamy, Jonathan] Christian Fellowship Hosp, Oddanchatram, Tamil Nadu, India; [Nesaraj, Joel] Bethesda Hosp, Ambur, Tamil Nadu, India; [Henry, Anil] Christian Hosp, Mungeli, Chhattisgarh, India; [Patil, Suvarna] BKL Walawalkar Hosp, Ratnagiri, Maharashtra, India; [Alvarez-Uria, Gerardo] Rural Dev Trust Hosp, Anantapur, Andhra Pradesh, India; [Armstrong, Lois] Duncan Hosp, Raxaul, Bihar, India	University of Bergen; Haukeland University Hospital; Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore; University of Bergen	Manoharan, A (corresponding author), Christian Med Coll & Hosp, Infect Dis Training & Res Ctr, Dept Med, Dept Med,Unit 1, Vellore, Tamil Nadu, India.; Manoharan, A (corresponding author), Christian Med Coll & Hosp, Infect Dis, Vellore, Tamil Nadu, India.	anandmanoharan@pushpagiri.in	Alvarez-Uria, Gerardo/G-6030-2012; Blomberg, Bjorn/B-9605-2015	Alvarez-Uria, Gerardo/0000-0003-1847-9614; Blomberg, Bjorn/0000-0001-5647-4297	National Centre for Tropical infectious diseases, Haukeland University Hospital, Bergen, Norway; Infectious Diseases Training and Research Center, Department of Medicine Unit I and infectious diseases, Christian Medical College, Vellore, India	National Centre for Tropical infectious diseases, Haukeland University Hospital, Bergen, Norway; Infectious Diseases Training and Research Center, Department of Medicine Unit I and infectious diseases, Christian Medical College, Vellore, India	The Infectious Diseases Training and Research Center, Department of Medicine Unit I and infectious diseases, Christian Medical College, Vellore, India and National Centre for Tropical infectious diseases, Haukeland University Hospital, Bergen, Norway funded all material used in this study, collection and analysis of data, and writing of the manuscript.	Aslanzadeh J, 2004, ANN CLIN LAB SCI, V34, P389; Babiker HA, 1999, MOL BIOCHEM PARASIT, V99, P143, DOI 10.1016/S0166-6851(98)00175-3; Bousema T, 2014, NAT REV MICROBIOL, V12, P833, DOI 10.1038/nrmicro3364; Chaturvedi HK, 2014, INT HEALTH, V6, P144, DOI 10.1093/inthealth/ihu020; Chew CH, 2012, J CLIN MICROBIOL, V50, P4012, DOI 10.1128/JCM.06454-11; Chrispal A, 2010, TROP DOCT, V40, P230, DOI 10.1258/td.2010.100132; Cunha MG, 2009, ACTA TROP, V111, P35, DOI 10.1016/j.actatropica.2009.02.003; Das N. G., 2000, Indian Journal of Malariology, V37, P88; Dhangadamajhi G, 2009, TROP BIOMED, V26, P326; Dhingra N, 2010, LANCET, V376, P1768, DOI 10.1016/S0140-6736(10)60831-8; Ganguly S, 2013, J CLIN MICROBIOL, V51, P1439, DOI 10.1128/JCM.03437-12; Golassa L, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1070-1; Golassa L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-352; Gupta B, 2010, TROP MED INT HEALTH, V15, P819, DOI 10.1111/j.1365-3156.2010.02549.x; Haanshuus CG, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-26; Hamer DH, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-210; Harris I, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-254; Joshi R, 2008, AM J TROP MED HYG, V78, P393, DOI 10.4269/ajtmh.2008.78.393; Kamugisha E M H, 2009, TANZANIA J HLTH RES, V11; Kocharekar Manali M, 2014, J Parasitol Res, V2014, P194651, DOI 10.1155/2014/194651; Krishna S, 2015, EMERG INFECT DIS, V21, P1853, DOI 10.3201/eid2110.150678; Krungkrai J, 2004, PARASITOLOGY, V129, P511, DOI 10.1017/S0031182004005888; Kumar A, 2012, ACTA TROP, V121, P246, DOI 10.1016/j.actatropica.2012.01.004; Kweka EJ, 2011, J INFECT DEV COUNTR, V5, P204, DOI 10.3855/jidc.1346; Mishra Gauravi, 2003, J Vector Borne Dis, V40, P109; Murphy SC, 2013, AM J TROP MED HYG, V89, P824, DOI 10.4269/ajtmh.12-0675; Okell LC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2241; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; Padley D, 2003, ANN TROP MED PARASIT, V97, P131, DOI 10.1179/000349803125002977; Rantala AM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-269; Rockett RJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-48; Shah NK, 2011, LANCET INFECT DIS, V11, P57, DOI 10.1016/S1473-3099(10)70214-0; Sharma SK, 2006, T ROY SOC TROP MED H, V100, P917, DOI 10.1016/j.trstmh.2006.01.007; Singh N, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-50; Singh N, 2003, AM J TROP MED HYG, V68, P602, DOI 10.4269/ajtmh.2003.68.602; Singh N, 2012, INDIA MALAR J, V11, P274, DOI DOI 10.1186/1475-2875-11-274; Singh N, 2006, AM J TROP MED HYG, V75, P812, DOI 10.4269/ajtmh.2006.75.812; Singh V, 2009, TRENDS PARASITOL, V25, P452, DOI 10.1016/j.pt.2009.06.004; Tajebe A, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-411; Van Hong Nguyen, 2013, Am J Trop Med Hyg, V89, P721, DOI 10.4269/ajtmh.13-0027; Wang B, 2014, J CLIN MICROBIOL, V52, P1838, DOI 10.1128/JCM.03615-13; WHO, 2015, WORLD MAL REP 2015; World Health Organization, 2012, MAL RAP DIAGN TESTS; Wu L, 2015, NATURE, V528, pS86, DOI 10.1038/nature16039	44	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158816	10.1371/journal.pone.0158816	http://dx.doi.org/10.1371/journal.pone.0158816			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27389396	gold, Green Published			2022-12-27	WOS:000379811500050
J	Horthongkham, N; Athipanyasilp, N; Pattama, A; Kaewnapan, B; Sornprasert, S; Srisurapanont, S; Kantakamalakul, W; Amaranond, P; Sutthent, R				Horthongkham, Navin; Athipanyasilp, Niracha; Pattama, Archiraya; Kaewnapan, Bualan; Sornprasert, Suthatta; Srisurapanont, Surangrat; Kantakamalakul, Wannee; Amaranond, Palanee; Sutthent, Ruengpung			Epidemiological, Clinical and Virological Characteristics of Influenza B Virus from Patients at the Hospital Tertiary Care Units in Bangkok during 2011-2014	PLOS ONE			English	Article							ANTIGENIC STRUCTURE; COCIRCULATING LINEAGES; EVOLUTIONARY PATTERN; SEQUENCE-ANALYSIS; HONG-KONG; HEMAGGLUTININ; SURVEILLANCE; VARIANTS; REASSORTMENT; DELETION	Influenza B virus, which causes acute respiratory infections, has increased in prevalence in recent years. Based on the nucleotide sequence of the hemagglutinin (HA) gene, influenza B virus can be divided into two lineages, Victoria and Yamagata, that co-circulate during the influenza season. However, analysis of the potential association between the clinical and virological characteristic and the lineage of influenza B viruses isolated in Thailand was lacking. To investigate influenza B virus genetically and determine its neuraminidase (NA) inhibitor susceptibility phenotype, a total of 6920 nasopharyngeal-wash samples were collected from patients with influenza-like illness between the years 2011 and 2014 and were screened for influenza B virus by real-time PCR. Of these samples, 3.1% (216/6920) were confirmed to contain influenza B viruses, and 110 of these influenza viruses were randomly selected for nucleotide sequence analysis of the HA and NA genes. Phylogenetic analysis of the HA sequences showed clustering into various clades: Yamagata clade 3 (11/110, 10%), Yamagata clade 2 (71/110, 64.5%), and Victoria clade 1 (28/110, 25.5%). The analysis of clinical characteristic demonstrated that the Victoria lineage was significantly associated with the duration of hospitalization, number of deceased cases, pneumonia, secondary bacterial infection and underlying disease. When combined with phylogenetic analysis of the NA sequences, four samples showed viruses with reassortant sequences between the Victoria and Yamagata lineages. Statistical analysis of the clinical outcomes and demographic data for the reassortant strains did not differ from those of the other strains in circulation. Oseltamivir-resistant influenza B viruses were not detected. Our findings indicated the co-circulation of the Victoria and Yamagata lineages over the past four cold seasons in Bangkok. We also demonstrated differences in the clinical symptoms between these lineages.	[Horthongkham, Navin; Athipanyasilp, Niracha; Pattama, Archiraya; Kaewnapan, Bualan; Sornprasert, Suthatta; Kantakamalakul, Wannee; Sutthent, Ruengpung] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok, Thailand; [Srisurapanont, Surangrat] Srinakharinwirot Univ, Fac Med, Dept Pathol, Bangkok, Thailand; [Amaranond, Palanee] Chulalongkorn Univ, Fac Allied Hlth Sci, Dept Blood Transfus, Bangkok, Thailand	Mahidol University; Srinakharinwirot University; Chulalongkorn University	Sutthent, R (corresponding author), Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok, Thailand.	ruengpung.sut@mahidol.ac.th	Horthongkham, Navin/AAZ-7963-2021		Faculty of Medicine, Srinakharinwirot University	Faculty of Medicine, Srinakharinwirot University	This work was funded by Faculty of Medicine, Srinakharinwirot University (to S. Srisurapanont).	BERTON MT, 1984, J VIROL, V52, P919, DOI 10.1128/JVI.52.3.919-927.1984; BERTON MT, 1985, VIROLOGY, V143, P583, DOI 10.1016/0042-6822(85)90396-4; Byarugaba DK, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-11; Chi XS, 2003, J CLIN MICROBIOL, V41, P5770, DOI 10.1128/JCM.41.12.5770-5773.2003; Chittaganpitch M., 2011, Regional Health Forum, V15, P57; Chittaganpitch M, 2012, INFLUENZA OTHER RESP, V6, P276, DOI 10.1111/j.1750-2659.2011.00302.x; Chiu SC, 2014, INT J INFECT DIS, V23, P94, DOI 10.1016/j.ijid.2014.02.017; Chiu SS, 2016, VACCINE, V34, P2164, DOI 10.1016/j.vaccine.2016.03.032; Escuret V, 2008, J CLIN VIROL, V41, P25, DOI 10.1016/j.jcv.2007.10.019; Gutierrez-Pizarraya A, 2012, J INFECTION, V65, P423, DOI 10.1016/j.jinf.2012.07.004; HOVANEC DL, 1984, VIROLOGY, V139, P384, DOI 10.1016/0042-6822(84)90384-2; KANEGAE Y, 1990, J VIROL, V64, P2860, DOI 10.1128/JVI.64.6.2860-2865.1990; KINNUNEN L, 1992, J GEN VIROL, V73, P733, DOI 10.1099/0022-1317-73-3-733; Kittikraisak W, 2015, INFLUENZA OTHER RESP, V9, P85, DOI 10.1111/irv.12302; Lindstrom SE, 1999, J VIROL, V73, P4413, DOI 10.1128/JVI.73.5.4413-4426.1999; McCullers JA, 1999, J VIROL, V73, P7343, DOI 10.1128/JVI.73.9.7343-7348.1999; Nerome R, 1998, ARCH VIROL, V143, P1569, DOI 10.1007/s007050050399; Ni FY, 2013, VIROLOGY, V446, P112, DOI 10.1016/j.virol.2013.07.035; Okomo-Adhiambo M, 2010, VIRUSES-BASEL, V2, P2269, DOI 10.3390/v2102269; Oong XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136254; Payungporn S, 2011, J VIROL METHODS, V177, P133, DOI 10.1016/j.jviromet.2011.07.008; RIVERA K, 1995, VIROLOGY, V206, P787, DOI 10.1006/viro.1995.1001; ROTA PA, 1990, VIROLOGY, V175, P59, DOI 10.1016/0042-6822(90)90186-U; Shaw MW, 2002, VIROLOGY, V303, P1, DOI 10.1006/viro.2002.1719; Sheu TG, 2008, ANTIMICROB AGENTS CH, V52, P3284, DOI 10.1128/AAC.00555-08; Sleeman K, 2011, EMERG INFECT DIS, V17, P2043, DOI 10.3201/eid1711.110787; Socan M, 2014, J CLIN VIROL, V61, P156, DOI 10.1016/j.jcv.2014.06.018; Tan Y, 2013, J VIROL, V87, P12447, DOI 10.1128/JVI.01039-13; Tewawong N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116302; Thailand Ministry of Public Health, 2011, CLIN PRACT GUID INFL; Wang QH, 2008, J VIROL, V82, P3011, DOI 10.1128/JVI.02477-07; WEBSTER RG, 1981, J GEN VIROL, V54, P243, DOI 10.1099/0022-1317-54-2-243; *WHO, 2002, WKLY EPIDEMIOL REC, V77, P57; World Health Organization, 2003, WKLY EPIDEMIOL REC, V77, P341; YAMASHITA M, 1988, VIROLOGY, V163, P112, DOI 10.1016/0042-6822(88)90238-3; Yang JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047179	36	20	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158244	10.1371/journal.pone.0158244	http://dx.doi.org/10.1371/journal.pone.0158244			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27387488	gold, Green Submitted, Green Published			2022-12-27	WOS:000379811500017
J	Burblies, N; Schulze, J; Schwarz, HC; Kranz, K; Motz, D; Vogt, C; Lenarz, T; Warnecke, A; Behrens, P				Burblies, Niklas; Schulze, Jennifer; Schwarz, Hans-Christoph; Kranz, Katharina; Motz, Damian; Vogt, Carla; Lenarz, Thomas; Warnecke, Athanasia; Behrens, Peter			Coatings of Different Carbon Nanotubes on Platinum Electrodes for Neuronal Devices: Preparation, Cytocompatibility and Interaction with Spiral Ganglion Cells	PLOS ONE			English	Article							RAMAN-SPECTROSCOPY; STIMULATION; NANOMATERIALS; PURIFICATION; COMPOSITES; GRAPHITE; DISORDER; RELEASE; SYSTEMS	Cochlear and deep brain implants are prominent examples for neuronal prostheses with clinical relevance. Current research focuses on the improvement of the long-term functionality and the size reduction of neural interface electrodes. A promising approach is the application of carbon nanotubes (CNTs), either as pure electrodes but especially as coating material for electrodes. The interaction of CNTs with neuronal cells has shown promising results in various studies, but these appear to depend on the specific type of neurons as well as on the kind of nanotubes. To evaluate a potential application of carbon nanotube coatings for cochlear electrodes, it is necessary to investigate the cytocompatibility of carbon nanotube coatings on platinum for the specific type of neuron in the inner ear, namely spiral ganglion neurons. In this study we have combined the chemical processing of as delivered CNTs, the fabrication of coatings on platinum, and the characterization of the electrical properties of the coatings as well as a general cytocompatibility testing and the first cell culture investigations of CNTs with spiral ganglion neurons. By applying a modification process to three different as-received CNTs via a reflux treatment with nitric acid, long-term stable aqueous CNT dispersions free of dispersing agents were obtained. These were used to coat platinum substrates by an automated spray-coating process. These coatings enhance the electrical properties of platinum electrodes, decreasing the impedance values and raising the capacitances. Cell culture investigations of the different CNT coatings on platinum with NIH3T3 fibroblasts attest an overall good cytocompatibility of these coatings. For spiral ganglion neurons, this can also be observed but a desired positive effect of the CNTs on the neurons is absent. Furthermore, we found that the well-established DAPI staining assay does not function on the coatings prepared from single-wall nanotubes.	[Burblies, Niklas; Schwarz, Hans-Christoph; Motz, Damian; Vogt, Carla; Behrens, Peter] Leibniz Univ Hannover, Inst Inorgan Chem, Hannover, Germany; [Schulze, Jennifer; Kranz, Katharina; Lenarz, Thomas; Warnecke, Athanasia] Hannover Med Sch, Dept Otorhinolaryngol Head & Neck Surg, Hannover, Germany; [Burblies, Niklas; Schulze, Jennifer; Schwarz, Hans-Christoph; Kranz, Katharina; Lenarz, Thomas; Warnecke, Athanasia; Behrens, Peter] Cluster Excellence Hearing4all, Hannover, Germany	Leibniz University Hannover; Hannover Medical School	Behrens, P (corresponding author), Leibniz Univ Hannover, Inst Inorgan Chem, Hannover, Germany.; Behrens, P (corresponding author), Cluster Excellence Hearing4all, Hannover, Germany.	Peter.Behrens@acb.uni-hannover.de	Warnecke, Athanasia/HHC-6174-2022	Motz, Damian Alexander/0000-0003-2013-9117	DFG Cluster of Excellence "Hearing4all" [EXC 1077/1]	DFG Cluster of Excellence "Hearing4all"	This work was supported by DFG Cluster of Excellence EXC 1077/1 "Hearing4all", http://hearing4all.eu/, NB JS KK.; This work was supported by the DFG Cluster of Excellence EXC 1077/1 "Hearing4all".	Anto BT, 2016, PHYS STATUS SOLIDI A, V213, P1447, DOI 10.1002/pssa.201532798; Baranauskas G, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/066013; Bareket-Keren L, 2012, FRONT NEURAL CIRCUIT, V6, P1; Belyanskaya L, 2009, NEUROTOXICOLOGY, V30, P702, DOI 10.1016/j.neuro.2009.05.005; Bostrom M, 2007, OTOL NEUROTOL, V28, P1109, DOI 10.1097/MAO.0b013e318159e710; Bruggemann D, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/26/265104; Cancado LG, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2196057; Castagnola E, 2010, PHYS STATUS SOLIDI B, V247, P2703, DOI 10.1002/pssb.201000217; Chen CH, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/48/485501; Dresselhaus MS, 2005, PHYS REP, V409, P47, DOI 10.1016/j.physrep.2004.10.006; Endo M, 2001, APPL PHYS LETT, V79, P1531, DOI 10.1063/1.1400774; Ferrari AC, 2007, SOLID STATE COMMUN, V143, P47, DOI 10.1016/j.ssc.2007.03.052; Ferrari AC, 2013, NAT NANOTECHNOL, V8, P235, DOI 10.1038/nnano.2013.46; Gillespie LN, 2001, NEUROREPORT, V12, P275, DOI 10.1097/00001756-200102120-00019; Grobert N, 2007, MATER TODAY, V10, P28, DOI 10.1016/S1369-7021(06)71789-8; Hou PX, 2008, CARBON, V46, P2003, DOI 10.1016/j.carbon.2008.09.009; Hu H, 2003, J PHYS CHEM B, V107, P13838, DOI 10.1021/jp035719i; Hu LB, 2010, CHEM REV, V110, P5790, DOI 10.1021/cr9002962; Hussain S., 2011, J MODERN PHYS, V2, P538, DOI DOI 10.4236/JMP.2011.26063; Keefer EW, 2008, NAT NANOTECHNOL, V3, P434, DOI 10.1038/nnano.2008.174; Kim YG, 2014, J BIOMATER APPL, V28, P790, DOI 10.1177/0885328213481637; Kotov NA, 2009, ADV MATER, V21, P3970, DOI 10.1002/adma.200801984; Krug HF, 2014, ANGEW CHEM INT EDIT, V53, P12304, DOI 10.1002/anie.201403367; Liu W, 2014, CELL TISSUE RES, V355, P267, DOI 10.1007/s00441-013-1735-2; Luo XL, 2011, BIOMATERIALS, V32, P6316, DOI 10.1016/j.biomaterials.2011.05.020; Marchesan S., 2014, MATER TODAY, V18, P12; Mattson MP, 2000, J MOL NEUROSCI, V14, P175, DOI 10.1385/JMN:14:3:175; Pimenta MA, 2007, PHYS CHEM CHEM PHYS, V9, P1276, DOI 10.1039/b613962k; Schroper F, 2008, ELECTROCHIM ACTA, V53, P6265, DOI 10.1016/j.electacta.2008.03.068; SLUYTERSREHBACH M, 1994, PURE APPL CHEM, V66, P1831, DOI 10.1351/pac199466091831; Stover T., 2009, HEAD NECK SURG, V8, P1, DOI DOI 10.3205/CTO000062; Thostenson ET, 2001, COMPOS SCI TECHNOL, V61, P1899, DOI 10.1016/S0266-3538(01)00094-X; Vaisman L, 2006, ADV COLLOID INTERFAC, V128, P37, DOI 10.1016/j.cis.2006.11.007; von Ilberg CA, 2011, AUDIOL NEURO-OTOL, V16, P1, DOI 10.1159/000327765; Wang K, 2006, NANO LETT, V6, P2043, DOI 10.1021/nl061241t; Warnecke A, 2007, NEUROREPORT, V18, P1683, DOI 10.1097/WNR.0b013e3282f0b5d7; Wefstaedt P, 2005, NEUROREPORT, V16, P2011, DOI 10.1097/00001756-200512190-00008; Worle-Knirsch JM, 2006, NANO LETT, V6, P1261, DOI 10.1021/nl060177c; Xie JN, 2006, SMART MATER STRUCT, V15, pN85, DOI 10.1088/0964-1726/15/4/N02; Yang KX, 2010, J ANAL ATOM SPECTROM, V25, P1290, DOI 10.1039/c0ja00012d; Yoon I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065715; Zhang Q, 2013, SMALL, V9, P1237, DOI 10.1002/smll.201203252	42	11	12	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158571	10.1371/journal.pone.0158571	http://dx.doi.org/10.1371/journal.pone.0158571			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27385031	Green Published, gold			2022-12-27	WOS:000379809400060
J	Lu, YC; Lee, YR; Liao, JD; Lin, CY; Chen, YY; Chen, PT; Tseng, YS				Lu, Yin-Che; Lee, Ying-Ray; Liao, Ji-Der; Lin, Ching-Yen; Chen, Yih-Yuan; Chen, Ping-Tzu; Tseng, Ya-Shih			Reversine Induced Multinucleated Cells, Cell Apoptosis and Autophagy in Human Non-Small Cell Lung Cancer Cells	PLOS ONE			English	Article							AURORA KINASE; ANTITUMOR-ACTIVITY; MITOTIC KINASE; OVEREXPRESSION; RESISTANCE; EXPRESSION; CARCINOMA; AMPLIFICATION; INHIBITOR; ERLOTINIB	Reversine, an A3 adenosine receptor antagonist, has been shown to induce differentiated myogenic-lineage committed cells to become multipotent mesenchymal progenitor cells. We and others have reported that reversine has an effect on human tumor suppression. This study revealed anti-tumor effects of reversine on proliferation, apoptosis and autophagy induction in human non-small cell lung cancer cells. Treatment of these cells with reversine suppressed cell growth in a time- and dosage-dependent manner. Moreover, polyploidy occurred after reversine treatment. In addition, caspase-dependent apoptosis and activation of autophagy by reversine in a dosage-dependent manner were also observed. We demonstrated in this study that reversine contributes to growth inhibition, apoptosis and autophagy induction in human lung cancer cells. Therefore, reversine used as a potential therapeutic agent for human lung cancer is worthy of further investigation.	[Lu, Yin-Che] Chia Nan Univ Pharm & Sci, Dept Hlth & Nutr, Tainan, Taiwan; [Lu, Yin-Che] Chia Yi Christian Hosp, Ditmanson Med Fdn, Div Hematol Oncol, Chiayi, Taiwan; [Lee, Ying-Ray; Lin, Ching-Yen; Chen, Ping-Tzu] Chia Yi Christian Hosp, Ditmanson Med Fdn, Dept Med Res, Chiayi, Taiwan; [Liao, Ji-Der; Tseng, Ya-Shih] Chung Hwa Univ Med Technol, Coll Med & Life Sci, Dept Med Lab Sci & Biotechnol, Tainan, Taiwan; [Chen, Yih-Yuan] Natl Chiayi Univ, Dept Biochem Sci & Technol, Chiayi, Taiwan; [Chen, Yih-Yuan] Chia Yi Christian Hosp, Ditmanson Med Fdn, Dept Internal Med, Chiayi, Taiwan	Chia Nan University of Pharmacy & Science; Chung Hua University; National Chiayi University	Tseng, YS (corresponding author), Chung Hwa Univ Med Technol, Coll Med & Life Sci, Dept Med Lab Sci & Biotechnol, Tainan, Taiwan.	shih415@mail.hwai.edu.tw		Lee, Ying-Ray/0000-0002-0349-0960	Chiayi Christian Hospital [R99-20]; Ministry of Science and Technology, ROC [MOST 104-2314-B-705-003]; Chung Hwa University of Medical Technology [1011001]	Chiayi Christian Hospital; Ministry of Science and Technology, ROC; Chung Hwa University of Medical Technology	This study was supported by research grants from Chiayi Christian Hospital (Grant R99-20), the Ministry of Science and Technology, ROC (MOST 104-2314-B-705-003), and Chung Hwa University of Medical Technology (Grant 1011001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnese V, 2007, ANN ONCOL, V18, P47, DOI 10.1093/annonc/mdm224; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Chieffi P, 2006, PROSTATE, V66, P326, DOI 10.1002/pros.20345; Chung BM, 2009, ONCOGENE, V28, P1821, DOI 10.1038/onc.2009.31; Clark P A, 1998, J Ky Med Assoc, V96, P440; D'Alise AM, 2008, MOL CANCER THER, V7, P1140, DOI 10.1158/1535-7163.MCT-07-2051; Filosto S, 2013, MOL CANCER THER, V12, P1579, DOI 10.1158/1535-7163.MCT-12-1029; Gritsko TM, 2003, CLIN CANCER RES, V9, P1420; Guo YA, 2013, MOL CANCER RES, V11, P282, DOI 10.1158/1541-7786.MCR-12-0558; Hamidi T, 2012, CLIN CANCER RES, V18, P5234, DOI 10.1158/1078-0432.CCR-12-0026; Hardwicke MA, 2009, MOL CANCER THER, V8, P1808, DOI 10.1158/1535-7163.MCT-09-0041; Hsieh TC, 2007, INT J ONCOL, V31, P1293; Hua SC, 2012, PHARM RES-DORDR, V29, P1990, DOI 10.1007/s11095-012-0727-3; Jani JP, 2010, MOL CANCER THER, V9, P883, DOI 10.1158/1535-7163.MCT-09-0915; Jemaa M, 2012, CELL CYCLE, V11, P2149, DOI 10.4161/cc.20621; Jeng YM, 2004, CLIN CANCER RES, V10, P2065, DOI 10.1158/1078-0432.CCR-1057-03; Kanda R, 2013, CANCER RES, V73, P6243, DOI 10.1158/0008-5472.CAN-12-4502; Kim YK, 2007, BIOCHEM BIOPH RES CO, V358, P553, DOI 10.1016/j.bbrc.2007.04.165; Kuo CH, 2014, BREAST CANCER-TOKYO, V21, P358, DOI 10.1007/s12282-012-0400-z; Lee YR, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-9; Li R, 2013, MOL CANCER THER, V12, P2200, DOI 10.1158/1535-7163.MCT-13-0095; Looyenga BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030820; Lu CH, 2012, BIOMED PHARMACOTHER, V66, P642, DOI 10.1016/j.biopha.2012.08.001; McMillin DW, 2010, NAT MED, V16, P483, DOI 10.1038/nm.2112; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Ogawa E, 2008, ANN SURG ONCOL, V15, P547, DOI 10.1245/s10434-007-9653-8; Perreira M, 2005, J MED CHEM, V48, P4910, DOI 10.1021/jm050221l; Pihan GA, 2001, CANCER RES, V61, P2212; Qin HX, 2013, CYTOTECHNOLOGY, V65, P643, DOI 10.1007/s10616-012-9520-8; Sato M, 2002, AM J RESP CELL MOL, V26, P127, DOI 10.1165/ajrcmb.26.1.4319; Scrima M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030427; Sen S, 2002, JNCI-J NATL CANCER I, V94, P1320; Shepherd FA, 2013, AM SOC CLIN ONCOL ED, V2013, P339, DOI DOI 10.1200/EDBOOK_AM.2013.33.339; Sorrentino R, 2005, J CLIN ENDOCR METAB, V90, P928, DOI 10.1210/jc.2004-1518; Sun YG, 2011, J THORAC ONCOL, V6, P699, DOI 10.1097/JTO.0b013e31820d9d11; Tatsuka M, 1998, CANCER RES, V58, P4811; Vischioni B, 2006, MOL CANCER THER, V5, P2905, DOI 10.1158/1535-7163.MCT-06-0301; Xu ZH, 2013, INT J CLIN EXP PATHO, V6, P1493; Xu ZH, 2014, MOL CARCINOGEN, V53, P917, DOI 10.1002/mc.22059; Yeh CT, 2013, CARCINOGENESIS, V34, P2918, DOI 10.1093/carcin/bgt255; Zeng WFF, 2007, J CLIN PATHOL, V60, P218, DOI 10.1136/jcp.2006.036806; Zhang XY, 2009, ANTICANCER RES, V29, P4497; Zhao M, 2011, LUNG CANCER, V73, P366, DOI 10.1016/j.lungcan.2011.01.002; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496; Zhu JJ, 2005, CANCER GENET CYTOGEN, V159, P10, DOI 10.1016/j.cancergencyto.2004.09.008; Zou ZZ, 2012, AUTOPHAGY, V8, P1798, DOI 10.4161/auto.22110	47	24	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158587	10.1371/journal.pone.0158587	http://dx.doi.org/10.1371/journal.pone.0158587			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27385117	Green Submitted, Green Published, gold			2022-12-27	WOS:000379809400061
J	Apesteguia, S; Smith, ND; Valieri, RJ; Makovicky, PJ				Apesteguia, Sebastian; Smith, Nathan D.; Juarez Valieri, Ruben; Makovicky, Peter J.			An Unusual New Theropod with a Didactyl Manus from the Upper Cretaceous of Patagonia, Argentina	PLOS ONE			English	Article							MEGARAPTOR-NAMUNHUAIQUII; DINOSAURIA THEROPODA; PRINCIPAL COMPONENTS; BAHARIYA FORMATION; EVOLUTION; OSTEOLOGY; ORIGIN; DIVERSIFICATION; BIOGEOGRAPHY; PHYLOGENY	Background Late Cretaceous terrestrial strata of the Neuquen Basin, northern Patagonia, Argentina have yielded a rich fauna of dinosaurs and other vertebrates. The diversity of saurischian dinosaurs is particularly high, especially in the late Cenomanian-early Turonian Huincul Formation, which has yielded specimens of rebacchisaurid and titanosaurian sauropods, and abelisaurid and carcharodontosaurid theropods. Continued sampling is adding to the known vertebrate diversity of this unit. Methodology/Principal Findings A new, partially articulated mid-sized theropod was found in rocks from the Huincul Formation. It exhibits a unique combination of traits that distinguish it from other known theropods justifying erection of a new taxon, Gualicho shinyae gen. et sp. nov. Gualicho possesses a didactyl manus with the third digit reduced to a metacarpal splint reminiscent of tyrannosaurids, but both phylogenetic and multivariate analyses indicate that didactyly is convergent in these groups. Derived characters of the scapula, femur, and fibula supports the new theropod as the sister taxon of the nearly coeval African theropod Deltadromeus and as a neovenatorid carcharodontosaurian. A number of these features are independently present in ceratosaurs, and Gualicho exhibits an unusual mosaic of ceratosaurian and tetanuran synapomorphies distributed throughout the skeleton. Conclusions/Significance Gualicho shinyae gen. et sp. nov. increases the known theropod diversity of the Huincul Formation and also represents the first likely neovenatorid from this unit. It is the most basal tetatanuran to exhibit common patterns of digit III reduction that evolved independently in a number of other tetanuran lineages. A close relationship with Deltadromaeus from the Kem Kem beds of Niger adds to the already considerable biogeographic similarity between the Huincul Formation and coeval rock units in North Africa.	[Apesteguia, Sebastian] Univ Maimonides, CEBBAD, Area Paleontol, Fdn Hist Nat Felix Azara, Buenos Aires, DF, Argentina; [Smith, Nathan D.] Nat Hist Museum Los Angeles Cty, Dinosaur Inst, Los Angeles, CA USA; [Juarez Valieri, Ruben] Gobierno Prov Rio Negro, Secretaria Cultura, Gen Roca, Argentina; [Makovicky, Peter J.] Field Museum Nat Hist, Integrat Res Ctr, Sect Earth Sci, Chicago, IL 60605 USA	Field Museum of Natural History (Chicago)	Makovicky, PJ (corresponding author), Field Museum Nat Hist, Integrat Res Ctr, Sect Earth Sci, Chicago, IL 60605 USA.	pmakovicky@fieldmuseum.org	Apesteguía, Sebastian/F-4034-2018	Apesteguía, Sebastian/0000-0002-0414-0524	Field Museum of Natural History; US National Science Foundation [EAR 0228607, ANT 0838925, PLR 1246379, EAR 1349554]; Consejo Nacional de Ciencia y Tecnologia; CONICET; Willi Hennig Society; Directorate For Geosciences [1246379] Funding Source: National Science Foundation	Field Museum of Natural History; US National Science Foundation(National Science Foundation (NSF)); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Willi Hennig Society; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Fieldwork was supported by funding from the Field Museum of Natural History to PJM. PJM and NDS were supported by grants from the US National Science Foundation over the course of this work (EAR 0228607; ANT 0838925; PLR 1246379; and EAR 1349554). SA was supported by the Consejo Nacional de Ciencia y Tecnologia.; We are grateful to Akiko Shinya, Alejandro Otero, Pablo Gallina, Jorge Gonzalez, and Attila Osi for assistance in the field, and to Juan Ignacio Canale and Alejandro Haluza for their assistance and hospitality in El Chocon. Rodolfo Coria, Philip Currie, and Hussam Zaher are thanked for discussions surrounding the provenance and history of excavation and preparation of the specimen. PJM and NDS are grateful to Pablo Chafrat for specimen access. Fieldwork that resulted in the discovery of the holotype of Gualicho shinyae was supported by a generous gift from Michael and Jacqueline Ferro through the Women's Board of The Field Museum. PJM and NDS were supported by grants from the US National Science Foundation over the course of this work (EAR 0228607; ANT 0838925; PLR 1246379; and EAR 1349554). SA was supported by CONICET. A single user copy of TNT used for this research was provided free through the generous support of the Willi Hennig Society. Diego Pol is thanked for his assistance in modifying the 'Term_length' script to include all taxa, and Sushma Reddy is thanked for assistance with R scripting.	Apestegufa S., 2007, 5 REUN ARG ICN 3 REU, P48; Apesteguia S., 2002, B 2 S CRETACIO AM, V6, P135; Azuma Y, 2000, CAN J EARTH SCI, V37, P1735, DOI 10.1139/e00-064; Baumel J.J., 1993, HDB AVIAN ANATOMY NO, P779; Bell MA, 2015, PALAEONTOLOGY, V58, P379, DOI 10.1111/pala.12142; Benson RBJ, 2008, GEOL MAG, V145, P778, DOI 10.1017/S0016756808005475; Benson RBJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1780; Benson RBJ, 2013, PALAEOGEOGR PALAEOCL, V372, P88, DOI 10.1016/j.palaeo.2012.10.028; Benson RBJ, 2010, ZOOL J LINN SOC-LOND, V158, P882, DOI 10.1111/j.1096-3642.2009.00569.x; Benson RBJ, 2010, NATURWISSENSCHAFTEN, V97, P71, DOI 10.1007/s00114-009-0614-x; Bonaparte JF, 1990, CONTRIB SCI NAT HIST; Bonaparte Jose F., 1993, Ameghiniana, V30, P271; Botelho JF, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001957; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; Britt B.B., 1991, Brigham Young University Geology Studies, V37, P1; BROCHU C. A., 2002, MEMOIR SOC VERTEBRAT, V22, P1; Brusatte SL, 2008, SCIENCE, V321, P1485, DOI 10.1126/science.1161833; Brusatte SL, 2014, CURR BIOL, V24, P2386, DOI 10.1016/j.cub.2014.08.034; Brusatte Stephen L., 2008, Monograph of the Palaeontographical Society, P1; Burch SH, 2014, J ANAT, V225, P271, DOI 10.1111/joa.12216; Calvo JO, 2004, AMEGHINIANA, V41, P555; Calvo JO, 2004, AMEGHINIANA, V41, P565; Canale J, 2009, NATURWISSENSCHAFTEN, V96, P409, DOI 10.1007/s00114-008-0487-4; Carpenter Kenneth, 2001, P90; Carrano MT, 2008, J SYST PALAEONTOL, V6, P183, DOI 10.1017/S1477201907002246; Carrano MT, 2007, J VERTEBR PALEONTOL, V27, P163, DOI 10.1671/0272-4634(2007)27[163:TASOMC]2.0.CO;2; Carrano MT, 2012, J SYST PALAEONTOL, V10, P211, DOI 10.1080/14772019.2011.630927; Carrano Matthew T., 2011, Smithsonian Contributions to Paleobiology, P1; Carrano MT, 2002, J MORPHOL, V253, P207, DOI 10.1002/jmor.10018; Carrano MT, 2002, J VERTEBR PALEONTOL, V22, P510, DOI 10.1671/0272-4634(2002)022[0510:TOOMKA]2.0.CO;2; Casal Gabriel A, 2015, Rev. Asoc. Geol. Argent., V72, P77; Catuneanu O, 2006, SEDIMENT GEOL, V190, P121, DOI 10.1016/j.sedgeo.2006.05.010; Cavin L, 2010, J AFR EARTH SCI, V57, P391, DOI 10.1016/j.jafrearsci.2009.12.007; Chiarenza AA, 2016, PEERJ, V4, DOI 10.7717/peerj.1754; Chure DJ, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P283; Claessens LPAM, 2004, J VERTEBR PALEONTOL, V24, P89, DOI 10.1671/A1116-8; Coria R., 2000, GAIA, V102, P89; Coria RA, 2006, GEODIVERSITAS, V28, P71; Currie Philip J., 2000, Geodiversitas, V22, P207; CURRIE PJ, 1993, CAN J EARTH SCI, V30, P2037, DOI 10.1139/e93-179; Ezcurra MD, 2012, SYST BIOL, V61, P553, DOI 10.1093/sysbio/syr115; FOOTE M, 1994, PALEOBIOLOGY, V20, P320, DOI 10.1017/S009483730001280X; Gallina Pablo A., 2005, Revista del Museo Argentino de Ciencias Naturales, V7, P153; Galton P.M., 1979, Brigham Young University Geology Studies, V26, P1; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hanson M, 2014, HIST BIOL, V26, P775, DOI 10.1080/08912963.2013.853056; Harris J.D., 1998, B NEW MEXICO MUSEUM, V13, P1; Hocknull SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006190; Holtz TR, 2004, DINOSAURIA, 2ND EDITION, P111; Ibrahim N, 2014, SCIENCE, V345, P1613, DOI 10.1126/science.1258750; Lamanna MC, 2002, J VERTEBR PALEONTOL, V22, P58, DOI 10.1671/0272-4634(2002)022[0058:ADATDF]2.0.CO;2; Leanza HA, 2004, CRETACEOUS RES, V25, P61, DOI 10.1016/j.cretres.2003.10.005; Carballido JL, 2012, HIST BIOL, V24, P631, DOI 10.1080/08912963.2012.672416; Madsen JH., 2000, UTAH GEOLOGICAL SURV, V2, P1; Madsen JH., 1976, UTAH GEOLOGICAL MINI, V109, P1; Makovicky PJ, 2010, P ROY SOC B-BIOL SCI, V277, P191, DOI 10.1098/rspb.2009.0236; Maxwell EE, 2007, J MORPHOL, V268, P423, DOI 10.1002/jmor.10527; Nesbitt SJ, 2011, B AM MUS NAT HIST, P1, DOI 10.1206/352.1; Novas F.E., 2001, SPECIAL PUBLICATION, V7, P145; Novas FE, 1998, J VERTEBR PALEONTOL, V18, P4, DOI 10.1080/02724634.1998.10011030; Novas FE, 2015, NATURE, V522, P331, DOI 10.1038/nature14307; Novas FE, 2013, CRETACEOUS RES, V45, P174, DOI 10.1016/j.cretres.2013.04.001; Ortega F, 2010, NATURE, V467, P203, DOI 10.1038/nature09181; Pol D, 2016, REPTILES EXTINTOS VO, V15, P172; Pol D, 2012, P ROY SOC B-BIOL SCI, V279, P3170, DOI 10.1098/rspb.2012.0660; Porfiri JD, 2014, CRETACEOUS RES, V51, P35, DOI 10.1016/j.cretres.2014.04.007; Rauhut OWM, 2003, SPEC PAP PALAEONTOL, P1; Revell LJ, 2009, EVOLUTION, V63, P3258, DOI 10.1111/j.1558-5646.2009.00804.x; Schweitzer CE, 2003, J PALEONTOL, V77, P888, DOI 10.1666/0022-3360(2003)077<0888:MCDBNA>2.0.CO;2; Sereno PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003303; Sereno PC, 1997, ANNU REV EARTH PL SC, V25, P435, DOI 10.1146/annurev.earth.25.1.435; Sereno PC, 1996, SCIENCE, V272, P986, DOI 10.1126/science.272.5264.986; Sereno PC, 2008, P ROY SOC LOND B BIO, V271, P1325; Smith JB, 2001, SCIENCE, V292, P1704, DOI 10.1126/science.1060561; Smith JB, 2006, J PALEONTOL, V80, P1179, DOI 10.1666/0022-3360(2006)80[1179:MOPSOA]2.0.CO;2; Smith ND, 2007, ZOOL J LINN SOC-LOND, V151, P377, DOI 10.1111/j.1096-3642.2007.00325.x; Turner AH, 2004, P ROY SOC B-BIOL SCI, V271, P2003, DOI 10.1098/rspb.2004.2840; Turner AH, 2009, J BIOGEOGR, V36, P612, DOI 10.1111/j.1365-2699.2008.02020.x; Tykoski RS, 2004, DINOSAURIA, 2ND EDITION, P47; Uyeda JC, 2015, SYST BIOL, V64, P677, DOI 10.1093/sysbio/syv019; Wainwright PC, 2005, INTEGR COMP BIOL, V45, P256, DOI 10.1093/icb/45.2.256; Wesley-Hunt GD, 2005, PALEOBIOLOGY, V31, P35, DOI 10.1666/0094-8373(2005)031<0035:TMDOCI>2.0.CO;2; White MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039364; Xu X, 2011, P NATL ACAD SCI USA, V108, P2338, DOI 10.1073/pnas.1011052108; Xu X, 2009, NATURE, V459, P940, DOI 10.1038/nature08124; Zanno LE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3827; Zanno LE, 2011, P NATL ACAD SCI USA, V108, P232, DOI 10.1073/pnas.1011924108	88	37	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0157793	10.1371/journal.pone.0157793	http://dx.doi.org/10.1371/journal.pone.0157793			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410683	gold, Green Published, Green Submitted			2022-12-27	WOS:000379508300012
J	Clark, EM; Jones, CA; Williams, JR; Kurti, AN; Norotsky, MC; Danforth, CM; Dodds, PS				Clark, Eric M.; Jones, Chris A.; Williams, Jake Ryland; Kurti, Allison N.; Norotsky, Mitchell Craig; Danforth, Christopher M.; Dodds, Peter Sheridan			Vaporous Marketing: Uncovering Pervasive Electronic Cigarette Advertisements on Twitter	PLOS ONE			English	Article							NICOTINE DELIVERY-SYSTEMS; AWARENESS	Background Twitter has become the "wild-west" of marketing and promotional strategies for advertisement agencies. Electronic cigarettes have been heavily marketed across Twitter feeds, offering discounts, "kid-friendly" flavors, algorithmically generated false testimonials, and free samples. Methods All electronic cigarette keyword related tweets from a 10% sample of Twitter spanning January 2012 through December 2014 (approximately 850,000 total tweets) were identified and categorized as Automated or Organic by combining a keyword classification and a machine trained Human Detection algorithm. A sentiment analysis using Hedonometrics was performed on Organic tweets to quantify the change in consumer sentiments over time. Commercialized tweets were topically categorized with key phrasal pattern matching. Results The overwhelming majority (80%) of tweets were classified as automated or promotional in nature. The majority of these tweets were coded as commercialized (83.65% in 2013), up to 33% of which offered discounts or free samples and appeared on over a billion twitter feeds as impressions. The positivity of Organic (human) classified tweets has decreased over time (5.84 in 2013 to 5.77 in 2014) due to a relative increase in the negative words 'ban', 'tobacco', 'doesn't', 'drug', 'against', 'poison', 'tax' and a relative decrease in the positive words like 'haha', 'good', 'cool'. Automated tweets are more positive than organic (6.17 versus 5.84) due to a relative increase in the marketing words like 'best', 'win', 'buy', 'sale', 'ealth', 'discount' and a relative decrease in negative words like 'bad', 'hate', 'stupid', 'don't'. Conclusions Due to the youth presence on Twitter and the clinical uncertainty of the long term health complications of electronic cigarette consumption, the protection of public health warrants scrutiny and potential regulation of social media marketing.	[Clark, Eric M.; Danforth, Christopher M.; Dodds, Peter Sheridan] Univ Vermont, Dept Math & Stat, Burlington, VT 05405 USA; [Clark, Eric M.; Williams, Jake Ryland; Danforth, Christopher M.; Dodds, Peter Sheridan] Computat Story Lab, Burlington, VT USA; [Clark, Eric M.; Williams, Jake Ryland; Danforth, Christopher M.; Dodds, Peter Sheridan] Univ Vermont, Ctr Complex Syst, Burlington, VT USA; [Clark, Eric M.; Jones, Chris A.; Norotsky, Mitchell Craig] Univ Vermont, Dept Surg, Burlington, VT 05405 USA; [Jones, Chris A.; Kurti, Allison N.] Univ Vermont, Vermont Ctr Behav & Hlth, Burlington, VT USA; [Jones, Chris A.] Univ Vermont, Vermont Ctr Clin & Translat Sci, Global Hlth Econ Unit, Burlington, VT USA; [Williams, Jake Ryland] Univ Calif Berkeley, Sch Informat, Berkeley, CA 94720 USA	University of Vermont; University of Vermont; University of Vermont; University of Vermont; University of Vermont; University of California System; University of California Berkeley	Clark, EM (corresponding author), Univ Vermont, Dept Math & Stat, Burlington, VT 05405 USA.; Clark, EM (corresponding author), Computat Story Lab, Burlington, VT USA.; Clark, EM (corresponding author), Univ Vermont, Ctr Complex Syst, Burlington, VT USA.; Clark, EM (corresponding author), Univ Vermont, Dept Surg, Burlington, VT 05405 USA.	eric.clark@uvm.edu	Dodds, Peter/C-9119-2014	Dodds, Peter/0000-0003-1973-8614	UVM Complex Systems Center; NSF [0846668]; NSF Big Data Grant [1447634]; National Institute of Health (NIH) [R01DA014028, R01HD075669]; Center of Biomedical Research Excellence Award from the National Institute of General Medical Sciences [P20GM103644]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD075669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014028] Funding Source: NIH RePORTER	UVM Complex Systems Center; NSF(National Science Foundation (NSF)); NSF Big Data Grant; National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center of Biomedical Research Excellence Award from the National Institute of General Medical Sciences; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors wish to acknowledge the Vermont Advanced Computing Core which provided High Performance Computing resources contributing to the research results. EMC was supported by the UVM Complex Systems Center; PSD was supported by NSF Career Award #0846668. PSD and CMD were supported by NSF Big Data Grant #1447634. CJ and AK are supported in part by the National Institute of Health (NIH) Research awards R01DA014028 & R01HD075669, and by the Center of Biomedical Research Excellence Award P20GM103644 from the National Institute of General Medical Sciences.	*AM SOC ADD MED, 2008, PUBL POL STAT NIC AD; Aphinyanaphongs Y, 2016, BIOCOMPUT-PAC SYM, P480; Avdalovic MV, 2012, CHEST, V141, P1371, DOI 10.1378/chest.12-0205; Bunnell RE, 2014, NICOTINE TOB RES; Callahan-Lyon P, 2014, TOB CONTROL, V23, P36, DOI 10.1136/tobaccocontrol-2013-051470; Cameron JM, 2014, TOB CONTROL, V23, P77, DOI 10.1136/tobaccocontrol-2012-050604; Cho JH, 2011, J ADOLESCENT HEALTH, V49, P542, DOI 10.1016/j.jadohealth.2011.08.001; Chu Z, 2010, 26TH ANNUAL COMPUTER SECURITY APPLICATIONS CONFERENCE (ACSAC 2010), P21; Chu Z, 2012, IEEE T DEPEND SECURE, V9, P811, DOI 10.1109/TDSC.2012.75; Clark EM, 2015, ARXIV150504342; Cobb NK, 2010, AM J PUBLIC HEALTH, V100, P2340, DOI 10.2105/AJPH.2010.199281; CONTROL CFD, 2014, HLTH CONSMOK 50 YE, P171; Dodds PS, 2015, P NATL ACAD SCI USA, V112, P2389, DOI 10.1073/pnas.1411678112; Dodds PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026752; Duke JC, 2014, PEDIATRICS, V134, pE29, DOI 10.1542/peds.2014-0269; Dutra LM, 2014, JAMA PEDIATR, V168, P684, DOI 10.1001/jamapediatrics.2013.5488; Eissenberg T, 2010, TOB CONTROL, V19, P87, DOI 10.1136/tc.2009.033498; Goniewicz ML, 2014, TOB CONTROL, V23, P133, DOI 10.1136/tobaccocontrol-2012-050859; Goniewicz ML, 2012, PEDIATRICS, V130, pE879, DOI 10.1542/peds.2011-3448; Grana R, 2014, CIRCULATION, V129, P1972, DOI 10.1161/CIRCULATIONAHA.114.007667; Grana RA, 2014, AM J PREV MED, V46, P395, DOI 10.1016/j.amepre.2013.12.010; Harris D., 2013, CAN EVIL DATA SCI FO; Hua M, 2013, TOB CONTROL, V22, P103, DOI 10.1136/tobaccocontrol-2011-050226; Huang JD, 2014, TOB CONTROL, V23, P26, DOI 10.1136/tobaccocontrol-2014-051551; Johnston L. D., 2014, MONITORING FUTURE NA; Kandra KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103462; Kim AE, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4466; Kosmider L, 2014, NICOTINE TOB RES, V16, P1319, DOI 10.1093/ntr/ntu078; Lee K., 2013, ICWSM, P331; Lee K., 2010, P 19 INT C WORLD WID, P1139, DOI DOI 10.1145/1772690.1772843; Lee K, 2010, SIGIR 2010: PROCEEDINGS OF THE 33RD ANNUAL INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH DEVELOPMENT IN INFORMATION RETRIEVAL, P435, DOI 10.1145/1835449.1835522; Lerner CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116732; Li HY, 2014, IEEE DATA MINING, P290, DOI 10.1109/ICDM.2014.59; Maarcher Ann, 2011, Morbidity and Mortality Weekly Report, V60, P1513; National Institute on Drug Abuse, 2012, RES REP SER IS NIC A; Palazzolo Dominic L, 2013, Front Public Health, V1, P56, DOI 10.3389/fpubh.2013.00056; Pearson JL, 2012, AM J PUBLIC HEALTH, V102, P1758, DOI 10.2105/AJPH.2011.300526; Pepper JK, 2013, J ADOLESCENT HEALTH, V52, P144, DOI 10.1016/j.jadohealth.2012.09.014; Ranganath S, UNDERSTANDING IDENTI; Smith A., 2013, 72 ONLINE ADULTS ARE; Sussan TE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116861; Trtchounian A, 2011, TOB CONTROL, V20, P47, DOI 10.1136/tc.2010.037259; U.S. Department of Health and Human Services, 2004, HLTH CONS SMOK REP S, P62; US Department of Health and Human Services, 2000, RED TOB US REP SURG; US Department of Health and Human Services and others, 2010, TOB SMOK CAUS DIS BI, P2; Vansickel AR, 2010, CANCER EPIDEM BIOMAR, V19, P1945, DOI 10.1158/1055-9965.EPI-10-0288; Wang G., 2012, P 21 INT C WORLD WID, P679, DOI [10.1145/2187836.2187928, DOI 10.1145/2187836.2187928]; WHO Study Group, 2007, World Health Organ Tech Rep Ser, P1; Williams JR, 2014, CORR; Williams M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057987; Wills TA, 2015, PEDIATRICS, V135, pE43, DOI 10.1542/peds.2014-0760; Zezima K., 2009, CIGARETTES SMOKE REG; Zhu SH, 2014, TOB CONTROL, V23, P3, DOI 10.1136/tobaccocontrol-2014-051670; Zhu SH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0079332, 10.1371/journal.pone.0071555]	54	48	48	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0157304	10.1371/journal.pone.0157304	http://dx.doi.org/10.1371/journal.pone.0157304			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ9CP	27410031	Green Submitted, gold, Green Published			2022-12-27	WOS:000379508300008
J	Dening, KH; King, M; Jones, L; Vickestaff, V; Sampson, EL				Dening, Karen Harrison; King, Michael; Jones, Louise; Vickestaff, Victoria; Sampson, Elizabeth L.			Advance Care Planning in Dementia: Do Family Carers Know the Treatment Preferences of People with Early Dementia?	PLOS ONE			English	Article							SURROGATE DECISION-MAKING; OLDER-ADULTS; COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; LIFE; SPOUSES; COMPETENCE; CAREGIVERS; EXPERIENCE; PHYSICIANS	Background and Aims When a person with dementia (PWD) has lost the ability to make treatment decisions, clinicians often rely on family carers to know and articulate these preferences with assumed accuracy. This study used the Life Support Preferences Questionnaire (LSPQ) to explore whether family carers' choices show agreement with the end of life care preferences of the person with dementia for whom they care and what factors influence this. Methods A cross-sectional study interviewing 60 dyads (a person with early dementia and preserved capacity and their family carer) each completing a modified LSPQ. We assessed how closely carers' choices resembled the PWD's preferences for treatment in three proposed health states: the here and now; severe stroke with coma; terminal cancer. Agreement between the PWD and their family carer responses was assessed using Kappa and Prevalence- Adjusted Bias-Adjusted Kappa (PABAK) statistics. We examined whether carer burden and distress, and relationship quality, influenced agreement. Results In interviews PWD were able to indicate their treatment preferences across all three scenarios. In the here-and-now most wanted antibiotics (98%), fewer cardio-pulmonary resuscitation (CPR) (50%) and tube feeding (47%). In severe stroke and coma antibiotics remained the more preferred treatment (88%), followed by CPR (57%) and tube feeding (30%). In advanced cancer PWD expressed lower preferences for all treatments (antibiotics 68%; CPR 50%; tube feeding 37%). Carers' choices were similar to the PWDs' preferences in the here-and-now (71%(k = 0.03; PABAK = 0.4) with less agreement for future hypothetical health states. In severe stroke and coma carers tended wrongly to suggest that the PWD preferred more intervention (antibiotic, 67%; k = -0.022; PABAK = -0.60; CPR, 73%; k = 0.20; PABAK = -0.20, tube feeding, 66%; k = 0.25; PABAK = -0.12). In advanced cancer the agreement between PWD and carers was low (antibiotics; k = -0.03; PABAK = -0.52; CPR, k = -0.07; PABAK = -0.45; tube feeding; k = 0.20; PABAK = -0.22). However, both PWD and carers showed marked uncertainty about their preferences for end of life treatment choices. Relationship quality, carer distress and burden had no influence on agreement. Conclusions This study is the first to have used the LSPQ with PWD in the UK to consider treatment options in hypothetical illness scenarios. Key finding are that family carers had a low to moderate agreement with PWD on preferences for end of life treatment. This underscores how planning for care at the end of life is beset with uncertainty, even when the carer and PWD perceive the care-giving/receiving relationship is good. Families affected by dementia may benefit from early and ongoing practical and emotional support to prepare for potential changes and aid decision making in the context of the realities of care towards the end of life.	[Dening, Karen Harrison] Dementia UK, Resource London, Second Floor, London, England; [Jones, Louise; Vickestaff, Victoria; Sampson, Elizabeth L.] UCL, Div Psychiat, Marie Curie Palliat Care Res Dept, 6th Floor,Maple House, London, England; [King, Michael] UCL, Fac Brain Sci, Div Psychiat, Maple House, London, England	University of London; University College London; University of London; University College London	Dening, KH (corresponding author), Dementia UK, Resource London, Second Floor, London, England.	Karen.harrison-dening@dementiauk.org	Sampson, Elizabeth L/B-8647-2009	Sampson, Elizabeth L/0000-0001-8929-7362; Vickerstaff, Victoria/0000-0002-3119-670X	Dementia UK; Marie Curie Palliative Care Research Department, Division of Psychiatry, UCL; Marie Curie [MCCC-FPR-11-U] Funding Source: researchfish	Dementia UK; Marie Curie Palliative Care Research Department, Division of Psychiatry, UCL; Marie Curie(European Commission)	This doctoral research study was supported by Dementia UK and the Marie Curie Palliative Care Research Department, Division of Psychiatry, UCL.	Alzheimer's Society, 2014, DEM 2014 OPP CHANG; Amjad H, 2014, J AM GERIATR SOC, V62, P1304, DOI 10.1111/jgs.12894; Ashton S, 2014, DEMENTIA-LONDON, DOI [10.1177/1471301214548521, DOI 10.1177/1471301214548521]; Ayalon L, 2012, INT PSYCHOGERIATR, V24, P1798, DOI 10.1017/S1041610212000877; Berger JT, 2005, J CLIN ETHIC, V16, P108; BYRT T, 1993, J CLIN EPIDEMIOL, V46, P423, DOI 10.1016/0895-4356(93)90018-V; Coppola KM, 1999, DEATH STUD, V23, P617, DOI 10.1080/074811899200803; Davies E, 2004, BETTER PALLIATIVE CA; Dening KH, 2013, PALLIATIVE MED, V27, P409, DOI 10.1177/0269216312464094; Denk CE, 1997, SOC SCI RES, V26, P95, DOI 10.1006/ssre.1996.0587; Department of Health (DH), 2012, PRIM MIN CHALL DEM D; Department of Health (DH), 2009, LIVING WELL DEMENTIA; DH, 2008, END LIF CAR STRAT; Digby R, 2014, COLLEGIAN, V21, P345, DOI 10.1016/j.colegn.2013.08.006; Ditto PH, 2003, HEALTH PSYCHOL, V22, P605, DOI 10.1037/0278-6133.22.6.605; EMANUEL EJ, 1992, JAMA-J AM MED ASSOC, V267, P2067; Fagerlin A, 2001, HEALTH PSYCHOL, V20, P166, DOI 10.1037/0278-6133.20.3.166; Fazel S, 1999, BRIT MED J, V318, P493, DOI 10.1136/bmj.318.7182.493; Fleiss J.L., 2013, STAT METHODS RATES P; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fratiglioni L, 2013, OXFORD TXB OLD AGE P, P389; Gjerdingen DK, 1999, ARCH FAM MED, V8, P421, DOI 10.1001/archfami.8.5.421; Goodman C, 2015, BMC PALLIAT CARE, V14, DOI 10.1186/s12904-015-0040-0; Gregory R, 2007, AGE AGEING, V36, P527, DOI 10.1093/ageing/afm104; Hansen L, 2004, J NURS SCHOLARSHIP, V36, P233, DOI 10.1111/j.1547-5069.2004.04043.x; Herbert R., 2000, CANADIAN J AGING, V19, P494, DOI DOI 10.1017/S0714980800012484; HIGH DM, 1994, CLIN GERIATR MED, V10, P445, DOI 10.1016/S0749-0690(18)30332-X; Hirschman KB, 2006, AM J GERIAT PSYCHIAT, V14, P659, DOI 10.1097/01.JGP.0000203179.94036.69; Hughes R, 2002, J ADV NURS, V37, P382, DOI 10.1046/j.1365-2648.2002.02100.x; Huisman M, 2000, QUAL QUANT, V34, P331, DOI 10.1023/A:1004782230065; Jolley N, 1999, LOCKE HIS PHILOS THO; Karlawish JHT, 2000, J AM GERIATR SOC, V48, P1014, DOI 10.1111/j.1532-5415.2000.tb06904.x; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kodadek Marie P, 2002, Pediatr Nurs, V28, P333; Livingston G, 2010, BMJ; Lord K, 2015, INT PSYCHOGERIATR, V27, P1301, DOI 10.1017/S1041610215000411; Low JA, 2003, INTERN MED J, V33, P345, DOI 10.1046/j.1445-5994.2003.00367.x; Mezey M, 1996, J AM GERIATR SOC, V44, P144, DOI 10.1111/j.1532-5415.1996.tb02430.x; Mishel M H, 1990, Image J Nurs Sch, V22, P256; Pearlman R A, 2000, J Palliat Med, V3, P37, DOI 10.1089/jpm.2000.3.37; Russ AJ, 2005, CULT MED PSYCHIAT, V29, P103, DOI 10.1007/s11013-005-4625-6; Sampson EL, 2006, AGE AGEING, V35, P187, DOI 10.1093/ageing/afj025; Scandrett KG, 2014, BMC PALLIAT CARE, V13, DOI 10.1186/1472-684X-13-21; Schellinger S, 2011, J PALLIAT MED, V14, P1224, DOI 10.1089/jpm.2011.0105; Schenker Y, 2012, J GEN INTERN MED, V27, P1657, DOI 10.1007/s11606-012-2129-y; Shalowitz DI, 2006, ARCH INTERN MED, V166, P493, DOI 10.1001/archinte.166.5.493; Spruytte N, 2002, PSYCHOL PSYCHOTHER-T, V75, P295, DOI 10.1348/147608302320365208; Sugarman J, 2001, J AM GERIATR SOC, V49, P1110, DOI 10.1046/j.1532-5415.2001.49218.x; Sulsamy DP, 1998, ANN INTERN MED, V128, P621; UHLMANN RF, 1988, J GERONTOL, V43, pM115, DOI 10.1093/geronj/43.5.M115; Vig EK, 2007, J GEN INTERN MED, V22, P1274, DOI 10.1007/s11606-007-0252-y; Wendler D, 2011, ANN INTERN MED, V154, P336, DOI 10.7326/0003-4819-154-5-201103010-00008; Whitlatch C. J., 2009, DEMENTIA-LONDON, V8, P223, DOI [DOI 10.1177/1471301209103259, 10.1177/1471301209103259]; WHO, 2004, PALL CAR OLD PEOPL B; Winter L, 2008, J PALLIAT MED, V11, P1109, DOI 10.1089/jpm.2008.0039; World Health Organization, 1992, ICD 10 INT STAT CLAS; ZARIT SH, 1986, GERONTOLOGIST, V26, P260, DOI 10.1093/geront/26.3.260	57	56	56	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159056	10.1371/journal.pone.0159056	http://dx.doi.org/10.1371/journal.pone.0159056			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ9CP	27410259	Green Published, Green Submitted, gold			2022-12-27	WOS:000379508300054
J	Alencar, J; de Mello, CF; Serra-Freire, NM; Guimaraes, AE; Gil-Santana, HR; Gleiser, RM				Alencar, Jeronimo; de Mello, Cecilia Ferreira; Serra-Freire, Nicolau Maues; Guimaraes, Anthony Erico; Gil-Santana, Helcio R.; Gleiser, Raquel M.			Biodiversity and Temporal Distribution of Immature Culicidae in the Atlantic Forest, Rio de Janeiro State, Brazil	PLOS ONE			English	Article							MOSQUITOS DIPTERA-CULICIDAE; ARTHROPODS; DIVERSITY; SAMPLE; PARK	To increase the knowledge of biodiversity and identify larval habitats used by immature mosquitoes in the Atlantic Forest, we conducted a study in areas with various stages of preservation within the Guapiacu Ecological Reserve in Cachoeiras de Macacu, Rio de Janeiro state. The Culicidae fauna were sampled during February, April, June, August, October, and December 2012; February, March, April, May, June, August, October, and December 2013; and January and March 2014. Immature mosquitoes were collected with dippers and suction tubes (mouth aspirators). Over the sampling period, 2697 larvae of 56 species were collected, some of which are recognized vectors of human diseases. The larval mosquito community found in artificial habitats, temporary ground water, and phytotel-mata differed between sites, except for the mosquito fauna in bromeliads, which were almost 80% similar. Species segregation was more evident between larval habitats than between sites. Culex usquatus was the dominant species and colonized the highest number of larval habitats. The artificial larval habitats found in REGUA were colonized by a great diversity of species and high abundance as well, thus human artifacts left by the public in the area that collect water may promote an increase in mosquito populations. Among the species collected, some are known or suspected vectors of pathogens to humans and/or veterinary relevance, and their medical relevance is discussed.	[Alencar, Jeronimo; de Mello, Cecilia Ferreira; Guimaraes, Anthony Erico; Gil-Santana, Helcio R.] Fiocruz MS, Inst Oswaldo Cruz, Diptera Lab, Rio De Janeiro, Brazil; [de Mello, Cecilia Ferreira] Univ Fed Rural Rio de Janeiro, Postgrad Program Anim Biol, Inst Biol, Seropedica, RJ, Brazil; [Serra-Freire, Nicolau Maues] Fiocruz MS, Inst Oswaldo Cruz, Natl Reference Lab Rickettsioses Vectors, Rio De Janeiro, Brazil; [Gleiser, Raquel M.] Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, CONICET, Ctr Relevamiento & Evaluac Recursos Agr & Nat,Ins, Cordoba, Argentina	Fundacao Oswaldo Cruz; Universidade Federal Rural do Rio de Janeiro (UFRRJ); Fundacao Oswaldo Cruz; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Alencar, J (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Diptera Lab, Rio De Janeiro, Brazil.; Gleiser, RM (corresponding author), Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, CONICET, Ctr Relevamiento & Evaluac Recursos Agr & Nat,Ins, Cordoba, Argentina.	jalencar@ioc.fiocruz.br; raquel.gleiser@unc.edu.ar	Gil-Santana, Hélcio Reinaldo/AAG-2534-2021	Gil-Santana, Hélcio Reinaldo/0000-0002-0544-348X; Gleiser, Raquel/0000-0003-0726-2639; Guimaraes, Anthony/0000-0002-9982-2471; Alencar, Jeronimo/0000-0001-7863-2698	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro-FAPERJ [112.076/2012]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq [301345/2013-9]	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro-FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro-FAPERJ (contract 112.076/2012) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq (301345/2013-9) for their financial support. Raquel M. Gleiser is a Career Member of CONICET, Argentina.; We thank the Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro-FAPERJ (contract 112.076/2012) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq (301345/2013-9) for their financial support. Raquel M. Gleiser is a Career Member of CONICET, Argentina. The authors thank Nicholas and Rachel Locke, president and vice president, and Jorge Bizarro, research coordinator, of REGUA, for the facilities granted for conducting the present study.	Alencar J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122268; Alencar J, 2013, REV SOC BRAS MED TRO, V46, P769, DOI 10.1590/0037-8682-1670-2013; Alencar J, 2011, J MED ENTOMOL, V48, P223, DOI 10.1603/ME09214; Alencar J, 2010, J AM MOSQUITO CONTR, V26, P249, DOI 10.2987/09-5896.1; ARAGAO MARIO B., 1956, REV BRASIL MALARIOL AND DOENCAS TROP, V8, P621; Nelson M. J., 1971, Contr Am ent Inst, V7, P1; Chao A, 2003, ENVIRON ECOL STAT, V10, P429, DOI 10.1023/A:1026096204727; Chao A, 2010, PROGRAM USERS GUIDE; Chao A, 2006, BIOMETRICS, V62, P361, DOI 10.1111/j.1541-0420.2005.00489.x; Colwell RK, 2013, ESTIMATES STAT ESTIM; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Consoli R. A. G. B., 1994, PRINCIPAIS MOSQUITOS; Couto AVS, 2010, MONOGRAPH U FEDERAL; DEANE L M, 1986, Memorias do Instituto Oswaldo Cruz, V81, P5, DOI 10.1590/S0074-02761986000600002; FARAN M E, 1981, Mosquito Systematics, V13, P1; Forattini OP, 2000, REV SAUDE PUBL, V34, P543, DOI 10.1590/S0034-89102000000500016; Forattini OP, 1965, ENTOMOLOGIA MED; Forattini OP, 2002, CULICIDOLOGIA MED; Foss KA, 2007, J AM MOSQUITO CONTR, V23, P476, DOI 10.2987/5582.1; Godfray HCJ, 1999, PHILOS T R SOC B, V354, P1811, DOI 10.1098/rstb.1999.0523; Gotelli N, 2013, ENCY BIODIVERSITY, V5; GUIMARAES A E, 1985, Memorias do Instituto Oswaldo Cruz, V80, P171, DOI 10.1590/S0074-02761985000200008; Guimaraes A. E., 1984, Memorias do Instituto Oswaldo Cruz, V79, P309, DOI 10.1590/S0074-02761984000300004; GUIMARAES AE, 1989, MEM I OSWALDO CRUZ, V84, P243, DOI 10.1590/S0074-02761989000800044; Hamilton AJ, 2010, AM NAT, V176, P90, DOI 10.1086/652998; Harbach R, 2008, FAMILY CULICIDAE MEI; Hutchings RSG, 2005, MED VET ENTOMOL, V19, P428, DOI 10.1111/j.1365-2915.2005.00587.x; Koppen W., 1936, HDB KLIMATOLOGIE, P7; Lamarre GPA, 2012, ZOOKEYS, P43, DOI 10.3897/zookeys.216.3332; Lane J., 1953, NEOTROPICAL CULICIDA, VI; Lane J., 1953, NEOTROPICAL CULICIDA, V2; Lopes J., 2002, BACIA RIO TIBAGI, V19, P327; Lopes Jose, 1997, Revista Brasileira de Zoologia, V14, P571, DOI 10.1590/S0101-81751997000300007; LOURENCO-DE-OLIVEIRA R, 1986, Memorias do Instituto Oswaldo Cruz, V81, P265; Lozovei A.L., 1976, Arquivos de Biologia e Tecnologia (Curitiba), V19, P25; Neves DP, 1977, BRAZ J BIOL, V37, P803; Odegaard F, 2000, BIOL J LINN SOC, V71, P583, DOI 10.1006/bijl.2000.0468; Rapini A, 2006, GREATER KNOWLEDGE BR, P27; Reinert JF, 2009, ZOOL J LINN SOC-LOND, V157, P700, DOI 10.1111/j.1096-3642.2009.00570.x; SERRAFREIRE NM, 2002, PLANEJAMENTO ANALISE; Shen TJ, 2003, ECOLOGY, V84, P798, DOI 10.1890/0012-9658(2003)084[0798:PTNONS]2.0.CO;2; Silva MB, 2007, SITIENTIBUS CB, V7, P125; THOMAS CD, 1990, NATURE, V347, P237, DOI 10.1038/347237a0; Veloso H.P., 1991, CLASSIFICACAO VEGETA; Ward R.A., 1982, P417; Wilkerson RC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133602	46	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0159240	10.1371/journal.pone.0159240	http://dx.doi.org/10.1371/journal.pone.0159240			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27404496	gold, Green Published, Green Submitted			2022-12-27	WOS:000379508200045
J	Hermes, R; Schwarzenberger, F; Goritz, F; Oh, S; Fernandes, T; Bernardino, R; Leclerc, A; Greunz, E; Mathew, A; Forsyth, S; Saragusty, J; Hildebrandt, TB				Hermes, Robert; Schwarzenberger, Franz; Goeritz, Frank; Oh, Serena; Fernandes, Teresa; Bernardino, Rui; Leclerc, Antoine; Greunz, Eva; Mathew, Abraham; Forsyth, Sarah; Saragusty, Joseph; Hildebrandt, Thomas Bernd			Ovarian down Regulation by GnRF Vaccination Decreases Reproductive Tract Tumour Size in Female White and Greater One-Horned Rhinoceroses	PLOS ONE			English	Article							CERATOTHERIUM-SIMUM-SIMUM; HORMONE VACCINE; BREEDING MANAGEMENT; FECAL PROGESTERONE; INDIAN RHINOCEROS; ESTROUS BEHAVIOR; BOAR TAINT; PHYTOESTROGENS; CONTRACEPTION; IMMUNIZATION	Reproductive tract tumours, specifically leiomyoma, are commonly found in female rhinoceroses. Similar to humans, tumour growth in rhinoceroses is thought to be sex hormone dependent. Tumours can form and expand from the onset of ovarian activity at puberty until the cessation of sex-steroid influences at senescence. Extensive tumour growth results in infertility. The aim of this study was to down regulate reproductive function of tumour-diseased and infertile females to stop further tumour growth using a Gonadotropin releasing factor (GnRF) vaccine. Four infertile southern white (Ceratotherium simum simum) and three Greater one-horned rhinoceroses (rhinoceros unicorns) with active ovaries and 2.7 +/- 0.9 and 14.0 +/- 1.5 reproductive tract tumours respectively were vaccinated against GnRF (Improvac (R), Zoetis, Germany) at 0, 4 and 16 weeks and re-boostered every 6-8 months thereafter. After GnRF vaccination ovarian and luteal activity was suppressed in all treated females. Three months after vaccination the size of the ovaries, the number of follicles and the size of the largest follicle were significantly reduced (P<0.03). Reproductive tract tumours decreased significantly in diameter (Greater-one horned rhino: P<0.0001; white rhino: P<0.01), presumably as a result of reduced sex-steroid influence. The calculated tumour volumes were reduced by 50.8 +/- 10.9% in Greater one-horned and 48.6 +/- 12.9% in white rhinoceroses. In conclusion, GnRF vaccine effectively down regulated reproductive function and decreased the size of reproductive tract tumours in female rhinoceros. Our work is the first to use down regulation of reproductive function as a symptomatic treatment against benign reproductive tumour disease in a wildlife species. Nonetheless, full reversibility and rhinoceros fertility following GnRF vaccination warrants further evaluation.	[Hermes, Robert; Goeritz, Frank; Saragusty, Joseph; Hildebrandt, Thomas Bernd] Leibniz Inst Zoo & Wildlife Res, PF 700430, D-10342 Berlin, Germany; [Schwarzenberger, Franz] Univ Vet Med, Biomed Sci, Vet Pl 1, A-1210 Vienna, Austria; [Oh, Serena; Mathew, Abraham] Singapore Zool Gardens, 80 Mandai Lakerd, Singapore 729826, Singapore; [Fernandes, Teresa; Bernardino, Rui] Lisbon Zoo, Vet Hosp, Estr Benf 158-160, Lisbon, Portugal; [Leclerc, Antoine] ZooParc Beauval, F-41110 St Aignan, France; [Greunz, Eva] Thoiry Zoo, F-78770 Thoiry, France; [Forsyth, Sarah] Colchester Zoo, Maldon Rd, Stanway CO3 0SL, Essex, England	Leibniz Institut fur Zoo und Wildtierforschung; University of Veterinary Medicine Vienna	Hermes, R (corresponding author), Leibniz Inst Zoo & Wildlife Res, PF 700430, D-10342 Berlin, Germany.	hermes@izw-berlin.de	Schwarzenberger, Franz/A-9236-2013; Leclerc, Antoine/F-4395-2014; Saragusty, Joseph/M-5030-2016	Schwarzenberger, Franz/0000-0002-2961-0545; Saragusty, Joseph/0000-0002-9274-7800				Baird DD, 2003, AM J OBSTET GYNECOL, V188, P100, DOI 10.1067/mob.2003.99; Boedeker NC, 2012, J ZOO WILDLIFE MED, V43, P603, DOI 10.1638/2011-0270.1; Brunius C, 2011, VACCINE, V29, P9514, DOI 10.1016/j.vaccine.2011.10.014; Cook H, 2010, Minerva Ginecol, V62, P225; Cooper NP, 2005, OBSTET GYNECOL SURV, V60, P132, DOI 10.1097/01.ogx.0000154688.02423.68; CRAMER SF, 1990, AM J CLIN PATHOL, V94, P435, DOI 10.1093/ajcp/94.4.435; Davis SR, 1999, RECENT PROG HORM RES, V54, P185; De Nys HM, 2010, J S AFR VET ASSOC, V81, P8; Donovan CE, 2013, ANIM REPROD SCI, V142, P42, DOI 10.1016/j.anireprosci.2013.09.002; FRIEDMAN AJ, 1991, OBSTET GYNECOL, V77, P720; Guldenschuh G, 2002, HUSBANDRY MANUAL GRE; Hermes R, 2009, THERIOGENOLOGY, V71, P393, DOI 10.1016/j.theriogenology.2008.10.008; Hermes R, 2006, THERIOGENOLOGY, V65, P1492, DOI 10.1016/j.theriogenology.2005.09.002; Hermes R, 2004, ANIM REPROD SCI, V82-3, P49, DOI 10.1016/j.anireprosci.2004.05.015; Hermes R, 2012, THERIOGENOLOGY, V78, P1217, DOI 10.1016/j.theriogenology.2012.05.015; Hermes R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092595; Higham JP, 2007, HORM BEHAV, V52, P384, DOI 10.1016/j.yhbeh.2007.06.003; Huggins C, 1941, CANCER RES, V1, P293; Imboden I, 2006, THERIOGENOLOGY, V66, P1866, DOI 10.1016/j.theriogenology.2006.04.038; Klein LV, 1997, ANN C AM ASS ZOO VET, P127; Lu A, 2011, HORM BEHAV, V59, P28, DOI 10.1016/j.yhbeh.2010.09.012; Lueders I, 2014, J ZOO WILDLIFE MED, V45, P611, DOI 10.1638/2013-0233R.1; Miller LA, 2004, J WILDLIFE DIS, V40, P725, DOI 10.7589/0090-3558-40.4.725; Miller LA, 2008, AM J REPROD IMMUNOL, V60, P214, DOI 10.1111/j.1600-0897.2008.00616.x; Munson L, 2006, THERIOGENOLOGY, V66, P126, DOI 10.1016/j.theriogenology.2006.03.016; Okolo S, 2008, BEST PRACT RES CL OB, V22, P571, DOI 10.1016/j.bpobgyn.2008.04.002; Patton ML, 2006, THERIOGENOLOGY, V66, P431, DOI 10.1016/j.theriogenology.2005.10.025; Penfold LM, 2014, ZOO BIOL, V33, P20, DOI 10.1002/zoo.21104; Powers JG, 2011, BIOL REPROD, V85, P1152, DOI 10.1095/biolreprod.110.088237; Radcliffe RM, 2000, J ZOO WILDLIFE MED, V31, P201, DOI 10.1638/1042-7260(2000)031[0201:SLGUBI]2.0.CO;2; Radcliffe Robin W., 2007, P543, DOI 10.1002/9780470376478.ch48; Sabry M, 2012, REPROD SCI, V19, P339, DOI 10.1177/1933719111432867; Schaffer N.E. M., 2001, INT EL RHIN RES S 7; Schulman ML, 2013, EQUINE VET J, V45, P111, DOI 10.1111/j.2042-3306.2012.00577.x; Schwarz C, 2014, TIERAERZTL PRAX G N, V42, P150; Schwarzenberger F, 2000, GEN COMP ENDOCR, V119, P300, DOI 10.1006/gcen.2000.7523; Schwarzenberger F, 2013, WIEN TIERARZTL MONAT, V100, P209; Schwarzenberger F, 1998, ANIM REPROD SCI, V53, P173, DOI 10.1016/S0378-4320(98)00112-2; Simms MS, 2000, BRIT J CANCER, V83, P443, DOI 10.1054/bjoc.2000.1315; Steck B, 2012, EUR ASS ZOOS AQ ANN; Stoops MA, 2004, REPRODUCTION, V128, P843, DOI 10.1530/rep.1.00328; Toh MF, 2012, STEROIDS, V77, P765, DOI 10.1016/j.steroids.2012.03.013; Tsigkou A, 2015, FERTIL STERIL, V104, P170, DOI 10.1016/j.fertnstert.2015.04.024; Tubbs C, 2012, ENDOCRINOLOGY, V153, P1444, DOI 10.1210/en.2011-1962; Valades GB, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-63; Versteege L, 2012, EAZA HUSBANDRY GUIDE, P75; Viswanathan M, 2007, EVID REP TECHNOL ASS, V154, P100; Walker WJ, 2002, BJOG-INT J OBSTET GY, V109, P1262, DOI 10.1046/j.1471-0528.2002.01449.x; Wilson M, 2010, J ZOO WILDLIFE MED, V41, P111, DOI 10.1638/2009-0128.1; Zamaratskaia G, 2008, REPROD DOMEST ANIM, V43, P351, DOI 10.1111/j.1439-0531.2007.00914.x; Zava DT, 1998, P SOC EXP BIOL MED, V217, P369	51	4	5	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0157963	10.1371/journal.pone.0157963	http://dx.doi.org/10.1371/journal.pone.0157963			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27403662	Green Published, gold			2022-12-27	WOS:000379508200005
J	Gamage, SMKW; McGrath, DJ; Persley, DM; Dietzgen, RG				Gamage, Shirani M. K. Widana; McGrath, Desmond J.; Persley, Denis M.; Dietzgen, Ralf G.			Transcriptome Analysis of Capsicum Chlorosis Virus-Induced Hypersensitive Resistance Response in Bell Capsicum	PLOS ONE			English	Article							PATHOGENESIS-RELATED PROTEINS; GLUTATHIONE S-TRANSFERASES; CELL-DEATH; MOLECULAR CHARACTERIZATION; DISEASE RESISTANCE; GENE-EXPRESSION; PROTEASE INHIBITORS; FUSARIUM-OXYSPORUM; DEFENSE RESPONSES; PROVIDES INSIGHTS	Background Capsicum chlorosis virus (CaCV) is an emerging pathogen of capsicum, tomato and peanut crops in Australia and South-East Asia. Commercial capsicum cultivars with CaCV resistance are not yet available, but CaCV resistance identified in Capsicum chinense is being introgressed into commercial Bell capsicum. However, our knowledge of the molecular mechanisms leading to the resistance response to CaCV infection is limited. Therefore, transcriptome and expression profiling data provide an important resource to better understand CaCV resistance mechanisms. Methodology/Principal Findings We assembled capsicum transcriptomes and analysed gene expression using Illumina HiSeq platform combined with a tag-based digital gene expression system. Total RNA extracted from CaCV/mock inoculated CaCV resistant (R) and susceptible (S) capsicum at the time point when R line showed a strong hypersensitive response to CaCV infection was used in transcriptome assembly. Gene expression profiles of R and S capsicum in CaCV-and buffer-inoculated conditions were compared. None of the genes were differentially expressed (DE) between R and S cultivars when mock-inoculated, while 2484 genes were DE when inoculated with CaCV. Functional classification revealed that the most highly up-regulated DE genes in R capsicum included pathogenesis-related genes, cell death-associated genes, genes associated with hormone-mediated signalling pathways and genes encoding enzymes involved in synthesis of defense-related secondary metabolites. We selected 15 genes to confirm DE expression levels by real-time quantitative PCR. Conclusion/Significance DE transcript profiling data provided comprehensive gene expression information to gain an understanding of the underlying CaCV resistance mechanisms. Further, we identified candidate CaCV resistance genes in the CaCV-resistant C. annuum x C. chinense breeding line. This knowledge will be useful in future for fine mapping of the CaCV resistance locus and potential genetic engineering of resistance into CaCV-susceptible crops.	[Gamage, Shirani M. K. Widana; Dietzgen, Ralf G.] Univ Queensland, Queensland Alliance Agr & Food Innovat, St Lucia, Qld, Australia; [McGrath, Desmond J.] AgriSci Queensland, Queensland Dept Agr & Fisheries, Gatton, Qld, Australia; [Persley, Denis M.] EcoSci Precinct, AgriSci Queensland, Queensland Dept Agr & Fisheries, Dutton Pk, Qld, Australia	University of Queensland	Dietzgen, RG (corresponding author), Univ Queensland, Queensland Alliance Agr & Food Innovat, St Lucia, Qld, Australia.	r.dietzgen@uq.edu.au	Kumari, Widana Gamage Shirani Manel/O-5603-2018; Dietzgen, Ralf Georg/A-5565-2010	Kumari, Widana Gamage Shirani Manel/0000-0003-4361-5622; Dietzgen, Ralf Georg/0000-0002-7772-2250	Queensland Department of Agriculture and Fisheries; University of Queensland through the Queensland Alliance for Agriculture and Food Innovation institute for RGD; Illumina through Miseq Pilot the Possibilities Grant Programme; "Faculty for the Future" PhD Fellowship from the Schlumberger Foundation, The Netherlands	Queensland Department of Agriculture and Fisheries; University of Queensland through the Queensland Alliance for Agriculture and Food Innovation institute for RGD; Illumina through Miseq Pilot the Possibilities Grant Programme; "Faculty for the Future" PhD Fellowship from the Schlumberger Foundation, The Netherlands	This research was jointly supported by the Queensland Department of Agriculture and Fisheries and the University of Queensland through internal support by the Queensland Alliance for Agriculture and Food Innovation institute for RGD. We thank Illumina for financial support through its Miseq Pilot the Possibilities Grant Programme. SMKWG was supported by a "Faculty for the Future" PhD Fellowship from the Schlumberger Foundation, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex D, 2000, PLANT J, V22, P415, DOI 10.1046/j.1365-313X.2000.00751.x; Antcheva N, 2001, PROTEIN SCI, V10, P2280, DOI 10.1110/ps.21701; ARANDA FJ, 1995, BBA-BIOMEMBRANES, V1234, P225, DOI 10.1016/0005-2736(94)00293-X; Ayliffe MA, 1999, PLANT J, V17, P287, DOI 10.1046/j.1365-313X.1999.00377.x; Aza-Gonzalez C, 2011, PLANT CELL REP, V30, P695, DOI 10.1007/s00299-010-0968-8; Back K, 2001, PLANT CELL PHYSIOL, V42, P475, DOI 10.1093/pcp/pce060; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Bernier F, 2001, PLANT PHYSIOL BIOCH, V39, P545, DOI 10.1016/S0981-9428(01)01285-2; Bindschedler LV, 2006, PLANT J, V47, P851, DOI 10.1111/j.1365-313X.2006.02837.x; Black L, 1991, PLANT DIS, V75; BOHLMANN H, 1994, CRIT REV PLANT SCI, V13, P1, DOI 10.1080/713608052; Chen H, 2016, MOL PLANT PATHOLOGY; Chen K, 2007, J PHYTOPATHOL, V155, P178, DOI 10.1111/j.1439-0434.2007.01217.x; Chen TZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080816; CHOI D, 1994, P NATL ACAD SCI USA, V91, P2329, DOI 10.1073/pnas.91.6.2329; Choi H, 2015, PLANT MOL BIOL, V88, P233, DOI 10.1007/s11103-015-0317-y; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; David P, 2010, THEOR APPL GENET, V121, P87, DOI 10.1007/s00122-010-1293-x; de Leon IP, 2002, PLANT J, V29, P61, DOI 10.1046/j.1365-313x.2002.01195.x; Diaz Jose, 2004, Phytochemistry Reviews, V3, P141, DOI 10.1023/B:PHYT.0000047801.41574.6e; Dinesh-Kumar SP, 2000, P NATL ACAD SCI USA, V97, P1908, DOI 10.1073/pnas.020367497; Dixon DP, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews3004; Edwards R, 2000, TRENDS PLANT SCI, V5, P193, DOI 10.1016/S1360-1385(00)01601-0; Epple P, 1997, PLANT CELL, V9, P509, DOI 10.1105/tpc.9.4.509; Finkemeier I, 2013, PLANT PHYSIOL, V162, P239, DOI 10.1104/pp.113.214114; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Goyer A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1666-2; Grant M, 2006, CURR OPIN PLANT BIOL, V9, P414, DOI 10.1016/j.pbi.2006.05.013; Guo YL, 2011, PLANT PHYSIOL, V157, P757, DOI 10.1104/pp.111.181990; HammondKosack KE, 1997, ANNU REV PLANT PHYS, V48, P575, DOI 10.1146/annurev.arplant.48.1.575; Hermosa MR, 2006, PHYSIOL MOL PLANT P, V68, P138, DOI 10.1016/j.pmpp.2006.09.004; Hwang IS, 2010, PLANT PHYSIOL, V152, P948, DOI 10.1104/pp.109.147827; Jupe F, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-75; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kim DS, 2014, PLANT MOL BIOL, V84, P329, DOI 10.1007/s11103-013-0137-x; Kim S, 2014, NAT GENET, V46, P270, DOI 10.1038/ng.2877; Kim YC, 2006, BIOCHEM BIOPH RES CO, V345, P638, DOI 10.1016/j.bbrc.2006.04.124; Kirsch C, 1997, PLANT PHYSIOL, V115, P283, DOI 10.1104/pp.115.1.283; Knierim D, 2006, ARCH VIROL, V151, P1761, DOI 10.1007/s00705-006-0749-4; Ko MK, 2005, PLANT MOL BIOL, V58, P529, DOI 10.1007/s11103-005-7088-9; Kong HY, 2002, PHYSIOL PLANTARUM, V115, P550, DOI 10.1034/j.1399-3054.2002.1150409.x; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kraikruan W, 2008, EFFECT CAPSAICIN GER; Krishnareddy M, 2008, PLANT DIS, V92, P1469, DOI 10.1094/PDIS-92-10-1469B; Kunkalikar SR, 2010, ARCH VIROL, V155, P1047, DOI 10.1007/s00705-010-0681-5; Lay FT, 2005, CURR PROTEIN PEPT SC, V6, P85, DOI 10.2174/1389203053027575; Lee BJ, 2009, FEBS LETT, V583, P2315, DOI 10.1016/j.febslet.2009.06.028; Lee H, 1999, J BIOL CHEM, V274, P36637, DOI 10.1074/jbc.274.51.36637; Lee SC, 2005, PLANTA, V221, P790, DOI 10.1007/s00425-005-1488-6; Li J, 2008, MOL PLANT, V1, P482, DOI 10.1093/mp/ssn013; LINTHORST HJM, 1993, PLANT MOL BIOL, V21, P985, DOI 10.1007/BF00023597; Liu HY, 2010, J INTEGR PLANT BIOL, V52, P315, DOI 10.1111/j.1744-7909.2010.00912.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopukhina A, 2001, PLANT PHYSIOL, V126, P1678, DOI 10.1104/pp.126.4.1678; Lu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043447; Mandal B, 2012, PLANT DIS, V96, P468, DOI 10.1094/PDIS-06-11-0520; Marrs KA, 1996, ANNU REV PLANT PHYS, V47, P127, DOI 10.1146/annurev.arplant.47.1.127; Maruthi MN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096642; McHale L, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-212; McMichael LA, 2002, AUSTRALAS PLANT PATH, V31, P231, DOI 10.1071/AP02016; Morgan PW, 1997, PHYSIOL PLANTARUM, V100, P620, DOI 10.1034/j.1399-3054.1997.1000325.x; Morimoto S, 2007, J BIOL CHEM, V282, P20739, DOI 10.1074/jbc.M700133200; Moscone EA, 2006, 6 INT SOL C GEN MEET, V745; Mun JH, 2009, MOL GENET GENOMICS, V282, P617, DOI 10.1007/s00438-009-0492-0; Nie XZ, 2002, GENOME, V45, P905, DOI [10.1139/g02-062, 10.1139/G02-062]; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Oh BJ, 1999, PLANT MOL BIOL, V41, P313, DOI 10.1023/A:1006336203621; Park CJ, 2004, PLANTA, V219, P797, DOI 10.1007/s00425-004-1290-x; Persley D., 2010, DIS VEGETABLE CROPS; Persley DM, 2006, AUSTRALAS PLANT PATH, V35, P161, DOI 10.1071/AP06015; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Premachandra WTSD, 2005, PHYTOPATHOLOGY, V95, P659, DOI 10.1094/PHYTO-95-0659; Qin C, 2014, P NATL ACAD SCI USA, V111, P5135, DOI 10.1073/pnas.1400975111; Qu ZL, 2006, PLANT CELL PHYSIOL, V47, P1058, DOI 10.1093/pcp/pcj076; Reddy M. K., 2014, SABRAO Journal of Breeding and Genetics, V46, P160; Roberts JA, 2000, ANN BOT-LONDON, V86, P223, DOI 10.1006/anbo.2000.1203; Roitsch T, 2003, J EXP BOT, V54, P513, DOI 10.1093/jxb/erg050; Rubio M, 2015, MOL PLANT PATHOL, V16, P164, DOI 10.1111/mpp.12169; RYAN CA, 1990, ANNU REV PHYTOPATHOL, V28, P425, DOI 10.1146/annurev.py.28.090190.002233; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schornack S, 2004, PLANT J, V37, P46, DOI 10.1046/j.1365-313X.2003.01937.x; Senthil G, 2005, J GEN VIROL, V86, P2615, DOI 10.1099/vir.0.81043-0; Stall RE, 2009, ANNU REV PHYTOPATHOL, V47, P265, DOI 10.1146/annurev-phyto-080508-081752; Stukkens Y, 2005, PLANT PHYSIOL, V139, P341, DOI 10.1104/pp.105.062372; Tang F, 2013, PLANT MOL BIOL, V82, P367, DOI 10.1007/s11103-013-0068-6; Thomma BPHJ, 2001, CURR OPIN IMMUNOL, V13, P63, DOI 10.1016/S0952-7915(00)00183-7; Tomita R, 2011, MOL PLANT MICROBE IN, V24, P108, DOI 10.1094/MPMI-06-10-0127; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Upchurch RG, 2008, BIOTECHNOL LETT, V30, P967, DOI 10.1007/s10529-008-9639-z; van der Biezen EA, 1998, CURR BIOL, V8, pR226, DOI 10.1016/S0960-9822(98)70145-9; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; van Ooijen G, 2007, ANNU REV PHYTOPATHOL, V45, P43, DOI 10.1146/annurev.phyto.45.062806.094430; Veloso J, 2014, PLANT BIOLOGY, V16, P177, DOI 10.1111/j.1438-8677.2012.00717.x; VICK BA, 1983, BIOCHEM BIOPH RES CO, V111, P470, DOI 10.1016/0006-291X(83)90330-3; Walters D, 2003, NEW PHYTOL, V159, P109, DOI 10.1046/j.1469-8137.2003.00802.x; WHITEHEAD IM, 1989, PHYTOCHEMISTRY, V28, P775, DOI 10.1016/0031-9422(89)80114-1; Widana Gamage S, 2015, ARCH VIROL, P1; Yang SM, 2014, INT J MOL SCI, V15, P10424, DOI 10.3390/ijms150610424; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zavala-Paramo G, 2000, PHYSIOL PLANTARUM, V110, P410, DOI 10.1034/j.1399-3054.2000.1100316.x; Zhang XC, 2003, PLANT CELL, V15, P2333, DOI 10.1105/tpc.013474	104	17	17	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2016	11	7							e0159085	10.1371/journal.pone.0159085	http://dx.doi.org/10.1371/journal.pone.0159085			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CN	27398596	Green Submitted, gold, Green Published			2022-12-27	WOS:000379508100017
J	Kim, HY; Jang, EJ; Park, B; Kim, TY; Shin, SA; Ha, YC; Jang, S				Kim, Ha Young; Jang, Eun Jin; Park, ByeongJu; Kim, Tae-Young; Shin, Soon-Ae; Ha, Yong-Chan; Jang, Sunmee			Development of a Korean Fracture Risk Score (KFRS) for Predicting Osteoporotic Fracture Risk: Analysis of Data from the Korean National Health Insurance Service	PLOS ONE			English	Article							POSTMENOPAUSAL WOMEN; HIP-FRACTURES; OLDER WOMEN; METAANALYSIS; BMD; MEN; QFRACTURESCORES; PERFORMANCE; COHORT; FRAX	Background Asian-specific prediction models for estimating individual risk of osteoporotic fractures are rare. We developed a Korean fracture risk prediction model using clinical risk factors and assessed validity of the final model. Methods A total of 718,306 Korean men and women aged 50-90 years were followed for 7 years in a national system-based cohort study. In total, 50% of the subjects were assigned randomly to the development dataset and 50% were assigned to the validation dataset. Clinical risk factors for osteoporotic fracture were assessed at the biennial health check. Data on osteoporotic fractures during the follow-up period were identified by ICD-10 codes and the nationwide database of the National Health Insurance Service (NHIS). Results During the follow-up period, 19,840 osteoporotic fractures were reported (4,889 in men and 14,951 in women) in the development dataset. The assessment tool called the Korean Fracture Risk Score (KFRS) is comprised of a set of nine variables, including age, body mass index, recent fragility fracture, current smoking, high alcohol intake, lack of regular exercise, recent use of oral glucocorticoid, rheumatoid arthritis, and other causes of secondary osteoporosis. The KFRS predicted osteoporotic fractures over the 7 years. This score was validated using an independent dataset. A close relationship with overall fracture rate was observed when we compared the mean predicted scores after applying the KFRS with the observed risks after 7 years within each 10th of predicted risk. Conclusion We developed a Korean specific prediction model for osteoporotic fractures. The KFRS was able to predict risk of fracture in the primary population without bone mineral density testing and is therefore suitable for use in both clinical setting and self-assessment. The website is available at http://www.nhis.or.kr.	[Kim, Ha Young] Wonkwang Univ, Sanbon Hosp, Dept Internal Med, Gunpo, South Korea; [Jang, Eun Jin] Andong Natl Univ, Dept Informat Stat, Andong, South Korea; [Park, ByeongJu] Kyungpook Natl Univ, Dept Stat, Daegu, South Korea; [Kim, Tae-Young] Hallym Univ, Dept Orthopaed Surg, Sch Med, Anyang, South Korea; [Shin, Soon-Ae] Natl Hlth Insurance Serv, Big Data Steering Dept, Seoul, South Korea; [Ha, Yong-Chan] Chung Ang Univ, Coll Med, Dept Orthopaed Surg, Seoul, South Korea; [Jang, Sunmee] Gachon Univ, Coll Pharm, Inchon, South Korea	Wonkwang University; Andong National University; Kyungpook National University; Hallym University; National Health Insurance Service; Chung Ang University; Chung Ang University Hospital; Gachon University	Ha, YC (corresponding author), Chung Ang Univ, Coll Med, Dept Orthopaed Surg, Seoul, South Korea.; Jang, S (corresponding author), Gachon Univ, Coll Pharm, Inchon, South Korea.	hayongch@naver.com; smjang@gachon.ac.kr	Kim, Hayoung/GQP-0924-2022	Ha, Yong-Chan/0000-0002-6249-0581	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health Welfare, Korea [HI13C1522]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health Welfare, Korea	This study was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Korea (grant number: HI13C1522). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Barrett-Connor E, 2005, J BONE MINER RES, V20, P185, DOI 10.1359/JBMR.041007; Black DM, 2001, OSTEOPOROSIS INT, V12, P519, DOI 10.1007/s001980170072; Bolland MJ, 2011, J BONE MINER RES, V26, P420, DOI 10.1002/jbmr.215; COOPER C, 1992, OSTEOPOROSIS INT, V2, P285, DOI 10.1007/BF01623184; Cummins NM, 2011, CALCIFIED TISSUE INT, V89, P172, DOI 10.1007/s00223-011-9504-2; De Laet C, 2005, OSTEOPOROSIS INT, V16, P1330, DOI 10.1007/s00198-005-1863-y; Gregg EW, 1998, ANN INTERN MED, V129, P81, DOI 10.7326/0003-4819-129-2-199807150-00002; Hippisley-Cox J, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4229; Johnell O, 2005, J BONE MINER RES, V20, P1185, DOI 10.1359/JBMR.050304; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P399, DOI 10.1007/s00198-008-0560-z; Kanis JA, 2007, OSTEOPOROSIS INT, V18, P1033, DOI 10.1007/s00198-007-0343-y; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P737, DOI 10.1007/s00198-004-1640-3; Kanis JA, 2004, BONE, V35, P1029, DOI 10.1016/j.bone.2004.06.017; Kanis JA, 2004, J BONE MINER RES, V19, P893, DOI 10.1359/JBMR.040134; Kanis JA, 2004, BONE, V35, P375, DOI 10.1016/j.bone.2004.03.024; Kanis JA, 2002, OSTEOPOROSIS INT, V13, P527, DOI 10.1007/s001980200069; Klotzbuecher CM, 2000, J BONE MINER RES, V15, P721, DOI 10.1359/jbmr.2000.15.4.721; Kung AWC, 2007, J BONE MINER RES, V22, P1080, DOI [10.1359/jbmr.070320, 10.1359/JBMR.070320]; Lee SH, 2010, J BONE MINER RES, V25, P369, DOI 10.1359/jbmr.090722; Lim S, 2008, J BONE MINER METAB, V26, P400, DOI 10.1007/s00774-007-0835-z; Lindsay R, 2001, JAMA-J AM MED ASSOC, V285, P320, DOI 10.1001/jama.285.3.320; Lippuner K, 2009, Rev Med Suisse, V5, P1304; Nayak S, 2014, OSTEOPOROSIS INT, V25, P23, DOI 10.1007/s00198-013-2504-5; Nguyen ND, 2008, OSTEOPOROSIS INT, V19, P1431, DOI 10.1007/s00198-008-0588-0; Nguyen ND, 2007, OSTEOPOROSIS INT, V18, P1109, DOI 10.1007/s00198-007-0362-8; Park C, 2011, J BONE MINER METAB, V29, P744, DOI 10.1007/s00774-011-0279-3; PECK WA, 1993, AM J MED, V94, P646; Sambrook PN, 2011, J BONE MINER RES, V26, P2770, DOI 10.1002/jbmr.503; Wolbers M, 2014, BIOSTATISTICS, V15, P526, DOI 10.1093/biostatistics/kxt059; Wolbers M, 2009, EPIDEMIOLOGY, V20, P555, DOI 10.1097/EDE.0b013e3181a39056; Yoo Je-Hyun, 2015, J Bone Metab, V22, P175, DOI 10.11005/jbm.2015.22.4.175; Yoon HK, 2011, J KOREAN MED SCI, V26, P1087, DOI 10.3346/jkms.2011.26.8.1087	33	21	23	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2016	11	7							e0158918	10.1371/journal.pone.0158918	http://dx.doi.org/10.1371/journal.pone.0158918			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CN	27399597	gold, Green Published, Green Submitted			2022-12-27	WOS:000379508100012
J	Brenner, B; Sarfaty, M; Purim, O; Kundel, Y; Amit, L; Abramovich, A; Gonik, US; Idelevich, E; Gordon, N; Medalia, G; Sulkes, A				Brenner, Baruch; Sarfaty, Michal; Purim, Ofer; Kundel, Yulia; Amit, Limor; Abramovich, Amir; Gonik, Udi Sadeh; Idelevich, Efraim; Gordon, Noa; Medalia, Gal; Sulkes, Aaron			A Phase Ib/II Study Evaluating the Combination of Weekly Docetaxel and Cisplatin Together with Capecitabine and Bevacizumab in Patients with Advanced Esophago-Gastric Cancer	PLOS ONE			English	Article							ADVANCED GASTRIC-CANCER; METASTATIC COLORECTAL-CANCER; FLUOROURACIL PLUS LEUCOVORIN; 1ST-LINE THERAPY; BREAST-CANCER; ORAL CAPECITABINE; 3-WEEKLY DOCETAXEL; III TRIAL; CHEMOTHERAPY; 5-FLUOROURACIL	Introduction Current treatment options for advanced esophagogastric cancer (AEGC) are still unsatisfactory. The aim of this prospective phase Ib/II study was to evaluate the safety and efficacy of a novel regimen, AVDCX, consisting of weekly docetaxel and cisplatin together with capecitabine and bevacizumab, in AEGC. Methods Patients with AEGC received treatment with different dose levels of AVDCX (cisplatin and docetaxel 25-35 mg/m(2), days 1,8, capecitabine 1,600 mg/m(2) days 1-14, bevacizumab 7.5 mg/kg, day 1, Q:21 days). The study's primary objectives were to establish the recommended phase II doses of docetaxel and cisplatin in AVDCX (phase Ib part) and to determine the tumor response rate (phase II part). Results The study was closed early, after the accrual of 22 patients, due to accumulating toxicity-related deaths. The median age was 59 years and 77% of patients had gastric or gastro-esophageal adenocarcinomas. Grade >= 3 adverse events were documented in 18 patients (82%), usually neutropenia (36%), fatigue (54%) or diarrhea (23%). There were three fatal toxicities (14%): mesenteric thromboembolism, gastric perforation and pancytopenic sepsis. The recommended phase II doses of cisplatin and docetaxel were determined to be 25 mg/m(2) and 30 mg/m(2), respectively. Twenty-one patients were evaluable for response: 12 (54%) had partial response (PR), 4 (18%) had stable disease (SD) and none had complete response (CR). Hence, the objective response rate (CR+PR) was 54% and the disease control rate (CR+PR+SD) was 72%. For the 17 patients treated at the MTD, the objective response rate was 41% and the disease control rate was 88%. The median overall survival (OS) for these patients was 13.9 months (range, 1.5-52.2 months) and the median progression-free survival was 7.6 months (range, 1.3-26.6 months). The 2-year OS rate reached 23.7%. Conclusions AVDCX was associated with a high rate of regimen related fatal adverse events and is not appropriate for further development in AEGC patients.	[Brenner, Baruch; Sarfaty, Michal; Purim, Ofer; Kundel, Yulia; Amit, Limor; Abramovich, Amir; Gordon, Noa; Medalia, Gal; Sulkes, Aaron] Beilinson Med Ctr, Rabin Med Ctr, Davidoff Canc Ctr, Inst Oncol, Petah Tiqwa, Israel; [Brenner, Baruch; Sarfaty, Michal; Purim, Ofer; Kundel, Yulia; Amit, Limor; Abramovich, Amir; Gonik, Udi Sadeh; Gordon, Noa; Medalia, Gal; Sulkes, Aaron] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Gonik, Udi Sadeh] Beilinson Med Ctr, Rabin Med Ctr, Dept Radiol, Petah Tiqwa, Israel; [Idelevich, Efraim] Kaplan Med Ctr, Inst Oncol, Rehovot, Israel; [Idelevich, Efraim] Hebrew Univ Jerusalem, Jerusalem, Israel	Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; Hebrew University of Jerusalem; Kaplan Medical Center; Hebrew University of Jerusalem	Brenner, B (corresponding author), Beilinson Med Ctr, Rabin Med Ctr, Davidoff Canc Ctr, Inst Oncol, Petah Tiqwa, Israel.; Brenner, B (corresponding author), Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel.	brennerb@clalit.org.il		Gordon, Noa/0000-0001-8187-6634; Sarfaty, Michal/0000-0002-9603-3207	Roche; Sanofi-Aventis pharmaceuticals	Roche(Roche Holding); Sanofi-Aventis pharmaceuticals(Sanofi-Aventis)	Roche and Sanofi-Aventis pharmaceuticals supplied the study drugs and funded the statistical analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051780; CORREA P, 1991, WORLD J SURG, V15, P228, DOI 10.1007/BF01659057; Cunningham D, 2008, NEW ENGL J MED, V358, P36, DOI 10.1056/NEJMoa073149; FRANCESCHI S, 1994, EUROPEAN JOURNAL OF CANCER PREVENTION, VOL 3, SUPPLEMENT 2, DEC 1994, P5, DOI 10.1097/00008469-199412002-00001; Hoff PM, 2001, J CLIN ONCOL, V19, P2282, DOI 10.1200/JCO.2001.19.8.2282; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kang YK, 2009, ANN ONCOL, V20, P666, DOI 10.1093/annonc/mdn717; Kundel Y, 2008, MED SCI MONITOR, V14, pCR190; Lyman GH, 2013, ONCOLOGIST, V18, P1321, DOI 10.1634/theoncologist.2013-0226; Miller Kathy D, 2003, Clin Breast Cancer, V3, P421, DOI 10.3816/CBC.2003.n.007; Moehler MH, 2009, J CLIN ONCOL, V27; O'Shaughnessy J, 2002, J CLIN ONCOL, V20, P2812, DOI 10.1200/JCO.2002.09.002; O'Shaughnessy JA, 2001, ANN ONCOL, V12, P1247, DOI 10.1023/A:1012281104865; Ohtsu A, 2011, J CLIN ONCOL, V29, P3968, DOI 10.1200/JCO.2011.36.2236; Ranpura V, 2011, JAMA-J AM MED ASSOC, V305, P487, DOI 10.1001/jama.2011.51; Rivera E, 2008, CANCER-AM CANCER SOC, V112, P1455, DOI 10.1002/cncr.23321; SANDLER AB, 2005, J CLIN ONCOL, V23; Sawada N, 1998, CLIN CANCER RES, V4, P1013; Schuette W, 2005, J CLIN ONCOL, V23, P8389, DOI 10.1200/JCO.2005.02.3739; Shah MA, 2006, J CLIN ONCOL, V24, P5201, DOI 10.1200/JCO.2006.08.0887; Shen L., 2014, GENEOVERLAP R PACKAG, P1; Sparano J, 2007, ASCO ANN M P; Sparano JA, 2007, J CLIN ONCOL, V25; Tabernero J, 2004, ANN ONCOL, V15, P1358, DOI 10.1093/annonc/mdh349; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Tebbutt N, 2007, J CLIN ONCOL, V25; Thuss-Patience PC, 2006, J CLIN ONCOL, V24, p195S; Van Cutsem E, 2001, J CLIN ONCOL, V19, P4097, DOI 10.1200/JCO.2001.19.21.4097; Van Cutsem E, 2006, J CLIN ONCOL, V24, P4991, DOI 10.1200/JCO.2006.06.8429; Vanhoefer U, 2000, J CLIN ONCOL, V18, P2648, DOI 10.1200/JCO.2000.18.14.2648; Wagner AD, 2010, COCHRANE DATABASE SY, V3; Zon R., 2006, EJC Supplements, V4, P47, DOI 10.1016/S1359-6349(06)80030-3	33	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0157548	10.1371/journal.pone.0157548	http://dx.doi.org/10.1371/journal.pone.0157548			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27390847	gold, Green Submitted, Green Published			2022-12-27	WOS:000380005400012
J	Hirjak, D; Hochlehnert, A; Thomann, PA; Kubera, KM; Schnell, K				Hirjak, Dusan; Hochlehnert, Achim; Thomann, Philipp Arthur; Kubera, Katharina Maria; Schnell, Knut			Evidence for Distinguishable Treatment Costs among Paranoid Schizophrenia and Schizoaffective Disorder	PLOS ONE			English	Article							BIPOLAR DISORDER; NEGATIVE SYMPTOMS; SYSTEM; CARE; POPULATION; PSYCHIATRY; DIAGNOSIS; STABILITY; VOLUME	Background Schizophrenia spectrum disorders result in enormous individual suffering and financial burden on patients and on society. In Germany, there are about 1,000,000 individuals suffering from schizophrenia (SZ) or schizoaffective disorder (SAD), a combination of psychotic and affective symptoms. Given the heterogeneous nature of these syndromes, one may assume that there is a difference in treatment costs among patients with paranoid SZ and SAD. However, the current the national system of cost accounting in psychiatry and psychosomatics in Germany assesses all schizophrenia spectrum disorders within one category. Methods The study comprised a retrospective audit of data from 118 patients diagnosed with paranoid SZ (F20.0) and 71 patients with SAD (F25). We used the mean total costs as well as partial cost, i.e., mean costs for medication products, mean personal costs and mean infrastructure costs from each patient for the statistical analysis. We tested for differences in the four variables between SZ and SAD patients using ANCOVA and confirmed the results with bootstrapping. Results SAD patients had a longer duration of stay than patients with SZ (p = .02). Mean total costs were significantly higher for SAD patients (p = .023). Further, we found a significant difference in mean personnel costs (p = .02) between patients with SZ and SAD. However, we found no significant differences in mean pharmaceutical costs (p = .12) but a marginal difference of mean infrastructure costs (p = .05) between SZ and SAD. We found neither a common decrease of costs over time nor a differential decrease in SZ and SAD. Conclusion We found evidence for a difference of case related costs of inpatient treatments for paranoid SZ and SAD. The differences in mean total costs seem to be primarily related to the mean personnel costs in patients with paranoid SZ and SAD rather than mean pharmaceutical costs, possibly due to higher personnel effort and infrastructure.	[Hirjak, Dusan; Thomann, Philipp Arthur; Kubera, Katharina Maria; Schnell, Knut] Heidelberg Univ, Dept Gen Psychiat, Ctr Psychosocial Med, Heidelberg, Germany; [Hochlehnert, Achim] Heidelberg Univ, Dept Gen Internal Med & Psychosomat, Ctr Psychosocial Med, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Hirjak, D (corresponding author), Heidelberg Univ, Dept Gen Psychiat, Ctr Psychosocial Med, Heidelberg, Germany.	dusan.hirjak@med.uni-heidelberg.de	Kubera, Katharina Maria/ABB-3450-2020; Hirjak, Dusan/W-2126-2019; Hirjak, Dusan/P-2777-2018					Andreasen NC, 1998, SCHIZOPHRENIA BULL, V24, P203, DOI 10.1093/oxfordjournals.schbul.a033321; Arnold SJM, 2015, SCHIZOPHRENIA BULL, V41, P233, DOI 10.1093/schbul/sbu009; Barber JA, 2000, STAT MED, V19, P3219, DOI 10.1002/1097-0258(20001215)19:23<3219::AID-SIM623>3.0.CO;2-P; Benabarre A, 2001, EUR PSYCHIAT, V16, P167, DOI 10.1016/S0924-9338(01)00559-4; BOGERTS B, 1985, ARCH GEN PSYCHIAT, V42, P784; Bora E, 2009, BRIT J PSYCHIAT, V195, P475, DOI 10.1192/bjp.bp.108.055731; Brenner I, 2010, PSYCHOPATHOLOGY, V43, P285, DOI 10.1159/000318812; Chen YR, 1998, J NERV MENT DIS, V186, P17, DOI 10.1097/00005053-199801000-00004; Cheniaux E, 2008, J AFFECT DISORDERS, V106, P209, DOI 10.1016/j.jad.2007.07.009; Cotton SM, 2013, SCHIZOPHR RES, V147, P169, DOI 10.1016/j.schres.2013.02.036; Du YH, 2015, NEUROIMAGE, V122, P272, DOI 10.1016/j.neuroimage.2015.07.054; Durla A, 2013, REV MED CHIR SOC MED, V117, P11; Falkai P, 2008, NEUROPSYCHOLOGIE SCH, P36; Godemann F, 2014, FORTSCHR NEUROL PSYC, V82, P634, DOI 10.1055/s-0034-1385266; Godemann F, 2014, QUALITY INPATIENT TR; Hirjak D, 2014, MOTOR ABNORMALITIES; Kalkulation Von Behandlungskosten, 2010, HDB KALULATION PSYCH; Klimke A, 2014, NERVENARZT, V85, P88, DOI 10.1007/s00115-013-3981-7; Konnopka A, 2009, PSYCHIAT PRAX, V36, P211, DOI 10.1055/s-0028-1090234; Kraepelin E, 1919, DEMENTIA PRAECOX PAR; Malhi GS, 2008, BIPOLAR DISORD, V10, P215, DOI 10.1111/j.1399-5618.2007.00564.x; Mancuso SG, 2015, J AFFECT DISORDERS, V172, P30, DOI 10.1016/j.jad.2014.09.035; Moller H.-J., 2008, PSYCHIAT PSYCHOTHERA; Moller HJ, 2000, NERVENARZT, V71, P345, DOI 10.1007/s001150050568; Pagel T, 2013, ACTA PSYCHIAT SCAND, V128, P238, DOI 10.1111/acps.12109; Pagel T, 2013, BIPOLAR DISORD, V15, P229, DOI 10.1111/bdi.12057; Perala J, 2007, ARCH GEN PSYCHIAT, V64, P19, DOI 10.1001/archpsyc.64.1.19; Schwartz JE, 2000, ARCH GEN PSYCHIAT, V57, P593, DOI 10.1001/archpsyc.57.6.593; Sicras-Mainar A, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0225-8; Sugibayashi Y, 2014, NEUROPSYCH DIS TREAT, V10, P1577, DOI 10.2147/NDT.S63009; Wolff-Menzler C, 2014, FORTSCHR NEUROL PSYC, V82, P394, DOI 10.1055/s-0034-1366577; Wolwer Wolfgang, 2006, Dialogues Clin Neurosci, V8, P115	32	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0157635	10.1371/journal.pone.0157635	http://dx.doi.org/10.1371/journal.pone.0157635			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27391238	Green Published, gold, Green Submitted			2022-12-27	WOS:000380005400016
J	Kim, IS; Kim, YS; Kim, YH; Park, AK; Kim, HW; Lee, JH; Yoon, HS				Kim, Il-Sup; Kim, Young-Saeng; Kim, Yul-Ho; Park, Ae-Kyung; Kim, Han-Woo; Lee, Jun-Hyuk; Yoon, Ho-Sung			Potential Application of the Oryza sativa Monodehydroascorbate Reductase Gene (OsMDHAR) to Improve the Stress Tolerance and Fermentative Capacity of Saccharomyces cerevisiae	PLOS ONE			English	Article							OXIDATIVE STRESS; SUPEROXIDE-DISMUTASE; ASCORBIC-ACID; ERYTHROASCORBIC ACID; ENHANCED TOLERANCE; ETHANOL-PRODUCTION; MESSENGER-RNA; YEAST STRAINS; CDNA CLONING; WINE YEAST	Monodehydroascorbate reductase (MDHAR; EC 1.6.5.4) is an important enzyme for ascorbate recycling. To examine whether heterologous expression of MDHAR from Oryza sativa (OsMDHAR) can prevent the deleterious effects of unfavorable growth conditions, we constructed a transgenic yeast strain harboring a recombinant plasmid carrying OsMDHAR (p426GPD::OsMDHAR). OsMDHAR-expressing yeast cells displayed enhanced tolerance to hydrogen peroxide by maintaining redox homoeostasis, proteostasis, and the ascorbate (AsA)-like pool following the accumulation of antioxidant enzymes and molecules, metabolic enzymes, and molecular chaperones and their cofactors, compared to wild-type (WT) cells carrying vector alone. The addition of exogenous AsA or its analogue isoascorbic acid increased the viability of WT and ara2 Delta cells under oxidative stress. Furthermore, the survival of OsMDHAR-expressing cells was greater than that of WT cells when cells at mid-log growth phase were exposed to high concentrations of ethanol. High OsMDHAR expression also improved the fermentative capacity of the yeast during glucose-based batch fermentation at a standard cultivation temperature (30 degrees C). The alcohol yield of OsMDHAR-expressing transgenic yeast during fermentation was approximately 25% (0.18 g.g(-1)) higher than that of WT yeast. Accordingly, OsMDHAR-expressing transgenic yeast showed prolonged survival during the environmental stresses produced during fermentation. These results suggest that heterologous OsMDHAR expression increases tolerance to reactive oxygen species-induced oxidative stress by improving cellular redox homeostasis and improves survival during fermentation, which enhances fermentative capacity.	[Kim, Il-Sup; Yoon, Ho-Sung] Kyungpook Natl Univ, Sch Life Sci, Plus KNU Creat BioRes Grp BK21, Daegu, South Korea; [Kim, Young-Saeng] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Kim, Yul-Ho] Rural Dev Adm, Highland Agr Res Inst, Natl Inst Crop Sci, Pyeongchang, South Korea; [Park, Ae-Kyung; Kim, Han-Woo; Lee, Jun-Hyuk] Korea Polar Res Inst, Div Polar Life Sci, Inchon, South Korea	Kyungpook National University; University of California System; University of California San Diego; Rural Development Administration (RDA), Republic of Korea; National Institute of Crop Science; Korea Institute of Ocean Science & Technology (KIOST); Korea Polar Research Institute (KOPRI)	Kim, IS; Yoon, HS (corresponding author), Kyungpook Natl Univ, Sch Life Sci, Plus KNU Creat BioRes Grp BK21, Daegu, South Korea.	92kis@hanmail.net; hsy@knu.ac.kr			Next-Generation BioGreen 21 Program, Rural Development Administration, Korea [PJ011122022016]	Next-Generation BioGreen 21 Program, Rural Development Administration, Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by a grant from the Next-Generation BioGreen 21 Program (No. PJ011122022016), Rural Development Administration, Korea.	Abbott DA, 2009, APPL ENVIRON MICROB, V75, P2320, DOI 10.1128/AEM.00009-09; Abreu-Cavalheiro A, 2013, BRAZ J MICROBIOL, V44, P665, DOI 10.1590/S1517-83822013000300001; Aguado A, 2015, ARCH BIOCHEM BIOPHYS, V580, P121, DOI 10.1016/j.abb.2015.07.006; Belloch C, 2008, INT J FOOD MICROBIOL, V122, P188, DOI 10.1016/j.ijfoodmicro.2007.11.083; Ben Rejeb I, 2004, CR BIOL, V327, P679, DOI 10.1016/j.crvi.2004.06.002; Breiman A, 2014, CURR PROTEIN PEPT SC, V15, P232, DOI 10.2174/1389203715666140331115603; Campagno C, 2001, YEAST, V18, P663, DOI 10.1002/yea.715; Chum HL, 2014, BIOFUEL BIOPROD BIOR, V8, P205, DOI 10.1002/bbb.1448; Ding JM, 2009, APPL MICROBIOL BIOT, V85, P253, DOI 10.1007/s00253-009-2223-1; Do H, 2014, ACTA CRYSTALLOGR F, V70, P1244, DOI 10.1107/S2053230X14015908; Drew DP, 2007, PLANTA, V225, P945, DOI 10.1007/s00425-006-0394-x; Du X, 2007, APPL MICROBIOL BIOT, V75, P1343, DOI 10.1007/s00253-007-0940-x; Eastmond PJ, 2007, PLANT CELL, V19, P1376, DOI 10.1105/tpc.106.043992; Eltayeb AE, 2007, PLANTA, V225, P1255, DOI 10.1007/s00425-006-0417-7; Fernandes PN, 2007, REDOX REP, V12, P236, DOI 10.1179/135100007X200344; Fierro-Risco J, 2013, APPL MICROBIOL BIOT, V97, P6867, DOI 10.1007/s00253-013-4850-9; Gallie DR, 2013, J EXP BOT, V64, P433, DOI 10.1093/jxb/ers330; Gay C, 1999, ANAL BIOCHEM, V273, P149, DOI 10.1006/abio.1999.4208; Gietz RD, 2001, BIOTECHNIQUES, V30, P816, DOI 10.2144/01304rv02; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Gillespie KM, 2007, NAT PROTOC, V2, P871, DOI 10.1038/nprot.2007.101; Gomez-Pastor R, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-4; Gomez-Pastor R, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-9; Gorsich SW, 2006, APPL MICROBIOL BIOT, V71, P339, DOI 10.1007/s00253-005-0142-3; Grabowska D, 2003, J BIOL CHEM, V278, P13984, DOI 10.1074/jbc.M210076200; Han D, 2003, J BIOL CHEM, V278, P5557, DOI 10.1074/jbc.M210269200; Herrero E, 2008, BBA-GEN SUBJECTS, V1780, P1217, DOI 10.1016/j.bbagen.2007.12.004; Husnik JI, 2006, METAB ENG, V8, P315, DOI 10.1016/j.ymben.2006.02.003; Jamieson DJ, 1998, YEAST, V14, P1511, DOI 10.1002/(SICI)1097-0061(199812)14:16<1511::AID-YEA356>3.3.CO;2-J; Kiani-Esfahani A, 2013, SYST BIOL REPROD MED, V59, P352, DOI 10.3109/19396368.2013.829536; Kim IS, 2013, APPL MICROBIOL BIOT, V97, P8997, DOI 10.1007/s00253-013-4729-9; Kim IS, 2013, APPL MICROBIOL BIOT, V97, P3519, DOI 10.1007/s00253-012-4410-8; Kim IS, 2013, MOL CELLS, V35, P210, DOI 10.1007/s10059-013-2258-0; Kwak MK, 2015, FEBS LETT, V589, P1863, DOI 10.1016/j.febslet.2015.04.050; Larsson S, 2001, APPL MICROBIOL BIOT, V57, P167, DOI 10.1007/s002530100742; Lee JS, 2001, BBA-GEN SUBJECTS, V1527, P31, DOI 10.1016/S0304-4165(01)00134-9; Li F, 2010, PHYSIOL PLANTARUM, V139, P421, DOI 10.1111/j.1399-3054.2010.01369.x; Lopez-Mirabal HR, 2008, BBA-MOL CELL RES, V1783, P629, DOI 10.1016/j.bbamcr.2007.10.013; Luo N, 2012, PLANT SCI, V197, P122, DOI 10.1016/j.plantsci.2012.09.010; MEHLHORN H, 1986, PLANT PHYSIOL, V82, P336, DOI 10.1104/pp.82.1.336; MISHRA NP, 1993, PLANT PHYSIOL, V102, P903, DOI 10.1104/pp.102.3.903; Morano KA, 2012, GENETICS, V190, P1157, DOI 10.1534/genetics.111.128033; Munhoz DC, 2004, J BIOL CHEM, V279, P35219, DOI 10.1074/jbc.M313773200; Noctor G, 2016, PLANT CELL ENVIRON, V39, P1140, DOI 10.1111/pce.12726; Omoto E, 2013, PHYSIOL PLANTARUM, V149, P1, DOI 10.1111/ppl.12017; Ostergaard J, 1997, J BIOL CHEM, V272, P30009, DOI 10.1074/jbc.272.48.30009; Priya S, 2013, FEBS LETT, V587, P1981, DOI 10.1016/j.febslet.2013.05.014; Rand JD, 2006, MOL BIOL CELL, V17, P387, DOI 10.1091/mbc.E05-06-0520; Ribeiro TP, 2015, FREE RADICAL BIO MED, V80, P67, DOI 10.1016/j.freeradbiomed.2014.12.005; Saini JK, 2015, 3 BIOTECH, V5, P337, DOI 10.1007/s13205-014-0246-5; Sakihama Y, 2000, BIOCHEM BIOPH RES CO, V279, P949, DOI 10.1006/bbrc.2000.4053; SANO S, 1994, PLANT CELL PHYSIOL, V35, P425; Shigeoka S, 2014, BIOSCI BIOTECH BIOCH, V78, P1457, DOI 10.1080/09168451.2014.942254; Singh S, 2013, FREE RADICAL BIO MED, V56, P89, DOI 10.1016/j.freeradbiomed.2012.11.010; Stanley D, 2010, J APPL MICROBIOL, V109, P13, DOI 10.1111/j.1365-2672.2009.04657.x; Steensels J, 2014, FEMS MICROBIOL REV, V38, P947, DOI 10.1111/1574-6976.12073; Sudhakar D, 1998, TRANSGENIC RES, V7, P371, DOI 10.1023/A:1008856703464; Sultana S, 2012, J PLANT PHYSIOL, V169, P311, DOI 10.1016/j.jplph.2011.09.004; Tan SX, 2010, J BIOL CHEM, V285, P6118, DOI 10.1074/jbc.M109.062844; Tan SX, 2009, MOL BIOL CELL, V20, P1493, DOI 10.1091/mbc.E08-07-0697; Tang HMV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000697; Tanghe A, 2006, BIODIVERSITY AND ECOPHYSIOLOGY OF YEASTS, P175, DOI 10.1007/3-540-30985-3_9; Verghese J, 2012, MICROBIOL MOL BIOL R, V76, P115, DOI 10.1128/MMBR.05018-11; Wang LY, 2009, BIOCHEM BIOPH RES CO, V384, P210, DOI 10.1016/j.bbrc.2009.04.101; WENZEL TJ, 1995, NUCLEIC ACIDS RES, V23, P883, DOI 10.1093/nar/23.5.883; Yoon HS, 2004, BBA-BIOENERGETICS, V1658, P181, DOI 10.1016/j.bbabio.2004.05.013; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024; Zhao XQ, 2009, J BIOTECHNOL, V144, P23, DOI 10.1016/j.jbiotec.2009.05.001	68	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158841	10.1371/journal.pone.0158841	http://dx.doi.org/10.1371/journal.pone.0158841			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27392090	gold, Green Submitted, Green Published			2022-12-27	WOS:000380005400141
J	Nguyen, THP; Pham, VTH; Nguyen, SH; Baulin, V; Croft, RJ; Phillips, B; Crawford, RJ; Ivanova, EP				The Hong Phong Nguyen; Pham, Vy T. H.; Song Ha Nguyen; Baulin, Vladimir; Croft, Rodney J.; Phillips, Brian; Crawford, Russell J.; Ivanova, Elena P.			The Bioeffects Resulting from Prokaryotic Cells and Yeast Being Exposed to an 18 GHz Electromagnetic Field	PLOS ONE			English	Article							MICROWAVE-RADIATION; BIOLOGICAL TISSUES; METABOLIC-ACTIVITY; MEMBRANE-FLUIDITY; IRRADIATION; FREQUENCIES; PERMEABILITY; CATARRHALIS; MODULATION; PROTEINS	The mechanisms by which various biological effects are triggered by exposure to an electromagnetic field are not fully understood and have been the subject of debate. Here, the effects of exposing typical representatives of the major microbial taxa to an 18 GHz microwave electromagnetic field (EMF) were studied. It appeared that the EMF exposure induced cell permeabilisation in all of the bacteria and yeast studied, while the cells remained viable (94% throughout the exposure), independent of the differences in cell membrane fatty acid and phospholipid composition. The resulting cell permeabilisation was confirmed by detection of the uptake of propidium iodine and 23 nm fluorescent silica nanospheres using transmission electron microscopy (TEM) and confocal laser scanning microscopy (CLSM). Upon EMF exposure, the bacterial cell membranes are believed to become permeable through quasi-endocytosis processes. The dosimetry analysis revealed that the EMF threshold level required to induce the uptake of the large (46 nm) nanopsheres was between three and six EMF doses, with a specific absorption rate (SAR) of 3 kW/kg and 5 kW/kg per exposure, respectively, depending on the bacterial taxa being studied. It is suggested that the taxonomic affiliation and lipid composition (e.g. the presence of phosphatidyl-glycerol and/or pentadecanoic fatty acid) may affect the extent of uptake of the large nanospheres (46 nm). Multiple 18 GHz EMF exposures over a one-hour period induced periodic anomalous increases in the cell growth behavior of two Staphylococcus aureus strains, namely ATCC 25923 and CIP 65.8(T).	[The Hong Phong Nguyen; Pham, Vy T. H.; Song Ha Nguyen; Phillips, Brian; Crawford, Russell J.; Ivanova, Elena P.] Swinburne Univ Technol, Fac Sci Engn & Technol, POB 218, Hawthorn, Vic 3122, Australia; [Baulin, Vladimir] Univ Rovira & Virgili, Dept Engn Quim, 26 Av Dels Paisos Catalans, Tarragona 43007, Spain; [Croft, Rodney J.] Univ Wollongong, Sch Psychol, Wollongong, NSW 2522, Australia	Swinburne University of Technology; Universitat Rovira i Virgili; University of Wollongong	Ivanova, EP (corresponding author), Swinburne Univ Technol, Fac Sci Engn & Technol, POB 218, Hawthorn, Vic 3122, Australia.	eivanova@swin.edu.au	Baulin, Vladimir/AAB-8593-2019; Baulin, Vladimir A/B-9718-2012; Nguyen, The Hong Phong/ABE-4841-2020; Ivanova, Elena P/B-1255-2019; Nguyen, The Hong Phong/U-2301-2018	Baulin, Vladimir/0000-0003-2086-4271; Baulin, Vladimir A/0000-0003-2086-4271; Nguyen, The Hong Phong/0000-0003-3847-6963; Ivanova, Elena P/0000-0002-5509-8071; Nguyen, The Hong Phong/0000-0003-3847-6963; Crawford, Russell/0000-0003-1054-5285; Croft, Rodney/0000-0002-5986-9136; Nguyen, Song Ha/0000-0002-7450-8814	Australian Centre for Electromagnetic Bioeffects Research (ACEBR); National Health & Medical Research Council Centre of Research Excellence (NHMRC); Marie Curie Actions under EU FP7 Initial Training Network [SNAL 608184]; National Health & Medical Research Council Centre of Research Excellence	Australian Centre for Electromagnetic Bioeffects Research (ACEBR); National Health & Medical Research Council Centre of Research Excellence (NHMRC); Marie Curie Actions under EU FP7 Initial Training Network; National Health & Medical Research Council Centre of Research Excellence	This work was partly supported by the Australian Centre for Electromagnetic Bioeffects Research (ACEBR, http://acebr.uow.edu.au/index.html T.H.P.N., Ro.J.C., E.P.I.), a National Health & Medical Research Council Centre of Research Excellence (NHMRC). VB and EI acknowledge funding from Marie Curie Actions under EU FP7 Initial Training Network SNAL 608184 (http://cordis.europa.eu/project/rcn/110943_en.html T.H.P.N., V.B.E.P.I.). This work was also supported by the National Health & Medical Research Council Centre of Research Excellence. The authors have no financial or personal relationship with other people or organisations that could inappropriately influence this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Nicolle Marshall for technical assistance. This work was partly supported by the Australian Centre for Electromagnetic Bioeffects Research (ACEBR, http://acebr.uow.edu.au/index.html T.H.P.N Ro.J.C E.P.I), a National Health & Medical Research Council Centre of Research Excellence (NHMRC). VB and EI acknowledge funding from Marie Curie Actions under EU FP7 Initial Training Network SNAL 608184 (http://cordis.europa.eu/project/rcn/110943_en.html T.H.P.N V.B E.P.I). The authors have no financial or personal relationship with other people or organisations that could inappropriately influence this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair RK, 2002, BIOPHYS J, V82, P1147, DOI 10.1016/S0006-3495(02)75473-8; Aitken RJ, 2005, INT J ANDROL, V28, P171, DOI 10.1111/j.1365-2605.2005.00531.x; Annous BA, 1997, APPL ENV MICROBIOL, V63; [Anonymous], [No title captured]; Apodaca G, 2002, AM J PHYSIOL-RENAL, V282, pF179, DOI 10.1152/ajprenal.2002.282.2.F179; Banik S, 2003, BIORESOURCE TECHNOL, V87, P155, DOI 10.1016/S0960-8524(02)00169-4; Beneduci A, 2012, BIOELECTROCHEMISTRY, V84, P18, DOI 10.1016/j.bioelechem.2011.10.003; Bohr H, 2000, PHYS REV E, V61, P4310, DOI 10.1103/PhysRevE.61.4310; Bohr H, 2000, BIOELECTROMAGNETICS, V21, P68, DOI 10.1002/(SICI)1521-186X(200001)21:1<68::AID-BEM10>3.0.CO;2-9; Celandroni F, 2004, J APPL MICROBIOL, V97, P1220, DOI 10.1111/j.1365-2672.2004.02406.x; Clark DE, 1996, ANNU REV MATER SCI, V26, P299, DOI 10.1146/annurev.ms.26.080196.001503; Cohen I, 2010, INT J RADIAT BIOL, V86, P390, DOI 10.3109/09553000903567912; Copty AB, 2006, BIOPHYS J, V91, P1413, DOI 10.1529/biophysj.106.084111; Dekiwadia CD, 2012, J PEPT SCI, V18, P527, DOI 10.1002/psc.2430; DREYFUSS MS, 1980, APPL ENVIRON MICROB, V39, P13, DOI 10.1128/AEM.39.1.13-16.1980; English NJ, 2003, J CHEM PHYS, V118, P1589, DOI 10.1063/1.1538595; Feldmann H, 2012, YEAST GROWTH YEAST C, P175; Gabriel S, 1996, PHYS MED BIOL, V41, P2251, DOI 10.1088/0031-9155/41/11/002; George DF, 2008, BIOELECTROMAGNETICS, V29, P324, DOI 10.1002/bem.20382; Gunstone FD, 1994, LIPID HDB; Gurisik E, 2006, CELL BIOL INT, V30, P793, DOI 10.1016/j.cellbi.2006.06.001; Haemmerich D, 2005, PHYSIOL MEAS, V26, P59, DOI 10.1088/0967-3334/26/1/006; Hasted JB., 1972, WATER COMPREHENSIVE, V1, P255; Inhan-Garip A, 2011, INT J RADIAT BIOL, V87, P1155, DOI 10.3109/09553002.2011.560992; LANDE MB, 1995, J GEN PHYSIOL, V106, P67, DOI 10.1085/jgp.106.1.67; Laurence JA, 2000, J THEOR BIOL, V206, P291, DOI 10.1006/jtbi.2000.2123; Le Quement C, 2012, BIOELECTROMAGNETICS, V33, P147, DOI 10.1002/bem.20693; LECHEVALIER MP, 1977, CRC CR REV MICROBIOL, V5, P109, DOI 10.3109/10408417709102311; Lentacker I, 2014, ADV DRUG DELIVER REV, V72, P49, DOI 10.1016/j.addr.2013.11.008; Li G, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2938692; Lipke PN, 1998, J BACTERIOL, V180, P3735, DOI 10.1128/JB.180.15.3735-3740.1998; LUFT JH, 1961, J BIOPHYS BIOCHEM CY, V9, P409, DOI 10.1083/jcb.9.2.409; McCormick JR, 2012, FEMS MICROBIOL REV, V36, P206, DOI 10.1111/j.1574-6976.2011.00317.x; MCLANUGH.SG, 1970, P NATL ACAD SCI USA, V67, P1268, DOI 10.1073/pnas.67.3.1268; Mortimer RK, 2000, GENOME RES, V10, P403, DOI 10.1101/gr.10.4.403; Mu QS, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-29; Murphy TF, 1996, MICROBIOL REV, V60, P267, DOI 10.1128/MMBR.60.2.267-279.1996; Nesin OM, 2011, BBA-BIOMEMBRANES, V1808, P792, DOI 10.1016/j.bbamem.2010.12.012; Panagopoulos DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062663; Pogodin S, 2012, ACS NANO, V6, P10555, DOI 10.1021/nn3028858; Purty S, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.71; Rai S, 1999, ELECTRO MAGNETOBIOL, V18, P221, DOI 10.3109/15368379909022578; Ruediger Hugo W, 2009, Pathophysiology, V16, P89, DOI 10.1016/j.pathophys.2008.11.004; Ruiz-Gomez MJ, 2009, ELECTROMAGN BIOL MED, V28, P201, DOI 10.1080/15368370802608696; Sato S, 1996, BIOTECHNOL TECH, V10, P145, DOI 10.1007/BF00158936; Shamis Y., 2012, J PHYS SCI APPL, V2, P143; Shamis Y, 2011, APPL ENVIRON MICROB, V77, P3017, DOI 10.1128/AEM.01899-10; Sheetz MP, 1996, TRENDS CELL BIOL, V6, P85, DOI 10.1016/0962-8924(96)80993-7; Shimanouchi T, 2009, COLLOID SURFACE B, V73, P156, DOI 10.1016/j.colsurfb.2009.05.014; Soghomonyan D, 2013, CELL BIOCHEM BIOPHYS, V67, P829, DOI 10.1007/s12013-013-9571-2; STACKEBRANDT E, 1995, INT J SYST BACTERIOL, V45, P682, DOI 10.1099/00207713-45-4-682; Nguyen THP, 2015, SCI REP-UK, V5, DOI 10.1038/srep10980; Torgomyan H, 2012, CELL BIOCHEM BIOPHYS, V62, P451, DOI 10.1007/s12013-011-9327-9; Torgomyan H, 2012, FEMS MICROBIOL LETT, V329, P131, DOI 10.1111/j.1574-6968.2012.02512.x; Torgomyan H, 2011, CURR MICROBIOL, V62, P962, DOI 10.1007/s00284-010-9811-2; Verduin CM, 2002, CLIN MICROBIOL REV, V15, P125, DOI 10.1128/CMR.15.1.125-144.2002; Verma A, 2010, SMALL, V6, P12, DOI 10.1002/smll.200901158; WAKSMAN SA, 1948, J BACTERIOL, V56, P259, DOI 10.1128/JB.56.3.259-269.1948; Wan HD, 2012, APPL BIOCHEM BIOTECH, V166, P1454, DOI 10.1007/s12010-012-9539-5; Zhao YN, 2011, ACS NANO, V5, P1366, DOI 10.1021/nn103077k	60	32	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158135	10.1371/journal.pone.0158135	http://dx.doi.org/10.1371/journal.pone.0158135			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391488	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400032
J	Peto, TJ; Tripura, R; Lee, SJ; Althaus, T; Dunachie, S; Nguon, C; Dhorda, M; Promnarate, C; Chalk, J; Imwong, M; von Seidlein, L; Day, NP; Dondorp, AM; White, NJ; Lubell, Y				Peto, Thomas J.; Tripura, Rupam; Lee, Sue J.; Althaus, Thomas; Dunachie, Susanna; Nguon, Chea; Dhorda, Mehul; Promnarate, Cholrawee; Chalk, Jeremy; Imwong, Mallika; von Seidlein, Lorenz; Day, Nicholas P.; Dondorp, Arjen M.; White, Nicholas J.; Lubell, Yoel			Association between Subclinical Malaria Infection and Inflammatory Host Response in a Pre-Elimination Setting	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; FALCIPARUM-MALARIA; CAMBODIA; EPIDEMIOLOGY; PREVALENCE; RESISTANCE; MORTALITY; KNOWLEDGE; CHILDREN	Background Subclinical infections in endemic areas of Southeast Asia sustain malaria transmission. These asymptomatic infections might sustain immunity against clinical malaria and have been considered benign for the host, but if they are associated with chronic low-grade inflammation this could be harmful. We conducted a case-control study to explore the association between subclinical malaria and C-reactive protein (CRP), an established biomarker of inflammation. Methods Blood samples from asymptomatic villagers in Pailin, Western Cambodia were tested for malaria by high-volume ultra-sensitive polymerase chain reaction (uPCR) to determine the Plasmodium species. Plasma CRP concentration was measured in 328 individuals with parasitaemia (cases) and compared with: i) the same individual's value at the first time point when they had no detectable parasites (n = 282); and ii) age-sex-and village-matched controls (n = 328) free of Plasmodium infection. Plasma CRP concentrations were compared against thresholds of 3mg/L and 10mg/L. Subgroup analysis was carried out for cases with P vivax and P falciparum mono-infections. Results Median plasma CRP level for all samples was 0.59mg/L (interquartile range: 0.24-1.64mg/L). CRP concentrations were higher in parasitaemic individuals compared with same-person-controls (p = 0.050); and matched-controls (p = 0.025). 4.9% of samples had CRP concentrations above 10mg/L and 14.6% were above 3mg/L. Cases were more likely to have plasma CRP concentrations above these thresholds than age/sex matched controls, odds ratio 3.5 (95% CI 1.5-9.8) and 1.8 (95% CI 1.1-2.9), respectively. Amongst cases, parasite density and CRP were positively correlated (p<0.001), an association that remained significant when controlling for age and fever. Individuals with P. vivax mono-infections had the highest plasma CRP concentrations with the greatest association with parasitaemia. Discussion In this setting persistent malaria infections in asymptomatic individuals were associated with moderately elevated plasma CRP concentrations; chiefly evident in cases with P. vivax mono-infections. As well as interrupting malaria transmission within the community, treatment of asymptomatic malaria infections, in particular radical cure of vivax malaria, may benefit the health of infected individuals.	[Peto, Thomas J.; Tripura, Rupam; Lee, Sue J.; Althaus, Thomas; Dunachie, Susanna; Chalk, Jeremy; Imwong, Mallika; von Seidlein, Lorenz; Day, Nicholas P.; Dondorp, Arjen M.; White, Nicholas J.; Lubell, Yoel] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Peto, Thomas J.; Lee, Sue J.; Dunachie, Susanna; Dhorda, Mehul; Chalk, Jeremy; von Seidlein, Lorenz; Day, Nicholas P.; Dondorp, Arjen M.; White, Nicholas J.; Lubell, Yoel] Univ Oxford, Ctr Trop Med & Global Hlth, Oxford, England; [Nguon, Chea] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia; [Dhorda, Mehul; Promnarate, Cholrawee] Mahidol Univ, Fac Trop Med, Worldwide Antimalarial Resistance Network, Bangkok, Thailand; [Imwong, Mallika] Mahidol Univ, Fac Trop Med, Dept Mol Trop Med & Genet, Bangkok, Thailand	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford; National Center Parasitology, Entomology & Malaria Control; Mahidol University; Worldwide Antimalarial Resistance Network (WWARN); Mahidol University	Peto, TJ (corresponding author), Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand.; Peto, TJ (corresponding author), Univ Oxford, Ctr Trop Med & Global Hlth, Oxford, England.	tom@tropmedres.ac	White, Nick/AAC-6527-2019; Althaus, Thomas/J-3759-2019; Imwong, Mallika/ABE-6493-2020	White, Nick/0000-0002-1897-1978; Althaus, Thomas/0000-0002-6997-3877; Lubell, Yoel/0000-0002-0237-1070; Dunachie, Susanna/0000-0001-5665-6293; Peto, Thomas/0000-0003-3197-9891	Bill and Melinda Gates Foundation [BMGF OPP1081420]; Wellcome Trust of Great Britain [101148/Z/13/Z]; Grand Challenges Canada Stars in Global Health award [S5 0443-01]; National Institute for Health Research [CL-2008-13-010] Funding Source: researchfish	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Wellcome Trust of Great Britain(Wellcome Trust); Grand Challenges Canada Stars in Global Health award; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by the Bill and Melinda Gates Foundation (gatesfoundation.org/) BMGF OPP1081420 and was part of the Wellcome Trust-Mahidol University-Oxford Tropical Medicine Research Programme funded by the Wellcome Trust of Great Britain (wellcome.ac.uk/) reference 101148/Z/13/Z. Yoel Lubell received a Grand Challenges Canada Stars in Global Health (grandchallenges.ca/) award to work on biomarkers of infection and their use as diagnostic tools in the rural tropics (Round 5, Grant number S5 0443-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosman P, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-394; Chen I, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001942; CNM, 2014, NAT TREATM GUID MAL; Cox J, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-371; de Mast Q, 2015, J INFECTION, V71, P587, DOI 10.1016/j.jinf.2015.08.005; Diez-Padrisa N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013226; Eriksson UK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070076; Imrie H, 2007, AM J TROP MED HYG, V76, P280, DOI 10.4269/ajtmh.2007.76.280; Imwong M, 2015, J INFECT DIS; Imwong M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0906-x; Imwong M, 2014, J CLIN MICROBIOL, V52, P3303, DOI 10.1128/JCM.01057-14; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Koenig W, 2008, CLIN CHEM, V54, P335, DOI 10.1373/clinchem.2007.100271; Kuper H, 2000, J INTERN MED, V248, P171, DOI 10.1046/j.1365-2796.2000.00742.x; Lim Sachiko, 2012, BMC Res Notes, V5, P405, DOI 10.1186/1756-0500-5-405; Lubell Y, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1272-6; Macy EM, 1997, CLIN CHEM, V43, P52; Maude RJ, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-385; Mugittu K, 2006, TROP MED INT HEALTH, V11, P1350, DOI 10.1111/j.1365-3156.2006.01688.x; Narayanasamy K, 2012, ACTA TROP, V121, P256, DOI 10.1016/j.actatropica.2012.01.008; Pelkonen T, 2015, T ROY SOC TROP MED H, V109, P535, DOI 10.1093/trstmh/trv046; Ridker PM, 2007, NUTR REV, V65, pS253, DOI [10.1111/j.1753-4887.2007.tb00372.x, 10.1301/nr.2007.dec.S253-S259]; Ridker PM, 2003, CIRCULATION, V107, P363, DOI 10.1161/01.CIR.0000053730.47739.3C; Schottenfeld D, 2006, CA-CANCER J CLIN, V56, P69, DOI 10.3322/canjclin.56.2.69; Sluydts V, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-387; von Seidlein L, 2015, EXPERT REV ANTI-INFE, V13, P715, DOI 10.1586/14787210.2015.1031744; Wu A.H.B., 2006, TIETZ CLIN GUIDE LAB; Yeo TW, 2010, J INFECT DIS, V202, P109, DOI 10.1086/653211; Yeung S, 2015, AM J TROP MED HYG, V92, P39, DOI 10.4269/ajtmh.14-0391; Yousuf O, 2013, J AM COLL CARDIOL, V62, P397, DOI 10.1016/j.jacc.2013.05.016	30	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158656	10.1371/journal.pone.0158656	http://dx.doi.org/10.1371/journal.pone.0158656			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27386859	Green Published, gold, Green Submitted			2022-12-27	WOS:000379811500033
J	Rostagno, C; Buzzi, R; Campanacci, D; Boccacini, A; Cartei, A; Virgili, G; Belardinelli, A; Matarrese, D; Ungar, A; Rafanelli, M; Gusinu, R; Marchionni, N				Rostagno, Carlo; Buzzi, Roberto; Campanacci, Domenico; Boccacini, Alberto; Cartei, Alessandro; Virgili, Gianni; Belardinelli, Andrea; Matarrese, Daniela; Ungar, Andrea; Rafanelli, Martina; Gusinu, Roberto; Marchionni, Niccolo			In Hospital and 3-Month Mortality and Functional Recovery Rate in Patients Treated for Hip Fracture by a Multidisciplinary Team	PLOS ONE			English	Article							PREOPERATIVE ECHOCARDIOGRAPHY; META-REGRESSION; SURGERY; DELAY; OUTCOMES; METAANALYSIS; DEMENTIA; TIME	Objectives Medical comorbidities affect outcome in elderly patients with hip fracture. This study was designed to preliminarily evaluate the usefulness of a hip-fracture unit led by an internal medicine specialist. Methods In-hospital and 3-month outcomes in patients with hip fracture were prospectively evaluated in 121 consecutive patients assessed before and followed after surgery by a multidisciplinary team led by internal medicine specialist; 337 consecutive patients were recalled from ICD-9 discharge records and considered for comparison regarding in-hospital mortality. Results In the intervention period, patients treated within 48 hours were 54% vs. 26% in the historical cohort (P< 0.0001). In-hospital mortality remained stable at about 2.3 per 1000 persondays. At 3 months, 10.3% of discharged patients had died, though less than 8% of patients developed postoperative complications (mainly pneumonia and respiratory failure). The presence of more than 2 major comorbidities and the loss of 3 or more BADL were independent predictors of death. 50/105 patients recovered previous functional capacity, but no independent predictor of functional recovery could be identified. Mean length of hospital stay significantly decreased in comparison to the historical cohort (13.6 +/- 4.7 vs 17 +/- 5 days, p = 0.0001). Combined end-point of mortality and length of hospitalization < 12 days was significantly lower in study period (27 vs 34%, p < 0.0132). Conclusions Identification and stabilization of concomitant clinical problems by internal medicine specialists may safely decrease time to surgery in frail subjects with hip fracture. Moreover, integrated perioperative clinical management may shorten hospital stay with no apparent increase in in-hospital mortality and ultimately improve the outcome. These results are to be confirmed by a larger study presently ongoing at our institution.	[Rostagno, Carlo] Univ Florence, Dipartimento Med Sperimentale & Clin, Florence, Italy; [Rostagno, Carlo; Cartei, Alessandro] AOU Careggi, SOD Med Interna & Postchirurg, Florence, Italy; [Buzzi, Roberto; Campanacci, Domenico] AOU Careggi, SOD Ortopedia & Traumatol, Florence, Italy; [Boccacini, Alberto] AOU Careggi, SOD Anestesia, Florence, Italy; [Virgili, Gianni; Belardinelli, Andrea; Matarrese, Daniela; Rafanelli, Martina; Gusinu, Roberto] AOU Careggi, Direz Sanit, Florence, Italy; [Ungar, Andrea; Marchionni, Niccolo] AOU Careggi, SOD Geriatria, Florence, Italy	University of Florence; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Florence; Azienda Ospedaliero Universitaria Careggi	Rostagno, C (corresponding author), Univ Florence, Dipartimento Med Sperimentale & Clin, Florence, Italy.; Rostagno, C (corresponding author), AOU Careggi, SOD Med Interna & Postchirurg, Florence, Italy.	carlo.rostagno@unifi.it	Rafanelli, Martina/AAB-3444-2019; rostagno, carlo/K-3658-2018; CAMPANACCI, DOMENICO ANDREA/Q-3862-2019; Rostagno, Carlo/N-6215-2019; , aungar/AAB-3720-2019; Marchionni, Niccolò/ABE-3977-2020; Virgili, Gianni/P-6607-2014	CAMPANACCI, DOMENICO ANDREA/0000-0002-3912-3943; Rostagno, Carlo/0000-0002-7764-8919; Marchionni, Niccolò/0000-0002-8101-4695; Ungar, Andrea/0000-0002-8965-4523; Virgili, Gianni/0000-0002-9960-2989	Italian Health Ministry and Regione Toscana	Italian Health Ministry and Regione Toscana	This work was supported by a Grant from the Italian Health Ministry and Regione Toscana.	Adunsky A, 2012, AGING CLIN EXP RES, V24, P233; Alibhai M, 2013, INDIAN J ANAESTH, V57, P408, DOI 10.4103/0019-5049.118538; Bielza Galindo Rafael, 2013, Rev Esp Geriatr Gerontol, V48, P26, DOI 10.1016/j.regg.2012.03.002; Cullen MW, 2011, J HOSP MED, V6, P507, DOI 10.1002/jhm.918; Doleman B, 2015, INJURY, V46, P954, DOI 10.1016/j.injury.2015.03.024; Grimes JP, 2002, AM J MED, V112, P702, DOI 10.1016/S0002-9343(02)01119-1; Harris I, 2012, ANZ J SURG, V82, P871, DOI 10.1111/j.1445-2197.2012.06319.x; Hebert-Davies J, 2012, INJURY, V43, P1978, DOI 10.1016/j.injury.2012.08.061; Heyburn G, 2012, ANAESTHESIA, V67, P1189, DOI 10.1111/j.1365-2044.2012.07330.x; Huang YF, 2012, REJUV RES, V15, P476, DOI 10.1089/rej.2011.1308; Huusko TM, 2000, BRIT MED J, V321, P1107, DOI 10.1136/bmj.321.7269.1107; Kammerlander C, 2010, OSTEOPOROSIS INT, V21, pS637, DOI 10.1007/s00198-010-1396-x; Kristoffersen DT, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-364; Manaqibwala MI, 2014, ARCH ORTHOP TRAUM SU, V134, P747, DOI 10.1007/s00402-014-1981-0; Marsh JL, 2007, J ORTHOP TRAUMA, V21, pS1, DOI 10.1097/00005131-200711101-00001; Orosz GM, 2002, J AM GERIATR SOC, V50, P1336, DOI 10.1046/j.1532-5415.2002.50353.x; Piscitellil P, 2011, CLIN CASES MINER BON, V8, P29; Rostagno C., 2013, OPEN ACCESS EMERG M, V03, P148, DOI [10.4172/2165-7548.1000148, DOI 10.4172/2165-7548.1000148]; Sanders KM, 1999, MED J AUSTRALIA, V170, P467, DOI 10.5694/j.1326-5377.1999.tb127845.x; Shiga T, 2008, CAN J ANAESTH, V55, P146, DOI 10.1007/BF03016088; Stoddart J, 2002, ANZ J SURG, V72, P405, DOI 10.1046/j.1445-2197.2002.02425.x	21	21	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158607	10.1371/journal.pone.0158607	http://dx.doi.org/10.1371/journal.pone.0158607			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27389193	Green Published, Green Submitted, gold			2022-12-27	WOS:000379811500029
J	Sone, D; Matsuda, H; Ota, M; Maikusa, N; Kimura, Y; Sumida, K; Yokoyama, K; Imabayashi, E; Watanabe, M; Watanabe, Y; Okazaki, M; Sato, N				Sone, Daichi; Matsuda, Hiroshi; Ota, Miho; Maikusa, Norihide; Kimura, Yukio; Sumida, Kaoru; Yokoyama, Kota; Imabayashi, Etsuko; Watanabe, Masako; Watanabe, Yutaka; Okazaki, Mitsutoshi; Sato, Noriko			Graph Theoretical Analysis of Structural Neuroimaging in Temporal Lobe Epilepsy with and without Psychosis	PLOS ONE			English	Article							POSTICTAL PSYCHOSIS; BRAIN NETWORKS; FUNCTIONAL CONNECTIVITY; CORTICAL THICKNESS; SMALL-WORLD; SCHIZOPHRENIA; ORGANIZATION; ABNORMALITIES; MRI	Purpose Psychosis is one of the most important psychiatric comorbidities in temporal lobe epilepsy (TLE), and its pathophysiology still remains unsolved. We aimed to explore the connectivity differences of structural neuroimaging between TLE with and without psychosis using a graph theoretical analysis, which is an emerging mathematical method to investigate network connections in the brain as a small-world system. Materials and Methods We recruited 11 TLE patients with unilateral hippocampal sclerosis (HS) presenting psychosis or having a history of psychosis (TLE-P group). As controls, 15 TLE patients with unilateral HS without any history of psychotic episodes were also recruited (TLE-N group). For graph theoretical analysis, the normalized gray matter images of both groups were subjected to Graph Analysis Toolbox (GAT). As secondary analyses, each group was compared to 14 age-and gender-matched healthy subjects. Results The hub node locations were found predominantly in the ipsilateral hemisphere in the TLE-N group, and mainly on the contralateral side in the TLE-P group. The TLE-P group showed significantly higher characteristic path length, transitivity, lower global efficiency, and resilience to random or targeted attack than those of the TLE-N group. The regional comparison in betweenness centrality revealed significantly decreased connectivity in the contralateral temporal lobe, ipsilateral middle frontal gyrus, and bilateral postcentral gyri in the TLE-P group. The healthy subjects showed well-balanced nodes/edges distributions, similar metrics to TLE-N group except for higher small-worldness/modularity/assortativity, and various differences of regional betweenness/clustering. Conclusion In TLE with psychosis, graph theoretical analysis of structural imaging revealed disrupted connectivity in the contralateral hemisphere. The network metrics suggested that the existence of psychosis can bring vulnerability and decreased efficiency of the whole-brain network. The sharp differences in structural networks between morphologically homogeneous groups are remarkable and may contribute to a better understanding of psychosis in TLE.	[Sone, Daichi; Kimura, Yukio; Sumida, Kaoru; Yokoyama, Kota; Sato, Noriko] Natl Ctr Neurol & Psychiat, Dept Radiol, Tokyo, Japan; [Sone, Daichi] Univ Tokyo, Grad Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Matsuda, Hiroshi; Maikusa, Norihide; Imabayashi, Etsuko] Natl Ctr Neurol & Psychiat, Integrat Brain Imaging Ctr, Tokyo, Japan; [Ota, Miho] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Disorder Res, Tokyo, Japan; [Watanabe, Masako; Watanabe, Yutaka; Okazaki, Mitsutoshi] Natl Ctr Neurol & Psychiat, Dept Psychiat, Tokyo, Japan	National Center for Neurology & Psychiatry - Japan; University of Tokyo; National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan	Sato, N (corresponding author), Natl Ctr Neurol & Psychiat, Dept Radiol, Tokyo, Japan.	snoriko@ncnp.go.jp	Sone, Daichi/J-7634-2019; Imabayashi, Etsuko/GLR-4602-2022	Sone, Daichi/0000-0001-9617-706X; Imabayashi, Etsuko/0000-0003-1708-3618; Yokoyama, Kota/0000-0001-5151-3146				Alexander-Bloch A, 2013, NAT REV NEUROSCI, V14, P322, DOI 10.1038/nrn3465; *APA, 1994, DSM 4 DIAGN STAT MAN; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Bernhardt BC, 2008, NEUROIMAGE, V42, P515, DOI 10.1016/j.neuroimage.2008.04.261; Bernhardt BC, 2015, EPILEPSY BEHAV, V50, P162, DOI 10.1016/j.yebeh.2015.06.005; Bernhardt BC, 2011, CEREB CORTEX, V21, P2147, DOI 10.1093/cercor/bhq291; Bettus G, 2009, HUM BRAIN MAPP, V30, P1580, DOI 10.1002/hbm.20625; Bonilha L, 2012, J NEUROL NEUROSUR PS, V83, P903, DOI 10.1136/jnnp-2012-302476; Clancy MJ, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-75; Collin G, 2013, EUR NEUROPSYCHOPHARM, V23, P46, DOI 10.1016/j.euroneuro.2012.09.001; DuBois JM, 2011, EPILEPSY BEHAV, V21, P132, DOI 10.1016/j.yebeh.2011.03.024; Engel J, 1996, EPILEPSY RES, V26, P141, DOI 10.1016/S0920-1211(96)00043-5; Evans AC, 2013, NEUROIMAGE, V80, P489, DOI 10.1016/j.neuroimage.2013.05.054; Falip M, 2009, SEIZURE-EUR J EPILEP, V18, P145, DOI 10.1016/j.seizure.2008.08.009; Fluegel D, 2006, EPILEPSIA, V47, P941, DOI 10.1111/j.1528-1167.2006.00527.x; Gaitatzis A, 2004, ACTA NEUROL SCAND, V110, P207, DOI 10.1111/j.1600-0404.2004.00324.x; Guarnieri R, 2005, PSYCHIAT RES-NEUROIM, V138, P75, DOI 10.1016/j.pscychresns.2004.10.003; Gutierrez-Galve L, 2012, EPILEPSIA, V53, P1077, DOI 10.1111/j.1528-1167.2012.03504.x; Guye M, 2010, MAGN RESON MATER PHY, V23, P409, DOI 10.1007/s10334-010-0205-z; Hilger E, 2013, EUR J NEUROL, V20, P955, DOI 10.1111/ene.12125; Hosseini SMH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040709; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525; Mega MS, 1997, J NEUROPSYCH CLIN N, V9, P315; Rusch N, 2004, J NEUROPSYCH CLIN N, V16, P148, DOI 10.1176/appi.neuropsych.16.2.148; Sundram F, 2010, BRIT J PSYCHIAT, V197, P482, DOI 10.1192/bjp.bp.110.080218; Tijms BM, 2013, NEUROBIOL AGING, V34, P2023, DOI 10.1016/j.neurobiolaging.2013.02.020; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; UMBRICHT D, 1995, AM J PSYCHIAT, V152, P224; van den Heuvel MP, 2014, NEUROPSYCHOL REV, V24, P32, DOI 10.1007/s11065-014-9248-7; van den Heuvel MP, 2010, J NEUROSCI, V30, P15915, DOI 10.1523/JNEUROSCI.2874-10.2010; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501; Yasuda CL, 2015, EPILEPSIA, V56, P1992, DOI 10.1111/epi.13225; Zalesky A, 2011, BIOL PSYCHIAT, V69, P80, DOI 10.1016/j.biopsych.2010.08.022; Zhang YC, 2012, SCHIZOPHR RES, V141, P109, DOI 10.1016/j.schres.2012.08.021	36	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158728	10.1371/journal.pone.0158728	http://dx.doi.org/10.1371/journal.pone.0158728			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27385130	gold, Green Published, Green Submitted			2022-12-27	WOS:000379809400080
J	Maurel, DB; Duan, PP; Farr, J; Cheng, AL; Johnson, ML; Bonewald, LF				Maurel, Delphine B.; Duan, Peipei; Farr, Joshua; Cheng, An-Lin; Johnson, Mark L.; Bonewald, Lynda F.			Beta-Catenin Haplo Insufficient Male Mice Do Not Lose Bone in Response to Hindlimb Unloading	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; OSTEOCYTES; OSTEOPOROSIS; SPACEFLIGHT; OSTEOBLASTS; SCLEROSTIN; ACTIVATION; RELEASE; DENSITY; MASS	As the beta-catenin pathway has been shown to be involved in mechanotransduction, we sought to determine if haploinsufficiency would affect skeletal response to unloading. It has previously been shown that deletion of both alleles of beta-catenin in bone cells results in a fragile skeleton highly susceptible to fracture, but deletion of one allele using Dmp1-Cre (Ctnnb1(+/loxP); Dmp1-Cre, cKO HET) has little effect on the 2 mo old skeleton. We found that under normal housing conditions, trabecular bone volume was significantly less in 5 mo old male cKO HET mice compared to controls (Ctrl/HET: Tb. BV/TV = 13.96 +/- 2.71/8.92 +/- 0.95%, Tb.N. = 4.88 +/- 0.51/3.95 +/- 0.44/mm, Tb. Sp. = 0.20 +/- 0.02/0.26 +/- 0.03mm, a 36%, 19% and 30% change respectively) but not in females suggesting an age and gender related effect. Before performing suspension experiments and to control for the environmental effects, animals with the same tail attachment and housing conditions, but not suspended (NS), were compared to normally housed (NH) animals. Attachment and housing resulted in weight loss in both genders and phenotypes. Cortical bone loss was observed in the cKO HET males (NH/NS, Ct BV/TV: 90.45 +/- 0.72/89.12 +/- 0.56%) and both diaphyseal (0.19 +/- 0.01/0.17 +/- 0.01mm) and metaphyseal (0.10 +/- 0.01/0.08 +/- 0.01mm) thickness, but not in female cKO HET mice suggesting that male cKO HET mice are susceptible to attachment and housing conditions. These results with transgenic mice emphasizes the importance of proper controls when attributing skeletal responses to unloading. With suspension, cKO HET male mice did not lose bone unlike female cKO HET mice that had greater trabecular bone loss than controls (Ctrl 9%:cKO HET 21% decrease Tb. N; Ctrl 12%: cKO HET 27% increase Tb. Sp.). Suspended and non-suspended mice lost weight compared to normally housed animals. Taken together, the data suggest a protective effect of beta-catenin against the effects of stress in males and partial protection against unloading in females.	[Maurel, Delphine B.; Duan, Peipei; Farr, Joshua; Johnson, Mark L.; Bonewald, Lynda F.] Univ Missouri, Sch Dent, Dept Oral & Craniofacial Sci, Kansas City, MO 64110 USA; [Cheng, An-Lin] Univ Missouri, Sch Nursing & Hlth Studies, Kansas City, MO USA; [Maurel, Delphine B.] Univ Bordeaux Segalen, Unite INSERM U1026, 146 Rue Leo Saignat, F-33076 Bordeaux, France; [Duan, Peipei] Sichuan Univ, West China Hosp Stomatol, Dept Orthodont, State Key Lab Oral Dis, Chengdu, Peoples R China	University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Sichuan University	Bonewald, LF (corresponding author), Univ Missouri, Sch Dent, Dept Oral & Craniofacial Sci, Kansas City, MO 64110 USA.	bonewaldl@umkc.edu	Bonewald, Lynda/Q-3638-2019		National Institutes of Health (NIH), National Institute of Aging (NIA) [1PO1AG039355]; NIH NIA [1PO1AG039355]; NATIONAL INSTITUTE ON AGING [P01AG039355] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Institute of Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health (NIH), National Institute of Aging (NIA) grant 1PO1AG039355.; This work was funded by NIH NIA, grant 1PO1AG039355.	Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; Borer KT, 2005, SPORTS MED, V35, P779, DOI 10.2165/00007256-200535090-00004; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Burger EH, 1999, FASEB J, V13, pS101, DOI 10.1096/fasebj.13.9001.s101; Choi HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007930; Dallas SL, 2013, ENDOCR REV, V34, P658, DOI 10.1210/er.2012-1026; Dallas SL, 2010, ANN NY ACAD SCI, V1192, P437, DOI 10.1111/j.1749-6632.2009.05246.x; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Devlin M, 2014, J BONE MINER RES S1, V29; Ferreira JA, 2011, JOVE-J VIS EXP, DOI 10.3791/2467; Gaignier F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092664; Gao YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082436; Genetos DC, 2007, J CELL PHYSIOL, V212, P207, DOI 10.1002/jcp.21021; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Grainger Michelle, 2011, Br J Nurs, V20, P171; Gupta S, 2012, AM J PHYSIOL-REG I, V303, pR159, DOI 10.1152/ajpregu.00499.2011; Henneicke H, 2014, J BONE MINER RES S1, V29; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Iwaniec U, 2012, J BONE MINER RES S1, V27; Javaheri B, 2014, J BONE MINER RES, V29, P705, DOI 10.1002/jbmr.2064; Johnson Mark L, 2012, Bonekey Rep, V1, P1, DOI 10.1038/bonekey.2012.1; Kamel MA, 2010, BONE, V47, P872, DOI 10.1016/j.bone.2010.08.007; Kamiya N, 2008, DEVELOPMENT, V135, P3801, DOI 10.1242/dev.025825; Kamiya N, 2010, J BONE MINER RES, V25, P200, DOI 10.1359/jbmr.090806; Kang KS, 2015, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00246; Kondoh S, 2014, BONE, V60, P68, DOI 10.1016/j.bone.2013.12.005; Kramer I, 2010, MOL CELL BIOL, V30, P3071, DOI 10.1128/MCB.01428-09; Laine CM, 2011, EUR J HUM GENET, V19, P875, DOI 10.1038/ejhg.2011.42; Lara-Castillo N, 2015, BONE, V76, P58, DOI 10.1016/j.bone.2015.03.019; Liedert A, 2010, BIOCHEM BIOPH RES CO, V394, P755, DOI 10.1016/j.bbrc.2010.03.065; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Lloyd SA, 2014, J BONE MINER RES, V29, P1118, DOI 10.1002/jbmr.2113; McGarry JG, 2005, BIOCHEM BIOPH RES CO, V330, P341, DOI 10.1016/j.bbrc.2005.02.175; Morey-Holton ER, 2002, J APPL PHYSIOL, V92, P1367, DOI 10.1152/japplphysiol.00969.2001; Moriishi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040143; Nagaraja MP, 2013, J CELL BIOCHEM, V114, P1001, DOI 10.1002/jcb.24454; Ozcivici E, 2014, BONE, V67, P122, DOI 10.1016/j.bone.2014.05.009; Qing H, 2012, J BONE MINER RES, V27, P1018, DOI 10.1002/jbmr.1567; Rikkonen T, 2006, EUR J APPL PHYSIOL, V97, P509, DOI 10.1007/s00421-006-0208-7; Sibonga JD, 2007, BONE, V41, P973, DOI 10.1016/j.bone.2007.08.022; Sung M, 2013, J MUSCULOSKEL NEURON, V13, P405; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; WOLF JH, 1995, ORTHOPADE, V24, P378; Yavropoulou Maria P, 2007, Hormones (Athens), V6, P279	44	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158381	10.1371/journal.pone.0158381	http://dx.doi.org/10.1371/journal.pone.0158381			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410430	Green Published, gold, Green Submitted			2022-12-27	WOS:000379508300022
J	Moles, J; Wagele, H; Ballesteros, M; Pujals, A; Uhl, G; Avila, C				Moles, Juan; Waegele, Heike; Ballesteros, Manuel; Pujals, Alvaro; Uhl, Gabriele; Avila, Conxita			The End of the Cold Loneliness: 3D Comparison between Doto antarctica and a New Sympatric Species of Doto (Heterobranchia: Nudibranchia)	PLOS ONE			English	Article							GASTROPODA HETEROBRANCHIA; OPISTHOBRANCHIA; GENUS; PHYLOGENY; MOLLUSCA; HISTOLOGY; INVERTEBRATES; SYSTEMATICS; MORPHOLOGY; DIVERSITY	Although several studies are devoted to determining the diversity of Antarctic heterobranch sea slugs, new species are still being discovered. Among nudibranchs, Doto antarctica Eliot, 1907 is the single species of this genus described from Antarctica hitherto, the type locality being the Ross Sea. Doto antarctica was described mainly using external features. During our Antarctic research on marine benthic invertebrates, we found D. antarctica in the Weddell Sea and Bouvet Island, suggesting a circumpolar distribution. Species affiliation is herein supported by molecular analyses using cytochrome c oxidase subunit I, 16S rRNA, and histone H3 markers. We redescribe D. antarctica using histology, micro-computed tomography (micro-CT), and 3D-reconstruction of the internal organs. Moreover, we describe a new, sympatric species, namely D. carinova Moles, Avila & Wagele n. sp., and provide an anatomical comparison between the two Antarctic Doto species. Egg masses in both species are also described here for the first time. We demonstrate that micro-CT is a useful tool for non-destructive anatomical description of valuable specimens. Furthermore, our high resolution micro-CT data reveal that the central nervous system of both Doto species possesses numerous accessory giant cells, suggested to be neurons herein. In addition, the phylogenetic tree of all Doto species sequenced to date suggests a scenario for the evolution of the reproductive system in this genus: bursa copulatrix seems to have been reduced and the acquisition of a distal connection of the oviduct to the nidamental glands is a synapomorphy of the Antarctic Doto species. Overall, the combination of thorough morphological and anatomical description and molecular analyses provides a comprehensive means to characterize and delineate species, thus suggesting evolutionary scenarios.	[Moles, Juan; Ballesteros, Manuel; Pujals, Alvaro; Avila, Conxita] Univ Barcelona, Dept Evolutionary Biol Ecol & Environm Sci, Ave Diagonal 645, E-08028 Barcelona, Catalonia, Spain; [Moles, Juan; Ballesteros, Manuel; Pujals, Alvaro; Avila, Conxita] Univ Barcelona, Biodivers Res Inst IrBIO, Ave Diagonal 645, E-08028 Barcelona, Catalonia, Spain; [Waegele, Heike] Zool Res Museum Alexander Koenig, Adenauerallee 160, D-53113 Bonn, Germany; [Uhl, Gabriele] Ernst Moritz Arndt Univ Greifswald, Museum & Inst Zool, Gen & Systemat Zool, Anklamer Str 20, D-17489 Greifswald, Germany	University of Barcelona; University of Barcelona; Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); Ernst Moritz Arndt Universitat Greifswald	Moles, J (corresponding author), Univ Barcelona, Dept Evolutionary Biol Ecol & Environm Sci, Ave Diagonal 645, E-08028 Barcelona, Catalonia, Spain.; Moles, J (corresponding author), Univ Barcelona, Biodivers Res Inst IrBIO, Ave Diagonal 645, E-08028 Barcelona, Catalonia, Spain.	moles.sanchez@gmail.com	Ballesteros, Manuel/M-1664-2014; Moles, Juan/H-4786-2018; Avila, Conxita/B-9466-2008	Ballesteros, Manuel/0000-0001-9055-1241; Moles, Juan/0000-0003-4511-4055; Avila, Conxita/0000-0002-5489-8376; Uhl, Gabriele/0000-0001-8758-7913	German Science foundation [INST 292/119-1 FUGG, INST 292/120-1 FUGG]; Spanish government through ECOQUIM project [REN2003-00545 a, REN2002-12006EANT]; Spanish government through ACTIQUIM project [CGL2007-65453, CTM2010-17415/ANT]; Spanish government through DISTANTCOM project [CTM2013-42667/ANT]; PhD grant of the Spanish Government (MEC) [BES-2011-045325]; Systematic Research Fund of the Systematics Association; Linnean Society of London	German Science foundation(German Research Foundation (DFG)); Spanish government through ECOQUIM project; Spanish government through ACTIQUIM project; Spanish government through DISTANTCOM project; PhD grant of the Spanish Government (MEC)(German Research Foundation (DFG)); Systematic Research Fund of the Systematics Association; Linnean Society of London	The authors are indebted to the German Science foundation for funding the Micro-CT at the imaging center of Greifswald (INST 292/119-1 FUGG and INST 292/120-1 FUGG) and to POM Steinhoff and J Krieger (both Greifswald) for help with the micro-CT scans. Funding was also provided by the Spanish government through the ECOQUIM (REN2003-00545 and REN2002-12006EANT), ACTIQUIM (CGL2007-65453, CTM2010-17415/ANT), and DISTANTCOM (CTM2013-42667/ANT) projects. J Moles was supported by a PhD grant of the Spanish Government (MEC; BES-2011-045325), and by the Systematic Research Fund of the Systematics Association and the Linnean Society of London.	Affeld S, 2009, J NAT PROD, V72, P298, DOI 10.1021/np800583e; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arntz WE, 2006, POLAR BIOL, V29, P83, DOI 10.1007/s00300-005-0047-8; BABA K, 1971, Publications of the Seto Marine Biological Laboratory, V19, P73; BABA KIKUTARO, 1938, JOUR DEPT AGRIC KYSY IMP UNIV, V6, P1; Boer HH, 1970, NETH J ZOOL, V27, P245; Bouchet P, 2005, INT J MALACOL, V47, P397; Clarke A, 2003, OCEANOGR MAR BIOL, V41, P47; Colgan DJ, 1998, AUST J ZOOL, V46, P419, DOI 10.1071/ZO98048; Dreyer TF, 1911, S AFR J SCI, VVIII, P340; DRUMMOND AJ, 2010, GENEIOUS V5 5; Eliot C., 1907, NAT ANTARCT EXP, V2, P1; Fischer MA, 2006, CONTRIB ZOOL, V75, P145, DOI 10.1163/18759866-0750304004; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Ghiglione C, 2013, ZOOKEYS, P37, DOI 10.3897/zookeys.341.6031; Gobbeler K, 2010, MOL PHYLOGENET EVOL, V55, P996, DOI 10.1016/j.ympev.2009.11.027; Goodheart JA, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150196; Greenwood PG, 2009, TOXICON, V54, P1065, DOI 10.1016/j.toxicon.2009.02.029; Gutt J, 1999, A WEGENER I POLAR MA, V301, P1; Jorger KM, 2008, ORG DIVERS EVOL, V8, P194, DOI 10.1016/j.ode.2007.09.002; Klussmann-Kolb A, 2001, ZOOL ANZ, V240, P119, DOI 10.1078/0044-5231-00011; KRESS A, 1975, J MAR BIOL ASSOC UK, V55, P691, DOI 10.1017/S0025315400017355; LEMCHE H, 1976, J MAR BIOL ASSOC UK, V56, P691, DOI 10.1017/S0025315400020737; Lovell LL, 2003, DEEP-SEA RES PT II, V50, P1799, DOI 10.1016/S0967-0645(03)00087-0; MacFarland FM, 1966, MEM CALIF ACAD SCI, V6, P1; Marcus E, 1963, STUDIES FAUNE CURACA, V33, P1; Marcus E., 1961, VELIGER            S, V3, P1; Marcus E.R., 1959, REPORTS LUND U CHILE, P69; MARCUS EDBR, 1972, B MAR SCI, V22, P284; Martynov AV, 2009, POLAR BIOL, V32, P53, DOI 10.1007/s00300-008-0503-3; Moles J, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-2831-0; Newcomb JM, 2007, J COMP PHYSIOL A, V193, P425, DOI 10.1007/s00359-006-0196-4; Odhner NH, 1934, NATUR HIST REP BR AN, V7, P229; Odhner NHJ, 1936, MEMOIRES MUSEE ROYAL, V2, P1056; Ortea JA, 1978, B ESTAC CENT ECOL, V7, P72; PICTON B E, 1981, Irish Naturalists' Journal, V20, P261; Pola M, 2015, J NAT HIST, V49, P2465, DOI 10.1080/00222933.2015.1034211; Pola M, 2010, MOL PHYLOGENET EVOL, V56, P931, DOI 10.1016/j.ympev.2010.05.003; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; POWELL A. W. B., 1960, REC AUCKLAND INST AND MUS, V5, P117; Putz A, 2011, EUR J ORG CHEM, V2011, P3733, DOI 10.1002/ejoc.201100347; Rambaut A., 2014, TRACER V1 6; Romano, 2002, SIMPLE FOOLS GUIDE P, P1, DOI DOI 10.1186/S13620-015-0060-3; Ronquist F., 2011, MAN MRBAYES, P1; Ruckert IM, 2008, ORG DIVERS EVOL, V8, P358, DOI 10.1016/j.ode.2008.09.001; Schiaparelli S, 2006, ANTARCT SCI, V18, P615, DOI 10.1017/S0954102006000654; SCHMEKEL L, 1977, MALACOLOGIA, V16, P467; Schmekel L., 1982, OPISTHOBRANCHIA MITT, P410; Shipman C, 2015, ZOOTAXA, V3973, P57, DOI 10.11646/zootaxa.3973.1.2; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Thiele J., 1912, ZOOLOGIE, V5, P183; Thiele J, 1931, HDB SYSTEMATISCHEN W, V1; THOMPSON TE, 1990, J MOLLUS STUD, V56, P393, DOI 10.1093/mollus/56.3.393; Wagele H, 2006, OCEANOGR MAR BIOL, V44, P197; Wagele H, 1998, ZOOL ANZ, V236, P119; Wagele H, 2000, ZOOL J LINN SOC-LOND, V130, P83, DOI 10.1006/zjls.1999.0214; Wagele H., 2008, PHYLOGENY EVOLUTION, P385; WEISS KR, 1976, BRAIN RES, V117, P33, DOI 10.1016/0006-8993(76)90554-0; Willan RC, 1984, MARINE MOLLUSCS 2; Wollscheid-Lengeling E, 2001, ORG DIVERS EVOL, V1, P241, DOI 10.1078/1439-6092-00022; WoRMS Editorial Board, WORLD REGISTER MARIN; Yang ZH, 1996, TRENDS ECOL EVOL, V11, P367, DOI 10.1016/0169-5347(96)10041-0	66	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0157941	10.1371/journal.pone.0157941	http://dx.doi.org/10.1371/journal.pone.0157941			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27411060	gold, Green Published, Green Submitted			2022-12-27	WOS:000379508300014
J	Ababou, A; Koronakis, V				Ababou, Abdessamad; Koronakis, Vassilis			Structures of Gate Loop Variants of the AcrB Drug Efflux Pump Bound by Erythromycin Substrate	PLOS ONE			English	Article							MULTIDRUG EFFLUX; TRANSPORTER; RESISTANCE; REVEAL; PHENIX	Gram-negative bacteria such as E. coli use tripartite efflux pumps such as AcrAB-TolC to expel antibiotics and noxious compounds. A key feature of the inner membrane transporter component, AcrB, is a short stretch of residues known as the gate/switch loop that divides the proximal and distal substrate binding pockets. Amino acid substitutions of the gate loop are known to decrease antibiotic resistance conferred by AcrB. Here we present two new AcrB gate loop variants, the first stripped of its bulky side chains, and a second in which the gate loop is removed entirely. By determining the crystal structures of the variant AcrB proteins in the presence and absence of erythromycin and assessing their ability to confer erythromycin tolerance, we demonstrate that the gate loop is important for AcrB export activity but is not required for erythromycin binding.	[Ababou, Abdessamad; Koronakis, Vassilis] Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge, England	University of Cambridge	Ababou, A; Koronakis, V (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge, England.	aa673@cam.ac.uk; vk103@cam.ac.uk		Koronakis, Vassilis/0000-0002-1353-1092	UK Medical Research Council; Wellcome Trust; MRC [G1001104, MR/N000994/1] Funding Source: UKRI; Medical Research Council [G1001104, MR/N000994/1] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the UK Medical Research Council and Wellcome Trust.; We thank the beam line staff at the Diamond Light Source (UK), Swiss Light Source (Switzerland), and the European Synchrotron Radiation Facility (Grenoble, France) for their help. We thank Dr D. Chirgadze for use of the Cambridge Biochemistry X-ray crystallography facility. This work was supported by grants from the UK Medical Research Council and Wellcome Trust.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bohnert JA, 2008, J BACTERIOL, V190, P8225, DOI 10.1128/JB.00912-08; Cha HJ, 2014, ANTIMICROB AGENTS CH, V58, P4767, DOI 10.1128/AAC.02733-13; DiMaio F, 2013, NAT METHODS, V10, P1102, DOI [10.1038/nmeth.2648, 10.1038/NMETH.2648]; Eicher T, 2012, P NATL ACAD SCI USA, V109, P5687, DOI 10.1073/pnas.1114944109; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Hinchliffe P, 2013, ANNU REV MICROBIOL, V67, P221, DOI 10.1146/annurev-micro-092412-155718; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Li XZ, 2004, DRUGS, V64, P159, DOI 10.2165/00003495-200464020-00004; Lu W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089143; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murakami S, 2008, CURR OPIN STRUC BIOL, V18, P459, DOI 10.1016/j.sbi.2008.06.007; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Nakashima R, 2011, NATURE, V480, P565, DOI 10.1038/nature10641; Nikaido H, 1998, CLIN INFECT DIS, V27, pS32, DOI 10.1086/514920; Nikaido H, 2009, BBA-PROTEINS PROTEOM, V1794, P769, DOI 10.1016/j.bbapap.2008.10.004; Pos KM, 2009, BBA-PROTEINS PROTEOM, V1794, P782, DOI 10.1016/j.bbapap.2008.12.015; Seeger MA, 2006, SCIENCE, V313, P1295, DOI 10.1126/science.1131542; Touze T, 2004, MOL MICROBIOL, V53, P697, DOI 10.1111/j.1365-2958.2004.04158.x; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wehmeier C, 2009, ANTIMICROB AGENTS CH, V53, P329, DOI 10.1128/AAC.00921-08; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	23	26	26	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0159154	10.1371/journal.pone.0159154	http://dx.doi.org/10.1371/journal.pone.0159154			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27403665	Green Published, gold, Green Submitted			2022-12-27	WOS:000379508200038
J	Kantomaa, MT; Tikanmaki, M; Kankaanpaa, A; Vaarasmaki, M; Sipola-Leppanen, M; Ekelund, U; Hakonen, H; Jarvelin, MR; Kajantie, E; Tammelin, TH				Kantomaa, Marko T.; Tikanmaki, Marjaana; Kankaanpaa, Anna; Vaarasmaki, Marja; Sipola-Leppanen, Marika; Ekelund, Ulf; Hakonen, Harto; Jarvelin, Marjo-Riitta; Kajantie, Eero; Tammelin, Tuija H.			Accelerometer-Measured Physical Activity and Sedentary Time Differ According to Education Level in Young Adults	PLOS ONE			English	Article							SITTING TIME; SOCIOECONOMIC DIFFERENCES; ENERGY-EXPENDITURE; METABOLIC SYNDROME; VIEWING TIME; RISK-FACTORS; HEALTH; ASSOCIATIONS; PARTICIPATION; OVERWEIGHT	This study examined the association of education level with objectively measured physical activity and sedentary time in young adults. Data from the Finnish ESTER study (20092011) (n = 538) was used to examine the association between educational attainment and different subcomponents of physical activity and sedentary time measured using hip-worn accelerometers (ActiGraph GT1M) for seven consecutive days. Overall physical activity, moderate-to-vigorous physical activity (MVPA), light-intensity physical activity and sedentary time were calculated separately for weekdays and weekend days. A latent profile analysis was conducted to identify the different profiles of sedentary time and the subcomponents of physical activity. The educational differences in accelerometer-measured physical activity and sedentary time varied according to the subcomponents of physical activity, and between weekdays and weekend days. A high education level was associated with high MVPA during weekdays and weekend days in both sexes, high sedentary time during weekdays in both sexes, and a low amount of light-intensity physical activity during weekdays in males and during weekdays and weekend days in females. The results indicate different challenges related to unhealthy behaviours in young adults with low and high education: low education is associated with a lack of MVPA, whereas high education is associated with a lack of light-intensity physical activity and high sedentary time especially during weekdays.	[Kantomaa, Marko T.; Kankaanpaa, Anna; Hakonen, Harto; Tammelin, Tuija H.] LIKES Res Ctr Sport & Hlth Sci, Jyvaskyla, Finland; [Kantomaa, Marko T.; Jarvelin, Marjo-Riitta] Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC Hlth Protect Agcy HPE,Ctr Environm & Hlth, London, England; [Tikanmaki, Marjaana; Sipola-Leppanen, Marika] Natl Inst Hlth & Welf, Chron Dis Prevent Unit, Helsinki, Finland; [Tikanmaki, Marjaana; Sipola-Leppanen, Marika] Natl Inst Hlth & Welf, Chron Dis Prevent Unit, Oulu, Finland; [Tikanmaki, Marjaana; Sipola-Leppanen, Marika; Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Vaarasmaki, Marja; Kajantie, Eero] Oulu Univ Hosp, Med Res Ctr Oulu, PEDEGO Res Unit, Oulu, Finland; [Vaarasmaki, Marja; Kajantie, Eero] Univ Oulu, Oulu, Finland; [Vaarasmaki, Marja; Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf Oulu, Dept Children & Young People & Families, Oulu, Finland; [Ekelund, Ulf] Norwegian Sch Sport Sci, Dept Sport Med, Oslo, Norway; [Ekelund, Ulf] Univ Cambridge, Med Res Council Epidemiol Unit, Cambridge, England; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Jarvelin, Marjo-Riitta] Oulu Univ Hosp, Unit Primary Care, Oulu, Finland; [Kajantie, Eero] Univ Helsinki, Cent Hosp, Childrens Hosp, Helsinki, Finland; [Kajantie, Eero] Univ Helsinki, Helsinki, Finland	Imperial College London; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; University of Oulu; University of Oulu; University of Oulu; Norwegian School of Sport Sciences; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; University of Oulu; University of Oulu; University of Helsinki; Helsinki University Central Hospital; University of Helsinki	Kantomaa, MT (corresponding author), LIKES Res Ctr Sport & Hlth Sci, Jyvaskyla, Finland.; Kantomaa, MT (corresponding author), Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC Hlth Protect Agcy HPE,Ctr Environm & Hlth, London, England.	m.kantomaa@imperial.ac.uk	Paalanne, Marika/ABE-5008-2020; Ekelund, Ulf/AAE-8471-2019	Paalanne, Marika/0000-0003-1626-9410; Ekelund, Ulf/0000-0003-2115-9267; Vaarasmaki, Marja/0000-0002-8234-4434; Kankaanpaa, Anna/0000-0002-6973-5385; Kantomaa, Marko/0000-0002-5937-3456; Jarvelin, Marjo-Riitta/0000-0002-2149-0630	Finnish Ministry of Education and Culture [OKM/123/626/2012]; Academy of Finland [273971, 127437, 129306, 130326, 134791, 263924]; Doctoral Programme in Public Health (DPPH); Emil Aaltonen Foundation; Finnish Foundation for Pediatric Research; Jalmari and Rauha Ahokas Foundation; Juho Vainio Foundation; National Graduate School of Clinical Investigation; Novo Nordisk Foundation; Signe and Ane Gyllenberg Foundation; Sigrid Juselius Foundation; Yrjo Jahnsson Foundation; Novo Nordisk Fonden [NNF12OC1016374, NNF15OC0016362] Funding Source: researchfish	Finnish Ministry of Education and Culture; Academy of Finland(Academy of Finland); Doctoral Programme in Public Health (DPPH); Emil Aaltonen Foundation; Finnish Foundation for Pediatric Research; Jalmari and Rauha Ahokas Foundation; Juho Vainio Foundation; National Graduate School of Clinical Investigation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Signe and Ane Gyllenberg Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Yrjo Jahnsson Foundation; Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was funded by the Finnish Ministry of Education and Culture (OKM/123/626/2012) and the Academy of Finland (grant 273971). The Ester study was supported by grants from the Academy of Finland (grants 127437, 129306, 130326, 134791, and 263924), Doctoral Programme in Public Health (DPPH), Emil Aaltonen Foundation, Finnish Foundation for Pediatric Research, Jalmari and Rauha Ahokas Foundation, Juho Vainio Foundation, National Graduate School of Clinical Investigation, Novo Nordisk Foundation, Signe and Ane Gyllenberg Foundation, Sigrid Juselius Foundation, and Yrjo Jahnsson Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauman A, 2011, AM J PREV MED, V41, P228, DOI 10.1016/j.amepre.2011.05.003; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Bischoff AL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056700, 10.1371/journal.pone.0071417]; Boyle T, 2011, AM J EPIDEMIOL, V173, P1183, DOI 10.1093/aje/kwq513; Buman MP, 2010, AM J EPIDEMIOL, V172, P1155, DOI 10.1093/aje/kwq249; Burton NW, 2012, AM J PREV MED, V42, P363, DOI 10.1016/j.amepre.2011.11.012; Camhi SM, 2011, PREV MED, V52, P358, DOI 10.1016/j.ypmed.2011.01.030; Chandola T, 2006, J R STAT SOC A STAT, V169, P337, DOI 10.1111/j.1467-985X.2006.00411.x; Chau JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080000; Chen IJ, 2008, NURS ECON, V26, P263; Clark BK, 2010, J PHYS ACT HEALTH, V7, P595, DOI 10.1123/jpah.7.5.595; Expert Committee on the Sport Services Offered by Higher Education, 2011, REC SPORT SERV PROV; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Hansen BH, 2014, INT J PUBLIC HEALTH, V59, P221, DOI 10.1007/s00038-013-0472-3; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046; Healy GN, 2007, DIABETES CARE, V30, P1384, DOI 10.2337/dc07-0114; Kirk MA, 2011, AM J PREV MED, V40, P476, DOI 10.1016/j.amepre.2010.12.015; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Matthews CE, 2002, MED SCI SPORT EXER, V34, P1376, DOI 10.1097/00005768-200208000-00021; Miettola S, 2013, EUR J EPIDEMIOL, V28, P87, DOI 10.1007/s10654-013-9763-5; Muthen B.O., 2012, MPLUS USERS GUIDE, V7th; Owen N, 2011, AM J PREV MED, V41, P189, DOI 10.1016/j.amepre.2011.05.013; Proper KI, 2007, INT J OBESITY, V31, P169, DOI 10.1038/sj.ijo.0803357; Rhodes RE, 2012, AM J PREV MED, V42, pE3, DOI 10.1016/j.amepre.2011.10.020; ROSS CE, 1995, AM SOCIOL REV, V60, P719, DOI 10.2307/2096319; Salmon J, 2000, INT J OBESITY, V24, P600, DOI 10.1038/sj.ijo.0801203; Santos R, 2010, INT J ENV RES PUB HE, V7, P1500, DOI 10.3390/ijerph7041500; Sipola-Leppanen M, 2015, AM J EPIDEMIOL, V181, P861, DOI 10.1093/aje/kwu443; Smith L, 2015, SPORTS MED, V45, P449, DOI 10.1007/s40279-015-0310-2; Smith L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-004103; SPSS, 2010, IBM SPSS STAT 19 COR; Stamatakis E, 2012, INT J EPIDEMIOL, V41, P1328, DOI 10.1093/ije/dys077; Statistics Finland, 2001, UNESCOS INTERNATIONA, P169; Sugiyama T, 2007, AM J PREV MED, V33, P444, DOI 10.1016/j.amepre.2007.07.035; Thorp AA, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-128; Tigbe WW, 2011, PREV MED, V53, P48, DOI 10.1016/j.ypmed.2011.04.018; Trost SG, 2002, MED SCI SPORT EXER, V34, P1996, DOI 10.1097/00005768-200212000-00020; Vaarasmaki M, 2009, AM J EPIDEMIOL, V169, P1209, DOI 10.1093/aje/kwp020; van Sluijs EMF, 2010, BRIT J SPORT MED, V44, P747, DOI 10.1136/bjsm.2008.049783; Wapllmann-Sperlich B, 2013, BMC PUBLIC HEALTH, V13, P196, DOI [10.1186/1471-2458-13-196, DOI 10.1186/1471-2458-13-196]; Wardle J, 2003, J EPIDEMIOL COMMUN H, V57, P440, DOI 10.1136/jech.57.6.440	43	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0158902	10.1371/journal.pone.0158902	http://dx.doi.org/10.1371/journal.pone.0158902			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ9CO	27403958	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000379508200019
J	Thakur, S; Grover, RK; Gupta, S; Yadav, AK; Das, BC				Thakur, Seema; Grover, Rajesh K.; Gupta, Sanjay; Yadav, Ajay K.; Das, Bhudev C.			Identification of Specific miRNA Signature in Paired Sera and Tissue Samples of Indian Women with Triple Negative Breast Cancer	PLOS ONE			English	Article							LYMPH-NODE METASTASES; CIRCULATING MICRORNAS; TAMOXIFEN RESISTANCE; RISK-FACTORS; EXPRESSION; BIOMARKER; MIR-155; MARKERS; MIR-21; TUMORS	Of several subtypes of breast cancer, triple negative breast cancer (TNBC) is a highly aggressive tumor that lacks expression of hormone receptors for estrogen, progesterone and human epidermal growth factor receptor 2 and shows a worst prognosis. The small noncoding RNAs (miRNAs) considered as master regulator of gene expression play a key role in cancer initiation, progression and drug resistance and have emerged as attractive molecular biomarkers for diagnosis, prognosis and treatment targets in cancer. We have done expression profiling of selected miRNAs in paired serum and tissue samples of TNBC patients and corresponding cell lines and compared with that of other subtypes, in order to identify novel serum miRNA biomarkers for early detection and progression of TNBC. A total of 85 paired tumor tissues and sera with an equal number of adjacent normal tissue margins and normal sera from age matched healthy women including tissue and sera samples from 15 benign fibroadenomas were employed for the study. We report for the first time an extremely high prevalence (73.9%) of TNBC in premenopausal women below 35 years of age and a significant altered expression of a panel of three specific oncogenic miRNAs-miR- 21, miR-221, miR-210, and three tumor suppressor miRNAs-miR-195, miR-145 and Let-7a in both tissues and corresponding sera of TNBC patients when compared with triple positive breast cancer (TPBC) patients. While miR-21, miR-221 and miR-210 showed significant over-expression, miR-195 and miR-145 were downregulated and well correlated with various clinicopathological and demographic risk factors, tumor grade, clinical stage and hormone receptor status. Interestingly, despite being a known tumor suppressor, Let-7a showed a significant overexpression in TNBCs. It is suggested that this panel of six miRNA signature may serve as a minimally invasive biomarker for an early detection of TNBC patients.	[Thakur, Seema; Yadav, Ajay K.; Das, Bhudev C.] Univ Delhi, Dr BR Ambedker Ctr Biomed Res, New Delhi, India; [Grover, Rajesh K.] Delhi State Canc Inst, Delhi, India; [Gupta, Sanjay] Guru Teg Bahadur Hosp, Delhi, India; [Das, Bhudev C.] Amity Univ, AIMMSCR, Stem Cell & Canc Res Lab, Sect 125, Noida 201313, Uttar Pradesh, India	University of Delhi; University of Delhi; University College of Medical Sciences; Amity University Noida	Das, BC (corresponding author), Univ Delhi, Dr BR Ambedker Ctr Biomed Res, New Delhi, India.; Das, BC (corresponding author), Amity Univ, AIMMSCR, Stem Cell & Canc Res Lab, Sect 125, Noida 201313, Uttar Pradesh, India.	bcdas@amity.edu			Department of Science & Technology (DST), Govt. of India, New Delhi, India under Women Scientist Scheme A (WOS-A) [SR/WOS-A/LS-177/2011]; Department of Science & Technology (DST), Govt. of India, New Delhi under J. C. Bose National Fellowship	Department of Science & Technology (DST), Govt. of India, New Delhi, India under Women Scientist Scheme A (WOS-A); Department of Science & Technology (DST), Govt. of India, New Delhi under J. C. Bose National Fellowship	Authors acknowledge the Department of Science & Technology (DST), Govt. of India, New Delhi, India, for the award of Women Scientist fellowship under Women Scientist Scheme A (WOS-A), Grand No. SR/WOS-A/LS-177/2011 to Seema Thakur for her doctoral research. Authors are also thankful to the Department of Science & Technology (DST), Govt. of India, New Delhi for partial funding under J. C. Bose National Fellowship to B. C. Das. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asaga S, 2011, CLIN CHEM, V57, P84, DOI 10.1373/clinchem.2010.151845; Avery-Kiejda KA, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-253; Avery-Kiejda KA, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-51; Bockmeyer CL, 2011, BREAST CANCER RES TR, V130, P735, DOI 10.1007/s10549-010-1303-3; Chan M, 2013, CLIN CANCER RES, V19, P4477, DOI 10.1158/1078-0432.CCR-12-3401; Chen JQ, 2009, BBA-REV CANCER, V1796, P162, DOI 10.1016/j.bbcan.2009.06.003; Chen LQ, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-52; Cuk K, 2013, INT J CANCER, V132, P1602, DOI 10.1002/ijc.27799; Dietze EC, 2015, NAT REV CANCER, V15, P248, DOI 10.1038/nrc3896; Dolle JM, 2009, CANCER EPIDEM BIOMAR, V18, P1157, DOI 10.1158/1055-9965.EPI-08-1005; Eichelser C, 2014, ONCOTARGET, V5, P9650, DOI 10.18632/oncotarget.2520; Eichelser C, 2013, CLIN CHEM, V59, P1489, DOI 10.1373/clinchem.2013.205161; Erbes T, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1190-4; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Gasparini P, 2014, ONCOTARGET, V5, P1174, DOI 10.18632/oncotarget.1682; Gezer U, 2014, ONCOL LETT, V8, P845, DOI 10.3892/ol.2014.2188; Gyparaki MT, 2014, CANCER LETT, V354, P1, DOI 10.1016/j.canlet.2014.07.036; Heneghan HM, 2010, ONCOLOGIST, V15, P673, DOI 10.1634/theoncologist.2010-0103; Heneghan HM, 2010, ANN SURG, V251, P499, DOI 10.1097/SLA.0b013e3181cc939f; Hu JH, 2015, TUMOR BIOL, V36, P251, DOI 10.1007/s13277-014-2611-8; Igglezou M, 2014, ANTICANCER RES, V34, P7443; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jack RH, 2013, EUR J CANCER, V49, P696, DOI 10.1016/j.ejca.2012.09.012; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiao QL, 2014, J THORAC DIS, V6, P1329, DOI 10.3978/j.issn.2072-1439.2014.08.13; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kawai M, 2014, CANCER-AM CANCER SOC, V120, P1548, DOI 10.1002/cncr.28601; Dang K, 2015, INT J MOL SCI, V16, P6353, DOI 10.3390/ijms16036353; Le Quesne J, 2010, MOL ONCOL, V4, P230, DOI 10.1016/j.molonc.2010.04.009; Li B, 2014, ASIAN PAC J CANCER P, V15, P3555, DOI 10.7314/APJCP.2014.15.8.3555; Li D, 2011, CLIN CANCER RES, V17, P1722, DOI 10.1158/1078-0432.CCR-10-1800; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mar-Aguilar F, 2013, DIS MARKERS, V34, P163, DOI [10.1155/2013/259454, 10.3233/DMA-120957]; Medimegh I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111877; Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200; Mishra S, 2015, CANCER LETT, V369, P67, DOI 10.1016/j.canlet.2015.07.045; Qi LQ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-163; Radojicic J, 2011, CELL CYCLE, V10, P507, DOI 10.4161/cc.10.3.14754; Rais G, 2012, EUR J CANCER, V48, pS57; Roth C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2766; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Sahlberg KK, 2015, CLIN CANCER RES, V21, P1207, DOI 10.1158/1078-0432.CCR-14-2011; Serguienko A, 2015, ONCOTARGET, V6, P2451, DOI 10.18632/oncotarget.3235; Shah S, 2012, BREAST CANC INDIA; Sisic L, 2015, ONCOL LETT, V10, P869, DOI 10.3892/ol.2015.3341; Svoboda M, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-31; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Vyas Dinesh, 2016, J Clin Med Res, V8, P162, DOI 10.14740/jocmr2365w; Wang FJ, 2010, GYNECOL ONCOL, V119, P586, DOI 10.1016/j.ygyno.2010.07.021; Wu JN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133643; Yang Q, 2014, ASIAN PAC J CANCER P, V16, P3229; Zhao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013735; Zhao JJ, 2008, J BIOL CHEM, V283, P31079, DOI 10.1074/jbc.M806041200; Zheng H, 2013, PLASMA MIRNAS DIAGNO; Zhu J, 2014, FRONT GENET, P5; Zhu Weizhu, 2009, BMC Res Notes, V2, P89, DOI 10.1186/1756-0500-2-89	56	49	49	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0158946	10.1371/journal.pone.0158946	http://dx.doi.org/10.1371/journal.pone.0158946			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27404381	gold, Green Published, Green Submitted			2022-12-27	WOS:000379508200022
J	Canetti, D; Kimhi, S; Hanoun, R; Rocha, GA; Galea, S; Morgan, CA				Canetti, Daphna; Kimhi, Shaul; Hanoun, Rasmiyah; Rocha, Gabriel A.; Galea, Sandro; Morgan, Charles A., III			How Personality Affects Vulnerability among Israelis and Palestinians following the 2009 Gaza Conflict	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; THOUGHT CONTROL STRATEGIES; POST TRAUMATIC STRESS; WAR-RELATED TRAUMA; SOCIAL SUPPORT; MENTAL-HEALTH; PSYCHOLOGICAL DISTRESS; PROTRACTED CONFLICT; PTSD SYMPTOMS; EXPOSURE	Can the onset of PTSD symptoms and depression be predicted by personality factors and thought control strategies? A logical explanation for the different mental health outcomes of individuals exposed to trauma would seem to be personality factors and thought control strategies. Trauma exposure is necessary but not sufficient for the development of PTSD. To this end, we assess the role of personality traits and coping styles in PTSD vulnerability among Israeli and Palestinian students amid conflict. We also determine whether gender and exposure level to trauma impact the likelihood of the onset of PTSD symptoms. Five questionnaires assess previous trauma, PTSD symptoms, demographics, personality factors and thought control strategies, which are analyzed using path analysis. Findings show that the importance of personality factors and thought control strategies in predicting vulnerability increases in the face of political violence: the higher stress, the more important the roles of personality and thought control strategies. Thought control strategies associated with introverted and less emotionally stable personality-types correlate positively with higher levels of PTSD symptoms and depression, particularly among Palestinians. By extension, because mental health is key to reducing violence in the region, PTSD reduction in conflict zones warrants rethinking.	[Canetti, Daphna] Univ Haifa, Sch Polit Sci, Haifa, Israel; [Kimhi, Shaul] Tel Hai Coll, Dept Psychol, Tel Hai, Israel; [Hanoun, Rasmiyah] An Najah Natl Univ, Fac Educ Sci, Nablus, Palestine; [Rocha, Gabriel A.] Carolinas Biofeedback Clin, Charlotte, NC USA; [Rocha, Gabriel A.] Doctors Making Housecalls, Durham, NC USA; [Galea, Sandro] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Morgan, Charles A., III] Univ New Haven, Natl Secur Program, New Haven, CT USA; [Morgan, Charles A., III] Yale Univ, Sch Med, New Haven, CT USA	University of Haifa; Tel Hai Academy College; An Najah National University; Boston University; University New Haven; Yale University	Canetti, D (corresponding author), Univ Haifa, Sch Polit Sci, Haifa, Israel.	dcanetti@poli.haifa.ac.il	Galea, Sandro/GLR-6066-2022	Galea, Sandro/0000-0002-7534-0945	Yale University School of Medicine; National Center for PTSD; Wilbur G. Downs International Health Fellowship	Yale University School of Medicine; National Center for PTSD; Wilbur G. Downs International Health Fellowship	This work was supported by Yale University School of Medicine, the National Center for PTSD, and the Wilbur G. Downs International Health Fellowship.	Ai AL, 2002, J TRAUMA STRESS, V15, P157, DOI 10.1023/A:1014864225889; Al-Krenawi A, 2009, BRIT J PSYCHIAT, V195, P427, DOI 10.1192/bjp.bp.108.050393; Amstadter Ananda B, 2008, J Aggress Maltreat Trauma, V17, P279, DOI 10.1080/10926770802403236; ARBUCKLE J. L., 2007, AMOS 16 0 USERS GUID; Bar-Tal D, 2000, POLIT PSYCHOL, V21, P351, DOI 10.1111/0162-895X.00192; Berger R, 2012, J ADOLESCENT HEALTH, V51, P453, DOI 10.1016/j.jadohealth.2012.02.011; Besser A, 2015, SELF IDENTITY, V14, P1, DOI 10.1080/15298868.2014.966143; Birmes P, 2005, EUR PSYCHIAT, V20, P145, DOI 10.1016/j.eurpsy.2004.06.033; Bonanno GA, 2005, CURR DIR PSYCHOL SCI, V14, P135, DOI 10.1111/j.0963-7214.2005.00347.x; Borja SE, 2009, PSYCHOL TRAUMA-US, V1, P118, DOI 10.1037/a0016011; Bowes L, 2013, TRAUMA VIOLENCE ABUS, V14, P195, DOI 10.1177/1524838013487807; Brajsa-Zganec A, 2005, CHILD ABUSE NEGLECT, V29, P31, DOI 10.1016/j.chiabu.2004.07.007; Brodaty H, 2004, INT J GERIATR PSYCH, V19, P968, DOI 10.1002/gps.1195; Bryant RA, 2001, J TRAUMA STRESS, V14, P213, DOI 10.1023/A:1007856103389; Bunevicius A, 2008, INT J SOC PSYCHIATR, V54, P494, DOI 10.1177/0020764008090843; Canetti D, 2014, FOREIGN AFF; Canetti D, 2014, LANCET, V384, P493, DOI 10.1016/S0140-6736(14)61328-3; Canetti D, 2014, J TRAUMA STRESS, V27, P345, DOI 10.1002/jts.21920; Canetti D, 2010, PSYCHIATRY, V73, P219, DOI 10.1521/psyc.2010.73.3.219; Canetti-Nisim D, 2009, J CONFLICT RESOLUT, V53, P363, DOI 10.1177/0022002709333296; Cardozo BL, 2000, JAMA-J AM MED ASSOC, V284, P569, DOI 10.1001/jama.284.5.569; Caska CM, 2013, ANXIETY STRESS COPIN, V26, P36, DOI 10.1080/10615806.2011.638053; Chipman KJ, 2011, ANXIETY STRESS COPIN, V24, P255, DOI 10.1080/10615806.2010.515304; de Jong JTVM, 2001, JAMA-J AM MED ASSOC, V286, P555, DOI 10.1001/jama.286.5.555; DeLongis A, 2005, J PERS, V73, P1633, DOI 10.1111/j.1467-6494.2005.00361.x; Digman JM, 1997, J PERS SOC PSYCHOL, V73, P1246, DOI 10.1037/0022-3514.73.6.1246; Dorfel D, 2008, J LOSS TRAUMA, V13, P422, DOI 10.1080/15325020701742136; Ehntholt KA, 2006, J CHILD PSYCHOL PSYC, V47, P1197, DOI 10.1111/j.1469-7610.2006.01638.x; FOA EB, 1993, J TRAUMA STRESS, V6, P459, DOI 10.1007/BF00974317; FOLKMAN S, 1986, J PERS SOC PSYCHOL, V50, P992, DOI 10.1037/0022-3514.50.5.992; Friedman G, 2005, J CONFLICT RESOLUT, V49, P360, DOI 10.1177/0022002705276566; Fujiwara T, 2008, J EPIDEMIOL COMMUN H, V62, P627, DOI 10.1136/jech.2007.064261; Galea S, 2003, AM J EPIDEMIOL, V158, P514, DOI 10.1093/aje/kwg187; Giacaman R, 2007, EUR J PUBLIC HEALTH, V17, P361, DOI 10.1093/eurpub/ckl260; Ginzburg K, 2010, J AFFECT DISORDERS, V123, P249, DOI 10.1016/j.jad.2009.08.006; Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1; Gross M. L., 2010, MORAL DILEMMAS MODER; Hadi F, 2006, J TRAUMA STRESS, V19, P653, DOI 10.1002/jts.20153; Hall BJ, 2008, J TRAUMA STRESS, V21, P22, DOI 10.1002/jts.20301; HOBFOLL SE, 1993, J COMMUNITY PSYCHOL, V21, P128, DOI 10.1002/1520-6629(199304)21:2<128::AID-JCOP2290210206>3.0.CO;2-5; HOBFOLL SE, 1989, AM PSYCHOL, V44, P513, DOI 10.1037/0003-066X.44.3.513; Hobfoll SE, 2006, J CONSULT CLIN PSYCH, V74, P207, DOI 10.1037/0022-006X.74.2.207; Ising Marcus, 2006, Dialogues Clin Neurosci, V8, P433; Jaksic N, 2012, PSYCHIAT DANUB, V24, P256; Johnson H, 2008, CLIN PSYCHOL REV, V28, P36, DOI 10.1016/j.cpr.2007.01.017; Kendler KS, 2002, AM J PSYCHIAT; KHAMIS V, 1993, J TRAUMA STRESS, V6, P555, DOI 10.1007/BF00974323; Lawrence JW, 2003, J BURN CARE REHABIL, V24, P63, DOI 10.1097/00004630-200301000-00016; Lazarus R.S., 1984, EMOTION ADAPTATION; Leskela U, 2009, J NERV MENT DIS, V197, P728, DOI 10.1097/NMD.0b013e3181b97960; Lindner EG, 2006, TERROR HOLY LAND INS, P123; Longo M, 2014, AM J POLIT SCI, V58, P1006, DOI 10.1111/ajps.12109; McCann SJH, 2010, ARCH SUICIDE RES, V14, P368, DOI 10.1080/13811118.2010.524070; Meiser-Stedman R, 2014, J CHILD ADOL PSYCHOP, V24, P47, DOI 10.1089/cap.2013.0052; Ozura A, 2012, PSYCHIAT DANUB, V24, P66; Pat-Horenczyk R, 2009, APPL PSYCHOL-INT REV, V58, P688, DOI 10.1111/j.1464-0597.2008.00372.x; Paunonen SV, 2001, J PERS SOC PSYCHOL, V81, P524, DOI 10.1037/0022-3514.81.3.524; Rammstedt B, 2007, J RES PERS, V41, P203, DOI 10.1016/j.jrp.2006.02.001; Rouhana N.M., 2004, PEACE AND CONFLICT J, V10, P33, DOI DOI 10.1207/S15327949PAC1001_3; Roussis P, 2006, PERS INDIV DIFFER, V40, P111, DOI 10.1016/j.paid.2005.06.019; Rutter M, 2006, ANN NY ACAD SCI, V1094, P1, DOI 10.1196/annals.1376.002; Rytwinski NK, 2014, J HEALTH PSYCHOL, V19, P509, DOI 10.1177/1359105312474913; Schnurr P, 2002, J CLIN GEROPSYCHOL, V8, P175, DOI [DOI 10.1023/A:1015992110544, 10.1023/A:1015992110544]; Slone M, 2014, J TRAUMA STRESS, V27, P353, DOI 10.1002/jts.21918; Solomon Z, 2005, J AM ACAD CHILD PSY, V44, P1167, DOI 10.1097/01.chi.0000161650.97643.e1; Solomon Z, 2007, J TRAUMA STRESS, V20, P303, DOI 10.1002/jts.20216; Stevanovic A, 2011, 19 EUR C PSYCH; Telhami S, 2005, RESOLUTION GRASPING; Thabet AZ, 2000, CHILD ABUSE NEGLECT, V24, P291, DOI 10.1016/S0145-2134(99)00127-1; Valdez CE, 2012, J PSYCHOPATHOL BEHAV, V34, P531, DOI 10.1007/s10862-012-9300-y; Watkins ER, 2009, INT J COGN THER, V2, P235, DOI 10.1521/ijct.2009.2.3.235; WELLS A, 1995, BEHAV RES THER, V33, P579, DOI 10.1016/0005-7967(94)00087-Z; Wilson JP, 2004, ASSESSING PSYCHOL TR, V2nd; Wisco BE, 2013, COGNITION EMOTION, V27, P1314, DOI 10.1080/02699931.2013.775109; ZEIDNER M, 1994, PERS INDIV DIFFER, V16, P459, DOI 10.1016/0191-8869(94)90072-8	75	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0156278	10.1371/journal.pone.0156278	http://dx.doi.org/10.1371/journal.pone.0156278			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27391240	Green Submitted, Green Published, gold			2022-12-27	WOS:000380005400003
J	Chang, YK; Choi, H; Jeong, JY; Na, KR; Lee, KW; Lim, BJ; Choi, DE				Chang, Yoon-Kyung; Choi, Hyunsu; Jeong, Jin Young; Na, Ki-Ryang; Lee, Kang Wook; Lim, Beom Jin; Choi, Dae Eun			Dapagliflozin, SGLT2 Inhibitor, Attenuates Renal Ischemia-Reperfusion Injury	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR; GENE-EXPRESSION; ERK ACTIVATION; TUBULAR CELLS; HIF; HIF-1-ALPHA; APOPTOSIS; FAILURE; GLUCOSE; LIVER	Dapagliflozin, a new type of drug used to treat diabetes mellitus (DM), is a sodium/glucose cotransporter 2 (SGLT2) inhibitor. Although some studies showed that SGLT2 inhibition attenuated reactive oxygen generation in diabetic kidney the role of SGLT2 inhibition is unknown. We evaluated whether SLT2 inhibition has renoprotective effects in ischemia-reperfusion (IR) models. We evaluated whether dapagliflozin reduces renal damage in IR mice model. In addition, hypoxic HK2 cells were treated with or without SGLT2 inhibitor to investigate cell survival, the apoptosis signal pathway, and the induction of hypoxia-inducible factor 1 (HIF1) and associated proteins. Dapagliflozin improved renal function. Dapagliflozin reduced renal expression of Bax, renal tubule injury and TUNEL-positive cells and increased renal expression of HIF1 in IR-injured mice. HIF1 inhibition by albendazole negated the renoprotective effects of dapagliflozin treatment in IR-injured mice. In vitro, dapagliflozin increased the expression of HIF1, AMP-activated protein kinase (AMPK), and ERK and increased cell survival of hypoxic HK2 cells in a dose-dependent manner. In conclusion, dapagliflozin attenuates renal IR injury. HIF1 induction by dapagliflozin may play a role in renoprotection against renal IR injury.	[Chang, Yoon-Kyung] Daejeon St Mary Hosp, Dept Nephrol, Daejeon, South Korea; [Chang, Yoon-Kyung] Catholic Univ Korea, Dept Nephrol, Seoul, South Korea; [Choi, Hyunsu] Daejeon St Mary Hosp, Clin Res Inst, Daejeon, South Korea; [Jeong, Jin Young; Na, Ki-Ryang; Lee, Kang Wook; Choi, Dae Eun] Chungnam Natl Univ, Sch Med, Dept Nephrol, Daejeon, South Korea; [Jeong, Jin Young] Chungnam Natl Univ, Sch Med, Dept Med Sci, Daejeon, South Korea; [Lim, Beom Jin] Yeonse Univ, Coll Med, Dept Pathol, Seoul, South Korea	Catholic University of Korea; Chungnam National University; Chungnam National University; Yonsei University; Yonsei University Health System	Choi, DE (corresponding author), Chungnam Natl Univ, Sch Med, Dept Nephrol, Daejeon, South Korea.; Lim, BJ (corresponding author), Yeonse Univ, Coll Med, Dept Pathol, Seoul, South Korea.	bjlim@yuhs.ac; daenii@cnu.ac.kr	Choi, Dae Eun/B-5996-2014	Choi, Dae Eun/0000-0003-2870-3958; Lim, Beom Jin/0000-0003-2856-0133; Na, Ki Ryang/0000-0002-0136-176X	Clinical Research Institute grant - Catholic University of Korea Daejeon St. Mary's Hospital [CMCDJ-A-2015-020]; faculty research grant of Yonsei University College of Medicine [6-2009-0103]	Clinical Research Institute grant - Catholic University of Korea Daejeon St. Mary's Hospital; faculty research grant of Yonsei University College of Medicine	This work was supported by a Clinical Research Institute grant (CMCDJ-A-2015-020) funded by The Catholic University of Korea Daejeon St. Mary's Hospital. This study was supported by a faculty research grant of Yonsei University College of Medicine for 2009 (6-2009-0103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adluri RS, 2011, ANTIOXID REDOX SIGN, V15, P1789, DOI 10.1089/ars.2010.3769; Baranova O, 2007, J NEUROSCI, V27, P6320, DOI 10.1523/JNEUROSCI.0449-07.2007; Chang YK, 2009, J UROLOGY, V181, P1434, DOI 10.1016/j.juro.2008.10.105; Choi DE, 2009, AM J PHYSIOL-RENAL, V297, pF362, DOI 10.1152/ajprenal.90609.2008; Conde E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033258; Cursio R, 2008, TRANSPL P, V40, P2042, DOI 10.1016/j.transproceed.2008.05.037; Fernando M, 2014, BIOMARK MED, V8, P1247, DOI [10.2217/bmm.14.86, 10.2217/BMM.14.86]; Gunaratnam L, 2009, J AM SOC NEPHROL, V20, P1877, DOI 10.1681/ASN.2008070804; Guo JY, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-79; Haase VH, 2006, KIDNEY INT, V69, P1302, DOI 10.1038/sj.ki.5000221; Haase VH, 2006, AM J PHYSIOL-RENAL, V291, pF271, DOI 10.1152/ajprenal.00071.2006; Hill P, 2008, J AM SOC NEPHROL, V19, P39, DOI 10.1681/ASN.2006090998; Knudsen AR, 2012, AM J PHYSIOL-GASTR L, V303, pG482, DOI 10.1152/ajpgi.00337.2011; Layton AT, 2016, AM J PHYSIOL-RENAL, V310, pF1269, DOI 10.1152/ajprenal.00543.2015; Lee KW, 2009, TOXICOLOGY, V257, P137, DOI 10.1016/j.tox.2008.12.017; Lee M, 2003, J BIOL CHEM, V278, P39653, DOI 10.1074/jbc.M306104200; Minet E, 2000, FEBS LETT, V468, P53, DOI 10.1016/S0014-5793(00)01181-9; Morrisey K, 1999, KIDNEY INT, V55, P2548, DOI 10.1046/j.1523-1755.1999.00454.x; Nakamura N, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0044-1; Nangaku M, 2008, NEPHRON EXP NEPHROL, V110, pE1, DOI 10.1159/000148256; O'Neill J, 2015, AM J PHYSIOL-RENAL, V309, pF227, DOI 10.1152/ajprenal.00689.2014; Panchapakesan U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054442; Schley G, 2012, AM J PATHOL, V181, P1595, DOI 10.1016/j.ajpath.2012.07.010; Song H, 2015, LIFE SCI, V126, P69, DOI 10.1016/j.lfs.2015.02.004; Vercauteren SR, 2003, AM J TRANSPLANT, V3, P570, DOI 10.1034/j.1600-6143.2003.00117.x; Veroux M, 2009, TRANSPL INFECT DIS, V11, P266, DOI 10.1111/j.1399-3062.2009.00388.x; Versteilen AMG, 2004, INT J ARTIF ORGANS, V27, P1019, DOI 10.1177/039139880402701203; Weidemann A, 2008, J AM SOC NEPHROL, V19, P486, DOI 10.1681/ASN.2007040419; Yang CC, 2009, TRANSPLANTATION, V88, P1251, DOI 10.1097/TP.0b013e3181bb4a07; Yeh CH, 2010, LIFE SCI, V86, P115, DOI 10.1016/j.lfs.2009.11.022; Zapata-Morales JR, 2014, J BIOL CHEM, V289, P346, DOI 10.1074/jbc.M113.526814; Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720	32	79	88	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158810	10.1371/journal.pone.0158810	http://dx.doi.org/10.1371/journal.pone.0158810			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391020	Green Published, gold, Green Submitted			2022-12-27	WOS:000380005400130
J	Cheng, XJ; Tian, XY; Wu, XJ; Xing, XF; Du, H; Zhou, CL; Zhang, QY; Hao, CY; Wen, XZ; Ji, JF				Cheng, Xiaojing; Tian, Xiuyun; Wu, Xiaojiang; Xing, Xiaofang; Du, Hong; Zhou, Chunlian; Zhang, Qingyun; Hao, Chunyi; Wen, Xianzi; Ji, Jiafu			Relationship between LAPTM4B Gene Polymorphism and Prognosis of Patients following Tumor Resection for Colorectal and Esophageal Cancers	PLOS ONE			English	Article							POOR-PROGNOSIS; SUSCEPTIBILITY; PROMOTES; PROTEIN; ANGIOGENESIS; ASSOCIATION	Background Lysosome-associated transmembrane-4 beta (LAPTM4B) is an oncogene that participates tumorgenesis in a variety of human solid tumors, and it has two alleles named as LAPTM4B *1 and *2. The present study aimed to identify the association of LAPTM4B genotype with clinicopathological features and prognosis in colorectal and esophageal cancer patients. Method Genotypes of LAPTM4B were determined by PCR in 167 colon cancer cases (72 patients in a discovery cohort and 95 patients in a testing cohort), 160 rectal cancer cases and 164 esophageal cancer cases. Association between the LAPTM4B gene polymorphism and clinicopathological variables was calculated by Chi-square test or Fisher's exact test. Patient survival differences were calculated by the Kaplan-Meier method. Prognostic factors were determined with Log-rank test and Cox regression model. Results LAPTM4B *1/1 was more frequently detected in colon cancer patients with lymph node metastasis and TNM III+IV stages in total colon cancer (discovery + testing cohorts). LAPTM4B *2/2 decreased in recurrent patients in total colon cancer patients (P = 0.045). Kaplan-Meier survival curves and Log-rank test showed that LAPTM4B *1 was correlated with shorter overall survival (OS) in discovery and testing cohorts of colon cancer (P = 0.0254 and 0.0292, respectively), but not in rectal and esophageal cancer cases (P = 0.7669 and 0.9356, respectively). Multivariate analysis showed that LAPTM4B genotype was an independent prognostic factor for OS in total colon cancer [P = 0.004, hazard ratio (HR) = 0.432; 95% confidence interval (CI) = 0.243-0.768], but not in rectal and esophageal cancers (P = 0.791, HR = 1.073, 95% CI = 0.638-1.804 and 0.998, HR = 1.000, 95% CI = 0.663-1.530, respectively). Conclusion These findings suggested that LAPTM4B allele *1 was a risk factor associated with poor prognosis in patients with colon cancer, but not in patients with rectal or esophageal cancers. LAPTM4B genotype status might be a useful prognostic indicator for patients that need surgical operation in colon cancer.	[Cheng, Xiaojing; Xing, Xiaofang; Du, Hong; Wen, Xianzi; Ji, Jiafu] Peking Univ Canc Hosp & Inst, Div Gastrointestinal Canc, Translat Res Lab, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R China; [Tian, Xiuyun; Hao, Chunyi] Peking Univ Canc Hosp & Inst, Minist Educ Beijing, Dept Hepatopancreatobiliary Surg, Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R China; [Wu, Xiaojiang; Ji, Jiafu] Peking Univ Canc Hosp & Inst, Dept Gastrointestinal Surg, Beijing, Peoples R China; [Zhou, Chunlian] Capital Med Univ, Beijing Friendship Hosp, Dept Nosocomial Infect Prevent & Control, Beijing, Peoples R China; [Zhang, Qingyun] Peking Univ Canc Hosp & Inst, Dept Clin Lab, Beijing, Peoples R China	Peking University; Peking University; Peking University; Capital Medical University; Peking University	Wen, XZ; Ji, JF (corresponding author), Peking Univ Canc Hosp & Inst, Div Gastrointestinal Canc, Translat Res Lab, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R China.; Hao, CY (corresponding author), Peking Univ Canc Hosp & Inst, Minist Educ Beijing, Dept Hepatopancreatobiliary Surg, Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R China.; Ji, JF (corresponding author), Peking Univ Canc Hosp & Inst, Dept Gastrointestinal Surg, Beijing, Peoples R China.	haochunyi@bjmu.edu.cn; wenxz@bjmu.edu.cn; jiafuji@outlook.com		JI, JIAFU/0000-0001-6878-5543; Hao, Chunyi/0000-0002-1233-1689	National Nature Science Foundation of China [81402308]; National High Technology Research and Development Program of China (863 Program) [2014AA020603]; capital health research and development of special [2016-2-2151]; Beijing municipal natural science foundation [7153161]; International science and technology cooperation program of China [2013DFG32720]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); capital health research and development of special; Beijing municipal natural science foundation(Beijing Natural Science Foundation); International science and technology cooperation program of China	The National Nature Science Foundation of China (No. 81402308), the National High Technology Research and Development Program of China (863 Program, No. 2014AA020603), the capital health research and development of special (No. 2016-2-2151), Beijing municipal natural science foundation, (No. 7153161), International science and technology cooperation program of China (No. 2013DFG32720).	Chen WQ, 2015, CHIN J CANCER, V34, DOI 10.1186/s40880-015-0042-6; Cheng XJ, 2008, ANN ONCOL, V19, P527, DOI 10.1093/annonc/mdm469; Cheng XJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121559; Deng Li-juan, 2005, Beijing Da Xue Xue Bao Yi Xue Ban, V37, P302; Fan MR, 2012, CANCER EPIDEMIOL, V36, P364, DOI 10.1016/j.canep.2011.12.004; Hashemi M, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0111-8; He Jing, 2003, Beijing Da Xue Xue Bao Yi Xue Ban, V35, P348; Kasper G, 2005, CANCER LETT, V224, P93, DOI 10.1016/j.canlet.2004.10.004; Li Changlin, 2006, Zhongguo Fei Ai Za Zhi, V9, P109, DOI 10.3779/j.issn.1009-3419.2006.02.02; Li L, 2010, ONCOGENE, V29, P5785, DOI 10.1038/onc.2010.303; Li L, 2011, ANAT REC, V294, P1135, DOI 10.1002/ar.21421; Li X, 2012, ORG MED CHEM LETT, V2, P2, DOI DOI 10.1371/J0URNAL.P0NE.0044916; Liu LY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118026; Liu XR, 2004, WORLD J GASTROENTERO, V10, P1555, DOI 10.3748/wjg.v10.i11.1555; Liu Y, 2007, ANN ONCOL, V18, P311, DOI 10.1093/annonc/mdl394; Maki Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep13846; Meng FL, 2015, CELL PHYSIOL BIOCHEM, V37, P890, DOI 10.1159/000430216; Meng FL, 2013, BIOMARKERS, V18, P136, DOI 10.3109/1354750X.2012.752526; Milkereit R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8250; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peng C, 2005, WORLD J GASTROENTERO, V11, P2704, DOI 10.3748/wjg.v11.i18.2704; Shao GZ, 2003, ONCOGENE, V22, P5060, DOI 10.1038/sj.onc.1206832; Shao GZ, 2003, THESIS; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Tan XJ, 2015, EMBO J, V34, P475, DOI 10.15252/embj.201489425; Tan XJ, 2015, CELL, V160, P145, DOI 10.1016/j.cell.2014.12.006; Tang H, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0974-8; Tang H, 2014, ONCOL REP, V31, P2454, DOI 10.3892/or.2014.3116; Welch HG, 2000, JAMA-J AM MED ASSOC, V283, P2975, DOI 10.1001/jama.283.22.2975; Xu Y, 2012, JPN J CLIN ONCOL, V42, P413, DOI 10.1093/jjco/hys026; Yang H, 2012, MED ONCOL, V29, P2809, DOI 10.1007/s12032-012-0173-4; Yang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034984; Yang H, 2010, J CANCER RES CLIN, V136, P275, DOI 10.1007/s00432-009-0659-4; Yin MZ, 2011, J SURG ONCOL, V104, P29, DOI 10.1002/jso.21912; Zhang HY, 2014, TUMOR BIOL, V35, P12737, DOI 10.1007/s13277-014-2599-0	35	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158715	10.1371/journal.pone.0158715	http://dx.doi.org/10.1371/journal.pone.0158715			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391361	gold, Green Submitted, Green Published			2022-12-27	WOS:000380005400108
J	Dias, JA; Fredrikson, GN; Ericson, U; Gullberg, B; Hedblad, B; Engstrom, G; Borgquist, S; Nilsson, J; Wirfalt, E				Dias, Joana A.; Fredrikson, Gunilla N.; Ericson, Ulrika; Gullberg, Bo; Hedblad, Bo; Engstrom, Gunnar; Borgquist, Signe; Nilsson, Jan; Wirfalt, Elisabet			Low-Grade Inflammation, Oxidative Stress and Risk of Invasive Post-Menopausal Breast Cancer - A Nested Case-Control Study from the Malmo Diet and Cancer Cohort	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; LOW-DENSITY-LIPOPROTEIN; CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; TNF-ALPHA; CARDIOVASCULAR-DISEASE; LINKING OBESITY; OXIDIZED LDL; CYTOKINES; MECHANISMS	Objective Although cancer promotes inflammation, the role of inflammation in tumor-genesis is less well established. The aim was to examine if low-grade inflammation is related to post-menopausal breast cancer risk, and if obesity modifies this association. Methods In the Malmo Diet and Cancer cohort, a nested case-control study was defined among 8,513 women free of cancer and aged 55-73 years at baseline (1991-96); 459 were diagnosed with invasive breast cancer during follow-up (until December 31st, 2010). In laboratory analyses of blood from 446 cases, and 885 controls (matched on age and date of blood sampling) we examined systemic inflammation markers: oxidized (ox)-LDL, interleukin (IL)-1 beta, IL-6, IL-8, tumor necrosis factor (TNF)-alpha, white blood cells, lymphocytes and neutrophils. Odds ratios (OR) and 95% confidence intervals (CI) for breast cancer risk was calculated using multivariable conditional logistic regression. Results Inverse associations with breast cancer were seen in fully-adjusted models, for 2nd and 3rd tertiles of ox-LDL, OR (95% CI): 0.65 (0.47-0.90), 0.63 (0.45-0.89) respectively, p-trend = 0.01; and for the 3rd tertile of TNF-alpha, 0.65 (0.43-0.99), p-trend = 0.04. In contrast, those in the highest IL-1 beta category had higher risk, 1.71 (1.05-2.79), p-trend = 0.01. Obesity did not modify associations between inflammation biomarkers and breast cancer. Conclusion Our study does not suggest that low-grade inflammation increase the risk of post-menopausal breast cancer.	[Dias, Joana A.; Gullberg, Bo; Wirfalt, Elisabet] Lund Univ, Dept Clin Sci, Nutr Epidemiol Res Grp, Malmo, Sweden; [Fredrikson, Gunilla N.; Nilsson, Jan] Lund Univ, Dept Clin Sci, Expt Cardiovasc Res, Malmo, Sweden; [Ericson, Ulrika] Lund Univ, Ctr Diabet, Dept Clin Sci, Diabet & Cardiovasc Dis Genet Epidemiol, Malmo, Sweden; [Hedblad, Bo; Engstrom, Gunnar] Lund Univ, Dept Clin Sci, Cardiovasc Epidemiol Res Grp, Malmo, Sweden; [Borgquist, Signe] Lund Univ, Dept Clin Sci, Div Oncol & Pathol, Lund, Sweden	Lund University; Lund University; Lund University; Lund University; Lund University	Dias, JA (corresponding author), Lund Univ, Dept Clin Sci, Nutr Epidemiol Res Grp, Malmo, Sweden.	joana.alves_dias@med.lu.se	Dias, Joana/A-4230-2015	Dias, Joana/0000-0003-4137-0932; Borgquist, Signe/0000-0001-7938-8893				Adamsson Eryd S, 2012, ARTERIOSCL THROM VAS, V32, P533, DOI 10.1161/ATVBAHA.111.240416; AIRC, 2007, FOOD NUTR PHYS ACT P; Allavena P, 2008, CURR OPIN GENET DEV, V18, P3, DOI 10.1016/j.gde.2008.01.003; Antoine C, 2014, CLIMACTERIC, V17, P116, DOI 10.3109/13697137.2013.829812; Baer HJ, 2006, INT J CANCER, V119, P2231, DOI 10.1002/ijc.22096; Ben-Shmuel S, 2016, HANDB EXP PHARMACOL, V233, P355, DOI 10.1007/164_2015_12; Borgquist S, 2009, INT J CANCER, V124, P402, DOI 10.1002/ijc.23850; Calle EE, 1996, LANCET, V347, P1713, DOI 10.1016/S0140-6736(96)90806-5; Cao W, 2005, BIOCHEM BIOPH RES CO, V330, P1034, DOI 10.1016/j.bbrc.2005.02.188; Chan DSM, 2015, CANCER EPIDEM BIOMAR, V24, P1439, DOI 10.1158/1055-9965.EPI-15-0324; Chen C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123088; CLEEMAN JI, 1988, ARCH INTERN MED, V148, P36, DOI 10.1001/archinte.148.1.36; Colditz GA, 2004, JNCI-J NATL CANCER I, V96, P218, DOI 10.1093/jnci/djh025; Cotoi OS, 2014, ARTERIOSCL THROM VAS, V34, P202, DOI 10.1161/ATVBAHA.113.302432; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Delimaris L, 2007, CLIN BIOCHEM, V40, P1129, DOI 10.1016/j.clinbiochem.2007.06.007; Dethlefsen C, 2013, BREAST CANCER RES TR, V138, P657, DOI 10.1007/s10549-013-2488-z; Dias JA, 2016, BIOMARKERS, V21, P562, DOI 10.3109/1354750X.2016.1160431; Duncan BB, 2003, DIABETES, V52, P1799, DOI 10.2337/diabetes.52.7.1799; Esquivel-Velazquez M, 2015, J INTERF CYTOK RES, V35, P1, DOI 10.1089/jir.2014.0026; Folkerd E, 2013, BREAST, V22, pS38, DOI 10.1016/j.breast.2013.07.007; Fredrikson GN, 2003, ARTERIOSCL THROM VAS, V23, P872, DOI 10.1161/01.ATV.0000067935.02679.B0; Gaiotti D, 2000, MOL CARCINOGEN, V27, P97, DOI 10.1002/(SICI)1098-2744(200002)27:2<97::AID-MC5>3.0.CO;2-V; Germano G, 2008, CYTOKINE, V43, P374, DOI 10.1016/j.cyto.2008.07.014; Gilbert CA, 2013, ANNU REV MED, V64, P45, DOI 10.1146/annurev-med-121211-091527; Grivennikov SI, 2011, ANN RHEUM DIS, V70, pI104, DOI 10.1136/ard.2010.140145; Grivennikov SI, 2010, CURR OPIN GENET DEV, V20, P65, DOI 10.1016/j.gde.2009.11.004; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Ho E, 2013, REDOX BIOL, V1, P483, DOI 10.1016/j.redox.2013.07.006; Hofmann JN, 2011, CYTOKINE, V56, P145, DOI 10.1016/j.cyto.2011.06.012; Holvoet P, 1998, CIRCULATION, V98, P1487, DOI 10.1161/01.CIR.98.15.1487; Howe LR, 2013, CLIN CANCER RES, V19, P6074, DOI 10.1158/1078-0432.CCR-12-2603; HULLEY SB, 1988, DRUGS, V36, P100, DOI 10.2165/00003495-198800363-00021; Izano M, 2016, INT J CANCER, V138, P1118, DOI 10.1002/ijc.29868; Khan S, 2013, CYTOKINE GROWTH F R, V24, P503, DOI 10.1016/j.cytogfr.2013.10.001; Krajcik RA, 2003, CANCER EPIDEM BIOMAR, V12, P945; Lahmann PH, 2003, INT J CANCER, V103, P246, DOI 10.1002/ijc.10799; Li C, 2009, EUR J CLIN NUTR, V63, P1448, DOI 10.1038/ejcn.2009.69; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Madeddu C, 2014, J CELL MOL MED, V18, P2519, DOI 10.1111/jcmm.12413; Madjid M, 2004, J AM COLL CARDIOL, V44, P1945, DOI 10.1016/j.jacc.2004.07.056; Manjer J, 2001, EUR J CANCER PREV, V10, P489, DOI 10.1097/00008469-200112000-00003; Merlo J, 2000, AM J EPIDEMIOL, V152, P788, DOI 10.1093/aje/152.8.788; Mittal R, 2014, CURRENT PHARM BIOTEC; Ni HB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142669; Nicolini A, 2006, CYTOKINE GROWTH F R, V17, P325, DOI 10.1016/j.cytogfr.2006.07.002; Osorio-Costa F, 2009, ARQ BRAS ENDOCRINOL, V53, P213, DOI 10.1590/S0004-27302009000200013; Paik JK, 2013, NUTR METAB CARDIOVAS, V23, P967, DOI 10.1016/j.numecd.2012.08.002; Porta C, 2009, IMMUNOBIOLOGY, V214, P761, DOI 10.1016/j.imbio.2009.06.014; Psychiatrists RCo, 1986, ALC OUR FAV DRUG; Purohit A, 2002, BREAST CANCER RES, V4, P65, DOI 10.1186/bcr425; RICHARDSON MT, 1994, J CLIN EPIDEMIOL, V47, P271, DOI 10.1016/0895-4356(94)90008-6; Ridker PM, 2003, CIRCULATION, V107, P363, DOI 10.1161/01.CIR.0000053730.47739.3C; Schneiders J, 2015, BRAIN BEHAV IMMUN, V48, P147, DOI 10.1016/j.bbi.2015.03.008; Scoccianti C, 2014, AM J PREV MED, V46, pS16, DOI 10.1016/j.amepre.2013.10.031; Siebert S, 2015, PHARMACOL REV, V67, P280, DOI 10.1124/pr.114.009639; Simpson ER, 2013, J MOL ENDOCRINOL, V51, pT51, DOI 10.1530/JME-13-0217; Simpson ER, 2013, MOL ENDOCRINOL, V27, P715, DOI 10.1210/me.2013-1011; Soria G, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-130; Suzuki K, 2004, CANCER EPIDEM BIOMAR, V13, P1781; Touvier M, 2015, BRIT J NUTR, V114, P347, DOI 10.1017/S000711451500183X; Trpkovic A, 2015, CRIT REV CL LAB SCI, V52, P70, DOI 10.3109/10408363.2014.992063; Vendramini-Costa DB, 2012, CURR PHARM DESIGN, V18, P3831; Vona-Davis L, 2013, J MAMMARY GLAND BIOL, V18, P291, DOI 10.1007/s10911-013-9299-z; WCRF, 2015, WORLD CANC RES FUND; Weber C, 1999, CLIN CHEM LAB MED, V37, P243, DOI 10.1515/CCLM.1999.043; Yudkin JS, 2000, ATHEROSCLEROSIS, V148, P209, DOI 10.1016/S0021-9150(99)00463-3; Zabirnyk O, 2010, CARCINOGENESIS, V31, P446, DOI 10.1093/carcin/bgp299; Zeyda M, 2009, GERONTOLOGY, V55, P379, DOI 10.1159/000212758; Zhao RJ, 2013, INT IMMUNOPHARMACOL, V17, P658, DOI 10.1016/j.intimp.2013.08.012	70	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158959	10.1371/journal.pone.0158959	http://dx.doi.org/10.1371/journal.pone.0158959			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391324	gold, Green Published, Green Submitted			2022-12-27	WOS:000380005400173
J	Hadler, C; Aliuos, P; Brandes, G; Warnecke, A; Bohlmann, J; Dempwolf, W; Menzel, H; Lenarz, T; Reuter, G; Wissel, K				Hadler, C.; Aliuos, P.; Brandes, G.; Warnecke, A.; Bohlmann, J.; Dempwolf, W.; Menzel, H.; Lenarz, T.; Reuter, G.; Wissel, K.			Polymer Coatings of Cochlear Implant Electrode Surface - An Option for Improving Electrode-Nerve-Interface by Blocking Fibroblast Overgrowth	PLOS ONE			English	Article							SPIRAL GANGLION NEURONS; SATELLITE GLIAL-CELLS; EXTRACELLULAR-MATRIX; ADHESION; HYDROGELS; FILMS; BONE; DEXAMETHASONE; TOPOGRAPHY; ATTACHMENT	Overgrowth of connective tissue and scar formation induced by the electrode array insertion increase the impedance and, thus, diminish the interactions between neural probes as like cochlear implants (CI) and the target tissue. Therefore, it is of great clinical interest to modify the carrier material of the electrodes to improve the electrode nerve interface for selective cell adhesion. On one side connective tissue growth needs to be reduced to avoid electrode array encapsulation, on the other side the carrier material should not compromise the interaction with neuronal cells. The present in vitro-study qualitatively and quantitatively characterises the interaction of fibroblasts, glial cells and spiral ganglion neurons (SGN) with ultrathin poly(N,N-dimethylacrylamide) (PDMAA), poly(2-ethyloxazoline) (PEtOx) and poly ([2-methacryloyloxy)ethyl]trimethylammoniumchlorid) (PMTA) films immobilised onto glass surfaces using a photoreactive anchor layer. The layer thickness and hydrophilicity of the polymer films were characterised by ellipsometric and water contact angle measurement. Moreover the topography of the surfaces was investigated using atomic force microscopy (AFM). The neuronal and non-neuronal cells were dissociated from spiral ganglions of postnatal rats and cultivated for 48 h on top of the polymer coatings. Immunocytochemical staining of neuronal and intermediary filaments revealed that glial cells predominantly attached on PMTA films, but not on PDMAA and PEtOx monolayers. Hereby, strong survival rates and neurite outgrowth were only found on PMTA, whereas PDMAA and PEtOx coatings significantly reduced the SG neuron survival and neuritogenesis. As also shown by scanning electron microscopy (SEM) SGN strongly survived and retained their differentiated phenotype only on PMTA. In conclusion, survival and neuritogenesis of SGN may be associated with the extent of the glial cell growth. Since PMTA was the only of the polar polymers used in this study bearing a cationic charge, it can be assumed that this charge favours adhesion of both glial cells and SG neurons glial cells and SGN.	[Aliuos, P.; Warnecke, A.; Bohlmann, J.; Lenarz, T.; Reuter, G.; Wissel, K.] Hannover Med Sch, Dept Otorhinolaryngol, Hannover, Germany; [Hadler, C.; Dempwolf, W.; Menzel, H.] Univ Technol Braunschweig, Inst Tech Chem, Braunschweig, Germany; [Aliuos, P.; Warnecke, A.; Lenarz, T.] Cluster Excellence Hearing 4 All, Hannover, Germany; [Brandes, G.] Hannover Med Sch, Inst Cell Biol, Ctr Anat, Hannover, Germany	Hannover Medical School; Braunschweig University of Technology; Hannover Medical School	Wissel, K (corresponding author), Hannover Med Sch, Dept Otorhinolaryngol, Hannover, Germany.	Wissel.Kirsten@mh-hannover.de	Warnecke, Athanasia/HHC-6174-2022; Menzel, Henning/AAZ-6446-2020		Deutsche Forschungsgemeinschaft [Sonderforschungsbereich (SFB) 599, SFB 599]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding by "Deutsche Forschungsgemeinschaft" as "Sonderforschungsbereich (SFB) 599", subproject D2, Speaker: TL, Reciever of funding: TL and HM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank S. Zwittian and G. Preiss, Institute of Cell Biology, Hannover Medical School for their helpful support. This study was funded by the Deutsche Forschungsgemeinschaft (SFB 599, subproject D2).	Adden N, 2007, J BIOMAT SCI-POLYM E, V18, P303, DOI 10.1163/156856207779996896; Aliuos P, 2014, J BIOMED MATER RES A, V102, P117, DOI 10.1002/jbm.a.34686; Aliuos P, 2013, J BIOMED MATER RES A, V101, P981, DOI 10.1002/jbm.a.34401; Bacakova L, 2011, BIOTECHNOL ADV, V29, P739, DOI 10.1016/j.biotechadv.2011.06.004; Bauer M, 2012, MACROMOL BIOSCI, V12, P986, DOI 10.1002/mabi.201200017; Berkingali N, 2008, HEARING RES, V243, P121, DOI 10.1016/j.heares.2008.07.003; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179; Bohl A, 2012, J MATER SCI-MATER M, V23, P2151, DOI 10.1007/s10856-012-4698-z; Brammer KS, 2012, TRENDS BIOTECHNOL, V30, P315, DOI 10.1016/j.tibtech.2012.02.005; Brigande JV, 2009, NAT NEUROSCI, V12, P679, DOI 10.1038/nn.2311; Burridge K, 2001, CURR OPIN CELL BIOL, V13, P525, DOI 10.1016/S0955-0674(00)00246-5; Busscher HJ, 2010, J DENT RES, V89, P657, DOI 10.1177/0022034510368644; Cai L, 2012, BIOMACROMOLECULES, V13, P342, DOI 10.1021/bm201763n; Chang BJ, 2002, COLLOID SURFACE A, V198, P519, DOI 10.1016/S0927-7757(01)00952-9; Chen YM, 2014, J BIOMED MATER RES A, V102, P2258, DOI 10.1002/jbm.a.34904; Clark G M, 1995, Ann Otol Rhinol Laryngol Suppl, V166, P40; Clark GM, 2014, COCHLEAR IMPLANTS IN, V15, P1; COLEMAN DL, 1974, J BIOMED MATER RES, V8, P199, DOI 10.1002/jbm.820080503; Dadsetan M, 2009, BIOMATERIALS, V30, P3874, DOI 10.1016/j.biomaterials.2009.04.018; Dahm M, 2001, ANN THORAC SURG, V71, pS437, DOI 10.1016/S0003-4975(01)02513-9; Dalby Matthew J, 2007, Curr Stem Cell Res Ther, V2, P129, DOI 10.2174/157488807780599220; Dalby MJ, 2004, BIOMATERIALS, V25, P77, DOI 10.1016/S0142-9612(03)00475-7; DUCKERT LG, 1983, LARYNGOSCOPE, V93, P841; Eshraghi AA, 2006, ANAT REC PART A, V288A, P473, DOI 10.1002/ar.a.20305; FAYAD J, 1991, ANN OTO RHINOL LARYN, V100, P807, DOI 10.1177/000348949110001004; Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Furze A, 2008, ACTA OTO-LARYNGOL, V128, P122, DOI 10.1080/00016480701390128; Gebert A, 1998, J MICROSC-OXFORD, V191, P297, DOI 10.1046/j.1365-2818.1998.00380.x; Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002; Hanani M, 2005, BRAIN RES REV, V48, P457, DOI 10.1016/j.brainresrev.2004.09.001; Harvey AG, 2013, EXPERT REV MED DEVIC, V10, P257, DOI [10.1586/erd.12.82, 10.1586/ERD.12.82]; Hickok NJ, 2012, ADV DRUG DELIVER REV, V64, P1165, DOI 10.1016/j.addr.2012.03.015; Hirose M, 2000, BIOMACROMOLECULES, V1, P377, DOI 10.1021/bm0002961; Hu YF, 2014, INT J PHARMACEUT, V476, P31, DOI 10.1016/j.ijpharm.2014.09.029; Huang Christie Qi, 2007, Cochlear Implants Int, V8, P123, DOI 10.1002/cii.336; Hutten M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104564; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Kawano A, 1998, ACTA OTO-LARYNGOL, V118, P313; Kim S, 2009, ACTA BIOMATER, V5, P144, DOI 10.1016/j.actbio.2008.07.033; Kronek J, 2011, J MATER SCI-MATER M, V22, P1725, DOI 10.1007/s10856-011-4346-z; LEE JH, 1993, J BIOMAT SCI-POLYM E, V4, P467; Lefebvre PP, 2002, AUDIOL NEURO-OTOL, V7, P165, DOI 10.1159/000058304; Lenarz Thomas, 2006, Audiol Neurootol, V11 Suppl 1, P34, DOI 10.1159/000095612; Liu W, 2014, CELL TISSUE RES, V355, P267, DOI 10.1007/s00441-013-1735-2; Liu YL, 2010, J R SOC INTERFACE, V7, pS631, DOI 10.1098/rsif.2010.0115.focus; Loizou PC, 2003, J ACOUST SOC AM, V114, P475, DOI 10.1121/1.1582861; Loschonsky S, 2008, BIOMACROMOLECULES, V9, P543, DOI 10.1021/bm7010714; Nadol JB, 2004, OTOL NEUROTOL, V25, P257, DOI 10.1097/00129492-200405000-00010; Paasche G, 2006, OTOL NEUROTOL, V27, P639, DOI 10.1097/01.mao.0000227662.88840.61; Pandiyarajan CK, 2013, MACROMOL BIOSCI, V13, P873, DOI 10.1002/mabi.201200445; Prucker O, 1999, J AM CHEM SOC, V121, P8766, DOI 10.1021/ja990962+; Reich U, 2008, J BIOMED MATER RES B, V87B, P146, DOI 10.1002/jbm.b.31084; Rozario T, 2010, DEV BIOL, V341, P126, DOI 10.1016/j.ydbio.2009.10.026; Ruhe J, 1999, J BIOMAT SCI-POLYM E, V10, P859, DOI 10.1163/156856299X00928; Samuel JDJS, 2004, LANGMUIR, V20, P10080, DOI 10.1021/la049428s; Schlie S, 2010, J BIOMATER APPL, V25, P217, DOI 10.1177/0885328209345553; Schmidt W, 2013, CURR PHARM BIOTECHNO, V14, P98; Somdas MA, 2007, AUDIOL NEURO-OTOL, V12, P277, DOI 10.1159/000103208; Sosnik A, 2005, J BIOMED MATER RES A, V75A, P295, DOI 10.1002/jbm.a.30419; TAMADA Y, 1994, J BIOMED MATER RES, V28, P783, DOI 10.1002/jbm.820280705; Tan F, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/5/055009; Tauhardt L, 2013, CHEM SOC REV, V42, P7998, DOI 10.1039/c3cs60161g; Tong J, 2011, BIOMATERIALS, V32, P3654, DOI 10.1016/j.biomaterials.2011.01.068; Treharne AJ, 2012, J BIOMED MATER RES A, V100A, P2358, DOI 10.1002/jbm.a.34178; Tykocinski M, 2001, OTOL NEUROTOL, V22, P33, DOI 10.1097/00129492-200101000-00007; Wang H, 2011, ACS APPL MATER INTER, V3, P3463, DOI 10.1021/am200690s; Wang X, 2011, ACTA BIOMATER, V7, P4149, DOI 10.1016/j.actbio.2011.07.011; Wardrop P, 2005, HEARING RES, V203, P54, DOI 10.1016/j.heares.2004.11.006; Wefstaedt P, 2005, NEUROREPORT, V16, P2011, DOI 10.1097/00001756-200512190-00008; Whitilon DS, 2009, NEUROSCIENCE, V161, P227, DOI 10.1016/j.neuroscience.2009.03.044; Wilkinson CDW, 2002, MAT SCI ENG C-BIO S, V19, P263, DOI 10.1016/S0928-4931(01)00396-4; Wise SG, 2009, INT J BIOCHEM CELL B, V41, P494, DOI 10.1016/j.biocel.2008.03.017; Wrzeszcz A, 2014, J BIOMED MATER RES A, V102, P442, DOI 10.1002/jbm.a.34719; Xu J, 1997, HEARING RES, V105, P1, DOI 10.1016/S0378-5955(96)00193-1; Zasonska BA, 2013, J BIOMED NANOTECHNOL, V9, P479, DOI 10.1166/jbn.2013.1552; Zhang QY, 2014, ACTA BIOMATER, V10, P1167, DOI 10.1016/j.actbio.2013.12.017	79	11	16	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0157710	10.1371/journal.pone.0157710	http://dx.doi.org/10.1371/journal.pone.0157710			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391483	Green Published, gold, Green Submitted			2022-12-27	WOS:000380005400019
J	Kunii, Y; Suzuki, Y; Shiga, T; Yabe, H; Yasumura, S; Maeda, M; Niwa, S; Otsuru, A; Mashiko, H; Abe, M				Kunii, Yasuto; Suzuki, Yuriko; Shiga, Tetsuya; Yabe, Hirooki; Yasumura, Seiji; Maeda, Masaharu; Niwa, Shin-ichi; Otsuru, Akira; Mashiko, Hirobumi; Abe, Masafumi		Mental Hlth Grp Fukushima Hlth Man	Severe Psychological Distress of Evacuees in Evacuation Zone Caused by the Fukushima Daiichi Nuclear Power Plant Accident: The Fukushima Health Management Survey	PLOS ONE			English	Article							MENTAL-HEALTH; RADIOACTIVE CONTAMINATION; CHERNOBYL DISASTER; HURRICANE-KATRINA; JAPAN; CONSEQUENCES; PERFORMANCE; EARTHQUAKES; DISORDERS; SURVIVORS	Background Following the Great East Japan Earthquake on March 11, 2011, the nuclear disaster at the Fukushima Daiichi Nuclear Power Plant has continued to affect the mental health status of residents in the evacuation zone. To examine the mental health status of evacuee after the nuclear accident, we conducted the Mental Health and Lifestyle Survey as part of the ongoing Fukushima Health Management Survey. Methods We measured mental health status using the Kessler 6-item psychological distress scale (K6) in a total of 73,569 (response rate: 40.7%) evacuees aged 15 and over who lived in the evacuation zone in Fukushima Prefecture. We then dichotomized responders using a 12/13 cutoff on the K6, and compared the proportion of K6 scores >= 13 and <= 12 in each risk factor including demographic information, socioeconomic variables, and disaster-related variables. We also performed bivariate analyses between mental health status and possible risk factors using the chi-square test. Furthermore, we performed multivariate regression analysis using modified Poisson regression models. Results The median K6 score was 5 (interquartile range: 1-10). The number of psychological distress was 8,717 (14.6%). We found that significant differences in the prevalence of psychological distress by almost all survey items, including disaster-related risk factors, most of which were also associated with increased Prevalence ratios (PRs). Additionally, we found that psychological distress in each evacuation zone was significantly positively associated with the radiation levels in their environment (r = 0.768, p = 0.002). Conclusion The earthquake, tsunami and subsequent nuclear accident likely caused severe psychological distress among residents in the evacuation zone in Fukushima Prefecture. The close association between psychological distress and the radiation levels shows that the nuclear accident seriously influenced the mental health of the residents, which might be exacerbated by increased risk perception. To provide prompt and appropriate support, continued psychosocial intervention for evacuees is strongly recommended.	[Kunii, Yasuto; Shiga, Tetsuya; Yabe, Hirooki; Mashiko, Hirobumi] Fukushima Med Univ, Sch Med, Dept Neuropsychiat, Fukushima, Japan; [Suzuki, Yuriko] Natl Inst Mental Hlth, Dept Adult Mental Hlth, Natl Ctr Neurol & Psychiat, Tokyo, Japan; [Yabe, Hirooki; Yasumura, Seiji; Maeda, Masaharu; Abe, Masafumi] Fukushima Med Univ, Radiat Med Sci Ctr Fukushima Hlth Management Surv, Fukushima, Japan; [Yasumura, Seiji] Fukushima Med Univ, Sch Med, Dept Publ Hlth, Fukushima, Japan; [Maeda, Masaharu] Fukushima Med Univ, Sch Med, Dept Disaster Psychiat, Fukushima, Japan; [Niwa, Shin-ichi] Fukushima Med Univ, Dept Psychiat, Aizu Med Ctr, Fukushima, Japan; [Otsuru, Akira] Fukushima Med Univ, Sch Med, Dept Radiat Hlth Management, Fukushima, Japan	Fukushima Medical University; National Center for Neurology & Psychiatry - Japan; Fukushima Medical University; Fukushima Medical University; Fukushima Medical University; Fukushima Medical University; Fukushima Medical University	Kunii, Y (corresponding author), Fukushima Med Univ, Sch Med, Dept Neuropsychiat, Fukushima, Japan.	kunii@fmu.ac.jp		Kunii, Yasuto/0000-0003-1569-7819	national "Health Fund for Children and Adults Affected by the Nuclear Incident"	national "Health Fund for Children and Adults Affected by the Nuclear Incident"	This study was supported by the national "Health Fund for Children and Adults Affected by the Nuclear Incident."	[Anonymous], 2006, HLTH EFF CHERN ACC S, P182; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Bromet EJ, 2011, CLIN ONCOL-UK, V23, P297, DOI 10.1016/j.clon.2011.01.501; Bromet EJ, 2007, HEALTH PHYS, V93, P516, DOI 10.1097/01.HP.0000279635.14108.02; Bromet EJ, 2014, HEALTH PHYS, V106, P206, DOI 10.1097/HP.0000000000000012; Bromet EJ, 2012, J RADIOL PROT, V32, pN71, DOI 10.1088/0952-4746/32/1/N71; DEW MA, 1987, AM J COMMUN PSYCHOL, V15, P167, DOI 10.1007/BF00919277; Furukawa TA, 2003, PSYCHOL MED, V33, P357, DOI 10.1017/S0033291702006700; Furukawa TA, 2008, INT J METH PSYCH RES, V17, P152, DOI 10.1002/mpr.257; Japan NPAo, 2015, DAM SIT POL COUNT AS; Kanda R, 2012, HEALTH PHYS, V102, P384, DOI 10.1097/HP.0b013e31823abef2; Kawakmi N, 2007, RES APPL USE STAT IN; Kessler RC, 2008, MOL PSYCHIATR, V13, P374, DOI 10.1038/sj.mp.4002119; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; Kilic C, 2006, ACTA PSYCHIAT SCAND, V114, P194, DOI 10.1111/j.1600-0447.2006.00786.x; Kunii Y, 2012, PSYCHIAT CLIN NEUROS, V66, P622, DOI 10.1111/j.1440-1819.2012.02409.x; Matsumoto J, 2014, PSYCHIAT CLIN NEUROS, V68, P182, DOI 10.1111/pcn.12112; Niitsu Tomihisa, 2014, BMC Res Notes, V7, P307, DOI 10.1186/1756-0500-7-307; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Revitalization & Comprehensive Planning Division PCD,, 2015, FUK PREF GOV STEPS R; Sakurai K, 2011, PSYCHIAT CLIN NEUROS, V65, P434, DOI 10.1111/j.1440-1819.2011.02236.x; Sastry N, 2013, SOC SCI MED, V80, P121, DOI 10.1016/j.socscimed.2012.12.009; Shigemura J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087516; Shigemura J, 2012, JAMA-J AM MED ASSOC, V308, P667, DOI 10.1001/jama.2012.9699; Survey USG, 2011, MAGN 9 0 NEAR E COAS; Suzuki Y, 2015, B WORLD HEALTH ORGAN, V93, P598, DOI 10.2471/BLT.14.146498; van Deventer E, 2012, J RADIOL PROT, V32, pN119, DOI 10.1088/0952-4746/32/1/N119; Viswanath B, 2013, INT J SOC PSYCHIATR, V59, P130, DOI 10.1177/0020764011423469; von Hippel FN, 2011, B ATOM SCI, V67, P27, DOI 10.1177/0096340211421588; Wada Akira, 2013, Fukushima J Med Sci, V59, P39; Xu JP, 2012, PSYCHIAT CLIN NEUROS, V66, P210, DOI 10.1111/j.1440-1819.2012.02331.x; Yabe H, 2014, FUKUSHIMA J MED SCI; Yasumura S, 2012, J EPIDEMIOL, V22, P375, DOI 10.2188/jea.JE20120105; Yokoyama Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102497	34	56	56	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158821	10.1371/journal.pone.0158821	http://dx.doi.org/10.1371/journal.pone.0158821			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27391446	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400135
J	Liu, LY; Mao, Z; Zhang, JH; Liu, N; Liu, QH				Liu, Linying; Mao, Zheng; Zhang, Jianhua; Liu, Na; Liu, Qing Huo			The Influence of Vesicle Shape and Medium Conductivity on Possible Electrofusion under a Pulsed Electric Field	PLOS ONE			English	Article							HIGH TEMPORAL RESOLUTION; CELL ELECTROFUSION; SPHEROIDAL CELLS; MEMBRANE-FUSION; GIANT VESICLES; MODEL; ELECTROPORATION; DEFORMATION; ORIENTATION; VACCINES	The effects of electric field on lipid membrane and cells have been extensively studied in the last decades. The phenomena of electroporation and electrofusion are of particular interest due to their wide use in cell biology and biotechnology. However, numerical studies on the electrofusion of cells (or vesicles) with different deformed shapes are still rare. Vesicle, being of cell size, can be treated as a simple model of cell to investigate the behaviors of cell in electric field. Based on the finite element method, we investigate the effect of vesicle shape on electrofusion of contact vesicles in various medium conditions. The transmembrane voltage (TMV) and pore density induced by a pulsed field are examined to analyze the possibility of vesicle fusion. In two different medium conditions, the prolate shape is observed to have selective electroporation at the contact area of vesicles when the exterior conductivity is smaller than the interior one; selective electroporation is more inclined to be found at the poles of the oblate vesicles when the exterior conductivity is larger than the interior one. Furthermore, we find that when the exterior conductivity is lower than the internal conductivity, the pulse can induce a selective electroporation at the contact area between two vesicles regardless of the vesicle shape. Both of these two findings have important practical applications in guiding electrofusion experiments.	[Liu, Linying; Mao, Zheng; Zhang, Jianhua; Liu, Na; Liu, Qing Huo] Xiamen Univ, Inst Electromagnet & Acoust, Xiamen 361005, Peoples R China; [Liu, Linying; Mao, Zheng; Zhang, Jianhua; Liu, Na; Liu, Qing Huo] Xiamen Univ, Dept Elect Sci, Xiamen 361005, Peoples R China; [Liu, Qing Huo] Duke Univ, Dept Elect & Comp Engn, Durham, NC 27708 USA	Xiamen University; Xiamen University; Duke University	Zhang, JH; Liu, QH (corresponding author), Xiamen Univ, Inst Electromagnet & Acoust, Xiamen 361005, Peoples R China.; Zhang, JH; Liu, QH (corresponding author), Xiamen Univ, Dept Elect Sci, Xiamen 361005, Peoples R China.; Liu, QH (corresponding author), Duke Univ, Dept Elect & Comp Engn, Durham, NC 27708 USA.	jhzh@xmu.edu.cn; qhliu@duke.edu	Liu, Qing/GWC-9222-2022; Liu, Qing Huo/AFO-6814-2022; Liu, Qing Huo/AFR-9899-2022	Liu, Qing Huo/0000-0001-5286-4423; Liu, Qing Huo/0000-0001-5286-4423	China Postdoctoral Science Foundation [2012M511447]; National Natural Science Foundation of China [11204257]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by China Postdoctoral Science Foundation (No. 2012M511447) and National Natural Science Foundation of China (No. 11204257). The funder (JZ) designed the experiments and analyzed the data and modified the paper.	ASENCOR FJ, 1993, BIOPHYS J, V64, P1626, DOI 10.1016/S0006-3495(93)81509-1; Batzing BL, 2002, MICROBIOLOGY AN INTR; Chang D.C., 1992, GUIDE ELECTROPORATIO; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; DeBruin KA, 1999, BIOPHYS J, V77, P1213, DOI 10.1016/S0006-3495(99)76973-0; Dimitrov V, 2013, PHYS CHEM CHEM PHYS, V15, P6303, DOI 10.1039/c3cp42873g; Dimova R, 2007, SOFT MATTER, V3, P817, DOI 10.1039/b703580b; Dimova R, 2009, SOFT MATTER, V5, P3201, DOI 10.1039/b901963d; Gantz DL, 1999, BIOPHYS J, V76, P1436, DOI 10.1016/S0006-3495(99)77304-2; Gimsa J, 2001, BIOPHYS J, V81, P1888, DOI 10.1016/S0006-3495(01)75840-7; Haluska CK, 2006, P NATL ACAD SCI USA, V103, P15841, DOI 10.1073/pnas.0602766103; HELFRICH W, 1974, Z NATURFORSCH C, VC 29, P510; Hu Q, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.011901; Hu Q, 2009, IEEE T BIO-MED ENG, V56, P1617, DOI 10.1109/TBME.2009.2015459; Kanduser M, 2014, EXPERT OPIN DRUG DEL, V11, P1885, DOI 10.1517/17425247.2014.938632; Kotnik T, 2000, BIOPHYS J, V79, P670, DOI 10.1016/S0006-3495(00)76325-9; Kotnik T, 2013, PHYS LIFE REV, V10, P351, DOI 10.1016/j.plrev.2013.05.001; Li JB, 2010, BIOMICROFLUIDICS, V4, DOI 10.1063/1.3324847; Maswiwat K, 2007, J PHYS D APPL PHYS, V40, P914, DOI 10.1088/0022-3727/40/3/033; MM S, 2011, PHYSICAL REVIEW E ST, V83, P557; NEEDHAM D, 1989, BIOPHYS J, V55, P1001, DOI 10.1016/S0006-3495(89)82898-X; Nesin OM, 2011, BBA-BIOMEMBRANES, V1808, P792, DOI 10.1016/j.bbamem.2010.12.012; Nganguia H, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.052718; Pucihar G, 2006, ANN BIOMED ENG, V34, P642, DOI 10.1007/s10439-005-9076-2; Pucihar G, 2012, IFMBE PROC, V37, P1326; Pucihar G, 2009, IEEE T BIO-MED ENG, V56, P1491, DOI 10.1109/TBME.2009.2014244; Radu M, 2005, BIOPHYS J, V89, P3548, DOI 10.1529/biophysj.104.057463; Rems L., 2014, 13 MED C MED BIOL EN, V41, P896; Rems L, 2013, SCI REP-UK, V3, DOI 10.1038/srep03382; Riske KA, 2005, BIOPHYS J, V88, P1143, DOI 10.1529/biophysj.104.050310; Riske Karin. A., 2006, Biophysical Reviews and Letters, V1, P387, DOI 10.1142/S179304800600032X; Salipante PF, 2014, SOFT MATTER, V10, P3386, DOI 10.1039/c3sm52870g; Smith KC, 2008, BIOPHYS J, V95, P1547, DOI 10.1529/biophysj.107.121921; Strioga MM, 2013, CRIT REV IMMUNOL, V33, P489; SUGAR IP, 1987, BIOPHYS CHEM, V26, P321, DOI 10.1016/0301-4622(87)80033-9; Techaumnat B, 2013, IEEE T DIELECT EL IN, V20, P1567, DOI 10.1109/TDEI.2013.6633685; TEISSIE J, 1986, BIOCHEM BIOPH RES CO, V140, P258, DOI 10.1016/0006-291X(86)91084-3; Trontelj K, 2008, BIOELECTROCHEMISTRY, V74, P124, DOI 10.1016/j.bioelechem.2008.06.003; Vacchelli E, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.25595; Vlahovska PM, 2009, BIOPHYS J, V96, P4789, DOI 10.1016/j.bpj.2009.03.054; vor dem Esche U, 2011, IMMUNOBIOLOGY, V216, P847, DOI 10.1016/j.imbio.2010.12.001; Xiao M, 1996, BIOELECTROCH BIOENER, V41, P161, DOI 10.1016/S0302-4598(96)05100-8; Zimmermann U, 1986, REV PHYSL BIOCH PHAR, V105, P175; Zimmermann U., 1996, ELECTROMANIPULATION	44	15	18	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158739	10.1371/journal.pone.0158739	http://dx.doi.org/10.1371/journal.pone.0158739			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391692	gold, Green Published, Green Submitted			2022-12-27	WOS:000380005400111
J	Poorolajal, J; Darvishi, N				Poorolajal, Jalal; Darvishi, Nahid			Smoking and Suicide: A Meta-Analysis	PLOS ONE			English	Article							NATIONALLY REPRESENTATIVE SAMPLE; HIGH-SCHOOL-STUDENTS; CIGARETTE-SMOKING; RISK-FACTORS; COMPLETED SUICIDE; FOLLOW-UP; PROTECTIVE FACTORS; UNITED-STATES; SUBSTANCE USE; IDEATION	Background Many studies have reported a positive association between smoking and suicide, but the results are inconsistent. This meta-analysis was carried out to estimate the association between smoking and suicidal ideation, suicide plan, suicide attempt, and suicide death. Methods Major electronic databases including PubMed, Web of Science, Scopus, and ScienceDirect were searched until May 2015. The reference lists of included studies were screened too. Epidemiological studies addressing the association between smoking and suicidal behaviors were enrolled. The heterogeneity across studies was explored by Q-test and I-2 statistic. The possibility of publication bias was assessed using Begg's and Egger's tests and Trim & Fill analysis. The results were reported based on risk ratio (RR) and odds ratio (OR) with 95% confidence intervals (CI) using a random-effects model. Results We identified a total of 8062 references and included 63 studies with 8,063,634 participants. Compared to nonsmokers, the current smokers were at higher risk of suicidal ideation (OR = 2.05; 95% CI: 1.53, 2.58; 8 studies; I-2 = 80.8%; P<0.001), suicide plan (OR = 2.36; 95% CI: 1.69, 3.02; 6 studies; I-2 = 85.2%; P<0.001), suicide attempt (OR = 2.84; 95% CI: 1.49, 4.19; 5 studies; I-2 = 89.6%; (P<0.001), and suicide death (RR = 1.83; 95% CI: 1.64, 2.02; 14 studies; I-2 = 49.7%; P = 0.018). Conclusions There is sufficient evidence that smoking is associated with an increased risk of suicidal behaviors. Therefore, smoking is a contributing factor for suicide. Although this association does not imply causation, however, smoking prevention and cessation should be the target of suicide prevention programs.	[Poorolajal, Jalal] Hamadan Univ Med Sci, Sch Publ Hlth, Modeling Noncommunicable Dis Res Ctr, Hamadan, Iran; [Poorolajal, Jalal] Hamadan Univ Med Sci, Sch Publ Hlth, Dept Epidemiol, Hamadan, Iran; [Darvishi, Nahid] Hamadan Univ Med Sci, Psychol Counseling Ctr, Hamadan, Iran		Darvishi, N (corresponding author), Hamadan Univ Med Sci, Psychol Counseling Ctr, Hamadan, Iran.	nahiddarvishi2008@yahoo.com	Poorolajal, Jalal/D-3506-2013		Hamadan University of Medical Sciences	Hamadan University of Medical Sciences	The authors would like to thank the Vice-chancellor of Research and Technology, Hamadan University of Medical Sciences, for financial support of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Vice-chancellor of Research and Technology, Hamadan University of Medical Sciences, for financial support of this study.	Afifi TO, 2007, CAN J PSYCHIAT, V52, P666, DOI 10.1177/070674370705201007; Almeida OP, 2012, BRIT J PSYCHIAT, V201, P466, DOI 10.1192/bjp.bp.112.110130; Amiri B, 2012, J RES HEALTH SCI, V12, P88; Angst J, 1998, J AFFECT DISORDERS, V51, P55, DOI 10.1016/S0165-0327(98)00156-6; [Anonymous], 2007, J PSYCHOL AFRICA, DOI DOI 10.1080/14330237.2007.10820150; [Anonymous], UND SUIC FACT SHEET; [Anonymous], DEF SELF DIR VIOL; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BENWELL MEM, 1990, PSYCHOPHARMACOLOGY, V102, P68, DOI 10.1007/BF02245746; Beratis S, 1997, COMPR PSYCHIAT, V38, P74, DOI 10.1016/S0010-440X(97)90084-5; Berlin I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122607; Boden JM, 2008, PSYCHOL MED, V38, P433, DOI 10.1017/S0033291707001547; Bohnert KM, 2014, ADDICTION, V109, P155, DOI 10.1111/add.12381; Bolton JM, 2010, AM J PUBLIC HEALTH, V100, P2473, DOI 10.2105/AJPH.2010.192252; Botega NJ, 2010, GEN HOSP PSYCHIAT, V32, P396, DOI 10.1016/j.genhosppsych.2010.02.004; Bronisch T, 2008, J AFFECT DISORDERS, V108, P135, DOI 10.1016/j.jad.2007.10.010; Castro-Diaz Sergio, 2013, Rev Colomb Psiquiatr, V43 Suppl 1, P27, DOI 10.1016/j.rcp.2013.11.003; Clarke DE, 2010, SUICIDE LIFE-THREAT, V40, P307, DOI 10.1521/suli.2010.40.4.307; Darvishi N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126870; Silva RLD, 2014, SCI WORLD J, DOI 10.1155/2014/357052; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dervic K, 2007, WIEN KLIN WOCHENSCHR, V119, P174, DOI 10.1007/s00508-006-0753-4; Deveci A, 2005, TURK PSIKIYATR DERG, V16, P170; Donald M, 2006, AUST NZ J PSYCHIAT, V40, P87, DOI 10.1111/j.1440-1614.2006.01747.x; Duval S, 2000, J AM STAT ASSOC, V95, P89, DOI 10.2307/2669529; Eaton DK, 2011, ARCH SUICIDE RES, V15, P113, DOI 10.1080/13811118.2011.565268; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Epstein JA, 2009, SUICIDE LIFE-THREAT, V39, P241, DOI 10.1521/suli.2009.39.3.241; GARRISON CZ, 1993, AM J PUBLIC HEALTH, V83, P179, DOI 10.2105/AJPH.83.2.179; Goodwin RD, 2013, J AFFECT DISORDERS, V145, P111, DOI 10.1016/j.jad.2012.05.003; Hallfors DD, 2004, AM J PREV MED, V27, P224, DOI 10.1016/j.amepre.2004.06.001; Han MA, 2009, PREV MED, V49, P248, DOI 10.1016/j.ypmed.2009.06.014; Hawton K, 2012, LANCET, V379, P2373, DOI 10.1016/S0140-6736(12)60322-5; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; HEMENWAY D, 1993, AM J PUBLIC HEALTH, V83, P249, DOI 10.2105/AJPH.83.2.249; Hemmingsson T, 2003, INT J EPIDEMIOL, V32, P1000, DOI 10.1093/ije/dyg203; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hintikka J, 2009, SOC PSYCH PSYCH EPID, V44, P29, DOI 10.1007/s00127-008-0401-6; Hockenberry JM, 2010, NICOTINE TOB RES, V12, P235, DOI 10.1093/ntr/ntp199; Husky MM, 2013, J AFFECT DISORDERS, V151, P1059, DOI 10.1016/j.jad.2013.08.035; Iwasaki M, 2005, ANN EPIDEMIOL, V15, P286, DOI 10.1016/j.annepidem.2004.08.011; Jee SH, 2011, EUR HEART J, V32, P2773, DOI 10.1093/eurheartj/ehr229; Jokinen J, 2007, PSYCHIAT RES, V150, P297, DOI 10.1016/j.psychres.2006.12.001; Juan W, 2010, J AFFECT DISORDERS, V126, P180, DOI 10.1016/j.jad.2010.02.121; Kessler RC, 2009, MOL PSYCHIATR, V14, P1132, DOI 10.1038/mp.2008.78; Kessler RC, 2007, J NERV MENT DIS, V195, P369, DOI 10.1097/NMD.0b013e3180303eb8; Kim CM, 2007, TISSUE ENG REGEN MED, V4, P60; Kokkevi A, 2012, EUR CHILD ADOLES PSY, V21, P443, DOI 10.1007/s00787-012-0276-7; Kumar MB, 2012, INT J CIRCUMPOL HEAL, V71, DOI 10.3402/ijch.v71i0.18829; Lee SJ, 2014, ASIAN PAC J CANCER P, V15, P2945, DOI 10.7314/APJCP.2014.15.7.2945; Legleye S, 2010, J AFFECT DISORDERS, V123, P108, DOI 10.1016/j.jad.2009.10.016; Leistikow B N, 2000, Inj Prev, V6, P277, DOI 10.1136/ip.6.4.277; Li DJ, 2012, J PSYCHIATR RES, V46, P1257, DOI 10.1016/j.jpsychires.2012.03.013; Lucas M, 2013, J AFFECT DISORDERS, V151, P1053, DOI 10.1016/j.jad.2013.08.033; Malone KM, 2003, AM J PSYCHIAT, V160, P773, DOI 10.1176/appi.ajp.160.4.773; Mann JJ, 2006, INT J NEUROPSYCHOPH, V9, P465, DOI 10.1017/S1461145705005687; McGee R, 2005, AM J PSYCHIAT, V162, P619, DOI 10.1176/appi.ajp.162.3.619; Miller M, 2000, AM J PUBLIC HEALTH, V90, P768, DOI 10.2105/AJPH.90.5.768; Miller M, 2011, DRUG ALCOHOL DEPEN, V113, P110, DOI 10.1016/j.drugalcdep.2010.07.016; Miller M, 2000, AM J EPIDEMIOL, V151, P1060, DOI 10.1093/oxfordjournals.aje.a010148; Miller M, 2012, ANNU REV PUBL HEALTH, V33, P393, DOI 10.1146/annurev-publhealth-031811-124636; Moher D, 2015, CULT MED PSYCHIAT, V4, DOI DOI 10.1023/B:MEDI.0000005484.26741.79; PAFFENBARGER RS, 1994, ACTA PSYCHIAT SCAND, V89, P16, DOI 10.1111/j.1600-0447.1994.tb05796.x; Park E, 2008, J KOREAN ACAD NURS, V38, P465, DOI 10.4040/jkan.2008.38.3.465; Park HS, 2006, J SCHOOL HEALTH, V76, P181, DOI 10.1111/j.1746-1561.2006.00092.x; Patsopoulos NA, 2008, INT J EPIDEMIOL, V37, P1148, DOI 10.1093/ije/dyn065; Perez-Amezcua B, 2010, SALUD PUBLICA MEXICO, V52, P324; Pfaff JJ, 2005, BRIT J GEN PRACT, V55, P269; Poorolajal J, 2016, J PUBLIC HEALTH-UK, V38, pE282, DOI 10.1093/pubmed/fdv148; Poorolajal J, 2015, ARCH IRAN MED, V18, P39, DOI 0151801/AIM.0010; Poorolajal Jalal, 2012, Epidemiol Health, V34, pe2012005, DOI 10.4178/epih/e2012005; Riala K, 2009, ANN EPIDEMIOL, V19, P329, DOI 10.1016/j.annepidem.2008.12.004; Rudatsikira E, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-176; Sankaranarayanan A, 2015, PLOS ONE, V10; Schneider B, 2005, EUR PSYCHIAT, V20, P129, DOI 10.1016/j.eurpsy.2004.04.016; SMITH GD, 1992, LANCET, V340, P709; Sonderman JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114852; Tanskanen A, 2000, ACTA PSYCHIAT SCAND, V101, P243, DOI 10.1046/j.0902-4441.2000.ap9s003.x; Tomori M, 2001, EUR CHILD ADOLES PSY, V10, P143, DOI 10.1007/s007870170038; Ursoniu S, 2009, WIEN KLIN WOCHENSCHR, V121, P564, DOI 10.1007/s00508-009-1218-3; Varnik P, 2012, INT J ENV RES PUB HE, V9, P760, DOI 10.3390/ijerph9030760; Valdivia M, 2015, REV MED CHILE, V143, P320, DOI 10.4067/S0034-98872015000300006; Wells G.A., 2000, VIS COMMUN Q; Wilson ML, 2012, INT J ENV RES PUB HE, V9, P4122, DOI 10.3390/ijerph9114122; Wong SS, 2013, SOC PSYCH PSYCH EPID, V48, P1611, DOI 10.1007/s00127-013-0721-z; Woods ER, 1997, PEDIATRICS, V99, P791, DOI 10.1542/peds.99.6.791; World Health Organization, 1998, GUID CONTR MON TOB E; World Health Organization, 2014, PREV SUIC PREV SUIC; Wu P, 2004, SUICIDE LIFE-THREAT, V34, P408, DOI 10.1521/suli.34.4.408.53733; Yi S, 2011, J KOREAN ACAD NURS, V41, P652, DOI 10.4040/jkan.2011.41.5.652; Zhang J, 2005, ANN EPIDEMIOL, V15, P167, DOI 10.1016/j.annepidem.2004.07.095	92	99	100	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0156348	10.1371/journal.pone.0156348	http://dx.doi.org/10.1371/journal.pone.0156348			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27391330	Green Submitted, Green Published, gold			2022-12-27	WOS:000380005400004
J	Rabinowitz, M; Latella, L; Stern, C; Jost, JT				Rabinowitz, Mitchell; Latella, Lauren; Stern, Chadly; Jost, John T.			Beliefs about Childhood Vaccination in the United States: Political Ideology, False Consensus, and the Illusion of Uniqueness	PLOS ONE			English	Article							IMMUNIZATION; DECISIONS; PARENTS; ORIENTATION; PREVALENCE; BEHAVIORS; ATTITUDES	Several contagious diseases were nearly eradicated through childhood vaccination, but some parents have decided in recent years not to fully vaccinate their children, raising new public health concerns. The question of whether and how beliefs about vaccination are linked to political ideology has been hotly debated. This study investigates the effects of ideology on perceptions of harms and benefits related to vaccination as well as judgments of others' attitudes. A total of 367 U.S. adults (131 men, 236 women; M-age = 34.92 years, range = 18-72) completed an online survey through Mechanical Turk. Results revealed that liberals were significantly more likely to endorse pro-vaccination statements and to regard them as "facts" (rather than "beliefs"), in comparison with moderates and conservatives. Whereas conservatives overestimated the proportion of like-minded others who agreed with them, liberals underestimated the proportion of others who agreed with them. That is, conservatives exhibited the "truly false consensus effect," whereas liberals exhibited an "illusion of uniqueness" with respect to beliefs about vaccination. Conservative and moderate parents in this sample were less likely than liberals to report having fully vaccinated their children prior to the age of two. A clear limitation of this study is that the sample is not representative of the U.S. population. Nevertheless, a recognition of ideological sources of potential variability in health-related beliefs and perceptions is a prerequisite for the design of effective forms of public communication.	[Rabinowitz, Mitchell; Latella, Lauren] Fordham Univ, Grad Sch Educ, New York, NY 10023 USA; [Stern, Chadly] Univ Illinois, Dept Psychol, Urbana, IL 61801 USA; [Jost, John T.] NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA	Fordham University; University of Illinois System; University of Illinois Urbana-Champaign; New York University	Rabinowitz, M (corresponding author), Fordham Univ, Grad Sch Educ, New York, NY 10023 USA.	mrabinowitz@fordham.edu		Jost, John/0000-0002-2844-4645; Rabinowitz, Mitchell/0000-0002-8774-5288				Aiken L. S., 1991, MULTIPLE REGRESSION; [Anonymous], 2007, INFLUENCE PSYCHOL PE; Bates AS, 1998, PEDIATRICS, V101, P591, DOI 10.1542/peds.101.4.591; Berezow, 2014, ARE LIBERALS CONSERV; Betsch C, 2012, VACCINE, V30, P3723, DOI 10.1016/j.vaccine.2012.03.078; Betsch C, 2010, J HEALTH PSYCHOL, V15, P446, DOI 10.1177/1359105309353647; Blank JM, 2015, ANN AM ACAD POLIT SS, V658, P18, DOI 10.1177/0002716214554756; Brunson EK, 2013, VACCINE, V31, P5466, DOI 10.1016/j.vaccine.2013.08.104; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Campbell Hank, 2012, SCI LEFT BEHIND FEEL; Clifford S., 2015, RES POLITICS, V2, DOI [10.1177/2053168015622072, DOI 10.1177/2053168015622072]; Cohen BH, 2013, J CHEM INF MODEL, V4th; Ecker UKH, 2014, PROCESSING INACCURATE INFORMATION: THEORETICAL AND APPLIED PERSPECTIVES FROM COGNITIVE SCIENCE AND THE EDUCATIONAL SCIENCES, P13; Festinger L., 1950, SOCIAL PRESSURE INFO; Fitzmaurice G, 2011, APPL LONGITUDINAL AN, V2nd; Fox M., 2015, NBC NEWS; FOX WS, 1974, PUBLIC OPIN QUART, V38, P352, DOI 10.1086/268171; Funk C, 2015, PEW RES CTR INTERNET; Gardner B, 2010, PSYCHOL HEALTH MED, V15, P220, DOI 10.1080/13548501003623963; Gelman A, 2010, RED STATE, BLUE STATE, RICH STATE, POOR STATE: WHY AMERICANS VOTE THE WAY THEY DO, EXPANDED EDITION, P1; Gerend MA, 2007, HEALTH PSYCHOL, V26, P745, DOI 10.1037/0278-6133.26.6.745; Gettier E., 1963, ANALYSIS, V23, P121, DOI [10.1093/analys/23.6.121, DOI 10.1093/ANALYS/23.6.121]; Goodwin GP, 2012, J EXP SOC PSYCHOL, V48, P250, DOI 10.1016/j.jesp.2011.08.006; Gore P, 1999, SOC SCI MED, V48, P1011, DOI 10.1016/S0277-9536(98)00410-9; Gvirsman SD., 2015, PUBLIC OPIN QUART, V79, P1; Hinman A, 1999, ANNU REV PUBL HEALTH, V20, P211, DOI 10.1146/annurev.publhealth.20.1.211; Iyengar S, 2009, J COMMUN, V59, P19, DOI 10.1111/j.1460-2466.2008.01402.x; Jost J.T., 2013, OXFORD HDB POLITICAL, P232, DOI DOI 10.1093/OXFORDHB/9780199585977.013.0024; Jost JT, 2008, SOC PERSONAL PSYCHOL, V2, P171, DOI 10.1111/j.1751-9004.2007.00056.x; Kahan D. M, 2014, CCP RISK PERCEPTION; Kennedy AM, 2005, PUBLIC HEALTH REP, V120, P252, DOI 10.1177/003335490512000306; Kenny D. A, 1994, INTERPERSONAL PERCEP; KENNY DA, 1984, ADV EXP SOC PSYCHOL, V18, P141, DOI 10.1016/S0065-2601(08)60144-6; Kraft PW, 2015, ANN AM ACAD POLIT SS, V658, P121, DOI 10.1177/0002716214554758; Krochik M., 2014, ADV MOTIVATION SCI, V1, P181, DOI [10.1016/bs.adms.2014.08.005, DOI 10.1016/BS.ADMS.2014.08.005]; KRUEGER J, 1993, J PERS SOC PSYCHOL, V65, P670, DOI 10.1037/0022-3514.65.4.670; Krueger J, 1994, J PERS SOC PSYCHOL, V68, P579; Kuhn T. S., 1996, STRUCTURE SCI REVOLU; Levendusky M, 2013, PARTISAN MEDIA POLAR; Lewandowsky S, 2012, PSYCHOL SCI PUBL INT, V13, P106, DOI 10.1177/1529100612451018; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Marsh EJ, 2003, J MEM LANG, V49, P519, DOI 10.1016/S0749-596X(03)00092-5; McCoy C, 2015, NEW REPUBLIC; McNemar Q., 1962, PSYCHOL STAT; Mooney C., 2012, REPUBLICAN BRAIN SCI; Mooney C., 2015, WASHINGTON POST; Moore P., 2015, POLL RESULTS VACCINA, V10, P2; PRENTICE DA, 1993, J PERS SOC PSYCHOL, V64, P243, DOI 10.1037/0022-3514.64.2.243; Prinstein MJ, 2005, J ABNORM CHILD PSYCH, V33, P293, DOI 10.1007/s10802-005-3566-4; Rabinowitz M, 2013, PSYCHOL LANGUAGE COM, V17, P241; Schwarz N, 2007, ADV EXP SOC PSYCHOL, V39, P127, DOI 10.1016/S0065-2601(06)39003-X; SHERMAN SJ, 1983, PERS SOC PSYCHOL B, V9, P197, DOI 10.1177/0146167283092003; Stern C, 2014, PERS SOC PSYCHOL B, V40, P1162, DOI 10.1177/0146167214537834; Stern C, 2014, PSYCHOL SCI, V25, P137, DOI 10.1177/0956797613500796; Straus I., 2015, NATL REV; Sturm LA, 2005, J DEV BEHAV PEDIATR, V26, P441, DOI 10.1097/00004703-200512000-00009; SULS J, 1988, J APPL SOC PSYCHOL, V18, P66, DOI 10.1111/j.1559-1816.1988.tb00006.x; Waters EA, 2009, HEALTH PSYCHOL, V28, P201, DOI 10.1037/a0013608; Xu XW, 2013, PERS SOC PSYCHOL B, V39, P1497, DOI 10.1177/0146167213499235; Ziemer KS, 2013, J HEALTH PSYCHOL, V18, P1360, DOI 10.1177/1359105312462432	60	45	45	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158382	10.1371/journal.pone.0158382	http://dx.doi.org/10.1371/journal.pone.0158382			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27391965	Green Submitted, gold, Green Published			2022-12-27	WOS:000380005400049
J	Verschuere, B; in 't Hout, W				Verschuere, Bruno; in 't Hout, Willem			Psychopathic Traits and Their Relationship with the Cognitive Costs and Compulsive Nature of Lying in Offenders	PLOS ONE			English	Article							CONCEALED INFORMATION; RESPONSE STYLES; DECEPTION; TRUTH; LIES; ANTISOCIALITY; VALIDITY	The cognitive view on deception holds that lying typically requires additional mental effort as compared to truth telling. Psychopathy, however, has been associated with swift and even compulsive lying, leading us to explore the ease and compulsive nature of lying in psychopathic offenders. We explored the costs of instructed lying versus truth telling through RTs and error rates in 52 violent male offenders, who were assessed with the Youth Psychopathic Traits Inventory (YPI). Our deception paradigm also included trials with the free choice to lie or tell the truth. By coupling monetary loss to slow and erroneous responding, we hypothesized that the frequency of lying despite likely negative consequences, would provide an index of compulsive lying. Offenders were slower and erred more often when lying than when telling the truth, and there was no robust association between psychopathy and the cognitive cost of lying. From an applied perspective, this suggests that psychopathy may not threaten the validity of computerized cognition-based lie detection. In the face of probable negative consequences, high grandiose-manipulative offenders chose to lie three times as often as low grandiose-manipulative offenders. Our new lying frequency index is a first attempt to create a much needed tool to empirically examine compulsive lying, and provides preliminary support for the compulsive nature of lying in grandiose-manipulative offenders. Alternative interpretation of the findings are discussed.	[Verschuere, Bruno] Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands; [in 't Hout, Willem] Forens Psychiat Ctr, Oostvaardersklin, Almere, Netherlands	University of Amsterdam	Verschuere, B (corresponding author), Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands.	b.j.verschuere@uva.nl		VERSCHUERE, BRUNO/0000-0002-6161-4415				Andershed H., 2002, PSYCHOPATHS CURRENT, P131, DOI DOI 10.1037/T07576-000; [Anonymous], 2013, INQUISIT 4 00 COMPUT; Arrington CM, 2004, PSYCHOL SCI, V15, P610, DOI 10.1111/j.0956-7976.2004.00728.x; Brazil IA, 2015, LANCET PSYCHIAT, V2, P115, DOI 10.1016/S2215-0366(14)00125-4; Bull R, 2015, WILEY SER PSYCH CR, P269; Caso L, 2005, J INVEST PSYCHOL OFF, V2, P195, DOI 10.1002/jip.32; Conradi HJ, 2016, J FORENSIC PSYCHI PS, V27, P92, DOI 10.1080/14789949.2015.1077264; Debey E, 2012, ACTA PSYCHOL, V140, P133, DOI 10.1016/j.actpsy.2012.03.004; Edens JF, 2006, J ABNORM PSYCHOL, V115, P131, DOI 10.1037/0021-843X.115.1.131; Fullam RS, 2009, BRIT J PSYCHIAT, V194, P229, DOI 10.1192/bjp.bp.108.053199; Gamer M., 2011, MEMORY DETECTION THE, P90, DOI [DOI 10.1017/CB09780511975196.006, 10.1007/ s10484- 014- 9244- y]; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Halevy R, 2014, HUM COMMUN RES, V40, P54, DOI 10.1111/hcre.12019; Hall JR, 2006, HDB PSYCHOPATHY, P459, DOI DOI 10.1016/J.JRP.2009.02.005; Hare R.D., 1991, MANUAL HARE PSYCHOPA; HARE RD, 1989, NATO ADV SCI I D-BEH, V47, P25; Hillege S, 2010, J ADOLESCENCE, V33, P83, DOI 10.1016/j.adolescence.2009.05.006; Hoffmann A, 2015, EXP PSYCHOL, V62, P403, DOI 10.1027/1618-3169/a000304; Jiang W, 2013, NEUROSCIENCE, V244, P90, DOI 10.1016/j.neuroscience.2013.03.055; Kaylor-Hughes CJ, 2011, CRIM BEHAV MENT HEAL, V21, P8, DOI 10.1002/cbm.785; Klaver JR, 2009, LEGAL CRIMINOL PSYCH, V14, P171, DOI 10.1348/135532508X289964; Lilienfeld SO, 2015, CURR DIR PSYCHOL SCI, V24, P298, DOI 10.1177/0963721415580297; Ray JV, 2013, PERSONAL DISORD, V4, P1, DOI 10.1037/a0026482; Robbins L., 1966, DEVIANT CHILDREN GRO, DOI [10.1093/sf/45.3.464, DOI 10.1093/SF/45.3.464]; Rogers R, 2002, J PERS ASSESS, V78, P31, DOI 10.1207/S15327752JPA7801_03; Sip KE, 2008, TRENDS COGN SCI, V12, P48, DOI 10.1016/j.tics.2007.11.008; Spence SA, 2001, NEUROREPORT, V12, P2849, DOI 10.1097/00001756-200109170-00019; Spence SA, 2008, NEUROCASE, V14, P68, DOI 10.1080/13554790801992776; Spidel A, 2011, LEGAL CRIMINOL PSYCH, V16, P335, DOI 10.1348/135532510X518722; Uzieblo K, 2010, ASSESSMENT, V17, P334, DOI 10.1177/1073191109356544; Van Bockstaele B, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00526; Van Bockstaele B, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01666; Verschuere B, 2005, PSYCHOPHYSIOLOGY, V42, P239, DOI 10.1111/j.1469-8986.2005.00279.x; Verschuere B, 2007, BIOL PSYCHOL, V74, P309, DOI 10.1016/j.biopsycho.2006.08.002; Verschuere B, 2011, CONSCIOUS COGN, V20, P908, DOI 10.1016/j.concog.2010.10.023; Vrij A, 1996, HUM COMMUN RES, V22, P544, DOI 10.1111/j.1468-2958.1996.tb00378.x; Vrij A, 2006, TRENDS COGN SCI, V10, P141, DOI 10.1016/j.tics.2006.02.003; Vrij A, 2012, J APPL RES MEM COGN, V1, P110, DOI 10.1016/j.jarmac.2012.02.004; Walczyk JJ, 2014, NEW IDEAS PSYCHOL, V34, P22, DOI 10.1016/j.newideapsych.2014.03.001	39	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158595	10.1371/journal.pone.0158595	http://dx.doi.org/10.1371/journal.pone.0158595			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27391854	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400086
J	Weber, SN; Bohner, A; Dapito, DH; Schwabe, RF; Lammert, F				Weber, Susanne Nicole; Bohner, Annika; Dapito, Dianne H.; Schwabe, Robert F.; Lammert, Frank			TLR4 Deficiency Protects against Hepatic Fibrosis and Diethylnitrosamine-Induced Pre-Carcinogenic Liver Injury in Fibrotic Liver	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; P-GLYCOPROTEIN GENE; HOMOZYGOUS DISRUPTION; LIPOPOLYSACCHARIDE; ACTIVATION; MICE; POLYMORPHISMS; CHOLANGITIS; MOLECULES; DISEASE	Background The development of hepatocellular carcinoma (HCC) is a common consequence of advanced liver fibrosis but the interactions between fibrogenesis and carcinogenesis are still poorly understood. Recently it has been shown that HCC promotion depends on Tolllike receptor (TLR) 4. Pre-cancerogenous events can be modelled in mice by the administration of a single dose of diethylnitrosamine (DEN), with HCC formation depending amongst others on interleukin (IL) 6 production. Mice lacking the hepatocanalicular phosphatidylcholine transporter ABCB4 develop liver fibrosis spontaneously, resemble patients with sclerosing cholangitis due to mutations of the orthologous human gene, and represent a valid model to study tumour formation in pre-injured cholestatic liver. The aim of this study was to investigate DEN-induced liver injury in TLR4-deficient mice with biliary fibrosis. Methods ABCB4-deficient mice on the FVB/NJ genetic background were crossed to two distinct genetic backgrounds (TLR4-sufficient C3H/HeN and TLR4-deficient C3H/HeJ) for more than 10 generations. The two congenic knockout and the two corresponding wild-type mouse lines were treated with a single dose of DEN for 48 hours. Phenotypic differences were assessed by measuring hepatic collagen contents, inflammatory markers (ALT, CRP, IL6) as well as hepatic apoptosis (TUNEL) and proliferation (Ki67) rates. Results Hepatic collagen accumulation is significantly reduced in ABCB4(-/-): TLR4(-/-)double-deficient mice. After DEN challenge, apoptosis, proliferation and inflammatory markers are decreased in TLR4-deficient in comparison to TLR4-sufficient mice. When combining ABCB4 and TLR4 deficiency with DEN treatment, hepatic IL6 expression and proliferation rates are lowest in fibrotic livers from the double-deficient line. Consistent with these effects, selective digestive tract decontamination in ABCB4(-/-) mice also led to reduced tumor size and number after DEN. Conclusion This study demonstrates that liver injury upon DEN challenge depends on pre-existing fibrosis and genetic background. The generation of ABCB4(-/): TLR4(-/-) double-deficient mice illustrates that TLR4-deficiency protects against hepatic injury in a preclinical mouse model of chronic liver disease.	[Weber, Susanne Nicole; Bohner, Annika; Lammert, Frank] Univ Saarland, Med Ctr, Dept Med 2, Homburg, Germany; [Dapito, Dianne H.; Schwabe, Robert F.] Columbia Univ, Dept Med, New York, NY USA	Saarland University; Columbia University	Lammert, F (corresponding author), Univ Saarland, Med Ctr, Dept Med 2, Homburg, Germany.	frank.lammert@uks.eu	Schwabe, Robert/AAY-6506-2021		local HOMFOR programme	local HOMFOR programme	The study was funded by the local HOMFOR programme (http://www.uniklinikum-saarland.de/forschung/homfor) to SNW.	Agundez JA, 2012, ONCOLOGY-BASEL, V82, P35, DOI 10.1159/000335606; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Dapito DH, 2012, CANCER CELL, V21, P504, DOI 10.1016/j.ccr.2012.02.007; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Fickert P, 2004, GASTROENTEROLOGY, V127, P261, DOI 10.1053/j.gastro.2004.04.009; Fox JG, 2010, GUT, V59, P88, DOI 10.1136/gut.2009.183749; Guo JS, 2009, HEPATOLOGY, V49, P960, DOI 10.1002/hep.22697; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harada K, 2003, LAB INVEST, V83, P1657, DOI 10.1097/01.LAB.0000097190.56734.FE; Hillebrandt S, 2002, GASTROENTEROLOGY, V123, P2041, DOI 10.1053/gast.2002.37069; Hochrath K, 2012, FASEB J, V26, P5081, DOI 10.1096/fj.12-209379; JAMALL IS, 1981, ANAL BIOCHEM, V112, P70, DOI 10.1016/0003-2697(81)90261-X; Katzenellenbogen M, 2007, MOL CANCER RES, V5, P1159, DOI 10.1158/1541-7786.MCR-07-0172; Kitamoto T, 2013, HUM GENET, V132, P783, DOI 10.1007/s00439-013-1294-3; Kluwe J, 2009, J MOL MED, V87, P125, DOI 10.1007/s00109-008-0426-z; Liu SB, 2002, INFECT IMMUN, V70, P3433, DOI 10.1128/IAI.70.7.3433-3442.2002; MAUAD TH, 1994, AM J PATHOL, V145, P1237; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Patin E, 2012, GASTROENTEROLOGY, V143, P1244, DOI 10.1053/j.gastro.2012.07.097; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Potikha T, 2013, HEPATOLOGY, V58, P192, DOI 10.1002/hep.26335; Rivera CA, 2007, J HEPATOL, V47, P571, DOI 10.1016/j.jhep.2007.04.019; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Roderfeld M, 2010, WORLD J HEPATOL, V2, P175, DOI 10.4254/wjh.v2.i5.175; Rogers AB, 2011, GUT MICROBES, V2, P52, DOI 10.4161/gmic.2.1.14761; Schwabe RF, 2006, GASTROENTEROLOGY, V130, P1886, DOI 10.1053/j.gastro.2006.01.038; Seki E, 2008, HEPATOLOGY, V48, P322, DOI 10.1002/hep.22306; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; SMIT JJM, 1993, CELL, V75, P451, DOI 10.1016/0092-8674(93)90380-9; Su GL, 2000, HEPATOLOGY, V31, P932, DOI 10.1053/he.2000.5634; Szabo G, 2006, HEPATOLOGY, V44, P287, DOI 10.1002/hep.21308; Uesugi T, 2001, HEPATOLOGY, V34, P101, DOI 10.1053/jhep.2001.25350; Uhrig A, 2005, J LEUKOCYTE BIOL, V77, P626, DOI 10.1189/jlb.0604332; Weber S, 2008, CLIN LIVER DIS, V12, P747, DOI 10.1016/j.cld.2008.07.012; Yu LX, 2010, HEPATOLOGY, V52, P1322, DOI 10.1002/hep.23845	38	17	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158819	10.1371/journal.pone.0158819	http://dx.doi.org/10.1371/journal.pone.0158819			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391331	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400134
J	Facciuolo, A; Gonzalez-Cano, P; Napper, S; Griebel, PJ; Mutharia, LM				Facciuolo, Antonio; Gonzalez-Cano, Patricia; Napper, Scott; Griebel, Philip J.; Mutharia, Lucy M.			Marked Differences in Mucosal Immune Responses Induced in Ileal versus Jejunal Peyer's Patches to Mycobacterium avium subsp paratuberculosis Secreted Proteins following Targeted Enteric Infection in Young Calves	PLOS ONE			English	Article							ANTIBODY-RESPONSE; LYMPHOID-TISSUE; JOHNES-DISEASE; T-CELLS; SHEEP; ANTIGENS; CATTLE; MACROPHAGES; MECHANISMS; GUT	In cattle, Mycobacterium avium subsp. paratuberculosis infection is primarily mediated through M cells overlying Peyer's patches (PP) in the ileum. The capacity of M. avium subsp. paratuberculosis to invade ileal PP (IPP) versus discrete PP in the jejunum (JPP) and subsequent differences in mucosal immune responses were investigated. Intestinal segments were surgically prepared in both mid-jejunum, containing two JPPs, and in terminal small intestine containing continuous IPP. M. avium subsp. paratuberculosis (10(9) CFU) was injected into the lumen of half of each intestinal segment when calves were 10-14 days-old and infection confirmed 1-2 months later by PCR and immunohistochemistry. Thirteen recombinant M. avium subsp. paratuberculosis proteins, previously identified as immunogenic, were used to analyze pathogen-specific B-and T-cell responses in PP and mesenteric lymph nodes. IgA plasma cell responses to 9 of 13 recombinant proteins were detected in JPP but not in IPP. Secretory IgA reacting in ELISA with 9 of the 13 recombinant proteins was detected in luminal contents from both jejunal and ileal segments. These observations support the conclusion that pathogen-specific IgA B cells were induced in JPP but not IPP early after a primary infection. The presence of secretory IgA in intestinal contents is consistent with dissemination of IgA plasma cells from the identified mucosa-associated immune induction sites. This is the first direct evidence for M. avium subsp. paratuberculosis uptake by bovine JPP and for local induction of pathogen-specific IgA plasma cell responses after enteric infection. We also provide evidence that bacterial invasion of IPP, a primary B lymphoid tissue, provides a novel strategy to evade induction of mucosal immune responses. Over 60% of PPs in the newborn calf small intestine is primary lymphoid tissue, which has significant implications when designing oral vaccines or diagnostic tests to detect early M. avium subsp. paratuberculosis infections.	[Facciuolo, Antonio; Mutharia, Lucy M.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON, Canada; [Gonzalez-Cano, Patricia; Napper, Scott; Griebel, Philip J.] Univ Saskatchewan, VIDO InterVac, Saskatoon, SK, Canada; [Napper, Scott] Univ Saskatchewan, Dept Biochem, Saskatoon, SK, Canada; [Griebel, Philip J.] Univ Saskatchewan, Sch Publ Hlth, Saskatoon, SK, Canada	University of Guelph; University of Saskatchewan; University of Saskatchewan; University of Saskatchewan	Mutharia, LM (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON, Canada.	lmuthari@uoguelph.ca		Facciuolo, Antonio/0000-0003-4551-9386	AAFC Growing Forward 2 Cluster - Beef Cattle Research Council [ANH.01.13]; Tier I CRC in Neonatal Mucosal Immunology [950-231111]	AAFC Growing Forward 2 Cluster - Beef Cattle Research Council; Tier I CRC in Neonatal Mucosal Immunology	This work was supported by the AAFC Growing Forward 2 Cluster - Beef Cattle Research Council (http://www.beefresearch.ca/) Grant # ANH.01.13 to LMM and PJG. PJG is funded by a Tier I CRC in Neonatal Mucosal Immunology provided by Canada Institutes for Health Research (CIHR) (www.cihr-irsc.gc.ca/e/193.html) Grant # 950-231111. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abitorabi MA, 1996, J IMMUNOL, V156, P3111; Allen AJ, 2009, CLIN VACCINE IMMUNOL, V16, P453, DOI 10.1128/CVI.00347-08; Arsenault RJ, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-54; Bannantine JP, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-5; Begg DJ, 2015, VET IMMUNOL IMMUNOP, V166, P125, DOI 10.1016/j.vetimm.2015.06.011; Benedictus A, 2008, PREV VET MED, V83, P215, DOI 10.1016/j.prevetmed.2007.07.008; Charavaryamath C, 2013, CLIN VACCINE IMMUNOL, V20, P156, DOI 10.1128/CVI.00496-12; Charavaryamath C, 2011, GUT MICROBES, V2, P134, DOI 10.4161/gmic.2.3.16483; Clarke CJ, 1996, J COMP PATHOL, V114, P419, DOI 10.1016/S0021-9975(96)80017-X; Everman JL, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00058; Facciuolo A, 2013, CLIN VACCINE IMMUNOL, V20, P1783, DOI 10.1128/CVI.00380-13; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fries P, 2011, DEV COMP IMMUNOL, V35, P1038, DOI 10.1016/j.dci.2011.04.003; Gonzalez J, 2005, J COMP PATHOL, V133, P184, DOI 10.1016/j.jcpa.2005.04.007; Griebel PJ, 1996, IMMUNOL TODAY, V17, P30, DOI 10.1016/0167-5699(96)80566-4; Harris NB, 2001, CLIN MICROBIOL REV, V14, P489, DOI 10.1128/CMR.14.3.489-512.2001; Hostetter J, 2005, CLIN DIAGN LAB IMMUN, V12, P793, DOI 10.1128/CDLI.12.6.793-796.2005; Khare S, 2009, VET PATHOL, V46, P717, DOI 10.1354/vp.08-VP-0187-G-FL; Koets A, 2002, INFECT IMMUN, V70, P3856, DOI 10.1128/IAI.70.7.3856-3864.2002; Liljavirta J, 2013, MUCOSAL IMMUNOL, V6, P942, DOI 10.1038/mi.2012.132; Lindhout E, 1997, IMMUNOL TODAY, V18, P573, DOI 10.1016/S0167-5699(97)01160-2; LOWDEN S, 1992, J ANAT, V181, P209; MOMOTANI E, 1988, VET PATHOL, V25, P131, DOI 10.1177/030098588802500205; Mortier RAR, 2014, J DAIRY SCI, V97, P5558, DOI 10.3168/jds.2014-8139; MOTYKA B, 1991, EUR J IMMUNOL, V21, P1951, DOI 10.1002/eji.1830210825; Mutwiri G, 1999, IMMUNOLOGY, V97, P455, DOI 10.1046/j.1365-2567.1999.00791.x; PARSONS KR, 1989, VET PATHOL, V26, P396, DOI 10.1177/030098588902600505; Ponnusamy D, 2013, RES VET SCI, V94, P306, DOI 10.1016/j.rvsc.2012.09.023; REYNAUD CA, 1995, CELL, V80, P115, DOI 10.1016/0092-8674(95)90456-5; Secott TE, 2004, INFECT IMMUN, V72, P3724, DOI 10.1128/IAI.72.7.3724-3732.2004; Sigurdardottir OG, 2001, VET PATHOL, V38, P184, DOI 10.1354/vp.38-2-184; Waters WR, 2003, INFECT IMMUN, V71, P5130, DOI 10.1128/IAI.71.9.5130-5138.2003; Wu CW, 2007, INFECT IMMUN, V75, P2110, DOI 10.1128/IAI.01739-06; Yasuda M, 2006, VET RES, V37, P401, DOI 10.1051/vetres:2006008; Yasuda M, 2004, DEV COMP IMMUNOL, V28, P357, DOI 10.1016/j.dci.2003.09.013	35	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158747	10.1371/journal.pone.0158747	http://dx.doi.org/10.1371/journal.pone.0158747			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27387969	gold, Green Published, Green Submitted			2022-12-27	WOS:000379811500040
J	Gigante, ED; Benaliouad, F; Zamora-Olivencia, V; Wise, RA				Gigante, Eduardo D.; Benaliouad, Faiza; Zamora-Olivencia, Veronica; Wise, Roy A.			Optogenetic Activation of a Lateral Hypothalamic-Ventral Tegmental Drive-Reward Pathway	PLOS ONE			English	Article							MEDIAL FOREBRAIN-BUNDLE; BRAIN-STIMULATION REWARD; SELF-STIMULATION; ELECTRICAL-STIMULATION; REFRACTORY PERIODS; PREOPTIC AREA; RAT; DOPAMINE; SEEKING; FIBERS	Electrical stimulation of the lateral hypothalamus can motivate feeding or can serve as a reward in its own right. It remains unclear whether the same or independent but anatomically overlapping circuitries mediate the two effects. Electrical stimulation findings implicate medial forebrain bundle (MFB) fibers of passage in both effects, and optogenetic studies confirm a contribution from fibers originating in the lateral hypothalamic area and projecting to or through the ventral tegmental area. Here we report that optogenetic activation of ventral tegmental fibers from cells of origin in more anterior or posterior portions of the MFB failed to induce either reward or feeding. The feeding and reward induced by optogenetic activation of fibers from the lateral hypothalamic cells of origin were influenced similarly by variations in stimulation pulse width and pulse frequency, consistent with the hypothesis of a common substrate for the two effects. There were, however, several cases where feeding but not self-stimulation or self-stimulation but not feeding were induced, consistent with the hypothesis that distinct but anatomically overlapping systems mediate the two effects. Thus while optogenetic stimulation provides a more selective tool for characterizing the mechanisms of stimulation-induced feeding and reward, it does not yet resolve the question of common or independent substrates.	[Gigante, Eduardo D.; Benaliouad, Faiza; Zamora-Olivencia, Veronica; Wise, Roy A.] NIDA, Intramural Res Program, NIH, Dept Hlth & Human Serv, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Wise, RA (corresponding author), NIDA, Intramural Res Program, NIH, Dept Hlth & Human Serv, Baltimore, MD 21224 USA.	rwise@intra.nida.nih.gov	Gigante, Eduardo/AAK-8556-2020; Core, Vector/CAF-4832-2022	Gigante, Eduardo/0000-0002-1486-5377; 	Intramural Research Program of the National Institute on Drug Abuse, National Institutes of Health; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000471] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute on Drug Abuse, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was funded by the Intramural Research Program of the National Institute on Drug Abuse, National Institutes of Health.	ANAND BK, 1951, P SOC EXP BIOL MED, V77, P323, DOI 10.3181/00379727-77-18766; BALL GG, 1970, PHYSIOL BEHAV, V5, P1343, DOI 10.1016/0031-9384(70)90118-6; Barbano MF, 2016, J NEUROSCIE IN PRESS; BIELAJEW C, 1982, PHYSIOL BEHAV, V28, P125, DOI 10.1016/0031-9384(82)90113-5; Bielajew C, 2001, BEHAV NEUROSCI, V115, P900, DOI 10.1037/0735-7044.115.4.900; BIELAJEW C, 1986, J NEUROSCI, V6, P919; BISHOP MP, 1963, SCIENCE, V140, P394, DOI 10.1126/science.140.3565.394; BOWER GH, 1958, J COMP PHYSIOL PSYCH, V51, P669, DOI 10.1037/h0038925; Bushnik T, 2000, BRAIN RES, V881, P103, DOI 10.1016/S0006-8993(00)02564-6; CROW TJ, 1971, EXPERIENTIA, V27, P662, DOI 10.1007/BF02136947; Geisler S, 2007, J NEUROSCI, V27, P5730, DOI 10.1523/JNEUROSCI.0012-07.2007; Geisler S, 2006, EUR J NEUROSCI, V24, P116, DOI 10.1111/j.1460-9568.2006.04928.x; Geisler S, 2008, REV NEUROSCIENCE, V19, P227; GLICKMAN SE, 1967, PSYCHOL REV, V74, P81, DOI 10.1037/h0024290; GRATTON A, 1988, BRAIN RES, V438, P264, DOI 10.1016/0006-8993(88)91345-5; GRATTON A, 1988, BRAIN RES, V438, P256, DOI 10.1016/0006-8993(88)91344-3; GRATTON A, 1983, BRAIN RES, V274, P25, DOI 10.1016/0006-8993(83)90518-8; HOEBEL BG, 1962, SCIENCE, V135, P375, DOI 10.1126/science.135.3501.375; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Jennings JH, 2015, CELL, V160, P516, DOI 10.1016/j.cell.2014.12.026; Jennings JH, 2013, SCIENCE, V341, P1517, DOI 10.1126/science.1241812; Kempadoo KA, 2013, J NEUROSCI, V33, P7618, DOI 10.1523/JNEUROSCI.2588-12.2013; MARGULES DL, 1962, SCIENCE, V135, P374, DOI 10.1126/science.135.3501.374; MENDELSON J, 1973, BEHAV BIOL, V8, P619, DOI 10.1016/S0091-6773(73)80147-6; MICCO DJ, 1974, BRAIN RES, V75, P172, DOI 10.1016/0006-8993(74)90780-X; MORGANE PJ, 1961, NATURE, V191, P672, DOI 10.1038/191672a0; Nieh EH, 2015, CELL, V160, P528, DOI 10.1016/j.cell.2015.01.003; NIEUWENHUYS R, 1982, J COMP NEUROL, V206, P49, DOI 10.1002/cne.902060106; OLDS J, 1956, SCI AM, V195, P105, DOI 10.1038/scientificamerican1056-105; OLDS ME, 1963, J COMP NEUROL, V120, P259, DOI 10.1002/cne.901200206; Paxinos G., 2013, RAT BRAIN STEREOTAXI; RANCK JB, 1975, BRAIN RES, V98, P417, DOI 10.1016/0006-8993(75)90364-9; ROBERTS WW, 1958, J COMP PHYSIOL PSYCH, V51, P391, DOI 10.1037/h0042900; ROUTTENB.A, 1969, J COMP PHYSIOL PSYCH, V68, P22, DOI 10.1037/h0027655; SHIZGAL P, 1980, J COMP PHYSIOL PSYCH, V94, P227, DOI 10.1037/h0077668; SOPER W Y, 1971, T.-I.-T. (Tower International Technomedical) Journal of Life Sciences, V1, P79; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P95; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P1; VALENSTEIN ES, 1970, PSYCHOL REV, V77, P16, DOI 10.1037/h0028581; VEENING JG, 1982, J COMP NEUROL, V206, P82, DOI 10.1002/cne.902060107; Wang H, 2007, P NATL ACAD SCI USA, V104, P8143, DOI 10.1073/pnas.0700384104; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; WISE RA, 1971, PHYSIOL BEHAV, V6, P569, DOI 10.1016/0031-9384(71)90207-1; WISE RA, 1974, BRAIN RES, V67, P187, DOI 10.1016/0006-8993(74)90272-8; Wise RA, 2013, BIOL PSYCHIAT, V73, P819, DOI 10.1016/j.biopsych.2012.09.001; YEOMANS JS, 1988, BRAIN RES, V450, P86, DOI 10.1016/0006-8993(88)91547-8; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936; ZIGMOND MJ, 1972, SCIENCE, V177, P1211	48	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158885	10.1371/journal.pone.0158885	http://dx.doi.org/10.1371/journal.pone.0158885			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27387668	gold, Green Published, Green Submitted			2022-12-27	WOS:000379811500058
J	Lee, JJ; Ho, CY; Chen, HJ; Huang, N; Yeh, JC; deFerranti, S				Lee, Jason Jiunshiou; Ho, ChinYu; Chen, Hsin-Jen; Huang, Nicole; Yeh, Jade Chienyu; deFerranti, Sarah			Is the 90th Percentile Adequate? The Optimal Waist Circumference Cutoff Points for Predicting Cardiovascular Risks in 124,643 15-Year-Old Taiwanese Adolescents	PLOS ONE			English	Article							3RD NATIONAL-HEALTH; BODY-MASS INDEX; METABOLIC SYNDROME; CHILDREN; OBESITY; CHILDHOOD; ADULTHOOD; AMERICAN; DISEASE; BMI	Adolescent obesity has increased to alarming proportions globally. However, few studies have investigated the optimal waist circumference (WC) of Asian adolescents. This study sought to establish the optimal WC cutoff points that identify a cluster of cardiovascular risk factors (CVRFs) among 15-year-old ethnically Chinese adolescents. This study was a regional population-based study on the CVRFs among adolescents who enrolled in all the senior high schools in Taipei City, Taiwan, between 2011 and 2014. Four cross-sectional health examinations of first-year senior high school (grade 10) students were conducted from September to December of each year. A total of 124,643 adolescents aged 15 (boys: 63,654; girls: 60,989) were recruited. Participants who had at least three of five CVRFs were classified as the high-risk group. We used receiver-operating characteristic curves and the area under the curve (AUC) to determine the optimal WC cutoff points and the accuracy of WC in predicting high cardiovascular risk. WC was a good predictor for high cardiovascular risk for both boys (AUC: 0.845, 95% confidence interval [CI]: 0.833-0.857) and girls (AUC: 0.763, 95% CI: 0.731-0.795). The optimal WC cutoff points were >= 78.9 cm for boys (77th percentile) and >= 70.7 cm for girls (77th percentile). Adolescents with normal weight and an abnormal WC were more likely to be in the high cardiovascular risk group (odds ratio: 3.70, 95% CI: 2.65-5.17) compared to their peers with normal weight and normal WC. The optimal WC cutoff point of 15-year-old Taiwanese adolescents for identifying CVRFs should be the 77th percentile; the 90th percentile of the WC might be inadequate. The high WC criteria can help health professionals identify higher proportion of the adolescents with cardiovascular risks and refer them for further evaluations and interventions. Adolescents' height, weight and WC should be measured as a standard practice in routine health checkups.	[Lee, Jason Jiunshiou; Ho, ChinYu] Taipei City Hosp, Yangming Branch, Dept Family Med, Taipei, Taiwan; [Lee, Jason Jiunshiou; Chen, Hsin-Jen] Natl Yang Ming Univ, Sch Med, Dept Publ Hlth, Taipei, Taiwan; [Lee, Jason Jiunshiou; Ho, ChinYu] Natl Taipei Univ Nursing & Hlth Sci, Dept Hlth Care Management, Taipei, Taiwan; [Ho, ChinYu] Natl Yang Ming Univ, Fac Med, Sch Med, Taipei, Taiwan; [Ho, ChinYu] Natl Taipei Univ Nursing & Hlth Sci, Dept Leisure Ind & Hlth Promot, Taipei, Taiwan; [Huang, Nicole] Natl Yang Ming Univ, Inst Hosp & Hlth Care Adm, Taipei, Taiwan; [Yeh, Jade Chienyu] Minist Hlth & Welf, Lo Sheng Sanat & Hosp, Dept Family Med, New Taipei, Taiwan; [deFerranti, Sarah] Boston Childrens Hosp, Dept Cardiol, Boston, MA USA	Taipei City Hospital; National Yang Ming Chiao Tung University; National Taipei University of Nursing & Health Science (NTUNHS); National Yang Ming Chiao Tung University; National Taipei University of Nursing & Health Science (NTUNHS); National Yang Ming Chiao Tung University; Harvard University; Boston Children's Hospital	Ho, CY (corresponding author), Taipei City Hosp, Yangming Branch, Dept Family Med, Taipei, Taiwan.; Ho, CY (corresponding author), Natl Taipei Univ Nursing & Hlth Sci, Dept Hlth Care Management, Taipei, Taiwan.; Ho, CY (corresponding author), Natl Yang Ming Univ, Fac Med, Sch Med, Taipei, Taiwan.; Ho, CY (corresponding author), Natl Taipei Univ Nursing & Hlth Sci, Dept Leisure Ind & Hlth Promot, Taipei, Taiwan.	dag21@tpech.gov.tw	Chen, Hsin-Jen/H-8393-2014	Chen, Hsin-Jen/0000-0003-4876-634X; Lee, Jason Jiunshiou/0000-0003-3638-8492	Department of Health of Taipei City Government, Taiwan [10003-4-005, 10102-62-082, 10301-62-079]	Department of Health of Taipei City Government, Taiwan	This study was funded by grants (10003-4-005, 10102-62-082, 10301-62-079) from the Department of Health of Taipei City Government, Taiwan (http://www.health.gov.tw/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Anderson PJ, 2001, INT J OBESITY, V25, P1782, DOI 10.1038/sj.ijo.0801837; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bauer KW, 2015, PEDIATR OBES, V10, P329, DOI 10.1111/ijpo.267; Chen W, 2010, PEDIATR NEONATOL, V51, P69, DOI 10.1016/S1875-9572(10)60014-9; Clasey JL, 1999, OBES RES, V7, P256, DOI 10.1002/j.1550-8528.1999.tb00404.x; de Ferranti SD, 2004, CIRCULATION, V110, P2494, DOI 10.1161/01.CIR.0000145117.40114.C7; Despres J P, 2006, J Endocrinol Invest, V29, P77; Ebbeling CB, 2002, LANCET, V360, P473, DOI 10.1016/S0140-6736(02)09678-2; Falkner B, 2004, HYPERTENSION, V43, P203, DOI 10.1161/01.HYP.0000109322.72948.24; Fernandez JR, 2004, J PEDIATR-US, V145, P439, DOI 10.1016/j.jpeds.2004.06.044; Freedman DS, 1999, AM J CLIN NUTR, V69, P308; Hirschler V, 2005, ARCH PEDIAT ADOL MED, V159, P740, DOI 10.1001/archpedi.159.8.740; Janssen I, 2002, ARCH INTERN MED, V162, P2074, DOI 10.1001/archinte.162.18.2074; Katzmarzyk PT, 2011, OBESITY, V19, P1272, DOI 10.1038/oby.2010.319; Lakshman R, 2012, CIRCULATION, V126, P1770, DOI 10.1161/CIRCULATIONAHA.111.047738; LEAN MEJ, 1995, BRIT MED J, V311, P158, DOI 10.1136/bmj.311.6998.158; Lee SJ, 2006, J PEDIATR-US, V149, P809, DOI 10.1016/j.jpeds.2006.08.075; Leibowitz KL, 2009, INT J PEDIATR OBES, V4, P150, DOI 10.1080/17477160802596130; Maffeis C, 2001, OBES RES, V9, P179, DOI 10.1038/oby.2001.19; Ng VWS, 2007, OBESITY, V15, P494, DOI 10.1038/oby.2007.588; O'Neill S, 2015, OBES REV, V16, P1, DOI 10.1111/obr.12229; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Savva SC, 2000, INT J OBESITY, V24, P1453, DOI 10.1038/sj.ijo.0801401; Singh AS, 2008, OBES REV, V9, P474, DOI 10.1111/j.1467-789X.2008.00475.x; Taylor SA, 2011, INT J PEDIATR OBES, V6, pE307, DOI 10.3109/17477166.2011.575149; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Wofford Linda G, 2008, J Pediatr Nurs, V23, P5, DOI 10.1016/j.pedn.2007.07.006; World Health Organization, 2008, WAIST CIRCUMFERENCE; Zhu SK, 2002, AM J CLIN NUTR, V76, P743, DOI 10.1093/ajcn/76.4.743; Zimmet P, 2007, PEDIATR DIABETES, V8, P299, DOI 10.1111/j.1399-5448.2007.00271.x	37	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158818	10.1371/journal.pone.0158818	http://dx.doi.org/10.1371/journal.pone.0158818			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27389572	Green Submitted, Green Published, gold			2022-12-27	WOS:000379811500051
J	Micheal, S; Siddiqui, SN; Zafar, SN; Iqbal, A; Khan, MI; den Hollander, AI				Micheal, Shazia; Siddiqui, Sorath Noorani; Zafar, Saemah Nuzhat; Iqbal, Aftab; Khan, Muhammad Imran; den Hollander, Anneke I.			Identification of Novel Variants in LTBP2 and PXDN Using Whole-Exome Sequencing in Developmental and Congenital Glaucoma	PLOS ONE			English	Article							ANTERIOR SEGMENT DYSGENESIS; BINDING-PROTEIN 2; CYTOCHROME P4501B1; MUTATIONS; GENE; CYP1B1; PEROXIDASIN; POPULATION; MOUSE; MYOC	Background Primary congenital glaucoma (PCG) is the most common form of glaucoma in children. PCG occurs due to the developmental defects in the trabecular meshwork and anterior chamber of the eye. The purpose of this study is to identify the causative genetic variants in three families with developmental and primary congenital glaucoma ( PCG) with a recessive inheritance pattern. Methods DNA samples were obtained from consanguineous families of Pakistani ancestry. The CYP1B1 gene was sequenced in the affected probands by conventional Sanger DNA sequencing. Whole exome sequencing (WES) was performed in DNA samples of four individuals belonging to three different CYP1B1-negative families. Variants identified by WES were validated by Sanger sequencing. Results WES identified potentially causative novel mutations in the latent transforming growth factor beta binding protein 2 (LTBP2) gene in two PCG families. In the first family a novel missense mutation (c.4934G>A; p.Arg1645Glu) co-segregates with the disease phenotype, and in the second family a novel frameshift mutation (c.4031_4032insA; p.Asp1345Glyfs*6) was identified. In a third family with developmental glaucoma a novel mutation (c.3496G>A; p.Gly1166Arg) was identified in the PXDN gene, which segregates with the disease. Conclusions We identified three novel mutations in glaucoma families using WES; two in the LTBP2 gene and one in the PXDN gene. The results will not only enhance our current understanding of the genetic basis of glaucoma, but may also contribute to a better understanding of the diverse phenotypic consequences caused by mutations in these genes.	[Micheal, Shazia; den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, Nijmegen, Netherlands; [Siddiqui, Sorath Noorani; Zafar, Saemah Nuzhat] Al Shifa Eye Trust Hosp, Dept Pediat Ophthalmol, Jhelum Rd, Rawalpindi, Pakistan; [Iqbal, Aftab] Univ Westminster, Sch Biosci, London, England; [Khan, Muhammad Imran; den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen, Netherlands	Radboud University Nijmegen; University of Westminster; Radboud University Nijmegen	den Hollander, AI (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, Nijmegen, Netherlands.; den Hollander, AI (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen, Netherlands.	Anneke.denHollander@radboudumc.nl	Hollander, Anneke den/N-4911-2014; Siddiqui, Sorath Noorani/AAT-9861-2020	Khan, Muhammad Imran/0000-0003-0276-5480	Shaffer grant from the Glaucoma Research Foundation; Glaucoomfonds; Oogfonds; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid; Stichting Blindenhulp	Shaffer grant from the Glaucoma Research Foundation; Glaucoomfonds; Oogfonds; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid; Stichting Blindenhulp	The authors thank the Stichting Blindenhulp, a Shaffer grant from the Glaucoma Research Foundation, the Glaucoomfonds, Oogfonds, and the Algemene Nederlandse Vereniging ter Voorkoming van Blindheid for providing the financial support.; We thank the Stichting Blindenhulp, a Shaffer grant from the Glaucoma Research Foundation, the Glaucoomfonds, Oogfonds, and the Algemene Nederlandse Vereniging ter Voorkoming van Blindheid for providing the financial support.	Abu-Amero KK, 2011, MOL VIS, V17, P2911; Ali M, 2009, AM J HUM GENET, V84, P664, DOI 10.1016/j.ajhg.2009.03.017; Bejjani BA, 1998, AM J HUM GENET, V62, P325, DOI 10.1086/301725; Choi A, 2015, EUR J HUM GENET, V23, P337, DOI 10.1038/ejhg.2014.119; Dandona L, 1998, ARCH OPHTHALMOL-CHIC, V116, P545, DOI 10.1001/archopht.116.4.514; Desir J, 2010, EUR J HUM GENET, V18, P761, DOI 10.1038/ejhg.2010.11; GIBSON MA, 1995, MOL CELL BIOL, V15, P6932; Gould DB, 2002, HUM MOL GENET, V11, P1185, DOI 10.1093/hmg/11.10.1185; Haji-Seyed-Javadi R, 2012, HUM MUTAT, V33, P1182, DOI 10.1002/humu.22105; Hirani R, 2007, MATRIX BIOL, V26, P213, DOI 10.1016/j.matbio.2006.12.006; Jun G, 2012, AM J HUM GENET, V91, P839, DOI 10.1016/j.ajhg.2012.09.004; Kakiuchi-Matsumoto T, 2001, AM J OPHTHALMOL, V131, P345, DOI 10.1016/S0002-9394(00)00808-4; Khan K, 2011, AM J HUM GENET, V89, P464, DOI 10.1016/j.ajhg.2011.08.005; Kim HJ, 2011, MOL VIS, V17, P2093; Kumar A, 2010, HUM GENET, V128, P365, DOI 10.1007/s00439-010-0858-8; Lazar E, 2015, FREE RADICAL BIO MED, V83, P273, DOI 10.1016/j.freeradbiomed.2015.02.015; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lim SH, 2013, AM J OPHTHALMOL, V155, P508, DOI 10.1016/j.ajo.2012.09.012; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; MD S, 2005, SHIELDS TEXTBOOK OF; Mohanty K, 2013, MOL VIS, V19, P78; Narooie-Nejad M, 2009, HUM MOL GENET, V18, P3969, DOI 10.1093/hmg/ddp338; Sharafieh R, 2013, OPHTHALMIC GENET, V34, P14, DOI 10.3109/13816810.2012.716486; Shipley JM, 2000, MOL CELL BIOL, V20, P4879, DOI 10.1128/MCB.20.13.4879-4887.2000; Tanwar M, 2009, MOL VIS, V15, P2926; Vehvilainen P, 2009, J CELL PHYSIOL, V221, P586, DOI 10.1002/jcp.21888; Vranka JA, 2015, EXP EYE RES, V133, P112, DOI 10.1016/j.exer.2014.07.014; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Yan XH, 2014, HUM MOL GENET, V23, P5597, DOI 10.1093/hmg/ddu274	29	19	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159259	10.1371/journal.pone.0159259	http://dx.doi.org/10.1371/journal.pone.0159259			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27409795	Green Submitted, Green Published, gold			2022-12-27	WOS:000379508300073
J	Cooper, I; Fridkin, M; Shechter, Y				Cooper, Itzik; Fridkin, Mati; Shechter, Yoram			Conjugation of Methotrexate-Amino Derivatives to Macromolecules through Carboxylate Moieties Is Superior Over Conventional Linkage to Amino Residues: Chemical, Cell-Free and In Vitro Characterizations	PLOS ONE			English	Article							TARGETED DRUG-DELIVERY; LONG-ACTING INSULIN; ALBUMIN-BINDING PRODRUG; PEPTIDE; VIVO; DESIGN; CIRCULATION; PROTEIN	In this study, we examined the possibility of introducing methotrexate (MTX) to the carboxyl ate rather than to the epsilon-amino side chains of proteins. We found that MIX amino compounds covalently linked to the carboxylate moieties of macromolecules, undergo unusual peptide-bond cleavage, with the release of the MTX amino derivatives from the conjugates. This event takes place at an accelerated rate under acidic conditions, and at a slower rate at physiological pH values. The glutamate portion of MTX is responsible for this behavior, with little or no contribution of the p-aminobenzoate-pteridine ring that is linked to the a amino side chain of the glutamate. Carboxylate-linked Fmoc-Glu-gamma-CONH-(CH2)(6)-NH2 undergoes hydrolysis in a nearly indistinguishable fashion. A free a carboxylate moiety is essential for this effect. Carboxylate linked Fmoc-glutamic-amide-gamma-CONH-(CH2)(6)-NH2 undergoes no hydrolysis under acidic conditions. Based on these findings, we engineered a cysteine specific MTX containing reagent. Its linkage to bovine serum albumin (BSA) yielded a conjugate with profound antiproliferative efficacy in a MTX-sensitive glioma cell line. In conclusion, carboxylate linked MTX-amino derivatives in particular, and carboxylate linked R-alpha-GLU-gamma amino compounds in general are equipped with'built-in chemical machinery' that releases them under mild acidic conditions.	[Cooper, Itzik] Sheba Med Ctr, BBB Grp, Joseph Sagol Neurosci Ctr, IL-52621 Ramat Gan, Israel; [Fridkin, Mati] Weizmann Inst Sci, Dept Organ Chem, IL-76100 Rehovot, Israel; [Shechter, Yoram] Weizmann Inst Sci, Dept Biomol Sci, IL-76100 Rehovot, Israel	Chaim Sheba Medical Center; Weizmann Institute of Science; Weizmann Institute of Science	Cooper, I (corresponding author), Sheba Med Ctr, BBB Grp, Joseph Sagol Neurosci Ctr, IL-52621 Ramat Gan, Israel.	Itzik.cooper@sheba.health.gov.il		cooper, itzik/0000-0003-0723-5542	Kimmelman grant from the Weizmann Institute	Kimmelman grant from the Weizmann Institute	This work was supported by a Kimmelman grant from the Weizmann Institute.	ALBERT A, 1958, NATURE, V182, P421, DOI 10.1038/182421a0; Cooper I, 2011, J NEUROCHEM, V116, P467, DOI 10.1111/j.1471-4159.2010.06934.x; Ettmayer P, 2004, J MED CHEM, V47, P2393, DOI 10.1021/jm0303812; Fiehn C, 2008, ANN RHEUM DIS, V67, P1188, DOI 10.1136/ard.2007.086843; Gershonov E, 1999, DIABETES, V48, P1437, DOI 10.2337/diabetes.48.7.1437; Gershonov E, 2000, J MED CHEM, V43, P2530, DOI 10.1021/jm990533m; HAZUM E, 1992, J BIOCHEM BIOPH METH, V24, P95, DOI 10.1016/0165-022X(92)90050-K; Huang X, 1999, J PEPT RES, V53, P126, DOI 10.1034/j.1399-3011.1999.00005.x; Huttunen KM, 2011, PHARMACOL REV, V63, P750, DOI 10.1124/pr.110.003459; KAUFMAN BT, 1976, ARCH BIOCHEM BIOPHYS, V172, P289, DOI 10.1016/0003-9861(76)90078-3; KULKARNI PN, 1985, CANCER IMMUNOL IMMUN, V19, P211; Lin CR, 2012, AM J THER, V19, P33, DOI 10.1097/MJT.0b013e3181f47f3f; Neumann E, 2010, EXPERT OPIN DRUG DEL, V7, P915, DOI 10.1517/17425247.2010.498474; Pasquetto MV, 2011, J IMMUNOTHER, V34, P611, DOI 10.1097/CJI.0b013e318234ecf5; Shechter Y, 2007, INT J PEPT RES THER, V13, P105, DOI 10.1007/s10989-006-9052-1; Shechter Y, 2005, BIOCONJUGATE CHEM, V16, P913, DOI 10.1021/bc050055w; Shechter Y, 2005, FEBS LETT, V579, P2439, DOI 10.1016/j.febslet.2005.03.044; Shechter Y, 2001, P NATL ACAD SCI USA, V98, P1212, DOI 10.1073/pnas.98.3.1212; Testa B, 2004, BIOCHEM PHARMACOL, V68, P2097, DOI 10.1016/j.bcp.2004.07.005; Tsubery H, 2004, J BIOL CHEM, V279, P38118, DOI 10.1074/jbc.M405155200; Warnecke A, 2007, ARCH PHARM, V340, P389, DOI 10.1002/ardp.200700025; Wosikowski K, 2003, CLIN CANCER RES, V9, P1917	22	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0158352	10.1371/journal.pone.0158352	http://dx.doi.org/10.1371/journal.pone.0158352			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27403959	Green Submitted, Green Published, gold			2022-12-27	WOS:000379508200008
J	Dauleh, S; Santeramo, I; Fielding, C; Ward, K; Herrmann, A; Murray, P; Wilm, B				Dauleh, Sumaya; Santeramo, Ilaria; Fielding, Claire; Ward, Kelly; Herrmann, Anne; Murray, Patricia; Wilm, Bettina			Characterisation of Cultured Mesothelial Cells Derived from the Murine Adult Omentum	PLOS ONE			English	Article							VASCULAR SMOOTH-MUSCLE; MESENCHYMAL STEM-CELLS; MYOCARDIAL-INFARCTION; PERITONEAL ADHESIONS; SEROSAL MESOTHELIUM; TRANSITION; INJURY; HEART; FIBROBLASTS; MECHANISM	The human omentum has been long regarded as a healing patch, used by surgeons for its ability to immunomodulate, repair and vascularise injured tissues. A major component of the omentum are mesothelial cells, which display some of the characteristics of mesenchymal stem/stromal cells. For instance, lineage tracing studies have shown that mesothelial cells give rise to adipocytes and vascular smooth muscle cells, and human and rat mesothelial cells have been shown to differentiate into osteoblast-and adipocyte-like cells in vitro, indicating that they have considerable plasticity. However, so far, long-term cultures of mesothelial cells have not been successfully established due to early senescence. Here, we demonstrate that mesothelial cells isolated from the mouse omentum could be cultured for more than 30 passages. While epithelial markers were downregulated over passages in the mesothelial cells, their mesenchymal profile remained unchanged. Early passage mesothelial cells displayed clonogenicitiy, expressed several stem cell markers, and up to passage 5 and 13, respectively, could differentiate along the adipogenic and osteogenic lineages, demonstrating stem/progenitor characteristics and differentiation potential.	[Dauleh, Sumaya; Santeramo, Ilaria; Fielding, Claire; Ward, Kelly; Murray, Patricia; Wilm, Bettina] Univ Liverpool, Inst Translat Med, Dept Cellular & Mol Physiol, Liverpool, Merseyside, England; [Herrmann, Anne] Univ Liverpool, Inst Integrat Biol, Dept Biochem, Liverpool, Merseyside, England; [Fielding, Claire] Univ Cambridge, Dept Haematol, Cambridge, England	University of Liverpool; University of Liverpool; University of Cambridge	Wilm, B (corresponding author), Univ Liverpool, Inst Translat Med, Dept Cellular & Mol Physiol, Liverpool, Merseyside, England.	b.wilm@liv.ac.uk	Wilm, Bettina/V-8621-2018	Wilm, Bettina/0000-0002-9245-993X; Herrmann, Anne/0000-0002-0858-419X	Biotechnology and Biological Sciences Research Council [BB/F016905/1]; Wellcome Trust [WT096566MA]; Nephrotools FP7 Marie Curie training grant; Alder Hey Children's Kidney fund; Neuroblastoma UK; Biotechnology and Biological Sciences Research Council [1091794] Funding Source: researchfish; Medical Research Council [MR/M012751/1] Funding Source: researchfish; MRC [MR/M012751/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Nephrotools FP7 Marie Curie training grant; Alder Hey Children's Kidney fund; Neuroblastoma UK; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank Nicole Cash, Daniel Turnham, Jonathan Hanmer, Aleksandra Rak-Raszeswka and Emma Smith for technical help, and Sokratis Theocharatos for the GFP-lentivirus vector. The work was supported by a PhD training grant, number BB/F016905/1, for SD, from the Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk/), and a Wellcome Trust (www.wellcome.ac.uk) 4 year PhD training grant, number WT096566MA, for KW. IS was funded by the Nephrotools FP7 Marie Curie training grant, and Alder Hey Children's Kidney fund. AH received funding from Neuroblastoma UK (neuroblastoma.org.uk). CF was self-funded for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahina K, 2011, HEPATOLOGY, V53, P983, DOI 10.1002/hep.24119; Chau YY, 2014, NAT CELL BIOL, V16, P367, DOI 10.1038/ncb2922; Chau YY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002404; Chen YT, 2014, J AM SOC NEPHROL, V25, P2847, DOI 10.1681/ASN.2013101079; Chong JJH, 2011, CELL STEM CELL, V9, P527, DOI 10.1016/j.stem.2011.10.002; CONNELL ND, 1983, CELL, V34, P245, DOI 10.1016/0092-8674(83)90155-1; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Davies Jamie A, 2012, Methods Mol Biol, V886, P135, DOI 10.1007/978-1-61779-851-1_12; Delany AM, 2003, ENDOCRINOLOGY, V144, P2588, DOI 10.1210/en.2002-221044; Dettman RW, 1998, DEV BIOL, V193, P169, DOI 10.1006/dbio.1997.8801; Essafi A, 2011, DEV CELL, V21, P559, DOI 10.1016/j.devcel.2011.07.014; Foley-Comer AJ, 2002, J CELL SCI, V115, P1383; Herrick SE, 2007, INT J ARTIF ORGANS, V30, P527, DOI 10.1177/039139880703000611; Herrick SE, 2004, INT J BIOCHEM CELL B, V36, P621, DOI 10.1016/j.biocel.2003.11.002; Herrick SE, 2000, J PATHOL, V192, P67; Holmdahl Lena E., 1994, Wound Repair and Regeneration, V2, P171, DOI 10.1046/j.1524-475X.1994.20306.x; Hsu YC, 2012, NAT REV MOL CELL BIO, V13, P103, DOI 10.1038/nrm3272; Karki S, 2014, FASEB J, V28, P1122, DOI 10.1096/fj.13-236828; Kawaguchi M, 2007, DEV DYNAM, V236, P2973, DOI 10.1002/dvdy.21334; Ksiazek K, 2006, J APPL PHYSIOL, V100, P988, DOI 10.1152/japplphysiol.01086.2005; Ksiazek K, 2013, AGEING RES REV, V12, P595, DOI 10.1016/j.arr.2013.01.008; Kuzma-Kuzniarska M, 2012, DIFFERENTIATION, V83, P128, DOI 10.1016/j.diff.2011.11.004; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Li YC, 2013, P NATL ACAD SCI USA, V110, P2324, DOI 10.1073/pnas.1214136110; Loureiro J, 2013, INT J NEPHROL, V2013, DOI 10.1155/2013/263285; Merrell AJ, 2016, NAT REV MOL CELL BIO; Minot C. S., 1890, American Naturalist, Vxxiv, P877; Mora CF, 2012, STEM CELLS DEV, V21, P296, DOI 10.1089/scd.2010.0470; PIFARRE R, 1968, AM J SURG, V115, P589, DOI 10.1016/0002-9610(68)90082-2; Que JW, 2008, P NATL ACAD SCI USA, V105, P16626, DOI 10.1073/pnas.0808649105; Rak-Raszewska A, 2012, ORGANOGENESIS, V8, P125, DOI 10.4161/org.22597; Ranghini E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062953; Rinkevich Y, 2012, NAT CELL BIOL, V14, P1251, DOI 10.1038/ncb2610; Sally ML, 2011, J CELL MOL MED, V15, P2095, DOI 10.1111/j.1582-4934.2010.01212.x; Shudo Y, 2011, J THORAC CARDIOV SUR, V142, P1188, DOI 10.1016/j.jtcvs.2011.07.002; Siegel N, 2010, HUM MOL GENET, V19, P3320, DOI 10.1093/hmg/ddq236; Siersbaek R, 2010, FEBS LETT, V584, P3242, DOI 10.1016/j.febslet.2010.06.010; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; Sulaiman H, 2000, J PATHOL, V192, P396, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH710>3.0.CO;2-4; Unbekandt M, 2010, KIDNEY INT, V77, P407, DOI 10.1038/ki.2009.482; Verardo R, 2014, STEM CELLS, V32, P2998, DOI 10.1002/stem.1791; von Gise A, 2011, DEV BIOL, V356, P421, DOI 10.1016/j.ydbio.2011.05.668; Wilm B, 2005, DEVELOPMENT, V132, P5317, DOI 10.1242/dev.02141; Winters NI, 2014, DEV BIOL, V391, P125, DOI 10.1016/j.ydbio.2014.04.003; Winters NI, 2012, DEVELOPMENT, V139, P2926, DOI 10.1242/dev.082396; Yanez-Mo M, 2003, NEW ENGL J MED, V348, P403, DOI 10.1056/NEJMoa020809; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060	48	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0158997	10.1371/journal.pone.0158997	http://dx.doi.org/10.1371/journal.pone.0158997			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27403660	Green Published, Green Submitted, gold			2022-12-27	WOS:000379508200027
J	Gopalani, M; Dhiman, A; Rahi, A; Kandari, D; Bhatnagar, R				Gopalani, Monisha; Dhiman, Alisha; Rahi, Amit; Kandari, Divya; Bhatnagar, Rakesh			Identification, Functional Characterization and Regulon Prediction of a Novel Two Component System Comprising BAS0540-BAS0541 of Bacillus anthracis	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION SYSTEMS; RESPONSE-REGULATOR; STREPTOCOCCUS-PNEUMONIAE; ESCHERICHIA-COLI; VANCOMYCIN RESISTANCE; STAPHYLOCOCCUS-AUREUS; VIRULENCE FACTOR; STRESS-RESPONSE; CELL-DIVISION; SUBTILIS	Two component systems (TCSs) can be envisaged as complex molecular devices that help the bacteria to sense its environment and respond aptly. 41 TCSs are predicted in Bacillus anthracis, a potential bioterrorism agent, of which only four have been studied so far. Thus, the intricate signaling network contributed by TCSs remains largely unmapped in B. anthracis and needs comprehensive exploration. In this study, we functionally characterized one such system composed of BAS0540 (Response regulator) and BAS0541 (Histidine kinase). BAS0540-BAS0541, the closest homolog of CiaRH of Streptococcus in B. anthracis, forms a functional TCS with BAS0541 displaying autophosphorylation and subsequent phosphotransfer to BAS0540. BAS0540 was also found to accept phosphate from physiologically relevant small molecule phosphodonors like acetyl phosphate and carbamoyl phosphate. Results of qRT-PCR and immunoblotting demonstrated that BAS0540 exhibits a constitutive expression throughout the growth of B. anthracis. Regulon prediction for BAS0540 in B. anthracis was done in silico using the consensus DNA binding sequence of CiaR of Streptococcus. The predicted regulon of BAS0540 comprised of 23 genes, which could be classified into 8 functionally diverse categories. None of the proven virulence factors were a part of the predicted regulon, an observation contrasting with the regulon of CiaRH in Streptococci. Electrophoretic mobility shift assay was used to show direct binding of purified BAS0540 to the upstream regions of 5 putative regulon candidates-BAS0540 gene itself; a gene predicted to encode cell division protein FtsA; a self-immunity gene; a RND family transporter gene and a gene encoding stress (heat) responsive protein. A significant enhancement in the DNA binding ability of BAS0540 was observed upon phosphorylation. Overexpression of response regulator BAS0540 in B. anthracis led to a prodigious increase of similar to 6 folds in the cell length, thereby conferring it a filamentous phenotype. Furthermore, the sporulation titer of the pathogen also decreased markedly by similar to 16 folds. Thus, this study characterizes a novel TCS of B. anthracis and elucidates its role in two of the most important physiological processes of the pathogen: cell division and sporulation.	[Gopalani, Monisha; Dhiman, Alisha; Rahi, Amit; Kandari, Divya; Bhatnagar, Rakesh] Jawaharlal Nehru Univ, Lab Mol Biol & Genet Engn, Sch Biotechnol, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Bhatnagar, R (corresponding author), Jawaharlal Nehru Univ, Lab Mol Biol & Genet Engn, Sch Biotechnol, New Delhi 110067, India.	rakeshbhatnagar@jnu.ac.in	Dhiman, Alisha/ABY-2171-2022	Dhiman, Alisha/0000-0002-4395-9292; Kandari, Divya/0000-0002-9575-0263	Department of Science and Technology, Govt. of India; Council of Scientific and Industrial Research-India; CSIR, Government of India; DST, Government of India; DBT, Government of India	Department of Science and Technology, Govt. of India(Department of Science & Technology (India)); Council of Scientific and Industrial Research-India(Council of Scientific & Industrial Research (CSIR) - India); CSIR, Government of India(Council of Scientific & Industrial Research (CSIR) - India); DST, Government of India(Department of Science & Technology (India)); DBT, Government of India(Department of Biotechnology (DBT) India)	This study was funded in part by Department of Science and Technology, Govt. of India. MG and AD acknowledge fellowships by Council of Scientific and Industrial Research-India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the financial support from CSIR, DST and DBT, Government of India. While Monisha Gopalani and Alisha Dhiman are recipients of a Senior Research Fellowship from CSIR, Government of India, Divya Kandari is a recipient of Junior Research Fellowship from DBT, Government of India. The funding agency has no role in study design or data analysis and interpretation. Mr. Ashok Kumar Sahu at AIRF, JNU is acknowledged for his technical help in Confocal microscopy experiments. We thank Shashwat Deepali Nagar for his inputs in the bioinformatics study.	Alm E, 2006, PLOS COMPUT BIOL, V2, P1329, DOI 10.1371/journal.pcbi.0020143; Barakat M, 2011, NUCLEIC ACIDS RES, V39, pD771, DOI 10.1093/nar/gkq1023; Barbieri CM, 2010, J BIOL CHEM, V285, P32325, DOI 10.1074/jbc.M110.157164; BEALL B, 1992, J BACTERIOL, V174, P2398, DOI 10.1128/JB.174.7.2398-2403.1992; BEALL B, 1991, GENE DEV, V5, P447, DOI 10.1101/gad.5.3.447; Belcheva A, 2008, J BIOL CHEM, V283, P12354, DOI 10.1074/jbc.M710010200; Bhate MP, 2015, STRUCTURE, V23, P981, DOI 10.1016/j.str.2015.04.002; Biasini M, 2014, NUCLEIC ACIDS RES; Bourret RB, 2002, J BIOL CHEM, V277, P9625, DOI 10.1074/jbc.R100066200; Brocker M, 2011, J BACTERIOL, V193, P1237, DOI 10.1128/JB.01032-10; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Comolli JC, 2002, J BACTERIOL, V184, P390, DOI 10.1128/JB.184.2.390-399.2002; de Been M, 2006, MICROBIOL-SGM, V152, P3035, DOI 10.1099/mic.0.29137-0; Dhiman A, 2014, FEBS OPEN BIO, V4, P65, DOI 10.1016/j.fob.2013.12.005; Dubrac S, 2004, J BACTERIOL, V186, P1175, DOI 10.1128/JB.186.4.1175-1181.2004; Feng XH, 2004, MOL MICROBIOL, V54, P823, DOI 10.1111/j.1365-2958.2004.04317.x; Feucht A, 2001, MOL MICROBIOL, V40, P115, DOI 10.1046/j.1365-2958.2001.02356.x; Fisher SL, 1996, BIOCHEMISTRY-US, V35, P4732, DOI 10.1021/bi9525435; Fukuchi K, 2000, MICROBIOL-UK, V146, P1573, DOI 10.1099/00221287-146-7-1573; Galperin MY, 2010, MOL BIOSYST, V6, P721, DOI 10.1039/b908047c; Galperin MY, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-35; Grimshaw CE, 1998, BIOCHEMISTRY-US, V37, P1365, DOI 10.1021/bi971917m; Halfmann A, 2011, J MOL MICROB BIOTECH, V20, P96, DOI 10.1159/000324893; Helmann JD, 2001, J BACTERIOL, V183, P7318, DOI 10.1128/JB.183.24.7318-7328.2001; Hoch JA, 2001, J BACTERIOL, V183, P4941, DOI 10.1128/JB.183.17.4941-4949.2001; Hoch JA, 1995, 2 COMPONENT SIGNAL T; HOLMAN TR, 1994, BIOCHEMISTRY-US, V33, P4625, DOI 10.1021/bi00181a024; Hudson MJ, 2008, INT J MED MICROBIOL, V298, P345, DOI 10.1016/j.ijmm.2007.09.007; Ibrahim YM, 2004, J BACTERIOL, V186, P5258, DOI 10.1128/JB.186.16.5258-5266.2004; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kjos M, 2010, J BACTERIOL, V192, P2068, DOI 10.1128/JB.01553-09; KOEHLER TM, 1994, J BACTERIOL, V176, P586, DOI 10.1128/jb.176.3.586-595.1994; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; Liu W, 1997, J BACTERIOL, V179, P6302, DOI 10.1128/jb.179.20.6302-6310.1997; Mao XZ, 2014, NUCLEIC ACIDS RES, V42, pD654, DOI 10.1093/nar/gkt1048; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marx P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-661; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Ng WL, 2005, J BACTERIOL, V187, P7444, DOI 10.1128/JB.187.21.7444-7459.2005; PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443; Periago PM, 2002, APPL ENVIRON MICROB, V68, P3486, DOI 10.1128/AEM.68.7.3486-3495.2002; Price CW, 2001, MOL MICROBIOL, V41, P757, DOI 10.1046/j.1365-2958.2001.02534.x; Puppe W, 1996, J BIOL CHEM, V271, P25027, DOI 10.1074/jbc.271.40.25027; Rangannan Vetriselvi, 2011, BMC Res Notes, V4, P257, DOI 10.1186/1756-0500-4-257; Ray JCJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000676; Ruiz D, 2008, MICROBIOL-SGM, V154, P3002, DOI 10.1099/mic.0.2008/020677-0; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SCHRODER I, 1994, J BACTERIOL, V176, P4985, DOI 10.1128/jb.176.16.4985-4992.1994; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Skerker JM, 2008, CELL, V133, P1043, DOI 10.1016/j.cell.2008.04.040; Skerker JM, 2005, PLOS BIOL, V3, P1770, DOI 10.1371/journal.pbio.0030334; Stephenson K, 2002, PHARMACOL THERAPEUT, V93, P293, DOI 10.1016/S0163-7258(02)00198-5; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; Thomas-Chollier M, 2011, NUCLEIC ACIDS RES, V39, pW86, DOI 10.1093/nar/gkr377; Throup JP, 2000, MOL MICROBIOL, V35, P566, DOI 10.1046/j.1365-2958.2000.01725.x; Xu HJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001104; Yamamoto K, 2005, J BIOL CHEM, V280, P1448, DOI 10.1074/jbc.M410104200; Zapf JW, 1996, BIOCHEMISTRY-US, V35, P2926, DOI 10.1021/bi9519361	59	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158895	10.1371/journal.pone.0158895	http://dx.doi.org/10.1371/journal.pone.0158895			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27392063	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400154
J	Jeong, SY; Lee, JH; Shin, Y; Chung, S; Kuh, HJ				Jeong, Su-Yeong; Lee, Ji-Hyun; Shin, Yoojin; Chung, Seok; Kuh, Hyo-Jeong			Co-Culture of Tumor Spheroids and Fibroblasts in a Collagen Matrix-Incorporated Microfluidic Chip Mimics Reciprocal Activation in Solid Tumor Microenvironment	PLOS ONE			English	Article							CANCER-ASSOCIATED FIBROBLASTS; STROMAL INTERACTIONS; COLON-CANCER; CELLS; RESISTANCE; CULTURE; MODEL; EXPRESSION; SYSTEM; POLYDIMETHYLSILOXANE	Multicellular 3D culture and interaction with stromal components are considered essential elements in establishing a 'more clinically relevant' tumor model. Matrix-embedded 3D cultures using a microfluidic chip platform can recapitulate the microscale interaction within tumor microenvironments. As a major component of tumor microenvironment, cancer-associated fibroblasts (CAFs) play a role in cancer progression and drug resistance. Here, we present a microfluidic chip-based tumor tissue culture model that integrates 3D tumor spheroids (TSs) with CAF in proximity within a hydrogel scaffold. HT-29 human colorectal carcinoma cells grew into 3D TSs and the growth was stimulated when co-cultured with fibroblasts as shown by 1.5-folds increase of % changes in diameter over 5 days. TS cultured for 6 days showed a reduced expression of Ki-67 along with increased expression of fibronectin when co-cultured with fibroblasts compared to mono-cultured TSs. Fibroblasts were activated under co-culture conditions, as demonstrated by increases in alpha-SMA expression and migratory activity. When exposed to paclitaxel, a survival advantage was observed in TSs co-cultured with activated fibroblasts. Overall, we demonstrated the reciprocal interaction between TSs and fibroblasts in our 7-channel microfluidic chip. The co-culture of 3D TS-CAF in a collagen matrix-incorporated microfluidic chip may be useful to study the tumor microenvironment and for evaluation of drug screening and evaluation.	[Jeong, Su-Yeong; Lee, Ji-Hyun; Kuh, Hyo-Jeong] Catholic Univ Korea, Grad Sch, Dept Biomed & Hlth Sci, Seoul, South Korea; [Shin, Yoojin] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Chung, Seok] Korea Univ, Sch Mech Engn, Seoul, South Korea; [Kuh, Hyo-Jeong] Catholic Univ Korea, Coll Med, Canc Evolut Res Ctr, Seoul, South Korea; [Kuh, Hyo-Jeong] Catholic Univ Korea, Coll Med, Dept Med Life Sci, Seoul, South Korea	Catholic University of Korea; Massachusetts Institute of Technology (MIT); Korea University; Catholic University of Korea; Catholic University of Korea	Kuh, HJ (corresponding author), Catholic Univ Korea, Grad Sch, Dept Biomed & Hlth Sci, Seoul, South Korea.; Kuh, HJ (corresponding author), Catholic Univ Korea, Coll Med, Canc Evolut Res Ctr, Seoul, South Korea.; Kuh, HJ (corresponding author), Catholic Univ Korea, Coll Med, Dept Med Life Sci, Seoul, South Korea.	hkuh@catholic.ac.kr			National Research Foundation of Korea (NRF) - Korea government (Ministry of Science, ICT and Future Planning) [2012R1A2A2A01003361, 2012R1A5A2047939]	National Research Foundation of Korea (NRF) - Korea government (Ministry of Science, ICT and Future Planning)	This work was supported by the National Research Foundation of Korea (NRF, http://www.nrf.re.kr) grant funded by the Korea government (Ministry of Science, ICT and Future Planning) (Nos. 2012R1A2A2A01003361 and 2012R1A5A2047939) to H-JK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli TM, 2012, EXPERT OPIN BIOL TH, V12, P1347, DOI 10.1517/14712598.2012.707181; Amornsupak K, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-955; An D, 2014, BIOMOL THER, V22, P355, DOI 10.4062/biomolther.2014.078; Aref AR, 2013, INTEGR BIOL-UK, V5, P381, DOI 10.1039/c2ib20209c; Beck B, 2013, NAT REV CANCER, V13, P727, DOI 10.1038/nrc3597; Bersini S, 2014, BIOMATERIALS, V35, P2454, DOI 10.1016/j.biomaterials.2013.11.050; Burguera EF, 2010, EUR CELLS MATER, V19, P166, DOI 10.22203/eCM.v019a17; Cao Y, 2015, CANCER LETT, V360, P141, DOI 10.1016/j.canlet.2015.01.041; Celgene Corporation, 2000, PHAS 2 STUD ABR NAB; Choe C, 2013, ANTICANCER RES, V33, P3715; Chuah YJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep18162; Cirri P, 2011, AM J CANCER RES, V1, P482; Cohen A, 2014, AUSTIN J GASTROENTER, V1, P1003; Davies S, 2015, BIOMED PHARMACOTHER, V71, P135, DOI 10.1016/j.biopha.2015.02.031; Denayer T, 2014, NEW HORIZ TRANSL MED, V2, P5, DOI 10.1016/j.nhtm.2014.08.001; Doillon CJ, 2004, ANTICANCER RES, V24, P2169; Elliott NT, 2012, BIOTECHNOL BIOENG, V109, P1326, DOI 10.1002/bit.24397; Fang Wei Bin, 2014, Front Biol (Beijing), V9, P114; Foty R, 2011, JOVE-J VIS EXP, DOI 10.3791/2720; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; Fuchs S, 2007, TISSUE ENG, V13, P2577, DOI 10.1089/ten.2007.0022; Fujita H, 2009, CANCER SCI, V100, P2309, DOI 10.1111/j.1349-7006.2009.01317.x; Fujiwara M, 2016, ONCOL LETT, V11, P2773, DOI 10.3892/ol.2016.4289; Halldorsson S, 2015, BIOSENS BIOELECTRON, V63, P218, DOI 10.1016/j.bios.2014.07.029; Han S, 2012, LAB CHIP, V12, P2305, DOI 10.1039/c2lc21285d; Havre PA, 2008, FRONT BIOSCI-LANDMRK, V13, P1634, DOI 10.2741/2787; Herrera M, 2013, CLIN CANCER RES, V19, P5914, DOI 10.1158/1078-0432.CCR-13-0694; Horman SR, 2013, J BIOMOL SCREEN, V18, P1298, DOI 10.1177/1087057113499405; Hu J, 2015, ONCOL LETT, V10, P2378, DOI 10.3892/ol.2015.3499; Huang SM, 2014, ENDOCR-RELAT CANCER, V21, P73, DOI 10.1530/ERC-13-0351; Jensen SA, 2010, EUR J CANCER, V46, P3233, DOI 10.1016/j.ejca.2010.07.046; Jia DS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-364; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Khawar IA, 2015, J CONTROL RELEASE, V201, P78, DOI 10.1016/j.jconrel.2014.12.018; Kim SY, 2012, ARCH PHARM RES, V35, P531, DOI 10.1007/s12272-012-0317-2; Kim S, 2013, LAB CHIP, V13, P1489, DOI 10.1039/c3lc41320a; Kim SA, 2015, EXP CELL RES, V335, P187, DOI 10.1016/j.yexcr.2015.05.016; Larrinaga G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119436; Lee DW, 2013, SENSOR ACTUAT B-CHEM, V177, P78, DOI 10.1016/j.snb.2012.10.129; Lee H, 2014, BIOMICROFLUIDICS, V8, DOI 10.1063/1.4894595; Liu TJ, 2010, LAB CHIP, V10, P1671, DOI 10.1039/c000022a; Majety M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127948; Mazzoccoli G, 2012, J CANCER RES CLIN, V138, P501, DOI 10.1007/s00432-011-1126-6; Mellor LF, 2014, AVIAT SPACE ENVIR MD, V85, P798, DOI 10.3357/ASEM.3905.2014; Mesker WE, 2007, CELL ONCOL, V29, P387; Miyanaga K, 2002, ANTICANCER RES, V22, P3941; Nebiker CA, 2014, CLIN CANCER RES, V20, P3094, DOI 10.1158/1078-0432.CCR-13-2774; Ongusaha PP, 2004, CANCER RES, V64, P5283, DOI 10.1158/0008-5472.CAN-04-0925; Paraiso KHT, 2013, BIOCHEM PHARMACOL, V85, P1033, DOI 10.1016/j.bcp.2013.01.018; Roussos ET, 2011, NAT REV CANCER, V11, P573, DOI 10.1038/nrc3078; Ryu J, 2010, ADV FUNCT MATER, V20, P2132, DOI 10.1002/adfm.200902347; Schyschka L, 2013, ARCH TOXICOL, V87, P1581, DOI 10.1007/s00204-013-1080-y; Shin Y, 2012, NAT PROTOC, V7, P1247, DOI 10.1038/nprot.2012.051; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Unger C, 2014, ADV DRUG DELIVER REV, V79-80, P50, DOI 10.1016/j.addr.2014.10.015; van Duinen V, 2015, CURR OPIN BIOTECH, V35, P118, DOI 10.1016/j.copbio.2015.05.002; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Zeng Fan, 2014, Journal of Pharmaceutical Investigation, V44, P493, DOI 10.1007/s40005-014-0154-z; Zheng LH, 2014, ONCOL LETT, V8, P479, DOI 10.3892/ol.2014.2225	61	160	164	3	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159013	10.1371/journal.pone.0159013	http://dx.doi.org/10.1371/journal.pone.0159013			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391808	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400190
J	Knappova, J; Pankova, H; Munzbergov, Z				Knappova, Jana; Pankova, Hana; Munzbergov, Zuzana			Roles of Arbuscular Mycorrhizal Fungi and Soil Abiotic Conditions in the Establishment of a Dry Grassland Community	PLOS ONE			English	Article							INFLUENCE PLANT DIVERSITY; ZEA-MAYS L.; AGRICULTURAL PRACTICES; VERTICAL-DISTRIBUTION; SPECIES RICHNESS; FIELD; COLONIZATION; DYNAMICS; BIOMASS; BENOMYL	Background The importance of soil biota in the composition of mature plant communities is commonly acknowledged. In contrast, the role of soil biota in the early establishment of new plant communities and their relative importance for soil abiotic conditions are still poorly understood. Aims and Methods The aim of this study was to understand the effects of soil origin and soil fungal communities on the composition of a newly established dry grassland plant community. We used soil from two different origins (dry grassland and abandoned field) with different pH and nutrient and mineral content. Grassland microcosms were established by sowing seeds of 54 species of dry grassland plants into the studied soils. To suppress soil fungi, half of the pots were regularly treated with fungicide. In this way, we studied the independent and combined effects of soil origin and soil community on the establishment of dry grassland communities. Key Results The effect of suppressing the soil fungal community on the richness and composition of the plant communities was much stronger than the effect of soil origin. Contrary to our expectations, the effects of these two factors were largely additive, indicating the same degree of importance of soil fungal communities in the establishment of species-rich plant communities in the soils from both origins. The negative effect of suppressing soil fungi on species richness, however, occurred later in the soil from the abandoned field than in the soil from the grassland. This result likely occurred because the negative effects of the suppression of fungi in the field soil were caused mainly by changes in plant community composition and increased competition. In contrast, in the grassland soil, the absence of soil fungi was limiting for plants already at the early stages of their establishment, i.e., in the phases of germination and early recruitment. While fungicide affects not only arbuscular mycorrhizal fungi but also other biota, our data indicate that changes in the AMF communities are the most likely drivers of the observed changes. The effects of other soil biota, however, cannot be fully excluded. Conclusions These results suggest that the availability of soil fungi may not be the most important limiting factor for the establishment of grassland species in abandoned fields if we manage to reduce the intensity of competition at these sites e.g., by mowing or grazing.	[Knappova, Jana; Pankova, Hana; Munzbergov, Zuzana] Acad Sci, Inst Bot, Zamek 1, Pruhonice 25243, Czech Republic; [Knappova, Jana; Munzbergov, Zuzana] Charles Univ Prague, Fac Sci, Dept Bot, Benatska 2, Prague 12801, Czech Republic	Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; Charles University Prague	Munzbergov, Z (corresponding author), Acad Sci, Inst Bot, Zamek 1, Pruhonice 25243, Czech Republic.; Munzbergov, Z (corresponding author), Charles Univ Prague, Fac Sci, Dept Bot, Benatska 2, Prague 12801, Czech Republic.	zuzmun@natur.cuni.cz	Pánková, Hana/H-1617-2014; Münzbergová, Zuzana/F-6321-2013; Knappová, Jana/I-7197-2016	Pánková, Hana/0000-0001-6012-541X; Münzbergová, Zuzana/0000-0002-4026-6220; Knappová, Jana/0000-0002-8095-2583	Grant agency of the Czech Republic [GACR 15-11635S]; Czech Academy of Sciences [RVO 67985939]	Grant agency of the Czech Republic(Grant Agency of the Czech Republic); Czech Academy of Sciences(Czech Academy of Sciences)	The study was support by Grant agency of the Czech Republic (www.gacr.cz, grant no. GACR 15-11635S) and institutional projects of Ministry of education (www.msmt.cz) and Czech Academy of Sciences (www.cas.cz, project no. RVO 67985939).; We thank Lenka Cosentino for help with maintenance and for evaluating the experiment, David Cmiral, Vaclav Rimal and Michal Knapp for help with soil collection, Helena Kebrtova, Vera Rydlova, Marketa Sequencova, Ondrej Minovsky and student helpers for harvesting and preparing root samples and the POPEKOL discussion group and two anonymous reviewers for useful comments on the previous version of the manuscript. The study was support by Grant agency of the Czech Republic (www.gacr.cz, grant no. GACR 15-11635S) and institutional projects of Ministry of education (www.msmt.cz) and Czech Academy of Sciences (www.cas.cz, project no. RVO 67985939).	AERTS R, 1991, OECOLOGIA, V87, P551, DOI 10.1007/BF00320419; AN ZQ, 1990, SOIL BIOL BIOCHEM, V22, P715, DOI 10.1016/0038-0717(90)90020-Z; Anderson RC, 2008, RESTOR ECOL, V16, P650, DOI 10.1111/j.1526-100X.2008.00488.x; Barni E, 2000, MYCORRHIZA, V10, P63, DOI 10.1007/s005720000059; Bever JD, 2003, NEW PHYTOL, V157, P465, DOI 10.1046/j.1469-8137.2003.00714.x; Boddington CL, 2000, PLANT SOIL, V218, P137, DOI 10.1023/A:1014966801446; Boddington CL, 2000, PLANT SOIL, V218, P145, DOI 10.1023/A:1014911318284; Boerner REJ, 1996, MYCORRHIZA, V6, P79, DOI 10.1007/s005720050111; Boyer LR, 2015, MYCORRHIZA, V25, P215, DOI 10.1007/s00572-014-0603-6; Braak Ter C., 1998, CANOCO REFERENCE MAN; Callaway RM, 1995, BOT REV, V61, P306, DOI 10.1007/BF02912621; Cerna L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116992; Chen SK, 2001, SOIL BIOL BIOCHEM, V33, P1971, DOI 10.1016/S0038-0717(01)00131-6; Chylova T, 2008, PRESLIA, V80, P183; Dhillion SS, 2004, CAN J BOT, V82, P104, DOI [10.1139/b03-139, 10.1139/B03-139]; Dostalek T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080535; Doubkova P, 2013, PLANT SOIL, V370, P149, DOI 10.1007/s11104-013-1610-7; Drouin P, 2010, J ENVIRON SCI HEAL B, V45, P757, DOI 10.1080/03601234.2010.515168; Duchicela J, 2013, J APPL ECOL, V50, P1266, DOI 10.1111/1365-2664.12130; Ejrnaes R, 2006, ECOLOGY, V87, P1225, DOI 10.1890/0012-9658(2006)87[1225:CAIEGS]2.0.CO;2; Environmental Protection Agency, 2001, BEN; Eriksson O, 1998, ECOL RES, V13, P229, DOI 10.1046/j.1440-1703.1998.00260.x; FITTER AH, 1986, NEW PHYTOL, V103, P767, DOI 10.1111/j.1469-8137.1986.tb00851.x; FITTER AH, 1988, NEW PHYTOL, V110, P201, DOI 10.1111/j.1469-8137.1988.tb00253.x; Foster BL, 2009, ECOL APPL, V19, P1884, DOI 10.1890/08-0849.1; FRIESE CF, 1991, MYCOLOGIA, V83, P409, DOI 10.2307/3760351; Fukami T, 2005, ECOL LETT, V8, P1283, DOI 10.1111/j.1461-0248.2005.00829.x; Fukami T, 2011, ECOL LETT, V14, P973, DOI 10.1111/j.1461-0248.2011.01663.x; Gange AC, 1999, OIKOS, V87, P615, DOI 10.2307/3546829; GANGE AC, 1993, FUNCT ECOL, V7, P616, DOI 10.2307/2390139; GIOVANNETTI M, 1980, NEW PHYTOL, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; GRIME JP, 1987, NATURE, V328, P420, DOI 10.1038/328420a0; GRYNDLER M, 1995, ROST VYROBA, V41, P533; HARLEY JL, 1987, NEW PHYTOL, V107, P741, DOI 10.1111/j.1469-8137.1987.tb00912.x; Hart MM, 2003, TRENDS ECOL EVOL, V18, P418, DOI 10.1016/S0169-5347(03)00127-7; Hart MM, 2002, NEW PHYTOL, V153, P335, DOI 10.1046/j.0028-646X.2001.00312.x; Hartnett DC, 1999, ECOLOGY, V80, P1187, DOI 10.1890/0012-9658(1999)080[1187:MIPCSA]2.0.CO;2; Helgason T, 2007, J ECOL, V95, P623, DOI 10.1111/j.1365-2745.2007.01239.x; Hemrova L, 2015, OIKOS, V124, P437, DOI 10.1111/oik.01130; Heneghan L, 2008, RESTOR ECOL, V16, P608, DOI 10.1111/j.1526-100X.2008.00477.x; Hijri I, 2006, MOL ECOL, V15, P2277, DOI 10.1111/j.1365-294X.2006.02921.x; Hoechst Schering AgrEvo, TECHN INF CARB; JAKOBSEN I, 1983, NEW PHYTOL, V93, P401, DOI 10.1111/j.1469-8137.1983.tb03440.x; JANOS DP, 1980, BIOTROPICA, V12, P56, DOI 10.2307/2388157; Jansa J, 2002, MYCORRHIZA, V12, P225, DOI [10.1007/s005572-002-0163-z, 10.1007/s00572-002-0163-z]; Janssens F, 1998, PLANT SOIL, V202, P69, DOI 10.1023/A:1004389614865; Johnson Nancy Collins, 1992, V54, P71; JOHNSON NC, 1991, OECOLOGIA, V86, P349, DOI 10.1007/BF00317600; JOHNSON NC, 1993, ECOL APPL, V3, P749, DOI 10.2307/1942106; JOHNSON NC, 1991, NEW PHYTOL, V117, P657, DOI 10.1111/j.1469-8137.1991.tb00970.x; Kabir Z, 1998, MYCORRHIZA, V8, P53, DOI 10.1007/s005720050211; Karanika ED, 2008, PLANT ECOL, V199, P225, DOI 10.1007/s11258-008-9427-9; Kardol P, 2014, J ECOL, V102, P622, DOI 10.1111/1365-2745.12234; Kardol P, 2013, OIKOS, V122, P84, DOI 10.1111/j.1600-0706.2012.20546.x; Knappova J, 2015, AGR ECOSYST ENVIRON, V200, P200, DOI 10.1016/j.agee.2014.11.008; Knappova J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065879; Knappova J, 2012, LANDSCAPE ECOL, V27, P97, DOI 10.1007/s10980-011-9680-5; KOSKE RE, 1989, MYCOL RES, V92, P486, DOI 10.1016/S0953-7562(89)80195-9; Lepa J., 2003, MULTIVARIATE ANAL EC; Lindborg R, 2006, BIODIVERS CONSERV, V15, P957, DOI 10.1007/s10531-004-3508-4; Lopez-Garcia A, 2014, OECOLOGIA, V176, P1075, DOI 10.1007/s00442-014-3091-7; Mader P, 2000, BIOL FERT SOILS, V31, P150, DOI 10.1007/s003740050638; MARTENSSON AM, 1992, SOIL BIOL BIOCHEM, V24, P435, DOI 10.1016/0038-0717(92)90206-D; Massenssini AM, 2014, PLANTA DANINHA, V32, P873, DOI 10.1590/S0100-83582014000400022; MCGONIGLE TP, 1990, NEW PHYTOL, V116, P629, DOI 10.1111/j.1469-8137.1990.tb00548.x; Merryweather J, 1996, NEW PHYTOL, V132, P307, DOI 10.1111/j.1469-8137.1996.tb01850.x; Middleton EL, 2012, RESTOR ECOL, V20, P218, DOI 10.1111/j.1526-100X.2010.00752.x; Mouillot D, 2006, OIKOS, V115, P349, DOI 10.1111/j.2006.0030-1299.14894.x; Mouquet N, 2004, OIKOS, V104, P77, DOI 10.1111/j.0030-1299.2004.12644.x; Munzbergova Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046704; Munzbergova Z, 2004, OIKOS, V105, P408, DOI 10.1111/j.0030-1299.2004.13017.x; Muthukumar T, 2004, MYCORRHIZA, V14, P65, DOI 10.1007/s00572-004-0296-3; NEWSHAM KK, 1994, J ECOL, V82, P805, DOI 10.2307/2261445; O'Connor PJ, 2002, NEW PHYTOL, V154, P209, DOI 10.1046/j.1469-8137.2002.00364.x; Oehl F, 2005, NEW PHYTOL, V165, P273, DOI 10.1111/j.1469-8137.2004.01235.x; Oehl F, 2003, APPL ENVIRON MICROB, V69, P2816, DOI 10.1128/AEM.69.5.2816-2824.2003; Olsen R., 1954, US DEP AGR CIRCULAR, V939, P1; Osbornova J., 1990, SUCCESSION ABANDONED, VVolume 15; Pankova H, 2008, OECOLOGIA, V157, P211, DOI 10.1007/s00442-008-1064-4; Pankova H, 2011, AM J BOT, V98, P850, DOI 10.3732/ajb.0900350; Poggio SL, 2011, WEED RES, V51, P241, DOI 10.1111/j.1365-3180.2011.00845.x; Puschel D, 2007, BASIC APPL ECOL, V8, P510, DOI 10.1016/j.baae.2006.09.002; Pywell RF, 2002, J APPL ECOL, V39, P294, DOI 10.1046/j.1365-2664.2002.00718.x; Raabova J, 2011, BASIC APPL ECOL, V12, P152, DOI 10.1016/j.baae.2011.01.001; READ DJ, 1988, P ROY SOC EDINB B, V94, P13, DOI 10.1017/S0269727000007065; REEVES FB, 1979, AM J BOT, V66, P6, DOI 10.2307/2442618; Richter BS, 2002, APPL SOIL ECOL, V20, P227, DOI 10.1016/S0929-1393(02)00038-0; Sakai S, 2004, J THEOR BIOL, V226, P253, DOI 10.1016/S0022-5193(03)00281-9; Schweiger PF, 2001, SOIL BIOL BIOCHEM, V33, P1231, DOI 10.1016/S0038-0717(01)00028-1; Skalova H, 1999, PLANT ECOL, V143, P129, DOI 10.1023/A:1009899803229; Smith MD, 1999, OECOLOGIA, V121, P574, DOI 10.1007/s004420050964; Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, P1; Standish RJ, 2007, J APPL ECOL, V44, P435, DOI 10.1111/j.1365-2664.2006.01262.x; Stover HJ, 2012, APPL SOIL ECOL, V60, P61, DOI 10.1016/j.apsoil.2012.02.016; Tognetti PM, 2012, BIOL INVASIONS, V14, P2531, DOI 10.1007/s10530-012-0249-2; van Breugel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082433; van der Heijden MGA, 2004, ECOL LETT, V7, P293, DOI 10.1111/j.1461-0248.2004.00577.x; van der Heijden MGA, 2003, NEW PHYTOL, V157, P569, DOI 10.1046/j.1469-8137.2003.00688.x; van der Heijden MGA, 1998, ECOLOGY, V79, P2082, DOI 10.1890/0012-9658(1998)079[2082:DAMFSA]2.0.CO;2; van der Wal A, 2009, RESTOR ECOL, V17, P308, DOI 10.1111/j.1526-100X.2007.00349.x; Verbruggen E, 2010, EVOL APPL, V3, P547, DOI 10.1111/j.1752-4571.2010.00145.x; Voriskova A, 2016, AGR ECOSYST ENVIRON, V221, P28, DOI 10.1016/j.agee.2016.01.012; Walker KJ, 2004, BIOL CONSERV, V119, P1, DOI 10.1016/j.biocon.2003.10.020; Wilson GWT, 1998, AM J BOT, V85, P1732, DOI 10.2307/2446507; WILSON JM, 1983, AUST J SOIL RES, V21, P73, DOI 10.1071/SR9830073; Yang HJ, 2011, GLOBAL CHANGE BIOL, V17, P2936, DOI 10.1111/j.1365-2486.2011.02423.x; Zhao RX, 2015, APPL SOIL ECOL, V88, P41, DOI 10.1016/j.apsoil.2014.11.016	107	9	10	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158925	10.1371/journal.pone.0158925	http://dx.doi.org/10.1371/journal.pone.0158925			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391899	gold, Green Published, Green Submitted			2022-12-27	WOS:000380005400165
J	Madico, G; Mpeirwe, M; White, L; Vinhas, S; Orr, B; Orikiriza, P; Miller, NS; Gaeddert, M; Mwanga-Amumpaire, J; Palaci, M; Kreiswirth, B; Straight, J; Dietze, R; Boum, Y; Jones-Lopez, EC				Madico, Guillermo; Mpeirwe, Moses; White, Laura; Vinhas, Solange; Orr, Beverley; Orikiriza, Patrick; Miller, Nancy S.; Gaeddert, Mary; Mwanga-Amumpaire, Juliet; Palaci, Moises; Kreiswirth, Barry; Straight, Joe; Dietze, Reynaldo; Boum, Yap, II; Jones-Lopez, Edward C.			Detection and Quantification of Mycobacterium tuberculosis in the Sputum of Culture-Negative HIV-infected Pulmonary Tuberculosis Suspects: A Proof-of-Concept Study	PLOS ONE			English	Article							XPERT MTB/RIF ASSAY; DIAGNOSTIC-ACCURACY; CONTROLLED-TRIAL; STANDARDS; CHILDREN; TB; METAANALYSIS; RESISTANCE; PROSPECTS; SETTINGS	Rationale Rapid diagnosis of pulmonary tuberculosis (TB) is critical for timely initiation of treatment and interruption of transmission. Yet, despite recent advances, many patients remain undiagnosed. Culture, usually considered the most sensitive diagnostic method, is sub-optimal for paucibacillary disease. Methods We evaluated the Totally Optimized PCR (TOP) TB assay, a new molecular test that we hypothesize is more sensitive than culture. After pre-clinical studies, we estimated TOP's per-patient sensitivity and specificity in a convenience sample of 261 HIV-infected pulmonary TB suspects enrolled into a TB diagnostic study in Mbarara, Uganda against MGIT culture, Xpert MTB/RIF and a composite reference standard. We validated results with a confirmatory PCR used for sequencing M. tuberculosis. Measurements and Results Using culture as reference, TOP had 100% sensitivity but 35% specificity. Against a composite reference standard, the sensitivity of culture (27%) and Xpert MTB/RIF (27%) was lower than TOP (99%), with similar specificity (100%, 98% and 87%, respectively). In unadjusted analyses, culture-negative/TOP-positive patients were more likely to be older (P<0.001), female (P<0.001), have salivary sputum (P = 0.05), sputum smear-negative (P<0.001) and less advanced disease on chest radiograph (P = 0.05). M. tuberculosis genotypes identified in sputum by DNA sequencing exhibit differential growth in culture. Conclusions These findings suggest that the TOP TB assay is accurately detecting M. tuberculosis DNA in the sputum of culture-negative tuberculosis suspects. Our results require prospective validation with clinical outcomes. If the operating characteristics of the TOP assay are confirmed in future studies, it will be justified as a "TB rule out" test.	[Madico, Guillermo; Gaeddert, Mary; Jones-Lopez, Edward C.] Boston Med Ctr, Dept Med, Infect Dis Sect, Boston, MA 02118 USA; [Madico, Guillermo; Gaeddert, Mary; Jones-Lopez, Edward C.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Mpeirwe, Moses; Orikiriza, Patrick; Mwanga-Amumpaire, Juliet; Boum, Yap, II] Epicentre, Med Sans Frontieres, Mbarara, Uganda; [Mpeirwe, Moses] Mbarara Univ Sci & Technol, Mbarara, Uganda; [White, Laura] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Vinhas, Solange; Palaci, Moises; Dietze, Reynaldo] Univ Fed Espirito Santo, Nucleo Doencas Infecciosas, Vitoria, Brazil; [Orr, Beverley] Boston Med Ctr, Clin Microbiol Lab, Boston, MA USA; [Miller, Nancy S.] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA; [Kreiswirth, Barry] Rutgers State Univ, Publ Hlth Res Inst, Newark, NJ USA; [Madico, Guillermo; Straight, Joe; Jones-Lopez, Edward C.] Thisis Diagnost Inc, Boston, MA USA	Boston Medical Center; Boston University; Mbarara University of Science & Technology; Boston University; Universidade Federal do Espirito Santo; Boston Medical Center; Boston University; Rutgers State University Newark; Rutgers State University New Brunswick	Jones-Lopez, EC (corresponding author), Boston Med Ctr, Dept Med, Infect Dis Sect, Boston, MA 02118 USA.; Jones-Lopez, EC (corresponding author), Boston Univ, Sch Med, Boston, MA 02118 USA.; Jones-Lopez, EC (corresponding author), Thisis Diagnost Inc, Boston, MA USA.	edward.jones@bmc.org		White, Laura F/0000-0002-0588-8235; Dietze, Reynaldo/0000-0002-6995-8001; Mpeirwe, Moses/0000-0001-5412-3418; Miller, Nancy/0000-0001-5878-0896; Jones Lopez, Edward/0000-0001-6323-286X	Uganda Research Student Support Fund (URSSF); Thisis Diagnostics, Inc.	Uganda Research Student Support Fund (URSSF); Thisis Diagnostics, Inc.	This work was supported by internal funds, The Uganda Research Student Support Fund (URSSF), and in part by Thisis Diagnostics, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, PUBLIC HLTH SERVICE; Armbruster David A, 2008, Clin Biochem Rev, V29 Suppl 1, pS49; Barnard M, 2012, J CLIN MICROBIOL, V50, P3712, DOI 10.1128/JCM.01958-12; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Boum Y, 2016, J CLIN MICROBIOL, V54, P1520, DOI 10.1128/JCM.00017-16; Boum Y, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0638-5; Boyles TH, 2014, INT J TUBERC LUNG D, V18, P876, DOI 10.5588/ijtld.13.0853; BPHC, 2013, TUB IMP BOST RES 201; Caliendo AM, 2013, CLIN INFECT DIS, V57, pS139, DOI 10.1093/cid/cit578; CDC, 2014, REP TUB US 2013; Chang K, 2012, J INFECTION, V64, P580, DOI 10.1016/j.jinf.2012.02.012; Dendukuri N, 2011, EVALUATING DIAGNOSTI; Denis M, 1997, MOL CELL PROBE, V11, P439, DOI 10.1006/mcpr.1997.0139; Denkinger CM, 2014, EUR RESPIR J, V44, P435, DOI 10.1183/09031936.00007814; Dorman S, 2015, INT J TUBERC LUNG D, V19, P504, DOI 10.5588/ijtld.15.0048; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Esmail H, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0437; Fennelly KP, 2012, J CLIN MICROBIOL, V50, P2096, DOI 10.1128/JCM.00572-12; Fontela PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007753; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Guwatudde D, 2003, AM J EPIDEMIOL, V158, P887, DOI 10.1093/aje/kwg227; Hadgu A, 2005, EPIDEMIOLOGY, V16, P604, DOI 10.1097/01.ede.0000173042.07579.17; Health A., 2014, TUBERCULOSIS ALBERTA; Holmes CB, 1998, INT J TUBERC LUNG D, V2, P96; Kana BD, 2008, MOL MICROBIOL, V67, P672, DOI 10.1111/j.1365-2958.2007.06078.x; Kent PT, 1985, GUIDE LEVEL 3 LAB; Khan MS, 2007, LANCET, V369, P1955, DOI 10.1016/S0140-6736(07)60916-7; Kieser KJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005010; Lawn SD, 2011, INT J TUBERC LUNG D, V15, P287; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Ministry of Health RoU, 2008, NAT TUB LEPR PROGR; Naaktgeboren CA, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5605; Nathan C, 2015, IMMUNOL REV, V264, P308, DOI 10.1111/imr.12275; Nhamoyebonde S, 2014, J INFECT DIS, V209, pS100, DOI 10.1093/infdis/jiu147; Nicol MP, 2013, CLIN INFECT DIS, V57, pE18, DOI 10.1093/cid/cit230; Pai M, 2015, J INFECT DIS, V211, pS21, DOI 10.1093/infdis/jiu803; Perez-Velez CM, 2012, NEW ENGL J MED, V367, P348, DOI 10.1056/NEJMra1008049; Reitsma JB, 2009, J CLIN EPIDEMIOL, V62, P797, DOI 10.1016/j.jclinepi.2009.02.005; Salgame P, 2015, TUBERCULOSIS, V95, P373, DOI 10.1016/j.tube.2015.04.003; Salimnia H, 2016, J CLIN MICROBIOL, V54, P687, DOI 10.1128/JCM.01679-15; Sloot R, 2014, AM J RESP CRIT CARE, V190, P1044, DOI 10.1164/rccm.201406-1159OC; STEAD WW, 1967, NEW ENGL J MED, V277, P1008, DOI 10.1056/NEJM196711092771906; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; Sterling T JC, 2015, C RETR OPP INF 2015; Theron G, 2016, CLIN INFECT DIS, V62, P995, DOI 10.1093/cid/civ1223; UNITAID, 2015, UNITAID TUB DIAGN TE, Vfourth.; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; WHO, 2009, STRAT TECHN ADV GROU; World Health Organization, 2014, END TB STRAT GLOB ST; World Health Organization, 2013, SYST SCREEN ACT TUB; World Health Organization, 2014, WHOHTMTB201408	52	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158371	10.1371/journal.pone.0158371	http://dx.doi.org/10.1371/journal.pone.0158371			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391604	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400046
J	Simon, N; Vasseur, M; Pinturaud, M; Soichot, M; Richeval, C; Humbert, L; Lebecque, M; Sidikou, O; Barthelemy, C; Bonnabry, P; Allorge, D; Decaudin, B; Odou, P				Simon, Nicolas; Vasseur, Michele; Pinturaud, Marine; Soichot, Marion; Richeval, Camille; Humbert, Luc; Lebecque, Michele; Sidikou, Ousseini; Barthelemy, Christine; Bonnabry, Pascal; Allorge, Delphine; Decaudin, Bertrand; Odou, Pascal			Effectiveness of a Closed-System Transfer Device in Reducing Surface Contamination in a New Antineoplastic Drug-Compounding Unit: A Prospective, Controlled, Parallel Study	PLOS ONE			English	Article							HOSPITAL PHARMACIES; WORKPLACE CONTAMINATION; ENVIRONMENTAL CONTAMINATION; CLEANING SOLUTIONS; ANTICANCER DRUGS; HAZARDOUS DRUGS; CYCLOPHOSPHAMIDE; AGENTS; EXPOSURE; EFFICACY	Background The objective of this randomized, prospective and controlled study was to investigate the ability of a closed-system transfer device (CSTD; BD-Phaseal) to reduce the occupational exposure of two isolators to 10 cytotoxic drugs and compare to standard compounding devices. Methods and Findings The 6-month study started with the opening of a new compounding unit. Two isolators were set up with 2 workstations each, one to compound with standard devices (needles and spikes) and the other using the Phaseal system. Drugs were alternatively compounded in each isolator. Sampling involved wiping three surfaces (gloves, window, worktop), before and after a cleaning process. Exposure to ten antineoplastic drugs (cyclophosphamide, ifosfamide, dacarbazine, 5-FU, methotrexate, gemcitabine, cytarabine, irinotecan, doxorubicine and ganciclovir) was assessed on wipes by LC-MS/MS analysis. Contamination rates were compared using a Chi(2) test and drug amounts by a Mann-Whitney test. Significance was defined for p<0.05. Overall contamination was lower in the "Phaseal" isolator than in the "Standard" isolator (12.24% vs. 26.39%; p < 0.0001) although it differed according to drug. Indeed, the contamination rates of gemcitabine were 49.3 and 43.4%(NS) for the Standard and Phaseal isolators, respectively, whereas for ganciclovir, they were 54.2 and 2.8% (p < 0.0001). Gemcitabine amounts were 220.6 and 283.6 ng for the Standard and Phaseal isolators (NS), and ganciclovir amounts were 179.9 and 2.4 ng (p < 0.0001). Conclusion This study confirms that using a CSTD may significantly decrease the chemical contamination of barrier isolators compared to standard devices for some drugs, although it does not eliminate contamination totally.	[Simon, Nicolas; Vasseur, Michele; Barthelemy, Christine; Decaudin, Bertrand; Odou, Pascal] GRITA Grp Rech Formes Injectables & Technol Assoc, EA 7365, F-59000 Lille, France; [Simon, Nicolas; Vasseur, Michele; Pinturaud, Marine; Lebecque, Michele; Sidikou, Ousseini; Decaudin, Bertrand; Odou, Pascal] CHU Lille, Inst Pharmacie, F-59000 Lille, France; [Soichot, Marion] Hop Lariboisiere, AP HP, Lab Toxicol, Paris, France; [Richeval, Camille; Humbert, Luc; Allorge, Delphine] CHRU Lille, Unite Fonct Toxicol, Pole Biol Pathol Genet, F-59037 Lille, France; [Bonnabry, Pascal] Univ Hosp Geneva, Pharm, Geneva, Switzerland; [Bonnabry, Pascal] Univ Geneva, Univ Lausanne, Sch Pharmaceut Sci, Geneva, Switzerland	Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; CHU Lille; University of Geneva; University of Geneva; University of Lausanne	Simon, N (corresponding author), GRITA Grp Rech Formes Injectables & Technol Assoc, EA 7365, F-59000 Lille, France.; Simon, N (corresponding author), CHU Lille, Inst Pharmacie, F-59000 Lille, France.	nicolas.simon@univ-lille2.fr	BARTHELEMY, Christine/A-8968-2017; SIMON, Nicolas/G-4328-2016	BARTHELEMY, Christine/0000-0001-9774-1857; allorge, delphine/0000-0003-2356-3319; SIMON, Nicolas/0000-0001-5257-440X	Becton-Dickinson laboratories, manufacturer of the tested device	Becton-Dickinson laboratories, manufacturer of the tested device	The study was funded by Becton-Dickinson laboratories, manufacturer of the tested device. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Society of Health-System Pharmacists, 2006, AM J HEALTH-SYST PH, V63, P1172, DOI DOI 10.2146/AJHP050529; Anastasi M, 2015, ANN OCCUP HYG, V59, P895, DOI 10.1093/annhyg/mev031; [Anonymous], 1996, AM J HEALTH-SYST PH, V53, P1669; Bobin-Dubigeon C, 2013, J ANAL TOXICOL, V37, P433, DOI 10.1093/jat/bkt045; Clark Bernadette A, 2013, J Oncol Pharm Pract, V19, P99, DOI 10.1177/1078155212468367; Comite Francais d'Accreditation, SH GTA 04 GUIDE TECH; Connor TH, 2002, AM J HEALTH-SYST PH, V59, P68, DOI 10.1093/ajhp/59.1.68; Connor TH, 2014, J OCCUP ENVIRON MED, V56, P901, DOI 10.1097/JOM.0000000000000249; Connor TH, 2010, J OCCUP ENVIRON MED, V52, P1019, DOI 10.1097/JOM.0b013e3181f72b63; De Ausen L, 2013, AM J HEALTH-SYST PH, V70, P619, DOI 10.2146/ajhp110678; Dekyndt B, 2015, J ONCOL PHARM PRACT, V21, P102, DOI 10.1177/1078155214520820; Edwards Michael S, 2013, J Oncol Pharm Pract, V19, P338, DOI 10.1177/1078155213499387; FALCK K, 1979, LANCET, V1, P1250; Favier B, 2012, J Oncol Pharm Pract, V18, P37, DOI 10.1177/1078155211401454; Fleury-Souverain S, 2015, EUR J HOSP PHARM, V22, P333, DOI 10.1136/ejhpharm-2014-000549; Forges Fabien, 2011, J Oncol Pharm Pract, V17, P61, DOI 10.1177/1078155210380291; GERPAC-Europharmat Workgroup, 2007, PREP ADM DRUGS RISK; Guillemette A, 2014, J ONCOL PHARM PRACT, V20, P426, DOI 10.1177/1078155213517127; Hama Koji, 2011, J Oncol Pharm Pract, V17, P55, DOI 10.1177/1078155210373671; HARRISON BR, 1981, AM J HOSP PHARM, V38, P1686, DOI 10.1093/ajhp/38.11.1686; Harrison BR, 2006, AM J HEALTH-SYST PH, V63, P1736, DOI 10.2146/ajhp050258; Hombourger B, 2004, EUR J HOSP PHARM, V5, P71; Hon CY, 2014, ANN OCCUP HYG, V58, P761, DOI 10.1093/annhyg/meu019; Ikeno Yohei, 2014, Gan To Kagaku Ryoho, V41, P611; International Society of Oncology Pharmacy Practicioners Standards Committee, 2007, J Oncol Pharm Pract, V13 Suppl, P1; Janes Alexia, 2015, Can J Hosp Pharm, V68, P279; Jorgenson J.A., 2007, HOSP PHARM, V42, P219, DOI 10.1310/hpj4203-219; Jorgenson JA., 2008, HOSP PHARM, V43, P718; Kopp B, 2013, ANN OCCUP HYG, V57, P374, DOI 10.1093/annhyg/mes073; Lamerie TQ, 2013, ANN OCCUP HYG, V57, P456, DOI 10.1093/annhyg/mes087; Le Garlantezec P., 2011, Annales Pharmaceutiques Francaises, V69, P182, DOI 10.1016/j.pharma.2011.03.001; Martin Susan, 2003, Oncol Nurs Forum, V30, P575, DOI 10.1188/03.ONF.575-581; Mason HJ, 2003, ANN OCCUP HYG, V47, P681, DOI 10.1093/annhyg/meg078; McDiarmid MA, 2010, J OCCUP ENVIRON MED, V52, P1028, DOI 10.1097/JOM.0b013e3181f73ae6; Miyake T, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-273; National Institute for Occupational Safety and Health, 2004, PREV OCC EXP ANT OTH, V2004-165; Nishigaki R, 2010, J JAPAN SOC HOSP PHA, V46, P113; Nussbaumer S, 2012, ANAL BIOANAL CHEM, V402, P2499, DOI 10.1007/s00216-011-5157-2; Nygren O, 2002, J ENVIRON MONITOR, V4, P739, DOI 10.1039/b205132j; Nygren O, 2008, ANN OCCUP HYG, V52, P95, DOI 10.1093/annhyg/mem067; Odraska P, 2013, ANN OCCUP HYG, V57, P240, DOI 10.1093/annhyg/mes057; Sanchez-Rubio Ferrandez J, 2012, Int J Pharm Compd, V16, P431; Sato Junya, 2010, Gan To Kagaku Ryoho, V37, P1753; Sessink P. J. M., 1999, HOSP PHARM, V34, P1311; Sessink Paul J M, 2013, Hosp Pharm, V48, P204, DOI 10.1310/hpj4803-204; Sessink Paul J M, 2011, J Oncol Pharm Pract, V17, P39, DOI 10.1177/1078155210361431; Siderov Jim, 2010, J Oncol Pharm Pract, V16, P19, DOI 10.1177/1078155209352543; Smith ST, 2014, J ONCOL PHARM PRACT, V20, P381, DOI 10.1177/1078155214526428; SPIVEY S, 2003, HOSP PHARM, V38, P135; Vyas N, 2014, J ONCOL PHARM PRACT; Wick C, 2003, AM J HEALTH-SYST PH, V60, P2314, DOI 10.1093/ajhp/60.22.2314; Yodaiken R E, 1986, Am J Hosp Pharm, V43, P1193; Yoshida J, 2009, ANN OCCUP HYG, V53, P153, DOI 10.1093/annhyg/men081; ZELLMER WA, 1981, AM J HOSP PHARM, V38, P1679, DOI 10.1093/ajhp/38.11.1679; ZIMMERMAN PF, 1981, AM J HOSP PHARM, V38, P1693, DOI 10.1093/ajhp/38.11.1693; Zock Matthew D, 2011, J Oncol Pharm Pract, V17, P49, DOI 10.1177/1078155210374673	56	35	35	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159052	10.1371/journal.pone.0159052	http://dx.doi.org/10.1371/journal.pone.0159052			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391697	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400202
J	Wu, GL; Kuo, TH; Tsay, TT; Tsai, IJ; Chen, PJ				Wu, Guan-Long; Kuo, Tzu-Hao; Tsay, Tung-Tsuan; Tsai, Isheng J.; Chen, Peichen J.			Glycoside Hydrolase (GH) 45 and 5 Candidate Cellulases in Aphelenchoides besseyi Isolated from Bird's-Nest Fern	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; FOLIAR NEMATODE; ROOT-KNOT; CD-HIT; EVOLUTION; PROTEINS; SEQUENCE; GENOME; FAMILY; BETA-1,4-ENDOGLUCANASE	Five Aphelenchoides besseyi isolates collected from bird's-nest ferns or rice possess different parasitic capacities in bird's-nest fern. Two different glycoside hydrolase (GH) 45 genes were identified in the fern isolates, and only one was found in the rice isolates. A Abe GH5-1 gene containing an SCP-like family domain was found only in the fern isolates. Abe GH5-1 gene has five introns suggesting a eukaryotic origin. A maximum likelihood phylogeny revealed that Abe GH5-1 is part of the nematode monophyletic group that can be clearly distinguished from those of other eukaryotic and bacterial GH5 sequences with high bootstrap support values. The fern A. besseyi isolates were the first parasitic plant nematode found to possess both GH5 and GH45 genes. Surveying the genome of the five A. besseyi isolates by Southern blotting using an 834 bp probe targeting the GH5 domain suggests the presence of at least two copies in the fern-origin isolates but none in the rice-origin isolates. The in situ hybridization shows that the Abe GH5-1 gene is expressed in the nematode ovary and testis. Our study provides insights into the diversity of GH in isolates of plant parasitic nematodes of different host origins.	[Wu, Guan-Long; Tsay, Tung-Tsuan; Chen, Peichen J.] Natl Chung Hsing Univ, Dept Plant Pathol, Taichung, Taiwan; [Kuo, Tzu-Hao; Tsai, Isheng J.] Acad Sinica, Biodivers Res Ctr, Taipei, Taiwan	National Chung Hsing University; Academia Sinica - Taiwan	Chen, PJ (corresponding author), Natl Chung Hsing Univ, Dept Plant Pathol, Taichung, Taiwan.	janetchen@nchu.edu.tw	Tsai, Isheng Jason/ABB-8273-2021	Tsai, Isheng Jason/0000-0002-2123-5058	Ministry of Science and Technology, Taiwan [MOST 103-2313-B-005-022-MY3]; National Chung Hsing University [104 S0516]; Academia Sinica [104-2313-B-001-001]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Chung Hsing University; Academia Sinica(Academia Sinica - Taiwan)	GW, PJC were funded by Ministry of Science and Technology, Taiwan, project #MOST 103-2313-B-005-022-MY3 and research grant 104 S0516 from National Chung Hsing University. IJT and THK were funded by Academia Sinica grant 104-2313-B-001-001.; We would like to thank Dr. Minn-Huey Lee for her kind advice and for her technical support with the Southern blot experiment, and Dr. Kuang Ren Chung and Dr. Wen Hsiung Ko for their suggestions and discussions about the manuscript. This research was partly funded by the Ministry of Science and Technology, Taiwan, project # MOST 103-2313-B-005-022-MY3, and research grant 104 S0516 from National Chung Hsing University. IJT and THK were funded by Academia Sinica 104-2313-B-001-001.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Alenda C, 2013, PHYSIOL MOL PLANT P, V84, P107, DOI 10.1016/j.pmpp.2013.08.004; [Anonymous], 2004, B OEPP, V34, P303; Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; Bird D. M., 2014, PARASITOLOGY, P1, DOI [10.1017/S0031182013002163, DOI 10.1017/S0031182013002163]; Buljan M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r74; Cantacessi C, 2012, MOL CELL PROBE, V26, P54, DOI 10.1016/j.mcp.2011.10.001; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Chalmers IW, 2012, PARASITOLOGY, V139, P1231, DOI 10.1017/S0031182012000704; Cotton JA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r43; Danchin EG, 2016, MOL BIOL EVOL; Danchin Etienne G J, 2011, Mob Genet Elements, V1, P269; de Boer JM, 1998, J NEMATOL, V30, P309; Dieterich C, 2009, TRENDS GENET, V25, P203, DOI 10.1016/j.tig.2009.03.006; Franklin M.T., 1972, CIH DESCRIPTIONS PLA, VVolume 1; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Fu Z, 2012, PHYTOPATHOLOGY, V102, P804, DOI 10.1094/PHYTO-12-11-0336; Haegeman A, 2012, GENE, V492, P19, DOI 10.1016/j.gene.2011.10.040; Haegeman A, 2011, MOL PLANT MICROBE IN, V24, P879, DOI 10.1094/MPMI-03-11-0055; Holterman M, 2006, MOL BIOL EVOL, V23, P1792, DOI 10.1093/molbev/msl044; Howe KL, 2016, NUCLEIC ACIDS RES, V44, pD774, DOI 10.1093/nar/gkv1217; Hsieh SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040886; Jamali S, 2006, J AGR TECHNOL, V2, P337; Jen FY, 2012, PLANT DIS, V96, P1763, DOI 10.1094/PDIS-03-12-0229-RE; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kersting AR, 2012, GENOME BIOL EVOL, V4, P316, DOI 10.1093/gbe/evs004; Khan MR, 2012, J NEMATOL, V44, P391; Kikuchi T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002219; Kikuchi T, 2014, NEMATOLOGY, V16, P99, DOI 10.1163/15685411-00002748; Kovalick GE, 2005, INSECT BIOCHEM MOLEC, V35, P825, DOI 10.1016/j.ibmb.2005.03.003; Li BW, 2005, MOL BIOCHEM PARASIT, V143, P49, DOI 10.1016/j.molbiopara.2005.05.005; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Manosalva P, 2015, NAT COMMUN, P6; Mayer WE, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-13; Mistry J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt263; Osman A, 2012, BIOTECHNOL ADV, V30, P652, DOI 10.1016/j.biotechadv.2011.11.002; Palomares-Rius JE, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-69; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rosso MN, 1999, MOL PLANT MICROBE IN, V12, P585, DOI 10.1094/MPMI.1999.12.7.585; Rybarczyk-Mydlowska K, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-221; Tang YT, 2014, NAT GENET, V46, P261, DOI 10.1038/ng.2875; Tsay T. T., 1998, Plant Protection Bulletin (Taichung), V40, P277; Tzeng C. Y., 2005, Plant Pathology Bulletin, V14, P67; Visser A, 2008, INT J PARASITOL, V38, P455, DOI 10.1016/j.ijpara.2007.08.008; Wang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091591; Wu HC, 2010, ENVIRON POLLUT, V158, P1741, DOI 10.1016/j.envpol.2009.11.015	50	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158663	10.1371/journal.pone.0158663	http://dx.doi.org/10.1371/journal.pone.0158663			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391812	Green Submitted, Green Published, gold			2022-12-27	WOS:000380005400099
J	Yang, Q; Rui, YY				Yang, Qiu; Rui, Yongyu			Two Multiplex Real-Time PCR Assays to Detect and Differentiate Acinetobacter baumannii and Non-baumannii Acinetobacter spp. Carrying bla(NDM), bla(OXA-23-Like), bla(OXA-40-Like), bla(OXA-51-Like), and bla(OXA-58-Like) Genes	PLOS ONE			English	Article							MELTING CURVE ANALYSIS; RAPID DETECTION; MOLECULAR EPIDEMIOLOGY; ESCHERICHIA-COLI; SYBR GREEN; IDENTIFICATION; ENTEROBACTERIACEAE; SURVEILLANCE; EMERGENCE; SPACER	Nosocomial infections caused by Acinetobacter spp. resistant to carbapenems are increasingly reported worldwide. Carbapenem-resistant Acinetobacter (CRA) is becoming a serious concern with increasing patient morbidity, mortality, and lengths of hospital stay. Therefore, the rapid detection of CRA is essential for epidemiological surveillance. Polymerase chain reaction (PCR) has been extensively used for the rapid identification of most pathogens. In this study, we have developed two multiplex real-time PCR assays to detect and differentiate A. baumannii and non-A. baumannii Acinetobacter spp, and common carbapenemase genes, including bla(NDM), bla(OXA-23-like), bla(OXA-40-like), bla(OXA-51-like), and bla(OXA-58-like). We demonstrate the potential utility of these assays for the direct detection of bla(NDM)-, bla(OXA-23-like)-, bla(OXA-40-like)-, bla(OXA-51-like)-, and bla(OXA-58-like)-positive CRA in clinical specimens. Primers were specifically designed, and two multiplex real-time PCR assays were developed: multiplex real-time PCR assay1 for the detection of Acinetobacter baumannii 16S-23S rRNA internal transcribed spacer sequence, the Acinetobacter recA gene, and class-B-metalloenzyme-encoding gene bla(NDM); and multiplex real-time PCR assay2 to detect class-D-oxacillinase-encoding genes (bla(OXA-23-like), bla(OXA-40-like), bla(OXA-51-like), and bla(OXA-58-like)). The assays were performed on an ABI Prism 7500 FAST Real-Time PCR System. CRA isolates were used to compare the assays with conventional PCR and sequencing. Known amounts of CRA cells were added to sputum and fecal specimens and used to test the multiplex real-time PCR assays. The results for target and nontarget amplification showed that the multiplex real-time PCR assays were specific, the limit of detection for each target was 10 copies per 20 mu L reaction volume, the assays were linear over six log dilutions of the target genes (r(2) > 0.99), and the Ct values of the coefficients of variation for intra- and interassay reproducibility were less than 5%. The multiplex real-time PCR assays showed 100% concordance with conventional PCR when tested against 400 CRA isolates and their sensitivity for the target DNA in sputum and fecal specimens was 10(2) CFU/mL. Therefore, these novel multiplex real-time PCR assays allow the sensitive and specific characterization and differentiation of bla(NDM)-, bla(OXA-23-like)-, bla(OXA-40-like)-, bla(OXA-51-like)-, and bla(OXA-58-like)-positive CRA, making them potential tools for the direct detection of CRA in clinical specimens and the surveillance of nosocomial infections.	[Yang, Qiu; Rui, Yongyu] Southern Med Univ, Nanfang Hosp, Lab Med Ctr, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Rui, YY (corresponding author), Southern Med Univ, Nanfang Hosp, Lab Med Ctr, Guangzhou, Guangdong, Peoples R China.	yongyuruigroup@sina.cm			 [2013B010404021];  [2014A010107011];  [2015A020211011];  [2015100101671]	; ; ; 	This work was supported by no. 2013B010404021 (http://pro.gdstc.gov.cn/egrantweb/), no. 2014A010107011 (http://pro.gdstc.gov.cn/egrantweb/), no. 2015A020211011 (http://pro.gdstc.gov.cn/egrantweb/), and no. 2015100101671 (http://pro.gdstc.gov.cn/egrantweb/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biedenbach D, 2015, ANTIMICROB AGENTS CH, V59, P826, DOI 10.1128/AAC.03938-14; Castanheira M, 2014, CLIN INFECT DIS, V59, pS367, DOI 10.1093/cid/ciu706; Chai Z, 2013, ARCH VIROL, V158, P407, DOI 10.1007/s00705-012-1504-7; Chang HC, 2005, J CLIN MICROBIOL, V43, P1632, DOI 10.1128/JCM.43.4.1632-1639.2005; Chassagne L, 2009, DIAGN MICR INFEC DIS, V64, P98, DOI 10.1016/j.diagmicrobio.2009.01.031; Chen TL, 2007, CLIN MICROBIOL INFEC, V13, P801, DOI 10.1111/j.1469-0691.2007.01744.x; Chen Y, 2011, J ANTIMICROB CHEMOTH, V66, P1255, DOI 10.1093/jac/dkr082; Chui L, 2005, DIAGN MICR INFEC DIS, V53, P47, DOI 10.1016/j.diagmicrobio.2005.03.007; Diene SM, 2014, CLIN MICROBIOL INFEC, V20, P831, DOI 10.1111/1469-0691.12655; Espinal P, 2012, CLIN MICROBIOL INFEC, V18, P1097, DOI 10.1111/j.1469-0691.2011.03696.x; Espinal P, 2012, J HOSP INFECT, V80, P56, DOI 10.1016/j.jhin.2011.08.013; Evans BA, 2014, CLIN MICROBIOL REV, V27, P241, DOI 10.1128/CMR.00117-13; Fu Y, 2012, J ANTIMICROB CHEMOTH, V67, P2114, DOI 10.1093/jac/dks192; Karageorgopoulos DE, 2008, LANCET INFECT DIS, V8, P751, DOI 10.1016/S1473-3099(08)70279-2; Karah N, 2011, J ANTIMICROB CHEMOTH, V66, P738, DOI 10.1093/jac/dkq521; Kuo SC, 2012, CLIN MICROBIOL INFEC, V18, P870, DOI 10.1111/j.1469-0691.2011.03682.x; Lefterova MI, 2013, J CLIN MICROBIOL, V51, P3000, DOI 10.1128/JCM.00991-13; Mendes RE, 2007, J CLIN MICROBIOL, V45, P544, DOI 10.1128/JCM.01728-06; Nakano R, 2015, J INFECT CHEMOTHER, V21, P202, DOI 10.1016/j.jiac.2014.11.010; Pan SY, 2013, J THORAC DIS, V5, P251, DOI 10.3978/j.issn.2072-1439.2013.05.08; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Rafei R, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0441-5; Schleicher X, 2013, CLIN MICROBIOL INFEC, V19, P737, DOI 10.1111/1469-0691.12026; Shorr AF, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0572-6; Souza TB, 2013, J CLIN MICROBIOL, V51, P1031, DOI 10.1128/JCM.02478-12; Turton JF, 2010, J CLIN MICROBIOL, V48, P1445, DOI 10.1128/JCM.02467-09; Uddin Mohammad Khaja Mafij, 2013, BMC Res Notes, V6, P291, DOI 10.1186/1756-0500-6-291; Vasoo S, 2013, J CLIN MICROBIOL, V51, P3609, DOI 10.1128/JCM.01731-13; Wang HY, 2014, J CLIN MICROBIOL, V52, P1911, DOI 10.1128/JCM.00389-14; Wang QQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066406; Woodford N, 2006, INT J ANTIMICROB AG, V27, P351, DOI 10.1016/j.ijantimicag.2006.01.004; Yamamoto N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133204; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09; Zheng F, 2015, MICROB DRUG RESIST, V21, P178, DOI 10.1089/mdr.2014.0085; Zheng LL, 2013, J VIROL METHODS, V187, P15, DOI 10.1016/j.jviromet.2012.06.024	35	14	17	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158958	10.1371/journal.pone.0158958	http://dx.doi.org/10.1371/journal.pone.0158958			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391234	Green Submitted, Green Published, gold			2022-12-27	WOS:000380005400172
J	Said, N; Engelhart, M; Kirches, C; Korkel, S; Holt, DV				Said, Nadia; Engelhart, Michael; Kirches, Christian; Koerkel, Stefan; Holt, Daniel V.			Applying Mathematical Optimization Methods to an ACT-R Instance-Based Learning Model	PLOS ONE			English	Article							ALGORITHM; SOAR	Computational models of cognition provide an interface to connect advanced mathematical tools and methods to empirically supported theories of behavior in psychology, cognitive science, and neuroscience. In this article, we consider a computational model of instance-based learning, implemented in the ACT-R cognitive architecture. We propose an approach for obtaining mathematical reformulations of such cognitive models that improve their computational tractability. For the well-established Sugar Factory dynamic decision making task, we conduct a simulation study to analyze central model parameters. We show how mathematical optimization techniques can be applied to efficiently identify optimal parameter values with respect to different optimization goals. Beyond these methodological contributions, our analysis reveals the sensitivity of this particular task with respect to initial settings and yields new insights into how average human performance deviates from potential optimal performance. We conclude by discussing possible extensions of our approach as well as future steps towards applying more powerful derivative-based optimization methods.	[Said, Nadia; Holt, Daniel V.] Heidelberg Univ, Inst Psychol, Hauptstr 47-51, D-69117 Heidelberg, Germany; [Said, Nadia; Engelhart, Michael; Kirches, Christian; Koerkel, Stefan] Heidelberg Univ, Interdisciplinary Ctr Sci Comp IWR, Neuenheimer Feld 205, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Said, N (corresponding author), Heidelberg Univ, Inst Psychol, Hauptstr 47-51, D-69117 Heidelberg, Germany.; Said, N (corresponding author), Heidelberg Univ, Interdisciplinary Ctr Sci Comp IWR, Neuenheimer Feld 205, D-69120 Heidelberg, Germany.	nadia.said@psychologie.uni-heidelberg.de		Kirches, Christian/0000-0002-3441-8822; , Nadia/0000-0002-0462-8554	Excellence Initiative of the German Research Council (DFG); DFG Graduate School (Heidelberg Graduate School of Mathematical and Computational Methods for the Sciences) [220]	Excellence Initiative of the German Research Council (DFG)(German Research Foundation (DFG)); DFG Graduate School (Heidelberg Graduate School of Mathematical and Computational Methods for the Sciences)	The authors gratefully acknowledge support by the Excellence Initiative of the German Research Council (DFG) and by DFG Graduate School 220 (Heidelberg Graduate School of Mathematical and Computational Methods for the Sciences).	Anderson J.R., 2007, CAN HUMAN MIND OCCUR; Anderson JR, 2005, COGNITIVE SCI, V29, P313, DOI 10.1207/s15516709cog0000_22; Anderson JR, 2004, PSYCHOL REV, V111, P1036, DOI 10.1037/0033-295x.111.4.1036; Arnold DV, 2002, IEEE T EVOLUT COMPUT, V6, P30, DOI [10.1109/4235.985690, 10.1023/A:1015059928466]; BERRY DC, 1984, Q J EXP PSYCHOL-A, V36, P209, DOI 10.1080/14640748408402156; Best BJ, 2009, P 9 INT C COGN MOD, P1; BOX MJ, 1965, COMPUT J, V8, P42, DOI 10.1093/comjnl/8.1.42; Chapelle O, 2010, INFORM RETRIEVAL, V13, P216, DOI 10.1007/s10791-009-9110-3; Chung PH, 2008, INT J HUM-COMPUT ST, V66, P217, DOI 10.1016/j.ijhcs.2007.09.001; Dawson MRW., 2008, MINDS MACHINES CONNE; DIENES Z, 1995, J EXP PSYCHOL LEARN, V21, P848, DOI 10.1037/0278-7393.21.4.848; Gigerenzer G, 2011, ANNU REV PSYCHOL, V62, P451, DOI 10.1146/annurev-psych-120709-145346; Gill P. E., 1974, Mathematical Programming, V7, P311, DOI 10.1007/BF01585529; Gluck K, 2007, P 16 C BEH REPR MOD, P73; Gonzalez C, 2003, COGNITIVE SCI, V27, P591, DOI 10.1016/S0364-0213(03)00031-4; Gonzalez C., 2005, TRANSFER KNOWLEDGE E; Gurney K, 2001, BIOL CYBERN, V84, P411, DOI 10.1007/PL00007985; Johnson S. G, 2010, NLOPT NONLINEAR OPTI; Kaelo P, 2006, J OPTIMIZ THEORY APP, V130, P253, DOI 10.1007/s10957-006-9101-0; Kase SE, 2008, P 30 ANN C COGN SCI, P1398; Klein G., 2002, BOUNDED RATIONALITY, V103, P114; Lagarias JC, 1998, SIAM J OPTIMIZ, V9, P112, DOI 10.1137/S1052623496303470; LAIRD JE, 1987, ARTIF INTELL, V33, P1, DOI 10.1016/0004-3702(87)90050-6; Laird JE, 2008, FRONT ARTIF INTEL AP, V171, P224; Lane Peter C. R., 2013, Journal of Artificial General Intelligence, V4, P1, DOI 10.2478/jagi-2013-0001; Lebiere C., 2001, P 10 C COMP GEN FORC; Lewandowsky S., 2010, COMPUTATIONAL MODELI; LOGAN GD, 1988, PSYCHOL REV, V95, P492, DOI 10.1037/0033-295X.95.4.492; Marcus Gary, 2003, ALGEBRAIC MIND INTEG; Martin MK, 2004, PROCEEDINGS OF THE SIXTH INTERNATIONAL CONFERENCE ON COGNITIVE MODELING, P178; Mitchell M., 1998, AN INTRODUCTION TO G; Moore LR, 2011, COMPUT MATH ORGAN TH, V17, P296, DOI 10.1007/s10588-011-9092-8; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; OReilly RC, 2012, LEABRA COGNITIVE ARC; Powell M.J.D., 2009, BOBYQA ALGORITHM BOU; Roberts S, 2000, PSYCHOL REV, V107, P358, DOI 10.1037/0033-295X.107.2.358; Sanner S, 2000, P 17 INT C MACH LEAR, P823, DOI DOI 10.1184/R1/6613298.V1; Stewart TC, 2008, P 30 ANN M COGN SCI; Sun W, 2006, SPRINGER SER OPTIM A, V1, P1, DOI 10.1007/b106451; Taatgen N. A., 2002, COGNITIVE SCI Q, V2, P163; Trelea IC, 2003, INFORM PROCESS LETT, V85, P317, DOI 10.1016/S0020-0190(02)00447-7; Walsh MM, 2015, COGNITIVE SCI, V39, P1131, DOI 10.1111/cogs.12192	43	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158832	10.1371/journal.pone.0158832	http://dx.doi.org/10.1371/journal.pone.0158832			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27387139	Green Submitted, gold, Green Published			2022-12-27	WOS:000379811500054
J	Wang, Q; Guo, YZ; Zhang, YT; Xue, JJ; Chen, ZC; Cheng, SY; Ou, MD; Cheng, KL; Zeng, WJ				Wang, Qing; Guo, Yi-Zhan; Zhang, Yi-Tao; Xue, Jiao-Jie; Chen, Zhi-Chong; Cheng, Shi-Yao; Ou, Mao-De; Cheng, Kang-Lin; Zeng, Wei-Jie			The Effects and Mechanism of Atorvastatin on Pulmonary Hypertension Due to Left Heart Disease	PLOS ONE			English	Article							RHO-KINASE INHIBITOR; SILDENAFIL IMPROVES; FAILURE PATIENTS; SECONDARY; DYSFUNCTION; 1-YEAR; RAT	Background Pulmonary hypertension due to left heart disease (PH-LHD) is one of the most common forms of PH, termed group 2 PH. Atorvastatin exerts beneficial effects on the structural remodeling of the lung in ischemic heart failure. However, few studies have investigated the effects of atorvastatin on PH due to left heart failure induced by overload. Methods Group 2 PH was induced in animals by aortic banding. Rats (n = 20) were randomly divided into four groups: a control group (C), an aortic banding group (AOB(63)), an atorvastatin prevention group (AOB(63)/ATOR(63)) and an atorvastatin reversal group (AOB(63)/ATOR(50-63)). Atorvastatin was administered for 63 days after banding to the rats in the AOB(63)/ATOR(63) group and from days 50 to 63 to the rats in the AOB(63)/ATOR(50-63) group. Results Compared with the controls, significant increases in the mean pulmonary arterial pressure, pulmonary arteriolar medial thickening, biventricular cardiac hypertrophy, wet and dry weights of the right middle lung, percentage of PCNA-positive vascular smooth muscle cells, inflammatory infiltration and expression of RhoA and Rho-kinase II were observed in the AOB(63) group, and these changes concomitant with significant decreases in the percentage of TUNEL-positive vascular smooth muscle cells. Treatment of the rats in the AOB(63)/ATOR(63) group with atorvastatin at a dose of 10 mg/kg/day significantly decreased the mean pulmonary arterial pressure, right ventricular hypertrophy, pulmonary arteriolar medial thickness, inflammatory infiltration, percentage of PCNA-positive cells and pulmonary expression of RhoA and Rho-kinase II and significantly augmented the percentage of TUNEL-positive cells compared with the AOB(63) group. However, only a trend of improvement in pulmonary vascular remodeling was detected in the AOB(63)/ATOR(50-63) group. Conclusions Atorvastatin prevents pulmonary vascular remodeling in the PH-LHD model by down-regulating the expression of RhoA/Rho kinase, by inhibiting the proliferation and increasing the apoptosis of pulmonary arterial smooth muscle cells, and by attenuating the inflammation of pulmonary arteries.	[Wang, Qing; Zhang, Yi-Tao; Xue, Jiao-Jie; Chen, Zhi-Chong; Cheng, Shi-Yao; Ou, Mao-De; Cheng, Kang-Lin; Zeng, Wei-Jie] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Cardiol, Guangzhou, Guangdong, Peoples R China; [Guo, Yi-Zhan] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Hepat Surg, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Cheng, KL; Zeng, WJ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 6, Dept Cardiol, Guangzhou, Guangdong, Peoples R China.	chengkangling@126.com; zengwj2011@126.com	Guo, Yizhan/ABG-3539-2020	Wang, Qing/0000-0002-3882-6540	National Natural Science Foundation of China [81400301]; Fundamental Research Funds for the Central Universities [21612312]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (81400301) and the Fundamental Research Funds for the Central Universities (21612312). The funders had no role in study design, decision to publish and preparation of manuscript.	Bussotti M, 2008, INT J CARDIOL, V126, P68, DOI 10.1016/j.ijcard.2007.03.118; Dai ZK, 2011, PEDIATR PULM, V46, P45, DOI 10.1002/ppul.21323; Duan S, 2010, EXP LUNG RES, V36, P573, DOI 10.3109/01902141003739715; Guazzi M, 2011, CIRCULATION, V124, P164, DOI 10.1161/CIRCULATIONAHA.110.983866; Guazzi M, 2011, CIRC-HEART FAIL, V4, P8, DOI 10.1161/CIRCHEARTFAILURE.110.944694; Jiang BH, 2010, J CARD FAIL, V16, P679, DOI 10.1016/j.cardfail.2010.03.003; Kaluski E, 2008, CARDIOLOGY, V109, P273, DOI 10.1159/000107791; Lewis GD, 2007, CIRCULATION, V116, P1555, DOI 10.1161/CIRCULATIONAHA.107.716373; Montalescot G, 1998, AM J CARDIOL, V82, P749, DOI 10.1016/S0002-9149(98)00439-1; Oka M, 2008, BRIT J PHARMACOL, V155, P444, DOI 10.1038/bjp.2008.239; Phrommintikul A, 2008, AM J PHYSIOL-HEART C, V294, pH1804, DOI 10.1152/ajpheart.01078.2007; Rakotoniaina Z, 2006, N-S ARCH PHARMACOL, V374, P195, DOI 10.1007/s00210-006-0112-z; Rhodes CJ, 2009, PHARMACOL THERAPEUT, V121, P69, DOI 10.1016/j.pharmthera.2008.10.002; Sola S, 2006, J AM COLL CARDIOL, V47, P332, DOI 10.1016/j.jacc.2005.06.088; Yin J, 2011, CIRC-HEART FAIL, V4, P198, DOI 10.1161/CIRCHEARTFAILURE.110.957050; Zhang Man, 2005, Zhonghua Xinxueguanbing Zazhi, V33, P73	16	15	15	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0157171	10.1371/journal.pone.0157171	http://dx.doi.org/10.1371/journal.pone.0157171			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27388289	Green Published, gold, Green Submitted			2022-12-27	WOS:000379811500002
J	von Wulffen, J; Sawodny, O; Feuer, R				von Wulffen, Joachim; Sawodny, Oliver; Feuer, Ronny		RecogNice-Team	Transition of an Anaerobic Escherichia coli Culture to Aerobiosis: Balancing mRNA and Protein Levels in a Demand-Directed Dynamic Flux Balance Analysis	PLOS ONE			English	Article							SCALE METABOLIC MODELS; GENE-EXPRESSION DATA; OXIDATIVE STRESS; GROWTH; TRANSCRIPTION; FERMENTATION; OPTIMIZATION; CONSTRAINTS; BIOREACTORS; OCCUPANCY	The facultative anaerobic bacterium Escherichia coli is frequently forced to adapt to changing environmental conditions. One important determinant for metabolism is the availability of oxygen allowing a more efficient metabolism. Especially in large scale bioreactors, the distribution of oxygen is inhomogeneous and individual cells encounter frequent changes. This might contribute to observed yield losses during process upscaling. Short-term gene expression data exist of an anaerobic E. coli batch culture shifting to aerobic conditions. The data reveal temporary upregulation of genes that are less efficient in terms of energy conservation than the genes predicted by conventional flux balance analyses. In this study, we provide evidence for a positive correlation between metabolic fluxes and gene expression. We then hypothesize that the more efficient enzymes are limited by their low expression, restricting flux through their reactions. We define a demand that triggers expression of the demanded enzymes that we explicitly include in our model. With these features we propose a method, demand-directed dynamic flux balance analysis, dddFBA, bringing together elements of several previously published methods. The introduction of additional flux constraints proportional to gene expression provoke a temporary demand for less efficient enzymes, which is in agreement with the transient upregulation of these genes observed in the data. In the proposed approach, the applied objective function of growth rate maximization together with the introduced constraints triggers expression of metabolically less efficient genes. This finding is one possible explanation for the yield losses observed in large scale bacterial cultivations where steady oxygen supply cannot be warranted.	[von Wulffen, Joachim; Sawodny, Oliver; Feuer, Ronny; RecogNice-Team] Univ Stuttgart, Inst Syst Dynam, Stuttgart, Germany	University of Stuttgart	von Wulffen, J (corresponding author), Univ Stuttgart, Inst Syst Dynam, Stuttgart, Germany.	vonwulffen@isys.uni-stuttgart.de		Feuer, Ronny/0000-0002-5653-7670	Federal Ministry of Education and Research of Germany (BMBF) [0316178A]	Federal Ministry of Education and Research of Germany (BMBF)(Federal Ministry of Education & Research (BMBF))	This study was funded by the Federal Ministry of Education and Research of Germany (BMBF, support code 0316178A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adadi R, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002575; Akesson M, 2004, METAB ENG, V6, P285, DOI 10.1016/j.ymben.2003.12.002; Becker SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000082; Beg QK, 2007, P NATL ACAD SCI USA, V104, P12663, DOI 10.1073/pnas.0609845104; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; BOLGIANO B, 1993, BIOCHIM BIOPHYS ACTA, V1141, P95, DOI 10.1016/0005-2728(93)90194-K; Brandt F, 2009, CELL, V136, P261, DOI 10.1016/j.cell.2008.11.016; Chandrasekaran S, 2010, P NATL ACAD SCI USA, V107, P17845, DOI 10.1073/pnas.1005139107; Colijn C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000489; Covert MW, 2008, BIOINFORMATICS, V24, P2044, DOI 10.1093/bioinformatics/btn352; Covert MW, 2003, J THEOR BIOL, V221, P309, DOI 10.1006/jtbi.2003.3071; Covert MW, 2001, J THEOR BIOL, V213, P73, DOI 10.1006/jtbi.2001.2405; De Vos D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028494; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Edwards JS, 2000, BMC BIOINFORMATICS, V1, DOI 10.1186/1471-2105-1-1; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Enfors SO, 2001, J BIOTECHNOL, V85, P175, DOI 10.1016/S0168-1656(00)00365-5; Feist AM, 2010, CURR OPIN MICROBIOL, V13, P344, DOI 10.1016/j.mib.2010.03.003; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Iuchi S, 1996, J BIOCHEM-TOKYO, V120, P1055; IUCHI S, 1990, J BACTERIOL, V172, P6020, DOI 10.1128/jb.172.10.6020-6025.1990; Junker BH, 2004, J BIOSCI BIOENG, V97, P347, DOI 10.1263/jbb.97.347; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kosuri S, 2013, P NATL ACAD SCI USA, V110, P14024, DOI 10.1073/pnas.1301301110; Lara AR, 2006, MOL BIOTECHNOL, V34, P355, DOI 10.1385/MB:34:3:355; LEIF H, 1995, EUR J BIOCHEM, V230, P538, DOI 10.1111/j.1432-1033.1995.tb20594.x; Lewis NE, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.47; Lindqvist A, 2000, ANTON LEEUW INT J G, V78, P23, DOI 10.1023/A:1002779201379; Machado D, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003580; Mahadevan R, 2002, BIOPHYS J, V83, P1331, DOI 10.1016/S0006-3495(02)73903-9; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; MAURIZI MR, 1992, EXPERIENTIA, V48, P178, DOI 10.1007/BF01923511; Molenaar D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.82; O'Brien EJ, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.52; Orth JD, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.65; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Oyarzun DA, 2009, B MATH BIOL, V71, P1851, DOI 10.1007/s11538-009-9427-5; Rapisarda VA, 1999, ARCH BIOCHEM BIOPHYS, V370, P143, DOI 10.1006/abbi.1999.1398; RICE CW, 1978, J BACTERIOL, V134, P115, DOI 10.1128/JB.134.1.115-124.1978; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schuetz R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100162; SCHULZE E, 1991, EUR J BIOCHEM, V201, P561, DOI 10.1111/j.1432-1033.1991.tb16315.x; Takors R, 2012, J BIOTECHNOL, V160, P3, DOI 10.1016/j.jbiotec.2011.12.010; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; van Berlo RJP, 2011, IEEE ACM T COMPUT BI, V8, P206, DOI 10.1109/TCBB.2009.55; VARMA A, 1994, APPL ENVIRON MICROB, V60, P3724, DOI 10.1128/AEM.60.10.3724-3731.1994; von Wulffen J, RNA SEQUENCING OF E; Waldherr S, 2015, J THEOR BIOL, V365, P469, DOI 10.1016/j.jtbi.2014.10.035; WASKIEWICZ DE, 1984, BIOCHEMISTRY-US, V23, P3136, DOI 10.1021/bi00309a005; Zaslaver A, 2004, NAT GENET, V36, P486, DOI 10.1038/ng1348; Zelezniak A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003572; Zhuang K, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.34	54	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158711	10.1371/journal.pone.0158711	http://dx.doi.org/10.1371/journal.pone.0158711			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384956	Green Published, Green Submitted, gold			2022-12-27	WOS:000379809400078
J	Iandiorio, MJ; Fair, JM; Chatzipanagiotou, S; Ioannidis, A; Trikka-Graphakos, E; Charalampaki, N; Sereti, C; Tegos, GP; Hoogesteijn, AL; Rivas, AL				Iandiorio, Michelle J.; Fair, Jeanne M.; Chatzipanagiotou, Stylianos; Ioannidis, Anastasios; Trikka-Graphakos, Eleftheria; Charalampaki, Nikoletta; Sereti, Christina; Tegos, George P.; Hoogesteijn, Almira L.; Rivas, Ariel L.			Preventing Data Ambiguity in Infectious Diseases with Four-Dimensional and Personalized Evaluations	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; SYSTEMS BIOLOGY; IN-VITRO; CHALLENGES; EMERGENCE; MODELS; HETEROGENEITY; HOMEOSTASIS; UNFOLDOMICS; COMPLEXITY	Background Diagnostic errors can occur, in infectious diseases, when anti-microbial immune responses involve several temporal scales. When responses span from nanosecond to week and larger temporal scales, any pre-selected temporal scale is likely to miss some (faster or slower) responses. Hoping to prevent diagnostic errors, a pilot study was conducted to evaluate a four-dimensional (4D) method that captures the complexity and dynamics of infectious diseases. Methods Leukocyte-microbial-temporal data were explored in canine and human (bacterial and/or viral) infections, with: (i) a non-structured approach, which measures leukocytes or microbes in isolation; and (ii) a structured method that assesses numerous combinations of interacting variables. Four alternatives of the structured method were tested: (i) a noise-reduction oriented version, which generates a single (one data point-wide) line of observations; (ii) a version that measures complex, three-dimensional (3D) data interactions; (iii) a non-numerical version that displays temporal data directionality (arrows that connect pairs of consecutive observations); and (iv) a full 4D (single line-, complexity-, directionality-based) version. Results In all studies, the non-structured approach revealed non-interpretable ( ambiguous) data: observations numerically similar expressed different biological conditions, such as recovery and lack of recovery from infections. Ambiguity was also found when the data were structured as single lines. In contrast, two or more data subsets were distinguished and ambiguity was avoided when the data were structured as complex, 3D, single lines and, in addition, temporal data directionality was determined. The 4D method detected, even within one day, changes in immune profiles that occurred after antibiotics were prescribed. Conclusions Infectious disease data may be ambiguous. Four-dimensional methods may prevent ambiguity, providing earlier, in vivo, dynamic, complex, and personalized information that facilitates both diagnostics and selection or evaluation of anti-microbial therapies.	[Iandiorio, Michelle J.; Rivas, Ariel L.] Univ New Mexico, Sch Med, Dept Internal Med, Albuquerque, NM 87131 USA; [Fair, Jeanne M.] Los Alamos Natl Lab, Global Secur, Mailstop M888, Los Alamos, NM 87545 USA; [Chatzipanagiotou, Stylianos] Natl & Kapodistrian Univ Athens, Sch Med, Aeginition Hosp, Dept Biopathol & Clin Microbiol, Athens, Greece; [Ioannidis, Anastasios] Univ Peloponnese, Fac Human Movement & Qual Life Sci, Dept Nursing, Sparta, Greece; [Trikka-Graphakos, Eleftheria; Charalampaki, Nikoletta; Sereti, Christina] Thriasio Gen Hosp, Dept Clin Microbiol, Magoula, Greece; [Tegos, George P.] Torrey Pines Inst Mol Studies, Port St Lucie, FL USA; [Tegos, George P.] Harvard Med Sch, Dept Dermatol, Boston, MA USA; [Tegos, George P.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Hoogesteijn, Almira L.] Ctr Invest Avanzadas, Dept Human Ecol, Merida, Mexico; [Rivas, Ariel L.] Univ New Mexico, Sch Med, Ctr Global Hlth, Div Infect Dis, Albuquerque, NM 87131 USA	University of New Mexico; United States Department of Energy (DOE); Los Alamos National Laboratory; Athens Medical School; National & Kapodistrian University of Athens; University of Peloponnese; Torrey Pines Institute for Molecular Studies, Florida; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of New Mexico	Rivas, AL (corresponding author), Univ New Mexico, Sch Med, Dept Internal Med, Albuquerque, NM 87131 USA.; Rivas, AL (corresponding author), Univ New Mexico, Sch Med, Ctr Global Hlth, Div Infect Dis, Albuquerque, NM 87131 USA.	alrivas@unm.edu		Sereti, Christina/0000-0002-2258-9333				Akinnusi ME, 2011, CRIT CARE MED, V39, P1944, DOI 10.1097/CCM.0b013e31821bd79e; Amarasingham A, 2015, P NATL ACAD SCI USA, V112, P6455, DOI 10.1073/pnas.1506400112; Anuforom O, 2015, MED MICROBIOL IMMUN, V204, P151, DOI 10.1007/s00430-014-0355-0; Auffray C, 2008, PROG BIOPHYS MOL BIO, V97, P79, DOI 10.1016/j.pbiomolbio.2007.09.002; Azimian A, 2012, J CLIN MICROBIOL, V50, P3581, DOI 10.1128/JCM.01727-12; Balk RA, 2014, VIRULENCE, V5, P20, DOI 10.4161/viru.27135; Bannoehr J, 2012, VET DERMATOL, V23, P253, DOI 10.1111/j.1365-3164.2012.01046.x; Becker JM, 2013, MIS QUART, V37, P665, DOI 10.25300/MISQ/2013/37.3.01; Boomer JS, 2014, VIRULENCE, V5, P45, DOI [10.4161/viru.26516, 10.4161/viru.27794]; Bork P, 2005, CELL, V121, P507, DOI 10.1016/j.cell.2005.05.001; Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528; Casadevall A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002136; Chatzimoschou A, 2015, ANTIMICROB AGENTS CH, V59, P2198, DOI 10.1128/AAC.04934-14; D'Alessandro LA, 2015, PROG BIOPHYS MOL BIO, V117, P78, DOI 10.1016/j.pbiomolbio.2014.11.005; Davis JS, 2015, SEMIN RESP CRIT CARE, V36, P3, DOI 10.1055/s-0034-1396906; de Haan J, 2006, ECOL COMPLEX, V3, P293, DOI 10.1016/j.ecocom.2007.02.003; Decousser JW, 2015, INT J ANTIMICROB AG, V46, P622, DOI 10.1016/j.ijantimicag.2015.07.022; Fair JM, 2015, TRANSBOUND EMERG DIS, V62, P437, DOI 10.1111/tbed.12162; Firsov AA, 2013, ANTIMICROB AGENTS CH, V57, P4956, DOI 10.1128/AAC.00578-13; Grainger DW, 2013, BIOMATERIALS, V34, P9237, DOI 10.1016/j.biomaterials.2013.08.043; Groesser SN, 2012, SYST DYNAM REV, V28, P46, DOI 10.1002/sdr.476; Humphreys P, 2008, MIND MACH, V18, P431, DOI 10.1007/s11023-008-9125-3; Huneman P, 2012, SYNTHESE, V185, P195, DOI 10.1007/s11229-010-9721-7; Hutchinson JW, 2000, J CONSUM RES, V27, P324, DOI 10.1086/317588; Klinke DJ, 2009, ANN BIOMED ENG, V37, P1886, DOI 10.1007/s10439-009-9733-y; Knowlton ER, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00427; Lake K, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.104031; Leitner G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123674; Ludewig B, 2012, EUR J IMMUNOL, V42, P3116, DOI 10.1002/eji.201242508; Moriarty TF, 2014, EUR CELLS MATER, V28, P112, DOI 10.22203/eCM.v028a09; Nadell CD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2770; Newson J, 2014, BLOOD, V124, P1748, DOI 10.1182/blood-2014-03-562710; Nielsen SN, 2013, ECOL INDIC, V28, P31, DOI 10.1016/j.ecolind.2012.12.015; Nish S, 2011, IMMUNITY, V34, P629, DOI 10.1016/j.immuni.2011.05.009; Noble D, 2010, PHILOS T R SOC A, V368, P1125, DOI 10.1098/rsta.2009.0245; Osinga HM, 2012, DISCRETE CONT DYN-A, V32, P2853, DOI 10.3934/dcds.2012.32.2853; Pomorska-Mol M, 2012, POL J VET SCI, V15, P583, DOI 10.2478/v10181-012-0089-0; Qu ZL, 2011, PROG BIOPHYS MOL BIO, V107, P21, DOI 10.1016/j.pbiomolbio.2011.06.004; Raffatellu M, 2006, INFECT IMMUN, V74, P19, DOI 10.1128/IAI.74.1.19-27.2006; Ricca RL, 2009, MS A MOD SIMUL, V3, P167, DOI 10.1007/978-88-470-1122-9_12; Rivas AL, 2015, CURR PHARM DESIGN, V21, P2122, DOI 10.2174/1381612821666150310104053; Rivas AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053984; Rosslenbroich B, 2011, SEMIN CANCER BIOL, V21, P156, DOI 10.1016/j.semcancer.2011.06.001; San Miguel M, 2012, EUR PHYS J-SPEC TOP, V214, P245, DOI 10.1140/epjst/e2012-01694-y; Shima K, 2011, ANTIMICROB AGENTS CH, V55, P2319, DOI 10.1128/AAC.01655-10; Sidjabat HE, 2007, J MED MICROBIOL, V56, P426, DOI 10.1099/jmm.0.46888-0; Stephan A, 2006, SYNTHESE, V151, P485, DOI 10.1007/s11229-006-9019-y; Towhid ST, 2013, CELL PHYSIOL BIOCHEM, V31, P102, DOI 10.1159/000343353; Uversky VN, 2014, CHEM REV, V114, P6844, DOI 10.1021/cr400713r; Uversky VN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S7; Valour F, 2014, CLIN MICROBIOL INFEC, V20, pO772, DOI 10.1111/1469-0691.12567; Van Regenmortel MHV, 2007, PROTEOMICS, V7, P965, DOI 10.1002/pmic.200600407; Vepsalainen K, 2000, BIOL PHILOS, V15, P211, DOI 10.1023/A:1006636918716; Woese CR, 2004, MICROBIOL MOL BIOL R, V68, P173, DOI 10.1128/MMBR.68.2.173-186.2004; Wolkenhauer O, 2013, FEBS J, V280, P5938, DOI 10.1111/febs.12311; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yip D, 2013, BIOCHEM BIOPH RES CO, V433, P327, DOI 10.1016/j.bbrc.2013.03.008; Zhang M, 2014, ANTIMICROB AGENTS CH, V58, P3217, DOI 10.1128/AAC.02410-14	58	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159001	10.1371/journal.pone.0159001	http://dx.doi.org/10.1371/journal.pone.0159001			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ9CP	27411058	Green Submitted, Green Published, gold			2022-12-27	WOS:000379508300047
J	Maor, Y; Malnick, SDH; Melzer, E; Leshno, M				Maor, Yaakov; Malnick, Stephen D. H.; Melzer, Ehud; Leshno, Moshe			Treatment of Chronic Hepatitis C in the Aged - Does It Impact Life Expectancy? A Decision Analysis	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; LIVER FIBROSIS PROGRESSION; HCV-RELATED CIRRHOSIS; ALL-CAUSE MORTALITY; NATURAL-HISTORY; VIRUS; SOFOSBUVIR; LEDIPASVIR; INFECTION; RISK	Background and Aims Recent studies have demonstrated that the efficacy of interferon-free direct-acting antiviral agents (DAAs) in patients over 70 is similar to that of younger age groups. Evidence continues to mount that life expectancy (LE) increases with successful treatment of hepatitis C (HCV) patients with advanced fibrosis. The evidence in older people is more limited. Our aim was to estimate the life year (LY) and quality-adjusted life year (QALY) gained by treatment of naive patients with HCV as a function of patient's age and fibrosis stage. Methods We constructed a Markov model of HCV progression toward advanced liver disease. The primary outcome was LY and QALY saved. The model and the sustained virological response of HCV infected subjects treated with a fixed-dose combination of the NS5B polymerase inhibitor Sofosbuvir and the NS5A replication complex inhibitor Ledipasvir were based on the published literature and expert opinion. Results Generally, both the number of LY gained and QALY gained gradually decreased with advancing age but the rate of decline was slower with more advanced fibrosis stage. For patients with fibrosis stage F1, F2 and F3, LY gained dropped below six months if treated by the age of 55, 65 or 70 years, respectively, while for a patient with fibrosis stage F4, the gain was one LY if treated by the age of 75. The QALY gained for treated over untreated elderly were reasonably high even for those treated at early fibrosis stage. Conclusions There is a significant life expectancy benefit to HCV treatment in patients up to age 75 with advanced-stage fibrosis.	[Maor, Yaakov; Malnick, Stephen D. H.; Melzer, Ehud] Kaplan Med Ctr, Inst Gastroenterol & Hepatol, Rehovot, Israel; [Malnick, Stephen D. H.] Kaplan Med Ctr, Dept Internal Med C, Rehovot, Israel; [Leshno, Moshe] Tel Aviv Univ, Fac Management, Tel Aviv, Israel; [Leshno, Moshe] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel	Hebrew University of Jerusalem; Kaplan Medical Center; Hebrew University of Jerusalem; Kaplan Medical Center; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine	Maor, Y (corresponding author), Kaplan Med Ctr, Inst Gastroenterol & Hepatol, Rehovot, Israel.	yaakovma1@clalit.org.il						Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; Backus LI, 2011, CLIN GASTROENTEROL H, V9, P509, DOI 10.1016/j.cgh.2011.03.004; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bruno S, 2007, HEPATOLOGY, V45, P579, DOI 10.1002/hep.21492; Bruno S, 2009, AM J GASTROENTEROL, V104, P1147, DOI 10.1038/ajg.2009.31; Centers for Disease Control and Prevention, MORTALITY TABLES; Davis GL, 2010, GASTROENTEROLOGY, V138, P513, DOI 10.1053/j.gastro.2009.09.067; Hezode C, 2013, HEPATOLOGY S, V58, p181A; Ickowicz E, 2012, J AM GERIATR SOC, V60, pE1, DOI 10.1111/j.1532-5415.2012.04188.x; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Morgan TR, 2010, HEPATOLOGY, V52, P833, DOI 10.1002/hep.23744; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Poynard T, 2001, J HEPATOL, V34, P730, DOI 10.1016/S0168-8278(00)00097-0; Poynard T, 2002, GASTROENTEROLOGY, V122, P1303, DOI 10.1053/gast.2002.33023; Poynard T, 2013, J HEPATOL, V59, P675, DOI 10.1016/j.jhep.2013.05.015; Ryder SD, 2004, GUT, V53, P451, DOI 10.1136/gut.2003.021691; Sangiovanni A, 2006, HEPATOLOGY, V43, P1303, DOI 10.1002/hep.21176; Smith BD, 2012, ANN INTERN MED, V157, P817, DOI 10.7326/0003-4819-157-9-201211060-00529; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375; van der Meer AJ, 2014, JAMA-J AM MED ASSOC, V312, P1927, DOI 10.1001/jama.2014.12627; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; Gomez EV, 2013, J HEPATOL, V58, P434, DOI 10.1016/j.jhep.2012.10.023; Zhou K, 2014, GASTROENTEROLOGY, V146, pS969; Zipprich A, 2012, LIVER INT, V32, P1407, DOI 10.1111/j.1478-3231.2012.02830.x	29	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0157832	10.1371/journal.pone.0157832	http://dx.doi.org/10.1371/journal.pone.0157832			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410963	gold, Green Published, Green Submitted			2022-12-27	WOS:000379508300013
J	Harapan, H; Anwar, S; Bustaman, A; Radiansyah, A; Angraini, P; Fasli, R; Salwiyadi, S; Bastian, RA; Oktiviyari, A; Akmal, I; Iqbalamin, M; Adil, J; Henrizal, F; Darmayanti, D; Pratama, R; Fajar, JK; Setiawan, AM; Imrie, A; Kuch, U; Groneberg, DA; Sasmono, T; Dhimal, M; Muller, R				Harapan, Harapan; Anwar, Samsul; Bustaman, Aslam; Radiansyah, Arsil; Angraini, Pradiba; Fasli, Riny; Salwiyadi, Salwiyadi; Bastian, Reza Akbar; Oktiviyari, Ade; Akmal, Imaduddin; Iqbalamin, Muhammad; Adil, Jamalul; Henrizal, Fenni; Darmayanti, Darmayanti; Pratama, Rovy; Fajar, Jonny Karunia; Setiawan, Abdul Malik; Imrie, Allison; Kuch, Ulrich; Groneberg, David Alexander; Sasmono, Tedjo; Dhimal, Meghnath; Mueller, Ruth			Community Willingness to Participate in a Dengue Study in Aceh Province, Indonesia	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; AFRICAN-AMERICAN WOMEN; GENETIC RESEARCH; CLINICAL-TRIALS; HEALTH RESEARCH; MYOCARDIAL-INFARCTION; PATIENT WILLINGNESS; GENERAL-POPULATION; PREVENTION TRIALS; PUBLIC-ATTITUDES	Background Dengue virus infection is the most rapidly spreading vector-borne disease in the world. Essential research on dengue virus transmission and its prevention requires community participation. Therefore, it is crucial to understand the factors that are associated with the willingness of communities in high prevalence areas to participate in dengue research. The aim of this study was to explore factors associated with the willingness of healthy community members in Aceh province, Indonesia, to participate in dengue research that would require phlebotomy. Methodology/Principal Findings A community-based cross-sectional study was carried out in nine regencies and municipalities of Aceh from November 2014 to March 2015. Interviews using a set of validated questionnaires were conducted to collect data on demography, history of dengue infection, socioeconomic status, and knowledge, attitude and practice regarding dengue fever. Two-step logistic regression and Spearman's rank correlation (r(s)) analysis were used to assess the influence of independent variables on dependent variables. Among 535 participants, less than 20% had a good willingness to participate in the dengue study. The factors associated with good willingness to participate were being female, working as a civil servant, private employee or entrepreneur, having a high socioeconomic status and good knowledge, attitude and practice regarding dengue. Good knowledge and attitude regarding dengue were positive independent predictors of willingness to participate (OR: 2.30 [95% CI: 1.36-3.90] and 3.73 [95% CI: 2.24-6.21], respectively). Conclusion/Significance The willingness to participate in dengue research is very low among community members in Aceh, and the two most important associated factors are knowledge and attitude regarding dengue. To increase participation rate, efforts to improve the knowledge and attitude of community members regarding dengue fever and dengue-related research is required before such studies are launched.	[Harapan, Harapan; Radiansyah, Arsil; Angraini, Pradiba; Fasli, Riny; Salwiyadi, Salwiyadi; Bastian, Reza Akbar; Oktiviyari, Ade; Akmal, Imaduddin; Iqbalamin, Muhammad; Adil, Jamalul; Henrizal, Fenni; Darmayanti, Darmayanti; Pratama, Rovy; Fajar, Jonny Karunia] Syiah Kuala Univ, Sch Med, Med Res Unit, Banda Aceh, Indonesia; [Harapan, Harapan] Syiah Kuala Univ, Sch Med, Trop Dis Ctr, Banda Aceh, Indonesia; [Harapan, Harapan] Syiah Kuala Univ, Sch Med, Dept Microbiol, Banda Aceh, Indonesia; [Harapan, Harapan; Imrie, Allison] Univ Western Australia, Sch Pathol & Lab Med, Nedlands, WA, Australia; [Anwar, Samsul] Syiah Kuala Univ, Fac Math & Nat Sci, Dept Stat, Banda Aceh, Indonesia; [Bustaman, Aslam] Syiah Kuala Univ, Fac Teacher Training & Educ, Dept Biol, Banda Aceh, Indonesia; [Setiawan, Abdul Malik] State Islamic Univ Maulana Malik Ibrahim, Fac Med & Hlth Sci, Dept Microbiol, Malang, Indonesia; [Kuch, Ulrich; Groneberg, David Alexander; Mueller, Ruth] Goethe Univ Frankfurt, Inst Occupat Med Social Med & Environm Med, Frankfurt, Germany; [Sasmono, Tedjo] Eijkman Inst Mol Biol, Jakarta, Indonesia; [Dhimal, Meghnath] NHRC, Minist Hlth Complex, Kathmandu, Nepal	Universitas Syiah Kuala; Universitas Syiah Kuala; Universitas Syiah Kuala; University of Western Australia; Universitas Syiah Kuala; Universitas Syiah Kuala; Goethe University Frankfurt; Eijkman Institute	Harapan, H (corresponding author), Syiah Kuala Univ, Sch Med, Med Res Unit, Banda Aceh, Indonesia.; Harapan, H (corresponding author), Syiah Kuala Univ, Sch Med, Trop Dis Ctr, Banda Aceh, Indonesia.; Harapan, H (corresponding author), Syiah Kuala Univ, Sch Med, Dept Microbiol, Banda Aceh, Indonesia.; Harapan, H (corresponding author), Univ Western Australia, Sch Pathol & Lab Med, Nedlands, WA, Australia.	harapan@unsyiah.ac.id	Setiawan, Abdul Malik/AAB-7458-2021; Dhimal, Meghnath/AAD-7261-2021; Sasmono, Tedjo/H-5680-2016; Groneberg, David/A-5132-2018; Oktiviyari, Ade/GPG-3649-2022; Imrie, Allison/AAH-2421-2019; Fajar, Jonny Karunia/N-8039-2018; Muller, Ruth/GXA-1300-2022; Harapan, Harapan/I-8741-2016; Muller, Ruth/D-2551-2009	Setiawan, Abdul Malik/0000-0002-6913-2007; Dhimal, Meghnath/0000-0001-7176-7821; Sasmono, Tedjo/0000-0003-0986-2590; Groneberg, David/0000-0001-8551-6556; Oktiviyari, Ade/0000-0002-1392-200X; Fajar, Jonny Karunia/0000-0002-0309-5813; Harapan, Harapan/0000-0001-7630-8413; Bastian, Reza Akbar/0000-0002-4062-0461; Muller, Ruth/0000-0003-3909-3876				Abdullah M.N., 2013, AM INT J CONT RES, V3, P69; Afshar R, 2012, SAUDI J KIDNEY DIS T, V23, P929, DOI 10.4103/1319-2442.100863; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bhatti P, 2005, CANCER EPIDEM BIOMAR, V14, P2449, DOI 10.1158/1055-9965.EPI-05-0463; Bonett DG, 2000, PSYCHOMETRIKA, V65, P23, DOI 10.1007/BF02294183; Bower P, 2007, FAM PRACT, V24, P601, DOI 10.1093/fampra/cmm051; Bower P, 2009, FAM PRACT, V26, P391, DOI 10.1093/fampra/cmp037; BPS, 2015, AC DAL ANGK 2015; Braunstein JB, 2008, MEDICINE, V87, P1, DOI 10.1097/MD.0b013e3181625d78; Brown DR, 2003, GERONTOLOGIST, V43, P62, DOI 10.1093/geront/43.1.62; Buchwald D, 2006, J GEN INTERN MED, V21, P648, DOI 10.1111/j.1525-1497.2006.00449.x; Bussey-Jones J, 2010, GENET MED, V12, P116, DOI 10.1097/GIM.0b013e3181cd6689; Caldwell PHY, 2003, J PEDIATR-US, V142, P554, DOI 10.1067/mpd.2003.192; Caprara A, 2015, T ROY SOC TROP MED H, V109, P99, DOI 10.1093/trstmh/tru187; Chu SH, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-014-1339-0; Clark MA, 2007, CANCER EPIDEM BIOMAR, V16, P2605, DOI 10.1158/1055-9965.EPI-07-0157; Comis RL, 2003, J CLIN ONCOL, V21, P830, DOI 10.1200/JCO.2003.02.105; Costenbader KH, 2007, ARTHRIT RHEUM-ARTHR, V57, P49, DOI 10.1002/art.22480; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Dhimal M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102028; Dias L, 2005, CLIN TRIALS, V2, P443, DOI 10.1191/1740774505cn113oa; Dong Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111321; Du W, 2008, J THORAC ONCOL, V3, P23, DOI 10.1097/JTO.0b013e31815e8bb2; Dunlop AL, 2011, J CLIN EPIDEMIOL, V64, P872, DOI 10.1016/j.jclinepi.2010.11.008; Effler PV, 2005, EMERG INFECT DIS, V11, P742; Filmer D, 1999, POPUL DEV REV, V25, P85, DOI 10.1111/j.1728-4457.1999.00085.x; Ford BM, 2006, CANCER EPIDEM BIOMAR, V15, P1355, DOI 10.1158/1055-9965.EPI-05-0816; Godskesen T, 2015, EUR J CANCER CARE, V24, P133, DOI 10.1111/ecc.12184; Green D, 2006, AM J EPIDEMIOL, V164, P845, DOI 10.1093/aje/kwj286; Hadisoemarto PF, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002427; Harapan H, 2016, KNOWLEDGE ATTI UNPUB; Harapan H, 2016, VACCINE, V34, P3670, DOI 10.1016/j.vaccine.2016.05.026; Hemachandra A, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-S3-P202; Hendren E, 2015, TRANSPLANTATION, V99, P1894, DOI 10.1097/TP.0000000000000533; Iacobucci D, 2003, J CONSUM PSYCHOL, V13, P478, DOI 10.1207/S15327663JCP1304_14; James DCS, 2016, TELEMED E-HEALTH, V22, P191, DOI 10.1089/tmj.2015.0071; Johnsson L, 2010, EUR J HUM GENET, V18, P1261, DOI 10.1038/ejhg.2010.106; Karyanti MR, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-412; Kemenkes RI, 2015, PROFIL KESEHATAN IND; Kettis-Lindblad A, 2006, EUR J PUBLIC HEALTH, V16, P433, DOI 10.1093/eurpub/cki198; Koenraadt CJ, 2005, AM J TROP MED HYG, V73, P156; Krousel-Wood MA, 2001, J TELEMED TELECARE, V7, P281, DOI 10.1258/1357633011936543; Lanfear DE, 2011, GENOME MED, V3, DOI 10.1186/gm255; Lanfear DE, 2008, CIRCULATION, V118, pS624; Limkakeng A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051328; Lin JS, 2005, J COMMUN HEALTH, V30, P451, DOI 10.1007/s10900-005-7280-5; Mammen MP, 2008, PLOS MED, V5, P1605, DOI 10.1371/journal.pmed.0050205; Mbunda T, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.22853; McCann SK, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-31; McDonald AM, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-9; McQuillan GM, 2006, GENET MED, V8, P354, DOI 10.1097/01.gim.0000223552.70393.08; McQuillan GM, 2003, GENET MED, V5, P35, DOI 10.1097/00125817-200301000-00006; Newman PA, 2014, VACCINE, V32, P5854, DOI 10.1016/j.vaccine.2014.08.043; Noordzij M, 2010, NEPHROL DIAL TRANSPL, V25, P1388, DOI 10.1093/ndt/gfp732; Perez-Guerra CL, 2012, HUM VACC IMMUNOTHER, V8, P905, DOI 10.4161/hv.20056; Prayitno A, 2016, INT J INFECT DIS, V45, P242, DOI 10.1016/j.ijid.2016.02.543; Pulley JM, 2008, CELL TISSUE BANK, V9, P55, DOI 10.1007/s10561-007-9051-2; Rocha C, 2009, AM J TROP MED HYG, V80, P656, DOI 10.4269/ajtmh.2009.80.656; Rodriguez H, 2015, J ALLERGY CLIN IMMUN, V135, pAB245, DOI 10.1016/j.jaci.2014.12.1737; Russell KM, 2008, APPL NURS RES, V21, P90, DOI 10.1016/j.apnr.2006.05.001; Shavers VL, 2002, ANN EPIDEMIOL, V12, P248, DOI 10.1016/S1047-2797(01)00265-4; Shavers-Hornaday V L, 1997, Ethn Health, V2, P31; Smit J, 2006, INT J STD AIDS, V17, P176, DOI 10.1258/095646206775809259; Suhud U., 2014, J ECO SUSTAIN DEV, V5, P91; Sygna K, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0948-y; Tapia-Conyer R, 2012, PAEDIATR INT CHILD H, V32, P10, DOI 10.1179/2046904712Z.00000000047; Treweek S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002360; Vanlerberghe V, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1959; Wang S, 1999, AM J HUM GENET, V65, pA411; Wang S, 2011, COMMUNITY GENET, V4, P18; Wendler D, 2006, PLOS MED, V3, P201, DOI 10.1371/journal.pmed.0030019; WHO, 2019, DENG SEV DENG; Wong ML, 2004, CLIN GENET, V65, P45, DOI 10.1111/j..2004.00192.x; World Health Organization, 2009, DENGUE GUIDELINES DI; Yap BW, 2011, J STAT COMPUT SIM, V81, P2141, DOI 10.1080/00949655.2010.520163; Yoon IK, 2012, J INFECT DIS, V206, P389, DOI 10.1093/infdis/jis357	76	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0159139	10.1371/journal.pone.0159139	http://dx.doi.org/10.1371/journal.pone.0159139			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ9CO	27404663	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000379508200036
J	Ye, YJ; Cai, M; Ju, YQ; Jiao, Y; Feng, L; Pan, HT; Cheng, TR; Zhang, QX				Ye, Yuanjun; Cai, Ming; Ju, Yiqian; Jiao, Yao; Feng, Lu; Pan, Huitang; Cheng, Tangren; Zhang, Qixiang			Identification and Validation of SNP Markers Linked to Dwarf Traits Using SLAF-Seq Technology in Lagerstroemia	PLOS ONE			English	Article							BULKED SEGREGANT ANALYSIS; SEQUENCE REPEAT MARKERS; DENSITY GENETIC-MAP; PLANT ARCHITECTURE; CRAPE MYRTLE; QTL ANALYSIS; LINKAGE MAP; APPLE-TREES; MICROSATELLITE MARKERS; INTERNODE LENGTH	The genetic control of plant architecture is a promising approach to breed desirable cultivars, particularly in ornamental flowers. In this study, the F-1 population (142 seedlings) derived from Lagerstroemia fauriei (non-dwarf) x L. indica 'Pocomoke' (dwarf) was pheno-typed for six traits (plant height (PH), internode length (IL), internode number, primary lateral branch height (PLBH), secondary lateral branch height and primary branch number), and the IL and PLBH traits were positively correlated with the PH trait and considered representative indexes of PH. Fifty non-dwarf and dwarf seedlings were pooled and subjected to a specific-locus amplified fragment sequencing (SLAF-seq) method, which screened 1221 polymorphic markers. A total of 3 markers segregating between bulks were validated in the F-1 population, with the M16337 and M38412 markers highly correlated with the IL trait and the M25207 marker highly correlated with the PLBH trait. These markers provide a predictability of approximately 80% using a single marker (M25207) and a predictability of 90% using marker combinations (M16337 + M25207) in the F-1 population, which revealed that the IL and the PLBH traits, especially the PLBH, were the decisive elements for PH in terms of molecular regulation. Further validation was performed in the BC1 population and a set of 28 Lagerstroemia stocks using allele-specific PCR (AS-PCR) technology, and the results showed the stability and reliability of the SNP markers and the co-determination of PH by multiple genes. Our findings provide an important theoretical and practical basis for the early prediction and indirect selection of PH using the IL and the PLBH, and the detected SNPs may be useful for marker-assisted selection (MAS) in crape myrtle.	[Pan, Huitang] Beijing Forestry Univ, Beijing Key Lab Ornamental Plants Germplasm Innov, Natl Engn Res Ctr Floriculture, Beijing Lab Urban & Rural Ecol Environm, Beijing 100083, Peoples R China; Beijing Forestry Univ, Coll Landscape Architecture, Beijing 100083, Peoples R China	Beijing Forestry University; Beijing Forestry University	Pan, HT (corresponding author), Beijing Forestry Univ, Beijing Key Lab Ornamental Plants Germplasm Innov, Natl Engn Res Ctr Floriculture, Beijing Lab Urban & Rural Ecol Environm, Beijing 100083, Peoples R China.	htpan@bjfu.edu.cn	Cheng, Tangren/HDM-6455-2022		12th Five Years Key Programs for Science and Technology Development of China [2013BAD01B07]; National Science Foundation of China [31470695]; Fundamental Research Funds for the Central Universities [BLYJ201612]; Special Fund for Beijing Common Construction Project (HTP)	12th Five Years Key Programs for Science and Technology Development of China(Chinese Academy of Sciences); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Special Fund for Beijing Common Construction Project (HTP)	This work was supported by 1) The 12th Five Years Key Programs for Science and Technology Development of China (#2013BAD01B07, http://program.most.gov.cn/, HTP); 2) National Science Foundation of China (No. 31470695, http://www.nsfc.gov.cn, HTP); 3) The Fundamental Research Funds for the Central Universities (No. BLYJ201612, http://graduate.bjfu.edu.cn/article-18-10121.aspx, YJY); and 4) Special Fund for Beijing Common Construction Project (HTP). The funders had role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bello MH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-903; Brickell C., 1996, ENCY GARDEN PLANTS, P250; Bundock PC, 2006, THEOR APPL GENET, V112, P358, DOI 10.1007/s00122-005-0137-6; Cai M, 2010, CONSERV GENET RESOUR, V2, P89, DOI 10.1007/s12686-010-9197-2; Celton JM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-155; Chen SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065122; Chutimanitsakun Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-4; Cregan PB, 1999, THEOR APPL GENET, V99, P811, DOI 10.1007/s001220051300; Dardick C, 2013, PLANT J, V75, P618, DOI 10.1111/tpj.12234; Dhanasekar P, 2007, PLANT BREEDING, V126, P551, DOI 10.1111/j.1439-0523.2007.01427.x; EGOLF DR, 1981, HORTSCIENCE, V16, P576; EGOLF DR, 1990, HORTSCIENCE, V25, P992, DOI 10.21273/HORTSCI.25.8.992; EGOLF DR, 1986, HORTSCIENCE, V21, P1250; Gargul JM, 2015, PLANT BIOTECHNOL J, V13, P51, DOI 10.1111/pbi.12234; Guidry R. K., 1975, FLORISTS REV, V157, P30; Han YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127065; He D, 2012, GENET MOL RES, V11, P3522, DOI 10.4238/2012.September.26.9; He D, 2014, PLANT BREEDING, V133, P138, DOI 10.1111/pbr.12100; Hwang J, 2014, MOL BREEDING, V34, P949, DOI 10.1007/s11032-014-0088-1; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Kalinina EY, 2011, CYTOL GENET+, V45, P101, DOI 10.3103/S0095452711020058; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Knox GW, 1992, CRAPEMYRTLE IN FLORI; Ku LX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020621; Kuraparthy V, 2008, FUNCT INTEGR GENOMIC, V8, P33, DOI 10.1007/s10142-007-0057-4; Li B, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1086; Li F, 2016, PLANT SCI, V242, P169, DOI 10.1016/j.plantsci.2015.05.012; Li YH, 2011, THEOR APPL GENET, V123, P973, DOI 10.1007/s00122-011-1640-6; Liu RZ, 2014, EUPHYTICA, V196, P51, DOI 10.1007/s10681-013-1013-0; Liu YS, 2008, GRANA, V47, P262, DOI 10.1080/00173130802457255; Liu Z, 2015, RICE, V8, DOI 10.1186/s12284-015-0042-9; Mencuccini M, 2015, PLANT CELL ENVIRON, V38, P1, DOI 10.1111/pce.12442; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Myburg AA, 2014, NATURE, V510, P356, DOI 10.1038/nature13308; One KT, 2014, J AM SOC HORTIC SCI, V139, P582, DOI 10.21273/JASHS.139.5.582; Peng H, 2015, EUPHYTICA, V202, P385, DOI 10.1007/s10681-014-1259-1; Petersen R, 2013, PLANTA, V238, P1, DOI 10.1007/s00425-013-1898-9; Peterson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037135; Pilcher RLR, 2008, J AM SOC HORTIC SCI, V133, P100, DOI 10.21273/JASHS.133.1.100; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Pounders C, 2007, HORTSCIENCE, V42, P1496, DOI 10.21273/HORTSCI.42.6.1496; Pounders C, 2007, HORTSCIENCE, V42, P1317, DOI 10.21273/HORTSCI.42.6.1317; Qi ZM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104871; Ripetti V, 2008, J EXP BOT, V59, P1399, DOI 10.1093/jxb/ern049; Segura V, 2008, NEW PHYTOL, V178, P302, DOI 10.1111/j.1469-8137.2007.02374.x; Seleznyova AN, 2007, ACTA HORTIC, P79, DOI 10.17660/ActaHortic.2007.732.6; Socquet-Juglard D, 2013, PLANT MOL BIOL REP, V31, P387, DOI 10.1007/s11105-012-0511-x; Sun XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058700; Takagi H, 2013, PLANT J, V74, P174, DOI 10.1111/tpj.12105; Teng F, 2013, PLANT J, V73, P405, DOI 10.1111/tpj.12038; Tong HN, 2014, PLANT CELL, V26, P4376, DOI 10.1105/tpc.114.132092; Wang N, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-148; Wang XW, 2015, INT J GENOMICS, V2015, DOI 10.1155/2015/528395; Wang X, 2011, J AM SOC HORTIC SCI, V136, P116, DOI 10.21273/JASHS.136.2.116; Wang XW, 2010, HORTSCIENCE, V45, P842, DOI 10.21273/HORTSCI.45.5.842; Wang YH, 2008, ANNU REV PLANT BIOL, V59, P253, DOI 10.1146/annurev.arplant.59.032607.092902; Wei QZ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1158; Xia C, 2015, EUPHYTICA, V202, P35, DOI 10.1007/s10681-014-1202-5; Xin M, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-014-1703-9; Xu FF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122206; Xu XW, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00768; Yang XM, 2014, PLANT BREEDING, V133, P335, DOI 10.1111/pbr.12154; Ye YJ, 2015, GENET MOL RES, V14, P4369, DOI 10.4238/2015.April.30.10; Zeng XH, 2011, THEOR APPL GENET, V122, P421, DOI 10.1007/s00122-010-1457-8; Zhang F, 2012, MOL BREEDING, V30, P1027, DOI 10.1007/s11032-011-9686-3; Zhang YX, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-141; Zhang ZY, 2014, DNA CELL BIOL, V33, P680, DOI 10.1089/dna.2014.2469; Zhu YM, 2011, MOL BREEDING, V27, P525, DOI 10.1007/s11032-010-9449-6	69	19	24	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0158970	10.1371/journal.pone.0158970	http://dx.doi.org/10.1371/journal.pone.0158970			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27404662	Green Published, gold, Green Submitted			2022-12-27	WOS:000379508200025
J	Dong, Y; Sun, Q; Liu, T; Wang, HY; Jiao, K; Xu, JH; Liu, X; Liu, HR; Wang, W				Dong, Yu; Sun, Qi; Liu, Teng; Wang, Huanyuan; Jiao, Kun; Xu, Jiahui; Liu, Xin; Liu, Huirong; Wang, Wen			Nitrative Stress Participates in Endothelial Progenitor Cell Injury in Hyperhomocysteinemia	PLOS ONE			English	Article							SYNTHASE-DEFICIENT MICE; NITRIC-OXIDE; METHYLENETETRAHYDROFOLATE REDUCTASE; CARDIOVASCULAR RISK; SUPEROXIDE-DISMUTASE; VASCULAR DYSFUNCTION; PLASMA HOMOCYSTEINE; PERIPHERAL-BLOOD; C677T MUTATION; PEROXYNITRITE	In order to investigate the role of nitrative stress in vascular endothelial injury in hyperhomocysteinemia (HHcy), thirty healthy adult female Wistar rats were randomly divided into three groups: control, hyperhomocysteinemia model, and hyperhomocysteinemia with FeTMPyP (peroxynitrite scavenger) treatment. The endothelium-dependent dilatation of thoracic aorta in vitro was determined by response to acetylcholine (ACh). The histological changes in endothelium were assessed by HE staining and scanning electron microscopy (SEM). The expression of 3-nitrotyrosine (NT) in thoracic aorta was demonstrated by immunohistochemistry and immunofluorescence, and the number of circulating endothelial progenitor cells (EPCs) was quantified by flow cytometry. Hyperhomocysteinemia caused significant endothelial injury and dysfunction including vasodilative and histologic changes, associated with higher expression of NT in thoracic aorta. FeTMPyP treatment reversed these injuries significantly. Further, the effect of nitrative stress on cultured EPCs in vitro was investigated by administering peroxynitrite donor (3-morpholino-sydnonimine, SIN-1) and peroxynitrite scavenger (FeTMPyP). The roles of nitrative stress on cell viability, necrosis and apoptosis were evaluated with 3-(4,5-dimethylthiazol)-2,5-diphenyl tetrazolium (MTT) assay, lactate dehydrogenase (LDH) release assay and terminal deoxynucleotidyl transferase dUTP nickend labeling (TUNEL) assay, respectively. Also, the phospho-eNOS expression and tube formation in Matrigel of cultured EPCs was detected. Our data showed that the survival of EPCs was much lower in SIN-1 group than in vehicle group, both the apoptosis and necrosis of EPCs were much more severe, and the p-eNOS expression and tube formation in Matrigel were obviously declined. Subsequent pretreatment with FeTMPyP reversed these changes. Further, pretreatment with FeTMPyP reversed homocysteine-induced EPC injury. In conclusion, this study indicates that nitrative stress plays a role in vascular endothelial injury in hyperhomocysteinemia, as well as induces endothelial progenitor cell injury directly.	[Dong, Yu; Sun, Qi; Liu, Teng; Wang, Huanyuan; Jiao, Kun; Xu, Jiahui; Liu, Xin; Liu, Huirong; Wang, Wen] Capital Med Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing, Peoples R China; [Dong, Yu; Sun, Qi; Liu, Teng; Wang, Huanyuan; Jiao, Kun; Xu, Jiahui; Liu, Xin; Liu, Huirong; Wang, Wen] Capital Med Univ, Beijing Key Lab Metab Disorders Related Cardiovas, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Wang, W (corresponding author), Capital Med Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing, Peoples R China.; Wang, W (corresponding author), Capital Med Univ, Beijing Key Lab Metab Disorders Related Cardiovas, Beijing, Peoples R China.	wangwen@ccmu.edu.cn	xu, jia/GSD-6347-2022; Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454	National Natural Science Foundation of China [448 81370450, 81370450]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding was provided by the National Natural Science Foundation of China (No. 448 81370450) to Wen Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the assistance of the Flow Cytometry Facility in the central laboratory in the Capital Medical University. We also thank Dr. Xiangjun Zeng, Yanan Gu and Ru Yuan from School of Basic Medical Sciences, Capital Medical University, for their selfless support with Matrigel and suggestions in capillary-like structures formation experiment. Funding was provided by the National Natural Science Foundation of China (No. 81370450) to Wen Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez B, 2004, FREE RADICAL BIO MED, V37, P813, DOI 10.1016/j.freeradbiomed.2004.06.006; Becchi C, 2008, INT J IMMUNOPATH PH, V21, P697, DOI 10.1177/039463200802100324; Bogoslovsky T, 2015, BIOMARK MED, V9, P625, DOI [10.2217/BMM.15.34, 10.2217/bmm.15.34]; Boos Christopher J., 2007, V139, P211; Brandes RP, 2005, CARDIOVASC RES, V66, P286, DOI 10.1016/j.cardiores.2004.12.027; Brown RM, 2016, METHODS MOL BIOL, V1430, P149, DOI 10.1007/978-1-4939-3628-1_9; Brunt Keith R., 2007, V139, P197; Calcerrada P, 2011, CURR PHARM DESIGN, V17, P3905, DOI 10.2174/138161211798357719; Cheng ZJ, 2011, BLOOD, V118, P1998, DOI 10.1182/blood-2011-01-333310; Cignarella Andrea, 2010, Cardiovascular & Hematological Agents in Medicinal Chemistry, V8, P147; Crabtree B, 2007, IN VITRO CELL DEV-AN, V43, P87, DOI 10.1007/s11626-007-9012-x; Crabtree MJ, 2008, AM J PHYSIOL-HEART C, V294, pH1530, DOI 10.1152/ajpheart.00823.2007; Davel AP, 2011, BRAZ J MED BIOL RES, V44, P920, DOI [10.1590/S0100-879X2011007500104, 10.1590/S0100-879X2011000900014]; Deloughery TG, 1996, CIRCULATION, V94, P3074, DOI 10.1161/01.CIR.94.12.3074; Fadini GP, 2012, CIRC RES, V110, P624, DOI 10.1161/CIRCRESAHA.111.243386; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; Girelli D, 1998, BLOOD, V91, P4158, DOI 10.1182/blood.V91.11.4158.411k23_4158_4163; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Kar S, 2003, FREE RADIC BIOL MED, V63, P161; Kavdia Mahendra, 2011, Critical Reviews in Biomedical Engineering, V39, P461, DOI 10.1615/CritRevBiomedEng.v39.i5.60; Kumar KH, 2013, NEUROTOXICOLOGY, V34, P150, DOI 10.1016/j.neuro.2012.11.002; Lentz SR, 2000, AM J PHYSIOL-HEART C, V279, pH970, DOI 10.1152/ajpheart.2000.279.3.H970; Lentz SR, 1996, J CLIN INVEST, V98, P24, DOI 10.1172/JCI118771; Maas R, 2003, ATHEROSCLEROSIS SUPP, V4, P15; MacMillan-Crow LA, 1998, BIOCHEMISTRY-US, V37, P1613, DOI 10.1021/bi971894b; Mayo JN, 2012, J CEREBR BLOOD F MET, V32, P825, DOI 10.1038/jcbfm.2011.185; Menegazzo L, 2012, BIOFACTORS, V38, P194, DOI 10.1002/biof.1016; Miller-Kasprzak E, 2007, ARCH IMMUNOL THER EX, V55, P247, DOI 10.1007/s00005-007-0027-5; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Refsum H, 2001, AM J CLIN NUTR, V74, P233; Sen S, 2011, CLIN SCI, V120, P263, DOI 10.1042/CS20100429; Smadja DM, 2009, CIRCULATION, V119, P374, DOI 10.1161/CIRCULATIONAHA.108.808246; Soriente L, 1998, STROKE, V29, P869, DOI 10.1161/01.STR.29.4.869; STAMLER JS, 1993, J CLIN INVEST, V91, P308, DOI 10.1172/JCI116187; STAMPFER MJ, 1992, JAMA-J AM MED ASSOC, V268, P877, DOI 10.1001/jama.268.7.877; Szabo C, 2002, MOL MED, V8, P571, DOI 10.1007/BF03402167; Tofler GH, 2002, THROMB HAEMOSTASIS, V88, P799; Tousoulis D, 2012, CURR VASC PHARMACOL, V10, P4, DOI 10.2174/157016112798829760; Tyagi N, 2005, AM J PHYSIOL-HEART C, V289, pH2649, DOI 10.1152/ajpheart.00548.2005; Ungvari Z, 1999, ARTERIOSCL THROM VAS, V19, P1899, DOI 10.1161/01.ATV.19.8.1899; van der Loo B, 2000, J EXP MED, V192, P1731, DOI 10.1084/jem.192.12.1731; Vizzardi E, 2007, CARDIOLOGY, V107, P354, DOI 10.1159/000099050; Widner B, 2002, CURR DRUG METAB, V3, P225, DOI 10.2174/1389200024605091; Zhang XH, 2000, AM J PHYSIOL-RENAL, V279, pF671, DOI 10.1152/ajprenal.2000.279.4.F671	44	18	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158672	10.1371/journal.pone.0158672	http://dx.doi.org/10.1371/journal.pone.0158672			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391949	Green Submitted, gold, Green Published			2022-12-27	WOS:000380005400100
J	Gan, MY; Liu, QY; Yang, CG; Gao, Q; Luo, T				Gan, Mingyu; Liu, Qingyun; Yang, Chongguang; Gao, Qian; Luo, Tao			Deep Whole-Genome Sequencing to Detect Mixed Infection of Mycobacterium tuberculosis	PLOS ONE			English	Article							MULTIDRUG-RESISTANT STRAIN; DRUG-RESISTANCE; REINFECTION; POPULATION; TRANSMISSION; PREVALENCE; PATTERNS; AFRICA; CHINA	Mixed infection by multiple Mycobacterium tuberculosis (MTB) strains is associated with poor treatment outcome of tuberculosis (TB). Traditional genotyping methods have been used to detect mixed infections of MTB, however, their sensitivity and resolution are limited. Deep whole-genome sequencing (WGS) has been proved highly sensitive and discriminative for studying population heterogeneity of MTB. Here, we developed a phylogenetic-based method to detect MTB mixed infections using WGS data. We collected published WGS data of 782 global MTB strains from public database. We called homogeneous and heterogeneous single nucleotide variations (SNVs) of individual strains by mapping short reads to the ancestral MTB reference genome. We constructed a phylogenomic database based on 68,639 homogeneous SNVs of 652 MTB strains. Mixed infections were determined if multiple evolutionary paths were identified by mapping the SNVs of individual samples to the phylogenomic database. By simulation, our method could specifically detect mixed infections when the sequencing depth of minor strains was as low as 1x coverage, and when the genomic distance of two mixed strains was as small as 16 SNVs. By applying our methods to all 782 samples, we detected 47 mixed infections and 45 of them were caused by locally endemic strains. The results indicate that our method is highly sensitive and discriminative for identifying mixed infections from deep WGS data of MTB isolates.	[Gan, Mingyu; Liu, Qingyun; Yang, Chongguang; Gao, Qian] Fudan Univ, Sch Basic Med Sci, Inst Biomed Sci, Key Lab Med Mol Virol,Minist Educ, Shanghai, Peoples R China; [Gan, Mingyu; Liu, Qingyun; Yang, Chongguang; Gao, Qian] Fudan Univ, Sch Basic Med Sci, Inst Biomed Sci, Minist Hlth, Shanghai, Peoples R China; [Gan, Mingyu; Liu, Qingyun; Yang, Chongguang; Gao, Qian] Fudan Univ, Inst Med Microbiol, Sch Basic Med Sci, Shanghai, Peoples R China; [Luo, Tao] Sichuan Univ, Sch Basic Med Sci, West China Ctr Med Sci, Lab Infect & Immun, Chengdu, Sichuan, Peoples R China	Fudan University; Fudan University; Fudan University; Sichuan University	Gao, Q (corresponding author), Fudan Univ, Sch Basic Med Sci, Inst Biomed Sci, Key Lab Med Mol Virol,Minist Educ, Shanghai, Peoples R China.; Gao, Q (corresponding author), Fudan Univ, Sch Basic Med Sci, Inst Biomed Sci, Minist Hlth, Shanghai, Peoples R China.; Gao, Q (corresponding author), Fudan Univ, Inst Med Microbiol, Sch Basic Med Sci, Shanghai, Peoples R China.; Luo, T (corresponding author), Sichuan Univ, Sch Basic Med Sci, West China Ctr Med Sci, Lab Infect & Immun, Chengdu, Sichuan, Peoples R China.	qgao99@yahoo.com; taoluo@scu.edu.cn	Yang, Chongguang/N-3298-2016; Yang, Chongguang/S-9117-2019; , 罗涛/AHA-1191-2022	Yang, Chongguang/0000-0001-8109-4974; Yang, Chongguang/0000-0001-8109-4974; Liu, Qingyun/0000-0002-2284-5050	National Natural Science Foundation of China (CN) [31301033]; Ministry of Science and Technology of the People's Republic of China [2014DFA30340]; National Science and Technology Major Project [2013ZX10004903-006]	National Natural Science Foundation of China (CN)(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Science and Technology Major Project	This study was supported by National Natural Science Foundation of China (CN) (31301033) (website: http://www.nsfc.gov.cn/) (PI: Tao Luo), Ministry of Science and Technology of the People's Republic of China (2014DFA30340) (website:http://www.most.gov.cn/index.htm) (PI: Qian Gao) and the National Science and Technology Major Project [2013ZX10004903-006] (website: http://www.most.gov.cn/index.htm) (PI: Qian Gao). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PF, 2003, NEW ENGL J MED, V349, P1149, DOI 10.1056/NEJMra021964; Casali N, 2014, NAT GENET, V46, P279, DOI 10.1038/ng.2878; Chan JZM, 2013, NEW ENGL J MED, V369, P289, DOI 10.1056/NEJMc1302295; Chaves F, 1999, AIDS, V13, P615, DOI 10.1097/00002030-199904010-00011; Cohen T, 2012, CLIN MICROBIOL REV, V25, P708, DOI 10.1128/CMR.00021-12; Cohen T, 2011, J CLIN MICROBIOL, V49, P385, DOI 10.1128/JCM.01378-10; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; Comas I, 2012, NAT GENET, V44, P106, DOI 10.1038/ng.1038; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; de Boer AS, 2000, J CLIN MICROBIOL, V38, P4478, DOI 10.1128/JCM.38.12.4478-4484.2000; Eyre DW, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003059; Firdessa R, 2013, EMERG INFECT DIS, V19, P460, DOI 10.3201/eid1903.120256; Ford CB, 2011, NAT GENET, V43, P482, DOI 10.1038/ng.811; Galagan JE, 2014, NAT REV GENET, V15, P307, DOI 10.1038/nrg3664; Guerra-Assuncao JA, 2015, J INFECT DIS, V211, P1154, DOI 10.1093/infdis/jiu574; Hanekom M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070178; Ismail F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114832; Koser CU, 2013, NEW ENGL J MED, V369, P290, DOI 10.1056/NEJMc1215305; Luo T, 2015, P NATL ACAD SCI USA, V112, P8136, DOI 10.1073/pnas.1424063112; Luo T, 2014, TUBERCULOSIS, V94, P434, DOI 10.1016/j.tube.2014.04.005; Niemann S, 2000, EMERG INFECT DIS, V6, P548, DOI 10.3201/eid0605.000518; Pang Y, 2015, J INFECTION, V71, P231, DOI 10.1016/j.jinf.2015.03.012; Plazzotta G, 2015, J THEOR BIOL, V368, P67, DOI 10.1016/j.jtbi.2014.12.009; Pulido-Tamayo S, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv478; Sandgren A, 2009, PLOS MED, V6, P132, DOI 10.1371/journal.pmed.1000002; Sun G, 2012, J INFECT DIS, V206, P1724, DOI 10.1093/infdis/jis601; THEISEN A, 1995, LANCET, V345, P1512, DOI 10.1016/S0140-6736(95)91073-5; Tukey JW, 1977, EXPLORATORY DATA ANA; van Rie A, 2005, AM J RESP CRIT CARE, V172, P636, DOI 10.1164/rccm.200503-449OC; Walker TM, 2014, LANCET RESP MED, V2, P285, DOI 10.1016/S2213-2600(14)70027-X; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; Warren RM, 2004, AM J RESP CRIT CARE, V169, P610, DOI 10.1164/rccm.200305-714OC; Wlodarska M, 2015, CLIN MICROBIOL REV, V28, P523, DOI 10.1128/CMR.00124-14; World Health Organization, 2015, WHOHTMTB201522; Zhang HT, 2013, NAT GENET, V45, P1255, DOI 10.1038/ng.2735	35	28	28	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159029	10.1371/journal.pone.0159029	http://dx.doi.org/10.1371/journal.pone.0159029			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391214	Green Submitted, Green Published, gold			2022-12-27	WOS:000380005400197
J	Kawano, S; Grassian, AR; Tsuda, M; Knutson, SK; Warholic, NM; Kuznetsov, G; Xu, SQ; Xiao, YH; Pollock, RM; Smith, JS; Kuntz, KK; Ribich, S; Minoshima, Y; Matsui, J; Copeland, RA; Tanaka, S; Keilhack, H				Kawano, Satoshi; Grassian, Alexandra R.; Tsuda, Masumi; Knutson, Sarah K.; Warholic, Natalie M.; Kuznetsov, Galina; Xu, Shanqin; Xiao, Yonghong; Pollock, Roy M.; Smith, Jesse S.; Kuntz, Kevin K.; Ribich, Scott; Minoshima, Yukinori; Matsui, Junji; Copeland, Robert A.; Tanaka, Shinya; Keilhack, Heike			Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma	PLOS ONE			English	Article							SOFT-TISSUE TUMORS; SWI/SNF COMPLEXES; FUSION; CANCER; GENES; H3K27; SYT; IDENTIFICATION; PROLIFERATION; CYTOGENETICS	The catalytic activities of covalent and ATP-dependent chromatin remodeling are central to regulating the conformational state of chromatin and the resultant transcriptional output. The enzymes that catalyze these activities are often contained within multiprotein complexes in nature. Two such multiprotein complexes, the polycomb repressive complex 2 (PRC2) methyltransferase and the SWItch/Sucrose Non-Fermentable (SWI/SNF) chromatin remodeler have been reported to act in opposition to each other during development and homeostasis. An imbalance in their activities induced by mutations/deletions in complex members (e.g. SMARCB1) has been suggested to be a pathogenic mechanism in certain human cancers. Here we show that preclinical models of synovial sarcoma-a cancer characterized by functional SMARCB1 loss via its displacement from the SWI/SNF complex through the pathognomonic SS18-SSX fusion protein-display sensitivity to pharmacologic inhibition of EZH2, the catalytic subunit of PRC2. Treatment with tazemetostat, a clinicalstage, selective and orally bioavailable small-molecule inhibitor of EZH2 enzymatic activity reverses a subset of synovial sarcoma gene expression and results in concentration-dependent cell growth inhibition and cell death specifically in SS18-SSX fusion-positive cells in vitro. Treatment of mice bearing either a cell line or two patient-derived xenograft models of synovial sarcoma leads to dose-dependent tumor growth inhibition with correlative inhibition of trimethylation levels of the EZH2-specific substrate, lysine 27 on histone H3. These data demonstrate a dependency of SS18-SSX-positive, SMARCB1-deficient synovial sarcomas on EZH2 enzymatic activity and suggests the potential utility of EZH2-targeted drugs in these genetically defined cancers.	[Grassian, Alexandra R.; Knutson, Sarah K.; Warholic, Natalie M.; Xiao, Yonghong; Pollock, Roy M.; Smith, Jesse S.; Kuntz, Kevin K.; Ribich, Scott; Tanaka, Shinya; Keilhack, Heike] Epizyme Inc, Cambridge, MA 02139 USA; [Kawano, Satoshi; Minoshima, Yukinori; Matsui, Junji] Eisai & Co Ltd, Tsukuba, Ibaraki, Japan; [Kuznetsov, Galina; Xu, Shanqin] Eisai Inc, Andover, MA USA; [Tsuda, Masumi; Tanaka, Shinya] Hokkaido Univ, Grad Sch Med, Dept Canc Pathol, Sapporo, Hokkaido, Japan	Eisai Co Ltd; Eisai Co Ltd; Hokkaido University	Grassian, AR; Ribich, S (corresponding author), Epizyme Inc, Cambridge, MA 02139 USA.	agrassian@epizyme.com; sribich@epizyme.com	Tanaka, Shinya/D-3586-2011		Epizyme, Inc.; Eisai Co; Eisai, Inc.	Epizyme, Inc.; Eisai Co(Eisai Co Ltd); Eisai, Inc.(Eisai Co Ltd)	This work was funded by Epizyme, Inc., Eisai Co, and Eisai, Inc. The funding entities had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaimy A, 2014, ADV ANAT PATHOL, V21, P394, DOI 10.1097/PAP.0000000000000038; Arnold MA, 2013, HUM PATHOL, V44, P881, DOI 10.1016/j.humpath.2012.08.014; Campbell JE, 2015, ACS MED CHEM LETT, V6, P491, DOI 10.1021/acsmedchemlett.5b00037; CLARK J, 1994, NAT GENET, V7, P502, DOI 10.1038/ng0894-502; Copeland RA, 2013, CLIN CANCER RES, V19, P6344, DOI 10.1158/1078-0432.CCR-13-0223; CREW AJ, 1995, EMBO J, V14, P2333, DOI 10.1002/j.1460-2075.1995.tb07228.x; Dabbs DJ., 2010, DIAGNOSTIC IMMUNOHIS; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; DELEEUW B, 1995, HUM MOL GENET, V4, P1097, DOI 10.1093/hmg/4.6.1097; Folpe AL, 1998, AM J SURG PATHOL, V22, P673, DOI 10.1097/00000478-199806000-00004; Haldar M, 2007, CANCER CELL, V11, P375, DOI 10.1016/j.ccr.2007.01.016; Hartel PH, 2007, MODERN PATHOL, V20, P760, DOI 10.1038/modpathol.3800795; Hiraga H, 1998, DIAGN MOL PATHOL, V7, P102, DOI 10.1097/00019606-199804000-00007; Hoglund M, 2005, INT J CANCER, V116, P401, DOI 10.1002/ijc.21021; Italiano A, 2015, EUROPEAN SOC MED ONC; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Kadoch C, 2013, CELL, V153, P71, DOI 10.1016/j.cell.2013.02.036; Kato H, 2002, J BIOL CHEM, V277, P5498, DOI 10.1074/jbc.M108702200; Klijn C, 2015, NAT BIOTECHNOL, V33, P306, DOI 10.1038/nbt.3080; Knutson SK, 2013, P NATL ACAD SCI USA, V110, P7922, DOI 10.1073/pnas.1303800110; Knutson SK, 2012, NAT CHEM BIOL, V8, P890, DOI [10.1038/NCHEMBIO.1084, 10.1038/nchembio.1084]; Kohashi K, 2010, MODERN PATHOL, V23, P981, DOI 10.1038/modpathol.2010.71; Lagarde P, 2013, J CLIN ONCOL, V31, P608, DOI 10.1200/JCO.2012.46.0147; LIMON J, 1991, GENE CHROMOSOME CANC, V3, P338, DOI 10.1002/gcc.2870030504; Lopes JM, 1998, ANAL CELL PATHOL, V16, P45; Lubieniecka JM, 2008, CANCER RES, V68, P4303, DOI 10.1158/0008-5472.CAN-08-0092; Middeljans E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033834; MIETTINEN M, 1993, HUM PATHOL, V24, P62, DOI 10.1016/0046-8177(93)90064-N; Nielsen TO, 2015, CANCER DISCOV, V5, P124, DOI 10.1158/2159-8290.CD-14-1246; NOJIMA T, 1990, ACTA PATHOL JAPON, V40, P486; Przybyl J, 2014, INT J BIOCHEM CELL B, V53, P505, DOI 10.1016/j.biocel.2014.05.006; Rando OJ, 2012, CURR OPIN GENET DEV, V22, P148, DOI 10.1016/j.gde.2012.02.013; Sandberg AA, 2002, CANCER GENET CYTOGEN, V133, P1, DOI 10.1016/S0165-4608(01)00626-4; Shain AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055119; Shen JK, 2016, SCI REP-UK, V6, DOI 10.1038/srep25239; Skytting B, 1999, J NATL CANCER I, V91, P974, DOI 10.1093/jnci/91.11.974; Sneeringer CJ, 2010, P NATL ACAD SCI USA, V107, P20980, DOI 10.1073/pnas.1012525107; Soni EEC, 2014, CLIN ORTHOP RELAT R, V472, P874, DOI 10.1007/s11999-013-3065-9; SONOBE H, 1992, LAB INVEST, V67, P498; Su L, 2012, CANCER CELL, V21, P333, DOI 10.1016/j.ccr.2012.01.010; Tsuda M, 2005, ONCOGENE, V24, P7984, DOI 10.1038/sj.onc.1208942; Turc-Carel C, 1995, Curr Top Pathol, V89, P73; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Wilson BG, 2010, CANCER CELL, V18, P316, DOI 10.1016/j.ccr.2010.09.006	44	42	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158888	10.1371/journal.pone.0158888	http://dx.doi.org/10.1371/journal.pone.0158888			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391784	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400151
J	Kim, S; Ahn, SH; Lee, JS; Song, JE; Cho, SH; Jung, S; Kim, SK; Kim, SH; Lee, KP; Kwon, KS; Lee, TH				Kim, Suhee; Ahn, Sun Hee; Lee, Jin-Sil; Song, Ji-Eun; Cho, Sung-Hyun; Jung, Seunggon; Kim, Seon-Kyu; Kim, Seok-Ho; Lee, Kwang-Pyo; Kwon, Ki-Sun; Lee, Tae-Hoon			Differential Matrix Metalloprotease (MMP) Expression Profiles Found in Aged Gingiva	PLOS ONE			English	Article							AGING HUMAN FIBROBLASTS; PERIODONTAL-LIGAMENT; IN-VITRO; DERMAL FIBROBLASTS; INFLAMMATION; COLLAGEN; INTERLEUKIN-1; TISSUE; IMMUNOSENESCENCE; POPULATION	The periodontium undergoes age-related cellular and clinical changes, but the involved genes are not yet known. Here, we investigated age-related genetic changes in gingiva at the transcriptomic level. Genes that were differentially expressed between young and old human gingiva were identified by RNA sequencing and verified by real-time PCR. A total of 1939 mRNA transcripts showed significantly differential expression between young and old gingival tissues. Matrix metalloprotease (MMP) regulation was the top pathway involved in gingival aging. MMP3, MMP9, MMP12, and MMP13 were upregulated in old gingival tissues, concomitantly with interleukin-1 beta (IL1B) expression. In vitro experiments using human gingival fibroblasts (hGFs) showed that MMP12 was upregulated in old hGFs compared to young hGFs. Moreover, the MMP3, MMP9 and IL1B levels were more highly stimulated by infection with the oral bacterium, Fusobacterium nucleatum, in old hGFs compared to young hGFs. Collectively, these findings suggest that, in gingiva, the upregulation of MMP12 may be a molecular hallmark of natural aging, while the upregulations of MMP3, MMM9, and IL1B may indicate externally (e.g., infection)-induced aging. These findings contribute to our understanding of the molecular targets involved in gingival aging.	[Kim, Suhee; Ahn, Sun Hee; Lee, Jin-Sil; Lee, Tae-Hoon] Chonnam Natl Univ, Sch Dent, Med Res Ctr Biomineralizat Disorders, Dept Oral Biochem,Dent Sci Res Inst, Gwangju, South Korea; [Kim, Suhee; Song, Ji-Eun; Cho, Sung-Hyun; Lee, Tae-Hoon] Chonnam Natl Univ, Grad Sch, Dept Mol Med BK21Plus, Gwangju, South Korea; [Jung, Seunggon] Chonnam Natl Univ, Sch Dent, Dept Oral & Maxillofacial Surg, Gwangju, South Korea; [Kim, Seon-Kyu] KRIBB, Personalized Genom Med Res Ctr, Daejeon, South Korea; [Kim, Seok-Ho; Lee, Kwang-Pyo; Kwon, Ki-Sun] KRIBB, Aging Res Ctr, Daejeon, South Korea	Chonnam National University; Chonnam National University; Chonnam National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Lee, TH (corresponding author), Chonnam Natl Univ, Sch Dent, Med Res Ctr Biomineralizat Disorders, Dept Oral Biochem,Dent Sci Res Inst, Gwangju, South Korea.; Lee, TH (corresponding author), Chonnam Natl Univ, Grad Sch, Dept Mol Med BK21Plus, Gwangju, South Korea.; Kwon, KS (corresponding author), KRIBB, Aging Res Ctr, Daejeon, South Korea.	kwonks@kribb.re.kr; thlee83@jnu.ac.kr	Lee, Tae-Hoon/AAR-3708-2021	Lee, Tae-Hoon/0000-0003-0105-1750; Lee, Kwang-Pyo/0000-0003-0067-6898; Kim, Seon-Kyu/0000-0002-4176-5187	Korea Mouse Phenotyping Project [NRF-2014M3A9D5073721]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [2014R1A2A2A01005448, 2013M3A9B6076413]; KRIBB Research Initiative Program	Korea Mouse Phenotyping Project; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning; KRIBB Research Initiative Program	This work was supported by Korea Mouse Phenotyping Project (NRF-2014M3A9D5073721) and also by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (2014R1A2A2A01005448 and 2013M3A9B6076413).; SKK, SHK, KPL and KSK were partly supported by the KRIBB Research Initiative Program.	Abiko Y, 1998, Ann Periodontol, V3, P350; BECK JD, 1990, J PERIODONTOL, V61, P521, DOI 10.1902/jop.1990.61.8.521; Benatti BB, 2008, CONNECT TISSUE RES, V49, P401, DOI 10.1080/03008200802171159; Bonnema DD, 2007, J CARD FAIL, V13, P530, DOI 10.1016/j.cardfail.2007.04.010; BURT BA, 1994, J AM DENT ASSOC, V125, P273, DOI 10.14219/jada.archive.1994.0034; Caceres M, 2014, J DENT RES, V93, P691, DOI 10.1177/0022034514533126; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Celenligil-Nazliel H, 2000, J PERIODONTOL, V71, P1567, DOI 10.1902/jop.2000.71.10.1567; Cominelli A, 2014, MOL HUM REPROD, V20, P767, DOI 10.1093/molehr/gau034; Davanian H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046440; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; DUMAS M, 1994, MECH AGEING DEV, V73, P179, DOI 10.1016/0047-6374(94)90050-7; Ejeil AL, 2003, J PERIODONTOL, V74, P188, DOI 10.1902/jop.2003.74.2.188; Fantuzzi G, 1997, J IMMUNOL, V158, P1818; Fiorellini JP, 2014, CARRANZAS CLIN PERIO, P9; Fitzsimmons TR, 2009, AUST DENT J, V54, P115, DOI 10.1111/j.1834-7819.2009.01103.x; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Gogly B, 1997, Clin Oral Investig, V1, P147; Gonsalves WC, 2008, AM FAM PHYSICIAN, V78, P845; Gonzalez OA, 2011, J DENT RES, V90, P880, DOI 10.1177/0022034511403744; HavemosePoulsen A, 1997, CRIT REV ORAL BIOL M, V8, P217, DOI 10.1177/10454411970080020801; HOU LT, 1993, J PERIODONTOL, V64, P1209, DOI 10.1902/jop.1993.64.12.1209; Huttner EA, 2009, SPEC CARE DENT, V29, P149, DOI 10.1111/j.1754-4505.2009.00082.x; IRWIN CR, 1994, J CELL SCI, V107, P1333; Ito A, 1996, J BIOL CHEM, V271, P14657, DOI 10.1074/jbc.271.25.14657; Khorramizadeh MR, 1999, MOL CELL BIOCHEM, V194, P99, DOI 10.1023/A:1006909021352; Kim SJ, 2009, BIOCHEM BIOPH RES CO, V378, P152, DOI 10.1016/j.bbrc.2008.09.015; KUMAR S, 1992, P NATL ACAD SCI USA, V89, P4683, DOI 10.1073/pnas.89.10.4683; Lee W, 1997, EXP CELL RES, V237, P383, DOI 10.1006/excr.1997.3802; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Liu Y, 2013, NEUROBIOL AGING, V34, P1231, DOI 10.1016/j.neurobiolaging.2012.10.015; Lu HH, 2009, J ORAL PATHOL MED, V38, P79, DOI 10.1111/j.1600-0714.2008.00717.x; Makrantonaki E, 2006, AGING CELL, V5, P331, DOI 10.1111/j.1474-9726.2006.00223.x; Makrantonaki E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050393; Manicone AM, 2008, SEMIN CELL DEV BIOL, V19, P34, DOI 10.1016/j.semcdb.2007.07.003; McCauley LK, 2002, J PERIODONTOL, V73, P1377, DOI 10.1902/jop.2002.73.11.1377; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045; Mombelli A, 1998, PERIODONTOL 2000, V16, P44, DOI 10.1111/j.1600-0757.1998.tb00115.x; Rawlinson A, 2000, J CLIN PERIODONTOL, V27, P738, DOI 10.1034/j.1600-051x.2000.027010738.x; Schonbeck U, 1998, J IMMUNOL, V161, P3340; SISMEYDURRANT HJ, 1991, ORAL MICROBIOL IMMUN, V6, P378, DOI 10.1111/j.1399-302X.1991.tb00510.x; Smith PC, 2015, J DENT RES, V94, P395, DOI 10.1177/0022034514563750; Takatsu M, 1999, MECH AGEING DEV, V110, P37, DOI 10.1016/S0047-6374(99)00041-X; VANDERVELDEN U, 1984, J CLIN PERIODONTOL, V11, P281; Williams RC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148024; Wolf J, 2012, EXP GERONTOL, V47, P749, DOI 10.1016/j.exger.2012.07.001; Yu TY, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-2; Zouboulis CC, 2011, CLIN DERMATOL, V29, P3, DOI 10.1016/j.clindermatol.2010.07.001	49	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158777	10.1371/journal.pone.0158777	http://dx.doi.org/10.1371/journal.pone.0158777			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391467	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400122
J	Malhotra, S; Vashist, P; Gupta, N; Kalaivani, M; Satpathy, G; Shah, A; Krishnan, S; Azad, R				Malhotra, Sumit; Vashist, Praveen; Gupta, Noopur; Kalaivani, Mani; Satpathy, Gita; Shah, Anita; Krishnan, Sujaya; Azad, Rajvardhan			Prevalence of Trachoma in Car-Nicobar Island, India after Three Annual Rounds of Mass Drug Administration with Azithromycin	PLOS ONE			English	Article							RISK-FACTORS; GLOBAL ELIMINATION; CHLAMYDIA; SENSITIVITY; SMEARS	Background A high proportion of active trachoma infection in children of Car-Nicobar Island was reported through the Trachoma Rapid Assessment survey conducted in year 2010 by the same researchers. Annual mass drug treatment with azithromycin was administered from years 2010-12 to all individuals residing in this island for reducing the burden of active trachoma infection. A cross-sectional prevalence survey was conducted in the year 2013 to assess the post-treatment burden of trachoma in this population. Methods In the 15 randomly selected compact segments from each village of the island, children aged 1-9 years were examined for evidence of active trachoma infection and participants aged ten years and above were examined for trachomatous trichiasis and corneal opacity. Results A total of 809 children (1-9 years) and 2735 adults were examined. Coverage with azithromycin for all the three rounds was more than 80%. The prevalence of active trachoma infection in children aged 1-9 years old was 6.8% (95% CI 5.1, 8.5) and Trachomatous Trichiasis (TT) was 3.9% (95% CI 3.2, 4.6). The risk factors associated with active trachoma infection were older age and unclean faces. The risk factors associated with TT were older age and lower literacy level. Conclusion Trachoma has not been eliminated from Car-Nicobar Island in accordance to 'Global Elimination of Trachoma, 2020' guidelines. Sustained efforts and continuous surveillance admixed with adequate programmatic response is imperative for elimination of trachoma in the island.	[Malhotra, Sumit; Vashist, Praveen; Gupta, Noopur] All India Inst Med Sci, Dr Rajendra Prasad Ctr Ophthalm Sci, Dept Community Ophthalmol, New Delhi, India; [Kalaivani, Mani] All India Inst Med Sci, Dept Biostat, New Delhi, India; [Satpathy, Gita] All India Inst Med Sci, Dr Rajendra Prasad Ctr Ophthalm Sci, Dept Ocular Microbiol, New Delhi, India; [Shah, Anita] Gobind Ballabh Pant Hosp, Port Blair, Andaman & Nicob, India; [Krishnan, Sujaya] Govt India, Minist Hlth & Family Welf, New Delhi, India; [Azad, Rajvardhan] All India Inst Med Sci, Dr Rajendra Prasad Ctr Ophthalm Sci, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; Dr. Rajendra Prasad Centre for Ophthalmic Sciences; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; Dr. Rajendra Prasad Centre for Ophthalmic Sciences; Govind Ballabh Pant Institute of Postgraduate Medical Education & Research; All India Institute of Medical Sciences (AIIMS) New Delhi; Dr. Rajendra Prasad Centre for Ophthalmic Sciences	Vashist, P (corresponding author), All India Inst Med Sci, Dr Rajendra Prasad Ctr Ophthalm Sci, Dept Community Ophthalmol, New Delhi, India.	praveenvashist@yahoo.com	Satpathy, Gita/GSI-9330-2022; GUPTA, NOOPUR/AAX-5043-2021	GUPTA, NOOPUR/0000-0001-8022-6656	National Programme for Control of Blindness, Andaman and Nicobar Islands; Ministry of Health and Family Welfare, Government of India	National Programme for Control of Blindness, Andaman and Nicobar Islands; Ministry of Health and Family Welfare, Government of India	This work was supported by the National Programme for Control of Blindness, Andaman and Nicobar Islands and Ministry of Health and Family Welfare, Government of India. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, RAP ASS TRACH IND; Blake K, 2007, MEASURING OVERCROWDI; Silva JC, 2015, OPHTHAL EPIDEMIOL, V22, P231, DOI 10.3109/09286586.2015.1037846; Edwards T, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001585; Ejere HOD, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002219.pub2; Emerson PM, 2001, MED VET ENTOMOL, V15, P314, DOI 10.1046/j.0269-283x.2001.00318.x; Frick KD, 2003, AM J TROP MED HYG, V69, P1; Government of India, 2013, NAT PROGR CONTR BLIN; Jip NF, 2008, OPHTHAL EPIDEMIOL, V15, P294, DOI 10.1080/09286580802256542; Kalua K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009067; Katz J, 1996, BRIT J OPHTHALMOL, V80, P1037, DOI 10.1136/bjo.80.12.1037; LINDNER LE, 1986, AM J CLIN PATHOL, V85, P180, DOI 10.1093/ajcp/85.2.180; Mariotti SP, 2003, AM J TROP MED HYG, V69, P33; Mohan M., 1989, NATL SURVEY BLINDNES; Mohile Mukula, 2002, Indian Journal of Ophthalmology, V50, P295; Mpyet C, 2015, OPHTHAL EPIDEMIOL, V22, P148, DOI 10.3109/09286586.2015.1045987; Mpyet C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040421; Negrel A., 2001, GUIDELINES RAPID ASS; Nicobar District, 2013, NICOBAR DISTRICT; Osama MB, 1995, BAHARAIN MED BULL, V17, P11; PREOBRAGENSKI V V, 1964, J All India Ophthalmol Soc, V12, P68; Roba AA, 2013, INT OPHTHALMOL, V33, P53, DOI 10.1007/s10792-012-9632-3; Salpietro CD, 1999, ARCH PEDIATRIE, V6, P317, DOI 10.1016/S0929-693X(99)80273-5; Schemann JF, 2002, INT J EPIDEMIOL, V31, P194, DOI 10.1093/ije/31.1.194; Solomon AW, 2015, OPHTHAL EPIDEMIOL, V22, P214, DOI 10.3109/09286586.2015.1037401; THOMAS BJ, 1984, J CLIN PATHOL, V37, P812, DOI 10.1136/jcp.37.7.812; THYLEFORS B, 1987, B WORLD HEALTH ORGAN, V65, P477; Vashist P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065918; WHO Global Health Observatory, 2010, TRACHOMA; World Health Organization, 2013, WKLY EPIDEMIOL REC, V88, P241; World Health Organization, 2015, OVERCROWDING; Wright HR, 2005, BRIT J OPHTHALMOL, V89, P526, DOI 10.1136/bjo.2005.066183	32	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158625	10.1371/journal.pone.0158625	http://dx.doi.org/10.1371/journal.pone.0158625			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391274	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400094
J	Xin, XH; Ming, QS; Zhang, JB; Wang, YP; Liu, ML; Yao, SQ				Xin, Xiuhong; Ming, Qingsen; Zhang, Jibiao; Wang, Yuping; Liu, Mingli; Yao, Shuqiao			Four Distinct Subgroups of Self-Injurious Behavior among Chinese Adolescents: Findings from a Latent Class Analysis	PLOS ONE			English	Article							MULTIDIMENSIONAL ANXIETY SCALE; BARRATT IMPULSIVENESS SCALE; SUICIDAL-BEHAVIOR; PSYCHOMETRIC PROPERTIES; DEPRESSIVE SYMPTOMS; COMMUNITY SAMPLE; LIFE EVENTS; HONG-KONG; HARM; PREVALENCE	Self-injurious behavior (SIB) among adolescents is an important public health issue worldwide. It is still uncertain whether homogeneous subgroups of SIB can be identified and whether constellations of SIBs can co-occur due to the high heterogeneity of these behaviors. In this study, a cross-sectional study was conducted on a large school-based sample and latent class analysis was performed (n = 10,069, mean age = 15 years) to identify SIB classes based on 11 indicators falling under direct SIB (DSIB), indirect SIB (ISIB), and suicide attempts (SAs). Social and psychological characteristics of each subgroup were examined after controlling for age and gender. Results showed that a four-class model best fit the data and each class had a distinct pattern of co-occurrence of SIBs and external measures. Class 4 (the baseline/normative group, 65.3%) had a low probability of SIB. Class 3 (severe SIB group, 3.9%) had a high probability of SIB and the poorest social and psychological status. Class 1 (DSIB+SA group, 14.2%) had similar scores for external variables compared to class 3, and included a majority of girls [odds ratio (OR) = 1.94]. Class 2 (ISIB group, 16.6%) displayed moderate endorsement of ISIB items, and had a majority of boys and older adolescents (OR = 1.51). These findings suggest that SIB is a heterogeneous entity, but it may be best explained by four homogenous subgroups that display quantitative and qualitative differences. Findings in this study will improve our understanding on SIB and may facilitate the prevention and treatment of SIB.	[Xin, Xiuhong; Ming, Qingsen; Liu, Mingli; Yao, Shuqiao] Cent S Univ, Inst Med Psychol, Xiangya Hosp 2, Changsha 410011, Hunan, Peoples R China; [Xin, Xiuhong] Ningxia Med Univ, Dept Med Psychol, Clin Med Coll, Ningxia, Peoples R China; [Xin, Xiuhong] Ningxia Med Univ, Gen Hosp, Mental Hlth Ctr, Ningxia, Peoples R China; [Zhang, Jibiao] Jianghan Univ, Sch Educ, Dept Psychol, Wuhan, Hubei, Peoples R China; [Wang, Yuping] Xi An Jiao Tong Univ, Sch Humanities & Social Sci, Xian, Peoples R China; [Liu, Mingli] Hunan Univ Sci & Technol, Sch Educ, Xiangtan, Hunan, Peoples R China	Central South University; Ningxia Medical University; Ningxia Medical University; Jianghan University; Xi'an Jiaotong University; Hunan University of Science & Technology	Yao, SQ (corresponding author), Cent S Univ, Inst Med Psychol, Xiangya Hosp 2, Changsha 410011, Hunan, Peoples R China.	Shuqiaoyao@163.com	Liu, Millie/GXG-8603-2022; xin, xiuhong/O-8806-2014		National Key Technologies Research and Development Program of the 11th 5-year plan of China [2009BAI77B02]; construct program of the key discipline in Hunan Province	National Key Technologies Research and Development Program of the 11th 5-year plan of China; construct program of the key discipline in Hunan Province	This study was supported by grants from the National Key Technologies Research and Development Program of the 11th 5-year plan of China (no. 2009BAI77B02), and from the construct program of the key discipline in Hunan Province.	American Psychiatric Association, DSM 5 SECT 3; Asparouhov T, 2009, STRUCT EQU MODELING, V16, P397, DOI 10.1080/10705510903008204; Auerbach RP, 2010, BRIT J CLIN PSYCHOL, V49, P547, DOI 10.1348/014466509X479681; Auerbach RP, 2010, COGNITIVE THER RES, V34, P159, DOI 10.1007/s10608-009-9238-x; Bracken-Minor KL, 2012, J PSYCHOPATHOL BEHAV, V34, P552, DOI 10.1007/s10862-012-9306-5; Brausch AM, 2010, J YOUTH ADOLESCENCE, V39, P233, DOI 10.1007/s10964-009-9482-0; Brent DA, 2006, NEW ENGL J MED, V355, P2719, DOI 10.1056/NEJMp068195; Bridge JA, 2006, J CHILD PSYCHOL PSYC, V47, P372, DOI 10.1111/j.1469-7610.2006.01615.x; Brunner R, 2014, J CHILD PSYCHOL PSYC, V55, P337, DOI 10.1111/jcpp.12166; Cheung YTD, 2013, SOC PSYCH PSYCH EPID, V48, P1133, DOI 10.1007/s00127-012-0640-4; Cloutier P, 2010, J YOUTH ADOLESCENCE, V39, P259, DOI 10.1007/s10964-009-9465-1; Crawford T, 2003, J ADOLESCENCE, V26, P623, DOI 10.1016/S0140-1971(03)00060-5; Dhingra K, 2015, J MENT HEALTH, V24, P4, DOI 10.3109/09638237.2014.910645; Duffy DF, 2009, PSYCHIATRY, V8, P238; Garnefski N., 2002, CERQ MANUAL USE COGN; Gratz KL, 2003, CLIN PSYCHOL-SCI PR, V10, P192, DOI 10.1093/clipsy/bpg022; Hamza CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059955; Hamza CA, 2012, CLIN PSYCHOL REV, V32, P482, DOI 10.1016/j.cpr.2012.05.003; Harrington R, 2001, BRIT MED BULL, V57, P47, DOI 10.1093/bmb/57.1.47; Hawton K, 2002, BMJ-BRIT MED J, V325, P1207, DOI 10.1136/bmj.325.7374.1207; Hawton K, 2012, LANCET, V379, P2373, DOI 10.1016/S0140-6736(12)60322-5; Henry KL, 2010, STRUCT EQU MODELING, V17, P193, DOI 10.1080/10705511003659342; HERPERTZ S, 1995, ACTA PSYCHIAT SCAND, V91, P57, DOI 10.1111/j.1600-0447.1995.tb09743.x; Hooley JM, 2008, APPL PREV PSYCHOL, V12, P155, DOI 10.1016/j.appsy.2008.08.001; Hsu YF, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-421; Juan W, 2010, J AFFECT DISORDERS, V126, P180, DOI 10.1016/j.jad.2010.02.121; Kapur N, 2013, BRIT J PSYCHIAT, V202, P326, DOI 10.1192/bjp.bp.112.116111; Kendler KS, 2013, PSYCHOL MED, V43, P2169, DOI 10.1017/S0033291713000081; Klonsky ED, 2011, PSYCHOL MED, V41, P1981, DOI 10.1017/S0033291710002497; Klonsky ED, 2008, J CONSULT CLIN PSYCH, V76, P22, DOI 10.1037/0022-006X.76.1.22; Kokkevi A, 2012, J CHILD PSYCHOL PSYC, V53, P381, DOI 10.1111/j.1469-7610.2011.02457.x; Law BMF, 2013, J PEDIATR ADOL GYNEC, V26, pS26, DOI 10.1016/j.jpag.2013.03.012; Liu RT, 2014, ARCH SUICIDE RES, V18, P251, DOI 10.1080/13811118.2013.824835; Liu XC, 1997, SOC PSYCH PSYCH EPID, V32, P63, DOI 10.1007/BF00788922; Madge N, 2008, J CHILD PSYCHOL PSYC, V49, P667, DOI 10.1111/j.1469-7610.2008.01879.x; Madge N, 2011, EUR CHILD ADOLES PSY, V20, P499, DOI 10.1007/s00787-011-0210-4; March JS, 1997, J AM ACAD CHILD PSY, V36, P554, DOI 10.1097/00004583-199704000-00019; Mohl B, 2014, SCAND J CHILD ADOLES, V2, P11, DOI 10.21307/sjcapp-2014-003; Muehlenkamp Jennifer J, 2012, Child Adolesc Psychiatry Ment Health, V6, P10, DOI 10.1186/1753-2000-6-10; Muthen B, 2000, ALCOHOL CLIN EXP RES, V24, P882, DOI 10.1111/j.1530-0277.2000.tb02070.x; Muthen B.O., 2012, MPLUS USERS GUIDE, V7th; Nock MK, 2006, PSYCHIAT RES, V144, P65, DOI 10.1016/j.psychres.2006.05.010; Nock MK, 2010, ANNU REV CLIN PSYCHO, V6, P339, DOI 10.1146/annurev.clinpsy.121208.131258; Norton R, 2013, NEW ENGL J MED, V368, P1723, DOI 10.1056/NEJMra1109343; Nyer M, 2013, ANN CLIN PSYCHIATRY, V25, P41; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; O'Connor RC, 2014, J AFFECT DISORDERS, V159, P46, DOI 10.1016/j.jad.2014.02.015; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; PEARCE CM, 1994, ACTA PSYCHIAT SCAND, V90, P324, DOI 10.1111/j.1600-0447.1994.tb01601.x; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Resch F, 2008, EUR CHILD ADOLES PSY, V17, P92, DOI 10.1007/s00787-008-1010-3; Rhebergen D, 2014, PSYCHOL MED, V44, P1701, DOI 10.1017/S0033291713002225; Rodgers S, 2014, J AFFECT DISORDERS, V156, P92, DOI 10.1016/j.jad.2013.11.021; Shek DTL, 2012, SCI WORLD J, P1, DOI 10.1100/2012/932540; Skegg K, 2005, LANCET, V366, P1471, DOI 10.1016/S0140-6736(05)67600-3; Somer O, 2015, SOC PSYCH PSYCH EPID, V50, P1163, DOI 10.1007/s00127-015-1060-z; Song HR, 2011, ASIAN J SOC PSYCHOL, V14, P176, DOI 10.1111/j.1467-839X.2011.01347.x; St Germain SA, 2012, PSYCHIAT RES, V197, P78, DOI 10.1016/j.psychres.2011.12.050; Sveticic J, 2012, MENT ILLN, V4, P73, DOI 10.4081/mi.2012.e15; Tatnell R, 2014, J ABNORM CHILD PSYCH, V42, P885, DOI 10.1007/s10802-013-9837-6; Victor SE, 2014, CLIN PSYCHOL REV, V34, P282, DOI 10.1016/j.cpr.2014.03.005; Wang J, 2012, J PSYCHIATR RES, V46, P980, DOI 10.1016/j.jpsychires.2012.04.014; Wang MC, 2013, J CLIN PSYCHOL, V69, P966, DOI 10.1002/jclp.21978; Wang MC, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-94; Weich S, 2011, PSYCHOL MED, V41, P2201, DOI 10.1017/S0033291711000249; Whitlock J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000240; Whitlock J, 2008, J CLIN CHILD ADOLESC, V37, P725, DOI 10.1080/15374410802359734; Wilkinson P, 2011, AM J PSYCHIAT, V168, P495, DOI 10.1176/appi.ajp.2010.10050718; [辛秀红 Xin Xiuhong], 2015, [中国心理卫生杂志, Chinese Mental Health Journal], V29, P355; Yang JA, 2010, J AFFECT DISORDERS, V127, P113, DOI 10.1016/j.jad.2010.04.023; Yao SQ, 2007, PERCEPT MOTOR SKILL, V104, P1169, DOI 10.2466/PMS.104.4.1169-1182; Yao SQ, 2007, CHILD PSYCHIAT HUM D, V38, P1, DOI 10.1007/s10578-006-0039-0; Zetterqvist M, 2013, J ABNORM CHILD PSYCH, V41, P759, DOI 10.1007/s10802-013-9712-5; Zhang NL, 2004, J MACH LEARN RES, V5, P697; Zhu XZ, 2008, COGNITION EMOTION, V22, P288, DOI 10.1080/02699930701369035	75	10	12	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158609	10.1371/journal.pone.0158609	http://dx.doi.org/10.1371/journal.pone.0158609			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27392132	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400089
J	Abe, M; Pelus, LM; Singh, P; Hirade, T; Onishi, C; Purevsuren, J; Taketani, T; Yamaguchi, S; Fukuda, S				Abe, Mariko; Pelus, Louis M.; Singh, Pratibha; Hirade, Tomohiro; Onishi, Chie; Purevsuren, Jamiyan; Taketani, Takeshi; Yamaguchi, Seiji; Fukuda, Seiji			Internal Tandem Duplication in FLT3 Attenuates Proliferation and Regulates Resistance to the FLT3 Inhibitor AC220 by Modulating p21(Cdkn1a) and Pbx1 in Hematopoietic Cells	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; GENE-EXPRESSION; PROGENITOR CELLS; STEM-CELLS; DEPENDENT KINASES; GROWTH ARREST; BCR-ABL; P21; P21(CIP1/WAF1); P21(WAF1/CIP1)	Internal tandem duplication (ITD) mutations in the Fms-related tyrosine kinase 3 (FLT3) gene (FLT3-ITD) are associated with poor prognosis in patients with acute myeloid leukemia (AML). Due to the development of drug resistance, few FLT3-ITD inhibitors are effective against FLT3-ITD+ AML. In this study, we show that FLT3-ITD activates a novel pathway involving p21(Cdkn1a) (p21) and pre-B cell leukemia transcription factor 1 (Pbx1) that attenuates FLT3-ITD cell proliferation and is involved in the development of drug resistance. FLT3-ITD up-regulated p21 expression in both mouse bone marrow c-kit(+)-Sca-1(+)-Lin(-)( KSL) cells and Ba/F3 cells. The loss of p21 expression enhanced growth factor-independent proliferation and sensitivity to cytarabine as a consequence of concomitantly enriching the S+G(2)/M phase population and significantly increasing the expression of Pbx1, but not Evi-1, in FLT3-ITD+ cells. This enhanced cell proliferation following the loss of p21 was partially abrogated when Pbx1 expression was silenced in FLT3-ITD+ primary bone marrow colony-forming cells and Ba/F3 cells. When FLT3-ITD was antagonized with AC220, a selective inhibitor of FLT3-ITD, p21 expression was decreased coincident with Pbx1 mRNA up-regulation and a rapid decline in the number of viable FLT3-ITD+Ba/F3 cells; however, the cells eventually became refractory to AC220. Overexpressing p21 in FLT3-ITD+Ba/F3 cells delayed the emergence of cells that were refractory to AC220, whereas p21 silencing accelerated their development. These data indicate that FLT3-ITD is capable of inhibiting FLT3-ITD+ cell proliferation through the p21/Pbx1 axis and that treatments that antagonize FLT3-ITD contribute to the subsequent development of cells that are refractory to a FLT3-ITD inhibitor by disrupting p21 expression.	[Abe, Mariko; Hirade, Tomohiro; Purevsuren, Jamiyan; Taketani, Takeshi; Yamaguchi, Seiji; Fukuda, Seiji] Shimane Univ, Sch Med, Dept Pediat, Izumo, Shimane, Japan; [Pelus, Louis M.; Singh, Pratibha] Indiana Univ, Sch Med, Dept Microbiol Immunol, Indianapolis, IN 46202 USA; [Onishi, Chie] Shimane Univ, Sch Med, Dept Hematol Oncol, Izumo, Shimane, Japan; [Taketani, Takeshi] Shimane Univ Hosp, Div Blood Transfus, Izumo, Shimane, Japan	Shimane University; Indiana University System; Indiana University-Purdue University Indianapolis; Shimane University; Shimane University	Abe, M; Fukuda, S (corresponding author), Shimane Univ, Sch Med, Dept Pediat, Izumo, Shimane, Japan.	itomari@med.shimane-u.ac.jp; sfukuda@med.shimane-u.ac.jp	Singh, Pratibha/AAI-9796-2020		Japan Society for the Promotion of Science [24791063, 20390298, 25461593]; National Heart Lung and Blood Institute [HL079654]; Japan Leukemia Research Fund; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Sankyo Biomedical Research Foundation; Mitsubishi Pharma Research Foundation; AstraZeneca Research Grant; Naito Foundation; Grants-in-Aid for Scientific Research [25461593] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Japan Leukemia Research Fund(Japan Leukemia Research Fund (JLRF)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Sankyo Biomedical Research Foundation; Mitsubishi Pharma Research Foundation; AstraZeneca Research Grant(AstraZeneca); Naito Foundation(Naito Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Support was provided by: Japan Society for the Promotion of Science [https://www.jsps.go.jp/] grant number 24791063 to MA; National Heart Lung and Blood Institute [http://www.nih.gov/] grant number HL079654 to LP; Japan Society for the Promotion of Science [https://www.jsps.go.jp/] grant number 20390298 to SF; Japan Society for the Promotion of Science [https://www.jsps.go.jp/] grant number 25461593 to SF; Japan Leukemia Research Fund [http://flrf.gr.jp/] to SF; Research Support Funds from the Mochida Memorial Foundation for Medical and Pharmaceutical Research [http://www.mochida.co.jp/zaidan/] to SF; Sankyo Biomedical Research Foundation and the Mitsubishi Pharma Research Foundation [http://www.ds-fdn.or.jp/] to SF; AstraZeneca Research Grant [http://www. astrazeneca.co.jp/] to SF; Naito Foundation [https://www.naito-f.or.jp/jp/index.php] to SF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braun SE, 1998, BLOOD CELL MOL DIS, V24, P138, DOI 10.1006/bcmd.1998.0181; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Cheng T, 2000, NAT MED, V6, P1235, DOI 10.1038/81335; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Coqueret O, 2000, J BIOL CHEM, V275, P18794, DOI 10.1074/jbc.M001601200; Daver N, 2015, BLOOD, V125, P3236, DOI 10.1182/blood-2014-10-605808; de Jonge HJM, 2011, LEUKEMIA, V25, P1825, DOI 10.1038/leu.2011.172; DiMartino JF, 2001, BLOOD, V98, P618, DOI 10.1182/blood.V98.3.618; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Ficara F, 2008, CELL STEM CELL, V2, P484, DOI 10.1016/j.stem.2008.03.004; Forster K, 2008, ANN HEMATOL, V87, P183, DOI 10.1007/s00277-007-0400-9; Fritah A, 2005, MOL CELL BIOL, V25, P2419, DOI 10.1128/MCB.25.6.2419-2430.2005; FRITSCHE M, 1993, ONCOGENE, V8, P307; Fukuda S, 2005, BLOOD, V105, P3117, DOI 10.1182/blood-2004-04-1440; Fukuda S, 2004, BLOOD, V103, P120, DOI 10.1182/blood-2003-05-1756; Fukuda S, 2009, BLOOD, V114, P394, DOI 10.1182/blood-2008-11-188714; Garcia-Wilson E, 2005, CELL CYCLE, V4, P1113; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Grunwald MR, 2015, SEMIN HEMATOL, V52, P193, DOI 10.1053/j.seminhematol.2015.03.004; Grunwald MR, 2013, INT J HEMATOL, V97, P683, DOI 10.1007/s12185-013-1334-8; HARPER JW, 1993, CELL, V75, P805; Harris TE, 2001, J BIOL CHEM, V276, P29200, DOI 10.1074/jbc.M011587200; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kelly LM, 2002, BLOOD, V99, P310, DOI 10.1182/blood.V99.1.310; Kitaura H, 2000, J BIOL CHEM, V275, P10477, DOI 10.1074/jbc.275.14.10477; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Lee YH, 2001, BIOCHEM BIOPH RES CO, V280, P675, DOI 10.1006/bbrc.2000.4215; Majetl R, 2009, P NATL ACAD SCI USA, V106, P3396, DOI 10.1073/pnas.0900089106; Mantel C, 1996, BLOOD, V88, P3710, DOI 10.1182/blood.V88.10.3710.bloodjournal88103710; Mishra A, 2000, AM J RESP CELL MOL, V22, P543, DOI 10.1165/ajrcmb.22.5.3851; Overton KW, 2014, P NATL ACAD SCI USA, V111, pE4386, DOI 10.1073/pnas.1409797111; Ozeki K, 2004, BLOOD, V103, P1901, DOI 10.1182/blood-2003-06-1845; Perkins ND, 2002, CELL CYCLE, V1, P39, DOI 10.4161/cc.1.1.98; Peterson LF, 2007, BLOOD, V109, P4392, DOI 10.1182/blood-2006-03-012575; Rego MA, 2012, ONCOGENE, V31, P366, DOI 10.1038/onc.2011.237; Saito Y, 2010, NAT BIOTECHNOL, V28, P275, DOI 10.1038/nbt.1607; Santos MA, 2014, NATURE, V514, P107, DOI 10.1038/nature13483; Shimabe M, 2009, ONCOGENE, V28, P4364, DOI 10.1038/onc.2009.288; Smith CC, 2012, NATURE, V485, P260, DOI 10.1038/nature11016; Spiekermann K, 2003, BLOOD, V101, P1494, DOI 10.1182/blood-2002-04-1045; Suzuki D, 2015, DEVELOPMENT, V142, P282, DOI 10.1242/dev.118307; Takahashi S, 2004, BIOCHEM BIOPH RES CO, V316, P85, DOI 10.1016/j.bbrc.2004.02.018; Tokunaga M, 2010, J BIOL CHEM, V285, P31774, DOI 10.1074/jbc.M110.118653; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; WALDMAN T, 1995, CANCER RES, V55, P5187; Zarrinkar PP, 2009, BLOOD, V114, P2984, DOI 10.1182/blood-2009-05-222034	48	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158290	10.1371/journal.pone.0158290	http://dx.doi.org/10.1371/journal.pone.0158290			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27387666	Green Published, gold, Green Submitted			2022-12-27	WOS:000379811500018
J	Kang, DH; Cho, KS; Ham, WS; Lee, H; Kwon, JK; Choi, YD; Lee, JY				Kang, Dong Hyuk; Cho, Kang Su; Ham, Won Sik; Lee, Hyungmin; Kwon, Jong Kyou; Choi, Young Deuk; Lee, Joo Yong			Comparison of High, Intermediate, and Low Frequency Shock Wave Lithotripsy for Urinary Tract Stone Disease: Systematic Review and Network Meta-Analysis	PLOS ONE			English	Review							DELIVERY; MINUTE; INCONSISTENCY; FRAGMENTATION; UROLITHIASIS; SLOW; MECHANISMS; DYNAMICS; TRIAL	Objectives To perform a systematic review and network meta-analysis of randomized controlled trials (RCTs) to determine the optimal shock wave lithotripsy (SWL) frequency range for treating urinary stones, i.e., high-frequency (100-120 waves/minute), intermediate-frequency (8090 waves/minute), and low-frequency (60-70 waves/minute) lithotripsy. Materials and Methods Relevant RCTs were identified from electronic databases for meta-analysis of SWL success and complication rates. Using pairwise and network meta-analyses, comparisons were made by qualitative and quantitative syntheses. Outcome variables are provided as odds ratios (ORs) with 95% confidence intervals (CIs). Results Thirteen articles were included in the qualitative and quantitative synthesis using pairwise and network meta-analyses. On pairwise meta-analyses, comparable inter-study heterogeneity was observed for the success rate. On network meta-analyses, the success rates of low- (OR 2.2; 95% CI 1.5-2.6) and intermediate-frequency SWL (OR 2.5; 95% CI 1.3-4.6) were higher than high-frequency SWL. Forest plots from the network meta-analysis showed no significant differences in the success rate between low-frequency SWL versus intermediate-frequency SWL (OR 0.87; 95% CI 0.51-1.7). There were no differences in complication rate across different SWL frequency ranges. By rank-probability testing, intermediate-frequency SWL was ranked highest for success rate, followed by low-frequency and high-frequency SWL. Low-frequency SWL was also ranked highest for low complication rate, with high- and intermediate-frequency SWL ranked lower. Conclusions Intermediate- and low-frequency SWL have better treatment outcomes than high- frequency SWL when considering both efficacy and complication.	[Kang, Dong Hyuk; Ham, Won Sik; Choi, Young Deuk; Lee, Joo Yong] Yonsei Univ, Severance Hosp, Coll Med, Dept Urol,Urol Sci Inst, Seoul, South Korea; [Cho, Kang Su] Yonsei Univ, Gangnam Severance Hosp, Urol Sci Inst, Coll Med,Dept Urol, Seoul, South Korea; [Lee, Hyungmin] Korea Ctr Dis Control & Prevent, Div Epidem Intelligence Serv, Osong, South Korea; [Kwon, Jong Kyou] Yonsei Univ Hlth Syst, Dept Urol, Severance Check Up, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Korea Centers for Disease Control & Prevention (KCDC); Korea CDC Center for Disease Prevention; Korea CDC Center for Infectious Disease Control; Yonsei University; Yonsei University Health System	Lee, JY (corresponding author), Yonsei Univ, Severance Hosp, Coll Med, Dept Urol,Urol Sci Inst, Seoul, South Korea.	joouro@yuhs.ac	; Lee, Joo Yong/C-3851-2013	Ham, Won Sik/0000-0003-2246-8838; Choi, Young Deuk/0000-0002-8545-5797; Lee, Joo Yong/0000-0002-3470-1767; Cho, Kang Su/0000-0002-3500-8833	Yonsei University College of Medicine [6-2014-0156]	Yonsei University College of Medicine(General Electric)	This study was supported by a faculty research grant from the Yonsei University College of Medicine for 2014 (6-2014-0156).	Caldwell DM, 2005, BMJ-BRIT MED J, V331, P897, DOI 10.1136/bmj.331.7521.897; Chang SH, 2012, J ENDOUROL A, pA343; CHOI MJ, 1993, PHYS MED BIOL, V38, P1561, DOI 10.1088/0031-9155/38/11/002; Chung DY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123800; Chung JH, 2013, KOREAN J UROL, V54, P289, DOI 10.4111/kju.2013.54.5.289; Davenport K, 2006, J UROLOGY, V176, P2055, DOI 10.1016/j.juro.2006.07.012; Dias S, 2013, MED DECIS MAKING, V33, P607, DOI 10.1177/0272989X12458724; Eisenmenger W, 2001, ULTRASOUND MED BIOL, V27, P683, DOI 10.1016/S0301-5629(01)00345-3; FLEISS JL, 1986, CONTROL CLIN TRIALS, V7, P267, DOI 10.1016/0197-2456(86)90034-6; GALBRAITH RF, 1988, STAT MED, V7, P889, DOI 10.1002/sim.4780070807; Greenstein A, 1999, UROLOGY, V54, P430, DOI 10.1016/S0090-4295(99)00176-4; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Honey RJD, 2009, J UROLOGY, V182, P1418, DOI 10.1016/j.juro.2009.06.019; Huber P, 1999, PHYS MED BIOL, V44, P1427, DOI 10.1088/0031-9155/44/6/301; Anglada-Curado FJ, 2013, INT J UROL, V20, P214, DOI 10.1111/j.1442-2042.2012.03133.x; Koo V, 2010, BJU INT, V105, P692, DOI 10.1111/j.1464-410X.2009.08919.x; Krahn U, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-131; Kwon JK, 2015, BMC UROL, V15, DOI 10.1186/s12894-015-0050-5; LABBE KA, 1987, ANN INTERN MED, V107, P224, DOI 10.7326/0003-4819-107-2-224; Lee JY, 2014, WORLD J MENS HEALTH, V32, P167, DOI 10.5534/wjmh.2014.32.3.167; Li KW, 2013, J UROLOGY, V190, P1260, DOI 10.1016/j.juro.2013.03.075; Li WM, 2007, UROL INT, V79, P124, DOI 10.1159/000106324; Madbouly K, 2005, J UROLOGY, V173, P127, DOI 10.1097/01.ju.0000147820.36996.86; Mazzucchi E, 2010, CLINICS, V65, P961, DOI 10.1590/S1807-59322010001000006; Mills EJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2914; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Neupane B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115065; Ng CF, 2012, J UROLOGY, V188, P837, DOI 10.1016/j.juro.2012.05.009; Nguyen DP, 2015, J UROLOGY, V194, P418, DOI 10.1016/j.juro.2015.01.110; Pace KT, 2005, J UROLOGY, V174, P595, DOI 10.1097/01.ju.0000165156.90011.95; Paterson RF, 2002, J UROLOGY, V168, P2211, DOI 10.1016/S0022-5347(05)64357-1; Robert M, 1999, J ENDOUROL, V13, P157, DOI 10.1089/end.1999.13.157; Rucker G, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0060-8; Salanti G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099682; Salem HK, 2014, J UROLOGY, V191, P1370, DOI 10.1016/j.juro.2013.11.028; Sutton AJ, 2000, BMJ-BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574; Yilmaz E, 2005, UROLOGY, V66, P1160, DOI 10.1016/j.urology.2005.06.111; Yuan JQ, 2013, EUR UROL, V63, P902, DOI 10.1016/j.eururo.2013.01.012; Zhong P, 2001, ULTRASOUND MED BIOL, V27, P119, DOI 10.1016/S0301-5629(00)00322-7	39	23	23	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158661	10.1371/journal.pone.0158661	http://dx.doi.org/10.1371/journal.pone.0158661			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27387279	Green Published, Green Submitted, gold			2022-12-27	WOS:000379811500035
J	Hamade, N; Hodge, WG; Rakibuz-Zaman, M; Malvankar-Mehta, MS				Hamade, Noura; Hodge, William G.; Rakibuz-Zaman, Muhammad; Malvankar-Mehta, Monali S.			The Effects of Low-Vision Rehabilitation on Reading Speed and Depression in Age Related Macular Degeneration: A Meta-Analysis	PLOS ONE			English	Article							OLDER-ADULTS; SELF-MANAGEMENT; BURDEN; AMD	Importance Age related macular degeneration (AMD) is a progressive eye disease that, as of 2015, has affected 11 million people in the U.S. and 1.5 million in Canada causing central vision blindness. By 2050, this number is expected to double to 22 million. Eccentric vision is the target of low-vision rehabilitation aids and programs for patients with AMD, which are thought to improve functional performance by improving reading speed and depression. Objective This study evaluates the effect of various low-vision rehabilitation strategies on reading speed and depression in patients 55 and older with AMD. Data Sources Computer databases including MEDLINE (OVID), EMBASE (OVID), BIOSIS Previews (Thomson-Reuters), CINAHL (EBSCO), Health Economic Evaluations Database (HEED), ISI Web of Science (Thomson-Reuters) and the Cochrane Library (Wiley) were searched from the year 2000 to January 2015. Study Selection Included papers were research studies with a sample size of 20 eyes or greater focused on AMD in adults aged 55 or older with low vision (20/60 or lower). Data Extraction and Synthesis Two independent reviewers screened and extracted relevant data from the included articles. Standardized mean difference (SMD) was chosen as an effect size to perform meta-analysis using STATA. Fixed-and random-effect models were developed based on heterogeneity. Main Outcomes Reading Speed and Depression Scores. Results A total of 9 studies (885 subjects) were included. Overall, a significant improvement in reading speed was found with a SMD of 1.01 [95% CI: 0.05 to 1.97]. Low-vision rehabilitation strategies including micro-perimetric biofeedback, microscopes teaching program significantly improved reading speed. Eccentric viewing training showed the maximum improvement in reading speed. In addition, a non-significant improvement in depression scores was found with a SMD of -0.44 [95% CI: -0.96 to 0.09]. Conclusion A considerable amount of research is required in the area of low-vision rehabilitation strategies for patients with AMD. Based on current research, low-vision rehabilitation aids improve reading speed. However, they do not have a significant effect on depression scores in those 55 and older with AMD.	[Hamade, Noura; Hodge, William G.; Rakibuz-Zaman, Muhammad; Malvankar-Mehta, Monali S.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Epidemiol & Biostat, London, ON, Canada; [Hodge, William G.; Malvankar-Mehta, Monali S.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Ophthalmol, London, ON, Canada; [Malvankar-Mehta, Monali S.] St Josephs Hosp, Ivey Eye Inst, Dept Ophthalmol, 268 Grosvenor St, London, ON N6A 4V2, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); McGill University; Western University (University of Western Ontario)	Malvankar-Mehta, MS (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Dept Epidemiol & Biostat, London, ON, Canada.; Malvankar-Mehta, MS (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Dept Ophthalmol, London, ON, Canada.; Malvankar-Mehta, MS (corresponding author), St Josephs Hosp, Ivey Eye Inst, Dept Ophthalmol, 268 Grosvenor St, London, ON N6A 4V2, Canada.	Monali.Malvankar@schulich.uwo.ca			Canadian National Institute for the Blind (CNIB) Barbara Tuck MacPhee Award [M - R - 14 - 351]	Canadian National Institute for the Blind (CNIB) Barbara Tuck MacPhee Award	This research has been funded by Canadian National Institute for the Blind (CNIB) Barbara Tuck MacPhee Award, grant number: M - R - 14 - 351. Received by MSMM and WBH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The author would like to thank Alex Mao as well as John Castello for help with finalizing search strategies for the review. In addition to the Ivey Eye Institute and the University of Western Ontario. This research has been funded by, Canadian National Institute for the Blind (CNIB) Barbara Tuck MacPhee Award. Dr. Monali Malvankar-Mehta is the corresponding author. She works independently of CNIB and she takes the responsibility for the integrity of the data and accuracy of the data analysis.	Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; BRESSLER NM, 1988, SURV OPHTHALMOL, V32, P375, DOI 10.1016/0039-6257(88)90052-5; Bright Focus Foundation, 2015, MAC DEG FACTS STAT; Brody BL, 2006, J AM GERIATR SOC, V54, P1557, DOI 10.1111/j.1532-5415.2006.00881.x; Brown MM, 2005, CAN J OPHTHALMOL, V40, P277, DOI 10.1016/S0008-4182(05)80070-5; Canadian National Institute for the Blind (CNIB), FAST FACTS VIS LOSS; Casten Robin J, 2004, Curr Opin Ophthalmol, V15, P181, DOI 10.1097/01.icu.0000120710.35941.3f; Cheong AMY, 2009, OPTOMETRY VISION SCI, V86, P1078, DOI 10.1097/OPX.0b013e3181b4c4d9; Cimarolli VR, 2012, CLIN REHABIL, V26, P748, DOI 10.1177/0269215511429162; Cruess A, 2007, CAN J OPHTHALMOL, V42, P836, DOI 10.3129/i07-153; Eaton A., 2013, PHARMACOTHERAPY J HU; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elliott D, 1991, IMPROVING RELIABILIT; Girdler SJ, 2010, BRIT J OPHTHALMOL, V94, P223, DOI 10.1136/bjo.2008.147538; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Horowitz A, 2006, J GERONTOL B-PSYCHOL, V61, pS274, DOI 10.1093/geronb/61.5.S274; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Nilsson UL, 2003, VISION RES, V43, P1777, DOI 10.1016/S0042-6989(03)00219-0; Rovner BW, 2002, AM J GERIAT PSYCHIAT, V10, P305; Scanlan JM, 2004, J VISUAL IMPAIR BLIN, V98, P601, DOI 10.1177/0145482X0409801005; Seiple W, 2011, INVEST OPHTH VIS SCI, V52, P2938, DOI 10.1167/iovs.10-6137; Smith HJ, 2005, ARCH OPHTHALMOL-CHIC, V123, P1042, DOI 10.1001/archopht.123.8.1042; Vingolo EM, 2007, APPL PSYCHOPHYS BIOF, V32, P185, DOI [10.1007/s10484-007-9038-6, 10.1007/sl0484-007-9038-6]	24	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159254	10.1371/journal.pone.0159254	http://dx.doi.org/10.1371/journal.pone.0159254			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR0DZ	27414030	Green Submitted, gold, Green Published			2022-12-27	WOS:000379579500111
J	Kripke, K; Okello, V; Maziya, V; Benzerga, W; Mirira, M; Gold, E; Schnure, M; Sgaier, S; Castor, D; Reed, J; Njeuhmeli, E				Kripke, Katharine; Okello, Velephi; Maziya, Vusi; Benzerga, Wendy; Mirira, Munamato; Gold, Elizabeth; Schnure, Melissa; Sgaier, Sema; Castor, Delivette; Reed, Jason; Njeuhmeli, Emmanuel			Voluntary Medical Male Circumcision for HIV Prevention in Swaziland: Modeling the Impact of Age Targeting	PLOS ONE			English	Article							TRIAL; MEN	Background Voluntary medical male circumcision (VMMC) for HIV prevention has been a priority for Swaziland since 2009. Initially focusing on men ages 15-49, the Ministry of Health reduced the minimum age for VMMC from 15 to 10 years in 2012, given the existing demand among 10- to 15-year-olds. To understand the implications of focusing VMMC service delivery on specific age groups, the MOH undertook a modeling exercise to inform policy and implementation in 2013-2014. Methods and Findings The impact and cost of circumcising specific age groups were assessed using the Decision Makers' Program Planning Tool, Version 2.0 (DMPPT 2.0), a simple compartmental model. We used age-specific HIV incidence from the Swaziland HIV Incidence Measurement Survey (SHIMS). Population, mortality, births, and HIV prevalence were imported from a national Spectrum/Goals model recently updated in consultation with country stakeholders. Baseline male circumcision prevalence was derived from the most recent Swaziland Demographic and Health Survey. The lowest numbers of VMMCs per HIV infection averted are achieved when males ages 15-19, 20-24, 25-29, and 30-34 are circumcised, although the uncertainty bounds for the estimates overlap. Circumcising males ages 25-29 and 20-24 provides the most immediate reduction in HIV incidence. Circumcising males ages 15-19, 20-24, and 25-29 provides the greatest magnitude incidence reduction within 15 years. The lowest cost per HIV infection averted is achieved by circumcising males ages 15-34: $870 U.S. dollars (USD). Conclusions The potential impact, cost, and cost-effectiveness of VMMC scale-up in Swaziland are not uniform. They vary by the age group of males circumcised. Based on the results of this modeling exercise, the Ministry of Health's Swaziland Male Circumcision Strategic and Operational Plan 2014-2018 adopted an implementation strategy that calls for circumcision to be scaled up to 50% coverage for neonates, 80% among males ages 10-29, and 55% among males ages 30-34.	[Kripke, Katharine] Avenir Hlth, Hlth Policy Project, Washington, DC USA; [Okello, Velephi; Maziya, Vusi] Minist Hlth, Mbabane, Swaziland; [Benzerga, Wendy; Mirira, Munamato] US Agcy Int Dev, Mbabane, Swaziland; [Gold, Elizabeth] Johns Hopkins Ctr Commun Programs, Baltimore, MD USA; [Schnure, Melissa] Palladium Grp, Hlth Policy Project, Washington, DC USA; [Sgaier, Sema] Bill & Melinda Gates Fdn, Seattle, WA USA; [Sgaier, Sema] Univ Washington, Dept Global Hlth, Seattle, WA USA; [Castor, Delivette; Reed, Jason] Jhpiego, Baltimore, MD USA; [Njeuhmeli, Emmanuel] USAID, Washington, DC USA	United States Agency for International Development (USAID); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Bill & Melinda Gates Foundation; University of Washington; University of Washington Seattle; Jhpiego; United States Agency for International Development (USAID)	Kripke, K (corresponding author), Avenir Hlth, Hlth Policy Project, Washington, DC USA.	kkripke@avenirhealth.org	Kripke, Katharine/J-2146-2019	Kripke, Katharine/0000-0001-8228-4577	American people through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR); U.S. Agency for International Development (USAID) [AIDOAA-A-10-00067, AID-OAA-14-00026]	American people through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR); U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID))	This manuscript is made possible by the generous support of the American people through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) with the U.S. Agency for International Development (USAID) under the Cooperative Agreement Health Policy Project, Agreement No. AIDOAA-A-10-00067, beginning September 30, 2010, and Cooperative Agreement Project SOAR (Supporting Operational AIDS Research), number AID-OAA-14-00026. The Health Policy Project is implemented by Futures Group, in collaboration with Plan International USA, Avenir Health (formerly Futures Institute), Partners in Population and Development, Africa Regional Office (PPD ARO), Population Reference Bureau (PRB), RTI International, and the White Ribbon Alliance for Safe Motherhood (WRA). USAID was involved in study design, decision to publish, and preparation of the manuscript. The findings and conclusions in this paper do not necessarily represent the views or positions of PEPFAR, USAID, or the U.S. Government.	Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Futures Institute, 2011, GOALS MAN MOD EST EF; Government of the Kingdom of Swaziland, 2014, EXT NAT MULT HIV AID; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Kripke K, 2015, EC EPIDEMIOLOG UNPUB; Kripke K, 2015, COST IMPACT VO UNPUB; Kripke K, 2015, VOLUNTARY MED UNPUB; Kripke K, 2015, MODELING IMPAC UNPUB; Kripke K., 2015, AGE TARGETING UNPUB; Ministry of Health, 2014, SWAZ MAL CIRC STRAT; Ministry of Health, 2012, SWAZ INC MEAS SURV S; Ministry of Health, 2009, POL SAF MAL CIRC HIV; NERCHA, 2015, SWAZ HIV INV CAS; Reed JB, 2012, 19 INT AIDS C JUL 22; Swaziland Central Statistical Office Macro International Inc, 2008, SWAZ DEM HLTH SURV 2; Swaziland Male Circumcision Task Force, 2009, STRAT IMPL PLAN SCAL; UNAIDS/WHO, 2007, NEW DAT MAL CIRC HIV; WHO & UNAIDS, 2011, JOINT STRAT ACT FRAM	19	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0156776	10.1371/journal.pone.0156776	http://dx.doi.org/10.1371/journal.pone.0156776			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410687	Green Published, gold			2022-12-27	WOS:000379508300003
J	Martinez-Garcia, A; Martin-Vivaldi, M; Rodriguez-Ruano, SM; Peralta-Sanchez, JM; Valdivia, E; Soler, JJ				Martinez-Garcia, Angela; Martin-Vivaldi, Manuel; Rodriguez-Ruano, Sonia M.; Manuel Peralta-Sanchez, Juan; Valdivia, Eva; Soler, Juan J.			Nest Bacterial Environment Affects Microbiome of Hoopoe Eggshells, but Not That of the Uropygial Secretion	PLOS ONE			English	Article							INTERGENIC SPACER ANALYSIS; UPUPA-EPOPS; ANTIMICROBIAL PROPERTIES; GLAND; NESTEDNESS; COMMUNITY; LOADS; ANTIBACTERIAL; POLYMORPHISM; DIVERSITY	The study of associations between symbiotic bacterial communities of hosts and those of surrounding environments would help to understand how bacterial assemblages are acquired, and how they are transmitted from one to another location (i.e. symbiotic bacteria acquisition by hosts). Hoopoes (Upupa epops) smear their eggshells with uropygial secretion (oily secretion produced in their uropygial gland) that harbors antibiotic producing bacteria. Trying to elucidate a possible role of nest material and cloaca microbiota in determining the bacterial community of the uropygial gland and the eggshells of hoopoes, we characterized bacterial communities of nest material, cloaca, uropygial gland and eggshells by the ARISA fingerprinting. Further, by adding material with scarce bacteria and antimicrobial properties, we manipulated the bacterial community of nest material and thus tested experimentally its effects on the microbiomes of the uropygial secretion and of the eggshells. The experiment did not influence the microbiome of the uropygial secretion of females, but affected the community established on eggshells. This is the first experimental evidence indicating that nest material influences the bacterial community of the eggshells and, therefore, probability of embryo infection. Some of the bacterial strains detected in the secretion were also in the bacterial communities of the nest material and of cloaca, but their occurrence within nests was not associated, which suggests that bacterial environments of nest material and cloaca are not sources of symbiotic bacteria for the gland. These results do not support a role of nest environments of hoopoes as reservoirs of symbiotic bacteria. We discuss possible scenarios explaining bacterial acquisition by hoopoes that should be further explored.	[Martinez-Garcia, Angela; Soler, Juan J.] Estn Expt Zonas Aridas CSIC, E-04120 Almeria, Spain; [Martin-Vivaldi, Manuel] Univ Granada, Dept Zool, E-18071 Granada, Spain; [Rodriguez-Ruano, Sonia M.; Manuel Peralta-Sanchez, Juan; Valdivia, Eva] Univ Granada, Dept Microbiol, E-18071 Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Zonas Aridas (EEZA); University of Granada; University of Granada	Martinez-Garcia, A (corresponding author), Estn Expt Zonas Aridas CSIC, E-04120 Almeria, Spain.	angela@eeza.csic.es	Peralta-Sanchez, Juan M/L-3159-2017; Martín-Vivaldi, Manuel/F-8256-2016; Rodríguez-Ruano, Sonia María/AAA-9938-2020; Valdivia, Eva/R-9978-2018; Soler, J. J./H-2363-2011; Martínez, Manuel Martín-Vivaldi/AAJ-6736-2021	Peralta-Sanchez, Juan M/0000-0003-4648-7988; Martín-Vivaldi, Manuel/0000-0002-5432-425X; Rodríguez-Ruano, Sonia María/0000-0001-6863-717X; Valdivia, Eva/0000-0002-9429-9634; Soler, J. J./0000-0003-2990-1489; Martínez, Manuel Martín-Vivaldi/0000-0002-5432-425X	European funds (FEDER) [CGL2013-48193-C3-1-P, CGL2013-48193-C3-2-P]; Junta de Andalucia [P09-RNM-4557]; Spanish Ministerio de Economia y Competitividad	European funds (FEDER)(European Commission); Junta de Andalucia(Junta de Andalucia); Spanish Ministerio de Economia y Competitividad(Spanish Government)	Support by funding was provided by Spanish Ministerio de Economia y Competitividad, European funds (FEDER) (CGL2013-48193-C3-1-P, CGL2013-48193-C3-2-P) and Junta de Andalucia (P09-RNM-4557). AM-G had a predoctoral grant from the Junta de Andalucia (P09-RNM-4557).	Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Almeida-Neto M, 2011, ENVIRON MODELL SOFTW, V26, P173, DOI 10.1016/j.envsoft.2010.08.003; Aziz NH, 1998, MICROBIOS, V93, P43; Barbaro L, 2008, BIODIVERS CONSERV, V17, P1073, DOI 10.1007/s10531-007-9241-z; Barrow P. A., 1994, MICROBIOLOGY AVIAN E, P117; Bent SJ, 2008, ISME J, V2, P689, DOI 10.1038/ismej.2008.44; Brandl HB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114861; Bruce J., 1994, P63; Cardinale M, 2004, APPL ENVIRON MICROB, V70, P6147, DOI 10.1128/AEM.70.10.6147-6156.2004; Clark L., 1991, Oxford Ornithology Series, P205; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Cook MI, 2005, ECOL LETT, V8, P532, DOI 10.1111/j.1461-0248.2005.00748.x; Cook MI, 2005, BEHAV ECOL, V16, P30, DOI 10.1093/beheco/arh131; Cramp S., 1998, THE COMPLETE BIRDS O; Cruz-Peragon F, 2006, GRASAS ACEITES, V57, P219; Danovaro R, 2006, APPL ENVIRON MICROB, V72, P5982, DOI 10.1128/AEM.01361-06; Ibanez-Alamo JD, 2014, J AVIAN BIOL, V45, P354, DOI 10.1111/jav.00353; Fisher MM, 1999, APPL ENVIRON MICROB, V65, P4630; FLEMING HP, 1973, APPL MICROBIOL, V26, P777, DOI 10.1128/AEM.26.5.777-782.1973; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Horrocks NPC, 2014, FRONT ZOOL, V11, DOI 10.1186/1742-9994-11-49; Lee WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103959; Legendre P., 2012, NUMERICAL ECOLOGY; Loisel P, 2006, ENVIRON MICROBIOL, V8, P720, DOI 10.1111/j.1462-2920.2005.00950.x; Long RA, 2005, APPL ENVIRON MICROB, V71, P8531, DOI 10.1128/AEM.71.12.8531-8536.2005; Martin-Platero AM, 2010, ANAL BIOCHEM, V397, P253, DOI 10.1016/j.ab.2009.10.041; Peralta-Sanchez JM, 2014, MICROB ECOL, V67, P480, DOI 10.1007/s00248-013-0338-5; Peralta-Sanchez JM, 2012, IBIS, V154, P725, DOI 10.1111/j.1474-919X.2012.01256.x; Martin-Platero AM, 2006, APPL ENVIRON MICROB, V72, P4245, DOI 10.1128/AEM.02940-05; Martin-Vivaldi M, 1999, BIRD STUDY, V46, P205, DOI 10.1080/00063659909461132; Martin-Vivaldi M, 2014, J ANIM ECOL, V83, P1289, DOI 10.1111/1365-2656.12243; Martin-Vivaldi M, 2010, P ROY SOC B-BIOL SCI, V277, P123, DOI 10.1098/rspb.2009.1377; Martin-Vivaldi M, 2009, J AVIAN BIOL, V40, P191, DOI 10.1111/j.1600-048X.2009.04393.x; Martinez-Garcia A, 2015, MICROB ECOL, V70, P1024, DOI 10.1007/s00248-015-0636-1; McFall-Ngai M, 2013, P NATL ACAD SCI USA, V110, P3229, DOI 10.1073/pnas.1218525110; Mennerat A, 2009, OECOLOGIA, V161, P849, DOI 10.1007/s00442-009-1418-6; Moller AP, 2013, OECOLOGIA, V173, P169, DOI 10.1007/s00442-013-2600-4; Peralta-Sanchez JM, 2010, FUNCT ECOL, V24, P426, DOI 10.1111/j.1365-2435.2009.01669.x; Perez-Gutierrez RA, 2013, ISME J, V7, P487, DOI 10.1038/ismej.2012.119; Poisot T, 2011, BIOL LETTERS, V7, P201, DOI 10.1098/rsbl.2010.0774; Ramette A, 2009, APPL ENVIRON MICROB, V75, P2495, DOI 10.1128/AEM.02409-08; Rehsteiner Ueli, 1996, Ornithologische Beobachter, V93, P277; Riley MA, 2002, ANNU REV MICROBIOL, V56, P117, DOI 10.1146/annurev.micro.56.012302.161024; Ruiz-Castellano C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148894; Ruiz-de-Castaneda R, 2011, CONDOR, V113, P200, DOI 10.1525/cond.2011.100035; Ruiz-Rodriguez M, 2009, J EXP BIOL, V212, P3621, DOI 10.1242/jeb.031336; Ruiz-Rodriguez M, 2014, APPL ENVIRON MICROB, V80, P6714, DOI 10.1128/AEM.02242-14; Ruiz-Rodriguez M, 2013, FEMS MICROBIOL ECOL, V85, P495, DOI 10.1111/1574-6941.12138; Ruiz-Rodriguez M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041843; Schaub M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0013115, 10.1371/journal.pone.0015046]; Scheuring I, 2012, ECOL LETT, V15, P1300, DOI 10.1111/j.1461-0248.2012.01853.x; Shawkey MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004522; Shawkey MD, 2003, J AVIAN BIOL, V34, P345, DOI 10.1111/j.0908-8857.2003.03193.x; Soler JJ, 2008, FUNCT ECOL, V22, P864, DOI 10.1111/j.1365-2435.2008.01448.x; Soler JJ, 2016, BIOL J LINN SOC, V118, P763, DOI 10.1111/bij.12772; Soler JJ, 2014, NATURWISSENSCHAFTEN, V101, P697, DOI 10.1007/s00114-014-1201-3; Soler JJ, 2011, BIOL J LINN SOC, V103, P836, DOI 10.1111/j.1095-8312.2011.01672.x; Soler Juan Jose, 2010, Open Ornithology Journal, V3, P93, DOI 10.2174/1874453201003010093; Strona G, 2014, J STAT SOFTW, V59, P1; Traveset A, 2014, J BIOGEOGR, V41, P823, DOI 10.1111/jbi.12243	60	24	24	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158158	10.1371/journal.pone.0158158	http://dx.doi.org/10.1371/journal.pone.0158158			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27409772	Green Published, Green Submitted, gold			2022-12-27	WOS:000379508300018
J	Babalola, S; Ricotta, E; Awantang, G; Lewicky, N; Koenker, H; Toso, M				Babalola, Stella; Ricotta, Emily; Awantang, Grace; Lewicky, Nan; Koenker, Hannah; Toso, Michael			Correlates of Intra-Household ITN Use in Liberia: A Multilevel Analysis of Household Survey Data	PLOS ONE			English	Article							BED NET USE; INSECTICIDE-TREATED NETS; BEHAVIOR-CHANGE; INTEGRATED CAMPAIGN; UNIVERSAL COVERAGE; NATIONAL CAMPAIGN; ENDEMIC AREAS; MASS-MEDIA; MALARIA; TANZANIA	Malaria is a major cause of morbidity and mortality in Liberia. At the same time, insecticide treated net (ITN) ownership and use remain low. Access is a key determinant of ITN use but it is not the only one; prior studies have identified factors that affect the use of ITNs in households with at least one ITN. These factors operate at the individual, household, and community levels. However, studies have generally not assessed the psychosocial or ideational determinants of ITN use. Using 2014 household survey data, this manuscript examines the socio-demographic, ideational, household, and community factors associated with household member use of ITNs in Liberia. Multilevel modeling was used to assess fixed effects at the individual, household, and community levels, and random effects at the household and cluster levels. The data showed significant residual clustering at the household level, indicating that there were unmeasured factors operating at this level that are associated with ITN use. The association of age with ITN use was moderated by sex such that men, older children, and teenagers were less likely to sleep under an ITN compared to women and children under five years old. Female caregivers' perceived severity of malaria, perceived self efficacy to detect a complicated case of malaria, and exposure to the "Take Cover" communication campaign were positively associated with ITN use by members of her household. The association with household size was negative, while the relationship with the number of ITNs was positive. Programs should seek to achieve universal coverage (that is, one ITN for every two household members) and promote the notion that everyone needs to sleep under an ITN every night. Programs should also seek to strengthen perceived severity of malaria and educate intended audience groups on the signs of malaria complications. Given the significance of residual clustering at the household level, interventions that engage men as heads of household and key decision-makers are relevant.	[Babalola, Stella; Ricotta, Emily; Awantang, Grace; Lewicky, Nan; Koenker, Hannah; Toso, Michael] Johns Hopkins Univ, Johns Hopkins Ctr Commun Programs, Hlth Commun Capacity Collaborat, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Babalola, S (corresponding author), Johns Hopkins Univ, Johns Hopkins Ctr Commun Programs, Hlth Commun Capacity Collaborat, Baltimore, MD 21218 USA.	stellababalola@jhu.edu	Ricotta, Emily/AGX-9953-2022	Ricotta, Emily/0000-0001-9928-8275	President's Malaria Initiative (PMI); U.S. President's Malaria Initiative (PMI)	President's Malaria Initiative (PMI)(United States Agency for International Development (USAID)President's Malaria Initiative (PMI)); U.S. President's Malaria Initiative (PMI)(United States Agency for International Development (USAID)President's Malaria Initiative (PMI))	President's Malaria Initiative (PMI) provided financial support for this study through the Health Communication Capacity Collaborative Project.; The authors acknowledge the guidance of the National Malaria Control Program in Liberia, and the support of the past Minister of Health (Dr. Walter Gwenigale) and the current Minister of Health (Dr. Bernice Dahn) in the collection and analysis of the survey data. We thank Dr. Marc Boulay, who led the design of the survey that produced the data analyzed in this manuscript. The authors also appreciate the financial support from the U.S. President's Malaria Initiative (PMI) that made data collection and analysis possible. Finally, we acknowledge the following people from PMI who reviewed earlier versions of this manuscript and provided constructive feedback: Christine Hershey, Christie Reed, and Christen Fornadel.	Adjah OES, 2014, MALARIA J, V13, P123; Aleme A, 2014, ETHIOP J HEALTH SCI, V24, P75, DOI 10.4314/ejhs.v24i1.10; Allen DR, 2014, QUALITATIVE ASSESSME; [Anonymous], 1998, COCHRANE DB SYST REV; [Anonymous], J TROPICAL MED; Astatke H, 2007, 2007 ANN C AM PUBL H; Babalola S, 2005, J FAM PLAN REPROD H, V31, P207, DOI 10.1783/1471189054484022; Babalola S, 2006, TROP MED INT HEALTH, V11, P1594, DOI 10.1111/j.1365-3156.2006.01701.x; Banek K, 2010, MALARIA J, V9, P10; Batisso E, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-183; Baume CA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-264; Beer N, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-606; Bennett A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037927; Bernard J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-65; Bonner K, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-73; Boulay M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-342; Bowen HL, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-36; Clarke P, 2007, SOCIOL METHOD RES, V35, P311, DOI 10.1177/0049124106292362; Eisele TP, 2010, INT J EPIDEMIOL, V39, P88, DOI 10.1093/ije/dyq026; Esimai O A, 2014, Glob J Health Sci, V7, P20, DOI 10.5539/gjhs.v7n2p20; Fegan GW, 2007, LANCET, V370, P1035, DOI 10.1016/S0140-6736(07)61477-9; Figueroa ME, 2010, CTR PUBLICATION HCI; Garcia-Basteiro AL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-179; Garley AE, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-119; Grabowsky M, 2005, B WORLD HEALTH ORGAN, V83, P195; Grabowsky M, 2007, TROP MED INT HEALTH, V12, P815, DOI 10.1111/j.1365-3156.2007.01862.x; Guo G, 2000, ANNU REV SOCIOL, V26, P441, DOI 10.1146/annurev.soc.26.1.441; Hightower A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-183; Hung WS, 2014, TRAVEL MED INFECT DI, V12, P370, DOI 10.1016/j.tmaid.2013.07.001; Iwashita H, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-176; Jombo GTA, 2010, ASIAN PAC J TROP MED, V3, P402, DOI 10.1016/S1995-7645(10)60098-3; Kilian A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119078; Killeen GF, 2007, PLOS MED, V4, P1246, DOI 10.1371/journal.pmed.0040229; Kincaid DL, 2000, COMMUN RES, V27, P723, DOI 10.1177/009365000027006003; Koenker HM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-203; Kulkarni MA, 2010, AM J TROP MED HYG, V82, P420, DOI 10.4269/ajtmh.2010.09-0597; Liberia Institute of Statistics and Geo-Information Services (LISGIS) Ministry of Health and Social Welfare [Liberia] National AIDS Control Program [Liberia] & ICF International, 2014, LIB DEM HLTH SURV 20; Loha E, 2013, MALARIA J, V12, P10; Lwin MO, 2014, PUBLIC HEALTH, V128, P654, DOI 10.1016/j.puhe.2014.03.008; Maas C.J.M., 2005, METHODOLOGY, V1, P86, DOI [10.1027/1614-2241.1.3.86, DOI 10.1027/1614-2241.1.3.86]; Maas CJM, 2004, COMPUT STAT DATA AN, V46, P427, DOI 10.1016/j.csda.2003.08.006; Macintyre K, 2006, TROP MED INT HEALTH, V11, P824, DOI 10.1111/j.1365-3156.2006.01637.x; Minakawa N, 2015, PARASITOLOGY, V142, P1516, DOI 10.1017/S0031182015000955; Ministry of Health and Social Welfare Republic of Liberia, 2014, MIN HLTH SOC WELF AN; Moiroux N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030558; Mujinja PGM, 2005, E AFR MED J, V81, P641; National Malaria Control Program (NMCP) [Liberia] Ministry of Health and Social Welfare (MOHSW) Liberia Institute of Statistics and Geo-information Services (LISGIS) and ICF International, 2012, LIB MAL IND SURV 201; Ng'ang'a PN, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-64; Nganda RY, 2004, MALARIA J, V3, P8; Nguyen HV, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-170; Nuwaha F, 2001, AM J TROP MED HYG, V65, P877, DOI 10.4269/ajtmh.2001.65.877; Panter-Brick C, 2006, SOC SCI MED, V62, P2810, DOI 10.1016/j.socscimed.2005.10.009; Pulford J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-83; Renggli S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-85; Rickard DG, 2011, PROG COMM HLTH PARTN, V5, P123, DOI 10.1353/cpr.2011.0018; Ricotta EE, 2015, MALARIA J, V14, DOI 10.1186/s12936-014-0531-0; Skarbinski J, 2007, AM J TROP MED HYG, V76, P1100, DOI 10.4269/ajtmh.2007.76.1100; Tchinda VHM, 2012, PAN AFR MED J, V12; Thwing J, 2008, TROP MED INT HEALTH, V13, P827, DOI 10.1111/j.1365-3156.2008.02070.x; Thwing JI, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-86; Watanabe N, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-441; Wolkon A, 2010, AM J TROP MED HYG, V83, P1014, DOI 10.4269/ajtmh.2010.09-0599; Yohannes K, 2000, ACTA TROP, V75, P173, DOI 10.1016/S0001-706X(00)00055-3; Zollner C, 2015, HEALTH POLICY PLANN, V30, P171, DOI 10.1093/heapol/czt108	64	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0158331	10.1371/journal.pone.0158331	http://dx.doi.org/10.1371/journal.pone.0158331			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ9CO	27403877	Green Published, Green Submitted, gold			2022-12-27	WOS:000379508200007
J	Park, SB; Seronello, S; Mayer, W; Ojcius, DM				Park, Seung Bum; Seronello, Scott; Mayer, Wasima; Ojcius, David M.			Hepatitis C Virus Frameshift/Alternate Reading Frame Protein Suppresses Interferon Responses Mediated by Pattern Recognition Receptor Retinoic-Acid-Inducible Gene-I	PLOS ONE			English	Article							F-PROTEIN; CORE PROTEIN; RNA; EXPRESSION; TRANSLATION; REGION; MECHANISMS; INHIBITION; PREDICTION; CLEAVAGE	Hepatitis C virus (HCV) actively evades host interferon (IFN) responses but the mechanisms of how it does so are not completely understood. In this study, we present evidence for an HCV factor that contributes to the suppression of retinoic-acid-inducible gene-1 (RIG-1)-mediated IFN induction. Expression of frameshift/alternate reading frame protein (F/ARFP) from HCV-2/+1 frame in Huh7 hepatoma cells suppressed type I IFN responses stimulated by HCV RNA pathogen -associated molecular pattern (PAMP) and poly(IC). The suppression occurred independently of other HCV factors; and activation of interferon stimulated genes, TNF alpha, IFN-lambda 1, and IFN-lambda 2/3 was likewise suppressed by HCV F/ARFP. Point mutations in the full-length HCV sequence (JFH1 genotype 2a strain) were made to introduce premature termination codons in the-2+1 reading frame coding for F/ARFP while preserving the original reading frame, which enhanced IFN alpha and IFN beta induction by HCV. The potentiation of IFN response by the F/ARFP mutations was diminished in Huh7.5 cells, which already have a defective RIG-I, and by decreasing RIG-I expression in Huh7 cells. Furthermore, adding F/ARFP back via trans-complementation suppressed IFN induction in the F/ARFP mutant. The F/ARFP mutants, on the other hand, were not resistant to exogenous IFN alpha. Finally, HCV-infected human liver samples showed significant F/ARFP antibody reactivity, compared to HCV-uninfected control livers. Therefore, HCV F/ARFP likely cooperates with other viral factors to suppress type I and III IFN induction occurring through the RIG-I signaling pathway. This study identifies a novel mechanism of pattern recognition receptor modulation by HCV and suggests a biological function of the HCV alternate reading frame in the modulation of host innate immunity.	[Park, Seung Bum; Seronello, Scott; Mayer, Wasima; Ojcius, David M.] Univ Calif Merced, Sch Nat Sci, Merced, CA 95343 USA; [Ojcius, David M.] Univ Pacific, Arthur A Dugoni Sch Dent, San Francisco, CA 94103 USA	University of California System; University of California Merced; University of the Pacific	Ojcius, DM (corresponding author), Univ Calif Merced, Sch Nat Sci, Merced, CA 95343 USA.; Ojcius, DM (corresponding author), Univ Pacific, Arthur A Dugoni Sch Dent, San Francisco, CA 94103 USA.	dojcius@pacific.edu	Ojcius, David/ABE-6557-2020	Ojcius, David/0000-0003-1461-4495; Park, Seung Bum/0000-0003-2834-9071	National Institutes of Health [R56AI083353]; University of California, Merced	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, Merced(University of California System)	This work was supported by the National Institutes of Health: R56AI083353 (JC), and University of California, Merced. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain C, 2004, J VIROL, V78, P10460, DOI 10.1128/JVI.78.19.10460-10469.2004; Baril M, 2005, NUCLEIC ACIDS RES, V33, P1474, DOI 10.1093/nar/gki292; Basu A, 2004, J GEN VIROL, V85, P2299, DOI 10.1099/vir.0.80028-0; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Boulant S, 2003, J BIOL CHEM, V278, P45785, DOI 10.1074/jbc.M307174200; Breiman A, 2005, J VIROL, V79, P3969, DOI 10.1128/JVI.79.7.3969-3978.2005; Choi JA, 2003, MOL CELL BIOL, V23, P1489, DOI 10.1128/MCB.23.5.1489-1497.2003; Chuang WCM, 2008, J GEN VIROL, V89, P1890, DOI 10.1099/vir.0.83677-0; Cohen M, 2007, DIGEST DIS SCI, V52, P2427, DOI 10.1007/s10620-006-9630-2; Dalagiorgou G, 2011, J GEN VIROL, V92, P1343, DOI 10.1099/vir.0.023010-0; de Mochel NSR, 2010, HEPATOLOGY, V52, P47, DOI 10.1002/hep.23671; Eng FJ, 2009, J VIROL, V83, P3104, DOI 10.1128/JVI.01679-08; Fiorucci M, 2007, J GEN VIROL, V88, P1149, DOI 10.1099/vir.0.82575-0; Gale M, 2005, NATURE, V436, P939, DOI 10.1038/nature04078; Hou J, 2014, CANCER CELL, V25, P49, DOI 10.1016/j.ccr.2013.11.011; Inoue K, 2012, BIOCHEM BIOPH RES CO, V428, P494, DOI 10.1016/j.bbrc.2012.10.079; Iversen MB, 2010, J INTERF CYTOK RES, V30, P573, DOI 10.1089/jir.2010.0063; Kaukinen P, 2013, J MED VIROL, V85, P71, DOI 10.1002/jmv.23442; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Komurian-Pradel F, 2004, HEPATOLOGY, V40, P900, DOI 10.1002/hep.20406; Kotta-Loizou I, 2013, J GEN VIROL, V94, P1528, DOI 10.1099/vir.0.050328-0; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; McMullan LK, 2007, P NATL ACAD SCI USA, V104, P2879, DOI 10.1073/pnas.0611267104; Morice Y, 2009, HEPATOLOGY, V49, P1449, DOI 10.1002/hep.22821; Nitta S, 2013, HEPATOLOGY, V57, P46, DOI 10.1002/hep.26017; Otsuka M, 2005, HEPATOLOGY, V41, P1004, DOI 10.1002/hep.20666; PARKIN NT, 1992, J VIROL, V66, P5147, DOI 10.1128/JVI.66.8.5147-5151.1992; Pickett BE, 2011, J VIRAL HEPATITIS, V18, P608, DOI 10.1111/j.1365-2893.2010.01342.x; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Seronello S, 2010, J BIOL CHEM, V285, P845, DOI 10.1074/jbc.M109.045740; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Sundararajan A, 1999, MOL CELL, V4, P1005, DOI 10.1016/S1097-2765(00)80229-4; Tsao ML, 2006, BIOCHEM BIOPH RES CO, V348, P271, DOI 10.1016/j.bbrc.2006.07.062; Tuplin A, 2004, J GEN VIROL, V85, P3037, DOI 10.1099/vir.0.80141-0; Vassilaki N, 2003, J BIOL CHEM, V278, P40503, DOI 10.1074/jbc.M305504200; Vassilaki N, 2008, J VIROL, V82, P11503, DOI 10.1128/JVI.01640-08; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Walewski JL, 2002, RNA, V8, P557, DOI 10.1017/S1355838202029023; Walewski JL, 2001, RNA, V7, P710, DOI 10.1017/S1355838201010111; Xu XD, 2014, MOL MED REP, V9, P730, DOI 10.3892/mmr.2013.1816; Xu ZM, 2003, J VIROL, V77, P1578, DOI 10.1128/JVI.77.2.1578-1583.2003; Xu ZM, 2001, EMBO J, V20, P3840, DOI 10.1093/emboj/20.14.3840; Yuksek K, 2009, J VIROL, V83, P612, DOI 10.1128/JVI.00832-08	46	11	11	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0158419	10.1371/journal.pone.0158419	http://dx.doi.org/10.1371/journal.pone.0158419			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27404108	Green Submitted, Green Published, gold			2022-12-27	WOS:000379508200009
J	Rahnert, JA; Zheng, B; Hudson, MB; Woodworth-Hobbs, ME; Price, SR				Rahnert, Jill A.; Zheng, Bin; Hudson, Matthew B.; Woodworth-Hobbs, Myra E.; Price, S. Russ			Glucocorticoids Alter CRTC-CREB Signaling in Muscle Cells: Impact on PGC-1 alpha Expression and Atrophy Markers	PLOS ONE			English	Article							SKELETAL-MUSCLE; UBIQUITIN LIGASES; GENE-EXPRESSION; IDENTIFICATION; COACTIVATORS; MICRORNAS; PROTEIN; TRANSCRIPTION; PROTEOLYSIS; BIOGENESIS	Muscle wasting associated with chronic diseases has been linked to decreased expression of PGC-1 alpha and overexpression of PGC-1 alpha counters muscle loss. CREB, in conjunction with the CREB-regulated transcription coactivator (CRTC2), is a positive modulator of PGC-1 alpha transcription. We previously reported that PGC-1 alpha expression is decreased in skeletal muscle of diabetic rats despite a high level of CREB phosphorylation (i.e., activation), suggesting that CRTC2-CREB signaling may be dysregulated. In this study, the relationship between CREB/CRTC signaling and PGC-1 alpha expression was examined in L6 myotubes treated with dexamethasone (Dex, 48h) to induce atrophy. Dex decreased PGC-1 alpha mRNA and protein as well as the levels of CRTC1 and CRTC2 in the nucleus. Dex also altered the nuclear levels of two known regulators of CRTC2 localization; the amount of calcinuerin catalytic A subunit (CnA) was decreased whereas SIK was increased. To assess PGC-1 alpha transcription, muscle cells were transfected with a PGC-1 alpha luciferase reporter plasmid (PGC-1 alpha-Luc). Dex suppressed PGC-1 alpha luciferase activity while both isobutylmethylxanthine (IBMX) and over-expression of CRTC1 or CRTC2 increased PGC-1 alpha-Luc activity. Mutation of the CRE binding site from PGC-1 alpha-Luc reporter attenuated the responses to both IBMX and the CRTC proteins. Consistent with the reporter gene results, overexpression of CRTC2 produced an increase in CRTC2 in the nucleus and in PGC-1 alpha mRNA and PGC-1 alpha protein. Overexpression of CRTC2 was not sufficient to prevent the decrease in PGC-1 alpha mRNA or protein by Dex. In summary, these data suggest that attenuated CREB/CRTC signaling contributes to the decrease in PGC-1 alpha expression during atrophy.	[Rahnert, Jill A.; Zheng, Bin; Hudson, Matthew B.; Woodworth-Hobbs, Myra E.; Price, S. Russ] Emory Univ, Dept Med, Div Renal, Atlanta, GA 30322 USA; [Zheng, Bin; Hudson, Matthew B.; Price, S. Russ] Atlanta Vet Affairs Med Ctr, Decatur, GA USA	Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System	Price, SR (corresponding author), Emory Univ, Dept Med, Div Renal, Atlanta, GA 30322 USA.; Price, SR (corresponding author), Atlanta Vet Affairs Med Ctr, Decatur, GA USA.	russ.price@emory.edu			National Institutes of Health [RO1DK95610, T32DK007656]; US Department of Veterans Affairs Biomedical Development Laboratory Research and Development Service [I01BX001456]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095610] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001456] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Veterans Affairs Biomedical Development Laboratory Research and Development Service; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health grants to SRP (RO1DK95610) and to JAR and MBH (T32DK007656), and a Merit Review Award from the US Department of Veterans Affairs Biomedical Development Laboratory Research and Development Service to SRP (I01BX001456).	Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bittinger MA, 2004, CURR BIOL, V14, P2156, DOI 10.1016/j.cub.2004.11.002; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Brault JJ, 2010, J BIOL CHEM, V285, P19460, DOI 10.1074/jbc.M110.113092; Braun TP, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00012; Bruno NE, 2014, EMBO J, V33, P1027, DOI 10.1002/embj.201386145; Chan MC, 2014, METABOLISM, V63, P441, DOI 10.1016/j.metabol.2014.01.006; Chinsomboon J, 2009, P NATL ACAD SCI USA, V106, P21401, DOI 10.1073/pnas.0909131106; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Du J, 2004, J CLIN INVEST, V113, P115, DOI 10.1172/JCI200418330; Gao YM, 2008, J APPL PHYSIOL, V105, P1772, DOI 10.1152/japplphysiol.90636.2008; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Hindi SM, 2014, FASEB J, V28, P1398, DOI 10.1096/fj.13-242123; Hu ZY, 2009, J CLIN INVEST, V119, P3059, DOI 10.1172/JCI38770; Hudson MB, 2014, AM J PHYSIOL-CELL PH, V307, pC314, DOI 10.1152/ajpcell.00395.2013; Hudson MB, 2014, AM J PHYSIOL-CELL PH, V306, pC551, DOI 10.1152/ajpcell.00266.2013; Ibrahim NM, 2000, BIOTECHNIQUES, V29, P782, DOI 10.2144/00294st04; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Menconi M, 2007, CRIT CARE MED, V35, pS602, DOI 10.1097/01.CCM.0000279194.11328.77; Mitch WE, 1999, AM J PHYSIOL-CELL PH, V276, pC1132, DOI 10.1152/ajpcell.1999.276.5.C1132; Miura S, 2007, ENDOCRINOLOGY, V148, P3441, DOI 10.1210/en.2006-1646; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Qin WP, 2010, BIOCHEM BIOPH RES CO, V403, P473, DOI 10.1016/j.bbrc.2010.11.061; Ravnskjaer K, 2007, EMBO J, V26, P2880, DOI 10.1038/sj.emboj.7601715; Roberts-Wilson TK, 2010, BBA-MOL CELL RES, V1803, P960, DOI 10.1016/j.bbamcr.2010.03.019; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Schakman O, 2013, INT J BIOCHEM CELL B, V45, P2163, DOI 10.1016/j.biocel.2013.05.036; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Sharma M, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00239; Shen H, 2013, MOL CELL BIOCHEM, V381, P105, DOI 10.1007/s11010-013-1692-9; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106; Wu ZD, 2006, P NATL ACAD SCI USA, V103, P14379, DOI 10.1073/pnas.0606714103; Zhang YG, 2014, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2014-17; Zheng B, 2010, FASEB J, V24, P2660, DOI 10.1096/fj.09-151480	38	27	28	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0159181	10.1371/journal.pone.0159181	http://dx.doi.org/10.1371/journal.pone.0159181			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27404111	gold, Green Published, Green Submitted			2022-12-27	WOS:000379508200042
J	Cano, I; Verner-Jeffreys, DW; van Aerle, R; Paley, RK; Peeler, EJ; Green, M; Rimmer, GSE; Savage, J; Joiner, CL; Bayley, AE; Mewett, J; Hulland, J; Feist, SW				Cano, Irene; Verner-Jeffreys, David W.; van Aerle, Ronny; Paley, Richard K.; Peeler, Edmund J.; Green, Matthew; Rimmer, Georgina S. E.; Savage, Jacqueline; Joiner, Claire L.; Bayley, Amanda E.; Mewett, Jason; Hulland, Jonathan; Feist, Stephen W.			Puffy Skin Disease Is an Emerging Transmissible Condition in Rainbow Trout Oncorhynchus mykiss Walbaum	PLOS ONE			English	Article							RICKETTSIA-LIKE ORGANISM; STRAWBERRY DISEASE; RIBOSOMAL-RNA; FISH; CELL; COMPLEX; LESIONS; VIRUS; TOOL	The transmission of puffy skin disease (PSD) to rainbow trout Oncorhynchus mykiss Walbaum was tested in the laboratory by conducting co-habitation challenges with puffy skin (PS)-affected fish (Trojans) collected from the field. Two separate challenges were conducted using Trojans sourced from two different sites and diploid (first trial) or triploid (second trial) naive fish. PSD-specific clinical signs were observed in both groups of naive fish, with 66% of the fish sampled during the challenges showing signs of varying severity. The first clinical features of PSD were presented as white oval skin patches on one or both flanks 15-21 days post-challenge (dpc). The extent of the lesions ranged from 10 to 90% of the body surface, depending on the severity of the lesion. Both the severity and number of affected fish increased during the challenge. Macroscopically, oedema of the skin and multi-focal petechial haemorrhaging were observed towards the end of the trials. Abnormal fish behaviour consisting of "flashing" and excessive mucous production was noted from 15 dpc onwards. Fish with severe PSD lesions also displayed inappetence and associated emaciation. Rodlet cells were observed in 41% of the fresh skin scrapes analysed from the second trial. Histologically epidermal oedema was observed in 31% of the naive fish showing gross pathology, with additional 12% displaying epidermal hyperplasia, mostly observed at the end of the challenge. Other concomitant features of the PSD lesions in challenged fish were epithelial erosion and sloughing, and occasionally mild or focal inflammation. No consistent pathology of internal organs was observed. The parasites Ichthyophthirius multifiliis and Ichthyobodo necator were observed in skin samples of a proportion of naive challenged fish and in Trojans but not in control fish. The presence of these and other known fish pathogens in the skin of PSD-fish was confirmed by high-throughput sequencing analysis. In summary, we have demonstrated that PSD is a transmissible condition. However, even though a number of known fish pathogens were identified in the skin tissues of PSD-fish, the actual causative infectious agent(s) remain(s) unknown.	[Cano, Irene; Verner-Jeffreys, David W.; van Aerle, Ronny; Paley, Richard K.; Peeler, Edmund J.; Green, Matthew; Rimmer, Georgina S. E.; Savage, Jacqueline; Joiner, Claire L.; Bayley, Amanda E.; Mewett, Jason; Hulland, Jonathan; Feist, Stephen W.] Ctr Environm Fisheries & Aquaculture Sci, Aquat Anim Dis, Barrack Rd, Weymouth DT4 8UB, Dorset, England	Centre for Environment Fisheries & Aquaculture Science	Verner-Jeffreys, DW (corresponding author), Ctr Environm Fisheries & Aquaculture Sci, Aquat Anim Dis, Barrack Rd, Weymouth DT4 8UB, Dorset, England.	david.verner-jeffreys@cefas.co.uk	Joiner, Claire/Q-5042-2019	van Aerle, Ronny/0000-0002-2605-6518	UK Department for Environment Food and Rural Affairs [FB002]	UK Department for Environment Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA))	The work was supported by UK Department for Environment Food and Rural Affairs. Contract FB002 awarded to Dr Stephen W. Feist and their Strategic Evidence Partnership Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams IP, 2009, MOL PLANT PATHOL, V10, P537, DOI [10.1111/J.1364-3703.2009.00545.X, 10.1111/j.1364-3703.2009.00545.x]; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANACKER RL, 1955, J BACTERIOL, V70, P738, DOI 10.1128/JB.70.6.738-741.1955; Atlas RM., 2004, HDB MICROBIOLOGICAL; Bengtsson-Palme J, 2015, MOL ECOL RESOUR, V15, P1403, DOI 10.1111/1755-0998.12399; Bernoth Eva-Maria, 1997, P1, DOI 10.1016/B978-012093040-1/50003-8; Bielek E, 2005, ANAT REC PART A, V283A, P239, DOI 10.1002/ar.a.20162; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Buller NB, 2004, BACTERIA FISH OTHER; Cafiso A, 2016, J FISH DIS, V39, P497, DOI 10.1111/jfd.12371; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lloyd SJ, 2011, J FISH DIS, V34, P701, DOI 10.1111/j.1365-2761.2011.01285.x; Lloyd SJ, 2008, DIS AQUAT ORGAN, V82, P111, DOI 10.3354/dao01969; MacFaddin J.F., 1985, MEDIA ISOLATION CULT, V1; Maddocks CE, 2015, J FISH DIS, V38, P653, DOI 10.1111/jfd.12306; Madetoja J, 2002, DIS AQUAT ORGAN, V52, P109, DOI 10.3354/dao052109; Marston DA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-444; Matthews RA, 2005, ADV PARASIT, V59, P159, DOI 10.1016/S0065-308X(05)59003-1; Metselaar M, 2010, J FISH DIS, V33, P849, DOI 10.1111/j.1365-2761.2010.01187.x; Miller RR, 2013, GENOME MED, V5, DOI 10.1186/gm485; Montagna M, 2013, APPL ENVIRON MICROB, V79, P3241, DOI 10.1128/AEM.03971-12; Mueller JH, 1941, P SOC EXP BIOL MED, V48, P330, DOI 10.3181/00379727-48-13311; Oidtmann B, 2013, J FISH DIS, V36, P921, DOI 10.1111/jfd.12086; Palacios G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011487; Peeler EJ, 2014, J FISH DIS, V37, P1021, DOI 10.1111/jfd.12241; Reite OB, 2005, FISH SHELLFISH IMMUN, V19, P253, DOI 10.1016/j.fsi.2005.01.002; ROBERTSON DA, 1981, J FISH DIS, V4, P113, DOI 10.1111/j.1365-2761.1981.tb01116.x; Suau A, 1999, APPL ENVIRON MICROB, V65, P4799; Todal JA, 2004, DIS AQUAT ORGAN, V58, P9, DOI 10.3354/dao058009; Touchon M, 2011, APPL ENVIRON MICROB, V77, P7656, DOI 10.1128/AEM.05625-11; Verner-Jeffreys DW, 2008, DIS AQUAT ORGAN, V79, P207, DOI 10.3354/dao01916; Wergeland HI, 2001, DIS AQUAT ORGAN, V44, P183, DOI 10.3354/dao044183; WOLF K, 1966, SCIENCE, V151, P1004, DOI 10.1126/science.151.3713.1004; Zobell CE, 1941, J MAR RES, V4, P42	37	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158151	10.1371/journal.pone.0158151	http://dx.doi.org/10.1371/journal.pone.0158151			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391648	gold, Green Submitted, Green Published			2022-12-27	WOS:000380005400033
J	Dopstadt, J; Neubauer, L; Tudzynski, P; Humpf, HU				Dopstadt, Julian; Neubauer, Lisa; Tudzynski, Paul; Humpf, Hans-Ulrich			The Epipolythiodiketopiperazine Gene Cluster in Claviceps purpurea: Dysfunctional Cytochrome P450 Enzyme Prevents Formation of the Previously Unknown Clapurines	PLOS ONE			English	Article							GLIOTOXIN BIOSYNTHESIS; ASPERGILLUS-FUMIGATUS; NATURAL-PRODUCTS; EPIPOLYTHIODIOXOPIPERAZINE TOXINS; EMERICELLA-HETEROTHALLICA; LEPTOSPHAERIA-MACULANS; HISTAMINE-RELEASE; MASS-SPECTROMETRY; FILAMENTOUS FUNGI; HYALODENDRON SP	Claviceps purpurea is an important food contaminant and well known for the production of the toxic ergot alkaloids. Apart from that, little is known about its secondary metabolism and not all toxic substances going along with the food contamination with Claviceps are known yet. We explored the metabolite profile of a gene cluster in C. purpurea with a high homology to gene clusters, which are responsible for the formation of epipolythiodiketopiperazine (ETP) toxins in other fungi. By overexpressing the transcription factor, we were able to activate the cluster in the standard C. purpurea strain 20.1. Although all necessary genes for the formation of the characteristic disulfide bridge were expressed in the overexpression mutants, the fungus did not produce any ETPs. Isolation of pathway intermediates showed that the common biosynthetic pathway stops after the first steps. Our results demonstrate that hydroxylation of the diketopiperazine backbone is the critical step during the ETP biosynthesis. Due to a dysfunctional enzyme, the fungus is not able to produce toxic ETPs. Instead, the pathway end-products are new unusual metabolites with a unique nitrogen-sulfur bond. By heterologous expression of the Leptosphaeria maculans cytochrome P450 encoding gene sirC, we were able to identify the end-products of the ETP cluster in C. purpurea. The thioclapurines are so far unknown ETPs, which might contribute to the toxicity of other C. purpurea strains with a potentially intact ETP cluster.	[Dopstadt, Julian; Humpf, Hans-Ulrich] Univ Munster, Inst Food Chem, Corrensstr 45, D-48149 Munster, Germany; [Neubauer, Lisa; Tudzynski, Paul] Univ Munster, Inst Plant Biol & Biotechnol, Schlosspl 8, D-48143 Munster, Germany	University of Munster; University of Munster	Humpf, HU (corresponding author), Univ Munster, Inst Food Chem, Corrensstr 45, D-48149 Munster, Germany.	humpf@uni-muenster.de	Humpf, Hans-Ulrich/AAV-4845-2020	Humpf, Hans-Ulrich/0000-0003-3296-3058	Deutsche Forschungsgemeinschaft [50/18 1, 730/11-1, 50/18-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research was funded by Deutsche Forschungsgemeinschaft grants 50/18 1 (to PT) and 730/11-1 (to HUH).; This research was funded by Deutsche Forschungsgemeinschaft grants 50/18-1 (to P.T.) and 730/11-1 (to H.-U.H.). We thank Jens Kohler for NMR measurements and Thierry Rouxel for providing a L. maculans DNA sample.	Bhatnagar I, 2015, INT J MED MICROBIOL, V305, P11, DOI 10.1016/j.ijmm.2014.09.005; Bok JW, 2006, INFECT IMMUN, V74, P6761, DOI 10.1128/IAI.00780-06; Borthwick AD, 2012, CHEM REV, V112, P3641, DOI 10.1021/cr200398y; Bove JF, 1970, THE STORY OF ERGOT; CENIS JL, 1992, NUCLEIC ACIDS RES, V20, P2380, DOI 10.1093/nar/20.9.2380; Chang SL, 2013, BIOORG MED CHEM LETT, V23, P2155, DOI 10.1016/j.bmcl.2013.01.099; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Cryle MJ, 2010, BIOCHEMISTRY-US, V49, P7282, DOI 10.1021/bi100910y; CURTIS PJ, 1977, J CHEM SOC P1, V1, P180; Davis C, 2011, CHEM BIOL, V18, P542, DOI 10.1016/j.chembiol.2010.12.022; Demarque DP, 2016, NAT PROD REP, V33, P432, DOI 10.1039/c5np00073d; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; DEVAULT RL, 1973, J ANTIBIOT, V26, P532, DOI 10.7164/antibiotics.26.532; Dolan SK, 2014, CHEM BIOL, V21, P999, DOI 10.1016/j.chembiol.2014.07.006; Duell ER, 2016, ACS CHEM BIOL, V11, P1082, DOI 10.1021/acschembio.5b00905; Eadie MJ, 2003, LANCET NEUROL, V2, P429, DOI 10.1016/S1474-4422(03)00439-3; Elliott CE, 2007, MOL PLANT PATHOL, V8, P791, DOI [10.1111/j.1364-3703.2007.00433.x, 10.1111/J.1364-3703.2007.00433.X]; ESSER K, 1978, THEOR APPL GENET, V53, P145, DOI 10.1007/BF00273574; Forseth RR, 2011, J AM CHEM SOC, V133, P9678, DOI 10.1021/ja2029987; Fox EM, 2008, MYCOL RES, V112, P162, DOI 10.1016/j.mycres.2007.08.017; Furtado NAJC, 2007, J MASS SPECTROM, V42, P1279, DOI 10.1002/jms.1166; Gardiner DM, 2005, FEMS MICROBIOL LETT, V248, P241, DOI 10.1016/j.femsle.2005.05.046; Gardiner DM, 2004, MOL MICROBIOL, V53, P1307, DOI 10.1111/j.1365-2958.2004.04215.x; Gerhards N, 2014, TOXINS, V6, P3281, DOI 10.3390/toxins6123281; Giesbert S, 2008, MOL PLANT PATHOL, V9, P317, DOI [10.1111/j.1364-3703.2008.00466.x, 10.1111/J.1364-3703.2008.00466.X]; Guo CJ, 2013, J AM CHEM SOC, V135, P7205, DOI 10.1021/ja3123653; Haarmann T, 2008, FUNGAL GENET BIOL, V45, P35, DOI 10.1016/j.fgb.2007.04.008; Hurne AM, 2002, J BIOL CHEM, V277, P31631, DOI 10.1074/jbc.M201699200; Hurne AM, 2000, J BIOL CHEM, V275, P25202, DOI 10.1074/jbc.M002278200; Husgen U, 1999, J PHYTOPATHOL, V147, P591, DOI 10.1046/j.1439-0434.1999.00432.x; JORDAN TW, 1987, TRENDS PHARMACOL SCI, V8, P144, DOI 10.1016/0165-6147(87)90184-2; JUNGEHULSING U, 1994, CURR GENET, V25, P101, DOI 10.1007/BF00309533; Kajula M, 2016, J NAT PROD; KAWAHARA N, 1990, CHEM PHARM BULL, V38, P73; KAWAHARA N, 1989, CHEM PHARM BULL, V37, P2592; KAWAHARA N, 1986, J CHEM SOC CHEM COMM, P1495, DOI 10.1039/c39860001495; KAWAHARA N, 1987, J CHEM SOC PERK T 1, P2099, DOI 10.1039/p19870002099; Keller NP, 1997, FUNGAL GENET BIOL, V21, P17, DOI 10.1006/fgbi.1997.0970; Kimura M, 2014, PATHWAYS GENES EVOLU, V71, P2105; Klaric MK, 2008, ARCH TOXICOL, V82, P247, DOI 10.1007/s00204-007-0245-y; Kremer A, 2010, MICROBIOL-SGM, V156, P278, DOI 10.1099/mic.0.033886-0; MANTLE PG, 1976, J GEN MICROBIOL, V93, P321, DOI 10.1099/00221287-93-2-321; Marroquin-Cardona AG, 2014, FOOD CHEM TOXICOL, V69, P220, DOI 10.1016/j.fct.2014.04.025; Mukherjee PK, 2012, MICROBIOL-SGM, V158, P35, DOI 10.1099/mic.0.053629-0; MULLBACHER A, 1986, MOL IMMUNOL, V23, P231, DOI 10.1016/0161-5890(86)90047-7; MUNDAY R, 1987, J APPL TOXICOL, V7, P17, DOI 10.1002/jat.2550070105; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Nielsen KF, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00071; Park HB, 2011, J NAT PROD, V74, P2309, DOI 10.1021/np200563x; Patron NJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-174; Pfohl-Leszkowicz A, FOOD CONTAMINANTS MY; Pretsch E., 2009, STRUCTURE DETERMINAT; Reece KM, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-91; Sambrook J, 1989, MOL CLONING; Schardl CL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003323; Scharf DH, 2014, J AM CHEM SOC, V136, P11674, DOI 10.1021/ja5033106; Scharf DH, 2013, ANGEW CHEM INT EDIT, V52, P11092, DOI 10.1002/anie.201305059; Scharf DH, 2013, J BIOTECHNOL, V163, P179, DOI 10.1016/j.jbiotec.2012.06.027; Scharf DH, 2012, ANGEW CHEM INT EDIT, V51, P10064, DOI 10.1002/anie.201205041; Scharf DH, 2011, J AM CHEM SOC, V133, P12322, DOI 10.1021/ja201311d; Scharf DH, 2010, J AM CHEM SOC, V132, P10136, DOI 10.1021/ja103262m; Scharf DH, 2015, GLIOTOXIN BANE BOON; Schrettl M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001124; Schumacher J, 2012, FUNGAL GENET BIOL, V49, P483, DOI 10.1016/j.fgb.2012.03.005; SMIT R, 1992, MOL GEN GENET, V234, P297, DOI 10.1007/BF00283850; STILLWELL MA, 1974, CAN J MICROBIOL, V20, P759, DOI 10.1139/m74-116; Stoev SD, 2012, EXP TOXICOL PATHOL, V64, P733, DOI 10.1016/j.etp.2011.01.008; STRUNZ GM, 1974, CAN J CHEM, V52, P325, DOI 10.1139/v74-052; STRUNZ GM, 1975, CAN J CHEM, V53, P295, DOI 10.1139/v75-040; Sun Y, 2012, J NAT PROD, V75, P111, DOI 10.1021/np200740e; SUTTON P, 1994, INFECT IMMUN, V62, P1192, DOI 10.1128/IAI.62.4.1192-1198.1994; Tenberge KB, 1996, PHYTOPATHOLOGY, V86, P1084, DOI 10.1094/Phyto-86-1084; Vargas WA, 2014, MICROBIOL-SGM, V160, P2319, DOI 10.1099/mic.0.079210-0; WARING P, 1988, J BIOL CHEM, V263, P18493; Waring P, 1996, GEN PHARMACOL, V27, P1311, DOI 10.1016/S0306-3623(96)00083-3; WARING P, 1995, BIOCHEM PHARMACOL, V49, P1195, DOI 10.1016/0006-2952(95)00039-3; Weindling R, 1934, PHYTOPATHOLOGY, V24, P1153; Welch TR, 2014, NAT PROD REP, V31, P1376, DOI 10.1039/c3np70097f; Wiemann P, 2014, J IND MICROBIOL BIOT, V41, P301, DOI 10.1007/s10295-013-1366-3; Williams DE, 1998, TETRAHEDRON LETT, V39, P9579, DOI 10.1016/S0040-4039(98)02277-1; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107	82	6	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158945	10.1371/journal.pone.0158945	http://dx.doi.org/10.1371/journal.pone.0158945			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27390873	Green Submitted, Green Published, gold			2022-12-27	WOS:000380005400168
J	Freeman, J				Freeman, Jacob			The Socioecology of Territory Size and a "Work-Around" Hypothesis for the Adoption of Farming	PLOS ONE			English	Article							ECOLOGY; INTENSIFICATION; MACROECOLOGY; ORIGINS	This paper combines theory from ecology and anthropology to investigate variation in the territory sizes of subsistence oriented agricultural societies. The results indicate that population and the dependence of individuals within a society on "wild" foods partly determine the territory sizes of agricultural societies. In contrast, the productivity of an agroecosystem is not an important determinant of territory size. A comparison of the population-territory size scaling dynamics of agricultural societies and human foragers indicates that foragers and farmers face the same constraints on their ability to expand their territory and intensify their use of resources within a territory. However, the higher density of food in an agroecosystem allows farmers, on average, to live at much higher population densities than human foragers. These macroecological patterns are consistent with a "work-around hypothesis" for the adoption of farming. This hypothesis is that as residential groups of foragers increase in size, farming can sometimes better reduce the tension between an individual's autonomy over resources and the need for social groups to function to provide public goods like defense and information.	[Freeman, Jacob] Utah State Univ, Anthropol Program, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University	Freeman, J (corresponding author), Utah State Univ, Anthropol Program, Logan, UT 84322 USA.	jacob.freeman@usu.edu		Freeman, Jacob/0000-0001-7402-8450				[Anonymous], 2005, CONDITIONS AGR GROWT; Barlow KR, 2002, AM ANTIQUITY, V67, P65, DOI 10.2307/2694877; Bettinger R., 1991, HUNTER GATHERERS ARC; Binford L.R., 2001, CONSTRUCTING FRAMES; Bohannan Paul, 1968, TIV EC; Brown J. H., 1995, MACROECOLOGY; Burnside WR, 2012, BIOL REV, V87, P194, DOI 10.1111/j.1469-185X.2011.00192.x; CASHDAN E, 1983, CURR ANTHROPOL, V24, P47, DOI 10.1086/202934; CLARK CW, 1986, THEOR POPUL BIOL, V30, P45, DOI 10.1016/0040-5809(86)90024-9; Eerkens JW, 2004, AM ANTIQUITY, V69, P653, DOI 10.2307/4128442; Flannery K., 2012, CREATION INEQUALITY; Flannery KV, 1985, GUILA NAQUITZ ARCHAI; Freeman J, 2015, J ANTHROPOL ARCHAEOL, V39, P110, DOI 10.1016/j.jaa.2015.03.002; Freeman J, 2012, HUM NATURE-INT BIOS, V23, P419, DOI 10.1007/s12110-012-9154-8; Freeman J, 2012, J ARCHAEOL SCI, V39, P3008, DOI 10.1016/j.jas.2012.04.039; Freeman J, 2012, GLOBAL ECOL BIOGEOGR, V21, P428, DOI 10.1111/j.1466-8238.2011.00687.x; Hamilton MJ, 2007, P NATL ACAD SCI USA, V104, P4765, DOI 10.1073/pnas.0611197104; Hamilton MJ, 2009, P NATL ACAD SCI USA, V106, P12255, DOI 10.1073/pnas.0905708106; Hamilton MJ, 2012, METABOLIC ECOLOGY SC, P67; HOLLING CS, 1992, ECOL MONOGR, V62, P447, DOI 10.2307/2937313; Jetz W, 2004, SCIENCE, V306, P266, DOI 10.1126/science.1102138; JOHNSON GA, 1983, HUM ECOL, V11, P175, DOI 10.1007/BF00891742; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; KEELEY LH, 1988, J ANTHROPOL ARCHAEOL, V7, P373, DOI 10.1016/0278-4165(88)90003-7; Kelt DA, 2001, AM NAT, V157, P637, DOI 10.1086/320621; Lee RB, 1972, HUNTERS GATHERERS TO, P326; MARSHALL L, 1960, AFRICA, V30, P325, DOI 10.2307/1157596; MCNAB BK, 1963, AM NAT, V97, P133, DOI 10.1086/282264; MURDOCK GP, 1969, ETHNOLOGY, V8, P329, DOI 10.2307/3772907; Nunn CL, 2000, AM NAT, V156, P519, DOI 10.1086/303405; Paternoster R, 1998, CRIMINOLOGY, V36, P859, DOI 10.1111/j.1745-9125.1998.tb01268.x; REDDING RW, 1988, J ANTHROPOL ARCHAEOL, V7, P56, DOI 10.1016/0278-4165(88)90007-4; Richerson PJ, 2001, AM ANTIQUITY, V66, P387, DOI 10.2307/2694241; Richerson PJ, 1999, HUM NATURE-INT BIOS, V10, P253, DOI 10.1007/s12110-999-1004-y; Steward J.H, 1938, BASIN PLATEAU ABORIG, V120; Tucker Bram Tange, 2001, BEHAV ECOLOGY EC VAR; WINTERHALDER B, 1988, J ANTHROPOL ARCHAEOL, V7, P289, DOI 10.1016/0278-4165(88)90001-3; Zhang YQ, 2004, AGR WATER MANAGE, V64, P107, DOI 10.1016/S0378-3774(03)00201-4	38	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158743	10.1371/journal.pone.0158743	http://dx.doi.org/10.1371/journal.pone.0158743			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DR6IK	27391955	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400113
J	Gomes, C; Sousa, R; Mendes, T; Borges, R; Vilares, P; Vasconcelos, V; Guilhermino, L; Antunes, A				Gomes, Cidalia; Sousa, Ronaldo; Mendes, Tito; Borges, Rui; Vilares, Pedro; Vasconcelos, Vitor; Guilhermino, Lucia; Antunes, Agostinho			Low Genetic Diversity and High Invasion Success of Corbicula fluminea (Bivalvia, Corbiculidae) (Muller, 1774) in Portugal	PLOS ONE			English	Article							FRESH-WATER CLAM; NON-REDUCTIONAL SPERMATOZOA; MOLECULAR PHYLOGENY; DNA; ANDROGENESIS; MORPHOLOGY; MORTALITY; LINEAGES; MOLLUSCA; AMPLIFICATION	The Asian clam, Corbicula fluminea, is an invasive alien species (IAS) originally from Asia that has spread worldwide causing major ecological and economic impacts in aquatic ecosystems. Here, we evaluated C. fluminea genetic (using COI mtDNA, CYTb mtDNA and 18S rDNA gene markers), morphometric and sperm morphology variation in Portuguese freshwater ecosystems. The COI marker revealed a single haplotype, which belongs to the Asian FW5 invasive lineage, suggesting a common origin for all the 13 Portuguese C. fluminea populations analysed. Morphometric analyses showed differences between the populations colonizing the North (with the exception of the Lima River) and the Centre/South ecosystems. The sperm morphology examination revealed the presence of biflagellate sperm, a distinctive character of the invasive androgenetic lineages. The low genetic variability of the Portuguese C. fluminea populations and the pattern of sperm morphology have been illuminating for understanding the demographic history of this invasive species. We hypothesize that these populations were derived from a unique introductory event of a Corbicula fluminea FW5 invasive androgenic lineage in the Tejo River, which subsequently dispersed to other Portuguese freshwater ecosystems. The C. fluminea asexual reproductive mode may have assisted these populations to become highly invasive despite the low genetic diversity.	[Gomes, Cidalia; Sousa, Ronaldo; Mendes, Tito; Borges, Rui; Vilares, Pedro; Vasconcelos, Vitor; Guilhermino, Lucia; Antunes, Agostinho] Univ Porto, Interdisciplinary Ctr Marine & Environm Res, CIIMAR CIMAR, Terminal Cruzeiros Porto Leixoes, Av Gen Norton de Matos S-N, P-4450208 Oporto, Portugal; [Gomes, Cidalia; Vilares, Pedro; Guilhermino, Lucia] Univ Porto, Lab Ecotoxicol, Dept Populat Study, Inst Biomed Sci Abel Salazar,ICBAS, Rua Jorge Viterbo Ferreira 228, P-4050313 Oporto, Portugal; [Sousa, Ronaldo] Univ Minho, Dept Biol, Ctr Mol & Environm Biol, CBMA, Campus Gualtar, P-4710057 Braga, Portugal; [Mendes, Tito; Borges, Rui; Vasconcelos, Vitor; Antunes, Agostinho] Univ Porto, Fac Sci, Dept Biol, FCUP, Rua Campo Alegre S-N Edificio FC5, P-4169007 Oporto, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Minho; Universidade do Porto	Antunes, A (corresponding author), Univ Porto, Interdisciplinary Ctr Marine & Environm Res, CIIMAR CIMAR, Terminal Cruzeiros Porto Leixoes, Av Gen Norton de Matos S-N, P-4450208 Oporto, Portugal.; Antunes, A (corresponding author), Univ Porto, Fac Sci, Dept Biol, FCUP, Rua Campo Alegre S-N Edificio FC5, P-4169007 Oporto, Portugal.	aantunes@ciimar.up.pt	Vasconcelos, Vitor/A-8933-2008; Borges, Rui/H-5873-2016; Sousa, Ronaldo/C-4887-2008	Vasconcelos, Vitor/0000-0003-3585-2417; Borges, Rui/0000-0002-5905-3778; Sousa, Ronaldo/0000-0002-5961-5515; Guilhermino, Lucia/0000-0002-1009-8967; Mendes, Tito/0000-0001-7590-5523; Antunes, Agostinho/0000-0002-1328-1732; Gomes, Cidalia/0000-0001-5119-7964; Borges, Rui/0000-0003-3931-9476	Portuguese Foundation for Science and Technology (FCT) [SFRH/BD/71041/2010]; FCT [UID/Multi/04423/2013, PTDC/AAG-GLO/6887/2014]; European Regional Development Fund (ERDF) by the Northern Regional Operational Program [NORTE-01-0145-FEDER-000035]; ERDF	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); European Regional Development Fund (ERDF) by the Northern Regional Operational Program; ERDF(European Commission)	Cidalia Gomes was supported by a PhD grant from the Portuguese Foundation for Science and Technology (FCT) (SFRH/BD/71041/2010). This research was partially supported by the Strategic Funding UID/Multi/04423/2013 through national funds provided by FCT and European Regional Development Fund (ERDF) in the framework of the program PT2020, the Structured Program of R&D&I INNOVMAR - Innovation and Sustainability in the Management and Exploitation of Marine Resources (NORTE-01-0145-FEDER-000035; Research Line ECOSERVICES) by the Northern Regional Operational Program (NORTE2020) and ERDF, and the FCT project PTDC/AAG-GLO/6887/2014.	Adamkewicz SL, 1997, MOL BIOL EVOL, V14, P619, DOI 10.1093/oxfordjournals.molbev.a025801; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2014, TRACER V1 6; ARAUJO R, 1993, AM MALACOL BULL, V10, P39; Baker AM, 2003, MOL ECOL, V12, P2707, DOI 10.1046/j.1365-294X.2003.01941.x; Belz CE, 2012, J SHELLFISH RES, V31, P777, DOI 10.2983/035.031.0322; Benson Dennis A, 2005, Nucleic Acids Res, V33, pD34; Britton J.C., 1979, P249; Britton J. C., 1982, MALACOL REV S, P1; Byrne M, 2000, HYDROBIOLOGIA, V418, P185, DOI 10.1023/A:1003986512832; Chicharo L, 2000, VALORIZACAO RECURSOS; Clavero M, 2012, AQUAT CONSERV, V22, P277, DOI 10.1002/aqc.2231; Corbicula Morton B., 1986, AM MALAC B, V2, P113; COUNTS CL, 1981, NAUTILUS, V95, P12; Crespo D, 2015, BIOL INVASIONS, V17, P2087, DOI 10.1007/s10530-015-0862-y; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Darrigran Gustavo, 2002, Biological Invasions, V4, P145, DOI 10.1023/A:1020521811416; Dill WA, 1993, INLAND FISHERIES EUR; Douda K, 2012, BIOL INVASIONS, V14, P127, DOI 10.1007/s10530-011-9989-7; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Espineira M, 2009, J AGR FOOD CHEM, V57, P495, DOI 10.1021/jf802787d; Ferreira Veronica, 2004, Limnetica, V23, P295; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Frischer ME, 2002, HYDROBIOLOGIA, V487, P33, DOI 10.1023/A:1022971918673; GARDNER JPA, 1991, MAR ECOL PROG SER, V71, P235, DOI 10.3354/meps071235; Giribet G, 2002, INVERTEBR BIOL, V121, P271; Glaubrecht M, 2003, MALACOLOGIA, V45, P1; Golani D, 2007, BIOLOGY LETT, V3, P541, DOI 10.1098/rsbl.2007.0308; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hatsumi Machiko, 1995, Venus the Japanese Journal of Malacology, V54, P185; Hedtke SM, 2008, EVOLUTION, V62, P1119, DOI 10.1111/j.1558-5646.2008.00344.x; Hedtke SM, 2011, P NATL ACAD SCI USA, V108, P9520, DOI 10.1073/pnas.1106742108; Hedtke SM, 2011, SYST BIOL, V60, P87, DOI 10.1093/sysbio/syq070; Higgins SN, 2010, ECOL MONOGR, V80, P179, DOI 10.1890/09-1249.1; HILLIS DM, 1982, AM MIDL NAT, V108, P74, DOI 10.2307/2425294; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ilarri MI, 2015, MAR FRESHWATER RES, V66, P549, DOI 10.1071/MF14004; Ilarri MI, 2012, J SEA RES, V72, P113, DOI 10.1016/j.seares.2011.10.002; Ilarri MI, 2011, BIOL INVASIONS, V13, P277, DOI 10.1007/s10530-010-9833-5; Ishibashi R, 2003, ZOOL SCI, V20, P727, DOI 10.2108/zsj.20.727; ITUARTE CF, 1994, NAUTILUS, V107, P129; Karatayev AY, 2007, BIOL INVASIONS, V9, P161, DOI 10.1007/s10530-006-9013-9; KIJVIRIYA V, 1991, AM MALACOL BULL, V8, P97; Kinzelbach Ragnar, 1991, Mainzer Naturwissenschaftliches Archiv, V29, P215; Komaru A, 1999, ZOOL SCI, V16, P105, DOI 10.2108/zsj.16.105; Komaru A, 1997, BIOL BULL, V193, P320, DOI 10.2307/1542934; Komaru A, 1998, DEV GENES EVOL, V208, P46, DOI 10.1007/s004270050152; Komaru A, 2001, DEV BIOL, V18, P87; Komaru A, 2006, ZOOL SCI, V23, P529, DOI 10.2108/zsj.23.529; Konishi K, 1998, J SHELLFISH RES, V17, P185; Korniushin AV, 2004, HYDROBIOLOGIA, V529, P251; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee Jun-Sang, 1997, Korean Journal of Systematic Zoology, V13, P233; Lee T, 2005, AM MALACOL BULL, V20, P113; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu J, 2006, BIOL INVASIONS, V8, P1461, DOI 10.1007/s10530-005-5838-x; McMahon RF, 2000, NONINDIGENOUS FRESHWATER ORGANISMS, P315; MCMAHON RF, 1982, NAUTILUS, V96, P134; McMahon RF, 2002, CAN J FISH AQUAT SCI, V59, P1235, DOI 10.1139/F02-105; Mergeay J, 2006, P R SOC B, V273, P2839, DOI 10.1098/rspb.2006.3661; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MOUTHON J, 1981, Basteria, V45, P109; Nagel K. O., 1989, MITT DTSCH MALAKOZOO, V17, P44; Nei M., 1987, MOL EVOLUTIONARY GEN; NORBERG J, 1995, J EXP MAR BIOL ECOL, V186, P207, DOI 10.1016/0022-0981(94)00158-A; Novais A, 2015, SCI TOTAL ENVIRON, V538, P664, DOI 10.1016/j.scitotenv.2015.08.106; Novais A, 2015, MAR ECOL PROG SER, V522, P157, DOI 10.3354/meps11168; OKAMOTO A, 1986, Venus the Japanese Journal of Malacology, V45, P194; Park JK, 2003, MOL PHYLOGENET EVOL, V29, P529, DOI 10.1016/S1055-7903(03)00138-6; Park JK, 2002, MOL CELLS, V14, P318; Pigneur LM, 2012, HEREDITY, V108, P581, DOI 10.1038/hdy.2012.3; Pigneur LM, 2014, MOL ECOL, V23, P5102, DOI 10.1111/mec.12912; Pigneur LM, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-147; PREZANT RS, 1984, SCIENCE, V225, P1491, DOI 10.1126/science.225.4669.1491; Qiu AD, 2001, J SHELLFISH RES, V20, P323; Ren MX, 2005, WEED RES, V45, P236, DOI 10.1111/j.1365-3180.2005.00445.x; Renard E, 2000, MOL ECOL, V9, P2009, DOI 10.1046/j.1365-294X.2000.01104.x; Roman J, 2007, TRENDS ECOL EVOL, V22, P454, DOI 10.1016/j.tree.2007.07.002; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Siripattrawan S, 2000, J MOLLUS STUD, V66, P423, DOI 10.1093/mollus/66.3.423; Sousa R, 2008, ANN LIMNOL-INT J LIM, V44, P85, DOI 10.1051/limn:2008017; Sousa R, 2006, ANN LIMNOL-INT J LIM, V42, P165, DOI 10.1051/limn/2006017; Sousa R, 2007, ESTUAR COAST SHELF S, V74, P166, DOI 10.1016/j.ecss.2007.04.011; Sousa R, 2014, HYDROBIOLOGIA, V735, P233, DOI 10.1007/s10750-012-1409-1; Sousa R, 2012, ANN LIMNOL-INT J LIM, V48, P105, DOI 10.1051/limn/2012003; Sousa R, 2009, BIOL INVASIONS, V11, P2367, DOI 10.1007/s10530-009-9422-7; Stanley SM, 1983, THE MOLLUSCA; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor JD, 2007, ZOOL SCR, V36, P587, DOI 10.1111/j.1463-6409.2007.00299.x; Teles M, 2007, SCI TOTAL ENVIRON, V372, P562, DOI 10.1016/j.scitotenv.2006.10.033; TSOI S C M, 1991, Malacological Review, V24, P25; Tsutsui ND, 2000, P NATL ACAD SCI USA, V97, P5948, DOI 10.1073/pnas.100110397; Vrijenhoek RC, 1998, BIOSCIENCE, V48, P617, DOI 10.2307/1313421; WILLIS GL, 1992, MAR BIOL, V112, P403, DOI 10.1007/BF00356285; Yamada M, 2010, NIPPON SUISAN GAKK, V76, P926, DOI 10.2331/suisan.76.926	96	17	21	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158108	10.1371/journal.pone.0158108	http://dx.doi.org/10.1371/journal.pone.0158108			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391333	Green Published, gold, Green Submitted			2022-12-27	WOS:000380005400030
J	Reynard, LN; Ratnayake, M; Santibanez-Koref, M; Loughlin, J				Reynard, Louise N.; Ratnayake, Madhushika; Santibanez-Koref, Mauro; Loughlin, John			Functional Characterization of the Osteoarthritis Susceptibility Mapping to CHST11-A Bioinformatics and Molecular Study	PLOS ONE			English	Article							GENOME-WIDE; EXPRESSION ANALYSIS; ALLELIC EXPRESSION; CELL-TYPES; CARTILAGE; SOX9; GENE; IDENTIFICATION; INSIGHTS; REVEALS	The single nucleotide polymorphism (SNP) rs835487 is associated with hip osteoarthritis (OA) at the genome-wide significance level and is located within CHST11, which codes for carbohydrate sulfotransferase 11. This enzyme post-translationally modifies proteoglycan prior to its deposition in the cartilage extracellular matrix. Using bioinformatics and experimental analyses, our aims were to characterise the rs835487 association signal and to identify the causal functional variant/s. Database searches revealed that rs835487 resides within a linkage disequilibrium (LD) block of only 2.7 kb and is in LD (r(2) >= 0.8) with six other SNPs. These are all located within intron 2 of CHST11, in a region that has predicted enhancer activity and which shows a high degree of conservation in primates. Luciferase reporter assays revealed that of the seven SNPs, rs835487 and rs835488, which have a pairwise r(2) of 0.962, are the top functional candidates; the haplotype composed of the OA-risk conferring G allele of rs835487 and the corresponding T allele of rs835488 (the G-T haplotype) demonstrated significantly different enhancer activity relative to the haplotype composed of the non-risk A allele of rs835487 and the corresponding C allele of rs835488 (the A-C haplotype) (p < 0.001). Electrophoretic mobility shift assays and supershifts identified several transcription factors that bind more strongly to the risk-conferring G and T alleles of the two SNPs, including SP1, SP3, YY1 and SUB1. CHST11 was found to be upregulated in OA versus non-OA cartilage (p < 0.001) and was expressed dynamically during chondrogenesis. Its expression in adult cartilage did not however correlate with rs835487 genotype. Our data demonstrate that the OA susceptibility is mediated by differential protein binding to the alleles of rs835487 and rs835488, which are located within an enhancer whose target may be CHST11 during chondrogenesis or an alternative gene.	[Reynard, Louise N.; Ratnayake, Madhushika; Loughlin, John] Newcastle Univ, Inst Cellular Med, Musculoskeletal Res Grp, Newcastle Upon Tyne, Tyne & Wear, England; [Santibanez-Koref, Mauro] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Reynard, LN (corresponding author), Newcastle Univ, Inst Cellular Med, Musculoskeletal Res Grp, Newcastle Upon Tyne, Tyne & Wear, England.	louise.reynard@newcastle.ac.uk		Reynard, Louise/0000-0002-6613-1797; Loughlin, John/0000-0003-2018-3361	Arthritis Research UK [19824, 20231]; Medical Research Council; Arthritis Research UK as part of the MRC-Arthritis Research UK Centre for Integrated Research into Musculoskeletal Ageing (CIMA); European Union's Seventh Framework Program for research, technological development and demonstration [305815]; NIHR Newcastle Biomedical Research Centre; MRC [MR/K006312/1] Funding Source: UKRI; Medical Research Council [MR/K006312/1] Funding Source: researchfish; Versus Arthritis [20231, 19824, 20771] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research UK as part of the MRC-Arthritis Research UK Centre for Integrated Research into Musculoskeletal Ageing (CIMA)(Versus Arthritis); European Union's Seventh Framework Program for research, technological development and demonstration; NIHR Newcastle Biomedical Research Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis)	This research was funded by Arthritis Research UK (http://www.arthritisresearchuk.org/; grant codes 19824 and 20231), by the Medical Research Council and Arthritis Research UK as part of the MRC-Arthritis Research UK Centre for Integrated Research into Musculoskeletal Ageing (CIMA; http://www.cimauk.org/), and by the European Union's Seventh Framework Program for research, technological development and demonstration under grant agreement number No. 305815 (D-BOARD; http://www.d-board.eu/dboard/index.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Patient tissue was provided by the Newcastle Bone and Joint Biobank supported by the NIHR Newcastle Biomedical Research Centre awarded to the Newcastle upon Tyne NHS Foundation Trust and Newcastle University. We thank the surgeons and research nurses at the Trust for providing us with access to these samples.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Barter MJ, 2015, STEM CELLS, V33, P3266, DOI 10.1002/stem.2093; Bauer DE, 2013, SCIENCE, V342, P253, DOI 10.1126/science.1242088; Bos SD, 2012, ANN RHEUM DIS, V71, P1254, DOI 10.1136/annrheumdis-2011-200981; Bos SD, 2008, CURR OPIN RHEUMATOL, V20, P553, DOI 10.1097/BOR.0b013e32830aba48; Cortes M, 2009, DEVELOPMENT, V136, P1697, DOI 10.1242/dev.030742; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Egli RJ, 2009, ARTHRITIS RHEUM-US, V60, P2055, DOI 10.1002/art.24616; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x; Gee F, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-53; Gualeni B, 2010, MATRIX BIOL, V29, P453, DOI 10.1016/j.matbio.2010.05.001; Han Y, 2008, MOL CELL BIOL, V28, P4999, DOI 10.1128/MCB.00695-08; Hawker GA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091286; Hunter DJ, 2006, BMJ-BRIT MED J, V332, P639, DOI 10.1136/bmj.332.7542.639; Karlsson C, 2010, OSTEOARTHR CARTILAGE, V18, P581, DOI 10.1016/j.joca.2009.12.002; Kluppel M, 2010, PROG MOL BIOL TRANSL, V93, P113, DOI 10.1016/S1877-1173(10)93006-8; Kluppel M, 2005, DEVELOPMENT, V132, P3989, DOI 10.1242/dev.01948; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Liu CF, 2015, NUCLEIC ACIDS RES, V43, P8183, DOI 10.1093/nar/gkv688; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; Machiela MJ, 2015, BIOINFORMATICS, V31, P3555, DOI 10.1093/bioinformatics/btv402; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Miyamoto Y, 2007, NAT GENET, V39, P529, DOI 10.1038/2005; Murdoch AD, 2007, STEM CELLS, V25, P2786, DOI 10.1634/stemcells.2007-0374; Ohba S, 2015, CELL REP, V12, P229, DOI 10.1016/j.celrep.2015.06.013; Panoutsopoulou K, 2011, ANN RHEUM DIS, V70, P864, DOI 10.1136/ard.2010.141473; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Raine EVA, 2012, ANN RHEUM DIS, V71, P2020, DOI 10.1136/annrheumdis-2012-201304; Reynard LN, 2014, HUM GENET, V133, P1059, DOI 10.1007/s00439-014-1447-z; Reynard LN, 2013, NAT REV RHEUMATOL, V9, P573, DOI 10.1038/nrrheum.2013.121; Rushton MD, 2014, ARTHRITIS RHEUMATOL, V66, P2450, DOI 10.1002/art.38713; Sandell LJ, 2012, NAT REV RHEUMATOL, V8, P77, DOI 10.1038/nrrheum.2011.199; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Styrkarsdottir U, 2014, NAT GENET, V46, P498, DOI 10.1038/ng.2957; Syddall CM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003557; Thiele H, 2004, P NATL ACAD SCI USA, V101, P10155, DOI 10.1073/pnas.0400334101; Ward LD, 2016, NUCLEIC ACIDS RES, V44, pD877, DOI 10.1093/nar/gkv1340; Xu Y, 2012, OSTEOARTHR CARTILAGE, V20, P1029, DOI 10.1016/j.joca.2012.05.006; YANT SR, 1995, NUCLEIC ACIDS RES, V23, P4353, DOI 10.1093/nar/23.21.4353; Yao BJ, 2015, NUCLEIC ACIDS RES, V43, P5394, DOI 10.1093/nar/gkv426; Zeggini E, 2012, LANCET, V380, P815, DOI 10.1016/S0140-6736(12)60681-3; Zou FG, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002707	45	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159024	10.1371/journal.pone.0159024	http://dx.doi.org/10.1371/journal.pone.0159024			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391021	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400195
J	Yang, WJ; Cai, XL; Han, XY; Ji, LN				Yang, Wenjia; Cai, Xiaoling; Han, Xueyao; Ji, Linong			Clinical Characteristics of Young Type 2 Diabetes Patients with Atherosclerosis	PLOS ONE			English	Article							COMPLICATIONS; MELLITUS; CORONARY; STENOSIS; COHORT	Objective The prevalence of type 2 diabetes is increasing rapidly in the young population. The clinical characteristics and risk factors for young type 2 diabetes patients with atherosclerosis are not fully explicated. The aim of the present study was to investigate various clinical and biochemical characteristics of young type 2 diabetic patients with atherosclerosis. Design and Methods This was a cross-sectional study. The study involved 2199 hospitalized patients with type 2 diabetes. The young patients were classified into the atherosclerotic group or the non-atherosclerotic group, and we also enrolled an older group with peripheral atherosclerosis disease and an age of at least 45 years. Comparisons were made between the different groups to investigate the cardiovascular and metabolic risk profiles of young type 2 diabetes patients with atherosclerosis. We also used logistic regression models to assess the atherosclerosis risk factors for young patients. Results Compared to older type 2 diabetes patients with atherosclerosis, young patients with atherosclerosis had more deleterious profiles of weight and hyperlipidemia. Only age and diabetes duration were found to be significant independent risk factors for atherosclerosis in young patients. The ratio of the presence of atherosclerosis in the lower extremity arteries alone was significantly higher in young patients than older patients (26.4% vs. 14.0%, P = 0.000). Conclusion Young type 2 diabetes patients with atherosclerosis have more adverse cardiovascular risk profiles and inadequate control of these risk factors. Lower extremity examination is of high importance in young patients.	[Yang, Wenjia; Cai, Xiaoling; Han, Xueyao; Ji, Linong] Peking Univ, Peoples Hosp, Dept Endocrinol & Metab, Beijing, Peoples R China	Peking University	Ji, LN (corresponding author), Peking Univ, Peoples Hosp, Dept Endocrinol & Metab, Beijing, Peoples R China.	jiln@bjmu.edu.cn	Linong, Ji/AAB-6543-2020	Yang, Wenjia/0000-0003-0610-5121; Cai, Xiaoling/0000-0002-7881-0543	National High Technology Research and Development Program of China [2012AA02A509]; National Key Basic Research Program of China [2011CB504000]; Beijing Science and Technology Committee Funding [D131100005313008]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Key Basic Research Program of China(National Basic Research Program of China); Beijing Science and Technology Committee Funding	This study is supported by National High Technology Research and Development Program of China (2012AA02A509); National Key Basic Research Program of China (2011CB504000) and Beijing Science and Technology Committee Funding (D131100005313008).	Adraktas DD, 2010, STROKE, V41, P1604, DOI 10.1161/STROKEAHA.109.577437; Benhalima K, 2011, PRIM CARE DIABETES, V5, P245, DOI 10.1016/j.pcd.2011.06.003; BOTS ML, 1994, ARTERIOSCLER THROMB, V14, P1885, DOI 10.1161/01.ATV.14.12.1885; CRAVEN TE, 1990, CIRCULATION, V82, P1230, DOI 10.1161/01.CIR.82.4.1230; Feltbower RG, 2003, ARCH DIS CHILD, V88, P676, DOI 10.1136/adc.88.8.676; Gunathilake W, 2010, QJM-INT J MED, V103, P881, DOI 10.1093/qjmed/hcq135; Harron KL, 2011, DIABETES CARE, V34, P652, DOI 10.2337/dc10-1512; Pasterkamp G, 1998, ATHEROSCLEROSIS, V137, P205, DOI 10.1016/S0021-9150(97)00255-4; Song SH, 2009, QJM-INT J MED, V102, P799, DOI 10.1093/qjmed/hcp121; Sosnowski C, 2007, KARDIOL POL, V65, P760; Waernbaum I, 2006, DIABETOLOGIA, V49, P653, DOI 10.1007/s00125-005-0135-x; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yu Li-bo, 2013, Zhonghua Yi Xue Za Zhi, V93, P2143	13	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159055	10.1371/journal.pone.0159055	http://dx.doi.org/10.1371/journal.pone.0159055			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391819	Green Published, gold, Green Submitted			2022-12-27	WOS:000380005400203
J	Liang, CN; Wang, LZ; Wu, XY; Wang, K; Ding, XZ; Wang, MC; Chu, M; Xie, XY; Qiu, Q; Yan, P				Liang, Chunnian; Wang, Lizhong; Wu, Xiaoyun; Wang, Kun; Ding, Xuezhi; Wang, Mingcheng; Chu, Min; Xie, Xiuyue; Qiu, Qiang; Yan, Ping			Genome-wide Association Study Identifies Loci for the Polled Phenotype in Yak	PLOS ONE			English	Article							CATTLE; GENE; SELECTION; INSIGHTS; FORMAT; HORN	The absence of horns, known as the polled phenotype, is an economically important trait in modern yak husbandry, but the genomic structure and genetic basis of this phenotype have yet to be discovered. Here, we conducted a genome-wide association study with a panel of 10 horned and 10 polled yaks using whole genome sequencing. We mapped the POLLED locus to a 200-kb interval, which comprises three protein-coding genes. Further characterization of the candidate region showed recent artificial selection signals resulting from the breeding process. We suggest that expressional variations rather than structural variations in protein probably contribute to the polled phenotype. Our results not only represent the first and important step in establishing the genomic structure of the polled region in yak, but also add to our understanding of the polled trait in bovid species.	[Liang, Chunnian; Wu, Xiaoyun; Chu, Min; Yan, Ping] Chinese Acad Agr Sci, Lanzhou Inst Husb & Pharmaceut Sci, Key Lab Yak Breeding Engn Gansu Prov, Lanzhou, Peoples R China; [Wang, Lizhong; Wang, Kun; Ding, Xuezhi; Wang, Mingcheng; Xie, Xiuyue; Qiu, Qiang] Lanzhou Univ, Coll Life Sci, State Key Lab Grassland Agroecosyst, Lanzhou, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Institute of Husbandry & Pharmaceutical Sciences, CAAS; Lanzhou University	Yan, P (corresponding author), Chinese Acad Agr Sci, Lanzhou Inst Husb & Pharmaceut Sci, Key Lab Yak Breeding Engn Gansu Prov, Lanzhou, Peoples R China.; Qiu, Q (corresponding author), Lanzhou Univ, Coll Life Sci, State Key Lab Grassland Agroecosyst, Lanzhou, Peoples R China.	qiuqiang@lzu.edu.cn; pingyanlz@163.com		wang, lizhong/0000-0002-3571-8771	Agricultural Science and Technology Innovation Program [CAAS-ASTIP-2014-LIHPS-01]; National Beef Cattle Industry Technology System [CARS-38]; National High Technology Research and Development Program of China [2013AA102505 3-2]; National Natural Science Foundation of China [31322052]; Fok Ying Tung Education Foundation [151105]; Fundamental Research Funds for the Central Universities [lzujbky-2016-k04]	Agricultural Science and Technology Innovation Program; National Beef Cattle Industry Technology System; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fok Ying Tung Education Foundation(Fok Ying Tung Education Foundation); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by grants from the Agricultural Science and Technology Innovation Program (www.caas.cn/en/research/research_program/index.shtml; CAAS-ASTIP-2014-LIHPS-01; P.Y.), National Beef Cattle Industry Technology & System (www.beefsys.com/; CARS-38; Q.Q.), the National High Technology Research and Development Program of China (www.most.gov.cn/eng/programmes1/; 2013AA102505 3-2; Q.Q.), the National Natural Science Foundation of China (www.nsfc.gov.cn/; 31322052; Q.Q.), the Fok Ying Tung Education Foundation (www.hydef.edu.cn; 151105; Q.Q.) and the Fundamental Research Funds for the Central Universities (www.moe.edu.cn; lzujbky-2016-k04; Q.Q.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Allais-Bonnet A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063512; Barrett Jeffrey C, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.ip71; Brenneman RA, 1996, J HERED, V87, P156, DOI 10.1093/oxfordjournals.jhered.a022975; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Capitan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049084; Capitan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022242; Carlson DF, 2016, NAT BIOTECHNOL, V34, P479, DOI 10.1038/nbt.3560; Chen H, 2010, GENOME RES, V20, P393, DOI 10.1101/gr.100545.109; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Drouet V, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/289728; GEORGES M, 1993, NAT GENET, V4, P206, DOI 10.1038/ng0693-206; Glatzer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067992; Gotz KU, 2015, LIVEST SCI, V179, P80, DOI 10.1016/j.livsci.2015.05.019; Graf B, 1999, APPL ANIM BEHAV SCI, V62, P153, DOI 10.1016/S0168-1591(98)00218-4; Guo XS, 2014, CRIT REV FOOD SCI, V54, P292, DOI 10.1080/10408398.2011.584134; Han Jianlin R.C., 2000, P 3 INT C YAK HELD L; Harlizius B, 1997, MAMM GENOME, V8, P255, DOI 10.1007/s003359900404; Hong Eun Pyo, 2012, Genomics & Informatics, V10, P117, DOI 10.5808/GI.2012.10.2.117; Lan X, 2012, NUCLEIC ACIDS RES, V40, P7690, DOI 10.1093/nar/gks501; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu WB, 2014, ANIM GENET, V45, P138, DOI 10.1111/age.12081; Mariasegaram M, 2012, ANIM GENET, V43, P683, DOI 10.1111/j.1365-2052.2012.02336.x; Mariasegaram M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-370; Medugorac I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039477; Ohadi M, 2015, AM J PRIMATOL, V77, P34, DOI 10.1002/ajp.22308; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Prayaga KC, 2007, AUST J AGR RES, V58, P1, DOI 10.1071/AR06044; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qiu Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10283; Qiu Q, 2012, NAT GENET, V44, P946, DOI 10.1038/ng.2343; Rothammer S, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-44; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Schaller GB, 1996, BIOL CONSERV, V76, P1, DOI 10.1016/0006-3207(96)85972-6; SCHMUTZ SM, 1995, MAMM GENOME, V6, P710, DOI 10.1007/BF00354293; Seichter D, 2012, ANIM GENET, V43, P595, DOI 10.1111/j.1365-2052.2011.02302.x; Sims D, 2014, NAT REV GENET, V15, P121, DOI 10.1038/nrg3642; Trapani JG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000480; Wang K, 2016, ANIM GENET, V47, P28, DOI 10.1111/age.12377; Wiedemar N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093435; Wiener DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127691; Wiener G, 2003, FAO REGIONAL OFFICE; Windig JJ, 2015, LIVEST SCI, V179, P96, DOI 10.1016/j.livsci.2015.05.021; Wunderlich KR, 2006, ANIM GENET, V37, P592, DOI 10.1111/j.1365-2052.2006.01538.x; Xu X, 2013, CURR BIOL, V23, P1031, DOI 10.1016/j.cub.2013.04.054; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394	47	12	19	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158642	10.1371/journal.pone.0158642	http://dx.doi.org/10.1371/journal.pone.0158642			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27389700	Green Published, gold, Green Submitted			2022-12-27	WOS:000379811500032
J	Makadzange, AT; Bogezi, C; Boyd, K; Gumbo, A; Mukura, D; Matubu, A; Ndhlovu, CE				Makadzange, Azure Tariro; Bogezi, Carola; Boyd, Kathryn; Gumbo, Anesu; Mukura, Dorinda; Matubu, Allen; Ndhlovu, Chiratidzo Ellen			Evaluation of the FACSPresto, a New Point of Care Device for the Enumeration of CD4% and Absolute CD4+T Cell Counts in HIV Infection	PLOS ONE			English	Article							STARTING ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; PERFORMANCE; AFRICA; INITIATION; MORTALITY; SYSTEMS; ADULTS; TESTS; RATES	Introduction Enumeration of CD4+ T lymphocytes is important for pre-ART disease staging and screening for opportunistic infections, however access to CD4 testing in resource limited settings is poor. Point of care (POC) technologies can facilitate improved access to CD4 testing. We evaluated the analytical performance of a novel POC device the FACSPresto compared to the FACSCalibur as a reference standard and to the PIMA, a POC device in widespread use in sub-Saharan Africa. Method Specimens were obtained from 253 HIV infected adults. Venous blood samples were analyzed on the FACSPresto and the FACSCalibur, in a subset of 41 samples additional analysis was done on the PIMA. Results The absolute CD4 count results obtained on the FACSPresto were comparable to those on the FACSCalibur with low absolute (9.5cells/mu l) and relative bias (3.2%). Bias in CD4% values was also low (1.06%) with a relative bias of 4.9%. The sensitivity was lower at a CD4 count threshold of <= 350cells/mu l compared with <= 500cells/mu l (84.9% vs. 92.8%) resulting in a high upward misclassification rate at low CD4 counts. Specificity at thresholds of <= 350cells/mu l and <= 500cells/mu l were 96.6% and 96.8% respectively. The PIMA had a high absolute (-68.6cells/mu l) and relative bias (-10.5%) when compared with the FACSCalibur. At thresholds of <= 350cells/mu l and <= 500cells/mu l the sensitivity was 100% and 95.5% respectively; specificity was 85.7% and 84.2% respectively. The coefficients of repeatability were 4.13%, 5.29% and 9.8% respectively. Discussion The analytic performance of the FACSPresto against the reference standard was very good with better agreement and precision than the PIMA. The FACSPresto had comparable sensitivity at a threshold of 500 cells/mu l and better specificity than the PIMA. However the FACSPresto showed reduced sensitivity at low CD4 count thresholds. Conclusion The FACSPresto can be reliably used as a POC device for enumerating absolute CD4 count and CD4% values.	[Makadzange, Azure Tariro] MIT & Harvard, Ragon Inst MGH, Cambridge, MA 02139 USA; [Makadzange, Azure Tariro; Bogezi, Carola; Boyd, Kathryn; Gumbo, Anesu; Ndhlovu, Chiratidzo Ellen] Univ Zimbabwe, Coll Hlth Sci, Dept Med, Harare, Zimbabwe; [Mukura, Dorinda; Matubu, Allen] Univ Zimbabwe, Coll Hlth Sci, Dept Obstet & Gynecol, UZ UCSF Collaborat Project, Harare, Zimbabwe	Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Zimbabwe; University of Zimbabwe	Makadzange, AT (corresponding author), MIT & Harvard, Ragon Inst MGH, Cambridge, MA 02139 USA.; Makadzange, AT (corresponding author), Univ Zimbabwe, Coll Hlth Sci, Dept Med, Harare, Zimbabwe.	amakadzange@mgh.harvard.edu	Gumbo, Anesu/ABC-2960-2021; Ndhlovu, Chiratidzo Ellen/N-8763-2013	Makadzange, Azure Tariro/0000-0001-5330-1470; Boyd, Kathryn/0000-0001-6290-8020; Ndhlovu, Chiratidzo Ellen/0000-0001-7863-7974	Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Research Resources) [UL1 TR001102]; Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health) [UL1 TR001102]; Harvard University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI104348] Funding Source: NIH RePORTER	Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Research Resources); Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health); Harvard University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was conducted with support from Harvard Catalyst vertical bar The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health Award UL1 TR001102) and financial contributions from Harvard University and its affiliated academic healthcare centers. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic healthcare centers, or the National Institutes of Health.	Bergeron M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041166; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bwana P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145586; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Davies MA, 2014, PEDIATR INFECT DIS J, V33, P608, DOI 10.1097/INF.0000000000000214; Drain PK, 2014, LANCET INFECT DIS, V14, P239, DOI 10.1016/S1473-3099(13)70250-0; Faal M, 2011, JAIDS-J ACQ IMM DEF, V58, pE54, DOI 10.1097/QAI.0b013e3182303921; FAHEY JL, 1990, NEW ENGL J MED, V322, P166, DOI 10.1056/NEJM199001183220305; Fajardo E, 2015, B WORLD HEALTH ORGAN, V93, P623, DOI 10.2471/BLT.14.146480; GOEDERT JJ, 1987, JAMA-J AM MED ASSOC, V257, P331, DOI 10.1001/jama.257.3.331; Hogg RS, 2001, JAMA-J AM MED ASSOC, V286, P2568, DOI 10.1001/jama.286.20.2568; Hyle EP, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001725; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; Jarvis JN, 2009, CLIN INFECT DIS, V48, P856, DOI 10.1086/597262; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Manabe YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034319; Mandy F, 2008, CYTOM PART B-CLIN CY, V74B, pS27, DOI 10.1002/cyto.b.20414; Mfinanga S, 2015, LANCET, V385, P2173, DOI 10.1016/S0140-6736(15)60164-7; Micek MA, 2009, JAIDS-J ACQ IMM DEF, V52, P397, DOI 10.1097/QAI.0b013e3181ab73e2; Mwau M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067612; Nelson LJ, 2014, AIDS, V28, pS217, DOI 10.1097/QAD.0000000000000239; Organization WH, 2013, CONS GUID US ANT DRU, P272; Petersen ML, 2014, AIDS, V28, P2097, DOI 10.1097/QAD.0000000000000349; Phillips A, 2015, NATURE, V528, pS68, DOI 10.1038/nature16046; POLLOCK MA, 1992, ANN CLIN BIOCHEM, V29, P556, DOI 10.1177/000456329202900512; Scott LE, 2003, CYTOM PART B-CLIN CY, V54B, P46, DOI 10.1002/cyto.b.10016; Scott LE, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0396-2; Stevens W, 2008, NAT REV MICROBIOL, V6, pS29, DOI 10.1038/nrmicro2000; Strauss K, 1996, CYTOMETRY, V26, P52; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Wade D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116663; Wade D, 2014, JAIDS-J ACQ IMM DEF, V66, pE98, DOI 10.1097/QAI.0000000000000214; WHO, 2004, SCALING UP ANTIRETRO	34	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0157546	10.1371/journal.pone.0157546	http://dx.doi.org/10.1371/journal.pone.0157546			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27388763	Green Submitted, Green Published, gold			2022-12-27	WOS:000379811500006
J	Benson, JF; Sikich, JA; Riley, SPD				Benson, John F.; Sikich, Jeff A.; Riley, Seth P. D.			Individual and Population Level Resource Selection Patterns of Mountain Lions Preying on Mule Deer along an Urban-Wildland Gradient	PLOS ONE			English	Article							HABITAT SELECTION; PREDATION; COUGARS	Understanding population and individual-level behavioral responses of large carnivores to human disturbance is important for conserving top predators in fragmented landscapes. However, previous research has not investigated resource selection at predation sites of mountain lions in highly urbanized areas. We quantified selection of natural and anthropogenic landscape features by mountain lions at sites where they consumed their primary prey, mule deer (Odocoileus hemionus), in and adjacent to urban, suburban, and rural areas in greater Los Angeles. We documented intersexual and individual-level variation in the environmental conditions present at mule deer feeding sites relative to their availability across home ranges. Males selected riparian woodlands and areas closer to water more than females, whereas females selected developed areas marginally more than males. Females fed on mule deer closer to developed areas and farther from riparian woodlands than expected based on the availability of these features across their home ranges. We suggest that mortality risk for females and their offspring associated with encounters with males may have influenced the different resource selection patterns between sexes. Males appeared to select mule deer feeding sites mainly in response to natural landscape features, while females may have made kills closer to developed areas in part because these are alternative sites where deer are abundant. Individual mountain lions of both sexes selected developed areas more strongly within home ranges where development occurred less frequently. Thus, areas near development may represent a trade-off for mountain lions such that they may benefit from foraging near development because of abundant prey, but as the landscape becomes highly urbanized these benefits may be outweighed by human disturbance.	[Benson, John F.; Riley, Seth P. D.] Univ Calif Los Angeles, Inst Environm & Sustainabil, La Kretz Ctr Calif Conservat Sci, Los Angeles, CA 90095 USA; [Benson, John F.; Sikich, Jeff A.; Riley, Seth P. D.] Natl Pk Serv, Santa Monica Mt Natl Recreat Area, Thousand Oaks, CA 91360 USA	University of California System; University of California Los Angeles; United States Department of the Interior	Benson, JF (corresponding author), Univ Calif Los Angeles, Inst Environm & Sustainabil, La Kretz Ctr Calif Conservat Sci, Los Angeles, CA 90095 USA.; Benson, JF (corresponding author), Natl Pk Serv, Santa Monica Mt Natl Recreat Area, Thousand Oaks, CA 91360 USA.	benson.johnf@gmail.com			La Kretz Center for California Conservation at UCLA; California State Parks; Santa Monica Mountains Fund; Santa Monica Mountains Conservancy/Mountains Recreation and Conservation Authority; Calabasas Landfill; National Park Service	La Kretz Center for California Conservation at UCLA; California State Parks; Santa Monica Mountains Fund; Santa Monica Mountains Conservancy/Mountains Recreation and Conservation Authority; Calabasas Landfill; National Park Service	The authors received funding for this research from the La Kretz Center for California Conservation at UCLA, California State Parks, the Santa Monica Mountains Fund, Santa Monica Mountains Conservancy/Mountains Recreation and Conservation Authority, and the Calabasas Landfill. The funding from the La Kretz Center for California Conservation came in the form of a postdoctoral fellowship for JFB made possible by an endowment from Morton La Kretz to UCLA through the Institute of the Environment and Sustainability. This fellowship was co-funded by the National Park Service. The other organizations noted above provided funding for mountain lion research that were not connected to specific grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the many NPS biologists and interns who assisted with fieldwork, including: J. Moriarty, J. Brown, E.C. York, C. Schoonmaker, E. Lara, C. Bromley, P. Roby, K. McCurdy, J. Fitzgerald, J. Golla, E. Bohling, and J. Dorcy. We thank B. Clarke, D. Kamradt, and L. Lee for assistance with GIS layers. We thank the La Kretz Center for California Conservation at UCLA, California State Parks, the Santa Monica Mountains Fund, Santa Monica Mountains Conservancy/Mountains Recreation and Conservation Authority, and the Calabasas Landfill for funding support.	Anderson CR, 2003, J WILDLIFE MANAGE, V67, P307, DOI 10.2307/3802772; Bank MS, 2002, J ZOOL, V258, P215, DOI 10.1017/S0952836902001334; BEIER P, 1993, CONSERV BIOL, V7, P94, DOI 10.1046/j.1523-1739.1993.07010094.x; BEIER P, 1995, J MAMMAL, V76, P1056, DOI 10.2307/1382599; Beier Paul, 2010, P141; Benson JF, 2013, METHODS ECOL EVOL, V4, P244, DOI 10.1111/2041-210x.12006; Beyer HL, 2010, PHILOS T R SOC B, V365, P2245, DOI 10.1098/rstb.2010.0083; BOWYER RT, 1986, CALIF FISH GAME, V72, P153; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Burdett CL, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00005.1; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CARSON RG, 1987, J WILDLIFE MANAGE, V51, P46, DOI 10.2307/3801627; Conner L. Mike, 2001, P275, DOI 10.1016/B978-012497781-5/50011-6; Conner LM, 2003, ECOLOGY, V84, P526, DOI 10.1890/0012-9658(2003)084[0526:ACODBA]2.0.CO;2; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; DeStefano S, 2003, FRONT ECOL ENVIRON, V1, P95, DOI 10.1890/1540-9295(2003)001[0095:ETEOSW]2.0.CO;2; Dickson BG, 2002, J WILDLIFE MANAGE, V66, P1235, DOI 10.2307/3802956; Elbroch LM, 2012, MAMM BIOL, V77, P377, DOI 10.1016/j.mambio.2012.02.010; Elbroch ML, 2013, PLOS ONE, V8; Ernest HB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107985; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Getz WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000207; Gillies CS, 2006, J ANIM ECOL, V75, P887, DOI 10.1111/j.1365-2656.2006.01106.x; Hebblewhite M, 2008, J APPL ECOL, V45, P834, DOI 10.1111/j.1365-2664.2008.01466.x; Kertson BN, 2011, ECOL APPL, V21, P2866, DOI 10.1890/11-0947.1; Knopff AA, 2014, BIOL CONSERV, V178, P136, DOI 10.1016/j.biocon.2014.07.017; KOEHLER GM, 1991, J MAMMAL, V72, P391, DOI 10.2307/1382112; Lele SR, 2013, J ANIM ECOL, V82, P1183, DOI 10.1111/1365-2656.12141; Logan K. A., 2001, DESERT PUMA; MACARTHUR R, 1966, AM NAT, V100, P319, DOI 10.1086/282425; Mysterud A, 1998, ECOLOGY, V79, P1435, DOI 10.1890/0012-9658(1998)079[1435:FRIHUA]2.0.CO;2; Noss RF, 1996, CONSERV BIOL, V10, P949, DOI 10.1046/j.1523-1739.1996.10040949.x; Riley SPD, 2014, CURR BIOL, V24, P1989, DOI 10.1016/j.cub.2014.07.029; Rotenberry JT, 1998, ECOLOGY, V79, P1160; Ruth TK, 2010, J WILDLIFE MANAGE, V74, P1122, DOI 10.2193/2009-058; Saether BE, 1998, AM NAT, V151, P441, DOI 10.1086/286131; Smith JA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2711; Soule ME, 1998, SCIENCE, V282, P1658, DOI 10.1126/science.282.5394.1658; STACEY PB, 1992, ECOL APPL, V2, P18, DOI 10.2307/1941886; Swenson J.E., 1983, Prairie Naturalist, V15, P97; Vickers WT, 2015, PLOS ONE, V10; Wilmers CC, PLOS ONE, V20138; Wood S., GEN ADDITIVE MODELS	43	29	31	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158006	10.1371/journal.pone.0158006	http://dx.doi.org/10.1371/journal.pone.0158006			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27411098	gold, Green Published			2022-12-27	WOS:000379508300015
J	Bilyk, O; Sekurova, ON; Zotchev, SB; Luzhetskyy, A				Bilyk, Oksana; Sekurova, Olga N.; Zotchev, Sergey B.; Luzhetskyy, Andriy			Cloning and Heterologous Expression of the Grecocycline Biosynthetic Gene Cluster	PLOS ONE			English	Article							STREPTOMYCES-GLOBISPORUS 1912; LANDOMYCIN-E PRODUCTION; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; JADOMYCIN BIOSYNTHESIS; RECOMBINATION CLONING; SELECTIVE ISOLATION; CYANOGENUS S136; COMPLEX GENOMES; TAR CLONING	Transformation-associated recombination (TAR) in yeast is a rapid and inexpensive method for cloning and assembly of large DNA fragments, which relies on natural homologous recombination. Two vectors, based on p15a and F-factor replicons that can be maintained in yeast, E. coli and streptomycetes have been constructed. These vectors have been successfully employed for assembly of the grecocycline biosynthetic gene cluster from Streptomyces sp. Acta 1362. Fragments of the cluster were obtained by PCR and transformed together with the "capture" vector into the yeast cells, yielding a construct carrying the entire gene cluster. The obtained construct was heterologously expressed in S. albus J1074, yielding several grecocycline congeners. Grecocyclines have unique structural moieties such as a dissacharide side chain, an additional amino sugar at the C-5 position and a thiol group. Enzymes from this pathway may be used for the derivatization of known active angucyclines in order to improve their desired biological properties.	[Bilyk, Oksana; Luzhetskyy, Andriy] Saarland Univ Campus, Helmholtz Inst Pharmaceut Res Saarland, Bldg C2-3, D-66123 Saarbrucken, Germany; [Sekurova, Olga N.; Zotchev, Sergey B.] Univ Vienna, Dept Pharmacognosy, A-1090 Vienna, Austria; [Luzhetskyy, Andriy] Univ Saarland, Pharmazeut Biotechnol, Bldg C2-3, D-66123 Saarbrucken, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Saarland University; University of Vienna; Saarland University	Luzhetskyy, A (corresponding author), Saarland Univ Campus, Helmholtz Inst Pharmaceut Res Saarland, Bldg C2-3, D-66123 Saarbrucken, Germany.; Luzhetskyy, A (corresponding author), Univ Saarland, Pharmazeut Biotechnol, Bldg C2-3, D-66123 Saarbrucken, Germany.	andriy.luzhetskyy@helmholtz-hzi.de		Zotchev, Sergey/0000-0002-9324-245X; Sekurova, Olga/0000-0001-5034-2015	ERC starting grant EXPLOGEN [281623]	ERC starting grant EXPLOGEN	This work was supported by the ERC starting grant EXPLOGEN No. 281623 to AL, https://erc.europa.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the ERC starting grant EXPLOGEN No. 281623 to AL.	Aakvik T, 2009, FEMS MICROBIOL LETT, V296, P149, DOI 10.1111/j.1574-6968.2009.01639.x; Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; Bates S, 1998, J BACTERIOL, V180, P6538, DOI 10.1128/JB.180.24.6538-6543.1998; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Berdy J, 2005, J ANTIBIOT, V58, P1, DOI 10.1038/ja.2005.1; Blin K, 2013, NUCLEIC ACIDS RES, V41, pW204, DOI 10.1093/nar/gkt449; Bonet B, 2015, J NAT PROD, V78, P539, DOI 10.1021/np500664q; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Demain AL, 2015, ANTIBIOTICS: CURRENT INNOVATIONS AND FUTURE TRENDS, P65; Du J, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks549; Erb A, 2009, CHEMBIOCHEM, V10, P1392, DOI 10.1002/cbic.200900054; Faust B, 2000, MICROBIOL-UK, V146, P147, DOI 10.1099/00221287-146-1-147; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Green M. R., 2012, MOLECULAR CLONING A; Gromyko O, 2004, J ANTIBIOT, V57, P383, DOI 10.7164/antibiotics.57.383; Han L, 2000, MICROBIOL-UK, V146, P903, DOI 10.1099/00221287-146-4-903; Itou H, 2001, J BIOCHEM-TOKYO, V129, P343, DOI 10.1093/oxfordjournals.jbchem.a002863; Kharel MK, 2012, ORG BIOMOL CHEM, V10, P4256, DOI 10.1039/c2ob07171a; Kharel MK, 2012, CURR OPIN CHEM BIOL, V16, P150, DOI 10.1016/j.cbpa.2012.03.007; Kim JH, 2010, BIOPOLYMERS, V93, P833, DOI 10.1002/bip.21450; Kouprina N, 2008, NAT PROTOC, V3, P371, DOI 10.1038/nprot.2008.5; Kouprina N, 2006, NAT REV GENET, V7, P805, DOI 10.1038/nrg1943; Larionov V, 1996, P NATL ACAD SCI USA, V93, P13925, DOI 10.1073/pnas.93.24.13925; Lee NCO, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv112; Lombo F, 2009, CHEMBIOCHEM, V10, P296, DOI 10.1002/cbic.200800425; Luzhetskyy A, 2006, Genetika, V42, P595; Luzhetskyy A, 2005, CHEMBIOCHEM, V6, P1406, DOI 10.1002/cbic.200500018; Luzhetskyy A, 2005, CHEM BIOL, V12, P725, DOI 10.1016/j.chembiol.2005.05.008; Metsa-Ketela M, 2004, J ANTIBIOT, V57, P502, DOI 10.7164/antibiotics.57.502; OXENDER DL, 1980, P NATL ACAD SCI-BIOL, V77, P1412, DOI 10.1073/pnas.77.3.1412; Palmu K, 2007, CHEMBIOCHEM, V8, P1577, DOI 10.1002/cbic.200700140; Paululat T, 2010, EUR J ORG CHEM, V2010, P2344, DOI 10.1002/ejoc.201000054; PODKOVYROV SM, 1995, GENE, V156, P151, DOI 10.1016/0378-1119(95)00053-9; Rebets Y, 2003, FEMS MICROBIOL LETT, V222, P149, DOI 10.1016/S0378-1097(03)00258-1; Rebets YV, 2006, FEMS MICROBIOL LETT, V256, P30, DOI 10.1111/j.1574-6968.2005.00087.x; Rix U, 2005, CHEMBIOCHEM, V6, P838, DOI 10.1002/cbic.200400395; Ross A. C., 2014, ACS SYNTH BIOL, DOI [10.1021/sb500280q, DOI 10.1021/SB500280Q]; Sambrook J., 1989, MOLECULAR CLONING A; Sekurova ON, 2004, J BACTERIOL, V186, P1345, DOI 10.1128/JB.186.5.1345-1354.2004; TODA S, 1993, J ANTIBIOT, V46, P875, DOI 10.7164/antibiotics.46.875; Trefzer A, 2000, CHEM BIOL, V7, P133, DOI 10.1016/S1074-5521(00)00079-X; Westrich L, 1999, FEMS MICROBIOL LETT, V170, P381, DOI 10.1111/j.1574-6968.1999.tb13398.x; Wexler M, 2005, ENVIRON MICROBIOL, V7, P1917, DOI 10.1111/j.1462-2920.2005.00854.x; Yamanaka K, 2014, P NATL ACAD SCI USA, V111, P1957, DOI 10.1073/pnas.1319584111; Zaburannyi N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-97; Zhang L, 2011, SCI REP-UK, V1, DOI 10.1038/srep00141; Zhang X, 2008, ANTIMICROB AGENTS CH, V52, P574, DOI 10.1128/AAC.00717-07; Zhu LL, 2005, J ORG CHEM, V70, P631, DOI 10.1021/jo0483623	49	45	47	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158682	10.1371/journal.pone.0158682	http://dx.doi.org/10.1371/journal.pone.0158682			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410036	Green Published, gold, Green Submitted			2022-12-27	WOS:000379508300030
J	Chiabotto, G; Bruno, S; Collino, F; Camussi, G				Chiabotto, Giulia; Bruno, Stefania; Collino, Federica; Camussi, Giovanni			Mesenchymal Stromal Cells Epithelial Transition Induced by Renal Tubular Cells-Derived Extracellular Vesicles	PLOS ONE			English	Article							EXOSOME-MEDIATED TRANSFER; CYCLIN D1; MIR-200 FAMILY; AMINOPEPTIDASE-A; GENE-EXPRESSION; REPRESSORS ZEB1; MICRORNAS; MICROVESICLES; MIGRATION; KIDNEY	Mesenchymal-epithelial interactions play an important role in renal tubular morphogenesis and in maintaining the structure of the kidney. The aim of this study was to investigate whether extracellular vesicles (EVs) produced by human renal proximal tubular epithelial cells (RPTECs) may induce mesenchymal-epithelial transition of bone marrow-derived mesenchymal stromal cells (MSCs). To test this hypothesis, we characterized the phenotype and the RNA content of EVs and we evaluated the in vitro uptake and activity of EVs on MSCs. MicroRNA (miRNA) analysis suggested the possible implication of the miR-200 family carried by EVs in the epithelial commitment of MSCs. Bone marrow-derived MSCs were incubated with EVs, or RPTEC-derived total conditioned medium, or conditioned medium depleted of EVs. As a positive control, MSCs were co-cultured in a transwell system with RPTECs. Epithelial commitment of MSCs was assessed by real time PCR and by immunofluorescence analysis of cellular expression of specific mesenchymal and epithelial markers. After one week of incubation with EVs and total conditioned medium, we observed mesenchymal-epithelial transition in MSCs. Stimulation with conditioned medium depleted of EVs did not induce any change in mesenchymal and epithelial gene expression. Since EVs were found to contain the miR-200 family, we transfected MSCs using synthetic miR-200 mimics. After one week of transfection, mesenchymal-epithelial transition was induced in MSCs. In conclusion, miR-200 carrying EVs released from RPTECs induce the epithelial commitment of MSCs that may contribute to their regenerative potential. Based on experiments of MSC transfection with miR-200 mimics, we suggested that the miR-200 family may be involved in mesenchymal-epithelial transition of MSCs.	[Chiabotto, Giulia; Collino, Federica; Camussi, Giovanni] Univ Turin, Dept Med Sci, Sch Med, Turin, Italy; [Bruno, Stefania] Univ Turin, Ctr Mol Biotechnol, Dept Mol Biotechnol & Hlth Sci, Turin, Italy	University of Turin; University of Turin	Camussi, G (corresponding author), Univ Turin, Dept Med Sci, Sch Med, Turin, Italy.	giovanni.camussi@unito.it	Collino, Federica/B-9956-2018; Camussi, Giovanni/J-7624-2016	Collino, Federica/0000-0002-3619-7701; BRUNO, Stefania/0000-0002-8879-9536; Camussi, Giovanni/0000-0003-2795-232X; Chiabotto, Giulia/0000-0002-1420-3517				Aliotta JM, 2007, STEM CELLS, V25, P2245, DOI 10.1634/stemcells.2007-0128; Aliotta JM, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.26166; Aliotta JM, 2012, J EXTRACELL VESICLES, V1, DOI 10.3402/jev.v1i0.18163; Aliotta JM, 2010, EXP HEMATOL, V38, P233, DOI 10.1016/j.exphem.2010.01.002; Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; Baer PC, 2009, CELL PROLIFERAT, V42, P29, DOI 10.1111/j.1365-2184.2008.00572.x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Birn H, 2006, KIDNEY INT, V69, P440, DOI 10.1038/sj.ki.5000141; Bruno S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033115; Bruno S, 2009, J AM SOC NEPHROL, V20, P1053, DOI 10.1681/ASN.2008070798; Campanaro S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-383; Chen X, 2012, TRENDS CELL BIOL, V22, P125, DOI 10.1016/j.tcb.2011.12.001; Chu PG, 2002, HISTOPATHOLOGY, V40, P403, DOI 10.1046/j.1365-2559.2002.01387.x; Collino F, 2015, J AM SOC NEPHROL, V26, P2349, DOI 10.1681/ASN.2014070710; Collino F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011803; Del Tatto M, 2011, EXP HEMATOL, V39, P1072, DOI 10.1016/j.exphem.2011.08.008; Dimuccio V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104490; Eckes B, 1998, J CELL SCI, V111, P1897; Fanni D, 2011, J MATERN-FETAL NEO M, V24, P64, DOI 10.3109/14767058.2011.613159; Gallo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030679; Gibbons DL, 2009, GENE DEV, V23, P2140, DOI 10.1101/gad.1820209; Goto Y, 2006, J BIOL CHEM, V281, P23503, DOI 10.1074/jbc.M603191200; Graham TR, 2008, CANCER RES, V68, P2479, DOI 10.1158/0008-5472.CAN-07-2559; Grange C, 2014, INT J MOL MED, V33, P1055, DOI 10.3892/ijmm.2014.1663; Guarino M, 2007, INT J BIOCHEM CELL B, V39, P2153, DOI 10.1016/j.biocel.2007.07.011; Hogan BLM, 2002, NAT REV GENET, V3, P513, DOI 10.1038/nrg840; Hupkes M, 2014, BMC MOL BIOL, V15, DOI 10.1186/1471-2199-15-1; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; Jang KJ, 2013, INTEGR BIOL-UK, V5, P1119, DOI 10.1039/c3ib40049b; Jiao J, 2013, ONCOTARGETS THER, V6, P667, DOI 10.2147/OTT.S44177; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kanazawa T, 2011, J VET MED SCI, V73, P601, DOI 10.1292/jvms.10-0493; Katakowski M, 2013, CANCER LETT, V335, P201, DOI 10.1016/j.canlet.2013.02.019; Katoh Y, 2008, INT J MOL MED, V22, P271, DOI 10.3892/ijmm_00000019; Kim HJ, 2007, MOL CELL BIOL, V27, P3165, DOI 10.1128/MCB.01315-06; Kim JK, 2009, J CELL PHYSIOL, V220, P292, DOI 10.1002/jcp.21791; Korpal M, 2008, RNA BIOL, V5, P115, DOI 10.4161/rna.5.3.6558; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lee JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084256; Lindoso RS, 2014, STEM CELLS DEV, V23, P1809, DOI 10.1089/scd.2013.0618; Lipschutz JH, 1998, AM J KIDNEY DIS, V31, P383, DOI 10.1053/ajkd.1998.v31.pm9506676; Liu Xia, 2015, Asian Pac J Cancer Prev, V16, P6201; Mani SA, 2007, P NATL ACAD SCI USA, V104, P10069, DOI 10.1073/pnas.0703900104; Martin PJ, 2015, BMC CELL BIOL, V16, DOI 10.1186/s12860-015-0057-5; Mejlvang J, 2007, MOL BIOL CELL, V18, P4615, DOI 10.1091/mbc.E07-05-0406; Messai Y, 2010, INT J ONCOL, V36, P1145, DOI 10.3892/ijo_00000597; Mongroo Perry S, 2010, Cancer Biol Ther, V10, P219; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Neviani P, 2015, FRONT MED-LAUSANNE, V2, DOI 10.3389/fmed.2015.00047; Njock MS, 2015, BLOOD, V125, P3202, DOI 10.1182/blood-2014-11-611046; Nurwidya F, 2014, BIOCHEM BIOPH RES CO, V455, P332, DOI 10.1016/j.bbrc.2014.11.014; Ono M, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005231; Owens DW, 2003, BIOESSAYS, V25, P748, DOI 10.1002/bies.10316; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Papadimou E, 2015, STEM CELL REP, V4, P685, DOI 10.1016/j.stemcr.2015.02.002; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Penfornis P, 2016, INT J CANCER, V138, P14, DOI 10.1002/ijc.29417; Perdigao-Henriques R, 2016, ONCOGENE, V35, P158, DOI 10.1038/onc.2015.69; Quesenberry PJ, 2010, ADV DRUG DELIVER REV, V62, P1141, DOI 10.1016/j.addr.2010.06.001; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Ratajczak J, 2006, LEUKEMIA, V20, P847, DOI 10.1038/sj.leu.2404132; Renzulli JF, 2010, J UROLOGY, V184, P2165, DOI 10.1016/j.juro.2010.06.119; Ridder K, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1008371; ROTHENPIELER UW, 1993, DEVELOPMENT, V119, P711; Shan J, 2009, MOL CELL, V36, P469, DOI 10.1016/j.molcel.2009.10.018; Singaravelu K, 2009, RENAL FAILURE, V31, P492, DOI 10.1080/08860220902928981; Singh R, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-256; Su HF, 2016, TUMOR BIOL, V37, P5355, DOI 10.1007/s13277-015-4393-z; Taliaferro-Smith L, 2015, ONCOTARGET, V6, P4757, DOI 10.18632/oncotarget.3023; Teague EMCO, 2010, HUM REPROD UPDATE, V16, P142, DOI 10.1093/humupd/dmp034; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tobin NP, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-417; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Wan JX, 2012, CELL BIOCHEM FUNCT, V30, P129, DOI 10.1002/cbf.1826; WANG JY, 1993, P NATL ACAD SCI USA, V90, P1222, DOI 10.1073/pnas.90.4.1222; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Xin HQ, 2012, STEM CELLS, V30, P1556, DOI 10.1002/stem.1129; Xu JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114627; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yuan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004722; Zhou J, 2015, ONCOTARGET, V6, P44332, DOI 10.18632/oncotarget.6293	90	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159163	10.1371/journal.pone.0159163	http://dx.doi.org/10.1371/journal.pone.0159163			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27409796	Green Published, gold			2022-12-27	WOS:000379508300062
J	Emary, E; Zawbaa, HM				Emary, E.; Zawbaa, Hossam M.			Impact of Chaos Functions on Modern Swarm Optimizers	PLOS ONE			English	Article							OPTIMIZATION ALGORITHM; FEATURE-SELECTION	Exploration and exploitation are two essential components for any optimization algorithm. Much exploration leads to oscillation and premature convergence while too much exploitation slows down the optimization algorithm and the optimizer may be stuck in local minima. Therefore, balancing the rates of exploration and exploitation at the optimization lifetime is a challenge. This study evaluates the impact of using chaos-based control of exploration/exploitation rates against using the systematic native control. Three modern algorithms were used in the study namely grey wolf optimizer (GWO), antlion optimizer (ALO) and moth-flame optimizer (MFO) in the domain of machine learning for feature selection. Results on a set of standard machine learning data using a set of assessment indicators prove advance in optimization algorithm performance when using variational repeated periods of declined exploration rates over using systematically decreased exploration rates.	[Emary, E.] Cairo Univ, Fac Comp & Informat, Dept Informat Technol, Cairo, Egypt; [Emary, E.] Arab Open Univ, Fac Comp Studies, Dept Comp, Shrouq, Egypt; [Zawbaa, Hossam M.] Beni Suef Univ, Fac Comp & Informat, Dept Informat Technol, Bani Suwayf, Egypt; [Zawbaa, Hossam M.] Univ Babes Bolyai, Fac Math & Comp Sci, Dept Comp Sci, Cluj Napoca, Romania	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Beni Suef University; Babes Bolyai University from Cluj	Zawbaa, HM (corresponding author), Beni Suef Univ, Fac Comp & Informat, Dept Informat Technol, Bani Suwayf, Egypt.; Zawbaa, HM (corresponding author), Univ Babes Bolyai, Fac Math & Comp Sci, Dept Comp Sci, Cluj Napoca, Romania.	hossam.zawbaa@gmail.com	Emary, Eid M/C-6131-2017; Zawbaa, Hossam M./O-6203-2014	Emary, Eid M/0000-0002-9537-2530; Zawbaa, Hossam M./0000-0001-6548-2993	IPROCOM Marie Curie initial training network - People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/ under REA grant [316555]	IPROCOM Marie Curie initial training network - People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/ under REA grant	This work was partially supported by the IPROCOM Marie Curie initial training network, funded through the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007-2013/ under REA grant agreement no. 316555.	Aguirregabiria JM, 2009, CHAOS SOLITON FRACT, V42, P2531, DOI 10.1016/j.chaos.2009.03.196; Bingqun Ren, 2011, Information Technology Journal, V10, P1908, DOI 10.3923/itj.2011.1908.1916; Bucolo M., 2002, IEEE Circuits and Systems Magazine, V2, P4, DOI 10.1109/MCAS.2002.1167624; Chandrashekar G, 2014, COMPUT ELECTR ENG, V40, P16, DOI 10.1016/j.compeleceng.2013.11.024; Chen H., 2013, MATHEMATICAL PROBLEM, V2013; Chizi B., 2009, SURVEY FEATURE SELEC, P1888; Chuang LY, 2011, EXPERT SYST APPL, V38, P12699, DOI 10.1016/j.eswa.2011.04.057; Emary E., 2014, 1ST INTERNATIONAL AF; Frank A., 2010, UCI MACHINE LEARNING; Gholipour A, 2006, NEURAL PROCESS LETT, V24, P217, DOI 10.1007/s11063-006-9021-x; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; Hassanien A.E., 2015, SWARM INTELLIGENCE P; Huang CL, 2009, NEUROCOMPUTING, V73, P438, DOI 10.1016/j.neucom.2009.07.014; Jun-Jie Yang, 2005, Proceedings of 2005 International Conference on Machine Learning and Cybernetics (IEEE Cat. No. 05EX1059), P2977; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Landassuri-Moreno V., 2011, ELECTRONICS ROBOTICS; Li B, 1998, CYBERNET SYST, V29, P409, DOI 10.1080/019697298125678; MARILL T, 1963, IEEE T INFORM THEORY, V9, P11, DOI 10.1109/TIT.1963.1057810; Mirjalili S, 2015, KNOWL-BASED SYST, V89, P228, DOI 10.1016/j.knosys.2015.07.006; Mirjalili S, 2015, ADV ENG SOFTW, V83, P80, DOI 10.1016/j.advengsoft.2015.01.010; Mirjalili S, 2014, ADV ENG SOFTW, V69, P46, DOI 10.1016/j.advengsoft.2013.12.007; Oh IS, 2004, IEEE T PATTERN ANAL, V26, P1424, DOI 10.1109/TPAMI.2004.105; Rice J.A., 2006, MATHEMATICAL STATIST; Shoghian S., 2012, COMP WOLF PACK SEARC, V6; Tavazoei MS, 2007, J COMPUT APPL MATH, V206, P1070, DOI 10.1016/j.cam.2006.09.008; Vohra R, 2012, COMMUNICATION NETWOR, V1, P75; Wang D.F., 2002, FIRST INTERNATIONAL; WHITNEY AW, 1971, IEEE T COMPUT, VC 20, P1100, DOI 10.1109/T-C.1971.223410; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Xin-She Yang, 2012, Unconventional Computation and Natural Computation. Proceedings of the 11th International Conference, UCNC 2012, P240, DOI 10.1007/978-3-642-32894-7_27; Xue B, 2014, APPL SOFT COMPUT, V18, P261, DOI 10.1016/j.asoc.2013.09.018; Xue B, 2013, IEEE T CYBERNETICS, V43, P1656, DOI 10.1109/TSMCB.2012.2227469; [杨琛 YANG Chen], 2008, [仪表技术与传感器, Intstrument Technique and Sensor], P107; Yang X., 2008, NATURE INSPIRED META, V2nd; Yang XS, 2010, STUD COMPUT INTELL, V284, P65, DOI 10.1007/978-3-642-12538-6_6; Zawbaa HM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150652	37	48	49	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158738	10.1371/journal.pone.0158738	http://dx.doi.org/10.1371/journal.pone.0158738			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410691	Green Submitted, Green Published, gold			2022-12-27	WOS:000379508300034
J	Ortega, RA; Carter, ES; Ortega, AE				Ortega, Ryan A.; Carter, Erin S.; Ortega, Albert E.			Nylon 6,6 Nonwoven Fabric Separates Oil Contaminates from Oil-in-Water Emulsions	PLOS ONE			English	Article							PERFORMANCE; POLYAMIDE	Industrial oil spills into aquatic environments can have catastrophic environmental effects. First responders to oil spills along the coast of the Gulf of Mexico in the southern United States have used spunbond nylon fabric bags and fences to separate spilled oil and oil waste from contaminated water. Low area mass density spunbond nylon is capable of sorbing more than 16 times its mass in low viscosity crude oil and more than 26 times its mass in higher viscosity gear lube oil. Nylon bags separated more than 95% of gear lube oil contaminate from a 4.5% oil-in-water emulsion. Field testing of spunbond nylon fences by oil spill first responders has demonstrated the ability of this material to contain the oily contaminate while allowing water to flow through. We hypothesize that the effectiveness of nylon as an oil filter is due to the fact that it is both more oleophilic and more hydrophilic than other commonly used oil separation materials. The nylon traps oil droplets within the fabric or on the surface, while water droplets are free to flow through the fabric to the water on the opposite side of the fabric.	[Ortega, Ryan A.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Carter, Erin S.; Ortega, Albert E.] Cerex Adv Fabr Inc, Pensacola, FL 32533 USA	Vanderbilt University	Ortega, AE (corresponding author), Cerex Adv Fabr Inc, Pensacola, FL 32533 USA.	AEOrtega@Cerex.com			Cerex Advanced Fabrics; Cerex Advanced Fabrics, Inc.	Cerex Advanced Fabrics; Cerex Advanced Fabrics, Inc.	This work was funded in part by a research budget from Cerex Advanced Fabrics, www.cerex.com. Authors EC and AO are research staff employed by Cerex Advanced Fabrics and participated in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for authors EC and AO, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; The authors would like to thank Bart Warner for donating Light Louisiana Sweet crude oil from a private well. This work was supported in part by funding from Cerex Advanced Fabrics, Inc.	Annunciado TR, 2005, MAR POLLUT BULL, V50, P1340, DOI 10.1016/j.marpolbul.2005.04.043; [Anonymous], 2009, SURFACE DESIGN APPL; [Anonymous], 2014, OLEOPHILIC FABRIC BE; [Anonymous], 2014, OLEPHILIC FABRIC FEN; [Anonymous], 2014, OLEOPHILIC FABRIC FE; Bachurova M, 2012, J ENG FIBER FABR, V7, P22; Briscoe BJ, 2000, COLLOID SURFACE A, V163, P151, DOI 10.1016/S0927-7757(99)00309-X; Broje V, 2007, J HAZARD MATER, V148, P136, DOI 10.1016/j.jhazmat.2007.02.017; Chen WJ, 2009, J MEMBRANE SCI, V337, P98, DOI 10.1016/j.memsci.2009.03.029; De Anda AR, 2011, POLYM ENG SCI, V51, P2129, DOI 10.1002/pen.22064; Goss B, 2010, PRACTICAL GUIDE ADHE; Hua FL, 2007, CHEM ENG J, V128, P169, DOI 10.1016/j.cej.2006.10.017; Kohan Melvin I., 1995, NYLON PLASTICS HDB; Kujawinski EB, 2011, ENVIRON SCI TECHNOL, V45, P1298, DOI 10.1021/es103838p; McNutt MK, 2012, P NATL ACAD SCI USA, V109, P20260, DOI 10.1073/pnas.1112139108; Michel J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065087; PARKER JP, 1977, J APPL POLYM SCI, V21, P821, DOI 10.1002/app.1977.070210322; PASTORE CM, 2001, SURFACE CHARACTERIST; Patel SU, 2014, SEP PURIF TECHNOL, V126, P62, DOI 10.1016/j.seppur.2014.02.009; Reed H, 2010, CITY GULF BREEZE DEE; SCHRADER EL, 1991, ENVIRON GEOL WATER S, V17, P157, DOI 10.1007/BF01701571; Telliard WA, 1999, 1664 US EPA; Wang H, 2014, ENVIRON SCI POLLUT R, V21, P1248, DOI 10.1007/s11356-013-2028-8; Wang QJ, 2007, APPL SURF SCI, V253, P9054, DOI 10.1016/j.apsusc.2007.05.030; Zhou JE, 2010, SEP PURIF TECHNOL, V75, P243, DOI 10.1016/j.seppur.2010.08.008	25	12	12	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158493	10.1371/journal.pone.0158493	http://dx.doi.org/10.1371/journal.pone.0158493			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27411088	Green Submitted, Green Published, gold			2022-12-27	WOS:000379508300026
J	Botting, N; Toseeb, U; Pickles, A; Durkin, K; Conti-Ramsden, G				Botting, Nicola; Toseeb, Umar; Pickles, Andrew; Durkin, Kevin; Conti-Ramsden, Gina			Depression and Anxiety Change from Adolescence to Adulthood in Individuals with and without Language Impairment	PLOS ONE			English	Article							FOLLOW-UP; PSYCHOSOCIAL OUTCOMES; EMOTIONAL HEALTH; CONTROL CHILDREN; YOUNG-PEOPLE; DISORDERS; HISTORY; LIFE; PREVALENCE; CHILDHOOD	This prospective longitudinal study aims to determine patterns and predictors of change in depression and anxiety from adolescence to adulthood in individuals with language impairment (LI). Individuals with LI originally recruited at age 7 years and a comparison group of age-matched peers (AMPs) were followed from adolescence (16 years) to adulthood (24 years). We determine patterns of change in depression and anxiety using the Child Manifest Anxiety Scale-Revised (CMAS-R) and Short Moods and Feelings Questionnaire (SMFQ). In addition to examining associations with gender, verbal and nonverbal skills, we use a time-varying variable to investigate relationships between depression and anxiety symptoms and transitions in educational/employment circumstances. The results show that anxiety was higher in participants with LI than age matched peers and remained so from adolescence to adulthood. Individuals with LI had higher levels of depression symptoms than did AMPs at 16 years. Levels in those with LI decreased post-compulsory schooling but rose again by 24 years of age. Those who left compulsory school provision (regardless of school type) for more choice-driven college but who were not in full-time employment or study by 24 years of age were more likely to show this depression pathway. Verbal and nonverbal skills were not predictive of this pattern of depression over time. The typical female vulnerability for depression and anxiety was observed for AMPs but not for individuals with LI. These findings have implications for service provision, career/employment advice and support for individuals with a history of LI during different transitions from adolescence to adulthood.	[Botting, Nicola] City Univ London, Language & Commun Sci, London, England; [Toseeb, Umar] Manchester Metropolitan Univ, Dept Psychol, Manchester, Lancs, England; [Pickles, Andrew] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England; [Durkin, Kevin] Univ Strathclyde, Sch Psychol Sci & Hlth, Glasgow, Lanark, Scotland; [Conti-Ramsden, Gina] Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England	City University London; Manchester Metropolitan University; University of London; King's College London; University of Strathclyde; University of Manchester	Conti-Ramsden, G (corresponding author), Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England.	gina.conti-ramsden@manchester.ac.uk	Pickles, Andrew/A-9625-2011	Pickles, Andrew/0000-0003-1283-0346; Botting, Nicola/0000-0003-1082-9501; Toseeb, Umar/0000-0002-7536-2722	Economic and Social Research Council [RES-062-23-2745]; Nuffield Foundation [EDU-8366, EDU-32083]; Wellcome Trust [060774]; Medical Research Council [G0802307]; National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London; ESRC [ES/I00064X/1] Funding Source: UKRI; MRC [MR/K005863/1, G0600555, G0401546, G0900678, G0802307, MR/J01348X/1, G0400065, G0500272] Funding Source: UKRI; Economic and Social Research Council [ES/I00064X/1] Funding Source: researchfish; Medical Research Council [G0400065, G0401546, G0900678, MR/J01348X/1, MR/K005863/1, G0600555, G0500272] Funding Source: researchfish	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Nuffield Foundation; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London(General Electric); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Sources of funding for GCR are the Economic and Social Research Council (grant RES-062-23-2745), the Nuffield Foundation (EDU-8366 and EDU-32083), and the Wellcome Trust (060774). Sources of funding for AP are the Medical Research Council (G0802307) and the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, SPSS SURVIVAL GUIDE; Arkkila E, 2008, LOGOP PHONIATR VOCO, V33, P179, DOI 10.1080/14015430802088289; Beitchman JH, 1996, J CHILD PSYCHOL PSYC, V37, P961, DOI 10.1111/j.1469-7610.1996.tb01493.x; Beitchman JH, 2001, J AM ACAD CHILD PSY, V40, P75, DOI 10.1097/00004583-200101000-00019; Beitchman JH, 2014, J AM ACAD CHILD PSY, V53, P1102, DOI 10.1016/j.jaac.2014.07.006; Bishop DVM, 2012, CHILD LANG TEACH THE, V28, P259, DOI 10.1177/0265659012459467; Bishop DVM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015112; BISHOP DVM, 1987, J SPEECH HEAR DISORD, V52, P156, DOI 10.1044/jshd.5202.156; Botting N, 2005, J CHILD PSYCHOL PSYC, V46, P317, DOI 10.1111/j.1469-7610.2004.00355.x; Brownlie EB, 2004, J ABNORM CHILD PSYCH, V32, P453, DOI 10.1023/B:JACP.0000030297.91759.74; Butterworth P, 2012, SOC PSYCH PSYCH EPID, V47, P1013, DOI 10.1007/s00127-011-0409-1; Charman T, 2015, INT J LANG COMM DIS, V50, P84, DOI 10.1111/1460-6984.12116; Clegg J, 2005, J CHILD PSYCHOL PSYC, V46, P128, DOI 10.1111/j.1469-7610.2004.00342.x; Collishaw S, 2004, J CHILD PSYCHOL PSYC, V45, P1350, DOI 10.1111/j.1469-7610.2004.00335.x; Conti-Ramsden G, 1999, J SPEECH LANG HEAR R, V42, P1195, DOI 10.1044/jslhr.4205.1195; Conti-Ramsden G, 2008, J CHILD PSYCHOL PSYC, V49, P516, DOI 10.1111/j.1469-7610.2007.01858.x; Conti-Ramsden G, 2012, J SPEECH LANG HEAR R, V55, P1716, DOI 10.1044/1092-4388(2012/10-0182); Conti-Ramsden G, 2009, INT J LANG COMM DIS, V44, P15, DOI 10.1080/13682820801921601; ContiRamsden G, 1997, J SPEECH LANG HEAR R, V40, P765, DOI 10.1044/jslhr.4004.765; COSTELLO EJ, 1988, J AM ACAD CHILD PSY, V27, P726, DOI 10.1097/00004583-198811000-00011; Dolan P, 2008, J ECON PSYCHOL, V29, P94, DOI 10.1016/j.joep.2007.09.001; Durkin K, 2009, INT J LANG COMM DIS, V44, P36, DOI 10.1080/13682820801921510; Howlin P, 2005, AUTISM, V9, P533, DOI 10.1177/1362361305057871; Howlin P, 2000, J CHILD PSYCHOL PSYC, V41, P561, DOI 10.1017/S0021963099005806; Johnson CJ, 2010, AM J SPEECH-LANG PAT, V19, P51, DOI 10.1044/1058-0360(2009/08-0083); Lindsay G, 2012, LANG SPEECH HEAR SER, V43, P445, DOI 10.1044/0161-1461(2012/11-0069); Lindsay G, 2010, INT J LANG COMM DIS, V45, P561, DOI 10.3109/13682820903324910; McLean CP, 2011, J PSYCHIATR RES, V45, P1027, DOI 10.1016/j.jpsychires.2011.03.006; Mok PLH, 2014, J CHILD PSYCHOL PSYC, V55, P516, DOI 10.1111/jcpp.12190; Myers L, 2011, INT J LANG COMM DIS, V46, P739, DOI 10.1111/j.1460-6984.2011.00048.x; Quene H, 2004, SPEECH COMMUN, V43, P103, DOI 10.1016/j.specom 2004.02.004; REYNOLDS CR, 1978, J ABNORM CHILD PSYCH, V6, P271, DOI 10.1007/BF00919131; Semel E., 2006, CLIN EVALUATION LANG, V4th UK ed.; Semel EM, 1987, CLIN EVALUATION LANG; Snowling MJ, 2006, J CHILD PSYCHOL PSYC, V47, P759, DOI 10.1111/j.1469-7610.2006.01631.x; SPSS, 2014, IBM SPSS STAT WIND V; St Clair MC, 2011, J COMMUN DISORD, V44, P186, DOI 10.1016/j.jcomdis.2010.09.004; StataCorp, 2013, STATA STAT SOFTW REL; Stothard SE, 1998, J SPEECH LANG HEAR R, V41, P407, DOI 10.1044/jslhr.4102.407; Thapar A, 2012, LANCET, V379, P1056, DOI 10.1016/S0140-6736(11)60871-4; Tomblin JB, 1997, J SPEECH LANG HEAR R, V40, P1245, DOI 10.1044/jslhr.4006.1245; Toppelberg CO, 2000, J AM ACAD CHILD PSY, V39, P143, DOI 10.1097/00004583-200002000-00011; Wadman R, 2011, INT J LANG COMM DIS, V46, P641, DOI 10.1111/j.1460-6984.2011.00033.x; Wadman R, 2011, J ADOLESCENCE, V34, P421, DOI 10.1016/j.adolescence.2010.06.010; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wechsler D., 1992, WECHSLER INTELLIGENC; Whitehouse AJO, 2009, INT J LANG COMM DIS, V44, P511, DOI 10.1080/13682820802708098; WOOD A, 1995, J CHILD PSYCHOL PSYC, V36, P327, DOI 10.1111/j.1469-7610.1995.tb01828.x; Yew SGK, 2013, J CHILD PSYCHOL PSYC, V54, P516, DOI 10.1111/jcpp.12009	49	20	20	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0156678	10.1371/journal.pone.0156678	http://dx.doi.org/10.1371/journal.pone.0156678			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ9CO	27404489	Green Accepted, Green Published, gold			2022-12-27	WOS:000379508200001
J	Li, XY; Liu, NJ; You, LZ; Ke, XL; Liu, HJ; Huang, ML; Waddington, SR				Li, Xiaoyun; Liu, Nianjie; You, Liangzhi; Ke, Xinli; Liu, Haijun; Huang, Malan; Waddington, Stephen R.			Patterns of Cereal Yield Growth across China from 1980 to 2010 and Their Implications for Food Production and Food Security	PLOS ONE			English	Article							USE EFFICIENCY; WHEAT YIELD; TEMPERATURE; IMPACT; RICE	After a remarkable 86% increase in cereal production from 1980 to 2005, recent crop yield growth in China has been slow. County level crop production data between 1980 and 2010 from eastern and middle China were used to analyze spatial and temporal patterns of rice, wheat and maize yield in five major farming systems that include around 90% of China's cereal production. Site-specific yield trends were assessed in areas where those crops have experienced increasing yield or where yields have stagnated or declined. We find that rice yields have continued to increase on over 12.3 million hectares (m. ha) or 41.8% of the rice area in China between 1980 and 2010. However, yields stagnated on 50% of the rice area (around 14.7 m. ha) over this time period. Wheat yields increased on 13.8 m. ha (58.2% of the total harvest area), but stagnated on around 3.8 m. ha (15.8% of the harvest area). Yields increased on a smaller proportion of the maize area (17.7% of harvest area, 5.3 m. ha), while yields have stagnated on over 54% (16.3 m. ha). Many parts of the lowland rice and upland intensive sub-tropical farming systems were more prone to stagnation with rice, the upland intensive sub-tropical system with wheat, and maize in the temperate mixed system. Large areas where wheat yield continues to rise were found in the lowland rice and temperate mixed systems. Land and water constraints, climate variability, and other environmental limitations undermine increased crop yield and agricultural productivity in these systems and threaten future food security. Technology and policy innovations must be implemented to promote crop yields and the sustainable use of agricultural resources to maintain food security in China. In many production regions it is possible to better match the crop with input resources to raise crop yields and benefits. Investments may be especially useful to intensify production in areas where yields continue to improve. For example, increased support to maize production in southern China, where yields are still rising, seems justified.	[Li, Xiaoyun; Liu, Nianjie; You, Liangzhi; Huang, Malan] Huazhong Agr Univ, Coll Econ & Management, Wuhan 430070, Hubei, Peoples R China; [You, Liangzhi] IFPRI, 2033 K St NW, Washington, DC 20006 USA; [Ke, Xinli] Huazhong Agr Univ, Coll Land Management, Wuhan 430070, Hubei, Peoples R China; [Liu, Haijun] Huazhong Agr Univ, Coll Life Sci & Technol, Wuhan 430070, Hubei, Peoples R China; [Waddington, Stephen R.] Apartado Postal 4-205, Cuernavaca 62451, Morelos, Mexico	Huazhong Agricultural University; CGIAR; International Food Policy Research Institute (IFPRI); Huazhong Agricultural University; Huazhong Agricultural University	Li, XY (corresponding author), Huazhong Agr Univ, Coll Econ & Management, Wuhan 430070, Hubei, Peoples R China.	lixiaoyun@mail.hzau.edu.cn	Liu, Haijun/AFN-0017-2022	Liu, Haijun/0000-0001-7717-893X	Human Social Science Young Fund of the Ministry of Education of China [12YJC630105]; National Natural Science Foundation of China [71203073]; Fund for Modern Agricultural Industry Technology System [nycytx-35]	Human Social Science Young Fund of the Ministry of Education of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fund for Modern Agricultural Industry Technology System	This work was supported by the Human Social Science Young Fund of the Ministry of Education of China (No. 12YJC630105), the National Natural Science Foundation of China (No. 71203073) and Fund for Modern Agricultural Industry Technology System (No. nycytx-35). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandratos N., 2012, 1203 ESA FAO, DOI DOI 10.1016/S0264-8377(03)00047-4; China Institute for Reform and Development, 2010, COMP RUR SURPL LAB T; Clarkson Research Services Ltd, 2015, MARITIME CHINA, V4, P10; Deng XZ, 2015, LAND USE POLICY, V45, P1, DOI 10.1016/j.landusepol.2015.01.007; Dobermann A, 2005, SCI CHINA SER C, V48, P745, DOI 10.1360/062005-268; Fan MS, 2012, J EXP BOT, V63, P13, DOI 10.1093/jxb/err248; Gibbon D., 2001, FARMING SYSTEMS POVE; Gibbon D., 2007, DROUGHT TOLERANT MAI; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Heffer P., 2013, ASSESSMENT FERTILIZE; Huang J, 2008, I CHANGE SUSTAINABLE; Huang JK, 2010, ASIAN J AGRIC DEV, V7, P93; [黄维 Huang Wei], 2010, [地理科学进展, Progress in Geography], V29, P677; Keyzer MA, 2005, ECOL ECON, V55, P187, DOI 10.1016/j.ecolecon.2004.12.002; Li X., 2013, WORLD AGR, V410, P135; Li XY, 2011, FOOD SECUR, V3, P19, DOI 10.1007/s12571-011-0111-x; Lin J, 1996, CAB RES ASIA PROGR P, P161; Liu YanSui, 2009, Scientia Agricultura Sinica, V42, P4269; [刘珍环 Liu Zhenhuan], 2013, [地理学报, Acta Geographica Sinica], V68, P680; Lobell DB, 2005, FIELD CROP RES, V94, P250, DOI 10.1016/j.fcr.2005.01.007; Lobell DB, 2007, ENVIRON RES LETT, V2, P625; Market Early-warning Expert Committee of Ministry of Agriculture, 2015, CHIN AGR OUTL REP 20; Ministiry of Agricultural in China, 2016, CROPP STRUCT ADJ PLA; Morton JF, 2007, P NATL ACAD SCI USA, V104, P19680, DOI 10.1073/pnas.0701855104; National Bureau of Statistics, 2014, CHIN STAT YB; National Development and Reform Commission, 2008, LONG TERM PLANN OUTL; Nicholls N, 1997, NATURE, V387, P484, DOI 10.1038/387484a0; Niu S, 2011, REPORTING REUTE 1106, phttp; Peng SB, 2004, P NATL ACAD SCI USA, V101, P9971, DOI 10.1073/pnas.0403720101; Piao SL, 2009, NATURE, V458, P1009, DOI 10.1038/nature07944; Qi M, 2014, CHINA POPULATION RES, V24, P127; Ray DK, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2296; Shen YanJun, 2011, Zhongguo Shengtai Nongye Xuebao / Chinese Journal of Eco-Agriculture, V19, P1004, DOI 10.3724/SP.J.1011.2011.01004; Tao FL, 2008, CLIM RES, V38, P83, DOI 10.3354/cr00771; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Tong CL, 2003, AGR ECOSYST ENVIRON, V95, P523, DOI 10.1016/S0167-8809(02)00182-2; Vitousek PM, 2009, SCIENCE, V324, P1519, DOI 10.1126/science.1170261; von Braun J, 2008, EUROCHOICES, V7, P30, DOI 10.1111/j.1746-692X.2008.00099.x; VONBRAUN J, 2006, PROMISES CHALLENGES; Waddington SR, 2009, G400836 GCP CGIAR SP; Waddington SR, 2010, FOOD SECUR, V2, P27, DOI 10.1007/s12571-010-0053-8; Wei X., 2015, PLOS ONE, V10; Xu Q, 2010, CHINA LAND SCI, V24, P76; [许月卿 Xu Yueqing], 2005, [北京大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Pekinensis], V41, P265; [徐志宇 Xu Zhiyu], 2013, [南京农业大学学报, Journal of Nanjing Agricultural University], V36, P79; You LZ, 2009, AGR FOREST METEOROL, V149, P1009, DOI 10.1016/j.agrformet.2008.12.004; Zhang FuSuo, 2008, Acta Pedologica Sinica, V45, P915	49	19	25	6	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0159061	10.1371/journal.pone.0159061	http://dx.doi.org/10.1371/journal.pone.0159061			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27404110	Green Submitted, gold, Green Published			2022-12-27	WOS:000379508200031
J	Schwacha, MG; Rani, M; Nicholson, SE; Lewis, AM; Holloway, TL; Sordo, S; Cap, AP				Schwacha, Martin G.; Rani, Meenakshi; Nicholson, Susannah E.; Lewis, Aaron M.; Holloway, Travis L.; Sordo, Salvador; Cap, Andrew P.			Dermal gamma delta T-Cells Can Be Activated by Mitochondrial Damage-Associated Molecular Patterns	PLOS ONE			English	Article							INFLAMMATORY RESPONSE; ANTIGEN RECEPTORS; THERMAL-INJURY; IMMUNE-SYSTEM; UP-REGULATION; BURN INJURY; WOUND SITE; LYMPHOCYTES; MECHANISMS; NECROSIS	Background Gamma delta T-cells have been shown to be important to the early immunoinflammatory response to injury, independent of infection. This unique T-cell population acts to regulate cell trafficking and the release of cytokines and growth factors. We propose this sterile inflammatory response is in part associated with damage associated molecular patterns (DAMPs) generated by major injury, such as burn, and mediated via toll-like receptors (TLRs). It is unknown whether DAMPs can activate resident gamma delta T-cells that reside in skin. Methods Gamma delta T-cells were isolated from the skin of male C57BL/6 mice by enzymatic digestion. Mitochondrial DAMPs (MTDs) were generated from mitochondria isolated from mouse livers by sonication and centrifugation. Dermal gamma delta T-cells were incubated with MTDs (0500 mu g/ml) for 24 hr and cells and supernatants were collected for analysis. Results MTDs activated dermal gamma delta T-cells, as evidenced by increased TLR2 and TLR4 expression following in vitro exposure. MTDs also induced the production of inflammatory cytokines (IL-1 beta, IL-6), and growth factors (PDGF and VEGF) by gamma delta T-cells. Conclusions These findings herein support the concept that MTDs released after tissue/cellular injury are capable of activating dermal gamma delta T-cells. We propose that the activation of this unique T-cell population is central in the initiation of sterile inflammation and also contributes to the subsequent healing processes.	[Schwacha, Martin G.; Rani, Meenakshi; Nicholson, Susannah E.; Lewis, Aaron M.; Holloway, Travis L.; Sordo, Salvador; Cap, Andrew P.] Univ Texas Hlth Sci Ctr San Antonio, Dept Surg, San Antonio, TX 78229 USA; [Schwacha, Martin G.; Cap, Andrew P.] US Army, Inst Surg Res, Blood Res, Ft Sam Houston, TX USA	University of Texas System; University of Texas Health San Antonio	Schwacha, MG (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Surg, San Antonio, TX 78229 USA.; Schwacha, MG (corresponding author), US Army, Inst Surg Res, Blood Res, Ft Sam Houston, TX USA.	Schwacha@uthscsa.edu	Nicholson, Susannah/AAI-2757-2021; Cap, Andrew Peter/GQZ-4426-2022	Holloway, Courtney Jean/0000-0003-3661-1957	National Institutes of Health [GM079122, 5T32GM079085]; UTHSCSA NIH [KL2 TR001118]; UTHSCSA Department of Surgery NIH T32 Training Grant [5T32GM079085]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001118, UL1TR001120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079122, T32GM079085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UTHSCSA NIH; UTHSCSA Department of Surgery NIH T32 Training Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health: GM079122, 5T32GM079085. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; These finding were presented in part at the 38th Annual Conference on Shock in Denver CO. This study was supported by NIH grant GM079122, SEN was supported in part by the UTHSCSA NIH grant KL2 TR001118, and TLH was supported under the UTHSCSA Department of Surgery NIH T32 Training Grant (5T32GM079085). The opinions or assertions contained herein are the private views of the author and are not to be construed as official or as reflecting the views of the Department of the Army or the Department of Defense. The authors declare that they have no competing interests. We thank Qiong Zhang for her excellent technical assistance in the laboratory and LuAnn Kirk for editorial assistance.	Alexander M, 2005, J BURN CARE REHABIL, V26, pS72; Alexander M, 2006, J BURN CARE RES, V27, P18, DOI 10.1097/01.bcr.0000188325.71515.19; ALLISON JP, 1991, ANNU REV IMMUNOL, V9, P679, DOI 10.1146/annurev.iy.09.040191.003335; BOISMENU R, 1994, SCIENCE, V266, P1253, DOI 10.1126/science.7973709; Cairns B, 2006, J TRAUMA, V61, P293, DOI 10.1097/01.ta.0000228969.46633.bb; Campanholle G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068640; Collins LV, 2004, J LEUKOCYTE BIOL, V75, P995, DOI 10.1189/jlb.0703328; Daniel T, 2007, SHOCK, V28, P278, DOI 10.1097/shk.0b013e318034264c; Flohe SB, 2008, INNATE IMMUN-LONDON, V14, P333, DOI 10.1177/1753425908100016; Foell D, 2007, NAT CLIN PRACT RHEUM, V3, P382, DOI 10.1038/ncprheum0531; FU YX, 1994, J IMMUNOL, V153, P3101; Girardi M, 2002, J EXP MED, V195, P855, DOI 10.1084/jem.20012000; HAAS W, 1993, ANNU REV IMMUNOL, V11, P637, DOI 10.1146/annurev.immunol.11.1.637; HAVRAN WL, 1991, SCIENCE, V252, P1430, DOI 10.1126/science.1828619; Havran WL, 2005, AM J PHYSIOL-GASTR L, V289, pG627, DOI 10.1152/ajpgi.00224.2005; He J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124469; Hwang PF, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-92; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; Krysko DV, 2011, TRENDS IMMUNOL, V32, P157, DOI 10.1016/j.it.2011.01.005; Lopez RD, 2002, IMMUNOL RES, V26, P207, DOI 10.1385/IR:26:1-3:207; MacLeod AS, 2011, CELL MOL LIFE SCI, V68, P2399, DOI 10.1007/s00018-011-0702-x; Manfredi AA, 2009, CRIT REV IMMUNOL, V29, P69, DOI 10.1615/CritRevImmunol.v29.i1.30; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Matsushima A, 2004, SHOCK, V22, P11, DOI 10.1097/01.shk.0000129203.84330.b3; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Nakahira K, 2015, ANTIOXID REDOX SIGN, V23, P1329, DOI 10.1089/ars.2015.6407; NISHIMURA H, 1995, EUR J IMMUNOL, V25, P1465, DOI 10.1002/eji.1830250551; Oppeltz RF, 2012, CYTOKINE, V60, P528, DOI 10.1016/j.cyto.2012.07.003; Rani M, 2011, SHOCK, V35, P47; Rani M, 2016, J BURN CARE RES, V37, pS290; Rani M, 2015, INNATE IMMUN-LONDON, V21, P140, DOI 10.1177/1753425913519350; Rani M, 2014, SHOCK, V42, P133, DOI 10.1097/SHK.0000000000000176; Rani M, 2014, J BURN CARE RES, V35, P46, DOI 10.1097/01.bcr.0000440705.91099.cc; Schwacha MG, 2014, INNATE IMMUN-LONDON, V20, P261, DOI 10.1177/1753425913488969; Schwacha MG, 2009, BURNS, V35, P318, DOI 10.1016/j.burns.2008.08.002; Schwacha MG, 2008, CYTOKINE, V44, P328, DOI 10.1016/j.cyto.2008.09.001; Schwacha MG, 2000, J LEUKOCYTE BIOL, V67, P644, DOI 10.1002/jlb.67.5.644; Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Tadema H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024315; Toth B, 2004, J LEUKOCYTE BIOL, V76, P545, DOI 10.1189/jlb.0404219; Zhang JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108156; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	45	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0158993	10.1371/journal.pone.0158993	http://dx.doi.org/10.1371/journal.pone.0158993			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27403524	Green Published, gold, Green Submitted			2022-12-27	WOS:000379508200026
J	Zimmer, HC; Offord, CA; Auld, TD; Baker, PJ				Zimmer, Heidi C.; Offord, Catherine A.; Auld, Tony D.; Baker, Patrick J.			Establishing a Wild, Ex Situ Population of a Critically Endangered Shade-Tolerant Rainforest Conifer: A Translocation Experiment	PLOS ONE			English	Article							PINE WOLLEMIA-NOBILIS; SEEDLING SURVIVAL; ROOT DEFORMATION; WETNESS DURATION; BLISTER RUST; LOGGING GAPS; CANOPY GAPS; GROWTH; LIGHT; RESTORATION	Translocation can reduce extinction risk by increasing population size and geographic range, and is increasingly being used in the management of rare and threatened plant species. A critical determinant of successful plant establishment is light environment. Wollemia nobilis (Wollemi pine) is a critically endangered conifer, with a wild population of 83 mature trees and a highly restricted distribution of less than 10 km(2). We used under-planting to establish a population of W. nobilis in a new rainforest site. Because its optimal establishment conditions were unknown, we conducted an experimental translocation, planting in a range of different light conditions from deeply shaded to high light gaps. Two years after the experimental translocation, 85% of plants had survived. There were two distinct responses: very high survival (94%) but very low growth, and lower survival (69%) and higher growth, associated with initial plant condition. Overall survival of translocated W. nobilis was strongly increased in planting sites with higher light, in contrast to previous studies demonstrating long-term survival of wild W. nobilis juveniles in deep shade. Trans location by under-planting may be useful in establishing new populations of shade-tolerant plant species, not least by utilizing the range of light conditions that occur in forest understories.	[Zimmer, Heidi C.; Baker, Patrick J.] Univ Melbourne, Sch Ecosyst & Forest Sci, Richmond, Vic, Australia; [Offord, Catherine A.] Australian Bot Garden, Royal Bot Gardens & Domain Trust, Australian PlantBank, Mt Annan, NSW, Australia; [Auld, Tony D.] Off Environm & Heritage NSW, Hurstville, NSW, Australia; [Auld, Tony D.] Univ New South Wales, Ctr Ecosyst Sci, Sydney, NSW, Australia	University of Melbourne; Office of Environment & Heritage - New South Wales; University of New South Wales Sydney	Zimmer, HC (corresponding author), Univ Melbourne, Sch Ecosyst & Forest Sci, Richmond, Vic, Australia.	Heidi.Zimmer@gmail.com		Zimmer, Heidi/0000-0002-8496-7360; Auld, Tony/0000-0002-8766-2829; Baker, Patrick/0000-0002-6560-7124	Australian Research Council Future Fellowship [FT120100715]; Australian Postgraduate Award; Wollemi Pine Recovery Team	Australian Research Council Future Fellowship(Australian Research Council); Australian Postgraduate Award(Australian Government); Wollemi Pine Recovery Team	PJB was supported by an Australian Research Council Future Fellowship (FT120100715). HCZ's doctoral research is funded by an Australian Postgraduate Award and the Wollemi Pine Recovery Team. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amponsah N. T., 2010, New Zealand Plant Protection, V63, P28; Aoki T, 2013, MYCOLOGIA, V105, P312, DOI 10.3852/12-262; ARAUZ LF, 1989, PHYTOPATHOLOGY, V79, P440, DOI 10.1094/Phyto-79-440; Ashton MS, 2001, FOREST ECOL MANAG, V154, P409, DOI 10.1016/S0378-1127(01)00512-6; Ashton PMS, 1997, J APPL ECOL, V34, P915, DOI 10.2307/2405282; Baryla A, 2001, PLANTA, V212, P696, DOI 10.1007/s004250000439; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Benson John, 2007, Cunninghamia, V10, P255; Brandeis TJ, 2001, CAN J FOREST RES, V31, P302, DOI 10.1139/cjfr-31-2-302; Bullock S, 2000, AUSTRALAS PLANT PATH, V29, P211, DOI 10.1071/AP00037; Burrows GE, 2007, ANN BOT-LONDON, V99, P609, DOI 10.1093/aob/mcm003; CANHAM CD, 1988, ECOLOGY, V69, P786, DOI 10.2307/1941027; Chambers TC, 1998, INT J PLANT SCI, V159, P160, DOI 10.1086/297534; Cole E, 2009, CAN J FOREST RES, V39, P580, DOI 10.1139/X08-198; Coopman RE, 2008, TREE PHYSIOL, V28, P1561, DOI 10.1093/treephys/28.10.1561; Crutsinger GM, 2006, SCIENCE, V313, P966, DOI 10.1126/science.1128326; Dalrymple SE, 2013, RESTOR ECOL, V21, P156, DOI 10.1111/j.1526-100X.2012.00932.x; Davis AS, 2005, NEW FOREST, V30, P295, DOI 10.1007/s11056-005-7480-y; Delcamp M, 2008, J VEG SCI, V19, P209, DOI 10.3170/2008-8-18360; Dey DC, 2012, NEW FOREST, V43, P955, DOI 10.1007/s11056-012-9330-z; Drayton B, 2012, RESTOR ECOL, V20, P299, DOI 10.1111/j.1526-100X.2011.00860.x; Dreistadt SH, 2008, PESTS LANDSCAPE TREE; Dumroese RK, 2013, NEW FOREST, V44, P881, DOI 10.1007/s11056-013-9377-5; Erefur C, 2011, NEW FOREST, V41, P263, DOI 10.1007/s11056-010-9226-8; Fahey RT, 2013, FOREST ECOL MANAG, V292, P139, DOI 10.1016/j.foreco.2012.12.026; Frazer G.W., 1999, GAP LIGHT ANAL GLA; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Guerrant EO, 2007, AUST J BOT, V55, P362, DOI 10.1071/BT06033; HALTER MR, 1993, FOREST ECOL MANAG, V56, P131, DOI 10.1016/0378-1127(93)90108-Y; Hardham AR, 2005, MOL PLANT PATHOL, V6, P589, DOI 10.1111/J.1364-3703.2005.00308.X; Hill KD, 1997, AUST J BOT, V45, P817, DOI 10.1071/BT96053; Hubbell SP, 1999, SCIENCE, V283, P554, DOI 10.1126/science.283.5401.554; Jackson ST, 2000, PALEOBIOLOGY, V26, P194, DOI 10.1666/0094-8373(2000)26[194:ROPPAC]2.0.CO;2; JOHNSON PS, 1984, CAN J FOREST RES, V14, P536, DOI 10.1139/x84-099; Jones W. G., 1995, Telopea, V6, P173; Jorgensen D, 2011, RESTOR ECOL, V19, P705, DOI 10.1111/j.1526-100X.2011.00834.x; Khurana E, 2001, ENVIRON CONSERV, V28, P39, DOI 10.1017/S0376892901000042; Kobe RK, 1999, ECOLOGY, V80, P187, DOI 10.1890/0012-9658(1999)080[0187:LGPATT]2.0.CO;2; Krause GH, 2001, PLANT CELL ENVIRON, V24, P1345, DOI 10.1046/j.0016-8025.2001.00786.x; Lefcheck J, R SQUARED GEN LINEAR; Lindstrom A, 1999, PLANT SOIL, V217, P29, DOI 10.1023/A:1004662127182; Maas-Hebner KG, 2005, FOREST ECOL MANAG, V208, P331, DOI 10.1016/j.foreco.2005.01.013; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; Macphail MK, 1995, GEOL TODAY, V11, P48; Man RZ, 2009, FOREST ECOL MANAG, V258, P1225, DOI 10.1016/j.foreco.2009.06.012; Mano J, 2000, OXIDATIVE STRESS PLA, P217; Maschinski J., 2012, PLANT REINTRODUCTION; Maschinski J, 2007, BIOL CONSERV, V134, P122, DOI 10.1016/j.biocon.2006.07.012; MAUNDER M, 1992, BIODIVERS CONSERV, V1, P51, DOI 10.1007/BF00700250; MCCONNAUGHAY KDM, 1991, ECOLOGY, V72, P94, DOI 10.2307/1938905; Mengel K., 1995, Iron nutrition in soils and plants. Proceedings of the Seventh International Symposium Zaragoza, Spain, 27 June-2 July 1993., P389; MICHAILIDES TJ, 1992, PHYTOPATHOLOGY, V82, P1399, DOI 10.1094/Phyto-82-1399; Muller H, 2013, BIODIVERS CONSERV, V22, P1837, DOI 10.1007/s10531-013-0504-6; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Murcia C, 2014, RESTOR ECOL, V22, P279, DOI 10.1111/rec.12100; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Navarro-Cerrillo RM, 2011, FOREST ECOL MANAG, V262, P2271, DOI 10.1016/j.foreco.2011.08.020; New South Wales Government DOC, 2006, WOLL PIN REC PLAN, P1; Nobis M, 2005, AGR FOREST METEOROL, V128, P243, DOI 10.1016/j.agrformet.2004.10.002; Offord CA, 1999, ANN BOT-LONDON, V84, P1, DOI 10.1006/anbo.1999.0882; Offord CA, 2014, AOB PLANTS, V6, DOI 10.1093/aobpla/plu011; Paquette A, 2006, ECOL APPL, V16, P1575, DOI 10.1890/1051-0761(2006)016[1575:SAGOUT]2.0.CO;2; Parrotta JA, 1997, FOREST ECOL MANAG, V99, P1, DOI 10.1016/S0378-1127(97)00190-4; Peakall R, 2003, MOL ECOL, V12, P2331, DOI 10.1046/j.1365-294X.2003.01926.x; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Rigg JL, 2016, PLANT SOIL IN PRESS; Romell E, 2008, FOREST ECOL MANAG, V255, P1452, DOI 10.1016/j.foreco.2007.11.003; Rout TM, 2007, ECOL MODEL, V201, P67, DOI 10.1016/j.ecolmodel.2006.07.022; Ruger N, 2009, J ECOL, V97, P1360, DOI 10.1111/j.1365-2745.2009.01552.x; RUEHLE JL, 1985, CAN J FOREST RES, V15, P586, DOI 10.1139/x85-095; Schulze M, 2008, FOREST ECOL MANAG, V255, P866, DOI 10.1016/j.foreco.2007.09.082; Seddon PJ, 2010, RESTOR ECOL, V18, P796, DOI 10.1111/j.1526-100X.2010.00724.x; Sinclair W. A., 1987, Diseases of trees and shrubs.; Slippers B, 2005, AUSTRALAS PLANT PATH, V34, P213, DOI 10.1071/AP05020; Smith CM, 2013, CAN J FOREST RES, V43, P90, DOI 10.1139/cjfr-2012-0127; Smith JA, 2011, PLANT DIS, V95, P633, DOI 10.1094/PDIS-10-10-0703; Smith JP, 2000, WEST N AM NATURALIST, V60, P165; South DB, 2005, FOREST ECOL MANAG, V204, P385, DOI 10.1016/j.foreco.2004.09.016; Stewart James D., 2000, Western Journal of Applied Forestry, V15, P177; Therneau T, PACKAGE SURVIVAL ANA; Vallee L., 2004, GUIDELINES TRANSLOCA; Webber BL, 2011, TRENDS ECOL EVOL, V26, P495, DOI 10.1016/j.tree.2011.06.007; WHITMORE TC, 1989, ECOLOGY, V70, P536, DOI 10.2307/1940195; Young TP, 2005, ECOL LETT, V8, P662, DOI 10.1111/j.1461-0248.2005.00764.x; Zaczek JJ, 1997, NEW FOREST, V13, P177, DOI 10.1023/A:1006578007777; Zimmer HC, 2014, BIODIVERS CONSERV, V23, P203, DOI 10.1007/s10531-013-0593-2	86	5	5	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0157559	10.1371/journal.pone.0157559	http://dx.doi.org/10.1371/journal.pone.0157559			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27403527	Green Published, Green Submitted, gold			2022-12-27	WOS:000379508200004
J	Antoniou, M; Ettlinger, M; Wong, PCM				Antoniou, Mark; Ettlinger, Marc; Wong, Patrick C. M.			Complexity, Training Paradigm Design, and the Contribution of Memory Subsystems to Grammar Learning	PLOS ONE			English	Article							SHORT-TERM-MEMORY; WORKING-MEMORY; INDIVIDUAL-DIFFERENCES; DECLARATIVE/PROCEDURAL MODEL; 2ND-LANGUAGE ACQUISITION; CORRECTIVE FEEDBACK; ARTIFICIAL LANGUAGE; PROCEDURAL MEMORY; TASK COMPLEXITY; STARTING SMALL	Although there is variability in nonnative grammar learning outcomes, the contributions of training paradigm design and memory subsystems are not well understood. To examine this, we presented learners with an artificial grammar that formed words via simple and complex morphophonological rules. Across three experiments, we manipulated training paradigm design and measured subjects' declarative, procedural, and working memory subsystems. Experiment 1 demonstrated that passive, exposure-based training boosted learning of both simple and complex grammatical rules, relative to no training. Additionally, procedural memory correlated with simple rule learning, whereas declarative memory correlated with complex rule learning. Experiment 2 showed that presenting corrective feedback during the test phase did not improve learning. Experiment 3 revealed that structuring the order of training so that subjects are first exposed to the simple rule and then the complex improved learning. The cumulative findings shed light on the contributions of grammatical complexity, training paradigm design, and domain-general memory subsystems in determining grammar learning success.	[Antoniou, Mark] Univ Western Sydney, MARCS Inst Brain Behav & Dev, Sydney, NSW, Australia; [Ettlinger, Marc] Dept Vet Affairs Northern Calif Heath Care Syst, Davis, CA USA; [Wong, Patrick C. M.] Chinese Univ Hong Kong, Dept Linguist & Modern Languages, Shatin, Hong Kong, Peoples R China; [Wong, Patrick C. M.] Chinese Univ Hong Kong, Brain & Mind Inst, Shatin, Hong Kong, Peoples R China	Western Sydney University; Chinese University of Hong Kong; Chinese University of Hong Kong	Wong, PCM (corresponding author), Chinese Univ Hong Kong, Dept Linguist & Modern Languages, Shatin, Hong Kong, Peoples R China.; Wong, PCM (corresponding author), Chinese Univ Hong Kong, Brain & Mind Inst, Shatin, Hong Kong, Peoples R China.	p.wong@cuhk.edu.hk	Antoniou, Mark/L-7724-2017	Antoniou, Mark/0000-0001-7735-573X; Wong, Patrick/0000-0002-6105-5027	US National Institutes of Health [R01DC008333, R01DC013315]; Hong Kong University Grants Committee [GRF 477513, 14117514]; Dr. Stanley Ho Medical Development Foundation; VA RRD Grant [1IK2RX000974]; Australian Research Council [DE150101053]	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hong Kong University Grants Committee; Dr. Stanley Ho Medical Development Foundation; VA RRD Grant; Australian Research Council(Australian Research Council)	This research was supported by the US National Institutes of Health grants R01DC008333 (P.W.) and R01DC013315 (B.C. & P.W.), the Hong Kong University Grants Committee (GRF 477513 and 14117514) (P.W.), Dr. Stanley Ho Medical Development Foundation (P.W.), VA RR&D Grant 1IK2RX000974 (M.E.), and Australian Research Council Discovery Early Career Research Award DE150101053 (M.A).	Abrahamsson N, 2009, LANG LEARN, V59, P249, DOI 10.1111/j.1467-9922.2009.00507.x; [Anonymous], 2004, PHONETICALLY BASED P; [Anonymous], 1991, STUD SECOND LANG ACQ, DOI DOI 10.1017/S0272263100010287; Antoniou M, 2015, J ACOUST SOC AM, V138, P571, DOI 10.1121/1.4923362; Antoniou M, 2015, J SPEECH LANG HEAR R, V58, P722, DOI 10.1044/2015_JSLHR-S-14-0259; Atkins PWB, 1998, APPL PSYCHOLINGUIST, V19, P537, DOI 10.1017/S0142716400010353; Baddeley A, 1998, PSYCHOL REV, V105, P158, DOI 10.1037/0033-295X.105.1.158; Baddeley A, 2003, J COMMUN DISORD, V36, P189, DOI 10.1016/S0021-9924(03)00019-4; BERKO J, 1958, WORD, V14, P150, DOI 10.1080/00437956.1958.11659661; Boeckx Cedric, 2007, UNDERSTANDING MINIMA; Christiansen MH, 2008, BEHAV BRAIN SCI, V31, P489, DOI 10.1017/S0140525X08004998; Conway CM, 2003, PROCEEDINGS OF THE TWENTY-FIFTH ANNUAL CONFERENCE OF THE COGNITIVE SCIENCE SOCIETY, PTS 1 AND 2, P270; Damasio H, 1996, NATURE, V380, P499, DOI 10.1038/380499a0; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; Eichenbaum H, 2001, FROM CONDITIONING TO; Ellis N. C., 1996, STUDIES 2 LANGUAGE A, V18, P91, DOI [10.1017/S0272263100014698, DOI 10.1017/S0272263100014698]; Ellis R., 2005, SYSTEM, V33, P209, DOI DOI 10.1016/J.SYSTEM.2004.12.006; Elman JL, 2005, TRENDS COGN SCI, V9, P111, DOI 10.1016/j.tics.2005.01.005; ELMAN JL, 1993, COGNITION, V48, P71, DOI 10.1016/0010-0277(93)90058-4; Ettlinger M, 2014, APPL PSYCHOLINGUIST, V35, P807, DOI 10.1017/S0142716412000586; Ettlinger M, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00211; Fedorenko E, 2006, J MEM LANG, V54, P541, DOI 10.1016/j.jml.2005.12.006; Ferreira VS, 2008, PSYCHOL SCI, V19, P940, DOI 10.1111/j.1467-9280.2008.02180.x; Fyfe ER, 2015, INSTR SCI, V43, P73, DOI 10.1007/s11251-014-9323-8; Gagne R, 1985, COND LEARN, V4th; Gathercole SE, 1999, APPL COGNITIVE PSYCH, V13, P65, DOI 10.1002/(SICI)1099-0720(199902)13:1<65::AID-ACP548>3.0.CO;2-O; Gibbons P., 2013, ROUTLEDGE ENCY 2 LAN, P563; Gibbons P., 2015, SCAFFOLDING LANGUAGE, V2nd; Gierut JA, 2007, AM J SPEECH-LANG PAT, V16, P6, DOI 10.1044/1058-0360(2007/003); Golestani N, 2009, BRAIN LANG, V109, P55, DOI 10.1016/j.bandl.2008.01.005; Gomez RL, 1997, COGNITIVE PSYCHOL, V33, P154, DOI 10.1006/cogp.1997.0654; Goo J, 2012, STUD SECOND LANG ACQ, V34, P445, DOI 10.1017/S0272263112000149; Goudbeek M, 2008, SPEECH COMMUN, V50, P109, DOI 10.1016/j.specom.2007.07.003; Hammond J., 2005, TEACHER VOICES 8 EXP; Hamrick P, 2015, LEARN INDIVID DIFFER, V44, P9, DOI 10.1016/j.lindif.2015.10.003; HARE M, 1995, COGNITION, V56, P61, DOI 10.1016/0010-0277(94)00655-5; Herzog MH, 1997, VISION RES, V37, P2133, DOI 10.1016/S0042-6989(97)00043-6; Kaushanskaya M, 2009, J EXP PSYCHOL LEARN, V35, P829, DOI 10.1037/a0015275; Kersten AW, 2001, J MEM LANG, V44, P250, DOI 10.1006/jmla.2000.2751; Kim Y, 2015, STUD SECOND LANG ACQ, V37, P549, DOI 10.1017/S0272263114000618; Kiran S, 2007, AM J SPEECH-LANG PAT, V16, P18, DOI 10.1044/1058-0360(2007/004); Knowlton BJ, 1996, SCIENCE, V273, P1399, DOI 10.1126/science.273.5280.1399; Kondaurova MV, 2008, J ACOUST SOC AM, V124, P3959, DOI 10.1121/1.2999341; Lai J, 2013, J COGN PSYCHOL, V25, P423, DOI 10.1080/20445911.2013.779247; Lai J, 2011, COGNITION, V118, P265, DOI 10.1016/j.cognition.2010.11.011; Linck JA, 2014, PSYCHON B REV, V21, P861, DOI 10.3758/s13423-013-0565-2; Mackey A., 2002, INDIVIDUAL DIFFERENC, P181, DOI [DOI 10.1075/LLLT.2, DOI 10.1075/LLLT.2.12MAC]; Mackey A, 2010, LANG LEARN, V60, P501, DOI 10.1111/j.1467-9922.2010.00565.x; Martin KI, 2012, STUD SECOND LANG ACQ, V34, P379, DOI 10.1017/S0272263112000125; Metcalfe J, 2009, MEM COGNITION, V37, P1077, DOI 10.3758/MC.37.8.1077; MIYAKE A, 1994, J MEM LANG, V33, P175, DOI 10.1006/jmla.1994.1009; Morgan-Short K, 2015, STUD SECOND LANG ACQ, V37, P383, DOI 10.1017/S0272263115000030; Morgan-Short K, 2014, BILING-LANG COGN, V17, P56, DOI 10.1017/S1366728912000715; Morgan-Short K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032974; Morgan-Short K, 2010, LANG LEARN, V60, P154, DOI 10.1111/j.1467-9922.2009.00554.x; Murphy GL, 2012, J MEM LANG, V67, P521, DOI 10.1016/j.jml.2012.07.005; Opitz B, 2003, NEUROIMAGE, V19, P1730, DOI 10.1016/S1053-8119(03)00170-8; Opitz B, 2004, J NEUROSCI, V24, P8436, DOI 10.1523/JNEUROSCI.2220-04.2004; Opitz B, 2007, HUM BRAIN MAPP, V28, P585, DOI 10.1002/hbm.20287; PAPAGNO C, 1991, J MEM LANG, V30, P331, DOI 10.1016/0749-596X(91)90040-Q; Parbery-Clark A, 2009, EAR HEARING, V30, P653, DOI 10.1097/AUD.0b013e3181b412e9; Perrachione TK, 2007, NEUROPSYCHOLOGIA, V45, P1899, DOI 10.1016/j.neuropsychologia.2006.11.015; Phillips LH, 1999, MEMORY, V7, P209, DOI 10.1080/741944066; PISONI DB, 1982, J EXP PSYCHOL HUMAN, V8, P297, DOI 10.1037/0096-1523.8.2.297; Poletiek FH, 2011, BIOLINGUISTICS, V5, P36; Revesz A, 2009, STUD SECOND LANG ACQ, V31, P437, DOI 10.1017/S0272263109090366; Robinson P., 2005, ANNU REV APPL LINGUI, V25, P46, DOI DOI 10.1017/S0267190505000036; Rossiter MJ, 2009, CAN MOD LANG REV, V65, P395, DOI 10.3138/cmlr.65.3.395; Russell J, 2006, LANG LEARN LANG TEAC, V13, P133; Sawyer M, 1992, LANGUAGE, V14, P25, DOI DOI 10.1017/S0272263100010457; Seger CA, 2008, NEUROSCI BIOBEHAV R, V32, P265, DOI 10.1016/j.neubiorev.2007.07.010; Shohamy D, 2004, BRAIN, V127, P851, DOI 10.1093/brain/awh100; Shohamy D, 2010, TRENDS COGN SCI, V14, P464, DOI 10.1016/j.tics.2010.08.002; Shohamy D, 2009, J COGNITIVE NEUROSCI, V21, P1820, DOI 10.1162/jocn.2009.21138; Squire LR, 1996, P NATL ACAD SCI USA, V93, P13515, DOI 10.1073/pnas.93.24.13515; Steinhauer K, 2000, J VOICE, V14, P137, DOI 10.1016/S0892-1997(00)80020-X; Thompson CK, 2007, AM J SPEECH-LANG PAT, V16, P30, DOI 10.1044/1058-0360(2007/005); Tomasello M., 2003, CONSTRUCTING LANGUAG; Tulving E., 1993, CURRENT DIRECTIONS P, V2, P67, DOI [10.1111/1467-8721.ep10770899, DOI 10.1111/1467-8721.EP10770899]; Tyler LK, 2005, P NATL ACAD SCI USA, V102, P8375, DOI 10.1073/pnas.0408213102; Ullman MT, 2001, NAT REV NEUROSCI, V2, P717, DOI 10.1038/35094573; Ullman MT, 2004, COGNITION, V92, P231, DOI 10.1016/j.cognition.2003.10.008; Unterrainer JM, 2003, COGNITIVE BRAIN RES, V17, P675, DOI 10.1016/S0926-6410(03)00191-5; Vicari S, 2003, NEUROPSYCHOLOGIA, V41, P108, DOI 10.1016/S0028-3932(02)00082-9; WeberFox CM, 1996, J COGNITIVE NEUROSCI, V8, P231, DOI 10.1162/jocn.1996.8.3.231; Wong PCM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064983; Woodcock R.W., 2001, WOODCOCK JOHNSON 3 T	87	13	13	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158812	10.1371/journal.pone.0158812	http://dx.doi.org/10.1371/journal.pone.0158812			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DR6IK	27391085	gold, Green Published, Green Submitted			2022-12-27	WOS:000380005400131
J	Bachsais, M; Naddaf, N; Yacoub, D; Salti, S; Alaaeddine, N; Aoudjit, F; Hassan, GS; Mourad, W				Bachsais, Meriem; Naddaf, Nadim; Yacoub, Daniel; Salti, Suzanne; Alaaeddine, Nada; Aoudjit, Fawzi; Hassan, Ghada S.; Mourad, Walid			The Interaction of CD154 with the alpha 5 beta 1 Integrin Inhibits Fas-Induced T Cell Death	PLOS ONE			English	Article							SOLUBLE CD40 LIGAND; MEDIATED APOPTOSIS; ENDOTHELIAL-CELLS; LYMPHOMA-CELLS; PLASMA-LEVELS; CANCER-CELLS; LIPID RAFTS; B-CELLS; ACTIVATION; EXPRESSION	CD154, a critical regulator of the immune response, is usually associated with chronic inflammatory, autoimmune diseases as well as malignant disorders. In addition to its classical receptor CD40, CD154 is capable of binding other receptors, members of the integrin family, the alpha IIb beta 3, alpha M beta 2 and alpha 5 beta 1. Given the role attributed to integrins and particularly the beta 1 integrins in inhibiting apoptotic events in normal as well as malignant T cells, we were highly interested in investigating the role of the CD154/alpha 5 beta 1 interaction in promoting survival of malignant T cells contributing as such to tumor development and/or propagation. To support our hypothesis, we first show that soluble CD154 binds to the T-cell acute lymphoblastic leukemia cell line, Jurkat E6.1 in a alpha 5 beta 1-dependent manner. Binding of soluble CD154 to alpha 5 beta 1 integrin of Jurkat cells leads to the activation of key survival proteins, including the p38 and ERK1/2 mitogen-activated protein kinases (MAPKs), phosphoinositide 3 kinase (PI-3K), and Akt. Interestingly, soluble CD154 significantly inhibits Fas-mediated apoptosis in T cell leukemia-lymphoma cell lines, Jurkat E6.1 and HUT78 cells, an important hallmark of T cell survival during malignancy progression. These anti-apoptotic effects were mainly mediated by the activation of the PI-3K/Akt pathway but also involved the p38 and the ERK1/2 MAPKs cascades. Our data also demonstrated that the CD154-triggered inhibition of the Fas-mediated cell death response was dependent on a suppression of caspase-8 cleavage, but independent of de novo protein synthesis or alterations in Fas expression on cell surface. Together, our results highlight the impact of the CD154/alpha 5 beta 1 interaction in T cell function/survival and identify novel targets for the treatment of malignant disorders, particularly of T cell origin.	[Bachsais, Meriem; Naddaf, Nadim; Yacoub, Daniel; Salti, Suzanne; Hassan, Ghada S.; Mourad, Walid] Ctr Hosp Univ Montreal, Lab Immunol Cellulaire & Mol, 900 Rue St Denis,Room 10-482, Montreal, PQ, Canada; [Alaaeddine, Nada] St Joseph Univ, Dept Pathol, Fac Med, Beirut, Lebanon; [Aoudjit, Fawzi] CHUL, Ctr Rech Immunol & Rhumatol, Boul Laurier, PQ, Canada	Universite de Montreal; Laval University	Mourad, W (corresponding author), Ctr Hosp Univ Montreal, Lab Immunol Cellulaire & Mol, 900 Rue St Denis,Room 10-482, Montreal, PQ, Canada.	mw.mourad@umontreal.ca		Aoudjit, Fawzi/0000-0001-9579-2941; Mourad, Walid/0000-0002-1859-9387; Hassan, Ghada S./0000-0002-1391-5248	Heart and Stroke Foundation of Canada (HSFC) [600663]; Pfizer/FRQS Innovation Fund [60597]	Heart and Stroke Foundation of Canada (HSFC)(Heart & Stroke Foundation of Canada); Pfizer/FRQS Innovation Fund	The study was supported by funds from the Heart and Stroke Foundation of Canada (HSFC): Award number 600663, and the Pfizer/FRQS Innovation Fund: Award number 60597. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alturaihi H, 2015, EUR J IMMUNOL, V45, P592, DOI 10.1002/eji.201444941; Andre P, 2002, NAT MED, V8, P247, DOI 10.1038/nm0302-247; Aoudjit F, 2000, BLOOD, V95, P2044, DOI 10.1182/blood.V95.6.2044; ARMITAGE RJ, 1992, NATURE, V357, P80, DOI 10.1038/357080a0; Bunn PA, 1996, J CELL BIOCHEM, P12; Bussolati B, 2002, INT J CANCER, V100, P654, DOI 10.1002/ijc.10545; Clodi K, 1998, BRIT J HAEMATOL, V103, P270, DOI 10.1046/j.1365-2141.1998.01031.x; De Toni-Costes F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009807; El Fakhry Y, 2012, J BIOL CHEM, V287, P18055, DOI 10.1074/jbc.M111.333989; El Fakhry Y, 2010, EUR J IMMUNOL, V40, P770, DOI 10.1002/eji.200939646; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Forsyth CB, 2002, ARTHRITIS RHEUM, V46, P2368, DOI 10.1002/art.10502; Garcia S, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2941; GARRONE P, 1995, J EXP MED, V182, P1265, DOI 10.1084/jem.182.5.1265; Gendron S, 2003, J BIOL CHEM, V278, P48633, DOI 10.1074/jbc.M305169200; Giancotti FG, 2003, ANNU REV CELL DEV BI, V19, P173, DOI 10.1146/annurev.cellbio.19.031103.133334; Heeschen C, 2003, NEW ENGL J MED, V348, P1104, DOI 10.1056/NEJMoa022600; Henn V, 1998, NATURE, V391, P591, DOI 10.1038/35393; Hill SC, 2005, J IMMUNOL, V174, P41, DOI 10.4049/jimmunol.174.1.41; Hock BD, 2006, CANCER, V106, P2148, DOI 10.1002/cncr.21816; Hsieh YT, 2013, BLOOD, V121, P1814, DOI 10.1182/blood-2012-01-406272; Ivanoff J, 2005, IMMUNOLOGY, V114, P53, DOI 10.1111/j.1365-2567.2004.02005.x; KARMANN K, 1995, P NATL ACAD SCI USA, V92, P4342, DOI 10.1073/pnas.92.10.4342; Kato K, 1999, J CLIN INVEST, V104, P947, DOI 10.1172/JCI7014; Khanna R, 1997, J IMMUNOL, V159, P5782; KROCZEK RA, 1994, IMMUNOL REV, V138, P39, DOI 10.1111/j.1600-065X.1994.tb00846.x; LEDERMAN S, 1992, J EXP MED, V175, P1091, DOI 10.1084/jem.175.4.1091; Leveille C, 2007, J BIOL CHEM, V282, P5143, DOI 10.1074/jbc.M608342200; Li DX, 2013, BIOCHEM BIOPH RES CO, V436, P467, DOI 10.1016/j.bbrc.2013.05.128; Lin YP, 2009, MOL IMMUNOL, V46, P3328, DOI 10.1016/j.molimm.2009.07.021; Liu CC, 2013, MOL CELL BIOL, V33, P4334, DOI 10.1128/MCB.00580-13; Loubaki L, 2010, MOL IMMUNOL, V47, P2112, DOI 10.1016/j.molimm.2010.03.011; Mach F, 1999, AM J PATHOL, V154, P229, DOI 10.1016/S0002-9440(10)65269-8; Mielczarek-Palacz A, 2013, HUM IMMUNOL, V74, P70, DOI 10.1016/j.humimm.2012.10.004; Mori Y, 2004, BLOOD, V104, P2149, DOI 10.1182/blood-2004-01-0236; Naci D, 2014, CELL SIGNAL, V26, P2008, DOI 10.1016/j.cellsig.2014.05.016; Naci D, 2012, J BIOL CHEM, V287, P17065, DOI 10.1074/jbc.M112.349365; Nadiri A, 2011, EUR J IMMUNOL, V41, P2358, DOI 10.1002/eji.201041143; Peters AL, 2009, SEMIN IMMUNOL, V21, P293, DOI 10.1016/j.smim.2009.05.012; Plumas J, 1998, BLOOD, V91, P2875, DOI 10.1182/blood.V91.8.2875.2875_2875_2885; Portt L, 2011, BBA-MOL CELL RES, V1813, P238, DOI 10.1016/j.bbamcr.2010.10.010; Pradelli LA, 2010, CELL MOL LIFE SCI, V67, P1589, DOI 10.1007/s00018-010-0285-y; Prasad KSS, 2003, P NATL ACAD SCI USA, V100, P12367, DOI 10.1073/pnas.2032886100; Roselli M, 2004, CLIN CANCER RES, V10, P610, DOI 10.1158/1078-0432.CCR-0348-03; Sanguigni V, 2005, CIRCULATION, V111, P412, DOI 10.1161/01.CIR.0000153810.81187.7D; Schattner E, 1996, IMMUNOL RES, V15, P246, DOI 10.1007/BF02918252; Schonbeck U, 2000, AM J PATHOL, V156, P7, DOI 10.1016/S0002-9440(10)64699-8; Stupack DG, 2002, J CELL SCI, V115, P3729, DOI 10.1242/jcs.00071; Su CC, 2007, J IMMUNOL, V179, P4589, DOI 10.4049/jimmunol.179.7.4589; Tamura N, 2001, J RHEUMATOL, V28, P2583; Toubi E, 2004, AUTOIMMUNITY, V37, P457, DOI 10.1080/08916930400002386; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9; Wierda WG, 2000, BLOOD, V96, P2917; Zirlik A, 2007, CIRCULATION, V115, P1571, DOI 10.1161/CIRCULATIONAHA.106.683201	54	7	7	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158987	10.1371/journal.pone.0158987	http://dx.doi.org/10.1371/journal.pone.0158987			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391025	gold, Green Submitted, Green Published			2022-12-27	WOS:000380005400182
J	Holliday, V; Surovell, T; Johnson, E				Holliday, Vance; Surovell, Todd; Johnson, Eileen			A Blind Test of the Younger Dryas Impact Hypothesis	PLOS ONE			English	Article							SOUTHERN HIGH-PLAINS; LUBBOCK LAKE SITE; EXTRATERRESTRIAL IMPACT; MURRAY SPRINGS; INDEPENDENT EVALUATION; BLACK MATS; BOUNDARY; NANODIAMONDS; EVENT; LAYER	The Younger Dryas Impact Hypothesis (YDIH) states that North America was devastated by some sort of extraterrestrial event similar to 12,800 calendar years before present. Two fundamental questions persist in the debate over the YDIH: Can the results of analyses for purported impact indicators be reproduced? And are the indicators unique to the lower YD boundary (YDB), i.e., similar to 12.8k cal yrs BP? A test reported here presents the results of analyses that address these questions. Two different labs analyzed identical splits of samples collected at, above, and below the similar to 12.8ka zone at the Lubbock Lake archaeological site (LL) in northwest Texas. Both labs reported similar variation in levels of magnetic micrograins (>300 mg/kg >12.8ka and <11.5ka, but <150 mg/kg 12.8ka to 11.5ka). Analysis for magnetic microspheres in one split, reported elsewhere, produced very low to nonexistent levels throughout the section. In the other split, reported here, the levels of magnetic microspherules and nanodiamonds are low or nonexistent at, below, and above the YDB with the notable exception of a sample <11,500 cal years old. In that sample the claimed impact proxies were recovered at abundances two to four orders of magnitude above that from the other samples. Reproducibility of at least some analyses are problematic. In particular, no standard criteria exist for identification of magnetic spheres. Moreover, the purported impact proxies are not unique to the YDB.	[Holliday, Vance] Univ Arizona, Dept Anthropol, Tucson, AZ 85721 USA; [Holliday, Vance] Univ Arizona, Dept Geosci, Tucson, AZ 85721 USA; [Surovell, Todd] Univ Wyoming, Dept Anthropol, Laramie, WY 82071 USA; [Johnson, Eileen] Texas Tech Univ Museum, Lubbock, TX 79409 USA	University of Arizona; University of Arizona; University of Wyoming; Texas Tech University System; Texas Tech University	Holliday, V (corresponding author), Univ Arizona, Dept Anthropol, Tucson, AZ 85721 USA.; Holliday, V (corresponding author), Univ Arizona, Dept Geosci, Tucson, AZ 85721 USA.	vthollid@email.arizona.edu		Surovell, Todd/0000-0001-6587-8621	Argonaut Archaeological Research Fund University of Arizona; College of Arts and Sciences, University of Wyoming	Argonaut Archaeological Research Fund University of Arizona; College of Arts and Sciences, University of Wyoming	Support was provided by Argonaut Archaeological Research Fund [http://www.argonaut.arizona.edu] University of Arizona, to VTH; and Basic Research Grant, College of Arts and Sciences, University of Wyoming to TS.	[Anonymous], 2000, GEOARCHAEOLOGY, DOI DOI 10.1002/(SICI)1520-6548(200003)15:3; Bement LC, 2014, P NATL ACAD SCI USA, V111, P1726, DOI 10.1073/pnas.1309734111; Boslough M, 2012, GEOPHYS MONOGR SER, V198, P13, DOI 10.1029/2012GM001209; Bunch TE, 2012, P NATL ACAD SCI USA, V109, pE1903, DOI 10.1073/pnas.1204453109; Daniel IR, 2008, N CAROLINA ARCHAEOLO, V57, P50; Daulton TL, 2010, P NATL ACAD SCI USA, V107, P16043, DOI 10.1073/pnas.1003904107; Firestone R., 2006, CYCLE COSMIC CATASTR; Firestone R, 2010, J SIB FED U ENG TECH, V3, P30; Firestone RB, 2007, P NATL ACAD SCI USA, V104, P16016, DOI 10.1073/pnas.0706977104; Firestone R.B., 2009, J COSMOL, V2, P256; Firestone RB, 2010, P NATL ACAD SCI USA, V107, pE105, DOI 10.1073/pnas.1003963107; French BM, 2010, EARTH-SCI REV, V98, P123, DOI 10.1016/j.earscirev.2009.10.009; Frison G.C., 2010, PREHISTORIC HUNTER G, V3rd; Haynes C. V., 1995, GEOARCHAEOLOGY, V10, P317, DOI DOI 10.1002/gea.3340100502; Haynes C.Vance., 1992, ICE AGE HUNTERS ROCK, P83; Haynes CV, 2008, P NATL ACAD SCI USA, V105, P6520, DOI 10.1073/pnas.0800560105; Haynes CV, 2010, P NATL ACAD SCI USA, V107, pE106, DOI 10.1073/pnas.1005384107; Haynes CV, 2010, P NATL ACAD SCI USA, V107, P4010, DOI 10.1073/pnas.0908191107; HAYNES CV, 1992, RADIOCARBON AFTER FOUR DECADES, P355; Hofman J. L., 1998, ARCHAEOLOGY GREAT PL, P87; HOLLIDAY V T, 1983, Plains Anthropologist, V28, P165; Holliday V. T., 1997, PALEOINDIAN GEOARCHA; Holliday VT, 2014, J QUATERNARY SCI, V29, P515, DOI 10.1002/jqs.2724; Holliday VT, 2010, CURR ANTHROPOL, V51, P575, DOI 10.1086/656015; HOLLIDAY VT, 1985, GEOL SOC AM BULL, V96, P1483, DOI 10.1130/0016-7606(1985)96<1483:AGOTLL>2.0.CO;2; HOLLIDAY VT, 1985, PLAINS ANTHROPOL, V30, P277, DOI 10.1080/2052546.1985.11909281; HOLLIDAY VT, 1985, CATENA, V12, P61, DOI 10.1016/S0341-8162(85)80005-9; Holliday VT., 2004, SOILS ARCHAEOLOGICAL, DOI [10.1002/9781118786352.wbieg0737, DOI 10.1002/9781118786352.WBIEG0737]; Israde-Alcantara I, 2012, P NATL ACAD SCI USA, V109, pE738, DOI 10.1073/pnas.1110614109; Johnson E., 2012, LUBBOCK LAKE LANDMAR, V21; Johnson E., 1987, LUBBOCK LAKE LATE QU; Kennett DJ, 2008, QUATERNARY SCI REV, V27, P2530, DOI 10.1016/j.quascirev.2008.09.006; Kennett DJ, 2009, SCIENCE, V323, P94, DOI 10.1126/science.1162819; Kennett DJ, 2009, P NATL ACAD SCI USA, V106, P12623, DOI 10.1073/pnas.0906374106; Kennett JP, 2015, P NATL ACAD SCI USA, V112, pE6723, DOI 10.1073/pnas.1520411112; Kennett JP, 2015, P NATL ACAD SCI USA, V112, pE4344, DOI 10.1073/pnas.1507146112; Kurbatov AV, 2010, J GLACIOL, V56, P747, DOI 10.3189/002214310794457191; LeCompte MA, 2013, P NATL ACAD SCI USA, V110, pE1652, DOI 10.1073/pnas.1300425110; LeCompte MA, 2012, P NATL ACAD SCI USA, V109, pE2960, DOI 10.1073/pnas.1208603109; Mahaney WC, 2010, GEOMORPHOLOGY, V116, P48, DOI 10.1016/j.geomorph.2009.10.007; Meltzer DJ, 2014, P NATL ACAD SCI USA, V111, pE2162, DOI 10.1073/pnas.1401150111; Nemeth P, 2015, NATURE SCI REPTS, DOI [10.1038/srep18381, DOI 10.1038/SREP18381]; Paquay FS, 2009, P NATL ACAD SCI USA, V106, P21505, DOI 10.1073/pnas.0908874106; Pigati JS, 2012, P NATL ACAD SCI USA, V109, P7208, DOI 10.1073/pnas.1200296109; Pinter N., 2008, GSA TODAY, V18, P37, DOI [10.1130/GSAT01801GW.1, DOI 10.1130/GSAT01801GW.1]; Pinter N, 2011, EARTH-SCI REV, V106, P247, DOI 10.1016/j.earscirev.2011.02.005; Quade J, 1998, QUATERNARY RES, V49, P129, DOI 10.1006/qres.1997.1959; Sellards E. H., 1952, EARLY MAN IN AM; STAFFORD T, 1981, AM ANTIQUITY, V46, P548, DOI 10.2307/280600; Surovell TA, 2012, J QUAT SCI S, P29; Surovell TA, 2009, P NATL ACAD SCI USA, V106, P18155, DOI 10.1073/pnas.0907857106; Thy P, 2015, J ARCHAEOL SCI, V54, P193, DOI 10.1016/j.jas.2014.11.027; Tian H, 2011, P NATL ACAD SCI USA, V108, P40, DOI 10.1073/pnas.1007695108; Van Hoesel A, 2015, METEORIT PLANET SCI, V50, P483, DOI 10.1111/maps.12435; van Hoesel A, 2014, QUATERNARY SCI REV, V83, P95, DOI 10.1016/j.quascirev.2013.10.033; van Hoesel A, 2012, P NATL ACAD SCI USA, V109, P7648, DOI 10.1073/pnas.1120950109; Wittke J, 2013, PNAS, V110, P2088; Wu YZ, 2013, P NATL ACAD SCI USA, V110, pE3557, DOI 10.1073/pnas.1304059110; Yang ZQ, 2008, DIAM RELAT MATER, V17, P937, DOI 10.1016/j.diamond.2008.01.104	59	11	11	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0155470	10.1371/journal.pone.0155470	http://dx.doi.org/10.1371/journal.pone.0155470			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27391147	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400002
J	Islam, MA; Jassim, WA; Cheok, NS; Zilany, MSA				Islam, Md. Atiqul; Jassim, Wissam A.; Cheok, Ng Siew; Zilany, Muhammad Shamsul Arefeen			A Robust Speaker Identification System Using the Responses from a Model of the Auditory Periphery	PLOS ONE			English	Article							WORD RECOGNITION; VOWEL EPSILON; NERVE; SPEECH; NOISE; REPRESENTATION; PREDICTION	Speaker identification under noisy conditions is one of the challenging topics in the field of speech processing applications. Motivated by the fact that the neural responses are robust against noise, this paper proposes a new speaker identification system using 2-D neurograms constructed from the responses of a physiologically-based computational model of the auditory periphery. The responses of auditory-nerve fibers for a wide range of characteristic frequency were simulated to speech signals to construct neurograms. The neurogram coefficients were trained using the well-known Gaussian mixture model-universal background model classification technique to generate an identity model for each speaker. In this study, three text-independent and one text-dependent speaker databases were employed to test the identification performance of the proposed method. Also, the robustness of the proposed method was investigated using speech signals distorted by three types of noise such as the white Gaussian, pink, and street noises with different signal-to-noise ratios. The identification results of the proposed neural-response-based method were compared to the performances of the traditional speaker identification methods using features such as the Mel-frequency cepstral coefficients, Gamma-tone frequency cepstral coefficients and frequency domain linear prediction. Although the classification accuracy achieved by the proposed method was comparable to the performance of those traditional techniques in quiet, the new feature was found to provide lower error rates of classification under noisy environments.	[Islam, Md. Atiqul; Jassim, Wissam A.; Cheok, Ng Siew; Zilany, Muhammad Shamsul Arefeen] Univ Malaya, Dept Biomed Engn, Fac Engn, Kuala Lumpur 50603, Malaysia	Universiti Malaya	Zilany, MSA (corresponding author), Univ Malaya, Dept Biomed Engn, Fac Engn, Kuala Lumpur 50603, Malaysia.	msazilany@gmail.com	Zilany, Muhammad S/C-1541-2012; NG, SIEW CHEOK/B-9232-2010	Zilany, Muhammad S/0000-0003-0181-0737; Jassim, Wissam/0000-0001-5998-142X	University of Malaya [UM.C/625/1/HIR/152, UM.C/625/1/HIR/MOHE/ENG/42, RP016B-13AET]	University of Malaya(Universiti Malaya)	This research was supported by the grants UM.C/625/1/HIR/152, UM.C/625/1/HIR/MOHE/ENG/42 and RP016B-13AET from the University of Malaya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This research was supported by the grants UM.C/625/1/HIR/152 and RP016B-13AET.	Bilmes J. A., 1998, INT COMPUTER SCI I, V4, P126, DOI DOI 10.1080/0042098032000136147; BIMBOT F, 1995, SPEECH COMMUN, V17, P177, DOI 10.1016/0167-6393(95)00013-E; Brookes M., 2011, VOICEBOX SPEECH PROC; Bruce V., 2003, VISUAL PERCEPTION PH, V4th; Campbell J., 1994, YOHO SPEAKER VERIFIC; Campbell JP, 1997, P IEEE, V85, P1437, DOI 10.1109/5.628714; Chi TS, 2012, J ACOUST SOC AM, V131, pEL368, DOI 10.1121/1.3697534; Cooke M, 2001, SPEECH COMMUN, V35, P141, DOI 10.1016/S0167-6393(00)00078-9; Dehak N, 2011, IEEE T AUDIO SPEECH, V19, P788, DOI 10.1109/TASL.2010.2064307; Dubno JR, 2005, J ACOUST SOC AM, V118, P914, DOI 10.1121/1.1953107; Ellis D. P., 2005, PLP RASTA MFCC INVER; FURUI S, 1981, IEEE T ACOUST SPEECH, V29, P254, DOI 10.1109/TASSP.1981.1163530; Ganapathy S., 2012, OD 2012 THE SPEAK LA; GLASBERG BR, 1990, HEARING RES, V47, P103, DOI 10.1016/0378-5955(90)90170-T; GREENWOOD DD, 1990, J ACOUST SOC AM, V87, P2592, DOI 10.1121/1.399052; Hermansky H, 1992, RASTA PLP SPEECH ANA; Hines A, 2012, SPEECH COMMUN, V54, P306, DOI 10.1016/j.specom.2011.09.004; Ibrahim RA, 2010, NEUROPHYSIOLOGICAL BASES OF AUDITORY PERCEPTION, P429, DOI 10.1007/978-1-4419-5686-6_40; Islam M, 2016, INT C INN BIOM ENG L; KIANG NYS, 1990, HEARING RES, V49, P1, DOI 10.1016/0378-5955(90)90091-3; Leonard R, 1993, LINGUISTIC DATA CONS; Li Q, 2011, IEEE T AUDIO SPEECH, V19, P1791, DOI 10.1109/TASL.2010.2101594; LIBERMAN MC, 1978, J ACOUST SOC AM, V63, P442, DOI 10.1121/1.381736; MAKHOUL J, 1975, P IEEE, V63, P561, DOI 10.1109/PROC.1975.9792; Mamun N, 2015, IEEE-ACM T AUDIO SPE, V23, P760, DOI 10.1109/TASLP.2015.2401513; Martinez J, 2012, CONIELECOMP 2012 22; Miller RL, 1997, J ACOUST SOC AM, V101, P3602, DOI 10.1121/1.418321; Muda L., 2010, J COMPUTING; Nakagawa S, 2012, IEEE T AUDIO SPEECH, V20, P1085, DOI 10.1109/TASL.2011.2172422; Nikias CL, 1993, IEEE SIGNAL PROC MAG, V10, P10, DOI 10.1109/79.221324; Oxenham AJ, 2003, JARO-J ASSOC RES OTO, V4, P541, DOI 10.1007/s10162-002-3058-y; Padilla MT, 2006, MISSING FEATURE THEO; PALMER AR, 1986, HEARING RES, V24, P1, DOI 10.1016/0378-5955(86)90002-X; Pascal J, 1998, J ACOUST SOC AM, V104, P1509, DOI 10.1121/1.424363; Patterson R., 1987, P PAP M IOC SPEECH G; Pelecanos J., 2001, FEATURE WARPING ROBU; Razali NF, 2014, INT SIGN PROC COMM S; REYNOLDS DA, 1995, IEEE T SPEECH AUDI P, V3, P72, DOI 10.1109/89.365379; Reynolds DA, 2000, DIGIT SIGNAL PROCESS, V10, P19, DOI 10.1006/dspr.1999.0361; Sato Nobuo, 2007, INFORM MEDIA TECHNOL, V2, P835; Shao Y, 2007, AC SPEECH SIGN PROC; Shera CA, 2002, P NATL ACAD SCI USA, V99, P3318, DOI 10.1073/pnas.032675099; Shera CA, 2010, JARO-J ASSOC RES OTO, V11, P343, DOI 10.1007/s10162-010-0217-4; SOONG FK, 1987, AT&T TECH J, V66, P14, DOI 10.1002/j.1538-7305.1987.tb00198.x; Studebaker GA, 1999, J ACOUST SOC AM, V105, P2431, DOI 10.1121/1.426848; Wong JC, 1998, HEARING RES, V123, P61, DOI 10.1016/S0378-5955(98)00098-7; YOUNG ED, 1979, J ACOUST SOC AM, V66, P1381, DOI 10.1121/1.383532; Young S., 2002, HIDDEN MARKOV MODEL; Zhao XJ, 2012, IEEE T AUDIO SPEECH, V20, P1608, DOI 10.1109/TASL.2012.2186803; Zilany MSA, 2007, J ACOUST SOC AM, V122, P402, DOI 10.1121/1.2735117; Zilany MSA, 2006, J ACOUST SOC AM, V120, P1446, DOI 10.1121/1.2225512; Zilany MSA, 2014, J ACOUST SOC AM, V135, P283, DOI 10.1121/1.4837815; Zilany MSA, 2009, J ACOUST SOC AM, V126, P2390, DOI 10.1121/1.3238250; ZUE V, 1990, SPEECH COMMUN, V9, P351, DOI 10.1016/0167-6393(90)90010-7	54	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158520	10.1371/journal.pone.0158520	http://dx.doi.org/10.1371/journal.pone.0158520			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27392046	gold, Green Submitted, Green Published			2022-12-27	WOS:000380005400076
J	Moore, JR; Varricchio, DJ				Moore, Jason R.; Varricchio, David J.			The Evolution of Diapsid Reproductive Strategy with Inferences about Extinct Taxa	PLOS ONE			English	Article							WATER-VAPOR CONDUCTANCE; PARENTAL-CARE; DINOSAUR EGGS; PHYLOGENETIC ANALYSIS; TROODON-FORMOSUS; AVIAN EGG; CLUTCHES; BEHAVIOR; EMBRYOS; ORIGIN	Diapsids show an extremely wide range of reproductive strategies. Offspring may receive no parental care, care from only one sex, care from both parents, or care under more complex regimes. Young may vary from independent, super-precocial hatchlings to altricial neonates needing much care before leaving the nest. Parents can invest heavily in a few young, or less so in a larger number. Here we examine the evolution of these traits across a composite phylogeny spanning the extant diapsids and including the limited number of extinct taxa for which reproductive strategies can be well constrained. Generalized estimating equation(GEE)-based phylogenetic comparative methods demonstrate the influences of body mass, parental care strategy and hatchling maturity on clutch volume across the diapsids. The influence of polygamous reproduction is not important despite a large sample size. Applying the results of these models to the dinosaurs supports the hypothesis of paternal care (male only) in derived non-avian theropods, previously suggested based on simpler analyses. These data also suggest that sauropodomorphs did not care for their young. The evolution of parental-care occurs in an almost linear series of transitions. Paternal care rarely gives rise to other care strategies. Where hatchling condition changes, diapsids show an almost unidirectional tendency of evolution towards increased altriciality. Transitions to social monogamy from the ancestral state in diapsids, where both sexes are polygamous, are common. In contrast, once evolved, polygyny and polyandry are very evolutionarily stable. Polygyny and maternal care correlate, as do polyandry and paternal care. Ancestralcharacter estimation (ACE) of these care strategies with the character transition likelihoods estimated from the original data gives good confidence at most important nodes. These analyses suggest that the basalmost diapsids had no parental care. Crocodilians independently evolved maternal care, paternal care evolved in the saurischian line, prior to derived theropod dinosaurs, and the most basal neognaths likely exhibited biparental care. Overall, the evolution of parental care among diapsids shows a persistent trend towards increased care of offspring, and more complex care strategies and behaviors with time. Reversions to reduced care are infrequent.	[Moore, Jason R.] Univ New Mexico, Honors Coll, Albuquerque, NM 87131 USA; [Varricchio, David J.] Montana State Univ, Dept Earth Sci, Bozeman, MT 59717 USA	University of New Mexico; Montana State University System; Montana State University Bozeman	Moore, JR (corresponding author), Univ New Mexico, Honors Coll, Albuquerque, NM 87131 USA.	jrm@unm.edu			National Science Foundation (Division of Earth Sciences) [0847777]	National Science Foundation (Division of Earth Sciences)(National Science Foundation (NSF))	This research was supported by National Science Foundation grant #0847777 (Division of Earth Sciences; http://www.nsf.gov/div/index.jsp?div=ear) to DJV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; ANDERSON JF, 1985, J ZOOL, V207, P53, DOI 10.1111/j.1469-7998.1985.tb04915.x; Antunes MT, 1998, MEM ACAD CIEN LISB, V37, P83; Auguie B, 2017, GRIDEXTRA MISCELLANE; Balshine S, 2012, EVOLUTION OF PARENTAL CARE, P62; Bennett P. M., 2002, OX ECOL EV; Betancur-R R, 2015, ECOL LETT, V18, P441, DOI 10.1111/ele.12423; Bever GS, 2009, AM MUS NOVIT, P1, DOI 10.1206/650.1; Birchard GF, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0036; Burley NT, 2002, PHILOS T R SOC B, V357, P241, DOI 10.1098/rstb.2001.0923; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carpenter K., 1999, EGGS NESTS BABY DINO; Chinsamy A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2377; Christiansen P., 2004, Historical Biology, V16, P85, DOI 10.1080/08912960412331284313; Clark James M., 1999, American Museum Novitates, V3265, P1; Cockburn A, 2006, P ROY SOC B-BIOL SCI, V273, P1375, DOI 10.1098/rspb.2005.3458; Cui J, 2007, STATA J, V7, P209, DOI 10.1177/1536867X0700700205; Darwin C., 1871, P423; Davies S., 2002, RATITES AND TINAMOUS; de Ricqles AJ, 2000, ZOOL J LINN SOC-LOND, V129, P349, DOI 10.1006/zjls.1999.0239; Deeming DC, 2006, PALAEONTOLOGY, V49, P171, DOI 10.1111/j.1475-4983.2005.00536.x; Deeming DC, 2002, OX ORN SER, V13, P1; deFraipont M, 1996, EVOLUTION, V50, P391, DOI 10.1111/j.1558-5646.1996.tb04501.x; Dong ZM, 1996, CAN J EARTH SCI, V33, P631, DOI 10.1139/e96-046; DUNHAM AE, 1989, GEOL S AM S, V238, P1; Dunning J.B., 2008, AVIAN BODY MASSES, V2; Elliott A., 1992, HDB BIRDS WORLD ALIV; Erickson GM, 2007, BIOL LETTERS, V3, P558, DOI 10.1098/rsbl.2007.0254; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ferguson MWJ., 1985, BIOL REPTILIA, P451; Field DJ, 2014, EVOL DEV, V16, P189, DOI 10.1111/ede.12081; Fisher RA, 1922, PHILOS T ROYAL SOC A, V222, P594; Gardner A, 2011, P ROY SOC B-BIOL SCI, V278, P196, DOI 10.1098/rspb.2010.1171; Gauthier J.A., 1988, Systematics Association Special Volume Series, P103; Geist NR, 1996, SCIENCE, V272, P712, DOI 10.1126/science.272.5262.712; Gill F. B., 1990, ORNITHOLOGY; Grellet-Tinner G, 2006, PALAEOGEOGR PALAEOCL, V232, P294, DOI 10.1016/j.palaeo.2005.10.029; Grellet-Tinner G, 2004, LIFE O PAST, P185; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; HANDFORD P, 1985, BIOL J LINN SOC, V25, P77, DOI 10.1111/j.1095-8312.1985.tb00387.x; Hansen TF, 1997, EVOLUTION, V51, P1341, DOI 10.1111/j.1558-5646.1997.tb01457.x; Heinroth O., 1922, Journal fuer Ornithologie Leipzig, V70, P172, DOI 10.1007/BF02537515; Henderson DM, 1999, PALEOBIOLOGY, V25, P88; Hirsch K.F., 1990, Journal of Vertebrate Paleontology, V10, P491; Hopp TP, 2004, LIFE O PAST, P234; Horner J.R., 1987, P50; Horner JR, 1999, J VERTEBR PALEONTOL, V19, P607, DOI 10.1080/02724634.1999.10011174; HORNER JR, 1984, SCI AM, V250, P130, DOI 10.1038/scientificamerican0484-130; Horner JR, 2001, PALEOBIOLOGY, V27, P39, DOI 10.1666/0094-8373(2001)027<0039:COOSEA>2.0.CO;2; HORNER JR, 1979, NATURE, V282, P296, DOI 10.1038/282296a0; HORNER JR, 1982, NATURE, V297, P675, DOI 10.1038/297675a0; HORNER JR, 1988, NATURE, V332, P256, DOI 10.1038/332256a0; Horner JR, 2000, ANNU REV EARTH PL SC, V28, P19, DOI 10.1146/annurev.earth.28.1.19; HOYT DF, 1979, AUK, V96, P73; Hugall AF, 2007, SYST BIOL, V56, P543, DOI 10.1080/10635150701477825; Isles TE, 2009, HIST BIOL, V21, P139, DOI 10.1080/08912960903450505; Iverson J.B., 1991, P87, DOI 10.1017/CBO9780511585739.008; Jackson FD, 2008, PALEOBIOLOGY, V34, P229, DOI 10.1666/0094-8373(2008)034[0229:COWVCI]2.0.CO;2; Jarvis ED, 2014, SCIENCE, V346, P1320, DOI 10.1126/science.1253451; Johnsgard P.A., 1991, BUSTARDS HEMIPODES S; Jones DN, 1995, MEGAPODES MEGAPODIID; Kavanau JL, 2007, SCI RES ESSAYS, V2, P263; Kavanau JL, 2010, MED HYPOTHESES, V74, P275, DOI 10.1016/j.mehy.2009.09.015; Kavanau JL., 1987, LOVEBIRDS COCKATIELS; Kendeigh S. C., 1952, ILLINOIS BIOL MONOGR; KITCHING J W, 1979, Palaeontologia Africana, V22, P41; Kohler G., 2005, INCUBATION REPTILE E; Lack, 1967, WILDFOWL TRUST ANNU, V18, P125; Lack D., 1968, ECOLOGICAL ADAPTATIO; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lu JC, 2011, SCIENCE, V331, P321, DOI 10.1126/science.1197323; Lyson TR, 2012, BIOL LETTERS, V8, P104, DOI 10.1098/rsbl.2011.0477; M?ller-Schwarze, 1984, BEHAV PENGUINS ADAPT; Mateus I, 1997, CR ACAD SCI II A, V325, P71, DOI 10.1016/S1251-8050(97)83275-2; MCKITRICK MC, 1992, AUK, V109, P828, DOI 10.2307/4088157; Mikhailov Konstantin, 1994, P88; NORELL MA, 1995, NATURE, V378, P774, DOI 10.1038/378774a0; Norell Mark A., 2001, American Museum Novitates, V3315, P1, DOI 10.1206/0003-0082(2001)315<0001:AEODTF>2.0.CO;2; OLSEN PD, 1994, AUST J ZOOL, V42, P307, DOI 10.1071/ZO9940307; Oring W, 1997, BIRDS N AM ONLINE; OWENS IPF, 1995, P ROY SOC B-BIOL SCI, V261, P227, DOI 10.1098/rspb.1995.0141; Owens IPF, 2002, PHILOS T R SOC B, V357, P283, DOI 10.1098/rstb.2001.0929; PAGANELLI CV, 1974, CONDOR, V76, P319, DOI 10.2307/1366345; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Paradis E, 2012, ANAL PHYLOGENETICS E, V2; Paul G., 1988, PREDATORY DINOSAURS; PECZKIS J, 1994, J VERTEBR PALEONTOL, V14, P520; Reisz RR, 2012, P NATL ACAD SCI USA, V109, P2428, DOI 10.1073/pnas.1109385109; Reynolds JD, 2002, PHILOS T R SOC B, V357, P269, DOI 10.1098/rstb.2001.0930; Ricklefs Robert E., 1998, Oxford Ornithology Series, V8, P366; ROSS HA, 1979, AM NAT, V113, P618, DOI 10.1086/283420; Royle NJ, 2012, EVOLUTION OF PARENTAL CARE, P1; Ruben JA, 2003, PHYSIOL BIOCHEM ZOOL, V76, P141, DOI 10.1086/375425; RUSSELL DA, 1969, CAN J EARTH SCI, V6, P595, DOI 10.1139/e69-059; Russell DA, 1982, SYLLOGEUS, V37, P1; SABATH K, 1991, Acta Palaeontologica Polonica, V36, P151; Sander PM, 2008, PALAEONTOGR ABT A, V284, P69; Sander PM, 2012, SCIENCE, V337, P806, DOI 10.1126/science.1224301; Sato T, 2005, SCIENCE, V308, P375, DOI 10.1126/science.1110578; Schluter D, 1997, EVOLUTION, V51, P1699, DOI 10.1111/j.1558-5646.1997.tb05095.x; Seddon N, 2003, IBIS, V145, P277, DOI 10.1046/j.1474-919X.2003.00150.x; Shine R, 1988, BIOL REPTILIA, V16, P276; Sillen-Tullberg Birgitta, 1994, Linnean Society Symposium Series, V17, P311; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; Somma L. A., 2003, PARENTAL BEHAV LEPID; Thorbjarnarson JB, 1996, HERPETOLOGICA, V52, P8; Trutnau L, 2006, CROCODYLIANS THEIR N; Tullberg BS, 2002, PHILOS T R SOC B, V357, P251, DOI 10.1098/rstb.2001.0932; Turner AH, 2012, B AM MUS NAT HIST, P5; VANRHIJN J, 1984, NETH J ZOOL, V34, P103, DOI 10.1163/002829684X00092; VANRHIJN JG, 1990, BEHAVIOUR, V115, P153, DOI 10.1163/156853990X00554; Varricchio DJ, 2013, PALEOBIOLOGY, V39, P278, DOI 10.1666/11042; Varricchio David J., 2003, Palaeovertebrata (Montpellier), V32, P149; Varricchio DJ, 2008, SCIENCE, V322, P1826, DOI 10.1126/science.1163245; Varricchio DJ, 1999, J VERTEBR PALEONTOL, V19, P91, DOI 10.1080/02724634.1999.10011125; Varricchio DJ, 2004, J VERTEBR PALEONTOL, V24, P931, DOI 10.1671/0272-4634(2004)024[0931:APAOPD]2.0.CO;2; Varricchio DJ, 1997, NATURE, V385, P247, DOI 10.1038/385247a0; Varricchio DJ, 2004, LIFE O PAST, P215; Varricchio DJ, 2002, J VERTEBR PALEONTOL, V22, P564, DOI 10.1671/0272-4634(2002)022[0564:EAEFTC]2.0.CO;2; Vehrencamp SL, 2000, BEHAV ECOL, V11, P334, DOI 10.1093/beheco/11.3.334; Walters M., 1994, BIRDS EGGS; Watson DM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117678; Weishampel DB, 2008, J VERTEBR PALEONTOL, V28, P1110, DOI 10.1671/0272-4634-28.4.1110; Werner J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072862; WESOLOWSKI T, 1994, AM NAT, V143, P39, DOI 10.1086/285595; Wesolowski T, 2004, BEHAV ECOL, V15, P520, DOI 10.1093/beheco/arh039; Yang R, 2010, MOL BIOL REP, V37, P3057, DOI 10.1007/s11033-009-9878-7; Zelenitsky DK, 2008, PALAEONTOLOGY, V51, P807, DOI 10.1111/j.1475-4983.2008.00770.x; Zelenitsky DK, 2002, CRETACEOUS RES, V23, P297, DOI 10.1006/cres.2002.1010; Zhao ZK., 2000, PALEONTOL SOC KOREA, V4, P115	131	9	10	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158496	10.1371/journal.pone.0158496	http://dx.doi.org/10.1371/journal.pone.0158496			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391420	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400070
J	Perez-Branguli, F; Zagar, Y; Shanley, DK; Graef, IA; Chedotal, A; Mitchell, KJ				Perez-Branguli, Francesc; Zagar, Yvrick; Shanley, Daniel K.; Graef, Isabella A.; Chedotal, Alain; Mitchell, Kevin J.			Reverse Signaling by Semaphorin-6A Regulates Cellular Aggregation and Neuronal Morphology	PLOS ONE			English	Article							ACTIN-CYTOSKELETAL REARRANGEMENTS; LAMINA-RESTRICTED PROJECTION; HIPPOCAMPAL MOSSY FIBERS; TRANSMEMBRANE SEMAPHORIN; SYNAPSE FORMATION; TYROSINE KINASES; STRUCTURAL BASIS; FAMILY KINASES; SMOOTH-MUSCLE; AXON GUIDANCE	The transmembrane semaphorin, Sema6A, has important roles in axon guidance, cell migration and neuronal connectivity in multiple regions of the nervous system, mediated by context-dependent interactions with plexin receptors, PlxnA2 and PlxnA4. Here, we demonstrate that Sema6A can also signal cell-autonomously, in two modes, constitutively, or in response to higher-order clustering mediated by either PlxnA2-binding or chemically induced multimerisation. Sema6A activation stimulates recruitment of Abl to the cytoplasmic domain of Sema6A and phosiphorylation of this cytoplasmic tyrosine kinase, as well as phos iphorylation of additional cytoskeletal regulators. Sema6A reverse signaling affects the surface area and cellular complexity of non-neuronal cells and aggregation and neurite formation of primary neurons in vitro. Sema6A also interacts with PlxnA2 in cis, which reduces binding by PlxnA2 of Sema6A in trans but not vice versa. These experiments reveal the complex nature of Sema6A biochemical functions and the molecular logic of the context-dependent interactions between Sema6A and PlxnA2.	[Perez-Branguli, Francesc; Shanley, Daniel K.; Mitchell, Kevin J.] Trinity Coll Dublin, Smurfit Inst Genet, Dublin 2, Ireland; [Perez-Branguli, Francesc; Shanley, Daniel K.; Mitchell, Kevin J.] Trinity Coll Dublin, Inst Neurosci, Dublin 2, Ireland; [Zagar, Yvrick; Chedotal, Alain] Univ Paris 06, Sorbonne Univ, INSERM UMR S968, CNRS UMR7210,Inst Vis, Paris, France; [Graef, Isabella A.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA	Trinity College Dublin; Trinity College Dublin; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Stanford University	Mitchell, KJ (corresponding author), Trinity Coll Dublin, Smurfit Inst Genet, Dublin 2, Ireland.; Mitchell, KJ (corresponding author), Trinity Coll Dublin, Inst Neurosci, Dublin 2, Ireland.	Kevin.Mitchell@tcd.ie	Chedotal, Alain/F-2750-2017	Chedotal, Alain/0000-0001-7577-3794	Science Foundation Ireland [07/IN.1/B969, 09/IN.1/B2614]; Fondation pour la Recherche Medicale (Programme "equipe FRM"); LABEX LIFESENSES - French state funds [ANR-10-LABX-65, ANR-11-IDEX-0004-02]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Fondation pour la Recherche Medicale (Programme "equipe FRM")(Fondation pour la Recherche Medicale); LABEX LIFESENSES - French state funds	This work was supported by grants from Science Foundation Ireland (07/IN.1/B969 and 09/IN.1/B2614) to KJM and by grants to Alain Chedotal from the Fondation pour la Recherche Medicale (Programme "equipe FRM") and the LABEX LIFESENSES (reference ANR-10-LABX-65) supported by French state funds managed by the Agence National pour la Recherche within the Investissements d'Avenir programme under reference ANR-11-IDEX-0004-02.	Andermatt I, 2014, DEVELOPMENT, V141, P3709, DOI 10.1242/dev.112185; Arbuzova A, 2002, BIOCHEM J, V362, P1, DOI 10.1042/0264-6021:3620001; Arpin M, 2011, CELL ADHES MIGR, V5, P199, DOI 10.4161/cam.5.2.15081; Bashaw GJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001941; Bell CH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001134; Bradley WD, 2009, J CELL SCI, V122, P3441, DOI 10.1242/jcs.039859; Bron R, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-21; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; Ebert AM, 2014, DEVELOPMENT, V141, P2473, DOI 10.1242/dev.103499; Eckhardt F, 1997, MOL CELL NEUROSCI, V9, P409, DOI 10.1006/mcne.1997.0644; Faulkner RL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-21; Godenschwege TA, 2002, NAT NEUROSCI, V5, P1294, DOI 10.1038/nn976; Godenschwege TA, 2009, J NEUROGENET, V23, P147, DOI 10.1080/01677060802441380; Haklai-Topper L, 2010, EMBO J, V29, P2635, DOI 10.1038/emboj.2010.147; Hernandez SE, 2004, CURR BIOL, V14, P691, DOI 10.1016/j.cub.2004.03.062; Hou TJ, 2006, PLOS COMPUT BIOL, V2, P46, DOI 10.1371/journal.pcbi.0020001; Huang XD, 2008, J CELL BIOL, V183, P711, DOI 10.1083/jcb.200801192; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Jackson RE, 2009, CURR BIOL, V19, pR504, DOI 10.1016/j.cub.2009.04.055; Janssen BJC, 2010, NATURE, V467, P1118, DOI 10.1038/nature09468; Jeong S, 2012, NEURON, V76, P721, DOI 10.1016/j.neuron.2012.09.018; Jia L, 2010, AM J PHYSIOL-CELL PH, V299, pC630, DOI 10.1152/ajpcell.00095.2010; Jones SB, 2004, J NEUROSCI, V24, P8510, DOI 10.1523/JNEUROSCI.1264-04.2004; Kain KH, 2001, J BIOL CHEM, V276, P16185, DOI 10.1074/jbc.M100095200; Kalwa H, 2012, J BIOL CHEM, V287, P29147, DOI 10.1074/jbc.M112.381517; Kerjan G, 2005, NAT NEUROSCI, V8, P1516, DOI 10.1038/nn1555; Kim YT, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00048; Klostermann A, 2000, J BIOL CHEM, V275, P39647, DOI 10.1074/jbc.M006316200; Komiyama T, 2007, CELL, V128, P399, DOI 10.1016/j.cell.2006.12.028; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Matsuoka RL, 2012, J NEUROSCI, V32, P6859, DOI 10.1523/JNEUROSCI.0267-12.2012; Matsuoka RL, 2011, NATURE, V470, P259, DOI 10.1038/nature09675; Mauti O, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-28; Nogi T, 2010, NATURE, V467, P1123, DOI 10.1038/nature09473; Pasterkamp RJ, 2012, NAT REV NEUROSCI, V13, P605, DOI 10.1038/nrn3302; Pecot MY, 2013, NEURON, V77, P299, DOI 10.1016/j.neuron.2012.11.007; Renaud J, 2008, NAT NEUROSCI, V11, P440, DOI 10.1038/nn2064; Runker AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026488; Ruenker AE, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-34; Siebold C, 2013, SEMIN CELL DEV BIOL, V24, P139, DOI 10.1016/j.semcdb.2012.11.003; SPENCER DM, 1993, SCIENCE, V262, P1019, DOI 10.1126/science.7694365; Sun LO, 2015, NEURON, V86, P971, DOI 10.1016/j.neuron.2015.03.064; Sun LO, 2013, SCIENCE, V342, P590, DOI 10.1126/science.1241974; Suto F, 2007, NEURON, V53, P535, DOI 10.1016/j.neuron.2007.01.028; Sweeney LB, 2007, NEURON, V53, P185, DOI 10.1016/j.neuron.2006.12.022; Tawarayama H, 2010, J NEUROSCI, V30, P7049, DOI 10.1523/JNEUROSCI.0073-10.2010; Tegtmeyer N, 2011, EUR J CELL BIOL, V90, P880, DOI 10.1016/j.ejcb.2010.11.006; Toyofuku T, 2004, NAT CELL BIOL, V6, P1204, DOI 10.1038/ncb1193; Trichet L, 2008, J CELL BIOL, V181, P19, DOI 10.1083/jcb.200710168; Wang T, 2013, J BIOL CHEM, V288, P20713, DOI 10.1074/jbc.M112.439877; Wang YX, 2013, ELIFE, V2, DOI 10.7554/eLife.01279; Yu L, 2010, J NEUROSCI, V30, P12151, DOI 10.1523/JNEUROSCI.1494-10.2010; Zandy NL, 2008, CELL CYCLE, V7, P444, DOI 10.4161/cc.7.4.5452	53	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158686	10.1371/journal.pone.0158686	http://dx.doi.org/10.1371/journal.pone.0158686			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27392094	Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400102
J	Schmidt, D; Peterlik, D; Reber, SO; Lechner, A; Mannel, DN				Schmidt, Dominic; Peterlik, Daniel; Reber, Stefan O.; Lechner, Anja; Maennel, Daniela N.			Induction of Suppressor Cells and Increased Tumor Growth following Chronic Psychosocial Stress in Male Mice	PLOS ONE			English	Article							REGULATORY T-CELLS; NECROSIS-FACTOR; SOCIAL STRESS; INDUCED COLITIS; IMMUNE-SYSTEM; BEARING MICE; INFLAMMATION; EXPANSION; CANCER; EXPRESSION	To study the impact of psychosocial stress on the immune system, male mice were subjected to chronic subordinate colony housing (CSC), a preclinically validated mouse model for chronic psychosocial stress. CSC substantially affected the cell composition of the bone marrow, blood, and spleen by inducing myelopoiesis and enhancing the frequency of regulatory T cells in the CD4 population. Expansion of the myeloid cell compartment was due to cells identified as immature inflammatory myeloid cells having the phenotype of myeloid-derived suppressor cells of either the granulocytic or the monocytic type. Catecholaminergic as well as TNF signaling were implicated in these CSC-induced cellular shifts. Although the frequency of regulatory cells was enhanced following CSC, the high capacity for inflammatory cytokine secretion of total splenocytes indicated an inflammatory immune status in CSC mice. Furthermore, CSC enhanced the suppressive activity of bone marrow-derived myeloid-derived suppressor cells towards proliferating T cells. In line with the occurrence of suppressor cell types such as regulatory T cells and myeloid-derived suppressor cells, transplanted syngeneic fibrosarcoma cells grew better in CSC mice than in controls, a process accompanied by pronounced angiogenesis and clustering of immature myeloid cells in the tumor tissue. In addition, tumor implantation after CSC reinforced the CSC-induced increase in myeloid-derived suppressor cells and regulatory T cell frequencies while the CSC-induced cellular changes eased off in mice without tumor. Together, our data suggest a role for suppressor cells such as regulatory T cells and myeloid-derived suppressor cells in the enhanced tumor growth after chronic psychosocial stress.	[Schmidt, Dominic; Lechner, Anja; Maennel, Daniela N.] Univ Regensburg, Inst Immunol, Regensburg, Germany; [Peterlik, Daniel] Univ Regensburg, Inst Zool, Lab Mol & Cellular Neurobiol, Regensburg, Germany; [Reber, Stefan O.] Univ Regensburg, Dept Behav & Mol Neurobiol, Inst Zool, Regensburg, Germany; [Reber, Stefan O.] Univ Ulm, Clin Psychosomat Med & Psychotherapy, Lab Mol Psychosomat, Ulm, Germany	University of Regensburg; University of Regensburg; University of Regensburg; Ulm University	Mannel, DN (corresponding author), Univ Regensburg, Inst Immunol, Regensburg, Germany.	daniela.maennel@klinik.uni-regensburg.de			Deutsche Forschungsgemeinschaft (DFG) [MA 760/20-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The work was supported by a grant (MA 760/20-1) by the Deutsche Forschungsgemeinschaft (DFG) to DNM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah DSA, 2011, INT IMMUNOL, V23, P317, DOI 10.1093/intimm/dxr007; Avitsur R, 2005, BRAIN BEHAV IMMUN, V19, P311, DOI 10.1016/j.bbi.2004.09.005; Avitsur R, 2002, J NEUROIMMUNOL, V132, P66, DOI 10.1016/S0165-5728(02)00310-7; Biermann H, 1999, J LEUKOCYTE BIOL, V65, P217, DOI 10.1002/jlb.65.2.217; Cao L, 2012, ANNU REV NEUROSCI, V35, P331, DOI 10.1146/annurev-neuro-062111-150546; Chen X, 2008, J IMMUNOL, V180, P6467, DOI 10.4049/jimmunol.180.10.6467; Chen X, 2007, J IMMUNOL, V179, P154, DOI 10.4049/jimmunol.179.1.154; Chen X, 2013, J IMMUNOL, V190, P1076, DOI 10.4049/jimmunol.1202659; Cuenca AG, 2011, MOL MED; Delano MJ, 2007, J EXP MED, V204, P1463, DOI 10.1084/jem.20062602; Delano MJ, 2011, J IMMUNOL, V186, P195, DOI 10.4049/jimmunol.1002104; Dhabhar FS, 2009, NEUROIMMUNOMODULAT, V16, P300, DOI 10.1159/000216188; Engler H, 2004, J NEUROIMMUNOL, V148, P106, DOI 10.1016/j.jneuroim.2003.11.011; ERICKSON SL, 1994, NATURE, V372, P560, DOI 10.1038/372560a0; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gehad AE, 2012, J INVEST DERMATOL, V132, P2642, DOI 10.1038/jid.2012.190; Harle P, 2005, ARTHRITIS RHEUM-US, V52, P1305, DOI 10.1002/art.20987; Heasman SJ, 2003, J ENDOCRINOL, V178, P29, DOI 10.1677/joe.0.1780029; Heidt T, 2014, NAT MED, V20, P754, DOI 10.1038/nm.3589; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hu X, 2014, J IMMUNOL, V192, P1320, DOI 10.4049/jimmunol.1203195; Huang B, 2006, CANCER RES, V66, P1123, DOI 10.1158/0008-5472.CAN-05-1299; Kim HR, 2012, NEUROIMMUNOMODULAT, V19, P187, DOI 10.1159/000331586; Korner H, 1997, EUR J IMMUNOL, V27, P2600, DOI 10.1002/eji.1830271020; Langgartner D, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00018; Levav I, 2000, AM J PUBLIC HEALTH, V90, P1601, DOI 10.2105/AJPH.90.10.1601; MANNEL DN, 1979, INFECT IMMUN, V24, P573; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Nagaraj S, 2010, J IMMUNOL, V184, P3106, DOI 10.4049/jimmunol.0902661; Okubo Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep03153; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Peranzoni E, 2010, CURR OPIN IMMUNOL, V22, P238, DOI 10.1016/j.coi.2010.01.021; Peters S, 2012, STRESS, V15, P403, DOI 10.3109/10253890.2011.631232; Polz J, 2014, IMMUN INFLAMM DIS, V2, P121, DOI 10.1002/iid3.19; Powell ND, 2013, P NATL ACAD SCI USA, V110, P16574, DOI 10.1073/pnas.1310655110; Powell ND, 2009, BRAIN BEHAV IMMUN, V23, P225, DOI 10.1016/j.bbi.2008.09.010; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; Reber SO, 2007, ENDOCRINOLOGY, V148, P670, DOI 10.1210/en.2006-0983; Reber SO, 2008, STRESS, V11, P225, DOI 10.1080/10253890701733351; Reber SO, 2011, BRAIN BEHAV IMMUN, V25, P1153, DOI 10.1016/j.bbi.2011.03.004; Reiche EMV, 2004, LANCET ONCOL, V5, P617, DOI 10.1016/S1470-2045(04)01597-9; Schmidt D, 2010, BRAIN BEHAV IMMUN, V24, P1097, DOI 10.1016/j.bbi.2010.04.014; Selye H, 1998, J NEUROPSYCH CLIN N, V10, P230; Smigiel KS, 2014, IMMUNOL REV, V259, P40, DOI 10.1111/imr.12170; THOENEN H, 1968, N-S ARCH PHARMAKOL, V261, P271, DOI 10.1007/BF00536990; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Voorhees JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058488; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Youn JI, 2012, J LEUKOCYTE BIOL, V91, P167, DOI 10.1189/jlb.0311177; Zhou Q, 2014, CYTOKINE, V65, P56, DOI 10.1016/j.cyto.2013.09.008	51	34	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159059	10.1371/journal.pone.0159059	http://dx.doi.org/10.1371/journal.pone.0159059			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391954	gold, Green Published, Green Submitted			2022-12-27	WOS:000380005400204
J	Arkhipenko, A; Syan, S; Victoria, GS; Lebreton, S; Zurzolo, C				Arkhipenko, Alexander; Syan, Sylvie; Victoria, Guiliana Soraya; Lebreton, Stephanie; Zurzolo, Chiara			PrPC Undergoes Basal to Apical Transcytosis in Polarized Epithelial MDCK Cells	PLOS ONE			English	Article							GPI-ANCHORED PROTEINS; CELLULAR PRION PROTEIN; 3-DIMENSIONAL CULTURE MODELS; MEMBRANE; TRAFFICKING; PATHWAYS; CLEAVAGE; NEURONS; DISEASE; BRAIN	The Prion Protein (PrP) is an ubiquitously expressed glycosylated membrane protein attached to the external leaflet of the plasma membrane via a glycosylphosphatidylinositol anchor (GPI). While the misfolded PrPSc scrapie isoform is the infectious agent of prion disease, the cellular isoform (PrPC) is an enigmatic protein with unclear function. Of interest, PrP localization in polarized MDCK cells is controversial and its mechanism of trafficking is not clear. Here we investigated PrP traffic in MDCK cells polarized on filters and in three-dimensional MDCK cysts, a more physiological model of polarized epithelia. We found that, unlike other GPI-anchored proteins (GPI-APs), PrP undergoes basolateral-to-apical transcytosis in fully polarized MDCK cells. Following this event full-length PrP and its cleavage fragments are segregated in different domains of the plasma membrane in polarized cells in both 2D and 3D cultures.	[Arkhipenko, Alexander; Syan, Sylvie; Victoria, Guiliana Soraya; Lebreton, Stephanie; Zurzolo, Chiara] Inst Pasteur, Unite Trafic Membranaire & Pathogenese, 25-28 Rue Docteur Roux, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Zurzolo, C (corresponding author), Inst Pasteur, Unite Trafic Membranaire & Pathogenese, 25-28 Rue Docteur Roux, F-75015 Paris, France.	zurzolo@pasteur.fr	Zurzolo, Chiara/AAH-5225-2019	Lebreton, Stephanie/0000-0002-9879-0404	MI CARNOT ICSA/PMI; Agence Nationale de la Recherche [ANR-14-JPCD-0002-01]; Equipe FRM (Fondation Recherche Medicale) [DEQ20140329557]; Universite Paris Saclay ED SDSV, Orsay, France; Ecole Normale Superieure de Paris Rue d'Ulm, Paris, France	MI CARNOT ICSA/PMI; Agence Nationale de la Recherche(French National Research Agency (ANR)); Equipe FRM (Fondation Recherche Medicale); Universite Paris Saclay ED SDSV, Orsay, France; Ecole Normale Superieure de Paris Rue d'Ulm, Paris, France	This work is supported by research grants from the MI CARNOT ICSA/PMI, Agence Nationale de la Recherche (ANR-14-JPCD-0002-01) and Equipe FRM (Fondation Recherche Medicale) 2014 (DEQ20140329557) to C.Z. A.A. was supported by Universite Paris Saclay ED SDSV, Orsay, France, Ecole Normale Superieure de Paris 45-46 Rue d'Ulm, Paris 75005, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APODACA G, 1994, J CELL BIOL, V125, P67, DOI 10.1083/jcb.125.1.67; Apodaca G, 2012, NAT CELL BIOL, V14, P1235, DOI 10.1038/ncb2635; Boland MP, 2010, J BIOL CHEM, V285, P32282, DOI 10.1074/jbc.M110.123398; Bonifacino JS, 2014, J CELL BIOL, V204, P7, DOI 10.1083/jcb.201310021; Bradke F, 1998, BBA-MOL CELL RES, V1404, P245, DOI 10.1016/S0167-4889(98)00060-3; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; BROWN DA, 1989, SCIENCE, V245, P1499, DOI 10.1126/science.2571189; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Campana V, 2005, TRENDS CELL BIOL, V15, P102, DOI 10.1016/j.tcb.2004.12.002; Campbell L, 2013, BBA-MOL BASIS DIS, V1832, P826, DOI 10.1016/j.bbadis.2013.02.020; Checler F, 2002, TRENDS NEUROSCI, V25, P616, DOI 10.1016/S0166-2236(02)02263-4; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Christensen HM, 2009, J NEUROCHEM, V108, P44, DOI 10.1111/j.1471-4159.2008.05719.x; Davis EM, 2015, CELL REP, V11, P1727, DOI 10.1016/j.celrep.2015.05.026; De Keukeleire B, 2007, BIOCHEM BIOPH RES CO, V354, P949, DOI 10.1016/j.bbrc.2007.01.096; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; DEHOOP MJ, 1993, J CELL SCI, P85; Deora A, 2006, CELL BIOL; Dong SL, 2007, BIOPOLYMERS, V88, P840, DOI 10.1002/bip.20860; DOTTI CG, 1990, CELL, V62, P63, DOI 10.1016/0092-8674(90)90240-F; Guillot-Sestier MV, 2009, J BIOL CHEM, V284, P35973, DOI 10.1074/jbc.M109.051086; Haigh CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134680; Hanzel D, 1991, Semin Cell Biol, V2, P341; Jimenez-Huete A, 1998, AM J PATHOL, V153, P1561, DOI 10.1016/S0002-9440(10)65744-6; Klinkert K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11166; Kretzschmar H, 2013, BRAIN PATHOL, V23, P321, DOI 10.1111/bpa.12045; Le Brun AP, 2014, BIOPHYS J, V107, P2313, DOI 10.1016/j.bpj.2014.09.027; LEBIVIC A, 1990, J CELL BIOL, V110, P1533, DOI 10.1083/jcb.110.5.1533; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Li AM, 2007, J NEUROSCI, V27, P852, DOI 10.1523/JNEUROSCI.4244-06.2007; Liang JJ, 2012, PRION, V6, DOI 10.4161/pri.22511; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; LISANTI MP, 1989, J CELL BIOL, V109, P2145, DOI 10.1083/jcb.109.5.2145; LISANTI MP, 1990, J MEMBRANE BIOL, V113, P155, DOI 10.1007/BF01872889; LISANTI MP, 1990, P NATL ACAD SCI USA, V87, P7419, DOI 10.1073/pnas.87.19.7419; Marijanovic Z, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000426; Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525; Muniz M, 2014, J CELL SCI, V127, P2793, DOI 10.1242/jcs.148056; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; Paladino S, 2006, J CELL BIOL, V172, P1023, DOI 10.1083/jcb.200507116; Paladino S, 2004, J CELL BIOL, V167, P699, DOI 10.1083/jcb.200407094; Paladino S, 2002, INT J MED MICROBIOL, V291, P439; Paladino S, 2014, NAT CHEM BIOL, V10, P350, DOI [10.1038/NCHEMBIO.1495, 10.1038/nchembio.1495]; Paladino S, 2008, J CELL SCI, V121, P4001, DOI 10.1242/jcs.036038; Pflanzner T, 2012, J CEREBR BLOOD F MET, V32, P628, DOI 10.1038/jcbfm.2012.7; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Puig B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024624; Radovanovic I, 2005, J NEUROSCI, V25, P4879, DOI 10.1523/JNEUROSCI.0328-05.2005; RODRIGUEZBOULAN E, 1992, ANNU REV CELL BIOL, V8, P395, DOI 10.1146/annurev.cb.08.110192.002143; Sarnataro D, 2002, TRAFFIC, V3, P810, DOI 10.1034/j.1600-0854.2002.31106.x; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schuck S, 2006, J CELL BIOL, V172, P963, DOI 10.1083/jcb.200603015; Senatore A, 2013, INT J CELL BIOL, V2013, DOI DOI 10.1155/2013/543803; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Tveit H, 2005, BIOCHEM BIOPH RES CO, V337, P232, DOI 10.1016/j.bbrc.2005.09.031; Uchiyama K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2873; Uelhoff A, 2005, J BIOL CHEM, V280, P5137, DOI 10.1074/jbc.C400560200; Vincent B, 2001, J BIOL CHEM, V276, P37743; Vincent B, 2008, CURR ALZHEIMER RES, V5, P202, DOI 10.2174/156720508783954749; Walmsley AR, 2009, MOL CELL NEUROSCI, V40, P242, DOI 10.1016/j.mcn.2008.10.012; Westergard L, 2011, J BIOL CHEM, V286, P44234, DOI 10.1074/jbc.M111.286195; Wik L, 2012, PRION, V6, DOI 10.4161/pri.22588; ZURZOLO C, 1992, EMBO J, V11, P2337, DOI 10.1002/j.1460-2075.1992.tb05293.x	63	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0157991	10.1371/journal.pone.0157991	http://dx.doi.org/10.1371/journal.pone.0157991			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27389581	Green Submitted, Green Published, gold			2022-12-27	WOS:000379811500011
J	de Andrade, FAG; Gomes, MN; Uieda, W; Begot, AL; Ramos, OD; Fernandes, MEB				de Andrade, Fernanda A. G.; Gomes, Murilo N.; Uieda, Wilson; Begot, Alberto L.; Ramos, Ofir de S.; Fernandes, Marcus E. B.			Geographical Analysis for Detecting High-Risk Areas for Bovine/Human Rabies Transmitted by the Common Hematophagous Bat in the Amazon Region, Brazil	PLOS ONE			English	Article							DESMODUS-ROTUNDUS; VAMPIRE BATS; SAO-PAULO; TIME DISTRIBUTION; RACCOON RABIES; UNITED-STATES; MINAS-GERAIS; VIRUS; DYNAMICS; PATTERNS	Background The common hematophagous bat, Desmodus rotundus, is one of the main wild reservoirs of rabies virus in several regions in Latin America. New production practices and changed land use have provided environmental features that have been very favorable for D. rotundus bat populations, making this species the main transmitter of rabies in the cycle that involves humans and herbivores. In the Amazon region, these features include a mosaic of environmental, social, and economic components, which together creates areas with different levels of risk for human and bovine infections, as presented in this work in the eastern Brazilian Amazon. Methodology We geo-referenced a total of 175 cases of rabies, of which 88% occurred in bovines and 12% in humans, respectively, and related these cases to a number of different geographical and biological variables. The spatial distribution was analyzed using the Kernel function, while the association with independent variables was assessed using a multi-criterion Analytical Hierarchy Process (AHP) technique. Findings The spatiotemporal analysis of the occurrence of rabies in bovines and humans found reduction in the number of cases in the eastern state of Para, where no more cases were recorded in humans, whereas high infection rates were recorded in bovines in the northeastern part of the state, and low rates in the southeast. The areas of highest risk for bovine rabies are found in the proximity of rivers and highways. In the case of human rabies, the highest concentration of high-risk areas was found where the highway network coincides with high densities of rural and indigenous populations. Conclusion The high-risk areas for human and bovine rabies are patchily distributed, and related to extensive deforested areas, large herds of cattle, and the presence of highways. These findings provide an important database for the generation of epidemiological models that could support the development of effective prevention measures and controls.	[de Andrade, Fernanda A. G.] Museu Paraense Emilio Goeldi, Campus Pesquisa, Belem, Para, Brazil; [Gomes, Murilo N.] Coordenadoria Def Agr, Escritorio Def Agr Sao Paulo, Sao Paulo, Brazil; [Uieda, Wilson] Univ Estadual Paulista, Dept Zool, Inst Biociencias, Botucatu, SP, Brazil; [Begot, Alberto L.] Secretaria Execut Saude Publ Estado Para, Dept Endemias, Belem, Para, Brazil; [Ramos, Ofir de S.] Lab Nacl Agr Para, Lab Virol, Lanagro, Para, Brazil; [Fernandes, Marcus E. B.] Fed Univ Para, Lab Ecol Manguezal, Campus Braganca, BR-66059 Belem, Para, Brazil; [de Andrade, Fernanda A. G.] Inst Fed Educ Ciencias & Tecnol, Dept Biol, Tucurui, Para, Brazil	Museu Paraense Emilio Goeldi; Universidade Estadual Paulista; Universidade Federal do Para	de Andrade, FAG (corresponding author), Museu Paraense Emilio Goeldi, Campus Pesquisa, Belem, Para, Brazil.; de Andrade, FAG (corresponding author), Inst Fed Educ Ciencias & Tecnol, Dept Biol, Tucurui, Para, Brazil.	fernanda.atanaena@ifpa.edu.br	Fernandes, Marcus/L-6242-2016	Fernandes, Marcus/0000-0003-3894-5248	Para State Research Foundation (FAPESPA), Brazil [146/2008]; Brazilian National Research Council (CNPq) [141121/2007-6]	Para State Research Foundation (FAPESPA), Brazil; Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was made possible by the financial support of the Para State Research Foundation (FAPESPA), Brazil, No. 146/2008, and the Brazilian National Research Council (CNPq), Process 141121/2007-6. These entities played no role in study design, data collection and analysis, or the decision to publish or prepare the manuscript.	Acha PN, 1988, NATURAL HIST VAMPIRE; Andrade FAG, 2008, STUD NEOTROP FAUNA E, V43, P169, DOI 10.1080/01650520802273456; ARELLANOSOTA C, 1988, REV INFECT DIS, V10, pS615; Barbosa TFS, 2008, VIROLOGY, V370, P228, DOI 10.1016/j.virol.2007.10.005; Barbosa TFS, 2007, CAD SAUDE COLET RIO, V15, P329; Fernandes MEB, 2013, BRAZ J INFECT DIS, V17, P251, DOI 10.1016/j.bjid.2012.10.015; Berger F, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002258; BRASS DA, 1994, RABIES BATS NATURAL; Camara G, 1996, COMPUT GRAPH, V20, P395, DOI 10.1016/0097-8493(96)00008-8; CHARLTON KM, 1979, CAN J COMP MED, V43, P168; Childs JE, 2000, P NATL ACAD SCI USA, V97, P13666, DOI 10.1073/pnas.240326697; Confalonieri UEC, 2014, ACTA TROP, V129, P33, DOI 10.1016/j.actatropica.2013.09.013; Confalonieri Ulisses E. C., 2005, Estud. av., V19, P221, DOI 10.1590/S0103-40142005000100014; Costa LJC, 2013, T ROY SOC TROP MED H, V107, P684, DOI 10.1093/trstmh/trt080; da Rosa EST, 2006, EMERG INFECT DIS, V12, P1197, DOI 10.3201/eid1708.050929; de Oliveira RS, 2015, REV INST MED TROP SP, V57, P497, DOI 10.1590/S0036-46652015000600006; FERNANDES MEB, 2000, B LAB HIDROBIOLOGIA, V13, P83; Findley J.S., 1993, BATS COMMUNITY PERSP; FLEMING TH, 1972, ECOLOGY, V53, P555, DOI 10.2307/1934771; Foranttini OP, 2004, ECOLOGIA EPIDEMIOLOG; FORMENT WL, 1971, J MAMMAL, V52, P227, DOI 10.2307/1378457; FORNES A, 1974, Journal of Wildlife Diseases, V10, P310; Fundacao Nacional do Indio &mdash; FUNAI, 2010, TEM TERR IND; Gao S, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-8; Gomes MN, 2011, ARQ BRAS MED VET ZOO, V63, P287, DOI 10.1590/S0102-09352011000200003; Gomes MN, 2006, PESQUI VET BRASIL, V26, P38, DOI 10.1590/S0100-736X2006000100008; Gomes MN, 2007, PESQUISA VET BRASIL, V27, P307, DOI 10.1590/S0100-736X2007000700009; Gomes MN, 2010, PREV VET MED, V93, P139, DOI 10.1016/j.prevetmed.2009.10.006; GREENHALL A M, 1983, Mammalian Species, P1, DOI 10.2307/3503895; Guerra MA, 2003, EMERG INFECT DIS, V9, P1143; Guo DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072352; Holmes EC, 2002, VIROLOGY, V292, P247, DOI 10.1006/viro.2001.1271; Instituto Brasilerio de Geografia e Estastica-IBGE, 2010, COD DE MUN; Institutode Pesquisas Espaciais, 2013, TERRAVIEW 4 2 2; Lee DN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042466; Lord RD, 1988, NATURAL HIST VAMPIRE; MAPA, 2009, CONTR RAIV HERB MAN; Menezes FL, 2008, ARQ BRAS MED VET ZOO, V60, P566, DOI 10.1590/S0102-09352008000300007; Ministerio do Meio Ambiente-MMA, 2010, DESM AM 1998 2008; Miranda EE, 2005, BRASIL EM RELEVO; MURRAY JD, 1986, PROC R SOC SER B-BIO, V229, P111, DOI 10.1098/rspb.1986.0078; O'Shea TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086261; Pavlovsky E. N., 1967, NATURAL NIDALITY TRA; Pozzobom J, 2001, ESTUD AV-SAO PAULO, V19, P45; Recuenco S, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-14; Schneider MC, 2009, REV PANAM SALUD PUBL, V25, P260, DOI 10.1590/S1020-49892009000300010; Silva F.C., 2008, NAEA PAP BELEM, V226, P1; Silva JA, 2001, ARQ BRAS MED VET ZOO, V53, P263; Sodre MM, 2010, REV INST MED TROP SP, V52, P75, DOI 10.1590/S0036-46652010000200003; Stoner-Duncan B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002867; Taddei VA, 1991, DISTRIBUICAO MORCEGO; Voigt CC, 2012, ETHOLOGY, V118, P260, DOI 10.1111/j.1439-0310.2011.02004.x; Wada MY, 2011, EPIDEMIOL SERV SAUDE, V20, P509, DOI 10.5123/S1679-49742011000400010	53	19	20	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0157332	10.1371/journal.pone.0157332	http://dx.doi.org/10.1371/journal.pone.0157332			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27388498	Green Published, gold, Green Submitted			2022-12-27	WOS:000379811500004
J	Geuss, MN; McCardell, MJ; Stefanucci, JK				Geuss, Michael N.; McCardell, Michael J.; Stefanucci, Jeanine K.			Fear Similarly Alters Perceptual Estimates of and Actions over Gaps	PLOS ONE			English	Article							HEIGHT PERCEPTION; GEOGRAPHICAL SLANT; ANXIETY; VISION; DISSOCIATIONS; AMYGDALA; AROUSAL; HILLS	Previous research has demonstrated an influence of one's emotional state on estimates of spatial layout. For example, estimates of heights are larger when the viewer is someone typically afraid of heights (trait fear) or someone who, in the moment, is experiencing elevated levels of fear (state fear). Embodied perception theories have suggested that such a change in perception occurs in order to alter future actions in a manner that reduces the likelihood of injury. However, other work has argued that when acting, it is important to have access to an accurate perception of space and that a change in conscious perception does not necessitate a change in action. No one has yet investigated emotional state, perceptual estimates, and action performance in a single paradigm. The goal of the current paper was to investigate whether fear influences perceptual estimates and action measures similarly or in a dissociable manner. In the current work, participants either estimated gap widths (Experiment 1) or were asked to step over gaps (Experiment 2) in a virtual environment. To induce fear, the gaps were placed at various heights up to 15 meters. Results showed an increase in gap width estimates as participants indicated experiencing more fear. The increase in gap estimates was mirrored in participants' stepping behavior in Experiment 2; participants stepped over fewer gaps when experiencing higher state and trait fear and, when participants actually stepped, they stepped farther over gap widths when experiencing more fear. The magnitude of the influence of fear on both perception and action were also remarkably similar (5.3 and 3.9 cm, respectively). These results lend support to embodied perception claims by demonstrating an influence on action of a similar magnitude as seen on estimates of gap widths.	[Geuss, Michael N.] Max Planck Inst Biol Cybernet, Tubingen, Germany; [McCardell, Michael J.; Stefanucci, Jeanine K.] Univ Utah, Dept Psychol, Salt Lake City, UT 84112 USA	Max Planck Society; Utah System of Higher Education; University of Utah	Geuss, MN (corresponding author), Max Planck Inst Biol Cybernet, Tubingen, Germany.	michael.geuss@tuebingen.mpg.de			Alexander von Humboldt fellowship	Alexander von Humboldt fellowship(Alexander von Humboldt Foundation)	This work was supported by an Alexander von Humboldt fellowship granted to the first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral DG, 2003, NEUROSCIENCE, V118, P1099, DOI 10.1016/S0306-4522(02)01001-1; Anderson AK, 2001, NATURE, V411, P305, DOI 10.1038/35077083; Barrett HC, 2006, PSYCHOL REV, V113, P628, DOI 10.1037/0033-295X.113.3.628; Barrett KC, PERSPECTIVES EMOTION; Beilock S. L, 2010, CHOKE WHAT SECRETS B; Bhalla M, 1999, J EXP PSYCHOL HUMAN, V25, P1076, DOI 10.1037/0096-1523.25.4.1076; Bocanegra BR, 2009, PSYCHOL SCI, V20, P707, DOI 10.1111/j.1467-9280.2009.02354.x; BOOTSMA R J, 1992, Ecological Psychology, V4, P1; Bruno N, 2001, J VISION, V1, P252; BUSS AH, 1989, AM PSYCHOL, V44, P1378, DOI 10.1037/0003-066X.44.11.1378; Canal-Bruland R, 2015, CONSCIOUS COGN, V34, P98, DOI 10.1016/j.concog.2015.04.006; Canal-Bruland R, 2013, ATTEN PERCEPT PSYCHO, V75, P1206, DOI 10.3758/s13414-013-0476-3; Clerkin EM, 2009, J ANXIETY DISORD, V23, P381, DOI 10.1016/j.janxdis.2008.12.002; COHEN DC, 1977, BEHAV THER, V8, P17, DOI 10.1016/S0005-7894(77)80116-0; Creem SH, 2001, ACTA PSYCHOL, V107, P43, DOI 10.1016/S0001-6918(01)00021-X; Deschamps T, 2004, J SPORTS SCI, V22; Durgin FH, 2012, J EXP PSYCHOL HUMAN, V38, P1582, DOI 10.1037/a0027805; Durgin FH, 2010, ACTA PSYCHOL, V134, P182, DOI 10.1016/j.actpsy.2010.01.009; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; Epstein S, 1984, STABILITY BEHAV TIME, P209; Fajen BR, 2005, PERCEPTION, V34, P717, DOI 10.1068/p5405; Firestone C, 2013, PERSPECT PSYCHOL SCI, V8, P455, DOI 10.1177/1745691613489835; Gagnon KT, 2013, EVOL HUM BEHAV, V34, P49, DOI 10.1016/j.evolhumbehav.2012.09.002; Glover S, 2004, BEHAV BRAIN SCI, V27, P57; Goodale MA, 1995, VISUAL BRAIN ACTION, V27, P134; Graydon MM, 2012, COGNITION EMOTION, V26, P1301, DOI 10.1080/02699931.2012.667391; Haffenden AM, 1998, J COGNITIVE NEUROSCI, V10, P122, DOI 10.1162/089892998563824; HARDY L, 1991, BRIT J PSYCHOL, V82, P163, DOI 10.1111/j.2044-8295.1991.tb02391.x; Higuchi T, 2000, JPN PSYCHOL RES, V42, P168, DOI 10.1111/1468-5884.00142; Jackson RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059690; Jackson RE, 2009, P R SOC B, V276, P1665, DOI 10.1098/rspb.2009.0004; JIANG Y, 1994, PERCEPT PSYCHOPHYS, V56, P691, DOI 10.3758/BF03208362; Jun E, 2015, ACM T APPL PERCEPT, V12, DOI 10.1145/2811266; Meehan M, 2002, ACM T GRAPHIC, V21, P645, DOI 10.1145/566570.566630; Nourrit D, 2003, J MOTOR BEHAV, V35, P151, DOI 10.1080/00222890309602130; Phelps EA, 2006, PSYCHOL SCI, V17, P292, DOI 10.1111/j.1467-9280.2006.01701.x; Pijpers JRR, 2005, Q J EXP PSYCHOL-A, V58, P421, DOI 10.1080/02724980343000945; Proffitt DR, 2006, PERSPECT PSYCHOL SCI, V1, P110, DOI 10.1111/j.1745-6916.2006.00008.x; Proffitt DR, 2013, PERSPECT PSYCHOL SCI, V8, P474, DOI 10.1177/1745691613489837; Proffitt DR, 2013, ACTION SCIENCE: FOUNDATIONS OF AN EMERGING DISCIPLINE, P171; Proffitt DR, 1995, PSYCHON B REV, V2, P409, DOI 10.3758/BF03210980; Seinfeld S, 2015, FRONT PSYCHOL, V6; Stefanucci JK, 2011, SOC PERSONAL PSYCHOL, V5, P296, DOI 10.1111/j.1751-9004.2011.00352.x; Stefanucci JK, 2012, PERCEPTION, V41, P1, DOI 10.1068/p7131; Stefanucci JK, 2009, PERCEPTION, V38, P1782, DOI 10.1068/p6437; Stefanucci JK, 2009, J EXP PSYCHOL HUMAN, V35, P424, DOI 10.1037/a0013894; Stefanucci JK, 2009, J EXP PSYCHOL GEN, V138, P131, DOI 10.1037/a0014797; Stins JF, 2013, ECOL PSYCHOL, V25, P357, DOI 10.1080/10407413.2013.842094; Stolarova M, 2006, CEREB CORTEX, V16; Storbeck J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092024; Sylvers P, 2011, CLIN PSYCHOL REV, V31, P122, DOI 10.1016/j.cpr.2010.08.004; Teachman BA, 2008, EMOTION, V8, P296, DOI 10.1037/1528-3542.8.2.296; Tooby J, ADAPTED MIND, P19; UNGERLEIDER LG, 1982, 2 CORTICAL VISUAL SY, V549, P549; Vishton PM, 2007, PSYCHOL SCI, V18, P713, DOI 10.1111/j.1467-9280.2007.01965.x; Wraga M, 2000, PSYCHOL SCI, V11, P239, DOI 10.1111/1467-9280.00248	56	11	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158610	10.1371/journal.pone.0158610	http://dx.doi.org/10.1371/journal.pone.0158610			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR3OC	27389399	Green Published, gold			2022-12-27	WOS:000379811500030
J	Zeng, H; Yang, WH; Lu, CZ; Lin, WQ; Zou, MH; Zhang, HZ; Wan, JF; Huang, XM				Zeng, Hui; Yang, Weihai; Lu, Chaozhong; Lin, Wenqiu; Zou, Minghong; Zhang, Hanzhou; Wan, Jifeng; Huang, Xuming			Effect of CPPU on Carbohydrate and Endogenous Hormone Levels in Young Macadamia Fruit	PLOS ONE			English	Article							ACTINIDIA-DELICIOSA; SHOOT GROWTH; ABSCISSION; YIELD; APPLE; SET; INTEGRIFOLIA; QUALITY; ACCUMULATION; REMOVAL	N-(2-Chloro-4-pyridyl)-N'-phenylurea (CPPU) is a highly active cytokinin-like plant growth regulator that promotes chlorophyll biosynthesis, cell division, and cell expansion. It also increases fruit set and accelerates fruit enlargement. However, there has been no report about the effect of CPPU on fruit development and its physiological mechanism in macadamia. In this study, we investigated the effect of CPPU treatment at early fruit development via foliar spray or raceme soaking at 20 mg.L-1 on fruit set and related physiology in macadamia. Changes in carbohydrate contents and endogenous hormones in leaves, bearing shoots and fruit were also examined. Results showed that CPPU significantly reduced young fruit drop and delayed the wave of fruit drop by 1-2 weeks. The treatment significantly decreased the contents of total soluble sugars and starch in the leaves, but increased them in the bearing shoots and total soluble sugars in the husk (pericarp) and seeds. These findings suggested that CPPU promoted carbohydrate mobilization from the leaves to the fruit. In addition, CPPU increased the contents of indole-3-acetic acid (IAA), gibberellin acid (GA(3)), and zeatin riboside (ZR) and decreased the abscisic acid (ABA) in the husk. Therefore, CPPU treatment reduced the early fruit drop by increasing carbohydrate availability and by modifying the balance among endogenous hormones.	[Zeng, Hui; Huang, Xuming] South China Agr Univ, Coll Hort, Guangzhou, Guangdong, Peoples R China; [Zeng, Hui; Yang, Weihai; Lu, Chaozhong; Lin, Wenqiu; Zou, Minghong; Zhang, Hanzhou; Wan, Jifeng] Chinese Acad Trop Agr Sci, South Subtrop Crop Res Inst, Zhanjiang, Guangdong, Peoples R China; [Zeng, Hui; Yang, Weihai; Lu, Chaozhong; Lin, Wenqiu; Zou, Minghong; Zhang, Hanzhou; Wan, Jifeng] Minist Agr, Key Lab Trop Fruit Biol, Zhanjiang, Guangdong, Peoples R China	South China Agricultural University; Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Huang, XM (corresponding author), South China Agr Univ, Coll Hort, Guangzhou, Guangdong, Peoples R China.	huangxm@scau.edu.cn			National Natural Science Foundation of China [31572082]; Hainan Province Natural Science Foundation [314110]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hainan Province Natural Science Foundation	This study was supported by the National Natural Science Foundation of China (Grant No. 31572082) and the Hainan Province Natural Science Foundation (Grant No. 314110).	Antognozzi E, 1997, ACTA HORTIC, P459, DOI 10.17660/ActaHortic.1997.444.70; Antognozzi E, 1996, SCI HORTIC-AMSTERDAM, V65, P37, DOI 10.1016/0304-4238(95)00852-7; Botton A, 2011, PLANT PHYSIOL, V155, P185, DOI 10.1104/pp.110.165779; Brown E, 2010, ACTA HORTIC, V884, P107, DOI 10.17660/ActaHortic.2010.884.11; Chen JianZhong, 2002, Journal of Fruit Science, V19, P139; CJ Xu, 1998, BIOTECHNOLOGY, V8, P41; CURRY EA, 1993, HORTSCIENCE, V28, P115, DOI 10.21273/HORTSCI.28.2.115; Eccher G, 2013, PLANT PHYSIOL, V161, P1952, DOI 10.1104/pp.112.208470; Fang JinBao, 2000, Acta Horticulturae Sinica, V27, P444; GILLASPY G, 1993, PLANT CELL, V5, P1439, DOI 10.1105/tpc.5.10.1439; Gomez-Cadenas A, 2000, PLANTA, V210, P636, DOI 10.1007/s004250050054; He XY, 2015, TROPICAL AGR SCI TEC, V38, P12; He Z., 1993, ENZYME LINKED IMMUNO; Hu Z.Q., 2005, J FRUIT SCI, V5, P34; Li XX, 2011, J PLANT PHYSIOL, V168, P920, DOI 10.1016/j.jplph.2010.11.005; Liu HX, 2001, CHINESE J TROPICAL C, V22, P36; McFadyen L, 2012, FUNCT PLANT BIOL, V39, P481, DOI 10.1071/FP11254; McFadyen L, 2012, SCI HORTIC-AMSTERDAM, V137, P125, DOI 10.1016/j.scienta.2012.01.028; McFadyen LM, 2011, ANN BOT-LONDON, V107, P993, DOI 10.1093/aob/mcr026; NAGAO MA, 1990, SCI HORTIC-AMSTERDAM, V43, P47, DOI 10.1016/0304-4238(90)90035-D; NeSmith DS, 2008, HORTSCIENCE, V43, P1446, DOI 10.21273/HORTSCI.43.5.1446; Ohara Hitoshi, 1997, Journal of the Japanese Society for Horticultural Science, V65, P693, DOI 10.2503/jjshs.65.693; Retamales JB, 2014, CHIL J AGR RES, V74, P157, DOI 10.4067/S0718-58392014000200005; SAKAI WS, 1985, PHYSIOL PLANTARUM, V64, P455, DOI 10.1111/j.1399-3054.1985.tb08522.x; SEDGLEY M, 1981, AUST J BOT, V29, P185, DOI 10.1071/BT9810185; Stopar M, 2001, SCI HORTIC-AMSTERDAM, V87, P65, DOI 10.1016/S0304-4238(00)00169-2; SUGIYAMA N, 1995, SCI HORTIC-AMSTERDAM, V60, P337, DOI 10.1016/0304-4238(94)00712-O; SUGIYAMA N, 1993, J HORTIC SCI, V68, P673, DOI 10.1080/00221589.1993.11516399; [陶丽 Tao Li], 2005, [热带作物学报, Chinese Journal of Tropical Crops], V26, P12; TRUEMAN SJ, 1994, ANN BOT-LONDON, V73, P23, DOI 10.1006/anbo.1994.1003; TRUEMAN SJ, 1994, ANN BOT-LONDON, V74, P667, DOI 10.1006/anbo.1994.1169; Trueman SJ, 1993, THESIS; Trueman SJ, 2010, AFR J AGR RES, V5, P3402; Trueman SJ, 2010, AFR J AGR RES, V5, P1523; Wang YangJie, 1997, Acta Horticulturae Sinica, V24, P84; WILLIAMS RR, 1980, AUST J EXP AGR, V20, P740, DOI 10.1071/EA9800740; Woolley D. J., 1992, Acta Horticulturae, P467; Wu S.R., 1988, PLANT PHYSL COMMUN, V5, P53; Xu H.S., 1995, CHIN J TROP CROPS, V16, P78; Yang JC, 2001, PLANT PHYSIOL, V127, P315, DOI 10.1104/pp.127.1.315; Yang MF, 2015, S CHINA FRUITS, V44, P54; Yang WH, 2009, SCI HORTIC-AMSTERDAM, V120, P194, DOI 10.1016/j.scienta.2008.10.009; Yang ZiQin, 2011, Journal of Fruit Science, V28, P428; Yu JQ, 2001, ACTA AGR NUCL SINICA, V15, P355; Zhang CX, 2009, PLANT GROWTH REGUL, V58, P25, DOI 10.1007/s10725-008-9349-5; Zhang ZL, 1990, GUIDEBOOK EXPT PLANT; Zheng SF, 2011, AGR RES APPL, V2, P20; Zhu H, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-138; Zou MingHong, 2009, Journal of Fruit Science, V26, P98	49	15	19	6	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158705	10.1371/journal.pone.0158705	http://dx.doi.org/10.1371/journal.pone.0158705			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27387814	Green Submitted, gold, Green Published			2022-12-27	WOS:000379811500039
J	Cho, Y; Chang, JS; Rha, KH; Hong, SJ; Choi, YD; Ham, WS; Kim, JW; Cho, J				Cho, Yeona; Chang, Jee Suk; Rha, Koon Ho; Hong, Sung Joon; Choi, Young Deuk; Ham, Won Sik; Kim, Jun Won; Cho, Jaeho			Does Radiotherapy for the Primary Tumor Benefit Prostate Cancer Patients with Distant Metastasis at Initial Diagnosis?	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; RADIATION-THERAPY; BREAST-CANCER; SURVIVAL; DISEASE; IMMUNOTHERAPY	Purpose/Objectives Treatment of the primary tumor reportedly improves survival in several types of metastatic cancer. We herein evaluated the efficacy and toxicity of radiotherapy for the primary tumor in prostate cancer with metastasis. Materials/Methods The study cohort included 140 men with metastatic prostate cancer at initial diagnosis. Metastatic sites were divided into 4 groups as follows: solitary bone, 2-4 bones, >= 5 bones, and visceral organs. Patient, tumor, and treatment characteristics, and clinical outcomes were compared between patients treated with (prostate radiotherapy [PRT] group) or without radiotherapy to the primary tumor. Results Patients in PRT group presented with a statistically significantly younger age (p = .02), whereas other characteristics showed no significant difference. Overall survival (OS) and biochemical failure-free survival (BCFFS) were improved in PRT patients (3-year OS: 69% vs. 43%, p = 0.004; 3-year BCFFS: 52% vs. 16%, p = 0.002). Multivariate analysis identified PRT as a significant predictor of both OS (hazard ratio [HR] = 0.43, p = 0.015). None of the 38 PRT patients experienced severe (grade >= 3) genitourinary or gastrointestinal toxicity. Conclusions Our data suggest that radiotherapy to the primary tumor was associated with improved OS and BCFFS in metastatic prostate cancer. The results of this study warrant prospective controlled clinical trials of this approach in stage IV prostate cancer patients with limited extent of bone metastasis and good performance status.	[Cho, Yeona; Chang, Jee Suk; Kim, Jun Won; Cho, Jaeho] Yonsei Univ, Coll Med, Dept Radiat Oncol, Seoul 120749, South Korea; [Rha, Koon Ho; Hong, Sung Joon; Choi, Young Deuk; Ham, Won Sik] Yonsei Univ, Coll Med, Dept Urol, Seoul 120749, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Cho, J (corresponding author), Yonsei Univ, Coll Med, Dept Radiat Oncol, Seoul 120749, South Korea.	jjhmd@yuhs.ac	Anshari, Dien/B-9544-2018; Cho, Yeona/AAT-3257-2021; Cho, Yoo Jin/I-8291-2018	Anshari, Dien/0000-0002-7984-0111; Cho, Yoo Jin/0000-0001-9590-9206; Borland, Ron/0000-0003-0059-178X; McKeever, Robert/0000-0002-5924-0514; Rha, Koon Ho/0000-0001-8588-7584; Ham, Won Sik/0000-0003-2246-8838; cho, Yeona/0000-0002-1202-0880; Hong, Sung Joon/0000-0001-9869-065X; Choi, Young Deuk/0000-0002-8545-5797; Chang, Jee Suk/0000-0001-7685-3382; Kim, Jun Won/0000-0003-1358-364X; Cho, Jaeho/0000-0001-9966-5157	Yonsei University College of Medicine [6-2014-0031]; NATIONAL CANCER INSTITUTE [R01CA167067] Funding Source: NIH RePORTER	Yonsei University College of Medicine(General Electric); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a faculty research grant from Yonsei University College of Medicine in 2014 (6-2014-0031).	Adli M, 2006, J NATL CANCER I, V98, P364, DOI 10.1093/jnci/djj077; Boehmer D, 2006, RADIOTHER ONCOL, V79, P259, DOI 10.1016/j.radonc.2006.05.012; Camphausen K, 2001, CANCER RES, V61, P2207; Coen JJ, 2002, J CLIN ONCOL, V20, P3199, DOI 10.1200/JCO.2002.01.086; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Demaria S, 2004, INT J RADIAT ONCOL, V58, P862, DOI 10.1016/j.ijrobp.2003.09.012; Engel J, 2010, EUR UROL, V57, P754, DOI 10.1016/j.eururo.2009.12.034; Flanigan RC, 2001, NEW ENGL J MED, V345, P1655, DOI 10.1056/NEJMoa003013; Gandaglia G, 2015, EUR UROL, V68, P325, DOI 10.1016/j.eururo.2014.07.020; Glass TR, 2003, J UROLOGY, V169, P164, DOI 10.1016/S0022-5347(05)64059-1; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Lam JS, 2006, J UROLOGY, V175, P27, DOI 10.1016/S0022-5347(05)00034-0; Lee IJ, 2009, INT J RADIAT ONCOL, V73, P1517, DOI 10.1016/j.ijrobp.2008.07.035; McGrath SD, 2010, BRACHYTHERAPY, V9, P137, DOI 10.1016/j.brachy.2009.07.005; Mickisch GHJ, 2001, LANCET, V358, P966, DOI 10.1016/S0140-6736(01)06103-7; Mohler JL, 2012, J NATL COMPR CANC NE, V10, P1081, DOI 10.6004/jnccn.2012.0114; Morgan SC, 2011, NAT REV CLIN ONCOL, V8, P504, DOI 10.1038/nrclinonc.2011.88; Nguyen DHA, 2012, ANN SURG ONCOL, V19, P3028, DOI 10.1245/s10434-012-2333-3; Nguyen DHA, 2012, INT J RADIAT ONCOL, V84, P39, DOI 10.1016/j.ijrobp.2011.11.046; Norgaard M, 2010, J UROLOGY, V184, P162, DOI 10.1016/j.juro.2010.03.034; Parker CC, 2013, BJU INT, V111, P697, DOI 10.1111/bju.12087; Postow MA, 2012, NEW ENGL J MED, V366, P925, DOI 10.1056/NEJMoa1112824; Rapiti E, 2006, J CLIN ONCOL, V24, P2743, DOI 10.1200/JCO.2005.04.2226; Staehler MD, 2010, WORLD J UROL, V28, P543, DOI 10.1007/s00345-010-0560-4; Suzman DL, 2014, THER ADV MED ONCOL, V6, P167, DOI 10.1177/1758834014529176; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Temple LKF, 2004, J CLIN ONCOL, V22, P3475, DOI 10.1200/JCO.2004.10.218; Weckermann D, 2009, J CLIN ONCOL, V27, P1549, DOI 10.1200/JCO.2008.17.0563; Zelefsky MJ, 2008, INT J RADIAT ONCOL, V70, P1124, DOI 10.1016/j.ijrobp.2007.11.044; Zelefsky MJ, 2002, INT J RADIAT ONCOL, V53, P1111, DOI 10.1016/S0360-3016(02)02857-2	32	74	75	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147191	10.1371/journal.pone.0147191	http://dx.doi.org/10.1371/journal.pone.0147191			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807740	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800057
J	Cho, YJ; Thrasher, JF; Swayampakala, K; Yong, HH; McKeever, R; Hammond, D; Anshari, D; Cummings, KM; Borland, R				Cho, Yoo Jin; Thrasher, James F.; Swayampakala, Kamala; Yong, Hua-Hie; McKeever, Robert; Hammond, David; Anshari, Dien; Cummings, K. Michael; Borland, Ron			Does Reactance against Cigarette Warning Labels Matter? Warning Label Responses and Downstream Smoking Cessation amongst Adult Smokers in Australia, Canada, Mexico and the United States	PLOS ONE			English	Article							PSYCHOLOGICAL REACTANCE; HEALTH WARNINGS; SENSATION SEEKING; TRAIT REACTANCE; IMPACT; MESSAGES	Objective Some researchers have raised concerns that pictorial health warning labels (HWLs) on cigarette packages may lead to message rejection and reduced effectiveness of HWL messages. This study aimed to determine how state reactance (i.e., negative affect due to perceived manipulation) in response to both pictorial and text-only HWLs is associated with other types of HWL responses and with subsequent cessation attempts. Methods Survey data were collected every 4 months between September 2013 and 2014 from online panels of adult smokers in Australia, Canada, Mexico, and the US were analyzed. Participants with at least one wave of follow-up were included in the analysis (n = 4,072 smokers; 7,459 observations). Surveys assessed psychological and behavioral responses to HWLs (i.e., attention to HWLs, cognitive elaboration of risks due to HWLs, avoiding HWLs, and forgoing cigarettes because of HWLs) and cessation attempts. Participants then viewed specific HWLs from their countries and were queried about affective state reactance. Logistic and linear Generalized Estimating Equation (GEE) models regressed each of the psychological and behavioral HWL responses on reactance, while controlling for socio-demographic and smoking-related variables. Logistic GEE models also regressed having attempted to quit by the subsequent survey on reactance, each of the psychological and behavioral HWL responses (analyzed separately), adjustment variables. Data from all countries were initially pooled, with interactions between country and reactance assessed; when interactions were statistically significant, country-stratified models were estimated. Results Interactions between country and reactance were found in all models that regressed psychological and behavioral HWL responses on study variables. In the US, stronger reactance was associated with more frequent reading of HWLs and thinking about health risks. Smokers from all four countries with stronger reactance reported greater likelihood of avoiding warnings and forgoing cigarettes due to warnings, although the association appeared stronger in the US. Both stronger HWLs responses and reactance were positively associated with subsequent cessation attempts, with no significant interaction between country and reactance. Conclusions Reactance towards HWLs does not appear to interfere with quitting, which is consistent with its being an indicator of concern, not a systematic effort to avoid HWL message engagement.	[Cho, Yoo Jin; Thrasher, James F.; Swayampakala, Kamala; Anshari, Dien] Univ South Carolina, Dept Hlth Promot Educ & Behav, Columbia, SC 29208 USA; [Thrasher, James F.] Natl Inst Publ Hlth, Dept Tobacco Res, Ctr Populat Hlth Res, Cuernavaca, Morelos, Mexico; [Yong, Hua-Hie; Borland, Ron] Canc Council Victoria, Melbourne, Vic, Australia; [McKeever, Robert] Univ South Carolina, Sch Journalism & Mass Commun, Columbia, SC 29208 USA; [Hammond, David] Univ Waterloo, Sch Publ Hlth & Hlth Syst, Waterloo, ON, Canada; [Anshari, Dien] Univ Indonesia, Fac Publ Hlth, Dept Hlth Educ & Behav Sci, Depok, Indonesia; [Cummings, K. Michael] Med Univ South Carolina, Dept Psychiat & Behav Sci, 171 Ashley Ave, Charleston, SC 29425 USA	University of South Carolina System; University of South Carolina Columbia; Instituto Nacional de Salud Publica; Cancer Council Victoria; University of South Carolina System; University of South Carolina Columbia; University of Waterloo; University of Indonesia; Medical University of South Carolina	Cho, YJ (corresponding author), Univ South Carolina, Dept Hlth Promot Educ & Behav, Columbia, SC 29208 USA.	ycho@email.sc.edu	Anshari, Dien/B-9544-2018; Cho, Yeona/AAT-3257-2021; Cho, Yoo Jin/I-8291-2018	Anshari, Dien/0000-0002-7984-0111; Cho, Yoo Jin/0000-0001-9590-9206; Borland, Ron/0000-0003-0059-178X; McKeever, Robert/0000-0002-5924-0514; Rha, Koon Ho/0000-0001-8588-7584; Ham, Won Sik/0000-0003-2246-8838; cho, Yeona/0000-0002-1202-0880; Hong, Sung Joon/0000-0001-9869-065X; Choi, Young Deuk/0000-0002-8545-5797; Chang, Jee Suk/0000-0001-7685-3382; Kim, Jun Won/0000-0003-1358-364X; Cho, Jaeho/0000-0001-9966-5157	U.S. National Cancer Institute [R01 CA167067]; NATIONAL CANCER INSTITUTE [R01CA167067] Funding Source: NIH RePORTER	U.S. National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Data collection and analyses for the study were funded by a grant from the U.S. National Cancer Institute (R01 CA167067). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanton H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096315; Borland R, 2009, TOB CONTROL, V18, P358, DOI 10.1136/tc.2008.028043; Borland R, 2014, UNDERSTANDING HARD T; Brehm SS, 1981, PSYCHOLOGICAL REACTA; Dillard JP, 2005, COMMUN MONOGR, V72, P144, DOI 10.1080/03637750500111815; Emery LF, 2014, NICOTINE TOB RES, V16, P263, DOI 10.1093/ntr/ntt124; Erceg-Hurn DM, 2011, J APPL SOC PSYCHOL, V41, P219, DOI 10.1111/j.1559-1816.2010.00710.x; Fathelrahman AI, 2013, TOB INDUC DIS, V11, DOI 10.1186/1617-9625-11-20; Gibson L, 2015, NICOTINE TOB RES, V17, P898, DOI 10.1093/ntr/ntv082; Grandpre J, 2003, HEALTH COMMUN, V15, P349, DOI 10.1207/S15327027HC1503_6; Hammond D, 2006, TOB CONTROL, V15, P19, DOI 10.1136/tc.2005.012294; Hammond D, 2004, AM J PUBLIC HEALTH, V94, P1442, DOI 10.2105/AJPH.94.8.1442; Hammond D, 2003, TOB CONTROL, V12, P391, DOI 10.1136/tc.12.4.391; Hammond D, 2007, AM J PREV MED, V32, P202, DOI 10.1016/j.amepre.2006.11.011; Hammond D, 2011, TOB CONTROL, V20, P327, DOI 10.1136/tc.2010.037630; HEATHERTON TF, 1989, BRIT J ADDICT, V84, P791; International Agency for Research on Cancer, 2008, METH EV TOB CONTR PO, V12; International Telecommunication Union, 2015, PERCENTAGE OF INDIVI; Kees J, 2006, J PUBLIC POLICY MARK, V25, P212, DOI 10.1509/jppm.25.2.212; Kees J, 2010, J PUBLIC POLICY MARK, V29, P265, DOI 10.1509/jppm.29.2.265; LaVoie NR, 2015, COMMUN RES; Maynard OM, 2014, DRUG ALCOHOL DEPEN, V136, P170, DOI 10.1016/j.drugalcdep.2014.01.001; Miller CH, 2010, HEALTH COMMUN, V25, P266, DOI 10.1080/10410231003698945; Noar SM, 2016, TOB CONTROL, V25, P341, DOI 10.1136/tobaccocontrol-2014-051978; O'Keefe DJ, 2003, COMMUN THEOR, V13, P251, DOI 10.1111/j.1468-2885.2003.tb00292.x; Peters E, 2007, NICOTINE TOB RES, V9, P473, DOI 10.1080/14622200701239639; Peters GJY, 2013, HEALTH PSYCHOL REV, V7, pS8, DOI 10.1080/17437199.2012.703527; Petty R. E., 1986, COMMUN PERSUATION; Quick BL, 2008, HUM COMMUN RES, V34, P448, DOI 10.1111/j.1468-2958.2008.00328.x; Quick BL, 2012, HEALTH COMMUN, V27, P1, DOI 10.1080/10410236.2011.567446; Quick BL, 2011, J HEALTH COMMUN, V16, P660, DOI 10.1080/10810730.2011.551989; Rains SA, 2007, HUM COMMUN RES, V33, P241, DOI 10.1111/j.1468-2958.2007.00298.x; Ruiter RAC, 2005, EUR J PUBLIC HEALTH, V15, P329, DOI 10.1093/eurpub/cki095; Shanahan P., 2001, EVALUATION OF THE HE; Slovic P, 2007, EUR J OPER RES, V177, P1333, DOI 10.1016/j.ejor.2005.04.006; Slovic P, 2006, CURR DIR PSYCHOL SCI, V15, P322, DOI 10.1111/j.1467-8721.2006.00461.x; Swayampakala K, 2015, HEALTH EDUC RES, V30, P35, DOI 10.1093/her/cyu022; Thrasher JF, 2015, NICOTINE TOB RES, V17, P870, DOI 10.1093/ntr/ntu246; Thrasher JF, 2010, SALUD PUBLICA MEXICO, V52, pS206, DOI 10.1590/S0036-36342010000800016; Thrasher JF, HLTH COMMUNICATION; Thrasher JF S K, CIGARETTE PACKAGE IN; WEGNER DM, 1994, PSYCHOL REV, V101, P34, DOI 10.1037/0033-295X.101.1.34; Wiium N, 2009, J APPL SOC PSYCHOL, V39, P1718, DOI 10.1111/j.1559-1816.2009.00501.x; WITTE K, 1992, COMMUN MONOGR, V59, P329, DOI 10.1080/03637759209376276; WITTE K, 1994, COMMUN MONOGR, V61, P113, DOI 10.1080/03637759409376328; World Health Organization, 2008, THIRD SESSION OF THE; Xu J, 2015, PSYCHOL HEALTH, V30, P423, DOI 10.1080/08870446.2014.977280; Yong HH, 2014, HEALTH PSYCHOL, V33, P1410, DOI 10.1037/hea0000056	48	74	75	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159245	10.1371/journal.pone.0159245	http://dx.doi.org/10.1371/journal.pone.0159245			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ9CP	26807740	Green Published, gold			2022-12-27	WOS:000379508300070
J	Perez-Cembranos, A; Leon, A; Perez-Mellado, V				Perez-Cembranos, Ana; Leon, Alicia; Perez-Mellado, Valentin			Omnivory of an Insular Lizard: Sources of Variation in the Diet of Podarcis lilfordi (Squamata, Lacertidae)	PLOS ONE			English	Article							PLANT CONSUMPTION; FEEDING ECOLOGY; DRY-WEIGHT; EVOLUTION; SELECTION; ENERGETICS; DIVERSITY; BIOMASS; LENGTH	Through 17 years and from a sample of 7,790 faecal pellets and 26,346 prey items, we studied the diet of the Balearic lizard Podarcis lilfordi in Aire Island (Menorca, Balearic Islands, Spain). We analysed the diet in terms of prey frequencies, as well as by their volume and biomass contributions. The diet of the Balearic lizard was extremely variable through the years, months and areas under study. The dominance of small clumped prey, particularly ants, was confirmed. However, the main contribution by volume corresponded to beetles, with a relevant role for Diplopoda and terrestrial Isopoda during some months and at particular areas of the island. Several prey items were probably captured at the base of shrubs, under stones or inside rock crevices. Therefore, our estimations of electivity would only be reliable for epigeal and flying prey. The capacity of the Balearic lizard to include marine subsidies in its diet, such as coastal crustaceans, is noteworthy. Also, its consumption of carrion from carcasses of gulls and rabbits and leftovers from human visitors is remarkable. Juvenile conspecifics can also be a sporadic food resource, especially during the second half of summer, whereas the consumption of vegetal matter is constant for each whole year. The shifts of vegetal exploitation among areas of the island and months take place according to availability of different plant species at each area or during a given period. Thus, lizards are able to conduct a thorough monitoring of plant phenology, exploiting a large variety of plant species. Omnivory does not imply the indiscriminate inclusion of any edible food in its diet. Rather, the inclusion of several food items means the adoption of a wide range of foraging behaviours adapted to the exploitation of each food resource.	[Perez-Cembranos, Ana; Leon, Alicia; Perez-Mellado, Valentin] Univ Salamanca, Dept Anim Biol, E-37008 Salamanca, Spain	University of Salamanca	Perez-Mellado, V (corresponding author), Univ Salamanca, Dept Anim Biol, E-37008 Salamanca, Spain.	valentin@usal.es	Carvalheiro, Roberto/I-2239-2013; Utsunomiya, Yuri Tani T/K-5214-2013; Carmo, Adriana S/E-4342-2016; Pérez-Cembranos, Ana/H-8542-2015; de Rezende Neves, Haroldo Henrique/F-9521-2012; León, Alicia/ABF-2086-2021; Carvalheiro, Roberto/AAG-2222-2020; MILANESI, Marco/P-7473-2015; Contreras-Castillo, Carmen Josefina/C-4696-2012; AJMONE MARSAN, Paolo/M-2466-2018	Carvalheiro, Roberto/0000-0002-4506-0555; Utsunomiya, Yuri Tani T/0000-0002-6526-8337; Carmo, Adriana S/0000-0002-2712-4789; Pérez-Cembranos, Ana/0000-0002-8296-2283; León, Alicia/0000-0001-5919-1858; Carvalheiro, Roberto/0000-0002-4506-0555; MILANESI, Marco/0000-0001-6244-7455; Contreras Castillo, Carmen Josefina/0000-0002-0554-4694; Solkner, Johann/0000-0002-1517-5829; AJMONE MARSAN, Paolo/0000-0003-3165-4579	Ministerio de Economia y Competitividad [CGL2012-39850-CO2-02]; FEDER funds from the European Union	Ministerio de Economia y Competitividad(Spanish Government); FEDER funds from the European Union(European Commission)	The study was funded by the research project CGL2012-39850-CO2-02 from the Spanish Ministry of Science and Innovation (currently: Ministerio de Economia y Competitividad) co-funded by FEDER funds from the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Angelici FM, 1997, ITAL J ZOOL, V64, P267, DOI 10.1080/11250009709356207; BAUMGARTNER LUTHER L., 1939, JOUR WILDLIFE MANAGEMENT, V3, P266, DOI 10.2307/3796113; BEST TL, 1984, J HERPETOL, V18, P291, DOI 10.2307/1564083; Bowles E, 2011, MOL ECOL RESOUR, V11, P530, DOI 10.1111/j.1755-0998.2010.02974.x; Boyer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075962; Bradley BJ, 2007, AM J PRIMATOL, V69, P699, DOI 10.1002/ajp.20384; BROWN RP, 1992, OECOLOGIA, V91, P500, DOI 10.1007/BF00650322; BROWN RP, 1994, FUNCT ECOL, V8, P427, DOI 10.2307/2390065; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; CALVER MC, 1982, AUST WILDLIFE RES, V9, P293; Canyelles X, 2003, INSECTES ILLES BALEA; Capizzi Dario, 1999, Herpetozoa, V11, P117; Castilla AM, 1996, COPEIA, P991, DOI 10.2307/1447663; CASTILLA AM, 1991, J HERPETOL, V25, P30, DOI 10.2307/1564791; Civantos E, 2013, AFR J HERPETOL, V62, P78, DOI 10.1080/21564574.2013.799101; COLLINS PT, 1992, AM MIDL NAT, V128, P404, DOI 10.2307/2426474; Cooper WE, 2002, J ZOOL, V257, P487, DOI 10.1017/S0952836902001085; Cronquist A., 1988, EVOLUTION CLASSIFICA; Diaz J.A., 1990, Donana Acta Vertebrata, V17, P67; Fialho RF, 2000, J HERPETOL, V34, P325, DOI 10.2307/1565437; Fish FE, 2007, J EXP BIOL, V210, P2811, DOI 10.1242/jeb.004267; Gillon Y, 1967, SECONDARY PRODUCTIVI, V2, P519; Hawlena D, 2009, OECOLOGIA, V161, P411, DOI 10.1007/s00442-009-1375-0; Herrel A, 2004, J EVOLUTION BIOL, V17, P974, DOI 10.1111/j.1420-9101.2004.00758.x; Herrel A, 2008, P NATL ACAD SCI USA, V105, P4792, DOI 10.1073/pnas.0711998105; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Hodar JA, 1996, ACTA OECOL, V17, P421; Hodar JA, 1997, MISC ZOOL, V20, P1; Ivlev V.S., 1961, EXPT ECOLOGY FEEDING; JACOBS J, 1974, OECOLOGIA, V14, P413, DOI 10.1007/BF00384581; Johnson MK, 1983, SAE831684 TECH PAP S, P1; Luiselli L, 2006, J TROP ECOL, V22, P91, DOI 10.1017/S0266467405002877; MacArthur R.H., 1967, THEORY ISLAND BIOGEO; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Magnusson WE, 2003, COPEIA, P13, DOI 10.1643/0045-8511(2003)003[0013:UOGFTE]2.0.CO;2; Magurran A.E., 2004, MEASURING BIOL DIVER; Maragou P., 1996, Herpetozoa, V9, P105; MARTIN J, 1993, OIKOS, V66, P318, DOI 10.2307/3544820; Mateo JA, ZOOL ANZ IN PRESS; Monti DM, 2013, BIOL J LINN SOC, V108, P144, DOI 10.1111/j.1095-8312.2012.02019.x; Moore P.D., 1991, BLACKWELL SCI PUBLI; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Ortmann Sylvia, 2006, P397; Ouboter MP, 1981, AMPHIB REPTIL, V2, P243; Pafilis P, 2009, NATURWISSENSCHAFTEN, V96, P1107, DOI 10.1007/s00114-009-0564-3; Pallmann P, 2012, MOL ECOL RESOUR, V12, P1068, DOI 10.1111/1755-0998.12004; Perera A, 2004, REV MENORCA, V86, P159; Perez-Cembranos A, 2015, SALAMANDRA, V51, P63; Perez-Cembranos A, 2015, ANIM COGN, V18, P629, DOI 10.1007/s10071-014-0831-3; Perez-Mellado V, HERPETOFAUNAS MEDITE; Perez-Mellado V., 1989, REV MENORCA, V80, P455; Perez-Mellado V., 1998, FAUNA IBERICA, P272; Perez-Mellado V., 2009, QUADERNS NATURA BALE; Perez-Mellado V., 2007, MAINLAND INSULAR LAC, P133; Perez-Mellado V, 2008, AMPHIBIA-REPTILIA, V29, P49, DOI 10.1163/156853808783431587; Perez-Mellado V, 2011, AMPHIBIA-REPTILIA, V32, P1, DOI 10.1163/017353710X530212; Perez-Mellado Valentin, 1993, Bonner Zoologische Beitraege, V44, P193; Pianka ER, 2003, WINDOWS EVOLUTION DI; POLIS GA, 1985, J HERPETOL, V19, P99, DOI 10.2307/1564425; Provenza Frederick D., 1993, P78; Punt W, 1980, NW EUROPEAN FLORA 2; Quayle A., 1983, British Journal of Herpetology, V6, P309; R Core Team, 2021, R LANGUAGE ENV STAT; Raia P, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-289; Roman P, 1971, TEJIDOS VEGETALES; SADEK RA, 1981, ZOOL J LINN SOC-LOND, V73, P313, DOI 10.1111/j.1096-3642.1981.tb01599.x; SAGE RD, 1982, AM MIDL NAT, V108, P407, DOI 10.2307/2425505; Sagonas K, 2014, BIOL J LINN SOC, V112, P469, DOI 10.1111/bij.12290; SALVADOR A., 1986, HDB REPTILIEN AMPHIB, P83; Scherer R., 2014, SIMBOOT SIMULTANEOUS; Stephens D.W., 1986, pi; Teerink B. J., 2003, HAIR W EUROPEAN MAMM; Valdes B., 1987, ATLAS POLINICO ANDAL; Van Damme R, 1999, J HERPETOL, V33, P663; VANDERPLOEG HA, 1979, ECOL MODEL, V7, P135, DOI 10.1016/0304-3800(79)90004-8; Westfall P.H., 1993, RESAMPLING BASED MUL, V279	77	42	42	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148947	10.1371/journal.pone.0148947	http://dx.doi.org/10.1371/journal.pone.0148947			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871439	Green Published, Green Submitted, gold			2022-12-27	WOS:000370054100078
J	Pereira, AGT; Utsunomiya, YT; Milanesi, M; Torrecilha, RBP; Carmo, AS; Neves, HHR; Carvalheiro, R; Ajmone-Marsan, P; Sonstegard, TS; Solkner, J; Contreras-Castillo, CJ; Garcia, JF				Pereira, Anirene G. T.; Utsunomiya, Yuri T.; Milanesi, Marco; Torrecilha, Rafaela B. P.; Carmo, Adriana S.; Neves, Haroldo H. R.; Carvalheiro, Roberto; Ajmone-Marsan, Paolo; Sonstegard, Tad S.; Solkner, Johann; Contreras-Castillo, Carmen J.; Garcia, Jose F.			Pleiotropic Genes Affecting Carcass Traits in Bos indicus (Nellore) Cattle Are Modulators of Growth	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; FACTOR-I CONCENTRATION; LINEAR MIXED MODELS; VISUAL SCORES; EXPRESSION; VARIANTS; ANGUS; PROOPIOMELANOCORTIN; MYOSTATIN; THICKNESS	Two complementary methods, namely Multi-Trait Meta-Analysis and Versatile Gene-Based Test for Genome-wide Association Studies (VEGAS), were used to identify putative pleiotropic genes affecting carcass traits in Bos indicus (Nellore) cattle. The genotypic data comprised over 777,000 single-nucleotide polymorphism markers scored in 995 bulls, and the phenotypic data included deregressed breeding values (dEBV) for weight measurements at birth, weaning and yearling, as well visual scores taken at weaning and yearling for carcass finishing precocity, conformation and muscling. Both analyses pointed to the pleomorphic adenoma gene 1 (PLAG1) as a major pleiotropic gene. VEGAS analysis revealed 224 additional candidates. From these, 57 participated, together with PLAG1, in a network involved in the modulation of the function and expression of IGF1 (insulin like growth factor 1), IGF2 (insulin like growth factor 2), GH1 (growth hormone 1), IGF1R (insulin like growth factor 1 receptor) and GHR (growth hormone receptor), suggesting that those pleiotropic genes operate as satellite regulators of the growth pathway.	[Pereira, Anirene G. T.; Contreras-Castillo, Carmen J.] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Dept Agroind Alimentos & Nutr, Piracicaba, Brazil; [Utsunomiya, Yuri T.; Torrecilha, Rafaela B. P.; Carmo, Adriana S.; Garcia, Jose F.] UNESP Univ Estadual Paulista, Dept Med Vet Prevent & Reprod Anim, Fac Ciencias Agr & Vet, Jaboticabal, SP, Brazil; [Milanesi, Marco; Garcia, Jose F.] UNESP Univ Estadual Paulista, Dept Apoio Prod & Saude Anim, Fac Med Vet & Aracatuba, Aracatuba, SP, Brazil; [Pereira, Anirene G. T.; Utsunomiya, Yuri T.; Milanesi, Marco; Torrecilha, Rafaela B. P.; Carmo, Adriana S.; Garcia, Jose F.] IAEA, Collaborating Ctr Anim Genom & Bioinformat, Aracatuba, SP, Brazil; [Neves, Haroldo H. R.] GenSys Consultores Assoc, Porto Alegre, RS, Brazil; [Carvalheiro, Roberto] UNESP Univ Estadual Paulista, Dept Zootecnia, Fac Ciencias Agr & Vet, Jaboticabal, SP, Brazil; [Ajmone-Marsan, Paolo] Univ Cattolica Sacro Cuore, Piacenza, Italy; [Sonstegard, Tad S.] Recombinetics Inc, St Paul, MN USA; [Solkner, Johann] BOKU Univ Nat Resources & Life Sci, Dept Sustainable Agr Syst, Div Livestock Sci, Vienna, Austria	Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista; Catholic University of the Sacred Heart; University of Natural Resources & Life Sciences, Vienna	Garcia, JF (corresponding author), UNESP Univ Estadual Paulista, Dept Med Vet Prevent & Reprod Anim, Fac Ciencias Agr & Vet, Jaboticabal, SP, Brazil.; Garcia, JF (corresponding author), UNESP Univ Estadual Paulista, Dept Apoio Prod & Saude Anim, Fac Med Vet & Aracatuba, Aracatuba, SP, Brazil.; Garcia, JF (corresponding author), IAEA, Collaborating Ctr Anim Genom & Bioinformat, Aracatuba, SP, Brazil.	jfgarcia@fmva.unesp.br	Carvalheiro, Roberto/I-2239-2013; Utsunomiya, Yuri Tani T/K-5214-2013; Carmo, Adriana S/E-4342-2016; Pérez-Cembranos, Ana/H-8542-2015; de Rezende Neves, Haroldo Henrique/F-9521-2012; León, Alicia/ABF-2086-2021; Carvalheiro, Roberto/AAG-2222-2020; MILANESI, Marco/P-7473-2015; Contreras-Castillo, Carmen Josefina/C-4696-2012; AJMONE MARSAN, Paolo/M-2466-2018	Carvalheiro, Roberto/0000-0002-4506-0555; Utsunomiya, Yuri Tani T/0000-0002-6526-8337; Carmo, Adriana S/0000-0002-2712-4789; Pérez-Cembranos, Ana/0000-0002-8296-2283; León, Alicia/0000-0001-5919-1858; Carvalheiro, Roberto/0000-0002-4506-0555; MILANESI, Marco/0000-0001-6244-7455; Contreras Castillo, Carmen Josefina/0000-0002-0554-4694; Solkner, Johann/0000-0002-1517-5829; AJMONE MARSAN, Paolo/0000-0003-3165-4579	National Counsel of Technological and Scientific Development (CNPq) [560922/2010-8, 483590/2010-0]; Sao Paulo Research Foundation (FAPESP) [2014/01095-8, 2013/02552-0]; Gensys Consultores Associados; Recombinetics, Inc	National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Gensys Consultores Associados; Recombinetics, Inc	This research was supported by: National Counsel of Technological and Scientific Development (CNPq-http://www.cnpq.br/) (process 560922/2010-8 and 483590/2010-0); and Sao Paulo Research Foundation (FAPESP-http://www.fapesp.br/) (process 2014/01095-8 and 2013/02552-0). Gensys Consultores Associados and Recombinetics, Inc provided support in the form of salaries for authors HHRN and TSS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adoligbe C, 2012, MOL BIOL REP, V39, P4067, DOI 10.1007/s11033-011-1188-1; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Amin N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001274; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bogdanovich S, 2008, MUSCLE NERVE, V37, P308, DOI 10.1002/mus.20920; Boligon AA, 2011, LIVEST SCI, V135, P238, DOI 10.1016/j.livsci.2010.07.011; Bolormaa S, 2011, J ANIM SCI, V89, P2297, DOI 10.2527/jas.2010-3138; Bolormaa S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004198; Bragdon B, 2011, CELL SIGNAL, V23, P609, DOI 10.1016/j.cellsig.2010.10.003; Cancian PH, 2014, SCI AGR, V71, P17, DOI 10.1590/S0103-90162014000100002; Cao JX, 2015, SCI REP-UK, V5, DOI 10.1038/srep13950; Capomaccio S, 2015, BIOINFORMATICS, V31, P2380, DOI 10.1093/bioinformatics/btv144; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chen L, 2005, FRONT BIOSCI-LANDMRK, V10, P1961, DOI 10.2741/1671; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Davis ME, 2003, J ANIM SCI, V81, P2164; Davis ME, 1997, J ANIM SCI, V75, P317; DeAtley KL, 2011, J ANIM SCI, V89, P2031, DOI 10.2527/jas.2010-3293; Eppig JT, 2015, NUCLEIC ACIDS RES, V43, pD726, DOI 10.1093/nar/gku967; Fortes M, 2013, EVIDENCE PLEIOTROPIS; Fortes M, 2012, BIOL; Fortes MRS, 2013, ANDROLOGY-US, V1, P644, DOI 10.1111/j.2047-2927.2013.00101.x; Fortes MRS, 2012, ANIM PROD SCI, V52, P143, DOI 10.1071/AN11165; Garrick DJ, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-17; Garrick DJ, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-55; Hartati H, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0229-5; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Karim L, 2011, NAT GENET, V43, P405, DOI 10.1038/ng.814; Keady SM, 2013, J ANIM SCI, V91, P654, DOI 10.2527/jas.2012-5850; Lindholm-Perry AK, 2012, ANIM GENET, V43, P216, DOI 10.1111/j.1365-2052.2011.02232.x; Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/nmeth.1681, 10.1038/NMETH.1681]; Listgarten J, 2012, NAT METHODS, V9, P525, DOI 10.1038/nmeth.2037; Littlejohn M, 2012, GENETIC VARIATION PL; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; McPherron Alexandra C., 2010, Immunology Endocrine & Metabolic Agents in Medicinal Chemistry, V10, P217; Neto LRP, 2012, ANIM GENET, V43, P785, DOI 10.1111/j.1365-2052.2012.02330.x; Neves HHR, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-17; Nishimura S, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-40; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rimbault M, 2013, GENOME RES, V23, P1985, DOI 10.1101/gr.157339.113; Ronnegrard L, 2010, HGLM PACKAGE FITTING, V2; ROSIE R, 1992, J NEUROENDOCRINOL, V4, P625, DOI 10.1111/j.1365-2826.1992.tb00212.x; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Taylor JA, 2007, BIOL REPROD, V76, P524, DOI 10.1095/biolreprod.106.055533; Taylor JF, 2014, AQUACULTURE, V420, pS8, DOI 10.1016/j.aquaculture.2013.02.017; Utsunomiya YT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088561; Utsunomiya YT, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-52; Velazquez MA, 2008, DOMEST ANIM ENDOCRIN, V35, P325, DOI 10.1016/j.domaniend.2008.07.002; Versteyhe Soetkin, 2013, Front Endocrinol (Lausanne), V4, P98, DOI 10.3389/fendo.2013.00098; Voz ML, 2000, CANCER RES, V60, P106; Xu Z Y, 2010, Animal, V4, P1541, DOI 10.1017/S1751731110000649; Xue M, 2011, INDIAN J ANIMAL SCI; Yang J, 2014, NAT GENET, V46, P100, DOI 10.1038/ng.2876; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011	55	42	42	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158165	10.1371/journal.pone.0158165	http://dx.doi.org/10.1371/journal.pone.0158165			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	26871439	gold, Green Published, Green Submitted			2022-12-27	WOS:000379508300019
